From 3b4af21abf1530c8620f5602d9f4a9ad569fc5b6 Mon Sep 17 00:00:00 2001 From: "vladimir.buzalka" Date: Fri, 29 May 2026 13:37:54 +0200 Subject: [PATCH] z230 --- ...45-12 77242113UCO3001 Clario MayoScore.csv | 39 + ...48-14 77242113UCO3001 Clario MayoDiary.csv | 1116 ++++++++ Clario/create_report_v1.4.py | 447 +++ ...sponsor-study-35472-samples-allSamples.csv | 1189 ++++++++ ...sponsor-study-35472-samples-allSamples.csv | 1189 ++++++++ ...sponsor-study-36940-samples-allSamples.csv | 1445 ++++++++++ ...sponsor-study-36940-samples-allSamples.csv | 1445 ++++++++++ ...36940-kit-inventory-on-hand-expiration.csv | 544 ++++ ...35472-kit-inventory-on-hand-expiration.csv | 285 ++ ...6940-activity-reports-documents-equery.csv | 75 + ...orts-documents-equery_unresponded_only.csv | 9 + ...udy-36940-test-results-930556-standard.csv | 75 + ...36940-test-results-930556-microbiology.csv | 3 + ...udy-36940-test-results-930525-standard.csv | 709 +++++ ...36940-test-results-930525-microbiology.csv | 6 + ...udy-36940-test-results-930549-standard.csv | 242 ++ ...36940-test-results-930549-microbiology.csv | 3 + ...udy-36940-test-results-930547-standard.csv | 500 ++++ ...36940-test-results-930547-microbiology.csv | 5 + ...udy-36940-test-results-930555-standard.csv | 409 +++ ...36940-test-results-930555-microbiology.csv | 6 + ...udy-36940-test-results-930557-standard.csv | 738 +++++ ...36940-test-results-930557-microbiology.csv | 6 + ...udy-36940-test-results-930539-standard.csv | 178 ++ ...36940-test-results-930539-microbiology.csv | 5 + ...udy-36940-test-results-930536-standard.csv | 127 + ...36940-test-results-930536-microbiology.csv | 3 + ...udy-36940-test-results-930553-standard.csv | 250 ++ ...36940-test-results-930553-microbiology.csv | 4 + ...udy-36940-test-results-930531-standard.csv | 243 ++ ...36940-test-results-930531-microbiology.csv | 3 + ...udy-35472-test-results-898745-standard.csv | 2448 +++++++++++++++++ .../Trash/download_test_results_v1.0.md | 238 ++ .../Trash/download_test_results_v1.0.py | 173 ++ .../Trash/download_test_results_v1.1.md | 231 ++ .../Trash/download_test_results_v1.1.py | 175 ++ .../browser_profile/BrowserMetrics-spare.pma | Bin 0 -> 4194304 bytes .../BrowserMetrics-6A19775F-5F30.pma | Bin 0 -> 4194304 bytes .../Default/Code Cache/js/0465d9acc1a21553_0 | Bin 0 -> 19000 bytes .../Default/Code Cache/js/07b02d729043e4bd_0 | Bin 0 -> 35312 bytes .../Default/Code Cache/js/082f498d82700fe3_0 | Bin 0 -> 19196 bytes .../Default/Code Cache/js/0b065879d458fa45_0 | Bin 0 -> 37912 bytes .../Default/Code Cache/js/0b329f0690cc9919_0 | Bin 0 -> 19480 bytes .../Default/Code Cache/js/0d4f51af893eb12f_0 | Bin 0 -> 18848 bytes .../Default/Code Cache/js/0dc87fae525b08c8_0 | Bin 0 -> 19196 bytes .../Default/Code Cache/js/0f31eb2365dfe72d_0 | Bin 0 -> 112688 bytes .../Default/Code Cache/js/0fa6e70e2ab6a198_0 | Bin 0 -> 29784 bytes .../Default/Code Cache/js/18d297792139a046_0 | Bin 0 -> 36520 bytes .../Default/Code Cache/js/19c0eee8cc47130e_0 | Bin 0 -> 30120 bytes .../Default/Code Cache/js/1a279d08513eac43_0 | Bin 0 -> 32760 bytes .../Default/Code Cache/js/1b59a768a7115c35_0 | Bin 0 -> 19196 bytes .../Default/Code Cache/js/1c3076e9c36ae0ad_0 | Bin 0 -> 32764 bytes .../Default/Code Cache/js/1e6b027ee9da702d_0 | Bin 0 -> 18796 bytes .../Default/Code Cache/js/1fd8922b7d038339_0 | Bin 0 -> 112808 bytes .../Default/Code Cache/js/21189d04c7818af7_0 | Bin 0 -> 55312 bytes .../Default/Code Cache/js/21e096c84ea13d9f_0 | Bin 0 -> 35560 bytes .../Default/Code Cache/js/2780e74491497cf0_0 | Bin 0 -> 31820 bytes .../Default/Code Cache/js/27cfbae9a082b5dd_0 | Bin 0 -> 19300 bytes .../Default/Code Cache/js/28102b08922e7bad_0 | Bin 0 -> 31332 bytes .../Default/Code Cache/js/2a2e2a437c07633b_0 | Bin 0 -> 36588 bytes .../Default/Code Cache/js/2b7ee25e23fcf372_0 | Bin 0 -> 37312 bytes .../Default/Code Cache/js/2e1b14b0cd01ab91_0 | Bin 0 -> 18392 bytes .../Default/Code Cache/js/304b381fcd40a260_0 | Bin 0 -> 18180 bytes .../Default/Code Cache/js/30f38219c225b80b_0 | Bin 0 -> 18180 bytes .../Default/Code Cache/js/315acd0d601e7899_0 | Bin 0 -> 31328 bytes .../Default/Code Cache/js/3346dd9501715af1_0 | Bin 0 -> 19196 bytes .../Default/Code Cache/js/342ceaa67adf2fbc_0 | Bin 0 -> 18776 bytes .../Default/Code Cache/js/353b980a5a9bd095_0 | Bin 0 -> 35328 bytes .../Default/Code Cache/js/3624cc1d0b168fa0_0 | Bin 0 -> 29784 bytes .../Default/Code Cache/js/3841c3e6c0548cd6_0 | Bin 0 -> 31396 bytes .../Default/Code Cache/js/3aa64af6159320d2_0 | Bin 0 -> 29784 bytes .../Default/Code Cache/js/3e552927c58d6b47_0 | Bin 0 -> 35316 bytes .../Default/Code Cache/js/3ee3150cbeaada59_0 | Bin 0 -> 18848 bytes .../Default/Code Cache/js/41050c8a4ec7148d_0 | Bin 0 -> 30692 bytes .../Default/Code Cache/js/4111e3345894e2e7_0 | Bin 0 -> 112424 bytes .../Default/Code Cache/js/42c13fe32396384e_0 | Bin 0 -> 18392 bytes .../Default/Code Cache/js/476a34567a9b24be_0 | Bin 0 -> 19196 bytes .../Default/Code Cache/js/48678032a5ccbd55_0 | Bin 0 -> 18392 bytes .../Default/Code Cache/js/48bb55e57c2fb30b_0 | Bin 0 -> 19500 bytes .../Default/Code Cache/js/4aa8bc80dd2db1e9_0 | Bin 0 -> 18180 bytes .../Default/Code Cache/js/4ae4d0b80121230e_0 | Bin 0 -> 36508 bytes .../Default/Code Cache/js/4f902d7ec0702ae9_0 | Bin 0 -> 18180 bytes .../Default/Code Cache/js/50a7cabdcc5f455c_0 | Bin 0 -> 19880 bytes .../Default/Code Cache/js/525f78d1464d97d5_0 | Bin 0 -> 36520 bytes .../Default/Code Cache/js/572c553ca7bc2439_0 | Bin 0 -> 30692 bytes .../Default/Code Cache/js/5c63a9af1b40b5a2_0 | Bin 0 -> 29784 bytes .../Default/Code Cache/js/5e3a19986c7641f2_0 | Bin 0 -> 31700 bytes .../Default/Code Cache/js/5ed57338c01e48dc_0 | Bin 0 -> 54504 bytes .../Default/Code Cache/js/5f00a5204e963cbb_0 | Bin 0 -> 35088 bytes .../Default/Code Cache/js/6075af960f008f21_0 | Bin 0 -> 18392 bytes .../Default/Code Cache/js/61108a49fee20cc1_0 | Bin 0 -> 35328 bytes .../Default/Code Cache/js/6732b54872fb71f2_0 | Bin 0 -> 18180 bytes .../Default/Code Cache/js/67b10b60301b03bf_0 | Bin 0 -> 18392 bytes .../Default/Code Cache/js/686121a6d196d5c0_0 | Bin 0 -> 19480 bytes .../Default/Code Cache/js/688bd1bfd07ba01a_0 | Bin 0 -> 18392 bytes .../Default/Code Cache/js/6e639c3d8c1c4a41_0 | Bin 0 -> 29784 bytes .../Default/Code Cache/js/6ed4b3b7ebdc670c_0 | Bin 0 -> 35316 bytes .../Default/Code Cache/js/6f4bfbe45f59345f_0 | Bin 0 -> 112688 bytes .../Default/Code Cache/js/7031e56fff3ebe90_0 | Bin 0 -> 19500 bytes .../Default/Code Cache/js/730a3c7b58f66a3a_0 | Bin 0 -> 49644 bytes .../Default/Code Cache/js/74d9a4b736ddd0a0_0 | Bin 0 -> 18180 bytes .../Default/Code Cache/js/7739bc48798c54f2_0 | Bin 0 -> 18392 bytes .../Default/Code Cache/js/78a873f4bc55d731_0 | Bin 0 -> 18180 bytes .../Default/Code Cache/js/791888f65ff62ec6_0 | Bin 0 -> 25096 bytes .../Default/Code Cache/js/791aa115f3631fe8_0 | Bin 0 -> 19084 bytes .../Default/Code Cache/js/793aab6913f01a4f_0 | Bin 0 -> 37644 bytes .../Default/Code Cache/js/7effe013c1380bd5_0 | Bin 0 -> 32740 bytes .../Default/Code Cache/js/8436ca4f5a3ce2f0_0 | Bin 0 -> 112424 bytes .../Default/Code Cache/js/86cf8b04d7f57e3c_0 | Bin 0 -> 35328 bytes .../Default/Code Cache/js/8a5dc2f9a114d343_0 | Bin 0 -> 29784 bytes .../Default/Code Cache/js/8b48c4906cede63a_0 | Bin 0 -> 35328 bytes .../Default/Code Cache/js/8cdae8265292de87_0 | Bin 0 -> 19196 bytes .../Default/Code Cache/js/9284633925dfe1e5_0 | Bin 0 -> 18392 bytes .../Default/Code Cache/js/98d7490707cbe557_0 | Bin 0 -> 31396 bytes .../Default/Code Cache/js/9a12693d3ccceca2_0 | Bin 0 -> 30688 bytes .../Default/Code Cache/js/9a576501480809c4_0 | Bin 0 -> 35440 bytes .../Default/Code Cache/js/9baa44924f50ef34_0 | Bin 0 -> 30740 bytes .../Default/Code Cache/js/9f283a3857533970_0 | Bin 0 -> 29784 bytes .../Default/Code Cache/js/a1517030f941f571_0 | Bin 0 -> 19500 bytes .../Default/Code Cache/js/a31f06830d0f8e47_0 | Bin 0 -> 18756 bytes .../Default/Code Cache/js/a4b06fa95a05fb7c_0 | Bin 0 -> 18848 bytes .../Default/Code Cache/js/a4c97f5fe7471d71_0 | Bin 0 -> 37440 bytes .../Default/Code Cache/js/a614f443718b7f31_0 | Bin 0 -> 112808 bytes .../Default/Code Cache/js/a62292e53f44be7e_0 | Bin 0 -> 19876 bytes .../Default/Code Cache/js/a6b07292f7657006_0 | Bin 0 -> 29784 bytes .../Default/Code Cache/js/a9f29da372a7a60a_0 | Bin 0 -> 18796 bytes .../Default/Code Cache/js/ab5a562e4d1011e2_0 | Bin 0 -> 29784 bytes .../Default/Code Cache/js/ac5ccfdd8a571540_0 | Bin 0 -> 29784 bytes .../Default/Code Cache/js/b09acd6bdaf74c5e_0 | Bin 0 -> 30732 bytes .../Default/Code Cache/js/b52c57f04bd32b2b_0 | Bin 0 -> 19488 bytes .../Default/Code Cache/js/b5368cd7955bccda_0 | Bin 0 -> 18180 bytes .../Default/Code Cache/js/b69574d14f3d5791_0 | Bin 0 -> 31396 bytes .../Default/Code Cache/js/b87d7f91a41334e8_0 | Bin 0 -> 31396 bytes .../Default/Code Cache/js/beb4c6366873570d_0 | Bin 0 -> 30732 bytes .../Default/Code Cache/js/bf7b79d29c342216_0 | Bin 0 -> 30692 bytes .../Default/Code Cache/js/c024c5ba9cfa635b_0 | Bin 0 -> 18392 bytes .../Default/Code Cache/js/c18b6a7c9aa7ae99_0 | Bin 0 -> 18392 bytes .../Default/Code Cache/js/c3f5c80634380f0c_0 | Bin 0 -> 32760 bytes .../Default/Code Cache/js/c4e8c7bab680f94a_0 | Bin 0 -> 19880 bytes .../Default/Code Cache/js/c50a6e0dbeab8e3f_0 | Bin 0 -> 54196 bytes .../Default/Code Cache/js/c71b380c4b70f8ac_0 | Bin 0 -> 18180 bytes .../Default/Code Cache/js/c7be3a8c7eabb311_0 | Bin 0 -> 112176 bytes .../Default/Code Cache/js/c9ff56ffbb7c3caf_0 | Bin 0 -> 54364 bytes .../Default/Code Cache/js/cabc06c4dcb6ba5e_0 | Bin 0 -> 18180 bytes .../Default/Code Cache/js/d0dd689fe1dab53d_0 | Bin 0 -> 30688 bytes .../Default/Code Cache/js/d33705d7d6c5fb22_0 | Bin 0 -> 18180 bytes .../Default/Code Cache/js/d559c24ae551e83c_0 | Bin 0 -> 19580 bytes .../Default/Code Cache/js/d5716c7e742ccab9_0 | Bin 0 -> 22832 bytes .../Default/Code Cache/js/d600489b718f625a_0 | Bin 0 -> 33892 bytes .../Default/Code Cache/js/d6d8083dbe1cd04c_0 | Bin 0 -> 35308 bytes .../Default/Code Cache/js/dbc2ff8f783b295e_0 | Bin 0 -> 31704 bytes .../Default/Code Cache/js/dbf6472577be38c2_0 | Bin 0 -> 18952 bytes .../Default/Code Cache/js/de07bea43667f00f_0 | Bin 0 -> 18228 bytes .../Default/Code Cache/js/de6be16d5969cebe_0 | Bin 0 -> 18796 bytes .../Default/Code Cache/js/e33309146194cf23_0 | Bin 0 -> 31664 bytes .../Default/Code Cache/js/e65226a48c996ab6_0 | Bin 0 -> 18848 bytes .../Default/Code Cache/js/e6c127bcc91f8806_0 | Bin 0 -> 35428 bytes .../Default/Code Cache/js/eef04da1cbf63454_0 | Bin 0 -> 18796 bytes .../Default/Code Cache/js/f30da3af09b26a53_0 | Bin 0 -> 18180 bytes .../Default/Code Cache/js/f6a3553b06c656c8_0 | Bin 0 -> 19880 bytes .../Default/Code Cache/js/f81a383884374bbb_0 | Bin 0 -> 29784 bytes .../Default/Code Cache/js/fb52b26ded5d847a_0 | Bin 0 -> 112808 bytes .../Default/Code Cache/js/fb59ae8f8e899517_0 | Bin 0 -> 39704 bytes .../Default/Code Cache/js/fc8871494fc2f3fe_0 | Bin 0 -> 31704 bytes .../Default/Code Cache/js/fd9f0532ac8c16f4_0 | Bin 0 -> 30732 bytes .../Default/Code Cache/js/fdaa363fef51f5c7_0 | Bin 0 -> 30732 bytes .../Default/Code Cache/js/fdd553b700166849_0 | Bin 0 -> 19196 bytes .../Default/Code Cache/js/fddbf0734c546849_0 | Bin 0 -> 29784 bytes .../Default/Code Cache/js/fddea2ae13831ac8_0 | Bin 0 -> 112688 bytes .../Default/Local Storage/leveldb/000162.ldb | Bin 0 -> 30021 bytes .../Default/Local Storage/leveldb/000164.log | Bin 0 -> 2682 bytes .../Default/Local Storage/leveldb/000165.ldb | Bin 0 -> 20511 bytes .../48942083-9fab-48af-8e92-6872acc200bf.tmp | 1 + .../55ad07c4-b281-4cb7-8a2c-a3c56d21f4ef.tmp | 1 + .../71a2d6a8-3908-4c40-877d-7b598def6aad.tmp | 1 + .../be7cf1cb-2675-417c-8230-da3b29e33fef.tmp | 1 + .../Default/Session Storage/000007.log | Bin 0 -> 50432 bytes .../Default/Session Storage/000008.ldb | Bin 0 -> 20314 bytes .../Sessions/Session_13424527059825092 | Bin 0 -> 39544 bytes .../Sessions/Session_13424527458527069 | Bin 0 -> 155802 bytes .../Default/Sessions/Tabs_13424527060091353 | Bin 0 -> 639190 bytes .../Default/Sessions/Tabs_13424527458837129 | Bin 0 -> 640282 bytes Covance_UCO3001/create_report_v2.0.py | 530 ++++ Covance_UCO3001/download_test_results_v1.2.md | 233 ++ Covance_UCO3001/download_test_results_v1.2.py | 199 ++ .../run_test_results_parallel_v1.0.py | 54 + EmailsImport/DockerCustomApp/app.md | 63 + 187 files changed, 15646 insertions(+) create mode 100644 Clario/Downloads/Zpracovano/2026-05-29_08-45-12 77242113UCO3001 Clario MayoScore.csv create mode 100644 Clario/Downloads/Zpracovano/2026-05-29_08-48-14 77242113UCO3001 Clario MayoDiary.csv create mode 100644 Clario/create_report_v1.4.py create mode 100644 Covance_MDD3003/Source/2026-05-29_100908 sponsor-study-35472-samples-allSamples.csv create mode 100644 Covance_MDD3003/Source/2026-05-29_111722 sponsor-study-35472-samples-allSamples.csv create mode 100644 Covance_UCO3001/Source/2026-05-29_100908 sponsor-study-36940-samples-allSamples.csv create mode 100644 Covance_UCO3001/Source/2026-05-29_111722 sponsor-study-36940-samples-allSamples.csv create mode 100644 Covance_UCO3001/Source/2026-05-29_112154 sponsor-study-36940-kit-inventory-on-hand-expiration.csv create mode 100644 Covance_UCO3001/Source/2026-05-29_112211 sponsor-study-35472-kit-inventory-on-hand-expiration.csv create mode 100644 Covance_UCO3001/Source/2026-05-29_112244 sponsor-study-36940-activity-reports-documents-equery.csv create mode 100644 Covance_UCO3001/Source/2026-05-29_112244 sponsor-study-36940-activity-reports-documents-equery_unresponded_only.csv create mode 100644 Covance_UCO3001/Source/2026-05-29_132515 sponsor-study-36940-test-results-930556-standard.csv create mode 100644 Covance_UCO3001/Source/2026-05-29_132533 sponsor-study-36940-test-results-930556-microbiology.csv create mode 100644 Covance_UCO3001/Source/2026-05-29_132552 sponsor-study-36940-test-results-930525-standard.csv create mode 100644 Covance_UCO3001/Source/2026-05-29_132609 sponsor-study-36940-test-results-930525-microbiology.csv create mode 100644 Covance_UCO3001/Source/2026-05-29_132636 sponsor-study-36940-test-results-930549-standard.csv create mode 100644 Covance_UCO3001/Source/2026-05-29_132657 sponsor-study-36940-test-results-930549-microbiology.csv create mode 100644 Covance_UCO3001/Source/2026-05-29_132740 sponsor-study-36940-test-results-930547-standard.csv create mode 100644 Covance_UCO3001/Source/2026-05-29_132758 sponsor-study-36940-test-results-930547-microbiology.csv create mode 100644 Covance_UCO3001/Source/2026-05-29_132820 sponsor-study-36940-test-results-930555-standard.csv create mode 100644 Covance_UCO3001/Source/2026-05-29_132838 sponsor-study-36940-test-results-930555-microbiology.csv create mode 100644 Covance_UCO3001/Source/2026-05-29_132901 sponsor-study-36940-test-results-930557-standard.csv create mode 100644 Covance_UCO3001/Source/2026-05-29_132918 sponsor-study-36940-test-results-930557-microbiology.csv create mode 100644 Covance_UCO3001/Source/2026-05-29_132944 sponsor-study-36940-test-results-930539-standard.csv create mode 100644 Covance_UCO3001/Source/2026-05-29_133002 sponsor-study-36940-test-results-930539-microbiology.csv create mode 100644 Covance_UCO3001/Source/2026-05-29_133022 sponsor-study-36940-test-results-930536-standard.csv create mode 100644 Covance_UCO3001/Source/2026-05-29_133047 sponsor-study-36940-test-results-930536-microbiology.csv create mode 100644 Covance_UCO3001/Source/2026-05-29_133105 sponsor-study-36940-test-results-930553-standard.csv create mode 100644 Covance_UCO3001/Source/2026-05-29_133123 sponsor-study-36940-test-results-930553-microbiology.csv create mode 100644 Covance_UCO3001/Source/2026-05-29_133151 sponsor-study-36940-test-results-930531-standard.csv create mode 100644 Covance_UCO3001/Source/2026-05-29_133208 sponsor-study-36940-test-results-930531-microbiology.csv create mode 100644 Covance_UCO3001/Source/2026-05-29_133237 sponsor-study-35472-test-results-898745-standard.csv create mode 100644 Covance_UCO3001/Trash/download_test_results_v1.0.md create mode 100644 Covance_UCO3001/Trash/download_test_results_v1.0.py create mode 100644 Covance_UCO3001/Trash/download_test_results_v1.1.md create mode 100644 Covance_UCO3001/Trash/download_test_results_v1.1.py create mode 100644 Covance_UCO3001/browser_profile/BrowserMetrics-spare.pma create mode 100644 Covance_UCO3001/browser_profile/BrowserMetrics/BrowserMetrics-6A19775F-5F30.pma create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/0465d9acc1a21553_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/07b02d729043e4bd_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/082f498d82700fe3_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/0b065879d458fa45_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/0b329f0690cc9919_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/0d4f51af893eb12f_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/0dc87fae525b08c8_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/0f31eb2365dfe72d_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/0fa6e70e2ab6a198_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/18d297792139a046_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/19c0eee8cc47130e_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/1a279d08513eac43_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/1b59a768a7115c35_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/1c3076e9c36ae0ad_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/1e6b027ee9da702d_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/1fd8922b7d038339_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/21189d04c7818af7_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/21e096c84ea13d9f_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/2780e74491497cf0_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/27cfbae9a082b5dd_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/28102b08922e7bad_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/2a2e2a437c07633b_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/2b7ee25e23fcf372_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/2e1b14b0cd01ab91_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/304b381fcd40a260_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/30f38219c225b80b_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/315acd0d601e7899_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/3346dd9501715af1_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/342ceaa67adf2fbc_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/353b980a5a9bd095_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/3624cc1d0b168fa0_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/3841c3e6c0548cd6_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/3aa64af6159320d2_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/3e552927c58d6b47_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/3ee3150cbeaada59_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/41050c8a4ec7148d_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/4111e3345894e2e7_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/42c13fe32396384e_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/476a34567a9b24be_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/48678032a5ccbd55_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/48bb55e57c2fb30b_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/4aa8bc80dd2db1e9_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/4ae4d0b80121230e_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/4f902d7ec0702ae9_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/50a7cabdcc5f455c_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/525f78d1464d97d5_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/572c553ca7bc2439_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/5c63a9af1b40b5a2_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/5e3a19986c7641f2_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/5ed57338c01e48dc_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/5f00a5204e963cbb_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/6075af960f008f21_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/61108a49fee20cc1_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/6732b54872fb71f2_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/67b10b60301b03bf_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/686121a6d196d5c0_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/688bd1bfd07ba01a_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/6e639c3d8c1c4a41_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/6ed4b3b7ebdc670c_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/6f4bfbe45f59345f_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/7031e56fff3ebe90_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/730a3c7b58f66a3a_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/74d9a4b736ddd0a0_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/7739bc48798c54f2_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/78a873f4bc55d731_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/791888f65ff62ec6_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/791aa115f3631fe8_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/793aab6913f01a4f_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/7effe013c1380bd5_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/8436ca4f5a3ce2f0_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/86cf8b04d7f57e3c_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/8a5dc2f9a114d343_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/8b48c4906cede63a_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/8cdae8265292de87_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/9284633925dfe1e5_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/98d7490707cbe557_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/9a12693d3ccceca2_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/9a576501480809c4_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/9baa44924f50ef34_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/9f283a3857533970_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/a1517030f941f571_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/a31f06830d0f8e47_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/a4b06fa95a05fb7c_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/a4c97f5fe7471d71_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/a614f443718b7f31_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/a62292e53f44be7e_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/a6b07292f7657006_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/a9f29da372a7a60a_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/ab5a562e4d1011e2_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/ac5ccfdd8a571540_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/b09acd6bdaf74c5e_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/b52c57f04bd32b2b_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/b5368cd7955bccda_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/b69574d14f3d5791_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/b87d7f91a41334e8_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/beb4c6366873570d_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/bf7b79d29c342216_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/c024c5ba9cfa635b_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/c18b6a7c9aa7ae99_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/c3f5c80634380f0c_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/c4e8c7bab680f94a_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/c50a6e0dbeab8e3f_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/c71b380c4b70f8ac_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/c7be3a8c7eabb311_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/c9ff56ffbb7c3caf_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/cabc06c4dcb6ba5e_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/d0dd689fe1dab53d_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/d33705d7d6c5fb22_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/d559c24ae551e83c_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/d5716c7e742ccab9_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/d600489b718f625a_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/d6d8083dbe1cd04c_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/dbc2ff8f783b295e_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/dbf6472577be38c2_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/de07bea43667f00f_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/de6be16d5969cebe_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/e33309146194cf23_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/e65226a48c996ab6_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/e6c127bcc91f8806_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/eef04da1cbf63454_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/f30da3af09b26a53_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/f6a3553b06c656c8_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/f81a383884374bbb_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/fb52b26ded5d847a_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/fb59ae8f8e899517_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/fc8871494fc2f3fe_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/fd9f0532ac8c16f4_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/fdaa363fef51f5c7_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/fdd553b700166849_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/fddbf0734c546849_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Code Cache/js/fddea2ae13831ac8_0 create mode 100644 Covance_UCO3001/browser_profile/Default/Local Storage/leveldb/000162.ldb create mode 100644 Covance_UCO3001/browser_profile/Default/Local Storage/leveldb/000164.log create mode 100644 Covance_UCO3001/browser_profile/Default/Local Storage/leveldb/000165.ldb create mode 100644 Covance_UCO3001/browser_profile/Default/Network/48942083-9fab-48af-8e92-6872acc200bf.tmp create mode 100644 Covance_UCO3001/browser_profile/Default/Network/55ad07c4-b281-4cb7-8a2c-a3c56d21f4ef.tmp create mode 100644 Covance_UCO3001/browser_profile/Default/Network/71a2d6a8-3908-4c40-877d-7b598def6aad.tmp create mode 100644 Covance_UCO3001/browser_profile/Default/Network/be7cf1cb-2675-417c-8230-da3b29e33fef.tmp create mode 100644 Covance_UCO3001/browser_profile/Default/Session Storage/000007.log create mode 100644 Covance_UCO3001/browser_profile/Default/Session Storage/000008.ldb create mode 100644 Covance_UCO3001/browser_profile/Default/Sessions/Session_13424527059825092 create mode 100644 Covance_UCO3001/browser_profile/Default/Sessions/Session_13424527458527069 create mode 100644 Covance_UCO3001/browser_profile/Default/Sessions/Tabs_13424527060091353 create mode 100644 Covance_UCO3001/browser_profile/Default/Sessions/Tabs_13424527458837129 create mode 100644 Covance_UCO3001/create_report_v2.0.py create mode 100644 Covance_UCO3001/download_test_results_v1.2.md create mode 100644 Covance_UCO3001/download_test_results_v1.2.py create mode 100644 Covance_UCO3001/run_test_results_parallel_v1.0.py create mode 100644 EmailsImport/DockerCustomApp/app.md diff --git a/Clario/Downloads/Zpracovano/2026-05-29_08-45-12 77242113UCO3001 Clario MayoScore.csv b/Clario/Downloads/Zpracovano/2026-05-29_08-45-12 77242113UCO3001 Clario MayoScore.csv new file mode 100644 index 0000000..b55fb8a --- /dev/null +++ b/Clario/Downloads/Zpracovano/2026-05-29_08-45-12 77242113UCO3001 Clario MayoScore.csv @@ -0,0 +1,39 @@ +"Protocol","Study Population","Country","Site","Principal Investigator","Participant ID","Baseline Stool Frequency","Visit","Visit Date","Endoscopy Completed?","Endoscopy Date","Bowel Preparation Start Date 1","Bowel Preparation End Date 1","Bowel Preparation Start Date 2","Bowel Preparation End Date 2","Central Endoscopy Score","Local Endoscopy Score","PGA Score","Eligible Day (-1)","Day (-1) Excluded Reason(s)","Eligible Day (-2)","Day (-2) Excluded Reason(s)","Eligible Day (-3)","Day (-3) Excluded Reason(s)","Eligible Day (-4)","Day (-4) Excluded Reason(s)","Eligible Day (-5)","Day (-5) Excluded Reason(s)","Eligible Day (-6)","Day (-6) Excluded Reason(s)","Eligible Day (-7)","Day (-7) Excluded Reason(s)","Eligible Day (-8)","Day (-8) Excluded Reason(s)","Eligible Day (-9)","Day (-9) Excluded Reason(s)","Eligible Day (-10)","Day (-10) Excluded Reason(s)","Eligible Day (-1) Stool Count","Eligible Day (-2) Stool Count","Eligible Day (-3) Stool Count","Eligible Day (-4) Stool Count","Eligible Day (-5) Stool Count","Eligible Day (-6) Stool Count","Eligible Day (-7) Stool Count","Eligible Day (-8) Stool Count","Eligible Day (-9) Stool Count","Eligible Day (-10) Stool Count","Stool Frequency Sub-score","Eligible Day (-1) Rectal Bleeding Score","Eligible Day (-2) Rectal Bleeding Score","Eligible Day (-3) Rectal Bleeding Score","Eligible Day (-4) Rectal Bleeding Score","Eligible Day (-5) Rectal Bleeding Score","Eligible Day (-6) Rectal Bleeding Score","Eligible Day (-7) Rectal Bleeding Score","Eligible Day (-8) Rectal Bleeding Score","Eligible Day (-9) Rectal Bleeding Score","Eligible Day (-10) Rectal Bleeding Score","Rectal Bleeding Sub-score","Partial Mayo Score","Modified Mayo Score","Full Mayo Score","Site Action","Last Mayo Score Submission","Week I-12 Clinical Responder","Week I-12 Clinical Remission","Clinical Flare","Loss of Response","Partial Mayo Response Post Loss of Response","Partial Mayo Response for Clinical Non-Responders" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","1","I-0","19 Feb 2026","Yes","05 Feb 2026","04 Feb 2026","04 Feb 2026","-","-","2","-","3","18 Feb 2026","-","17 Feb 2026","-","16 Feb 2026","-","15 Feb 2026","-","14 Feb 2026","-","13 Feb 2026","-","12 Feb 2026","-","11 Feb 2026","Day Not Applicable for Calculation","10 Feb 2026","Day Not Applicable for Calculation","09 Feb 2026","Day Not Applicable for Calculation","10","8","7","5","7","8","8","-","-","-","3","1","1","1","0","1","1","1","-","-","-","1","7","6","9","-","08 Apr 2026 07:11:25","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","1","I-2","04 Mar 2026","-","-","-","-","-","-","-","-","3","03 Mar 2026","-","02 Mar 2026","-","01 Mar 2026","-","28 Feb 2026","-","27 Feb 2026","-","26 Feb 2026","-","25 Feb 2026","-","24 Feb 2026","Day Not Applicable for Calculation","23 Feb 2026","Day Not Applicable for Calculation","22 Feb 2026","Day Not Applicable for Calculation","5","4","5","4","5","6","6","-","-","-","2","1","0","1","0","1","0","1","-","-","-","1","6","","","-","28 May 2026 10:04:05","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","1","I-4","18 Mar 2026","-","-","-","-","-","-","-","-","2","17 Mar 2026","-","16 Mar 2026","-","15 Mar 2026","-","14 Mar 2026","-","13 Mar 2026","-","12 Mar 2026","-","11 Mar 2026","-","10 Mar 2026","Day Not Applicable for Calculation","09 Mar 2026","Day Not Applicable for Calculation","08 Mar 2026","Day Not Applicable for Calculation","5","5","5","4","5","4","5","-","-","-","2","1","0","0","1","1","1","0","-","-","-","1","5","","","-","08 Apr 2026 07:11:43","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","1","I-8","05 May 2026","-","-","-","-","-","-","-","-","1","04 May 2026","-","03 May 2026","-","02 May 2026","-","01 May 2026","-","30 Apr 2026","-","29 Apr 2026","-","28 Apr 2026","-","27 Apr 2026","Day Not Applicable for Calculation","26 Apr 2026","Day Not Applicable for Calculation","25 Apr 2026","Day Not Applicable for Calculation","3","3","4","4","5","4","4","-","-","-","2","1","1","1","1","1","1","1","-","-","-","1","4","","","-","28 May 2026 14:42:53","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","1","I-12","13 May 2026","Yes","06 May 2026","05 May 2026","05 May 2026","-","-","1","-","1","12 May 2026","-","11 May 2026","-","10 May 2026","-","09 May 2026","-","08 May 2026","-","07 May 2026","-","06 May 2026","Endoscopy","05 May 2026","Bowel Preparation for Procedure;Day Not Applicable for Calculation","04 May 2026","-","03 May 2026","Day Not Applicable for Calculation","5","4","6","5","5","5","-","-","3","-","2","1","0","1","1","1","1","-","-","1","-","1","4","4","5","-","28 May 2026 14:43:11","Clinical Responder","No","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","1","I-0","08 Apr 2026","Yes","18 Mar 2026","17 Mar 2026","18 Mar 2026","-","-","2","-","2","07 Apr 2026","-","06 Apr 2026","-","05 Apr 2026","-","04 Apr 2026","Missing Diary","03 Apr 2026","-","02 Apr 2026","-","01 Apr 2026","-","31 Mar 2026","Day Not Applicable for Calculation","30 Mar 2026","Day Not Applicable for Calculation","29 Mar 2026","Day Not Applicable for Calculation","3","3","4","-","3","3","4","-","-","-","1","0","0","0","-","0","0","1","-","-","-","0","3","3","5","-","-","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","1","I-2","23 Apr 2026","-","-","-","-","-","-","-","-","2","22 Apr 2026","Missing Diary","21 Apr 2026","-","20 Apr 2026","-","19 Apr 2026","-","18 Apr 2026","-","17 Apr 2026","-","16 Apr 2026","-","15 Apr 2026","Day Not Applicable for Calculation","14 Apr 2026","Day Not Applicable for Calculation","13 Apr 2026","Day Not Applicable for Calculation","-","3","3","6","5","5","4","-","-","-","2","-","0","0","1","1","1","1","-","-","-","1","5","","","-","-","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","1","I-4","06 May 2026","-","-","-","-","-","-","-","-","1","05 May 2026","-","04 May 2026","-","03 May 2026","-","02 May 2026","-","01 May 2026","-","30 Apr 2026","-","29 Apr 2026","-","28 Apr 2026","Day Not Applicable for Calculation","27 Apr 2026","Day Not Applicable for Calculation","26 Apr 2026","Day Not Applicable for Calculation","6","3","2","3","3","3","3","-","-","-","1","1","0","0","0","1","1","0","-","-","-","0","2","","","-","28 May 2026 14:43:38","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012003","1","I-0","27 May 2026","Yes","13 May 2026","12 May 2026","12 May 2026","-","-","3","-","2","26 May 2026","-","25 May 2026","-","24 May 2026","-","23 May 2026","-","22 May 2026","-","21 May 2026","-","20 May 2026","-","19 May 2026","Day Not Applicable for Calculation","18 May 2026","Day Not Applicable for Calculation","17 May 2026","Day Not Applicable for Calculation","6","9","7","8","9","7","8","-","-","-","3","2","2","2","2","1","1","1","-","-","-","2","7","8","10","-","27 May 2026 07:24:39","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","1","I-0","20 Mar 2026","Yes","19 Feb 2026","-","-","-","-","3","-","3","19 Mar 2026","-","18 Mar 2026","-","17 Mar 2026","-","16 Mar 2026","-","15 Mar 2026","-","14 Mar 2026","-","13 Mar 2026","-","12 Mar 2026","Day Not Applicable for Calculation","11 Mar 2026","Day Not Applicable for Calculation","10 Mar 2026","Day Not Applicable for Calculation","7","7","8","8","7","8","5","-","-","-","3","2","1","1","1","1","1","0","-","-","-","1","7","7","10","-","20 Mar 2026 07:03:23","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","1","I-2","08 Apr 2026","-","-","-","-","-","-","-","-","2","07 Apr 2026","Medication For Diarrhea","06 Apr 2026","Medication For Diarrhea","05 Apr 2026","Medication For Diarrhea","04 Apr 2026","Medication For Diarrhea","03 Apr 2026","Medication For Diarrhea","02 Apr 2026","Medication For Diarrhea","01 Apr 2026","Medication For Diarrhea","31 Mar 2026","Medication For Diarrhea;Day Not Applicable for Calculation","30 Mar 2026","Medication For Diarrhea;Day Not Applicable for Calculation","29 Mar 2026","Day Not Applicable for Calculation","-","-","-","-","-","-","-","-","-","-","Non-Evaluable","-","-","-","-","-","-","-","-","-","-","Non-Evaluable","Non-Evaluable","Non-Evaluable","Non-Evaluable","-","-","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","1","I-4","15 Apr 2026","-","-","-","-","-","-","-","-","3","14 Apr 2026","-","13 Apr 2026","-","12 Apr 2026","-","11 Apr 2026","-","10 Apr 2026","-","09 Apr 2026","-","08 Apr 2026","-","07 Apr 2026","Medication For Diarrhea;Day Not Applicable for Calculation","06 Apr 2026","Medication For Diarrhea;Day Not Applicable for Calculation","05 Apr 2026","Medication For Diarrhea;Day Not Applicable for Calculation","9","22","20","19","17","18","18","-","-","-","3","1","3","2","2","2","2","2","-","-","-","2","8","","","-","04 May 2026 22:06:47","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","1","I-8","18 May 2026","-","-","-","-","-","-","-","-","2","17 May 2026","-","16 May 2026","-","15 May 2026","-","14 May 2026","-","13 May 2026","-","12 May 2026","-","11 May 2026","-","10 May 2026","Day Not Applicable for Calculation","09 May 2026","Day Not Applicable for Calculation","08 May 2026","Day Not Applicable for Calculation","7","5","9","7","7","8","8","-","-","-","3","1","1","1","1","1","1","1","-","-","-","1","6","","","-","-","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","1","I-0","26 May 2026","Yes","14 May 2026","13 May 2026","13 May 2026","-","-","2","-","2","25 May 2026","-","24 May 2026","-","23 May 2026","-","22 May 2026","-","21 May 2026","-","20 May 2026","-","19 May 2026","-","18 May 2026","Day Not Applicable for Calculation","17 May 2026","Day Not Applicable for Calculation","16 May 2026","Day Not Applicable for Calculation","8","8","6","7","7","6","7","-","-","-","3","2","2","2","2","2","2","2","-","-","-","2","7","7","9","-","-","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","1","I-0","05 May 2026","Yes","24 Apr 2026","23 Apr 2026","23 Apr 2026","-","-","2","-","2","04 May 2026","-","03 May 2026","-","02 May 2026","-","01 May 2026","-","30 Apr 2026","-","29 Apr 2026","-","28 Apr 2026","-","27 Apr 2026","Day Not Applicable for Calculation","26 Apr 2026","Day Not Applicable for Calculation","25 Apr 2026","Day Not Applicable for Calculation","5","5","5","5","5","5","5","-","-","-","2","1","1","1","1","1","1","1","-","-","-","1","5","5","7","-","05 May 2026 11:19:40","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","1","I-2","19 May 2026","-","-","-","-","-","-","-","-","1","18 May 2026","-","17 May 2026","-","16 May 2026","-","15 May 2026","-","14 May 2026","-","13 May 2026","-","12 May 2026","-","11 May 2026","Day Not Applicable for Calculation","10 May 2026","Day Not Applicable for Calculation","09 May 2026","Day Not Applicable for Calculation","5","4","5","5","5","4","6","-","-","-","2","1","1","1","1","1","1","1","-","-","-","1","4","","","-","19 May 2026 10:38:25","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","5","I-0","07 Apr 2026","Yes","24 Mar 2026","22 Mar 2026","22 Mar 2026","-","-","2","-","2","06 Apr 2026","-","05 Apr 2026","-","04 Apr 2026","-","03 Apr 2026","-","02 Apr 2026","-","01 Apr 2026","-","31 Mar 2026","-","30 Mar 2026","Day Not Applicable for Calculation","29 Mar 2026","Day Not Applicable for Calculation","28 Mar 2026","Day Not Applicable for Calculation","8","11","5","9","11","10","13","-","-","-","3","1","2","2","2","2","2","2","-","-","-","2","7","7","9","-","04 May 2026 08:44:52","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","5","I-2","22 Apr 2026","-","-","-","-","-","-","-","-","2","21 Apr 2026","-","20 Apr 2026","-","19 Apr 2026","-","18 Apr 2026","-","17 Apr 2026","-","16 Apr 2026","-","15 Apr 2026","-","14 Apr 2026","Day Not Applicable for Calculation","13 Apr 2026","Day Not Applicable for Calculation","12 Apr 2026","Day Not Applicable for Calculation","7","5","6","6","7","8","2","-","-","-","1","1","0","1","1","1","2","0","-","-","-","1","4","","","-","04 May 2026 08:45:07","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","5","I-4","07 May 2026","-","-","-","-","-","-","-","-","1","06 May 2026","-","05 May 2026","-","04 May 2026","-","03 May 2026","-","02 May 2026","-","01 May 2026","-","30 Apr 2026","-","29 Apr 2026","Day Not Applicable for Calculation","28 Apr 2026","Day Not Applicable for Calculation","27 Apr 2026","Day Not Applicable for Calculation","8","7","7","8","4","11","7","-","-","-","1","2","1","1","1","0","1","1","-","-","-","1","3","","","-","-","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","1","I-0","24 Mar 2026","Yes","12 Mar 2026","11 Mar 2026","11 Mar 2026","-","-","2","-","2","23 Mar 2026","-","22 Mar 2026","-","21 Mar 2026","-","20 Mar 2026","-","19 Mar 2026","-","18 Mar 2026","-","17 Mar 2026","-","16 Mar 2026","Day Not Applicable for Calculation","15 Mar 2026","Day Not Applicable for Calculation","14 Mar 2026","Day Not Applicable for Calculation","8","6","5","7","6","7","6","-","-","-","3","1","1","1","0","1","1","1","-","-","-","1","6","6","8","-","05 Apr 2026 22:41:27","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","1","I-2","08 Apr 2026","-","-","-","-","-","-","-","-","2","07 Apr 2026","-","06 Apr 2026","-","05 Apr 2026","-","04 Apr 2026","-","03 Apr 2026","-","02 Apr 2026","-","01 Apr 2026","-","31 Mar 2026","Day Not Applicable for Calculation","30 Mar 2026","Day Not Applicable for Calculation","29 Mar 2026","Day Not Applicable for Calculation","5","2","3","6","5","5","5","-","-","-","2","0","0","0","0","1","1","0","-","-","-","0","4","","","-","28 May 2026 23:19:03","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","1","I-4","21 Apr 2026","-","-","-","-","-","-","-","-","0","20 Apr 2026","-","19 Apr 2026","-","18 Apr 2026","-","17 Apr 2026","-","16 Apr 2026","-","15 Apr 2026","-","14 Apr 2026","-","13 Apr 2026","Day Not Applicable for Calculation","12 Apr 2026","Day Not Applicable for Calculation","11 Apr 2026","Day Not Applicable for Calculation","4","3","4","3","3","4","4","-","-","-","2","0","0","0","0","0","0","0","-","-","-","0","2","","","-","27 May 2026 12:54:41","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","1","I-0","12 May 2026","Yes","21 Apr 2026","20 Apr 2026","21 Apr 2026","-","-","2","-","2","11 May 2026","-","10 May 2026","-","09 May 2026","-","08 May 2026","-","07 May 2026","-","06 May 2026","-","05 May 2026","Missing Diary","04 May 2026","Day Not Applicable for Calculation","03 May 2026","Day Not Applicable for Calculation","02 May 2026","Day Not Applicable for Calculation","2","1","1","1","1","2","-","-","-","-","0","0","0","0","0","0","0","-","-","-","-","0","2","2","4","-","28 May 2026 23:19:30","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","1","I-2","26 May 2026","-","-","-","-","-","-","-","-","1","25 May 2026","-","24 May 2026","Missing Diary","23 May 2026","-","22 May 2026","-","21 May 2026","-","20 May 2026","-","19 May 2026","-","18 May 2026","Missing Diary;Day Not Applicable for Calculation","17 May 2026","Day Not Applicable for Calculation","16 May 2026","Day Not Applicable for Calculation","1","-","1","2","1","2","2","-","-","-","1","0","-","0","0","0","0","0","-","-","-","0","2","","","-","28 May 2026 23:19:51","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","1","I-0","28 May 2026","Yes","19 May 2026","18 May 2026","19 May 2026","-","-","3","-","3","27 May 2026","-","26 May 2026","-","25 May 2026","-","24 May 2026","-","23 May 2026","-","22 May 2026","-","21 May 2026","-","20 May 2026","Day Not Applicable for Calculation","19 May 2026","Endoscopy;Bowel Preparation for Procedure;Day Not Applicable for Calculation","18 May 2026","Bowel Preparation for Procedure;Day Not Applicable for Calculation","14","15","15","15","15","15","15","-","-","-","3","2","3","3","2","2","3","3","-","-","-","3","9","9","12","-","28 May 2026 10:22:48","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adolescent","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","1","Unscheduled 1","04 May 2026","Yes","20 Apr 2026","12 Apr 2026","15 Apr 2026","-","-","2","-","3","03 May 2026","-","02 May 2026","-","01 May 2026","-","30 Apr 2026","-","29 Apr 2026","-","28 Apr 2026","-","27 Apr 2026","-","26 Apr 2026","Day Not Applicable for Calculation","25 Apr 2026","Day Not Applicable for Calculation","24 Apr 2026","Day Not Applicable for Calculation","5","6","6","7","6","3","3","-","-","-","2","0","0","0","0","0","0","0","-","-","-","0","5","4","7","-","-","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adolescent","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","1","I-0","18 May 2026","Yes","01 May 2026","01 May 2026","01 May 2026","-","-","2","-","3","17 May 2026","-","16 May 2026","-","15 May 2026","-","14 May 2026","-","13 May 2026","-","12 May 2026","-","11 May 2026","-","10 May 2026","Day Not Applicable for Calculation","09 May 2026","Day Not Applicable for Calculation","08 May 2026","Day Not Applicable for Calculation","6","6","6","6","6","6","6","-","-","-","3","0","0","0","0","0","0","0","-","-","-","0","6","5","8","-","18 May 2026 08:36:37","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","1","I-0","07 Apr 2026","Yes","16 Mar 2026","15 Mar 2026","16 Mar 2026","-","-","3","-","3","06 Apr 2026","-","05 Apr 2026","-","04 Apr 2026","-","03 Apr 2026","-","02 Apr 2026","-","01 Apr 2026","-","31 Mar 2026","-","30 Mar 2026","Day Not Applicable for Calculation","29 Mar 2026","Day Not Applicable for Calculation","28 Mar 2026","Day Not Applicable for Calculation","11","11","10","11","11","10","9","-","-","-","3","2","2","2","2","2","2","2","-","-","-","2","8","8","11","-","20 Apr 2026 09:27:58","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","1","I-2","20 Apr 2026","-","-","-","-","-","-","-","-","3","19 Apr 2026","-","18 Apr 2026","-","17 Apr 2026","-","16 Apr 2026","-","15 Apr 2026","-","14 Apr 2026","-","13 Apr 2026","-","12 Apr 2026","Day Not Applicable for Calculation","11 Apr 2026","Day Not Applicable for Calculation","10 Apr 2026","Day Not Applicable for Calculation","8","7","9","8","8","7","8","-","-","-","3","2","2","1","1","1","2","1","-","-","-","1","7","","","-","20 Apr 2026 09:29:01","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","1","I-4","05 May 2026","-","-","-","-","-","-","-","-","1","04 May 2026","-","03 May 2026","-","02 May 2026","-","01 May 2026","-","30 Apr 2026","-","29 Apr 2026","-","28 Apr 2026","-","27 Apr 2026","Day Not Applicable for Calculation","26 Apr 2026","Day Not Applicable for Calculation","25 Apr 2026","Day Not Applicable for Calculation","6","6","6","6","7","7","6","-","-","-","3","0","0","1","1","1","1","1","-","-","-","1","5","","","-","-","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222002","1","I-0","19 Feb 2026","Yes","11 Feb 2026","10 Feb 2026","11 Feb 2026","-","-","2","-","2","18 Feb 2026","-","17 Feb 2026","-","16 Feb 2026","-","15 Feb 2026","-","14 Feb 2026","-","13 Feb 2026","-","12 Feb 2026","-","11 Feb 2026","Endoscopy;Bowel Preparation for Procedure;Day Not Applicable for Calculation","10 Feb 2026","Bowel Preparation for Procedure;Day Not Applicable for Calculation","09 Feb 2026","Day Not Applicable for Calculation","3","2","2","3","4","3","2","-","-","-","1","1","1","0","0","0","2","2","-","-","-","1","4","4","6","-","19 Feb 2026 15:41:35","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","1","I-0","09 Mar 2026","Yes","11 Feb 2026","10 Feb 2026","11 Feb 2026","-","-","2","-","2","08 Mar 2026","-","07 Mar 2026","-","06 Mar 2026","-","05 Mar 2026","-","04 Mar 2026","-","03 Mar 2026","Missing Diary","02 Mar 2026","Missing Diary","01 Mar 2026","Missing Diary;Day Not Applicable for Calculation","28 Feb 2026","Missing Diary;Day Not Applicable for Calculation","27 Feb 2026","Missing Diary;Day Not Applicable for Calculation","7","7","6","6","7","-","-","-","-","-","3","2","2","2","2","2","-","-","-","-","-","2","7","7","9","-","22 Mar 2026 18:34:58","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","1","I-2","27 Mar 2026","-","-","-","-","-","-","-","-","2","26 Mar 2026","-","25 Mar 2026","-","24 Mar 2026","-","23 Mar 2026","-","22 Mar 2026","-","21 Mar 2026","-","20 Mar 2026","-","19 Mar 2026","Day Not Applicable for Calculation","18 Mar 2026","Day Not Applicable for Calculation","17 Mar 2026","Day Not Applicable for Calculation","7","3","3","3","5","5","5","-","-","-","2","0","0","1","1","1","1","2","-","-","-","1","5","","","-","08 Apr 2026 07:36:56","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","1","I-4","08 Apr 2026","-","-","-","-","-","-","-","-","2","07 Apr 2026","-","06 Apr 2026","-","05 Apr 2026","-","04 Apr 2026","-","03 Apr 2026","-","02 Apr 2026","-","01 Apr 2026","-","31 Mar 2026","Day Not Applicable for Calculation","30 Mar 2026","Day Not Applicable for Calculation","29 Mar 2026","Day Not Applicable for Calculation","3","3","4","4","5","4","3","-","-","-","2","1","0","0","2","1","1","2","-","-","-","1","5","","","-","08 Apr 2026 07:59:35","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","1","I-8","04 May 2026","-","-","-","-","-","-","-","-","2","03 May 2026","-","02 May 2026","-","01 May 2026","-","30 Apr 2026","-","29 Apr 2026","-","28 Apr 2026","-","27 Apr 2026","-","26 Apr 2026","Day Not Applicable for Calculation","25 Apr 2026","Day Not Applicable for Calculation","24 Apr 2026","Missing Diary;Day Not Applicable for Calculation","3","5","3","3","3","2","3","-","-","-","1","0","0","0","0","0","0","0","-","-","-","0","3","","","-","04 May 2026 07:52:47","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","1","I-0","09 Apr 2026","Yes","08 Apr 2026","31 Mar 2026","01 Apr 2026","-","-","2","-","2","08 Apr 2026","Endoscopy","07 Apr 2026","-","06 Apr 2026","-","05 Apr 2026","-","04 Apr 2026","-","03 Apr 2026","-","02 Apr 2026","-","01 Apr 2026","Bowel Preparation for Procedure;Day Not Applicable for Calculation","31 Mar 2026","Bowel Preparation for Procedure;Day Not Applicable for Calculation","30 Mar 2026","-","-","3","3","4","3","4","3","-","-","3","1","-","2","2","2","2","2","2","-","-","2","2","5","5","7","-","-","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","1","I-2","22 Apr 2026","-","-","-","-","-","-","-","-","2","21 Apr 2026","-","20 Apr 2026","-","19 Apr 2026","-","18 Apr 2026","-","17 Apr 2026","-","16 Apr 2026","-","15 Apr 2026","-","14 Apr 2026","Day Not Applicable for Calculation","13 Apr 2026","Day Not Applicable for Calculation","12 Apr 2026","Day Not Applicable for Calculation","3","3","5","3","2","3","2","-","-","-","1","1","2","2","1","1","1","2","-","-","-","1","4","","","-","22 Apr 2026 14:12:15","N/A","N/A","N/A","N/A","N/A","N/A" +"77242113UCO3001","Adult","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","1","I-4","05 May 2026","-","-","-","-","-","-","-","-","2","04 May 2026","-","03 May 2026","-","02 May 2026","-","01 May 2026","-","30 Apr 2026","-","29 Apr 2026","-","28 Apr 2026","-","27 Apr 2026","Day Not Applicable for Calculation","26 Apr 2026","Day Not Applicable for Calculation","25 Apr 2026","Day Not Applicable for Calculation","4","2","2","2","2","2","2","-","-","-","1","1","1","1","1","2","1","1","-","-","-","1","4","","","-","05 May 2026 07:28:55","N/A","N/A","N/A","N/A","N/A","N/A" diff --git a/Clario/Downloads/Zpracovano/2026-05-29_08-48-14 77242113UCO3001 Clario MayoDiary.csv b/Clario/Downloads/Zpracovano/2026-05-29_08-48-14 77242113UCO3001 Clario MayoDiary.csv new file mode 100644 index 0000000..947b8e7 --- /dev/null +++ b/Clario/Downloads/Zpracovano/2026-05-29_08-48-14 77242113UCO3001 Clario MayoDiary.csv @@ -0,0 +1,1116 @@ +"Protocol","Country","Site","PI Name","Subject ID","Age at Informed Consent","Baseline Stool Count","Confirm Baseline Stool Count","Report Date","Report Start Date/Time","Report End Date/Time","Duration","Form Number","Role","Original Source","Current Source","Constipation (Code)","Constipation","Diarrhea (Code)","Diarrhea","Irregularity (Code)","Irregularity","Not Applicable (Code)","Not Applicable","Stool Frequency","Stool Frequency Confirmation (Code)","Stool Frequency Confirmation","MAYO050 (Code)","MAYO050","Data Comment","Retro Data Entry Visit Flag (Code)","Retro Data Entry Visit Flag","Admin Language","Admin Device (Code)","Admin Device","Data Flag (Code)","Data Flag","User Name","Paper Source (Code)","Paper Source" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","22-Jan-2026 ","22-Jan-2026 18:01:10","22-Jan-2026 18:01:44","00:34","1","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","23-Jan-2026 ","23-Jan-2026 21:22:44","23-Jan-2026 21:23:25","00:41","2","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","24-Jan-2026 ","24-Jan-2026 18:04:18","24-Jan-2026 18:04:36","00:18","3","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","27-Jan-2026 ","28-Jan-2026 18:33:09","28-Jan-2026 18:33:24","00:15","4","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","28-Jan-2026 ","28-Jan-2026 18:34:00","28-Jan-2026 18:34:20","00:20","5","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","29-Jan-2026 ","29-Jan-2026 21:36:05","29-Jan-2026 21:36:22","00:17","6","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","30-Jan-2026 ","31-Jan-2026 00:05:37","31-Jan-2026 00:05:58","00:21","7","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","8","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","31-Jan-2026 ","31-Jan-2026 23:13:18","31-Jan-2026 23:13:35","00:17","8","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","01-Feb-2026 ","01-Feb-2026 19:26:08","01-Feb-2026 19:26:36","00:28","9","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","02-Feb-2026 ","02-Feb-2026 18:01:48","02-Feb-2026 18:02:06","00:18","10","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","03-Feb-2026 ","03-Feb-2026 18:02:54","03-Feb-2026 18:03:20","00:26","11","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","04-Feb-2026 ","04-Feb-2026 18:02:37","04-Feb-2026 18:03:09","00:32","12","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","05-Feb-2026 ","05-Feb-2026 22:23:29","05-Feb-2026 22:23:46","00:17","13","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","06-Feb-2026 ","06-Feb-2026 22:20:04","06-Feb-2026 22:20:19","00:15","14","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","07-Feb-2026 ","07-Feb-2026 18:02:19","07-Feb-2026 18:02:51","00:32","15","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","08-Feb-2026 ","08-Feb-2026 18:03:25","08-Feb-2026 18:03:46","00:21","16","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","9","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","09-Feb-2026 ","09-Feb-2026 19:06:44","09-Feb-2026 19:07:24","00:40","17","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","9","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","10-Feb-2026 ","10-Feb-2026 22:25:12","10-Feb-2026 22:25:32","00:20","18","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","11-Feb-2026 ","12-Feb-2026 18:34:50","12-Feb-2026 18:35:15","00:25","19","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","11","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","12-Feb-2026 ","12-Feb-2026 18:35:49","12-Feb-2026 18:36:01","00:12","20","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","13-Feb-2026 ","13-Feb-2026 18:14:41","13-Feb-2026 18:14:55","00:14","21","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","14-Feb-2026 ","14-Feb-2026 18:01:52","14-Feb-2026 18:02:30","00:38","22","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","15-Feb-2026 ","16-Feb-2026 19:00:39","16-Feb-2026 19:00:56","00:17","23","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","16-Feb-2026 ","16-Feb-2026 19:01:41","16-Feb-2026 19:01:54","00:13","24","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","17-Feb-2026 ","17-Feb-2026 18:35:12","17-Feb-2026 18:35:26","00:14","25","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","18-Feb-2026 ","18-Feb-2026 18:02:21","18-Feb-2026 18:02:37","00:16","26","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","10","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","19-Feb-2026 ","20-Feb-2026 20:40:28","20-Feb-2026 20:40:55","00:27","27","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","7","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","20-Feb-2026 ","20-Feb-2026 20:41:50","20-Feb-2026 20:42:13","00:23","28","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","10","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","21-Feb-2026 ","21-Feb-2026 22:17:51","21-Feb-2026 22:18:05","00:14","29","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","22-Feb-2026 ","23-Feb-2026 18:59:42","23-Feb-2026 18:59:59","00:17","30","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","23-Feb-2026 ","23-Feb-2026 19:00:43","23-Feb-2026 19:00:57","00:14","31","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","24-Feb-2026 ","24-Feb-2026 18:33:05","24-Feb-2026 18:33:18","00:13","32","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","25-Feb-2026 ","25-Feb-2026 20:00:09","25-Feb-2026 20:00:22","00:13","33","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","26-Feb-2026 ","26-Feb-2026 21:45:08","26-Feb-2026 21:45:42","00:34","34","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","27-Feb-2026 ","27-Feb-2026 21:43:17","27-Feb-2026 21:43:33","00:16","35","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","28-Feb-2026 ","28-Feb-2026 18:53:08","28-Feb-2026 18:53:54","00:46","36","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","01-Mar-2026 ","01-Mar-2026 19:53:01","01-Mar-2026 19:53:40","00:39","37","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","02-Mar-2026 ","02-Mar-2026 18:05:10","02-Mar-2026 18:05:26","00:16","38","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","03-Mar-2026 ","03-Mar-2026 19:44:37","03-Mar-2026 19:45:11","00:34","39","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","04-Mar-2026 ","04-Mar-2026 18:45:15","04-Mar-2026 18:45:35","00:20","40","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","05-Mar-2026 ","05-Mar-2026 18:58:16","05-Mar-2026 18:58:36","00:20","41","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","06-Mar-2026 ","06-Mar-2026 18:28:33","06-Mar-2026 18:28:49","00:16","42","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","07-Mar-2026 ","07-Mar-2026 19:46:29","07-Mar-2026 19:46:47","00:18","43","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","08-Mar-2026 ","08-Mar-2026 20:05:17","08-Mar-2026 20:05:48","00:31","44","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","09-Mar-2026 ","09-Mar-2026 19:06:21","09-Mar-2026 19:06:43","00:22","45","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","10-Mar-2026 ","10-Mar-2026 18:19:08","10-Mar-2026 18:19:29","00:21","46","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","11-Mar-2026 ","11-Mar-2026 21:03:53","11-Mar-2026 21:04:07","00:14","47","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","12-Mar-2026 ","12-Mar-2026 18:17:30","12-Mar-2026 18:17:50","00:20","48","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","13-Mar-2026 ","13-Mar-2026 18:05:59","13-Mar-2026 18:07:01","01:02","49","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","14-Mar-2026 ","14-Mar-2026 20:44:54","14-Mar-2026 20:45:13","00:19","50","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","15-Mar-2026 ","15-Mar-2026 18:36:33","15-Mar-2026 18:36:52","00:19","51","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","16-Mar-2026 ","16-Mar-2026 22:48:59","16-Mar-2026 22:49:17","00:18","52","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","17-Mar-2026 ","17-Mar-2026 18:02:01","17-Mar-2026 18:02:18","00:17","53","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","18-Mar-2026 ","18-Mar-2026 21:00:45","18-Mar-2026 21:01:25","00:40","54","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","19-Mar-2026 ","19-Mar-2026 21:31:31","19-Mar-2026 21:32:18","00:47","55","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","20-Mar-2026 ","21-Mar-2026 14:10:40","21-Mar-2026 14:10:56","00:16","56","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","21-Mar-2026 ","21-Mar-2026 23:09:00","21-Mar-2026 23:09:18","00:18","57","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","22-Mar-2026 ","22-Mar-2026 19:08:29","22-Mar-2026 19:08:50","00:21","58","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","23-Mar-2026 ","23-Mar-2026 18:16:57","23-Mar-2026 18:17:14","00:17","59","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","24-Mar-2026 ","24-Mar-2026 21:05:21","24-Mar-2026 21:05:35","00:14","60","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","25-Mar-2026 ","25-Mar-2026 21:08:43","25-Mar-2026 21:09:39","00:56","61","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","26-Mar-2026 ","26-Mar-2026 20:46:45","26-Mar-2026 20:47:05","00:20","62","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","27-Mar-2026 ","27-Mar-2026 20:55:30","27-Mar-2026 20:55:57","00:27","63","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","28-Mar-2026 ","28-Mar-2026 20:00:16","28-Mar-2026 20:00:32","00:16","64","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","29-Mar-2026 ","29-Mar-2026 22:09:04","29-Mar-2026 22:09:18","00:14","65","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","30-Mar-2026 ","31-Mar-2026 11:57:59","31-Mar-2026 11:58:17","00:18","66","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","31-Mar-2026 ","01-Apr-2026 18:21:26","01-Apr-2026 18:22:46","01:20","67","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","01-Apr-2026 ","01-Apr-2026 18:23:44","01-Apr-2026 18:23:58","00:14","68","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","02-Apr-2026 ","02-Apr-2026 20:54:02","02-Apr-2026 20:54:22","00:20","69","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","03-Apr-2026 ","03-Apr-2026 19:54:40","03-Apr-2026 19:55:08","00:28","70","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","04-Apr-2026 ","04-Apr-2026 18:11:01","04-Apr-2026 18:11:24","00:23","71","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","05-Apr-2026 ","05-Apr-2026 23:04:39","05-Apr-2026 23:05:04","00:25","72","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","06-Apr-2026 ","06-Apr-2026 21:42:50","06-Apr-2026 21:43:12","00:22","73","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","07-Apr-2026 ","07-Apr-2026 21:43:47","07-Apr-2026 21:44:05","00:18","74","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","08-Apr-2026 ","09-Apr-2026 21:36:29","09-Apr-2026 21:36:45","00:16","75","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","09-Apr-2026 ","09-Apr-2026 21:39:42","09-Apr-2026 21:40:10","00:28","76","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","10-Apr-2026 ","10-Apr-2026 18:05:18","10-Apr-2026 18:05:37","00:19","77","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","11-Apr-2026 ","11-Apr-2026 23:16:18","11-Apr-2026 23:16:50","00:32","78","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","12-Apr-2026 ","12-Apr-2026 20:31:50","12-Apr-2026 20:32:07","00:17","79","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","13-Apr-2026 ","13-Apr-2026 22:52:20","13-Apr-2026 22:52:40","00:20","80","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","14-Apr-2026 ","14-Apr-2026 21:00:55","14-Apr-2026 21:01:12","00:17","81","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","15-Apr-2026 ","15-Apr-2026 21:26:28","15-Apr-2026 21:26:45","00:17","82","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","16-Apr-2026 ","16-Apr-2026 20:36:59","16-Apr-2026 20:37:29","00:30","83","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","17-Apr-2026 ","17-Apr-2026 18:35:45","17-Apr-2026 18:36:18","00:33","84","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","18-Apr-2026 ","19-Apr-2026 19:09:05","19-Apr-2026 19:09:27","00:22","85","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","19-Apr-2026 ","19-Apr-2026 19:10:48","19-Apr-2026 19:11:05","00:17","86","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","20-Apr-2026 ","20-Apr-2026 21:41:27","20-Apr-2026 21:42:05","00:38","87","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","21-Apr-2026 ","21-Apr-2026 18:16:50","21-Apr-2026 18:17:13","00:23","88","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","24-Apr-2026 ","25-Apr-2026 21:27:18","25-Apr-2026 21:27:37","00:19","89","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","25-Apr-2026 ","25-Apr-2026 21:28:48","25-Apr-2026 21:29:07","00:19","90","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","26-Apr-2026 ","26-Apr-2026 21:20:40","26-Apr-2026 21:21:09","00:29","91","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","27-Apr-2026 ","27-Apr-2026 19:23:32","27-Apr-2026 19:23:57","00:25","92","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","28-Apr-2026 ","28-Apr-2026 20:20:00","28-Apr-2026 20:20:16","00:16","93","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","29-Apr-2026 ","29-Apr-2026 18:40:54","29-Apr-2026 18:41:13","00:19","94","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","30-Apr-2026 ","01-May-2026 19:13:21","01-May-2026 19:13:42","00:21","95","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","01-May-2026 ","01-May-2026 19:15:10","01-May-2026 19:15:41","00:31","96","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","02-May-2026 ","02-May-2026 20:04:07","02-May-2026 20:04:25","00:18","97","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","03-May-2026 ","03-May-2026 20:30:45","03-May-2026 20:31:11","00:26","98","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","04-May-2026 ","04-May-2026 22:14:16","04-May-2026 22:14:39","00:23","99","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","05-May-2026 ","05-May-2026 18:03:33","05-May-2026 18:03:59","00:26","100","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","06-May-2026 ","06-May-2026 19:09:27","06-May-2026 19:10:10","00:43","101","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","07-May-2026 ","07-May-2026 22:20:20","07-May-2026 22:20:44","00:24","102","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","08-May-2026 ","08-May-2026 22:31:15","08-May-2026 22:31:30","00:15","103","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","09-May-2026 ","09-May-2026 22:14:16","09-May-2026 22:14:41","00:25","104","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","10-May-2026 ","10-May-2026 22:59:00","10-May-2026 22:59:24","00:24","105","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","11-May-2026 ","11-May-2026 21:17:29","11-May-2026 21:18:07","00:38","106","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","12-May-2026 ","12-May-2026 20:23:13","12-May-2026 20:24:06","00:53","107","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","13-May-2026 ","13-May-2026 18:08:45","13-May-2026 18:09:03","00:18","108","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","15-May-2026 ","15-May-2026 23:21:17","15-May-2026 23:21:35","00:18","109","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","16-May-2026 ","17-May-2026 18:26:06","17-May-2026 18:26:24","00:18","110","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","17-May-2026 ","17-May-2026 18:27:28","17-May-2026 18:27:43","00:15","111","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","18-May-2026 ","18-May-2026 20:31:21","18-May-2026 20:31:43","00:22","112","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","19-May-2026 ","19-May-2026 18:40:11","19-May-2026 18:40:28","00:17","113","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","20-May-2026 ","20-May-2026 22:17:46","20-May-2026 22:18:01","00:15","114","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","21-May-2026 ","21-May-2026 20:03:10","21-May-2026 20:03:28","00:18","115","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","22-May-2026 ","22-May-2026 18:35:01","22-May-2026 18:35:16","00:15","116","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","23-May-2026 ","23-May-2026 22:25:17","23-May-2026 22:26:05","00:48","117","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","24-May-2026 ","25-May-2026 18:08:43","25-May-2026 18:09:27","00:44","118","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","25-May-2026 ","25-May-2026 18:10:27","25-May-2026 18:11:02","00:35","119","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","26-May-2026 ","26-May-2026 20:54:59","26-May-2026 20:55:19","00:20","120","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","27-May-2026 ","27-May-2026 22:05:34","27-May-2026 22:06:07","00:33","121","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012001","48","1","","28-May-2026 ","28-May-2026 18:48:45","28-May-2026 18:48:59","00:14","122","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","02-Mar-2026 ","02-Mar-2026 18:03:24","02-Mar-2026 18:03:45","00:21","1","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","03-Mar-2026 ","03-Mar-2026 19:43:48","03-Mar-2026 19:45:18","01:30","2","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","04-Mar-2026 ","04-Mar-2026 19:03:27","04-Mar-2026 19:03:48","00:21","3","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","05-Mar-2026 ","05-Mar-2026 19:15:46","05-Mar-2026 19:16:04","00:18","4","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","06-Mar-2026 ","06-Mar-2026 18:23:46","06-Mar-2026 18:25:08","01:22","5","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","07-Mar-2026 ","07-Mar-2026 19:05:22","07-Mar-2026 19:05:45","00:23","6","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","08-Mar-2026 ","08-Mar-2026 19:09:52","08-Mar-2026 19:10:47","00:55","7","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","09-Mar-2026 ","09-Mar-2026 19:08:05","09-Mar-2026 19:08:19","00:14","8","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","10-Mar-2026 ","10-Mar-2026 18:15:08","10-Mar-2026 18:15:19","00:11","9","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","11-Mar-2026 ","11-Mar-2026 20:13:00","11-Mar-2026 20:13:15","00:15","10","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","12-Mar-2026 ","12-Mar-2026 19:05:47","12-Mar-2026 19:06:03","00:16","11","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","13-Mar-2026 ","13-Mar-2026 18:59:16","13-Mar-2026 18:59:52","00:36","12","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","14-Mar-2026 ","14-Mar-2026 20:12:42","14-Mar-2026 20:13:14","00:32","13","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","15-Mar-2026 ","15-Mar-2026 22:50:36","15-Mar-2026 22:50:57","00:21","14","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","16-Mar-2026 ","16-Mar-2026 18:15:35","16-Mar-2026 18:15:52","00:17","15","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","17-Mar-2026 ","17-Mar-2026 21:15:59","17-Mar-2026 21:16:11","00:12","16","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","18-Mar-2026 ","18-Mar-2026 18:32:31","18-Mar-2026 18:33:05","00:34","17","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","19-Mar-2026 ","19-Mar-2026 22:19:19","19-Mar-2026 22:19:35","00:16","18","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","20-Mar-2026 ","21-Mar-2026 21:58:25","21-Mar-2026 21:58:52","00:27","19","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","21-Mar-2026 ","21-Mar-2026 21:59:25","21-Mar-2026 21:59:50","00:25","20","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","22-Mar-2026 ","22-Mar-2026 18:16:36","22-Mar-2026 18:17:03","00:27","21","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","23-Mar-2026 ","23-Mar-2026 18:15:48","23-Mar-2026 18:16:13","00:25","22","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","24-Mar-2026 ","24-Mar-2026 19:56:01","24-Mar-2026 19:56:15","00:14","23","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","25-Mar-2026 ","25-Mar-2026 20:46:53","25-Mar-2026 20:47:12","00:19","24","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","26-Mar-2026 ","26-Mar-2026 20:54:13","26-Mar-2026 20:54:28","00:15","25","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","27-Mar-2026 ","27-Mar-2026 23:09:08","27-Mar-2026 23:09:26","00:18","26","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","28-Mar-2026 ","28-Mar-2026 20:02:00","28-Mar-2026 20:02:18","00:18","27","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","29-Mar-2026 ","29-Mar-2026 21:11:54","29-Mar-2026 21:12:13","00:19","28","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","30-Mar-2026 ","31-Mar-2026 11:57:02","31-Mar-2026 11:57:16","00:14","29","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","31-Mar-2026 ","01-Apr-2026 18:10:49","01-Apr-2026 18:11:06","00:17","30","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","01-Apr-2026 ","01-Apr-2026 18:11:44","01-Apr-2026 18:12:00","00:16","31","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","02-Apr-2026 ","02-Apr-2026 18:12:37","02-Apr-2026 18:12:55","00:18","32","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","03-Apr-2026 ","03-Apr-2026 21:58:59","03-Apr-2026 21:59:15","00:16","33","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","05-Apr-2026 ","05-Apr-2026 23:02:10","05-Apr-2026 23:02:29","00:19","34","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","06-Apr-2026 ","06-Apr-2026 22:14:46","06-Apr-2026 22:15:03","00:17","35","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","07-Apr-2026 ","07-Apr-2026 21:02:39","07-Apr-2026 21:02:52","00:13","36","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","08-Apr-2026 ","09-Apr-2026 21:40:54","09-Apr-2026 21:41:13","00:19","37","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","09-Apr-2026 ","09-Apr-2026 21:41:51","09-Apr-2026 21:42:08","00:17","38","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","10-Apr-2026 ","10-Apr-2026 20:05:38","10-Apr-2026 20:05:53","00:15","39","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","11-Apr-2026 ","11-Apr-2026 23:17:33","11-Apr-2026 23:17:46","00:13","40","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","12-Apr-2026 ","12-Apr-2026 18:21:45","12-Apr-2026 18:22:02","00:17","41","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","13-Apr-2026 ","13-Apr-2026 22:47:41","13-Apr-2026 22:48:01","00:20","42","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","14-Apr-2026 ","14-Apr-2026 22:06:10","14-Apr-2026 22:06:29","00:19","43","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","15-Apr-2026 ","15-Apr-2026 19:38:20","15-Apr-2026 19:38:45","00:25","44","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","16-Apr-2026 ","17-Apr-2026 18:32:51","17-Apr-2026 18:33:06","00:15","45","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","17-Apr-2026 ","17-Apr-2026 18:34:57","17-Apr-2026 18:35:14","00:17","46","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","18-Apr-2026 ","19-Apr-2026 18:11:33","19-Apr-2026 18:11:51","00:18","47","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","19-Apr-2026 ","19-Apr-2026 18:12:51","19-Apr-2026 18:13:09","00:18","48","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","20-Apr-2026 ","20-Apr-2026 21:40:01","20-Apr-2026 21:40:36","00:35","49","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","21-Apr-2026 ","21-Apr-2026 19:09:36","21-Apr-2026 19:09:49","00:13","50","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","24-Apr-2026 ","25-Apr-2026 19:44:57","25-Apr-2026 19:45:15","00:18","51","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","25-Apr-2026 ","25-Apr-2026 19:46:37","25-Apr-2026 19:47:02","00:25","52","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","26-Apr-2026 ","26-Apr-2026 21:19:11","26-Apr-2026 21:19:40","00:29","53","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","27-Apr-2026 ","28-Apr-2026 18:23:35","28-Apr-2026 18:23:51","00:16","54","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","28-Apr-2026 ","28-Apr-2026 18:25:15","28-Apr-2026 18:25:30","00:15","55","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","29-Apr-2026 ","29-Apr-2026 20:13:53","29-Apr-2026 20:14:08","00:15","56","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","30-Apr-2026 ","01-May-2026 19:10:14","01-May-2026 19:10:37","00:23","57","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","01-May-2026 ","01-May-2026 19:11:24","01-May-2026 19:11:41","00:17","58","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","02-May-2026 ","02-May-2026 18:48:16","02-May-2026 18:48:47","00:31","59","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","03-May-2026 ","03-May-2026 20:28:17","03-May-2026 20:28:34","00:17","60","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","04-May-2026 ","04-May-2026 21:19:12","04-May-2026 21:19:32","00:20","61","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","05-May-2026 ","05-May-2026 18:01:14","05-May-2026 18:01:32","00:18","62","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","06-May-2026 ","06-May-2026 19:34:21","06-May-2026 19:35:29","01:08","63","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","07-May-2026 ","07-May-2026 22:31:00","07-May-2026 22:31:21","00:21","64","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","08-May-2026 ","08-May-2026 22:36:30","08-May-2026 22:36:51","00:21","65","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","09-May-2026 ","09-May-2026 22:10:53","09-May-2026 22:11:08","00:15","66","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","10-May-2026 ","10-May-2026 20:03:46","10-May-2026 20:04:16","00:30","67","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","11-May-2026 ","11-May-2026 19:05:57","11-May-2026 19:06:14","00:17","68","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","12-May-2026 ","12-May-2026 20:13:55","12-May-2026 20:14:35","00:40","69","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","13-May-2026 ","13-May-2026 20:47:02","13-May-2026 20:47:37","00:35","70","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","14-May-2026 ","14-May-2026 20:49:31","14-May-2026 20:49:46","00:15","71","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","15-May-2026 ","15-May-2026 23:18:53","15-May-2026 23:19:24","00:31","72","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","16-May-2026 ","17-May-2026 18:08:11","17-May-2026 18:08:34","00:23","73","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","17-May-2026 ","17-May-2026 18:09:32","17-May-2026 18:10:09","00:37","74","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","18-May-2026 ","18-May-2026 21:06:45","18-May-2026 21:07:04","00:19","75","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","19-May-2026 ","19-May-2026 18:37:55","19-May-2026 18:38:08","00:13","76","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","20-May-2026 ","20-May-2026 22:15:44","20-May-2026 22:16:06","00:22","77","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","21-May-2026 ","21-May-2026 21:44:30","21-May-2026 21:44:46","00:16","78","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","22-May-2026 ","22-May-2026 18:49:41","22-May-2026 18:49:54","00:13","79","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","23-May-2026 ","23-May-2026 22:23:52","23-May-2026 22:24:37","00:45","80","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","24-May-2026 ","25-May-2026 18:07:16","25-May-2026 18:07:52","00:36","81","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","25-May-2026 ","25-May-2026 18:08:56","25-May-2026 18:09:26","00:30","82","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","26-May-2026 ","26-May-2026 21:43:50","26-May-2026 21:44:07","00:17","83","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012002","79","1","","27-May-2026 ","27-May-2026 22:01:50","27-May-2026 22:02:46","00:56","84","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012003","52","1","","05-May-2026 ","05-May-2026 18:01:55","05-May-2026 18:02:09","00:14","1","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","8","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012003","52","1","","06-May-2026 ","06-May-2026 20:29:15","06-May-2026 20:29:29","00:14","2","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012003","52","1","","07-May-2026 ","07-May-2026 22:18:42","07-May-2026 22:19:01","00:19","3","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012003","52","1","","08-May-2026 ","08-May-2026 22:31:03","08-May-2026 22:31:18","00:15","4","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012003","52","1","","09-May-2026 ","09-May-2026 22:22:24","09-May-2026 22:22:43","00:19","5","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012003","52","1","","10-May-2026 ","10-May-2026 23:12:50","10-May-2026 23:13:05","00:15","6","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012003","52","1","","11-May-2026 ","11-May-2026 21:16:13","11-May-2026 21:16:37","00:24","7","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012003","52","1","","12-May-2026 ","12-May-2026 22:36:19","12-May-2026 22:36:35","00:16","8","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012003","52","1","","13-May-2026 ","13-May-2026 20:07:41","13-May-2026 20:08:02","00:21","9","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012003","52","1","","15-May-2026 ","15-May-2026 23:23:21","15-May-2026 23:23:32","00:11","10","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012003","52","1","","16-May-2026 ","17-May-2026 21:56:34","17-May-2026 21:56:46","00:12","11","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012003","52","1","","17-May-2026 ","17-May-2026 21:57:29","17-May-2026 21:57:49","00:20","12","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012003","52","1","","18-May-2026 ","18-May-2026 22:48:11","18-May-2026 22:48:25","00:14","13","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012003","52","1","","19-May-2026 ","19-May-2026 18:38:52","19-May-2026 18:39:17","00:25","14","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012003","52","1","","20-May-2026 ","20-May-2026 22:15:48","20-May-2026 22:16:02","00:14","15","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012003","52","1","","21-May-2026 ","21-May-2026 19:42:51","21-May-2026 19:43:04","00:13","16","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012003","52","1","","22-May-2026 ","22-May-2026 18:04:07","22-May-2026 18:04:26","00:19","17","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","9","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012003","52","1","","23-May-2026 ","23-May-2026 22:26:18","23-May-2026 22:26:29","00:11","18","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","8","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012003","52","1","","24-May-2026 ","25-May-2026 18:08:46","25-May-2026 18:09:14","00:28","19","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012003","52","1","","25-May-2026 ","25-May-2026 18:10:28","25-May-2026 18:10:50","00:22","20","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","9","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012003","52","1","","26-May-2026 ","26-May-2026 21:13:16","26-May-2026 21:13:33","00:17","21","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","6","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10001","Matej Falc","CZ100012003","52","1","","27-May-2026 ","27-May-2026 22:03:15","27-May-2026 22:04:03","00:48","22","Patient","Handheld","Handheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10003","Leksa Vaclav","CZ100032001","30","2","","13-May-2026 ","13-May-2026 21:40:48","13-May-2026 21:41:52","01:04","1","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10003","Leksa Vaclav","CZ100032001","30","2","","14-May-2026 ","14-May-2026 21:39:37","14-May-2026 21:40:25","00:48","2","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10003","Leksa Vaclav","CZ100032001","30","2","","15-May-2026 ","15-May-2026 23:28:11","15-May-2026 23:28:26","00:15","3","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10003","Leksa Vaclav","CZ100032001","30","2","","16-May-2026 ","16-May-2026 22:36:22","16-May-2026 22:36:56","00:34","4","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10003","Leksa Vaclav","CZ100032001","30","2","","17-May-2026 ","17-May-2026 21:24:12","17-May-2026 21:24:34","00:22","5","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10003","Leksa Vaclav","CZ100032001","30","2","","18-May-2026 ","18-May-2026 22:07:40","18-May-2026 22:07:59","00:19","6","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10003","Leksa Vaclav","CZ100032001","30","2","","19-May-2026 ","19-May-2026 22:03:42","19-May-2026 22:03:55","00:13","7","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10003","Leksa Vaclav","CZ100032001","30","2","","20-May-2026 ","20-May-2026 23:04:59","20-May-2026 23:05:17","00:18","8","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10003","Leksa Vaclav","CZ100032001","30","2","","21-May-2026 ","21-May-2026 23:14:46","21-May-2026 23:15:04","00:18","9","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10003","Leksa Vaclav","CZ100032001","30","2","","22-May-2026 ","22-May-2026 23:02:18","22-May-2026 23:02:43","00:25","10","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10003","Leksa Vaclav","CZ100032001","30","2","","23-May-2026 ","23-May-2026 21:45:15","23-May-2026 21:45:28","00:13","11","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10003","Leksa Vaclav","CZ100032001","30","2","","24-May-2026 ","24-May-2026 22:28:16","24-May-2026 22:29:20","01:04","12","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10003","Leksa Vaclav","CZ100032001","30","2","","25-May-2026 ","25-May-2026 22:41:05","25-May-2026 22:48:09","07:04","13","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10003","Leksa Vaclav","CZ100032001","30","2","","26-May-2026 ","26-May-2026 23:09:08","26-May-2026 23:10:22","01:14","14","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10003","Leksa Vaclav","CZ100032001","30","2","","27-May-2026 ","27-May-2026 22:44:40","27-May-2026 22:45:03","00:23","15","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","14-Feb-2026 ","14-Feb-2026 18:03:39","14-Feb-2026 18:04:26","00:47","1","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","15-Feb-2026 ","15-Feb-2026 18:01:50","15-Feb-2026 18:02:24","00:34","2","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","16-Feb-2026 ","16-Feb-2026 18:01:30","16-Feb-2026 18:01:56","00:26","3","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","17-Feb-2026 ","17-Feb-2026 18:01:04","17-Feb-2026 18:01:14","00:10","4","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","18-Feb-2026 ","18-Feb-2026 18:02:17","18-Feb-2026 18:02:32","00:15","5","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","19-Feb-2026 ","19-Feb-2026 18:09:20","19-Feb-2026 18:09:50","00:30","6","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","5","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","20-Feb-2026 ","20-Feb-2026 18:14:47","20-Feb-2026 18:15:20","00:33","7","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","21-Feb-2026 ","21-Feb-2026 18:03:34","21-Feb-2026 18:03:56","00:22","8","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","22-Feb-2026 ","22-Feb-2026 20:08:20","22-Feb-2026 20:08:34","00:14","9","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","23-Feb-2026 ","23-Feb-2026 18:01:20","23-Feb-2026 18:01:41","00:21","10","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","24-Feb-2026 ","24-Feb-2026 18:01:33","24-Feb-2026 18:01:44","00:11","11","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","25-Feb-2026 ","25-Feb-2026 19:01:41","25-Feb-2026 19:01:55","00:14","12","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","26-Feb-2026 ","26-Feb-2026 18:03:34","26-Feb-2026 18:03:52","00:18","13","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","1","Yes","0","","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","27-Feb-2026 ","27-Feb-2026 20:42:12","27-Feb-2026 20:42:21","00:09","14","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","28-Feb-2026 ","28-Feb-2026 18:01:04","28-Feb-2026 18:01:15","00:11","15","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","01-Mar-2026 ","01-Mar-2026 18:01:16","01-Mar-2026 18:01:32","00:16","16","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","02-Mar-2026 ","03-Mar-2026 05:26:34","03-Mar-2026 05:26:46","00:12","17","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","03-Mar-2026 ","03-Mar-2026 18:04:19","03-Mar-2026 18:04:31","00:12","18","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","04-Mar-2026 ","04-Mar-2026 18:01:30","04-Mar-2026 18:01:49","00:19","19","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","05-Mar-2026 ","05-Mar-2026 18:45:17","05-Mar-2026 18:45:33","00:16","20","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","7","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","06-Mar-2026 ","06-Mar-2026 18:01:03","06-Mar-2026 18:01:14","00:11","21","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","8","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","07-Mar-2026 ","07-Mar-2026 18:02:17","07-Mar-2026 18:02:32","00:15","22","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","8","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","08-Mar-2026 ","08-Mar-2026 19:22:45","08-Mar-2026 19:23:09","00:24","23","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","9","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","09-Mar-2026 ","09-Mar-2026 18:31:35","09-Mar-2026 18:31:47","00:12","24","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","10-Mar-2026 ","11-Mar-2026 04:23:18","11-Mar-2026 04:23:33","00:15","25","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","9","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","11-Mar-2026 ","11-Mar-2026 19:37:36","11-Mar-2026 19:37:46","00:10","26","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","12-Mar-2026 ","12-Mar-2026 18:38:17","12-Mar-2026 18:38:48","00:31","27","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","13-Mar-2026 ","13-Mar-2026 18:11:32","13-Mar-2026 18:12:40","01:08","28","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","14-Mar-2026 ","15-Mar-2026 18:01:21","15-Mar-2026 18:01:42","00:21","29","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","15-Mar-2026 ","15-Mar-2026 18:02:03","15-Mar-2026 18:02:15","00:12","30","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","16-Mar-2026 ","16-Mar-2026 18:01:07","16-Mar-2026 18:01:18","00:11","31","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","17-Mar-2026 ","17-Mar-2026 18:01:24","17-Mar-2026 18:01:45","00:21","32","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","18-Mar-2026 ","18-Mar-2026 18:01:37","18-Mar-2026 18:01:49","00:12","33","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","19-Mar-2026 ","19-Mar-2026 22:33:50","19-Mar-2026 22:34:02","00:12","34","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","20-Mar-2026 ","20-Mar-2026 18:15:17","20-Mar-2026 18:15:44","00:27","35","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","1","Yes","0","","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","22-Mar-2026 ","23-Mar-2026 14:36:21","23-Mar-2026 14:36:42","00:21","36","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","1","Yes","0","","15","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","23-Mar-2026 ","23-Mar-2026 18:01:19","23-Mar-2026 18:01:30","00:11","37","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","1","Yes","0","","17","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","24-Mar-2026 ","24-Mar-2026 18:01:21","24-Mar-2026 18:01:30","00:09","38","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","1","Yes","0","","13","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","25-Mar-2026 ","25-Mar-2026 18:25:02","25-Mar-2026 18:25:32","00:30","39","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","1","Yes","0","","13","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","26-Mar-2026 ","26-Mar-2026 21:16:14","26-Mar-2026 21:16:57","00:43","40","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","1","Yes","0","","8","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","27-Mar-2026 ","27-Mar-2026 18:01:41","27-Mar-2026 18:02:23","00:42","41","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","1","Yes","0","","8","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","28-Mar-2026 ","28-Mar-2026 18:02:57","28-Mar-2026 18:03:21","00:24","42","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","1","Yes","0","","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","29-Mar-2026 ","29-Mar-2026 19:21:39","29-Mar-2026 19:21:51","00:12","43","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","1","Yes","0","","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","30-Mar-2026 ","30-Mar-2026 18:44:16","30-Mar-2026 18:44:28","00:12","44","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","1","Yes","0","","10","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","31-Mar-2026 ","31-Mar-2026 21:37:52","31-Mar-2026 21:38:05","00:13","45","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","1","Yes","0","","14","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","01-Apr-2026 ","01-Apr-2026 21:10:45","01-Apr-2026 21:11:02","00:17","46","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","1","Yes","0","","12","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","02-Apr-2026 ","03-Apr-2026 18:42:35","03-Apr-2026 18:42:48","00:13","47","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","1","Yes","0","","10","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","03-Apr-2026 ","03-Apr-2026 18:43:12","03-Apr-2026 18:43:21","00:09","48","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","1","Yes","0","","11","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","04-Apr-2026 ","04-Apr-2026 22:55:47","04-Apr-2026 22:55:57","00:10","49","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","1","Yes","0","","13","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","05-Apr-2026 ","06-Apr-2026 18:01:34","06-Apr-2026 18:01:49","00:15","50","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","1","Yes","0","","10","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","06-Apr-2026 ","06-Apr-2026 18:02:13","06-Apr-2026 18:02:23","00:10","51","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","1","Yes","0","","16","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","07-Apr-2026 ","07-Apr-2026 20:36:00","07-Apr-2026 20:36:10","00:10","52","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","1","Yes","0","","17","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","08-Apr-2026 ","09-Apr-2026 18:12:35","09-Apr-2026 18:12:49","00:14","53","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","18","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","09-Apr-2026 ","09-Apr-2026 18:13:13","09-Apr-2026 18:13:27","00:14","54","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","18","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","10-Apr-2026 ","11-Apr-2026 18:01:29","11-Apr-2026 18:01:43","00:14","55","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","17","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","11-Apr-2026 ","11-Apr-2026 18:02:09","11-Apr-2026 18:02:19","00:10","56","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","19","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","12-Apr-2026 ","12-Apr-2026 18:01:35","12-Apr-2026 18:01:55","00:20","57","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","20","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","13-Apr-2026 ","13-Apr-2026 18:01:30","13-Apr-2026 18:01:51","00:21","58","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","22","1","Yes, I confirm this is the correct stool count","3","Blood alone passed","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","14-Apr-2026 ","14-Apr-2026 19:02:00","14-Apr-2026 19:02:23","00:23","59","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","9","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","15-Apr-2026 ","15-Apr-2026 18:26:38","15-Apr-2026 18:26:49","00:11","60","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","12","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","18-Apr-2026 ","19-Apr-2026 14:44:39","19-Apr-2026 14:44:50","00:11","61","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","19-Apr-2026 ","19-Apr-2026 18:01:18","19-Apr-2026 18:01:27","00:09","62","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","20-Apr-2026 ","20-Apr-2026 20:33:26","20-Apr-2026 20:33:37","00:11","63","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","21-Apr-2026 ","22-Apr-2026 21:55:40","22-Apr-2026 21:55:51","00:11","64","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","22-Apr-2026 ","22-Apr-2026 21:56:21","22-Apr-2026 21:56:30","00:09","65","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","23-Apr-2026 ","23-Apr-2026 18:46:35","23-Apr-2026 18:46:49","00:14","66","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","9","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","24-Apr-2026 ","25-Apr-2026 18:23:56","25-Apr-2026 18:24:09","00:13","67","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","25-Apr-2026 ","25-Apr-2026 18:24:36","25-Apr-2026 18:24:46","00:10","68","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","9","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","26-Apr-2026 ","26-Apr-2026 21:00:47","26-Apr-2026 21:00:56","00:09","69","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","27-Apr-2026 ","27-Apr-2026 18:22:29","27-Apr-2026 18:22:37","00:08","70","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","28-Apr-2026 ","28-Apr-2026 22:44:39","28-Apr-2026 22:44:49","00:10","71","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","9","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","29-Apr-2026 ","29-Apr-2026 22:49:50","29-Apr-2026 22:49:59","00:09","72","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","8","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","30-Apr-2026 ","30-Apr-2026 20:47:29","30-Apr-2026 20:47:37","00:08","73","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","10","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","01-May-2026 ","01-May-2026 21:43:23","01-May-2026 21:43:33","00:10","74","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","9","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","02-May-2026 ","02-May-2026 21:07:46","02-May-2026 21:07:56","00:10","75","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","9","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","03-May-2026 ","03-May-2026 21:43:35","03-May-2026 21:43:47","00:12","76","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","05-May-2026 ","06-May-2026 18:20:31","06-May-2026 18:20:43","00:12","77","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","9","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","06-May-2026 ","06-May-2026 18:21:12","06-May-2026 18:21:22","00:10","78","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","07-May-2026 ","07-May-2026 20:37:45","07-May-2026 20:38:13","00:28","79","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","10","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","08-May-2026 ","08-May-2026 18:31:28","08-May-2026 18:31:38","00:10","80","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","09-May-2026 ","09-May-2026 21:38:50","09-May-2026 21:38:58","00:08","81","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","10-May-2026 ","10-May-2026 22:01:51","10-May-2026 22:02:04","00:13","82","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","11-May-2026 ","11-May-2026 22:42:31","11-May-2026 22:42:39","00:08","83","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","12-May-2026 ","12-May-2026 19:03:36","12-May-2026 19:03:48","00:12","84","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","13-May-2026 ","13-May-2026 20:59:19","13-May-2026 20:59:30","00:11","85","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","14-May-2026 ","14-May-2026 20:18:42","14-May-2026 20:18:54","00:12","86","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","15-May-2026 ","15-May-2026 20:48:11","15-May-2026 20:48:21","00:10","87","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","9","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","16-May-2026 ","17-May-2026 19:32:54","17-May-2026 19:33:03","00:09","88","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","17-May-2026 ","17-May-2026 19:33:35","17-May-2026 19:33:43","00:08","89","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","18-May-2026 ","18-May-2026 20:55:22","18-May-2026 20:55:31","00:09","90","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","19-May-2026 ","19-May-2026 22:00:42","19-May-2026 22:00:50","00:08","91","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","20-May-2026 ","20-May-2026 19:56:20","20-May-2026 19:56:35","00:15","92","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","21-May-2026 ","21-May-2026 20:02:23","21-May-2026 20:02:32","00:09","93","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","22-May-2026 ","22-May-2026 22:00:12","22-May-2026 22:00:25","00:13","94","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","7","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","23-May-2026 ","23-May-2026 22:09:23","23-May-2026 22:09:31","00:08","95","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","24-May-2026 ","25-May-2026 19:37:07","25-May-2026 19:37:19","00:12","96","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","25-May-2026 ","25-May-2026 19:37:51","25-May-2026 19:38:01","00:10","97","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","26-May-2026 ","26-May-2026 19:50:53","26-May-2026 19:51:00","00:07","98","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062001","19","1","","27-May-2026 ","27-May-2026 21:24:04","27-May-2026 21:24:12","00:08","99","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","20-Apr-2026 ","20-Apr-2026 21:15:38","20-Apr-2026 21:16:41","01:03","1","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","21-Apr-2026 ","21-Apr-2026 18:03:25","21-Apr-2026 18:04:56","01:31","2","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","22-Apr-2026 ","22-Apr-2026 19:12:37","22-Apr-2026 19:13:09","00:32","3","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","23-Apr-2026 ","23-Apr-2026 20:30:34","23-Apr-2026 20:31:02","00:28","4","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","24-Apr-2026 ","24-Apr-2026 20:09:04","24-Apr-2026 20:09:46","00:42","5","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","25-Apr-2026 ","25-Apr-2026 20:06:32","25-Apr-2026 20:07:07","00:35","6","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","26-Apr-2026 ","26-Apr-2026 21:59:32","26-Apr-2026 22:00:01","00:29","7","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","27-Apr-2026 ","27-Apr-2026 19:38:17","27-Apr-2026 19:38:44","00:27","8","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","28-Apr-2026 ","28-Apr-2026 23:29:55","28-Apr-2026 23:30:19","00:24","9","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","29-Apr-2026 ","29-Apr-2026 19:44:25","29-Apr-2026 19:44:49","00:24","10","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","30-Apr-2026 ","30-Apr-2026 18:03:54","30-Apr-2026 18:04:24","00:30","11","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","01-May-2026 ","01-May-2026 21:14:03","01-May-2026 21:14:43","00:40","12","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","02-May-2026 ","02-May-2026 18:01:20","02-May-2026 18:01:55","00:35","13","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","03-May-2026 ","03-May-2026 23:02:06","03-May-2026 23:02:39","00:33","14","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","04-May-2026 ","04-May-2026 22:02:36","04-May-2026 22:03:10","00:34","15","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","05-May-2026 ","05-May-2026 20:28:15","05-May-2026 20:29:13","00:58","16","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","06-May-2026 ","06-May-2026 18:07:07","06-May-2026 18:08:40","01:33","17","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","07-May-2026 ","07-May-2026 21:39:42","07-May-2026 21:40:09","00:27","18","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","08-May-2026 ","08-May-2026 19:18:31","08-May-2026 19:19:10","00:39","19","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","09-May-2026 ","09-May-2026 22:03:28","09-May-2026 22:04:07","00:39","20","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","10-May-2026 ","10-May-2026 21:59:21","10-May-2026 22:00:01","00:40","21","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","11-May-2026 ","11-May-2026 20:50:01","11-May-2026 20:50:22","00:21","22","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","12-May-2026 ","12-May-2026 22:35:56","12-May-2026 22:36:50","00:54","23","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","13-May-2026 ","13-May-2026 21:41:50","13-May-2026 21:42:19","00:29","24","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","14-May-2026 ","14-May-2026 21:16:25","14-May-2026 21:17:02","00:37","25","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","15-May-2026 ","15-May-2026 21:52:56","15-May-2026 21:53:22","00:26","26","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","16-May-2026 ","16-May-2026 18:31:25","16-May-2026 18:31:51","00:26","27","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","17-May-2026 ","17-May-2026 20:47:42","17-May-2026 20:48:00","00:18","28","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","18-May-2026 ","19-May-2026 06:20:57","19-May-2026 06:21:20","00:23","29","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","19-May-2026 ","19-May-2026 20:42:32","19-May-2026 20:42:58","00:26","30","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","20-May-2026 ","21-May-2026 06:15:07","21-May-2026 06:15:24","00:17","31","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","21-May-2026 ","21-May-2026 21:38:28","21-May-2026 21:39:00","00:32","32","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","22-May-2026 ","22-May-2026 22:14:30","22-May-2026 22:14:59","00:29","33","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","23-May-2026 ","23-May-2026 22:46:03","23-May-2026 22:46:25","00:22","34","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","24-May-2026 ","25-May-2026 07:10:54","25-May-2026 07:11:24","00:30","35","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","25-May-2026 ","25-May-2026 19:21:24","25-May-2026 19:21:48","00:24","36","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10006","Michal Konecny","CZ100062002","49","1","","26-May-2026 ","26-May-2026 20:04:29","26-May-2026 20:05:07","00:38","37","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","31-Mar-2026 ","31-Mar-2026 18:29:57","31-Mar-2026 18:47:37","17:40","1","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","01-Apr-2026 ","01-Apr-2026 18:31:44","01-Apr-2026 18:33:40","01:56","2","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","02-Apr-2026 ","02-Apr-2026 18:36:48","02-Apr-2026 18:37:55","01:07","3","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","03-Apr-2026 ","03-Apr-2026 18:33:32","03-Apr-2026 18:34:22","00:50","4","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","04-Apr-2026 ","04-Apr-2026 18:34:52","04-Apr-2026 18:35:36","00:44","5","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","05-Apr-2026 ","05-Apr-2026 19:08:11","05-Apr-2026 19:08:38","00:27","6","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","06-Apr-2026 ","06-Apr-2026 18:33:36","06-Apr-2026 18:34:13","00:37","7","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","07-Apr-2026 ","07-Apr-2026 18:47:34","07-Apr-2026 18:48:10","00:36","8","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","08-Apr-2026 ","09-Apr-2026 18:23:22","09-Apr-2026 18:24:09","00:47","9","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","09-Apr-2026 ","09-Apr-2026 18:24:36","09-Apr-2026 18:25:06","00:30","10","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","10-Apr-2026 ","10-Apr-2026 18:01:29","10-Apr-2026 18:02:12","00:43","11","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","11-Apr-2026 ","11-Apr-2026 18:17:12","11-Apr-2026 18:18:02","00:50","12","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","12-Apr-2026 ","12-Apr-2026 18:04:08","12-Apr-2026 18:05:08","01:00","13","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","13-Apr-2026 ","13-Apr-2026 18:29:53","13-Apr-2026 18:30:18","00:25","14","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","14-Apr-2026 ","14-Apr-2026 18:16:55","14-Apr-2026 18:17:17","00:22","15","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","15-Apr-2026 ","15-Apr-2026 18:11:38","15-Apr-2026 18:12:08","00:30","16","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","16-Apr-2026 ","16-Apr-2026 18:09:46","16-Apr-2026 18:10:31","00:45","17","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","17-Apr-2026 ","17-Apr-2026 18:42:09","17-Apr-2026 18:43:13","01:04","18","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","18-Apr-2026 ","18-Apr-2026 18:15:17","18-Apr-2026 18:16:21","01:04","19","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","19-Apr-2026 ","19-Apr-2026 19:05:45","19-Apr-2026 19:06:13","00:28","20","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","20-Apr-2026 ","20-Apr-2026 18:27:20","20-Apr-2026 18:28:23","01:03","21","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","21-Apr-2026 ","21-Apr-2026 18:19:48","21-Apr-2026 18:20:25","00:37","22","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","22-Apr-2026 ","22-Apr-2026 18:12:05","22-Apr-2026 18:12:42","00:37","23","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","0","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","23-Apr-2026 ","23-Apr-2026 18:05:12","23-Apr-2026 18:05:40","00:28","24","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","24-Apr-2026 ","24-Apr-2026 18:15:58","24-Apr-2026 18:16:23","00:25","25","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","25-Apr-2026 ","25-Apr-2026 18:27:21","25-Apr-2026 18:27:43","00:22","26","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","26-Apr-2026 ","26-Apr-2026 19:37:21","26-Apr-2026 19:37:44","00:23","27","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","27-Apr-2026 ","27-Apr-2026 18:32:55","27-Apr-2026 18:33:18","00:23","28","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","28-Apr-2026 ","28-Apr-2026 18:12:37","28-Apr-2026 18:13:06","00:29","29","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","29-Apr-2026 ","29-Apr-2026 18:22:57","29-Apr-2026 18:23:18","00:21","30","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","30-Apr-2026 ","30-Apr-2026 18:05:56","30-Apr-2026 18:06:38","00:42","31","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","01-May-2026 ","01-May-2026 18:06:30","01-May-2026 18:06:53","00:23","32","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","02-May-2026 ","02-May-2026 18:06:44","02-May-2026 18:07:10","00:26","33","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","03-May-2026 ","03-May-2026 18:20:14","03-May-2026 18:20:40","00:26","34","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","04-May-2026 ","04-May-2026 18:10:14","04-May-2026 18:10:39","00:25","35","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","05-May-2026 ","05-May-2026 18:13:52","05-May-2026 18:14:14","00:22","36","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","06-May-2026 ","06-May-2026 18:27:25","06-May-2026 18:27:43","00:18","37","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","07-May-2026 ","07-May-2026 18:16:09","07-May-2026 18:16:34","00:25","38","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","08-May-2026 ","08-May-2026 18:05:30","08-May-2026 18:05:50","00:20","39","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","09-May-2026 ","09-May-2026 18:03:43","09-May-2026 18:04:01","00:18","40","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","10-May-2026 ","10-May-2026 18:13:20","10-May-2026 18:13:42","00:22","41","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","11-May-2026 ","11-May-2026 18:02:26","11-May-2026 18:02:54","00:28","42","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","12-May-2026 ","12-May-2026 18:16:11","12-May-2026 18:16:34","00:23","43","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","13-May-2026 ","13-May-2026 18:13:23","13-May-2026 18:13:42","00:19","44","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","14-May-2026 ","14-May-2026 18:18:23","14-May-2026 18:18:56","00:33","45","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","15-May-2026 ","15-May-2026 18:05:23","15-May-2026 18:05:47","00:24","46","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","16-May-2026 ","16-May-2026 19:15:24","16-May-2026 19:15:50","00:26","47","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","17-May-2026 ","17-May-2026 18:42:31","17-May-2026 18:42:46","00:15","48","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","18-May-2026 ","18-May-2026 18:07:10","18-May-2026 18:07:31","00:21","49","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","19-May-2026 ","19-May-2026 18:08:00","19-May-2026 18:08:22","00:22","50","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","20-May-2026 ","20-May-2026 18:46:47","20-May-2026 18:47:10","00:23","51","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","21-May-2026 ","21-May-2026 18:25:08","21-May-2026 18:25:33","00:25","52","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","22-May-2026 ","22-May-2026 18:10:28","22-May-2026 18:10:57","00:29","53","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","23-May-2026 ","23-May-2026 18:49:12","23-May-2026 18:49:37","00:25","54","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","24-May-2026 ","24-May-2026 18:24:57","24-May-2026 18:25:19","00:22","55","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","25-May-2026 ","25-May-2026 18:59:42","25-May-2026 19:00:03","00:21","56","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","26-May-2026 ","26-May-2026 19:02:50","26-May-2026 19:03:13","00:23","57","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092001","49","1","","27-May-2026 ","27-May-2026 18:16:05","27-May-2026 18:16:24","00:19","58","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","16-Apr-2026 ","16-Apr-2026 18:04:28","16-Apr-2026 18:06:48","02:20","1","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","17-Apr-2026 ","17-Apr-2026 21:22:55","17-Apr-2026 21:25:27","02:32","2","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","0","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","18-Apr-2026 ","19-Apr-2026 20:05:25","19-Apr-2026 20:07:39","02:14","3","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","0","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","19-Apr-2026 ","19-Apr-2026 20:08:07","19-Apr-2026 20:12:24","04:17","4","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","20-Apr-2026 ","21-Apr-2026 21:33:43","21-Apr-2026 21:36:30","02:47","5","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","21-Apr-2026 ","21-Apr-2026 21:37:06","21-Apr-2026 21:38:37","01:31","6","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","0","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","22-Apr-2026 ","23-Apr-2026 22:28:26","23-Apr-2026 22:30:27","02:01","7","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","0","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","23-Apr-2026 ","23-Apr-2026 22:31:08","23-Apr-2026 22:32:58","01:50","8","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","24-Apr-2026 ","25-Apr-2026 19:10:46","25-Apr-2026 19:13:10","02:24","9","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","25-Apr-2026 ","25-Apr-2026 19:13:39","25-Apr-2026 19:14:21","00:42","10","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","26-Apr-2026 ","26-Apr-2026 20:00:34","26-Apr-2026 20:01:48","01:14","11","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","0","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","27-Apr-2026 ","27-Apr-2026 20:59:09","27-Apr-2026 21:03:03","03:54","12","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","28-Apr-2026 ","29-Apr-2026 12:06:59","29-Apr-2026 12:09:04","02:05","13","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","29-Apr-2026 ","30-Apr-2026 20:47:12","30-Apr-2026 20:48:25","01:13","14","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","30-Apr-2026 ","30-Apr-2026 20:48:54","30-Apr-2026 20:49:27","00:33","15","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","0","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","01-May-2026 ","01-May-2026 23:05:43","01-May-2026 23:08:41","02:58","16","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","02-May-2026 ","02-May-2026 21:59:39","02-May-2026 22:00:07","00:28","17","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","03-May-2026 ","03-May-2026 20:48:50","03-May-2026 20:49:39","00:49","18","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","04-May-2026 ","04-May-2026 23:06:12","04-May-2026 23:07:05","00:53","19","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","05-May-2026 ","05-May-2026 22:34:33","05-May-2026 22:36:46","02:13","20","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","06-May-2026 ","07-May-2026 20:20:36","07-May-2026 20:21:23","00:47","21","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","07-May-2026 ","07-May-2026 20:21:51","07-May-2026 20:22:22","00:31","22","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","09-May-2026 ","10-May-2026 09:56:26","10-May-2026 09:57:46","01:20","23","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","12-May-2026 ","12-May-2026 23:17:00","12-May-2026 23:17:43","00:43","24","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","13-May-2026 ","13-May-2026 19:25:14","13-May-2026 19:26:42","01:28","25","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","0","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","14-May-2026 ","14-May-2026 18:38:36","14-May-2026 18:39:02","00:26","26","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","15-May-2026 ","15-May-2026 22:58:22","15-May-2026 22:59:14","00:52","27","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","16-May-2026 ","16-May-2026 23:23:13","16-May-2026 23:23:30","00:17","28","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","17-May-2026 ","18-May-2026 12:46:24","18-May-2026 12:47:00","00:36","29","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10009","Jiri Pumprla","CZ100092002","55","1","","18-May-2026 ","18-May-2026 23:24:01","18-May-2026 23:26:28","02:27","30","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","18-Mar-2026 ","18-Mar-2026 18:17:26","18-Mar-2026 18:18:51","01:25","1","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","19-Mar-2026 ","19-Mar-2026 18:01:22","19-Mar-2026 18:02:22","01:00","2","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","20-Mar-2026 ","20-Mar-2026 18:01:14","20-Mar-2026 18:02:17","01:03","3","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","21-Mar-2026 ","21-Mar-2026 18:28:25","21-Mar-2026 18:28:40","00:15","4","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","9","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","22-Mar-2026 ","22-Mar-2026 18:01:58","22-Mar-2026 18:02:15","00:17","5","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","9","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","23-Mar-2026 ","24-Mar-2026 00:33:23","24-Mar-2026 00:33:51","00:28","6","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","24-Mar-2026 ","24-Mar-2026 18:01:20","24-Mar-2026 18:01:42","00:22","7","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","25-Mar-2026 ","25-Mar-2026 18:05:59","25-Mar-2026 18:06:09","00:10","8","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","9","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","26-Mar-2026 ","26-Mar-2026 18:57:42","26-Mar-2026 18:58:00","00:18","9","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","8","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","27-Mar-2026 ","27-Mar-2026 18:05:26","27-Mar-2026 18:05:44","00:18","10","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","8","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","28-Mar-2026 ","28-Mar-2026 18:34:55","28-Mar-2026 18:35:13","00:18","11","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","11","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","29-Mar-2026 ","29-Mar-2026 18:01:26","29-Mar-2026 18:01:40","00:14","12","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","10","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","30-Mar-2026 ","30-Mar-2026 18:15:14","30-Mar-2026 18:15:34","00:20","13","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","10","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","31-Mar-2026 ","31-Mar-2026 18:03:24","31-Mar-2026 18:03:43","00:19","14","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","13","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","01-Apr-2026 ","01-Apr-2026 18:19:46","01-Apr-2026 18:20:00","00:14","15","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","10","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","02-Apr-2026 ","02-Apr-2026 19:54:55","02-Apr-2026 19:55:05","00:10","16","Patient","BYODHandheld","BYODHandheld","0","","0","","1","Yes","0","","11","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","03-Apr-2026 ","03-Apr-2026 22:16:32","03-Apr-2026 22:16:45","00:13","17","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","9","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","04-Apr-2026 ","04-Apr-2026 18:04:41","04-Apr-2026 18:05:01","00:20","18","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","5","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","05-Apr-2026 ","05-Apr-2026 22:47:52","05-Apr-2026 22:48:02","00:10","19","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","11","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","06-Apr-2026 ","07-Apr-2026 06:06:47","07-Apr-2026 06:07:10","00:23","20","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","1","Yes","0","","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","07-Apr-2026 ","07-Apr-2026 18:10:33","07-Apr-2026 18:11:05","00:32","21","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","08-Apr-2026 ","09-Apr-2026 21:11:31","09-Apr-2026 21:12:00","00:29","22","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","09-Apr-2026 ","09-Apr-2026 21:12:19","09-Apr-2026 21:12:49","00:30","23","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","10-Apr-2026 ","10-Apr-2026 18:04:26","10-Apr-2026 18:04:42","00:16","24","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","11-Apr-2026 ","11-Apr-2026 19:27:38","11-Apr-2026 19:27:54","00:16","25","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","13","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","12-Apr-2026 ","12-Apr-2026 18:01:17","12-Apr-2026 18:01:29","00:12","26","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","13-Apr-2026 ","14-Apr-2026 05:43:24","14-Apr-2026 05:43:41","00:17","27","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","14-Apr-2026 ","14-Apr-2026 18:23:04","14-Apr-2026 18:23:16","00:12","28","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","15-Apr-2026 ","15-Apr-2026 18:01:41","15-Apr-2026 18:01:50","00:09","29","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","16-Apr-2026 ","16-Apr-2026 18:20:20","16-Apr-2026 18:20:33","00:13","30","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","17-Apr-2026 ","17-Apr-2026 18:30:28","17-Apr-2026 18:30:46","00:18","31","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","18-Apr-2026 ","18-Apr-2026 22:43:21","18-Apr-2026 22:43:31","00:10","32","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","19-Apr-2026 ","19-Apr-2026 18:20:54","19-Apr-2026 18:21:17","00:23","33","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","20-Apr-2026 ","21-Apr-2026 06:17:37","21-Apr-2026 06:18:03","00:26","34","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","21-Apr-2026 ","21-Apr-2026 18:01:02","21-Apr-2026 18:01:33","00:31","35","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","22-Apr-2026 ","22-Apr-2026 19:26:08","22-Apr-2026 19:26:32","00:24","36","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","23-Apr-2026 ","23-Apr-2026 18:11:27","23-Apr-2026 18:11:39","00:12","37","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","24-Apr-2026 ","24-Apr-2026 21:33:17","24-Apr-2026 21:33:38","00:21","38","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","13","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","25-Apr-2026 ","25-Apr-2026 21:50:02","25-Apr-2026 21:50:24","00:22","39","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","26-Apr-2026 ","26-Apr-2026 19:05:52","26-Apr-2026 19:06:03","00:11","40","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","27-Apr-2026 ","27-Apr-2026 18:39:18","27-Apr-2026 18:39:30","00:12","41","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","28-Apr-2026 ","28-Apr-2026 18:31:50","28-Apr-2026 18:32:10","00:20","42","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","29-Apr-2026 ","29-Apr-2026 18:46:29","29-Apr-2026 18:46:58","00:29","43","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","11","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","30-Apr-2026 ","30-Apr-2026 18:14:43","30-Apr-2026 18:15:07","00:24","44","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","01-May-2026 ","01-May-2026 22:22:43","01-May-2026 22:22:57","00:14","45","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","11","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","02-May-2026 ","02-May-2026 18:04:04","02-May-2026 18:04:16","00:12","46","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","03-May-2026 ","03-May-2026 18:02:06","03-May-2026 18:03:05","00:59","47","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","04-May-2026 ","04-May-2026 18:33:13","04-May-2026 18:33:26","00:13","48","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","05-May-2026 ","05-May-2026 19:02:55","05-May-2026 19:03:06","00:11","49","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","06-May-2026 ","06-May-2026 18:03:45","06-May-2026 18:04:11","00:26","50","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","07-May-2026 ","07-May-2026 21:26:53","07-May-2026 21:27:10","00:17","51","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","08-May-2026 ","08-May-2026 18:36:10","08-May-2026 18:36:31","00:21","52","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","09-May-2026 ","10-May-2026 19:42:33","10-May-2026 19:42:51","00:18","53","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","10-May-2026 ","10-May-2026 19:43:17","10-May-2026 19:43:27","00:10","54","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","11-May-2026 ","12-May-2026 06:36:35","12-May-2026 06:36:58","00:23","55","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","11","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","12-May-2026 ","13-May-2026 05:13:59","13-May-2026 05:14:14","00:15","56","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","13-May-2026 ","13-May-2026 18:05:45","13-May-2026 18:05:57","00:12","57","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","14-May-2026 ","14-May-2026 18:41:45","14-May-2026 18:41:59","00:14","58","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","15-May-2026 ","15-May-2026 19:46:08","15-May-2026 19:46:37","00:29","59","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","16-May-2026 ","16-May-2026 19:28:50","16-May-2026 19:29:04","00:14","60","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","17-May-2026 ","17-May-2026 19:42:34","17-May-2026 19:42:45","00:11","61","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","18-May-2026 ","18-May-2026 18:05:59","18-May-2026 18:06:14","00:15","62","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","19-May-2026 ","19-May-2026 19:20:23","19-May-2026 19:20:39","00:16","63","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","20-May-2026 ","20-May-2026 18:44:46","20-May-2026 18:44:58","00:12","64","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","21-May-2026 ","21-May-2026 18:26:11","21-May-2026 18:26:22","00:11","65","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","22-May-2026 ","22-May-2026 18:00:39","22-May-2026 18:01:09","00:30","66","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","23-May-2026 ","23-May-2026 19:15:06","23-May-2026 19:15:15","00:09","67","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","11","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","24-May-2026 ","24-May-2026 18:08:48","24-May-2026 18:09:01","00:13","68","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","25-May-2026 ","25-May-2026 21:52:52","25-May-2026 21:53:04","00:12","69","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","26-May-2026 ","26-May-2026 19:41:29","26-May-2026 19:41:42","00:13","70","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10012","Stefan Konecny","CZ100122001","22","5","Yes, I confirm this is the correct stool count.","27-May-2026 ","27-May-2026 19:08:12","27-May-2026 19:08:25","00:13","71","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","27-Feb-2026 ","27-Feb-2026 23:03:44","27-Feb-2026 23:05:27","01:43","1","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","28-Feb-2026 ","28-Feb-2026 22:00:47","28-Feb-2026 22:01:40","00:53","2","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","01-Mar-2026 ","01-Mar-2026 23:09:45","01-Mar-2026 23:10:07","00:22","3","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","02-Mar-2026 ","03-Mar-2026 21:17:31","03-Mar-2026 21:18:07","00:36","4","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","03-Mar-2026 ","03-Mar-2026 21:18:25","03-Mar-2026 21:18:51","00:26","5","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","04-Mar-2026 ","04-Mar-2026 21:07:08","04-Mar-2026 21:07:32","00:24","6","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","05-Mar-2026 ","05-Mar-2026 21:46:49","05-Mar-2026 21:47:07","00:18","7","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","06-Mar-2026 ","06-Mar-2026 20:40:38","06-Mar-2026 20:40:58","00:20","8","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","07-Mar-2026 ","07-Mar-2026 21:42:08","07-Mar-2026 21:42:22","00:14","9","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","08-Mar-2026 ","08-Mar-2026 21:03:19","08-Mar-2026 21:04:22","01:03","10","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","09-Mar-2026 ","09-Mar-2026 19:46:43","09-Mar-2026 19:47:09","00:26","11","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","10-Mar-2026 ","10-Mar-2026 20:21:28","10-Mar-2026 20:21:44","00:16","12","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","11-Mar-2026 ","11-Mar-2026 19:06:20","11-Mar-2026 19:06:34","00:14","13","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","12-Mar-2026 ","12-Mar-2026 21:14:54","12-Mar-2026 21:15:33","00:39","14","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","13-Mar-2026 ","13-Mar-2026 20:57:55","13-Mar-2026 20:58:17","00:22","15","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","14-Mar-2026 ","15-Mar-2026 07:17:23","15-Mar-2026 07:18:13","00:50","16","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","15-Mar-2026 ","15-Mar-2026 20:10:10","15-Mar-2026 20:10:42","00:32","17","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","16-Mar-2026 ","16-Mar-2026 22:25:52","16-Mar-2026 22:26:14","00:22","18","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","17-Mar-2026 ","17-Mar-2026 22:09:11","17-Mar-2026 22:09:28","00:17","19","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","18-Mar-2026 ","18-Mar-2026 20:38:45","18-Mar-2026 20:39:02","00:17","20","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","19-Mar-2026 ","19-Mar-2026 20:16:41","19-Mar-2026 20:16:54","00:13","21","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","20-Mar-2026 ","20-Mar-2026 22:41:13","20-Mar-2026 22:41:30","00:17","22","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","21-Mar-2026 ","21-Mar-2026 21:18:07","21-Mar-2026 21:19:04","00:57","23","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","22-Mar-2026 ","22-Mar-2026 22:15:27","22-Mar-2026 22:15:47","00:20","24","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","23-Mar-2026 ","23-Mar-2026 20:42:59","23-Mar-2026 20:43:09","00:10","25","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","24-Mar-2026 ","24-Mar-2026 20:00:24","24-Mar-2026 20:01:00","00:36","26","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","25-Mar-2026 ","25-Mar-2026 20:21:59","25-Mar-2026 20:22:17","00:18","27","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","26-Mar-2026 ","26-Mar-2026 21:44:02","26-Mar-2026 21:44:15","00:13","28","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","27-Mar-2026 ","28-Mar-2026 01:49:30","28-Mar-2026 01:49:52","00:22","29","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","28-Mar-2026 ","28-Mar-2026 20:43:13","28-Mar-2026 20:43:29","00:16","30","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","29-Mar-2026 ","29-Mar-2026 22:28:00","29-Mar-2026 22:28:35","00:35","31","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","30-Mar-2026 ","30-Mar-2026 21:46:17","30-Mar-2026 21:46:29","00:12","32","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","31-Mar-2026 ","31-Mar-2026 20:40:46","31-Mar-2026 20:40:58","00:12","33","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","01-Apr-2026 ","01-Apr-2026 21:24:04","01-Apr-2026 21:24:19","00:15","34","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","02-Apr-2026 ","02-Apr-2026 21:40:44","02-Apr-2026 21:40:59","00:15","35","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","03-Apr-2026 ","03-Apr-2026 22:39:57","03-Apr-2026 22:40:09","00:12","36","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","04-Apr-2026 ","04-Apr-2026 22:20:46","04-Apr-2026 22:21:00","00:14","37","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","05-Apr-2026 ","05-Apr-2026 22:23:58","05-Apr-2026 22:24:11","00:13","38","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","06-Apr-2026 ","06-Apr-2026 22:45:16","06-Apr-2026 22:45:36","00:20","39","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","07-Apr-2026 ","07-Apr-2026 23:22:12","07-Apr-2026 23:22:24","00:12","40","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","08-Apr-2026 ","09-Apr-2026 18:14:46","09-Apr-2026 18:14:59","00:13","41","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","09-Apr-2026 ","09-Apr-2026 18:15:24","09-Apr-2026 18:15:34","00:10","42","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","10-Apr-2026 ","10-Apr-2026 22:19:01","10-Apr-2026 22:19:17","00:16","43","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","11-Apr-2026 ","11-Apr-2026 22:52:56","11-Apr-2026 22:53:14","00:18","44","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","12-Apr-2026 ","12-Apr-2026 21:27:59","12-Apr-2026 21:28:08","00:09","45","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","13-Apr-2026 ","14-Apr-2026 00:16:06","14-Apr-2026 00:16:21","00:15","46","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","14-Apr-2026 ","14-Apr-2026 21:23:53","14-Apr-2026 21:24:03","00:10","47","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","15-Apr-2026 ","15-Apr-2026 18:45:29","15-Apr-2026 18:45:37","00:08","48","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","16-Apr-2026 ","16-Apr-2026 21:46:45","16-Apr-2026 21:46:56","00:11","49","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","17-Apr-2026 ","17-Apr-2026 21:47:44","17-Apr-2026 21:47:55","00:11","50","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","18-Apr-2026 ","18-Apr-2026 21:08:02","18-Apr-2026 21:08:16","00:14","51","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","19-Apr-2026 ","19-Apr-2026 21:06:45","19-Apr-2026 21:06:58","00:13","52","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","20-Apr-2026 ","20-Apr-2026 21:23:26","20-Apr-2026 21:23:36","00:10","53","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","21-Apr-2026 ","21-Apr-2026 21:56:38","21-Apr-2026 21:56:58","00:20","54","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","22-Apr-2026 ","22-Apr-2026 21:18:10","22-Apr-2026 21:18:20","00:10","55","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","23-Apr-2026 ","23-Apr-2026 21:46:41","23-Apr-2026 21:46:54","00:13","56","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","24-Apr-2026 ","24-Apr-2026 21:59:32","24-Apr-2026 21:59:56","00:24","57","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","25-Apr-2026 ","25-Apr-2026 22:34:04","25-Apr-2026 22:34:16","00:12","58","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","26-Apr-2026 ","26-Apr-2026 18:32:29","26-Apr-2026 18:32:39","00:10","59","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","27-Apr-2026 ","27-Apr-2026 20:48:50","27-Apr-2026 20:49:05","00:15","60","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","28-Apr-2026 ","28-Apr-2026 21:33:40","28-Apr-2026 21:33:56","00:16","61","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","29-Apr-2026 ","29-Apr-2026 22:24:17","29-Apr-2026 22:24:31","00:14","62","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","30-Apr-2026 ","30-Apr-2026 20:44:59","30-Apr-2026 20:45:10","00:11","63","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","01-May-2026 ","01-May-2026 22:08:20","01-May-2026 22:08:36","00:16","64","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","02-May-2026 ","02-May-2026 22:47:23","02-May-2026 22:47:36","00:13","65","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","03-May-2026 ","03-May-2026 22:04:34","03-May-2026 22:04:46","00:12","66","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","04-May-2026 ","04-May-2026 22:18:22","04-May-2026 22:18:37","00:15","67","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","05-May-2026 ","05-May-2026 20:52:05","05-May-2026 20:52:21","00:16","68","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","06-May-2026 ","06-May-2026 21:53:26","06-May-2026 21:53:40","00:14","69","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","07-May-2026 ","07-May-2026 22:03:10","07-May-2026 22:03:25","00:15","70","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","08-May-2026 ","09-May-2026 08:05:31","09-May-2026 08:06:06","00:35","71","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","09-May-2026 ","09-May-2026 22:35:37","09-May-2026 22:36:16","00:39","72","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","10-May-2026 ","10-May-2026 22:57:33","10-May-2026 22:57:43","00:10","73","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","11-May-2026 ","11-May-2026 22:05:17","11-May-2026 22:05:27","00:10","74","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","12-May-2026 ","12-May-2026 22:11:54","12-May-2026 22:12:06","00:12","75","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","13-May-2026 ","13-May-2026 19:03:38","13-May-2026 19:03:48","00:10","76","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","14-May-2026 ","14-May-2026 21:45:03","14-May-2026 21:45:12","00:09","77","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","15-May-2026 ","15-May-2026 21:23:03","15-May-2026 21:23:15","00:12","78","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","16-May-2026 ","16-May-2026 22:50:45","16-May-2026 22:50:54","00:09","79","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","17-May-2026 ","17-May-2026 23:21:33","17-May-2026 23:21:47","00:14","80","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","18-May-2026 ","18-May-2026 20:53:38","18-May-2026 20:53:47","00:09","81","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","19-May-2026 ","19-May-2026 22:30:38","19-May-2026 22:30:47","00:09","82","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","20-May-2026 ","20-May-2026 22:46:06","20-May-2026 22:46:26","00:20","83","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","21-May-2026 ","21-May-2026 21:37:09","21-May-2026 21:37:24","00:15","84","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","22-May-2026 ","22-May-2026 22:05:40","22-May-2026 22:05:59","00:19","85","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","23-May-2026 ","24-May-2026 10:05:24","24-May-2026 10:05:44","00:20","86","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","24-May-2026 ","24-May-2026 22:03:18","24-May-2026 22:03:28","00:10","87","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","25-May-2026 ","26-May-2026 07:34:48","26-May-2026 07:35:03","00:15","88","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","26-May-2026 ","26-May-2026 21:00:23","26-May-2026 21:00:32","00:09","89","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132001","29","1","","27-May-2026 ","27-May-2026 23:02:15","27-May-2026 23:02:28","00:13","90","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","01-Apr-2026 ","01-Apr-2026 20:42:48","01-Apr-2026 20:44:08","01:20","1","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","02-Apr-2026 ","02-Apr-2026 22:34:46","02-Apr-2026 22:35:23","00:37","2","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","03-Apr-2026 ","03-Apr-2026 19:40:50","03-Apr-2026 19:41:26","00:36","3","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","04-Apr-2026 ","04-Apr-2026 21:34:52","04-Apr-2026 21:35:20","00:28","4","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","05-Apr-2026 ","05-Apr-2026 20:47:56","05-Apr-2026 20:48:17","00:21","5","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","06-Apr-2026 ","06-Apr-2026 23:05:55","06-Apr-2026 23:06:13","00:18","6","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","07-Apr-2026 ","07-Apr-2026 21:39:21","07-Apr-2026 21:39:43","00:22","7","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","08-Apr-2026 ","09-Apr-2026 18:02:39","09-Apr-2026 18:03:05","00:26","8","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","09-Apr-2026 ","09-Apr-2026 18:03:29","09-Apr-2026 18:03:43","00:14","9","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","10-Apr-2026 ","10-Apr-2026 18:17:13","10-Apr-2026 18:17:32","00:19","10","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","11-Apr-2026 ","11-Apr-2026 18:02:06","11-Apr-2026 18:02:31","00:25","11","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","12-Apr-2026 ","12-Apr-2026 20:40:55","12-Apr-2026 20:41:15","00:20","12","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","13-Apr-2026 ","13-Apr-2026 19:31:34","13-Apr-2026 19:31:48","00:14","13","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","14-Apr-2026 ","14-Apr-2026 20:27:48","14-Apr-2026 20:28:12","00:24","14","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","15-Apr-2026 ","16-Apr-2026 07:42:13","16-Apr-2026 07:42:32","00:19","15","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","16-Apr-2026 ","16-Apr-2026 19:55:45","16-Apr-2026 19:56:05","00:20","16","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","17-Apr-2026 ","17-Apr-2026 21:11:08","17-Apr-2026 21:11:44","00:36","17","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","18-Apr-2026 ","18-Apr-2026 18:24:43","18-Apr-2026 18:24:57","00:14","18","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","19-Apr-2026 ","20-Apr-2026 09:13:58","20-Apr-2026 09:14:22","00:24","19","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","20-Apr-2026 ","20-Apr-2026 18:50:09","20-Apr-2026 18:50:29","00:20","20","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","21-Apr-2026 ","21-Apr-2026 18:02:37","21-Apr-2026 18:05:29","02:52","21","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","18","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","22-Apr-2026 ","22-Apr-2026 22:35:07","22-Apr-2026 22:35:25","00:18","22","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","23-Apr-2026 ","24-Apr-2026 08:04:27","24-Apr-2026 08:04:41","00:14","23","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","24-Apr-2026 ","25-Apr-2026 09:53:31","25-Apr-2026 09:53:51","00:20","24","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","25-Apr-2026 ","25-Apr-2026 21:15:46","25-Apr-2026 21:15:58","00:12","25","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","26-Apr-2026 ","26-Apr-2026 22:16:21","26-Apr-2026 22:16:32","00:11","26","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","27-Apr-2026 ","27-Apr-2026 21:04:26","27-Apr-2026 21:04:39","00:13","27","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","28-Apr-2026 ","29-Apr-2026 17:52:10","29-Apr-2026 17:53:02","00:52","28","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","29-Apr-2026 ","30-Apr-2026 22:35:16","30-Apr-2026 22:36:01","00:45","29","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","30-Apr-2026 ","30-Apr-2026 22:36:45","30-Apr-2026 22:37:21","00:36","30","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","01-May-2026 ","01-May-2026 21:49:37","01-May-2026 21:49:54","00:17","31","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","02-May-2026 ","02-May-2026 22:03:41","02-May-2026 22:03:53","00:12","32","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","03-May-2026 ","03-May-2026 20:30:41","03-May-2026 20:30:52","00:11","33","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","04-May-2026 ","04-May-2026 23:27:30","04-May-2026 23:27:43","00:13","34","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","06-May-2026 ","07-May-2026 18:06:55","07-May-2026 18:07:08","00:13","35","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","07-May-2026 ","07-May-2026 18:07:33","07-May-2026 18:07:44","00:11","36","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","08-May-2026 ","08-May-2026 22:42:00","08-May-2026 22:42:16","00:16","37","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","09-May-2026 ","10-May-2026 21:18:31","10-May-2026 21:18:44","00:13","38","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","10-May-2026 ","10-May-2026 21:20:11","10-May-2026 21:20:22","00:11","39","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","11-May-2026 ","12-May-2026 10:48:02","12-May-2026 10:48:16","00:14","40","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","12-May-2026 ","12-May-2026 22:37:05","12-May-2026 22:37:24","00:19","41","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","15-May-2026 ","16-May-2026 21:29:32","16-May-2026 21:29:53","00:21","42","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","16-May-2026 ","16-May-2026 21:30:21","16-May-2026 21:31:03","00:42","43","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","17-May-2026 ","17-May-2026 20:09:06","17-May-2026 20:09:20","00:14","44","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","19-May-2026 ","20-May-2026 22:54:46","20-May-2026 22:55:16","00:30","45","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","20-May-2026 ","20-May-2026 22:56:47","20-May-2026 22:57:06","00:19","46","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","21-May-2026 ","22-May-2026 18:02:38","22-May-2026 18:02:50","00:12","47","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","22-May-2026 ","22-May-2026 18:03:46","22-May-2026 18:04:09","00:23","48","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","23-May-2026 ","23-May-2026 21:39:50","23-May-2026 21:40:02","00:12","49","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","25-May-2026 ","26-May-2026 18:01:24","26-May-2026 18:01:41","00:17","50","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132002","29","1","","26-May-2026 ","26-May-2026 18:02:05","26-May-2026 18:02:19","00:14","51","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132003","49","0","","26-May-2026 ","26-May-2026 20:55:38","26-May-2026 20:56:02","00:24","1","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10013","David Stepek","CZ100132003","49","0","","27-May-2026 ","27-May-2026 19:26:19","27-May-2026 19:26:34","00:15","2","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","11","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","21-Apr-2026 ","21-Apr-2026 19:20:32","21-Apr-2026 19:22:54","02:22","1","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","14","","","3","Blood alone passed","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","22-Apr-2026 ","22-Apr-2026 19:08:50","22-Apr-2026 19:10:28","01:38","2","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","12","","","3","Blood alone passed","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","23-Apr-2026 ","23-Apr-2026 18:47:18","23-Apr-2026 18:47:46","00:28","3","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","10","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","24-Apr-2026 ","24-Apr-2026 20:09:26","24-Apr-2026 20:10:25","00:59","4","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","10","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","24-Apr-2026 ","25-Apr-2026 19:58:59","25-Apr-2026 19:59:32","00:33","5","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","10","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","25-Apr-2026 ","25-Apr-2026 19:59:57","25-Apr-2026 20:00:25","00:28","6","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","26-Apr-2026 ","26-Apr-2026 18:17:01","26-Apr-2026 18:17:45","00:44","7","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","27-Apr-2026 ","27-Apr-2026 19:51:27","27-Apr-2026 19:52:00","00:33","8","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","28-Apr-2026 ","28-Apr-2026 20:01:23","28-Apr-2026 20:01:47","00:24","9","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","12","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","29-Apr-2026 ","29-Apr-2026 18:53:09","29-Apr-2026 18:53:39","00:30","10","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","13","","","3","Blood alone passed","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","30-Apr-2026 ","30-Apr-2026 19:59:27","30-Apr-2026 19:59:51","00:24","11","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","13","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","01-May-2026 ","01-May-2026 19:30:00","01-May-2026 19:30:47","00:47","12","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","13","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","02-May-2026 ","02-May-2026 23:09:28","02-May-2026 23:09:52","00:24","13","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","10","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","03-May-2026 ","03-May-2026 21:23:26","03-May-2026 21:23:59","00:33","14","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","13","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","04-May-2026 ","04-May-2026 19:29:17","04-May-2026 19:29:50","00:33","15","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","13","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","05-May-2026 ","05-May-2026 22:29:06","05-May-2026 22:29:41","00:35","16","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","14","","","3","Blood alone passed","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","06-May-2026 ","06-May-2026 20:10:08","06-May-2026 20:10:42","00:34","17","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","17","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","07-May-2026 ","07-May-2026 19:28:33","07-May-2026 19:28:49","00:16","18","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","12","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","08-May-2026 ","08-May-2026 19:32:48","08-May-2026 19:33:22","00:34","19","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","15","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","09-May-2026 ","09-May-2026 19:58:49","09-May-2026 20:00:29","01:40","20","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","23","1","Yes, I confirm this is the correct stool count","3","Blood alone passed","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","10-May-2026 ","10-May-2026 20:11:37","10-May-2026 20:12:05","00:28","21","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","21","1","Yes, I confirm this is the correct stool count","3","Blood alone passed","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","11-May-2026 ","11-May-2026 21:26:07","11-May-2026 21:26:32","00:25","22","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","21","1","Yes, I confirm this is the correct stool count","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","12-May-2026 ","12-May-2026 20:55:03","12-May-2026 20:55:28","00:25","23","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","18","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","13-May-2026 ","13-May-2026 20:35:38","13-May-2026 20:35:54","00:16","24","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","19","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","14-May-2026 ","14-May-2026 20:01:12","14-May-2026 20:01:34","00:22","25","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","17","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","15-May-2026 ","15-May-2026 20:30:56","15-May-2026 20:31:10","00:14","26","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","20","","","3","Blood alone passed","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","16-May-2026 ","16-May-2026 19:36:34","16-May-2026 19:36:54","00:20","27","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","18","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","17-May-2026 ","17-May-2026 19:57:53","17-May-2026 19:58:15","00:22","28","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","20","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","18-May-2026 ","18-May-2026 19:28:19","18-May-2026 19:28:52","00:33","29","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","18","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","19-May-2026 ","19-May-2026 20:01:15","19-May-2026 20:01:41","00:26","30","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","17","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","20-May-2026 ","20-May-2026 19:30:02","20-May-2026 19:30:24","00:22","31","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","13","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","21-May-2026 ","21-May-2026 19:34:46","21-May-2026 19:35:04","00:18","32","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","15","","","3","Blood alone passed","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","22-May-2026 ","22-May-2026 20:01:59","22-May-2026 20:02:19","00:20","33","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","15","","","3","Blood alone passed","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","23-May-2026 ","23-May-2026 22:20:42","23-May-2026 22:20:58","00:16","34","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","15","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","24-May-2026 ","24-May-2026 21:51:20","24-May-2026 21:51:41","00:21","35","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","15","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","25-May-2026 ","25-May-2026 20:47:57","25-May-2026 20:48:23","00:26","36","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","15","","","3","Blood alone passed","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","26-May-2026 ","26-May-2026 19:54:28","26-May-2026 19:54:46","00:18","37","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","15","","","3","Blood alone passed","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","27-May-2026 ","27-May-2026 19:35:37","27-May-2026 19:35:58","00:21","38","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","14","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162001","48","1","","28-May-2026 ","28-May-2026 20:08:12","28-May-2026 20:08:36","00:24","39","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","13","","","3","Blood alone passed","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10016","Robert Mudr","CZ100162002","42","1","","27-May-2026 ","27-May-2026 22:05:52","27-May-2026 22:06:46","00:54","1","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","13-Apr-2026 ","13-Apr-2026 18:02:00","13-Apr-2026 18:03:08","01:08","1","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","14-Apr-2026 ","14-Apr-2026 18:01:42","14-Apr-2026 18:02:26","00:44","2","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","15-Apr-2026 ","15-Apr-2026 18:01:38","15-Apr-2026 18:02:04","00:26","3","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","16-Apr-2026 ","16-Apr-2026 18:32:28","16-Apr-2026 18:32:52","00:24","4","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","17-Apr-2026 ","17-Apr-2026 18:01:23","17-Apr-2026 18:01:40","00:17","5","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","18-Apr-2026 ","18-Apr-2026 18:01:26","18-Apr-2026 18:01:37","00:11","6","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","19-Apr-2026 ","19-Apr-2026 18:01:23","19-Apr-2026 18:01:40","00:17","7","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","20-Apr-2026 ","20-Apr-2026 20:46:30","20-Apr-2026 20:46:51","00:21","8","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","21-Apr-2026 ","21-Apr-2026 18:13:48","21-Apr-2026 18:13:57","00:09","9","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","22-Apr-2026 ","22-Apr-2026 18:06:03","22-Apr-2026 18:06:18","00:15","10","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","23-Apr-2026 ","23-Apr-2026 18:09:32","23-Apr-2026 18:09:44","00:12","11","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","24-Apr-2026 ","24-Apr-2026 18:01:08","24-Apr-2026 18:01:22","00:14","12","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","25-Apr-2026 ","25-Apr-2026 18:36:43","25-Apr-2026 18:36:56","00:13","13","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","26-Apr-2026 ","26-Apr-2026 18:01:56","26-Apr-2026 18:02:12","00:16","14","Patient","BYODHandheld","BYODHandheld","1","Yes","0","","0","","0","","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","27-Apr-2026 ","27-Apr-2026 18:01:05","27-Apr-2026 18:01:19","00:14","15","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","28-Apr-2026 ","28-Apr-2026 21:12:00","28-Apr-2026 21:12:13","00:13","16","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","29-Apr-2026 ","29-Apr-2026 18:01:04","29-Apr-2026 18:01:15","00:11","17","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","30-Apr-2026 ","30-Apr-2026 18:56:10","30-Apr-2026 18:56:21","00:11","18","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","7","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","01-May-2026 ","01-May-2026 18:01:23","01-May-2026 18:01:39","00:16","19","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","02-May-2026 ","02-May-2026 18:01:21","02-May-2026 18:01:39","00:18","20","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","03-May-2026 ","03-May-2026 18:01:14","03-May-2026 18:01:26","00:12","21","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","04-May-2026 ","04-May-2026 18:01:29","04-May-2026 18:02:07","00:38","22","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","05-May-2026 ","05-May-2026 18:18:48","05-May-2026 18:19:11","00:23","23","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","06-May-2026 ","06-May-2026 18:01:52","06-May-2026 18:02:05","00:13","24","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","07-May-2026 ","07-May-2026 18:01:54","07-May-2026 18:02:38","00:44","25","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","08-May-2026 ","08-May-2026 18:01:35","08-May-2026 18:01:45","00:10","26","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","09-May-2026 ","09-May-2026 18:01:07","09-May-2026 18:01:23","00:16","27","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","10-May-2026 ","10-May-2026 18:01:29","10-May-2026 18:02:07","00:38","28","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","11-May-2026 ","11-May-2026 20:05:03","11-May-2026 20:05:14","00:11","29","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","12-May-2026 ","12-May-2026 19:46:23","12-May-2026 19:46:39","00:16","30","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","13-May-2026 ","13-May-2026 21:37:54","13-May-2026 21:38:14","00:20","31","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","14-May-2026 ","14-May-2026 19:47:34","14-May-2026 19:48:33","00:59","32","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","15-May-2026 ","15-May-2026 18:04:38","15-May-2026 18:04:49","00:11","33","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","16-May-2026 ","16-May-2026 18:01:42","16-May-2026 18:02:35","00:53","34","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","17-May-2026 ","17-May-2026 19:30:43","17-May-2026 19:31:40","00:57","35","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","18-May-2026 ","18-May-2026 19:46:33","18-May-2026 19:46:59","00:26","36","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","19-May-2026 ","19-May-2026 18:02:50","19-May-2026 18:03:08","00:18","37","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","20-May-2026 ","20-May-2026 18:02:27","20-May-2026 18:02:40","00:13","38","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","21-May-2026 ","21-May-2026 20:51:11","21-May-2026 20:51:22","00:11","39","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","22-May-2026 ","22-May-2026 21:27:22","22-May-2026 21:27:31","00:09","40","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","23-May-2026 ","23-May-2026 22:20:05","23-May-2026 22:20:21","00:16","41","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","24-May-2026 ","24-May-2026 20:24:10","24-May-2026 20:24:27","00:17","42","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","25-May-2026 ","25-May-2026 21:49:27","25-May-2026 21:49:36","00:09","43","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","26-May-2026 ","26-May-2026 22:32:04","26-May-2026 22:32:17","00:13","44","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10020","Lucie Gonsorcikova","CZ100201001","15","1","","27-May-2026 ","27-May-2026 22:44:49","27-May-2026 22:45:01","00:12","45","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","01-Mar-2026 ","02-Mar-2026 18:40:39","02-Mar-2026 18:42:35","01:56","1","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","02-Mar-2026 ","02-Mar-2026 18:42:58","02-Mar-2026 18:44:02","01:04","2","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","03-Mar-2026 ","03-Mar-2026 18:16:16","03-Mar-2026 18:17:20","01:04","3","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","11","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","04-Mar-2026 ","04-Mar-2026 19:00:11","04-Mar-2026 19:00:54","00:43","4","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","10","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","05-Mar-2026 ","05-Mar-2026 18:08:45","05-Mar-2026 18:09:18","00:33","5","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","06-Mar-2026 ","06-Mar-2026 18:18:34","06-Mar-2026 18:19:08","00:34","6","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","11","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","07-Mar-2026 ","07-Mar-2026 18:01:32","07-Mar-2026 18:02:01","00:29","7","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","08-Mar-2026 ","08-Mar-2026 18:09:54","08-Mar-2026 18:10:19","00:25","8","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","10","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","09-Mar-2026 ","09-Mar-2026 18:50:13","09-Mar-2026 18:50:41","00:28","9","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","10","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","10-Mar-2026 ","10-Mar-2026 18:24:14","10-Mar-2026 18:24:43","00:29","10","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","11-Mar-2026 ","11-Mar-2026 19:06:52","11-Mar-2026 19:07:11","00:19","11","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","11","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","12-Mar-2026 ","12-Mar-2026 18:07:54","12-Mar-2026 18:08:18","00:24","12","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","11","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","13-Mar-2026 ","13-Mar-2026 18:12:06","13-Mar-2026 18:12:30","00:24","13","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","10","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","14-Mar-2026 ","15-Mar-2026 18:30:45","15-Mar-2026 18:31:18","00:33","14","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","15-Mar-2026 ","15-Mar-2026 18:32:00","15-Mar-2026 18:32:31","00:31","15","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","16-Mar-2026 ","16-Mar-2026 19:00:29","16-Mar-2026 19:01:41","01:12","16","Patient","BYODHandheld","BYODHandheld","1","Yes","0","","0","","0","","24","1","Yes, I confirm this is the correct stool count","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","17-Mar-2026 ","17-Mar-2026 18:03:41","17-Mar-2026 18:04:05","00:24","17","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","11","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","18-Mar-2026 ","18-Mar-2026 19:07:09","18-Mar-2026 19:07:36","00:27","18","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","11","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","19-Mar-2026 ","19-Mar-2026 19:24:39","19-Mar-2026 19:25:08","00:29","19","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","11","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","20-Mar-2026 ","20-Mar-2026 18:39:21","20-Mar-2026 18:39:53","00:32","20","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","10","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","21-Mar-2026 ","21-Mar-2026 18:49:04","21-Mar-2026 18:49:27","00:23","21","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","12","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","22-Mar-2026 ","22-Mar-2026 18:12:30","22-Mar-2026 18:12:57","00:27","22","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","11","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","23-Mar-2026 ","23-Mar-2026 18:07:23","23-Mar-2026 18:07:47","00:24","23","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","24-Mar-2026 ","24-Mar-2026 19:10:30","24-Mar-2026 19:11:07","00:37","24","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","10","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","25-Mar-2026 ","25-Mar-2026 19:10:29","25-Mar-2026 19:10:52","00:23","25","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","11","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","26-Mar-2026 ","26-Mar-2026 19:14:57","26-Mar-2026 19:15:22","00:25","26","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","27-Mar-2026 ","27-Mar-2026 18:12:05","27-Mar-2026 18:12:28","00:23","27","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","11","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","28-Mar-2026 ","28-Mar-2026 18:02:25","28-Mar-2026 18:02:48","00:23","28","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","12","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","29-Mar-2026 ","29-Mar-2026 18:09:12","29-Mar-2026 18:09:37","00:25","29","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","10","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","30-Mar-2026 ","30-Mar-2026 18:09:29","30-Mar-2026 18:09:52","00:23","30","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","31-Mar-2026 ","31-Mar-2026 18:18:41","31-Mar-2026 18:19:11","00:30","31","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","01-Apr-2026 ","01-Apr-2026 19:27:09","01-Apr-2026 19:27:31","00:22","32","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","10","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","02-Apr-2026 ","02-Apr-2026 18:11:54","02-Apr-2026 18:12:24","00:30","33","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","11","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","03-Apr-2026 ","03-Apr-2026 18:38:38","03-Apr-2026 18:38:58","00:20","34","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","11","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","04-Apr-2026 ","04-Apr-2026 18:03:04","04-Apr-2026 18:03:28","00:24","35","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","10","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","05-Apr-2026 ","05-Apr-2026 18:13:29","05-Apr-2026 18:13:50","00:21","36","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","11","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","06-Apr-2026 ","06-Apr-2026 20:42:37","06-Apr-2026 20:42:57","00:20","37","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","11","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","07-Apr-2026 ","07-Apr-2026 18:58:01","07-Apr-2026 18:58:20","00:19","38","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","08-Apr-2026 ","09-Apr-2026 18:05:31","09-Apr-2026 18:05:59","00:28","39","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","09-Apr-2026 ","09-Apr-2026 18:06:30","09-Apr-2026 18:07:07","00:37","40","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","10-Apr-2026 ","10-Apr-2026 18:13:58","10-Apr-2026 18:14:20","00:22","41","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","11-Apr-2026 ","11-Apr-2026 18:02:38","11-Apr-2026 18:03:02","00:24","42","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","12-Apr-2026 ","12-Apr-2026 18:08:16","12-Apr-2026 18:08:44","00:28","43","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","13-Apr-2026 ","13-Apr-2026 19:20:43","13-Apr-2026 19:21:05","00:22","44","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","14-Apr-2026 ","14-Apr-2026 18:18:45","14-Apr-2026 18:19:12","00:27","45","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","15-Apr-2026 ","15-Apr-2026 18:01:54","15-Apr-2026 18:02:17","00:23","46","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","16-Apr-2026 ","16-Apr-2026 18:04:15","16-Apr-2026 18:04:39","00:24","47","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","17-Apr-2026 ","17-Apr-2026 18:05:38","17-Apr-2026 18:06:11","00:33","48","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","18-Apr-2026 ","18-Apr-2026 18:02:10","18-Apr-2026 18:02:38","00:28","49","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","19-Apr-2026 ","19-Apr-2026 19:24:43","19-Apr-2026 19:25:10","00:27","50","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","20-Apr-2026 ","20-Apr-2026 18:36:26","20-Apr-2026 18:36:54","00:28","51","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","21-Apr-2026 ","21-Apr-2026 18:10:57","21-Apr-2026 18:11:17","00:20","52","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","10","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","22-Apr-2026 ","22-Apr-2026 18:47:22","22-Apr-2026 18:47:44","00:22","53","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","23-Apr-2026 ","23-Apr-2026 18:04:27","23-Apr-2026 18:04:52","00:25","54","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","24-Apr-2026 ","24-Apr-2026 18:03:12","24-Apr-2026 18:03:36","00:24","55","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","25-Apr-2026 ","25-Apr-2026 20:48:03","25-Apr-2026 20:48:23","00:20","56","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","26-Apr-2026 ","26-Apr-2026 19:10:03","26-Apr-2026 19:10:28","00:25","57","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","27-Apr-2026 ","27-Apr-2026 18:10:02","27-Apr-2026 18:10:25","00:23","58","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","28-Apr-2026 ","28-Apr-2026 18:03:12","28-Apr-2026 18:03:35","00:23","59","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","29-Apr-2026 ","29-Apr-2026 18:09:26","29-Apr-2026 18:10:02","00:36","60","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","30-Apr-2026 ","01-May-2026 18:26:24","01-May-2026 18:27:02","00:38","61","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","01-May-2026 ","01-May-2026 18:27:45","01-May-2026 18:28:20","00:35","62","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","02-May-2026 ","02-May-2026 19:54:00","02-May-2026 19:54:30","00:30","63","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","03-May-2026 ","03-May-2026 18:24:50","03-May-2026 18:25:14","00:24","64","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","04-May-2026 ","05-May-2026 19:36:17","05-May-2026 19:36:48","00:31","65","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","05-May-2026 ","05-May-2026 19:37:23","05-May-2026 19:37:43","00:20","66","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","06-May-2026 ","06-May-2026 18:18:59","06-May-2026 18:19:20","00:21","67","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","07-May-2026 ","07-May-2026 18:04:36","07-May-2026 18:05:00","00:24","68","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","08-May-2026 ","08-May-2026 18:22:35","08-May-2026 18:22:53","00:18","69","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","09-May-2026 ","09-May-2026 18:39:28","09-May-2026 18:39:51","00:23","70","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","10-May-2026 ","10-May-2026 18:30:41","10-May-2026 18:31:24","00:43","71","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","11-May-2026 ","11-May-2026 18:23:54","11-May-2026 18:24:14","00:20","72","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","12-May-2026 ","12-May-2026 18:23:43","12-May-2026 18:24:00","00:17","73","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","13-May-2026 ","13-May-2026 18:27:48","13-May-2026 18:28:14","00:26","74","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","14-May-2026 ","14-May-2026 18:11:36","14-May-2026 18:11:53","00:17","75","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","15-May-2026 ","15-May-2026 19:19:15","15-May-2026 19:19:34","00:19","76","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","16-May-2026 ","16-May-2026 18:44:47","16-May-2026 18:45:07","00:20","77","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","17-May-2026 ","17-May-2026 19:48:23","17-May-2026 19:48:53","00:30","78","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","18-May-2026 ","18-May-2026 18:08:29","18-May-2026 18:08:53","00:24","79","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","19-May-2026 ","19-May-2026 18:09:31","19-May-2026 18:10:01","00:30","80","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","20-May-2026 ","20-May-2026 18:18:41","20-May-2026 18:19:07","00:26","81","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","21-May-2026 ","21-May-2026 18:23:15","21-May-2026 18:24:11","00:56","82","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","22-May-2026 ","22-May-2026 18:06:32","22-May-2026 18:07:05","00:33","83","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","23-May-2026 ","23-May-2026 18:20:11","23-May-2026 18:20:38","00:27","84","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","24-May-2026 ","24-May-2026 18:08:45","24-May-2026 18:09:06","00:21","85","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","25-May-2026 ","25-May-2026 18:11:49","25-May-2026 18:12:14","00:25","86","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","26-May-2026 ","26-May-2026 18:15:47","26-May-2026 18:16:11","00:24","87","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10021","Martin Bortlik","CZ100212001","61","1","","27-May-2026 ","27-May-2026 18:14:45","27-May-2026 18:15:04","00:19","88","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","15-Jan-2026 ","15-Jan-2026 22:48:04","15-Jan-2026 22:48:28","00:24","1","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","9","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","16-Jan-2026 ","16-Jan-2026 18:55:34","16-Jan-2026 18:56:14","00:40","2","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","17-Jan-2026 ","17-Jan-2026 18:01:51","17-Jan-2026 18:02:19","00:28","3","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","18-Jan-2026 ","18-Jan-2026 18:25:55","18-Jan-2026 18:26:19","00:24","4","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","19-Jan-2026 ","19-Jan-2026 18:10:54","19-Jan-2026 18:11:19","00:25","5","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","20-Jan-2026 ","20-Jan-2026 18:04:44","20-Jan-2026 18:05:02","00:18","6","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","21-Jan-2026 ","21-Jan-2026 18:06:08","21-Jan-2026 18:06:32","00:24","7","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","22-Jan-2026 ","22-Jan-2026 18:49:45","22-Jan-2026 18:50:08","00:23","8","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","23-Jan-2026 ","23-Jan-2026 20:50:48","23-Jan-2026 20:51:10","00:22","9","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","3","Blood alone passed","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","24-Jan-2026 ","24-Jan-2026 23:07:44","24-Jan-2026 23:08:20","00:36","10","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","25-Jan-2026 ","25-Jan-2026 20:58:21","25-Jan-2026 20:58:46","00:25","11","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","26-Jan-2026 ","26-Jan-2026 20:36:58","26-Jan-2026 20:37:09","00:11","12","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","27-Jan-2026 ","27-Jan-2026 20:54:52","27-Jan-2026 20:55:08","00:16","13","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","28-Jan-2026 ","28-Jan-2026 18:14:23","28-Jan-2026 18:14:40","00:17","14","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","29-Jan-2026 ","29-Jan-2026 18:50:46","29-Jan-2026 18:51:05","00:19","15","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","30-Jan-2026 ","30-Jan-2026 18:26:27","30-Jan-2026 18:26:45","00:18","16","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","31-Jan-2026 ","31-Jan-2026 19:52:40","31-Jan-2026 19:52:54","00:14","17","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","01-Feb-2026 ","01-Feb-2026 18:40:02","01-Feb-2026 18:40:16","00:14","18","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","02-Feb-2026 ","02-Feb-2026 19:32:39","02-Feb-2026 19:32:58","00:19","19","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","03-Feb-2026 ","03-Feb-2026 18:01:25","03-Feb-2026 18:01:39","00:14","20","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","04-Feb-2026 ","04-Feb-2026 18:59:17","04-Feb-2026 18:59:46","00:29","21","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","05-Feb-2026 ","05-Feb-2026 18:13:09","05-Feb-2026 18:13:33","00:24","22","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","06-Feb-2026 ","06-Feb-2026 18:17:15","06-Feb-2026 18:17:32","00:17","23","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","07-Feb-2026 ","07-Feb-2026 18:55:47","07-Feb-2026 18:56:19","00:32","24","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","08-Feb-2026 ","08-Feb-2026 18:01:33","08-Feb-2026 18:01:46","00:13","25","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","09-Feb-2026 ","09-Feb-2026 18:31:24","09-Feb-2026 18:31:36","00:12","26","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","10-Feb-2026 ","11-Feb-2026 18:49:47","11-Feb-2026 18:50:04","00:17","27","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","11-Feb-2026 ","11-Feb-2026 18:50:24","11-Feb-2026 18:50:38","00:14","28","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","12-Feb-2026 ","12-Feb-2026 18:36:48","12-Feb-2026 18:37:03","00:15","29","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","13-Feb-2026 ","13-Feb-2026 18:44:19","13-Feb-2026 18:44:46","00:27","30","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","14-Feb-2026 ","15-Feb-2026 19:02:43","15-Feb-2026 19:03:08","00:25","31","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","15-Feb-2026 ","15-Feb-2026 19:03:35","15-Feb-2026 19:03:54","00:19","32","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","16-Feb-2026 ","16-Feb-2026 18:24:47","16-Feb-2026 18:24:59","00:12","33","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","17-Feb-2026 ","17-Feb-2026 18:19:20","17-Feb-2026 18:19:33","00:13","34","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","18-Feb-2026 ","19-Feb-2026 21:30:15","19-Feb-2026 21:30:32","00:17","35","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","19-Feb-2026 ","19-Feb-2026 21:30:55","19-Feb-2026 21:31:06","00:11","36","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","20-Feb-2026 ","20-Feb-2026 18:07:24","20-Feb-2026 18:07:39","00:15","37","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","21-Feb-2026 ","21-Feb-2026 18:04:27","21-Feb-2026 18:04:45","00:18","38","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","22-Feb-2026 ","22-Feb-2026 18:27:54","22-Feb-2026 18:28:07","00:13","39","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","23-Feb-2026 ","23-Feb-2026 20:13:02","23-Feb-2026 20:13:16","00:14","40","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","24-Feb-2026 ","24-Feb-2026 18:10:58","24-Feb-2026 18:11:27","00:29","41","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","9","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","25-Feb-2026 ","25-Feb-2026 19:28:29","25-Feb-2026 19:28:55","00:26","42","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","26-Feb-2026 ","26-Feb-2026 18:36:10","26-Feb-2026 18:36:28","00:18","43","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","27-Feb-2026 ","28-Feb-2026 22:20:16","28-Feb-2026 22:20:35","00:19","44","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","28-Feb-2026 ","28-Feb-2026 22:20:57","28-Feb-2026 22:21:08","00:11","45","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222001","41","3","","01-Mar-2026 ","01-Mar-2026 18:29:02","01-Mar-2026 18:29:21","00:19","46","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222002","39","1","","23-Jan-2026 ","23-Jan-2026 18:44:00","23-Jan-2026 18:44:48","00:48","1","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222002","39","1","","24-Jan-2026 ","24-Jan-2026 20:04:49","24-Jan-2026 20:05:45","00:56","2","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222002","39","1","","25-Jan-2026 ","26-Jan-2026 18:05:41","26-Jan-2026 18:06:13","00:32","3","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222002","39","1","","26-Jan-2026 ","26-Jan-2026 18:06:31","26-Jan-2026 18:06:49","00:18","4","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222002","39","1","","27-Jan-2026 ","27-Jan-2026 22:05:35","27-Jan-2026 22:05:59","00:24","5","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222002","39","1","","28-Jan-2026 ","28-Jan-2026 19:49:36","28-Jan-2026 19:49:50","00:14","6","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222002","39","1","","29-Jan-2026 ","29-Jan-2026 19:33:56","29-Jan-2026 19:34:09","00:13","7","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222002","39","1","","30-Jan-2026 ","30-Jan-2026 18:48:41","30-Jan-2026 18:48:57","00:16","8","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222002","39","1","","31-Jan-2026 ","31-Jan-2026 20:02:38","31-Jan-2026 20:02:51","00:13","9","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222002","39","1","","01-Feb-2026 ","01-Feb-2026 20:59:03","01-Feb-2026 20:59:19","00:16","10","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222002","39","1","","02-Feb-2026 ","02-Feb-2026 18:01:41","02-Feb-2026 18:01:59","00:18","11","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222002","39","1","","03-Feb-2026 ","03-Feb-2026 18:22:38","03-Feb-2026 18:23:07","00:29","12","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222002","39","1","","04-Feb-2026 ","04-Feb-2026 18:59:50","04-Feb-2026 19:00:03","00:13","13","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222002","39","1","","05-Feb-2026 ","05-Feb-2026 19:40:08","05-Feb-2026 19:40:20","00:12","14","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222002","39","1","","06-Feb-2026 ","06-Feb-2026 18:11:13","06-Feb-2026 18:11:32","00:19","15","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222002","39","1","","07-Feb-2026 ","08-Feb-2026 14:02:35","08-Feb-2026 14:03:10","00:35","16","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222002","39","1","","08-Feb-2026 ","08-Feb-2026 18:25:38","08-Feb-2026 18:26:04","00:26","17","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222002","39","1","","09-Feb-2026 ","09-Feb-2026 20:19:15","09-Feb-2026 20:19:25","00:10","18","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222002","39","1","","10-Feb-2026 ","10-Feb-2026 21:54:07","10-Feb-2026 21:54:42","00:35","19","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222002","39","1","","11-Feb-2026 ","11-Feb-2026 18:34:20","11-Feb-2026 18:34:44","00:24","20","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222002","39","1","","12-Feb-2026 ","12-Feb-2026 19:11:56","12-Feb-2026 19:12:14","00:18","21","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222002","39","1","","13-Feb-2026 ","13-Feb-2026 19:51:22","13-Feb-2026 19:51:34","00:12","22","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222002","39","1","","14-Feb-2026 ","14-Feb-2026 18:02:05","14-Feb-2026 18:03:12","01:07","23","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222002","39","1","","15-Feb-2026 ","15-Feb-2026 18:45:30","15-Feb-2026 18:45:56","00:26","24","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222002","39","1","","16-Feb-2026 ","16-Feb-2026 19:01:35","16-Feb-2026 19:02:07","00:32","25","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222002","39","1","","17-Feb-2026 ","17-Feb-2026 19:58:00","17-Feb-2026 19:58:26","00:26","26","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222002","39","1","","18-Feb-2026 ","18-Feb-2026 19:35:30","18-Feb-2026 19:36:48","01:18","27","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","04-Mar-2026 ","04-Mar-2026 18:45:26","04-Mar-2026 18:45:57","00:31","1","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","05-Mar-2026 ","05-Mar-2026 20:32:08","05-Mar-2026 20:33:10","01:02","2","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","06-Mar-2026 ","06-Mar-2026 19:51:49","06-Mar-2026 19:52:07","00:18","3","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","07-Mar-2026 ","07-Mar-2026 20:14:59","07-Mar-2026 20:15:18","00:19","4","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","08-Mar-2026 ","08-Mar-2026 21:42:48","08-Mar-2026 21:42:58","00:10","5","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","09-Mar-2026 ","09-Mar-2026 21:47:51","09-Mar-2026 21:48:12","00:21","6","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","10-Mar-2026 ","10-Mar-2026 21:33:00","10-Mar-2026 21:34:34","01:34","7","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","11-Mar-2026 ","11-Mar-2026 21:05:27","11-Mar-2026 21:05:46","00:19","8","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","12-Mar-2026 ","12-Mar-2026 21:40:59","12-Mar-2026 21:41:44","00:45","9","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","13-Mar-2026 ","13-Mar-2026 19:50:45","13-Mar-2026 19:51:55","01:10","10","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","14-Mar-2026 ","14-Mar-2026 18:04:37","14-Mar-2026 18:04:50","00:13","11","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","15-Mar-2026 ","15-Mar-2026 19:58:48","15-Mar-2026 19:59:01","00:13","12","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","16-Mar-2026 ","16-Mar-2026 20:52:43","16-Mar-2026 20:53:00","00:17","13","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","17-Mar-2026 ","17-Mar-2026 20:33:05","17-Mar-2026 20:33:21","00:16","14","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","18-Mar-2026 ","18-Mar-2026 22:02:13","18-Mar-2026 22:02:45","00:32","15","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","19-Mar-2026 ","19-Mar-2026 21:20:17","19-Mar-2026 21:20:33","00:16","17","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","20-Mar-2026 ","20-Mar-2026 19:07:44","20-Mar-2026 19:07:56","00:12","18","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","21-Mar-2026 ","21-Mar-2026 18:42:15","21-Mar-2026 18:42:28","00:13","19","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","22-Mar-2026 ","22-Mar-2026 19:24:00","22-Mar-2026 19:25:07","01:07","20","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","23-Mar-2026 ","23-Mar-2026 18:24:50","23-Mar-2026 18:25:19","00:29","21","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","24-Mar-2026 ","24-Mar-2026 20:58:13","24-Mar-2026 20:58:34","00:21","22","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","25-Mar-2026 ","25-Mar-2026 18:01:28","25-Mar-2026 18:01:40","00:12","23","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","26-Mar-2026 ","26-Mar-2026 19:59:46","26-Mar-2026 19:59:59","00:13","24","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","27-Mar-2026 ","27-Mar-2026 19:05:42","27-Mar-2026 19:06:36","00:54","25","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","28-Mar-2026 ","28-Mar-2026 21:40:08","28-Mar-2026 21:40:33","00:25","26","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","29-Mar-2026 ","30-Mar-2026 02:54:17","30-Mar-2026 02:55:12","00:55","27","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","30-Mar-2026 ","30-Mar-2026 19:29:58","30-Mar-2026 19:30:29","00:31","28","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","31-Mar-2026 ","31-Mar-2026 19:54:16","31-Mar-2026 19:54:28","00:12","29","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","01-Apr-2026 ","01-Apr-2026 19:00:10","01-Apr-2026 19:01:09","00:59","30","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","02-Apr-2026 ","03-Apr-2026 05:28:24","03-Apr-2026 05:28:44","00:20","31","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","03-Apr-2026 ","03-Apr-2026 20:36:14","03-Apr-2026 20:36:50","00:36","32","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","04-Apr-2026 ","04-Apr-2026 18:40:00","04-Apr-2026 18:41:36","01:36","33","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","05-Apr-2026 ","05-Apr-2026 18:53:00","05-Apr-2026 18:53:58","00:58","34","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","06-Apr-2026 ","06-Apr-2026 18:09:33","06-Apr-2026 18:10:09","00:36","35","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","07-Apr-2026 ","07-Apr-2026 19:18:44","07-Apr-2026 19:19:47","01:03","36","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","08-Apr-2026 ","09-Apr-2026 12:37:30","09-Apr-2026 12:37:48","00:18","37","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","09-Apr-2026 ","09-Apr-2026 20:55:59","09-Apr-2026 20:56:29","00:30","38","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","10-Apr-2026 ","10-Apr-2026 22:53:17","10-Apr-2026 22:53:40","00:23","39","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","11-Apr-2026 ","11-Apr-2026 20:04:52","11-Apr-2026 20:05:06","00:14","40","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","12-Apr-2026 ","12-Apr-2026 21:58:52","12-Apr-2026 21:59:11","00:19","41","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","13-Apr-2026 ","13-Apr-2026 21:45:51","13-Apr-2026 21:46:02","00:11","42","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","14-Apr-2026 ","14-Apr-2026 20:39:25","14-Apr-2026 20:39:58","00:33","43","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","15-Apr-2026 ","15-Apr-2026 20:14:56","15-Apr-2026 20:16:04","01:08","44","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","16-Apr-2026 ","16-Apr-2026 20:20:38","16-Apr-2026 20:21:56","01:18","45","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","17-Apr-2026 ","18-Apr-2026 04:36:28","18-Apr-2026 04:36:51","00:23","46","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","18-Apr-2026 ","18-Apr-2026 18:45:45","18-Apr-2026 18:46:34","00:49","47","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","19-Apr-2026 ","19-Apr-2026 21:11:57","19-Apr-2026 21:12:23","00:26","48","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","20-Apr-2026 ","20-Apr-2026 18:30:44","20-Apr-2026 18:31:27","00:43","49","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","21-Apr-2026 ","21-Apr-2026 19:33:38","21-Apr-2026 19:34:05","00:27","50","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","22-Apr-2026 ","23-Apr-2026 05:04:23","23-Apr-2026 05:04:33","00:10","51","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","23-Apr-2026 ","23-Apr-2026 21:46:23","23-Apr-2026 21:47:03","00:40","52","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","25-Apr-2026 ","26-Apr-2026 06:44:01","26-Apr-2026 06:44:16","00:15","53","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","26-Apr-2026 ","26-Apr-2026 19:53:35","26-Apr-2026 19:54:20","00:45","54","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","27-Apr-2026 ","27-Apr-2026 18:16:59","27-Apr-2026 18:17:38","00:39","55","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","28-Apr-2026 ","28-Apr-2026 18:27:59","28-Apr-2026 18:28:13","00:14","56","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","29-Apr-2026 ","29-Apr-2026 20:30:50","29-Apr-2026 20:31:01","00:11","57","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","30-Apr-2026 ","30-Apr-2026 21:43:01","30-Apr-2026 21:43:29","00:28","58","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","01-May-2026 ","01-May-2026 21:30:29","01-May-2026 21:30:42","00:13","59","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","02-May-2026 ","02-May-2026 22:01:00","02-May-2026 22:01:10","00:10","60","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","03-May-2026 ","03-May-2026 20:11:42","03-May-2026 20:12:16","00:34","61","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","04-May-2026 ","04-May-2026 18:41:10","04-May-2026 18:41:25","00:15","62","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","05-May-2026 ","05-May-2026 19:24:22","05-May-2026 19:24:54","00:32","63","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","06-May-2026 ","06-May-2026 21:53:22","06-May-2026 21:54:12","00:50","64","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","07-May-2026 ","07-May-2026 21:12:19","07-May-2026 21:12:29","00:10","65","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","08-May-2026 ","08-May-2026 18:11:04","08-May-2026 18:11:14","00:10","66","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","09-May-2026 ","09-May-2026 19:52:08","09-May-2026 19:52:17","00:09","67","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","10-May-2026 ","10-May-2026 19:39:21","10-May-2026 19:40:22","01:01","68","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","11-May-2026 ","11-May-2026 18:56:35","11-May-2026 18:56:46","00:11","69","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","12-May-2026 ","12-May-2026 18:17:34","12-May-2026 18:18:06","00:32","70","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","13-May-2026 ","13-May-2026 21:41:52","13-May-2026 21:42:04","00:12","71","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","14-May-2026 ","14-May-2026 20:29:40","14-May-2026 20:30:52","01:12","72","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","15-May-2026 ","15-May-2026 18:44:45","15-May-2026 18:44:59","00:14","73","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","16-May-2026 ","16-May-2026 18:11:24","16-May-2026 18:11:52","00:28","74","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","17-May-2026 ","18-May-2026 18:42:40","18-May-2026 18:43:20","00:40","75","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","18-May-2026 ","18-May-2026 18:43:51","18-May-2026 18:44:00","00:09","76","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","19-May-2026 ","19-May-2026 21:58:19","19-May-2026 21:58:29","00:10","77","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","20-May-2026 ","20-May-2026 18:41:02","20-May-2026 18:41:24","00:22","78","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","21-May-2026 ","21-May-2026 21:05:33","21-May-2026 21:05:54","00:21","79","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","22-May-2026 ","22-May-2026 21:17:24","22-May-2026 21:17:38","00:14","80","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","23-May-2026 ","23-May-2026 18:42:12","23-May-2026 18:42:28","00:16","81","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","24-May-2026 ","24-May-2026 21:24:54","24-May-2026 21:25:21","00:27","82","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","25-May-2026 ","25-May-2026 19:37:39","25-May-2026 19:38:41","01:02","83","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","26-May-2026 ","26-May-2026 20:52:27","26-May-2026 20:53:19","00:52","84","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222003","39","1","","27-May-2026 ","27-May-2026 18:37:02","27-May-2026 18:37:22","00:20","85","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222004","62","2","","03-Mar-2026 ","04-Mar-2026 11:19:17","04-Mar-2026 11:53:02","33:45","1","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","8","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222004","62","2","","04-Mar-2026 ","04-Mar-2026 18:04:55","04-Mar-2026 18:05:39","00:44","2","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222004","62","2","","05-Mar-2026 ","05-Mar-2026 18:01:34","05-Mar-2026 18:02:10","00:36","3","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222004","62","2","","06-Mar-2026 ","06-Mar-2026 18:01:58","06-Mar-2026 18:02:42","00:44","4","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222004","62","2","","07-Mar-2026 ","07-Mar-2026 18:52:44","07-Mar-2026 18:53:15","00:31","5","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222004","62","2","","08-Mar-2026 ","08-Mar-2026 19:16:55","08-Mar-2026 19:17:25","00:30","6","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222004","62","2","","09-Mar-2026 ","09-Mar-2026 18:03:55","09-Mar-2026 18:04:22","00:27","7","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222004","62","2","","10-Mar-2026 ","10-Mar-2026 22:05:01","10-Mar-2026 22:05:54","00:53","8","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222004","62","2","","11-Mar-2026 ","11-Mar-2026 19:47:14","11-Mar-2026 19:47:34","00:20","9","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222004","62","2","","12-Mar-2026 ","12-Mar-2026 18:09:02","12-Mar-2026 18:09:41","00:39","10","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222004","62","2","","13-Mar-2026 ","14-Mar-2026 18:47:40","14-Mar-2026 18:48:18","00:38","11","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222004","62","2","","14-Mar-2026 ","14-Mar-2026 18:48:43","14-Mar-2026 18:49:08","00:25","12","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222004","62","2","","16-Mar-2026 ","17-Mar-2026 02:08:04","17-Mar-2026 02:08:39","00:35","13","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222004","62","2","","17-Mar-2026 ","17-Mar-2026 18:27:58","17-Mar-2026 18:28:17","00:19","14","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222004","62","2","","18-Mar-2026 ","18-Mar-2026 18:16:46","18-Mar-2026 18:17:14","00:28","15","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222004","62","2","","19-Mar-2026 ","20-Mar-2026 18:47:51","20-Mar-2026 18:48:14","00:23","16","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222004","62","2","","20-Mar-2026 ","20-Mar-2026 18:48:37","20-Mar-2026 18:48:54","00:17","17","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222004","62","2","","21-Mar-2026 ","21-Mar-2026 18:03:32","21-Mar-2026 18:04:08","00:36","18","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","7","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222004","62","2","","23-Mar-2026 ","24-Mar-2026 01:29:03","24-Mar-2026 01:29:24","00:21","19","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","04-Mar-2026 ","04-Mar-2026 20:05:13","04-Mar-2026 20:06:22","01:09","1","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","05-Mar-2026 ","05-Mar-2026 20:56:18","05-Mar-2026 20:56:52","00:34","2","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","06-Mar-2026 ","06-Mar-2026 20:35:33","06-Mar-2026 20:36:03","00:30","3","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","07-Mar-2026 ","07-Mar-2026 21:51:03","07-Mar-2026 21:51:41","00:38","4","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","08-Mar-2026 ","08-Mar-2026 21:58:24","08-Mar-2026 21:58:44","00:20","5","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","09-Mar-2026 ","09-Mar-2026 20:43:38","09-Mar-2026 20:43:55","00:17","6","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","10-Mar-2026 ","10-Mar-2026 21:52:06","10-Mar-2026 21:52:26","00:20","7","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","11-Mar-2026 ","11-Mar-2026 21:26:55","11-Mar-2026 21:27:18","00:23","8","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","12-Mar-2026 ","13-Mar-2026 06:06:13","13-Mar-2026 06:06:39","00:26","9","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","13-Mar-2026 ","13-Mar-2026 20:35:28","13-Mar-2026 20:35:47","00:19","10","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","14-Mar-2026 ","14-Mar-2026 21:12:23","14-Mar-2026 21:12:39","00:16","11","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","15-Mar-2026 ","16-Mar-2026 02:24:42","16-Mar-2026 02:25:07","00:25","12","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","16-Mar-2026 ","16-Mar-2026 19:52:46","16-Mar-2026 19:53:05","00:19","13","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","17-Mar-2026 ","17-Mar-2026 20:44:50","17-Mar-2026 20:45:06","00:16","14","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","18-Mar-2026 ","18-Mar-2026 18:02:48","18-Mar-2026 18:03:12","00:24","15","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","19-Mar-2026 ","19-Mar-2026 18:24:13","19-Mar-2026 18:24:27","00:14","16","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","20-Mar-2026 ","20-Mar-2026 20:53:18","20-Mar-2026 20:53:34","00:16","17","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","21-Mar-2026 ","21-Mar-2026 19:58:33","21-Mar-2026 19:58:52","00:19","18","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","22-Mar-2026 ","22-Mar-2026 20:57:32","22-Mar-2026 20:57:48","00:16","19","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","23-Mar-2026 ","23-Mar-2026 20:25:57","23-Mar-2026 20:26:19","00:22","20","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","24-Mar-2026 ","24-Mar-2026 20:00:09","24-Mar-2026 20:00:26","00:17","21","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","25-Mar-2026 ","25-Mar-2026 19:46:02","25-Mar-2026 19:46:19","00:17","22","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","26-Mar-2026 ","26-Mar-2026 20:34:57","26-Mar-2026 20:35:36","00:39","23","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","27-Mar-2026 ","27-Mar-2026 20:26:42","27-Mar-2026 20:27:00","00:18","24","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","6","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","28-Mar-2026 ","28-Mar-2026 19:58:42","28-Mar-2026 19:58:55","00:13","25","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","29-Mar-2026 ","29-Mar-2026 20:46:26","29-Mar-2026 20:46:38","00:12","26","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","30-Mar-2026 ","30-Mar-2026 22:11:21","30-Mar-2026 22:11:35","00:14","27","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","31-Mar-2026 ","31-Mar-2026 22:46:39","31-Mar-2026 22:47:25","00:46","28","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","01-Apr-2026 ","01-Apr-2026 21:38:53","01-Apr-2026 21:39:31","00:38","29","Patient","BYODHandheld","BYODHandheld","0","","1","Yes","0","","0","","5","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","02-Apr-2026 ","02-Apr-2026 21:22:31","02-Apr-2026 21:22:58","00:27","30","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","03-Apr-2026 ","03-Apr-2026 21:13:09","03-Apr-2026 21:13:24","00:15","31","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","04-Apr-2026 ","04-Apr-2026 21:48:32","04-Apr-2026 21:48:47","00:15","32","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","05-Apr-2026 ","05-Apr-2026 22:11:06","05-Apr-2026 22:11:18","00:12","33","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","06-Apr-2026 ","06-Apr-2026 22:24:02","06-Apr-2026 22:24:13","00:11","34","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","07-Apr-2026 ","07-Apr-2026 21:17:38","07-Apr-2026 21:17:49","00:11","35","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","08-Apr-2026 ","09-Apr-2026 19:34:11","09-Apr-2026 19:35:01","00:50","36","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","09-Apr-2026 ","09-Apr-2026 19:35:23","09-Apr-2026 19:35:44","00:21","37","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","10-Apr-2026 ","10-Apr-2026 20:45:38","10-Apr-2026 20:45:51","00:13","38","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","11-Apr-2026 ","11-Apr-2026 21:18:17","11-Apr-2026 21:18:37","00:20","39","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","12-Apr-2026 ","12-Apr-2026 21:52:59","12-Apr-2026 21:53:16","00:17","40","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","13-Apr-2026 ","13-Apr-2026 20:06:14","13-Apr-2026 20:06:28","00:14","41","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","14-Apr-2026 ","14-Apr-2026 20:32:26","14-Apr-2026 20:33:15","00:49","42","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","15-Apr-2026 ","15-Apr-2026 22:47:23","15-Apr-2026 22:47:48","00:25","43","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","16-Apr-2026 ","16-Apr-2026 22:09:53","16-Apr-2026 22:26:28","16:35","44","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","17-Apr-2026 ","17-Apr-2026 21:45:10","17-Apr-2026 21:45:34","00:24","45","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","18-Apr-2026 ","18-Apr-2026 20:13:56","18-Apr-2026 20:14:28","00:32","46","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","19-Apr-2026 ","19-Apr-2026 21:05:25","19-Apr-2026 21:05:47","00:22","47","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","5","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","20-Apr-2026 ","20-Apr-2026 19:50:05","20-Apr-2026 19:50:31","00:26","48","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","21-Apr-2026 ","21-Apr-2026 21:06:17","21-Apr-2026 21:06:38","00:21","49","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","22-Apr-2026 ","22-Apr-2026 21:58:23","22-Apr-2026 21:58:37","00:14","50","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","1","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","23-Apr-2026 ","23-Apr-2026 20:20:07","23-Apr-2026 20:20:30","00:23","51","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","24-Apr-2026 ","24-Apr-2026 21:02:15","24-Apr-2026 21:02:44","00:29","52","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","25-Apr-2026 ","25-Apr-2026 21:46:33","25-Apr-2026 21:46:44","00:11","53","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","26-Apr-2026 ","26-Apr-2026 21:47:59","26-Apr-2026 21:48:16","00:17","54","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","27-Apr-2026 ","27-Apr-2026 22:14:24","27-Apr-2026 22:14:48","00:24","55","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","28-Apr-2026 ","28-Apr-2026 22:15:05","28-Apr-2026 22:15:20","00:15","56","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","29-Apr-2026 ","29-Apr-2026 21:40:35","29-Apr-2026 21:40:53","00:18","57","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","30-Apr-2026 ","30-Apr-2026 22:25:00","30-Apr-2026 22:25:11","00:11","58","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","01-May-2026 ","01-May-2026 22:29:53","01-May-2026 22:30:10","00:17","59","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","02-May-2026 ","02-May-2026 20:46:50","02-May-2026 20:47:02","00:12","60","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","03-May-2026 ","03-May-2026 22:35:34","03-May-2026 22:35:49","00:15","61","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","04-May-2026 ","05-May-2026 05:52:09","05-May-2026 05:52:35","00:26","62","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","05-May-2026 ","05-May-2026 21:58:12","05-May-2026 21:58:35","00:23","63","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","06-May-2026 ","07-May-2026 08:49:07","07-May-2026 08:49:20","00:13","64","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","07-May-2026 ","07-May-2026 21:53:49","07-May-2026 21:54:04","00:15","65","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","08-May-2026 ","08-May-2026 21:54:15","08-May-2026 21:54:26","00:11","66","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","0","No blood seen","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","09-May-2026 ","09-May-2026 21:16:14","09-May-2026 21:16:33","00:19","67","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","10-May-2026 ","10-May-2026 22:31:35","10-May-2026 22:31:45","00:10","68","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","11-May-2026 ","11-May-2026 22:06:26","11-May-2026 22:06:52","00:26","69","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","12-May-2026 ","12-May-2026 21:01:56","12-May-2026 21:02:12","00:16","70","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","13-May-2026 ","13-May-2026 22:30:52","13-May-2026 22:31:05","00:13","71","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","1","Streaks of blood with stool less than half the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","14-May-2026 ","14-May-2026 21:57:20","14-May-2026 21:57:33","00:13","72","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","15-May-2026 ","15-May-2026 22:18:39","15-May-2026 22:18:59","00:20","73","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","16-May-2026 ","16-May-2026 22:35:15","16-May-2026 22:35:26","00:11","74","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","17-May-2026 ","17-May-2026 19:49:55","17-May-2026 19:51:44","01:49","75","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","2","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","18-May-2026 ","18-May-2026 20:08:02","18-May-2026 20:08:15","00:13","76","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","19-May-2026 ","19-May-2026 23:07:57","19-May-2026 23:08:13","00:16","77","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","20-May-2026 ","20-May-2026 21:05:24","20-May-2026 21:05:35","00:11","78","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","21-May-2026 ","21-May-2026 22:39:47","21-May-2026 22:40:29","00:42","79","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","22-May-2026 ","22-May-2026 22:47:30","22-May-2026 22:47:42","00:12","80","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","23-May-2026 ","23-May-2026 21:43:46","23-May-2026 21:43:56","00:10","81","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","24-May-2026 ","24-May-2026 22:10:38","24-May-2026 22:10:48","00:10","82","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","25-May-2026 ","25-May-2026 21:58:41","25-May-2026 21:58:55","00:14","83","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","3","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","26-May-2026 ","26-May-2026 21:30:28","26-May-2026 21:30:46","00:18","84","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","10","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" +"77242113UCO3001","Czech Republic","DD5-CZ10022","Petr Hrabak","CZ100222005","33","1","","27-May-2026 ","27-May-2026 22:00:22","27-May-2026 22:00:36","00:14","85","Patient","BYODHandheld","BYODHandheld","0","","0","","0","","1","Yes","4","","","2","Obvious blood with stool most of the time","","","","Czech (Czech Republic)","3","Handheld","","","Participant","","" diff --git a/Clario/create_report_v1.4.py b/Clario/create_report_v1.4.py new file mode 100644 index 0000000..6c0e91c --- /dev/null +++ b/Clario/create_report_v1.4.py @@ -0,0 +1,447 @@ +""" +create_report.py +Verze: 1.4 +Datum: 2026-05-29 + +Generuje Excel report (.xlsm) pro studii 77242113UCO3001 z MongoDB databáze Clario. +Výstup: U:/Dropbox/!!!Days/Downloads Z230/YYYY-MM-DD 77242113UCO3001 Clario Reports.xlsm + +Zdroj dat: + MongoDB 192.168.1.76, databáze Clario + Kolekce Clario.MayoScore — skóre Mayo per pacient × visit + Kolekce Clario.MayoDiary — denní záznamy deníku pacienta + +Listy: + MayoScore — jeden řádek = pacient × visit + sloupec „KLIKNI SEM" naviguje na filtrovaný EligibleDays + řádky I-0 s Modified Mayo < 5 červeně tučně + MayoDiary — jeden řádek = denní záznam deníku pacienta + EligibleDays — jeden řádek = jeden eligible day z MayoScore obohacený o data z MayoDiary; + included/excluded flag, excluded dny šedě na žlutém pozadí + +VBA makro (Worksheet_SelectionChange na listu MayoScore): + Klik na sloupec „KLIKNI SEM" → přepne na EligibleDays a vyfiltruje záznamy + pro daného pacienta a visit. Vyžaduje povolení maker při otevření souboru. +""" + +VERSION = "1.4" + +from datetime import datetime +from pathlib import Path +import time + +from pymongo import MongoClient +from openpyxl import Workbook +from openpyxl.styles import Font, PatternFill, Alignment, Border, Side +from openpyxl.utils import get_column_letter +import xlwings as xw + +# --------------------------------------------------------------------------- +# Konfigurace +# --------------------------------------------------------------------------- + +MONGO_URI = "mongodb://192.168.1.76:27017" +DB_NAME = "Clario" +OUTPUT_DIR = Path(r"U:\Dropbox\!!!Days\Downloads Z230") + +VISIT_ORDER = ["I-0", "I-2", "I-4", "I-8", "I-12"] + +COLUMNS_SCORE = [ + ("KLIKNI SEM", lambda d: "▶ klikni sem"), + ("Site", lambda d: d.get("site", {}).get("name", "")), + ("Subject ID", lambda d: d.get("subject", {}).get("id", "")), + ("Visit", lambda d: d["fields"].get("Visit", "")), + ("Visit Date", lambda d: d["fields"].get("Visit Date", "")), + ("Baseline Stool Frequency", lambda d: _num(d["fields"].get("Baseline Stool Frequency", ""))), + ("Central Endoscopy Score", lambda d: _num(d["fields"].get("Central Endoscopy Score", ""))), + ("PGA Score", lambda d: _num(d["fields"].get("PGA Score", ""))), + ("Stool Frequency Sub-score", lambda d: _num(d["fields"].get("Stool Frequency Sub-score", ""))), + ("Rectal Bleeding Sub-score", lambda d: _num(d["fields"].get("Rectal Bleeding Sub-score", ""))), + ("Partial Mayo Score", lambda d: _num(d["fields"].get("Partial Mayo Score", ""))), + ("Modified Mayo Score", lambda d: _num(d["fields"].get("Modified Mayo Score", ""))), + ("Full Mayo Score", lambda d: _num(d["fields"].get("Full Mayo Score", ""))), +] + +COLUMNS_DIARY = [ + ("Subject ID", lambda d: d.get("subject", {}).get("id", "")), + ("Report Date", lambda d: d["fields"].get("Report Date", "")), + ("Baseline Stool Count", lambda d: _num(d["fields"].get("Baseline Stool Count", ""))), + ("Stool Frequency", lambda d: _num(d["fields"].get("Stool Frequency", ""))), + ("MAYO050", lambda d: d["fields"].get("MAYO050", "")), + ("Not Applicable", lambda d: d["fields"].get("Not Applicable", "")), + ("Constipation", lambda d: d["fields"].get("Constipation", "")), + ("Diarrhea", lambda d: d["fields"].get("Diarrhea", "")), + ("Irregularity", lambda d: d["fields"].get("Irregularity", "")), +] + +# --------------------------------------------------------------------------- +# Helpers +# --------------------------------------------------------------------------- + +def _num(value): + """Převede číselný string na int, jinak vrátí původní hodnotu nebo None.""" + if value == "" or value is None: + return None + try: + return int(value) + except (ValueError, TypeError): + try: + return float(value) + except (ValueError, TypeError): + return value + + +def _visit_sort_key(doc): + visit = doc["fields"].get("Visit", "") + try: + idx = VISIT_ORDER.index(visit) + except ValueError: + idx = len(VISIT_ORDER) + return (doc.get("site", {}).get("name", ""), doc.get("subject", {}).get("id", ""), idx, visit) + + +def _iso_to_date(value): + """ISO string → Python date pro Excel.""" + if not isinstance(value, str): + return value + try: + return datetime.fromisoformat(value).date() + except ValueError: + return value + + +# --------------------------------------------------------------------------- +# Styly +# --------------------------------------------------------------------------- + +HEADER_FILL = PatternFill("solid", fgColor="1F497D") +HEADER_FONT = Font(bold=True, color="FFFFFF", size=10) +CELL_FONT = Font(size=10) +ALIGN_CTR = Alignment(horizontal="center", vertical="center", wrap_text=False) +ALIGN_LEFT = Alignment(horizontal="left", vertical="center") + +THIN = Side(style="thin", color="BFBFBF") +BORDER = Border(left=THIN, right=THIN, top=THIN, bottom=THIN) + +# zebra +FILL_ODD = PatternFill("solid", fgColor="FFFFFF") +FILL_EVEN = PatternFill("solid", fgColor="EBF1DE") + +SCORE_COLS = {"Partial Mayo Score", "Modified Mayo Score", "Full Mayo Score"} +SCORE_FILL = PatternFill("solid", fgColor="FFC7CE") # červená pro skóre ≥ 5 (placeholder — nepoužíváme podmíněné formátování) + + +# --------------------------------------------------------------------------- +# Sestavení sheetu +# --------------------------------------------------------------------------- + +def _build_sheet(ws, docs, columns, date_cols, center_cols, col_widths, row_font_fn=None): + headers = [c[0] for c in columns] + + for col_idx, header in enumerate(headers, 1): + cell = ws.cell(row=1, column=col_idx, value=header) + cell.font = HEADER_FONT + cell.fill = HEADER_FILL + cell.alignment = ALIGN_CTR + cell.border = BORDER + ws.row_dimensions[1].height = 28 + + for row_idx, doc in enumerate(docs, 2): + fill = FILL_EVEN if row_idx % 2 == 0 else FILL_ODD + font = row_font_fn(doc) if row_font_fn else CELL_FONT + for col_idx, (col_name, getter) in enumerate(columns, 1): + value = getter(doc) + if col_name in date_cols and isinstance(value, str): + value = _iso_to_date(value) + cell = ws.cell(row=row_idx, column=col_idx, value=value) + cell.font = font + cell.fill = fill + cell.border = BORDER + cell.alignment = ALIGN_CTR if col_name in center_cols else ALIGN_LEFT + + for col_idx, (col_name, _) in enumerate(columns, 1): + ws.column_dimensions[get_column_letter(col_idx)].width = col_widths.get(col_name, 14) + + for col_name in date_cols: + if col_name in headers: + letter = get_column_letter(headers.index(col_name) + 1) + for row_idx in range(2, len(docs) + 2): + ws[f"{letter}{row_idx}"].number_format = "DD-MMM-YYYY" + + ws.freeze_panes = "A2" + ws.auto_filter.ref = f"A1:{get_column_letter(len(headers))}1" + + +def _score_row_font(doc): + visit = doc["fields"].get("Visit", "") + try: + mod_mayo = int(doc["fields"].get("Modified Mayo Score", "")) + except (ValueError, TypeError): + mod_mayo = None + if visit == "I-0" and mod_mayo is not None and mod_mayo < 5: + return Font(size=10, bold=True, color="FF0000") + return CELL_FONT + + +def build_mayo_score_sheet(ws, docs): + _build_sheet( + ws, docs, COLUMNS_SCORE, + date_cols={"Visit Date"}, + center_cols={"KLIKNI SEM", "Visit", "Central Endoscopy Score", "PGA Score", + "Stool Frequency Sub-score", "Rectal Bleeding Sub-score", + "Partial Mayo Score", "Modified Mayo Score", "Full Mayo Score", + "Baseline Stool Frequency"}, + col_widths={ + "KLIKNI SEM": 14, + "Site": 18, "Subject ID": 16, "Visit": 12, "Visit Date": 14, + "Baseline Stool Frequency": 14, "Central Endoscopy Score": 14, + "PGA Score": 10, "Stool Frequency Sub-score": 14, + "Rectal Bleeding Sub-score": 14, "Partial Mayo Score": 14, + "Modified Mayo Score": 14, "Full Mayo Score": 13, + }, + row_font_fn=_score_row_font, + ) + # Speciální styl pro sloupec KLIKNI SEM — vypadá jako tlačítko/odkaz + link_font = Font(size=10, bold=True, color="FFFFFF") + link_fill = PatternFill("solid", fgColor="2E75B6") + for row in range(2, len(docs) + 2): + cell = ws.cell(row=row, column=1) + cell.font = link_font + cell.fill = link_fill + cell.alignment = ALIGN_CTR + + +def build_mayo_diary_sheet(ws, docs): + _build_sheet( + ws, docs, COLUMNS_DIARY, + date_cols={"Report Date"}, + center_cols={"Baseline Stool Count", "Stool Frequency", "Not Applicable", + "Constipation", "Diarrhea", "Irregularity"}, + col_widths={ + "Subject ID": 16, "Report Date": 14, "Baseline Stool Count": 14, + "Stool Frequency": 14, "MAYO050": 48, "Not Applicable": 14, + "Constipation": 14, "Diarrhea": 12, "Irregularity": 14, + }, + ) + + +def build_eligible_days_sheet(ws, score_docs, diary_docs): + # Lookup diary records by (subject_id, date_part YYYY-MM-DD) + diary_lookup: dict[tuple, dict] = {} + for d in diary_docs: + subj = d.get("subject", {}).get("id", "") + date_iso = d["fields"].get("Report Date", "") + date_part = date_iso[:10] if date_iso else "" + if subj and date_part: + diary_lookup[(subj, date_part)] = d + + headers = [ + "Included", "Subject ID", "Visit", "Visit Date", "Day", + "Report Date", "Baseline Stool Count", "Stool Frequency", + "MAYO050", "Not Applicable", "Constipation", "Diarrhea", "Irregularity", + ] + col_widths = { + "Included": 10, "Subject ID": 16, "Visit": 10, "Visit Date": 14, "Day": 8, + "Report Date": 14, "Baseline Stool Count": 14, "Stool Frequency": 14, + "MAYO050": 48, "Not Applicable": 14, "Constipation": 14, + "Diarrhea": 12, "Irregularity": 14, + } + center_cols = {"Included", "Visit", "Day", "Baseline Stool Count", "Stool Frequency", + "Not Applicable", "Constipation", "Diarrhea", "Irregularity"} + date_cols = {"Visit Date", "Report Date"} + no_fill = PatternFill("solid", fgColor="FFF2CC") # žlutá pro excluded dny + + for col_idx, header in enumerate(headers, 1): + cell = ws.cell(row=1, column=col_idx, value=header) + cell.font = HEADER_FONT + cell.fill = HEADER_FILL + cell.alignment = ALIGN_CTR + cell.border = BORDER + ws.row_dimensions[1].height = 28 + + row_idx = 2 + for score_doc in score_docs: + subj = score_doc.get("subject", {}).get("id", "") + visit = score_doc["fields"].get("Visit", "") + visit_date = score_doc["fields"].get("Visit Date", "") + + for n in range(1, 11): + day_date_iso = score_doc["fields"].get(f"Eligible Day (-{n})") + if not day_date_iso or day_date_iso == "-": + continue + date_part = day_date_iso[:10] + excl_reason = score_doc["fields"].get(f"Day (-{n}) Excluded Reason(s)", "") + included = "No" if excl_reason and excl_reason != "-" else "Yes" + + diary = diary_lookup.get((subj, date_part), {}) + df = diary.get("fields", {}) + + fill = no_fill if included == "No" else (FILL_EVEN if row_idx % 2 == 0 else FILL_ODD) + font = Font(size=10, color="808080") if included == "No" else CELL_FONT + + values = [ + included, + subj, + visit, + _iso_to_date(visit_date) if isinstance(visit_date, str) else visit_date, + f"-{n}", + _iso_to_date(day_date_iso), + _num(df.get("Baseline Stool Count", "")), + _num(df.get("Stool Frequency", "")), + df.get("MAYO050", ""), + df.get("Not Applicable", ""), + df.get("Constipation", ""), + df.get("Diarrhea", ""), + df.get("Irregularity", ""), + ] + + for col_idx, (header, value) in enumerate(zip(headers, values), 1): + cell = ws.cell(row=row_idx, column=col_idx, value=value) + cell.font = font + cell.fill = fill + cell.border = BORDER + if header in date_cols: + cell.number_format = "DD-MMM-YYYY" + cell.alignment = ALIGN_CTR if header in center_cols else ALIGN_LEFT + + row_idx += 1 + + for col_idx, header in enumerate(headers, 1): + ws.column_dimensions[get_column_letter(col_idx)].width = col_widths.get(header, 14) + + ws.freeze_panes = "A2" + ws.auto_filter.ref = f"A1:{get_column_letter(len(headers))}1" + + +# --------------------------------------------------------------------------- +# Timing helper +# --------------------------------------------------------------------------- + +def _tick(label: str, t0: float) -> float: + """Vypíše dobu od t0 a vrátí aktuální čas jako nový t0.""" + elapsed = time.perf_counter() - t0 + print(f" {label:<30} {elapsed:6.2f} s") + return time.perf_counter() + + +# --------------------------------------------------------------------------- +# Main +# --------------------------------------------------------------------------- + +def main(): + t_total = time.perf_counter() + print("Spouštím generování reportu...") + print() + + # -- 1. MongoDB: připojení + načtení + seřazení -------------------------- + t = time.perf_counter() + client = MongoClient(MONGO_URI, serverSelectionTimeoutMS=5000) + client.admin.command("ping") + db = client[DB_NAME] + score_docs = list(db["Clario.MayoScore"].find({})) + diary_docs = list(db["Clario.MayoDiary"].find({})) + client.close() + score_docs.sort(key=_visit_sort_key) + diary_docs.sort(key=lambda d: ( + d.get("subject", {}).get("id", ""), + d["fields"].get("Report Date", ""), + )) + t = _tick(f"MongoDB (ping, fetch, sort → {len(score_docs)} + {len(diary_docs)} záznamů)", t) + + # -- 2–4. Tvorba listů --------------------------------------------------- + wb = Workbook() + ws_score = wb.active + ws_score.title = "MayoScore" + build_mayo_score_sheet(ws_score, score_docs) + t = _tick("List MayoScore (KLIKNI SEM, zebra, červené I-0, autofilter)", t) + + ws_diary = wb.create_sheet("MayoDiary") + build_mayo_diary_sheet(ws_diary, diary_docs) + t = _tick("List MayoDiary (zebra, formátování dat, autofilter)", t) + + ws_days = wb.create_sheet("EligibleDays") + build_eligible_days_sheet(ws_days, score_docs, diary_docs) + t = _tick("List EligibleDays (diary lookup, included/excluded flag, autofilter)", t) + + # -- 5. Uložení XLSX ----------------------------------------------------- + OUTPUT_DIR.mkdir(parents=True, exist_ok=True) + today = datetime.now().strftime("%Y-%m-%d") + filename = f"{today} 77242113UCO3001 Clario Reports.xlsx" + output_path = OUTPUT_DIR / filename + xlsx_path = output_path.with_suffix(".xlsx") + xlsm_path = output_path.with_suffix(".xlsm") + wb.save(str(xlsx_path)) + t = _tick("Uložení XLSX (openpyxl, dočasný soubor)", t) + + # -- 6. Injektování VBA -------------------------------------------------- + inject_vba(xlsx_path, xlsm_path) + xlsx_path.unlink(missing_ok=True) + _tick("Injektování VBA (xlwings: open → AddFromString → SaveAs .xlsm)", t) + + # -- Souhrn -------------------------------------------------------------- + total = time.perf_counter() - t_total + print() + print(f" {'Celkem':<30} {total:6.2f} s") + print() + print(f"Uloženo: {xlsm_path}") + + +def inject_vba(xlsx_path: Path, xlsm_path: Path) -> None: + vba_code = '''\ +Private Sub Worksheet_SelectionChange(ByVal Target As Range) + If Target.Row < 2 Then Exit Sub + If Target.Rows.Count > 1 Then Exit Sub + If Target.Column <> 1 Then Exit Sub + + Dim subjectId As String + Dim visit As String + subjectId = CStr(Me.Cells(Target.Row, 3).Value) + visit = CStr(Me.Cells(Target.Row, 4).Value) + + If subjectId = "" Or visit = "" Then Exit Sub + + Dim ws As Worksheet + On Error Resume Next + Set ws = ThisWorkbook.Sheets("EligibleDays") + On Error GoTo 0 + If ws Is Nothing Then Exit Sub + + Application.ScreenUpdating = False + + ws.AutoFilterMode = False + ws.Range("A1").AutoFilter + ws.Range("A1").AutoFilter Field:=2, Criteria1:=subjectId + ws.Range("A1").AutoFilter Field:=3, Criteria1:=visit + + ws.Activate + ws.Range("A2").Select + + Application.ScreenUpdating = True +End Sub +''' + + app = xw.App(visible=False) + try: + wb = app.books.open(str(xlsx_path)) + # Najdi VBComponent odpovídající listu "MayoScore" podle tab názvu + vb_comp = None + for comp in wb.api.VBProject.VBComponents: + if comp.Type == 100: # xlSheet + try: + if comp.Properties("Name").Value == "MayoScore": + vb_comp = comp + break + except Exception: + pass + if vb_comp is None: + # fallback: první sheet (Sheet1) + vb_comp = wb.api.VBProject.VBComponents("Sheet1") + vb_comp.CodeModule.AddFromString(vba_code) + wb.api.SaveAs(str(xlsm_path), FileFormat=52) # 52 = xlOpenXMLWorkbookMacroEnabled + wb.close() + finally: + app.quit() + + +if __name__ == "__main__": + main() diff --git a/Covance_MDD3003/Source/2026-05-29_100908 sponsor-study-35472-samples-allSamples.csv b/Covance_MDD3003/Source/2026-05-29_100908 sponsor-study-35472-samples-allSamples.csv new file mode 100644 index 0000000..94fee19 --- /dev/null +++ b/Covance_MDD3003/Source/2026-05-29_100908 sponsor-study-35472-samples-allSamples.csv @@ -0,0 +1,1189 @@ +Protocol Code,Investigator No.,Investigator Name,Patient No.,Collection Date,Protocol Visit Code,Kit Receipt Date,Container Receipt Date,Accession,Container No.,Container Barcode No.,Specimen Type,Sample Status,Expected Receipt Condition,Actual Receipt Condition,Container Label Line 1,Container Label Line 2,SM Sample Status,SMART Specimen Class Description,Aliquot Created Date,Aliquoted Date,Collection Time,Container Receipt Time,Country,Courier,Kit Receipt Time,Parent Barcode Number,Parent Sample Type,Project,Region,Screening No.,Shipped To Organization Name,Site Waybill No.,Site - Scheduled Shipment Date,Site - Shipment Created Date,Site - Shipment Details Entered Date,SMART Specimen Class,Visit Description,Parent Barcode,Children Barcode +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,08-Aug-2025,P1SCR,09-Aug-2025,,6225350971,1,622535097101,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:30,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,08-Aug-2025,P1SCR,09-Aug-2025,09-Aug-2025,6225350971,2,622535097102,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:30,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,08-Aug-2025,P1SCR,09-Aug-2025,09-Aug-2025,6225350971,3,622535097103,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,10:30,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,08-Aug-2025,P1SCR,09-Aug-2025,09-Aug-2025,6225350971,4,622535097104,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:30,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,08-Aug-2025,P1SCR,09-Aug-2025,09-Aug-2025,6225350971,5,622535097105,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:30,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,08-Aug-2025,P1SCR,09-Aug-2025,09-Aug-2025,6225350971,6,622535097106,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,10:30,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,08-Aug-2025,P1SCR,09-Aug-2025,,6225350971,7,622535097107,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:30,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,08-Aug-2025,P1SCR,09-Aug-2025,12-Aug-2025,6225350971,8,622535097108,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:30,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,08-Aug-2025,P1SCR,09-Aug-2025,,6225350971,9,622535097109,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:30,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,08-Aug-2025,P1SCR,09-Aug-2025,09-Aug-2025,6225350971,10,622535097110,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:30,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,19-Sep-2025,P1SCR,20-Sep-2025,,6225350972,1,622535097201,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:20,,Czech Republic,,22:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,19-Sep-2025,P1SCR,20-Sep-2025,20-Sep-2025,6225350972,3,622535097203,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:20,22:00,Czech Republic,,22:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,19-Sep-2025,P1SCR,20-Sep-2025,20-Sep-2025,6225350972,4,622535097204,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:20,22:00,Czech Republic,,22:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,19-Sep-2025,P1SCR,20-Sep-2025,20-Sep-2025,6225350972,2,622535097202,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:20,22:00,Czech Republic,,22:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,19-Sep-2025,P1SCR,20-Sep-2025,20-Sep-2025,6225350972,5,622535097205,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:20,22:00,Czech Republic,,22:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,19-Sep-2025,P1SCR,20-Sep-2025,20-Sep-2025,6225350972,6,622535097206,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:20,22:00,Czech Republic,,22:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,19-Sep-2025,P1SCR,20-Sep-2025,,6225350972,7,622535097207,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:20,,Czech Republic,,22:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,19-Sep-2025,P1SCR,20-Sep-2025,24-Sep-2025,6225350972,8,622535097208,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:20,07:00,Czech Republic,,22:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,19-Sep-2025,P1SCR,20-Sep-2025,,6225350972,9,622535097209,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:20,,Czech Republic,,22:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,19-Sep-2025,P1SCR,20-Sep-2025,20-Sep-2025,6225350972,10,622535097210,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:20,22:00,Czech Republic,,22:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,07-Nov-2025,P1SCR,08-Nov-2025,,6225350975,1,622535097501,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:10,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,07-Nov-2025,P1SCR,08-Nov-2025,08-Nov-2025,6225350975,2,622535097502,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,07-Nov-2025,P1SCR,08-Nov-2025,08-Nov-2025,6225350975,3,622535097503,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,08:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,07-Nov-2025,P1SCR,08-Nov-2025,08-Nov-2025,6225350975,5,622535097505,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,07-Nov-2025,P1SCR,08-Nov-2025,08-Nov-2025,6225350975,6,622535097506,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,08:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,07-Nov-2025,P1SCR,08-Nov-2025,08-Nov-2025,6225350975,4,622535097504,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,07-Nov-2025,P1SCR,08-Nov-2025,,6225350975,7,622535097507,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:10,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,07-Nov-2025,P1SCR,08-Nov-2025,12-Nov-2025,6225350975,8,622535097508,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:10,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,07-Nov-2025,P1SCR,08-Nov-2025,,6225350975,9,622535097509,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:10,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,07-Nov-2025,P1SCR,08-Nov-2025,08-Nov-2025,6225350975,10,622535097510,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,08:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,10-Oct-2025,P1SCR,11-Oct-2025,,6225350977,1,622535097701,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:20,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,10-Oct-2025,P1SCR,11-Oct-2025,11-Oct-2025,6225350977,2,622535097702,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,10-Oct-2025,P1SCR,11-Oct-2025,11-Oct-2025,6225350977,3,622535097703,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,10-Oct-2025,P1SCR,11-Oct-2025,11-Oct-2025,6225350977,4,622535097704,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,10-Oct-2025,P1SCR,11-Oct-2025,11-Oct-2025,6225350977,5,622535097705,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,10-Oct-2025,P1SCR,11-Oct-2025,11-Oct-2025,6225350977,6,622535097706,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,10-Oct-2025,P1SCR,11-Oct-2025,,6225350977,7,622535097707,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:20,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,10-Oct-2025,P1SCR,11-Oct-2025,15-Oct-2025,6225350977,8,622535097708,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:20,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,10-Oct-2025,P1SCR,11-Oct-2025,,6225350977,9,622535097709,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:20,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,10-Oct-2025,P1SCR,11-Oct-2025,11-Oct-2025,6225350977,10,622535097710,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,05-Sep-2025,P1DBBL,06-Sep-2025,06-Sep-2025,6225350981,1,622535098101,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,05-Sep-2025,P1DBBL,06-Sep-2025,,6225350981,2,622535098102,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,07:55,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,05-Sep-2025,P1DBBL,06-Sep-2025,09-Sep-2025,6225350981,3,622535098103,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,07:55,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,05-Sep-2025,P1DBBL,06-Sep-2025,,6225350981,4,622535098104,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,07:55,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,05-Sep-2025,P1DBBL,06-Sep-2025,06-Sep-2025,6225350981,5,622535098105,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,05-Sep-2025,P1DBBL,06-Sep-2025,06-Sep-2025,6225350981,6,622535098106,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,07-Nov-2025,P1DBBL,08-Nov-2025,,6225350982,2,622535098202,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:30,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,07-Nov-2025,P1DBBL,08-Nov-2025,12-Nov-2025,6225350982,3,622535098203,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:30,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,07-Nov-2025,P1DBBL,08-Nov-2025,08-Nov-2025,6225350982,1,622535098201,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:30,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,05-Sep-2025,P1DBBL,06-Sep-2025,06-Sep-2025,6225350981,7,622535098107,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,07-Nov-2025,P1DBBL,08-Nov-2025,,6225350982,4,622535098204,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:30,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,07-Nov-2025,P1DBBL,08-Nov-2025,08-Nov-2025,6225350982,5,622535098205,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:30,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,07-Nov-2025,P1DBBL,08-Nov-2025,08-Nov-2025,6225350982,6,622535098206,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,09:30,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,07-Nov-2025,P1DBBL,08-Nov-2025,08-Nov-2025,6225350982,7,622535098207,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:30,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,17-Oct-2025,P1DBBL,18-Oct-2025,18-Oct-2025,6225350984,1,622535098401,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:45,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,17-Oct-2025,P1DBBL,18-Oct-2025,,6225350984,2,622535098402,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:45,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,17-Oct-2025,P1DBBL,18-Oct-2025,22-Oct-2025,6225350984,3,622535098403,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:45,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,17-Oct-2025,P1DBBL,18-Oct-2025,,6225350984,4,622535098404,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:45,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,17-Oct-2025,P1DBBL,18-Oct-2025,18-Oct-2025,6225350984,5,622535098405,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:45,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,17-Oct-2025,P1DBBL,18-Oct-2025,18-Oct-2025,6225350984,6,622535098406,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,10:45,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,17-Oct-2025,P1DBBL,18-Oct-2025,18-Oct-2025,6225350984,7,622535098407,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:45,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,17-Oct-2025,P2OLBL,18-Oct-2025,18-Oct-2025,6225350988,5,622535098805,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,17-Oct-2025,P2OLBL,18-Oct-2025,18-Oct-2025,6225350988,6,622535098806,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,09:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,17-Oct-2025,P2OLBL,18-Oct-2025,18-Oct-2025,6225350988,7,622535098807,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,17-Oct-2025,P2OLBL,18-Oct-2025,,6225350988,8,622535098808,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,17-Oct-2025,P2OLBL,18-Oct-2025,18-Oct-2025,6225350988,1,622535098801,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,17-Oct-2025,P2OLBL,18-Oct-2025,18-Oct-2025,6225350988,9,622535098809,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,17-Oct-2025,P2OLBL,18-Oct-2025,,6225350988,2,622535098802,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,17-Oct-2025,P2OLBL,18-Oct-2025,22-Oct-2025,6225350988,3,622535098803,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:00,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,17-Oct-2025,P2OLBL,18-Oct-2025,,6225350988,4,622535098804,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,19-Aug-2025,P1SCR,21-Aug-2025,,6225351002,1,622535100201,"Whole Blood, EDTA, Dry",Not Received,Ambient,,HEMATOLOGY,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,19-Aug-2025,P1SCR,21-Aug-2025,,6225351002,2,622535100202,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,19-Aug-2025,P1SCR,21-Aug-2025,,6225351002,3,622535100203,"Urine, Cargile Preservative UA",Not Received,Ambient,,URINALYSIS,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,19-Aug-2025,P1SCR,21-Aug-2025,,6225351002,4,622535100204,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,19-Aug-2025,P1SCR,21-Aug-2025,,6225351002,5,622535100205,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,19-Aug-2025,P1SCR,21-Aug-2025,21-Aug-2025,6225351002,6,622535100206,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,19-Aug-2025,P1SCR,21-Aug-2025,,6225351002,7,622535100207,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,19-Aug-2025,P1SCR,21-Aug-2025,,6225351002,8,622535100208,"Serum, SST",Not Received,Ambient,,TSH,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,19-Aug-2025,P1SCR,21-Aug-2025,,6225351002,9,622535100209,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,19-Aug-2025,P1SCR,21-Aug-2025,,6225351002,10,622535100210,"Serum, SST",Not Received,Ambient,,CHEMISTRY,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,03-Nov-2025,P1SCR,04-Nov-2025,,6225351004,1,622535100401,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:08,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351004,2,622535100402,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351004,3,622535100403,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,12:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351004,4,622535100404,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351004,5,622535100405,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351004,6,622535100406,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,12:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,03-Nov-2025,P1SCR,04-Nov-2025,,6225351004,7,622535100407,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:08,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351004,8,622535100408,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,03-Nov-2025,P1SCR,04-Nov-2025,,6225351004,9,622535100409,"Red Cells, Clot",Not Received,,,TSH,,,,,,12:08,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351004,10,622535100410,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,12:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,09-Sep-2025,P1SCR,10-Sep-2025,10-Sep-2025,6225351006,2,622535100602,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,09-Sep-2025,P1SCR,10-Sep-2025,,6225351006,1,622535100601,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,09-Sep-2025,P1SCR,10-Sep-2025,10-Sep-2025,6225351006,3,622535100603,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,09-Sep-2025,P1SCR,10-Sep-2025,10-Sep-2025,6225351006,4,622535100604,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,09-Sep-2025,P1SCR,10-Sep-2025,10-Sep-2025,6225351006,5,622535100605,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,09-Sep-2025,P1SCR,10-Sep-2025,10-Sep-2025,6225351006,6,622535100606,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,09-Sep-2025,P1SCR,10-Sep-2025,,6225351006,7,622535100607,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,09-Sep-2025,P1SCR,10-Sep-2025,10-Sep-2025,6225351006,8,622535100608,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,09-Sep-2025,P1SCR,10-Sep-2025,,6225351006,9,622535100609,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,09-Sep-2025,P1SCR,10-Sep-2025,10-Sep-2025,6225351006,10,622535100610,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,16-Sep-2025,P1SCR,17-Sep-2025,17-Sep-2025,6225351036,1,622535103601,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,16-Sep-2025,P1SCR,17-Sep-2025,,6225351036,3,622535103603,"Urine, Cargile Preservative UA",Not Received,Ambient,,URINALYSIS,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,16-Sep-2025,P1SCR,17-Sep-2025,,6225351036,4,622535103604,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,16-Sep-2025,P1SCR,17-Sep-2025,,6225351036,2,622535103602,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,16-Sep-2025,P1SCR,17-Sep-2025,,6225351036,5,622535103605,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,16-Sep-2025,P1SCR,17-Sep-2025,,6225351036,7,622535103607,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,16-Sep-2025,P1SCR,17-Sep-2025,,6225351036,8,622535103608,"Serum, SST",Not Received,Ambient,,TSH,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,16-Sep-2025,P1SCR,17-Sep-2025,,6225351036,6,622535103606,"Plasma, EDTA",Not Received,Frozen,,INSULIN,FROZEN,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,11-Nov-2025,P1SCR,12-Nov-2025,,6225351037,2,622535103702,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,10:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,16-Sep-2025,P1SCR,17-Sep-2025,,6225351036,9,622535103609,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,11-Nov-2025,P1SCR,12-Nov-2025,,6225351037,3,622535103703,"Urine, Cargile Preservative UA",Not Received,Ambient,,URINALYSIS,,,,,,10:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,16-Sep-2025,P1SCR,17-Sep-2025,17-Sep-2025,6225351036,10,622535103610,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,11-Nov-2025,P1SCR,12-Nov-2025,12-Nov-2025,6225351037,1,622535103701,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,11-Nov-2025,P1SCR,12-Nov-2025,,6225351037,6,622535103706,"Plasma, EDTA",Not Received,Frozen,,INSULIN,FROZEN,,,,,10:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,11-Nov-2025,P1SCR,12-Nov-2025,,6225351037,9,622535103709,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,11-Nov-2025,P1SCR,12-Nov-2025,,6225351037,8,622535103708,"Serum, SST",Not Received,Ambient,,TSH,,,,,,10:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,11-Nov-2025,P1SCR,12-Nov-2025,12-Nov-2025,6225351037,10,622535103710,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,11-Nov-2025,P1SCR,12-Nov-2025,,6225351037,7,622535103707,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,11-Nov-2025,P1SCR,12-Nov-2025,,6225351037,4,622535103704,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,10:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,11-Nov-2025,P1SCR,12-Nov-2025,,6225351037,5,622535103705,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,16-Sep-2025,P1SCR,17-Sep-2025,17-Sep-2025,6225351040,2,622535104002,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,16-Sep-2025,P1SCR,17-Sep-2025,,6225351040,1,622535104001,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,16-Sep-2025,P1SCR,17-Sep-2025,17-Sep-2025,6225351040,5,622535104005,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,16-Sep-2025,P1SCR,17-Sep-2025,17-Sep-2025,6225351040,4,622535104004,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,16-Sep-2025,P1SCR,17-Sep-2025,17-Sep-2025,6225351040,6,622535104006,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,16-Sep-2025,P1SCR,17-Sep-2025,17-Sep-2025,6225351040,8,622535104008,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,16-Sep-2025,P1SCR,17-Sep-2025,,6225351040,9,622535104009,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,16-Sep-2025,P1SCR,17-Sep-2025,17-Sep-2025,6225351040,3,622535104003,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,16-Sep-2025,P1SCR,17-Sep-2025,,6225351040,7,622535104007,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080003,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351041,3,622535104103,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,11:43,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080003,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351041,5,622535104105,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:43,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080003,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351041,6,622535104106,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,11:43,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080003,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351041,4,622535104104,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:43,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080003,06-Aug-2025,P1SCR,07-Aug-2025,,6225351041,7,622535104107,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:43,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080003,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351041,8,622535104108,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:43,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080003,06-Aug-2025,P1SCR,07-Aug-2025,,6225351041,1,622535104101,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:43,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,16-Sep-2025,P1SCR,17-Sep-2025,17-Sep-2025,6225351040,10,622535104010,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080003,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351041,2,622535104102,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:43,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080003,06-Aug-2025,P1SCR,07-Aug-2025,,6225351041,9,622535104109,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:43,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080003,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351041,10,622535104110,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:43,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,26-Aug-2025,P1SCR,27-Aug-2025,,6225351042,1,622535104201,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:08,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,26-Aug-2025,P1SCR,27-Aug-2025,27-Aug-2025,6225351042,4,622535104204,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,26-Aug-2025,P1SCR,27-Aug-2025,27-Aug-2025,6225351042,3,622535104203,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,11:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,26-Aug-2025,P1SCR,27-Aug-2025,27-Aug-2025,6225351042,5,622535104205,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,26-Aug-2025,P1SCR,27-Aug-2025,27-Aug-2025,6225351042,6,622535104206,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,11:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,26-Aug-2025,P1SCR,27-Aug-2025,27-Aug-2025,6225351042,2,622535104202,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,26-Aug-2025,P1SCR,27-Aug-2025,27-Aug-2025,6225351042,10,622535104210,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,26-Aug-2025,P1SCR,27-Aug-2025,28-Aug-2025,6225351042,8,622535104208,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,26-Aug-2025,P1SCR,27-Aug-2025,,6225351042,9,622535104209,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:08,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,26-Aug-2025,P1SCR,27-Aug-2025,,6225351042,7,622535104207,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:08,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,10-Dec-2025,P1SCR,11-Dec-2025,,6225351044,1,622535104401,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:20,,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,10-Dec-2025,P1SCR,11-Dec-2025,11-Dec-2025,6225351044,2,622535104402,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:20,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,10-Dec-2025,P1SCR,11-Dec-2025,11-Dec-2025,6225351044,3,622535104403,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,10:20,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,10-Dec-2025,P1SCR,11-Dec-2025,11-Dec-2025,6225351044,4,622535104404,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:20,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,10-Dec-2025,P1SCR,11-Dec-2025,11-Dec-2025,6225351044,5,622535104405,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:20,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,10-Dec-2025,P1SCR,11-Dec-2025,11-Dec-2025,6225351044,6,622535104406,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,10:20,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,10-Dec-2025,P1SCR,11-Dec-2025,,6225351044,7,622535104407,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:20,,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,10-Dec-2025,P1SCR,11-Dec-2025,,6225351044,9,622535104409,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:20,,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,10-Dec-2025,P1SCR,11-Dec-2025,11-Dec-2025,6225351044,10,622535104410,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:20,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,05-Aug-2025,P1SCR,06-Aug-2025,,6225351045,1,622535104501,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:58,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,05-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351045,2,622535104502,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,05-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351045,3,622535104503,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,11:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,10-Dec-2025,P1SCR,11-Dec-2025,11-Dec-2025,6225351044,8,622535104408,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:20,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,05-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351045,4,622535104504,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,05-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351045,5,622535104505,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,05-Aug-2025,P1SCR,06-Aug-2025,,6225351045,7,622535104507,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:58,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,05-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351045,8,622535104508,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,05-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351045,6,622535104506,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,11:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,05-Aug-2025,P1SCR,06-Aug-2025,,6225351045,9,622535104509,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:58,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,05-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351045,10,622535104510,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,10-Sep-2025,P1SCR,11-Sep-2025,,6225351046,1,622535104601,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,13:31,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,10-Sep-2025,P1SCR,11-Sep-2025,11-Sep-2025,6225351046,3,622535104603,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,13:31,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,10-Sep-2025,P1SCR,11-Sep-2025,11-Sep-2025,6225351046,4,622535104604,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,13:31,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,10-Sep-2025,P1SCR,11-Sep-2025,11-Sep-2025,6225351046,5,622535104605,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,13:31,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,10-Sep-2025,P1SCR,11-Sep-2025,11-Sep-2025,6225351046,6,622535104606,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,13:31,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,10-Sep-2025,P1SCR,11-Sep-2025,11-Sep-2025,6225351046,8,622535104608,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,13:31,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,10-Sep-2025,P1SCR,11-Sep-2025,11-Sep-2025,6225351046,2,622535104602,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,13:31,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,10-Sep-2025,P1SCR,11-Sep-2025,,6225351046,9,622535104609,"Red Cells, Clot",Not Received,,,TSH,,,,,,13:31,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,10-Sep-2025,P1SCR,11-Sep-2025,11-Sep-2025,6225351046,10,622535104610,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,13:31,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,10-Sep-2025,P1SCR,11-Sep-2025,,6225351046,7,622535104607,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,13:31,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,02-Jul-2025,P1SCR,03-Jul-2025,03-Jul-2025,6225351047,2,622535104702,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:12,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,02-Jul-2025,P1SCR,03-Jul-2025,03-Jul-2025,6225351047,3,622535104703,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,11:12,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,02-Jul-2025,P1SCR,03-Jul-2025,03-Jul-2025,6225351047,4,622535104704,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:12,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,02-Jul-2025,P1SCR,03-Jul-2025,03-Jul-2025,6225351047,5,622535104705,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:12,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,02-Jul-2025,P1SCR,03-Jul-2025,03-Jul-2025,6225351047,6,622535104706,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,11:12,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,02-Jul-2025,P1SCR,03-Jul-2025,03-Jul-2025,6225351047,8,622535104708,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:12,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,02-Jul-2025,P1SCR,03-Jul-2025,,6225351047,1,622535104701,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:12,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,02-Jul-2025,P1SCR,03-Jul-2025,,6225351047,7,622535104707,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:12,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,02-Jul-2025,P1SCR,03-Jul-2025,,6225351047,9,622535104709,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:12,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,02-Jul-2025,P1SCR,03-Jul-2025,03-Jul-2025,6225351047,10,622535104710,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:12,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,30-Jul-2025,P1DBBL,31-Jul-2025,31-Jul-2025,6225351049,1,622535104901,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:55,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,30-Jul-2025,P1DBBL,31-Jul-2025,,6225351049,2,622535104902,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:55,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,30-Jul-2025,P1DBBL,31-Jul-2025,31-Jul-2025,6225351049,3,622535104903,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:55,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,30-Jul-2025,P1DBBL,31-Jul-2025,,6225351049,4,622535104904,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:55,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,30-Jul-2025,P1DBBL,31-Jul-2025,31-Jul-2025,6225351049,5,622535104905,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:55,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,30-Jul-2025,P1DBBL,31-Jul-2025,31-Jul-2025,6225351049,6,622535104906,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,11:55,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,30-Jul-2025,P1DBBL,31-Jul-2025,31-Jul-2025,6225351049,7,622535104907,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:55,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,08-Oct-2025,P1DBBL,09-Oct-2025,09-Oct-2025,6225351050,1,622535105001,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:19,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,08-Oct-2025,P1DBBL,09-Oct-2025,,6225351050,2,622535105002,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:19,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,08-Oct-2025,P1DBBL,09-Oct-2025,,6225351050,4,622535105004,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:19,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,08-Oct-2025,P1DBBL,09-Oct-2025,09-Oct-2025,6225351050,5,622535105005,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:19,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,08-Oct-2025,P1DBBL,09-Oct-2025,09-Oct-2025,6225351050,6,622535105006,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,11:19,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,08-Oct-2025,P1DBBL,09-Oct-2025,09-Oct-2025,6225351050,3,622535105003,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:19,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,26-Aug-2025,P1DBBL,27-Aug-2025,27-Aug-2025,6225351051,1,622535105101,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:47,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,26-Aug-2025,P1DBBL,27-Aug-2025,,6225351051,2,622535105102,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:47,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,26-Aug-2025,P1DBBL,27-Aug-2025,28-Aug-2025,6225351051,3,622535105103,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:47,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,08-Oct-2025,P1DBBL,09-Oct-2025,09-Oct-2025,6225351050,7,622535105007,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:19,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,26-Aug-2025,P1DBBL,27-Aug-2025,,6225351051,4,622535105104,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:47,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,26-Aug-2025,P1DBBL,27-Aug-2025,27-Aug-2025,6225351051,6,622535105106,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,12:47,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,26-Aug-2025,P1DBBL,27-Aug-2025,27-Aug-2025,6225351051,5,622535105105,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:47,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,26-Aug-2025,P1DBBL,27-Aug-2025,27-Aug-2025,6225351051,7,622535105107,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:47,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,16-Sep-2025,P1DBBL,17-Sep-2025,17-Sep-2025,6225351052,3,622535105203,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,16-Sep-2025,P1DBBL,17-Sep-2025,17-Sep-2025,6225351052,5,622535105205,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,16-Sep-2025,P1DBBL,17-Sep-2025,17-Sep-2025,6225351052,6,622535105206,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,12:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,16-Sep-2025,P1DBBL,17-Sep-2025,,6225351052,2,622535105202,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,16-Sep-2025,P1DBBL,17-Sep-2025,,6225351052,4,622535105204,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,16-Sep-2025,P1DBBL,17-Sep-2025,17-Sep-2025,6225351052,1,622535105201,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,16-Sep-2025,P1DBBL,17-Sep-2025,17-Sep-2025,6225351052,7,622535105207,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,10-Sep-2025,P2OLBL,11-Sep-2025,11-Sep-2025,6225351056,1,622535105601,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,10-Sep-2025,P2OLBL,11-Sep-2025,,6225351056,2,622535105602,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,10-Sep-2025,P2OLBL,11-Sep-2025,11-Sep-2025,6225351056,3,622535105603,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,10-Sep-2025,P2OLBL,11-Sep-2025,,6225351056,4,622535105604,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,10-Sep-2025,P2OLBL,11-Sep-2025,11-Sep-2025,6225351056,5,622535105605,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,10-Sep-2025,P2OLBL,11-Sep-2025,11-Sep-2025,6225351056,6,622535105606,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,10-Sep-2025,P2OLBL,11-Sep-2025,11-Sep-2025,6225351056,7,622535105607,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,10-Sep-2025,P2OLBL,11-Sep-2025,,6225351056,8,622535105608,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,10-Sep-2025,P2OLBL,11-Sep-2025,11-Sep-2025,6225351056,9,622535105609,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Oct-2025,P2OLBL,08-Oct-2025,08-Oct-2025,6225351057,1,622535105701,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:02,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Oct-2025,P2OLBL,08-Oct-2025,,6225351057,2,622535105702,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:02,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Oct-2025,P2OLBL,08-Oct-2025,08-Oct-2025,6225351057,3,622535105703,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:02,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Oct-2025,P2OLBL,08-Oct-2025,,6225351057,4,622535105704,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:02,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Oct-2025,P2OLBL,08-Oct-2025,08-Oct-2025,6225351057,5,622535105705,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:02,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Oct-2025,P2OLBL,08-Oct-2025,08-Oct-2025,6225351057,6,622535105706,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,12:02,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Oct-2025,P2OLBL,08-Oct-2025,08-Oct-2025,6225351057,7,622535105707,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:02,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Oct-2025,P2OLBL,08-Oct-2025,,6225351057,8,622535105708,"Red Cells, Clot",Not Received,,,TSH,,,,,,12:02,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Oct-2025,P2OLBL,08-Oct-2025,08-Oct-2025,6225351057,9,622535105709,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,12:02,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,14-Oct-2025,EW,15-Oct-2025,15-Oct-2025,6225351066,1,622535106601,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,12:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Early Withdrawal,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,14-Oct-2025,EW,15-Oct-2025,15-Oct-2025,6225351066,3,622535106603,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Early Withdrawal,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,14-Oct-2025,EW,15-Oct-2025,,6225351066,4,622535106604,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:30,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Early Withdrawal,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,14-Oct-2025,EW,15-Oct-2025,15-Oct-2025,6225351066,7,622535106607,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Early Withdrawal,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,14-Oct-2025,EW,15-Oct-2025,,6225351066,8,622535106608,"Red Cells, Clot",Not Received,,,TSH,,,,,,12:30,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Early Withdrawal,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,14-Oct-2025,EW,15-Oct-2025,15-Oct-2025,6225351066,9,622535106609,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,12:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Early Withdrawal,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,14-Oct-2025,EW,15-Oct-2025,,6225351066,6,622535106606,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:30,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Early Withdrawal,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,14-Oct-2025,EW,15-Oct-2025,15-Oct-2025,6225351066,5,622535106605,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Early Withdrawal,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,14-Oct-2025,EW,15-Oct-2025,15-Oct-2025,6225351066,2,622535106602,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Early Withdrawal,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,08-Sep-2025,P1SCR,09-Sep-2025,,6225351070,3,622535107003,"Urine, Cargile Preservative UA",Not Received,Ambient,,URINALYSIS,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,08-Sep-2025,P1SCR,09-Sep-2025,09-Sep-2025,6225351070,4,622535107004,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,10:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,08-Sep-2025,P1SCR,09-Sep-2025,,6225351070,2,622535107002,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,08-Sep-2025,P1SCR,09-Sep-2025,,6225351070,5,622535107005,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,08-Sep-2025,P1SCR,09-Sep-2025,,6225351070,6,622535107006,"Plasma, EDTA",Not Received,Frozen,,INSULIN,FROZEN,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,08-Sep-2025,P1SCR,09-Sep-2025,,6225351070,1,622535107001,"Whole Blood, EDTA, Dry",Not Received,Ambient,,HEMATOLOGY,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,08-Sep-2025,P1SCR,09-Sep-2025,,6225351070,9,622535107009,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,08-Sep-2025,P1SCR,09-Sep-2025,,6225351070,8,622535107008,"Serum, SST",Not Received,Ambient,,TSH,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,08-Sep-2025,P1SCR,09-Sep-2025,,6225351070,7,622535107007,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,08-Sep-2025,P1SCR,09-Sep-2025,,6225351070,10,622535107010,"Serum, SST",Not Received,Ambient,,CHEMISTRY,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351072,2,622535107202,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351072,3,622535107203,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351072,4,622535107204,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351072,5,622535107205,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351072,6,622535107206,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Aug-2025,P1SCR,07-Aug-2025,,6225351072,7,622535107207,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:40,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Aug-2025,P1SCR,07-Aug-2025,,6225351072,1,622535107201,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:40,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351072,10,622535107210,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Aug-2025,P1SCR,07-Aug-2025,,6225351072,9,622535107209,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:40,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351072,8,622535107208,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110005,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351074,2,622535107402,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110005,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351074,3,622535107403,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110005,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351074,4,622535107404,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110005,03-Nov-2025,P1SCR,04-Nov-2025,,6225351074,1,622535107401,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:40,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110005,03-Nov-2025,P1SCR,04-Nov-2025,,6225351074,7,622535107407,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:40,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110005,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351074,10,622535107410,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110005,03-Nov-2025,P1SCR,04-Nov-2025,,6225351074,9,622535107409,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:40,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110005,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351074,6,622535107406,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110005,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351074,5,622535107405,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,03-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351076,2,622535107602,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,03-Aug-2025,P1SCR,06-Aug-2025,,6225351076,1,622535107601,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:05,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110005,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351074,8,622535107408,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,03-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351076,3,622535107603,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,03-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351076,5,622535107605,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,03-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351076,6,622535107606,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,03-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351076,4,622535107604,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,03-Aug-2025,P1SCR,06-Aug-2025,,6225351076,7,622535107607,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:05,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,03-Aug-2025,P1SCR,06-Aug-2025,,6225351076,9,622535107609,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:05,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,03-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351076,10,622535107610,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,03-Aug-2025,P1SCR,06-Aug-2025,07-Aug-2025,6225351076,8,622535107608,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110004,03-Oct-2025,P1SCR,04-Oct-2025,04-Oct-2025,6225351077,3,622535107703,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:33,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110004,03-Oct-2025,P1SCR,04-Oct-2025,,6225351077,1,622535107701,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:33,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110004,03-Oct-2025,P1SCR,04-Oct-2025,04-Oct-2025,6225351077,4,622535107704,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:33,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110004,03-Oct-2025,P1SCR,04-Oct-2025,04-Oct-2025,6225351077,5,622535107705,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:33,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110004,03-Oct-2025,P1SCR,04-Oct-2025,04-Oct-2025,6225351077,6,622535107706,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:33,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110004,03-Oct-2025,P1SCR,04-Oct-2025,,6225351077,7,622535107707,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:33,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110004,03-Oct-2025,P1SCR,04-Oct-2025,04-Oct-2025,6225351077,8,622535107708,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:33,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110004,03-Oct-2025,P1SCR,04-Oct-2025,,6225351077,9,622535107709,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:33,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110004,03-Oct-2025,P1SCR,04-Oct-2025,04-Oct-2025,6225351077,10,622535107710,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:33,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110004,03-Oct-2025,P1SCR,04-Oct-2025,04-Oct-2025,6225351077,2,622535107702,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:33,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,14-Nov-2025,P1SCR,15-Nov-2025,15-Nov-2025,6225351078,5,622535107805,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,14-Nov-2025,P1SCR,15-Nov-2025,15-Nov-2025,6225351078,6,622535107806,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,10:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,14-Nov-2025,P1SCR,15-Nov-2025,,6225351078,7,622535107807,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:22,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,14-Nov-2025,P1SCR,15-Nov-2025,15-Nov-2025,6225351078,8,622535107808,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,14-Nov-2025,P1SCR,15-Nov-2025,,6225351078,9,622535107809,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:22,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,14-Nov-2025,P1SCR,15-Nov-2025,15-Nov-2025,6225351078,4,622535107804,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,14-Nov-2025,P1SCR,15-Nov-2025,15-Nov-2025,6225351078,3,622535107803,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,10:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,14-Nov-2025,P1SCR,15-Nov-2025,15-Nov-2025,6225351078,2,622535107802,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,14-Nov-2025,P1SCR,15-Nov-2025,,6225351078,1,622535107801,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:22,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,14-Nov-2025,P1SCR,15-Nov-2025,15-Nov-2025,6225351078,10,622535107810,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,04-Nov-2025,P1SCR,05-Nov-2025,,6225351080,1,622535108001,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,07:03,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,04-Nov-2025,P1SCR,05-Nov-2025,05-Nov-2025,6225351080,2,622535108002,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,07:03,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,04-Nov-2025,P1SCR,05-Nov-2025,,6225351080,7,622535108007,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,07:03,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,04-Nov-2025,P1SCR,05-Nov-2025,06-Nov-2025,6225351080,8,622535108008,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,07:03,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,04-Nov-2025,P1SCR,05-Nov-2025,,6225351080,9,622535108009,"Red Cells, Clot",Not Received,,,TSH,,,,,,07:03,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,04-Nov-2025,P1SCR,05-Nov-2025,05-Nov-2025,6225351080,3,622535108003,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,07:03,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,04-Nov-2025,P1SCR,05-Nov-2025,05-Nov-2025,6225351080,10,622535108010,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,07:03,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,26-Sep-2025,P1SCR,27-Sep-2025,,6225351081,1,622535108101,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:10,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,26-Sep-2025,P1SCR,27-Sep-2025,27-Sep-2025,6225351081,3,622535108103,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,04-Nov-2025,P1SCR,05-Nov-2025,05-Nov-2025,6225351080,4,622535108004,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:03,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,26-Sep-2025,P1SCR,27-Sep-2025,27-Sep-2025,6225351081,4,622535108104,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,26-Sep-2025,P1SCR,27-Sep-2025,27-Sep-2025,6225351081,2,622535108102,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,26-Sep-2025,P1SCR,27-Sep-2025,27-Sep-2025,6225351081,5,622535108105,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,04-Nov-2025,P1SCR,05-Nov-2025,05-Nov-2025,6225351080,5,622535108005,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,07:03,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,04-Nov-2025,P1SCR,05-Nov-2025,05-Nov-2025,6225351080,6,622535108006,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,07:03,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,26-Sep-2025,P1SCR,27-Sep-2025,27-Sep-2025,6225351081,8,622535108108,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,26-Sep-2025,P1SCR,27-Sep-2025,27-Sep-2025,6225351081,10,622535108110,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,26-Sep-2025,P1SCR,27-Sep-2025,,6225351081,9,622535108109,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:10,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,28-Aug-2025,P1DBBL,29-Aug-2025,,6225351082,2,622535108202,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,26-Sep-2025,P1SCR,27-Sep-2025,,6225351081,7,622535108107,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:10,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,28-Aug-2025,P1DBBL,29-Aug-2025,29-Aug-2025,6225351082,3,622535108203,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,28-Aug-2025,P1DBBL,29-Aug-2025,,6225351082,4,622535108204,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,26-Sep-2025,P1SCR,27-Sep-2025,27-Sep-2025,6225351081,6,622535108106,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,28-Aug-2025,P1DBBL,29-Aug-2025,29-Aug-2025,6225351082,5,622535108205,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,28-Aug-2025,P1DBBL,29-Aug-2025,29-Aug-2025,6225351082,6,622535108206,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,11:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,28-Aug-2025,P1DBBL,29-Aug-2025,29-Aug-2025,6225351083,1,622535108301,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,07:07,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,28-Aug-2025,P1DBBL,29-Aug-2025,,6225351083,2,622535108302,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,07:07,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,28-Aug-2025,P1DBBL,29-Aug-2025,29-Aug-2025,6225351083,3,622535108303,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,07:07,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,28-Aug-2025,P1DBBL,29-Aug-2025,,6225351083,4,622535108304,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,07:07,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,28-Aug-2025,P1DBBL,29-Aug-2025,29-Aug-2025,6225351083,5,622535108305,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,07:07,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,28-Aug-2025,P1DBBL,29-Aug-2025,29-Aug-2025,6225351082,1,622535108201,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,28-Aug-2025,P1DBBL,29-Aug-2025,29-Aug-2025,6225351083,6,622535108306,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,07:07,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,28-Aug-2025,P1DBBL,29-Aug-2025,29-Aug-2025,6225351082,7,622535108207,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,28-Aug-2025,P1DBBL,29-Aug-2025,29-Aug-2025,6225351083,7,622535108307,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:07,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,22-Oct-2025,P1DBBL,23-Oct-2025,23-Oct-2025,6225351084,1,622535108401,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,22-Oct-2025,P1DBBL,23-Oct-2025,,6225351084,4,622535108404,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,22-Oct-2025,P1DBBL,23-Oct-2025,23-Oct-2025,6225351084,3,622535108403,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,22-Oct-2025,P1DBBL,23-Oct-2025,23-Oct-2025,6225351084,5,622535108405,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,22-Oct-2025,P1DBBL,23-Oct-2025,,6225351084,2,622535108402,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,22-Oct-2025,P1DBBL,23-Oct-2025,23-Oct-2025,6225351084,7,622535108407,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,22-Oct-2025,P1DBBL,23-Oct-2025,23-Oct-2025,6225351084,6,622535108406,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,08:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,05-Dec-2025,EOT,06-Dec-2025,06-Dec-2025,6225351093,2,622535109302,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:23,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,05-Dec-2025,EOT,06-Dec-2025,06-Dec-2025,6225351093,1,622535109301,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:23,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,05-Dec-2025,EOT,06-Dec-2025,06-Dec-2025,6225351093,3,622535109303,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:23,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,05-Dec-2025,EOT,06-Dec-2025,06-Dec-2025,6225351093,5,622535109305,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:23,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,05-Dec-2025,EOT,06-Dec-2025,,6225351093,4,622535109304,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:23,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,05-Dec-2025,EOT,06-Dec-2025,,6225351093,6,622535109306,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:23,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,05-Dec-2025,EOT,06-Dec-2025,06-Dec-2025,6225351093,7,622535109307,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:23,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,05-Dec-2025,EOT,06-Dec-2025,,6225351093,8,622535109308,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:23,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,05-Dec-2025,EOT,06-Dec-2025,06-Dec-2025,6225351093,9,622535109309,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:23,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,08-Oct-2025,EOT,09-Oct-2025,09-Oct-2025,6225351094,1,622535109401,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,08-Oct-2025,EOT,09-Oct-2025,09-Oct-2025,6225351094,3,622535109403,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,08-Oct-2025,EOT,09-Oct-2025,09-Oct-2025,6225351094,2,622535109402,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,08-Oct-2025,EOT,09-Oct-2025,,6225351094,4,622535109404,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:16,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,08-Oct-2025,EOT,09-Oct-2025,09-Oct-2025,6225351094,5,622535109405,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,08-Oct-2025,EOT,09-Oct-2025,,6225351094,6,622535109406,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:16,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,08-Oct-2025,EOT,09-Oct-2025,09-Oct-2025,6225351094,7,622535109407,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,08-Oct-2025,EOT,09-Oct-2025,,6225351094,8,622535109408,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:16,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,09-Oct-2025,EOT,10-Oct-2025,10-Oct-2025,6225351095,1,622535109501,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,09-Oct-2025,EOT,10-Oct-2025,10-Oct-2025,6225351095,2,622535109502,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,09-Oct-2025,EOT,10-Oct-2025,10-Oct-2025,6225351095,3,622535109503,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,09-Oct-2025,EOT,10-Oct-2025,10-Oct-2025,6225351095,5,622535109505,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,09-Oct-2025,EOT,10-Oct-2025,10-Oct-2025,6225351095,7,622535109507,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,09-Oct-2025,EOT,10-Oct-2025,,6225351095,8,622535109508,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,09-Oct-2025,EOT,10-Oct-2025,,6225351095,4,622535109504,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,09-Oct-2025,EOT,10-Oct-2025,,6225351095,6,622535109506,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,08-Oct-2025,EOT,09-Oct-2025,09-Oct-2025,6225351094,9,622535109409,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,08:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,09-Oct-2025,EOT,10-Oct-2025,10-Oct-2025,6225351095,9,622535109509,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120001,06-Aug-2025,P1SCR,07-Aug-2025,,6225351106,1,622535110601,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,13:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120001,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351106,2,622535110602,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,13:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120001,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351106,4,622535110604,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,13:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120001,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351106,5,622535110605,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,13:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120001,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351106,3,622535110603,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,13:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120001,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351106,6,622535110606,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,13:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120001,06-Aug-2025,P1SCR,07-Aug-2025,,6225351106,7,622535110607,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,13:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120001,06-Aug-2025,P1SCR,07-Aug-2025,08-Aug-2025,6225351106,8,622535110608,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,13:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120001,06-Aug-2025,P1SCR,07-Aug-2025,,6225351106,9,622535110609,"Red Cells, Clot",Not Received,,,TSH,,,,,,13:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120001,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351106,10,622535110610,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,13:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120002,03-Sep-2025,P1SCR,04-Sep-2025,,6225351109,1,622535110901,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,13:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120002,03-Sep-2025,P1SCR,04-Sep-2025,04-Sep-2025,6225351109,4,622535110904,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120002,03-Sep-2025,P1SCR,04-Sep-2025,04-Sep-2025,6225351109,5,622535110905,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120002,03-Sep-2025,P1SCR,04-Sep-2025,04-Sep-2025,6225351109,6,622535110906,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120002,03-Sep-2025,P1SCR,04-Sep-2025,,6225351109,7,622535110907,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,13:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120002,03-Sep-2025,P1SCR,04-Sep-2025,05-Sep-2025,6225351109,8,622535110908,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120002,03-Sep-2025,P1SCR,04-Sep-2025,04-Sep-2025,6225351109,2,622535110902,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120002,03-Sep-2025,P1SCR,04-Sep-2025,,6225351109,9,622535110909,"Red Cells, Clot",Not Received,,,TSH,,,,,,13:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120002,03-Sep-2025,P1SCR,04-Sep-2025,04-Sep-2025,6225351109,10,622535110910,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120003,01-Oct-2025,P1SCR,02-Oct-2025,,6225351110,1,622535111001,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120003,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351110,2,622535111002,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120003,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351110,3,622535111003,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,11:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120003,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351110,4,622535111004,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120003,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351110,5,622535111005,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120003,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351110,6,622535111006,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,11:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120003,01-Oct-2025,P1SCR,02-Oct-2025,,6225351110,7,622535111007,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120002,03-Sep-2025,P1SCR,04-Sep-2025,04-Sep-2025,6225351109,3,622535110903,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120003,01-Oct-2025,P1SCR,02-Oct-2025,,6225351110,9,622535111009,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120003,01-Oct-2025,P1SCR,02-Oct-2025,03-Oct-2025,6225351110,8,622535111008,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120003,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351110,10,622535111010,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,01-Oct-2025,P1SCR,02-Oct-2025,,6225351111,1,622535111101,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,13:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351111,2,622535111102,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351111,3,622535111103,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351111,4,622535111104,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351111,5,622535111105,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351111,6,622535111106,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,01-Oct-2025,P1SCR,02-Oct-2025,03-Oct-2025,6225351111,8,622535111108,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,01-Oct-2025,P1SCR,02-Oct-2025,,6225351111,9,622535111109,"Red Cells, Clot",Not Received,,,TSH,,,,,,13:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,01-Oct-2025,P1SCR,02-Oct-2025,,6225351111,7,622535111107,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,13:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351111,10,622535111110,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,22-Oct-2025,P1DBBL,23-Oct-2025,23-Oct-2025,6225351120,1,622535112001,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,22-Oct-2025,P1DBBL,23-Oct-2025,,6225351120,2,622535112002,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,22-Oct-2025,P1DBBL,23-Oct-2025,24-Oct-2025,6225351120,3,622535112003,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,22-Oct-2025,P1DBBL,23-Oct-2025,,6225351120,4,622535112004,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,22-Oct-2025,P1DBBL,23-Oct-2025,23-Oct-2025,6225351120,5,622535112005,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,22-Oct-2025,P1DBBL,23-Oct-2025,23-Oct-2025,6225351120,6,622535112006,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,12:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,22-Oct-2025,P1DBBL,23-Oct-2025,23-Oct-2025,6225351120,7,622535112007,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,05-Dec-2025,EOT,06-Dec-2025,06-Dec-2025,6225351126,2,622535112602,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,15:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,05-Dec-2025,EOT,06-Dec-2025,06-Dec-2025,6225351126,1,622535112601,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,15:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,05-Dec-2025,EOT,06-Dec-2025,06-Dec-2025,6225351126,3,622535112603,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,15:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,05-Dec-2025,EOT,06-Dec-2025,,6225351126,4,622535112604,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,15:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,05-Dec-2025,EOT,06-Dec-2025,10-Dec-2025,6225351126,5,622535112605,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,15:00,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,05-Dec-2025,EOT,06-Dec-2025,,6225351126,6,622535112606,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,15:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,05-Dec-2025,EOT,06-Dec-2025,,6225351126,8,622535112608,"Red Cells, Clot",Not Received,,,TSH,,,,,,15:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,05-Dec-2025,EOT,06-Dec-2025,06-Dec-2025,6225351126,7,622535112607,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,15:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,05-Dec-2025,EOT,06-Dec-2025,06-Dec-2025,6225351126,9,622535112609,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,15:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,01-Apr-2026,P2OLD29,02-Apr-2026,,6226313625,2,622631362502,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,01-Apr-2026,P2OLD29,02-Apr-2026,02-Apr-2026,6226313625,1,622631362501,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,01-Apr-2026,P2OLD29,02-Apr-2026,02-Apr-2026,6226313625,3,622631362503,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,01-Apr-2026,P2OLD29,02-Apr-2026,02-Apr-2026,6226313625,5,622631362505,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,01-Apr-2026,P2OLD29,02-Apr-2026,,6226313625,4,622631362504,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,01-Apr-2026,P2OLD29,02-Apr-2026,02-Apr-2026,6226313625,6,622631362506,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,01-Apr-2026,P2OLD29,02-Apr-2026,02-Apr-2026,6226313625,7,622631362507,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Feb-2026,P2OLD29,17-Feb-2026,,6226550646,2,622655064602,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:18,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Feb-2026,P2OLD29,17-Feb-2026,17-Feb-2026,6226550646,1,622655064601,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:18,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Feb-2026,P2OLD29,17-Feb-2026,17-Feb-2026,6226550646,7,622655064607,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:18,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Feb-2026,P2OLD29,17-Feb-2026,17-Feb-2026,6226550646,5,622655064605,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:18,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Feb-2026,P2OLD29,17-Feb-2026,,6226550646,4,622655064604,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:18,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Feb-2026,P2OLD29,17-Feb-2026,17-Feb-2026,6226550646,6,622655064606,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,09:18,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Feb-2026,P2OLD29,17-Feb-2026,17-Feb-2026,6226550646,3,622655064603,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:18,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,21-Jan-2026,P1DBBL,22-Jan-2026,,6226551697,4,622655169704,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:23,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,21-Jan-2026,P1DBBL,22-Jan-2026,22-Jan-2026,6226551697,5,622655169705,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:23,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,21-Jan-2026,P1DBBL,22-Jan-2026,22-Jan-2026,6226551697,1,622655169701,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:23,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,21-Jan-2026,P1DBBL,22-Jan-2026,22-Jan-2026,6226551697,6,622655169706,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,11:23,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,21-Jan-2026,P1DBBL,22-Jan-2026,22-Jan-2026,6226551697,7,622655169707,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:23,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,29-Oct-2025,P1DBBL,30-Oct-2025,30-Oct-2025,6226551698,1,622655169801,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,21-Jan-2026,P1DBBL,22-Jan-2026,22-Jan-2026,6226551697,3,622655169703,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:23,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,29-Oct-2025,P1DBBL,30-Oct-2025,,6226551698,4,622655169804,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,21-Jan-2026,P1DBBL,22-Jan-2026,,6226551697,2,622655169702,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:23,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,29-Oct-2025,P1DBBL,30-Oct-2025,,6226551698,2,622655169802,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,29-Oct-2025,P1DBBL,30-Oct-2025,30-Oct-2025,6226551698,6,622655169806,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,10:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,29-Oct-2025,P1DBBL,30-Oct-2025,30-Oct-2025,6226551698,3,622655169803,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,29-Oct-2025,P1DBBL,30-Oct-2025,30-Oct-2025,6226551698,5,622655169805,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,29-Oct-2025,P1DBBL,30-Oct-2025,30-Oct-2025,6226551698,7,622655169807,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,23-Apr-2026,P2OLD29,25-Apr-2026,,6226560887,4,622656088704,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,16:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,23-Apr-2026,P2OLD29,25-Apr-2026,20-May-2026,6226560887,3,622656088703,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,16:00,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,23-Apr-2026,P2OLD29,25-Apr-2026,,6226560887,2,622656088702,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,16:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,23-Apr-2026,P2OLD29,25-Apr-2026,25-Apr-2026,6226560887,1,622656088701,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,16:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,23-Apr-2026,P2OLD29,25-Apr-2026,25-Apr-2026,6226560887,5,622656088705,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,16:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,23-Apr-2026,P2OLD29,25-Apr-2026,25-Apr-2026,6226560887,6,622656088706,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,16:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,25-Mar-2026,EOT,26-Mar-2026,26-Mar-2026,6226560888,1,622656088801,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,17:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,23-Apr-2026,P2OLD29,25-Apr-2026,25-Apr-2026,6226560887,7,622656088707,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,16:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,25-Mar-2026,EOT,26-Mar-2026,26-Mar-2026,6226560888,3,622656088803,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,17:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,25-Mar-2026,EOT,26-Mar-2026,26-Mar-2026,6226560888,7,622656088807,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,17:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,25-Mar-2026,EOT,26-Mar-2026,26-Mar-2026,6226560888,9,622656088809,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,17:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,25-Mar-2026,EOT,26-Mar-2026,20-May-2026,6226560888,5,622656088805,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,17:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,25-Mar-2026,EOT,26-Mar-2026,,6226560888,4,622656088804,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,17:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,25-Mar-2026,EOT,26-Mar-2026,,6226560888,8,622656088808,"Red Cells, Clot",Not Received,,,TSH,,,,,,17:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,25-Mar-2026,EOT,26-Mar-2026,26-Mar-2026,6226560888,2,622656088802,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,17:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,25-Mar-2026,EOT,26-Mar-2026,,6226560888,6,622656088806,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,17:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,06-Mar-2026,P2DBW25,07-Mar-2026,07-Mar-2026,6226560891,2,622656089102,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,14:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 DB Every 12 Weeks,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,06-Mar-2026,P2DBW25,07-Mar-2026,07-Mar-2026,6226560891,3,622656089103,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,14:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 DB Every 12 Weeks,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,06-Mar-2026,P2DBW25,07-Mar-2026,07-Mar-2026,6226560891,1,622656089101,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,14:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 DB Every 12 Weeks,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,06-Mar-2026,P2DBW25,07-Mar-2026,,6226560891,4,622656089104,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,14:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 DB Every 12 Weeks,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,06-Mar-2026,P2DBW25,07-Mar-2026,,6226560891,6,622656089106,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,14:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 DB Every 12 Weeks,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,06-Mar-2026,P2DBW25,07-Mar-2026,,6226560891,8,622656089108,"Red Cells, Clot",Not Received,,,TSH,,,,,,14:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 DB Every 12 Weeks,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,06-Mar-2026,P2DBW25,07-Mar-2026,20-May-2026,6226560891,5,622656089105,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,14:00,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 DB Every 12 Weeks,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,06-Mar-2026,P2DBW25,07-Mar-2026,07-Mar-2026,6226560891,7,622656089107,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,14:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 DB Every 12 Weeks,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,06-Mar-2026,P2DBW25,07-Mar-2026,07-Mar-2026,6226560891,9,622656089109,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,14:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 DB Every 12 Weeks,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,03-Feb-2026,P2OLD29,04-Feb-2026,17-Feb-2026,6226561517,3,622656151703,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:23,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,03-Feb-2026,P2OLD29,04-Feb-2026,,6226561517,4,622656151704,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:23,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,03-Feb-2026,P2OLD29,04-Feb-2026,04-Feb-2026,6226561517,5,622656151705,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:23,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,03-Feb-2026,P2OLD29,04-Feb-2026,,6226561517,2,622656151702,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:23,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,03-Feb-2026,P2OLD29,04-Feb-2026,04-Feb-2026,6226561517,1,622656151701,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:23,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,03-Feb-2026,P2OLD29,04-Feb-2026,04-Feb-2026,6226561517,6,622656151706,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,10:23,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,03-Feb-2026,P2OLD29,04-Feb-2026,04-Feb-2026,6226561517,7,622656151707,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:23,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,08-Oct-2025,P2OLD29,09-Oct-2025,09-Oct-2025,6226686952,1,622668695201,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:20,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,08-Oct-2025,P2OLD29,09-Oct-2025,,6226686952,2,622668695202,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:20,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,08-Oct-2025,P2OLD29,09-Oct-2025,09-Oct-2025,6226686952,3,622668695203,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:20,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,08-Oct-2025,P2OLD29,09-Oct-2025,,6226686952,4,622668695204,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:20,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,08-Oct-2025,P2OLD29,09-Oct-2025,09-Oct-2025,6226686952,5,622668695205,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:20,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,08-Oct-2025,P2OLD29,09-Oct-2025,09-Oct-2025,6226686952,6,622668695206,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,09:20,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,08-Oct-2025,P2OLD29,09-Oct-2025,09-Oct-2025,6226686952,7,622668695207,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:20,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,13-Jan-2026,P2DBBL,14-Jan-2026,14-Jan-2026,6226686953,1,622668695301,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,13:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,13-Jan-2026,P2DBBL,14-Jan-2026,14-Jan-2026,6226686953,2,622668695302,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,13:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,13-Jan-2026,P2DBBL,14-Jan-2026,14-Jan-2026,6226686953,3,622668695303,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,13:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,13-Jan-2026,P2DBBL,14-Jan-2026,,6226686953,4,622668695304,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,13:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,13-Jan-2026,P2DBBL,14-Jan-2026,14-Jan-2026,6226686953,5,622668695305,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,13:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,13-Jan-2026,P2DBBL,14-Jan-2026,,6226686953,6,622668695306,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,13:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Apr-2026,P2DBW13,08-Apr-2026,08-Apr-2026,6226686954,7,622668695407,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:01,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,13-Jan-2026,P2DBBL,14-Jan-2026,,6226686953,8,622668695308,"Red Cells, Clot",Not Received,,,TSH,,,,,,13:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,13-Jan-2026,P2DBBL,14-Jan-2026,14-Jan-2026,6226686953,9,622668695309,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,13:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,13-Jan-2026,P2DBBL,14-Jan-2026,14-Jan-2026,6226686953,7,622668695307,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,13:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Apr-2026,P2DBW13,08-Apr-2026,08-Apr-2026,6226686954,1,622668695401,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:01,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Apr-2026,P2DBW13,08-Apr-2026,08-Apr-2026,6226686954,3,622668695403,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:01,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Apr-2026,P2DBW13,08-Apr-2026,,6226686954,4,622668695404,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:01,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Apr-2026,P2DBW13,08-Apr-2026,08-Apr-2026,6226686954,5,622668695405,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:01,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Apr-2026,P2DBW13,08-Apr-2026,08-Apr-2026,6226686954,6,622668695406,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,12:01,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Apr-2026,P2DBW13,08-Apr-2026,,6226686954,2,622668695402,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:01,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,22-Apr-2026,P2OLD29,23-Apr-2026,23-Apr-2026,6226752554,6,622675255406,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,15:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,25-Mar-2026,EOT,26-Mar-2026,26-Mar-2026,6226752555,2,622675255502,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,15:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,22-Apr-2026,P2OLD29,23-Apr-2026,23-Apr-2026,6226752554,5,622675255405,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,15:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,25-Mar-2026,EOT,26-Mar-2026,26-Mar-2026,6226752555,3,622675255503,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,15:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,22-Apr-2026,P2OLD29,23-Apr-2026,,6226752554,4,622675255404,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,15:30,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,22-Apr-2026,P2OLD29,23-Apr-2026,23-Apr-2026,6226752554,7,622675255407,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,15:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,25-Mar-2026,EOT,26-Mar-2026,,6226752555,4,622675255504,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,15:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,25-Mar-2026,EOT,26-Mar-2026,20-May-2026,6226752555,5,622675255505,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,15:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,22-Apr-2026,P2OLD29,23-Apr-2026,,6226752554,2,622675255402,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,15:30,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,22-Apr-2026,P2OLD29,23-Apr-2026,23-Apr-2026,6226752554,3,622675255403,"Plasma, EDTA",Received,Frozen,Default Return Ambient,INSULIN,FROZEN,,,,,15:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,22-Apr-2026,P2OLD29,23-Apr-2026,23-Apr-2026,6226752554,1,622675255401,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,15:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,25-Mar-2026,EOT,26-Mar-2026,26-Mar-2026,6226752555,1,622675255501,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,15:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,25-Mar-2026,EOT,26-Mar-2026,26-Mar-2026,6226752555,7,622675255507,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,15:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,25-Mar-2026,EOT,26-Mar-2026,,6226752555,8,622675255508,"Red Cells, Clot",Not Received,,,TSH,,,,,,15:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,25-Mar-2026,EOT,26-Mar-2026,26-Mar-2026,6226752555,9,622675255509,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,15:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,25-Mar-2026,EOT,26-Mar-2026,,6226752555,6,622675255506,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,15:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,05-Nov-2025,EOT,06-Nov-2025,06-Nov-2025,6226780853,1,622678085301,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,05-Nov-2025,EOT,06-Nov-2025,06-Nov-2025,6226780853,5,622678085305,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,05-Nov-2025,EOT,06-Nov-2025,06-Nov-2025,6226780853,2,622678085302,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,05-Nov-2025,EOT,06-Nov-2025,06-Nov-2025,6226780853,3,622678085303,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,05-Nov-2025,EOT,06-Nov-2025,,6226780853,4,622678085304,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,05-Nov-2025,EOT,06-Nov-2025,,6226780853,8,622678085308,"Red Cells, Clot",Not Received,,,TSH,,,,,,12:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,05-Nov-2025,EOT,06-Nov-2025,06-Nov-2025,6226780853,9,622678085309,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,05-Nov-2025,EOT,06-Nov-2025,,6226780853,6,622678085306,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,05-Nov-2025,EOT,06-Nov-2025,06-Nov-2025,6226780853,7,622678085307,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,09-Dec-2025,EOT,10-Dec-2025,10-Dec-2025,6226780855,1,622678085501,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,09-Dec-2025,EOT,10-Dec-2025,10-Dec-2025,6226780855,2,622678085502,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,09-Dec-2025,EOT,10-Dec-2025,,6226780855,4,622678085504,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,09-Dec-2025,EOT,10-Dec-2025,10-Dec-2025,6226780855,5,622678085505,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,09-Dec-2025,EOT,10-Dec-2025,,6226780855,6,622678085506,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,09-Dec-2025,EOT,10-Dec-2025,10-Dec-2025,6226780855,7,622678085507,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,09-Dec-2025,EOT,10-Dec-2025,,6226780855,8,622678085508,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,09-Dec-2025,EOT,10-Dec-2025,10-Dec-2025,6226780855,9,622678085509,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,09-Dec-2025,EOT,10-Dec-2025,10-Dec-2025,6226780855,3,622678085503,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,18-Nov-2025,EOT,19-Nov-2025,19-Nov-2025,6226780856,1,622678085601,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,11:06,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,18-Nov-2025,EOT,19-Nov-2025,19-Nov-2025,6226780856,2,622678085602,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:06,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,18-Nov-2025,EOT,19-Nov-2025,19-Nov-2025,6226780856,3,622678085603,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:06,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,18-Nov-2025,EOT,19-Nov-2025,,6226780856,4,622678085604,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:06,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,18-Nov-2025,EOT,19-Nov-2025,,6226780856,6,622678085606,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:06,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,18-Nov-2025,EOT,19-Nov-2025,19-Nov-2025,6226780856,7,622678085607,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:06,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,18-Nov-2025,EOT,19-Nov-2025,,6226780856,8,622678085608,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:06,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,18-Nov-2025,EOT,19-Nov-2025,19-Nov-2025,6226780856,9,622678085609,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:06,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,14-Jan-2026,EOT,15-Jan-2026,15-Jan-2026,6226780857,3,622678085703,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:18,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,14-Jan-2026,EOT,15-Jan-2026,,6226780857,6,622678085706,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:18,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,14-Jan-2026,EOT,15-Jan-2026,15-Jan-2026,6226780857,5,622678085705,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:18,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,14-Jan-2026,EOT,15-Jan-2026,15-Jan-2026,6226780857,7,622678085707,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:18,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,14-Jan-2026,EOT,15-Jan-2026,,6226780857,8,622678085708,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:18,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,14-Jan-2026,EOT,15-Jan-2026,15-Jan-2026,6226780857,9,622678085709,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:18,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,14-Jan-2026,EOT,15-Jan-2026,15-Jan-2026,6226780857,1,622678085701,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,11:18,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,14-Jan-2026,EOT,15-Jan-2026,,6226780857,4,622678085704,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:18,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,14-Jan-2026,EOT,15-Jan-2026,15-Jan-2026,6226780857,2,622678085702,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:18,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,18-Nov-2025,EOT,19-Nov-2025,19-Nov-2025,6226780856,5,622678085605,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:06,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,18-Feb-2026,P1DBBL,19-Feb-2026,,6226785739,3,622678573903,"Urine, Cargile Preservative UA",Not Received,Ambient,,URINALYSIS,,,,,,10:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,18-Feb-2026,P1DBBL,19-Feb-2026,,6226785739,2,622678573902,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,10:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,18-Feb-2026,P1DBBL,19-Feb-2026,,6226785739,4,622678573904,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,10:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,18-Feb-2026,P1DBBL,19-Feb-2026,,6226785739,7,622678573907,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,18-Feb-2026,P1DBBL,19-Feb-2026,,6226785739,9,622678573909,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,18-Feb-2026,P1DBBL,19-Feb-2026,,6226785739,5,622678573905,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,18-Feb-2026,P1DBBL,19-Feb-2026,,6226785739,6,622678573906,"Plasma, EDTA",Not Received,Frozen,,INSULIN,FROZEN,,,,,10:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,18-Feb-2026,P1DBBL,19-Feb-2026,,6226785739,8,622678573908,"Serum, SST",Not Received,Ambient,,TSH,,,,,,10:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,18-Feb-2026,P1DBBL,19-Feb-2026,,6226785739,1,622678573901,"Whole Blood, EDTA, Dry",Not Received,Ambient,,HEMATOLOGY,,,,,,10:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,18-Feb-2026,P1DBBL,19-Feb-2026,19-Feb-2026,6226785739,10,622678573910,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,15-Dec-2025,P1SCR,16-Dec-2025,,6226785740,1,622678574001,"Whole Blood, EDTA, Dry",Not Received,Ambient,,HEMATOLOGY,,,,,,10:53,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,15-Dec-2025,P1SCR,16-Dec-2025,,6226785740,7,622678574007,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:53,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,15-Dec-2025,P1SCR,16-Dec-2025,,6226785740,5,622678574005,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:53,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,15-Dec-2025,P1SCR,16-Dec-2025,16-Dec-2025,6226785740,8,622678574008,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:53,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,15-Dec-2025,P1SCR,16-Dec-2025,,6226785740,2,622678574002,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,10:53,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,15-Dec-2025,P1SCR,16-Dec-2025,,6226785740,6,622678574006,"Plasma, EDTA",Not Received,Frozen,,INSULIN,FROZEN,,,,,10:53,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,15-Dec-2025,P1SCR,16-Dec-2025,,6226785740,3,622678574003,"Urine, Cargile Preservative UA",Not Received,Ambient,,URINALYSIS,,,,,,10:53,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,15-Dec-2025,P1SCR,16-Dec-2025,,6226785740,4,622678574004,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,10:53,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,15-Dec-2025,P1SCR,16-Dec-2025,,6226785740,9,622678574009,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:53,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,15-Dec-2025,P1SCR,16-Dec-2025,16-Dec-2025,6226785740,10,622678574010,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:53,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,04-Nov-2025,P2OLD29,05-Nov-2025,,6226804961,2,622680496102,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:05,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,04-Nov-2025,P2OLD29,05-Nov-2025,,6226804961,4,622680496104,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:05,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,04-Nov-2025,P2OLD29,05-Nov-2025,05-Nov-2025,6226804961,3,622680496103,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,10-Mar-2026,P2DBBL,11-Mar-2026,11-Mar-2026,6226804962,5,622680496205,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,10-Mar-2026,P2DBBL,11-Mar-2026,11-Mar-2026,6226804962,7,622680496207,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,10-Mar-2026,P2DBBL,11-Mar-2026,11-Mar-2026,6226804962,9,622680496209,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,04-Nov-2025,P2OLD29,05-Nov-2025,05-Nov-2025,6226804961,6,622680496106,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,12:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,04-Nov-2025,P2OLD29,05-Nov-2025,05-Nov-2025,6226804961,5,622680496105,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,10-Mar-2026,P2DBBL,11-Mar-2026,11-Mar-2026,6226804962,3,622680496203,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,04-Nov-2025,P2OLD29,05-Nov-2025,05-Nov-2025,6226804961,1,622680496101,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,10-Mar-2026,P2DBBL,11-Mar-2026,,6226804962,4,622680496204,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,10-Mar-2026,P2DBBL,11-Mar-2026,,6226804962,8,622680496208,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,04-Nov-2025,P2OLD29,05-Nov-2025,05-Nov-2025,6226804961,7,622680496107,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,10-Mar-2026,P2DBBL,11-Mar-2026,,6226804962,6,622680496206,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,10-Mar-2026,P2DBBL,11-Mar-2026,11-Mar-2026,6226804962,2,622680496202,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,10-Mar-2026,P2DBBL,11-Mar-2026,11-Mar-2026,6226804962,1,622680496201,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,11-Dec-2025,EOT,13-Dec-2025,13-Dec-2025,6226935606,2,622693560602,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:05,21:00,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,11-Dec-2025,EOT,13-Dec-2025,,6226935606,4,622693560604,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,09:05,,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,11-Dec-2025,EOT,13-Dec-2025,13-Dec-2025,6226935606,3,622693560603,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:05,21:00,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,11-Dec-2025,EOT,13-Dec-2025,,6226935606,5,622693560605,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:05,,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,11-Dec-2025,EOT,13-Dec-2025,13-Dec-2025,6226935606,1,622693560601,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:05,21:00,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,11-Dec-2025,EOT,13-Dec-2025,,6226935606,7,622693560607,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:05,,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,11-Dec-2025,EOT,13-Dec-2025,16-Dec-2025,6226935606,6,622693560606,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:05,05:55,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,11-Dec-2025,EOT,13-Dec-2025,13-Dec-2025,6226935606,8,622693560608,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:05,21:00,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,11-Dec-2025,EOT,13-Dec-2025,,6226935606,9,622693560609,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:05,,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,02-Jan-2026,P2OLD29,03-Jan-2026,03-Jan-2026,6226976943,1,622697694301,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,02-Jan-2026,P2OLD29,03-Jan-2026,,6226976943,2,622697694302,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,02-Jan-2026,P2OLD29,03-Jan-2026,31-Jan-2026,6226976943,3,622697694303,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:00,07:20,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,02-Jan-2026,P2OLD29,03-Jan-2026,,6226976943,4,622697694304,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,02-Jan-2026,P2OLD29,03-Jan-2026,03-Jan-2026,6226976943,6,622697694306,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,12:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,02-Jan-2026,P2OLD29,03-Jan-2026,03-Jan-2026,6226976943,7,622697694307,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,02-Jan-2026,P2OLD29,03-Jan-2026,03-Jan-2026,6226976943,5,622697694305,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Nov-2025,P2OLD29,07-Nov-2025,,6226991311,4,622699131104,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:14,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Nov-2025,P2OLD29,07-Nov-2025,07-Nov-2025,6226991311,5,622699131105,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:14,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Nov-2025,P2OLD29,07-Nov-2025,07-Nov-2025,6226991311,6,622699131106,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,08:14,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Nov-2025,P2OLD29,07-Nov-2025,07-Nov-2025,6226991311,7,622699131107,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:14,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Nov-2025,P2OLD29,07-Nov-2025,07-Nov-2025,6226991311,3,622699131103,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:14,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Nov-2025,P2OLD29,07-Nov-2025,07-Nov-2025,6226991311,1,622699131101,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:14,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Nov-2025,P2OLD29,07-Nov-2025,,6226991311,2,622699131102,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:14,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,14-Nov-2025,P2OLD29,15-Nov-2025,15-Nov-2025,6227043302,1,622704330201,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,14-Nov-2025,P2OLD29,15-Nov-2025,,6227043302,4,622704330204,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:10,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,14-Nov-2025,P2OLD29,15-Nov-2025,15-Nov-2025,6227043302,5,622704330205,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,14-Nov-2025,P2OLD29,15-Nov-2025,19-Nov-2025,6227043302,3,622704330203,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:10,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,14-Nov-2025,P2OLD29,15-Nov-2025,,6227043302,2,622704330202,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:10,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,14-Nov-2025,P2OLD29,15-Nov-2025,15-Nov-2025,6227043302,6,622704330206,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,09:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,14-Nov-2025,P2OLD29,15-Nov-2025,15-Nov-2025,6227043302,7,622704330207,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,17-Dec-2025,P2OLD29,18-Dec-2025,18-Dec-2025,6227072419,1,622707241901,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:17,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,17-Dec-2025,P2OLD29,18-Dec-2025,,6227072419,2,622707241902,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:17,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,17-Dec-2025,P2OLD29,18-Dec-2025,,6227072419,4,622707241904,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:17,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,17-Dec-2025,P2OLD29,18-Dec-2025,18-Dec-2025,6227072419,6,622707241906,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,11:17,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,17-Dec-2025,P2OLD29,18-Dec-2025,18-Dec-2025,6227072419,3,622707241903,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:17,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,17-Dec-2025,P2OLD29,18-Dec-2025,18-Dec-2025,6227072419,7,622707241907,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:17,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,17-Dec-2025,P2OLD29,18-Dec-2025,18-Dec-2025,6227072419,5,622707241905,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:17,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,28-Nov-2025,P2OLBL,29-Nov-2025,,6227106905,2,622710690502,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,28-Nov-2025,P2OLBL,29-Nov-2025,29-Nov-2025,6227106905,1,622710690501,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,28-Nov-2025,P2OLBL,29-Nov-2025,03-Dec-2025,6227106905,3,622710690503,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:00,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,28-Nov-2025,P2OLBL,29-Nov-2025,,6227106905,4,622710690504,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,28-Nov-2025,P2OLBL,29-Nov-2025,29-Nov-2025,6227106905,6,622710690506,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,09:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,28-Nov-2025,P2OLBL,29-Nov-2025,29-Nov-2025,6227106905,5,622710690505,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,28-Nov-2025,P2OLBL,29-Nov-2025,29-Nov-2025,6227106905,7,622710690507,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,28-Nov-2025,P2OLBL,29-Nov-2025,,6227106905,8,622710690508,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,28-Nov-2025,P2OLBL,29-Nov-2025,29-Nov-2025,6227106905,9,622710690509,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,19-Dec-2025,P2OLBL,20-Dec-2025,20-Dec-2025,6227106906,1,622710690601,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:25,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,19-Dec-2025,P2OLBL,20-Dec-2025,,6227106906,2,622710690602,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:25,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,19-Dec-2025,P2OLBL,20-Dec-2025,23-Dec-2025,6227106906,3,622710690603,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:25,07:00,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,19-Dec-2025,P2OLBL,20-Dec-2025,,6227106906,4,622710690604,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:25,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,19-Dec-2025,P2OLBL,20-Dec-2025,20-Dec-2025,6227106906,5,622710690605,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:25,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,19-Dec-2025,P2OLBL,20-Dec-2025,20-Dec-2025,6227106906,6,622710690606,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,09:25,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,19-Dec-2025,P2OLBL,20-Dec-2025,20-Dec-2025,6227106906,9,622710690609,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:25,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,19-Dec-2025,P2OLBL,20-Dec-2025,20-Dec-2025,6227106906,7,622710690607,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:25,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,19-Dec-2025,P2OLBL,20-Dec-2025,,6227106906,8,622710690608,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:25,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,27-Jan-2026,P1DBBL,28-Jan-2026,28-Jan-2026,6227144560,6,622714456006,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,08:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,27-Jan-2026,P1DBBL,28-Jan-2026,28-Jan-2026,6227144560,7,622714456007,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,27-Jan-2026,P1DBBL,28-Jan-2026,28-Jan-2026,6227144560,1,622714456001,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,25-Nov-2025,P1DBBL,26-Nov-2025,,6227144561,2,622714456102,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,27-Jan-2026,P1DBBL,28-Jan-2026,28-Jan-2026,6227144560,5,622714456005,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,25-Nov-2025,P1DBBL,26-Nov-2025,26-Nov-2025,6227144561,1,622714456101,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,25-Nov-2025,P1DBBL,26-Nov-2025,,6227144561,4,622714456104,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,25-Nov-2025,P1DBBL,26-Nov-2025,26-Nov-2025,6227144561,3,622714456103,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,25-Nov-2025,P1DBBL,26-Nov-2025,26-Nov-2025,6227144561,5,622714456105,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,27-Jan-2026,P1DBBL,28-Jan-2026,28-Jan-2026,6227144560,3,622714456003,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,25-Nov-2025,P1DBBL,26-Nov-2025,26-Nov-2025,6227144561,6,622714456106,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,10:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,27-Jan-2026,P1DBBL,28-Jan-2026,,6227144560,4,622714456004,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:25,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,27-Jan-2026,P1DBBL,28-Jan-2026,,6227144560,2,622714456002,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:25,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,11-Dec-2025,P1DBBL,13-Dec-2025,13-Dec-2025,6227144562,1,622714456201,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:13,21:00,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,11-Dec-2025,P1DBBL,13-Dec-2025,13-Dec-2025,6227144562,5,622714456205,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:13,21:00,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,25-Nov-2025,P1DBBL,26-Nov-2025,26-Nov-2025,6227144561,7,622714456107,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,11-Dec-2025,P1DBBL,13-Dec-2025,13-Dec-2025,6227144562,7,622714456207,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:13,21:00,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,11-Dec-2025,P1DBBL,13-Dec-2025,,6227144562,4,622714456204,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:13,,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,11-Dec-2025,P1DBBL,13-Dec-2025,,6227144562,2,622714456202,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:13,,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,11-Dec-2025,P1DBBL,13-Dec-2025,16-Dec-2025,6227144562,3,622714456203,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:13,05:55,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,11-Dec-2025,P1DBBL,13-Dec-2025,13-Dec-2025,6227144562,6,622714456206,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,08:13,21:00,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,09-Jan-2026,EOT,10-Jan-2026,10-Jan-2026,6227178908,7,622717890807,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:20,08:00,Czech Republic,,08:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,09-Jan-2026,EOT,10-Jan-2026,10-Jan-2026,6227178908,9,622717890809,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:20,08:00,Czech Republic,,08:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,30-Jan-2026,EOT,31-Jan-2026,31-Jan-2026,6227178909,3,622717890903,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:30,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,09-Jan-2026,EOT,10-Jan-2026,,6227178908,6,622717890806,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:20,,Czech Republic,,08:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,30-Jan-2026,EOT,31-Jan-2026,,6227178909,4,622717890904,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:30,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,09-Jan-2026,EOT,10-Jan-2026,10-Jan-2026,6227178908,2,622717890802,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:20,08:00,Czech Republic,,08:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,30-Jan-2026,EOT,31-Jan-2026,31-Jan-2026,6227178909,1,622717890901,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:30,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,09-Jan-2026,EOT,10-Jan-2026,,6227178908,8,622717890808,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:20,,Czech Republic,,08:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,09-Jan-2026,EOT,10-Jan-2026,10-Jan-2026,6227178908,1,622717890801,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:20,08:00,Czech Republic,,08:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,30-Jan-2026,EOT,31-Jan-2026,31-Jan-2026,6227178909,2,622717890902,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:30,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,30-Jan-2026,EOT,31-Jan-2026,04-Feb-2026,6227178909,5,622717890905,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:30,07:00,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,09-Jan-2026,EOT,10-Jan-2026,,6227178908,4,622717890804,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:20,,Czech Republic,,08:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,09-Jan-2026,EOT,10-Jan-2026,10-Jan-2026,6227178908,3,622717890803,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:20,08:00,Czech Republic,,08:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,30-Jan-2026,EOT,31-Jan-2026,,6227178909,6,622717890906,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:30,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,30-Jan-2026,EOT,31-Jan-2026,,6227178909,8,622717890908,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:30,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,30-Jan-2026,EOT,31-Jan-2026,31-Jan-2026,6227178909,9,622717890909,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:30,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,30-Jan-2026,EOT,31-Jan-2026,31-Jan-2026,6227178909,7,622717890907,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:30,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-May-2026,EOT,06-May-2026,06-May-2026,6227178910,1,622717891001,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-May-2026,EOT,06-May-2026,06-May-2026,6227178910,3,622717891003,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,07:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-May-2026,EOT,06-May-2026,,6227178910,4,622717891004,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,07:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-May-2026,EOT,06-May-2026,06-May-2026,6227178910,2,622717891002,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-May-2026,EOT,06-May-2026,20-May-2026,6227178910,5,622717891005,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,07:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,09-Jan-2026,EOT,10-Jan-2026,14-Jan-2026,6227178908,5,622717890805,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:20,07:00,Czech Republic,,08:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-May-2026,EOT,06-May-2026,,6227178910,8,622717891008,"Red Cells, Clot",Not Received,,,TSH,,,,,,07:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-May-2026,EOT,06-May-2026,06-May-2026,6227178910,9,622717891009,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,07:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,06-Mar-2026,EOT,07-Mar-2026,07-Mar-2026,6227178911,2,622717891102,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:50,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-May-2026,EOT,06-May-2026,06-May-2026,6227178910,7,622717891007,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,07:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,06-Mar-2026,EOT,07-Mar-2026,07-Mar-2026,6227178911,1,622717891101,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:50,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,06-Mar-2026,EOT,07-Mar-2026,,6227178911,4,622717891104,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:50,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,06-Mar-2026,EOT,07-Mar-2026,11-Mar-2026,6227178911,5,622717891105,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:50,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,06-Mar-2026,EOT,07-Mar-2026,,6227178911,6,622717891106,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:50,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,06-Mar-2026,EOT,07-Mar-2026,07-Mar-2026,6227178911,7,622717891107,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:50,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,06-Mar-2026,EOT,07-Mar-2026,07-Mar-2026,6227178911,9,622717891109,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:50,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-May-2026,EOT,06-May-2026,,6227178910,6,622717891006,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,07:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,06-Mar-2026,EOT,07-Mar-2026,07-Mar-2026,6227178911,3,622717891103,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:50,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,09-Jan-2026,EOT,10-Jan-2026,10-Jan-2026,6227178912,1,622717891201,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:10,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,06-Mar-2026,EOT,07-Mar-2026,,6227178911,8,622717891108,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:50,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,09-Jan-2026,EOT,10-Jan-2026,10-Jan-2026,6227178912,2,622717891202,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:10,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,09-Jan-2026,EOT,10-Jan-2026,10-Jan-2026,6227178912,3,622717891203,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:10,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,09-Jan-2026,EOT,10-Jan-2026,14-Jan-2026,6227178912,5,622717891205,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:10,07:00,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,09-Jan-2026,EOT,10-Jan-2026,,6227178912,4,622717891204,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:10,,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,09-Jan-2026,EOT,10-Jan-2026,10-Jan-2026,6227178912,7,622717891207,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:10,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,09-Jan-2026,EOT,10-Jan-2026,,6227178912,8,622717891208,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:10,,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,09-Jan-2026,EOT,10-Jan-2026,,6227178912,6,622717891206,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:10,,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,09-Jan-2026,EOT,10-Jan-2026,10-Jan-2026,6227178912,9,622717891209,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:10,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-Dec-2025,P1DBBL,06-Dec-2025,06-Dec-2025,6227261230,1,622726123001,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-Dec-2025,P1DBBL,06-Dec-2025,,6227261230,2,622726123002,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,07:55,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-Dec-2025,P1DBBL,06-Dec-2025,,6227261230,4,622726123004,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,07:55,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-Dec-2025,P1DBBL,06-Dec-2025,06-Dec-2025,6227261230,5,622726123005,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-Dec-2025,P1DBBL,06-Dec-2025,10-Dec-2025,6227261230,3,622726123003,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,07:55,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-Dec-2025,P1DBBL,06-Dec-2025,06-Dec-2025,6227261230,6,622726123006,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-Dec-2025,P1DBBL,06-Dec-2025,06-Dec-2025,6227261230,7,622726123007,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,19-May-2026,P2OLD29,20-May-2026,20-May-2026,6227261835,1,622726183501,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,00:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,19-May-2026,P2OLD29,20-May-2026,,6227261835,2,622726183502,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,00:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,19-May-2026,P2OLD29,20-May-2026,21-May-2026,6227261835,3,622726183503,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,19-May-2026,P2OLD29,20-May-2026,,6227261835,4,622726183504,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,00:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,19-May-2026,P2OLD29,20-May-2026,20-May-2026,6227261835,5,622726183505,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,00:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,19-May-2026,P2OLD29,20-May-2026,20-May-2026,6227261835,6,622726183506,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,00:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,19-May-2026,P2OLD29,20-May-2026,20-May-2026,6227261835,7,622726183507,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,00:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,06-Jan-2026,EOT,08-Jan-2026,08-Jan-2026,6227261836,1,622726183601,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:11,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,06-Jan-2026,EOT,08-Jan-2026,08-Jan-2026,6227261836,2,622726183602,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:11,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,06-Jan-2026,EOT,08-Jan-2026,08-Jan-2026,6227261836,3,622726183603,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:11,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,06-Jan-2026,EOT,08-Jan-2026,,6227261836,4,622726183604,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:11,,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,06-Jan-2026,EOT,08-Jan-2026,08-Jan-2026,6227261836,5,622726183605,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:11,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,06-Jan-2026,EOT,08-Jan-2026,,6227261836,6,622726183606,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:11,,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,06-Jan-2026,EOT,08-Jan-2026,08-Jan-2026,6227261836,7,622726183607,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:11,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,06-Jan-2026,EOT,08-Jan-2026,,6227261836,8,622726183608,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:11,,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,06-Jan-2026,EOT,08-Jan-2026,08-Jan-2026,6227261836,9,622726183609,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:11,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,02-Jan-2026,EOT,03-Jan-2026,03-Jan-2026,6227498379,3,622749837903,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:28,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,02-Jan-2026,EOT,03-Jan-2026,03-Jan-2026,6227498379,1,622749837901,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:28,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,02-Jan-2026,EOT,03-Jan-2026,03-Jan-2026,6227498379,2,622749837902,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:28,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Jan-2026,EOT,31-Jan-2026,,6227498380,8,622749838008,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:36,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Jan-2026,EOT,31-Jan-2026,31-Jan-2026,6227498380,7,622749838007,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:36,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,02-Jan-2026,EOT,03-Jan-2026,03-Jan-2026,6227498379,7,622749837907,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:28,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Jan-2026,EOT,31-Jan-2026,31-Jan-2026,6227498380,9,622749838009,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,08:36,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,02-Jan-2026,EOT,03-Jan-2026,03-Jan-2026,6227498379,9,622749837909,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:28,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Jan-2026,EOT,31-Jan-2026,31-Jan-2026,6227498380,1,622749838001,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:36,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Jan-2026,EOT,31-Jan-2026,,6227498380,6,622749838006,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:36,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Jan-2026,EOT,31-Jan-2026,31-Jan-2026,6227498380,3,622749838003,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:36,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,02-Jan-2026,EOT,03-Jan-2026,03-Jan-2026,6227498379,5,622749837905,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:28,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Jan-2026,EOT,31-Jan-2026,31-Jan-2026,6227498380,2,622749838002,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:36,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Jan-2026,EOT,31-Jan-2026,31-Jan-2026,6227498380,5,622749838005,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:36,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,02-Jan-2026,EOT,03-Jan-2026,,6227498379,4,622749837904,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:28,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Jan-2026,EOT,31-Jan-2026,,6227498380,4,622749838004,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:36,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,02-Jan-2026,EOT,03-Jan-2026,,6227498379,8,622749837908,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:28,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,02-Jan-2026,EOT,03-Jan-2026,,6227498379,6,622749837906,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:28,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,13-Jan-2026,EOT,14-Jan-2026,14-Jan-2026,6227520242,9,622752024209,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,13-Jan-2026,EOT,14-Jan-2026,14-Jan-2026,6227520242,3,622752024203,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,29-Apr-2026,EOT,30-Apr-2026,30-Apr-2026,6227520243,7,622752024307,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:20,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,29-Apr-2026,EOT,30-Apr-2026,30-Apr-2026,6227520243,5,622752024305,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:20,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,13-Jan-2026,EOT,14-Jan-2026,,6227520242,4,622752024204,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,13-Jan-2026,EOT,14-Jan-2026,14-Jan-2026,6227520242,1,622752024201,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,29-Apr-2026,EOT,30-Apr-2026,30-Apr-2026,6227520243,3,622752024303,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:20,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,29-Apr-2026,EOT,30-Apr-2026,,6227520243,6,622752024306,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:20,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,29-Apr-2026,EOT,30-Apr-2026,30-Apr-2026,6227520243,1,622752024301,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,11:20,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,29-Apr-2026,EOT,30-Apr-2026,,6227520243,4,622752024304,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:20,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,29-Apr-2026,EOT,30-Apr-2026,,6227520243,8,622752024308,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:20,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,13-Jan-2026,EOT,14-Jan-2026,14-Jan-2026,6227520242,2,622752024202,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,13-Jan-2026,EOT,14-Jan-2026,,6227520242,6,622752024206,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,13-Jan-2026,EOT,14-Jan-2026,14-Jan-2026,6227520242,5,622752024205,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,29-Apr-2026,EOT,30-Apr-2026,30-Apr-2026,6227520243,2,622752024302,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:20,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,13-Jan-2026,EOT,14-Jan-2026,,6227520242,8,622752024208,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,13-Jan-2026,EOT,14-Jan-2026,14-Jan-2026,6227520242,7,622752024207,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,29-Apr-2026,EOT,30-Apr-2026,30-Apr-2026,6227520243,9,622752024309,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:20,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,04-Mar-2026,EOT,05-Mar-2026,05-Mar-2026,6227520245,2,622752024502,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,04-Mar-2026,EOT,05-Mar-2026,05-Mar-2026,6227520245,3,622752024503,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,04-Mar-2026,EOT,05-Mar-2026,,6227520245,8,622752024508,"Red Cells, Clot",Not Received,,,TSH,,,,,,12:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,04-Mar-2026,EOT,05-Mar-2026,05-Mar-2026,6227520245,1,622752024501,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,04-Mar-2026,EOT,05-Mar-2026,05-Mar-2026,6227520245,9,622752024509,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,04-Mar-2026,EOT,05-Mar-2026,,6227520245,4,622752024504,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,04-Mar-2026,EOT,05-Mar-2026,05-Mar-2026,6227520245,5,622752024505,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,04-Mar-2026,EOT,05-Mar-2026,,6227520245,6,622752024506,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,04-Mar-2026,EOT,05-Mar-2026,05-Mar-2026,6227520245,7,622752024507,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,27-Jan-2026,P1SCR,28-Jan-2026,,6227541249,1,622754124901,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,27-Jan-2026,P1SCR,28-Jan-2026,28-Jan-2026,6227541249,2,622754124902,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,27-Jan-2026,P1SCR,28-Jan-2026,28-Jan-2026,6227541249,3,622754124903,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,27-Jan-2026,P1SCR,28-Jan-2026,28-Jan-2026,6227541249,6,622754124906,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,27-Jan-2026,P1SCR,28-Jan-2026,28-Jan-2026,6227541249,4,622754124904,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,27-Jan-2026,P1SCR,28-Jan-2026,,6227541249,7,622754124907,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,27-Jan-2026,P1SCR,28-Jan-2026,28-Jan-2026,6227541249,5,622754124905,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,25-Mar-2026,P1DBBL,26-Mar-2026,26-Mar-2026,6227541251,1,622754125101,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,06:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,25-Mar-2026,P1DBBL,26-Mar-2026,,6227541251,2,622754125102,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,06:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,27-Jan-2026,P1SCR,28-Jan-2026,28-Jan-2026,6227541249,10,622754124910,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,27-Jan-2026,P1SCR,28-Jan-2026,30-Jan-2026,6227541249,8,622754124908,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,27-Jan-2026,P1SCR,28-Jan-2026,,6227541249,9,622754124909,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,20-Feb-2026,P1DBBL,21-Feb-2026,21-Feb-2026,6227541252,6,622754125206,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,10:45,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,20-Feb-2026,P1DBBL,21-Feb-2026,21-Feb-2026,6227541252,1,622754125201,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:45,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,25-Mar-2026,P1DBBL,26-Mar-2026,26-Mar-2026,6227541251,7,622754125107,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,06:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,20-Feb-2026,P1DBBL,21-Feb-2026,25-Feb-2026,6227541252,3,622754125203,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:45,07:00,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,25-Mar-2026,P1DBBL,26-Mar-2026,,6227541251,4,622754125104,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,06:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,20-Feb-2026,P1DBBL,21-Feb-2026,,6227541252,2,622754125202,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:45,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,20-Feb-2026,P1DBBL,21-Feb-2026,,6227541252,4,622754125204,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:45,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,25-Mar-2026,P1DBBL,26-Mar-2026,26-Mar-2026,6227541251,6,622754125106,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,06:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,20-Feb-2026,P1DBBL,21-Feb-2026,21-Feb-2026,6227541252,5,622754125205,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:45,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,20-Feb-2026,P1DBBL,21-Feb-2026,21-Feb-2026,6227541252,7,622754125207,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:45,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,25-Mar-2026,P1DBBL,26-Mar-2026,26-Mar-2026,6227541251,5,622754125105,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,06:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,05-May-2026,P2OLBL,06-May-2026,06-May-2026,6227541256,1,622754125601,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,07:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,05-May-2026,P2OLBL,06-May-2026,06-May-2026,6227541256,5,622754125605,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,07:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,05-May-2026,P2OLBL,06-May-2026,,6227541256,2,622754125602,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,07:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,05-May-2026,P2OLBL,06-May-2026,,6227541256,4,622754125604,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,07:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,05-May-2026,P2OLBL,06-May-2026,06-May-2026,6227541256,7,622754125607,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,05-May-2026,P2OLBL,06-May-2026,20-May-2026,6227541256,3,622754125603,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,07:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,25-Mar-2026,P1DBBL,26-Mar-2026,26-Mar-2026,6227541251,3,622754125103,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,06:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,05-May-2026,P2OLBL,06-May-2026,06-May-2026,6227541256,6,622754125606,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,07:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,05-May-2026,P2OLBL,06-May-2026,06-May-2026,6227541256,9,622754125609,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,07:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,16-Jan-2026,P2OLBL,17-Jan-2026,21-Jan-2026,6227541257,3,622754125703,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,07:55,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,05-May-2026,P2OLBL,06-May-2026,,6227541256,8,622754125608,"Red Cells, Clot",Not Received,,,TSH,,,,,,07:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,16-Jan-2026,P2OLBL,17-Jan-2026,,6227541257,8,622754125708,"Red Cells, Clot",Not Received,,,TSH,,,,,,07:55,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,16-Jan-2026,P2OLBL,17-Jan-2026,17-Jan-2026,6227541257,1,622754125701,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,16-Jan-2026,P2OLBL,17-Jan-2026,17-Jan-2026,6227541257,5,622754125705,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,16-Jan-2026,P2OLBL,17-Jan-2026,17-Jan-2026,6227541257,6,622754125706,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,16-Jan-2026,P2OLBL,17-Jan-2026,,6227541257,4,622754125704,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,07:55,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,16-Jan-2026,P2OLBL,17-Jan-2026,17-Jan-2026,6227541257,7,622754125707,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,16-Jan-2026,P2OLBL,17-Jan-2026,17-Jan-2026,6227541257,9,622754125709,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,07-Apr-2026,P2OLBL,08-Apr-2026,,6227541258,2,622754125802,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Feb-2026,P2OLD29,14-Feb-2026,,6227541259,4,622754125904,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,16-Jan-2026,P2OLBL,17-Jan-2026,,6227541257,2,622754125702,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,07:55,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Feb-2026,P2OLD29,14-Feb-2026,18-Feb-2026,6227541259,3,622754125903,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:45,07:10,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,07-Apr-2026,P2OLBL,08-Apr-2026,08-Apr-2026,6227541258,9,622754125809,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Feb-2026,P2OLD29,14-Feb-2026,14-Feb-2026,6227541259,6,622754125906,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Feb-2026,P2OLD29,14-Feb-2026,14-Feb-2026,6227541259,7,622754125907,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,07-Apr-2026,P2OLBL,08-Apr-2026,08-Apr-2026,6227541258,1,622754125801,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,07-Apr-2026,P2OLBL,08-Apr-2026,,6227541258,4,622754125804,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,07-Apr-2026,P2OLBL,08-Apr-2026,08-Apr-2026,6227541258,6,622754125806,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Feb-2026,P2OLD29,14-Feb-2026,14-Feb-2026,6227541259,1,622754125901,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,07-Apr-2026,P2OLBL,08-Apr-2026,08-Apr-2026,6227541258,5,622754125805,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,07-Apr-2026,P2OLBL,08-Apr-2026,08-Apr-2026,6227541258,7,622754125807,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,07-Apr-2026,P2OLBL,08-Apr-2026,08-Apr-2026,6227541258,3,622754125803,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Feb-2026,P2OLD29,14-Feb-2026,14-Feb-2026,6227541259,5,622754125905,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,16-Jan-2026,P2OLD29,17-Jan-2026,17-Jan-2026,6227541260,1,622754126001,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:40,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,16-Jan-2026,P2OLD29,17-Jan-2026,17-Jan-2026,6227541260,5,622754126005,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:40,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,16-Jan-2026,P2OLD29,17-Jan-2026,,6227541260,2,622754126002,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:40,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,16-Jan-2026,P2OLD29,17-Jan-2026,21-Jan-2026,6227541260,3,622754126003,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:40,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,07-Apr-2026,P2OLBL,08-Apr-2026,,6227541258,8,622754125808,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Feb-2026,P2OLD29,14-Feb-2026,,6227541259,2,622754125902,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,05-May-2026,P2OLD29,06-May-2026,06-May-2026,6227541261,1,622754126101,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,13:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,16-Jan-2026,P2OLD29,17-Jan-2026,,6227541260,4,622754126004,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:40,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,16-Jan-2026,P2OLD29,17-Jan-2026,17-Jan-2026,6227541260,6,622754126006,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,10:40,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,05-May-2026,P2OLD29,06-May-2026,,6227541261,2,622754126102,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,13:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,05-May-2026,P2OLD29,06-May-2026,,6227541261,4,622754126104,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,13:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,16-Jan-2026,P2OLD29,17-Jan-2026,17-Jan-2026,6227541260,7,622754126007,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:40,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,05-May-2026,P2OLD29,06-May-2026,06-May-2026,6227541261,5,622754126105,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,13:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,05-May-2026,P2OLD29,06-May-2026,06-May-2026,6227541261,6,622754126106,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,13:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,05-May-2026,P2OLD29,06-May-2026,20-May-2026,6227541261,3,622754126103,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,13:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,05-May-2026,P2OLD29,06-May-2026,06-May-2026,6227541261,7,622754126107,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,13:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,07-Apr-2026,P2DBW13,08-Apr-2026,,6227541264,2,622754126402,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,07-Apr-2026,P2DBW13,08-Apr-2026,08-Apr-2026,6227541264,1,622754126401,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,07-Apr-2026,P2DBW13,08-Apr-2026,,6227541264,4,622754126404,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,07-Apr-2026,P2DBW13,08-Apr-2026,08-Apr-2026,6227541264,3,622754126403,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,07-Apr-2026,P2DBW13,08-Apr-2026,08-Apr-2026,6227541264,6,622754126406,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,08:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,07-Apr-2026,P2DBW13,08-Apr-2026,08-Apr-2026,6227541264,5,622754126405,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,07-Apr-2026,P2DBW13,08-Apr-2026,08-Apr-2026,6227541264,7,622754126407,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110009,21-Jan-2026,P1SCR,22-Jan-2026,22-Jan-2026,6227542160,6,622754216006,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,10:11,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110009,21-Jan-2026,P1SCR,22-Jan-2026,,6227542160,7,622754216007,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:11,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110009,21-Jan-2026,P1SCR,22-Jan-2026,22-Jan-2026,6227542160,5,622754216005,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:11,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110009,21-Jan-2026,P1SCR,22-Jan-2026,,6227542160,9,622754216009,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:11,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110009,21-Jan-2026,P1SCR,22-Jan-2026,22-Jan-2026,6227542160,2,622754216002,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:11,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110009,21-Jan-2026,P1SCR,22-Jan-2026,22-Jan-2026,6227542160,10,622754216010,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:11,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,05-Jan-2026,P1SCR,06-Jan-2026,,6227542161,1,622754216101,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:58,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110009,21-Jan-2026,P1SCR,22-Jan-2026,22-Jan-2026,6227542160,8,622754216008,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:11,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110009,21-Jan-2026,P1SCR,22-Jan-2026,,6227542160,1,622754216001,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:11,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,05-Jan-2026,P1SCR,06-Jan-2026,06-Jan-2026,6227542161,4,622754216104,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,05-Jan-2026,P1SCR,06-Jan-2026,06-Jan-2026,6227542161,2,622754216102,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,05-Jan-2026,P1SCR,06-Jan-2026,06-Jan-2026,6227542161,8,622754216108,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,05-Jan-2026,P1SCR,06-Jan-2026,06-Jan-2026,6227542161,3,622754216103,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,10:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,05-Jan-2026,P1SCR,06-Jan-2026,06-Jan-2026,6227542161,6,622754216106,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,10:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,05-Jan-2026,P1SCR,06-Jan-2026,06-Jan-2026,6227542161,10,622754216110,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110009,21-Jan-2026,P1SCR,22-Jan-2026,22-Jan-2026,6227542160,4,622754216004,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:11,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110009,21-Jan-2026,P1SCR,22-Jan-2026,22-Jan-2026,6227542160,3,622754216003,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,10:11,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,05-Jan-2026,P1SCR,06-Jan-2026,,6227542161,9,622754216109,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:58,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,05-Jan-2026,P1SCR,06-Jan-2026,,6227542161,7,622754216107,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:58,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,05-Jan-2026,P1SCR,06-Jan-2026,06-Jan-2026,6227542161,5,622754216105,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,10-Mar-2026,EOT,11-Mar-2026,11-Mar-2026,6227542170,5,622754217005,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,10-Mar-2026,EOT,11-Mar-2026,11-Mar-2026,6227542170,1,622754217001,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,10-Mar-2026,EOT,11-Mar-2026,11-Mar-2026,6227542170,7,622754217007,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,10-Mar-2026,EOT,11-Mar-2026,11-Mar-2026,6227542170,3,622754217003,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,10-Mar-2026,EOT,11-Mar-2026,,6227542170,8,622754217008,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:30,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,10-Mar-2026,EOT,11-Mar-2026,11-Mar-2026,6227542170,2,622754217002,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,10-Mar-2026,EOT,11-Mar-2026,,6227542170,6,622754217006,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:30,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Mar-2026,EOT,17-Mar-2026,17-Mar-2026,6227542171,1,622754217101,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,10-Mar-2026,EOT,11-Mar-2026,11-Mar-2026,6227542170,9,622754217009,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Mar-2026,EOT,17-Mar-2026,17-Mar-2026,6227542171,3,622754217103,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,10-Mar-2026,EOT,11-Mar-2026,,6227542170,4,622754217004,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:30,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Mar-2026,EOT,17-Mar-2026,17-Mar-2026,6227542171,5,622754217105,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Mar-2026,EOT,17-Mar-2026,17-Mar-2026,6227542171,2,622754217102,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Mar-2026,EOT,17-Mar-2026,,6227542171,6,622754217106,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:16,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Mar-2026,EOT,17-Mar-2026,,6227542171,8,622754217108,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:16,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Mar-2026,EOT,17-Mar-2026,17-Mar-2026,6227542171,7,622754217107,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Mar-2026,EOT,17-Mar-2026,17-Mar-2026,6227542171,9,622754217109,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Mar-2026,EOT,31-Mar-2026,31-Mar-2026,6227542172,2,622754217202,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:31,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Mar-2026,EOT,17-Mar-2026,,6227542171,4,622754217104,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:16,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Mar-2026,EOT,31-Mar-2026,31-Mar-2026,6227542172,3,622754217203,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:31,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Mar-2026,EOT,31-Mar-2026,31-Mar-2026,6227542172,1,622754217201,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:31,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Mar-2026,EOT,31-Mar-2026,31-Mar-2026,6227542172,5,622754217205,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:31,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Mar-2026,EOT,31-Mar-2026,,6227542172,6,622754217206,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:31,,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Mar-2026,EOT,31-Mar-2026,31-Mar-2026,6227542172,9,622754217209,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:31,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Mar-2026,EOT,31-Mar-2026,31-Mar-2026,6227542172,7,622754217207,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:31,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Mar-2026,EOT,31-Mar-2026,,6227542172,4,622754217204,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:31,,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Mar-2026,EOT,31-Mar-2026,,6227542172,8,622754217208,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:31,,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Jan-2026,EOT,17-Jan-2026,17-Jan-2026,6227542173,1,622754217301,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:48,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Jan-2026,EOT,17-Jan-2026,17-Jan-2026,6227542173,5,622754217305,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:48,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Jan-2026,EOT,17-Jan-2026,,6227542173,6,622754217306,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:48,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Jan-2026,EOT,17-Jan-2026,17-Jan-2026,6227542173,7,622754217307,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:48,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Jan-2026,EOT,17-Jan-2026,,6227542173,8,622754217308,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:48,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Jan-2026,EOT,17-Jan-2026,17-Jan-2026,6227542173,2,622754217302,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:48,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Jan-2026,EOT,17-Jan-2026,17-Jan-2026,6227542173,9,622754217309,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,08:48,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Jan-2026,EOT,17-Jan-2026,17-Jan-2026,6227542173,3,622754217303,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:48,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Jan-2026,EOT,17-Jan-2026,,6227542173,4,622754217304,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:48,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227542182,2,622754218202,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:16,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227542182,3,622754218203,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:16,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Apr-2026,P2OLBL,11-Apr-2026,,6227542182,4,622754218204,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,08:16,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Apr-2026,P2OLBL,11-Apr-2026,,6227542182,5,622754218205,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:16,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227542182,8,622754218208,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,08:16,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227542182,1,622754218201,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:16,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Apr-2026,P2OLBL,11-Apr-2026,,6227542182,7,622754218207,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:16,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Apr-2026,P2OLBL,11-Apr-2026,,6227542182,9,622754218209,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:16,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227542182,6,622754218206,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:16,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227542182,10,622754218210,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:16,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,11-Dec-2025,EOT,13-Dec-2025,13-Dec-2025,6226935606,10,622693560610,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:05,21:00,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,11-Dec-2025,EOT,13-Dec-2025,13-Dec-2025,6226935606,11,622693560611,"Serum, SST",Received,Ambient,Default Return Ambient,,,,,,,09:05,21:00,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,27-Feb-2026,P1SCR,28-Feb-2026,28-Feb-2026,6227547329,2,622754732902,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,27-Feb-2026,P1SCR,28-Feb-2026,28-Feb-2026,6227547329,3,622754732903,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,08:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,27-Feb-2026,P1SCR,28-Feb-2026,28-Feb-2026,6227547329,4,622754732904,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,27-Feb-2026,P1SCR,28-Feb-2026,28-Feb-2026,6227547329,6,622754732906,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,08:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,27-Feb-2026,P1SCR,28-Feb-2026,,6227547329,7,622754732907,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,27-Feb-2026,P1SCR,28-Feb-2026,28-Feb-2026,6227547329,5,622754732905,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,27-Feb-2026,P1SCR,28-Feb-2026,04-Mar-2026,6227547329,8,622754732908,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:00,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,27-Feb-2026,P1SCR,28-Feb-2026,28-Feb-2026,6227547329,10,622754732910,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,08:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,27-Feb-2026,P1SCR,28-Feb-2026,,6227547329,9,622754732909,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,30-Jan-2026,P1SCR,31-Jan-2026,31-Jan-2026,6227547330,2,622754733002,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:40,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,30-Jan-2026,P1SCR,31-Jan-2026,,6227547330,1,622754733001,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:40,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,30-Jan-2026,P1SCR,31-Jan-2026,31-Jan-2026,6227547330,3,622754733003,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,11:40,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,30-Jan-2026,P1SCR,31-Jan-2026,31-Jan-2026,6227547330,4,622754733004,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:40,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,30-Jan-2026,P1SCR,31-Jan-2026,31-Jan-2026,6227547330,5,622754733005,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:40,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,30-Jan-2026,P1SCR,31-Jan-2026,31-Jan-2026,6227547330,6,622754733006,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,11:40,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,30-Jan-2026,P1SCR,31-Jan-2026,,6227547330,7,622754733007,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:40,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,30-Jan-2026,P1SCR,31-Jan-2026,04-Feb-2026,6227547330,8,622754733008,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:40,07:00,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,30-Jan-2026,P1SCR,31-Jan-2026,,6227547330,9,622754733009,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:40,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,30-Jan-2026,P1SCR,31-Jan-2026,31-Jan-2026,6227547330,10,622754733010,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:40,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227547331,2,622754733102,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,27-Feb-2026,P1SCR,28-Feb-2026,,6227547329,1,622754732901,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227547331,3,622754733103,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227547331,4,622754733104,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227547331,5,622754733105,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227547331,6,622754733106,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,06-Mar-2026,P1SCR,07-Mar-2026,,6227547331,7,622754733107,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:20,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,06-Mar-2026,P1SCR,07-Mar-2026,11-Mar-2026,6227547331,8,622754733108,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:20,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,27-Feb-2026,P1DBBL,28-Feb-2026,28-Feb-2026,6227547332,1,622754733201,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:35,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,27-Feb-2026,P1DBBL,28-Feb-2026,,6227547332,2,622754733202,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:35,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,27-Feb-2026,P1DBBL,28-Feb-2026,04-Mar-2026,6227547332,3,622754733203,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:35,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,27-Feb-2026,P1DBBL,28-Feb-2026,,6227547332,4,622754733204,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:35,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,27-Feb-2026,P1DBBL,28-Feb-2026,28-Feb-2026,6227547332,5,622754733205,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:35,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,27-Feb-2026,P1DBBL,28-Feb-2026,28-Feb-2026,6227547332,6,622754733206,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,11:35,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,27-Feb-2026,P1DBBL,28-Feb-2026,28-Feb-2026,6227547332,7,622754733207,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:35,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,06-Mar-2026,P1SCR,07-Mar-2026,,6227547331,1,622754733101,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:20,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,25-Mar-2026,P1DBBL,26-Mar-2026,26-Mar-2026,6227547333,1,622754733301,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,25-Mar-2026,P1DBBL,26-Mar-2026,,6227547333,2,622754733302,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,25-Mar-2026,P1DBBL,26-Mar-2026,26-Mar-2026,6227547333,3,622754733303,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,25-Mar-2026,P1DBBL,26-Mar-2026,,6227547333,4,622754733304,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,25-Mar-2026,P1DBBL,26-Mar-2026,26-Mar-2026,6227547333,6,622754733306,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,25-Mar-2026,P1DBBL,26-Mar-2026,26-Mar-2026,6227547333,5,622754733305,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,25-Mar-2026,P1DBBL,26-Mar-2026,26-Mar-2026,6227547333,7,622754733307,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,06-Mar-2026,P1SCR,07-Mar-2026,,6227547331,9,622754733109,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:20,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227547331,10,622754733110,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,10-Apr-2026,P2SCR,11-Apr-2026,,6227547336,1,622754733601,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:15,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,10-Apr-2026,P2SCR,11-Apr-2026,11-Apr-2026,6227547336,2,622754733602,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:15,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,10-Apr-2026,P2SCR,11-Apr-2026,11-Apr-2026,6227547336,3,622754733603,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,08:15,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,10-Apr-2026,P2SCR,11-Apr-2026,11-Apr-2026,6227547336,4,622754733604,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:15,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,10-Apr-2026,P2SCR,11-Apr-2026,11-Apr-2026,6227547336,5,622754733605,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:15,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,10-Apr-2026,P2SCR,11-Apr-2026,11-Apr-2026,6227547336,6,622754733606,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,08:15,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,10-Apr-2026,P2SCR,11-Apr-2026,,6227547336,7,622754733607,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:15,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,10-Apr-2026,P2SCR,11-Apr-2026,15-Apr-2026,6227547336,8,622754733608,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:15,07:00,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,10-Apr-2026,P2SCR,11-Apr-2026,,6227547336,9,622754733609,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:15,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,10-Apr-2026,P2OLBL,11-Apr-2026,,6227547337,2,622754733702,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:15,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,10-Apr-2026,P2OLBL,11-Apr-2026,15-Apr-2026,6227547337,3,622754733703,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:15,07:00,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,10-Apr-2026,P2OLBL,11-Apr-2026,,6227547337,4,622754733704,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:15,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227547337,6,622754733706,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,11:15,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227547337,5,622754733705,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:15,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227547337,9,622754733709,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:15,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,05-May-2026,P2OLBL,06-May-2026,,6227547338,2,622754733802,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,05-May-2026,P2OLBL,06-May-2026,20-May-2026,6227547338,3,622754733803,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,05-May-2026,P2OLBL,06-May-2026,06-May-2026,6227547338,1,622754733801,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,05-May-2026,P2OLBL,06-May-2026,,6227547338,4,622754733804,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,05-May-2026,P2OLBL,06-May-2026,06-May-2026,6227547338,7,622754733807,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,05-May-2026,P2OLBL,06-May-2026,06-May-2026,6227547338,5,622754733805,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,05-May-2026,P2OLBL,06-May-2026,06-May-2026,6227547338,6,622754733806,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,09:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,10-Apr-2026,P2OLBL,11-Apr-2026,,6227547337,8,622754733708,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:15,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227547337,7,622754733707,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:15,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,05-May-2026,P2OLBL,06-May-2026,,6227547338,8,622754733808,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,05-May-2026,P2OLBL,06-May-2026,06-May-2026,6227547338,9,622754733809,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227547337,1,622754733701,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:15,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,10-Apr-2026,P2SCR,11-Apr-2026,11-Apr-2026,6227547336,10,622754733610,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,08:15,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,01-Feb-2026,P1SCR,03-Feb-2026,03-Feb-2026,6227767267,3,622776726703,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,12:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,01-Feb-2026,P1SCR,03-Feb-2026,03-Feb-2026,6227767267,4,622776726704,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,01-Feb-2026,P1SCR,03-Feb-2026,,6227767267,1,622776726701,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:25,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,01-Feb-2026,P1SCR,03-Feb-2026,03-Feb-2026,6227767267,2,622776726702,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,01-Feb-2026,P1SCR,03-Feb-2026,,6227767267,7,622776726707,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:25,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,01-Feb-2026,P1SCR,03-Feb-2026,03-Feb-2026,6227767267,5,622776726705,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,01-Feb-2026,P1SCR,03-Feb-2026,03-Feb-2026,6227767267,6,622776726706,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,12:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,01-Feb-2026,P1SCR,03-Feb-2026,,6227767267,9,622776726709,"Red Cells, Clot",Not Received,,,TSH,,,,,,12:25,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,01-Feb-2026,P1SCR,03-Feb-2026,04-Feb-2026,6227767267,8,622776726708,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,01-Feb-2026,P1SCR,03-Feb-2026,03-Feb-2026,6227767267,10,622776726710,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,12:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,05-May-2026,EOT,06-May-2026,06-May-2026,6227768458,2,622776845802,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,05-May-2026,EOT,06-May-2026,,6227768458,4,622776845804,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,05-May-2026,EOT,06-May-2026,06-May-2026,6227768458,1,622776845801,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,05-May-2026,EOT,06-May-2026,06-May-2026,6227768458,3,622776845803,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,05-May-2026,EOT,06-May-2026,20-May-2026,6227768458,5,622776845805,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,05-May-2026,EOT,06-May-2026,,6227768458,6,622776845806,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,05-May-2026,EOT,06-May-2026,,6227768458,8,622776845808,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,05-May-2026,EOT,06-May-2026,06-May-2026,6227768458,7,622776845807,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Mar-2026,EOT,14-Mar-2026,14-Mar-2026,6227768459,1,622776845901,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:00,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Mar-2026,EOT,14-Mar-2026,14-Mar-2026,6227768459,3,622776845903,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:00,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Mar-2026,EOT,14-Mar-2026,,6227768459,4,622776845904,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:00,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,05-May-2026,EOT,06-May-2026,06-May-2026,6227768458,9,622776845809,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,27-Mar-2026,EOT,28-Mar-2026,,6227768460,4,622776846004,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:00,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Mar-2026,EOT,14-Mar-2026,,6227768459,6,622776845906,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:00,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,27-Mar-2026,EOT,28-Mar-2026,08-Apr-2026,6227768460,5,622776846005,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:00,07:00,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,27-Mar-2026,EOT,28-Mar-2026,28-Mar-2026,6227768460,2,622776846002,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:00,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Mar-2026,EOT,14-Mar-2026,14-Mar-2026,6227768459,7,622776845907,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:00,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,27-Mar-2026,EOT,28-Mar-2026,28-Mar-2026,6227768460,3,622776846003,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:00,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Mar-2026,EOT,14-Mar-2026,,6227768459,8,622776845908,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:00,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Mar-2026,EOT,14-Mar-2026,18-Mar-2026,6227768459,5,622776845905,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:00,07:00,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Mar-2026,EOT,14-Mar-2026,14-Mar-2026,6227768459,9,622776845909,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:00,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,27-Mar-2026,EOT,28-Mar-2026,28-Mar-2026,6227768460,7,622776846007,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:00,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,27-Mar-2026,EOT,28-Mar-2026,,6227768460,8,622776846008,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:00,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,27-Mar-2026,EOT,28-Mar-2026,28-Mar-2026,6227768460,1,622776846001,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:00,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,27-Mar-2026,EOT,28-Mar-2026,28-Mar-2026,6227768460,9,622776846009,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:00,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Mar-2026,EOT,14-Mar-2026,14-Mar-2026,6227768459,2,622776845902,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:00,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,27-Mar-2026,EOT,28-Mar-2026,,6227768460,6,622776846006,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:00,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,28-Jan-2026,P1SCR,30-Jan-2026,,6227775505,1,622777550501,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,16:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,28-Jan-2026,P1SCR,30-Jan-2026,30-Jan-2026,6227775505,5,622777550505,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,16:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,28-Jan-2026,P1SCR,30-Jan-2026,30-Jan-2026,6227775505,4,622777550504,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,16:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,28-Jan-2026,P1SCR,30-Jan-2026,30-Jan-2026,6227775505,6,622777550506,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,16:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,28-Jan-2026,P1SCR,30-Jan-2026,,6227775505,7,622777550507,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,16:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,28-Jan-2026,P1SCR,30-Jan-2026,30-Jan-2026,6227775505,2,622777550502,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,16:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,28-Jan-2026,P1SCR,30-Jan-2026,30-Jan-2026,6227775505,3,622777550503,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,16:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,28-Jan-2026,P1SCR,30-Jan-2026,,6227775505,9,622777550509,"Red Cells, Clot",Not Received,,,TSH,,,,,,16:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,15-Feb-2026,P1DBBL,17-Feb-2026,,6227775508,2,622777550802,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,15:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,15-Feb-2026,P1DBBL,17-Feb-2026,17-Feb-2026,6227775507,1,622777550701,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,13:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,15-Feb-2026,P1DBBL,17-Feb-2026,17-Feb-2026,6227775508,5,622777550805,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,15:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,15-Feb-2026,P1DBBL,17-Feb-2026,18-Feb-2026,6227775507,3,622777550703,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,13:30,07:10,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,15-Feb-2026,P1DBBL,17-Feb-2026,,6227775507,4,622777550704,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,13:30,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,15-Feb-2026,P1DBBL,17-Feb-2026,18-Feb-2026,6227775508,3,622777550803,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,15:10,07:10,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,15-Feb-2026,P1DBBL,17-Feb-2026,17-Feb-2026,6227775507,6,622777550706,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,13:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,15-Feb-2026,P1DBBL,17-Feb-2026,17-Feb-2026,6227775507,7,622777550707,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,13:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,15-Feb-2026,P1DBBL,17-Feb-2026,17-Feb-2026,6227775507,5,622777550705,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,13:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,15-Feb-2026,P1DBBL,17-Feb-2026,17-Feb-2026,6227775508,7,622777550807,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,15:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,15-Feb-2026,P1DBBL,17-Feb-2026,17-Feb-2026,6227775508,6,622777550806,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,15:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,15-Feb-2026,P1DBBL,17-Feb-2026,17-Feb-2026,6227775508,1,622777550801,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,15:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,15-Feb-2026,P1DBBL,17-Feb-2026,,6227775507,2,622777550702,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,13:30,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,28-Jan-2026,P1SCR,30-Jan-2026,30-Jan-2026,6227775505,10,622777550510,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,16:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,15-Feb-2026,P1DBBL,17-Feb-2026,,6227775508,4,622777550804,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,15:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,28-Jan-2026,P1SCR,30-Jan-2026,31-Jan-2026,6227775505,8,622777550508,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,16:50,07:20,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,17-Feb-2026,P1SCR,18-Feb-2026,18-Feb-2026,6227797406,3,622779740603,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,11:03,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,17-Feb-2026,P1SCR,18-Feb-2026,18-Feb-2026,6227797406,6,622779740606,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,11:03,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,17-Feb-2026,P1SCR,18-Feb-2026,18-Feb-2026,6227797406,5,622779740605,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:03,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,17-Feb-2026,P1SCR,18-Feb-2026,18-Feb-2026,6227797406,4,622779740604,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:03,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,17-Feb-2026,P1SCR,18-Feb-2026,18-Feb-2026,6227797406,8,622779740608,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:03,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,17-Feb-2026,P1SCR,18-Feb-2026,,6227797406,9,622779740609,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:03,,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,17-Feb-2026,P1SCR,18-Feb-2026,,6227797406,7,622779740607,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:03,,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,17-Feb-2026,P1SCR,18-Feb-2026,18-Feb-2026,6227797406,2,622779740602,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:03,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,17-Feb-2026,P1SCR,18-Feb-2026,,6227797406,1,622779740601,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:03,,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110012,06-Mar-2026,P1SCR,07-Mar-2026,,6227797407,1,622779740701,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:22,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110012,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227797407,3,622779740703,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110012,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227797407,4,622779740704,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,17-Feb-2026,P1SCR,18-Feb-2026,18-Feb-2026,6227797406,10,622779740610,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:03,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110012,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227797407,5,622779740705,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110012,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227797407,6,622779740706,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110012,06-Mar-2026,P1SCR,07-Mar-2026,,6227797407,7,622779740707,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:22,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110012,06-Mar-2026,P1SCR,07-Mar-2026,,6227797407,9,622779740709,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:22,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110011,02-Mar-2026,P1SCR,03-Mar-2026,03-Mar-2026,6227797408,5,622779740805,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110011,02-Mar-2026,P1SCR,03-Mar-2026,03-Mar-2026,6227797408,6,622779740806,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110011,02-Mar-2026,P1SCR,03-Mar-2026,03-Mar-2026,6227797408,4,622779740804,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110012,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227797407,10,622779740710,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110012,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227797407,2,622779740702,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110012,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227797407,8,622779740708,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110011,02-Mar-2026,P1SCR,03-Mar-2026,,6227797408,1,622779740801,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:05,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110011,02-Mar-2026,P1SCR,03-Mar-2026,03-Mar-2026,6227797408,8,622779740808,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110011,02-Mar-2026,P1SCR,03-Mar-2026,03-Mar-2026,6227797408,2,622779740802,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110011,02-Mar-2026,P1SCR,03-Mar-2026,03-Mar-2026,6227797408,3,622779740803,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110011,02-Mar-2026,P1SCR,03-Mar-2026,,6227797408,7,622779740807,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:05,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110011,02-Mar-2026,P1SCR,03-Mar-2026,,6227797408,9,622779740809,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:05,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110011,02-Mar-2026,P1SCR,03-Mar-2026,03-Mar-2026,6227797408,10,622779740810,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Mar-2026,P1DBBL,11-Mar-2026,11-Mar-2026,6227844725,3,622784472503,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:21,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Mar-2026,P1DBBL,11-Mar-2026,11-Mar-2026,6227844725,6,622784472506,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,10:21,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Mar-2026,P1DBBL,11-Mar-2026,11-Mar-2026,6227844725,5,622784472505,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:21,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Mar-2026,P1DBBL,11-Mar-2026,,6227844725,4,622784472504,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:21,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Mar-2026,P1DBBL,11-Mar-2026,11-Mar-2026,6227844725,7,622784472507,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:21,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Mar-2026,P1DBBL,11-Mar-2026,11-Mar-2026,6227844725,1,622784472501,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:21,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Mar-2026,P1DBBL,11-Mar-2026,,6227844725,2,622784472502,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:21,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,28-Jan-2026,P1SCR,30-Jan-2026,30-Jan-2026,6227775505,11,622777550511,"Serum, SST",Received,Ambient,Default Return Ambient,,,,,,,16:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,07-Apr-2026,P2OLD29,08-Apr-2026,08-Apr-2026,6228114460,1,622811446001,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:21,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,07-Apr-2026,P2OLD29,08-Apr-2026,,6228114460,4,622811446004,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:21,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,07-Apr-2026,P2OLD29,08-Apr-2026,08-Apr-2026,6228114460,5,622811446005,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:21,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,07-Apr-2026,P2OLD29,08-Apr-2026,08-Apr-2026,6228114460,6,622811446006,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,09:21,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,07-Apr-2026,P2OLD29,08-Apr-2026,,6228114460,2,622811446002,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:21,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,07-Apr-2026,P2OLD29,08-Apr-2026,08-Apr-2026,6228114460,3,622811446003,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:21,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,07-Apr-2026,P2OLD29,08-Apr-2026,08-Apr-2026,6228114460,7,622811446007,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:21,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,10-Mar-2026,P2DBBL,11-Mar-2026,,6226804962,10,622680496210,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,11:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,07-Apr-2026,P2OLD29,08-Apr-2026,,6228114460,8,622811446008,"Urine, no preservative",Not Received,Ambient,,,,,,,,09:21,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,31-Mar-2026,EOT,01-Apr-2026,02-Apr-2026,6228232037,5,622823203705,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,31-Mar-2026,EOT,01-Apr-2026,,6228232037,6,622823203706,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,31-Mar-2026,EOT,01-Apr-2026,,6228232037,8,622823203708,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,31-Mar-2026,EOT,01-Apr-2026,01-Apr-2026,6228232037,9,622823203709,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,31-Mar-2026,EOT,01-Apr-2026,01-Apr-2026,6228232037,7,622823203707,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,31-Mar-2026,EOT,01-Apr-2026,01-Apr-2026,6228232037,1,622823203701,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,31-Mar-2026,EOT,01-Apr-2026,01-Apr-2026,6228232037,3,622823203703,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,31-Mar-2026,EOT,01-Apr-2026,,6228232037,4,622823203704,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,31-Mar-2026,EOT,01-Apr-2026,01-Apr-2026,6228232037,2,622823203702,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,04-May-2026,EOT,05-May-2026,05-May-2026,6228234297,1,622823429701,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:44,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,04-May-2026,EOT,05-May-2026,05-May-2026,6228234297,2,622823429702,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:44,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,04-May-2026,EOT,05-May-2026,05-May-2026,6228234297,3,622823429703,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:44,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,04-May-2026,EOT,05-May-2026,05-May-2026,6228234297,7,622823429707,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:44,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,04-May-2026,EOT,05-May-2026,,6228234297,8,622823429708,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:44,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,13-May-2026,EOT,14-May-2026,14-May-2026,6228234298,1,622823429801,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,04-May-2026,EOT,05-May-2026,06-May-2026,6228234297,5,622823429705,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:44,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,04-May-2026,EOT,05-May-2026,,6228234297,6,622823429706,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:44,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,04-May-2026,EOT,05-May-2026,05-May-2026,6228234297,9,622823429709,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,08:44,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,13-May-2026,EOT,14-May-2026,,6228234298,6,622823429806,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,13-May-2026,EOT,14-May-2026,14-May-2026,6228234298,5,622823429805,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,13-May-2026,EOT,14-May-2026,14-May-2026,6228234298,2,622823429802,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,13-May-2026,EOT,14-May-2026,14-May-2026,6228234298,9,622823429809,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,08:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,13-May-2026,EOT,14-May-2026,,6228234298,4,622823429804,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,04-May-2026,EOT,05-May-2026,,6228234297,4,622823429704,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:44,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,13-May-2026,EOT,14-May-2026,,6228234298,8,622823429808,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,13-May-2026,EOT,14-May-2026,14-May-2026,6228234298,3,622823429803,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,21-Apr-2026,EOT,23-Apr-2026,23-Apr-2026,6228234300,5,622823430005,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:37,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,13-May-2026,EOT,14-May-2026,14-May-2026,6228234298,7,622823429807,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,21-Apr-2026,EOT,23-Apr-2026,23-Apr-2026,6228234300,2,622823430002,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:37,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,21-Apr-2026,EOT,23-Apr-2026,23-Apr-2026,6228234300,1,622823430001,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:37,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,21-Apr-2026,EOT,23-Apr-2026,23-Apr-2026,6228234300,3,622823430003,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:37,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,21-Apr-2026,EOT,23-Apr-2026,,6228234300,6,622823430006,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:37,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,21-Apr-2026,EOT,23-Apr-2026,23-Apr-2026,6228234300,9,622823430009,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:37,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,21-Apr-2026,EOT,23-Apr-2026,,6228234300,8,622823430008,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:37,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,21-Apr-2026,EOT,23-Apr-2026,,6228234300,4,622823430004,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:37,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,21-Apr-2026,EOT,23-Apr-2026,23-Apr-2026,6228234300,7,622823430007,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:37,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,25-Mar-2026,EOT,26-Mar-2026,,6226560888,10,622656088810,"Urine, no preservative",Not Received,Ambient,,,,,,,,17:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,25-Mar-2026,EOT,26-Mar-2026,,6226752555,10,622675255510,"Urine, no preservative",Not Received,Ambient,,,,,,,,15:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,01-Apr-2026,P2OLD29,02-Apr-2026,,6226313625,8,622631362508,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,11:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Apr-2026,P2DBW13,08-Apr-2026,,6226686954,10,622668695410,"Serum, SST",Cancelled,Ambient,,TSH,,,,,,12:01,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Apr-2026,P2DBW13,08-Apr-2026,,6226686954,9,622668695409,"Red Cells, Clot",Not Received,,,TSH,,,,,,12:01,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Apr-2026,P2DBW13,08-Apr-2026,,6226686954,8,622668695408,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,12:01,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,07-Apr-2026,P2DBW13,08-Apr-2026,,6227541264,10,622754126410,"Serum, SST",Cancelled,Ambient,,TSH,,,,,,08:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,07-Apr-2026,P2DBW13,08-Apr-2026,,6227541264,8,622754126408,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,08:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,07-Apr-2026,P2DBW13,08-Apr-2026,,6227541264,9,622754126409,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,07-Apr-2026,P2OLBL,08-Apr-2026,,6227541258,10,622754125810,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,09:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227542182,11,622754218211,"Serum, SST",Received,Ambient,Default Return Ambient,,,,,,,08:16,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,10-Apr-2026,P2OLBL,11-Apr-2026,,6227547337,10,622754733710,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,11:15,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,22-Apr-2026,P2OLD29,23-Apr-2026,,6226752554,8,622675255408,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,15:30,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,23-Apr-2026,P2OLD29,25-Apr-2026,,6226560887,8,622656088708,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,16:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,05-May-2026,P2OLD29,06-May-2026,,6227541261,8,622754126108,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,13:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,05-May-2026,P2OLBL,06-May-2026,,6227541256,10,622754125610,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,07:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,05-May-2026,P2OLBL,06-May-2026,,6227547338,10,622754733810,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,09:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,22-May-2026,EOT,23-May-2026,23-May-2026,6228605652,2,622860565202,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,22-May-2026,EOT,23-May-2026,,6228605652,4,622860565204,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:20,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,22-May-2026,EOT,23-May-2026,27-May-2026,6228605653,5,622860565305,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:00,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,22-May-2026,EOT,23-May-2026,23-May-2026,6228605652,1,622860565201,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,22-May-2026,EOT,23-May-2026,23-May-2026,6228605652,9,622860565209,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,22-May-2026,EOT,23-May-2026,23-May-2026,6228605653,1,622860565301,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,12:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,22-May-2026,EOT,23-May-2026,23-May-2026,6228605652,3,622860565203,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,22-May-2026,EOT,23-May-2026,,6228605653,8,622860565308,"Red Cells, Clot",Not Received,,,TSH,,,,,,12:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,22-May-2026,EOT,23-May-2026,23-May-2026,6228605653,9,622860565309,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,12:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,22-May-2026,EOT,23-May-2026,,6228605652,8,622860565208,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:20,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,22-May-2026,EOT,23-May-2026,,6228605652,6,622860565206,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:20,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,22-May-2026,EOT,23-May-2026,,6228605653,6,622860565306,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,22-May-2026,EOT,23-May-2026,23-May-2026,6228605653,7,622860565307,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,22-May-2026,EOT,23-May-2026,23-May-2026,6228605653,2,622860565302,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,22-May-2026,EOT,23-May-2026,23-May-2026,6228605652,7,622860565207,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,22-May-2026,EOT,23-May-2026,,6228605653,4,622860565304,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,22-May-2026,EOT,23-May-2026,27-May-2026,6228605652,5,622860565205,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:20,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,22-May-2026,EOT,23-May-2026,23-May-2026,6228605653,3,622860565303,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,19-May-2026,P2OLD29,20-May-2026,,6227261835,8,622726183508,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,00:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, diff --git a/Covance_MDD3003/Source/2026-05-29_111722 sponsor-study-35472-samples-allSamples.csv b/Covance_MDD3003/Source/2026-05-29_111722 sponsor-study-35472-samples-allSamples.csv new file mode 100644 index 0000000..94fee19 --- /dev/null +++ b/Covance_MDD3003/Source/2026-05-29_111722 sponsor-study-35472-samples-allSamples.csv @@ -0,0 +1,1189 @@ +Protocol Code,Investigator No.,Investigator Name,Patient No.,Collection Date,Protocol Visit Code,Kit Receipt Date,Container Receipt Date,Accession,Container No.,Container Barcode No.,Specimen Type,Sample Status,Expected Receipt Condition,Actual Receipt Condition,Container Label Line 1,Container Label Line 2,SM Sample Status,SMART Specimen Class Description,Aliquot Created Date,Aliquoted Date,Collection Time,Container Receipt Time,Country,Courier,Kit Receipt Time,Parent Barcode Number,Parent Sample Type,Project,Region,Screening No.,Shipped To Organization Name,Site Waybill No.,Site - Scheduled Shipment Date,Site - Shipment Created Date,Site - Shipment Details Entered Date,SMART Specimen Class,Visit Description,Parent Barcode,Children Barcode +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,08-Aug-2025,P1SCR,09-Aug-2025,,6225350971,1,622535097101,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:30,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,08-Aug-2025,P1SCR,09-Aug-2025,09-Aug-2025,6225350971,2,622535097102,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:30,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,08-Aug-2025,P1SCR,09-Aug-2025,09-Aug-2025,6225350971,3,622535097103,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,10:30,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,08-Aug-2025,P1SCR,09-Aug-2025,09-Aug-2025,6225350971,4,622535097104,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:30,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,08-Aug-2025,P1SCR,09-Aug-2025,09-Aug-2025,6225350971,5,622535097105,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:30,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,08-Aug-2025,P1SCR,09-Aug-2025,09-Aug-2025,6225350971,6,622535097106,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,10:30,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,08-Aug-2025,P1SCR,09-Aug-2025,,6225350971,7,622535097107,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:30,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,08-Aug-2025,P1SCR,09-Aug-2025,12-Aug-2025,6225350971,8,622535097108,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:30,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,08-Aug-2025,P1SCR,09-Aug-2025,,6225350971,9,622535097109,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:30,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,08-Aug-2025,P1SCR,09-Aug-2025,09-Aug-2025,6225350971,10,622535097110,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:30,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,19-Sep-2025,P1SCR,20-Sep-2025,,6225350972,1,622535097201,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:20,,Czech Republic,,22:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,19-Sep-2025,P1SCR,20-Sep-2025,20-Sep-2025,6225350972,3,622535097203,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:20,22:00,Czech Republic,,22:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,19-Sep-2025,P1SCR,20-Sep-2025,20-Sep-2025,6225350972,4,622535097204,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:20,22:00,Czech Republic,,22:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,19-Sep-2025,P1SCR,20-Sep-2025,20-Sep-2025,6225350972,2,622535097202,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:20,22:00,Czech Republic,,22:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,19-Sep-2025,P1SCR,20-Sep-2025,20-Sep-2025,6225350972,5,622535097205,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:20,22:00,Czech Republic,,22:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,19-Sep-2025,P1SCR,20-Sep-2025,20-Sep-2025,6225350972,6,622535097206,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:20,22:00,Czech Republic,,22:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,19-Sep-2025,P1SCR,20-Sep-2025,,6225350972,7,622535097207,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:20,,Czech Republic,,22:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,19-Sep-2025,P1SCR,20-Sep-2025,24-Sep-2025,6225350972,8,622535097208,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:20,07:00,Czech Republic,,22:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,19-Sep-2025,P1SCR,20-Sep-2025,,6225350972,9,622535097209,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:20,,Czech Republic,,22:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,19-Sep-2025,P1SCR,20-Sep-2025,20-Sep-2025,6225350972,10,622535097210,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:20,22:00,Czech Republic,,22:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,07-Nov-2025,P1SCR,08-Nov-2025,,6225350975,1,622535097501,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:10,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,07-Nov-2025,P1SCR,08-Nov-2025,08-Nov-2025,6225350975,2,622535097502,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,07-Nov-2025,P1SCR,08-Nov-2025,08-Nov-2025,6225350975,3,622535097503,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,08:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,07-Nov-2025,P1SCR,08-Nov-2025,08-Nov-2025,6225350975,5,622535097505,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,07-Nov-2025,P1SCR,08-Nov-2025,08-Nov-2025,6225350975,6,622535097506,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,08:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,07-Nov-2025,P1SCR,08-Nov-2025,08-Nov-2025,6225350975,4,622535097504,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,07-Nov-2025,P1SCR,08-Nov-2025,,6225350975,7,622535097507,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:10,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,07-Nov-2025,P1SCR,08-Nov-2025,12-Nov-2025,6225350975,8,622535097508,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:10,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,07-Nov-2025,P1SCR,08-Nov-2025,,6225350975,9,622535097509,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:10,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,07-Nov-2025,P1SCR,08-Nov-2025,08-Nov-2025,6225350975,10,622535097510,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,08:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,10-Oct-2025,P1SCR,11-Oct-2025,,6225350977,1,622535097701,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:20,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,10-Oct-2025,P1SCR,11-Oct-2025,11-Oct-2025,6225350977,2,622535097702,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,10-Oct-2025,P1SCR,11-Oct-2025,11-Oct-2025,6225350977,3,622535097703,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,10-Oct-2025,P1SCR,11-Oct-2025,11-Oct-2025,6225350977,4,622535097704,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,10-Oct-2025,P1SCR,11-Oct-2025,11-Oct-2025,6225350977,5,622535097705,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,10-Oct-2025,P1SCR,11-Oct-2025,11-Oct-2025,6225350977,6,622535097706,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,10-Oct-2025,P1SCR,11-Oct-2025,,6225350977,7,622535097707,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:20,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,10-Oct-2025,P1SCR,11-Oct-2025,15-Oct-2025,6225350977,8,622535097708,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:20,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,10-Oct-2025,P1SCR,11-Oct-2025,,6225350977,9,622535097709,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:20,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,10-Oct-2025,P1SCR,11-Oct-2025,11-Oct-2025,6225350977,10,622535097710,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,05-Sep-2025,P1DBBL,06-Sep-2025,06-Sep-2025,6225350981,1,622535098101,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,05-Sep-2025,P1DBBL,06-Sep-2025,,6225350981,2,622535098102,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,07:55,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,05-Sep-2025,P1DBBL,06-Sep-2025,09-Sep-2025,6225350981,3,622535098103,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,07:55,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,05-Sep-2025,P1DBBL,06-Sep-2025,,6225350981,4,622535098104,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,07:55,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,05-Sep-2025,P1DBBL,06-Sep-2025,06-Sep-2025,6225350981,5,622535098105,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,05-Sep-2025,P1DBBL,06-Sep-2025,06-Sep-2025,6225350981,6,622535098106,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,07-Nov-2025,P1DBBL,08-Nov-2025,,6225350982,2,622535098202,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:30,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,07-Nov-2025,P1DBBL,08-Nov-2025,12-Nov-2025,6225350982,3,622535098203,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:30,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,07-Nov-2025,P1DBBL,08-Nov-2025,08-Nov-2025,6225350982,1,622535098201,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:30,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,05-Sep-2025,P1DBBL,06-Sep-2025,06-Sep-2025,6225350981,7,622535098107,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,07-Nov-2025,P1DBBL,08-Nov-2025,,6225350982,4,622535098204,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:30,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,07-Nov-2025,P1DBBL,08-Nov-2025,08-Nov-2025,6225350982,5,622535098205,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:30,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,07-Nov-2025,P1DBBL,08-Nov-2025,08-Nov-2025,6225350982,6,622535098206,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,09:30,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,07-Nov-2025,P1DBBL,08-Nov-2025,08-Nov-2025,6225350982,7,622535098207,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:30,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,17-Oct-2025,P1DBBL,18-Oct-2025,18-Oct-2025,6225350984,1,622535098401,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:45,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,17-Oct-2025,P1DBBL,18-Oct-2025,,6225350984,2,622535098402,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:45,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,17-Oct-2025,P1DBBL,18-Oct-2025,22-Oct-2025,6225350984,3,622535098403,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:45,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,17-Oct-2025,P1DBBL,18-Oct-2025,,6225350984,4,622535098404,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:45,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,17-Oct-2025,P1DBBL,18-Oct-2025,18-Oct-2025,6225350984,5,622535098405,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:45,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,17-Oct-2025,P1DBBL,18-Oct-2025,18-Oct-2025,6225350984,6,622535098406,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,10:45,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,17-Oct-2025,P1DBBL,18-Oct-2025,18-Oct-2025,6225350984,7,622535098407,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:45,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,17-Oct-2025,P2OLBL,18-Oct-2025,18-Oct-2025,6225350988,5,622535098805,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,17-Oct-2025,P2OLBL,18-Oct-2025,18-Oct-2025,6225350988,6,622535098806,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,09:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,17-Oct-2025,P2OLBL,18-Oct-2025,18-Oct-2025,6225350988,7,622535098807,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,17-Oct-2025,P2OLBL,18-Oct-2025,,6225350988,8,622535098808,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,17-Oct-2025,P2OLBL,18-Oct-2025,18-Oct-2025,6225350988,1,622535098801,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,17-Oct-2025,P2OLBL,18-Oct-2025,18-Oct-2025,6225350988,9,622535098809,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,17-Oct-2025,P2OLBL,18-Oct-2025,,6225350988,2,622535098802,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,17-Oct-2025,P2OLBL,18-Oct-2025,22-Oct-2025,6225350988,3,622535098803,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:00,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,17-Oct-2025,P2OLBL,18-Oct-2025,,6225350988,4,622535098804,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,19-Aug-2025,P1SCR,21-Aug-2025,,6225351002,1,622535100201,"Whole Blood, EDTA, Dry",Not Received,Ambient,,HEMATOLOGY,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,19-Aug-2025,P1SCR,21-Aug-2025,,6225351002,2,622535100202,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,19-Aug-2025,P1SCR,21-Aug-2025,,6225351002,3,622535100203,"Urine, Cargile Preservative UA",Not Received,Ambient,,URINALYSIS,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,19-Aug-2025,P1SCR,21-Aug-2025,,6225351002,4,622535100204,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,19-Aug-2025,P1SCR,21-Aug-2025,,6225351002,5,622535100205,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,19-Aug-2025,P1SCR,21-Aug-2025,21-Aug-2025,6225351002,6,622535100206,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,19-Aug-2025,P1SCR,21-Aug-2025,,6225351002,7,622535100207,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,19-Aug-2025,P1SCR,21-Aug-2025,,6225351002,8,622535100208,"Serum, SST",Not Received,Ambient,,TSH,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,19-Aug-2025,P1SCR,21-Aug-2025,,6225351002,9,622535100209,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,19-Aug-2025,P1SCR,21-Aug-2025,,6225351002,10,622535100210,"Serum, SST",Not Received,Ambient,,CHEMISTRY,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,03-Nov-2025,P1SCR,04-Nov-2025,,6225351004,1,622535100401,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:08,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351004,2,622535100402,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351004,3,622535100403,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,12:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351004,4,622535100404,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351004,5,622535100405,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351004,6,622535100406,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,12:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,03-Nov-2025,P1SCR,04-Nov-2025,,6225351004,7,622535100407,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:08,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351004,8,622535100408,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,03-Nov-2025,P1SCR,04-Nov-2025,,6225351004,9,622535100409,"Red Cells, Clot",Not Received,,,TSH,,,,,,12:08,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351004,10,622535100410,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,12:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,09-Sep-2025,P1SCR,10-Sep-2025,10-Sep-2025,6225351006,2,622535100602,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,09-Sep-2025,P1SCR,10-Sep-2025,,6225351006,1,622535100601,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,09-Sep-2025,P1SCR,10-Sep-2025,10-Sep-2025,6225351006,3,622535100603,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,09-Sep-2025,P1SCR,10-Sep-2025,10-Sep-2025,6225351006,4,622535100604,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,09-Sep-2025,P1SCR,10-Sep-2025,10-Sep-2025,6225351006,5,622535100605,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,09-Sep-2025,P1SCR,10-Sep-2025,10-Sep-2025,6225351006,6,622535100606,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,09-Sep-2025,P1SCR,10-Sep-2025,,6225351006,7,622535100607,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,09-Sep-2025,P1SCR,10-Sep-2025,10-Sep-2025,6225351006,8,622535100608,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,09-Sep-2025,P1SCR,10-Sep-2025,,6225351006,9,622535100609,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,09-Sep-2025,P1SCR,10-Sep-2025,10-Sep-2025,6225351006,10,622535100610,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,16-Sep-2025,P1SCR,17-Sep-2025,17-Sep-2025,6225351036,1,622535103601,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,16-Sep-2025,P1SCR,17-Sep-2025,,6225351036,3,622535103603,"Urine, Cargile Preservative UA",Not Received,Ambient,,URINALYSIS,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,16-Sep-2025,P1SCR,17-Sep-2025,,6225351036,4,622535103604,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,16-Sep-2025,P1SCR,17-Sep-2025,,6225351036,2,622535103602,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,16-Sep-2025,P1SCR,17-Sep-2025,,6225351036,5,622535103605,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,16-Sep-2025,P1SCR,17-Sep-2025,,6225351036,7,622535103607,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,16-Sep-2025,P1SCR,17-Sep-2025,,6225351036,8,622535103608,"Serum, SST",Not Received,Ambient,,TSH,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,16-Sep-2025,P1SCR,17-Sep-2025,,6225351036,6,622535103606,"Plasma, EDTA",Not Received,Frozen,,INSULIN,FROZEN,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,11-Nov-2025,P1SCR,12-Nov-2025,,6225351037,2,622535103702,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,10:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,16-Sep-2025,P1SCR,17-Sep-2025,,6225351036,9,622535103609,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,11-Nov-2025,P1SCR,12-Nov-2025,,6225351037,3,622535103703,"Urine, Cargile Preservative UA",Not Received,Ambient,,URINALYSIS,,,,,,10:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,16-Sep-2025,P1SCR,17-Sep-2025,17-Sep-2025,6225351036,10,622535103610,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,11-Nov-2025,P1SCR,12-Nov-2025,12-Nov-2025,6225351037,1,622535103701,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,11-Nov-2025,P1SCR,12-Nov-2025,,6225351037,6,622535103706,"Plasma, EDTA",Not Received,Frozen,,INSULIN,FROZEN,,,,,10:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,11-Nov-2025,P1SCR,12-Nov-2025,,6225351037,9,622535103709,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,11-Nov-2025,P1SCR,12-Nov-2025,,6225351037,8,622535103708,"Serum, SST",Not Received,Ambient,,TSH,,,,,,10:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,11-Nov-2025,P1SCR,12-Nov-2025,12-Nov-2025,6225351037,10,622535103710,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,11-Nov-2025,P1SCR,12-Nov-2025,,6225351037,7,622535103707,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,11-Nov-2025,P1SCR,12-Nov-2025,,6225351037,4,622535103704,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,10:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,11-Nov-2025,P1SCR,12-Nov-2025,,6225351037,5,622535103705,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,16-Sep-2025,P1SCR,17-Sep-2025,17-Sep-2025,6225351040,2,622535104002,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,16-Sep-2025,P1SCR,17-Sep-2025,,6225351040,1,622535104001,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,16-Sep-2025,P1SCR,17-Sep-2025,17-Sep-2025,6225351040,5,622535104005,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,16-Sep-2025,P1SCR,17-Sep-2025,17-Sep-2025,6225351040,4,622535104004,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,16-Sep-2025,P1SCR,17-Sep-2025,17-Sep-2025,6225351040,6,622535104006,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,16-Sep-2025,P1SCR,17-Sep-2025,17-Sep-2025,6225351040,8,622535104008,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,16-Sep-2025,P1SCR,17-Sep-2025,,6225351040,9,622535104009,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,16-Sep-2025,P1SCR,17-Sep-2025,17-Sep-2025,6225351040,3,622535104003,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,16-Sep-2025,P1SCR,17-Sep-2025,,6225351040,7,622535104007,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080003,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351041,3,622535104103,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,11:43,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080003,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351041,5,622535104105,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:43,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080003,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351041,6,622535104106,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,11:43,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080003,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351041,4,622535104104,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:43,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080003,06-Aug-2025,P1SCR,07-Aug-2025,,6225351041,7,622535104107,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:43,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080003,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351041,8,622535104108,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:43,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080003,06-Aug-2025,P1SCR,07-Aug-2025,,6225351041,1,622535104101,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:43,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,16-Sep-2025,P1SCR,17-Sep-2025,17-Sep-2025,6225351040,10,622535104010,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080003,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351041,2,622535104102,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:43,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080003,06-Aug-2025,P1SCR,07-Aug-2025,,6225351041,9,622535104109,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:43,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080003,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351041,10,622535104110,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:43,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,26-Aug-2025,P1SCR,27-Aug-2025,,6225351042,1,622535104201,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:08,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,26-Aug-2025,P1SCR,27-Aug-2025,27-Aug-2025,6225351042,4,622535104204,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,26-Aug-2025,P1SCR,27-Aug-2025,27-Aug-2025,6225351042,3,622535104203,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,11:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,26-Aug-2025,P1SCR,27-Aug-2025,27-Aug-2025,6225351042,5,622535104205,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,26-Aug-2025,P1SCR,27-Aug-2025,27-Aug-2025,6225351042,6,622535104206,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,11:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,26-Aug-2025,P1SCR,27-Aug-2025,27-Aug-2025,6225351042,2,622535104202,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,26-Aug-2025,P1SCR,27-Aug-2025,27-Aug-2025,6225351042,10,622535104210,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,26-Aug-2025,P1SCR,27-Aug-2025,28-Aug-2025,6225351042,8,622535104208,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,26-Aug-2025,P1SCR,27-Aug-2025,,6225351042,9,622535104209,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:08,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,26-Aug-2025,P1SCR,27-Aug-2025,,6225351042,7,622535104207,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:08,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,10-Dec-2025,P1SCR,11-Dec-2025,,6225351044,1,622535104401,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:20,,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,10-Dec-2025,P1SCR,11-Dec-2025,11-Dec-2025,6225351044,2,622535104402,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:20,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,10-Dec-2025,P1SCR,11-Dec-2025,11-Dec-2025,6225351044,3,622535104403,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,10:20,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,10-Dec-2025,P1SCR,11-Dec-2025,11-Dec-2025,6225351044,4,622535104404,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:20,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,10-Dec-2025,P1SCR,11-Dec-2025,11-Dec-2025,6225351044,5,622535104405,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:20,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,10-Dec-2025,P1SCR,11-Dec-2025,11-Dec-2025,6225351044,6,622535104406,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,10:20,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,10-Dec-2025,P1SCR,11-Dec-2025,,6225351044,7,622535104407,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:20,,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,10-Dec-2025,P1SCR,11-Dec-2025,,6225351044,9,622535104409,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:20,,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,10-Dec-2025,P1SCR,11-Dec-2025,11-Dec-2025,6225351044,10,622535104410,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:20,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,05-Aug-2025,P1SCR,06-Aug-2025,,6225351045,1,622535104501,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:58,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,05-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351045,2,622535104502,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,05-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351045,3,622535104503,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,11:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,10-Dec-2025,P1SCR,11-Dec-2025,11-Dec-2025,6225351044,8,622535104408,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:20,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,05-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351045,4,622535104504,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,05-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351045,5,622535104505,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,05-Aug-2025,P1SCR,06-Aug-2025,,6225351045,7,622535104507,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:58,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,05-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351045,8,622535104508,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,05-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351045,6,622535104506,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,11:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,05-Aug-2025,P1SCR,06-Aug-2025,,6225351045,9,622535104509,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:58,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,05-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351045,10,622535104510,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,10-Sep-2025,P1SCR,11-Sep-2025,,6225351046,1,622535104601,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,13:31,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,10-Sep-2025,P1SCR,11-Sep-2025,11-Sep-2025,6225351046,3,622535104603,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,13:31,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,10-Sep-2025,P1SCR,11-Sep-2025,11-Sep-2025,6225351046,4,622535104604,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,13:31,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,10-Sep-2025,P1SCR,11-Sep-2025,11-Sep-2025,6225351046,5,622535104605,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,13:31,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,10-Sep-2025,P1SCR,11-Sep-2025,11-Sep-2025,6225351046,6,622535104606,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,13:31,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,10-Sep-2025,P1SCR,11-Sep-2025,11-Sep-2025,6225351046,8,622535104608,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,13:31,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,10-Sep-2025,P1SCR,11-Sep-2025,11-Sep-2025,6225351046,2,622535104602,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,13:31,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,10-Sep-2025,P1SCR,11-Sep-2025,,6225351046,9,622535104609,"Red Cells, Clot",Not Received,,,TSH,,,,,,13:31,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,10-Sep-2025,P1SCR,11-Sep-2025,11-Sep-2025,6225351046,10,622535104610,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,13:31,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,10-Sep-2025,P1SCR,11-Sep-2025,,6225351046,7,622535104607,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,13:31,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,02-Jul-2025,P1SCR,03-Jul-2025,03-Jul-2025,6225351047,2,622535104702,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:12,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,02-Jul-2025,P1SCR,03-Jul-2025,03-Jul-2025,6225351047,3,622535104703,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,11:12,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,02-Jul-2025,P1SCR,03-Jul-2025,03-Jul-2025,6225351047,4,622535104704,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:12,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,02-Jul-2025,P1SCR,03-Jul-2025,03-Jul-2025,6225351047,5,622535104705,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:12,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,02-Jul-2025,P1SCR,03-Jul-2025,03-Jul-2025,6225351047,6,622535104706,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,11:12,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,02-Jul-2025,P1SCR,03-Jul-2025,03-Jul-2025,6225351047,8,622535104708,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:12,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,02-Jul-2025,P1SCR,03-Jul-2025,,6225351047,1,622535104701,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:12,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,02-Jul-2025,P1SCR,03-Jul-2025,,6225351047,7,622535104707,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:12,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,02-Jul-2025,P1SCR,03-Jul-2025,,6225351047,9,622535104709,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:12,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,02-Jul-2025,P1SCR,03-Jul-2025,03-Jul-2025,6225351047,10,622535104710,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:12,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,30-Jul-2025,P1DBBL,31-Jul-2025,31-Jul-2025,6225351049,1,622535104901,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:55,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,30-Jul-2025,P1DBBL,31-Jul-2025,,6225351049,2,622535104902,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:55,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,30-Jul-2025,P1DBBL,31-Jul-2025,31-Jul-2025,6225351049,3,622535104903,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:55,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,30-Jul-2025,P1DBBL,31-Jul-2025,,6225351049,4,622535104904,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:55,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,30-Jul-2025,P1DBBL,31-Jul-2025,31-Jul-2025,6225351049,5,622535104905,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:55,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,30-Jul-2025,P1DBBL,31-Jul-2025,31-Jul-2025,6225351049,6,622535104906,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,11:55,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,30-Jul-2025,P1DBBL,31-Jul-2025,31-Jul-2025,6225351049,7,622535104907,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:55,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,08-Oct-2025,P1DBBL,09-Oct-2025,09-Oct-2025,6225351050,1,622535105001,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:19,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,08-Oct-2025,P1DBBL,09-Oct-2025,,6225351050,2,622535105002,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:19,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,08-Oct-2025,P1DBBL,09-Oct-2025,,6225351050,4,622535105004,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:19,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,08-Oct-2025,P1DBBL,09-Oct-2025,09-Oct-2025,6225351050,5,622535105005,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:19,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,08-Oct-2025,P1DBBL,09-Oct-2025,09-Oct-2025,6225351050,6,622535105006,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,11:19,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,08-Oct-2025,P1DBBL,09-Oct-2025,09-Oct-2025,6225351050,3,622535105003,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:19,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,26-Aug-2025,P1DBBL,27-Aug-2025,27-Aug-2025,6225351051,1,622535105101,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:47,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,26-Aug-2025,P1DBBL,27-Aug-2025,,6225351051,2,622535105102,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:47,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,26-Aug-2025,P1DBBL,27-Aug-2025,28-Aug-2025,6225351051,3,622535105103,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:47,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,08-Oct-2025,P1DBBL,09-Oct-2025,09-Oct-2025,6225351050,7,622535105007,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:19,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,26-Aug-2025,P1DBBL,27-Aug-2025,,6225351051,4,622535105104,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:47,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,26-Aug-2025,P1DBBL,27-Aug-2025,27-Aug-2025,6225351051,6,622535105106,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,12:47,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,26-Aug-2025,P1DBBL,27-Aug-2025,27-Aug-2025,6225351051,5,622535105105,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:47,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,26-Aug-2025,P1DBBL,27-Aug-2025,27-Aug-2025,6225351051,7,622535105107,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:47,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,16-Sep-2025,P1DBBL,17-Sep-2025,17-Sep-2025,6225351052,3,622535105203,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,16-Sep-2025,P1DBBL,17-Sep-2025,17-Sep-2025,6225351052,5,622535105205,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,16-Sep-2025,P1DBBL,17-Sep-2025,17-Sep-2025,6225351052,6,622535105206,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,12:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,16-Sep-2025,P1DBBL,17-Sep-2025,,6225351052,2,622535105202,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,16-Sep-2025,P1DBBL,17-Sep-2025,,6225351052,4,622535105204,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,16-Sep-2025,P1DBBL,17-Sep-2025,17-Sep-2025,6225351052,1,622535105201,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,16-Sep-2025,P1DBBL,17-Sep-2025,17-Sep-2025,6225351052,7,622535105207,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,10-Sep-2025,P2OLBL,11-Sep-2025,11-Sep-2025,6225351056,1,622535105601,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,10-Sep-2025,P2OLBL,11-Sep-2025,,6225351056,2,622535105602,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,10-Sep-2025,P2OLBL,11-Sep-2025,11-Sep-2025,6225351056,3,622535105603,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,10-Sep-2025,P2OLBL,11-Sep-2025,,6225351056,4,622535105604,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,10-Sep-2025,P2OLBL,11-Sep-2025,11-Sep-2025,6225351056,5,622535105605,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,10-Sep-2025,P2OLBL,11-Sep-2025,11-Sep-2025,6225351056,6,622535105606,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,10-Sep-2025,P2OLBL,11-Sep-2025,11-Sep-2025,6225351056,7,622535105607,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,10-Sep-2025,P2OLBL,11-Sep-2025,,6225351056,8,622535105608,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,10-Sep-2025,P2OLBL,11-Sep-2025,11-Sep-2025,6225351056,9,622535105609,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Oct-2025,P2OLBL,08-Oct-2025,08-Oct-2025,6225351057,1,622535105701,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:02,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Oct-2025,P2OLBL,08-Oct-2025,,6225351057,2,622535105702,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:02,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Oct-2025,P2OLBL,08-Oct-2025,08-Oct-2025,6225351057,3,622535105703,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:02,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Oct-2025,P2OLBL,08-Oct-2025,,6225351057,4,622535105704,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:02,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Oct-2025,P2OLBL,08-Oct-2025,08-Oct-2025,6225351057,5,622535105705,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:02,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Oct-2025,P2OLBL,08-Oct-2025,08-Oct-2025,6225351057,6,622535105706,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,12:02,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Oct-2025,P2OLBL,08-Oct-2025,08-Oct-2025,6225351057,7,622535105707,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:02,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Oct-2025,P2OLBL,08-Oct-2025,,6225351057,8,622535105708,"Red Cells, Clot",Not Received,,,TSH,,,,,,12:02,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Oct-2025,P2OLBL,08-Oct-2025,08-Oct-2025,6225351057,9,622535105709,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,12:02,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,14-Oct-2025,EW,15-Oct-2025,15-Oct-2025,6225351066,1,622535106601,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,12:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Early Withdrawal,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,14-Oct-2025,EW,15-Oct-2025,15-Oct-2025,6225351066,3,622535106603,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Early Withdrawal,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,14-Oct-2025,EW,15-Oct-2025,,6225351066,4,622535106604,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:30,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Early Withdrawal,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,14-Oct-2025,EW,15-Oct-2025,15-Oct-2025,6225351066,7,622535106607,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Early Withdrawal,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,14-Oct-2025,EW,15-Oct-2025,,6225351066,8,622535106608,"Red Cells, Clot",Not Received,,,TSH,,,,,,12:30,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Early Withdrawal,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,14-Oct-2025,EW,15-Oct-2025,15-Oct-2025,6225351066,9,622535106609,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,12:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Early Withdrawal,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,14-Oct-2025,EW,15-Oct-2025,,6225351066,6,622535106606,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:30,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Early Withdrawal,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,14-Oct-2025,EW,15-Oct-2025,15-Oct-2025,6225351066,5,622535106605,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Early Withdrawal,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,14-Oct-2025,EW,15-Oct-2025,15-Oct-2025,6225351066,2,622535106602,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Early Withdrawal,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,08-Sep-2025,P1SCR,09-Sep-2025,,6225351070,3,622535107003,"Urine, Cargile Preservative UA",Not Received,Ambient,,URINALYSIS,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,08-Sep-2025,P1SCR,09-Sep-2025,09-Sep-2025,6225351070,4,622535107004,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,10:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,08-Sep-2025,P1SCR,09-Sep-2025,,6225351070,2,622535107002,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,08-Sep-2025,P1SCR,09-Sep-2025,,6225351070,5,622535107005,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,08-Sep-2025,P1SCR,09-Sep-2025,,6225351070,6,622535107006,"Plasma, EDTA",Not Received,Frozen,,INSULIN,FROZEN,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,08-Sep-2025,P1SCR,09-Sep-2025,,6225351070,1,622535107001,"Whole Blood, EDTA, Dry",Not Received,Ambient,,HEMATOLOGY,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,08-Sep-2025,P1SCR,09-Sep-2025,,6225351070,9,622535107009,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,08-Sep-2025,P1SCR,09-Sep-2025,,6225351070,8,622535107008,"Serum, SST",Not Received,Ambient,,TSH,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,08-Sep-2025,P1SCR,09-Sep-2025,,6225351070,7,622535107007,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,08-Sep-2025,P1SCR,09-Sep-2025,,6225351070,10,622535107010,"Serum, SST",Not Received,Ambient,,CHEMISTRY,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351072,2,622535107202,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351072,3,622535107203,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351072,4,622535107204,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351072,5,622535107205,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351072,6,622535107206,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Aug-2025,P1SCR,07-Aug-2025,,6225351072,7,622535107207,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:40,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Aug-2025,P1SCR,07-Aug-2025,,6225351072,1,622535107201,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:40,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351072,10,622535107210,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Aug-2025,P1SCR,07-Aug-2025,,6225351072,9,622535107209,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:40,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351072,8,622535107208,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110005,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351074,2,622535107402,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110005,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351074,3,622535107403,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110005,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351074,4,622535107404,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110005,03-Nov-2025,P1SCR,04-Nov-2025,,6225351074,1,622535107401,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:40,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110005,03-Nov-2025,P1SCR,04-Nov-2025,,6225351074,7,622535107407,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:40,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110005,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351074,10,622535107410,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110005,03-Nov-2025,P1SCR,04-Nov-2025,,6225351074,9,622535107409,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:40,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110005,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351074,6,622535107406,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110005,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351074,5,622535107405,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,03-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351076,2,622535107602,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,03-Aug-2025,P1SCR,06-Aug-2025,,6225351076,1,622535107601,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:05,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110005,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351074,8,622535107408,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,03-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351076,3,622535107603,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,03-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351076,5,622535107605,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,03-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351076,6,622535107606,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,03-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351076,4,622535107604,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,03-Aug-2025,P1SCR,06-Aug-2025,,6225351076,7,622535107607,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:05,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,03-Aug-2025,P1SCR,06-Aug-2025,,6225351076,9,622535107609,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:05,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,03-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351076,10,622535107610,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,03-Aug-2025,P1SCR,06-Aug-2025,07-Aug-2025,6225351076,8,622535107608,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110004,03-Oct-2025,P1SCR,04-Oct-2025,04-Oct-2025,6225351077,3,622535107703,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:33,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110004,03-Oct-2025,P1SCR,04-Oct-2025,,6225351077,1,622535107701,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:33,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110004,03-Oct-2025,P1SCR,04-Oct-2025,04-Oct-2025,6225351077,4,622535107704,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:33,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110004,03-Oct-2025,P1SCR,04-Oct-2025,04-Oct-2025,6225351077,5,622535107705,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:33,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110004,03-Oct-2025,P1SCR,04-Oct-2025,04-Oct-2025,6225351077,6,622535107706,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:33,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110004,03-Oct-2025,P1SCR,04-Oct-2025,,6225351077,7,622535107707,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:33,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110004,03-Oct-2025,P1SCR,04-Oct-2025,04-Oct-2025,6225351077,8,622535107708,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:33,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110004,03-Oct-2025,P1SCR,04-Oct-2025,,6225351077,9,622535107709,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:33,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110004,03-Oct-2025,P1SCR,04-Oct-2025,04-Oct-2025,6225351077,10,622535107710,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:33,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110004,03-Oct-2025,P1SCR,04-Oct-2025,04-Oct-2025,6225351077,2,622535107702,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:33,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,14-Nov-2025,P1SCR,15-Nov-2025,15-Nov-2025,6225351078,5,622535107805,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,14-Nov-2025,P1SCR,15-Nov-2025,15-Nov-2025,6225351078,6,622535107806,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,10:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,14-Nov-2025,P1SCR,15-Nov-2025,,6225351078,7,622535107807,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:22,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,14-Nov-2025,P1SCR,15-Nov-2025,15-Nov-2025,6225351078,8,622535107808,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,14-Nov-2025,P1SCR,15-Nov-2025,,6225351078,9,622535107809,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:22,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,14-Nov-2025,P1SCR,15-Nov-2025,15-Nov-2025,6225351078,4,622535107804,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,14-Nov-2025,P1SCR,15-Nov-2025,15-Nov-2025,6225351078,3,622535107803,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,10:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,14-Nov-2025,P1SCR,15-Nov-2025,15-Nov-2025,6225351078,2,622535107802,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,14-Nov-2025,P1SCR,15-Nov-2025,,6225351078,1,622535107801,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:22,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,14-Nov-2025,P1SCR,15-Nov-2025,15-Nov-2025,6225351078,10,622535107810,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,04-Nov-2025,P1SCR,05-Nov-2025,,6225351080,1,622535108001,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,07:03,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,04-Nov-2025,P1SCR,05-Nov-2025,05-Nov-2025,6225351080,2,622535108002,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,07:03,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,04-Nov-2025,P1SCR,05-Nov-2025,,6225351080,7,622535108007,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,07:03,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,04-Nov-2025,P1SCR,05-Nov-2025,06-Nov-2025,6225351080,8,622535108008,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,07:03,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,04-Nov-2025,P1SCR,05-Nov-2025,,6225351080,9,622535108009,"Red Cells, Clot",Not Received,,,TSH,,,,,,07:03,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,04-Nov-2025,P1SCR,05-Nov-2025,05-Nov-2025,6225351080,3,622535108003,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,07:03,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,04-Nov-2025,P1SCR,05-Nov-2025,05-Nov-2025,6225351080,10,622535108010,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,07:03,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,26-Sep-2025,P1SCR,27-Sep-2025,,6225351081,1,622535108101,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:10,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,26-Sep-2025,P1SCR,27-Sep-2025,27-Sep-2025,6225351081,3,622535108103,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,04-Nov-2025,P1SCR,05-Nov-2025,05-Nov-2025,6225351080,4,622535108004,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:03,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,26-Sep-2025,P1SCR,27-Sep-2025,27-Sep-2025,6225351081,4,622535108104,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,26-Sep-2025,P1SCR,27-Sep-2025,27-Sep-2025,6225351081,2,622535108102,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,26-Sep-2025,P1SCR,27-Sep-2025,27-Sep-2025,6225351081,5,622535108105,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,04-Nov-2025,P1SCR,05-Nov-2025,05-Nov-2025,6225351080,5,622535108005,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,07:03,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,04-Nov-2025,P1SCR,05-Nov-2025,05-Nov-2025,6225351080,6,622535108006,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,07:03,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,26-Sep-2025,P1SCR,27-Sep-2025,27-Sep-2025,6225351081,8,622535108108,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,26-Sep-2025,P1SCR,27-Sep-2025,27-Sep-2025,6225351081,10,622535108110,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,26-Sep-2025,P1SCR,27-Sep-2025,,6225351081,9,622535108109,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:10,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,28-Aug-2025,P1DBBL,29-Aug-2025,,6225351082,2,622535108202,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,26-Sep-2025,P1SCR,27-Sep-2025,,6225351081,7,622535108107,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:10,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,28-Aug-2025,P1DBBL,29-Aug-2025,29-Aug-2025,6225351082,3,622535108203,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,28-Aug-2025,P1DBBL,29-Aug-2025,,6225351082,4,622535108204,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,26-Sep-2025,P1SCR,27-Sep-2025,27-Sep-2025,6225351081,6,622535108106,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,28-Aug-2025,P1DBBL,29-Aug-2025,29-Aug-2025,6225351082,5,622535108205,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,28-Aug-2025,P1DBBL,29-Aug-2025,29-Aug-2025,6225351082,6,622535108206,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,11:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,28-Aug-2025,P1DBBL,29-Aug-2025,29-Aug-2025,6225351083,1,622535108301,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,07:07,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,28-Aug-2025,P1DBBL,29-Aug-2025,,6225351083,2,622535108302,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,07:07,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,28-Aug-2025,P1DBBL,29-Aug-2025,29-Aug-2025,6225351083,3,622535108303,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,07:07,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,28-Aug-2025,P1DBBL,29-Aug-2025,,6225351083,4,622535108304,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,07:07,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,28-Aug-2025,P1DBBL,29-Aug-2025,29-Aug-2025,6225351083,5,622535108305,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,07:07,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,28-Aug-2025,P1DBBL,29-Aug-2025,29-Aug-2025,6225351082,1,622535108201,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,28-Aug-2025,P1DBBL,29-Aug-2025,29-Aug-2025,6225351083,6,622535108306,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,07:07,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,28-Aug-2025,P1DBBL,29-Aug-2025,29-Aug-2025,6225351082,7,622535108207,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,28-Aug-2025,P1DBBL,29-Aug-2025,29-Aug-2025,6225351083,7,622535108307,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:07,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,22-Oct-2025,P1DBBL,23-Oct-2025,23-Oct-2025,6225351084,1,622535108401,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,22-Oct-2025,P1DBBL,23-Oct-2025,,6225351084,4,622535108404,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,22-Oct-2025,P1DBBL,23-Oct-2025,23-Oct-2025,6225351084,3,622535108403,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,22-Oct-2025,P1DBBL,23-Oct-2025,23-Oct-2025,6225351084,5,622535108405,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,22-Oct-2025,P1DBBL,23-Oct-2025,,6225351084,2,622535108402,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,22-Oct-2025,P1DBBL,23-Oct-2025,23-Oct-2025,6225351084,7,622535108407,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,22-Oct-2025,P1DBBL,23-Oct-2025,23-Oct-2025,6225351084,6,622535108406,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,08:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,05-Dec-2025,EOT,06-Dec-2025,06-Dec-2025,6225351093,2,622535109302,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:23,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,05-Dec-2025,EOT,06-Dec-2025,06-Dec-2025,6225351093,1,622535109301,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:23,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,05-Dec-2025,EOT,06-Dec-2025,06-Dec-2025,6225351093,3,622535109303,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:23,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,05-Dec-2025,EOT,06-Dec-2025,06-Dec-2025,6225351093,5,622535109305,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:23,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,05-Dec-2025,EOT,06-Dec-2025,,6225351093,4,622535109304,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:23,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,05-Dec-2025,EOT,06-Dec-2025,,6225351093,6,622535109306,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:23,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,05-Dec-2025,EOT,06-Dec-2025,06-Dec-2025,6225351093,7,622535109307,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:23,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,05-Dec-2025,EOT,06-Dec-2025,,6225351093,8,622535109308,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:23,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,05-Dec-2025,EOT,06-Dec-2025,06-Dec-2025,6225351093,9,622535109309,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:23,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,08-Oct-2025,EOT,09-Oct-2025,09-Oct-2025,6225351094,1,622535109401,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,08-Oct-2025,EOT,09-Oct-2025,09-Oct-2025,6225351094,3,622535109403,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,08-Oct-2025,EOT,09-Oct-2025,09-Oct-2025,6225351094,2,622535109402,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,08-Oct-2025,EOT,09-Oct-2025,,6225351094,4,622535109404,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:16,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,08-Oct-2025,EOT,09-Oct-2025,09-Oct-2025,6225351094,5,622535109405,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,08-Oct-2025,EOT,09-Oct-2025,,6225351094,6,622535109406,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:16,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,08-Oct-2025,EOT,09-Oct-2025,09-Oct-2025,6225351094,7,622535109407,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,08-Oct-2025,EOT,09-Oct-2025,,6225351094,8,622535109408,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:16,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,09-Oct-2025,EOT,10-Oct-2025,10-Oct-2025,6225351095,1,622535109501,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,09-Oct-2025,EOT,10-Oct-2025,10-Oct-2025,6225351095,2,622535109502,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,09-Oct-2025,EOT,10-Oct-2025,10-Oct-2025,6225351095,3,622535109503,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,09-Oct-2025,EOT,10-Oct-2025,10-Oct-2025,6225351095,5,622535109505,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,09-Oct-2025,EOT,10-Oct-2025,10-Oct-2025,6225351095,7,622535109507,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,09-Oct-2025,EOT,10-Oct-2025,,6225351095,8,622535109508,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,09-Oct-2025,EOT,10-Oct-2025,,6225351095,4,622535109504,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,09-Oct-2025,EOT,10-Oct-2025,,6225351095,6,622535109506,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,08-Oct-2025,EOT,09-Oct-2025,09-Oct-2025,6225351094,9,622535109409,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,08:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,09-Oct-2025,EOT,10-Oct-2025,10-Oct-2025,6225351095,9,622535109509,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120001,06-Aug-2025,P1SCR,07-Aug-2025,,6225351106,1,622535110601,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,13:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120001,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351106,2,622535110602,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,13:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120001,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351106,4,622535110604,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,13:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120001,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351106,5,622535110605,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,13:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120001,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351106,3,622535110603,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,13:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120001,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351106,6,622535110606,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,13:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120001,06-Aug-2025,P1SCR,07-Aug-2025,,6225351106,7,622535110607,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,13:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120001,06-Aug-2025,P1SCR,07-Aug-2025,08-Aug-2025,6225351106,8,622535110608,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,13:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120001,06-Aug-2025,P1SCR,07-Aug-2025,,6225351106,9,622535110609,"Red Cells, Clot",Not Received,,,TSH,,,,,,13:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120001,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351106,10,622535110610,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,13:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120002,03-Sep-2025,P1SCR,04-Sep-2025,,6225351109,1,622535110901,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,13:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120002,03-Sep-2025,P1SCR,04-Sep-2025,04-Sep-2025,6225351109,4,622535110904,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120002,03-Sep-2025,P1SCR,04-Sep-2025,04-Sep-2025,6225351109,5,622535110905,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120002,03-Sep-2025,P1SCR,04-Sep-2025,04-Sep-2025,6225351109,6,622535110906,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120002,03-Sep-2025,P1SCR,04-Sep-2025,,6225351109,7,622535110907,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,13:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120002,03-Sep-2025,P1SCR,04-Sep-2025,05-Sep-2025,6225351109,8,622535110908,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120002,03-Sep-2025,P1SCR,04-Sep-2025,04-Sep-2025,6225351109,2,622535110902,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120002,03-Sep-2025,P1SCR,04-Sep-2025,,6225351109,9,622535110909,"Red Cells, Clot",Not Received,,,TSH,,,,,,13:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120002,03-Sep-2025,P1SCR,04-Sep-2025,04-Sep-2025,6225351109,10,622535110910,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120003,01-Oct-2025,P1SCR,02-Oct-2025,,6225351110,1,622535111001,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120003,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351110,2,622535111002,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120003,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351110,3,622535111003,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,11:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120003,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351110,4,622535111004,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120003,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351110,5,622535111005,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120003,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351110,6,622535111006,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,11:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120003,01-Oct-2025,P1SCR,02-Oct-2025,,6225351110,7,622535111007,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120002,03-Sep-2025,P1SCR,04-Sep-2025,04-Sep-2025,6225351109,3,622535110903,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120003,01-Oct-2025,P1SCR,02-Oct-2025,,6225351110,9,622535111009,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120003,01-Oct-2025,P1SCR,02-Oct-2025,03-Oct-2025,6225351110,8,622535111008,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120003,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351110,10,622535111010,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,01-Oct-2025,P1SCR,02-Oct-2025,,6225351111,1,622535111101,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,13:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351111,2,622535111102,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351111,3,622535111103,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351111,4,622535111104,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351111,5,622535111105,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351111,6,622535111106,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,01-Oct-2025,P1SCR,02-Oct-2025,03-Oct-2025,6225351111,8,622535111108,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,01-Oct-2025,P1SCR,02-Oct-2025,,6225351111,9,622535111109,"Red Cells, Clot",Not Received,,,TSH,,,,,,13:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,01-Oct-2025,P1SCR,02-Oct-2025,,6225351111,7,622535111107,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,13:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351111,10,622535111110,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,22-Oct-2025,P1DBBL,23-Oct-2025,23-Oct-2025,6225351120,1,622535112001,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,22-Oct-2025,P1DBBL,23-Oct-2025,,6225351120,2,622535112002,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,22-Oct-2025,P1DBBL,23-Oct-2025,24-Oct-2025,6225351120,3,622535112003,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,22-Oct-2025,P1DBBL,23-Oct-2025,,6225351120,4,622535112004,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,22-Oct-2025,P1DBBL,23-Oct-2025,23-Oct-2025,6225351120,5,622535112005,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,22-Oct-2025,P1DBBL,23-Oct-2025,23-Oct-2025,6225351120,6,622535112006,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,12:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,22-Oct-2025,P1DBBL,23-Oct-2025,23-Oct-2025,6225351120,7,622535112007,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,05-Dec-2025,EOT,06-Dec-2025,06-Dec-2025,6225351126,2,622535112602,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,15:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,05-Dec-2025,EOT,06-Dec-2025,06-Dec-2025,6225351126,1,622535112601,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,15:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,05-Dec-2025,EOT,06-Dec-2025,06-Dec-2025,6225351126,3,622535112603,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,15:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,05-Dec-2025,EOT,06-Dec-2025,,6225351126,4,622535112604,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,15:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,05-Dec-2025,EOT,06-Dec-2025,10-Dec-2025,6225351126,5,622535112605,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,15:00,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,05-Dec-2025,EOT,06-Dec-2025,,6225351126,6,622535112606,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,15:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,05-Dec-2025,EOT,06-Dec-2025,,6225351126,8,622535112608,"Red Cells, Clot",Not Received,,,TSH,,,,,,15:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,05-Dec-2025,EOT,06-Dec-2025,06-Dec-2025,6225351126,7,622535112607,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,15:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,05-Dec-2025,EOT,06-Dec-2025,06-Dec-2025,6225351126,9,622535112609,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,15:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,01-Apr-2026,P2OLD29,02-Apr-2026,,6226313625,2,622631362502,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,01-Apr-2026,P2OLD29,02-Apr-2026,02-Apr-2026,6226313625,1,622631362501,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,01-Apr-2026,P2OLD29,02-Apr-2026,02-Apr-2026,6226313625,3,622631362503,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,01-Apr-2026,P2OLD29,02-Apr-2026,02-Apr-2026,6226313625,5,622631362505,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,01-Apr-2026,P2OLD29,02-Apr-2026,,6226313625,4,622631362504,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,01-Apr-2026,P2OLD29,02-Apr-2026,02-Apr-2026,6226313625,6,622631362506,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,01-Apr-2026,P2OLD29,02-Apr-2026,02-Apr-2026,6226313625,7,622631362507,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Feb-2026,P2OLD29,17-Feb-2026,,6226550646,2,622655064602,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:18,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Feb-2026,P2OLD29,17-Feb-2026,17-Feb-2026,6226550646,1,622655064601,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:18,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Feb-2026,P2OLD29,17-Feb-2026,17-Feb-2026,6226550646,7,622655064607,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:18,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Feb-2026,P2OLD29,17-Feb-2026,17-Feb-2026,6226550646,5,622655064605,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:18,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Feb-2026,P2OLD29,17-Feb-2026,,6226550646,4,622655064604,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:18,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Feb-2026,P2OLD29,17-Feb-2026,17-Feb-2026,6226550646,6,622655064606,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,09:18,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Feb-2026,P2OLD29,17-Feb-2026,17-Feb-2026,6226550646,3,622655064603,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:18,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,21-Jan-2026,P1DBBL,22-Jan-2026,,6226551697,4,622655169704,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:23,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,21-Jan-2026,P1DBBL,22-Jan-2026,22-Jan-2026,6226551697,5,622655169705,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:23,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,21-Jan-2026,P1DBBL,22-Jan-2026,22-Jan-2026,6226551697,1,622655169701,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:23,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,21-Jan-2026,P1DBBL,22-Jan-2026,22-Jan-2026,6226551697,6,622655169706,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,11:23,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,21-Jan-2026,P1DBBL,22-Jan-2026,22-Jan-2026,6226551697,7,622655169707,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:23,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,29-Oct-2025,P1DBBL,30-Oct-2025,30-Oct-2025,6226551698,1,622655169801,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,21-Jan-2026,P1DBBL,22-Jan-2026,22-Jan-2026,6226551697,3,622655169703,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:23,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,29-Oct-2025,P1DBBL,30-Oct-2025,,6226551698,4,622655169804,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,21-Jan-2026,P1DBBL,22-Jan-2026,,6226551697,2,622655169702,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:23,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,29-Oct-2025,P1DBBL,30-Oct-2025,,6226551698,2,622655169802,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,29-Oct-2025,P1DBBL,30-Oct-2025,30-Oct-2025,6226551698,6,622655169806,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,10:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,29-Oct-2025,P1DBBL,30-Oct-2025,30-Oct-2025,6226551698,3,622655169803,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,29-Oct-2025,P1DBBL,30-Oct-2025,30-Oct-2025,6226551698,5,622655169805,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,29-Oct-2025,P1DBBL,30-Oct-2025,30-Oct-2025,6226551698,7,622655169807,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,23-Apr-2026,P2OLD29,25-Apr-2026,,6226560887,4,622656088704,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,16:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,23-Apr-2026,P2OLD29,25-Apr-2026,20-May-2026,6226560887,3,622656088703,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,16:00,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,23-Apr-2026,P2OLD29,25-Apr-2026,,6226560887,2,622656088702,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,16:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,23-Apr-2026,P2OLD29,25-Apr-2026,25-Apr-2026,6226560887,1,622656088701,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,16:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,23-Apr-2026,P2OLD29,25-Apr-2026,25-Apr-2026,6226560887,5,622656088705,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,16:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,23-Apr-2026,P2OLD29,25-Apr-2026,25-Apr-2026,6226560887,6,622656088706,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,16:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,25-Mar-2026,EOT,26-Mar-2026,26-Mar-2026,6226560888,1,622656088801,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,17:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,23-Apr-2026,P2OLD29,25-Apr-2026,25-Apr-2026,6226560887,7,622656088707,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,16:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,25-Mar-2026,EOT,26-Mar-2026,26-Mar-2026,6226560888,3,622656088803,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,17:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,25-Mar-2026,EOT,26-Mar-2026,26-Mar-2026,6226560888,7,622656088807,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,17:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,25-Mar-2026,EOT,26-Mar-2026,26-Mar-2026,6226560888,9,622656088809,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,17:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,25-Mar-2026,EOT,26-Mar-2026,20-May-2026,6226560888,5,622656088805,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,17:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,25-Mar-2026,EOT,26-Mar-2026,,6226560888,4,622656088804,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,17:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,25-Mar-2026,EOT,26-Mar-2026,,6226560888,8,622656088808,"Red Cells, Clot",Not Received,,,TSH,,,,,,17:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,25-Mar-2026,EOT,26-Mar-2026,26-Mar-2026,6226560888,2,622656088802,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,17:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,25-Mar-2026,EOT,26-Mar-2026,,6226560888,6,622656088806,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,17:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,06-Mar-2026,P2DBW25,07-Mar-2026,07-Mar-2026,6226560891,2,622656089102,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,14:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 DB Every 12 Weeks,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,06-Mar-2026,P2DBW25,07-Mar-2026,07-Mar-2026,6226560891,3,622656089103,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,14:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 DB Every 12 Weeks,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,06-Mar-2026,P2DBW25,07-Mar-2026,07-Mar-2026,6226560891,1,622656089101,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,14:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 DB Every 12 Weeks,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,06-Mar-2026,P2DBW25,07-Mar-2026,,6226560891,4,622656089104,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,14:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 DB Every 12 Weeks,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,06-Mar-2026,P2DBW25,07-Mar-2026,,6226560891,6,622656089106,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,14:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 DB Every 12 Weeks,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,06-Mar-2026,P2DBW25,07-Mar-2026,,6226560891,8,622656089108,"Red Cells, Clot",Not Received,,,TSH,,,,,,14:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 DB Every 12 Weeks,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,06-Mar-2026,P2DBW25,07-Mar-2026,20-May-2026,6226560891,5,622656089105,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,14:00,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 DB Every 12 Weeks,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,06-Mar-2026,P2DBW25,07-Mar-2026,07-Mar-2026,6226560891,7,622656089107,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,14:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 DB Every 12 Weeks,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,06-Mar-2026,P2DBW25,07-Mar-2026,07-Mar-2026,6226560891,9,622656089109,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,14:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 DB Every 12 Weeks,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,03-Feb-2026,P2OLD29,04-Feb-2026,17-Feb-2026,6226561517,3,622656151703,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:23,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,03-Feb-2026,P2OLD29,04-Feb-2026,,6226561517,4,622656151704,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:23,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,03-Feb-2026,P2OLD29,04-Feb-2026,04-Feb-2026,6226561517,5,622656151705,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:23,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,03-Feb-2026,P2OLD29,04-Feb-2026,,6226561517,2,622656151702,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:23,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,03-Feb-2026,P2OLD29,04-Feb-2026,04-Feb-2026,6226561517,1,622656151701,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:23,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,03-Feb-2026,P2OLD29,04-Feb-2026,04-Feb-2026,6226561517,6,622656151706,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,10:23,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,03-Feb-2026,P2OLD29,04-Feb-2026,04-Feb-2026,6226561517,7,622656151707,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:23,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,08-Oct-2025,P2OLD29,09-Oct-2025,09-Oct-2025,6226686952,1,622668695201,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:20,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,08-Oct-2025,P2OLD29,09-Oct-2025,,6226686952,2,622668695202,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:20,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,08-Oct-2025,P2OLD29,09-Oct-2025,09-Oct-2025,6226686952,3,622668695203,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:20,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,08-Oct-2025,P2OLD29,09-Oct-2025,,6226686952,4,622668695204,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:20,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,08-Oct-2025,P2OLD29,09-Oct-2025,09-Oct-2025,6226686952,5,622668695205,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:20,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,08-Oct-2025,P2OLD29,09-Oct-2025,09-Oct-2025,6226686952,6,622668695206,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,09:20,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,08-Oct-2025,P2OLD29,09-Oct-2025,09-Oct-2025,6226686952,7,622668695207,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:20,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,13-Jan-2026,P2DBBL,14-Jan-2026,14-Jan-2026,6226686953,1,622668695301,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,13:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,13-Jan-2026,P2DBBL,14-Jan-2026,14-Jan-2026,6226686953,2,622668695302,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,13:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,13-Jan-2026,P2DBBL,14-Jan-2026,14-Jan-2026,6226686953,3,622668695303,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,13:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,13-Jan-2026,P2DBBL,14-Jan-2026,,6226686953,4,622668695304,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,13:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,13-Jan-2026,P2DBBL,14-Jan-2026,14-Jan-2026,6226686953,5,622668695305,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,13:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,13-Jan-2026,P2DBBL,14-Jan-2026,,6226686953,6,622668695306,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,13:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Apr-2026,P2DBW13,08-Apr-2026,08-Apr-2026,6226686954,7,622668695407,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:01,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,13-Jan-2026,P2DBBL,14-Jan-2026,,6226686953,8,622668695308,"Red Cells, Clot",Not Received,,,TSH,,,,,,13:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,13-Jan-2026,P2DBBL,14-Jan-2026,14-Jan-2026,6226686953,9,622668695309,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,13:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,13-Jan-2026,P2DBBL,14-Jan-2026,14-Jan-2026,6226686953,7,622668695307,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,13:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Apr-2026,P2DBW13,08-Apr-2026,08-Apr-2026,6226686954,1,622668695401,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:01,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Apr-2026,P2DBW13,08-Apr-2026,08-Apr-2026,6226686954,3,622668695403,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:01,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Apr-2026,P2DBW13,08-Apr-2026,,6226686954,4,622668695404,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:01,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Apr-2026,P2DBW13,08-Apr-2026,08-Apr-2026,6226686954,5,622668695405,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:01,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Apr-2026,P2DBW13,08-Apr-2026,08-Apr-2026,6226686954,6,622668695406,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,12:01,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Apr-2026,P2DBW13,08-Apr-2026,,6226686954,2,622668695402,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:01,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,22-Apr-2026,P2OLD29,23-Apr-2026,23-Apr-2026,6226752554,6,622675255406,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,15:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,25-Mar-2026,EOT,26-Mar-2026,26-Mar-2026,6226752555,2,622675255502,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,15:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,22-Apr-2026,P2OLD29,23-Apr-2026,23-Apr-2026,6226752554,5,622675255405,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,15:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,25-Mar-2026,EOT,26-Mar-2026,26-Mar-2026,6226752555,3,622675255503,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,15:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,22-Apr-2026,P2OLD29,23-Apr-2026,,6226752554,4,622675255404,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,15:30,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,22-Apr-2026,P2OLD29,23-Apr-2026,23-Apr-2026,6226752554,7,622675255407,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,15:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,25-Mar-2026,EOT,26-Mar-2026,,6226752555,4,622675255504,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,15:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,25-Mar-2026,EOT,26-Mar-2026,20-May-2026,6226752555,5,622675255505,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,15:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,22-Apr-2026,P2OLD29,23-Apr-2026,,6226752554,2,622675255402,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,15:30,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,22-Apr-2026,P2OLD29,23-Apr-2026,23-Apr-2026,6226752554,3,622675255403,"Plasma, EDTA",Received,Frozen,Default Return Ambient,INSULIN,FROZEN,,,,,15:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,22-Apr-2026,P2OLD29,23-Apr-2026,23-Apr-2026,6226752554,1,622675255401,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,15:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,25-Mar-2026,EOT,26-Mar-2026,26-Mar-2026,6226752555,1,622675255501,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,15:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,25-Mar-2026,EOT,26-Mar-2026,26-Mar-2026,6226752555,7,622675255507,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,15:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,25-Mar-2026,EOT,26-Mar-2026,,6226752555,8,622675255508,"Red Cells, Clot",Not Received,,,TSH,,,,,,15:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,25-Mar-2026,EOT,26-Mar-2026,26-Mar-2026,6226752555,9,622675255509,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,15:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,25-Mar-2026,EOT,26-Mar-2026,,6226752555,6,622675255506,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,15:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,05-Nov-2025,EOT,06-Nov-2025,06-Nov-2025,6226780853,1,622678085301,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,05-Nov-2025,EOT,06-Nov-2025,06-Nov-2025,6226780853,5,622678085305,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,05-Nov-2025,EOT,06-Nov-2025,06-Nov-2025,6226780853,2,622678085302,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,05-Nov-2025,EOT,06-Nov-2025,06-Nov-2025,6226780853,3,622678085303,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,05-Nov-2025,EOT,06-Nov-2025,,6226780853,4,622678085304,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,05-Nov-2025,EOT,06-Nov-2025,,6226780853,8,622678085308,"Red Cells, Clot",Not Received,,,TSH,,,,,,12:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,05-Nov-2025,EOT,06-Nov-2025,06-Nov-2025,6226780853,9,622678085309,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,05-Nov-2025,EOT,06-Nov-2025,,6226780853,6,622678085306,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,05-Nov-2025,EOT,06-Nov-2025,06-Nov-2025,6226780853,7,622678085307,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,09-Dec-2025,EOT,10-Dec-2025,10-Dec-2025,6226780855,1,622678085501,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,09-Dec-2025,EOT,10-Dec-2025,10-Dec-2025,6226780855,2,622678085502,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,09-Dec-2025,EOT,10-Dec-2025,,6226780855,4,622678085504,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,09-Dec-2025,EOT,10-Dec-2025,10-Dec-2025,6226780855,5,622678085505,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,09-Dec-2025,EOT,10-Dec-2025,,6226780855,6,622678085506,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,09-Dec-2025,EOT,10-Dec-2025,10-Dec-2025,6226780855,7,622678085507,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,09-Dec-2025,EOT,10-Dec-2025,,6226780855,8,622678085508,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,09-Dec-2025,EOT,10-Dec-2025,10-Dec-2025,6226780855,9,622678085509,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,09-Dec-2025,EOT,10-Dec-2025,10-Dec-2025,6226780855,3,622678085503,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,18-Nov-2025,EOT,19-Nov-2025,19-Nov-2025,6226780856,1,622678085601,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,11:06,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,18-Nov-2025,EOT,19-Nov-2025,19-Nov-2025,6226780856,2,622678085602,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:06,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,18-Nov-2025,EOT,19-Nov-2025,19-Nov-2025,6226780856,3,622678085603,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:06,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,18-Nov-2025,EOT,19-Nov-2025,,6226780856,4,622678085604,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:06,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,18-Nov-2025,EOT,19-Nov-2025,,6226780856,6,622678085606,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:06,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,18-Nov-2025,EOT,19-Nov-2025,19-Nov-2025,6226780856,7,622678085607,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:06,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,18-Nov-2025,EOT,19-Nov-2025,,6226780856,8,622678085608,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:06,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,18-Nov-2025,EOT,19-Nov-2025,19-Nov-2025,6226780856,9,622678085609,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:06,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,14-Jan-2026,EOT,15-Jan-2026,15-Jan-2026,6226780857,3,622678085703,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:18,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,14-Jan-2026,EOT,15-Jan-2026,,6226780857,6,622678085706,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:18,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,14-Jan-2026,EOT,15-Jan-2026,15-Jan-2026,6226780857,5,622678085705,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:18,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,14-Jan-2026,EOT,15-Jan-2026,15-Jan-2026,6226780857,7,622678085707,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:18,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,14-Jan-2026,EOT,15-Jan-2026,,6226780857,8,622678085708,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:18,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,14-Jan-2026,EOT,15-Jan-2026,15-Jan-2026,6226780857,9,622678085709,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:18,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,14-Jan-2026,EOT,15-Jan-2026,15-Jan-2026,6226780857,1,622678085701,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,11:18,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,14-Jan-2026,EOT,15-Jan-2026,,6226780857,4,622678085704,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:18,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,14-Jan-2026,EOT,15-Jan-2026,15-Jan-2026,6226780857,2,622678085702,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:18,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,18-Nov-2025,EOT,19-Nov-2025,19-Nov-2025,6226780856,5,622678085605,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:06,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,18-Feb-2026,P1DBBL,19-Feb-2026,,6226785739,3,622678573903,"Urine, Cargile Preservative UA",Not Received,Ambient,,URINALYSIS,,,,,,10:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,18-Feb-2026,P1DBBL,19-Feb-2026,,6226785739,2,622678573902,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,10:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,18-Feb-2026,P1DBBL,19-Feb-2026,,6226785739,4,622678573904,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,10:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,18-Feb-2026,P1DBBL,19-Feb-2026,,6226785739,7,622678573907,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,18-Feb-2026,P1DBBL,19-Feb-2026,,6226785739,9,622678573909,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,18-Feb-2026,P1DBBL,19-Feb-2026,,6226785739,5,622678573905,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,18-Feb-2026,P1DBBL,19-Feb-2026,,6226785739,6,622678573906,"Plasma, EDTA",Not Received,Frozen,,INSULIN,FROZEN,,,,,10:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,18-Feb-2026,P1DBBL,19-Feb-2026,,6226785739,8,622678573908,"Serum, SST",Not Received,Ambient,,TSH,,,,,,10:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,18-Feb-2026,P1DBBL,19-Feb-2026,,6226785739,1,622678573901,"Whole Blood, EDTA, Dry",Not Received,Ambient,,HEMATOLOGY,,,,,,10:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,18-Feb-2026,P1DBBL,19-Feb-2026,19-Feb-2026,6226785739,10,622678573910,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,15-Dec-2025,P1SCR,16-Dec-2025,,6226785740,1,622678574001,"Whole Blood, EDTA, Dry",Not Received,Ambient,,HEMATOLOGY,,,,,,10:53,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,15-Dec-2025,P1SCR,16-Dec-2025,,6226785740,7,622678574007,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:53,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,15-Dec-2025,P1SCR,16-Dec-2025,,6226785740,5,622678574005,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:53,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,15-Dec-2025,P1SCR,16-Dec-2025,16-Dec-2025,6226785740,8,622678574008,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:53,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,15-Dec-2025,P1SCR,16-Dec-2025,,6226785740,2,622678574002,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,10:53,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,15-Dec-2025,P1SCR,16-Dec-2025,,6226785740,6,622678574006,"Plasma, EDTA",Not Received,Frozen,,INSULIN,FROZEN,,,,,10:53,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,15-Dec-2025,P1SCR,16-Dec-2025,,6226785740,3,622678574003,"Urine, Cargile Preservative UA",Not Received,Ambient,,URINALYSIS,,,,,,10:53,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,15-Dec-2025,P1SCR,16-Dec-2025,,6226785740,4,622678574004,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,10:53,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,15-Dec-2025,P1SCR,16-Dec-2025,,6226785740,9,622678574009,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:53,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,15-Dec-2025,P1SCR,16-Dec-2025,16-Dec-2025,6226785740,10,622678574010,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:53,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,04-Nov-2025,P2OLD29,05-Nov-2025,,6226804961,2,622680496102,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:05,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,04-Nov-2025,P2OLD29,05-Nov-2025,,6226804961,4,622680496104,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:05,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,04-Nov-2025,P2OLD29,05-Nov-2025,05-Nov-2025,6226804961,3,622680496103,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,10-Mar-2026,P2DBBL,11-Mar-2026,11-Mar-2026,6226804962,5,622680496205,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,10-Mar-2026,P2DBBL,11-Mar-2026,11-Mar-2026,6226804962,7,622680496207,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,10-Mar-2026,P2DBBL,11-Mar-2026,11-Mar-2026,6226804962,9,622680496209,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,04-Nov-2025,P2OLD29,05-Nov-2025,05-Nov-2025,6226804961,6,622680496106,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,12:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,04-Nov-2025,P2OLD29,05-Nov-2025,05-Nov-2025,6226804961,5,622680496105,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,10-Mar-2026,P2DBBL,11-Mar-2026,11-Mar-2026,6226804962,3,622680496203,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,04-Nov-2025,P2OLD29,05-Nov-2025,05-Nov-2025,6226804961,1,622680496101,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,10-Mar-2026,P2DBBL,11-Mar-2026,,6226804962,4,622680496204,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,10-Mar-2026,P2DBBL,11-Mar-2026,,6226804962,8,622680496208,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,04-Nov-2025,P2OLD29,05-Nov-2025,05-Nov-2025,6226804961,7,622680496107,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,10-Mar-2026,P2DBBL,11-Mar-2026,,6226804962,6,622680496206,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,10-Mar-2026,P2DBBL,11-Mar-2026,11-Mar-2026,6226804962,2,622680496202,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,10-Mar-2026,P2DBBL,11-Mar-2026,11-Mar-2026,6226804962,1,622680496201,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,11-Dec-2025,EOT,13-Dec-2025,13-Dec-2025,6226935606,2,622693560602,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:05,21:00,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,11-Dec-2025,EOT,13-Dec-2025,,6226935606,4,622693560604,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,09:05,,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,11-Dec-2025,EOT,13-Dec-2025,13-Dec-2025,6226935606,3,622693560603,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:05,21:00,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,11-Dec-2025,EOT,13-Dec-2025,,6226935606,5,622693560605,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:05,,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,11-Dec-2025,EOT,13-Dec-2025,13-Dec-2025,6226935606,1,622693560601,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:05,21:00,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,11-Dec-2025,EOT,13-Dec-2025,,6226935606,7,622693560607,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:05,,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,11-Dec-2025,EOT,13-Dec-2025,16-Dec-2025,6226935606,6,622693560606,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:05,05:55,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,11-Dec-2025,EOT,13-Dec-2025,13-Dec-2025,6226935606,8,622693560608,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:05,21:00,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,11-Dec-2025,EOT,13-Dec-2025,,6226935606,9,622693560609,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:05,,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,02-Jan-2026,P2OLD29,03-Jan-2026,03-Jan-2026,6226976943,1,622697694301,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,02-Jan-2026,P2OLD29,03-Jan-2026,,6226976943,2,622697694302,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,02-Jan-2026,P2OLD29,03-Jan-2026,31-Jan-2026,6226976943,3,622697694303,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:00,07:20,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,02-Jan-2026,P2OLD29,03-Jan-2026,,6226976943,4,622697694304,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,02-Jan-2026,P2OLD29,03-Jan-2026,03-Jan-2026,6226976943,6,622697694306,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,12:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,02-Jan-2026,P2OLD29,03-Jan-2026,03-Jan-2026,6226976943,7,622697694307,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,02-Jan-2026,P2OLD29,03-Jan-2026,03-Jan-2026,6226976943,5,622697694305,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Nov-2025,P2OLD29,07-Nov-2025,,6226991311,4,622699131104,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:14,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Nov-2025,P2OLD29,07-Nov-2025,07-Nov-2025,6226991311,5,622699131105,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:14,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Nov-2025,P2OLD29,07-Nov-2025,07-Nov-2025,6226991311,6,622699131106,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,08:14,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Nov-2025,P2OLD29,07-Nov-2025,07-Nov-2025,6226991311,7,622699131107,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:14,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Nov-2025,P2OLD29,07-Nov-2025,07-Nov-2025,6226991311,3,622699131103,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:14,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Nov-2025,P2OLD29,07-Nov-2025,07-Nov-2025,6226991311,1,622699131101,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:14,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Nov-2025,P2OLD29,07-Nov-2025,,6226991311,2,622699131102,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:14,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,14-Nov-2025,P2OLD29,15-Nov-2025,15-Nov-2025,6227043302,1,622704330201,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,14-Nov-2025,P2OLD29,15-Nov-2025,,6227043302,4,622704330204,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:10,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,14-Nov-2025,P2OLD29,15-Nov-2025,15-Nov-2025,6227043302,5,622704330205,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,14-Nov-2025,P2OLD29,15-Nov-2025,19-Nov-2025,6227043302,3,622704330203,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:10,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,14-Nov-2025,P2OLD29,15-Nov-2025,,6227043302,2,622704330202,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:10,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,14-Nov-2025,P2OLD29,15-Nov-2025,15-Nov-2025,6227043302,6,622704330206,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,09:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,14-Nov-2025,P2OLD29,15-Nov-2025,15-Nov-2025,6227043302,7,622704330207,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,17-Dec-2025,P2OLD29,18-Dec-2025,18-Dec-2025,6227072419,1,622707241901,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:17,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,17-Dec-2025,P2OLD29,18-Dec-2025,,6227072419,2,622707241902,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:17,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,17-Dec-2025,P2OLD29,18-Dec-2025,,6227072419,4,622707241904,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:17,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,17-Dec-2025,P2OLD29,18-Dec-2025,18-Dec-2025,6227072419,6,622707241906,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,11:17,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,17-Dec-2025,P2OLD29,18-Dec-2025,18-Dec-2025,6227072419,3,622707241903,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:17,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,17-Dec-2025,P2OLD29,18-Dec-2025,18-Dec-2025,6227072419,7,622707241907,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:17,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,17-Dec-2025,P2OLD29,18-Dec-2025,18-Dec-2025,6227072419,5,622707241905,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:17,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,28-Nov-2025,P2OLBL,29-Nov-2025,,6227106905,2,622710690502,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,28-Nov-2025,P2OLBL,29-Nov-2025,29-Nov-2025,6227106905,1,622710690501,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,28-Nov-2025,P2OLBL,29-Nov-2025,03-Dec-2025,6227106905,3,622710690503,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:00,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,28-Nov-2025,P2OLBL,29-Nov-2025,,6227106905,4,622710690504,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,28-Nov-2025,P2OLBL,29-Nov-2025,29-Nov-2025,6227106905,6,622710690506,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,09:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,28-Nov-2025,P2OLBL,29-Nov-2025,29-Nov-2025,6227106905,5,622710690505,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,28-Nov-2025,P2OLBL,29-Nov-2025,29-Nov-2025,6227106905,7,622710690507,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,28-Nov-2025,P2OLBL,29-Nov-2025,,6227106905,8,622710690508,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,28-Nov-2025,P2OLBL,29-Nov-2025,29-Nov-2025,6227106905,9,622710690509,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,19-Dec-2025,P2OLBL,20-Dec-2025,20-Dec-2025,6227106906,1,622710690601,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:25,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,19-Dec-2025,P2OLBL,20-Dec-2025,,6227106906,2,622710690602,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:25,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,19-Dec-2025,P2OLBL,20-Dec-2025,23-Dec-2025,6227106906,3,622710690603,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:25,07:00,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,19-Dec-2025,P2OLBL,20-Dec-2025,,6227106906,4,622710690604,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:25,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,19-Dec-2025,P2OLBL,20-Dec-2025,20-Dec-2025,6227106906,5,622710690605,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:25,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,19-Dec-2025,P2OLBL,20-Dec-2025,20-Dec-2025,6227106906,6,622710690606,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,09:25,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,19-Dec-2025,P2OLBL,20-Dec-2025,20-Dec-2025,6227106906,9,622710690609,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:25,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,19-Dec-2025,P2OLBL,20-Dec-2025,20-Dec-2025,6227106906,7,622710690607,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:25,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,19-Dec-2025,P2OLBL,20-Dec-2025,,6227106906,8,622710690608,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:25,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,27-Jan-2026,P1DBBL,28-Jan-2026,28-Jan-2026,6227144560,6,622714456006,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,08:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,27-Jan-2026,P1DBBL,28-Jan-2026,28-Jan-2026,6227144560,7,622714456007,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,27-Jan-2026,P1DBBL,28-Jan-2026,28-Jan-2026,6227144560,1,622714456001,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,25-Nov-2025,P1DBBL,26-Nov-2025,,6227144561,2,622714456102,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,27-Jan-2026,P1DBBL,28-Jan-2026,28-Jan-2026,6227144560,5,622714456005,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,25-Nov-2025,P1DBBL,26-Nov-2025,26-Nov-2025,6227144561,1,622714456101,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,25-Nov-2025,P1DBBL,26-Nov-2025,,6227144561,4,622714456104,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,25-Nov-2025,P1DBBL,26-Nov-2025,26-Nov-2025,6227144561,3,622714456103,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,25-Nov-2025,P1DBBL,26-Nov-2025,26-Nov-2025,6227144561,5,622714456105,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,27-Jan-2026,P1DBBL,28-Jan-2026,28-Jan-2026,6227144560,3,622714456003,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,25-Nov-2025,P1DBBL,26-Nov-2025,26-Nov-2025,6227144561,6,622714456106,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,10:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,27-Jan-2026,P1DBBL,28-Jan-2026,,6227144560,4,622714456004,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:25,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,27-Jan-2026,P1DBBL,28-Jan-2026,,6227144560,2,622714456002,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:25,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,11-Dec-2025,P1DBBL,13-Dec-2025,13-Dec-2025,6227144562,1,622714456201,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:13,21:00,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,11-Dec-2025,P1DBBL,13-Dec-2025,13-Dec-2025,6227144562,5,622714456205,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:13,21:00,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,25-Nov-2025,P1DBBL,26-Nov-2025,26-Nov-2025,6227144561,7,622714456107,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,11-Dec-2025,P1DBBL,13-Dec-2025,13-Dec-2025,6227144562,7,622714456207,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:13,21:00,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,11-Dec-2025,P1DBBL,13-Dec-2025,,6227144562,4,622714456204,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:13,,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,11-Dec-2025,P1DBBL,13-Dec-2025,,6227144562,2,622714456202,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:13,,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,11-Dec-2025,P1DBBL,13-Dec-2025,16-Dec-2025,6227144562,3,622714456203,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:13,05:55,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,11-Dec-2025,P1DBBL,13-Dec-2025,13-Dec-2025,6227144562,6,622714456206,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,08:13,21:00,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,09-Jan-2026,EOT,10-Jan-2026,10-Jan-2026,6227178908,7,622717890807,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:20,08:00,Czech Republic,,08:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,09-Jan-2026,EOT,10-Jan-2026,10-Jan-2026,6227178908,9,622717890809,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:20,08:00,Czech Republic,,08:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,30-Jan-2026,EOT,31-Jan-2026,31-Jan-2026,6227178909,3,622717890903,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:30,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,09-Jan-2026,EOT,10-Jan-2026,,6227178908,6,622717890806,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:20,,Czech Republic,,08:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,30-Jan-2026,EOT,31-Jan-2026,,6227178909,4,622717890904,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:30,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,09-Jan-2026,EOT,10-Jan-2026,10-Jan-2026,6227178908,2,622717890802,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:20,08:00,Czech Republic,,08:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,30-Jan-2026,EOT,31-Jan-2026,31-Jan-2026,6227178909,1,622717890901,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:30,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,09-Jan-2026,EOT,10-Jan-2026,,6227178908,8,622717890808,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:20,,Czech Republic,,08:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,09-Jan-2026,EOT,10-Jan-2026,10-Jan-2026,6227178908,1,622717890801,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:20,08:00,Czech Republic,,08:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,30-Jan-2026,EOT,31-Jan-2026,31-Jan-2026,6227178909,2,622717890902,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:30,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,30-Jan-2026,EOT,31-Jan-2026,04-Feb-2026,6227178909,5,622717890905,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:30,07:00,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,09-Jan-2026,EOT,10-Jan-2026,,6227178908,4,622717890804,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:20,,Czech Republic,,08:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,09-Jan-2026,EOT,10-Jan-2026,10-Jan-2026,6227178908,3,622717890803,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:20,08:00,Czech Republic,,08:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,30-Jan-2026,EOT,31-Jan-2026,,6227178909,6,622717890906,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:30,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,30-Jan-2026,EOT,31-Jan-2026,,6227178909,8,622717890908,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:30,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,30-Jan-2026,EOT,31-Jan-2026,31-Jan-2026,6227178909,9,622717890909,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:30,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,30-Jan-2026,EOT,31-Jan-2026,31-Jan-2026,6227178909,7,622717890907,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:30,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-May-2026,EOT,06-May-2026,06-May-2026,6227178910,1,622717891001,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-May-2026,EOT,06-May-2026,06-May-2026,6227178910,3,622717891003,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,07:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-May-2026,EOT,06-May-2026,,6227178910,4,622717891004,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,07:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-May-2026,EOT,06-May-2026,06-May-2026,6227178910,2,622717891002,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-May-2026,EOT,06-May-2026,20-May-2026,6227178910,5,622717891005,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,07:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,09-Jan-2026,EOT,10-Jan-2026,14-Jan-2026,6227178908,5,622717890805,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:20,07:00,Czech Republic,,08:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-May-2026,EOT,06-May-2026,,6227178910,8,622717891008,"Red Cells, Clot",Not Received,,,TSH,,,,,,07:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-May-2026,EOT,06-May-2026,06-May-2026,6227178910,9,622717891009,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,07:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,06-Mar-2026,EOT,07-Mar-2026,07-Mar-2026,6227178911,2,622717891102,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:50,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-May-2026,EOT,06-May-2026,06-May-2026,6227178910,7,622717891007,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,07:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,06-Mar-2026,EOT,07-Mar-2026,07-Mar-2026,6227178911,1,622717891101,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:50,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,06-Mar-2026,EOT,07-Mar-2026,,6227178911,4,622717891104,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:50,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,06-Mar-2026,EOT,07-Mar-2026,11-Mar-2026,6227178911,5,622717891105,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:50,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,06-Mar-2026,EOT,07-Mar-2026,,6227178911,6,622717891106,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:50,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,06-Mar-2026,EOT,07-Mar-2026,07-Mar-2026,6227178911,7,622717891107,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:50,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,06-Mar-2026,EOT,07-Mar-2026,07-Mar-2026,6227178911,9,622717891109,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:50,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-May-2026,EOT,06-May-2026,,6227178910,6,622717891006,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,07:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,06-Mar-2026,EOT,07-Mar-2026,07-Mar-2026,6227178911,3,622717891103,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:50,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,09-Jan-2026,EOT,10-Jan-2026,10-Jan-2026,6227178912,1,622717891201,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:10,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,06-Mar-2026,EOT,07-Mar-2026,,6227178911,8,622717891108,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:50,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,09-Jan-2026,EOT,10-Jan-2026,10-Jan-2026,6227178912,2,622717891202,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:10,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,09-Jan-2026,EOT,10-Jan-2026,10-Jan-2026,6227178912,3,622717891203,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:10,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,09-Jan-2026,EOT,10-Jan-2026,14-Jan-2026,6227178912,5,622717891205,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:10,07:00,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,09-Jan-2026,EOT,10-Jan-2026,,6227178912,4,622717891204,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:10,,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,09-Jan-2026,EOT,10-Jan-2026,10-Jan-2026,6227178912,7,622717891207,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:10,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,09-Jan-2026,EOT,10-Jan-2026,,6227178912,8,622717891208,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:10,,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,09-Jan-2026,EOT,10-Jan-2026,,6227178912,6,622717891206,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:10,,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,09-Jan-2026,EOT,10-Jan-2026,10-Jan-2026,6227178912,9,622717891209,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:10,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-Dec-2025,P1DBBL,06-Dec-2025,06-Dec-2025,6227261230,1,622726123001,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-Dec-2025,P1DBBL,06-Dec-2025,,6227261230,2,622726123002,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,07:55,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-Dec-2025,P1DBBL,06-Dec-2025,,6227261230,4,622726123004,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,07:55,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-Dec-2025,P1DBBL,06-Dec-2025,06-Dec-2025,6227261230,5,622726123005,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-Dec-2025,P1DBBL,06-Dec-2025,10-Dec-2025,6227261230,3,622726123003,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,07:55,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-Dec-2025,P1DBBL,06-Dec-2025,06-Dec-2025,6227261230,6,622726123006,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-Dec-2025,P1DBBL,06-Dec-2025,06-Dec-2025,6227261230,7,622726123007,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,19-May-2026,P2OLD29,20-May-2026,20-May-2026,6227261835,1,622726183501,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,00:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,19-May-2026,P2OLD29,20-May-2026,,6227261835,2,622726183502,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,00:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,19-May-2026,P2OLD29,20-May-2026,21-May-2026,6227261835,3,622726183503,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,19-May-2026,P2OLD29,20-May-2026,,6227261835,4,622726183504,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,00:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,19-May-2026,P2OLD29,20-May-2026,20-May-2026,6227261835,5,622726183505,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,00:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,19-May-2026,P2OLD29,20-May-2026,20-May-2026,6227261835,6,622726183506,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,00:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,19-May-2026,P2OLD29,20-May-2026,20-May-2026,6227261835,7,622726183507,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,00:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,06-Jan-2026,EOT,08-Jan-2026,08-Jan-2026,6227261836,1,622726183601,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:11,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,06-Jan-2026,EOT,08-Jan-2026,08-Jan-2026,6227261836,2,622726183602,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:11,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,06-Jan-2026,EOT,08-Jan-2026,08-Jan-2026,6227261836,3,622726183603,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:11,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,06-Jan-2026,EOT,08-Jan-2026,,6227261836,4,622726183604,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:11,,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,06-Jan-2026,EOT,08-Jan-2026,08-Jan-2026,6227261836,5,622726183605,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:11,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,06-Jan-2026,EOT,08-Jan-2026,,6227261836,6,622726183606,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:11,,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,06-Jan-2026,EOT,08-Jan-2026,08-Jan-2026,6227261836,7,622726183607,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:11,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,06-Jan-2026,EOT,08-Jan-2026,,6227261836,8,622726183608,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:11,,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,06-Jan-2026,EOT,08-Jan-2026,08-Jan-2026,6227261836,9,622726183609,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:11,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,02-Jan-2026,EOT,03-Jan-2026,03-Jan-2026,6227498379,3,622749837903,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:28,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,02-Jan-2026,EOT,03-Jan-2026,03-Jan-2026,6227498379,1,622749837901,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:28,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,02-Jan-2026,EOT,03-Jan-2026,03-Jan-2026,6227498379,2,622749837902,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:28,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Jan-2026,EOT,31-Jan-2026,,6227498380,8,622749838008,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:36,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Jan-2026,EOT,31-Jan-2026,31-Jan-2026,6227498380,7,622749838007,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:36,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,02-Jan-2026,EOT,03-Jan-2026,03-Jan-2026,6227498379,7,622749837907,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:28,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Jan-2026,EOT,31-Jan-2026,31-Jan-2026,6227498380,9,622749838009,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,08:36,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,02-Jan-2026,EOT,03-Jan-2026,03-Jan-2026,6227498379,9,622749837909,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:28,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Jan-2026,EOT,31-Jan-2026,31-Jan-2026,6227498380,1,622749838001,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:36,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Jan-2026,EOT,31-Jan-2026,,6227498380,6,622749838006,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:36,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Jan-2026,EOT,31-Jan-2026,31-Jan-2026,6227498380,3,622749838003,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:36,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,02-Jan-2026,EOT,03-Jan-2026,03-Jan-2026,6227498379,5,622749837905,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:28,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Jan-2026,EOT,31-Jan-2026,31-Jan-2026,6227498380,2,622749838002,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:36,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Jan-2026,EOT,31-Jan-2026,31-Jan-2026,6227498380,5,622749838005,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:36,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,02-Jan-2026,EOT,03-Jan-2026,,6227498379,4,622749837904,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:28,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Jan-2026,EOT,31-Jan-2026,,6227498380,4,622749838004,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:36,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,02-Jan-2026,EOT,03-Jan-2026,,6227498379,8,622749837908,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:28,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,02-Jan-2026,EOT,03-Jan-2026,,6227498379,6,622749837906,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:28,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,13-Jan-2026,EOT,14-Jan-2026,14-Jan-2026,6227520242,9,622752024209,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,13-Jan-2026,EOT,14-Jan-2026,14-Jan-2026,6227520242,3,622752024203,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,29-Apr-2026,EOT,30-Apr-2026,30-Apr-2026,6227520243,7,622752024307,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:20,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,29-Apr-2026,EOT,30-Apr-2026,30-Apr-2026,6227520243,5,622752024305,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:20,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,13-Jan-2026,EOT,14-Jan-2026,,6227520242,4,622752024204,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,13-Jan-2026,EOT,14-Jan-2026,14-Jan-2026,6227520242,1,622752024201,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,29-Apr-2026,EOT,30-Apr-2026,30-Apr-2026,6227520243,3,622752024303,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:20,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,29-Apr-2026,EOT,30-Apr-2026,,6227520243,6,622752024306,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:20,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,29-Apr-2026,EOT,30-Apr-2026,30-Apr-2026,6227520243,1,622752024301,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,11:20,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,29-Apr-2026,EOT,30-Apr-2026,,6227520243,4,622752024304,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:20,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,29-Apr-2026,EOT,30-Apr-2026,,6227520243,8,622752024308,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:20,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,13-Jan-2026,EOT,14-Jan-2026,14-Jan-2026,6227520242,2,622752024202,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,13-Jan-2026,EOT,14-Jan-2026,,6227520242,6,622752024206,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,13-Jan-2026,EOT,14-Jan-2026,14-Jan-2026,6227520242,5,622752024205,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,29-Apr-2026,EOT,30-Apr-2026,30-Apr-2026,6227520243,2,622752024302,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:20,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,13-Jan-2026,EOT,14-Jan-2026,,6227520242,8,622752024208,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,13-Jan-2026,EOT,14-Jan-2026,14-Jan-2026,6227520242,7,622752024207,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,29-Apr-2026,EOT,30-Apr-2026,30-Apr-2026,6227520243,9,622752024309,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:20,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,04-Mar-2026,EOT,05-Mar-2026,05-Mar-2026,6227520245,2,622752024502,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,04-Mar-2026,EOT,05-Mar-2026,05-Mar-2026,6227520245,3,622752024503,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,04-Mar-2026,EOT,05-Mar-2026,,6227520245,8,622752024508,"Red Cells, Clot",Not Received,,,TSH,,,,,,12:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,04-Mar-2026,EOT,05-Mar-2026,05-Mar-2026,6227520245,1,622752024501,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,04-Mar-2026,EOT,05-Mar-2026,05-Mar-2026,6227520245,9,622752024509,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,04-Mar-2026,EOT,05-Mar-2026,,6227520245,4,622752024504,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,04-Mar-2026,EOT,05-Mar-2026,05-Mar-2026,6227520245,5,622752024505,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,04-Mar-2026,EOT,05-Mar-2026,,6227520245,6,622752024506,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,04-Mar-2026,EOT,05-Mar-2026,05-Mar-2026,6227520245,7,622752024507,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,27-Jan-2026,P1SCR,28-Jan-2026,,6227541249,1,622754124901,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,27-Jan-2026,P1SCR,28-Jan-2026,28-Jan-2026,6227541249,2,622754124902,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,27-Jan-2026,P1SCR,28-Jan-2026,28-Jan-2026,6227541249,3,622754124903,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,27-Jan-2026,P1SCR,28-Jan-2026,28-Jan-2026,6227541249,6,622754124906,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,27-Jan-2026,P1SCR,28-Jan-2026,28-Jan-2026,6227541249,4,622754124904,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,27-Jan-2026,P1SCR,28-Jan-2026,,6227541249,7,622754124907,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,27-Jan-2026,P1SCR,28-Jan-2026,28-Jan-2026,6227541249,5,622754124905,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,25-Mar-2026,P1DBBL,26-Mar-2026,26-Mar-2026,6227541251,1,622754125101,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,06:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,25-Mar-2026,P1DBBL,26-Mar-2026,,6227541251,2,622754125102,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,06:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,27-Jan-2026,P1SCR,28-Jan-2026,28-Jan-2026,6227541249,10,622754124910,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,27-Jan-2026,P1SCR,28-Jan-2026,30-Jan-2026,6227541249,8,622754124908,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,27-Jan-2026,P1SCR,28-Jan-2026,,6227541249,9,622754124909,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,20-Feb-2026,P1DBBL,21-Feb-2026,21-Feb-2026,6227541252,6,622754125206,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,10:45,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,20-Feb-2026,P1DBBL,21-Feb-2026,21-Feb-2026,6227541252,1,622754125201,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:45,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,25-Mar-2026,P1DBBL,26-Mar-2026,26-Mar-2026,6227541251,7,622754125107,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,06:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,20-Feb-2026,P1DBBL,21-Feb-2026,25-Feb-2026,6227541252,3,622754125203,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:45,07:00,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,25-Mar-2026,P1DBBL,26-Mar-2026,,6227541251,4,622754125104,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,06:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,20-Feb-2026,P1DBBL,21-Feb-2026,,6227541252,2,622754125202,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:45,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,20-Feb-2026,P1DBBL,21-Feb-2026,,6227541252,4,622754125204,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:45,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,25-Mar-2026,P1DBBL,26-Mar-2026,26-Mar-2026,6227541251,6,622754125106,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,06:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,20-Feb-2026,P1DBBL,21-Feb-2026,21-Feb-2026,6227541252,5,622754125205,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:45,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,20-Feb-2026,P1DBBL,21-Feb-2026,21-Feb-2026,6227541252,7,622754125207,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:45,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,25-Mar-2026,P1DBBL,26-Mar-2026,26-Mar-2026,6227541251,5,622754125105,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,06:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,05-May-2026,P2OLBL,06-May-2026,06-May-2026,6227541256,1,622754125601,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,07:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,05-May-2026,P2OLBL,06-May-2026,06-May-2026,6227541256,5,622754125605,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,07:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,05-May-2026,P2OLBL,06-May-2026,,6227541256,2,622754125602,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,07:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,05-May-2026,P2OLBL,06-May-2026,,6227541256,4,622754125604,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,07:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,05-May-2026,P2OLBL,06-May-2026,06-May-2026,6227541256,7,622754125607,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,05-May-2026,P2OLBL,06-May-2026,20-May-2026,6227541256,3,622754125603,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,07:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,25-Mar-2026,P1DBBL,26-Mar-2026,26-Mar-2026,6227541251,3,622754125103,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,06:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,05-May-2026,P2OLBL,06-May-2026,06-May-2026,6227541256,6,622754125606,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,07:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,05-May-2026,P2OLBL,06-May-2026,06-May-2026,6227541256,9,622754125609,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,07:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,16-Jan-2026,P2OLBL,17-Jan-2026,21-Jan-2026,6227541257,3,622754125703,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,07:55,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,05-May-2026,P2OLBL,06-May-2026,,6227541256,8,622754125608,"Red Cells, Clot",Not Received,,,TSH,,,,,,07:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,16-Jan-2026,P2OLBL,17-Jan-2026,,6227541257,8,622754125708,"Red Cells, Clot",Not Received,,,TSH,,,,,,07:55,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,16-Jan-2026,P2OLBL,17-Jan-2026,17-Jan-2026,6227541257,1,622754125701,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,16-Jan-2026,P2OLBL,17-Jan-2026,17-Jan-2026,6227541257,5,622754125705,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,16-Jan-2026,P2OLBL,17-Jan-2026,17-Jan-2026,6227541257,6,622754125706,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,16-Jan-2026,P2OLBL,17-Jan-2026,,6227541257,4,622754125704,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,07:55,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,16-Jan-2026,P2OLBL,17-Jan-2026,17-Jan-2026,6227541257,7,622754125707,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,16-Jan-2026,P2OLBL,17-Jan-2026,17-Jan-2026,6227541257,9,622754125709,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,07-Apr-2026,P2OLBL,08-Apr-2026,,6227541258,2,622754125802,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Feb-2026,P2OLD29,14-Feb-2026,,6227541259,4,622754125904,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,16-Jan-2026,P2OLBL,17-Jan-2026,,6227541257,2,622754125702,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,07:55,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Feb-2026,P2OLD29,14-Feb-2026,18-Feb-2026,6227541259,3,622754125903,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:45,07:10,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,07-Apr-2026,P2OLBL,08-Apr-2026,08-Apr-2026,6227541258,9,622754125809,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Feb-2026,P2OLD29,14-Feb-2026,14-Feb-2026,6227541259,6,622754125906,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Feb-2026,P2OLD29,14-Feb-2026,14-Feb-2026,6227541259,7,622754125907,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,07-Apr-2026,P2OLBL,08-Apr-2026,08-Apr-2026,6227541258,1,622754125801,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,07-Apr-2026,P2OLBL,08-Apr-2026,,6227541258,4,622754125804,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,07-Apr-2026,P2OLBL,08-Apr-2026,08-Apr-2026,6227541258,6,622754125806,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Feb-2026,P2OLD29,14-Feb-2026,14-Feb-2026,6227541259,1,622754125901,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,07-Apr-2026,P2OLBL,08-Apr-2026,08-Apr-2026,6227541258,5,622754125805,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,07-Apr-2026,P2OLBL,08-Apr-2026,08-Apr-2026,6227541258,7,622754125807,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,07-Apr-2026,P2OLBL,08-Apr-2026,08-Apr-2026,6227541258,3,622754125803,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Feb-2026,P2OLD29,14-Feb-2026,14-Feb-2026,6227541259,5,622754125905,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,16-Jan-2026,P2OLD29,17-Jan-2026,17-Jan-2026,6227541260,1,622754126001,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:40,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,16-Jan-2026,P2OLD29,17-Jan-2026,17-Jan-2026,6227541260,5,622754126005,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:40,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,16-Jan-2026,P2OLD29,17-Jan-2026,,6227541260,2,622754126002,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:40,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,16-Jan-2026,P2OLD29,17-Jan-2026,21-Jan-2026,6227541260,3,622754126003,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:40,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,07-Apr-2026,P2OLBL,08-Apr-2026,,6227541258,8,622754125808,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Feb-2026,P2OLD29,14-Feb-2026,,6227541259,2,622754125902,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,05-May-2026,P2OLD29,06-May-2026,06-May-2026,6227541261,1,622754126101,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,13:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,16-Jan-2026,P2OLD29,17-Jan-2026,,6227541260,4,622754126004,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:40,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,16-Jan-2026,P2OLD29,17-Jan-2026,17-Jan-2026,6227541260,6,622754126006,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,10:40,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,05-May-2026,P2OLD29,06-May-2026,,6227541261,2,622754126102,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,13:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,05-May-2026,P2OLD29,06-May-2026,,6227541261,4,622754126104,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,13:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,16-Jan-2026,P2OLD29,17-Jan-2026,17-Jan-2026,6227541260,7,622754126007,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:40,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,05-May-2026,P2OLD29,06-May-2026,06-May-2026,6227541261,5,622754126105,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,13:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,05-May-2026,P2OLD29,06-May-2026,06-May-2026,6227541261,6,622754126106,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,13:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,05-May-2026,P2OLD29,06-May-2026,20-May-2026,6227541261,3,622754126103,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,13:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,05-May-2026,P2OLD29,06-May-2026,06-May-2026,6227541261,7,622754126107,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,13:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,07-Apr-2026,P2DBW13,08-Apr-2026,,6227541264,2,622754126402,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,07-Apr-2026,P2DBW13,08-Apr-2026,08-Apr-2026,6227541264,1,622754126401,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,07-Apr-2026,P2DBW13,08-Apr-2026,,6227541264,4,622754126404,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,07-Apr-2026,P2DBW13,08-Apr-2026,08-Apr-2026,6227541264,3,622754126403,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,07-Apr-2026,P2DBW13,08-Apr-2026,08-Apr-2026,6227541264,6,622754126406,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,08:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,07-Apr-2026,P2DBW13,08-Apr-2026,08-Apr-2026,6227541264,5,622754126405,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,07-Apr-2026,P2DBW13,08-Apr-2026,08-Apr-2026,6227541264,7,622754126407,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110009,21-Jan-2026,P1SCR,22-Jan-2026,22-Jan-2026,6227542160,6,622754216006,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,10:11,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110009,21-Jan-2026,P1SCR,22-Jan-2026,,6227542160,7,622754216007,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:11,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110009,21-Jan-2026,P1SCR,22-Jan-2026,22-Jan-2026,6227542160,5,622754216005,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:11,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110009,21-Jan-2026,P1SCR,22-Jan-2026,,6227542160,9,622754216009,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:11,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110009,21-Jan-2026,P1SCR,22-Jan-2026,22-Jan-2026,6227542160,2,622754216002,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:11,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110009,21-Jan-2026,P1SCR,22-Jan-2026,22-Jan-2026,6227542160,10,622754216010,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:11,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,05-Jan-2026,P1SCR,06-Jan-2026,,6227542161,1,622754216101,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:58,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110009,21-Jan-2026,P1SCR,22-Jan-2026,22-Jan-2026,6227542160,8,622754216008,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:11,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110009,21-Jan-2026,P1SCR,22-Jan-2026,,6227542160,1,622754216001,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:11,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,05-Jan-2026,P1SCR,06-Jan-2026,06-Jan-2026,6227542161,4,622754216104,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,05-Jan-2026,P1SCR,06-Jan-2026,06-Jan-2026,6227542161,2,622754216102,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,05-Jan-2026,P1SCR,06-Jan-2026,06-Jan-2026,6227542161,8,622754216108,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,05-Jan-2026,P1SCR,06-Jan-2026,06-Jan-2026,6227542161,3,622754216103,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,10:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,05-Jan-2026,P1SCR,06-Jan-2026,06-Jan-2026,6227542161,6,622754216106,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,10:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,05-Jan-2026,P1SCR,06-Jan-2026,06-Jan-2026,6227542161,10,622754216110,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110009,21-Jan-2026,P1SCR,22-Jan-2026,22-Jan-2026,6227542160,4,622754216004,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:11,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110009,21-Jan-2026,P1SCR,22-Jan-2026,22-Jan-2026,6227542160,3,622754216003,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,10:11,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,05-Jan-2026,P1SCR,06-Jan-2026,,6227542161,9,622754216109,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:58,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,05-Jan-2026,P1SCR,06-Jan-2026,,6227542161,7,622754216107,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:58,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,05-Jan-2026,P1SCR,06-Jan-2026,06-Jan-2026,6227542161,5,622754216105,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,10-Mar-2026,EOT,11-Mar-2026,11-Mar-2026,6227542170,5,622754217005,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,10-Mar-2026,EOT,11-Mar-2026,11-Mar-2026,6227542170,1,622754217001,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,10-Mar-2026,EOT,11-Mar-2026,11-Mar-2026,6227542170,7,622754217007,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,10-Mar-2026,EOT,11-Mar-2026,11-Mar-2026,6227542170,3,622754217003,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,10-Mar-2026,EOT,11-Mar-2026,,6227542170,8,622754217008,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:30,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,10-Mar-2026,EOT,11-Mar-2026,11-Mar-2026,6227542170,2,622754217002,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,10-Mar-2026,EOT,11-Mar-2026,,6227542170,6,622754217006,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:30,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Mar-2026,EOT,17-Mar-2026,17-Mar-2026,6227542171,1,622754217101,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,10-Mar-2026,EOT,11-Mar-2026,11-Mar-2026,6227542170,9,622754217009,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Mar-2026,EOT,17-Mar-2026,17-Mar-2026,6227542171,3,622754217103,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,10-Mar-2026,EOT,11-Mar-2026,,6227542170,4,622754217004,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:30,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Mar-2026,EOT,17-Mar-2026,17-Mar-2026,6227542171,5,622754217105,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Mar-2026,EOT,17-Mar-2026,17-Mar-2026,6227542171,2,622754217102,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Mar-2026,EOT,17-Mar-2026,,6227542171,6,622754217106,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:16,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Mar-2026,EOT,17-Mar-2026,,6227542171,8,622754217108,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:16,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Mar-2026,EOT,17-Mar-2026,17-Mar-2026,6227542171,7,622754217107,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Mar-2026,EOT,17-Mar-2026,17-Mar-2026,6227542171,9,622754217109,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Mar-2026,EOT,31-Mar-2026,31-Mar-2026,6227542172,2,622754217202,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:31,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Mar-2026,EOT,17-Mar-2026,,6227542171,4,622754217104,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:16,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Mar-2026,EOT,31-Mar-2026,31-Mar-2026,6227542172,3,622754217203,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:31,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Mar-2026,EOT,31-Mar-2026,31-Mar-2026,6227542172,1,622754217201,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:31,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Mar-2026,EOT,31-Mar-2026,31-Mar-2026,6227542172,5,622754217205,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:31,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Mar-2026,EOT,31-Mar-2026,,6227542172,6,622754217206,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:31,,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Mar-2026,EOT,31-Mar-2026,31-Mar-2026,6227542172,9,622754217209,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:31,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Mar-2026,EOT,31-Mar-2026,31-Mar-2026,6227542172,7,622754217207,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:31,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Mar-2026,EOT,31-Mar-2026,,6227542172,4,622754217204,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:31,,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Mar-2026,EOT,31-Mar-2026,,6227542172,8,622754217208,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:31,,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Jan-2026,EOT,17-Jan-2026,17-Jan-2026,6227542173,1,622754217301,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:48,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Jan-2026,EOT,17-Jan-2026,17-Jan-2026,6227542173,5,622754217305,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:48,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Jan-2026,EOT,17-Jan-2026,,6227542173,6,622754217306,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:48,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Jan-2026,EOT,17-Jan-2026,17-Jan-2026,6227542173,7,622754217307,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:48,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Jan-2026,EOT,17-Jan-2026,,6227542173,8,622754217308,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:48,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Jan-2026,EOT,17-Jan-2026,17-Jan-2026,6227542173,2,622754217302,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:48,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Jan-2026,EOT,17-Jan-2026,17-Jan-2026,6227542173,9,622754217309,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,08:48,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Jan-2026,EOT,17-Jan-2026,17-Jan-2026,6227542173,3,622754217303,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:48,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Jan-2026,EOT,17-Jan-2026,,6227542173,4,622754217304,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:48,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227542182,2,622754218202,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:16,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227542182,3,622754218203,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:16,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Apr-2026,P2OLBL,11-Apr-2026,,6227542182,4,622754218204,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,08:16,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Apr-2026,P2OLBL,11-Apr-2026,,6227542182,5,622754218205,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:16,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227542182,8,622754218208,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,08:16,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227542182,1,622754218201,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:16,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Apr-2026,P2OLBL,11-Apr-2026,,6227542182,7,622754218207,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:16,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Apr-2026,P2OLBL,11-Apr-2026,,6227542182,9,622754218209,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:16,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227542182,6,622754218206,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:16,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227542182,10,622754218210,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:16,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,11-Dec-2025,EOT,13-Dec-2025,13-Dec-2025,6226935606,10,622693560610,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:05,21:00,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,11-Dec-2025,EOT,13-Dec-2025,13-Dec-2025,6226935606,11,622693560611,"Serum, SST",Received,Ambient,Default Return Ambient,,,,,,,09:05,21:00,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,27-Feb-2026,P1SCR,28-Feb-2026,28-Feb-2026,6227547329,2,622754732902,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,27-Feb-2026,P1SCR,28-Feb-2026,28-Feb-2026,6227547329,3,622754732903,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,08:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,27-Feb-2026,P1SCR,28-Feb-2026,28-Feb-2026,6227547329,4,622754732904,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,27-Feb-2026,P1SCR,28-Feb-2026,28-Feb-2026,6227547329,6,622754732906,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,08:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,27-Feb-2026,P1SCR,28-Feb-2026,,6227547329,7,622754732907,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,27-Feb-2026,P1SCR,28-Feb-2026,28-Feb-2026,6227547329,5,622754732905,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,27-Feb-2026,P1SCR,28-Feb-2026,04-Mar-2026,6227547329,8,622754732908,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:00,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,27-Feb-2026,P1SCR,28-Feb-2026,28-Feb-2026,6227547329,10,622754732910,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,08:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,27-Feb-2026,P1SCR,28-Feb-2026,,6227547329,9,622754732909,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,30-Jan-2026,P1SCR,31-Jan-2026,31-Jan-2026,6227547330,2,622754733002,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:40,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,30-Jan-2026,P1SCR,31-Jan-2026,,6227547330,1,622754733001,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:40,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,30-Jan-2026,P1SCR,31-Jan-2026,31-Jan-2026,6227547330,3,622754733003,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,11:40,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,30-Jan-2026,P1SCR,31-Jan-2026,31-Jan-2026,6227547330,4,622754733004,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:40,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,30-Jan-2026,P1SCR,31-Jan-2026,31-Jan-2026,6227547330,5,622754733005,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:40,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,30-Jan-2026,P1SCR,31-Jan-2026,31-Jan-2026,6227547330,6,622754733006,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,11:40,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,30-Jan-2026,P1SCR,31-Jan-2026,,6227547330,7,622754733007,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:40,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,30-Jan-2026,P1SCR,31-Jan-2026,04-Feb-2026,6227547330,8,622754733008,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:40,07:00,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,30-Jan-2026,P1SCR,31-Jan-2026,,6227547330,9,622754733009,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:40,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,30-Jan-2026,P1SCR,31-Jan-2026,31-Jan-2026,6227547330,10,622754733010,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:40,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227547331,2,622754733102,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,27-Feb-2026,P1SCR,28-Feb-2026,,6227547329,1,622754732901,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227547331,3,622754733103,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227547331,4,622754733104,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227547331,5,622754733105,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227547331,6,622754733106,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,06-Mar-2026,P1SCR,07-Mar-2026,,6227547331,7,622754733107,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:20,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,06-Mar-2026,P1SCR,07-Mar-2026,11-Mar-2026,6227547331,8,622754733108,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:20,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,27-Feb-2026,P1DBBL,28-Feb-2026,28-Feb-2026,6227547332,1,622754733201,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:35,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,27-Feb-2026,P1DBBL,28-Feb-2026,,6227547332,2,622754733202,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:35,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,27-Feb-2026,P1DBBL,28-Feb-2026,04-Mar-2026,6227547332,3,622754733203,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:35,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,27-Feb-2026,P1DBBL,28-Feb-2026,,6227547332,4,622754733204,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:35,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,27-Feb-2026,P1DBBL,28-Feb-2026,28-Feb-2026,6227547332,5,622754733205,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:35,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,27-Feb-2026,P1DBBL,28-Feb-2026,28-Feb-2026,6227547332,6,622754733206,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,11:35,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,27-Feb-2026,P1DBBL,28-Feb-2026,28-Feb-2026,6227547332,7,622754733207,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:35,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,06-Mar-2026,P1SCR,07-Mar-2026,,6227547331,1,622754733101,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:20,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,25-Mar-2026,P1DBBL,26-Mar-2026,26-Mar-2026,6227547333,1,622754733301,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,25-Mar-2026,P1DBBL,26-Mar-2026,,6227547333,2,622754733302,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,25-Mar-2026,P1DBBL,26-Mar-2026,26-Mar-2026,6227547333,3,622754733303,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,25-Mar-2026,P1DBBL,26-Mar-2026,,6227547333,4,622754733304,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,25-Mar-2026,P1DBBL,26-Mar-2026,26-Mar-2026,6227547333,6,622754733306,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,25-Mar-2026,P1DBBL,26-Mar-2026,26-Mar-2026,6227547333,5,622754733305,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,25-Mar-2026,P1DBBL,26-Mar-2026,26-Mar-2026,6227547333,7,622754733307,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,06-Mar-2026,P1SCR,07-Mar-2026,,6227547331,9,622754733109,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:20,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227547331,10,622754733110,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,10-Apr-2026,P2SCR,11-Apr-2026,,6227547336,1,622754733601,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:15,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,10-Apr-2026,P2SCR,11-Apr-2026,11-Apr-2026,6227547336,2,622754733602,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:15,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,10-Apr-2026,P2SCR,11-Apr-2026,11-Apr-2026,6227547336,3,622754733603,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,08:15,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,10-Apr-2026,P2SCR,11-Apr-2026,11-Apr-2026,6227547336,4,622754733604,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:15,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,10-Apr-2026,P2SCR,11-Apr-2026,11-Apr-2026,6227547336,5,622754733605,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:15,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,10-Apr-2026,P2SCR,11-Apr-2026,11-Apr-2026,6227547336,6,622754733606,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,08:15,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,10-Apr-2026,P2SCR,11-Apr-2026,,6227547336,7,622754733607,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:15,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,10-Apr-2026,P2SCR,11-Apr-2026,15-Apr-2026,6227547336,8,622754733608,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:15,07:00,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,10-Apr-2026,P2SCR,11-Apr-2026,,6227547336,9,622754733609,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:15,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,10-Apr-2026,P2OLBL,11-Apr-2026,,6227547337,2,622754733702,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:15,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,10-Apr-2026,P2OLBL,11-Apr-2026,15-Apr-2026,6227547337,3,622754733703,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:15,07:00,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,10-Apr-2026,P2OLBL,11-Apr-2026,,6227547337,4,622754733704,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:15,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227547337,6,622754733706,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,11:15,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227547337,5,622754733705,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:15,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227547337,9,622754733709,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:15,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,05-May-2026,P2OLBL,06-May-2026,,6227547338,2,622754733802,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,05-May-2026,P2OLBL,06-May-2026,20-May-2026,6227547338,3,622754733803,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,05-May-2026,P2OLBL,06-May-2026,06-May-2026,6227547338,1,622754733801,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,05-May-2026,P2OLBL,06-May-2026,,6227547338,4,622754733804,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,05-May-2026,P2OLBL,06-May-2026,06-May-2026,6227547338,7,622754733807,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,05-May-2026,P2OLBL,06-May-2026,06-May-2026,6227547338,5,622754733805,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,05-May-2026,P2OLBL,06-May-2026,06-May-2026,6227547338,6,622754733806,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,09:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,10-Apr-2026,P2OLBL,11-Apr-2026,,6227547337,8,622754733708,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:15,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227547337,7,622754733707,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:15,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,05-May-2026,P2OLBL,06-May-2026,,6227547338,8,622754733808,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,05-May-2026,P2OLBL,06-May-2026,06-May-2026,6227547338,9,622754733809,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227547337,1,622754733701,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:15,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,10-Apr-2026,P2SCR,11-Apr-2026,11-Apr-2026,6227547336,10,622754733610,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,08:15,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,01-Feb-2026,P1SCR,03-Feb-2026,03-Feb-2026,6227767267,3,622776726703,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,12:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,01-Feb-2026,P1SCR,03-Feb-2026,03-Feb-2026,6227767267,4,622776726704,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,01-Feb-2026,P1SCR,03-Feb-2026,,6227767267,1,622776726701,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:25,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,01-Feb-2026,P1SCR,03-Feb-2026,03-Feb-2026,6227767267,2,622776726702,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,01-Feb-2026,P1SCR,03-Feb-2026,,6227767267,7,622776726707,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:25,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,01-Feb-2026,P1SCR,03-Feb-2026,03-Feb-2026,6227767267,5,622776726705,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,01-Feb-2026,P1SCR,03-Feb-2026,03-Feb-2026,6227767267,6,622776726706,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,12:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,01-Feb-2026,P1SCR,03-Feb-2026,,6227767267,9,622776726709,"Red Cells, Clot",Not Received,,,TSH,,,,,,12:25,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,01-Feb-2026,P1SCR,03-Feb-2026,04-Feb-2026,6227767267,8,622776726708,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,01-Feb-2026,P1SCR,03-Feb-2026,03-Feb-2026,6227767267,10,622776726710,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,12:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,05-May-2026,EOT,06-May-2026,06-May-2026,6227768458,2,622776845802,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,05-May-2026,EOT,06-May-2026,,6227768458,4,622776845804,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,05-May-2026,EOT,06-May-2026,06-May-2026,6227768458,1,622776845801,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,05-May-2026,EOT,06-May-2026,06-May-2026,6227768458,3,622776845803,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,05-May-2026,EOT,06-May-2026,20-May-2026,6227768458,5,622776845805,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,05-May-2026,EOT,06-May-2026,,6227768458,6,622776845806,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,05-May-2026,EOT,06-May-2026,,6227768458,8,622776845808,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,05-May-2026,EOT,06-May-2026,06-May-2026,6227768458,7,622776845807,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Mar-2026,EOT,14-Mar-2026,14-Mar-2026,6227768459,1,622776845901,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:00,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Mar-2026,EOT,14-Mar-2026,14-Mar-2026,6227768459,3,622776845903,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:00,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Mar-2026,EOT,14-Mar-2026,,6227768459,4,622776845904,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:00,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,05-May-2026,EOT,06-May-2026,06-May-2026,6227768458,9,622776845809,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,27-Mar-2026,EOT,28-Mar-2026,,6227768460,4,622776846004,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:00,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Mar-2026,EOT,14-Mar-2026,,6227768459,6,622776845906,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:00,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,27-Mar-2026,EOT,28-Mar-2026,08-Apr-2026,6227768460,5,622776846005,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:00,07:00,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,27-Mar-2026,EOT,28-Mar-2026,28-Mar-2026,6227768460,2,622776846002,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:00,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Mar-2026,EOT,14-Mar-2026,14-Mar-2026,6227768459,7,622776845907,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:00,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,27-Mar-2026,EOT,28-Mar-2026,28-Mar-2026,6227768460,3,622776846003,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:00,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Mar-2026,EOT,14-Mar-2026,,6227768459,8,622776845908,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:00,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Mar-2026,EOT,14-Mar-2026,18-Mar-2026,6227768459,5,622776845905,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:00,07:00,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Mar-2026,EOT,14-Mar-2026,14-Mar-2026,6227768459,9,622776845909,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:00,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,27-Mar-2026,EOT,28-Mar-2026,28-Mar-2026,6227768460,7,622776846007,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:00,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,27-Mar-2026,EOT,28-Mar-2026,,6227768460,8,622776846008,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:00,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,27-Mar-2026,EOT,28-Mar-2026,28-Mar-2026,6227768460,1,622776846001,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:00,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,27-Mar-2026,EOT,28-Mar-2026,28-Mar-2026,6227768460,9,622776846009,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:00,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Mar-2026,EOT,14-Mar-2026,14-Mar-2026,6227768459,2,622776845902,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:00,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,27-Mar-2026,EOT,28-Mar-2026,,6227768460,6,622776846006,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:00,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,28-Jan-2026,P1SCR,30-Jan-2026,,6227775505,1,622777550501,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,16:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,28-Jan-2026,P1SCR,30-Jan-2026,30-Jan-2026,6227775505,5,622777550505,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,16:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,28-Jan-2026,P1SCR,30-Jan-2026,30-Jan-2026,6227775505,4,622777550504,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,16:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,28-Jan-2026,P1SCR,30-Jan-2026,30-Jan-2026,6227775505,6,622777550506,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,16:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,28-Jan-2026,P1SCR,30-Jan-2026,,6227775505,7,622777550507,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,16:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,28-Jan-2026,P1SCR,30-Jan-2026,30-Jan-2026,6227775505,2,622777550502,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,16:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,28-Jan-2026,P1SCR,30-Jan-2026,30-Jan-2026,6227775505,3,622777550503,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,16:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,28-Jan-2026,P1SCR,30-Jan-2026,,6227775505,9,622777550509,"Red Cells, Clot",Not Received,,,TSH,,,,,,16:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,15-Feb-2026,P1DBBL,17-Feb-2026,,6227775508,2,622777550802,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,15:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,15-Feb-2026,P1DBBL,17-Feb-2026,17-Feb-2026,6227775507,1,622777550701,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,13:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,15-Feb-2026,P1DBBL,17-Feb-2026,17-Feb-2026,6227775508,5,622777550805,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,15:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,15-Feb-2026,P1DBBL,17-Feb-2026,18-Feb-2026,6227775507,3,622777550703,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,13:30,07:10,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,15-Feb-2026,P1DBBL,17-Feb-2026,,6227775507,4,622777550704,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,13:30,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,15-Feb-2026,P1DBBL,17-Feb-2026,18-Feb-2026,6227775508,3,622777550803,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,15:10,07:10,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,15-Feb-2026,P1DBBL,17-Feb-2026,17-Feb-2026,6227775507,6,622777550706,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,13:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,15-Feb-2026,P1DBBL,17-Feb-2026,17-Feb-2026,6227775507,7,622777550707,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,13:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,15-Feb-2026,P1DBBL,17-Feb-2026,17-Feb-2026,6227775507,5,622777550705,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,13:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,15-Feb-2026,P1DBBL,17-Feb-2026,17-Feb-2026,6227775508,7,622777550807,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,15:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,15-Feb-2026,P1DBBL,17-Feb-2026,17-Feb-2026,6227775508,6,622777550806,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,15:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,15-Feb-2026,P1DBBL,17-Feb-2026,17-Feb-2026,6227775508,1,622777550801,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,15:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,15-Feb-2026,P1DBBL,17-Feb-2026,,6227775507,2,622777550702,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,13:30,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,28-Jan-2026,P1SCR,30-Jan-2026,30-Jan-2026,6227775505,10,622777550510,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,16:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,15-Feb-2026,P1DBBL,17-Feb-2026,,6227775508,4,622777550804,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,15:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,28-Jan-2026,P1SCR,30-Jan-2026,31-Jan-2026,6227775505,8,622777550508,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,16:50,07:20,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,17-Feb-2026,P1SCR,18-Feb-2026,18-Feb-2026,6227797406,3,622779740603,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,11:03,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,17-Feb-2026,P1SCR,18-Feb-2026,18-Feb-2026,6227797406,6,622779740606,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,11:03,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,17-Feb-2026,P1SCR,18-Feb-2026,18-Feb-2026,6227797406,5,622779740605,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:03,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,17-Feb-2026,P1SCR,18-Feb-2026,18-Feb-2026,6227797406,4,622779740604,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:03,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,17-Feb-2026,P1SCR,18-Feb-2026,18-Feb-2026,6227797406,8,622779740608,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:03,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,17-Feb-2026,P1SCR,18-Feb-2026,,6227797406,9,622779740609,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:03,,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,17-Feb-2026,P1SCR,18-Feb-2026,,6227797406,7,622779740607,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:03,,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,17-Feb-2026,P1SCR,18-Feb-2026,18-Feb-2026,6227797406,2,622779740602,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:03,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,17-Feb-2026,P1SCR,18-Feb-2026,,6227797406,1,622779740601,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:03,,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110012,06-Mar-2026,P1SCR,07-Mar-2026,,6227797407,1,622779740701,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:22,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110012,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227797407,3,622779740703,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110012,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227797407,4,622779740704,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,17-Feb-2026,P1SCR,18-Feb-2026,18-Feb-2026,6227797406,10,622779740610,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:03,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110012,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227797407,5,622779740705,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110012,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227797407,6,622779740706,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110012,06-Mar-2026,P1SCR,07-Mar-2026,,6227797407,7,622779740707,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:22,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110012,06-Mar-2026,P1SCR,07-Mar-2026,,6227797407,9,622779740709,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:22,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110011,02-Mar-2026,P1SCR,03-Mar-2026,03-Mar-2026,6227797408,5,622779740805,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110011,02-Mar-2026,P1SCR,03-Mar-2026,03-Mar-2026,6227797408,6,622779740806,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110011,02-Mar-2026,P1SCR,03-Mar-2026,03-Mar-2026,6227797408,4,622779740804,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110012,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227797407,10,622779740710,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110012,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227797407,2,622779740702,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110012,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227797407,8,622779740708,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110011,02-Mar-2026,P1SCR,03-Mar-2026,,6227797408,1,622779740801,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:05,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110011,02-Mar-2026,P1SCR,03-Mar-2026,03-Mar-2026,6227797408,8,622779740808,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110011,02-Mar-2026,P1SCR,03-Mar-2026,03-Mar-2026,6227797408,2,622779740802,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110011,02-Mar-2026,P1SCR,03-Mar-2026,03-Mar-2026,6227797408,3,622779740803,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110011,02-Mar-2026,P1SCR,03-Mar-2026,,6227797408,7,622779740807,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:05,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110011,02-Mar-2026,P1SCR,03-Mar-2026,,6227797408,9,622779740809,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:05,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110011,02-Mar-2026,P1SCR,03-Mar-2026,03-Mar-2026,6227797408,10,622779740810,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Mar-2026,P1DBBL,11-Mar-2026,11-Mar-2026,6227844725,3,622784472503,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:21,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Mar-2026,P1DBBL,11-Mar-2026,11-Mar-2026,6227844725,6,622784472506,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,10:21,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Mar-2026,P1DBBL,11-Mar-2026,11-Mar-2026,6227844725,5,622784472505,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:21,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Mar-2026,P1DBBL,11-Mar-2026,,6227844725,4,622784472504,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:21,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Mar-2026,P1DBBL,11-Mar-2026,11-Mar-2026,6227844725,7,622784472507,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:21,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Mar-2026,P1DBBL,11-Mar-2026,11-Mar-2026,6227844725,1,622784472501,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:21,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Mar-2026,P1DBBL,11-Mar-2026,,6227844725,2,622784472502,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:21,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,28-Jan-2026,P1SCR,30-Jan-2026,30-Jan-2026,6227775505,11,622777550511,"Serum, SST",Received,Ambient,Default Return Ambient,,,,,,,16:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,07-Apr-2026,P2OLD29,08-Apr-2026,08-Apr-2026,6228114460,1,622811446001,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:21,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,07-Apr-2026,P2OLD29,08-Apr-2026,,6228114460,4,622811446004,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:21,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,07-Apr-2026,P2OLD29,08-Apr-2026,08-Apr-2026,6228114460,5,622811446005,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:21,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,07-Apr-2026,P2OLD29,08-Apr-2026,08-Apr-2026,6228114460,6,622811446006,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,09:21,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,07-Apr-2026,P2OLD29,08-Apr-2026,,6228114460,2,622811446002,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:21,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,07-Apr-2026,P2OLD29,08-Apr-2026,08-Apr-2026,6228114460,3,622811446003,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:21,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,07-Apr-2026,P2OLD29,08-Apr-2026,08-Apr-2026,6228114460,7,622811446007,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:21,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,10-Mar-2026,P2DBBL,11-Mar-2026,,6226804962,10,622680496210,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,11:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,07-Apr-2026,P2OLD29,08-Apr-2026,,6228114460,8,622811446008,"Urine, no preservative",Not Received,Ambient,,,,,,,,09:21,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,31-Mar-2026,EOT,01-Apr-2026,02-Apr-2026,6228232037,5,622823203705,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,31-Mar-2026,EOT,01-Apr-2026,,6228232037,6,622823203706,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,31-Mar-2026,EOT,01-Apr-2026,,6228232037,8,622823203708,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,31-Mar-2026,EOT,01-Apr-2026,01-Apr-2026,6228232037,9,622823203709,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,31-Mar-2026,EOT,01-Apr-2026,01-Apr-2026,6228232037,7,622823203707,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,31-Mar-2026,EOT,01-Apr-2026,01-Apr-2026,6228232037,1,622823203701,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,31-Mar-2026,EOT,01-Apr-2026,01-Apr-2026,6228232037,3,622823203703,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,31-Mar-2026,EOT,01-Apr-2026,,6228232037,4,622823203704,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,31-Mar-2026,EOT,01-Apr-2026,01-Apr-2026,6228232037,2,622823203702,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,04-May-2026,EOT,05-May-2026,05-May-2026,6228234297,1,622823429701,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:44,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,04-May-2026,EOT,05-May-2026,05-May-2026,6228234297,2,622823429702,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:44,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,04-May-2026,EOT,05-May-2026,05-May-2026,6228234297,3,622823429703,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:44,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,04-May-2026,EOT,05-May-2026,05-May-2026,6228234297,7,622823429707,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:44,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,04-May-2026,EOT,05-May-2026,,6228234297,8,622823429708,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:44,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,13-May-2026,EOT,14-May-2026,14-May-2026,6228234298,1,622823429801,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,04-May-2026,EOT,05-May-2026,06-May-2026,6228234297,5,622823429705,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:44,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,04-May-2026,EOT,05-May-2026,,6228234297,6,622823429706,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:44,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,04-May-2026,EOT,05-May-2026,05-May-2026,6228234297,9,622823429709,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,08:44,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,13-May-2026,EOT,14-May-2026,,6228234298,6,622823429806,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,13-May-2026,EOT,14-May-2026,14-May-2026,6228234298,5,622823429805,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,13-May-2026,EOT,14-May-2026,14-May-2026,6228234298,2,622823429802,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,13-May-2026,EOT,14-May-2026,14-May-2026,6228234298,9,622823429809,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,08:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,13-May-2026,EOT,14-May-2026,,6228234298,4,622823429804,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,04-May-2026,EOT,05-May-2026,,6228234297,4,622823429704,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:44,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,13-May-2026,EOT,14-May-2026,,6228234298,8,622823429808,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,13-May-2026,EOT,14-May-2026,14-May-2026,6228234298,3,622823429803,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,21-Apr-2026,EOT,23-Apr-2026,23-Apr-2026,6228234300,5,622823430005,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:37,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,13-May-2026,EOT,14-May-2026,14-May-2026,6228234298,7,622823429807,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,21-Apr-2026,EOT,23-Apr-2026,23-Apr-2026,6228234300,2,622823430002,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:37,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,21-Apr-2026,EOT,23-Apr-2026,23-Apr-2026,6228234300,1,622823430001,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:37,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,21-Apr-2026,EOT,23-Apr-2026,23-Apr-2026,6228234300,3,622823430003,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:37,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,21-Apr-2026,EOT,23-Apr-2026,,6228234300,6,622823430006,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:37,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,21-Apr-2026,EOT,23-Apr-2026,23-Apr-2026,6228234300,9,622823430009,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:37,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,21-Apr-2026,EOT,23-Apr-2026,,6228234300,8,622823430008,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:37,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,21-Apr-2026,EOT,23-Apr-2026,,6228234300,4,622823430004,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:37,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,21-Apr-2026,EOT,23-Apr-2026,23-Apr-2026,6228234300,7,622823430007,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:37,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,25-Mar-2026,EOT,26-Mar-2026,,6226560888,10,622656088810,"Urine, no preservative",Not Received,Ambient,,,,,,,,17:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,25-Mar-2026,EOT,26-Mar-2026,,6226752555,10,622675255510,"Urine, no preservative",Not Received,Ambient,,,,,,,,15:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,01-Apr-2026,P2OLD29,02-Apr-2026,,6226313625,8,622631362508,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,11:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Apr-2026,P2DBW13,08-Apr-2026,,6226686954,10,622668695410,"Serum, SST",Cancelled,Ambient,,TSH,,,,,,12:01,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Apr-2026,P2DBW13,08-Apr-2026,,6226686954,9,622668695409,"Red Cells, Clot",Not Received,,,TSH,,,,,,12:01,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Apr-2026,P2DBW13,08-Apr-2026,,6226686954,8,622668695408,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,12:01,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,07-Apr-2026,P2DBW13,08-Apr-2026,,6227541264,10,622754126410,"Serum, SST",Cancelled,Ambient,,TSH,,,,,,08:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,07-Apr-2026,P2DBW13,08-Apr-2026,,6227541264,8,622754126408,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,08:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,07-Apr-2026,P2DBW13,08-Apr-2026,,6227541264,9,622754126409,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,07-Apr-2026,P2OLBL,08-Apr-2026,,6227541258,10,622754125810,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,09:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227542182,11,622754218211,"Serum, SST",Received,Ambient,Default Return Ambient,,,,,,,08:16,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Retest,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,10-Apr-2026,P2OLBL,11-Apr-2026,,6227547337,10,622754733710,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,11:15,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,22-Apr-2026,P2OLD29,23-Apr-2026,,6226752554,8,622675255408,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,15:30,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,23-Apr-2026,P2OLD29,25-Apr-2026,,6226560887,8,622656088708,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,16:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,05-May-2026,P2OLD29,06-May-2026,,6227541261,8,622754126108,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,13:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,05-May-2026,P2OLBL,06-May-2026,,6227541256,10,622754125610,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,07:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,05-May-2026,P2OLBL,06-May-2026,,6227547338,10,622754733810,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,09:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,22-May-2026,EOT,23-May-2026,23-May-2026,6228605652,2,622860565202,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,22-May-2026,EOT,23-May-2026,,6228605652,4,622860565204,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:20,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,22-May-2026,EOT,23-May-2026,27-May-2026,6228605653,5,622860565305,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:00,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,22-May-2026,EOT,23-May-2026,23-May-2026,6228605652,1,622860565201,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,22-May-2026,EOT,23-May-2026,23-May-2026,6228605652,9,622860565209,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,22-May-2026,EOT,23-May-2026,23-May-2026,6228605653,1,622860565301,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,12:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,22-May-2026,EOT,23-May-2026,23-May-2026,6228605652,3,622860565203,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,22-May-2026,EOT,23-May-2026,,6228605653,8,622860565308,"Red Cells, Clot",Not Received,,,TSH,,,,,,12:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,22-May-2026,EOT,23-May-2026,23-May-2026,6228605653,9,622860565309,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,12:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,22-May-2026,EOT,23-May-2026,,6228605652,8,622860565208,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:20,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,22-May-2026,EOT,23-May-2026,,6228605652,6,622860565206,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:20,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,22-May-2026,EOT,23-May-2026,,6228605653,6,622860565306,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,22-May-2026,EOT,23-May-2026,23-May-2026,6228605653,7,622860565307,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,22-May-2026,EOT,23-May-2026,23-May-2026,6228605653,2,622860565302,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,22-May-2026,EOT,23-May-2026,23-May-2026,6228605652,7,622860565207,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,22-May-2026,EOT,23-May-2026,,6228605653,4,622860565304,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,22-May-2026,EOT,23-May-2026,27-May-2026,6228605652,5,622860565205,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:20,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,22-May-2026,EOT,23-May-2026,23-May-2026,6228605653,3,622860565303,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, +42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,19-May-2026,P2OLD29,20-May-2026,,6227261835,8,622726183508,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,00:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, diff --git a/Covance_UCO3001/Source/2026-05-29_100908 sponsor-study-36940-samples-allSamples.csv b/Covance_UCO3001/Source/2026-05-29_100908 sponsor-study-36940-samples-allSamples.csv new file mode 100644 index 0000000..7fe468b --- /dev/null +++ b/Covance_UCO3001/Source/2026-05-29_100908 sponsor-study-36940-samples-allSamples.csv @@ -0,0 +1,1445 @@ +Protocol Code,Investigator No.,Investigator Name,Patient No.,Collection Date,Protocol Visit Code,Kit Receipt Date,Container Receipt Date,Accession,Container No.,Container Barcode No.,Specimen Type,Sample Status,Expected Receipt Condition,Actual Receipt Condition,Container Label Line 1,Container Label Line 2,SM Sample Status,SMART Specimen Class Description,Aliquot Created Date,Aliquoted Date,Collection Time,Container Receipt Time,Country,Courier,Kit Receipt Time,Parent Barcode Number,Parent Sample Type,Project,Region,Screening No.,Shipped To Organization Name,Site Waybill No.,Site - Scheduled Shipment Date,Site - Shipment Created Date,Site - Shipment Details Entered Date,SMART Specimen Class,Visit Description,Parent Barcode,Children Barcode +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,24-Jan-2026,6227323203,1,622732320301,Whole Blood QuantiFERON Nil,Received,,Default Discard/Not Return,QUANTIFERON PLUS,NIL-GRAY,,,,,08:00,12:40,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,24-Jan-2026,6227323203,2,622732320302,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,08:00,12:40,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,24-Jan-2026,6227323203,3,622732320303,Whole Blood QuantiFERON TB1,Received,,Default Discard/Not Return,QUANTIFERON PLUS,TB1-GREEN,,,,,08:00,12:40,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,24-Jan-2026,6227323203,7,622732320307,Whole Blood QuantiFERON Mitoge,Received,,Default Discard/Not Return,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,08:00,12:40,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,24-Jan-2026,6227323203,8,622732320308,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,08:00,12:40,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,24-Jan-2026,6227323203,5,622732320305,Whole Blood QuantiFERON TB2,Received,,Default Discard/Not Return,QUANTIFERON PLUS,TB2-YELLOW,,,,,08:00,12:40,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,24-Jan-2026,6227323203,6,622732320306,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,08:00,12:40,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,23-Jan-2026,6227323203,11,622732320311,"Red Cells, Clot",Received,,Default Discard/Not Return,"HIV SCREEN,",HEPATITIS B & C,,,,,08:00,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,24-Jan-2026,6227323203,4,622732320304,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,08:00,12:40,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,23-Jan-2026,6227323203,14,622732320314,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,08:00,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,23-Jan-2026,6227323203,12,622732320312,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,08:00,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,23-Jan-2026,6227323203,15,622732320315,"Serum, SST",Received,Ambient,Default Return Ambient,FSH,,,,,,08:00,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,04-Mar-2026,6227323204,1,622732320401,Whole Blood QuantiFERON Nil,Received,,Default Discard/Not Return,QUANTIFERON PLUS,NIL-GRAY,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,23-Jan-2026,6227323203,9,622732320309,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:00,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,04-Mar-2026,6227323204,3,622732320403,Whole Blood QuantiFERON TB1,Received,,Default Discard/Not Return,QUANTIFERON PLUS,TB1-GREEN,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,04-Mar-2026,6227323204,4,622732320404,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,04-Mar-2026,6227323204,2,622732320402,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,04-Mar-2026,6227323204,6,622732320406,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,04-Mar-2026,6227323204,7,622732320407,Whole Blood QuantiFERON Mitoge,Received,,Default Discard/Not Return,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,04-Mar-2026,6227323204,5,622732320405,Whole Blood QuantiFERON TB2,Received,,Default Discard/Not Return,QUANTIFERON PLUS,TB2-YELLOW,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,,6227323203,10,622732320310,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,08:00,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,23-Jan-2026,6227323203,13,622732320313,"Red Cells, Clot",Received,,Default Discard/Not Return,"CHEM PANEL, BETA",HCG & FSH,,,,,08:00,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,03-Mar-2026,6227323204,9,622732320409,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,03-Mar-2026,6227323204,10,622732320410,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,03-Mar-2026,6227323204,11,622732320411,"Red Cells, Clot",Received,,Default Discard/Not Return,"HIV SCREEN,",HEPATITIS B & C,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,03-Mar-2026,6227323204,13,622732320413,"Red Cells, Clot",Received,,Default Discard/Not Return,"CHEM PANEL, BETA",HCG & FSH,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,03-Mar-2026,6227323204,14,622732320414,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,03-Mar-2026,6227323204,15,622732320415,"Serum, SST",Received,Ambient,Default Return Ambient,FSH,,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,04-Mar-2026,6227323204,8,622732320408,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,1,622732320501,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,03-Mar-2026,6227323204,12,622732320412,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,2,622732320502,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,4,622732320504,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,7,622732320507,"Red Cells, Clot",Received,,Default Discard/Not Return,SM04/SERUM ADA PRE,,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,3,622732320503,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,PLASMA PK TROUGH,,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,6,622732320506,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,10,622732320510,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,9,622732320509,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,8,622732320508,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,5,622732320505,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,SM02/PLASMAPK PEAK,,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,11,622732320511,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,13,622732320513,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,14,622732320514,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,15,622732320515,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,16,622732320516,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,18,622732320518,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,1,622732320601,"Whole Blood, EDTA, Dry",Cancelled,Ambient,,HEMATOLOGY,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,17,622732320517,"Red Cells, Clot",Received,,Default Discard/Not Return,"CHEM, LIPID PANEL",& CRP,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,12,622732320512,"Red Cells, Clot",Received,,Default Discard/Not Return,SM06/SERUM,BIOMARKERS,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,4,622732320604,"Plasma, EDTA",Not Received,Frozen,Specimen not submitted,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,7,622732320607,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,8,622732320608,"Serum, SST",Not Received,Frozen,Specimen not submitted,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,9,622732320609,"Serum, SST",Not Received,Frozen,Specimen not submitted,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,10,622732320610,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,SM10/FECAL,BIOMARKERS,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,11,622732320611,Whole Blood PAXgene RNA,Not Received,Frozen,Specimen not submitted,SM07/WB RNA,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,12,622732320612,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,2,622732320602,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,6,622732320606,"Plasma, EDTA",Not Received,Frozen,Specimen not submitted,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,3,622732320603,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,5,622732320605,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,23-Apr-2026,6227323206,17,622732320617,"Red Cells, Clot",Received,,Default Discard/Not Return,"CHEM, LIPID PANEL",& CRP,,,,,,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,14,622732320614,"Serum, SST",Not Received,Frozen,Specimen not submitted,SM06/SERUM BIOM,77242113UCO3001-2,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,23-Apr-2026,6227323206,18,622732320618,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,24-Apr-2026,6227323207,2,622732320702,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-2 TROUGH,77242113UCO3001,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,16,622732320616,"Feces, unpreserved",Not Received,Frozen,Specimen not submitted,FECAL CALPROTECTIN,FROZEN,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,,6227323207,3,622732320703,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,24-Apr-2026,6227323207,1,622732320701,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,PLASMA PK TROUGH,,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,15,622732320615,"Serum, SST",Not Received,Frozen,Specimen not submitted,SM06/SERUM BIOM,77242113UCO3001-3,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,13,622732320613,"Serum, SST",Not Received,Frozen,Specimen not submitted,SM06/SERUM BIOM,77242113UCO3001-1,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,,6227323207,4,622732320704,"Plasma, EDTA",Not Received,Frozen,Specimen not submitted,PLASMA PK I-2 PEAK,77242113UCO3001,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,24-Apr-2026,6227323207,5,622732320705,"Red Cells, Clot",Received,,Default Discard/Not Return,SM04/SERUM ADA PRE,,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,24-Apr-2026,6227323207,6,622732320706,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-1,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,24-Apr-2026,6227323207,7,622732320707,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-2,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,24-Apr-2026,6227323207,8,622732320708,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-1,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,,6227323207,9,622732320709,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-2,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,,6227323207,10,622732320710,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-3,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,,6227323207,11,622732320711,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-4,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,,6227323207,12,622732320712,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-5,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,24-Apr-2026,6227323207,13,622732320713,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,24-Apr-2026,6227323207,14,622732320714,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,24-Apr-2026,6227323207,16,622732320716,"Red Cells, Clot",Received,,Default Discard/Not Return,CHEM PANEL &,CRP,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,24-Apr-2026,6227323207,17,622732320717,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,1,622732320801,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,PLASMA PK TROUGH,,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,2,622732320802,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-2 TROUGH,77242113UCO3001,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,3,622732320803,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,SM02/PLASMAPK PEAK,,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,5,622732320805,"Red Cells, Clot",Received,,Default Discard/Not Return,SM04/SERUM ADA PRE,,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,4,622732320804,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-2 PEAK,77242113UCO3001,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,7,622732320807,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-2,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,,6227323208,8,622732320808,"Stool, unpreserved",Cancelled,Frozen,,STOOL I-2,77242113UCO3001-1,,,,,07:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,,6227323208,10,622732320810,"Stool, unpreserved",Cancelled,Frozen,,STOOL I-2,77242113UCO3001-3,,,,,07:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,24-Apr-2026,6227323207,15,622732320715,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,,6227323208,11,622732320811,"Stool, unpreserved",Cancelled,Frozen,,STOOL I-2,77242113UCO3001-4,,,,,07:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,,6227323208,9,622732320809,"Stool, unpreserved",Cancelled,Frozen,,STOOL I-2,77242113UCO3001-2,,,,,07:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,,6227323208,12,622732320812,"Stool, unpreserved",Cancelled,Frozen,,STOOL I-2,77242113UCO3001-5,,,,,07:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,13,622732320813,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,14,622732320814,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,15,622732320815,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,16,622732320816,"Red Cells, Clot",Received,,Default Discard/Not Return,CHEM PANEL &,CRP,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,17,622732320817,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,6,622732320806,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-1,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,2,622732321002,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,4,622732321004,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,1,622732321001,"Red Cells, Clot",Received,,Default Discard/Not Return,CHEM PANEL &,CRP,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,3,622732321003,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,,6227323210,6,622732321006,"Stool, unpreserved",Cancelled,Frozen,,STOOL I-4,77242113UCO3001-1,,,,,07:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,5,622732321005,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,,6227323210,7,622732321007,"Stool, unpreserved",Cancelled,Frozen,,STOOL I-4,77242113UCO3001-2,,,,,07:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,,6227323210,8,622732321008,"Stool, unpreserved",Cancelled,Frozen,,STOOL I-4,77242113UCO3001-3,,,,,07:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,,6227323210,9,622732321009,"Stool, unpreserved",Cancelled,Frozen,,STOOL I-4,77242113UCO3001-4,,,,,07:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,10,622732321010,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-4,77242113UCO3001-5,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,12,622732321012,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-4 TROUGH,77242113UCO3001,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,14,622732321014,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-4 PEAK,77242113UCO3001,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,11,622732321011,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,PLASMA PK TROUGH,,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,13,622732321013,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,SM02/PLASMAPK PEAK,,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,15,622732321015,"Red Cells, Clot",Received,,Default Discard/Not Return,SM04/SERUM ADA PRE,,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,16,622732321016,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-1,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,17,622732321017,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-2,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,18,622732321018,"Red Cells, Clot",Received,,Default Discard/Not Return,SM06/SERUM,BIOMARKERS,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,19,622732321019,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,21,622732321021,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,20,622732321020,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,22,622732321022,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,28-Jan-2026,SCRNSTOOL,29-Jan-2026,29-Jan-2026,6227323211,1,622732321101,"Stool, ova & parasites(form)",Received,Ambient,Default Return Ambient,OVA & PARASITES 1,FORMALIN,,,,,06:00,07:40,Czech Republic,,07:40,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,28-Jan-2026,SCRNSTOOL,29-Jan-2026,29-Jan-2026,6227323211,2,622732321102,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,06:00,07:40,Czech Republic,,07:40,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,28-Jan-2026,SCRNSTOOL,29-Jan-2026,29-Jan-2026,6227323211,3,622732321103,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,06:00,07:40,Czech Republic,,07:40,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,28-Jan-2026,SCRNSTOOL,29-Jan-2026,29-Jan-2026,6227323211,4,622732321104,"Stool, ova & parasites(PVA)",Received,Ambient,Default Return Ambient,OVA & PARASITES 2,PVA,,,,,06:00,07:40,Czech Republic,,07:40,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,03-Mar-2026,SCRNSTOOL,05-Mar-2026,05-Mar-2026,6227323212,1,622732321201,"Stool, ova & parasites(form)",Received,Ambient,Default Return Ambient,OVA & PARASITES 1,FORMALIN,,,,,13:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,03-Mar-2026,SCRNSTOOL,05-Mar-2026,05-Mar-2026,6227323212,3,622732321203,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,13:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,03-Mar-2026,SCRNSTOOL,05-Mar-2026,05-Mar-2026,6227323212,4,622732321204,"Stool, ova & parasites(PVA)",Received,Ambient,Default Return Ambient,OVA & PARASITES 2,PVA,,,,,13:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,03-Mar-2026,SCRNSTOOL,05-Mar-2026,05-Mar-2026,6227323212,2,622732321202,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,13:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRNSTOOL,30-Apr-2026,,6227323213,1,622732321301,"Stool, ova & parasites(form)",Not Received,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,07:55,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRNSTOOL,30-Apr-2026,30-Apr-2026,6227323213,2,622732321302,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRNSTOOL,30-Apr-2026,30-Apr-2026,6227323213,3,622732321303,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRNSTOOL,30-Apr-2026,,6227323213,4,622732321304,"Stool, ova & parasites(PVA)",Not Received,Ambient,,OVA & PARASITES 2,PVA,,,,,07:55,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,DNA,20-Feb-2026,20-Feb-2026,6227323217,1,622732321701,"Whole Blood, EDTA, Dry",Shipped,Frozen,Default Return Frozen,SM08/WB DNA,77242113UCO3001,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,DNA,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,DNA,19-Mar-2026,19-Mar-2026,6227323219,1,622732321901,"Whole Blood, EDTA, Dry",Shipped,Frozen,Default Return Frozen,SM08/WB DNA,77242113UCO3001,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,DNA,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,05-Feb-2026,BXSCR,06-Feb-2026,06-Feb-2026,6227323223,1,622732322301,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,05-Feb-2026,BXSCR,06-Feb-2026,07-Feb-2026,6227323223,2,622732322302,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:20,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,05-Feb-2026,BXSCR,06-Feb-2026,07-Feb-2026,6227323223,3,622732322303,"Biopsy, Frozen Tissue",Shipped,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:20,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,05-Feb-2026,BXSCR,06-Feb-2026,,6227323223,4,622732322304,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,18-Mar-2026,BXSCR,19-Mar-2026,20-Mar-2026,6227323224,2,622732322402,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,18-Mar-2026,BXSCR,19-Mar-2026,19-Mar-2026,6227323224,1,622732322401,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,18-Mar-2026,BXSCR,19-Mar-2026,20-Mar-2026,6227323224,3,622732322403,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,18-Mar-2026,BXSCR,19-Mar-2026,,6227323224,4,622732322404,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,2,622732323102,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,3,622732323103,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL,","BHCG, FSH & CRP",,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,4,622732323104,"Serum, SST",Not Received,Ambient,,"CHEM, LIPID PANEL",BETA HCG & CRP,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,19-Mar-2026,6227323231,5,622732323105,"Serum, SST",Received,Ambient,Default Return Ambient,FSH,,,,,,,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,6,622732323106,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,23-Apr-2026,6227323231,8,622732323108,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,7,622732323107,"Serum, SST",Not Received,Ambient,,"HIV SCREEN,",HEPATITIS B & C,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,1,622732323101,"Whole Blood, EDTA, Dry",Not Received,Ambient,,HEMATOLOGY,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,9,622732323109,"Whole Blood, EDTA, Dry",Not Received,,,HCV RNA COBAS 6800,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,10,622732323110,"Plasma, EDTA",Not Received,Frozen,,HCV RNA COBAS 6800,FROZEN,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,12,622732323112,"Plasma, EDTA",Not Received,Frozen,,HBV DNA COBAS 6800,FROZEN,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,14,622732323114,Whole Blood PAXgene RNA,Not Received,Frozen,,SM07/WB RNA,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,13,622732323113,"Stool, unpreserved",Not Received,Frozen,,SM10/FECAL,BIOMARKERS,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,17,622732323117,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-2,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,18,622732323118,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-3,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,15,622732323115,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,16,622732323116,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-1,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,11,622732323111,"Whole Blood, EDTA, Dry",Not Received,,,HBV DNA COBAS 6800,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,19,622732323119,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,20,622732323120,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-2,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,22,622732323122,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-4,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,21,622732323121,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-3,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,25,622732323125,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-1,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,26,622732323126,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-2,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,24,622732323124,"Red Cells, Clot",Not Received,,,SM05/SERUM ADA,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,23,622732323123,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-5,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,27,622732323127,"Whole Blood, EDTA, Dry",Not Received,,,SM03/PLASMA PK,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,28,622732323128,"Plasma, EDTA",Not Received,Frozen,,PLASMA PK,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,29,622732323129,"Whole Blood, EDTA, Dry",Not Received,,,HIV-1/HIV-2,QUALITATIVE RNA,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,30,622732323130,"Plasma, EDTA",Not Received,Frozen,,HIV-1/HIV-2 QUAL,RNA FROZEN,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,3,622732323203,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL,","BHCG, FSH & CRP",,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,4,622732323204,"Serum, SST",Cancelled,Ambient,,"CHEM, LIPID PANEL",BETA HCG & CRP,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,5,622732323205,"Serum, SST",Not Received,Ambient,,FSH,,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,6,622732323206,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,7,622732323207,"Serum, SST",Not Received,Ambient,,"HIV SCREEN,",HEPATITIS B & C,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,8,622732323208,"Feces, unpreserved",Not Received,Frozen,Specimen not submitted,FECAL CALPROTECTIN,FROZEN,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,1,622732323201,"Whole Blood, EDTA, Dry",Not Received,Ambient,,HEMATOLOGY,,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,2,622732323202,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,10,622732323210,"Plasma, EDTA",Not Received,Frozen,,HCV RNA COBAS 6800,FROZEN,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,12,622732323212,"Plasma, EDTA",Not Received,Frozen,,HBV DNA COBAS 6800,FROZEN,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,14,622732323214,Whole Blood PAXgene RNA,Not Received,Frozen,,SM07/WB RNA,77242113UCO3001,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,13,622732323213,"Stool, unpreserved",Not Received,Frozen,,SM10/FECAL,BIOMARKERS,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,11,622732323211,"Whole Blood, EDTA, Dry",Not Received,,,HBV DNA COBAS 6800,,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,15,622732323215,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,9,622732323209,"Whole Blood, EDTA, Dry",Not Received,,,HCV RNA COBAS 6800,,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,16,622732323216,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-1,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,17,622732323217,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-2,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,21,622732323221,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-3,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,23,622732323223,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-5,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,26,622732323226,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-2,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,20,622732323220,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-2,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,24,622732323224,"Red Cells, Clot",Not Received,,,SM05/SERUM ADA,,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,22,622732323222,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-4,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,27,622732323227,"Whole Blood, EDTA, Dry",Not Received,,,SM03/PLASMA PK,,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,25,622732323225,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-1,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,19,622732323219,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,28,622732323228,"Plasma, EDTA",Not Received,Frozen,,PLASMA PK,77242113UCO3001,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,18,622732323218,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-3,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,29,622732323229,"Whole Blood, EDTA, Dry",Not Received,,,HIV-1/HIV-2,QUALITATIVE RNA,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,2,622732323302,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,19-Mar-2026,6227323233,4,622732323304,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",BETA HCG & CRP,,,,,,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,30,622732323230,"Plasma, EDTA",Not Received,Frozen,,HIV-1/HIV-2 QUAL,RNA FROZEN,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,19-Mar-2026,6227323233,3,622732323303,"Red Cells, Clot",Received,,Default Discard/Not Return,"CHEM, LIPID PANEL,","BHCG, FSH & CRP",,,,,,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,6,622732323306,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,7,622732323307,"Serum, SST",Not Received,Ambient,,"HIV SCREEN,",HEPATITIS B & C,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,1,622732323301,"Whole Blood, EDTA, Dry",Not Received,Ambient,,HEMATOLOGY,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,5,622732323305,"Serum, SST",Not Received,Ambient,,FSH,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,8,622732323308,"Feces, unpreserved",Not Received,Frozen,,FECAL CALPROTECTIN,FROZEN,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,9,622732323309,"Whole Blood, EDTA, Dry",Not Received,,,HCV RNA COBAS 6800,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,10,622732323310,"Plasma, EDTA",Not Received,Frozen,,HCV RNA COBAS 6800,FROZEN,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,13,622732323313,"Stool, unpreserved",Not Received,Frozen,,SM10/FECAL,BIOMARKERS,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,12,622732323312,"Plasma, EDTA",Not Received,Frozen,,HBV DNA COBAS 6800,FROZEN,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,16,622732323316,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-1,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,14,622732323314,Whole Blood PAXgene RNA,Not Received,Frozen,,SM07/WB RNA,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,15,622732323315,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,11,622732323311,"Whole Blood, EDTA, Dry",Not Received,,,HBV DNA COBAS 6800,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,17,622732323317,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-2,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,19,622732323319,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,24,622732323324,"Red Cells, Clot",Not Received,,,SM05/SERUM ADA,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,20,622732323320,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-2,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,23,622732323323,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-5,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,26,622732323326,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-2,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,25,622732323325,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-1,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,22,622732323322,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-4,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,27,622732323327,"Whole Blood, EDTA, Dry",Not Received,,,SM03/PLASMA PK,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,21,622732323321,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-3,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,18,622732323318,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-3,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,29,622732323329,"Whole Blood, EDTA, Dry",Not Received,,,HIV-1/HIV-2,QUALITATIVE RNA,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,30,622732323330,"Plasma, EDTA",Not Received,Frozen,,HIV-1/HIV-2 QUAL,RNA FROZEN,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,28,622732323328,"Plasma, EDTA",Not Received,Frozen,,PLASMA PK,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,22-Apr-2026,6227323234,2,622732323402,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,07:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,,6227323234,3,622732323403,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,07:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,22-Apr-2026,6227323234,4,622732323404,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,07:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,,6227323234,5,622732323405,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,07:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,,6227323234,1,622732323401,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,07:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,22-Apr-2026,6227323234,6,622732323406,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,07:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,21-Apr-2026,6227323234,10,622732323410,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,22-Apr-2026,6227323234,8,622732323408,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,07:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,,6227323234,11,622732323411,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,07:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,,6227323234,7,622732323407,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,07:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,21-Apr-2026,6227323234,9,622732323409,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,,6227323234,15,622732323415,"Serum, SST",Cancelled,Ambient,,FSH,FROZEN,,,,,07:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,21-Apr-2026,6227323234,14,622732323414,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,07:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,,6227323234,13,622732323413,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,07:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,21-Apr-2026,6227323234,12,622732323412,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,07:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,,6227323236,2,622732323602,"Plasma, QuantiFERON Nil",Cancelled,Frozen,,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,,6227323236,1,622732323601,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,,6227323236,3,622732323603,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,,6227323236,4,622732323604,"Plasma, QuantiFERON TB1",Cancelled,Frozen,,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,,6227323236,8,622732323608,"Plasma, QuantiFERON Mitoge",Cancelled,Frozen,,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,,6227323236,5,622732323605,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,18-Feb-2026,6227323236,9,622732323609,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:03,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,,6227323236,7,622732323607,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,,6227323236,6,622732323606,"Plasma, QuantiFERON TB2",Cancelled,Frozen,,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,,6227323236,11,622732323611,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,18-Feb-2026,6227323236,12,622732323612,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,07:03,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,18-Feb-2026,6227323236,10,622732323610,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:03,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,,6227323236,13,622732323613,"Red Cells, Clot",Not Received,,,"CHEM PANEL, BETA",HCG & FSH,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,18-Feb-2026,6227323236,14,622732323614,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,07:03,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,18-Feb-2026,6227323236,15,622732323615,"Serum, SST",Received,Ambient,Default Return Ambient,FSH,,,,,,07:03,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,2,622732323702,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,4,622732323704,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,1,622732323701,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,,6227323237,3,622732323703,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,08:00,,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,,6227323237,7,622732323707,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,08:00,,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,8,622732323708,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,,6227323237,5,622732323705,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,08:00,,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,6,622732323706,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,11,622732323711,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,,6227323237,12,622732323712,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,08:00,,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,9,622732323709,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,13,622732323713,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,10,622732323710,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,15,622732323715,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,14,622732323714,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,,6227323237,17,622732323717,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL",& CRP,,,,,08:00,,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,18,622732323718,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,16,622732323716,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,1,622732323801,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,2,622732323802,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,4,622732323804,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,,6227323238,5,622732323805,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,,6227323238,7,622732323807,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,8,622732323808,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,6,622732323806,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,10,622732323810,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,11,622732323811,Whole Blood PAXgene RNA,In Inventory,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,13,622732323813,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,,6227323238,12,622732323812,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,9,622732323809,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,16,622732323816,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,15,622732323815,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,14,622732323814,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,18,622732323818,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,,6227323238,17,622732323817,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL",& CRP,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,09-Apr-2026,6227323240,2,622732324002,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-2 TROUGH,77242113UCO3001,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,,6227323240,1,622732324001,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,07:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,09-Apr-2026,6227323240,15,622732324015,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,09-Apr-2026,6227323240,13,622732324013,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,,6227323240,16,622732324016,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,07:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,09-Apr-2026,6227323240,14,622732324014,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,,6227323240,5,622732324005,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,07:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,09-Apr-2026,6227323240,4,622732324004,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-2 PEAK,77242113UCO3001,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,,6227323240,8,622732324008,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-1,,,,,07:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,,6227323240,9,622732324009,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-2,,,,,07:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,09-Apr-2026,6227323240,6,622732324006,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-1,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,,6227323240,3,622732324003,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,07:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,,6227323240,10,622732324010,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-3,,,,,07:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,09-Apr-2026,6227323240,7,622732324007,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-2,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,09-Apr-2026,6227323240,17,622732324017,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,09-Apr-2026,6227323240,12,622732324012,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-5,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,,6227323240,11,622732324011,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-4,,,,,07:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,,6227323238,3,622732323803,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,,6227323242,1,622732324201,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,2,622732324202,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,3,622732324203,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,4,622732324204,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,5,622732324205,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,,6227323242,9,622732324209,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-4,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,,6227323242,10,622732324210,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-5,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,,6227323242,7,622732324207,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-2,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,,6227323242,8,622732324208,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-3,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,,6227323242,11,622732324211,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,6,622732324206,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-4,77242113UCO3001-1,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,,6227323242,13,622732324213,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,12,622732324212,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-4 TROUGH,77242113UCO3001,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,,6227323242,15,622732324215,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,16,622732324216,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-1,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,17,622732324217,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-2,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,19,622732324219,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,14,622732324214,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-4 PEAK,77242113UCO3001,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,21,622732324221,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,,6227323242,18,622732324218,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,20,622732324220,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,22,622732324222,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCSTOOL,18-Mar-2026,,6227323243,1,622732324301,"Stool, ova & parasites(form)",Not Received,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,09:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCSTOOL,18-Mar-2026,,6227323243,3,622732324303,"Culture, Stool",Cancelled,Ambient,,STOOL CULTURE,,,,,,09:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRNSTOOL,18-Feb-2026,,6227323244,1,622732324401,"Stool, ova & parasites(form)",Not Received,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,07:20,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCSTOOL,18-Mar-2026,,6227323243,4,622732324304,"Stool, ova & parasites(PVA)",Not Received,Ambient,,OVA & PARASITES 2,PVA,,,,,09:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRNSTOOL,18-Feb-2026,18-Feb-2026,6227323244,2,622732324402,"Stool, unpreserved",Cancelled,Frozen,,C-DIFF TOXIN,& PCR FROZEN,,,,,07:20,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCSTOOL,18-Mar-2026,18-Mar-2026,6227323243,2,622732324302,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,09:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRNSTOOL,18-Feb-2026,18-Feb-2026,6227323244,3,622732324403,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,07:20,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRNSTOOL,18-Feb-2026,,6227323244,4,622732324404,"Stool, ova & parasites(PVA)",Not Received,Ambient,,OVA & PARASITES 2,PVA,,,,,07:20,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCSTOOL,12-Mar-2026,12-Mar-2026,6227323245,3,622732324503,"Culture, Stool",Received,Ambient,Default Return Frozen,STOOL CULTURE,,,,,,09:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCSTOOL,12-Mar-2026,,6227323245,4,622732324504,"Stool, ova & parasites(PVA)",Cancelled,Ambient,,OVA & PARASITES 2,PVA,,,,,09:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCSTOOL,12-Mar-2026,,6227323245,1,622732324501,"Stool, ova & parasites(form)",Cancelled,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,09:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCSTOOL,12-Mar-2026,,6227323245,2,622732324502,"Stool, unpreserved",Cancelled,Frozen,,C-DIFF TOXIN,& PCR FROZEN,,,,,09:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,DNA,21-Mar-2026,21-Mar-2026,6227323251,1,622732325101,"Whole Blood, EDTA, Dry",Shipped,Frozen,Default Return Frozen,SM08/WB DNA,77242113UCO3001,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,DNA,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,TB,18-Feb-2026,,6227323252,1,622732325201,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,TB,18-Feb-2026,18-Feb-2026,6227323252,2,622732325202,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,07:03,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,TB,18-Feb-2026,,6227323252,3,622732325203,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,TB,18-Feb-2026,18-Feb-2026,6227323252,4,622732325204,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,07:03,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,TB,18-Feb-2026,,6227323252,5,622732325205,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,TB,18-Feb-2026,18-Feb-2026,6227323252,6,622732325206,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,07:03,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,TB,18-Feb-2026,,6227323252,7,622732325207,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,TB,18-Feb-2026,18-Feb-2026,6227323252,8,622732325208,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,07:03,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,TB,12-Mar-2026,12-Mar-2026,6227323253,2,622732325302,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,09:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,TB,12-Mar-2026,,6227323253,1,622732325301,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,09:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,TB,12-Mar-2026,12-Mar-2026,6227323253,6,622732325306,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,09:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,TB,12-Mar-2026,,6227323253,5,622732325305,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,09:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,TB,12-Mar-2026,,6227323253,3,622732325303,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,09:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,TB,12-Mar-2026,12-Mar-2026,6227323253,8,622732325308,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,09:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,TB,12-Mar-2026,,6227323253,7,622732325307,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,09:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,19-Feb-2026,BXSCR,21-Feb-2026,21-Feb-2026,6227323254,2,622732325402,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,19-Feb-2026,BXSCR,21-Feb-2026,21-Feb-2026,6227323254,1,622732325401,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,19-Feb-2026,BXSCR,21-Feb-2026,,6227323254,4,622732325404,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,TB,12-Mar-2026,12-Mar-2026,6227323253,4,622732325304,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,09:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,19-Feb-2026,BXSCR,21-Feb-2026,21-Feb-2026,6227323254,3,622732325403,"Biopsy, Frozen Tissue",Shipped,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,05:55,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,14-May-2026,BXSCR,15-May-2026,15-May-2026,6227323256,1,622732325601,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,14-May-2026,BXSCR,15-May-2026,15-May-2026,6227323256,2,622732325602,Biopsy RNA Later,In Inventory,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,14-May-2026,BXSCR,15-May-2026,15-May-2026,6227323256,3,622732325603,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,14-May-2026,BXSCR,15-May-2026,,6227323256,4,622732325604,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,7,622732326407,"Serum, SST",Not Received,Ambient,,"HIV SCREEN,",HEPATITIS B & C,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,6,622732326406,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,12-Mar-2026,6227323264,1,622732326401,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,12-Mar-2026,6227323264,2,622732326402,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,9,622732326409,"Whole Blood, EDTA, Dry",Not Received,,,HCV RNA COBAS 6800,,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,10,622732326410,"Plasma, EDTA",Not Received,Frozen,,HCV RNA COBAS 6800,FROZEN,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,3,622732326403,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL,","BHCG, FSH & CRP",,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,8,622732326408,"Feces, unpreserved",Not Received,Frozen,,FECAL CALPROTECTIN,FROZEN,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,11,622732326411,"Whole Blood, EDTA, Dry",Not Received,,,HBV DNA COBAS 6800,,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,4,622732326404,"Serum, SST",Not Received,Ambient,,"CHEM, LIPID PANEL",BETA HCG & CRP,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,13,622732326413,"Stool, unpreserved",Not Received,Frozen,,SM10/FECAL,BIOMARKERS,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,12,622732326412,"Plasma, EDTA",Not Received,Frozen,,HBV DNA COBAS 6800,FROZEN,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,15,622732326415,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,14,622732326414,Whole Blood PAXgene RNA,Not Received,Frozen,,SM07/WB RNA,77242113UCO3001,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,17,622732326417,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-2,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,16,622732326416,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-1,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,18,622732326418,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-3,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,20,622732326420,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-2,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,5,622732326405,"Serum, SST",Not Received,Ambient,,FSH,,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,22,622732326422,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-4,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,21,622732326421,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-3,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,23,622732326423,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-5,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,24,622732326424,"Red Cells, Clot",Not Received,,,SM05/SERUM ADA,,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,25,622732326425,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-1,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,19,622732326419,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,26,622732326426,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-2,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,27,622732326427,"Whole Blood, EDTA, Dry",Not Received,,,SM03/PLASMA PK,,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,28,622732326428,"Plasma, EDTA",Not Received,Frozen,,PLASMA PK,77242113UCO3001,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,29,622732326429,"Whole Blood, EDTA, Dry",Not Received,,,HIV-1/HIV-2,QUALITATIVE RNA,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,30,622732326430,"Plasma, EDTA",Not Received,Frozen,,HIV-1/HIV-2 QUAL,RNA FROZEN,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,18-Mar-2026,6227323265,1,622732326501,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,3,622732326503,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL,","BHCG, FSH & CRP",,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,4,622732326504,"Serum, SST",Not Received,Ambient,,"CHEM, LIPID PANEL",BETA HCG & CRP,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,18-Mar-2026,6227323265,2,622732326502,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,5,622732326505,"Serum, SST",Not Received,Ambient,,FSH,,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,8,622732326508,"Feces, unpreserved",Not Received,Frozen,,FECAL CALPROTECTIN,FROZEN,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,6,622732326506,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,7,622732326507,"Serum, SST",Not Received,Ambient,,"HIV SCREEN,",HEPATITIS B & C,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,9,622732326509,"Whole Blood, EDTA, Dry",Not Received,,,HCV RNA COBAS 6800,,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,10,622732326510,"Plasma, EDTA",Not Received,Frozen,,HCV RNA COBAS 6800,FROZEN,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,11,622732326511,"Whole Blood, EDTA, Dry",Not Received,,,HBV DNA COBAS 6800,,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,12,622732326512,"Plasma, EDTA",Not Received,Frozen,,HBV DNA COBAS 6800,FROZEN,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,13,622732326513,"Stool, unpreserved",Not Received,Frozen,,SM10/FECAL,BIOMARKERS,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,14,622732326514,Whole Blood PAXgene RNA,Not Received,Frozen,,SM07/WB RNA,77242113UCO3001,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,15,622732326515,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,21,622732326521,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-3,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,18,622732326518,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-3,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,17,622732326517,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-2,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,25,622732326525,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-1,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,22,622732326522,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-4,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,20,622732326520,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-2,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,29,622732326529,"Whole Blood, EDTA, Dry",Not Received,,,HIV-1/HIV-2,QUALITATIVE RNA,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,27,622732326527,"Whole Blood, EDTA, Dry",Not Received,,,SM03/PLASMA PK,,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,24,622732326524,"Red Cells, Clot",Not Received,,,SM05/SERUM ADA,,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,16,622732326516,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-1,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,19,622732326519,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,28,622732326528,"Plasma, EDTA",Not Received,Frozen,,PLASMA PK,77242113UCO3001,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,26,622732326526,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-2,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,30,622732326530,"Plasma, EDTA",Not Received,Frozen,,HIV-1/HIV-2 QUAL,RNA FROZEN,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,23,622732326523,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-5,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,,6227323266,1,622732326601,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,16:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,,6227323266,3,622732326603,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,16:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,17-Jan-2026,6227323266,2,622732326602,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,16:45,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,,6227323266,5,622732326605,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,16:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,,6227323266,7,622732326607,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,16:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,17-Jan-2026,6227323266,6,622732326606,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,16:45,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,16-Jan-2026,6227323266,9,622732326609,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,16:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,16-Jan-2026,6227323266,10,622732326610,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,16:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,17-Jan-2026,6227323266,8,622732326608,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,16:45,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,17-Jan-2026,6227323266,4,622732326604,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,16:45,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,16-Jan-2026,6227323266,12,622732326612,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,16:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,,6227323266,13,622732326613,"Red Cells, Clot",Not Received,,,"CHEM PANEL, BETA",HCG & FSH,,,,,16:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,,6227323266,11,622732326611,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,16:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,16-Jan-2026,6227323266,14,622732326614,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,16:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,,6227323266,15,622732326615,"Serum, SST",Cancelled,Ambient,,FSH,,,,,,16:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,,6227323268,1,622732326801,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,30-Jan-2026,6227323268,2,622732326802,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,,6227323268,3,622732326803,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,30-Jan-2026,6227323268,4,622732326804,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,,6227323268,5,622732326805,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,30-Jan-2026,6227323268,6,622732326806,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,,6227323268,7,622732326807,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,24-Jan-2026,6227323268,12,622732326812,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,,6227323268,13,622732326813,"Red Cells, Clot",Not Received,,,"CHEM PANEL, BETA",HCG & FSH,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,24-Jan-2026,6227323268,14,622732326814,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,,6227323268,15,622732326815,"Serum, SST",Cancelled,Ambient,,FSH,,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,30-Jan-2026,6227323268,8,622732326808,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,24-Jan-2026,6227323268,10,622732326810,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,24-Jan-2026,6227323268,9,622732326809,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,,6227323268,11,622732326811,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,,6227323270,3,622732327003,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,08:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,2,622732327002,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,4,622732327004,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,,6227323270,5,622732327005,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,08:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,6,622732327006,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,1,622732327001,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,8,622732327008,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,,6227323270,7,622732327007,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,08:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,10,622732327010,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,9,622732327009,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,11,622732327011,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,,6227323270,12,622732327012,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,08:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,13,622732327013,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,14,622732327014,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,15,622732327015,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,18,622732327018,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,,6227323270,17,622732327017,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL",& CRP,,,,,08:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,16,622732327016,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,,6227323272,1,622732327201,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,07:10,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,28-Mar-2026,6227323272,2,622732327202,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-2 TROUGH,77242113UCO3001,,,,,07:10,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,28-Mar-2026,6227323272,12,622732327212,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-5,,,,,07:10,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,28-Mar-2026,6227323272,13,622732327213,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,07:10,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,,6227323272,3,622732327203,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,07:10,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,,6227323272,11,622732327211,"Stool, unpreserved",Cancelled,Frozen,,STOOL I-2,77242113UCO3001-4,,,,,07:10,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,28-Mar-2026,6227323272,14,622732327214,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:10,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,28-Mar-2026,6227323272,15,622732327215,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:10,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,28-Mar-2026,6227323272,17,622732327217,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,07:10,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,,6227323272,10,622732327210,"Stool, unpreserved",Cancelled,Frozen,,STOOL I-2,77242113UCO3001-3,,,,,07:10,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,,6227323272,16,622732327216,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,07:10,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,,6227323272,5,622732327205,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,07:10,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,28-Mar-2026,6227323272,6,622732327206,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-1,,,,,07:10,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,28-Mar-2026,6227323272,4,622732327204,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-2 PEAK,77242113UCO3001,,,,,07:10,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,28-Mar-2026,6227323272,7,622732327207,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-2,,,,,07:10,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,,6227323272,8,622732327208,"Stool, unpreserved",Cancelled,Frozen,,STOOL I-2,77242113UCO3001-1,,,,,07:10,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,,6227323272,9,622732327209,"Stool, unpreserved",Cancelled,Frozen,,STOOL I-2,77242113UCO3001-2,,,,,07:10,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,,6227323274,1,622732327401,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,2,622732327402,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,3,622732327403,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,5,622732327405,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,4,622732327404,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,,6227323274,6,622732327406,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-1,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,,6227323274,7,622732327407,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-2,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,,6227323274,8,622732327408,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-3,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,,6227323274,9,622732327409,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-4,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,,6227323274,11,622732327411,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,10,622732327410,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-4,77242113UCO3001-5,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,12,622732327412,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-4 TROUGH,77242113UCO3001,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,20,622732327420,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,21,622732327421,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,,6227323274,13,622732327413,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,22,622732327422,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,,6227323274,15,622732327415,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,19,622732327419,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,16,622732327416,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-1,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,14,622732327414,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-4 PEAK,77242113UCO3001,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,17,622732327417,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-2,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,,6227323274,18,622732327418,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRNSTOOL,16-Jan-2026,,6227323276,1,622732327601,"Stool, ova & parasites(form)",Not Received,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,16:55,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRNSTOOL,16-Jan-2026,16-Jan-2026,6227323276,2,622732327602,"Stool, unpreserved",Cancelled,Frozen,,C-DIFF TOXIN,& PCR FROZEN,,,,,16:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRNSTOOL,16-Jan-2026,,6227323276,4,622732327604,"Stool, ova & parasites(PVA)",Not Received,Ambient,,OVA & PARASITES 2,PVA,,,,,16:55,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRNSTOOL,16-Jan-2026,16-Jan-2026,6227323276,3,622732327603,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,16:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRNSTOOL,24-Jan-2026,,6227323277,1,622732327701,"Stool, ova & parasites(form)",Cancelled,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,10:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRNSTOOL,24-Jan-2026,24-Jan-2026,6227323277,3,622732327703,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,10:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRNSTOOL,24-Jan-2026,24-Jan-2026,6227323277,2,622732327702,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,10:10,12:40,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRNSTOOL,24-Jan-2026,,6227323277,4,622732327704,"Stool, ova & parasites(PVA)",Cancelled,Ambient,,OVA & PARASITES 2,PVA,,,,,10:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,DNA,10-Mar-2026,10-Mar-2026,6227323283,1,622732328301,"Whole Blood, EDTA, Dry",Shipped,Frozen,Default Return Frozen,SM08/WB DNA,77242113UCO3001,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,DNA,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,18-Feb-2026,BXSCR,19-Feb-2026,19-Feb-2026,6227323286,1,622732328601,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,10:20,Czech Republic,,10:20,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,18-Feb-2026,BXSCR,19-Feb-2026,21-Feb-2026,6227323286,3,622732328603,"Biopsy, Frozen Tissue",Shipped,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,05:55,Czech Republic,,10:20,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,18-Feb-2026,BXSCR,19-Feb-2026,21-Feb-2026,6227323286,2,622732328602,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,05:55,Czech Republic,,10:20,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,18-Feb-2026,BXSCR,19-Feb-2026,,6227323286,4,622732328604,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,10:20,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,11-Feb-2026,BXSCR,12-Feb-2026,12-Feb-2026,6227323287,1,622732328701,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,11-Feb-2026,BXSCR,12-Feb-2026,14-Feb-2026,6227323287,3,622732328703,"Biopsy, Frozen Tissue",Shipped,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:45,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,11-Feb-2026,BXSCR,12-Feb-2026,,6227323287,4,622732328704,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,11-Feb-2026,BXSCR,12-Feb-2026,14-Feb-2026,6227323287,2,622732328702,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,05:55,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,2,622732329502,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,3,622732329503,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL,","BHCG, FSH & CRP",,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,1,622732329501,"Whole Blood, EDTA, Dry",Not Received,Ambient,,HEMATOLOGY,,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,6,622732329506,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,5,622732329505,"Serum, SST",Not Received,Ambient,,FSH,,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,7,622732329507,"Serum, SST",Not Received,Ambient,,"HIV SCREEN,",HEPATITIS B & C,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,8,622732329508,"Feces, unpreserved",Not Received,Frozen,,FECAL CALPROTECTIN,FROZEN,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,11,622732329511,"Whole Blood, EDTA, Dry",Not Received,,,HBV DNA COBAS 6800,,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,9,622732329509,"Whole Blood, EDTA, Dry",Not Received,,,HCV RNA COBAS 6800,,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,10,622732329510,"Plasma, EDTA",Not Received,Frozen,,HCV RNA COBAS 6800,FROZEN,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,14-Mar-2026,6227323295,4,622732329504,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",BETA HCG & CRP,,,,,08:40,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,12,622732329512,"Plasma, EDTA",Not Received,Frozen,,HBV DNA COBAS 6800,FROZEN,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,13,622732329513,"Stool, unpreserved",Not Received,Frozen,,SM10/FECAL,BIOMARKERS,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,14,622732329514,Whole Blood PAXgene RNA,Not Received,Frozen,,SM07/WB RNA,77242113UCO3001,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,16,622732329516,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-1,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,15,622732329515,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,17,622732329517,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-2,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,19,622732329519,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,18,622732329518,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-3,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,20,622732329520,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-2,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,23,622732329523,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-5,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,22,622732329522,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-4,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,21,622732329521,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-3,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,25,622732329525,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-1,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,26,622732329526,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-2,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,27,622732329527,"Whole Blood, EDTA, Dry",Not Received,,,SM03/PLASMA PK,,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,24,622732329524,"Red Cells, Clot",Not Received,,,SM05/SERUM ADA,,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,29,622732329529,"Whole Blood, EDTA, Dry",Not Received,,,HIV-1/HIV-2,QUALITATIVE RNA,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,30,622732329530,"Plasma, EDTA",Not Received,Frozen,,HIV-1/HIV-2 QUAL,RNA FROZEN,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,28,622732329528,"Plasma, EDTA",Not Received,Frozen,,PLASMA PK,77242113UCO3001,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,2,622732329702,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,14-Mar-2026,6227323297,4,622732329704,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",BETA HCG & CRP,,,,,07:45,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,6,622732329706,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,5,622732329705,"Serum, SST",Not Received,Ambient,,FSH,,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,1,622732329701,"Whole Blood, EDTA, Dry",Not Received,Ambient,,HEMATOLOGY,,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,3,622732329703,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL,","BHCG, FSH & CRP",,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,7,622732329707,"Serum, SST",Not Received,Ambient,,"HIV SCREEN,",HEPATITIS B & C,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,8,622732329708,"Feces, unpreserved",Not Received,Frozen,,FECAL CALPROTECTIN,FROZEN,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,10,622732329710,"Plasma, EDTA",Not Received,Frozen,,HCV RNA COBAS 6800,FROZEN,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,9,622732329709,"Whole Blood, EDTA, Dry",Not Received,,,HCV RNA COBAS 6800,,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,11,622732329711,"Whole Blood, EDTA, Dry",Not Received,,,HBV DNA COBAS 6800,,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,12,622732329712,"Plasma, EDTA",Not Received,Frozen,,HBV DNA COBAS 6800,FROZEN,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,14,622732329714,Whole Blood PAXgene RNA,Not Received,Frozen,,SM07/WB RNA,77242113UCO3001,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,13,622732329713,"Stool, unpreserved",Not Received,Frozen,,SM10/FECAL,BIOMARKERS,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,18,622732329718,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-3,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,16,622732329716,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-1,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,15,622732329715,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,20,622732329720,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-2,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,19,622732329719,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,17,622732329717,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-2,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,21,622732329721,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-3,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,23,622732329723,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-5,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,25,622732329725,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-1,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,27,622732329727,"Whole Blood, EDTA, Dry",Not Received,,,SM03/PLASMA PK,,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,26,622732329726,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-2,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,28,622732329728,"Plasma, EDTA",Not Received,Frozen,,PLASMA PK,77242113UCO3001,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,29,622732329729,"Whole Blood, EDTA, Dry",Not Received,,,HIV-1/HIV-2,QUALITATIVE RNA,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,30,622732329730,"Plasma, EDTA",Not Received,Frozen,,HIV-1/HIV-2 QUAL,RNA FROZEN,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,22,622732329722,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-4,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,24,622732329724,"Red Cells, Clot",Not Received,,,SM05/SERUM ADA,,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,,6227323299,1,622732329901,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,08:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,,6227323299,3,622732329903,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,08:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,15-May-2026,6227323299,4,622732329904,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,08:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,,6227323299,5,622732329905,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,08:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,15-May-2026,6227323299,2,622732329902,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,08:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,,6227323299,7,622732329907,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,08:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,15-May-2026,6227323299,8,622732329908,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,08:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,14-May-2026,6227323299,9,622732329909,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,15-May-2026,6227323299,6,622732329906,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,08:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,,6227323299,11,622732329911,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,08:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,14-May-2026,6227323299,12,622732329912,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,08:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,14-May-2026,6227323299,10,622732329910,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,,6227323299,13,622732329913,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,08:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,14-May-2026,6227323299,15,622732329915,"Serum, SST",Received,Ambient,Default Return Ambient,FSH,,,,,,08:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,14-May-2026,6227323299,14,622732329914,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,08:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRNSTOOL,14-May-2026,14-May-2026,6227323309,1,622732330901,"Stool, ova & parasites(form)",Received,Ambient,Default Return Ambient,OVA & PARASITES 1,FORMALIN,,,,,09:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRNSTOOL,14-May-2026,14-May-2026,6227323309,2,622732330902,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,09:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRNSTOOL,14-May-2026,14-May-2026,6227323309,4,622732330904,"Stool, ova & parasites(PVA)",Received,Ambient,Default Return Ambient,OVA & PARASITES 2,PVA,,,,,09:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRNSTOOL,14-May-2026,14-May-2026,6227323309,3,622732330903,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,09:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,27-May-2026,BXSCR,28-May-2026,28-May-2026,6227323320,1,622732332001,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,27-May-2026,BXSCR,28-May-2026,,6227323320,2,622732332002,Biopsy RNA Later,Not Received,Frozen,,SM13/BIOPSY RNA,FROZEN,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,27-May-2026,BXSCR,28-May-2026,,6227323320,3,622732332003,"Biopsy, Frozen Tissue",Not Received,Frozen,,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,27-May-2026,BXSCR,28-May-2026,,6227323320,4,622732332004,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,,6227323330,1,622732333001,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,08:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,03-Apr-2026,6227323330,2,622732333002,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,,6227323330,3,622732333003,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,08:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,,6227323330,5,622732333005,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,08:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,03-Apr-2026,6227323330,4,622732333004,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,,6227323330,7,622732333007,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,08:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,03-Apr-2026,6227323330,8,622732333008,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,01-Apr-2026,6227323330,9,622732333009,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,03-Apr-2026,6227323330,6,622732333006,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,01-Apr-2026,6227323330,10,622732333010,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,,6227323330,11,622732333011,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,08:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,,6227323330,13,622732333013,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,08:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,01-Apr-2026,6227323330,12,622732333012,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,,6227323330,15,622732333015,"Serum, SST",Cancelled,Ambient,,FSH,FROZEN,,,,,08:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,01-Apr-2026,6227323330,14,622732333014,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,,6227323332,1,622732333201,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,12:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,21-Apr-2026,6227323332,2,622732333202,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,12:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,,6227323332,3,622732333203,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,12:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,21-Apr-2026,6227323332,6,622732333206,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,12:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,21-Apr-2026,6227323332,4,622732333204,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,12:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,21-Apr-2026,6227323332,8,622732333208,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,12:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,17-Apr-2026,6227323332,9,622732333209,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,12:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,,6227323332,5,622732333205,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,12:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,17-Apr-2026,6227323332,10,622732333210,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,,6227323332,7,622732333207,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,12:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,,6227323332,11,622732333211,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,12:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,17-Apr-2026,6227323332,12,622732333212,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,12:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,17-Apr-2026,6227323332,14,622732333214,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,12:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,,6227323332,13,622732333213,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,12:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,17-Apr-2026,6227323332,15,622732333215,"Serum, SST",Received,Ambient,Default Return Ambient,FSH,,,,,,12:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,1,622732333401,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,4,622732333404,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,2,622732333402,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,,6227323334,5,622732333405,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,11:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,,6227323334,3,622732333403,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,11:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,6,622732333406,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,,6227323334,7,622732333407,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,11:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,8,622732333408,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,9,622732333409,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,10,622732333410,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,11,622732333411,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,,6227323334,12,622732333412,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,11:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,13,622732333413,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,14,622732333414,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,15,622732333415,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,16,622732333416,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,,6227323334,17,622732333417,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL",& CRP,,,,,11:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,18,622732333418,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,2,622732333502,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMPK I-2 TROUGH,77242113UCO3001,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,,6227323335,3,622732333503,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,10:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,,6227323335,5,622732333505,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,10:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,,6227323335,1,622732333501,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,10:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,7,622732333507,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-2,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,6,622732333506,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-1,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,4,622732333504,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMA PK I-2 PEAK,77242113UCO3001,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,8,622732333508,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-1,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,9,622732333509,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-2,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,11,622732333511,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-4,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,10,622732333510,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-3,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,13,622732333513,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,15,622732333515,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,,6227323335,16,622732333516,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,10:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,17,622732333517,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,14,622732333514,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,12,622732333512,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-5,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,02-Apr-2026,SCRNSTOOL,03-Apr-2026,03-Apr-2026,6227323340,2,622732334002,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,06:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,02-Apr-2026,SCRNSTOOL,03-Apr-2026,03-Apr-2026,6227323340,4,622732334004,"Stool, ova & parasites(PVA)",Received,Ambient,Default Return Ambient,OVA & PARASITES 2,PVA,,,,,06:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,02-Apr-2026,SCRNSTOOL,03-Apr-2026,03-Apr-2026,6227323340,3,622732334003,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,06:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,02-Apr-2026,SCRNSTOOL,03-Apr-2026,03-Apr-2026,6227323340,1,622732334001,"Stool, ova & parasites(form)",Received,Ambient,Default Return Ambient,OVA & PARASITES 1,FORMALIN,,,,,06:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,20-Apr-2026,SCRNSTOOL,21-Apr-2026,21-Apr-2026,6227323341,1,622732334101,"Stool, ova & parasites(form)",Received,Ambient,Default Return Ambient,OVA & PARASITES 1,FORMALIN,,,,,06:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,20-Apr-2026,SCRNSTOOL,21-Apr-2026,21-Apr-2026,6227323341,2,622732334102,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,06:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,20-Apr-2026,SCRNSTOOL,21-Apr-2026,21-Apr-2026,6227323341,3,622732334103,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,06:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,20-Apr-2026,SCRNSTOOL,21-Apr-2026,21-Apr-2026,6227323341,4,622732334104,"Stool, ova & parasites(PVA)",Received,Ambient,Default Return Ambient,OVA & PARASITES 2,PVA,,,,,06:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,DNA,06-May-2026,06-May-2026,6227323346,1,622732334601,"Whole Blood, EDTA, Dry",In Inventory,Frozen,Default Return Frozen,SM08/WB DNA,77242113UCO3001,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,DNA,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,05-May-2026,TB,07-May-2026,,6227323348,1,622732334801,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,09:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,05-May-2026,TB,07-May-2026,07-May-2026,6227323348,2,622732334802,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,09:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,05-May-2026,TB,07-May-2026,,6227323348,3,622732334803,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,09:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,05-May-2026,TB,07-May-2026,07-May-2026,6227323348,4,622732334804,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,09:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,05-May-2026,TB,07-May-2026,,6227323348,5,622732334805,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,09:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,05-May-2026,TB,07-May-2026,,6227323348,7,622732334807,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,09:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,05-May-2026,TB,07-May-2026,07-May-2026,6227323348,6,622732334806,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,09:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,05-May-2026,TB,07-May-2026,07-May-2026,6227323348,8,622732334808,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,09:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,24-Apr-2026,BXSCR,28-Apr-2026,,6227323351,4,622732335104,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,24-Apr-2026,BXSCR,28-Apr-2026,28-Apr-2026,6227323351,3,622732335103,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,24-Apr-2026,BXSCR,28-Apr-2026,28-Apr-2026,6227323351,2,622732335102,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,24-Apr-2026,BXSCR,28-Apr-2026,28-Apr-2026,6227323351,1,622732335101,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,BDL,06-May-2026,,6227323355,1,622732335501,"Red Cells, Clot",Not Received,,,DRUG LEVEL TESTING,,,,,,11:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biologic Drug Level,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,BDL,06-May-2026,06-May-2026,6227323355,2,622732335502,"Serum, SST",Shipped,Frozen,Default Return Frozen,"ADA, GOL, INF",UST OR VED FROZEN,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biologic Drug Level,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,,6227635139,1,622763513901,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,,6227635139,3,622763513903,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,03-Apr-2026,6227635139,8,622763513908,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,08:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,03-Apr-2026,6227635139,4,622763513904,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,08:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,03-Apr-2026,6227635139,2,622763513902,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,08:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,,6227635140,5,622763514005,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,13:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,28-Feb-2026,6227635140,8,622763514008,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,13:20,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,,6227635139,13,622763513913,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,03-Apr-2026,6227635139,6,622763513906,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,08:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,28-Feb-2026,6227635140,6,622763514006,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,13:20,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,,6227635140,7,622763514007,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,13:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,27-Feb-2026,6227635140,9,622763514009,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,13:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,02-Apr-2026,6227635139,10,622763513910,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,,6227635139,15,622763513915,"Serum, SST",Cancelled,Ambient,,FSH,FROZEN,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,02-Apr-2026,6227635139,12,622763513912,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,08:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,02-Apr-2026,6227635139,9,622763513909,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,,6227635139,7,622763513907,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,28-Feb-2026,6227635140,4,622763514004,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,13:20,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,,6227635139,11,622763513911,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,28-Feb-2026,6227635140,2,622763514002,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,13:20,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,,6227635140,3,622763514003,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,13:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,,6227635140,1,622763514001,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,13:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,,6227635139,5,622763513905,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,02-Apr-2026,6227635139,14,622763513914,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,08:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,27-Feb-2026,6227635140,12,622763514012,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,13:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,27-Feb-2026,6227635140,14,622763514014,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,13:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,,6227635141,1,622763514101,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,,6227635140,15,622763514015,"Serum, SST",Cancelled,Ambient,,FSH,FROZEN,,,,,13:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,08-May-2026,6227635141,2,622763514102,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,,6227635140,11,622763514011,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,13:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,27-Feb-2026,6227635140,10,622763514010,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,13:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,,6227635141,3,622763514103,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,,6227635140,13,622763514013,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,13:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,08-May-2026,6227635141,8,622763514108,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,07-May-2026,6227635141,9,622763514109,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,,6227635141,11,622763514111,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,07-May-2026,6227635141,12,622763514112,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,07-May-2026,6227635141,10,622763514110,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,,6227635141,13,622763514113,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,,6227635141,7,622763514107,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,08-May-2026,6227635141,6,622763514106,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,,6227635142,3,622763514203,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,09:40,,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,4,622763514204,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,13,622763514213,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,,6227635142,5,622763514205,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,09:40,,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,,6227635141,5,622763514105,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,08-May-2026,6227635141,4,622763514104,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,6,622763514206,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,14,622763514214,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,2,622763514202,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,10,622763514210,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,1,622763514201,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,15,622763514215,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,,6227635142,7,622763514207,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,09:40,,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,9,622763514209,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,16,622763514216,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,,6227635142,17,622763514217,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL",& CRP,,,,,09:40,,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,07-May-2026,6227635141,14,622763514114,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,,6227635141,15,622763514115,"Serum, SST",Cancelled,Ambient,,FSH,FROZEN,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,,6227635142,12,622763514212,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,09:40,,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,11,622763514211,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,8,622763514208,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,18,622763514218,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,09-Apr-2026,6227635144,7,622763514407,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-2,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,09-Apr-2026,6227635144,6,622763514406,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-1,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,,6227635144,3,622763514403,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,08:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,09-Apr-2026,6227635144,2,622763514402,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-2 TROUGH,77242113UCO3001,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,,6227635144,1,622763514401,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,08:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,08-Apr-2026,6227635144,15,622763514415,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,,6227635144,16,622763514416,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,08:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,09-Apr-2026,6227635144,8,622763514408,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-1,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,09-Apr-2026,6227635144,10,622763514410,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-3,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,09-Apr-2026,6227635144,4,622763514404,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-2 PEAK,77242113UCO3001,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,08-Apr-2026,6227635144,17,622763514417,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,09-Apr-2026,6227635144,12,622763514412,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-5,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,09-Apr-2026,6227635144,11,622763514411,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-4,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,08-Apr-2026,6227635144,14,622763514414,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,09-Apr-2026,6227635144,13,622763514413,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,,6227635144,5,622763514405,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,08:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,09-Apr-2026,6227635144,9,622763514409,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-2,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,2,622763514602,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,3,622763514603,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,23-Apr-2026,6227635146,8,622763514608,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-4,77242113UCO3001-3,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,23-Apr-2026,6227635146,9,622763514609,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-4,77242113UCO3001-4,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,23-Apr-2026,6227635146,10,622763514610,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-4,77242113UCO3001-5,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,16,622763514616,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-1,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,14,622763514614,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-4 PEAK,77242113UCO3001,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,21,622763514621,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,4,622763514604,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,5,622763514605,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,,6227635146,15,622763514615,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,,6227635146,18,622763514618,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,,6227635146,11,622763514611,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,,6227635146,13,622763514613,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,23-Apr-2026,6227635146,6,622763514606,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-4,77242113UCO3001-1,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,22,622763514622,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,23-Apr-2026,6227635146,7,622763514607,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-4,77242113UCO3001-2,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,19,622763514619,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,,6227635146,1,622763514601,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,17,622763514617,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-2,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,12,622763514612,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-4 TROUGH,77242113UCO3001,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,20,622763514620,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRNSTOOL,02-Apr-2026,02-Apr-2026,6227635148,3,622763514803,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRNSTOOL,02-Apr-2026,02-Apr-2026,6227635148,4,622763514804,"Stool, ova & parasites(PVA)",Received,Ambient,Default Return Ambient,OVA & PARASITES 2,PVA,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRNSTOOL,02-Apr-2026,02-Apr-2026,6227635148,1,622763514801,"Stool, ova & parasites(form)",Received,Ambient,Default Return Ambient,OVA & PARASITES 1,FORMALIN,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,07-May-2026,SCRNSTOOL,08-May-2026,08-May-2026,6227635150,2,622763515002,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,05:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,07-May-2026,SCRNSTOOL,08-May-2026,08-May-2026,6227635150,3,622763515003,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,05:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRNSTOOL,27-Feb-2026,27-Feb-2026,6227635149,2,622763514902,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,07-May-2026,SCRNSTOOL,08-May-2026,08-May-2026,6227635150,4,622763515004,"Stool, ova & parasites(PVA)",Received,Ambient,Default Return Ambient,OVA & PARASITES 2,PVA,,,,,05:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRNSTOOL,02-Apr-2026,02-Apr-2026,6227635148,2,622763514802,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRNSTOOL,27-Feb-2026,27-Feb-2026,6227635149,1,622763514901,"Stool, ova & parasites(form)",Received,Ambient,Default Return Ambient,OVA & PARASITES 1,FORMALIN,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRNSTOOL,27-Feb-2026,27-Feb-2026,6227635149,4,622763514904,"Stool, ova & parasites(PVA)",Received,Ambient,Default Return Ambient,OVA & PARASITES 2,PVA,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRNSTOOL,27-Feb-2026,27-Feb-2026,6227635149,3,622763514903,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,07-May-2026,SCRNSTOOL,08-May-2026,08-May-2026,6227635150,1,622763515001,"Stool, ova & parasites(form)",Received,Ambient,Default Return Ambient,OVA & PARASITES 1,FORMALIN,,,,,05:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,DNA,26-Mar-2026,26-Mar-2026,6227635156,1,622763515601,"Whole Blood, EDTA, Dry",Shipped,Frozen,Default Return Frozen,SM08/WB DNA,77242113UCO3001,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,DNA,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,DNA,27-May-2026,27-May-2026,6227635155,1,622763515501,"Whole Blood, EDTA, Dry",In Inventory,Frozen,Default Return Frozen,SM08/WB DNA,77242113UCO3001,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,DNA,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,21-Apr-2026,BXSCR,22-Apr-2026,,6227635159,4,622763515904,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,21-Apr-2026,BXSCR,22-Apr-2026,22-Apr-2026,6227635159,1,622763515901,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,21-Apr-2026,BXSCR,22-Apr-2026,23-Apr-2026,6227635159,2,622763515902,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,21-Apr-2026,BXSCR,22-Apr-2026,23-Apr-2026,6227635159,3,622763515903,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,12-Mar-2026,BXSCR,13-Mar-2026,14-Mar-2026,6227635161,3,622763516103,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:20,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,12-Mar-2026,BXSCR,13-Mar-2026,,6227635161,4,622763516104,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,12-Mar-2026,BXSCR,13-Mar-2026,13-Mar-2026,6227635161,1,622763516101,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,12-Mar-2026,BXSCR,13-Mar-2026,14-Mar-2026,6227635161,2,622763516102,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:20,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,,6227635171,1,622763517101,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,23-Apr-2026,6227635171,2,622763517102,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,,6227635171,5,622763517105,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,,6227635171,7,622763517107,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,,6227635171,3,622763517103,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,23-Apr-2026,6227635171,6,622763517106,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,23-Apr-2026,6227635171,4,622763517104,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,22-Apr-2026,6227635171,10,622763517110,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,22-Apr-2026,6227635171,14,622763517114,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,22-Apr-2026,6227635171,15,622763517115,"Serum, SST",Received,Ambient,Default Return Ambient,FSH,,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,,6227635171,11,622763517111,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,23-Apr-2026,6227635171,8,622763517108,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,22-Apr-2026,6227635171,9,622763517109,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,,6227635171,13,622763517113,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,22-Apr-2026,6227635171,12,622763517112,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,,6227635173,2,622763517302,"Plasma, QuantiFERON Nil",Not Received,Frozen,,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,12:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,,6227635173,6,622763517306,"Plasma, QuantiFERON TB2",Not Received,Frozen,,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,12:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,,6227635173,7,622763517307,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,12:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,,6227635173,8,622763517308,"Plasma, QuantiFERON Mitoge",Not Received,Frozen,,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,12:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,,6227635173,5,622763517305,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,12:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,28-May-2026,6227635173,10,622763517310,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,,6227635173,4,622763517304,"Plasma, QuantiFERON TB1",Not Received,Frozen,,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,12:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,28-May-2026,6227635173,9,622763517309,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,12:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,,6227635173,1,622763517301,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,12:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,,6227635173,3,622763517303,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,12:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,28-May-2026,6227635173,14,622763517314,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,12:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,,6227635173,13,622763517313,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,12:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,29-May-2026,6227635174,1,622763517401,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,28-May-2026,6227635173,15,622763517315,"Serum, SST",Received,Ambient,Default Return Ambient,FSH,,,,,,12:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,3,622763517403,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,,6227635173,11,622763517311,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,12:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,29-May-2026,6227635174,2,622763517402,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,28-May-2026,6227635173,12,622763517312,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,12:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,9,622763517409,"Serum, SST",Not Received,Frozen,Specimen not submitted,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,5,622763517405,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,11,622763517411,Whole Blood PAXgene RNA,Not Received,Frozen,Specimen not submitted,SM07/WB RNA,77242113UCO3001,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,6,622763517406,"Plasma, EDTA",Not Received,Frozen,Specimen not submitted,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,12,622763517412,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,4,622763517404,"Plasma, EDTA",Not Received,Frozen,Specimen not submitted,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,7,622763517407,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,8,622763517408,"Serum, SST",Not Received,Frozen,Specimen not submitted,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,13,622763517413,"Serum, SST",Not Received,Frozen,Specimen not submitted,SM06/SERUM BIOM,77242113UCO3001-1,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,10,622763517410,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,SM10/FECAL,BIOMARKERS,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,14,622763517414,"Serum, SST",Not Received,Frozen,Specimen not submitted,SM06/SERUM BIOM,77242113UCO3001-2,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,29-May-2026,6227635174,18,622763517418,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,17,622763517417,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL",& CRP,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,15,622763517415,"Serum, SST",Not Received,Frozen,Specimen not submitted,SM06/SERUM BIOM,77242113UCO3001-3,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,16,622763517416,"Feces, unpreserved",Not Received,Frozen,Specimen not submitted,FECAL CALPROTECTIN,FROZEN,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRNSTOOL,28-May-2026,,6227635180,1,622763518001,"Stool, ova & parasites(form)",Not Received,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,13:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRNSTOOL,28-May-2026,28-May-2026,6227635180,3,622763518003,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,13:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRNSTOOL,28-May-2026,,6227635180,4,622763518004,"Stool, ova & parasites(PVA)",Not Received,Ambient,,OVA & PARASITES 2,PVA,,,,,13:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRNSTOOL,28-May-2026,,6227635180,2,622763518002,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,C-DIFF TOXIN,& PCR FROZEN,,,,,13:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,24-Apr-2026,SCRNSTOOL,25-Apr-2026,,6227635182,4,622763518204,"Stool, ova & parasites(PVA)",Not Received,Ambient,,OVA & PARASITES 2,PVA,,,,,08:45,,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,24-Apr-2026,SCRNSTOOL,25-Apr-2026,25-Apr-2026,6227635182,3,622763518203,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,08:45,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,24-Apr-2026,SCRNSTOOL,25-Apr-2026,,6227635182,1,622763518201,"Stool, ova & parasites(form)",Not Received,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,08:45,,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,24-Apr-2026,SCRNSTOOL,25-Apr-2026,,6227635182,2,622763518202,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,C-DIFF TOXIN,& PCR FROZEN,,,,,08:45,,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,19-May-2026,BXSCR,20-May-2026,21-May-2026,6227635193,2,622763519302,Biopsy RNA Later,In Inventory,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,19-May-2026,BXSCR,20-May-2026,20-May-2026,6227635193,1,622763519301,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,19-May-2026,BXSCR,20-May-2026,21-May-2026,6227635193,3,622763519303,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,19-May-2026,BXSCR,20-May-2026,,6227635193,4,622763519304,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,,6227635204,1,622763520401,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,12:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,03-Mar-2026,6227635204,2,622763520402,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,12:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,,6227635204,3,622763520403,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,12:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,26-Feb-2026,6227635204,15,622763520415,"Serum, SST",Received,Ambient,Default Return Ambient,FSH,,,,,,12:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,26-Feb-2026,6227635204,9,622763520409,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,12:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,26-Feb-2026,6227635204,10,622763520410,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,,6227635204,11,622763520411,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,12:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,26-Feb-2026,6227635204,12,622763520412,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,12:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,,6227635204,13,622763520413,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,12:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,,6227635204,5,622763520405,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,12:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,03-Mar-2026,6227635204,4,622763520404,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,12:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,26-Feb-2026,6227635204,14,622763520414,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,12:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,,6227635204,7,622763520407,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,12:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,03-Mar-2026,6227635204,6,622763520406,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,12:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,03-Mar-2026,6227635204,8,622763520408,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,12:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227635207,2,622763520702,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,09-Apr-2026,6227635207,8,622763520708,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,,6227635207,5,622763520705,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,10:37,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,09-Apr-2026,6227635207,4,622763520704,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,09-Apr-2026,6227635207,9,622763520709,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227635207,1,622763520701,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,09-Apr-2026,6227635207,11,622763520711,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,,6227635207,3,622763520703,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,10:37,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,09-Apr-2026,6227635207,6,622763520706,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,,6227635207,17,622763520717,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL",& CRP,,,,,10:37,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227635207,18,622763520718,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,28-Apr-2026,6227635208,2,622763520802,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-2 TROUGH,77242113UCO3001,,,,,08:43,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,,6227635208,3,622763520803,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,08:43,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,09-Apr-2026,6227635207,13,622763520713,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,,6227635208,1,622763520801,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,08:43,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,,6227635207,7,622763520707,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,10:37,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,09-Apr-2026,6227635207,10,622763520710,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,,6227635207,12,622763520712,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,10:37,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,09-Apr-2026,6227635207,16,622763520716,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,28-Apr-2026,6227635208,7,622763520807,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-2,,,,,08:43,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,,6227635208,9,622763520809,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-2,,,,,08:43,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,,6227635208,10,622763520810,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-3,,,,,08:43,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,,6227635208,11,622763520811,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-4,,,,,08:43,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,09-Apr-2026,6227635207,14,622763520714,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,09-Apr-2026,6227635207,15,622763520715,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,,6227635208,12,622763520812,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-5,,,,,08:43,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,28-Apr-2026,6227635208,4,622763520804,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-2 PEAK,77242113UCO3001,,,,,08:43,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,28-Apr-2026,6227635208,6,622763520806,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-1,,,,,08:43,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,28-Apr-2026,6227635208,8,622763520808,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-1,,,,,08:43,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,21-Apr-2026,6227635208,17,622763520817,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,08:43,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,21-Apr-2026,6227635208,14,622763520814,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:43,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,,6227635208,5,622763520805,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,08:43,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,28-Apr-2026,6227635208,13,622763520813,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,08:43,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,,6227635208,16,622763520816,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,08:43,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,21-Apr-2026,6227635208,15,622763520815,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:43,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,06-May-2026,6227635211,2,622763521102,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,06-May-2026,6227635211,3,622763521103,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,06-May-2026,6227635211,4,622763521104,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,,6227635211,1,622763521101,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,,6227635211,8,622763521108,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-3,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,,6227635211,10,622763521110,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-5,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,07-May-2026,6227635211,6,622763521106,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-4,77242113UCO3001-1,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,,6227635211,5,622763521105,"Feces, unpreserved",Not Received,Frozen,Specimen not submitted,FECAL CALPROTECTIN,FROZEN,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,,6227635211,11,622763521111,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,,6227635211,13,622763521113,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,07-May-2026,6227635211,14,622763521114,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-4 PEAK,77242113UCO3001,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,,6227635211,7,622763521107,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-2,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,07-May-2026,6227635211,19,622763521119,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,07-May-2026,6227635211,16,622763521116,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-1,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,07-May-2026,6227635211,20,622763521120,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,,6227635211,9,622763521109,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-4,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,07-May-2026,6227635211,21,622763521121,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,07-May-2026,6227635211,22,622763521122,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,07-May-2026,6227635211,17,622763521117,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-2,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,,6227635211,18,622763521118,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,07-May-2026,6227635211,12,622763521112,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-4 TROUGH,77242113UCO3001,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,01-Mar-2026,SCRNSTOOL,03-Mar-2026,03-Mar-2026,6227635213,2,622763521302,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,14:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,01-Mar-2026,SCRNSTOOL,03-Mar-2026,03-Mar-2026,6227635213,3,622763521303,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,14:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,01-Mar-2026,SCRNSTOOL,03-Mar-2026,03-Mar-2026,6227635213,4,622763521304,"Stool, ova & parasites(PVA)",Received,Ambient,Default Return Ambient,OVA & PARASITES 2,PVA,,,,,14:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,,6227635211,15,622763521115,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,01-Mar-2026,SCRNSTOOL,03-Mar-2026,03-Mar-2026,6227635213,1,622763521301,"Stool, ova & parasites(form)",Received,Ambient,Default Return Ambient,OVA & PARASITES 1,FORMALIN,,,,,14:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,DNA,09-Apr-2026,09-Apr-2026,6227635218,1,622763521801,"Whole Blood, EDTA, Dry",Shipped,Frozen,Default Return Frozen,SM08/WB DNA,77242113UCO3001,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,DNA,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,16-Mar-2026,BXSCR,18-Mar-2026,18-Mar-2026,6227635223,2,622763522302,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,16-Mar-2026,BXSCR,18-Mar-2026,18-Mar-2026,6227635223,1,622763522301,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,16-Mar-2026,BXSCR,18-Mar-2026,18-Mar-2026,6227635223,3,622763522303,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,16-Mar-2026,BXSCR,18-Mar-2026,,6227635223,4,622763522304,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,20-Mar-2026,6227697718,2,622769771802,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,09:18,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,,6227697718,3,622769771803,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,09:18,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,,6227697718,5,622769771805,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,09:18,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,,6227697718,1,622769771801,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,09:18,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,20-Mar-2026,6227697718,6,622769771806,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,09:18,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,20-Mar-2026,6227697718,4,622769771804,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,09:18,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,,6227697718,7,622769771807,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,09:18,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,,6227697718,11,622769771811,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,09:18,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,,6227697718,13,622769771813,"Red Cells, Clot",Not Received,,,"CHEM PANEL, BETA",HCG & FSH,,,,,09:18,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,19-Mar-2026,6227697718,10,622769771810,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:18,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,19-Mar-2026,6227697718,14,622769771814,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,09:18,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,19-Mar-2026,6227697718,15,622769771815,"Serum, SST",Received,Ambient,Default Return Ambient,FSH,,,,,,09:18,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,20-Mar-2026,6227697718,8,622769771808,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,09:18,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,1,622769771901,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,2,622769771902,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,4,622769771904,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,,6227697719,5,622769771905,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,11:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,,6227697719,3,622769771903,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,11:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,8,622769771908,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,,6227697719,7,622769771907,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,11:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,6,622769771906,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,10,622769771910,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,19-Mar-2026,6227697718,9,622769771809,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:18,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,11,622769771911,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,19-Mar-2026,6227697718,12,622769771812,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,09:18,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,9,622769771909,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,,6227697719,12,622769771912,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,11:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,13,622769771913,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,14,622769771914,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,,6227697719,17,622769771917,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL",& CRP,,,,,11:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,15,622769771915,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,16,622769771916,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,18,622769771918,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6227697722,6,622769772206,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-1,,,,,09:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6227697722,7,622769772207,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-2,,,,,09:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6227697722,13,622769772213,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,09:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,,6227697722,10,622769772210,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-3,,,,,09:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6227697722,12,622769772212,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-5,,,,,09:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,,6227697722,11,622769772211,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-4,,,,,09:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6227697722,14,622769772214,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,,6227697722,8,622769772208,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-1,,,,,09:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6227697722,15,622769772215,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,,6227697722,9,622769772209,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-2,,,,,09:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6227697722,2,622769772202,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-2 TROUGH,77242113UCO3001,,,,,09:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,,6227697722,5,622769772205,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,09:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,,6227697722,3,622769772203,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,09:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6227697722,4,622769772204,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-2 PEAK,77242113UCO3001,,,,,09:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,,6227697722,1,622769772201,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,09:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,,6227697723,1,622769772301,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,12:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,08-May-2026,6227697723,4,622769772304,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,08-May-2026,6227697723,2,622769772302,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,12:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,08-May-2026,6227697723,3,622769772303,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,12:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,,6227697723,5,622769772305,"Feces, unpreserved",Not Received,Frozen,Specimen not submitted,FECAL CALPROTECTIN,FROZEN,,,,,12:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,,6227697723,7,622769772307,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-2,,,,,12:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,,6227697722,16,622769772216,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,09:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6227697722,17,622769772217,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,09:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,08-May-2026,6227697723,21,622769772321,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,12:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,,6227697723,6,622769772306,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-1,,,,,12:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,08-May-2026,6227697723,12,622769772312,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-4 TROUGH,77242113UCO3001,,,,,12:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,,6227697723,13,622769772313,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,12:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,08-May-2026,6227697723,14,622769772314,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-4 PEAK,77242113UCO3001,,,,,12:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,,6227697723,9,622769772309,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-4,,,,,12:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,,6227697723,18,622769772318,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,12:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,08-May-2026,6227697723,16,622769772316,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-1,,,,,12:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,08-May-2026,6227697723,17,622769772317,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-2,,,,,12:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,,6227697723,8,622769772308,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-3,,,,,12:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,,6227697723,15,622769772315,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,12:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,08-May-2026,6227697723,19,622769772319,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,12:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,,6227697723,10,622769772310,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-5,,,,,12:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,08-May-2026,6227697723,20,622769772320,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,12:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,08-May-2026,6227697723,22,622769772322,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,12:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,,6227697723,11,622769772311,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,12:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,17-Mar-2026,SCRNSTOOL,19-Mar-2026,,6227697725,1,622769772501,"Stool, ova & parasites(form)",Not Received,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,17:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,17-Mar-2026,SCRNSTOOL,19-Mar-2026,19-Mar-2026,6227697725,3,622769772503,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,17:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,17-Mar-2026,SCRNSTOOL,19-Mar-2026,,6227697725,4,622769772504,"Stool, ova & parasites(PVA)",Not Received,Ambient,,OVA & PARASITES 2,PVA,,,,,17:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,17-Mar-2026,SCRNSTOOL,19-Mar-2026,19-Mar-2026,6227697725,2,622769772502,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,17:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,23-Mar-2026,BXSCR,24-Mar-2026,26-Mar-2026,6227697736,2,622769773602,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,DNA,08-Apr-2026,08-Apr-2026,6227697731,1,622769773101,"Whole Blood, EDTA, Dry",Shipped,Frozen,Default Return Frozen,SM08/WB DNA,77242113UCO3001,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,DNA,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,23-Mar-2026,BXSCR,24-Mar-2026,24-Mar-2026,6227697736,1,622769773601,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,23-Mar-2026,BXSCR,24-Mar-2026,,6227697736,4,622769773604,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,23-Mar-2026,BXSCR,24-Mar-2026,26-Mar-2026,6227697736,3,622769773603,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,5,622769774505,"Serum, SST",Not Received,Ambient,,FSH,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,1,622769774501,"Whole Blood, EDTA, Dry",Not Received,Ambient,,HEMATOLOGY,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,6,622769774506,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,4,622769774504,"Serum, SST",Not Received,Ambient,,"CHEM, LIPID PANEL",BETA HCG & CRP,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,08-May-2026,6227697745,8,622769774508,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,3,622769774503,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL,","BHCG, FSH & CRP",,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,2,622769774502,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,7,622769774507,"Serum, SST",Not Received,Ambient,,"HIV SCREEN,",HEPATITIS B & C,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,9,622769774509,"Whole Blood, EDTA, Dry",Not Received,,,HCV RNA COBAS 6800,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,14,622769774514,Whole Blood PAXgene RNA,Not Received,Frozen,,SM07/WB RNA,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,16,622769774516,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-1,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,18,622769774518,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-3,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,17,622769774517,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-2,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,13,622769774513,"Stool, unpreserved",Not Received,Frozen,,SM10/FECAL,BIOMARKERS,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,12,622769774512,"Plasma, EDTA",Not Received,Frozen,,HBV DNA COBAS 6800,FROZEN,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,11,622769774511,"Whole Blood, EDTA, Dry",Not Received,,,HBV DNA COBAS 6800,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,15,622769774515,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,19,622769774519,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,10,622769774510,"Plasma, EDTA",Not Received,Frozen,,HCV RNA COBAS 6800,FROZEN,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,30,622769774530,"Plasma, EDTA",Not Received,Frozen,,HIV-1/HIV-2 QUAL,RNA FROZEN,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,20,622769774520,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-2,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,22,622769774522,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-4,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,25,622769774525,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-1,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,23,622769774523,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-5,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,26,622769774526,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-2,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,21,622769774521,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-3,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,29,622769774529,"Whole Blood, EDTA, Dry",Not Received,,,HIV-1/HIV-2,QUALITATIVE RNA,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,27,622769774527,"Whole Blood, EDTA, Dry",Not Received,,,SM03/PLASMA PK,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,24,622769774524,"Red Cells, Clot",Not Received,,,SM05/SERUM ADA,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,28,622769774528,"Plasma, EDTA",Not Received,Frozen,,PLASMA PK,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,,6227810899,1,622781089901,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,11:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,,6227810899,3,622781089903,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,11:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,,6227810899,2,622781089902,"Plasma, QuantiFERON Nil",Cancelled,Frozen,,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,11:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,,6227810899,4,622781089904,"Plasma, QuantiFERON TB1",Cancelled,Frozen,,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,11:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,,6227810899,5,622781089905,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,11:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,,6227810899,6,622781089906,"Plasma, QuantiFERON TB2",Cancelled,Frozen,,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,11:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,03-Mar-2026,6227810899,10,622781089910,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,,6227810899,11,622781089911,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,11:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,03-Mar-2026,6227810899,12,622781089912,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,11:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,,6227810899,13,622781089913,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,11:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,03-Mar-2026,6227810899,14,622781089914,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,11:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,,6227810899,15,622781089915,"Serum, SST",Cancelled,Ambient,,FSH,,,,,,11:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,,6227810899,8,622781089908,"Plasma, QuantiFERON Mitoge",Cancelled,Frozen,,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,11:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,03-Mar-2026,6227810899,9,622781089909,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,11:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,06-Mar-2026,6227810900,2,622781090002,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,06-Mar-2026,6227810900,4,622781090004,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,06-Mar-2026,6227810900,6,622781090006,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,,6227810900,7,622781090007,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,06-Mar-2026,6227810900,8,622781090008,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,05-Mar-2026,6227810900,9,622781090009,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,05-Mar-2026,6227810900,10,622781090010,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,,6227810900,3,622781090003,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,,6227810900,5,622781090005,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,05-Mar-2026,6227810900,12,622781090012,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,,6227810900,14,622781090014,"Serum, SST",Cancelled,Ambient,,CHEM PANEL &,BETA HCG,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,,6227810900,13,622781090013,"Red Cells, Clot",Not Received,,,"CHEM PANEL, BETA",HCG & FSH,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,,6227810900,15,622781090015,"Serum, SST",Cancelled,Ambient,,FSH,FROZEN,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,,6227810901,1,622781090101,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,12:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,05-Mar-2026,6227810901,2,622781090102,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,12:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,,6227810901,3,622781090103,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,12:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,05-Mar-2026,6227810901,4,622781090104,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,12:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,,6227810900,1,622781090001,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,05-Mar-2026,6227810901,6,622781090106,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,12:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,,6227810901,7,622781090107,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,12:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,05-Mar-2026,6227810901,8,622781090108,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,12:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,04-Mar-2026,6227810901,9,622781090109,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,12:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,,6227810901,10,622781090110,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,12:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,,6227810901,11,622781090111,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,12:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,04-Mar-2026,6227810901,12,622781090112,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,12:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,,6227810901,14,622781090114,"Serum, SST",Cancelled,Ambient,,CHEM PANEL &,BETA HCG,,,,,12:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,,6227810901,13,622781090113,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,12:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,,6227810899,7,622781089907,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,11:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,,6227810900,11,622781090011,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,,6227810901,5,622781090105,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,12:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,,6227810901,15,622781090115,"Serum, SST",Cancelled,Ambient,,FSH,,,,,,12:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRNSTOOL,05-Mar-2026,05-Mar-2026,6227810904,2,622781090402,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,09:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRNSTOOL,05-Mar-2026,05-Mar-2026,6227810904,3,622781090403,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,09:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRNSTOOL,05-Mar-2026,,6227810904,4,622781090404,"Stool, ova & parasites(PVA)",Cancelled,Ambient,,OVA & PARASITES 2,PVA,,,,,09:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRNSTOOL,04-Mar-2026,,6227810905,1,622781090501,"Stool, ova & parasites(form)",Cancelled,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,12:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRNSTOOL,04-Mar-2026,04-Mar-2026,6227810905,2,622781090502,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,12:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRNSTOOL,04-Mar-2026,04-Mar-2026,6227810905,3,622781090503,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,12:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRNSTOOL,04-Mar-2026,,6227810905,4,622781090504,"Stool, ova & parasites(PVA)",Cancelled,Ambient,,OVA & PARASITES 2,PVA,,,,,12:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRNSTOOL,05-Mar-2026,,6227810904,1,622781090401,"Stool, ova & parasites(form)",Cancelled,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,09:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,05-Feb-2026,BXSCR,06-Feb-2026,06-Feb-2026,6227323223,5,622732322305,"Tissue , Paraffin Block",Shipped,,Default Return Ambient,,,,,,,00:00,13:01,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,3,622793314203,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,5,622793314205,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,2,622793314202,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,4,622793314204,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,6,622793314206,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-4,77242113UCO3001-1,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,1,622793314201,"Red Cells, Clot",Received,,Default Discard/Not Return,CHEM PANEL &,CRP,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,,6227933142,7,622793314207,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-2,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,,6227933142,10,622793314210,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-5,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,12,622793314212,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-4 TROUGH,77242113UCO3001,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,,6227933142,9,622793314209,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-4,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,11,622793314211,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,PLASMA PK TROUGH,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,,6227933142,8,622793314208,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-3,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,14,622793314214,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-4 PEAK,77242113UCO3001,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,17,622793314217,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-2,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,13,622793314213,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,SM02/PLASMAPK PEAK,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,18,622793314218,"Red Cells, Clot",Received,,Default Discard/Not Return,SM06/SERUM,BIOMARKERS,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,1,622793314301,"Red Cells, Clot",Received,,Default Discard/Not Return,"CHEM, LIPID PANEL",& CRP,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,15,622793314215,"Red Cells, Clot",Received,,Default Discard/Not Return,SM04/SERUM ADA PRE,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,19,622793314219,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,2,622793314302,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,21,622793314221,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,22,622793314222,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,20,622793314220,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,16,622793314216,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-1,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,4,622793314304,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,,6227933143,8,622793314308,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-12,77242113UCO3001-4,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,,6227933143,7,622793314307,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-12,77242113UCO3001-3,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,3,622793314303,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,20,622793314320,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,,6227933143,6,622793314306,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-12,77242113UCO3001-2,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,,6227933143,9,622793314309,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-12,77242113UCO3001-5,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,11,622793314311,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMPK I-12TROUGH,77242113UCO3001,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,19,622793314319,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,17,622793314317,"Red Cells, Clot",Received,,Default Discard/Not Return,SM06/SERUM,BIOMARKERS,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,22,622793314322,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,EXPEDITED FRZN,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,10,622793314310,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,PLASMA PK TROUGH,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,16,622793314316,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-12 PRE,77242113UCO3001-2,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,23,622793314323,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,18,622793314318,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,12,622793314312,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,SM02/PLASMAPK PEAK,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,15,622793314315,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-12 PRE,77242113UCO3001-1,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,14,622793314314,"Red Cells, Clot",Received,,Default Discard/Not Return,SM04/SERUM ADA PRE,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,13,622793314313,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMAPK I-12 PEAK,77242113UCO3001,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,5,622793314305,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-12,77242113UCO3001-1,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,21,622793314321,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,11-Feb-2026,BXSCR,12-Feb-2026,12-Feb-2026,6227323287,5,622732328705,"Tissue , Paraffin Block",Shipped,,Default Return Ambient,,,,,,,00:00,12:52,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,16-Apr-2026,6227993962,2,622799396202,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,12:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,,6227993962,15,622799396215,"Serum, SST",Cancelled,Ambient,,FSH,FROZEN,,,,,12:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,16-Apr-2026,6227993962,4,622799396204,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,12:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,,6227993962,1,622799396201,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,12:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,14-Apr-2026,6227993962,10,622799396210,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,14-Apr-2026,6227993962,14,622799396214,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,12:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,,6227993962,3,622799396203,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,12:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,16-Apr-2026,6227993962,8,622799396208,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,12:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,14-Apr-2026,6227993962,12,622799396212,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,12:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,,6227993962,11,622799396211,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,12:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,,6227993962,7,622799396207,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,12:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,14-Apr-2026,6227993962,9,622799396209,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,12:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,,6227993962,5,622799396205,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,12:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,16-Apr-2026,6227993962,6,622799396206,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,12:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,,6227993962,13,622799396213,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,12:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,20-May-2026,6227993966,14,622799396614,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,,6227993966,17,622799396617,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL",& CRP,,,,,09:28,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,19-May-2026,6227993966,2,622799396602,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,,6227993966,3,622799396603,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,09:28,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,,6227993966,12,622799396612,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,09:28,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,19-May-2026,6227993966,1,622799396601,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,20-May-2026,6227993966,13,622799396613,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,,6227993966,7,622799396607,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,09:28,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,20-May-2026,6227993966,15,622799396615,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,20-May-2026,6227993966,8,622799396608,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,20-May-2026,6227993966,4,622799396604,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,20-May-2026,6227993966,10,622799396610,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,20-May-2026,6227993966,11,622799396611,Whole Blood PAXgene RNA,In Inventory,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,20-May-2026,6227993966,6,622799396606,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,,6227993966,5,622799396605,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,09:28,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,20-May-2026,6227993966,16,622799396616,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,19-May-2026,6227993966,18,622799396618,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,20-May-2026,6227993966,9,622799396609,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRNSTOOL,14-Apr-2026,,6227993971,4,622799397104,"Stool, ova & parasites(PVA)",Not Received,Ambient,,OVA & PARASITES 2,PVA,,,,,06:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRNSTOOL,14-Apr-2026,14-Apr-2026,6227993971,3,622799397103,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,06:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRNSTOOL,14-Apr-2026,,6227993971,1,622799397101,"Stool, ova & parasites(form)",Not Received,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,06:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRNSTOOL,14-Apr-2026,14-Apr-2026,6227993971,2,622799397102,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,06:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,DNA,20-May-2026,20-May-2026,6227993977,1,622799397701,"Whole Blood, EDTA, Dry",In Inventory,Frozen,Default Return Frozen,SM08/WB DNA,77242113UCO3001,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,DNA,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,15-Apr-2026,BXSCR,16-Apr-2026,16-Apr-2026,6227993984,1,622799398401,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,15-Apr-2026,BXSCR,16-Apr-2026,17-Apr-2026,6227993984,3,622799398403,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,15-Apr-2026,BXSCR,16-Apr-2026,,6227993984,4,622799398404,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,15-Apr-2026,BXSCR,16-Apr-2026,17-Apr-2026,6227993984,2,622799398402,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,BDL,20-May-2026,20-May-2026,6227993987,2,622799398702,"Serum, SST",Shipped,Frozen,Default Return Frozen,"ADA, GOL, INF",UST OR VED FROZEN,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biologic Drug Level,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,BDL,20-May-2026,,6227993987,1,622799398701,"Red Cells, Clot",Not Received,,,DRUG LEVEL TESTING,,,,,,09:28,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biologic Drug Level,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRNSTOOL,18-Feb-2026,18-Feb-2026,6227323244,5,622732324405,,Cancelled,,,,,,,,,07:20,12:28,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRNSTOOL,18-Feb-2026,18-Feb-2026,6227323244,6,622732324406,,Cancelled,,,,,,,,,07:20,12:28,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,18-Feb-2026,BXSCR,19-Feb-2026,19-Feb-2026,6227323286,5,622732328605,"Tissue , Paraffin Block",In Inventory,,Default Return Ambient,,,,,,,00:00,15:49,Czech Republic,,10:20,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,01-Apr-2026,BXSCR,02-Apr-2026,04-Apr-2026,6228023951,2,622802395102,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,01-Apr-2026,BXSCR,02-Apr-2026,02-Apr-2026,6228023951,1,622802395101,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,01-Apr-2026,BXSCR,02-Apr-2026,04-Apr-2026,6228023951,3,622802395103,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,01-Apr-2026,BXSCR,02-Apr-2026,,6228023951,4,622802395104,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,19-Feb-2026,BXSCR,21-Feb-2026,21-Feb-2026,6227323254,5,622732325405,"Tissue , Paraffin Block",Shipped,,Default Return Ambient,,,,,,,00:00,14:49,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,3,622803655303,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,PLASMA PK TROUGH,,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,5,622803655305,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,SM02/PLASMAPK PEAK,,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,7,622803655307,"Red Cells, Clot",Received,,Default Discard/Not Return,SM04/SERUM ADA PRE,,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,8,622803655308,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,4,622803655304,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,1,622803655301,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,6,622803655306,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,2,622803655302,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,12,622803655312,"Red Cells, Clot",Received,,Default Discard/Not Return,SM06/SERUM,BIOMARKERS,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,13,622803655313,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,15,622803655315,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,11,622803655311,Whole Blood PAXgene RNA,In Inventory,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,17,622803655317,"Red Cells, Clot",Received,,Default Discard/Not Return,"CHEM, LIPID PANEL",& CRP,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,18,622803655318,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,14,622803655314,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,9,622803655309,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,16,622803655316,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,4,622803655404,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,5,622803655405,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,SM02/PLASMAPK PEAK,,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,1,622803655401,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,6,622803655406,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,7,622803655407,"Red Cells, Clot",Received,,Default Discard/Not Return,SM04/SERUM ADA PRE,,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,9,622803655409,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,10,622803655410,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,8,622803655408,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,10,622803655310,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,3,622803655403,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,PLASMA PK TROUGH,,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,11,622803655411,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,2,622803655402,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,12,622803655412,"Red Cells, Clot",Received,,Default Discard/Not Return,SM06/SERUM,BIOMARKERS,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,13,622803655413,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,14,622803655414,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,15,622803655415,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,16,622803655416,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,17,622803655417,"Red Cells, Clot",Received,,Default Discard/Not Return,"CHEM, LIPID PANEL",& CRP,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,18,622803655418,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,,6228114608,1,622811460801,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,07:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,,6228114608,7,622811460807,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,07:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,,6228114608,3,622811460803,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,07:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,,6228114608,6,622811460806,"Plasma, QuantiFERON TB2",Not Received,Frozen,,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,07:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,,6228114608,8,622811460808,"Plasma, QuantiFERON Mitoge",Not Received,Frozen,,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,07:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,29-May-2026,6228114608,9,622811460809,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,,6228114608,4,622811460804,"Plasma, QuantiFERON TB1",Not Received,Frozen,,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,07:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,,6228114608,5,622811460805,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,07:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,29-May-2026,6228114608,11,622811460811,"Red Cells, Clot",Received,,Default Discard/Not Return,"HIV SCREEN,",HEPATITIS B & C,,,,,07:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,29-May-2026,6228114608,10,622811460810,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,,6228114608,2,622811460802,"Plasma, QuantiFERON Nil",Not Received,Frozen,,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,07:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,29-May-2026,6228114608,12,622811460812,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,07:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,29-May-2026,6228114608,14,622811460814,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,07:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,,6228114608,15,622811460815,"Serum, SST",Cancelled,Ambient,,FSH,FROZEN,,,,,07:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,29-May-2026,6228114608,13,622811460813,"Red Cells, Clot",Received,,Default Discard/Not Return,CHEM PANEL &,BETA HCG,,,,,07:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,01-May-2026,6228114610,1,622811461001,Whole Blood QuantiFERON Nil,Received,,Default Discard/Not Return,QUANTIFERON PLUS,NIL-GRAY,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,01-May-2026,6228114610,2,622811461002,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,01-May-2026,6228114610,5,622811461005,Whole Blood QuantiFERON TB2,Received,,Default Discard/Not Return,QUANTIFERON PLUS,TB2-YELLOW,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,01-May-2026,6228114610,3,622811461003,Whole Blood QuantiFERON TB1,Received,,Default Discard/Not Return,QUANTIFERON PLUS,TB1-GREEN,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,01-May-2026,6228114610,6,622811461006,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,01-May-2026,6228114610,4,622811461004,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,30-Apr-2026,6228114610,10,622811461010,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,30-Apr-2026,6228114610,11,622811461011,"Red Cells, Clot",Received,,Default Discard/Not Return,"HIV SCREEN,",HEPATITIS B & C,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,30-Apr-2026,6228114610,9,622811461009,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,01-May-2026,6228114610,7,622811461007,Whole Blood QuantiFERON Mitoge,Received,,Default Discard/Not Return,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,30-Apr-2026,6228114610,12,622811461012,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,30-Apr-2026,6228114610,13,622811461013,"Red Cells, Clot",Received,,Default Discard/Not Return,CHEM PANEL &,BETA HCG,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,30-Apr-2026,6228114610,14,622811461014,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,01-May-2026,6228114610,8,622811461008,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,,6228114610,15,622811461015,"Serum, SST",Cancelled,Ambient,,FSH,FROZEN,,,,,07:55,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCSTOOL,23-Apr-2026,23-Apr-2026,6228137359,3,622813735903,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCSTOOL,23-Apr-2026,23-Apr-2026,6228137359,1,622813735901,"Stool, ova & parasites(form)",Received,Ambient,Default Return Ambient,OVA & PARASITES 1,FORMALIN,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCSTOOL,23-Apr-2026,23-Apr-2026,6228137359,4,622813735904,"Stool, ova & parasites(PVA)",Received,Ambient,Default Return Ambient,OVA & PARASITES 2,PVA,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCSTOOL,23-Apr-2026,23-Apr-2026,6228137359,2,622813735902,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,1,622817339701,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,4,622817339704,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,,6228173397,3,622817339703,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,10:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,2,622817339702,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,6,622817339706,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,8,622817339708,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,,6228173397,5,622817339705,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,10:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,,6228173397,7,622817339707,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,10:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,,6228173397,12,622817339712,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,10:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,16,622817339716,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,18,622817339718,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,,6228173397,17,622817339717,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL",& CRP,,,,,10:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,9,622817339709,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,14,622817339714,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,11,622817339711,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,10,622817339710,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,15,622817339715,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,13,622817339713,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6228179932,14,622817993214,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,14:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,,6228179932,9,622817993209,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-2,,,,,14:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6228179932,15,622817993215,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,14:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,,6228179932,16,622817993216,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,14:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,,6228179932,12,622817993212,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-5,,,,,14:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6228179932,13,622817993213,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,14:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6228179932,17,622817993217,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,14:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,,6228179932,10,622817993210,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-3,,,,,14:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,,6228179932,11,622817993211,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-4,,,,,14:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,,6228179932,1,622817993201,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,14:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,,6228179932,3,622817993203,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,14:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6228179932,4,622817993204,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-2 PEAK,77242113UCO3001,,,,,14:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6228179932,7,622817993207,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-2,,,,,14:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6228179932,2,622817993202,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-2 TROUGH,77242113UCO3001,,,,,14:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6228179932,8,622817993208,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001,,,,,14:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,,6228179936,1,622817993601,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,2,622817993602,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,6,622817993606,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-4,77242113UCO3001,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,4,622817993604,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,,6228179936,10,622817993610,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-5,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,5,622817993605,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,14,622817993614,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-4 PEAK,77242113UCO3001,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,,6228179936,11,622817993611,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,12,622817993612,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-4 TROUGH,77242113UCO3001,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,,6228179936,13,622817993613,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,16,622817993616,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-1,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,,6228179936,15,622817993615,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,,6228179936,9,622817993609,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-4,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,19,622817993619,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,,6228179936,18,622817993618,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,3,622817993603,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,17,622817993617,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-2,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6228179932,6,622817993206,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-1,,,,,14:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,,6228179932,5,622817993205,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,14:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,20,622817993620,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,21,622817993621,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,,6228179936,8,622817993608,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-3,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,,6228179936,7,622817993607,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-2,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,22,622817993622,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,DNA,10-Apr-2026,10-Apr-2026,6228179942,1,622817994201,"Whole Blood, EDTA, Dry",Shipped,Frozen,Default Return Frozen,SM08/WB DNA,77242113UCO3001,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,DNA,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,20-May-2026,BX12,21-May-2026,23-May-2026,6228179945,3,622817994503,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,20-May-2026,BX12,21-May-2026,23-May-2026,6228179945,4,622817994504,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,BIOPSY PK,77242113UCO3001,,,,,00:00,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,20-May-2026,BX12,21-May-2026,21-May-2026,6228179945,1,622817994501,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,20-May-2026,BX12,21-May-2026,23-May-2026,6228179945,2,622817994502,Biopsy RNA Later,In Inventory,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRNSTOOL,21-Apr-2026,,6228194341,1,622819434101,"Stool, ova & parasites(form)",Cancelled,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,07:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRNSTOOL,21-Apr-2026,,6228194341,4,622819434104,"Stool, ova & parasites(PVA)",Cancelled,Ambient,,OVA & PARASITES 2,PVA,,,,,07:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRNSTOOL,21-Apr-2026,21-Apr-2026,6228194341,3,622819434103,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,07:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRNSTOOL,21-Apr-2026,21-Apr-2026,6228194341,2,622819434102,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,07:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,12-Mar-2026,BXSCR,13-Mar-2026,13-Mar-2026,6227635161,5,622763516105,"Tissue , Paraffin Block",Shipped,,Default Return Ambient,,,,,,,00:00,15:58,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,16-Mar-2026,BXSCR,18-Mar-2026,18-Mar-2026,6227635223,5,622763522305,"Tissue , Paraffin Block",Shipped,,Default Return Ambient,,,,,,,00:00,13:49,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,19-Mar-2026,6227323233,31,622732323331,"Serum, SST",Received,Ambient,Default Return Ambient,,,,,,,,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,18-Mar-2026,BXSCR,19-Mar-2026,19-Mar-2026,6227323224,5,622732322405,"Tissue , Paraffin Block",Shipped,,Default Return Ambient,,,,,,,00:00,15:46,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,06-May-2026,BX12,07-May-2026,09-May-2026,6228252072,3,622825207203,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:30,Czech Republic,,08:30,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,06-May-2026,BX12,07-May-2026,07-May-2026,6228252072,1,622825207201,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,08:30,Czech Republic,,08:30,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,13-May-2026,BXSCR,14-May-2026,,6228252073,4,622825207304,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,13-May-2026,BXSCR,14-May-2026,15-May-2026,6228252073,2,622825207302,Biopsy RNA Later,In Inventory,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,06-May-2026,BX12,07-May-2026,09-May-2026,6228252072,4,622825207204,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,BIOPSY PK,77242113UCO3001,,,,,00:00,07:30,Czech Republic,,08:30,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,06-May-2026,BX12,07-May-2026,09-May-2026,6228252072,2,622825207202,Biopsy RNA Later,In Inventory,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:30,Czech Republic,,08:30,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,13-May-2026,BXSCR,14-May-2026,15-May-2026,6228252073,3,622825207303,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,13-May-2026,BXSCR,14-May-2026,14-May-2026,6228252073,1,622825207301,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,23-Mar-2026,BXSCR,24-Mar-2026,24-Mar-2026,6227697736,5,622769773605,"Tissue , Paraffin Block",Shipped,,Default Return Ambient,,,,,,,00:00,15:15,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,1,622830822401,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,2,622830822402,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,,6228308224,5,622830822405,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,10:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,6,622830822406,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,,6228308224,7,622830822407,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,10:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,9,622830822409,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,10,622830822410,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,8,622830822408,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,11,622830822411,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,13,622830822413,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,,6228308224,3,622830822403,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,10:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,4,622830822404,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,14,622830822414,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,16,622830822416,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,15,622830822415,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,,6228308224,12,622830822412,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,10:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,,6228308224,17,622830822417,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL",& CRP,,,,,10:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,18,622830822418,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,01-Apr-2026,BXSCR,02-Apr-2026,02-Apr-2026,6228023951,5,622802395105,"Tissue , Paraffin Block",Shipped,,Default Return Ambient,,,,,,,00:00,15:31,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,,6228398115,3,622839811503,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,27-May-2026,6228398115,2,622839811502,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMPK I-2 TROUGH,77242113UCO3001,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,27-May-2026,6228398115,4,622839811504,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMA PK I-2 PEAK,77242113UCO3001,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,27-May-2026,6228398115,6,622839811506,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-1,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,,6228398115,5,622839811505,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,27-May-2026,6228398115,7,622839811507,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-2,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,27-May-2026,6228398115,8,622839811508,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,,6228398115,10,622839811510,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-3,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,,6228398115,9,622839811509,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-2,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,,6228398115,11,622839811511,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-4,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,,6228398115,12,622839811512,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-5,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,27-May-2026,6228398115,13,622839811513,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,27-May-2026,6228398115,14,622839811514,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,,6228398115,1,622839811501,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,27-May-2026,6228398115,17,622839811517,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,27-May-2026,6228398115,15,622839811515,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,,6228398115,16,622839811516,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,19,622817339719,,Cancelled,,,,,,,,,10:35,13:56,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,15-Apr-2026,BXSCR,16-Apr-2026,16-Apr-2026,6227993984,5,622799398405,"Tissue , Paraffin Block",In Inventory,,Default Return Ambient,,,,,,,00:00,17:04,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,21-Apr-2026,BXSCR,22-Apr-2026,22-Apr-2026,6227635159,5,622763515905,"Tissue , Paraffin Block",In Inventory,,Default Return Ambient,,,,,,,00:00,17:18,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,25-May-2026,BXSCR,26-May-2026,26-May-2026,6228501732,1,622850173201,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,25-May-2026,BXSCR,26-May-2026,28-May-2026,6228501732,2,622850173202,Biopsy RNA Later,In Inventory,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,25-May-2026,BXSCR,26-May-2026,,6228501732,4,622850173204,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,25-May-2026,BXSCR,26-May-2026,28-May-2026,6228501732,3,622850173203,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,24-Apr-2026,BXSCR,28-Apr-2026,28-Apr-2026,6227323351,5,622732335105,"Tissue , Paraffin Block",Shipped,,Default Return Ambient,,,,,,,00:00,14:22,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,06-May-2026,SCRNSTOOL,07-May-2026,,6228610564,1,622861056401,"Stool, ova & parasites(form)",Not Received,Ambient,,,,,,,,09:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,06-May-2026,SCRNSTOOL,07-May-2026,,6228610564,3,622861056403,"Culture, Stool",Cancelled,Ambient,,,,,,,,09:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,06-May-2026,SCRNSTOOL,07-May-2026,,6228610564,4,622861056404,"Stool, ova & parasites(PVA)",Not Received,Ambient,,,,,,,,09:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,06-May-2026,SCRNSTOOL,07-May-2026,07-May-2026,6228610564,2,622861056402,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,09:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,06-May-2026,BX12,07-May-2026,07-May-2026,6228252072,5,622825207205,"Tissue , Paraffin Block",Shipped,,Default Return Ambient,,,,,,,00:00,15:52,Czech Republic,,08:30,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,08-May-2026,6227697745,31,622769774531,,In Inventory,,Default Return Frozen,,,,,,,,16:05,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,13-May-2026,BXSCR,14-May-2026,14-May-2026,6228252073,5,622825207305,"Tissue , Paraffin Block",In Inventory,,Default Return Ambient,,,,,,,00:00,12:51,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,14-May-2026,BXSCR,15-May-2026,15-May-2026,6227323256,5,622732325605,"Tissue , Paraffin Block",In Inventory,,Default Return Ambient,,,,,,,00:00,13:06,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,19-May-2026,BXSCR,20-May-2026,20-May-2026,6227635193,5,622763519305,"Tissue , Paraffin Block",In Inventory,,Default Return Ambient,,,,,,,00:00,17:34,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,20-May-2026,BX12,21-May-2026,21-May-2026,6228179945,5,622817994505,"Tissue , Paraffin Block",In Inventory,,Default Return Ambient,,,,,,,00:00,14:59,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,25-May-2026,BXSCR,26-May-2026,26-May-2026,6228501732,5,622850173205,"Tissue , Paraffin Block",In Inventory,,Default Return Ambient,,,,,,,00:00,13:03,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,27-May-2026,BXSCR,28-May-2026,28-May-2026,6227323320,5,622732332005,"Tissue , Paraffin Block",In Inventory,,Default Return Ambient,,,,,,,00:00,14:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, diff --git a/Covance_UCO3001/Source/2026-05-29_111722 sponsor-study-36940-samples-allSamples.csv b/Covance_UCO3001/Source/2026-05-29_111722 sponsor-study-36940-samples-allSamples.csv new file mode 100644 index 0000000..7fe468b --- /dev/null +++ b/Covance_UCO3001/Source/2026-05-29_111722 sponsor-study-36940-samples-allSamples.csv @@ -0,0 +1,1445 @@ +Protocol Code,Investigator No.,Investigator Name,Patient No.,Collection Date,Protocol Visit Code,Kit Receipt Date,Container Receipt Date,Accession,Container No.,Container Barcode No.,Specimen Type,Sample Status,Expected Receipt Condition,Actual Receipt Condition,Container Label Line 1,Container Label Line 2,SM Sample Status,SMART Specimen Class Description,Aliquot Created Date,Aliquoted Date,Collection Time,Container Receipt Time,Country,Courier,Kit Receipt Time,Parent Barcode Number,Parent Sample Type,Project,Region,Screening No.,Shipped To Organization Name,Site Waybill No.,Site - Scheduled Shipment Date,Site - Shipment Created Date,Site - Shipment Details Entered Date,SMART Specimen Class,Visit Description,Parent Barcode,Children Barcode +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,24-Jan-2026,6227323203,1,622732320301,Whole Blood QuantiFERON Nil,Received,,Default Discard/Not Return,QUANTIFERON PLUS,NIL-GRAY,,,,,08:00,12:40,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,24-Jan-2026,6227323203,2,622732320302,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,08:00,12:40,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,24-Jan-2026,6227323203,3,622732320303,Whole Blood QuantiFERON TB1,Received,,Default Discard/Not Return,QUANTIFERON PLUS,TB1-GREEN,,,,,08:00,12:40,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,24-Jan-2026,6227323203,7,622732320307,Whole Blood QuantiFERON Mitoge,Received,,Default Discard/Not Return,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,08:00,12:40,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,24-Jan-2026,6227323203,8,622732320308,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,08:00,12:40,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,24-Jan-2026,6227323203,5,622732320305,Whole Blood QuantiFERON TB2,Received,,Default Discard/Not Return,QUANTIFERON PLUS,TB2-YELLOW,,,,,08:00,12:40,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,24-Jan-2026,6227323203,6,622732320306,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,08:00,12:40,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,23-Jan-2026,6227323203,11,622732320311,"Red Cells, Clot",Received,,Default Discard/Not Return,"HIV SCREEN,",HEPATITIS B & C,,,,,08:00,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,24-Jan-2026,6227323203,4,622732320304,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,08:00,12:40,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,23-Jan-2026,6227323203,14,622732320314,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,08:00,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,23-Jan-2026,6227323203,12,622732320312,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,08:00,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,23-Jan-2026,6227323203,15,622732320315,"Serum, SST",Received,Ambient,Default Return Ambient,FSH,,,,,,08:00,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,04-Mar-2026,6227323204,1,622732320401,Whole Blood QuantiFERON Nil,Received,,Default Discard/Not Return,QUANTIFERON PLUS,NIL-GRAY,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,23-Jan-2026,6227323203,9,622732320309,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:00,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,04-Mar-2026,6227323204,3,622732320403,Whole Blood QuantiFERON TB1,Received,,Default Discard/Not Return,QUANTIFERON PLUS,TB1-GREEN,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,04-Mar-2026,6227323204,4,622732320404,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,04-Mar-2026,6227323204,2,622732320402,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,04-Mar-2026,6227323204,6,622732320406,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,04-Mar-2026,6227323204,7,622732320407,Whole Blood QuantiFERON Mitoge,Received,,Default Discard/Not Return,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,04-Mar-2026,6227323204,5,622732320405,Whole Blood QuantiFERON TB2,Received,,Default Discard/Not Return,QUANTIFERON PLUS,TB2-YELLOW,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,,6227323203,10,622732320310,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,08:00,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,23-Jan-2026,6227323203,13,622732320313,"Red Cells, Clot",Received,,Default Discard/Not Return,"CHEM PANEL, BETA",HCG & FSH,,,,,08:00,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,03-Mar-2026,6227323204,9,622732320409,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,03-Mar-2026,6227323204,10,622732320410,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,03-Mar-2026,6227323204,11,622732320411,"Red Cells, Clot",Received,,Default Discard/Not Return,"HIV SCREEN,",HEPATITIS B & C,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,03-Mar-2026,6227323204,13,622732320413,"Red Cells, Clot",Received,,Default Discard/Not Return,"CHEM PANEL, BETA",HCG & FSH,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,03-Mar-2026,6227323204,14,622732320414,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,03-Mar-2026,6227323204,15,622732320415,"Serum, SST",Received,Ambient,Default Return Ambient,FSH,,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,04-Mar-2026,6227323204,8,622732320408,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,1,622732320501,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,03-Mar-2026,6227323204,12,622732320412,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,2,622732320502,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,4,622732320504,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,7,622732320507,"Red Cells, Clot",Received,,Default Discard/Not Return,SM04/SERUM ADA PRE,,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,3,622732320503,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,PLASMA PK TROUGH,,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,6,622732320506,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,10,622732320510,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,9,622732320509,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,8,622732320508,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,5,622732320505,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,SM02/PLASMAPK PEAK,,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,11,622732320511,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,13,622732320513,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,14,622732320514,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,15,622732320515,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,16,622732320516,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,18,622732320518,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,1,622732320601,"Whole Blood, EDTA, Dry",Cancelled,Ambient,,HEMATOLOGY,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,17,622732320517,"Red Cells, Clot",Received,,Default Discard/Not Return,"CHEM, LIPID PANEL",& CRP,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,12,622732320512,"Red Cells, Clot",Received,,Default Discard/Not Return,SM06/SERUM,BIOMARKERS,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,4,622732320604,"Plasma, EDTA",Not Received,Frozen,Specimen not submitted,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,7,622732320607,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,8,622732320608,"Serum, SST",Not Received,Frozen,Specimen not submitted,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,9,622732320609,"Serum, SST",Not Received,Frozen,Specimen not submitted,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,10,622732320610,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,SM10/FECAL,BIOMARKERS,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,11,622732320611,Whole Blood PAXgene RNA,Not Received,Frozen,Specimen not submitted,SM07/WB RNA,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,12,622732320612,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,2,622732320602,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,6,622732320606,"Plasma, EDTA",Not Received,Frozen,Specimen not submitted,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,3,622732320603,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,5,622732320605,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,23-Apr-2026,6227323206,17,622732320617,"Red Cells, Clot",Received,,Default Discard/Not Return,"CHEM, LIPID PANEL",& CRP,,,,,,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,14,622732320614,"Serum, SST",Not Received,Frozen,Specimen not submitted,SM06/SERUM BIOM,77242113UCO3001-2,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,23-Apr-2026,6227323206,18,622732320618,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,24-Apr-2026,6227323207,2,622732320702,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-2 TROUGH,77242113UCO3001,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,16,622732320616,"Feces, unpreserved",Not Received,Frozen,Specimen not submitted,FECAL CALPROTECTIN,FROZEN,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,,6227323207,3,622732320703,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,24-Apr-2026,6227323207,1,622732320701,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,PLASMA PK TROUGH,,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,15,622732320615,"Serum, SST",Not Received,Frozen,Specimen not submitted,SM06/SERUM BIOM,77242113UCO3001-3,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,13,622732320613,"Serum, SST",Not Received,Frozen,Specimen not submitted,SM06/SERUM BIOM,77242113UCO3001-1,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,,6227323207,4,622732320704,"Plasma, EDTA",Not Received,Frozen,Specimen not submitted,PLASMA PK I-2 PEAK,77242113UCO3001,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,24-Apr-2026,6227323207,5,622732320705,"Red Cells, Clot",Received,,Default Discard/Not Return,SM04/SERUM ADA PRE,,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,24-Apr-2026,6227323207,6,622732320706,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-1,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,24-Apr-2026,6227323207,7,622732320707,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-2,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,24-Apr-2026,6227323207,8,622732320708,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-1,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,,6227323207,9,622732320709,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-2,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,,6227323207,10,622732320710,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-3,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,,6227323207,11,622732320711,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-4,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,,6227323207,12,622732320712,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-5,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,24-Apr-2026,6227323207,13,622732320713,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,24-Apr-2026,6227323207,14,622732320714,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,24-Apr-2026,6227323207,16,622732320716,"Red Cells, Clot",Received,,Default Discard/Not Return,CHEM PANEL &,CRP,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,24-Apr-2026,6227323207,17,622732320717,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,1,622732320801,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,PLASMA PK TROUGH,,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,2,622732320802,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-2 TROUGH,77242113UCO3001,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,3,622732320803,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,SM02/PLASMAPK PEAK,,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,5,622732320805,"Red Cells, Clot",Received,,Default Discard/Not Return,SM04/SERUM ADA PRE,,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,4,622732320804,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-2 PEAK,77242113UCO3001,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,7,622732320807,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-2,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,,6227323208,8,622732320808,"Stool, unpreserved",Cancelled,Frozen,,STOOL I-2,77242113UCO3001-1,,,,,07:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,,6227323208,10,622732320810,"Stool, unpreserved",Cancelled,Frozen,,STOOL I-2,77242113UCO3001-3,,,,,07:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,24-Apr-2026,6227323207,15,622732320715,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,,6227323208,11,622732320811,"Stool, unpreserved",Cancelled,Frozen,,STOOL I-2,77242113UCO3001-4,,,,,07:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,,6227323208,9,622732320809,"Stool, unpreserved",Cancelled,Frozen,,STOOL I-2,77242113UCO3001-2,,,,,07:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,,6227323208,12,622732320812,"Stool, unpreserved",Cancelled,Frozen,,STOOL I-2,77242113UCO3001-5,,,,,07:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,13,622732320813,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,14,622732320814,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,15,622732320815,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,16,622732320816,"Red Cells, Clot",Received,,Default Discard/Not Return,CHEM PANEL &,CRP,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,17,622732320817,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,6,622732320806,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-1,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,2,622732321002,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,4,622732321004,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,1,622732321001,"Red Cells, Clot",Received,,Default Discard/Not Return,CHEM PANEL &,CRP,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,3,622732321003,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,,6227323210,6,622732321006,"Stool, unpreserved",Cancelled,Frozen,,STOOL I-4,77242113UCO3001-1,,,,,07:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,5,622732321005,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,,6227323210,7,622732321007,"Stool, unpreserved",Cancelled,Frozen,,STOOL I-4,77242113UCO3001-2,,,,,07:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,,6227323210,8,622732321008,"Stool, unpreserved",Cancelled,Frozen,,STOOL I-4,77242113UCO3001-3,,,,,07:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,,6227323210,9,622732321009,"Stool, unpreserved",Cancelled,Frozen,,STOOL I-4,77242113UCO3001-4,,,,,07:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,10,622732321010,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-4,77242113UCO3001-5,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,12,622732321012,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-4 TROUGH,77242113UCO3001,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,14,622732321014,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-4 PEAK,77242113UCO3001,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,11,622732321011,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,PLASMA PK TROUGH,,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,13,622732321013,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,SM02/PLASMAPK PEAK,,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,15,622732321015,"Red Cells, Clot",Received,,Default Discard/Not Return,SM04/SERUM ADA PRE,,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,16,622732321016,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-1,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,17,622732321017,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-2,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,18,622732321018,"Red Cells, Clot",Received,,Default Discard/Not Return,SM06/SERUM,BIOMARKERS,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,19,622732321019,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,21,622732321021,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,20,622732321020,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,22,622732321022,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,28-Jan-2026,SCRNSTOOL,29-Jan-2026,29-Jan-2026,6227323211,1,622732321101,"Stool, ova & parasites(form)",Received,Ambient,Default Return Ambient,OVA & PARASITES 1,FORMALIN,,,,,06:00,07:40,Czech Republic,,07:40,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,28-Jan-2026,SCRNSTOOL,29-Jan-2026,29-Jan-2026,6227323211,2,622732321102,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,06:00,07:40,Czech Republic,,07:40,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,28-Jan-2026,SCRNSTOOL,29-Jan-2026,29-Jan-2026,6227323211,3,622732321103,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,06:00,07:40,Czech Republic,,07:40,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,28-Jan-2026,SCRNSTOOL,29-Jan-2026,29-Jan-2026,6227323211,4,622732321104,"Stool, ova & parasites(PVA)",Received,Ambient,Default Return Ambient,OVA & PARASITES 2,PVA,,,,,06:00,07:40,Czech Republic,,07:40,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,03-Mar-2026,SCRNSTOOL,05-Mar-2026,05-Mar-2026,6227323212,1,622732321201,"Stool, ova & parasites(form)",Received,Ambient,Default Return Ambient,OVA & PARASITES 1,FORMALIN,,,,,13:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,03-Mar-2026,SCRNSTOOL,05-Mar-2026,05-Mar-2026,6227323212,3,622732321203,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,13:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,03-Mar-2026,SCRNSTOOL,05-Mar-2026,05-Mar-2026,6227323212,4,622732321204,"Stool, ova & parasites(PVA)",Received,Ambient,Default Return Ambient,OVA & PARASITES 2,PVA,,,,,13:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,03-Mar-2026,SCRNSTOOL,05-Mar-2026,05-Mar-2026,6227323212,2,622732321202,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,13:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRNSTOOL,30-Apr-2026,,6227323213,1,622732321301,"Stool, ova & parasites(form)",Not Received,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,07:55,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRNSTOOL,30-Apr-2026,30-Apr-2026,6227323213,2,622732321302,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRNSTOOL,30-Apr-2026,30-Apr-2026,6227323213,3,622732321303,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRNSTOOL,30-Apr-2026,,6227323213,4,622732321304,"Stool, ova & parasites(PVA)",Not Received,Ambient,,OVA & PARASITES 2,PVA,,,,,07:55,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,DNA,20-Feb-2026,20-Feb-2026,6227323217,1,622732321701,"Whole Blood, EDTA, Dry",Shipped,Frozen,Default Return Frozen,SM08/WB DNA,77242113UCO3001,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,DNA,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,DNA,19-Mar-2026,19-Mar-2026,6227323219,1,622732321901,"Whole Blood, EDTA, Dry",Shipped,Frozen,Default Return Frozen,SM08/WB DNA,77242113UCO3001,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,DNA,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,05-Feb-2026,BXSCR,06-Feb-2026,06-Feb-2026,6227323223,1,622732322301,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,05-Feb-2026,BXSCR,06-Feb-2026,07-Feb-2026,6227323223,2,622732322302,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:20,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,05-Feb-2026,BXSCR,06-Feb-2026,07-Feb-2026,6227323223,3,622732322303,"Biopsy, Frozen Tissue",Shipped,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:20,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,05-Feb-2026,BXSCR,06-Feb-2026,,6227323223,4,622732322304,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,18-Mar-2026,BXSCR,19-Mar-2026,20-Mar-2026,6227323224,2,622732322402,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,18-Mar-2026,BXSCR,19-Mar-2026,19-Mar-2026,6227323224,1,622732322401,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,18-Mar-2026,BXSCR,19-Mar-2026,20-Mar-2026,6227323224,3,622732322403,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,18-Mar-2026,BXSCR,19-Mar-2026,,6227323224,4,622732322404,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,2,622732323102,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,3,622732323103,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL,","BHCG, FSH & CRP",,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,4,622732323104,"Serum, SST",Not Received,Ambient,,"CHEM, LIPID PANEL",BETA HCG & CRP,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,19-Mar-2026,6227323231,5,622732323105,"Serum, SST",Received,Ambient,Default Return Ambient,FSH,,,,,,,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,6,622732323106,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,23-Apr-2026,6227323231,8,622732323108,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,7,622732323107,"Serum, SST",Not Received,Ambient,,"HIV SCREEN,",HEPATITIS B & C,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,1,622732323101,"Whole Blood, EDTA, Dry",Not Received,Ambient,,HEMATOLOGY,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,9,622732323109,"Whole Blood, EDTA, Dry",Not Received,,,HCV RNA COBAS 6800,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,10,622732323110,"Plasma, EDTA",Not Received,Frozen,,HCV RNA COBAS 6800,FROZEN,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,12,622732323112,"Plasma, EDTA",Not Received,Frozen,,HBV DNA COBAS 6800,FROZEN,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,14,622732323114,Whole Blood PAXgene RNA,Not Received,Frozen,,SM07/WB RNA,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,13,622732323113,"Stool, unpreserved",Not Received,Frozen,,SM10/FECAL,BIOMARKERS,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,17,622732323117,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-2,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,18,622732323118,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-3,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,15,622732323115,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,16,622732323116,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-1,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,11,622732323111,"Whole Blood, EDTA, Dry",Not Received,,,HBV DNA COBAS 6800,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,19,622732323119,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,20,622732323120,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-2,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,22,622732323122,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-4,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,21,622732323121,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-3,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,25,622732323125,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-1,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,26,622732323126,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-2,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,24,622732323124,"Red Cells, Clot",Not Received,,,SM05/SERUM ADA,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,23,622732323123,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-5,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,27,622732323127,"Whole Blood, EDTA, Dry",Not Received,,,SM03/PLASMA PK,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,28,622732323128,"Plasma, EDTA",Not Received,Frozen,,PLASMA PK,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,29,622732323129,"Whole Blood, EDTA, Dry",Not Received,,,HIV-1/HIV-2,QUALITATIVE RNA,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,30,622732323130,"Plasma, EDTA",Not Received,Frozen,,HIV-1/HIV-2 QUAL,RNA FROZEN,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,3,622732323203,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL,","BHCG, FSH & CRP",,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,4,622732323204,"Serum, SST",Cancelled,Ambient,,"CHEM, LIPID PANEL",BETA HCG & CRP,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,5,622732323205,"Serum, SST",Not Received,Ambient,,FSH,,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,6,622732323206,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,7,622732323207,"Serum, SST",Not Received,Ambient,,"HIV SCREEN,",HEPATITIS B & C,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,8,622732323208,"Feces, unpreserved",Not Received,Frozen,Specimen not submitted,FECAL CALPROTECTIN,FROZEN,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,1,622732323201,"Whole Blood, EDTA, Dry",Not Received,Ambient,,HEMATOLOGY,,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,2,622732323202,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,10,622732323210,"Plasma, EDTA",Not Received,Frozen,,HCV RNA COBAS 6800,FROZEN,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,12,622732323212,"Plasma, EDTA",Not Received,Frozen,,HBV DNA COBAS 6800,FROZEN,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,14,622732323214,Whole Blood PAXgene RNA,Not Received,Frozen,,SM07/WB RNA,77242113UCO3001,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,13,622732323213,"Stool, unpreserved",Not Received,Frozen,,SM10/FECAL,BIOMARKERS,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,11,622732323211,"Whole Blood, EDTA, Dry",Not Received,,,HBV DNA COBAS 6800,,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,15,622732323215,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,9,622732323209,"Whole Blood, EDTA, Dry",Not Received,,,HCV RNA COBAS 6800,,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,16,622732323216,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-1,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,17,622732323217,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-2,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,21,622732323221,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-3,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,23,622732323223,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-5,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,26,622732323226,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-2,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,20,622732323220,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-2,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,24,622732323224,"Red Cells, Clot",Not Received,,,SM05/SERUM ADA,,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,22,622732323222,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-4,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,27,622732323227,"Whole Blood, EDTA, Dry",Not Received,,,SM03/PLASMA PK,,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,25,622732323225,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-1,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,19,622732323219,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,28,622732323228,"Plasma, EDTA",Not Received,Frozen,,PLASMA PK,77242113UCO3001,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,18,622732323218,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-3,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,29,622732323229,"Whole Blood, EDTA, Dry",Not Received,,,HIV-1/HIV-2,QUALITATIVE RNA,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,2,622732323302,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,19-Mar-2026,6227323233,4,622732323304,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",BETA HCG & CRP,,,,,,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,30,622732323230,"Plasma, EDTA",Not Received,Frozen,,HIV-1/HIV-2 QUAL,RNA FROZEN,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,19-Mar-2026,6227323233,3,622732323303,"Red Cells, Clot",Received,,Default Discard/Not Return,"CHEM, LIPID PANEL,","BHCG, FSH & CRP",,,,,,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,6,622732323306,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,7,622732323307,"Serum, SST",Not Received,Ambient,,"HIV SCREEN,",HEPATITIS B & C,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,1,622732323301,"Whole Blood, EDTA, Dry",Not Received,Ambient,,HEMATOLOGY,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,5,622732323305,"Serum, SST",Not Received,Ambient,,FSH,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,8,622732323308,"Feces, unpreserved",Not Received,Frozen,,FECAL CALPROTECTIN,FROZEN,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,9,622732323309,"Whole Blood, EDTA, Dry",Not Received,,,HCV RNA COBAS 6800,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,10,622732323310,"Plasma, EDTA",Not Received,Frozen,,HCV RNA COBAS 6800,FROZEN,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,13,622732323313,"Stool, unpreserved",Not Received,Frozen,,SM10/FECAL,BIOMARKERS,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,12,622732323312,"Plasma, EDTA",Not Received,Frozen,,HBV DNA COBAS 6800,FROZEN,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,16,622732323316,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-1,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,14,622732323314,Whole Blood PAXgene RNA,Not Received,Frozen,,SM07/WB RNA,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,15,622732323315,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,11,622732323311,"Whole Blood, EDTA, Dry",Not Received,,,HBV DNA COBAS 6800,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,17,622732323317,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-2,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,19,622732323319,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,24,622732323324,"Red Cells, Clot",Not Received,,,SM05/SERUM ADA,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,20,622732323320,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-2,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,23,622732323323,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-5,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,26,622732323326,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-2,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,25,622732323325,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-1,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,22,622732323322,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-4,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,27,622732323327,"Whole Blood, EDTA, Dry",Not Received,,,SM03/PLASMA PK,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,21,622732323321,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-3,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,18,622732323318,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-3,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,29,622732323329,"Whole Blood, EDTA, Dry",Not Received,,,HIV-1/HIV-2,QUALITATIVE RNA,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,30,622732323330,"Plasma, EDTA",Not Received,Frozen,,HIV-1/HIV-2 QUAL,RNA FROZEN,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,28,622732323328,"Plasma, EDTA",Not Received,Frozen,,PLASMA PK,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,22-Apr-2026,6227323234,2,622732323402,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,07:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,,6227323234,3,622732323403,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,07:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,22-Apr-2026,6227323234,4,622732323404,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,07:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,,6227323234,5,622732323405,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,07:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,,6227323234,1,622732323401,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,07:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,22-Apr-2026,6227323234,6,622732323406,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,07:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,21-Apr-2026,6227323234,10,622732323410,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,22-Apr-2026,6227323234,8,622732323408,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,07:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,,6227323234,11,622732323411,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,07:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,,6227323234,7,622732323407,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,07:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,21-Apr-2026,6227323234,9,622732323409,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,,6227323234,15,622732323415,"Serum, SST",Cancelled,Ambient,,FSH,FROZEN,,,,,07:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,21-Apr-2026,6227323234,14,622732323414,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,07:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,,6227323234,13,622732323413,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,07:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,21-Apr-2026,6227323234,12,622732323412,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,07:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,,6227323236,2,622732323602,"Plasma, QuantiFERON Nil",Cancelled,Frozen,,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,,6227323236,1,622732323601,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,,6227323236,3,622732323603,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,,6227323236,4,622732323604,"Plasma, QuantiFERON TB1",Cancelled,Frozen,,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,,6227323236,8,622732323608,"Plasma, QuantiFERON Mitoge",Cancelled,Frozen,,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,,6227323236,5,622732323605,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,18-Feb-2026,6227323236,9,622732323609,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:03,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,,6227323236,7,622732323607,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,,6227323236,6,622732323606,"Plasma, QuantiFERON TB2",Cancelled,Frozen,,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,,6227323236,11,622732323611,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,18-Feb-2026,6227323236,12,622732323612,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,07:03,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,18-Feb-2026,6227323236,10,622732323610,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:03,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,,6227323236,13,622732323613,"Red Cells, Clot",Not Received,,,"CHEM PANEL, BETA",HCG & FSH,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,18-Feb-2026,6227323236,14,622732323614,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,07:03,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,18-Feb-2026,6227323236,15,622732323615,"Serum, SST",Received,Ambient,Default Return Ambient,FSH,,,,,,07:03,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,2,622732323702,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,4,622732323704,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,1,622732323701,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,,6227323237,3,622732323703,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,08:00,,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,,6227323237,7,622732323707,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,08:00,,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,8,622732323708,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,,6227323237,5,622732323705,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,08:00,,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,6,622732323706,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,11,622732323711,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,,6227323237,12,622732323712,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,08:00,,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,9,622732323709,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,13,622732323713,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,10,622732323710,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,15,622732323715,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,14,622732323714,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,,6227323237,17,622732323717,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL",& CRP,,,,,08:00,,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,18,622732323718,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,16,622732323716,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,1,622732323801,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,2,622732323802,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,4,622732323804,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,,6227323238,5,622732323805,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,,6227323238,7,622732323807,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,8,622732323808,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,6,622732323806,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,10,622732323810,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,11,622732323811,Whole Blood PAXgene RNA,In Inventory,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,13,622732323813,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,,6227323238,12,622732323812,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,9,622732323809,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,16,622732323816,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,15,622732323815,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,14,622732323814,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,18,622732323818,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,,6227323238,17,622732323817,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL",& CRP,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,09-Apr-2026,6227323240,2,622732324002,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-2 TROUGH,77242113UCO3001,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,,6227323240,1,622732324001,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,07:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,09-Apr-2026,6227323240,15,622732324015,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,09-Apr-2026,6227323240,13,622732324013,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,,6227323240,16,622732324016,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,07:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,09-Apr-2026,6227323240,14,622732324014,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,,6227323240,5,622732324005,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,07:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,09-Apr-2026,6227323240,4,622732324004,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-2 PEAK,77242113UCO3001,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,,6227323240,8,622732324008,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-1,,,,,07:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,,6227323240,9,622732324009,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-2,,,,,07:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,09-Apr-2026,6227323240,6,622732324006,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-1,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,,6227323240,3,622732324003,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,07:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,,6227323240,10,622732324010,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-3,,,,,07:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,09-Apr-2026,6227323240,7,622732324007,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-2,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,09-Apr-2026,6227323240,17,622732324017,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,09-Apr-2026,6227323240,12,622732324012,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-5,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,,6227323240,11,622732324011,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-4,,,,,07:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,,6227323238,3,622732323803,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,,6227323242,1,622732324201,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,2,622732324202,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,3,622732324203,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,4,622732324204,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,5,622732324205,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,,6227323242,9,622732324209,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-4,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,,6227323242,10,622732324210,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-5,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,,6227323242,7,622732324207,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-2,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,,6227323242,8,622732324208,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-3,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,,6227323242,11,622732324211,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,6,622732324206,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-4,77242113UCO3001-1,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,,6227323242,13,622732324213,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,12,622732324212,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-4 TROUGH,77242113UCO3001,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,,6227323242,15,622732324215,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,16,622732324216,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-1,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,17,622732324217,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-2,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,19,622732324219,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,14,622732324214,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-4 PEAK,77242113UCO3001,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,21,622732324221,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,,6227323242,18,622732324218,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,20,622732324220,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,22,622732324222,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCSTOOL,18-Mar-2026,,6227323243,1,622732324301,"Stool, ova & parasites(form)",Not Received,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,09:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCSTOOL,18-Mar-2026,,6227323243,3,622732324303,"Culture, Stool",Cancelled,Ambient,,STOOL CULTURE,,,,,,09:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRNSTOOL,18-Feb-2026,,6227323244,1,622732324401,"Stool, ova & parasites(form)",Not Received,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,07:20,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCSTOOL,18-Mar-2026,,6227323243,4,622732324304,"Stool, ova & parasites(PVA)",Not Received,Ambient,,OVA & PARASITES 2,PVA,,,,,09:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRNSTOOL,18-Feb-2026,18-Feb-2026,6227323244,2,622732324402,"Stool, unpreserved",Cancelled,Frozen,,C-DIFF TOXIN,& PCR FROZEN,,,,,07:20,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCSTOOL,18-Mar-2026,18-Mar-2026,6227323243,2,622732324302,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,09:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRNSTOOL,18-Feb-2026,18-Feb-2026,6227323244,3,622732324403,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,07:20,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRNSTOOL,18-Feb-2026,,6227323244,4,622732324404,"Stool, ova & parasites(PVA)",Not Received,Ambient,,OVA & PARASITES 2,PVA,,,,,07:20,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCSTOOL,12-Mar-2026,12-Mar-2026,6227323245,3,622732324503,"Culture, Stool",Received,Ambient,Default Return Frozen,STOOL CULTURE,,,,,,09:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCSTOOL,12-Mar-2026,,6227323245,4,622732324504,"Stool, ova & parasites(PVA)",Cancelled,Ambient,,OVA & PARASITES 2,PVA,,,,,09:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCSTOOL,12-Mar-2026,,6227323245,1,622732324501,"Stool, ova & parasites(form)",Cancelled,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,09:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCSTOOL,12-Mar-2026,,6227323245,2,622732324502,"Stool, unpreserved",Cancelled,Frozen,,C-DIFF TOXIN,& PCR FROZEN,,,,,09:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,DNA,21-Mar-2026,21-Mar-2026,6227323251,1,622732325101,"Whole Blood, EDTA, Dry",Shipped,Frozen,Default Return Frozen,SM08/WB DNA,77242113UCO3001,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,DNA,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,TB,18-Feb-2026,,6227323252,1,622732325201,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,TB,18-Feb-2026,18-Feb-2026,6227323252,2,622732325202,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,07:03,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,TB,18-Feb-2026,,6227323252,3,622732325203,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,TB,18-Feb-2026,18-Feb-2026,6227323252,4,622732325204,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,07:03,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,TB,18-Feb-2026,,6227323252,5,622732325205,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,TB,18-Feb-2026,18-Feb-2026,6227323252,6,622732325206,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,07:03,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,TB,18-Feb-2026,,6227323252,7,622732325207,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,TB,18-Feb-2026,18-Feb-2026,6227323252,8,622732325208,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,07:03,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,TB,12-Mar-2026,12-Mar-2026,6227323253,2,622732325302,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,09:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,TB,12-Mar-2026,,6227323253,1,622732325301,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,09:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,TB,12-Mar-2026,12-Mar-2026,6227323253,6,622732325306,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,09:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,TB,12-Mar-2026,,6227323253,5,622732325305,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,09:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,TB,12-Mar-2026,,6227323253,3,622732325303,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,09:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,TB,12-Mar-2026,12-Mar-2026,6227323253,8,622732325308,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,09:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,TB,12-Mar-2026,,6227323253,7,622732325307,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,09:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,19-Feb-2026,BXSCR,21-Feb-2026,21-Feb-2026,6227323254,2,622732325402,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,19-Feb-2026,BXSCR,21-Feb-2026,21-Feb-2026,6227323254,1,622732325401,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,19-Feb-2026,BXSCR,21-Feb-2026,,6227323254,4,622732325404,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,TB,12-Mar-2026,12-Mar-2026,6227323253,4,622732325304,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,09:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,19-Feb-2026,BXSCR,21-Feb-2026,21-Feb-2026,6227323254,3,622732325403,"Biopsy, Frozen Tissue",Shipped,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,05:55,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,14-May-2026,BXSCR,15-May-2026,15-May-2026,6227323256,1,622732325601,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,14-May-2026,BXSCR,15-May-2026,15-May-2026,6227323256,2,622732325602,Biopsy RNA Later,In Inventory,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,14-May-2026,BXSCR,15-May-2026,15-May-2026,6227323256,3,622732325603,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,14-May-2026,BXSCR,15-May-2026,,6227323256,4,622732325604,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,7,622732326407,"Serum, SST",Not Received,Ambient,,"HIV SCREEN,",HEPATITIS B & C,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,6,622732326406,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,12-Mar-2026,6227323264,1,622732326401,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,12-Mar-2026,6227323264,2,622732326402,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,9,622732326409,"Whole Blood, EDTA, Dry",Not Received,,,HCV RNA COBAS 6800,,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,10,622732326410,"Plasma, EDTA",Not Received,Frozen,,HCV RNA COBAS 6800,FROZEN,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,3,622732326403,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL,","BHCG, FSH & CRP",,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,8,622732326408,"Feces, unpreserved",Not Received,Frozen,,FECAL CALPROTECTIN,FROZEN,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,11,622732326411,"Whole Blood, EDTA, Dry",Not Received,,,HBV DNA COBAS 6800,,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,4,622732326404,"Serum, SST",Not Received,Ambient,,"CHEM, LIPID PANEL",BETA HCG & CRP,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,13,622732326413,"Stool, unpreserved",Not Received,Frozen,,SM10/FECAL,BIOMARKERS,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,12,622732326412,"Plasma, EDTA",Not Received,Frozen,,HBV DNA COBAS 6800,FROZEN,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,15,622732326415,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,14,622732326414,Whole Blood PAXgene RNA,Not Received,Frozen,,SM07/WB RNA,77242113UCO3001,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,17,622732326417,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-2,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,16,622732326416,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-1,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,18,622732326418,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-3,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,20,622732326420,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-2,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,5,622732326405,"Serum, SST",Not Received,Ambient,,FSH,,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,22,622732326422,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-4,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,21,622732326421,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-3,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,23,622732326423,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-5,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,24,622732326424,"Red Cells, Clot",Not Received,,,SM05/SERUM ADA,,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,25,622732326425,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-1,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,19,622732326419,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,26,622732326426,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-2,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,27,622732326427,"Whole Blood, EDTA, Dry",Not Received,,,SM03/PLASMA PK,,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,28,622732326428,"Plasma, EDTA",Not Received,Frozen,,PLASMA PK,77242113UCO3001,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,29,622732326429,"Whole Blood, EDTA, Dry",Not Received,,,HIV-1/HIV-2,QUALITATIVE RNA,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,30,622732326430,"Plasma, EDTA",Not Received,Frozen,,HIV-1/HIV-2 QUAL,RNA FROZEN,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,18-Mar-2026,6227323265,1,622732326501,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,3,622732326503,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL,","BHCG, FSH & CRP",,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,4,622732326504,"Serum, SST",Not Received,Ambient,,"CHEM, LIPID PANEL",BETA HCG & CRP,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,18-Mar-2026,6227323265,2,622732326502,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,5,622732326505,"Serum, SST",Not Received,Ambient,,FSH,,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,8,622732326508,"Feces, unpreserved",Not Received,Frozen,,FECAL CALPROTECTIN,FROZEN,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,6,622732326506,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,7,622732326507,"Serum, SST",Not Received,Ambient,,"HIV SCREEN,",HEPATITIS B & C,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,9,622732326509,"Whole Blood, EDTA, Dry",Not Received,,,HCV RNA COBAS 6800,,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,10,622732326510,"Plasma, EDTA",Not Received,Frozen,,HCV RNA COBAS 6800,FROZEN,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,11,622732326511,"Whole Blood, EDTA, Dry",Not Received,,,HBV DNA COBAS 6800,,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,12,622732326512,"Plasma, EDTA",Not Received,Frozen,,HBV DNA COBAS 6800,FROZEN,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,13,622732326513,"Stool, unpreserved",Not Received,Frozen,,SM10/FECAL,BIOMARKERS,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,14,622732326514,Whole Blood PAXgene RNA,Not Received,Frozen,,SM07/WB RNA,77242113UCO3001,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,15,622732326515,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,21,622732326521,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-3,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,18,622732326518,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-3,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,17,622732326517,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-2,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,25,622732326525,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-1,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,22,622732326522,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-4,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,20,622732326520,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-2,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,29,622732326529,"Whole Blood, EDTA, Dry",Not Received,,,HIV-1/HIV-2,QUALITATIVE RNA,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,27,622732326527,"Whole Blood, EDTA, Dry",Not Received,,,SM03/PLASMA PK,,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,24,622732326524,"Red Cells, Clot",Not Received,,,SM05/SERUM ADA,,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,16,622732326516,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-1,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,19,622732326519,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,28,622732326528,"Plasma, EDTA",Not Received,Frozen,,PLASMA PK,77242113UCO3001,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,26,622732326526,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-2,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,30,622732326530,"Plasma, EDTA",Not Received,Frozen,,HIV-1/HIV-2 QUAL,RNA FROZEN,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,23,622732326523,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-5,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,,6227323266,1,622732326601,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,16:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,,6227323266,3,622732326603,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,16:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,17-Jan-2026,6227323266,2,622732326602,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,16:45,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,,6227323266,5,622732326605,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,16:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,,6227323266,7,622732326607,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,16:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,17-Jan-2026,6227323266,6,622732326606,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,16:45,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,16-Jan-2026,6227323266,9,622732326609,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,16:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,16-Jan-2026,6227323266,10,622732326610,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,16:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,17-Jan-2026,6227323266,8,622732326608,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,16:45,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,17-Jan-2026,6227323266,4,622732326604,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,16:45,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,16-Jan-2026,6227323266,12,622732326612,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,16:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,,6227323266,13,622732326613,"Red Cells, Clot",Not Received,,,"CHEM PANEL, BETA",HCG & FSH,,,,,16:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,,6227323266,11,622732326611,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,16:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,16-Jan-2026,6227323266,14,622732326614,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,16:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,,6227323266,15,622732326615,"Serum, SST",Cancelled,Ambient,,FSH,,,,,,16:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,,6227323268,1,622732326801,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,30-Jan-2026,6227323268,2,622732326802,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,,6227323268,3,622732326803,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,30-Jan-2026,6227323268,4,622732326804,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,,6227323268,5,622732326805,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,30-Jan-2026,6227323268,6,622732326806,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,,6227323268,7,622732326807,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,24-Jan-2026,6227323268,12,622732326812,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,,6227323268,13,622732326813,"Red Cells, Clot",Not Received,,,"CHEM PANEL, BETA",HCG & FSH,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,24-Jan-2026,6227323268,14,622732326814,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,,6227323268,15,622732326815,"Serum, SST",Cancelled,Ambient,,FSH,,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,30-Jan-2026,6227323268,8,622732326808,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,24-Jan-2026,6227323268,10,622732326810,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,24-Jan-2026,6227323268,9,622732326809,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,,6227323268,11,622732326811,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,,6227323270,3,622732327003,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,08:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,2,622732327002,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,4,622732327004,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,,6227323270,5,622732327005,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,08:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,6,622732327006,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,1,622732327001,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,8,622732327008,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,,6227323270,7,622732327007,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,08:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,10,622732327010,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,9,622732327009,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,11,622732327011,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,,6227323270,12,622732327012,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,08:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,13,622732327013,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,14,622732327014,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,15,622732327015,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,18,622732327018,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,,6227323270,17,622732327017,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL",& CRP,,,,,08:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,16,622732327016,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,,6227323272,1,622732327201,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,07:10,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,28-Mar-2026,6227323272,2,622732327202,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-2 TROUGH,77242113UCO3001,,,,,07:10,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,28-Mar-2026,6227323272,12,622732327212,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-5,,,,,07:10,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,28-Mar-2026,6227323272,13,622732327213,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,07:10,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,,6227323272,3,622732327203,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,07:10,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,,6227323272,11,622732327211,"Stool, unpreserved",Cancelled,Frozen,,STOOL I-2,77242113UCO3001-4,,,,,07:10,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,28-Mar-2026,6227323272,14,622732327214,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:10,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,28-Mar-2026,6227323272,15,622732327215,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:10,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,28-Mar-2026,6227323272,17,622732327217,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,07:10,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,,6227323272,10,622732327210,"Stool, unpreserved",Cancelled,Frozen,,STOOL I-2,77242113UCO3001-3,,,,,07:10,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,,6227323272,16,622732327216,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,07:10,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,,6227323272,5,622732327205,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,07:10,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,28-Mar-2026,6227323272,6,622732327206,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-1,,,,,07:10,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,28-Mar-2026,6227323272,4,622732327204,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-2 PEAK,77242113UCO3001,,,,,07:10,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,28-Mar-2026,6227323272,7,622732327207,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-2,,,,,07:10,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,,6227323272,8,622732327208,"Stool, unpreserved",Cancelled,Frozen,,STOOL I-2,77242113UCO3001-1,,,,,07:10,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,,6227323272,9,622732327209,"Stool, unpreserved",Cancelled,Frozen,,STOOL I-2,77242113UCO3001-2,,,,,07:10,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,,6227323274,1,622732327401,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,2,622732327402,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,3,622732327403,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,5,622732327405,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,4,622732327404,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,,6227323274,6,622732327406,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-1,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,,6227323274,7,622732327407,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-2,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,,6227323274,8,622732327408,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-3,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,,6227323274,9,622732327409,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-4,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,,6227323274,11,622732327411,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,10,622732327410,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-4,77242113UCO3001-5,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,12,622732327412,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-4 TROUGH,77242113UCO3001,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,20,622732327420,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,21,622732327421,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,,6227323274,13,622732327413,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,22,622732327422,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,,6227323274,15,622732327415,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,19,622732327419,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,16,622732327416,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-1,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,14,622732327414,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-4 PEAK,77242113UCO3001,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,17,622732327417,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-2,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,,6227323274,18,622732327418,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRNSTOOL,16-Jan-2026,,6227323276,1,622732327601,"Stool, ova & parasites(form)",Not Received,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,16:55,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRNSTOOL,16-Jan-2026,16-Jan-2026,6227323276,2,622732327602,"Stool, unpreserved",Cancelled,Frozen,,C-DIFF TOXIN,& PCR FROZEN,,,,,16:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRNSTOOL,16-Jan-2026,,6227323276,4,622732327604,"Stool, ova & parasites(PVA)",Not Received,Ambient,,OVA & PARASITES 2,PVA,,,,,16:55,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRNSTOOL,16-Jan-2026,16-Jan-2026,6227323276,3,622732327603,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,16:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRNSTOOL,24-Jan-2026,,6227323277,1,622732327701,"Stool, ova & parasites(form)",Cancelled,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,10:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRNSTOOL,24-Jan-2026,24-Jan-2026,6227323277,3,622732327703,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,10:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRNSTOOL,24-Jan-2026,24-Jan-2026,6227323277,2,622732327702,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,10:10,12:40,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRNSTOOL,24-Jan-2026,,6227323277,4,622732327704,"Stool, ova & parasites(PVA)",Cancelled,Ambient,,OVA & PARASITES 2,PVA,,,,,10:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,DNA,10-Mar-2026,10-Mar-2026,6227323283,1,622732328301,"Whole Blood, EDTA, Dry",Shipped,Frozen,Default Return Frozen,SM08/WB DNA,77242113UCO3001,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,DNA,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,18-Feb-2026,BXSCR,19-Feb-2026,19-Feb-2026,6227323286,1,622732328601,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,10:20,Czech Republic,,10:20,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,18-Feb-2026,BXSCR,19-Feb-2026,21-Feb-2026,6227323286,3,622732328603,"Biopsy, Frozen Tissue",Shipped,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,05:55,Czech Republic,,10:20,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,18-Feb-2026,BXSCR,19-Feb-2026,21-Feb-2026,6227323286,2,622732328602,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,05:55,Czech Republic,,10:20,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,18-Feb-2026,BXSCR,19-Feb-2026,,6227323286,4,622732328604,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,10:20,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,11-Feb-2026,BXSCR,12-Feb-2026,12-Feb-2026,6227323287,1,622732328701,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,11-Feb-2026,BXSCR,12-Feb-2026,14-Feb-2026,6227323287,3,622732328703,"Biopsy, Frozen Tissue",Shipped,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:45,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,11-Feb-2026,BXSCR,12-Feb-2026,,6227323287,4,622732328704,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,11-Feb-2026,BXSCR,12-Feb-2026,14-Feb-2026,6227323287,2,622732328702,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,05:55,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,2,622732329502,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,3,622732329503,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL,","BHCG, FSH & CRP",,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,1,622732329501,"Whole Blood, EDTA, Dry",Not Received,Ambient,,HEMATOLOGY,,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,6,622732329506,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,5,622732329505,"Serum, SST",Not Received,Ambient,,FSH,,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,7,622732329507,"Serum, SST",Not Received,Ambient,,"HIV SCREEN,",HEPATITIS B & C,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,8,622732329508,"Feces, unpreserved",Not Received,Frozen,,FECAL CALPROTECTIN,FROZEN,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,11,622732329511,"Whole Blood, EDTA, Dry",Not Received,,,HBV DNA COBAS 6800,,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,9,622732329509,"Whole Blood, EDTA, Dry",Not Received,,,HCV RNA COBAS 6800,,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,10,622732329510,"Plasma, EDTA",Not Received,Frozen,,HCV RNA COBAS 6800,FROZEN,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,14-Mar-2026,6227323295,4,622732329504,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",BETA HCG & CRP,,,,,08:40,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,12,622732329512,"Plasma, EDTA",Not Received,Frozen,,HBV DNA COBAS 6800,FROZEN,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,13,622732329513,"Stool, unpreserved",Not Received,Frozen,,SM10/FECAL,BIOMARKERS,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,14,622732329514,Whole Blood PAXgene RNA,Not Received,Frozen,,SM07/WB RNA,77242113UCO3001,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,16,622732329516,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-1,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,15,622732329515,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,17,622732329517,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-2,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,19,622732329519,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,18,622732329518,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-3,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,20,622732329520,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-2,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,23,622732329523,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-5,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,22,622732329522,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-4,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,21,622732329521,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-3,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,25,622732329525,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-1,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,26,622732329526,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-2,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,27,622732329527,"Whole Blood, EDTA, Dry",Not Received,,,SM03/PLASMA PK,,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,24,622732329524,"Red Cells, Clot",Not Received,,,SM05/SERUM ADA,,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,29,622732329529,"Whole Blood, EDTA, Dry",Not Received,,,HIV-1/HIV-2,QUALITATIVE RNA,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,30,622732329530,"Plasma, EDTA",Not Received,Frozen,,HIV-1/HIV-2 QUAL,RNA FROZEN,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,28,622732329528,"Plasma, EDTA",Not Received,Frozen,,PLASMA PK,77242113UCO3001,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,2,622732329702,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,14-Mar-2026,6227323297,4,622732329704,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",BETA HCG & CRP,,,,,07:45,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,6,622732329706,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,5,622732329705,"Serum, SST",Not Received,Ambient,,FSH,,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,1,622732329701,"Whole Blood, EDTA, Dry",Not Received,Ambient,,HEMATOLOGY,,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,3,622732329703,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL,","BHCG, FSH & CRP",,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,7,622732329707,"Serum, SST",Not Received,Ambient,,"HIV SCREEN,",HEPATITIS B & C,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,8,622732329708,"Feces, unpreserved",Not Received,Frozen,,FECAL CALPROTECTIN,FROZEN,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,10,622732329710,"Plasma, EDTA",Not Received,Frozen,,HCV RNA COBAS 6800,FROZEN,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,9,622732329709,"Whole Blood, EDTA, Dry",Not Received,,,HCV RNA COBAS 6800,,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,11,622732329711,"Whole Blood, EDTA, Dry",Not Received,,,HBV DNA COBAS 6800,,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,12,622732329712,"Plasma, EDTA",Not Received,Frozen,,HBV DNA COBAS 6800,FROZEN,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,14,622732329714,Whole Blood PAXgene RNA,Not Received,Frozen,,SM07/WB RNA,77242113UCO3001,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,13,622732329713,"Stool, unpreserved",Not Received,Frozen,,SM10/FECAL,BIOMARKERS,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,18,622732329718,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-3,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,16,622732329716,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-1,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,15,622732329715,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,20,622732329720,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-2,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,19,622732329719,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,17,622732329717,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-2,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,21,622732329721,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-3,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,23,622732329723,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-5,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,25,622732329725,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-1,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,27,622732329727,"Whole Blood, EDTA, Dry",Not Received,,,SM03/PLASMA PK,,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,26,622732329726,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-2,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,28,622732329728,"Plasma, EDTA",Not Received,Frozen,,PLASMA PK,77242113UCO3001,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,29,622732329729,"Whole Blood, EDTA, Dry",Not Received,,,HIV-1/HIV-2,QUALITATIVE RNA,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,30,622732329730,"Plasma, EDTA",Not Received,Frozen,,HIV-1/HIV-2 QUAL,RNA FROZEN,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,22,622732329722,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-4,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,24,622732329724,"Red Cells, Clot",Not Received,,,SM05/SERUM ADA,,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,,6227323299,1,622732329901,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,08:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,,6227323299,3,622732329903,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,08:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,15-May-2026,6227323299,4,622732329904,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,08:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,,6227323299,5,622732329905,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,08:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,15-May-2026,6227323299,2,622732329902,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,08:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,,6227323299,7,622732329907,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,08:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,15-May-2026,6227323299,8,622732329908,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,08:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,14-May-2026,6227323299,9,622732329909,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,15-May-2026,6227323299,6,622732329906,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,08:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,,6227323299,11,622732329911,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,08:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,14-May-2026,6227323299,12,622732329912,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,08:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,14-May-2026,6227323299,10,622732329910,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,,6227323299,13,622732329913,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,08:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,14-May-2026,6227323299,15,622732329915,"Serum, SST",Received,Ambient,Default Return Ambient,FSH,,,,,,08:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,14-May-2026,6227323299,14,622732329914,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,08:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRNSTOOL,14-May-2026,14-May-2026,6227323309,1,622732330901,"Stool, ova & parasites(form)",Received,Ambient,Default Return Ambient,OVA & PARASITES 1,FORMALIN,,,,,09:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRNSTOOL,14-May-2026,14-May-2026,6227323309,2,622732330902,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,09:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRNSTOOL,14-May-2026,14-May-2026,6227323309,4,622732330904,"Stool, ova & parasites(PVA)",Received,Ambient,Default Return Ambient,OVA & PARASITES 2,PVA,,,,,09:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRNSTOOL,14-May-2026,14-May-2026,6227323309,3,622732330903,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,09:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,27-May-2026,BXSCR,28-May-2026,28-May-2026,6227323320,1,622732332001,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,27-May-2026,BXSCR,28-May-2026,,6227323320,2,622732332002,Biopsy RNA Later,Not Received,Frozen,,SM13/BIOPSY RNA,FROZEN,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,27-May-2026,BXSCR,28-May-2026,,6227323320,3,622732332003,"Biopsy, Frozen Tissue",Not Received,Frozen,,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,27-May-2026,BXSCR,28-May-2026,,6227323320,4,622732332004,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,,6227323330,1,622732333001,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,08:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,03-Apr-2026,6227323330,2,622732333002,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,,6227323330,3,622732333003,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,08:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,,6227323330,5,622732333005,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,08:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,03-Apr-2026,6227323330,4,622732333004,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,,6227323330,7,622732333007,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,08:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,03-Apr-2026,6227323330,8,622732333008,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,01-Apr-2026,6227323330,9,622732333009,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,03-Apr-2026,6227323330,6,622732333006,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,01-Apr-2026,6227323330,10,622732333010,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,,6227323330,11,622732333011,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,08:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,,6227323330,13,622732333013,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,08:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,01-Apr-2026,6227323330,12,622732333012,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,,6227323330,15,622732333015,"Serum, SST",Cancelled,Ambient,,FSH,FROZEN,,,,,08:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,01-Apr-2026,6227323330,14,622732333014,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,,6227323332,1,622732333201,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,12:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,21-Apr-2026,6227323332,2,622732333202,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,12:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,,6227323332,3,622732333203,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,12:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,21-Apr-2026,6227323332,6,622732333206,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,12:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,21-Apr-2026,6227323332,4,622732333204,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,12:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,21-Apr-2026,6227323332,8,622732333208,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,12:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,17-Apr-2026,6227323332,9,622732333209,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,12:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,,6227323332,5,622732333205,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,12:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,17-Apr-2026,6227323332,10,622732333210,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,,6227323332,7,622732333207,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,12:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,,6227323332,11,622732333211,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,12:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,17-Apr-2026,6227323332,12,622732333212,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,12:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,17-Apr-2026,6227323332,14,622732333214,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,12:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,,6227323332,13,622732333213,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,12:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,17-Apr-2026,6227323332,15,622732333215,"Serum, SST",Received,Ambient,Default Return Ambient,FSH,,,,,,12:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,1,622732333401,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,4,622732333404,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,2,622732333402,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,,6227323334,5,622732333405,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,11:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,,6227323334,3,622732333403,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,11:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,6,622732333406,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,,6227323334,7,622732333407,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,11:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,8,622732333408,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,9,622732333409,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,10,622732333410,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,11,622732333411,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,,6227323334,12,622732333412,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,11:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,13,622732333413,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,14,622732333414,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,15,622732333415,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,16,622732333416,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,,6227323334,17,622732333417,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL",& CRP,,,,,11:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,18,622732333418,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,2,622732333502,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMPK I-2 TROUGH,77242113UCO3001,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,,6227323335,3,622732333503,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,10:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,,6227323335,5,622732333505,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,10:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,,6227323335,1,622732333501,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,10:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,7,622732333507,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-2,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,6,622732333506,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-1,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,4,622732333504,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMA PK I-2 PEAK,77242113UCO3001,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,8,622732333508,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-1,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,9,622732333509,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-2,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,11,622732333511,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-4,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,10,622732333510,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-3,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,13,622732333513,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,15,622732333515,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,,6227323335,16,622732333516,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,10:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,17,622732333517,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,14,622732333514,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,12,622732333512,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-5,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,02-Apr-2026,SCRNSTOOL,03-Apr-2026,03-Apr-2026,6227323340,2,622732334002,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,06:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,02-Apr-2026,SCRNSTOOL,03-Apr-2026,03-Apr-2026,6227323340,4,622732334004,"Stool, ova & parasites(PVA)",Received,Ambient,Default Return Ambient,OVA & PARASITES 2,PVA,,,,,06:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,02-Apr-2026,SCRNSTOOL,03-Apr-2026,03-Apr-2026,6227323340,3,622732334003,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,06:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,02-Apr-2026,SCRNSTOOL,03-Apr-2026,03-Apr-2026,6227323340,1,622732334001,"Stool, ova & parasites(form)",Received,Ambient,Default Return Ambient,OVA & PARASITES 1,FORMALIN,,,,,06:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,20-Apr-2026,SCRNSTOOL,21-Apr-2026,21-Apr-2026,6227323341,1,622732334101,"Stool, ova & parasites(form)",Received,Ambient,Default Return Ambient,OVA & PARASITES 1,FORMALIN,,,,,06:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,20-Apr-2026,SCRNSTOOL,21-Apr-2026,21-Apr-2026,6227323341,2,622732334102,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,06:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,20-Apr-2026,SCRNSTOOL,21-Apr-2026,21-Apr-2026,6227323341,3,622732334103,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,06:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,20-Apr-2026,SCRNSTOOL,21-Apr-2026,21-Apr-2026,6227323341,4,622732334104,"Stool, ova & parasites(PVA)",Received,Ambient,Default Return Ambient,OVA & PARASITES 2,PVA,,,,,06:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,DNA,06-May-2026,06-May-2026,6227323346,1,622732334601,"Whole Blood, EDTA, Dry",In Inventory,Frozen,Default Return Frozen,SM08/WB DNA,77242113UCO3001,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,DNA,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,05-May-2026,TB,07-May-2026,,6227323348,1,622732334801,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,09:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,05-May-2026,TB,07-May-2026,07-May-2026,6227323348,2,622732334802,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,09:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,05-May-2026,TB,07-May-2026,,6227323348,3,622732334803,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,09:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,05-May-2026,TB,07-May-2026,07-May-2026,6227323348,4,622732334804,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,09:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,05-May-2026,TB,07-May-2026,,6227323348,5,622732334805,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,09:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,05-May-2026,TB,07-May-2026,,6227323348,7,622732334807,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,09:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,05-May-2026,TB,07-May-2026,07-May-2026,6227323348,6,622732334806,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,09:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,05-May-2026,TB,07-May-2026,07-May-2026,6227323348,8,622732334808,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,09:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,24-Apr-2026,BXSCR,28-Apr-2026,,6227323351,4,622732335104,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,24-Apr-2026,BXSCR,28-Apr-2026,28-Apr-2026,6227323351,3,622732335103,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,24-Apr-2026,BXSCR,28-Apr-2026,28-Apr-2026,6227323351,2,622732335102,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,24-Apr-2026,BXSCR,28-Apr-2026,28-Apr-2026,6227323351,1,622732335101,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,BDL,06-May-2026,,6227323355,1,622732335501,"Red Cells, Clot",Not Received,,,DRUG LEVEL TESTING,,,,,,11:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biologic Drug Level,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,BDL,06-May-2026,06-May-2026,6227323355,2,622732335502,"Serum, SST",Shipped,Frozen,Default Return Frozen,"ADA, GOL, INF",UST OR VED FROZEN,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biologic Drug Level,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,,6227635139,1,622763513901,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,,6227635139,3,622763513903,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,03-Apr-2026,6227635139,8,622763513908,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,08:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,03-Apr-2026,6227635139,4,622763513904,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,08:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,03-Apr-2026,6227635139,2,622763513902,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,08:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,,6227635140,5,622763514005,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,13:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,28-Feb-2026,6227635140,8,622763514008,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,13:20,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,,6227635139,13,622763513913,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,03-Apr-2026,6227635139,6,622763513906,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,08:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,28-Feb-2026,6227635140,6,622763514006,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,13:20,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,,6227635140,7,622763514007,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,13:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,27-Feb-2026,6227635140,9,622763514009,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,13:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,02-Apr-2026,6227635139,10,622763513910,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,,6227635139,15,622763513915,"Serum, SST",Cancelled,Ambient,,FSH,FROZEN,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,02-Apr-2026,6227635139,12,622763513912,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,08:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,02-Apr-2026,6227635139,9,622763513909,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,,6227635139,7,622763513907,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,28-Feb-2026,6227635140,4,622763514004,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,13:20,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,,6227635139,11,622763513911,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,28-Feb-2026,6227635140,2,622763514002,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,13:20,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,,6227635140,3,622763514003,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,13:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,,6227635140,1,622763514001,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,13:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,,6227635139,5,622763513905,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,02-Apr-2026,6227635139,14,622763513914,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,08:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,27-Feb-2026,6227635140,12,622763514012,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,13:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,27-Feb-2026,6227635140,14,622763514014,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,13:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,,6227635141,1,622763514101,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,,6227635140,15,622763514015,"Serum, SST",Cancelled,Ambient,,FSH,FROZEN,,,,,13:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,08-May-2026,6227635141,2,622763514102,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,,6227635140,11,622763514011,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,13:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,27-Feb-2026,6227635140,10,622763514010,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,13:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,,6227635141,3,622763514103,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,,6227635140,13,622763514013,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,13:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,08-May-2026,6227635141,8,622763514108,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,07-May-2026,6227635141,9,622763514109,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,,6227635141,11,622763514111,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,07-May-2026,6227635141,12,622763514112,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,07-May-2026,6227635141,10,622763514110,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,,6227635141,13,622763514113,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,,6227635141,7,622763514107,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,08-May-2026,6227635141,6,622763514106,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,,6227635142,3,622763514203,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,09:40,,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,4,622763514204,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,13,622763514213,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,,6227635142,5,622763514205,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,09:40,,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,,6227635141,5,622763514105,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,08-May-2026,6227635141,4,622763514104,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,6,622763514206,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,14,622763514214,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,2,622763514202,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,10,622763514210,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,1,622763514201,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,15,622763514215,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,,6227635142,7,622763514207,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,09:40,,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,9,622763514209,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,16,622763514216,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,,6227635142,17,622763514217,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL",& CRP,,,,,09:40,,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,07-May-2026,6227635141,14,622763514114,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,,6227635141,15,622763514115,"Serum, SST",Cancelled,Ambient,,FSH,FROZEN,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,,6227635142,12,622763514212,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,09:40,,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,11,622763514211,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,8,622763514208,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,18,622763514218,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,09-Apr-2026,6227635144,7,622763514407,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-2,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,09-Apr-2026,6227635144,6,622763514406,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-1,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,,6227635144,3,622763514403,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,08:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,09-Apr-2026,6227635144,2,622763514402,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-2 TROUGH,77242113UCO3001,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,,6227635144,1,622763514401,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,08:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,08-Apr-2026,6227635144,15,622763514415,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,,6227635144,16,622763514416,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,08:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,09-Apr-2026,6227635144,8,622763514408,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-1,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,09-Apr-2026,6227635144,10,622763514410,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-3,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,09-Apr-2026,6227635144,4,622763514404,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-2 PEAK,77242113UCO3001,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,08-Apr-2026,6227635144,17,622763514417,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,09-Apr-2026,6227635144,12,622763514412,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-5,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,09-Apr-2026,6227635144,11,622763514411,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-4,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,08-Apr-2026,6227635144,14,622763514414,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,09-Apr-2026,6227635144,13,622763514413,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,,6227635144,5,622763514405,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,08:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,09-Apr-2026,6227635144,9,622763514409,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-2,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,2,622763514602,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,3,622763514603,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,23-Apr-2026,6227635146,8,622763514608,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-4,77242113UCO3001-3,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,23-Apr-2026,6227635146,9,622763514609,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-4,77242113UCO3001-4,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,23-Apr-2026,6227635146,10,622763514610,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-4,77242113UCO3001-5,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,16,622763514616,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-1,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,14,622763514614,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-4 PEAK,77242113UCO3001,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,21,622763514621,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,4,622763514604,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,5,622763514605,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,,6227635146,15,622763514615,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,,6227635146,18,622763514618,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,,6227635146,11,622763514611,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,,6227635146,13,622763514613,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,23-Apr-2026,6227635146,6,622763514606,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-4,77242113UCO3001-1,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,22,622763514622,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,23-Apr-2026,6227635146,7,622763514607,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-4,77242113UCO3001-2,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,19,622763514619,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,,6227635146,1,622763514601,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,17,622763514617,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-2,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,12,622763514612,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-4 TROUGH,77242113UCO3001,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,20,622763514620,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRNSTOOL,02-Apr-2026,02-Apr-2026,6227635148,3,622763514803,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRNSTOOL,02-Apr-2026,02-Apr-2026,6227635148,4,622763514804,"Stool, ova & parasites(PVA)",Received,Ambient,Default Return Ambient,OVA & PARASITES 2,PVA,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRNSTOOL,02-Apr-2026,02-Apr-2026,6227635148,1,622763514801,"Stool, ova & parasites(form)",Received,Ambient,Default Return Ambient,OVA & PARASITES 1,FORMALIN,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,07-May-2026,SCRNSTOOL,08-May-2026,08-May-2026,6227635150,2,622763515002,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,05:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,07-May-2026,SCRNSTOOL,08-May-2026,08-May-2026,6227635150,3,622763515003,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,05:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRNSTOOL,27-Feb-2026,27-Feb-2026,6227635149,2,622763514902,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,07-May-2026,SCRNSTOOL,08-May-2026,08-May-2026,6227635150,4,622763515004,"Stool, ova & parasites(PVA)",Received,Ambient,Default Return Ambient,OVA & PARASITES 2,PVA,,,,,05:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRNSTOOL,02-Apr-2026,02-Apr-2026,6227635148,2,622763514802,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRNSTOOL,27-Feb-2026,27-Feb-2026,6227635149,1,622763514901,"Stool, ova & parasites(form)",Received,Ambient,Default Return Ambient,OVA & PARASITES 1,FORMALIN,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRNSTOOL,27-Feb-2026,27-Feb-2026,6227635149,4,622763514904,"Stool, ova & parasites(PVA)",Received,Ambient,Default Return Ambient,OVA & PARASITES 2,PVA,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRNSTOOL,27-Feb-2026,27-Feb-2026,6227635149,3,622763514903,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,07-May-2026,SCRNSTOOL,08-May-2026,08-May-2026,6227635150,1,622763515001,"Stool, ova & parasites(form)",Received,Ambient,Default Return Ambient,OVA & PARASITES 1,FORMALIN,,,,,05:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,DNA,26-Mar-2026,26-Mar-2026,6227635156,1,622763515601,"Whole Blood, EDTA, Dry",Shipped,Frozen,Default Return Frozen,SM08/WB DNA,77242113UCO3001,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,DNA,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,DNA,27-May-2026,27-May-2026,6227635155,1,622763515501,"Whole Blood, EDTA, Dry",In Inventory,Frozen,Default Return Frozen,SM08/WB DNA,77242113UCO3001,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,DNA,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,21-Apr-2026,BXSCR,22-Apr-2026,,6227635159,4,622763515904,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,21-Apr-2026,BXSCR,22-Apr-2026,22-Apr-2026,6227635159,1,622763515901,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,21-Apr-2026,BXSCR,22-Apr-2026,23-Apr-2026,6227635159,2,622763515902,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,21-Apr-2026,BXSCR,22-Apr-2026,23-Apr-2026,6227635159,3,622763515903,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,12-Mar-2026,BXSCR,13-Mar-2026,14-Mar-2026,6227635161,3,622763516103,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:20,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,12-Mar-2026,BXSCR,13-Mar-2026,,6227635161,4,622763516104,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,12-Mar-2026,BXSCR,13-Mar-2026,13-Mar-2026,6227635161,1,622763516101,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,12-Mar-2026,BXSCR,13-Mar-2026,14-Mar-2026,6227635161,2,622763516102,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:20,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,,6227635171,1,622763517101,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,23-Apr-2026,6227635171,2,622763517102,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,,6227635171,5,622763517105,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,,6227635171,7,622763517107,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,,6227635171,3,622763517103,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,23-Apr-2026,6227635171,6,622763517106,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,23-Apr-2026,6227635171,4,622763517104,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,22-Apr-2026,6227635171,10,622763517110,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,22-Apr-2026,6227635171,14,622763517114,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,22-Apr-2026,6227635171,15,622763517115,"Serum, SST",Received,Ambient,Default Return Ambient,FSH,,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,,6227635171,11,622763517111,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,23-Apr-2026,6227635171,8,622763517108,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,22-Apr-2026,6227635171,9,622763517109,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,,6227635171,13,622763517113,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,22-Apr-2026,6227635171,12,622763517112,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,,6227635173,2,622763517302,"Plasma, QuantiFERON Nil",Not Received,Frozen,,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,12:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,,6227635173,6,622763517306,"Plasma, QuantiFERON TB2",Not Received,Frozen,,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,12:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,,6227635173,7,622763517307,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,12:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,,6227635173,8,622763517308,"Plasma, QuantiFERON Mitoge",Not Received,Frozen,,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,12:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,,6227635173,5,622763517305,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,12:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,28-May-2026,6227635173,10,622763517310,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,,6227635173,4,622763517304,"Plasma, QuantiFERON TB1",Not Received,Frozen,,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,12:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,28-May-2026,6227635173,9,622763517309,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,12:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,,6227635173,1,622763517301,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,12:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,,6227635173,3,622763517303,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,12:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,28-May-2026,6227635173,14,622763517314,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,12:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,,6227635173,13,622763517313,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,12:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,29-May-2026,6227635174,1,622763517401,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,28-May-2026,6227635173,15,622763517315,"Serum, SST",Received,Ambient,Default Return Ambient,FSH,,,,,,12:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,3,622763517403,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,,6227635173,11,622763517311,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,12:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,29-May-2026,6227635174,2,622763517402,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,28-May-2026,6227635173,12,622763517312,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,12:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,9,622763517409,"Serum, SST",Not Received,Frozen,Specimen not submitted,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,5,622763517405,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,11,622763517411,Whole Blood PAXgene RNA,Not Received,Frozen,Specimen not submitted,SM07/WB RNA,77242113UCO3001,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,6,622763517406,"Plasma, EDTA",Not Received,Frozen,Specimen not submitted,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,12,622763517412,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,4,622763517404,"Plasma, EDTA",Not Received,Frozen,Specimen not submitted,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,7,622763517407,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,8,622763517408,"Serum, SST",Not Received,Frozen,Specimen not submitted,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,13,622763517413,"Serum, SST",Not Received,Frozen,Specimen not submitted,SM06/SERUM BIOM,77242113UCO3001-1,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,10,622763517410,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,SM10/FECAL,BIOMARKERS,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,14,622763517414,"Serum, SST",Not Received,Frozen,Specimen not submitted,SM06/SERUM BIOM,77242113UCO3001-2,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,29-May-2026,6227635174,18,622763517418,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,17,622763517417,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL",& CRP,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,15,622763517415,"Serum, SST",Not Received,Frozen,Specimen not submitted,SM06/SERUM BIOM,77242113UCO3001-3,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,16,622763517416,"Feces, unpreserved",Not Received,Frozen,Specimen not submitted,FECAL CALPROTECTIN,FROZEN,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRNSTOOL,28-May-2026,,6227635180,1,622763518001,"Stool, ova & parasites(form)",Not Received,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,13:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRNSTOOL,28-May-2026,28-May-2026,6227635180,3,622763518003,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,13:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRNSTOOL,28-May-2026,,6227635180,4,622763518004,"Stool, ova & parasites(PVA)",Not Received,Ambient,,OVA & PARASITES 2,PVA,,,,,13:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRNSTOOL,28-May-2026,,6227635180,2,622763518002,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,C-DIFF TOXIN,& PCR FROZEN,,,,,13:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,24-Apr-2026,SCRNSTOOL,25-Apr-2026,,6227635182,4,622763518204,"Stool, ova & parasites(PVA)",Not Received,Ambient,,OVA & PARASITES 2,PVA,,,,,08:45,,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,24-Apr-2026,SCRNSTOOL,25-Apr-2026,25-Apr-2026,6227635182,3,622763518203,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,08:45,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,24-Apr-2026,SCRNSTOOL,25-Apr-2026,,6227635182,1,622763518201,"Stool, ova & parasites(form)",Not Received,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,08:45,,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,24-Apr-2026,SCRNSTOOL,25-Apr-2026,,6227635182,2,622763518202,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,C-DIFF TOXIN,& PCR FROZEN,,,,,08:45,,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,19-May-2026,BXSCR,20-May-2026,21-May-2026,6227635193,2,622763519302,Biopsy RNA Later,In Inventory,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,19-May-2026,BXSCR,20-May-2026,20-May-2026,6227635193,1,622763519301,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,19-May-2026,BXSCR,20-May-2026,21-May-2026,6227635193,3,622763519303,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,19-May-2026,BXSCR,20-May-2026,,6227635193,4,622763519304,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,,6227635204,1,622763520401,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,12:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,03-Mar-2026,6227635204,2,622763520402,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,12:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,,6227635204,3,622763520403,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,12:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,26-Feb-2026,6227635204,15,622763520415,"Serum, SST",Received,Ambient,Default Return Ambient,FSH,,,,,,12:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,26-Feb-2026,6227635204,9,622763520409,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,12:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,26-Feb-2026,6227635204,10,622763520410,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,,6227635204,11,622763520411,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,12:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,26-Feb-2026,6227635204,12,622763520412,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,12:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,,6227635204,13,622763520413,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,12:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,,6227635204,5,622763520405,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,12:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,03-Mar-2026,6227635204,4,622763520404,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,12:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,26-Feb-2026,6227635204,14,622763520414,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,12:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,,6227635204,7,622763520407,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,12:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,03-Mar-2026,6227635204,6,622763520406,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,12:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,03-Mar-2026,6227635204,8,622763520408,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,12:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227635207,2,622763520702,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,09-Apr-2026,6227635207,8,622763520708,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,,6227635207,5,622763520705,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,10:37,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,09-Apr-2026,6227635207,4,622763520704,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,09-Apr-2026,6227635207,9,622763520709,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227635207,1,622763520701,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,09-Apr-2026,6227635207,11,622763520711,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,,6227635207,3,622763520703,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,10:37,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,09-Apr-2026,6227635207,6,622763520706,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,,6227635207,17,622763520717,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL",& CRP,,,,,10:37,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227635207,18,622763520718,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,28-Apr-2026,6227635208,2,622763520802,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-2 TROUGH,77242113UCO3001,,,,,08:43,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,,6227635208,3,622763520803,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,08:43,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,09-Apr-2026,6227635207,13,622763520713,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,,6227635208,1,622763520801,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,08:43,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,,6227635207,7,622763520707,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,10:37,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,09-Apr-2026,6227635207,10,622763520710,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,,6227635207,12,622763520712,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,10:37,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,09-Apr-2026,6227635207,16,622763520716,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,28-Apr-2026,6227635208,7,622763520807,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-2,,,,,08:43,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,,6227635208,9,622763520809,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-2,,,,,08:43,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,,6227635208,10,622763520810,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-3,,,,,08:43,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,,6227635208,11,622763520811,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-4,,,,,08:43,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,09-Apr-2026,6227635207,14,622763520714,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,09-Apr-2026,6227635207,15,622763520715,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,,6227635208,12,622763520812,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-5,,,,,08:43,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,28-Apr-2026,6227635208,4,622763520804,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-2 PEAK,77242113UCO3001,,,,,08:43,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,28-Apr-2026,6227635208,6,622763520806,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-1,,,,,08:43,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,28-Apr-2026,6227635208,8,622763520808,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-1,,,,,08:43,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,21-Apr-2026,6227635208,17,622763520817,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,08:43,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,21-Apr-2026,6227635208,14,622763520814,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:43,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,,6227635208,5,622763520805,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,08:43,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,28-Apr-2026,6227635208,13,622763520813,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,08:43,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,,6227635208,16,622763520816,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,08:43,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,21-Apr-2026,6227635208,15,622763520815,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:43,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,06-May-2026,6227635211,2,622763521102,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,06-May-2026,6227635211,3,622763521103,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,06-May-2026,6227635211,4,622763521104,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,,6227635211,1,622763521101,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,,6227635211,8,622763521108,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-3,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,,6227635211,10,622763521110,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-5,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,07-May-2026,6227635211,6,622763521106,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-4,77242113UCO3001-1,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,,6227635211,5,622763521105,"Feces, unpreserved",Not Received,Frozen,Specimen not submitted,FECAL CALPROTECTIN,FROZEN,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,,6227635211,11,622763521111,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,,6227635211,13,622763521113,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,07-May-2026,6227635211,14,622763521114,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-4 PEAK,77242113UCO3001,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,,6227635211,7,622763521107,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-2,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,07-May-2026,6227635211,19,622763521119,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,07-May-2026,6227635211,16,622763521116,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-1,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,07-May-2026,6227635211,20,622763521120,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,,6227635211,9,622763521109,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-4,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,07-May-2026,6227635211,21,622763521121,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,07-May-2026,6227635211,22,622763521122,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,07-May-2026,6227635211,17,622763521117,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-2,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,,6227635211,18,622763521118,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,07-May-2026,6227635211,12,622763521112,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-4 TROUGH,77242113UCO3001,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,01-Mar-2026,SCRNSTOOL,03-Mar-2026,03-Mar-2026,6227635213,2,622763521302,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,14:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,01-Mar-2026,SCRNSTOOL,03-Mar-2026,03-Mar-2026,6227635213,3,622763521303,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,14:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,01-Mar-2026,SCRNSTOOL,03-Mar-2026,03-Mar-2026,6227635213,4,622763521304,"Stool, ova & parasites(PVA)",Received,Ambient,Default Return Ambient,OVA & PARASITES 2,PVA,,,,,14:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,,6227635211,15,622763521115,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,01-Mar-2026,SCRNSTOOL,03-Mar-2026,03-Mar-2026,6227635213,1,622763521301,"Stool, ova & parasites(form)",Received,Ambient,Default Return Ambient,OVA & PARASITES 1,FORMALIN,,,,,14:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,DNA,09-Apr-2026,09-Apr-2026,6227635218,1,622763521801,"Whole Blood, EDTA, Dry",Shipped,Frozen,Default Return Frozen,SM08/WB DNA,77242113UCO3001,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,DNA,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,16-Mar-2026,BXSCR,18-Mar-2026,18-Mar-2026,6227635223,2,622763522302,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,16-Mar-2026,BXSCR,18-Mar-2026,18-Mar-2026,6227635223,1,622763522301,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,16-Mar-2026,BXSCR,18-Mar-2026,18-Mar-2026,6227635223,3,622763522303,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,16-Mar-2026,BXSCR,18-Mar-2026,,6227635223,4,622763522304,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,20-Mar-2026,6227697718,2,622769771802,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,09:18,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,,6227697718,3,622769771803,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,09:18,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,,6227697718,5,622769771805,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,09:18,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,,6227697718,1,622769771801,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,09:18,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,20-Mar-2026,6227697718,6,622769771806,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,09:18,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,20-Mar-2026,6227697718,4,622769771804,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,09:18,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,,6227697718,7,622769771807,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,09:18,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,,6227697718,11,622769771811,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,09:18,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,,6227697718,13,622769771813,"Red Cells, Clot",Not Received,,,"CHEM PANEL, BETA",HCG & FSH,,,,,09:18,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,19-Mar-2026,6227697718,10,622769771810,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:18,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,19-Mar-2026,6227697718,14,622769771814,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,09:18,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,19-Mar-2026,6227697718,15,622769771815,"Serum, SST",Received,Ambient,Default Return Ambient,FSH,,,,,,09:18,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,20-Mar-2026,6227697718,8,622769771808,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,09:18,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,1,622769771901,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,2,622769771902,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,4,622769771904,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,,6227697719,5,622769771905,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,11:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,,6227697719,3,622769771903,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,11:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,8,622769771908,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,,6227697719,7,622769771907,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,11:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,6,622769771906,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,10,622769771910,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,19-Mar-2026,6227697718,9,622769771809,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:18,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,11,622769771911,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,19-Mar-2026,6227697718,12,622769771812,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,09:18,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,9,622769771909,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,,6227697719,12,622769771912,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,11:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,13,622769771913,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,14,622769771914,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,,6227697719,17,622769771917,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL",& CRP,,,,,11:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,15,622769771915,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,16,622769771916,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,18,622769771918,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6227697722,6,622769772206,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-1,,,,,09:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6227697722,7,622769772207,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-2,,,,,09:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6227697722,13,622769772213,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,09:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,,6227697722,10,622769772210,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-3,,,,,09:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6227697722,12,622769772212,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-5,,,,,09:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,,6227697722,11,622769772211,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-4,,,,,09:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6227697722,14,622769772214,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,,6227697722,8,622769772208,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-1,,,,,09:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6227697722,15,622769772215,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,,6227697722,9,622769772209,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-2,,,,,09:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6227697722,2,622769772202,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-2 TROUGH,77242113UCO3001,,,,,09:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,,6227697722,5,622769772205,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,09:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,,6227697722,3,622769772203,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,09:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6227697722,4,622769772204,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-2 PEAK,77242113UCO3001,,,,,09:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,,6227697722,1,622769772201,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,09:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,,6227697723,1,622769772301,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,12:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,08-May-2026,6227697723,4,622769772304,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,08-May-2026,6227697723,2,622769772302,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,12:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,08-May-2026,6227697723,3,622769772303,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,12:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,,6227697723,5,622769772305,"Feces, unpreserved",Not Received,Frozen,Specimen not submitted,FECAL CALPROTECTIN,FROZEN,,,,,12:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,,6227697723,7,622769772307,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-2,,,,,12:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,,6227697722,16,622769772216,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,09:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6227697722,17,622769772217,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,09:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,08-May-2026,6227697723,21,622769772321,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,12:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,,6227697723,6,622769772306,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-1,,,,,12:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,08-May-2026,6227697723,12,622769772312,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-4 TROUGH,77242113UCO3001,,,,,12:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,,6227697723,13,622769772313,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,12:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,08-May-2026,6227697723,14,622769772314,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-4 PEAK,77242113UCO3001,,,,,12:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,,6227697723,9,622769772309,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-4,,,,,12:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,,6227697723,18,622769772318,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,12:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,08-May-2026,6227697723,16,622769772316,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-1,,,,,12:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,08-May-2026,6227697723,17,622769772317,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-2,,,,,12:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,,6227697723,8,622769772308,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-3,,,,,12:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,,6227697723,15,622769772315,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,12:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,08-May-2026,6227697723,19,622769772319,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,12:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,,6227697723,10,622769772310,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-5,,,,,12:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,08-May-2026,6227697723,20,622769772320,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,12:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,08-May-2026,6227697723,22,622769772322,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,12:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,,6227697723,11,622769772311,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,12:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,17-Mar-2026,SCRNSTOOL,19-Mar-2026,,6227697725,1,622769772501,"Stool, ova & parasites(form)",Not Received,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,17:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,17-Mar-2026,SCRNSTOOL,19-Mar-2026,19-Mar-2026,6227697725,3,622769772503,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,17:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,17-Mar-2026,SCRNSTOOL,19-Mar-2026,,6227697725,4,622769772504,"Stool, ova & parasites(PVA)",Not Received,Ambient,,OVA & PARASITES 2,PVA,,,,,17:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,17-Mar-2026,SCRNSTOOL,19-Mar-2026,19-Mar-2026,6227697725,2,622769772502,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,17:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,23-Mar-2026,BXSCR,24-Mar-2026,26-Mar-2026,6227697736,2,622769773602,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,DNA,08-Apr-2026,08-Apr-2026,6227697731,1,622769773101,"Whole Blood, EDTA, Dry",Shipped,Frozen,Default Return Frozen,SM08/WB DNA,77242113UCO3001,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,DNA,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,23-Mar-2026,BXSCR,24-Mar-2026,24-Mar-2026,6227697736,1,622769773601,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,23-Mar-2026,BXSCR,24-Mar-2026,,6227697736,4,622769773604,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,23-Mar-2026,BXSCR,24-Mar-2026,26-Mar-2026,6227697736,3,622769773603,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,5,622769774505,"Serum, SST",Not Received,Ambient,,FSH,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,1,622769774501,"Whole Blood, EDTA, Dry",Not Received,Ambient,,HEMATOLOGY,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,6,622769774506,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,4,622769774504,"Serum, SST",Not Received,Ambient,,"CHEM, LIPID PANEL",BETA HCG & CRP,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,08-May-2026,6227697745,8,622769774508,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,3,622769774503,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL,","BHCG, FSH & CRP",,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,2,622769774502,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,7,622769774507,"Serum, SST",Not Received,Ambient,,"HIV SCREEN,",HEPATITIS B & C,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,9,622769774509,"Whole Blood, EDTA, Dry",Not Received,,,HCV RNA COBAS 6800,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,14,622769774514,Whole Blood PAXgene RNA,Not Received,Frozen,,SM07/WB RNA,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,16,622769774516,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-1,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,18,622769774518,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-3,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,17,622769774517,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-2,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,13,622769774513,"Stool, unpreserved",Not Received,Frozen,,SM10/FECAL,BIOMARKERS,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,12,622769774512,"Plasma, EDTA",Not Received,Frozen,,HBV DNA COBAS 6800,FROZEN,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,11,622769774511,"Whole Blood, EDTA, Dry",Not Received,,,HBV DNA COBAS 6800,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,15,622769774515,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,19,622769774519,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,10,622769774510,"Plasma, EDTA",Not Received,Frozen,,HCV RNA COBAS 6800,FROZEN,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,30,622769774530,"Plasma, EDTA",Not Received,Frozen,,HIV-1/HIV-2 QUAL,RNA FROZEN,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,20,622769774520,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-2,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,22,622769774522,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-4,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,25,622769774525,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-1,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,23,622769774523,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-5,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,26,622769774526,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-2,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,21,622769774521,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-3,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,29,622769774529,"Whole Blood, EDTA, Dry",Not Received,,,HIV-1/HIV-2,QUALITATIVE RNA,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,27,622769774527,"Whole Blood, EDTA, Dry",Not Received,,,SM03/PLASMA PK,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,24,622769774524,"Red Cells, Clot",Not Received,,,SM05/SERUM ADA,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,28,622769774528,"Plasma, EDTA",Not Received,Frozen,,PLASMA PK,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,,6227810899,1,622781089901,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,11:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,,6227810899,3,622781089903,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,11:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,,6227810899,2,622781089902,"Plasma, QuantiFERON Nil",Cancelled,Frozen,,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,11:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,,6227810899,4,622781089904,"Plasma, QuantiFERON TB1",Cancelled,Frozen,,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,11:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,,6227810899,5,622781089905,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,11:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,,6227810899,6,622781089906,"Plasma, QuantiFERON TB2",Cancelled,Frozen,,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,11:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,03-Mar-2026,6227810899,10,622781089910,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,,6227810899,11,622781089911,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,11:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,03-Mar-2026,6227810899,12,622781089912,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,11:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,,6227810899,13,622781089913,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,11:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,03-Mar-2026,6227810899,14,622781089914,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,11:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,,6227810899,15,622781089915,"Serum, SST",Cancelled,Ambient,,FSH,,,,,,11:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,,6227810899,8,622781089908,"Plasma, QuantiFERON Mitoge",Cancelled,Frozen,,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,11:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,03-Mar-2026,6227810899,9,622781089909,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,11:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,06-Mar-2026,6227810900,2,622781090002,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,06-Mar-2026,6227810900,4,622781090004,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,06-Mar-2026,6227810900,6,622781090006,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,,6227810900,7,622781090007,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,06-Mar-2026,6227810900,8,622781090008,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,05-Mar-2026,6227810900,9,622781090009,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,05-Mar-2026,6227810900,10,622781090010,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,,6227810900,3,622781090003,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,,6227810900,5,622781090005,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,05-Mar-2026,6227810900,12,622781090012,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,,6227810900,14,622781090014,"Serum, SST",Cancelled,Ambient,,CHEM PANEL &,BETA HCG,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,,6227810900,13,622781090013,"Red Cells, Clot",Not Received,,,"CHEM PANEL, BETA",HCG & FSH,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,,6227810900,15,622781090015,"Serum, SST",Cancelled,Ambient,,FSH,FROZEN,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,,6227810901,1,622781090101,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,12:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,05-Mar-2026,6227810901,2,622781090102,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,12:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,,6227810901,3,622781090103,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,12:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,05-Mar-2026,6227810901,4,622781090104,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,12:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,,6227810900,1,622781090001,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,05-Mar-2026,6227810901,6,622781090106,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,12:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,,6227810901,7,622781090107,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,12:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,05-Mar-2026,6227810901,8,622781090108,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,12:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,04-Mar-2026,6227810901,9,622781090109,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,12:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,,6227810901,10,622781090110,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,12:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,,6227810901,11,622781090111,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,12:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,04-Mar-2026,6227810901,12,622781090112,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,12:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,,6227810901,14,622781090114,"Serum, SST",Cancelled,Ambient,,CHEM PANEL &,BETA HCG,,,,,12:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,,6227810901,13,622781090113,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,12:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,,6227810899,7,622781089907,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,11:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,,6227810900,11,622781090011,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,,6227810901,5,622781090105,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,12:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,,6227810901,15,622781090115,"Serum, SST",Cancelled,Ambient,,FSH,,,,,,12:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRNSTOOL,05-Mar-2026,05-Mar-2026,6227810904,2,622781090402,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,09:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRNSTOOL,05-Mar-2026,05-Mar-2026,6227810904,3,622781090403,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,09:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRNSTOOL,05-Mar-2026,,6227810904,4,622781090404,"Stool, ova & parasites(PVA)",Cancelled,Ambient,,OVA & PARASITES 2,PVA,,,,,09:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRNSTOOL,04-Mar-2026,,6227810905,1,622781090501,"Stool, ova & parasites(form)",Cancelled,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,12:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRNSTOOL,04-Mar-2026,04-Mar-2026,6227810905,2,622781090502,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,12:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRNSTOOL,04-Mar-2026,04-Mar-2026,6227810905,3,622781090503,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,12:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRNSTOOL,04-Mar-2026,,6227810905,4,622781090504,"Stool, ova & parasites(PVA)",Cancelled,Ambient,,OVA & PARASITES 2,PVA,,,,,12:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRNSTOOL,05-Mar-2026,,6227810904,1,622781090401,"Stool, ova & parasites(form)",Cancelled,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,09:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,05-Feb-2026,BXSCR,06-Feb-2026,06-Feb-2026,6227323223,5,622732322305,"Tissue , Paraffin Block",Shipped,,Default Return Ambient,,,,,,,00:00,13:01,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,3,622793314203,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,5,622793314205,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,2,622793314202,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,4,622793314204,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,6,622793314206,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-4,77242113UCO3001-1,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,1,622793314201,"Red Cells, Clot",Received,,Default Discard/Not Return,CHEM PANEL &,CRP,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,,6227933142,7,622793314207,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-2,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,,6227933142,10,622793314210,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-5,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,12,622793314212,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-4 TROUGH,77242113UCO3001,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,,6227933142,9,622793314209,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-4,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,11,622793314211,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,PLASMA PK TROUGH,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,,6227933142,8,622793314208,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-3,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,14,622793314214,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-4 PEAK,77242113UCO3001,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,17,622793314217,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-2,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,13,622793314213,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,SM02/PLASMAPK PEAK,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,18,622793314218,"Red Cells, Clot",Received,,Default Discard/Not Return,SM06/SERUM,BIOMARKERS,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,1,622793314301,"Red Cells, Clot",Received,,Default Discard/Not Return,"CHEM, LIPID PANEL",& CRP,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,15,622793314215,"Red Cells, Clot",Received,,Default Discard/Not Return,SM04/SERUM ADA PRE,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,19,622793314219,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,2,622793314302,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,21,622793314221,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,22,622793314222,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,20,622793314220,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,16,622793314216,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-1,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,4,622793314304,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,,6227933143,8,622793314308,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-12,77242113UCO3001-4,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,,6227933143,7,622793314307,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-12,77242113UCO3001-3,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,3,622793314303,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,20,622793314320,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,,6227933143,6,622793314306,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-12,77242113UCO3001-2,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,,6227933143,9,622793314309,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-12,77242113UCO3001-5,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,11,622793314311,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMPK I-12TROUGH,77242113UCO3001,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,19,622793314319,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,17,622793314317,"Red Cells, Clot",Received,,Default Discard/Not Return,SM06/SERUM,BIOMARKERS,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,22,622793314322,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,EXPEDITED FRZN,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,10,622793314310,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,PLASMA PK TROUGH,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,16,622793314316,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-12 PRE,77242113UCO3001-2,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,23,622793314323,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,18,622793314318,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,12,622793314312,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,SM02/PLASMAPK PEAK,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,15,622793314315,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-12 PRE,77242113UCO3001-1,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,14,622793314314,"Red Cells, Clot",Received,,Default Discard/Not Return,SM04/SERUM ADA PRE,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,13,622793314313,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMAPK I-12 PEAK,77242113UCO3001,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,5,622793314305,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-12,77242113UCO3001-1,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,21,622793314321,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,11-Feb-2026,BXSCR,12-Feb-2026,12-Feb-2026,6227323287,5,622732328705,"Tissue , Paraffin Block",Shipped,,Default Return Ambient,,,,,,,00:00,12:52,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,16-Apr-2026,6227993962,2,622799396202,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,12:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,,6227993962,15,622799396215,"Serum, SST",Cancelled,Ambient,,FSH,FROZEN,,,,,12:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,16-Apr-2026,6227993962,4,622799396204,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,12:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,,6227993962,1,622799396201,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,12:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,14-Apr-2026,6227993962,10,622799396210,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,14-Apr-2026,6227993962,14,622799396214,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,12:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,,6227993962,3,622799396203,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,12:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,16-Apr-2026,6227993962,8,622799396208,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,12:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,14-Apr-2026,6227993962,12,622799396212,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,12:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,,6227993962,11,622799396211,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,12:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,,6227993962,7,622799396207,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,12:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,14-Apr-2026,6227993962,9,622799396209,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,12:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,,6227993962,5,622799396205,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,12:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,16-Apr-2026,6227993962,6,622799396206,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,12:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,,6227993962,13,622799396213,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,12:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,20-May-2026,6227993966,14,622799396614,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,,6227993966,17,622799396617,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL",& CRP,,,,,09:28,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,19-May-2026,6227993966,2,622799396602,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,,6227993966,3,622799396603,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,09:28,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,,6227993966,12,622799396612,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,09:28,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,19-May-2026,6227993966,1,622799396601,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,20-May-2026,6227993966,13,622799396613,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,,6227993966,7,622799396607,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,09:28,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,20-May-2026,6227993966,15,622799396615,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,20-May-2026,6227993966,8,622799396608,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,20-May-2026,6227993966,4,622799396604,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,20-May-2026,6227993966,10,622799396610,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,20-May-2026,6227993966,11,622799396611,Whole Blood PAXgene RNA,In Inventory,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,20-May-2026,6227993966,6,622799396606,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,,6227993966,5,622799396605,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,09:28,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,20-May-2026,6227993966,16,622799396616,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,19-May-2026,6227993966,18,622799396618,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,20-May-2026,6227993966,9,622799396609,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRNSTOOL,14-Apr-2026,,6227993971,4,622799397104,"Stool, ova & parasites(PVA)",Not Received,Ambient,,OVA & PARASITES 2,PVA,,,,,06:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRNSTOOL,14-Apr-2026,14-Apr-2026,6227993971,3,622799397103,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,06:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRNSTOOL,14-Apr-2026,,6227993971,1,622799397101,"Stool, ova & parasites(form)",Not Received,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,06:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRNSTOOL,14-Apr-2026,14-Apr-2026,6227993971,2,622799397102,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,06:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,DNA,20-May-2026,20-May-2026,6227993977,1,622799397701,"Whole Blood, EDTA, Dry",In Inventory,Frozen,Default Return Frozen,SM08/WB DNA,77242113UCO3001,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,DNA,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,15-Apr-2026,BXSCR,16-Apr-2026,16-Apr-2026,6227993984,1,622799398401,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,15-Apr-2026,BXSCR,16-Apr-2026,17-Apr-2026,6227993984,3,622799398403,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,15-Apr-2026,BXSCR,16-Apr-2026,,6227993984,4,622799398404,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,15-Apr-2026,BXSCR,16-Apr-2026,17-Apr-2026,6227993984,2,622799398402,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,BDL,20-May-2026,20-May-2026,6227993987,2,622799398702,"Serum, SST",Shipped,Frozen,Default Return Frozen,"ADA, GOL, INF",UST OR VED FROZEN,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biologic Drug Level,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,BDL,20-May-2026,,6227993987,1,622799398701,"Red Cells, Clot",Not Received,,,DRUG LEVEL TESTING,,,,,,09:28,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biologic Drug Level,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRNSTOOL,18-Feb-2026,18-Feb-2026,6227323244,5,622732324405,,Cancelled,,,,,,,,,07:20,12:28,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRNSTOOL,18-Feb-2026,18-Feb-2026,6227323244,6,622732324406,,Cancelled,,,,,,,,,07:20,12:28,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,18-Feb-2026,BXSCR,19-Feb-2026,19-Feb-2026,6227323286,5,622732328605,"Tissue , Paraffin Block",In Inventory,,Default Return Ambient,,,,,,,00:00,15:49,Czech Republic,,10:20,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,01-Apr-2026,BXSCR,02-Apr-2026,04-Apr-2026,6228023951,2,622802395102,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,01-Apr-2026,BXSCR,02-Apr-2026,02-Apr-2026,6228023951,1,622802395101,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,01-Apr-2026,BXSCR,02-Apr-2026,04-Apr-2026,6228023951,3,622802395103,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,01-Apr-2026,BXSCR,02-Apr-2026,,6228023951,4,622802395104,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,19-Feb-2026,BXSCR,21-Feb-2026,21-Feb-2026,6227323254,5,622732325405,"Tissue , Paraffin Block",Shipped,,Default Return Ambient,,,,,,,00:00,14:49,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,3,622803655303,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,PLASMA PK TROUGH,,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,5,622803655305,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,SM02/PLASMAPK PEAK,,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,7,622803655307,"Red Cells, Clot",Received,,Default Discard/Not Return,SM04/SERUM ADA PRE,,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,8,622803655308,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,4,622803655304,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,1,622803655301,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,6,622803655306,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,2,622803655302,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,12,622803655312,"Red Cells, Clot",Received,,Default Discard/Not Return,SM06/SERUM,BIOMARKERS,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,13,622803655313,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,15,622803655315,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,11,622803655311,Whole Blood PAXgene RNA,In Inventory,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,17,622803655317,"Red Cells, Clot",Received,,Default Discard/Not Return,"CHEM, LIPID PANEL",& CRP,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,18,622803655318,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,14,622803655314,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,9,622803655309,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,16,622803655316,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,4,622803655404,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,5,622803655405,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,SM02/PLASMAPK PEAK,,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,1,622803655401,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,6,622803655406,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,7,622803655407,"Red Cells, Clot",Received,,Default Discard/Not Return,SM04/SERUM ADA PRE,,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,9,622803655409,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,10,622803655410,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,8,622803655408,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,10,622803655310,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,3,622803655403,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,PLASMA PK TROUGH,,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,11,622803655411,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,2,622803655402,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,12,622803655412,"Red Cells, Clot",Received,,Default Discard/Not Return,SM06/SERUM,BIOMARKERS,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,13,622803655413,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,14,622803655414,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,15,622803655415,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,16,622803655416,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,17,622803655417,"Red Cells, Clot",Received,,Default Discard/Not Return,"CHEM, LIPID PANEL",& CRP,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,18,622803655418,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,,6228114608,1,622811460801,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,07:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,,6228114608,7,622811460807,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,07:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,,6228114608,3,622811460803,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,07:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,,6228114608,6,622811460806,"Plasma, QuantiFERON TB2",Not Received,Frozen,,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,07:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,,6228114608,8,622811460808,"Plasma, QuantiFERON Mitoge",Not Received,Frozen,,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,07:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,29-May-2026,6228114608,9,622811460809,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,,6228114608,4,622811460804,"Plasma, QuantiFERON TB1",Not Received,Frozen,,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,07:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,,6228114608,5,622811460805,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,07:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,29-May-2026,6228114608,11,622811460811,"Red Cells, Clot",Received,,Default Discard/Not Return,"HIV SCREEN,",HEPATITIS B & C,,,,,07:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,29-May-2026,6228114608,10,622811460810,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,,6228114608,2,622811460802,"Plasma, QuantiFERON Nil",Not Received,Frozen,,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,07:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,29-May-2026,6228114608,12,622811460812,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,07:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,29-May-2026,6228114608,14,622811460814,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,07:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,,6228114608,15,622811460815,"Serum, SST",Cancelled,Ambient,,FSH,FROZEN,,,,,07:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,29-May-2026,6228114608,13,622811460813,"Red Cells, Clot",Received,,Default Discard/Not Return,CHEM PANEL &,BETA HCG,,,,,07:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,01-May-2026,6228114610,1,622811461001,Whole Blood QuantiFERON Nil,Received,,Default Discard/Not Return,QUANTIFERON PLUS,NIL-GRAY,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,01-May-2026,6228114610,2,622811461002,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,01-May-2026,6228114610,5,622811461005,Whole Blood QuantiFERON TB2,Received,,Default Discard/Not Return,QUANTIFERON PLUS,TB2-YELLOW,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,01-May-2026,6228114610,3,622811461003,Whole Blood QuantiFERON TB1,Received,,Default Discard/Not Return,QUANTIFERON PLUS,TB1-GREEN,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,01-May-2026,6228114610,6,622811461006,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,01-May-2026,6228114610,4,622811461004,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,30-Apr-2026,6228114610,10,622811461010,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,30-Apr-2026,6228114610,11,622811461011,"Red Cells, Clot",Received,,Default Discard/Not Return,"HIV SCREEN,",HEPATITIS B & C,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,30-Apr-2026,6228114610,9,622811461009,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,01-May-2026,6228114610,7,622811461007,Whole Blood QuantiFERON Mitoge,Received,,Default Discard/Not Return,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,30-Apr-2026,6228114610,12,622811461012,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,30-Apr-2026,6228114610,13,622811461013,"Red Cells, Clot",Received,,Default Discard/Not Return,CHEM PANEL &,BETA HCG,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,30-Apr-2026,6228114610,14,622811461014,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,01-May-2026,6228114610,8,622811461008,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,,6228114610,15,622811461015,"Serum, SST",Cancelled,Ambient,,FSH,FROZEN,,,,,07:55,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCSTOOL,23-Apr-2026,23-Apr-2026,6228137359,3,622813735903,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCSTOOL,23-Apr-2026,23-Apr-2026,6228137359,1,622813735901,"Stool, ova & parasites(form)",Received,Ambient,Default Return Ambient,OVA & PARASITES 1,FORMALIN,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCSTOOL,23-Apr-2026,23-Apr-2026,6228137359,4,622813735904,"Stool, ova & parasites(PVA)",Received,Ambient,Default Return Ambient,OVA & PARASITES 2,PVA,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCSTOOL,23-Apr-2026,23-Apr-2026,6228137359,2,622813735902,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,1,622817339701,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,4,622817339704,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,,6228173397,3,622817339703,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,10:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,2,622817339702,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,6,622817339706,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,8,622817339708,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,,6228173397,5,622817339705,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,10:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,,6228173397,7,622817339707,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,10:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,,6228173397,12,622817339712,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,10:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,16,622817339716,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,18,622817339718,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,,6228173397,17,622817339717,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL",& CRP,,,,,10:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,9,622817339709,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,14,622817339714,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,11,622817339711,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,10,622817339710,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,15,622817339715,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,13,622817339713,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6228179932,14,622817993214,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,14:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,,6228179932,9,622817993209,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-2,,,,,14:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6228179932,15,622817993215,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,14:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,,6228179932,16,622817993216,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,14:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,,6228179932,12,622817993212,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-5,,,,,14:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6228179932,13,622817993213,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,14:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6228179932,17,622817993217,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,14:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,,6228179932,10,622817993210,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-3,,,,,14:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,,6228179932,11,622817993211,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-4,,,,,14:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,,6228179932,1,622817993201,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,14:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,,6228179932,3,622817993203,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,14:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6228179932,4,622817993204,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-2 PEAK,77242113UCO3001,,,,,14:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6228179932,7,622817993207,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-2,,,,,14:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6228179932,2,622817993202,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-2 TROUGH,77242113UCO3001,,,,,14:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6228179932,8,622817993208,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001,,,,,14:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,,6228179936,1,622817993601,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,2,622817993602,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,6,622817993606,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-4,77242113UCO3001,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,4,622817993604,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,,6228179936,10,622817993610,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-5,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,5,622817993605,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,14,622817993614,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-4 PEAK,77242113UCO3001,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,,6228179936,11,622817993611,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,12,622817993612,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-4 TROUGH,77242113UCO3001,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,,6228179936,13,622817993613,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,16,622817993616,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-1,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,,6228179936,15,622817993615,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,,6228179936,9,622817993609,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-4,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,19,622817993619,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,,6228179936,18,622817993618,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,3,622817993603,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,17,622817993617,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-2,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6228179932,6,622817993206,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-1,,,,,14:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,,6228179932,5,622817993205,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,14:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,20,622817993620,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,21,622817993621,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,,6228179936,8,622817993608,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-3,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,,6228179936,7,622817993607,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-2,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,22,622817993622,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,DNA,10-Apr-2026,10-Apr-2026,6228179942,1,622817994201,"Whole Blood, EDTA, Dry",Shipped,Frozen,Default Return Frozen,SM08/WB DNA,77242113UCO3001,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,DNA,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,20-May-2026,BX12,21-May-2026,23-May-2026,6228179945,3,622817994503,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,20-May-2026,BX12,21-May-2026,23-May-2026,6228179945,4,622817994504,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,BIOPSY PK,77242113UCO3001,,,,,00:00,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,20-May-2026,BX12,21-May-2026,21-May-2026,6228179945,1,622817994501,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,20-May-2026,BX12,21-May-2026,23-May-2026,6228179945,2,622817994502,Biopsy RNA Later,In Inventory,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRNSTOOL,21-Apr-2026,,6228194341,1,622819434101,"Stool, ova & parasites(form)",Cancelled,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,07:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRNSTOOL,21-Apr-2026,,6228194341,4,622819434104,"Stool, ova & parasites(PVA)",Cancelled,Ambient,,OVA & PARASITES 2,PVA,,,,,07:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRNSTOOL,21-Apr-2026,21-Apr-2026,6228194341,3,622819434103,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,07:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRNSTOOL,21-Apr-2026,21-Apr-2026,6228194341,2,622819434102,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,07:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,12-Mar-2026,BXSCR,13-Mar-2026,13-Mar-2026,6227635161,5,622763516105,"Tissue , Paraffin Block",Shipped,,Default Return Ambient,,,,,,,00:00,15:58,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,16-Mar-2026,BXSCR,18-Mar-2026,18-Mar-2026,6227635223,5,622763522305,"Tissue , Paraffin Block",Shipped,,Default Return Ambient,,,,,,,00:00,13:49,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,19-Mar-2026,6227323233,31,622732323331,"Serum, SST",Received,Ambient,Default Return Ambient,,,,,,,,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,18-Mar-2026,BXSCR,19-Mar-2026,19-Mar-2026,6227323224,5,622732322405,"Tissue , Paraffin Block",Shipped,,Default Return Ambient,,,,,,,00:00,15:46,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,06-May-2026,BX12,07-May-2026,09-May-2026,6228252072,3,622825207203,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:30,Czech Republic,,08:30,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,06-May-2026,BX12,07-May-2026,07-May-2026,6228252072,1,622825207201,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,08:30,Czech Republic,,08:30,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,13-May-2026,BXSCR,14-May-2026,,6228252073,4,622825207304,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,13-May-2026,BXSCR,14-May-2026,15-May-2026,6228252073,2,622825207302,Biopsy RNA Later,In Inventory,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,06-May-2026,BX12,07-May-2026,09-May-2026,6228252072,4,622825207204,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,BIOPSY PK,77242113UCO3001,,,,,00:00,07:30,Czech Republic,,08:30,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,06-May-2026,BX12,07-May-2026,09-May-2026,6228252072,2,622825207202,Biopsy RNA Later,In Inventory,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:30,Czech Republic,,08:30,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,13-May-2026,BXSCR,14-May-2026,15-May-2026,6228252073,3,622825207303,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,13-May-2026,BXSCR,14-May-2026,14-May-2026,6228252073,1,622825207301,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,23-Mar-2026,BXSCR,24-Mar-2026,24-Mar-2026,6227697736,5,622769773605,"Tissue , Paraffin Block",Shipped,,Default Return Ambient,,,,,,,00:00,15:15,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,1,622830822401,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,2,622830822402,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,,6228308224,5,622830822405,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,10:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,6,622830822406,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,,6228308224,7,622830822407,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,10:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,9,622830822409,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,10,622830822410,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,8,622830822408,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,11,622830822411,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,13,622830822413,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,,6228308224,3,622830822403,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,10:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,4,622830822404,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,14,622830822414,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,16,622830822416,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,15,622830822415,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,,6228308224,12,622830822412,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,10:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,,6228308224,17,622830822417,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL",& CRP,,,,,10:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,18,622830822418,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,01-Apr-2026,BXSCR,02-Apr-2026,02-Apr-2026,6228023951,5,622802395105,"Tissue , Paraffin Block",Shipped,,Default Return Ambient,,,,,,,00:00,15:31,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,,6228398115,3,622839811503,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,27-May-2026,6228398115,2,622839811502,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMPK I-2 TROUGH,77242113UCO3001,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,27-May-2026,6228398115,4,622839811504,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMA PK I-2 PEAK,77242113UCO3001,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,27-May-2026,6228398115,6,622839811506,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-1,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,,6228398115,5,622839811505,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,27-May-2026,6228398115,7,622839811507,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-2,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,27-May-2026,6228398115,8,622839811508,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,,6228398115,10,622839811510,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-3,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,,6228398115,9,622839811509,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-2,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,,6228398115,11,622839811511,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-4,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,,6228398115,12,622839811512,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-5,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,27-May-2026,6228398115,13,622839811513,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,27-May-2026,6228398115,14,622839811514,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,,6228398115,1,622839811501,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,27-May-2026,6228398115,17,622839811517,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,27-May-2026,6228398115,15,622839811515,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,,6228398115,16,622839811516,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,19,622817339719,,Cancelled,,,,,,,,,10:35,13:56,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, +77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,15-Apr-2026,BXSCR,16-Apr-2026,16-Apr-2026,6227993984,5,622799398405,"Tissue , Paraffin Block",In Inventory,,Default Return Ambient,,,,,,,00:00,17:04,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,21-Apr-2026,BXSCR,22-Apr-2026,22-Apr-2026,6227635159,5,622763515905,"Tissue , Paraffin Block",In Inventory,,Default Return Ambient,,,,,,,00:00,17:18,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,25-May-2026,BXSCR,26-May-2026,26-May-2026,6228501732,1,622850173201,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,25-May-2026,BXSCR,26-May-2026,28-May-2026,6228501732,2,622850173202,Biopsy RNA Later,In Inventory,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,25-May-2026,BXSCR,26-May-2026,,6228501732,4,622850173204,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,25-May-2026,BXSCR,26-May-2026,28-May-2026,6228501732,3,622850173203,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,24-Apr-2026,BXSCR,28-Apr-2026,28-Apr-2026,6227323351,5,622732335105,"Tissue , Paraffin Block",Shipped,,Default Return Ambient,,,,,,,00:00,14:22,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,06-May-2026,SCRNSTOOL,07-May-2026,,6228610564,1,622861056401,"Stool, ova & parasites(form)",Not Received,Ambient,,,,,,,,09:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,06-May-2026,SCRNSTOOL,07-May-2026,,6228610564,3,622861056403,"Culture, Stool",Cancelled,Ambient,,,,,,,,09:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,06-May-2026,SCRNSTOOL,07-May-2026,,6228610564,4,622861056404,"Stool, ova & parasites(PVA)",Not Received,Ambient,,,,,,,,09:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,06-May-2026,SCRNSTOOL,07-May-2026,07-May-2026,6228610564,2,622861056402,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,09:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,06-May-2026,BX12,07-May-2026,07-May-2026,6228252072,5,622825207205,"Tissue , Paraffin Block",Shipped,,Default Return Ambient,,,,,,,00:00,15:52,Czech Republic,,08:30,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,08-May-2026,6227697745,31,622769774531,,In Inventory,,Default Return Frozen,,,,,,,,16:05,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, +77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,13-May-2026,BXSCR,14-May-2026,14-May-2026,6228252073,5,622825207305,"Tissue , Paraffin Block",In Inventory,,Default Return Ambient,,,,,,,00:00,12:51,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,14-May-2026,BXSCR,15-May-2026,15-May-2026,6227323256,5,622732325605,"Tissue , Paraffin Block",In Inventory,,Default Return Ambient,,,,,,,00:00,13:06,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,19-May-2026,BXSCR,20-May-2026,20-May-2026,6227635193,5,622763519305,"Tissue , Paraffin Block",In Inventory,,Default Return Ambient,,,,,,,00:00,17:34,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,20-May-2026,BX12,21-May-2026,21-May-2026,6228179945,5,622817994505,"Tissue , Paraffin Block",In Inventory,,Default Return Ambient,,,,,,,00:00,14:59,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,25-May-2026,BXSCR,26-May-2026,26-May-2026,6228501732,5,622850173205,"Tissue , Paraffin Block",In Inventory,,Default Return Ambient,,,,,,,00:00,13:03,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, +77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,27-May-2026,BXSCR,28-May-2026,28-May-2026,6227323320,5,622732332005,"Tissue , Paraffin Block",In Inventory,,Default Return Ambient,,,,,,,00:00,14:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, diff --git a/Covance_UCO3001/Source/2026-05-29_112154 sponsor-study-36940-kit-inventory-on-hand-expiration.csv b/Covance_UCO3001/Source/2026-05-29_112154 sponsor-study-36940-kit-inventory-on-hand-expiration.csv new file mode 100644 index 0000000..b405441 --- /dev/null +++ b/Covance_UCO3001/Source/2026-05-29_112154 sponsor-study-36940-kit-inventory-on-hand-expiration.csv @@ -0,0 +1,544 @@ +Project No.,Region,Country,Site,Kit Type,Description,Accession,Shipped Date,Expiration Date,Days to Expiration +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,1,Screening,6227323202,"Nov 21, 2025","May 31, 2026",1 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,1,Screening,6228114609,"Mar 10, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,2,Induction Week 0,6228036552,"Feb 27, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,2,Induction Week 0,6228462182,"Apr 28, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,2,Induction Week 0,6228462184,"Apr 28, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,2,Induction Week 0,6228462183,"Apr 28, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,3,Induction Week 2,6227933141,"Feb 18, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,3,Induction Week 2,6228462185,"Apr 28, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,3,Induction Week 2,6228462186,"Apr 28, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,3,Induction Week 2,6228462187,"Apr 28, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,4,Induction Week 4,6227323209,"Nov 21, 2025","May 31, 2026",1 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,4,Induction Week 4,6228462189,"Apr 28, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,4,Induction Week 4,6228462188,"Apr 28, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,5,Induction Week 12,6227810906,"Jan 29, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,5,Induction Week 12,6227933144,"Feb 18, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,5,Induction Week 12,6228462190,"Apr 28, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,5,Induction Week 12,6228462191,"Apr 28, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,6,Maintenance Week 4,6227933145,"Feb 18, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,6,Maintenance Week 4,6227933146,"Feb 18, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,7,Maintenance Week 12,6227933147,"Feb 18, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,7,Maintenance Week 12,6227933148,"Feb 18, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-1,Stool Pathogens,6228137358,"Mar 12, 2026","Jan 29, 2027",244 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-1,Stool Pathogens,6228137357,"Mar 12, 2026","Jan 29, 2027",244 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-1,Stool Pathogens,6228462192,"Apr 28, 2026","May 25, 2027",360 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-1,Stool Pathogens,6228462193,"Apr 28, 2026","May 25, 2027",360 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-1,Stool Pathogens,6228462194,"Apr 28, 2026","May 25, 2027",360 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-1,Stool Pathogens,6228462196,"Apr 28, 2026","May 25, 2027",360 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-1,Stool Pathogens,6228462197,"Apr 28, 2026","May 25, 2027",360 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-1,Stool Pathogens,6228462195,"Apr 28, 2026","May 25, 2027",360 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-2,TB Testing,6227323220,"Nov 21, 2025","Jun 30, 2026",31 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-2,TB Testing,6227323221,"Nov 21, 2025","Jun 30, 2026",31 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-3,Biopsy,6227323222,"Nov 21, 2025","Sep 12, 2026",105 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-3,Biopsy,6228252071,"Mar 26, 2026","Jul 20, 2027",416 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-4,Induction ED,6227323225,"Nov 21, 2025","May 31, 2026",1 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-4,Induction ED,6227323226,"Nov 21, 2025","May 31, 2026",1 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-5,Biologic Drug Level,6227323227,"Nov 21, 2025","Jun 30, 2026",31 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-5,Biologic Drug Level,6227323228,"Nov 21, 2025","Jun 30, 2026",31 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-6,Maintenance ED,6227810907,"Jan 29, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-6,Maintenance ED,6227810909,"Jan 29, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-6,Maintenance ED,6227810908,"Jan 29, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-8,Liver Function Tests,6227323229,"Nov 21, 2025","Jul 1, 2026",32 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-8,Liver Function Tests,6227323230,"Nov 21, 2025","Jul 1, 2026",32 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-9,LTE Maintenance ED,6227810910,"Jan 29, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-9,LTE Maintenance ED,6227810911,"Jan 29, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-9,LTE Maintenance ED,6227810912,"Jan 29, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-10,Safety FU,6227323214,"Nov 21, 2025","May 31, 2026",1 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-10,Safety FU,6227323215,"Nov 21, 2025","May 31, 2026",1 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-11,DILI,6227323216,"Nov 21, 2025","May 31, 2026",1 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-12,DNA,6227323218,"Nov 21, 2025","Aug 31, 2026",93 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-12,DNA,6228252069,"Mar 26, 2026","Mar 31, 2027",305 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-12,DNA,6228252070,"Mar 26, 2026","Mar 31, 2027",305 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-12,DNA,6228252068,"Mar 26, 2026","Mar 31, 2027",305 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,U,Unscheduled,6228462198,"Apr 28, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,U,Unscheduled,6228462199,"Apr 28, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,U,Unscheduled,6228462200,"Apr 28, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,U,Unscheduled,6228462202,"Apr 28, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,U,Unscheduled,6228462201,"Apr 28, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,U,Unscheduled,6228462203,"Apr 28, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,U,Unscheduled,6228462206,"Apr 28, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,U,Unscheduled,6228462205,"Apr 28, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,U,Unscheduled,6228462204,"Apr 28, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,U,Unscheduled,6228462207,"Apr 28, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,U,Unscheduled,6228489756,"May 1, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,U,Unscheduled,6228489757,"May 1, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,U,Unscheduled,6228489758,"May 1, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,U,Unscheduled,6228489761,"May 1, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,U,Unscheduled,6228489760,"May 1, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,U,Unscheduled,6228489759,"May 1, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,U,Unscheduled,6228489763,"May 1, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,U,Unscheduled,6228489762,"May 1, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,1,Screening,6227323298,"Nov 21, 2025","Jun 30, 2026",31 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,1,Screening,6227323300,"Nov 21, 2025","Jun 30, 2026",31 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,2,Induction Week 0,6227323301,"Nov 21, 2025","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,2,Induction Week 0,6227323302,"Nov 21, 2025","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,3,Induction Week 2,6227323303,"Nov 21, 2025","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,3,Induction Week 2,6227323304,"Nov 21, 2025","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,4,Induction Week 4,6227323306,"Nov 21, 2025","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,4,Induction Week 4,6227323305,"Nov 21, 2025","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,5,Induction Week 12,6228676757,"May 15, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-1,Stool Pathogens,6227323307,"Nov 21, 2025","Dec 26, 2026",210 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-1,Stool Pathogens,6227323308,"Nov 21, 2025","Dec 26, 2026",210 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-2,TB Testing,6227323316,"Nov 21, 2025","Jun 30, 2026",31 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-2,TB Testing,6227323317,"Nov 21, 2025","Jun 30, 2026",31 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-3,Biopsy,6227323319,"Nov 21, 2025","Sep 12, 2026",105 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-3,Biopsy,6227323318,"Nov 21, 2025","Sep 12, 2026",105 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-4,Induction ED,6227323321,"Nov 21, 2025","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-4,Induction ED,6227323322,"Nov 21, 2025","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-5,Biologic Drug Level,6227323323,"Nov 21, 2025","Jun 30, 2026",31 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-5,Biologic Drug Level,6227323324,"Nov 21, 2025","Jun 30, 2026",31 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-6,Maintenance ED,6228676759,"May 15, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-6,Maintenance ED,6228676760,"May 15, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-6,Maintenance ED,6228676758,"May 15, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-8,Liver Function Tests,6227323326,"Nov 21, 2025","Jul 1, 2026",32 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-8,Liver Function Tests,6227323325,"Nov 21, 2025","Jul 1, 2026",32 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-9,LTE Maintenance ED,6228676762,"May 15, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-9,LTE Maintenance ED,6228676763,"May 15, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-9,LTE Maintenance ED,6228676761,"May 15, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-10,Safety FU,6227323310,"Nov 21, 2025","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-10,Safety FU,6227323311,"Nov 21, 2025","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-11,DILI,6227323312,"Nov 21, 2025","Jun 30, 2026",31 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-12,DNA,6227323313,"Nov 21, 2025","Aug 31, 2026",93 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-12,DNA,6227323314,"Nov 21, 2025","Aug 31, 2026",93 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-12,DNA,6227323315,"Nov 21, 2025","Aug 31, 2026",93 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,U,Unscheduled,6227323328,"Nov 21, 2025","Aug 31, 2026",93 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,U,Unscheduled,6227323327,"Nov 21, 2025","Aug 31, 2026",93 +213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,U,Unscheduled,6227323329,"Nov 21, 2025","May 31, 2026",1 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,1,Screening,6227323235,"Nov 21, 2025","Jun 30, 2026",31 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,1,Screening,6228492883,"Apr 23, 2026","Nov 30, 2026",184 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,1,Screening,6228492884,"Apr 23, 2026","Nov 30, 2026",184 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,1,Screening,6228492885,"Apr 23, 2026","Nov 30, 2026",184 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,2,Induction Week 0,6228265099,"Mar 27, 2026","Jan 31, 2027",246 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,2,Induction Week 0,6228265098,"Mar 27, 2026","Jan 31, 2027",246 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,2,Induction Week 0,6228265100,"Mar 27, 2026","Jan 31, 2027",246 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,3,Induction Week 2,6227323239,"Nov 21, 2025","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,3,Induction Week 2,6228407563,"Apr 15, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,3,Induction Week 2,6228407564,"Apr 15, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,3,Induction Week 2,6228407565,"Apr 15, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,4,Induction Week 4,6227323241,"Nov 21, 2025","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,4,Induction Week 4,6228461735,"Apr 21, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,4,Induction Week 4,6228461736,"Apr 21, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,4,Induction Week 4,6228461734,"Apr 21, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,5,Induction Week 12,6228013269,"Feb 25, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,5,Induction Week 12,6228492886,"Apr 23, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,6,Maintenance Week 4,6228194338,"Mar 23, 2026","Sep 30, 2026",123 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,6,Maintenance Week 4,6228690541,"May 19, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-1,Stool Pathogens,6228194340,"Mar 23, 2026","Mar 5, 2027",279 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-1,Stool Pathogens,6228194339,"Mar 23, 2026","Mar 5, 2027",279 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-3,Biopsy,6227323255,"Nov 21, 2025","Sep 12, 2026",105 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-3,Biopsy,6228690542,"May 19, 2026","Aug 7, 2027",434 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-3,Biopsy,6228690544,"May 19, 2026","Aug 7, 2027",434 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-3,Biopsy,6228690543,"May 19, 2026","Aug 7, 2027",434 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-4,Induction ED,6227323257,"Nov 21, 2025","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-4,Induction ED,6227323258,"Nov 21, 2025","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-5,Biologic Drug Level,6227323260,"Nov 21, 2025","Jun 30, 2026",31 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-5,Biologic Drug Level,6227323259,"Nov 21, 2025","Jun 30, 2026",31 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-6,Maintenance ED,6228013270,"Feb 25, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-6,Maintenance ED,6228013271,"Feb 25, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-6,Maintenance ED,6228013272,"Feb 25, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-8,Liver Function Tests,6227323261,"Nov 21, 2025","Jul 1, 2026",32 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-8,Liver Function Tests,6227323262,"Nov 21, 2025","Jul 1, 2026",32 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-9,LTE Maintenance ED,6228013275,"Feb 25, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-9,LTE Maintenance ED,6228013273,"Feb 25, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-9,LTE Maintenance ED,6228013274,"Feb 25, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-10,Safety FU,6227323246,"Nov 21, 2025","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-10,Safety FU,6227323247,"Nov 21, 2025","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-11,DILI,6227323248,"Nov 21, 2025","Jun 30, 2026",31 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-12,DNA,6227323250,"Nov 21, 2025","Aug 31, 2026",93 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-12,DNA,6227323249,"Nov 21, 2025","Aug 31, 2026",93 +213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,U,Unscheduled,6227323263,"Nov 21, 2025","Aug 31, 2026",93 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,1,Screening,6227323331,"Nov 23, 2025","Jun 30, 2026",31 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,1,Screening,6227765941,"Jan 29, 2026","Sep 30, 2026",123 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,1,Screening,6227765942,"Jan 29, 2026","Sep 30, 2026",123 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,1,Screening,6227765943,"Jan 29, 2026","Sep 30, 2026",123 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,2,Induction Week 0,6227323333,"Nov 23, 2025","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,2,Induction Week 0,6227765944,"Jan 29, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,2,Induction Week 0,6227765945,"Jan 29, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,2,Induction Week 0,6227765946,"Jan 29, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,3,Induction Week 2,6227323336,"Nov 23, 2025","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,3,Induction Week 2,6227765948,"Jan 29, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,3,Induction Week 2,6227765947,"Jan 29, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,3,Induction Week 2,6227765949,"Jan 29, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,4,Induction Week 4,6227323337,"Nov 23, 2025","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,4,Induction Week 4,6227323338,"Nov 23, 2025","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,4,Induction Week 4,6227765950,"Jan 29, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,4,Induction Week 4,6227765951,"Jan 29, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,4,Induction Week 4,6227765952,"Jan 29, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,5,Induction Week 12,6227765953,"Jan 29, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,5,Induction Week 12,6227765954,"Jan 29, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,5,Induction Week 12,6227765955,"Jan 29, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-1,Stool Pathogens,6227323339,"Nov 23, 2025","Dec 26, 2026",210 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-1,Stool Pathogens,6227765956,"Jan 29, 2026","Jan 15, 2027",230 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-1,Stool Pathogens,6227765957,"Jan 29, 2026","Jan 15, 2027",230 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-1,Stool Pathogens,6227765958,"Jan 29, 2026","Jan 15, 2027",230 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-1,Stool Pathogens,6227765959,"Jan 29, 2026","Jan 15, 2027",230 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-2,TB Testing,6227323349,"Nov 23, 2025","Jun 30, 2026",31 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-2,TB Testing,6227765963,"Jan 29, 2026","Sep 30, 2026",123 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-2,TB Testing,6227765964,"Jan 29, 2026","Sep 30, 2026",123 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-2,TB Testing,6227765965,"Jan 29, 2026","Sep 30, 2026",123 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-2,TB Testing,6227765966,"Jan 29, 2026","Sep 30, 2026",123 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-3,Biopsy,6227323350,"Nov 23, 2025","Sep 12, 2026",105 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-3,Biopsy,6227323352,"Nov 23, 2025","Sep 12, 2026",105 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-3,Biopsy,6227765967,"Jan 29, 2026","Nov 28, 2026",182 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-3,Biopsy,6227765968,"Jan 29, 2026","Nov 28, 2026",182 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-3,Biopsy,6227765970,"Jan 29, 2026","Nov 28, 2026",182 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-3,Biopsy,6227765969,"Jan 29, 2026","Nov 28, 2026",182 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-4,Induction ED,6227323353,"Nov 23, 2025","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-4,Induction ED,6227323354,"Nov 23, 2025","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-5,Biologic Drug Level,6227323356,"Nov 23, 2025","Jun 30, 2026",31 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-5,Biologic Drug Level,6227765973,"Jan 29, 2026","Dec 31, 2026",215 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-5,Biologic Drug Level,6227765972,"Jan 29, 2026","Dec 31, 2026",215 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-5,Biologic Drug Level,6227765974,"Jan 29, 2026","Dec 31, 2026",215 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-5,Biologic Drug Level,6227765971,"Jan 29, 2026","Dec 31, 2026",215 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-6,Maintenance ED,6228357528,"Apr 7, 2026","Jan 31, 2027",246 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-6,Maintenance ED,6228357529,"Apr 7, 2026","Jan 31, 2027",246 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-6,Maintenance ED,6228357530,"Apr 7, 2026","Jan 31, 2027",246 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-8,Liver Function Tests,6227323357,"Nov 23, 2025","Jul 1, 2026",32 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-8,Liver Function Tests,6227323358,"Nov 23, 2025","Jul 1, 2026",32 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-9,LTE Maintenance ED,6228357532,"Apr 7, 2026","Jan 31, 2027",246 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-9,LTE Maintenance ED,6228357533,"Apr 7, 2026","Jan 31, 2027",246 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-9,LTE Maintenance ED,6228357531,"Apr 7, 2026","Jan 31, 2027",246 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-10,Safety FU,6227323342,"Nov 23, 2025","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-10,Safety FU,6227323343,"Nov 23, 2025","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-11,DILI,6227323344,"Nov 23, 2025","Jun 30, 2026",31 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-12,DNA,6227323347,"Nov 23, 2025","Aug 31, 2026",93 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-12,DNA,6227323345,"Nov 23, 2025","Aug 31, 2026",93 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-12,DNA,6227765961,"Jan 29, 2026","Dec 31, 2026",215 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-12,DNA,6227765962,"Jan 29, 2026","Dec 31, 2026",215 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-12,DNA,6227765960,"Jan 29, 2026","Dec 31, 2026",215 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,U,Unscheduled,6227323359,"Nov 23, 2025","Aug 31, 2026",93 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,U,Unscheduled,6227323361,"Nov 23, 2025","Aug 31, 2026",93 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,U,Unscheduled,6227323360,"Nov 23, 2025","Aug 31, 2026",93 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,U,Unscheduled,6227765975,"Jan 29, 2026","Oct 31, 2026",154 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,U,Unscheduled,6227765976,"Jan 29, 2026","Oct 31, 2026",154 +213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,U,Unscheduled,6227765977,"Jan 29, 2026","Oct 31, 2026",154 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,1,Screening,6227993930,"Feb 17, 2026","Oct 31, 2026",154 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,1,Screening,6227993931,"Feb 17, 2026","Oct 31, 2026",154 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,1,Screening,6227993932,"Feb 17, 2026","Oct 31, 2026",154 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,2,Induction Week 0,6227993933,"Feb 17, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,2,Induction Week 0,6227993934,"Feb 17, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,3,Induction Week 2,6227993935,"Feb 17, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,3,Induction Week 2,6227993936,"Feb 17, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,4,Induction Week 4,6227993937,"Feb 17, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,4,Induction Week 4,6227993938,"Feb 17, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-1,Stool Pathogens,6227993941,"Feb 17, 2026","Jan 15, 2027",230 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-1,Stool Pathogens,6227993940,"Feb 17, 2026","Jan 15, 2027",230 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-1,Stool Pathogens,6227993939,"Feb 17, 2026","Jan 15, 2027",230 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-2,TB Testing,6227993949,"Feb 17, 2026","Oct 31, 2026",154 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-2,TB Testing,6227993948,"Feb 17, 2026","Oct 31, 2026",154 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-3,Biopsy,6227993952,"Feb 17, 2026","Nov 28, 2026",182 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-3,Biopsy,6227993951,"Feb 17, 2026","Nov 28, 2026",182 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-3,Biopsy,6227993950,"Feb 17, 2026","Nov 28, 2026",182 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-4,Induction ED,6227993954,"Feb 17, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-4,Induction ED,6227993953,"Feb 17, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-5,Biologic Drug Level,6227993955,"Feb 17, 2026","Dec 31, 2026",215 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-5,Biologic Drug Level,6227993956,"Feb 17, 2026","Dec 31, 2026",215 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-8,Liver Function Tests,6227993957,"Feb 17, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-8,Liver Function Tests,6227993958,"Feb 17, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-10,Safety FU,6227993943,"Feb 17, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-10,Safety FU,6227993942,"Feb 17, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-11,DILI,6227993944,"Feb 17, 2026","Sep 30, 2026",123 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-12,DNA,6227993945,"Feb 17, 2026","Dec 31, 2026",215 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-12,DNA,6227993946,"Feb 17, 2026","Dec 31, 2026",215 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-12,DNA,6227993947,"Feb 17, 2026","Dec 31, 2026",215 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,U,Unscheduled,6227993959,"Feb 17, 2026","Dec 31, 2026",215 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,U,Unscheduled,6227993960,"Feb 17, 2026","Dec 31, 2026",215 +213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,U,Unscheduled,6227993961,"Feb 17, 2026","Dec 31, 2026",215 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,1,Screening,6227697716,"Jan 12, 2026","Aug 31, 2026",93 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,1,Screening,6227697717,"Jan 12, 2026","Aug 31, 2026",93 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,2,Induction Week 0,6227697720,"Jan 12, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,2,Induction Week 0,6228398468,"Apr 14, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,2,Induction Week 0,6228398470,"Apr 14, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,2,Induction Week 0,6228398469,"Apr 14, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,3,Induction Week 2,6227697721,"Jan 12, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,3,Induction Week 2,6228512528,"Apr 28, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,3,Induction Week 2,6228512526,"Apr 28, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,3,Induction Week 2,6228512527,"Apr 28, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,4,Induction Week 4,6227697724,"Jan 12, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,4,Induction Week 4,6228628517,"May 11, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,4,Induction Week 4,6228628515,"May 11, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,4,Induction Week 4,6228628516,"May 11, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,5,Induction Week 12,6228251912,"Mar 26, 2026","Jan 31, 2027",246 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,6,Maintenance Week 4,6228628518,"May 11, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-1,Stool Pathogens,6227697726,"Jan 12, 2026","Jan 14, 2027",229 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-1,Stool Pathogens,6227697727,"Jan 12, 2026","Jan 14, 2027",229 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-2,TB Testing,6227697735,"Jan 12, 2026","Aug 31, 2026",93 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-2,TB Testing,6227697734,"Jan 12, 2026","Aug 31, 2026",93 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-3,Biopsy,6227697737,"Jan 12, 2026","May 11, 2027",346 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-3,Biopsy,6227697738,"Jan 12, 2026","May 11, 2027",346 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-4,Induction ED,6227697740,"Jan 12, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-4,Induction ED,6227697739,"Jan 12, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-5,Biologic Drug Level,6227697741,"Jan 12, 2026","Dec 31, 2026",215 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-5,Biologic Drug Level,6227697742,"Jan 12, 2026","Dec 31, 2026",215 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-6,Maintenance ED,6228251914,"Mar 26, 2026","Jan 31, 2027",246 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-6,Maintenance ED,6228251913,"Mar 26, 2026","Jan 31, 2027",246 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-6,Maintenance ED,6228251915,"Mar 26, 2026","Jan 31, 2027",246 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-8,Liver Function Tests,6227697743,"Jan 12, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-8,Liver Function Tests,6227697744,"Jan 12, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-9,LTE Maintenance ED,6228251918,"Mar 26, 2026","Jan 31, 2027",246 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-9,LTE Maintenance ED,6228251916,"Mar 26, 2026","Jan 31, 2027",246 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-9,LTE Maintenance ED,6228251917,"Mar 26, 2026","Jan 31, 2027",246 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-10,Safety FU,6227697728,"Jan 12, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-10,Safety FU,6227697729,"Jan 12, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-11,DILI,6227697730,"Jan 12, 2026","Jul 31, 2026",62 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-12,DNA,6227697733,"Jan 12, 2026","Dec 31, 2026",215 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-12,DNA,6227697732,"Jan 12, 2026","Dec 31, 2026",215 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,U,Unscheduled,6227697747,"Jan 12, 2026","Oct 31, 2026",154 +213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,U,Unscheduled,6227697746,"Jan 12, 2026","Oct 31, 2026",154 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,1,Screening,6228367755,"Apr 8, 2026","Nov 30, 2026",184 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,1,Screening,6228367756,"Apr 8, 2026","Nov 30, 2026",184 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,1,Screening,6228367757,"Apr 8, 2026","Nov 30, 2026",184 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,2,Induction Week 0,6227635143,"Jan 5, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,2,Induction Week 0,6228308225,"Apr 1, 2026","Jan 31, 2027",246 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,2,Induction Week 0,6228308226,"Apr 1, 2026","Jan 31, 2027",246 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,3,Induction Week 2,6227635145,"Jan 5, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,3,Induction Week 2,6228398114,"Apr 14, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,3,Induction Week 2,6228398116,"Apr 14, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,4,Induction Week 4,6227635147,"Jan 5, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,4,Induction Week 4,6228501725,"Apr 26, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,4,Induction Week 4,6228501727,"Apr 26, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,4,Induction Week 4,6228501726,"Apr 26, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,5,Induction Week 12,6228308227,"Apr 1, 2026","Jan 31, 2027",246 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,5,Induction Week 12,6228367758,"Apr 8, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,6,Maintenance Week 4,6228501728,"Apr 26, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,6,Maintenance Week 4,6228501729,"Apr 26, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-1,Stool Pathogens,6228367759,"Apr 8, 2026","Mar 5, 2027",279 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-1,Stool Pathogens,6228367760,"Apr 8, 2026","Mar 5, 2027",279 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-1,Stool Pathogens,6228367761,"Apr 8, 2026","Mar 5, 2027",279 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-2,TB Testing,6227635158,"Jan 5, 2026","Aug 31, 2026",93 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-2,TB Testing,6227635157,"Jan 5, 2026","Aug 31, 2026",93 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-3,Biopsy,6227635160,"Jan 5, 2026","Oct 15, 2026",138 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-3,Biopsy,6228501731,"Apr 26, 2026","Aug 7, 2027",434 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-3,Biopsy,6228501730,"Apr 26, 2026","Aug 7, 2027",434 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-4,Induction ED,6227635163,"Jan 5, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-4,Induction ED,6227635162,"Jan 5, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-5,Biologic Drug Level,6227635164,"Jan 5, 2026","Dec 31, 2026",215 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-5,Biologic Drug Level,6227635165,"Jan 5, 2026","Dec 31, 2026",215 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-6,Maintenance ED,6228095872,"Mar 5, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-6,Maintenance ED,6228095870,"Mar 5, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-6,Maintenance ED,6228095871,"Mar 5, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-8,Liver Function Tests,6227635167,"Jan 5, 2026","Sep 12, 2026",105 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-8,Liver Function Tests,6227635166,"Jan 5, 2026","Sep 12, 2026",105 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-9,LTE Maintenance ED,6228095874,"Mar 5, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-9,LTE Maintenance ED,6228095873,"Mar 5, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-9,LTE Maintenance ED,6228095875,"Mar 5, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-10,Safety FU,6227635151,"Jan 5, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-10,Safety FU,6227635152,"Jan 5, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-11,DILI,6227635153,"Jan 5, 2026","Jul 31, 2026",62 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-12,DNA,6227635154,"Jan 5, 2026","Dec 31, 2026",215 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,U,Unscheduled,6227635168,"Jan 5, 2026","Oct 31, 2026",154 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,U,Unscheduled,6227635169,"Jan 5, 2026","Oct 31, 2026",154 +213069,EMEA,CZE,CZ10013 - Dr.David Stepek,U,Unscheduled,6227635170,"Jan 5, 2026","Oct 31, 2026",154 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,1,Screening,6227259263,"Nov 13, 2025","May 31, 2026",1 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,1,Screening,6227259264,"Nov 13, 2025","May 31, 2026",1 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,1,Screening,6227259265,"Nov 13, 2025","May 31, 2026",1 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,1,Screening,6228510217,"Apr 30, 2026","Nov 30, 2026",184 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,1,Screening,6228510218,"Apr 30, 2026","Nov 30, 2026",184 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,2,Induction Week 0,6227259267,"Nov 13, 2025","May 31, 2026",1 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,2,Induction Week 0,6227259266,"Nov 13, 2025","May 31, 2026",1 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,2,Induction Week 0,6228510219,"Apr 30, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,2,Induction Week 0,6228510220,"Apr 30, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,3,Induction Week 2,6227259268,"Nov 13, 2025","May 31, 2026",1 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,3,Induction Week 2,6227259269,"Nov 13, 2025","May 31, 2026",1 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,3,Induction Week 2,6228510221,"Apr 30, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,3,Induction Week 2,6228510222,"Apr 30, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,4,Induction Week 4,6227259270,"Nov 13, 2025","May 31, 2026",1 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,4,Induction Week 4,6227259271,"Nov 13, 2025","May 31, 2026",1 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,T-1,Stool Pathogens,6227259274,"Nov 13, 2025","Dec 26, 2026",210 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,T-1,Stool Pathogens,6227259273,"Nov 13, 2025","Dec 26, 2026",210 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,T-1,Stool Pathogens,6227259272,"Nov 13, 2025","Dec 26, 2026",210 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,T-2,TB Testing,6227259281,"Nov 13, 2025","Jun 30, 2026",31 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,T-2,TB Testing,6227259282,"Nov 13, 2025","Jun 30, 2026",31 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,T-3,Biopsy,6227259283,"Nov 13, 2025","Sep 12, 2026",105 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,T-3,Biopsy,6227259284,"Nov 13, 2025","Sep 12, 2026",105 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,T-3,Biopsy,6227259285,"Nov 13, 2025","Sep 12, 2026",105 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,T-4,Induction ED,6227259286,"Nov 13, 2025","May 31, 2026",1 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,T-4,Induction ED,6227259287,"Nov 13, 2025","May 31, 2026",1 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,T-5,Biologic Drug Level,6227259289,"Nov 13, 2025","Jun 30, 2026",31 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,T-5,Biologic Drug Level,6227259288,"Nov 13, 2025","Jun 30, 2026",31 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,T-8,Liver Function Tests,6227259290,"Nov 13, 2025","Jul 1, 2026",32 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,T-8,Liver Function Tests,6227259291,"Nov 13, 2025","Jul 1, 2026",32 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,T-10,Safety FU,6227259276,"Nov 13, 2025","May 31, 2026",1 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,T-10,Safety FU,6227259275,"Nov 13, 2025","May 31, 2026",1 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,T-11,DILI,6227259277,"Nov 13, 2025","May 31, 2026",1 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,T-12,DNA,6227259280,"Nov 13, 2025","Aug 31, 2026",93 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,T-12,DNA,6227259278,"Nov 13, 2025","Aug 31, 2026",93 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,U,Unscheduled,6227259294,"Nov 13, 2025","May 31, 2026",1 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,U,Unscheduled,6227259293,"Nov 13, 2025","May 31, 2026",1 +213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,U,Unscheduled,6227259292,"Nov 13, 2025","May 31, 2026",1 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,1,Screening,6227635172,"Jan 5, 2026","Aug 31, 2026",93 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,2,Induction Week 0,6227635175,"Jan 5, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,3,Induction Week 2,6227635176,"Jan 5, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,3,Induction Week 2,6227635177,"Jan 5, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,4,Induction Week 4,6227635178,"Jan 5, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,4,Induction Week 4,6227635179,"Jan 5, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,5,Induction Week 12,6228501793,"Apr 26, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-1,Stool Pathogens,6227635181,"Jan 5, 2026","Jan 14, 2027",229 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-2,TB Testing,6227635189,"Jan 5, 2026","Aug 31, 2026",93 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-2,TB Testing,6227635190,"Jan 5, 2026","Aug 31, 2026",93 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-3,Biopsy,6227635191,"Jan 5, 2026","Oct 15, 2026",138 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-3,Biopsy,6227635192,"Jan 5, 2026","Oct 15, 2026",138 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-4,Induction ED,6227635195,"Jan 5, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-4,Induction ED,6227635194,"Jan 5, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-5,Biologic Drug Level,6227635197,"Jan 5, 2026","Dec 31, 2026",215 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-5,Biologic Drug Level,6227635196,"Jan 5, 2026","Dec 31, 2026",215 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-6,Maintenance ED,6228501795,"Apr 26, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-6,Maintenance ED,6228501794,"Apr 26, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-6,Maintenance ED,6228501796,"Apr 26, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-8,Liver Function Tests,6227635198,"Jan 5, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-8,Liver Function Tests,6227635199,"Jan 5, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-9,LTE Maintenance ED,6228501797,"Apr 26, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-9,LTE Maintenance ED,6228501798,"Apr 26, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-9,LTE Maintenance ED,6228501799,"Apr 26, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-10,Safety FU,6227635183,"Jan 5, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-10,Safety FU,6227635184,"Jan 5, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-11,DILI,6227635185,"Jan 5, 2026","Jul 31, 2026",62 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-12,DNA,6227635188,"Jan 5, 2026","Dec 31, 2026",215 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-12,DNA,6227635186,"Jan 5, 2026","Dec 31, 2026",215 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-12,DNA,6227635187,"Jan 5, 2026","Dec 31, 2026",215 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,U,Unscheduled,6227635200,"Jan 5, 2026","Oct 31, 2026",154 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,U,Unscheduled,6227635202,"Jan 5, 2026","Oct 31, 2026",154 +213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,U,Unscheduled,6227635201,"Jan 5, 2026","Oct 31, 2026",154 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,1,Screening,6227993964,"Feb 18, 2026","Sep 30, 2026",123 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,1,Screening,6227993963,"Feb 18, 2026","Sep 30, 2026",123 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,2,Induction Week 0,6227993965,"Feb 18, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,2,Induction Week 0,6228707090,"May 22, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,2,Induction Week 0,6228707091,"May 22, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,2,Induction Week 0,6228707092,"May 22, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,2,Induction Week 0,6228711855,"May 29, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,3,Induction Week 2,6227993967,"Feb 18, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,3,Induction Week 2,6227993968,"Feb 18, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,4,Induction Week 4,6227993969,"Feb 18, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,4,Induction Week 4,6227993970,"Feb 18, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,5,Induction Week 12,6228436352,"Apr 19, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-1,Stool Pathogens,6227993973,"Feb 18, 2026","Jan 15, 2027",230 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-1,Stool Pathogens,6227993972,"Feb 18, 2026","Jan 15, 2027",230 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-2,TB Testing,6227993980,"Feb 18, 2026","Oct 31, 2026",154 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-2,TB Testing,6227993981,"Feb 18, 2026","Oct 31, 2026",154 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-3,Biopsy,6227993983,"Feb 18, 2026","May 11, 2027",346 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-3,Biopsy,6227993982,"Feb 18, 2026","May 11, 2027",346 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-4,Induction ED,6227993985,"Feb 18, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-4,Induction ED,6227993986,"Feb 18, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-5,Biologic Drug Level,6227993988,"Feb 18, 2026","Dec 31, 2026",215 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-5,Biologic Drug Level,6228711856,"May 29, 2026","May 31, 2027",366 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-6,Maintenance ED,6228436354,"Apr 19, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-6,Maintenance ED,6228436353,"Apr 19, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-6,Maintenance ED,6228436355,"Apr 19, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-8,Liver Function Tests,6227993989,"Feb 18, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-8,Liver Function Tests,6227993990,"Feb 18, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-9,LTE Maintenance ED,6228436356,"Apr 19, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-9,LTE Maintenance ED,6228436357,"Apr 19, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-9,LTE Maintenance ED,6228436358,"Apr 19, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-10,Safety FU,6227993974,"Feb 18, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-10,Safety FU,6227993975,"Feb 18, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-11,DILI,6227993976,"Feb 18, 2026","Sep 30, 2026",123 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-12,DNA,6227993978,"Feb 18, 2026","Dec 31, 2026",215 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-12,DNA,6227993979,"Feb 18, 2026","Dec 31, 2026",215 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,U,Unscheduled,6227993991,"Feb 18, 2026","Dec 31, 2026",215 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,U,Unscheduled,6227993992,"Feb 18, 2026","Dec 31, 2026",215 +213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,U,Unscheduled,6227993993,"Feb 18, 2026","Dec 31, 2026",215 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,1,Screening,6227635205,"Jan 5, 2026","Aug 31, 2026",93 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,1,Screening,6227635203,"Jan 5, 2026","Aug 31, 2026",93 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,2,Induction Week 0,6227635206,"Jan 5, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,2,Induction Week 0,6228398426,"Apr 14, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,2,Induction Week 0,6228398427,"Apr 14, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,2,Induction Week 0,6228398428,"Apr 14, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,3,Induction Week 2,6227635209,"Jan 5, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,3,Induction Week 2,6228492827,"Apr 23, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,3,Induction Week 2,6228492828,"Apr 23, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,3,Induction Week 2,6228492826,"Apr 23, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,4,Induction Week 4,6227635210,"Jan 5, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,4,Induction Week 4,6228605821,"May 7, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,4,Induction Week 4,6228605823,"May 7, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,4,Induction Week 4,6228605822,"May 7, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,5,Induction Week 12,6228084840,"Mar 4, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,6,Maintenance Week 4,6228605824,"May 7, 2026","Feb 28, 2027",274 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-1,Stool Pathogens,6227635214,"Jan 5, 2026","Jan 14, 2027",229 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-1,Stool Pathogens,6227635212,"Jan 5, 2026","Jan 14, 2027",229 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-2,TB Testing,6227635221,"Jan 5, 2026","Aug 31, 2026",93 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-2,TB Testing,6227635222,"Jan 5, 2026","Aug 31, 2026",93 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-3,Biopsy,6227635224,"Jan 5, 2026","Nov 25, 2026",179 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-3,Biopsy,6227635225,"Jan 5, 2026","Nov 25, 2026",179 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-4,Induction ED,6227635226,"Jan 5, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-4,Induction ED,6227635227,"Jan 5, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-5,Biologic Drug Level,6227635228,"Jan 5, 2026","Dec 31, 2026",215 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-5,Biologic Drug Level,6227635229,"Jan 5, 2026","Dec 31, 2026",215 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-6,Maintenance ED,6228084843,"Mar 4, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-6,Maintenance ED,6228084842,"Mar 4, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-6,Maintenance ED,6228084841,"Mar 4, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-8,Liver Function Tests,6227635230,"Jan 5, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-8,Liver Function Tests,6227635231,"Jan 5, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-9,LTE Maintenance ED,6228084845,"Mar 4, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-9,LTE Maintenance ED,6228084844,"Mar 4, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-9,LTE Maintenance ED,6228084846,"Mar 4, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-10,Safety FU,6227635215,"Jan 5, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-10,Safety FU,6227635216,"Jan 5, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-11,DILI,6227635217,"Jan 5, 2026","Jul 31, 2026",62 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-12,DNA,6227635219,"Jan 5, 2026","Dec 31, 2026",215 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-12,DNA,6227635220,"Jan 5, 2026","Dec 31, 2026",215 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,U,Unscheduled,6227635234,"Jan 5, 2026","Oct 31, 2026",154 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,U,Unscheduled,6227635233,"Jan 5, 2026","Oct 31, 2026",154 +213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,U,Unscheduled,6227635232,"Jan 5, 2026","Oct 31, 2026",154 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,1,Screening,6227323267,"Nov 21, 2025","Jun 30, 2026",31 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,1,Screening,6228137352,"Mar 11, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,1,Screening,6228137353,"Mar 11, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,1,Screening,6228137354,"Mar 11, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,1,Screening,6228179928,"Mar 23, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,1,Screening,6228179930,"Mar 23, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,1,Screening,6228179929,"Mar 23, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,2,Induction Week 0,6227323269,"Nov 21, 2025","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,2,Induction Week 0,6228173395,"Mar 18, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,2,Induction Week 0,6228173396,"Mar 18, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,3,Induction Week 2,6227323271,"Nov 21, 2025","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,3,Induction Week 2,6228179931,"Mar 23, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,3,Induction Week 2,6228179933,"Mar 23, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,4,Induction Week 4,6227323273,"Nov 21, 2025","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,4,Induction Week 4,6228179934,"Mar 23, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,4,Induction Week 4,6228179935,"Mar 23, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,5,Induction Week 12,6227752380,"Jan 20, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,5,Induction Week 12,6227810902,"Jan 28, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,5,Induction Week 12,6228137356,"Mar 11, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,5,Induction Week 12,6228137355,"Mar 11, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,6,Maintenance Week 4,6228023948,"Feb 25, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,6,Maintenance Week 4,6228023949,"Feb 25, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,12,LTE Maintenance Wk56,6228179938,"Mar 23, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,12,LTE Maintenance Wk56,6228179937,"Mar 23, 2026","Oct 11, 2026",134 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-1,Stool Pathogens,6227323275,"Nov 21, 2025","Dec 26, 2026",210 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-1,Stool Pathogens,6227810903,"Jan 28, 2026","Jan 15, 2027",230 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-1,Stool Pathogens,6228179939,"Mar 23, 2026","Jan 29, 2027",244 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-1,Stool Pathogens,6228179940,"Mar 23, 2026","Jan 29, 2027",244 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-2,TB Testing,6227323284,"Nov 21, 2025","Jun 30, 2026",31 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-2,TB Testing,6227323285,"Nov 21, 2025","Jun 30, 2026",31 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-3,Biopsy,6227323288,"Nov 21, 2025","Sep 12, 2026",105 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-3,Biopsy,6228023950,"Feb 25, 2026","Nov 28, 2026",182 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-3,Biopsy,6228023952,"Feb 25, 2026","May 11, 2027",346 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-3,Biopsy,6228179946,"Mar 23, 2026","Jul 20, 2027",416 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-3,Biopsy,6228179944,"Mar 23, 2026","Jul 20, 2027",416 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-4,Induction ED,6227323289,"Nov 21, 2025","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-4,Induction ED,6227323290,"Nov 21, 2025","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-5,Biologic Drug Level,6227323291,"Nov 21, 2025","Jun 30, 2026",31 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-5,Biologic Drug Level,6227323292,"Nov 21, 2025","Jun 30, 2026",31 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-6,Maintenance ED,6227752381,"Jan 20, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-6,Maintenance ED,6227752383,"Jan 20, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-6,Maintenance ED,6227752382,"Jan 20, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-8,Liver Function Tests,6227323293,"Nov 21, 2025","Jul 1, 2026",32 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-8,Liver Function Tests,6227323294,"Nov 21, 2025","Jul 1, 2026",32 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-9,LTE Maintenance ED,6227752385,"Jan 20, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-9,LTE Maintenance ED,6227752386,"Jan 20, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-9,LTE Maintenance ED,6227752384,"Jan 20, 2026","Oct 7, 2026",130 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-10,Safety FU,6227323279,"Nov 21, 2025","May 31, 2026",1 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-10,Safety FU,6227323278,"Nov 21, 2025","May 31, 2026",1 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-11,DILI,6227323280,"Nov 21, 2025","May 31, 2026",1 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-12,DNA,6227323281,"Nov 21, 2025","Jul 31, 2026",62 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-12,DNA,6227323282,"Nov 21, 2025","Jul 31, 2026",62 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-12,DNA,6228179941,"Mar 23, 2026","Mar 31, 2027",305 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-12,DNA,6228179943,"Mar 23, 2026","Mar 31, 2027",305 +213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,U,Unscheduled,6227323296,"Nov 21, 2025","Aug 31, 2026",93 +title,value,,,,,,,, +Search,,,,,,,,, +Site,"CZ10001 Dr. Matej Falc, CZ10010 Dr.Nabil El Lababidi, CZ10022 Dr. Petr Hrabak, CZ10020 Dr.Lucie Gonsorcikova, CZ10012 Dr.Stefan Konecny, CZ10021 Dr.Martin Bortlik, CZ10016 Dr.Robert Mudr, CZ10003 Dr. Leksa Vaclav, CZ10009 Dr. Jiri Pumprla, CZ10015 Dr.Jan Matous, CZ10013 Dr.David Stepek, CZ10006 Dr. Michal Konecny",,,,,,,, +Expiration Date Range,From - To - ,,,,,,,, +Shipped Date Range,From - To - ,,,,,,,, +Kit Type,,,,,,,,, +Ignore Record Limit,TRUE,,,,,,,, diff --git a/Covance_UCO3001/Source/2026-05-29_112211 sponsor-study-35472-kit-inventory-on-hand-expiration.csv b/Covance_UCO3001/Source/2026-05-29_112211 sponsor-study-35472-kit-inventory-on-hand-expiration.csv new file mode 100644 index 0000000..9cfdc22 --- /dev/null +++ b/Covance_UCO3001/Source/2026-05-29_112211 sponsor-study-35472-kit-inventory-on-hand-expiration.csv @@ -0,0 +1,285 @@ +Project No.,Region,Country,Site,Kit Type,Description,Accession,Shipped Date,Expiration Date,Days to Expiration +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,1,Part 1 Screening,6225350973,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,1,Part 1 Screening,6225350970,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,1,Part 1 Screening,6225350974,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,1,Part 1 Screening,6225350976,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,1,Part 1 Screening,6225350978,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,1,Part 1 Screening,6225350979,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,1,Part 1 Screening,6227541248,"Dec 25, 2025","Oct 7, 2026",130 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,1,Part 1 Screening,6227541247,"Dec 25, 2025","Oct 7, 2026",130 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,1,Part 1 Screening,6228149461,"Mar 13, 2026","Oct 11, 2026",134 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,1,Part 1 Screening,6228149462,"Mar 13, 2026","Oct 11, 2026",134 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,1,Part 1 Screening,6228149463,"Mar 13, 2026","Oct 11, 2026",134 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,2,Part 1 DB Baseline,6225350980,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,2,Part 1 DB Baseline,6225350983,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,2,Part 1 DB Baseline,6227261232,"Nov 18, 2025","May 31, 2026",1 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,2,Part 1 DB Baseline,6227261231,"Nov 18, 2025","May 31, 2026",1 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,2,Part 1 DB Baseline,6227541250,"Dec 25, 2025","Oct 7, 2026",130 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,2,Part 1 DB Baseline,6227541253,"Dec 25, 2025","Oct 7, 2026",130 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,3,Part 2 Screening,6225350985,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,3,Part 2 Screening,6225350986,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,3,Part 2 Screening,6225350987,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,3,Part 2 Screening,6227547334,"Dec 31, 2025","Oct 7, 2026",130 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,3,Part 2 Screening,6227547335,"Dec 31, 2025","Oct 7, 2026",130 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,4,Part 2 OL Induction Baseline,6225350989,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,4,Part 2 OL Induction Baseline,6227541255,"Dec 25, 2025","Oct 7, 2026",130 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,4,Part 2 OL Induction Baseline,6227541254,"Dec 25, 2025","Oct 7, 2026",130 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,4,Part 2 OL Induction Baseline,6227547339,"Dec 31, 2025","Oct 7, 2026",130 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,5,Part 2 OL Induction Day 29,6226573502,"Aug 21, 2025","Jul 1, 2026",32 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,5,Part 2 OL Induction Day 29,6226889397,"Oct 7, 2025","May 31, 2026",1 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,5,Part 2 OL Induction Day 29,6227261233,"Nov 18, 2025","May 31, 2026",1 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,5,Part 2 OL Induction Day 29,6227541263,"Dec 25, 2025","Oct 7, 2026",130 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,5,Part 2 OL Induction Day 29,6227541262,"Dec 25, 2025","Oct 7, 2026",130 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,6,Part 2 DB Baseline,6226573503,"Aug 21, 2025","Jul 1, 2026",32 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,6,Part 2 DB Baseline,6226889398,"Oct 7, 2025","May 31, 2026",1 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,6,Part 2 DB Baseline,6227043303,"Oct 23, 2025","Jul 31, 2026",62 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,6,Part 2 DB Baseline,6227261234,"Nov 18, 2025","May 31, 2026",1 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,6,Part 2 DB Baseline,6228149464,"Mar 13, 2026","Oct 11, 2026",134 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,6,Part 2 DB Baseline,6228149465,"Mar 13, 2026","Oct 11, 2026",134 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,7,Part 2 DB Week 13,6226649754,"Aug 29, 2025","May 31, 2026",1 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,7,Part 2 DB Week 13,6226889399,"Oct 7, 2025","May 31, 2026",1 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,7,Part 2 DB Week 13,6227541265,"Dec 25, 2025","Oct 7, 2026",130 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,7,Part 2 DB Week 13,6227541267,"Dec 25, 2025","Oct 7, 2026",130 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,7,Part 2 DB Week 13,6227541268,"Dec 25, 2025","Oct 7, 2026",130 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,7,Part 2 DB Week 13,6227541266,"Dec 25, 2025","Oct 7, 2026",130 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-1,Part 2 DB Every 12 Weeks,6226573504,"Aug 21, 2025","Jul 1, 2026",32 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-1,Part 2 DB Every 12 Weeks,6226573505,"Aug 21, 2025","Jul 1, 2026",32 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-1,Part 2 DB Every 12 Weeks,6226573507,"Aug 21, 2025","Jul 1, 2026",32 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-1,Part 2 DB Every 12 Weeks,6226573506,"Aug 21, 2025","Jul 1, 2026",32 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-1,Part 2 DB Every 12 Weeks,6226573508,"Aug 21, 2025","Jul 1, 2026",32 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-1,Part 2 DB Every 12 Weeks,6227541269,"Dec 25, 2025","Oct 7, 2026",130 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-1,Part 2 DB Every 12 Weeks,6227541270,"Dec 25, 2025","Oct 7, 2026",130 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-1,Part 2 DB Every 12 Weeks,6227541272,"Dec 25, 2025","Oct 7, 2026",130 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-1,Part 2 DB Every 12 Weeks,6227541271,"Dec 25, 2025","Oct 7, 2026",130 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-2,End of Phase/Treatment,6225350990,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-2,End of Phase/Treatment,6225350991,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-2,End of Phase/Treatment,6225350992,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-2,End of Phase/Treatment,6225350993,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-2,End of Phase/Treatment,6225350994,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-2,End of Phase/Treatment,6227768461,"Jan 27, 2026","Oct 7, 2026",130 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-2,End of Phase/Treatment,6228605654,"May 7, 2026","Feb 28, 2027",274 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-2,End of Phase/Treatment,6228605655,"May 7, 2026","Feb 28, 2027",274 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-3,Early Withdrawal,6225350996,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-3,Early Withdrawal,6225350995,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-3,Early Withdrawal,6225350997,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-3,Early Withdrawal,6225350998,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-3,Early Withdrawal,6225350999,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-3,Early Withdrawal,6227768462,"Jan 27, 2026","Oct 7, 2026",130 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-3,Early Withdrawal,6227768463,"Jan 27, 2026","Oct 7, 2026",130 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-3,Early Withdrawal,6227768464,"Jan 27, 2026","Oct 7, 2026",130 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-3,Early Withdrawal,6227768465,"Jan 27, 2026","Oct 7, 2026",130 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-4,Liver Monitoring,6225351000,"Feb 24, 2025","Sep 1, 2025",-270 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-4,Liver Monitoring,6227547340,"Dec 31, 2025","Sep 12, 2026",105 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-4,Liver Monitoring,6227768466,"Jan 27, 2026","Oct 7, 2026",130 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-5,Suspected Liver Event FU,6225351001,"Feb 24, 2025","Jul 31, 2025",-302 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-5,Suspected Liver Event FU,6227547341,"Dec 31, 2025","Jul 31, 2026",62 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-5,Suspected Liver Event FU,6227768467,"Jan 27, 2026","Jul 31, 2026",62 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,U,Retest,6225351003,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,U,Retest,6226649755,"Aug 29, 2025","May 31, 2026",1 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,U,Retest,6226649756,"Aug 29, 2025","May 31, 2026",1 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,U,Retest,6227178914,"Nov 14, 2025","Aug 31, 2026",93 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,U,Retest,6227178913,"Nov 14, 2025","Aug 31, 2026",93 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,U,Retest,6227178915,"Nov 14, 2025","Aug 31, 2026",93 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,U,Retest,6227178916,"Nov 14, 2025","Aug 31, 2026",93 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,U,Retest,6227178917,"Nov 14, 2025","Aug 31, 2026",93 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,U,Retest,6227178919,"Nov 14, 2025","Aug 31, 2026",93 +212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,U,Retest,6227178918,"Nov 14, 2025","Aug 31, 2026",93 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,1,Part 1 Screening,6225351038,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,1,Part 1 Screening,6225351039,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,1,Part 1 Screening,6225351043,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,1,Part 1 Screening,6227520226,"Dec 26, 2025","Aug 31, 2026",93 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,1,Part 1 Screening,6227520225,"Dec 26, 2025","Aug 31, 2026",93 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,1,Part 1 Screening,6227520227,"Dec 26, 2025","Aug 31, 2026",93 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,2,Part 1 DB Baseline,6225351048,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,2,Part 1 DB Baseline,6226551696,"Aug 22, 2025","Apr 17, 2026",-42 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,2,Part 1 DB Baseline,6226551699,"Aug 22, 2025","Apr 17, 2026",-42 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,2,Part 1 DB Baseline,6226551700,"Aug 22, 2025","Apr 17, 2026",-42 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,2,Part 1 DB Baseline,6226655163,"Sep 5, 2025","May 31, 2026",1 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,2,Part 1 DB Baseline,6226655166,"Sep 5, 2025","May 31, 2026",1 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,2,Part 1 DB Baseline,6226655165,"Sep 5, 2025","May 31, 2026",1 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,2,Part 1 DB Baseline,6226655162,"Sep 5, 2025","May 31, 2026",1 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,2,Part 1 DB Baseline,6226655164,"Sep 5, 2025","May 31, 2026",1 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,3,Part 2 Screening,6225351053,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,3,Part 2 Screening,6225351054,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,3,Part 2 Screening,6225351055,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,3,Part 2 Screening,6227520230,"Dec 26, 2025","Aug 31, 2026",93 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,3,Part 2 Screening,6227520228,"Dec 26, 2025","Aug 31, 2026",93 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,3,Part 2 Screening,6227520229,"Dec 26, 2025","Aug 31, 2026",93 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,4,Part 2 OL Induction Baseline,6226780849,"Sep 24, 2025","May 31, 2026",1 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,4,Part 2 OL Induction Baseline,6226780851,"Sep 24, 2025","May 31, 2026",1 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,4,Part 2 OL Induction Baseline,6226780848,"Sep 24, 2025","May 31, 2026",1 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,4,Part 2 OL Induction Baseline,6226780852,"Sep 24, 2025","May 31, 2026",1 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,4,Part 2 OL Induction Baseline,6226780850,"Sep 24, 2025","May 31, 2026",1 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,4,Part 2 OL Induction Baseline,6227520231,"Dec 26, 2025","Aug 31, 2026",93 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,4,Part 2 OL Induction Baseline,6227520233,"Dec 26, 2025","Aug 31, 2026",93 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,4,Part 2 OL Induction Baseline,6227520232,"Dec 26, 2025","Aug 31, 2026",93 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,5,Part 2 OL Induction Day 29,6226550654,"Aug 21, 2025","Jul 1, 2026",32 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,5,Part 2 OL Induction Day 29,6226561520,"Aug 21, 2025","Jul 1, 2026",32 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,5,Part 2 OL Induction Day 29,6227072416,"Oct 20, 2025","Jul 31, 2026",62 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,5,Part 2 OL Induction Day 29,6227072415,"Oct 20, 2025","Jul 31, 2026",62 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,5,Part 2 OL Induction Day 29,6227072418,"Oct 20, 2025","Jul 31, 2026",62 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,5,Part 2 OL Induction Day 29,6227072417,"Oct 20, 2025","Jul 31, 2026",62 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,6,Part 2 DB Baseline,6226313626,"Jul 14, 2025","Apr 17, 2026",-42 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,6,Part 2 DB Baseline,6226550655,"Aug 21, 2025","Jul 1, 2026",32 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,6,Part 2 DB Baseline,6226561521,"Aug 21, 2025","Jul 1, 2026",32 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,6,Part 2 DB Baseline,6227520234,"Dec 26, 2025","Aug 31, 2026",93 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,6,Part 2 DB Baseline,6227520235,"Dec 26, 2025","Aug 31, 2026",93 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,6,Part 2 DB Baseline,6227520236,"Dec 26, 2025","Aug 31, 2026",93 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,7,Part 2 DB Week 13,6226313627,"Jul 14, 2025","Apr 17, 2026",-42 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,7,Part 2 DB Week 13,6226550656,"Aug 21, 2025","Jul 1, 2026",32 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,7,Part 2 DB Week 13,6226561522,"Aug 21, 2025","Jul 1, 2026",32 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,7,Part 2 DB Week 13,6226804963,"Sep 25, 2025","May 31, 2026",1 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-1,Part 2 DB Every 12 Weeks,6226313628,"Jul 14, 2025","Apr 17, 2026",-42 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-1,Part 2 DB Every 12 Weeks,6226313629,"Jul 14, 2025","Apr 17, 2026",-42 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-1,Part 2 DB Every 12 Weeks,6226313630,"Jul 14, 2025","Apr 17, 2026",-42 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-1,Part 2 DB Every 12 Weeks,6226313631,"Jul 14, 2025","Apr 17, 2026",-42 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-1,Part 2 DB Every 12 Weeks,6226313632,"Jul 14, 2025","Apr 17, 2026",-42 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-1,Part 2 DB Every 12 Weeks,6227520237,"Dec 26, 2025","Aug 31, 2026",93 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-1,Part 2 DB Every 12 Weeks,6227520239,"Dec 26, 2025","Aug 31, 2026",93 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-1,Part 2 DB Every 12 Weeks,6227520240,"Dec 26, 2025","Aug 31, 2026",93 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-1,Part 2 DB Every 12 Weeks,6227520241,"Dec 26, 2025","Aug 31, 2026",93 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-1,Part 2 DB Every 12 Weeks,6227520238,"Dec 26, 2025","Aug 31, 2026",93 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-2,End of Phase/Treatment,6225351058,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-2,End of Phase/Treatment,6225351059,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-2,End of Phase/Treatment,6225351061,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-2,End of Phase/Treatment,6225351062,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-2,End of Phase/Treatment,6225351060,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-2,End of Phase/Treatment,6226780854,"Sep 24, 2025","May 31, 2026",1 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-2,End of Phase/Treatment,6227520244,"Dec 26, 2025","Aug 31, 2026",93 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-2,End of Phase/Treatment,6227520246,"Dec 26, 2025","Aug 31, 2026",93 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-3,Early Withdrawal,6225351065,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-3,Early Withdrawal,6225351067,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-3,Early Withdrawal,6225351064,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-3,Early Withdrawal,6225351063,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-3,Early Withdrawal,6227520248,"Dec 26, 2025","Aug 31, 2026",93 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-3,Early Withdrawal,6227520250,"Dec 26, 2025","Aug 31, 2026",93 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-3,Early Withdrawal,6227520247,"Dec 26, 2025","Aug 31, 2026",93 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-3,Early Withdrawal,6227520249,"Dec 26, 2025","Aug 31, 2026",93 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-3,Early Withdrawal,6227520251,"Dec 26, 2025","Aug 31, 2026",93 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-4,Liver Monitoring,6225351068,"Feb 24, 2025","Sep 1, 2025",-270 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-5,Suspected Liver Event FU,6225351069,"Feb 24, 2025","Jul 31, 2025",-302 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,U,Retest,6225351071,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,U,Retest,6228023802,"Feb 25, 2026","Oct 11, 2026",134 +212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,U,Retest,6228023803,"Feb 25, 2026","Oct 11, 2026",134 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,1,Part 1 Screening,6225351073,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,1,Part 1 Screening,6225351075,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,1,Part 1 Screening,6225351079,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,1,Part 1 Screening,6227542163,"Dec 25, 2025","Oct 7, 2026",130 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,1,Part 1 Screening,6227542162,"Dec 25, 2025","Oct 7, 2026",130 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,1,Part 1 Screening,6228149810,"Mar 13, 2026","Oct 11, 2026",134 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,1,Part 1 Screening,6228149812,"Mar 13, 2026","Oct 11, 2026",134 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,1,Part 1 Screening,6228149811,"Mar 13, 2026","Oct 11, 2026",134 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,2,Part 1 DB Baseline,6225351085,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,2,Part 1 DB Baseline,6225351086,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,2,Part 1 DB Baseline,6227542165,"Dec 25, 2025","Oct 7, 2026",130 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,2,Part 1 DB Baseline,6227542164,"Dec 25, 2025","Oct 7, 2026",130 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,2,Part 1 DB Baseline,6227844727,"Feb 1, 2026","Oct 11, 2026",134 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,2,Part 1 DB Baseline,6227844726,"Feb 1, 2026","Oct 11, 2026",134 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,3,Part 2 Screening,6225351087,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,3,Part 2 Screening,6225351088,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,3,Part 2 Screening,6225351089,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,3,Part 2 Screening,6227542167,"Dec 25, 2025","Oct 7, 2026",130 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,3,Part 2 Screening,6227542168,"Dec 25, 2025","Oct 7, 2026",130 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,3,Part 2 Screening,6227542169,"Dec 25, 2025","Oct 7, 2026",130 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,3,Part 2 Screening,6227542166,"Dec 25, 2025","Oct 7, 2026",130 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,4,Part 2 OL Induction Baseline,6225351091,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,4,Part 2 OL Induction Baseline,6225351090,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,5,Part 2 OL Induction Day 29,6226935605,"Oct 14, 2025","May 31, 2026",1 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,5,Part 2 OL Induction Day 29,6228013045,"Feb 26, 2026","Oct 11, 2026",134 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,6,Part 2 DB Baseline,6226550647,"Aug 18, 2025","Jul 1, 2026",32 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,6,Part 2 DB Baseline,6226561518,"Aug 21, 2025","Jul 1, 2026",32 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,6,Part 2 DB Baseline,6226991312,"Oct 26, 2025","May 31, 2026",1 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,6,Part 2 DB Baseline,6228013046,"Feb 26, 2026","Oct 11, 2026",134 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,6,Part 2 DB Baseline,6228114461,"Mar 11, 2026","Oct 11, 2026",134 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,6,Part 2 DB Baseline,6228398393,"Apr 15, 2026","Feb 28, 2027",274 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,7,Part 2 DB Week 13,6226550648,"Aug 18, 2025","Jul 1, 2026",32 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,7,Part 2 DB Week 13,6226561519,"Aug 21, 2025","Jul 1, 2026",32 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,7,Part 2 DB Week 13,6226991313,"Oct 26, 2025","May 31, 2026",1 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,7,Part 2 DB Week 13,6227261837,"Nov 20, 2025","Oct 7, 2026",130 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,7,Part 2 DB Week 13,6227261838,"Nov 20, 2025","Oct 7, 2026",130 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,7,Part 2 DB Week 13,6228114462,"Mar 11, 2026","Oct 11, 2026",134 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-1,Part 2 DB Every 12 Weeks,6226550649,"Aug 18, 2025","Jul 1, 2026",32 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-1,Part 2 DB Every 12 Weeks,6226550650,"Aug 18, 2025","Jul 1, 2026",32 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-1,Part 2 DB Every 12 Weeks,6226550652,"Aug 18, 2025","Jul 1, 2026",32 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-1,Part 2 DB Every 12 Weeks,6226550651,"Aug 18, 2025","Jul 1, 2026",32 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-1,Part 2 DB Every 12 Weeks,6226550653,"Aug 18, 2025","Jul 1, 2026",32 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-2,End of Phase/Treatment,6225351092,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-2,End of Phase/Treatment,6225351096,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-2,End of Phase/Treatment,6227498378,"Dec 22, 2025","Aug 31, 2026",93 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-2,End of Phase/Treatment,6228232036,"Mar 25, 2026","Jan 3, 2027",218 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-2,End of Phase/Treatment,6228232038,"Mar 25, 2026","Jan 3, 2027",218 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-2,End of Phase/Treatment,6228234299,"Mar 30, 2026","Jan 3, 2027",218 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-3,Early Withdrawal,6225351097,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-3,Early Withdrawal,6225351099,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-3,Early Withdrawal,6225351101,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-3,Early Withdrawal,6225351100,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-3,Early Withdrawal,6225351098,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-3,Early Withdrawal,6227542174,"Dec 25, 2025","Oct 7, 2026",130 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-3,Early Withdrawal,6227542176,"Dec 25, 2025","Oct 7, 2026",130 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-3,Early Withdrawal,6227542175,"Dec 25, 2025","Oct 7, 2026",130 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-3,Early Withdrawal,6227542177,"Dec 25, 2025","Oct 7, 2026",130 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-4,Liver Monitoring,6225351102,"Feb 24, 2025","Sep 1, 2025",-270 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-4,Liver Monitoring,6227542179,"Dec 25, 2025","Sep 12, 2026",105 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-4,Liver Monitoring,6227542178,"Dec 25, 2025","Sep 12, 2026",105 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-5,Suspected Liver Event FU,6225351103,"Feb 24, 2025","Jul 31, 2025",-302 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-5,Suspected Liver Event FU,6227542180,"Dec 25, 2025","Jun 30, 2026",31 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-5,Suspected Liver Event FU,6227542181,"Dec 25, 2025","Jun 30, 2026",31 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,U,Retest,6225351104,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,U,Retest,6225351105,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,U,Retest,6227542183,"Dec 25, 2025","Oct 7, 2026",130 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,U,Retest,6228417882,"Apr 15, 2026","Feb 28, 2027",274 +212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,U,Retest,6228417883,"Apr 15, 2026","Feb 28, 2027",274 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,1,Part 1 Screening,6225351107,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,1,Part 1 Screening,6225351108,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,1,Part 1 Screening,6225351112,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,1,Part 1 Screening,6225351113,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,1,Part 1 Screening,6225351114,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,1,Part 1 Screening,6225351115,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,1,Part 1 Screening,6227767268,"Jan 27, 2026","Oct 7, 2026",130 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,1,Part 1 Screening,6227775503,"Jan 23, 2026","Oct 7, 2026",130 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,1,Part 1 Screening,6227775504,"Jan 23, 2026","Oct 7, 2026",130 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,2,Part 1 DB Baseline,6225351117,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,2,Part 1 DB Baseline,6225351116,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,2,Part 1 DB Baseline,6225351118,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,2,Part 1 DB Baseline,6225351119,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,2,Part 1 DB Baseline,6227767269,"Jan 27, 2026","Oct 7, 2026",130 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,2,Part 1 DB Baseline,6227767270,"Jan 27, 2026","Oct 7, 2026",130 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,2,Part 1 DB Baseline,6227775506,"Jan 23, 2026","Oct 7, 2026",130 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,3,Part 2 Screening,6225351123,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,3,Part 2 Screening,6225351122,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,3,Part 2 Screening,6225351121,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,3,Part 2 Screening,6228742569,"May 25, 2026","Feb 28, 2027",274 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,3,Part 2 Screening,6228742568,"May 25, 2026","Feb 28, 2027",274 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,4,Part 2 OL Induction Baseline,6225351124,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,4,Part 2 OL Induction Baseline,6225351125,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,6,Part 2 DB Baseline,6226976944,"Oct 26, 2025","May 31, 2026",1 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,6,Part 2 DB Baseline,6228521304,"Apr 30, 2026","Feb 28, 2027",274 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,7,Part 2 DB Week 13,6226560889,"Aug 20, 2025","Jul 1, 2026",32 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,7,Part 2 DB Week 13,6226752556,"Sep 17, 2025","May 31, 2026",1 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,7,Part 2 DB Week 13,6226976945,"Oct 26, 2025","May 31, 2026",1 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,T-1,Part 2 DB Every 12 Weeks,6226560890,"Aug 20, 2025","Jul 1, 2026",32 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,T-1,Part 2 DB Every 12 Weeks,6226560892,"Aug 20, 2025","Jul 1, 2026",32 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,T-1,Part 2 DB Every 12 Weeks,6226560894,"Aug 20, 2025","Jul 1, 2026",32 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,T-1,Part 2 DB Every 12 Weeks,6226560893,"Aug 20, 2025","Jul 1, 2026",32 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,T-1,Part 2 DB Every 12 Weeks,6228389162,"Apr 15, 2026","Feb 28, 2027",274 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,T-1,Part 2 DB Every 12 Weeks,6228389161,"Apr 15, 2026","Feb 28, 2027",274 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,T-2,End of Phase/Treatment,6225351129,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,T-2,End of Phase/Treatment,6225351128,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,T-2,End of Phase/Treatment,6225351130,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,T-2,End of Phase/Treatment,6225351127,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,T-3,Early Withdrawal,6225351131,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,T-3,Early Withdrawal,6225351132,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,T-3,Early Withdrawal,6225351133,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,T-3,Early Withdrawal,6225351134,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,T-3,Early Withdrawal,6225351135,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,T-4,Liver Monitoring,6225351136,"Feb 24, 2025","Sep 1, 2025",-270 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,T-5,Suspected Liver Event FU,6225351137,"Feb 24, 2025","Jul 31, 2025",-302 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,U,Retest,6225351139,"Feb 24, 2025","Dec 1, 2025",-179 +212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,U,Retest,6225351138,"Feb 24, 2025","Dec 1, 2025",-179 +title,value,,,,,,,, +Search,,,,,,,,, +Site,"CZ10004 Dr. Erik Herman, CZ10012 Dr.Ales Urban, CZ10011 Dr. Marta Lendlova, CZ10008 Dr.Zdenek Solle",,,,,,,, +Expiration Date Range,From - To - ,,,,,,,, +Shipped Date Range,From - To - ,,,,,,,, +Kit Type,,,,,,,,, +Ignore Record Limit,TRUE,,,,,,,, diff --git a/Covance_UCO3001/Source/2026-05-29_112244 sponsor-study-36940-activity-reports-documents-equery.csv b/Covance_UCO3001/Source/2026-05-29_112244 sponsor-study-36940-activity-reports-documents-equery.csv new file mode 100644 index 0000000..687aab1 --- /dev/null +++ b/Covance_UCO3001/Source/2026-05-29_112244 sponsor-study-36940-activity-reports-documents-equery.csv @@ -0,0 +1,75 @@ +Site,Country,Visit,Visit Collection Date,Accession,Subject,eQueryId,Create Date,Response Date Time,Issue Type,Status,Time Before Response,User Name,Email,Study Role +CZ10022 - Dr. Petr Hrabak,CZECH REPUBLIC,Unscheduled,"Mar 13, 2026 8:40 AM",6227323295,CZ100222004,2047932,"Mar 17, 2026 3:49 PM","Mar 17, 2026 9:07 PM",VST,Closed,5h 17m,Jana Pomahacova,jana.pomahacova@clinoxus.com,Investigator +CZ10022 - Dr. Petr Hrabak,CZECH REPUBLIC,Unscheduled,"Mar 13, 2026 7:45 AM",6227323297,CZ100222005,2047949,"Mar 17, 2026 3:56 PM","Mar 17, 2026 9:09 PM",VST,Closed,5h 12m,Jana Pomahacova,jana.pomahacova@clinoxus.com,Investigator +CZ10022 - Dr. Petr Hrabak,CZECH REPUBLIC,Induction Week 0,"Mar 9, 2026 8:50 AM",6227323270,CZ100222003,2038559,"Mar 11, 2026 4:39 PM","Mar 11, 2026 8:32 PM","AGE, ADT201, AMT58660, AMT3542",Closed,3h 53m,Jana Pomahacova,jana.pomahacova@clinoxus.com,Investigator +CZ10022 - Dr. Petr Hrabak,CZECH REPUBLIC,Induction Week 2,"Mar 27, 2026 7:10 AM",6227323272,CZ100222003,2073305,"Apr 1, 2026 7:54 PM","Apr 2, 2026 7:37 AM",AMT58660,Closed,11h 43m,Jana Pomahacova,jana.pomahacova@clinoxus.com,Investigator +CZ10022 - Dr. Petr Hrabak,CZECH REPUBLIC,Induction Week 4,"Apr 8, 2026 8:05 AM",6227323274,CZ100222003,2086982,"Apr 10, 2026 1:00 PM","Apr 10, 2026 1:06 PM",AMT58660,Closed,5m,Katerina Havlikova,katerina.havlikova@clinoxus.com,Investigator +CZ10022 - Dr. Petr Hrabak,CZECH REPUBLIC,Screening,"Mar 2, 2026 11:00 AM",6227810899,CZ100222003,2029805,"Mar 5, 2026 6:36 PM","Mar 6, 2026 9:01 AM","AMT58660, AMT3542",Closed,14h 24m,Jana Pomahacova,jana.pomahacova@clinoxus.com,Investigator +CZ10022 - Dr. Petr Hrabak,CZECH REPUBLIC,Screening,"Mar 4, 2026 9:20 AM",6227810900,CZ100222005,2031896,"Mar 6, 2026 6:45 PM","Mar 6, 2026 7:25 PM","AMT58660, AMT3542",Closed,40m,Jana Pomahacova,jana.pomahacova@clinoxus.com,Investigator +CZ10022 - Dr. Petr Hrabak,CZECH REPUBLIC,Screening,"Mar 3, 2026 12:10 PM",6227810901,CZ100222004,2029774,"Mar 5, 2026 6:23 PM","Mar 6, 2026 7:24 PM","AMT58660, AMT3542",Closed,1d,Jana Pomahacova,jana.pomahacova@clinoxus.com,Investigator +CZ10022 - Dr. Petr Hrabak,CZECH REPUBLIC,Induction Week 0,"Apr 9, 2026 10:35 AM",6228173397,CZ100222005,2089669,"Apr 13, 2026 2:06 PM","Apr 23, 2026 12:53 PM",PCFCOM,Closed,9d,Jana Pomahacova,jana.pomahacova@clinoxus.com,Investigator +CZ10021 - Dr.Martin Bortlik,CZECH REPUBLIC,Screening,"Feb 25, 2026 12:15 PM",6227635204,CZ100212001,2019716,"Feb 27, 2026 12:09 PM","Mar 3, 2026 11:11 AM","AMT58660, AMT3542",Closed,3d,Zdenka Dvorakova,dvorakova.zdenka@nemcb.cz,Investigator +CZ10021 - Dr.Martin Bortlik,CZECH REPUBLIC,Induction Week 0,"Apr 7, 2026 10:37 AM",6227635207,CZ100212001,2085089,"Apr 9, 2026 2:54 PM","Apr 15, 2026 7:20 AM","AMT58660, AMT15602",Closed,5d,Tereza Hosnova,hosnova.tereza2@nemcb.cz,Investigator +CZ10021 - Dr.Martin Bortlik,CZECH REPUBLIC,Induction Week 2,"Apr 20, 2026 8:43 AM",6227635208,CZ100212001,2106304,"Apr 22, 2026 7:04 PM","Apr 23, 2026 9:21 AM",AMT58660,Closed,14h 16m,Tereza Hosnova,hosnova.tereza2@nemcb.cz,Investigator +CZ10021 - Dr.Martin Bortlik,CZECH REPUBLIC,Induction Week 4,"May 5, 2026 10:00 AM",6227635211,CZ100212001,2133221,"May 9, 2026 6:24 PM","May 11, 2026 2:34 PM",AMT58660,Closed,1d,Tereza Hosnova,hosnova.tereza2@nemcb.cz,Investigator +CZ10020 - Dr.Lucie Gonsorcikova,CZECH REPUBLIC,Screening,"Apr 13, 2026 12:20 PM",6227993962,CZ100201001,2094721,"Apr 15, 2026 6:02 PM","Apr 21, 2026 12:47 PM","AMT58660, AMT3542",Closed,5d,Zuzana Zahradnikova,zuzana.zahradnikova@ftn.cz,Investigator +CZ10020 - Dr.Lucie Gonsorcikova,CZECH REPUBLIC,Induction Week 0,"May 18, 2026 9:28 AM",6227993966,CZ100201001,2156061,"May 22, 2026 9:37 PM","May 25, 2026 6:43 AM","ADT201, AMT58660, AMT3542",Closed,2d,Zuzana Zahradnikova,zuzana.zahradnikova@ftn.cz,Investigator +CZ10016 - Dr.Robert Mudr,CZECH REPUBLIC,Screening,"Apr 21, 2026 10:45 AM",6227635171,CZ100162001,2109874,"Apr 24, 2026 2:00 PM",,AMT58660,Closed,,,, +CZ10016 - Dr.Robert Mudr,CZECH REPUBLIC,Screening,"Apr 21, 2026 10:45 AM",6227635171,CZ100162001,2123465,"May 4, 2026 7:16 PM","May 5, 2026 10:04 AM",AMT58660,Closed,14h 48m,Petr Pekny,petr.pekny@nmskb.cz,Investigator +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Induction Week 0,"Mar 24, 2026 9:40 AM",6227635142,CZ100132001,2064220,"Mar 26, 2026 9:37 PM",,"AMT58660, AMT3542",Closed,,,, +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Induction Week 0,"Mar 24, 2026 9:40 AM",6227635142,CZ100132001,2066330,"Mar 27, 2026 6:43 PM","Mar 30, 2026 10:41 PM",AMT58660,Closed,3d,David Stepek,dstepek@vnbrno.cz,Investigator +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Induction Week 2,"Apr 7, 2026 8:50 AM",6227635144,CZ100132001,2087084,"Apr 10, 2026 1:27 PM",,AMT58660,Closed,,,, +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Induction Week 2,"Apr 7, 2026 8:50 AM",6227635144,CZ100132001,2100086,"Apr 18, 2026 11:15 AM","Apr 22, 2026 7:51 PM",AMT58660,Closed,4d,David Stepek,dstepek@vnbrno.cz,Investigator +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Induction Week 4,"Apr 21, 2026 8:45 AM",6227635146,CZ100132001,2108501,"Apr 23, 2026 6:55 PM",,AMT58660,Closed,,,, +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Induction Week 4,"Apr 21, 2026 8:45 AM",6227635146,CZ100132001,2123492,"May 4, 2026 7:24 PM","May 5, 2026 3:30 PM",AMT58660,Closed,20h 6m,David Stepek,dstepek@vnbrno.cz,Investigator +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Screening,"Apr 1, 2026 8:00 AM",6227635139,CZ100132002,2101883,"Apr 20, 2026 6:49 PM","Apr 22, 2026 7:51 PM",AMT58660,Closed,2d,David Stepek,dstepek@vnbrno.cz,Investigator +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Screening,"Apr 1, 2026 8:00 AM",6227635139,CZ100132002,2090916,"Apr 13, 2026 9:15 PM",,AMT58660,Closed,,,, +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Screening,"Apr 1, 2026 8:00 AM",6227635139,CZ100132002,2079289,"Apr 6, 2026 3:21 PM",,AMT58660,Closed,,,, +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Screening,"Feb 26, 2026 1:20 PM",6227635140,CZ100132001,2033901,"Mar 9, 2026 3:53 PM","Mar 16, 2026 10:08 PM","SCD, AMT58660, AMT3542",Closed,7d,David Stepek,dstepek@vnbrno.cz,Investigator +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Screening,"Feb 26, 2026 1:20 PM",6227635140,CZ100132001,2023257,"Mar 2, 2026 6:47 PM",,"SCD, AGE, AMT58660, AMT3542",Closed,,,, +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Screening,"May 6, 2026 10:45 AM",6227635141,CZ100132003,2137874,"May 12, 2026 8:03 PM","May 19, 2026 7:48 AM",AMT58660,Closed,6d,,, +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Biopsy,"Apr 21, 2026 12:00 AM",6227635159,CZ100132002,2109534,"Apr 24, 2026 12:45 PM",,ADT8471,Closed,,,, +CZ10013 - Dr.David Stepek,CZECH REPUBLIC,Biopsy,"Apr 21, 2026 12:00 AM",6227635159,CZ100132002,2123486,"May 4, 2026 7:23 PM","May 5, 2026 3:30 PM",ADT8471,Closed,20h 7m,David Stepek,dstepek@vnbrno.cz,Investigator +CZ10012 - Dr.Stefan Konecny,CZECH REPUBLIC,Unscheduled,,6227697745,,2140058,"May 13, 2026 7:02 PM","May 26, 2026 9:46 AM",PCFCOM,Response Received,12d,Kristyna Hosova,hosova.kristyna@fnbrno.cz,Investigator +CZ10012 - Dr.Stefan Konecny,CZECH REPUBLIC,Screening,"Mar 18, 2026 9:18 AM",6227697718,CZ100122001,2053959,"Mar 20, 2026 2:52 PM","Mar 23, 2026 12:00 PM","SCT, AMT58660",Closed,2d,Kristyna Hosova,hosova.kristyna@fnbrno.cz,Investigator +CZ10012 - Dr.Stefan Konecny,CZECH REPUBLIC,Induction Week 0,"Apr 7, 2026 11:45 AM",6227697719,CZ100122001,2085069,"Apr 9, 2026 2:48 PM","Apr 9, 2026 6:28 PM",AMT58660,Closed,3h 39m,Kristyna Hosova,hosova.kristyna@fnbrno.cz,Investigator +CZ10012 - Dr.Stefan Konecny,CZECH REPUBLIC,Induction Week 2,"Apr 22, 2026 9:25 AM",6227697722,CZ100122001,2113315,"Apr 27, 2026 6:35 PM","Apr 27, 2026 8:50 PM",AMT58660,Closed,2h 14m,Kristyna Hosova,hosova.kristyna@fnbrno.cz,Investigator +CZ10012 - Dr.Stefan Konecny,CZECH REPUBLIC,Induction Week 4,"May 7, 2026 12:40 PM",6227697723,CZ100122001,2142322,"May 14, 2026 7:10 PM","May 14, 2026 7:42 PM",AMT58660,Closed,31m,Kristyna Hosova,hosova.kristyna@fnbrno.cz,Investigator +CZ10012 - Dr.Stefan Konecny,CZECH REPUBLIC,Biopsy,"Mar 23, 2026 12:00 AM",6227697736,CZ100122001,2060524,"Mar 25, 2026 12:53 PM","Mar 25, 2026 2:09 PM",AMT23260,Closed,1h 15m,Kristyna Hosova,hosova.kristyna@fnbrno.cz,Investigator +CZ10009 - Dr. Jiri Pumprla,CZECH REPUBLIC,Screening,"Mar 31, 2026 8:30 AM",6227323330,CZ100092001,2075611,"Apr 2, 2026 5:37 PM",,AMT58660,Closed,,,, +CZ10009 - Dr. Jiri Pumprla,CZECH REPUBLIC,Screening,"Mar 31, 2026 8:30 AM",6227323330,CZ100092001,2085558,"Apr 9, 2026 5:08 PM","Apr 10, 2026 2:06 PM",AMT58660,Closed,20h 58m,Jiri Pumprla,research@vilazdravi.cz,Investigator +CZ10009 - Dr. Jiri Pumprla,CZECH REPUBLIC,Screening,"Apr 16, 2026 12:00 PM",6227323332,CZ100092002,2101792,"Apr 20, 2026 6:19 PM","Apr 23, 2026 1:22 PM",AMT58660,Closed,2d,Marketa Menyhardova,menyhardova@vilazdravi.cz,Investigator +CZ10009 - Dr. Jiri Pumprla,CZECH REPUBLIC,Induction Week 0,"May 5, 2026 11:30 AM",6227323334,CZ100092001,2133224,"May 9, 2026 6:30 PM","May 13, 2026 10:10 AM","AMT58660, ADT809",Closed,3d,Marketa Menyhardova,menyhardova@vilazdravi.cz,Investigator +CZ10009 - Dr. Jiri Pumprla,CZECH REPUBLIC,Induction Week 2,"May 19, 2026 10:50 AM",6227323335,CZ100092001,2158952,"May 26, 2026 12:21 PM","May 27, 2026 9:03 AM",AMT58660,Closed,20h 42m,Marketa Menyhardova,menyhardova@vilazdravi.cz,Investigator +CZ10006 - Dr. Michal Konecny,CZECH REPUBLIC,Unscheduled,"Mar 17, 2026 8:00 AM",6227323265,CZ100062001,2052144,"Mar 19, 2026 4:08 PM","Mar 24, 2026 9:29 AM","PSX, SCT, AGE",Closed,4d,Michal Konecny,konecnymi@seznam.cz,Investigator +CZ10006 - Dr. Michal Konecny,CZECH REPUBLIC,Screening,"Apr 20, 2026 7:45 AM",6227323234,CZ100062002,2106334,"Apr 22, 2026 7:18 PM","Apr 22, 2026 7:36 PM",AMT58660,Closed,18m,Michal Konecny,konecnymi@seznam.cz,Investigator +CZ10006 - Dr. Michal Konecny,CZECH REPUBLIC,Induction Week 0,"Mar 20, 2026 8:00 AM",6227323237,CZ100062001,2064023,"Mar 26, 2026 7:00 PM","Mar 27, 2026 9:04 AM",PCFCOM,Closed,14h 3m,Michal Konecny,konecnymi@seznam.cz,Investigator +CZ10006 - Dr. Michal Konecny,CZECH REPUBLIC,Induction Week 0,"Mar 20, 2026 8:00 AM",6227323237,CZ100062001,2061456,"Mar 25, 2026 6:16 PM","Mar 26, 2026 8:38 AM",AMT58660,Closed,14h 22m,Michal Konecny,konecnymi@seznam.cz,Investigator +CZ10006 - Dr. Michal Konecny,CZECH REPUBLIC,Induction Week 2,"Apr 8, 2026 7:10 AM",6227323240,CZ100062001,2086807,"Apr 10, 2026 12:21 PM","Apr 18, 2026 10:40 PM","AMT58660, ADT809",Closed,8d,Michal Konecny,konecnymi@seznam.cz,Investigator +CZ10006 - Dr. Michal Konecny,CZECH REPUBLIC,Induction Week 4,"Apr 15, 2026 8:45 AM",6227323242,CZ100062001,2102704,"Apr 21, 2026 11:22 AM","Apr 22, 2026 7:36 PM",AMT58660,Closed,1d,Michal Konecny,konecnymi@seznam.cz,Investigator +CZ10006 - Dr. Michal Konecny,CZECH REPUBLIC,Biopsy,"Feb 19, 2026 12:00 AM",6227323254,CZ100062001,2014333,"Feb 24, 2026 4:13 PM","Feb 24, 2026 8:20 PM",VST,Closed,4h 6m,Michal Konecny,konecnymi@seznam.cz,Investigator +CZ10003 - Dr. Leksa Vaclav,CZECH REPUBLIC,Screening,"May 13, 2026 8:15 AM",6227323299,CZ100032001,2154732,"May 22, 2026 12:36 PM","May 25, 2026 8:57 AM",AMT58660,Closed,2d,Leksa Vaclav,vaclav.leksa@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Screening,"Mar 2, 2026 7:00 AM",6227323204,CZ100012002,2032628,"Mar 9, 2026 10:33 AM","Mar 9, 2026 11:58 AM",AMT58660,Closed,1h 24m,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Screening,"Mar 2, 2026 7:00 AM",6227323204,CZ100012002,2026645,"Mar 4, 2026 12:58 PM","Mar 6, 2026 6:01 PM","AMT58660, AMT3542",Closed,2d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Induction Week 0,,6227323206,,2112374,"Apr 27, 2026 2:17 PM","May 5, 2026 11:24 AM","PCFCOM, ADT201, AMT58660, AMT3542",Closed,7d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Induction Week 2,"Apr 23, 2026 7:40 AM",6227323207,CZ100012002,2113312,"Apr 27, 2026 6:35 PM","Apr 28, 2026 9:06 PM",AMT58660,Closed,1d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Induction Week 2,"Mar 4, 2026 7:00 AM",6227323208,CZ100012001,2030545,"Mar 6, 2026 11:02 AM","Mar 6, 2026 11:42 AM","AMT58660, AMT688",Closed,39m,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Induction Week 4,"Mar 18, 2026 7:05 AM",6227323210,CZ100012001,2053955,"Mar 20, 2026 2:50 PM","Mar 25, 2026 3:29 PM","SCD, AMT58660",Closed,5d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Stool Pathogens,"Jan 28, 2026 6:00 AM",6227323211,CZ100012001,1976585,"Jan 30, 2026 1:21 PM","Feb 6, 2026 2:37 PM","VST, AGE",Closed,7d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Stool Pathogens,"Jan 28, 2026 6:00 AM",6227323211,CZ100012001,1991148,"Feb 9, 2026 7:43 PM","Feb 13, 2026 8:04 AM",AGE,Closed,3d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Biopsy,"Feb 5, 2026 12:00 AM",6227323223,CZ100012001,1989998,"Feb 9, 2026 1:42 PM","Feb 10, 2026 6:46 PM",VST,Closed,1d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Unscheduled,,6227323231,,2053405,"Mar 20, 2026 12:14 PM","Mar 30, 2026 12:54 AM",PCFCOM,Closed,9d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Unscheduled,"Apr 22, 2026 7:40 AM",6227323232,CZ100012001,2141856,"May 14, 2026 4:23 PM","May 19, 2026 12:54 PM","SCD, AGE",Closed,4d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Unscheduled,"Apr 22, 2026 7:40 AM",6227323232,CZ100012001,2152157,"May 21, 2026 11:32 AM","May 26, 2026 8:15 AM",AGE,Closed,4d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Unscheduled,"Apr 22, 2026 7:40 AM",6227323232,CZ100012001,2112413,"Apr 27, 2026 2:24 PM","May 5, 2026 11:25 AM","PSX, SCT, VST, AGE, ADT201",Closed,7d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Unscheduled,"Apr 22, 2026 7:40 AM",6227323232,CZ100012001,2126904,"May 6, 2026 12:02 PM","May 12, 2026 4:58 PM","SCT, VST, AGE",Closed,6d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Unscheduled,,6227323233,,2053482,"Mar 20, 2026 12:40 PM","Mar 27, 2026 9:58 AM",PCFCOM,Closed,6d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Induction Week 0,"Apr 8, 2026 7:10 AM",6228036554,CZ100012002,2089973,"Apr 13, 2026 3:26 PM","Apr 21, 2026 1:32 PM",AMT15602,Closed,7d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Biopsy,"May 13, 2026 12:00 AM",6228252073,CZ100012003,2147778,"May 19, 2026 10:13 AM","May 21, 2026 4:38 PM",VST,Closed,2d,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Induction Week 4,"May 6, 2026 8:05 AM",6227933142,CZ100012002,2134478,"May 11, 2026 2:54 PM","May 11, 2026 3:11 PM","AMT58660, AMT3542",Closed,16m,Matej Falc,matesfalc@seznam.cz,Investigator +CZ10001 - Dr. Matej Falc,CZECH REPUBLIC,Induction Week 12,"May 13, 2026 8:05 AM",6227933143,CZ100012001,2147202,"May 18, 2026 7:51 PM","May 19, 2026 8:38 AM",AMT58660,Closed,12h 47m,Matej Falc,matesfalc@seznam.cz,Investigator +title,value,,,,,,,,,,,,, +Search,,,,,,,,,,,,,, +Site,"930551, 930556, 930525, 930549, 930543, 930547, 930555, 930557, 930539, 930536, 930553, 930531",,,,,,,,,,,,, +Unresponded Only?,FALSE,,,,,,,,,,,,, +Posted,From - To - ,,,,,,,,,,,,, diff --git a/Covance_UCO3001/Source/2026-05-29_112244 sponsor-study-36940-activity-reports-documents-equery_unresponded_only.csv b/Covance_UCO3001/Source/2026-05-29_112244 sponsor-study-36940-activity-reports-documents-equery_unresponded_only.csv new file mode 100644 index 0000000..652a478 --- /dev/null +++ b/Covance_UCO3001/Source/2026-05-29_112244 sponsor-study-36940-activity-reports-documents-equery_unresponded_only.csv @@ -0,0 +1,9 @@ +Site,Country,Visit,Visit Collection Date,Accession,Subject,eQueryId,Create Date,Response Date Time,Issue Type,Status,Time Before Response,User Name,Email,Study Role +,,,,,,,,,,,,,, +,,,,,,,,,,,,,, +,,,,,,,,,,,,,, +title,value,,,,,,,,,,,,, +Search,,,,,,,,,,,,,, +Site,"930551, 930556, 930525, 930549, 930543, 930547, 930555, 930557, 930539, 930536, 930553, 930531",,,,,,,,,,,,, +Unresponded Only?,TRUE,,,,,,,,,,,,, +Posted,From - To - ,,,,,,,,,,,,, diff --git a/Covance_UCO3001/Source/2026-05-29_132515 sponsor-study-36940-test-results-930556-standard.csv b/Covance_UCO3001/Source/2026-05-29_132515 sponsor-study-36940-test-results-930556-standard.csv new file mode 100644 index 0000000..3271150 --- /dev/null +++ b/Covance_UCO3001/Source/2026-05-29_132515 sponsor-study-36940-test-results-930556-standard.csv @@ -0,0 +1,75 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,, +Subject,Subject Data Revision,Screen No.,Age,Age Unit,Gender,Visit,Visit Data Revision,Collected Time,Accession,Test Group,Test,Administrative Question,Value,Result Data Revision,Flags,Cancellation Reason,Comments,Range,Units +CZ100032001,,,,,Female,Biopsy,,"May 27, 2026 12:00 AM",6227323320,ANATOMICAL SITE,Anatomical Site,Y,15-20cm from anal verge,,,,,, +CZ100032001,,,,,Female,Biopsy,,"May 27, 2026 12:00 AM",6227323320,BIOPSY COLLECTION METHOD,Collection Method,Y,colonoscopy,,,,,, +CZ100032001,,,,,Female,Biopsy,,"May 27, 2026 12:00 AM",6227323320,BIOPSY FIXATIVE USED,Fixative Used,,10% NBF,,,,,, +CZ100032001,,,,,Female,Biopsy,,"May 27, 2026 12:00 AM",6227323320,DATE/TIME PLACED IN FORMALIN,Date Sample placed in Formalin,Y,27-May-2026,,,,,, +CZ100032001,,,,,Female,Biopsy,,"May 27, 2026 12:00 AM",6227323320,DATE/TIME PLACED IN FORMALIN,Time Sample placed in Formalin,Y,08:10,,,,,, +CZ100032001,,,,,Female,Biopsy,,"May 27, 2026 12:00 AM",6227323320,DIAGNOSIS,Diagnosis:,Y,Ulcerative Colitis,,,,,, +CZ100032001,,,,,Female,Biopsy,,"May 27, 2026 12:00 AM",6227323320,INFLAMED AREA,Inflamed area?,,Yes,,,,,, +CZ100032001,,,,,Female,Biopsy,,"May 27, 2026 12:00 AM",6227323320,TISSUE BIOPSY EMBEDDING1,Biopsy technical QC-CL,,Smpl meets HT requirements,,,,,, +CZ100032001,,,,,Female,Biopsy,,"May 27, 2026 12:00 AM",6227323320,TISSUE BIOPSY EMBEDDING1,Biopsy processing Time-CL,,,,,,,, +CZ100032001,,,,,Female,Biopsy,,"May 27, 2026 12:00 AM",6227323320,TISSUE BIOPSY EMBEDDING1,Biopsy processing Date-CL,,,,,,,, +CZ100032001,,,,,Female,Biopsy,,"May 27, 2026 12:00 AM",6227323320,TISSUE BIOPSY EMBEDDING1,Biopsy Comments-CL,,,,,,,, +CZ100032001,,,,,Female,Biopsy,,"May 27, 2026 12:00 AM",6227323320,TISSUE BIOPSY EMBEDDING1,# of Cassettes-(FI)-CL,,,,,,,, +CZ100032001,,,,,Female,Biopsy,,"May 27, 2026 12:00 AM",6227323320,ULCERATED AREA,Is biopsy site ulcerated?,,No,,,,,, +CZ100032001,,,,,Female,Stool Pathogens,,"May 13, 2026 9:30 AM",6227323309,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100032001,,,,,Female,Stool Pathogens,,"May 13, 2026 9:30 AM",6227323309,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100032001,,,,,Female,Stool Pathogens,,"May 13, 2026 9:30 AM",6227323309,OVA AND PARASITES 1,Concentrate Exam,,No ova or parasites found,,,,,, +CZ100032001,,,,,Female,Stool Pathogens,,"May 13, 2026 9:30 AM",6227323309,OVA AND PARASITES 1,Smear for Microsporidia,,No Microsporidia seen.,,,,,, +CZ100032001,,,,,Female,Stool Pathogens,,"May 13, 2026 9:30 AM",6227323309,OVA AND PARASITES 1,Modified acid-fast stain,,No coccidian parasites seen,,,,,, +CZ100032001,,,,,Female,Stool Pathogens,,"May 13, 2026 9:30 AM",6227323309,OVA AND PARASITES 2,Trichrome Smear,,,,,Test group cancelled: Specimen received in expired coll. container; unable to perform test.,,, +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.1,,,,,0 - 6.2,umol/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,Alkaline Phosphatase,,85,,,,,35 - 104,U/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,ALT (SGPT),,9,,,,,4 - 43,U/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,AST (SGOT),,11,,,,,8 - 40,U/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,GGT,,9,,,,,4 - 49,U/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,LDH,,128,,,,,53 - 234,U/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,Urea Nitrogen,,4.0,,,,,1.4 - 8.6,mmol/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,75,,,,,31 - 101,umol/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,Serum Glucose,,4.8,,,,,3.9 - 5.6,mmol/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,Serum Uric Acid,,192,,,,,125 - 428,umol/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,Calcium (EDTA),,2.24,,,,,2.07 - 2.64,mmol/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,Phosphorus,,1.00,,,,,0.71 - 1.65,mmol/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,Total Protein,,71,,,,,61 - 84,g/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,Creatine Kinase,,85,,,,,26 - 192,U/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,Serum Potassium,,4.1,,,,,3.5 - 5.2,mmol/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,Serum Bicarbonate,,23.8,,,,,19.3 - 29.3,mmol/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CHEMISTRY PANEL,Magnesium,,0.79,,,,,0.66 - 1.07,mmol/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,94,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,Yes,,,,,, +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,114,,L,,,116 - 164,g/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.36,,,,,0.34 - 0.48, +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.1,,,,,4.1 - 5.6,TI/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,28,,,,,26 - 34,pg +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,87,,,,,79 - 98,fL +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,8.80,,,,,3.8 - 10.7,GI/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,6.53,,,,,1.96 - 7.23,GI/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.32,,,,,0.91 - 4.28,GI/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.47,,,,,0.12 - 0.92,GI/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.44,,,,,0 - 0.57,GI/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,,0 - 0.2,GI/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,74.2,,,,,40.5 - 75,% +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,15.0,,L,,,15.4 - 48.5,% +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.4,,,,,2.6 - 10.1,% +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,5.0,,,,,0 - 6.8,% +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,513,,H,,,140 - 400,GI/L +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEPATITIS B SURFACE AB,Anti-HBs II QUAL,,Reactive,,,,,Ref Rng :$Non Reactive, +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Negative,,,,,Normal=Negative, +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,SERUM BETA HCG,"B-hCG, Qualitative",,Negative,,,,,Ref Rng: Negative, +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,SERUM BETA HCG,"B-hCG, Quantitative",,<0.6,,,,,Units: mIU/mL$Pre-menopausal$<5.0: Negative$5.0-24.9:Borderline$>/= 25.0: Positive, +CZ100032001,,,,,Female,Screening,,"May 13, 2026 8:15 AM",6227323299,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, diff --git a/Covance_UCO3001/Source/2026-05-29_132533 sponsor-study-36940-test-results-930556-microbiology.csv b/Covance_UCO3001/Source/2026-05-29_132533 sponsor-study-36940-test-results-930556-microbiology.csv new file mode 100644 index 0000000..fba7493 --- /dev/null +++ b/Covance_UCO3001/Source/2026-05-29_132533 sponsor-study-36940-test-results-930556-microbiology.csv @@ -0,0 +1,3 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,,,,,, +Subject,Screening Number,Age,Age Unit,Gender,Visit Description,Collected Time,Accession,Test Group,Specimen,Organism,Growth,Cancellation Reason,Test Description,Test Result,Drug Name/Agent,MIC Result,Units,MIC Interpretation,Disk Diffusion Result,Disk Diffusion Interpretation,Subject Data Revision,Visit Data Revision,Result Data Revision +CZ100032001 - null,,,,Female,SCRNSTOOL Stool Pathogens,"May 13, 2026 9:30 AM",6227323309,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,, diff --git a/Covance_UCO3001/Source/2026-05-29_132552 sponsor-study-36940-test-results-930525-standard.csv b/Covance_UCO3001/Source/2026-05-29_132552 sponsor-study-36940-test-results-930525-standard.csv new file mode 100644 index 0000000..65d2d3f --- /dev/null +++ b/Covance_UCO3001/Source/2026-05-29_132552 sponsor-study-36940-test-results-930525-standard.csv @@ -0,0 +1,709 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,, +Subject,Subject Data Revision,Screen No.,Age,Age Unit,Gender,Visit,Visit Data Revision,Collected Time,Accession,Test Group,Test,Administrative Question,Value,Result Data Revision,Flags,Cancellation Reason,Comments,Range,Units +CZ100222003,,,,,Male,Biopsy,,"May 20, 2026 12:00 AM",6228179945,ANATOMICAL SITE,Anatomical Site,Y,15-20cm from anal verge,,,,,, +CZ100222003,,,,,Male,Biopsy,,"May 20, 2026 12:00 AM",6228179945,BIOPSY COLLECTION METHOD,Collection Method,Y,colonoscopy,,,,,, +CZ100222003,,,,,Male,Biopsy,,"May 20, 2026 12:00 AM",6228179945,BIOPSY FIXATIVE USED,Fixative Used,,10% NBF,,,,,, +CZ100222003,,,,,Male,Biopsy,,"May 20, 2026 12:00 AM",6228179945,DATE/TIME PLACED IN FORMALIN,Date Sample placed in Formalin,Y,20-May-2026,,,,,, +CZ100222003,,,,,Male,Biopsy,,"May 20, 2026 12:00 AM",6228179945,DATE/TIME PLACED IN FORMALIN,Time Sample placed in Formalin,Y,11:44,,,,,, +CZ100222003,,,,,Male,Biopsy,,"May 20, 2026 12:00 AM",6228179945,DIAGNOSIS,Diagnosis:,Y,Ulcerative Colitis,,,,,, +CZ100222003,,,,,Male,Biopsy,,"May 20, 2026 12:00 AM",6228179945,INFLAMED AREA,Inflamed area?,,Yes,,,,,, +CZ100222003,,,,,Male,Biopsy,,"May 20, 2026 12:00 AM",6228179945,TISSUE BIOPSY EMBEDDING1,Biopsy technical QC-CL,,Smpl meets HT requirements,,,,,, +CZ100222003,,,,,Male,Biopsy,,"May 20, 2026 12:00 AM",6228179945,TISSUE BIOPSY EMBEDDING1,Biopsy processing Time-CL,,10:00,,,,,, +CZ100222003,,,,,Male,Biopsy,,"May 20, 2026 12:00 AM",6228179945,TISSUE BIOPSY EMBEDDING1,Biopsy processing Date-CL,,22-May-2026,,,,,, +CZ100222003,,,,,Male,Biopsy,,"May 20, 2026 12:00 AM",6228179945,TISSUE BIOPSY EMBEDDING1,Biopsy Comments-CL,,Received in 10% NBF,,,,,, +CZ100222003,,,,,Male,Biopsy,,"May 20, 2026 12:00 AM",6228179945,TISSUE BIOPSY EMBEDDING1,# of Cassettes-(FI)-CL,,1,,,,,, +CZ100222003,,,,,Male,Biopsy,,"May 20, 2026 12:00 AM",6228179945,ULCERATED AREA,Is biopsy site ulcerated?,,Yes,,,,,, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,ALP<2XULN,ALP<2XULN,,Criteria Met,,,,,, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,ALT>/=3XULN,ALT >/= 3 X ULN,,Criteria not met,,,,,, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,ALT>/=3XULN & TBIL>/=2XULN,ALT >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,AST>/=3XULN,AST >/= 3 X ULN,,Criteria not met,,,,,, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,AST>/=3XULN & TBIL>/=2XULN,AST >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,Total Bilirubin,,11,,,,,3 - 21,umol/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.5,,,,,0 - 6.2,umol/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,Alkaline Phosphatase,,68,,,,,40 - 129,U/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,ALT (SGPT),,10,,,,,5 - 48,U/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,AST (SGOT),,17,,,,,8 - 40,U/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,GGT,,10,,,,,10 - 61,U/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,LDH,,164,,,,,53 - 234,U/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,Urea Nitrogen,,5.1,,,,,1.4 - 8.6,mmol/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,101,,,,,40 - 110,umol/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,Serum Glucose,,4.4,,,,,3.9 - 5.6,mmol/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,Serum Uric Acid,,255,,,,,125 - 488,umol/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,Calcium (EDTA),,2.45,,,,,2.07 - 2.64,mmol/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,Phosphorus,,1.10,,,,,0.71 - 1.65,mmol/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,Total Protein,,66,,,,,61 - 84,g/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,Albumin-BCG,,43,,,,,33 - 49,g/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,Creatine Kinase,,131,,,,,39 - 308,U/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,Serum Sodium,,142,,,,,132 - 147,mmol/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,Serum Potassium,,4.5,,,,,3.5 - 5.2,mmol/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,Serum Bicarbonate,,25.4,,,,,19.3 - 29.3,mmol/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,Serum Chloride,,105,,,,,94 - 112,mmol/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CHEMISTRY PANEL,Magnesium,,0.82,,,,,0.66 - 1.07,mmol/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,87,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,FECAL COLLECTION D/T,Stool Collection Date,Y,05-May-2026,,,,,, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,FECAL COLLECTION D/T,Stool Collection Time,Y,06:40,,,,,, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,145,,,,,127 - 181,g/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.42,,,,,0.39 - 0.54, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.8,,,,,4.5 - 6.4,TI/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,30,,,,,26 - 34,pg +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,88,,,,,79 - 96,fL +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.72,,,,,3.8 - 10.7,GI/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.17,,,,,1.96 - 7.23,GI/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.71,,,,,0.91 - 4.28,GI/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.36,,,,,0.12 - 0.92,GI/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.44,,,,,0 - 0.57,GI/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,55.4,,,,,40.5 - 75,% +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,30.0,,,,,15.4 - 48.5,% +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.3,,,,,2.6 - 10.1,% +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,7.7,,H,,,0 - 6.8,% +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.6,,,,,0 - 2,% +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,294,,,,,140 - 400,GI/L +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,05-May-2026,,,,,, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,07:40,,,,,, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,05-May-2026,,,,,, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,08:50,,,,,, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,05-May-2026,,,,,, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,07:40,,,,,, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,SM09/STOOL PK COLL D/T,Stool Collection Date,Y,05-May-2026,,,,,, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,SM09/STOOL PK COLL D/T,Stool Collection Time,Y,06:40,,,,,, +CZ100222005,,,,,Male,Induction Week 4,,"May 5, 2026 7:40 AM",6228179936,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,ALP<2XULN,ALP<2XULN,,Criteria Met,,,,,, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,ALT>/=3XULN,ALT >/= 3 X ULN,,Criteria not met,,,,,, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,ALT>/=3XULN & TBIL>/=2XULN,ALT >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,AST>/=3XULN,AST >/= 3 X ULN,,Criteria not met,,,,,, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,AST>/=3XULN & TBIL>/=2XULN,AST >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,Total Bilirubin,,4,,,,,3 - 21,umol/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.1,,,,,0 - 6.2,umol/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,Alkaline Phosphatase,,65,,,,,40 - 129,U/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,ALT (SGPT),,7,,,,,5 - 48,U/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,AST (SGOT),,17,,,,,8 - 40,U/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,GGT,,7,,L,,,10 - 61,U/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,LDH,,147,,,,,53 - 234,U/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,Urea Nitrogen,,5.2,,,,,1.4 - 8.6,mmol/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,88,,,,,40 - 110,umol/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,Serum Glucose,,4.5,,,,,3.9 - 5.6,mmol/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,Serum Uric Acid,,261,,,,,125 - 488,umol/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,Calcium (EDTA),,2.31,,,,,2.07 - 2.64,mmol/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,Phosphorus,,1.13,,,,,0.71 - 1.65,mmol/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,Total Protein,,65,,,,,61 - 84,g/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,Albumin-BCG,,41,,,,,33 - 49,g/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,Creatine Kinase,,112,,,,,39 - 308,U/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,Serum Potassium,,4.0,,,,,3.5 - 5.2,mmol/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,Serum Bicarbonate,,23.2,,,,,19.3 - 29.3,mmol/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CHEMISTRY PANEL,Magnesium,,0.76,,,,,0.66 - 1.07,mmol/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,102,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,FECAL COLLECTION D/T,Stool Collection Date,Y,22-Apr-2026,,,,,, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,FECAL COLLECTION D/T,Stool Collection Time,Y,05:40,,,,,, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,143,,,,,127 - 181,g/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.41,,,,,0.39 - 0.54, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.8,,,,,4.5 - 6.4,TI/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,30,,,,,26 - 34,pg +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,86,,,,,79 - 96,fL +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.68,,,,,3.8 - 10.7,GI/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.92,,,,,1.96 - 7.23,GI/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.94,,,,,0.91 - 4.28,GI/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.39,,,,,0.12 - 0.92,GI/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.40,,,,,0 - 0.57,GI/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,58.7,,,,,40.5 - 75,% +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,29.0,,,,,15.4 - 48.5,% +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.9,,,,,2.6 - 10.1,% +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,5.9,,,,,0 - 6.8,% +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,308,,,,,140 - 400,GI/L +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,22-Apr-2026,,,,,, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,14:15,,,,,, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,22-Apr-2026,,,,,, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,15:25,,,,,, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,22-Apr-2026,,,,,, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,14:15,,,,,, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,SM09/STOOL PK COLL D/T,Stool Collection Date,Y,22-Apr-2026,,,,,, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,SM09/STOOL PK COLL D/T,Stool Collection Time,Y,05:40,,,,,, +CZ100222005,,,,,Male,Induction Week 2,,"Apr 22, 2026 2:15 PM",6228179932,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,Total Bilirubin,,8,,,,,3 - 21,umol/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,4.2,,,,,0 - 6.2,umol/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,Alkaline Phosphatase,,71,,,,,40 - 129,U/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,ALT (SGPT),,7,,,,,5 - 48,U/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,AST (SGOT),,16,,,,,8 - 40,U/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,GGT,,7,,L,,,10 - 61,U/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,LDH,,153,,,,,53 - 234,U/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,Urea Nitrogen,,4.9,,,,,1.4 - 8.6,mmol/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,86,,,,,40 - 110,umol/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,Serum Glucose,,4.2,,,,,3.9 - 5.6,mmol/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,Serum Uric Acid,,299,,,,,125 - 488,umol/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,Calcium (EDTA),,2.35,,,,,2.07 - 2.64,mmol/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,Phosphorus,,1.05,,,,,0.71 - 1.65,mmol/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,Total Protein,,68,,,,,61 - 84,g/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,Albumin-BCG,,43,,,,,33 - 49,g/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,Creatine Kinase,,116,,,,,39 - 308,U/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,Serum Sodium,,141,,,,,132 - 147,mmol/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,Serum Potassium,,4.1,,,,,3.5 - 5.2,mmol/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,Serum Bicarbonate,,23.9,,,,,19.3 - 29.3,mmol/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CHEMISTRY PANEL,Magnesium,,0.80,,,,,0.66 - 1.07,mmol/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,106,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,FECAL COLLECTION D/T,Stool Collection Date,Y,09-Apr-2026,,,,,, +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,FECAL COLLECTION D/T,Stool Collection Time,Y,05:55,,,,,, +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,146,,,,,127 - 181,g/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.43,,,,,0.39 - 0.54, +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.9,,,,,4.5 - 6.4,TI/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,30,,,,,26 - 34,pg +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,88,,,,,79 - 96,fL +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.07,,,,,3.8 - 10.7,GI/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.83,,,,,1.96 - 7.23,GI/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.67,,,,,0.91 - 4.28,GI/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.32,,,,,0.12 - 0.92,GI/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.19,,,,,0 - 0.57,GI/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,63.1,,,,,40.5 - 75,% +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,27.6,,,,,15.4 - 48.5,% +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.2,,,,,2.6 - 10.1,% +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.2,,,,,0 - 6.8,% +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.8,,,,,0 - 2,% +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,314,,,,,140 - 400,GI/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,LIPID PANEL,Direct HDL-C 4th Generation,,1.90,,H,,,1.03 - 1.53,mmol/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,LIPID PANEL,Triglycerides (GPO),,0.43,,L,,,0.56 - 3.62,mmol/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,LIPID PANEL,Cholesterol (High Performance),,3.22,,L,,,3.88 - 6.83,mmol/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,LIPID PANEL,LDL Chol Friedewald 4th,,1.12,,,,,0 - 3.34,mmol/L +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,09-Apr-2026,,,,,, +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,10:35,,,,,, +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,09-Apr-2026,,,,,, +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,11:45,,,,,, +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,09-Apr-2026,,,,,, +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,10:35,,,,,, +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,SM10/FECAL BMRKS COLL D/T,Stool Collection Date,Y,09-Apr-2026,,,,,, +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,SM10/FECAL BMRKS COLL D/T,Stool Collection Time,Y,05:55,,,,,, +CZ100222005,,,,,Male,Induction Week 0,,"Apr 9, 2026 10:35 AM",6228173397,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,ALP<2XULN,ALP<2XULN,,Criteria Met,,,,,, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,ALT>/=3XULN,ALT >/= 3 X ULN,,Criteria not met,,,,,, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,ALT>/=3XULN & TBIL>/=2XULN,ALT >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,AST>/=3XULN,AST >/= 3 X ULN,,Criteria not met,,,,,, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,AST>/=3XULN & TBIL>/=2XULN,AST >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,Total Bilirubin,,10,,,,,3 - 21,umol/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.9,,,,,0 - 6.2,umol/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,Alkaline Phosphatase,,64,,,,,40 - 129,U/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,ALT (SGPT),,42,,,,,5 - 48,U/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,AST (SGOT),,31,,,,,8 - 40,U/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,GGT,,24,,,,,10 - 61,U/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,LDH,,225,,,,,53 - 234,U/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,Urea Nitrogen,,10.1,,H,,,1.4 - 8.6,mmol/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,110,,,,,40 - 110,umol/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,Serum Glucose,,4.6,,,,,3.9 - 5.6,mmol/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,Serum Uric Acid,,455,,,,,125 - 488,umol/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,Calcium (EDTA),,2.42,,,,,2.07 - 2.64,mmol/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,Phosphorus,,1.20,,,,,0.71 - 1.65,mmol/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,Total Protein,,72,,,,,61 - 84,g/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,Creatine Kinase,,367,,H,,,39 - 308,U/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,Serum Bicarbonate,,24.7,,,,,19.3 - 29.3,mmol/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CHEMISTRY PANEL,Magnesium,,0.77,,,,,0.66 - 1.07,mmol/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,76,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,FECAL COLLECTION D/T,Stool Collection Date,Y,08-Apr-2026,,,,,, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,FECAL COLLECTION D/T,Stool Collection Time,Y,05:15,,,,,, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,135,,,,,127 - 181,g/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.39,,,,,0.39 - 0.54, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.6,,,,,4.5 - 6.4,TI/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,29,,,,,26 - 34,pg +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,85,,,,,79 - 96,fL +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.70,,,,,3.8 - 10.7,GI/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.33,,,,,1.96 - 7.23,GI/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.26,,,,,0.91 - 4.28,GI/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.40,,,,,0.12 - 0.92,GI/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.67,R,H,,,0 - 0.57,GI/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,40.8,,,,,40.5 - 75,% +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,39.6,,,,,15.4 - 48.5,% +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.0,,,,,2.6 - 10.1,% +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,11.7,R,H,,,0 - 6.8,% +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.9,,,,,0 - 2,% +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,282,,,,,140 - 400,GI/L +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,08-Apr-2026,,,,,, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,08:05,,,,,, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,08-Apr-2026,,,,,, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,09:15,,,,,, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,08-Apr-2026,,,,,, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,08:05,,,,,, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,SM09/STOOL PK COLL D/T,Stool Collection Date,Y,08-Apr-2026,,,,,, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,SM09/STOOL PK COLL D/T,Stool Collection Time,Y,05:15,,,,,, +CZ100222003,,,,,Male,Induction Week 4,,"Apr 8, 2026 8:05 AM",6227323274,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100222005,,,,,Male,Biopsy,,"Apr 1, 2026 12:00 AM",6228023951,ANATOMICAL SITE,Anatomical Site,Y,15-20cm from anal verge,,,,,, +CZ100222005,,,,,Male,Biopsy,,"Apr 1, 2026 12:00 AM",6228023951,BIOPSY COLLECTION METHOD,Collection Method,Y,colonoscopy,,,,,, +CZ100222005,,,,,Male,Biopsy,,"Apr 1, 2026 12:00 AM",6228023951,BIOPSY FIXATIVE USED,Fixative Used,,10% NBF,,,,,, +CZ100222005,,,,,Male,Biopsy,,"Apr 1, 2026 12:00 AM",6228023951,DATE/TIME PLACED IN FORMALIN,Date Sample placed in Formalin,Y,01-Apr-2026,,,,,, +CZ100222005,,,,,Male,Biopsy,,"Apr 1, 2026 12:00 AM",6228023951,DATE/TIME PLACED IN FORMALIN,Time Sample placed in Formalin,Y,08:46,,,,,, +CZ100222005,,,,,Male,Biopsy,,"Apr 1, 2026 12:00 AM",6228023951,DIAGNOSIS,Diagnosis:,Y,Ulcerative Colitis,,,,,, +CZ100222005,,,,,Male,Biopsy,,"Apr 1, 2026 12:00 AM",6228023951,INFLAMED AREA,Inflamed area?,,Yes,,,,,, +CZ100222005,,,,,Male,Biopsy,,"Apr 1, 2026 12:00 AM",6228023951,TISSUE BIOPSY EMBEDDING1,Biopsy technical QC-CL,,Smpl meets HT requirements,,,,,, +CZ100222005,,,,,Male,Biopsy,,"Apr 1, 2026 12:00 AM",6228023951,TISSUE BIOPSY EMBEDDING1,Biopsy processing Time-CL,,10:00,,,,,, +CZ100222005,,,,,Male,Biopsy,,"Apr 1, 2026 12:00 AM",6228023951,TISSUE BIOPSY EMBEDDING1,Biopsy processing Date-CL,,03-Apr-2026,,,,,, +CZ100222005,,,,,Male,Biopsy,,"Apr 1, 2026 12:00 AM",6228023951,TISSUE BIOPSY EMBEDDING1,Biopsy Comments-CL,,Received in 10% NBF,,,,,, +CZ100222005,,,,,Male,Biopsy,,"Apr 1, 2026 12:00 AM",6228023951,TISSUE BIOPSY EMBEDDING1,# of Cassettes-(FI)-CL,,1,,,,,, +CZ100222005,,,,,Male,Biopsy,,"Apr 1, 2026 12:00 AM",6228023951,ULCERATED AREA,Is biopsy site ulcerated?,,No,,,,,, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,ALP<2XULN,ALP<2XULN,,Criteria Met,,,,,, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,ALT>/=3XULN,ALT >/= 3 X ULN,,Criteria not met,,,,,, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,ALT>/=3XULN & TBIL>/=2XULN,ALT >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,AST>/=3XULN,AST >/= 3 X ULN,,Criteria not met,,,,,, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,AST>/=3XULN & TBIL>/=2XULN,AST >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,Total Bilirubin,,4,,,,,3 - 21,umol/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,<1.4,,,,,0 - 6.2,umol/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,Alkaline Phosphatase,,58,,,,,40 - 129,U/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,ALT (SGPT),,26,,,,,5 - 48,U/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,AST (SGOT),,24,,,,,8 - 40,U/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,GGT,,14,,,,,10 - 61,U/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,LDH,,170,,,,,53 - 234,U/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,Urea Nitrogen,,9.4,R,H,,,1.4 - 8.6,mmol/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,104,,,,,40 - 110,umol/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,Serum Glucose,,4.7,,,,,3.9 - 5.6,mmol/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,Serum Uric Acid,,353,,,,,125 - 488,umol/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,Calcium (EDTA),,2.36,,,,,2.07 - 2.64,mmol/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,Phosphorus,,1.32,,,,,0.71 - 1.65,mmol/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,Total Protein,,68,,,,,61 - 84,g/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,Albumin-BCG,,42,,,,,33 - 49,g/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,Creatine Kinase,,167,,,,,39 - 308,U/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,Serum Sodium,,141,,,,,132 - 147,mmol/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,Serum Bicarbonate,,23.9,,,,,19.3 - 29.3,mmol/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,Serum Chloride,,105,,,,,94 - 112,mmol/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CHEMISTRY PANEL,Magnesium,,0.73,,,,,0.66 - 1.07,mmol/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,80,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,FECAL COLLECTION D/T,Stool Collection Date,Y,27-Mar-2026,,,,,, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,FECAL COLLECTION D/T,Stool Collection Time,Y,05:40,,,,,, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,133,,,,,127 - 181,g/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.39,,,,,0.39 - 0.54, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.5,,,,,4.5 - 6.4,TI/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,29,,,,,26 - 34,pg +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,86,,,,,79 - 96,fL +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.92,,,,,3.8 - 10.7,GI/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.29,,,,,1.96 - 7.23,GI/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.57,,,,,0.91 - 4.28,GI/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.41,,,,,0.12 - 0.92,GI/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.61,R,H,,,0 - 0.57,GI/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,,0 - 0.2,GI/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,38.7,R,L,,,40.5 - 75,% +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,43.4,,,,,15.4 - 48.5,% +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.9,,,,,2.6 - 10.1,% +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,10.3,R,H,,,0 - 6.8,% +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.7,,,,,0 - 2,% +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,252,,,,,140 - 400,GI/L +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,27-Mar-2026,,,,,, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,07:10,,,,,, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,27-Mar-2026,,,,,, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,08:20,,,,,, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,27-Mar-2026,,,,,, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,07:10,,,,,, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,SM09/STOOL PK COLL D/T,Stool Collection Date,Y,27-Mar-2026,,,,,, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,SM09/STOOL PK COLL D/T,Stool Collection Time,Y,05:40,,,,,, +CZ100222003,,,,,Male,Induction Week 2,,"Mar 27, 2026 7:10 AM",6227323272,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,Total Bilirubin,,3,,,,Result verified by repeat analysis,3 - 21,umol/L +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,<1.4,,,,Result verified by repeat analysis,0 - 6.2,umol/L +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,Alkaline Phosphatase,,85,,,,,40 - 129,U/L +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,ALT (SGPT),,20,,,,,5 - 48,U/L +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,AST (SGOT),,15,,,,,8 - 40,U/L +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,GGT,,19,,,,,10 - 50,U/L +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,LDH,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,Urea Nitrogen,,5.5,,,,,1.4 - 8.6,mmol/L +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,108,,,,,40 - 119,umol/L +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,Serum Glucose,,4.9,,,,,3.9 - 5.6,mmol/L +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,Serum Uric Acid,,429,,,,,149 - 494,umol/L +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,Calcium (EDTA),,2.07,,,,,2.07 - 2.64,mmol/L +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,Phosphorus,,1.02,,,,,0.71 - 1.65,mmol/L +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,Total Protein,,55,,L,,,60 - 80,g/L +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,Albumin-BCG,,35,,,,,33 - 49,g/L +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,Creatine Kinase,,49,,,,,39 - 308,U/L +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,Serum Sodium,,148,,H,,,135 - 145,mmol/L +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,Serum Potassium,,4.0,,,,,3.5 - 5.2,mmol/L +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,Serum Bicarbonate,,24.4,,,,,19.3 - 29.3,mmol/L +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,Serum Chloride,,110,,,,,94 - 112,mmol/L +CZ100222004,,,,,Male,Unscheduled,R,"Mar 13, 2026 8:40 AM",6227323295,CHEMISTRY PANEL,Magnesium,,0.82,,,,,0.66 - 0.98,mmol/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,Total Bilirubin,,9,,,,,3 - 21,umol/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.2,,,,,0 - 6.2,umol/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,Alkaline Phosphatase,,73,,,,,40 - 129,U/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,ALT (SGPT),,5,,,,,5 - 48,U/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,AST (SGOT),,15,,,,,8 - 40,U/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,GGT,,6,R,L,,,10 - 61,U/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,LDH,,149,,,,,53 - 234,U/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,Urea Nitrogen,,3.8,,,,,1.4 - 8.6,mmol/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,91,,,,,40 - 110,umol/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,Serum Glucose,,4.6,,,,,3.9 - 5.6,mmol/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,Serum Uric Acid,,277,,,,,125 - 488,umol/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,Calcium (EDTA),,2.42,,,,,2.07 - 2.64,mmol/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,Phosphorus,,1.23,,,,,0.71 - 1.65,mmol/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,Total Protein,,68,,,,,61 - 84,g/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,Creatine Kinase,,119,,,,,39 - 308,U/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,Serum Potassium,,4.7,,,,,3.5 - 5.2,mmol/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,Serum Bicarbonate,,27.4,,,,,19.3 - 29.3,mmol/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100222005,,,,,Male,Unscheduled,R,"Mar 13, 2026 7:45 AM",6227323297,CHEMISTRY PANEL,Magnesium,,0.81,,,,,0.66 - 1.07,mmol/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.7,,,,,0 - 6.2,umol/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,Alkaline Phosphatase,,91,,,,,40 - 129,U/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,ALT (SGPT),,79,R,H,,,5 - 48,U/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,AST (SGOT),,51,R,H,,,8 - 40,U/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,GGT,,45,,,,,10 - 61,U/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,LDH,,228,,,,,53 - 234,U/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,Urea Nitrogen,,8.3,,,,,1.4 - 8.6,mmol/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,106,,,,,40 - 110,umol/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,Serum Glucose,,4.4,,,,,3.9 - 5.6,mmol/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,Serum Uric Acid,,418,,,,,125 - 488,umol/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,Calcium (EDTA),,2.32,,,,,2.07 - 2.64,mmol/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,Phosphorus,,1.10,,,,,0.71 - 1.65,mmol/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,Total Protein,,68,,,,,61 - 84,g/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,Albumin-BCG,,41,,,,,33 - 49,g/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,Creatine Kinase,,250,,,,,39 - 308,U/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,Serum Potassium,,4.5,,,,,3.5 - 5.2,mmol/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,Serum Bicarbonate,,25.4,,,,,19.3 - 29.3,mmol/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CHEMISTRY PANEL,Magnesium,,0.73,,,,,0.66 - 1.07,mmol/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,79,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,FECAL COLLECTION D/T,Stool Collection Date,Y,09-Mar-2026,,,,,, +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,FECAL COLLECTION D/T,Stool Collection Time,Y,08:55,,,,,, +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,134,,,,,127 - 181,g/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.39,,,,,0.39 - 0.54, +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.5,,,,,4.5 - 6.4,TI/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,30,,,,,26 - 34,pg +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,Normocytic,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,87,,,,,79 - 96,fL +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.70,,,,,3.8 - 10.7,GI/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.17,,,,,1.96 - 7.23,GI/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.01,,,,,0.91 - 4.28,GI/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.39,,,,,0.12 - 0.92,GI/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,1.08,R,H,,,0 - 0.57,GI/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,47.4,,,,,40.5 - 75,% +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,29.9,,,,,15.4 - 48.5,% +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.8,,,,,2.6 - 10.1,% +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,16.1,R,H,,,0 - 6.8,% +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.8,,,,,0 - 2,% +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,262,,,,,140 - 400,GI/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,LIPID PANEL,Direct HDL-C 4th Generation,,1.13,,,,,1.03 - 1.53,mmol/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,LIPID PANEL,Triglycerides (GPO),,0.84,,,,,0.56 - 3.62,mmol/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,LIPID PANEL,Cholesterol (High Performance),,5.14,,,,,3.88 - 6.83,mmol/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,LIPID PANEL,LDL Chol Friedewald 4th,,3.63,,H,,,0 - 3.34,mmol/L +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,09-Mar-2026,,,,,, +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,08:50,,,,,, +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,09-Mar-2026,,,,,, +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,10:05,,,,,, +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,09-Mar-2026,,,,,, +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,08:50,,,,,, +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,SM10/FECAL BMRKS COLL D/T,Stool Collection Date,Y,09-Mar-2026,,,,,, +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,SM10/FECAL BMRKS COLL D/T,Stool Collection Time,Y,08:55,,,,,, +CZ100222003,,,,,Male,Induction Week 0,,"Mar 9, 2026 8:50 AM",6227323270,SUBJECT HEIGHT (CM),Height (cm),Y,190,,,,,cm, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,Total Bilirubin,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,Alkaline Phosphatase,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,ALT (SGPT),,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,AST (SGOT),,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,GGT,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,LDH,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,Urea Nitrogen,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,Serum Glucose,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,Serum Uric Acid,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,Calcium (EDTA),,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,Phosphorus,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,Total Protein,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,Albumin-BCG,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,Creatine Kinase,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,Serum Sodium,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,Serum Potassium,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,Serum Bicarbonate,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,Serum Chloride,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,CHEMISTRY PANEL,Magnesium,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,148,,,,,127 - 181,g/L +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.44,,,,,0.39 - 0.54, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.9,,,,,4.5 - 6.4,TI/L +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,30,,,,,26 - 34,pg +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,89,,,,,79 - 96,fL +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.67,,,,,3.8 - 10.7,GI/L +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.96,,,,,1.96 - 7.23,GI/L +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.68,,,,,0.91 - 4.28,GI/L +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.51,,,,,0.12 - 0.92,GI/L +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.42,,,,,0 - 0.57,GI/L +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.10,,,,,0 - 0.2,GI/L +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,59.3,,,,,40.5 - 75,% +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,25.2,,,,,15.4 - 48.5,% +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.7,,,,,2.6 - 10.1,% +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,6.3,,,,,0 - 6.8,% +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.5,,,,,0 - 2,% +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,341,,,,,140 - 400,GI/L +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEPATITIS B SURFACE AB,Anti-HBs II QUAL,,Reactive,,,,,Ref Rng :$Non Reactive, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Negative,,,,,Normal=Negative, +CZ100222005,,,,,Male,Screening,,"Mar 4, 2026 9:20 AM",6227810900,SUBJECT HEIGHT (CM),Height (cm),Y,188,,,,,cm, +CZ100222005,,,,,Male,Stool Pathogens,,"Mar 4, 2026 9:10 AM",6227810904,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100222005,,,,,Male,Stool Pathogens,,"Mar 4, 2026 9:10 AM",6227810904,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100222005,,,,,Male,Stool Pathogens,,"Mar 4, 2026 9:10 AM",6227810904,OVA AND PARASITES 1,Concentrate Exam,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Stool Pathogens,,"Mar 4, 2026 9:10 AM",6227810904,OVA AND PARASITES 1,Smear for Microsporidia,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Stool Pathogens,,"Mar 4, 2026 9:10 AM",6227810904,OVA AND PARASITES 1,Modified acid-fast stain,,,,,Test group cancelled: No specimen received,,, +CZ100222005,,,,,Male,Stool Pathogens,,"Mar 4, 2026 9:10 AM",6227810904,OVA AND PARASITES 2,Trichrome Smear,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Stool Pathogens,,"Mar 3, 2026 12:20 PM",6227810905,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100222004,,,,,Male,Stool Pathogens,,"Mar 3, 2026 12:20 PM",6227810905,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100222004,,,,,Male,Stool Pathogens,,"Mar 3, 2026 12:20 PM",6227810905,OVA AND PARASITES 1,Concentrate Exam,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Stool Pathogens,,"Mar 3, 2026 12:20 PM",6227810905,OVA AND PARASITES 1,Smear for Microsporidia,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Stool Pathogens,,"Mar 3, 2026 12:20 PM",6227810905,OVA AND PARASITES 1,Modified acid-fast stain,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Stool Pathogens,,"Mar 3, 2026 12:20 PM",6227810905,OVA AND PARASITES 2,Trichrome Smear,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,Total Bilirubin,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,Alkaline Phosphatase,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,ALT (SGPT),,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,AST (SGOT),,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,GGT,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,LDH,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,Urea Nitrogen,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,Serum Glucose,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,Serum Uric Acid,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,Calcium (EDTA),,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,Phosphorus,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,Total Protein,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,Albumin-BCG,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,Creatine Kinase,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,Serum Sodium,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,Serum Potassium,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,Serum Bicarbonate,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,Serum Chloride,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CHEMISTRY PANEL,Magnesium,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,,,,Test group cancelled: No specimen received,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,91,,L,,,125 - 170,g/L +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.31,,L,,,0.37 - 0.51, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,3.7,,L,,,4 - 5.8,TI/L +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,25,,L,,,26 - 34,pg +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,86,,,,,80 - 100,fL +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,11.98,,H,,,3.8 - 10.7,GI/L +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,9.38,,H,,,1.96 - 7.23,GI/L +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.49,,,,,0.8 - 3,GI/L +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.88,,,,,0.12 - 0.92,GI/L +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.18,,,,,0 - 0.57,GI/L +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,78.4,,H,,,40.5 - 75,% +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,12.4,,L,,,15.4 - 48.5,% +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.3,,,,,2.6 - 10.1,% +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.5,,,,,0 - 6.8,% +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.4,,,,,0 - 2,% +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,465,,H,,,130 - 394,GI/L +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEPATITIS B SURFACE AB,Anti-HBs II QUAL,,Non-Reactive,,,,,Ref Rng :$Non Reactive, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Negative,,,,,Normal=Negative, +CZ100222004,,,,,Male,Screening,,"Mar 3, 2026 12:10 PM",6227810901,SUBJECT HEIGHT (CM),Height (cm),Y,158,,,,,cm, +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.9,,,,,0 - 6.2,umol/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,Alkaline Phosphatase,,78,,,,,40 - 129,U/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,ALT (SGPT),,69,,H,,,5 - 48,U/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,AST (SGOT),,33,,,,,8 - 40,U/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,GGT,,38,,,,,10 - 61,U/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,LDH,,213,,,,,53 - 234,U/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,Urea Nitrogen,,8.9,,H,,,1.4 - 8.6,mmol/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,105,,,,,40 - 110,umol/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,Serum Glucose,,4.4,,,,,3.9 - 5.6,mmol/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,Serum Uric Acid,,414,,,,,125 - 488,umol/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,Calcium (EDTA),,2.40,,,,,2.07 - 2.64,mmol/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,Phosphorus,,1.17,,,,,0.71 - 1.65,mmol/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,Total Protein,,70,,,,,61 - 84,g/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,Albumin-BCG,,43,,,,,33 - 49,g/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,Creatine Kinase,,157,,,,,39 - 308,U/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,Serum Potassium,,4.5,,,,,3.5 - 5.2,mmol/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,Serum Bicarbonate,,25.4,,,,,19.3 - 29.3,mmol/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CHEMISTRY PANEL,Magnesium,,0.74,,,,,0.66 - 1.07,mmol/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,80,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,138,,,,,127 - 181,g/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.40,,,,,0.39 - 0.54, +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.7,,,,,4.5 - 6.4,TI/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,30,,,,,26 - 34,pg +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,86,,,,,79 - 96,fL +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.87,,,,,3.8 - 10.7,GI/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.24,,,,,1.96 - 7.23,GI/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.46,,,,,0.91 - 4.28,GI/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.34,,,,,0.12 - 0.92,GI/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.79,R,H,,,0 - 0.57,GI/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,,0 - 0.2,GI/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,38.2,R,L,,,40.5 - 75,% +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,41.9,,,,,15.4 - 48.5,% +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.7,,,,,2.6 - 10.1,% +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,13.5,R,H,,,0 - 6.8,% +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.7,,,,,0 - 2,% +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,302,,,,,140 - 400,GI/L +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEPATITIS B SURFACE AB,Anti-HBs II QUAL,,Reactive,,,,,Ref Rng :$Non Reactive, +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,,,,Test group cancelled: No specimen received,,, +CZ100222003,,,,,Male,Screening,,"Mar 2, 2026 11:00 AM",6227810899,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100222001,,,,,Male,Biopsy,,"Feb 18, 2026 12:00 AM",6227323286,ANATOMICAL SITE,Anatomical Site,Y,15-20cm from anal verge,,,,,, +CZ100222001,,,,,Male,Biopsy,,"Feb 18, 2026 12:00 AM",6227323286,BIOPSY COLLECTION METHOD,Collection Method,Y,colonoscopy,,,,,, +CZ100222001,,,,,Male,Biopsy,,"Feb 18, 2026 12:00 AM",6227323286,BIOPSY FIXATIVE USED,Fixative Used,,10% NBF,,,,,, +CZ100222001,,,,,Male,Biopsy,,"Feb 18, 2026 12:00 AM",6227323286,DATE/TIME PLACED IN FORMALIN,Date Sample placed in Formalin,Y,18-Feb-2026,,,,,, +CZ100222001,,,,,Male,Biopsy,,"Feb 18, 2026 12:00 AM",6227323286,DATE/TIME PLACED IN FORMALIN,Time Sample placed in Formalin,Y,07:39,,,,,, +CZ100222001,,,,,Male,Biopsy,,"Feb 18, 2026 12:00 AM",6227323286,DIAGNOSIS,Diagnosis:,Y,Ulcerative Colitis,,,,,, +CZ100222001,,,,,Male,Biopsy,,"Feb 18, 2026 12:00 AM",6227323286,INFLAMED AREA,Inflamed area?,,No,,,,,, +CZ100222001,,,,,Male,Biopsy,,"Feb 18, 2026 12:00 AM",6227323286,TISSUE BIOPSY EMBEDDING1,Biopsy technical QC-CL,,Smpl meets HT requirements,,,,,, +CZ100222001,,,,,Male,Biopsy,,"Feb 18, 2026 12:00 AM",6227323286,TISSUE BIOPSY EMBEDDING1,Biopsy processing Time-CL,,10:00,,,,,, +CZ100222001,,,,,Male,Biopsy,,"Feb 18, 2026 12:00 AM",6227323286,TISSUE BIOPSY EMBEDDING1,Biopsy processing Date-CL,,20-Feb-2026,,,,,, +CZ100222001,,,,,Male,Biopsy,,"Feb 18, 2026 12:00 AM",6227323286,TISSUE BIOPSY EMBEDDING1,Biopsy Comments-CL,,Received in 10% NBF,,,,,, +CZ100222001,,,,,Male,Biopsy,,"Feb 18, 2026 12:00 AM",6227323286,TISSUE BIOPSY EMBEDDING1,# of Cassettes-(FI)-CL,,1,,,,,, +CZ100222001,,,,,Male,Biopsy,,"Feb 18, 2026 12:00 AM",6227323286,ULCERATED AREA,Is biopsy site ulcerated?,,No,,,,,, +CZ100222003,,,,,Male,Biopsy,,"Feb 11, 2026 12:00 AM",6227323287,ANATOMICAL SITE,Anatomical Site,Y,15-20cm from anal verge,,,,,, +CZ100222003,,,,,Male,Biopsy,,"Feb 11, 2026 12:00 AM",6227323287,BIOPSY COLLECTION METHOD,Collection Method,Y,colonoscopy,,,,,, +CZ100222003,,,,,Male,Biopsy,,"Feb 11, 2026 12:00 AM",6227323287,BIOPSY FIXATIVE USED,Fixative Used,,10% NBF,,,,,, +CZ100222003,,,,,Male,Biopsy,,"Feb 11, 2026 12:00 AM",6227323287,DATE/TIME PLACED IN FORMALIN,Date Sample placed in Formalin,Y,11-Feb-2026,,,,,, +CZ100222003,,,,,Male,Biopsy,,"Feb 11, 2026 12:00 AM",6227323287,DATE/TIME PLACED IN FORMALIN,Time Sample placed in Formalin,Y,14:38,,,,,, +CZ100222003,,,,,Male,Biopsy,,"Feb 11, 2026 12:00 AM",6227323287,DIAGNOSIS,Diagnosis:,Y,Ulcerative Colitis,,,,,, +CZ100222003,,,,,Male,Biopsy,,"Feb 11, 2026 12:00 AM",6227323287,INFLAMED AREA,Inflamed area?,,Yes,,,,,, +CZ100222003,,,,,Male,Biopsy,,"Feb 11, 2026 12:00 AM",6227323287,TISSUE BIOPSY EMBEDDING1,Biopsy technical QC-CL,,Smpl meets HT requirements,,,,,, +CZ100222003,,,,,Male,Biopsy,,"Feb 11, 2026 12:00 AM",6227323287,TISSUE BIOPSY EMBEDDING1,Biopsy processing Time-CL,,10:00,,,,,, +CZ100222003,,,,,Male,Biopsy,,"Feb 11, 2026 12:00 AM",6227323287,TISSUE BIOPSY EMBEDDING1,Biopsy processing Date-CL,,13-Feb-2026,,,,,, +CZ100222003,,,,,Male,Biopsy,,"Feb 11, 2026 12:00 AM",6227323287,TISSUE BIOPSY EMBEDDING1,Biopsy Comments-CL,,Received in 10% NBF,,,,,, +CZ100222003,,,,,Male,Biopsy,,"Feb 11, 2026 12:00 AM",6227323287,TISSUE BIOPSY EMBEDDING1,# of Cassettes-(FI)-CL,,1,,,,,, +CZ100222003,,,,,Male,Biopsy,,"Feb 11, 2026 12:00 AM",6227323287,ULCERATED AREA,Is biopsy site ulcerated?,,Yes,,,,,, +CZ100222002,,,,,Male,Stool Pathogens,,"Jan 23, 2026 10:10 AM",6227323277,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100222002,,,,,Male,Stool Pathogens,,"Jan 23, 2026 10:10 AM",6227323277,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100222002,,,,,Male,Stool Pathogens,,"Jan 23, 2026 10:10 AM",6227323277,OVA AND PARASITES 1,Concentrate Exam,,,,,Test group cancelled: No specimen received,,, +CZ100222002,,,,,Male,Stool Pathogens,,"Jan 23, 2026 10:10 AM",6227323277,OVA AND PARASITES 1,Smear for Microsporidia,,,,,Test group cancelled: No specimen received,,, +CZ100222002,,,,,Male,Stool Pathogens,,"Jan 23, 2026 10:10 AM",6227323277,OVA AND PARASITES 1,Modified acid-fast stain,,,,,Test group cancelled: No specimen received,,, +CZ100222002,,,,,Male,Stool Pathogens,,"Jan 23, 2026 10:10 AM",6227323277,OVA AND PARASITES 2,Trichrome Smear,,,,,Test group cancelled: No specimen received,,, +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.9,,,,,0 - 6.2,umol/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,Alkaline Phosphatase,,55,,,,,40 - 129,U/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,ALT (SGPT),,25,,,,,5 - 48,U/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,AST (SGOT),,24,,,,,8 - 40,U/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,GGT,,12,,,,,10 - 61,U/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,LDH,,190,,,,,53 - 234,U/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,Urea Nitrogen,,8.5,,,,,1.4 - 8.6,mmol/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,115,,H,,,40 - 110,umol/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,Serum Glucose,,4.4,,,,,3.9 - 5.6,mmol/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,Serum Uric Acid,,337,,,,,125 - 488,umol/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,Calcium (EDTA),,2.44,,,,,2.07 - 2.64,mmol/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,Phosphorus,,0.86,,,,,0.71 - 1.65,mmol/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,Total Protein,,71,,,,,61 - 84,g/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,Albumin-BCG,,43,,,,,33 - 49,g/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,Creatine Kinase,,144,,,,,39 - 308,U/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,Serum Sodium,,141,,,,,132 - 147,mmol/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,Serum Potassium,,4.1,,,,,3.5 - 5.2,mmol/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,Serum Bicarbonate,,27.5,,,,,19.3 - 29.3,mmol/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CHEMISTRY PANEL,Magnesium,,0.75,,,,,0.66 - 1.07,mmol/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,CKD-EPI 2021,CKD-EPI 2021 Without Race,,72,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,136,,,,,127 - 181,g/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.39,,,,,0.39 - 0.54, +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.6,,,,,4.5 - 6.4,TI/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,30,,,,,26 - 34,pg +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,87,,,,,79 - 96,fL +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.82,,,,,3.8 - 10.7,GI/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.49,,,,,1.96 - 7.23,GI/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.54,,,,,0.91 - 4.28,GI/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.41,,,,,0.12 - 0.92,GI/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.34,,,,,0 - 0.57,GI/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,,0 - 0.2,GI/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,42.7,,,,,40.5 - 75,% +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,43.7,,,,,15.4 - 48.5,% +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.0,,,,,2.6 - 10.1,% +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,5.9,,,,,0 - 6.8,% +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.6,,,,,0 - 2,% +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,224,,,,,140 - 400,GI/L +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEPATITIS B SURFACE AB NON-US,Anti-HBs II QUAL,,Reactive,,,,,Ref Rng :$Non Reactive, +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100222002,,,,,Male,Screening,,"Jan 23, 2026 10:00 AM",6227323268,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Negative,,,,,Normal=Negative, +CZ100222001,,,,,Male,Stool Pathogens,R,"Jan 15, 2026 4:55 PM",6227323276,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,,,,Test group cancelled: Specimen received beyond stability,,, +CZ100222001,,,,,Male,Stool Pathogens,R,"Jan 15, 2026 4:55 PM",6227323276,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,,,,Test group cancelled: Specimen received beyond stability,,, +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,Total Bilirubin,,<3,,L,,Result verified by repeat analysis,3 - 21,umol/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.4,,,,,0 - 6.2,umol/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,Alkaline Phosphatase,,140,,H,,,40 - 129,U/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,ALT (SGPT),,23,,,,,5 - 48,U/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,AST (SGOT),,28,,,,,8 - 40,U/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,GGT,,136,,H,,,10 - 61,U/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,LDH,,186,,,,,53 - 234,U/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,Urea Nitrogen,,3.9,,,,,1.4 - 8.6,mmol/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,78,,,,,40 - 110,umol/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,Serum Glucose,,4.9,,,,,3.9 - 5.6,mmol/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,Serum Uric Acid,,408,,,,,125 - 488,umol/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,Calcium (EDTA),,2.31,,,,,2.07 - 2.64,mmol/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,Phosphorus,,1.13,,,,,0.71 - 1.65,mmol/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,Total Protein,,77,,,,,61 - 84,g/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,Albumin-BCG,,41,,,,,33 - 49,g/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,Creatine Kinase,,131,,,,,39 - 308,U/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,Serum Bicarbonate,,23.1,,,,,19.3 - 29.3,mmol/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CHEMISTRY PANEL,Magnesium,,0.82,,,,,0.66 - 1.07,mmol/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,CKD-EPI 2021,CKD-EPI 2021 Without Race,,111,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,85,,L,,,127 - 181,g/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.30,,L,,,0.39 - 0.54, +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.1,,L,,,4.5 - 6.4,TI/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,21,,L,,,26 - 34,pg +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,Microcytic,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,Anisocytosis,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,74,,L,,,79 - 96,fL +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,15.03,,H,,,3.8 - 10.7,GI/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,11.38,,H,,,1.96 - 7.23,GI/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.59,,,,,0.91 - 4.28,GI/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.82,,,,,0.12 - 0.92,GI/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.13,,,,,0 - 0.57,GI/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.11,,,,,0 - 0.2,GI/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,75.7,,H,,,40.5 - 75,% +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,17.3,,,,,15.4 - 48.5,% +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.4,,,,,2.6 - 10.1,% +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,0.9,,,,,0 - 6.8,% +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.7,,,,,0 - 2,% +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,529,,H,,,140 - 400,GI/L +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEPATITIS B SURFACE AB NON-US,Anti-HBs II QUAL,,Non-Reactive,,,,,Ref Rng :$Non Reactive, +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100222001,,,,,Male,Screening,,"Jan 15, 2026 4:45 PM",6227323266,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Negative,,,,,Normal=Negative, diff --git a/Covance_UCO3001/Source/2026-05-29_132609 sponsor-study-36940-test-results-930525-microbiology.csv b/Covance_UCO3001/Source/2026-05-29_132609 sponsor-study-36940-test-results-930525-microbiology.csv new file mode 100644 index 0000000..a4242f9 --- /dev/null +++ b/Covance_UCO3001/Source/2026-05-29_132609 sponsor-study-36940-test-results-930525-microbiology.csv @@ -0,0 +1,6 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,,,,,, +Subject,Screening Number,Age,Age Unit,Gender,Visit Description,Collected Time,Accession,Test Group,Specimen,Organism,Growth,Cancellation Reason,Test Description,Test Result,Drug Name/Agent,MIC Result,Units,MIC Interpretation,Disk Diffusion Result,Disk Diffusion Interpretation,Subject Data Revision,Visit Data Revision,Result Data Revision +CZ100222001 - null,,,,Male,SCRNSTOOL Stool Pathogens,"Jan 15, 2026 4:55 PM",6227323276,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,R, +CZ100222002 - null,,,,Male,SCRNSTOOL Stool Pathogens,"Jan 23, 2026 10:10 AM",6227323277,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,, +CZ100222004 - null,,,,Male,SCRNSTOOL Stool Pathogens,"Mar 3, 2026 12:20 PM",6227810905,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,, +CZ100222005 - null,,,,Male,SCRNSTOOL Stool Pathogens,"Mar 4, 2026 9:10 AM",6227810904,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,, diff --git a/Covance_UCO3001/Source/2026-05-29_132636 sponsor-study-36940-test-results-930549-standard.csv b/Covance_UCO3001/Source/2026-05-29_132636 sponsor-study-36940-test-results-930549-standard.csv new file mode 100644 index 0000000..533a201 --- /dev/null +++ b/Covance_UCO3001/Source/2026-05-29_132636 sponsor-study-36940-test-results-930549-standard.csv @@ -0,0 +1,242 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,, +Subject,Subject Data Revision,Screen No.,Age,Age Unit,Gender,Visit,Visit Data Revision,Collected Time,Accession,Test Group,Test,Administrative Question,Value,Result Data Revision,Flags,Cancellation Reason,Comments,Range,Units +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,ALP<2XULN,ALP<2XULN,,Criteria Met,,,,,, +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,ALT>/=3XULN,ALT >/= 3 X ULN,,Criteria not met,,,,,, +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,ALT>/=3XULN & TBIL>/=2XULN,ALT >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,AST>/=3XULN,AST >/= 3 X ULN,,Criteria not met,,,,,, +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,AST>/=3XULN & TBIL>/=2XULN,AST >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.3,,,,,0 - 6.2,umol/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,Alkaline Phosphatase,,82,,,,,35 - 104,U/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,ALT (SGPT),,18,,,,,4 - 43,U/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,AST (SGOT),,17,,,,,8 - 40,U/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,GGT,,11,,,,,4 - 49,U/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,LDH,,151,,,,,53 - 234,U/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,Urea Nitrogen,,2.1,,,,,1.4 - 8.6,mmol/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,55,,,,,31 - 101,umol/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,Serum Glucose,,4.8,,,,,3.9 - 5.6,mmol/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,Serum Uric Acid,,277,,,,,125 - 428,umol/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,Calcium (EDTA),,2.54,,,,,2.07 - 2.64,mmol/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,Phosphorus,,0.81,,,,,0.71 - 1.65,mmol/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,Total Protein,,84,,,,,61 - 84,g/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,Albumin-BCG,,51,,H,,,33 - 49,g/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,Creatine Kinase,,55,,,,,26 - 192,U/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,Serum Bicarbonate,,23.5,,,,,19.3 - 29.3,mmol/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CHEMISTRY PANEL,Magnesium,,0.89,,,,,0.66 - 1.07,mmol/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,129,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,FECAL COLLECTION D/T,Stool Collection Date,Y,,,,,,, +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,FECAL COLLECTION D/T,Stool Collection Time,Y,,,,,,, +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,127,,,,Result verified by repeat analysis,116 - 164,g/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.39,,,,,0.34 - 0.48, +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.7,,,,Result verified by repeat analysis,4.1 - 5.6,TI/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,27,,,,Result verified by repeat analysis,26 - 34,pg +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,Anisocytosis,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,83,,,,Result verified by repeat analysis,79 - 98,fL +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.41,,,,Result verified by repeat analysis,3.8 - 10.7,GI/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.73,,,,,1.96 - 7.23,GI/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.41,,,,,0.91 - 4.28,GI/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.22,,,,,0.12 - 0.92,GI/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.04,,,,,0 - 0.57,GI/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.00,,,,,0 - 0.2,GI/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,62.0,,,,,40.5 - 75,% +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,32.0,,,,,15.4 - 48.5,% +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.0,,,,,2.6 - 10.1,% +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.0,,,,,0 - 6.8,% +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.0,,,,,0 - 2,% +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,340,,,,Result verified by repeat analysis,140 - 400,GI/L +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,07-May-2026,,,,,, +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,12:40,,,,,, +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,07-May-2026,,,,,, +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,14:20,,,,,, +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,07-May-2026,,,,,, +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,12:40,,,,,, +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,SM09/STOOL PK COLL D/T,Stool Collection Date,Y,,,,,,, +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,SM09/STOOL PK COLL D/T,Stool Collection Time,Y,,,,,,, +CZ100122001,,,,,Female,Induction Week 4,,"May 7, 2026 12:40 PM",6227697723,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,ALP<2XULN,ALP<2XULN,,Criteria Met,,,,,, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,ALT>/=3XULN,ALT >/= 3 X ULN,,Criteria not met,,,,,, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,ALT>/=3XULN & TBIL>/=2XULN,ALT >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,AST>/=3XULN,AST >/= 3 X ULN,,Criteria not met,,,,,, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,AST>/=3XULN & TBIL>/=2XULN,AST >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,Total Bilirubin,,4,,,,,3 - 21,umol/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.7,,,,,0 - 6.2,umol/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,Alkaline Phosphatase,,71,,,,,35 - 104,U/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,ALT (SGPT),,24,,,,,4 - 43,U/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,AST (SGOT),,19,,,,,8 - 40,U/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,GGT,,12,,,,,4 - 49,U/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,LDH,,138,,,,,53 - 234,U/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,Urea Nitrogen,,3.5,,,,,1.4 - 8.6,mmol/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,56,,,,,31 - 101,umol/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,Serum Glucose,,5.1,,,,,3.9 - 5.6,mmol/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,Serum Uric Acid,,296,,,,,125 - 428,umol/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,Calcium (EDTA),,2.55,,,,,2.07 - 2.64,mmol/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,Phosphorus,,0.77,,,,,0.71 - 1.65,mmol/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,Total Protein,,77,,,,,61 - 84,g/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,Creatine Kinase,,49,,,,,26 - 192,U/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,Serum Potassium,,4.3,,,,,3.5 - 5.2,mmol/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,Serum Bicarbonate,,25.3,,,,,19.3 - 29.3,mmol/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,Serum Chloride,,100,,,,,94 - 112,mmol/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CHEMISTRY PANEL,Magnesium,,0.83,,,,,0.66 - 1.07,mmol/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,129,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,FECAL COLLECTION D/T,Stool Collection Date,Y,22-Apr-2026,,,,,, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,FECAL COLLECTION D/T,Stool Collection Time,Y,05:30,,,,,, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,128,,,,Result verified by repeat analysis,116 - 164,g/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.40,,,,Result verified by repeat analysis,0.34 - 0.48, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.9,,,,Result verified by repeat analysis,4.1 - 5.6,TI/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,26,,,,Result verified by repeat analysis,26 - 34,pg +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,81,,,,Result verified by repeat analysis,79 - 98,fL +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.60,,,,Result verified by repeat analysis,3.8 - 10.7,GI/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.39,,,,,1.96 - 7.23,GI/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.54,,,,,0.91 - 4.28,GI/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.47,,,,Result verified by repeat analysis,0.12 - 0.92,GI/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.12,,,,Result verified by repeat analysis,0 - 0.57,GI/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.07,,,,Result verified by repeat analysis,0 - 0.2,GI/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,66.6,,,,Result verified by repeat analysis,40.5 - 75,% +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,23.5,,,,Result verified by repeat analysis,15.4 - 48.5,% +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.2,,,,Result verified by repeat analysis,2.6 - 10.1,% +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.8,,,,Result verified by repeat analysis,0 - 6.8,% +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.0,,,,Result verified by repeat analysis,0 - 2,% +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,300,,,,Result verified by repeat analysis,140 - 400,GI/L +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,22-Apr-2026,,,,,, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,09:25,,,,,, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,22-Apr-2026,,,,,, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,10:45,,,,,, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,22-Apr-2026,,,,,, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,09:25,,,,,, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,SM09/STOOL PK COLL D/T,Stool Collection Date,Y,22-Apr-2026,,,,,, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,SM09/STOOL PK COLL D/T,Stool Collection Time,Y,05:30,,,,,, +CZ100122001,,,,,Female,Induction Week 2,,"Apr 22, 2026 9:25 AM",6227697722,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,Total Bilirubin,,5,,,,,3 - 21,umol/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.5,,,,,0 - 6.2,umol/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,Alkaline Phosphatase,,66,,,,,35 - 104,U/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,ALT (SGPT),,25,,,,,4 - 43,U/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,AST (SGOT),,24,,,,,8 - 40,U/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,GGT,,12,,,,,4 - 49,U/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,LDH,,157,,,,,53 - 234,U/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,Urea Nitrogen,,3.0,,,,,1.4 - 8.6,mmol/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,51,,,,,31 - 101,umol/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,Serum Glucose,,4.4,,,,,3.9 - 5.6,mmol/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,Serum Uric Acid,,258,,,,,125 - 428,umol/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,Calcium (EDTA),,2.35,,,,,2.07 - 2.64,mmol/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,Phosphorus,,0.84,,,,,0.71 - 1.65,mmol/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,Total Protein,,71,,,,,61 - 84,g/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,Creatine Kinase,,51,,,,,26 - 192,U/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,Serum Bicarbonate,,23.0,,,,,19.3 - 29.3,mmol/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CHEMISTRY PANEL,Magnesium,,0.82,,,,,0.66 - 1.07,mmol/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,131,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,FECAL COLLECTION D/T,Stool Collection Date,Y,07-Apr-2026,,,,,, +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,FECAL COLLECTION D/T,Stool Collection Time,Y,06:00,,,,,, +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,115,R,L,,,116 - 164,g/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.36,,,,,0.34 - 0.48, +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.5,,,,,4.1 - 5.6,TI/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,25,R,L,,,26 - 34,pg +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,80,,,,,79 - 98,fL +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,9.11,,,,,3.8 - 10.7,GI/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,6.31,,,,,1.96 - 7.23,GI/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.15,,,,,0.91 - 4.28,GI/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.54,,,,,0.12 - 0.92,GI/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.05,,,,,0 - 0.57,GI/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.06,,,,,0 - 0.2,GI/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,69.3,,,,,40.5 - 75,% +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,23.6,,,,,15.4 - 48.5,% +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.9,,,,,2.6 - 10.1,% +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,0.5,,,,,0 - 6.8,% +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.7,,,,,0 - 2,% +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,386,,,,,140 - 400,GI/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,LIPID PANEL,Direct HDL-C 4th Generation,,1.35,,,,,1.03 - 1.53,mmol/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,LIPID PANEL,Triglycerides (GPO),,1.11,,,,,0.41 - 1.63,mmol/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,LIPID PANEL,Cholesterol (High Performance),,4.41,,,,,3.31 - 5.64,mmol/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,LIPID PANEL,LDL Chol Friedewald 4th,,2.55,,,,,0 - 3.34,mmol/L +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,07-Apr-2026,,,,,, +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,11:45,,,,,, +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,07-Apr-2026,,,,,, +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,13:35,,,,,, +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,07-Apr-2026,,,,,, +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,11:45,,,,,, +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,SM10/FECAL BMRKS COLL D/T,Stool Collection Date,Y,07-Apr-2026,,,,,, +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,SM10/FECAL BMRKS COLL D/T,Stool Collection Time,Y,06:00,,,,,, +CZ100122001,,,,,Female,Induction Week 0,,"Apr 7, 2026 11:45 AM",6227697719,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100122001,,,,,Female,Biopsy,,"Mar 23, 2026 12:00 AM",6227697736,ANATOMICAL SITE,Anatomical Site,Y,15 cm,,,,,, +CZ100122001,,,,,Female,Biopsy,,"Mar 23, 2026 12:00 AM",6227697736,BIOPSY COLLECTION METHOD,Collection Method,Y,colonoscopy,,,,,, +CZ100122001,,,,,Female,Biopsy,,"Mar 23, 2026 12:00 AM",6227697736,BIOPSY FIXATIVE USED,Fixative Used,,10% NBF,,,,,, +CZ100122001,,,,,Female,Biopsy,,"Mar 23, 2026 12:00 AM",6227697736,DATE/TIME PLACED IN FORMALIN,Date Sample placed in Formalin,Y,23-Mar-2026,,,,,, +CZ100122001,,,,,Female,Biopsy,,"Mar 23, 2026 12:00 AM",6227697736,DATE/TIME PLACED IN FORMALIN,Time Sample placed in Formalin,Y,09:42,,,,,, +CZ100122001,,,,,Female,Biopsy,,"Mar 23, 2026 12:00 AM",6227697736,DIAGNOSIS,Diagnosis:,Y,Ulcerative Colitis,,,,,, +CZ100122001,,,,,Female,Biopsy,,"Mar 23, 2026 12:00 AM",6227697736,INFLAMED AREA,Inflamed area?,,Yes,,,,,, +CZ100122001,,,,,Female,Biopsy,,"Mar 23, 2026 12:00 AM",6227697736,TISSUE BIOPSY EMBEDDING1,Biopsy technical QC-CL,,Smpl meets HT requirements,,,,,, +CZ100122001,,,,,Female,Biopsy,,"Mar 23, 2026 12:00 AM",6227697736,TISSUE BIOPSY EMBEDDING1,Biopsy processing Time-CL,,10:00,,,,,, +CZ100122001,,,,,Female,Biopsy,,"Mar 23, 2026 12:00 AM",6227697736,TISSUE BIOPSY EMBEDDING1,Biopsy processing Date-CL,,25-Mar-2026,,,,,, +CZ100122001,,,,,Female,Biopsy,,"Mar 23, 2026 12:00 AM",6227697736,TISSUE BIOPSY EMBEDDING1,Biopsy Comments-CL,,Received in 10% NBF,,,,,, +CZ100122001,,,,,Female,Biopsy,,"Mar 23, 2026 12:00 AM",6227697736,TISSUE BIOPSY EMBEDDING1,# of Cassettes-(FI)-CL,,1,,,,,, +CZ100122001,,,,,Female,Biopsy,,"Mar 23, 2026 12:00 AM",6227697736,ULCERATED AREA,Is biopsy site ulcerated?,,Yes,,,,,, +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,Total Bilirubin,,<3,R,L,,Result verified by repeat analysis,3 - 21,umol/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,<1.4,,,,Result verified by repeat analysis,0 - 6.2,umol/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,Alkaline Phosphatase,,74,,,,,35 - 104,U/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,ALT (SGPT),,23,,,,,4 - 43,U/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,AST (SGOT),,23,,,,,8 - 40,U/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,GGT,,9,,,,,4 - 49,U/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,LDH,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,Urea Nitrogen,,2.5,,,,,1.4 - 8.6,mmol/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,55,,,,,31 - 101,umol/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,Serum Glucose,,5.5,,,,,3.9 - 5.6,mmol/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,Serum Uric Acid,,226,,,,,125 - 428,umol/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,Calcium (EDTA),,2.39,,,,,2.07 - 2.64,mmol/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,Phosphorus,,0.90,,,,,0.71 - 1.65,mmol/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,Total Protein,,73,,,,,61 - 84,g/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,Creatine Kinase,,84,,,,,26 - 192,U/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,Serum Sodium,,142,,,,,132 - 147,mmol/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,Serum Potassium,,5.1,,,,,3.5 - 5.2,mmol/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,Serum Bicarbonate,,19.2,,L,,,19.3 - 29.3,mmol/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CHEMISTRY PANEL,Magnesium,,0.83,,,,,0.66 - 1.07,mmol/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,129,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,Yes,,,,,, +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,111,R,L,,,116 - 164,g/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.36,,,,,0.34 - 0.48, +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.6,,,,,4.1 - 5.6,TI/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,24,R,L,,,26 - 34,pg +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,78,R,L,,,79 - 98,fL +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,7.66,,,,,3.8 - 10.7,GI/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,5.37,,,,,1.96 - 7.23,GI/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.63,,,,,0.91 - 4.28,GI/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.55,,,,,0.12 - 0.92,GI/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.08,,,,,0 - 0.57,GI/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,70.2,,,,,40.5 - 75,% +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,21.2,,,,,15.4 - 48.5,% +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.2,,,,,2.6 - 10.1,% +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.1,,,,,0 - 6.8,% +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.4,,,,,0 - 2,% +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,412,R,H,,,140 - 400,GI/L +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEPATITIS B SURFACE AB,Anti-HBs II QUAL,,Non-Reactive,,,,,Ref Rng :$Non Reactive, +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Negative,,,,,Normal=Negative, +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,SERUM BETA HCG,"B-hCG, Qualitative",,Negative,,,,,Ref Rng: Negative, +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,SERUM BETA HCG,"B-hCG, Quantitative",,<0.6,,,,,Units: mIU/mL$Pre-menopausal$<5.0: Negative$5.0-24.9:Borderline$>/= 25.0: Positive, +CZ100122001,,,,,Female,Screening,R,"Mar 18, 2026 9:18 AM",6227697718,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100122001,,,,,Female,Stool Pathogens,,"Mar 17, 2026 5:30 PM",6227697725,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100122001,,,,,Female,Stool Pathogens,,"Mar 17, 2026 5:30 PM",6227697725,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,Negative,,,,,Ref Rng:Negative, diff --git a/Covance_UCO3001/Source/2026-05-29_132657 sponsor-study-36940-test-results-930549-microbiology.csv b/Covance_UCO3001/Source/2026-05-29_132657 sponsor-study-36940-test-results-930549-microbiology.csv new file mode 100644 index 0000000..a05daf8 --- /dev/null +++ b/Covance_UCO3001/Source/2026-05-29_132657 sponsor-study-36940-test-results-930549-microbiology.csv @@ -0,0 +1,3 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,,,,,, +Subject,Screening Number,Age,Age Unit,Gender,Visit Description,Collected Time,Accession,Test Group,Specimen,Organism,Growth,Cancellation Reason,Test Description,Test Result,Drug Name/Agent,MIC Result,Units,MIC Interpretation,Disk Diffusion Result,Disk Diffusion Interpretation,Subject Data Revision,Visit Data Revision,Result Data Revision +CZ100122001 - null,,,,Female,SCRNSTOOL Stool Pathogens,"Mar 17, 2026 5:30 PM",6227697725,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,, diff --git a/Covance_UCO3001/Source/2026-05-29_132740 sponsor-study-36940-test-results-930547-standard.csv b/Covance_UCO3001/Source/2026-05-29_132740 sponsor-study-36940-test-results-930547-standard.csv new file mode 100644 index 0000000..d606dbc --- /dev/null +++ b/Covance_UCO3001/Source/2026-05-29_132740 sponsor-study-36940-test-results-930547-standard.csv @@ -0,0 +1,500 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,, +Subject,Subject Data Revision,Screen No.,Age,Age Unit,Gender,Visit,Visit Data Revision,Collected Time,Accession,Test Group,Test,Administrative Question,Value,Result Data Revision,Flags,Cancellation Reason,Comments,Range,Units +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,ALP<2XULN,ALP<2XULN,,Criteria Met,,,,,, +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,ALT>/=3XULN,ALT >/= 3 X ULN,,Criteria not met,,,,,, +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,ALT>/=3XULN & TBIL>/=2XULN,ALT >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,AST>/=3XULN,AST >/= 3 X ULN,,Criteria not met,,,,,, +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,AST>/=3XULN & TBIL>/=2XULN,AST >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,Total Bilirubin,,10,,,,,3 - 21,umol/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.8,,,,,0 - 6.2,umol/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,Alkaline Phosphatase,,73,,,,,40 - 129,U/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,ALT (SGPT),,17,,,,,5 - 48,U/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,AST (SGOT),,22,,,,,8 - 40,U/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,GGT,,18,,,,,10 - 61,U/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,LDH,,164,,,,,53 - 234,U/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,Urea Nitrogen,,5.1,,,,,1.4 - 8.6,mmol/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,89,,,,,40 - 110,umol/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,Serum Glucose,,5.4,,,,,3.9 - 5.6,mmol/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,Serum Uric Acid,,346,,,,,125 - 488,umol/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,Calcium (EDTA),,2.46,,,,,2.07 - 2.64,mmol/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,Phosphorus,,1.01,,,,,0.71 - 1.65,mmol/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,Total Protein,,75,,,,,61 - 84,g/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,Albumin-BCG,,49,,,,,33 - 49,g/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,Creatine Kinase,,206,,,,,39 - 308,U/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,Serum Bicarbonate,,20.1,,,,,19.3 - 29.3,mmol/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CHEMISTRY PANEL,Magnesium,,0.85,,,,,0.66 - 1.07,mmol/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,103,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,FECAL COLLECTION D/T,Stool Collection Date,Y,26-May-2026,,,,,, +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,FECAL COLLECTION D/T,Stool Collection Time,Y,07:00,,,,,, +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,151,,,,,127 - 181,g/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.44,,,,,0.39 - 0.54, +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.6,,,,,4.5 - 6.4,TI/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,33,,,,,26 - 34,pg +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,97,,H,,,79 - 96,fL +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.61,,,,,3.8 - 10.7,GI/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.81,,,,,1.96 - 7.23,GI/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.03,,,,,0.91 - 4.28,GI/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.50,,,,,0.12 - 0.92,GI/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.23,,,,,0 - 0.57,GI/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,50.0,,,,,40.5 - 75,% +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,36.1,,,,,15.4 - 48.5,% +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,8.9,,,,,2.6 - 10.1,% +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,4.0,,,,,0 - 6.8,% +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.0,,,,,0 - 2,% +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,283,,,,,140 - 400,GI/L +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,26-May-2026,,,,,, +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,09:05,,,,,, +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,26-May-2026,,,,,, +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,10:10,,,,,, +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,26-May-2026,,,,,, +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,09:05,,,,,, +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,SM09/STOOL PK COLL D/T,Stool Collection Date,Y,26-May-2026,,,,,, +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,SM09/STOOL PK COLL D/T,Stool Collection Time,Y,07:00,,,,,, +CZ100132002,,,,,Male,Induction Week 2,,"May 26, 2026 9:05 AM",6228398115,SUBJECT HEIGHT (CM),Height (cm),Y,196,,,,,cm, +CZ100132003,,,,,Female,Biopsy,,"May 25, 2026 12:00 AM",6228501732,ANATOMICAL SITE,Anatomical Site,Y,15-20cm from anal verge,,,,,, +CZ100132003,,,,,Female,Biopsy,,"May 25, 2026 12:00 AM",6228501732,BIOPSY COLLECTION METHOD,Collection Method,Y,colonoscopy,,,,,, +CZ100132003,,,,,Female,Biopsy,,"May 25, 2026 12:00 AM",6228501732,BIOPSY FIXATIVE USED,Fixative Used,,10% NBF,,,,,, +CZ100132003,,,,,Female,Biopsy,,"May 25, 2026 12:00 AM",6228501732,DATE/TIME PLACED IN FORMALIN,Date Sample placed in Formalin,Y,25-May-2026,,,,,, +CZ100132003,,,,,Female,Biopsy,,"May 25, 2026 12:00 AM",6228501732,DATE/TIME PLACED IN FORMALIN,Time Sample placed in Formalin,Y,09:05,,,,,, +CZ100132003,,,,,Female,Biopsy,,"May 25, 2026 12:00 AM",6228501732,DIAGNOSIS,Diagnosis:,Y,Ulcerative Colitis,,,,,, +CZ100132003,,,,,Female,Biopsy,,"May 25, 2026 12:00 AM",6228501732,INFLAMED AREA,Inflamed area?,,,,,,,, +CZ100132003,,,,,Female,Biopsy,,"May 25, 2026 12:00 AM",6228501732,TISSUE BIOPSY EMBEDDING1,Biopsy technical QC-CL,,Smpl meets HT requirements,,,,,, +CZ100132003,,,,,Female,Biopsy,,"May 25, 2026 12:00 AM",6228501732,TISSUE BIOPSY EMBEDDING1,Biopsy processing Time-CL,,12:00,,,,,, +CZ100132003,,,,,Female,Biopsy,,"May 25, 2026 12:00 AM",6228501732,TISSUE BIOPSY EMBEDDING1,Biopsy processing Date-CL,,27-May-2026,,,,,, +CZ100132003,,,,,Female,Biopsy,,"May 25, 2026 12:00 AM",6228501732,TISSUE BIOPSY EMBEDDING1,Biopsy Comments-CL,,Received in 10% NBF,,,,,, +CZ100132003,,,,,Female,Biopsy,,"May 25, 2026 12:00 AM",6228501732,TISSUE BIOPSY EMBEDDING1,# of Cassettes-(FI)-CL,,1,,,,,, +CZ100132003,,,,,Female,Biopsy,,"May 25, 2026 12:00 AM",6228501732,ULCERATED AREA,Is biopsy site ulcerated?,,Yes,,,,,, +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,Total Bilirubin,,5,,,,,3 - 21,umol/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.9,,,,,0 - 6.2,umol/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,Alkaline Phosphatase,,77,,,,,40 - 129,U/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,ALT (SGPT),,19,,,,,5 - 48,U/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,AST (SGOT),,21,,,,,8 - 40,U/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,GGT,,16,,,,,10 - 61,U/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,LDH,,159,,,,,53 - 234,U/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,Urea Nitrogen,,5.0,,,,,1.4 - 8.6,mmol/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,96,,,,,40 - 110,umol/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,Serum Glucose,,5.0,,,,,3.9 - 5.6,mmol/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,Serum Uric Acid,,342,,,,,125 - 488,umol/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,Calcium (EDTA),,2.48,,,,,2.07 - 2.64,mmol/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,Phosphorus,,1.05,,,,,0.71 - 1.65,mmol/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,Total Protein,,76,,,,,61 - 84,g/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,Albumin-BCG,,49,,,,,33 - 49,g/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,Creatine Kinase,,204,,,,,39 - 308,U/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,Serum Sodium,,141,,,,,132 - 147,mmol/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,Serum Bicarbonate,,21.8,,,,,19.3 - 29.3,mmol/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CHEMISTRY PANEL,Magnesium,,0.85,,,,,0.66 - 1.07,mmol/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,94,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,FECAL COLLECTION D/T,Stool Collection Date,Y,12-May-2026,,,,,, +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,FECAL COLLECTION D/T,Stool Collection Time,Y,08:50,,,,,, +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,154,,,,,127 - 181,g/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.44,,,,,0.39 - 0.54, +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.6,,,,,4.5 - 6.4,TI/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,33,,,,,26 - 34,pg +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,96,,,,,79 - 96,fL +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.64,,,,,3.8 - 10.7,GI/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.04,,,,,1.96 - 7.23,GI/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.81,,,,,0.91 - 4.28,GI/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.59,,,,,0.12 - 0.92,GI/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.16,,,,,0 - 0.57,GI/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,53.9,,,,,40.5 - 75,% +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,32.0,,,,,15.4 - 48.5,% +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,10.4,,H,,,2.6 - 10.1,% +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.8,,,,,0 - 6.8,% +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.9,,,,,0 - 2,% +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,275,,,,,140 - 400,GI/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,LIPID PANEL,Direct HDL-C 4th Generation,,1.26,,,,,1.03 - 1.53,mmol/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,LIPID PANEL,Triglycerides (GPO),,1.63,,,,,0.5 - 2.81,mmol/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,LIPID PANEL,Cholesterol (High Performance),,4.71,,,,,3.31 - 6.1,mmol/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,LIPID PANEL,LDL Chol Friedewald 4th,,2.70,,,,,0 - 3.34,mmol/L +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,PA1 EEA-2?,Approved to use EEA-2?,,No,,,,,, +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,12-May-2026,,,,,, +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,10:25,,,,,, +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,12-May-2026,,,,,, +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,11:30,,,,,, +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,12-May-2026,,,,,, +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,10:25,,,,,, +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,SM10/FECAL BMRKS COLL D/T,Stool Collection Date,Y,12-May-2026,,,,,, +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,SM10/FECAL BMRKS COLL D/T,Stool Collection Time,Y,08:50,,,,,, +CZ100132002,,,,,Male,Induction Week 0,,"May 12, 2026 10:25 AM",6228308224,SUBJECT HEIGHT (CM),Height (cm),Y,196,,,,,cm, +CZ100132003,,,,,Female,Stool Pathogens,,"May 7, 2026 5:45 AM",6227635150,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100132003,,,,,Female,Stool Pathogens,,"May 7, 2026 5:45 AM",6227635150,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100132003,,,,,Female,Stool Pathogens,,"May 7, 2026 5:45 AM",6227635150,OVA AND PARASITES 1,Concentrate Exam,,No ova or parasites found,,,,,, +CZ100132003,,,,,Female,Stool Pathogens,,"May 7, 2026 5:45 AM",6227635150,OVA AND PARASITES 1,Smear for Microsporidia,,No Microsporidia seen.,,,,,, +CZ100132003,,,,,Female,Stool Pathogens,,"May 7, 2026 5:45 AM",6227635150,OVA AND PARASITES 1,Modified acid-fast stain,,No coccidian parasites seen,,,,,, +CZ100132003,,,,,Female,Stool Pathogens,,"May 7, 2026 5:45 AM",6227635150,OVA AND PARASITES 2,Trichrome Smear,,No ova or parasites found,,,,,, +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.1,,,,,0 - 6.2,umol/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,Alkaline Phosphatase,,95,,,,,35 - 104,U/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,ALT (SGPT),,16,,,,,4 - 43,U/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,AST (SGOT),,22,,,,,8 - 40,U/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,GGT,,34,,,,,4 - 49,U/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,LDH,,151,,,,,53 - 234,U/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,Urea Nitrogen,,2.8,,,,,1.4 - 8.6,mmol/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,68,,,,,31 - 101,umol/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,Serum Glucose,,5.2,,,,,3.9 - 5.6,mmol/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,Serum Uric Acid,,357,,,,,125 - 428,umol/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,Calcium (EDTA),,2.31,,,,,2.07 - 2.64,mmol/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,Phosphorus,,1.09,,,,,0.71 - 1.65,mmol/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,Total Protein,,71,,,,,61 - 84,g/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,Creatine Kinase,,51,,,,,26 - 192,U/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,Serum Sodium,,141,,,,,132 - 147,mmol/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,Serum Potassium,,4.1,,,,,3.5 - 5.2,mmol/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,Serum Bicarbonate,,23.1,,,,,19.3 - 29.3,mmol/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,Serum Chloride,,106,,,,,94 - 112,mmol/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CHEMISTRY PANEL,Magnesium,,0.81,,,,,0.66 - 1.07,mmol/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,95,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,Yes,,,,,, +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,133,,,,,116 - 164,g/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.40,,,,,0.34 - 0.48, +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.7,,,,,4.1 - 5.6,TI/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,28,,,,,26 - 34,pg +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,84,,,,,79 - 98,fL +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.91,,,,,3.8 - 10.7,GI/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.94,,,,,1.96 - 7.23,GI/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.35,,,,,0.91 - 4.28,GI/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.40,,,,,0.12 - 0.92,GI/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.13,,,,,0 - 0.57,GI/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.09,,,,,0 - 0.2,GI/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,71.5,,,,,40.5 - 75,% +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,19.5,,,,,15.4 - 48.5,% +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.8,,,,,2.6 - 10.1,% +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.9,,,,,0 - 6.8,% +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.3,,,,,0 - 2,% +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,271,,,,,140 - 400,GI/L +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEPATITIS B SURFACE AB,Anti-HBs II QUAL,,Non-Reactive,,,,,Ref Rng :$Non Reactive, +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Negative,,,,,Normal=Negative, +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,SERUM BETA HCG,"B-hCG, Qualitative",,Negative,,,,,Ref Rng: Negative, +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,SERUM BETA HCG,"B-hCG, Quantitative",,<0.6,,,,,Units: mIU/mL$Pre-menopausal$<5.0: Negative$5.0-24.9:Borderline$>/= 25.0: Positive, +CZ100132003,,,,,Female,Screening,,"May 6, 2026 10:45 AM",6227635141,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,ALP<2XULN,ALP<2XULN,,Criteria Met,,,,,, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,ALT>/=3XULN,ALT >/= 3 X ULN,,Criteria not met,,,,,, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,ALT>/=3XULN & TBIL>/=2XULN,ALT >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,AST>/=3XULN,AST >/= 3 X ULN,,Criteria not met,,,,,, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,AST>/=3XULN & TBIL>/=2XULN,AST >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.6,,,,,0 - 6.2,umol/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,Alkaline Phosphatase,,88,,,,,40 - 129,U/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,ALT (SGPT),,36,,,,,5 - 48,U/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,AST (SGOT),,30,,,,,8 - 40,U/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,GGT,,21,,,,,10 - 61,U/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,LDH,,172,,,,,53 - 234,U/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,Urea Nitrogen,,6.2,,,,,1.4 - 8.6,mmol/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,71,,,,,40 - 110,umol/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,Serum Glucose,,4.6,,,,,3.9 - 5.6,mmol/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,Serum Uric Acid,,297,,,,,125 - 488,umol/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,Calcium (EDTA),,2.45,,,,,2.07 - 2.64,mmol/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,Phosphorus,,1.22,,,,,0.71 - 1.65,mmol/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,Total Protein,,74,,,,,61 - 84,g/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,Albumin-BCG,,48,,,,,33 - 49,g/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,Creatine Kinase,,177,,,,,39 - 308,U/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,Serum Bicarbonate,,26.7,,,,,19.3 - 29.3,mmol/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,Serum Chloride,,100,,,,,94 - 112,mmol/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CHEMISTRY PANEL,Magnesium,,0.83,,,,,0.66 - 1.07,mmol/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,123,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,FECAL COLLECTION D/T,Stool Collection Date,Y,21-Apr-2026,,,,,, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,FECAL COLLECTION D/T,Stool Collection Time,Y,06:20,,,,,, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,152,,,,,127 - 181,g/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.43,,,,,0.39 - 0.54, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.9,,,,,4.5 - 6.4,TI/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,31,,,,,26 - 34,pg +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,Normocytic,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,89,,,,,79 - 96,fL +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.31,,,,,3.8 - 10.7,GI/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,1.98,,,,,1.96 - 7.23,GI/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.64,,,,,0.91 - 4.28,GI/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.30,,,,,0.12 - 0.92,GI/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.30,,,,,0 - 0.57,GI/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.09,,,,,0 - 0.2,GI/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,46.0,,,,,40.5 - 75,% +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,38.0,,,,,15.4 - 48.5,% +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.0,,,,,2.6 - 10.1,% +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,7.0,,H,,,0 - 6.8,% +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,2.0,,,,,0 - 2,% +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,226,,,,,140 - 400,GI/L +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,21-Apr-2026,,,,,, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,08:45,,,,,, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,21-Apr-2026,,,,,, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,09:50,,,,,, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,21-Apr-2026,,,,,, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,08:45,,,,,, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,SM09/STOOL PK COLL D/T,Stool Collection Date,Y,21-Apr-2026,,,,,, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,SM09/STOOL PK COLL D/T,Stool Collection Time,Y,06:20,,,,,, +CZ100132001,,,,,Male,Induction Week 4,,"Apr 21, 2026 8:45 AM",6227635146,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100132002,,,,,Male,Biopsy,,"Apr 21, 2026 12:00 AM",6227635159,ANATOMICAL SITE,Anatomical Site,Y,15-20cm from anal verge,,,,,, +CZ100132002,,,,,Male,Biopsy,,"Apr 21, 2026 12:00 AM",6227635159,BIOPSY COLLECTION METHOD,Collection Method,Y,colonoscopy,,,,,, +CZ100132002,,,,,Male,Biopsy,,"Apr 21, 2026 12:00 AM",6227635159,BIOPSY FIXATIVE USED,Fixative Used,,10% NBF,,,,,, +CZ100132002,,,,,Male,Biopsy,,"Apr 21, 2026 12:00 AM",6227635159,DATE/TIME PLACED IN FORMALIN,Date Sample placed in Formalin,Y,21-Apr-2026,,,,,, +CZ100132002,,,,,Male,Biopsy,,"Apr 21, 2026 12:00 AM",6227635159,DATE/TIME PLACED IN FORMALIN,Time Sample placed in Formalin,Y,08:45,,,,,, +CZ100132002,,,,,Male,Biopsy,,"Apr 21, 2026 12:00 AM",6227635159,DIAGNOSIS,Diagnosis:,Y,Ulcerative Colitis,,,,,, +CZ100132002,,,,,Male,Biopsy,,"Apr 21, 2026 12:00 AM",6227635159,INFLAMED AREA,Inflamed area?,,Yes,,,,,, +CZ100132002,,,,,Male,Biopsy,,"Apr 21, 2026 12:00 AM",6227635159,TISSUE BIOPSY EMBEDDING1,Biopsy technical QC-CL,,Smpl meets HT requirements,,,,,, +CZ100132002,,,,,Male,Biopsy,,"Apr 21, 2026 12:00 AM",6227635159,TISSUE BIOPSY EMBEDDING1,Biopsy processing Time-CL,,12:00,,,,,, +CZ100132002,,,,,Male,Biopsy,,"Apr 21, 2026 12:00 AM",6227635159,TISSUE BIOPSY EMBEDDING1,Biopsy processing Date-CL,,23-Apr-2026,,,,,, +CZ100132002,,,,,Male,Biopsy,,"Apr 21, 2026 12:00 AM",6227635159,TISSUE BIOPSY EMBEDDING1,Biopsy Comments-CL,,Received in 10% NBF,,,,,, +CZ100132002,,,,,Male,Biopsy,,"Apr 21, 2026 12:00 AM",6227635159,TISSUE BIOPSY EMBEDDING1,# of Cassettes-(FI)-CL,,1,,,,,, +CZ100132002,,,,,Male,Biopsy,,"Apr 21, 2026 12:00 AM",6227635159,ULCERATED AREA,Is biopsy site ulcerated?,,Yes,,,,,, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,ALP<2XULN,ALP<2XULN,,Criteria Met,,,,,, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,ALT>/=3XULN,ALT >/= 3 X ULN,,Criteria not met,,,,,, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,ALT>/=3XULN & TBIL>/=2XULN,ALT >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,AST>/=3XULN,AST >/= 3 X ULN,,Criteria not met,,,,,, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,AST>/=3XULN & TBIL>/=2XULN,AST >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,Total Bilirubin,,9,,,,,3 - 21,umol/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.8,,,,,0 - 6.2,umol/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,Alkaline Phosphatase,,87,,,,,40 - 129,U/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,ALT (SGPT),,27,,,,,5 - 48,U/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,AST (SGOT),,25,,,,,8 - 40,U/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,GGT,,14,,,,,10 - 61,U/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,LDH,,174,,,,,53 - 234,U/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,Urea Nitrogen,,5.5,,,,,1.4 - 8.6,mmol/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,87,,,,,40 - 110,umol/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,Serum Glucose,,4.9,,,,,3.9 - 5.6,mmol/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,Serum Uric Acid,,299,,,,,125 - 488,umol/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,Calcium (EDTA),,2.44,,,,,2.07 - 2.64,mmol/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,Phosphorus,,1.17,,,,,0.71 - 1.65,mmol/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,Total Protein,,73,,,,,61 - 84,g/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,Albumin-BCG,,49,,,,,33 - 49,g/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,Creatine Kinase,,177,,,,,39 - 308,U/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,Serum Bicarbonate,,26.5,,,,,19.3 - 29.3,mmol/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CHEMISTRY PANEL,Magnesium,,0.79,,,,,0.66 - 1.07,mmol/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,107,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,FECAL COLLECTION D/T,Stool Collection Date,Y,07-Apr-2026,,,,,, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,FECAL COLLECTION D/T,Stool Collection Time,Y,06:30,,,,,, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,150,,,,,127 - 181,g/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.45,,,,,0.39 - 0.54, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.9,,,,,4.5 - 6.4,TI/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,31,,,,,26 - 34,pg +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,92,,,,,79 - 96,fL +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.89,,,,,3.8 - 10.7,GI/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.33,,,,,1.96 - 7.23,GI/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.84,,,,,0.91 - 4.28,GI/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.25,,,,,0.12 - 0.92,GI/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.37,,,,,0 - 0.57,GI/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.09,,,,,0 - 0.2,GI/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,47.7,,,,,40.5 - 75,% +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,37.7,,,,,15.4 - 48.5,% +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.2,,,,,2.6 - 10.1,% +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,7.7,R,H,,,0 - 6.8,% +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.8,,,,,0 - 2,% +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,217,,,,,140 - 400,GI/L +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,07-Apr-2026,,,,,, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,08:50,,,,,, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,07-Apr-2026,,,,,, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,10:00,,,,,, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,07-Apr-2026,,,,,, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,08:50,,,,,, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,SM09/STOOL PK COLL D/T,Stool Collection Date,Y,07-Apr-2026,,,,,, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,SM09/STOOL PK COLL D/T,Stool Collection Time,Y,06:30,,,,,, +CZ100132001,,,,,Male,Induction Week 2,,"Apr 7, 2026 8:50 AM",6227635144,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100132002,,,,,Male,Stool Pathogens,,"Apr 1, 2026 8:30 AM",6227635148,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100132002,,,,,Male,Stool Pathogens,,"Apr 1, 2026 8:30 AM",6227635148,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100132002,,,,,Male,Stool Pathogens,,"Apr 1, 2026 8:30 AM",6227635148,OVA AND PARASITES 1,Concentrate Exam,,No ova or parasites found,,,,,, +CZ100132002,,,,,Male,Stool Pathogens,,"Apr 1, 2026 8:30 AM",6227635148,OVA AND PARASITES 1,Smear for Microsporidia,,No Microsporidia seen.,,,,,, +CZ100132002,,,,,Male,Stool Pathogens,,"Apr 1, 2026 8:30 AM",6227635148,OVA AND PARASITES 1,Modified acid-fast stain,,No coccidian parasites seen,,,,,, +CZ100132002,,,,,Male,Stool Pathogens,,"Apr 1, 2026 8:30 AM",6227635148,OVA AND PARASITES 2,Trichrome Smear,,No ova or parasites found,,,,,, +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.5,,,,,0 - 6.2,umol/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,Alkaline Phosphatase,,69,,,,,40 - 129,U/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,ALT (SGPT),,20,,,,,5 - 48,U/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,AST (SGOT),,18,,,,,8 - 40,U/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,GGT,,15,,,,,10 - 61,U/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,LDH,,130,,,,,53 - 234,U/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,Urea Nitrogen,,6.0,,,,,1.4 - 8.6,mmol/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,82,,,,,40 - 110,umol/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,Serum Glucose,,7.1,,H,,,3.9 - 5.6,mmol/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,Serum Uric Acid,,301,,,,,125 - 488,umol/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,Calcium (EDTA),,2.45,,,,,2.07 - 2.64,mmol/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,Phosphorus,,1.42,,,,,0.71 - 1.65,mmol/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,Total Protein,,66,,,,,61 - 84,g/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,Creatine Kinase,,91,,,,,39 - 308,U/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,Serum Bicarbonate,,22.2,,,,,19.3 - 29.3,mmol/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CHEMISTRY PANEL,Magnesium,,0.75,,,,,0.66 - 1.07,mmol/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,114,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,147,,,,,127 - 181,g/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.41,,,,,0.39 - 0.54, +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.3,R,L,,,4.5 - 6.4,TI/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,34,,,,,26 - 34,pg +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,96,,,,,79 - 96,fL +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,7.60,,,,,3.8 - 10.7,GI/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.44,,,,,1.96 - 7.23,GI/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.11,,,,,0.91 - 4.28,GI/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.65,,,,,0.12 - 0.92,GI/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.28,,,,,0 - 0.57,GI/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.12,,,,,0 - 0.2,GI/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,58.4,,,,,40.5 - 75,% +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,27.8,,,,,15.4 - 48.5,% +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,8.6,,,,,2.6 - 10.1,% +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.7,,,,,0 - 6.8,% +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.5,,,,,0 - 2,% +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,256,,,,,140 - 400,GI/L +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEPATITIS B SURFACE AB,Anti-HBs II QUAL,,Reactive,,,,,Ref Rng :$Non Reactive, +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Negative,,,,,Normal=Negative, +CZ100132002,,,,,Male,Screening,,"Apr 1, 2026 8:00 AM",6227635139,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,Total Bilirubin,,9,,,,,3 - 21,umol/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.4,,,,,0 - 6.2,umol/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,Alkaline Phosphatase,,80,,,,,40 - 129,U/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,ALT (SGPT),,24,,,,,5 - 48,U/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,AST (SGOT),,19,,,,,8 - 40,U/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,GGT,,13,,,,,10 - 61,U/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,LDH,,166,,,,,53 - 234,U/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,Urea Nitrogen,,7.7,,,,,1.4 - 8.6,mmol/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,89,,,,,40 - 110,umol/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,Serum Glucose,,4.3,,,,,3.9 - 5.6,mmol/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,Serum Uric Acid,,336,,,,,125 - 488,umol/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,Calcium (EDTA),,2.41,,,,,2.07 - 2.64,mmol/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,Phosphorus,,1.04,,,,,0.71 - 1.65,mmol/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,Total Protein,,72,,,,,61 - 84,g/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,Albumin-BCG,,47,,,,,33 - 49,g/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,Creatine Kinase,,135,,,,,39 - 308,U/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,Serum Potassium,,4.3,,,,,3.5 - 5.2,mmol/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,Serum Bicarbonate,,22.2,,,,,19.3 - 29.3,mmol/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CHEMISTRY PANEL,Magnesium,,0.78,,,,,0.66 - 1.07,mmol/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,103,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,FECAL COLLECTION D/T,Stool Collection Date,Y,24-Mar-2026,,,,,, +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,FECAL COLLECTION D/T,Stool Collection Time,Y,07:30,,,,,, +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,156,,,,,127 - 181,g/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.46,,,,,0.39 - 0.54, +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.1,,,,,4.5 - 6.4,TI/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,31,,,,,26 - 34,pg +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,92,,,,,79 - 96,fL +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.53,,,,,3.8 - 10.7,GI/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.00,,,,,1.96 - 7.23,GI/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.61,,,,,0.91 - 4.28,GI/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.25,,,,,0.12 - 0.92,GI/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.57,,,,,0 - 0.57,GI/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.10,,,,,0 - 0.2,GI/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,54.3,,,,,40.5 - 75,% +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,29.0,,,,,15.4 - 48.5,% +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.6,,,,,2.6 - 10.1,% +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,10.4,R,H,,,0 - 6.8,% +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.8,,,,,0 - 2,% +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,235,,,,,140 - 400,GI/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,LIPID PANEL,Direct HDL-C 4th Generation,,1.91,,H,,,1.03 - 1.53,mmol/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,LIPID PANEL,Triglycerides (GPO),,0.67,,,,,0.5 - 2.81,mmol/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,LIPID PANEL,Cholesterol (High Performance),,4.26,,,,,3.31 - 6.1,mmol/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,LIPID PANEL,LDL Chol Friedewald 4th,,2.04,,,,,0 - 3.34,mmol/L +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,24-Mar-2026,,,,,, +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,09:40,R,,,,, +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,24-Mar-2026,,,,,, +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,10:45,,,,,, +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,24-Mar-2026,,,,,, +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,09:40,R,,,,, +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,SM10/FECAL BMRKS COLL D/T,Stool Collection Date,Y,24-Mar-2026,,,,,, +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,SM10/FECAL BMRKS COLL D/T,Stool Collection Time,Y,07:30,,,,,, +CZ100132001,,,,,Male,Induction Week 0,,"Mar 24, 2026 9:40 AM",6227635142,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100132001,,,,,Male,Biopsy,,"Mar 12, 2026 12:00 AM",6227635161,ANATOMICAL SITE,Anatomical Site,Y,15-20cm from anal verge,,,,,, +CZ100132001,,,,,Male,Biopsy,,"Mar 12, 2026 12:00 AM",6227635161,BIOPSY COLLECTION METHOD,Collection Method,Y,colonoscopy,,,,,, +CZ100132001,,,,,Male,Biopsy,,"Mar 12, 2026 12:00 AM",6227635161,BIOPSY FIXATIVE USED,Fixative Used,,10% NBF,,,,,, +CZ100132001,,,,,Male,Biopsy,,"Mar 12, 2026 12:00 AM",6227635161,DATE/TIME PLACED IN FORMALIN,Date Sample placed in Formalin,Y,12-Mar-2026,,,,,, +CZ100132001,,,,,Male,Biopsy,,"Mar 12, 2026 12:00 AM",6227635161,DATE/TIME PLACED IN FORMALIN,Time Sample placed in Formalin,Y,07:52,,,,,, +CZ100132001,,,,,Male,Biopsy,,"Mar 12, 2026 12:00 AM",6227635161,DIAGNOSIS,Diagnosis:,Y,Ulcerative Colitis,,,,,, +CZ100132001,,,,,Male,Biopsy,,"Mar 12, 2026 12:00 AM",6227635161,INFLAMED AREA,Inflamed area?,,Yes,,,,,, +CZ100132001,,,,,Male,Biopsy,,"Mar 12, 2026 12:00 AM",6227635161,TISSUE BIOPSY EMBEDDING1,Biopsy technical QC-CL,,Smpl meets HT requirements,,,,,, +CZ100132001,,,,,Male,Biopsy,,"Mar 12, 2026 12:00 AM",6227635161,TISSUE BIOPSY EMBEDDING1,Biopsy processing Time-CL,,10:00,,,,,, +CZ100132001,,,,,Male,Biopsy,,"Mar 12, 2026 12:00 AM",6227635161,TISSUE BIOPSY EMBEDDING1,Biopsy processing Date-CL,,14-Mar-2026,,,,,, +CZ100132001,,,,,Male,Biopsy,,"Mar 12, 2026 12:00 AM",6227635161,TISSUE BIOPSY EMBEDDING1,Biopsy Comments-CL,,Received in 10% NBF,,,,,, +CZ100132001,,,,,Male,Biopsy,,"Mar 12, 2026 12:00 AM",6227635161,TISSUE BIOPSY EMBEDDING1,# of Cassettes-(FI)-CL,,1,,,,,, +CZ100132001,,,,,Male,Biopsy,,"Mar 12, 2026 12:00 AM",6227635161,ULCERATED AREA,Is biopsy site ulcerated?,,No,,,,,, +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.7,,,,,0 - 6.2,umol/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,Alkaline Phosphatase,,95,,,,,40 - 129,U/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,ALT (SGPT),,25,,,,,5 - 48,U/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,AST (SGOT),,16,,,,,8 - 40,U/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,GGT,,16,,,,,10 - 61,U/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,LDH,,149,,,,,53 - 234,U/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,Urea Nitrogen,,7.1,,,,,1.4 - 8.6,mmol/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,89,,,,,40 - 110,umol/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,Serum Glucose,,6.6,,H,,,3.9 - 5.6,mmol/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,Serum Uric Acid,,358,,,,,125 - 488,umol/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,Calcium (EDTA),,2.32,,,,,2.07 - 2.64,mmol/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,Phosphorus,,1.05,,,,,0.71 - 1.65,mmol/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,Total Protein,,72,,,,,61 - 84,g/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,Albumin-BCG,,47,,,,,33 - 49,g/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,Creatine Kinase,,100,,,,,39 - 308,U/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,Serum Potassium,,3.8,,,,,3.5 - 5.2,mmol/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,Serum Bicarbonate,,23.4,,,,,19.3 - 29.3,mmol/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CHEMISTRY PANEL,Magnesium,,0.75,,,,,0.66 - 1.07,mmol/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,103,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,154,,,,,127 - 181,g/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.45,,,,,0.39 - 0.54, +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.0,,,,,4.5 - 6.4,TI/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,31,,,,,26 - 34,pg +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,90,,,,,79 - 96,fL +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.82,,,,,3.8 - 10.7,GI/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.88,,,,,1.96 - 7.23,GI/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.03,,,,,0.91 - 4.28,GI/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.26,,,,,0.12 - 0.92,GI/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.57,,,,,0 - 0.57,GI/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.08,,,,,0 - 0.2,GI/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,49.4,,,,,40.5 - 75,% +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,34.9,,,,,15.4 - 48.5,% +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.4,,,,,2.6 - 10.1,% +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,9.9,,H,,,0 - 6.8,% +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.4,,,,,0 - 2,% +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,222,,,,,140 - 400,GI/L +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEPATITIS B SURFACE AB,Anti-HBs II QUAL,,Non-Reactive,,,,,Ref Rng :$Non Reactive, +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Negative,,,,,Normal=Negative, +CZ100132001,,,,,Male,Screening,,"Feb 26, 2026 1:20 PM",6227635140,SUBJECT HEIGHT (CM),Height (cm),Y,163,,,,,cm, +CZ100132001,,,,,Male,Stool Pathogens,,"Feb 26, 2026 10:35 AM",6227635149,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100132001,,,,,Male,Stool Pathogens,,"Feb 26, 2026 10:35 AM",6227635149,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100132001,,,,,Male,Stool Pathogens,,"Feb 26, 2026 10:35 AM",6227635149,OVA AND PARASITES 1,Concentrate Exam,,No ova or parasites found,,,,,, +CZ100132001,,,,,Male,Stool Pathogens,,"Feb 26, 2026 10:35 AM",6227635149,OVA AND PARASITES 1,Smear for Microsporidia,,No Microsporidia seen.,,,,,, +CZ100132001,,,,,Male,Stool Pathogens,,"Feb 26, 2026 10:35 AM",6227635149,OVA AND PARASITES 1,Modified acid-fast stain,,No coccidian parasites seen,,,,,, +CZ100132001,,,,,Male,Stool Pathogens,,"Feb 26, 2026 10:35 AM",6227635149,OVA AND PARASITES 2,Trichrome Smear,,No ova or parasites found,,,,,, diff --git a/Covance_UCO3001/Source/2026-05-29_132758 sponsor-study-36940-test-results-930547-microbiology.csv b/Covance_UCO3001/Source/2026-05-29_132758 sponsor-study-36940-test-results-930547-microbiology.csv new file mode 100644 index 0000000..b9b31df --- /dev/null +++ b/Covance_UCO3001/Source/2026-05-29_132758 sponsor-study-36940-test-results-930547-microbiology.csv @@ -0,0 +1,5 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,,,,,, +Subject,Screening Number,Age,Age Unit,Gender,Visit Description,Collected Time,Accession,Test Group,Specimen,Organism,Growth,Cancellation Reason,Test Description,Test Result,Drug Name/Agent,MIC Result,Units,MIC Interpretation,Disk Diffusion Result,Disk Diffusion Interpretation,Subject Data Revision,Visit Data Revision,Result Data Revision +CZ100132001 - null,,,,Male,SCRNSTOOL Stool Pathogens,"Feb 26, 2026 10:35 AM",6227635149,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,, +CZ100132002 - null,,,,Male,SCRNSTOOL Stool Pathogens,"Apr 1, 2026 8:30 AM",6227635148,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,, +CZ100132003 - null,,,,Female,SCRNSTOOL Stool Pathogens,"May 7, 2026 5:45 AM",6227635150,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,, diff --git a/Covance_UCO3001/Source/2026-05-29_132820 sponsor-study-36940-test-results-930555-standard.csv b/Covance_UCO3001/Source/2026-05-29_132820 sponsor-study-36940-test-results-930555-standard.csv new file mode 100644 index 0000000..71d4c30 --- /dev/null +++ b/Covance_UCO3001/Source/2026-05-29_132820 sponsor-study-36940-test-results-930555-standard.csv @@ -0,0 +1,409 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,, +Subject,Subject Data Revision,Screen No.,Age,Age Unit,Gender,Visit,Visit Data Revision,Collected Time,Accession,Test Group,Test,Administrative Question,Value,Result Data Revision,Flags,Cancellation Reason,Comments,Range,Units +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,Total Bilirubin,,18,,,,,3 - 21,umol/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,5.8,,,,,0 - 6.2,umol/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,Alkaline Phosphatase,,63,,,,,40 - 129,U/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,ALT (SGPT),,12,,,,,5 - 48,U/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,AST (SGOT),,18,,,,,8 - 40,U/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,GGT,,17,,,,,10 - 61,U/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,LDH,,124,,,,,53 - 234,U/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,Urea Nitrogen,,3.2,,,,,1.4 - 8.6,mmol/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,76,,,,,40 - 110,umol/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,Serum Glucose,,5.2,,,,,3.9 - 5.6,mmol/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,Serum Uric Acid,,298,,,,,125 - 488,umol/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,Calcium (EDTA),,2.33,,,,,2.07 - 2.64,mmol/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,Phosphorus,,1.21,,,,,0.71 - 1.65,mmol/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,Total Protein,,69,,,,,61 - 84,g/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,Albumin-BCG,,41,,,,,33 - 49,g/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,Creatine Kinase,,106,,,,,39 - 308,U/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,Serum Potassium,,4.0,,,,,3.5 - 5.2,mmol/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,Serum Bicarbonate,,23.8,,,,,19.3 - 29.3,mmol/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,CHEMISTRY PANEL,Magnesium,,0.81,,,,,0.66 - 1.07,mmol/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,FECAL COLLECTION D/T,Stool Collection Date,Y,26-May-2026,,,,,, +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,FECAL COLLECTION D/T,Stool Collection Time,Y,06:20,,,,,, +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,129,,,,,127 - 181,g/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.40,,,,,0.39 - 0.54, +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.3,,L,,,4.5 - 6.4,TI/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,30,,,,,26 - 34,pg +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,92,,,,,79 - 96,fL +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.10,,,,,3.8 - 10.7,GI/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.34,,,,,1.96 - 7.23,GI/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.09,,,,,0.91 - 4.28,GI/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.48,,,,,0.12 - 0.92,GI/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.16,,,,,0 - 0.57,GI/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,65.5,,,,,40.5 - 75,% +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,21.4,,,,,15.4 - 48.5,% +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,9.5,,,,,2.6 - 10.1,% +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.2,,,,,0 - 6.8,% +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.4,,,,,0 - 2,% +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,270,,,,,140 - 400,GI/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,IS SUBJECT FASTING?,Is Subject Fasting?,Y,,,,,,, +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,LIPID PANEL,Direct HDL-C 4th Generation,,0.90,,L,,,1.03 - 1.53,mmol/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,LIPID PANEL,Triglycerides (GPO),,0.88,,,,,0.62 - 3.69,mmol/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,LIPID PANEL,Cholesterol (High Performance),,2.48,,L,,Result verified by repeat analysis,4.19 - 7.24,mmol/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,LIPID PANEL,LDL Chol Friedewald 4th,,1.18,,,,,0 - 3.34,mmol/L +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,PA1 EEA-2?,Approved to use EEA-2?,,,,,,,, +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,26-May-2026,,,,,, +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,07:15,,,,,, +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,26-May-2026,,,,,, +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,09:05,,,,,, +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,26-May-2026,,,,,, +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,07:15,,,,,, +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,SM10/FECAL BMRKS COLL D/T,Stool Collection Date,Y,26-May-2026,,,,,, +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,SM10/FECAL BMRKS COLL D/T,Stool Collection Time,Y,06:20,,,,,, +CZ100062002,,,,,Male,Induction Week 0,,"May 26, 2026 9:20 AM",6227323238,SUBJECT HEIGHT (CM),Height (cm),Y,,,,,,, +CZ100062002,,,,,Male,Biopsy,,"May 14, 2026 12:00 AM",6227323256,ANATOMICAL SITE,Anatomical Site,Y,15-20,,,,,, +CZ100062002,,,,,Male,Biopsy,,"May 14, 2026 12:00 AM",6227323256,BIOPSY COLLECTION METHOD,Collection Method,Y,colonoscopy,,,,,, +CZ100062002,,,,,Male,Biopsy,,"May 14, 2026 12:00 AM",6227323256,BIOPSY FIXATIVE USED,Fixative Used,,10% NBF,,,,,, +CZ100062002,,,,,Male,Biopsy,,"May 14, 2026 12:00 AM",6227323256,DATE/TIME PLACED IN FORMALIN,Date Sample placed in Formalin,Y,14-May-2026,,,,,, +CZ100062002,,,,,Male,Biopsy,,"May 14, 2026 12:00 AM",6227323256,DATE/TIME PLACED IN FORMALIN,Time Sample placed in Formalin,Y,08:15,,,,,, +CZ100062002,,,,,Male,Biopsy,,"May 14, 2026 12:00 AM",6227323256,DIAGNOSIS,Diagnosis:,Y,Ulcerative Colitis,,,,,, +CZ100062002,,,,,Male,Biopsy,,"May 14, 2026 12:00 AM",6227323256,INFLAMED AREA,Inflamed area?,,Yes,,,,,, +CZ100062002,,,,,Male,Biopsy,,"May 14, 2026 12:00 AM",6227323256,TISSUE BIOPSY EMBEDDING1,Biopsy technical QC-CL,,Smpl meets HT requirements,,,,,, +CZ100062002,,,,,Male,Biopsy,,"May 14, 2026 12:00 AM",6227323256,TISSUE BIOPSY EMBEDDING1,Biopsy processing Time-CL,,10:00,,,,,, +CZ100062002,,,,,Male,Biopsy,,"May 14, 2026 12:00 AM",6227323256,TISSUE BIOPSY EMBEDDING1,Biopsy processing Date-CL,,16-May-2026,,,,,, +CZ100062002,,,,,Male,Biopsy,,"May 14, 2026 12:00 AM",6227323256,TISSUE BIOPSY EMBEDDING1,Biopsy Comments-CL,,Received in 10% NBF,,,,,, +CZ100062002,,,,,Male,Biopsy,,"May 14, 2026 12:00 AM",6227323256,TISSUE BIOPSY EMBEDDING1,# of Cassettes-(FI)-CL,,1,,,,,, +CZ100062002,,,,,Male,Biopsy,,"May 14, 2026 12:00 AM",6227323256,ULCERATED AREA,Is biopsy site ulcerated?,,No,,,,,, +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.6,,,,,0 - 6.2,umol/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,Alkaline Phosphatase,,65,,,,,40 - 129,U/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,ALT (SGPT),,13,,,,,5 - 48,U/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,AST (SGOT),,24,,,,,8 - 40,U/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,GGT,,17,,,,,10 - 61,U/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,LDH,,151,,,,,53 - 234,U/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,Urea Nitrogen,,3.7,,,,,1.4 - 8.6,mmol/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,71,,,,,40 - 110,umol/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,Serum Glucose,,4.6,,,,,3.9 - 5.6,mmol/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,Serum Uric Acid,,338,,,,,125 - 488,umol/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,Calcium (EDTA),,2.32,,,,,2.07 - 2.64,mmol/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,Phosphorus,,1.19,,,,,0.71 - 1.65,mmol/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,Total Protein,,72,,,,,61 - 84,g/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,Creatine Kinase,,281,,,,,39 - 308,U/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,Serum Sodium,,142,,,,,132 - 147,mmol/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,Serum Potassium,,4.0,,,,,3.5 - 5.2,mmol/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,Serum Bicarbonate,,26.0,,,,,19.3 - 29.3,mmol/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CHEMISTRY PANEL,Magnesium,,0.81,,,,,0.66 - 1.07,mmol/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,108,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,140,,,,,127 - 181,g/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.41,,,,,0.39 - 0.54, +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.6,,,,,4.5 - 6.4,TI/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,30,,,,,26 - 34,pg +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,Anisocytosis,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,89,,,,,79 - 96,fL +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.17,,,,,3.8 - 10.7,GI/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.25,,,,,1.96 - 7.23,GI/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.20,,,,,0.91 - 4.28,GI/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.38,,,,,0.12 - 0.92,GI/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.22,,,,,0 - 0.57,GI/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.11,,,,,0 - 0.2,GI/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,54.0,,,,,40.5 - 75,% +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,28.9,,,,,15.4 - 48.5,% +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,9.1,,,,,2.6 - 10.1,% +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,5.3,,,,,0 - 6.8,% +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,2.7,,H,,,0 - 2,% +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,306,,,,,140 - 400,GI/L +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEPATITIS B SURFACE AB,Anti-HBs II QUAL,,Reactive,,,,,Ref Rng :$Non Reactive, +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Negative,,,,,Normal=Negative, +CZ100062002,,,,,Male,Screening,,"Apr 20, 2026 7:45 AM",6227323234,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100062002,,,,,Male,Stool Pathogens,,"Apr 20, 2026 7:45 AM",6228194341,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100062002,,,,,Male,Stool Pathogens,,"Apr 20, 2026 7:45 AM",6228194341,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100062002,,,,,Male,Stool Pathogens,,"Apr 20, 2026 7:45 AM",6228194341,OVA AND PARASITES 1,Concentrate Exam,,,,,Test group cancelled: No specimen received,,, +CZ100062002,,,,,Male,Stool Pathogens,,"Apr 20, 2026 7:45 AM",6228194341,OVA AND PARASITES 1,Smear for Microsporidia,,,,,Test group cancelled: No specimen received,,, +CZ100062002,,,,,Male,Stool Pathogens,,"Apr 20, 2026 7:45 AM",6228194341,OVA AND PARASITES 1,Modified acid-fast stain,,,,,Test group cancelled: No specimen received,,, +CZ100062002,,,,,Male,Stool Pathogens,,"Apr 20, 2026 7:45 AM",6228194341,OVA AND PARASITES 2,Trichrome Smear,,,,,Test group cancelled: No specimen received,,, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,ALP<2XULN,ALP<2XULN,,Criteria Met,,,,,, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,ALT>/=3XULN,ALT >/= 3 X ULN,,Criteria not met,,,,,, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,ALT>/=3XULN & TBIL>/=2XULN,ALT >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,AST>/=3XULN,AST >/= 3 X ULN,,Criteria not met,,,,,, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,AST>/=3XULN & TBIL>/=2XULN,AST >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.3,,,,,0 - 6.2,umol/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,Alkaline Phosphatase,,91,,,,,40 - 129,U/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,ALT (SGPT),,8,,,,,5 - 48,U/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,AST (SGOT),,14,,,,,8 - 40,U/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,GGT,,14,,,,,10 - 61,U/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,LDH,,118,,,,,53 - 234,U/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,Urea Nitrogen,,1.6,,,,,1.4 - 8.6,mmol/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,92,,,,,40 - 110,umol/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,Serum Glucose,,4.7,,,,,3.9 - 5.6,mmol/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,Serum Uric Acid,,424,,,,,125 - 488,umol/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,Calcium (EDTA),,2.51,,,,,2.07 - 2.64,mmol/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,Phosphorus,,1.29,,,,,0.71 - 1.65,mmol/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,Total Protein,,78,,,,,61 - 84,g/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,Albumin-BCG,,42,,,,,33 - 49,g/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,Creatine Kinase,,41,,,,,39 - 308,U/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,Serum Bicarbonate,,24.0,,,,,19.3 - 29.3,mmol/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,Serum Chloride,,96,,,,,94 - 112,mmol/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CHEMISTRY PANEL,Magnesium,,0.93,,H,,,0.7 - 0.9,mmol/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,106,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,FECAL COLLECTION D/T,Stool Collection Date,Y,14-Apr-2026,,,,,, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,FECAL COLLECTION D/T,Stool Collection Time,Y,20:30,,,,,, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,122,R,L,,,127 - 181,g/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.42,,,,,0.39 - 0.54, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.1,,,,,4.5 - 6.4,TI/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,24,R,L,,,26 - 34,pg +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,Normocytic,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,83,,,,,79 - 96,fL +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,14.93,R,H,,,3.8 - 10.7,GI/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,10.00,R,H,,,1.96 - 7.23,GI/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.54,,,,,0.91 - 4.28,GI/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,1.79,R,H,,,0.12 - 0.92,GI/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.60,R,H,,,0 - 0.57,GI/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.00,,,,,0 - 0.2,GI/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,67.0,,,,,40.5 - 75,% +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,17.0,,,,,15.4 - 48.5,% +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,12.0,R,H,,,2.6 - 10.1,% +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,4.0,,,,,0 - 6.8,% +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.0,,,,,0 - 2,% +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,647,R,H,,,140 - 400,GI/L +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,14-Apr-2026,,,,,, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,07:15,,,,,, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,14-Apr-2026,,,,,, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,08:40,,,,,, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,14-Apr-2026,,,,,, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,07:15,,,,,, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,SM09/STOOL PK COLL D/T,Stool Collection Date,Y,14-Apr-2026,,,,,, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,SM09/STOOL PK COLL D/T,Stool Collection Time,Y,20:30,,,,,, +CZ100062001,,,,,Male,Induction Week 4,,"Apr 15, 2026 8:45 AM",6227323242,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,ALP<2XULN,ALP<2XULN,,Criteria Met,,,,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,ALT>/=3XULN,ALT >/= 3 X ULN,,Criteria not met,,,,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,ALT>/=3XULN & TBIL>/=2XULN,ALT >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,AST>/=3XULN,AST >/= 3 X ULN,,Criteria not met,,,,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,AST>/=3XULN & TBIL>/=2XULN,AST >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,Total Bilirubin,,8,,,,,3 - 21,umol/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.6,,,,,0 - 6.2,umol/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,Alkaline Phosphatase,,85,,,,,40 - 129,U/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,ALT (SGPT),,9,,,,,5 - 48,U/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,AST (SGOT),,19,,,,,8 - 40,U/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,GGT,,14,,,,,10 - 61,U/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,LDH,,113,,,,,53 - 234,U/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,Urea Nitrogen,,2.0,,,,,1.4 - 8.6,mmol/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,86,,,,,40 - 110,umol/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,Serum Glucose,,4.5,,,,,3.9 - 5.6,mmol/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,Serum Uric Acid,,410,,,,,125 - 488,umol/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,Calcium (EDTA),,2.43,,,,,2.07 - 2.64,mmol/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,Phosphorus,,1.28,,,,,0.71 - 1.65,mmol/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,Total Protein,,72,,,,,61 - 84,g/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,Albumin-BCG,,43,,,,,33 - 49,g/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,Creatine Kinase,,64,,,,,39 - 308,U/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,Serum Potassium,,4.6,,,,,3.5 - 5.2,mmol/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,Serum Bicarbonate,,23.2,,,,,19.3 - 29.3,mmol/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CHEMISTRY PANEL,Magnesium,,0.93,R,H,,,0.7 - 0.9,mmol/L +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,115,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,FECAL COLLECTION D/T,Stool Collection Date,Y,08-Apr-2026,,,,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,FECAL COLLECTION D/T,Stool Collection Time,Y,07:10,,,,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,08-Apr-2026,,,,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,07:10,,,,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,08-Apr-2026,,,,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,08:20,,,,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,08-Apr-2026,,,,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,07:10,,,,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,SM09/STOOL PK COLL D/T,Stool Collection Date,Y,08-Apr-2026,,,,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,SM09/STOOL PK COLL D/T,Stool Collection Time,Y,07:10,,,,,, +CZ100062001,,,,,Male,Induction Week 2,,"Apr 8, 2026 7:10 AM",6227323240,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.5,,,,,0 - 6.2,umol/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,Alkaline Phosphatase,,89,,,,,40 - 129,U/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,ALT (SGPT),,8,,,,,5 - 48,U/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,AST (SGOT),,17,,,,,8 - 40,U/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,GGT,,18,,,,,10 - 61,U/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,LDH,,141,,,,,53 - 234,U/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,Urea Nitrogen,,2.5,,,,,1.4 - 8.6,mmol/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,76,,,,,40 - 110,umol/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,Serum Glucose,,4.0,,,,,3.9 - 5.6,mmol/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,Serum Uric Acid,,415,,,,,125 - 488,umol/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,Calcium (EDTA),,2.41,,,,,2.07 - 2.64,mmol/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,Phosphorus,,1.26,,,,,0.71 - 1.65,mmol/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,Total Protein,,75,,,,,61 - 84,g/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,Creatine Kinase,,119,,,,,39 - 308,U/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,Serum Potassium,,4.1,,,,,3.5 - 5.2,mmol/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,Serum Bicarbonate,,23.3,,,,,19.3 - 29.3,mmol/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CHEMISTRY PANEL,Magnesium,,0.90,,,,,0.7 - 0.9,mmol/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,128,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,FECAL COLLECTION D/T,Stool Collection Date,Y,20-Mar-2026,,,,,, +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,FECAL COLLECTION D/T,Stool Collection Time,Y,08:00,,,,,, +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,121,,L,,,127 - 181,g/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.39,,,,,0.39 - 0.54, +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.8,,,,,4.5 - 6.4,TI/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,25,,L,,,26 - 34,pg +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,Normocytic,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,81,,,,,79 - 96,fL +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,13.09,,H,,,3.8 - 10.7,GI/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,9.29,,H,,,1.96 - 7.23,GI/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.23,,,,,0.91 - 4.28,GI/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,1.31,,H,,,0.12 - 0.92,GI/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.13,,,,,0 - 0.57,GI/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.13,,,,,0 - 0.2,GI/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,71.0,,,,,40.5 - 75,% +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,17.0,,,,,15.4 - 48.5,% +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,10.0,,,,,2.6 - 10.1,% +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.0,,,,,0 - 6.8,% +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.0,,,,,0 - 2,% +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,445,,H,,,140 - 400,GI/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,IS SUBJECT FASTING?,Is Subject Fasting?,Y,No,,,,,, +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,LIPID PANEL,Direct HDL-C 4th Generation,,1.53,,,,,1.03 - 1.53,mmol/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,LIPID PANEL,Triglycerides (GPO),,0.81,,,,,0.42 - 1.67,mmol/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,LIPID PANEL,Cholesterol (High Performance),,4.16,,,,,2.95 - 5.12,mmol/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,LIPID PANEL,LDL Chol Friedewald 4th,,2.26,,,,,0 - 3.34,mmol/L +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,20-Mar-2026,,,,,, +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,08:00,,,,,, +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,20-Mar-2026,,,,,, +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,09:00,,,,,, +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,20-Mar-2026,,,,,, +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,08:00,,,,,, +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,SM10/FECAL BMRKS COLL D/T,Stool Collection Date,Y,20-Mar-2026,,,,,, +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,SM10/FECAL BMRKS COLL D/T,Stool Collection Time,Y,08:00,,,,,, +CZ100062001,,,,,Male,Induction Week 0,,"Mar 20, 2026 8:00 AM",6227323237,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100062001,,,,,Male,Stool Pathogens,,"Mar 17, 2026 9:00 AM",6227323243,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100062001,,,,,Male,Stool Pathogens,,"Mar 17, 2026 9:00 AM",6227323243,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100062001,R,,,,Male,Unscheduled,R,"Mar 17, 2026 8:00 AM",6227323265,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,R,,,,Male,Unscheduled,R,"Mar 17, 2026 8:00 AM",6227323265,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,R,,,,Male,Unscheduled,R,"Mar 17, 2026 8:00 AM",6227323265,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,R,,,,Male,Unscheduled,R,"Mar 17, 2026 8:00 AM",6227323265,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,R,,,,Male,Unscheduled,R,"Mar 17, 2026 8:00 AM",6227323265,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,R,,,,Male,Unscheduled,R,"Mar 17, 2026 8:00 AM",6227323265,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,R,,,,Male,Unscheduled,R,"Mar 17, 2026 8:00 AM",6227323265,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,R,,,,Male,Unscheduled,R,"Mar 17, 2026 8:00 AM",6227323265,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,R,,,,Male,Unscheduled,R,"Mar 17, 2026 8:00 AM",6227323265,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,R,,,,Male,Unscheduled,R,"Mar 17, 2026 8:00 AM",6227323265,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,R,,,,Male,Unscheduled,R,"Mar 17, 2026 8:00 AM",6227323265,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,R,,,,Male,Unscheduled,R,"Mar 17, 2026 8:00 AM",6227323265,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,R,,,,Male,Unscheduled,R,"Mar 17, 2026 8:00 AM",6227323265,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,R,,,,Male,Unscheduled,R,"Mar 17, 2026 8:00 AM",6227323265,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,R,,,,Male,Unscheduled,R,"Mar 17, 2026 8:00 AM",6227323265,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,R,,,,Male,Unscheduled,R,"Mar 17, 2026 8:00 AM",6227323265,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,R,,,,Male,Unscheduled,R,"Mar 17, 2026 8:00 AM",6227323265,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,R,,,,Male,Unscheduled,R,"Mar 17, 2026 8:00 AM",6227323265,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Stool Pathogens,,"Mar 11, 2026 9:15 AM",6227323245,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,,,,Test group cancelled: No specimen received,,, +CZ100062001,,,,,Male,Stool Pathogens,,"Mar 11, 2026 9:15 AM",6227323245,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,,,,Test group cancelled: No specimen received,,, +CZ100062001,,,,,Male,Stool Pathogens,,"Mar 11, 2026 9:15 AM",6227323245,OVA AND PARASITES 1,Concentrate Exam,,,,,Test group cancelled: No specimen received,,, +CZ100062001,,,,,Male,Stool Pathogens,,"Mar 11, 2026 9:15 AM",6227323245,OVA AND PARASITES 1,Smear for Microsporidia,,,,,Test group cancelled: No specimen received,,, +CZ100062001,,,,,Male,Stool Pathogens,,"Mar 11, 2026 9:15 AM",6227323245,OVA AND PARASITES 1,Modified acid-fast stain,,,,,Test group cancelled: No specimen received,,, +CZ100062001,,,,,Male,Stool Pathogens,,"Mar 11, 2026 9:15 AM",6227323245,OVA AND PARASITES 2,Trichrome Smear,,,,,Test group cancelled: No specimen received,,, +CZ100062001,,,,,Male,TB Testing,,"Mar 11, 2026 9:10 AM",6227323253,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Negative,,,,,Normal=Negative, +CZ100062001,,,,,Male,Unscheduled,,"Mar 11, 2026 9:05 AM",6227323264,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Unscheduled,,"Mar 11, 2026 9:05 AM",6227323264,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Unscheduled,,"Mar 11, 2026 9:05 AM",6227323264,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Unscheduled,,"Mar 11, 2026 9:05 AM",6227323264,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Unscheduled,,"Mar 11, 2026 9:05 AM",6227323264,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Unscheduled,,"Mar 11, 2026 9:05 AM",6227323264,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Unscheduled,,"Mar 11, 2026 9:05 AM",6227323264,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Unscheduled,,"Mar 11, 2026 9:05 AM",6227323264,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Unscheduled,,"Mar 11, 2026 9:05 AM",6227323264,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Unscheduled,,"Mar 11, 2026 9:05 AM",6227323264,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Unscheduled,,"Mar 11, 2026 9:05 AM",6227323264,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Unscheduled,,"Mar 11, 2026 9:05 AM",6227323264,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Unscheduled,,"Mar 11, 2026 9:05 AM",6227323264,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Unscheduled,,"Mar 11, 2026 9:05 AM",6227323264,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Unscheduled,,"Mar 11, 2026 9:05 AM",6227323264,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Unscheduled,,"Mar 11, 2026 9:05 AM",6227323264,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Unscheduled,,"Mar 11, 2026 9:05 AM",6227323264,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Unscheduled,,"Mar 11, 2026 9:05 AM",6227323264,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100062001,,,,,Male,Biopsy,R,"Feb 19, 2026 12:00 AM",6227323254,ANATOMICAL SITE,Anatomical Site,Y,18,,,,,, +CZ100062001,,,,,Male,Biopsy,R,"Feb 19, 2026 12:00 AM",6227323254,BIOPSY COLLECTION METHOD,Collection Method,Y,sigmoidoscopy,,,,,, +CZ100062001,,,,,Male,Biopsy,R,"Feb 19, 2026 12:00 AM",6227323254,BIOPSY FIXATIVE USED,Fixative Used,,10% NBF,,,,,, +CZ100062001,,,,,Male,Biopsy,R,"Feb 19, 2026 12:00 AM",6227323254,DATE/TIME PLACED IN FORMALIN,Date Sample placed in Formalin,Y,19-Feb-2026,,,,,, +CZ100062001,,,,,Male,Biopsy,R,"Feb 19, 2026 12:00 AM",6227323254,DATE/TIME PLACED IN FORMALIN,Time Sample placed in Formalin,Y,07:20,,,,,, +CZ100062001,,,,,Male,Biopsy,R,"Feb 19, 2026 12:00 AM",6227323254,DIAGNOSIS,Diagnosis:,Y,Ulcerative Colitis,,,,,, +CZ100062001,,,,,Male,Biopsy,R,"Feb 19, 2026 12:00 AM",6227323254,INFLAMED AREA,Inflamed area?,,Yes,,,,,, +CZ100062001,,,,,Male,Biopsy,R,"Feb 19, 2026 12:00 AM",6227323254,TISSUE BIOPSY EMBEDDING1,Biopsy technical QC-CL,,Smpl meets HT requirements,,,,,, +CZ100062001,,,,,Male,Biopsy,R,"Feb 19, 2026 12:00 AM",6227323254,TISSUE BIOPSY EMBEDDING1,Biopsy processing Time-CL,,10:00,,,,,, +CZ100062001,,,,,Male,Biopsy,R,"Feb 19, 2026 12:00 AM",6227323254,TISSUE BIOPSY EMBEDDING1,Biopsy processing Date-CL,,23-Feb-2026,,,,,, +CZ100062001,,,,,Male,Biopsy,R,"Feb 19, 2026 12:00 AM",6227323254,TISSUE BIOPSY EMBEDDING1,Biopsy Comments-CL,,Received in 10% NBF,,,,,, +CZ100062001,,,,,Male,Biopsy,R,"Feb 19, 2026 12:00 AM",6227323254,TISSUE BIOPSY EMBEDDING1,# of Cassettes-(FI)-CL,,1,,,,,, +CZ100062001,,,,,Male,Biopsy,R,"Feb 19, 2026 12:00 AM",6227323254,ULCERATED AREA,Is biopsy site ulcerated?,,Yes,,,,,, +CZ100062001,,,,,Male,Stool Pathogens,,"Feb 16, 2026 7:20 AM",6227323244,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,,,,Test group cancelled: Specimen received beyond stability,,, +CZ100062001,,,,,Male,Stool Pathogens,,"Feb 16, 2026 7:20 AM",6227323244,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,,,,Test group cancelled: Specimen received beyond stability,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,Total Bilirubin,,<3,,L,,Result verified by repeat analysis,3 - 21,umol/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,<1.4,,,,,0 - 6.2,umol/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,Alkaline Phosphatase,,93,,,,,55 - 149,U/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,ALT (SGPT),,9,,,,,5 - 48,U/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,AST (SGOT),,14,,,,,8 - 40,U/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,GGT,,64,,H,,,10 - 61,U/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,LDH,,105,,,,,53 - 234,U/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,Urea Nitrogen,,1.5,,,,,1.4 - 8.6,mmol/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,68,,,,,40 - 110,umol/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,Serum Glucose,,4.2,,,,,3.9 - 5.6,mmol/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,Serum Uric Acid,,288,,,,,125 - 488,umol/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,Calcium (EDTA),,2.32,,,,,2.07 - 2.64,mmol/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,Phosphorus,,0.85,,,,,0.71 - 1.65,mmol/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,Total Protein,,70,,,,,61 - 84,g/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,Albumin-BCG,,39,,,,,33 - 49,g/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,Creatine Kinase,,34,,L,,,39 - 308,U/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,Serum Sodium,,141,,,,,132 - 147,mmol/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,Serum Bicarbonate,,25.5,,,,,19.3 - 29.3,mmol/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CHEMISTRY PANEL,Magnesium,,0.95,,H,,,0.7 - 0.9,mmol/L +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,CKD-EPI 2021,CKD-EPI 2021 Without Race,,133,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,,,,Test cancelled: Clotted Blood Received,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,,,,Test cancelled: Clotted Blood Received,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,,,,Test cancelled: Clotted Blood Received,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,,,,Test cancelled: Clotted Blood Received,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,,,,Test cancelled: Clotted Blood Received,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,,,,Test cancelled: Clotted Blood Received,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,,,,Test cancelled: Clotted Blood Received,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,,,,Test cancelled: Clotted Blood Received,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,,,,Test cancelled: Clotted Blood Received,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,,,,Test cancelled: Clotted Blood Received,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,,,,Test cancelled: Clotted Blood Received,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,,,,Test cancelled: Clotted Blood Received,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,,,,Test cancelled: Clotted Blood Received,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,,,,Test cancelled: Clotted Blood Received,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,,,,Test cancelled: Clotted Blood Received,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,,,,Test cancelled: Clotted Blood Received,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,,,,Test cancelled: Clotted Blood Received,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,,,,Test cancelled: Clotted Blood Received,,, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEPATITIS B SURFACE AB NON-US,Anti-HBs II QUAL,,Reactive,,,,,Ref Rng :$Non Reactive, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100062001,,,,,Male,Screening,,"Feb 16, 2026 7:03 AM",6227323236,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,,,,Test group cancelled: No specimen received,,, +CZ100062001,,,,,Male,TB Testing,,"Feb 16, 2026 7:03 AM",6227323252,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Indeterminate,,,,,Normal=Negative, diff --git a/Covance_UCO3001/Source/2026-05-29_132838 sponsor-study-36940-test-results-930555-microbiology.csv b/Covance_UCO3001/Source/2026-05-29_132838 sponsor-study-36940-test-results-930555-microbiology.csv new file mode 100644 index 0000000..90a8458 --- /dev/null +++ b/Covance_UCO3001/Source/2026-05-29_132838 sponsor-study-36940-test-results-930555-microbiology.csv @@ -0,0 +1,6 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,,,,,, +Subject,Screening Number,Age,Age Unit,Gender,Visit Description,Collected Time,Accession,Test Group,Specimen,Organism,Growth,Cancellation Reason,Test Description,Test Result,Drug Name/Agent,MIC Result,Units,MIC Interpretation,Disk Diffusion Result,Disk Diffusion Interpretation,Subject Data Revision,Visit Data Revision,Result Data Revision +CZ100062001 - null,,,,Male,SCRNSTOOL Stool Pathogens,"Feb 16, 2026 7:20 AM",6227323244,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,, +CZ100062001 - null,,,,Male,UNSCSTOOL Stool Pathogens,"Mar 11, 2026 9:15 AM",6227323245,STOOL CULTURE,,,,Test group cancelled: Specimen received beyond stability,,,,,,,,,,, +CZ100062001 - null,,,,Male,UNSCSTOOL Stool Pathogens,"Mar 17, 2026 9:00 AM",6227323243,STOOL CULTURE,,,,Test group cancelled: No specimen received,,,,,,,,,,, +CZ100062002 - null,,,,Male,SCRNSTOOL Stool Pathogens,"Apr 20, 2026 7:45 AM",6228194341,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,, diff --git a/Covance_UCO3001/Source/2026-05-29_132901 sponsor-study-36940-test-results-930557-standard.csv b/Covance_UCO3001/Source/2026-05-29_132901 sponsor-study-36940-test-results-930557-standard.csv new file mode 100644 index 0000000..969a6a7 --- /dev/null +++ b/Covance_UCO3001/Source/2026-05-29_132901 sponsor-study-36940-test-results-930557-standard.csv @@ -0,0 +1,738 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,, +Subject,Subject Data Revision,Screen No.,Age,Age Unit,Gender,Visit,Visit Data Revision,Collected Time,Accession,Test Group,Test,Administrative Question,Value,Result Data Revision,Flags,Cancellation Reason,Comments,Range,Units +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,Total Bilirubin,,13,,,,,3 - 21,umol/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,,,,,,, +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,Alkaline Phosphatase,,90,,,,,40 - 129,U/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,ALT (SGPT),,27,,,,,5 - 48,U/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,AST (SGOT),,35,,,,,8 - 40,U/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,GGT,,63,R,H,,,10 - 61,U/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,LDH,,167,,,,,53 - 234,U/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,Urea Nitrogen,,7.1,,,,,1.4 - 8.6,mmol/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,95,,,,,40 - 110,umol/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,Serum Glucose,,5.3,,,,,3.9 - 5.6,mmol/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,Serum Uric Acid,,342,,,,,125 - 488,umol/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,Calcium (EDTA),,2.56,,,,,2.07 - 2.64,mmol/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,Phosphorus,,0.97,,,,,0.71 - 1.65,mmol/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,Total Protein,,84,,,,,61 - 84,g/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,Albumin-BCG,,43,,,,,33 - 49,g/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,Creatine Kinase,,217,,,,,39 - 308,U/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,Serum Potassium,,5.2,,,,,3.5 - 5.2,mmol/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,Serum Bicarbonate,,20.1,,,,,19.3 - 29.3,mmol/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CHEMISTRY PANEL,Magnesium,,0.85,,,,,0.66 - 1.07,mmol/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,86,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,,,,,,, +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,153,,,,,127 - 181,g/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.49,,,,,0.39 - 0.54, +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.4,,,,,4.5 - 6.4,TI/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,28,,,,,26 - 34,pg +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,89,,,,,79 - 96,fL +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,10.70,,,,,3.8 - 10.7,GI/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,6.42,,,,,1.96 - 7.23,GI/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,3.25,,,,,0.91 - 4.28,GI/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.75,,,,,0.12 - 0.92,GI/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.19,,,,,0 - 0.57,GI/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.10,,,,,0 - 0.2,GI/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,60.0,,,,,40.5 - 75,% +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,30.4,,,,,15.4 - 48.5,% +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.0,,,,,2.6 - 10.1,% +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.7,,,,,0 - 6.8,% +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.9,,,,,0 - 2,% +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,483,R,H,,,140 - 400,GI/L +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,,,,,,, +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEPATITIS B SURFACE AB,Anti-HBs II QUAL,,,,,,,, +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,,,,,,, +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,,,,,,, +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,,,,,,, +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,,,,,,, +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,,,,,,, +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,,,,,,, +CZ100012004,,,,,Male,Screening,,"May 28, 2026 7:30 AM",6228114608,SUBJECT HEIGHT (CM),Height (cm),Y,178,,,,,cm, +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.0,,,,,0 - 6.2,umol/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,Alkaline Phosphatase,,104,,,,,40 - 129,U/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,ALT (SGPT),,15,,,,,5 - 48,U/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,AST (SGOT),,17,,,,,8 - 40,U/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,GGT,,16,,,,,10 - 61,U/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,LDH,,165,,,,,53 - 234,U/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,Urea Nitrogen,,6.4,,,,,1.4 - 8.6,mmol/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,91,,,,,40 - 119,umol/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,Serum Glucose,,5.2,,,,,3.9 - 5.6,mmol/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,Serum Uric Acid,,324,,,,,149 - 494,umol/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,Calcium (EDTA),,2.38,,,,,2.07 - 2.64,mmol/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,Phosphorus,,0.82,,,,,0.71 - 1.65,mmol/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,Total Protein,,75,,,,,61 - 84,g/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,Creatine Kinase,,82,,,,,39 - 308,U/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,Serum Sodium,,141,,,,,132 - 147,mmol/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,Serum Potassium,,4.7,,,,,3.5 - 5.2,mmol/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,Serum Bicarbonate,,20.6,,,,,19.3 - 29.3,mmol/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,Serum Chloride,,105,,,,,94 - 112,mmol/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CHEMISTRY PANEL,Magnesium,,0.84,,,,,0.66 - 1.07,mmol/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,87,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,FECAL COLLECTION D/T,Stool Collection Date,Y,,,,,,, +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,FECAL COLLECTION D/T,Stool Collection Time,Y,,,,,,, +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,159,,,,,127 - 181,g/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.50,,,,,0.39 - 0.54, +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.4,,,,,4.5 - 6.4,TI/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,29,,,,,26 - 34,pg +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,92,,,,,79 - 96,fL +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,9.01,,,,,3.8 - 10.7,GI/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,7.04,,,,,1.96 - 7.23,GI/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.38,,,,,0.91 - 4.28,GI/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.44,,,,,0.12 - 0.92,GI/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.11,,,,,0 - 0.57,GI/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,,0 - 0.2,GI/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,78.1,,H,,,40.5 - 75,% +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,15.3,,L,,,15.4 - 48.5,% +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.9,,,,,2.6 - 10.1,% +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.2,,,,,0 - 6.8,% +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,265,,,,,140 - 400,GI/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,LIPID PANEL,Direct HDL-C 4th Generation,,1.34,,,,,1.03 - 1.53,mmol/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,LIPID PANEL,Triglycerides (GPO),,0.65,,,,,0.65 - 3.61,mmol/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,LIPID PANEL,Cholesterol (High Performance),,4.32,,L,,,4.4 - 7.53,mmol/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,LIPID PANEL,LDL Chol Friedewald 4th,,2.68,,,,,0 - 3.34,mmol/L +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,,,,,,, +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,,,,,,, +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,,,,,,, +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,,,,,,, +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,,,,,,, +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,,,,,,, +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,SM10/FECAL BMRKS COLL D/T,Stool Collection Date,Y,,,,,,, +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,SM10/FECAL BMRKS COLL D/T,Stool Collection Time,Y,,,,,,, +CZ100012003,,,,,Male,Induction Week 0,,"May 27, 2026 7:25 AM",6228036553,SUBJECT HEIGHT (CM),Height (cm),Y,175,,,,,cm, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,ALP<2XULN,ALP<2XULN,,Criteria Met,,,,,, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,ALT>/=3XULN,ALT >/= 3 X ULN,,Criteria not met,,,,,, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,ALT>/=3XULN & TBIL>/=2XULN,ALT >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,AST>/=3XULN,AST >/= 3 X ULN,,Criteria not met,,,,,, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,AST>/=3XULN & TBIL>/=2XULN,AST >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.8,,,,,0 - 6.2,umol/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,Alkaline Phosphatase,,62,,,,,40 - 129,U/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,ALT (SGPT),,46,,,,,5 - 48,U/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,AST (SGOT),,23,,,,,8 - 40,U/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,GGT,,30,,,,,10 - 61,U/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,LDH,,238,,H,,,53 - 234,U/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,Urea Nitrogen,,4.4,,,,,1.4 - 8.6,mmol/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,84,,,,,40 - 110,umol/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,Serum Glucose,,4.6,,,,,3.9 - 5.6,mmol/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,Serum Uric Acid,,328,,,,,125 - 488,umol/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,Calcium (EDTA),,2.43,,,,,2.07 - 2.64,mmol/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,Phosphorus,,1.26,,,,,0.71 - 1.65,mmol/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,Total Protein,,67,,,,,61 - 84,g/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,Albumin-BCG,,42,,,,,33 - 49,g/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,Creatine Kinase,,96,,,,,39 - 308,U/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,Serum Bicarbonate,,25.1,,,,,19.3 - 29.3,mmol/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CHEMISTRY PANEL,Magnesium,,0.87,,,,,0.66 - 1.07,mmol/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,99,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,FECAL COLLECTION D/T,Stool Collection Date,Y,12-May-2026,,,,,, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,FECAL COLLECTION D/T,Stool Collection Time,Y,18:00,,,,,, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,142,,,,,127 - 181,g/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.42,,,,,0.39 - 0.54, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.8,,,,,4.5 - 6.4,TI/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,30,,,,,26 - 34,pg +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,87,,,,,79 - 96,fL +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,8.67,,,,,3.8 - 10.7,GI/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,5.93,,,,,1.96 - 7.23,GI/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.10,,,,,0.91 - 4.28,GI/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.49,,,,,0.12 - 0.92,GI/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.11,,,,,0 - 0.57,GI/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,,0 - 0.2,GI/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,68.4,,,,,40.5 - 75,% +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,24.3,,,,,15.4 - 48.5,% +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.7,,,,,2.6 - 10.1,% +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.3,,,,,0 - 6.8,% +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.4,,,,,0 - 2,% +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,343,,,,,140 - 400,GI/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,LIPID PANEL,Direct HDL-C 4th Generation,,2.02,,H,,,1.03 - 1.53,mmol/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,LIPID PANEL,Triglycerides (GPO),,1.21,,,,,0.62 - 3.69,mmol/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,LIPID PANEL,Cholesterol (High Performance),,5.32,,,,,4.19 - 7.24,mmol/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,LIPID PANEL,LDL Chol Friedewald 4th,,2.75,,,,,0 - 3.34,mmol/L +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,13-May-2026,,,,,, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,08:05,,,,,, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,13-May-2026,,,,,, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,09:30,,,,,, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,13-May-2026,,,,,, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,08:05,,,,,, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,SM09/STOOL PK COLL D/T,Stool Collection Date,Y,12-May-2026,,,,,, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,SM09/STOOL PK COLL D/T,Stool Collection Time,Y,18:00,,,,,, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,SM10/FECAL BMRKS COLL D/T,Stool Collection Date,Y,12-May-2026,,,,,, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,SM10/FECAL BMRKS COLL D/T,Stool Collection Time,Y,18:00,,,,,, +CZ100012001,,,,,Male,Induction Week 12,,"May 13, 2026 8:05 AM",6227933143,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100012003,,,,,Male,Biopsy,R,"May 13, 2026 12:00 AM",6228252073,ANATOMICAL SITE,Anatomical Site,Y,30,,,,,, +CZ100012003,,,,,Male,Biopsy,R,"May 13, 2026 12:00 AM",6228252073,BIOPSY COLLECTION METHOD,Collection Method,Y,colonoscopy,,,,,, +CZ100012003,,,,,Male,Biopsy,R,"May 13, 2026 12:00 AM",6228252073,BIOPSY FIXATIVE USED,Fixative Used,,10% NBF,,,,,, +CZ100012003,,,,,Male,Biopsy,R,"May 13, 2026 12:00 AM",6228252073,DATE/TIME PLACED IN FORMALIN,Date Sample placed in Formalin,Y,13-May-2026,,,,,, +CZ100012003,,,,,Male,Biopsy,R,"May 13, 2026 12:00 AM",6228252073,DATE/TIME PLACED IN FORMALIN,Time Sample placed in Formalin,Y,09:00,,,,,, +CZ100012003,,,,,Male,Biopsy,R,"May 13, 2026 12:00 AM",6228252073,DIAGNOSIS,Diagnosis:,Y,Ulcerative Colitis,,,,,, +CZ100012003,,,,,Male,Biopsy,R,"May 13, 2026 12:00 AM",6228252073,INFLAMED AREA,Inflamed area?,,Yes,,,,,, +CZ100012003,,,,,Male,Biopsy,R,"May 13, 2026 12:00 AM",6228252073,TISSUE BIOPSY EMBEDDING1,Biopsy technical QC-CL,,Smpl meets HT requirements,,,,,, +CZ100012003,,,,,Male,Biopsy,R,"May 13, 2026 12:00 AM",6228252073,TISSUE BIOPSY EMBEDDING1,Biopsy processing Time-CL,,10:00,,,,,, +CZ100012003,,,,,Male,Biopsy,R,"May 13, 2026 12:00 AM",6228252073,TISSUE BIOPSY EMBEDDING1,Biopsy processing Date-CL,,15-May-2026,,,,,, +CZ100012003,,,,,Male,Biopsy,R,"May 13, 2026 12:00 AM",6228252073,TISSUE BIOPSY EMBEDDING1,Biopsy Comments-CL,,Received in 10% NBF,,,,,, +CZ100012003,,,,,Male,Biopsy,R,"May 13, 2026 12:00 AM",6228252073,TISSUE BIOPSY EMBEDDING1,# of Cassettes-(FI)-CL,,1,,,,,, +CZ100012003,,,,,Male,Biopsy,R,"May 13, 2026 12:00 AM",6228252073,ULCERATED AREA,Is biopsy site ulcerated?,,Yes,,,,,, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,ALP<2XULN,ALP<2XULN,,Criteria Met,,,,,, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,ALT>/=3XULN,ALT >/= 3 X ULN,,Criteria not met,,,,,, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,ALT>/=3XULN & TBIL>/=2XULN,ALT >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,AST>/=3XULN,AST >/= 3 X ULN,,Criteria not met,,,,,, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,AST>/=3XULN & TBIL>/=2XULN,AST >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,Total Bilirubin,,11,,,,,3 - 21,umol/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.5,,,,,0 - 6.2,umol/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,Alkaline Phosphatase,,99,,,,,35 - 104,U/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,ALT (SGPT),,18,,,,,4 - 43,U/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,AST (SGOT),,29,,,,,8 - 40,U/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,GGT,,23,,,,,5 - 50,U/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,LDH,,181,,,,,53 - 234,U/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,Urea Nitrogen,,5.3,,,,,1.4 - 10.4,mmol/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,54,,,,,31 - 110,umol/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,Serum Glucose,,6.0,,H,,,3.9 - 5.6,mmol/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,Serum Uric Acid,,293,,,,,149 - 446,umol/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,Calcium (EDTA),,2.53,,,,,2.07 - 2.64,mmol/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,Phosphorus,,1.19,,,,,0.71 - 1.65,mmol/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,Total Protein,,79,,,,,60 - 80,g/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 46,g/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,Creatine Kinase,,143,,,,,26 - 192,U/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,Serum Sodium,,141,,,,,135 - 145,mmol/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,Serum Potassium,,4.6,,,,,3.5 - 5.2,mmol/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,Serum Bicarbonate,,22.3,,,,,19.3 - 29.3,mmol/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CHEMISTRY PANEL,Magnesium,,0.91,,,,,0.66 - 0.98,mmol/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,91,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,FECAL COLLECTION D/T,Stool Collection Date,Y,05-May-2026,,,,,, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,FECAL COLLECTION D/T,Stool Collection Time,Y,18:00,,,,,, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,145,,,,,115 - 158,g/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.44,,,,,0.34 - 0.48, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.0,,,,,3.9 - 5.5,TI/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,29,,,,,26 - 34,pg +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,88,,,,,80 - 100,fL +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.54,,,,,3.8 - 10.7,GI/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.11,,,,,1.96 - 7.23,GI/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.15,,,,,0.8 - 3,GI/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.23,,,,,0.12 - 0.92,GI/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.02,,,,,0 - 0.57,GI/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,46.5,,,,,40.5 - 75,% +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,47.4,,,,,15.4 - 48.5,% +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.1,,,,,2.6 - 10.1,% +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,0.5,,,,,0 - 6.8,% +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,117,R,L,,,130 - 394,GI/L +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,06-May-2026,,,,,, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,08:05,,,,,, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,06-May-2026,,,,,, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,09:05,,,,,, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,06-May-2026,,,,,, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,08:05,,,,,, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,SM09/STOOL PK COLL D/T,Stool Collection Date,Y,05-May-2026,,,,,, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,SM09/STOOL PK COLL D/T,Stool Collection Time,Y,18:00,,,,,, +CZ100012002,,,,,Female,Induction Week 4,,"May 6, 2026 8:05 AM",6227933142,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100012001,,,,,Male,Biopsy,,"May 6, 2026 12:00 AM",6228252072,ANATOMICAL SITE,Anatomical Site,Y,15-20cm from anal verge,,,,,, +CZ100012001,,,,,Male,Biopsy,,"May 6, 2026 12:00 AM",6228252072,BIOPSY COLLECTION METHOD,Collection Method,Y,colonoscopy,,,,,, +CZ100012001,,,,,Male,Biopsy,,"May 6, 2026 12:00 AM",6228252072,BIOPSY FIXATIVE USED,Fixative Used,,10% NBF,,,,,, +CZ100012001,,,,,Male,Biopsy,,"May 6, 2026 12:00 AM",6228252072,DATE/TIME PLACED IN FORMALIN,Date Sample placed in Formalin,Y,06-May-2026,,,,,, +CZ100012001,,,,,Male,Biopsy,,"May 6, 2026 12:00 AM",6228252072,DATE/TIME PLACED IN FORMALIN,Time Sample placed in Formalin,Y,07:20,,,,,, +CZ100012001,,,,,Male,Biopsy,,"May 6, 2026 12:00 AM",6228252072,DIAGNOSIS,Diagnosis:,Y,Ulcerative Colitis,,,,,, +CZ100012001,,,,,Male,Biopsy,,"May 6, 2026 12:00 AM",6228252072,INFLAMED AREA,Inflamed area?,,Yes,,,,,, +CZ100012001,,,,,Male,Biopsy,,"May 6, 2026 12:00 AM",6228252072,TISSUE BIOPSY EMBEDDING1,Biopsy technical QC-CL,,Smpl meets HT requirements,,,,,, +CZ100012001,,,,,Male,Biopsy,,"May 6, 2026 12:00 AM",6228252072,TISSUE BIOPSY EMBEDDING1,Biopsy processing Time-CL,,10:00,,,,,, +CZ100012001,,,,,Male,Biopsy,,"May 6, 2026 12:00 AM",6228252072,TISSUE BIOPSY EMBEDDING1,Biopsy processing Date-CL,,08-May-2026,,,,,, +CZ100012001,,,,,Male,Biopsy,,"May 6, 2026 12:00 AM",6228252072,TISSUE BIOPSY EMBEDDING1,Biopsy Comments-CL,,Received in 10% NBF,,,,,, +CZ100012001,,,,,Male,Biopsy,,"May 6, 2026 12:00 AM",6228252072,TISSUE BIOPSY EMBEDDING1,# of Cassettes-(FI)-CL,,1,,,,,, +CZ100012001,,,,,Male,Biopsy,,"May 6, 2026 12:00 AM",6228252072,ULCERATED AREA,Is biopsy site ulcerated?,,No,,,,,, +CZ100012003,,,,,Male,Stool Pathogens,,"Apr 29, 2026 7:55 AM",6227323213,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100012003,,,,,Male,Stool Pathogens,,"Apr 29, 2026 7:55 AM",6227323213,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,Total Bilirubin,,8,,,,,3 - 21,umol/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.0,,,,,0 - 6.2,umol/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,Alkaline Phosphatase,,115,,,,,40 - 129,U/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,ALT (SGPT),,22,,,,,5 - 48,U/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,AST (SGOT),,21,,,,,8 - 40,U/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,GGT,,15,,,,,10 - 61,U/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,LDH,,151,,,,,53 - 234,U/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,Urea Nitrogen,,5.4,,,,,1.4 - 8.6,mmol/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,88,,,,,40 - 119,umol/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,Serum Glucose,,5.4,,,,,3.9 - 5.6,mmol/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,Serum Uric Acid,,306,,,,,149 - 494,umol/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,Calcium (EDTA),,2.39,,,,,2.07 - 2.64,mmol/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,Phosphorus,,0.90,,,,,0.71 - 1.65,mmol/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,Total Protein,,75,,,,,61 - 84,g/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,Albumin-BCG,,47,,,,,33 - 49,g/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,Creatine Kinase,,100,,,,,39 - 308,U/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,Serum Potassium,,4.8,,,,,3.5 - 5.2,mmol/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,Serum Bicarbonate,,21.5,,,,,19.3 - 29.3,mmol/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CHEMISTRY PANEL,Magnesium,,0.90,,,,,0.66 - 1.07,mmol/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,91,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,161,,,,,127 - 181,g/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.49,,,,,0.39 - 0.54, +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.5,,,,,4.5 - 6.4,TI/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,30,,,,,26 - 34,pg +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,89,,,,,79 - 96,fL +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,7.61,,,,,3.8 - 10.7,GI/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,5.63,,,,,1.96 - 7.23,GI/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.42,,,,,0.91 - 4.28,GI/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.38,,,,,0.12 - 0.92,GI/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.13,,,,,0 - 0.57,GI/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,,0 - 0.2,GI/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,74.0,,,,,40.5 - 75,% +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,18.7,,,,,15.4 - 48.5,% +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.0,,,,,2.6 - 10.1,% +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.7,,,,,0 - 6.8,% +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,242,,,,,140 - 400,GI/L +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEPATITIS B SURFACE AB,Anti-HBs II QUAL,,Non-Reactive,,,,,Ref Rng :$Non Reactive, +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Negative,,,,,Normal=Negative, +CZ100012003,,,,,Male,Screening,,"Apr 29, 2026 7:55 AM",6228114610,SUBJECT HEIGHT (CM),Height (cm),Y,175,,,,,cm, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,ALP<2XULN,ALP<2XULN,,Criteria Met,,,,,, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,ALT>/=3XULN,ALT >/= 3 X ULN,,Criteria not met,,,,,, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,ALT>/=3XULN & TBIL>/=2XULN,ALT >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,AST>/=3XULN,AST >/= 3 X ULN,,Criteria not met,,,,,, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,AST>/=3XULN & TBIL>/=2XULN,AST >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,Total Bilirubin,,14,,,,,3 - 21,umol/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,4.5,,,,,0 - 6.2,umol/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,Alkaline Phosphatase,,102,,,,,35 - 104,U/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,ALT (SGPT),,17,,,,,4 - 43,U/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,AST (SGOT),,25,,,,,8 - 40,U/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,GGT,,23,,,,,5 - 50,U/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,LDH,,154,,,,,53 - 234,U/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,Urea Nitrogen,,4.3,,,,,1.4 - 10.4,mmol/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,53,,,,,31 - 110,umol/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,Serum Glucose,,6.3,,H,,,3.9 - 5.6,mmol/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,Serum Uric Acid,,252,,,,,149 - 446,umol/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,Calcium (EDTA),,2.50,,,,,2.07 - 2.64,mmol/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,Phosphorus,,1.16,,,,,0.71 - 1.65,mmol/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,Total Protein,,76,,,,,60 - 80,g/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 46,g/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,Creatine Kinase,,83,,,,,26 - 192,U/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,Serum Sodium,,140,,,,,135 - 145,mmol/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,Serum Potassium,,4.1,,,,,3.5 - 5.2,mmol/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,Serum Bicarbonate,,23.8,,,,,19.3 - 29.3,mmol/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CHEMISTRY PANEL,Magnesium,,0.94,,,,,0.66 - 0.98,mmol/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,91,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,FECAL COLLECTION D/T,Stool Collection Date,Y,23-Apr-2026,,,,,, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,FECAL COLLECTION D/T,Stool Collection Time,Y,07:40,,,,,, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,144,,,,Result verified by repeat analysis,115 - 158,g/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.43,,,,,0.34 - 0.48, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.0,,,,Result verified by repeat analysis,3.9 - 5.5,TI/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,29,,,,Result verified by repeat analysis,26 - 34,pg +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,86,,,,,80 - 100,fL +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,3.47,,L,,Result verified by repeat analysis,3.8 - 10.7,GI/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,1.78,,L,,Result verified by repeat analysis,1.96 - 7.23,GI/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.46,,,,,0.8 - 3,GI/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.16,,,,Result verified by repeat analysis,0.12 - 0.92,GI/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.04,,,,Result verified by repeat analysis,0 - 0.57,GI/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,Result verified by repeat analysis,0 - 0.2,GI/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,51.4,,,,Result verified by repeat analysis,40.5 - 75,% +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,42.2,,,,Result verified by repeat analysis,15.4 - 48.5,% +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.5,,,,Result verified by repeat analysis,2.6 - 10.1,% +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.0,,,,Result verified by repeat analysis,0 - 6.8,% +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.9,,,,Result verified by repeat analysis,0 - 2,% +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,118,,L,,Result verified by repeat analysis,130 - 394,GI/L +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,23-Apr-2026,,,,,, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,07:40,,,,,, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,,,,,,, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,,,,,,, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,23-Apr-2026,,,,,, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,07:40,,,,,, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,SM09/STOOL PK COLL D/T,Stool Collection Date,Y,23-Apr-2026,,,,,, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,SM09/STOOL PK COLL D/T,Stool Collection Time,Y,07:40,,,,,, +CZ100012002,,,,,Female,Induction Week 2,,"Apr 23, 2026 7:40 AM",6227323207,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100012001,,,,,Male,Stool Pathogens,,"Apr 22, 2026 7:00 AM",6228137359,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100012001,,,,,Male,Stool Pathogens,,"Apr 22, 2026 7:00 AM",6228137359,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100012001,,,,,Male,Stool Pathogens,,"Apr 22, 2026 7:00 AM",6228137359,OVA AND PARASITES 1,Concentrate Exam,,No ova or parasites found,,,,,, +CZ100012001,,,,,Male,Stool Pathogens,,"Apr 22, 2026 7:00 AM",6228137359,OVA AND PARASITES 1,Smear for Microsporidia,,No Microsporidia seen.,,,,,, +CZ100012001,,,,,Male,Stool Pathogens,,"Apr 22, 2026 7:00 AM",6228137359,OVA AND PARASITES 1,Modified acid-fast stain,,No coccidian parasites seen,,,,,, +CZ100012001,,,,,Male,Stool Pathogens,,"Apr 22, 2026 7:00 AM",6228137359,OVA AND PARASITES 2,Trichrome Smear,,No ova or parasites found,,,,,, +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,Total Bilirubin,,12,,,,,3 - 21,umol/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.7,,,,,0 - 6.2,umol/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,Alkaline Phosphatase,,96,,,,,35 - 104,U/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,ALT (SGPT),,17,,,,,4 - 43,U/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,AST (SGOT),,28,,,,,8 - 40,U/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,GGT,,19,,,,,5 - 50,U/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,LDH,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,Urea Nitrogen,,5.3,,,,,1.4 - 10.4,mmol/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,56,,,,,31 - 110,umol/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,Serum Glucose,,6.2,R,H,,,3.9 - 5.6,mmol/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,Serum Uric Acid,,284,,,,,149 - 446,umol/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,Calcium (EDTA),,2.50,,,,,2.07 - 2.64,mmol/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,Phosphorus,,1.20,,,,,0.71 - 1.65,mmol/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,Total Protein,,78,,,,,60 - 80,g/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 46,g/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,Creatine Kinase,,113,,,,,26 - 192,U/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,Serum Sodium,,140,,,,,135 - 145,mmol/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,Serum Potassium,,4.9,,,,,3.5 - 5.2,mmol/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,Serum Bicarbonate,,24.0,,,,,19.3 - 29.3,mmol/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CHEMISTRY PANEL,Magnesium,,0.97,,,,,0.66 - 0.98,mmol/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,90,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,FECAL COLLECTION D/T,Stool Collection Date,Y,07-Apr-2026,,,,,, +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,FECAL COLLECTION D/T,Stool Collection Time,Y,18:00,,,,,, +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,143,,,,,115 - 158,g/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.44,,,,,0.34 - 0.48, +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.1,,,,,3.9 - 5.5,TI/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,28,,,,,26 - 34,pg +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,87,,,,,80 - 100,fL +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,3.59,R,L,,,3.8 - 10.7,GI/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,1.64,R,L,,,1.96 - 7.23,GI/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.72,,,,,0.8 - 3,GI/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.19,,,,,0.12 - 0.92,GI/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.03,,,,,0 - 0.57,GI/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,45.6,,,,,40.5 - 75,% +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,47.9,,,,,15.4 - 48.5,% +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.2,,,,,2.6 - 10.1,% +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,0.7,,,,,0 - 6.8,% +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,126,R,L,,,130 - 394,GI/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,LIPID PANEL,Direct HDL-C 4th Generation,,2.07,R,H,,,1.03 - 1.53,mmol/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,LIPID PANEL,Triglycerides (GPO),,1.04,,,,,0.63 - 2.71,mmol/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,LIPID PANEL,Cholesterol (High Performance),,4.56,R,L,,,5.35 - 9.1,mmol/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,LIPID PANEL,LDL Chol Friedewald 4th,,2.01,,,,,0 - 3.34,mmol/L +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,08-Apr-2026,,,,,, +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,07:10,,,,,, +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,08-Apr-2026,,,,,, +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,08:15,,,,,, +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,08-Apr-2026,,,,,, +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,07:10,,,,,, +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,SM10/FECAL BMRKS COLL D/T,Stool Collection Date,Y,07-Apr-2026,,,,,, +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,SM10/FECAL BMRKS COLL D/T,Stool Collection Time,Y,18:00,,,,,, +CZ100012002,,,,,Female,Induction Week 0,,"Apr 8, 2026 7:10 AM",6228036554,SUBJECT HEIGHT (CM),Height (cm),Y,170,,,,,cm, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,ALP<2XULN,ALP<2XULN,,Criteria Met,,,,,, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,ALT>/=3XULN,ALT >/= 3 X ULN,,Criteria not met,,,,,, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,ALT>/=3XULN & TBIL>/=2XULN,ALT >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,AST>/=3XULN,AST >/= 3 X ULN,,Required testing unavailable,,,,,, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,AST>/=3XULN & TBIL>/=2XULN,AST >/=3xULN & TBIL >/=2xULN,,Required testing unavailable,,,,,, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,Alkaline Phosphatase,,66,,,,,40 - 129,U/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,ALT (SGPT),,50,,H,,,5 - 48,U/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,AST (SGOT),,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,GGT,,25,,,,,10 - 61,U/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,LDH,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,Urea Nitrogen,,6.7,,,,,1.4 - 8.6,mmol/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,89,,,,,40 - 110,umol/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,Serum Glucose,,5.1,,,,,3.9 - 5.6,mmol/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,Serum Uric Acid,,302,,,,,125 - 488,umol/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,Calcium (EDTA),,2.50,,,,,2.07 - 2.64,mmol/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,Phosphorus,,1.95,R,H,,,0.71 - 1.65,mmol/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,Total Protein,,76,,,,,61 - 84,g/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,Creatine Kinase,,66,,,,,39 - 308,U/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,Serum Potassium,,4.9,,,,,3.5 - 5.2,mmol/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,Serum Bicarbonate,,24.8,,,,,19.3 - 29.3,mmol/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CHEMISTRY PANEL,Magnesium,,0.95,,,,,0.66 - 1.07,mmol/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,92,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,FECAL COLLECTION D/T,Stool Collection Date,Y,17-Mar-2026,,,,,, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,FECAL COLLECTION D/T,Stool Collection Time,Y,18:00,,,,,, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,154,,,,,127 - 181,g/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.47,,,,,0.39 - 0.54, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.2,,,,,4.5 - 6.4,TI/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,30,,,,,26 - 34,pg +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,91,,,,,79 - 96,fL +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.77,,,,,3.8 - 10.7,GI/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,5.03,,,,,1.96 - 7.23,GI/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.25,,,,,0.91 - 4.28,GI/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.39,,,,,0.12 - 0.92,GI/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.07,,,,,0 - 0.57,GI/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,74.3,,,,,40.5 - 75,% +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,18.6,,,,,15.4 - 48.5,% +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.8,,,,,2.6 - 10.1,% +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.0,,,,,0 - 6.8,% +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.4,,,,,0 - 2,% +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,327,,,,,140 - 400,GI/L +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,18-Mar-2026,R,,,,, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,18:00,,,,,, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,18-Mar-2026,R,,,,, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,18:00,,,,,, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,18-Mar-2026,R,,,,, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,18:00,,,,,, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,SM09/STOOL PK COLL D/T,Stool Collection Date,Y,17-Mar-2026,,,,,, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,SM09/STOOL PK COLL D/T,Stool Collection Time,Y,18:00,,,,,, +CZ100012001,,,,,Male,Induction Week 4,,"Mar 18, 2026 7:05 AM",6227323210,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100012002,,,,,Female,Biopsy,,"Mar 18, 2026 12:00 AM",6227323224,ANATOMICAL SITE,Anatomical Site,Y,25 DISTANCE IN CM FROM ANAL VERGE,,,,,, +CZ100012002,,,,,Female,Biopsy,,"Mar 18, 2026 12:00 AM",6227323224,BIOPSY COLLECTION METHOD,Collection Method,Y,colonoscopy,,,,,, +CZ100012002,,,,,Female,Biopsy,,"Mar 18, 2026 12:00 AM",6227323224,BIOPSY FIXATIVE USED,Fixative Used,,10% NBF,,,,,, +CZ100012002,,,,,Female,Biopsy,,"Mar 18, 2026 12:00 AM",6227323224,DATE/TIME PLACED IN FORMALIN,Date Sample placed in Formalin,Y,18-Mar-2026,,,,,, +CZ100012002,,,,,Female,Biopsy,,"Mar 18, 2026 12:00 AM",6227323224,DATE/TIME PLACED IN FORMALIN,Time Sample placed in Formalin,Y,09:30,,,,,, +CZ100012002,,,,,Female,Biopsy,,"Mar 18, 2026 12:00 AM",6227323224,DIAGNOSIS,Diagnosis:,Y,Ulcerative Colitis,,,,,, +CZ100012002,,,,,Female,Biopsy,,"Mar 18, 2026 12:00 AM",6227323224,INFLAMED AREA,Inflamed area?,,Yes,,,,,, +CZ100012002,,,,,Female,Biopsy,,"Mar 18, 2026 12:00 AM",6227323224,TISSUE BIOPSY EMBEDDING1,Biopsy technical QC-CL,,Smpl meets HT requirements,,,,,, +CZ100012002,,,,,Female,Biopsy,,"Mar 18, 2026 12:00 AM",6227323224,TISSUE BIOPSY EMBEDDING1,Biopsy processing Time-CL,,10:00,,,,,, +CZ100012002,,,,,Female,Biopsy,,"Mar 18, 2026 12:00 AM",6227323224,TISSUE BIOPSY EMBEDDING1,Biopsy processing Date-CL,,20-Mar-2026,,,,,, +CZ100012002,,,,,Female,Biopsy,,"Mar 18, 2026 12:00 AM",6227323224,TISSUE BIOPSY EMBEDDING1,Biopsy Comments-CL,,Received in 10% NBF,,,,,, +CZ100012002,,,,,Female,Biopsy,,"Mar 18, 2026 12:00 AM",6227323224,TISSUE BIOPSY EMBEDDING1,# of Cassettes-(FI)-CL,,1,,,,,, +CZ100012002,,,,,Female,Biopsy,,"Mar 18, 2026 12:00 AM",6227323224,ULCERATED AREA,Is biopsy site ulcerated?,,Yes,,,,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,ALP<2XULN,ALP<2XULN,,Required testing unavailable,,,,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,ALT>/=3XULN,ALT >/= 3 X ULN,,Required testing unavailable,,,,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,ALT>/=3XULN & TBIL>/=2XULN,ALT >/=3xULN & TBIL >/=2xULN,,Required testing unavailable,,,,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,AST>/=3XULN,AST >/= 3 X ULN,,Required testing unavailable,,,,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,AST>/=3XULN & TBIL>/=2XULN,AST >/=3xULN & TBIL >/=2xULN,,Required testing unavailable,,,,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,Total Bilirubin,,18,,,,,3 - 21,umol/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,Alkaline Phosphatase,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,ALT (SGPT),,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,AST (SGOT),,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,GGT,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,LDH,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,Urea Nitrogen,,5.2,,,,,1.4 - 8.6,mmol/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,80,,,,,40 - 110,umol/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,Serum Glucose,,5.4,,,,,3.9 - 5.6,mmol/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,Serum Uric Acid,,276,,,,,125 - 488,umol/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,Calcium (EDTA),,2.24,,,,,2.07 - 2.64,mmol/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,Phosphorus,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,Total Protein,,71,,,,,61 - 84,g/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,Albumin-BCG,,43,,,,,33 - 49,g/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,Creatine Kinase,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,Serum Potassium,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,Serum Bicarbonate,,20.3,,,,,19.3 - 29.3,mmol/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CHEMISTRY PANEL,Magnesium,,0.88,,,,,0.66 - 1.07,mmol/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,105,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,FECAL COLLECTION D/T,Stool Collection Date,Y,03-Mar-2026,,,,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,FECAL COLLECTION D/T,Stool Collection Time,Y,18:00,R,,,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,155,,,,,127 - 181,g/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.48,,,,,0.39 - 0.54, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.1,,,,,4.5 - 6.4,TI/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,30,,,,,26 - 34,pg +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,93,,,,,79 - 96,fL +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.57,,,,,3.8 - 10.7,GI/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.08,,,,,1.96 - 7.23,GI/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.16,,,,,0.91 - 4.28,GI/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.26,,,,,0.12 - 0.92,GI/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.05,,,,,0 - 0.57,GI/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,73.3,,,,,40.5 - 75,% +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,20.7,,,,,15.4 - 48.5,% +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.7,,,,,2.6 - 10.1,% +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,0.9,,,,,0 - 6.8,% +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.4,,,,,0 - 2,% +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,343,,,,,140 - 400,GI/L +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,04-Mar-2026,,,,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,07:00,R,,,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,04-Mar-2026,,,,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,08:00,,,,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,04-Mar-2026,,,,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,07:00,R,,,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,SM09/STOOL PK COLL D/T,Stool Collection Date,Y,03-Mar-2026,,,,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,SM09/STOOL PK COLL D/T,Stool Collection Time,Y,18:00,R,,,,, +CZ100012001,,,,,Male,Induction Week 2,,"Mar 4, 2026 7:00 AM",6227323208,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100012002,,,,,Female,Stool Pathogens,,"Mar 3, 2026 1:00 PM",6227323212,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100012002,,,,,Female,Stool Pathogens,,"Mar 3, 2026 1:00 PM",6227323212,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100012002,,,,,Female,Stool Pathogens,,"Mar 3, 2026 1:00 PM",6227323212,OVA AND PARASITES 1,Concentrate Exam,,No ova or parasites found,,,,,, +CZ100012002,,,,,Female,Stool Pathogens,,"Mar 3, 2026 1:00 PM",6227323212,OVA AND PARASITES 1,Smear for Microsporidia,,No Microsporidia seen.,,,,,, +CZ100012002,,,,,Female,Stool Pathogens,,"Mar 3, 2026 1:00 PM",6227323212,OVA AND PARASITES 1,Modified acid-fast stain,,No coccidian parasites seen,,,,,, +CZ100012002,,,,,Female,Stool Pathogens,,"Mar 3, 2026 1:00 PM",6227323212,OVA AND PARASITES 2,Trichrome Smear,,No ova or parasites found,,,,,, +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,Total Bilirubin,,10,,,,,3 - 21,umol/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.5,,,,,0 - 6.2,umol/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,Alkaline Phosphatase,,100,,,,,35 - 104,U/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,ALT (SGPT),,17,,,,,4 - 43,U/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,AST (SGOT),,24,,,,,8 - 40,U/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,GGT,,27,,,,,5 - 50,U/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,LDH,,120,,,,,53 - 234,U/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,Urea Nitrogen,,4.9,,,,,1.4 - 10.4,mmol/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,49,,,,,31 - 110,umol/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,Serum Glucose,,7.0,,H,,,3.9 - 5.6,mmol/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,Serum Uric Acid,,233,,,,,149 - 446,umol/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,Calcium (EDTA),,2.40,,,,,2.07 - 2.64,mmol/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,Phosphorus,,1.05,,,,,0.71 - 1.65,mmol/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,Total Protein,,75,,,,,60 - 80,g/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 46,g/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,Creatine Kinase,,101,,,,,26 - 192,U/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,Serum Sodium,,140,,,,,135 - 145,mmol/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,Serum Potassium,,3.9,,,,,3.5 - 5.2,mmol/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,Serum Bicarbonate,,22.1,,,,,19.3 - 29.3,mmol/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CHEMISTRY PANEL,Magnesium,,0.89,,,,,0.66 - 0.98,mmol/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,93,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,No,,,,,, +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,145,,,,,115 - 158,g/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.43,,,,,0.34 - 0.48, +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.0,,,,,3.9 - 5.5,TI/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,29,,,,,26 - 34,pg +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,85,,,,,80 - 100,fL +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,3.95,,,,,3.8 - 10.7,GI/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,1.86,,L,,,1.96 - 7.23,GI/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.81,,,,,0.8 - 3,GI/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.25,,,,,0.12 - 0.92,GI/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.02,,,,,0 - 0.57,GI/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,47.1,,,,,40.5 - 75,% +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,45.7,,,,,15.4 - 48.5,% +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.3,,,,,2.6 - 10.1,% +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,0.4,,,,,0 - 6.8,% +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,150,,,,,130 - 394,GI/L +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEPATITIS B SURFACE AB,Anti-HBs II QUAL,,Non-Reactive,,,,,Ref Rng :$Non Reactive, +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Negative,,,,,Normal=Negative, +CZ100012002,,,,,Female,Screening,,"Mar 2, 2026 7:00 AM",6227323204,SUBJECT HEIGHT (CM),Height (cm),Y,170,,,,,cm, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,Total Bilirubin,,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,Alkaline Phosphatase,,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,ALT (SGPT),,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,AST (SGOT),,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,GGT,,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,LDH,,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,Urea Nitrogen,,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,Serum Glucose,,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,Serum Uric Acid,,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,Calcium (EDTA),,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,Phosphorus,,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,Total Protein,,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,Albumin-BCG,,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,Creatine Kinase,,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,Serum Sodium,,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,Serum Potassium,,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,Serum Bicarbonate,,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,Serum Chloride,,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CHEMISTRY PANEL,Magnesium,,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,CKD-EPI 2021,CKD-EPI 2021 Without Race,,Required testing unavailable,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,FECAL COLLECTION D/T,Stool Collection Date,Y,18-Feb-2026,,,,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,FECAL COLLECTION D/T,Stool Collection Time,Y,18:00,,,,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,140,,,,,127 - 181,g/L +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.42,,,,,0.39 - 0.54, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.7,,,,,4.5 - 6.4,TI/L +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,30,,,,,26 - 34,pg +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,91,,,,,79 - 96,fL +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,8.88,,,,,3.8 - 10.7,GI/L +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,5.46,,,,,1.96 - 7.23,GI/L +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.78,,,,,0.91 - 4.28,GI/L +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.47,,,,,0.12 - 0.92,GI/L +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.14,,,,,0 - 0.57,GI/L +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,,0 - 0.2,GI/L +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,61.4,,,,,40.5 - 75,% +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,31.2,,,,,15.4 - 48.5,% +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.3,,,,,2.6 - 10.1,% +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.6,,,,,0 - 6.8,% +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.4,,,,,0 - 2,% +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,330,,,,,140 - 400,GI/L +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,LIPID PANEL,Direct HDL-C 4th Generation,,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,LIPID PANEL,Triglycerides (GPO),,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,LIPID PANEL,Cholesterol (High Performance),,,,,Test cancelled: Quantity not sufficient,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,LIPID PANEL,LDL Chol Friedewald 4th,,Required testing unavailable,,,,,0 - 3.34,mmol/L +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,19-Feb-2026,,,,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,07:20,,,,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,19-Feb-2026,,,,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,08:50,,,,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,19-Feb-2026,,,,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,07:20,,,,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,SM10/FECAL BMRKS COLL D/T,Stool Collection Date,Y,18-Feb-2026,,,,,, +CZ100012001,,,,,Male,Induction Week 0,,"Feb 19, 2026 7:20 AM",6227323205,SM10/FECAL BMRKS COLL D/T,Stool Collection Time,Y,18:00,,,,,, +CZ100012001,,,,,Male,Biopsy,R,"Feb 5, 2026 12:00 AM",6227323223,ANATOMICAL SITE,Anatomical Site,Y,30,,,,,, +CZ100012001,,,,,Male,Biopsy,R,"Feb 5, 2026 12:00 AM",6227323223,BIOPSY COLLECTION METHOD,Collection Method,Y,colonoscopy,,,,,, +CZ100012001,,,,,Male,Biopsy,R,"Feb 5, 2026 12:00 AM",6227323223,BIOPSY FIXATIVE USED,Fixative Used,,10% NBF,,,,,, +CZ100012001,,,,,Male,Biopsy,R,"Feb 5, 2026 12:00 AM",6227323223,DATE/TIME PLACED IN FORMALIN,Date Sample placed in Formalin,Y,05-Feb-2026,,,,,, +CZ100012001,,,,,Male,Biopsy,R,"Feb 5, 2026 12:00 AM",6227323223,DATE/TIME PLACED IN FORMALIN,Time Sample placed in Formalin,Y,08:30,,,,,, +CZ100012001,,,,,Male,Biopsy,R,"Feb 5, 2026 12:00 AM",6227323223,DIAGNOSIS,Diagnosis:,Y,Ulcerative Colitis,,,,,, +CZ100012001,,,,,Male,Biopsy,R,"Feb 5, 2026 12:00 AM",6227323223,INFLAMED AREA,Inflamed area?,,Yes,,,,,, +CZ100012001,,,,,Male,Biopsy,R,"Feb 5, 2026 12:00 AM",6227323223,TISSUE BIOPSY EMBEDDING1,Biopsy technical QC-CL,,Smpl meets HT requirements,,,,,, +CZ100012001,,,,,Male,Biopsy,R,"Feb 5, 2026 12:00 AM",6227323223,TISSUE BIOPSY EMBEDDING1,Biopsy processing Time-CL,,10:00,,,,,, +CZ100012001,,,,,Male,Biopsy,R,"Feb 5, 2026 12:00 AM",6227323223,TISSUE BIOPSY EMBEDDING1,Biopsy processing Date-CL,,07-Feb-2026,,,,,, +CZ100012001,,,,,Male,Biopsy,R,"Feb 5, 2026 12:00 AM",6227323223,TISSUE BIOPSY EMBEDDING1,Biopsy Comments-CL,,Received in 10% NBF,,,,,, +CZ100012001,,,,,Male,Biopsy,R,"Feb 5, 2026 12:00 AM",6227323223,TISSUE BIOPSY EMBEDDING1,# of Cassettes-(FI)-CL,,1,,,,,, +CZ100012001,,,,,Male,Biopsy,R,"Feb 5, 2026 12:00 AM",6227323223,ULCERATED AREA,Is biopsy site ulcerated?,,Yes,,,,,, +CZ100012001,,,,,Male,Stool Pathogens,R,"Jan 28, 2026 6:00 AM",6227323211,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100012001,,,,,Male,Stool Pathogens,R,"Jan 28, 2026 6:00 AM",6227323211,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100012001,,,,,Male,Stool Pathogens,R,"Jan 28, 2026 6:00 AM",6227323211,OVA AND PARASITES 1,Concentrate Exam,,No ova or parasites found,,,,,, +CZ100012001,,,,,Male,Stool Pathogens,R,"Jan 28, 2026 6:00 AM",6227323211,OVA AND PARASITES 1,Smear for Microsporidia,,No Microsporidia seen.,,,,,, +CZ100012001,,,,,Male,Stool Pathogens,R,"Jan 28, 2026 6:00 AM",6227323211,OVA AND PARASITES 1,Modified acid-fast stain,,No coccidian parasites seen,,,,,, +CZ100012001,,,,,Male,Stool Pathogens,R,"Jan 28, 2026 6:00 AM",6227323211,OVA AND PARASITES 2,Trichrome Smear,,No ova or parasites found,,,,,, +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.4,,,,,0 - 6.2,umol/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,Alkaline Phosphatase,,61,,,,,40 - 129,U/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,ALT (SGPT),,23,,,,,5 - 48,U/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,AST (SGOT),,17,,,,,8 - 40,U/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,GGT,,24,,,,,10 - 61,U/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,LDH,,146,,,,,53 - 234,U/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,Urea Nitrogen,,3.9,,,,,1.4 - 8.6,mmol/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,79,,,,,40 - 110,umol/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,Serum Glucose,,5.5,,,,,3.9 - 5.6,mmol/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,Serum Uric Acid,,338,,,,,125 - 488,umol/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,Calcium (EDTA),,2.37,,,,,2.07 - 2.64,mmol/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,Phosphorus,,0.48,,LT,,Result verified by repeat analysis,0.71 - 1.65,mmol/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,Total Protein,,69,,,,,61 - 84,g/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,Albumin-BCG,,43,,,,,33 - 49,g/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,Creatine Kinase,,60,,,,,39 - 308,U/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,Serum Potassium,,4.6,,,,,3.5 - 5.2,mmol/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,Serum Bicarbonate,,25.1,,,,,19.3 - 29.3,mmol/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CHEMISTRY PANEL,Magnesium,,0.92,,,,,0.66 - 1.07,mmol/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,CKD-EPI 2021,CKD-EPI 2021 Without Race,,106,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,151,,,,,127 - 181,g/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.45,,,,,0.39 - 0.54, +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.0,,,,,4.5 - 6.4,TI/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,30,,,,,26 - 34,pg +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,91,,,,,79 - 96,fL +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.92,,,,,3.8 - 10.7,GI/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.40,,,,,1.96 - 7.23,GI/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.00,,,,,0.91 - 4.28,GI/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.27,,,,,0.12 - 0.92,GI/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.15,,,,,0 - 0.57,GI/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.10,,,,,0 - 0.2,GI/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,69.1,,,,,40.5 - 75,% +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,20.2,,,,,15.4 - 48.5,% +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.6,,,,,2.6 - 10.1,% +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.1,,,,,0 - 6.8,% +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,2.0,,,,,0 - 2,% +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,309,,,,,140 - 400,GI/L +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEPATITIS B SURFACE AB NON-US,Anti-HBs II QUAL,,Non-Reactive,,,,,Ref Rng :$Non Reactive, +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100012001,,,,,Male,Screening,,"Jan 22, 2026 8:00 AM",6227323203,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Negative,,,,,Normal=Negative, diff --git a/Covance_UCO3001/Source/2026-05-29_132918 sponsor-study-36940-test-results-930557-microbiology.csv b/Covance_UCO3001/Source/2026-05-29_132918 sponsor-study-36940-test-results-930557-microbiology.csv new file mode 100644 index 0000000..e9d3b93 --- /dev/null +++ b/Covance_UCO3001/Source/2026-05-29_132918 sponsor-study-36940-test-results-930557-microbiology.csv @@ -0,0 +1,6 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,,,,,, +Subject,Screening Number,Age,Age Unit,Gender,Visit Description,Collected Time,Accession,Test Group,Specimen,Organism,Growth,Cancellation Reason,Test Description,Test Result,Drug Name/Agent,MIC Result,Units,MIC Interpretation,Disk Diffusion Result,Disk Diffusion Interpretation,Subject Data Revision,Visit Data Revision,Result Data Revision +CZ100012001 - null,,,,Male,SCRNSTOOL Stool Pathogens,"Jan 28, 2026 6:00 AM",6227323211,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,R, +CZ100012001 - null,,,,Male,UNSCSTOOL Stool Pathogens,"Apr 22, 2026 7:00 AM",6228137359,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,, +CZ100012002 - null,,,,Female,SCRNSTOOL Stool Pathogens,"Mar 3, 2026 1:00 PM",6227323212,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,, +CZ100012003 - null,,,,Male,SCRNSTOOL Stool Pathogens,"Apr 29, 2026 7:55 AM",6227323213,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,, diff --git a/Covance_UCO3001/Source/2026-05-29_132944 sponsor-study-36940-test-results-930539-standard.csv b/Covance_UCO3001/Source/2026-05-29_132944 sponsor-study-36940-test-results-930539-standard.csv new file mode 100644 index 0000000..54c2205 --- /dev/null +++ b/Covance_UCO3001/Source/2026-05-29_132944 sponsor-study-36940-test-results-930539-standard.csv @@ -0,0 +1,178 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,, +Subject,Subject Data Revision,Screen No.,Age,Age Unit,Gender,Visit,Visit Data Revision,Collected Time,Accession,Test Group,Test,Administrative Question,Value,Result Data Revision,Flags,Cancellation Reason,Comments,Range,Units +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,Total Bilirubin,,5,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,Alkaline Phosphatase,,50,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,ALT (SGPT),,8,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,AST (SGOT),,10,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,GGT,,15,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,LDH,,167,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,Urea Nitrogen,,4.9,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,91,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,Serum Glucose,,5.7,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,Serum Uric Acid,,239,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,Calcium (EDTA),,2.22,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,Phosphorus,,0.91,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,Total Protein,,60,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,Albumin-BCG,,35,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,Creatine Kinase,,,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,Serum Sodium,,140,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,Serum Potassium,,3.8,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,Serum Bicarbonate,,26.1,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,Serum Chloride,,102,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,CHEMISTRY PANEL,Magnesium,,0.88,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,FECAL COLLECTION D/T,Stool Collection Date,Y,,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,FECAL COLLECTION D/T,Stool Collection Time,Y,,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,118,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.37,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.0,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,29,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,92,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,12.78,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,9.55,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.58,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.46,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.12,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.06,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,74.8,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,20.3,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,3.6,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.0,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.4,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,371,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,IS SUBJECT FASTING?,Is Subject Fasting?,Y,,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,LIPID PANEL,Direct HDL-C 4th Generation,,1.18,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,LIPID PANEL,Triglycerides (GPO),,1.61,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,LIPID PANEL,Cholesterol (High Performance),,4.55,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,LIPID PANEL,LDL Chol Friedewald 4th,,,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,PA1 EEA-2?,Approved to use EEA-2?,,,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,SM10/FECAL BMRKS COLL D/T,Stool Collection Date,Y,,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,SM10/FECAL BMRKS COLL D/T,Stool Collection Time,Y,,,,,,, +Removed,,,,,,Induction Week 0,,"May 28, 2026 10:45 AM",6227635174,SUBJECT HEIGHT (CM),Height (cm),Y,,,,,,, +CZ100162002,,,,,Male,Stool Pathogens,,"May 27, 2026 1:15 PM",6227635180,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,,,,,,, +CZ100162002,,,,,Male,Stool Pathogens,,"May 27, 2026 1:15 PM",6227635180,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,,,,,,, +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.7,,,,,0 - 6.2,umol/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,Alkaline Phosphatase,,105,,,,,40 - 129,U/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,ALT (SGPT),,17,,,,,5 - 48,U/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,AST (SGOT),,18,,,,,8 - 40,U/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,GGT,,14,,,,,10 - 61,U/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,LDH,,194,,,,,53 - 234,U/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,Urea Nitrogen,,5.4,,,,,1.4 - 8.6,mmol/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,69,,,,,40 - 110,umol/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,Serum Glucose,,5.9,,H,,,3.9 - 5.6,mmol/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,Serum Uric Acid,,242,,,,,125 - 488,umol/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,Calcium (EDTA),,2.39,,,,,2.07 - 2.64,mmol/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,Phosphorus,,0.82,,,,,0.71 - 1.65,mmol/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,Total Protein,,70,,,,,61 - 84,g/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,Albumin-BCG,,47,,,,,33 - 49,g/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,Creatine Kinase,,67,,,,,39 - 308,U/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,Serum Potassium,,4.7,,,,,3.5 - 5.2,mmol/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,Serum Bicarbonate,,23.9,,,,,19.3 - 29.3,mmol/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,CHEMISTRY PANEL,Magnesium,,0.89,,,,,0.66 - 1.07,mmol/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,140,,,,,127 - 181,g/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.42,,,,,0.39 - 0.54, +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.6,,,,,4.5 - 6.4,TI/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,30,,,,,26 - 34,pg +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,91,,,,,79 - 96,fL +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.92,,,,,3.8 - 10.7,GI/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,5.54,,,,,1.96 - 7.23,GI/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.14,,,,,0.91 - 4.28,GI/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.20,,,,,0.12 - 0.92,GI/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.03,,,,,0 - 0.57,GI/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,80.1,,H,,,40.5 - 75,% +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,16.5,,,,,15.4 - 48.5,% +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,2.8,,,,,2.6 - 10.1,% +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,0.4,,,,,0 - 6.8,% +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.2,,,,,0 - 2,% +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,363,,,,,140 - 400,GI/L +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEPATITIS B SURFACE AB,Anti-HBs II QUAL,,Non-Reactive,,,,,Ref Rng :$Non Reactive, +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,PA1 EEA-2?,Approved to use EEA-2?,,,,,,,, +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,,,,,,, +CZ100162002,,,,,Male,Screening,,"May 27, 2026 12:35 PM",6227635173,SUBJECT HEIGHT (CM),Height (cm),Y,,,,,,, +CZ100162001,,,,,Male,Biopsy,,"May 19, 2026 12:00 AM",6227635193,ANATOMICAL SITE,Anatomical Site,Y,15-20cm from anal verge,,,,,, +CZ100162001,,,,,Male,Biopsy,,"May 19, 2026 12:00 AM",6227635193,BIOPSY COLLECTION METHOD,Collection Method,Y,colonoscopy,,,,,, +CZ100162001,,,,,Male,Biopsy,,"May 19, 2026 12:00 AM",6227635193,BIOPSY FIXATIVE USED,Fixative Used,,10% NBF,,,,,, +CZ100162001,,,,,Male,Biopsy,,"May 19, 2026 12:00 AM",6227635193,DATE/TIME PLACED IN FORMALIN,Date Sample placed in Formalin,Y,19-May-2026,,,,,, +CZ100162001,,,,,Male,Biopsy,,"May 19, 2026 12:00 AM",6227635193,DATE/TIME PLACED IN FORMALIN,Time Sample placed in Formalin,Y,09:40,,,,,, +CZ100162001,,,,,Male,Biopsy,,"May 19, 2026 12:00 AM",6227635193,DIAGNOSIS,Diagnosis:,Y,Ulcerative Colitis,,,,,, +CZ100162001,,,,,Male,Biopsy,,"May 19, 2026 12:00 AM",6227635193,INFLAMED AREA,Inflamed area?,,Yes,,,,,, +CZ100162001,,,,,Male,Biopsy,,"May 19, 2026 12:00 AM",6227635193,TISSUE BIOPSY EMBEDDING1,Biopsy technical QC-CL,,Smpl meets HT requirements,,,,,, +CZ100162001,,,,,Male,Biopsy,,"May 19, 2026 12:00 AM",6227635193,TISSUE BIOPSY EMBEDDING1,Biopsy processing Time-CL,,12:00,,,,,, +CZ100162001,,,,,Male,Biopsy,,"May 19, 2026 12:00 AM",6227635193,TISSUE BIOPSY EMBEDDING1,Biopsy processing Date-CL,,21-May-2026,,,,,, +CZ100162001,,,,,Male,Biopsy,,"May 19, 2026 12:00 AM",6227635193,TISSUE BIOPSY EMBEDDING1,Biopsy Comments-CL,,Received in 10% NBF,,,,,, +CZ100162001,,,,,Male,Biopsy,,"May 19, 2026 12:00 AM",6227635193,TISSUE BIOPSY EMBEDDING1,# of Cassettes-(FI)-CL,,1,,,,,, +CZ100162001,,,,,Male,Biopsy,,"May 19, 2026 12:00 AM",6227635193,ULCERATED AREA,Is biopsy site ulcerated?,,Yes,,,,,, +CZ100162001,,,,,Male,Stool Pathogens,,"May 6, 2026 9:30 AM",6228610564,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100162001,,,,,Male,Stool Pathogens,,"May 6, 2026 9:30 AM",6228610564,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100162001,,,,,Male,Stool Pathogens,,"Apr 24, 2026 8:45 AM",6227635182,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,,,,,,, +CZ100162001,,,,,Male,Stool Pathogens,,"Apr 24, 2026 8:45 AM",6227635182,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,,,,,,, +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,Total Bilirubin,,10,,,,,3 - 21,umol/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.8,,,,,0 - 6.2,umol/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,Alkaline Phosphatase,,60,,,,,40 - 129,U/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,ALT (SGPT),,11,,,,,5 - 48,U/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,AST (SGOT),,16,,,,,8 - 40,U/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,GGT,,18,,,,,10 - 61,U/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,LDH,,186,,,,,53 - 234,U/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,Urea Nitrogen,,6.8,,,,,1.4 - 8.6,mmol/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,96,,,,,40 - 110,umol/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,Serum Glucose,,5.9,,H,,,3.9 - 5.6,mmol/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,Serum Uric Acid,,233,,,,,125 - 488,umol/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,Calcium (EDTA),,2.34,,,,,2.07 - 2.64,mmol/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,Phosphorus,,0.76,,,,,0.71 - 1.65,mmol/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,Total Protein,,69,,,,,61 - 84,g/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,Albumin-BCG,,43,,,,,33 - 49,g/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,Creatine Kinase,,36,R,L,,,39 - 308,U/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,Serum Bicarbonate,,26.8,,,,,19.3 - 29.3,mmol/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CHEMISTRY PANEL,Magnesium,,0.85,,,,,0.66 - 1.07,mmol/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,84,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,154,,,,,127 - 181,g/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.45,,,,,0.39 - 0.54, +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.0,,,,,4.5 - 6.4,TI/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,31,,,,,26 - 34,pg +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,90,,,,,79 - 96,fL +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,13.56,,H,,,3.8 - 10.7,GI/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,11.03,,H,,,1.96 - 7.23,GI/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.38,,,,,0.91 - 4.28,GI/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.65,,,,,0.12 - 0.92,GI/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.36,,,,,0 - 0.57,GI/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.14,,,,,0 - 0.2,GI/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,81.3,,H,,,40.5 - 75,% +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,10.2,,L,,,15.4 - 48.5,% +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.8,,,,,2.6 - 10.1,% +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.7,,,,,0 - 6.8,% +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.0,,,,,0 - 2,% +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,233,,,,,140 - 400,GI/L +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEPATITIS B SURFACE AB,Anti-HBs II QUAL,,Non-Reactive,,,,,Ref Rng :$Non Reactive, +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Negative,,,,,Normal=Negative, +CZ100162001,,,,,Male,Screening,,"Apr 21, 2026 10:45 AM",6227635171,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, diff --git a/Covance_UCO3001/Source/2026-05-29_133002 sponsor-study-36940-test-results-930539-microbiology.csv b/Covance_UCO3001/Source/2026-05-29_133002 sponsor-study-36940-test-results-930539-microbiology.csv new file mode 100644 index 0000000..035d1ae --- /dev/null +++ b/Covance_UCO3001/Source/2026-05-29_133002 sponsor-study-36940-test-results-930539-microbiology.csv @@ -0,0 +1,5 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,,,,,, +Subject,Screening Number,Age,Age Unit,Gender,Visit Description,Collected Time,Accession,Test Group,Specimen,Organism,Growth,Cancellation Reason,Test Description,Test Result,Drug Name/Agent,MIC Result,Units,MIC Interpretation,Disk Diffusion Result,Disk Diffusion Interpretation,Subject Data Revision,Visit Data Revision,Result Data Revision +CZ100162001 - null,,,,Male,SCRNSTOOL Stool Pathogens,"Apr 24, 2026 8:45 AM",6227635182,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,, +CZ100162001 - null,,,,Male,SCRNSTOOL Stool Pathogens,"May 6, 2026 9:30 AM",6228610564,STOOL CULTURE,,,,Test group cancelled: No specimen received,,,,,,,,,,, +CZ100162002 - null,,,,Male,SCRNSTOOL Stool Pathogens,"May 27, 2026 1:15 PM",6227635180,STOOL CULTURE,,,,,,,,,,,,,,, diff --git a/Covance_UCO3001/Source/2026-05-29_133022 sponsor-study-36940-test-results-930536-standard.csv b/Covance_UCO3001/Source/2026-05-29_133022 sponsor-study-36940-test-results-930536-standard.csv new file mode 100644 index 0000000..0f4a823 --- /dev/null +++ b/Covance_UCO3001/Source/2026-05-29_133022 sponsor-study-36940-test-results-930536-standard.csv @@ -0,0 +1,127 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,, +Subject,Subject Data Revision,Screen No.,Age,Age Unit,Gender,Visit,Visit Data Revision,Collected Time,Accession,Test Group,Test,Administrative Question,Value,Result Data Revision,Flags,Cancellation Reason,Comments,Range,Units +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,2003 SCHWARTZ EGFR,2003 Schwartz eGFR,,191,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,Total Bilirubin,,9,,,,,3 - 21,umol/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.0,,,,,0 - 6.2,umol/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,Alkaline Phosphatase,,282,,,,,82 - 331,U/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,ALT (SGPT),,16,,,,,6 - 43,U/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,AST (SGOT),,26,,,,,10 - 40,U/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,GGT,,15,,,,,0 - 51,U/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,LDH,,214,,,,,105 - 235,U/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,Urea Nitrogen,,4.0,,,,,1.4 - 8.6,mmol/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,51,,,,,23 - 83,umol/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,Serum Glucose,,4.3,,,,,3.9 - 5.6,mmol/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,Serum Uric Acid,,336,,,,,184 - 416,umol/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,Calcium (EDTA),,2.47,,,,,2.1 - 2.57,mmol/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,Phosphorus,,1.58,,,,,0.71 - 1.65,mmol/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,Total Protein,,85,,H,,,61 - 84,g/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,29 - 47,g/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,Creatine Kinase,,65,,,,,18 - 363,U/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,Serum Sodium,,136,,,,,132 - 147,mmol/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,Serum Potassium,,4.7,,,,,3.5 - 5.2,mmol/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,Serum Bicarbonate,,23.4,,,,,19.3 - 29.3,mmol/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,Serum Chloride,,100,,,,,94 - 112,mmol/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CHEMISTRY PANEL,Magnesium,,0.81,,,,,0.7 - 0.9,mmol/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,CRP COPY,C Reactive Protein COPY,,1.9,,,,,0.4 - 2,mg/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,FECAL CALPROTECTIN COPY,Fecal Calprotectin COPY,,3749.9,,H,,,Normal: <80ug/g$Borderline: 80-160$ug/g. Elevated:>160$ug/g, +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,FECAL COLLECTION D/T,Stool Collection Date,Y,17-May-2026,,,,,, +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,FECAL COLLECTION D/T,Stool Collection Time,Y,18:00,,,,,, +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,114,,L,,,127 - 181,g/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.37,,L,,,0.39 - 0.54, +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.2,,L,,,4.5 - 6.4,TI/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,27,,,,,26 - 34,pg +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,87,,,,,79 - 96,fL +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,9.73,,,,,4.35 - 13.15,GI/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,5.06,,,,,1.65 - 8.15,GI/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,3.42,,,,,0.95 - 5.25,GI/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.83,,,,,0.4 - 1.3,GI/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.34,,H,,,0 - 0.3,GI/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.10,,,,,0 - 0.2,GI/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,52.0,,,,,40.5 - 75,% +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,35.1,,,,,15.4 - 48.5,% +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,8.5,,H,,,4 - 8,% +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.5,,H,,,0 - 2.8,% +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.0,,,,,0 - 1,% +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,607,,H,,,140 - 400,GI/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,LIPID PANEL,Direct HDL-C 4th Generation,,1.27,,,,,1.03 - 1.53,mmol/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,LIPID PANEL,Triglycerides (GPO),,1.17,,,,,0.42 - 1.67,mmol/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,LIPID PANEL,Cholesterol (High Performance),,3.50,,,,,2.95 - 5.12,mmol/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,LIPID PANEL,LDL Chol Friedewald 4th,,1.69,,,,,0 - 3.34,mmol/L +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,18-May-2026,,,,,, +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,09:28,,,,,, +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,18-May-2026,,,,,, +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,10:52,,,,,, +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,18-May-2026,,,,,, +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,09:28,,,,,, +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,SM10/FECAL BMRKS COLL D/T,Stool Collection Date,Y,17-May-2026,,,,,, +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,SM10/FECAL BMRKS COLL D/T,Stool Collection Time,Y,18:00,,,,,, +CZ100201001,,,,,Male,Induction Week 0,,"May 18, 2026 9:28 AM",6227993966,SUBJECT HEIGHT (CM),Height (cm),Y,157,,,,,cm, +CZ100201001,,,,,Male,Biopsy,,"Apr 15, 2026 12:00 AM",6227993984,ANATOMICAL SITE,Anatomical Site,Y,20-25,,,,,, +CZ100201001,,,,,Male,Biopsy,,"Apr 15, 2026 12:00 AM",6227993984,BIOPSY COLLECTION METHOD,Collection Method,Y,colonoscopy,,,,,, +CZ100201001,,,,,Male,Biopsy,,"Apr 15, 2026 12:00 AM",6227993984,BIOPSY FIXATIVE USED,Fixative Used,,10% NBF,,,,,, +CZ100201001,,,,,Male,Biopsy,,"Apr 15, 2026 12:00 AM",6227993984,DATE/TIME PLACED IN FORMALIN,Date Sample placed in Formalin,Y,15-Apr-2026,,,,,, +CZ100201001,,,,,Male,Biopsy,,"Apr 15, 2026 12:00 AM",6227993984,DATE/TIME PLACED IN FORMALIN,Time Sample placed in Formalin,Y,13:00,,,,,, +CZ100201001,,,,,Male,Biopsy,,"Apr 15, 2026 12:00 AM",6227993984,DIAGNOSIS,Diagnosis:,Y,Ulcerative Colitis,,,,,, +CZ100201001,,,,,Male,Biopsy,,"Apr 15, 2026 12:00 AM",6227993984,INFLAMED AREA,Inflamed area?,,Yes,,,,,, +CZ100201001,,,,,Male,Biopsy,,"Apr 15, 2026 12:00 AM",6227993984,TISSUE BIOPSY EMBEDDING1,Biopsy technical QC-CL,,Smpl meets HT requirements,,,,,, +CZ100201001,,,,,Male,Biopsy,,"Apr 15, 2026 12:00 AM",6227993984,TISSUE BIOPSY EMBEDDING1,Biopsy processing Time-CL,,10:00,,,,,, +CZ100201001,,,,,Male,Biopsy,,"Apr 15, 2026 12:00 AM",6227993984,TISSUE BIOPSY EMBEDDING1,Biopsy processing Date-CL,,17-Apr-2026,,,,,, +CZ100201001,,,,,Male,Biopsy,,"Apr 15, 2026 12:00 AM",6227993984,TISSUE BIOPSY EMBEDDING1,Biopsy Comments-CL,,Received in 10% NBF,,,,,, +CZ100201001,,,,,Male,Biopsy,,"Apr 15, 2026 12:00 AM",6227993984,TISSUE BIOPSY EMBEDDING1,# of Cassettes-(FI)-CL,,1,,,,,, +CZ100201001,,,,,Male,Biopsy,,"Apr 15, 2026 12:00 AM",6227993984,ULCERATED AREA,Is biopsy site ulcerated?,,No,,,,,, +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,2003 SCHWARTZ EGFR,2003 Schwartz eGFR,,211,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.2,,,,,0 - 6.2,umol/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,Alkaline Phosphatase,,322,,,,,82 - 331,U/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,ALT (SGPT),,20,,,,,6 - 43,U/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,AST (SGOT),,29,,,,,10 - 40,U/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,GGT,,17,,,,,0 - 51,U/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,LDH,,221,,,,,105 - 235,U/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,Urea Nitrogen,,3.6,,,,,1.4 - 8.6,mmol/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,46,,,,,23 - 83,umol/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,Serum Glucose,,4.1,,,,,3.9 - 5.6,mmol/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,Serum Uric Acid,,326,,,,,184 - 416,umol/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,Calcium (EDTA),,2.57,,,,,2.1 - 2.57,mmol/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,Phosphorus,,1.72,,H,,,0.71 - 1.65,mmol/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,Total Protein,,87,,H,,,61 - 84,g/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,29 - 47,g/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,Creatine Kinase,,94,,,,,18 - 363,U/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,Serum Sodium,,136,,,,,132 - 147,mmol/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,Serum Potassium,,4.9,,,,,3.5 - 5.2,mmol/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,Serum Bicarbonate,,20.7,,,,,19.3 - 29.3,mmol/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,Serum Chloride,,100,,,,,94 - 112,mmol/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,CHEMISTRY PANEL,Magnesium,,0.77,,,,,0.7 - 0.9,mmol/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,118,,L,,Result verified by repeat analysis,127 - 181,g/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.37,,L,,,0.39 - 0.54, +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.2,,L,,Result verified by repeat analysis,4.5 - 6.4,TI/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,28,,,,Result verified by repeat analysis,26 - 34,pg +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,87,,,,,79 - 96,fL +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,10.04,,,,Result verified by repeat analysis,4.35 - 13.15,GI/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,5.19,,,,Result verified by repeat analysis,1.65 - 8.15,GI/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,3.73,,,,,0.95 - 5.25,GI/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.77,,,,Result verified by repeat analysis,0.4 - 1.3,GI/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.29,,,,Result verified by repeat analysis,0 - 0.3,GI/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,Result verified by repeat analysis,0 - 0.2,GI/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,51.7,,,,Result verified by repeat analysis,40.5 - 75,% +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,37.2,,,,Result verified by repeat analysis,15.4 - 48.5,% +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.6,,,,Result verified by repeat analysis,4 - 8,% +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.9,,H,,Result verified by repeat analysis,0 - 2.8,% +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,Result verified by repeat analysis,0 - 1,% +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,490,,H,,Result verified by repeat analysis,140 - 400,GI/L +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEPATITIS B SURFACE AB,Anti-HBs II QUAL,,Reactive,,,,,Ref Rng :$Non Reactive, +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Negative,,,,,Normal=Negative, +CZ100201001,,,,,Male,Screening,,"Apr 13, 2026 12:20 PM",6227993962,SUBJECT HEIGHT (CM),Height (cm),Y,157,,,,,cm, +CZ100201001,,,,,Male,Stool Pathogens,,"Apr 13, 2026 6:00 AM",6227993971,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100201001,,,,,Male,Stool Pathogens,,"Apr 13, 2026 6:00 AM",6227993971,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,Negative,,,,,Ref Rng:Negative, diff --git a/Covance_UCO3001/Source/2026-05-29_133047 sponsor-study-36940-test-results-930536-microbiology.csv b/Covance_UCO3001/Source/2026-05-29_133047 sponsor-study-36940-test-results-930536-microbiology.csv new file mode 100644 index 0000000..4dfdeb2 --- /dev/null +++ b/Covance_UCO3001/Source/2026-05-29_133047 sponsor-study-36940-test-results-930536-microbiology.csv @@ -0,0 +1,3 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,,,,,, +Subject,Screening Number,Age,Age Unit,Gender,Visit Description,Collected Time,Accession,Test Group,Specimen,Organism,Growth,Cancellation Reason,Test Description,Test Result,Drug Name/Agent,MIC Result,Units,MIC Interpretation,Disk Diffusion Result,Disk Diffusion Interpretation,Subject Data Revision,Visit Data Revision,Result Data Revision +CZ100201001 - null,,,,Male,SCRNSTOOL Stool Pathogens,"Apr 13, 2026 6:00 AM",6227993971,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,, diff --git a/Covance_UCO3001/Source/2026-05-29_133105 sponsor-study-36940-test-results-930553-standard.csv b/Covance_UCO3001/Source/2026-05-29_133105 sponsor-study-36940-test-results-930553-standard.csv new file mode 100644 index 0000000..2a84d67 --- /dev/null +++ b/Covance_UCO3001/Source/2026-05-29_133105 sponsor-study-36940-test-results-930553-standard.csv @@ -0,0 +1,250 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,, +Subject,Subject Data Revision,Screen No.,Age,Age Unit,Gender,Visit,Visit Data Revision,Collected Time,Accession,Test Group,Test,Administrative Question,Value,Result Data Revision,Flags,Cancellation Reason,Comments,Range,Units +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,ALP<2XULN,ALP<2XULN,,Criteria Met,,,,,, +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,ALT>/=3XULN,ALT >/= 3 X ULN,,Criteria not met,,,,,, +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,ALT>/=3XULN & TBIL>/=2XULN,ALT >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,AST>/=3XULN,AST >/= 3 X ULN,,Criteria not met,,,,,, +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,AST>/=3XULN & TBIL>/=2XULN,AST >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,Total Bilirubin,,17,,,,,3 - 21,umol/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,5.0,,,,,0 - 6.2,umol/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,Alkaline Phosphatase,,60,,,,,35 - 104,U/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,ALT (SGPT),,18,,,,,4 - 43,U/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,AST (SGOT),,21,,,,,8 - 40,U/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,GGT,,15,,,,,4 - 49,U/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,LDH,,154,,,,,53 - 234,U/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,Urea Nitrogen,,3.4,,,,,1.4 - 8.6,mmol/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,73,,,,,31 - 101,umol/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,Serum Glucose,,4.6,,,,,3.9 - 5.6,mmol/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,Serum Uric Acid,,196,,,,,149 - 446,umol/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,Calcium (EDTA),,2.47,,,,,2.07 - 2.64,mmol/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,Phosphorus,,1.10,,,,,0.71 - 1.65,mmol/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,Total Protein,,73,,,,,61 - 84,g/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,Albumin-BCG,,48,,,,,33 - 49,g/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,Creatine Kinase,,100,,,,,26 - 192,U/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,Serum Sodium,,136,,,,,132 - 147,mmol/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,Serum Bicarbonate,,22.8,,,,,19.3 - 29.3,mmol/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,Serum Chloride,,100,,,,,94 - 112,mmol/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CHEMISTRY PANEL,Magnesium,,0.81,,,,,0.66 - 1.07,mmol/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,86,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,FECAL COLLECTION D/T,Stool Collection Date,Y,19-May-2026,,,,,, +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,FECAL COLLECTION D/T,Stool Collection Time,Y,06:20,,,,,, +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,137,,,,,116 - 164,g/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.40,,,,,0.34 - 0.48, +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.4,,,,,4.1 - 5.6,TI/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,32,,,,,26 - 34,pg +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,91,,,,,79 - 98,fL +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.57,,,,,3.8 - 10.7,GI/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.33,,,,,1.96 - 7.23,GI/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.77,,,,,0.91 - 4.28,GI/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.29,,,,,0.12 - 0.92,GI/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.12,,,,,0 - 0.57,GI/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.06,,,,,0 - 0.2,GI/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,65.9,,,,,40.5 - 75,% +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,26.9,,,,,15.4 - 48.5,% +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.4,,,,,2.6 - 10.1,% +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.8,,,,,0 - 6.8,% +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.9,,,,,0 - 2,% +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,258,,,,,140 - 400,GI/L +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,19-May-2026,,,,,, +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,10:50,,,,,, +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,19-May-2026,,,,,, +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,11:55,,,,,, +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,19-May-2026,,,,,, +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,10:50,,,,,, +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,SM09/STOOL PK COLL D/T,Stool Collection Date,Y,19-May-2026,,,,,, +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,SM09/STOOL PK COLL D/T,Stool Collection Time,Y,06:20,,,,,, +CZ100092001,,,,,Female,Induction Week 2,,"May 19, 2026 10:50 AM",6227323335,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,Total Bilirubin,,12,,,,,3 - 21,umol/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,4.5,,,,,0 - 6.2,umol/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,Alkaline Phosphatase,,55,,,,,35 - 104,U/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,ALT (SGPT),,15,,,,,4 - 43,U/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,AST (SGOT),,18,,,,,8 - 40,U/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,GGT,,13,,,,,4 - 49,U/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,LDH,,152,,,,,53 - 234,U/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,Urea Nitrogen,,5.1,,,,,1.4 - 8.6,mmol/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,62,,,,,31 - 101,umol/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,Serum Glucose,,4.7,,,,,3.9 - 5.6,mmol/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,Serum Uric Acid,,178,,,,,149 - 446,umol/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,Calcium (EDTA),,2.44,,,,,2.07 - 2.64,mmol/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,Phosphorus,,1.09,,,,,0.71 - 1.65,mmol/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,Total Protein,,71,,,,,61 - 84,g/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,Albumin-BCG,,47,,,,,33 - 49,g/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,Creatine Kinase,,87,,,,,26 - 192,U/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,Serum Sodium,,142,,,,,132 - 147,mmol/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,Serum Potassium,,4.6,,,,,3.5 - 5.2,mmol/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,Serum Bicarbonate,,21.5,,,,,19.3 - 29.3,mmol/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CHEMISTRY PANEL,Magnesium,,0.94,,,,,0.66 - 1.07,mmol/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,105,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,FECAL COLLECTION D/T,Stool Collection Date,Y,05-May-2026,,,,,, +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,FECAL COLLECTION D/T,Stool Collection Time,Y,06:30,,,,,, +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,140,,,,,116 - 164,g/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.41,,,,,0.34 - 0.48, +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.5,,,,,4.1 - 5.6,TI/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,31,,,,,26 - 34,pg +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,92,,,,,79 - 98,fL +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.60,,,,,3.8 - 10.7,GI/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.94,,,,,1.96 - 7.23,GI/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.22,,,,,0.91 - 4.28,GI/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.32,,,,,0.12 - 0.92,GI/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.10,,,,,0 - 0.57,GI/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,63.9,,,,,40.5 - 75,% +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,26.5,,,,,15.4 - 48.5,% +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.9,,,,,2.6 - 10.1,% +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.2,,,,,0 - 6.8,% +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,207,,,,,140 - 400,GI/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,LIPID PANEL,Direct HDL-C 4th Generation,,1.70,,H,,,1.03 - 1.53,mmol/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,LIPID PANEL,Triglycerides (GPO),,0.59,,,,,0.59 - 2.96,mmol/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,LIPID PANEL,Cholesterol (High Performance),,4.49,,,,,4.42 - 7.53,mmol/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,LIPID PANEL,LDL Chol Friedewald 4th,,2.52,,,,,0 - 3.34,mmol/L +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,PA1 EEA-2?,Approved to use EEA-2?,,No,,,,,, +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,05-May-2026,,,,,, +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,11:30,,,,,, +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,05-May-2026,,,,,, +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,12:45,,,,,, +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,05-May-2026,,,,,, +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,11:30,,,,,, +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,SM10/FECAL BMRKS COLL D/T,Stool Collection Date,Y,05-May-2026,,,,,, +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,SM10/FECAL BMRKS COLL D/T,Stool Collection Time,Y,06:30,,,,,, +CZ100092001,,,,,Female,Induction Week 0,,"May 5, 2026 11:30 AM",6227323334,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100092002,,,,,Female,TB Testing,,"May 5, 2026 9:00 AM",6227323348,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Negative,,,,,Normal=Negative, +CZ100092001,,,,,Female,Biopsy,,"Apr 24, 2026 12:00 AM",6227323351,ANATOMICAL SITE,Anatomical Site,Y,15-20cm from anal verge,,,,,, +CZ100092001,,,,,Female,Biopsy,,"Apr 24, 2026 12:00 AM",6227323351,BIOPSY COLLECTION METHOD,Collection Method,Y,colonoscopy,,,,,, +CZ100092001,,,,,Female,Biopsy,,"Apr 24, 2026 12:00 AM",6227323351,BIOPSY FIXATIVE USED,Fixative Used,,10% NBF,,,,,, +CZ100092001,,,,,Female,Biopsy,,"Apr 24, 2026 12:00 AM",6227323351,DATE/TIME PLACED IN FORMALIN,Date Sample placed in Formalin,Y,24-Apr-2026,,,,,, +CZ100092001,,,,,Female,Biopsy,,"Apr 24, 2026 12:00 AM",6227323351,DATE/TIME PLACED IN FORMALIN,Time Sample placed in Formalin,Y,11:09,,,,,, +CZ100092001,,,,,Female,Biopsy,,"Apr 24, 2026 12:00 AM",6227323351,DIAGNOSIS,Diagnosis:,Y,Ulcerative Colitis,,,,,, +CZ100092001,,,,,Female,Biopsy,,"Apr 24, 2026 12:00 AM",6227323351,INFLAMED AREA,Inflamed area?,,Yes,,,,,, +CZ100092001,,,,,Female,Biopsy,,"Apr 24, 2026 12:00 AM",6227323351,TISSUE BIOPSY EMBEDDING1,Biopsy technical QC-CL,,Smpl meets HT requirements,,,,,, +CZ100092001,,,,,Female,Biopsy,,"Apr 24, 2026 12:00 AM",6227323351,TISSUE BIOPSY EMBEDDING1,Biopsy processing Time-CL,,12:00,,,,,, +CZ100092001,,,,,Female,Biopsy,,"Apr 24, 2026 12:00 AM",6227323351,TISSUE BIOPSY EMBEDDING1,Biopsy processing Date-CL,,29-Apr-2026,,,,,, +CZ100092001,,,,,Female,Biopsy,,"Apr 24, 2026 12:00 AM",6227323351,TISSUE BIOPSY EMBEDDING1,Biopsy Comments-CL,,Received in 10% NBF,,,,,, +CZ100092001,,,,,Female,Biopsy,,"Apr 24, 2026 12:00 AM",6227323351,TISSUE BIOPSY EMBEDDING1,# of Cassettes-(FI)-CL,,1,,,,,, +CZ100092001,,,,,Female,Biopsy,,"Apr 24, 2026 12:00 AM",6227323351,ULCERATED AREA,Is biopsy site ulcerated?,,No,,,,,, +CZ100092002,,,,,Female,Stool Pathogens,,"Apr 20, 2026 6:10 AM",6227323341,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100092002,,,,,Female,Stool Pathogens,,"Apr 20, 2026 6:10 AM",6227323341,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100092002,,,,,Female,Stool Pathogens,,"Apr 20, 2026 6:10 AM",6227323341,OVA AND PARASITES 1,Concentrate Exam,,No ova or parasites found,,,,,, +CZ100092002,,,,,Female,Stool Pathogens,,"Apr 20, 2026 6:10 AM",6227323341,OVA AND PARASITES 1,Smear for Microsporidia,,No Microsporidia seen.,,,,,, +CZ100092002,,,,,Female,Stool Pathogens,,"Apr 20, 2026 6:10 AM",6227323341,OVA AND PARASITES 1,Modified acid-fast stain,,No coccidian parasites seen,,,,,, +CZ100092002,,,,,Female,Stool Pathogens,,"Apr 20, 2026 6:10 AM",6227323341,OVA AND PARASITES 2,Trichrome Smear,,No ova or parasites found,,,,,, +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,Total Bilirubin,,9,,,,,3 - 21,umol/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.3,,,,,0 - 6.2,umol/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,Alkaline Phosphatase,,56,,,,,35 - 104,U/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,ALT (SGPT),,11,,,,,4 - 43,U/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,AST (SGOT),,25,,,,,8 - 40,U/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,GGT,,10,,,,,4 - 49,U/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,LDH,,159,,,,,53 - 234,U/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,Urea Nitrogen,,6.1,,,,,1.4 - 8.6,mmol/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,90,,,,,31 - 101,umol/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,Serum Glucose,,4.9,,,,,3.9 - 5.6,mmol/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,Serum Uric Acid,,268,,,,,149 - 446,umol/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,Calcium (EDTA),,2.43,,,,,2.07 - 2.64,mmol/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,Phosphorus,,1.14,,,,,0.71 - 1.65,mmol/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,Total Protein,,70,,,,,61 - 84,g/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,Creatine Kinase,,176,,,,,26 - 192,U/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,Serum Potassium,,4.6,,,,,3.5 - 5.2,mmol/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,Serum Bicarbonate,,27.2,,,,,19.3 - 29.3,mmol/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CHEMISTRY PANEL,Magnesium,,0.93,,,,,0.66 - 1.07,mmol/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,65,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,Yes,,,,,, +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,138,,,,,116 - 164,g/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.39,,,,,0.34 - 0.48, +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.3,,,,,4.1 - 5.6,TI/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,32,,,,,26 - 34,pg +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,90,,,,,79 - 98,fL +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.05,,,,,3.8 - 10.7,GI/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,1.87,,L,,,1.96 - 7.23,GI/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.72,,,,,0.91 - 4.28,GI/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.29,,,,,0.12 - 0.92,GI/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.14,,,,,0 - 0.57,GI/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,46.1,,,,,40.5 - 75,% +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,42.6,,,,,15.4 - 48.5,% +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.2,,,,,2.6 - 10.1,% +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.4,,,,,0 - 6.8,% +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.6,,,,,0 - 2,% +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,216,,,,,140 - 400,GI/L +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEPATITIS B SURFACE AB,Anti-HBs II QUAL,,Non-Reactive,,,,,Ref Rng :$Non Reactive, +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Positive,,RX,,Result verified by repeat analysis,Normal=Negative, +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,SERUM BETA HCG,"B-hCG, Qualitative",,Negative,,,,,Ref Rng: Negative, +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,SERUM BETA HCG,"B-hCG, Quantitative",,0.6,,,,,Units: mIU/mL$Pre-menopausal$<5.0: Negative$5.0-24.9:Borderline$>/= 25.0: Positive, +CZ100092002,,,,,Female,Screening,,"Apr 16, 2026 12:00 PM",6227323332,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100092001,,,,,Female,Stool Pathogens,,"Apr 2, 2026 6:15 AM",6227323340,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100092001,,,,,Female,Stool Pathogens,,"Apr 2, 2026 6:15 AM",6227323340,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100092001,,,,,Female,Stool Pathogens,,"Apr 2, 2026 6:15 AM",6227323340,OVA AND PARASITES 1,Concentrate Exam,,No ova or parasites found,,,,,, +CZ100092001,,,,,Female,Stool Pathogens,,"Apr 2, 2026 6:15 AM",6227323340,OVA AND PARASITES 1,Smear for Microsporidia,,No Microsporidia seen.,,,,,, +CZ100092001,,,,,Female,Stool Pathogens,,"Apr 2, 2026 6:15 AM",6227323340,OVA AND PARASITES 1,Modified acid-fast stain,,No coccidian parasites seen,,,,,, +CZ100092001,,,,,Female,Stool Pathogens,,"Apr 2, 2026 6:15 AM",6227323340,OVA AND PARASITES 2,Trichrome Smear,,No ova or parasites found,,,,,, +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,Total Bilirubin,,9,,,,,3 - 21,umol/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.4,,,,,0 - 6.2,umol/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,Alkaline Phosphatase,,56,,,,,35 - 104,U/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,ALT (SGPT),,15,,,,,4 - 43,U/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,AST (SGOT),,17,,,,,8 - 40,U/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,GGT,,12,,,,,4 - 49,U/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,LDH,,137,,,,,53 - 234,U/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,Urea Nitrogen,,2.7,,,,,1.4 - 8.6,mmol/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,58,,,,,31 - 101,umol/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,Serum Glucose,,5.2,,,,,3.9 - 5.6,mmol/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,Serum Uric Acid,,207,,,,,125 - 428,umol/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,Calcium (EDTA),,2.43,,,,,2.07 - 2.64,mmol/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,Phosphorus,,1.15,,,,,0.71 - 1.65,mmol/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,Total Protein,,67,,,,,61 - 84,g/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,Creatine Kinase,,81,,,,,26 - 192,U/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,Serum Sodium,,141,,,,,132 - 147,mmol/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,Serum Potassium,,4.3,,,,,3.5 - 5.2,mmol/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,Serum Bicarbonate,,23.7,,,,,19.3 - 29.3,mmol/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CHEMISTRY PANEL,Magnesium,,0.91,,,,,0.66 - 1.07,mmol/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,107,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,Yes,,,,,, +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,147,,,,,116 - 164,g/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.43,,,,,0.34 - 0.48, +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.7,,,,,4.1 - 5.6,TI/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,31,,,,,26 - 34,pg +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,91,,,,,79 - 98,fL +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.74,,,,,3.8 - 10.7,GI/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.76,,,,,1.96 - 7.23,GI/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.18,,,,,0.91 - 4.28,GI/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.46,,,,,0.12 - 0.92,GI/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.26,,,,,0 - 0.57,GI/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.09,,,,,0 - 0.2,GI/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,65.5,,,,,40.5 - 75,% +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,20.6,,,,,15.4 - 48.5,% +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.9,,,,,2.6 - 10.1,% +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,4.5,,,,,0 - 6.8,% +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.5,,,,,0 - 2,% +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,263,,,,,140 - 400,GI/L +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEPATITIS B SURFACE AB,Anti-HBs II QUAL,,Non-Reactive,,,,,Ref Rng :$Non Reactive, +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,PA1 EEA-2?,Approved to use EEA-2?,,No,,,,,, +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Negative,,,,,Normal=Negative, +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,SERUM BETA HCG,"B-hCG, Qualitative",,Negative,,,,,Ref Rng: Negative, +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,SERUM BETA HCG,"B-hCG, Quantitative",,<0.6,,,,,Units: mIU/mL$Pre-menopausal$<5.0: Negative$5.0-24.9:Borderline$>/= 25.0: Positive, +CZ100092001,,,,,Female,Screening,,"Mar 31, 2026 8:30 AM",6227323330,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, diff --git a/Covance_UCO3001/Source/2026-05-29_133123 sponsor-study-36940-test-results-930553-microbiology.csv b/Covance_UCO3001/Source/2026-05-29_133123 sponsor-study-36940-test-results-930553-microbiology.csv new file mode 100644 index 0000000..95b16c0 --- /dev/null +++ b/Covance_UCO3001/Source/2026-05-29_133123 sponsor-study-36940-test-results-930553-microbiology.csv @@ -0,0 +1,4 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,,,,,, +Subject,Screening Number,Age,Age Unit,Gender,Visit Description,Collected Time,Accession,Test Group,Specimen,Organism,Growth,Cancellation Reason,Test Description,Test Result,Drug Name/Agent,MIC Result,Units,MIC Interpretation,Disk Diffusion Result,Disk Diffusion Interpretation,Subject Data Revision,Visit Data Revision,Result Data Revision +CZ100092001 - null,,,,Female,SCRNSTOOL Stool Pathogens,"Apr 2, 2026 6:15 AM",6227323340,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,, +CZ100092002 - null,,,,Female,SCRNSTOOL Stool Pathogens,"Apr 20, 2026 6:10 AM",6227323341,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,, diff --git a/Covance_UCO3001/Source/2026-05-29_133151 sponsor-study-36940-test-results-930531-standard.csv b/Covance_UCO3001/Source/2026-05-29_133151 sponsor-study-36940-test-results-930531-standard.csv new file mode 100644 index 0000000..4d4b87b --- /dev/null +++ b/Covance_UCO3001/Source/2026-05-29_133151 sponsor-study-36940-test-results-930531-standard.csv @@ -0,0 +1,243 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,, +Subject,Subject Data Revision,Screen No.,Age,Age Unit,Gender,Visit,Visit Data Revision,Collected Time,Accession,Test Group,Test,Administrative Question,Value,Result Data Revision,Flags,Cancellation Reason,Comments,Range,Units +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,ALP<2XULN,ALP<2XULN,,Criteria Met,,,,,, +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,ALT>/=3XULN,ALT >/= 3 X ULN,,Criteria not met,,,,,, +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,ALT>/=3XULN & TBIL>/=2XULN,ALT >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,AST>/=3XULN,AST >/= 3 X ULN,,Criteria not met,,,,,, +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,AST>/=3XULN & TBIL>/=2XULN,AST >/=3xULN & TBIL >/=2xULN,,Criteria not met,,,,,, +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,Total Bilirubin,,4,,,,Result verified by repeat analysis,3 - 21,umol/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.6,,,,,0 - 6.2,umol/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,Alkaline Phosphatase,,113,,,,,40 - 129,U/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,ALT (SGPT),,12,,,,,5 - 48,U/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,AST (SGOT),,18,,,,,8 - 40,U/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,GGT,,23,,,,,10 - 50,U/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,LDH,,195,,,,,53 - 234,U/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,Urea Nitrogen,,2.7,,,,,1.4 - 8.6,mmol/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,73,,,,,40 - 119,umol/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,Serum Glucose,,5.7,,H,,,3.9 - 5.6,mmol/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,Serum Uric Acid,,409,,,,,149 - 494,umol/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,Calcium (EDTA),,2.32,,,,,2.07 - 2.64,mmol/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,Phosphorus,,1.01,,,,,0.71 - 1.65,mmol/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,Total Protein,,73,,,,,60 - 80,g/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,Albumin-BCG,,41,,,,,33 - 49,g/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,Creatine Kinase,,159,,,,,39 - 308,U/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,Serum Sodium,,139,,,,,135 - 145,mmol/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,Serum Potassium,,5.1,,,,,3.5 - 5.2,mmol/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,Serum Bicarbonate,,21.3,,,,,19.3 - 29.3,mmol/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,Serum Chloride,,105,,,,,94 - 112,mmol/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CHEMISTRY PANEL,Magnesium,,0.90,,,,,0.66 - 0.98,mmol/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,100,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,FECAL COLLECTION D/T,Stool Collection Date,Y,05-May-2026,,,,,, +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,FECAL COLLECTION D/T,Stool Collection Time,Y,06:50,,,,,, +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,98,,L,,,125 - 170,g/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.34,,L,,,0.37 - 0.51, +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.5,,,,,4 - 5.8,TI/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,22,,L,,Result verified by repeat analysis,26 - 34,pg +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,Microcytic,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,76,,L,,,80 - 100,fL +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,9.13,,,,Result verified by repeat analysis,3.8 - 10.7,GI/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,6.41,,,,,1.96 - 7.23,GI/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.42,,,,,0.8 - 3,GI/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.93,,H,,,0.12 - 0.92,GI/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.29,,,,,0 - 0.57,GI/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.08,,,,,0 - 0.2,GI/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,70.2,,,,,40.5 - 75,% +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,15.6,,,,,15.4 - 48.5,% +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,10.1,,,,,2.6 - 10.1,% +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.1,,,,,0 - 6.8,% +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.9,,,,,0 - 2,% +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,812,,HT,,,130 - 394,GI/L +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,05-May-2026,,,,,, +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,10:00,,,,,, +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,05-May-2026,,,,,, +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,13:00,,,,,, +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,05-May-2026,,,,,, +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,10:00,,,,,, +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,SM09/STOOL PK COLL D/T,Stool Collection Date,Y,05-May-2026,,,,,, +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,SM09/STOOL PK COLL D/T,Stool Collection Time,Y,06:50,,,,,, +CZ100212001,,,,,Male,Induction Week 4,,"May 5, 2026 10:00 AM",6227635211,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,ALP<2XULN,ALP<2XULN,,Criteria Met,,,,,, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,ALT>/=3XULN,ALT >/= 3 X ULN,,Criteria not met,,,,,, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,ALT>/=3XULN & TBIL>/=2XULN,ALT >/=3xULN & TBIL >/=2xULN,,Unable to calc due to LOQ,,,,,, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,AST>/=3XULN,AST >/= 3 X ULN,,Criteria not met,,,,,, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,AST>/=3XULN & TBIL>/=2XULN,AST >/=3xULN & TBIL >/=2xULN,,Unable to calc due to LOQ,,,,,, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,Total Bilirubin,,<3,,L,,Result verified by repeat analysis,3 - 21,umol/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,<1.4,,,,Result verified by repeat analysis,0 - 6.2,umol/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,Alkaline Phosphatase,,112,,,,,40 - 129,U/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,ALT (SGPT),,8,,,,,5 - 48,U/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,AST (SGOT),,14,,,,,8 - 40,U/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,GGT,,27,,,,,10 - 50,U/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,LDH,,150,,,,,53 - 234,U/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,Urea Nitrogen,,2.4,,,,,1.4 - 8.6,mmol/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,74,,,,,40 - 119,umol/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,Serum Glucose,,6.1,,H,,,3.9 - 5.6,mmol/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,Serum Uric Acid,,378,,,,,149 - 494,umol/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,Calcium (EDTA),,2.36,,,,,2.07 - 2.64,mmol/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,Phosphorus,,1.02,,,,,0.71 - 1.65,mmol/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,Total Protein,,70,,,,,60 - 80,g/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,Albumin-BCG,,40,,,,,33 - 49,g/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,Creatine Kinase,,77,,,,,39 - 308,U/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,Serum Sodium,,139,,,,,135 - 145,mmol/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,Serum Potassium,,5.2,,,,,3.5 - 5.2,mmol/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,Serum Bicarbonate,,22.9,,,,,19.3 - 29.3,mmol/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CHEMISTRY PANEL,Magnesium,,0.87,,,,,0.66 - 0.98,mmol/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,99,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,FECAL COLLECTION D/T,Stool Collection Date,Y,20-Apr-2026,,,,,, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,FECAL COLLECTION D/T,Stool Collection Time,Y,06:00,,,,,, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,106,,L,,,125 - 170,g/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.36,,L,,,0.37 - 0.51, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.6,,,,,4 - 5.8,TI/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,23,,L,,,26 - 34,pg +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,77,,L,,,80 - 100,fL +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,9.30,,,,,3.8 - 10.7,GI/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,6.31,,,,,1.96 - 7.23,GI/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.61,,,,,0.8 - 3,GI/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.94,,H,,,0.12 - 0.92,GI/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.35,,,,,0 - 0.57,GI/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.09,,,,,0 - 0.2,GI/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,67.8,,,,,40.5 - 75,% +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,17.3,,,,,15.4 - 48.5,% +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,10.2,,H,,,2.6 - 10.1,% +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.8,,,,,0 - 6.8,% +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.0,,,,,0 - 2,% +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,796,,HT,,,130 - 394,GI/L +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,20-Apr-2026,,,,,, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,08:45,,,,,, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,20-Apr-2026,,,,,, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,10:24,,,,,, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,20-Apr-2026,,,,,, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,08:45,,,,,, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,SM09/STOOL PK COLL D/T,Stool Collection Date,Y,20-Apr-2026,,,,,, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,SM09/STOOL PK COLL D/T,Stool Collection Time,Y,06:00,,,,,, +CZ100212001,,,,,Male,Induction Week 2,,"Apr 20, 2026 8:43 AM",6227635208,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,Total Bilirubin,,4,,,,,3 - 21,umol/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,<1.4,,,,,0 - 6.2,umol/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,Alkaline Phosphatase,,121,,,,,40 - 129,U/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,ALT (SGPT),,13,,,,,5 - 48,U/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,AST (SGOT),,18,,,,,8 - 40,U/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,GGT,,39,,,,,10 - 50,U/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,LDH,,158,,,,,53 - 234,U/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,Urea Nitrogen,,3.0,,,,,1.4 - 8.6,mmol/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,80,,,,,40 - 119,umol/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,Serum Glucose,,4.9,,,,,3.9 - 5.6,mmol/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,Serum Uric Acid,,446,,,,,149 - 494,umol/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,Calcium (EDTA),,2.37,,,,,2.07 - 2.64,mmol/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,Phosphorus,,1.20,,,,,0.71 - 1.65,mmol/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,Total Protein,,74,,,,,60 - 80,g/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,Albumin-BCG,,43,,,,,33 - 49,g/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,Creatine Kinase,,64,,,,,39 - 308,U/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,Serum Sodium,,141,,,,,135 - 145,mmol/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,Serum Potassium,,5.2,,,,,3.5 - 5.2,mmol/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,Serum Bicarbonate,,21.0,,,,,19.3 - 29.3,mmol/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,Serum Chloride,,106,,,,,94 - 112,mmol/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CHEMISTRY PANEL,Magnesium,,0.88,,,,,0.66 - 0.98,mmol/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,97,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,FECAL COLLECTION D/T,Stool Collection Date,Y,06-Apr-2026,,,,,, +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,FECAL COLLECTION D/T,Stool Collection Time,Y,16:00,,,,,, +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,113,,L,,,125 - 170,g/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.39,,,,,0.37 - 0.51, +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.9,,,,,4 - 5.8,TI/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,23,,L,,,26 - 34,pg +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,Anisocytosis,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,79,,L,,,80 - 100,fL +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,12.49,,H,,,3.8 - 10.7,GI/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,8.91,,H,,,1.96 - 7.23,GI/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.02,,,,,0.8 - 3,GI/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,1.14,,H,,,0.12 - 0.92,GI/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.33,,,,,0 - 0.57,GI/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.09,,,,,0 - 0.2,GI/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,71.3,,,,,40.5 - 75,% +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,16.2,,,,,15.4 - 48.5,% +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,9.1,,,,,2.6 - 10.1,% +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.6,,,,,0 - 6.8,% +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.7,,,,,0 - 2,% +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,584,,H,,,130 - 394,GI/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,LIPID PANEL,Direct HDL-C 4th Generation,,1.01,R,L,,,1.03 - 1.53,mmol/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,LIPID PANEL,Triglycerides (GPO),,1.57,,,,,0.65 - 2.94,mmol/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,LIPID PANEL,Cholesterol (High Performance),,5.40,,,,,4.53 - 7.71,mmol/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,LIPID PANEL,LDL Chol Friedewald 4th,,3.67,,H,,,0 - 3.34,mmol/L +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,SM01/PLASMA PK TROUGH COLL D/T,Collection Date Predose,Y,07-Apr-2026,,,,,, +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,SM01/PLASMA PK TROUGH COLL D/T,Collection Time Predose,Y,10:37,,,,,, +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,SM02/PLASMA PK PEAK COLL D/T,Collection Date Post dose,Y,07-Apr-2026,,,,,, +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,SM02/PLASMA PK PEAK COLL D/T,Post Dose Collection Time,Y,11:55,,,,,, +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,SM04/SERUM ADA PRE COLL D/T,Collection Date Predose,Y,07-Apr-2026,,,,,, +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,SM04/SERUM ADA PRE COLL D/T,Collection Time Predose,Y,10:37,,,,,, +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,SM10/FECAL BMRKS COLL D/T,Stool Collection Date,Y,06-Apr-2026,,,,,, +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,SM10/FECAL BMRKS COLL D/T,Stool Collection Time,Y,16:00,,,,,, +CZ100212001,,,,,Male,Induction Week 0,,"Apr 7, 2026 10:37 AM",6227635207,SUBJECT HEIGHT (CM),Height (cm),Y,N/A (subject >/= 18 years of age),,,,,cm, +CZ100212001,,,,,Male,Biopsy,,"Mar 16, 2026 12:00 AM",6227635223,ANATOMICAL SITE,Anatomical Site,Y,20,,,,,, +CZ100212001,,,,,Male,Biopsy,,"Mar 16, 2026 12:00 AM",6227635223,BIOPSY COLLECTION METHOD,Collection Method,Y,colonoscopy,,,,,, +CZ100212001,,,,,Male,Biopsy,,"Mar 16, 2026 12:00 AM",6227635223,BIOPSY FIXATIVE USED,Fixative Used,,10% NBF,,,,,, +CZ100212001,,,,,Male,Biopsy,,"Mar 16, 2026 12:00 AM",6227635223,DATE/TIME PLACED IN FORMALIN,Date Sample placed in Formalin,Y,16-Mar-2026,,,,,, +CZ100212001,,,,,Male,Biopsy,,"Mar 16, 2026 12:00 AM",6227635223,DATE/TIME PLACED IN FORMALIN,Time Sample placed in Formalin,Y,13:00,,,,,, +CZ100212001,,,,,Male,Biopsy,,"Mar 16, 2026 12:00 AM",6227635223,DIAGNOSIS,Diagnosis:,Y,Ulcerative Colitis,,,,,, +CZ100212001,,,,,Male,Biopsy,,"Mar 16, 2026 12:00 AM",6227635223,INFLAMED AREA,Inflamed area?,,Yes,,,,,, +CZ100212001,,,,,Male,Biopsy,,"Mar 16, 2026 12:00 AM",6227635223,TISSUE BIOPSY EMBEDDING1,Biopsy technical QC-CL,,Smpl meets HT requirements,,,,,, +CZ100212001,,,,,Male,Biopsy,,"Mar 16, 2026 12:00 AM",6227635223,TISSUE BIOPSY EMBEDDING1,Biopsy processing Time-CL,,10:00,,,,,, +CZ100212001,,,,,Male,Biopsy,,"Mar 16, 2026 12:00 AM",6227635223,TISSUE BIOPSY EMBEDDING1,Biopsy processing Date-CL,,19-Mar-2026,,,,,, +CZ100212001,,,,,Male,Biopsy,,"Mar 16, 2026 12:00 AM",6227635223,TISSUE BIOPSY EMBEDDING1,Biopsy Comments-CL,,Received in 10% NBF,,,,,, +CZ100212001,,,,,Male,Biopsy,,"Mar 16, 2026 12:00 AM",6227635223,TISSUE BIOPSY EMBEDDING1,# of Cassettes-(FI)-CL,,1,,,,,, +CZ100212001,,,,,Male,Biopsy,,"Mar 16, 2026 12:00 AM",6227635223,ULCERATED AREA,Is biopsy site ulcerated?,,Yes,,,,,, +CZ100212001,,,,,Male,Stool Pathogens,,"Mar 1, 2026 2:00 PM",6227635213,C. DIFF EIA,"C. diff GDH Ag,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100212001,,,,,Male,Stool Pathogens,,"Mar 1, 2026 2:00 PM",6227635213,C. DIFF EIA,"C.diff Toxin A&B,stool-CL",,Negative,,,,,Ref Rng:Negative, +CZ100212001,,,,,Male,Stool Pathogens,,"Mar 1, 2026 2:00 PM",6227635213,OVA AND PARASITES 1,Concentrate Exam,,No ova or parasites found,,,,,, +CZ100212001,,,,,Male,Stool Pathogens,,"Mar 1, 2026 2:00 PM",6227635213,OVA AND PARASITES 1,Smear for Microsporidia,,No Microsporidia seen.,,,,,, +CZ100212001,,,,,Male,Stool Pathogens,,"Mar 1, 2026 2:00 PM",6227635213,OVA AND PARASITES 1,Modified acid-fast stain,,No coccidian parasites seen,,,,,, +CZ100212001,,,,,Male,Stool Pathogens,,"Mar 1, 2026 2:00 PM",6227635213,OVA AND PARASITES 2,Trichrome Smear,,No ova or parasites found,,,,,, +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,Total Bilirubin,,<3,,L,,Result verified by repeat analysis,3 - 21,umol/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,<1.4,,,,Result verified by repeat analysis,0 - 6.2,umol/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,Alkaline Phosphatase,,120,,,,,40 - 129,U/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,ALT (SGPT),,15,,,,,5 - 48,U/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,AST (SGOT),,19,,,,,8 - 40,U/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,GGT,,39,,,,,10 - 50,U/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,LDH,,174,,,,,53 - 234,U/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,Urea Nitrogen,,3.0,,,,,1.4 - 8.6,mmol/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,75,,,,,40 - 119,umol/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,Serum Glucose,,4.8,,,,,3.9 - 5.6,mmol/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,Serum Uric Acid,,357,,,,,149 - 494,umol/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,Calcium (EDTA),,2.34,,,,,2.07 - 2.64,mmol/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,Phosphorus,,1.06,,,,,0.71 - 1.65,mmol/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,Total Protein,,70,,,,,60 - 80,g/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,Albumin-BCG,,43,,,,,33 - 49,g/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,Creatine Kinase,,149,,,,,39 - 308,U/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,Serum Sodium,,141,,,,,135 - 145,mmol/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,Serum Potassium,,4.9,,,,,3.5 - 5.2,mmol/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,Serum Bicarbonate,,18.4,,L,,,19.3 - 29.3,mmol/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CHEMISTRY PANEL,Magnesium,,0.79,,,,,0.66 - 0.98,mmol/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,CKD-EPI 2021 WITH ADOLESCENTS,CKD-EPI 2021 woRace wAdol -PS,,99,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HBV ELIGIBILITY MET?,HBV Eligibility Criteria Met?,,Yes,,,,,, +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,120,,L,,,125 - 170,g/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.40,,,,,0.37 - 0.51, +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.0,,,,,4 - 5.8,TI/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEMATOLOGY&DIFFERENTIAL PANEL,MCH,,24,,L,,,26 - 34,pg +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,79,,L,,,80 - 100,fL +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,8.50,,,,,3.8 - 10.7,GI/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,5.09,,,,,1.96 - 7.23,GI/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.97,,,,,0.8 - 3,GI/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,1.07,,H,,,0.12 - 0.92,GI/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.27,,,,,0 - 0.57,GI/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.10,,,,,0 - 0.2,GI/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,59.9,,,,,40.5 - 75,% +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,23.3,,,,,15.4 - 48.5,% +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,12.6,,H,,,2.6 - 10.1,% +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.1,,,,,0 - 6.8,% +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.2,,,,,0 - 2,% +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,567,,H,,,130 - 394,GI/L +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEPATITIS B CORE AB NON-US,Hepatitis B Core Total,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEPATITIS B SURFACE AB,Anti-HBs II QUAL,,Non-Reactive,,,,,Ref Rng :$Non Reactive, +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEPATITIS B SURFACE AG NON-US,Hep B Surface AgII,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HEPATITIS C VIRUS AB NON-US,Hepatitis C Virus Antibody,,Non-Reactive,,,,,Ref Rng:$Non Reactive, +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HIV 1/2 AG/AB SCREEN,anti-HIV-1/2 antibodies,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HIV 1/2 AG/AB SCREEN,HIV -1 p24 antigen,,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,HIV 1/2 AG/AB SCREEN,"HIV 1/2 Ag/Ab Screen, Cobas",,Non-Reactive,,,,,Ref Rng$Non-Reactive, +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,PA1 EEA-2?,Approved to use EEA-2?,,Yes,,,,,, +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,QUANTIFERON GOLD MITOGEN/INTER,"QFT,TBGoldPlusInt,pl-4-Tubes",,Negative,,,,,Normal=Negative, +CZ100212001,,,,,Male,Screening,,"Feb 25, 2026 12:15 PM",6227635204,SUBJECT HEIGHT (CM),Height (cm),Y,178,,,,,cm, diff --git a/Covance_UCO3001/Source/2026-05-29_133208 sponsor-study-36940-test-results-930531-microbiology.csv b/Covance_UCO3001/Source/2026-05-29_133208 sponsor-study-36940-test-results-930531-microbiology.csv new file mode 100644 index 0000000..9f10aa5 --- /dev/null +++ b/Covance_UCO3001/Source/2026-05-29_133208 sponsor-study-36940-test-results-930531-microbiology.csv @@ -0,0 +1,3 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,,,,,, +Subject,Screening Number,Age,Age Unit,Gender,Visit Description,Collected Time,Accession,Test Group,Specimen,Organism,Growth,Cancellation Reason,Test Description,Test Result,Drug Name/Agent,MIC Result,Units,MIC Interpretation,Disk Diffusion Result,Disk Diffusion Interpretation,Subject Data Revision,Visit Data Revision,Result Data Revision +CZ100212001 - null,,,,Male,SCRNSTOOL Stool Pathogens,"Mar 1, 2026 2:00 PM",6227635213,STOOL CULTURE,Stool,,,,Final Report,No enteric pathogens isolated,,,,,,,,, diff --git a/Covance_UCO3001/Source/2026-05-29_133237 sponsor-study-35472-test-results-898745-standard.csv b/Covance_UCO3001/Source/2026-05-29_133237 sponsor-study-35472-test-results-898745-standard.csv new file mode 100644 index 0000000..d9b79db --- /dev/null +++ b/Covance_UCO3001/Source/2026-05-29_133237 sponsor-study-35472-test-results-898745-standard.csv @@ -0,0 +1,2448 @@ +"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,, +Subject,Subject Data Revision,Screen No.,Age,Age Unit,Gender,Visit,Visit Data Revision,Collected Time,Accession,Test Group,Test,Administrative Question,Value,Result Data Revision,Flags,Cancellation Reason,Comments,Range,Units +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.1,,,,,0 - 5,mg/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CELLULAR ELEMENTS,Ur WBC/HPF,,2,,,,,0 - 12,/HPF +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,Total Bilirubin,,5,,,,,3 - 21,umol/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.6,,,,,0 - 6.2,umol/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,Alkaline Phosphatase,,87,,,,,35 - 104,U/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,ALT (SGPT),,20,,,,,4 - 43,U/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,AST (SGOT),,24,,,,,8 - 40,U/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,GGT,,30,,,,,4 - 49,U/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,LDH,,154,,,,,53 - 234,U/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,Urea Nitrogen,,5.2,,,,,1.4 - 8.6,mmol/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,49,,,,,31 - 101,umol/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,Glucose Fasting,,4.9,,,,,3.9 - 5.6,mmol/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,Serum Uric Acid,,314,,,,,125 - 428,umol/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,Calcium (EDTA),,2.51,,,,,2.07 - 2.64,mmol/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,Phosphorus,,1.25,,,,,0.71 - 1.65,mmol/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,Total Protein,,74,,,,,61 - 84,g/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,Albumin-BCG,,47,,,,,33 - 49,g/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,Creatine Kinase,,202,,H,,,26 - 192,U/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,Serum Potassium,,4.8,,,,,3.5 - 5.2,mmol/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,Serum Bicarbonate,,21.2,,,,,19.3 - 29.3,mmol/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,144,,,,,116 - 164,g/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.44,,,,,0.34 - 0.48, +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.5,,,,,4.1 - 5.6,TI/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,97,,,,,79 - 98,fL +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,8.81,,,,,3.8 - 10.7,GI/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.47,,,,,1.96 - 7.23,GI/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,3.67,,,,,0.91 - 4.28,GI/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.43,,,,,0.12 - 0.92,GI/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.17,,,,,0 - 0.57,GI/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.06,,,,,0 - 0.2,GI/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,50.7,,,,,40.5 - 75,% +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,41.7,,,,,15.4 - 48.5,% +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.8,,,,,2.6 - 10.1,% +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.0,,,,,0 - 6.8,% +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.7,,,,,0 - 2,% +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,504,,H,,,140 - 400,GI/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,6.6,,H,,,<6.5 %, +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,23.94,,H,,,1.9 - 23,uIU/mL +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,LIPID PANEL,Direct HDL-C 4th Generation,,1.34,,,,,1.03 - 1.53,mmol/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,LIPID PANEL,Triglycerides (GPO),,2.54,,H,,,0.51 - 2.42,mmol/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,LIPID PANEL,Cholesterol (High Performance),,6.04,,,,,4.01 - 6.85,mmol/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,LIPID PANEL,LDL Chol Friedewald 4th,,3.54,,H,,,0 - 3.34,mmol/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,RETICULOCYTES,Reticulocyte Count %,,1.8,,,,,0.6 - 2.5,% +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,TSH,TSH 3rd IS-QT,,3.138,,,,,0.45 - 5.33,mIU/L +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,URINE MACRO PANEL,Ur Specific Gravity,,1.020,,,,,1 - 1.04, +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,URINE MACRO PANEL,Ur Leukocyte Esterase,,Trace,,H,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,End of Phase/Treatment,,"May 22, 2026 12:00 PM",6228605653,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,C-REACTIVE PROTEIN,C Reactive Protein HS,,10.2,,H,,,0 - 5,mg/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,<1.4,,,,,0 - 6.2,umol/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,Alkaline Phosphatase,,90,,,,,35 - 104,U/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,ALT (SGPT),,17,,,,,4 - 43,U/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,AST (SGOT),,20,,,,,8 - 40,U/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,GGT,,22,,,,,5 - 50,U/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,LDH,,185,,,,,53 - 234,U/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,Urea Nitrogen,,6.0,,,,,1.4 - 10.4,mmol/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,64,,,,,31 - 110,umol/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,Glucose Fasting,,6.3,R,H,,,3.9 - 5.6,mmol/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,Serum Uric Acid,,316,,,,,149 - 446,umol/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,Calcium (EDTA),,2.38,,,,,2.07 - 2.64,mmol/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,Phosphorus,,1.07,,,,,0.71 - 1.65,mmol/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,Total Protein,,80,,,,,60 - 80,g/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,Albumin-BCG,,47,R,H,,,33 - 46,g/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,Creatine Kinase,,88,,,,,26 - 192,U/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,Serum Sodium,,136,,,,,135 - 145,mmol/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,Serum Potassium,,4.7,,,,,3.5 - 5.2,mmol/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,Serum Bicarbonate,,18.7,R,L,,,19.3 - 29.3,mmol/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,163,R,H,,,115 - 158,g/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.50,R,H,,,0.34 - 0.48, +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.1,,,,,3.9 - 5.5,TI/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,97,,,,,80 - 100,fL +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,11.22,R,H,,,3.8 - 10.7,GI/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,6.82,,,,,1.96 - 7.23,GI/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,3.47,R,H,,,0.8 - 3,GI/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.75,,,,,0.12 - 0.92,GI/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.11,,,,,0 - 0.57,GI/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.07,,,,,0 - 0.2,GI/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,60.8,,,,,40.5 - 75,% +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,30.9,,,,,15.4 - 48.5,% +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.7,,,,,2.6 - 10.1,% +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.0,,,,,0 - 6.8,% +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.6,,,,,0 - 2,% +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,285,,,,,130 - 394,GI/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.9,,,,,<6.5 %, +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,15.61,,,,,1.9 - 23,uIU/mL +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,LIPID PANEL,Direct HDL-C 4th Generation,,1.36,,,,,1.03 - 1.53,mmol/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,LIPID PANEL,Triglycerides (GPO),,2.89,R,H,,,0.63 - 2.71,mmol/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,LIPID PANEL,Cholesterol (High Performance),,7.08,,,,,5.35 - 9.1,mmol/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,LIPID PANEL,LDL Chol Friedewald 4th,,4.40,,H,,,0 - 3.34,mmol/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,RETICULOCYTES,Reticulocyte Count %,,1.1,,,,,0.6 - 2.5,% +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,TSH,TSH 3rd IS-QT,,0.546,,,,,0.45 - 5.33,mIU/L +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,URINE MACRO PANEL,Ur Specific Gravity,,1.016,,,,,1.01 - 1.03, +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,URINE MACRO PANEL,Ur Blood,,Trace,,,,,Ref Rng:$Negative-Trace, +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040005,,,72,years,Female,End of Phase/Treatment,,"May 22, 2026 9:20 AM",6228605652,URINE MICRO PANEL,Ur Microscopic,,Negative,,,,, NEGATIVE$,NEGATIVE +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,C-REACTIVE PROTEIN,C Reactive Protein HS,,2.3,,,,,0 - 5,mg/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CELLULAR ELEMENTS,Ur WBC/HPF,,8,,,,,0 - 12,/HPF +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,Total Bilirubin,,8,,,,,3 - 21,umol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.2,,,,,0 - 6.2,umol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,Alkaline Phosphatase,,83,,,,,35 - 104,U/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,ALT (SGPT),,22,,,,,4 - 43,U/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,AST (SGOT),,24,,,,,8 - 40,U/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,GGT,,32,,,,,4 - 49,U/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,LDH,,169,,,,,53 - 234,U/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,Urea Nitrogen,,5.2,,,,,1.4 - 8.6,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,51,,,,,31 - 101,umol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,Glucose Fasting,,5.0,,,,,3.9 - 5.6,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,Serum Uric Acid,,383,,,,,125 - 428,umol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,Calcium (EDTA),,2.52,,,,,2.07 - 2.64,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,Phosphorus,,1.20,,,,,0.71 - 1.65,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,Total Protein,,75,,,,,61 - 84,g/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,Creatine Kinase,,201,,H,,,26 - 192,U/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,Serum Potassium,,4.8,,,,,3.5 - 5.2,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,Serum Bicarbonate,,21.6,,,,,19.3 - 29.3,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,143,,,,,116 - 164,g/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.42,,,,,0.34 - 0.48, +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.4,,,,,4.1 - 5.6,TI/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,95,,,,,79 - 98,fL +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,10.33,,,,,3.8 - 10.7,GI/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,6.06,,,,,1.96 - 7.23,GI/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,3.53,,,,,0.91 - 4.28,GI/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.53,,,,,0.12 - 0.92,GI/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.17,,,,,0 - 0.57,GI/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,58.6,,,,,40.5 - 75,% +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,34.1,,,,,15.4 - 48.5,% +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.1,,,,,2.6 - 10.1,% +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.6,,,,,0 - 6.8,% +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,525,R,H,,,140 - 400,GI/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,16.12,,,,,1.9 - 23,uIU/mL +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,LIPID PANEL,Direct HDL-C 4th Generation,,1.37,,,,Result verified by repeat analysis,1.03 - 1.53,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,LIPID PANEL,Triglycerides (GPO),,2.79,,H,,,0.51 - 2.42,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,LIPID PANEL,Cholesterol (High Performance),,6.50,,,,,4.01 - 6.85,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,LIPID PANEL,LDL Chol Friedewald 4th,,3.85,,H,,,0 - 3.34,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,RETICULOCYTES,Reticulocyte Count %,,1.5,,,,,0.6 - 2.5,% +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,URINE MACRO PANEL,Ur Specific Gravity,,1.029,,,,,1 - 1.04, +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,URINE MACRO PANEL,Ur Protein,,Trace,,H,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,URINE MACRO PANEL,Ur Leukocyte Esterase,,Trace,,H,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 2 OL Induction Day 29,R,"May 5, 2026 1:15 PM",6227541261,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.1,,,,,0 - 5,mg/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.3,,,,,0 - 6.2,umol/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,Alkaline Phosphatase,,66,,,,,35 - 104,U/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,ALT (SGPT),,18,,,,,4 - 43,U/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,AST (SGOT),,25,,,,,8 - 40,U/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,GGT,,36,,,,,4 - 49,U/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,LDH,,192,,,,,53 - 234,U/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,Urea Nitrogen,,5.2,,,,,1.4 - 8.6,mmol/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,57,,,,,31 - 101,umol/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,Glucose Fasting,,4.5,,,,,3.9 - 5.6,mmol/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,Serum Uric Acid,,277,,,,,149 - 446,umol/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,Calcium (EDTA),,2.08,,,,,2.07 - 2.64,mmol/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,Phosphorus,,0.90,,,,,0.71 - 1.65,mmol/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,Total Protein,,62,,,,,61 - 84,g/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,Albumin-BCG,,41,,,,,33 - 49,g/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,Creatine Kinase,,84,,,,,26 - 192,U/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,Serum Sodium,,144,,,,,132 - 147,mmol/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,Serum Potassium,,3.5,,,,,3.5 - 5.2,mmol/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,Serum Bicarbonate,,22.5,,,,,19.3 - 29.3,mmol/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,CHEMISTRY PANEL,Serum Chloride,,109,,,,,94 - 112,mmol/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,132,,,,,116 - 164,g/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.40,,,,,0.34 - 0.48, +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.2,,,,,4.1 - 5.6,TI/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,96,,,,,79 - 98,fL +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.40,,,,,3.8 - 10.7,GI/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.63,,,,,1.96 - 7.23,GI/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.90,,,,,0.91 - 4.28,GI/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.78,,,,,0.12 - 0.92,GI/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.05,,,,,0 - 0.57,GI/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,48.8,,,,,40.5 - 75,% +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,35.1,,,,,15.4 - 48.5,% +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,14.4,R,H,,,2.6 - 10.1,% +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,0.9,,,,,0 - 6.8,% +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.9,,,,,0 - 2,% +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,248,,,,,140 - 400,GI/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.5,,,,,<6.5 %, +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,2.25,,,,,1.9 - 23,uIU/mL +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,LIPID PANEL,Direct HDL-C 4th Generation,,1.92,,H,,,1.03 - 1.53,mmol/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,LIPID PANEL,Triglycerides (GPO),,1.20,,,,,0.59 - 2.96,mmol/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,LIPID PANEL,Cholesterol (High Performance),,3.66,,L,,,4.42 - 7.53,mmol/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,LIPID PANEL,LDL Chol Friedewald 4th,,1.19,,,,,0 - 3.34,mmol/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,RETICULOCYTES,Reticulocyte Count %,,1.1,,,,,0.6 - 2.5,% +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,TSH,TSH 3rd IS-QT,,3.352,,,,,0.45 - 5.33,mIU/L +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,URINE MACRO PANEL,Ur Specific Gravity,,1.023,,,,,1 - 1.04, +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,URINE MACRO PANEL,Ur pH,,5.0,,,,,5 - 8, +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040009,,,58,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 9:50 AM",6227547338,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.3,,,,,0 - 5,mg/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,Total Bilirubin,,10,,,,,3 - 21,umol/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.5,,,,,0 - 6.2,umol/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,Alkaline Phosphatase,,137,,H,,,35 - 104,U/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,ALT (SGPT),,11,,,,,4 - 43,U/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,AST (SGOT),,14,,,,,8 - 40,U/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,GGT,,14,,,,,5 - 50,U/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,LDH,,170,,,,,53 - 234,U/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,Urea Nitrogen,,5.3,,,,,1.4 - 8.6,mmol/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,61,,,,,31 - 101,umol/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,Glucose Fasting,,5.6,,,,,3.9 - 5.6,mmol/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,Serum Uric Acid,,204,,,,,149 - 446,umol/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,Calcium (EDTA),,2.40,,,,,2.07 - 2.64,mmol/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,Phosphorus,,0.96,,,,,0.71 - 1.65,mmol/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,Total Protein,,73,,,,,60 - 80,g/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,Creatine Kinase,,78,,,,,26 - 192,U/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,Serum Sodium,,145,,,,,135 - 145,mmol/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,Serum Potassium,,4.7,,,,,3.5 - 5.2,mmol/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,Serum Bicarbonate,,21.6,,,,,19.3 - 29.3,mmol/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,CHEMISTRY PANEL,Serum Chloride,,109,,,,,94 - 112,mmol/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,150,,,,,115 - 158,g/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.47,,,,,0.34 - 0.48, +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.9,,,,,3.9 - 5.5,TI/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,96,,,,,80 - 100,fL +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,7.17,,,,,3.8 - 10.7,GI/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.80,,,,,1.96 - 7.23,GI/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.79,,,,,0.8 - 3,GI/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.41,,,,,0.12 - 0.92,GI/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.08,,,,,0 - 0.57,GI/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.09,,,,,0 - 0.2,GI/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,53.0,,,,,40.5 - 75,% +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,38.9,,,,,15.4 - 48.5,% +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.8,,,,,2.6 - 10.1,% +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.1,,,,,0 - 6.8,% +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.3,,,,,0 - 2,% +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,239,,,,,130 - 394,GI/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.5,,,,,<6.5 %, +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,4.88,,,,,1.9 - 23,uIU/mL +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,LIPID PANEL,Direct HDL-C 4th Generation,,1.85,,H,,,1.03 - 1.53,mmol/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,LIPID PANEL,Triglycerides (GPO),,0.61,,L,,,0.63 - 2.71,mmol/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,LIPID PANEL,Cholesterol (High Performance),,5.06,,,,,4.86 - 8.28,mmol/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,LIPID PANEL,LDL Chol Friedewald 4th,,2.93,,,,,0 - 3.34,mmol/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,RETICULOCYTES,Reticulocyte Count %,,1.1,,,,,0.6 - 2.5,% +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,TSH,TSH 3rd IS-QT,,0.955,,,,,0.45 - 5.33,mIU/L +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,URINE MACRO PANEL,Ur Specific Gravity,,1.025,,,,,1.01 - 1.03, +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040008,,,63,years,Female,End of Phase/Treatment,,"May 5, 2026 8:45 AM",6227768458,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,C-REACTIVE PROTEIN,C Reactive Protein HS,,4.2,,,,,0 - 5,mg/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,Total Bilirubin,,5,,,,,3 - 21,umol/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.0,,,,,0 - 6.2,umol/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,Alkaline Phosphatase,,62,,,,,35 - 104,U/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,ALT (SGPT),,14,,,,,4 - 43,U/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,AST (SGOT),,19,,,,,8 - 40,U/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,GGT,,16,,,,,5 - 50,U/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,LDH,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,Urea Nitrogen,,4.3,,,,,1.4 - 8.6,mmol/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,64,,,,,31 - 101,umol/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,Glucose Fasting,,5.8,,H,,,3.9 - 5.6,mmol/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,Serum Uric Acid,,216,,,,,149 - 446,umol/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,Calcium (EDTA),,2.38,,,,,2.07 - 2.64,mmol/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,Phosphorus,,1.09,,,,,0.71 - 1.65,mmol/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,Total Protein,,63,,,,,60 - 80,g/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,Albumin-BCG,,42,,,,,33 - 49,g/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,Creatine Kinase,,151,,,,,26 - 192,U/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,Serum Sodium,,142,,,,,135 - 145,mmol/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,Serum Bicarbonate,,21.4,,,,,19.3 - 29.3,mmol/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,CHEMISTRY PANEL,Serum Chloride,,108,,,,,94 - 112,mmol/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,152,,,,,115 - 158,g/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.46,,,,,0.34 - 0.48, +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.6,,,,,3.9 - 5.5,TI/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,100,,,,,80 - 100,fL +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,7.94,,,,,3.8 - 10.7,GI/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,6.03,,,,,1.96 - 7.23,GI/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.45,,,,,0.8 - 3,GI/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.32,,,,,0.12 - 0.92,GI/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.10,,,,,0 - 0.57,GI/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,,0 - 0.2,GI/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,75.9,R,H,,,40.5 - 75,% +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,18.3,,,,,15.4 - 48.5,% +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.0,,,,,2.6 - 10.1,% +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.3,,,,,0 - 6.8,% +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.6,,,,,0 - 2,% +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,244,,,,,130 - 394,GI/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.4,,,,,<6.5 %, +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,7.00,,,,,1.9 - 23,uIU/mL +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,LIPID PANEL,Direct HDL-C 4th Generation,,1.24,,,,,1.03 - 1.53,mmol/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,LIPID PANEL,Triglycerides (GPO),,0.74,,,,,0.63 - 2.71,mmol/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,LIPID PANEL,Cholesterol (High Performance),,4.25,,L,,,4.86 - 8.28,mmol/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,LIPID PANEL,LDL Chol Friedewald 4th,,2.67,,,,,0 - 3.34,mmol/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,RETICULOCYTES,Reticulocyte Count %,,1.0,,,,,0.6 - 2.5,% +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,TSH,TSH 3rd IS-QT,,1.798,,,,,0.45 - 5.33,mIU/L +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,URINE MACRO PANEL,Ur Specific Gravity,,1.016,,,,,1.01 - 1.03, +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040007,,,66,years,Female,Part 2 OL Induction Baseline,,"May 5, 2026 7:50 AM",6227541256,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.9,,,,,0 - 5,mg/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,Total Bilirubin,,11,,,,,3 - 21,umol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.4,,,,,0 - 6.2,umol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,Alkaline Phosphatase,,81,,,,,35 - 104,U/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,ALT (SGPT),,23,,,,,4 - 43,U/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,AST (SGOT),,19,,,,,8 - 40,U/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,GGT,,19,,,,,4 - 49,U/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,LDH,,193,,,,,53 - 234,U/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,Urea Nitrogen,,4.7,,,,,1.4 - 8.6,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,72,,,,,31 - 101,umol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,Glucose Fasting,,5.2,,,,,3.9 - 5.6,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,Serum Uric Acid,,206,,,,,149 - 446,umol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,Calcium (EDTA),,2.43,,,,,2.07 - 2.64,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,Phosphorus,,1.36,,,,,0.71 - 1.65,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,Total Protein,,65,,,,,61 - 84,g/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,Creatine Kinase,,82,,,,,26 - 192,U/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,Serum Sodium,,145,,,,,132 - 147,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,Serum Potassium,,4.3,,,,,3.5 - 5.2,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,Serum Bicarbonate,,25.9,,,,,19.3 - 29.3,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,CHEMISTRY PANEL,Serum Chloride,,105,,,,,94 - 112,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,139,,,,,116 - 164,g/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.43,,,,,0.34 - 0.48, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.5,,,,,4.1 - 5.6,TI/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,96,,,,,79 - 98,fL +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.84,,,,,3.8 - 10.7,GI/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.66,,,,,1.96 - 7.23,GI/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.78,,,,,0.91 - 4.28,GI/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.27,,,,,0.12 - 0.92,GI/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.08,,,,,0 - 0.57,GI/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,,0 - 0.2,GI/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,55.0,,,,,40.5 - 75,% +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,36.8,,,,,15.4 - 48.5,% +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.7,,,,,2.6 - 10.1,% +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.7,,,,,0 - 6.8,% +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.8,,,,,0 - 2,% +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,274,,,,,140 - 400,GI/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.1,,,,,<6.5 %, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,5.31,,,,,1.9 - 23,uIU/mL +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,LIPID PANEL,Direct HDL-C 4th Generation,,1.64,,H,,,1.03 - 1.53,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,LIPID PANEL,Triglycerides (GPO),,0.68,,,,,0.59 - 2.96,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,LIPID PANEL,Cholesterol (High Performance),,5.02,,,,,4.42 - 7.53,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,LIPID PANEL,LDL Chol Friedewald 4th,,3.07,,,,,0 - 3.34,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,RETICULOCYTES,Reticulocyte Count %,,0.9,,,,,0.6 - 2.5,% +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,TSH,TSH 3rd IS-QT,,1.896,,,,,0.45 - 5.33,mIU/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,URINE MACRO PANEL,Ur Specific Gravity,,1.022,,,,,1 - 1.04, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,URINE MACRO PANEL,Ur pH,,6.5,,,,,5 - 8, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"May 5, 2026 7:15 AM",6227178910,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,C-REACTIVE PROTEIN,C Reactive Protein HS,,2.6,,,,,0 - 5,mg/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,Total Bilirubin,,<3,,L,,Result verified by repeat analysis,3 - 21,umol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,<1.4,,,,,0 - 6.2,umol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,Alkaline Phosphatase,,88,,,,,35 - 104,U/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,ALT (SGPT),,24,,,,,4 - 43,U/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,AST (SGOT),,21,,,,,8 - 40,U/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,GGT,,32,,,,,4 - 49,U/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,LDH,,156,,,,,53 - 234,U/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,Urea Nitrogen,,4.0,,,,,1.4 - 8.6,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,39,,,,,31 - 101,umol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,Glucose Fasting,,5.0,,,,,3.9 - 5.6,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,Serum Uric Acid,,335,,,,,125 - 428,umol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,Calcium (EDTA),,2.12,,,,,2.07 - 2.64,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,Phosphorus,,1.07,,,,,0.71 - 1.65,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,Total Protein,,66,,,,,61 - 84,g/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,Albumin-BCG,,39,,,,,33 - 49,g/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,Creatine Kinase,,135,,,,,26 - 192,U/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,Serum Sodium,,142,,,,,132 - 147,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,Serum Potassium,,4.1,,,,,3.5 - 5.2,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,Serum Bicarbonate,,20.2,,,,,19.3 - 29.3,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,CHEMISTRY PANEL,Serum Chloride,,109,,,,,94 - 112,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,DIRECT LDL,Direct LDL-C 3rd Gen,,3.40,,H,,,<3.36 mmol/L, +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,145,,,,,116 - 164,g/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.44,,,,,0.34 - 0.48, +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.5,,,,,4.1 - 5.6,TI/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,96,,,,,79 - 98,fL +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,11.75,,H,,,3.8 - 10.7,GI/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,6.71,,,,,1.96 - 7.23,GI/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,4.08,,,,,0.91 - 4.28,GI/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.60,,,,,0.12 - 0.92,GI/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.24,,,,,0 - 0.57,GI/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.11,,,,,0 - 0.2,GI/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,57.1,,,,,40.5 - 75,% +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,34.7,,,,,15.4 - 48.5,% +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.1,,,,,2.6 - 10.1,% +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.1,,,,,0 - 6.8,% +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.9,,,,,0 - 2,% +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,550,,H,,,140 - 400,GI/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,6.7,R,H,,,<6.5 %, +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,73.67,R,H,,,1.9 - 23,uIU/mL +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,LIPID PANEL,Direct HDL-C 4th Generation,,1.00,,L,,Result verified by repeat analysis,1.03 - 1.53,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,LIPID PANEL,Triglycerides (GPO),,5.91,,H SF,,,0.51 - 2.42,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,LIPID PANEL,Cholesterol (High Performance),,5.54,,,,,4.01 - 6.85,mmol/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,LIPID PANEL,LDL Chol Friedewald 4th,,,,,Test cancelled: Invalid/High Triglycerides,,, +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,RETICULOCYTES,Reticulocyte Count %,,1.7,,,,,0.6 - 2.5,% +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,TSH,TSH 3rd IS-QT,,2.578,,,,,0.45 - 5.33,mIU/L +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,URINE MACRO PANEL,Ur Specific Gravity,,1.006,,,,,1 - 1.04, +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 2 OL Induction Baseline,,"Apr 10, 2026 11:15 AM",6227547337,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.7,,,,,0 - 5,mg/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.8,,,,,0 - 6.2,umol/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,Alkaline Phosphatase,,69,,,,,35 - 104,U/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,ALT (SGPT),,25,,,,,4 - 43,U/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,AST (SGOT),,36,,,,,8 - 40,U/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,GGT,,43,,,,,4 - 49,U/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,LDH,,193,,,,,53 - 234,U/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,Urea Nitrogen,,4.6,,,,,1.4 - 8.6,mmol/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,65,,,,,31 - 101,umol/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,Glucose Fasting,,4.8,,,,,3.9 - 5.6,mmol/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,Serum Uric Acid,,321,,,,,149 - 446,umol/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,Calcium (EDTA),,2.13,,,,,2.07 - 2.64,mmol/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,Phosphorus,,0.91,,,,,0.71 - 1.65,mmol/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,Total Protein,,65,,,,,61 - 84,g/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,Albumin-BCG,,42,,,,,33 - 49,g/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,Creatine Kinase,,93,,,,,26 - 192,U/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,Serum Sodium,,142,,,,,132 - 147,mmol/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,Serum Potassium,,3.7,,,,,3.5 - 5.2,mmol/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,Serum Bicarbonate,,25.6,,,,,19.3 - 29.3,mmol/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CHEMISTRY PANEL,Serum Chloride,,107,,,,,94 - 112,mmol/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.65,,,,,1.25 - 1.92,mL/sec +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,65,,,,,31 - 101,umol/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,75.1,,,,,kg, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,No,,,,,, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,GFR,EGFR by MDRD,,81,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,134,,,,,116 - 164,g/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.40,,,,,0.34 - 0.48, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.2,,,,,4.1 - 5.6,TI/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,96,,,,,79 - 98,fL +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.08,,,,,3.8 - 10.7,GI/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.60,,,,,1.96 - 7.23,GI/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.79,,,,,0.91 - 4.28,GI/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.52,,,,,0.12 - 0.92,GI/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.12,,,,,0 - 0.57,GI/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,51.1,,,,,40.5 - 75,% +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,35.3,,,,,15.4 - 48.5,% +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,10.2,R,H,,,2.6 - 10.1,% +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.4,,,,,0 - 6.8,% +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.9,,,,,0 - 2,% +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,267,,,,,140 - 400,GI/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.5,,,,,<6.5 %, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,4.13,,,,,1.9 - 23,uIU/mL +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,LIPID PANEL,Direct HDL-C 4th Generation,,2.21,,H,,,1.03 - 1.53,mmol/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,LIPID PANEL,Triglycerides (GPO),,0.81,,,,,0.59 - 2.96,mmol/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,LIPID PANEL,Cholesterol (High Performance),,3.95,,L,,,4.42 - 7.53,mmol/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,LIPID PANEL,LDL Chol Friedewald 4th,,1.37,,,,,0 - 3.34,mmol/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,No,,,,,, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,RETICULOCYTES,Reticulocyte Count %,,1.4,,,,,0.6 - 2.5,% +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,TSH,TSH 3rd IS-QT,,3.004,,,,,0.45 - 5.33,mIU/L +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,URINE MACRO PANEL,Ur Specific Gravity,,1.020,,,,,1 - 1.04, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040009,,,58,years,Female,Part 2 Screening,,"Apr 10, 2026 8:15 AM",6227547336,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,C-REACTIVE PROTEIN,C Reactive Protein HS,,3.0,,,,,0 - 5,mg/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,Total Bilirubin,,5,,,,,3 - 21,umol/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,<1.4,,,,,0 - 6.2,umol/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,Alkaline Phosphatase,,94,,,,,35 - 104,U/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,ALT (SGPT),,17,,,,,4 - 43,U/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,AST (SGOT),,19,,,,,8 - 40,U/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,GGT,,17,,,,,5 - 50,U/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,LDH,,163,,,,,53 - 234,U/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,Urea Nitrogen,,4.3,,,,,1.4 - 10.4,mmol/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,68,,,,,31 - 110,umol/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,Glucose Fasting,,5.4,,,,,3.9 - 5.6,mmol/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,Serum Uric Acid,,265,,,,,149 - 446,umol/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,Calcium (EDTA),,2.38,,,,,2.07 - 2.64,mmol/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,Phosphorus,,1.45,,,,,0.71 - 1.65,mmol/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,Total Protein,,78,,,,,60 - 80,g/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,Albumin-BCG,,47,R,H,,,33 - 46,g/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,Creatine Kinase,,80,,,,,26 - 192,U/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,Serum Sodium,,137,,,,,135 - 145,mmol/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,Serum Potassium,,4.6,,,,,3.5 - 5.2,mmol/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,Serum Bicarbonate,,21.7,,,,,19.3 - 29.3,mmol/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,159,R,H,,,115 - 158,g/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.47,,,,,0.34 - 0.48, +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.1,,,,,3.9 - 5.5,TI/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,93,,,,,80 - 100,fL +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,9.76,,,,,3.8 - 10.7,GI/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,5.09,,,,,1.96 - 7.23,GI/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,3.77,R,H,,,0.8 - 3,GI/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.73,,,,,0.12 - 0.92,GI/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.11,,,,,0 - 0.57,GI/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.07,,,,,0 - 0.2,GI/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,52.1,,,,,40.5 - 75,% +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,38.6,,,,,15.4 - 48.5,% +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.5,,,,,2.6 - 10.1,% +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.2,,,,,0 - 6.8,% +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.7,,,,,0 - 2,% +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,307,,,,,130 - 394,GI/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.8,,,,,<6.5 %, +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,LIPID PANEL,Direct HDL-C 4th Generation,,1.36,,,,,1.03 - 1.53,mmol/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,LIPID PANEL,Triglycerides (GPO),,3.03,,H,,,0.63 - 2.71,mmol/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,LIPID PANEL,Cholesterol (High Performance),,7.15,,,,,5.35 - 9.1,mmol/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,LIPID PANEL,LDL Chol Friedewald 4th,,4.40,,H,,,0 - 3.34,mmol/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,RETICULOCYTES,Reticulocyte Count %,,1.6,,,,,0.6 - 2.5,% +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,TSH,TSH 3rd IS-QT,,1.854,,,,,0.45 - 5.33,mIU/L +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,URINE MACRO PANEL,Ur Specific Gravity,,1.012,,,,,1.01 - 1.03, +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,URINE MACRO PANEL,Ur pH,,5.0,,,,,5 - 8, +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040005,,,72,years,Female,Part 2 OL Induction Baseline,,"Apr 7, 2026 9:45 AM",6227541258,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.3,,,,,0 - 5,mg/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,Total Bilirubin,,5,,,,,3 - 21,umol/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.6,,,,,0 - 6.2,umol/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,Alkaline Phosphatase,,100,,,,,35 - 104,U/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,ALT (SGPT),,30,,,,,4 - 43,U/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,AST (SGOT),,27,,,,,8 - 40,U/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,GGT,,18,,,,,4 - 49,U/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,LDH,,235,,H,,,53 - 234,U/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,Urea Nitrogen,,5.4,,,,,1.4 - 8.6,mmol/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,76,,,,,31 - 101,umol/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,Glucose Fasting,,4.7,,,,,3.9 - 5.6,mmol/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,Serum Uric Acid,,308,,,,,149 - 446,umol/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,Calcium (EDTA),,2.33,,,,,2.07 - 2.64,mmol/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,Phosphorus,,1.09,,,,,0.71 - 1.65,mmol/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,Total Protein,,71,,,,,61 - 84,g/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,Creatine Kinase,,119,,,,,26 - 192,U/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,Serum Bicarbonate,,24.5,,,,,19.3 - 29.3,mmol/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,143,,,,,116 - 164,g/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.42,,,,,0.34 - 0.48, +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.8,,,,,4.1 - 5.6,TI/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,Normocytic,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,89,,,,,79 - 98,fL +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.03,,,,,3.8 - 10.7,GI/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.95,,,,,1.96 - 7.23,GI/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.62,,,,,0.91 - 4.28,GI/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.32,,,,,0.12 - 0.92,GI/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.13,,,,,0 - 0.57,GI/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,58.6,,,,,40.5 - 75,% +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,32.2,,,,,15.4 - 48.5,% +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.3,,,,,2.6 - 10.1,% +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.5,,,,,0 - 6.8,% +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.4,,,,,0 - 2,% +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,,,,Test cancelled: Platelet clumps present,,, +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.6,,,,,<6.5 %, +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,8.28,,,,,1.9 - 23,uIU/mL +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,LIPID PANEL,Direct HDL-C 4th Generation,,1.34,,,,,1.03 - 1.53,mmol/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,LIPID PANEL,Triglycerides (GPO),,1.17,,,,,0.59 - 2.96,mmol/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,LIPID PANEL,Cholesterol (High Performance),,6.97,,,,,4.42 - 7.53,mmol/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,LIPID PANEL,LDL Chol Friedewald 4th,,5.09,,H,,,0 - 3.34,mmol/L +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,RETICULOCYTES,Reticulocyte Count %,,1.7,,,,,0.6 - 2.5,% +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,TSH,TSH 3rd IS-QT,,,,,Test group cancelled: No specimen received,,, +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,URINE MACRO PANEL,Ur Specific Gravity,,1.022,,,,,1 - 1.04, +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,URINE MACRO PANEL,Ur pH,,6.0,,,,,5 - 8, +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 2 DB Week 13,,"Apr 7, 2026 8:35 AM",6227541264,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.8,,,,,0 - 5,mg/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CELLULAR ELEMENTS,Ur WBC/HPF,,7,,,,,0 - 12,/HPF +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,Total Bilirubin,,14,,,,,3 - 21,umol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,5.1,,,,,0 - 6.2,umol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,Alkaline Phosphatase,,86,,,,,35 - 104,U/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,ALT (SGPT),,61,R,H,,,4 - 43,U/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,AST (SGOT),,37,,,,,8 - 40,U/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,GGT,,25,,,,,4 - 49,U/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,LDH,,181,,,,,53 - 234,U/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,Urea Nitrogen,,4.3,,,,,1.4 - 8.6,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,75,,,,,31 - 101,umol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,Glucose Fasting,,6.1,R,H,,,3.9 - 5.6,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,Serum Uric Acid,,287,,,,,149 - 446,umol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,Calcium (EDTA),,2.34,,,,,2.07 - 2.64,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,Phosphorus,,1.16,,,,,0.71 - 1.65,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,Total Protein,,64,,,,,61 - 84,g/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,Creatine Kinase,,52,,,,,26 - 192,U/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,Serum Potassium,,4.3,,,,,3.5 - 5.2,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,Serum Bicarbonate,,25.7,,,,,19.3 - 29.3,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,151,,,,,116 - 164,g/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.45,,,,,0.34 - 0.48, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.0,,,,,4.1 - 5.6,TI/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,91,,,,,79 - 98,fL +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,7.52,,,,,3.8 - 10.7,GI/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.64,,,,,1.96 - 7.23,GI/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.27,,,,,0.91 - 4.28,GI/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.38,,,,,0.12 - 0.92,GI/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.15,,,,,0 - 0.57,GI/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.08,,,,,0 - 0.2,GI/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,61.7,,,,,40.5 - 75,% +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,30.2,,,,,15.4 - 48.5,% +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.0,,,,,2.6 - 10.1,% +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.0,,,,,0 - 6.8,% +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.0,,,,,0 - 2,% +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,310,,,,,140 - 400,GI/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,6.4,,,,,<6.5 %, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,18.47,,,,,1.9 - 23,uIU/mL +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,LIPID PANEL,Direct HDL-C 4th Generation,,0.95,R,L,,,1.03 - 1.53,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,LIPID PANEL,Triglycerides (GPO),,1.13,,,,,0.59 - 2.96,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,LIPID PANEL,Cholesterol (High Performance),,2.38,,L,,Result verified by repeat analysis,4.42 - 7.53,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,LIPID PANEL,LDL Chol Friedewald 4th,,0.91,,,,,0 - 3.34,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,RETICULOCYTES,Reticulocyte Count %,,2.0,,,,,0.6 - 2.5,% +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,TSH,TSH 3rd IS-QT,,0.827,,,,,0.45 - 5.33,mIU/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,URINE MACRO PANEL,Ur Specific Gravity,,1.019,,,,,1 - 1.04, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,URINE MACRO PANEL,Ur Leukocyte Esterase,,+2,,H SF,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Mar 27, 2026 10:00 AM",6227768460,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.7,,,,,0 - 5,mg/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,Total Bilirubin,,19,,,,,3 - 21,umol/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,5.6,,,,,0 - 6.2,umol/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,Alkaline Phosphatase,,122,,H,,,35 - 104,U/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,ALT (SGPT),,9,,,,,4 - 43,U/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,AST (SGOT),,15,,,,,8 - 40,U/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,GGT,,12,,,,,5 - 50,U/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,LDH,,154,,,,,53 - 234,U/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,Urea Nitrogen,,6.0,,,,,1.4 - 8.6,mmol/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,65,,,,,31 - 101,umol/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,Glucose Fasting,,6.3,,H,,,3.9 - 5.6,mmol/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,Serum Uric Acid,,223,,,,,149 - 446,umol/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,Calcium (EDTA),,2.31,,,,,2.07 - 2.64,mmol/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,Phosphorus,,0.91,,,,,0.71 - 1.65,mmol/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,Total Protein,,68,,,,,60 - 80,g/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,Creatine Kinase,,85,,,,,26 - 192,U/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,Serum Sodium,,140,,,,,135 - 145,mmol/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,Serum Potassium,,4.3,,,,,3.5 - 5.2,mmol/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,Serum Bicarbonate,,23.4,,,,,19.3 - 29.3,mmol/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,CHEMISTRY PANEL,Serum Chloride,,106,,,,,94 - 112,mmol/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,147,,,,,115 - 158,g/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.45,,,,,0.34 - 0.48, +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.7,,,,,3.9 - 5.5,TI/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,94,,,,,80 - 100,fL +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.41,,,,,3.8 - 10.7,GI/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.51,,,,,1.96 - 7.23,GI/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.33,,,,,0.8 - 3,GI/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.35,,,,,0.12 - 0.92,GI/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.13,,,,,0 - 0.57,GI/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.09,,,,,0 - 0.2,GI/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,54.7,,,,,40.5 - 75,% +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,36.2,,,,,15.4 - 48.5,% +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.5,,,,,2.6 - 10.1,% +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.1,,,,,0 - 6.8,% +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.4,,,,,0 - 2,% +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,232,,,,,130 - 394,GI/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,4.38,,,,,1.9 - 23,uIU/mL +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,LIPID PANEL,Direct HDL-C 4th Generation,,1.74,R,H,,,1.03 - 1.53,mmol/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,LIPID PANEL,Triglycerides (GPO),,0.57,R,L,,,0.63 - 2.71,mmol/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,LIPID PANEL,Cholesterol (High Performance),,4.75,R,L,,,4.86 - 8.28,mmol/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,LIPID PANEL,LDL Chol Friedewald 4th,,2.75,,,,,0 - 3.34,mmol/L +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,RETICULOCYTES,Reticulocyte Count %,,0.9,,,,,0.6 - 2.5,% +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,URINE MACRO PANEL,Ur Specific Gravity,,1.006,,,,,1.01 - 1.03, +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040008,,,63,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 8:45 AM",6227547333,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,C-REACTIVE PROTEIN,C Reactive Protein HS,,8.5,R,H,,,0 - 5,mg/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,Total Bilirubin,,5,,,,,3 - 21,umol/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.3,,,,,0 - 6.2,umol/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,Alkaline Phosphatase,,61,,,,,35 - 104,U/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,ALT (SGPT),,15,,,,,4 - 43,U/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,AST (SGOT),,17,,,,,8 - 40,U/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,GGT,,14,,,,,5 - 50,U/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,LDH,,150,,,,,53 - 234,U/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,Urea Nitrogen,,4.4,,,,,1.4 - 8.6,mmol/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,56,,,,,31 - 101,umol/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,Glucose Fasting,,5.7,,H,,,3.9 - 5.6,mmol/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,Serum Uric Acid,,207,,,,,149 - 446,umol/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,Calcium (EDTA),,2.32,,,,,2.07 - 2.64,mmol/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,Phosphorus,,0.89,,,,,0.71 - 1.65,mmol/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,Total Protein,,63,,,,,60 - 80,g/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,Albumin-BCG,,41,,,,,33 - 49,g/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,Creatine Kinase,,78,,,,,26 - 192,U/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,Serum Sodium,,142,,,,,135 - 145,mmol/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,Serum Bicarbonate,,23.4,,,,,19.3 - 29.3,mmol/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,CHEMISTRY PANEL,Serum Chloride,,107,,,,,94 - 112,mmol/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,149,,,,,115 - 158,g/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.44,,,,,0.34 - 0.48, +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.5,,,,,3.9 - 5.5,TI/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,97,,,,,80 - 100,fL +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.75,,,,,3.8 - 10.7,GI/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.15,,,,,1.96 - 7.23,GI/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.07,,,,,0.8 - 3,GI/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.38,,,,,0.12 - 0.92,GI/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.13,,,,,0 - 0.57,GI/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,72.1,,,,,40.5 - 75,% +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,18.6,,,,,15.4 - 48.5,% +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.7,,,,,2.6 - 10.1,% +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.2,,,,,0 - 6.8,% +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.4,,,,,0 - 2,% +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,234,,,,,130 - 394,GI/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,5.19,,,,,1.9 - 23,uIU/mL +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,LIPID PANEL,Direct HDL-C 4th Generation,,1.30,,,,,1.03 - 1.53,mmol/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,LIPID PANEL,Triglycerides (GPO),,0.41,,L,,,0.63 - 2.71,mmol/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,LIPID PANEL,Cholesterol (High Performance),,4.53,,L,,,4.86 - 8.28,mmol/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,LIPID PANEL,LDL Chol Friedewald 4th,,3.04,,,,,0 - 3.34,mmol/L +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,RETICULOCYTES,Reticulocyte Count %,,1.1,,,,,0.6 - 2.5,% +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,URINE MACRO PANEL,Ur Specific Gravity,,1.019,,,,,1.01 - 1.03, +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,URINE MACRO PANEL,Ur pH,,5.0,,,,,5 - 8, +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040007,,,66,years,Female,Part 1 DB Baseline,,"Mar 25, 2026 6:50 AM",6227541251,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.9,,,,,0 - 5,mg/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,Total Bilirubin,,11,,,,,3 - 21,umol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.0,,,,,0 - 6.2,umol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,Alkaline Phosphatase,,78,,,,,35 - 104,U/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,ALT (SGPT),,29,,,,,4 - 43,U/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,AST (SGOT),,24,,,,,8 - 40,U/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,GGT,,23,,,,,4 - 49,U/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,LDH,,214,,,,,53 - 234,U/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,Urea Nitrogen,,3.9,,,,,1.4 - 8.6,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,80,,,,,31 - 101,umol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,Glucose Fasting,,5.4,,,,,3.9 - 5.6,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,Serum Uric Acid,,248,,,,,149 - 446,umol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,Calcium (EDTA),,2.38,,,,,2.07 - 2.64,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,Phosphorus,,0.93,,,,,0.71 - 1.65,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,Total Protein,,64,,,,,61 - 84,g/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,Creatine Kinase,,128,,,,,26 - 192,U/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,Serum Sodium,,142,,,,,132 - 147,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,Serum Potassium,,4.5,,,,,3.5 - 5.2,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,Serum Bicarbonate,,25.8,,,,,19.3 - 29.3,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,CHEMISTRY PANEL,Serum Chloride,,105,,,,,94 - 112,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,138,,,,,116 - 164,g/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.42,,,,,0.34 - 0.48, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.5,,,,,4.1 - 5.6,TI/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,94,,,,,79 - 98,fL +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.44,,,,,3.8 - 10.7,GI/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.15,,,,,1.96 - 7.23,GI/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.79,,,,,0.91 - 4.28,GI/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.33,,,,,0.12 - 0.92,GI/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.15,,,,,0 - 0.57,GI/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,57.9,,,,,40.5 - 75,% +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,32.9,,,,,15.4 - 48.5,% +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.0,,,,,2.6 - 10.1,% +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.7,,,,,0 - 6.8,% +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.6,,,,,0 - 2,% +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,290,,,,,140 - 400,GI/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.1,,,,,<6.5 %, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,5.23,,,,,1.9 - 23,uIU/mL +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,LIPID PANEL,Direct HDL-C 4th Generation,,1.67,,H,,,1.03 - 1.53,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,LIPID PANEL,Triglycerides (GPO),,0.88,,,,,0.59 - 2.96,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,LIPID PANEL,Cholesterol (High Performance),,5.28,,,,,4.42 - 7.53,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,LIPID PANEL,LDL Chol Friedewald 4th,,3.21,,,,,0 - 3.34,mmol/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,RETICULOCYTES,Reticulocyte Count %,,1.4,,,,,0.6 - 2.5,% +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,TSH,TSH 3rd IS-QT,,1.525,,,,,0.45 - 5.33,mIU/L +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,URINE MACRO PANEL,Ur Specific Gravity,,1.019,,,,,1 - 1.04, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,URINE MACRO PANEL,Ur pH,,7.0,,,,,5 - 8, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,End of Phase/Treatment,,"Mar 13, 2026 9:00 AM",6227768459,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,C-REACTIVE PROTEIN,C Reactive Protein HS,,4.4,,,,,0 - 5,mg/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,Total Bilirubin,,14,,,,,3 - 21,umol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.8,,,,,0 - 6.2,umol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,Alkaline Phosphatase,,81,,,,,35 - 104,U/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,ALT (SGPT),,25,,,,,4 - 43,U/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,AST (SGOT),,25,,,,,8 - 40,U/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,GGT,,52,,H,,,4 - 49,U/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,LDH,,153,,,,,53 - 234,U/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,Urea Nitrogen,,3.3,,,,,1.4 - 8.6,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,66,,,,,31 - 101,umol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,Glucose Fasting,,5.4,,,,,3.9 - 5.6,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,Serum Uric Acid,,273,,,,,125 - 428,umol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,Calcium (EDTA),,2.45,,,,,2.07 - 2.64,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,Phosphorus,,1.02,,,,,0.71 - 1.65,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,Total Protein,,74,,,,,61 - 84,g/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,Creatine Kinase,,118,,,,,26 - 192,U/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,Serum Sodium,,137,,,,,132 - 147,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,Serum Potassium,,4.3,,,,,3.5 - 5.2,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,Serum Bicarbonate,,23.2,,,,,19.3 - 29.3,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,CHEMISTRY PANEL,Serum Chloride,,100,,,,,94 - 112,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,131,,,,,116 - 164,g/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.39,,,,,0.34 - 0.48, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.1,,,,,4.1 - 5.6,TI/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,96,,,,,79 - 98,fL +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.38,,,,,3.8 - 10.7,GI/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.04,,,,,1.96 - 7.23,GI/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.60,,,,,0.91 - 4.28,GI/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.49,,,,,0.12 - 0.92,GI/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.23,,,,,0 - 0.57,GI/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,47.6,,,,,40.5 - 75,% +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,40.7,,,,,15.4 - 48.5,% +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.6,,,,,2.6 - 10.1,% +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.6,,,,,0 - 6.8,% +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,315,,,,,140 - 400,GI/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.2,,,,,<6.5 %, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,5.83,,,,,1.9 - 23,uIU/mL +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,LIPID PANEL,Direct HDL-C 4th Generation,,1.70,,H,,Result verified by repeat analysis,1.03 - 1.53,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,LIPID PANEL,Triglycerides (GPO),,2.24,,,,,0.51 - 2.42,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,LIPID PANEL,Cholesterol (High Performance),,5.71,,,,,4.01 - 6.85,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,LIPID PANEL,LDL Chol Friedewald 4th,,2.98,,,,,0 - 3.34,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,RETICULOCYTES,Reticulocyte Count %,,1.9,,,,,0.6 - 2.5,% +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,TSH,TSH 3rd IS-QT,,4.319,,,,,0.45 - 5.33,mIU/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,URINE MACRO PANEL,Ur Specific Gravity,,1.021,,,,,1 - 1.04, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Mar 6, 2026 9:50 AM",6227178911,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.0,,,,,0 - 5,mg/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,Total Bilirubin,,11,,,,,3 - 21,umol/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.2,,,,,0 - 6.2,umol/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,Alkaline Phosphatase,,130,,H,,,35 - 104,U/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,ALT (SGPT),,10,,,,,4 - 43,U/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,AST (SGOT),,14,,,,,8 - 40,U/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,GGT,,13,,,,,5 - 50,U/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,LDH,,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,Urea Nitrogen,,5.6,,,,,1.4 - 8.6,mmol/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,63,,,,,31 - 101,umol/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,Glucose Fasting,,5.4,,,,,3.9 - 5.6,mmol/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,Serum Uric Acid,,232,,,,,149 - 446,umol/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,Calcium (EDTA),,2.49,,,,,2.07 - 2.64,mmol/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,Phosphorus,,0.93,,,,,0.71 - 1.65,mmol/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,Total Protein,,73,,,,,60 - 80,g/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,Creatine Kinase,,59,,,,,26 - 192,U/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,Serum Sodium,,141,,,,,135 - 145,mmol/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,Serum Bicarbonate,,25.2,,,,,19.3 - 29.3,mmol/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.61,,,,,1.25 - 1.92,mL/sec +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,63,,,,,31 - 101,umol/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,75.5,,,,,kg, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,No,,,,,, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,FSH,Follicle Stimulating Hormone,,57.83,,,,,Follicular:$3.90-8.80 IU/L$Midcycle:$4.50-22.50 IU/L$Luteal:$1.80-5.10 IU/L$Postmenopausal:$16.70-113.60 IU/L, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,GFR,EGFR by MDRD,,83,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,159,R,H,,,115 - 158,g/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.49,R,H,,,0.34 - 0.48, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.2,,,,,3.9 - 5.5,TI/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,93,,,,,80 - 100,fL +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.19,,,,,3.8 - 10.7,GI/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.31,,,,,1.96 - 7.23,GI/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.30,,,,,0.8 - 3,GI/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.34,,,,,0.12 - 0.92,GI/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.18,,,,,0 - 0.57,GI/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.06,,,,,0 - 0.2,GI/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,53.5,,,,,40.5 - 75,% +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,37.2,,,,,15.4 - 48.5,% +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.5,,,,,2.6 - 10.1,% +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.9,,,,,0 - 6.8,% +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.0,,,,,0 - 2,% +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,255,,,,,130 - 394,GI/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.6,,,,,<6.5 %, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,3.27,,,,,1.9 - 23,uIU/mL +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,LIPID PANEL,Direct HDL-C 4th Generation,,1.70,,H,,,1.03 - 1.53,mmol/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,LIPID PANEL,Triglycerides (GPO),,0.84,,,,,0.63 - 2.71,mmol/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,LIPID PANEL,Cholesterol (High Performance),,5.60,,,,,4.86 - 8.28,mmol/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,LIPID PANEL,LDL Chol Friedewald 4th,,3.52,,H,,,0 - 3.34,mmol/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,MICROORGANISMS,Ur Bacteria,,Present,,,,,Ref Rng:Not present, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,Yes,,,,,, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,RETICULOCYTES,Reticulocyte Count %,,1.0,,,,,0.6 - 2.5,% +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,TSH,TSH 3rd IS-QT,,0.932,,,,,0.45 - 5.33,mIU/L +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,URINE MACRO PANEL,Ur Specific Gravity,,1.006,,,,,1.01 - 1.03, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,URINE MACRO PANEL,Ur Leukocyte Esterase,,+1,,H,,,Ref Rng:Negative, +CZ100040008,,,63,years,Female,Part 1 Screening,,"Mar 6, 2026 9:20 AM",6227547331,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.3,,,,,0 - 5,mg/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CELLULAR ELEMENTS,Ur WBC/HPF,,48,R,H,,,0 - 12,/HPF +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,Total Bilirubin,,4,,,,,3 - 21,umol/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.6,,,,,0 - 6.2,umol/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,Alkaline Phosphatase,,89,,,,,35 - 104,U/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,ALT (SGPT),,16,,,,,4 - 43,U/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,AST (SGOT),,17,,,,,8 - 40,U/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,GGT,,28,,,,,4 - 49,U/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,LDH,,141,,,,,53 - 234,U/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,Urea Nitrogen,,4.6,,,,,1.4 - 8.6,mmol/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,52,,,,,31 - 101,umol/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,Glucose Fasting,,6.7,R,H,,,3.9 - 5.6,mmol/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,Serum Uric Acid,,325,,,,,125 - 428,umol/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,Calcium (EDTA),,2.52,,,,,2.07 - 2.64,mmol/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,Phosphorus,,1.23,,,,,0.71 - 1.65,mmol/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,Total Protein,,75,,,,,61 - 84,g/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,Creatine Kinase,,205,R,H,,,26 - 192,U/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,Serum Sodium,,137,,,,,132 - 147,mmol/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,Serum Potassium,,4.6,,,,,3.5 - 5.2,mmol/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,Serum Bicarbonate,,24.4,,,,,19.3 - 29.3,mmol/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CHEMISTRY PANEL,Serum Chloride,,100,,,,,94 - 112,mmol/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,CRYSTALS,Ur Calcium Oxalate Crystals,,Present,,,,,Ref Rng:Not present, +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,138,,,,,116 - 164,g/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.42,,,,,0.34 - 0.48, +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.4,,,,,4.1 - 5.6,TI/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,96,,,,,79 - 98,fL +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,9.95,,,,,3.8 - 10.7,GI/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,5.30,,,,,1.96 - 7.23,GI/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,3.84,R,,,,0.91 - 4.28,GI/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.62,,,,,0.12 - 0.92,GI/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.14,,,,,0 - 0.57,GI/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,53.3,,,,,40.5 - 75,% +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,38.6,,,,,15.4 - 48.5,% +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.2,,,,,2.6 - 10.1,% +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.4,,,,,0 - 6.8,% +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,486,R,H,,,140 - 400,GI/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,118.97,R,H,,,1.9 - 23,uIU/mL +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,LIPID PANEL,Direct HDL-C 4th Generation,,1.32,,,,,1.03 - 1.53,mmol/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,LIPID PANEL,Triglycerides (GPO),,2.60,R,H,,,0.51 - 2.42,mmol/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,LIPID PANEL,Cholesterol (High Performance),,5.47,,,,,4.01 - 6.85,mmol/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,LIPID PANEL,LDL Chol Friedewald 4th,,2.96,,,,,0 - 3.34,mmol/L +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,RETICULOCYTES,Reticulocyte Count %,,1.4,,,,,0.6 - 2.5,% +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,URINE MACRO PANEL,Ur Specific Gravity,,1.033,R,,,,1 - 1.04, +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,URINE MACRO PANEL,Ur Protein,,+2,R,H SF,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,URINE MACRO PANEL,Ur Ketones,,Trace,R,H,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,URINE MACRO PANEL,Ur Leukocyte Esterase,,+3,R,H SF,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 1 DB Baseline,,"Feb 27, 2026 11:35 AM",6227547332,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,C-REACTIVE PROTEIN,C Reactive Protein HS,,9.0,R,H,,,0 - 5,mg/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CELLULAR ELEMENTS,Ur WBC/HPF,,6,,,,,0 - 12,/HPF +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CELLULAR ELEMENTS,Ur Squamous Epithelial Cells,,38,,,,,0 - 3,/HPF +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,Total Bilirubin,,11,,,,,3 - 21,umol/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.5,,,,,0 - 6.2,umol/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,Alkaline Phosphatase,,65,,,,,35 - 104,U/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,ALT (SGPT),,16,,,,,4 - 43,U/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,AST (SGOT),,17,,,,,8 - 40,U/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,GGT,,16,,,,,5 - 50,U/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,LDH,,183,,,,,53 - 234,U/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,Urea Nitrogen,,4.2,,,,,1.4 - 8.6,mmol/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,58,,,,,31 - 101,umol/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,Glucose Fasting,,5.0,,,,,3.9 - 5.6,mmol/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,Serum Uric Acid,,133,R,L,,,149 - 446,umol/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,Calcium (EDTA),,2.43,,,,,2.07 - 2.64,mmol/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,Phosphorus,,0.91,,,,,0.71 - 1.65,mmol/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,Total Protein,,63,,,,,60 - 80,g/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,Albumin-BCG,,42,,,,,33 - 49,g/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,Creatine Kinase,,87,,,,,26 - 192,U/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,Serum Sodium,,139,,,,,135 - 145,mmol/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,Serum Bicarbonate,,22.0,,,,,19.3 - 29.3,mmol/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CHEMISTRY PANEL,Serum Chloride,,106,,,,,94 - 112,mmol/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.29,,,,,1.25 - 1.92,mL/sec +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,58,,,,,31 - 101,umol/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,58.2,,,,,kg, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,No,,,,,, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,GFR,EGFR by MDRD,,90,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,148,,,,,115 - 158,g/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.45,,,,,0.34 - 0.48, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.6,,,,,3.9 - 5.5,TI/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,99,,,,,80 - 100,fL +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.46,,,,,3.8 - 10.7,GI/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.63,,,,,1.96 - 7.23,GI/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.19,,,,,0.8 - 3,GI/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.49,,,,,0.12 - 0.92,GI/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.12,,,,,0 - 0.57,GI/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,66.4,,,,,40.5 - 75,% +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,21.7,,,,,15.4 - 48.5,% +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,9.0,,,,,2.6 - 10.1,% +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.2,,,,,0 - 6.8,% +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.6,,,,,0 - 2,% +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,247,,,,,130 - 394,GI/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.4,,,,,<6.5 %, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,3.23,,,,,1.9 - 23,uIU/mL +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,LIPID PANEL,Direct HDL-C 4th Generation,,1.28,,,,,1.03 - 1.53,mmol/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,LIPID PANEL,Triglycerides (GPO),,0.70,,,,,0.63 - 2.71,mmol/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,LIPID PANEL,Cholesterol (High Performance),,4.86,,,,,4.86 - 8.28,mmol/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,LIPID PANEL,LDL Chol Friedewald 4th,,3.26,,,,,0 - 3.34,mmol/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,MICROORGANISMS,Ur Bacteria,,Present,,,,,Ref Rng:Not present, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,MISCELLANEOUS ELEMENTS,Ur Mucous,,Present,,,,,Ref Rng:Not present, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,No,,,,,, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,RETICULOCYTES,Reticulocyte Count %,,1.2,,,,,0.6 - 2.5,% +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,TSH,TSH 3rd IS-QT,,1.723,,,,,0.45 - 5.33,mIU/L +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,URINE MACRO PANEL,Ur Specific Gravity,,1.023,,,,,1.01 - 1.03, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,URINE MACRO PANEL,Ur Protein,,Trace,R,H,,,Ref Rng:Negative, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,URINE MACRO PANEL,Ur Glucose,,Trace,R,H,,,Ref Rng:Normal, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040007,,,66,years,Female,Part 1 Screening,,"Feb 27, 2026 8:00 AM",6227547329,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,C-REACTIVE PROTEIN,C Reactive Protein HS,,3.1,,,,,0 - 5,mg/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,Total Bilirubin,,4,,,,,3 - 21,umol/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.6,,,,,0 - 6.2,umol/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,Alkaline Phosphatase,,89,,,,,35 - 104,U/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,ALT (SGPT),,14,,,,,4 - 43,U/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,AST (SGOT),,15,,,,,8 - 40,U/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,GGT,,17,,,,,5 - 50,U/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,LDH,,151,,,,,53 - 234,U/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,Urea Nitrogen,,6.7,,,,,1.4 - 10.4,mmol/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,70,,,,,31 - 110,umol/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,Glucose Fasting,,5.7,R,H,,,3.9 - 5.6,mmol/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,Serum Uric Acid,,312,,,,,149 - 446,umol/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,Calcium (EDTA),,2.45,,,,,2.07 - 2.64,mmol/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,Phosphorus,,1.48,,,,,0.71 - 1.65,mmol/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,Total Protein,,77,,,,,60 - 80,g/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 46,g/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,Creatine Kinase,,66,,,,,26 - 192,U/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,Serum Sodium,,139,,,,,135 - 145,mmol/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,Serum Potassium,,4.7,,,,,3.5 - 5.2,mmol/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,Serum Bicarbonate,,21.8,,,,,19.3 - 29.3,mmol/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,161,R,H,,,115 - 158,g/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.48,,,,,0.34 - 0.48, +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.3,,,,,3.9 - 5.5,TI/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,91,,,,,80 - 100,fL +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,9.57,,,,,3.8 - 10.7,GI/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,5.16,,,,,1.96 - 7.23,GI/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,3.42,R,H,,,0.8 - 3,GI/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.76,,,,,0.12 - 0.92,GI/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.15,,,,,0 - 0.57,GI/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.06,,,,,0 - 0.2,GI/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,54.0,,,,,40.5 - 75,% +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,35.8,,,,,15.4 - 48.5,% +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,8.0,,,,,2.6 - 10.1,% +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.6,,,,,0 - 6.8,% +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.6,,,,,0 - 2,% +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,300,,,,,130 - 394,GI/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,7.83,,,,,1.9 - 23,uIU/mL +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,LIPID PANEL,Direct HDL-C 4th Generation,,1.33,,,,,1.03 - 1.53,mmol/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,LIPID PANEL,Triglycerides (GPO),,2.03,,,,,0.63 - 2.71,mmol/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,LIPID PANEL,Cholesterol (High Performance),,6.94,,,,,5.35 - 9.1,mmol/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,LIPID PANEL,LDL Chol Friedewald 4th,,4.68,,H,,,0 - 3.34,mmol/L +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,RETICULOCYTES,Reticulocyte Count %,,1.8,,,,,0.6 - 2.5,% +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,URINE MACRO PANEL,Ur Specific Gravity,,1.009,,,,,1.01 - 1.03, +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040005,,,72,years,Female,Part 1 DB Baseline,,"Feb 20, 2026 10:45 AM",6227541252,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.1,,,,,0 - 5,mg/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CELLULAR ELEMENTS,Ur WBC/HPF,,5,,,,,0 - 12,/HPF +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CELLULAR ELEMENTS,Ur Transitional Epi Cells,,1,,,,,0 /HPF, +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,Total Bilirubin,,11,,,,,3 - 21,umol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.3,,,,,0 - 6.2,umol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,Alkaline Phosphatase,,79,,,,,35 - 104,U/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,ALT (SGPT),,21,,,,,4 - 43,U/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,AST (SGOT),,21,,,,,8 - 40,U/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,GGT,,17,,,,,4 - 49,U/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,LDH,,205,,,,,53 - 234,U/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,Urea Nitrogen,,3.7,,,,,1.4 - 8.6,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,73,,,,,31 - 101,umol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,Glucose Fasting,,5.2,,,,,3.9 - 5.6,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,Serum Uric Acid,,239,,,,,149 - 446,umol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,Calcium (EDTA),,2.44,,,,,2.07 - 2.64,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,Phosphorus,,1.25,,,,,0.71 - 1.65,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,Total Protein,,70,,,,,61 - 84,g/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,Creatine Kinase,,100,,,,,26 - 192,U/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,Serum Sodium,,141,,,,,132 - 147,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,Serum Potassium,,4.6,,,,,3.5 - 5.2,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,Serum Bicarbonate,,25.3,,,,,19.3 - 29.3,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,140,,,,,116 - 164,g/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.42,,,,,0.34 - 0.48, +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.6,,,,,4.1 - 5.6,TI/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,93,,,,,79 - 98,fL +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.66,,,,,3.8 - 10.7,GI/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.75,,,,,1.96 - 7.23,GI/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.38,,,,,0.91 - 4.28,GI/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.39,,,,,0.12 - 0.92,GI/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.12,,,,,0 - 0.57,GI/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,58.9,,,,,40.5 - 75,% +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,29.6,,,,,15.4 - 48.5,% +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,8.4,,,,,2.6 - 10.1,% +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.6,,,,,0 - 6.8,% +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,312,,,,,140 - 400,GI/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,2.82,,,,,1.9 - 23,uIU/mL +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,LIPID PANEL,Direct HDL-C 4th Generation,,1.68,,H,,,1.03 - 1.53,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,LIPID PANEL,Triglycerides (GPO),,0.71,,,,,0.59 - 2.96,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,LIPID PANEL,Cholesterol (High Performance),,5.23,,,,,4.42 - 7.53,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,LIPID PANEL,LDL Chol Friedewald 4th,,3.22,,,,,0 - 3.34,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,RETICULOCYTES,Reticulocyte Count %,,1.3,,,,,0.6 - 2.5,% +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,URINE MACRO PANEL,Ur Specific Gravity,,1.023,,,,,1 - 1.04, +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,URINE MACRO PANEL,Ur pH,,6.5,,,,,5 - 8, +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,URINE MACRO PANEL,Ur Protein,,Trace,,H,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,URINE MACRO PANEL,Ur Leukocyte Esterase,,Trace,,H,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 2 OL Induction Day 29,,"Feb 13, 2026 8:45 AM",6227541259,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.4,,,,,0 - 5,mg/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CELLULAR ELEMENTS,Ur WBC/HPF,,>150,,HT,,,0 - 12,/HPF +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,Total Bilirubin,,4,,,,,3 - 21,umol/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.5,,,,,0 - 6.2,umol/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,Alkaline Phosphatase,,76,,,,,35 - 104,U/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,ALT (SGPT),,16,,,,,4 - 43,U/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,AST (SGOT),,20,,,,,8 - 40,U/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,GGT,,25,,,,,4 - 49,U/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,LDH,,130,,,,,53 - 234,U/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,Urea Nitrogen,,5.1,,,,,1.4 - 8.6,mmol/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,53,,,,,31 - 101,umol/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,Glucose Fasting,,5.2,,,,,3.9 - 5.6,mmol/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,Serum Uric Acid,,357,,,,,125 - 428,umol/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,Calcium (EDTA),,2.43,,,,,2.07 - 2.64,mmol/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,Phosphorus,,1.26,,,,,0.71 - 1.65,mmol/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,Total Protein,,69,,,,,61 - 84,g/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,Albumin-BCG,,43,,,,,33 - 49,g/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,Creatine Kinase,,154,,,,,26 - 192,U/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,Serum Potassium,,4.5,,,,,3.5 - 5.2,mmol/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,Serum Bicarbonate,,23.0,,,,,19.3 - 29.3,mmol/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,2.63,,H,,,1.25 - 1.92,mL/sec +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,53,,,,,31 - 101,umol/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,87.2,,,,,kg, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,Yes,,,,,, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,GFR,EGFR by MDRD,,107,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,142,,,,,116 - 164,g/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.42,,,,,0.34 - 0.48, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.5,,,,,4.1 - 5.6,TI/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,92,,,,,79 - 98,fL +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,11.22,R,H,,,3.8 - 10.7,GI/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,6.93,,,,,1.96 - 7.23,GI/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,3.51,,,,,0.91 - 4.28,GI/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.50,,,,,0.12 - 0.92,GI/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.22,,,,,0 - 0.57,GI/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,61.8,,,,,40.5 - 75,% +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,31.3,,,,,15.4 - 48.5,% +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.4,,,,,2.6 - 10.1,% +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.0,,,,,0 - 6.8,% +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,509,R,H,,,140 - 400,GI/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,6.4,,,,,<6.5 %, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,39.05,,H,,,1.9 - 23,uIU/mL +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,LIPID PANEL,Direct HDL-C 4th Generation,,1.21,,,,,1.03 - 1.53,mmol/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,LIPID PANEL,Triglycerides (GPO),,3.23,,H,,,0.51 - 2.42,mmol/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,LIPID PANEL,Cholesterol (High Performance),,5.80,,,,,4.01 - 6.85,mmol/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,LIPID PANEL,LDL Chol Friedewald 4th,,3.11,,,,,0 - 3.34,mmol/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,No,,,,,, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,RETICULOCYTES,Reticulocyte Count %,,1.9,,,,,0.6 - 2.5,% +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,SERUM BETA HCG,"B-hCG, Qualitative",,Negative,,,,,Ref Rng: Negative, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,SERUM BETA HCG,"B-hCG, Quantitative",,<0.6,,,,,Units: mIU/mL$Pre-menopausal$<5.0: Negative$5.0-24.9:Borderline$>/= 25.0: Positive, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,TSH,TSH 3rd IS-QT,,2.280,,,,,0.45 - 5.33,mIU/L +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,URINE MACRO PANEL,Ur Specific Gravity,,1.023,,,,,1 - 1.04, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,URINE MACRO PANEL,Ur Protein,,Trace,,H,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,URINE MACRO PANEL,Ur Leukocyte Esterase,,+3,,H SF,,,Ref Rng:Negative, +CZ100040006,,,48,years,Female,Part 1 Screening,,"Jan 30, 2026 11:40 AM",6227547330,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,C-REACTIVE PROTEIN,C Reactive Protein HS,,7.3,,H,,,0 - 5,mg/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CELLULAR ELEMENTS,Ur WBC/HPF,,32,,H,,,0 - 12,/HPF +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,Total Bilirubin,,13,,,,,3 - 21,umol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,4.9,,,,,0 - 6.2,umol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,Alkaline Phosphatase,,94,,,,,35 - 104,U/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,ALT (SGPT),,55,,H,,,4 - 43,U/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,AST (SGOT),,30,,,,,8 - 40,U/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,GGT,,27,,,,,4 - 49,U/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,LDH,,175,,,,,53 - 234,U/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,Urea Nitrogen,,4.6,,,,,1.4 - 8.6,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,75,,,,,31 - 101,umol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,Glucose Fasting,,7.2,,H,,,3.9 - 5.6,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,Serum Uric Acid,,263,,,,,149 - 446,umol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,Calcium (EDTA),,2.41,,,,,2.07 - 2.64,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,Phosphorus,,0.95,,,,,0.71 - 1.65,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,Total Protein,,69,,,,,61 - 84,g/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,Albumin-BCG,,47,,,,,33 - 49,g/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,Creatine Kinase,,38,,,,,26 - 192,U/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,Serum Potassium,,4.7,,,,,3.5 - 5.2,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,Serum Bicarbonate,,25.0,,,,,19.3 - 29.3,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,159,,,,,116 - 164,g/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.47,,,,,0.34 - 0.48, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.2,,,,,4.1 - 5.6,TI/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,90,,,,,79 - 98,fL +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,7.29,,,,,3.8 - 10.7,GI/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.53,,,,,1.96 - 7.23,GI/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.07,,,,,0.91 - 4.28,GI/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.45,,,,,0.12 - 0.92,GI/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.15,,,,,0 - 0.57,GI/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.08,,,,,0 - 0.2,GI/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,62.2,,,,,40.5 - 75,% +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,28.5,,,,,15.4 - 48.5,% +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.2,,,,,2.6 - 10.1,% +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.1,,,,,0 - 6.8,% +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.1,,,,,0 - 2,% +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,296,,,,,140 - 400,GI/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,6.4,,,,,<6.5 %, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,33.25,,H,,,1.9 - 23,uIU/mL +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,LIPID PANEL,Direct HDL-C 4th Generation,,1.02,,L,,,1.03 - 1.53,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,LIPID PANEL,Triglycerides (GPO),,1.15,,,,,0.59 - 2.96,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,LIPID PANEL,Cholesterol (High Performance),,2.80,,L,,,4.42 - 7.53,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,LIPID PANEL,LDL Chol Friedewald 4th,,1.25,,,,,0 - 3.34,mmol/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,MICROORGANISMS,Ur Bacteria,,Present,,,,,Ref Rng:Not present, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,RETICULOCYTES,Reticulocyte Count %,,1.6,,,,,0.6 - 2.5,% +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,TSH,TSH 3rd IS-QT,,0.595,,,,,0.45 - 5.33,mIU/L +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,URINE MACRO PANEL,Ur Specific Gravity,,1.015,,,,,1 - 1.04, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,URINE MACRO PANEL,Ur pH,,6.0,,,,,5 - 8, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,URINE MACRO PANEL,Ur Leukocyte Esterase,,+3,,H SF,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,End of Phase/Treatment,,"Jan 30, 2026 9:30 AM",6227178909,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,C-REACTIVE PROTEIN,C Reactive Protein HS,,2.8,,,,,0 - 5,mg/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CELLULAR ELEMENTS,Ur RBC/HPF,,1,,,,,0 - 8,/HPF +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CELLULAR ELEMENTS,Ur WBC/HPF,,2,,,,,0 - 12,/HPF +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.5,,,,,0 - 6.2,umol/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,Alkaline Phosphatase,,87,,,,,35 - 104,U/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,ALT (SGPT),,14,,,,,4 - 43,U/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,AST (SGOT),,16,,,,,8 - 40,U/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,GGT,,15,,,,,5 - 50,U/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,LDH,,150,,,,,53 - 234,U/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,Urea Nitrogen,,5.0,,,,,1.4 - 10.4,mmol/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,63,,,,,31 - 110,umol/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,Glucose Fasting,,7.0,,H,,,3.9 - 5.6,mmol/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,Serum Uric Acid,,320,,,,,149 - 446,umol/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,Calcium (EDTA),,2.39,,,,,2.07 - 2.64,mmol/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,Phosphorus,,1.31,,,,,0.71 - 1.65,mmol/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,Total Protein,,78,,,,,60 - 80,g/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 46,g/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,Creatine Kinase,,87,,,,,26 - 192,U/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,Serum Sodium,,139,,,,,135 - 145,mmol/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,Serum Bicarbonate,,23.1,,,,,19.3 - 29.3,mmol/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.29,,,,,1.25 - 1.92,mL/sec +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,63,,,,,31 - 110,umol/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,68.5,,,,,kg, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,CRYSTALS,Ur Calcium Oxalate Crystals,,Present,,,,,Ref Rng:Not present, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,No,,,,,, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,FSH,Follicle Stimulating Hormone,,78.10,,,,,Follicular:$3.90-8.80 IU/L$Midcycle:$4.50-22.50 IU/L$Luteal:$1.80-5.10 IU/L$Postmenopausal:$16.70-113.60 IU/L, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,GFR,EGFR by MDRD,,81,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,165,,H,,,115 - 158,g/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.48,,,,,0.34 - 0.48, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.3,,,,,3.9 - 5.5,TI/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,90,,,,,80 - 100,fL +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,10.07,,,,,3.8 - 10.7,GI/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,6.15,,,,,1.96 - 7.23,GI/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,3.08,,H,,,0.8 - 3,GI/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.65,,,,,0.12 - 0.92,GI/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.14,,,,,0 - 0.57,GI/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,61.0,,,,,40.5 - 75,% +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,30.6,,,,,15.4 - 48.5,% +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.5,,,,,2.6 - 10.1,% +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.4,,,,,0 - 6.8,% +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,269,,,,,130 - 394,GI/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.9,,,,,<6.5 %, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,47.53,,H,,,1.9 - 23,uIU/mL +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,LIPID PANEL,Direct HDL-C 4th Generation,,1.28,,,,,1.03 - 1.53,mmol/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,LIPID PANEL,Triglycerides (GPO),,1.84,,,,,0.63 - 2.71,mmol/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,LIPID PANEL,Cholesterol (High Performance),,6.82,,,,,5.35 - 9.1,mmol/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,LIPID PANEL,LDL Chol Friedewald 4th,,4.70,,H,,,0 - 3.34,mmol/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,MICROORGANISMS,Ur Bacteria,,Present,,,,,Ref Rng:Not present, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,Yes,,,,,, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,RETICULOCYTES,Reticulocyte Count %,,1.4,,,,,0.6 - 2.5,% +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,TSH,TSH 3rd IS-QT,,1.806,,,,,0.45 - 5.33,mIU/L +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,URINE MACRO PANEL,Ur Specific Gravity,,1.025,,,,,1.01 - 1.03, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,URINE MACRO PANEL,Ur Protein,,Trace,,H,,,Ref Rng:Negative, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,URINE MACRO PANEL,Ur Blood,,Trace,,,,,Ref Rng:$Negative-Trace, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040005,,,72,years,Female,Part 1 Screening,,"Jan 27, 2026 9:00 AM",6227541249,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,C-REACTIVE PROTEIN,C Reactive Protein HS,,2.0,,,,,0 - 5,mg/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CELLULAR ELEMENTS,Ur WBC/HPF,,27,,H,,,0 - 12,/HPF +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,Total Bilirubin,,13,,,,,3 - 21,umol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,4.7,,,,,0 - 6.2,umol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,Alkaline Phosphatase,,84,,,,,35 - 104,U/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,ALT (SGPT),,53,,H,,,4 - 43,U/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,AST (SGOT),,26,,,,,8 - 40,U/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,GGT,,26,,,,,4 - 49,U/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,LDH,,172,,,,,53 - 234,U/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,Urea Nitrogen,,5.2,,,,,1.4 - 8.6,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,75,,,,,31 - 101,umol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,Glucose Fasting,,6.8,,H,,,3.9 - 5.6,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,Serum Uric Acid,,279,,,,,149 - 446,umol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,Calcium (EDTA),,2.39,,,,,2.07 - 2.64,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,Phosphorus,,1.21,,,,,0.71 - 1.65,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,Total Protein,,66,,,,,61 - 84,g/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,Creatine Kinase,,45,,,,,26 - 192,U/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,Serum Potassium,,4.7,,,,,3.5 - 5.2,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,Serum Bicarbonate,,25.1,,,,,19.3 - 29.3,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,CRYSTALS,Ur Calcium Oxalate Crystals,,Present,,,,,Ref Rng:Not present, +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,153,,,,,116 - 164,g/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.46,,,,,0.34 - 0.48, +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.0,,,,,4.1 - 5.6,TI/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,92,,,,,79 - 98,fL +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,8.45,,,,,3.8 - 10.7,GI/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.94,,,,,1.96 - 7.23,GI/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.68,,,,,0.91 - 4.28,GI/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.51,,,,,0.12 - 0.92,GI/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.24,,,,,0 - 0.57,GI/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.09,,,,,0 - 0.2,GI/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,58.4,,,,,40.5 - 75,% +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,31.7,,,,,15.4 - 48.5,% +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.0,,,,,2.6 - 10.1,% +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.9,,,,,0 - 6.8,% +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.0,,,,,0 - 2,% +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,302,,,,,140 - 400,GI/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,13.07,,,,,1.9 - 23,uIU/mL +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,LIPID PANEL,Direct HDL-C 4th Generation,,0.98,,L,,,1.03 - 1.53,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,LIPID PANEL,Triglycerides (GPO),,0.95,,,,,0.59 - 2.96,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,LIPID PANEL,Cholesterol (High Performance),,2.57,,L,,Result verified by repeat analysis,4.42 - 7.53,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,LIPID PANEL,LDL Chol Friedewald 4th,,1.15,,,,,0 - 3.34,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,RETICULOCYTES,Reticulocyte Count %,,2.1,,,,,0.6 - 2.5,% +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,URINE MACRO PANEL,Ur Specific Gravity,,1.023,,,,,1 - 1.04, +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,URINE MACRO PANEL,Ur Leukocyte Esterase,,+3,,H SF,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 2 OL Induction Day 29,,"Jan 16, 2026 10:40 AM",6227541260,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.9,,,,,0 - 5,mg/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CELLULAR ELEMENTS,Ur WBC/HPF,,5,,,,,0 - 12,/HPF +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CELLULAR ELEMENTS,Ur Transitional Epi Cells,,1,,,,,0 /HPF, +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,Total Bilirubin,,8,,,,,3 - 21,umol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.9,,,,,0 - 6.2,umol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,Alkaline Phosphatase,,71,,,,,35 - 104,U/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,ALT (SGPT),,17,,,,,4 - 43,U/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,AST (SGOT),,20,,,,,8 - 40,U/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,GGT,,18,,,,,4 - 49,U/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,LDH,,203,,,,,53 - 234,U/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,Urea Nitrogen,,3.2,,,,,1.4 - 8.6,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,70,,,,,31 - 101,umol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,Glucose Fasting,,5.1,,,,,3.9 - 5.6,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,Serum Uric Acid,,221,,,,,149 - 446,umol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,Calcium (EDTA),,2.34,,,,,2.07 - 2.64,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,Phosphorus,,1.12,,,,,0.71 - 1.65,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,Total Protein,,64,,,,,61 - 84,g/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,Creatine Kinase,,96,,,,,26 - 192,U/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,Serum Sodium,,142,,,,,132 - 147,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,Serum Bicarbonate,,27.1,,,,,19.3 - 29.3,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,134,,,,,116 - 164,g/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.40,,,,,0.34 - 0.48, +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.3,,,,,4.1 - 5.6,TI/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,93,,,,,79 - 98,fL +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.16,,,,,3.8 - 10.7,GI/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.30,,,,,1.96 - 7.23,GI/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.50,,,,,0.91 - 4.28,GI/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.23,,,,,0.12 - 0.92,GI/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.13,,,,,0 - 0.57,GI/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.01,,,,,0 - 0.2,GI/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,55.2,,,,,40.5 - 75,% +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,36.0,,,,,15.4 - 48.5,% +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.5,,,,,2.6 - 10.1,% +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.0,,,,,0 - 6.8,% +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.3,,,,,0 - 2,% +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,272,,,,,140 - 400,GI/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.3,,,,,<6.5 %, +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,2.94,,,,,1.9 - 23,uIU/mL +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,LIPID PANEL,Direct HDL-C 4th Generation,,1.49,,,,,1.03 - 1.53,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,LIPID PANEL,Triglycerides (GPO),,0.80,,,,,0.59 - 2.96,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,LIPID PANEL,Cholesterol (High Performance),,4.76,,,,,4.42 - 7.53,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,LIPID PANEL,LDL Chol Friedewald 4th,,2.90,,,,,0 - 3.34,mmol/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,RETICULOCYTES,Reticulocyte Count %,,1.3,,,,,0.6 - 2.5,% +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,TSH,TSH 3rd IS-QT,,1.175,,,,,0.45 - 5.33,mIU/L +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,URINE MACRO PANEL,Ur Specific Gravity,,1.016,,,,,1 - 1.04, +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,URINE MACRO PANEL,Ur pH,,7.0,,,,,5 - 8, +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,URINE MACRO PANEL,Ur Leukocyte Esterase,,+1,,H,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 2 OL Induction Baseline,,"Jan 16, 2026 7:55 AM",6227541257,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,C-REACTIVE PROTEIN,C Reactive Protein HS,,2.8,,,,,0 - 5,mg/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,Total Bilirubin,,4,,,,Result verified by repeat analysis,3 - 21,umol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.5,,,,,0 - 6.2,umol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,Alkaline Phosphatase,,78,,,,,35 - 104,U/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,ALT (SGPT),,40,,,,,4 - 43,U/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,AST (SGOT),,33,,,,,8 - 40,U/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,GGT,,49,,,,,4 - 49,U/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,LDH,,151,,,,,53 - 234,U/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,Urea Nitrogen,,3.6,,,,,1.4 - 8.6,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,68,,,,,31 - 101,umol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,Glucose Fasting,,5.0,,,,,3.9 - 5.6,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,Serum Uric Acid,,300,,,,,125 - 428,umol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,Calcium (EDTA),,2.31,,,,,2.07 - 2.64,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,Phosphorus,,1.35,,,,,0.71 - 1.65,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,Total Protein,,67,,,,,61 - 84,g/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,Albumin-BCG,,43,,,,,33 - 49,g/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,Creatine Kinase,,102,,,,,26 - 192,U/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,Serum Potassium,,4.5,,,,,3.5 - 5.2,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,Serum Bicarbonate,,25.0,,,,,19.3 - 29.3,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,126,,,,,116 - 164,g/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.37,,,,,0.34 - 0.48, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,3.9,,L,,,4.1 - 5.6,TI/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,96,,,,,79 - 98,fL +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.94,,,,,3.8 - 10.7,GI/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.95,,,,,1.96 - 7.23,GI/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,3.05,,,,,0.91 - 4.28,GI/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.61,,,,,0.12 - 0.92,GI/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.29,,,,,0 - 0.57,GI/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,,0 - 0.2,GI/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,42.5,,,,,40.5 - 75,% +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,43.9,,,,,15.4 - 48.5,% +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,8.7,,,,,2.6 - 10.1,% +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,4.2,,,,,0 - 6.8,% +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.6,,,,,0 - 2,% +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,341,,,,,140 - 400,GI/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.3,,,,,<6.5 %, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,4.23,,,,,1.9 - 23,uIU/mL +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,LIPID PANEL,Direct HDL-C 4th Generation,,1.37,,,,,1.03 - 1.53,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,LIPID PANEL,Triglycerides (GPO),,1.49,,,,,0.51 - 2.42,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,LIPID PANEL,Cholesterol (High Performance),,4.70,,,,,4.01 - 6.85,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,LIPID PANEL,LDL Chol Friedewald 4th,,2.65,,,,,0 - 3.34,mmol/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,RETICULOCYTES,Reticulocyte Count %,,2.7,,H,,,0.6 - 2.5,% +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,TSH,TSH 3rd IS-QT,,3.282,,,,,0.45 - 5.33,mIU/L +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,URINE MACRO PANEL,Ur Specific Gravity,,1.009,,,,,1 - 1.04, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,End of Phase/Treatment,,"Jan 9, 2026 10:20 AM",6227178908,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.5,,,,,0 - 5,mg/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.2,,,,,0 - 6.2,umol/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,Alkaline Phosphatase,,99,,,,,35 - 104,U/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,ALT (SGPT),,30,,,,,4 - 43,U/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,AST (SGOT),,30,,,,,8 - 40,U/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,GGT,,18,,,,,4 - 49,U/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,LDH,,205,,,,,53 - 234,U/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,Urea Nitrogen,,4.2,,,,,1.4 - 8.6,mmol/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,76,,,,,31 - 101,umol/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,Glucose Fasting,,5.1,,,,,3.9 - 5.6,mmol/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,Serum Uric Acid,,323,,,,,149 - 446,umol/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,Calcium (EDTA),,2.27,,,,,2.07 - 2.64,mmol/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,Phosphorus,,1.05,,,,,0.71 - 1.65,mmol/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,Total Protein,,73,,,,,61 - 84,g/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,Albumin-BCG,,47,,,,,33 - 49,g/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,Creatine Kinase,,161,,,,,26 - 192,U/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,Serum Potassium,,3.7,,,,,3.5 - 5.2,mmol/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,Serum Bicarbonate,,24.3,,,,,19.3 - 29.3,mmol/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,CHEMISTRY PANEL,Serum Chloride,,100,,,,,94 - 112,mmol/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,144,,,,,116 - 164,g/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.41,,,,,0.34 - 0.48, +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.8,,,,,4.1 - 5.6,TI/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,Normocytic,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,86,,,,,79 - 98,fL +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.41,,,,,3.8 - 10.7,GI/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.46,,,,,1.96 - 7.23,GI/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.53,,,,,0.91 - 4.28,GI/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.25,,,,,0.12 - 0.92,GI/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.15,,,,,0 - 0.57,GI/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,55.7,,,,,40.5 - 75,% +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,34.8,,,,,15.4 - 48.5,% +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.6,,,,,2.6 - 10.1,% +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.3,,,,,0 - 6.8,% +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.6,,,,,0 - 2,% +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,,,,Test cancelled: Platelet clumps present,,, +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.7,,,,,<6.5 %, +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,8.57,,,,,1.9 - 23,uIU/mL +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,LIPID PANEL,Direct HDL-C 4th Generation,,1.14,,,,,1.03 - 1.53,mmol/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,LIPID PANEL,Triglycerides (GPO),,1.23,,,,,0.59 - 2.96,mmol/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,LIPID PANEL,Cholesterol (High Performance),,6.67,,,,,4.42 - 7.53,mmol/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,LIPID PANEL,LDL Chol Friedewald 4th,,4.97,,H,,,0 - 3.34,mmol/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,RETICULOCYTES,Reticulocyte Count %,,1.5,,,,,0.6 - 2.5,% +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,TSH,TSH 3rd IS-QT,,2.238,,,,,0.45 - 5.33,mIU/L +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,URINE MACRO PANEL,Ur Specific Gravity,,1.019,,,,,1 - 1.04, +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,URINE MACRO PANEL,Ur pH,,6.0,,,,,5 - 8, +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,End of Phase/Treatment,,"Jan 9, 2026 9:10 AM",6227178912,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,C-REACTIVE PROTEIN,C Reactive Protein HS,,3.3,,,,,0 - 5,mg/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CELLULAR ELEMENTS,Ur WBC/HPF,,9,,,,,0 - 12,/HPF +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,Total Bilirubin,,14,,,,,3 - 21,umol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,4.8,,,,,0 - 6.2,umol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,Alkaline Phosphatase,,94,,,,,35 - 104,U/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,ALT (SGPT),,50,,H,,,4 - 43,U/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,AST (SGOT),,27,,,,,8 - 40,U/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,GGT,,24,,,,,4 - 49,U/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,LDH,,167,,,,,53 - 234,U/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,Urea Nitrogen,,4.6,,,,,1.4 - 8.6,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,72,,,,,31 - 101,umol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,Glucose Fasting,,6.3,,H,,,3.9 - 5.6,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,Serum Uric Acid,,274,,,,,149 - 446,umol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,Calcium (EDTA),,2.43,,,,,2.07 - 2.64,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,Phosphorus,,1.21,,,,,0.71 - 1.65,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,Total Protein,,67,,,,,61 - 84,g/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,Creatine Kinase,,45,,,,,26 - 192,U/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,Serum Sodium,,141,,,,,132 - 147,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,Serum Potassium,,5.0,,,,,3.5 - 5.2,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,Serum Bicarbonate,,25.7,,,,,19.3 - 29.3,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,154,,,,,116 - 164,g/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.46,,,,,0.34 - 0.48, +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.1,,,,,4.1 - 5.6,TI/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,90,,,,,79 - 98,fL +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,8.24,,,,,3.8 - 10.7,GI/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,5.24,,,,,1.96 - 7.23,GI/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.33,,,,,0.91 - 4.28,GI/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.45,,,,,0.12 - 0.92,GI/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.15,,,,,0 - 0.57,GI/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.06,,,,,0 - 0.2,GI/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,63.6,,,,,40.5 - 75,% +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,28.3,,,,,15.4 - 48.5,% +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.4,,,,,2.6 - 10.1,% +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.9,,,,,0 - 6.8,% +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.8,,,,,0 - 2,% +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,330,,,,,140 - 400,GI/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,6.1,,,,,<6.5 %, +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,14.65,,,,,1.9 - 23,uIU/mL +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,LIPID PANEL,Direct HDL-C 4th Generation,,1.03,,,,,1.03 - 1.53,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,LIPID PANEL,Triglycerides (GPO),,1.18,,,,,0.59 - 2.96,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,LIPID PANEL,Cholesterol (High Performance),,2.69,,L,,,4.42 - 7.53,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,LIPID PANEL,LDL Chol Friedewald 4th,,1.12,,,,,0 - 3.34,mmol/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,RETICULOCYTES,Reticulocyte Count %,,2.1,,,,,0.6 - 2.5,% +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,TSH,TSH 3rd IS-QT,,1.264,,,,,0.45 - 5.33,mIU/L +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,URINE MACRO PANEL,Ur Specific Gravity,,1.021,,,,,1 - 1.04, +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,URINE MACRO PANEL,Ur pH,,6.0,,,,,5 - 8, +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,URINE MACRO PANEL,Ur Leukocyte Esterase,,+3,,H SF,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 2 OL Induction Baseline,,"Dec 19, 2025 9:25 AM",6227106906,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.8,,,,,0 - 5,mg/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CELLULAR ELEMENTS,Ur WBC/HPF,,2,,,,,0 - 12,/HPF +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,Total Bilirubin,,10,,,,,3 - 21,umol/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.0,,,,,0 - 6.2,umol/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,Alkaline Phosphatase,,85,,,,,35 - 104,U/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,ALT (SGPT),,20,,,,,4 - 43,U/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,AST (SGOT),,18,,,,,8 - 40,U/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,GGT,,22,,,,,4 - 49,U/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,LDH,,199,,,,,53 - 234,U/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,Urea Nitrogen,,3.6,,,,,1.4 - 8.6,mmol/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,69,,,,,31 - 101,umol/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,Glucose Fasting,,5.0,,,,,3.9 - 5.6,mmol/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,Serum Uric Acid,,242,,,,,149 - 446,umol/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,Calcium (EDTA),,2.44,,,,,2.07 - 2.64,mmol/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,Phosphorus,,1.18,,,,,0.71 - 1.65,mmol/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,Total Protein,,70,,,,,61 - 84,g/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,Creatine Kinase,,113,,,,,26 - 192,U/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,Serum Sodium,,141,,,,,132 - 147,mmol/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,Serum Potassium,,4.5,,,,,3.5 - 5.2,mmol/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,Serum Bicarbonate,,29.7,,H,,,19.3 - 29.3,mmol/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,136,,,,,116 - 164,g/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.41,,,,,0.34 - 0.48, +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.4,,,,,4.1 - 5.6,TI/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,93,,,,,79 - 98,fL +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.80,,,,,3.8 - 10.7,GI/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.73,,,,,1.96 - 7.23,GI/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.58,,,,,0.91 - 4.28,GI/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.36,,,,,0.12 - 0.92,GI/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.10,,,,,0 - 0.57,GI/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,56.9,,,,,40.5 - 75,% +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,32.9,,,,,15.4 - 48.5,% +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.6,,,,,2.6 - 10.1,% +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.2,,,,,0 - 6.8,% +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.4,,,,,0 - 2,% +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,308,,,,,140 - 400,GI/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,1.74,,L,,,1.9 - 23,uIU/mL +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,LIPID PANEL,Direct HDL-C 4th Generation,,1.50,,,,,1.03 - 1.53,mmol/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,LIPID PANEL,Triglycerides (GPO),,0.88,,,,,0.59 - 2.96,mmol/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,LIPID PANEL,Cholesterol (High Performance),,5.66,,,,,4.42 - 7.53,mmol/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,LIPID PANEL,LDL Chol Friedewald 4th,,3.76,,H,,,0 - 3.34,mmol/L +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,RETICULOCYTES,Reticulocyte Count %,,1.3,,,,,0.6 - 2.5,% +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,URINE MACRO PANEL,Ur Specific Gravity,,1.016,,,,,1 - 1.04, +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,URINE MACRO PANEL,Ur pH,,7.5,,,,,5 - 8, +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,URINE MACRO PANEL,Ur Leukocyte Esterase,,Trace,,H,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 1 DB Baseline,,"Dec 5, 2025 7:55 AM",6227261230,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,C-REACTIVE PROTEIN,C Reactive Protein HS,,3.0,,,,,0 - 5,mg/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.3,,,,,0 - 6.2,umol/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,Alkaline Phosphatase,,72,,,,,35 - 104,U/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,ALT (SGPT),,19,,,,,4 - 43,U/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,AST (SGOT),,18,,,,,8 - 40,U/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,GGT,,45,,,,,4 - 49,U/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,LDH,,135,,,,,53 - 234,U/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,Urea Nitrogen,,4.2,,,,,1.4 - 8.6,mmol/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,59,,,,,31 - 101,umol/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,Glucose Fasting,,5.1,,,,,3.9 - 5.6,mmol/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,Serum Uric Acid,,277,,,,,125 - 428,umol/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,Calcium (EDTA),,2.35,,,,,2.07 - 2.64,mmol/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,Phosphorus,,1.06,,,,,0.71 - 1.65,mmol/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,Total Protein,,73,,,,,61 - 84,g/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,Creatine Kinase,,94,,,,,26 - 192,U/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,Serum Potassium,,4.8,,,,,3.5 - 5.2,mmol/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,Serum Bicarbonate,,23.2,,,,,19.3 - 29.3,mmol/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,125,,,,,116 - 164,g/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.38,,,,,0.34 - 0.48, +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.0,R,L,,,4.1 - 5.6,TI/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,96,,,,,79 - 98,fL +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.92,,,,,3.8 - 10.7,GI/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.08,,,,,1.96 - 7.23,GI/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.93,,,,,0.91 - 4.28,GI/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.56,,,,,0.12 - 0.92,GI/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.31,,,,,0 - 0.57,GI/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,,0 - 0.2,GI/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,44.5,,,,,40.5 - 75,% +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,42.3,,,,,15.4 - 48.5,% +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,8.1,,,,,2.6 - 10.1,% +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,4.4,,,,,0 - 6.8,% +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.6,,,,,0 - 2,% +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,304,,,,,140 - 400,GI/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,7.03,,,,,1.9 - 23,uIU/mL +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,LIPID PANEL,Direct HDL-C 4th Generation,,1.36,,,,,1.03 - 1.53,mmol/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,LIPID PANEL,Triglycerides (GPO),,2.05,,,,,0.51 - 2.42,mmol/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,LIPID PANEL,Cholesterol (High Performance),,5.46,,,,,4.01 - 6.85,mmol/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,LIPID PANEL,LDL Chol Friedewald 4th,,3.16,,,,,0 - 3.34,mmol/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,RETICULOCYTES,Reticulocyte Count %,,1.8,,,,,0.6 - 2.5,% +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,TSH,TSH 3rd IS-QT,,1.135,,,,,0.45 - 5.33,mIU/L +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,URINE MACRO PANEL,Ur Specific Gravity,,1.023,,,,,1 - 1.04, +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,Part 2 OL Induction Baseline,,"Nov 28, 2025 9:00 AM",6227106905,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.7,,,,,0 - 5,mg/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,Total Bilirubin,,5,,,,,3 - 21,umol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.8,,,,,0 - 6.2,umol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,Alkaline Phosphatase,,100,,,,,35 - 104,U/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,ALT (SGPT),,29,,,,,4 - 43,U/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,AST (SGOT),,33,,,,,8 - 40,U/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,GGT,,17,,,,,4 - 49,U/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,LDH,,257,,H,,,53 - 234,U/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,Urea Nitrogen,,5.1,,,,,1.4 - 8.6,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,72,,,,,31 - 101,umol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,Glucose Fasting,,5.1,,,,,3.9 - 5.6,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,Serum Uric Acid,,318,,,,,149 - 446,umol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,Calcium (EDTA),,2.35,,,,,2.07 - 2.64,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,Phosphorus,,1.06,,,,,0.71 - 1.65,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,Total Protein,,72,,,,,61 - 84,g/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,Albumin-BCG,,47,,,,,33 - 49,g/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,Creatine Kinase,,276,,H,,,26 - 192,U/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,Serum Bicarbonate,,24.3,,,,,19.3 - 29.3,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,137,,,,,116 - 164,g/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.40,,,,,0.34 - 0.48, +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.6,,,,,4.1 - 5.6,TI/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,87,,,,,79 - 98,fL +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.48,,,,,3.8 - 10.7,GI/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.40,,,,,1.96 - 7.23,GI/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.48,,,,,0.91 - 4.28,GI/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.49,,,,,0.12 - 0.92,GI/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.10,,,,,0 - 0.57,GI/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.01,,,,,0 - 0.2,GI/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,53.5,,,,,40.5 - 75,% +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,33.1,,,,,15.4 - 48.5,% +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,10.9,R,H,,,2.6 - 10.1,% +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.3,,,,,0 - 6.8,% +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.2,,,,,0 - 2,% +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,143,,,,,140 - 400,GI/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,5.90,,,,,1.9 - 23,uIU/mL +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,LIPID PANEL,Direct HDL-C 4th Generation,,1.12,,,,,1.03 - 1.53,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,LIPID PANEL,Triglycerides (GPO),,1.26,,,,,0.59 - 2.96,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,LIPID PANEL,Cholesterol (High Performance),,5.71,,,,,4.42 - 7.53,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,LIPID PANEL,LDL Chol Friedewald 4th,,4.01,,H,,,0 - 3.34,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,RETICULOCYTES,Reticulocyte Count %,,1.8,,,,,0.6 - 2.5,% +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,URINE MACRO PANEL,Ur Specific Gravity,,1.020,,,,,1 - 1.04, +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,URINE MACRO PANEL,Ur pH,,6.0,,,,,5 - 8, +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 2 OL Induction Day 29,,"Nov 14, 2025 9:10 AM",6227043302,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.7,,,,,0 - 5,mg/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CELLULAR ELEMENTS,Ur WBC/HPF,,10,,,,,0 - 12,/HPF +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,Total Bilirubin,,14,,,,,3 - 21,umol/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,5.2,,,,,0 - 6.2,umol/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,Alkaline Phosphatase,,91,,,,,35 - 104,U/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,ALT (SGPT),,49,,H,,,4 - 43,U/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,AST (SGOT),,31,,,,,8 - 40,U/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,GGT,,22,,,,,4 - 49,U/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,LDH,,176,,,,,53 - 234,U/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,Urea Nitrogen,,5.0,,,,,1.4 - 8.6,mmol/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,75,,,,,31 - 101,umol/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,Glucose Fasting,,6.8,,H,,,3.9 - 5.6,mmol/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,Serum Uric Acid,,282,,,,,149 - 446,umol/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,Calcium (EDTA),,2.46,,,,,2.07 - 2.64,mmol/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,Phosphorus,,1.34,,,,,0.71 - 1.65,mmol/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,Total Protein,,67,,,,,61 - 84,g/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,Creatine Kinase,,51,,,,,26 - 192,U/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,Serum Potassium,,5.1,,,,,3.5 - 5.2,mmol/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,Serum Bicarbonate,,22.7,,,,,19.3 - 29.3,mmol/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,147,,,,,116 - 164,g/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.44,,,,,0.34 - 0.48, +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.9,,,,,4.1 - 5.6,TI/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,89,,,,,79 - 98,fL +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,7.87,,,,,3.8 - 10.7,GI/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.64,,,,,1.96 - 7.23,GI/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.53,,,,,0.91 - 4.28,GI/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.42,,,,,0.12 - 0.92,GI/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.20,,,,,0 - 0.57,GI/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.07,,,,,0 - 0.2,GI/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,58.9,,,,,40.5 - 75,% +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,32.3,,,,,15.4 - 48.5,% +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.4,,,,,2.6 - 10.1,% +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.5,,,,,0 - 6.8,% +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.9,,,,,0 - 2,% +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,294,,,,,140 - 400,GI/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,12.54,,,,,1.9 - 23,uIU/mL +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,LIPID PANEL,Direct HDL-C 4th Generation,,0.96,,L,,,1.03 - 1.53,mmol/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,LIPID PANEL,Triglycerides (GPO),,0.90,,,,,0.59 - 2.96,mmol/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,LIPID PANEL,Cholesterol (High Performance),,2.39,,L,,Result verified by repeat analysis,4.42 - 7.53,mmol/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,LIPID PANEL,LDL Chol Friedewald 4th,,1.02,,,,,0 - 3.34,mmol/L +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,MICROORGANISMS,Ur Bacteria,,Present,,,,,Ref Rng:Not present, +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,RETICULOCYTES,Reticulocyte Count %,,1.6,,,,,0.6 - 2.5,% +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,URINE MACRO PANEL,Ur Specific Gravity,,1.017,,,,,1 - 1.04, +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,URINE MACRO PANEL,Ur Leukocyte Esterase,,+2,,H SF,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 1 DB Baseline,,"Nov 7, 2025 9:30 AM",6225350982,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.3,,,,,0 - 5,mg/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CELLULAR ELEMENTS,Ur RBC/HPF,,1,,,,,0 - 8,/HPF +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CELLULAR ELEMENTS,Ur WBC/HPF,,7,,,,,0 - 12,/HPF +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,Total Bilirubin,,11,,,,,3 - 21,umol/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.5,,,,,0 - 6.2,umol/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,Alkaline Phosphatase,,84,,,,,35 - 104,U/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,ALT (SGPT),,18,,,,,4 - 43,U/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,AST (SGOT),,19,,,,,8 - 40,U/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,GGT,,21,,,,,4 - 49,U/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,LDH,,206,,,,,53 - 234,U/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,Urea Nitrogen,,4.0,,,,,1.4 - 8.6,mmol/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,78,,,,,31 - 101,umol/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,Glucose Fasting,,5.5,,,,,3.9 - 5.6,mmol/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,Serum Uric Acid,,260,,,,,149 - 446,umol/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,Calcium (EDTA),,2.42,,,,,2.07 - 2.64,mmol/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,Phosphorus,,1.17,,,,,0.71 - 1.65,mmol/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,Total Protein,,68,,,,,61 - 84,g/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,Creatine Kinase,,107,,,,,26 - 192,U/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,Serum Bicarbonate,,22.4,,,,,19.3 - 29.3,mmol/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.58,,,,,1.25 - 1.92,mL/sec +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,78,,,,,31 - 101,umol/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,81.6,,,,,kg, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,No,,,,,, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,GFR,EGFR by MDRD,,67,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,136,,,,,116 - 164,g/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.41,,,,,0.34 - 0.48, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.4,,,,,4.1 - 5.6,TI/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,93,,,,,79 - 98,fL +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.09,,,,,3.8 - 10.7,GI/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.99,,,,,1.96 - 7.23,GI/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.48,,,,,0.91 - 4.28,GI/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.34,,,,,0.12 - 0.92,GI/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.15,,,,,0 - 0.57,GI/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.12,,,,,0 - 0.2,GI/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,58.8,,,,,40.5 - 75,% +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,29.2,,,,,15.4 - 48.5,% +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.7,,,,,2.6 - 10.1,% +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.0,,,,,0 - 6.8,% +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,2.3,,H,,,0 - 2,% +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,313,,,,,140 - 400,GI/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,5.1,,,,,<6.5%, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,4.19,,,,,1.9 - 23,uIU/mL +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,LIPID PANEL,Direct HDL-C 4th Generation,,1.52,,,,,1.03 - 1.53,mmol/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,LIPID PANEL,Triglycerides (GPO),,1.01,,,,,0.59 - 2.96,mmol/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,LIPID PANEL,Cholesterol (High Performance),,5.29,,,,,4.42 - 7.53,mmol/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,LIPID PANEL,LDL Chol Friedewald 4th,,3.31,,,,,0 - 3.34,mmol/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,No,,,,,, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,RETICULOCYTES,Reticulocyte Count %,,1.4,,,,,0.6 - 2.5,% +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,TSH,TSH 3rd IS-QT,,1.461,,,,,0.45 - 5.33,mIU/L +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,URINE MACRO PANEL,Ur Specific Gravity,,1.024,,,,,1 - 1.04, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,URINE MACRO PANEL,Ur pH,,6.5,,,,,5 - 8, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,URINE MACRO PANEL,Ur Protein,,Trace,R,H,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040004,,,54,years,Female,Part 1 Screening,,"Nov 7, 2025 8:10 AM",6225350975,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,C-REACTIVE PROTEIN,C Reactive Protein HS,,3.5,,,,,0 - 5,mg/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,Total Bilirubin,,9,,,,,3 - 21,umol/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.7,,,,,0 - 6.2,umol/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,Alkaline Phosphatase,,77,,,,,35 - 104,U/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,ALT (SGPT),,27,,,,,4 - 43,U/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,AST (SGOT),,25,,,,,8 - 40,U/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,GGT,,45,,,,,4 - 49,U/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,LDH,,161,,,,,53 - 234,U/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,Urea Nitrogen,,3.5,,,,,1.4 - 8.6,mmol/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,63,,,,,31 - 101,umol/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,Glucose Fasting,,5.2,,,,,3.9 - 5.6,mmol/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,Serum Uric Acid,,261,,,,,125 - 428,umol/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,Calcium (EDTA),,2.38,,,,,2.07 - 2.64,mmol/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,Phosphorus,,1.12,,,,,0.71 - 1.65,mmol/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,Total Protein,,71,,,,,61 - 84,g/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,Creatine Kinase,,99,,,,,26 - 192,U/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,Serum Sodium,,141,,,,,132 - 147,mmol/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,Serum Potassium,,4.7,,,,,3.5 - 5.2,mmol/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,Serum Bicarbonate,,21.9,,,,,19.3 - 29.3,mmol/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,CHEMISTRY PANEL,Serum Chloride,,105,,,,,94 - 112,mmol/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,126,,,,,116 - 164,g/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.39,,,,,0.34 - 0.48, +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.1,,,,,4.1 - 5.6,TI/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,96,,,,,79 - 98,fL +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,7.55,,,,,3.8 - 10.7,GI/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.59,,,,,1.96 - 7.23,GI/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.09,,,,,0.91 - 4.28,GI/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.63,,,,,0.12 - 0.92,GI/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.20,,,,,0 - 0.57,GI/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,60.9,,,,,40.5 - 75,% +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,27.7,,,,,15.4 - 48.5,% +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,8.3,,,,,2.6 - 10.1,% +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.6,,,,,0 - 6.8,% +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,% +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,324,,,,,140 - 400,GI/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,5.08,,,,,1.9 - 23,uIU/mL +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,LIPID PANEL,Direct HDL-C 4th Generation,,1.54,,H,,Result verified by repeat analysis,1.03 - 1.53,mmol/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,LIPID PANEL,Triglycerides (GPO),,2.08,,,,,0.51 - 2.42,mmol/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,LIPID PANEL,Cholesterol (High Performance),,5.37,,,,,4.01 - 6.85,mmol/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,LIPID PANEL,LDL Chol Friedewald 4th,,2.88,,,,,0 - 3.34,mmol/L +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,RETICULOCYTES,Reticulocyte Count %,,2.1,,,,,0.6 - 2.5,% +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,URINE MACRO PANEL,Ur Specific Gravity,,1.017,,,,,1 - 1.04, +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,Part 1 DB Baseline,,"Oct 17, 2025 10:45 AM",6225350984,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.5,,,,,0 - 5,mg/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CELLULAR ELEMENTS,Ur WBC/HPF,,5,,,,,0 - 12,/HPF +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.0,,,,,0 - 6.2,umol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,Alkaline Phosphatase,,99,,,,,35 - 104,U/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,ALT (SGPT),,32,,,,,4 - 43,U/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,AST (SGOT),,32,,,,,8 - 40,U/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,GGT,,18,,,,,4 - 49,U/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,LDH,,232,,,,,53 - 234,U/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,Urea Nitrogen,,4.7,,,,,1.4 - 8.6,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,77,,,,,31 - 101,umol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,Glucose Fasting,,5.3,,,,,3.9 - 5.6,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,Serum Uric Acid,,392,,,,,149 - 446,umol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,Calcium (EDTA),,2.37,,,,,2.07 - 2.64,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,Phosphorus,,1.06,,,,,0.71 - 1.65,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,Total Protein,,73,,,,,61 - 84,g/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,Creatine Kinase,,160,,,,,26 - 192,U/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,Serum Bicarbonate,,23.1,,,,,19.3 - 29.3,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,143,,,,,116 - 164,g/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.41,,,,,0.34 - 0.48, +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.7,,,,,4.1 - 5.6,TI/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,Normocytic,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,88,,,,,79 - 98,fL +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.39,,,,,3.8 - 10.7,GI/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.58,,,,,1.96 - 7.23,GI/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.36,,,,,0.91 - 4.28,GI/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.31,,,,,0.12 - 0.92,GI/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.13,,,,,0 - 0.57,GI/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,58.8,,,,,40.5 - 75,% +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,30.9,,,,,15.4 - 48.5,% +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.1,,,,,2.6 - 10.1,% +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.9,,,,,0 - 6.8,% +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.4,,,,,0 - 2,% +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,,,,Test cancelled: Platelet clumps present,,, +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,5.8,,,,,<6.5%, +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,LIPID PANEL,Direct HDL-C 4th Generation,,1.11,,,,,1.03 - 1.53,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,LIPID PANEL,Triglycerides (GPO),,1.60,,,,,0.59 - 2.96,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,LIPID PANEL,Cholesterol (High Performance),,6.83,,,,,4.42 - 7.53,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,LIPID PANEL,LDL Chol Friedewald 4th,,4.99,,H,,,0 - 3.34,mmol/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,MICROORGANISMS,Ur Bacteria,,Present,,,,,Ref Rng:Not present, +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,RETICULOCYTES,Reticulocyte Count %,,1.7,,,,,0.6 - 2.5,% +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,TSH,TSH 3rd IS-QT,,2.025,,,,,0.45 - 5.33,mIU/L +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,URINE MACRO PANEL,Ur Specific Gravity,,1.018,,,,,1 - 1.04, +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,URINE MACRO PANEL,Ur pH,,7.0,,,,,5 - 8, +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,URINE MACRO PANEL,Ur Leukocyte Esterase,,Trace,R,H,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 2 OL Induction Baseline,,"Oct 17, 2025 9:00 AM",6225350988,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,C-REACTIVE PROTEIN,C Reactive Protein HS,,3.9,,,,,0 - 5,mg/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CELLULAR ELEMENTS,Ur WBC/HPF,,42,,H,,,0 - 12,/HPF +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,Total Bilirubin,,13,,,,,3 - 21,umol/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,4.7,,,,,0 - 6.2,umol/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,Alkaline Phosphatase,,83,,,,,35 - 104,U/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,ALT (SGPT),,69,,H RX,,,4 - 43,U/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,AST (SGOT),,40,,,,,8 - 40,U/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,GGT,,27,,,,,4 - 49,U/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,LDH,,190,,,,,53 - 234,U/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,Urea Nitrogen,,3.8,,,,,1.4 - 8.6,mmol/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,72,,,,,31 - 101,umol/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,Glucose Fasting,,7.5,,H,,,3.9 - 5.6,mmol/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,Serum Uric Acid,,309,,,,,149 - 446,umol/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,Calcium (EDTA),,2.40,,,,,2.07 - 2.64,mmol/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,Phosphorus,,1.28,,,,,0.71 - 1.65,mmol/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,Total Protein,,66,,,,,61 - 84,g/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,Creatine Kinase,,48,,,,,26 - 192,U/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,Serum Sodium,,141,,,,,132 - 147,mmol/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,Serum Bicarbonate,,24.7,,,,,19.3 - 29.3,mmol/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.65,,,,,1.25 - 1.92,mL/sec +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,72,,,,,31 - 101,umol/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,79.2,,,,,kg, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,No,,,,,, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,GFR,EGFR by MDRD,,74,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,151,,,,,116 - 164,g/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.45,,,,,0.34 - 0.48, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.0,,,,,4.1 - 5.6,TI/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,91,,,,,79 - 98,fL +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,9.69,,,,,3.8 - 10.7,GI/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,6.48,,,,,1.96 - 7.23,GI/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.44,,,,,0.91 - 4.28,GI/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.48,,,,,0.12 - 0.92,GI/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.23,,,,,0 - 0.57,GI/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.07,,,,,0 - 0.2,GI/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,66.8,,,,,40.5 - 75,% +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,25.1,,,,,15.4 - 48.5,% +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.9,,,,,2.6 - 10.1,% +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.3,,,,,0 - 6.8,% +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.8,,,,,0 - 2,% +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,324,,,,,140 - 400,GI/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,6.6,,H,,,<6.5%, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,13.86,,,,,1.9 - 23,uIU/mL +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,LIPID PANEL,Direct HDL-C 4th Generation,,0.89,,L,,,1.03 - 1.53,mmol/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,LIPID PANEL,Triglycerides (GPO),,1.13,,,,,0.59 - 2.96,mmol/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,LIPID PANEL,Cholesterol (High Performance),,2.44,,L,,Result verified by repeat analysis,4.42 - 7.53,mmol/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,LIPID PANEL,LDL Chol Friedewald 4th,,1.03,,,,,0 - 3.34,mmol/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,MICROORGANISMS,Ur Bacteria,,Present,,,,,Ref Rng:Not present, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,MISCELLANEOUS ELEMENTS,Ur Mucous,,Present,,,,,Ref Rng:Not present, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,No,,,,,, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,RETICULOCYTES,Reticulocyte Count %,,2.0,,,,,0.6 - 2.5,% +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,TSH,TSH 3rd IS-QT,,1.524,,,,,0.45 - 5.33,mIU/L +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,URINE MACRO PANEL,Ur Specific Gravity,,1.024,,,,,1 - 1.04, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,URINE MACRO PANEL,Ur Protein,,Trace,,H,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,URINE MACRO PANEL,Ur Leukocyte Esterase,,+3,,H SF,,,Ref Rng:Negative, +CZ100040003,,,55,years,Female,Part 1 Screening,,"Oct 10, 2025 9:20 AM",6225350977,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,C-REACTIVE PROTEIN,C Reactive Protein HS,,2.1,,,,,0 - 5,mg/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,Total Bilirubin,,10,,,,,3 - 21,umol/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.9,,,,,0 - 6.2,umol/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,Alkaline Phosphatase,,82,,,,,35 - 104,U/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,ALT (SGPT),,23,,,,,4 - 43,U/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,AST (SGOT),,23,,,,,8 - 40,U/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,GGT,,47,,,,,4 - 49,U/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,LDH,,153,,,,,53 - 234,U/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,Urea Nitrogen,,4.3,,,,,1.4 - 8.6,mmol/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,69,,,,,31 - 101,umol/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,Glucose Fasting,,5.2,,,,,3.9 - 5.6,mmol/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,Serum Uric Acid,,322,,,,,125 - 428,umol/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,Calcium (EDTA),,2.47,,,,,2.07 - 2.64,mmol/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,Phosphorus,,1.05,,,,,0.71 - 1.65,mmol/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,Total Protein,,79,,,,,61 - 84,g/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,Albumin-BCG,,48,,,,,33 - 49,g/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,Creatine Kinase,,104,,,,,26 - 192,U/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,Serum Potassium,,4.8,,,,,3.5 - 5.2,mmol/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,Serum Bicarbonate,,22.9,,,,,19.3 - 29.3,mmol/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.88,,,,,1.25 - 1.92,mL/sec +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,69,,,,,31 - 101,umol/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,78.6,,,,,kg, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,Result verified by repeat analysis,Neg;$Cutoff = 50 ng/mL, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,Yes,,,,,, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,GFR,EGFR by MDRD,,80,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,137,,,,,116 - 164,g/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.46,,,,,0.34 - 0.48, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.3,,,,,4.1 - 5.6,TI/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,106,,H,,,79 - 98,fL +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.54,,,,,3.8 - 10.7,GI/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.33,,,,,1.96 - 7.23,GI/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.64,,,,,0.91 - 4.28,GI/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.36,,,,,0.12 - 0.92,GI/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.15,,,,,0 - 0.57,GI/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.07,,,,,0 - 0.2,GI/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,42.0,,,,,40.5 - 75,% +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,47.6,,,,,15.4 - 48.5,% +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.5,,,,,2.6 - 10.1,% +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.7,,,,,0 - 6.8,% +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.2,,,,,0 - 2,% +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,301,,,,,140 - 400,GI/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,5.3,,,,,<6.5%, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,4.36,,,,,1.9 - 23,uIU/mL +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,LIPID PANEL,Direct HDL-C 4th Generation,,1.94,,H,,,1.03 - 1.53,mmol/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,LIPID PANEL,Triglycerides (GPO),,1.55,,,,,0.51 - 2.42,mmol/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,LIPID PANEL,Cholesterol (High Performance),,6.28,,,,,4.01 - 6.85,mmol/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,LIPID PANEL,LDL Chol Friedewald 4th,,3.63,,H,,,0 - 3.34,mmol/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,No,,,,,, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,RETICULOCYTES,Reticulocyte Count %,,1.2,,,,,0.6 - 2.5,% +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,SERUM BETA HCG,"B-hCG, Qualitative",,Negative,,,,,Ref Rng: Negative, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,SERUM BETA HCG,"B-hCG, Quantitative",,<0.6,,,,,Units: mIU/mL$Pre-menopausal$<5.0: Negative$5.0-24.9:Borderline$>/= 25.0: Positive, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,TSH,TSH 3rd IS-QT,,1.391,,,,,0.45 - 5.33,mIU/L +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,URINE MACRO PANEL,Ur Specific Gravity,,1.018,,,,,1 - 1.04, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,URINE MACRO PANEL,Ur pH,,6.0,,,,,5 - 8, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040002,,,46,years,Female,Part 1 Screening,,"Sep 19, 2025 9:20 AM",6225350972,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,C-REACTIVE PROTEIN,C Reactive Protein HS,,2.1,,,,,0 - 5,mg/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,Total Bilirubin,,5,,,,,3 - 21,umol/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.6,,,,,0 - 6.2,umol/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,Alkaline Phosphatase,,104,,,,,35 - 104,U/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,ALT (SGPT),,30,,,,,4 - 43,U/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,AST (SGOT),,27,,,,,8 - 40,U/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,GGT,,20,,,,,4 - 49,U/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,LDH,,224,,,,,53 - 234,U/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,Urea Nitrogen,,4.6,,,,,1.4 - 8.6,mmol/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,75,,,,,31 - 101,umol/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,Glucose Fasting,,5.2,,,,,3.9 - 5.6,mmol/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,Serum Uric Acid,,358,,,,,149 - 446,umol/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,Calcium (EDTA),,2.38,,,,,2.07 - 2.64,mmol/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,Phosphorus,,1.33,,,,,0.71 - 1.65,mmol/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,Total Protein,,72,,,,,61 - 84,g/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,Creatine Kinase,,159,,,,,26 - 192,U/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,Serum Sodium,,142,,,,,132 - 147,mmol/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,Serum Bicarbonate,,23.6,,,,,19.3 - 29.3,mmol/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,135,,,,,116 - 164,g/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.40,,,,,0.34 - 0.48, +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.5,,,,,4.1 - 5.6,TI/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,89,,,,,79 - 98,fL +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.75,,,,,3.8 - 10.7,GI/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.17,,,,,1.96 - 7.23,GI/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.12,,,,,0.91 - 4.28,GI/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.29,,,,,0.12 - 0.92,GI/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.10,,,,,0 - 0.57,GI/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.07,,,,,0 - 0.2,GI/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,45.7,,,,,40.5 - 75,% +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,44.7,,,,,15.4 - 48.5,% +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.1,,,,,2.6 - 10.1,% +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.1,,,,,0 - 6.8,% +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.4,,,,,0 - 2,% +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,157,,,,,140 - 400,GI/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,11.38,,,,,1.9 - 23,uIU/mL +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,LIPID PANEL,Direct HDL-C 4th Generation,,1.10,,,,,1.03 - 1.53,mmol/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,LIPID PANEL,Triglycerides (GPO),,1.77,,,,,0.59 - 2.96,mmol/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,LIPID PANEL,Cholesterol (High Performance),,6.54,,,,,4.42 - 7.53,mmol/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,LIPID PANEL,LDL Chol Friedewald 4th,,4.63,,H,,,0 - 3.34,mmol/L +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,RETICULOCYTES,Reticulocyte Count %,,3.5,,H,,,0.6 - 2.5,% +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,URINE MACRO PANEL,Ur Specific Gravity,,1.015,,,,,1 - 1.04, +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,URINE MACRO PANEL,Ur pH,,6.5,,,,,5 - 8, +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 1 DB Baseline,,"Sep 5, 2025 7:55 AM",6225350981,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Retest,,"Aug 19, 2025 10:00 AM",6225351002,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100040001,,,56,years,Female,Retest,,"Aug 19, 2025 10:00 AM",6225351002,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.7,,,,,0 - 5,mg/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CELLULAR ELEMENTS,Ur WBC/HPF,,10,,,,,0 - 12,/HPF +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,Total Bilirubin,,5,,,,,3 - 21,umol/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.7,,,,,0 - 6.2,umol/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,Alkaline Phosphatase,,106,,H,,,35 - 104,U/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,ALT (SGPT),,28,,,,,4 - 43,U/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,AST (SGOT),,26,,,,,8 - 40,U/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,GGT,,19,,,,,4 - 49,U/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,LDH,,241,,H,,,53 - 234,U/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,Urea Nitrogen,,4.6,,,,,1.4 - 8.6,mmol/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,87,,,,,31 - 101,umol/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,Glucose Fasting,,6.5,,H,,,3.9 - 5.6,mmol/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,Serum Uric Acid,,349,,,,,149 - 446,umol/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,Calcium (EDTA),,2.40,,,,,2.07 - 2.64,mmol/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,Phosphorus,,0.95,,,,,0.71 - 1.65,mmol/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,Total Protein,,74,,,,,61 - 84,g/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,Creatine Kinase,,140,,,,,26 - 192,U/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,Serum Bicarbonate,,23.9,,,,,19.3 - 29.3,mmol/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.23,,L,,,1.25 - 1.92,mL/sec +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,87,,,,,31 - 101,umol/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,72.5,,,,,kg, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,No,,,,,, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,FSH,Follicle Stimulating Hormone,,50.25,,,,,Follicular:$3.90-8.80 IU/L$Midcycle:$4.50-22.50 IU/L$Luteal:$1.80-5.10 IU/L$Postmenopausal:$16.70-113.60 IU/L, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,GFR,EGFR by MDRD,,59,,,,,mL/min/1.73m^2$No Ref Rng, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,139,,,,,116 - 164,g/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.42,,,,,0.34 - 0.48, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.7,,,,,4.1 - 5.6,TI/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,90,,,,,79 - 98,fL +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.75,,,,,3.8 - 10.7,GI/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.40,,,,,1.96 - 7.23,GI/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.88,,,,,0.91 - 4.28,GI/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.34,,,,,0.12 - 0.92,GI/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.08,,,,,0 - 0.57,GI/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.06,,,,,0 - 0.2,GI/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,50.5,,,,,40.5 - 75,% +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,39.4,,,,,15.4 - 48.5,% +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.2,,,,,2.6 - 10.1,% +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.6,,,,,0 - 6.8,% +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.3,,,,,0 - 2,% +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,163,,,,,140 - 400,GI/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,4.7,,,,,<6.5%, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,,,,Test cancelled: Hemolysis-test not performed,,, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,LIPID PANEL,Direct HDL-C 4th Generation,,0.97,,L,,,1.03 - 1.53,mmol/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,LIPID PANEL,Triglycerides (GPO),,3.99,,H,,,0.59 - 2.96,mmol/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,LIPID PANEL,Cholesterol (High Performance),,6.69,,,,,4.42 - 7.53,mmol/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,LIPID PANEL,LDL Chol Friedewald 4th,,3.89,,H,,,0 - 3.34,mmol/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,Yes,,,,,, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,RETICULOCYTES,Reticulocyte Count %,,2.9,,H,,,0.6 - 2.5,% +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,TSH,TSH 3rd IS-QT,,2.272,,,,,0.45 - 5.33,mIU/L +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,URINE MACRO PANEL,Ur Specific Gravity,,1.024,,,,,1 - 1.04, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,URINE MACRO PANEL,Ur Protein,,Trace,R,H,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,URINE MACRO PANEL,Ur Leukocyte Esterase,,+1,R,H,,,Ref Rng:Negative, +CZ100040001,,,56,years,Female,Part 1 Screening,,"Aug 8, 2025 10:30 AM",6225350971,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE diff --git a/Covance_UCO3001/Trash/download_test_results_v1.0.md b/Covance_UCO3001/Trash/download_test_results_v1.0.md new file mode 100644 index 0000000..c6fc9c4 --- /dev/null +++ b/Covance_UCO3001/Trash/download_test_results_v1.0.md @@ -0,0 +1,238 @@ +# download_test_results_v1.0.py — dokumentace + +**Verze:** 1.0 · **Datum:** 2026-05-29 +**Umístění:** `U:\PythonProject\Janssen\Covance_UCO3001\download_test_results_v1.0.py` + +--- + +## 1. Účel + +Automatické stažení reportu **Standard Test Results** z portálu Labcorp Sponsor +Portal (`xsp.labcorp.com`) pro studii **77242113UCO3001** (interní study ID +**36940**). Skript projde **všech 12 center** studie, u každého vyexportuje grid +do CSV a uloží ho timestampovaný do adresáře `Source/`. + +> Pozn.: Stahuje se záložka **Standard** (ne Microbiology). URL končí +> `/standard-test-results`. + +--- + +## 2. Spuštění + +```bat +U:\PythonProject\Janssen\.venv\Scripts\python.exe ^ + U:\PythonProject\Janssen\Covance_UCO3001\download_test_results_v1.0.py +``` + +- Prohlížeč běží **viditelně** (`headless=False`), maximalizovaný. +- Používá **persistent profile** (`browser_profile/` vedle skriptu) — session + (přihlášení) přežívá mezi spuštěními. + +--- + +## 3. Konfigurace (konstanty v hlavičce skriptu) + +| Konstanta | Hodnota / význam | +|---|---| +| `EMAIL` | `vbuzalka@its.jnj.com` (login přes iMedidata/OKTA na xsp.covance.com) | +| `PASSWORD` | heslo k účtu (uložené přímo v kódu) | +| `LOGIN_URL` | `https://xsp.covance.com/` — po přihlášení redirect na xsp.labcorp.com | +| `OUT_DIR` | `U:\PythonProject\Janssen\Covance_UCO3001\Source` | +| `PROFILE_DIR` | `browser_profile/` vedle skriptu (persistent Chromium profil) | +| `STUDY` | `36940` (interní study ID pro 77242113UCO3001) | +| `SITE_IDS` | seznam 12 interních čísel center — viz níže | + +### Interní čísla center (SITE_IDS) + +``` +930551, 930556, 930525, 930549, 930543, 930547, +930555, 930557, 930539, 930536, 930553, 930531 +``` + +> **Zdroj:** převzato z `download_equeries_report_v1.1.py` (proměnná `SITES`). +> Jsou to **interní ID** Labcorpu, **nikoli** čísla center typu CZ10001. +> V URL test-results se používá právě toto interní ID: +> `…/test-results/{SITE_ID}/standard-test-results`. + +### Generování REPORTS (DRY) + +`REPORTS` se sestaví automaticky z `SITE_IDS` — URL i název souboru mají vzor +napsaný jen jednou. **Přidání/odebrání centra = úprava seznamu `SITE_IDS`.** + +--- + +## 4. Výstupní soubory + +Formát názvu (timestamp + popisný název): + +``` +{YYYY-MM-DD_HHMMSS} sponsor-study-36940-test-results-{SITE_ID}-standard.csv +``` + +Příklad: +``` +2026-05-29_125710 sponsor-study-36940-test-results-930557-standard.csv +``` + +- Timestamp se generuje pro **každý** report zvlášť (v okamžiku exportu). +- Staré soubory se **nikdy nemažou** (verzování přes timestamp). +- Browser dočasný název se na disk neukládá — `expect_download` zachytí download + event a `save_as()` ho uloží pod naším názvem. + +--- + +## 5. Průběh skriptu (kroky + logging) + +Každý krok se loguje s časem (`[HH:MM:SS]`, `flush=True` → vypisuje průběžně). + +| Fáze | Co dělá | +|---|---| +| START | spustí prohlížeč | +| LOGIN | otevře login; **pokud je session aktivní, přihlášení přeskočí** | +| Pro každé centrum: | | +| KROK 1/5 | navigace na report URL | +| KROK 2/5 | čeká na řádky gridu `.ag-row` **nebo** prázdný grid; pak stabilizace počtu | +| KROK 3/5 | klik na viditelné tři tečky (`more_horiz`) → otevře menu | +| KROK 4/5 | klik na viditelné „Export to CSV" → zachytí download | +| KROK 5/5 | uloží soubor do `OUT_DIR` | +| KONEC | souhrn `hotovo X/12` + seznam selhaných center | + +### Příklad výstupu + +``` +[12:56:35] START: prohlizec spusten. +[12:56:35] LOGIN: otviram login stranku... +[12:56:49] LOGIN: prihlaseni OK (...) +[12:56:49] === Centrum 930557 (studie 36940) === +[12:56:59] KROK 1/5: stranka nactena (...) +[12:57:05] KROK 2/5: radky se objevily, cekam na stabilizaci poctu... +[12:57:06] ...kontrola #1: 153 radku +[12:57:08] ...kontrola #2: 153 radku +[12:57:10] KROK 2/5: data stabilni (153 radku v gridu). +[12:57:10] KROK 3/5: menu otevreno. +[12:57:11] KROK 4/5: stahovani zachyceno, ukladam soubor... +[12:57:11] KROK 5/5: HOTOVO -> ...\2026-05-29_125710 sponsor-study-36940-test-results-930557-standard.csv +``` + +--- + +## 6. Klíčové technické poznatky (PROČ to tak je) — ověřeno přes Chrome DevTools + +Stránka test-results je **Angular SPA** s knihovnou **MDL** a tabulkou **AG Grid**. +Tyto detaily byly zjištěny živou inspekcí DOM (Claude in Chrome MCP), ne hádáním: + +### 6.1 Čekání na data = řádky AG Gridu +- Grid je `` → `` (AG Grid). +- Data jsou načtena, jakmile se objeví řádky **`div.ag-row`** (count jde z 0 → N; + pro 930557 to bylo 153 řádků). +- **Řádky jsou `position-absolute`** (virtuální render AG Gridu) → Playwright je + **nepovažuje za „visible"**. Proto: + - ❌ `wait_for_selector("div.ag-row")` (default `state="visible"`) **timeoutuje** + i když řádky existují. + - ✅ čekat na **přítomnost v DOM**: + `wait_for_function("() => document.querySelectorAll('div.ag-row').length > 0")`. +- Stabilizace: počet řádků se čte opakovaně co 2 s, dokud se 2× po sobě neshodne. + +### 6.2 „Fetching Data" / spinner — POZOR, NEPLATÍ pro tuto stránku +- Na test-results stránce **NENÍ** text „Fetching Data" (ten je na *samples* + reportu, jiná stránka!). +- Je tu element ``, ale ten jen krátce problikne `` + při route-loadingu, **ne** během načítání dat gridu → nelze na něj spoléhat. +- Spolehlivý signál je výhradně **objevení `.ag-row`**. + +### 6.3 Tři tečky (export) — na stránce jsou DVA `` +- Na stránce existují **2× ``**: jeden **skrytý**, jeden viditelný. +- Existují **3× ikona `more_horiz`**: 1 mimo export (toolbar), 1 ve skrytém + ag-export, 1 ve viditelném. +- Proto je nutný filtr na viditelnost: + ✅ `page.locator("ag-export button:visible", has_text="more_horiz").first.click()` + +### 6.4 „Export to CSV" — v DOM jsou DVĚ položky +- Po otevření menu existují **2× `mdl-menu-item` „Export to CSV"** (jedna skrytá + z neviditelného ag-export, jedna viditelná). Stejně tak 2× „Export to Excel". +- Proto: + ✅ `page.locator("mdl-menu-item:visible", has_text="Export to CSV").first.click()` + - ❌ `get_by_text("Export to CSV")` → **strict mode violation** (2 elementy). + +### 6.5 Prázdné centrum (ověřeno přes Chrome MCP na centru 930551) +- AG Grid při 0 záznamech zobrazí no-rows overlay s textem **„No Data"**. +- Struktura: `.ag-overlay` → `.ag-overlay-panel` → + **`.ag-overlay-no-rows-wrapper`** → `No Data`. +- ⚠️ Třída **NENÍ** `.ag-overlay-no-rows-center` (to byl chybný předpoklad, + na který detekce nikdy nezabrala) — správně je **`.ag-overlay-no-rows-wrapper`**. +- ⚠️ Text „No Data" **NENÍ** v `.ag-body-viewport` (ten je prázdný, + `height: 1px`) — je v samostatném overlay sourozenci. +- ⚠️ Na stránce jsou **2 overlaye** (jeden skrytý, jeden viditelný) — stejně + jako u `ag-export`. Proto kontrola **viditelnosti** `offsetParent !== null`. +- Detekce (KROK 2): + ```js + () => { + if (document.querySelectorAll('div.ag-row').length > 0) return false; + return [...document.querySelectorAll('.ag-overlay-no-rows-wrapper')] + .some(e => e.offsetParent !== null); + } + ``` +- KROK 2 čeká na `.ag-row` **NEBO** tuto detekci → centrum bez dat + necheká zbytečně 120 s a export se přeskočí. + +--- + +## 7. Login logika (sdílená napříč Covance skripty) + +```python +page.goto(LOGIN_URL) +page.wait_for_load_state("networkidle") +if not page.get_by_label("Email").is_visible(): + return # session aktivní → login přeskočit +# jinak: Email → Next → Password → Verify → wait redirect (code= zmizí z URL) +``` + +- **Proč `is_visible()` a ne kontrola URL:** po `goto(LOGIN_URL)` zůstane URL + `xsp.covance.com` i po redirectu na dashboard, takže URL test je nespolehlivý. + Spolehlivé je, zda **existuje pole Email** (login formulář) nebo ne. +- `is_visible()` neháže výjimku — když pole není, vrátí `False`. + +--- + +## 8. Chrome flagy proti „Restore pages" / broken session + +V `args` launchu: +``` +--disable-restore-session-state # neobnovovat předchozí session +--disable-session-crashed-bubble # potlačit "Chromium didn't shut down correctly" +``` +Důvod: při natvrdo ukončeném skriptu (kill) Chromium jinak při dalším startu +nabídne „Restore pages?" dialog, který rozbil interakci. + +--- + +## 9. Robustnost smyčky + +- Každé centrum je v `try/except` → **chyba u jednoho nezastaví zbytek**. +- Na konci souhrn: `hotovo X/12` + seznam `SELHALA centra: …`. +- Selhané centrum v logu = snadno se dohledá a vyřadí/opraví ID. + +--- + +## 10. Možná budoucí rozšíření + +- **Microbiology záložka**: existuje i `…/test-results/{SITE}/microbiology…` + (analogická stránka, pravděpodobně stejná AG Grid logika). +- **Druhá studie** (MDD3003, study 35472): přidat další `STUDY` + `SITE_IDS` + a obalit do vnější smyčky (vzor viz `download_samples_report` se seznamem STUDIES). +- **Ověření počtu**: počet `.ag-row` se loguje — dá se porovnat s počtem řádků + ve staženém CSV jako sanity check. + +--- + +## 11. Příbuzné skripty (stejná složka / portál) + +| Skript | Co stahuje | +|---|---| +| `download_samples_report_v1.1.py` | All Samples (sampletracking, čeká na „Fetching Data") | +| `download_kit_inventory_v2.1.py` | Kit inventory (on-hand expiration) | +| `download_equeries_report_v1.1.py` | eQuery reporty (zdroj SITE_IDS) | +| `download_test_results_v1.0.py` | **tento** — Standard Test Results | + +Všechny sdílejí: persistent profile, login logiku s `is_visible()` checkem, +`ag-export` + „Export to CSV" pattern (equeries/test-results). diff --git a/Covance_UCO3001/Trash/download_test_results_v1.0.py b/Covance_UCO3001/Trash/download_test_results_v1.0.py new file mode 100644 index 0000000..5c58af0 --- /dev/null +++ b/Covance_UCO3001/Trash/download_test_results_v1.0.py @@ -0,0 +1,173 @@ +# ============================================================================= +# Název: download_test_results_v1.0.py +# Verze: 1.0 +# Datum: 2026-05-29 +# Popis: Stahuje Standard Test Results ze xsp.labcorp.com pro studii 36940. +# Čeká na načtení AG Grid řádků (.ag-row) před exportem. +# Výstup: timestampované CSV do adresáře Source/. +# ============================================================================= +from playwright.sync_api import sync_playwright +from datetime import datetime +import os + + +def log(msg): + print(f"[{datetime.now().strftime('%H:%M:%S')}] {msg}", flush=True) + +EMAIL = "vbuzalka@its.jnj.com" +PASSWORD = "%zT3Wqfc9)cWua5" +LOGIN_URL = "https://xsp.covance.com/" +OUT_DIR = r"U:\PythonProject\Janssen\Covance_UCO3001\Source" +PROFILE_DIR = os.path.join(os.path.dirname(os.path.abspath(__file__)), "browser_profile") + +# Studie + jejich interni cisla center. +# 36940 = 77242113UCO3001 (zdroj center: download_equeries_report SITES) +# 35472 = druha studie +STUDIES = [ + { + "study": "36940", + "sites": [ + "930551", "930556", "930525", "930549", "930543", "930547", + "930555", "930557", "930539", "930536", "930553", "930531", + ], + }, + { + "study": "35472", + "sites": [ + "898745", "898739", "898733", "898744", "898727", + ], + }, +] + +# Typy reportu: zalozka v URL + suffix v nazvu souboru. +REPORT_TYPES = [ + {"slug": "standard-test-results", "suffix": "standard"}, + {"slug": "microbiology", "suffix": "microbiology"}, +] + +REPORTS = [ + { + "site": sid, + "study": st["study"], + "type": rt["suffix"], + "url": f"https://xsp.labcorp.com/sponsor/study/{st['study']}/test-results/{sid}/{rt['slug']}", + "filename": f"sponsor-study-{st['study']}-test-results-{sid}-{rt['suffix']}.csv", + } + for st in STUDIES + for sid in st["sites"] + for rt in REPORT_TYPES +] + + +def login(page): + log("LOGIN: otviram login stranku...") + page.goto(LOGIN_URL) + page.wait_for_load_state("networkidle") + if not page.get_by_label("Email").is_visible(): + log(f"LOGIN: session uz aktivni, prihlaseni preskoceno ({page.url})") + return + log("LOGIN: zadavam email...") + page.get_by_label("Email").fill(EMAIL) + page.get_by_role("button", name="Next").click() + page.wait_for_load_state("networkidle") + log("LOGIN: zadavam heslo...") + page.get_by_label("Password").fill(PASSWORD) + page.get_by_role("button", name="Verify").click() + log("LOGIN: cekam na presmerovani po prihlaseni...") + page.wait_for_url(lambda url: "code=" not in url, timeout=60000) + page.wait_for_load_state("networkidle", timeout=60000) + page.wait_for_timeout(2000) + log(f"LOGIN: prihlaseni OK ({page.url})") + + +def download_report(page, report): + log(f"=== Centrum {report['site']} / {report['type']} (studie {report['study']}) ===") + + log(f"KROK 1/5: navigace na report URL...") + page.goto(report["url"]) + log(f"KROK 1/5: stranka nactena ({page.url})") + + # Grid je AG Grid uvnitř . Data jsou nactena, jakmile + # se v gridu objevi radky (.ag-row jde z 0 -> N). Pockej na prvni radek + # a pak na stabilizaci poctu (proti castecnemu renderu). + log("KROK 2/5: cekam na radky gridu (.ag-row) nebo prazdny grid ('No Data')...") + # AG Grid radky jsou position-absolute (virtualni render), takze nejsou + # "visible" dle Playwrightu -> cekej na pritomnost v DOM, ne na viditelnost. + # Prazdne centrum: AG Grid vykresli no-rows overlay s textem "No Data" ve + # wrapperu .ag-overlay-no-rows-wrapper. POZOR: trida NENI -no-rows-center; + # navic jsou na strance 2 overlaye (jeden skryty) -> kontroluj viditelny + # (offsetParent != null). Detekuj, aby to u centra bez dat necekalo 120 s. + EMPTY_GRID_JS = """() => { + if (document.querySelectorAll('div.ag-row').length > 0) return false; + return [...document.querySelectorAll('.ag-overlay-no-rows-wrapper')] + .some(e => e.offsetParent !== null); + }""" + page.wait_for_function( + f"""() => document.querySelectorAll('div.ag-row').length > 0 + || ({EMPTY_GRID_JS})()""", + timeout=120000, + ) + if page.evaluate(EMPTY_GRID_JS): + log("KROK 2/5: centrum bez dat ('No Data' overlay) — preskakuji export.") + return + log("KROK 2/5: radky se objevily, cekam na stabilizaci poctu...") + prev = -1 + for i in range(20): # max ~40 s stabilizace + cnt = page.locator("div.ag-row").count() + log(f" ...kontrola #{i+1}: {cnt} radku") + if cnt == prev and cnt > 0: + break + prev = cnt + page.wait_for_timeout(2000) + page.wait_for_timeout(2000) # buffer + log(f"KROK 2/5: data stabilni ({prev} radku v gridu).") + + # Tri tecky: na strance jsou 2x (jeden skryty), klikni na + # VIDITELNY more_horiz button. + log("KROK 3/5: klikam na viditelne tri tecky (more_horiz)...") + page.locator("ag-export button:visible", has_text="more_horiz").first.click() + log("KROK 3/5: menu otevreno.") + + timestamp = datetime.now().strftime("%Y-%m-%d_%H%M%S") + dest = os.path.join(OUT_DIR, f"{timestamp} {report['filename']}") + log("KROK 4/5: klikam na 'Export to CSV' a cekam na stahovani...") + with page.expect_download(timeout=60000) as dl: + # 2x "Export to CSV" v DOM (jeden skryty) -> klikni na VIDITELNY + page.locator("mdl-menu-item:visible", has_text="Export to CSV").first.click() + log("KROK 4/5: stahovani zachyceno, ukladam soubor...") + dl.value.save_as(dest) + log(f"KROK 5/5: HOTOVO -> {dest}") + + +if __name__ == "__main__": + with sync_playwright() as p: + context = p.chromium.launch_persistent_context( + user_data_dir=PROFILE_DIR, + headless=False, + args=[ + "--disable-blink-features=AutomationControlled", + "--start-maximized", + "--disable-restore-session-state", + "--disable-session-crashed-bubble", + ], + no_viewport=True, + user_agent="Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/136.0.0.0 Safari/537.36", + accept_downloads=True, + ) + context.add_init_script("Object.defineProperty(navigator, 'webdriver', {get: () => undefined})") + page = context.new_page() + log("START: prohlizec spusten.") + login(page) + ok, failed = 0, [] + for idx, report in enumerate(REPORTS, 1): + log(f">>> Report {idx}/{len(REPORTS)}") + try: + download_report(page, report) + ok += 1 + except Exception as e: + failed.append(f"{report['site']}/{report['type']}") + log(f"CHYBA u centra {report['site']}/{report['type']}: {e!r} — pokracuji dalsim.") + log(f"KONEC: hotovo {ok}/{len(REPORTS)} reportu.") + if failed: + log(f"KONEC: SELHALA centra: {', '.join(failed)}") + context.close() diff --git a/Covance_UCO3001/Trash/download_test_results_v1.1.md b/Covance_UCO3001/Trash/download_test_results_v1.1.md new file mode 100644 index 0000000..fcb4b92 --- /dev/null +++ b/Covance_UCO3001/Trash/download_test_results_v1.1.md @@ -0,0 +1,231 @@ +# download_test_results_v1.1.py — dokumentace + +**Verze:** 1.1 · **Datum:** 2026-05-29 +**Umístění:** `U:\PythonProject\Janssen\Covance_UCO3001\download_test_results_v1.1.py` + +> **Změny v1.1 oproti 1.0:** přidána **druhá studie 35472 (MDD)** a druhý typ +> reportu **Microbiology**. Dříve jen 36940 + Standard. + +--- + +## 1. Účel + +Automatické stažení reportů **Test Results** z portálu Labcorp Sponsor Portal +(`xsp.labcorp.com`). Skript projde **2 studie × jejich centra × 2 typy reportu**, +u každého vyexportuje grid do CSV a uloží ho timestampovaný do `Source/`. + +| Studie | Interní ID | Význam | Počet center | +|---|---|---|---| +| UC | `36940` | 77242113UCO3001 | 12 | +| MDD | `35472` | druhá studie | 5 | + +Typy reportu (záložka v URL): **Standard** (`/standard-test-results`) a +**Microbiology** (`/microbiology`). + +**Celkem: (12 + 5) × 2 = 34 reportů** (prázdná centra se přeskakují, viz 6.5). + +--- + +## 2. Spuštění + +```bat +U:\PythonProject\Janssen\.venv\Scripts\python.exe ^ + U:\PythonProject\Janssen\Covance_UCO3001\download_test_results_v1.1.py +``` + +- Prohlížeč běží **viditelně** (`headless=False`), maximalizovaný. +- **Persistent profile** (`browser_profile/` vedle skriptu) — session přežívá. + +### Dočasný test (1 centrum / studie) + +Pro rychlé ověření stačí dočasně zúžit `STUDIES`, např.: + +```python +STUDIES = [ + {"study": "36940", "sites": ["930557"]}, # UC — centrum s daty + {"study": "35472", "sites": ["898745"]}, # MDD — první centrum +] +``` + +→ proběhnou 4 reporty (2 centra × 2 typy). Po testu vrátit plný seznam. + +--- + +## 3. Konfigurace (konstanty v hlavičce skriptu) + +| Konstanta | Hodnota / význam | +|---|---| +| `EMAIL` | `vbuzalka@its.jnj.com` (login přes iMedidata/OKTA na xsp.covance.com) | +| `PASSWORD` | heslo k účtu (uložené přímo v kódu) | +| `LOGIN_URL` | `https://xsp.covance.com/` — po přihlášení redirect na xsp.labcorp.com | +| `OUT_DIR` | `U:\PythonProject\Janssen\Covance_UCO3001\Source` | +| `PROFILE_DIR` | `browser_profile/` vedle skriptu (persistent Chromium profil) | +| `STUDIES` | seznam studií, každá má `study` (interní ID) + `sites` (interní ID center) | +| `REPORT_TYPES` | `standard-test-results`/`standard` a `microbiology`/`microbiology` | + +### Interní čísla center + +``` +36940 (UC): 930551, 930556, 930525, 930549, 930543, 930547, + 930555, 930557, 930539, 930536, 930553, 930531 +35472 (MDD): 898745, 898739, 898733, 898744, 898727 +``` + +> **Pozor:** jsou to **interní ID** Labcorpu, **nikoli** čísla center typu +> CZ10001. V URL test-results se používá právě toto interní ID: +> `…/test-results/{SITE_ID}/{standard-test-results|microbiology}`. +> (Pozn.: 36940 zdroj = `download_equeries_report_v1.1.py SITES`; +> 35472 zdroj = ručně dodaná čísla center.) + +### Generování REPORTS (DRY) + +`REPORTS` se sestaví automaticky jako **kartézský součin** +`STUDIES × sites × REPORT_TYPES`. Přidání/odebrání centra, studie nebo typu +reportu = úprava příslušného seznamu, vzor URL i názvu se píše jen jednou. + +--- + +## 4. Výstupní soubory + +Formát názvu (timestamp + popisný název): + +``` +{YYYY-MM-DD_HHMMSS} sponsor-study-{STUDY}-test-results-{SITE_ID}-{TYP}.csv +``` + +`{TYP}` = `standard` nebo `microbiology`. Příklady: +``` +2026-05-29_131121 sponsor-study-36940-test-results-930557-standard.csv +2026-05-29_131500 sponsor-study-36940-test-results-930557-microbiology.csv +2026-05-29_131800 sponsor-study-35472-test-results-898745-standard.csv +``` + +- Timestamp se generuje pro **každý** report zvlášť (v okamžiku exportu). +- Staré soubory se **nikdy nemažou** (verzování přes timestamp). +- `expect_download` zachytí download event, `save_as()` uloží pod naším názvem. + +--- + +## 5. Průběh skriptu (kroky + logging) + +Každý krok se loguje s časem (`[HH:MM:SS]`, `flush=True`). + +| Fáze | Co dělá | +|---|---| +| START | spustí prohlížeč | +| LOGIN | otevře login; **pokud je session aktivní, přihlášení přeskočí** | +| Pro každý report (studie × centrum × typ): | | +| KROK 1/5 | navigace na report URL | +| KROK 2/5 | čeká na řádky gridu `.ag-row` **nebo** prázdný grid („No Data"); pak stabilizace počtu | +| KROK 3/5 | klik na viditelné tři tečky (`more_horiz`) → otevře menu | +| KROK 4/5 | klik na viditelné „Export to CSV" → zachytí download | +| KROK 5/5 | uloží soubor do `OUT_DIR` | +| KONEC | souhrn `hotovo X/34` + seznam selhaných (`site/typ`) | + +Log u každého reportu ukazuje i typ: `=== Centrum 930557 / microbiology (studie 36940) ===`. + +--- + +## 6. Klíčové technické poznatky (PROČ to tak je) — ověřeno přes Chrome MCP + +Stránka test-results je **Angular SPA** s knihovnou **MDL** a tabulkou **AG Grid**. +Microbiology záložka má **stejnou** strukturu jako Standard → vše níže platí pro oba. + +### 6.1 Čekání na data = řádky AG Gridu +- Data jsou načtena, jakmile se objeví řádky **`div.ag-row`** (count 0 → N). +- **Řádky jsou `position-absolute`** (virtuální render) → Playwright je + **nepovažuje za „visible"**. Proto: + - ❌ `wait_for_selector("div.ag-row")` (default visible) **timeoutuje**. + - ✅ `wait_for_function("() => document.querySelectorAll('div.ag-row').length > 0")`. +- Stabilizace: počet řádků se čte co 2 s, dokud se 2× po sobě neshodne. +- **POZN.: počet `.ag-row` se „zastropuje"** (typicky ~153) kvůli virtuálnímu + renderu — NENÍ to skutečný počet záznamů. Slouží jen jako signál „data jsou". + **Export do CSV ale vyexportuje VŠECHNY řádky** (ověřeno: různé velikosti CSV). + +### 6.2 „Fetching Data" / spinner — NEPLATÍ pro tuto stránku +- Na test-results **NENÍ** text „Fetching Data" (ten je na *samples* reportu). +- `` jen problikne při route-loadu → nespoléhat. Signál = `.ag-row`. + +### 6.3 Tři tečky (export) — na stránce jsou DVA `` +- 2× `` (1 skrytý), 3× ikona `more_horiz`. Proto filtr na viditelnost: + ✅ `page.locator("ag-export button:visible", has_text="more_horiz").first.click()` + +### 6.4 „Export to CSV" — v DOM jsou DVĚ položky +- 2× `mdl-menu-item` „Export to CSV" (1 skrytá). Proto: + ✅ `page.locator("mdl-menu-item:visible", has_text="Export to CSV").first.click()` + - ❌ `get_by_text("Export to CSV")` → strict mode violation (2 elementy). + +### 6.5 Prázdné centrum (ověřeno přes Chrome MCP na centru 930551) +- AG Grid při 0 záznamech zobrazí no-rows overlay s textem **„No Data"**. +- Struktura: `.ag-overlay` → `.ag-overlay-panel` → + **`.ag-overlay-no-rows-wrapper`** → `No Data`. +- ⚠️ Třída **NENÍ** `.ag-overlay-no-rows-center` (chybný předpoklad, nikdy + nezabral) — správně je **`.ag-overlay-no-rows-wrapper`**. +- ⚠️ Text „No Data" **NENÍ** v `.ag-body-viewport` (ten je prázdný, `height: 1px`). +- ⚠️ Na stránce jsou **2 overlaye** (1 skrytý, 1 viditelný) → kontrola + viditelnosti `offsetParent !== null`. +- Detekce (KROK 2): + ```js + () => { + if (document.querySelectorAll('div.ag-row').length > 0) return false; + return [...document.querySelectorAll('.ag-overlay-no-rows-wrapper')] + .some(e => e.offsetParent !== null); + } + ``` +- KROK 2 čeká na `.ag-row` **NEBO** tuto detekci → prázdné centrum necheká + zbytečně 120 s a export se přeskočí. + +--- + +## 7. Login logika (sdílená napříč Covance skripty) + +```python +page.goto(LOGIN_URL) +page.wait_for_load_state("networkidle") +if not page.get_by_label("Email").is_visible(): + return # session aktivní → login přeskočit +# jinak: Email → Next → Password → Verify → wait redirect (code= zmizí z URL) +``` + +- **Proč `is_visible()` a ne kontrola URL:** po `goto(LOGIN_URL)` zůstane URL + `xsp.covance.com` i po redirectu, takže URL test je nespolehlivý. +- `is_visible()` neháže výjimku — když pole není, vrátí `False`. + +--- + +## 8. Chrome flagy proti „Restore pages" / broken session + +``` +--disable-restore-session-state # neobnovovat předchozí session +--disable-session-crashed-bubble # potlačit "Chromium didn't shut down correctly" +``` + +--- + +## 9. Robustnost smyčky + +- Každý report je v `try/except` → **chyba u jednoho nezastaví zbytek**. +- Na konci souhrn: `hotovo X/34` + seznam `SELHALA centra: site/typ, …`. + +--- + +## 10. Možná budoucí rozšíření + +- **Další studie / centra**: přidat položku do `STUDIES`. +- **Další typ reportu**: přidat položku do `REPORT_TYPES` (slug + suffix). +- **Ověření počtu**: počet `.ag-row` se loguje — POZOR, je zastropený virtuálním + renderem, takže ho nelze porovnávat s počtem řádků v CSV (CSV má všechny). + +--- + +## 11. Příbuzné skripty (stejná složka / portál) + +| Skript | Co stahuje | +|---|---| +| `download_samples_report_v1.1.py` | All Samples (sampletracking, čeká na „Fetching Data") | +| `download_kit_inventory_v2.1.py` | Kit inventory (on-hand expiration) | +| `download_equeries_report_v1.1.py` | eQuery reporty (zdroj SITE_IDS pro 36940) | +| `download_test_results_v1.1.py` | **tento** — Test Results (Standard + Microbiology, 2 studie) | + +Všechny sdílejí: persistent profile, login s `is_visible()` checkem, +`ag-export` + „Export to CSV" pattern. diff --git a/Covance_UCO3001/Trash/download_test_results_v1.1.py b/Covance_UCO3001/Trash/download_test_results_v1.1.py new file mode 100644 index 0000000..bb9c7e7 --- /dev/null +++ b/Covance_UCO3001/Trash/download_test_results_v1.1.py @@ -0,0 +1,175 @@ +# ============================================================================= +# Název: download_test_results_v1.1.py +# Verze: 1.1 +# Datum: 2026-05-29 +# Popis: Stahuje Test Results ze xsp.labcorp.com pro 2 studie (36940, 35472), +# oba typy reportu (Standard + Microbiology), pres vsechna centra. +# Ceka na nacteni AG Grid radku (.ag-row); prazdne centrum ('No Data') +# preskoci. Vystup: timestampovane CSV do adresare Source/. +# Zmeny v1.1: + studie 35472, + report typ microbiology (driv jen 36940/standard). +# ============================================================================= +from playwright.sync_api import sync_playwright +from datetime import datetime +import os + + +def log(msg): + print(f"[{datetime.now().strftime('%H:%M:%S')}] {msg}", flush=True) + +EMAIL = "vbuzalka@its.jnj.com" +PASSWORD = "%zT3Wqfc9)cWua5" +LOGIN_URL = "https://xsp.covance.com/" +OUT_DIR = r"U:\PythonProject\Janssen\Covance_UCO3001\Source" +PROFILE_DIR = os.path.join(os.path.dirname(os.path.abspath(__file__)), "browser_profile") + +# Studie + jejich interni cisla center. +# 36940 = 77242113UCO3001 (UC) — zdroj center: download_equeries_report SITES +# 35472 = druha studie (MDD) +STUDIES = [ + { + "study": "36940", + "sites": [ + "930551", "930556", "930525", "930549", "930543", "930547", + "930555", "930557", "930539", "930536", "930553", "930531", + ], + }, + { + "study": "35472", + "sites": [ + "898745", "898739", "898733", "898744", "898727", + ], + }, +] + +# Typy reportu: zalozka v URL + suffix v nazvu souboru. +REPORT_TYPES = [ + {"slug": "standard-test-results", "suffix": "standard"}, + {"slug": "microbiology", "suffix": "microbiology"}, +] + +REPORTS = [ + { + "site": sid, + "study": st["study"], + "type": rt["suffix"], + "url": f"https://xsp.labcorp.com/sponsor/study/{st['study']}/test-results/{sid}/{rt['slug']}", + "filename": f"sponsor-study-{st['study']}-test-results-{sid}-{rt['suffix']}.csv", + } + for st in STUDIES + for sid in st["sites"] + for rt in REPORT_TYPES +] + + +def login(page): + log("LOGIN: otviram login stranku...") + page.goto(LOGIN_URL) + page.wait_for_load_state("networkidle") + if not page.get_by_label("Email").is_visible(): + log(f"LOGIN: session uz aktivni, prihlaseni preskoceno ({page.url})") + return + log("LOGIN: zadavam email...") + page.get_by_label("Email").fill(EMAIL) + page.get_by_role("button", name="Next").click() + page.wait_for_load_state("networkidle") + log("LOGIN: zadavam heslo...") + page.get_by_label("Password").fill(PASSWORD) + page.get_by_role("button", name="Verify").click() + log("LOGIN: cekam na presmerovani po prihlaseni...") + page.wait_for_url(lambda url: "code=" not in url, timeout=60000) + page.wait_for_load_state("networkidle", timeout=60000) + page.wait_for_timeout(2000) + log(f"LOGIN: prihlaseni OK ({page.url})") + + +def download_report(page, report): + log(f"=== Centrum {report['site']} / {report['type']} (studie {report['study']}) ===") + + log(f"KROK 1/5: navigace na report URL...") + page.goto(report["url"]) + log(f"KROK 1/5: stranka nactena ({page.url})") + + # Grid je AG Grid uvnitř . Data jsou nactena, jakmile + # se v gridu objevi radky (.ag-row jde z 0 -> N). Pockej na prvni radek + # a pak na stabilizaci poctu (proti castecnemu renderu). + log("KROK 2/5: cekam na radky gridu (.ag-row) nebo prazdny grid ('No Data')...") + # AG Grid radky jsou position-absolute (virtualni render), takze nejsou + # "visible" dle Playwrightu -> cekej na pritomnost v DOM, ne na viditelnost. + # Prazdne centrum: AG Grid vykresli no-rows overlay s textem "No Data" ve + # wrapperu .ag-overlay-no-rows-wrapper. POZOR: trida NENI -no-rows-center; + # navic jsou na strance 2 overlaye (jeden skryty) -> kontroluj viditelny + # (offsetParent != null). Detekuj, aby to u centra bez dat necekalo 120 s. + EMPTY_GRID_JS = """() => { + if (document.querySelectorAll('div.ag-row').length > 0) return false; + return [...document.querySelectorAll('.ag-overlay-no-rows-wrapper')] + .some(e => e.offsetParent !== null); + }""" + page.wait_for_function( + f"""() => document.querySelectorAll('div.ag-row').length > 0 + || ({EMPTY_GRID_JS})()""", + timeout=120000, + ) + if page.evaluate(EMPTY_GRID_JS): + log("KROK 2/5: centrum bez dat ('No Data' overlay) — preskakuji export.") + return + log("KROK 2/5: radky se objevily, cekam na stabilizaci poctu...") + prev = -1 + for i in range(20): # max ~40 s stabilizace + cnt = page.locator("div.ag-row").count() + log(f" ...kontrola #{i+1}: {cnt} radku") + if cnt == prev and cnt > 0: + break + prev = cnt + page.wait_for_timeout(2000) + page.wait_for_timeout(2000) # buffer + log(f"KROK 2/5: data stabilni ({prev} radku v gridu).") + + # Tri tecky: na strance jsou 2x (jeden skryty), klikni na + # VIDITELNY more_horiz button. + log("KROK 3/5: klikam na viditelne tri tecky (more_horiz)...") + page.locator("ag-export button:visible", has_text="more_horiz").first.click() + log("KROK 3/5: menu otevreno.") + + timestamp = datetime.now().strftime("%Y-%m-%d_%H%M%S") + dest = os.path.join(OUT_DIR, f"{timestamp} {report['filename']}") + log("KROK 4/5: klikam na 'Export to CSV' a cekam na stahovani...") + with page.expect_download(timeout=60000) as dl: + # 2x "Export to CSV" v DOM (jeden skryty) -> klikni na VIDITELNY + page.locator("mdl-menu-item:visible", has_text="Export to CSV").first.click() + log("KROK 4/5: stahovani zachyceno, ukladam soubor...") + dl.value.save_as(dest) + log(f"KROK 5/5: HOTOVO -> {dest}") + + +if __name__ == "__main__": + with sync_playwright() as p: + context = p.chromium.launch_persistent_context( + user_data_dir=PROFILE_DIR, + headless=False, + args=[ + "--disable-blink-features=AutomationControlled", + "--start-maximized", + "--disable-restore-session-state", + "--disable-session-crashed-bubble", + ], + no_viewport=True, + user_agent="Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/136.0.0.0 Safari/537.36", + accept_downloads=True, + ) + context.add_init_script("Object.defineProperty(navigator, 'webdriver', {get: () => undefined})") + page = context.new_page() + log("START: prohlizec spusten.") + login(page) + ok, failed = 0, [] + for idx, report in enumerate(REPORTS, 1): + log(f">>> Report {idx}/{len(REPORTS)}") + try: + download_report(page, report) + ok += 1 + except Exception as e: + failed.append(f"{report['site']}/{report['type']}") + log(f"CHYBA u centra {report['site']}/{report['type']}: {e!r} — pokracuji dalsim.") + log(f"KONEC: hotovo {ok}/{len(REPORTS)} reportu.") + if failed: + log(f"KONEC: SELHALA centra: {', '.join(failed)}") + context.close() diff --git a/Covance_UCO3001/browser_profile/BrowserMetrics-spare.pma b/Covance_UCO3001/browser_profile/BrowserMetrics-spare.pma new file mode 100644 index 0000000000000000000000000000000000000000..98fc2c0bd7fa41623709dbf737993f8b9e26311d GIT binary patch literal 4194304 zcmeIufdBvi0K=g9Qy=7oP+`D;0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj G_#PMozyJXN literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/BrowserMetrics/BrowserMetrics-6A19775F-5F30.pma b/Covance_UCO3001/browser_profile/BrowserMetrics/BrowserMetrics-6A19775F-5F30.pma new file mode 100644 index 0000000000000000000000000000000000000000..ac308e366a220e07491550e268a14191a552b761 GIT binary patch literal 4194304 zcmeEv2Ygh;_Wx{X0Td#Lf{27BMH8wJK!r^LBuF3jn)2?FF5)c-}HtVp7eLQHNaKu7~MW`g7pQeDb54 z{2XU$t`P`&f+52ja+a0(id-RIAa#N(P*#%#uCFBEDi5aGan&Ib!gWUPub$-iD9r>A zJ#$M?D^P1t8&D#sEvOx+J?Ie7p`Z?+jv$iDVW3W+&Y;6VT|h^Gjs$fDbpss*IvR8g zC>hin)E9ItXaHysCB6;rLzyAVQViAbt zz5)+L&*lV?&CgQ+er3BMYrzuvGmkyxg}djT2$nSDF9E)pZ?YqnRqmRgv%Q|sbR$?% z7LtC`aBYs98GjN4O5t+PZ8v;1gqrY!LnJ===?yQp?$l-Ih!awWq>dUnd|2wpl#wG+ z+(xBQ)^**-cW-UoyOrTh$Yd6LnayC3Xj*w_J)kIq-Pf&(ls&JF+ePI zh|3*fjl)cGox?G?-J#`u#+=<{>!lyh#{Jcgp7vmuzaKey9PV3n*z;4D+QsL;lq=>W zQetVy@mhy`t`!ck*RiNiZ35(@jAK!PxH_Tlh~cgg?qQ<~Q{2U_VJRbu(+X2YyGD#m zDK>@;KVfLG;XYx=@YM;c4t*eDwZnbP=r?bAIrpSdAFo~T{30=E!IpJpJ8l?$SNo+K z25;Y#a{sLOXu zRULDF%_(a<#~dh;-`yMpO;pL~7s73=p; z`SH-RzE8-#AwPe5$9YRo4^i-`3{f4)GfK))$z`^jlTjM*l^auhRrzRcCU{F+B?dWC z{ml0UjWVMsWS~N{M5UszR0l2L^9)y@sFVWBx<1wCHCm$59S?t0Ppy7SeSW{kTOxg{ zc41nm6d|Mds7_nLWCVP{V5U*&DKaP+wF^^y7A6oQyqRXb@KlG&jV!}eSwrEeEsCT$ zLbVUw?P;py@~S+cB0^VB7UNYr($5|)fBKY}o}j9?<$fyl(_P-V^7-n;k*V6DWP2RB zu3)gr7jWmeym+txVJ4YR^@Yx9z)7@3rs6R~PkTI>u8^zH6*QcFPez#sIU2109A=s5 zWe=;$1SK6U5b#s)8O*eM)C=z`_xplIE=rbx##=3E^$OQ;45m72@&V zp>rGQ5LcY%5dU}+8pV?mr2I(6fMU^?tw-E|6DePSB6Wewz<+Xh%GKn*@|@#4ypep` z<#bPm{L|IWmuy@blQZUsp5mIQ!VHg6PtFuK#1hd<66O`AKhmq#Lhw3Xh)wD(bHRV} znb%3xDDqZ(+_m%Q)lbts8OCepD_0?Ax&j`lXbGlHsD^6QZMgGX#YT?LZKS3ft|Fgz zqNmKrgEGc&hF}Fk6@Cg!<=b9P?Dz>E%e~h0PtP$PlVklkXbw$fj3&(=9{ufybbIO} zw>`S-_qL=Wm4=_g&S!V3*BNDo%R8ak6H>r4d|st4E~*(W>tH;1sa~_*lyEWrWw@vC zgnuhd?qQrD!bS6bssnpLtlyqi@m|os>)1rFq+$GaKD%rA5RrdIz!fab3!!e#&GZC| z0*2q^Eviu=P~;~hBc0V0*NfJSnM&S|SEE}KQ8^WWYq)J#uQ29)T zMREzR`h00MaOmk!8oJyPp>T_ZbLB-7Z+Pv}OI}m4bNLnGdK;hJo4`5IfO>4A%Trbn zV6;LcBOv1)06cnngtyvsr+nT5cj7rgWb=AK82q90^WO$bymRJ*-p?xk$RKwzWYanZ z^CeTeP&u984F!Dunmk`cpvag}^4ZR3 zNE)6gK9?IyYvnF4w6I#Enc=HILDl*!3Y!ILET6f4aKEItqtw0=ZZ5}qJxhdwHdc9P zzip}Wn;T2+LU?IZIffieKBBf5?fFPgoKfoXdW|v>DW}w44M4hjycB0Gi0jvCxD(F_ zBAcI2um2lg898;@_I~x`Zs#MoG#aj4Uzw+f#7j%4rW)Fkel2=*J$+t(900!S-9BGZ zg#CW){qo}@E_j0cks+JfALdJ@cG1$$GYmK7eRNO)f3rY;CVy$1cqjWU1G6ScK5!nS>Z<{JseMtd<>; zDMH5;oxEK~28!sO%vAGg=Swy&TDns_<(^P5HNrvDljoUdq-Gk$E?y@6m&=!)fn=<= zU;gCS?bmw=XC3+5Bfq@B&!NhXL)iK3o@W$QpmC~6omAy_23_7%CyHz(MuqOw92c#| z^UAv!K<}p#d&S1n>FgVm2md~cntEv%kDbr%P2kDJAk{UG9t(~};$ zlG9OuIte?U-DBXe)QfN&=|ApWIb`L&;yHbk00h|%T$#`5vOS{|!&Y~$&sUb3kCvAv zovuL5X|B0Og`b6xigAQdf)z5a+cNIT>SL{^JSOi7{yFcxD(3_%9-eXMo|n2`L2WV_ zg4F_7=1Zn_!I;Yk_yeAxkx^3uf0b@~ zdH1JE>8 z*zqu5gCcLEi7L5e2Qz);E{}Jz54#}T*8XyP9O+jXr)~(}{9Q|X`pl1+zE`Es{`7XQ zw4dTSVNv{mS8ransO1|~QwDytgT^srs2;V%mHCpXU2=?aU!W${)}}=MPWSmjG;zjE zjoNx4!U)UxvFlhB5#vefuka*-zt?mA^6GA##N9V1-&D7M^m$NgNV5pQX@J9glO3`0 zu;TBokd2F~Vi>StHc?h)1XPnOx26OtU1gaS0XeZxb$V-3c}sz)Lrn3OcOJjd*p2#i z>eH#egc?fjbHeaQ?rWmC3)Q31piI!IpaM_;bQvfNdJ6P0=ny>L$)I_lr$Jp%X=*@w zKnqZLj%_K#cc2ei3Gok9{0WIdyp4(Yy%;=xgn`9^B+S{M|I5Z4{BDfX>yoi23v#8p ziRdlzA2N_Q(fYXy@l%;t1pkBY{piFM|7<6EE#7_Qn=K6h9QsCSN4J34+N1264!AcYG4P0 zs7#IkjRK7Uodg;W$^cCSO$O2UXgX*n=ycFIAd;~M~R~Le=1FZpV0&N5B1|_0A^#P3o zodr4%^fwSxsp1n*Ta<;Npff;=K#zi`d~i8hjkLKQZzsXPI6;V7mbYQBxgKvl^hoiK zMF|s!Ia^etxJtwInE56uU?| z`nD|VcNqZZtSbP3YI7HO?Jd; z22O7i;?7APA;ZR;tZDWDwC zRM0d~E{OV9YIE~IGeG$uYJX1y(foZjh}z;aKxcx^0-X(_wz&Z00u_RaKyDC~mxkKC ztue|~Y0LKF!o5GI9lNY>`q~AE1cu8$^A$IGJ@9g6tpWP{vXnY27?P_4WN%Maw`niV ze0*2-(gzc=Ug$_ZqvfCZiW|K)g)`e-W;E6w>$v2g2vIUFd;5{qw!QFP@ObNuZ#;O! z!nal0Ps5_|2lJzd)Lq=Ttl|>22+sXkEedf0{xdGRZvoQhEv|D{E*rCP01X+WA-R%t z?R?3`rT#p@oVQR#fmsCN^b=8mVx_+#u<9KMsh=_KrYc1J^4>?2)jk)Z?-zl^NAT1lAm`I+ zGw)bF_IgEW49W`@od47SYI39@{PYxdzGUMvEiWTb;}4}`*FF?uMe?53pxM0^H=OG^~{nUxA)%jd@!eA)ZJS;`_Gf$Jz_= zDaNArc0jl!jHvJG$H1qqx%_y zof9iiNiRYEqXF)MNky0EQI6^`=h%;VWN(La1(gG2 z@dXfrMUS?N1PS8=K^*n^A#&S(-La>AJ+}SBcw}kFUpx3_zR8YQ(N;|9U!3!>n(53W z^$RV^R|F+HT7&fR>&Ku3SrNfQ_f$&tcK(ddI~m1i_IaFekRhAeS>{WocCq8h4k}I1 z44;Y2^sD383mg=$6GS$$U%qEm06_d+(lz&9TmE6U?q?H5GUSi+{mhq4?PAAaz6GRI zue_)V|Fs})PpUCMizSaw`yLvY-(%orPKt048atoe?KrZ7Q}AY5S)|LUg-1?*Zyf1& z*!J0VJC3iI&+&8mc0Ri|l75b>s1yo1+w-Tze*Uaiew}oB#+)lTeoo)cXLn~2sdhbu z(05~T09{@MRs(8GZ8tpW<$wmpvE={S6Yb`|yS3~B)z2#ZoCEqf=5xAi>;0P#ucYCX zz${k~tHDL2>dnpPg`jl^!1=HaIOw^YAhOXsiB=$e-_Me)>`Qm2Ul{^h8kU2d&+fEo zL+bWP?eFyav9u?(Z%%h5jRo8&m?6BXgjESuZ8Ht}3$(N{S%QTD?C_8)1ZIS~+|n?a zh$XilR<1m*%cO^XWju`6&S&>LPl*>@uroIs%TzfodXXqN5#toJF4G7i@AIiffQZ~o z9OJ>G_z9D}Jvn#p_1_#aFL?mDks+Jb#hEXe+J*K*$Ql!QwNN?M!s2xOm`G82P7vAc zK)wV2E<&F^J z;g`~HXg>ozGnW~3XOZ>{-I>HjeM2(tDLkz+F9S~AZ!q)KWb90{?lW19&X;%@AhLUd z`hXI_Kk1=x&$Le*;_9h$QbKz!Uv~lt6o%%8G|phYWNH^Yhgm1(GJen;%84-i9O!eA z%&Fg^u?4#8X1@>H9bwR=iyok3K1bo|)vPm;0oX!Gv*wNG{ax(sK+!|Nq;} zP3PiPj17;w;oYJ4m786!^miz(%qKs(q4H+Fw47%I=&e00(qXmGRYps-(SEcJf#Q)9 z^<|XrBo_={#^~;w1SxL1c5;*4x7?ranHuZe-8- zfFTV%Zwov%^G$ZdGW%m{*8F9znr!z(ylkh|t+L(lRSV+ulg7nP-@k9o=0Mf=Kibo0 zek5V@rit|BmLR>Htw8!zt@!!r9@$|TC%t#+q2GOQ&+&ee4;iwlePO<2YL`j5`RIrO z?kc>=M|~vLXJmgs8!Mx|qjmf^V0>&GGrc1}oPPVV33eRJ*C5E-JZvb+4*JT}QcyNl zsX_+&OmkU!S^#_cu=yl9Ki1{44tU70T;F3X*9j&-#-D2P zO?JeJANNc;EkVB9N`aF>j5`^)^mHlBTGO4{gW3%IfpLONJT0l+4I^BOV_!Ir+>Y2* zHGAb(b6l&a1B9XM?}RJ!B~!ahHA1PGQ}a?Yy}>MB5Zh$rwqm(tDt*=AO8A=UZz(Bi zYpMUCIW6@k{XuDQO>`i$?kl z%uU9k)Ljw~;?g^yquq_Y>9ZZ;%^w}Yhq>Xf!!aNHtd*#_BvEua^$=0=>S5x9C%TD_ zL;Hyvo<2dm^FWUHF2^r6PQO*Gy6G$NXpcNce*do=hgUvFB56r|8f?q{hV7ZeiOM&8 zsY9((L+<;x)jdUScf8T!$EPw^UqX?PA)Cfg%$H2Gdr0KSE?BETUbOE8J@r5#UVv_8>v)U_kfDnWj1?fg9ydc5{{s5T zU$EAh<`5(=maE=gjh_e*FisHZT9a>SBjs8!0prBVlk3PW;o1S`eE03MztVhwjFN9c zgs-^KYdyJ62!=f6XeE>$kEa(6%9$_(@a!G&?9YIf;Q1@tKu-Y~+>L^aWf^fP%A*s5 zsnL){70P8x$m5$MQ6^Ei_aB4xfIcX{1F%M#g7M%8_#2D-%z(_NK<|GV-jgW8SObHL z7i)$1>(!9yD&)lm=;gMfE&d16?&=VmvEaUK4rF$tLmcrgW>ZHdh_Sh+pa*XdK%S1X0VeD8wt*ZXi;*ZVfStmqAD2;VuImgF-_4 z6FMU=??gUsM;?BRGTaT3{D4Z*5d+#&5y@`M@2}6nTJ&6u9Z)gGy)MLGdOE~+OB~Q& zC5SKfCkO+LQJ>AN#Fm6aF|kK`v2<=n@sYcWxaZy;qAGQuc%=7eF=oOv;rOjw%9Z7> z_baoq01l=x`L9k&5S||5qwvq->0^PH46;VbpZSuhUE-4eG_UFmgP1HCo=V#PqvP5W z16Nk31d&qy=Ak8Bu3p&jbhUMhaWP+mByZ!wHQhM30^4X!a5CH?T)DhfXRC6`@@fG$ zWMxFJJ_Jh3wM*}OYR7xmJw8N+R&5<*zn}RgJ7UTAO-PZ>8~k!<;-4oEZct4FcA)3` zE&9QAr&w`7d~)qAaWeKv%pUVAMc(0!k&C9MB;L;nq4>c#>hal~#+fFBDV|~jZIdyf z5|txZfAmS&CH|~l8O_zdZT?4XL|;%p(6ONYAXKaWy7gG9^LqJBL&HSnfXgqsihBE& zcf9ypyZ)`;K?|hJ5z;zB*!k?P^=sHcR_rOE6&X55DK!I!qhPk6ves)Xu+aYX^N}D3w2Zg<=Rm9 znFgkiD$p`mT(84uYjwGB*_;LbAuqmf69cqH9??JcG;Q3;d-+DWmHr4uE2EtKarN8(3^Rkm)xL{3S z4cO9<32l|-Ra04?D`A_{iWF3DQAaN)I}|b<*^0nl5v6vQ$y>c zS&!}e^v7q`JVuzvkiRy#GG8*aOQZE+q9+gxS<}x#siycieS5z~(VjGPL%9FIA)j*+ zJl?hQ*`4wuGl0H58=ZW)uab1q`V3f?`=&V3@0Rn=<x-L>@d^U|X! zC&L4mhdQLo<)MB5nqx=?x;sq<+5P-3wO#D)$(nnYl9z_%BYZ80^EC{23gZNk-B5XY zVDzddN=9X+!dV*fN51WR$;O4(oilTxaz}?<>2aflV{Nll4>V-DHGOVB^!I#MoiyY5 z^WS?3E1JrXP4$fVCOcwr`dFGsrw#WJ2+)R2r$ZbKY#G+@=>5-n8y-wu#`BqI89ERo9 zU^~5a=bFva?_H>TM&*@d*R1;a zo?1?)rMzh=?0j}N&l^w!6AWH(G~Zl$CBUc-@%|%|o9FVn3w_npjw*J3h!zPTO)T3C!K=xvr73~GZslQi7eR^SO3G!?*knO=-L^m@L2wu*}Jke-X$ z;qAbA+m>u-?64Pg(sdKt?X0>)`Q&ng_cv{Pc5fI@1OTA}Oq|M+S0Q&C6jxxI0Rq>7 zNKQ@Zjk*8iew_O+D)TgF=m1Irbpjm@IuZnxq|^=dg53`^2s9XU0_a3g1_;x6x&M|1 zH*-PNpvyoctGhv)K-)po2p@(F84iMKSzHWy81xNj5HiyT+5mzoPE>$?o5byNJP{()oi`agT` z51&CprwrkvaRc*BcEqYbPn2(@8d%?;B|b~OC7v0({(iIXjN(myJil1UMd79T%lt^f z=1u+doo=^$>lJT)d4o!4iY2X}zSxMcR5m%^!X~cq;Hl@ewkwOSPY{P!Z*8}I@%OZZ zB26N$G@oa_$&Of4Pn`e_0{S0sXj&om-Bx0hYj!}VVrvjK2|+#gA>h^KXQQ4B=12mHCpXU2?GkN*i;r+K-c)b6nLq zo}z${bPre%Euw8N$}^@Gf4V(66mbw{s>6CazRsKlIpIcl#bwvDpfPOX*{JtB+ixb; zgO1PV89z)QSejW55tGHgmK%zFVfa@z-3j>68MoY+*p;AGb(+^vx~e+Qpkh-Y=huTeFfJ zhrgKN$ZK<>8G-S=M|Pd*~=VK84ZwF{LSITWOo6xIp?}KkGayd}BDs_2cZebeXke z$$a2WJwz(-5ENf(*Lgfo+(ZzKZ)iM2bvDT)y6+1@^^xr={iiVz`E76Bqx#7&GZiGWO`hWJr?*9r* z9M?hn|1SxIk@@!e!cQ>Vyy5aey7$Q@Z>nk2c!YW6kLnAS>!smvR8F~mm`;&$s{f~Z z3d7;(zg}+X|9_h~*q*8KU@r&ye|wqH%g=vXdHHXD-enK~&+Ghilr)^Ms7%<$Y2>=3 z*GYFKe09n1T%O1u&3BnkesrUM^CU8t%AZ>v8LQCLoW>?*phd75&)yh#{O@Cr%&9ls zUzPRk(@IxmG;w5HHO`_4m8hTy@6n*9J;k+VL=7gCcJucxL$2 zt8R?|NrrD~M`)i(8gTHwfs;RVx1)TjHr;98>pHj-kLA`-K0bN-sK4wl>^sPgllcg4 zG3I-C%AzeeRVvT){2C8ER;+Y0Uh+Ks`n1>RSR`r4CjBwL#l3_X7`N|dNyjXD3 zfGZEmp^&)+v=Lx(N2rQHuXoFUkJ4i~Qkz6`R{gw*+dlg7=s(Ikk5i$|eIMBUVdt~E zH6O93Fw0X?D$l5M1w&F;%4ZlB%V|i36^Fe&TG9G2@#&8*EbqJXOF!WwLs)5i$b8Av zE>m5Vo)Xz2qIq=V6(_uEt3CyYPsZWRXmE>sbTB13;CSm2e9KM~lO-S5RjPdqF0SyL?2VqNspvMb?-UA(r0)g%7qB|O#_dz@HASWV2x+0<*p(JdDLFnxm zcz%vSrYjlyJ&(is*tqor`K@j!W?pLP1tT_X>A8C zO2;WvQh9E#KXspt+3p_IV>Co54f&^e7V}MZ#9~|ujjTAnvS4Fqtn-@!>a1WGPebp^ z&KdmKx3$kdkVR#J4B?^uh|HHv?P9LwMTY5U84HcTwBiZXMTYDz%(hscC+r0dikESq z_|zL;+@Imby%{#McTi4v2i6;UG~N8Y1uRExR@USWZuMw3zOx5 z`LZM4$HQx&W(YBZxU~Aw)qAO*AVc`*{9@)yrgn)hKj|a| zdB%j=p^orj5SOzR=f#%Sl-lq4_~yO$OPiu!P6^oM#{2`rN8jv0Pp>AA7JPcX=3W$Aemir%yyD&thaYXP zr_4Vvd{hr`o&vt$#^7{)#NIe?%`H1>$xky+>0rmj`~$-k9fwTAV7%Nj&(`}}>qYV< zDitRz!a@5-X+2=s#W*M7T(N^(|Ng{~7YnLeoJjX%6kbO?zH*J(KSZYqsYP&0%SO3h4xC9@`0o>8D)J=nFdqlm?mzIt_$rs9g711N&_dy)Z^+hW`!J z0t4uUpk8?P#`f8+k3&x3OGb5nyr}v!L@y1?$9%e_>^=7dG* zHI#opUGn()ieox_$>}mKJD=T~k4w&wE$zmhIB-qLTpGT|m2GNLqUFlYKX6=mbPk=* zJIyQih3oZm#bqkirsTFPn0@uk{&iHmq+z+)`Rv|&xyk&DsvFFR*1_iXcO5C`U>K(x z_oPnB0{^4*&+^G_Y|_-fmVR5%mF~$fPCH+@9zgv}<@bGR8U$R5hzak3)LW>HboPS;XUOd3?%Ks8IOpYl1nSNw*@7EXdQMWi1L@8SMTT2E{6jQKW{_zytw~k zF9&ztmZ5w`pV!W3_xQ^zPB+1vo5Sh2w#I?$ng!Y4-~avy^oYuEKG^x}9zU)*m~-PJ zn3!`@SRGgC6)Lu->fWZztrt;I31U`GB&P5KfC$wGuz$t zDu-uWc0Ri|7nj+MSmd=L4qQ9l_$KY{>{CwWbQzbO&+g5}rMeLdt|5z6Y)$3kkdnKG zOxyC%Tuzs9+4<}qKdur3D?Unng1~zJu{{o4i~BCQrf_1vL7Xn*vh&&ffN-T$c|xTr zzQ**f{v|5*rsQ{in^qmpe!SfsjDvC7`RpD)PA`4om~}iB`E^|y8&}2TL&wfIu@_Yz zX&9HC&+hT#a$)SA62t*~MWK`;1D}SIAPqAjy}quC1Lu}jl|@GQ^@|w?yp~2Xr$eG`w^-+tf+%4bw=c0Rkuk1H4~lkG{0+uYeA$4q*^k#wz!wW)l4 z=A8c5d7MM%aQZAaJD=U-$4BK3Z64Z`a#@3M-~?XkE%vAqsORtMIB@QF-t)r+*Z;nW zaWGChpWWlfi4Rbu6w=puWz7g90?yy8>r`w_$uDhHx1qC#J@7rI^wJP6TCZci$&Og@ z;|k&xx)j4(g3&O&BW1=AhRyhP#ewhX(#7r1I&-zutxyy!H#?u)$i$D&jqm&6bO^M} zQg^0;Tk6N6zba-^@>`hnz`0%CfA(`Tcm$uF&+hT#s|XgR6qWjXcnLHG$Evzi3}IL- zzX8h?uPJ;5ci+7Hgvx=}E1yyM+4<}qKfXd<7)U9hl>sw?Fl@%RB@TR}F3Uc5=AN}w z?WN)Twe#7%8TcY=18DucX18l;mkX#8!!#wocT=3s?q6=E>9jPA&(3G}`0-J{L2Cml zWEd99O{`SBrf^+!e$F$;zOnjAQU<9&a(WEnCK;tK-1e zZp4NomR{ket>fW(KMrNXDL3vEbAY4v6o(NJ*PGhE zsaTtm<85CXM&}ow>DR&pK=^3?1@ldI#EKuE8g1DJ4m3q#d`UN{Xq&>feDjmXv_5Y| z9|pkkv-8=p1l2gq!E4p6y;XN;Nx-2I%WFFK;q+qdLfV&h8Q z)%mvB!{^j;x{S-tXZQGVp?s0p{2sif6_8zTid%i0g5nB;xPESm1LrMo@9lH+?k%Lo zmxgiL`Rv{doKO;APHBEEh{NmkV%DvS>x4z=Hncvl@ttwA-%MXMmBTYWJD=U-$A|Ge zzLvsS97Y5zx4m)TdTP(UNuQ3IcnPP=xa@p(Z#FL5ltah2;x-j)Q*wJ|)T|wyI)7Ej z=`%h%pWWlf7oBeei!j|aH~Q%LIz+ByH9elcdFoYjuIfJWADlkpv-8p@_)QGmu*8X-~95{PyFUSp-jOxfZ7^j`j?(yUF7DEGR&=;9Vk*4<>v+h)} zHI=__-Scc()%7iUak`Al&S&@daYgHG{ZeR^-<~*d4t=CB;f!xypT#&Br=8F4@#Dle z%3tVXO@=PN74!$DDfw-C(wEULu=6hEGg?3Fe0Gl?R}f#uODPQCXmK=oDHQ=|O-qfU zx#r|T9~TcWQ*R1qO2={Mzft#!hjFm{?0j~QA7`c1Kk9ha$AQONm6LhWLv8D=YuNeC z$K#TC^n5H>qhe`FKItn~ojLiWW4d#CEFU|c-Q$;!-j2{Krj};J(jLph50OAqI9J@* zVs6zH>waMzjML6%_xN#|`p`&AtYQem;{GChx8gO0@BM8Z?&v5sXDOf2`e5g?`+?$P zokbWCF~0Hls92lAcjd^O?$5dC#C>I0es(^)A22>sR}n@;jIS;Zd?(zR{`2~Adr9>s z4db)(+5Ld=IfHU9fL>1)tyQt=@*4)0em-fSDyIkfZt6*y=3{OZtcL>2~des666r+wdOi}HO>)_(Tf z`;3F-Y3H+h{PI*wx+#8_Hzfo$WXe3BuiT2yf1ip~&u=@vmoI(1Qd;*< zVmyr3&S&@d@#_6w8D3^qnglnL2zZqkYj8C(N?pEPABc_ji6@VL!|R>2hw(68JD=ST z46mA%G_V|J(HpIc1MdybeLSz{^GC_GZo z-+z2$QH#sIKVp>f8O3GivwQq(wUrojIaZRGR%eE<8-@j13x{GhaZ=5dU zvh&$Jeq8!K#1vBc;$SX%Css9CI?i=*;C$s#SFaZ9|59)KW#=~^Cyu44z=z@GJjEYM zDZ^P|71(QHMx^&61?v^FDS4JWdH1tR&+Gme<6wE(`Rsmx^3*zQbl5nHgyRe2hU<+m zQ8b13h>fY93U38IW1u!CM8(M+s*W@FaTR-0a-5J_R`5WFh5H!?nM{m!En7d(`!uiqX{#P#8 zI`b3`&p7RTc8?z?cFcHET!ko{6jpD4>f*pPA^nIKKYD7>9h@%Xvh&$Jeq13sp#{@F ze4`{%66v4(*a5#TZ5fZ%ZcwQ-CC650KfCajum3oW@i1OHpWWlfOXGj{nB9$-Wa3Z~#-J~j20QR(s=vPs3>B+lxV zyCz)P`b@^b;ed{5;cU+xy{>vPmaohRq{-~&!9>zZt8*f_QA7%{S{idmri_RnM{O02=!ufwF3K*GG1d5@{!iuJ>X)2~LEN;K* z;=sA{vd$l_`f9$}^G0#n`OU{ke35lfAH+@_4Ma< ze)I7K{f3Knn5b8d)b2DZzU1d(N_4_}hIazc?}dOAgQV#?EK=`0LGFqed=crqIS%i+(Eic@ge9x&v}KnM@IB~c7F5mhUlPdS_-!8-_+Z|tQS>+-6nw#v*(WSW&#Z}?<$hE;RBII(J_M(ctDV)=nO#LDA;fx%{ z!Sb~8**$)onx2>5u*G32v|y*pu`UjLr+%?x%li+N)N=Za&(3G}KZh?`Fm;@ZUQ)3) zCC3wXR==Eg$JgI74#sKcv-_XK87Y|h_$ zmiey#6%|`kay;Xii?^L!^2iCCF5|NE**$(-(7!+n?8g)$h>t|#GkbE#qvvz-tFiIz z{QLTuw~pBSGpEn^?0j~QAD?x+gI)&*zhV=dSA8p&m0Dp$%@#)0pJD;!^}fBLQ?IepH5JD=U-&wuonfeLg$O%Lh9h?wQ+ z->On+syrO^_TnB}A1x&+hT(uLmC< zLT8QPn(Q9ELDdDBIi}+bzZF}aZ8nJFH5-hz%Z>+RS$ zf4OQ*S;EBGyBG)KwDZ|Lew@*%Blk-Z*e>dL`HW@Sv01GY-aS z=d*kKI2)5^u+&#&4&yL{t3|}zPFBAY`yBZ(6Ej}>etY6r#>05+e0ERAsfOjQz+8Mg z!n{j&;Y$O+;FVsMY3Z-qrb0PkQM~j$2vSrezAMC&*)3$6KTH{OTV+l^vt?3v>1yYz zm~b|n%9_-f__zu>-6foOm{3^Won1~d+o37QPb1(9Oz zED&|i<)BJXE$DL4b)Z{7_kw6?iiYJoK;ME$uw6jMfigg6foec2K#zfTf?8s6A{BH7 z=t|JjpkG00(00rRJqtRlCDI0M0`+NyZz6ykm>w?xwQ3{8a?lBhI4={l90EEU0y+T# zItBtd3IZAg0p&tKOCX@nA)wPCoNo>n;^rfSsOT!hxkur9$4BGcEo@Yr(+lU}^;PA8 z&x2cpN8xgtww)d8^7Ml(^m>&0o(k@SMe#QzkJgv;KDeatPO1Tn363J%3F+@_oASadvfz(esf9uyftvRQ`8@Z|86t0|4a+n4ws8`gV| zT`tTgKe{pTyPJ3>RQt;?@DHiKk#8!=Pqfhy))pLlfP)OAHF*Zq^fe+x!@J*s6whR~ED}iXRb_vgV{?t~Os z+z(OSuetwCaxHlD>Sq^RHTYyshjG~X>~6(jrVczVx7qHHSm*d!U=pn5{%3 zyB&>eIr?EA`rkj$_nwIU_6)RWE6~4=$Dre3jIXF0>pmX#sX|;(BE*FkVSI9@5Yyg9 zKYyr0JUi1NE_u))3I-+!k|+1SE08w#zqxhz1LFh%hG?k$==8$tm7pw1PF<*lu zZ{xv*KHJj1Zn2e1yL^^?EJXGLefD+T^VF5pSCgSJC1kyy`I4z!2uEHBBUU==0C$F; zntFV~tG-BNC|xe4AE}5~F820y(`Q25vu@V9%PLyGJk3m#@i1S5B5!SY>@ZSi<`Bl9 zMJ{`7IP7vM_(F)?0~Y5!@%55HcDXRWX&e)(jiL%_M;jH6UXGW2rD9{b*zu6-^8;SG zL8MDZ$Ke#eK z!f4{AIewdn=AhF-3H(P$AdCV{{n60;UU_yvTu-RX+snP#9od5%{QobOz`^$HUo6mr z(fyy6KrNn*$Ja?;t4DRhqV_9%sYB_vGB8Hmrgj~l`}?9#ejIamWS*zmIft&+gImX#f1UQy?UfMTG4lEA??!};LtTr#2y>=s|QCIg>c*pOBq#Bim@!0w7 z9>tT7x2Vkz1=&#L8rZS!4M8E8k2h3QNL_ES1-QsCu7>1v=TId+$CO*n>7mw^dVf+Bk?tSrZK?m~d9|K@oA$sF z#t9-h9FGeXyRN&1IQo7kEh~s$pPcx`;`c6DNcUt|UUt56jZ0n@IsLoWLz*k6WIRYO zP;XElP+w3#(6ONYpaGzPph2MHKq;WXprIgYM@|5Z0*wZZ1)T&M2XcbYoQescNuX@d z6cEjSr-SlAvp`f)&IY+aloutSxgZ}X2&w|j2VDTV2t@Pl#h|M}%Rx7SZUNm1S_^s* z^caX5t<9iUK~TNO^_ov$Q`7q+=yy;n2iBE9r1R+wqVmAyCJcA(FABcL9~dVHUK-T@ zx9fh_qRGF_BG}T9Kk{woOExZAy>G0Zu@@}xah1!4euAW;)}|O=oeiITp6$m2f3pAP zufP9T{QjGpYMhc8=|h+=ncBsse_(wGsbZw5#g)@9_(AblK6d>__#bGG(th~cm&=!= z52p$WL-|MPGhZ^bi#2^D8_{?uPqnZ({W@Fv_U9kJ7v(Fpw#BB$6Hejh=k%GcB`t5Q z>09+4c72rpHx-(n-=2P5xFpWGm)bKLQ*wKz=MCMHp*Z-S z{@Z15|4)9%FrRJ3{hz%ym3C8Z|Fb9$ruM%jfm$TY1%g%Y)*OzSED_xT>)&C1m6n<#MMPY-|?9bTu_Y z9__9zU

zCCB)L&ptnG+pDEGEIm;iRdk5xeQ}Z)bjRUh*ygTc>=#FijKp5zl!5(3 z-sFMe%(*GTedSP5w)O-OdTq2gfA>k^lB9I8c<4lN-So-grr=bu>e}hz-iK$3N8UYM zZ2afh;)Sk7;`PxbV%zC+McsU#*mYx2?AcHy_I@}Y`BE#|_PQ8pFB08~t`xm4UWT-< zMcOOGm@jS=>4~=>?K_b6UE++nYemtO_ap6xk@jQayxkkb#YxW~?afI0CGof5YvPV; z-$dH)BJKCZQ~&%>Z0`CA(*6Qze=Yt#f4BJJ#vhUPKasW^tU8d@G^MhvAExb7Il<+| zK8`2XW3PYex~}`LqG`7@s`w<-UXEE;Fl4L{+opX~K>qhU^!!;zc6*qnlF~39JD=S#V&*cDN@aMu z5v(W+S@mJt_gmAYDGSx1EbtSms(zxlfceaMIPzmuy_j{Y>fVL-O*t z1MHBLpU85R1+mVoShNpq8rCu+2Y<2t!d`CaIeE-MeIAc7{+)UiDl;_y=KLwZ^AZj& zFN{gw_q9AY^nyQbuO+pFG%P1OpWRJ4VY`l@?e?OhE!5wJ^n`ojz>$-kB$x!5U*HAqcdlECQSX#23 z{E^}G?R@15Jq{g#K;OF#rmCt;`y|epZWQB;fl_$V%SCm9_4#S6M&q_wIhcpO`2I+W z^X8>PU)a+nL{m^{IDI>x-ShC7r7}bAxx+3=H`;nYp*>9Aq8hHl6I)nu za2@H|2m4sxdo_jp*S_2%eUQ-`np9;Nhn>&vYF}GwMyU@aG}9=oC`rxt&h=vZwN zYO>{)DlVoLJS%K?8Y&kFyFcsdI0t*}H9WMRmHCW=ZQ99&ZEa;4F2Ab~iuRBP%6}-< zrEJ_LrW{wO2;Vy)-I^|+0WGcaX$Vi+ozIt5z5I`#?0A^ZIM{9w&qM?18x5eb;#qIQ zLvto-&kB%uWxFA3DUI{_%a5|qj#T0^iGgX@ zb``*lHlWgRYyl36mvPWNJ-^=04!ZY-n!ar}wa|LUFiSRzX@Kv zii&nN5Wt}!Zsl1oFSA-(<&+f5sWYF2|(<(wmJ~ck5 zML_Od?_xy+YL z?PAsYMfQP3w$|3dFQ-4NjWvCHJG-TyL)`gh;?fagjwpQaDdqQe6lzMJ`C8KQ)|!6g zZ3}a^m$jX(v!!p>JC^o$2>7T4PM`Trr*GAJMudPsdb#i?TIFEJL1{cW zKz~*>-z$s)I2UKHocPt!(m;TbX@8|(_ zoDSo#^Vz*29Mj9@aq^b+!K8N9`bt>r?ZzD|AD!_=my2g|{AxNE6m~wlH<-RrQURG@ z5*8UHn6kl6a1XZ1BXAhR^=2J##gfbLiNEftJ-fii>8cXu5OzMhGcKp6d_oyssh53W zO{#Wpo{DaLr(r@h#t`((t2KPH(2B;wm%S@#{?w7iFPuK(v-8>gPvN7Tsew?1ACc+x zZWnM;x=s+;_V##}r-k@E?b!}Xj=N$R_m}is)c!CZe=R0%oMvCO0--ryYY%A}&wx2C z#Ns#hfBxv}JD;-SVZH?n{xlO$L{hq(lCbZZ49lsZ_NjZ-z}oHG?mg|zmeQ+~XJ1^I zuei}`gY6TT`uiBpV!U1CQ3n+0?b8b2Aw-O)p>fW&=bifY%<41FqdX-;{#)V7e96=< zc}6IN5gules;J~*woStv=97Mhj4qb}wD<|bIP7v+F~}hvo;<(Z$KQST&ki(*hvD+W ze8r7kA-7HramAXSM(znEIf`l00W%In zIG8V)+NBX3x~Qb@T3orlZMWg5H~zqji8tJRY1Ps9_gy;LEJ%!l`5FXyYsC>sKC=3% z%b_62Du;UM_i%{NKaU&y+dEgy&sSa}`N90A)7P>gfD1rZJ34~ENslRDxo!lHM$$CM$dHPRvh4z`4-5&0u z^@Q&^9M?JN>EPvnByg}jJ0P(g4D??r0egL+zL)!Y>c6=!C-IOQ_swKed&PY`+h9q< z{`mhv`=A8=FGwJs{-5iH{=77d=YF2+hHmq{9_HYE^CfVwJ!`(q4u<&em4LmzoPvhv zVsz$LKqLVW>9earb3mtpXwjM8L74)|135wCLDN9AfnXG95a?JCZEQ#d4FwGb4FUBB z4Fr+DY!LaQy{a8e;&~Ibl{9yvu?UYd=w3H^o2lRHe)v8fcS?te#xqP5mUSN#ACHfS zA1hw+f6)Bjkw8=Z|77zqxm?i3rb9skK)ImXK_|hH?jM4EH*9+Ei|PiIe^PO3#O)ckACyOW-ZXX(Z}p7sx1J*ylBb~`ZNE;Zia zmV=KD%eOhq9Xa|s<`$$&@i=8%(Y{4L?{sfn|G^V)di-%}^U08Z+BeI5$o{@;TX9f7LVbbD|FpA6X)iusbMT^hz= zo`s0hlp&W=AAsmMwgU$lCy4GEIv;XmUdisG=KpjAjl0N@bvUlfmrU)_FpjAeHEAu5& zyVS!Ww|uK}rAaEhkL7>z90l4#LfaPUj0qa!CWCr|`hsYFHwZ*yB_1QuT#v?8wAUg7 zlm*HGO$W^a(U{Btm4Skw`JjtIi$Tjlw}9>etp`01dJFV1=m!wCkjwL?2f#iNG#%st zEd>1y^f>4}(668#s0`_#IiTx6&w^+p_W%^!0?>`14?xK+5eMi|P&*8gia^hR`eQ(S z4X6zUl^229BqAQr@mL^#4KyEv^bzfa_yzO|27hZY_`3;*i zm21D=|KO_h@xV`ptdnqMzGP~bdgUd@RozgL(d$pw;VN>c8NYqs3Ppe0&yS7S{nkxy zKwQ#L2x?E5Z?Yp+Jsk4gzU?Gk)LwTeUP@>w*(+Rh>E{bN~p)@`0co+_^{WUfoK&w7Xe5B$?!7!JvdeZ zui?pEa21jLgX~Yov1p_fM)n37k0jKMOfSW zfpn-hjRo8|2AEC-o8z_<>=!r654i9e0; zH%(@Gxmz6vuC}+AIF?i;J#7JnKaKI@!j)l`yS$1* ze7Dwvk39JzZLXP+UcZNoi9NnQJow`AogbfZHnl@!$R?>XUoy2zw4HIg@rpz+H9Kg& zGRZrYm1iBt`Z#brap}~(AKdjbc9<%|IGC?Nkhc*W^wzBhhxZ5E4MNe&c`nYgruNGT zqWBwXcN4$7Z_N3{U6SoMm@gC8E)g8Lt{QrUQjPC}sTq|;=3(d!3rNS6l^z?{*+okq zZa4I-SM9i%uR)TxjpBl!(haXs>e z4b`QFc+HLXp#OssXpRK*elKaFDuGT!An$DNGf=!+QhwfZ$k1*B&DTt&zYe%E-=21Z z?-78hzsF_H@v^<@q?ycgMDm|rk4ZjCTJ|SC`2U~;{^upI3`z3*HXNfK=Vm#?6W4{q zgC;$Tkbl}&0+qJhgGKvHXwL%uCxrloA)@~jMm;@l4$%DB@CTUe z!C(g^Ai^ko)ZRAq-WG|+UN%XOOLc*b-JSV!`R1VgrzCK&J^NGQI~e%COairdULHSg z#khp}XD5i-DY~b=Uq27)!w;6{TyyrzXK*`4HtDIEkG~cZ(SJ6iNSB)iS&{qYNzoGEWeB$XQ&nO{vuskdz7l-K-`vT?ifJ%IX*GJ!& zjjkutHwkh095be1y9y4$Gb7V+CS!8|CC)f$yps&#?}H>~v=)Dz==y8ID+{vetavgc zOB!c0Uoy2zgE;eyGIbo{L>D&DxUp^*#LM6 z;2e_KTBLX`x%j#n&NMz~jq;mtGGBuzZ<~Qr9pgkG5mLvMo7c4b5+}A6?|%K}>`Pue zx0M|i^ZyL4QlHq{Zc=OETNBvy?DoX{c3jN=6Sy)0zF;uZpfYF* z4Uy^imd$8dZtJsKi_C>99{7jnFrOVC^Zx`sIu5ej$TD1&bSN-oDohx}@*9%hG``Z3 zB=Jh#vAbWJ_x+E@QeYUa7tB}O=(QQ;O^GhA%0q`Dn(!>`%k~)fDAmjft4{u;?P1T+ z`SfI{o*#xQ^CeTeGy`A$^eHnvL3K24xm+`x?(*WR!7{cmt}MrDe9N|}_GQ^Am`Qy* zy!-Oxk2>1(nfV$-dD{$}wygsyuXTJ~Piq<!&`@0?{1}=xpH`x)Z8TeHDOk&d-=P+Voe6wc7 zmfxMdJEh$><&$)JY#jcgqjTD9?q_PA zlzb@Hna}aEZJt9s!#CIPN(gj_x3jEFGJ??VL=MxM=_>PJrQIBugb@Lkt98Id`M~*x zTgP}@^nEzSn-f2K_Vv@~H6e>>j33v22s3kOdka@ij$D^p7DkP+@I5yCyR~yZ?c?Y0 zY&XV_51*$5NBLTy>EpRQap1aX-F<0ECw1Duc-U@?-wa&l{sbJnT? zGgU3){B3A_eB}2vhyT>q`2pi2y&GxY?0j~gl#yc|?=LGI>VQj@EIr@ES+UD|r=90c zT)A>JZ;O`sOu5Z`PLFMKn}&IKB({uXxV$;8x!B4jw{M{2`>G6gdJPWXEY^3l=(tt@ zmtLOeSzCeh{p*X@ZG8FmD;}H3=_(02gq_dsdH4`_0JSSMD-`kvCwcQxjd<2FlZ0 z3%ayWp>Oe9YIN$=l}OGY=4-fI)HuUoB!``Bl4Om+wA@b@`<_7~ID= zRQbYwU>l#^Bl#$+JT{buYQU1)c0)7>(94l1jGcc|!t>vHv3Ssh96zUT=d*hxecr{| zz_$>{uciG14vN-zYU= z%jf=|U-*CQy$O6%)z&_IIsgSl5aoiR5=68JMg&9@ho%%LbEO5U2sE^zjg%%PEfi6S zh+4#ax)82bB z%oj}M!TTE`Q?YahsVMn`t13KMe#Jy5_w$5x(3GVg% zasC5!pPlAnJ+OS{ivW~|Rlao{Mi>p;tLbC&6|r$p@W)L#CD3*H^7qQ9B7-3x4m_DJ zn9752a0j#D^%oID`aC7=1*6PM4bM|R-9Quttw3Z)<3RML_Erjr)>6>iawC)Ie}c;Y zQ+uBcVVA#HzWIOl!|u$V%K!eaya@~8(DDAS2tO?3|BMEzkWi=`i?;4!kohY(jnlt0 zu1o(90dZ%JN>&>9B0lA-!{*-Np84cPHQ^hBf=)Vd1LLXKwCMMhV4;Ax5>#!MZHq(xH5ucV4?W`hb9MR5S7p<; zjeIB1AeX~!SPwy~9tvPb19>z^F#eV+sR?IvyJo;nZ~tj`>NuEBZd6kr2Zd-ISFedf z?&c$VpIFegEfrD1NTk^Rpz+yWk&9id;x0=eI0Og$d(%p-zc*UEU!At>#H_-JRFn$C za&8~)wB%k1SQIJdMf9(=)C@#iUlA=nW6K}yEiJfJpr0e z7(Q_#j}^(0^N@lscZ&V^N5z_Xm+jd)n2w7RM&^e^L+7)-g3kgZ+C8f~Am1)sNl!}WB*e3r{^MSl1*5YN#~8*K{J$4CtInG$b}qbh$KsAtKl|=_%0pyi zeo8QyFS(JYf+xd0Etu`a{kP)I=3*K>fP4f%>GfYduY>xK)aGpoqCOIq=h-1I<|FY6;^ zx;>svuVigKdQ8)6Ssvrj`E1`Xo*uS%7R7;Q`LA!Bvo7O$`WeD79-Ytj4dXHOLk=3y zPwG|n`svhY`AZ2YNwZiUvXuO&=_m7Qd;N5M`t0)8%I^J|<*|NrKHE2p$JCF8$I||d15bCmCpR%y9m{fwo;u$ihpCT|C4MZr;_Hzu>7{&zy3|ZSJsCvZsg}Ux!^16(l+P;`X%>-c>kIrZNhVf+i{B#Q}&D;Ai-JliB zDz54{aE+U>WMA(A`8@4`7$bvuSB-z@xab!|3PcrG+O_ujda<@m_4r-u6D1y*p2!#T z84thX*OxWptGIT=fvfyU-@40o-QJJovc7aa+sBW~n!u_M0H?3=nfCg6Zo#g7gYK(6 zo#iqvozM31cS_nY4yJMAfQM~3m~d}&*Myuk0L z7LK)_UUZ$k+*ZFL($4!6$w9Du4S-#F^drf{8%6{x)i698UVfgo7Z~yyGD{FiIHyx^j96rm}`E0Mt zH@60bHK5Ah8;AV%6F)8fY0l`;96rm}`E0Mr5C0oY|3x?0|NhxW{PoQ*PqnJI9zy5a z$(O0$I)7akhx}HfH?%m|tqXS-!ueh2+sP+IP%XlGP|Ka78}0RQ^%X--828X{Z{^DJ=@Fon))%k3%$xRRVrlQ<&RZqIsf_bZd=m}6lWkIrX%6;Ct}YP?j& zA^)`N7B64^z?S_SKFinnY_G_dt81~B#amKO4VLuLc8z(nY1-1!UwzDS7>CYhdj&@(c3=ASB%!9y)SK<~&@RdKqx;7* zzvu8-zRqWRMSfpjAW-Hn4RdmQrP$mcCmA?-TJ%vJ2cCJmyV$!JYg7*&S(3u zbgT)Tf=Q)fY^4<+lv#ix1c#hIQg5->$G#a;9^UtAlL;I?%h&mAugIr%8^+T`hNVSx zLI-O8SQUr-b50!FVdW`3=WzHeU+1&EA|Hi?xs4&c*q1*EJ4?lgl`ObI@W6WLcB{P} z-n(Ml+S<}FLs$;u(D`g16^9~UO_w!s$S)h-f6j)zcW>wLS-#F^dqw_GBmp-Hi9+Wv zbXTX~h<)>a0mt;9#!KdH_WF3H|Cz5Zy?@z3mdAK>KHDpJum)aiBPsS$+t!@uFsl&L*ui3gE+XBGl5jW1E&vvrTx6m5rwZGKR9_$3d>;}I-l)F zVr9Ro#@OWC$U=7++l+_yPx#N1XUg z?JF#w@#%cFcjeP2eD4G=hBl@-2Tn%mF~mK=Q_KaKnqJCpm!Y}fnZ5`jsgV)~&ky&z zdm=C8GWBy<#Ze*C?2@IcT{vULenqPE=I(&pctcQcZfoX_v|Chco z6=69i;m98rp3x_#`6Ci>1PAls++wob6FnRow8v&5_WzZ50^#xZ5L~nT^11f%|FOBv zzDFKAy@-WK90`WbXZ!l{`;`>AF)3xH1GOAUnP)Hmt%rAbf3EHME{D(Zbw1lSEZ;f8 zQ-}dDZNotb9$6n1z(d9bqOZ_*y+pd$R)#ye25ss_c6Sy2TD0?@?>l(`GPyevu9;76 zRAcTVa*ER+JaSWry5k`P$1Fc(zID6?Q%qtmUEPN<>z2;fHaq^se439VL+hIo@npVW zDi4c3M)eex8*SKuHiBivrIzxm67ucR<8|JmnLQrO8_yz0KB3V0Y#&WNcIgQmVh5_} zP)!#O>=LlU@#=%4f@>GvxsK(?m`gBpKHJ;kaE=TVXX7M~l0xA{EibC$z%#k)3p`g$A$cr?kz4xD}nq}fmlxtOxD}w_s4d0Z_~8h)`{eo4CB%H(iZ0g zsP&*(?pewm%I|%H1-$hm+`=;hP}9{a;3Ii1Q*JWejX>%=&B&E~<{f<4zft0f)YHs| zbBn>^nH-<5IEd2%E8XNf31INl873zM(=W0}!#kXr|cTpMI;F|NM8^<4b9?>xBp3E4*9B z*VN=ANQ;Su&nc>RtM1sd10RgL61Y^kgga!~(>*9Hm)Pfr&+~8FGicKGS@0&z+2&K{ zo7M)W^YG>pu`8DHK#`k@t|~a>cwGhgWLzNnik7~1tz1}faO{gI$&eAx?{py=hT~r*7*!BZd}>e`KCm52mx?9 zYdk3F<&s1$LJz=X%NG~d=^E{G`}brv*3p0 z^1c-LJETYTTL~)Wr}{f`tE_sY-#`nH)qA1J@9Fx<`rLybC7Yp=%w(iH=9}#BYnZ2W zsxN?b7TodeOGg!0%aMbSYgexi8N4pPZg!xCeu>{pDPr4x!hG~HYx)=A@V4H^=_dIuWtHT_rN&GB1)uaxQnkG{4cf@vIJ(K75` zykL(w`()WoKXz_)#im!m7DoC=FmyiK*TXm1GYyI=5O>~*CG_Ge*dM1RQTH6vMV9jc zYY`CP`@8Eku@q6P)1)<;$AD-8i`Hh+y37usQ$bxp^gF4OK)-!3XcUMhU9SMm1kswy zhe0oaJ_RM>ho^$FK{So|JctU_L5ScgP$Duw0CWI!BN9;V1IXU@dQi|lWVm-RRJ7iTp;?2c1~6G%$~oTe%sKUPYW^iRD@C{XDTk2Dw#s3P9enyGjKdkN#PLpG+!CzO|`sAdBB=3 zkc7lIN864VpWFGy8JizYFi!8?ugigEL#jzGncWFeKJx`rc}V$ETwkPv476{HVDA9Y z@22)-D&+D#f0M_2)2lV?)PBG^4Hrp9a<`1v)vf)-b=tda|6!^{q$m0{%!hM}p#xSX zn$4l0bF{al028=$W|w);0Lm_O0nAzpKGpP+_MlZy(eh8#)}!`s**d5<3zfLA-dy9e zeRMo#sV2b)r>b7IX*l%wA`j>PTyx%#(ta;8POq5z&FCZhb~sy|EZ&1*b{(i0idPZFNY7fj{R03J`N7(=2IP9>d$BkDBx<@{Yy zEw%3gkG`Vq7y9X4_ZN>JyMVT13PW!?H;DNrJN%OQ%Upioq`g8oz=&=t^p@hR2k({0 z>wSI2;<%S7nEnp1#}GakSIP=&yivL10i_HwjM7Wa`?cjq2}bLqzn!xA;^)&SKFJU+ zD*u=-n94)qvWN~}KTFQkcv=Mclpa_w(eigq^6pi4{4qi*5N;QUmgjc{ zVEn^FwNtvU9Oq1-1whj&150?hz6DQ9bJU;l==DMBLkY(GN2Y%8*1M~hjLwwu2oLFl z`H~xXTJd0g#6%oqOyl#;oPfvU9Es^2I-CPH&r+&E-Hu;M@x$#>YBx5AVs=CE$K%}| z_HTkmZHaE6qd+MjiXT!E>5$$s{m5_npACJh|1&?@J6?Cu{QkG{DB9Kdq2KxPfdr!i zMZ_VPMR3dcuo~%(bnODsTQ5JmjY&5CJZr+TguCuo@fSrb%yEclN_Whc+{knIBQ=>YKu=oIMcCsfk!p*=kANYv%P50%wx7q@*Bj$vFN`ik~DJw0vjDwOC?Ey>0My;v2N4W86_>T9UIs1jD&*t)& z+&6|V=93%Mu)Z^V`8Wi+q%<3Yp4dZ&l2GbjjKgBGFa%GG!|@n}8o?1wA3ImiD{Z^w zo_gyhb-oA)55~cAWxO*gYdfnt4*Bg1FMl*p(Yh6fFA?LMEsf9i(d7>>!Ei7R+{5A6 zRQbWE@zHISy&j(Wsbk~c=UkO7eMi!T&S(4RIM9B`r_BPsa6PT!SQiJ5b+26e@TS?f z9bh@E51r5U4dC!$_gHypnY);CWC$KOUG!dUuaBHt#y&Xg$?w{+9LAyZ**-dsbf0h1 zWOo2PM^*m1IOK1B^P9XL$A9@KhtKkLKHE1Szsy@)DrT6}cu0HP{`Y_CeP_sDwU>_L z@L9gjXZz^#&2r-6GOz4CTlG*A2aanWZL&TqI3vVz7>CYh`{+2#!4x>6fH)nbt+Cg` zZ9U$4sOa%|JZ&E?FLi!w`P|G8TJq&)$R`9Y5WSN@R4=IWLw%MT7d$`dt#i!kQn;h` zJ@et*V)*x8>IwMFGLnlbr&4KJaAZAUuZO9XpPt<2vhU}xFzF+~(D`i7I9RwWClyqt zL$w`U8wZZdMrU+5VaU)YSq|gS`D`B@2kp2nHWQ~6lbTP8*4pc3$^IJG)?KGu%JLYG z&S(4RcuXk$G3+!=x>Rx0#et*al}Ww#J-oKw`d*zM8%KW+x}ms8n@de=e(^tP-_N;j z!p^L-KP;Kda#$ZapY2&6=y3*0oul0)rLG`OWgqIMOB90WN5CQH*OpIN<3sP)P?-Li zPcGTu7_f=H$*_E#FKr|BxpJH@Mt&)^I%VHVu6Mz7YeAWufAWN}Q5cr?Zyfk;S@yfb zb@9&^wlM(^K02q7`6fI3V*S|R%f>hYhOqmVnfv$EaWUg*tKO&`M7=b}I`jjt*hfRW zhWE4Qn>~H%Nds9h>rLmgJ>$aibfFK@7}?c=D83qM_i`CW?LIVTMH`sR_`lH zT(ahipHI5_Gq8o}Y(90qX>AP8?i-lqFLjDsfK-=H{~<;47<7)0E-kRO?^-^C9|z+C z(U+bt9M2{gZ{#nyB{*Q|`sw5l<}?uXyO=MS%7f$ACf!-a9jbtXf#AWJ?>If9emh++RKRva&$+vgkgkoD5a-RZU%s1KLmpRfbr`garrPbfG`4qdZ zvi(@AXpXF6G#po*p^{t&pIn|)Z?MO6_O6e<3!Ggwmjx0YigBIK_I7wAP|U&60EfBy zMGSP&5&M^TO6B_C02rtH+Ruda{UY8`}$Riu?IsK9KJ8<-tFr-ha zADC~l!>&q33P6^In>l zCd0UxFS(It!?>_sL>zF0F>6cgyD+<2Si(2hRUjzFSM-96Jx+ho<~!QGHY4ZNzGNef z7}iINPUo}zF!vO1p{Td8lA5NRM|*K@dnqMB+9OdKD9ab4Cn}D*IB>kwZ|@K7+H~5& za!604EuGKy^>EOHM?DnQc1GKm?Des9Qtwax%76M#meWambTV{4+t-(-hhR{8wP!^fgq$A9qq$Tal(S8Yi! zJ{@sS<0l5ppU=OaZB5VZ}dZX%HqAwJ?T4Y_TIA4iafogCJ{f0PEQkeI0)Hou9+@Rt-ce�|KclaYBLp&nn_(tZ|Ne_k-kjZL)J_fw3%X!tTi zxdX5M_^#tED-IeP$C5;&4)}`4yf-FqTY_=D=*OGN_d^}er~Va>*U-2=uK}TUGxfV@jGx9v zX&nyz9zYfAS!(dD)+dATKN;%39g1-risOHy+iHXrZr3B;s19_2C|c;7%3gJTVCv`3 z4_e^-gj68R81t#~O>09rnaJ6%+>b?fG;-lC#sTZJ0dEx6Nc#G^{WOb*ZHwYS5Kloy znJ34GF_~K!s|7Y#K+}GMM4#uhT+1>`HtE|8q7tU1(koDaW+s>vXx8+ydHV}Z!SqhR zY%23jcK8*(yfx^gMP{^viUu^oi!LkRlJjX5?pA~OaB4A8nrtj^YPFh2~y{7`UUqJnm z|G_7xzPaWnvm;3_(hKuN0Lp^~{ssnpSeuB+bn{dd8W{A@xh~~iPtaVzKx+v&9p~<} z>P4TQpy0n<+oyEw&lBm20AUC@?FV7L$qv5;miWuCYSrhZYGPqjb%ZLfjeP_`aFq*o^U5DvRItbzakX+UiUY(sfV`NajIH_b^>TR`1+*!#YY z3!j`{N?mDTXl)y?8*^3g%k^Q(r}ntUx%Thg zdPnCuB$Eu|()rT1AzV-mPI^Nd0SzV36=m39(hxp%eMMCq_#P}uzjIXMzaD4#j8EsY zeS>JJj5C|qcY|{&8YFU7x6{L1){HL>GzapHx>SR#QAH;9T}<5K8DVhwuTWc z{bqOz#PV}$hN3wtoT@ndU&O{y+xuwazNxFn^=Ns{6I5oBp{-xkA7Q@aMxN1dkbIQT zg%}G7;&`PJ+(%$ZzXxq_q%BM`Rxf`1zLBn)g|kgj=i^N{m>)qPztr?=RRhjy^_GZ? zMJ}sATplmlZOuo~`bDl@_bl1zX*VdJJi~MVCE>|@!BietcZXgy9X1i^)?-vN%r?8% zBRpk6k829E{G11Z;r~gP=u(k_!d=(pqBI1btqgCm?=EakA{8+)7yC7T}X@>$o{7zg9j z`D`C41DqC|ICe)2orzU!F<`3exmE!mAq?vg-!%7E(H?8KlaF##4NW%cvft`Bc#C&7 zA6$01Y;l^!0zv0f!X%Q$D+x3Tf`9+qsh zy05y@_0{y_bUe(rfWbd;;mO95Rtd;bpKk^piVxNgeN&s1=LdHVIU!RWIg28QLc@oOUH&pG5(&l z3+s62t$sWAtR!Q2o43QO_jf{k!T)&YV8yhepRs zc@DfNeKKEiBhQF1F^{I}LrJ01k2>Daa(`?*y?Z4Y_l}!&apAU8U(@k0KY~Pl#f?YP zl&YsH8(cfEi@o`*jjQHA+v>>Q(xhA}Pe@P9m)ywH4i^=1X5T<~s=|}gaoT~{dMZCR z$$0L-%G)l8rm-`fgg@=cgguW_Q3nr5EOtf7K{* zv(cZF#Y==KnlEa{R?SyMKgPyGaw;c0cV*A7wublnuNA`A*5fm#2KqU2Z+Qe)rn{t| z*aLJt{-DNBEpWwZCy=bc??3sh(W;>N08=o%6N~|2zR3>1Mhf{i+;BL?r7tL?lyznPi9_0%LRlaS$>n!@0D#{bE5K#TBbT_v5(&=zzYh^q5;AX-;M zZBJ^4cK~$+bplZbursI&=nN2@QE(QhCy34}I1fZ+Wg4h2i1OuN&~Olqb<;w%%Rp|> zM9?JA6`-l0t3k6sb3k)Ji$V8-9s<#T=X%g4&^FMApxvPTpua#zBI=F@bq1Xa8VI@+ zR1BH{ng^-|(H40uV=~YLH&PIJRL`V=#(}N@-2>VP+5nE<*Cv;njabSetx zv7m*ZcR{T&;C2aU8R#2O9}G0#3fc`yZ(!B`uFNV^Y_mY9qCd=O~?w_(hlh~F>?{TW2sR7BcZMB0E^sKe)AjW8nZ zL`2%@_rf0{?N&ru9U^V(CSZ9BeVC7+qdkW4>;Z~zoPpmw!8q71!FcoZ1Y^>93C7Mr z*hhC+f{{~#^R%x;nY#dX4<#7wUPv(JVvS5+v`a5KBGI_x)I?)U-$Y}XJJFbaEg}l} zl*%+D14}=v_wUwnjo0L==dw+|w(Z$x&1!Sh@#Gl>q2XK(3Rm(4Q+c3%bNl_cagDdN z($WrbM6c4=fcpv%w>N4u90joRfcU&le4_oZ_&o0!E5hqr2nW@I%qKUhK^t%)R#Q98 z^>b99PVqQV+L#vXHiQqxk%q(dknF?dDw47o8&ucH-Fn4}k(1V6NZDB!!a-Wm`GSoH zF!4c{J!IoFX@{MvX^-3e8I*e zT6<%7$taYra=cs&-H5pb>0=dMtdG#2_U()V-aaQ@wJH5>w<(a`2`IgoZ?eO$NW#ES zKKh;5+>C0+9mp?|7kYx5?<*-mH3SPRtu^nV_4|i-CwYpe4J^Too~JMXMN%rU_RCuS zMOusKk6a)dhu0bIK!G*zhYv=zyzbfO?k9&Zo#2J)MdnLxnLR5~d1I!oz&YjXdMUgLWg; znwET)Dspc`KRTZ3{G*K>?T>T4`_8g1Qj;=$5gz78kjO8)^u_a5AvouBm6<4WjSD=I zqsLP_mk&7e$3kQScgNUUYHMW79-E+9Z4w%V<}k3CXeXmY*ugG*p-0L4CQ?) z>X45SQW~fNU{IBaI{yZ|QPqgOo~V*c&B^~!g^B;^S5W&1RfzEiXb|W)6dEt$JsOT~ zU?t*zGTOhAY4T&)u|swvwPzR?v&DbGJA~iB>0>j}2mMADh<-DDQ(4U8p!hTnoN(!z z3zjv0hrY>3-6YiGOIx(950RF(#s}bTv&80*j~-Ixk*yPEMLzj&IFRkDg!1!^v|d4NGj>$BmmNKz16!2ggfZvVFXK+3NGLm!7sZll@CP zNruj6`+7LC%lv+vT^7vD7(s4AAeLVX`SiOuUK-;YO-DmLPwL8B7q5F^(Y2SD(IVVa zt&_+&;8tx1~WneKMcisK!i&&K&3g z*N)QuC1I`p{wnIAz_>v4`{-Wlu};=_ReRDy^)mE2QbiPGiY>3`ChMby@A38H$R`kB4x#lt>{PIk3QM+=p&&cIvSPZq*HMB)Wr$L9oHuq zkD|ZQtVyDA+~`DO=9)yK>q%&r-I-(*oR(}{z9rdsuA-5Vk>A(|jc;PyKQqNx^>$O^ z_EAR|{r}P2Xx6TUah>mIt-y6Pn9RJc19Pv(<<)oAHOUc6zJspO8@2P}VG z9P%g4-B{Z0%<p@M1ygyje3})e#7Rp!sj!d>@36~HyCsdiR^o$kWj3?d zOUlK$e{>7{`gXb*0OMjlhs*DJxO5cPDCWSpK^?>ypdap3uJP0{5~lpndXyMl-A z&t*R2;5Xwj^R>7^$<&wFa!Xrp$*roFJoKf>sOd#7U)=k)oK^neqSI(Bg$%t;#*_Ji zsXQ15IurEEmGT8Q3k{s?$MnA0a+jW}@#1(&Ins(JTDzo0QpRcTKmOdC zH|Y9fz6d~hMAskV8j5qP6l_>(U0muGzExb?;=q;q#wB%a&RVsns}ir&-ekT4Nqk1f z)vpALn9Drq912vlYK_iC#|zuNMO<3a|4~+bMXO(@4fu5Wn2TDCT&3VT1-O{6Q5Cc7t3EA4b$zvn||D0uz>Jj^FIs>#NZ zWgL`0n(m;(NCZY5Fb0i;Ug*WfBRct5a&X?Lxb7v4P-F}-FfFq{6$0gaS`C~eo^fKx zQH&F3Vjwng>eL_bud(mA&AXnsaymu>rIBzG>halL?$^q|B9>CzsS?0^aCwfeEWb!J z&Vpv6*;9}{P41Y&oprLq!~R3~V0@{#>q^B(Wf~QJ>Udk9#l>HFRyG-p>RlLmCm8(< z=9}#Bi^sVlb4b>~wh&yh{JqCmLaw9z?y3r^5D>{%_lxXc ziMEzs|FXpXPx%5v0XdUp>-qfMlHVn#)`u*%jKHU86jUBtmz-fYq zrgJl`yx;p$OTFV^#x^ssLkIWGys$d8VI5}uEC%oAXFp9Fwk&N z7KrAfMu4(GIiQiCQJ~SFTo8?4UJ4om!f>H67Bmht9+U@igC>CTK?NWWXd(#7Q?C2M z`*IM9H=`Id8B_xDf&8E=KmicNZz-q@GzCQCrIgO7ioOyw9ds4wYS1+x8Ym2bt_95m zT?d*4x*l``=tdCL4>aa_6KD?TX3#C5TS2#hDnYk{=7Q#d=7Sc1?f@+WEdt#Mq7L6( zpe3NCpu0i$fT}>tK=*>~1KkgL0Q4YeIj9=60`w5*VbCL>m7qsKkAYT!R)Zb~tpPm& zS_^s-^b}|v=xNY1pl3nrLC=An2WJ;0F=!X)6HqPaQ_yFie}X;-eF54H z+5_4P`V#aN=xfk7pl?CnfxZXTf%bv+gARax0R0I13G_4QAm|s+ub|&Rzk~h&{R#RD zL}d+%kr{1Mto0dL{kNH8|BwBk=D^$S5HKSO|0_&W^H&`8U-4`H^L|9qe;%a6hz@Ju zum=7EHBbdi+%Ky*Em0tJ;fZELz45P#VMiNpOqtyF_28?G1~e8<#a01-~d-nKMsM~myFMWaUC*@Prv7^yzkLQ=eeI< zmio(rZan@)bqwKSz6d~h*y3vdSp~ufLWxU#&1oCH*a6ocdxMj*F;Ox&-E>=yH{sxM3MGhopHik| zOT_h@#LZBDf3@=aNrpZyNrB!!cIJaW{r=DL3r!I8qWN3qlN;6Wjl$TxVJd+}19N<| z9w0mk)ZID{ns&O@&xV525NIVD#g8=ZeguWTe(19F!c9l?KK2@!fC&frVm`T1%@EHN zPjN=N6Vv>3e&S>-6T)b%xS!9w7%zwknIfz>qv6w1Uxpbms(v;D7a13b05`WaxDQp3E0a<&otM2B-Q01-!Y0|0iwXL}bi!%hA&+_~CR~)WxcwWY{$V z@p`7zTM~_DUb$_}2dBMLz->)>Q~qH-{p0G&7?Ys1 zWnJ9-XgNo?W!KpF@_=vFr$cTzc>J16bbQRWfWtqr@zJ%>154t7X_;@Y22L^@pZa{Q ze{iz#`gP5I{=9m^?D^Elhap{)9+@wg%0tH)Rb}!hS}z7yDT0M>wR}uFBewohD-(?s zuTN=x*1S*G>H1^70!e)8xcGmO&Q!$}V}(Z~T8%3B=5$wUgDVfXTF>0{<%;30D|B4U zKQvtR<5hzv#uXS}r89PXlI*=*i!a-L>V-?y{P_>$Pv+aV36cj=;AU9Eq+?3Sn**x4O}* zC1c;}OhYijFdm)H_9mVY9tfqYYz2(qz>OIw6xmcLjaHqBjJid7$h0#UW%U}t=W*A}Vi ztl}(t9J{}JVbAoR_M@dE4dc-HY#+wq@|xoNm6T%bhq<~5S2F~Iv`!j0(Ezg6?~d;F zcxL@PV8kQ6o}a<;7>~|p`?&GY%ph(tbYmkgmAtB+R>gtqo0Y5Yc5FUC!=l14E}hTz z@#13lYCVwI!(LA}9`*F{^=G_6LzKcW9-Ytjc6c%Z*oPJf4#6^&610fS*puVGobUF= zfvaRni``8&+})PtGA^CZ_J@c|i$!ZZmiM&R+mxo`$KJa9pqj3#;=nWJ)Y7ANY=8SvmdAK>KHJBO zM~^tQyiDz7uctxxU%zSCgyt()F5}YqY#%2sOS`Zp4jjLoa9`>-O}lhuIgCT+v%MXT zVWJ7)E*>a~@o=i*0e>%s%#`>jpLdauefV zoI0QF|ArogR~1*$dG`8yJT!IkxTR~Svs}id^V!}G*9cDm9d}wUW~&eY$7>30YJqWq zNM5vd-}>5@UU+r?8!O2j8OEjarLEHLYoNVl#Z^B>)ppLJIPjfYa!u>k5=zWoZv>yt z|6BOrNsY&D=iBRR*3zYY2W>pPh~=@qbUxeL#bf_sZ(&g>mV}`>DA!8Mnz9N3a6E2{ z1J}TF5-ZQY|BW|TF5}YqY=7vutZ}L8t>^-Kz3ravUwP8Hwe|WxI{$CuGd-&Hc%6nz zAKxV}Uwpshsgqh?u$bkt-gG|OhxH}~ENG05j!zJa(wsv)h3@=m(xsZtLl;{06Aj1t z^EX0Mmg8@lbhf6>E7vmC~u z^VvQQ9JHsx(tcSL2aX$749mG`Nvkd_hjHk9wvPh`9kHt=TiU0 z#~yd)Z7h%R=zO-1g(t^{i}_54YB{ql4je7&I{opyt0^s;5r%Q-e73j6L7ODp#jXNT z-J01wXzf?!rCaq=fWR@8U|9!Sy2(h{Uo-d?mdm(wKHJB_CC2-TvF(PAZ=K?ycr!xq z$n{07h9_FR|8!=Drf1F?lf&{DkIrX%4G*?W7I;f(q{m#3tEQKtzE*uili%d>Js+gr zklcjBXZbpx?PJT2G;P)NVwk7kxDW`19}P$9;8$t}zObiWKSk#s3Jy#~mKF{3=1(f2 zn31LmFOHw8IB@N}u<5o}?sE(@y@%UnI-l+1(T~72ummHSUeUXgjYk=R8h@$%?Bnmc zODy6-snj+C!Ox?D6<7zv$r7NhiF+@)(cKXZ!FeBA9{_ zfTCg1)+f|zIE)+TC6R7Y#$g@z$47`Uke^4rP&$3h?@P~;0EAv>KQ!}MKEJcCC>GH) z0he7m&Dd~)iEAL~+DDp1G?yn(B#JC9ysGi#A8egZr1gWzAU+>%$I2$go7cZ|d!yBT zvQ9JwQ--JcZ04Kn@GBGhjD3M=Slom2ENA`EIDg7`Q%#tOm3WxX;qp5w9#p8=m<$VAZd1agy#Q92jyYsR zP89@DdC2Q)NFK}Nun)ig-)SHO(Oh4p4zn)@S0C7OeDj$zY5R>ZGCmUw=9}#BD+9x_ z#aMF`$z%hA=Dj>(qmP=8)LsBbpY0pKxTjozM1mxYDuq2)WwQZ!gNS*Uz~x@4KONLnUpo z5QcH+e728?!#sqlymY9$m<}m}CpErmFSeG$)F85%%fez1E3s_BZ+RMX6P; z0}>3K&-StOPWc47#~|p`&f8LFC(W0g;O(My&aBhY{{pq`qX;HG15MreDuQYr#!bPG=}9c z4xP{Tv2aAv38S(06RUuSj0;3^qSZ5Ft1i4KWzaqK)&=N%3WrQAJY=uNOX?_leJsrK zU1j`!9c`HthV`NI**=zhsSoK=Ex&6t94+C52A=sIsMOmNjb`p{nSXtBUa*}hh}zlI zj%L2e4!^L{cmPfX_G2A1=7tOSU+SKv2fPJ1(`Tr+P+nPOIj2C?Pv&TA{OJ9Tic1m= z-&5(n!mpqF@JLfK`5;`(4+AnksNaDuDUNf*aTWOT_@j3g@Nee=+R{< zXDZxQJ?Zg9(%LQk;OnDYV;`6KN#=hVS73ewk^JJgvFIeyxCSb;(wqV)4$i{;12cldo+1OIIrs6yh`^Nao)_57j#ue(3||G!TIhs(2npDquF^xv-m zwf)#~g8g}0uU-A-pMPb0e|_1ws_n(X*~(9b7@CjiMExz_oDjfXh9jjq4+Vqye0prKVIPta5?`l9VF zex0`dHQ(BwA}s2B0Lhqj{^CErt9xUc#1U!tF`wM1W`M_6j2#_fXOje?aI(dDc-Rok z2lQf}@MLc=2<+6yC_@vz3W1S+X@5+b#~$BFm)u?1JN>9!9Ut>mZ1k<5amK)>1LJEz z47x8tkAGc8L;p9FM&fnPzp)|r|1bC<2<7;yL3~mAam4_VRGQgg!MrlJx#dW>C+Eo~ zU-wGq1*RiKO`-v2Y$2lak;PHm^7uBx0S_df@@p;RbNCbv>B|9Pdt+k6o)+}!_727V z*(mmDiv4=iUhUuQfIWrjGVQ1fN99u1KX9(l#;qse)A(W9>23CWTq5=;)Boh2o;qK! z@v!{<{vL6WKn`x7l!E|4C+%y;N^*423%X-;82kqu75I#lBXtC*it$V^ReFnNjQ=ialLGqx(-&?CCsC-9AsTFN$Ix zQtX3K?5h-eI@DATzecgYDT;lqVt;ECd!sn=`|pZk?@;WQM6pj(?C*|ZpQqU0AH_bT z*wg(c_%j?JPCr$OJ)K9d+t(=eG!UoT*DCf;M6ov}M}GgaQS2Rx{fklT(-iwxqS)st z_FJOZhZOs*QS7S}dunjv&rtPKqu9S2#lBXtr#nD(|3*pV_is1t)%JNM?8%P{L~m-# zP#wk!&G?%n(g=$j0=qo>XnY&@u(k=62WpI_EM&hQsb1VB9*uENm_w$ziU zJ}aISgx3_5)hoex?TG8>ctYdaeP`}$wd1$X$&L)Y6YyldU@DK{lS{lf>)4440mQK) zSY9QT!KF`=_ZQMKFtpCy;=W1cHZ8TC)7BpwR}FCI-q&j2&j*s86n%i(~+rG7}I_Is()?Lh%3^YzPrxxjtQ#QpCd zMSK{NeH5O|7fj`${oe4BHdW85S6KBNP44F{ZmRjTWb76Wn$x4sXZvV!oo2hTAR9}# zBcg%dZ?`Z z#k_#MzIxw2`<-C-EyuH5#-;PwJ}R!TzQo0!G4ZMGsl9RF>otF9PT~tc+{@z`gs(Bu z5%U=rzoX(4Ye;cbERN-2cPb8l&|XioCZ`_w=Ftg{aJfP_QhhvEUfBu*}>MjezxO6_-9}+IQti|-G;>w$1udgf5df?V?XAG~mUrgu6 z#Fbq(A&5gw%BYL0m7NSt#dR6Ut`m%#ojR3fQtD0)B zuO3(Zuw;9|vo$Q2ap`=vkBW;Ey;w0w8XAtXM6kL6=N~mx@u)a6%k6Q_PaSsI*Eg5G z!Z;YG&S(3mIFi3@_19Ex3U;`R_~vr*fCOdbSMy#6a&by;FzuLdFFm{p#llR$YVjzll9BzvcV1^IWD+=rFDZd^fE%x_vWp5-nJ;uy`5C4TXN?IF^eiYIh+Y&^MFHa6y@4nFwjU2BV+ z8Xo3bz~CPX9u!cKi-w{jQt`CJ?5d%B4t^5YwjH4l$G^1_7lGc`QSSD=Vb3!Z5D(GXQ3p+xK7>fzG= zl%|+ed*YFaW=Fq}?S-Smk3-Tx6_j^4ehx`x|ErEekjCxYyqWg%@6X@!!qGofy|sq( zgv>Ju2J?0B$ij3Ouydpz2WEPBV_swfu%-PE`D9!m3Rhoenet#`W9B*SlLuxMcil^a zk1$O@RQ@wxFqMaS59tUTzl#pPEN?S?K`hnvW8;a*F!z);RL)ggXKlws8~0p$*RS5M zFZtpRvzQb3lkjA|0!e&AG9ADo*A6>z_ZF5X&?*F+%!0#}aYMX33x%4lxaGxhq{hs>rHw49`|;91Z-hgKRTc7t@yO~sfWfoKbUrdeSCdz z=WSoibabUIfiR3m=d-;Pj~ZWAFstB!Q8*lEZ#~brmKEJIv zV#k|AMho?Ee0+Yf8;!mImI2ZHf}cm=st_>at-R4b9*5nK-+IM)@7%+9SZ_L??X7s# zc#H>~b)7(Jg?+p}cVnxHKHoeOp08zmIzKwTaJ<@rt3m**x6Qz17tjA(nOK?uY^M^|3_u-!$eL{*uP4-1J)gLB1#iC)zlUliogW>a8n0F~ zDvlk%L5A}~v~u*PiKS26xMk>PEQjMy=d-<4PvQ8pf`H>H5XV>fO;#KQu%q#kgCM>S zv!H3&myhRkrtZHmj6>(MJ*^@11oAyj)Mxn~aVaKZ1sfa?HTa;xEgFK$4|x5w7Ea9X zgzqyzAk`qo=a^$3Ur%&8@s3%iEpAU`3K@DQ;K_W!R33bOyG+;tao#db_|d)$k9wYa z^z-`phyly_>D%JKd3w=n_YHEq{-lnR`3gkw85?K)^WAOWTJ&0evo+rJ{&w2vWaE<4 zJIsEj)f+S4F@X_oYHucvr-4YvTZEmvBt5vY}*m_*UmT2px>N&YwB?wZ*|QiJ2Lc6z?1ocsXV9#7u)gl zbAS2;0=|HAgvVVl!jq2*BPcy_KbG@9ab+DDc`Lz(?NlCrvp@d-UwJbwDkpO1+OHE_ zxH9j)jw}4b7z4i-nS31!76XbCY;fvMUr(UaJCWAf%Y%||uBf~-h{hA;`gL5TKEfkb z4>}MKm3y=NuDm24H?Ljwt%!^Jy~D;Z`kA z%kQw)$A&p~T>bIa4-Tw{!{i?Vj%-gM^~veZpRigi>89mEdpxtxJigbZqyCw$<6-`x z;K7wT;XCL0`bs8x3nRGHbh9W9T#LqS`ElL0h4u8r{DyE@(+$ohERA3wKPnE#B5S)q zA2%iUFC?^hE&ufu4*Dk3$b9O2!NvpY?(x&9NDL02fX*5gBB0WvK~%b?kg7j9q!5Bz z?x$4&2epS>poYvd=hwZL->#tNRpTFej*bUUNRcj|HTk-~k%Nai&2kXy(S3fur@%>T zF;R(Rx`RcA10J{@seybBe`fXFmfdxzxIHZ0U^CdU(w9KQ84q*LA4ys;vf!Sgk$@PWPik^>NJ?AG~PZrzc-q3oBtL4Ej|%U$F78oG*eH?d$VR@_ND} z0laL(NQGO%$?YpjXGFSD%dxb(ta^=>FFGCD<&S$ijc&u?j1?ba4V};S!`xH6SZj$P z3ulHezl;hlS1{)_b-+XVVEsi)e|d!+2jwPS+I)g3 zklqQ#1cUh|JN%;bC$|j-Ie!Q{2c8_SJ0O?y#qF=JzJS($sCp_|V%1Z$aj0MOj=Lc1 z)@8qn!10(bPT`v0Oy{#b4XR?};sjjoRyvIuSmHuA9OLP9<>mxD9<0=Xo_y0df>k^R zfrk*Wp6FXoXSMy;Uvk?+7k$luEj;b`ji2PK6NPkprELv)h=b3Lt%^N=GblMgtjKh5Dd})jIHiv*m9LwxO zGiG7{2Q$l@tG27U-EED(XzBdf-*R?_E*WE%9&!y3J#{|gi&p+;;P_>%q$u>zVV1bR zGTW1nBO*(uQQO{QdQ{VU#XVMBo8gAyyBc^)FaGX@Z5JjP8=F5+{@Ixqy~Yy{4%kz< z#(ey1F*x`K=V!W6IiVSaWQEPL1-_~O^XIg+1_~-9jsww}{S!g$K_`Pcfv9}y0&;@r zH`4kmT60CeD+5GpsA#>^NYG`Vd=M=@rb7X*2Hgmn3%VQhFz9Iz=?kiuftL{iae7Rt zimg|FT9Wb5lQTNqbIhJfU9ZfiFjZsGtK3Jxsuj-Ecn#UeZ<(HCFEcZt-un-VLo-fv=wsAbERlV zT6}WS5)dljkmXmzA%A1=+qa&p{qQpm-yuF6hR$bu{BA{lmKW=k=x{3w267t$F^-gb z?e&m5=HpY2eR2C}@=L~HK6Soe<6+VNz!HH;i3Ur3u_zAtdpixA(|u}qI5sR_=PU9R zJ@hRLmii{+D9wWUF(Q4a@#478ULS4d@0jfqoiAX&3}SbV}~E#6H3@H1Lq3PbuKJj@qN<)Ppat2lCeQXT9>O(&TTSoNXHuj`*= zoci^m=!?9@4SxLt{-BHKEe3sAeh%8!C z62QHyQV&ivdOU?VIj@B7{Gm1(CgglnYfGQ1eu^H9t)Fg#l8jzcGOnE2re;$6_R_xt zFNz=LOK#-ZATCQPvFgWI9vjED!N4*4gvTk38eS5iJI*6kK^L zV(TYsM3OOX)s7xduNro|j*IybMDi;xTrpx$EwAfr@YQ7}8E1uzcjpawbm=o~rF?3K zQv5OhZ{bt&Vif}5c&vOVw!SJyCK->czVM;>t`pzT@i6~i!&5&-S1I_?9*&K#+vp@? z!MFh}HZJqOqT^%!zlbkJ%*v3}{JGf%@3vf&Yc0N?-*(EX+Lszh|6KnuKL%bgD97dg zNOWh5Wfee8WJ~_cdnC5r{Ff#f@4EJV-~NRwM(a43|95cIk4Zsb}lBnE$tM#fU{U{wjbk0RnhjA{pNlP3r#lbH91`f~hOs4Z|2CzQ!0jpB*UW zM?ZIqg5fZjZ?eNL3oaV45f^EMhol?CMd4C8M)Qk1fQ!e!rfz?}J>@CY{-9$2M?tLZ%A?fe#@l`KZQ48t~8%I-?TQ+w=z%m3Of6h`*H3L4JEpZaYPw@ zB<4xYsZUd`6F&K2ulO_)=TZ}&5g6?Z0}fk>)3}Aq<4exP`%20lO2A=#ADvNM~+n-n{9BU z%x!Lb)#vt)zOMM<0UZbP!vM^Wm^j3(h{H>Y(biYn8M%+g)&~W>zvjo2ldE5$ZGXaW z{OEkPkBP%_7oqf_;@KMqo~s&K?wAh}`e^IkBcqdSZBe zrh}MdIjpv69p8uZv=AUR!E*Wm;F<){cPnMruK(2 z#5lN`FC0(B{+)~5$;QagMW^<^-09|m%mJK~4w)bMh4QQ6-duxR>C;Ur_PtQ*k>J?Zw%`l6ILT~hGh6AW1vk( zrPepS*V*Ign|W~bEhqeO56h!;K&e6Jv%MW2R*Z_H1~^C`tQTru(fT{fxsMa_&Rje< zMAII^FpeKIKHEpbf#C>R@lQtNa9=)l!zqco+739;1n0n;a5LXz zhhKja_b42W;p^-6mzD)QxPdSVa8p7J-i*KE+1PsD3;ZLWo;vNa)UMy@_?aIDZhrht z{I0SBZ(R7*a;EKiEBU+rzzb3fyBh!2OM^V!~9?1R&P=&%+niNv`?blD2# z=y3-i9Wd(&P{RP-5#dGc_pJgRGMvBld4_H!$;MmR)!$@$+pVh>4F$uXelev7=8FK7 zhh<%eSXW#x=XP zNazC3X?QYUfg(QR#KRfg(jUov-l`ux-g1M<#;o(k!O8!yOdpLfWZ?eNL1y2s{yDKe4eM#5W_KI7Hc(PG8KI+{iN;E?LLt_-MVESlgf=QuUPja%?@-g_4c4 zPH%OS>(~uF45XM!&z@$N!Ks|4Oq84&!2e z1d;rThAXU}9G|RT6+NkVGB?H66G?ck_4wWQIPQFj<&vIATRNZZqv07?Sc1g{h_gTd zvj)YOOo-$^HQs7%@N_FkGUnx6`_Qv*-BhWUQ_N=^{Emi4lvDl6^NZ2QMkCfU5$Hym zw-__BY6QULLd7ew^|Z~CWV~|iIT!t-+XC0c4k?*lR4y=IawE?}#ARs{sQOdmv+d^C zI4fr+8=vO?{&jBIhA&?=p>VoqegvWXiiXpS&w)6cq+X0x!5iysoeiFDvy%Tm_U-~K zimre7_#led*sa)&*c~V;Hg*RB3Q9?+nAqLj*xlXO-QC^Yt?&2D?t$46S-kK2x$fux zKFoD}c6QI~%>3renU148^naY9;?y%uMi@tIOIzfdOgAQnx1t%(Z}UrA-kcAc?$?QZ z+4ks`pY!w0R_t=VW2KZ>cRkmqT$eh{*R8i?dU#;QFVT#T!$RsU4djfGvA&V{&*ansJ%tnFTat)yeIe%=9nXU&SyKjF)sw|`4k82oy-?!Y)(x=Nf z4DUm56F0*K7%G-=cdM@6cW&4z*XF|%#xIW5#QgbPV-@1mzt@V%AJ!WGU>HB=xs2)h z{;0dAl6YAkW3TQLz<#EeIM>gfp5|P;=*Jc!AH?Ot;?Woy})>gDA zX&jNrFR{GKbYpUOOS8O(FVlAF;q9;UYw-!w^x|9<2Qhw`t|n?em@~#_JWQ@)%Zo{dlSTZ$Ekr*2C$0|=o=H9C_9xBH?;33^ zCpBwPzJZ(+IluMkvU{Y7gQ3-J?koBa#JKW%Bra_LMQ^1g!-yP6jl-9n7r#eD^* z=x)Jpxqj2nk541xD%o8hSY}+ftE%y|nRhT<-o%+DKyi8>> ze&^QnFBNwfC8edSfmI2I9aGNP90CL`xZ9rr->LGZ@h(a_$L%ZlP?L%kVEy*eJO^K7JX0y&(4>ajj52W)5iL;qGGy z#Mpy&J>hZMe16nF@nmlHGuJQc^FyY~IAmL1)78IcCP2NLoMNM9km+&OCtV!+^@JF< zBNi#}a;*T>Ps-KCT9jH)=V%6sQr0s_PfaEwc=HeW){nC44l@qEj_ zv39;i>x_2=N6aUEy7_oSWD&t=_j_&5nvbJcXwjr&T0K1^$0PGapDw%0G0FK;-#sY6 zJ&KIc#uFNic)B#bUL=)$${;yD8IL|)c8?++H8lNv3ZX~2eX%`fK7TG9&ZZoz{oAH9vJ%h=Xfbj9^vqcG|2RUCZ zMI(+|d)mynH6buejz`9!PnX^QFkh(4(Z^NZI3b3i&8M~(%;!^qhSu?NwJ4WGj$g*7 zPnX>zkB=+Y4gEO}&pxF%2++mxC>n7*Tj*NdD^vay&8)eY)%}Hhye%YVo=gyGA~oD0SnKnpmXk`qbuD7B9n*hMl@x z8SAK5d)3Aj8jZMa^bU005HKkGek2)}K0UIyM2yjk%JjbGl9$crSLodHMOM$>Jy?!c z#-&e}-J_Xb+#D-%F(Svb`E@E9amBk>ecHoPIF5&)NEF)aM_>IOFFo)?jk6xaAG`W!Uc!@BNYKGA`NHyx_;odw;}|U_3!V z&)WGJN?f9GfEaIN%jK9x^K(sDcC?cCpJ?R#)TbM|@@#Ol-$$gz6@I;28&}C|=8wl8 z9lw@xUir-hTZtROXc8D&%41`?@n?9;_;MEYdWy4`OCaY^y=5&M>I%b=YaP5CB$&%m zuI_vjD@z(%$m5`<#3jdTL%PU|&BpHHILPL@`T4vh_R;eWbFGdT@-bpQ%X9{3(nLRQ z`T7|*!;S6KfX#JLZ*GO`D)w=x^^KEv;<~Y6@L{y%cD?Bh)8!{U-Nbd_Q%p~*=F1lI zRaxnHxI%aTk@ECdcsbCgi~ouy`fznciTo%>H5hbJd~ zQLIuT6}TN#NrSXV2a!MGSe=&X{J&{_d798+TB@g2{X6LAzf2dy)HZ)1AC0x|7&eE$ z%fHo(M9%*(;ueuRK*S}!i_^#2_dK`DbpP#&f(3qgU%E`^?LEDEWdo*}o)PtVRtL5pr(>bXPoD;m)j>sy(wCTc$ZV0w(NfeK#^ zxz*Lrk9`&OP(!=EsCe7_a#!i;ET@NWRvMooHpD4D_31Ly=*JoLa%U1W1J{<9SHvwE z2Z(%&Y`d}Je9yK$a%|rhTl|qm{4X}2GF?s7eEfyDP0G1GUTt}pa>smm2)eha^yJO2 zy+xd&5p7W(WV)KD`G|hJn)0m=lHu7xmg~*LDa*B3=ZF}z)6w>>`RQmj;L^M|L*iKL zr$eSQNR#FdrsJ1#t=5WYJb>1g>ooVwmutUgw=Q&YX*XX6V~E#6(WlGq(T~$ixz+~F zz_sQ25OIsf0V1Br%JswSSJ$4*(5<53pN9X5sg>!Xe{J&@;x;YUx_CnwxLnV9+&5ny zR&JRQFL{A!_WJT5)3vdR@6nG}TdpI5v}G8wJP#p0S)RoLVljaZN*OzBQB?t|=dh+U|@cIU|<@y!zifM3wXh*i6G__b*B4v)t zFULRnbQyH?x0+kbLd0!<=TCKUr>U+bxMfo5{+n!e3t2IqUPf-#BEZp_3>)g zb54)Umy1EWtLH7ArBx1nyfR%As`@qh@oLJoK1haS3t7HBh*Oqt@p4`fi#FfWJT^Za zMXQEgKa%~eqkcMMI)gN6{$M)v<(u1n{Coq%%MQGGD%1GHQ5Zv)>yt~wE8=i~Xh&AQ z&$f1Kd;9HIu^X&5hPW*heY)%({dl7;-;oB-NVLo6m?!4TdEm;~ou*}|aM}=eL^+q~ zGH%)a3-Ozj^WVj-E$=0tnlC4XQgyelSN)Z!u3l|KTP&Y4-IyHSihkUh@*YXBV;G_= zABUn5=dR(NJHLKLi?#(v=Q2G!K;sumVZb>X*Mp{$A=s-{N4$TdggkzKai!BdEha z#HY+>kLTu>!$XVGPbweF%3B6!h~Gldr_1iqk2~t+Fv^KwWMPogk^6=D1;4#_xzFxs*l`Mol~JY;=ke<8`yUaO3~tJ5xWK%XwV zM?dbUmxtd?gf`!Ezc#-dT)*GjdtuWr4fMy$GF`?k+kYW`ljY!dahsHX;x7tux zq91qE<^OjRVN(9znJ@nCu;e-7O-96G>sl=@HjcJU*B&_j@6Vstt}^~h}&Gb zZ&#^ni7)5(?9!JLnJ(j%?dZp?Dfhn%mVw$rmit%4E6e@sNXmWaC-c+uy;UjCNhPPP z&`*y{m(wBJe=t4zaxX3)w{r<_ckuJ9?B&T7IdT6;807lC?Pv4lKFO75=X1q-V=dz` z#BHJI(`EPQ#~XFIk2H8jqAmAnzL+ofvpS}nJE2OPc+4)f5%G(9W@WlDIlT23;x{Sx zzl&RY93Dp8=E{B1pEKf(TD5nxzMRPP@PLh9q93=W+(#0uEyI)L{T6Y`^8O)`@;>IP z`RT}?rRLF*p`Z8Zr$eUyjp@*rcf%z}v3l2Bgbp)Kk66z;e=}d+n@*ehJgI9@c{_Lb zdS0I{lts1lWnY%iOust%KoOx+ubicSo4sfAlIEaXp_ryIHe$BkJknlIb!Y+5VHb z)b}TK;7!$4e1hZ&p-=`S^KHye^ZC~FmDkAFUskQx$0yTeT(bR_;^PjFAaQdRjduBQ zQqQVHoM(yby4!%Vp~K=NX*yP(R}|$j0c!!7t`1c55ovs)3N$3YrvHO+MsoGXG~Q3q zh}Y`HqV1)EawXEoE7SkMcq2J`Z@QeVwltr=r?M|}ymRuVl|EjX{tw0*#aT_$xIJQ< zk2_VZ7xR~Q-}g(okm>(m+)gnT_>HlEdksbwV_hUk=%;$6MXRdo|*|h$wk5{JugYibP_imcM_HoU} z`zl4&y}7cMb&?{33U zwv6vZ<^87_1$05UDit&>hY(rxe=AZxpXr8RNr}BIQ$K? z;_r(IM#S+?-KQ*Wz!vu>i~C;1J%Zx8skm2LJg}G*IguCQdUz3(M0q%(CK{k6#Csz; zqZfuj9A}Ar#w|F8+xUcJ#9t6~;g6{h2eEIFi^GbxmKbDL;}|EFN@dMU$ijs&=na)p>Mz;~O zi+FBT9D|sy&ukN!me0hlIzZ>1e zI!%-ZSwC6Md7Y2;=$Ys~NopgeUmRWN)74}?jL(f#bLW)^qKZlJ++0=9ZibiIHS%+y z-Y4#fP>-|KUbOL4OdNH7(CKa8>_nox-4SEh?JZKHYLfHQCT@#R$w zu7N!J5#a09#a+}`V7j?6ISU;9)kRa1Lu^4q1Y&)WW1PfvOdvS474LMY6l+k{a?$0P{u5mt29YX%S~j<)xK$i zW7`dKb&&zfzz#*9@|dd z8Itm@AuyJBvF))?WV(z?wxbcB`jTElNX9}<&!Ld{=A6uYzEy10HCD;7pXNB|JazQ zy)Dkpcmti`gqAqO^Ww!7zkl*ed)%}+8gXCfRLk;vfbB2$1jO0v~Hr}vk#Jg_!HixU<#vaqhE7N71vi-N>jpR(0c6sZT%6$H|I&yRKkBxI5 z>f@E^GEUk4Tk%G5CQBQ)eQNV@->|AuZgz?Z3-xi!bQ!N~|E;*AIFqG~`%yIFuGu9~ z-##ncdh6qs=`vo~{#$WJaVAR}cW4^(`Msoy)8^PM;y2UBEz@PZvi-N>*6oBF?szc_ zS-U(sr!^njr5F`VaT?$#P&p-xADkm8U9|YoK6ce9H3h$0gCQ&f4UfH9Ga>)OjSf3 zG2#$I?AD8EP6Q5Z)hj{b+L=fbdn=;5m{vi2|6L=xi+*C7=;eTZ{y5Sbrw!EkBjyXI z7S#D6@>JwIrx?`vCFhyQZ!v!a`JJ!7ZDQunZ?h)S4ns(l`)jXQzC_~yk<pTd>^6 zb=etV0UHH%lpRTAEKadT=i7~QeT+2Xu*KxO<15{G zLncj8&!gO`%KHf0zF!ua$5MHo^6i8i$@?!_*}Akk^b9!+LDju^w}c~SQQXuwTvDN)3y)BW^P=h*QR912)c&;P!^YP9cB5m9U;GZHs?RjG{?)eDAZrs9cJjN4jQM-)q zN={)cuQFZquWceLuQJWoUwy%+UA-U|`MN$Ogq~$QxwD$j_uLt`+9i)WR6Js)Hlh`e zAK~eSj! z4QXzPenlhN7JSNdHBs|nKF+#9fpy!nXDHStrtwV4VOoyDa>Y}xx4a_G&|6uu(5hk)B?imw&d#XAGz)# z_WML!VgVQD*~Rr1@!+dCx0(fF70IOt#U8~WZceNMaT2O2+#s&8gkUV@V=K<$C6cg^ z6+uf3gLsJSGsLnv1iY3k@QVf__BM%L)28K{w@sR*S5P@*pSoP333Ug%qVrNkw^HK~Y?sxSmr_Q4Vw6B(W#o zyYRlBL0lVRBeH0@qV(L$^^@z0GX0C9>|*6o#lb?^-N{0^Hr+yLaK=LUktCLKx=}3U z*8EtCEBC_faJ5u=U$9iXn#NX!K8>xU8y81eTgOT%lbt);Q&}sbJcxA=A3w>Yqv7?Nl3kQzi|};uA8qpo<;Jd>uWtu0_a>f!9u8i9K2BU+GQI!s zl$rRN_O?`32K4B^Z~r7?%^ZgPPf@OAx;8fP{m} zw0KDPeMq8Qi@0REVW<(GBCgt;OY}4>SG+Kj4OaNVXM7E9V`rPp<0g8WdnSJ&x9mTvwqe>0$Iq++)x63@VkXv+-&h}h zWBu5g@8b5?+N5{lKQ$oM*|retcX7-v@>!HvRhZyPSXeJQVr-Pd3`+*&~0{<@VGkE9LYt_vd{_Y|JO-wP-{p^k+ zE3TuT3Sv85@e?swN|{!3kaGCd+P!?&p8GiGFMm*95pBJaX?*OX9tm-$xFF6w;S z+|f!&*`-Gh-#uf`>*JE?e?Kn6oL1*B1JmZ)CE^q1+X132);(hTAa)Q%z0tWlB~z|1 zt^K&A-^i`3e$+;6M?`s(>Bi*nR@C_>%NuV#_H*I&M1~cq=y@?@zNIM>^>QHozterz zy5|`amXOP%Xj`x}$aL`^ZS&i>s&wPw2+l&t(5mwiY2)pB?rsh~ZoJgmk)=Wot0Z4U zoO1mj(+%U7zkY3plEIPnr~Rjx2SRij`CqZ!if%vA8Sek;f1)#g^m!xm-LUVV?`rrh z{*x49xsm@D$6sQ3ikWw0LNuG0`4i2I`j`Ipcjk{=E`Arfe)*Bho9NG6zrP#i|5|#? z{Q2*mS@*~dqi(^E&9Q}9a%zsC8G4toYV?O*Y3hntHzYeCyHDcdO9NRb- zw@{8G=zm@ebxPTgW8rtGIhd9?Mx{2ji{Et&Z>h(FpH9A8#v0o{=iAJ6a z62lhb5#8kY_^LLdo9r&Xiw^RCqAi9ae~WH0O-v5_Q#lYy!O|};qO6JMfMS||KL=vw z&%ZwpqKY79{zR2K|9-c~=8uR$ zM(lHndpgB@75_;EaotAlZ}ByzF_Qx^^T$jE{mY$W=Fh)81IpO`_*Y1eOJ z9jEoX{$kQ2av)~@MC8SP0(<6Mb|DXRG+&YQ{SyyQ7F zu}>z>mx^!O|}jHi23{{b3i|T#BY3uUUp6VJpolWzC7Lf$5+Ok@a!?T(Id+ML#W~7m+Ac7r1^FH4R|Kl7=!UK*M`A< zA{4dJ#$)4Y{=G8i?5_n^pO&!uA!Gj{-$ZlXm~QwL@hP9PckuMC;^o=Fvz@1xXJD|M z<~z@f`tce7_sYDbNl|R+RpgKQ{v+bij!%qB`@HL+XvEuZ?ezpb%6+M-kGH=uJt9)W zw?B*5@S5--KhwB9I$A2)@rt-BLVI7V%r`Ms?RW7zvZf-5f2aRYWB;PuTX!=5JnrRw z9cJ02p8t;C)W#5_g`!WF-TxrpSU5Vk+j$1GaaRk3ms%DVGa$KKtd2%}X)C-OFeT;W z{&M^>K7G3E{#WAjb8Fuw$j^&cQb&Xus)^It%X~f#9c+C*^iG}2G7cH1K3#VI<2VCY zz3>{1Hl95B-_5i>7scCrd{%>s|8#HExxO5~j8C5~yZ>=~%x5=ucfU3P>N|-eGSWD} z)wILsdo<$x*0O4^V`E$XlArqYzZ0*gcx_yp4u&cLMBZu&s&@V3UjQ?{d@zotu2CRLeZ!Hh3SZLjjJu+w(L}j<9i3=_{Ddzo7t9= zGL7f271i@7ALjVgE%5kSBk^4{GERNEp)2orGroV+{QjQYcM|Kd-)|wb<>OE^;+^pF zbi9Tqy3~^K$awYXvil#zOPs&oGHCPFDcF3zHV$dCc*2Mr;g3bhIQ8j&Ax>G2ql`C{ z5sKwf|K1ZhK2a7VktV*&M#L)0NiOt@LtRFkjHacu7YCv-%|DU@`sYp!<>T)SS`I_D z#n9w;G5^Hzr+jurbc<AwmP+Ab(f)h${B%8hG$JHn+;YK7sDt0$C#) zUq`EiGEBL@Hl};jah}>1S7}hC;pFSytB0L4u7E|H;{20L*Mz8k{cCZmFUoEZ7}U<> z{K_LyX&%k*@-ggb66JA{g!hi$3Q~Tk|1{*Ih)<>)lfzqo9A76-7tynReJGxh7yF7a zO-v5NVs8%ZoTLm)jSy525Zy{O@K@%#_FEfJqMM zmly4EW6bhml2tK3Vsb#yo*$et#PqnTVx=VN@#$)6c6jr7m$)TfX*gkgmaPqXJ&;*v z*#21jk}kV9pkgDpATLq>Wq@Z8^RZPoN7DNG~USS%bNe9YU&1EhZKlq+-Qn;^Rm^H>2kQTEl*O) zQ5$ZOpi)~u^^I)R-3*t7P41UiO&nsl4iIgz&Jp{yZP~Hy65oD>bwMlTL>%w>`KHI~ z^3=@`^MgZ%<7Ju7-%T1#zR8;;g1r4iR@LOHrMthZ%&Jj!LvLef$$Y6eEb4edTPIOo zUP_z1&&M^>+BP)we~y<0i{oRNZW0VXq8m^3x`sZr*CV@)Fr82O`ot~~Z=LM(?^I|N z`lYZqfTn2!5syq)6Ez=^)^`|QV}qe?FRB@>>g(UAlegh4h}w53Ge~=WS)Py=^X;E% z#IVF&Iby2Cv5ojG+k90Uk@ioH(>U1w^DS+;u^Ab4xe*iF|G~f~jW4wCCnub0duTHK zk}kV9ac^f>4+RF)ZAXQ8U09SHJ>ArWyRm0L5Vgh!*YWkK;_Vk0tgRqVyL^S};)-m& z^DJT7PXQji&U`dXf;z9odPkXo7-yS0-^AKf zri=e*8OO|Qa-Er#fQV09Z=GCUh#16X zOI!mH>l3+M5gTH094IbpiPfdJJ|fy1yM7{U`)mm?7&$(gEhg4I%BHC7owiLBM>V%Q4d!i9D%6HQk+JZ9vmie+wDL zRz)d)ikKfM%1KKLrASr_C5NMhlBA=B;yJ-W*~HxvBR^Rvc|l4W)b~T$JdCN6FYq@+;|fXS|>MN9e))EX^brVIFp69%f{qm6&gd80abrUPtEB zI11autP}$Z*o4y5?Z&()<;r;aQXkx6>e0BOC~K%>agaaD(j5yWG$598g@d&$xne7e zJH%1WSjScKF|z!&8PCXR96&g~+z)#wwUu(KiSgn3)0lqWjg;u&BWu8)=KFY%YXEuVtv=l7BAPOk@3iM zLu$mQnRwc_*9By<{-0pFzbEEpdvwcBeO1j??6OX8rDVG^I*aXxc6MLXyC)*zk?9eU z7`~Z_N92#Ono{mbqZeC<@+j`7aV8#FKj^G)iJFTn7-H-$?(@7vchSiC`Aa>o&aoBm z3HQgP+}P+Xi;~)O<5SE}nQlmp_^j;Z>FyKgMCGypc2(V}@}(Awi;rt?8)tv__M*BW z<6pILw4E4r9ASHGl(Q99uTALu<(OFKiblpE(+#N+pHao(uhxPjYDH3%5PFf@rCVm= zs8~O?((%%_Z3Si@o9v*=51Aejf#KV4<7ns`=;CEM{vnf0%a6zvF`7`;yM=l*IwyvB z@l4R3D)oGai}i(QM4Kf!JY7xHeAIF2;@LsH1ZgL#ZFk_VMJ_k`a~x>6%R4v!71J;8 z^I#RDzK2>f2=(h`5^?W!eL%BzEG1luxjaE(#8#>qZ7oQE(frql9(oP?nHFf(e z%8?+ZmsP2{KBHyQ7VEf}=0BSQ+Vz0PRMT>$KR)%lXrnXVY}#A8R};-{8XQLbdV zKH7*fVprFvl6!k!fA>aemCAKF;_!&5d37;8%JqQFw5a2-xoo3k@=Cb1ZQMHr^>N7b zzZ3`i8rl$@Tzojq;a}gq165X0ZJQed4bj9ohB(Fe#rpeq&Bdg7L-yJBus)G<;r8$3 zll<=`W4gXSCr0Jl!QaK(uA#4QZ5N;5N=v5D7xLb8eKv}H$kDK$&UUH7yJof(;wYj&4=c}8=a;c_NYkI4BQZZ^x|*o@sKhC( zPGVJ7**A!LC;ZvSxC93Iy9XHmRH{#7yEN!8!Ptp#qqDm4_jmbyJYIVUUu3!kQ3}atH%O)Xy-*fu&baR8`#k< z2$ARPUaR}HMQ9gAF%$>8-0JZ|DcbDnDP&=k!;wks{r60Oi0ZO|4jXa`rgLF}i9{h|)= zfG0YFLk0D?$D6hfeBp=A@Q0Ykfe1nua9E-42L#jZjvnZVUg(WJ2ti-;Lw^jwKn%iQ zi1p7<48w4Yz(|b3XpF&FjKg?LfGDYxFd0)Y71J;sGcXggFdLzmgSnW8`B;F3SOl@& zS%RflhUHj+l~{$#}E93*q~b=7C6*YVj~W$5EtS&Iv(O90TLn+ z5<}E;ZG)sphU7?rlt_itNQ1OU2U&l8M!si4X4oPNvLYL@BL{Lq9KYvA9^^$nMwXo99_hURDiQ73pSv_>1Wg$vrj6>e}xdvt&YJi(#A z(g|Mhh7ZJf4L@`ShpS2e0uh8R5XZ&c5RC5Vfu87v-spo6^hH1P#{dk(APmM348<@E z#|VtXD2&D!jKw&N#{^8oBuvH>OvN-z#|+HGEX+nI=3p-7VLldMAr@gVmS8ECVL4V{ zC01cI)?h8xVLdirBQ{|(wqPr^VLNtUCw3tWyRip*u@C!k00(ghhj9c)aSX?C0w-|_ zr*Q^naSrEk0T*!zmvIGGaShjT12=ICw{Zt|aS!+L01xp9kMRUg@eI%L0x$6juki+N z@ec3t0Uz-RpYa7>@eSYc13w{l@GTGvmWYiwutHo|BOc--0TLn+5`*gD6&oZ)G9*U| zq(myDMjE6=I;2MiWJD%phApxnE3zRwav&#iAvf|MFY+Nj3cwBpVUI#63{HnBMNtgJ zQ354V3Z+p7;@n?3lt%?rgaay}G8|C_RZ$I2sE!(_iCUCfi zG(&T=KufejYqUXIxS$3~(fsq)6(HMiV7>DtgfQgud$(Vwvn1<_FymeVLuMwAP(U$j^HSc;W$pMCT`(2 z?%*!&;XWSVAs*o|p5Q5-;W=L5C0^k*-rz0X;XOX!BR=6XzThjq;X8idC&a}+3&esY zVj~W$5Es^nhxkZPU@g{RJvLw?HeoZiU@Nv^J9c0vb|DPAu?Ksx5BqTd2XP38aRf(k499T- zCvgg=aRz5`4(D+J7jX%faRpa#4cBo4H*pKMaR+yC5BKo^5Ag_(@dQut4A1cbFYyYm z@dj`44)5^+AMpvF@daP;4d3wtKcU2C`G>gg#1gR)2Uds+Ys5o*BtSwWLSiI=4U!@m zk|PCDA{A024bmbV(jx;hA`>#h7Fm!L*^nJMkP}>TQF0>>@**GdqX6t6PA=J_5DG(F z_bG~ED2@^k=jBVGG|HeXcrA%i9u-g#;#_qlRE9WlRs~g24Nj)aV-40~9oAz5HewSt zV+*!o8@6Kyc48O8up4`@7yGau2XGLFa2Q8$6vuEJCvXy{a2jWD7Uyst7jO}ma2Z!{ z71wYbH*gcTa2t1U7x!=<5AYC=@EA|<6wmM+FYpqt@EULM7Vq#LAMg>M@EKq572oh3 zKkySu9F~8?f+b=j4y+It)`*ArNPvV$gv3Y!8zeLL@)G4AB3PU`k_AtU?2uz zFos|#hG95HU?fIiG{#^o#$h}rU?L`AGNxcEreQi}U?yf^HbOB6b1@I|u>cFP2#c`< zOR)^gu>vcx3ahaOYq1XNu>l*g37fG6Td@t>u>(7?3t`xeJ=lwV*pCA^h(kDxBRGm< zIF1uIiBmX@GdPQLIFAdsh)cMPE4YelxQ-jRiCeghJGhH`xQ_>Th(~ygCwPiyc#ao% ziC1`yH+YM8c#jYGh)?*8FZhaY_>Ld=3B`)#AF*JG*oXrw#Dz8DAwI-CF$s|fiID_0 zNQz`gjuc3VRN!_8B@MXEKuHHK?<*OQ5t)z~w#b64$cF65ft<*N+{lBx$cOwW06TEI zs$!2qD2yT~iee~^5-5pMD2*~Gi*hKB3aAJNR6=Dqq6(^_8k|raHBb|^P#bkn7tW}M z`e=ZLXoSXSf~IJO=4gSIXoc2jgSK!%JGjCP?r4t=@PH>eq7%Hp34cl^Ll zC~;Z-5et@xjX1DETyVRS5)bi_011%@iID_0NQz`gjuc3VR7j09NQ-nxj|>p^Wo1HU z*dhzEA{(+J2XZ18aw8A&A|LXj0PIi@_9%qHD1xFWhT4JD1)*nhw`X^if}+B zRE8s}pem}t3Dr>pHBk$-Q3rM5jC!b#255*zXpAOkie_kz7HEl9XpJ^#3m3G5E8O6Y z_UHf)c%maZ!3*B-fiL{f8U6@BAcD{ZUC|A}=#C!fiC*Z9J_tcy^h19Pz(5SbU<|=f z48w4Yz(|b3XpF&FjKg?Lz(h>KWK6+SOv7}{z)Z}-Y=mMC=3*Y^V*wUo5f)r6Sr_1cW@W?a32rw5RdQ}Pw*7a@EkAj60h(Y zZ}1lH@E#xV5uflGU+@**@Et$!6XF373&esYVj~W$5Es^nhxkZeq7%fu$lmaQFZ|FM{s=%Ig3twB(G9`qjvnZV zUg(WJ2ti-;Lw^jwKn%iQ48c$g!*GniNQ}a0jKNrp!+1=~qXH_z0pdRK%5X##R7Ev7p*m`y zCTgKJ>Yy&1Q4jUe01eRyjnM>6(G1Pe0xi)Btg&W+_9vvW_JMctDbb=SW z;R9dzp)>pufItMH3%a5kg3%p4&=bAT8+{OhzUYVk7=VEoguxhsp%{kY7=e)(h0z#; zu^5N(n1G3xgvpqKshEc8n1Pv?h1m$j9L&W$%*O&O#3C%l5-i0sEXNA0#44=D8mz@S ztj7jy#3pRU7Hq{fY{w4l#4dzkH}+sJ_F+E`;2;j+Fpl6Tj^Q{?;3Q7rG|u2G&fz>R z;36*JGOpk%uHiav;3jV2Htygq?%_Tj;2|F2F`nQlp5ZxO;3Zz+HQwMY-r+qy;3Gca zGrr&}zTrE5;3vcbIu?ipOTb93@Z^r6ArESq5cM z4&_k+72$wNs0>F`K~+?P6RM*IYN8fuqYmoA8TC*f4bTvc&=^h76wS~aEzlCJ&>C&f z7A|N9SGd6)?a=`q@I*&+f)~8u17G-|GyD;NKm?%+x}qC`(H%X|6TQ$IeGr1a=!gCo zfPol3~(fsq)6(HMiV7>DtgfQgud$(Vwvn1<_FymeVLuMwAP(U$ zj^HSc;W$pMCT`(2?%*!&;XWSVAs*o|p5Q5- z;W=L5C0^k*-rz0X;XOX!BR=6XzThjq;X8idC&a^f7KjB)#6}!gAug;D5Al%z36Thi zkpwnKieyNR6iA6wNR2c|i*!hj49JK~$P8O#K~`i#cH}@#+B~TKjP#R@W7UfVL6;KflsD#RJL={v;H8`O@+p*HHEE}T&h_0a$g z(Fl#v1WnNl&Cvoa(F(2625sSjc5sCo+|eE#-~mr`L??K`8$R%bA3DPy0SH78x}Yn% zAsF4!13l3Tz0n6D=!<^nj{z8nK^Tl77>Z#Sju9A%Q5cOe7>jWjj|rHFNtlc&n2Kqb zjv1JVS(uGb%)wmD!+b2jLM*~!EWuJN!*Z;^O02?atif8W!+LDMMr^`nY{6D+!*=Yz zPV7P$c4H6rVjuS701o014&w-p;uwzO1Ww`2Yy04m}`Mp zutaRcffeGy8u1Vx36K!tdCJ5{0vjYnG9*U|q(myDMjE6=I;2MiWJD%phApxnE3zRw zav&#iAvf|MFY+Nj3cwBpVUI!(?_(%}q9}&qD1nkFh0-X4vM7i0sDO%aKqXX$BdVY( zs=*1>Q3Ewm3$;-Pb>WP9sE-C{h(>6PCTNOgXpR)a zV-40~9oAz5HewStV+*!o8@6Kyc48O8up4`@7yGau2XGLFa2Q8$6vuEJCvXy{a2jWD z7Uyst7jO}ma2Z!{71wYbH*gcTa2t1U7x!=<5AYC=@EA|<6wmM+FYpqt@EULM7Vq#L zAMg>M@EKq572oh3KkyUcp?nL(f+b=j4y+It)`*ArNPvV$gv3Y!8ze8KuMHB zX_P@(ltXz`Kt(v95-P(HRZtbx;DqX^ftsj=+NguNa7I1UM*}oOBQ!=6G(|HsM+>w> zE3`%%w1o@W!4+V01?h^h7W8MjwQr zFZ!WB24EltVK9bZD28D;MqngHVKl~IEXH9xCSW2aVKSy*DyCsNW?&{}VKzcB2XiqG z^RWO6u?UN?1WU0D%drA0u?nlP25Yen>#+eFu?d^81zWKV+pz;Xu?u0?jXl_leb|o! zIEX_yj3YRTV>pfzIEhm@jWallb2yI+xQI)*j4QZ`Yq*XZxQSc1jXSuDd$^AWc!)=M zj3;=CXLybmc!^hdjW>9UcX*Ev_=r#Vj4$|#Z}^TM_z6*AmIY$L60s2nR)`C0#6x@} zKtd!!VkChLk|G(BBLz|-6;dM&(jpzwBLgxb6EedVS&$XkkR3UY6STQ4LP0jvAPNQ`eOhFVh{#n2!>)9hGPUqViZPW48~#{#$y5|ViG1} z3Z`Njreg+XVism26mu{a^DrL^un>!|7)!7e%di|PuoA1V8f&l?>#!ahuo0WE8C$Rw z+prxwuoJrwhTYhMz1WBSIDmsVgu^(3qd11+IDwNmh0{2Lvp9$IxPXhegv+>stGI^i zxPhCvh1@?7 zkqz0A138fkxseBXkq`M%0Cp${dlW)p6hToGLvfTqNt8lqltEdPLwQs{ML2+02r8A~ zh$^UxYH&hz)Id$tLT%JRT{xp2>Z1V~q7fRS37VoAnxh3;q7`_xozezv;evK>g&W+_ z9v$ETPjo~lc)=S!@P!{b!yf?%L=d{5E4m>V-O&R*(F?uN2O;Q-e&~+@7>Gd_j3F3` zVHl1P7>Q9BjWHODaTt#Yn21T3j47CkX_$@~n2A}KjZnq5B6do_TvB!;t&qw2#(?yj^hMQ z;uKEf49?;l&f@|u;u0?73a;WBuHy!7;udb>4({R}?&AR-;t?L>37+B^p5p~x;uT)w z4c_7%-s1y4;uAjO3%=qTzT*deLOj54fmpCaY{Y>T;=&s75FZJU5Q&f&NnnGdNQUG{ zfs{yv)JTK0NQd;ufQ-n5%&PAsC8b7>*GbiBTAhF&K++7>@~iFz)GybYOKLptiyV2z(#DsW^BP$Y{Pc!z)tK!7$k7>c6=N}?1>qYTQT9Ll2tD#8JkP#KP>f~u$nCsaob)I=@R zMjh0JGwPu}8lWK>p)s1EDVm`julvmRalKRSc`R7j}6#} zP1uYr*otk~jvd&ET?oT&?7?2_!+spVK^($i9Klf>!*QIzNu0uIoWWU~!+Bi5MO?yV zT)|ab!*$%iP29q5+`(Pk!+ku!Lp;J`Ji${u!*jgAOT5Bsyun+%!+U(dM|{F(e8E?I z!*~3^Ply-ySRfWG5gTz}g}AUrJj6!=Bt#-4MiST{DUu;MQXnN#AvMwI zpb{#>5#pVmRZ$I2sE!(_iCUCfiG(&T=KufejYqUXIxS$pTcMGIV^`S;7j-l zzJ_n$TlfxE!1wS2{0Kk6&+rTU3M=6^_#OU$KjAO<8~y=Vw5t&`h9=MywtzH9hi1?m zTELdj5?aAl&>AveYuE<1g*LDqY!5p?Ti6kHf}LR(*cEnz-60e9fIVR^*c#bopeGy-z2FGQf^6sweV{M&gZ?l8 za$q1F2}i*o7z{%o7xLg}7z+7N0K?!I7!D)gSQrVT;5Zl!$HN#H3w{^}g-`?m7!Soz z0zsGn6QL9)K?uT729qHIDcbfpg(Jm<#8_1#lr;1Q)|4a4F1#%iwaj0Gd+zEHV0=OIQfqUUT_z&C<55Pir5FUd6!o%=Ccmy7WMerCr4o|?7 z@Dw}^&%k1M7M_FW;RSdRUV@il3A_TY!vDc*@H)H!Z^BY|3*Lrz;9YnR-iHrh8GHyI z!N>3kd0SdF3=SYf^Kjy90J|pP&f>FKu)6;KINU@A<5Dwqx@z=?1Y z%z%@j8cu;zVJ4ggv*2_%17^dSa2A{m=fE5|7tVvZa6ViB7s5qwFc1Uv~(!PD>zEQV*{Id~pkfEVE zEQPn=ZFmRXh4y$PuL6ghJBzNw1*C`FYE^$VSnfZJ~#k6!-3ER zy23%w4GxAwpgSB2hd~eM35P>3I0CXD8+t<@=nMUzKMa5z7zjtgQ7{Mw!w|@YJUAML zLOvA0FgON=!w5JQM#3mK4o1WAFb2kgAI3o;6hQ#SLot*<5GKGxD1}K7f-sc9WQagH zR6r$6fvGSJs$e>t04KspFau78YB&W>g_&>~%!1S5444gP!dY-OoC9;){5t5pIH;VLsdfx5903JKOuo#|&=iqsG0bYcc z;AL0>ufVJDfAAW-4sXDluoT{cx8WUl7v6*S;R9F(AHqlQF?<4_!e{U~EQc@POZW=D zhHv0o_zqUU_wWP!2tUEk@C*D3E8#cz9sYnn;V<|b{sC)y>OVAwCeReNfHX*lX3!j3 zz?RSwTESM(8ZuyO*ao(RHn1IR4?93x*b#PuonaT)6?TK&Artn1Jz+1{8}@;A&>lL# zzOWy3g#Dot_}~EO33Y{SEIg&_UGMtzrQ>(UZ+6sQ*2V9@qExcvWH!iN;y4d< zz3X`_G9>41ogHf4f9e^8z;5!M3a4^gXlzzl?^^zZ&0Zcqe&y?G&e8SD^H>1O)I--D zosWKh6jl_^XCaLfJAU5$h4!D``(sxLNm-Zm@^C7*g~nzTJ@|*Dz9V9bZ_7FclD@a@ zHuVm>Wr37~-p~j7LODw_ybMd=6?hf?4_<@U;SG2b zmcm=`HoODx!h7&Od;rVfL-+_jhEL#A_zXUW;}6-ChP%w!d|d9>;vtfJ#>J5VL#{y`$H%2!2!@24umcs zP2@q)4GxAwpgSB2hd~eM35P>3I0CXD8+t<@=nMUzKMa5z7zjtgQ7{Mw!w|@YJUAML zLOvA0FgON=!w5JQM#3mK4o1WAFb2kgAI3o;6hQ#SLot*<5GKGxD1}K7f-sc9WQagH zR6r$6fvGSJs$e>t04KspFau78YB&W>g_&>~%!1S5444gP!dY-OoC9;w#O_$xg76hjFFVFFBqQkVoG2tyf6h6s?o-hC1qc=t)~KIz>j zH_iLx4crKCgqz@Im=CwWt#BLM4tKzva2G6qyWt+V7w&`q!2R$5EQAN)A^0ym4F7{i z;89ovkHO>c1Uv~(!PD>zEQV*{Id~pkfEVEEQPn=ZFmRX zh4Uj`1-imP&pTcMGIV^`S;7j-lzJ_n$TlfxE z!1wS2{0Kk6&+rTU3M=6^_#OU$KjAO<8~y>S3H2WuLlbBUTR{E$j$8!OpM?><#-sJ7^CbU|-k|I>P?Y z34Cw>bcO?=3v`8ppc@2vV16wkpcSpe^r`#LPXc*L|e z=gY$sPR6E)=O2~ZLSwVab8vPjI7$9F+x0v=k8@OyrLE(i$1lL|LYUU7srBRHgJk&2 znsV1y_XZowEbw?&mwXjH__yRq!SeE8I8>e&E)5n|`Hl&OOPznn?HA(zK?~*a&%Q5s z;O%DR3&xgwtRaoDOGz)TcAyEI1p^fjMw4oCkB^e2_9N^-q3lxi85` zUGDGODpb8gMspc{h;wzx>rw8rOH0F3yF_C%^;uaDeGVMdbVy~|d86f;#O(@OuvNJ& zG&c3nCx?II4Md^})o`xbXWrJS?Q_h%#b?fbetM;mq*k9z6f4IyyDk~lPHlIz=6%@CI=oj;t8Dma>)UJQGQVS)^-Pyh zje7mGW8+h2W;e;I+;WQ#Sy6cBal5o^|I8EHENZdsuD_0K+3Bdj3;o1yQa4b|u5X(E z3%5^h-?rN|wMIWzaplyPzqq02>+$wgxx{I@I_&HGv3OAzd;D0^*Z)N~&rNiU8CP+M zWM&|_DnYt|N*c#P3&;S;L(i>hff|gvI{D*{!OR=;*bL|8k7ku)N-0DUqQISU)rZ6P&iS#bevQT+RqugOT2xG@DuyU zT#GStrq9ipoMyc_@1eIBl$Q6r+zD#+#82#_a(>3Sm_2+2C6RDNMQNZSNyQg=X$>64#I5uaD4UUPSiw@V_u zcH8^;EA8zb-unL;_WH>Cs{L z)b_aWzg>>`?=FK**K|}5w_N?*dJGH%Cb?}PVa@Wg$fZZ3^0M=&H->l0ZX?53wv&3q z=%nSA+hR6}%FC2Ms3KLNG4&de8E>CNdVO8?OJ4uaLsx3Ls+U`?{&nfqw=!anY1LJh zO}$p2mpp%DgXD)C^EhaY-HCD38}5;*8dmYZmD}DibXLBjk622=_NHR|GQE~0g(92!J3&M_?cCC+Zjhy*{+D>=gGqt@k+h29?9Rt5Abjr75*G5=O z<+Tb$5Ap+%DZ#?P@Ni@zhRO|TxtA8Gvdou1F<2HCBsbJQ7%8uaT~0I}^ZvF7Jtck3 zR~ZZ7(cT&{m~nw;-#%DQd9uTV?CjIuxO}Yqz-2-cwkj8y>2fE9g5$!|=x+NXg(Y;q z#|LPre0pH(7%Cnb@Rx@}(iWQSWzJsl`Y;vBY7HHjkTZ3}mVQa+$ViLHyMI^k_~G&c zC;LWhRc;H7O+IaQBv?`9i&-MtV5`rdz?49#Rl_-&f6LJ$Re2ANZ1v__fxVl%%e%@A z73{;fyL?XG&;sAU5Dj*5kP#!}uzxs`AFxNCb0dSog?1IS&o}dJ+TN-4%bC^Vs$sM5 z{Xq55cET-J|D^imjvrr85*QjN3`dHhC)BW4d$rvswLXXaRCU?G`NL}4b=Ai$ua`bC z(}}%|{*ye;*|)#Ae&zgn=vVrCw;3(Z&yt}q+o^tTx%!)_`rP?BBwS$+o(76~S2-^c z;@YjOcB$=EaOMqJz0P=cYj^olx$2?&6#5JZhl}ai(ZicWXVV{&XJh+Rv;HlvhhB&7 zIJaj12inRsW80~n+;a6#s#o;$0E$8d zxN2ur6M>fVW$4w2-`OC0xd+M}sAfmrah@>jH4d#_r#}Dmmk$h($4uL4|JN;7f8&1V z>qA2oETsRRGn5V`4LgC%dM|$jZl*6|w!1-Dho;s(=e~JI+ln;n`t~DdeST-lFFQy; zoY+PB|0=hI#wN}#(VL2PyM57?vM<^MLrzw4dp zOMZQVTZ-)@f12=oqVlM?cDI`L@!8LAyaT8v1}!&j_lwWBME$2X|8MU%hHw4shnjGv zeUNFn2o*h;}6+d^z~Qx$N9^hMwrmmpmtc?G2RY);kP$rBJcZii@!Ov=6&_wOAh}2-T!1o z%Wo#K7U-dJ31hlAJ!hium|i3a{Y40b zd*#~dNcTT5t)dTi^x|-&Dtd~kPj#nwedN7JI<&>GW8QkP(})9`S;a@yO#JARi!JMWck<9NB^a1$za1?I=kpdIkUgH^68xO;6T+MM zw*);>wUZ^+?|$8%PhG@YPsfS9q-MM2jxTeLjNYkpb8v35(pvMlE1iwf!G0c*(s%cN?9o^TAN*BaY{SS?Y;c;I$G+QWJZ8SN?b6il7fL%>m)o+-`!^jo;Hqxw zAI(0irAw~<1N=e1FT1j$q`y2*GXyY*!M^OmLK&+q_tCodi$ubaKH(zyhzOSnl5aIP zeRf`V^fA+uw5p^2b~}N;$g)B98L&0X#&|hRx60(u>QeUYp+nzV-a(GVNjTZM<+hkj zey}(c48>{L-ybZkj6{0|)r8S<)xB$c`jX3AfWH6Z&}!U$+?*pn{j5xm#Ys7oty^x3 z*+kQqXVy?*kTE1*F5g(io~Nq`qv~ z+?u_-XOQq6huyPu=Dq#;%dt4k54YU$rH>E^k0%>^LnJW3r^d?JaUfZMHr7Vt2i0Qkg(!(@BB)>by~96Ig(cGAYbxRHz{B9 zelm~tTWpjKvKO0+9n5j61Ip(N>Cvd)nTT!Y*tC)5ma9K+%fpchf2e}D)&ZYvh6c(? z{e|r82cm*VCGT#Fj`8z!By}5otyKCj{%Qv` z^_cI{!+oEZ6W;pbqmKssvg>7}SLtT{bnh8|e|7ikCGM?9-!!B1 z@K)cBi6$iZvmLpq@~F6W7q7=~MiK+HH+*;A$Vt^u+y6r}QbM{Sm}Z+dU4GI=yBykkn}z(h$Ty zQ5eLVjjQHLw7f1pqN&}cWy{rJ#70?8n_hzapj#rDBvIO8=7w?GnSB&zB!I)r!ARCW;Buvp;|YR zs?9?}BY9A0#vWvnbt8GXn!z4Kr$%69u?MPA-1jzlS*fqD>kYZrz5MDCyIF0C2Perl zXIm?`rLj$->l?@bTVxUwB)Mq4&T39kJ1?n+9xq-q_n&u)cD&l^;G`wxzBzaMTDc>x z-6qmwXgFM<>1PsB(wFDf6{P?4E@zEzKXPjMUC71MHBoLWXt7uq5Osd}!^b;oqyb-wX zLpi&qTYJyEwbRHw@*3~MJ1%i@gO+w*<+jk+B-c+0+!TLl??A=WKp`Dw?=+HrGJ7x4uuBRkC z_sF@6`|o@Cb*hik(b;Vkx%wy7(;SyFmEvUcec1dIde!h}?_Gas`r?^4?^z)EFHY)* z41M`jN0^n0jUPOKz{M=3Dcv=NXy%omeh^^=dmUcPfu*(%pXVidXGCD3y!MbcWuwuV`TpQ@33Gjr4W+e$}@^tF$8V<5$fFq}HqL!oRw8Yd52Iyi?1+TdsPo zI#0ItV<)p}*n_ijP9|tRc0eD^$M-uf>mg~G{mq5=OL^CPls=T)rpJ<@Q(APsgF|b} zr7N%casF7pqo>pEHKO%Xxr8xY5`FD&vh0z^zJbD^d|Aqgran12@%l*DL3GmhSdvb7 z{||hf_TS}cITok(bIToH#y?k?XIyK)m_9Ow96h0iy|%l{(MO!x$9-S0{azbBztg^t z=xe!JeX?D0J0do*a+Y7oFenoW!XY1nf80tZ**C3nJ1d=gt37#!87i@p;@$(y9hh3b zRyREN;cFQ^e44)6%Pm*`SWe{Bv&vRQ4M>wW9K7N>)H121I~Y~ z!Yt(E|=w}*7udSUcBg_DKCES z)>q|8^p%+*!AO7`DxW^`XrEB=5|`fY_}sti$_IBi_wO1CvuPjGU-~$iAU2fgLW0y- z=~Hh3W=6X^+cVcI6;C1OwKkVz%cl`@Yk^s8ymeD$XZs?zgM|izl7sclwsFEkaY9y zQ{Cm+9iRSQoj%y=gw^=HePRoE`IFc#8;dj(MWnrv_cb-tXB~HY;nnBMWG;tU-^)fN zukT}@%&@`-w2SQXNZ$$3>Ta*0E%jaH?(61nM(l~=%!14vSI*l7nPKOj66AAHMwt5X z1!+~E5`UVoxFu8iIX+VvTL<)Fa2~k<<`W)2~U9e%ALb zt!EFLJbGNs^>5m;R-%f4l;W?Fp19-q|annDym)lcvjZ&$?YR4 z{(jp#)6YKmo-f?@W0kL>pE5wJf4^7Z#m3YG@>z@nmRaG)X*ER>nc_WWV{ z&6^#SS&kOhL%*9k&dBK2r>e8+A?004y<4vS_BvWa0#jpka(J+!B;P+Nkjs47Ur*+L1XY{Jy$74^)Kb!y^Rq#!tsG0WG2ipd-0Ib9 zCeP`z)1k=4$-WU=mD@sNlfzIu#e~Hq%gLmoLBY_(a_7gOFyrAx@*2-vjKtKZWNdu> z7MsiSvCfY!`7F&UKk1r#=I(R!b_LNiMIWhGDvye5clFVyfDc8{)_!48&6!%ya>m8$ zBW;b$rLuNl-P~Qid4EOQR@O7Ock6Xkt3z6AK1iO3J}Q^sro#$M7q9JI_T}}pU5I5e zhJ;%HlD<3tb$rB(OVc!E>-)GaeYIYj`fLpPn&oY&D}UYZqgHlK=l>zU|0{CzVb#N< z7oz#Aa`XD+I9C5-?_hn>UiAwV^Y}1{w$%9$KYF5$Ps;e-yu$eM=DyF$DSMrF*v+4e z-G&t@9Osma9;?XJKcPMaCBaBh9v@UOaW6bE80cNfz#s3SjD;OL5P?|^Gx#mvO1NDn z0&UM0qQCZwvJUKVR1iP&`tpiWw>P7Id$h;sMW_F$=}5aIEsk5R{~ zH!AQnkoC!Tpm56i&hJA3=35G-G}c>FiJpVY81$^BgEo^!^F}V@3nm2?a1mcJ__=_> zbo(}}FW!bVr)f*~r8M`)u8(E1-um9$hxTPYbtl&6=*n8sH1IiDtTjG>b))kbI~~bd z9Yy3(8RyMlJ?=TIHGUQAs4qbN6zgWZ$J)-nVyo>MSxxv}^W%|?tbI;vWaaV43@iCV zgQs?HY(>U4wq9XD_vcxVyqJZupL?*0)st^?_rJBN)vfy$)?ROJVf{8c&H6bv-MY%x z%q|aP^~sngt~_TJbJ4hLNK|ezCZt=Bv|4`8#BpQJ@kMK_wjV0DBQQ4gE;j{XXSj-G zS!KwI%dfp}ElHtQ)}(Z6`j}g`+Uk-s4!L(nCvnwF<%UZ3;cDnLB+Mv85hL@3tQqCZ z7>j<==`SrENB>bGoDWjorQMrWlH87EW$9KRy+!jA@1An|AeX)>x0N(DYo~9lW}13t z29xVqQ=V>p+G?xp(L+Djy)kt_oZ408jx@GiGd%-E=4Y`Io7v7TOrhuO#_86!Lk2A` zK0NDvx_Q`1OYb{Hq#+ms# zcVcq;bv`NGI&JLZyLam`@QlBrA3CdkDtBUyZC69TzCoUlb%Z>VDD=L+0KN3S|9W=Y z3`ui#)L-g%_tMn&{UP68zU=(|f6A%0a}IX1+;a72au1804)#|$k5>bDewRxzyYhC> zOtz}$2=q`rpE{veSkkDD`iq`R@#i*I`#dD??YM=-&6j#N|GYPTYI1Q6w;|g}98D+% zDvye5ce?r#3q?5#G}*ns*vp1$LTdS25>9QW2frASGvVN4j?e_uPHwsS$MVc%07G*mn_WTdH(!w&R?lT zdMx=Z$aO2?FVCIQglid~8)L5_F8#1*)6S9S*3<%K`!J#`b-laxnl|TM@Wvxc(b%r6N~4LN~p*lGP+Sr0ufny}yW3o<)>=G42` zdnA<`D%gjK^x%uKN*3^9ydiEHyN?F8e=rm*FNr-O#6PD@PHm^0vaBl(zHD+h+WcFx zZ^TyR_0dlTUn|RH{Ayr`VG+Nyw8KIZLt?ZVB2asEh{WzkQit5{wXzP`+PeMavCVv6 zKO}!OW;^X?s5~mJ-6gUY)Ba*6iz(+kQ5VU>wY?ID9Y-cx(ND(dbI@A{vCDqGl;=!sC#9`aXCAA}+pjwdnB}CpGI@P#yDZIWzI*>| z?)_)ml2K8Wda;-Cs&cocv8KituNv&1)<43~b?mcF`+vH%-sen7uE)yibZd(fzFXSu z|2{dbdo)35FGUZP*GrGM@pRw7;!rpupE$?@Hw^6<^V5u1VfLe2LD;njw!QL;%v4+q zdL0>4lV8WYQ`4>GN8S7NO|9Sgsb5rKy$+Q(@O8MFo$0_D@EFxjek9pIQ=f~KWGprtOyp)@DY>z7K zr)qwvd|h5g?3Ge&af%yv$*D@N|I%6M))zb6|JKbv?f>*ePSD!tN0m3Q{;Q}gV|{9G zYkG2hr=5{*ZFA~jkG22%pR-yqRwqvFt#U^i+a_#J>R*qeMMalLi-phVyma~ji}#GahOV{0 z%Gb?x=(wE@G8)#2W{I@xQjYYwaZi40pVO_A`P+S-JZIJCJQ=6bayvJL-4=IhZB3l` z@`MTBynM~s(ZnSUx&Np!lXl-3m`P46&Z*@525ai-iAC)`O*tXvK$j3#6sL4~k zoSg}xm)-wGFCFi=II>&1)Pb6)zl?V*$6uWGf8G7}5&Wms?9PXOvh%$CZYi=u#=bjI zc~o4xGxU~{QW^{e+Yx_PC&PeZa^BKG!5GU`$ zB%f7o3yn=8{gU3ST>6>$o_TU|{j66qtjssB|NN16uD;$08PiYYhHCah~Ty{50V6{@-sY&9&_gjc(oYsJ9h2?<>2AFFg9PSVH)q&IdUm zX0y}umy*8ZcQ(j=XORBc68<24^vK)hb7;M~UFKK&=O1#j9E;160>suW7pb_~_b&G0 zGyHK;?VK;VMNGAEhB4#&W7Ez^t;ZJcTwS%roC_atQsMvB?SmgIw_N?}r-v`Q!cnVF z^c8*IV0oFW)*Cne+-!F2{+MXK!-xygt%LsDYr;*Hd7T%F5pnw5rE*6a+t%vGbfj`w z%>vsPqd5g(TW)vB?UN)kG~X7a&}a6=>DG(04*Rgj_$S_X>!b3RCeG1n=wmNbE#tW? zOKZ&gbmB4f9C2oHyDglTZZ-L;>Y4sSUtHnVQ{{E)sq>zkb>QufHuEWK^)e=rn*E;@ zDfC=^MY^@;l~0B;2MnI>)>Gvv^{i_ilq;uA`z^IwYo~rDDtF7yX=Tm+Ysl>UE5CVf zr|7%^=`YE1fXY+qCG&~Hg<)2!KJdWRu;1+aobss8!R~bG^E+Bq?7Cv!cVv#&x^`kN zO+QguQhyu5t;xG!X@iB$(M5~tW^-v;hRpK2v0j{(Dc!G$p7qT?v5VS9_iK`#cTU4v zz{`u6JT;VxJ+Djm%}KtoQ~A#n%|)#uop@>#E?zV{soul0I$&e3!l zdhc#;MJJV|(og+0{OahoCjHLUiQgSob#=?@`n@)NkhNF05(U zS=} zpUNH$*`G<3Rw{q7=fbo)Oq`Iw-{rY%^u|BS2L!}{g)Ln+mwxc21)D3lQYnpDN z_N}fy?3$*rIh^-zEF1OBH_tZpwbZKZkNZq_`{efbes5eBFw4G|cNWirKfh( z0@5yP+gz7X6191Cg z$Fsotv_P`Hfz<1bp>D5Fdn8M1L*9q#Ge0ev?w+4#0nY-S1vaz=bWPq3t%sNX#%%$w z@3C>`&$`lXT|URvHAXJ|x@3Jj_0#>jy7mnb@8)<-8^VqoLz>cNy34rx`Ax>v%(1oA z(c2wYeb1F=%!Zn;ne2JBzWV$d!nw;qeXm*C1F^B!F4Wgz>n@zuH`#mTe%;yGi`lb) zX93Rwo&`J$coy(1;90=4fM)^E0-gmt3wRdrEZ|wdvw&v-&jOwWJPUXh@GRh2z_Wm7 z0nY-S1w0FQ7Vs?KS-`V^X93Rwo&`J$coy(1;90=4fM)^E0-gmt3wRdrEZ|wdvw&v- z&jOwWJPUXh@GRh2z_Wm70nY-S1w0FQ7Vs?KS-`V^X93Rwo&`J$coy(1;90=4fM)^E z0-gmt3wRdrEZ|wdvw&v-&jOwWJPUXh@GRh2Ah`u*-)C9D3#t|$IBbvn=AYO_ZKL}&NzXf{VJ+b0Ma-UN8C9wL2V}DUf!t7aSM~Gujs-TB zd{~>dRP$2r2@Tcf(0DheeSPmca?M(=H-@&(t%F>L%2HjE`fK>r$ zTVB`ihNw4n#qG&Ayamkm**sob&7>}@Y1vubGP<_9y3ZHARd@4P!f72>fA_f?^7n?e zTSH&F+PJPZQsg@}bfW7qz832-Ei)-C!=}tT_AKDGfcAIY^7{Tx_Iy^~IM!u2cRkSd zW^K}R$C)Uu`h-bz-ujZsePmtgSl{QTRL}US?9q_@nN(?|@)vtMbu1#^j zKHgz$igu~5&QeF+<=SjJ{*C1;QTtX`AGW@B-Wbi#dgsJP?`aD0TDj#|;UK>5?(yyW9>tYN` z`e18w&1zSPNBeWSZ>Z~D+j!RI`qnmWIbYIOJJlyX(|+c0ea>CmFzY+Lwbgf1J>T8; zsOvgbr`*&P$EGN+&)AY_!$fsFRaq9>COU6@+bfX{qMPccWkA~zy;rSIJyi!YO_j;s zM8e2#vA;g|tG~z+<%{@xZu7T*jHCVA$I_(yn{8Kpa^0&R^|8{12_x-tqBh*rCQ+Mb z`mgU}ZJ*agx*OZIu8V8jT;lZF70YUzBs0ZNaR*b|>E7+Xx%^(=*S8`1w+)?Fb=j;g zc|)gf#;0lO-t^mCj@Nb$z=p8Hy3CJt8TW>;m6zt4Ss>ZHZOvj_w`Zm5M{DZ!4X5EZ z=KZF8EgO2i!lrDyjk!$z8+4O<uVT-|Y^^_g#}Y?sPEk*;2SPGpr$OJ+X5tw|Z! zRIYY&80Xp;u3AvTrr=IQBKz_dWJzJb*1jiGLv`fkYM4S64`&-}CvX&WzX&jOwW zJPV|%Lu&%Ys@yByT_nx#Du8*dKn!lr%= zTHj>vmHYaZU@x3!0nY-S1w0FQ7Vs?KS-`V^X93Rwo&`J$coy(1;90=4fM)^E0-gmt z3wRdrEZ|wdvw&v-&jOwWJPUXh@GRh2z_Wm70nY-S1w0FQ7Vs?KS-`V^X93Rwo&`J$ zcoy(1;90=4fM)^E0-gmt3wRdrEZ|wdvw&v-&jOwWJPUXh@GRh2z_Wm70nY-S1w0FQ z7Vs?KS-`V^X93Rwo&`J$coy(1;90=4fM)^E0-gmt3wRdrEZ|wdvp_>zpmQtB3SLmP z_`qR%X&Q{_+);olg^szxu)l>j&6y<>UD2S z|EIPtY@yeg$OdkilvTy;SJ&?~)p1MN)dwfQF%j&|uSv$*G z89eFIC9h{#f1lp#qSLk+c{z_+wmX#VKRA^~#kITPfpLApp^8ALqC9t8c_1<+5b+fR zD@p^y{pI_7m%*1kr3py-mUZYVa`jJyq% zdH&+Sps>Hl*Kb-`AQGH}Vf>{&kro6e1w+NYp@H&nWu(v!gec%E3Kv#NFei>ocA{U+ zO`n}NAN?Ncx#IQ0or?~dVLhHFY0r=POMd1xiPztqp9Hnu%xHg8m)xzgZkkEdiEWss$p^|m_q`!mod;$lE_Rw zYnrB6(#O>LA;&TA7S&qWvgR4rk&&Kex06~Pw#2U`c zcBnIU&~|8Ehwl%Uc+Gabq1MBh<+e)+IQ zB=!p1!%s?J#Q<>fNh`+$XHTakmpCa?mb{1*cUp1+&>S2!=W!6 z1u`&s9E^v_a1xvim&0xF2>c&>2~AOQ56FfhI2-PV&tMmn9}btnN6?irHV3|kv0TtQ zP{c+32{&?KW4W--T-Xj=*bZD+S1v3}fqjV!%Wq9vwzXw_%!U2Rh4trt_QsBubth%{ zjonFSFU#sde_&2W%R08RW!>J*vM%nywf45G&_K&N?P$xIG19Usi!5ta*s@+cfw<4K ztn;Zb$KS$rVD*JdEbHFSE$iS$jjS_wZDjr4vyt`Tm`0YA2eSHPF4wAo+IFHve7TYP zFVR~i=QXkRp7Zky99k!TSpNIT|9iRBQ(V6|%wlzBt8!atYzBsc6+wR~-GX5Qx!0C* zEACxcQ9&!#r^FvB4oE{Vt~4+>Tofn>%N-$)?m@-CP=1A7jN7KK{azK+!6_gz~~ju#7%}dB4irGG;$1$BWuG zx9zvAsHt`8`wNbncYV4wr&q^cA3b~8F!wPWa;RHtFqezmqa8PW4o|BaLlS>e(keX;QEv zpY}hgo)q;}+SM7zE{i1{b92Pc)42JAvW*Q+St%dZL*=9UFQd6B?)x#dd9C7h{8_g0P`S;$2X znghF?%cJpn_3@YOoIfd}-SnSFEk!fOU2E^IwcK*`PpC(ql0f0ae!2ZAot33zGOil5 zJ}-3Xp>1nt+L1SNKO9R?>#dH*?z`gL(LLo@oMY$9R*^ftN$e5T!L&oxRc5wHH zXHRTq?R4nH?Z%%K=-DosfTS<=LFJmR?pLux-(dMf$&YB~Qp1^gWVTMO$HHl8R`=~L z@$Y*2Z_Ou0%X@Pa7Clt1@#=mRJ^F+qdL~G^_c9GhW+&yH=k&rIdSp)V?Z@rR*H7lD_0~pVDx7AU>l_JrK)^HoR6u{de>Wb2mOVm5tBB4Hj*`}1rsz5RS1pn`<~-@wq6@WepT zz`Q=ufOFYvxmb)IVuNg`%O2DER}Q}M=kEtcPq+J6($jLw)xQos`b{dUsLJzKl;nm6 z1S?;2 z^Ze|k44V119KFOoY9}epblt4B^uflw^^K06+sqM2@yDzFnwL9^=v!bcVzL9m7rSdo>_`z+rEX)9bJVq9fErb0b z9>XF$j)g0WO9lrf$>2h?OE2e|&s$kL#MkQ@`m9BS8QZy$b;p=TKVH6Dn)T8)mA{O8 z>c{g!VnCeeBX&`_Ei^WD>EmcJtQ_TrmjptldiL3!smNwKYDBrw9Y#$Nr15yzJ$iMDZcEo%%_5Qy23%8r0iurWP>Uw;bxJ zWsW|qq-#N6}Je_g-UEPN_so7V4@oY>X%3!NJH=8``WPB7af%>&H`%?pCn+Fbku4J&@0OKgEG44A0?Bo3Wgs^wbu<{2t8 z^F`~B_^H3-sW=TMzf~q>L!8rdaLR}LmUA_X{Fbt$PRfwPrT%iRo-b{H_({B)p2TI= zdpS?_^ZUvtx{p2dunP%*lksBd&#K%O8k>~kUi9_j-!JOO zp%Y16{n{>g509oJx_ZvDfM)^AT7VI>J}-9FXZQG`*elc5uH=bF+FYZybLvu~RpjbF zkjLdng+FAEVfYwk;pIhex;>~@`-ZD`I6QHZKQeJ}AW|GC%CC%!_ZJ3oBMgu6l+BBa z2oJFupV<%3+bh2PaqFA+Zie;V^3cGYhJQ6#?k(cFg0w#>w}r;0KKf>tmRgydBX*N{ z3}xt{?+-88{_Wyj@H59Ds@ui%lzw(rt0wk)HH-Ff|I9zStvEW(+9CWwt25`9SKraY zvFKvLiJmIwXPm3+xj*(6v0UwIpSO&y=xe?|6kX&wS)K=^A1Zy+ona4<#};Wbd%++$ z9%P*7JdiT86k4F_0Js3Yg|XbYzlM1jyOf)J88`R^T>4?$>~|xv2#MvA*lQ%#fllxV z7^>M`q{}nX$pCr2lD>_UDY2pFQd_{Rx6RteKR-+D zkba(9I5u|MA?eq%bW`1^!2?s;ZOO>g;Wl|Uw2mD@sN z6CD9W9p26jVoFrSVEe>s!f3iyhvezbo{(YnSUC9iTV8wU&6$-_>YQ}t`c-ZVjZIv- z*;D+%Qop4k-$HO#?Jp0%?9vyK^nzhTe!7bb0ckUlIQ$NMY zbxZmxw}r+gE`28V6f!JKvpuXl!F;I>`^I0tyWN&(XJ0+wt8IRGD_4`4WgpC1MXvtQ zJhz8sOL%KkB=fo=;Zi9D*-Z1963{^uZ5Dmmq1ut!fwk$(CqlK;5|^IKsqjVk&u(v7 z2i*B#&t(UsS!ccQP{zs!zUcXfG!i(`Q|zR2TWD<7K+pUV?w~rRteTp7PTMcFJ<|u= z`@-9wU%?Cq$EiKta`msjp1I@4_bIEa%c^p(Po*7-!tnl*e%N}{I^!Q$l zV|t1`Rj&H!evS1^Xw~@n2TNS~CMu`Hj{6`~{LHx%RUfshTdw}Ap>HUOS>xtOOxr)X zU9%2Ovocm5*t*9pSC0JOwvHxRPF1e@>3&W1beq*IrxErrdi9HoH+iuvpd|q zNE&>c>Zx)^8r!a>p0Sq6RsGF!x+I033wowmuW$8D?mY`XJi@J~%3~TjM{BO9+oDc< z=6j_QUwr<%%jw+ZEv;v>^AD*Wde`X>OT&*-yQ*VWBef*1=A6!#1)DCKmWheDr<&HGAt+!r@&1TWPwDmLli91W@4p&Z} zbrKzsN3XK1{iAkreCpoL#!Ig^t6%E(jbAo*hBw{Zn?w)ux-<@RFU{%}AUPv&$+cs2;-{A_ z$Ab8aBYGQ^OE}X{&yzSMehn{sO+(~zzV!7}F2Chm*_%%MHBLESj`g>OS6$ranqkd2 zy<^V;Y5{kBkuoNe$Mykv2A1bKLCThvRoR}Dl zqJzY1!p~YKX^5YDuewM;iBFt{bAH9*)ZgCTvp^yXWKlrt(;rK8ZbQqo9wds_Ec4>; z{+;NY`pVqtY8^MzQJJ<4>L=%F9Tb`PYu(p)^&GR#YdawGDP)XR+94UQ)%h>tuW54V zxsB8UUj141USpP9t*0u}x**x9^~0+_8)@NQ4{D|AuQh}UW*OA@wCqW_6es0UoEcV+ z#ZSU%+0}C-yp-L#&ed|Q;UzvfR#XQ>aq){>+kXiw$Eu6`)_6Fyoys(f2<2FR>#_be z(>KGazg~~{d2ZvfKn9t#HvKitWAmyK$xQ!^`FL&Z;l4Jth3?({=I{E1F~hHqWAi=6 za>jY3?Z{4&@X;ro_)V)`S$oP@wm7|}p;5W})cioPy_SZI?dFyGD_A3864Pb;k-`$* zp+>MS`*FKSOd3oP}d`Vc}tj#1k&DX_8^4+YV zhnKHztH-~eFFPuAz8<#g|7Oi8{Ue|;iA}}zaLFAh-=`*OhvoaiNddmtol>Q)J+nev-^9HBR*H;P;zHyI^ABHss&DU35a`jJ`uX+CR@~PoSQS>9u`sS^~ znF(5NtB0gnraldkzj{5AmbyeT_1oC@=DfRkc`_;&n-}1oudot(-uif_In#Ihy~BRD zI#<@6hbw89RqjY*+x*F;zA59&?d2q7*)jF0!Dy0Csoslgc(;w^UBWRS?*y-fb|90e z%HJQjjY&kELHB$TOhqnOwZqqlJ_Uok!iZys~N( zezT+gvK~nm^Q6UPf#j3B+$_E>&D#2g#w(w?yx9zv*s)z1TPZgxccigx;&l;Z*@^gt z5$1A==qY+EK@Ukk8)PrvSjrf4_k$X-j#0;b+y2_ZI{J!zPQCfys+&KFX7DHYiykWH zXPg@xo)ET|@CnhWAI?%_eAHeTVA|qfmZ4)JWpqKhf~qp7XlHV^+HG!r%x>2=zHNV* z%Uz#xuj3I?9<{7$xfDxFJo|u@@eGh_l(H_@E92>Mj?U$fxWpEM#Nj?h0((kqP9=*LMAs&WmM7o9 zT*uEhga=N(FgEpCR1dx0d+7JQdhcHJqNb~Qx#j9#U%iG6jMuB02(OpvPb*{KGb( z_a4?Ox0@Aezgw>U^{LPKfx^m2V2r&2o3pG>{P$~%Qs}kd?F{Rb$NDxpyZZKX9DSUA zgY=gK49a=iBU18|%@lr)8hfX4&DRq6QLu#6BulJ#-(hkKG}x zopNpJQbT+V(f*2Bg7n?AZP9+A=qkunN;@RS63*=BsZ8UMbLIHo?#$=j6_gXPNjAt{ z>?!?c{qBuJtML>2@A1Y({#jyMagL1}*UBAfY+K+T=Nk|SSITg5LBt=DrK!T9E^+<1 z*~iDHD|zLvFZ(t2&HiZdQw18clXs0Qw_N?>%jc@~B~hCq=bH7n?U>~CM#8r|{kKW) zRu=y?OMc))uN~N`+!h*}c)jB5O(LC4edeQ&#GehaPh_V9SLVLi>iWiV3%1=p(XCq^ z^>+2AR<)Da#>qKmyV7}V3j2(1ZFN3z)W_XMoUrKj_D+hTkF+Z)ccigxGW(din0hQs zr3cZ!``hTr|G8v`PMVU~Pps&ct3Tz|F1F5y4ezs9@>pek!j-yQe4IV9{3+}~aS@=^^lb>Rb;9Wr^n)Y=<#LVg^w;je9yNv9o54vSAR`3s)xNI zVv!0BP0W1B8<*N1Z(NmeN$+LF&uTiVhg+`xnq*Xup)6=u5l~?rdMvGn9!EU(__ZHA zz2AIINA+;a)nAj0>fwCCsX|*1-+_JoRdMY}NnvVx_}+hYuX7){_B2gL^>EA8Uz3cp zN1fWl*WVTO(C5Jyx}Ru`cy5`dr~0_%>hIDgktT<@?NVKo+AfQqe&UW%2VQ%rrlWee zTz$ESkLNy)^5P$IAD6 zV4we-Kf?)XEhk}V_f@WX=sx-?}hW4T9~>%lI)`P8;q#gin6?VNs0W6Ld9fB7qhf#qRlJkV`nLG#LT{u&}w zgpRop=OcP1H%K66I#iajZa4wDaI!QcIvzBlH2%IV^L|-sqV|6bIJCYP*`e$585RF) zD?e~zwx(=VZVQb~bePOprawAZmctwjUw#=&o<;?O{Z->=947{(xS@V*?eL+2$(4cf z3Z6+Y)SC3q#lESWgfY?ZiOx+V)A0Z1y_Y{5ckX-nvvKE-d4E_zJDlqNaMGn0pZe)Z zWA4?f())v3uKw}&hrz*e78J2>0=Z?fuv8^~hf&2U-j$&uAAi&^zV?5xs)<1F4;kV3 z`>A`Jd>-pjKQrT^TfX1&rJeKvM$VA?smfI!-N%}GpR)#aei@@^avPfx7}`H)joW>V zU-r^w%e_qAGs`%Ej>ov$a`~-rXdgRvm0zAqWC8OzYF>)+QTpqS{*nHU zIQg#uDIY4gg~rAxAAN&G_Me8x-=@*8i7%&S{pnnmy8isM)5-lGz4(@kG^tGcAk%Wo z)!)#=>B|Hn&R@vTt@5!(0(~m}37|~g6gqz%H7q3mDHHcxwFte$WrLJ6cl{B+pK@3J zv|^j3#d0i8>?2#Z+!nJ*^uKm$C`0GkI&J3H@OH`271 zUyl7|#H2KqXEhjLP5N`1PNKb|TfC19Flkwf_wjxuvw&Hjs>@TClT#jBn)Ti9TRf_9 zYB_Ps)jw7)cvvZxf3SzBHQ>{~RgTD@((ab!cksbMBjW$i@A4^6o70{&v;#@&hMf(%Guq78;wl|HF$u zRBADy1ldoCeR)z0hMXth{E5M`GN$v7AP%#g>2Aa+hj*=E<6w?^%;S2+WrLKnMD6+) zw~hLvNuV%K!ijUrz^;~C?)X}kQ4XC_=k$&W!qIDW7eeznK5J@neKMa&w@QXxa?!Gq zA>Z;>Z?+SCq+X~zDz4ob`a~bvV-n2=r@FeUjntIb|EikzpT+2zs-HWj;GgEtJrvkY z*3A?r`$lY4ZVQb~o#PGm|7KQ}IV0rp<7o3viZ8EX6PdF$g8yG?I{tvS7r&KewQoH7 z>PaoPyY|m$hfwqod#T(|!9Gl>N8doHziMc}UoQWO$=DA_IW^Z6m9iwsNfFgPtK_Wo zVVi->9h0?HbeyIY$2zwxgJZc4R7|+8=gs)Z9HTZM@k?Bio}?pAjs8lS1>-0JxIbP<7s<>=pJ z``hoYc{Rg2YWj2EJ@ww*FR7j~Z&>tHxyGyeHPCZ#peR^5Nhh>MRc*-s$rYXTekAu* zSvphhJ9163R<_KGZVNI#vlGb6A$e}oexvlCGhq+d6ZV3=LEh1~gZ9t?_J#eRBgnFs zG6v-Xd5PT_4g`7UA@l#_-q#HdhC@L5g@?jn&;xqH;m`|?fGm*m)EoLhU+4$@VF2WS zWb%=46bu3>Q$rvZq~muq4266sfMFotM9Ab?>8BnG@=b)y*FO$MgY+}Tz*z9ZIFK?z z5wP#;W_jv_}?E%!NJXIPJXJmb)F4w(A9>Z#>ko`cqqwzIe*Z}aEE_(0i0Y|! zRe4N9=V(p!ti!Bv?;Dq+ZzGbCdL{b+j0asmdv;c9>!z$X&lxm%%#U5AalolvRqjY* z+tt)J@jA9x*0k%q(~|3%HKDb2{Y$S8$o*^Q(-$;#bWyviJf@*@wB~vyw(LBj)%w+W zR(v^dw*%deZf%Wx^U+WL${6^we+c6C1i9a-+!h*}dh3aTm1o9Bq1%H82K4UwBJnLL%BrmcI4SJT(M_{p*C zr3#pGekOGiR-K&RP_C}HMDF%enaXv)wz`<{>ap5Mf9rm2(^`}B8!~N)Yfapmp65<0 zQ9NpEci6h*5-w3Z?(^&OTjSAvs&gcqk|?bDX?*5yJx+9<$jo!<3bVTMRB@`mJAIYQ z-aKBD^fe#XCZ5$z*BxH3L-*=0x`}hk-MZ>;C-mBFH7-qi?P81Nj~S1qVahg_W4X4? z`TA1j)4%!JQ`yGz_blL9z_Wm70nY-S1w0FQ7Vs?KS-`V^X93Rwo&`J$cotaq7O3In zlKI|K=BUVA9GNF5@11ndVS_t~Uup2jHzn zD`*Ciw=#W5+Fse4b(^2IOO)4%WE$Sv*Utjx{Hd~Alb4r8Po`UYoLg}JiEVznPUq1{ zUP*aTxjR*(yy)jLeFNhI5xd;TCo|EnYP96&`Lj9Da=hsF_<3lerF;uwu6wrRq^Ebg zymf~bQl7*)Wva2Iaz`55)}>b@P}FZqpmzDFRldWPxw46zmPOqs3ggKd-U1zn((KP| z!SC(~k}=Cu&K=3Wzsf0YX6?}OUhD0<4}VABXX%zNV9s6{;b>BU6tV8Dxu3YJpkg@hz<&HGA zHS~}wCg08Zi>eC3&RRHKVhwZjl(_nTXL5b4#p%{n2e%mgOuK`&ck83_m?q9qef9AT z2~3TJjsH%~x+}R}3o_HKGr#Tp!AIj7O=%o$0Hhp9yQK2f)yw`XmT21~=hlF>M>Q$* z$=fsCdarQ*oau`WztOFa$|X+I#jf3#FyBml+_sW<%=>=l1@ZQB-}lQX-y;v0Ip~c? zroSNVs5mX(DtDx@t)X8&>nl0MDJHa=bMu2`vs^7sp^v0e6+Gsu-@o2ks)Fq#|75jL zx7-%9i6!l`KM9R4`o!0T0a;2ZH-s`3kwAcjSHorbQ~mN$Y;I*m+;`Mt?@n$fNo(QN zAN70Wh9htIfA+2fzNupCPuW_5LJ`Cwh-DK*jb#;Z>qad|q0$0HKpNW62GXP^DYUp% zajAPzpW<_iK9{Pf^@)l*>Qe!iS5Xu1&&cvx`h7=n>auThFFbYh7OH>Aa6V+d!4268 zE>m-a;ijf%@o?mD>5YNEJ+op;pUci0HZ!B+*3%wJrC=oN?>PxVo7q`eX^Y74%8E&0&H zD|H;q=kWO&6^B+B2Jj-M*PKTp%ViTvzcPQHvPXU6r|Ec@&p7xR9Z$B$>nMdrU3ZCD zedKwa9%$gNmR_jskj5zZYF>{QTNh=DXCA5PaF$lDF`seqwOM>>1%ijw@}}(3$Z|?) zj2E}`9c}w)Xnm%RgZUgjUt5Gji#vKZ0OI&dcq}rmm2bq0caNXwNh*A>pN@<9>Qq^5!wLH7~ke7_yTXoi;JHVpZ+%Yk`Hx!%vZ6|{Z8U* zK4MLe)%dM?+$vAK9X0BhcoE3D=*!=-2d+1Acc{K&egwQ`J!~|kf_gJaEe!O4dCeE= zab@|XJQ2CyLa#Ku`^@S&YkH)bugm(EQ0aVjSLCPRah7DbJjL^&=u>L3pc)aJ`2ltpWa^>Lu-3_!VZT}dqUUU?*TyN4tYE`GQTw}*m^dAk!5 zQ0wdDXCjwNjf1*~7b?bgnEayOL*uDrXfHX{JIt3%#ZvM$_2pbnH%2W;;ZuP})$5j5 zX7@RU1Pd!`zq39HE(-4ZYiF0g^un>vbI^o~(CK`34~HufAho`!dO5P33NMcrhuzWo zq^{-TD`-zV8I}|C4Q|M88J+@9=s8nykEN`9>hlJ$H?Aq@bLZX4>GQ#nZaFjgKy z2>ZZ-ILx3o+H^4VZ-}BrP1SOPs)b;P6AQL|2L*O4F3aiTFMiHxR~N zFlv7^VO8}0-!s17>()K>*>Z+P@kg+`O%_Lq(b6({sH8#2 zdOk_TYHRyy<-h~v{8b%r&Z!(dcEzpnV)g8MpSk?SgBG#EZo)(DQ07Zd70ZgJ+==#Q z2p6}Z@cbqa^*5vG4WzP~)(_En4pes2+5?)?>j$DKwc|k(K@QMj5FHo&At(h2d?9Ev z=u9N~F-ZKwP&h5b2OJ7dGvH|=Jbe%q_B>S1S7RXlZ+($JjuzrtC{sECijYPZBb@V4 z-k}r!%zHvS)GJP0cr6X*k|>KD%4x96sJ@iUPXGWyIIwMIMK!1s*c#Ac#leriVD*3vY`T*K8bg z$!G7roqaj@WH{cLZ*W7lg2xOte8dOv3gZ~`iWP@G?mehHL2OAobJ+V&d_DCO#0wc3 zi=gz!e92U-Je-wGibri@t128`^n~0vSjt9Rbc;y)HWn&)D!s+>Avx>i3@MF=KZxoe zzDD4q@{;AmWv6=H$(I8^Ncc4Gtk)TWvA$rm(E041@9-{g7CWYSyz_A~Z?@A7ZT6%_ z*elh)Vt^*oS)rTEkqIVi* zjhr&OU&G12njTQR_eAV7-(&|bbe?*a-EW_R{vzfKii>d!wGB+1#3Ikgf@HCP2&ZnZymt?X*6tB#eOvNHR=+F8c6r;FvRLIB+La4#B z9DdPjR(a^-e)Vs(6Sw{SiD{b_pJIE0A{AyVh{9*SWGa?5d>O25YA)gM$*0u(wOI>a zkB^);+lkqkH??|VO3mf`{Tx2?m7wLVHT7ozP1@q|{)ew#*>4H)OA0VV5LJ=wBMLi#w+K7aV!ZO7#uL<~1Wj&QO z+9P_qjK1;XAz7=>2u!6S zO`06j*7>HhI)99oJq|T2bGk}!h&j8f?XsG8tnDE^{Hn{7MEQj_&zfiY%;J1G03K1h zkooK{U&EbaV=MrYv#xSI8;*0ZtoKP+9~npL|JsRnPZ)E}v0wFBLG2$hjDz_GH)JdQ zFC}=I^rh1!yp_cm7NDoqd8j}X9Q1rqpU>a>G4L!6UrUo>+B)BGwan*hIOI7xhCCD( zeow_U3g;G(Ne59msK*nzwZ8Jal4r$>|D}5}hQ6y_P56eZ1y}U-hFK23y|_%is3nuq;w>^R6H@>$s_g@6BS$injtR`(s!!DXwl#{p>V9Y^ z4qMk_?H37`eoNy#WD-D>-G8+lk6s z+9Yn=HuwW`*g~Y>eM+y)*S|VU2a;M6wF66Qg!C zOoJt?eur^5@s!CEraHVO&SHPQ8~`=m(9;!h`+_Jf#nK8%W8WIJT~zmJ^m?r9;{%JDxZ0LWjFpG?YgtiNAoY{{@0X%ny&|a7CB!Re%?-8 z^0=q#+5_g*J#C7M@-?+Pn6FDw$=BG2Vq{<1)|llfuB0gx)xFY~e3D+Iz@~bP)&b`L z*AvHYU02+*WcZU8Jl>VkzUm%O+*kCyc{=66QRe$Reo608AIRtj;ieg*%3~D1m-2Xe zGtUxx^`e1aUUAxpLVkq8A+tu~8(j4N919EVb7&sWmWxjDR3|3NaRTnd%JMl5@1(hz zl|H|xyugXGJ14obonD`RqQ8RPO#!hywr_4{375hQz*6gdu!4rlC5l-lE~AJ~hTbQN znLQ@~wY^pQUu!X(hdI1HtWrS>waRb)#~gUpoC%oLbr)CL08@(5 zhou9?zI?F% zMz7|8)O@d&Z^6MbGmJ===E@H)7x>D4a2cZW**$jsV!{x4w55im$0Mzej5ao> zz8|~avl7tbhsrG~8)9bvkboXPbUrZ6eehb4{R8D+7ex&|o!bd3Q4dFJpMP6^Z;z?J zUT_PSmBv0HA-0)(U6K`FbQIz@ z44yoO1b-I>ZP#|i`czaPzXRHVXjohX;mz$QuufBme_+5j1&cMukAiBl$^^f#=LJrrxZ(&9v?vN$p2T3la> z6QBMXC;onXE75jwE74ZAJEJ?ZjBW>ME_qBid%i9P`9BvQebGAZk&pVtt$*p{xDMSb;&M*AIqsHY8sjF7J)qT*MdMlx zpS7gbjl(}~b?~ppx4vu3?X6#!e^8q~JO0*&;vZ3aF2z$Vh|_V(Pm$9JJ)d!Rb-#X3 zTzBR_so@1 zh*T4cCsi7I?_O`0Q#=^C*@_|Db9x-o8!JFuF07zJ8YUeio`2s7_JDX&(iB4XPWtCzaY%w1XWuU7- zFM>MbqbosiDD$2Jt;WX1U!|{^$i#1;K@d-RC2Gm^DZ+XpCH>^cHNrvKY2yEs{reZ<4 z%K|&b9Xgq>e;wCg43a zr-8Plh+p!qI<#)s&%LRfCnM7pY~~x>kR9B|pln@0tH{($!+Vfz6HUc%VcQ>sh4vxS zybQ%VB~>&ni=2+%R0k)RVnCxcD}%>+3?RiH~iH-Y{MdIj`3C>|ej z6lf~wBG6NypF!zJH%mZYgQg(;yb8+4$5UJAW~3ztL^clTDHjQ|5^3rsfX(iR_6)#o z0oZ{^Uk_j)r4EOzucy5^D1g`Z72@H67!x}h^*9<{k7A$BCmFzu1pL-i_&o)A@on%heJ@5xr; z+(TQ7TP|-cMs;W-7TnlIymnGs(f*gV;`GLLV*U&9V(R(?@pjktV#1jn#QJWDqVn@j zqWdpNVohOJ@t^kHMgK#4i0^LdC9b(4MU?d)AhJ#!EFK@3D$@g}XFv<4=Y-#^^S?=O zqd2NXdoQO=rxe_Z`$k>y$q{Wbmx3h?UE{FJo%tp^c$soat_^F_vI?^uc7LVUk?-*P zY*}6p=})7F8bF+%Rv>&b=^#W|6a9rbS@B}}i&B()03ledrGi<&h4snJ<}&)ujHL;IPj}Ej<*9S5YZ@ z6Yy95(tm`0!EFLNkr#CX8NT)}9xGOX=m5g#4*XKTK;4LxCEzK)yu3S@b^ zbGWVhdh1(&r{Tdjp1fzw@dMDzl!oNk8FFO4$qrtc$3x4if&#SmE~Ic(L0j8rh1gS0 zCLI(mz8k;lC?;)u;>i!6kGq=M%w(t?KGlw>|UU<%QHIAw$n4!e+i?DpvD&%_Ir^*glUt-ES46 zSP4HES897JF6#TBOCcH#h!>w+{CrjpI=1WAE_^uo#ivtgUWg33D^iZkmrTWK9@hlB z&!0;RN&FtS!%)Dm)43-!o*k)Q&+R`-CDgx1H%g`xY8#>}CHsA}jDeB{_bt$^l6^p$ zqo#2H3^NOKvE-Uzk_(cK94A%dbyXDk4H^Xbc7HK<`5iBGby9@FP(OvzA@e0uv35m% z^m+=2;+5tBHUk&0PdezD8O{R{w(6eHA>`ig?UTweJYn7c0(Ua$AiUaSy+hi)UBzWj zcRzmNLo<7ke94fE>ARROnTll{=gIJT7W$xdU>qxw&$U-&Vi3WPUXeMhW4>F5YcRcb zwBn+9grRU>Ux@MlRpZVrTa+NYYx2j{-n{KOqX!ql#e4;lyp>2C&`ZnYI!>26kO{+!Q9}at4*&E;iHm&o!;*c>nZamu4}hxhAwrYEqZ;LKKiwsn-2Rmhw&Kg(w;)+vwIMyMeor#cSR)^KE}PG z*wpBKWa5YfFKS$yITlOMPe$VvW5+hL(V%wi)O@!c-$ACi^iaPgUUW%+q38H#7RKr6 zf%%M|ufgxwspLz2)q?5@M^pXfYWY=nP-ML8x5bNZ3woV#^@Wp9Kf`Vy;(h@087E(Z zczL{A>gk{4b(T8aQ166=N=^?dy^z<;T_jfy-r_Ozq!=>_oN`0Nr?oDt- z%~RA*#aO)A;Z@^#6Y!B~E}j#9j2CB*NdI-c`=%T{o|(_M_}T=Y(b%))6ck`0Zf7Fj z@KMEEcW`99qkf7P@BMt(ge|kn?$+xm<}*&dwj6H@Dld2%00rYeIWpe*U*pA1Pi=nU z!{Y0=>+)qjZ-g_9*zaw@wh>{`ktMx3+yWTF1wH#>Lkr_;M>< zekT^qQ&y(75*0_YQ)kQ3Cg$yYvJmQbtn3k4&V%9;g!{vB>l)uGEYiP&`HY{hE&2|8 zmhAP-9y;6Oojq(9lDB2vuHul$-%*v6BpyF|)y3)mdL>t{=a|p<`P$?=&<^l>iajn{ z&X6Iy09ehBDLo_OE&RT-cxCPdzbzj1_wNUr?MAMbna?=++H$-t%a3Y0*&GFLa$`V&h8r$^R2uZE) zYI=p_9tUS#zhc9h&SFMN#=^@B?^=G#Ame?~qfYH1<{R9Q9YkztXAsxy<22E)I2Ri} z5H`G^@{Y!B0>IU-CTH>4_h0`b^|`4ot2Nze{pKJj=p?*U-_VuEwP>JfL$9wlB)u0e zoLk=bd&ZiJzUT*cGPJINa5G;r6)VGDJRft*3(*$Ogl-RqEi-dsJ~pFx<~tpkWp+1) z9B6Zl1?Sd&p>c*M`hPC>w*>%*zJvF-DM9R!TN=9~8Bwp3WI@L463ctyF<&zN;#Mqv z_U{Bh#f+MNsC^x74tRIsacA=b*7M z_Pv{qEWYQ2ukSHxM{YkdU&T)MyNKV?4&NRH*H)}=efQ>jHh22GthCh+#y2o7=C>SI z)OqA^g16wUKRmJ=3Cp>QJFlus8U5maQVnF34$_bgm~U`HcJp#H2anL*+==OAOTReb z2x~i#=P`Lcd23^5;h%W^M=1|ozhkUfaI<`wA3|!}HIG-HPYx?iu?gO&^%wcNGj#?( z%U61Te=?f@W>>$DavsT_%>Md)HNeK@VlC1anRF20)#ste?bMnJI()ln33oHhws)&0 ze0r9QQ5@!A=pE|PX^h(3+-|sr=Jn-1wZYc(P4c7mkY!%=!h=RQ*Jb@;lxnQ!rj=M` z^4VX$s^L$mD8bJ9u?w(rT@F9cGgTn|{(6K@hQFWI645;KcF^oA7S-V*rd>1Yie(9v zuj}D6pPo@o)9~}1iyX#Y12tXIx`YMli{`!B4@^DMicgQ9`sG-^ar(_)XMb_bS;nlM z;V1P2nXd;CnxA(-D@qA^ebgBopKr@{_>0Se98rT8Sx$vVTXB%y2$EF;@Qvs_bWzTu z@gie=_V-I2|4DiE;2|>N{Vf%)-8gwt{CD7-fP6+roPzC4#(2t<; z0J03!8wvIfP#OUJ2wDSB&jZwd0BQsPJ&Oj%WtiZ)0}*~O7Po(gj`}zNvH{Q&SR`-& z038QF3jpYI0D2yPGV>tYS-@0|`5mlAY5g}LzP%sc_6qL52DWZ-;=7DE@pDz2=&&MA z+=GoOOQ*FGo3Vyp3~4PMe7v39YtvFv${3B|C%(~8PvzAWu@s?3t6UFSc_pV)9`d~ZS|3HTFJEarmOQvFlMr%== z$m9G>Rb1+Mz@Z&MB7k=}-PYQy=~l->dl-JHPCRhd!oOds<6*u6Mc(cto+cAA>bT(g z)X4a%x+jXSej0QBuu&;49Ut>|7hh<(8Ye zk|;j8YIaSxQ_t!*66G-&+P_NW4D%&Zv4ZVl%eZbRw>MeAqD~%}=S@kL>8FY}Wmsgq zd50#7PGVGbaYd{ak6#=Gh8L~(xnbX!Tc4&Ohl;bs0GiZ_aUH$}mlG&oV5mi^%G z{-b;SZli_8Fq|HkZ*W8QuF5x*BTb!tXxx*pYI>*}8Ckw*M<`&M#j4-wTrl+XV(Q!kMrCy&4k2wnIA%G-0d7* zCApe_^(3L<-5LdNMQWm$`p&7(K7Q%u?2|P4GJlux%ItMUC06JJOW<%hPQ@D-6W?|kgTQ#JWAfA{ce@&#aBzAF#_*RO@6BjerLzq6P!IQ^9y9~@gj&xPwxrR64y?0~S6WTh=C6v3ki2Ldq6DOm-*>N%Us!TS-;o?X zjfv1|BAw6fL3xG8RgD$Gax>c;Cys)xwq;h9n>x+%%baul`NhVnd~1IsB{MqCixwaJ zUB_v?E@m8zQ|Gh$AAmDdjlom3ebS)e)#n`~hWp>IzxPA;YQ{tPLFNjL&+arAM62xc z%k0?Z#{cLTU>7tWLJc|X2*d;Yyqf-MPqxZ09G(|%?~!oDxFM7bq+vWdpWPWjcs%(I z7uuQ_i?Y$6gHOR0KnPTB?C$!vAW#Ohlh;V^Qt4-Uoj1f#YXV*{8ZELD3kyw>fIS zndGj!Szw05j=AMCqiv+{f_m@ zcjQbOTuk2)0C7B3jW^~c(!itgkMbF%7j-?s37vla?b3k{e8+PibdAGI2=npRVw!wM ze&rmTP9{%~qHz-1s)6GUum*jB(^Kh_`uht!#{MVrC;(!7$)^}{P6Lndg=?=|b8qAF zv{X^at=A9} zBBzt0(-TGNx9@*;#o%{u(bEa@;hn`a!M{8EU?QX>^*dHY`Hnh!qR6j4=f!i@7R2k{ z!F;!s7IllN*W;N>AKh*xs&{_}e$O1uIK1-Zu8q)0Vtadr1Ak z33wvZZ(+Vi!~=mNFL^8w{*9-l3}ME>&`{Y%3KwcS`V(JG&C_@-?;EdKjfzcrfM z@PhH_{D}Bk08VXRCryfu>#%2U&Yw2p=mR-i#-;PwJ*?a!2uqbyJ@8QaNe9uD8sT$6 zRYzf8%Jlo6#jW^tQ0uF{>vttMhG9H9pWVaaNq1piJx2XVDPl3DD;gKbsP;R2h-KqV z6<1nbbX?=UzGB^)&G%p>jbRv<&S&=);es;uh3J{6$kh02IMo_|qA_0fI~#%bhjYiC zxV04PHm*xw@Z5si8oJFRiH7nW^BE6cBjZ8_NH0-QiA{Ks%7K>X$Dy20^?D+R^lNqp zQQ3Yth*oQ*f$~8v&=sH+psk?MfW8#e6&2}n(1oZ>uR~7xsjUz%Lj--`=@58&3_P6! zPY1%&?E{4H!_#?bLVN~KPcDc4(<`9|{&67|ek;UzW8%a=Zio|?9n?yE^Jpv4_mbA) ztG~Aq7yk}VAxBKn%XLL52%qbvM#!7%rLNyqCsQ1&@liB6dOEpa!f*Api)RJ!sx+KV zbUwR>j}K$3I32lL;qm&@OR^kpABF+&l8R?5@Q_IdQS9sGPMtGRyjyN-<$d$qTgaUZ z;i2^j%$H2XYJ#Vr%;_z`-aZUM7_ALDT8MUYK_OJhP*H<-xt^%Vx5|gwL{#9Z=WLeE z*f_y|S^OAtSV`h(1)KSJ++u=wFi47pggDd4?WYx5ekwd*Qa~JkbqJs1Z`8J|PV}v+ zdxPRWr#!oZ?%t@lmz-8Ukla;y7Zq6LT>^J~9H{rTpW4$unRN!7q#-{@>N;PtVFka> zvK}PgGgmn|jwB9UM)DQPGc51zQ>=Ja&NA>MgFokBr%0WjD12AGvv%eSZ+FNxs^wt( zGoNwrHHc?|T_1xYol0Sbp=|jMpAXt#ra7UxZlUdDd&Q8{)YNhxhJC6=$UBnJCJ^Cn zNjXAa#bpVWG)lc%R6$XBLgUwcK!ZTY{_^bC99(I>dLHOJ(9IyKOg4jh#GzaOQ3jy( zly;Oa{{fwc#F>V~IS9o8RAq~$2=rL2qqKEEoTIF%OhOrhIps0QsHafg+}n?I{$btz zaOgWe2|AQ>g&=uzIkF02alEXY8aZAXU6{9isMU_!9-R7s9xu#?cNPhw_jQoYUXde*02;Z77o>Ms6y z)DK;{e51ANnXf>Rx8d=~23Tlrgw?83m>`bd1_ckvDctz$=nvkxHGAy5|H4@sns=q0 z%{pJQVP)W?-T5|*#N^>b8Aq`(xgRP{E%QX9PP4`jiUZl6;r-A#3ll}_)7Sj^h`-H{ zhs^*uewfeU@-@6Xg7HIBWmG&`);BZ)2bpwGxOk}tj`OxXbKQG~zU=v*7B9?~9w=6L z9L>aw4Gn0Se5~UN6*D5^qTm|+{Yzh+Rn(#opzVRZ}^;o3zxH1 zz|HMEZ`DN}!c=3r)A-SLxU1=a|2XAHf;EK-V<%$0K@WU zzQGOI`8ZU_OEYn_p(He7Vap$zIc4%#YdK$gdgSmM&PfzU-Z$&)hsWRWLY)~tni#U2 zXMQMT0%yhSDen1h&q8ArvsE4mv#ofjO@$_oU_EG6-3}B(<_|6`-n4Yl zA~Rr?2lGvK@DjvB8F;L_#83|#6o(}~Y7st}bP&Z0*E2kRwE4V5aewL7ZA+g$Zulcw zdB%KtUp2w-Y0PMnn@|i5g>Eeul8UU~PiPWAMQ8^uXrFpN`P=r+-x_*<-1foK=no8i ze{0yxmrTV9hR-(>919#S+axz~VFjidDZP)U{aLyre~ep>v5oO4!`e{Hn(js9~R z^rD$h&!~ojm#ayXcxWbBSjx*m_Q>&)j00#II%h1~)_d{T=}9Cp0}r)Fn6F}?`yd`m zyfj6Vf@e8D=Ku%i=T&EArcs@)mg|jhSMxJvnYN%hEbe=1*wI(#)MDNBl7rLN47%EOtY?T+Sfh0g%{~ae>GuF+h zfxOKJ!};ez1*Ad0vf& zT7*xA(hH^EaP8T99H+gM{?obd(sN{t^wL}Ce8V+tdcmRwmI~5~+0IvSBsrqv7_e;P zSL-@n@(72+ICMU{bBId*0glNi1ZAoL_azNI_>gDjbsBly;j1Vt0|)j% zntTqQuVHX-dNAhBpmL}Zl>)2@0fdRW?dGgLo%G- znQw4Ib{L%Fd|@R!&P}Q;edgHQ1XJFe04((%a7K&&+$YwYdUx_&v+wQxz=+>a&v5)t zH2EQf#$7m^ZXCjHcNNgWUq9pF_fl}fa$N~L93IQn68~k<@zzY4bKc)yxF%c2d!EVX zaQPYruZ({kt%|b@I5-@}smis;Y0cl%q3j0Qj`w;Ef8zlP`=`YpT)y@0r;nz4GMvA4 zzTw(zIb)Hjq0h^R=`y@Xa^0EnJ?dX$xJ|Z2N#_KO@ljpX14Q`xg9d}>dyo|5c)j}F zTk+kLp1FKYz&-hyH!@DF>9BZREzMrHpV18j=|i8@}f&^JCYT1opNB z_C&+p`V+g4N#Ku^fSzCeNWYu&i~BD$9z&$(i*R`* z9IrY5WBix|_LKznMSh{t9~$?d_88SKL~5Q1mp8)k@LJ5oB(PT{urKlpeISiHQhuRv zGR`x&4H`Xv=>LNc#%^K~*ozXNg-bNvO!GdCORVGHR1eS?co7mbuWPvW-_LgFx8b|N zl*Y*zbwew`e1jXZgY)npFN3z=G&;eQ2SS0Mo_qv z9%A{ABw-jmekkvd{HP5tH;W<5i_VhQ?xS=|~8jF|65)T(Y zR0dIdg$(B*mLsQqz8X)(>^&ucaPdR+0j*J`_5s%uYW#4V?I}z#e?t<`66O9HX{vbQ813+MlX1OoU7 z?niCEJ=BjP{U%NHyn{EW{I?S}{BU_Oor6h+E`4D$UosUds7HkLbf7=w_Y`|vww$5Z z;_daZa{Q3Ki~^73OYN{CfB^LI8^!yux7^n;A;1oP_z3saV1M-9*n76itwF zWO=|a)R2T!CX)sVo6leEa=@Q`QD4(|35}ufI57P;B!e5%gc~E}w9C)Lt}zMhZ3*c4 zh0?8_E-CG*>6hH;zdlX~R`6YN=jYfzy2eaQ0)J)+1dxcswI9Rfg+KFm{#mgH0G!(= zwaX*7PioIg5C^1QUUl)2?GB;%BSTkepDC@9C(d$1IZbovM+st=Z%G#jwL`d^ zRj+)%%bx#5UQESzs`;CA29VCa=1jQwq&T3I$7KSw3)v7)uN&DdcKzcepvO-df{5jX zKVHte>Z2Y%(fpzO!~5Upo`~`nw?}a+4aYHGna@||^OgB@4aZa6|4R3I{M-`d<4JZg z`9%@ZALyI{zo@<K;o>Y7mk`h%HhTYi zcY<@Z@a1rE-NIL+KBoK4|M|)u{L%l}-T%)Xa^y029{8(E(zq3sly`1T3&CiY|GhW_53P5A5{n)b6n!MxW~ zj6-WO?8Wm-y*OH@#8EO7s=Ko$<+2u2oVaKl;2o(P4p&x$;}Hg(PyeYNrhVwN2ZsLZ z&wv#(F$w&sB*6P1Xn%Tr3-YmV{IHaiE%7h$M~;*?BZbaqcbw=~?v&?E`D~V{KzSC2 zEtIA6tKG%O>KQIi@q9-~R;8oBlV0qvwEGR6>gu}g^((FW=qW$ayd>+9rLbp=zV06n zPncM9ICUst=o$x``35&+(=id_d>+y;k7LV99CCWnHZ46r*OuWZv(q82UV574#rx)I zOo@VEedP4a{!lKc@+x}HI(|y$IgpOt#!4Yd$G??|J?@wiN>#K z{$vxzx5=b~D4py3sK~9=o0s-4_SMm{9chgG5Z8py?z_BBd9K%9j*V0)@QBCX#k=w1 zrCyiL9eCP8-&*h~Y;~TX7Vc!yLFAT}(OJ$Dq@EzeFH={Zkye!;%1+ui_^#ycy=Wek z49&^YJOT41Q?W8Vp7~CPJZG71eCfqBlZ!LYGw7`IeCHxyB%|U;`XDlniudA0!?iDe z+u`gNmmO)m9>l?XlO4P?i=)8fx4TSKI2y4CZ>aMTyx)yHQt#y39NjM%fgE&+92L%o&`_58f~+ywD?+j~+5t^NI}{zn@8Ueqg?iBx-(c zvLn*)A%F{)GdUlI@<+J+*eRaQ;@7s``#O!E_HNc0Mk=CtHNwSw!`F}<#FgbKt}J)B z{pL2!&^n9)kG|ew>;gQO?ex;h3sr7OA4SHus;;xR>G}BVX=C2J`uZhSe9R9aGwxb~ zZvs|)@Nb5oLF!tsDaQXj_#6vMcX@#UsDV4&Dt)+qxV#Xo?H6L&KCUQPbehK;b z?d4Am@jo&qX#~wYh1Lx)-{Lv`1oLs8-5Iu!L3!fykE2~y@(F%FmXBEy#u_wgi>Uc{ zPnRE|&|`Oh1_|uz{Ib8KN2=qfuR{G4&M!ubWEP>@K_nR)NjqMrAvq@6)MTu=t4c4=wtH zeKYEtIHB{|J=mYKEbbrYuBhY@B;(!_8c31~{A`(?1r9HIc{Vzy&Qs~1;&XUUcKH02 zUWbj9teeNz(fCp<-?PMH{lAbTVt36+AeLXOlA*p|%)}(noCIR|B_x?xyD}t;*j;!D z?CbopH^xE2f4P+#8(*}_Bla)61Oi}lKP=(b$n$D>-p=A5OD}uhaov(``usif^-zNS zFxIC&!C{||?$uD6*70gOjW4}Y@vS#c`AmmPxb+3wujwqV@%XOVbkL+_`usifcLQH= z8eeu44Ydxj{+}YySpBRBBX%2B0*&Buc~c*kAfIV2Ki5=t7QeK4`@RVe4SQBEZb4ON}R?`s?Sb(r_O zSN|U7@6z|+^D?1+#y@-LY>#*LFxzf?&q@H`_!-qY^7jn7zO#7zxCi2UG_LtZFK?N@ zOW(5-@e?eR&GlX?{=)W=@fZHRvpDjnNehQ`JTyVa&-`7&zZ3DH#ACJ*h+F`jPy|f8+7N$?cboxZE75rgHyq ztkPvZJ)@c??JxEGtlemr)FTkay`lxUmkn?G)w|n!ef&2KH}h4@bib>(_4>O(!CBTZ zx_mFVZu$C$2OQA2Si{Nuox&M$?W(DgaBihbUBIg1%}I)mcf{61>&`7NerKHtjM76d zqzC5jGTzV`Y6Tv-);2ueSa~0kaIAe4l11z;yaX)k=9Tz)f$arAd8`qR< zyJjjaOof>aqWw9{mrTVny5DQ|6*?ioRCp93(m)6xPKRten3KB%ejc-=JvSH*^JRi>c zHhLg!--z%jU8RHQO6#m?S4bTcD?K&r=&Nxnmao33 zr0j|9!^n*c;b?^)^CeTUg5gi_6x&@nj!Li7=XVzSY`L_5)KQY|_j{dlkm$^JYH?*e zh20{{qhWbxQT2swSmTv%6}(`+-y2s-@60#Z!AlU2DUYDm%OJFZ>I#R?BA3lkaO6GO zS)AX$>sQ;;&I#hkH*qjO2*AA2aRlSVCnLr-xzZg(gl(-BJXHrpmJ0=u`RvFJH7V;C zn!$-_@@85SKD$T5W0X}=tEzk@0Gs0}xw{pQp6^#3ks#bt*C+NoBm2A=W_dXV?^8T6 zUwW!oK|I!cr52OENpqEKrWTs;rv}9Mw)U{5>wm+I#v_*k_pFoeajw50LELvm?Nigr zuc)T^5;Byo2_N$%Q?V3$#g*6(o$YkEN^H`m1SASEu}I<1==;S}{2Jvc@|WfuId73T zXf}x?NNct!d}^;yxk$P?X`?ym>r4XCc@YPKx`OD8Dbjb=9Yke)GN=dW5D=~5?FAy; zwv->JEK33P0rds-1N8?D0HNv-s7Ayf&=H`)pd&#?fsO{*K*xYmK|?@8LBl}9K_ft< zKloVCD9~sS#p`jP<3ZSVE=~lU1WE&?gEBywpe)c>P&VjfP!4DuXguf?&;(E}Xd-A5 zC=YZhi0Tc>TLqvgps65A+l3%1t4{;X0L=u=0-X+;4JrcJL32RGpb`+3Ideg!pfZpX zG!HZ%dfzAe<13DK}13C|MK4>xM z0?>t^i$E8HYC)HPE(Ki%x*T)`=t|I4pgPbJ(AA)8K-Yr)2D%P(J!mQD2GHL@H-c^g z-3+<~bSo$Tx(#$Y=pUdvKzD-f0^JR&2i*g@7jz$J8R&k{1E2>%4WNfW{{%e@S`K;y z^eE^t&RdRwOZ6%E6jLBIoO}%M!$(Q4intQ|Z`)+SAK0tw5BonJ<}&6(wKW^3nL2gw~Oh z5(W&#JC`%tfrm^wC=R5TgXFf&*=E(I(I=DGq@m~NX`L_Gu<|P$E>~umqj=sC2G{&2q0gGwI=s!j-p}3e0zS7dVR@HVY0a zj~GWnZ)-m62DgJi6+gy_n;tG1L4N1Acb)fH+g{g^Y{(dL!uXiUH@G2N295?I()~22 zy9BLiq<^oc+#%bM4qtv{MTN)fA8O0+_{;Dbm4A#U&;mR^ZoB7*&C^#6$?c;0K*crcu;_AHo$>h65v8wx&fzjHozLzq#x)Tt-4{4aR90M#Ex`5G zo#!PTnmLth84q8>;0m#t zNn7-80L1Alp-*&N2cLB54<~v%QWYx=%S-38dk91@y@yyjE-j6bAFA8}Ex@<+vGIr9 zV|UX=Pe`nbwer_bp(%I^R^nBtSqfe3nt8MjuUP_yvMcw zy5}Pu2lICgheb5fiyGLRe@0<^j7&O+$~Ar5m)yQT>e|1}Ev)~A?#a+t2-!McvS9_& zuRiW;j4xXH(Pc+k+cQ+>wFBjK7h>)6|L#qG-co#_E3wZnE9st$(T;D`gm1XgJh9KW z5IxmgyBn*Ry>i+^R=-dkh%==y+l|=}ha4)CuLSVn&DF>B0M)l#=ThCA2s*$d!b)-@ zOoW~8$?(zL*vK&@UN)TOLjdxXaxamSYeC7uOHg6(^uSg;V&yyVJ{OU5`c;fi2>xz4p z3?K2>%!!nDt4w#PCl~Hy(m_k8? zQvsrInJ<}&6%3a~xg6e8D;?fysPL@7IG=+aQ@?vX!jIO@Z9j6;+Kkf{=W`JB-SqW3 zpWTDu%aCok4k%M7fnyDbzdJC*D(}EWaYny66W{jErf2FN?<}S-d-C*kCl)VBJ<#x( z<;{G98?v=zd$jm&(yJV?Kt$*Zaq75Z8x>yoq`jz!Ur(X+y2?*9LA>U-SI( z(h&*bs=l>t&iH0rN9t#jp)187^CeTU^mYdS&-Y`E1)WamaMQG$%O&TVF`7BSgRy(F z5d?qgL5y#66nu@q*RgKQ@>jdq-qP_gUx6lX84tIE_`iX#(&_S#bGHDd1!vu`=;<&w zXHuIjH@*L$k#hLV+XTVSfj<)>DV$uptel~zuo@v9Q<9zDnbyq(9;k{lRC-Zj> zXN%;i!nMeCGw_n(a!uD4Om45;dew%Z4`-fC_hgJW5}NQ0*QV`YYy3x%>jW$hau?Gu zvPG^5BctQI{?H>kR(*3dTJVNpoI0P~8P{&4Q=0-;&IhaIhY>!@i$iUCrFv~w-m5j= zqxz{1@}aVY;;}i?_PB{V?jCyQFPmth0>&t((eE+&1~+7DvRa<}7W-P}q44(97Y1i!;*7jRtX z*nL@cza5ZjnPr687P^62R4u59+OkGo%8}lW;m+;7Qy!X;N;0Z9-6@@lG10%v zmGjCCMRi-=z-!X*ca>{=b`Q!|`>sUET&{EPCTDe#c5qg{uzwH0kE+dLAHGyoA1|%H$iNhV16P$7bY%@QDqtr+^rDJ#eYv5^gm;3Y) z8SZ4#LG-R(Pi=i5L3}o0#%WLfXVAgqPKLgd+U?AjOvTdM8yKc^WH|f_9S*l_8mGHU zjL$RQQSnrr7#UApLxNb<|Jjli4{WK?@i1S3B5!p(M&P0H);G=WRH{+SxW70lGM=Tq zJB!@cpX_?`sn;L3o(#3q$kzFi4Xa7KpbO`6kg`EHR$|exa;eA9 z59yJH$4X3(YH=kwQF?9w&N%!}2hmj@M@ao=g6Mt!H)&^ncF2KAa3@1COzD~VlBrk> zf!oiFkk%K=3ft`2t2nB%tT<>agTg6-U>CGcrR8^G%ZB4GP2Bu74`)cMgjna(vt)D} z7-(OBS#OWq?#j0>aAafT2^t!QiU2;Gu z!&l>9%-)j{Q0t?Fv6O2=cVLce=*8u}jC;m18Um6e)O@>w%p7P<#Hwx{ZaDE^3ir)coF(w9?!& z&G8lZQE&eUKcWT_dmtu({Y(O}e7K)QNDR(jQUbAj_?L|K*hlYY5{Tu){VYOaaQ>1K zQ2Vp%(SM}=X*!7dX>?EH4eEZj^8eg@$oF^O`2pC{82!08q4U{2*q;q;q_gE?>;HTQ zZU3Q_%^0InR{W{sWMXP`JlD70mQhi8a2@w6=}P?0vAf50$X6rLtr&1bF(@{O#$)tnG zO`pd|UY;P%x#8oyj;|f_jyX&d9H(JEy|0>3I&zki+SE|;KH1@>G=*eM&!>PG=PKaf zar&7{l1@ERbKk7EzjH?EowWBweLrDZ=>4r{7FJ)NxetOn%i+ak$9icIh&pe$67JFR z_pe`!`0>KVr4^L#$;f*@|wO5eMzV9rybZcnWiSBG2*F}(E02hjGrJ7qomQ-px599 ziXWOESf$~haaO{@>(p>7%8nWz_r&;5i|C#Vr~xO@$UPdB_wz!sX{ z%JjHga-M)nKdc`J;6;|lb`1~h$8Q9&{tVoT-w)Z?ZF@r-JAMFk=zEn(*469FC2L- z-IL*Tuk#I8RgO-ZIh2jHreiUP?XR9v;q!YP_VP@-yTnPVu(GkiJD5L=1vYBFNIBgq z#}ow82UIZ=`wq6By*Xi4f_QVtoUx}S|Iqbi69Dbuq;YoUo9y5v6wk)~DsyAXxN_QE zPOGP!UPrmZZSEQkm81L9J_LN;xygty$`3rBNAX97uj)PX=&Ig_dxm&y)MwRucBd=z zRo=e5SL?kMNI%i)z4yNObiiF#{BEua|iLJonw`2A@01vqQDx7Ui*HqSb0o5Lc^>S@GrQlY)|F6`!+xk9;6@i8!Ib&5@ zkZ-bsmmn^46O9F)Twd?3#-8qC=Uiv81gNETwO-z&;iI+y)rkRY$Q^R#6uG3KU(eC^ zK6dGbZ47|R1)b0C5%DQ4a5es_imc^RIQ=RoU3Bu5^*63uz~L|sozLz;9CFnOHA`q; zniNpFpB+j6hPC}*X-_53wZ`A^h@2BZN%jQcytSWEp1 z99n2N2W$Im48!D^%f(Sdxondv%r+(#C_;fh)(@beLg{LMDxdn`qxypSf%=06fDQ+d zFb08+01XCFJNPKj(I6Y>7*Hx`2#BURhk=HJNTJ9`(6OLVpwXZ)pyNQtgH8ZZoB1SA z8Ymr<0m=krfyRQeK_`Q9K;uB;L8pKwfO0_-L6bmvAlhp=8I%ty08If+1x*7Lf~JE` z1I+-<1kD1S4w?-r0@*=xK*b=c-yNX2pi)p7$O)PUnh&CdF|@9fIt?CB1?UWr7eswh zL~%^-6lCxyXm9A9YD741fYyTE1ib}X2YMUy4ro2-UC?`=_dzru@*!vgXd`G7=p)d_ zp#OkA0euSk4D>l@Gw8pdFF;>{z5;y>`UbQGv=#I%XdCD|(D$GpKtF>12igw$3G_4Q z7tjvSub|&Rzk{ekjsvv5Io)sN-S20!7~L6dv0|$HLGH^8I=R-{vUz)}Py1 z^qrcps9@>F({+5z-#vV2WI9T{Sm(>*V|iYu$BVAAMUJc7Ryl_2r(fmn|8vQEUnX`i z0a5(Zcn9+%;H0J4E~ndpPE2r>S%C+|2exK}q$guPq;yp;7itkeB8b8zVx!(i;;~!o z`o~B>kDourS8Lp|p9kZH>ez5`&CkTHRtc!(_NWSL{w_k}a3~%x^dyKck9pzCik?ZL z$9V8dBB7nmu%4G&3y7xHB)laZFxRNWr-)Kx2i>= zSJOe!8KHF09-glpXzb$JRMJMAzoB7fL+>Op@LwY~p4932t(&qSAQ(;u%$H2XYEe3% z8o=kbmsbq8)H}l5rJWA{5KU5^YPzIgQkJ}Sw!3q;0%|{!q32q`X1-)9RuB)Ldz$I> z_Pvm?R##=%4*J4*Y%Sw#y604fQ>n0t1$ioVYxA;hj@0n{brsD)syBaEx8W68}oy~Q)L?AJL9hPMULl`kCMb~ zmt?;7d&bDibll93in}G}JMQ}DSk8AW^hf@lyibxu&oLKX+4Z3rgZ1xW{w{rwexBfN ze9sCcel}G{{vN`5?Zu_9*vHrkU6i0;DBTZ&&3wsJtS0FSZD*R8bJ=o+?nbiOqv!0> zHyQcan3ttIPM=GCX(Ia1JdzmI3B+#;BE#-<&wi=*%%kVX@Rj&v_-g!XYV-5zv(esZ z>PuwKAMIb{&|xiq0;%14U6$ewP6aVDU&DosQJ#%sd8!1aDjj=&yeQvG`0ZG-`^TNp`qjLGcGcNBs@t##rzNw<1Q+m zq0QqdIybs}zWDaup4Dlsm)I0M9f61WJB??U6;CZZ;PQ9SVk@3->G;sIAL;z={LasD zxJIYGc;C8<976& zXsXKb$vQMH_3|!S85GSO-p5Q#0x=21BoLE8OaeP4fmnUCQ{sv}9Fssy0x=21B(R4h zu)SB){!wp)MQcv>gxOR6?g^~n{G>i+OU>?l>(0Kb_F2{YmSWwXp4-`P-=DC@u*4(~ zlfa)(02QnesIzqkSs@-Uq1eyAFq_x%g_1AI^`K@B(;<_s4A3_MiM4ZjB&S z-}yHaZkzk&d!0I*0zMhSa|&$cOQvG64p*tnHIn{yi@x(obLX0V1aM`1wU1f%$ArTt z?mPcq9UP9gSx$7N^DvlidKce+Fwqhf5vl%;c4a@+>kBRqE%Md z(&s{Vn)#=|?wc=FD>+K!>7DBS+#0;f@tXFy6;HVRl|SVs59|K%Lnrh8I>Jr*b(kMQ zV%#-{M`}36BWk>D*235Kg{9unS)_eG@V3iNA92EeI~u#+d%zFcU(b9!{NTPY*6)LZ z7v|zj2s@6lX5E>pvK-nNhJzwXT=HyZQyCsS4S-lqwNF^(q~mP7v$L4vdGCwVo4Xb2 zIGO*);WT_w@eO)1GQLe4JBwB)PAvJf@V=VcNQo&7%aQq#saP$M#1>MYMfx64RuaLacta$vWgRUhm67T|IB z`#dx7+mq`!JjSE***zQ{^Q0Igdmzbn*-JGXMNdbU%jF%{X7zYFF{rkLap?RO9|W}s%0c9j^vfrb^z~tEv#xM z+RQ!XJ@Wg&+%F&gdi9Om%#rml$wTKe4pP%k$|f>go;kKmoF3wLWZ{U8Vp7f#(z+bl zw@dYW9dJ;;E}cCIbKT^ve(A!eZ~6GlUM1tn*^mcxcbk0um1$0QiD#h?yN3P6WfL3= z9Hh7%CIv+4lJq?{AY9d7^0UTtCtRt|MaMNNx#FG^7I_z+*~@OhHQMCEJBw+G>lBaSz1Q>!CjT4HH8{Q1yDvUOJQsL3-D`Kb9Ih;vi)w6Sqp@x} zW`gQGGF2ch-|}9F{{0W-ocH2qT{^QG5E%~?6FOgd4vTT57f-NPJG?%l*`URL3&LG_ z-ptZ})=ejs8PXVXh!Z-W-8tMzZbz0ErFnj}yBKX$zr#j%!Oyp(!=ish|Ncq8-JkZ> zJ&k|ka2SWqXZPlDWI25E{m@2Yz){;LbuUH7F?K`8^nvz{&w^X*{H)Z3D zhN2(tqc`$T>^Z8W?u?`E{m&250}6Kt!ezc>Di(#CS>`C74;AT|E{~fI6ZAprs!J0< z4c=k-*8xYg`fKVvmpyoW#_+p1D8fNf(E04n`4!h8L#9-edeL1S>vERTK~MCIT3)2A zjvjuu?B{wN{@{fE>_3OE^V!`JevaK+ve52zsAo6XGV`WLK^bqTcp6%Or~aZ5=hUv4 zyu-j@qz9_cna?=*8XZqA4!-hMGb9yH+M4L{x$&xRHaxL${u&(*^BD(UqvOeP`sOnl zYkW1f08e1tlUELEQ+gPO$ML1}**!WQsNXK9NHj31@+o>Hx_n+->{zlS|MoQ;9^=vZ z>>eFYL0)c1JR*P>IX{V4t>p=v;?iK%;n107?S_)N8*%5xZMU_){sSJ?BbGGH@nzFF zD}(yxUQd;?94!GP7^swU(G>{?N0$T-z)E-KdP*EFsY=N7R~^?_+5&vf^?Bo%Epcm> zo395i&GB1=&pgQ3;a%V?mZgAIpHb>-(dAZjV%NFfw(Heon`U$T7U9aMEGebB!i^r2 z*Z9;1TsS^A0T-Ec5TzSxd+OsYU;X0yTfg%TdKXU8aQf2u?4IxN`_Y)i86b8j(yY#@ zoMTI$Q|UuXZ=%Ofhs{Y9i5LVdr_Q6tJ=w9qWALa;S3DnwkoslvGY2Tu_^o=~idS5G zO>4rO0HtkJA9i?&Fii4Zc3k04y{3I-0wTOU@pa5M*}+Tx87^D!ptbzUV&nXhGw48Q zoUJB%B{*cw4<%6RH8duOlNx$H*d_IrZKs(bQ(a8srpyllGH(c% ztX`=Jh&xAxRF~BRii)FF!=aBKZ+bI9JbX{T4ZnUe^Fh)#MTY8q!ohsWR4gkFEqL41 zTtY@&HnrSJ#`lupbfw2r%{u7u`e=2=(*;vrWqB|T=1UJ0%Zg)cm7_S=YYZDdYPxAy z9~ln?Gkw`x^CsE<^S~G8z&fRyK1esrSD?t-u<3?Uj65{OZFhx_uCV&KjXY)KK{Xua ztGsCUyYfynKV$AO3G6Eg1dyPqzKYb}Tz-xE=Tr{3K+3ue2@Ios$dQ7q@S?NRLz7S9A`PJfq`G@k{&g46_9h&rB^nUBJ z&NY4i<^Jd@4%-MTPUw7g&vleI?KWw%%4lx3kF7$V!JIa*v_k{HLH?$j-$HFnYIm#W ze*W(_&##wVe|&$l*(b+~=-f}{<8h0b=>B2@b4z$=Q>|{1dGCzM`qK^`6(IloMH}dyY`)= zmx%^Ua(>4g(!zz`lOM18rhYJJ@#N!424v_v+rehOWGdDKd!@U$Or~Zzlcl!r>pqB{ z-nxE2YW?(uV=iPbS*|*t-7~zH-NOo=g-*=xA$Bv%ppx8Sq8R5R1?Ac!#+zzBNdC|& zcYU1-y>aZ%AKY+A!AJR-PZ{r18a*7nGUglHkS*ie;li9v2`wu^it~Ftm`H+VWqV0= zXk}3iUg7vy3LNyk9RHLD+Jbl-IB7$ISU&9Su>)?uY$@jh!a?N>^YPbW2*+ecDRQ1M z{w&92sKZK1lVQ|!p9BBNaQNZU-^9D#ue@@{mj7e#Jiw!x}R{;qiT|-qs zLYEJFG~DO z%l+blD7fEWFb-l>!PqyKrPgDiO%MAx$bpZ;RgJiVzjR2uBthy!30e;=H>H84O%H8> zf)Nm_9V+oZCB%T(+nz3&pN6ac!$xnvb&KnHyB)M#4zq^f>j#g2SdC%zkG#){)fjk`BT7Owpx3-n+{xA7S2m3ZHcjABE0#14M&)d*B!~c#2a`~&e zT^99uaC^kwE)%Q#?ya*qVetjiWnF?5FlGO6U55GF+e!5*=vg=0=$Vlx;4=vrCT+Tt(erx!z!TpTSD8xU9xG%!hrqvY_ zuGz~<$8P3_OR%~E!Y(KZt(>3hV?FHtVufktG;tn3x(yGhYNtu zcPn1!tm=UtD~Mvf0W^e0a1k_yCLogyn}Kw`T0l#<7-RrNCP21=)*wcc!GdoFKTSrXa$pKfg=rv}YzFX&bTt!Z!ECq=a$yc!4>!PEm2*x8rHy_a2KqFyCDzO!9B1Z?uGl{es};jz(&{v55i{H z0uRB%uoWJGN8vHp2HW9rcmj67PIwZYf~Vmbcov?6UGO}-0J~uiya;>YCCG<;@G`st zufl8aI_!r7@CF=&H{mTf1aHG(I08rE9e5Xx!F%vNd;rJcLpT8+!N>3kd_H*gxxz_;)nd=EdskMI+mg`eRU_!WMG-{BAV6QtmEK?sCGDF}noPzJ&w z0?I-;C=ZcP0pweam7p?IfvOFc1boA|%0J7y?6K7z~H2VFZkXQ7{_Dz*tCzagYM3 z;D+%q0n#8Hu7Qb=0h7Q3UdV*W;Dap4h8&mzQ(+oRhZ%4!%!FAm8?J*~m;=|t4KNqx z!F*T%3tKy`~+v=XZQtvh2P+J_yhg~ z8PIe=2!ui@2!qm42Eri%%0f9P50Ov-Dnccw3{{{iRDxGNG=*l+99lq2xEL;hXlMnkp$)W!cF-O!h0CA=bc9ZDIdq0ApbK0H zU7;JqKzE3R9?%ndfjoR02l3Dcu7bYM5BkFZNPvMb2ofO)2Ez~-3d3MHTn!^&B#eU5 zFb2j#GK_;1NCh{HhY64d>2M89gbbJj9`HgYOa>ohK{n*T6qpLrU^>izYhfnLg4u8# z z@GLwByWn|v0d~V4coFu(OOOxy;AMCPUWM1-b=VIF;0-tkZ^Bz}2;PRna0HIRJMbhj0Quf{)=7_!LgUDfkRNhcDnu_zJ#;Z{ReXfp6hE_#S?MAK@oB3qQjz z@GJZVzr!E!C&&P;3ql|iN zu7#N}3ueQ0kPCC*dbk1R!aSG{3t%BEf*WBm+ypnnEwBWZ!ZKJ6D_|wu3b(=SunO*g z)vyNcgu7rZ+zolK4(@^Va4*~k_rn9Q0XD)Wcn~(j7I+9AhOO`jJPMD&HrNi2!xOLr zcEXeJ6g&;jz_aii?1Jav1=tOH;6>OAFF`)+gO}kIcoklQ*I_>#fH&YEya{i?A$S`O z!x1GTrWQevR_S>T5bp}i$d@FAhg~WOz<&DL!QLtxP_qgiTbT*eRljF zu0~y!F?vhi>}vIo9bpm1!ROOMHa>U3pbm3yAHGi7{t_g*kfoLzLd!z*&?9f> zzb_cjs5QPT>7wt`^V7J;UYc00B}g@-gO=&v)>yXvrv~|t<)ISDx}g87*hJevWb#}8 zSG^CS0-3Bk;lI-Yc_g?szgYjJ)kp09A-}cXwDljPeMiUEb2;n(m<8m9l3M@&^t84|;z|d%M+%!C_}s!`D3h%Q*utrU5Aj(Lwzjx$LX2f5diud%HQRe1uB-V@n%Xwfet(APqReNRaDmxgoSHg0C-^ zEod?uds+JrWBGp)V!$XHZO?t~ii}V-%Pk6B6V`H!{{Q;=T5g=cvIxF@aJ#v{2<&h5 zi_?{g)*qd(Yom5ldD5Pju2LM=ChmWAk{J@WkR=72`_dPYuF4#ezoNx7cX zI}!`J4Jom12grVY^$KFyS7dUm^iuS1eZ2lHu@2UCt4z91LK%>KG^`c`eXNcPHn38d zOtu$x9_w*>pOVPz`#8V&CgqSW zqwHmnF3XB5&!oJNa>yyqFoF~QD=c7bkK|SkZjad8W%7sb7{7S#@OXJRt*&$A zdV2ydWlK((9&NP93K}L%@HZdxiH`TAX9u1#QYx1Nbvsd2i7@Ku7-VuC$)A#st&h7OzsB}t%zet0 z$7S2Gs25V+Sh49NU7nkIxC-R5k2Mr}{Xn-N`2SZ8Twl&xSb9A3)R;Bp;zQ+jo)Kg} zd4IE(`^5!Oq1Trwh11O!q%34l{r?x1;QGDO7M01oEq<@Qfd2n>x!zvr_2b;h8QE$5 z6Yo`y}~A=sEH$>|x%FZPeYxN0ms@r(&nfTk}O;F?uD`ickk;Y<=Q}cUqhd zc~Dvm=3G?iziPQfC1W+X|5(s}K1UU+9?fb7+s9r$MfCcy@ZnrJ??WtH;$u z4=pcRkKoH&d(_r?V~0%-dpbqcqdz^dUa6!XW420 zj~r3?+pxG1t(uRo=`T3NJn|lXEjP~^SQhFx=RBu&u4eZ3sMKNMAYLJt_9u%G%epSd zSuK#sx&-UKrsO|ssrA=d+kb1h6aVj8AP=XI@?YP_wOT^=rLBG=?Lo;?W{x-amhIMk zOsTW{J1pRoX8|kPea!wlu&1;3ziNSL{Bhl$&8J-=J`w{GOW7su0R7$!R@JSqj(EPu z1s}ANbqS_Vxz3TBTbW1b9-o|(k?ntXi1A(?w`_|7-OfJ6b#tHWQ)y#J?z0c>s+%O| zwCXjsLGgMW-m~)3y(b=?z@bLadfDZAdqR(1(SF^G*G_7=wf%aE>xvCx^u|KsFCPut zJzzzCvfgA~m$|7nx!x}C@#q(uXnq|i@ctbAiXC2FWbPS7r0o;lFhW_cBiG3FZ~J-?jWYR6$0MHuO# z(^2%7wuANi6R%DF>5t^4^_ytDB$n|cE$3%Ykk`^0nU9y$^6`#|^199mKE?%j`%0EK zhi4+QjQy>894~<$YnFEUr24Q%^X+VnD8w3Np9oER4B%hIBR6nF*ga>vGxk@<^T$OnvxnnoX{^ z`@b*4UHWwMz3%SRX#W>6^ry;#^mJ=HG@ddqWRf8g>)w+2uv)LB1NFKEa>eb3Demto`U!CD5bC$@T}Q ze9c?a{h!}y^JiB;%g8w>_K2lF=dCBw$*dj5->ys)y55r15 zRan2#e$IczZ!;g5<=MaDdjIa%u=>gIV*Et@OVstxuHg%7Y5ISe_GI3RO|G{WR<8KJ z=wT^Eg7Zz<#YOw8oV(@B(fyxXbKzWl9j%95uD2JaM?s;MtUDc?M3R5Xf#X)@jZko?$mSjS$IkDc6rb{rc&fvx$@|_5wt#bx!zu+ zK76bpNEr^Y+NV}@@%rSI>wBWPca1zcZv?H6U9Ptmt&fM-A7=7?es_WISnI{DCD3R2 z+(Y;6>$HERzMj^{F4x-&(+9I8dHsqcW~XOl_#IlOnH-x3QtnCnJE2wacG_9vrJOj$ZzbULooQ>36yW`u+6Y$s?ZTi;wH;YyIqUy}d;G z6(|<(NlbHRj4w#l;PPNv>)?K#%o~w8XSL{6>G!EVKeqRsEBn-uN4$+7vGfnL+%GPO zg6{|frsl~l=Yq~2dt3cIyiM`#@~B#SUb-sjA$i4v5kybX)-E^1EY7Eg@qXXr6!~Ia zFK%iUd@#-G?|JAWAqM3C%Dr%DpC1{+Lpu z#2o3o&2onEHp^&fePkthV>8^zyeie}Z=1@oR=qm5E#6Mu-&{I-?cAFuoBEjgOL}R! z)t!e;%E?RyzTv@#xBcS@*7VCqFA3USg|$!byy(>i`!AU`OJ7&p%P!a33%zg7 zmn!r;3VB^?f;ThA_^by9Z2(;^WVS0_pG!OL|KpWqxdr8w*=`O|c6mwlVK%gUuv*el zK9S3f;B0x5@f5dlFFG*e!Q!~f?U5x%~xzKLPk)p=0eQiM+)*HHWdN=z%%z90nOC=nuz5_m|I+XOLmNlED50t@%-P zC_eq}d}Gmj$3~TEuE!H4=I*r8a;=Y!@p1cS&(~^Ppxq>wn9! zrG&NWxdA;TXumHkKlXY2h1l|w_U_Pn==8M9_4Xm@ZoYEcpKl(UFT{@SpED`eo8k4L zp7Fl5tbp3`F+vPGz|$XXr?`{Sn1eGoGgUH4P`e_oW3ZlumA6+d`E%`CM|1AcdT2fE za=rZ=J*CJ>dwol<$C*& zj(iczlRC~jO&%XQR`Z_ueT#s>0Mn??) zk$G#qyBoViv6TNS^LmDHeSQA8Qf3)#EhkQ~U4piU{rQ}@2g<9aKhHaqu9lXIZ)WUj zlwXoBwcL~jmZG00IWsHGo6QGT-9Do+;U45o%%m0HFFnQQrNs4mQq9rW;C5f;<-z(C zmOeXj&b)iw=7$pX6?OX9<$62%3{B3OWPWoF-!^JLujeZF^sL03%uHT*ZSHBci|QP# zhutn6e=M)2MeO)?S<7Sd%QP^Lmm|b3TCT6Jspuzo_s4If)VSnF!Ztn>7 z{PHEIXY5$>@Gtn81buxiH>H6kZEjz7PG&*95iJjPN#5pxE@Q5m@eOeKel$HVvq@ka zGAPH>*Xzv;YFFhKqhC~fgnGB_Z50kqUcRh~I2A$br{$(Juspwh^tv+qpSv@5I*)?> zQ{@rsbWH0~v>kW#iBLOkJ$T=bcdUF_-XkSJ>#60YG_X9sp630Ae#zX+^GgfZ%uGi^ec3Y?v>usP zn)PxwWMYQG%7Mj;=QY^TYEi4IY?mOhi=~zuLd&B6z@9;_Zhp0}pqmxsPqn%h-!4dd zw$toM?drza+XY%~xwNtRkG2c4GQFOx!0<;xEygWl+|OY<%ZC*&>vwLlAcAMA+>M1XJS^g%o#O4-PzaenUI|}z$3jJw@+FK`cP~6 z*{xf!UUok^o5=mkIo->yJy@fmehw#`6G{20<@&rj?w>p*eS+CoikTp@Xw7yXwSRA) zmvY1?F5HYlNP~fctnKt8=p+AL+o>>rx?}nc89hF#x=mm29%JPmWtZ#iF$wX;cT$*; z9Frn*YomMkzw2#&aa}rFGSjzUyZ=C|UYRk)>(%Gwo1U$?{c3pyq!F}UcDdeue!b#7 zeD6fkv@o@T`dO-b(dj4G8g|#s`(L`@#l`x%S}(g?Z?~jhkfC_5Z#qMtlP0BS2X^5g zt3NF*MxWgN5vtCdx3jMscCfZr5|<$Qh(Bq$A+#(47Yj}}8Rj@g8IH>ZT|QNcE!sX& z2@z_~AEockdv)<@dB>Urt&f(Q(!jDi{i=!nYX=+1?4w)lkyp(1cMW8o?*$#7-u=YL5qBG2tc?+@ka18ROKlH@{iU2PDt~o(WB7%ymKz|&j}c}X z^~cOGyIgM%9xt#A5cHE#DC5&m1AEFAE)=R%m0^u=kn)u`*JM(MF}w=wzBspW!sJARn__RkIa^J31+{% z@;P#IEAM|b+S}Yt&*TBgBri?KOzy8_(WW%p+jjp*;y`KFNqH%4Izifll1Bw;+es|j zrEOPO-bL($zsUmj^clo?C4D4Kq+ZkQYFU@GlD4|uCf+3JB-;ch|6zo`IoQ*uKj)V` zDQO`#mo$*{(D}(pAB^!Y4Aya|RfCHkhuYJy!=Bx~{#_)^BuMOHspW>yvgpef!d^afwdq)tAvH^Rw05k}+2N_dS`n&@(mgZQ6S@TS}rncu#7|LTL&ND=uvI%KxAbm^Evpzo(yh68#71r^aSI3W4a&GaYXU@ zxGH^oD&nW>+vw|cH&(hUyIgO#=wlssFGQsnPb!o7GWhZ!ipP7#d;NC{;)4prg`8OH zyQ?^T->s~kxNuYUi7FFEKj2rW3$f%kE!TSL_YbKkrB#w z@8|E|UR8B&?!VA#V$nm(_4RdZ(W5U@2{U>O=x4t2CfYC~b5F8;-syq+yY_s4JtwLJ z(*6{5-qtZ9C;SU7VD*=%u|@k!?&t_L<8@!-x;r}O|IpV|Qv0oz+f}#ti*8p$OYOig zfIHfF9wb^%95fEK`-}a2CH*b_R1%+(eZ(K7f279_ST*h=iA=UjJyeo&vD<%r$m1Ut zlyk-S%h~55)%Fwbl~0Jgw6lDNQG(oulk!E&4WVUGq`wSJW*)9*LN8;sq}=?M`4GHY zFUNeDo}9+ozZ#ZYv_GpY<<%XnPv1THz`>yx_;t|wX}Lu;W3@>A%*hZk6Cy|_InY`^ z97iwlrx=h}%0clx{a(Kf9V@D4Q_sdmR*s67ITaFgKGSkj8dw&lmw!f=7>V4LWz?-! z`%D{Gv>r#$Xl1PZ2+nG!spw zoRA>pgdXdXG?gIgiCmE2SJ(XEEdOZ>L~#a5ADMT10KYk0xkc`tsB6P}HT%7rq=B`5 zJ5{@^VgDH9k`A{p>0k-8=7U*{yM8}>tUE%V*$qkjs+YG zI2Ld$;8?)1fMWs20*(b73pf^VEZ|tcv4CR%#{!N8{#Fa<`xAfbNu8597H}-!SirG> zV*$qkjs^aUE#S1D{)-dW`D=~^91A!Wa4g_hz_Ea10mlN41sn@F7H}-!SirG>V*$qk zjs+YGI2Ld$;8?)1fMWs20*(b73pf^VEZ|tcv4CR%#{!N891A!Wa4g_hpoA81<`b6C zP|j|S1sn@F7H}-!SirG>V*$qkjs+YGI2QOPEFgU^r~ma&7|=P?v4CR%#{!N891A!W za4g_hz_Ea10mlN41sn@F7H}-!SirG>V*$qkjs+YGI2Ld$;8?)1fMWs20*(b73pf^V zEZ|tcv4CR%#{!N891A!Wa4g_hz_Ea10mlN41sn@F7H}-!SirG>V*$qkjs+YGI2Ld$ z;8?)1fMWs20*(b73pf^VEZ|tcv4CR%#{!N891A!Wa4g_hz_Ea10mlN41sn@F7H}-! zSirG>V*$qkjs+YGI2Ld$;8?)1fMWs20{=r6SjvA*Up_s*>hRPvwd$5N{&@^b7j)}h zQMDy*-9@QihwPd>?SiuE;aT+tmYsP2CF}l>J(QXQe-gCZ5Ly;PIz}gYk~6c?yxBe6 zS#Do?az^?LcdXZw?Vgt1FFnQQO?0PtJ*ip#WAZqy=+kC!gG9?|{BoYSxAAE1op{WkDs=U$oqQDf}hYJ1H|g z!=0GoOV2#VMeP1@l+#uUQ|cWO?rPSLbHaMW_Y&U;UKj(HLv@g}uL(_{0W^h%5C!Ex z{*m}Y84#b4pnXDOPHhD3FZ#D%{68N}!vfkr5~7OskFEGm{r3;=^S=MoPwnDO)44FH zlqXtlH)y~=f(sA3U+Ci`og~lWBB~ll8cW)if=CcqJrIA8@&NZV(!T<+_5nGEq`e%Y z(_3P_&Z-lNu|O`{wO=f45bPI{FQq&_z2BuWMjRS(0KaMSRIi_AeRglP$D-Ik(B+1f zo6^8C;1_1O5gnVHlIHI2PD`GW?#=P3UF>SDS0wGulE~s460S5OV=4MbxZ8}3rTB{W z3GpF&NVg0A=HJ$OdRL=h``PR1sD{+jQL%qay8YxMY2TWPyg+2s(|);KJ-hv^xhuNA z*RW>vfb2B4&ph&c`OSJ>$unYK$v;x2iv2`$$yX9rgt|}}s)FRb2++q!e$#o6)q--^ zn(wUJWgjP)7RV*i`R#b)V1LQIZI#ikJKjsF&SQUgu-iptRrfzHU;5>t(wXD0mKxHm z8^vF=+z?t80e|V6JY%}mTg;tG;vbgN6|72nO8QD{$6Ehd*X3Y2#_AVZR#+@D9qi}P z^8faDA%9T&M|iVf|ESbd8U7L8gfcRH*6nFc%Bl{Lo6ElYTGas$`VBLKSo}lF?e@Yy z`g&86Glr&nQoU0XeBNo(qho#U-zmfh`sD|MCBWrEaeQm2Ux#9w7wxPLv&9}_v@|Ih-toLiS~-C73wNh;gg!dVz| z^9*ruwg02-4c4t#vr5(_jPx(iP_1%>@l%fS+U+6Pj-->=9l35 zEe@C8(*3}l;wDDW*SE{{_VZj{XB|<&2-f^^`jTKf*xLaK7nfB#U61WO_QK@)4=reA z9A6QQq@34seSIBw&q()7jP945?&;-Ap5%@moS8})FZm=o!RPK3o8aHko?rCwe@fh)LsK)w2*u%Q?L6d-LOkD^v#v^S{$%m5vB$goObAo9BtDn?rU9_J} zi!Q5fY+b9z6*s+^UOJ<#Va9oMio{Q}+-}#R{KT7;UEnBxho8u`rQIO?G-=IB+SdXp zn`P{$KXgayFbe1Ah&Mn}coX?4xDCXA#LvVM;xl9eqhG>qM$obU=l@J(Z4YcH#!oWW zMymO>p8TW!ZOyhE%8NE^BxxXiqUCnO72zi_6DIiF6DVC$EhUQ-*ahW$o1*=;QeLFm zqK>S&`Ox|`oxElWYJIf4aD8M*(wjvqz%zl>N$J_va;{jtjufNU)^(9;z{9m`j;*yf zY`_hs23jvIFIKO3Pi9Vb)?d;qvu)A#N?0GMp2=u5`e2I>7P(hTjxzI*q@R`-u2=k| z%nWTaudgH~%i}~k9V@jfTCdahMye;8mi>Nx-zT15*2vUA+e^#OqZhXwd|A}iG&l#0 z<95W9WLYiNYLpQc{dN?iU$d_&t9#m1n}2p*Za-buX#KSOFX2 zzDw_qRL^I$Ty*v7su#51Z(3H{Rm-)WIyUu9pnX!b;jHCa?xjWBZP=zrHR`~Nw|@H5 z!v4K32-ZW(_4Re^*Td&7UKQgIt6jn`D_Wnk4@RmbGiF4r|2F!HlNZQHWgwqwxgoSH zOnnlwr)LDU+0H4;tae#dj2^4DM5;RzKWP5ThtnfRkCzd@fF4?IQNdU>_2`>C-J4T% z0{IWLmiMhY6m6G|4@as?hrZco?kxP6n- zvt)RyXNG$c1<7C5bt@;->D=*(V)SI+ypzkT{Ce=7Q(6ygN4s2aH}#D1q@;O$ejWR{ zvwi6)S$|noUJw>l%8WUm?*~+Lv1H7Z*gPzUC;ykaYLd zOs_ALd-dEt6dR;RdAjaom(lX`Bg z8|Ya5)qc1X)Pjt6%Kba*Jv^yV^fp;HYZz9X@DE$S>c<_s740tvN>x#1bJz3>dG_kn zeai;7%e36Ci0Q}0`O7)YMP=3NKrwpBHRpI&ebv9*_4<~3K|ODmYyC{UjC%u~>>l2f z94S@Jj8?C*AKdM(= zY|(nD?q$_?sjDk~dVSUnW6frxs)GWO@3ma(qhnLAKzrl-CJW?!IrgvSe>q0yaj}?; znaOYI9qIhfsuTVu3*>PgUC(ywQMBLW?ub-xb!xEPbM(Wcm!C6dujqPA%k65F+;7e; z1LR!R{C1=m{bc`38-`u@?V=sMWnF@9x7g+8Ry_`p$Ouk)iu?RdeU5T@oIu-cTF;{G zw&Tf2)qmEMV@)^Dk9gi+X=%G@xzz~(~-*k z=(ag+OSe1S*MI9s>!;;fFCCluB_uNnW;6p5)7_8I)moAc@E2fFU8 z=5H`-y|i5GqhnLAn3NPZ&E;|F8R^+Yx0$T%_qg6g+exm`<*QQD^25I=n9`;F%PtSr zC&4S)Fc)9!!_?(eZn1eY%%QlpMOHb+siv{i{x&wgXgzoFKc3CHVZS^3qK$iA zmzk^F)8gipl5(Q~O2kRYm*7ar|b~ zV?Eb)?*H?ctT~c`O0A%R6~EAOLugrOzZjR3p5brkC;8mQjag%_^VRQCUuVH|xEIEP z%;AtUmHTEBVHAkJ#6kk}1o5ecAn7ghAHqSJDAL-Lc@VNLHIK;UAINoZE2l4j4GIg^ z^0rdnVE?es&&r=rLCt&d;PC;cr?od*_vV~t@eeJxUt^Hllj`;{B-V>ZF}PLFxT0^m zvEIWw$=|$|kso)edE_c0?XMe((Z@IxJg@?{I*mG<_2YtNO%P!a3gY`u7U)Ce!`)Fj5h>|e?r5f`_>xm(YxmV9{RZ+=^x14 zdtDxgokS+(f*|(Nzoop;>k`Xvv7?~n^3P;lj??J!MPdp1xB1Jwj+{gGmupIpb&<)w z_Wfm>J{PO!1lcaZzK@pc*xak|Wl8oa{76Uo-(&%6c^fyl=zLpiP+7IC!uy9O-u=Q0 zY&-#QZa$WLqw}%kKk~B3r+6mTt z%ui#x`6wcz`%mQ1{N7uj2h6m?knSYte_N^_;s7o(wJL4?*d~S5< zm*cwDsWATP$1an*>p}hV%;X&3k$kl*0FV;^BsRax%F6C*ZYb7 z=L<52wf*@vI`aQ-7O>{;@KHtQ?<3^@AHMlMwDvn2j{J1$0VBC}{?>B)AJO?V+H7B! zIDgx_2l~AKX#SS`rt_4n3sQ$mT`m23-M7~YYaJJ+ zo6e_&ZL`bdzg7nMpZ~7^*{-wm`&q3We>9xX_^Ym2+8xmh0HM&AwieeeB0LzyJFzuz|m% z+udo&Md#aG#^F|!yX{u*%0sDD`~#?$bG+nREw@{!WcgN}X_PsM$=NAs_Q679VyW6? z(X-jOU_I^qgZ%Q$XFYbZ^XN7G@BHDT-z$kuT2Cz(nKjt-ENDO23YcOQJzs}m7Z=lZ zK2?nVTc0eimZgWZeREi=xMe~W-wTuW z$R;C*{UsIbazo7GoagjlWhalu^=jaj#31PMM9WQSU|E!($X>xw>{-m%h-LLmUlh) z`=TV%;M(3={(q={p)EFRy%RO5tkJ)WK?y0>rO1%Hn#W6I+FU#MEml?9#R+f4dz zbqVq;xGe2*L(HO|_ZlyaVQynHDxTtI3ZE}JCe@pnosgdCW}G}H!yG8L>an2&dVIDh zW6GuZ17r$~5wsq5x!zuw9{t?D3GM_Qcu3C3(yHWgfKJbR@44wI?N|Mtr)HkAYEz%~ zorbh(HMd<=Gd(k_nf0)i>+9>-oR=4ylaYZrtP=(OJJ`$DBod+(g=i{?QJ(b`>?e)X zPv8cAzXK;(KL*di?JyhSpb5x(;AH-g{1YjAr3{vOTC^27+(>64CzQYfRzFS149+iN zV`)dX?yS_|0UwT))Aju&vRa!PGWMDM3A2CcqSVrI*~c0ZyT@jva|Y=iV&M#vp^Io*$H-2&Owq;EpdQd!%k^`rdcB_^fLd!xw^)99; zm^;LSHavE2cDenNH0}Auatg!8W!$_qbb@X$3kIXY5Hdj};@A1T1V+OpAoE$}-w3+B zVrq=Q34hrFRzF#YpGesg17cHIm%2vJ<6>1cc;SsJF1{u+D@uM4qQJ#c%SC1l+Be!q z_s+~2l+3g;U-}HAU)+P0tr1QM5ZLlXRlSzQo0OG?NK>P2~X~Fu~{r5EbuD+qe*^%`QKK!R- zGJ>m;>AzZTN&`!sj~FHJx&1duqj~IhJX4mEJt^+!#HqY}9DzmF)06F+9`E594H<_r z&t>=Pc{I>oWYaicdZbaNQuG_Kv`6Hhh>r_S_`kP+)vw3S3~tA`x%_yTb}{3q!?!#a zHNC8Qa&`EZ-pnQUeKFG1tpSN9<)D_^HP(KV$XkO`b24Z$Xo(CqC8hD|%2XMvG$!S6 za5u^;YdN@<@=xk)@eL`;bel$sMfol6tk-3mM)sE=zh%2VUXBspvc|HHKDWerUsjDE z+vONJk3ahaokMSvShmYKBuFe+<+5&-^RwVwa;%{D(Xs5K&!f+!_tQFwTnFoMvY!O| zaasr2ChI!r^H_D!+azzweOD*^`&u9u)pWfOH!HYa$Y&efQgxhszVMVgnN>CZmyZu^ zeCLjtvM%8Y|I#iu#4LD^XHTEc>&qhRdZ&6Q{f*i3)6CvG;{xm>*B{aF^QZMO+V{lI z#9t*pNgGDyl*#QX>6c1-hT#Pj1ua0zgI+KKrod_t{V8g$BMO>-e}Mlf*N6d$mxJ_= zr$v@h-{rSI#HxCv|MOY<$2|71_TPHQ!gxcymdifYQ1HB=@x~>JtzNuiH;2~@c{9>e zrbow7Y#FcYw$3L`n_YB!Hg|kwHFeCxU%$Cx!W6oOMi6^T`Kjf8aY1D25tp8o?e$HM z=KTlhyr-=%?}p5Zj?YR=&dBcN^G*s3)=H{mXJ@#Bo)cBq1=~mLFJ+wW7w+0zUe!w3 za?{A}ZMNLwzw%&W(M!wy;)19zgLgUf1P5oah?eIIGqbgfS0Ly|D6D%K$8KP${c{6) zNjam_P1eOntnL48TR!MjwM)HCh>c)$VtK;OF4x-=bH@4HS-hD(#oa4CgVulG9hy?j zL=U14Vp3*&R?L*-^bF|{#CWF1@ZvJ_jb(k^Q`{MHu7#lWY@HiyKkdhQJZ#l-k?PP* z{f~Y3)7o(Z{EA5Wiv6_QFD{6TmpCVqsA4`{CB{%28uP(<-rc{awSL}Jj2`*u@yN)H zPv3KS51*MkgWU3N62<}A8gDi>Zg5J{nkP9xr1fik zeXxG^c6!I%k!ss3qkH!GvH$1S_;t|wX}Lu;W7X78KYe_jyR1oGH7Pf1XkfjLFA)#(M)9M)s02SFT@Nc`oINl{Ezw&1@hk-LL;~c z8bcFk3eBK7v;eUWu4dF1xvb0ou=cM9B9l7C8v0m%h)#aDwMhT5Rck%5bgoz@Q103D zP2Ao{RqJ5p8}%35a5`HILeS}`<)$>SH2pF$CD}vi%iWj^d`~h=+h~ym(lpxt(rtZY zE-Tuu-Wk?Z18snYq^%TD7b#obwVu)>M=)OyJSbjDk}e*M;gt1W!h8MOM(z?1Mv?n zH-wgj=^y>vlW6{$AIll!<~f{n-iFQ?li3@7w6$u9h8!nEt|erE6u*SL0?XVUevmfO!?oS*2drH?DAzv%t# zG1}daJ zjrJEUx2s_KOK^M6=4Poy0v{TuNMDKEI?X5jbldFd95aSbc{ix-pG_Xue9`EkX2w|4>hP@u0(lrua zuB9VybsM7qu(tP_NI_r=8J6EUmUX>4SFaG$T>Os;*7ANU=^`Npq+GQ3$4>8yRFBQ~ zT-$eY|FzNwmZ1BIT5d`MOG|k_Fvp!^eDgt?PFd0_D5RTc)u-EvV14ZE|D~@)s=D18 z-u}kXtV_Oo&%CDAN6Q16m}{m!h4ottCL;%RS*`jUu<2vBPwUqh59xPkc-3mR3~1rM zu+~S*OR7&HrZEn+=A*QgMce1V>yfI}2v1`Dm)v!0>@lyb_0jT@>Jw=57H%hNJ+Sn) zV7=^iI*r~_LPyTb-`we)X01#OHj(e7eW~Sz>!q8Ny8RpLO?4Y>&c3`&-IFq%b~uh} z&Cf6LTiS=x4%GMcr2dz_zWkPQUdD~2ogi6Xknw7XB@gIeU6*47X*URZe>q0ZV?CG1 ztigI7tNedu-I|}GZV&bo`}a?`-c>2(wlBtD1$*g@e?h#+b!@tOS5lg z{h}p9o!$%_#X97@ixcR6+i{ydcE8O$5UDD!Yue$8U`f zC>k$s^zmxKY(^pETQo+I_!q}(w_5aHx+>V7_VTjQ!AP}Y{fO)896Yu^CssT-P=0H< zA+#(k1I4D60m0Dp>@@yE@}w+NbM6mi^Sy;+pK*gdX?mvHHnuFMwd&jLj$nQ5_TKs? z->pflR{6>%VcoCxXC!TJEw`v@tOnGRu^p^x-dQl`KmA49$_cIhdcdZyeO~+7!;z}X z%cHJ899wI|j~h+Rw7yzyN&`#NKjM=5^%ZxJ#*27ClDCI@yxZray3CoBndIee1h1_0 zwO1;aL$$wdSRLGslD>_kYQkkM^>Voz4kfTX?e$r0ZdvxyC3pDkx1a5jf3%#RK|$A# zGOoe!hB1i(tt2&#{f4o$maqC?v6Bu`#$Bm@lrXl|AFbB}|1VvxTJO_U7`5odig#b! zU7y~(-j&KO*W3B}q%pI|EETfMPayLOIzIL%FH$E%%4^Sp(|eaq4@pbuBgFkl{V;Xv z_j2x}$L8Ljrq;hG^_K+EqZ~^uH-wf&;d=D{Hc6ExZ zKlJyr<2`&W(H$84<0RH{;w*ZJePTdjX(LE`Lyt=?e4m!bW5-{q(6Y-{(pHcl^8`dM zEjNUgg_$pl8V(+?^RJPFBWSup5Jc* z{T-{z*!?ANCev3Wzl)aA$FTMftou3Z|92L!`pd%g!Tw@zXNnf>-);2Ujw;g&=8%cM zh}YQVhM2|q{Ke95x4KJExwq@SV14Z6UevujKYM2X_rILj{zq^B1-1WbxzpOpQfOgM_Tf)>EUp#a9*FDUO=<92_<#DbVx+Tp!G%9J>Whdyu>^o4%V9|k}I41__D2uUy)hQLr52GS3$x%lm;*P!JXipWU@_bbOF-JpE8teR z9qxcNa2MPS>tH?H4;x`KJPeP*cGv+=!L#r@?17iyWq1t^z?<+k9ED@>0i1wO;4}CN z&cF}wGyD!N7j-^FKqOR#>QEc%fjrXH7~~U;GOwgPbb>1(7UG~E41%FB5|Uv&WPp6D zVH(Vaxo{&ah1=jxxCi80*bl?w@C@vMSKuHVh2wA%zJZ_MPbfoSUlD3TeP{};p%Zk6 zt3Vzf9|hyV3)4ZqEpap44(s4ScpRRGSK%<6fUn?ZkY~gyLp^8?mqK?K03#tCrodcS z4tekpJOi)7yYM;u3=yTUD>R2r&<9392F!vbunr!By>Jx1gg>Eb82=GELjt&A1}ug9 z;c0jiJ_i?_xZ2PL;$a+I3%A0u?6DMerR47zuOW0eB6*hdLCou^^B9-wMycXHbnn>~4?&cfd>VBQ!2gzJ>W9_tHLx zdXeO9m=90E8E8hwZ!FvaZ$gEN*b?T$Zjk457ik|9|iZrY3N*) zJPU6@!)o{}?1t*qnX?biK-C&bT?4zJ9+Ri0!69f@i+l~=!_eC32o0E^Dc?{z10(A& zPZTbz%k`jUJ@kM-VG0$>*N|49^nh_u_#UJ-pdJEGL+k>%jkwQy5#X8cbW*PQ-)3(^M$w$Fw~< z!1hZiyDlRScc7f^$XwG->7%0;fsAJFRtQ$_GO=b_+Nk0C;>eNQZ5W)-$e5AVDucq^@nmVZ@5yK zS5uaapk5e78916eGghhllF0)p_;4!6j^~>(6Y!yQ%B_h?ZOh>Qd$4aN<;G;CR%VgL zIn+~AX&X*g>Z2K4ccxNL%*H;sl(E-io4KUde9F#+ky<{EdA-|i+&*O5=|RqEIK`Oh1v123R%*`#`BrPayl0^!^Ng`igq-3}wdmO1*FvTmL5Y zi%U%{5OCs0sVrJ(+-i%T8s z?o#`EyVUW%E)_;WeI*6;O%&*6{p;8NdHP~T2LJ&=OB0R?q91$7w;>UtE^S5Z(e zr=b3pf_macm->T(`aue69|d(11@%A*>T4*d@1~$WO+h{SluLb1LA`>4dISY^3 z3hE3B>PIQ4Yc&f|c@)&~6x7uzs6#2Jt5Z;4ML~TZ1@%RlA!;85^-2orc@)%ZDX2f7 zppM%dqTZpPzKw!<76tVZ3hLJ=s5^WeqF$$7&IHSd~G6+SIg?V1;=9$FEq-dY!`+HMV1`Ok)`Rj-Ar^~XZhXJ3S>iNA)bmgP#R z=5-&~c_l_#1PI*eH$+@Le*X5;D;=QHR!;cg1E2UzNl~OalDW(1l zp}klmOnuuTOpWUrrWz%Msms#C)LpZ~)UcIdDt!~%cZI3thr`sCui0L@wED4LY1QoHShqskhqxP3peLpWv`Cdk4G$^C;x|C6|SC>&kr4xPTe!-8J6xsx9IigC8==m0i%>VZ zBhV02UdFz)`lddYKYELVt za_%dq=Dk^tdbPZIxlMT$Hm*M2y&_UI;oke^KOj&D-l?YI zE~%~}=2TZT-mb2)F0P@P%&no?y;no6>rfMYYN|(1*Hp;^YN-Ve*HXZd% ztv{pH<2zfaX;WIOi!N)U_MUB{u6eets=J__IytDlI?~`$_1kxssxkX6Qx)#%plZzS zsOFC9q{erVSE%{lbWzuSe5LC2URSmMXgAgOof!4p``uN?ld!TL0x=JnB-B&gIuAiFJbby*UHbEt?9jID;I7t1{ zEJ+>88LSSyG(<(#AEs7ZJ6v7+-qq^e9wSx$Bcs&ti^iz+caBxhUNBDWTAQMFHFK-O zJI1TJ1JcxnFVfYDTPCWXI!sbupY*6@YctiaBYdiNRJL0BMUFc2%v81D_UXzq?OL^a z>@2lD;W~A3+#EHl_YG=W|9R^4s0C_J&LZ{m%EhYmGdHU>UoBBbn=Dr+(pIXYkKLwD zl(|Dix!0&2uiT~fcg|BcZofxW>~x=+zxM%Eee@>v@t>Pj-OUfHPscr~GA`P#j-Gx( z4b6X2ReA6k)!~j^>bvE;RradA>eR-4YW7R7stITIt2djzslLDFZS~ueN7aS3-cz?+ ze_ZAM@{wwhds4kn^$T^~_OI0)?r&B6ML(*2XMR?Rum7$ZJ?V1gY!7oS*cIWr?cGS% ziPBYEo4eO=wO?|9>zOYvbS)au$o2laOkq$s2;A- zW8+J^<>?2*O{#zSH}_Au9J0UxQ2dro$JF7=ea&S zx!AQWY`JSk=T)x0H?DOZJaeyWv+qGy*T_d*r=Q>9YP#$>SKn**x?awG%@ujiTdo^E zc-M7jr;l9wwtnuK+4Eah%dmhgMM!*~b|Llu z=o~WktsWsOU+Wjr>+>NYAuY#-3|X2U^5z9uA?0708FKr&`61=*UK--svpS?^<@-WD zpZ{=3-6l_l4E$zKNc2bhLq>(X8?vb1ry*lrJQK3)n%_g-=n@h7cGv2m!zVWgt?}k1 zp|7|v552ra@6cuql0rval^nW$qbD@~ikYEzh20qXQ>j&cJ)_N>!fvL#cPFMufHhqi)!s4sF6RcJ&N=@ywa2iB*q|JI=KSO-t39w&Jftc1_NUszApeQq>aokFhkg9CTf+*f$C8D8t{#x_l=S5!Xg##t zlm?c?=uwa`Rz2c&7HyB?jVh?7*VkNe#p6@g4YBE=gsT5a1-F0Gc)tbxls}G)SUQF9V%PlGxt3~Tk;HE+L zI9-e$-L9&jrne{MiJ)`9!vxdM_nS!UQqkH(0 zr|K6!%Kw#+#|6(fPF;%a;ZO;ppc~|Zp=1cLe+NGIr*=Vac6=K$D>K$mg|P@&h@Qi$ zk-pWjG2<%TYBI)Bi+*u!&RIvPopl*c#kh0oGtLmj_g)(?4$+VoXV+@i8XAxIxHl#{I5GuldLqqsLOlGj2oQI~fnUhyTSm zz!LiZp-(b4x0`tbukrVf@*h9p8Qkv~N2cE%R@0@fz1XGZ^`u{&;!=6@>0>|YQY5E} zhz?QZ7Kf;Ak)dkoflyVQK4jFoGDe#scP<8yKOu_9$v8l_N1|{HNgqAWMa*B4Aju3GtV`O;HgTwOAaXgTJcx|i+_?89`w4ox>?7Mqas!glcwU(#EO`DY zmGv8eVG3ism#(&Y7i2v6Rpgm4z)yQ(p#{_f(V65|Q9v>qx0tDKQGXu(RK>&R8b`~dZb*po!2&yvOt0yA^jRHH-wgjS^wGR!)vqjaAzb> zH>#XGj?sE_+gtqmPkJr>s*4 zcoKYG`7}I=8}Fzns1J2{`x|wbE+g#Ma(@5oEnxNIwEUv|I3NFN)1z_PdsFXt|7+SD z62yPRkG0&C2A1dZW79n>evDIC>*XPwViYndSb73Y6r;_E`xMMy(e-a`$&*&5@bKUudb`)w*(!VznrDjPfp_}VxJhlouthpZ5ciPbyzs_`cFRj z+`Q%ETF*i*p(+Q6pJ=%$4J-?rr<`g&$wm@9S0@-dU(4~Lhn5F4FxQHl9~^ibpPGxQuN;!c|FZh6{e1t5-(q`7 z1IZ7%Z7O~*NIKa=VKTjsv_0tp{MUqO{1aV2Ryq{yx5LQv!(kPE^v%gl7uBj;Lya2I zd1sZLT|=g{GfRtg7*za4%k74d_Do!McBZcInbqg#3DfgDaa##T?fm`jy`%Z2rmUg?; zm8)S5(9JgHNv$Qm8}eWs+ym?3UbqkLhX-H-Y=lklAZ&&$@DMxJnF}Lb5;%%@U z9tUpU8*{C864RYG=3G5Z{0uw`&%rKu9$tXmum@g*z3>v`!#;Q!UV&GEApzt4>HCQf zz#DK7-h{W{5WEeC;Rqasci>$(2JgZ9@Bti$58(uS1RujE@F|>xQ}7vl4qw2R@D+Rw z-@s`&1K+}T@ICwhKf+IN7Ji0b;8*w!euqEcPmqGx1tB2s7Giiqg+Xa3158mc=985r zE(hg7=9X1}iXiWjmw9GYKJo?s8FOe2ZJ;f*1Exx-OW`u;03D$dTn?S#3Sb(A zG3Tu-aW{y8?jUpEdO%O;1-&5-;-L>*1${y0$n}Q-kN^W=5F|np81LC99ty)?ILPqx z2p9>{ejE*BU@S0oLyZH5l2j_VVLVKLG)RYQU?OC|B=CS2GGQ|KAPce~2d2POU>b;; z4m03dmi^Z0!v^iEQ95+0#?GUa2wnX ztKbe;4Qt>|xC_?8-H-?C;2u~H_riT}KRf^%U?XgT2Vpa8frsE>*b0xpqwpAPgYED* zJOMjkCp-yH!PD>zJPXgkE_fbZfZebMUWC2y66C`^co|-SSK&2y9rnWkcmoc?oA4GK zg16x?9D$?o4!jG;;5~RBK7ix!A)J7Z;A8j%K82HT3O<9+;S2Z@zJjme8#oPT;9K|( zzK0*+NB9ZO!q4yv{0hIp@9+ow2{IVwf)EIWQV<5Ef$2Uf93r4Bl!NjR2^B!*Y*vEG zPzB_ZFx8+s)BvUlsajAQE`T~v7wW-Og~a>pe?k6_HZd&1|6Uybb`yFGh6{(;7aHU-5>_KLoD=wp3n<=Lmb3IA7FZu z>I?m#KMa5b7zl$P5oDg~U>E{JLE3UO)2@?xP`CFs(B4C=V$9;#SPy00`kZOhD`z$i zzIxK5_VExcXZN6>Uu4QiP-;$!+wyu?-2#kHh?N(K^2lfU`02(gOXS7AR=v8tUA$fi z4R&QMuK($Us~ee@m)NCNH`4MTrTAfXND}xmR`g)`A{JvX$-e1BdCzH1X5fwmuRC>{ z?-Tof>|Fe-coec(uF8_X zs;SAB_{jSg!40qAjwL=jA3c36|NB_@zTm1&Ev;gxPl#J@|1@P|OXX=^_RCLA9{YJ% zP>=cWx!w@I$RU1YdF&ID>NW+DxCRwcFS76U1{BjD{1zbUXzyUSIeb>ldxlAjr@VCZ zC2TQv;Igy%cA$#?*`%EB3vRc*;f#~a%`Meko7eStEYSar5&POdnYblRgl{S$GEPFc zwRYan|4f{4%;bDK6Vw&7A1E2r3`A_igD5RALt8;&n3y3k%y!p#%uC0#bd1;22v7GJ zj=Au0qw-B>`enBP71qF?p&dN_K{JtIXWex{5I>)#E> z4d1)!h4|d9Emd-xBOdGePD}N{nUAmO``}4gYZ7h!yq{p>M);=IfSa-I8G|d!xR>q6 zJ3TYYtt4AG_2DHna zvyZvtwok4*^`j~FFR4NwqTYpX{=NqFo;3|8SmXRFoQmbB9@;eWVWKP^ zr`j~DyoXt}=C9Nco16p_XU#F_M{|uy6RC`y%@?Vx7;pE}fZl)8KMC)@=6mba=-+#t z``V@@H*~r5R&H9tN&gkTsi8*o-+UZi7tCmmv$U5whH1yS55Ydy52QQp8Paic=KH^) zt+a&uAHV2$sr@`0FQ&a;3p~AXQm;!7KVVarKB>*DUoPXU@J)3zh!^V<2h-ZuxAzyI z!07-?8_-nHD%{iFUkbVvv=($Fh-1O&pwmE?1@C?ET_6rkr29e4cMj+*5Z8RuKzD-v z1u6jXJ`Z#PXgp{LXbfmDXdsBg67kCLaiGINn6_H)(b6Y%3Q}kI+%xF{;@Hv_bTEkH z3dav>umy;FZS0B5({3{dtLFdoS8Tv!ZFTN!n>CORhz9xK&sa?$d z4xSfjzK4~M_pk!UBkR;9wc&Qe+~3#^IZFpTSUhc*@8Sh*IGe)rGk}~3XakB@C{*mwW{jvTS`{Jdn+)G24#WVpaKx>1H+R*9D4?U(n0LQhk!bR z*e^Nf<1eBr${9Pf$`@s|1r;oZQIu2Ou*=Sv$^F>9o&tjt}6f7a+G zR%*})`g(%pNV~F~bYfi0{ka+lpgOT5ncsxlGj4@)yp{h)Sb1-v`r_gFNh?ORn7wzf zQ=NbgMw|#A$-`WP|3`=?kXY|qRwaD@xH2)p>a$rWfqj>@Vme6vU-d@FSG{HFxmVxv z>N}5ff&s^8_N-s{HaB#Y=fzR~Up1htKby_O@6vJ0d7EyNn&F-*Abx3M=nJkTj=tC^ z;qjj7Nn)SGXBzUwm$YD6j(nz-ddZZ$^d*kI$i*~zeZrS~A_vn6k7-D9FFw;qdh+yi zA`|)I^n6T9XXX>x7{{^G?JG6k@q4uee#6QIS_fAvoMby$1t%i zbrJ89k9^iopZP@=rjh!XR^lWb<0LHQ(Pw_9)#DfzVj4Q#XCB@QnfJ^~N1t&d;pyeD zUJ`i{k6_IG%`{;47vkOp;v9}^aPH4?PDs46Kd`+8Q+nI7jivp~Frpltp@FV4qlumd~Wl5Tb{789YSZ_#My9eLwFYFJx6MN4-!~Vj)B708kL$uYh)|GKa z#ucVzdAf~fm^dS!>3Prbh-I@J-jgqJ#GjPIuwI_rlPBqKjt>_2>t#Qwy&G5b%apq~n#yqNp@YM=%Ut&cyCK~%nnk_<`$ z$=r$dlSKQ~98c-9eVK=0$%|m!*sG7bl9uTtkL2UM)Ipv&^5~eCj&ULrdA#R%PM`NWNqOWE zv%Hr)3^R|&A$-Y?C@U@HCr{Gr^)qbVgB5dsGYteF5AE4LClr0Pq%}vV(0lhhr;U3y z+jH=2cyN>O5(l4~2;b(0u6X`C(lw*RJ!f>8AIJR7 zcjK7KGMCRSDQW;R-JaseV>JyE%qk?{+>`hf{0q+LlgQVd+|$=dPZJC8m<9q!F8ElL z((%^~;@zFB)ceAs7*HHZ&0zkW|la2+%hbSda`NZ4I;01yP4o4GO-};V6 zc}+nNqihd|&m4{c9SP#|ZqDU658!xDO>xX;5tJ)fR2`PV+AUlFze4b_F`2)*Vf&HM zHbE`PZgo+gV{UF$&VRH5C-@M)#ndkK@DcnJ#vM#k!#38wk31HN{t@lD0(1oEScudF z?K%&WvkKfNqjBcq{$jNAB8YG;(tClAc(gIUBhLkWin7lFjRtiB@tqsa*(tG%foxMG zts7f;Pe&dp=4=fF;0Zpq^Pk_qWr3(8^ZlYp`y{B^FW((9wp*+D2RvC$RoCG|_~hxX z9zLx16Zs;#ovH>E>G;s|HWX&Xe1Cj6s5|l>0&E-(d+;Od!ddtU9|1?70!NR5t_O8P zNAC{)<%oX(>G}dw_-aM z;Q#988HiihBudMR~Ztg{G|A7e^J=J==wC#5N$0_5e-1!%o_i8O3hw za3Q;ShAR9%!A0eP;kZE5UT$2L056@}ly}VBKS8~8=oiD*z5l}dmvbP8TNlKI@GYix z0WR`grA5=cmF}X!l{gR^A6VuQ8*X2@oSn|(JWqvkIDJn?EO4GmJPb-417;V56dUN7$UhP<9&5d+CckiENw; zGYWQXD&FPyLhgSe|1~)KW;M>A*@E)+#{Wplh*KYx$Ep9~V3?zEm`UfdCTiseP1Gr~ zo2uFE_EKx`KY;o?-ArxVg8%7*f0$N&UkladyacuO-d3u^kR-Kr!amCX(|&5j=mXRW zf2w+V;i2k|SC3Hd&+VhiS7)kqpN>%Ro)dAfO^M2Fca|Dje5Kkv@&Wbk%^TIG^0>HV zU-yh_zIbNbDM`!Y#+Ju5d8zxfCP%b?waG{K;GY`-3+Vo5W+0^7`DdXMI<^V>t?8gj z%W=L2b8gvKwjm3IYOQ?i=VEVJ9OLLDFT+eLj(igFAZf&B8uGbEL?TXTXT&ibc`T3n zNe6-`d(6c&@JDK(3WbZE-PkeQ&bkp-#L5o>|BIRHmv%@{{~oTJu z$6w*w+|ZTtGn}>TnwyWEO)8jI;44YNl|{8s}L3KjGblQq^+gY?897d(dM$h zvybt+4fb!&rD%iM-?;A%Q)t;^Zej3!6zOlY&-|W=>$p@tsj$!c`M`9inX|*HcNz6~%%X}mWOMaFiajb{;EQj&*i4Ddxjy~gw6UIw< zQYL+-V?Nfa%glR8PoMdjUig%o_sl~cZ8^gt5A%@EG%TOQG^Ci@JvC5;pC$IS`VeRP zTF@y$eSX2={aT+`ec@+iwm#+oG_mRwB!k2d_7(d^EZht(fP6P-%|s6zs>FD z+;3A3O;F3*J@`P*mcHxxf3oSM-wNO6hOW;2c7!)LEvh%(-U1*MqnJZL9DnF2o#2ms zO~xV$U=HMKEdxDMzai8fp5Xb6V&?wM25O!Rw@8(Z|?*p9*Iu}$8!WNKqmiYbf z*MVLEeE|9%lmG*g3hE2W1I+|gfq4Ef&;I3EyZd3F&H{NsH-KIT;a^m%JP^;?*#bHo zw(M-s+n^li{T@&k7_}Qg-C?L60ZoaA&B8=sEvO2HtpH6r43mMum=ui1B>q%PBp$+I zF9{QjbFk>x2MSt;Mcx(IaI3~bhzvu$|E<%87m+qir zLF+(ogU$iX0A+y=0d)gW|6EIQUc)xvT9b1dB93bxncqNc%TD9xTWbgWRLlO-Cl6|< zv&T@I<;aV|8sV%M~8sH{y!; z+M2>;z+I3?i z_v^T)OP}+fR8TsI^Be9xqy_!n!SJE*JA*ob7^aQjGZjn)ET7{z({jw`_)TKD9J~3f zjy}hBj_Xn<$8=0Dto;a%>)exI8fp_$7AqZj%tL#`eB^Wgg6T1psUz|+ow3RwpK0hb zKhugHr~`)Si$16uAp~P?H`YKEew*~$%#2XK<=HFzKe@dSUoaT+>p915twFy&w%@mj zqo*(EUf`R+>8P3y&~X1y_~hxXuHWXmU1j+${{Kg-v*LvDSsp(Qb_^!2LFc3#at=M& zJ2QR?u9=@0<~*3VXIUi1i({BPreWV>-(}xoKVTn`KEuAsxp;2S?*yNH{sPd;p!uMC zK>^U&AP)4d^&o zew;H-lJIiv&|g33AAj{v&n>y{Ic}TO*%9HJ5=FqtNLQt2R>dqGC92;0c~TDh{Ej$c zi1vl9vEz-M+8%c#%yKvm(WeuiJkH}d7SVnQWgtu(bF7*Op~*i}1VQ+J-39OiWV}fq z7=GRs$5zg_bAN-L=Fa^#FTb@Kc*dwps>;rIFF>Wh$v%MaZEolaoZ!99oOy*MZX9&) zD)*MAo#3q~ogpbI5s>RE_(fX#isq@Sc2-T^#U=#c?p}DwXp4JzlaqQe>(4zL0oSf0vZ9zM&i%mUj)hr z4Fqw|HWeh}kY29+3lJG|^)wIwM{rS`=T^tOu8P3y34y8L?kt zd%%jh9n?So>Fe+@Bpe?~WmUD_-6Gw zJ_b*p?kV)(zue3V;bUvC{%G$LbG+cVLd+#B&N!<)eA;c==T zK2{ise;zpXnDf1EQ<;zYqK&1k zq~8|Ae#bqPn6ouN9SZ)dbDi;Di~e!JtVK%>N}Y1Wk?W4L3K0AY-_&aZ_^)Rwop8c3 z1uJIx*&r9_LQpqk!l$g3eP#dQ`i{1hd8h&QG0s<`ALAb#3`t!KXbRhQ*Ux7q~=PK0lBLsuOqIbQ34Xq*Z? z*5!AHY$a1K2NAEb@05#s_H&Mf;%GaF3;JwRwkP8$bqa{cJsI>a68s3C_Jy|Lk8rx) z@`gLlizkh1t;Rf*_WpU5kGBjE%y6PN;oIEMRo5H#UVL@`z|5E=2arYjdD)2Y_A}?l z8zAT2KhCS2cJY&koAYDgha|8=4ayOmESvp157`a_aV%rs)915d!`Xf$s)Fsvz8sq; zLkWL?t45iEkD5`=_)sGg)Vb%4cMU!7!PVwGS@@=i4dSETNMPqQ@e-Rin;QLV?{&Ov z$P32{=YPE*p3IxmM<=MV`%gc2X364H&3Uu%&0o_XULsARk=ewHULMB+I{Gp$$aq2f z5}RjIJAbTOg5t%##OFKXrFaa^1sHSs@`1NKaIZPf6uv2KWAGBm)HvaWbqIFM`pA#X zJ58p69b3@oS;iDc9V(ar?vs^~!TCzuWJo8(Q}N%GMIk$Kdl~;oIEM75W=j z;hW|i;wtTV{5X&N+tIrBvZC#4aBfHY%lRGWfSk)yO0K;)FXY_44JZl3IXdTnoHKI0 z!FMmX_UHPI^LlJ$So;86I~`$$^`Mf+5*sQ&^e&XL3e;21-%OT473*pvx7hxpmCtt zplZ-^5YICBFQ`2RzAVrwpvypygT4ZFf-#!_S^#Myp8~jtp;`{k&@cnU${SaO3 zOlVf+LBG0vAui8A+a3nG8{z%ne+OECum?06G#rGVZDEx2uBo7-LHPOByWQ*`XdVmi z2gB$37b>>$kx$3{GZbs(L9<#8D!2M3;9%{)^@ZON1eIH3AL~60lnElQ07S=p?2F7t z2iVm)G<%%`H0s=;b)ir`jTH;VG!WB3Oan0u?4Sm!kzVG1l?ArN%>s|M-aKz>Bj$(0 zw?4XI+prDipWDo?h~p0Df5Nx9p{q9klM@~B53fd-=KJw4=*POtN^qJ3k9Uw`9&1pZ zKEAP}?jQ`)*7!sp!?!i><6I9@2W#xY6eZ^V1P$nTSvt)bFY&GfHSF=}hfer+S?BqM zn8?8iUW9Lo+*rKGv5%4PVwU-P?=j`Fo*QE7X{|3fN9qCMdH~Z(i(0@Z7MYgw8kyU$ zAJOS^9GkOeT$kWyihbEyANNcMSSmJ91vkbZmFFabwzpwm z@NpaFfSaK?!%7Q%)~v-5Px`Qxen1LsVFH)letlvX4mi%^^A%VmrshQL4#91d9OzJrZ2b<+|UAkw;ZCpv*+PZQqFNWf95=yYjr+j zz#}1R?%WkV=h1vdkqJ5;ghx8oIW6)t|cjO$rgL)yJ!Q2QT*5EneTX+t(SDZQ&5Bg4Y$Eh=J zj8pACiBn%5+eD?-G*Jib(^NfmWm7e;?_TP#+P&1Q_080ZC!4ELU+k@J8`eV2+S*b* z^KhcN?UUB(+qrF3^NN3{pTBLV`r(1u51Ug}?Yu+PzHN?B=dC+RUHVi8~tJ*91BvQqpdF!2r!-)SShvu|gaQLhzy2RIu2r>Wz z%Moi_uj!5$lz5I~F&EQ-XrKxKv9Fo@hca+kpdjA%qJ5Qf>Nh;pR?T~E{oRwl>$2^H zK{k?xBcAqE__z&ou&;IJ)aR6y@hkmE$JATjMu;3sPc`KT*yo->zDu9Gt!-H)_Hn0- z{^`9l-fMp7iVUm1#kf)q;fD!<8(ofZzKU|33=mO{owfJux7?fK`Xvd(cRtt;xgW=M zerHfOP&$YbQ^zAfwE5FPb3rh(ss^+gv=Q_Zs0$im9Oxp@vml;JHVee}BXZFM{{fZ3 z?stRD=S22L&_S^KUfBH~Ak-5O>U9W}4ZEKVyFU>R*AF>BsfE~hc%X|?_jSiNGZX%a z)1*@T$N<~9p1mKAn8rG&@o(=ME2G$TK)~v=S%3Rq78CHV)Ib20i=8bv)7j2;JuLyx zJ9^%5Z{iCNq<>EX6Piy8-(qSP-Olm=1=Gly=btqe=UNp}gTJRt=50)V_BT373lnR7 zt4EtJeUkAp7t_G5&_E>$k$#(WPI$jH&n?`Detmq(nXlcy-yui(f&i8MIN_Tzq2CV8 zk&U;JIJuz2ZEd!h{gwGJ#jxIS;QkpUp^s^Zg?kx?SS|a3^bZ8X!g9}eNlRYL#Wb)x zXdr+eA^o*FN`K|={p`xQ=e2unZ!Qlk$NtJ)bdztfaWVVr;4)8%cSeO<;sXds{ki8m z+l!=sCa9AV&wuWTFU}jqJtR7@7s9u>p=-VR=ePVd@8P@M9 z3YIdKz2WRbY=v%Pgh!u_`RU|7ns29$U1J*fduTu(=hsH-w-b|9#q*oTy?NJ^>pBI+ zmwqdJ^H-Vu7DK+Lyx2aAL+nM_Mb7pjqbfm7&F=r-)eEN2vL2YB5~;V2Z&Ym7%l8zR z#IzIGvar6XVIOCor=1X6L0|eef|is1E%%Xprjfjop7#t(oP?QQcns6=K9XyQA1Q5& z7t_G5)Ib1*Nq?=4(qCEc^mN~yZTdFjV<^kX{KDi*yxCv#eBQA6g>I*6E_JpS#S0Qt z>$5tx|9a?(vt*x6?1k{9Uh&QP^XIzVWr#HGMQ8B1{?OMT(wD_&nX$e~EyUcOs(}E0 zxY&zHi=6vwYITCDUOH;(t;b#7{j}iVEB#gYrXH>Ss=cohd=D|dVwRoK?6*l^bBrgk z@3I51rg>Nyn3;OLuSNW{Lr87LG?vZZ4tH|Yd z<$LD4kN0FV+3$HCN@@8_l<&cCf1G`u?S6EqZBTm#C+;^P(29Bg*-e>r^xdI36p0?$=n<{||@Y!rUjTKurd z_+cIK!}iAy%f$nLmH1(W_+eA=!*1`0bKCI4PR0*=3qNdgFQp1HlnNY&wi%4)w|EHL zZ9LleB>V=f!&>_BKhFa=%kUCB$Gr||?!ouikK^~guGFS4@C-OUPF;%cvdag@sTYdz zV}JoZ4@H(boYY)F&4-@jo8Qf;%M(?~JsPs!#EI`21Y>HaBzyPUPGK z`EE`=k+TxjKosIs-pAw~@qyq~LcjOH9|@X>um}Di&=rWE0Llar2TTuknA7j|a9E<) zO`|jrKq|2#Yp-<1N9vLUb=RRUuAG$Cd2`KwUbM;=d4lQ=7>i4QaXj@}aw z=!(`iDHGvWgVymL5wk!AARJ+!-U07^(9@ugL2rR*D=I+8gU}tV^EhaqSRUsh==Rop zgg%O>hfA<_I~Tw&5`1jE+8H02S0yOV(S>(;mMs5n`1k14aDorvTTJZ|0Uz?T$x77_ zK3F>21*X<|XXaw~uYmfaVMc)1&KaNqAle)LZ@(s>n~){|$^mr&;q@1*U8Q}IB<6NN z0|BHJe5mWf@nL@dR&Wi@)qkInD<`_!!=e3<1l=AHs^ z%sBx>yFuL0W}FGi1a$;`13qoZKA`6iz8xgzl<*y1;)z<|xW%a!af<1~9_y;`%LN}@ zYn<^>1^j&dYPNg(uRS`O_z=FS$O!nz@s<`=_r8mgM>wD1GBVP-2ke+@qy_>=C*#hNTf=c;u6wrwM;nH<>~YZWE+xNgw<~xF4ZwA; z@Xcz06Z~Tzyj10RPwrpeeYkvE)473#V9_TaB^PsN4 z2Im%Mg1E=p9z+B)FKt20{XPvWL3Y7M!5!iFC_)@*+ZoMO)BWyzApN!kwJmS(9f#cU zUczl$D8Q`+5g)=QPj~r+#qOet5`1!>X8$V{%u4)tR#t+4u0E`ʤO=knuZ__UGk zB2UGvw9)=zw+{tG`ah!F3&S>&H6E~f5-~s`CO9q-OT-56i7oyjQYwh)X_Ejci{Lpr zrek_KhUvsN!{)u7j&b4|;!AwYk7;0MG{AM5^yBI~!~3y$jzul{`Oq8k?hgF?Na@!> zKt8;$-H(ND$^bi$|JN1ydvxuw7QR)t-&?6cxs*rtJGW!+_f!vFA)B3I49$*Rk*GcI)HjW~5PK?HXI07kilZ*xP}#>!>APoW7`i6W$bW!&xje?Kzu zu;aH=ZaX)@m3>csZ~)0ge##~MkVJOKmMiT4;qk18uZ47p{nR z_ocOv>y;NCZ2ClQ&e$s-vj=FYSNKl#j`PfN=X**E-6LG(ep?hv2IevQvsuory4U-< ztn-3RYuO2^lYIIz*7KJ#EOSXo57r*zbbMCc7mgFt{%-`1Qu8law&13>t9xEXpv8 zs0D7CPiT4T>W?<980WP$A-E8}sUH&;G6DF#xQNz1jAt85UuQeZyq~|4BAme5!iV1OdYHM`p3?4YPtG6dlW6 z_n0$ImIFuQ7JfP0wYpn*a}M}$f)nA}+|bntC;AlC#0g8#+lXP3;D)w>BJjQqNah>l z>lk4ku^R|Rbb37z6U3Nd`(l+(IOAj^aCF1ZZ>+lOp=Y025Y(OEMEIskop2)GS}~7_ zldjCw`p%^(9GFcy2}~_C)wLH*|HvNtWL` z%Ts8lHE|LuArvBZ#7@Zg!+VZ3qUT!$sLbhO|AcN_c~tkUU0_Ca^R`&u=`K@=$Q5Une$oUo02vHFZ#5$9$vbl zz}URj)aqY%ua85O8=Ud75qN5n-!;DNncMF+=e5E&e@P?oVoh(&afo&#Hm^0c`Pbd+ zc4g^H&NzwxPlB5G_!UJHx}CM}YEBs7hJyIoitsI_c5%W{%cph-&M@r{j}h66aXNJ@Lx-%C97oOn08P27E`cM_{?ytg!jth~QZB9ExyTfPc__sIK_q$?yaJ$F30DiIH zW5XNH_(_H{Bz2FA0Kh|;)^X^2|k2xDlig0hWOm>qMgJ?q;}QoY)o6S44uRl zkQWc4-JnlxusrhV6En0Uk{-d`-UaXr1s}Crobi$OW`g?WwJz;iPyYJONv{@Jx)FQ` z-&B~6kCE63@0EVc*Rjo4vZvHjSWIXB>Ie0(+M z5YW+}<3Te)oR4n=^+x8Epb``?8wI?N0=`87@1lT2H2U}W2R{WENXB)=H@*1ZIhA8@ zHWR)HU3@dnLit#!c{rTp;*D|Ymg}3S>sL2bFO6uX=2h*jepuO3J=?d9>VCt%YM(V7 z)VufgP%GLWrw$rCN!?d*x|%oUK2_%XMP1#GhdZezn4~w@xj!sHe;NN`|DVP^+rIs(x1O@}CH+D8rV<;`A9C!& zFr-J=CH&d*Fu@9IXPCskN1r%h|4Raq$9_l~OAPI)PPe1$qu_=*y6&jXlY346`F&U# z9zkP0m+gUTh)-_FH3ByyU6ny2ifmP&x^e#lXB_9fk8{8uZNKuWYur8@D23Bzwp4gP0{&Y3GPrt|!Eix2HKBx2fBlaT53t-(x*@ z>B8sc&OiP68(yvEBufIc1V|Fa3%IbN^xpPaDBt?T?0ra_2+(S)*rraw-oXnJ#Eq_ z)4TmRCRKcT(TZJw3LxDea4fwXhPIDO)q zVYz1+OvAY$e^s+TCw-Jw5w`Z#q0cjfe0de6xxM@KNuR z0~04=<5(WUbast)INDY6(;gB(Lc|doZhc8Ys2-m4FXYLUB66F*$=*cbv68?vxfg) z+ng6Bdpp|Vh`xkx3K>~n6WyK}#r}}>RjL>nskg@NQ&1l~7w9lh1}G1NZ3cA<=yMSN zH}FTG)le{hhwK-a?SrIYj{2t)pY6kTV4HAngc>4|&$g95ir^pOs!^)oIq;Qp`)ok_ zjgN1+aM`(2`{Q2>TTa?X_@%d zozL$GbV*j7H|Wq@Tl^IrJ7n_q<=B>1S>?u?IZz|VxOIm5=Z zEdSIz=R^3WejM?kePQ`~aT2Y)7|%8r8^Cs#u|>uljz5eih8QP!VP3%%f);M*?@3O_ z$?_kaagy{yf;#iJHpN#xzP6Ql?uYPA-8thV^h$a|IMLf*53?S&tF%Acm2)xrB#sTV z2Qn9vc9!&JSx8#XH6~5HOuH#V$H~T@opF-!Q-XT4^ssC5t~hRmdH#p+O*J{=MBe^u zcwXYvR$?2(XWhgGaYB4>9N``{?`a#zBVL3AXJFMir~2v=?STOuC+at6oD}?$pk99W z(G!227C78|4_)}C3Y~Eh`ohw*Cu}dV3$znl*3*}9LB<5#PB5%v2Df|U7{TAYtDU}n zO^@Slf9U@&ne*3b;Ar1pl6$`#ci{`>`5?kKw-uK#TF zyb$4=T52p_WNK^Tg>56_1%28YX)oUE_C;{Qc%~ys8v2441naOOWr@$YNG@7@q&&ML zPv2Kr(##nz+kvOU3tv29nSbGO^LtC-n>uPVUP4n`s|XV}Wa@3kFo`%I(S~rY!f@;y z5h&pgcDkKezqd1Px;9T#uMQb?$1%T5nz0}#S1x>hCm?)N+(zRjIOR3*(iH{j`(8R$ zh!MFr>y>-P$K0;dfR2~#Eu8T(DLzp>e9q#VH~;j_k>-3?_@-oy#!Kv6JX3Xl%X=L! zT@#)0Qq?k16?~ubS^N9We8fCgMEK^9Y&2eihm4r^#Vn8av>9SIWL)CC%yBtiG3POy z)^J|$=p}4#Iy|42|gOz{*6s%m%e*nb=)jTa>mVe;A+c; zU!QNf`I$@2`LFOzZS5#-WExz9Mlzo(>g~obi8v4}#OA-I_W!th9XA`2opF=iHc{ zSp+}ZqTq+6_v>)$aoI1gt#>|&$!A)+ox+a{TFAc?B=V)VcgA;hN}`%EIWReH^Z4%O zc_qT9OuE}C`OL#hP@su(y$*(nRnzJCWthad8v6zD%wJ2Ay>IpbncM4m!H&5o8qoI* z3Jwg%ky7E`L97MNj{N16ft_D#mTjJ2B7C#D25}VWFcV~sh8MH^U45_HONNOnVv3G9 z|AllH=OnYo2!^d{bc!;zd3V)Xv6XUemrbroGKN8*|S#7pI5GBQ|7hKrApUa~|3n zhWXx+%!kbUh}vyk4St!}m-ItSyo8^BQr$UGUEJ-L!qWR{KQYfg5x%LY2JzCE!%$F| zi6684KkA-15gc%SLPvbW&I_?rQFp09Nbpm3m@|Gh0AG2}d@*9h%7lZ>^FoAQS8y<} zqxdnussFR_BbcH143lVI=uaV|{Tv?q;E__<-O26uv=q^{2RVa7|FsbxKv z9eNCC`IbWdeWo1xLT$h1iRL*X!VgJihoZ|D;ZPA| z{j+f`a!0a@9Mg$u8E1)W&f~>#yxr5Bj+?;Y&bZkMT;=`r?7cVL(&Je3ToK`$`fD_9 z41@S*X2l0xclSI>yGq~GS3?ken=ua)Sz6E4j(}lU7n3cntBS~cgsjiR1-cL z`HwY|_Ilque?<6=mnXtuB*<*`D`Hr;m1g<8XWyXhl=TRG_6N=lNW5nmOvAY+`%APk zktF6KXh82*Nxhu$QkI^mI`sW;zb!rcCY$Gx2;Z!tVf=>h66q5M6F0g#N+~FERCJ zmM48qeD*!|7xtgO;yjTW)GONqrL40n=W3`Ge2Azs}>L1}+!G_o#$# zF|~`XPaesTmQz;7Xw%M?~WjqjYBxt$FFC%6#4%?(}a;lg^>9|Q-IMZyR7q-D;> zYNV}MD%)8w!?tEve8C9s>4b0J+1D5*bZtZr2arVYu_OvUx*nFS796@P_lw;0%+bN3 z1s}pUYpjQl;ETCpKlJ)j`a9!ueb;2w_QjGW`*wLb`vneOa8keUZEomVuYT)Y8L3^V z0Fu`I{wVbqcTZONb8hXw|G=r;It8nc`h_2=*$&mKpDzlAst>Dw)v?aMKV?9o>c8ou zqjKh6Gi)dgBb?MPe487(>h&8Voh60YKiU5{CtzQbz9;>SeT!lGOh*w&5|(&94a0hV z+{WAvXrKyd1)rJ6IpZV#@MM+HB>mDJj~#YKM$ixnK7?;p?Sv2AlZA|d zbm($yj3URj^kj90@7Wa}uX+B>PQj`~4&jF+utQFA=q5y$qaf2+A631Q)e+teA77J^ zRL=jOKqqnt-{yv{PIB0vblJvCUk}wrk)!KT$*NV-`=4}Qbkw3n!Ky?K;fEx!LyeF_ zhilkAS|H0=FYAv^R+n7y_J-ltOzdRhRrot0j}F@~d6Kf7SvFZ4b$Bg?Qi!rxiB z!Ws{SRDon%*giO1UrL4V6HgkHsQ$6N$(rw)uAF4PpDBDNxgxxhS*Id%{$Q5#N8bm{ zm{kqKGG`%!O|YlGm#O0QT-(sRfQE96x2)$axNd5OI1 zs1;Ecl>SVgZN_$#Fxyg|lZelFIuj2zH+F4|2K4pf+B|1`q~cJue&w6*_;=FcSB~M~ z`f!2|;oIEMwE=uY+5)pOnRsE}rgO6G#Dr%^ZZEJqf~A`JI~+pZ8xB(^>C(I?I*dr(Y-cCFL(mYyH3H}g4lU~HoLDRu87o`3d?xATI)7rhDJ zlrFN~v`5oH%|+51`vv<5eIZK7enj1nr2jGeXFC18n)Oliw(ZztHT3!iFKXNW+mH4R z3MzUNzA3w--Ws%0;q&y`@!{=hKIhFFm#FU8KA=~(z#BQ{b6(*)$rbj0B?89qFWZ_trX`QQ@TK2~kEob)(170WQzkj%q;f){x^C}D zqh2X}aewo9CAV$Xj~js7+F`aEoD6r3zME?G_M)y2Kccg4l# zKDqGCU*U|Cuq|>ctB%|B6P$6Ik(sRiyYaOxw{^X5q4_*m_&X*~XqQ!&V^tJ6HfG`Z z&MUw9r zKhr*Q>=v6(`%I$KZN7{RV(Z1eOM27ROMa`M*rm}L(C00IDb9GQ%t=-k_E@`M(yYri zn9qxaZ&uu3e>U+F8Um~$bh%QdI?I(ZI9YWpKKI9|-#`9e)6NKgr{ywCjxN{oC~~bD zlB~M)xcG*bvo5~de4Z@)ot7(Pdg|#b_atY1P0CGH&wbi%(Xsu$n{C=3;qSCuAyZUO zuB}nz+CD5ubsJ$;!K5>(;)BKejfX zKMVi&%4NVmOup0tXZbQl0{5x&ibp&OI9D;ox_sd<{Izu0es)KWd`Lw<Mtn72_yf+t@na{U{Zz)#0G&tW8+!znL z|0=xbI1%xQlh|`^(T45oc**cM<7El(^nZ8%vee}-o@+km7Jhi?4(Im?UW|v{JBpV` z?X1f{`w-2s44uTDkQWc4U7;U)-W~ouZt+ZKysQVFUKsk&R~2*DFEgKa3m<9?a}C;; z1|EK!cxg;~hgI0f8y#nQnAwR9uHQ+-4t?3nZ59l3kB?!>XXXcMw{^OGSu)ERFWZ5q z)Y~`a-{0@XcII<$;hTzT5HFD)f+Mqu7pLb{Y$s_iwx{gTNZZQuZ}AyVw_48o!dARV+`WwWJ)5CET zvK*v87j&{WdY!}uu|=Xi`Lmvn>v}Bkh3nCLKE51!Ub(SHS+ki5CFb*S;Y0K=*9bk< ze^`zZBI%L+hI*1`<@6~r`x$jclK%N;+vFP5E&B_q+*yy4#wV+S;}3se^p-Wt%;)98 zM{!}U@p_D8&6KJ{X(C^xAzuf?9Sq9-4f>lq_uKdh$?E%uYLgeey7|BPL51cbp6{ax zAGcx7l8>8y!Hu=CZdbXt6yq;aNxdolM5}$Wz>~J3tt@Ddb;Hf~;p{J^#(aF#8y#Lc zOt#gOn@n6yzQx8R*Ht=WqRU@c?DnM%D<4W&nEGP1re2H(gd|I>V5-vqSB40s8 zbp4$@Yt$o&o8Ep(>KFM;zQi|LKDMj3+~fE9BI>b9lXF`XIm=30tE;Yis``t8$CMuw z6l5%X;!F4jHrfSPAd#OGjG*g4-@2y&#)1(k`GJ;_2rlmqIq=I(h=_Dhey*de2=wMugR=l)Muth~8zurk4$ z@Pq6+&jD{aE?Aop0AEGfSa*3viJuLxuX}0@d1&MI0@duVRL@h#zrso?C%0VFzjpiA z!~z}tI9!EqF|~_>JVQLba=(qpvF_OwFmK4G_s5h|L;WC9J5|n0R3jcv9PfY8Kc2dy z>knc-5WdCKE@%}$x?#TC@As6>C{N2ODe=zDhjnnxaAy_L;^xmQEyQm|h3pUVzF-E* z5G+uZnEPur5J2@}FEdVe#>o=k=*V;W&+jwvy#Ir_u^iVn#EI~O>^g6Rx6oA*#6{Xj z?a@gexDE5IQT!;gb#(8BmU`2&cOS# zi@zH1)u8*kz7ecn@F9Ftta|v!_sn+>D?L6tm~bn6b3A3c(}sv$6?@Np84QWm`hXKi zj=60>$)J5fFu&IL-U)tJ(2*dH2U(yIpc6nI&}pE5f$ju71Ns7#f=Y*h&H+6QY6k&0 zCVv1bh9FH~;2#7nfH3FdN8b%$T4I566UOI%LT#&CD>WVy05`^H>J44S8c$99bDY@K z4&sJ6^FAyxb`z!neOzB};NP6@Fyna-jdPdz`oD$n0Q7eO%8wE4)9ZKH9|Uk9lulKC&WbkWeLP!O)Zdj?u?{Q%wh=tyuin0<={-+n;emD7}n=gOcR;lWaAHZ=<_#&71 z_I%8KNMTI~vEZEJD)AIqy36xIx_Q0QhG3Rt=g5UeeaSpX$`St?C{5<3!i(gGwf{NM z_1HsBtvkt7|$CnnnN{dR|MT08~-DQMAj<=%JKddygL=B%` zR-PM=A<`(?#N$X=3-gRs*{ITzbAUPU6o?RJU~eYWa-SMdjSvqw54BPK0kU zwTp%m+fG^e`wi*8cHoYcby#|d#dHY6;*q>1@|tOoS)ul6EmeB@n-b5jR* z=(Az!ydU=oiY4QY@J(s!;e+FhWlqMrXL*-w2tLL3Md#An$O7T>HdcK^p{Ab?`U zj+8BM#!2QgiR$!}Z!fO7X2R)Q6Vgou(T)h;VrrLqII#yB%mQb5=Kv-8xTh|TK2Q7T z>6x=v$A36ns<8LP4^k#y;mzXa z5^LSCbqMzT3jVvS67t?x@j<`u<_&ym#B969_c5`eK7=oFh@bDDSAxCp($E~(UMra6 zE!W`bpd&z;Aa*EJYwd#%g-^Zr1YruVu$67C;p5@6--_efg7Z8&u9q3s`$;dDssgf#oBh z;dlE=@z^HcJ6(h6=n8+K7mG^0zob`(9M5=cSL?K8jGVoQ;oW_4pDWWt}~q z4-2iub}&N?e6b%J8X?cLPqyE2%+T++-DJ5ImV#QunS6;K<@TqIA3K7oar23q*Y7WJ z53Y0isrqP|fzUBJ0JZ*%l+>a+6cw(C6_q%76`OC+b`aRgy z#ag#;Bp<%^3VYtL4f3!LW`U>%hS^a1e!#82-B^3Zrw6X19CY;Ka23AI4P7J4GsIO= zGR;*ua|jlwMONYfuF`JB|8mArWl?K&)@4tA3s#~{iJ^3*Hs)0IM$zLSz#-sE=T1e zXFV`O*GWJ17?f9VPp}&6c@&>YnS6;4mm_~(Ie;Op5mbehG=QtL$9BjO4HvaX9k()2 zzM4aU<){zJVe&0DE+bu~p6Phxm6q!&$D@8c9`?^mE5(QyOb~!C^;a&AUjGRzzEA2| z{Opoo_BuV7e2I@(KSo@i|71%Fy&cqL(d%#fraIg8Sa9KkO62#Oe8>8W+~tKnkF|9p z=>iCd9s-S!}&yn(_9ZbH&NBsR>pNFq1(4tGa00Pnu z@mECGL(XM2*B(3Wt)C>n$YJs&KB63+LT_pC+#p>K)s3kC5tpyUg2N8ILduu=O}@lO ztRH9$&O?Jzgtte^lIVJP?!y5eEIfIiRH;YgF!>T6S&m|t&wVmLIl~>?mJP#2O(W!J zzv!B>_5=5MTj~)xOuocNl%ov8y|>U?aVsDFcIkR$bbUOr?z5Q-efMxWZ8?#{ zPwHfkJ$#0(6KWs_$8QqLa5BEOeUo88xj#n-F@cfq- z+VzL*gz%Y0cXe{)xqRjBVMX>E6yf$E^(yD_s=8SlbyU%{3r=0L$UiDLaN<=LYupyT zUMIs7-P5d5I=jSGI&+-6(w|@Koomgr?36V4(l1vIK6n!+{^xW%K+qpw_+T=@o zgn4j9Ss5N$lw+TL4y;5u=6raQ!hYnE=kk>LdoynhNaUJyb+}&SeWr9wUVfUe)>^4u zHb3`=7G*zAW?nkMg~_*Lm2#5HnzFkJX}-#>M*ya9C`8v=Z4~)7_>)!1soy>I$zdmr zC9dcwALm=bx0u?+Nj_U|ktM4^8KSr9Yohn3!W-VXxXZ?@AEj#1o5`2>=yKW08tEx7 zN3&Y*=vb{9EI^;Xr(WwUUoGBW`oGFC&Cl=u^aZBggfDW5AKD1uY|Pr~%&(X>%YzAg zku6z%g>Sm6&^>t8H13Y;@+^lubkgt5=Za->lGSkuPmH>J>VQQT_plcfe6GZH6uwn} zcG2X~D<0@Y=L{gliu51TbZ?yDeUP9bL+JX4m`aq#K;&N=a#>PM$iT-?Ja4-)71sd`%=P zXv)QBzSz`kK(26nZjB;O&H6;O`myJyCwl|a_za#-^dx+n8@g)pu&MYIc%r8W^EXRj zIVIk5yQ?lm7U`!|H#+NurMKR=^us&S+R3!V+MnPqg~=C5u+pF7Dx8-#Xjoo;+8~$T zH4P1wHX7?qYkHqH#8ZO(t$dH)UCy0X9toC(k#mj}t92w@&h(q2%Q^J&CUZR9Kb!e3N4Nk|b^n2kde5TP|n4HVyv{Mh>zkMF_RYcD{MjYm!kNAEa_n3Ic+$R^ zH%Hgo(XHbDc}m4GT?A*8zd7U)zFlhQ8YYh|fi2Y_x3z-Q$D{SApTCp#pdokBhJ&x| zpStiYiD&(E3k<%^#TcUF%dVOGYZaJy6}i(!c`dt$#Hk?aq2|^PFWm+?^mT z2}NHO-xA(#=6JRAg+#UFm89IM)!*KGBl6M7JX-iRH*^h?lbylZlcbRL(oVW2Zq=^40;bz{$=5FTF*Ps_%8;@BdbIns?q zXHjtKGunquU(5=F@5Qn#UCwPwo%P1_FAv@FeZ|tBC*RH+ILf&{uEMvN+9h1hi9Q&r zK@~yU)mRx>Tn#EB{u+9ZNvraA2iZ0xI=db0aO~Q!2K4?{dAl=?sjW=-07oHYYe=6rk$QB;ACb7l<1%&{yj2OnVh?TL$(Rkxe!4rh6~{+OsX z54r5KSKG(s@_k)8J_n^e5WdCKE}A^DC56|l!jc3(S|E z_ul-@)>hRW25$>C6leF;i|{QWv`Yke##WT#tCcbgD?UHgUG`TaR8=T#uW%tzp5A_I z4LMDF&gxHF=6QZ?MQ=XBwH)!pS)R$a*tmr1PO~O=){8hYw<~pX474VA0i>-P|L+Xf zS424;yJFMg?Z?;6o9g5+_|fICo*agat2K8=um8$Rrk(iCnJwz}ucdyIAEAD$LQNUg z-f?E|_lw=_5X?wi((zfjlQZo$@gvxdlux&}dN@+r81MIMpawCopR;_$za*-> z8BdJ={JziDo8yY`rCjkFA)nnP48crXbDx2IErwaq>|g7bp&`uqBEMr5*G~d5f0t+= zZ2q?*yq}u;h4H^7sy@dZusOFVeZ->RL|f)L!Z(Go_Y3n2U8Py2Fcxm>(-7DZ%pAb0 zn?B%mAAYP+5;pIOU+FAQMqDfP#Xo-?bl=%4zWS6OZ^4N?!ne7htAjkjsb8HaRwi9P zOAL9;dBnyht<=yHdt4U3uIyj7eGSPY{E#Ges3CdkYsOBm+tu{@o%K_>S1XmasQsAu zPA%3?j<@rReuUpxd3xd96|3@h?|hx$^Zb+kyg!T*5cy z((JuGU$;l4;Iv0(?Ynlp$-N+|jeA#IUl8(aSMq6+Vq*rBu!F8E((Cq}?M^aXIuxv@ zGvgb3&vufwV*9b}NDOn_r@uFdY3SI#B*`cJm~k-|)4<6>8H@yu|fd-6=Dm)TI9$={XtT=oW+zPqy6SXsYQ1Ajz+ zk@*>YS;r9P#30|X;J8Js^Iq`Id(z*%7jyrJ zaUF9r&baH5am;2pp2frynM}UL#zosdvi6MZ59!hd;foJ`kY=A*W4$1ZeM-ERQG(M0 z@saGX(&^r`(SDp38Z4*^zR0=tS!X%7w`rxO<_+IACVl${ZG-tKC!fO#Kgh20G&!~B zdfGWA!4HOOpcs9BgnFVapkp}Z{#p%~?UMy@l0fkwX(vh;Yb$Eu&vyY-DgC(MIp==7 zq-`tp@Pi$?9l0^@PL92F98=kkg>Nyni`I{|ooc*ff=_dqY!yiAPkBE2`+>h+KYZ>r zb0$1GrNzS09NT#;9Nlk0zI_+E^4)Bl2R7H`E3%K93OfpSe5o5JltKS_)K<%tt4 zo$2wFTKtT6mo+!@FVW(U|K8Krj9;b2fB3}(UHK}#4TiE?Qt{$Ih>Bbd% zd`0-y$vY0$n5mDuDI3D|ZodCia8DcM zJ7xIyX(es@Ol?A|YtNV2Uxgo%#16^J4A$A-c&UN@2z)8*=a=>4@%6gLZ+#aUKyvA~ zOCSf^GYdqYcAY<8e?Ro6l$-YPW!+dq?9ee?6I_LFF||vMZ(f<-n>NAY^H;b^j(5+? z$7f%`v&WfC*F)-mqT7uVSN*#9_E(QOshesM;O}SsbW?(S`z~}1)<3Rnmi3~p2x7mc z2XQ22Dgt5$G9iav59`qJvjOq^{aGOU_uIPCzwdviDD%@h10&x<63f|g#wn98@gis5 z$k03WL8YaQa?gdNmdN-#XmHM;{H(C=LULaUZ#T9X?YjP*;%&EWJoc3BUyZTlu;u2t z6~Y%e#1F|6Y_M_jtfQwZkwEaW)~GiUUe?dJu;(4i9;AwCKW_!2#|+XfWbM_$*U*)>Jty{Ii9$aX!zC z8EzlOopC-_X*oY;mOQBl2wsw2#djS8YF{lppy;SsS9G?%?W=*J887dvB_lo8wEA2L zw=wq@Xsp0!oboBXMoA52BcHt)!oI@g`01>mi(WIueTW7K%i{ z40`(&zaCwlGmg0Mu4Qdq{iQyU$K*@AgFKwg;N>1~sii$bE`2F;O&0Cd?3bc{ zOTD(aYNkxS#OJzQWf;z7IfAzUo4L z&S^OruS~wgPxO=)dFPg=<+%M>b6lPh*3P&9Ncz>bM$}tg_T~GROz!n1^U_JZCf|<5 z_lm)K2bUI>xaPRi@`p}J(*+11q10czDf;hz{*GhGlspx3{x z5%piR{g{5u`_AcV*Bcs_g)jArZ`MB{J72FpY(7=CIr{J4mY#U|rZJ~nBjwBQH~A7D zq5f=Fxu-Bp2qf0=w+(V|PLd^sMDS-uj#m_f^nh`UyyHR5jleR_xgsoW_e2H zsZ=Cn`*S@P|3)IdV+fVYGIcw)1o6@A*wxDyUA=Tl+W}I)Emxc}`4V4GuHYojGvE3W z5?>w6!Wz~c?5^Q@N_sQ8JZ&en82(Vx6}O0f=yM(?e33(ZktY|^H{Tq*^M>;-IEm5i z=Tg+mafOwEI{K_v_!d*U1V5}qWjv-D#uCSQ*%rf| z$`&!kRf6L%uvGU2=a~2qUvHm`Ez$K+_3)ipRpmcTG364zCXyAz*Pb+A`q05UwT0F&}U%&vmwUsDze ztSme|0LEAv;J>H z-_vHESUsrI^;TwFYO>5$hKRfqaQxC$I zdc_x9k1xXs`R*Nuv~Cyk-iC5s;Ms9O%2@ft@!UFmB0ClE2Vr;>Eu?`s8yaPL0|p zer6^wtzS^~QOo>mcwpL__fH$0Ja^7H=wcgX;)Om|j~G#*gA@o>p~dy#W-p$OlcKu> zM^f3JjM-6ieO!_QJ#)6&eB9<=e(}2GC;T$;;*b85d&O96%p{ym!4n~d1u=8r2!4tz zH-g@tRDaxZ{jg`xW4CGP6fF)NuqpF7~Q^l~!K zQDWjnZyq|ic;h!l?BWtaYje;cc!tqUiVl$+V|vsfqgCJOyIJemTvYrNN z1hZJ*$o%L;@FCyj1^LMFBHLgwbQ9<&hYaV!?_9!29-f`zKqH*e9xO8SH~>GwveP$I zoj1Sp!R4P6s6Etsk8ZrQ-ysuRhO=Sde7oTBm}XMvCitBDR9V|aBcTxQvBl*(N$nnm z8ZS}f8ydxIlNB8~#!Y2DY@u(~=c#&zbL7yw*1pD?ilEdOxU#A2MKV6xo8sZ3&IE&^`X7BCRI7h zr^d;vo6^SJeZOd#?!W#J$UpqNn?E<{7Q9X~-EE-TPGTPZg`aA9%XD=){<4x?w|?%E z$6RG3KMw#u1#c&+{WVV)TmB>uM?@nvDfZbMZo+Uo)%M(v*pcgqj!c_Yyq>dzbD$CQ ziGDXizbRKm0NPaHLO_2Us^NcY$4}u@UrznGu=-zr-beOgGu);KEqI2}P4oKg){f4F z=tc3&>YO(ISp45q{lk3C@nqv`1#0gxzSA2{?ba*e5-}Av+Z(~_w9(Cz=|;vPAq>6) zJgv)_?mM#F=UidO?M0eL8E(3<=O=Lz3l4xq{Qdy)Px>p|0K+^@v#RwH-#1s&ny|U1 z>4oz+uqHXs2qD(>iv4~XPqrOCtnGiZd{zfNGOpV|OWZ4ejTu>-dcS?H`{h&-!jpeI zAD!d0dHX8$?T=5|Yx^q>?f0jd$9?PWsuDfRQzl-r)W&Jfd{n>+U?cyuqNvA3~F7uRac#<->h-To2~HHE-|Q>f?K^DVyb! zYrI^-QP*-ctqGfJn!kr|ttlU`ep~Y;-kS0ub*%F^8fCwf?GXDYUOfmVtR|zctIhA~ z%svz$FY1ap571{tcXe{NgKqurii74!eZ(^2Jb>U$GTr+gEPNwruPe(LZoGa5y9t|| znbul)VSZf4AV`1K*=tIl%!V|3rfnQB%ZK0Tc>HV|FIPt_vwWBb_ZCt=Sf{csrS8hO zAI?@8#ueRfRYWha&4EniqqBx(#d=KYFqV_>oVJu7oSsd_VcI2l^d-LxV#M%Z=@!;2mu0f7~D+Z`j4X4Y({DS7we1Rz)ND_#qMwU~@k% zKEt)z&Rluwb|h!P)=8rTmOg*C0?(8g8qrH(REJwH6N$CBNg)PuE;lJHg{O%>zcZX~}qTD4w z=n{M@=#suj8c8}m6E;fcli5FFUO#;K)Z1h3Soo;qOM0laCSLrT<5Q|@ltxb4dUl_U z)9EqGZRN`D>W@#yuK4S_^WQPcP4Gg8*v-+C;r!M#!ulftT`v3JIeD3>Bo14byLq6W zGFt?o%`@ilNuetF4Sk9kGgj1{*HdlzdarKdSJw9%=yo!gF6B<}cuX_)KCUQwmbP}q ze7yD%`^@aiefR~>=m_=^;LZr%edsKaInigq61^X^NjhImy)P{5t^zy%Dg52W|J-W2 zQ^0n8O}Yf1Mid@WdOr-G1mNDa5H5YwmEVn^%Uhp5+3A>fba!>rigSv+Rg|F9x+&{&>H;pbAy4&&f{?`Nt%<_>uSsq@Q2shTA-CX&s4vO?L_sTvu z4twR38=uxzD6f3h7Uy%zw=aURe_)?~h5o&qV>0iZq8ipg`uJ!O{D~_9(B_5$?zdJL z;J?4km+#ZL%PUV$s@(UUtz>-1aJ&aq@C>7yGJh;KBN7d`9|H3RNuF$g`&e-ng&((~ z;(Uy9AVL<;W(o5uJKOZdztCN_Ws2^9{_X3{IW(K-`pbSjxs!qPw1?5hMN5!B(=7tf zE(D~VM{{n0+Wh4^{?Txj?_}wFkw%Ws1dqowWAeq_|L*XGTQH{JUSju59!Bg75Pqnw zQvB%Ze|ijQ(*1`Vnesog(*t$%H^)`HAB1=Ujo8jp`oBKko-JH@tn{bm;t}7RUwR7O zlgEKI#{pAc)bg4L!g~WFLa!^#YPm*cpO+O99SFr(j9L~UGel~trWSJ=_+tw zZRm^MzOcv~Z=4y+Of)`q_5?Te`!d>IobdLs5Jy|5SAyrh#xI_}tU`f$QCBMm*0jEG-#{+_^+cab1}<95D68Ip1;Zzd8GBp7A))(Kygi^o8w~ z*LHO@>G0?=IbiCG>EF?wSEo*Kj~7Aa>}Y%KTt}0DwM&ory%pt=-(s7_)2kFmJiSWs z!gFQjfTu4hzIghQ;)UnR%mGhdQhf3BCB+NRm6-#%_S@znI=?UIbxh!!W%z!8rU<}( z-o($G``vaPgY^OU5|H9w?rRj9@KJWniSK>zb ztG@D0pFO%z_3Qo64)>nAIRA!Yos(IFzk;_D)&8>3J#usz55IB(>vYUB=rHf$>Qi5+ zPTl18>t36-+vSua8lgk*4mS0losKb+C&w%vx1Dz1&!TbZ{4nWYcx&(7_et!z!Pq_d z07E)D;a~7JQv1t7$LK_jCTTGzlG(1T$?-3BY)u>PnWkhBxSlFwe>iPJnq-~TMR}IT zfg}e!eMz6^_Vgtw8lEEq2TXm*5TwJPq&*T_CoB_A_otg}3k~<|@T@SlF}i-_k_Mu9 zWxb#%$R+Z)~~P}kO+_S*}${`I&|zIS?VoSWwN*Mc`$ znd~3Z;SNObDY`W!8cBo$GTiVLO~z=Y49DBsomM2G)75x#cDm-hTcCQKbJ(1d4;*^# zI}4ms^Mo$Jw~?;#!FaV!R+I0$&2&53^Xjex)@1*^qw&_Gr)3VTOYJe=W_9X|H;>q| zysYmbJbg(?fTu4hUU;s|9Psod#TQRsQoQh7nK`ho=}YFfaQbOxU(I|rdX_;yNo}SI};rCu1e>zSH zo8{BiwNA54`OLEw_4Ldz9fu1YmlCghI&RsJvURb)Mm;oj(R|Ltb?KjZ>sgt&SrCQcdTdY0hLJd^8L#i1Z}qQ!ir#bsr_ zku_M|DvkI9*k@N34Mw8Dc)f2#)H*rA-F0Io7gfa*{!m$j7d=n6e7H4Qr*k>zBz;8y z+7@6kpbnd`W*u|alYOo(RQLbkwsQ*4SvYw%1HcHKf_Jc~|5nh6+o>i810dAOK$FlP?|InaZWQ)T7^-R69NPf46UNTjx2`41NpVNj3G~e(!-jj;Yu1?dxW-0JhLS zD3P812{#t1_v*fy|J#Ef{W{c*FY+RI7oD_PL4S(6Ch`K>(@QDI{|4kF^v?(VG$QYr z?%TTfzMCp{UC_zhH7MUeZLLhaoe=(<`>kwc9E)4mqPSjtL?j$9#wxSDq&y2@B>y4P zTh8AzGXT_`Egfkk{=C-ApBT7vt@oeEwX&(?duu1X$ul79bZ<~Bt zz$d5Q;zRF6@D4WhpKM=-*VW>hyc+bK{2`yySTx-ZRAEK&$$~#LE{GnJoyZ^z^hux8 z7adim^?5rI?$p;QK6oyV18b54>#E*twI-S5<>hg};J~`re>7gfeq=joww30y8INN{ z8gHG{;e+?zG6#My`ocFg^}~ENx#8)H$r10lB@PTi0DU~ebbI%2ww|lw@l~GyL@y1 z?kgWYcw?6i^0gEADtH&2wAxCi6&TA^s#x45bZxZb{BDtVpt2q1{0U{2?<+=k>$psK z@%Lky=OlBi7Nuo&IeHL%MQp>FK&GHn{cW- zmKx? z%Qm(3Oz04un~09WxLfW!jA@^Bz_l9|o!sMX$w$_mOuYDKqyr~_OyX*0D1;gu6}zv@ zAB|b4$`c{^&T}>rka}^z6(3I z%lz7B{;}~}-kGzvh!Z5y4QMWBauZxMj`WU7Zx=<)8z zh1-q~+mYRH3~l1YKS@v1@=DzWuN9b1&%`+`)3fsVA8vbO?h8%YCllW~dQt_Z)3Y4( zkT1fYOzq{yWlsekt=njn(JeXqa-}a-)OJ#R@h|*sydlNkGsm93 zFL~J>;}QK`>`a^alW@&=uU0hQ)iWLkR+R&dNI>*`$c?Fa2FiBB)z>KQhg>p3sY51y ze@Dr)J=Fa_9r)-`H=lpSPYHOyaK8ulYYN^*YJX#`aKMUM(ekQlE073TQQy%CD`8>Z zYw|3Y;dSw-Rbz$f?Gqc_-LR6xEI5R|g$8{?h8EcKOY^Yl@!KDt>{j+-54D&7^wTze zc=F0iw{TL}2^Q%Syre7ksL0faZ+JLR5y78(x@Bd|S6m$o1xAjksE(r3!mx7zLdSr) z2A^A)mJehLj-v;C#SfJ+Izgv9VMW6ii*WQfn%u$dI!8_R0e`+?%CoCJA2$x18 zwfgKWwWAY#uen}YG>|b!slXLv!yZFKBnKp2srSfS*l4(&g zl@D=Tt6{H6+9F1huwoOpz8k&2JK-UtpK0{R=c6C`&EJMjC|$YVyEnU)68X!1rr=F} zI^Ug?MJ@Z3LSJQV0P{_p;r8Kcv-pVOGB-jla*}JgF`Qm!nlyROt>-{4<&#UQW*M5# zk_PeAVb;g8-m3Rsnu{m#*EhSp%BL-Sld_=A8btaoEH}?M99SLYBYe+=$E**jODr44 zll~2ywrNdT66g11w^Tlv_|qJYI>528^dB>Y6W(R>lQ5o*bqp|SRp*(S<8^a*o$m}o z{b9LsUdiiUfC-v0%ZF|Cs+de=!ZgWymVxvMBoBtq6i58mciSu<@`L=6c7S7E@|Mr5 zT6RdnGp*!+Sw8EsEcd{>>vQj|WJQMzuCMzqYhj!`pmR^v^|}`x3_LM%_5`<~pnh?j zEO_%JopCa59;mVcxk8$Z? z9ZGrxpP8N`{nP!is%Wq_J}gp|;78HU06sHKOrt&ISeJde^=FgLOwaln1YehR8cl1{ zabo?x{&l%o_I!4^;hSId-q(F^J*MoUeOxw>m-*nR;9Ydma^#p-7OQYlgl?Dxs+!vVUomqj%GPv>UFaL+tEWWJNCWVrVw7-gJADx$c(M-== zE0n%9_1p}@c%Eq+2L>RTK7J*iw*)lzOu7 z?7y(SlQQ&p-5j^t58qt*bVn94pUrY0u#BWk#0JVUtC0h>V6?5;((Pu}cPI~9%z2H>e z+~4`0Bi|l&9@`cgmPcp&3*JU*f6h2=lvRUILyG;_Op9%z)BT|!mhZ8rzbq08R@D#m zVO>8I@dtdx<>mIIMR~R5TmFZqkzI)2+!+EE+vf;yi`OHY8bQIfyp4`tc2yeS7F18{l<9B6I%kbmSO^@?pjfxMM^ zOXn}$o>?^xw6=V5&5h+{8oj*qax}xqvmRb>>zl2w%Qw8;^0@5w+dm&teC&z!)EgS| za0C1c-bQMF&bX{J7@k&wFEjBuDQ{8XV~nS>IJi+btVN>K!6D=F{{Kp+hjY5@YYaF< zskg^0od~CT>+Ku%N?f@i@>D2lV-z1%{roeKqIL9=iFjgLi#k%wv+S zBd1-Ii5LIe=5w0Pn>8WiiS)`~790KdhdbclKr*|GUV&hk^8Q-;v<$1hhYgzBInzJg!Ir`=XrF zx%ll6!Z$+E^?5HXi8eV|Z)9qdB{8pF5l-Z0oAbYHr^U2}mu1_xZ#fGMp6ziU8wYZg zQR$~hTDiny7#$ebj3@rm_mT8XTaTx^C0wpJ3Ex&*&qsGNJw6N0v|Gwg!kg)|6mM1h z^*mQ49WSoO0gnS72RsgV9Pl{calqq%#{rK69tS)QcpUIJ;Bmm?fX4xk10DxF4tN~! zIN))>$hz2%=$H#coK%T?$+}WKi0*}qd6n->94ybe6BbN-&R}CM|U$l zJ`2vYTa%xjj>MDn+s0 zSA_s?Ewd#~wa!16@-b6nd9ge^{V_Sy{?BbGAC^t;_9w+lF#`v3DIf1%i42TeLnv>* z-5O%Fm(4oIfpxVn)e_yhKi%fD6qJq^Tx)GfLu|%3_c!W(^f#Z0GmRO>e9jhL!ip_n z`79tf+9tiknQ@70tI0L3T*74wlj%KLLvyyYTa%6#*5iQ30gnS72RsgV9Pl{calqq% z#{rK69tS)QcpUIJ;Bmm?fX4xk10DxF4tN~!IIu2pU`?O*)Esa0wHmqwxCX?#7u#Ngf^P|@`+M%p9B6I%NGehWwAmKuM*LdB z>HeNOGY9g)OtXI5i5=E8Xf|1cc{P`n#|MWq`hD|#k4eA(xNujc0tlA>mQs(6?0m>_ z+>gA+oeyug;o!n^?)}cu(o%dB!~2f~Z}Qu@|G1=LROtwREMDf1SC{#tG2A;}o~Wv_ zVzJ4Ikd5Fq$O94C?62lQUatcz0Q3MngfLeE?g88dxC{_=?K5Fd1so0-}jx9J&eY%Ss$EEA9d4Ksl=y%0cJ4UxC-R$oJ^2%(2MSlfv zzD2J3TOOQA^=k1RbLzu>0QPsE18fC&7GOa+q#2rqXUg&wfLg$K2=8IA`F2A9^m`9L zxum-vfTqf^GX7IfskiI9X#@jAUX~m3!up!&4IeDb_G6ZdJvDk+82~L}@T?jfw=Ukgu{f;E!7f<4+G{`?3j8jYvc2 zn|*wDyNru~ld`6a%tj^r*uHyR4yXD@=WmOnH@0^D$I=;`2N}cr1%X{^O|I@F2x9?^56mGGfTZvAGKif;eyU8XkN8d(S zHIZn2vA?R?@{P5o`$IwS4a_Wygo0J|1AQZFz+yX&c`v=x?fv0fnoPB2$2ABdd{-xC ze=nvMdUMhEETNy?%_y1L^7v z=@GopBX(|d6~*eqRpnLDU~Sxu*Z^Dj)#s$_^)92Fe*eeUyl`{P7wm7)kgkpKFL)cN z{W)}vw&F7)(P=)ri!{t1_g9WBwbev5AgttnO%C}lIen|kyZpKLpi8JgFwB25{0rVj zYJchZ+gV3LrB--KyxI<>>p}mCEx-Sw=bl+IX0HohG~ZwFTGqBRJ%984eU;&W72Rh5 zO>wm!9l%+LCH$C|13kMOvgx70F1vL$`62l1^rZ14O<;982Kig&%MsR9o8CC4%T$vu zg3nGz6TT!X23>C!G%BqoEl~b2x0vx_{?;bk2}KVgpUOU0SQmB0#3+ABttpbr*emKGj4l4lgcdsJpg<= z_D@(B5%0VK9G+>G1G@h7nVeldn8<@C4~o8V{`8}F;vfsg;eTEd?_g8^PQ5b1idR*m zWj#4z#o}YFSR@gxvg{$KEinjg$_e|9EX&pyy}WgIYtrz-X6Arizs)n`r0 z@H(q1;dFG_f7Ru8(3JFk6!T_XFcE{Eakt#ZA&oj{Ozkb(&v}u@QA~Z>T09I}%Ev%^kE@vjx<09?>Gdv~ zPL2y#0#3Sk=Im;JPc`c2e_Y$WSAf%Vwqbd)T^78HPFjvWmHO)=iMTJ>JQqh2;ka*P zcuXR0MQb9l_$YrcJR<6cBDqGV>l%YDbABVgs;Bz?o~i-!MvuGcF%HCFgf785*wlY! zx+)@Ze~9ftv$QoL3DK`X)6)56(ls~GQ~COAJz&GDx*jmD%*k8m5`2mx$K}vf8MAB_ zVZPKM$v@2sldchw=vb>Z5{*OI2l_??!@*d!6<~MJ)_$cHYxEU{veQ>Gxu+V~uXN4@ z|2zGchuuj*p-=Fc=^GZQO4L~4cxl9s{Ev~<^e6u+e6`&LPLq~!RIqb~n!LM;LaW$_~g=FK&GHn~bu<^$RM0*?PAZLVSQB z-@4#m@HSHWlbMss7-lAXMVQ;KjSH?Q9GFlODv8&Gh_OSYjqB@b)A=Lw=j=$ozs;9u z#g*!H;8mAImwnLxaW_xW(-rgx-bE*^il{#v3t`^ICsd?nqy#h0iUubKt88JDi2dQv z#|Qi4In&y_*`7)K*4nH;IV9)2DEkHkwt>V;-3q5?TFHSS2(OnT%aHTVG`aA#4&kJJ z?{ji`{h4W=bZPkUr4J_hme?8K&*{f>QYK#f9sMo0;>D53w4goqu)R$Aqnu}=SJ&sc z27Q_Oztbj`j{4hSelCyM#z`|znRxNns^JmEWpvcJk2UNgxZ zST`b~@T(-6&aWXu3+#2od0345_Qxl?EvoFT9)4reb_b1{HGtz}8uE+%2f^D&?XMhD zp@BpQt(&hn5{_G#|3NKWHLa-X3B>&j|s-C`ynqR;4;=Yld zs^7VP`RVA{B4Ir7iOpTfGH z>X93J+_mzAEB}Ti1KaRDn7`m%bkdT-a3;%Qz7l_I%ycU{nFDcjT!M9$!-`pmA$+Kd zr})5fGW%6b{Id6YF1-KKvNxXo(2;1;(+4ZLf@c`rm~><$0uglm%1>nH#~|=yn=8K< zx!>Fi=bHQwyiNn%CLQVgDE8OZ>Rd^m-<%D4XheQ9@#X9@PdIhl9gKI8C*?%&8VR=3kyEGRI4)?-U>|oR^c{N! zoaLmkSQ?32c7;UQjX6P;S#J(PYK}yt=a42}b?JPBrrCP7taxKp@Z|GD7lZ!jec^-u z`ADMhU02V>Avw}7`1I7VufSfp@eK>cs!$d9Cxxt{P$=T`F=UODaT-A!p^?GT@De3Yn?ZkjX zmHK(yf|DCT_tU#o%(>v_{8whU^WUO>f){$kmU>`6hZ={r3V&?cumng!D_a@!m7x(n zqBdbiG38j&SrwZ@AdUeDT(_r99Oqxjdr$tsgdB}t-&LQMU0xPKo`&pqaq!{`yH=R; zB6u^~T;zqa;>n50xsLU$*DHNb&)%-DgdA;u>m~1>ch<4tz1-K3dPVT&+Z9J@Y9s8Y zqwa7jmD1v}Vt+Wmoeh?=SXY7;6CG%K?$2z`xo1@J($j9hgY*|0K{xA$A^>gH7aUvb z`$bNeG5D#^yWMjz>7}8K*>)v(8>#)JWVUpxWevxY?Ui@X= ze|W$t%ko+)6e_N^s-|JCGFoK!(Mp3gL2Q{pW8o`_V7Au^Iej;#(Et$o${JcOugkAG z{Dy75-l4}I7#W6k9{vSyBelPxL_9J%7z)|zc%{Ku+&6qW+D;i}rL~_8XJxMsmw>)U z>;Cb`Wphf#ui!uo<~RWRe}cD>+Fvq%jIki=Wl^gt7~?eZWGhQstaO4?G ze%PIlem4B>H_maz#oh;;hkwDFBqZf!cwIc|uZlxFYR1e6TLI{{6$;q1|IDKiAbPX- zymUIu`IWh#vuc~Kx4v%WW-k=E0>FL~~V3Cx!M&?4l`Xr?AjvIgJ%E=?HpmzU#X9+?u+n zHDT99Ui_YEo`;tcJ#V}uyPnrx)Lq?v;kDb{`^05iKJaWmn=PW}f;V|3n(A}f?N;jf zurZ^Y)f8t1AC-=$-zJB1dv2?awl!XERC%FRHwWsFf#~=A+3EUi&c~9LjV}6Y-5h9{snI%wZGK(+UKtg`uzM5f!>XX$b4n}K#Q_U&gSHicg-36FcFgBaj@&mvIt1S=9qHpnXH|}aS!Xp|qcVo=Kv;MVPOdNW z$71-rB_Qu&_cq-OI#N5N>jd3wlL?$(lxMC75i*4ZI-`-WOiMR{7hCr;-MNG@<9N@% zKMpL!D@i-l_u6zlH^-C9Q4j2U>$sPnm~+}IEIl=2J}gLzwG98 zz0b5i`T3(_Pk;P=;Dnvr_hPvhqVxrCzOFs)#MVsgq#Yj&2O=|Kz7)#c%_>`he50}0 zJKY)+4%Igqm-5_$8_`iNg1}u2_Y26VE9@s=b8K=Jzz^U$_|5>1F}a4x^)tG;?$2k+ zE27zbZn`rW`g^>BE$^fFE${IQc01vn&E#zz@;fOL zFaB-Vx8TlG&yl_!Zb^S;E$5j4!;=p3yX?RQk z`{{zWk=kDwJ|>NqL_z^>WFHx>O~jprul?LG`nuoZyVL8LiJv+9MJGh^)#rOZ^ZB5= zx~tkpU%mey+f?5hbHDpP$IV~xTGqC+44>EY^a13JkK)k($H3d6z@cWC74p~bn|Xbh z>`3LlB*S(=+YB0sXsyYwka6$Y9bbJo=*zLMAzTDZ)UF1aYCP^*H31kLGU-@flAuBY$hjxZ?+MLPe z*IXRpc~;U+fIa}KDCeW7FP>SyIiTxr-Tmq94C_wTqZ3hSPTy$2UH##I{fx$F{=)c< zJV%a3`jdipu&MuKe=>FILh=BUa{IVC?8T4P;Fy!DX;u_xw;(FpJ$+t}sp)+fwtu-A znJ47A(nB6f)lW>%obM`ppu76NzF+OKTf=KljCV7T_Y=ICZ}R=p_l=nIT}N1Pn*njm zbMbwf)KmKV>25PW^H~quoZF1!J$oEj*Epc>KkoZzx*nVJTg##6-~DsaJ-tsj{>T0Q z@QD4YqQ`>g~Wdk{ScE!9qC!G>x3@i2wopwII`~8x_+xCv+MUF z=>I31?EUm5J+|EJ`0PZ0P-*NcZ#d;eYwI)`B{Ise1vq8I_Cr94B!uj_(Na&sYpQ)A$DHjHWq#U|`V$u_Xa{ZtGluq|+L^5rJjC za?w-i{ClhaWqc2s@^v$fUc*7tc6zQP8BL zE%h<$5K_)Mm~}7fT(&3t7N8$sR{-hc+QwkO2mrrJIuTF+`jdJixY4aER76rIpe`~WD#gxPpB6t6+iF92cZg0R;>*r_1w zauBvNHlL5gWb9@;;;aoQTd%!wCgK4~?QuBn?i;DpGZjd0l2VVKtkhFyD|Is}n!nEj zyrk42Un=!V&pcIeSe|;aHc#zxN1l55t30*Gp`Fxsb2_Q5^E#`~XLeQ_=66vu@93gl ztKLBEI&4FA(9o`GR&~CLKi*B9RI;&pyT_*LnH>w%O&9b~_m%Zl)~qemB}2DXZ(Xsy z+Uv@l)TonoR~4J>qZ0obq+WctNKp<@#P+!$4d9K)OUd)u<)!ZRp6awy_IUlxHwWMQ z_Y=Pd2bIDr+43TI;&hWHFQ$+npf0bATF8IyTRqigOU8V-&3B1!|F``Ob~d}?pYker zJ#V_x^0(y`Ti9YaD#VajosJ0$v-4r`J3ZCydw(!+;ddwBv+(?z>@4@hKj{#>jnw{{ z(lHjt58+T)gOJ&XBjqvc#dJE%b-HDs^Y9+GJ^Jlg+YPyv2Q$K)10WrOw~^Xkmi3pi zXoNRkVgZqhFm9Yilrrg&`CBf_kSgjZ`%Uamv2O*{vHMqIv#%uv>SY^SU^F+w5+~q# z*_Oo7am~5)bejwFd&TSWGXJIQ^3vz;-PJ$dfB4~79{6ql{_cdh$cx}jK4p;?N=Zdz zv{i@eQ?dB$#5Co_OfS>3lpo8SazjA1YuEqmbF;6_XZAbUXQ%8@?sOTU4CZR|c)7;; zy@YGTi%9)4;pOb|lK);$weQVGe%bxOM|Qiqzrz8k=LB!^#W_FJ?KWZ$Ko~WOk4La2 z_XXhewNd^$yFQd&r4MJ(au^pwzd@rGd`?3|L?uV9%<4i`1YZ%!e2Xv zr=3vh#P@(w^$B&8AI0ea?wf7r2B8-GUc-#cn^k zArnYc=X2jh+3B72VNbQ;jEnMKoiK2@)CWSZ;Dt`H+fJ`7!AB>ogndZ9!DglNc~J{= z_y4G;y3_xD(UyI-y~m_m@ItTH?MAo5<}^OfdNn(r7k=DRb=tMG_kRZ+`uLqLLBeOj z3!P%OhTbGoDJe2a{;|3{GUaHc&=zkvAGwAp$*#$BI`USBSME4zG^z1dwY%^Uw^!3);2 zrhEzB#R(2#rj9ao~E16Qg?B@L6G`Hucv_aOgnHuZ@;hk zS9ZBt3Ay|2xi>fHRT+NBlq#mCPbP;u*0WwuEq^b&Je9rMUA?&C#?!x= z{_8;%Mm;5X^X+n!r&N`MUQ|WIS!J=uV@<0lJBv(mrPn)pKZ$h|=SWyLv2R5`y1n`d zOju1uucwAA$u3uo?{`<*zOwtI=mEptGv!L~CYkLcSIO>FlXW`g=gE`F^|kk`%hU1} zf z&Hhh!HM8=yC5N4MaM+Y5!JDM4sys=J@5zzL*^c$B_e*Cj%PvRDAZIVVbwankEB|=? zGx^SYNWCO@^X+n!Bcos1V)c|${iM@k)>W*Fq<_l2QtYR)&LWOs-EKEro@omQ^!9G? zXW8Xy(5Ky1<*z*&{_y-ye>CMv@ForIBv(>RdGcg3xPv|G^3?y!?D910^X}@XaCG~k z*N(eBub=ZGQcnrqe7zjyDSdHGx~1t;dv?-hyC?l4dg^YWL+Tvb(odqzJ{0RBy4jBs zH*JE%gVQ#|V%IdTA{?o#5vddBb<=xdz{oefH(#N-s+|u8nN$MrRo0PUjj*|N= zS{~jtkt;LbmYykJB5N|f;~przj$+-#X9)|ZU1!nG#W3FbYV`K*nxC@ERo%DU)fT6{ zz5ka#?!2ifSAsYB*iLeltf(4MSo(fUGryLeMMl_udGgc}w_5LSmXGke^(lEVRtE>n z@?jp*zgr#od1{h6{vO>ISFniUStw4z+sPz?wu`40Fc zJ>LNQ1_D+BPP%yJ?Af5}_7@j#IimFc_T^k44P}V=3f@L)e@?!*n0>lG<{O>B^-XkH zF>HzECkoB>v%U6LW8zwLHX?74k42CVmUj_=wKmiQYn77Mg0=Ii%wdjteQx)-dE<2PV-L+ zStDzpRKD@iVBGSRL&?*=(_7GqU&uT8uRsCHxm$I=byvTf|M!b$U)odcx%UyO&&@aX znz_G|h2$@I2b=oOlE3yUh8(0bc+P#enB3zzV>z zsCX6v4#(hm0pKVsOnd-17wawiV}Sh~U;!2^Zo)@ymu#ZcWmsUv@w;jVI0E`uO@hwf*D3FU?c0ckQH} z+NYB$JgJlFI=hql=GjiF@2{QI=ZADw_nqEZz5BP$YH{x_YWrXpHSpOk>c(9*P(RMz zKz-VIL$zJQhHAowUDf0{UDdAp<*Prum#?nBvYQGYyOBCzz{YCu7MrM#3O7~vZr9zG z1BjUYU1_F%LaMae$HjRN6qkL51Bys-9)y6Rck2r{Jd=?FtXQSKo86_ru7`_&gDNG@ zxR}tnK%KEvUAz!>k0Ga?bp016^eTg_({zHaus#vIgH8QA?RD~NCDgSwwUHRAlRy$T z!XFGJqSjb^1sj3HJEj&E>1xY&<51OBo#R1SUFhZ~-?t7#osh|#p9!hqp48lQUT8e8 z?#BjXAmurrYkGN7Cs16f&yMJSz4P*3g&P#8KY#b?H(w@(9@ZcA7|jn*AeN`#9c=2~ zEYD;qI>)c55(H)b!pBpXDa=R+RC7FaLZtr>!lRxJn-A)9OD0==Lz$NPfossH{_Qnr zrb{;=mpl;6HfC7!S;BdCiUSRBihM3J{=vkPp>r{EoI z>R-+=+0S=GZNl!oRMv)Y9yRvd#?hoIQ?3~EQ#bmduARx64W!UrmtSDZNfB@)i{*}P zMOwf0w$c~sdxc(MG~1AFQg7lNU!}6r?Xy4ADveZ48;>uutN8n{_Z#lH&42UpN8WD}qS(169|bRTh@GNGT)wf)J6hq7O|!qg zNPe_CCW6XZr{@~b!(560vLipxc!~0uOb?pGR2DG;8k?tV~H9ZSs)Sgc5TtdP5EPwLyN(Kx0gIIV50&R z?|kc%vupo3{>_~oiVj3ViP9$b_dK@tKUoZ_Yncob?5#%gvG=>GdDmoymZ@Jy8c9bJvrNkgLA0R|Ia|uVnG= ztQ=uPZUpaOQ~$Zh4eJ}sgH>^(F{Z+7GX%oWTz!*DJ+muQIcKUH7&}u~JynsNOt_Zf z>T$#^bVyvW>EE1N;_9{;R?=k{aWjk=&V1JOjB&+ZY{BuFLksr9sk5Hx*c_M(@}%F_ zzju0j!1*rrBL<-3`1800C(r6xpfH^ar!u;Bk|$RA(xfW(D0htc)fFCm3`Ju5l;MY5^IED>3WW-rZsAGIhTwx z;lyu!v*+Q3MULignJ!1{uj~EM#gMc9+Ya9A)qeZ!Q0_8HoMrFTkd#k$v$rOwXoT)3*MxvJXlj3vWoq?t1ta{nOI<}m7(#!@3U(~kgeChjSC%c_0dmrJhxc4=Nf90_iT@IKY{`FgzAX)P1f^|Mq*fQv)6mbAL*m(d3f$M#{pfBWUeh9vKI-2lfoD~gDu6I?r5ee$!0ZHFX zuQ|LKF4yPwPA}Jd*R^nsAUIji?vO68vX5fkzDj-j zZem_5<}0=Q)1dqVxkV*rIY+5PiYEEP0kmwRtr=tD)mAh$es*7KWEiiE6`+75t+#U} z{ZjnTM0dk6J=DNgPrduLey5%J8b7dyVYNa23*JU*f32b$@#X?V9+tO2&%EP%sPfl; zo_gPNkB!bNbTSos1h0`|JDaD6Vo)I*91)Gwq?l)OS7S6%ng$-eXI(gxeGD4mtKc1M>c4q9k&DCv2(`fJ>JPxey95D5zBlE+pTI@EtEp$r!w#4<~cpM-H1_1PaCvj|B zq@CfjZuEZBvi;NhBMo02;M`OG^M>l^l6ki`{HH)Y_Ua>r(NVA5+2w7g1Il#SjtX8+ zo9<*gI=l|^C+I3+Z8hYqz+l^nH6@DkM+3--~|R zx&b`h5l*cgJ5%|vOt?nN^;!bQT$Duu{RH5&-LyTkdN^S2V_+F@FDHi;vi8B8MUTWL z&NChd)^`q=`ont7)1UQSD!lj4l>@U8Q0Ber4rqB^f8y@pZ%;Y-Urp9I1aIamvs>~p zA`a*aB(T#NlbT%T@Q21)RTl11k_k+mp1B97`n_!T%=Js=_4Yn9_TI}kcgZep#&$Tg zmV$TDNh=FI!>o|Mo)d+Y;p$+(-DlW{1T*z-lL@xL(OerYc(L1%^m-S?99NNd1bl*+ z(KHtxQ>7V=S^n&owNySW`De_?L$-+neG!ZL*?8;6mo7woQF6m|&wah&$V1t8=Gdme z_2)Xyvcc)~iMbxtr&FQY0b3y(XO1qnlo@*#K|sr_l|l@-<4)f(WcWi%2B;U;SPiyz!WjjxZU`$Ngemh$RI zH12a3_$o&_iOqv0?evnvv(vfw$O85HZ5!YE{CUw)!zgSpLZ{#zZ0bLEI>)4a#^K9I zZBw}~LRKV&<6F)1To@y%C(G#r95&Igck{#9z1RM_^kidGNUl zfN6?NH-Y^h;&?UzZO?RU4(RR1;<4%L@f_kz2FUkYCF2UzpY};?J#V{XhMe8oc`wm( z!JBW}NM%Oh7OPsjPH1)J3uHYmr@n#z0XNGlhO3^6(g4fd#oNhN4o?$Zi z5huVf@(y$hp0@rD^z%%|;Xo#RVVlD3j~wz7_^g+sxPfj`w)8ViCLF_u!eEG^I77Uc=K6k5ZmqWbR6p??H8Qrv{{AqK|ns|<>Y4mb;Fq!{z4VO9g`iX7CYs)-pU3vC-uUW?w zsQg3s-n#14owmMxZ--wjPtNxW-od8+vyF#G20~W$SzgSWA}OJ-PenR?=J)i=Pb^T6 zf4$|EC%*N_0fQ+-FdWm9KEc~a?aw`jG;P=4_#i$qnGy4q_@jXlT(*dfNQ5Q_F-IN1 zc)i@Jii87_#B4Z(zPX@}GFSwl&Aj#bge4pGQ2vIuDwozBbk7P3I*iaKcn6#M&qg2j zEP^bnG9C;CXWHLvnLj)-5bw-wxsdn&ChZtuY?}Krzmk;#buSgjLbU9 ziiWL_eKs^h&H@Nu=C?q{qN)P*>7h5gSp4-*+n&+W$w%lAyn{{sH%mt)K5a@;k^Y_Q zl2fwtgQ>qa^4@I^c(il?^QWPmhkwD_NbN5x9S%>%vScL65L9gBi=3M%_}191t>+}X z*saN{xv+X#y1TjXI-cRpIOemo5fV?2V}_M5v?bgIaJwpI<0#%tlQ!{m)8_bwIB9d> z^h^ilK&JlpnkHA5Ki!>)j$Hh8Ih8a-j&(o5Nt(K!$g>$=p6O4}jUHdp7Jtd3xo6@f z4AT*}g!k-@!GRKxVYWAJ6Kj_lk2B1r>>3fsOs6ex$h-)Y8IeDcUE=9xeJo)lyx0;J zLF_ORme1?6DZ|T~<<+ZZ;X2gE7mS-=T7?lY5D|Z-IR0_>AR2 zV0%lPw7bkkFJnA5F%l+6lA6R{pAkdAbhEsLALKjBgnb+C*J8P`Y-kIPJf~aAjd2); z{UG`=zF9sD8smh%0t>0GjHO>WQr$#x!RHjZE>^S5_hiYc;VJO2O3dG zrv9wya^qQ1(jQy%9O&3Nn*D)}O6}^D8IGMf#+JT0^YZGKjw%Ujmo86VoVg}XU)HW1 zt}D5F`r_%!x+1F`flg0fJbmd1a=5P0pr3DDcV=pzA?GyB^Q}uZC{&ZWzH;@wZq?gQB{R&M(^TogV zU-RT#gA(^}J{gMyF%QIq7s*@ShBj@BJD6i&GOT z2F<+jNV;i+4ioSAHl5s z4ihi_S@|&{>aTGbqSLYL+;o1hufzR918`W_+hdkaWZG|D_VpjnANBAzvd4gQYyhqZ zo?&!j(jokSBE{nVa20t$Bl=_RgLmH33B!N$Ipwo@T>AGMb?3FrpUrB*>M8q?Iv>bX673 zz>b%r9z;zk=`?8cU1QM4o-yf|jgI4E`|fo)oNDgf(~kPB->2`a{;Klt#$hi~zfq%ZlKc=0#Oi?46R@R12C8dtbShI!Y?Tzz zX(w_c5;oWMNDIePo>}`G(A$fKi(2kaR0O(@uXuY@smKlOJV=h<%{Q`#!NZ37Dr*C1 zDBTW?dlc$0f80L__f|2EuIKYEPL0ngmzmB%oi=gHtG@np>D`i_Lr*7V;>Ew*nqr^% z&y!foLjE|e%c=1R0luO@pt8n4%8EyWRZfgda?AcG+j2*TCFRs}bNEz9$Hj1F*i2ze z9G_c?mnqKg5vSL8C6}bji+P_n-+%JQU)*ri!kP=K*a?CmAGgN8;BBP#XV!PTu56eU zx8x|_@RX26+*m7C8wukAv*1iyjvJANwCBq}7xO6s(9Tp3zxLSEd)@N-@fX6|HVntm zCf-KlFFReOk;t?}Z8=)=bm~B*eL81)e`D6A>3lQ4w`HD#9tkXbV&BJaxWy%a^z{aP zf_KqLD?5EnDJzTO6W2N`CJ8jcA^ht4cb(~!t0M;-uL@r15<5G6ML0mZekO#i*#h>~ z1)T9Y)tqBcr+sp4X|sgap6zkK(-%))JT1tb1D?Kk`jWe}cp*J~@$|*hg4{VU7eQrw zHQ=Vy_>cX0bDzfYuL{&npMQ4k!U4Nq+38ZwDmwFu+@~RU8>#)Zd7lP%XJ~sf^!bN{ z8l4>H^?kCF;__74`$TQ}hUZ`q58yqO=@$oy$fT!sJApZn!Beg&G zT&?o@Slp^{9!jx76~p0H)&2yK0l9}FhBLn^s)NyZy>s$c%y+C6jW95i)9GB$0-Z|^ zEmXh0b9(1r-~Zu*N|zR)Q}7yzwsTeJ91*oFp;MnfE&F43e&*j=s16_U$>vL|i-z1t z0%3$s!8_R0f3tK}L~xO6l9!l3!D73yKHTU3(&q!)wE`=8kSxw3{rb?E4S z&D!p%Eua7PH%do}9>Lp4?XOvS$P}tcF&DFx8Ulf$93I#2v&SSlWsGwH%!#$e1^~_# z@VpD2e^ChFUMQZ4u_M3-7z`K<;Ck}8fV%)60Cq)UX99izT#7`;A<<)z=v_#33KG2y ziOxZy(~#&?B>EK+t=UPbv-U=uLzVhR8SY#ODiyy#sp0o4^~$G8eLWyg-G6bOx@W^q zYUVAS)bMC$b;s#l)ckihP{n`ls_tFcO%2W4RQ3F!Q2n;u=IYsZwo!j<+*xhVYah@w zL`|(PS4Y1eQvdni#p-$A!|IlEzES`D<>0(+U%f7`|KGRhG~&faI!!(4(#}UU-qL02 zLESg3fBmDbv5!hOx}bMt(;rLE?Xk^E?`+O8f_j~y*C&lFlw-r;g=+VMKAX00(a%S8 zyJHJ*CsmGuw~^Xkv*k!7)XGtp@7mk4%hR$V$kWWpZ*98YmB)0R$XWXo9fH?Lu$|4) zF)9)WP7dN^z?4ieLLo9V8pXOPpxP_DV&PdTT1eKKD8bnMdB^?Ar0>H2K; zpZF%X9&`UsSD$xpe)u!zy;y(mhFV+Vb+4@v(|-xsszj7y5I{Oy(% zlCRKZ;>BOGll_uublKI7Y%&-gu8P*za{obj+#gT4E1o*v3hzp<2Q%?);&0bZU0U+g zUnPH`&%}$rNgsx5JW|-+=9DYn=7BEeQv{%$iEsPOx+i$m%U_-*`3hYoUi`Dtl>^@z zk&u*Y+1=@UGw(5Eo`s1{rRUD*J)dqGq0huSzD?zAXkrqCt2|L#i|t|DG>qE}?fr5w zYtd7S&^}eChpnb#FSKGSRWDWa_-Lrm3WS2^}WBB|46>>NP6br@zeh)G0T~ zz3Fqxr+r-OOB=4s$t=hT`CJ5`T?n8Y%-UY5k}lo*!l~|ic8_R}H-6y|*)|TJIyJ$I zf90qmUr{(792blxV$MdZ80w~DT++QJhJf<1a!Cqgvb#lT=ZC6gy*ICGydCB`{%GYhl z$Q<8t&*uITz_ZsX2h8&6;!;EX$Omw|FS6-+CBN+xyrZ*C!%2A0ZaW9e@;S&&$}69? z^Rzu-%kinlkvWpC2}U`sS5xDstX|;L{Sv13!SoL_)}S zbi#_(qX&=fG?rJLPo+i$!wLJVNTvECtlp1gx|!r8*Kqp0@t`Nt-^*M#o_}1Sx?q#P zT{>b#P0_CI3&=XB;9Ydm8XCpTP#BVo@(05e)lthIh~apKDR?)I`Nt;0VeGx;Cr@q+ zeg0-q3-mC`%}*5{mMGcbC6Qy=9Ipu8O*U!eOpiUP3Hn2B%)YS6cdozBUQnPO8NB?> zs;vY2^}1}=6S)t-)Zc76=O&renr`@VzlIojS9un@IlTBcXSX$8bLn+Nysp1}o=TT< zbKa&A{%_A&e$1iMx^C&Lx;k|z_eTice8=)&O>M|3_E%L~zT!v#J34}~Y4)a$QhcWs zt`hmy=~(itGaes;#8?Kbuk!&Dq0rMe8o(uSwa}Vp-TBr#bLpmW6FSQ4 z!&NpN+N1yioAS!|tVeQ{gr~44oe3&`M%r43t=tNRUESXVSY0=1>aV=Q*kbBOvBs1 zE1Y!pM|H!a=$_cA5T0v&=fDCmK=e8P#gsm0+P^!uSD`A|=H3r>IR3x^*Kh6YP?B+n z;7xvV8y2^``sAE7KA=mE#U>o$gTosJ`pQ`AxVvQalh$ykS}g9KwTAP5>|j2`!*#D= zeAmmRyY&5@WiMr?fAQvp>b$M~@~5Lu-G8DsqeMfPBb&+=UlkeH!QE zbpIi5r2J!Aid95-RGD^sW!iq032(Mc z&tXIMK4XVRivKM62|XrW{FC$lNqQ=9q8(1yGze)x1gRGn=Rn70wVyxohn?nsAo&O# zCSLrT(vePpp8tfmTIR!Vr(Jr;X(K*P?qihvO?>nD<8VrhN2DxtxmcD%{vVDW@M_~T zqm%pZB!3g%eEua?B5LnObcaM(w-90wNvEgo?UwnmQQ4>^CtdPJazCulW8#~qhb2@M z;cRoZfHFRR7b>6!mif$H*7_`n(4U3>CbZib|X^W1_LI>c@&ALUkb zx)n8JZ7rQAPI5-qV;|~RA+76c^4TvE6 zlK)P2elYC^XMWu0`K@+IF5gJ`n0SVzX-Wr9p4AA@_uuvXFnj(he<@JUz8C-ZS$BPS z_jv{%1n=aU`p=Mmh-+3IalDbD+HtwBn6aG|KRpiHV`-N;rpPv)$P`~s%X51i&^fR! z=!;HobM9Q^UMe@*)FJkl8ISr!lS>*-Nbi4r#VcO*yrSi59zlq)B25>)_s;&6sr7# zfBN~2BQLz*yuCQl%Yf2g#$Y-DVtePoLrbzN-F^?FX;KNs6;&vW6D7bY7A`odG{ zqeal;I|>JGvDFh(yZ8C+lit)(-G9M%1?tFKZhj{6_8vXOKa;-YBOVRqTH0nC;r>Zm zEp0Sy;@A(>_dB}5ZA-%HIM3~IU|r)tBM8>}&zb1YChOV!GNsj8Tqb?amIlX>n`aB) z`FR}p9dn?y`to~Z1>0`6+pG(uZKqA}jK=|;1Lph${n(}vxJtslct6hmuVTRo&F?n?CoK$q(=Pg)*fz`X#+zFL;yMZ2kJ?R}s_KI~Qwou{{p}%=1oX{8rHWumgTLQ}UN}L=!Lm+3Bi} zB;q5(xNv(?Fcgf}`-&4a3GU*XZk1ODC&$Zi2*2f|q<@z%E3eQ-7U91+IuCkf`8B$-{H)0a6VARb<{)FTb@3)x3sPM>6!gcetRu-JbN&d z8-i|}HcrQQ?$yNsuRcq0mh-nf|3l=@tJ6}v@mvlEJbg(?0`)~-TlVxN#T(D%aKO`- zlq7iVONtksD>DZ?eM#|!`oeLh*B?vq#B-%{z|)r$KRkU&@xpUu=77H5v}6aKc$zxL zr90f*S=RpqrDjan*v}LW>N@ze8{!Xax;r0WXy@Ty@HSHW!>wWVMRm@)4NpVB!OJ{) zFyI>+id5ka?V`zXoIhTPL&!&lYZJJ_*f!Pp*Z1FVX8IqxNevn?aY zyccbGmU%I;C5~seKL@<>X@8!!XNtdvcAa|M-iG^2x$eTbbEYqK2b`W+k2%nYcbD(e z8~Ua1gP8c4vtMIEBwu~L_cNa_tSM9rKX`e}_!sW`?N*m(Y-hPYT<|VBX=U37VPDSa zuj2L$_gG^4j8?mOA7+L8ylbHrAoMKav8^E?@>2Izwq)B7`Kd_I%s(!UWqQ#cbR@ys}aXL!@kOk-_5 zdwj{v`39gxUh{p}=Y{7Y0QXvrMx?SED z{sqr4x=G4wNjzSQt4C@h;h4pXQQSbwFp$iIU@qVy z@DN}=;9V?3z-NHZ0bc;V1bhYf8n7Jj4d7eAcYqau?*Tsm{tH+M_!00E;Ag=90KWi!1^fnJ zV~_{v1n3Ol*@GJZHUxA9*$2iPBQ0N_BtAizO@g8_#C1_OAp?_q$$0Yd;qfT4h5z%amYzzDz*fD*t+z>$EX z0HuIYfYE?4fHJ_*fU$sbKn0)@Fb*&tFadB3;8?(Mfa3ut08Rv)1egf$1115g00Dpn zm<*T#s0Q#t;HiLVfDoVt5C%j5wSbcWQ9uk32P6Q~0W$z~fO^18z$t)J0jB{@2b=+D z0GtUp3vf2z9KgAN^8n`qW&th$TnM-b@CU%ffJ*?E0%ij)16&Tc0&peZD!|o%Ie=>b z*8;8sTo1Sba3kO*z|DY0z#jpB0{kD~7QmkYw*qbh%mw@fa68}*z@31*0CxlK0n7v3 z3%Cz(Ki~ntUjYvS9sUnxe*r52KLUON z{0#UX;1|HJfZqTd%;W(&0XhS^05$+@2#XcN8>ofJ?)&T{{PS3mB2?)Wc^CG!Xbo!h$lfr;=vFOF^Wn;2n6H^gd?Cr zhGaqpCNptn0s#-=3Ep_DvZCv_ctin>$0{n9=(@OyvR>c`>gS4z3SNu%_kZ2}W~wWl znMp_xq3idnuIg9SRsVkVUR_;X)h9NNX`kMG-$_%xO;K?$U4o!_3a;>dUt`^@dltj=po^i`QPdelXp@5WZ%(GF>A|moP44?=Foi6I_)+BTf}u z&Oa^P%$F2|b%M=(B~dK-%1>PbvALk_!lY9#IYi|P(S4oBZMYvAo|^RN;4Nv%=U=+A+!H$H7@e+Frem5kXg( zBVUW4r$Bu>#+BDMHeZg<{Iva-Tkuq0;Q1Ha)aK+bzWP~}6Q)Oy=sxY;>DLGLjB?F!c^nK=LrG_uR3SR! zDClSAOACaN%;t4Lo3P>4W8f9lw@$wKn45Z1_fIoAe-5oh=WxzY*IY*)?JTV^!Vnp` zTuM(#)*j>fL~Qt?Z9hUkY^_54dOicI;_xSr`mlTA4P zAvoVEEMd8?a(iQGR{8|?Q|OYG-sfFpMtjK z3iNmWiFWX~1aT`m0Z(6^C@xstO#FOx3(@VgB+<5iJJI{_6tVE_BShafdx_r<8zfSe zPZr}kTq=(FcD?v?@G%J;AFNIok~k-E@xAvo8+O~Q7F|+WClMd1?gpfo|3gxox(x9F zuc6iXcqQ#y5AlNJgzjy#_Z*PxPcbm||2-c$zv`aT?8?Wez92(x0Fk19=jqzYHAw~|ja*IR871{K5E zY3M@_YWH7w(T55izqCdAcd2v(LwK6w%5;q=U99;u8WSF;Xt5UI%K0yeBmZL;=Rf^o z&eH!<{XvFwsX4Ap*ND<3O8%ykjAb0D8L|2Bh}`M`7ug655eBXUNT z`Mm5hrI#zIoO|JPX&)FVb{X82EV4lJ__3rjF}7j3GBIG(0i~YVA9X9cR)}_fKkoC zs8?XC!K|C1O3&&RW!=eP=M_)4tWoZ+6+eR1f%+O!&tmK#y-b^ zPrWdXIuUaK=!JLhi!tN?@a;6DdnV=(hG1+x9R07+=zrxS-KpTU6K#1Z#-HUF`=Sae zzYOE*>yR!g>~HSDc=i#DZP$S@uVSpV4P)kA2yd1k26RmjXF70#`LG0W&-4Uw_5}%| z+h5^6l^}k{Ai4|#)=d}`PQ^egAMO2bPb7+azeN8$t(kC?HWSaUXeQSE&`ex2thu=J zj^-lxV{@_OycXh)7ttp;tEG79nU-Qob}O;?%~oPqAW0M*-CBJ3Mr*O@_BLWfd0TPA zq;_KWm_x+7Q`?KTF6bbxc`R8x*DOWM_I46WzV9p+E$t%io6%KVKl%ufJpCv!@b+Uc zUhFP5-rhr8GxK<{!gGT7>q94t!~3O+iNEw0@26ylM=m%+j65?-ESok=WPf_L7_n`f zs2p1$va_a(ch{DPvtIX#+^gq`=XX_!i#lH;CN{rSOxb+5c;~8z#O2wm#f2ST5*M|8 zSNt$!r|7fgH&OOsNK&7tz4CvzH(NXR<7N-7>)ZU&K36tBKKsMw zIaS#$4w<{MMYHF+wfwa0(v}ajOl=jM^Kh$|dXG$cw!`kEAsz2+eevlt+sv-cXgl-z zBij9XYWqW8Y;$P)g^SWV{ASM;9kV{~(CLxt8#))<(!0y!?RFm4`tD7Kckle> zky8s>9MfvGGqva6zC8B)=T`Lmxc{=WJ96JVY3QTF`+T|J_kNchpLptvizaF+$NjEU zhz8XQv_Etq>LcDCIwx>zZ>npmjPOoVig)J?C9RK)tBc|92fGJ$`gQXcSI$iqm!5sg z%t7})v+h&S$Z&ndbe$Txay8``QZWOoX>g*ZAIBMbCb?a6wVI3cmhj2vi$PU2LvC}! zlAq~XpmaeJwrL^`l!EDM`Rr|0^(n7-;*wl&JXGzPoDhv2&nw8U)WlQ$Uacuwo!+{W>P<=-2U21{3y;IKv+?b{kYC5yvhv1Cj8-rgPVaj?B$PlDxd?HTan6SByL9RZsMI~jI5 zEIuD=|F&ERcOmR8uz!cer(^LfEPY@9FYM2-Dc~9LjlUl*295cfJT*Fh3ocI?+yqJ;o4e&|6DeXSg_-%WHG(jC3EKQ{^Dlt zM>8&_bGqzC#TA&~3u48zj7i3mJl%|^>eeM1p6$c1&Z+SG<&?)Gb264D9r?u+&QIr8 zLM=LnXZw7!-P->J9#=l?KteiAqyYXvb_HF56jwi4Yvt?;7Bt^s`{erFW

@$a^my$P?l^rY(3pY3+}G}b+e*9x(jPH|+D@0wYLh4tEM_B?D|UxG#Cj$tlm z5KG>%g1U$xV$pk!-|zD~hPvjsi(L70-NB+#{r6$hdE*6zW_(o0C9suPB(`YEN?Nrf zGJL1|0^?pDj-^hTA$(JTkLd{#NX<&mD8N-VplR@pJt<@aGZX@v_VS%jCd!dZh9 znU6_MbGfSD0V(s(1|O9-?aH%1XCQ==xUSMUJRY1wEByLj0~&q>r6a$hh`4Pe7=p`q ztAUsD&w?e_im#cYdtcrEh}XVAux1#qO6Tx+@Isd>JV8ggf>cW)ge&9Aoe>*f{?}W- zeWKuUTKcCM#;4LbydL=a#=^HF4tyW4dH23ulQu!Kb;I~nI)~Q-U%y!R78S+j-^5uT zdM|X3$mIMPpGxQOdf@9H3tw7sYYxPhuu1sfK?A8O{saE*p`g#@ck;#H3zF5`Q>%Ym~v8*&@sLQCaDPCX1 zW;$+7CLVm@`daHIC@7WsTE<(6%?>Dk#%tA1Z~oi$LtlO??Ry4A@#*bUI)}%F*Hz*~ zg^gx=jvE_%(63OzihzRKNH7^0QvEHj!{odg>gw+hd0M@XgzSI5YCz)lEY+Q?ttHHg z0`swB&!5<3!P(p7eilW4+@PzET9%)=Kjp~t1*q`2&o#kUKFT=*Khx1#B6OKG)k{Uf zgp=0yW&)>-gZM4K#}0&(q4%ILE4{gF=izVu^7~5z&-;>M>hVZ#n66VJSIhUv_Bhc^ z8`5NImD#;m_$=Ney(mWbBeA}Z-1Tbd7HKgk>U4@~G`a|+cavRG;lT$TJy{ELPyz4R?pItc~$;jRst917^P5XJ9 z12zY24%i&9Iq+xZfK`8u+RMhae`X&2k=U)uhx%+Oe-FW?Drgy=P4IoY@Vmg9MVDCE2O4B_PqFU9ev^!1K-Mgef6iAY1raIGvpix zZD6`ija>P=zy5JuKkZ}e3>@ZxUAd%XMm$#;o~F#Nm=Vx6B`Vg_N`=Gogc(;w<_SZ8 z+tY!@vTD6dbC>a$x^$N4R%2bF^E2$mlh45(XK(*Am-(*pQZ9$O%8Z`jdYj|WbL^MX zV3&I|?(AKdT|RrqzovfLE}y36@ZP0wm(Sku zuc@D2gbb*kO8cCwM?aNJ7A&8EC|Pt`dSc78pC4;;3Pps$wszY3UZ!hA>B9YK z%l{&1yIr@h*j=QbUBNgCu%8MU#-Xm~EvQKrZ)H|5Sh3*6wZ|KIF%G61-EW^ z$2T)>`|8VgUwyOFBNtnZ6Od(-8_JjZA!ND#K`tBl8#T$v!EDs}tp}K4)ki;=dGtrV zyF6d89{NRP!}SWwcOmxQoOI8l+7g<6{ond@;vr}FczqVR30MiwboE_~b@_BWR({au zcg}Q8b_YwfO^QdkyfcHPScOH)^hZ0r2=kBj&GMB^@H^f33CA>LP>F=O{>!+*T>n|E zzq%_o*Rf`8!BW;ga_N5@rmHxOUCs5yRmNVh6sHQ7^IfIn8@e(<|Gy&}b^Mm?YbkzE zT(|VWHb3toIVVH;9)c^=HKKH>mG5}k^ge+9JoHHNd#5js{ob#WkXH5|lRQtI{cq4CkvYW>YgqxcuH} zH^zSN;ZICE-3_AI>O>!-6iT&P3 ze)0XMuRS7WaJrnYO6PFSH~eR#g?ttKHFm!5WZl){gOT6V`fo#}tNCV?muJ%nj7$#! zFqJc}CnWr`<#-KobzU^&N&6Y*KxVVr<-=jN`^R%Y9!vc3Xlw*32iAkY?O4X&&Go7} zE~jU2`~0#y`Y#$!+X-k!ufq~*(K)=fKQ+IyWyPIQpy&qd+IaIGChZ-zcdIyA|7vnqc zc$XJD8DO%Ieu~e<|M8Cea;M)FnYvqoXSlxIsNk^r-jcfV{s(&e`1#kI6@5FRFMTSV z!}FabE)5Iqf;4`DBio6skBpB%j`1$1X98LS90`n%-$4x(y*P}FtMGx?->WY8c;w35 z>-u%qpXP6mIG0tSb9hu-*&Y{8u`CBXfGwtN3X2n+K=?l&x2 z9-AK-cb}5}!u78|!TB%_mCoTNelRy!jx~9iSWcqM@#XIhVuiWAraF)M1@iggUtU@0 z*fae8lUTn=p6J|BrgOUN4$qtD7}|em-+snkW7@IN2&{r-eXdgSwb~b=;4Am|A0L?< zr2NQ`OW#kKt`Vh6INx0N%u?)9kzeXW1*2`qrD?9Lw_R77%YhU~t=BHe`tsUif{&f5 z^IzAG1ZWAz@_2kWNgP|N=POk&A za_%`esHoU68mCzMiU<)R%W|5IbwsgnZ13}rZq4W48g3>Thf0qFhjxq-ZTO~f&A=n` zWzQqA@qC$ZefmB3F8>GT$9Pmahv&MS<@&cOY5+!fji$(vOIuqy@kwE{54+Z)%FV*BK=?e7oj36` zhtb_Mv>VS=8~VJr`#jTnMuON0_E1>b-xm>L*O5W z?GC0bh3(Noh-YAnp%C5Cuzw5tK@!eZ#-CS77@Uv6B*9aMz{Sg?;APt2WzN9MJdBr_ zg_o(o%e<3{JzDWH@8M-`!ppplmw6a3lQ9^3k`6=I803i!sy91vu5=mBd&cp14=+T2 z@irm;SuMnAtAX`DLUj8a@6jSboYEsf{A*}}ICWNn*mHA&xOzi^nEyk9C`rc)Kprqv zvjDGbYLC{(kekYHlf~RqTTg#9?e^;j-%L;IazpbzOxLNAYYe&3$0y+tih2L7(tpI3 z<4ca2_DI{MkNv-@m{t@o? zGES9FX_Kih&KztQ%$uLl^KyN#BnH0fACg62Pw=%Z+wc5zVGnvbQm#zbsgY|8d}!9q z{F3pcJsF)}TYpRzcdU8q%Ky8){fwTFeKN!^k~5}jMClR(&%~hHgKwu1OfsHTG4Le) znk-V^EV$tHhd*` zCza0OG4PBHVngBxn%e(m(s%_`p>6gP4ygSxDjza-8R>lZqpynqfZK=U)zS4i13jEO zcMhDr&NJ)B<@6v7*Dp-hsgY|8eb$!SQf#@N3&p@u+N`7a>f4{6Tyf-m>r@;}k08)} z@!*jD7dPQaUt^vZp}rn*D(x5{oNx8`jB;pw(!a2PcEVHW7HNj~(gxgNxS1iFKoAvXa#PB7gdhaJ?pLEq3Jj)~>Pm@F{%Fvpg&+D^2H6>DFNc=bKrcwt~s zJdK%Flx*xEn*;UcKq{VKeGdIAqR-c~c`QE(VQRaHA=p9t4GOQm-x;-hd_bseV6xvK zJvafWjGtMN6r zuH^i5*-8*9ox^M6;d7e&BfL)fM&>%(H4k$kb%2z=Czifw9xtftp7LHw7BAbCpEl$XF2S;EnMWyzY zQ=dC#zNP*wAeWxk#w&7Kb!Z06w z%9~SqwfOyI@{=LlbXDmZ8JDy>1&siIG4bgQpNspZUc z#=~xGT>5VmfF&2RC`STR&iq}H(!*4~#wT6&iPCr`)_AY+a@zk>qB$*+N1AdaUXyD~ zzrtr5n*(B>>t_gpDAxzvziNuQz%JkVb3iR0d_oP^AN5boexk8CVAZ}+pNV=!whlEm zx9#-)>>N<*vvj-=f9tdRLVtYes^vp#leivZ_m4+;@FK9wXa6pHwS10~^k@G@esG{u z%crkVK6c%hzA{y^R+qbX7w7rV_5nKK`Jk0G61V`f!cYNIre;eK`;qJOSI_{b?JBk6Bo>ie$ zJ)c%_Gd(8m@UC{+*L9!2U&F!ECwlC4>va_c>8DaHYjxa0MAB2XTBHVEY<+JafcZq zS*^SLY<=)=-Cp_l-`v*gWtkwDuD(9@f6uDGPn6!E8yk{fnI(3(DDpVxXuJ3F>6my( z#!>l=d7T@5*Q0+F3Q^I{X_LM(4dK16eQepRif8i}2lo$|9verV+l#-fU2~lt?H^&| zfjqeKIu`x?)YRg?uQJl3|D^UP?}cCGweR~OC`I23CcZ(be)QuRSG{r0ZEMI+MqlIK zx)xmz6=FnLITp4$y}@B_kIO-q@vd@@vj|S0!V@(8r&XCmI|fA7HLB&CdiG&r=)(I> zTeJA?ueAkch)elXzdKB)1SDh5e=;^=c1fig`#&uyse{%_vdeN@7ZYNI*Y%uD|8sFb z?O*=6(8rIK>c09KTL(JTUHZ}x`8x2qRred(x>YxC4y2H}^yQCyN0L3BL$T%X zk1Pp0Z;XklDuvl}fght(%8KXb6T)p%i^Ur%jqo`0?SYM{0^>*fj}W{!LzeS2m{G55Vw z#txh$E^m8+&MBVPX1dD1$N~oAe|&5}o9}Y^i%N66Gu>WSWC;KQA~#vVpsTDLf9?le z{y9#M5UB=E+V5+9hmPU>zNY@Q`yd)it8#WEXt89}mJcv#ADK)Pl3b5O%XR<)X}!8_ zY!28Q&^e&iZ~Xtd&7b{)10lfRcC;|r+>T}r>7ccv>1PV@^Q86X6XJEHDGRpkc=JST z6RsI*iw+S9VY)#MJJ_w=ywEPYydozMbeCx#ttU7Gv&U7qDsbox&N88cHh9x_PC(wL zWltRV)*Lmi=z?wi{_%>D0O3mkKBjZJ?8e5YZEac$UI+;=-9h$vOcpHVYgMl0|2+Sb?tv#3-arvy7$4JhYUCOl z-((y^Qj2Y-{aDun7xi@*7x}4AB%g~i{Fy5{FYS3HZPlt7!bRv*x<A3OQfVCH8xE-gMXe7smA&Pwz*DTsnt|=^9bGX!%Zddy9Q@`Bk;hDqQ(} ztK!J_;d4Lx?}o3t_E+;|x|F5nRr8fzSqqojhpva2-%(i|K(`%kEgX zV&s!+$xlYdkx+}ShZ_7IT2bzyWmc|0PGym&f=)*thNDR6SkZt(V}~OjG>=PX5Iq}$ zWxlKeF3KkhmRzfP<(gG{t~&GU&qD~-4C7Mi9Io*tDlS7KuorbLa7ZKs%lHbq#^&2+ zb8}Cd^InhNIe*5d(m6afKAmqk8w!6Elwf_8&O77yEEB#xz(@II!IEpmzlDj{lsxR8 zg`MPd!}wG>hsVYz@y`OJysob5@YwwOwbeyGe_wpY-JCz;Q|TP8;HyK*%ZNBU3DhAi-V;cwjCbggM1zm~pYNV84XLaXz9O>>04+r656&ubbQR)GY;JNk&MG=9Rfvmv=={Qx$pwID;_EK(6|lnc1{k&0e{TEfhVyT` zFKq=qOQs!g(^aJtm5gz2GiLSzfeOD%JMNI$61hA}k2dFv*Vgv5TnzlH`}ZdHiXQ#? z&)WRboY91j47t?KGF>A|7dr1S+lR%c0e28h3LSK)g;wFpa^3Y9bH3{P?f|YImOuIN z_%7bJDU1xcwBD5I8d18?IfvP$Zcj04V>-Llfn~hdixh`v`>-1+)|(hGby zkCaTiy4^Q&9zaYp5`d%svVVo(M@&-tr#4!6i(JAqLzEpxpbLjGi;z5nnb zm$WZG@uu+kI-I{skCJ~rmMa%KJwC5XVnr1mU_PX##>O%3zfV0frbqJ^I3LEL(mC9M z52%u6;G{*pn<%#n)ySXJj`=`-l1q8KcSOS9fBENk?F&KH4Ck-XIou+Di4Tz?k#VGV zkBy^KtInTKoqV)|^I;q+ox?3~7<`Ceptwt5xjZ%k2N~vvm0tY&@sgb{&Q6=AMZ|@1 zsB{jm8^^?e%Rkf|z#{f}RI3;#=&`6&BLT)$er#-9)82h!Wv?+?zTkWrmrCdG`r;bl z4FoZP;3^(6kAO2w5t48w_lS*i`W3_8I-$+TfsBK3s&o#I8>b{?x}@tV)JXW&$ARyy zk8`i@GPwIF&Y$tAbPjI-zPebcB`LRO8ONFV8M-n-ucx!oc5KxFKSI2JYywh!#7u$i#*Un?P{Oy|H} z4SP52YS?#SX#jTuUScZjEwEc)>AcA**e_sbqC(ySdp9~WB`t&)g}z$>`ffKS3Go~H zZq)$vR{(k+fGz=`TdA)GK!pG_^jIN&?1g7hYr3Fu!NKScK~knn!g-Zo?4=dh$r}@( zJMIFmr*W3$+d{nks}QMa3Bo@mLHv9Z+WWT>MDcNn;;99RV(90I;`)+i;+p?86Ay)& zi(gzVL@xlkAAq(2P}c9Q#l;V_6|2yR-0(pMG4rw%v1ZAk;_AMKi${x&7VC456;;3W z5|7{S5TAMmijs>4i|NTDMW2#MV&{v+!f|tjI4+H5WJA<9()yKExZ`>-uUBmO_-Vr5 z91py;`5)U}?TsgO`Irj%V7f+>F1mbV&2hRt^zXPyMkrbpEa$%&`J;Hk?E{r*39LLH zdF8u5&&}xda1jrrDE`JadUnXVC~i=O{* zk8g(4GXbCKeSW8ZUY^hA$#>5u{)UhM<%#%7@uuCT)Q5vj8&@r#hvF!lIHEKy=z}PAwY@orUfuFltz^%NX8Ev9Jm5KC>x;RF zt#reRW`4@PJ6JfNw*UL;y;%m?-Bbc=L|Ki2kV*> zJO9(Kb-j4~tf_Qtmu5JBmCoU{@;3tFkxN;2$S=>;Vp>?cSLvKDxfCX+A&1%i=p2yO z8-*Yj_?)hN$F1wB8y8lsdA)pN)?nkjZhUIj%uNPeeJ-nrR_VECxIOORJO>tlX620t zIEK4|Sie{9@(1Tla(XK8K{FK(l749a9|H&HGZf$ANe1NgD&@n>@>_N55^ep*_F-7B zS@`|(>Jc5qxkvu%Ujw@JSof_VOjsVEtt(_YZcWCF6W^Wr2QS9l&w(W^#>wFU2bLjD z$D2$ao-+X|Ha0J3{DdjfCuNPAsDIt1FZB_9PabZ@tNz!Ndv-@LI5&IK*`C!KHqgt$ z5MOB>B-1sbbcu;K2E-83;`*pY!KdbNhY+h_&AUPp?OgG43Cni2? zevZkSG-7zxgdCGREY6L{Lnh>*1#;o_G5q~ot^=B~F33gR@^>mKu7>0%>s?pKE14`K zE!r0V%TUCgmWkpoUpZ)bj9B{F8Siv{=aZM0YdhiUc}_&mOs6=qG4o&F3jhn$9Q3E# zL~O?E!BQuGP?-L6OUpCk;C0_g#{-M|qT49_>Taz%>>ljQKFi3A-n|oWFx?=Bow{() zc@5aRARuF*heAkD<}W8?#bct$Z3V@(iWe;n4zu0(I8ayl(9?DCo^^!7*^Ty$949_x zb}ZsRwDO_wy7)?TwiM4cO~Zj$<-@sBy(X6x-$yGWwJzkeY&U)mQ2&PeMXQwdQ0=!- zsxyc6dhf96+wS8W^fF7RMdxsHdnoraN4xwpU0DSa{4UqT@?!dllb(_Ly`|&K?Xwl0 z4&SYL?Tu5*wyiPxk%Z?kND|W-2fKCSF&5sNB8+x=(Qf-sKYgs%MAt@t0s2=)=HDI# zZ|b^4t)HHU70Zine&jX6@cR4HuKVqzDFtl|K!i65c$sdH!;UFihnBDLClLMvqRvf! z#~2?r!^crh+A}hqMdM@h?~_MzCLR6d__LQ&2N#C$bj6kF8d18K@yO+wi@#hvD9{LR z=rQiM(*H&xKlZxS9lP#Gxb4#0-r_7-zEnDgoAF@0H8N{*J_4&?S+1+%$oJe?lkPcc zQsR70m-AKW99}EmF-||WFYx(|2=aUHi6j5Zy8oxu(I2f^#p!eYDxJe?=Rav^76Pka z`MoPA#OC)!w~xsx8}R=9oG$09(mA|VzWEgx)_Q$&oO+BZIGq2UIP!nv$Cj%L9f#9! zRWqEwO6Txe`Hyza^twyjE`#w^h{*X@PK^EjgYW9RXZh;qCvf_lze?xuTKP})`N}4^ zDs}BM|6e91#m>L$@u9<4T{dZeo-g-F5(LvZUv_Kdugxz^9DzeeeEQxkddw;~%!jHt zaQv_1w!x1sT|SHRVLqsI4zGnH9|xYyo_Drup8ltJwUmF_WOF^Fj<<6We%78FPCTUi ziRNK;6hy||{W0z)9)xhA za2|Ja{&l(BZ>cNXrZ+AJmLNHn^X=0kaz^dz`d+QId4=u8&Bdi3)SOE>Z*iQk;i{Dn zefqdj<4_qpP|{4NII^jA&f+MSb2j<}{Tz8tf54^9DopTY%|PRavwm{j#l}&%UAxk{qeb;bMen88IsLD zxH4TMN|(CZJ!71V$?OTfNPEY4;^`+@>4gUpA2v2aoAO!wU`dP5#(to=2p|_@W zEAf8|Hw=YW{QStYG2^?WPo)2P$xytuxH4TMN|(C%Gs=lmm9cM9Ac!3whPd!u%~iX5 zAT}Z`##cHcQht>0`t$Vf<6S4V5;G2SYq|b)evhOg^Lr3jnj_f*%lmxg47z;NQCA$Y79`E^d#H2{kMbUIyaf91 zNQm*}y3BGws*nU*h)z45vk0%acCCNtwU5uM(sAi>K>NZlo#MzQ-&ItBLjdPF@|`8F z;JgX$@_+*;5>^DYeKfO6T}88L+Zc~4=)!=6KMZH%?|1AEhlE1Ni14xA@V5gw58MC8 zalkabfc((-E(@0AgZxxp@;)iQZ*<)CTZghK#&o0>o`5UU5#3~r+7u^q7Q6h$%wDc9 z5OfSfHIiRi5yZxR-Vr5vK3Y_O6EC$L43I(ymgTy-#4OjOg({i+)uQX6Lev-6P#5+u8SioieA@6w+y6k8YvR`+PF!+j{$|cJ*B@5j zW4|gKnDx?--N*9=FqAI6J=3M6HE(3Uc&H`u*yV>lVz*3#*OQ&@ptc+8Xs6qY%>&C^ zdI}*p%-`(_t{q?=)oWV|gjlw5gtk9Hr(N4VIrOX#j>V^A&5&$#fP^sJAcq}eAFH7i zW#vFJ#|>nTVLp$?Hy87|ObPUJ6ctUMKD@kQL>b1MLvgx&u`AnIRO&MAS5sMPE`O_f z?Yhow9c!+9n~ym)WH(VTJq*n7SmJYgo%9_&SP_T|SIsPQd8+e1$?lFK^XH1UAHL(% zsl2X+_(tTGt^m?xV;T7-x z{#cFp;IPMyY*|j2uA;G&lSsWM@{Ihsza~G=-}KbIN#r=HzX}9?pN&4V+^h9vnzy6) zWa)~lNA{X_^=~uul=yv^uBLDGKH>Tjk=6buKQGsXvY*4PT#84!LhIFNdX@G^qJBma ztZf>`fe;>J`AG6dmygnN$j9+dmp`8R;E0|^p;28#^&-<%6jt(~)2M5r^^CMdpq12N z(z+?seZp+_kcyHLd~~ZzemEahcGP={$24~NS=-%v4lF_vEI;YN=<>4|^0obpk3W9$ z+{&&~jd>!f%Se8ht|E#pKl&3^azf=z^#vKKC&*9oN{0L#PBilCW0r`^&mzb+d&z-n zJkN4cImav~YX561VA%tqH&cp93L8WjX3PH+uh!QvGDqn}=QBGcBt#-N29>wZN6>8d17f%2A|$hW$u!#9LjB z719a8GQNU&W;s{;TdRP-{kE1LUA%qHduxpE#VqGcm!N50D}3SpR!npamv0pZ-E(`& zt}X9YT&f>Up0C=a$d6i2Qp!hkShefWyC(KK*2sp+pgmeQrW@q2VH>y?VlzOO$AWWCyPaddgfy{Mxo`S_a0 zIBumIZbrIorOb>>f^3$J72!>nThYE8lbp7X1YNRJ63XIRUcal4^olkI<+cxy?p%h{oTK; z?vulFNrbNjq?_qsV1~yMpHwf`g-dQP@-8*=P3;HO0QW;l*UawF_Oz`91PF%pjp;fy za<#%0sh?}3idWAfIYjr_^>cLo)HhU?m+dj+h0^YK+H0o_o^@7>WkyCMFNZ*Cm~N26 zj+MOVv~c}ADPu&yhgA#O7dlz5Dlaq3ua(}9y8eh2-Df6V%X71ghv{J;hQ|tzmEM~` z;aQnaNtegg_xsQ3-{pvtTK%r-JJaLBCF#40$29+QrI}Bvo-YR8kA6BnboBR6<`o%} zEv)BEj|Wdg&m(9WTfYg1t>bEGH2hxHr;Uo7Sn1PE|NQs6zivKmG@TnvhV_Z*IyG{Q zSD&z|dNysqpC9z&LwLZXPX!BO>r?f4yM8_L)iWPc$2ClkAkux7xFmgwhG)@L(e-Hu z@P^*|^!MxE8Mb7uqEAeZ2Tw$wR5Xo0t|2_OUa6(h@OxRWQm;14i zE2hVV%R;ZL@MK&8#UU^+~JX?YH z@ojfJ_xR*hBj*|!bGym(c<|_D8Sd|($bvX*&gaDehQ1;rfe;Fa#yeKupVd6ndn#M9 zwrM&J$oigqy;*Lo^nLk>HE-#eR_Oo`r;F&*hI3M6f^3n!U!*msmmAokR@eq&O zJA3SmS*{}eur!w+?Pv%I@%&TLO=etH`kr=pX8X&}Ew1ch03cj#fs5$|IqX>BvKoh4 zf3aP{WN3C~a2t?E6~@tDb2;*<0~9$Z^*G4oB;|BRbEiV=O6 z=Y$?xH+He2|4cW5!i^QKi2m1w%B}}gKJIV#ayyoETXeZ8{Yyu2|G=?ZZ=A6qy}j`w z+-@*keLpL?(P`m+nI=5Lv-KxKP^4)6G14EN|w78uY zx0`WV$Brfx{8hEK(xqPkK{p}lDpSLTq<{?$i zm>w5iNzNLAGjFMxuU2w6v~OnlXIYQ8N~A@`FjW2|hfLRq(#5L$BXSroO7nb4)t%9C zZpVAv+vnNA(@risQJycM^$bjxAZlJKoT{8Uy>p!U?kaWnQ>dKDu&dwM*L}?ax!pWh-$PmL>F`@e0D z5M#Pgt9MABnH~=gMW6Ls{dYdgb*)rJwjQgT{bTOsar6#FUaa)_+p=qKTQ}pV4($xM z+)rV;`WEr(vq@->h%CpIe~+!#*Ix4cC6D(za-FKzOpgnfq}S2#BrS`sSCm)VpSI60 zK5y7DXDRy4^my<@^jk$^=1<1G(eW$+-j^=!KB9At-dT@uHeO-E$qlu2meH);JuH^?b7;FIIYfdqtbqGJm?QP}L`^iO70hcwcNi|F`dnvA^8jY`%(%>2cwb^gJ4##nsXEY8UW6`nq>{ z&RXA3+ax_Fy<&Picp`ePqG_03sd?6QPkLwTUR~UYj~+ra9zUl)5M5p<#rN9`zVFno ztG1j&H!xHW(>yuTHKKH}(krDNHh)ibWEB_tvBgb(xwFV+9xrcI@LB2oN3(9a^5u0e zdXo$cgs(a9F~dwEOAQp zKz;CaT^_rf-w5^|u=Jd}MolpW%EZUc;3Lx|XqwjwU!-1$h0a`$=B|v6uNwGQFZurT z?(cm6_18uP!2JQH$AeFi!_m%0`kt@m&2<#JYPfx0e-6m)?p8%!tm=isUg_JtVp`TM z^1KiISHpA_ft5U4)e9^%@;JWmq1gI=tLvlVFWqv%@v9v2=-|E+NB01h%)uq1m{ zLVcVXYZd910M~8whOvkOsSn(yI=ZwPqeY5IeGY+fr>9Bi6;sZMa4;a(f zKtOFvqF}lS1a7QwSe4JDjC^U<*j&#f*TgQT6Z_A(-7{m*C92#oJuX~QIYq-00v%K)P79CA@@Ko9rhfG*1&5XV2XAK`QMgdmbEY#cb}jMAdL9R^&A>$_n%)p*25pH;0g<5J7BdQT^D$u|E5e}C)P$E);$4A%opmmq0g z16NKZPP4$ND&C;e6W%Zo+q%yz#eS}Ne)k;wexyeo=JN&1@sC2#kskE*D|74H9*U$o z>IK>_FdjqSW@STl1GjlHo&3hDspS3QJ_Ho3f2mKI%S+wYanb)$#1R!mZ`|NIIq_LT zj_5lW)!R&0Uusf@V|ccH9u9V-b$ch2`d!Xq$FK^I$1#lL+&$mr7~w7QyTXN8Tv23{ z9TKaN@FlH@jxX)U6ft}E(t%@keEf`xkLity4>N*(*G#{!!duMgX5hn9yzLFQCtO!h z8cd@%%AqYp#z}oMK96(R2D=`s`kF z=0(+pk}*!EHzLjfL0?7~r#wDM-eAT_=d)3TRnuRHZ+=|YdOP0Zs66rZwqK@we}z*= zMD+milj*f^`eykYIo{$4K3t6By(iL^+WOwTRMl&b>~H5q)VCh1Z+w|gv7U_;E~jPt z4-O8<(q_W^}6bXj^glZm%m!LpC%BV-JZBZ{rcjhb##-q%-FSdQiAWPej){iD*BziU-(iY_-bkgI~K zg2(6O_}s-G&C=L448Tcln6AD@9C9Z zu4oUb&rn>V$(C^PIG4l8JrK;k>Tgq7Ft3T1^f`gcmjsXesPVt!;Umg?)pkcvA}!8()F))6r=jRRP*X@8}9D;cy}#FZkL&^ z!od6|ohyZ1KqGU7quoV*9}cAQd5Z&%$mv*^1`WFK-HML;64g)u>TjQO?B}aFP0|V0 zE7Cct$0&dPPl)CbX&rM1So$xH{#~Yh7YS(^Y&z`eu+%0@gq;a{5$tWSPr|+r+ZLH* z!!Cq<8}z!eMW%janv6^bA=8e?^dHz1B|jDaqV*DD zN*^J{;IQCxa)j8OkMAiiq%&WL*KR>L4tq#=M~HV?C5VE-3F6XA6U57}CkV&DM3J>J zQA|Ixnb`D2Gx7P_=EA$Sg?RYemf|OOlK9opMhwqyCqDeVy=dD$MWnuSsJPF6gt#*? zRdiT;yx8-xL)^SRLmXE#R7^fLUyT1-v3T%b^TavDH;ZP)kBa+uY!M^IwMbYu?2Lp{ zU%EJ<`RG>@&RLV5`1bPq65pJ8O0&n(K5F*JS&uc}GrFe5;kSO&^48pmNw@Akw9SJ* z3}~00{z7|_3pA-zm3tPSuF;ecGeZ*4tRIob60XkIiUyX3d)5Q8!Mu_KR5 zbGJm-V|tB@_kN$$dC2qO^F*oNLfWj-H8L*H#;)bnenLKJ2nIF z>nSN?F8l8EA4{pT1k)Xs>J_GIMCmfx`g;fU?R)`u(C0VeHg!G1xX=wwj3r#! zxn_BO*Rbq7<3Uwkh^*FcY98^%v3ky?)sF+Ryoe8@%S++5j$-qX&o2IK`=rjVb<*>p zc|?*IrmMNfBQH3XIV>=$ypXKOb%>gNL+ckdD{0)#{pSh3O|W1FY6&sOP)Jn<55K! zr_j6u8R{#Oyf9rON|$)#C0hL=C8c>|$%!pXD#sf4UY3_#G314E&dNPJwBe1E-|jSE zP`{JT!(h5W4m-NMj3_JjM23RVx-c@H)E&{~x9YzgMavQ0-}~y7>tD_>I>6+R{4zZZ z#PGz4CoIBh`>3W@*L^Ixrsv{`Q&;*nUFU!-FL|FwmzNsIQ~$HxuipJZ!R_*XHY6`h zSNUql3w?PCV8dLj{~9|Z;PT`D30ewPyB8i!UgYwY{c4`}ebaG3o?l4b$ym7lIixUt7^jMaAQ&w&sg zVfiWjI=1{Q`efw=Yft|jD+F|-mt}LI(m6b;{ET#B!_6YUyIkM!-AaP0kPzeB5eL4n zC--UAac-YqXgxIA|7ad<7etR$rFwb38Aui`%x+^w+Ivn;;cIenHkF_`Y zeUyI+@@Kk~wdSoWe^#JHQvQp-iJt#1;CuY_<9=B3-i5b3V`N10vDA-Xx>+JIaznL-u}K( zD5S?ECrnon=yH-Doab?w)RgtaNbh5DL%px-Ih!6o2dWU2pL6F z;eHU)Ri5eck?ZspdtBP5hMYOrq@sS`8z@bZLpD^Fc6l;4_N^<+OZqP{6oa!IU2ngrmIMGIho`RR5(5Q*QTK^k8_?y%cDQ3$_u4WO&iIEEFZF8 ze=_#9A$7MTTb~#8{$jzD zUoz8s8k`{>wm}InU1gZA&$;g41Z>1N)K^qN+q&tBZK=~Tp3QAy<4O3>dA$b@+0c&n z+9NzPFVFOb;^E$lD!(L0`@&Gai!8}2<;n63uV!r7)%l>759v1XhOHi}VON{S4da{q zl)U~R>5%C9T-r889NDVh9Xnro<$h!Mp~*jeKVZ6?Hu?4XWg?cS48<;=E^m}7hE-Zi zLX{gLT9vmIO-sPOG${w<@yOyBazj9#Er0Ak=S_Y3SE?_`P`M@I%5;q=U39t0Dk{QJ zBJLS(4>q>4Y>#9dnVq7`Z&&<#KA`>1P3`9F%1koyqWXyBm+2A&%^M2`3#}@zs$BAW ztLfYK`-TI#$VMKw@_KY^iy$tn2L!d8kK>7Eq@k91J(9JfHWCNa^3m&=MoQdHX0JI= zgA{l^e3w#Rr>;vB{Scn_0nYij`H|Nsv&*)uoHTsc$eXVwMTMdAJO)>$Yeeai=bY&p z<-?BE`VqtdN1n@H;`5g|z1XDM=|!mDF~&K^JyTmSJJ}s9#fM{hz*Rf~pMV^r-IcE5 zA;X6aH`0{bmtCD{MNeejtr&h6Y|=;}f>Tcai5?l3R(<%?PIDKYNH;JP|3qAwt`VgR zww0-%T^k+w?w~8jI}-qD1m?(hmbilRCb-L|kMVhtNhO|<>n|w@&3m*#p!^!s$nRfy zsQLYA%`%Pa3PxjY@x^xrQobMd`Sgp|O16Hd|1Yk;e@nbS(-P1Br{N*dh97_L<-bcP6+TM29xsu#CfP?8W2J(k-&@YT* zy@aM;Z4^SJA}*Cf=)V8nkkmCrJblKlH;axe9&pRVB?Z*RtL@A((8w4t^qV-YArz!q z-ZaV5>SAG-(oi!nsk6kwVzFauR5Im%xou(A;E;!m;PpIdH z&@;{(*FM<%nd_@qH>vDeK)aYuaby$MxgqGvn2!#bS>bW|wPdPsWqi5E#>Thy*0~!$ z%W)l};$ymujr@Co&va^tD(6>X|2$gNL3IyV)ezsJ$$hjiH7)x-HV4%5Da6Mms)uO4 zlC};acN#277=3r5ei^qL)Q+&;Y};a-w&$R+ z&IDh!#}{z*Gagp;M^1BJ`02mKllMhNf6_c`{m~1~mec)PfYtKJ1YD}RjOxn-p6h>h zDNy!X-J24yZ|cnfwR~tEkIII|Ys7o<%Vog#3O~pnEbL&VHtAf%avu zIG~mf&96|s#q}E{&irSWXtE(XmkGOaxb1H^2h{S(L{i-DsHrmV*`;vVZ*{MxVc*w} z18VtX<8jg*E2EZ$RUDhvxExT+$L=3AE`RqnHMM+BK!WuBi~0bhFLHkXx8c44`J;`I zDBL!C&jGc3X#7KC8Xmh)8F4v~%l$ekH~NN2_vGjA-{dF5&+)xZwXgN%0IyT!eG}*l z9j!Ma-cvu0T`C*mIrAOfKg6i=lnE4sjb%s%MOewOtNN|(iDsLIb3iR0d%nHlyljdm z)$+0XGflzehNr2Pk3HYsa9%dWlWO^7A``p)X$np^EKRk1?D_VF@v*6%Qp?9~f0~NZ z4NF%oAA7#NVSH?=r_}PX=i8f#(+x{kEuTyzWA_gl#>=L7N-dvkWMa>^HwC8~mZn-h zcK@JZd~B+x)bg?C+nb8h4NF%oAA7#NVSH?=r~Yj7?e>2dx+G-aLzDd9_emhrcP#ow zLWaLT$ln_D5c_I#;Naze+8)u~9;_<|FIV=TH?IN|{vW;c+!SprlobVDX4{DuZ0WUZ z7DpLic(N2ahfj9R$j0Uw4&D#Z;i_~M(Z1U_iGt#!!czXU&&;CPDMC)4(pKe%_xVPU zW~hHdhF$&6zV0gysO3ZXavR9*zQSVXQ=0>7`EZ%ATl)!{vM)KHmJjU#V3*ClEP?2G zS(Q)pCmI%NmwChZrj}2`QZYY8YYoZD>km1GT~5r2_}qq;5Am7yt>H4T#|-iDyS}m1 z@`<)LU0rEYS&=23;r|sWE|;0DGsKOC8MS<v+kM8@lj)d|a2<>D# z#gWZ;m$%sE$7aEKejn{YKgx~$c(Gkle@9MPd2n8>{VqxVl31~&gciZi^9Xx@lk&}i zC70`kJnSL&+J;w;S%vU_pE4^qt@Opv0|+P67nb%3Wx7U`E|@YX_hCyXw|Ayvh-;?X zI~qrtYkPD$$T!{V3K=I>oc=7%(A^@7q{dX>QM{UZb{RF@8>1-M{xuOVCdKwQ6{%Pgc@ZjJjpN z1g$++=^QS%gZinyZfu7?+Kp3iyfe`kDR=pU^Tzm!UD$d%$D^GUFoOCz>b}~PPdvs- z-r{>Qp49C)d&>c}eD*fIrg*+H5~Y3-$^XG-((uA^zj_qzds#3c-gqG+J#Acbp}C(; zdQNu7#Vtj%E-Ri8^Kh=f`MplN+~>T6`qyM=9HN~oV9+(9bjdF&brn~5Xt*$;)bDZ@ zXZyTCzt7{rP$#P>h$GrYc!Mtg9H(b!gi-6v_w+dTaRwB|$@B<9-B%Bs-Y76@)j!nc*yl{B+_vv+4(J?^ z^?J$W=JARPQA%JdvEllnDJ$0%T#_RC4!iP^)U5y8u+pf2Sg)C`^0l6Njcw_RaJ(5# z*D`l2M5fZOXzVdaW2dL`f$#TKK9nEj6)QhAT)n4scpi>iIZeK&Z;e*Z(X+PMKR6)I zOB7sz_8G9UV5!{5Pvf&fDD$Ly9z81^;XUs>H0iz*U+~j^tYoMir*Q+*HKKIk^@{mL zes_5=;Fy##%2(v{&~$~{Kf-xR$&1Cf z;eOH%;3M31;iu=0pIp?x|K{CA8jE-GA?o8AMWzHFywL35X*$8YM~hqjd$qG zpGA0)+~)05;T2zWS-U!A^PL}@MmI3D7j!dRnXVC~i+--~Xjd6da??2F$oBgJ0bUNO zk#HDdz*m6^vp?p|@q+5OOG>U$y@Z_%mDT=cWI3t1%G^)Q9MVDi4wZhU5I;{^e}3|! z6tVQ{GrHv57+QA|{g?nl%^Jx$(>0=W!8uWeOzV<9+Fj)L;c!Tww-{%M`hCR}MTTVS z4~60=7t%d8T&L>t%GAbln=0MLL%45KszP>LuWY`?EH9xe6Eu0*lMR{JvVCp()hS}( zGuN(otYF&vd(PHzvb-=|MK8&V%kOr2-1A+s$kbY=tv-5Aq`dhJlFkO9D$OqRN+$L)B5zwoYeI_4NFHk*1 z)~+MeQmXsjs(wFQicaGr+x&4HQ0Jo^fWq=kuIz6pN=~Dp&)d)09N1qtU>Yah9DSTf zm~RiA^q*AU&Al0aAI;OJ7M;U$o!*&~ok0x!{EiU;{S#Ae1->@%f;wY8onypUJSO* z^jenIyU_TI=@BHlkJ(_c-cesC=osUhSPpbFxd~&{e(NC(zfvEH`p|3$IgOQx-{f-t zn&|pl!DAas4yf(7Wu!lt$mK~exIBr*G9dS><#5tHk_QSW*-+(%p66%b)zaqY$(1dK zlS_uj= zgCr5c3)iqN4FXPhc^`F_dDb72P1d6@2zZEIm)zDxm!G%&HV6L990&nC>v_^$(e<3( zbNnF*DXw>(TTOm4q~~;1=^7aqD?QIHbrsEa`Dgf?{$lj6WEGb*T2Dc)hgK>0s1B09 zE7KFZ-|7ARnnfe^?lA5dpGv2=Wa7X#K&o-{KCwhl0f&$#^K}QrHJ=_f93y{ zCjRe7URTHUCesO{Y^?B(bb4pYOpFFnttYu&l=}zNWw)v;WgNEO=D@+k0eRja?H;pU zTh&9(4>y&)`{AH6=8-a>#}lq^j33oxTq{`nP~DDj{U6XjD_iR&ta;|ajjgAD~EBK1{>rclb_>R zr6EV8aJ5gy&&u)Yvcv=biLjKz5jXlVeKZr*lWzQie58a zee-zrTJ1cj?KQW>B#&fS2UtFt&i9Oi<8pj*Igb1c`{_CMv&(r~g)vQb$uAp9hYY*= zUG4k2=<0JEk6p&e_tD%~X+?Y14*ThGsrdDio-vPbh9@_0a{bGVgW zTa8olUFTQ0yx7sicu>Yw`bhNph8`LFoA=D_+d6IHd>NNY=kPdiX;qDiD})4ioRait zY+Pf$I&ZNNY=kPdijd8h($2$Y~8`1)yjITNle5vEEdoZK*;X62g#;4Lb zJYIZQM&>WJz$cIM%AbhNzx2ma#3xs*Ij-5xDQj05008I)W}5YrHucZW0a>q8*GAXt?a=!T?Z*20bjz<)$9YUw`4O*Pt6c}R zz2>nN$s<|PaWX8QOy_$&G!mENlgn}BXV}ka@;$knw^bO^WS9K1p)|;_tKZeWuZyle z$MM*u@K|x=xa_yx1D6BTf97#Z*A3D2dMot)-Td|6?SA)-)k6%H&|U`A?`FEnsrdDp zS4xK0=ZwLU%{eaKLn{2iO3y*nd(v07tcP@OWuoapy!v64u1&K!@Mqyb2tZlyS1Ed5 zj4=8Z&Fk{u6_*zNZ&S(NpPod1GNku(Rp}ZT7c0H5HNO)@!{zllrO!pLmnhFGum0(S zNw;P_%lR`tmCoUD;Imk-Q#ashB+UHG{g)Z9%FpEIQ^Z9VPg(H$j7|$qFaU8q%5=ub zt`*)o*6Y*_5{aqncH}yf>qVNHx9dUXyzSZ?5F!L7uzsh$6kWe}K>sT<&b;m9nj@Bm z3`Ju7X1dB#EB&^f*NFV^;~1YcjMGu|I-355v3X#5?|leTkF-w+AG{q!VOVZdq?Aj4Z{aI26v$u?v!B)O)7K$0IbG6@v?zsj9lu+P<>0XMSh~uJ@rd?JizrP zKZl^0hM$QU@c@iqm(TuPsA~Bn11`xw_r>MW6JO_7pX zJ|`d(Y8z~QXbNuEKTW%Q>d&)%`Gi_NwC6va&&&EFkADdl(Mi8p$2cCl6vsA=#{s*1 z8jqJvk&;?IU6Bdt3|TU)7v%Ez#wtvUY+o9k19tf|I!hZhL3w>=+V1G@Fie8OEj3_0YK1>6_MrsSstp zrT<{YSBy*uBmYOR2l%Iy7A*ee@GYnExno=}GM#a;YsI%(>%vq}cvxKz%jwDUwLCuH zFk9c56SjM>av+2k=lW)|qR&?KP4n*ee00ghU*E+1($|n3DpWd$>*q6Md5cPY{v401 z42P>~2e>@4a2Y^))zKuVb>l-V4+q#_m z+R23-pa0J2a1g%Zu+oj`jEmiR;2Y`=1fAHLW|-esmgjfPar-I)c|M#h>GBWt&GpKt z@&5oS7y0{BL+Tp!8NTOn8r5y8p*U>SF!i3(Q|Sl8yUBxZu`Ea~+*$9^8(%bfIxsvFWv%AWG3?_{*5jrNH>1eVTY z?E-rg>~XLT*g>$PU}wNCfV~Iy4cHVUI0N=Y*fB`>C)lk>{0AgniiC5J@Jb}S5edJ9 zg!drf`;W$1ug44F!G_?Q1`BcCcp)at5@P68LY(r55dZu?oUPj{K@7VnL7ciXL6l#R zC?*YPCR+DsE{LCC6+x&~ZxJn)p?8nR)D@5TXPfvqP=jdPUZ-oP_(sklR`p`>Z`hY3 z<@_s-I_JnCZ~jY9pX8GCg6V3m7J3o+AtOBd5TCA4+G;(k=4W+Zmz-F|wW8Hmp13`= zO6x$Uh46wbPvwdF$;w%v5f4>)+6;O7%Zu+0cwo#YuD&lI0t}rYMDoORjVN6#c`(b5JWsl+d35>d+N_g!@AEI;*|z4chj;y3=N_#oA^BlC^ORi+`H@Ed z`=1=ib&u@l_lf2n%yK0EZ@8mnbUDgx(Mg;<`mE{ae{|GumBl(oxxdGBmCqJ(RJ(sS z!G~yN?jRm+NV}!x*^ql#X1IQmX`H4Njl&KGH-wkub}OxQba`3Ss*^bK?6R*a$Byhk z{U0(cFHF~|k!!u=#eq{Yi#@Ip-tvlI&Kyi}1Zv3-l_ixK+el8f?~mYsJiaV!8(n_Z zL%#anJvga**Y~&l(-0t*AEvACP(S(6JJv2FqSiZH2dL@q&AnWAG)4M*gKd9*HUxlN z?}QGCE;piGC-KtT<6n96(3^VBSLBB2>igDDZt{ckJTCb-*(Q@8S!QHESeIK0z@_1`ea&-BjlzzBo%d_8XSUH4KCHbM=k4oq8`pHjL5q9bixM#RM!FjS2 zna}@OpAsEsYR67ue#OpS=@0CgoPs${GA!pz*Qt?f{cz%QO*tlU(Xm(MyRq6oS*Gjq zN6_28x;PL*0N0P=(CBhg*r}6f{rAE%#{YQX2mdpe&T_+aHJ|#)4adf5qgvZ$fe93Yor)m4^=78L<&p0f){49ZdExGXROD2CYZ}EzDdYUXhOjmPaiSYTu-;L^? zM{wlnl@1cw7xfNdjU_X&!qxXZSnfl3QLc9?505T4TOn6Hzu&#_-dhJH@9d#-h~~zkz zBQHstV`Rzl!*mr%{p2US>;Y|C5Gx^qPJhs)&9paEj#zdWS3~PBe%^MiIUvhXZfbNn zs)n2${hykNcdkzO-{`aT^k}?K-{Y9B=3*g7R_g=m?h_das&b^}(^U7e9Ljz*zi44< z+yn7mUUwNfHo6>%?w!PW3sxMm=ZSAV=I<*kM@(0FwAXTE@y&(uu#zh(OSUQw`+nbY zKwiJJ>$vE0mDi(_XuJG}|4ew{oR<9Eh2@IrD*C;btH`$)O4~}F)I9h0Uao8GcCmik zl;tV2S9Ey__3R|3w%C4Y!J5ju`Fjk@6Vuh)_g zrfY9M?cTECotJa0geO{AuJZYO!|@b+4o5Br6-Qaiy%YJ0i@SHw?+4x9mgjG{95A2d zWxwHa2j+ArPPH6xIt}$@?ALYN&@>K&`{i=5-DZua^rNFir;?8*EG+#(@VpM=iTSF| z8jdH9Au!iNY19{24Qap0_)_y12?y7JJl>Ho#2Qx>$3%Yt>1WuF$Yv%9I0~D6;?5$hSmE*oma0vP{Oi(Dj#Z%qwT=i%C4^0OGhix7mfKM^$6Mnn@wjO5>AH!%U;3%@Q#>!k zxMIGVcSgmY+b8o}QA6;=&s_CYnIqvn*FZIH<$1=$1ZzC`PKXv?^m}aU>}J2T=XoN= z6Z2I`8jh#B=Z+|?J;fJeisfxcJB#Cp__Z}q0T$z{c(^sbHUocKZ%avUJ$2bPUm0H{ zqvd-vf5dz>g&_E%_W}PC^F@p~6^m*f55%zC4zC_*jhna;IDcCI#~;h=8%Oqt9OH)h zIydlNZ`_1AKSa-zo@eBl26VkQk9_=ynXrfS(}@6FxCw-j+n3J zrT#dwo)2Q1pr+H1u#83dxFK;KDEIo1QN~YVk~MyOz}Nax&zu{|*RJC6d&Up*RlU_8 zKi2aC-Si>ett^b0Ror&F&k%jPuG=Yy5N>7cK6){-GPE%zfuN{^l&> zhxux*>W?43!+QQE6plijSLKX^8>RtyykXk}YaFGHj~1mJpKurC*BtSyVuzToO2ep- z#z(Ek8|s*^X)Ii*Z8J5j${z^_*MMw);wM|h;S0Yiu#lq9`+#$ZU?#3tZ}pvID2Di-g9eqob8-xB+WQtzA6!;B7FN} zJs(pa{HSX*2aQ!tP&+k=FwZ>0edbF6nyu)>4mX6+RH|2ebD-Ne z*&e0Ou*Od%@YS_huX(AvpL&|#+u`>Jncrym*@O9*1N~X5y5AdNxt(1x%NkERfw%LY zc(#Anv^B%{eI3RV^VK};u|2Zw-FcZv{ii-j>#&TYnp3TDlz2+CILNhq?P+T|*V;FY z`D$u=j-!2JekNk;)F&D|EaPb4>DD+ZJ1tsV;z;T|cT>^NJU_$si1}(NdyXUPc^Y2l zpr%*fu#6M=xW4fm=-12bq|G64M7lcvjz{l2Xw`OFCagKa5$#f@@-;U8_8dpS=WAr# z$7NaLzVwV}k-7cD0p(-gKb_ylVcavHn8xo&SyboCv=3Coi{?Qk~X#S_!;)7JYPE!ZS0DJI??P>wHHp~_iPwP%vU90>r(%Et!d_WR18JNx6~)rIN?%6 z!|kQ&d~00AtC|$d!?_a6uP?#{o6zqJ2 zSAPwZ;}*upc9%6i(hH(R#<>gU54`Y~V^n-FUzH#TK7zf^?#E07FRBLjt#B#CVZ3zl zSmVX*jutzXM7?&?U!7mM#>fWQd3s-u`3BqX1;GogpKDTl_!EyDG*|;=h=K8u;I+m_ z1@Lpo#8uy+y8PSW(=!Jd%Hnnn^TWW6sWH=7 z^-!?!xC8Nds`_teShg#<%dGLS4)|H{&h6Wd`Q)5GReUgCl_!W@3D%A=VTR&};6~Nt zz7>}H)!Rehh9v*|@(W(tv9o7PmXQrA&z(dwKi^>cy&$-u_De0C$nB`O3#{>5dS0}+ z;-HixPA-c2O~o(s{Q?*VLFAC@#ai-2aI0!?-wMn2Zq`NCc&P%OuDtBK7U0+Ixdxb9>>Qf~%y6YfzZ zF64I9$}(%*w7EE1BtHMgr^#K`{&NPs;0DL-DCXYCvA+6TjRVKjoKU-s|Z;+ooJ`?D=Xv#(Xv1Ao!8nJ^O?mV*Iclsn^t} z7&F|BNMy9%9Nmxp22B=sI)hH*pwfrt@GOFMZtXudbf+-HOih^%NOr%va?IK%yZyGw?<8yE4FxFUh8O>`OS^rfO#~<`{RJ zUVVIyqdxcSZ`W2MLyWh|>#XtC<=SZR@x=SCihXhI3A+#0HNkjezN()9LK=cM?E}RG zDx|GqsOpyj9<8jkmaaqDA4)Eq2fS zZRT4i7*R3an6IYLgm??uXWbLLF=b0KQ#~a3D*a+jPv@$zrS6pJ|EIaoBb`5|Ka>pLUy(f@vE%u zL-~Wz;>t_D*;|Xd$IV_JS$j5wsfA{6~jjz%g zPvYTdQQ4_xe4F@5*BwU{4IJZ%`8qf7-)MN+N5&5#bwuFV?#Ypiw=R!b3mbFe;jlknOqGb2#cSfGH zQ@_-2-5R~0Spm^Jm>?j6d?C%>=D!}wypDrMv1Yv1et ztNFDG6Q+%3t<`1w^|>nKj_p~+v(|Xq2|Uhg_Rzt3B{Tk~u7_s6s;nS*lh@V%=lhw2 zpAj5QKRE(AL?%&hAluhi z<1YQBXc0f9wR=&?ZJ(*@rkStmx$$wgZ}vYUwoiTX=CF*jS!=CvR`qhU$mzAE`nTbE z6V&z7%s0m#bRV{cwbyL^1^TA7)atyGDo3y|VS{W<1S7$;)3`jj9^JUk8fWpZMvKL( z4$4hE?aKb@I%?*t(lvoS!+6KO*B`A}=>5@B=z#kT+h4QBUHbZHQ8pp(+MUTm z20b-aw+g&|pZQ_nF4N_;=NWG!HOYEZRfdL!+5WL#AB;6L?Y(_}1q5Jx41B{HA7!sc zi?(Y%%R2qhC&qr%TGtkR_m=j*X1yeIw;D**w{HJlk_C?L>{v0kx<`^fX zZ(HM}1~|$Z{r!`t&n#K-a|gZVZj1W~C(KuM6$B@8`+Be8r6IO}?F!?iA#tht+SkJ} zUMk@ zI1Al&Z+32j>md@0h~|;_d8#r+!h5a(880=PtnrfgUbKjM|FCK8MQU1=(J^4WFkh9# z3NH*2+7F~4$Ki2!8o%8_m?7*ij#T*~;reMnZtwQkY>k)V_oKxl2QO>2;mlfK0oH*mEVKA1A<9m9=mqh=Xz^-#|F%y}Y&+l?@X2xg#C)9__#fx7yK|k{g|>`*m&==5 z;3zD#r8_*?*a?CTnk>xs=udC!6HROZ`E5W;)P@INUpTioZo zcI`)5-_S8RD)02K@-;U8f|d8=Tu1gohi9(K?#V%mVyG=h$zF+j*$$O{62cDQ+W#vU z{n zU~*2d7c3karhQDP!#=XzqI#Z=BXuWhJmN<*fPOKQz~wsk3v;<{k8>SBslA1GY($5z zcB0%*>@~XZ=-rR>%Q6PTe#HgU?_xeKH#u(I!2a2|H*TAhoRaA%_M)F|&&zWyapX*M z*b7|+6Vsi=j=aKSZIfI}Qqsq3@wo9Xw|hE}KyX8K&-DL}Fp;=TP zB4jgwx196<|~ z;97tPH_X?V(qApy94ieF_^T$HHl;&2(&vs{8JGw(PxBaY`tZQz{)LoOgAe6;M8=hT z+~7p^^9ba2P~tDvc=G)eEnfQV!l_#y?lZO{PjYB6%LMUsrG`LJjeI~cae9@Vk|o;)RItf z#dSKJJkX!1`V96)SnfY3M8#+#BpJ^per8K?ERM5wbrYkGifvQzPqgr6Rjv8)i@Tzq zG9Dz`C+4ep2!Lo$aixQg#-Pbr;Yq)uasMM2t)D(+Je4)K#?v<7t>nBn2d`Z%o_yZu zKQo?~ucqE`JY{%G@*LCMId(5$>fgo_=O=x zUjH?(#pm-4$I~QxiL1!VfRgL!?cvD#-lkiQNIz@{%j1_<;q&>1%bS#)jm4qPxz0Rq z2}>=6tmnkm)_V4}j1f=0`q?dm);w|J8A?6Ce3qB}hRcob`nv7T05oJH6I*~ zV2m|k_GSB&(8(G{6&--1TWl3o8xH#9%)|6}{5UfB=GcS2w;q62Sp8|foW3qz_c)E* zpH^k~H^UK}>DrdtQDt4MakUM&+f}~foM+3rA2Zl^Sd1&?tIv>8vFG+lZ}Xwm>hPe- zYYaOTdG_j4YP@hYqVkXXb+g7(YS$Q1(7$>4j=9zOv4#kYC+4e?H5^a=We%tlz1WM) zYxj5^Ih@X(;wyqF)?m~6K19#>DvP$p7fG_dbkXLAU;J+L)gvjSkKrCJqWpZF8~6`` zFLl1L?zR-7k?m^>> zmmGE74LqJo^7eqd%$G#f4jU$KU@TSEYk6#Fy(a(Ux_`_aN6q1JI+C*& zqqt>x6T63&x6i`|efjMvi|=K*bbAsdR6d_?m|o3eKoqCkzT6pxy#LI~J$uyJu6M9J zEU(Jv^9_?X_!tnyE#udBP-s1mm~hO3OYi&kE*=MB{4$^AWxru^2gZP8Jf!ysE$5Hd zuXm1`Q*P(+1(Ne1;FtLsXM*`eV@P#4w^7C&RfBf&gb}TdmBe}amZsxPR><5uMzzX!2!PEP~ zvOMv9BM3xB2g4 zuOM=yp8@!1zQ&aPg2)qK1@wcBT6M89T}jzq=VJek4nD-i^0^NQt*;523$A^ndDV}q ze9V_b(+&f|)TysJWupixKrCOIKB47%`bf{ABhq@!Td$?A>yO?BV!pxldqLz2umbus zD-CzcII9Rlu7?+%cjNzUpYgIP7xVoB83zF&>eQP_CfVL?i?h~K>Y*`WLGz9qE_m;h z&K{#d%>6;;hapcu#DJdgEDf=+Nm|g4jTjO80Bm}$jj@l2Dyus7MP(@B>Zbv@T~glH z8c!7SrL)TWUNPaM)qfbuCXd=t%vVznfTvD;hlQnTM9lVK`(f5{ruT~x_Z)xLxaC8} z_U-+PE)nCN`C-Tz5IunVpis|rpi{ICg^GLWl5OE{x zpdrUKxS8>{eV{e|(g(zdR_(rjlb$aF=FYFecx;|@9#T)(l7O|FJ``~gQmmZzVp2u&U3^T zvL@>GWxQ=X+8S^1N5zPgyBw|u3!d>A(++;TF<(uo3Gvow-+yJB6R9`Vr`P!58brzV zEj`{EZa7pfO%!4`1GIf>vFmc=xzv1`Dsr$H24PF?=?|=g0>YX(Han! ztHk3&=O?lE1qXe6aZSe(!;n&bXq^D_5j44`%TMUKhy;z($W z%yi~CCff__^Bo@TcznTPd!7?79ywhFN%+zT-Q$A*Bu`_Ek5gXurrX=;H$~nn5h>%P z3V0!x1fsmE??=+P$=@%JdhgH6CY@y{gYXg!)G(i}ksaejnqQs*fGh@nU2ccRTM`%> z3~P@ec|2c?u$DLL#2E2>hs2RjWS`r5a8F$-l9%2SX1**d9oIu%%XM9iiF;MXaKnsO z_QSpJK)6nBuU3V?5$PkXZ0%#qF6p|Kb;EX2<@5PQ!BLR)cXD~n9chh!l4afS&MVwY zUTMj4vD_-3&o_?TdZDJFTUpO>Cxw>x`#-jLe!udX6)X?StMd7L|97|yRo-B9V=+JUMn3=TjzUG4;XSrBzmCxrn#fIs*_By_5B*1p0 zCJecU6`pnFsKHNUvRo{;%IEWqBX`~F`DA>TCx_Piw!_DH|F>XSaf#BdWj@Qzem&%` z_xg|Yl+f~?R@~j&;`~?Np7pgZ5$SsXtO@g3PWI~|?;ee#)gU3p%f_+R^2d*f5#v_& zzH93>SGF6b14Xlg)GlW}%guh1${)sfT2r^@33icoIzR3D``d5}<8Rh@Yy4G>ixDGt z#s0l<&`j}~@g^6+knqQRRf49)U-;vmO^rh}-}MPcFf7DoD2#EqaiTR2<0r(3&pjV> zAGYl8vhR&~5XK?%RsAibux=-bg~?Y_hD z&wN#~rpI0V=X=(LkP3`h)#!=WJ$~)kZB8PA;K-x#d**9Q>2IB%9!1&SyK5uV3KHphj+$ig*bgEfT!Q>in zi)h^<_PZ&ZF3Y9z`MiZ((+k{&WRgs>JYA-RAqX`B`MTvXmz#Jj;G^;@ z&$H`sb4;QA`d%M8#>f>B4eXm5*pq%mT{+oXzSFaa|8eS`l`S@Bvw+{CcAPRWAp6u>8fIo zY)?totZ(+|y2f^;h>-K0HQSu;Ryfxh)Z;L$EBo+`qkG`|M@i0kAFbaof@PxiJdI;A zA3>7~mhaI;w6nc_St`7`@@uqS;<>fQCu8*�tH9%(SA?N*O=0uDQW8e`k!kC`og5RS}N1-mfOwS6}f2Y zfr?$52|{>J8U82T@Yk>(o?5-J;}hIoB|i!+R_4<+vIDB-VHu_^gZ8|36{Hk-wB?s1 zp>ayTx)dHiKX;Z{KczpMpgq5hco$^;gthT>M`rqKXLRV7dJY|v)1PBhExvwM2qS&H z3*(m}(^Zt6OJ-Hbde|98`i?$VugExP<{FNl(^vU?zK-;1jKHf2U|cBoA9ClK^&n>V zZ%KG6v&V>Y7oT`K-LgJoh4Y-&ryag(oemU|<1lE0`E-r!g32-3UOXhlUSgZ+^yXqO z^;Bn}7lSGpB?Z}{1~=1lIj!Hf&vHDJ2HA0{!>B$ZyHDna>O5LE+#56qM8o;4Q=G4@3vp6U@L zp1U6F;nSOm_}R@x&ZjNJBi&nzS0}a;XZ+Ghlvl-y^DjSCYPw0B402)4ZHHv zmM1>9{vTOB(i8K;lFt@eFd0v&j?j90`PD0aDEaxzmt?s}Z_E!%F4mi&r^$tL{o`;x zM8MB+n<7szJ-u`7`3avs^4qPlJftV)tMa7V3k#RHJUP71-grhCFd%3zOfPhJ&~WfN z{1!LEIlsV>lZFpA;1nX`c5L)1IXklEne`P+zRZ!`le#}RE=`q>`Ko+D@s5jpAl8eR zAEVi`YVc&+meos$8FxK03T*LS_jO-vnLm`wm*&W)_5$+_w%<#iJ~;`m3(ZHJXU|Kv zyY2Yi0|uxag7=+7XwFhnT+Eux#sk#T|o8FP7uF8a^2VgzmDuVDiJKr>3YI`S_+@f8|mY15g^53 zn_l370v0BD!=S69YEp4ZNP^Y4E$oPR#%ss4%5lI5+& zd8(gSUtCwo&-2@KcgG$dez6#rX^!Pp`Fx%p=VS*)^Ro-lpjzyt2D9GiODmY~LfdbW zYrZxtNg2RRJ`g{@ET_4jMCa#$ijP8Fe#%2H;86VDZ}rd@Mo%3^$K+TZm9L)_LTcf0 z(W4TTSyTX7ASum?WZ0olYFvydAgRzw#d|qMJ>x?}ET32qTE6?vUa<4qU!DJO`YfNy z=kwO`jkbHe4od;$daw-gg?gT!%--7Kh+AHn&*`&#Dxc4DyEMg_lL8ESTqOoa?~rBW z7I|}AOA1W5>aoyV4ubV7&hInrk=fH`p~b8_mP6(9dBafJGIH(cba5!HfCaFj)0nX+ zPb&>HB`M>4CFBXEmp@;5c2tkqXRYJ(SRR$n=UIX};{%JQtljf|u8ywLKvKKtsB z#NH3&a(XO}%IEVT{amQUsL`SArgj$%hn z%4mE(y};`z_AN#BZT-M?b9r}#r@N!K_@IIN}ywMEQiY1 z&kAAmEo{ko4!dWx$F-yo_A15hwc9f7g$uPYktDxtxTzGx&uyUFED!fTe0XlpZ?6IWj8L?<}M9x!j1NZdyCV2i#mbym|}iHT=- zYfR~HT>5k#8KWU5FXpASA)OjrL%6W&7q`SU)GMdHF^vg#0mXu-e|!XpK01~JngOD= zFfBMBL){ia%>lg)%7vUXcXlHB%GV>p`H1ihMEEBnJf^DcM%OD4ryEYzkxug7OpYu6Lh^@W9--@7!&AjrPPhbAOY>25jh>o#=C_mp| z`#sVt2*r;E9WxysEQQcUhN!zx6nI~_6nC&3Wr`g12+0P>?Yie*Z2wyRr#J1O^vRJ= z<)8T)Q~D!0lBSHCGzP0g+-{f0TbMFy-1s4Lw16o0Zhp1Y7{j3m5`c#AJqlIXh7v*_P{WIY;=buU&;o1FLl(_lP zoZ~6Z;g^5jZ0mEL$5b3JpRSP|r9WoeBrI=m=h;g#OWY3qY$-g>cPY}PXPpG1`~-XM zEl&LI*JkI>xnIw(ejPn`=HoV#^XEI+UN9!VC=Y#9fFQ&Fp1EvSb}IP}_S`@J`llh^ zclh{k^|>?OlsE#EKAt$5Svh(eU4PuBc0g%S=zQlaKBIEPrd0$5&GGYA`FvhW*NM)S zmshT#hiXeh3kvElG|B*4P35?O_1|T2XgLl)wqNJJ&tImENm5!Yhsw8>Bh~K7S%QXe zZF%J9F>r|)hkX%gKTsLu?AdM|nNhK1?ywJjw|(`xibLkpHL@eUj7P&LZ=Aab9Xxc@ zbu9XD5$Pe6oo7t6!S!q(sjWnIpTWaA{oiib83r!=4(vpkMuHb z(s)`um(M$_(&Oj~w|_KAEpErN7`f4dBy_YdQV$Fw%da zdd>Ik7oP1e-?|)8Lgljvlzs-js6E$(Rx_Bgp4*g|@yE}b9w66;|LgV7<#*fL^Xo%e zew*Q+`J4{>T6zne_R;q2g&0@x8$!7ru0G4$zM=U*lC2WC`st4s+LlAEDJLagR-N_D z=iX!Vn9(HA=3AN1>9IfAwZLT?L)%;7&)7<4dZBHGb1B;g7d1_^HVEmvDciw1CiFQ4 zDo0eeQ@LV$Pd*V{M||=rOpfoRW9G@nGLQImIf^IZA{uC@1}YE%+oxG)o6Bw73(d5C zNjh52<=3o!htjG@x?%c&{H4zp7zq;&y8+eAH`snpdlRO}O>Jn~B$u&5)o4v8V{aQ; z3!UjgWfo}Bk*P4vn`{q5uCwyL^%dUx)Q9L&XpZEf??^D;VEetGawWOldCqKZ-h1$s zvRZ=4?TylNLhGyj&0{-Fbf0|3Oe1BMi}`+mjDw(ZCFf$$2wMa>Ypbdh_wn;vSsIXs z+IQvXoN3BDH%7eFreFaj@zwHmRcoIqeR&K8;7A^tuV=o-l>X?sf&5QLe_*ugc?Owm zu@Vtb`f|I2(hj$sLHz=1Ur_s;+7;BMpnfN{A^L&(gN_8*KvXFvfJT8*Kodb3AbRHW zK#M?UgDwRTu2+Jd0&M_&3fc+k26=6u$siZ#TF?ui??G`ezOz8rfwq8-fMG8Ny$7Ox z?R}ubk+}y!qmjX{LARivI}eor?L=@Q8ZzV1m|BF!)YE889f5|_<7h~^(1@CWN8?80 z>BSz{0|gDHzGx_o>MO)UhocQRP>8#aLcd`M=Almz;%AIo9X=ZJrV6nv9sTQBLhQDq zos}oVm?eY~WJBznn1Hz!5-nz}=pH!DL-tdHt2DFE>|8JC;M`^Z8J6B+byHD#i_rkBwo-am(xrejE|k?{KXVjC;wC!awslefFum z=%tlvW$eQ;&sm%XgIbCUINkIM&HV?eUDR=uK|Sv5`ue#GPR+hRkNFtbz>eaWcFfng zfqx@i%pvKoYEVA{BkMu?5gRWyr%!bOh7ZMN$TcE*!`o#S#fZ@p#ru=yT=b#w$^cT< z`w`3!q^uvQ>FdQ+lVvQeF!UNXz^rO|kn1&iwx|}g_CBftjF*L9&vn7IT|uY{8q}Ze zhx-o$q1w>KW=SVx<5M9VJvZ+6keuX>hCU)Ld<~T2QpSH)S?KaVW5b|x`ycWrsb6#C zQ$5LigYEaYw@S0$#$ck}iOq4O+r7EAezZAjQbA4z-sGicEz7e#40+z$`s?dsmJXw4 zjpkS$<{NCk7gC<2`SU%F`KUff8gsk6@)B$Pl;M2AmVR${?)G3N%kwm>J@EPu^ZkMt z2eLdFMV@)~YzIr=@=$%2>~fb(b1W*tJXj$n@A=y~1988M|EG`+rzxl5Gp?g`Jn5HO z%TM>+ef|*_T+#LOm+6=s$xr_(pSa{g%Af8mcH~WVEd~I_I`go)K+c8vyP7-0kWXCm z#pzF;T>877dO$vv&*$qSAKB&{Y%dv1P9GxVa#C?wXgxmAQJk8THfJQu!Fp8rd_JU{ z(+eE=a~(NoQcc4+6jteCftMqoOS%5+a=E!4L318+KA1B_XM^WspK&j`xL3_I>Mm%G zUet9v)xcBSFJq@Za?|B zN*6|4y){sQI~X4oS6ky_C-5_W{HX6Xwi}d{d8n>%st3uQFkcm*PJEK|nJBxmnV9`ZGtusYX5xX} z&BQ7Fn~Nb+n~U^wnv3@yYA!zcq`9~{riJJ>sfD=kq81|hb9*or=V)Gg`&&^W@3c*);ZR(i z|6}`^NA2?bJOxGxj>dsUu37oZ!58$MVz%SVmy*^Fq?UqHjhVn1~M0z0ofbFkuC{A2r=|Y{iym>!9Dc4WAHwDTA=}T?*u0whGuvPM{ z-M+Z^`N~strEvYkd{tHE@}Mo+vf-U{thUB$J%Jvh|HX}9_WMqN{1{;Edpvl;M8xeq z4fv2W+wV3vo9(v)=jMUr_f#%en{(?;clKNWw&to}zws95@hV?GYaX{z?5DP8mpzY0 zuSJ5sJyP3rB`+T1uz7aQ!dx(cUhNf%FE7cFS>2e^_AJ2FK$n$ zd_Es$xgJyO_1NWdEw_ua?lrfIOV_NAIu;4kK;D1S?B7=39U~6?{DRZ_)~uNP3B66&h`e9HfOC)qWz?vs8~!{Y>>R)y?RhY5hd1`)N)15uoEh z6F^STwV-!FgK;yh89N0LWFmqpL{Nzc&O`)@P%(FkM!XmdnTU#fJk~<}G70O#@-Y^8 zBi`BgAI1((h!R&;MTtw@7zZk9F1mf)LJax2m5ATcRxJL#qquHEv^cqIZ}I;60piU0 z31Z2wY2t=c7KtSf`^1~;KNp{WGdha&SXVz0B8KHCkL>6eqH6h`0{^{ZqCP3LX~u&3fk=-OrhYZ`xk=AipjjXck!fv)aqtfmCzsRs zmF99v*dtw)V^HGRp+{f66Xm64;;Q!RCg0j+B-YcBzI ztf!+0uSmU=8=ika-FzyV`Ra*($P`8G?nkglINoNxfryZ@3H4=*j13M-$Zs&#tY$@(~_b!kH0=>EjQiw?d~hv zHoLI()P6=JEG)|Uu0 zWqFgtsq>JY6_rKmGjn;Y^Wp>WL@DyjIH{3vLSv+Hx3|{b&&V2scd8eUsv-4w9!=}` zhy9T!c>IHKLTF*W7L@*i;AC{3Yp%A1_h?)vm4r zTnD0)aT5QiHBQQbqqon0FMjD+&daXot80sK!hBVS!EvJXR%Dpe8z=o~rXaXcC$$RAy=UZaNTnqW@7F4#2@ z-hW>MrN{!8SKm|C{i$M{fBd}*{`@Pu^_%(q^}JWZr}D~tRU=ehGd=c#Ld>*ky+6GC z@5SzE+<_Wsq|fu383=RSa$It|WZg4nyQ1#fIq>Niao>?UZhB_PKU>Z|4Fi!zoFpgn z<+$m%ww$y?GQ)|T$|u3xV6Q{{4j&4JT>o@MnAXrxxuv!SwLLn4hJxMztw$gO*DM9C z099fzkcL(c1JT?qwOOc4Q#q$NXg-nRq2VVwN5^!I>Y6wZjZt!XY!kqWI70*SxW>-s ztZ_2y*%)zpi&-V@zPe=7{p~N*Oee2f@&(vVj!Z997S85R2dV=!SrcwxTI z4g6*nM2?Q*Kp0xr;-R?+;?Z@4og+XzKS6wQ90&OnKRLn_T7w&@{L1U#Nd~gpR2IojvrWfz zXsva(RQDea8VsVg0@?0ypiEFUs0ef!=x)#&(AOZ^^I{BW8HnZ(d!rDRf_?*?2b(bv zh3x-8n;^(H5F{Q#JPIMO1YX<>Ar6Jn=n3O-8yXiI(2#f@b6qzcfplP8)*Pqn52mcn zb?^`&YzOh`bY#C?164xiV<6`@P*@Adnhn1gVF&Wi4d-H!uX7O5OSpCcC=E0K#B1!y z#*xl(xnJ*eOho#}?b@@TFkNR%?cwOZ@5+z`Zntk<8z={)cXeJb;guM1Z?8vei#k2m zil;TX957$i2(@$4@RDx6+g0eqmg%%FG`<>y*Ico|w{xCT+oTLP`H-MokKK8^-gZ^v zi-h-%2Fj5v1mNqC|54fEAp z5Ki=Uwu}{ey)1(+Q#2|T@V>ius%di7O1-nf{aNMM}?^EIaQ7aT7-RIpuwwoNyG=sz|sxip*nL8&g0cqt#3^^liR|K8}@NJ;`TrTrMQRjv-3?e zeiA26(#Ch=Ug;#V2YmVVI^Zk2@}q%Ae$eg0|Gj;lmfC&zCws$ujVb-n`&ruJeGJVk zw4t>&x~Q;3Ldd=}{ws<7uN@M80efu?AC(8P-!ykjZ7%8q%414oKhfOM>?j=*Q7P6- zG7chczt@1=j;wmeJpQo`xnB<|eJe&>IeHbDPjTh)qjqliJX?FWlET!Eq<@u9TyoT( z8tcF)s=gEt-(heSIJCF5XpfJKqPb`y&~-c>BKM~V%Y;S3CAZ-TuY_-E-%}HX#yqGW zK)9xU7LA#aU8nI8o>w94lO-bjQ+c2|fXYTs5RIo&e*&)_YGZHIFQa}!9H=j-ALua9 z;h-Zx{Xqjj13`m8M}h`}XnY1kH`;r`$H0#V;T0XNeKi#RaUfFF2_SmMlE!jQ1Pup` z08#(%BoMl=;$%=FC$^|(=)Gu2I$^+$t zXbj5*a)TCuJfK1lJ>(+LV$c#$F{lKz6m%x&EYR7Yb3o^UN!cebP?!c zP#NeF(50ZuK$nA-gRTHw2`UF&1-cq^4QK`ETF`Z%>p>Nu8$dULZUWs5x&?GA=r)iK zbUWw{(4C;WKzD=g0o@B)3Azt-Kj;C_gP?~%t3VHfDnYA3kANNpJqCIl^aSWhP!;GY z(9@u2K+l4n13eFV0aOio5%dyh4d`XiE1>z4GRck2Y&Y*K$9Q`NWf*zf~{ob4B}(;6r(MkItBs z#|9^zax&3==5k{@*v=}H}KaFV<3a@ zyr3ZONx;_xl!a4)AAtA+fGzrVU4NuwBwMSWOT4CZu@pJ-Hy8P$@sUfAmlP1~&$1l( zTnKsx`R)%IitAp%i=*<+OBZG~6B$kewL?93%qw7Xu?5 zK(x2*ZNSJCAZ)84%5k3F(Qg5I3D;i)It7$s(DCqxf#N{}L2;k~hEI4w(b4KTc>9GT z`_Fh8xWyVTWt(Hf^6GClueE)#RFwDtd*az24Lfln{F!7M@XVKi+JVl*`CWMK-+|r*oe63K zx)=9e4VnugdppG-vcY6K$c79B9R(s>91S8&kl!D4q~SCFaD>Tj^#l=S*v|LC@&4j` z$Oz*m_akfEtOKro8hM8&>Wncj#N549Qvuhv%vbdi9&S<`ZrUubARAjK7P|5l$|g0_GT$Musy*MTkvc|ij} zD{<~D&^%BAh%kfdRKrVO_=JtaK!jxKX5+ef$_6)t2KVwd>kX5p8oR-)pP#pe(ov9X}M?oFke+k9r&pY7;R5{#rPmH z6+aYz6bKN~+HzD++yJ^1%vNAt0Q>R@Y|c%nbKZmfp|+O`_GdHrv=`W`xUM;<0QV3^ z4h0b&sQp20Kz`O_Gte~C>;`Fth-?V?oj`OgVS(C@NJ8uDQ5Z>TVd9Z(Bsr11h8;Rb zJTw9K8zNZ9NK~|xm%3azPH=f%2YJaQfdKhh z^Kf+Tnk5Mfw%l|63HMO|j;^EcTQFZ^N`Ew7uD|~yzd}Wy2=u>Cg|`A}+0k?|>8AIi z%04yg7e!Jl8$J{^+Ann$&gTy9x+~?lAODIo^7ssV(l7HRQM5ynM;p(f@1%RMQI@^X zVN1i8q&+k2dCnYtcfn+P5wDkv$6c~sZ$g;UQsbs@8Hn|{?W=%3sSMNmzB%x_e1`W9 z+P@cD^?8h#GjZv}Q*W{_dyBvWM|B#>&wPz3{gM3K2=k=OE41k^d}S0BYBg#OZ;VK< zXOSFof0kq*`$P7K>ZfQB*)gii$fluaX>}Xrnd(Hs!6eWu&^*u*(50Z;LC=7we*GIX z5NXW{gQ4pS!!`-_b|osvlVAj6fYAh$izm8b z3`m7TY-M`gBV9y zhjE^7Fb2{&N*p{gN_^_Vn{p3Ei6ngS`lIA#V$&Vizpra^vHPm#qH;hBv29ZevC`L4 z+Z1yu|e0w>sVr6==2}o>mtS=Alxp4j_n7m>l_hj?NQBTtox=y9Q+Y>igE( zzPi7T5uaXSzo6if>xciaK-Uc0SLUnws%>BKndLz1lg(?b_cV@EBT~X#KG|1J`-3o< zd*njJTi-|8+i4F^d)-#zeOW2D%vZG&wA>mE zC2Tc{Em85cT;4PqH>>q7#mAT@pNPsLwdbkcrM{TaMAP_mj)Nn74ans;^+$8R3{82h&6rHt-%%B{ z?J>qGjipk*hWV;2{&g|h1~-fCd3Ze%p9%BW^zUkG9d(B%(BGv#iQF%vJ`Ja(#$BIq zu@NtQm!(?CCs{2T?~%XXeZpIJd|u?6eIx0B9F^r3_-DSxl>W$0&2-GI^#$)zT*LOU zW=Ft2Ql8ZHu!-Aa#OE`dubwx!=Y{;P89rC9>6iIZlG-7qYkrSyngg9&t-n}^D}1&sitP+f@pgr_rpQYPA81eXaLp5ZtJLAWEgYEa~wAV@5-XeQmz>3ea7v*_{ zsKK3NU*z#9e%|z~>3LCGi=G{|wYW|po5SPg7$)+MUD0?t<%-6ydVnxoq>W+qg?~6` zAPB=o+L{4cCqQ$7qe0_AQ$eSKazHN7nV>Szb)b7dRiM{FHK3g!dT-?zP#VYsx&ibu zi1dgm4I@xOl!DlPi{H%kBj=CDE$RAn&yAw;+^0x%%^@nds9JoDjX$m4pwa3a*L;1* z&o*W;Mu7QzDGoUO(lFBB^5qBd_uk!ZH{Z|ct9(9RSNgVmd<_^Em4Y~Z@w++y{QOce zm-pC+4qs86J8a#)^8RrAQ*=zOi}A1WH8%c&q)!IQRb*(O6xVS2rD3F>FtFy*PW=yh ziR0(=RX(4uJAGXPgda}7&CbyI-*w`t3CAzZCdg}!(^vU?-Xi@e^u5SD<3d@E@-XD+ z*e~|-{$G!Ni_>8_R6d^%DTe`wa@@fBi2H*|YG7U=nEko-@l)^ozuos|=;`ZqL1&Z) z=4%m1e|6d)y}d}-Ky~G{^DPxPV0o$_58*utM1HXH`AOfMnRooX`!bx?T%7T*^7XUk zd7IkbLzAYSwB6bR?O0i^^gqpdQr~Z(wDOL>>&oLU{5G4@jnfX|YVrBJJfBost}(^5 zL7cwVYI2^_?dI2_Oyzl_A{T!rq)mU=N9Wlz9WUN^;Ic!?+a%w?>5^VayDFd06OK|a z3uhZ&Fwcb#*X3b04sYJjbDKX1yR7F4Db6x6yibZ)zMkXf^i@8ePj%Scn1q_= z%%d-0jxWG5sRFw@*yrXsa%@u^-X$*2!VHIJu`?TOo>JV%_(}ZBj2~)uP(4Kxz*~EN zzqJPPe)atF4eMqt`eg$(OyJ%H$f*Cre4QKkpE7lfZCYlgEp2WglGMM|>?-n5(wfV{ zKc&y}ldTA}aD*SqtDfJ$@en#$4=3YrGxA4bCxIwlI;P~Zdg=Rt;!qrZN7tnfRkhnl z$K>?%qiXT>vsjyB9@bjT!{XlZuZX7*%-S$HB!PxUXLOvQe(>xSsIAd@Ta$kMN=O z=c(vuh9fvo!o>+a>p0MfQX1-^A)3nehY3>=S3eE-a5>j2JDXeMWLC3S@n_ySpI%(u z{0cOsHAnNsgcIf)Y`=$kjE2y>9%r`pK`_@sr(?3c0AGyp*v2`$$u43PX5c)kLG8Vk zq461xY*zt&loKu(e%gRfL@x5obv^8@f4P1vZxI`^-flH@_^(rUC5(f5n>QAg+i!6#L(5g3exmKo>1%G|^!56vnNazBo^YKqCBrt| zjdeshcq6M|o|D>fjy&glCt7f}6jyGB8)L}EtNyZ{s=|=x#H6=|jd}bZ{}2<)qw>R+ zXL>=dwwZfQnwuKBdg;>Fp>p}pYGqyiDXn&^UTX2j*B>9$(kOW39gHW)e3plOy@1=s zIz5G6`an}jhQnJ3JvqHjtan4hc>1>#vCT@h%lHhfNW{Hrd+Z+0JkIq1Svfgh6>Y5ZH4Eo$ zXI|6sv-391ps`SLJB@rXU*`t?>&%xUd#nS)N~ZitIZH$oa=s`}!voRQD_>=8&H17_ zg!)cAZxoO7Q&wCs?aObOyri@XvgWDg9+E z%EP#V*FKllbs9ZM8<KRZT^u>w!9@wSE`eg9e3P9eB1d8UnP@@NvCawb z;0o-bR!f{bOM^45+A5;BDPA-EwC-UEz8j$-VH8EzK zsP#@IaP-t0J5HN3<(W9uzB6By&5V;V#g6PE9?uS1-$d-Zs=-J&qJg?KAh#QfW39_C z#nS!5!naR(`OI66H~M{KZx4e7X1@ijL7g35ut9mil-b_`df;dwc|7_^Y(s8Hnab=KE@WW`5`hvvNS zImP|@^61-tdwJ9XPKV`C`FviLL+km_*NXfS=vT^e#Pu-iBbXecCyoB>##tYX=X6*O zmCxr@Ik1~|P*F;81GP_RU87HtLv1Hf+#j7&F#okXV(m1ZLXPBUg@5L2OzBURL;HRb zP3XEbq?qP&<9nL*pw_<>?YLD}9k%7#*%MCG6`-Zx8~@CglGYA`mR~UCeqW}isL-3~ zTIj&&oBUk1^|qF$3i6I_cE%r<@9I~BuBql|of-A_m~XKCp1D2X@9)VXXxFOk0B#48 zPvuq{4uEf{!S8D~Tm13$7MDa$MKtiA(|}xVyBumRx2hd;9}+9tZu)N6B@dNf@~Dwh zF1O5A6<{v6QgID*^|V`jC}4H<_vE^r%P*&+uSd{BTt>;~W46wHHMQO|ir9BmlaX*l0|5=l{k*KhtjjIkb?UQ~ zCHIdxeEQdh(Iq?D7uJ;dftd9pDz~Bgd2$KX@00DxHbt(iZ}s)`vs`V&cgL*xj_$Cp zot<=L$qUcY{5m<3t3CdiuQ8=RbxuP2EL@;}l``76RvyP%Ilx*!#fQg=%!PBu_x~r; zaeT5K0jY`Ft<0B1&<=y@2TZvgtOto6tF~X`2F8lx$5xh(^jx-uvG^|Tr}E2uHJ94_a7ucHD|?~CJJVT!{ff1%YW>+109potL2YiKk1eE8dLf+_XGUnJpL+Dtskk( zQ6G?WLu)Qby(ATfF*NCa2ac|z{v+K(M7pB!IP$sdGM|0E9+&v`!YWZ(EE^q@Q^Ptp^1r`opcEP7^13bFTwc}sG4+^Ov1Db7@270O z@SUd&JGdJ6Q+Z{+swZ=KHC9LZXYnyd0#M3!P`N3D%(jxgX{`&WsP$p1X&{3TIm7(!_%vzn1Me?1+ z3A#$CjF4StzN#oHx1q;%0wq{2ziNE{X1FQpfu@M_-_%JYt$j-a^0-CuaC7-p$3Hit zd_T~;yv;w|PDYPPcU*p%ujbBZiP55H)2L^#_E@;s4);1$mPj~!4V2{x6?W`vp#=~J;Fkeks!o}!38q~@Ota+kqgW*Gs!zx@~jMVpftF#YsV zdXzOj;!eVRy(8!65f6U9NVOZxS9K=gBh6iCKqRHefzJcvx#rsQ(u@%<6({w5j`h7> zl`|5y)<7vvvmHr1*^HBI=q%BDh?{5OTW0IVYx^x-KDg(K%MSa(KRT&DpD3a7IaL}* z)Lw5+o2S2Kh*umv^vYDBeno|p{$`|4b}0!&@zOE%*W~>#Hcgu~@ckCAr!X$ar}dM} zN6_TLe~)%Fw!oP0aTOJ4>pDvj3+tsU*{m1Z_l+*vi4R#^`-5%qti)Kc>EKzd|LUK( z!FVl6>xWXinfWH65a4m)jFLjUo0N&ojS$_J}>+7 zHGCZLBO2J>G*F5Rad}M`XI);~q{NC_zi!*>!s~nYOE(lj<3?0onQyTD9+y|_=|JC2 zGL==jNbT1~%Bx>>k%Nc^YH2|3*X~4lr8+DLL_Uw#_BagRl>P9HqbqSf=KZSwt*|@q zio=lQOMG~cvYszQd=xchpPn%hIU_kefPdnXF4=ziPecwHRRg7n zjq$sAk~KaOCdP`pQkP8~HoM}w6yt#%iu(y4%vXi06CX*1_yAPx@dH{P9>IsI#l06U zMbeCqS(8KCx1JX)dFX~|KQtR*6l^Zny$rsZlK?)n_LOelGV)wYj0@w8^vS*zBYlpa z>>I@`&ug@q62LDdug+J4B`$tD>5bFUZ;GR1a=LwKR*SEn)%$1EVa2w}*x19^9Y^cP z+L9d}?+k3xgB^}M$=F1FSo(-=MyL{L(k~5Qva5$d1iXBPSwAikt~Z33XtmozP~Yj(lI;vn0XPuZVkw| zO`mGU31F?Y6L!L%vwSICDt=wo;_+j4ySLFXIbGjTwfOp3yf=y$@&S$#8K5@2H=6G7 zX#3RU0LB1zA-zvafZ-O*iXFmCHRXRxIE2$<0p;x-E7{4_cL=f9sFR6Z18u^k-iG z;9t*HOBA)AN%aXyVUxc+%$S?Rx)N zZ0zrLISai0{cYvvwmA&Be*E<2+vnfZ=QdR?<~LBTahL#hlW_8L%R0l{pQm;)*-UwV zA@9hO2e&@yojY!!lW^om;h*_BH}KEnA1MWe#vaOal;@;vo$YS>TzntHOB-a$a>UKC zmSY>_JU!=}PpzmO=uqi>fcedKsJ+{ zUYF{}{7>(zMC=i3qv5{XpBp&Oj9=0-Jrmxqo>F^b;(}LiDRux!y6dHRy=w9Kyo?)K zyp^#ydv2=N>z2_hzYi;yr_GRu@R0-}EYLBvXLy}kCC)!IckBC~P5Npu&5MzX0}+my zPdwSF@?c|fZTJ4<0((B@2(n!s{lg*yag&VOZU}Q4a(uG91i zi)i4#sDV-lP34=`eIyoGm)kB2W5w#Lx(`UYA$c6vJ#o07$}RH|G&wG}ruMc`X6Zt; zydDf5$8Cxz5{PIZq5)9}9dLOqcbm(r+P>Y6@|;@w+^@^ud}Ck-qn_n;ILud7%H=gR zGc!FSV@5K*)Ix0mt*L^~5gDyq?B;>*fKG8aXa^5mqOHlG)-Ij!z%Rh+E-h*wDp0xo z!0C}VRJSrwT}(VC9BNLjTgf)4Jmb=cw+9+niF+7Nn?2TeO2FGb?@t&#I4mMi19-{Iqnw`Mi?h_j*saYa@5u{vY>?{e+|=sjH3jvx&K6S zU4$(6Z&BjrM{|xZEsPakR=yVVm*au5A;yDayTp7|ng-%%8ht>G;;aH$*(17!L?UdE z&wW3uHi?X{roxmDviQp>^hI&&A%oL9g-ignHt+|hk zf0b{X*80Ec9{S*C0czgVjLZzw2&*`#H`cKO9Iy?p1m&=UrZPU10;Nxv{Z6Zk4^G5(Cr$OgKxl&xfIPxJM zp>SUC{)YMeN~_vXIUq+qz2C=tjVb+6KIHEgLZ|o=U6P}4Ty{QPCXWN<7Mt~`KF4^R zU)^@)!!?I~Hm|@)gXTT7{*b{p*nUqRnQX_0{jhv&yxUkes;|-1?osDah)Fs* zK|5RbUj2lLgG>X8q9X2^)3uKegN4>grQ zSbi?+l>CtGqh}+pmtA>O|MrjA9Wyuv-7Ys5Dxc4*`7xfvL`TVFXCc1Umz`^#;ga>6 zwKOzN(>@wekyTp&TCc9yUcEY}`yH%*@}p2&GoP-J9m~bv|1>s%nCA74 zDRg?FC`X2?$dj$vT)IzwZl!02)>HhjpEutcyI}yQsmm2BR6d_q<qni}?r~PE7`f)P|7Y(y;G-(G_YF-fU_=wJVQ3Oj*9ZzxED1>< zkw5|o&GN{SEF==LVRwUxbyZXZ3yKB%qM+CjQBimT`c%XMK3gm(%3s6|R@A5dzwh3A zcIQqun}8seo&A0H-aRvS=FH5QGxg3KyUWVDp;mrb?HHB|p$i{!*Z8sLCveE4he=}{ znrhBDDq|pgH-rpQ^(ObCVxNfl7B@RT1%hBf^l8btvE?`&_WM0`^#Gse(3=L?8MqF2 z%8k(V7-@3jGCzCaIls2UR6Bh64viagir=bVwYEF9LlV!6UHN_M>d>zWU=}2K_R~0_XMm1g6US}BXogNFWiR)6!$eq z2__j!HVj{4oS$SQfAv;X*{Pm)Z@S+KX#j4_U!hyn$W_u!^k$K#s?6pAhY?|9#XRWQ zFxKG}%GoJhKV2$sGm5P9rJj@a9Mh&PAnj{@lSsY6y-9iAJm(U*pW(g$&!JBNx&wy* zM*v3y#{t>E5MUHg3QPuqz*WFJfQ-BWd;{zQW{w58FU)noOTZprt_YZGGg%Hs-v`FG zLYe?fKP1h0c)fw1BW-&c$_!XCB#m^xX(!O_qWx!-=w3CH4$gxyKmKk;t*;kc}I`LFjra z=;gr@ezS_Qnu+-OwcO{e^49pxS3~emZ6{ui|1|c^`V+tIv=mU=5#`gI?Jvp%%ZoZr zcltf$GrP`waj}#e-r4^Wx*ic-ULx%pb1Viu!Xi)QcxS(B3;3YP1Slub_Gy~__!kSW z$$9o|x}$l+6sR{6bh>35X;(>m2J3gt^^|s_#y`M=Q|>*c9GkDGH;KxH^1|~KFifC+pKa1S zxfRmw~y_C&OeK_glRi5Z)$qyULKqO6xi?m>agqXIc&<&Y-iI@-pRkvO`>vX zCjSl6o5f$kP`opO_``f*KX)bgVZ1~>q+e8mh)&rp?S8&@ZT-|m2OPEZM)r?s*bZ!i ztI$oNauI!!?ekVwdu*+S{89u&WX zZ=tJx^I7M+D1ec#Nzr+x`{wc;gj>n)jaNJCkL5jgHQVT$y0tVy>$-GX48Gq_O}f-| z_mcmc!9ZXV0j9UmO`>u!H0+IdVIIG z95>e9o~`gX|EAdbrgk>^`4!9l*Q;&G#pl}$vAs)uBlPXWX9ImhJ;1R&n(e6*bieff zR*3OyJO%#TDWJAr(r#{gKf7|@<^`>fc~h3pm~)?uVTDGQSX1Aq>yRRY5T#tISS3q< zQs{@hZ)YL+P{W~iQTubjTb=qwAD>=__oqC)>$Ab*U8()-g2^|iZ-kD&4x{s#Q&q|p zDc~^2AHd?j3O|}RO2Z}uf61@R12Y(Pyn+9vjYGQF$(@0-zi+e0zfnz7_EBGo6CLuB zep?g$f7mZNB=6D1r=9x($4h7)1t>26crO)D z<>hw#m#`FX9ekJ1amu+qe!LQV`_At$qjlTfubwo-@`dwrL-9{&+W)r(so zFN}XCz&pp}sbkdjxYu<2;9^(yu2&%|oH=Lg@}Y35$}%ku4vjnSLhCA@JHh(vhK`W zK4>j|Y0kPc-CzDE3%brG&1NmGubD_Y$f$BterIgCSqZs1pnu`dQ>Xu0H`UG@so#aJ zv#H6AxgQYMm7@K@a|^hiOR*Qj&EqS4lOki#(e?}!3GITnuOry(9L^krO3%%Y-?#)V5 z3rN4c?cGlK%^0w!wVntIZhjuQd~*3+(0hGv_+eE4WxcsBjYi~G=oU3{6+RsME+ZBp zL{x28Fx~{$14(_zI}ta3d!rwe6F-1Y4IE`Xn-A2WkEnoh7m(ZsVb>zT|IopS?|1d^Z9$z8Qs%7Xw$8Kkt^lJmKAHQzS%o>VXvX_b+zFIu_zrru?3E*Dn`0Fr@@Qv+U zVzaK+4+|cMUH%g9PckOV&$#4)^}UYO+Z950Foi!_`E!LA;Mi>m88nDi?o_{6zSOcN zZ3R_ta~zZZrJSno%X2I{aTC8cOaWDXH!g@RC%F$M8P$X4ymI8;!+YLpC%EWoq3aYsNF+q4M?Y`L$Is4zt6Y4ejUauVX zvuZ9__UwTxKIjfQjmVAAEo$Vd%gxCipBEpYacs#PpGkvLwf!f0gZ=1eCJ3VNJAa{* zU#@LR1X4R2hWm|fpLBx#jMrNi{rB5DfAfJ(Bm4^8qDHQb@EcxHB<&#?H>(X{BV6$`NPii(DN@H_6J`5e%)Sg7oIO=i*7hxA#|O~M$*H~zi4x7dVWec zjp=oj|7nYy{OkF-1^ll_th{YM|Ji*cZH0fKHsM)Ho>J%*HF9l6{+f>Ud}Y`)jjfSY`5yhKlW#p= zSAy?u8}`1Uze(3VmMhcysnAgn(3i%kgW5%|4MB z{@+&fd*0pFF#k^PspTg01amtw9;C~M@pzJP>J!hubkffSZ6*Ii9|~PhnK3^?JLBpeEUURuaH~{#AU=zpq+eE<;8f?DKBgz5GDUkGLGMWTww_J zGrrv4KYab*pCo^!-VwSU9bH~TOo}`Ko?Yj+4vR0Wtnn9AQ3f*r)E&xS(lcrQ>t25T`(+u1kzxiV=@p?nIcPGyhPZ2U zv8{l|mtWxz6ye+R-lhl9%9+#WKhHl&cYQAW&%@#N=R}p8HBHD3Lk~Xi=E>ilvbK-C z^Oji-d*T|QJ9%u5+!S-OFP=70inAsxu?e?>SznZ_aLRME?+kD2b-<^yju^d^b~Mb( z1926)NmMRP@@0PmW34aoJH}g6o^tZTwhXZae0J?~$-fxPF;}J6C*1bs$G!LmhHtdM zRp=&BxirZS2CqCm%>A2Ze@66DD*TA0m&g~Y&GY8l?#%C+z(2=HGJ(d-r%5;bSToc( zMeN=7!)F>@?8(1#oZA}EE<&}7J&qzi7j1R}XH-b-<5Av|U zwr4zMKizaZ-kz6rz^%7@m5A3&Bk_1gql^9TjfWCbeCcCpSBcMJ@T>AeUP1uv8K2;P zVvpmGhW(8ny>;kQ)yuCr&1RT>uw5i{n;gDvZG7_lb}kP0)c7&kD)J@u7Uf354hMn< zwI9&-nb`5*d+)w=*@AO#d~dP%L4P@Vr_;qg%j=z3;c?l^1U+Rq60@+2`IG@bEF2_Y= z{DI$$aGa47Ph88!*d+tpccK%({aCpF1oyh;x1~dfha074~Fb}vFSO`20EC*HsYk+!S9qRuN>{hJ0*2eUa$J$w{EUECL- zK28UY0geT@rs)JA0~i2MFAoHA0qW*_fSE!4JRB$nsG~;%Cj->eY_ygDXtEd{pd4W0 zRsoX%>g+RsGl6q}AVA%HF)$st0=OEu4!9Ax6}TOs9;aN0zMY0=Y45Cg*(pEzcwyR0 zNyal(F62uJ8fyL%o5D@pYK{@dcE_olM7izw~?f zD`7-@i$CqG6sSeOA}6`4t@dOFXw)CfCuEmno#8{(ZGCNDXw?p6(}0-}=2e?m% z2P;T?IQ-pj?+m7fyBy)tpG<&vDT~Ii7RJRJ|FawY%KvWEg+0Ew>TEvKNVq!PvPIdf z@K3bDO>?Q|G6ms4;+wH1cDbNmFR#03UF%~qzGmBzhT-mltI$oNa*4#3(<;SY?u!=Y z1@3}?guh$~pZ)2SIlGu~FUc{CH>aGi4o;2FF1+%Tcc!*VHbVSog?}Kz57RAj_!0D~L;My&&{(!1hBV z{Gr~FZeN|&~-MNloJ>BZT2^uZ;H!_o{~HFe-OcoK3fMlVR_61 zc&E;!+9*Ncfu6TVq!`_1;-)|%OPLE=;UhBH3&wiO`jp6Iu4@8jN?+~S3me5SGVQ9=W{WsA0A zxIT2~$LtE64G{49>a4}9s3&VG1FmdO8MX$;PT|h+t4?n^`DzW%SuWJ`4S%>`){!$G zPpXk{g)f~h_Kom0+{5z(3w+rguDZ6_!nqOH=F?SF<*xRZd#!pU1dk-$7B_>xd#^sP z=Dn+@d@bP%e>z?4w}HQt(1WS6hlw2H%A4MD>NCAPTv(rE^gsFFMF&h7eb|e(EbR(L z*d7+T@FjPS|B*)wM!JSzybSkI?ur0wJnre`tqEjKaaUAw1iq-c4Ar9Fk1^SX`c3?c zc4r!~9;D&3z$9$r#g5)KzWw)qZ6=~9a-H&SY`F=(jrQ}6Ge4V}@m)RJEi`u`fhjja zx2TaTzk-_op2=AWDK=pIV8Wj&8n^mx12)AbXDJ73;!joh_CUdos|M=yQv=X z!ZMl(@XoTP)*tg>pM30jsf*4yO^#7AKD6aU=y=6pC@<>11GXYj&bhFhb6i7}lMmo8 zd1%b2{jp8&#g_BJwMoX}y}GoVvCoKH%cV88O*t339!^Am7gT$y*dsFQ^9Jj{Q}80| zvsk=}-_3C&ZsYfDOMxI>6aAO?L2S9Gem}`r^WM$H4?p}{g9P6as5V}nc z-@;=jt~6IMzTv9OD_~uS^}J{l!-Sv&R6REdH1<1m-N64k4Wzi)!6~5jr^-KyEgvf( zKcA1ycyVCabEofX^EJ=bA41pJm3FtiKZ)DyM7av8tp5~~x-1+|Fb-!Dpbz7&llOJG znT2rL!&1hX;<6$swR7%jJ8Bc;hWU{R@GkT8@;whZe09$Hlz}aG%i}YRm468h=$37x z{qTIRn}gKoeA^C#xQl*UxxvW?$2Qn6EbN zxSWrtkcZW5=ry z_NQF*)VUu#e|ZJlW;6!@)Z0QgiOQw%csY)fGv~(C`0WQjBn-v7t$qyR4av8RPn_|~ zfE{Hibz_q8S@#d7;?bC0wD^+O-g##&^NWV}1YCt~Q6pE;JM8Zx+iL5$eZTTSdM5}V z!{3^9tdu2AcI*!P(d$xD5#}L4FW~pilXCqE=SsPTh4ZCc$C3d+Tpa7;HX>hWm=`Rs z`Zx^j`mJdB@r6D6cjPk--SMi^O)@Ub7eMb%OLbuOs_iv#<|YEY?QgxfQHo2+KegTp ze(IDT_Tea_>i$FSAJeiff9RXXr3jKw?td$E{B@W{_#En)fVor-`H3!2_@f8vctql7 zPQDnn+P|dx<#(Lq@6&d1mM+&qryJEY!k3kP_G!)o-IFRR?V2=%m!+I706#Rb@^h6p z^~tYikKxpgX(T^&y4W|uk2Orn&V$7n+k}p+lnwMl@JRS8{Jd%Yo*Mbp3!kt1fyrzd z;ZLWF{kHSx$}605lp{aee&Nhdwndnyvd_yp@ZaH~u2Z+S3XqMCH;5 zfA+9}b=G5Vm!ww1{oGjBNLY%uj`7rtuVSZb2=RJnQtq7t-@5N>#)*c0l5e4#MCH;5 z-?@FP{5JC+1E|b*S57UK!rPymgpgs(Z_ceeQzc^A4K4a$u=J{I2B&Fd@hRZOVhIvX1Lqsj^ET?vEsVpM(G zX|uC@Cc+WNUZs~zA@?kk5L^&6__$zmFM?x&eM=WQ5BqsbFSzBd z$LkkLnoGV4U1yQ`I%0S}+vgsi%g)tY$8LQERjd!Vhzq8<`5T1WaQ*PLQ;+HEA?WXw z?N+~){KTYP=sykb3AhT~Bq|qO9&yeR2S6X&d? znQ1IOQXA04UJoDV^$l@X)j4>e+Ylgp)PB=6A6K5b;D^%}StU*Wy1n^pgEMrN1k5Jq4RBKM}F9BtE}lQiVCgZ}}Ka zj@Sl^%aNYqJLkVz&vj~Hjbdkl6_)RnHfBP;9_)Bio0UH&84LU6f4jgxsO28aL>TI8 z>LH<RlP6Pf0j0H*nH!uz; z1XS#R|1@~V7t@{R0ER%AAsh8xgNX*_bCA9N@@Xiz0U;B0?r1w zPW)WpJRk_14_p9T2uuYo0xkwF0j2?$0@HyRz-7SYz!kui0Ok8C;A&tNa1C%Ra2;?x z!1m`2z>UC7z|Fudz^%Y-KnR!v+z#9U%mwBFcLH|-^MSj8dw_d^`+)m_2Y?5G1;9hV zLf~Ow5%37`DDW7t7UTybR8Na6DsJhwJ=AgxP=Opf7JO$z@5Kn=>ehRQ&mHtIY zYZpeF*BCqJ(ax*SzF|O1JL=T8oG%c%o+6QTGLCh_91k(aKxOJedatbd!urBYbeNPKC#B4$qX)E!zo_9?La8=%6>S1sHqznQU?x z^B2B;+-3Kjb0D8-gb$r=**3)oCMrB-_&g1R!elA39gz`)2f|nNF3$7`e%aS-uWf15 z!npQJ*OUx=cC+8JmyP`P*o!=$+Ld1t-e>z==)#ZO*?!L+T7(6h=KlM3wlIq<7y5V5 z@}7QYZ~~@<`mDO8ot0K9)q3VTlrP@nCY}O+#S{pFX(_Lr+9sQ_oC%tg3Cg$3k8MJE z9v8Z+@}-Yo^X>yWjg(iRThz!^$}8sa?LFo_Wz=!(d(or<3}5;Q3|IW7y%_degwOKb zoO(qcpInJ}{O5;u{$BzErrmU?)Y#@K`@;F)>A?^iOR*6C;QkBIbOj&Fk4v&5kg+8aw2^}%0hGNm0jSrwGwvxar>nJ z8&9Hl3KJu8!u-+CRZnS`Y|KCBg*PsAKYhcOnw$t-=giiRW6k!Axu^SBYzZ{BIID1M zT(&x~3P=<};+; zRsTy{^smZ)obPxF#8V)i0)NI7Q0uwi{?2+X+C0MLLpnXae*eNWi3{sF zj-Kgsv6p%-s~m^bR@6+&s;t0r7HdhAz3eXAQ|jf=z2mz*m9I^%run+*_O2JS`uDqB z`e2%a?5j?nyJ2nbDTu{i{IlZ5Kn=IDR7qEe-)ekzjjk zIXqvUmTdAN{9p;4xz0%4mt{^uzjF`y;AnngWg2T5u7#n~#h&~O_f&iFiEq^edmxfq z`-r`o9y7J@+rkm&q+~xRzBADCde(U_eRXel{(<2=0au}$MCH=R`f4i?u<^3r-h^3R znT7{RkBlQ@=T9ftr?)(;{m8>V;n7T{AwQgt6uM0g-y-}-ehl>C9Ih&4P@ex}kB{H1 z(J;TshpdzAhW`=UU(S_;w!|xdf z0uum!E1C;*0`{`OxbU60X?_Z*dd}#ZZ0>WF8RPX|*WbHg)u081(O1ZeTHJsZ(EN8 z4?)|W=TI8`ob?yi$Z}Y`5Muw|r&f1fj`weF+bi?N{BLJ{XA8{3wtNd6&K<^#hZn~+ zRt0c|qd9-Z>WfRYO_PDEs{a-vdFb^|rft&~b^dKO_-}<*V&%g z)c3H39{2m{ANB$o_%{Gn1>t2m6_RWu1WVx`!jeev662EHjr-sk4 zYi)b-zY+E<&6GD}TUh7H_a7h`vqz2Zd*;3GOS8miW0w0iEpJx*8^*o#AGV!&hoGY#D{XF!Mp$Z~A-u&o~Jf8ugXj zsRsz!$1-$t931g`|Kk8mo15pT9)Wvz;23~%8#m4rn1;VnjzcHJmJ8$fWVB~r_^{g^ zW1o?{>oHtQ+cn48UMfiQ$UrI)DxSK z69ivAZ^GTz@AZAYaKdvRdHSPH7klatO-}5yN@Q16OHfojmXR5oj}Z90ys%=#dvC10 ztH1s?1s%G-Av5xF((N zupF_yZzd1!bW1D*Rsdsxp1{dA`r*#+1os5m0up{lJkvjZ=q$XD2l_?7X-}i_r9NA> zf8DDppXFJx>h$|8L0N*r zL^%<<9%L*zp<7*#Fi#2k&hpG>)kr>*rpprDQa+l}Bg^1M*CW(lvGmCPuoqs)!#_oj zsP#)Q*C`*tO+U3TJG=vvjc)(jv+X+E-+jt^(#XAkI-zq`B2vjP-m&FF=q6FQsPe%9 zB0qOqgQx4@hH@EezctDT^Sd3uZ=;zpsC@=%?09ON)FTO+l#s@VM zt;~1IhwK|r_#VDdoAuCtQwJv-8E4J;V*FL#d6TSaGrTXm(Digu*ZX`aI(+Dgz#$S&>>tcj@wRs_udPU-Sj*5$Xr(0V&s% z1A=bYP8tam0+bcrrvtQSUyC#{&iDC@E`V7d(=YDPC^E%+3ed%-(XE7s$FMs-|D8<` zkrVl7JIpB``uJygL9+44=EM88>3Z0U1uHB?@&*!`?Qfy$X{E|XSdUIDnP=9bMdCPf7lao^%zC`}$dW7X#Z$r?{Q2_Nw0YDj}&JjHl zZ;v1`w$h-h64oOnBb;)gw?~#kjy^m4?l0bYe|(XQ_fYRsj|g24UX_!EdZb~)M3)!c zzo!0ECgSaqrc!C!?Spt#>Yb9&5qV+vBY53xbKk3VkfVdHy()G2$YkTz^!5Yi-<|Nw zU5{D)8=2=2y3R?qJK!GS_qgn)h&8p*$HnvQF$L#|+P`Pm89)&*5uiR;2y6fjfk2!G zdls>1itm#;?Uv%Edp9~ca{q!aeXhEPABin&TCoBw8EkMB{~ zqq-VM&RH38o#D>F_yg8%eXkLpAqae$f)_xDMq&uQ_OTj5jqd-Ht63| zo(cBFIsjrwi)QA4NFB+38ug_I0PALZN%SMzSbSgZcntU3_$+#t&k_#rL<+z%FaPmq zw%62mNTdDV(Wv@z6Xc)q%mjF6T8{^655qq0WA0yuN5eDxfxy%wKfjyLG?af{bvmgu z)R&QSbgTjW&MCIZrj~ruD$|9YG5RlpqR9=nxNWLhSysL))S?BXEb|{J_ zZ7uFo02d0 zK7_7^0(s?`K}8L_!FR%jm7tjkB0kBWYF<+)iWAlKNGx|#-ez6Gu-RA*Ah@;5Ow6U?}W+UY4nyb$G zX7%xVCM`pKO2ayWawBw;s9d%|Zd`fU`8ndnA1OZ)X0$tHf`}Vu3aI0pi6yb+hi_v2 z>~EO3zU@!#>rZ;$Qh&w}TmK0i&K)MQ{=U#1zz|xMZCi+YH2rok{NtE} znBC-|iMtw)T6gSqc7?FN>+%;<+7x`#V-GVOafXf^525S9MdFd?AL=a%cztZmH2iLW zX(xV~4(yAX-^Ms+I%5-eE=FYoeC#7{-BXz)VEig-E{x z+<*dCj))IN#Iq3bB1HUb2*(OUyaytE?_S^;{jk&|jPs$A9l0;&QBetx?2K@_zuK` zv7RBM&f=YQ4$Gv}C2|MJwBtQ)nwJ8qKF{^WmW%n2o9CDHs=YYlh|OJW@7YeEJ{P(k zYBafUWx1;Y_`ImhJp065iPNMT$O-e5dCk06^OycN^`CCyX8WeVOn4{#=Gw`z<)j{R z^nV{0-m>RY7p-DBrV%+2xe{!cl}GPW_6RwER|!t#8Jd&t8d@`HoX1x%-a3g9ltOQ1MJbMEw46KmDXekwqqp1mO6ObF zoVCjv=|9=8n|zadoi6sx=EojTQ`-ym8bA8{BE#sEIQ!(s*Ure}d*2@Ke4S+?w^G>VK+YU)8ol8~y!U#s1D= z|J{XsUp2k!VNX9Z0lv#;>dz7kNRFJl5F>9GBiv(`M`wN7;xkES-V>1OLZ=(mG?L!A zZh!P7SLM(+(^)QbIV`D7HjZnv>#%n&d+%YpJ7e}OSicBe<%Q3>92V3B3dR@s$~-=& zEQXK(%y(Hg&3D;urD58{&CX4M5P}zdo^iHQPIUblf*d{iaUaj}8wamj$PP2iTnIMh zMCcYZa;2OAoby)OsMe+s+LyL$%l1~z>Z32Z{LDsS;&?vG6U!Ar!~cZHl$1H%r3^|N zm~Czu_oZ$j*w5yC0ozy9!7PvLYm?6RMP~6BH%bbqdavy{&h`k?%+!rY%%yz}zj_Vi zYqwkO`LudV^4PCzKSX|nu6S)eHX=XRV8R=yK($kbB|iagskhR85mOrueUm|oWew!%oGV}bsP(cFUAnvoT@Pq0 z<;9g(I0Z9%4fSPQZuFGhx&Ku?6S^?A+!z<2-`{7*lfEyW@3zrqn|*QW8KLX3X+&;v z`&jzL)Hn75Gt|pxG|)4;e~tau^+sIJG?r4okFM&O^r=nvD~_$-viCO|?+!OttU9l! zq0@z{M&u>03S-aa$g?Fk_A*)*Y9`ABag%oACh*1l&jfha>;1*Bzqi-rIUm)z-r$@$ zO(%eIEOe8oT*y~ZQGTSJ&#bJjQtEoWo@YCahHbf6CJ0O6yZWN0`^7zOyJ!8&bL+?U zt+jk5-!uo?bn9Q_YV%!GF`>#GsPTC+D<^P^j`B&ilN8(;KKsEl5x)4JfJEcGj%vR^ zv2O``mVMQJjbh&ljau51O^M%vi=Fwxv|*bz4U1mhEcl=#7xq&QJnXYGUYl^#aiG&M ze#{r4n?&Ve$1fK<*ZIrc6Fu3UfV-m7ZWq|E$w*OSaHu&!`)9|vyFa46H z%frZacl#Fgd8no28}A8-rOP_+rxrUOmU+sCxGSpgQL@hy&=?8gMM;m0Y0ms+`g2W-x_|Gyt8V#q z^}FwdNTx=B7<=|^g>Dn#j z)02%?PI=w?*$bYkh3tUAFnr3J&`qLpvBQsYIQLj{#BF=8Bjda)*ZQ#k$8|$kPUTob zb};_;0@zQaE=&hFppy*@28sZ#ljc~g7dR8R1h^KM3p@g>1h_{3Tc8~jCcnAK1x^R9 z1Qr7y0Ugoc9}3I>UIsd$A%8mXA0V|A_R|3NL;<@NI0S|NMIeX*HV_%#1sT6L3Vdf2 z_-rVaX-Mxcp(N`PvHlGU<=R6LcR_ZYjttm@j_>1GWcfl0;?*5{bD+}L{V;sblV%vV z9*wY|FLE*=C%J}EQ-C#Rqp)VI1n-=Vysd%z^RZU(O1Qff;Xi<|mK(;T*9?RCkF1Tl zjto)XCWB-#4U(fle@N_XCsA*)+)#hgoDIr zZ4%YK)0GkX7Ol3koeQs-M)*HRql>-pAK4{$th!CEBYkHheAR#YT?Nl@C-6Z3ZS(xX_89&~GB_mTj{CvSZ!DFq^cV$*q zde88b4XAUFx$8E@=EwQnld3Dj&0xp8SM@c{_Mbk_vNDe`aga6?r1ugCIwfv z|AcN)BiG0}2FG^{`CjkD8gtWo7n{ZdeeOvf^QBONm2RpYV|iwJuz$t0gOhOG&gZ!K z<5FNYf)cr&e_d>OX?tz5abnLFsVxs*yO%C6Lf1KOhP+hx{hH9glepaIDf#F6ua29h zU+>h1EZge1201^x{o4Ll|9I&li3Rl~wWdxNd$YbOcl$hL*%jt8I=9c%e;(H$PasUf zx)W<>bt8lqMUHE4aLTbhZ(0w2pZsXdxij|bk;48s4f&zo6S_%ME{*X6HC<4})qk!b z7wS3^xtBYvOgrA=rgf=q259UE8z%=DE(^}R$t%UuPUme^p=i!@La{mmPCvZ3Q zpG~)@k*g`cj`d|l)n#?AM%O!~;#HO>Y4>s7Q^Jb)>RhK4yrt=WPtN(*mp(Y+(C32F ze|rlah+=TEo9u$<%lb&5UL ztqnjLtND}|id~MYZ%sD-b#(6y!NjwBh5YawCd1ArpIl;1T|CB(mI7+~ zJoon4@-iRtG^+j7Wv!=-Y@^GI&^7PP^05{2(&)N|xZLO|yL11mdZu=6Y`Lk2Tylzpss#g1b|G}KRV(=Y{8J(D;u zcKd;Ezd7@Vi$?zP+fU*X>m>uVlTH`=M&zZjbqyn`CRTaRz&N-%?wER4Y&o6=zJE$S ze$C|k>+k7cpI6lyd{K^tF8s*dd0tha*N=4;JSQszp;Oy0;$FQ|E(Me;_66k5x=_Zp z@YtxK8=hBnKkoqRMb^JZ0NsIO0O_ORF>dS>Sb)3q*J|%}%7y;jOFiV~#UEZTJtt%C zsVmqJg(xj3Pqvr3JgIUc&ulkQe)@ty8jDm39yo` z)8MDbQ|Ml&Jn7>{#y!c#?dKd9ICb&l9$(q>M`z%D>KUQyEK;7>$99}2rJoyw42~uz zQfKil&$|EH@}DwBeZw|5=Mt&EsB19gX38ApkD$A_u~Hy}o5;z!`(w*V#(l}g(J60_ zn>6G58#>q%!Ct&iIT5<$Yvc+!+1mXGUAcLKa&wA`O;2?BiTJ$zpC}iU8_G{2K>48# zO9H5~;_`z;&`c2jMSe;iaE_aEsE+AZf~d88V6xG_e$83OJ~QgYgYEH5?nB3NBy@!Z^D)9l zWPcA=jQ#&7Ao3^TO^!`ao;j|`XO2-YO=LWi`NK9F(~6Kb9`AI=bR=lx&S%=iP4iPg z?Z3{3d@wCD0p2;T%sf)}<9n{>iJwnc`oC~fnROUzGM#Rcap8QsV?JG`+3f`g{-d0e z>uUdK&BL+fHEm(C@ztvS>(&md?rM$DdS9E$~?yb2>y>Ye#hb{e&I20v=o?z|Dxwc zFLKH;^Mh#~+86sDo;3n1G!5hOz0dq1xcBAXSQ2LCK?~%B(CJ1slpFQ?^OHS3@9;pt zTs#APS2f7%oluGXtjb6ABThc3=U9KILb+%!=Liehk4w$)ChWo#k5ZM>6dF(!M^R*Ddq! z5Z-uCK&x5kbfX$QU4~U-g8-Lx^l?6lahA8HDln?tQ)PeAVGW;|olSF5kE9pZg@wQ$ z+!kEro&5z(c?4R zkFtOb5hjIW!>ztOK6xnx4-%i5;77uX7M}%*eYE&wEN(hJ>vIZ@>U{FYyZ5yj5IOok zn=X9Gz3KRH&5=CUoIb z?&P=0e(q5X>n&Sc%{~M}lKe*vXx4Xh*#&Zb&0;0UiQ|0$qV&z#xF_S@vPr zreIyhuvy=+|HA$Z$KqJ#XjK1cPeYm*^;u|t)w|l>*|N+jCy3K-Ww@j)NjA=XA^E$N zOOuULHhjIy0Z+Jw1-`UWs}lCCFNChAL!^D4Q(NuvVZBUMz+H)PG_Y z3%Ce)4d??QyA$AEgFJ8QRz&?u2+czfqV{M+EkxnI7fNq;1pF~7*wG0190YtO0zL}? zKZ1ZKAmH~AaNSAx9%T%^Gnr@@@12kF$(ym3bt(FRA7Ve^!~~-wK1kU(J;5k`C&B1) zTnl6Ff)>Vy$F(#b{HUez?t)gv>GN6}&%Dsa=-_H=TwK4a@#Lfe)(%CCjopyt=12$AgnBhrJrDPP3X={lTmU5(*%>$S6!^naKy4Q-emb_kowgkH zddD8$EI+&RsXveU)Z|t4t4X_c6*m!yX4O6j%QB!89qSIR8Q=59*Fg-()`TlHBj!%}`}e=ILC zOuYQYNSuGDRS@xJdEq$A7Onj1{bDB3>|ftp)w%YtQa;nX&Q1lcI-OLSDChksr&U{h z4GF)~DyRO?!>?VLZ0uRoa^>LZ8{3Vwyf^zY>~9I(CWmiP`{i;NGF*kwpHcM%%O1i0 zFdO!2S;SvQzgI1rw2PbVp91Q*O~#8(`Owcp4nck%+i*9Mmec34| zx*n;A997Iq?bG{^9}?cO6Z-(XPdO2~o^FtnX0J~OZ;B32bh%-0)GfTT?&jTQ0Z&fT z7@e+|-|{}6W4WdKxQU(uA&^CG7O#mdH=R}|8?KI_vvbC;t9a5*aLyr7ZiKFfvQ2X1 z8j_QpH)06=(&dLV=C=ycqM2AS5tpB6DYo@ANB#7QbAFNI>TE-lAR}a5OZ8W2cWiik zztLUnpg1?w5;H_Xx5?pKr2ix9T269LaTk^PDyjp;Cv%#Rr`g0%|)-UJc*@L%>^Yf_OvXQ~sv2TrNhU zmBD@{;`!TdyZvAKYsto&zjc4D{a!csVt|Trb9$aZUwO;pUtR`927sd~^eP06hT=nVa7brQyyo`@R7CdnW(`fPuhZ zfcY>2I0bM66M!n91~><}2)F{c9+(5%2RsHm4Xgp)1HJ%$0op@0Qh+|dAmCKM56l4O z0V{y_fM0;lknv1_>xr%eo&Yui`=XNK*^Epl|elZ~}~*Dks>_}PQg?SetQMZGF?J^osIr>L~tQ&v;y@wxH} zip#Mcp)7ooMxnLZqS)=9=y&B~rx$-CV&BMJ*v z>zG?kG!UN#?Pk`w61E;z{Qn=H0wDw`@{{&nZ26h_ZnE*<(yu@I_~(xoKJuhhqt8MC zrXCWy9s^B&?7!yeJw6^MRO#XOOV&2`wx!bRir(+i!`NQ`DVGxg>gF7PV-Y6-oSWx5 z99fTzCXv~uVKazrMy5o3ole>2m5?9m^Gtwg$!F?x+4ljD#u-09w&2uxKR?4~nsWQ9 z(@ioi*jRYND0cwW7pgA5RdwaoR84S=2vk&71nRH_bSbul2v=+Jo;nUy@_y5NUA%r} z*@EAeoi6VSUpigvo68q>BeS@+-kgS;l(&uGi|HikMLA+yS>4C(iDNH0v`6;?FW!TR z3B$vOTHq>liyFCRVI#B(4^HahjkW$H9PmE529>(?M_j6WRIhWE`!YD{4Qv6%UVi3G zzVqw+ms4L1lBs`$Zj-||=oA-s3bD_o!sbnuRXT1AS6v@eY`?`Y z8#7D{;kR(TGu`z1b^+pZbDP9dYTjP-P12we|#E9Irp{WIcnqo?f7 z{jchoj15k`sMo8VV1I9RQrnDv123RnqY*tLbc-6fHX=8+nk@3x;CRR0u3T0Frb)$B z)tA(f5|-t{x~hCvZ;UPPYryx5)06jb?RntwU2OeGf2kjZuKLaAM)=O{y$$<*=zedH z|8f1eb*ZSfL$*L(nrc5TnZ0Dg?7Y{)Q?HbBO1n-ME+{Wb{qN!^b9ErAe4y7?;H#KW z!7*7HRc@z!(lj5J-8AF)Yo5;k!Ft;&Z@lVsu_qrRhUZ%yAK@a`+^1Gf>MW?@V7Oi4 zRDL>r+B84&M;w39sW%L0ZKa3BPXhQ6y6_=)JzcB@hE<40;d~Nn;|Y7WW(>uv_1J=D z@N;LUIS>A?cFau@p5&8G7yCxabz}RpgcXx2Keb;v^`r-$j|b%Z+w{+pjZ0T8Iqb=P zx&IlGXoW0#Qs}~u+$Ei?FQ)trPr$_noOGLk29c^C<^3Ifr@p~3ylLz%g8eW0P4ts) zOL{cBXf*v@hTj}_`g{DpweP9!qdk+xIULoF;l$0KI|WpI*Y+!CyFnihXG}gCv*^P6 z(=PZ)V#Rg?dy6_GUbw>{`0{mpxz9`4PJCA@>;k z*y)1CNEFp15%4TPrCkcZaQR*8XoM^Nt_1x!&AwK#cR^86SE+n& zf_+o%pp_+`Tyg1D$7bVI(@;JrB|6w)w<)aW^pEFG|0p2;@+7>85qL}M9U|&2r zqxXKB+TG;^ou(haeuL0WqH>9>Gm!Ng_$EAjRDiiPiRro!*J$;4U(m_R)*7|kZq(w% zIAJ>7aUNII{A*@ERCwPz*V_T{o`6*XLbu7`8|4x0N_$KV-!G2$_BMh=?=WwXmNQ{U=7+m1VB-Kr+I>Q|sF5rA zr_4C^%gSoVfG$8+pc~K~=m8uI^aNP`4gq=rhXRKIhXb4gI|5)eNm*x`gzKM< z0*(f#AE|@Wfnxx!iRurq?qgZw`lu6u3?LI20AvBIz;b|rz#t$O$OBFS1_Sv37hnzr z3IOWoVZd;p2;i9g2w)^I3K$KH0Zs;(&rnh3`Xp7~RsZOe2R25S{_4C-*`<$N|LE9* zZe#w?Fwa`yDs+>mTy%NJuE1eBKL0?UcM|G8h)7iFFpLoVpdO(fOZ+Le9%FFV6xQGW z_Sj{vY5+4UcJ2YuhtDr~T~AXDMGL zD12;3q{IH-pPl>W`43*-wi@rzP=;Br3Edj|bA#{_dTx^-(W+WA*9ubk~^YY67k}fmN3CmMHB)*JIJJ9Ap(y9|r-E z+vUv&_x^j@7F;kR;oqvhpgt3Nv%*ytV5{|h?r*Wn4gFp|X~I!+{o_B<^}Nva@TspF zv!{#%AzQl69k06#aP9{ z@G=43bv;=Q`))sPIq12EXV2i8WSSa)`bFp_QMojf5A?T+E2`@9CYd9qtjAUTA+P%I zAhIB|=G;|z4<^KpPa5od+&`g1@|T|edVGYghuJVbRz$XUJk)l|;+7pvHY8v4^Yc2j z=xE%w{~k})9l5xZ<VKif?>jyPRK2&ZwNq~N{%}UCj>d3L@iWV(9Qnhmc80P2OSuuc&T+H!9@=NR zoX{U>59oewkN-Q;@9n|gpUsaD7!tjo(l)l71lx2p_V-@;<%-R3-zfDXbu;Be=z9FN zxn8n2kp83PN9RBOKXwYJ_0#CxV$08B$XB=f%LiTd#Y2OoPEUvTlpmq%p;6D+GNi75 zi@Lre);_d-;c>h^(o=Wm{a42kHbQQgH<@-GQMa(&E9*S*Xxw@3ZJ%sdG3-`8({K!n zSDkK>aiQFBork%i!W!Mcgq1zpHxLIHvz6oXR$8YzJKN`}?PAOEwB0)z8NYnc>+X!w z-Rwaaop>{d3&sgAJ)iLmfJr@*wieHVO5ey6(O0 zv#wR0{_muvw4<@wEiDY8Thz#v@;ux#0Xy{i>TJ=)DcjlJNt`@0&!9CQA>-o8W$uxY zTY++*9LcTA5%-SNWr_deX6K}UzRw*sQ9OTkPF}=A{qv`Q+Kx!u+gWc%TPHNJPvXS8 zH;w#IVrJ>O1Vg8bz1fb?&ix+ZuELm=&pv0{RI@|ewbovDDnHA?5B<*sc$Yc6G)#oO zS@1y#NXDUCrcRsH|20l`nMU~0>0%#^AD$cGaoJx!6LGVB%jE*xq<-82 zK4>Ie^zjJVz0_|^PTr5Vbi0ZZg)rpfNL+<(5|xWR-)5dsZEn4RSvGtHR)vp^+?DnL zX)=O^uc5HFXl;O-JJ%I^%?;S`)v6Dtw`0V@GHSnOW>VAX)~dKN|KYp5dr7~T{BnL! z=;E*3nQrPi33khLu%~WFg&(USO3PjH;3*qe;i)WZ$X9BzGaaMJ`(D7lH?pzbnBP!^;GC=eVH0uI2pB|N7vZ&OiPp?H{^p0oOvu zUx#T1Um8o8#T-{rB}0~Kxg6cm$zQbo#yNF^uPvW&Y9;5HX*hr05?7&{MCAhh)P1P3 zygom-Evu}UP#(ZJ>gC?D%u4h+tW8YtUJ#Jt|m|=(=Wt6)5K^*#8r{!ixE* z$%p+n`uwVG>B8)c9HSO>990ivd;aIz4(2t>Ey4Z^*O4%9_)K|;n@9=-@hIhKKIDgb zEfcWxTEqU|`1g-p@wt1+Q=B)U;XMIYp_@eIqRhFw{pAB{cnoO4;7Hd_9q&&&z$w4c z>V;o-`EcO}Bl?^zK_rCl*Ya{S~Yo*lN|x8v-JU~k*uGMlcyr}F`gQiWoTJp-~Ty?#%4X^5Ock^&EyFI*q8 z4*W=Xl;uP~wKooo*t0=KIamAj^I_jqe9Dh1dZcRLO9S-yRM>QQ=`dRt9~V9|FY}kX zCsLD+ukcL@*C#3PRpPl4d~z$Lmb@GjkT-^u}sEUT4{K zcw0+3aUL-)<~=0#ie6q1vLR91P>T5uD=R)b@EjPJ2tqt0Nht#9r(U` z%Na#8mOOu}=tb%!)~iCtUx#Us{=T~EfOohjz_XBXLbCb6M6?9AeF;H+$)9}p&pMC& zB59X80*n9o!&5+&>&4w;%TK3n9gP(|`sO{JH+UE3A&tn7&@F1@s>=^L@(^vmr?iF( z(uW7U{P+>;=Ff0rOGlq~f)AUE@NHdg*f3|?$X17R5;r?B1%e1$^iKW3PPx(BL+L#_ z8U;(wdia=ir+qTf=2_%M=z3Iixq<#GGDB+#`-Fje8jTT!`I#F|8@8A z|IQQ$;;+cZ=$=mb(Ca0>dBGbW&z^ckQZ=7xq`j=uEnBPqt=5;2k0BLkB(tST1){ds z6AyKUAN;bfxsU3WHZ6>6zjRGm2mZ!?GAg*Dtm9?t0-ektL_UQs;mTc?&q#eOqhOXx zeZE27|Eu1&r5xz*NL!X^ApPCurbo1PgYJKG{ffK$^QC|~ZWYqXZ8W`MtiEhwpZc{2 zOH4#>=yb8y%Pj_kM^u-&0~p`;V1qpA?1smwLwHg2SjJ&aJra$d1D+~wm)q~=XC*x0 zN2iN@41Vx=Qx!+o3q2lRm`!`|-)wf%j}RdIt<(66)-U<#)5Wt27eDwq-=z`$bh>5R zP|uF2D)W@G58xhGiSG$HOyZXfHQ1EPwrs-(t_I?~QKXx8?l@&tzo| zWATUmmTkI4ja>EgW1TP(9|EBoFde1f%J4Zp5k&anewr>=_lzC{bzd^g3+0YJXO2;;3A7&u_@VinVh_^*P7C=5) z;eTcfA0J%w{6{5K>3yb;w;V}%T42-lS9STY#`%gW$~;2?HE^5)NO@X=@WuZR!3g~h z+V&ieC_J)h{(f9h+3x2(ei~OsWeOww{bbWEYUHZ(XPxdGoxf^?FaG1mRC5eC1zrjN zGZlOC&-vq^ZEt=b*gJOlgHz*zBi`@3<>Co4tQyt_I-PE5bpDa5==P5DNXJIiM;S-O z4nG9`2EA4^XWeo0ve}NJVfwNB3*96t7d?E8Ar*`-@Ri{ccBeA8-_iS7iJ(hZinsB{ zos~eNe$>?-?+TwyL}V%7J#!pEjc>2{4$K2UYb1S zx$AzuNx~C;bh_B<{Nz=Yda(gRDZi?*Co1x?!z~ggKQsHq=4TW59rMsVp-Vow;>3OI z0Hr($UHFi@&QGlN5#Q0vQ+v=@cd}o@`4F0TU23Jn&bX@ODJ4C&ypX@FNA`H>4A0)- zDp=%Kr%POPdC9J+#?B$=e?(Wmj&Y3n&ETi&xo5pOKE3}u2~YUZ>0+<*GoaFoHhr17 ztlN)?{8A5wX;C+;<0)y!G@UNJ_c-tDS!W(5&C+nasMDLrhm86;zcmRq`KnMJd~Y#;N#T5i>6+QrR|O@Sc1 zmv(Xa@v-G%CFEvP@Apn9+#~6^3v9MTE`+XgtII{vB(FDsGd@h=fMZ>+%lje+loRTA z_NPSG(@yO17&kjG1=M-2j1!&m!G8W=hJ8Xuqu=O3bZQK}XRlp14Cjz5@YJlfz%?F+XJ^|XHfE)$<3zz{c0loryBA-fuI{@Yxx;f_s;jfhY<;YjO zZuW$Fzg6&rPfLDR?w~n|fE(HSQsESl(%PPry~^CQ-TQ`HKG11TQ9{a!MI{ zXMb^8hBJJYbV`CX>!rgpVE^rpt7m?CSFeR>d>MxG;q0#o-6Sd(hR>sdhS#8Z z>qCWXo-I)5tMK}88iTce592TM>+&k&Ps6okNV+D?Ot_GA%*}R|4}HF*Q)Wk_&xdy$ zIsALqD`&5_N(Sd=84scB0qW@(DFrfLf(6!|QmYYrR-V%|e>XmUz$cU6`Lay-6WPDXro%gj z(fKo1E0z^hSzl>b^_}oH4dILb^o0DS0AfF1v8Ns55VY;d|H?s5{dgD(DkqFWqZ5q| zlauOG2X-{B`22|hyM5pLOxB?^Om z0&p+eMZibE0Z6DZz%9Th!11X3ZvtAPp?3zb1(*iqor(t2+rS(svU8y%1Ly!=jET+1 zut0KmOypmL?piNI=vQ=%cR_>(BSNoWa3F*Ttw4m1>x!@rHjGKVu%9eGQo80S_j=hbviFs{x? zFse>ZFwU5jVD#YO*^mol`FV)$PU+`?gJzqpaocQ9;|}8~u#G7&AMa7Gu^+NvlvCdZ z(V|1KH0q&;kC}GU#9(npW1ki;@0xpEg}Va>nqZ(NOnobKlc-$KzSF<64IiU4&|Qiz z;p^-JJgjdkx#>>;hfekmYhuf@?Wun`wnQDwu{>Q5t7Dp7VBa0+2|#_B`k4K)zCeE< z0~iQ!EVBqW85jpl1OmXhz@-3n^XUFm_z?IW;D$t9f&RcqAOKtgJO-=8G8FuU?p_-s*^+vV15i8{xNj;-q7LI2cn&yg75pg8pazvu;=(8hVjH< zs1MRG4hvm=HYz8|$Nb0DjF}muwIc`+{CczT3d%8!=wG2*)W~()^{;j6v5cmRkALNH^l0TP8cpIV_vW|} zx6$su_x)&o#%X_z6qp7!rF`d()ylW_-B71fI~v!1e*YsU{!%K(RI({49cq0YA zN<3=8r|=>1P{-{PJx#}>bkNk9-Hi3m>hUPE>5fR?&(_5w`hGNN;7h_4zSZ=vZwBA_ zA3g6~vhl4}I^RQV`u5;ES}vr(V@dxl;8XaJc!X?wj^oW9-*o!V>3u`@yk%Ry#A~Jz zxxZbbi~ZK6f1W2W-rWA3lcuH@DYy#%i@~27KEqb~!Q~U0=6}KMS?)*9xNnZ>IWEHg zLmFM|e+U23vcplXr-5IUAH7_sl{X!qpIat8dBIEdgN0v-&;K;K*#D0BL<$EyO93Qb z3c;t!2YFa*+f%OERx}-t`$rAh?CCmeI9@Z2#Nz>tF804W9#M108Lw3Et@1^l)Oup{ zL}&X>|4w%?-oNPM?9%5iJ?__1n{f=gn*B1NOMK+6$4lLB#AW3GryVmZtE+N3#}`Vl z@^k*zS8}P|NncWKnT%beaHH2lP`8TUXF6^{krGE z)+g8DIda7(gId&{m|0|EL>uIqg{>RJnj!4zNuAd>WF6DWq-}$`^bvf%@b$#l~ zkL8@bX4e@HiyZNufS=Iu*J1SXY&G4AJZ>L$e7BcWXZbwlz`M13J(e`MM)+l;SGCG|$49_pvkHa|&B-dx zD;PR9r#Lrf_|TkU>)moB4%2OG+MAJ3BTtf!5sLNH7+rTK|F_n?ycfU!xl=$LM_*j) zl>hrM!^LrwlwgvvWW(?!ozCcJT=?D_Bq3f~Lci5z27A+UA-L3oJ=EnQs{b`>vA#@ zr;Lv&JVXra(` z?sYk7W_@2(W7qg4mVRzSzNm-mM`KOl%DnStgYRWOo%iZZp|5@v{Uv%>=%%O2g?wR*OPLz+ zX9kMOYXW87GpgWDFIVC(y|Ch}cou*B!&5-jzsn&XP0gG6)@MxX;9ju_%ScT__cVT+ zZvBf~b-6WX%P_-jH=+H}zN=gZJ|rB<3&W@dM2<(F=Pdu?CWJ|mBhMP~8biNu>|RHD zez%cq8K*#{pzz;L-9*YOD5Br2Ci!o^x>d~TLgTaCkT$_CUmEJuIl zvcvo!e}u?~66L?;qdKpUc!5(+^mzp)z`xclNLsaF-y`<1Q-gBS0@5OMn;gEyloMET zv3*v#yJ~{RZ@#0J>)FlVXZQ0j@DA?v+Y1t)waj!kL#K;f|uw`}!jzmuo-IO~6AP?R5*AE8V5a&LqWvzg~IuQ(I{j`ey--v1--jg{GG z^k_7l*XFp<-}$rtSLG!4qNerxPa|CUx30hNN@?FQEqE@S(DisWA}99b3bnrVhT4u> z2R>*r0s61YEA0~6b=|eN>kA2POWm99I^!yIx=~Fdd^qK`0auV;cp~**@M0%ldOwNb zz5nEx@(Y)|@G75aELlltK(}lSqZ!{hyTUX3|KHyIgvL>Y0RZ2IA_WhMC@Oe}UR0FT zgH*vwqgxCTX`3J^LZ#be6(J-cu{EWa97HSiABrACFc*V((u0*AR452V6hs9}4_ZVJ zMJX*+1U>kDv-{%g8XAhn{vOP{&3m)+zWwd&?Aw{lyonfgBX1iM7mY8*b(DFN=KA}$ z<=Kt<5pR!fyKVOK;hW;plq!{e;cBnE#8vWit93G)RX?KFiTL;K42{NcJRzO(|88!H zI7&OY{+w2N^?4rPMAWCtNKBb$eeQ4S{fN20e!b%3*H3*P#Z}7Xa_PbHsyJr-j(O4e zcxQg5Jr!9F>UTlITt|KT+k1H9_xZz*ez|7o=pRFG_5#TGu8a6ed9Qda>yK|T-o?(^ ziN*`Pzss?Pvi+ToxU!v*m@?1b;(4~S+@B~OHufBw{ptMqTUYaOrd%%PgXL9m%*N)X z+A+xc+(L}l+HAGsw&2nG%8`nC3oJ)o+HV}`cNzR#?tL!qkM!B}%f}9HJ#_ru?D?fh z_j{z2SB16NSm!`zrgh)sLVJEb?vE6MQpTV}t;|M$3QcWoCpFUL9t zpOyQ*IFwf1k9e@|Qv199`(P=ykKEoyV#>T+@3(vDvc~4e?l_e;OJ^Tn-FH>1e0{`s zN2a0wlvl+u>un#~XAd+d4$e-k4bfTe_icH;f4f|HW>a_Etoviz`}TBP(H#Fre&m7I zw!iVtU1hx)Uq(4tUh4Zk7dsZ_ql?%3l#ImLhs7Q7S6nr@f4?Ic}XVkyutVCyWf`S_3XJBs4AwnPWRRg zxixBL*UHMRRl8bdpjK8^wScc?Ah%{_W+>BNtyWI$>|l1FX6>xnflPmOf3@1RY6pTf zax-gH59QPdW!I=)J=>@l2jYuP`(Ld8{fYH${J*z}`a2K>7p1=ecFS}VoD!RoxG9q@ zaH1IeSrQJFhRq@PIR~tHnjXljk-cr; z>o>GUFX*BQZ%K*wz}{am1}Mfr$Q}&ee+Z90g03G!&rf015UBPUBn*dFKZov;^#v@J zTO;80kGI$JpAj#+hoRn>X#vke&RDmQB}T|Es|}DVvvlITIMKP$}SmciDHJdv_{cIj!S+_6b&T0 zNE8Y3g;XpaML@30bLm|oiq~RwE9r4j`Ts@Xa zGNmAj{neuwQzMEFHKRzX6~*hdmAeG$MsY|I>P0b3y48ga6g|2{akhIDsXY{{m-;v{ ziV2gVFiuu|v!ggQM|sYT;@z*KST`??CE6SuDsjXz|bxRMszb!q`QHpZy6}| zj)Bth(Ypp3ePH0~Xan9c2Ey{jSObaU47@hpz&?qYVBk%;D=$qna9IA5N0L0%KyaFY zs?vC-fwNNfYXdFj8~9WDe`8?!LdE>nz_*JG+*oX&^Y;c8iFK8MbMnTI299kua9&n# zGca$bfvjBy2FrKyvA+24++!g0i-DJAgk&F5e-10ZlLk)7^xqA{pVk^@4EWC(D0<#N zwHpSm+*A*5>Gem-=dp5pqV?oEDf>dX{A-}R$w;fBMrIZ>Qlz+%(9>DA5H*8WtMaBnzq;StD;(H}bLEk(`=F7Rje|l!r8^YvffqAohAj z=GHe-qlJ+cQoN;Vma%f8m60uNjM&;6DJ{q3FKN}m$gGa)T_?@yuAaT6_;Ry{kv%;X zqqmX7zN-6UJ^nBVSKd4`sy+qmCu@MNUe~#YPs( zttCcYUuxv}awBzDXfIZ(R}%BRk!fqxI|=@%-pci#j5JwiWb%3=<_$*Tq`CaG(a1ZS zj9d}-799t|&)RP}v|at(p<`mF_HCE)-EAa$kCFO^m9yj=HS(>*{h|Jf@vL%}kEQzs zBbRO(>3z${54Vj}x?|*?=a=k(6s9U8cyHJQEG_O|+HXHB4-I*@U~EiTCO&o{Vc`BCD~9nR20tiCfaX zsfnV^6uY^JZBn9B&H8cd@NsoVxruq zCe}&MAtpYMf5bo3#Is>0z2`C!Jx2A8HL*bsN%3(ej?OYMb+(DKb4)axYoe1BS!g2e zI};=1;BpfMD@-h2X`<=(CVp9E!oJ!>yC0PE8WXM7>NUCbqlxt!OqAMaVwW73TANIa z+HB&fShpy5*&(;n?oz4Fs;6IJ$@2uap2%KKO4Esy2uUK7LjnfUL3i9Ux+{2?hv zOxP}(I4N~6nfU6miF((ypZ82$6vqP-Yb5HSi8_x=)O=!Mj}(7q;zN1$KNEK)C(2B5 ztC{zUnRT3*IVpcj>k?*Wl{8Z{*36|UW=5o&Ip{FcCc{iapP3)!Ex(yTa#g%RGqYux zjL$XGAWygXW}?Do5@c$1GZmX^9a-PZjH9_3Ya28D#rcYvJXtKa+L}4~s+sdLxwDxU zvhocxTgBVOOy90%{*t@WuZNlAGNPxMX=3eVrcrM*n`Ey{dCyFl_sw+dYvzy)>aSb| zm>DZI2AXLuKZ|v+@{kiBXpISGj!2`4W+qND>-~e7Bv~}YOz;~sze>q(&3qx>tu>SJ zqnTln{gauQ(s7-c?(5C0*kGpIM$M50n>2r$nI%7)c`U7Vn3*Sk@6_X6W?tWIX0<%o zW2W0L>cM{HcR+O=)aznCVy2TUI%+2In3?EPX4=Z!-_4Xbtsb4#_&?1wkyTRRyqT^S z%+$VU=H?AEAKx?+xMilgd@qk~o7s6seHPCHGZW<0Lo;8qGm>H1B$%xg*)WXco!_G5Vva zlNHU@oM?*VM$<-?%ALGuI^;(aR}jrG*;^P*Ue##))uV~75lw@d(YzwXYeh3!j@FK* zdYx#Z8Y#BqHIC*)(`b4$i{|_0(M)O?%{*z?M)O{Y=Iyr8EN&M~%~zv&DzjgYrfr94 zf*qqdCg0t2kLLLxt@VN8%IKk5dzc;%kLIt>qj8RiW}38| z8O@AY(ZtM-ro1$q8_nu@ybh&qUk2fA4gO6iF)xYn(NP_Y4;+U zeFh8Fj21pOS$HTmi-pEk3!7ziF$>YfEi@=$VPHuM`=wNzg$m*$LEf+?8CH#!7Ryh0bzBlDx`8CP|dvLN_TB zu#h3s<_3w?4lMsCVW5sTjASjaB0P)F9v^Fj+fs;U-= zyli2roULb}VSNi18(G-a*h1AN7IsRJW)^n0ws1^_zG9(rI}3hUC~>b^X!Dw0mt7q# zRP1Eo&CV7+?P}qYWOP%$64Tp4=Gztqzhhy~`xct?RbTp9F!#4mT9yp3;2LG&-7hVi zmxmHN+QNv$me0$$Q*$3+RL-ky)NZ^syd}5*JQwyt}sh;N+vSi!~3$vrF z{2}!WR>m5wxJ_0HqpggR!xk%-VyyU!Sm|HXNy5sAy%Cypd+*AMvMKnJeE3AuH`N zt^Al}<)pOBw(_wI$+5Cf>f~D4D~7O@V+B_365dQ?qH=@N9EPkO4OTLyPK7@ z^8UM4wo3H-R{F}ozE)cIvl7$as=c=|LJkhFQZUe}?=xCoRu8w*@^dTJFRUcV=dyo< zmGDR_O{J$8CMh?WIN8drDOU2Qs&CVjr_`QdWxiaUsoZ8+3Cywbk?fdj#XiqUNBMTX zl}8J#bos{0(uK<9TPt3fvdl`Y)mDCz9zR$aEZ4-h*2*0DLB?&eGGLo>l2Y5%Z%N&u zTIAqP9TR)4j5%iIx&)3}`C4xMZsoPpIu68g#!5e#aZ&xata)-w%3skwO8VdGo2mDb9c5#%{4UuB8y^~NjFel_!(`)ovyHA+8}m!pu$8pYIM&8yIVv~h znVgKXkyXmZ2k|yW$Wi&!Zew?XjV4JpuDoO;Sk}hCayI^!6Xk7Gs$ipgMa`8@QnbEQ zsBB}5%#?HTN~-cpvyoKA#%MX3Zlk)xhQViJo(%Wf*cY&oAJjVH&a<(&felYX8}B!= z>1&ydj!kTA6hkxR-CAQ`v2jQe+S$0?QR}^BuAR9xa#9$k_a#Nx{un{j=AKR!Qt7OurHl9k= z&lK|u8$CxUmPC)X(O2qzWn-z_8DpcvSR1Xz*;p-4#;fLOHeN`L8Hy!Qb8PgI)pKo3 znP;QVd>h4ADG&K|wetAE#?Cc1iu|ZNW%ExqZmiQ@Y)~w*?oq$w)-N_*|JBB^y*5hk z*B;7jIeI{SIBsL1oReE8Z4{ig(MaC^!^S%KMdHucs4Sh%+W1Z;oYV0ltL5cCZA_G9 z=WRTa$MG@Lu*cA_LJU)7zg)?SA&?)#hY~J~;gGDW7DLtQF*s|*@R97O9Ye5A42$Z< z(7bgF10=6a4AxilSaRFO;Aj`a`x00X%ZGC9r&u!A#d36gEC)BlQhH-7#WuyVMsyH! zU5;&yrTn&7X8at>sO_;#*%8Z#-LVYW6U%VJ z7Rw!R{1(g3bFq~CGZyQ`Sei@lQY-_n#%bBo3CkDMtUr|&Cqbdv3{arBRm<7cs! ziDN?lIL^xF-|6`^dR}7J$FW|_8}ynq+a1R&S$;_IPbI3^b>#d#@Pr4)_iRP|C+u2G7*y-Lw*P$_s*X00s6-%@!` zDL(qG6u-#XE2UU_wG>g;N-^+eDTY2P#X(u~Zz-1jSBgi{nRqrE;;|Xy`NtH`zvg(_ zM8`8!$r35}17r-cl%$I~Gxo~7a_9nS}4;>oBGPd_=47EgC) zJU>W-jCl42;z<_` zs`QJeSpRr@1LGMif69VEiuI9VeH_oIPvS8Q(OCKJvv~Rpjc21w9u`mf7xBC&1ry?F zJ2{?jr23S2@~6c!Tv|+z=l-mC3TMaj)tq?DU&qr#y3bP$OXEpdrn-NOXZ)sk&Pcf} z@wDC%ub-7v&#rj(?~bSMFY&b6AJ5lv>_9xf-;XEtK|D!M?FTu=MCA^*Up7OcHD#Qboj_l%TMggm6%WMochd8<)L;~$czzoF3b5*c70H! z*m7iool$e`9GC73>zjoO1?zFRQx1E3YD&`^OEniBV-|UQ+U*+rH?Od12r|tZ4!A_Nn z>f2xH?M*vfWcn>TckkP&^vq6wV}efACGb=-izV=hd{;by1&ImVk}s1JSol%`cf?UP zfy1c@yp)!}UsV#YdJ||a+XD%F6-?lij0z=CB`bk;eKiMU(k4#{(^dFzVwr>(Bx==BeCNOY$0y|{> z>I9npkibkau2*k%CQxiw0_FE5P;P$$-Q~JWKB#$8_czsgF@a6e;93GHw-e|k%N`}L z@mT_v=Lvcrl}Kk}BFiP-oJftBM81+hkwi9>N+dcykx4Hl(y?qJ%jBnWiF%Kp$PIZ? zA(7lliTaEwktvlE*_@h)EiI91ve=!-eR(~Q$OoZBoij@0jQk!>WMK6~cF5A2i9D>U z@h>Mr(?njhOw@VCM4q=xOih&@Bm5?H;EqdP~Pm9#44%YKMBKtB<@R@PZaYr z#T=T%vnb$o#gqPBzDeCqU6^}yfjab zrOx~$nlDIVdzEC0rzhj{Ceu7Wnc1?lMlzO~$y60jtz-tuw%W<;t&>bb-DG-8!=}kh zmBr1HiEok2*Ybx{X_?F#$#0X)aH-NRnRRa@W9pJj$?nOt?3v75sn$#D_Ex;NlU1YQ z$?;E;c`#Dzj!GtOLNYgJB$GQ+&(BHb^rB?a7AN!Z(q!KHL2HQfr)2v4oXkckwKti0 z`;xgKH4o@Hu^iM|l6WYYPBLA-Jdw-^dFg`Y{-trU;z}}G|4ydJ)nvy1lT7{l$xN0C z&y)E)rZh*Sue~&vQ%mDdE6t07(v+!DnyzxDZE247DowfGr8&L5BC~E+B<^WNUK3-H z6b8nputTmoQ*iiGcwdfJOJQjB6dE>5VXDmOn8JoPQ;6=CLd8BQw3e@A$>0ur7s7j0- zSBcZob9N>AZK}jl*}bh2aX%~8;Yz%GsuB~W%7scg=TeDUmvtLknXI_VOzK>j>TgwM zw50T}%nErbfdQ5IQ`(QJ%o6Fnp)%LDS0-~uWwsx$OzCHpnL;WTBvdk$hViLPm7EHx z{F9POR;5(jl~Z-zLyu*UE0u^hm2JLMp7~R$9Y|%q%n7A(O%7zHvNA`n$^5)j>V@^V zK#wI@m`d-esbo}3)%T}V{ToPSVC_`yyqwCt`l)Pgq;;C6va5M26<$fDhpcXwO7+)L z_1Rr2Z91jm>XS-;aSzt(AEvTaR(_VsjZw<^%T)dypUP)bl!w%wrnxgx87+NgrZQl5 zD%-_7CzWDL6;FD7pUS+=nlEqeOr_kuRJx0Ae=7A)q%v9h{*g-Rxm4bf6Mv=h^A*ki zJCz4FQhD(pmAVg8IrCVxJxgVs+IG@+s+~q`oixriPor;}G`7l$*U~83J&o3~_&tsND2+jqHY$yQW3`@SOip9r zH)-6FVr$bFu|17rGUONK^=lgI4yIu`l*W6<(x`Jhjq&p6R2t3yOk=hzyQ1+o(3F1rdPa;nf!rb_cj6=qA%YE@YGY86bcRiRA3Dm4C|c~zJ$@9nHY zjpJ2x-A)yrU#i0WD^)1`y9y(3R?+7JdQMi}uY%E*P9wP*n@)amI>TjQrF1NTbbY3n z&Zo`Nxz;6}%&zG)ek+|tAEk3o+}~*2vUKjq^v&t~wlkdyyV4nRB%L+CrNePO|9d*8 z&!&@hE}fZ|(rIuxo$*)FnIo6~PRDgEof$IzpLAW@lTMu*>0FRrH#PQFI_>3MnRqu{ z=fl%kdM};3GW}^foBvD46y@MO`9yX}aifD4CI{Q)SWyR`7IUz>xPz<`4%Q|)c#-U& zS7`?`%R0DN&O!6?4$@NfT$+P3QrY2Pzr<%a7%H9o4(tI3sWM6a2s&sGa?rZKK{rV$ zbP$jQ@=sL^pIy-nEJGwjgO~$8gB}MRoR%LCJ9J%|gJnk@ymZWgUj|Cyapii# z!9yu>(m~C$s^O-CHMg`sw;klki3bjzJarKBOg)ohQv11s(J!?3(mcw^bc2%^qmwUV zoE$CUq()IE%St$TwWO2zu}*z9;?y-)PJWYv<(wo`a57xRr#LxP$;r!=oy>4(j&yZ8 z=_h}S*X87<-$`Pwlh^Z{l&$LIOf4ss>o}PxYhQNqqMnmp^_{F~JeF0TI{8^bL!1o$%*j9USl$@sq~aG&ewCBbYJ`)L zBbC3blefN9Pe!W_IV(4%!&l0EjB+3ABvppXo0GNv6esnkIk`O3iF>wU&QZ*TPRcJ* z{_@rm<+{{K`(^5_%v<5)>Pjbz);bxz-pR2IPHJvczc%Z+ElxIWb+Tcb6T^0`{fm>v zziVwNecFjr{`u3%zKiO!O!-SWN%AF)x$NYST#_c&owU27K1$kMCt0#cZrxKJ_no{i z=bmUE|8?@YRQu0KQ`s&tQ5g)9G4eDzgKvstuvXqFn!zV>S8|JIuvj*WBR+%ENf}(1 zg~=K#{mW-izH$aWxh7AgXKDtk(=w=3C4(H9@5hc@g9*~`4ZSW0C828u!)1m< z_srnk_cQoRB7HSZwn%jU4Eo6^dH6vFH%4R-8kND(FEjW{W{=Kbxx76ggY;>-ou0ut z={r-grRuB%zrb8{V#*|xL6qFBEjI|HIs`4W*70%E=tC^ zXkALrC%ecgB8c2G2ZPWJ=4Y8SuQ>hN4AT1a$NfS)5Q(Bo#!Gu?BZJ~Tj=7AsxJD-4GC3uaj%Yx z;`Lm#tnXr{{4NjW-DWPflPa2Gv3 zcX3+&mdp{#X{3u0a!aa!M+Uaj|r)i@FnCd_CF4D(N{z^W>&vPIFOj zri;nnxHz-WMZ<5k<}$4>Grx1OOv){H(Pf2;-^8#={gnN3MjEfy+#g&-uTh;ps?MKO zr>t7<;>iXVLpQlNxJ|WfcTq{ooN&?Ur22Ep#gPjx&Pl!NF2>z(5p~nWkXtS?Zfl?9 zp+w(tF+jH5b>Y3|qSXV{_)z=#SbJi2vo_jIn#IjNtD90WZa$OlMck|`>ZU?5H<#nx zxD(vWl8U9>bSvZL-T+D7P=WAFY3A}{<51ra#HHmb2F~Ko2UkE`ZjW7YwV^;6E|CBehW9B zw{|mCnzeD$NsdXGwr)nrb(z}E&AC_IJZPGop_HcryT9BwFhbK!5*D6^XR>Rhr(eVR>=0xJ;aRg zFi6Ia@^I=)4=<1QFm;TFb7Pg$IITBPYfSR+NM=p;@YfU%cjUjR>d7>XlMd58oRKCo zJnWU4Gd;|d(X%`po2|!lJhY#yx@Gh{51r?5 zXtvA4&vH`P0Lz=RI_n2NJ&MVVSIxo|ilvk(*aM#9#HWQLbJ0 z;J>N0CHJm}PwsiREia_%ef3h_f8b%mL+z;ydgNi-V-F3Udbnco>T?e-vt?zBmq$gs zyjj#sR7o#&W4%}sy*wbRnkUm=^OE+uSJz}Hu4G7~PF~u{7CF_~%ls~0u66a&_DwGpyL;*O zmY0(1e$FRkA3vP(`&N*^!I54`mG(93ywcc_;#!@P7F?&XMlKf+7b zkzT$VrPyD2@sIWLwRD{5Wzi(%GTFXcO#+>m|_Af85-}Lg$Eid-lUQXQi z^2r1B`JtEWN2>p^_C%^ZRi08FA6=t-9G6W-A11Sp_vKBCkL6Y$AK5%KA+s9(BkJ~;U9sEA_g?tRi z^syz&r)$xD{4N!9eTb)X2xJ#>%s$ zkMiwRM+em*|HzQ8K8p4B(c*2*m(zWGq`aqm`}%NxqalxF+(+Hm`~q#wC+f~ z{-x@Xf4=e&80%x6n8*8QJkiIA$v)0Z@lko2kBM@2x{uVEJ|;<@**<=n<0E~p#z^IP z8YA}?_{d-A(=|0dYJ96TrN&|(tEK2lAI-nlx^i{358oOeb7j~%AMW+qhYdddl1ZC= z{INxQvdxF*7ax6p^$|LxeK_jli(@_>OS4lxrv2{Y;b|X{Gd{kP&(8Vy^-mvp=as)) zx$I-cT^|?jY5aX3A3yT3>#^4R*Ti4v^m zr*eJ8YvAX!{4IMM`-yAnXNVkb<|nCzpZP8Qv}^BYUI)F_(N7ckPI5c>=`2Z|{bWdi zbnNP(xH$M@1B$n=e2FljA{4DC}XRYk$rQF|D?(Zpg+1uC8`~Cb3lfwRf8p}4Z z4)ilXhD(J(epU_k^W+0R-9J>lA8Y=n%6F)rUxxW<@wsx4zbD9i_3In;K$eMVp=$nC z{aob7yu`0_9)1?C_LJ~~pFV5-{Pd%r8teQt+vI23W>p}9aggQu=^pBrO*VRWc-t<%N zmY?-9<)P|*r1~CfPi5XyKUbgmdF8pD`_IpQ0z{$$gpC0jip3NlQAWribAYPR0eTk? z@Ui5U2=KCO5JPN$ccpYvfDE}L59H0{0Lx1UC|4#xVTAxqB&MRq$(M38B|wcz0s3SF z7$RX;fCjQz%$@*!Wlk`_<&a*_3~)0yKxTe`Z=_>kfJIdU1gk5Dmz6{P0HYfOc-AyP z_2vOqNqnmS?OF%eE1lW~bZu{d&}(|FQ-CL(1NyzE089D=xbv>!y%(U_-~iJ;2vGSW z)%|6F*GC69ARkT$uw$a;P73h5RGboEocumj_ooL~HX}fprCMW|=B`k0HU{`)Q$Xje zwC0Wgw|52@ygR@bzXUk=t9r3Fz&**^uk~e%JUkHK?SldSJ*|BI2oQHxHOt=f0R~+N zuGsvB+AS=U)TNq?v)u6894w6zoNcRRo(whZ!eRhyPS_Ns)I>?yzL4D2F+8u*5 zm-U?$vrCXKy9SBx6{KD7AeY|`a!>37g1kB~$UZqGS%b93V6E{%kc1C|H2yTmQLY#*cC#swK9-%kzlcv_Hd(^c2ZAb-sY(qgvio*U%Y*FkE|3sQPP zkdEI3IV_jOuu%Da8>G_WAQNPflv<&hepO9-m5aQ*KgievK{y!X!y`eO91YUrSdh2> z(Y%{Mdfp0BcsoejJ3(R}1!?m*$R1huRCz~**li3^+#KQ~nIM12gXj>^mJnOzkW{yZ z7-0+1w`7R#%7wUJKExXpLaa;)(W+92S(QT+OAV1)B}C73#gGlo5C&I>cV(APuLnYW zD4VlFm~#|MN`^zUj)YiP5aLE*h-I}xG-?oHQbUbt6ry&k5Tjd%^x1HT&tC~~plyg( zUJY@&eTbBfA;wG1&LKv<5z@J&5R3YUxHTZea~U--#7t>5C`4B|Ddj&1vE)OoIV8k@ z&s3At7#h;gks)?U(cvMcd>+C&Dn#QiLu`?UUxkQ_Ro$|2d`Q2S7{WL)#3tD9a$epQC<#tzIt->3oD@$`NU^ zJjCytwdR%(d$uaqUCL#52=AVdem5ti&$HCu1FG}9^1rAx; zV#mD@MIMAmk}u`x!w|1OR{t%TY_w+LvSsqDWG2<)GHEPZBsxBmQnE;H*)wUMkcm4v zllMz!60DGktx_gUDrd4){*`vAnOu?Bv`lu%DY-5soSD2NJ>_LrCS%>1^!8-3#+ym1 zFOw>{dYqTZu!fnsZaR~2<4nBGGU?YmlkROYb?uSjyrDI_X7X0AOf0=KnJv2}WKwKW zCQBmg!|CGrFxwtM9=Y~vnZ`3+lw9eK{M(t8gM>AP{ zER#yVWit1q@;{YH>)$h}eKr&G`AmL~&Z43P*w-S9aLX*3$_hF1P8P}UX7S;mEb7h6V%&VqUywzDbdu#uvUspGiE*LIUm=^O6|*^2Bby4fvMJgin}TuK3>%-#)#=&1vmu)wH)d0Pb2gXuW#c-K z%}go&M>Z|bWV2H){+*5US~k{~*bGSJ*hs^0Yd?V|{J|l(MB0U!5F#p>et}V);?cyBXmY5Ye zB&^EewbeQ7mkaV>Lk@`tb9ntw4hQ6-3_7m+Cl&Yi9EQn}KXXXFpuA+&-5j3W%i-wL z935-9obcq5pPj2~iE|k{T#rA`W%B4;nvBV1%Gg{!8lTI~3AtoW%%z@mmFkmo88Ic7 zC-TP9T$V1&rObD^_+*G&TbYZ0RW4u4i#@s2{8g_V*1XG_cO{p)H*%TyFqhMha+&@j zmrF(Sa23xZyF?zH;`6AQkf-l)dHNog$9!iVr84sPCYZ;<+&pgNoGlUNADL7#%pb8~8pMSu7awM~6i*2Ak?c$iQ#3iu2EtW`Z+}F(b?{Pndn)FkxSqDj}_t8D_AQ&I;2pJIrBepC4vn zI7~t$%=PMFf;Gd;mzuT1jH(mnnG|_BOtX4newJYk6tkgXHVV_GahN$x!jxzlW=}KS zwg~gF%xD?rLMzQ_9p>fN!i;@A4DG|L=n&>%$1q(xDQ?#=)w_jRCEec&v$98+3O&OV z_6almU5%5H1H!Z(sQP8tP^~*m>kbd|!${2^6{g3R>eX2FYFwDBQe(V&G9k=Ud1spX zJ3UOlxr#YoF&8MN6!|91f@NWLtalrqP|WXP{4!j$?wOxx4CFXR6RbLxzG zaW+h+n_=D)_pLAySs@Q^t0#BVLuvjv%=9N=VxETCLWF2TgbS7k<&q+FNsjQFlq;+I z<#bA)MsR0EsGS{QbWVf@1rheY93j4bgrV|z zg9ry2Mkr_$!Pq21y`~Y?i=#z^cUngHQ`WbQ@Y<^p-ja5&MVR+`gcWk7Lj+H!2(x8G z=Lm=1h)}hQ;&)a2Zi+8EdqgPOD?+mDkRoqKNRoMS^_>V0W$?QZets{)K^gLXgkSoq z4(Z)5!kYdO-v3ayLn1u?EP`!l1fQIe3d2>KjFiKlN2vBighukY#Ep#b$|%K>Q9fb zLH5Yt8OncVgutu_&E`ayHa9|>g%N&O9^u)F2!@{`ys;y~(w*wz-UwBWtF{vno}7#@ z_DqBmXCu@(r~3X>4i_S3K;Z?#EVPA@?^I^2gRfjvguMqI zT`S}h$+}+1hc^njA;oSN(&A1bJEY)VA;az$GG1mqC}hl|LT1XzYQ?71di&}9DE*f| zA8#&}rJMiz=bQGM4__b9z0=h$GdE6e5;tUZ{?)5 z?`rbCkDPO!CnfTxY4y9T%+~(vH-AaRuy|kR_xw=l(s}ac$&;r{-aI99m&lPbEnl9T zIZNivlcRL$5@qtI=P#MFI4w%&qDk@MX*rAME>*fz$-HGsl*(JCblx(#bLTKJ#<>iR z+5aEw|Nm}ekl+7*4#sjcDI;CN!?IGoa?&KIyyV1j6s#cCM_ffItdf+DgSds2m8E4> zq{HZ4l|D73uNYQS`WxA6OC9k~S1Cs~=@WKNkg_b6Vo(*`u?aWu7&Vp<8!n*tKB><& z$y>}%o3S7F(5SedM&V!yKmCIaCH>SFeMEy;%&Zo7JGB*$heyHK+$JdJSqB zZqWV`2K|ZBB@H@W+Mp-p46;-m6yMpPF_?*RT?`tCPhGj)&7iE^4T{CL9tJh;Mc>{A&Bb1X^&vJ``Ww^`zvJxy z<{fBI?m-519&FG~>>6T_ZKy$M*fETpU>IRgG3>>_QQRMGP~R~Iy&BJ4XgGmbCmE#4 z1`Wo_DddbJQw?%WBW`?{PV6%b%7fjwjLvfmikxduf%yilTVPPmg$51B6u1`~l(5X8 z%qtDLy~?2RtBHS|LHRI!y+LQNe}h3CHZmWwZ!+jSZld8hvI)z+^XbaOZ+MF@y z<(*=f_I7Ko)quh3*LebJ;R85yr9T4I+%7FE#C+_=(CkKy4mD~(m{E7oz-!b6 zSR;%&?=xz0B*&2!Yt-0yqq-zMd^NG3s4@qmm04HK?Fb zjS3re4v9sLdV}G`j9QO>kX+oTahQXCC5W-4QFq}j%{hdYF={VXmo@4>LdqFc992-S zyipG^t%6bZibnm0uu4XaL`r3&Dp%z^;(y{c>Y{BmVn(^2X^#`X7*(jcQJrfT6;#ux zML2=Ws9DRX*|m*Yfd^Px$EZ(rjoQ`3sHgadsZEKa89BE!s!1!OCbTx{5dOuZwnmxT z88r~D4n{?z94?`CC!>ycHY$5}))Cix81FWPw|0^B?Scm5C zjhggGi$+l2pk)hm-KkHEGK{lbS4I zY_wTy(gI9fVp86vCUwO=3|MZ`egv#A$+(I+*D(inZ#L;0PH&<9+e}(^*rawx$@8K~ z`L0sKYbM3rG^xjJ;(uY%dAq-IIs6si@|OoCGWly@W`7;X;;)g}{S_GMuQlip=C5ry zjjUdOJ;&~Ff9;6ySMg|nRl&>{e`SgFS9Nqw^w&gGPV(37RDZp|rF4Ipa`|gXL6r1Y z$twPOUBh1o>-lR~Gk@i2!?Cus$4~A2wXlP~K6LU|a%X?F#_=xxy3^fX=X?9>CUW)h z*I6|0>#whv(9d6y{r$BIDFgjg2x)`-HEpoJ9-!b5=D}n%97d*#gur zEI^~N6+SPwaRg%{0yGPUk?Nxzwj(GiK>gza)HXgqy>JQla4sQ0H*g{`K(A0ZDL_@R z9)8III*n&2pAw)C7@QiQ->@z%KzDE~XMh^#4$v1I%M+lF`4~Tcfa(?qP;|in)hj|w z6$8|&GUK3LwE+D&nAk=Ks13@GAuhPb(jQkQ2B_~OVpUuRB}gv{PzSX{a^sK4bTQOxJBMi0<_p+)*`1_{j-`i9eeN;GqanuBGjy9UbFtf z+;Fq%M9?)2xlT&3d25tjN5?i;u<3`l+~Ct`cUg z#2sWPY1S|J3k6DE!7W<5Zc3f#uBie~v&GHV+S<1t!PHfv24 zvp%52PiDPArD|raM#-Pa1#9sU+kY{uTy=h8RZX*&*D}jn->i0cfC3H7DvRlOjw%hA z2lpG9mGf7#@;5fCMiaA|;1)_Xr5^YOcQdono10Yxu9jv^LwZ}YOzq5ihEM3z!OROV zvqmAflUYN$P;Vr5HR~nrbtASOW<~cjD@$MI!J+=tW1v~dgUqTn*sO-wJcRy3xsCPk z3^VJ%2(yeM&B{2+tkf}PwM8#{!s)TpV;t)-$*c~O*)vnA|8(wSC0@fb)2wiu#icoB zRi8^-^UVDIV6V(KYwJR@0vDMzf0|fl)w9{sdJj*^f$DHTQ zD)t9^;7@As7i)acti6}1`&HT?^%`q}-?8%sb-c;mxy7DD=G&|x8lV?8W8)pOj-caR z)&(E$lhXrg3;RR*U^))q1FHW+4$u=~L1DDSM7%(@r)I?=(;N1t!6JX7MP9@NSTrAZ zQNe7{zX-HhR1WR!7Fk^uEpl7*1pR|J7i`f~*fLn;$z)N>EEaw8F87D>*HCk9xT*TA0@&dp?UYqcKkAwxXYmnr>szz|KQOm}MHw1e6oL83-q@lSO)Toy)S}d87B$3md}?k{`F0k) z>1vT*H)275q;{u*89fvc!YO2xXPk) zc!qYXnRAUrA!{wlzrmt1Xo|O(vxU99m9e*z!%mCx?qdC5+-*^*Q`Gu2>w_!kafbP^ z6ZOwhcYMX9a~383L7o4!CSSa!2U1&zp!U<7vC}GEA9VdPK#C5tyVS000h~r3d3q#L=L-E z8C_OIq8N^&YoJv_@d3w!t#W#-%8I-=iq09V8jOF@Da5K$8Le89*{X6`ts0N~*_jKm zVOF(+JKU-ou=%X2iu;jP#YI_l9`mEET7%=L6l0Y!k@iT&@2HjAs%3es`VHq$H?LIz z`G^^#aju|M846hyfg(7C%Ehc|gHolf8i(1~hUR6g>Vi7utnx2!RS4!+V18VwVpWx@ zR@FzBpR78F_SLNFk5~AHZa-V~$1hg(scu!Cnv9RRxQ!0AsB>+rrqp51y3C1fs9(=2 zOMR;{<8))jZDQ4o7FI3A0aR;gRYOc@LvC%!tsS|cM|-O-<36%?uqt0it4iZ3@^`W- zygxM_VAWU@7-*Gi5aZ!2o}%AitIVUVT7leSt=f~YJq&BBm!_(C94Eymq`|EEjZ~9slijOee zW}WX^wdEeUBJd&k{KFbOvg+#pJ+^Av6YBKTs)5hh=P#^Egy$9Y!tA$JUHF%M{+|8& zk^P6jPgXTR8yG)ZHR>y|ePe%qr;VRYO$|16#zCV^=h4L9rZWLH4K~{}0Y^~WX;VU= zOcA{FOO_pez zLeK)iv5bu#_&v_1L&zU*)7%7`Rv{vZ81X&Xrn)IMwS+UxrnUGb-NyS-HjPJePMenJ zCYL-m#pSi>I38nGew(Tku<_c^rqYFMno`)N#YJoyUDT%6cvsw}0wswJB}&@OBPjZKx-Qv3Bb zP1<79eC+?7wL{l!Hhn|DPGZ|-Q>VQ)`3~6hGa8}%L7Q?MwkiC$P51E{HBV5-le9&D zgq~s^R5)!@?=v<%KWo!x)ICRi&)c;10=2kkQ^QL(wZ&a@yG%QLx?EY7m)q~C<$K11=YvgGVEt&*Y^=b7PmKSWyuR4< z-&fY}1z>RPAin*RFP5?Pgb@?sj#>Ao%sLt9gIBy2Crbt`CFl zG7hn;_fWe=!he`uMNt{4!|f`JH~4{3BbaxzT{n<8#;%rFjps-k%N#h37US&NfsPaG znmLI+uuQgVFHR$9s$DSGfALGJtP!w0N8IzFTx|4>65ened! zvq#YGiCxv6vWK79briXuGaib)u}e4;EnQe?0E+0$&jIoqECegPP+OHp-#H z28SLQ9V%pUs2isFJM^pBq4roBf(L#}9t>SHPj$8bN^ zq1jl0@9~V6;Lu_$N_HrBxN_-`xkF>|xs^k; zJ3F)u#d_|ROsVS$-WM4grij>J4ZW&ou?ib z9D0YPe>jx(r$a}u^DpAL=+N#o z%%NFWj)KpL`-MZzZ~`A-dg)Lr?8Ry1edW+#Ohm@l4z)lxJVyRE4wc1mWO+-SFc+`! z9qs;gXctbP#5;#3V&}otlMMn^U>a8jIkvJ5>j}k;~!KR5+YYt#vsS7Ur`p%#0TsPcdAN+Q;pHV=hQ!_66w?hJVacSQ*|*6Q=*;Pf%_;L z<5YMov11Xs#5q+w-l-?}fV&CAnar3lr#Mw6)v2$jn#LUIPA$vfRQp^`eL;oX+|KJ% zlYF$#@6>?;P9+v}YAmJ~aw@2>Q*VnnWiRT~C76miRU3JVGZs3RaOyXFMoKBC-eY%Z zr+Sug>KQVXB_|lmF)#jut-Mn?&>cgusiIRiaiy|TepQ@`LVdKx2^^@#y5KWhzc5a9 zr;62Zsxrpo1Ul8EzO|fMgVwd3T3E-aLUofls)EW@>qrBpF$iFLV zH^#|x6{jZRGXlmECk{j7SVv696=WIDIh;W31Y*Qp6q-m}$U4cXZzwg{sX17QEK{f- zPRyV#Go7jj(=4a9z%bjXf^*p8NMFF%sJ76l8MuSIix>;zuy8RsEph7CrA{?mMm)>e z6DyqZtYXg9PPJR()Kwf@>y&T3Q>h5wz#fNtBl{mO5VgsvAvl4+-`GR=b+c3Xw@~M; zPM!Xpn6?u$%sZ(&I`5*cyNO{BwcbnY``qRFJ2{bO*clF6mXW|yv8Txw=@=@DAkT?%oyG(6a)@flp27~;}^j4s{F1uUc9%Awqt_*cyL9mX;#@it?^4YKmrThnK0|RS zf4WOWa=26~r%P9{KbK3za}#48#>neZCbUA^d@ilU4m?1n0*r%(1znnl2ZdcaQpBYf zEnWJGrfpnm-`1r@?ObxScd0t2;7A9T4tHg4wC?WGan$PRlD!vs_GbP*ETw0x#ZRc5(#7u{#ObaO88&T}bdzDp4cT-vyhI2XIrZL>>$ z+sNavOM6aG=aViao3Ixh2L!4gY7S%^ z7zfiH9nf%CpeBw8)CbfV8K~Ez0+lp6Q28-?Y@jwy2-Mn%9G?=Xb5jGgbVi_B&J5JC zS%F$TCs5l^Xl|gM&kt1g1%Zl33miqzBIa5as7f#|4^--^KsCV*99SKwvoNn^?)8B> zvLR5NHV5i9e%l_X4Ldl$J5Uey1*+_UKpj6EsH;Z;wf<R#aiP5-YgXwW3>vD!WzfC$~!e;#T+SZhflZ*2bD{MbskJ+HRGp z=jJuITLT)=ud!Rtn=p4Xw|vdr`q09y6)oL*hGK2pI)ER@-sIS=ZW+eA^>Bh)H72^%WD?^{A+M=!1y6UY6+AQCsx#BAwApU8Kv%3q%6$6aEk-PG zD}4!h?50k5hM)IPkG*b9!g(a_b1NT)qsV@a9bvtWy44J8upR##bF0G%<~_-popvk7 zS+}a5bE`gPUts<}+Es|R}D=h!3a{MfC%Pw4y9&9yvkU3*5I zUb1gqxpnM~TXWvCp6K(5_IQqtpWW&Q`xiH_-`skDGXJ@C4l{nZ^%?y_g0vIIV96My z>+m3Tj0jSUFGx@EFfvGcqJnfaI!Mc6g0wL%NGlVAbRa26 zb8-Y}e%>JM%@?Es`Ds@mNH+=wDY$Tu1{Yy2EGx=f#e+1wM3BNu25A&rrGvBq_A){G z6^Bu#T#)9L4^l*BVnNBOLE4IMSod>~qJIg}Y#hX^T0t6JH%K{t4N|oMK^ikQNI%aA z(uzm)4G-3yh+x%-57x}IU@gOt^kC)68LYgyf>o+&u&QBmwP1az9;`Yw_=%3Sg4L}~ zuo~12RIA5?Sl0HVeNx89&^yP zTQGY%SWgB8>)I&BnH;PZ(}VSLeX!}u`i@|2LEz3{{erD1 zzAISwF=cPCn(Ygg@j$TVq0GTxjfMLN`QQ>#j|Hm>rW_CEJ;h+1LZ>sq`u8m3oD0_B zi@`c_nYgY5Yryqjoq*#;unOJ`)~dgW>2|ON-w#&6Kf#**Bv=h!25S~hW5O%$zYf;T zALN9eRECk-BTHhT1@$)iMnkM1H{fJeQ|9({$|;?WfttR4ko3#QvVnw!C+ zb{Rd|gyva1+Md;;4B0#yiSu}o-J^A(9u@O?lpO9+vj~p{M7VA&n{IKRxJ6&q;3iSc%F48~m^HQdA6;Wf(d^=K^~AlE*RrXcTr zk4j_y0goyk<~&v&@u=xB_6SCw^eD$EkD7e-Xc4kz%Ahjng`Al)@LV#3YGuiwIcXUb zRy%`cHqW3-_;DzMp1#VUSsya!cf3ZtUx%QGtB zPDWiq&3`j$&DV^2jJ=sMas5^%&C8NWS?Xp|>js$=)+Uo4cF3fW-7~5Ez)V_yJd=#) zGRgmYCe1WtR&QTsUV~@W&ykt61pD)6*0JK5m90!>wMWqvnR#zDGr#jQt8S(&Iun@uy*t^ymfYt@PD`hGGy*EfXfXKc(LsvHGE zRTlek25Sq3s!E|yT|n)^p*n=}MMBl3XsD_e3ss&HphUAhpJkyPz}Xod_#-g#EkGhq1uG%eM5B$qxyxa&Opv%5Kf`+&`{+X7OLdo zp(=oX(O^WVKBDcYQ1!wtv>Y9(ZrF-zV?y-^GslMN=D1J=PYl&q+`}u(m=vn_Q#d{~ zlG*r`qStdCJ2CsWP>tR~F8F}Z-&y+| zp{j-EIEiw5L$zdosAe6Y-@#CwN4rC;?P2PKhDSox>UgNS$XoH6NR?{x7_O{t_lb^)ThB!SR}5>RmfbTN{O`Oye+JLr{}26=)i!*k)n+-ZD(v z+lFaj`!F@^5T^Vc!!)K-m?FA_sYTZ?o$VGTXAj0elU`ve*E>vKaG-CPZuJY(b9@^R zrqKh#WEm7D)37kvM}{eNR2ZKtg=xs-Fug|LlrUwV7p7cjj{Z1=jPt{kw3xYYcuAPj zmWA=zPMAjEIKIMvTbPFJ2-BHUya;!{2o|SKq5n@N3{zCCqB*Re@iodet3M@Cl3Cd9@L?_Fk33blky9RP8`~IFEpi zUX8)xPF~%{l+M%vWx9B^4~@Ed)gH%j2@AS;^#rwhP=}sgUBjwgUO9Vvl?`|Mc$LuC zt7bUZkM{k&T8o|oz1oW|gXn{kh-uVfhF4qg501@Z+}Xs7b#sUx zwdOLtO3Krrr z8gF4tT*vpVUS<5a^xEmwYTQT8UDODtc6(KMk5^4_3Rmz0 z`SyA>9256>H4owYz3PuYu=ODM93sA>UOmRpV_y9Q-*K-F;nWGnLC{HRjuv>2(x({b zG;5CgXS^zU&a0Xiy-K^})d^h3xGP@GM(Jzhe4TxY-!SJ6xjmqE|FAb6dDRMuPs!~W z`yXSmAElprxt7YS(Qjz;mfHU7)hq1$z~24nRo2h!`G9b)-wxMNgj&Lt-5RcVRI`Wc zx3F;4jStt&0^zb33)dc8EfubZh$$bg)fK|E4arr)`CcOJ@vc_5{A!1*8w%GAR|S-8 z7_OS_nWIy<{=~a3;R^1?I4Id8oNHnkuV=VCeQ4h|T;=+O%h;c`gTqyOXt=(P4A;=5 zjK4Nq*O0J|_|}K(JXUT9muX|TY@5P07ppMow{YFViOu1vxFuXuaRVt^!&PHjxQgru zSFb(cYI}rv&xLEkAM{1QwQ#j~5U#FpJq+i%v~aCKsmI~!gy+cnBwS0e34Tw*br6l8 zg{$cEaBan>7vakNl6v41zP~1yx8Zt%_8-HwAAh3yCu;pIT)%z~R|j1A5w3ZP&=Nz0 zHX)}eLPv4e5uu2{2z3sQ&_9UxMyOtFgvKOBC^=VzHWZ3b_j(a3+c82 zMCiu(2u=PYLUDgZ$a^V5_t5Whgf64q71~^lP~XQ9TK6J?|DPh%>U)H88+7pGpV#6l?Y=+2Yen^tJjl84jCI74RRNcAtJjtiz{vIE*Lw$LZs3 zRK^PQNp2tCY4hoB5aXa~uuq#qeA*x3<8`r5moO^br&%bJgShZKr%!Ei`P37QbNe(p zk5AX}2wU^}bPz3zGFLI5K44{WpG+lu3dR^bK)sSaU4XlkkL%NYYK~L*4>e2sGzl-t z`1Dsq4JOV$mWWpB?zL4xvkYTD;V!wrk0KJ>zZgDQF`#`;B=I z`qcWgkIz7Ts(*&M<4@!`>*Lx0ay;i#3-rY*{En}vaNeid_!FHk__XH_AJ27&|4*Ol z;5giWQPYd88C;iHPpp9Jici_l3@vZ^v>dhnCN8{0#oIoe!+qH9`ji z#HT6GsLyks^1Nd0Ueo5SPY2NDolgxuP%r$dNDcCfl-&@ik*H;i)NE6va+o8z6q{p? zNd4rD)Em@JiPTkeDjumzu$GPFv$04m!hWb6=g=P`%SZD4tVq465XtudBh}%TNDaV- z>XF)m4mBfXt`(^x$XbVX4I;VrKT@}wM)DbYq@3*{S=&hE?+~fIU5TMbq#9s#&q!@U zr(Tiz9c_C@>H_-oiPUmz#zRE+jZ{v|M@qj)dHP3cCT^n20Aj%v{5B|3)kZ|B$rR$6 z9m%ybk=lXJC^k1zM`4*4sRT5`!TFI2S{SJ?WLy-fva2I?87DSH%J5sH8f}hLjV+9a z5&yR>QgPcOHEB0>-5;sU2O`ztM5Kn}50pF^sZ-c{DpJqz39U{O1CC+pnMi%W^s|u) zJQt~jxPw0D>5n28$OSX-9F{*KmHRKwV;Kfqq&+@k)8$CrL+};mMKAn~HP<8c0L5=c zD(MzAM;i>i7pd(JB6a^^q(UAuCgPqF?~6!2i;q;}SLFJdT#@kubA66f%P*1Y{$Hd{ zqJg5+4=%qb)kRC3L}f#i>LI@|N*A%#6s3>w_m9#LObFmUdYYru(Gn$Dqx28nVW2Ha zlkHJj0E;6^T`?HL+#H8HC`y-tqx2BfJyB|cW*MWn7BWhmGDm3;-rxtqvqtF*ZlZEF zV!|@~ls!tn;t$-$n$Re1$CI!qHS|WQEtVjEc$B7LDK`0{v={!7QJRC)D8|NPOp9h* zgv3NC5>xR6zsE)?ZyfWZa(tBR3ADvxG)sw6i_|F9N{dqe^eA=CK@PbXFK?8Z7Kqa2 zLQyJMI7+jMP!}vJN({JGEQ;U1QF>N9O12Ul!xNk;8KtYGqm-pgluQ+))CgygzfzP| z;0tP2CRcQA8l^)$qSU=7weQWCeWO%u2(=qd-_cQ;F+NJoCq}8<4Ca|lo3&9|j*;t$ zX@8W8++eM=QEZw1#x$c(-U39~rH_xH^il#zd<<=Hn7d%!<|^lI=*Mr-Kr(b|iw z+oP3fN3^0)4rh0f$L?rN-4m_nd!v`Mr%ASA?i%DCL`=@w1y$$#b}krU~I)xWW5y4XUWm(gRKa<60O^Kj;O2AdT=dT zi>^nj-VNrv8LcbGbt_ud+tK>-akLyySd*vJ`Q>+aBv3iIa z=2)d?id9>j$Q-NpSvi+2R-KWYJyw0fVzmQpy|L;GzwlT!jEL22U#wQ*JOdUh z#mCB4I98>wxCrfv(hn<3#Of}Jl!}$TbgVL?Cobbz`B=qQh}BIzN0*9>S1DG@D#vOw z##ANVYO$J$Ww>6Qcx%M+J&0IUtsBedKe76!9{20VY9ZcXdxKc@ZWOD%Ets!mtSZ9T zI+oY}v0BV&yN8EaguZf}fL`7N>9g&JF9 z_5D;V*T}`{6@FmpnOOaDAyzw4?;>?UrAx7@4_%H`4`jbij)=X<91ml45N9*S@m-WS z<-Z%J)%b=S_u|wUSMU_^_v4fY!*LjYpu&SV{-2Ih`-gFQh5s<@QJnTaj??02ak`D< z=W*(awP^PuPV?{%Q7_{Z`YKLu5cWDwgWkr;@839;##v;17pF#8iBtHDjvt8gV;t9w z#_26`ev0F>#yDL>l`nCcg6OZ@{~o7;ir1g;_lxJd4e>gMErxjAhu0Xdniz$%$ZU#N zT`b0J1o_9SI67e&uE7!zul(qO<+u!|IbKE39t&^|CQG~uq9c~$5(2F8DvZ8Zi<@xU z;#CZtumO$j@#>6^sP2qcDObFngv9Fu!ZOComo;8#n1c7=@k)(|*EnCiW=6)VSv-9) zGf%ucdE-?XYx0qI{&-EmVRR@Iui?m1I9{)ip$KsljaSBE@#ZI>F*gPzb7E8U8}C=mb@W zN#J#Bf*d&$)H+v!VsaB78lhaC1obOOJZN7iLH%JYoS`sCv+)Yr$hvfK(HA2~^#DI;s_bfqqo+oJ2 z%LIkJN>Cyqz9uN>8~2gzM}j)S=a;Bo;V~pC5?*7XlHG~wg5kJ|sGvmUz;75DoT%$a z^dzbicHjysW=PZ|lnF`HQk=lQP{u^%Lw}6LcT~)js2`}9IZ<^mCQG9JMuq4^)xsfM zk4e;1)QL@0OZ*v^s2T~03QkPaTeL}H9&Ex{G)_*`dhAAtlth_Q6V((qkuxokYXcJX z3C{FH6+l@`#2viEh#ZO9ibFXQl_giAieewExf9h5>+lz9sylBm1G$RCx)C#v4WL}j0nsJhdLaYmvF&g2}vW7n)i?O(ug zY+9J811PhIHCUXe-b)g7W;f^eaUPrYa~@?5aQm6EjY z=Oo3{NaFjSNy<_yNptHb>Fcja%F#AS3t?-Qq`d8kxnq*1bV}m$;Uul>ktB1^B#pz- z-bpIhCrN9Nt#6Vp4NB4r6dRJHUxqR#N)AiXC$t%!#NQ)JQiah;dNMXiV<#l>nPrl$ zPD)a<8A-~%FiE`@Cn;`8l1d*;(m>oi#MplId^hA=3C#e&Tq0*@&tv;Qk180(S z4)JG`^br4Cq~E0^MO;qe{Vv8w+HGRSNnE&-q#t)#uX{pvCNs`v#%@<<&N;_o#mZX~4@?VlheNWPKSj@>PfuojW{fYjzWDR#FYYO}`Cu=-h zS&~&B&$A|LX0~KK3QJamH(3M1lT{!hS!K}{d3?#bg}Kqmx`uHv$(o0{vB_$dH(5Jy z6lL=zt0%$=F)jiNC(DcFFceMZ|CwaHsFr2x*$E zF3pm)t9dflO(ttSYy*n!J}OxmMklNDm}G^HO;!R1&rQ~DWS*a_OSp$@ z3z9W$ak4TkN!E}R9LI!J$@+VBvR1E2)_oLPM;-7Pxz;CZ5q57+<~axTz$tikCaW>t z?@HFJ-Nd;kS>5m(vhGb*rG3d7gTnihRT+OF?O?KQ;wj1=qMpZ-HTHC}PNLr#YKh>p z$?ABHIL{|59z)>$D_Nb8;|k;6NY)74zscI&qCM8%XT4DBVX}(;LmRAmnXGO9CF?aR z{~#Cemtqv;m!ft^Hl?UzP>R;$*WeU&LIzKY#^4byWK5AOQ;H7a4|LC*qGyLr~|$oPtkxADH@ABCsVZU6#Y-9$a|LD zE~F^>Z^pfyBKw^bZ9}8GDT=+9q9sp=<0)}CQ&rHFs&e=j#oVdRh^hr{y$Gu--J|M#(lU_Qe{a?RR|6s zF-NKzO3(+fB~#U|PO4hgOXcr9rt&vwQZ)iO8m3Bp zQ&kg9;p&&FD*YLEK&r+LPE~^;scMh7p{Y7Jh4`nYYAISwOVyBBsj5CZRn3rTPO9q8 zOI4p`shWTp>r>ThW2%NDZBwe&{g$eP&8cd;HC4wBrE1dARLw`ZW5kDy$5Ztbznw|d z#7n92-A>ikfuV|U`$g{|1_PzB@7Bk(*tvw z-oj)_Q)|?;rfG#EO_`l(ipB-F1Jg9bou=L)X_}pp^Qe|7P0JCLIZbb3()3qsn)b%i zFCk51a;51%#NW86|bG9s%VU3*it7=kL#sr ze1kMiY{VSDrYR#1BDisy%41P8;%k?tsaS-H?Ws!#a_N-DbDA{G@1Mr|h0KZe6R6=t z=0MF!#5g;R>)_H<9p<@d`n(`brx&K_1|}>@(}$(hds&*UqTli~MXpTKd-$(P<9cyw zupv#3EomxwoPKzZ7AMIGPcKr7D{1_-)3sJpo%f&9wFnhs(=`e;lG2qkHC@H<46W1BH9tLFRdS|lXx?-^ zDV(mpMH#YP$TZrSmtuI1bOx>8gd3 zzohF%4d$*%4lvfDP3?3|tdp*Db3WU-u&OO%w`1%M=}PI$ zT==g`y5@FE=Wp(&t4)t|zK20g&;eO`lV_iF1@~i|L5zd{uxfC+;)l|2Sh}8%N>`)N z>1u~eW5{uAx|WVh*S+!SdO9&(XD6jAd@}XG8q}DQu60w>b!S?-yfesW*8gg{4=AUq zFW%!ndJzy%I!IG`o6u8+NzV-=nVHN`CkZGZ(yP+jA1O+a4gy0Hq>EG$l-@z4BfUvS zdT;N`TkpBnXNBC{bI#uTBxB0G=d%6BIK7@3rz5lCv^YIZgJ+ZL93Ed1r%p@bG-X+w z9xsoReu-0um2o=$EBmgZ@6~Y%t>v+GaT>lUPUruOV+|+jzAa9P+vC)22lKO&Iolnl zV*8lG{q%W|`8^b;3P<7;I7Y3Glfy}JIz_&x<5UiZ;W`ti-e=?V;#`~_T#VE2*W;A; zMx0tB9S3n5&YRrFG9=!LQ+NCY+wC}=z!NOF6Q>$?iS55Q{fjXfOnlBaDG{5IC9{ch zdQBRh&!nkH%5PFD96{laO&WpPB~9``rA*3;A=q8o#QP|d##b_F9?~kC)Dh=UwyH@J zFrcPMW8tf1Qd8{3hjmOEh%xadrK4#BliJ}Ql(e%yD*8<7Vwlt)SMdbD_=y)kG&Jcs zoB@*#;5xPhP3jaf>H9>Ju3=`fN%_MjMX?5%Q-}qZ;7T>AT4R%TAX`(D{LR=0#hX(H z=VOq}aL{z&a)(zo~z{>~=d!mKXz)y*Uu zPT~9RCe4Af2RVFg((Aq^_33BQv_U3y8%+K13r?We5R;!m~{J3F|RdSMxEquire$4rXEC<5Hp}^?S)Q-V8iu;<&GO>qh|TD>$*de($Q!>P<5sh- zZZoU?cC*f6;tsPCc2c{2W)NLA8MD4PYt|*yJ!jUZ7tE|_VAgjYhtju?qo4aOy7c}b>rrk4Z z_an1uEXt8=QQNSEb&Tn+g+*peO|vKx zv8X-9<8I8N@+~bI*2*IL=N1Lg4>#cb!lE^8EJ|)`QPXx7O~AdcELzsyq7Ar+|8*o! z6zy!$eY`>GF7%Cu$k3DRnA69i)2Q3eq5}ObDgy%>29Wna_8VzY13W~=Q5KEFzu%F= zXp7n`wP-e8FC*vWaxth$Z#WUE%7R@kcXDONR4W!yHz0P~ktUBe?ZYG>vB zh?R4EtSZyls$pMS)$AMk9d6an$UM@jZ8(IdSU-w>zq9gtr&XU#wJL^9)2tdZ-Krn) zC$`SA>K#_4(-ywjRxOxg)z!J=z16Bd+pL=i*>J_%hS=pu`s8z)#7xtliHJh&CF;-Q#DN7BT-qo_Hqs^uz zh{W5}36GGNVAE^lwA=I-vN~*9jnaObV#wdnrZQNBECJ#|#$=nUm>#w%m|{~43_-_K z`bVTO{o@f5o03N}o3eMb>2KuhWYd?OZ7SZyriut5uB%O5P^OzrCj5p1J;(u%(YU8g zQ-;}e3?sg^X)2tt`%kqg!wj~~wrTTRo8DmMJe#(_GvCH>^^CE=rp3!_x{e>0 z6C-M@uxZRMHq~Eg)1D3F{ku&Yuot0?HZ9v^Q>#CS3%hY}w@nTA*whr?KO(=US1VqP5oeCq0vxl(>na{2vn^g9<5Sdv3n^%go*0Hn z_z7$90K*%^tC&5WV^iYgcE$6VB3@m*^ku|rx<6jk8pUgSAf7e7<5hhUV{G7+Fr@7#ntSpSjVoa4ejcHPa4@7->y4YmSUG9)vk1mY;M;s z^l4$&C^Sg3t4M45M$R^N6~!g2>S$NiPIhJPOj|rbmM)Bgl3neJAa6IjN?`}g-R-=$ zv#U*CyEb51KRcgS?ELO*SKLs$;&EvNZAaR51edXRl%2mXcC{L9*B{u2+hgr&I?k^C z)9kv1&t}>+1TB8DYdRV&uqzGLg?5flvvX{&U7j^|HAaKAc6Hlp=QFBZpYOA)J0|b9 ztL8s7m4_v{*q+V|~pBjW>dd1BXo{P4=IzcA#rUE@*vja^G& zeQTFDqeDw^I+KHQogM0(*`ZyyiBJ{?Yu!0C7c1}vmaGmL_!SA+9GZ<9*&Rwl4@}32 zq7EG`!G51O)CIXpI#d#Y_ewc*7n{pD^e+<2JM^@ILmewRGywn-#Ji;e6*p7F& z6h}Wb9jsyQ&_JxH$2iDX-=SKlVsR)L#~Kh@0?+o_`%`KeQxK69!YCgKntBdMHI>9~c*<(+C)fqn23w&EQMRC3CKK^Tp3 zm7S_n#ig@yhaNo7~?$kr%?BP@ym~jx#@Upj4rTUN$#$pX# z45W{tPQ8WwJH~}?tdsTYoSHGmsYQ5(!fTysw8N?HxN*R#JO_#82(jQ8?xDz09HXAd zdxF|x9@gOedncV5c*?00|2Xv;?(IqwQ9>)cfOF3$~6s_&j zNKC5lV!Z^Hvf5m#f$Iq_<+HoA%j?p86b-qQfN9uQKs?&7*9F2%KXsR=T6a;XXqc6TXzZ2KI>y7)fIr2=zQk4qB%&v#VH@tCb!E54 zqDeKkhTuglx60ObD^ESQ>fwRStzz+Rb@IA(#phOgzgzBPx4K|*bGJT7b8AAxtxsZZ zEo|vl(&uhvZtYezEb8dyGlyHNy0~TU=H~n|xAuMQ)_t`3#;x9%_g-(e9DUq6*4M2@ z{oMKir%C^^Wa0C|+nB&%xg|tD2 zpWXTm$(tD)=do!E`EGNo_%61guR;H(H zhy9tG_s(oXi5JWtHfQiCXI_tLz+J$j4!Bg>d`cuMD~^*{{DK@wzWs2k)gdu<#D^K zNBO#Wbh@X9i^O@<5d*R4y{|p2!S2yoyz1jor+yyJQTC`_e~%Jz7|#ZJlw*)byZ-0V zDHIy!QFRQ*8PxgKqi(}JT8_ITJZdq@qaoOczTa~@+M}0PH`b%>6Fq7*mAr5sS*CeZ z0s+jy7Fcx=8$wx2z$5$aK?MIOCHn`?$Kp5-ssT??AT1LkZFrY#ZVIsacw(& z@8CX8;KEMg-bFl^i~aBIW`6g0IJecKhsd$tqxNWbz@uImdeEaQXmrS<`xy4OM@w)I zukqxFN1Km&H0T&P9;eL-k7nQv@}Km``ravz&cbn;e(}j!+Tx4z?2p;+UGS*EMYbdT z3OOPFRgX%d>c7N)jq$I0RPL5XU)}ZS1=`;8aGscl?^Vg+0snsJVckNHZlUO7kLsc^ zzIj57DEX9F&;nzT_c`^%r!PE8K}QV3T(o}a(MarlO&nRhYKW$AWb^86F0YJoUNu1v zOt0Y87ZttATgj`fmAyKI0ad&zQ`IX=H6Fw2>R#RkiwF?Xh{~i>GhgLJ7N9MO|L5J?7QNJ}+zQd08vNs}+sB+JyB1ud0T;>VS3l zDaos7vR5C3y{d#|*ozxzmEu)T97N?*#=)03fSbtPn0`^ZiC6K6;4EICWK*v^nAyy$ zjcC}MwitsoIMITCN5~gfu^{Tz4!B}owZw2N!&cmHMIFBIa$b{HHCi)1ZlFzDuWqB# zmtHl;PPA`FO!(?6uPU_n>P=5C*B!*yUhPJMZ@e1ytylX;dNpE z!>5#ZpW+($_)WzpZ-P%ZFw^c+s?(?9E}#5OeR4MQsbU+SZg%tODduP{)$5HlQALrmw<7++*#DA!M-N!l4^o=iW_%sKf-=ys=pLU_( zZR&W>r(TbF?1@j;k@l3haSI)vQEz=iM?`kMT(7mMEz<6EAG zDD%#z0a%COGE_W+!MTfuZe%pHE0e+RkcP^kNESn*@mp3yy|Nivg?-r#)yrXMF7o6w z^ffLb^#enDP&1dI*~pdKP(NHnAdjI12z+R;HmbofEryonHx&EGP{)rAEym7*h6)s- zFN`W|=xGr{&x;xwU(C=q#SLXHVQ4DKePU=mT9h=Dqm-cw2$wOm2oJEQEd6~-oN$#V z_6mj;Rx3KCf?R2iCa^zC$2?pP?=|h$@DmvABzX-_SDTYG|kv{=&*e zhH34dqWYl!OQPxrrfjQ-kj%7`GXHHm6MsLsioZ z<&GE{fIHY1qdydBN&ZM~Ma=l>b3+p+fNEB%A{cO~9~0hAtuh|A-Z)Z>jkxL(j0_JLctk>V%u9JlarK zoW_tb?1PnKsna+^^KcIOfm__dhVh2BPBi$OMV%*8J0wprv>WxNGJn&k)pVY(Gs!RA zV7)@>f|9d&PR}tkaju~c=NXDeLrh=H{Utn)adauME@$qrZ-t@mzwmrqNj@0ytD$3P zx606Q^jyvStfg-2czygv{WlmY{JWu%o5<}C#zfaY4c4|JW*ozHByT2;?Zm&sP@kQK zhGW1kLzVXM`ohA!%-24~!TJ4$vK}z>Ju)9OH1H7d$`$}*$esgJ?0hjt3YYL zYM1rvIof>cSH{o$ik0_kZ$-cAR`P2PPE__Qp^9IJajL3c&8z!00*A1phM((V&=-Ee zJ>;$FS6k$+?Ux6S>iK1@?^iW5kHc^EYaPni7#kfh3{O!c-mh}#fi-r&9^xIEIsDoW zztgWj5$9rTRP(Se*5ef%UcW}-FJ$!5KiXjdZlI(=Uzmu$QNT|=7=!J219L;ax?u&b zpl~C<8e$lB;T7ry7#HjD7UrOz>p1we8h21JL_Lv?)A%USuMkFK7cwOIWkGlRjC07J z?3WAuu@-kxChS)ejKMZMMwJx$#w;8`wp71t=#HOo0mT~o)fi*36E9Gs3AMm%97XP? ze)%vI8}JC#n)x}t(66PqiBFqTFO0(uJVlKbevUt+rnrhSX?{g86-SUO;+GS>u^iV> zGD<&~h`;c0j5@XP%joJ?iSM|dKcKeF1NsR~S_J4npu6x#0#Y=f8*KwB_hmr;;3m4X z3+TXC0e(*oXmgi<+V==(ZohyoU_$?Z=ApuXfW93V(3n91o%}W++n9jzjSZ*`x??p; zjSFZZb|Lc*0jp{|cziA@alv4Ej5u zvxfuv;Rv-j9*`MRPXrV`8Bj~iKE*iy1XT1iv0(SPfLdK720Xt+?w5%Hb*_->19HKz zhm41!j{^GUaX_7)1k@kBpR)aVfHmI(+WD5pGY8caA7lxt80O+_)}Sh74=TArP?;+R zxfWzltI(!OP`&U9O{)cU2KVv5>Op0%7nBDtkfVN3<8a3uXI)T@)(7>=(V*^P&at3YqR#Q4CY~U^lR@Ra98^QRMV>1` zO~Qk#K`s0@$eJ)gtw5`rL3KlkTR~la7}SrCgBtcUsNi$9y&(6Ow0jlQ%-2D#OA*w; zcR`L_3u#uykQQYMX>{h0x?~9{oIRxaxkD8dA=(B!E#VjG+#8xYP*+WWjhIGpn z(pyhRKYK$u=?iJD5z+-r@P{-H6&i;0ZKDv^un(yO2BFY^kW!I-U`U0Lj#q<18aOzl ziFks!Gw25sX3`HT%%Y!k+RUaO^uoT4+}}ie*pH+?$n#Hf+)SI@Azj48J>-RodqWz& zFC^Fgkn&v!DTIs{L&}e7cyfs`FH?u>A!WG{;{1z{_8@pOq@}k)YI2*r?}hXZtL}%m zc3eol2O%wZ$heO}8ugsE==&n1?~wOpNS$7VROB_c84|S=(Ts`ejK@gIoTxYWAWI_0 zye4X9)`59~AW7HZD3qk+!buvB>nK?yNll9;={^b+OJZH}B>i0~N$2rp z=_Iu&o1}v{{b`auZp-%0^wlLv8}Y1blJb3%q_RVklyg*)W=%}eib+YzKbOAdC#g5C z`ebdA+GEYeBzZR_sq>%Q?nzR=Q%R~^Az3?`ChN~HlJ#kuWaaIZEZd@FwcVbq zq3E(VS)~pq>lQ{HNmh@O$$A1y-mu!{536i)SQ|eNYisMUwzUasV*9WT;8~Bba`g;r zI-*~PmDne&=KaI!i{}Hv+A%P!)X`x*8W+~t$zfHP5|*Zh)fgwy^2e}T^TNt7Kdc8! z>33sT_i%VqSUvs-YdBtEz@K6D+7i~sTf?fpJ*)*giD?)6;=?^*W!W26#eHGf_lH&g zSXc#5hE)lx&W82Bb74)s7}gpry~H?|!y5Y}teG#ua=#3#^Q*A(zYZ&i=@^?OMRPw$ z(PjLaD@7ezr|1w~;>4m9ja$Mk9xP2!`(-KGgu*LR6ke6Wnk^}+yFNwhuz!1sY&%jE z!TFsjs?oQQq4B1N`2U2CalB#qyR*MXc z)dw%@G*&jFu`KNytMI1ATqiM2KebKM&W>ps+BHp&dZnpNpEUi2uluEGBo_Bi)9^uQ znmjm-bNSK~H-=lx_#sVY#;2+7q%_T%oF><_G|p*A)3O<9`gdlUZmy%B^=Ue^Ax*#k zo~E3Cq{)sko71#;OPYG`PE)aCX}WkhO+Pzpdt*edC-i~ZPstHCG3G@?m+FIjZEUQPxw4>MLhd^^>Bykjy^esOmJQEfkAt6o&PQ>J)bN zjj|qpRO_${{rg8%Y(P}akZWL6#c>)HzKyCaiVTmcA`T+U$f#Oj)OX|p+nA{Oq1xD} z;*on?l4>5>q8>jL#V{ zrL~Uf%Qi9ngw&BSEygCiMvhT2+3+2vA?tTBy+On8W9o%tSUsA)#>8~vhnTG6V``1@ zNXIqQoe+~7ThVf2jQ77WRhSgh9^6CI$uSMVF<7R=xMo{SOK=>QQE+NZP0$A0P;pvJ z=ILz1o*6N&j~P>mS(p>kQhYc!rn?w4FQ!-6Fh8ck3t~EhmJ4HQyE>*0Ct^B!DyEC* z_fJfRa0?ku$5aD0Ov7_zJrh&yvoWqYAJZv&?y2rBFCS-+WO>_bBsc%}zZ>1=lzTAt qTK1h)i$0mKew<~}u-m1R7lkquethUe`vlLj|KBdt|8MaBZvPL=){;{I literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/082f498d82700fe3_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/082f498d82700fe3_0 new file mode 100644 index 0000000000000000000000000000000000000000..2994468dbf36b9dae41f6d01fb4d7419e5269b63 GIT binary patch literal 19196 zcmY-1cXX817w++IGCkCUObSQ~BxEMjXVPa9I!Nyzs5C{8qNsp?6)6HDy;lJd1OY)o zI!IM|ZvxU4>AmWGes`_=$IV)wHSL^z_TJ|unY{A`->dI^SElE)=O&=4%&2>(P&Z`e zW@iSgg@V;;`?9kFHG?_9YQft6nzeF*IkiKza%+V`Sy}$vYQd1NX6i=T>@9R|WgsA`BCQ3l}E=s>>*eTPDa8hha;-*Zp!0}>G zyg1yDKTE=a(y%cEzvh57PjlsX7;IrZ5f?HDJeX#daj1Lu~KV%PtA3ugipFo#Sp~vU2Vh~jO0uqM8tHYq1WPJ&X zp9S^;q@!SxfY{24aO+*Pn(y>it&DRZvxA&kR*rXf;8U>+qS_`8ND55OUWHjZx^%^`)`mcljQf^a9Sqrfo~;Yuljuu z7R#H5ppRS;j;P-)t}J#JamxK z7r-gg<)e!*O6pvK*0Sq=E^E(a{1uod@mHbJ-&$L4%D?i?HF)ul^180^azb9dp&W0* zGU;{;`pY%hdl$~ilzXsHlJCRa2Vi&z8)UB(Jc0&tS2{k1RkBk)e*$AA`YF8i3_g^= zbEqyWWsA&wp?*b2(N}ziD5}bjvPrUyQ4ElgQp*%YOW7eKEKy9CmewfVlw*<~6Ga0t z7l|T4zLbi^qX@`#c`m(5MDbdzZY4b~iX8b~;*z4MBxmG?v`^N&vQgBK7gDTT6rW0V zN)&Y^x{~I|U>PTMDo1fzrZ}QF=ZvCpMij5gD(UHpqOvcFL)lRz=0x$bd?lx)T&^C= zM44O=#op>sjII$yhni6&)r#Wv+R9x5b)z^S3H72FB3rtFTDEWNDosqE6veVvP4s-Xf$6Ji{@W>KOvg6iP5x9j^@j> zX!ci$rZ7F4269@CxuU7=iKeln_@Y_hk0vt^%~*M}W;B1)isqSoQ9GI^Qdl>drLs;Q zONn~Xd@Nh*M-yle&GV+w^llza#TJSs*IP!@u2nQ$<+_Y(9nFVrqA|as9NI>c+##A> zouaub?{$u5@SD*L?;1^!ZqYP-JDOteMpIfoc`uqqA4T)`sA#;SqY29!W1>kM8_jFu zqS+%c??#fFOqB$s+^IT0m>12T((l`7rY%s+@1pr` zVKg@uMbr7mXcmffh1QmH^2X|Dj%IcR4UD1Soi{@n+ zF4+gvql3}p9*?H^3FRs$CH}P5IunimTr@?`M^o)aG*@q`m$#J5Bjxp2xjxaF@`IFp zp`8AWro7QWtD**G6f;nyxPj9p418VEz$_^iYoK|Yfvqy4l!58eGTy+Oa$L$KXsp~$ zG!T_!V4duiNV0*!r48Jd%<=|m3l$8MltJ=aMFY7h26k35a6-maHZWJ>Qw_9BQw&M* z8wkn`c_Hrv46F(oNDCQwBg;S^@n#z+lpp1Bj)AVZ2G)cP{4Rqd1}2EPz(B)70~=(1 zH3L7(JJk(*Dt9EOrh$d>c^%~;4eAG2=~AIse@4E!e( zhZ$%#T)B=j;2Lk>y$J@+%d?3Ftdk6!oNVBmDeA2(n{Lptrhdr@X}QS2BDwXwf!7xs z=q}rq7d)$}1Xru~a{U(rP1YEgwAO%Woq;%MF2Afd@a_f! zSH-bs4kd5jeC8)+6WvLa-pMYfR_ z@@9^aq+BEEGFi^#8EKGjq^-W9jTCLB z*v*Y>k-Dvn`hI2Pi416KWMw3zV+AChuN`z)PK z7_nV6azg4}HuCiqBlWIpU+)>YD2@k4ewL_*M(R9Lzoq6ABfF&dGb10%tN$6fD>+dn zid#*5P|T#`&cq4%OInvOF|(wJqOm3}S1~a>-Nb%}i8dJ~8v0DEmbd*T2FTyy4VsuG zOJrQGi3WMP%{LJhHjyAxs+*|TRO`svW+oiXO<3EQ=qJusOytQTxz*Oh;a5$Zmr0#X zypZK@nAj}dH%;{EV&anAmA>6g9FyTaOiUGPPZN!Lnb;t^W%Bzb%6wp=V;>U-WI#XV z@}Y?_Qlr0#=JKmp2PzLa{*l%gZ{mO+1!X+f2-rzqae~4im5M zG_g{i>@v~yH}zt#^4zET_Um;q9Wv2L79KW{c*KPHq=~jN=ah*Or%k*h6XlZB`a`{v zqw?ac;{0i%iL8(c=S_6EV50U#6E|;|`1GcUz%3Ki+-NfkWrO@D+l^-Go6L+goAnEj8M_>`n%VC* z^Pb1d9m)2YSs?4g;5Snz%gp8+GevUEw2{SfC(lfWd^2$cW`@Y_LNj?)&G@UEG1oBD zpr)BuqGsc zHD5LJRA#+yrfml^!H#B*$a(pwlbOH7^M;voZ<(!Ud>d~)e2Fv$5%-r5- zru{B6J*3EPGfnrXH*!>NOUynqZ_0a;d{OJm8QFT>Ox6uEDYwjYyKSbgToeCYGvCNk zIelNRKQ!Z&mmZnvDoY=mDf>h{duHbPb2IH;nAsC;p_;+MFr$TsVzXFiY_+gaRu;2h zE^eVg2@Cy8TG%V4;w)4UXDJIm%A zLLaAvOLA9oT^cLR-4;5_AxZKo51A-YehXctOu#~hOp`x@$}ME!H5rj<;fXBCvant< zvMuz^(HOZYFGVbRPh}yyz(O5aCC>{jbg!yfB=WL_DRQ=+g@*N&yIgE!VM}8RRhwAY zE=8JI*xA~`5gGi7h05(L_+^2_y=tM&YkFOFbhJ>hlZCfBTll<-h0BuBRXIycFAJIP zSQz-Og1)B%&q8VW{zD6{krv+j%EEbhD6yj~+!$wJ(*z59zSCNZ6jvt6 z?(Z#puwJ!G;YJHpwp;k;qJ{S_Sy*$~Li!ceCSS{iCh$pkBV6RlK8veG5lO8QGyCdnUV zt$be2%G~l+UPz6KR#wOxX;%Ibf4Y@9@`Dhv(k|1=>MScKq+Pa^Pi0V!l?75K*UD~* z4qG`=VC7z+l~?LpSt|D%Sn1r*%DeKN>}jMN8Y|Z(R?f(fW>$We1Wk3U}d=M|IkW7f2)3WDGymW)Jn@?R;*uINs?i*ces`C2rEscheS_QellT_m0Odo zAMY`Fn=)n`tF5+sY@hZH^WDTq_;ryLna~&A0OAw^kM}P%htD@yg^S zR%)%Z@{4r;$;v>vCcafxX3I}9c7v4NeFP`?u@Z*llI>5i8dvaLmd# za_f|p*G}tr5X%`WeP#MZ_2Y`>$q^}kRr@LFf2nt}_HQeWYgV#k=|5J=+|WE(f78lu z61lCtxTC$fYh|BYlz*kjJu7Jstb8kF9_g5n&z@L0_Eg8wGaakXRflYmYx4VlS`!<+ zqHGM5Q<5ER<70!35pqkq8*Th(veCtAV_pdxwvsj)$J*E^hvlX`lM`_^vP#+bDBi|! zIV_*sZR||2(Im;n)t77p%i8E)&cM~?sJZf4iq@A3m2Hfc8FEfuNmYJn zHj=8?7$t|(ZB%#Ii1yi-D?|M@_5^I?2epp4^K2|?V8heU#s`gT`u=94V-p+eCAyjN zZmqGe*f<~w?QC4{sP*2qaat<&urWq9_O#*XW#gT9Y@C(U-pb(v8_%UlADh0H+4Q~4 z#%2k9Xk$Qs8-Gic0X7CpiGen9<)%b^WFua(KDALpR>;K9Z9J8#Unu66HhPRyEHRI= z(MRfjZDX53&$vu*U0m2+%No@=A`JR8MVC=dC4 zrSka6#`d3W6j`l2W#cb4ZmiK>tWzwp?oz+x)^9dm|J}xs-8M?^)gH<$IlNDOIA&vk zoReE8Y!sZf(MUe{!^Rr;4u{4+9du{@FA{)wgdjaXihgqyMSy&KCGX?;JIPaY`WN3raZ?vG;` zXNcpBER2a`P?0$HO8ug7%qbSfKXRscoPO5C(Mh((#?dc6j$g%ECXVs_;y5eAe$ewj z>v@S?8^>BPt2QI<$4 zYdo3BXW6Hi8kc>2omw0OEXeG^X;={8q2ERH8-iRxY*&$tcooRM;y;%U7tUcZB>o*nV* z-5F1x-{NVtH=b|g$i8?^-H#{rK|D!M;~D>NJZGgbc77Lol%077J6%n7R!Ww|&WBbz zTg79u^Psq$swM1VCqTE!9TdOMRgDvmVVWM}neJJDOT-mi9Emql`3 zE^V{p-EL>gPCNhZR?Gv+TfUMyN9~N0-{qTAcCJh1({}#2V5iDO_3e^+d(+OFGVPX~ zyZ7x>dS<7eAwj1E6L>0_#S-{Tekh*6{KN!q$ydngQk4X( z-UOP<)<6PZ2NO6cBSQ&P$x7fo8JnFz)jT~XHNpujFG%2-JgAyLvl>?+sa+EI=Mic3G`o@z&4q;GJ&Q)B``w_Yt@_W z2^8CrK>0lhl-rv?H@Pm8_G_NhJ*rwSCa^&oTuUJ3b^<+R$)g0;KTE*!JVEcH66tJ6 zWU0iP5~&fB$k!4mlE}JJiJ0RPnfOv79m^)NM1CoksQ3Me+>j>~63MNUsL#X_nOr%M zjj4&)(h{jAi`$foAFCi0?XqRwe1 z^1NLl@4T7FTG`Syk#;>3Ss=6DRX)8FX)42|bzkKoZ}d;(G-*FmCPZE zH9V0zBN8!uok(zOBA>`*89F^d=l5Ck1vVMlI%~SLuL{?B`zz8Y0@A& zi3`#*H;KOaNodZ@``TQidR!OFK zdNMw5GR^aonI+q6Bx9+WOjYsJN~XVTsh!O3I>{u|O{SMLY?{mzS=20<_!h~0BY#Mh zmdX4q`E8OJDplGgv*wLtjBh4WvRg7Odn7YQs`b>my%g`AWYws6a_qBY9*oesBa?|6 zpUlna$>h$^^RtsVy)c=yMag`+IGMM9(i-CYC7Is8CbM2j?M`Oyo@8!F&3$@KEc>;V zBpyhnlT4GZjwf?mUb>*Umo!e6T}@{5U&$2tJDG9+Bvb!>GLxjj^JIp_l;)81v6tpb zYH9pwrFl_Mnld#?(?!m-EzRMcr772|G^e*#WajOP#67LZYhoypLjU*_w#nbl6de8( zK9FP8QW#u4g@(;im?E<~rm*g<6wF;ysMtG&*7CJ{KQM&{GHyr;Ex$}*jtm}^!tY~K zu#Z!mnVK^zg-o$7N};(dTAzY%Qwjs+o2@B)`&$aP<@duWbUTs4PtxH^3XSfkFjbCO zDq$^BiRKcMT#4spD^aIhC7gjuBy_DrN0~pM5)D47#AGQyvJzv)R^qhum{p0s8!E9_ zc5bOe+^>ptuo5qyti%MVa-ovW!&IWy72U>GCM&Ko6FXO?`rDNmB`N(XvrL{!;KR!N zDeXsA=6mV2t}@rQRwi>>WwsuxOzCHpnM^7dBvdk$hViLPk(>&t{F9POR;5(jl~Z*t zM2}^FE0u^hl`Xzhp7~R$9Y|%K%nqe;P4;D`vOGtx$-KN&>V@^VK#wI@m`bmzsbo}3 z)z7C?{ToQ7f9+K6yqwCt`l)Peq;;C6vZHw_6<$fDyR2-NO7+)L^%-I+Z91jm>YYkI zaSzn%AE&ZPmVc4TjgiXvt5p6Sm&zBDm50=xs=3os86~}Er1IgcRJMwDb}GddE1vZH zF_pO+HDBJ^o=UkrsdN+H-c;%zPi2zy`6HFobE&*5$1kPw>s8JFE0qT~QhD(pmAVg8 zIrCVxJxgVc+(r^_?qo1@YnMTjpG=7mSacNAAPveqwwrgxs8XrmJ z(rFBlZDrCZ@lqOH%cgNHEse}7n(IvCo)l!Haa9_4)0iv?A;rl}!<&~z^@22Z)J`L| zP8w&Mr_rZP8k=R=YiShimPTt?^uES^lEwf@8<|G`F1yM3bUj~wJNN6wF<`9s!*nH6&nA~+$v0y_qSJ}#<428&Zr8{FIVCI z)hZPJRfQ2ZtLXCuJtxcWSHWOQr;+>}n@)amIzwearF1NTbbWrA&gae2x%Or{nO)Lp z{B}AEKS}4FxWCo7CF$IeX&ciyx;>o=JJK0_D4m~=ro%Bke=42RXVXbLm(GmK=`^^K z&bX`T%$6&ErQ^Dm&U6{~Pr9x}N~g|^bS_BGn;Ls7o%ZscOt_n_bLHtQzL(Bjnf5fD zjsK-%jB@b4d?q`jxWPdSql2w-q^N_>i#ga?+(A|e2dk1CyhwJ?v$TU5WgT2B=b(9c z2WhE#F3rIisqApDSK>1q43pS?MfrCqOp}B*5@Si15~FR`ouxOW`r)dECK6DRRO=&9ln?rh}hv zX>V>j$dls_96WjIAm*9+B}b(8a|fedXy2uIl#^-EPGSsBzKU^jxQLS)MV%}u;pEkl zPUgir^?8X?*M~VdD*MYhNvPmtsEkW-amn%D&?$8|R;&jqi{t~at$xXkL#9Sw@ z=Q$}`)ybJ!PAb=NGC@|o?Bqo~Cq3&s`MHsk4vn3B*F@u+I+@wb$))B_T?68zo2-?e zUvcuht&<+@oLqj@$>`Ud9DChK#|}=~bayhlhm#ULogD1#B#t2{grw$N_EIt zxhWmKR_>#f`xqywGF0B0r1d8|sXx`pl^IUlvlMf-VlHq}exdT0x4&1ei=DJzqTb5f zWlsKH?quOAC!^LnIkL`4&GqWnMm@L5$@&N7 zQGJ%lmz0wvU)Go_P7cUrX>#33yF2Qmq}_FrB@5-&J>_xV$p>=oiT3edC&Q%Le@>dp zR*8wqV1SI4r{)a4Et0`1dADc=pUGXxEuO(5*(i?q3{EFya9tK8YpnDupF#P`8TjOy zJe3})8LUjppi-3#a%7$>gWqy8I3*KuGng+4c^SNxpTSGlM4btJr2| z&|kimC-c>(#Tl4>$YAc$3>N>G!FuVtLi6OY6#kUKGTA2HwHds+S^e3PL8)K0mWCc(aR=aV}by((}nKa>}@PSqv|^ zC?!K=Pgxh?axOYoaPfUb7o}5NT(0E8mFi-KBv*0KA>G9R+3a*-ak&`hc9EXx;+-rP zABiK|#k)B!eJ1MShTP6`ksWsNos=zf@kUh_z2%04s=K&X$3^jaE?U-iv0YBdLwT>6 zi#5#^uZ4>Osn||=_fS1OUF?+$^71<_4u0VxX^4wdsXWw0_hBwh%U_Z?Tse(!FdkO5>01|P7Px5moz`5U z^<~BnE|y5Sr7qrF=HjSCuTVc_ubh#_D>e5g7v`T;=W5mYi|UjWYh659=VI^%7yGxU zwyiG89Czt@9QEd;i$fP&oRfOjU5vfqBI>4#LAP9F+}0k+LowfR@u6(G>%x1_MXLv@ z@1gecvG&8{W|i4Zn#Ii?tD90WZoZIiMcgbe>ZU?5H&^1_xD(vWl!~R@bS>lN-+Z818%lN+*k|U zd?+vKx+(s$n_Y53>eX{Iw!WLF25$N^a${@krb!bwn`K@LH^W-HnIg^FxalNEq)b~k zBjvhGY3JtLt8SjQcT=sSYU|`?;9G9Cc6H-;*RAWl+)RGY&Dr;*kMi#4W}b^T8Z9 zm*m`c>hB`AJ|kD}mbzKC%uV^_ZfdSjzAN24lXrgBKCDu$>)k|tchg9$yWJ$o2x-38 z%^Ol~pBsNf9uj4^94O+UYEchGi+N~X+{0FB7^m@)RLVoTOq28R z9-7)cOi1u>I?+S@BoE#)9{RrI;fnMu@8PEk8k6FoM->k%(>+vjc&L!!;VqX(*ExGg zsOjOgS|0Yw(>flVBlGa1EN$rFK_d@uHuf;OsfT0DJk)OPVcx4AuD#~L(B4D64jx*| z=N&z|ZrMXlXXPn}yJ_tKT6>^J=gK^KAK;;Ih=*meb(n{k;T{IaxRD-Ce&yliQ68p@ z_Hb^DavH1kCTNX`9v;ceNgggu_Hal3o1&gf)i~)e&BGaKGTp;&sX4>L3>h`k!;x8f zJljM2IjUPm&Gpb}o`*&AJtTkYVW4~|L%#R0XR-ERiE@xyKX~|RsfVdjcA1AamaAW@ zv}db5OqYdH`xg(-Hh6flQG2x6!*bamRko;iTNQVkhlx^TyN6~wJp3yAW$;ez?=J1( zZ#oX-w0yJI!(aP6wArs-9`rEwkcX(l9!eec(Ds;z-=*3K4>u%q%ENpa@rQ?lXY~A8 z4};Em`0Y;*ub%hNO&&=2qK752MtWTKa7b=m^$`EJhxKypx(EMFtu48CJ$!c0!)mF)PWxyj3TONC8@YKUqi&vj_c$p>3W4t^n;^nQPUZP5RsT=FXlIZ1O zS>2ZNvPBL`jq+YbRPgdt-bwMYs*;!ADtjrJ=4F3|ZoOVw`@HOws{t=@K`*a_yd>r6 zHsWPYfyNYi`LC*%+SL`ahF9-%z0_==`3=2HY31cyYcGx4D2H}lM!)K%Q713+-t=;< zi9%^212Q{@ROwjF)eu;{-1YCo1PjUd~MMQhAz}3G&}`FDdq9eCCbM!*^uYV}dh z<|8P-7WdIN-p4ShX7}m)iI1%kljviBv@h*rK^Y$jFZtMA*+*QOk3sU0OXJ)=7I}T# z_W9`G_pvAB2owjD$mszxj)}W{sNz_lkrjGJFO`-7Wr5yMVI?%{-f5FzgPP3{p@3o3|ZsD zy;l3M&c`L0xY5TSo3tlee0YBI(dTy`p#$27!#=(|;^VP2JLzNUDIX6{`-q(J@q>JE z&d2Y6`p7%4{N?HuAJgypxNuM7@B8@lk&hjZwcfuzcE$OrThY(x6hHq-(Mo={ruvDg z;%9&ilazEnUg_@ev&`w|VTPa2-G0*je*N8opL6m!&re}kuS=VVpVnmOZKd0p{+1=PrTvI=TVGlp6WLr<={+@DwU%AWfK7Kyv z>t~1*_Vd$NwurUApATiIR2blA#Xvt#KJwG;W7Yeq=6|ky2mASLh@Te2l!N>=UgoJ^ z->L_)M2rhm^LOg!LO-VO{W^c)XTeH82|xMiy~@uotNqkioiI;fft`&lX{j`$gIR6RT9r`mBp!%zB|Bu&p~KQH>JeOWcj zuB+OQzx{kFjsEd7@w)mdhMRus-SV?mCO=gDk5unt?Xk>#>gVrgeqMR5=l=7vmjIEd z0AWLbhGH=WNR;7nz!adWIY6)C0X~)75&>S8brKyL;5{jw6d*$`%L92UIl$7=0m_vL zP*@>A6N#y)aq^WMP6<$>Qh?qW0R~Cf6`+A^6q6@FADJBta3!SIGXvbr4Um~1;9Kcf z7+_)50Kw|Y;brAeKftI40iHDtP`!D86%yYnK)cofcFPIb`$~XLZ3DXYH$dn$jp-EN zN#}t6&MLt7y#w5NPjTN5&}?9UsUHQX{E6!SD!}Wb0_>BI#|PLpL31YtI3*P)2N)}- zrs)2(086F^D6?2=EYaL$>e2cDpKS=}yp-157U1^w00Vah`0}>^`+rwYb_cj8d3&|K zY?6oj0=%<7z`v)J_a6b`&Z>49EvIGodDS8VE(F+eF@XP4fC8B&r!FgxtIA1c$xZq8 zuK?Ho4)E%=0B!yW@b1k3t8WFUa$9lk1So$`Yu{I&AFIz#0ptCHL`p*K4d#>KT z2r%j20B8QwaY2x_vdI|4Y!1>_##(~Rk}lRD#ft=KSv1IY`LkG%8ukXQQ$*(2=-D&|K)52C23$gAD#E$nH@= z^1lwUb+mFB8)Sg|I3>vAsX@9gF<}xg=&%-gG2h= zGQ@T%IyA)OVIiy|Lp1&>#3p(8b%@9q)h+ACh4eR*Aq*2jY>>TDI5ET=xjIR4C+oE- zA>w79oRub16?0k$%k&U=GeUemGsGR4HY>#W+3MFf>h*$<&QB<&9FjImL!8>EH8+LW zwOP6DP%b+|cz1>LH$fqNwx#~=Q=R9P|3$4Kha~y3YLd6Fg!u7li16Pbw%rR+P&alg6@1%<-9&l7({1o=N+JOx($td{8=*V1-O< zl`?5kIg`!uue3|e%;Y8MAuqc!8RO2RmnV~-y_ux?GO3cQ$9b6y zX_%?&sxt{U&cxd+lfKO}>DDGw*C8p+8(OnVCU5u5#L_F1S+Zk%CdDRZ5;ZrIy7Tn> zBIUY7x&DyJfMuB&S7%cHmrT~l#Wk5Y*JZMEz1G>Jbv9=*a))v{oXN@~nN&KO$($3) z|70euPi0d3Y$m4jnVd3bQPG;k5?dBgrL(A8CX2%_W${{87W1>SIFXyhkmgzJX^};^ zWfo0knH+jIi{$sR_;^4T_2yXty=&(1 zORXHzYv)j>ehyzZ$f0ke9F}#@;b9Mr@0G*wk8?QiNe)#%&Eei>Ipht>;d|L6b4TQG zb4m`G({lJ$){1?44(6FTG@O;g200|%=jSl*yBw}9%%Sa~9Nv+bWjQ3Q$lIqa1S z@?c#KiTiVS{Xh=;>um z)pf#&isoI-rS6SfCOpjL^rKv+y~yQq(L7wm^T;ld zN2mBaswU*=XIq|rw&gL;nMbLNJiZO)u^=~(8+mz*2%Hid~QCw=H-(! zU*i|#Gw3^w5%cnV8vdA1(bZb_bUr^_%xC|le4UfXC;4i=da3pP&S%-ReAY|$Klyxe zJ)fJh_GUg&xAQ43OXb0xeBQj9&yy$lRDGtn@{9cUJfC-7D8J}1#f)J-merOp|60TJ zvW1ykJj~e=Vg8YcCBys?8>T^Am~!!9c1rPtFrUcw#4tsZ!#pk@*7=IC&QXMQjv~xw zvM6119AU;g!x%Ec4Dp27;|&w`g{czKI+VJ@`N zoYrApel5(H*Tc|0%(4z)9(D}VrIX@z2~)jmm=)6P?J&!`hpEsbOkwXZL*LUlDfwZT z*8Nq#3>mC-hiKiQVSXB+`6I)0|4O|Yqh5^-^S9I(r=E-t^HkoQs{T$3(|3+y&Qr|! ziYZ0D4Ksg9m>oZBA69E0WXLayy+*OuhWUC!n4=rR)Y=rL-nKAfw}*+^5oYl2FuV7J zxw1dZBl+<_m@U%bP?#o1)lVsNEKG*{emqR6Q(@Yk)_ocGN0^gm)QhuWI^7KOzPN9N ziO4c}cw0TWqaI50$6=;D2@~@)%qAk3qa$3fL@1XO;mza-N2Od@-7ly6a;rjwtdt0K zD@8a~IYQaA2n(x3=o^Z#Av1zID?;t;2%~Z$G$@F$_vHxj^&k*d8)eaFnog&PV;hiHKcq2m9Hx<8& z;&)Yi+1@=u(Vh{KWt$XvCqk0UmA~JO@K6T67vb0UBkY$!A4K@AkLr+KeIxwbFTw{O z>vm9t=U+sy4UXWGlTu-*YLgLia9D(DUq)yo!z6A*gjYr?mK+n;SITcxgv8MiD$96b zOoV*-N)C^W=-7$SL|z#mVa|jIB`2zvazkcJif~iRQz96rMyNk6!aCU{1E(wh84&_A zBQ%>GVd|U+Z5BlMX=#LK%OXVo65)+)5f*P(4|hkXa!j=ykMQI~gfV9#96uYO&NlL9Wv{$>Rvv?ySxv}{$tjMfDdZBxL2S2VV50iSg!;6lFw9Q_NJ zDkCNraBxZi)ut9uVNL;WeN(`3S+S^qC*K#)ZE=ClD;F?qO97AM%H;ywR|~NJU4XG% zA@$1_a;!oj-=!6Dvq~Yarx)^yvyeF%g$xK3Qt{0~x^^k#gq-bJNa{OLg_J%~NENAlQsYl)ytw`@En-07H literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/0b065879d458fa45_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/0b065879d458fa45_0 new file mode 100644 index 0000000000000000000000000000000000000000..a4bc386b30f4ee4a0cb0c2dc5611f9a4d78a4097 GIT binary patch literal 37912 zcmXus1z6PS8ph$54ih9zL_oSb46s|VyJPL{HP*uJ?(XjH?(U8?v0L}NkI#3`b=~JD z49x$lVHJllyndHudD{Q@X(J-VRHuJubkRs$iSVfC5|OF#3DG4J(qhvRBBD}@N5sY_ zM8-uFFBu;hQz9WDCOj=QB03>FKB0JQ@u>L7@U)18QVHRaQ6-AUTj_nAb;&vd_l5u6 zPVD!m?)v|c7W7El(^BM^G1FQEZWsbt|e1K z2@%L$l3G_0fwfgBUp0|>YP(8H7iq7&tBb^_GU~5d)Kd!s>d=DbBH+-TT67SBOe05E z5peBEt$XQp)!N<^*H_nCZRk&5{uY6j1E}2~5!g7GivJ@5Zo{bla1m%@#EuYw6)H1B zq~SZ!awSC9Y2rc{=Pwgh@nAGNt|aI44% zuEj z7F%4kjr}DRd!>p7NW0ENiF<2}lwg)7DrE!4bEl^=*eVR0I-Wb2N(D4QRdMN_gU(s)?5xT=N6#v=y{fh0$&pat73d8r!u+a?t`UIJi)KEo?Hnx>^W0dr%=Q+%aBjp^+y==F@SjG~<^RvgM}% zT8Q(eGFq@KM9x|mVocQD@}c9t7BW46?gd&1R1Tv0TG*=E2a`{@g}}u)a*wwVD62-R zTSoo_eV;K!3)6~F*HjBRW8Bw{OQXgmECf7CQo~Xf0yF zSX+VeRkRQ|R*AAz(e+aOj0`Ots;>J~(?WU~vl{BTR1X?aToYYa)xRl?)WRbppt*&> z3}bUk3xOZ4sBLQtfxB%i#J8=Ep*`i+!lN!!qnkbk)TBZ5;vWm~8cr1^>v>m`rjXTC z3xS+!ow}@Srdi0uxpZTmg+ST)R8tFG7FfuRg*x6vRCBSuUo|tjuF$ioLf6nNE!}M)9tMm0>igco87u!do85-e%g1yLSV)r8gfL>&QYp;%tB!QDY83b zA<*;xuIsPW-WwEpQ^%*0jMKL*B-dRF`NwEyV=1u7mI~Qf3WOVvv`{)Ljm>5$@Z0F> zW+|}Kooabn3N$wc<+haQyq2;dAAQ%t)&exf%Ti#ox225mqjQBV1&aDp1ufh%t_E8Q zq=r&uEqI61^9W0U36a#Igr&gklJrk0OM!1j(K31+wbsZ{&QhSiI#k|LA}i3(s+Izs z)2U!}OM#`vs~VO9^=eXUExb|_Yf-P-mIAhQs6t(xo7!c3(?ZR9^gs()>eGHLTr!?& z!Lu>>X`z>q*3?qqxO#7NX=W)fqy=TPwiL+H#!{;OWhvP@(ep97jw);%C2OJicyga$ zDbQddoz{ZmBxaJ(tkT zr8=f%v~0Ph!0Q#%Y=fo1y^Yj-n|_?Syq6wmVbcLxc*Ig5_9*q$t}zB2vlKXToT5+Y z`Br6(3@yZ+*Yk5h*W)_P{9-9^|0`Agrt?$HjWt@x_luhS)-kIB)>ePi%xWbtI~!%m zZY6Ll2aU~XB{0{>=42(1?o5ZYFftd-(n1XvYN3T|Mt(Odfw9J0cPjx4589=LQ$~uX zmB5hP^ic~j1*nu3#EWujVX$$cpp`&^HytZvC2-xC=wl_Y&~Wj!5~$}#r?lW5K~Y+G zZT!+g$4J^5WhLMjP0eGi1iBkxaaICFjSX7(8c(egtORx>(@8B1NukMFuq{Fri&_cn zF%}oM64+vNOx1Cz0meHm#FwDuS{PKCCTgKV8LF>^vxaLqD}njtDXqGdKy@Q~4J(2C z#&|7Ut4aH6TM0NcqTE`zY&_ON&BipRiIqUMrc}L+UQ5mTiBrAa~lj+A4D}e>m>7y1BXX-d+S;;zMw-yS|x6-d2 zbV>`?jT$TTF`-r%nJcXX8m^+BYpn#ztfR5(^>Lzp8IBvQ1ZHfZ*IJ0$MhmsD&Um%m zN}$RPn!3|Uz-AXYYa!j(zS~Nm(;j-Jg^+zTTMKfKMrz^wAu4)U&$YUBga#kgwLWGg zamT6r1uKE~D*lp{EHj*M>p0XN!|JY;Ko{f58!LehnY8(>l|Z3)^g#;=A85H2Vm?vd z&sG8>4A(DuhSd`F@~eJ*`A+q-S_>@9M(ecTo1I?guon2+i6We>1&SN%wV!iY>(@If z;ASl_#FMUhTMIn&r?4Pvf$|~b7iuk#C4#C&S_^E9rs{Fl0>6wF@p>KQkwE@hm}cBb zv=*q4M0K^$A&vHxwH62|M_tQX3p_L?RI(O`txU7E@URMHYN1h8%394@pjtW|(85`x zOigQn8pbOvd^0-LvKHu5mp0Y27U)x-JR4XG99E8vtfjZnt+BPh!KU<~g|)z)R#d&U zuA91JwEN3i;DQm{)>@!TJF48tT40aSsk4qt4Ky;f5Yv?wYhk0&th=?qYa^oHw#huok#9 zho;Z97Pvc)D$chSXli6xs^?KTub~VroLfsp)>#XzSWi_qSPPukNUoc#1?p|4;4Qk| zs^(T&p@qzCv~!oWK(5_%R0~&)l6$NLM(w5VTJSqcU9_b@`8?g$g7-yocw{Yb-6-=!&$Sx+l*+xb7MS*d9%&)q6K&Cg#b+x0#af`m zH#)9`>_4c#7V7^;@3jzbVe?0JdmDjn*~mA$jegCtk?Y34TBw!7M&{(Sk*rSiq_B-Z zhCiJPuo0*oL>0qr1hyG}Mc4@RF`jE7EQ;o8VYM+a!A77$B27%vx0OXQxoKf~Diy41 zBhby*SzmVlErhk8?k#Nu z9veN{+6Y`VGTP}nsTqcSdmWFe)PeSBVOm$p)6GVpNq0K0g+4vWt(VSUjW^PI+X$o^ z2etNnb-u>6el`MOljx!rDov)zQ)~pRrjmyimQSOoB{l*ljhxGD1V$KZw%P~;ZKI)D zh}%xHwa{b-wb^MSux=OS-)$ohWh~xfBe47ctvqNW@YSe!*hXNX@$V5mr|RobYIw{> zV3YCfxQ#&T6O?&I_gST#rHpgBKkBPtbJ0eisj>W$jzhU$Cfge}0(Fh~H*ExR+@fE1 z^}MLG`&2~>8x5}qHq!E;jg)#sZ(iF740uD4nKlBc#s)2Xc}qv$*$9MwqDfk~@tMke zu@QLjmBPQ<2+T89{MPfXGXJBWTIesfe|*qFf+a22!XD#4EgZ3?@;0^t6KqNBZ1pc! zY{k{MU~emME`+*-+6ufg;=*kOmKwXXU==~7V{HZY$5WOBTY=ifDlNQAq{d0M0?tKf zs1{BYrNm;k0uiZXn`SFep#;^@LiUn0MtiB0t)!MFi%PZvOO3?JdVlI#Rcc$!R$xOq zO{rlku+XSj+g6}X9qL%uR$xUvs@vFBAgYP2)KZs?2U_UYl>XI1Xmh&P!dAey6*;uA z75LeQQv2!n)dpkC5L{xw6O9hy**|t(C9d2Ii>rqs-C9(TDW4gIBP55ok?xp z+6weAUT7iWJuT3}t&imWSwByO8F|0h3bZ!Xezg_I_l=hRu$5OoZKd8XI&EnuP~3`! zTiXeIHXQ8i1S;FpUM+0OMz-1Q1S;g9-Z||A&KS9z?F77xz+83$8;mb5b^`bE(62&v z0(E_8zOS7?4nNAPg{g(c_JxD3p0)TQFa2AqiJM}oxnF^b*!DhZX+m8KVNl@r~6vSn?ggh5LbjsYhkPL zv#6aw+hUYb)=pr$akreEK*jR(sFIz)fyz{@ik-j_BTF?qfn&AkvKEHaA)k770ujbi zEjZVw+70Xkju}Ur*a;MDO0AmN2@GmUPqYx!nr3Rju>-|)v=ivtiH>)(6R6UiruNWt zplo_lZY`|rMZu%&1iFl-2U_@SIE}Frcs-H!O|}y_y^Ne!=)BY*W2zQTt)yP6@DY0X$WEZ^W7_e=PQd>urD)+FW6ldZf$A@5<||zX;+nS zl7C)%fvLvrd^#63C_gPMU@!2?NGoVBu+eDlXD{$lMflsxe4|czdx5pa#|riW%_>qS zEi5xmSF#uIuS^}P=={_jV`w#dfs;n1bbEo7#@p)l0*z|WfV%bqmkiJP_5vden@08m zwT-!rbstr>CbXudy?{k4D&1PwRc$r8b+H%NZ`gLT7wB&E?rtwos|Pvuv=_*2WN6`B zFDla8ULf7*poLAtsK#)60s9f;p@rebnGD@ul{}KFYN4HBImKR}k}-Lzy+GzPN}6sj zFlYw7)k3LRv`7ojXH)Gtx^^mZ9{sI_!}G~?p}jy8W7#6zYxQL@wOC>=uxcsgUZ!iK z!i;IF?FCA1qU~B}yP5iG;e`>t)m~tpu~`cf_E4___5x>&T!-uh1{=PI?FBN7b4PSv z)TmQ5?y|kWDcSss^{{fEMiTP!BE4dPKdS>iJL^#$_!Oct+Q?;Qudm z)56Z@6!5}cAl6v>QXgw7&ui+Th23u`<*mJd=R0cjULPmwtno+-zl|&(>;?Qj(Go4> z`9e#zFz_2){cbN1@q;%1)b&><|092K5a?h*eYJ4Yh_iGM=x;?MwUBAFwRRBLU_&kK z9RwETAcvd|0+pR;uNE#DZ?y2kxbEyA5Sxqoxi|=97?-p#$d!({IS5qopl5j<1fud$ z@B9t|{~Ff{I0zK-qBaE`1g;wcy&VK@8eTpQ0^^L?TDWJ_@pTaB;O8J7g=viTlD~tb z29RaAgTO*#ScHSX=}1b7auBFugd{o$tf)Yt6&(b+RiZ~)Xi|lCYr(P_?X9J2tdi=` zc`dlrqgPEF1jhYEx3o~O9gWw*-u4vG!9hB9bdbA-Z)XRA4&CUd7OHfosXZL@_cRXr zdm7rWh3HG%aj2rVMfr_-+*Y$3fud z2x>RVL14dOJH|nvyHRGWgTN}|-8ct<#^b5x1P6gl#ZOIm+GJnHQ6Sw&sOu;YP>;H4A#$

@m)Gm0u{UDB(U@{z0*R#6*_XyNg(HavVY_x zkZwdhaT4hLoYuZ@68L7EcceJqFkp^dR7C2*+&+05NKO4Q&!kz5op3_bwP3T0?rNdhF`A==wdZN@Egio)W32zzSs?ut&DFx-w{-A> zUQcEFNN;~R3rx+H>yHOo$XA#uY2ijH`K09%DAS(W_sJ!&-PkcWmq4Cr)KUwPD`?L8 zTmt_ZKF9U`)ZbU=gcj~Tqpi<#30SwrsvCV=T?86?&?+qi5;?kMAx5lYY}(EmRiQKTc}F)q)mTxeBzlp-ozdwWD74t^$XQPzP6mPuZzh4p)Kk zIVq=;t3W-&%h^@Gf9k5=H>K`cNOYlLuC4+XjB;+S0@n<0cUOUp#%eEDfk1zH6XYt8 z5KKuSt^&EkC`+WPz~ERqqlIB{v?kG2;H$AG$yK0A3N=b~6y^Qv*bQN$|MNL<`3fOI>YFg;JjhgS&xv6!A{ccx*se9>x z7Ao$eZTnpXEDw<5L7ks!Xspn}1LN^wSAno2bl{k)!0%J!a9+o$svD!VQ2Gi@)WS() z!A)0zSBB3mT~BrUAr*e)Dp2Jy<$j~*R<$r@X1WTz|44;?xC->Na{J?;7QP!X+1vyM z8f&t<2`qM}Of8J|q@{V?1l}0|`P>99_)=a!H~l*cH+fu`?8Dpy(v3rrZUSSY=!O_L3u(!;zKEN^593oYH-TztG)D{BOHjcIZUXI$LzQ$qYIR!@lC zp@mwgG>p=Q>%7%ixo1*YVsCi&b2RvX*%y9+EVK(Dp% z&5IHWxeE+2run!F?DZuFKX-xR#)=SkfsaPRNOysL(KIo^U7t(iE_aNZ$?gKZQ|Yi4 zR+XU7W!wddmnEs{F7T@cm8t2j&&6|>pY^C?3wME?#(~!E0`=O{QZ3BuM7EuEeNdL0!@vXS{S^U&S+uxR;shtU0|_MaKF32&?9tS3mcD8%rTvZ z8fZiw*Yl;OouY?YXndOHpLG{_Y4kYfF0kdaO0xaKZU z#aMAm&zJgWWZrQXnEsg_Xnw8z^IU{AEyo!r>vVeqjbK?c@n*uz;WE?EjatJogls_>#(h^c0wCc>VMg819(+kBeI9?n+O6a|=ZH(XS%81@fd( zOD)`~OPAW`7RcX$ZXGHpFy}2fe=jJ|z_7~VEzsMA4r}3gAO%Et3v@HC7WWnyl1de; zc?(Q8<~8va*wu<`TYC!>>`b+^FxFVv*IVF|F>$E3K#dVJUkgLV(8&qj0Kq-9 zvYksYTCiV1=~`H^o5J^b3-mP>9P$=ea)RD!;p8Q1bKP5Dv(fmew?L(jG(!tl?F#*2 zpQVsMy5ZlSZkiadY-P}R~ zJ@(KlEgU;Q&Ibz#*k7QsHwp<%HVQv1B=GVPm3&%A;H8t#AF<9p0#lk%>R&zrV+`+} zJ_75E?^=lLMfbJPXcVo~LWf=S;*gI(%walo)kh%r51J;v0uPPooW24TU1+)%;=Sml zx355KAqw&F6`1c&FSXDom{P)g1rCJMj|g9ZQjxSs3-hAsg%-}n(E4~^fgi@AME!VG zE}7OB(c9GzBdVycK!;)!RNPmfS{j9x^ws|s_)70m^scP0z=!g*x00{G{Hk;`-B-Y? z4z<<7rh1gxz*pdMBdXohS0K1E_0&R0UuxT5KVNM%*8ij9SFcA={AgWg^?M@yGtF1v ztWj!)uA54oMPszkc{cT$>nm``2%G0CkZl#!)Tt=!p~6o zYrX*Tg0uJu^fYSb^b=_BMBBA+z?o*a_z65Vnz{N3M0ij?E%@Z7p;|bchjQfg z6KI`}UikS5#1y9XfqGr_!6*{sC-BUu5auT^&2WqM6L_3JVTpbMsYU2$DL(^y7npgIZr$}4@ViH| zpZE(@cuEtW`3uZ5p8o4E5d4B>X<_0^y8g;vUlYe)O24LuT4?`#1<21gK%l)J-O++i0G-i-OArmwLemIxjSLX*HKu59M+HcQ zXsT5tK%lkZT{J)-(pap0Su8;66{q`U0|ed~tI7ok>@q^i2S~RH0rJ>*m>wYT!B|s0 zKwys%RwF=q)C`cP#=FLP-^#KH?bgC+qe#;L8QLsBJ{gDG1PEL)#{Ctb&(#T#d4^Nl z0IA(BK!0|ca`p}osMUv#Y2o7Eft0nK`;&DrGKxofjZbbOD`Q7$8u3IgMQrAn@B5zac=N+D0nB zDL`Q2X0qI(>!zx2r&&7!1hVX;>U;F&Gddv()xn zfWR$d+l2su78hytr2v7vmnlLEy^W$*b)IV2HTtZDEZ3>T-2j0OZ)i(qfPn8?O4P!& zPxS43fPmuK>eAAKz;otx}t@1`N_>IP+*ub(K}G!Mjf8(Yf;3j8WZ?aK!WY^g+zD+dZJt3vKo_5RhIYV)YF95%;7NTN*C0^fYQsQj(wJ(u4HTHyj&igQ6u8itJh}!7 zj4;;r3KZC9^zI!fkYV`u)xA*92GUn8Y#c-fwGcfxQ2PE8C@+n#T4+9$3XTXAIB8th zLd^`yIWkZnpRq#=e~qSGWAtn&ALFhT-WZL?>RPL19tsq=dx9$83>0W=dUL(LINZ^(Sz0$%`Pui-5 zo&~6YPmn;k@j?sVjds340-OA(P~jkfcw{_59F>Cv3K$c#aJ>qZsTw5Ez&KtrNZ@h<%F`%FV3aYqS&+aaqhj+QfdqMK=*77iO>JA(x3@25ov^!%t?2gzRxlaA4Xvq1tIjdths zJgR=i8!g0Kpe0%;dyU3l4-)8glcv2761e+;Dt!#n?*|4+-p|zROOU`NBj@)Zfm%Q4 zm=-qtq`JR?1Qz@zr~iTk8cFaUOD%#0+$^bqb+Eu<8*;G?7Rc#LwQ>auxOq~1o?wBp zhE?8Rfn3H=Eu79r$@zl?nt9R6g24j0z3EAzV1Zy?nym%T!qnJ5Sm3;|KQLIpE|?~U z1Pl1bP{-I{fq*#b6dx>b-*}rCED)DW%e0WMC^at@EYR6_t%c}R`cOJpAbUBgQ9fAU zh;dU3pN%fnf(3S@Q$TecmnvcutQRcc)=u}KeXyJ{9%`X%N4oG&uz<%<^3{URFlswI zSm2fslMyV?ZzN@C;e#=Hbg;l2qt+PRXVuEMp#`sTv}$~?K$*$3U}~_yMx))dV1a(d z8!g1lpmMW=1*R^cJ4=HFDlVf7t95?rp)q@no&&Yo$iFsNpv5}6q6N#1luHX|j5}JW zyosi6*6S+UEtGwm?w_i$osMW><4*dvD_CI29y)g*SitQN<+&Ct(DXXJzM<*gx6&8CRku_CI!6>7DzTeYr*y%_0qz=_Z0RaSfJ)7n)6xrP7VD^9c@Acw%U@P zU5LPGd&=b)BJhvVCQFFG`mE%YEkxj{3x&9a2+T1G<_-~Poriws4G}1rpUxKu5g6w~ zSA9bSO8Jqme~3W40J^P(Q-S0h93n8-$P5b+h>f77TG(a0j|>qwkP;&HMMI>Q@vBUT zK=!h9TnpEYa^*qXPu&oK zQN}AROs_}x>W2t?Z$!nLgb18&N_|^}2pnon0i8kwI(4RLT|xxzb~UN{pN^A@f7`2IhXrbd4+PYQG zz3RT3Qci{lR5I*O={Zpz#z-xspP}Yj$bXhXwQ%Mfb-$$dtA-iHE{6zIF*2{{c~x>> z*XKcq)PGDLeufAn{-%{$*z_NLmrwya3mUG4vzAoEDpX*Z4ZX1q6=-Nj$qu0c6%9K_ zy&vUnWN6`h7AlrCR3K|MO3xlDaLB0WtoNlF8Xmbq1^kVfT6o|>Rb4{`CcDus_fUcI z9u$@*RG>#*da8x?1!%KZs6bV3YF9W^V3R);3J4YO3ZhoQq5Ar-ElPiCR<+6&P1FRIXMFl~U=nsD7xxiw0!XC{&uKS@JGpLUiCXS*T zqeBJCj-lz}LIv)Pr^*v_ebl(g^kRz6LwzykObr!yJdNII;lJsWb%ve|b`;N(#+W&w0+;7fiFtavYBZnPX<^JlYPu*?RxAz`&n47X3nPr7D?F1qyAYBHQ#arDhq+wNPq1{n!&K@NF*@+pmuq zwcgmHg~A7@_#r)KYQ$lhqJ=C+sM^s`frEzoaeaKMh9~H(78abLf6s;r)ILY$F6g;a z6E2d)rBH!fSE%mQP=S+1@#{Js_1cKO87i>Y7Us@>kkxpr$+b7!fIaJ`d(dUbve|6w1 zRrnq%@XRjkk5Gp&{W*m&nQN?f3={a0g<53|6R^lhWt_qU?A+;dzAyp1{B%GI7mTz5 zVFDw)=(`p=dehcIVFD+7D5qbTz_}pG8K!TmTH$m|3(q3M#5s!UM287@BvPFeeOt{h zLOF}-eW?G6QK{50feUH$t6Z3VUo=cgRG@Pe_1bEBO}bYrOrUaYDpOC_K#i+Um70bL zENVe7T80VKZAAs!gbB3%i>_;7NLxD9E=(Y)J>}>aCQ!2z9o51u!@F~sKw!Tx>D)g| z9vEGQgbCysN==7_30yQbWP}N{97$_Ng$cYEOA+J41Qr-gCWi?upF$o}b$!*H>Etsr zOklF{-z;5URca1x)xz|7x_Rc*ZAb)8(r3L4* zG*}DED^X_UaDlZos6Zp#57n|UUDd)%V{l9Te3h*ORqq%saM-xjIb6WID>-)8^;Lm? zQ|AFXKJ{}TjT;g!aCIm(86K{G4$!%dB*)SE`Kpica%{Lnjt`fGhRwuqfy$HV+SG7? zJJZN#M!3La}?cZ3Us?4)kH^f90w8&me`xYg}_)armfE>!3V z>V7g@Ao@HNzoh41jkru-wNUK_&A1sZ@c9;{+zA(0W9-zzKlkY5{cwTA2UJ-L&z{n( z_u&E$KTx%gdL1?33myF$E->^r9e0ipC{vKec}EERXB_g45O6F^eYD{1PwN6B1U?7R zppXaw|A+{E{q+dBXM9bJ(4V`DkfO=7P7AeDXkL*BfgDB2Dm6l2i}5opLST4F@+lu7 z(6$2I(!#0AQD?MaojaKNzd9U;)m*w{BhzV(ZcHvQ@A09{Yj zaS-*>!r&ovVrYaw_2KmIq6mSoB{WY9QOl^$a@|*DvyvKZj1XA5iQG0v2z1^`+qXps zr0t+;dm;p8>?MbN5dzl^Q2s*^0%MJ7ry~UJo}o%-BLu!&pdyzd1lAhYFGmQByh0bQ z>VB$>8}#2JJ+rFR6WXeU@=o**72#LUuf9Z z2!YSW!tZ)s)bk%y=Vye#u>a_cL<*!>P_k8|Kt;pOI#R&h$k3j*iIift)FFGMzyKp5 zN2EYmW0%&_DN?!^xjiBUf{Z6x_++&5jFh#xBPD+xD(V#}P{nX87%7n37_GhJ9Vuyr zsB=)Hz+fXeSm&cE7<;ugp^?(vm=_f(@HCnR$LQy(HwhGz6e+O8Xi_v%V0kf$N{tlQ zRhBHv>wMLi3iP9Dq(EvqZPbEGO{!NbQs9))v~Hxpih2~?AW~psQ~K5{Qea36TG=^L z;9VDL(pAT&s`aHA{UQZ?{wDX)k3W+g zIFnY-iWJDRikhz0@hhKol(1XRgBrMpvh0i0=f&vU4%6Eskpg{>(TEd~0_RRr(Nntr z>VuJZCQ@Lfu}=%1&r-*8kpjPO>6+dq=ev;tgN;)U^!=*OLpty%QXt|n-F%{RR0W^W z1T8H2mtH-O6sZ4#YQKyW==6rRWkw1VeoNQiMG6%7Kr27$_|?3x^z@saJyr8NmH!bb zF!3i@{?aq0rv9co|3wN^l&C-USw{)j+R_BOD1q!*s7BT(f&1CW!zoIjku#msLMay- z;~FLK%gAt#5;*Tc#XO?~=H#R9`J)6{6`-|VQ3Cl3(hn`979xv)C;{tWDjyQ1|BgYF zI7ZRRm?(jFv9vxpN}y3uT3RehAR?8#%SQ>csX+eKq6DVYpxZU01S-^`agCw`t~RDp zO?2LBXEU;Bq2p7dTarurD1mw%=xN6&0oPtszju_tX`@kJ9j98_kKFo42~-|LQwK*0 z)EGfSMn?&p8be8AqXZ6(BgYB4E~<~QVS1Fn*BR7$W|Y93+4Oi$ltA^lG-kf;r@Fj= zN-T^L$i0}FEQu1hU_8}=i9BBpwJs?ml-8c^exqW7bW2Ig=&9|5;$(`_#P!t*&_OnV^+}u z*=^`=Ele_QYvGeE+1f=5>^IJ9A=RET9HIrf=cG0HqXj+|pypoD0_(l0W}#?-IX;xl zH(J2AFtziK7PxKf3XB%845ltxI2umbBK7lCe`9ZKw17=Kb=N}9WU7@CEwHo*y)GIp zu(~8wst_$xD(dG}qEa=Z1;*5(Us@PmhtAfG7N}F7ZZ(P)@NPmAwNRoNjcOh(;MS6s z_ly?E>_tDdFse7r)4 znteJ~b$mbdI;!ic_8p_JP0D zj1f3piIOYF2!vIOksj$W(xx``(0VnbV$EU%UNxtvmbw<|ulCea3w9mIMGJF{Ra)5I zi9)*S+NvW)%kD7(vArm~^1uZ-_>{jSJm5VV$3pH2K^3{5#ROT9Lv{uiQ z>a&i9Yhn3D%C<@8p{%!2`Ry?RyNu&nc(j88cf|+|#5x8sw?THbv*+)aQaC$!_ zAJ9EleT-{bXm*gsXd(3w)zCs~W7N?Yf$2u#i5UI&uIcS5-OID|LVNifwY#L}T5Y;a zg|5U1gd0V##Rv>F=3kEycy@zo-HZ_^b(d@&=-kvz+t@z}+Q$m4b|8z~u>xiC(51Yw z0u5qmaa^o`OFUgqh!uEZTuqD>_+B|yhNjc$>ahaJHK?i<))^N&#R_EDM&YT$VKX)Oe8q~%)ZzA0AXHq(eLu>u*}Xv>aRX|jvX?T!^F zznAO}#Ogn!P7RLhnyVTosrRW^ftxpD<=gF8>2pWNa*wLs*ELl+pHj-RSb=iJp4YJg z@tHK@t&U0M{YXC?;{={%q39fO0`^X1ohwct-G$s;;{-0}p_v8Z1Ri)%)q-&X4UOZ4 z;-siAMHh~fJH_JUMjCmQj1$OOfr?Cs6Bs&?p3jUE=(LNr?T!;j-AhkS#|Z?VrP*4@ zew%9Ci4!? z;sxSUXt@?Tm!Rz>;|2UnQR(vW0%I#sk4o_Z>)O)icJTs(I#5Rcc!BeOQ?UW@0u_x9 z1LFk}2h&O|>@yaQj2Cz_onmIj3oJ2qYQc3D+0Ka{;J4~XrdC+hcT5@k_fqT~vqB~gh2OB3jIVxqvv zWE$HvQQ%55+T1Hq;74z2+b2=rz*w>$pD6HbE``od6qswYU9TUnHg2HK+Y$xR_tMOL zi2{!M$?IaGK&wl1O$$qI(yLpE0;?WS&nJljd!JJ1Grhh#{Fbu3PZa2DOtVN5xNAvs z?2`nV<)W1?NdmcD=~CV#{XK#HIzNrnLP0NTT`)-?)t`pcOcFR%i;`+5>FdlSNfqO0 zog{%*O)08*lEC{mbY*OkK;H2*S_^{~((y$}0`ZF}X{p}78oZ3&Yr%FsRosvykaZi) zxux?}n;#{~xyMOz@dD#v?fnqK0$DxjYk_2ekzRDdCt06AldR91p@CXh;ZGF; z^g3!%AXx<^3k(gV(_zU1$>CHuI$5AY4E5DQ?pSIPmn?9>Xq1#Jur!(6Qj!H;rBYOh zWPwFSiBib|qe{~cEo3Q6)ygFc95jYj&~d8M6)Cxrj#JgHO!KNF3*@Lu$Ezg^!>2s50ftF3_M@t>AN^MOWwb14-THiKVz^fe< z?VKzytP6eCLe5@PtGDjGF?5K|Rh=G6$-{K6YV%0?F-otk+K#3v8onE8zyzb6aqlaxPfEmH&@+EIRw6oD3=bVUpK^HGcZ`hIoA$n;7Pi1ns2g;E5r z`cOW<6oKW1sYi5*z@8WiiA@nG6-Q&@Qv@m$p)+Mu1YF9~5G@R^KxZqa2o$MAR#j32 z%2lPES_r64oob{A+&6aC)!S8r`t+9;>NTK+4O0Zx8P6K02!uAJxmw6*M(3NS2o!5U zXIkp`l}l?HqJ<-EDQo)_0Z-$w7P53C4=pS-o_9(S_-yp;k|J=hE1lEA;BIuHdy2qS zqeG7rfh|3$TmKY+EraRjKPdtZLnvGeHw>>~DFPwJNG)6#PQ^#02vjnLYn?|@olz+Q zCyc9F2p+9#Hiq2Cr3m;K|EuZ#LZXPGIFA2H5t5dCsGy+Ipw>)ZEDDObHxc#0C=>r} zkpyXfDJj893kbHmJp&f#1KK73#9 zFwD$7Zv#_FWhfUrsjSrKxov^PSBMlUb5siV9Sbb1O01zWzu~%TflU}8H8c+-*eQ~0 zEwDD@9hDW;i8n5K?j*KeXevv+FPv@*EbEcTrLvceV(z&G*7`~;ZnnUd8Oz&f-;mOF z(dwafB&Sm}bXj00x`o|qft~IZgH$%_6Cr(cf8=_3k7vcr=iY>M6kasLvd(=<;cGazg;bge%$1IE?}g`)Ke zJ0e9?q5?aUB)(EvXtLP1TY-6u=)DRoKShjC+51$nGEIS9H7cnrJwv!M71+`&QRq-$ zp8cZukOCV%r?BaQg44KJt?;2nADoL>>4aPQaGYC z+?zEDV?{)+20L~{_^52~l*WcUjVdGYibh$9#=P;dT4R+{gJ~U6L_=FQ%)u P`|{}9h4X?IPB8rs6`utK literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/0b329f0690cc9919_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/0b329f0690cc9919_0 new file mode 100644 index 0000000000000000000000000000000000000000..7d715077f4946258b25963822889bc17929b3ced GIT binary patch literal 19480 zcmY-1cXU+M8}9LMGBu$lWKuv{AR#lEnM_NcN$9=zBGME=iXzgnAw_!cRY0T(2#V4{ zs`Oq&K)NEmSG~{gu66&oto7l{oU`}4-~H}GW^(2Xp0_{#u0)SluT4Njxm^3zC2h#| zRjux;?oH3g&h(~NuIve9SFcTvu-=FWA?EJsmIQ{JlgR9an9QMjABb<{6C2?1#S>Q|| zC|nrs$e%^wXmQvYfM2t~nxnpQCa65CLh)+Qr6H_p1SK0o8~H`5G=UzH*c8&GrhL#s zedRz)_~u=W*#q9|3HPK(Z?N@Ktp18M05S)`51+!b&!F??(EUqTI|M3y1+l~7?Geyb zGQNgoa&IKOGYYy%ozc)zvd2Jm={yd4%b@Y_wY-|3c$4ABwGh1yoIk?4pJ2NzTn|e& zE4Qt%Sq@6>HmD_*Um;$O%N6-wS$FM%Q!;)x%$K5jp!Po1L2SQ4l1!8R2jIL+JqX`Q z>><_u7_5-@jzb^0A)Hk0Wu631K{feLikyZoWSq=BquQPa(;u+yB1Gz}DIurix-|b2 z8eE3ZUnbvxMG|up%Kfde<*xiIAKrpD|0u89YABUma4kD-D*d;*52utg3@-ZQ8x52eF%STB3!%NH$+-jlxKF@#Z3 zevoaFX$)hajFxJqFq+988D$A$wluSG~Ag4~gI3F==mj4JX*3Y7}ubID8$qo#zHQy&>BlcYxZ zFwV=qq%daK!?@%Kqd{sIZ_9e=;S8g^Cye8nVZ>#HQA@_ic`22x=Q35M=Y?^oav0;Q zgweig81dD@c&EDNA-}(oFMDsBE z%P=X@B8*ewY8A$&)@s{E^?WCc%k4C;4q<%SQ8kvUVt+S`net=jFkZbMMz=0uT8z? zFQ=X1RCb5cKoULSEb)eu?h9w4yjL}xKdOcEO1`Qd&I`$}8O|!%B+sQt?QlMoopr+T z)eYx$qi}jP38!pR#gg02!fDeyoGx-(CbbBsf6H*pt&~ISa1z>wv#(<~59Q-d;S7B* zoRM9^DbO{XMjwPz=%a9o%V!^lQ-5$ce~%3(ZG1REd3QoMaTCL7J1Lxl5;-}X_vN9y zH6@&5a!sB|!i;eIGsCGU4d#S%QA&OjPSZu<{3-pu4QJL8#r!Uu@0NyhXIVI%eh6o& zSl4Q7xg_uY9L~wD;arw=JHmOoE1X)p!&xX9d%_tc-^=HE5!$^koWO57E+ZxLsA_dA zoa{5n2;N@^C-3jOBUDfoSYJOjNJyVX)mG=vcFW*baH_Gqd za7r5uG%sjiP9XyY3L7|I#K5?s2IfhjC<9HR4eXRr#SF}rW-$idlQU8(R&C{eoPn@- z1DoW4gc1x4EpFhkq?a~OT_|Iqs0@+c${NT{G_bdvfwMBHyn%%hlVqSxvSLW0*MMK{ z$Q$|4XJEbGK(b!N-_0=4N76D45+t8HLG9RpRG8fYqon`zE6LC!Qcu&t$mh;{~w z%SpK=&D$H8+d;MKs6Jg)vkw$s?shY<<(RJ)@cULO*in(4Aodx&o=1%Q{CjOG+Sn1ncQ1$ z;GGo)y2-AU241f+P;<4`Y>jFvkv|xi`IBla{-3o5a{Ctp4L2B=w$XrTlYwYyBEM`l z@X;3KB(7~bUxZ(EUdYj%T8CXacXn%i_h?>w4P@>!Q0JKDC0Qp7d?(R=XdT3GQS*`O zcMbHsXW+;C2Fg7!;E_j?{YW*F^d|-eJvH#P*q#~qR{nXe^XsM7sGyOBg^aA0q{2ov z%bg-dK8rHqjW$wA*2vRhMxC!lO2--*nqcHiqLC{pM$%G^)NvU}b{i?+HPYB;WNpAm z(@Z08D8%bzuWS2y?GcrIv zX>a7$jz%86r+nU5u3fa1?jIOACeCg~KJIR$!AC~6$Va`5d?EKFy|WX3!r z7v~$Px4=k8DX>KK`QFG#IkL(~-fAPu));B@gOT6X8nLZ2(&k6y{F9O9>vc@-{cL38 zCL_f*8`&eLrP>xFqqiD)Db{VuU3SS^JG6FtG++5;uaOG-j07a(H|4!wdCPP8`+$+* z2aWu9*hsIVM*fh*<63{|c-Bb7RU>Dm=5-_EZWyV3TkHME$W^gFG4hjyJvCC}nd&W7 zUl`dZg5vHO%#kWalL|xktrsQ*iE!d zHBrxF;%E85Yhs}MEopue^JJw=$~I9qN84NzVL=nIGNZDIvW+y3Y;0`8-o%8prHOvx zXk{WtmdU-=CQiI<;<7w_$HegtCZ=^V@kZ9XYht^ky=S6NXA{@tpEPRq#d zCT5DYhl%<B_^@=-4n(|emJ@rj8JeM}scf&G+Qe-jg=$^a8h9)7ZY=&!v+&wH=0L-i0D9#QO%YQZTT$=APu~7cnt>=48ytCKDI(f0rM3>)Gn?uU;u;zF~$HjEq zL`PYA!bIFj6XtU!TFZjpO%yqA;w_mf*QDAXs+pXUHy0J>PZJGgt(3WJqVp9K)vubk zd&k7*cTM>2nW!v3$g}$bPiOw@KOb+Cm$*E|@TiJ}cikZ4q&9suj)y#~Q6V=UBu3;vuzG6#G z12bnDnd#Qp%nwb>lxeDc&CE=dg;KAj`nNLkVQVwX+L)>OwwaeQ?;SH6+L>wH-i*J4 znUiu^26r^`m$=_GbLl-ZN$;D9=xXNmK#exmdgc-+3Gc%>x95b`$ znu(lernJ;sU}oJ0jknQ^Ws{lZ(qpq~v|aW3)yz;?zQ@e{y=L0&Gt*rP95B=9pz0*2 z3vbFunuy9Qt%8pbE*-o{W zCN2w|%YFU^e7i(LnS4Z=ZtM!#*0}B-!TG%ZG8e7=g z!oo=z+R8%tHWs|HM55oe(6X(L%bpGv%67EyekTiGcD8U`QoAU3iR@`1{X+|bKC-ay z6AKOds7`$?nEF{LF3bB{aE`X{@fZu2<*7uCwQy&Wg>6$T9Q;mWEmK^XCI^;V_++!@ zDEV70RM>6dpQ{#nU$d~`x`mV*nwxwjb8lH_`j7Istu?-5p_H_h?;cwy`9$@9s`|@K z@jcU+FD!I_X<_Xv&F8g+44L@G!n`mme@N|cD-#S>Tt+MTW-FuRn8nKVNGsj~R{9mR z5?k0xM_F3LN?cK^e*d=E4edNznRKa zs?WBvNdBIq{N`Hm&A0NI>{?*Ow$Mrk`EHSwXN#@8_pOx`OO(rZR?=kpN-NdYS@}h} z{b*&7+!D`vEA!i-1kq9D+M$jNCf~|5w?#e4U8y!JLu?PmoL@-iL$d|SV z_QpogFg}8tZ$;oQ8Nq;35&R`*N=HzxOaxuas;_*JsPUyt`3T0#9JwT|l9XR^1o0Ij z7%L}IBB*SSAlwtdLK*Ij;Gi#pT))NPFzM7r`g>BlPnvf({KM*ev0Vm3IrZ zZ56>$iER_X?G766g9y$`+3pcckgYu;u=kAM!w)04C`rAP!zU5EmWF*I^s_8NKg%N6 zE`k0L3>*-_-%?><1Vg3Bpa`<%u7nMaAVxAikD!XIm8oAw@KP#%rI=qw(0#OGiFs@U zeWd2N2v*30@e#D25JB^a5v-FJlQid<5xkKqvlUCi=10&&)-8x&`oai$EsCJDAnG=aGH7TSsDV6UisyTO7rwa_g5U(lQ)pl4XH+!(Vxsv~tRtv ze+&<@V+iKNa6LDMQ+Y9b-YkawQu3V`Hg$}_+$n~0vbakO_oQu~7%KFQp-{gVJOg4F zB!9}{fr|B+VtpRN=r3XjAELJM{Z}#c8XCi9nKmqjl&@pxEqRk;Xgw{4Z>93|7;isA9x81m=EFm8Sfrf*_sC|wt74l80vT&a2g9K)n7Fm zIJ7s0KEK7#{7?+v$jQSo{QfwGq$e@Nzl>q>zcE~t2H4mywlEuu3^ux$Y^;+Ei;ezP z8#~1vVdF_*8x@P#m{8P4(I^{jq)fC;?~iTtk(?MC!)-Q>N$pr0XCyJs##&ifM(t8; z+)cIVy|9g3myP0SHVXJ`49T!@NQP(H_&&$RbJ>z>qhZKKyUI3}%l0bjTieFLIyU0! z+W1)7)VJyPBO4nV=y@acku{BNTyAc|*}_JhmdfuP8{K4fPaD-gv@ubdeqqWuyIt-9%wknR)+h*hE?KZ-9XuMx-yd%rx zvRvC`BW<^h9eZv3dq6RdDsLGhHBQ->B>Ux?-)-EM^5<>*am7Z3tE$^I)%LE9_hi;R z8xJ4bDEG=nKSQi8DaP_r(hJ4%g?wK)mc?Kb9G-W4S6B?PF=yF_tTm^j<6<$;{5N4E`XNy^_`=mT7WX5_-n6QbGe``C5*B z8B2?yu`HDO!!`B@fVYa@qR2lWaYD1HouC+@;X-UqvGgf zh+~z+nBu4s8OJ#B6^LU~u{g{zaZG(Hjt(W`SSi1hiqrf4IPS=cGI3;=i_>RqaZE2C z$JV4cB9h~%B+FcJJeGHSaSRT`>DpBs7v%R~90MxHu}fA|jpJ!ewXYQijpBIIEKb)z z<9OXBjt}39W25Zo5=WaJaV(MfA1R++aWs;V(xR_&k#`5gac)o?!8F2m=?aZI)@jpN%Daom?n-^UU6LmVAtmJInZjzh9}eH^W} z#<5t+ZjWQw?l_Lh+C3U$ZyaBUZ=Y&#AdV~2{$Lyn4#)A2^gW_>$22$j`gk0RPR4Op zemSMsr{jn}6GuZ?c3$<8dl%xE@idOBvW|GZiHYa7^zp>AT@t+Uv`>#`uS93WGfV1b z#&bn_WXIDtH=Z3*H>ho;cnVgIC$dUBW$P$T!+0_q#p@bjJa1aWQ?q3}!&}F5>iu}i zbcx5~Y{S)IkI4z#I>FPU6+j;SHl-Kj)*}Wj1qTj^x)S65@%Mpzw zaYqyAD6?eDnFP+rTUXTgn%c?gn+a_HD}e%kCot)s1nN9aV49S9oxq65;vAPgw&L7K zDvmd~IB)WbQ=&?7I?ILD#W~TVIHh_P=lssH%)MWh=$B<_D~1Az42Vf&m;CKW#O_Vx z6FFTek)f3nsn88W{^BAeb%#M~v3vb_>%A>(BEphTX?q+y9P`#O;YGIVSr`zI!1 zo1{2%)n{HJ>0(`$NE2DMIT6pcLI}`c#w?yvC{u7CGJ)6jn(*8yw^&clPQ%+mT zVJ%ROCK8!Yj@Kp2QKM8j9KLeIb}2^(Sv;^Dbw4Y|bSXW$91|v%SY-^sJafYNaH- zJ|*ejKoSG0C-Ide?FoYuQ^HdpO?f=Nt>TUp%scJJ$^`H z;a2sR_je~z>R=LG#d9c$I%krYCVl=$BI!~RAIX_(N&I?K{r^hh$(;9WQx3%OqY_$+)7R+y@L8Wl6fR~sma`wx@pNwm)L;fWG9oBlT78jWcE}~CaOj< z7n>y0r)4tRWp&$R3U*DVg)Hl>wx1<4P?AR{Ghl+olhkR+EcrH>2U2K#G9z~;b5e%< zro8qiv*AcG#-qvfKAB97)5%PdXXlb>@@F#hWaUk@zne_yd&%s6k<8||DqtyDflHYc zD3VoydNMu^ehPNwVY+Hd6eJjx5e->6?mh|3Tfhwmf=pLvFyuMz6$2TjG z|5pV@-L0U{9kfr@Jg$HtB8B?$cT@_w2`LPhCFN4E_)_%wX9{07PT|&jDWrE!p}_|! zEd4BnN8Pb!5PcT%__J?^UQy%gHX$1>$%imscdu;Nh)4`tTN6t@1C zf-%faZ}~#@NMVDWrbatE_{oi>&1{8`Jc ze~)%n)V8xpTy^YxQrFHkxzfbWBl*6moh_2q%ue6tc5cXn_IAQM*x4)xC9k8MVV&$e zkzHNwoRaY$*qJX;-R!jNZr8m7c8U&AJ_9vRIsTcQgfHxjlwL#Z{PLBZl%aN(er?x1 ze|Fl9vh(vKJO56$({qZQ=-GCL&(WOc+6m3G^L)OY{BP{+UudVsQaj_8sjU=PZl|_P zk_kW9nJX8h@mj@{`BG<{j{m4R{A8zy9F^|t)#hid$uD+hZ%~|#db~xCx9agWjj_{? zb(ft6yX|a~0tdAQhwXGbV&}a4e9W%<{p_qfVdt%rcDyn`@=q)8Gj^UzfwOk1UetW< z+WG08*6O~U969sE&Wo3JB44R~a#E_lwlnsP&I4%@=3rL1gGhseF_8{V6mU?bpo5h~ z9K2oB!J;UKK1*@vel!QC7Y?A>4 z9E_BdK@M(y;o!Nf{nEj&5*XrO&{q!rk>~R6Fb8G7cCcU0O7oEpijGqLvOzu=qneD> zJmjL>mG{OJzr%ye*Ljsw>`#hkC0OB|G5s{G}H<;r!1gLW%b zTUof;!QX2fEM4zl>_!JCH#w-fS@qhgecK#t-tJ)24hP{oHTG`~8vL%YrTBRV4*BO# z2M4dJ&NBU)a*~AWYIDQEQMoP+Z#!u7Ky{SlhYm7isoZ;{JRUpvL@vG1I{xcmgjD*^ zK_l5IkzuI}l=1S?oXWQaQdut_6-?y|c_`V1Q&}ck#U7K&`S?_B%aR1Om42mDDP2Al zkKB@%(mg4ab;+retB^{TEOMsuTUIK+%arU?7E5eSDs6L9IV4wPSfx~|)=#CG6ltKC zGEvSpOr>TcwUvF%Q#si-l@jez87)IPr7~ISy{qGLL}ELqGF)bhxqB)ff0D{q66&LN zvQ5nWQt2zB<>}y5?u<+&FgleJV^X;$^TwvKN;4hVrXK z%ui*2jFT6ORi_oHn7&VC;i^AP0_9^4yUqKx*thpu-ujOV_F}nbtaVwXH)6_dn(f(rgHI7s@`9w^48N-Iz7`Ir0C03 zTD(eSul(>jmDX<*^WRjW{!67DPL_l@i4Aws*63uh$w`daNzrI0EsAM>f|INgPHKta zEhoifm>ewWBv{Hxr!r2KmvvG+(aH64PMk?j=14*XC+$<59F^@3Cl;rZNiHWT=}tb( za57lznNB{+a_X~ECwJt2j+4xwlkcQtzLR$=I_V{MBv9GOqZ&>M*LKpZj+5Q;yF8VT z8#~$1MDdzB$&<2ely`T{r-ze6az$!==;YW}PU43-Ns{uzopc-F*ReoCuPPvSuw#$%_&a4ndW4zbf2z%a#zx4I;lO!$+T~sTv+0y-gg>v zrN);z-#b|;rB*q4Z?%(C624aTltXes8mv>_ADx(g(ma3GJb%$VW$i{MFE%+Dy2Z(n z9h%!tCne4}bsvvvbIwV-Kb;)E;^dOFxbEcTU#j;l<#OA}#5+#H?m8KA&q?Zit(iO( z^8+XSW!pn1X^)&Vf1>$5)!IJS`j}j-H@ir-xHxEaQ7qEMSJJhBi!}vZlquxmMvMzr ztc$r)wz!KfC0zXbmWyhoTpTU!(&t1jPA9pjp6nti#YK0!i$COm!$q{y#Spod<|4!E z(!H}THpxSuiya{s)_fQJkxCpE3qECGn5e-~4Z0KUUENbdv zL<<))q;X3Z9p$8yXzgOO+?E+_TwHqF#mjasDs|A@I=UG2zKfk*T-ZNy=^h^!(?51` zvA6V5-u+xmmF1E*z(tdxE@lmL5josNhY>El=Wy|pB#u;VM!9tT(M633iZ?}Vrnwj> z=Vq#2vt3LO*L)YBEO2p6E`6u^E_3NKbk%N^i`A=LlwRYa>RRQy&c!SF@F%Uqdd+pS zi_m@-^~HL?MZAoXCWl#~ctueo^i+C|R4 znv<;iPqn~}CCtqTIUMdL&*0`elbgF{H}6>71S8zk6HBCbZGR-_3gs+>CGJ=5%8>)tk6k z^tPK@ZQU5!xvAaWO$+(5gIo7XyUFULJmo}JjXh9f4|3~Tnp^J++~f~)vs!kJa1%Mw z%|Mwn+ReE!ZfcEnGh@7)OB0mSM2$B^V@!4POy*8=b8Wht2lC$x)numHN&8uDE=a@K zZVpJ*Id102*tu>_&eQYxZrUx-yk+b{HyszbS+>|s!nbY)$=5P$xtoJ4v<54cgH-$8 z&6rhgW=hG`Zr)v^dac)*{p@D8ES2iNxOuh3&5NyCqwQ|i$QG%vL$%wfxVzj;l>)on zG~VOpS2-d>_iBCjX$^nVc_8QIn?r8?I_#$95!LdTn~BHWgq?6x?3A0}tHe%;M+xqH)1%-?P{%dOjP zymvLWWIuHC#UnTO<&9K)tXj$^Puy&Jsx_5?&)n>I?xyZbH#aS5`aC3!d9o%ljb{bY zc)ws8VMWuZ8I^`5E{&%pwJnv#4ml=ON~bZZOd2oc!^AY!mrLWf@@W)JPUA?bwrOd! z@T9R`V0hx{W$I(sP8(?in_ z)nCr{@{rhD`S$VP_)PIW_wf1)595cb&oGZ(M>Osz9Ur6l$Uoye_$GK*D5gms8cgwU zW}1f!(>;`*>0ydooaG^Dj)$qzYo3Q+=6gt4pf*x|q1wpf#U65(cyu3)hbrG`OsTTW z!#XLr#zT`IG_L%;&V%PC4+~`21`n={T8B*@uF2G`9{$*-HQC|8{hNnA`#l7XY8_5^ z`1+)W=hFC`hnc^7czWJL=z@pu<*Q2`_W$W2=d$vbn>Rene(2%KBej3*;qzx6_B_{k z|9aRL?WJZ}FXI!v{3iv=dD)rdC9;B-figl8Q@o@}H@lbB4lhqry?p8NlH&F1`w?C) z$@3g9`9U3*mLV_m^Sl(v_hP8*1YR87^f8dRaTj%ZtHYx_+wp zey;vsdKoN3hI;vJnDQF#rRfOeB7H`B$r$D3o-7&dewQ!!MCcbtQ6xC)$u#6(NZs_Qt6DBk>|WjlSUVGj$HLp{krNX`)+ED|Mv2^)c?oJ)Z1DsG2Hc1 z`<|DLGX1G)`b;%^uJc9~zV!0@jg=Jx;&Bh6MU>H?xR!*ANgf`G?d7)YA0jlM52!><$Ux? z^)W<(P9Jq;tC-wA`pA60j~f9UPxo;*+edn?k8h*~hLa>O0lP?^1TUkBRd83_YIZW94igC01yRmFl}%HQMas zi!DA~`_h=ZeB9sdW6)k7U;pOg$bQx2fR9I#b4cUMHhFs3$A?FJ{Ci$`|KTJ0qUJ8+ z<-8oYthva*D?WBy_2IqdBTr_@@7I;bP30u>WpYQpo za9?pA_$d8IV?S1%pR3LF36Wer)~y zygk6rL1{NgF$epJ{nSr`Fa1m#qPczTXXqF|2gdrz9p`7~c;zzD&p`QMhM(s%{dAe7 z`ONWiZLXiD^EBTDeolVlr|LpK#TWbO@U5R?aznzGD8KLglw0O!vMiNit2KxHn!^D< z=cLvlKNAl7;fSA4kNatO!cVu8em?w1{qFkde$P+-eXYv_KT*&8w0!PopKN%kyu$+Q zH3TSZ3hjs!w zPi^W4sNOul*cJhOHXUF@s{n^v2Wa(nfb;DFBz6ceNvd`VF#6qqu3rUM+AqMp{sCUg z=m7!dNb`XKI?GupJvhMfPc`O{0R6wxoTSRofPP;Muv-ca4={a10PE-g4aNl6CQru& z2u;wuW%HzfzWW)#FeShiIVAa011yl6(-e2Qj?D-VBZuXpG@PlJvjSLV2gsQd;LEuI z9>}bD0WQy1y}nVcmjrYTL^0*Kv|JV7_pKUpTY!DrmFphmvNu55zJR{36wv2ss_$XV z^Rn{4sxjoaBwW{=%rCY^|K=`<{#&UX1%+9aiOQ=*d7*(2xV zwiI!s^Okg%TF!JPxYFtAPUokzbdo&jRLIuzoOFiOOV_>J=>!|3lh!z$zD?5U+A>}D zJ}J(-8nbgcAM{Aa(lecTvS)HSg{GzxwlJNVi?n~4a$TuhzfWi2>U4}hr&H&bbT-M= z4e2;GrL%Xl#@VKEwx=_Ck8(PZ&bpK7lslEqg0ss1Tskd&PpA6DbWE4i`Q4mBS!)I> zBQgjpoOn-7$;(?ku7_S$ruEa<97heeJYilyf8 ztv`n)**V^^Q7CF9M=Aj zL$9B6XtFhjS=(}m+@3?3<2k&4B8M~b?e96VGqbUH5Y+@Gyr# zGCeGpi{ZJlw5{3&(-^;T-`sDOGDYy zDwo?GbMe2M%fqg@oEn$QTN82_BVR7eW#6J)vKFiTl3a#-r#50mHSREtJ3Ppbqtt(NkZxmC zs|l*r#2|l5l}W0}L2B;`GI4j1usuPB9td*aV2~R}f;^KSjt1Ew?T-g(cuMt@5~qWt z%KkG!iv1p>^?5y(Nq+=6cR{td7^LIfAic$PFGxsM%hUU+$ph6;nmi9O>qU^rmqE4> z!W?Ugg7OoO6qYbJ(hcALS!U{s97$=>GB~;CWlyBAw=Imh%M-?nQE6r#WftV|{x^A?k+sY6 zc(FW>t}F6%tvZhpJMwrYH?HU5x|xUV?>vm9@~KlgpVMXX`7Sx1yA|?zCncX&j(irR z<}=WjPuchK>C!o$vvRRVK1mG>qg%x9#0za^i?Tl4v2dp;*l z=TrP_J{6?;Iko>??Zx?bKD}?{^Mz#G&gauR`P`90_w#A`AfH{5_b8uXkMo%%bD!ih z{#ibA@^P5{`zBkng^}9)-#?B=Z7;TJb#Z&e8~yr^nEK>R&VYSqUk%J& X_R;W@mHmwh_WOVR^gm4ee}DcDzb6sM literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/0d4f51af893eb12f_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/0d4f51af893eb12f_0 new file mode 100644 index 0000000000000000000000000000000000000000..fbc04a1ccb5edad618cc43f59dd61b7bb0a6f4fb GIT binary patch literal 18848 zcmY-1cX-p~7x(dZo1{s~Y-u_`R-vUyv(w$AWe?dKL1icivP5J%ks*8UJ!J_9h{#5! zvNwo;Y-R6_KA+!nUC$p6*YzUfd*A1r``n>TzxfvLyPtkvqU)>ICZM7mKH2qM-QcU7 z5%6YsD_8Y;0~vwrYMEK-RV#VZy_Ev#m8w^(UfJu1 zcBM3LR=`)?pcsc@3Qqf9tpELaWBcj<-p1)~e;8bmKH;!erW@g`SXIPbnQVr?io%iN zur&>S%>qk~#>?p-WLJga)u3YoSlJLtHiA~NL8>%{u9DaU(xs++++1_zt9M}Dhsx6x z+INF{Qlux?`Y2Xk#p(x{1K`Im;MteZ;VbC!4XhammA-}8A@J@{=p-56!BV+54Bj6O zou&2&Xd&4np}KS!4LxPR82Cdm-*{q@n+Sw6*kKO$=wF# zUm;$O$z^H06L#%_lQL#E%#osd;O%|tf!Kb7B$+I~?}u|T=>RN}*n{fzQCKeRk3lcF zE}VeEGF#G4LN)nMikyP4WwgvXt-hWE)1R>I0z_Vf5^_?mNwdG8{v~K5#V>yB!?3#+8lJ?JMl z<={iOAX6W~5=nRr51)YHDQuC0lJ^YOKiBI`zIg%TB>W|O^a}cl|20&WwbDL3jNalk zgi%p`l>WvrMo2YN7)@o53^#`{Lz-H`XfLNEH!_Sm5>X(GSouySOQC{clr0>FUvA55 z=~g6+&*eXPFG`OkB|3~OStc7KuUHuK#2OREyRufIa18@ z)$fU6OqdjgVY1dYJB+h)ROj3a5l*cY1S&7OH$z7 zaJI{Fxh@H9!bz6CQl(uu`{bc~`aw8@+J`f&qvmu9r{Txp6#7KaCQPp)uai1y2bLD-ZSn`9Ee53gPhEv*Tpjkl!GYc6gP}sn^A_hhmH85KWMHy%u zZD6MiFJ@qdG>tLPUQSD?SdEqYaR$QT4Q!JA5=t;IsJMa0l3vWu#$nFqs%l_~d{aYpNS&Gn-jzdQd)vU= z+6JmLG0;Q`H`SVDtekFUU|S0V*474!%L%zE&Dt24)mFW0r#YR}vyT;D?shh?uZv=I zGZ5EH>;6iQzt-b{1|EK^+Qu7jPB8H4L<6rT8JIU!{gYKQ40>&-C(?AOfu(Y9nSuA0 z8+g6aK+RR!gVpMhME+=C+E4141b$XeWtH6CV4%S-1}1MbVA^CLS{loS%?3W%V&I0j zw&^t>{Hnc{BRkdGU3xw2)}HNAt$Ph*?lVyPsOpuh;|9K$=s(q4F*b|-UeL(=LPl0eQeh)^iWvDa%7`!8 zNF`YA!Bv8^@IYMtu+$w;&HIwtpiHnMS(kz$*T?2%JaZHti+TaCPw5GsrtgmJ}Lal$QSbNe?}fkR+x#x789QpGU@eX;*9()&5M|rRn$bmC==Hzm>8B~ z;;`LBi&PVJy(WH^k9{Wk%Rk}?n3ydqWPG-XIyt({H4zpx5i3(Gn<(2*d1PZF6ZXa? zEGD}4HDH+zq#5A#VHBqmd zi7hgvr->4unP}U~#1ZM=NBR4j7%Nr!nP@D(ie-Ru%jwS*dxD8$Qg5P(iIYrvKVTwW zmP|1bSY+aNDf+#M@8pN|CQ^SkF<3G;n3ySTe=*T%qls0UOqANJIkIqz=I=1E>{k=d zrP(eM^X2c|dc4QP`+H5Sl^6R=bo@>0KB)Q*X-$W9TujGIw38*rO~jor5pmW;OPTwJ zi6ZCJn+qEMmx%_lM#@|=(c!X*>Q_wMy<_65yC(eiOjMR1<=K4`yC0ZvKQS>u&OS9! z^O=d8&rNt=nwTR?|5Y9TnRqQ<5WyqK4v%1oY?1$Dw=sg+rU=GGMCgZ%2yAlH62W0t z1fRMicp#bH2o}pGG58{=krBc6tOyEZN6@xF#9FusDYLGCW znT}GzZzffy%U=Q2lxAjlx|tWUBE!sPNzF9VBTL8St&myoMa*R8nW-V`<#oQ9&K1ps zYMGfT7v45gx3-xp^~~(3Z>C}cGrOfgBQtxOn>ita-Z4|Yl^LHbmgslQw0KX)Wlvi( zW!stg=mRs~bTD&GQah?fiR@-3y}OwKpP1SAnVAN?)Pvq;OnuB0mt}p;I7gWIbflR} z@>HTmnYlCG%(jVU4t%d%OBGip%l>6%KHIGIO8!gCe{Lhs0g_$ld&8&H)^}IHdA>-bdnH^@~ zPkB4s!dQa^m(fCggoP1u)NJ8eqy=9A3w;V&h%IcPoh&J0A+D%JKSNsBA?9KhYS=7H zkh8HC4#rt16K|nIf`yc~EKHU^OIrA*l!f`FExeH`Wi70c50fq25?_jix$;hJ3oGSu z9Sa}SweX32F9+%=R(<7cVBx$BZe-zisn^)TGP&QxLhGg$zG`XVxFo!5;X5(4w$MUm zx3N&Dt%V;tSP1(_^>(zdUOxNO!gh)H%t9~e*ULil-WDSJShR;0hRNZ+7V`R8^nF12 zW$h3PO@~^rd}kqEhRVTV7J|bqG?Xq9K1sF7#K{)!O|g(WRqLOoI;Hvy3k&3*nW}A; z1^*liU&^kz7Hsn^w3Y7{Sa`P3LiN<-&^p=lob}Lt+lX0IDgaYg;O zu6c4oO5d<>MpFJ(-(=%I7VI}IWXQ@}7E0XFJlTBLLg>Es;DPq!p@lT)wec*&A!6LA;e4Z&?YHw9>DXmA~b5 zX)EQ*Sm{(&bLHzq<(D$$t&EYGa#7w%Qhmu*;wxAgCC5{&RJL0Q_ga}RLwr^a_^spy zlt)}SR+iSW;;w7uvwBv2J+jiaftAe?-bi&f*VuQg9Ff>oR&KXdzK^Y(ld@f`jFqij zt=PL+>E7MS1xf0m8a}h~S{n4S>T8cxUwf=uowu_SDcm9DaOu9YeCt@K!6rSKZnA-}Ix9qX*@{>e&#pH-)9-C*U;FWQSuiY1nP z>X+R6&C2_~TRE}cO7Vl*Lzykd52+8QtSpv`a_@|lymMCS$!C9B`9*${nDbW3OS=nJ zevkk=^atb_%(_VJENGgD~e%zqZqg^ii48}Hiha`gc@*Of(VUkhkLiU@=Ne zDMknJFD=Hb)y4Q*%I_=2mnVzyn_Re2jP?H%BkX1|`rR$YpjX8>EI<8Qj1~VCI5EU82yHccx#z)7{MEcueXcHg9a*j$x5ho)Sauv>1j+lj$)$o)ts>>=;JRiNQ24h6d7UzSgij zhQt+G_s=nm-x9-lDYY$z=DT9_bBxxrCx(N2W9ao;49yP4Fi%b#is6sPF(f^SA^v3y z6aJ0ig4D;x?_vwHvA|%Xqshiv$uQgKYq7CY+*TV;3frhy#Kzd7Hi|~sXeDK$ZF;Y2 zqnG5w*cf87aa7)pwQ*V!<7}*v6=gIo#m3!Ko8F(=$aUE$?y*t8Z)0GFje{~I)5Z@u zHlE9tTpJBSHduyj!m#JVy=x-(rKZMe&5^Jy3B@kxs7%!Y?#;EXe2#YHp;!S(Z>+0(_*o_l=MQed@Vl|j%8t7 zEcaw&LM)5lisgaWOU80EDVDdAW4T%(7KF+CcE?g^Pb{Sm#8T>DES==GOg^l6QuCzNdL@=E zQs-tYiT7jaDl4AFviVgk=GU=$9~H+3hB#JAj46&Pk#UR`e}OnQ6^kPxCXPvO#nHB8 z94ll)sW`n)kK>NKC=*9^xj22E6UUVDacoVB!MtjHI9W+c6%IycgJx=*6dM^y>Wak{(b7f{x~j6 zn*(voJru_+>3vw^j%sc4-LW_poQUJDY&fadr{ah|9Y+IMdQSb4d*|br`ZSI!vX*$} z#l&-4dU@m7E(yMP+N8&`SE4iGnJ#rQ`cnVgIC$dUBWos)= zgLpC<#_L>JJa3xEQ?o@pLt4gj@}qdlbd1N?EuM@|Z#{?#nV}y%16E9StFJE z#1q~(p2t$+YsLIlF$cx-d`LW}G|fyTKB%$D6%5-?XyprW{|CD2cHR8L@k zjRazACeTglHcViuENzrPOp^rW$)8f8X#zh%E(y$) zN?nz=o8om(&>9s_PJNxgli|ucB7x`$3EZ8LK=w>MKPQ26OA<(4n!s1f6Zm+Ya)@I? z0zH0BV6zn4pTPVB3EYvYhxDA74=b0%9Z8^_OqY?T6F4nzUDn*I8Yio6B(VMO1Pc6< z!1!AU)P9`6WGVAHfuWJbIVQbq#krnT9A9#A-sBahM3v%nkn=5zbG&PDN_8vFxt(R1 zb-ygpFU#_t7z!lPFD8*)@{c1CyDyQ?nSr?U6`x z87<2OB=SVY4^E`%cZtlEL8B7+eOw~8@rpA`b7m)!E|#TVgGW} z`LY~Sr1Xe#j2%~wbJAsYIeKp?$8y=bqa4w{D%R0*)H+*^iBjQmIh{8tN44v^jVez@ zba^IyP@c*kmuHkD_9@RQc`5$B<@rlmk0{SF>9(mnH+PmNeOGyQo+?lASLK;P5|<^d zXcBc}l9(!4Ws9-Xvc6lBn)aVu8#_OX8*+N>5^S zmX67SoFv{3>T#YPOCUdqZWWVAt(2tiPf7YWkVL=gNj#{P#G~3tY^|p}4U^c@IEgav zB+*&cwo0P%drA6?EQuEFl5qA&qK~)+==c{&te4f_CUIwkY95)yzvGkmc8cnd>eDoL zMiQf>$IK-9&Q4;dc;+NgXu0A^*B_IZzg6?)quoiAI*>#s@g7W~_UR-hORqnZNV=HB zCvy5~62IQi{J)cUawmy5Pm-wlG>P-iwYFDD{2~uuCvn}FjL(!z(a2<+1(N9_&59<| zH7c16vLiZ~X)(!Ml@Dwh8=uVQQoeXHgJoBVWQx3%OvjSR+)Pd;y@KXCl6fR~sma`s zI-X>vNNk$oWGCavNv3jMGJC2g6ICOb3yqWM)gqbgvg*BL3U*4Sxh(Cev0omj#v{q}JdsR|Q^|~%XJ?aX{8uuw zWyKARzne_yd&%s6k<8||Dqt>Ifs2_HD3Voyx-wN7hbk~zx>TybFYi{s_+AA{^sYet z|CwKb>C$s|1*)8?pzCES@cLQ>9^a@y{@)cCez$_o-Rn77{kQ@KYYO$`pQsda6H*u= zi_4{8_NVBxycE7^l)}ySDWrEuq5j7yEcr5pN8(zfaVt`IAk(*|aB_DFW%i^n=2!|p zolJpKdj5|T&Rs|$`CD&rU~4%(vs0g>tK+omQ3X{8h`Ye~)&SzinrexN6(^td5|>+Sx1zB(I&F!5`RpBD*@-IVod4wlhbfI@@W{#jek^?G){&diraf za_mbx318b8COrn)+3>BMltFfud}r6SVRl*%xAXIOJO56w(`}-i=oxl~%+#7^*$K_I z^L&n-{CReMpKqte5<8=pYOIX?(N3c^c51J+Gk%@w{7HS@U}wfJb_#6N{Vlq`Rrj}P z-cCD~U3Tj4wzEwN98g~m+39@P&N=z{s9o24*;#Si&RZw!_@tlYpHeNS?L3tNXY5qH zpc?Pm`RShef8S1yoPJ{G#Y;PpuhbJcA=O{o8TCecD~-b(Ob>SuX>c$y(!ucp4yqJ% zu%d{AcZ)h$5arNk6%Jk3;hcQC`QInu%5ptt-j9;bu5 zJ_m8x4&KjkP_m+f^VJ-bui;>#tgq$Z&D##T)^_kyJqK;-JNUkV#y4~@tC54NjUBp< z!9ge4C_la9;B`v}U0OM~_O635?>RX2zJs=H9JJ`{U``hYMY=jT+QUJ7PY2)0%DxV^ zNxyy$hDpi*2RFWU@Lbk>{o1PMwmI0m-NB|E4#IaT_iqmB|DoJc{G0=a z-1^JGfh+2>Ou4F>B;lIITz7Cpu1SO24q81>A0_#rgA7?B_a3Q^#|}P|i!Zc~|2h~d zmHutNlImHaw_F2q>?2IoT>blmC7G7F*}uo5}T9Cd%39`l*=->QYuyJrP5T2 z)K^RyCubU@QnR7P%D!f)oOmyl60K7iAp<{1WrEcGP{-x4#CAw!h|G|PE~$L_St{R3 zsF%jcHi_tyN^cn_NY`=O7{t=q)gN8^i(cNubGN16=$W= zKz4#M2uS{k6kEv{y-fJ{Zo=g6^R949@@oY@x-Ry=P42t*5Dc@Jwrv zqAycv{wkHd^5g4NTE0=te^ZJ2FO}9fSsdmhHr&a3MkfnRPGTaQ6peP$yqKO(aFSKR zNi8wF<)oMlmIEc71WP&jpp27cWt|jHbaJhn6K9f>nUYY!Nt+ZWM`XLhiP`C7yvs>S zx|8l1PVAXZKFM*(s_pj?((-JKl$)=B(eCrMI%h?CAkot%^OVNO0D?qrxe zl93~w%#!A#oO~o_rOX&7%f~vYInl|y$xhZtmnoVjcO`wAlecF&nY_r!`NdA^ey@Bh zlv`&0;ADlATIr*UyF<-P4>+#M%jcbyEp=Op#M_C%ga!~-XNW!pn1o<~laJ<-~p zYVV$_|0WmfBU~h#T^z8uC>H7BTj^B5#p;4C$`o>OJ;sGA*2OF-Tiiv*5-$FI%SE+P zE{>FT>9ZXdr;=P$Pj-=%;-ZV)#hwuJdM>Q>T{LLmV!JG8;$moX7gMEC3m5I=gp_FMVuak5 zsjXaGeAmUx)-Ecw)!N#*81RvcogH1+KXK_=CKppab#bAm^ith@TuhQ>lGo2g<3TQ_ z4|Wkb#6{boF1=51@slJDQ*Va5bk5L4jj@V1QDY{%=r3odsb4c(j1|`$7oW{_aaAsU zul_D|>2qrJZl#M=t6Y>`?V{=$)w|ZkE9w4|_F=u&y4gkOcNg`PV~%}_ZM?k3OR z=6jQyyAf{QH@gX1-P9Fxq?PBn4#20guBGctkjGKlw zHxpysoQrc)JKl|_gqz-Pxw$S~OS@TDMq?7)bgAHGZHk+6b~j~G-F)P9>$+Pvu~pr? zSIx~qd0E4)^ImR#l$CYeJgMiVeSJ4$8oD{v$W8UeZWg@j=H`2D46WU~-NsFG`KGN~ z*UGxd`apHc@lML!U%3akb^gn(@B41@2fJA%JBPZ79OkCKj343V>_|7YM!A_f#?8gC zs%f0^O;nCaZl1}k$!@Mraq~d_o2s5n(>Q4}-OYJvFvHD$sXEimOc^!H&57B1JjYGz zxmvf3n(wCF0yj$+x=C2%W`KMrgO|BEuv~kvLN!RWAKZ*w>1LXgT;=A&)#}%J?b*+6 zX2=q$zQN6_EpA?H)gEnkvs$)Dg&peMPQ~5jW|9=x?WWNlH@`~UKJDFa+JBjM(9Pe6 z+_X5X{vCBQ?wFgf<8F$bbkp*bo8P6<88>$%?GHB#W%!?Nj-J=^7u*cI=;pV-+`N0q zO(%IG!7FZ7$j#ese0P;YvLCwn`jMOa@pcT?x3n;T}2 zKA-R~TUJMUcvir}M+H5E74=Xv%7Z!1!_$(wE#+Z{9F;1iJq$17;iYs>^sv61hu_M3 zD4OiyaH?)S9-4bS?3EjS577Y+@1%K%&(Uqj!`wWL$@lPIMGw_0D`pjs-m`kBT1WHi zdYIbG!^P$v>bFo0tvrl**F(K_9u~CsaI=GlmLGX2+sQ-6k3F1`L7hG9@8Ti1tA`@p zJv95o!yY*&i9I|xKKIb$3lEp%(?K3e4EE4&h=*hH<1h~$hI{y7gkq2O;2Y~r+fxsj&$Q;}>akRM zsXC=JUOI$%IVD>RUW_I$pUFpNFDorxN?E-G(%2~zB4rx@?%dTo(dQ?{}H56N-YbmxYspsWhebw32OX=2HM;om}Zppw7UJ7;d z(xkiQ%efw25__uNUS1quD&ALKUVrUn%plDf?A7-O8tsY*0`Cd7t z%2F?DrQm8Wjek^L`Dd*c?@wOl%HUtTxHf7ZHhH-!leT*KbDQ>LhZpy6UV8oRCGCjz z;kcLYPI!4Pjm~z@_iU8`}j#-SMf2lnve3eeRQtl;={DeN9#2{7O(XYyUs_C z^*%QI?4!yrJ{oQDF>R|4>oy;!clao^)5mC;a=^!hgFfmVQq4zwRYNV+P}|R_I(}X?^i#R9pEVNG%ulQ4e)dbdmVRB2 z>L=|z9c$<3#Rq=<-i)7RJ^VcQRPlQHX*9skw9oyN|5EE7>F51Xeh$eO6a4I&sJWB; z{2^th_!%dEOx6AAepbxzQ)0PttkB$5>dj_9UvKg29FKDD@^gQ;p8FYKP_(g`Q)yjpYQppaNp0F2YyOFQvAp2;dAxyg`Z|G{nUQtXZ&mR>y4ku|N1%q zpZ1yn+l&DsA_9yv2Pj-1K+}Q&{wfq8J}N-#=m3YMdQ5;(wt#*oG{CU907v2jR7?mk zt7L#)r2>3ZI>5>@0ZNq(@JcF|3lL@xU~~rbdk+C30|Az$2Y8SXV0BP&^8+ld7|=Dx z0TOEm=u{^_N~3_TB@XasvjBCP2N=^jps&Ho-8R6+4-~I`fRP;n#B>eNs#}2T-2>SA z26(q$fCJKcfMR|gAohy@^}h))d7#$vU4TI&1MD9aAa`_tonutXxB&g-$Eg9HPYcj- zy4Eo>z|~m+n#|TZ=LR@2FF@7#0g5jS&~{OPqjFus7puPS1C(1DV1g`>Vym=<-?fJQ z0nSRTg8{}K3g{Pe1AK8TK!f7}I-dy8{g&q44bbIYfc*ObT0RI6^(;V(=K=P~FE3Sh zSQ>i`X%sf4@uf_VKjle88WH9+w#yNzY)NC7HH}_H)A*rO8jnk-@nM-XRwt&>tXvwi z%BN8%DUGBGX>>_Z4B6yJBixzBr?SVZZMV=SsJ67r|C1%G={#D#-WyJyz_1v=US(c*fx#vQuTv0Mtqp2b1Z2r z>66C2zG=Lc5&hDbDb4z)(Lv5g>Ce+x_Jwi|Or!6&T9Z^6l%}7#(%3BphomuOXd0Fg zY1AK?#x{96I*rg+ty?yaPt)(RrD2$u#uhm!`IFL^D>o)9?i3xHnnsKqk_*ycnqp2* z!#pF6oSA8SGb@b;GJSR$m*%Kn^VI9bY5JL6G3A)FSeeEjTa|NL8vC}Z);+3aZyKI` zY5LueG<}Yv{vOggFRA`3$|1)j;hNSYA74-7#~Wz`|4C!lqcjRUNh4lH%JHXZy#HMN zH>b1Nl8)1w&a0y7RE|!kzHF0-m~@KC61itfr*&*Pu7q?xE1piEOgh$b=`<*x&UX1% zS|z1(L!y$?*&}D=wiI!s^OkgxTF!LFy3&~?-Q4N?KW3*BHb0%33p7WbO5=s;Tomh~bhgS-xhm$R ziZ9b-$qLo@LpuFer888PtVzfCb2_y*q_au($(3KyacoLwy6oMY&Iw7~l8$Mc)+7hE zYfU>8Lr%*Fzos)vD(_6EsdSVPd(xRIIlrar_q5ZwzhCP)l+H~#aajF4p3d46>6AN} zj#mbsPG{~J?ZMe}n*Whb^$W^(N$ZTrpsXc>71j*Gif2%>L3>Ic)a3(v0 z!HqLG&?JLk(+nEQDmnH^1__^L@J0U&-kzVqxCNTOFoRfWCo7j_@ML)gk*nmQ=KYmH z=tc(9OJ{PaOePJ>W^%SlCS|H+Qm{@YdE+t}JU)|urf2fWrc8d`oJr-anOr-NiStk< zGo|pKnKV70$!@vwcP5UTnM{{5cQX0tZYIf(GwD?>i_PV;bbc?3-`!b6d9(ON9^__` z70P0X^r)J}hH6=)RL`PD?JP#u$)b0?ELL^S;%OI+@0P`|FS0oDWfm2`%A&43`Z|l8 zfmtk*Z8Cp&7I&v+kv=_(MY2(BGqQ-7rSY?~*doWI^TI3^e4oY5C0VpwnnibsT$M%a znk?R1o5ex7EKfFN5qCI?_m5<8NUli#Q@VdfasS9-u#A^ue`S$yS@p@9hgrOMl*RFv zS^9UA&1rWwxtZCz9ypt^L-crPHj_tX(_lHVm5C}2dO+cn_*M3 zc_AMz&u00GY)br)jaLTB&DGiX)?_nJ-t5b!>hC&sRP(ND-i>T(-pOX-(`?Q?%VzqU zY_1i|!C5$m%py6oi^-v4Y>vJ^=ji)$4htMP6idxvQ6PuK**V-y&Ks$UMB`{%G@bPkrWIoz0?gL`fcv!(Ou9M=4pLywDzLM+@3?3V>x_u zJcrY==#Lz3pUYwSr5yTP%VFzv&A*YuuKPI@c$mWgnG%-Eh45TvS#tTHST4(Aaw%@h z)$3ljrE(cAWy|E!v1~4tQ*s&9ELZQ_a&-+#E)8VQJGtC$mrLNoTpo7H<>csG-Wr?B zNcm=dF8dbblC@Cd7w0nYdySEZ)w$IDF_(frEAP2n)?LZv@YP(7UCSlmMy`6PeE;OK z>SivRCG%D;U*68;u57%UOW6Hf3d>4)@*tP?4|93(BA1G<6jwILf3I`t{zmnM2PtF> z@`e0t4)U)hNH=ScDTRYvC=%qBOez}W&!`}EqJxx*39?rT#|HUQcE<%Nm=NT7>7dSA z1a+<=sB;xTzLupanqv<#!4bre8f36L$N^7~pf^Z`H04PTGC+!F1ZkTY z1o=v4G!1gOndUSPQtQ1SW8V)#>maMz1bNyvNQZWc+aXBhjzQK)r;mfI?i{2{mmv8) zf(-do2(srV?ZeO72N}FUv42tQjX_3l33764kZRk4yuB;PxZOd* z_5>NUKgj+AL9QPT@=Sg_5@d(8ITobBN%d1ooC=aEzn>0L?2jNV&*{F5|1-$h^XkQg zAnoo3=_#&zK|-=hp59ka9;k=X_<4}&FM>qA46=<75#b>&n?sa}579m$#7QYtQuj;g zzT7JlA|o+G&2k}5l@C!eImD6*A$q5U*peQ?l@X$PW{6Q)A?oCXI9Mx0OzjYZWN4ib zhw6sNs~5u1AjI1ZLu?d#lMtUY4e^(3Y#HLccSC$Et=~^DgqS-qMA1p=rQDI3lSABC)G!(Abk?^bX3 zhp2E$Yd#&~#Tn%}8)EGF5T`GMsBtkw6M6lYYP=j`txUV4y}7G;@2S>@+KWda{oX)` zLeDhzxq2;WW%C%2m`6@Z9**jH^r(@?C5fz^N5eXK>=0-DJbE_BJicy|$K^hG*!$%%O@>d&FOlc+asHD}&zt#tEg84-`QlDKccjq$e40GSXP4wX%4hK7e8$VH zC;5zdmd{K%Q>oCDYTaKx4%2_DQ#N7DGTr>&Kbg%hHU1$hX~?XDw=C7Z?QkQh*5oOL aTJK-;D7NmzvwN;=|9|uJKN9?ZfBp})9aud8 literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/0dc87fae525b08c8_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/0dc87fae525b08c8_0 new file mode 100644 index 0000000000000000000000000000000000000000..6028e9aa77a5216ae349610b16abbf9b9b7cb751 GIT binary patch literal 19196 zcmY-1cXX817w++IGCkCUObSQ~BxEMjXVPa9I!Nyzs5C{8qNsp?6)6HDy;lK|CLkzE z2dPT$AOg|_>AmWGes`_=$7QY0ns&}Ud++m_nY{Bx->dI^SElE)=O&=4taC3ot{ZZK zS%I3hvvYmbYXySY!C+1`Uv@CFT6R`2(J%)Ckq8 zR;_l9KRdU2b}fTq?29it^?$Mc_wUbmqW*WAC;{EOApN3Yr%W@#NwF!3n=;7)$BRMn z;&4O$DhUTl!^RN&ngiB6&6VR}$gK&bYeCm0u&gPRZ3e$cjpmTj0y3qpyxm%JWOp0* z<_)dY6W;6vx1_}TVDG0GA1X$F$Q}qkd<>61fi9mykI!M{AgJ~QBn*XDhe0>V`Vtn& zt>N(c2{Y>ql7i6Ks~bt6{-<<+c&l z%O1(!1eRYRNe;<*X}%S_4^#kuRx`%T3c?)zw*vCc=3<&x~}nZLSDY19B;yM z>2?eH%Qe}17tY9(d$3TF@59{(V0Z`{WUmxFf(CL|IzEQgvQs{P0%IlmDZKRzK9s<7 zs4lByi_CnXenm&oSA2#js>%R99b-JNl{di({e-FCu?5WC~C+HDON6uPbE7g zin?jg*qIg-pl2cMHSC3_) zOfHCGZ}lif*NCD+%_x#;Me%xV)*y)L8;JN57ND9*K4O&z27xRZJ+7sT;K6jSBLE>S#t zD~j%2qd3zoiq!6!*Hb;75XJb3Q5Ytv_E}M!oUIz>MDgA?QLLF8MXUKyY~CG(Wp5Py z{^vv#8&5{z`6G%we@0R2OcY;84^uR&%+XY`L{q0|G+!5s=3jX~A)2*`(X>vE=F7Bb z_E(9fFg={>qFLaNCNmJtSb4K%G=J8L=9zp^JDMj_ST~wwvQ8dL ziF(m|EL-bG6KD|4^QO`CZXQj=7K$a;TSn8aRWx1Yx{PZb&4+EGF~6c5+D4PyA(~yC zqPZ*Yb&h86o6!vK8cmUI(KLNKnqu!pQ(8WGFPcUlMRRpjG~UtCgyoGf(Ik$I=CyIr z?2(x9(Yz&h<)sPH9F&XlNRp>S6Py}NRcSmUnln=Nn`m0hi{>xs_iZ%O7AWR-(R{Zs znj4Fv>HI@93&pxpYs*=AeidtlARI-0jh1?TBWed@rBsjbi(*XhOe5^Rf(= z>;vl2!Dw=iN7MX-a+Q-3e@bhej>dmBnxf~TsdgipD>v24Tgv5;@_MXXpJ+|_Udp~u zPX9(z-e{mzQ3ErI87NZRz^M`jzAkBCmK2LM&^*q-RvA&sz;tODZ{STiF69z5R&FO6 zh)OcBPIgNq*}&k^2JTB{c>}eD3I%3=m@DzA2HK@5hNSon z1m%Xjkaq$GRtF8Fg$%rrWuT9Evker=5Arz2K-XLYYr+P8m%$MO6U1C#pkbkb4Klx) zfuH1^>IOcQJCak=z(V=Fj`ENObq%~K`@~+)z?}L9YP2xWLW;Lk%`!%gw=%G)jR9MG z1EuANT$ENF49x7P-gVNPZtB_FiZ3_28`#xDF?tzD?4!Cr)#K0fc#wgQ{ce(azg?cG5KNy($lX@$`pVfQ0{)>SoYYa?UYrwS5K%6v}U)CFVcY}c| z;@+g=MEF(5gB;kZ{%_MUvt9eTL-p)5kiE-5{e!AUat<5#PU8Ml|HW`d^~j~02728x z@Z)U*mF^hu$vw%vr(Q|s0|Nse8u(J|j|_Y(|2)=l^;COP)X3aoMwUxzaU<*HMhPRI z#2WF(8L1{K(i-Bw2ZyfX4c2DCM@s-13MHIn?Ak!=#w-bjD>po5WLI~lq6rq+E+Id#>o^myCI zL2-3A@?H-kjo&r0LEi0cUAN53n{nRTleq`iR`Q|etIyoT4#~L|2)5w%rM$XJO(r}KEPEurnk+|=T443`O zj1(+4vS@{orau_@ZKVRUv?U)vdc(FvVK$EzbkKfELV3M8M?>FfBTH|K49ceNjao_mQE*( z*e)13A$2bq`TDYvde^nD_l#T+#{(ljNz_9lbsnkTQuB$CT~hp+k&oro|BT#~oG25; zttLJwX3}wI;)MJytxK4gS<*z&SQD43m>8aJV!y*gn+y{TeI|aExBVst$W`$MP0W&| zGA`FdgFM~ln}`aVNRTPjO;l{Eb!2Tb6OQI4tZhv66Xz=?@???RYHQ-~t0vCLq|PQ@ z$ci^iY!>gECi-+SaZ&C{-|i-k$?zT~ri!(viAKFlY>?eD`F#^*J}}X-kBI{^pr3O2 z(8L(2(ceUK`Bkg~m4_VvNNbEYaY!0XFfn1GNuN1PB+0_bCVrCOwbX;Si+gcOL*O@4{Uh`!B2F2N8V)3sg9!sljCg#fD+x2*diPv|U zSS3$(ndthPda+k|?o)mH^}3i2ndl@751U9lV#0jVL|d8jhlvuWOuQr$<)YO3Q@xU- z^5Tr*{AHqvtdt7pOmsPKqV@$7H*c8u^rnfxEfdw{2YGbc#P&Pd2k|^GFS*D%wd zrkPiycr7!d)$5pvYNXhb*VxSQre?Y~GxI}pGZR~ynJW$3Xx=Mk-f3%QQ9Cm= zUp4boX1#8vZ3i>Kj%JR?Ir*rQnZL#JhMBW(nn``jjIEoQ=L59XM~W+>25aphdOXz3 z#bIWg!_7>UmNU#upJ^s$mYMR>aE_T(YqZu{GnRE`7E90d>dR*J=vOm?W$_L(w|AOp zzspPyDYDy4(>>~q9F^M=v(L<%@}4AL(E4&(wq7@rb;C@`Ei>J2o9Qdp#DCY!H?mAl z-Ph|6&3NUdM`pUpvd3o1K2gt}nYsSlOuH9m_C#B#X0R~KXyKvQEEXDDEo_uk#VnYM zTWCz z3%zqRMsCVW5sN-kS;#K1P)AnF^Fj;VtEv`>yli2LoT+D_VSVK;7aCdE(%3@PCKk3! zk!BWlwzhCY2ESsVaytutSs-z*T4?i{UY8vmEmZ7e;jPXVKJQ}Tl4NvM&JxqhLgqUb z2EJ=y*9R7w^igm6S}^sqP+As$Xu&no!h2s?I42J!c9ex1<1B2NU}4X9T5FNw$|Tvn z*un?vRl5{!v`}Tcg?}zsc>kh>HJ2=;Usi4Mh0MHWp~XMSD!l!F#4mtw5= zi&*Jb)Jj5eE1hIv2`h;ut@{1g$`-MdvQo!xWxSkBu(CJNN`)jVU6QS&zhq^S{8`q@ z=jE)-EpO$8)Tn4>rM!`5MgC`)yiu5;5{pw#r%PlJ~Bx9_p#Etua%g7 zRviOYhRgmBtrYaP>b*;O$f}`MS`M>f{nAR343oXXt%OHdX(~M=dZO}^36recnrtP1 ziuyNIxk~NnR_4jo8Om>_mB4H(pUAd3R_t@Fbd>MrS$QS+YR6d}qZglb2el zwaUsb()~v(1Ld0dR$G}ZKg!q*RzBRKoTSuN)g`IhREzB2u47}jmC;A6T$jKxE8obi zKdiiVO2>m(PFv|K(=VtWmo-n0Nck(;Pf7n}VSw8*Ge_ThiTV;|G(CE>;`!O4zWKw9z=$#zr|TH|3d}h_jJZ%Em|WHipY# z`P^<}XM&9;Nj9#$WFuJCM*ng){+8qAZB(jYqgzGImCsVNzEr4eW3<9Ih<~zy2D1a&&FIC>bJ2cU?V@Mb;O-#V^ISeo`yC)Xk^pRHya(B*jO*o&6Ia* zjeW(&0ZC|Q<9bJ}_qL5wQn81PF|x6z4M#5<@4REIz;l{^`zny1=$AvLBemPF0A(Nk8S;FOI<^1+`r*2r%Xf7(W6>2$`%_cH#hju%-aFaKp@f-F5}d$kD-P=hK3bl zm?C@SN?r_s{1`r#aA6DwWKFdgs#cG|Su2K5WLxbRf^}k8ST}~|tz-C5^4i2;eMOHY zw`~lLb}@V)f%&m~EZ2UCC38(Ihu6lke_br4*T+(9Lo7du4q~p$k*(EdyEuZg3RY>kbhUwjb^o_S)i#M4ohN-1kR zu`%(yDkVy2d|W&&WPm-M4oUGW5l88GJ}MJWMum9#%JH;#x;f+dQ5s~#vpWz^LNJ~? zx$%Va;<=O`&(VT-K5ZG#?^5>lc-D1_$J{xdlQO?+Jh$YvKJirP8&9!*@%Z}3Gf@7L z`2!T|6UF*8o{^u$6Fo>{<@+z<={-1}^)hKlJn3J?^S%^}kEiXVc)peDljF&s8qZK^ zF)g0^Gvg_o70=hR<1u{`PZQ}jS2Zk&CuOPX{yCm;8{#=Fk;d5hUF=bI<{9jCHQ8AuSr$7VTJ3BV zkIl}5;&!T*ursEloszM3+DU~tyFL@!=_7gZc81#R9F%$qc8*I*qMenpw1UQ^+qs!x z*Jofm`EEO^NO>@+xb4v&STk-Z>LGbPW$S17R%-unp@A#p89qY8`ybI z+BLH4_aHlK8|!gX&5;$&?3`<5$JN?S{Wi+)bvxZ`<{JUE*4=8W>O6nZ7GfsY&Z~m}zT`Hfl^XGXxRW7J+7uDOFcHWd}x9r@# zZ>Q2TJN*m^IwhFEQ^_orz-RJ(@dV~4CU8r>N={(GO9|W&N7)1prY7)GS^^iVBw+O> z&|J0#68Jipz)2YyN}x(s0`JM#>;$Uj={czpPGChr0?*_@)dZT=NMNQEubDu_1_|_# zt&I|x(l&t$lGP!BmYotfFR5=P@UBellE6oAC$LkzJrkHD=OnpT0!t+_Ab~IC;O7an z9-P2jX*5)84^w`!LtY<|z#{24E`crICQx*NVk}9Z|FQ(O$-GqwH2pDw8Ddzg-fT~x z*p39s?@6HC-UPbIb(yqZ^Q7)k)p{X;4btFR0x7o>=qXDdC9wWk0+#0q`W%%=XG0>( zB;J%rjhIBfmOzn2)|E=c9G}RLBC30H+2q)6NdLr9oNzFta*46lz6QOA$FIpz*oMs}= z+a>bOn~AKIEnO37*E5j?GW%WS(>sx-GF)2sRW9;I|3pp>Or-Khi7c0npDS0%9HLmm z6R9&I5yRJs1ji=wiCmJQvlBTe8y6<>?UF=p%h~S}N&F#^PBKjf{g}vJS-(1wS2iXx zUn*`+WXSeJ4#>(KT4QG-pGjbsdayf@^U`5YB6Id7@{jc0uW<)en|ygFk$FcFxhcOK zRqSJlBppwri7Yy$e#x!ViA;Hz$OTzN65qrpab5cOlGrTC{v7yF8S)`X;ebs`pDG`okpdOPS9U^9#isoW$dyNpu^Y#E()q zLh-*={Ly-TY!Z7WC6PE;bEoNcRuY}$`RpXN&q<=>H%YuSSC6I6yd;{>PhxA8WQwOJ z-blvyW-=waCDXD;GIOL_Pp#Wa@!m;RjfyA7K1=4o2(3FZnYi)E z+?<|F?hHLYJDF1plSx~Y%%@9|dHYALAHTXm>!sB0WajQk=7!YVr{~17Uu#L? zfn++#H2LayGRNhm^O}26<7D}jWH$euOp&X}jQb~<`uCHWBo&?~Gc2Ywhoq0aG?!CL z<4-Hii-OXWsZp9Pa=LA44)-igxn89?wY4HMZ&xJlX+>TWLy;8v$EUDOt~yh2_*3{m zj#W!xaP<@#HcMfO%enZg_yJSv6X$EIK( zr#Le;XI2WCVqKI%b6K=L1>dF=2Ff>EQ~36`6mHA!hg0ZwB84BN!{rnj-A`ev9J5ry zTBH)qB__EN&&yV#PPs}r1C>bVT8WM_e?TP~d{T+YQhsD5#*D4RDd{n*5`8yRVu|eB zQi-@<73*LnUOrig2~y>JC7p+pTxBM9u1xi}D>F(``c-DRJe9zQmHA8B zkF3mM>9wvh*S1zBb6aJ$9;;00XO)>uD(59sGL?q$sZ5ca3aR{)l1f&kRNR$QbuL7Y zWq>P{h&PojzEqz1Q>h(DWuD9qrE*R7Wu~$sN3Y4eyj1Fi^|(NfC0LkBud1nJR7=(S zQ>y+ONTq-6RPMZ-%DwujY;2@;nx?X&c`6lNNu|52YL`m&*HZNzVk&JqrQ+(HNK{*KlJxmAmDIDTyer2qrt<3*&Hp=<2RBlA@gSAD4^uh) zShYP%WsTf@p2}ro8h%q6C1cWX6-lF?v?`fK&)776ku7m)OpQ-JCuyvIsS1{|RXCen zg%UYcXed*pd87)nq(`+Xta-Hx#@DJ)rf(G*|IgeiOq2JwSE0tSD!R_73ePW9;r^8> z6#iX>5jU&o`vpBGEACgpU`wZwT#Zd9KRKPDvY=8rmO#3`zf9-zX6ameGo8#X=`?;j zorRyIb5GpgYTVLv?#Q%_=^WjjPK6!mj6RgkPe;??n4bS5ol|GhNjsa)j7#Y>xSY};7Jli_ zHFXZ!k8tqwI0yfZchGBsgShDqhR#sUGaW=`Ie0wVLE$$JexK{0&O!%YFVa{kve?0x z9~?AWsTeX_>aTJz?nmYPlY*~xT==13Q(lfLq|cwJ6z`kf@^I(a?M zN!hASPSMS|jhu97?Bu&98sF5(%w|q5Hh1b85GUPat^D+g zljm)n^l0bg(yLBJzvkrF>rOg$aMGr`li59-l<4W?U~eZ$?>qTYmVM}Cll1TJWVoac zbaLf0Cy!<2=T3f=&>$xRzi{%8JeD_xIH~xhli%fpv>NWD()RR%FL(a%e z>F~93AFbTSI7yYE^427+KiNtBsZK7>aN?e&n6njgfs^tJmA|~bSh+57(tfFWD|44S zxw^v1!qrYjt#xu_os*jD)vt|uZj+Pso1LuN;v{;j*8a^&<3F^vls@IeDgXTCWX}cl zStegpPLg~{V=g;6AeW@cbtmoasE?9%*GZNvlw0?d$9*Rs$k`{_$A6s+lWPAtX)0SK zCMtsgGFqORGx)Yh2CL=Wq8WT9cO|!Y28(2)IN~!nm6XACS&*!;(yx355ye+!&rgXk-S5zslgE%o>%!GI?iw2I*6EJ1v8=(r1QZOVybfG?8D$Hamm< z^0hpfuRblw!1R3vbC+eX9Ie9kL0Fg9@PHG%f~Yqb0UKe|HxqS-3-p$%h2b^3|@MeLFY%RK}tT&p!Ks1 zcFGUWGidulG5^gV_P-3;<6=RSi-c$wuNhs;H@S#6yC@mwqID@fpX?&1jEk4W@REyC zGDP;2brCM-qH_foiz~V)o#NtBB^Rz#7c(Teii-~EE)K|MrwfbA#W=T%^h_7;WV!fA z9N8}3&2i~FQ5QGlcAksuu#4}cY@v%cs=DYcHzZWu#l1Q%iq~_|vc8M$@`pT>_nNs_ z(_HadxG0c{?UZ*9)zj0(UO6u>zvJTI7cP>9xJZ@CLtS(q=Hit6Et$iW(+C&C<(_=? zm5Z6udX$T|?PAFo7j-AN_-2xemC|Ff=E+UToa&<93>TBWb#Z!ui-zB6&81pj zW_<5rsgzsh;?3nQj!N`O^;7oBX=%JlbANPU{z-NItU7;Dow9PRizn+`4Bp^k{}$D@ z)kT@(E?tkK-kfxC=)8-wQt!Hpu{T^q-E=YNmWzzr+9P==<~uGvludVCc<;Gr^+5GK z)LuT;ewf^>HoHl)xY=WMQ!2*I7t*bWn-xXfR4C@=a=aUNf}5FAv9z16W!(JxlABuP z+#D$H*7rbej-|S(o#rMr-AxaNn?Gf@(@mVq%^pE69>*Q|0&6bE8YoVJD znMCY2s$H%xmFhSZg;^q*)s`o#cp=Y3pXB zT$d^B+?;*Y&C~X7s&!Oto!kt3%gxrVZXEBrb-kCH$?v&2^S<;^-u>K6l*Lle-%azu zZl(=!6EoCJ$6;=Lrf~CztccFS@z++)duUs!3M;r(WQ}66Il-?2GnL zVDRvr$-_;vhu1A0!Zr^L#S-HoQHINbA|9$1^-#2!hvvmSY?X#_8ZSwuJfzDsIT!Dt zsoleb1P`YYJ=9O~;4R~!?@JyoOV9EieypG|DIR)M@vti0LnViY3K<^Wa(Q%}vxkJ5 z9$u^EVXr)`+y&o^rUG)*hg>2YPg_%%jf%9twweST0+Kd59VAVStPq>EYy89$p^hVajL^ zXU8a~v086})|lwwk<6Ur;o@WucjUh*>d91%lMd57oR%ijJ?xg6Gd#?YQ8PUpnWe|G zJ+z;rx@FW{51rEStzxC@$hVehbJ4gN1HvYkPT90i+Z zzIrJiJn*pYq4rb;Jo2#Rv4;jvJzTMP^?iqzS+XL=%cCM*-YV)Ps-%~?v0f~RULKa! zZ8!r2N%TBox@DdmF@=C}{Ql4%j zUgi{NOre+ms(PtiT`_BT^*Pr|%?6s^(94uoUe31m(zuOsXy;}0t6my)@-pvDFW0(w zY5SI!iru_)ecQ_k8Qk5=?jBz9dwMDHj+a*Ndf6eTB&D|(=SN<8f9&O)yf@fOnIT>} z4fS$Jei-hh%Lp&uk5ufhz4*s?`9?ZU@Un2Ca-QVn^b{|Zr+Jwm|4moUGgY%pnXNqM zD9>+ne~B0CQm?LSR)1D_`RfNSg{!>`{n^X#jb3^l^z!2&#W}1or!?lYm$DbVynfTm zx3|35Z+kg@-^*tY)VGITvLC7D$Lg_Ed#XI8JU+Ta`8XyU3_gq|A0NnD79Y#3KFZmA z1m)M_KKjP{7$(*1KK(rLu~lLceGHKHrF|?Y<0IiEAG<62h)eS^NIr6DoZH7DuaDb4 zA07NY_Jn+VnCW9vmQUBV`}jjD=K2^bA63)%>RPjgk1f)yrjKp4eDtoZTbskxf&z)=ljTC;L~+7K5BfYHKoQPAFHJ33LnjX(7JMUl@H%fKIX`fH9p*H zwGZojT$G6$ef+sed$Prc=QkgHe)kbNpnW*(=I6rkO`Wc<#=RYZ0$9Bb8~cfC>SvG~Z00Aag`asX{j_WEXKn|**3nNB`Cf86 z`ROc4o&97;fpqNRra;b*mM>#5w|Q||98ciG*?&j)?| z43WZqej3XbvG(`#p$wG@1N^KU=;z5te!6|EdOy|t&z0|BKfev}(_)x%kiW;vJoW2a z^+1-2ae-?7PW@cy$F$h5^A~;=tn!oaqo3ZZ{rvK?pBiiYG~3{3>PA1dO@5AV@l$TA zpRZ-|9zSRH`f0RJ{g6ioRr6s#%jConKO>H+XUF_hJML%rNk5aM>1plf1wXYfsb<-A zMf-8p&!^JpA3qbXtFL0X>8IW;KWk<3L)HIC^*+`f%iO1au0Heg%5y#UpP#)1h(rYl z8v-;Gi!nf=43`6@09DNadKC}wspOUj@UpCv=-2@7N$I2j8FEP;$Xm$)mX!`ru1tW! z3IUo(Oht{8ujFt_fEtwo^v(z{NW!iF4P>L3JOTR1>|lV)A-$d%;AU=s%=`e~O2@(g z3#$eQR#y%$D~I|4Ml}fVtZ9Ji%>%5I_*MbhwGOabPRQO@0(5E{(6zq-La%8|rvOhn z2lRJV0T%ZTaOXY6eLq06fdQs|6rl1as{gA1ua63_Pd*+WVA}-EofzN`sW>^nSovd$ z?oSJ_bb5d?OSHyP&0Ve@tq<_ohJemXY0Yf`Zf_4TaA$xoe+#hxclBgV zCjA@W^nW@o2+~$I8H1S3LHf#AOORR8#Tuk|ksvLL2H7ru6$^4hl466jj|;M2YR3l| zWe@T~h9?F&kQAh9a*&y2gY+pEe}xhf3^zJpmmVZ?SpzBQ4Sr0tnI9L zZwC3QOOW`ULE7~Sa`~Mg_78)++CRu1X+KagKMIoYagfHJ2bnZTwS5_6@K-^0j|!6i zb&##2mCM*51LTJ(K^{*H(si2ZnGxjT%pfghsopt3j(iiO=G-8q=LhNdZIFX))2#OA^MaI@qM`v z_sfTPqe6%kDIr=_3Nf>Ch+?TBQmcgMk**lB&KV-w72-YF;nVAZ5Fg9NtPrLg#gdZY z5UnF278HcIQ5a%rtq_eGgqYY+V;Y61-73VW)**dQ9AeljA@;Qm@ye?qPPGq_(lNw1 zso6Qi$Tvbdw-jPwzYw=R4Dnn>_75>bS`7%%MNUZhk3uZ|SZfXn@!=P$NoouZ>37Qz z+okBx5R-?6u#ODT_^S|`?4@Jg59GXbm|e$(K}yOocOD5~BnYe73JS&+=^|(wL%O)|$XHrTQ$}M{)?GrL_Cuj0O=}dwZGO<<4 zq)FvWHp{=#E;W-Y5}TIE4ml~;rGzt+m!yZh?8;<}JCk0XOn&lalIqK(O0FK~Wiq5; zrmm~bB-}U?Z?jDLHqWG6n@nAYq&RPA%`Ta|-7^zQuS{mij`5iko0v(|+)V1u)ANgz z>r&0vY1vrn{ySi zX<9LxlQpubP%E3F4YDa1o6V4M*<78L&AaQe`FVXd)i-8yX-_t;ec8;A;(un-@^m)a z<-*_DIIm?hO)A{T=B=CAq}|V^Po*5zSI*Hn!5n_~V0hlSF+W)8p9 z$|1dW4t471@O6V6`Zmg8dG{P1_R#oVISl_ehXbGFQ1#Os?tPX+-k=;7%O;sSB8Qt( za>$&P!?&_l?9+2F&&;9WtQIg_Az@_>udT{qubh_$ z>vBlkpTp}1a@Z#qWWX`qKcTpP=Q1dQp-j!VH-pFOb!(2{1%4OP%TrL&O!&N+w>=Jo& ziqE5JLZ05+^7P)8$2?~qr84sPHkikP+&pgNuyp9=(6gqxr@>rfte2W^*1D4(0LI;XIDZw}0eu{Zt-H z&gIeXQXU&GYyOoyw%yL7$lW{!%H*hg&P3-k)0$7`Qu!>7&!@CKU&p&{%jGjdDpts+ zYsGx3r{^=cRlYtq+)awg~g7Om7+Hd@Idq z9p>fN!i;%64DG`#?-1r;$1q(wDQ=fA)w_mSDc#-_(}Wlv-UxT{G!-v6nkx$uQ!A_x-m?xO=0S73o~|mn5Z3L2Ja5Ddrz3l z`@=kv9}a}sA{`EeX>wHklrqP{WXSKw!<70XOxshsFXR3UbMmx$aVAWsn_=D;_pLAy zSuPK6t0#BVLuvjv%(N$AVxETCLU}zGd zUegF`#nB?dyDcO9C2QM8c$W#D@eetkc}ei`&Zgx~t84(Zi5!cYAoeDJYu z2Ss@PMFiX62tGL}6^5!d86gLUMX2^=ghnz<;zmSxWu#)sF>!sR{6M6Li8^Y-q;pl$#(T{cZ4d(RNL_gPfkP_b2`HDGZE^XRegUc zhw~9u$;jNg}k0#$Scl5=42EyAW%rfHw)?7rH~VHre`6k?-VjoY7Z`C)R016 z$f3!FBu_15xO~5%koy}8`Ezq2hmRFf`a~gBr1nXT|3l-&b+wT9uNCr{WL+=h;~RzC zkYcwBX>q5JZBlTrkRkUA87DIz6f*izAv5GewPKTNz4P>bl>T=`xj84B>*oLdJ6}2J tC0pa&AAhs(=HRR4>UXL%ZEUW)(0+AnyTptQd!J4CfAjQzYxw{E{U84Vybb^W literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/0f31eb2365dfe72d_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/0f31eb2365dfe72d_0 new file mode 100644 index 0000000000000000000000000000000000000000..98cb01e971388de02136f49dac98b4722f5c2f0d GIT binary patch literal 112688 zcmeFa33OD&);4^4N@rjQ5HJD6Fo=MN%o0Ry5(p43lOZ6Y!s#TPq)E~p(w#uK>Wzqq z;6=vZhzf{;f`AH&ii(KLLsV20L{zRIG7kw(-}BVa=@7l|`>y|6-}kS7{SBS&bE@`G zd+*w{Yge7>&UY8R*sS1}Umb>FB;tMUjVFJ`htZ=;uYO5MJ$oc1rS$01x&MHKTLz@` zyQORY?nzy`rwmBxoY1{nzmy&+2}zy%rS$6BwOiMuP|sVlyPqZ49H8b9r1Fi?x;Gg@&yy_KFGiu>A>DMtD?Zd7n1c$W~#? zo3yspspwW^tGBEUzvWfgqsv>iu{Q*Sv$Z{@JR-`r)Y00}q^WI!J$8SBEv#u&WxWlC zVgCNdAAeZdId8LMZJB5(vx6*OoAJJ6HH;Kdo@nx(CEj@?yE(t%^Ry@AC8XCr7yjym% z7!Ql0@D#X<1{8ZU@!ebxB$nnQ+>vu0+*ubla@>J5*QEZQqG7HADA_RIgy;wzx$l90 zN8yIYKN2PVay|K3hB*~Pi;PDr_GTlR6h2{d1f$6n+e@MIog%gY2upQ7ZQ4F>!Tl69sbWbiUa{K+j zJ;LW_g_DE?2QBsu{gxcSIC18tb5F{L;rq>Hz=vwUIPAHU z@Fu91>GPJjivlU$Vo25%aA!dV_ z>K5E66U9aQ*10Gje@RY1pEuwF(IPVz(B!P-{i(wnp)jiy;`3xC73Cxa0!5yT;(*&Q zpJpXUcuLu`<47PA63+Kbai^t#Kxf^TsSh{7l16yK9n_x z%zkcH28m?n7yENZX6Cx-28wPMDlum(h0Gpt+Yn;$_y_okGCWyXZg09P2Uwa?-oR2` zc#_#0F}BE3q<&2;+S$O1xhV+d$Wf6vOL)ychOK+QJ%X9_st53 za0Xk|AZFdZXKtVg7Usifa(($(sA1mEHp6h%pLygS?mfWm9^ne)rlpv@QCKFBAB^sj$l`pT&+kt4X1OO1&o&3+ zhBVs~Mxderu3TPEf#`lI-mH`ob^?$X3_(dO=hl?B5<~*7q5yO@9FjK|qZo1qlaaSS z;%7&?BPqS#pp>-n{f49@4I4GWFc(v2Xkz5t(;iB+&{gDjLu2lIpg)5q0zKfH+`jZU z4MPqTAtwGNZlVXEN~;DpyjESMpRb@0_L~JPM?eB?!O+t6`Hdgj0pRmyy3HZ@LQQnF zjA+pe-#vceWrR6-11VXafGZ>4Eqk3gImk(0%i+)15@~@X}H?+DisoB zqYZN`zOb3uExT={x`Wm=yl8+I*JfKq-`ilXmkP@f7zeq$S^4giq9PiUVZK6f!?KGS zJU9SupMHz{8Rif|Lk}enyu6zI!S4=;-jzn$%UB4gDM>r7C)6aDCjc`;M^WgeblDlt z0;OKVd>jRi*v*H+O@Io--sg9IPQ+~|PappGlwlZM71fy&o4rEoDJ=43!gtdB z_|0gj$`O0+aJcy>tD)`lCiZ=oZAZ6DFLHVP-~z(|n$?#b7TkL$HeDvHNaB&b=n4v@ zlU#E9_pQi7mhcNnMMbVs!`y@$Y~1p*(>t&Yz6`&+2=3Ed&jL_gdHcY(NEJhbFTcb+ zz>^=4Zln%d52`D>+`O9HgQXn$q||`Bz&uQzVGipo&pt(ug{Dm|y~Bgf=guDGomAv1 z1mB;cpiJP{IQL;k2dTu>XJ?i`IDiC!J^QEpEIMd$z}L@z zm0!+X5NOIg>(Y7Kt;zBQkEa^_2`u9p2NrA6e zj#MjAB+<^Ecd(SQ^LRahl*s|uJg8+1Y5VV`q(u1A z4^BJ7l}Yn6Uq^$07+qmW*LME~6$sN;XeQ$e1+e_w5GN64iFgkJEQdjYM<{W1#ll?L zD`KI{JlRFig>VDKpt!#1x}HKp;B$y4+nrgO$$67uW>bWKU*B-YD9Q)JgR3|{08@1Z z%ueJN*1oafnd7wfpk`&5fw<7mNX9UGq2hFbr=sEa!hMOMS9&+UxtVyt|AAHu=aPTO zS%fmCi6)Zz!G=AzQ;bxAuRuh_hB=vqpnf>*-CmsDa7I8M?aEIRzD37s<`uM|Ob|F` z_54mv!GTD|cB$r_=z6-D)Dul(5PCbf-poRn->HfogM`y#s0&491&sieCMyibx^B6a zHd5p+@RhjxF?d3|A%9}Hly-gr4Y=5w=k-nUs>r^d3)(=?%hscjrpfHioI?@BgGpi z!r)T~LS@2wn!XmZ3W#A1Fp?i}8^h=4;buqNLIvnVW`X$4>BH=-zQ@6Pd zgy(U4r4IWEzk-m1Istssr5`*PG&kuo409$60o^mxccnV2QNn;eOwO@s+`Ye>5FmSn zbVF~dX7&A~_ZW7HV9*Z{OyY-hid<(Ue}1Yf`#z zWUdH=5ZPtw;Qoa6w z3%&+?m?Q;dr+v5ZD=ItK8%AbAS6Q5+7$&B}LO^|AyS0ZL2E{m^grO^7_N67D{i7c| z^#){x&=JA&JCFp?j%#$_AzC2Hday5prbe&=EsY#t$2wHZ*BS>ev+XS5`pd zX8P|rO1a6Y@F?MG)$|qvAsGXf+26fbmj;c%0|6C$o3BXDYc``onc$$j_3Y2d!5yvu zx-I(69wpjx|B~ORN;E3y_so6d8`SHy{&GL5XUd7NpH?8;2kw~@pk(%zCG#gXpyj%~ zoTsb7Zw*;PVOqb6cuHM(?o_V~GaCXDY=J;U(Y$vlcdy%>fe8rj@HhE^Twx?|d5a4nb$GO=aRY>*k&4%L zj-@<2{xJxi@(i<#O$J;=>-7W3Fl3pO?{WEs1-y^efD?%N=xd{TQPf559QWiDf2ONY zOz#nI1Vw!!^GvaJ(_K;3d>nt^1wr+9|K`6*16Pt52YyAt$mc87*dhFl89;%UcV{)7 zc2lKrM%5#!VXlGpqy$@af9w`Y5c;bQ^rZtg%n_0)c#sb1O`hg3!znZ4(}9@HxN;bS zh#V07D5}aqu5VWOY!b{ZEzEU$IkckzKNF8g5G4hNlxU+d89!=7|D^Pk@%@I68kTMb04qbU>E9m}O7M7-i+qzXGa%{={9$Wn z2CVaFguz6Ea7U=X`2}guOyB$#g^1RQjF>q>HD=zY^NLxJ31ecMU~Ysy&=??nGUlg` zD8iuQCsKxO-DMS^U9xP#5}_Le`(ozP6=a&F7&4OD~2k2&ZtUtlPGE3VCYGyxE}6j)V2_Cx|g zi_-vo4wF~59GeGDnT#^bW4sA}`1_Whb7F84?#1JWYwPcJ7bYX6h7^L|3{#e6T{yfK zr3|l}?a2YXbX*YH`dPbNLd%F;$T2wGFefPJF!#l`2|dYGFi}#(V48lx%7T$=ilgD{389PhXXky6SI~JD5PL}_qgb!V42ONzeJ>E znC~boeN(Fb#&{lOP+FG5Pd<6Pf{J`479@e zNL{lIDmr45FNT{>!mKb9q3P?3*VkjyrCC+mlz9?2<$%1o`0yR967c2ZY zt-(#=*y`AQ7kjB6vSn|;{6l5|AC*c3)0^GP?&s0+@M!ohuclZoWhsy|#04dO%JGAX29h*#WJ>z@^gBnSj5N$N+$a;M55MtPC!!W^Ze*Y|-!11~ zW;|sN#8-+pOk=;6Zn;fYxmpRtS3YXfo&y+C=>haeW>;W0s(se2mZ7qJUg_@P<@{ns zhWu3r=t!V`!)7DTBB4j^D zOUBUZ4qM+7-a{rDM6w1GHLwc4QQS3q+B-VXkb?rCe}qNIk-6{I!eZJ42L?G+M{yzz z1}ygNdEy`gW)5YpNy>9e3Wj+=33kBrx*xGa(gUZtMGBQmX4#&}$l5%L0x{*AzH=dc zA!a1LJU6qUA~P-0JHkd+O7n$G)3Q5nWH_OmuUI5u_QG7FWHNf|AD^<1$RJzv(npwX9PJLre1XNG>WqvQtS8$0^tc61LA!El6p zMT63Z4l!RL4mg*)JzV_xnz3ZomvgFKVh4n2Fct%;O8G$ zEcGl#eympEMwzg)>7$o<*krCp$&8sCf6a!#K*OCm;Df~AFi3y=D}*I;non+RFq|eN zdPUGxqRQ(^o{QHn?@Z+W;zD|C{|Fi?^Wa|GB=W^=%O0mgfed6S=pd;=ILou^Z6()* zGGIx~#&`2~c2g9t91!1wmQ|hbL}4dN4k%Y2%M`uB z>$O+IT&Ym6Z=2kYO7Zyb2#!N$J1_-53miL^fBQLm7FG*Jz(0CJ22IS2WY2)1RgC_r zKgn{i8zrWqSqvim<{V&>z2oq5pO~q$cSwn&4Ox&|nP}p%V=svW8Y5|j;?%1-3{9L0 z-{0_)aI+K8(@-uoIsFDlBax>-rJBJEaC(&7BFK@*xdX=@q%{Ve(a1t~rpJ{ZTx%{vRWJ^04Rb!|Bx60@W5sGKvgXPr z8h*a74#`2~HM+g|1uH;-O&48EC8LC58CKq!Vk>tN`sa88~4s zwG%WNJJI&gG#w)&Qx7wqY{N=&o4q-7QY z2U+Yr$$gY8YBylcW&v32yJ*K}vh~S6A1Bn>rQItv3vWN*n!E1-zlKO}EXEfi96a#f z_1OUai3Ld}LDzgo$$a!3 zDF+mXe?bDjqgwiug+{clXQ3;yGcTLlwHcqaRmPk@J8L zL#9|_MImifisSI-uYW>u_z;K|APhGv*c00JDj(S#-^Kb= z61HGq`A0`BTnq3crZj(7#5xT6CSJ@G;9XVZjk%+0Y^O2n$I?3|4Y?!f&XFOx#NSB@ zP3^kvj|^cwdMT$b3((M>y^8-}Lq&QyG_Q<%<`?+mjHqjF#Ha8D+pZVM#$vCB`MxxF z4!RX9j%EdTg5;O}!O4%2&vmBnX&}%<@|*78C;$eGOvnyHjxqyQGHCXCTBIN8vC&=?7O!MW(37XkD7eV!rH96lpC6oHi;)ob z%{r(EJP`Qo*k1o;ugLa7L<~}UvNdSxylssNL}&G@WIo}x;tvuFkl^acJ(&)JKHvq1 z;2V*xi|uz#_C3rrSf8pyKS0su$M2fXB6tiLQH%v0v=)?hY1GIXVo)efk3 zD3F8EsqlJ-*+MVe<^bkt@!cH8rhut)x&1fMjFmBPwG+*eJcIg`$B*Aa>fDp$3Lqwq zheUxEl8IdL=mcCK1_iqQ_##``uzmUkBIH<)+@KsKHc??f*D&JKTuKMy7PorAE6T$0F z5Q|h|EDrAHLxl_q5kv+bPhBF3q!)?ZZe)hs4}PNGbZSWYaSB&;Cs?_et~8vMn*S>S z0zMT^CgOq}HEsKK``J;egU~b|x2Kt%(QdQ>>Kpe~))Yz`V;Myw7qTN!{HS2;{`UX+ zmZ)hV^bICMEa|XkN1VTb$YH2zx-2IdX1Hq9yi)TQ$=0yqf(%4+txy|61=Ypd+c%;m zE2Ut<1Yw+!Is@O!tEOKgLlk7<7zFF->@-x77}mYjwjnX(`!eB+Ww|+-lmWl4YD2X2 z9K*1;F}KL&$Fv0Q#eAF&_LqO2If#qD_fgVBf#P%CrrWMPCLUo2sSH*Di$dpTsNtWLj>g&>6OBm=dFb#N!KvEyZLsSW_G3QN66|1M$?a|97| zrv!KPnFH8NFdMex_r_#4-E>!c!{|VuMbi$kv`d$zR^4h&UjmdouIPO+hZa9d3J+ zBA$fhrfOS)nEjAOdQjOV6B3@1T<8!5#oGYKfuUr=k(*G{aQk3j7r>gNI<>?2e~>C% zm5c)lsWGT!`o`5o>~=^XaqUX(j{`|FzzT@VW^R1(HHQ6C_N?SVUd^XNGnqnM3=vTe zv!`_4Pdmi&XK|rhMgnFB3J5Kq-Fs|z2MV!$i~0r6AR!gJIC9KyqN{QLs|XAUiz=s3 zkBApPlRJ0Z*z!Z<8>xLXaOH$PMIxH#mKkVOtX;7} zG%85y>o=AjrZ-lO1D=b!4v^eiP8?9}#+8Q*It=VX?f3WO;bX?9CG}4oE_WoF1_cE! zHtk3+p<3Kte{qq!AJ(2hq(3pR@Ji%z=@*#>644q`gi<{qu%q{P=c|XRf$jjB5j67e z6^=azZz+&Qo`+~tdPs9KC{nn4B0F4Rh*jWrkvsxUT$Bmg2YX*QPPov_yIBFQQ4HEg zCrnzxK|Ywy5;HOQXxuX|;Sc#gdSZdtiYZ;UbZ_QN${!*=F}CL$lpprAaA&IK4Y^1{ zgSn#zOKuQ75H4SI?LCwkAkPi%(uvjwvxEaq6Ps>?Pd^CMa@jZXsRl1g$#F1KlEYIB zf~|V9-mwY4r1yJi}t50S$6=9eOJ zl53;1fqbRjRyQ_nK~k8#al8*;5e-u}++aJ}-Z*eM+c9kTcpcD)K*oH96(GM3fA=+( zeO7lIa6pTvcshKwvoSjc1BGmSn)?(~r)CSr6Dl1$U`HZO8a@n#iC_p`3rLe^Jue2^ z@d2OO+=F5|5F(9yc}gw~0{&LUm1C652H!RO5n)E`Yie*b`%slYIryiwH{ zA1LR6qUmhU{@9w!nh|$x|5mc zgg_47%ikV#56Apqe-SGUD%V9~ZNNLKLYgb@dNM_7UC$9vJO*{7{x;r~ClW3N>S+Vf zHFi;wX!oX_BZg9ca3yks*()pn(#?N=`ZglXR6F~{Or{0-hy1s`-Tp;dJhUFPb{SfN z@)6a@9e;0Zr|ro-NZ6mFHbt8=K|(6}KwjECDnL!m4o$P&O)G*V58m1(S5^r0lR0d; zi^&`ZLCHm{Q+Fklv5K70k4)Dwh1mu;$^@26Z+HEQ`tbPs`SQ6N0k$Ocu?siZo=ZDV z9bx4UY))EGKO@N(tlS?R=rei>{ugK^WUtlE0=(oGbZ^j=&(gEYbcjmCmVy^cMz z*==fSR4vQ3lG+5BCUr*Lt0I^*SC+>Yl&f87rs*sFvxTdYIbW`l9v(dubv- zi7~4XNlu`XfobnPhkj-U^Y}%68XK@(!^Kcy!KiibeKix$x-5wYeI9WFBGcue(2H+l5zruMl;b)8%%k8J%cmE@ z&8|wg-sa7}rI-*`x+in)HJVOM^TYt+Rp(S-_4Dx zy(L5XO=s^x7YkYVL4|DU3?bP4&9~*TK@3LCqxeFU_y3ysBSj$A+Mo_WZ#7Y(aO&OD zPYIW-90A*6CId&A(9!H)KU>C$4Q5=}->!o`s+@aALHP)Yph5FGzB7e7Qc5V24_QKD zB0F|{G^(0N zNFswo>al&OwCB+)VhU5e&=+hPwp;<1bnFN78~sFq7RrUUpd8G4wFRJ+lJbM%QN^ zd>4{r9xd0*#WzZ!)6Z9`CGGNBhOn`9Mp;i5f5StOOihx4$_%#b5n6yJNU((S82SUMP^?bm*fIc4638Pk$-B=cp?PWy;VI zW2I2UqX&2<7SG{&1O6dyZ%!Z=6|*(x*B&0gUW7fL40&WSHdnQK?Cu67v=d?XA}|wU zJNh6hIO3B#Sj}as>daMR#g-~e+htc`$V!fmqCy#sszIG81*0zG3baa)a8g!P{!HUc zGB6&A3_iFfETj-OXgcLX?8Xnw!tx$PnZ(RIQ$_G>;5&cBS&UfHMjK} z<{nkB{+_{QWR3~$J1{1gTcIH|m5%hReBpxc z#sy%}wDq_3eOvk@ZO>WmV7C5oN)7NC?|$_nnWFP!?$Vrs0>DG{2MgTaQ1#MLB=O+} zY(fY=9gO80m^{P-Hjf?pWs6`_M$N&cG;@mNhG!g{`d5n|NC{8RA&-P6*J&R($>xC(gYyT-iJS(%w}f!r27_}W>ArSXHye3}6 zn~3mJz1U4H^Kf`jRq1)areVL+MzY)`0j$#dO+@~)C>-sLoI;tw8Hs)LLZnl{ zP?;zmH>~$C79)2(xiH_8$;X7vF-oc9R{tROmj%6UP*xzYUaAE)I{5x0FVF|6k((xn zi5WJRipdOHfJ!Bs?zn-Kuq9URj1X~)derJAFe_C&efF(3@{`M5E9t(WOa+)>il6DT zt7fXskm}_Vm3p5m0L&~Us@dZ%*B1kmzj}?qtV9h;W8S!Dli0WMK%(3xLCCQ{?@Wj? zPv8^dF!aB=@AoDZB~vQM*bY-FUU&HTziB&S%}33w#k4S;)B(AE@mDnu1^1bq^d)auK!MFUNU-+y!VJ0BTv~sCVc(_U_;)uV*{+lyHyT|J`mXs7AgO zu@oN`HH)Nz(27fk*UqP@$`G5|T*WRIBt(^nuH0Yo3JFc3i@+2PktY^QlE|6z?Ho2)@ZTrAI0F>f&u@(Uk{Ee2B2pxF23J?CjflljyPcl6w^ znvz_<%SOf#em4?t;t^H!;;mB7U}*5o30H&|LX!ROW(8njS?$@u10@hm0{Og!nq!XYfg zV@4V8t$pD-V5p9J#TFesR_R$9x{hk}1mDU*?C@eMw1~rjZ6$6{Io^LJZWSF4q##L* z@(Rj(-TrgRB-Ahks83}>3HL{Wcw#ya4;8@I`^~;k7P=XvIQ`Yf4-%5GA7-e&V)mY~ zG(xn0=J>@TP8pBVU>qP8XHjW_qCNY%+|k6K9{|A!gZ?Mg1RUk>H4`b}OfHJ>u!i8G z1hi>aIG%jZE*=&|KqMwZXgJPP0F!XCuv+iU7b@s3ioLF)QXFm}o=3x$Hgg)PV4wz> zO{cHCTW;isuE;Mw6jm_t0s1gUJC))gw< zivs70x@HS}Qg{_N|0;GJgl5ysvBZQ(=D;6)){413cTtKbq|z|uMvN#oS{Y_LFwfTQ zx%qf&_DPtbNGGV+6UhjwflLpd_7#~HNfd=V-0`9ZoC6hiSb zIcE++VVTk3o`{$J_^0vz)%TBR8{eVr`?Gtx{OY>;zW!wSe^p1<<>&vTZYbRU^gHSN zpQ80Yd*f~L)ZOJb^g0$ z|4(rdKJ@+HrThQa``>Fv|4E*q`U(C1S1_#eS7p5aSLJ_o|F3ZUck8oW==-nm{olM# z{{C;$*R;vUfA!XN|4)8up8ikL{C@*2w)@ZcsBwfQ&l8Pt?zXf@apfTRdm3+X!lpgK zW*=kk<+d1BgHd>51B-#M&iID&Q@q3pnB92*CKGq+0L=R$OqPi=OP!?+5DOXrm#-*W z%W=!YqHOWwHmEZ`JIeDflgf0JvB13rZ+lCJJmu3q#w4(_z^XW@XIP`j3Bp9JCcpQu7iUu$kCKw^UtpPRw+xl#V+U zP>iC)3EOv}K%FTnM#@T5FVqxO7D_@y)hcWQt_5yOEiwIwpno)`i}w4%{z6QRl$ba> z5Su*kDHNu}bPqUNjJIU|di%mfLQKqBQB0hQ{t(K1%p8cRBLp!4Zwd6S2I9PlKy2Hw zP@t>Nv;8Qf#kOc3gGwzrVvimSciveim*Tb>m{#Bw7q!0|l3^7&Rh2etMI%c|RkZOR z1j5t#c!;I_c}op}SfZUrGDw6k2M8!DYNEu$Jj1_3Sytld4egcUEn9k@WB$S#;^D02 z#~NVe5YH|E+zNq9pxeV05Hq?I52stlYXOY_z}_IxGn$f?Dd&GDY60B{{a7GwK?yU{ ztJtHl|5OWz+o!k{Lb8`)w~txqwi-4=>zv|0SqrKwM06kC66ztx0wqBW#m}EZp~}RO zxVWp#yl$k43w4TdJ1U)oEZue2r*_!=4`R022eQHuOh1I1^jh{VPC+$MJAvElz*as9 zcf`)S6z=@YF-RD6FVc%AN_hlt%TRiCNRQZYrs0+FY*N;)CeB*X4Lx{&HVmvsm3@OC zRlBQ|BL#R2Z{;%WaT2{SEcyk$9MNUkup($!*cizKSPVNKUe%70T2*W&gs@3R$+{t| zMcH~({U?L}9V~T)wEm1OjfNt)sb(Y7)S@%X&_Nc16r@^h4F4m8#ytBdn zh0TqIQTAowv%(B(dDtwc#flCqq&mkEKR25aA!j_D*%3X$Xkc;1GrelXzj?wCqgAJ* zlum`3lUP2=39 zTsR*)T5*+WXn&Fs539vnK5xoHs}mQR-~p-8+Fpk}t-fj?$ICOJj1DSqVI~qVe9^V` ziHgg)I7WJ&Nbg(v%*QFwNrF2PpWM)pFhKLU4Iw2lKL0@g#4|ASTw(#g9+Nv8s zp6{cxaaT$cg5y<#v)P8Vc~z9{1}iLkU$@Iv>;C$Cb1E-ivfp5v1!c=VzsM3ZCzDd) z$V2O-ICaz@gAKSQSm%DmOE<#gMnapGSm#ZaEcjOO+TEcXBW0o(52fiK z*>#|2R0fBQLSKGqwkJQIi!$~xbA{p4a5+L;i_dMLWR&51Kw>`LL1Y>4nPO9eJa2}m z3}b=B#coDi%s!tFwXs}kbPDb&jcyOoX!T$`$e9{ZM0sk*5M^I#tJBmDS83T7Wly?n zRJ69(_C;MTx?E*(?2oGYr*q#}XGPTIW$62fRpC8s5w})WMJPA)miSl*ddA*Zi zbcX|yCyI-{qr5z1c_fR&9$#w=Tey*IZypa%4Ohla1TP^P7?0u$p$#0v269DOHSpVz z2Et^$y-)-+;uU3oxqaE?S1+%*WYpQUs>S&WYcHR_WUQ#azapx#r~UjT%dNIb+q&}$ zn;MQN8=CPK9^ienU|tuncHFKkR)(uJ3^vB%?5cRz4gmevxERX2QgjPA#GQBxWcGIxU1ykh%#}Z2IyE0 znCwazWRHalTTfirLOx6%UVg2;v8p_$r7e1{3g2*AFw?o4KCyqoE`Z%`ILlV9VdRFI z5{KK0Zgz{cnXPiEeY$-gg1gI(zjUupLt$YF)kB;TZH)6sCSz;995J0E_^HH;QO@At zdjoEr`ho>)$GJWX7V_HRf@2L|V&I>JiOt^W);+nEwo4an@c33oMI)PF%2};);d#p> zm|?U5PyN9YbL=x`Y`LA07I!lQo6L1~Va*Fn60*cD%p!+$Esi19$TED=2Fpb_8B2bl zqPDoRUGW?0UT%RySOBG4;^AJhId=24^|q(+5Ln{Mr0L1p%P8G{;8;*D`iOP{Y;#qp z?v95z4u<$i4txrM2$-$tY4Ke(%)4P~&Z2>C zM&;i^35}qkk01&;{1+(O6~Cv^oQ6(wb>3dbd2OVnvop?;5sm9`y!q+;!Rma@dB{57 zdEDC1`K`6zyaoA`rvrTQ1rfq#EY^yLt@ieNq8z<1+8j|~Q+r>uJDb@qH?v=IS5?|0 z>RlaI5y!S7SlPd%wnZ|+d;UFvKM$AL!94=&ro}LqMKoS z)twp&9gY^|9`MjmXv0$6ap8043j@@%3<%cvBUE(4Mp;LT(mB-&Whc?8`Psu**sIYRBM(lMSO? zDf@E8qzKu)^k6}02^Rpgua#ND%kZfT5Yd6?T|IDXM`-U-ouDAeFxKKN5L&PXcp&k9 z@t7Z1J+InZWR%ZwLl{Og;9`%x6`vNy4Ez)cl({hK6Tr3@Qj=0niU1IkCmN^^DqCv- ztsewiOVvPM+7%E*M@m3x*lGct1;ET98t4&=0@7W9niD&<@LA2?o?OGY#-o8;R|Abk zWk)Sa9RcuA5GciJA0s89P3I0kh1G(JEi{Z|yrm=_u`ND@B)Tx99W>b>#5p+iW7pDF2m>`5)Pl+f#EKx4BW$j+LQQJ| zpc>YIl4^JdFu!X!N_5=NhsAb6?tA6gjmmv$v&;jYMm6v(fL`i9iQo`#*$4J(pUcpe z%FM@SOf8@n08sdp0wU?L9TUWPu6z~(+kUPlT>vbNYhig27`i{LNq-xr_>EJfz4&ZW z3+R3TycPs{Km%!heE_LzhO7iLu8nHE8$xxH`qqtcuOjW>g^K%*##8K~#oY@>$i@gvCJ{1-%jsR{ouZ5*Q zFid)0V}UphH%^pCqSN}o4T&pEx@E<&wQ`H~hplvte{8j0 z*(O}0wG8*At=?u4iGTXJX1GafEx~7t8t6ITJp;tP7lFL{JP}``lJWg^>x!L3{rXPp zFT42Vz1`NIcJoWw9_!jYl30goUH5EyE;cxJzz**NfFJ<(E|Fc!us(ieiFIgYFEJSadD^rxA;}aME{W6C)?kwZeB%nwE zX{pXYQQKM+pMM|8rp=%jJ3ot~Fkc@&V0-Ez8weTJGAWQB9158p_ArJU;=yZt%0Oxn z*gpnBf#@D9UgyDz~e}L4%JmOz!}i=JVa08}aqUW40A@1qb$Zyp~+F z3I}PK5eHv)4T>-U1Wpc3qpB-ue9RR?G6&mOx3xFI(SkON% z1kjDOfOdXn7|$NiK&jQsg7J!0IX<~K#FrG497xZ8ZW!yo(15pxmCIG8rl>|17vb}! z8ep7f?gBu|FE!BIa0S#z0U>%YI@JQ|2Y}y?XrSFr0MRJ4Sw8`wn`;4W_!eheeW!sM zTLBcRM-0VA=UPB_0pPt;8fd=*K$M`?6-Hj8OD&)Z092jPK&4oFK`25MN25ALfg#lB zS_4c<@bR;T(d(QBY;Rj6rxZvG2r!IxMz zEwzA#{AL&f|Ik1;g$W5#@EU9hz{FwJ_!Ks%9OLT%TJNwJ7A8?d&$FP$OH=Ky&9pl$ zm=cJm`9l4|GmqFWJ%Z^|B4!7&M@HD^%oSSJeqkw4B-G$hsw*nYV%(1Bq9xev7J#v7 z995|0<@oGf18gDG^(6pY5gO}PA!E4asK)a%m#rOknNy|c7WKaXG0#H&Y z&>Uul;0bklqj5bG7b*ohgqb0FQ7*5n{%6UydLn=!S}>$g3S>bcLRRZwNBil2{vcFxETqy@aVXi3ATuaakCO^kuh=o5^PaT;*t|= zbzXC$C0G=q;R2hy@-Vjz>%C* zl0_q`NDq6v)fkz)~^N_XX6(E@OL~d zEKTtyyPDqWUbzN9{c8bD0KmZ@P(p+P(tTwufKqA!{Q`icSlE)3F4_RZ4yK2ObpRR= z3Z(quW`Hzr2Y)D%ggO@b<74~&UD%cnpBFC?c0sBKE`=y{M}G|{2i8Ez@%k1Zn<5a- z4Te@<@3UXrC(uPI{!(o77u4vKZvfe#P-IH#bBL<5Zq`RufQ8QVHvlX(6ino%uLD43 zcL4U9n|A|h(8d3F#6Igg^04eX`|=<7g+xAv4ocVX{Hhc@?@?xBv$fuNng^JL_*oP<@UJJ`AU^ozp<=l%~ zo>f?Qj?vXvwgAhBT39CDYB3h$EgH?WsASjC7iikxCHN4(;z#$yk5DXrBMP6@q5bQ? zGOv%8#89gO(oxV>R89*euN2wxHtg?7yjqdxuGrW7V#ityGCh(tOq|MZTj^u`FP;-q zXBT4d;KYeS*WnCi3&zMAl;~aBfJWPapwoSUuya&0PEL2c{IH{;k@(dN#}kk6%gI@e z9gjL-@N53%m^YhWxT+y7;>+sjT{mhwkfeu_>cio&E$*u9|4sExT&UqOxNmC!A}Xwz zP+4{s<3-UAyRWzlr}J&}`E0x&++%2oasFU&VdN0&llG35*x^~cip0B92#D)vv@(8> zQbdYyMYLmL<`UmteBMUVc+vO{EW1zqM$UM7LXDzW-a_MN2gi??chcpqRN(&S?HWG< z2H*)|XK2t@Vb6)igtB0HU+H4wXr%0-tw;0x27R5Fm}SV0(iQNEhCUT71n| zZxAU_)ZOg8rk`#iafr8z$cusdsjF%Me+fCMLQyI~bpX14iu4<{+KZ4J3p`lZ)*n!_ zS4ewimdA;o>}})5K^>$dd@wL8j~i@_DtFxt%oTwU?4kbl7%(JgkH}AIpD%74ta^~~ z)(!NC)}Tk63#lAIf0d&Hdz(%C<8D7HN4Z$nfoCx(;m`-*lt-Q zou>{s&I8CD3MBTc)8VNoz!PoaLPY_=-IJDf?5B*i6s%!?!y@%ak!WiRj=%EsD8scI zoa~;dxRK*~Xz#oTguS&jL;Z_eesDX9w82xdnQr-$A(F}h^c5XbaHvL15wplecfcsi zdB|aZDBAT4C>6}o)KpNX`{O0l3~~N2KC|$K-sB6t1#7B*89(%i!g_H_Y`cRMZER%|KM9hrf09`JE`u-t zz3G%O1TnMe+`Y%Hr-Ogl)h^)9?$EBL2B7D_d;HUYNW{qQ?Sfi-oqH*4&MI2ku2o@= zt>%~gtHTby$}f+v3EQ;>tNw|z z#Ec#dPR9-u*MwR?zX4$CDh>26ozH8jC|LlMR}1KI06euu1GSF;CC;LCz+nYYel4KI zYb{3KbsDHjN)YxK9O`WV6C)&OSNE?J*X1`Y#;o@>;By!iLZQL{<*h-Cj^#zvU;lxI z>0t*@r~sV+^3?*GxY=S1`%nYDVO2o!N*3V&Dy#*R4}gYSG|)n(^GHe0rXv6}u@=xa z09^T416{9y^vn$@Orxk4(0ALg@o&2V;)t>G)@cjrcEkZ6>TnN`r_y5-&r!hSuZ1ZY zSYFqd>>q@S$p^u-_pbx6Kn*bI{r3VWX@_P3{kGxTKdr2vDK&~~ z;A7mn7np9`rLn;;jkRQ!Iy5$X0!!!`WIbRJzv+S^VIZn^_XUo@KcIKNgx=lY@!2S* zi}>Lg=gZGJ(RF`*)_LN2XFVhF(h}#~rA~D38OxmCEaR6mFF2oB&N}ZbckW&3v{@1> zUUvTWGK;={#aX$UUpB6Be!GTWo>}W$u+E8;`WtULkG#*y<(r)wH?wH^ht9QI`DM*^ z=dSJi^3)FJM?3h%Ks>kNmy=*Qwmg`IIkDXN!AjC)Q$p@ntaZ*>C!oS>+&{U|x&3YY z5*zDF7j!3s@6ZL7`jF0~S~4C7x%iKT%6L`QY=)6IBS`#kw$c;_7P^*Jz%scOmf65? z=|_dd-X#n`G;*!p)&MH41r&bVVx;^WLVD}lKCvp}kw40))l2&!={CSJr52Xsz;Nqn zg~j<1Nwd|QP7~;Q0R5vD&`1Czo!9(sulCluU$h0-y`f;ST&KtaNb8F*q~_&ra>dt| zKRU~gOHH-swUqu3O!je38IN1!;|3tSFBGA6|3GKItT~CW0F3PGK&Cyw?ymvHNpCCw z`c!J5FC7XKo(`fEU;`}_$lfdG|^uNH@|f0h&~o(*5TD%|Es zT)!%O?W=-j*pjJNPz9o!FZM38{zK1)pLrqNX-izRJbd0NA-FnN5EmVvSS9U^!|8b95=L&%wb5IJQgL^QfzL ziY5VUdZ+}&R>{u+;A*CUjuVJ|SsPU{fF7;|6y3sVJc_q8PspqH)+0M9FQ2!@nKRsg z8#)B{1GX8pu-$*1)mVym5Zlp;#s`T_nnlneh%MAZ_XoB|YGJe7U^VW>TS}o+OF{SP z6adYv1vC)=867mxmtwyx8E*(K=m`e^YE~#zK9jA}r~vhlT0;{T%KF-HEmF+E`l#n6 z#WaiAf+aXmu+=PBA2J9T?pC)^yEy0x4q!yqo(oapH4u_LV2a01`4ZE90Nt0rS_Ul%0MySAt3~I$`XG&07*Gt%kg?S#V*uwszR@%vV?#o=Drng5Aw*m)wn_kg$@`h9!1haL&JGQN+0?;oqw_B-|6Ow-i%sw5w5| zHanD>8ey&jrRPU#E0bxH=jj?K&JG~ju#ST61kjvXK=Grj zM#5bhC<23^gwjJS56GGu3Ke0Y>GRiHl<9x)=cXUbIue+gTE53 z(x6p35hlo;+7Bs16lsWHihzFJ{+q=TJv@UwhCQhh4*ha9$C+x6<1H{DU8rqbCkgHb zo4d4GibqBooa`kK5RLS|l`u+clge9-eG@Jl_f#~gj4<})U3OTP^=MLg!q^v8wJf?x z<#}T-3^MQ1MSFQvlgbMQo|bfkC0w?Ii#kmzTN??Nt&!#F;sM@a{ZjXm*J-E75d$?`5$!^U4P->l{t9@0?$HPMhupZ;B#%7n&CWqk(r}w`} zKdLtkDqm*UFKR{8OzF({^9#F`qW|j=c212EmaUgg0DB9>2zw81%@1w8astP|+@K7G zYnYS;=RI?`M0~iVMn_KyE0+jqx9sQRfp9@6Lg9~B3s4Jd zK*<^FZ-7b5(Qu!M=QKh`s|>)E*MQ@Se;yzn%+*k<>_}!Z!J#vWnE+Z83bc&3@rQq3R4a+ zb<=D`)V&&64YuftE&@@nyuV;87s$G6WWo;(V9s*hiw9Raz*QTvg-_nQ^h-N2_iG~> zjeCd`224KuFZ#STAjCT3dbY^nd>6S+{3@Y4BypgXz~ND3J4GG^aYTEZrM%t?(`^pZ z4Q^%qXrP2WTno%(eOebK{ zHe>%RD+hIpb(YPFJ9hglhmC`LSnIHGxGZPnzHYYgI(r&L>~2P(UJ0ceGkIH}<%jp+}cy#eBNNMk%MCG4A=qo1b zZr9SPPW{k*JP%+`gmyczGv-48+>KM%EzRZb98@xne;={xM;U9NCDprMPW%w@*pEVo zdgJ4}`VbR6h+_rHcruiTSWzwpfrXPbXCK+Y8I`CVf)7AXg#ulDFvAC-4k5VQIH202 zYh$D#(HO_`)Kz?U9S7BM59q#9Yn#ACQ0^RJa3y!$DNa+-@HHH~cs^N#l2umgU)#Xs zvvy;v)gf$PT!-Ha=nTk?FoEFnzjI97MmI!Ko+_r;9UW!(A|1M3|0+b$z8czQ+ z8az!)^iHSBR?|Hq-$BN}LxPNwU; zI2HtrXG4M10JaDqFX2pPOD}kV{PrNh*V3mVe|$O;X1xEI$k!M1OU3h%zb%c#rj)hI zBAsVKfRq|Pr&}30DNIn-zQiZbN^R33BMVixzPB<5W>E=xV*z+~Om_>aL z08O9NK!>=HPoV3;00sFE04=En)ENMe1%X=H07QG%Q`vg~v@{e*ET5APHNdrxF>#>= zxS%}`q{H2mc|xpBj34jC&ICXpI2ql2Q)4bxjc0Ts4$GCl(w0LcR{p_@*15D!H*B|D z8iq$_?Hh1Uh_JSo8q>pJSbI8fEJ4lVp=umU;6TKt98a7IR_;T)mW8%U34Zr7t1)|x zmf;0FI7t!4f&q$fDxhAd0mbE(w^0Az>oiQ=2mn!p?G(_109sxPDEu|6@&4-?sDVEJ zKwJGZ0KFIrq-^msfULnOC^gsNe?1;qbppSr9n5~&ua~>V$%me#Jp`05g`!kV?v7o! z&%UWS`M{{i(LzcJfClC@di{mp=xYo6HeXu6CEec z5#~9}u6%sY(AfYg#O}E28T4Qzmf||P8(m?KY7?=op80JBLl&`rEsMYLHNb0sBu0f| zOj0t6o{z?EQ&F^Z`c~`X_~h}l@*+|;K_F!hEd1qsBfaGVW~41alU*7*k8CV%NNc`>KtWT zR!)^zd+bSJDTpd1{&654W+pqdT< z)$%VxTOM?7gYc7K-{WYmqu+-6X;bKpBw|cAcx)8fJ*m>RynDAQi+vvsjsaH3T7{)M*~4cN}VaC5`Z!hSM%;Cl{msI7AVf3AMNj2rY>{udKfkid9=-u>yQ*olYrZjM{nE{P0?k?-+N`VnOhjXo;NpzN>SM6jx2OE@q4@F2 z;5g*R>Tx3KYHd=HFW*poa!zx7a!%d-6-Hb$%g(%W;@q5A!@(@uUuka82WZ}AH1GPW z>@yk%XDQZ=*9~h|r7@kaehy80HMD8ZQDY}TNNMc)(57|f%rXXr&JXHX;A~d^yUPZe z#kjj%H%&>pY3x0B-F?&DojTu?Fdlkj$949oOP_k8SEGtQUjDuxAn{XOMFsHzU%Wyk z9(;|*1dKm3BJjm~yz#k#g8Uxw{z7*q4t~e)jN|t!IzidD+bu(ePb8VY;oaXC@AU=Z zi~a6+@f)o-0nk?zk6$hjN6yFdH#Rh8f4s{d!nY@@cf8SHT4!L<=i;=+*&K~5m{3`* z`{HiGS#UP{9-RJ`dl{#}g`s;ERU%J?Q%@X`;$X%)OPdoVur zzaN`pqvIM^6Bc-8n6 z?>v&tEd+dpF^)k8w z+TU7vu}*nCs(5E3+m5_*XX`EOZbX;QimOXJ4VI0Gs(LxC?A)v8)|_or=i^laPn}+S z?$p^vD|+qP9d*8E)v2>Fd*hmI&HMR$lRa^Dx8(hFDYjYV&&@8L#E^KYy#B-XrtP;x zUF!Xlqgm8XxBh(c+I6QE_A{<4?KF&K;)%xQ`5nFT5oIdsQ z^@(TWcjTWtYri3?5)Uo4uk}!o9yXIdb{K2+z}_xeg+&IJ=Q=u%cy5G@_;SG3qAk|8 z^`hrQl(m8f9un3({zINTV{O86*dB+|Yn1IRfsw5ZwY^$d?+5;=qigZ3# zj#H&-7)<%1Ke+<~+S4cL-~GVSUmK9zYw+K(Ap69|L3=s*=k~G_!nHO#R~cv9m3O|% zzN~AVeK4G`NteTyUr&RH*hwSV!LN0CpS9JCI(uv7x#+0NcQ)L&u$|GUd_i1Y0>&(J z!A|ZfJOAqWHRqbt*|uuL=`(B3pFY=QMbhrQQ5Skvoj!LB?Bk=nlNaNfUHG|K<*8-Y z#I^kBVS6)a9=7KBCx5!w0tVxVZ~sx$#oi}vEu&7}dg|xa>rO8mVq7l`W>=%IosFE^ zyPXNYVMkn@ZF#4w+HY$V@p0~1Sj>%y=i2VfKYz}CQ|&B(ww3(74x`g&uoaK3wyoSu zL%_??G0|}Jx3>-Ne8lM7D6v6V+4fL-(YB(8x23R^b)mL$FNe1!K&0H%icnJt9@WN? zduq|ETNoDve-RHOHx`&ep3e}T>VXL7b94n=@2@AeW2oJjM)^YfyNxHAKoBz08x_k2 zLlXnaF1~tk%>`?n9jk6Vdv5K;vlpx@I_}*cb*X37*$cLPaS_||&RljZi+kAOZ2xi8 z<=&^P;rwfhj5_tdIQtIpsERJ^ySsO@sgPbNO9&((o6w|$8cI-5dQl`mZjw#1vMHue z6#aq)QG}0lE7DbLh#ecE*k~q-f{KC)DhkpHC0nX-E~i{JnJ|MFb2d+&YEoH;Xd z=FFLyGeg@h1#UkJGp@t`vIhQv7-J7Xluhl_JlSzHdrKel6cq>3?o>MDd8zkJ5Zg<7 zu`!Ev1wcY<`}AUS1^%L5{kvB_ev1~H{Cf*Q%FL$6ktoZ5xG6OXFSlzhE+va5g5{=S zs*?9%F+u1CRb}H)-tSQmN`t8>jDpU!np(_FVJ3982FqtLn7(OI{al@GK*l9wle6uT zImk;{iHs`KNMc{(dhsgOuaug))9AZSafQXA;iw$!Z-&%f)=RCDb&3yxaUr%-da=1@ zqHoZTN6BDK_{OY!j3CqMs&J}XA71Kwj(SWs1jS#oRg1y>kl_8*U;KxB&Aj(2S8{0# z`U`Fp;$i`RtJ`IT#-S{3<(+s#aOD@7jUU{4MOeqO4E(?#hVCJ%%@u3|HYhwEDS{p2 zcMN_v$C#U<)cuH3+G5-vW!i@?7u0<*Moe&>bF{UnJ_uGy)58B^hdhWl-gU?zHMB3c zP5q7<8XK{WbJ(4zk3s>oad|PHpS00^tyO5{t|}|TazBZj?-qku)euQyTfXzFH%M&r z>10OyrF*A;J$8{KW?zg`>hj9jy?6Y+I!47-L>_0f^6Nro8?y1+Jv**;YQaJf*Kn8y zzXz1amMgJHbYB#d^M&*H=_kJ%Hw8c>{Vy0XqfW1N60gM=_c$+{KZhOmEmt~w-t(n< zbP$#x=g$b30ykE&FKUNPR(iwA-ca{OnfCNQr*_yAWBk-{;k+q0QDv{0LpNmxHjA%d zz$d&Z;L@VD$Su9Sz~<0B0c``$MM)Ad$X?s*xaRskN~aZx<|y@% zi#&7o#S3T7cYfOP*@BC$UACX84^^yDrf2%_SGwVq9{iPVPh&2$B}Vx;O8v|(%R)AjDgM>@17Lb!BjP}?hPY2|TK4^BFfa)81sv_SLRFm?e#UyZTSXs;0`$-%YPAfY+aI_lX5nq$y?m7BfI(mdTV}0O&0*kQ0CnSdhx|b<83_vRJkO^tKo1 zeE>pmh%^UP0Yd_oKFb$@dB+Qri1*_lrn?JMFv1fjK7XA^lE-Ve0ilt;^2Ft>v#Ij7T}H^o_5z;q<~aORxa^@A^|)$dM} ze@SXpyof_J{g~q_|a%N9UHySD48zZc?f=xZ3djIZ$QLjs87d-Tp?S&*?{6?i$xXc zl$egAziejK#P+}Pif^#hQH=5`QiAkZ3pVq?rWzq4cGhRpZ9{lNF1>t+h9&!&XX)3W(kS;9(;)zCzR{FxKx zm=UF{LheGX3CWkbvvdgAS(oCHe7k*gtUsniZpz00ke<$!We(m3D}XfyDd{(n&9PF_ zsFRQE9^-2UPLlb*Nqdclv}?fHR+>uck(^R=tmz zoTKrsNNs>VwJh@A^#UCOU;J1)ilwCDPF|XivXfGS6JJklHNwW{bx%W z9e#>?If_Q6C0(M$=yse_i{Z8v$}O3vT~9P${Z{KmH0O`Oaj*DGHkxiyBsIpQ6yV}b z6jtGgE4Ce^hd|Kf^;1Vhi87DC6Pm)HrEc#Ft5157$63t5l;YNd2Ogmm%SA5Kxe;oQ zAOsdygQC=fkqF2A6A#DTey-7>6B+E`f@lz-0-;ZgsX4~@8LZt_WoVm;=CnO4x30Yg z5Aji!3r2BFF zwbo!Ph%+XdVodwHn?v{ZKkpNcu>wq3OXQvcSj5rkEtXh3?B8PPv_Hm_-r|e7oBa{6 z&i-TFH`|(oF98?QTMXTBm&jT{mIfRB&zl1G!lX8JPj4~xz{410dW&Boqhv}3IscSR zp#->w_=qtPYp7{>z@7&5=1&K>pY~-$kdMIr=`Dc+hqU=`9_GM_x&x z40jy4eu) z@C)`oXG&(ngX_~40N)7|S@NJ5(mHL|u?ya>=Q37_F zeY2OD{nsf7ie6=mTvuiG&t67@RZC>H!5Fy{^@>WJuhW*b?QPu66iO3KqmaJJy3Q8B z2O=Di5@bj=u7n>0;fPS>xmlJRgvKQf_O*VIfd zT?pNP#>!S=~0~`?>mf1yRI-*V_ZShI;{O&?f_`KmC796=Ap% zP*oKuJE2f9J|QW8sLyfx#puuJbL^Vyqa61L8dshTuE=Vo54nv+?gqMZmm+i53AsDR za~IG$uC9 z-a`&Q(&vyJY%&4>(c|pCY7V_upS}zRGA4itTXquA>WiL>Pu==?EOnp*-3c7lC*U?} zy*khbM*Aq&AOXxKuoR>sZsK^>{TziAOe?UM6?{q%h85hWn$2^eTr6jOn3p1~M-)x@ zyJo5I{aUqiB=sk4mVa>!!Ub4g*AVhSFkZ%x0RPiO^~PATkkF4{X6S}XMgz`DYDSOJ z=JOg(Pzp2B!CYHh+LI=IeBJl^MP3Oqk_XIxQ(}MB6d0$rZNyA=dYh>Ohz7%6Rzqnz ziA@iwk+CX4eHh8^kyrc}Gf?lpi z04PIzmy8i!w;Ufp)DwVVy(GwB1c)3aR08BUp!vVOdeCfUj$#vl zR1U+Vvq`Mn_$?%Jlv&1JZTAc|KHr43wn90OMbq!^xg&#srImr#I!kgi=cp;;@tft^ zHL*lCWuH2EEMR?Sb*4zMu^Vi;JW3o)vQOj{n?ctNR5SZuJX310iTW*E?dvshK>A=_ zW8e*39~9?13b6i}?(4TeV0pDVo~O;vTBL+!75f4_j1=|PwXT|Pt7y=uMp81WJ=%jJ ztz-_sjL;HXEYq1-0>-IA{IG@(f+~ws4>0y?@Qprds>w6*3n?QU5_BgfE}*<>)M}p^ z^`{zkr?#%1Z2jdwPCZKPyRyRJG)I@^`>B`BZe!gY9O5c%yd;OF$+aBp$J6c~YEnML z#d(D=Tmv@F?w4S9ln?@mwAnx55%TitXn;{1PX{gR?hS6B-rzdCCc2x)^)9i9a7f@?HgvuFd3V=8)>=#2WE7{BAJUV7EG^rA21^Ap(N~6-hoT@BcgPf zciOcCD8uAmg|IoUtfIZ6WWGY;zYCQ@okm1N$Z*48WI}fKq*^Y~W;V_F751 zuG-kHEAZ&!gFPhs!z^++Hu{9m?(_9eKA?nOx)K2LLoWJZ_e(eY^$$`aFELl~kc$D> zk1`MU0z(2Wrnd%#0Tp>^J~qUt5$tO=zIKRWUytEyM;t@<*~(z72yYFE!&mJ1f-xJ~ zS)5gTjZq_vP;6df3`BhWMp#dfmi#th9!c<^w!8^Vgq0CQdlDXi%NmB{L&S~ zfm8N7A>~y1)fd0$odvBI;hes7rJwtEU;5qO{kuQ?rah+O{Q+`bq24g8p=c1KNR^du zHlx#Be4=3oN0KdE1sj;z!fe9E$m$xcOd~s(`$(`ljcKmWLB2^8kh`iQV9d29<-ze% z;b{o0#c?t+#&^K&*K0hsadQh0w@i?zWu`hFJ2?t$lA8P;paWi@WdPiGy#&ql5uk7Z zI!XfY0yzM9Qi9mLnt;)K6{U5IGUf$)50Ia6J}d7r9yiG|C?$tK0M+b;GE6inVAd$u5wu0Ld=nCxE{20P%e^yJo<#JyXC){f}Gy{;!lN=vA!c zr5(ZLrCP3CX-Ds8&^zcskJgd?14_qk(ouVU-WO*{5jx6e7B46+SyY_K*9r-0vUq<1 zwJ*J>JviH>?73NHX)`JX7X;};k~!iKC|`M@jssDYB~WJTt{P*#XPD-bfF1IJtpMaV zH>_W+gh>hh2H0UQn0c;A8IFsUu-Tf^KrpKLvb25&>}xOBEI?MdVY{j&EK=kR(Giqy zykMIF@tNmJt*kS_$Z1cG8WPEAz`pf@bp~Xz8+NX%%$uzA2&zZVPvF zOg6X@7VbS{;j*!DXM>#NCv##Lt`jJqiq9;HGwDm_2cs(3{n77bE+@;0heViGG$sdi2=Du+Us^}^%j`uZ z3+)6zUulS;xt-;oXHKWN9R|S?x=d%$_~Kbp%Bb`S`pECrSZ3ei%%ciBp5nfGffVun z*gwmu&X67Ma?KJ7R9AmLERI@}I4B87_Z!p(eC`Zq;{(hS*~?ICiQac{oi0<2=FE?w zW%gKA&$-C&H*+YNRyZa|tH>>6b|s}VZ|*mxG&7+_c8>2xUZ!XaU#j&zG{uC&Goup|sK^ zwrI|m)KBpHql)vexeLZtmO5!! zDuovSbCmY3ke6+gc0LXy9iO*&eDP#w9^K!vwDJ=w*iw=TV+rpgt(vJ>kFjozu`-@X znOLD`r;DRUQwLhOB(IFEeI2bi;2LJQhE7AXcy~Ar%OdP$_BP?`+HI4;}wZjm~oZG zxwNp8H)oGQq8M@emYb9kT)e%%9izS&BW!o6lCGf1UnhqtG`tiu$M*xZq(aUdORw3E zpM$pj5(J}C@vY)C--{7j&4@SBRthx0cs)V3!-y9q?ywFDUfnxF@<7&UbO z48jU&eTwy_jEpf+V#Qr$h?I2K)GTjRlSYuLp)=SW@1fnWK%8cq6 zYN0a23p5gdYZ@fz6oKf77Foa@0GjCqnhC(Dha~8%Oi8lW5ujOKpt%6_enf&=2&6X& zg8{nH1H?sm6CfwnN?4l^A$9lhB4Z&y-sFL#Xq@U3CgtD@5_dTU@u+A8jV!THfM$Dv zS^>EHq68UY0U{B`iIlLyWnLtzvrL7wd&>Sz2?@Nf*`i=zo5s2h2 z+jj&&Sze&-0DSwd1O*X@L@3*FBtUaLKwN|$zh_d)n4JIxogM$IT2rj4x8gcHo7&Az*-VT4k7UhLH zRhk5j0bALEt&m%VTLo$spVdm2POWgL7!%F3SuN2AyWNe6mX)f>nCQFGtQr&jSNfQZ zi2*AuKE}krmA)2ZV$e!IUt?m2mHvLl#EvTi{EdmhD+4h%8nQAd(3lvyvO|zDF>GbW z4#vdrmBAg2i4iM9f{lrhD?>w!iBT)VLXC;hE5pN#i7_i9!i|ZsD=d& ziF$Hk=apTe#j2V*L$>AU!W4*{>L%@k4O#Xpt<(<26jHFV43|OmRq`Jq3k(g6_C}b{ zuh4EUtaHUbe$RrxwC>Uef6e4aV^68@`O2qG3g2n=4`kKs;jf{ZbJMRT?wPpPJeaDT*=nF!mZO#zXUoq5( zQHX3)ok0CJJ$2EmUIyhiTO?O^_}1`q31p{*=vvC}9x&>Ez5rmtMG49ShV+u`9j(Be z^1{r+`!BRg%vmgg418TSX3PvbPHP_tP)14)zfRtK3VwSXef)Ia#RbugoM;4+1=|at7ClHvb{imlW5B&fti@9=2H(A%BwN2dcnkXi zuJI94Hj*=tsLKkPf~Obt)PTg$9J*I=8y(hs|Spls5utJ7bijWh*jW; z>J8K-FVxLI9Cx7((omjimK0hafZDu3mjRgCStfO>5g=d8z{v9H3(%ilpfUi=T_osP zG5nWnPx}G$mlq}u@86y%F)@DRo}iQ@dogDJxSt@nCd;_s9yuvWe*s6 zgoXofBw2!HA}|p*XQiDp0H}YwP~Y`Zl{;(_rTK_O%Th581n7zvXdM6#rAknU1t6*y zR@4=;F9!hx70o_wkJUB+9#4~?bb|m%sngzigBQqvz>l5!NzgtYTK-H8T^g8JNT?V+ zP+Woyz-&RlNL~e#Ee$-ZgoF(N%;W*1Ro}x0sLF(N2|B9Y#LZ?|T0;R+y+AhuutI_? ze!+-`FfzZ0M7tZKTP8MjAA9YREimZ`FX%-`FQbgRhcnXfS9`_wHw=2 z0YlL4M8FoYVq0p0QJ~`QMWqxJt{E?rJ_1eXY21zmD!>ah5r_j5B&x*+Gtg8~WXCuL zpg=FsPXNrAC_(#Z+L}Oe%rh1s=4(T_@QO^iECFE3bO~BUasCJ-jp0myI(Vg2FavW@ zH%icKKME>Hoq|M-1FEAQB{X#kFtcxJ-v>VbLdX}}Fxr9Pv5r^qWe^iTC|B0;Ye6yC zgCZ>nD4wk<|H-C)tI-uuYUS%8RXandM>UY|h&LKb55H<|PRm+39t1=51ckb<2D$#4 z%-Ut6fXQL>^?-$Xz(`w71)wt)LvZd#ndrc9(jjtybpudgUZ~VORr#t!pvZT1amUf8 z+&;9ilP6B0sAC8X=XtKyBv1?YqILn4zAlwK*o^`t1vnX?2rtl|05q0K(2HgPk|A%W z02Jv3dJTYK6%uqS>`%_0L`?;X9jfH2Xe6Vmg;2ALBu=S*fW&jlJkrZ#b=K(pk zSi;_rFxgchcBB&H0VCa4v_w^QE|s7Ni?m^-B{2)AST9t~U8=J3K7k^8YSxFtj=JqB zHi%Pd_#~%P9kW3xPESeH^reWhdgy`nHT~Y&(5Grcsc!m-x-uI*8>c9FyBQQac~B(J zNgkG#9$QWH+=u0zdMLE^VNNZB*SxcaT2J<}K&-Q#n5gAfK&o+#6wp))VAOtPWuc`k zUGy*(5^PO_s+_{55B;_ExzL}VgVVw7hD&GmD^Zh*M+3F4dTQaMcmf(#$Dnh7xkwTx1lDUU1)V-4ykWzI3 z*Ikcehqa6YB5M;#)qPmY!yktp{5X_C5Cw{?cJo6#M;!FRSx3f ztWPzIAdobXL0vH-@F_j?AR(Wh0Xh8|c(?}gSG#)-4`p7Tz<=&H_ zPn_oRxeG5DCOojUN@!ShH*_{eE9CLGxxz;m4W*_ixVl<6Ujv;dMgr5)F&zm zXFHOd|DlwO-ArfS=)2TP;F3IWG>*9qh#fAJQyhIGySatHBzs}r{76*>eIiq8u?Ub1 zjJ61%US6Q_06ZZWStO^uudWu4DYeDS@LKkv*-|9ns8wpO1o9+TGRga6Np80Pe z=6y$exHpKs^j6rRx57yKNtbNHzfn+0I4p1L2PyztoxIiH?B{_h&51_tYpwj@99+fG*0*%fyB@IIa z%2WDzpm^7I7??+nNnEv=dMRR2Hu3v`>+gZ1e)Rp5s`ANi5@j~kc<$F*1JE^IppyVR zcuIn%N|4l>)c_6f0&N7K{ImpZLqb#oWqqjuW}p|Q2Jd(JLt^@>f;(BhwEzwB0`&)= z+65|<{w$eN9YBLUKwN&Yk!Iz4T)bM$HId(h)rG17c8=L^b)qeWM2< zWSug^3p5>o&!Q#hVF{A;VlzNPy+D!O%*xOn64Yi8-X+;BJ`Kew1fZxE8FAJwx)Ds^C1vfW5tsH5w_84oSlbi<6JtkH#Opss zSPU88{ur_S1U>rlM8umX>C4@xBhD_5j521dyf5;b`y-LH*83xmuct3}Z;0Hxg}x~M zTd$l%W_8DheEWUGrSA!^s2Ow^2UP|7+#LGDQdjD{zf|$da)cT=DQnNI);lk`}@rR>9yuZ0A+fC{sus6kf1hIfMn}I07hk;7wC2XHasLj z_Y#QMlltWofUfldy$(R=V-hq9u0K!yJ_YJJFH{l`uewk{CbAv%x!MENcn=iUfqQ{z zeO#uNEYF&dHGD5%6FgvK)dZ|HE7R6VP+zk+)k5~C`vAJ$3se9=_YD%%Srs6uHTDB^ zgBNHt0O}?Q(g;Knl-kegEeFo4ZFVHyvDz-?F!aZ;m1fD^;BJsn|Z!uH*k2ByZG{6k0SI zmkj4 zF?RfZ-&ZDcf6ApBJ(|nkQ3ogz)McJN#u;XZ`toefr22m zqwo_bWP4ExV^kIM$1Q9_D{8U2$H5f9#-dG;}!}4gf`m-yezpswA7%_yj+=FKcjjp4< zcK$c|{D0}4hu1`ZwT8YxhWPL%cv;1A3cXZM;bEZ%-@H;rBk^*qE90;tKLL|E;v8TO z4;Xc*4+1c-qXY#R1xObAd4O)wgV+!`6M*iRpwthMk312*cAel|HjA9CYnPN$RKoZbkaOzEvB}((Fr(wq zt8tN>GU8k`0?Ar~KtW287icg59lJ=-Dpi1FrT!bBVm(M`{S-hx>;~374vBc-?dbR4 z<;<@`&IKor`wF5`KV1gV557pM_{AxRR{!weA3;nF~W3d{gdnI0taJrj@^gu?L5_m5vh*MG^YLzO$< z2Z<9RDjT~IM9cL=MZQx&@E{^y@Pd0BD<#kh2`IftDu5LpKvJr|05UjT!VVh{P@BqI z=GzQVr59)_0Iv*}pd)4hl1;z|poMyn$aga!)(onudVkfX>E!r7w!H-c^axEg(!|DcL#uf$(BI zVIj;4kc}EIGx!FtM5Iw<4;2XD5)UA)aJdGM78k5io_;H{5d_d}UZ4)xYW(3unbr~C zcB@7^0Cc+^B!qbckgZc?C6Z&$=QqUc+rYEUG$OAJPa8m#Rt`#y+z~{VdJv_$P(RH_ z=`fQ7+ThZ(UpyIe{$qIE1AD-*JzU|nL2GP6p zM1`=P1;K_anE?k^-BfL5#}o_T-5x+{4_g75HebRXCoN3*ma01rpnJSPD**V>1)3;9 z-M}@euucHo>jiS=`Y5mB;`y2=RkLKTGeFC|Kzji2cSul(>{+B*?gG$#ULY#~-`pZW zO#~vHCX1yjKr1{zykq|ZkRDD6D}t9+C_^a>D}eWV0I3tm0OZah2|Hzi>ZMjARc|+d z9`FJ^48Z783A$fxr?2AyTImHU24K^z5_GRofRcsSy94x~7wB^U`Yw{7R9}FoR!H@d z0MIHg&=>&TUMxTean?dGYDBVM=mFSjFW4bK?q4F)+DD=wkW`#K0s5~V#6o6dfPJxt z+0ZQ;Kg6CP*B)jOr0LdCsFw%S+(~|Ijwo0fGo^d|q)@Qu| z>318fs{7FTu0w}XI*by;XU&zEFREgpva0Wjec>+pvh|+WkME%`&)pll=U)2q^L?=| zt)MS$D`THqMPC#nMT+4y`m99_>V_Ia(j^5&OLCKt<2_ZBN|${@J>q)F^^?rxw6 z3Pxj-2<@L}!YX~Sm=rM@EJx7*xQWYx^5Z)nlE#A+wY5Z~utqP__J`p0(986HLq%ZrYQ0@V1sI#KM1DPK5IlLzJh3Z(iD!0_ewlvZg%-XFHba)+` zNF}T9MfyVSxuRqZUg3}#2yq3@T58$Xx?(HRk%jNtnm`Bk&v5EhPNI75Tr@vYTOf zj)hi@KcjlM{DZ+$$>;AVF1DA^fdlx?0xr`0=knG2;Zwi_a`(P{hT?A}2}FumiJETQ z7}gzozWd{BH$;>9te_1iv?__yG5a&!h&VHwe8S*E4O7$G%rM)g8!1{0oj~B@-yCLP zZwEF9E^d>1>_yPNTirqX$`XT=uanSVP!r#IIqOMMjo6euy|ARxnK#y+i%A$RV^>>< zwz#8CQ)>>O0|v%IrOCBXT;u~F@-Orv7d`x=PxvVRT_?3`n@RXrWd}MKuv)z)5Y|S? zdLN~7gRnN(vSKRfhdzk?<%3w7M>kf{!UAe!^m*rl*sni`1ta**Y6yvXSL?RNNDbNZ z^Klvg4sPW3zU&MTheN3oDKm|`;R|2OctpP3b;Ng^<>?@j(75%b8PrzGoh21E3V_2- zqeA&(2jQ$o#;&IR2-_cQs2eu+4*i!}PMa2Oj&dsYU0<;fn;jk)5J1JAnv}JOdOlVu zS?IbX`o$~dC;Ce1QhErU(ZWOB35iC+ju?ZBWi->}f}ko#(JF|i58uLn_!L<2AH_?c zPk&^%IVP5Z>KG3cwwYQldIr_h)smgv5xO@46AmnmjD~E&Grdkm9+d<|#sNJMh(Sj7 zp%H7nzBJjA7{nV^4!ame_X-BEQi!ulolb*xcMwS%Nm_DhYlriNsE!140EUf z7teb;QsjPblqGu5AD#dvW&qVpvlfh$QgAV79iY_ZNiL9A0w1x4>;Vm@m$ioa|Dm!qbEESt!*^W$p2ojTC`1RRTE!DOt#Gb;A8w4^8 zY{+JhGOo|2Ot9W;=7*n>cFD10a#U=RrCJ?1D1lA7^X?;$z1y(j=UuG7Ved{Xsl=Xg zdUwYYRm`_oM0f1`-L&4p54h>hECsW6diT=>wOc7KeBS`xMfJb==20P}{x}a}bFJWS z+}9VvNqX3dTTxcB1k^d-IgNMyO!qZx-CPLT^8V_7I{!^P=Gom(D2?0t?_ny|URG98 zHbyJ0sKowNqJ?Mi8#6nw=7*>>_A+d5&bQM(RrYNEL(!LsH!fhfcXJoGaAhaXq*61N z&m08>v@2FIJVYk|jK!09T%_^IG$@|koJ#7bgqLw07E4NQ^Y85o)E<$nC z5HG90zR;V>ht6r4iC3^hQ>n3Neq$(!FXR3SB!1>Q9nhsqa-DX*UmJmkD8kR|__}(v zGQOcvT@tU}5w9+bH#{{ZWYdUVmQ#-c#g7-ts_fHe^dS0wOrKQxGj<^Re=z$oj{O+N ze)JzS7Ek&Q8iyx+$Bi48RoM?9{JDQ+}J?Yoynm+XZAfnc z@6)F*o{Swt1jePaC*#JBp&w(%(QBYQR-vl(sng2&F#a&>JsO zsi!5(&&r#NwcGW9W~;$uw!RogLVJGj_MueSE796V!AXvKLGV9)>7jAvl%rJaMdc3r z(uy)i9-iZ2G`bi>U#2?MVfg2vWbDuz*7USKbgx&ZYagYa!k$-P?~T87FTZy41!|k9 zI%Ope)MFIr*5HuGsX!g2h3J%)I!d)X{8xhiO3Eqq2Ra6Kr}E4#EGsFpXZ6m?OJTZV z_4=onel0E3iYrQrZb2^vmN%RygU3GZndknbs+8|QTPs%Vzx5x-`W_C13M&Mmxy;sekVQ!N)`we+R1_6ZR;hw@OyTGCR5Eavx=2is zp~>Xqvb^DwO{20pmWMpb!(u!Zee_{n9!##YGc1Mx2qz@?VqhE_qeCC$+RM>iQMFE# zs>#$-+KU&m!hB%BtU!|BteKhfGbhbr_x4}7{4`T8OwqyrO0|NzS^7i`**Yku|HeKE zP+R8B$=zXn(*Z=A;^a5{H2UB_lW%jFy08rk1&1`4LlcKY4endT+(W>OccCe26hBSQ=Cg!rz~z1)40=2A;I!(x=!1k$w^yVU zYUPU748ox}LX2A$!l6WMn{2AV`1^~jRy~AS;Y|p^DHLreh?M;sp>z=XRS<%4nC~W~ z3!hCqLB(pQjEeR+NPVLx$IF8AH3V;*6y&gJi5~IKO4RA*kp{z6jtdlTC>xeyuiAfH zHeP);JzzE-eNpKL+64_w8f5u1Sq#LJFGZS6qBE$8%%b;sGoRQ!8$a5Qt=OyE5ZkW< zcr^GTw%=UwUSl^?-kR(*K&ZL+&n($M%>{vW*zcP&8haBnWKXMQQ9^!-U_xpR_2};;e4$lQ0dx!6&ZrApU{+r4b_nlDld30~W z+Fr}4Ry)ckvm^*VVb|DvqO0K)wcK&Auu967(EUl*PQI4tvilPef)L-;bia@~B1#YF zg9xOMT!5O6P1XVCbR&XB`=lF9J^_|=qw3os-Dvg?@J%=R1mdfu1OD?3#(#dH0cxDF zZIe%b)jvGF%|9~0FWndrjVFPz_%EnaXu7dO7yQ@J8j@}dj>or<1pF7;6aR%J1^A~M z!+YVy2pfJ!rnMWgB1kDon?4ur#iqgs!T0*B94*y{zr)WHw{7Ep5n!2}FD`%MFO(Q< z>ceSlOjn?>D;-D%`0z-J!_@M|$Wf{Q5|q~X$KR3xNu(BPGhg1_n_%A`S|5jHIOKxGVu#Pb?|-!XT@dK=|8=$enrxzrj{GPaPg5hJ zLj>WhfxvKdtw-x0j;CMgTR$6=s>w#}ALQqe>qMR!#VQY(pA5j(%1+~p$swOnW z9sxKJifD|0zbSoFaJ#&sq|}B5E(@VFY~^-m zzAd++%xNnxbmUjqG-rja2(8{`UksgaHDe8dM!B(uFgBjGnnI6;^LVDNTFrk_t;PUE z9zstRUK+*=i#!(6 z*satpl6g28fBi^M_;|+DWp~iA_FMGQUDUC{jH81x1obst^c8)qy);ce*Zx9s$#{|5 zjF=zRJGRiC6@Qr?y5id^?(IP0;StAJ0`3%C{Rw#!aG>SnJW`OXW$E76W+1Ukx&M+N zl!p=^6C~T=)$)%iJ9+j}IHCSMJMy_^#Y;gb#;axrZCVKw)M2^K;g&0_uzGe$J~)Bb zk-r3T8~|d!6d+}f2nK8S7+%;zmFLlYhBx+MH){sgWPNA2u<- zg2Uk0i;+e{3}y!yg=*H5(JN+L+=k^Y&>B%i;U`90fs$4Zi~4T4KS<}GOSnFp2Ei;C z4u;0ZaEy1^5BLwqCE@3f_%Db4i>IIR7!r1DI{dSLL_{lB0Nx=ud#I~vL z07HQdDf_5_3Je;%u!IT>_wvV{)hOE~We%L(q&Z!ahX39WK3M?Up+v}&Xso`l^a!=Z zqDrjc!)%v&M79l5cBF`)qLe5h<>Dm#ph+Y8xMut!+h$Tk_5qhLcNf{#TWN}Ho5e!< zQW5N@bG+GcDy#(f44?`)6&6k!XMgz&pp2mn#i)EOq;HNkHp9bBwihu(e9&K3%P<|a zKA}Oq1J|mA26n4)O*L!x>}Z}|cu|Pl&?6f^#JIyf56k*kK7joBR(QoQ>}6c46Zu*f z(t#nsk&d7Ov z+M*dH)9hMaNwE_R91R=p)40L*X#Ml)g*a`jWRZN0+@R`ki#nd2#4v5!Ya2+dvGMIh zt&D;`((uZEcfVmIQGVa9mBS5;M?ynV@vYJBds|VS#>FHGmxY*tl6}sDc>Niw=lJll ztLaj$eGI^ccLb;!%Tn}x-YUHMY&%G%b_lQEvs0FwSW_cYSq;c@dPsXehNiEE?w0Qg zkTty0pxm{{ASz*|pP(NOx>N;!!CxNhnsT9U6L`Qzx)1#D_$+FjWtGJ`@wjVgM?9Q{hFvO>PmmCKJj9DH0u`p`v_5>LabP39 zR46@~JLB@={n5|3^Q~x)mg8^|_cQwO3F!^BMzht}*-@&(_iueo#31Md*l3Y(cW_|m;|zswFMfm*3?7gv^ARs~vu zf_X+T&6cgLLqM>#5D8>IgB|5O<(AOkoO=>La!yIkEtuT3PNc34 zp+YCK6AbKSaQ9$Z3R5yAWpi2lY|F$TwXeZ@v_ZPZXT9?Qrh5uCOe2A73<@<6*A4h< zwHr)EWjij;qt}2v6pMxy1(|`@@BcSQZ$Q2m5Vc3VnjEjD#;bkf)dBHpdb~P3UL6&$j*nL-#;a4~ z)y#M*mRW~SHj=r~FKtj--+^GD$w2DnC~i?J>4S@2d*tzTZ21^w;L0f&D|+Nnp^fBn z`*QA^My80+S2U`t0vpw3K8@;omPYj$zCVZS4O|BUsSgiaqjtvi;2PEJvqp`Y^t{QpTAk@vtwsb@<0z$S%r{i4-Eh5!`vXGoLZ)Ah+BdjHorvo&&b+XP)Zj?? z8q02ce+2_Z_16xyY6~ty$67T8*JX1pPSL1U-^Tvg-9+JFNS%5%q>c(a=k}%hI{D@!-)*H%zNA<_lyjyatqusSQ@iyAL@{Us8@u-;9#TB9~hE*{i8KJFyF#bzL& ztUxaN!U5Dr>>($lup!~O_{B{JV%w0E}HgOEmdhpDb87SI|p!x!Wb}_Ze%@RHB z8$kQAq`jmErwy|~Fshd|nM2xOg!0;ea9NyOyB={Oi2WmonXUaE5<(y=gfmK|3MUa4 z0=4Ee`$ElG3C)e~+UN|U@?Tt6r9BC>uSiDMC%72(C^np>$*mE3F)fde%Qc@-I4Kd= zRq0L!T{a@ZAJWF58$LKreQ5=zhw^apg*%}dR*v3TkZ%H{{exsSkNKCRrXVT9|EJ;e z%$r($E+fX zc>daKP&~UqP^}dq%q7h#(0pCctZh#dE2P{ssS2TTvt>bAz(%98aFgUTggDh}rDdS{ zhNNnFIKXnyk2>gu4W2=IiEIy4*?niI27k@d3K*K&4`vY)BW- z=jeI=E9d=nPSQrNk>U!Zx8f0=7O7K<+nn3e!E+UV>T;lJ9!(!S%YF{i3?0p2Bn&pBSJq zESvpuPa9C9`{Bu|_h`Ihcajd{&&b$-D~11{_T4D;E^~Tf0Yzy!H^Vg}LLV3q$$;xe z43}wJge;Ra;Bcqp5Z2qQce_oYXF38n1v-(*qy71%ZzpEsO<^4b(js8u(oj12HtG>` zaLp*RTjOcwIo`@whgr+nLRo8$-Ktsh#rXu*ibAczT4u-6wc>Kz$GOX?Xj5zk*h(FU z-RdZ|x+aIMY@*9S!lq1lNkKlnQ7Yn^zUXMXWTImpxs2Sae#w%c&!_9n%7o2kp`N9rsl}j` zY8B;alt)D_0tvPp&5=ko7}bMs50DE$>LK#?gviyR?o707{eBnF6TY}3I?-aOkH?a3 zB__aUAV5oD=$|?`3#J?99De9 z{|IjVpy$=hj-z=Mw}lw}lCnt@{J=%`YNM%vY~3AqS$Akp0gajQi+h>5lA(XVk5ju7-VaKIh}q zb8+Ug4xHNTgU4nZF1n&QrrSQ}1*|>_P@lQG>cR^bww?D6{N%aCXU@KO;mmperycv7 z0$K*PojD)y8UCtg&IcX9Nz0vMOdl`!qqXD4@Oz9QJw6WnD4=!tAE!g({%8&OBcL^| z?T@%ir#E%z-)ai~u;5hd#mEL6D*fStQx~H*`2<{S2)Rd%?eSsY?tqKKPyHSjaBAou zr#o*yQ(vKUy~@0|uxXUvUob0YUX`UJTLBxS^H#t-9I_Q8SdJE0nW$(!9IYTYBSbM6 zdv>Jndo7);kRu9|D2bopN z<5uyx2sXz-hb8fsNq4x&bk>uJ(m#pB4~!TkiaHJ#iu(}t);phigya z7L{^)kuyz39Vs6lPzj}>3tNaqqmpwr5Tx!GJGc>PbO96{p3c9%0suCU9I`M*}sv+@=$b)SKC_psfv={{fS$-R`ktvx|`l$;Ek zQndfGm7V(F&3Q?D;l@(Fz+ctnyy2 zP8}8}Eq&F^3yOvNmZ?FO%s|U3KSN+`Hc+U;6WD$?`Yu0)n`i)&fS*K|>gl!2Z8|#e z4>E8T*zKjMnv+)0vSxAD*KZD>g3@xRL(Z)jgBAv#m6ilISbQ~Hc-3&}Rl}jj#wHEN z`fa5Sny+ui<|ji^qieAvrNu@zm+#6Z`8bMmot4C>$t5&yH zLYoB2pSY-}x2L`b)IXKgo0>kKX%BB?qkOWST|OYDEW{QM?MINj9^3p_ppkqs$jL6) zb2RXUV}TS5?O5P@KhPHiOVn#z3rqe!8o2%#B81>J%Ex_w)enI${UGjhF~G4*^KN=U z>;Gt#!(RuRrkZ(gXJ$#ppe4 zlo<_Y^x60bh}M{4#sy2xN(wMVTaNeKl^>fwwB`(x^2I2@-x`cj^%Jg#!QBB@p-#Ew z&!%hcBPE&3Pr}4BNd+AfXu~0Q1qJL|d8ys$WGC#=ywAMHYtF{weYV^U2NQuYaJZzD zR_c{HH3t)YDxaO^Y+(`83hmL+Cgt5Rf+s%A)z5f+4X!?uT-|S&9CELLdQ8j`Dr_n{ zztZU}hgz@~+t@-{n^sv-l3$WrSf0Dzs1-W&+wbCi=P^01bX|E0Y<#U&V7Ixudt+X@|d*jr-5DT8)Q zUKL@P2rZn%=F?X>Txh}`D3g^qFu9YGEqHl=W&Wy?RMJ;~=5Iy=k#4`;Yb^8lYIjF;Y zBAS*bYelHzm1Vi$NGo2bA*I|hM`;DMEB*z?Y@m6P_TqWZMfPxUVTrcE%A$gmO$8cA zAyTyER8~|#RFp-hqnyNNcjjS!8Rbxh+%j$L)N(-GX~$+XWS#T@>1|G0DDaZX3exLR zflGz%((}+FI9n8o%b__-3P7Z|lKn?o1fnT|K%wrq!nUC^pzR7+ZwyVa2%SX{v>^&3 z$61oQ;MPji51S(&BC*@B{|+>Z;D+NKpdP?aGpM;X@qpO^6n$bQ8k!ftqqZ?XiJ8Q{x`%b{ffial`y74BN4Wue&ajD; zapT$n77YIysTca-{5PG?in%yWAhm;%M=V26d-hy2MoBERp{}bPI2+e7$EOX*rLn+x@eejLuPv|cTx?ov{NjV&l&em(-e>%S0Y^Br4%~m>G9E(42 zR=C-^9Y=qgt#p#NIya_Xb>OOu!5y5*&Im9h12P6t57s{tu}S9S@c4oRj0E#{8dRMLh{ z*Rx%k+^0x$Vh>Guh7Cr=(t~RCva!Z{Zwz}MgVeVpsv$Ss{8*;;CJulcgk$+w)uIWV zNBZ8Lh{~i?7U#fB8H)`QMB85OnsFdom{y|3qJkdwU=a_{?|F_#4c0X|#38XyWEm^f zHP!!mA1wT^VSg(v`j~?V3~4D@sq+)E=FY`$nxQcM8u2XYr1|r)VhO*`EqK3)|IS6< zyvDn>Agx-FW12pe^C9HMp_V`7xxIJO0NqZzGGHQmj4$QX*n3!@*@lY=skYsY!-MG_v*iCNbMV$8uGv8 zj>XSV{^zBpvelWlY+HL9^Tc)3Y7{XzHrA)#K^>w+t}~b59A*OA?%oziPI@E zuOZPTcZq~Ek+8nf--P#>%Mmcc|Bz%IrMLQy`Hxb1S>@O*%`!*yci~8x-ZlS1e?I7c zCo@KyjZgS>IZRC)HbQYZo902n7;ZhEvHErzQ1T9smQvw9D(0UR5%E+p-S4yI`V7_01hf_eYU#t#{{z z;4rM~!W{IJ+?s|%FOcTpy_158X(|{lA>Die=6)BYQU8TkwRdsCiSZ|}=n>I%*N0&b ze#8XgI~s5CR?vuUSkKx6VC^TVF<4499xIwyI&y(j9MVYsnMC0}ap2iKVfXB%RKD07 z_V_-YT!u`I><4{n4{P0ldfqS+s+s@F0n z^>^Ry?L@_)m6ozi@YRIAE%vTuq?vQ!a$+}DcT5~iwd~SBbfNXqW11E%*DW@1>}_Q`ApV>ePKHYEz1OFhxC_q8>?6 zkEN)`Q`BEm)Ke)sC3lrM4E1b^u7h7?)?UP6Hs8wwZMf@E-_zEkX8i0?)38i^rmto? zqbdowSe07Su6u3(=oc5L{i?5P)w8|$RLGH}F)CcSx|Zp(x=3pi zA_Kq540zcWs-rtq=Dds5agp1KZ^^48|B5v!gp>6r}+(xi*;voRXq{DegiK_ z!9?G9Frm-gS}^guWWsA!fYjQbFB~6DFJRO0M3f?_HFrPZs*PRohHFlm3RLIQr*fjn zEd4aEpr$QBR?bJXFP3vpg}?PQKkuiCOK*vdsbu{SaXnZ+C0M_TN>)4D(ASN!Va$R} z-Krr{eI-JTh@e_o(>yVmYUTX-@Mq)}&c|L~#ogv*6{4y+tJ0p9z?ZHo+U;>>1?v&G zDEV+g&(9X{b6ScLg8MR}p_UZ7#IqDO(b|ZMlpfzP`HC$YKg3!W8?DA-Hi;b@zNh3| z+P*h!Lg2j5oYIIb<89zZuu;l1eLFg;p#^E{2zhv4FK-`c$aDO7own zEwEc@lbf}o#7Yattl$hTIT1$8N^e;g71{|~>MU78#E5bCD{21I?RLCJB;XgbVhNgL znsLgU`0ShHZ+C8Rm*Usl@a#AX4C^ z){AOGe0P&i6E3VdQGF4HQbia_^MFf;JL$vYPBJ2v4$Yxm+BPRAn1T_j=wC3Q&0)R_ z6W%W9hb}_V>x2E3(Ifrauc+!|Icg_GLmzW^1{UU2DQb8r+hppRmW1YpHUA{?c3j%b z7->Yty*8MXN!IOIwm+Q_?>0Yz2%+qQ)q{KiJa^BuFdFeR({9Db&+2x(?$C3 z@Ok9rtjKwzp>XnIY8tZ%N^^*8o`D?paCvjTId={Ve?RwOWBvzIS&MCmtO+-^Zbrhx zxsKr?T=4MCgSKJpl#)r$79JRc?=DX|O*2%`6ax2qmtzWnTj!okTmp{#zz+umP^(^v7d+$G&A)gHq(-eH7M|$?%lMd}9#U_F<4Z#Gj7;c(U zG4Q*_Un0Xz)w)h+* z44!AfamVgGvfG4n68XJ3^d7SM&dN21NXv=oC^63`rupfe>&OhJSy%G;kqJXN*}lhT z9dX#xSuxZS;X}6uUh^={#l)=w-0JK@e2?}$(~WrONpn9#Vf;LYMQzw?81U2W#70j{ zy5X*3dE2b6>Sme9WKX43d zn?LG$AMN?UU?W}VJ3i#mTRJbGY|lwOkK*l6SIq*B&C6IiZz0wp3;`ol?8^o&p zmThP{HgsEa(U9=E{%7*Y1iTBGuU&onY+`L*R?^a}!H~TsCkgzJOju)~dNAzW zYHH?WQs!3hAmC%*5yWQIh#D0$f0V&L`-fD~OOEoH#h6pY3?Wv}VhIh#6%gZ}u}k_8 zIZPstw%=gSub7P07kH-@Q+C+u8eI!3qPAK+o~r(u+CUv(!}@U(sRNvc%Csn9{@j$M zS*Rt+s8m_Wq=tu&SUOLxZbY3yMWgqict_%4RuU`s{F!5m$j{(L4()|1p%@CMEIzra zhb@cfQ(R^!#rX-)ksv_&9d)7I&81m$5}BeOnK&2U+8BgC)HuR@GVs3J;1n*^& zq-WC7Oa3M^0<*wM_CR6>H>bUAEufp2Fjx3cVYell9Ew!#6CxhIkMsxTXLIfNo1H-q zfQo-?$pq5J7$7UzH}IPwfukcII8GYK2{C6+pt}^!^F;R{g+v6QR|@}6YhMCqV-@~? zp68tz%R82FEpu;nGmfz@si+A>B@{x48vDM?*pj7TFgQ)wrLvW=6%i^jMV3+srJ@v~ zP%1@H>HfdZdGEb*RsZGp`TY5O=X}p|p0h9SIp;m^xp*I;(jE{O1TyfhK9@vYKEO+B z3xW$`aFt`cyitPO zVyr#p344#>$VCj*me{MGeb#=U(g7LAVe7WN{;qoA7D;Cd+4O=L6I=VA!57H2!)p7b zPd1V6|Bw_*&mI{uh5n@}F*NS=_a9P79Z^UU!Kb|^KO{X47n=+l17S>&|Md32zSV7{ zSfsH^`@Zw)oUt;2wBAGr9+U8IuZW>=g;V7v3++QiZN1ki)?2!V^&WDFDFyG57nf0G z_hW&6c@noQ0LAmn>>sltaf=Xcp<0^f6?pi~6O`BYn{Ti2y$dtSaEpkufQ(kn zamqoy0hO|u{LsWMQb~|`D`k7LRT3njb?oxmX|ROWvH3S!!E5=daZSYQfWFm`7F;qc z-F)b#)H%}QQoQenDh|b2GkN0mtB60|y+!hMuB^$_5uaS#e$~On?V+vZf4|t@f6Y~` z|8UV*3fMXN-0=DF;!!X5<@Re|#MYNPA6M*P3&AVU&r<8syT(7yj zt4*@6HtmfXZSk!Z4mZfoV>LWiy(V*k`ra)~22WOb2dd=hUAzBhP2}kv@*8q$?wyN+ z*Vu{_i?I(S_3pq8TctMTD!WqAs6DJw*O?Jgfsi_r1slYK4YzvO;U>)S87R5@ntbAbR zE_sMm3acR{`0+y=Os_4@rFV>&C%rrDY_HpcyG^V0|5WyAnLULSkYe$!Vh&sX6F>iT zVs!8_RTuZ!a)xVS5C2cR)`wTTR=M%mdCb-dv+Ro%={%iE_r`C~q7JbiGYIDFg)!G_+sT!^ z7h0ayp&k=kCk>WRkBNMeWmQ8jw$I`9bqDN%-MD4BWL4r%tGu6)3#~^}y`Mjlb}bWJ z`F{Tz+VxdwiTG!K)JC=m<)1us%3Ag)>!h)~uHt z#OpH{e{k%mf6X3adf=F4PfSY(!AZ^`^^%twa{LMhz;I3t$C^gshVL;o$Mna=^fkxI zkuWSgWxT?rkMgD-2cfLtjW6NjOreve(80D??-4juh0DbTd*`|a3>_uMReO$-Yx8S{ zrwlj(*Kd^UA>ow@?mhdhV1c8t7{%_eH<{mZtZhIlyIarkl36A5#I-Lz{k3f2g;FDj zJcsqIIa)3-w{wk7Q?4gSAF{I#Odv5+>6QZT(tYM^c;uj+hsew%>?Yw3Zaa4UoBzP$R?7=XgHlC?xySJuzD$M?1-Rz z@S|gJw;1bK<1p(u6XUQhU}9rf7c_CPtP7a}ajXlQf(2N|n?eOy7cqqku`X)d!mNv# zc$al?QzV{sf+<>rbqQ0fC~Kc7UW|1~lTe&>8B-#Gwcq$k@DWqe$A?X+l6=UNF2%Z{ zDN~wtC6ic&b!FpEWL?Ds{QQx*DZsj_DSH!ZZOWBpUCop)$2!GSD9^gKsaSz^9aE_y z>w2bgCH}xvsm%LKQWe%sO>z?JyG_+(*3FHs%K9NwO|$M`QmV1;YO1HO?rv&SXZ@(D zS%dXsrdCbXX{L59);&y}+WelWTZeT|Q?D-TUZ#FM*1b)G`mFnyn;Wq1YZ~6nd(ABk zS@$!y-oks#ZMU-SZyMdkdZ20Ch{5 zEm=QqTHVijtZChf^%JH|Yu4k;18rE3HxE9*dV*>DAnS>yU0c>qn)dBjPc{#=XPsp_ zJj8m6>DYnwRMV*=>uKiUPOP&{=Z9HOH(ffjo?*InVLj74(v`I_-5z26lnONu^Bpq^%65|DC?zW_%PPXO!{yRoHiNh z95`i0WN_f5899RWax-cq2fj9=N3nj=ugv3PSg$Z+A7`Cwo*2t|r5X1G>s4m_ zIM%Dpgz>D`nu!xwzighI$odtN`6TOgW>O{xPMFD)IPj&(n#_8GnUckNqnSE|17DbF zQ(12|+0$5WG1Id-aNNw8&iZvTa|Y`-jG4*$P4kptz18GA#d@20I*0XJ=9#Bi?>4iZ zVZG1Hp2hkDGiNsI56#>;toNIFb6FoS^XGBkm{~BN^%1jh0S7)e&o1P^XJ*l}tUoc& zE#knZ=K1GXA2lyL&w-<6@e3UI#4K6N`ct!X3G2_yvZbs)H_Ml?K4xBA&iYI9(u=H5 znH4W_;IPSE!T3p^mAM@F$gEn)frDoCD%PjXn$@hoF>BXw;9c|bS`O?mue{9qTeI#J z*58@+>sWtpUR}@n2eaW-))&pj4Xl4OuWe-gliBnd>q}_3vieRt~&v-rC0cs@eV)>uV-&JL^Bp+j$(wGw;03`Y*HN9oE;) z&K<1(Ht+6a9W=Y%Wu+CF-Me5CnLWE^IkH);>Vu#ePk~G3bQ4dEBLi#eLtDs zuE1t6oda9UHB4!Adoq7q%(Zbb4B;kP3R zH<&Bk0kj|$5c)7^Au1@eGiYHdB(w{tONHTor84pO?G4DfLWWCRg+2mWl!^%L4qA+g z3Vjr`I29B67-#|&hyRz9DM1M$OM}cuC4}|>ElEB&FINU1I*Y6qWTmN;(B7bBsI*W# z&P^hf5!x5jPl-bNfd*sB474&;5;`2T3RM=G4w^(&gl2#yQ!;)fbA%hq;*=2*o8QrXk%d6jzs+Tc{!8TCB{ibc@KIf$TQARp>0x zMs%Cd*`ST7kCbSO`xslexaK|TT?5cTR_`TYovCOG7nH2k-Y)ggYcM4BKJCy>mOG!cb2S(!|FQe-6|n?#wQfhU8?Or}XfCxT|tWKl?j z!W7C9={QKI(iD;UA)Q83h2ns{$);&SZvvf8*+R>L&Yv|MN^=u7mX&^tj_&`Uy_facN) zp-n+oQm)WupsQ%5(7Qla(<-6&fUcp{Lhl7#OKXJQ2l_It71|Q?6?$3d{h;gU6``#_ z*V8(otwCR<^+F#2-9WDjeGqgbZ4lZP^flTjv>oUsdJQ!2II3kcZ4x>PbPH`3h0aiT zowkT{WKdPXh@(^>J*XO_2j7HH1u}xuRbY5f^~(sR2Zsmo6Qr!FY{jMR;-ng61h?U) zIPHYJda}20mwVWKJH?|9_)A*54+9c{Pq0A__JS;m8C%#HgOtQRNL-3z2KT=Y_8lsL zHmt`^`HrmMPwGVjq=Vx6SS`?L)tS^4&nuCAthKowQ8uA!!U zNR?FbL6yCqD&zO5B-BtLqf8qN4<4W@h$}rh?Ar(uiIXbrToq(P+ukjhdd(fv<(pPjJe%S0$-N4^Ktw2hud`0(re$gDiCcLDP zngTybcmWgQr>HGB!tN_!w^s+$3Y1^gY3hLFhn2pej-HZj#+QQ+W3+HDs}(izW2l#d zXQ+$k>O1RY5L%Z}6OUMFym~w%*d1fae|f-HaG~BI9v;p2kcN@xzdU?*gNGjZ9(pNJ zm!zK~?2Ey{%j-AP$0~U}@N%%9(zk{J&N@#6ZqOWfgXUng);Q(ArF%Hw3nVW;@&g`r zgL-;60Vt903441|s98VIDC@@?0wj~8)qV^Ka6{+6NRMMIEukApjjhCwy##}((GPEI zwm;GnUZlRCka@I>?4N18N>PC!7>6#=Tj+s}hXjA23Gn|5n!oDfjWkb2T7cK)ex*sF za4sX9VbW(17`z~yke4jn1c6unQgk`#!7EV92o~RLn_gMS$^qs#+K!%jyQCOf!=X0j zW#@OAis4=*U8QVkh-zhXC|so(UWkJ(p@Ctuctvfzxwu9-o=PRCT%%_^6|~JiXm*tP zTs$*W(w{UR$|@JNTjft$80EeQ!D0K~O7)#;0gkkpzbH=zB_wHJM(}w&X^QD4%3P>5`o%G=N)@GvsP_&wry{lK*C`avxJ_`il9*zWz!Ln9nzmE7zwvn|PXygD+`^G5)VVi`X9WEn!=r&@^j)PpsVP3* zt&-nY4Soui5-&yaIa!D^LC~KgXXc-A(zhw>m)i%CjD-d=*#^ z`>(E1kv~^@lz)_3(Ou!MWCQ)b5+6qcZWSe|%wIy%C`wX=zk)o@3QW_*KwQ0YTA>SLn@`3#4T>GKWx4(Y?w^~WUwAFFAxq>q=- zU#O&8IF4jcYl-5!g$srT9~mPHlUmUrT8b>(%JDV|?=fAJ^jBEa^AY6tL;`|cP@AMG zP>f0Vi9j3f8H9iz35*K2B&nAq+=vw6ZpZ$Mtq%M6PxQDC6Zz4oOcd}Eh34~h*blP! zr7hH`$w+_#M^vZ^z2d%|%X;Bdxr57t4G)(2+7`$lnVnU%lJJDMGU=15!I5ApCs{xK zleUVo@8qiFjf1GABj~)tf*Om_Cj4QP|7^0kPPG@!tT%7?{=4PSgUq`(Kt zhc!ql>&Q}59^bNqzMJ~C?A$75lJ%& z>{h-uQIfkUuuJ){eu?O`Abm#p9^}Bz8;8R1GDKy!<$EzdMQyk{Rpa5oc6=YXJA}38 z`^o)Y*hAc!+zY}w@B`!@D6Av5CI1j%owz-@XN5h?9mqW=tTT5a_d8)-xHGxm3hT;U z$vrRZ5$;CrkHWg~qvY=`tUITXzpt=IxhMJi2z!islY3EE8uulCPhmZ{Ke;~$>&XMj z-%nUC9!&n>!g}*ia?c3s!^6q_Mp$3YAonw27qPeC9uwA&N0a}Eu>Slwxt|Lgz)z6> zRbc~pJh@*A8^jaI{X*Da&LsavVMBN_xt|If%2UWaDr^`}BliNB+k|7RL+7pC)V!KTGamVUP23 zmR}(EBVkYQ5^@g+8^_DY-7joBzew(f!Y1$vaz79@kynztPuP>Zn%wt=W%62b-xD^8 zUmnuDK zv2DV~J?k7i`|Mm+$Iy+PWGcX7bBH5 zAIZRqU*pBKS-@W)7M%dPkiQfPFXmZ3ArwB%BK}HfQPAi3YoQpM&GURxXb}oc4)J_F zNS`AzAIa6ZHc{pU#{FY9U6@uaMs}2oG=eWdO!;a{`83oZUWTYtgDaRZoeYJroWDUd zp`2Yo&Q6oRM!2X;@|lp@i(nBoDFCd`BB^+Z&w9aMq;pZ?75uFv4oeBd+?OvPaULJW zKSX#g{}|yb`R6F_tN1%F)S>(f%40R3lk)JRbk{J}DJb1!@U@J^2soYrQ(orZC>bkj z1X33f%YdJUCh~if{cYH>`x$XR0Xz0RBlhF4W5+XM{|a_Y|EIjd#K}_T*lIwy-t#L} z8X$8KFD`F6AC`Fou(zQTlBt_Ag4;2ZU&k@*?O0^5=UAcXL3g`qoF06YaX=39Kxv);qyVcm|3 zw61wvktM5dA**k5Wr;Q;=)NUsd55bYM$8}d?NMdC4W)>E&>QCI-qIGDwkEs@;9G<( zGHI#49Wasi?46t4XtbTCQ@ z+p4-LDc?shn?d;ydLZaspojTap?8BGK{o_#juH4{ZjRjQ){)RYi3$zVCEX_Cf)~KZ z;SC#=m@DZA5a6fi%N%$^na|LXA$#y2gK>B@i2aHDkr>KXM?iyidxHpF%o_#s6T4kT*{?cC1;?1}G zJ93Zia)1V)V|~Y0J?l9h1nYUe=2_?P5ZljI1^vye$I!aQ+g6@73?+d+5}A)XYBBR}aS$bHF6P9}To98b2fzX+wDcuGiVxu-Oh zUCYjKwpCh&{k5NY2DaI8!V~TI5>hh>ro5KN%9Yp~O6Xj_07nF7uz^5}Rj}vjl0r!V5xa zUhJiLA-k5H<3(2K1=Rd+{1<%M0YKL1_!?Z#!87i6me049UI2cTmsq|K{pA{8hq`_i z<@^UPl{#Gn>7V>}bRf&1@jMd#7rz)v!1G=LUSij>bDV1v@Ei*5I~b3^i#Fd6n$81ms~#W)mt^sa#8 ztYx(}H&N&ZMF>|>@R=ld7agQLhu>yya^_oVMQFpD3aBvsG`m`Ta@c; znPJmCyO{GpXq^TvD4+e8{LUs^g7M1 za3@+8vD>!eE{WJ3X-n=45qpfaKNqpbTKltMyL7^Z$n!$%i^y{fNx%euAv)%J99W>T zOFH``0|;`p%pXcQAF#VXSZN23m_aMiWDjy+zQ3VbaT|)o+r04#(c5B1fW9(F6pGL! zI*jbf5Ea>NIfRLd-#OwH5)ODcP>}+;$@v)NQx-qUVXfsHJVWd(0xOX0^3G>r4;7qP zPh&6PIbbR}ah~-YABVM)Q^2!UcD}R?ejd7I73ZsvZ$APt% z`6e`F^X6c1*3KDB2C6yV+BBs&=b~)YoeQwpJq~EraDIrg)pUN0vej~ajDBI1>-%+-P4!Y`;TO4*UuS}PDCF&wHhm>i( z<6s=LGMoC;kPH5~r|N8+nY*3IDT${z|sVW#8e%i#{4os3_8dsSbKp#CE4s%u)6w=bT`I z6PTrZHJr3rD!Yl}a|%ir?kq2&l8C6O<9ZR@&81;&=ER5NO@#F>r-*08xll)C-|dtQ zMQxfpMa3mO*up92gfpAV6>MUkL7TY8sT9iAY>Dk&r?TTdBkVpW$tpb^n!TdcWAWC~ zsfw15w7n^FzN1vl3C{wfU6mh`9=IQ(>i_BPZWY(VRP(=GUl-Sp3D>HJW|+}oyIaKd z2-S5$B^_SnV351tsc#1h8Sq*;IBYG&Z;NWBQGhtF;}l2LM4E5tb$3%oWwmqe za%A0&wSQK7=WfeCKx=%+N$`Alo8S1tMPol8yMuENzG;+7$&rfd=-lhLPYLVfw6s-d zP|puLtwKsOJ*C!;JHu0Yz$#6LQfH^F*BEfr$0^}8sjf~t>z*A9&rTol%E`{|A94cI z!t!oW@{UemYFOSqO8zj?d=S}s)Uh8&Y3x{JJ?3je|bb^Ee;N^odUe0pQ~aS}Hf%X`BN zhc*SP(mqZgEBdu|AGmudI8OMIQ2g6X`>fyq&lZ`Tk{X2kVXq~tuQSBv=?G@-`7g-D zcQ~Y>o?l;onBf#=A%(;L6=nv)#7<4t0B0m#xhee#_&{fr4gV7HVcQorU9yHb<1GIo5|Ede8v+`SfUqlL(j6Zf zh{jv`tPE$OO#pUdvPL*hT7C+Aq?2j+Y4B0bB+I`6AMH%G@tgr4<78R+S@6f5DVAeb zCTpxS)$;GapKzvGeQe8QjdQZC{5<%0XS(IslgXOk%&P-8e|8%I>swf z`^G2-$-jt(hE!_o*<@up&sg2!tgumFKq5QB)Kl05()u2ZVk|*?A zHU;yYJft)1z97o|9qYc(*%{@IqKo+7W!)D!d!pP?oDui;to!rMz9@GTam4*Y>%Q1I z5aqrk%KanjzSO~uuaWdEi*o0FmWED-!P0cLxSIWQXJ2D#W@EqV=LN&`06KnaYKU_9Mv>E_yc4T zB0`4kqGyX5^?pPe?*7j-toK5*Y4{oZ-)Z>8liD;~2A4FTEk>o`Hyi6!$RrILtPS^9 zi!CY*e;^Hb$(6Oy`O6LjEo4Vgw?T2e=9HG=g8HDxF}c4EuVcW+1jh%1;GaQ@9hK2`p1wbcf=C znIUso<~|iuv#vj_{%{r7noFmZs0;syxBd^PL{R6Bi>5JWs@N9fzRa|kT zqih=Pa)M4tn6S^4xV$(d9uJ5ozOID%{{bkQnAUNLX{DRuQ&yD8BrbRod3I}VK)E43 zFonDO8x^wgXI@hyke^@4fo^^}<`Nf9t1n@2)%fBYkamPyysq`*p+Y{PW8r`kNlN* zyjt=6doli#OAO&S!eu4C^V9dwQuERiUBcmzqjMTA<9t~@%a1YIXMT*~G>R!X@LHPW zRl*3jq_E$x)YFwR^2#k7UVchMGu$dg>Xn}85yBQ1uSUaq`E6KQS~$FL>ZFZ$afeeF z4%;*H%g{@8*uT_^R~8b!gdzXKz0OO6#NpMbmpb_?lhl9Q`zQOFdqW@LC&r`~N{kr` z%m8Ksi-6_8Mqn$j6F3H(0?q@MfNKC1PK+r8lmi+9ZGeuz5FiKGQzpON7ywKaK^}CE0<$5YD)0l815$v7 zz&gmc0xiM202_hBz)r~a0VlxE0#|^9q{NtHpdpZ&guq*Zv=h=DBpsLp%m#9SjY*QS z!wBOTZ~&6?z$x(SFpDH7#*_li!+y!;;W}7sJY0ZMKqVjrs0TCxngK0=jzD){0FVxh z1*QVCfki+ruo1|^(;j(UjbOch0G({%i zlq#epNIRel&;u9%qyuAtNx%$XHn0d-4y*w-0$YKdHkQL+$ADA7dEgRo4WOcE6hHzn z1Q-QO0Hy*tMG^HP`I8IVx}sSMIRe`wqQfA^fK$Ll;2IEH4B06L$8yCa$0@Kj13Cgj zfKkANVpHHU18g?12v`oR5l>q{@_@6z6%iCFj*MJU`ugH`cANYz+vDRa0)mN>_bq8flJ`m07^jAKmy zyh2djK?eZozyx3_kduJe7lAAX)&S=b=5?S@RfGj>Opxl%gUdcqJ(e&H)+?|klt76A z$v`cj5zqo?19XJPK0rD!378Em2Q~tEzyaVC&=I=nzyu%%m|sF7%LQ8pYyt9s!@ybK z8c@iGM3nL&Y9JY?1*8HkfsQ~AV1g(u2FdkFcw4~ofCIpJ;1X~RppsJGMM@$-pd64a zT*Cw!0xblPwE;Q;-Af|i0U%v8NFTTk0Y(86fT<#!4U!IxvA`lA7uX8f7MMqYW8fEI zUW6H24V@I23M>cK0kNgffq^!_1RxjK2b>3DOC!HPLm(AsQ5q4p1L*?v00sc*z*u0C zIOfQoMX)UgHUg)BOMt%&q6RtweSjQb4X_h93Y-W0iAV~N0@MR21*HVk0#Z|??7Dyr z02;xy9WVr#3M>M0Am0e=1P%kofK$L0xa9$RfCIo$-~@0Mh^>xx1zZHbCU!sS2Pg%U z1CoJSKtmuEXaTeVIs!d_AwWI&PX$^6V_}~J%m8Ksi-6@oasc53P&AD|nh9wG(h=wm z^Z|wdqksv(R3HbK4=e_9fpx$ZAP?9B8~~02CxElS6`&7N5PK7HaFet`KUgIo1*iw4 z0xfPr)a^jJ3mE{C4ve+>Q^9h8`M_cz7gz^u0rG%7zyaVWZ~{0BTm-HF*MZowh#4pa zlmk+LdO#zf8PF1FR~FHBmp=nwO9y64sll8I@9(IKo_7A{5JzS)`0SW z8d7$B#9unx#tNAVk^{^K76ZA!R8gL9m2=^D9YkAzJYWxS0Jsi$Y)vGhro`Q_COou( zwR=s8VS-qXLhA%@7FZ6ajlc=uBJ5WHDvu%s{9@KZq(E|cc&t}mo)66+ZdraNSa+~K zzz|>*Faekf}MSXTkT=E)zbg951ovJc|Jz%h}Y1-S@Z0j`Un zP(`Q#exOoC2x?W7QfmZjGoU5VPQ=}9Z0AoWm^few^X1@C5g8gQk@Q4OPK9|#o)PcX_}UVS?476NYg$tC6()- zfN-i z$`sY`zo9LPgzlrluic#Ng}ojdRvhAzsc~o`Y=yKVU*Dd(u^vGu}?dqy(HY)hX&$|n6>y&%x%-Zr*{~Z6x;MJdn{mFbg`rrQo DX;42g literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/0fa6e70e2ab6a198_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/0fa6e70e2ab6a198_0 new file mode 100644 index 0000000000000000000000000000000000000000..68cf35bc46297f5e9df6ecc4e7122a85b589c02a GIT binary patch literal 29784 zcmWjL1$a}}8^`fqo3=?CX<8^0Myb0c#cNc8+hDj3cbDPAHr(Bv!EhO_gW;}&G2Go{ z*#GMO{`tm?f~Fu-ekUC{$PKjC~dso1SCUOk!PgQ}0`Dy8pyYZ_)9oo7SM-GdFE{;idz~dg-PrpWO7x z!(Gii-F3#_U7PZ_Yabrvb=QFacNGeB*9Pn=;I8@w-SyXZ?urj`S1+6oc30~VckRh> z*IAUwb=RRX?s{0>U8XATYEso*9gtGfU8S)X)>`gri-qV>n;7WPz+F?CyQ_N(cfIZ6 zuGp^b8ina7-_2b=<3o4u_i$Iip6-gq=U(n=+MB+8+%+4!P`EF-!8E{KjqwLw4P@M( z-BoOmySff`*EVb);x3<|?s8!3Fy;jJU)`03UHEwfk4L(z-zaxIAIn&1JdRu^xO33D zYcPJB#GG+pvb$_k$Q$pblKV7w6~_)-MAupF3ZLz+)Vc0jHP2l|=DX_`OoDx(yW*C( zEATgWU0?35u`9@bmAg)@bJtZg-sCQieeODnqJO&UI6MxrCdb|N>@;~@ahLZ$?wXH_ zZ^-#QHT>wVLGb>MaZCnHg57LT5CZH5g<%Tbqk^A79WWj{0t~u{uzUtxLuP)1rea>8 zLC*>pRH~psJ@64h-x<^xJ2146K_i0<8d%t%8)y`4kaws-r@{=H7|u30q751yYf!fY z?k5{`$6?TQr$Gf$44PBSpjWt7+@Lq53`$HjXi%C#O)?BRiI=4fTAjuAY=g#N7W(Iq zPp&~X5nP6S2r6sPF5E81Jj)xDjjCu+!JxaCQqiFGl??pdFlacEsu&dey+Kt_A9t!7 zRK5mnaQFvl(BScd)pgK_BWHw7r=@kMJIon=@t$=F{4s zW^D`_*VdrdFm^ELXSD5N(4npd73xXdaiy0*Pk%CKRBwY?_cN&TaD&>6H0S}sMj2Fe zfl%mgC5Q?sNh_KTHxe7`Y$x7=4ykEY%plVM(VkVoHiS@ zYO6sB+sSE%L6*bB;5tLd&-XO?YR}iuVQ?J{UCL@b#&_fB> zhQA7VXiKn%_Jw)qCYnTeC_d6dVX+?Cnc|`P#XXdp?xFE$o#CNf$jtQ6p)3#mQQkwQ z3Lff)%{4r752o?u)H4=qH#mL8gc39UV}7|CrsRI#0h_I4mvN7{GtP+VsZ zg>)h3t{!UG%|ng*kyC#Ur495@HC!6%q2Wk-6dN`j}Z zCwuCG(^DQrJ+&wext_|c>ZupCJhiWZr-rrg)Qz5=I@QNhNk4naF^FwL=sU+#v5P&m zdcCJc?(tOJqn5a^|j-+8Hj zVK0pi^^#wNmj=XmseP=MdgB6a;bfeb{=wmRFFi*_f|sgcHQW-tbPSL2F3C#=i+kyP zN&1)aQvFmfMW%VFK_>Ald8thm+Mz*pFP$CirR0%bYKID=7#H@@^v9*~Uh1^bOU`{> zn(@#}3oS-1uo^X>pixt?6OS;xkWtHmj9L`tSC za2%I$D8;C1MT}Zo%&51;jS4S8&Ul|?)c4s&*>a5f4L6WC*Qg&brkqhTaicsr;^zuR z-9fjC+=pjnqc&qd9-vhfqkgYy)H~#SZ`5AAMCIy6^~MV1)*yeZ#CvS{!Km^zxyAC@ zMlG#l)QP%AT}QKeMg=!CssrvIwUJTfFcnWwwJ~Gkb`ztD{Ag6Erbg9jMn7DGt2y<+ zXV_a9&)`;(J)HB@bL5{tQiu}o_ z0{s{Re-5BFKO2=e$f)XrjcSYyL+C%0`&f-U!>GfrMj3`1m2ZSm?MG1ye892M)MO0n zFu|x!6FFWcQ}?Mn#&39mJkyN|!3kWLWmL`C7w=H>9yvn~85p?`Azya(4^J{ zO!^Q;yl|7gp-ZGmg`-W{j31Is>W%p&Ofr`=DG*I@q?AcTQ%!1*-Y}$_^a7Q$O;QIE3@qR?ei6<;k@IV^lWr95d-v6~?Y=Qs3`Q>QTd_8Z}M&r;bU(>zcF| zC-5Hi8=ABR-!Qw8NqHNa6pFbh)YPP>%}naw+@$0dCN;(tyzFk0TMu$T`Jaf{+a!A* zlWO)g=_(5Lr#^TzfHnh7TKBU_#Rr+xX0S=mkUi9-qqu}O=sAore=*64MRlil8q|Y-< z8a&gaaaf6jStk9B2dFoj$8#7Db?2Eh2L%@p1G^WROX!;Xd{)H|ZoEqr(cu``x5~l_r&1V^Uc($1BX*$Z@ubxLe47n@J_MQ+pV8nB+Q2 z{f?P50GH6~IAdcQ8lIq*_=E{3O^QE54bPgCgdXRp@p+SSFLFHM(IwUzId_>WT0A1> z#~de5Sg)rX$N2df$LkA|{=lEOj(IPs5e~!rn*RTByx}IkV%8_xe_>3Mw`zKOt0@M; z&&ON&Y~Bh-77n4iueXNc9S-?>%bLeq1yKTjp=(}m4aRG93GkLHpSKnTdaHavZ;eH% zLc~UNVQ+PSJ;YnJ;1lMpYPcQlt(XXJoxSc<-pZTqtx#m*D5_+6s~ucryfp?hu^BDPdaGV}Z+TYmRsiN!^wy=S z-l|&7Tiw3*);@Hs?yUiMj^eew)u|5ks_U&u^@vrUSlEn)4ZLM)=&e8;Yf9f{-kR3R zTZ^$5)mwXOTs!h@Pre<<7ri=q>mo{a_EyLMYBbPWsXu$mHi$krfk)^+*jvVt-dcuY zqrJ5UbH{k=943$T)~@m1nmU7;V-J3q>8%#Cz144yw_ai1TyL$xz}=iyh$M_y=cAPUJ_^x~G!a)Y?1_)+z4B3~*W7=@oZkBACi1-V(Iw1$PmY-P!ABoH zGVlL<^yL$^`Rt=&1x~B<%If3c~gV^lxa^KD=sS);Bb5 zX;xo^wK1zcHlS@g`k{OWvuYu&qgfMCq?1{{busHJs&zH%Q+Koe?qODXPqVsX5Zrp1 z)pCGYJrO+6tapRWG7K@R&rq|5!*iHfrBMaRznGPQm-vPezcTJfv;IN+D6?8)1)jh$ znlW$;t;U$O6`jYKHGKkoV47&wE*yj3WV34EEvig4YveTAVdr$lpJCPltU-ZU%n!}6 zXSP{G=P*w==9$$6195OZu@{(?57`TuBgXyzc9B^-a0D4ks4Who_A;}kVlh_zX4Y+# zUO^tH^gCl<0t&8V-Oy+iYqOg9V%{3FZr~a6t|Jy!VjG^Vr(PS(`UR75V53zo71sA3vx;6L=No24-Q@T~LrlOu6uZrFc!zaI z=eyM79yP@N`_$zD#|Sz+G^_d}j^W2<{e@yrh=;7FW_|z6tUqz|IcxROtl6*4dV}0I z^g)fcX3c+R)^oVt^BCLV_`op)ePj*M4kr=vAI}-=Mc^m13VmiA%){a@Jn!%n{~_Wl z^@8CWHODoql|}pAExK>8DBZ)N9+={3(T_%pI%2V(MS1gE)IF5@xQS=D8pdt7MUfE} z*&;1!h{?!^;&HS^GqDU`V~H1M(LyXpw5XWVqFqHSI*O7-Et-l&_^-G{4@+3|4z){J zv;wKA7G1;-X%^i=>vZ-bUxr2B&@$7a-!Z$iMdxc-RIj#0_b{f8MP2Gz{qE8Df3S2~e z7F$#SLvR!GS6lQPpV4WJMSBsu)}sD6g6MS?wOen|B{bh?QMWC`*-FjO3;&|_HjDn; zNv(G=pWPOv?V&Dvsr5eg|7p>L{lq+Ak=I`qUBSk~79}6C=mfq$N>0b9Co+#)6mr6% zKIngvb|`#`dYrcC4HloV$Z^)91K4(se9l|6;{t1P(V{h2a@C^s|5{Y}nnf$|@VZ6U zZm^cOEoyRy`8~F129_f233)%Ys09w=9Xy^{)CRk73?-ghG#KNN?}bIJ&;t)p>ZL{H za0mrnQ76pC3w%X~*A{KZVdT8AXd>pLz*~!&p$je|{vENf6z|~ip1R^MoI{ll^uuZ- zeWW%Rj#tR~&m!|DVqymF<1Ko8CNEq-xi9R)GF1LbJ#g3ED!aj|w%CEM9#)m~v}y!y zqo$WtOYt5_Mk}wGtSVx%Y8aj%)7z>Ui1x9nDB5BHY-X$KVF!v@teOmq)vA>?s|x#C zbrFBrt%~!rY7XrFRvp0LAo>@!$}8BaGT4T9*d1b3)ljRNqEnbv_fR$5s?)fOmY+^`#Y+cFkjcCad{qg7{+-pQ&8Sc1!)nSU47 zt}Aoy#{9dpcB8DkRd15~_hIPbLTtb1d?89M1k0VFiMEZF0Lcs}EeTHkI zRkQFL3QVGYI6RHIOt-25JZ4z65$-dsN}I(o4(B{#qxyWSrr`!kEFc!fVE#hpw8*L- z7hBbM3HdDLm{?|2p5=_W!m19xTlF{gt+Xm^wN=RoS;H|7`&y2FJVnGhtA^k(eAjaf z;l~YDmD)(1H(7P;4|3W<&MxIMNi10|j^)-!7HoMYsLRmEOfHSi68U*2-OyrVx_zqjg#4_5X2 z$XK}WAM^P{UB2=hkWKg8ZK~{H(?p|9S4=jw@V4nbTA6JMu-NpAzfEKF+B81Erh)lv zx|QFiUV%2v#J@-@U{gzM$775yXwzPtfX{a}-Z$9v8Qz6#T7%BPHYvoWeg79@)A3lF zYRB2+k!a)mw@sy-Hf5&RsrtD(mSezIoY|4)|XkXH%mDq|q$e&6aG)}W= z4(?>wbRg5Fr>$-Jgy!vR>e$|Uc+$9|i39;VJmY)Zt-bL9GuO+&BQbh5CoYDfDjx}mR%B7YBGMPLXv zVIP8f(gw{@xRct3OC5-e{Da;)0tF_~NwQ@Y$C;95+ zWM3_w=Bw7zeRXh#uU5?R)n=s6_SKWQzA7}&SFvb?zu>okv6lF%GK@=omAu?n&9D`F zSNQ4#j4K&?wXY7W@l}@%zPgU}TYR-dtOomD}s9L;HR8_W@t6{>xYQkNN7y zGrqceky`xYtGYLRRpNoKYCZGS^Eb@(gRjPX@zpFhyMDtJgPqsNc3Ew96~t&?yUN+^ z+JN`)@UyEFmZFirU6b(OJGoKz0*|itnP^vw1!#Z3? zOb5G$;X2-Qw9BoNT?t+7>fOVxoSt@t^s=kUPj0?)sfp!fUY}fgrcHPA9 zzt|NwoZC^%VYFRs$JpgQ)~>tb?5Z{1u4WU6Gl_Xkw#$F2U2TwOnqBp#+vS*PS1WYK zN+ivtA70_td3HG$F^?V836D`@C-vB6*94qG{BFBS;umD@VcP-L>o2=n;CF1ny@Pgj zI?T97ShHhxrJS&<+DW?_V&-YaKV#QZ)V*rg@Edk@xM`R1mR-Hj=Qi8!Q|AYE?RrSx zM|M63x9jp_>hz4`=DA%5U)nY6E$fNCA83y!=={;H{xJV%=lz>qcTo0=T_-W^n_VB# zKfq7ha1f?^ema!jPlp5jbO9#{`l)GQKeY|sQvLK#nxFhL{4_X|v9P2xV`cm4mmEKZ>ptH9u{_XRNB>r^p}tG!y&qypEqn*7sA&kAA8? z&`+aA`>Dn>KP|gY-w=Q84E0y7Sbt4-_-hG<$h`&k{^_Q!fzp7(Hb$|U=(_i&! zaf{A%{MDnLzZ%u|*LMy4WpC=Q>&^VNuerY-wDi}CR{n}+-0_HnzdAJ&zji%%c~muq%&NqUi2CnuHR2@~8~v?#-i0``L%z z4&+hugL!loBah@!%F#S(_9>4RpkV&IDvRDI5}23Q1bJ1bKwiyq1nzLrRq(RYgNosS%|5NUIg33V4YZ&4ZNFHb{Ls z1*v5BAT7WZ1oQ|}H0Ggt?;s7uM0`f8K0#WEkiJ1$hnoF@bQDqjgERv5ex?lu;V3eO z2C3+U&tg}iYW2~&gA68ErT8vPJ7otmK7j39N!3hbU4q)&*S6{MS3IGb9d z-kcz9N8ntxAz^WlrY;H6ViZ{#q%zCM84p(m=^Y|hvmM(obA6CTZX|cSL(m_r+twh} zK}#G#`CUO;v?oY2_R?=(kWQh)pRD12YJ$cGg4E_vkb2_tksuX56Qm#TBhDlDLXZmn z!}?<^4rA!mAniiIYeAZe4Oo3WNJAzT)(iMfDy%|t3acnuVgUX`zPW{!u&}UNVgI7S zax5vVIbp&2jIfAcCF25;qJy<4Hdq7Wg0&R^3Bfvoxz&R855|2Tta)fxJy`YH1ZxY_ zHdvW>3Ac8^T8cvLgVht0@Bs@u1ZypPItFVhZr~ZJbqdxgcy$ieC@ky}tm~N6l{`?k zTd;PcN%vrN#35Y3ydJ@Nh`PPV<)>g>#`505vi1qqcevR%SaJP=)dKta(|!QCZ3tE^ zw8kXN$3-;V7_83tx+z%s{s>kl{EDc}!776yTY^<-EA7yGTd-E(Hi~Q~Cmh`otSUQ$ z)eJ{5es{12>ZG zoa4bNeKJ^wF9hof##{>4Oq99IT&@JGAJ${m4f4Jdth@Ju<+>lNHi&;j-j7*JjK&_6 zc@oU$(!m<}k~XiX+v{LG$F_IDihLief**r5+be|Yze4mEf=nSQb)~W?GKR0$q-4MARgs2Oipv1!vEyj{(A^L!?FG6H^ z6{3ge_&!8?a27Q`P=n7Q`tfUsI^oi{5Y17j7P*IN9g28_>Mz{1geufGR9*c;bq}$@ zp=uBvs!{QwN-P?xHR+-1*&tNqI*00E?@*amg{t9!Q2lc%R1?pHD&}0Mf-i*X7W!Wd z)kSo;M4P`u)$c*5Ry_^X(C49Q^EFh(+{2WEvzTHC(@OkVW-th6K@-Q_#&iru}DJR1C9En^`hN%_$VLAT5CsaHYrn)$buBXGa^Gq0j zld0+1FxA5$*w2OOr}NYfwu{si%V4|2ysw67DeC@9o_K~z*TZxYx8ZY>eM#Z^8(p%) zbphVx!a27Yt_9cwm1iHSR0~(9AHp>dYifpTSNCvz-z!`zehSxSbm<+gKhVBUxK5*Q z-*7F(2HZttzi<`7TqN}mSDpdknvSceI*_=yg!O~MRsGj+HJcQ!oioGv+%jBS@ex_G z!}S+TbHWve7T7m8Tz>PzIX@RJ_x0gwvLRfxHim2Fo^S>34Ogqf;razS;e3V>uBOk)`$f2VehJqRG*X26!{!#D`e=1}J5S&`OU8y@#h~goa?87mp$D2;IXQ{Ol82#AVMI40vE{)moHi5SL5mDmWG<7kV8Xpt15 zR>={nf~6SeL`%zhE7K7_jcLf?@Q znl?5q#R8n^&{4yaI;9w z#Wwghk5mV|N8uKcs*PJH-ZD~;yGAOqTcn0`XM2xGWe<;3Km0v{Sfe79Gb2)iP-JGL za&ZJvvm+HWCsI2XMr!CEk=liVTOyTzD{&4)YA?F~#XdwIBoDkq&%^Y`KSv`Kax79~ zaRCv>BQ+6)Pef`M@|}-V84SiIJVL<>k(}3#R9|d@-=#=h$K0!tx`d+FBISKOQfD7T z%JMK$Z6A^2<4A3N7O8hw@tj)V_ZN}8){D|hRBacfi1tz1JUB`(P-SS8VuwX(@5m_q zhdQI9lr$zvjiyFvHmXjGQe)gf_KYY!Ma8*M{QZd1h?P@u^{{V> zQVlG_NqmIYA5qH0P)tO%%~9Hd&;P&O5~c69MrqTrC@no1r45KX6{R&ee>#f)U!yb! zndcc7rVCLDycnhCm!i}aRW3)V8NRy`rAIjT5Am-?X&{3BjZ!a!UW?KyTtfHjQ7V2T zO2^@KlQ_4cbPt~}<8~C+<3#Ci6#I{D7^i3*Mx=YRybaNE=8sl;91e`u+k(;RTR2)< z(LOj@{ooc7t;V6zni&=?pNwd^urQNtrK7n%JX$xA>57)QOtcVnxrqxEJ?w63p>R)vkx+KyVAqV@G?G@nsN>p8w* z@$qQ=a5`Gs(BM4tLFEh4Y6xA7RxcE~LjH)p${2T}wGSuq#c*w5j7r^%(F%M<%B>i6 z#U(sK?Cls8$1m8AGpKkcMqAMFZj7Ge3x?f~(Vhn}TKG6d*OB-nM%}Rz9iGN$4&ET* zS&V|7$LJ*rzlhPGS21#X9iuWhfqZXb)C9lbC_bX|JMw%V!*v@mdW9k%VmQ|qqw}cx zUyLRp@)M80#wbm(Itx#?SPjNWY;=#+Z3G))RU0F40)ZZ}s*i=Z4nNOWWupt0;4(~J zu_}dbSc;3V8e^4-j+lp&@G!+H4V|$R7vSX`s|@tRN?e8ACstYLf;DJrj#XE@M@?(2 zT((#}42V@&!C1WwiB)oFtj2`JYI=CATEuc&JXU#1#HtE@FUcHB5w~=#@@2)Udv>g% zb7IxLOsrO*VcA%9z$;WMPc9XhcV*_dC00KpWoxW*a2S!>iLonI!!E_@(T!MDxF5^; z*I1=Kh*d@SK4kmzSVg>G%$Kn$_9|BQ-^VKSL#zgVB=7%Xwdq@|o}rRkoQk-|X_;4? zZXm-HC$o2)w)@BF16JmV(+*_kjnlkrA7 zPHl_EDXLhU`lk^G9n<490EUb>{g@f2gwk=^RXI+du%=3!cB6aMIN2J+sWQI7w_%*7 z;#DKYZ5+q@>o`rui?(sRr;byT8F8A4cQfO(XjYs~Z;jKmU2!^(;k)BB9YK5I)ORnr z?2FT%$K#|EaoULe=zTIy(xTdlsj{&*K!2&`)vl`^;l}_bpDH5#|=J zACbpBUf~Ef#4FJruWtASeVmDfgi3kiH34M<;*~c52Fgi>t9rij8`4}i7Qd@dW3q>@oJ5;G4b+`kJl@-OJEGF z!wED^jMr-HKu%J;nkUEWDvCJbIp-X&53oApm5Op0j~jS~O(~35BwnS9#%njci^Z!4 zR^c4#6pz;&3@aJ0fYf-kPm9+dXqg_b^bBI5Qf9oa!&W+8-SH7Ev#1y5WXJ1EPP{U6 z$*oL0&x?39tProKcw31YRgRadK6SaltOS}f7 zXjl5;D5AT^D{l|xJ~&=;@!ybm-5kc))8dsjow?#Gw$F&yo_TD?y7}?ii?R!-=fZgP zSro71JJ`RQ{aCk${V2Pa{rlq8m3X1eL`{ctmmD!h| zpKKALGJOdLo7PbP3x?ea^ zp}~n77?P;e&_vCSOw?tJiAvNQ)Q?V7ixP?2io)rMY6#zqLeeDr+gm2`S#Y9O!)IWk_Tb8hMCBcssIH?D6*M|g zgJ&md2Lk6N>H_{ z64m)+qP{ytzkd?-D{fz<4%f)zHZ_3jZlX%xOVsjbiQ4=nQ7=&CTOyyACCbk&Nga^r zk)+OkNm`8`{gc!MdGjP`6z=16z9iZ5Cutwfpl4u`9%Dj*Bz+7?QrA%W#3tzzOmRty zX^^C0NNb#=@#xY#Nf+^=O_E$~lk@?#+9gTtlT;IByAuzqdnai~ANo&C(l1Dym8AA4 zJUdBAIE(UglJqM|%}r7T6rD$o3zHPTC`lQp3I8QY`nr_7mnG>2hW$ofzb9$wsw7oh zo1{MbX>%Y+z0misB)J`=4)}a1NdpfjX*7x-Nz$sL^gouQ;1kU4bdn$?!U&q-F_CCM6xX{(dfdu_6Q zfn!~=R;^D~+=gVe-;}I_es(huWgHw?oS;4h32r zio|KyeH|KNcc@Q*Lo@TSAJy|av=kA64!w+W=v=fzyJG1V=g_F44t+sXDThA5l(Ec-9DGmCp?MXFUCp6W z)g7w)gF~sc99oN=XkFW(?79wBLsJ~Y#(EAtXyDM;Mh=Z{!Wcg~ln?vh-_)TBSkQv} zIyf{L3s9*eb?L-hx;XfM&7rvi9K82tOmrMa4aYMEYEK}?nGQa8b*LtcvmN?4&!J=U z9r_337C7{7G4)>J(BJ64)S>X-9C{1SPG zmd~lC`JH^9#>x30C*P%UYFz=Ru7BrLTCh_SF%K0&oEjDCIsi7sDdYIuGelor-MD zxOm&fsafrudVw!k-k#VUh~3Glq^^vGFWsD)-NVW6usGGOmy_$bs0liuKp*DW*D3%0 z#2G{!e8KX;PQ?zT-!P}1jBu*SNT)g=|0w1-+Ns53oVqpEsYm0TIx)eikcrd-zoXV9 zr&djN>c$kOf~PT`8El{B)aN-)ot^8{ig`{An$KJpu>W_bI<9nT+A62staeIkooc_% zsSE3AyMfpnovQW+`!+lE>rSVx?RN5gUh4j*Q{V4*s_OyP=P%amkW=3sWetxJ^91XA z%Bh&MPE|Qitu8Q!OU&tS=6l7dD4c=oAE$a>b?W24PQAS0)b{&M*&jI70`qVJSCIRV z$5@5$A341oVts#ZYj!gPto_-15b|>z7vq5U;R=v9o79) z)D&kCm^VekQ7kw`WucH1*)bT0LQ_;cEJYLJQnUyS<5ScD{~|mwMUya~NQ%axe9;uu z#S!=xPtib(%}mie)GeK&Hn@!7Y}zBXe2O|(NKt>>!CS1YNWPd*DMcTUTO~!uaUXlD zrl@1J6pj8qMfWhLMvDA@NKs>Kf=5kq!A-bor6{R(iVnb7H$@fe(FTR;QwR7rV7?7g zwExExookw+&CSTOWr_y1O;N#i)Tw<6*Ge&e)asa`U+@eSJEiCm=5{7l*A!*oZ;bAi zq6Nt9&K!EB=yTr`_34+Q89%3}>mcffwYZ4y2B#=-D78ipBo3oa(^K>u?lV%<99?h{ zrDu}=EaJg;c8Y$QlcMzqoSUL0*n&YDimBnVl3IX!DDb?bs$e9J!~aD|Rl+drz)Qrv zEU6ZlgLCkCRZ>~#iB))vsMjUc2vczahBqZu3SF@bHxc-@q-w%hvXs(Fl~TQoQfkz! zlnNaxrPqn6ib+c4dw;2#jcW)=PE}LP!xiLnq^do3!sbj>L#%~cN~)@12ri;%g;aj? zBUOaWqMGK@*pW*kK2v8h@yE>*3@ zr|S07R0S`twAp`khMEfJe*; zogSz1*>0*lo=~T!shrnN)n`kZid)k(*_NhVzG*5Sn5H4PULcL%!${L~XPV9+sYse$ z<4dVDRZmS*oziKVh-X=8+K`>5pUbA{93E6llk595{y$HXca1c)`XNo}HPfU9X-dWP zhG}ZlC{0hBq$&ExG!1K-rtD^Es@o<_lkmK4npU+-)6fp&gMyvX^a2a|r0EJu^h;Af z|1`OcNKGHFrYieM+riG;IJcfs+YdV6$($zOST@@qJwL30d z9m=HZcQh)S&hoMllNY@$^{UKcwYo@DyEyiidm`H7%u6yYC zYr1}e$B15u^;8n}JL$@Nny&sxewMD%_zPh#(scv*zNM=s_+nF z9y(-X=yx>A%uq+X#`jqn`i#(u8EOLmN*M~na(Gr@Jh<1$P&#J*kfEwIiBpR>XjGdx zc#ZGtl2^S9nL1?XG<-T{sCB0d73!QJXO|3hMp)MjrC=)px|0*84a?AZ4F4rV(~^RNIlERXa1(bXSH>9Li9o!_@dA^NY?@E6j_@)K{F2&D0IFip$iC z_)Lv;WNJqWw?#5F7v+m)%9)y}r8u9SsXKTBkBm&^MFfh%g_>xA9vFrxSb|M>iC;@+ z>bvYrK4Z&N8CNE+^D@=B9I+~7YG%buB~{MU{wkTOTP;(`Qy8myY0b4{DSSefwoS}Z zwaHmrW0j?T)3W3@BTK){%u>eeES;N^r8e`j^lg5YrY+1;;^Hjr4a!!X;A}k$$>w*O zvN=DIt<|^{ldb)6*;CT$8X|pJHlKrMYck4i%2sWZ{v%smk7V<{AzRIkW~&>f9?Mpd8`&C; z0k^WX1D$SXYaqJZ$(HMRwuYeCi)@vF`%C8XHe1Iq;ZwFwV({l|O+>LT*;@<>GR59PiAgtGMoG`VsVb9B6vOHq5jq!mD-jge!NgtTtAkhe^1co zWR7ZMH42}~(eGz+bQ&Gc=4cQ${NFk9Jx|jlzZ}^<;d748;`9G~$a}+p-^VA3Si_{8>unE`x?^3P?{++9fmvi+QWv=C_J%(V@?Oa{Kll!^y ze~_zAPjfW|KfK7*0Q~qiSHB|d12sq37xKh+a;XgBO)gbOYqLvVzH=$OkW1}?U7CWb z2`=?OMl$9Kr57kz&7~~Nz@KFg#(y8(Z&CVfl)V%l#m?L_O}U7Cpb>sg^ znGY@%`RLLGr2fZT@%uNI+*sw$#xnX}P4@v_HTm{&{D*90%dUWevIInwCBr|^lam}s z($mv2&p?)f$VPTi1O%iY6a)lX%9bTEWyvaKgUs@>DJVmfJ<9U^`d;s!>-t=2PV(Hj zpF2q}nv*=4SJI=>uX|+UGfcoL9K$0NFY8eww8t>a!X}&n7XeiTG3bvO*oj-{{EkNx z(YmHbUm@!Qk1E#js9=4M>f>%>kD{7*^tsogE2c-?eI9vYJ?e#N?L2xl=+TsrN97_O zE$ZNrzoSPvI(t+TOL}-zp{GZydwJBfkB9q%J=*_;M|aR=phtr+?_YyFYBt!T6GJ>| zIn<-?a2l0{F^`kT#LD3w-NSDQ#QD;r4AdCqQO+?QT}~vgWNL%$IEITjo$68L`5rA@ zL_7Sl*rV8OY#SG_Wjp=d>Cx-ye1;BtJW4t4(QcGH;ZfsL9(BU4vmO;a=TTLhKF>Vf zzf7$$C6l-)a)nx6_o&HT>WY2$Ji3kc_dObq^AA1B{)pvh`q;xWqkM+4S?n8Z%VsEF zVMDdxDQ@U9TrOqkG2SeVGKO}ba+IMtWeuJGS2;t&%NsiTp24%$2G?I$2Pu}JpK&CMfw;z)8Al#WkWrXfF=L> z!eG2JL+dbfkfCRT4Shb;;CTZ>^@kaX!BJEhZfFD!p?iX%!+4CmBMhZ~ZRj*gjxzKv z#^5aKjyBY1jG-0y>l;Ju#~Jzxn=#~DrV|W3#rlbc`X(9Ljaw)`)zBx{feF(L-Nwh$ zna2g>oMEUeY|O=WTteHKhW_(|!8I6aio;kw$IxpjhW5;*KB)%dyRd8?>&`dScrnZI z#u7s>(PgQ@JyC`l;-3}NawVUwGBgEAt66uAp&IK99skA9mQ98-k+zNcBKvkjQFtFM z@W(D)$=ZSmcXI!OZC^7~=sI=9-#Bx_P^FuOy8UG+3tev;+#_vp-HQI)H5gOE&`s2P zV5k)aJ|s_+e?(4bkBKP!gj(XQEJJbVfl)|B=ck6oV&8M}$>miGv_Z4nUcJokl~u{B z*64?sRlMp{)vLnQyxQ@OS4S|sx>pryc-62b%dqBMulB*I<<;!>yxLydtLrH6fmc7H zQXQ}2@OM40YBuo7Y(iYzMA@cZm5KH;zOh#+ID}%RmvIlgTG`U8E!bdtRm1h_Gpxq~ zzgOW{uU-v!RSnCr57+T=oLBvE2=BzREqsE5xPd&ah>JH{d({LXoI@67xAkf>TC}4L z60sJi+VgXWe&Q+?hP_Hdbi}I;7=z{5fjb}5|4v?AM6J$j7uV6Ht5<)b+9zJM!)|o{ zlw8oQn^#r3d-bBfmodNbg;#s<(Lk@pjrQumSg*cG^zyx{S94}~HFdjJ+jf%wF0U5t z_v-tT6Tv zs3~`tsjT6qIwzQF{iUftzA|+mB2aweL34faHn>y9SRubWE4QGENIse&_1MPVFD{6PQEVHW*Gso5sKyXe~- z+M-V~eM_Ou0@hhfUifHTC(2M;0>n6pw1Rkzr)^U za(}p~+}lmn-DxTs%aC^${Y5?W#7>-q(o7XVGmOF%<4q#IjF`g11 zk!R$LM$hRN_Tk4DU>@sh;CxKfrLmA3SxjHSs@mIl6VDMwjL(^09Mr449b-csH-EL}vP zf~6(6i@g0w7Ir6u#^f?Y=RZB~?Y;t!kwT-cKA1z`n1p}5&BRbCFZ$(Q*<1P7d7mHh4`ml|~ z^#ZormYD5m)80~zprryKOT%#s`y<3d=??TCu^*E&x^=Wvv6H0-*xlLU+La|2J&}l2 zIF5TL($&%jXpQkmN99l0k2s3zpIS;r&2E;qqEC0~fFhrf6SDVUd-(BlOHNNqGqD|~ zdRZ#hn|*^*$kx|VOUy*=ewNDix3mtg46sxZK4hSIf~6@KHNw(m6#bf9QF}BsA7|+? z7LI4Xd`q2h1Mf_*)Ej5;RU+$P)kNwv$xdn#u7xoBkzRj0-_sP(FoYdak9UR7-{CS!#k7nE4~~OF52ld>Of}VBcZ? zN=toz;&@y|e{kYwOP{W`bQ1m7uy58;v-O-Czfk*)mP&21GC)u|d zQwaU3A()H(<^WL6shb}yLWy121k%q%cl&Ku1y>Kgxe_mzE53IppH)l z?$`IJQ3Ic9e#mn88u?VAG4b&kM&S`kH}R8Jc;08jHht#UwsH#X?+1d5c&`!fz<bbbO41>C+nALRFWVAsJ`zT8vLFCLkTz{5~~AUo6IX6pi&M8pE&-f1yIa zr`AZsPCP*MIAUWCjv;rvPmR$R3vdxpt$b>QiP()S)M`yFkb>hV(8ebdBe4T9fh8uXR9reN_q~Q^2wfAxV6*a|GR0#SM!gL%%{*X`2F$gR02g-+ugCrbAu?ThQ z;*-_er?TUjFKVl6J6j9Ty1h+&TYte9;^jSITi3hVs`QDi|G^FP`qb9JZZ_X5+S=C3 zR`-6kQis~Qh$+Kt%|n&pwnit|N*rM;W3;WtiMEPNwABUalWgVq&ejI(fj!yQ(kZq^ zB-!dW%hu26Jlj@(JVond)=9Ay+GuMQoK3dExQeD*Y*pTB>+ij`s_!EQ+{S?YwvHXJ zHRhnLCx>m-Jwoot!ie8&ojYplyJPh4q^%Dz{gkahhOLh;u?;-AOx~HclJ43%ic$A$ zO+}gewgx`1)$<`g=Wx^pujX_Vg;c!E<)~U7N3m5L<*4fLo&ra!(WSbh0eFTsH65MB z9en++qdfH;8OTE32974-)`t%Fu{*lk+|j$yjxuo%gFFuJVsf;_>!_&hCc!`2n98JaDtBw}^?(j^oqm}shhNC_xd(+Xidyam1;Aqq%N6r&I%c7r8 zY4^<0?B@<+YdSjgkHh^luI9YrYDsoi6LPrfmD5!qkE;d+TvaaUYGol;8w-a*K+m!d#)zdcJ*f+S4Zo*N~`B;bA4hqa23_i)eY=u zM69N+{?pvm&1hFI4Off3t};wlsg|pYnBsFa4^>*Y8r{-mykl2oF#;uryNXAi1Xrby zjAtWUC4A{B2@jDvi#V7vn>eU4hd9Z!Ng)mfVE<<3w~!wWz`vD#{z@OW(PodUOGw&F zzfg6bt1vZn#=@(^cy~>Gy3{ z|6uhUm+{kGnRi_+yvKI$yBha|wiuG-YCH-*b@ll(SEZjb%@(6&2)`1eo_GL%ju^c_ z;es)WDiotu*nyITW7G_Ji^S*-8kC6PodYpSLH`{wntV7$w@<`qk^HKj&94RsVNZ6y z?&Dw%ze?ovDDTlYo}Pf)g@Mi2gIuJl2~=!6|0fxwJ%n0 z9F5gYj6D{sei^ZPh=zp&>RL3Qim?H0?ikRH&H?T05>Qh2fDYnuzku@h4`?RBUj!60 zIG}dJ0vduR!vji72q=C+K=&sFbZ%NeRlW~M(*tUS40QM*py+u4Wt$(+-DSkx9MEkX z-4am0tpSa}GYtPVpaI(hDz+n_cXtJ}a5p)nvn~ql4JhZnfU52fsOf=#8k`8IL`Fc> zu=-p;U!M+ev3RLoEoRaDTE8V<5V|2 zPK%JdCr*?1#_6?vae90wPBC}m)H`pyN*0S(eXK{%;_+I9;w9r1#%km%6|aHlQ7&Ge zSBRHgF*mL6)t-3m!dLrxOsK0Bxz>xr`=s3RML+O#RCd|QKRio|U} zZQCBypgloFoe1huW>Aao1(k9?$TJf`ZOk5$Cr3#2a))#gV+w}UqEJYG7Y?aNkr3x9 z%iazt!xPdEMo3fakWLN?>HQHQ75*|LA4bd!>D-)<$|Q$$2mCfAzi_JyhshH z_5$MLA`%vcRA4FdxV|Q&Mr%W|@CTl)3#sP%kVaw>&Z5MIkQ~fIo{b?Dhi^+ri_m6! zNDuJFk&q7K=J^oc)rA!OkQk`*h(6*560<_OjHgdS>hLV2UfIK1fetys>WyMK!#bBM ztTMU7I)w8`$`e-YykTuae11O1gQ&3luZI=JVdN_tR&&H)HZoASTv%lhsSwu5%3-}% zC9I|IgcVyO%=4vTb!#401AkZ-V_7EGYwoyP7VVa5{-Ydz92Y*<)P z!^3Ke{0U*bjx(q-I;^fJJtnNGIE0*I!}=KG#?u!xP7G@(YEBHR2?|UKGwym=gRyH$ zSiYn%_j8AJ7Q2$e%9aw=TBKpf+^{C4hS`^49h*o0=CcltK3v0hX}_1}!>Si^{_HHz^6{D^{`Bl@IEL<JMbvdoM4z3C==kY~E@9~ZM05lGQ>7HIs zA7tY-oW{{W0+avym)5`k{@%YAKi2Hh-lSAh%w literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/18d297792139a046_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/18d297792139a046_0 new file mode 100644 index 0000000000000000000000000000000000000000..8e40ba91206cbd8a3bc727bff94f77c7cd3c891d GIT binary patch literal 36520 zcmWjL1$dKZ7sm0sN!nPGrVYj0v}v0*ZQA1Q?u-rB;qEfr-DSADGX@MD4#RE3VK~Em zID_y1ab3Tw$@@NX&Uv2D$eZS9*llIDj-S5-ODch&YvZ!;Lj`k|$&oit$x@|D=gONq zN7os z6)7k7;|5k%m6lbL4x&$W`qYv>V|Z=pZ)C44b;dv4rCdFv57;qL%CcDUp*nhEBd*~g zYAqo)oJF5KQr|0*r$mr8VK45WNy#9M#{N=4`Ujm#2dN+WmI+cwxgcdmzluR>P&r8b zG5fn9y>A^PbDJRT#1VMf1}T7AXomQ9LHYydak_nw(mDjG7>aZcQlCCS8j14#g7mC^ zkOmG2(s&FV#8@MO^z&%qL-?2=1y2oiQVBKuSx)G$_cY^fbX^`Hc}JIJ8CgAM9B#GoD6In*HAFoSYn`*3oCVWdGNup5I$bAOCM{l*&f zVghra@kC;sY>=iHGz2TBk~0oXGsyWfapT=|VxM79KJ3Cpbe&^R++2eS%{OS>0)uid zG-w2-!nN3-wlMuco0A4TKTFJ44YFP{C?^_YI2K|Zrv7cvteXb4xW$^I@NHtbV^HLMgHB-I z1A`hqW}asTEqQLxvNz=NuR(W_@Rr)VHz*9Hunwk=tQ`hp6&}F)$)JoV^O-hZ408Wx zP=8#;fv@bJAfuKWj5=;KDr1OIKbVc$hY=Q|rs9s(D3{%+D6|eWs0C=QVSV1xUf-8iW+qqDaDO?g%Kr;T91E_TGFWTn1lYMh_$p)x8W(v zIYgB+YByGwH|j1TD;QN0)zF}#QTOq4C8O+>jrtYQRg4;iw5mo`tJ&TpF$M)gMLQAV{HW7I=<#~O8Ll2Lgkvv2CA!0Gq^p|sE%`udNj|dtn-a(fzt~ZW3f?*%Z$pk+NgFoxyGoP>luHeQO7nJHF`5^ zxP=_I8nte_QGuQ0u!}r#1!MNG&-N0>5!UN0^IfIyb)!l>AP)3LmWS*WOnk(id(2!< zsSVzv%`>A4JU42<3mywthn8=Rn*5G6e{YoWgHa1DCQY=ORK{k~a;&hMv?kOftHY#v z@H$PpkDpv7jm1V33^yrDgh>GmL8h$S#tt0LZqhc7Nx8fx?Z<7@k2C2gn#6M+DG4S` z!85c;Vh+Dad6P}rjy^d|`aPFPmvftxoX4a&sFRm5@|jdAKl9-~6f0m-WI>b0plo52 zrlWKblO~~cQImF~STU21lrZVH3MN@9n$!&s@JA)at7cN&>L%^P*6&R!RL`Vw4NR)p z#H2$_P1?}Rq=T?EH|Z&YT2Ln}M#h#V&BEl?CM`vJ8)9o`(!LJN*^xe-h`qB(FNLcpOT$cBHQc1D$TE_+MwxU4XGc@dG0ZvE zq}cH$`6e*WM3X8^GpQdY&M;}oOlmuuy5Svi&M|2oj=??Gq|Nh8YPN{E(QdIx3ovbo zN%@zW)E#^96?K-IG!T0cvce?eDq>nk4A`~Fq%SzJnVh#U=5OqSt?ZS(Cf&udgC=!2 zOq{3LBWF2=iRXzO1unBLS4>K}Zc?wC+DOiIt2WwxJV2#QitgxtHtwE>gU~R<-Wc38=DR#vKYkO?4N+txW z8fN-}l_fD)HPJOCSd&mS5UiW&!Fq-ZIfG@&6RahLQ94+qs|D+2tzhkMKuj%ym9HJg z+S4B2bqLnNPQiNDC0MClgVh#Cx&`Z2Ph##v{K(TcSf|jkU$8!7V*g;p4G7jwqzwvI z5#$>e=Mj>mCXZWgbjH<6-ngso}xehQNqmEk=fs!5WQEcsC|k!zKkQYAX5QBz8;- z*3y~5$}}rjhY*+>EaN=#L<2ORAFQDZgS84b5w(bzQFlqO{7Zwi{?}lQ*~|Uo!TRf5 zu-g32EJy@?$|8HuKZ#ROq;3jKuD_E=V2dl}8VCDZW zSmPCWypg+i22I7ELH2~mS$AsUYZs9roo%V8@KqJ}t$ zd$?7S`6`e@wb~*2g5eFQWwQ{y zY!#wmLqhZ?_Ku<^W9Wm5W2pyR~}&LvpRxGO`H ze^rRmR);8NO^A$ZLp1f55Ovy2-oJ&Y^!5-1|4!TeAxb$)d^miL^A|!`{}63JqZ_Qv zBi89dh!%&Mwa8)CfUIUs$M1NInc2-+5oOjgk6C|VZj4#=Vrd&^)*m>J`|)PI!LtPV z`8bzo)&`tTGV40N_|38zL(fXjTW@L!m}ymB(~EMYYDvgS$=4%Kf8R1)G{xtC?BNa06wU zQxANBtA$xPTbfl2&emrAjGXPwGIcQP2|l22Co?aA%^Hn}E@lnwM!k{J-K^)h(}UQ0 znU(O9Sy}oq4-O2V9)rwE9c)&OA!aqkrlIs7#%-*Jd$?KqMw(?DWmd+~W~Glct37(- z15S*i9^+Y$$!2w$!k(E%{ikyuEAbNUnP$b{6fVp$tL9wdnrG(!IrhqYv$iZWD{PTj z^Ou>GxPm&uvC6EV+Q{9 zHUGn`e)t_f9bxT`vYyy?oc)X2`1yocqfW68PBZ5jvr3#}5By0D{$h>Ko3;BQb-zp- zq+el8@EdkqqmI|vJ2%*q$b6GEL?iUZCj4^CtV8I0n{~nayX16_+QNRHKA4Vuc!!$* zkOTCHSWpzLF$vF*?Xg)&$n=W6X|O2RXpslL5R2yHHY%AddV?^VMHSG|Zjse#(IS^c zk1!yda}gFzgDrza?o1Z7&SKFAFXP2o^bK7SEZU6dM2oiKhjfd2V+3aBuxLQURNc)Y8LhV&Y~XQTl9TRi>}qNXjEN`_Td!Xqkcn+HsBlP zHnJ!~V~b)jAK9B)^sJdh{hM2q-om2BxQY)gEvneTqF3E53hF^D7=ZMi)bS^aYU3_O z^|r{>$D*2jExL}Z{i!V;51`LLi#86jDBoa<+6=MiIlf@cP>V_qv*# z%84a-jaDNqI)R@?F%Ldq`e=*Vj{FlG?g)s zVVXs|aU2h@>1Wzbx2O|tV)zVVoMq9F*%nR2S_I};bQup(Z!Y)e5ew=ruxK8#E@BMq zS!|JE3Arw{XdSG}EvkxV7_q{l+$$|Afkt?Mf3bg+MW^uu9ab~v8jB*=T2yd@Mdi>O zuQ6vc`*{mvZzG2t7Ukc``oXx%qB6&+^$FGom(c4Z^J51Zo}%vfjLD}hN;yZJ|FkF# zJ^o@H&RbOaqD6n>@g?>PO5G=4w0KP1PuOcuS=(nkUNGo6kBgTU{e}a$i3P8y6OO|E zhW?+}v$&0~nDd$T|1qb;blpH;u&H0tNKDx?50V+>9gwkksrt71_M$5FL} zRqarwtX1PN8(Yz`oK@XWuYy&<6|IWI{7TG^OVzBZR^6(G==Pme`_Zw6RRiz>U(n-w ztIqvkRo|Lc<*Uv3n2Vd}REIj(wQ6cT=B&@0*ouY?tg~&1hxSQtU&G z)>bvf#CGJ?p4>W+8+vuL>LTtUdnc<3bhfH29;09vt6~OFW1FBea9@qgA6n6WbT| z=U3VU+0@)%Q&;Ra+H?lZf^9k(V$%?_O%rhlB^@>;huP$D*%Ux`+(G|vn>J^(X*>ny|YuWTG{;h3O%Q`l#z%!JrXVatw zv|BHqFQ0-&i|z-)hqrgzO-; zoi=sZZIgGOP2ZylD(<%_*Fl?Nj@Wb;FH!p_bv#B}3_#Rz=0T+sHuX7a)6-KneMJ4! z)c1@{Th3C8^ENfUU{ibCMvsfM!-q>YJ-%Yo?prqb9ug1SkEkQI;}c3fwrL8kV)#>= z>bSGhywxb^^bg-)y3U{v9jfiuAOrI|d`Dmt8Ff*wquBfp)zcVwZ8KU44exH44GQ?JAC{NFQNW zQM|%8j2_9nW9+(yl(BZT#%er8j&aO^6KFNwuI=bN(XN@3=>y9YyLRIQ!l&8wJ>H_~ zbi2mPpdEgn$^5hIT7(VAGKc)o9DC>5HEbSvBF6%|x?mvwSjgCm?8=Cei^&la|NnD| zUAu4$MVC=q97XLFc1_1ptXpZhYM(bFc_2i2M8|=D;=g6>; zv9K09@cdWmwaKm#n1(}}?J{j4S8T;0__tCs^hED%?2qks{eu!aSYwRF@tx$ei+oV# zch&^c(PFnU#4)+ypX zZPyJ$^H=Pefj3uK-)nZ| zxk1dg?DE}a|Dho!;~(U`%Raovx})=b>hTXX#K8yD3`{i@88UYN+z& z4At)3p*oHNc|tWEOYkXQs2=4H)jQNK7^>AMR47yz@k8NI-9hUjoJYo@q56iF#X_|P zbBl-Se63K`s~xI;FuqQxy3`GotzM{B;#0#=4Qv^zaroFKRCT+CYAZ_g3gvZEs7|0# z-%yqA7pg4?8W5@uLqoM~RH(wHhwAg9P-R|1eU^r*B8K8N7OoG~3w%MR4WZfx|1Y8H zk7G#O7^-%^hUyZUZw^(rZH%*>nxPl|M(rJ;I`BKS-c3GxLREM#b=gO)_jCS0s3sp| z%tN6HIUK61*nBip>BmBK3f~evGiQ1a{L*p zL)h^b@thCUt_!Tm#ZYa)vg@Jx_3uzsxe=i(cw*~cH$^X z{Tr$&ScoidL)8pja1kl*7z@ks4yO0i6^HQ`s(zp!)+6mBwZSO7Mu|_MvVUew%)$e_ zMUOAUg$pSEALpddA#G&w_4!thskiED=7ho#kP+jCJ$yn%G%AsHJ5ou){dW&6U9r~%9Lr;*Y zJUPKwfqC&CY!w~Kg`OCOjg=j`j!RV?3aaK%JQ|`cj$&U8)&(Eo{DE<5I#i;TLsc;W zN71D=^{wO38nmtJ(878S6{+vg2E;UQs6s=BP9mm}LnE;f_ZmAC(bS>6=+%t#*w~!) zY2i@wmc-YZ+^`23+ARk$-pAZmfgnDh^G; zM}&+cP8@{BvyPaKOUN>Tb2y5`iNuK8C^Ct-kae;{Ur=U>LvyeaS*B7y9GyX3W;)aW zrdbYchGDith3Bxxk#hlKqsBsqX5bd`FJdf=$HK+rw8WtwmpasV8SyM_f`&j>jJT8tBKb9VMsP-xL4mO--EiO0|i%JN(NIdu* zXD-q1GLN0>%=tHQqudP#@3A_RfH^pa8(4RX`ro{ z6HLnL)IOYoEt`|q3r>B3HM>(A(AndZVw~Fle@RZA^gC5M*(p=1lh09{T)XE~v0P4- z$?fE`c&GN}ajIlqV$8=F`JKvyHfUeKskPXSd&pFXanQK1Q}b}Is8ffEIrXfyQ=iei zol_m#JJqCvQ=uK5s)?yM)XAxX-I*J0dpdOlb$)Wn-kUu8Fn?e2>gUvu0Zw@ak<(!M z;UgvvaVmKjH5}no?~zXZFq*kgXq;1d$8&6gQ&}cDdHguF5@C~^O2hfdPSu*?)FUjJ z>eRo}h<&X3? zzaOQ}$DB&VtG|f#np4AWICVNYOtllkl-Mv#d620`nBp-MTd*IVp0q)8ME43)3NB#O zPht8Q&3lJwCA#(r(?G=Z4O1$H!`LrOF68VVrdH^VZUe%!5xdcOV3_)&_8`WAaR}|v z35|z`Y0}6ry+gfGVR|__Oo1_BDu~(R!t~3;Fs+@$@u^`tJuOU2XN0Ns%rN~iD@?2B zglQ{^%nj4i`C-bwAWVL=!eN9jVyn9A=9(~*N=x_l^1>ko(N!HF>acrHx$FH(zZVXAvOO!*&% zsn+u_z4(`0KZI%ge_@&vGbQ@D$3T3lL=MiDMe z#lvhay~XGlmzJVQasGTq^y8OFe74^r4nZztnaqwhpn@b*Wqf7q7ux z8rXz>ONy#>fROK8Gfc zUDOFr@cr-9W4B9_aRw=STq=MOD7Kelhgh$}F15fKY{Nf)xYX$=^B!Z(PPmloluOl5 zyVMY~&ocixm!6^Sb(cona;d{@m&|uu>V-acIre}$KXhsLBlpd=@ELqK0@<1MCgxSBJ=`LnoJRhM$7m4#yga%%X&{2e5i%{X~5nA;(G2V>Okh>8I`6oit9}&~z2razgDZy^tMz#>QdYj$)441{NOE6g7 z3d3ehx49LY!L7OIkkPG;Xqm;WI$7P?h78%<8ig}R%1POM*{IAy7d~{libSecdH9-B)e5O#jOIVZVkX6h)8p*A-1J6eh#;C=5*^7YUFZj z0d69Yn=x?#h4Z?#40j5+HK?FlNrgCv3-A|qt6&kg1|zbVTaPiJgj>O--FjDse9F3c z4dRx&oLgh?8nw$aH%3%&>jf%SbZZ=9E4kGXeJi_l3ZtvIRkEsEi&3|lTaM~(Rjc9V zI#;)T`@yaCHJJldYq?dqj$7sHyLF|3TSXhX^?M_?(i*#U5{H|(_0x}Tg6>+vECX8(3){>EKC69G$3f|(=cw(CDRu8>THHgPJ#I}!{=IIM#r%Eb zc#!j0dC0Bif3V*$=9pW#j=R|w7oROO5iqs3ViHp<IRU$R} z`$*NT8>x=yHab$@O^8(PX^}E4i{y1iB=2cPs`s8qjXD&mO?Z!<7a|pYJyK5|MJmhV zNHu*Dsb$!KBgpY0Qk_d?)Rg`iRbzNYl^L5+vnOZNAy}tmv%ZhZtR>i6Fth$BnOWJ&WmZQNUy+&jZ!`0IC9~>h%A%7=S$NE3(W87> zG@^VK&90Y4p1xU>{Z$r)_slNS+UzQ{A-h%`&91McYri_-P+QHq!prE$1}7nm_QN^hrfd|DLOC`D;A zLVu<R~7j?!nO%!$%%ES}3+q24@VL+1G$ zLttr?rZ0=qQsiD9rLrrCALdo89UiTX(mN!q=R9^`_ODSIvzc7*4pG0c{@bHe2Q6_7 z6?R8y$=)c<+DE_rQ96ST2Uy#K)Cr9bMXAk^DD}jbV^NAe7o{KYBhI7rg(zjc#=gJ= z9L2EfQQD2HH=;Bjo3Q>S`QY~LD1EpSr40YDS5W>z6xS$4Y5QaPJc&}!(YLL=Ca+OBC;qN9o8{_Rlx+j)_)FWQ~oMJ1$ynu^XxJ(efunD=J5{ zI^iO+RE^e|YSB9MU9=AW5G_N^XyvQL@!HYqQ#V>$nnbHy(`a2mc(Z5~Y96h`7Sa0J zI$GP>M{8lnXf^H>t%9ASHMUE%V!K7FRrhF}>JcqRFUCN#-qEViCt9DduV1uo^pDn4 zd>I(6F@vII85}Ls@MzgbMJs)DG@oZhYv`0{y+qj5Xl0)ltvqOn0XTq+^P?45%v?CQ zBw9I^Me~_bv_|3xKI8TJXa#SL*6{7oI(eM@{*2}tv}mnF(W}v#e=}NnUq)-5*P}1+ z#(R{G3rI`!Xo=sWfyo}O$@eHS;L$N$#Qf?WUBkrhJX(NuH9YE#^zS`tgB5$#p%NP|u_P@OORAHT0+pf*N^L1+yA^ROm;K5}JBsXy#Eav`0vDk2b*F z!lO#?wxk~lweskEYme%+@n{>=)}vy0g`jpGEl2kD9`(dje8A!k9{mDaM~}*2I&R@P zs&^tjoIyxukH%tg7msdYYFBE3a@{=IgC^ZQ>WCw_fCW7~dW5>YsKrknUBRl}9y$7W zlnuB0dX(JHqZZiTpY{VhT8p0sd9)kd2Ga-KhmqTGkBX0=&d4&E`xyB%^_bz&X8eOc zW-<0`V#c~T!{x*k7}VcreYy3qUmPF$5njY;!(!mJnDpz@NM;|EOKx2sPcB&qW2DuR^u*m z@1$lpzRRPkzkAdS$8ibYP++%5BQR-?NAnP~*P{VAhb{Zb?Evu|_UIvo{o&DH@E-B# z0FEDJ9E2ZZ4bTd2QT90FoL~>&?n&x;+N0X%J<4&xqocTr@s~WBjj~tB`6~MszhcfU za=S+z|6#8@@Td(^9+TS>9upXcy(s(C!?j%=jd?|z*VOloM=!AB9eeq`M_E7e7zl~s z+V>b8MwBH+*{w11qlP_3zedNXzCT9S3&qG@B1XUCa+w(2hp%FcR#%GAR-{&o;k&A| z$G>%A6jV1xJy5iMj4GjY;~3TM$Q)f_^e6u97NdwBjDym>Vz^G1@qUVtyD#ng#i&C6 z7#Ro9c1Vos4vW#}Q85~}l=0Wb=n9h85#Rb4ox#ctF*5xUBiqIp&BZEA{xwE-aCB3Q zDsPU_G+aa4mKfFA8lz&{W7PZi7_~pdyr*L{@f>{-awSHs?!~A(ocCk6PA*1kQ08Hb zy5K4DKZ?;(Y(&uG80|;XCowAiG)7zS;aQCGKBpe|fUhsf<#mi6q2v1)?Zuy{`GH!0 ziP4W=W7G+kzQt&sVztB&tBuHQiq&D<4vkf8Sgg86#OfdTJ+W$#7^|@{qu#Nytcz8{L$SJcCRS6<#VYBqSa~kQ>JIu}jMYVSxI~-FvFi6QR_mU{ z@;fY6ZNA1TufeNQ_!B=Hy;_TF_=?;nuLi&y>{ZziuM*8(rCPjtj(%3JrXbYjRVDlf zhuy1Rkr?V#2OPvB{NwQQwk~6Zc_o*Z?>TyPJDhP)J;JL^kzVbM_3}F1s|y&N)2mr1 zl8d#UcJN0l3tlgc@=@NxQ7O%y*dk5 z886q&d({%h@gHiJ^=dMnmGkPa@?PCSrV3t7L%$kc6|U=5PyAWWt1I=%2NfE6wHk4a zs9$5R);IC$;g4R8XzEqIX4I^?SG|$51;??VrB~ltd3B<-SFPH3WoYYF{tnc+Be8a- zCSA#)JLC57YS;j;G7R*p%}6h=x#%~_tD&Q*56X}6swVnliPg z3%x3hMT@+AUgFg{L@n`Z@lvmLt@di}8n4=~rOxY_V}n=Wzpy^PdbM;L`R(_r?FlcR z0ejW(B>Ce{qtY3#>f%pyJ?qu)=e#@zqYi(1RS!qt`inI@ z&mMvEBKrp`;JoBjHnhM-w7%}ua@75s`0yN+Z+dkacVWBjRc2gA@*S`GJfP1buckhs zo=>U&3--%P+PwB^AG-bPRik&*5KNlR+Z3l<<~S}%kJA?$$3x@v zog+@KFw7mNx@mE`j4mbPbOF}#aePh~r$yKcRp1;3U{u98zRwq@XO-gkK5Cpg{Sc>t z*ibW0zoS#_IGO9j=@7Ekqg|soz6%kjo6Y06o*+(+4sq;>I2G&^r`_F&qgR|7Vf9aO z+KMi{yaGYw4j8n6z z#5FsP>xkmC9UoC*Zk!IoGA~ZaXo3Cn;}pIyPSMD?C{E>9$LS)DZj6)R*EluV6sKC7 z84n}>Z)=>Aw#8}TjyPT08K=p+sPo=9W!@L3R!8GB0_RZrSe%Yy_whJA!3VTCK`i(K z(@w_e9j2d(Q`l+7!!7hZLw^)IOHP=9r?8xhQ{KNgk7XEmp7!{NjThr|2N9Q;7rpT} z9%IebINd|Z>v0O)p#ErwVRz!R?OvSj-j7q{L&inYV`6?5$2AIZYWjk_Uy?U6zGJ?R zaccc3PCfsN(=jwsy!yi#6tDVdjbo^4h*tv?G{);Z)|%q=9>Kx!8j6V_+{aJmcy+eK zOV)V(gMTr|7OyGxcrAb>G+x~?1jAh%hbuf@7b4m;tDYBplRGJKakUO(a-ZemSTytd&{bi5jS;?*8YP%tK5KVvC2dgHYl!Ey1L zgYY9rj z@-SZhcr`B+uZuJU#32KGUIMgITZGTMAYnYlQC;#p@G5F>tC~95;-%(1?WL%q{pz;e6G#Ur-`{D#0$4^TV6tOHpg;yk~8%!$` z_^v~ORMZSnf#iSy}FqEEw< ze9HB`PqrU?Du;epj}Q1G0tF}-1>iD#(p-;ax_377UK3^y!CDKJ6Rh(S zpDIuFX%8Ar_h~Mw&G4x)?xEx?pPr%8d>_A0e7wFRSA?$fDfcGE+)P{i3fC5&zQ+oj z#z%zw=2I~Y!xR{|`cxg;@CDXw+(x$T)a!&#%TN2X3CU-C+JN(CeLOezX&#E5XMR{N z_>}pgPt7m+)D@|heOigCSA1%Q$;fuqr^l#qjk==xb=C(_fBV!6u{V5LhfC;wlN#Rg z=_EpKGwvPM7@slgE-~R0qV5s%10UZf@TtjTpB_H->E<))@|+sI@~PW9AJFuoU2*zh23D3z)NK?i zlPG)HL}kWLxQHhe6XmazsOxx&Zj~9cN}`rkP1Gigtxn7}5;YUcaJ42e*Gl9&E{UpM zKatP&67^35?l(--Li~$ujS|(TNuqYQV!qais*I2}i88iLYS+g z7}zIKfkDiL7K0O&X=tLlVD2!+8=t6~za*;S=0xp8tu2ZAdOVS9AQSZh->~##qJB7= zs2ylm&ueNm5yyLdJiS)C4PW93Rp79dW)-;=14@y+-a2Nqm-^r1PluDM?e2 z@R|ExlT=uK{fXcpKi^&P>ohhS{JIN|(XZMVjZ?^M@~b`;<0is`{VItrScWUGg!oku z-LM=N;V}DE3>~omr(v@ART!PI92XE`^{XiQVJ)u1W%H{9x?lsE+WqQ^_o(UctBljH zN0ENLLv%*JyjlIqfvI>K<5zmDU*o-g&5ZM_g`d8dna?kGe!r?>O#$*Q=+{IXM5iKt zjXR!^X#8Q6cLHn|PtwzIges#cWRIfn%6{%Gfzpf#zIyJ08 zEr0NP3`JXqk4X=tMAvF2J~;tm@WM3-_oz?9sII)^{XW=clT?455JzGKu^}8 zmtTMNK|g9afY=B6)oZX{8td1fiHwDolZbgTwVy&AW>D{0ehtIkIexyA@7LA&e$89R z`YiG*X$d*5@~hAqzs{i4TECvG^YdJXbws}nemOU?cE9@71|_#K4{~j%Esi2#Cw1BF z*YHbzJ-+2v#Rv39p@)7|Lf9j}qEP#>U!Sn%3H#)kU*A7xPraZI;$Kq#SAOMv&A2!N z!yCUIy!R{igP-T#tnnwmYM>{!eDmu$DhDMiw;@?2Faj$=l64D3Ey=Q5la(1eBa-z2 zYu(A(g_0SPwIDK?&z_Uj7eSel^%OCglT{m|(I;y%e@B2m*^*T+d$N|Hq$ipGPm^^y zCRq()lhp+lZ?Ym$4a@KsN+cw!k}sL}HB+HkVIMDjw6ZTN(KC6aZlT(WjoN!Djz!oP4I*}f&KGrU15`VnqJisIlg zrYO~wqHY+0%ZLw8Q7-(7VG$|1iWGN>x?nplp>l>4O-8xM6fMP3yn!;Nr~n3F9KND* zrWAcc<;*Fnhp|~w^fxLcq^J%K;Hoc0k5Ml%MXm8?Qi^INrzj#NMX%8=z&zN9Q)rr+ zqV?E?QfVnNrKhMlt|NDj6s~DW(FZtkrl=6gV-jxRIY#D6(H0!YouVvxQdAs!V9lGN z9$1IJP$yrC=3#h&6h#(FQTxIv`VB3Mq^L+y#zf^}DY^+~@f3B(N3<+K{V=a&ivBB= zqGF|qvuq0g*QKao#S}fm+sf3eN{Y(Vr|x)(rVUbb4tJ5KVT!7tStDu=dt>rxlA@JO zQxw!JMYi@SdWw1-QdGK2iiRLhSH{C}Bz8|xh91;qNQ&m;)6f*%9!~zKG9g6`CZ#C* z)D+eKnHXoJsPIhA;VX8|O3~g09LL6mDcXl}i&%rjDeAK%MJIQ0eh=rdaWCglZXf6O zr>Mz+6m>kBqP1vzEJdA=^*C#DnxAJ_Km3g;XH(SbB5Q>@msoc^L!~Pz>Ts1k`5)^5 z>o?X0Con<*O$-X?vmwCy0|7n77YsE8bTc@>-$4jyE%KNHa#;hah9Fyj?_LKq6aU%+ zIu;sG|A>IL!kr(3VMyVC-oRRp@i4r6Kq(ahnpZiX5>*1)^L;?RS^>V} z98i`z0o|@2(Ad1t?U($`KN%!<8YsV3il0Y z4YKtM=)&NDo}t9hfPNUpyeK_9pbuy_BEa8145-qWfF6wtXxzjApP2`Ad2&E4W(1Ud zVL-hX2lzb~P}%(f4Z`&UjD0YmZFqpgM*}h*qn`K!RgMR=`b0qcP6l)u{!;+tFm zF@2^TvVRGvHa7nk(CDuLO^3yts!}*?N!6biU`y2qN2;bGICH8dz?mgg4e>N9NlAXPshx(MSU ztZ1q{SPnz+RDLg|>RIJfC00q*@T$aDEmhSqv1zJKVotP$1s=YV~^Pp6%#MRNM$}lEXUB{*>YFw(4F=TG4b|LfpR9(OwWLuD`pBJYp(~?vT zUBPioT$QT7SEp+AnpE9IiFMQgACYH$sup3_wp5<0P!Al3dq=98;_c2<&Duqrzo)7P zenr;Zsj9LkRbx?fZ>p-|FXY&ts_S@+@&~BrkyMR4k*Z_pf09}v;#8_SpC-;Tsq$ke zJb$IC3vyjz+-s>CiM!WXyBoB}`n#+b%G^&?@qcK8RnJqk^}kfTMAdKP0{&W(!h_P( z0jZ`mbq-I{di)rXrY^|fPSaRCz}bvxa%M`?ew;(k%xQXp$yw6$F(yr2W9j2h(`Q(c z)0EU8jlc1froxTWGzndrr|BYIwnwBkZXdn7dPtypb z&Ph{yM9)oA8vaCud1)Gng7ec<5qTC6EJ;&Q)I`LxG<{u8+$+*_3&U3u*P1jf zUzeszzoetg$#aU_&Za5hZ^pfu zCi|^4ZAFvYX-d44rX`Pv<1ukK(pA`*t_paA60UUq=3u%Wg{Ny;#&o?zv&`wbn`mx-2=;6^VUF$(61qxzn{E zPr81{o31~LrE74>bWK2kQuIM$>2!6dm#)?g()ru6>HPhrbd5x=#_3YObk#<4IQyro z+5pBKn67a{($#2ax;i3hSi1I4CH`sYT8dUbr)%h}bk&@lt`^8NCtdaDrK|6_=h|lNRCQq9)z1VA7F_CjC*Fc2!IoUCX4`s8HXeXUJ(asf^8}8kpuVseQaj zeehiala{>WH0c#`xlCGv`}oLfQV$G96`x68`Aw|pV^T(tz9S|bN;Iii)Ff+)Nk3yF zK5t@@vzbW|w8l=XZf?@`mL`o&GiiJ}W3)1&r#ot zCVlwCqz?EB<(``K=`)j#J~!#^E0gZMp+;EpmKan18eP`RT25xJF*Ngif?4y>sG?aTky6d9nsH_|#4UVb zGHZ_6tZ+@U{#Vzm8xFJjH=uv7S*LIflYC}9@tc)3U{+!DM|;DpZ$oBXM~jGA*%HmH zfyZ`ykYrXjc;z&!4_t%kD2w!=ZuTT?alhGgIV|R8cRCT zcPIMpVpfgrjD^=d%$n89%=+GDb@%{J@s9J7ARFl)$Ma-GNirDkV z&a4p|%{up|nf1!3`&P3Owwcv^JM*)HIooAciM`C>KKeYs{2nr^(qXegN2%2@ayUUw zC&~AeSrza%Jg3d-bH=RaXU)2Q!K~k}nU(*#S#6Mk12_fu4W45;5^kE+0|()_W!7;# z#?sqnneGtVe`fuQv6(DatjkhQR%^FzL z9{-@UljBi2U{P1Yq5-&q$M`u&yqM6)qGxc2EZUE2*c`T~bHt)=6D+!l*+~`^j9L`K z8e~l-7F>iU#iANbEZUA7%`6Hw=NOc1K^;)ACHbaWw5^pzM_OC7?o;AyYtfJ|EGpiC zI(4*gO%M4arL#p}<39wuSacI}y3$v7iySzKZ+loY5AL4i@TEns`dQSszeO_!Thx6B z^~29NjuJyHs{TJ}jb5leoH|Xn=q@tPu;?>%!$CBdN&Mf@AKss3(O0uA`UOSjSoA%9 z#gJ9CmHJ;j&BIj`yIW5ojKY2tyjM?+FdQ3jA64$xQya|25#)YQPYux<%W(@89@bMD zrs4pyJgTSq=#Is>h@y|{DH-N^^<}GHU(Fr$mG)_UmE2Wd535^MsfLv`cC4C(b0`yM zRcmD66bhTH>WGcVXSOO8KO>XHstAVRIBFSI))uzvlb}_#u>nOJTlEAdQmpFK)T*cH zY-?kc`*W*&UsyF9bvsz)$1Tk1Xw_+q>%{nQb++mm>U6Q{2A*SWSE~y2Vr*pYZB;?c zz~e8iTJ@DxJHE9l%NQ%)8CkUxjmKK`<2b9@jkoIZBCAR*wyNI`R`pzB)e!7J)gP^z z`H#LideU<=RZ%_!*hESaoHqRrR-7bq15STh(v}wcBe|$$eHG!g;ja zZ`IZVR`ow*)hHbP%c|agTNQWMs(nYTy7!M&Wlvf4HQt=I>a#OeT}0ipR(*Wl%Gw=P z4ZKMm(dCwvbMCCldYieqW955Zt4?CZU8{CIw5rb|tBO3fY79z0v8vfKE7xXG!{=5_ zd&OL3vS}bJnQbh&Z<8mBO+B*O^eT@{b@JLYIiF2`yl>N9Sn}KSXF;0+MQs{}^Tlke zUux4H^eAD|d`vgn^fzkMwCN#K%cj@$ZA!G-)U*L(;J=18t#aD53AZuWXVVc}k1&1$ z$6^Yu<4~eaxsq&Z7qzigI{me@$%^TzHl?N6)BzK5C*7ust!x_J+9v0xHigk2*Wv%n zrZsJCN@{0Qv-UPk!rd=yTHe8?^|*llbs|p`?_$$Eyhhos^o<9|)Qjzy*Vm>~sN3JB zLIZ3n2LtN|lJ_8+`V8aPkv28J17sd$(@6X~nmoqX)OMLobMb09dH+P7$hN{J+gh7? z8`oyo)M$rIxp&(%Xb*F+-=^IMY^r+DrV)p1av!#-@e!LY z9%bJN+Tr;>HqAI?)9L3n?aypinJjjl z&1P4T>~<~8Vb@BWc+ai^dF+~6)Xw^Mc1Ue9*Y&}6){17F5qAB6tRwB(ibHsUUq>;{Xgl8> z+x5wGyV9|7hFxQ4+Vvg&#FjaBy~U~w+9EL5u0`|ccRqF4Vprd-cFo&nSLTa$HN-_EADc3nW>w{|6i)kakWbMPXQLyI#zR3*DZ?NK6! zLsjt$^5t@{ESy8P@P2NG&gOUMaUqA|3Oh8Wh(q;?I^?eE&`{K>=8y+_QL%hdMbNT8gxIhdSdS5*j-63b~yQ9Yl7QL#t6X=ukQeHgc#OmLOY*xR5!? zAvRczvtAXV!Ya+C;mc4rFgx;UzOu^0qv^9>t0p1pc<*RRj%Vy^+ry0#7B*t zjPKNKEKhdImEu$eMz(NjC;GN@Y7`ozI#sL<7^nWgUfdezRI~9;4VdB7O?)!jsiA23y;C#Mc#%`7urGFU&Z3iZ#hvo4ajFR# ztaYmU9w&d>I`!#Zr+Q%OKBsD4aOxWjyyVmdbh+%*AauLpl;^Hf!%+L4Q(k1gPcDz0 z+J^}*ojQo2ubi5Q+OM5j2KyVQ{Fz-^hErKwtOejwpR6wJ#0^BUxmXL*rTJKa*RW-G z$-pmYn8T&HFy(Y96+JN%$BVmkq!h<}QJ_McQ zguCeFa;b{jrDoXTA!khRy41zz(#HXp%y1;T^cgNUbE*7f@jNJ=c4^o%mzLnb3zzb} zbm{ObmtG<9E#o4K+^U?#tsS_F)4AQ+lGm*x82PbVSw3;AJ0{~09wD)UTN${CM-|;_ zUWsGyJ+|O23RQ8-hQSzv@m1ZbQ_ZdQFjaRegtj%@`W7F?xm6K~@0i@WkJT2pCe(Cm z9S+xW>r5TD&enCSU_G~T*xV|M_Q>p@J>uVqck3LoIo+xT4}31SK6Vplz^$ptZhe>H z)@D>~;+6xSztfaHo4J*Wnl0V>6IW29m0QWUh83T=brKERyEUncTfbpn54Rp5cTcy< z!HNTTiWhy{D$|#IFb-?*d=PyMbL$P9qZt>0acaklRV0*?Kq1QLIFDF|2d zs23b@?8kYFN4aWx6szsgNKC2kVLcI#vO7F7;aWqF3OGI5>G$X!ibp(Zh#A<5$B7=5 zNb;yB=AeFxN9p(#7g3;@M|E+jg-3Z>dNe=Xqg|NrsfT+qd1UV3QB!2@>`^rw=;2Y$ zJ|0<6YLG{6{5Qm-qC?sKwMR8@=o^oo!}_g9t?(Nzq2xG^T=)*#F?phg|GyH$B#&(9 zFokiEe=2QJai&KhEW#mVpG^$7nBmcTb3GdMy+=PI$0Fjyv>!a$h|iaLG!b)Gdb9(j ze(}hUU8_CXyOw%h@+c0zs~&a2BV@luJ>R+R(O+=f@bEd7M}=;CI2X*LH1x(I{DJ&W z=^Nf>9@TvA(J@$GkS~_L^(YfF{VIo73yOGEtfW^Vbi^2}#9=%^p;BJi(GmkN3%}zO z`0!hmkbqv8fvvcWHdVbEho&{W8j9z&yeePYt9-d0{toeKRadW^-Mw7@=+)jYy}F0C zUwPFB3*PDDm8-8;NBeozxW88ua1s>;@Epf*2`dJA^#FejqMspNoj~>BUS%8M)y1*I zl|gN=8HaHmp?O{{T}&Hf`oXK;khF=haSj_dlkZlqO73JETJ7>`4odDO_dQ<4_IWvn zncNOB9_AkLY6s4s$Wi72j^kc^hJTRz1a&>_Rlze}RmRD)JV(uo%nK%6A_f$=Ox>@0 z6@Q;Oz@7(Q-No6*US)a0b~vAU`Tdz~DD|BA!=_9=<<9Su3Eo0Jb;QM@K0QU*Vkqv@ z7F;di)0|R1oqgvcp9Yrpu~wds&n4N9xrR@_;Pg8|pZYiQDMx}&+f(SbnNKrt0y$gx z`1$KoyEZf-I`{W+ZM{$R z2KbbKzwvaCPq_yBwDW&HokWr0KE+`KPNUA(K6M}A(@(hbjZZB{`7{(8(C=Fw$M{&& z!l!lPeCjdTr`FTS3+Iq+hEJss!aQuo1vH=OQ^W6ke9q|8u6g7(-^bdz)M)|x7W(A) z!N(f9K9yPG(;Kv1>f?N8pKN&h6Lna@wv|3j!sJyPyV|GfYki8MACCOy)5hO@x`ZYh zeEJ64H&H8O+3ZsZ)I=j(-A3Qrd5+^azk|4U5)bBM-#fdQ-`zg0zxL??a_#e}1KRKR zsW*ll@aZxdAM)uQhX3W$QryKWJU;BxrXxNLK1zZ zSaP_}zaRKm*VCt)DE`Q&x@dy09up%~^5_?_| zM|Qs&p&48`{CbneFQbBAP0yw(*Dt70+plE&SJ$r^_5IrI@GB5c-?)iVPQQwK{M;AOuMY!$)}HjU z_KROD8vC^ozlQv(9`UOq*5Ug^zhX&#y%+VX3YKFJuA_CbU%hYuRZ|!TpJP96AZHW$ zMcJl)#Ul-8@EoO^`Q^jx=6-EJqZYKqSggVEmi#-7d~pSfVt#FhC*7}B7=h*3f_ts0 z!)Jc3b@R*AhVgM7ZQJ>E3spY%s|9wTLwjPv7hm{Qse@myd-=IHD!%k<7aDx!*Ql@k z+Bed#Z^rsLzre3KGyIye*{@Ao$zz*ei}(69?HDm0r_Ymql|Mu6&-#_`0(HPQmzX;o zyz1AW+yU**7hqk6fXaOm(9foTlH&t1Hwf@uOhEpI0bR#zXFw_LfJ%A-3N{PK-8`Vm zZ3DW|J)kF8*dw4KJp+pM4(Q`A1A5vopsf7^x{b(yfSwNwsLh~&nhpu*>d=55qUiqu z8jaKVWOzWGaS1KI4rmh!j0mVX7UBt<-vl%qyO26EpyT*(R6uj_6S9pB=mUht1^BEz zz}kWV?iU%*-}rVyK>20_R05+=_&ah%t6AiZqO$}1EF;f3v_XiNVnc%^ z0cBbm&};aX1@!6ifV$z#ih%a73~0%^fcpL#&ne&@VW( zKcF550$O(@ptr}U(}jTE;Kz&11L|I)9>{$;pnkZ3>Q~s0^8W_7CY%~y4QLSlL)^6h z*WlAPKD!>!JbZeCwl@RXiNd$2h^IU9k_pKc|lu z^pEtH#0>i@^1~kd_?j5s@H#}fw*d{rI*gE^l9>#yYc+H|v!R_?48FfKQ~|}Z85)D% zvK#81!_X@1&1tA!E<^K?FSnsDaRDjs8QP7Sc?``(p1g+o;|fCg3@t+FeS@`w4bFuz zw5*_^^bZVm`q0pi*iqO}p(6B!QAG_sDQ4(daYGYJ82YNDp{%70O-F@~4E>6hr48jO zW9U4hl@mRbsmGy5Xe7Zs4EVj znqg=h?jRI2v>bUF8S0FKSlQT+DMaiML(LNmJw&4Lp4ofr>4b~Y65 zVrV8d<9Js?A9Z7Ha2%O>7;21}u=F%ks+Xa)$lTjd5d?7p?m>noVfbJ}7g6wk#0tyT z)O?hor&u(adHI$);RdRXG1LvGFmx=(VC6XKG~UnxoP{Rvh?`hH(a@I327hN!=c&{V zNz)ANLcQtC-wbLslh^BP^2;z-&y%{K^ju!k^9)U%Z|MC6hT_o(Gk@gyQeMY6vW!@N zV(zeag`pll^LkuKKKSMrLr2kmm7!zkwVL@^OWoG-{`ighuQycmcS9pLlG`7QiEe)y zto=yLIErgX+C&`Nh=04GzB>$!z`&h`s_f?dg~fZAuf2?ebNdWs-*4z!WIbSL&>`Z- z??-t5;=N2@m486tJTfBB|6Bp{<=k@)BT0S*Y2XEkh#_Rhzb$ZGB4qv?DeU>N4n&Cke&l}`^ zyFq=HFR0OlgK`!L>RT)*5mceFLDeoF)HAgGIH=5@1eIPfs6CZ~s#_(f-8fz~sD{;o z`Wq*!2h}1jsBdrx+f7048$)0C8F!JtW>D>rw{}oIJggU#y?#(Ntn5e79@ILNb1*hK zVmO|lSbR_w&=YH%K|R1*G5YBg@7a)f#! z1E=soLQoNm!A@jK49bQc_yK28FexYx24F4jpj& z<2*_<391RkVF#YW)RbCaE{-5?v!DVPhV^)e8qI^8ml)JC+`z{zs29d#JD$MQGRS$0 z)D%}xE;Xn$Ovhp5Nejx2KKKb&Q94FHn2dw?Fr7NJ4a(>iRH@NCFBnq079o9)rY%GC zAJQEJ(?U`#r0eZMs_=P8|KJ9?whw9l7a_if4rx=@kUI1XX@38Z&STPmkQSiQz>vNk z6w=tiA)WX-B*)m03XBV>EqY)z%8UCgphv4E`%nAv~*HPgD2A-f8#ZdO%KU5 zBcz_QLiz=5W{1=ZFVHlDc5_2YTOZOagnthyhAVJx45{KDA^o>Iq-uMJ6L-;jZ%Bvt zg*0M+NKc>BmEgo(QQG=ALAne?s~L#ZM6r z)}0Qi$ysti>kGt#XBVl%CE`Jy%jA8ZyfFL$W25-PkiL2pQkTae4M3kKY=0Kw{sN`gp@S<_l}1Kdikd9|)^pD69lz35WFoX5vXC ztSbq$L4(AweoG0<)h?{5UFZ|7z6xs%M)wVCe?J}vgjp{wtXp`0U|0uHWf1LQ8XVST zJVf6iVI3bD*05n=O`H_gAq<-w)+7|2LXK0zDm#t%R)_ThKdlMt54hKcHE&&5jeia6 z=Oba=!Mvkktwfz;VNE_xoF~G{dnv3&c!PYG!gSE9V!nu0ydTl}{1JWgK|~p4BZ^gt=zi6Ru2hTYSoMf@)re@JDWYlSh{jnWx>Y-( zzw1P_y>3Js>d|NYh)UQZx`8cr`f^6p&>hiDPegBg5&htg=tLl*`9?(NF)0|)0#s@g z(btV5${C8N6b7Tnz=%?ib5KM@k%5a@<6lT@hWtmzK9B(k0^r77a}T%8F+k=F)vYv zYY}C;9^qP!h;}1xZh$#f%_3Hdce33BO3LLw&?dfqS46z zBBIVOBP#Za$4m)YhFInVb-^PfW=+s*yq7J3^Jfz@J9~nvJ=8DED!oM#G#87NsA`!KRUc{Cl_gORu|I2~3TI2ypqz;sStwE0;3|@+ zq@szMh-)ZaEK$vhC+Z#wl}KbQ|3v*&CQ;|`dD%p@EuW|ZIQ4O&K5WPKF7(wkQ5*2I zTcQelm8kN=5|w*YqUKCa)QTyIDmb6M7AC3>uHo1ZiTY@5qB>yBhD7-{CaTMyJnl|Z z|C5QTS}94}nX?q+#f~CrM@gPSQ<`Je;JSCzA9Sw)|1G zD;QPzq^LH08r7CIQEhD-)#MIQ?Z?xeQRV3s)l9^`j4GjTR4oQX)ep}GMzwuVR4HSk zdN@9+GgG6gG%YGkkE#hypw)L#c@{*KX<=0Nm(lNrsP5wLjZyXdBdQU2iGhDc)q8VP zA8v^%Zd+7~b`aA}j>Y@Cqsq1?s>*w#a_)<&{?VukpNOgoR-K9Je`lkbdLgPcSay+d zE=4u&aa6OPN9BDHRhO4h6?_#{7&9?0Te9ZAm#jN!HVQ z$x67NtZundROG`H)x$b;DU_ncC{!dxF|0!FqAB_cojyuY=W;0ul~2*Y3Mm?zn4;c2 zQWO}IqO}WCv~pL9wqfWV`q-Z$%jFbhsEJx;YNEb)QKyM=7)@mB&_qQyHsRi)srtTM zs&;fr)v#`6Aq%1umF-6^S> zGc{G78L3A9vny34j;89u zrBwa!AXRf8rgA-3s@7*olQ(Oc>gGt(d5p-Hrbh3l>A(DGDo`Me_b2;4Nz(~$n!fX; zX;LUn$NHqH=HN8tACjgZ2G2~>nK@}Ho{^>lIE%@1(^O?%nl9rZUe8aH<$LV zro2mej_a$_WM7je16T2KZJKJVOVcon$7vM)HBDhGK+g4PDum$1G%ZH6&1rgsGKbQ1 z5I4`J@f~EEJdf!EwV#k9ZeZ;5G+o4t7intsGEH5x#PkzdWsRvDKFk)=nd~tY&k@rB zoWrB!1} zsvcvVikQA|$5cNtrt?W06OE}(3)({IF^$6TzA>G|j(#!jVG+|h?8JZpF_jn?Q*-1Q z6jMo@LZz=`YKLMYVycV-$Tl*j))+OKT;LcRQ-9PL7gId)j*oG#znJ=B+oYI+lVe<) z5z}dG%ZMq{+!*%@k7+yl&5LRL{1|f?)8Pf=w~%9S1mArhQ6BePzZH_CEu6kwDb=a1!D)w~#_DEN1n{<8NHeKH%Wn{X3#74YA zu2Jc7U^HeR`{;DNMx$@j)f-2#dJKJyP1p4a>9S8uR~t-32Cky+q;z?)1+6Bh^E+|6 zDosh(Zrnw)sp%Suqp(d&=RSw&T8d-1gu>I))f8>96_sbC%Q};7*gY$qd&;J()Evx9 z*D}06KV5e)ctN^eV*SE&69XXk<3+Vq(x(?wcGM!472@cG_ zGh{!VuG(kP)#7ZrPCD~W_jY~pD3hecPn`95_`m;|i}zYL^;DS_M<3nFm$LB2nY67% dR%c91E8JpGmRv(T9Z&uLc3J*^ga7yVe*pF|$lL$` literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/19c0eee8cc47130e_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/19c0eee8cc47130e_0 new file mode 100644 index 0000000000000000000000000000000000000000..12613adf89a48d3d16e5a80f1702181b399a3094 GIT binary patch literal 30120 zcmW*T1$TXH#8ckc=#)j)~cNso(xVt-pA;X3Ym*MU(hP%5A z`+t7_yMUj?@YFx=G0l`vF_WNd*>4k*J0qSc`w~0H+oaYp2xb zvJ{l*q4n5>TWIX|&5Bv{u2+qMTe&zT7$aJJhb_RhxQ}$rH86~ z^3W$wgPM66bUMJGjkyfkgGady+MmauLir6^j~xXJs#nmUzrQmmF3_N!I2UA4t6+n6 zWf^n^WwH%ASjM1-gW4mxhC!vV8@8GTwZTGkuSE=WuW!(lW(IX@ZqVD# z2E}wSXcVTSd{={h!G~_#?`}}R9tK6>b5Dbs^rCNXgJxp~3ily5nEM;l2!G<$0LJ~r zpkf0J>N3cnt@vxOLB2x_a$?I+<^;p924!Lgei^~zkp}f0Wzh4njD<$y$aR82nrP4< z{5FX>WB+7>>{G}a@1~ObG=qv`8!n*BEQ7*k8Dl*@oVVDHRLW5$L7?l4v zgRU<(XzU8|UuDqAwFX^9qm2f6?lI^HitaV&7(5TKCdUkVc8a{N807PhLGy9p4LQH3 zh93BspZ^TXi=0o4|Jk5iUkvJpOW6CBb@VW5sllitMx*k28}*~fsNEQ5Hfj#;45Q5O)J*QjgA$Y<14%*$`ovjRqyDri)9 zd_>@PMm54V3@K#P$Uvh86gKJx8U`8V6JpfKP@^V>u?@~BqejOV)is{`Nk-jq8g<=e zRDoop<`gsP6|NOG>P;!55>kvBm}*qxbfZonuC!4vF)Y)l)wqWQw^3s-3;nXlE!(J@ z2r9!q1eP^w2X2>R-sO#QqbllGFzPO*R5WT`B_n^Aj2e!_Dn`Y8Z&Vf3!=36zmH&Y@ zIP{}YU1}QTU(2WkID`wRRokeUb&OhuJ6K%Ts1Nmw`m3o?kMJIon=xi{=GMxnrmc+{ z*T$&VFts=87qsbY)WI%B73#q{;7U)Up8jmqs9vmFU;Y9QGpZLl4L7RwNTVJgbd*s= zC$OgfGlhJRZz^%{Xd3sY8`WX9Q4i-BRdB9R&2eHL{TCV)wZy0ztBJSPsKe`x8nJ;| zZzRV}My=XnRQzA$xXq}`7`fA^YP%ToAT>Qj{44akYE;&J#zj9Ac))sM+(V9qM@A(- zG4gkdxuf+{qe?zAs{eD2N324Nw?<8PXVi-KMj1aCHQ(&19A8f@#WIVh?%F-|v%^zs zk*}bq;;|Kf7xL8RAW!WH_0&x?4);`Cgr`DdJheU9Q}v2_Dm%?nR)fJn5@YI^7p4tcBW}bS2am_uo5P4g8Y6d2>^3-A^wf0oSww~JEo>(1d z-_cXCojeuXnVh?LszFyzHR?-F{XCUAz*E(5afqju5B1bv!##Bwr$!KWl&3<*cxuBO z+Ai=^+l8K*yvS1}7JI52c4GM|Pi#-rSmQ?c^383qEuviDZ8qdUexr`p88%I+T2SwdU)w%Z!abO;w9%mwhgB5 z952Nz_R{KgUK+W}OLdNT>FjAQwLR-4kBeSfao0(~^+zsmZOe=N z-s+0tx89eee<^R(OYv4js<-NA5WkYQT34YR>R0#HnL*x48tJXJs4$9g;TTPSTpaJM zjvKt?+T*Pm552X}YSIFmN&O3&G!@(N2-6Fhv@Fo1B|#>g#q3~{>W0uZ%%lT2hr8h> zy~fiBlRja4B>SUGT7whOCSAqn7?XTsO==luQg=*;n^dicNq-bG>1}b7!b*@c-e;Qhz1t*vmPxI*#Mrpq*rXyqnN+HYNj00& z57&^>jC$ZR9L-H~wJ<3IQ(AGqok^bUO?r$E=+n`}i$Ie`AfU5JgS%2|#C0?28E$na z$DSrd{A^NzzKnsr{i)3_CM66ssrn$38e#ol`VZkgRwLI?>hP;c#^EOA9brQeJYRf8(tvSbd!Q{9Oq}5RAV+d%`x%Z;ux80lHUT8<}NWQ zYMDv4PRK_eDn&T{*l_e$);vBY?Gizjda;?A^mCZcI%z9OYv8$TZ=X}HlncXB}a zpNZMaEJts%YVg4^VeDkLNHR>dZ514hk+H26iqq%dm)fEH-Nue3qJ3 z1y3<-nOQ}CGbjQ4`F&qqV>4hI8#WXt8Ff+&H%(IvN!2H`b2 z=kZZaULP&W@1ybseKZ!O3NaR<3j3%%9Kk-S3Exm3Rm1HtA4P}z=p^Pw_~>^WMCC{y z8RKY=1pJBG#eB4+xR2K11nQOWk#|XQ#z>q<^-=CLAB7+TM^GixM{SW)#z$i?6PwVY ztdHuJ_mNixALYT^iaxqn)kjsU`KasnKH7s0)qT_-&r!UVk2=<-esz2_sV=eV5eu8p zpuUgH4SbXzN1M>MsgI_$^wDDMM)g)c8rPP5+mUa3@q-N*k~W^!rU=FI*Z9;eY9h|kEYI`=GcWFXZoo5Y#;TVhZDGWlv8 z_9NEMS3wS6#iJW;p`X96Hstly=6tk4)BL{bgjJ!w+KTF7zA{JnDi2yBAc`31i9e%# zwHKvgd^J1PSIZF+@2f8On&7K?iN1Q{_EkzYv5=MHt0TxR zYU3&LJm;%M=Y7=-VITl5ixA6MZqBd153aV;R zW&DiAH~~jpivsaiefl@BXb)aBx9A(1w6LfTLR(u@59`sUE&Wiwy+t*V+QFiUDALiQ z-#T0L71g>}^r@Rgm%3Y&*2AK17zmG^7PaVaQ4a(Su;|?&i;ROU>OI7w;qV%2QE5~` z(lCqC@e7VFqU9KiwxH8Ei>6PY56lxS+JU3+pKQ?& zc#A4iEgCtEcGy0h@n=}H0BcZS7V|?h?3!)SkU7i~&UqGf#sD0cPwWL2<%N48bHup+ z-7d0d8xA9V3AM!`)LLfIR4m4--z>U~(ksXVm40UoOhCbvtQ#7xVr^D4U(8!$(G5I9 z?zP0iN^Hfmb<}IUMZ+)|`!`tRxskbI6ZRu!6E#B*^xDjEvc;l%$lS^rV+4-;#eB9g zALMLjO)wSBcUZItYcY5ywL;rn^xbVy@*a!w?WHdJEy}={zsdVBH9W$ck8;eS%`svf zC+`y$UBjf47BxC$(T3BkEvlYj&SxzOIma=Cob#+Z241iz;UcxfoJ;J#Y|%8lzQX$c zV^Ps- z3GtBm)S~a7S+o~Np0idjEt>t>qBqEXLm&L`)}s0EEP9Td_dLd5aDLzzfa9L&SwFFfz?6#pUoEA@i$8#Tu@{2{CM8LYZ*v?|Ths_vNLWz|n6 zt2$t@zg4;OS=B9s`?!f`xEjiBm{k$sR@o!0YJkZ|kK}QbRWq>+Ut@?DYt=$5NU*Ay z%c>nktU7{{MXj2OMfk6{RS!#8^$xX4S+xQwDOO#;kEvGOLaQ|PBX7D@-_Rn%s^2lY zv{mP7T2;4}RrfHawpE?$Smj&Ss^9Qm1FHtKuxd0uwzjHH7ppcQv!|8U+*Tb$#XeSL z_qA#xJo;PJey~-Whg;=0)v8YmtjfQL`Yg7p0tVwI=C8KuIXHO6K4xGLr?sRT3fB!yPaC^U_LvoO5H_Wc2ny;?B8qEgnh)^ZJ1j3w#s?Ns{Pn{mVC}x zwe37>a>1%KSaQ{>b^lsb`I=QL@$kA;*KV+ux2J|;T=4m zS=Aala1s1`FdVOt`JYvmPsGFw+{asV|4d#uk8)qw zhh?bzm3rW=!6t{%rZ(7yubwuQ^s;FLZli{`O-u0}i6$GbqiiZ-wrMDyAj8L|8Hn<= zsVLfD0qho=>S7y;T5XyPtIejBcAEnMaJ8X*ew`mR>0XFT&pg{T;w#hrlrZU)y zci0(hQ`HcgnxJE-P4`eW%%)Sgi|BBh>R~7*McA|jw^2IMrr;=Y#{zVXw#gl1(?h(& z%~VM$8a8Ftw5bZl;t)F5qQ13l`WOFWcJ`*}8>fu~B`#P1A4#B^D41V=#Xqb6RB6Pm678w1j+?a!f3r&4m=*)l#UWl8S5Ffc+N5M z!lq&`Z5r@~zb|h&Uf$6kt=`-8;|H7ieq=11|Bv~6qAp)~4#=*12D>VI+BMN+*A=r} z&3){;kCqm@@>uN}7GT%d+;)x6W7mMZcHPQnSI_)*&BVV*Enrs*{DsFDU(l}II1boa@`*|i3pg6vYTU3>l~+OA_UcGZft%QL~wd2+i-x$MeFwkxNIU6-({s9o-2 z$3@pK3+VP`Ia`;&2|rfA-T9H0$N3-_WJE zp9UbfkDn4S6vn=Oa=_KkPc6|6UHkiKEq0*O06+CZtzU=(;~?6jBN`3$)A(Qg^bU20 z`{~69KgEyqQz^_G?WaG+`Dx{NwomfYiOGIiJk3w7ru*r@3_q=y<)=+Zo9(A3bNy6k zo}XgS5`V*g0b?!kQ)QTz`YCC-pPFI|cCYZ$ahO&z_G&-vU*o6F>-}^c>o)so%@+1= z^V6N3ek!-yPY3t;>C%2bt^V6j_mBGNr_+AAdx2W~~An_TNSRJOi@_uviEMt@M~C9OIMl1VLs>l>3hwDp zm7g7YjX!!h^rg2$MFu!Dc#uQqhB$N+zYlXLb~v}An8Rp?+Kh3?FxH{F;~c6v-l3)w zh%|)z~*6VMFn&WqD#=Qd$bv(qlhgq|u4kaIVsM-mK8erxr#y{=QQ`EWY z(C`}$wZG|*>6Sx1(fc;r?o;On4()hI-$xEUFL&tjW9sybn-bvJ|Ae0 zC+PIip?}_t$wGFX*o(h5gkg z*k7GO{1qAMuSd8W=CAGH{<;+5uO*TG`Xkz3zs31$cf7x5CHre`34iS<>93Shv`g{V zKdJr-NcY#E493Ee(v0Qy*RU*q1!wzf1ngz}wFZ{5{`v{~P`13kW>@f6NELEHb~S%( z#AmGf!Cw(S`fDck;CXF-jjZRd#GOozZwCmTa#OKsvV&2bpzC}UVy%J1E>CKw~ir?YakWOb6)UzyMtyL7a&JYB@DP z&sGO$?wSA{_#;5CHZjKj0G-FxZ?r`ok6apyn_ju}op&zvGUd`IILx_Z@X4juGjgfi z%v@@K*U+q7%E3g;N5R>-v=LqA=F(bxKGT182`$pM%#1g z1uE>wrIjeUGnXcz#I9T_gSoqNsnS07;kW&{)a*bmox#Y%xs-e)mzsXcr3EOMFSp8~ z7mDQ1&1-_(s$C$rW;t`KaGl(m-Xgco9IODKg^>7kMgL=<2+h|tvCqh^E~S0&Z~+2@~ZmKyviAs zS2HK%)qeO)%&X<|^Xkyjyo$Y%SLaddbzc4cDX$)2N4|Vq_mEF>3glCPdim6*VLlaZ zn@@K;=F{*V`PAW;d|G`lpNuE+$?I!AO*iCM@6i0bm&&gn!t!eoc9qJn1Md9#u55mF zKaj70}GO1r*e$fC{}VApahP86R%M8>H_@h*yl2Zaz4!f`}Cs0Mo1S%6_aRc6E19hTYpw?FiRCvWetwEnk zfx3p|DuJqs2B`8wpz0yDW}qtIC0;ZOR92fn_3jv`lHCHe09TNwd!V8)57m1GY6vFc zGg|fz)Jg>R3DjED=o_dbi0l`r5vcnMZ7>i=kUk_(MTZ6|VOXG2@EY%b4OF`kf$D`; zBLmeP8*zD5pzdS(=s;Z^6R3dkff|ilc#dfk0`+zh+b0L|xqYBEz&eGRU;*wTerljv zU@7il#WeaOa5}X?u^EBtgcaC1GfW*3G;CQO*RCn6TWT?Qr-*(1ugLwWsXq4ql|MbNTp8%sn)q5InM{_5Uya% z#URZ@naj-SN|5?u9cJAi|2sjtdoM^i_k+|LagWIVF>8v^*o87rg7_>uNF!g;<`wmO z9i->j`YuQj?}JqEV~}Qh2Xoz6u>MA%Iaq~!f)#`6mSC+b9ISdV!Md6fEK6pvw&PMx zuu!K$<&Sd;M&5;q2`=B8j}YzbDc?ZIldpK(tFYusu2!uxWt zTHXm(H`wn6b6r5Nen-xOV0Fe5lz14d#aQwzSRe591-ZTo)z4i z^fg!=aq(NQ<|ssq3?W*JBAy}o8#k>X3h@h3mw*u6LrhSJ>PLlWR9uJ>iiT)ST8Mho z4^g>JA$r&=MCMf?YOp^<|C|ib#M2>)J{zK-^C7y0eiuS?0qrl+=2D3IJ_ymOry&~h zJVdR(hNze!R9QHKDaKH(#6S3oBA%h@k5I2rmGKT$lqpmR=1@IDU!PD-gw;1x74Zc& zOQ_Z%${MQn*oTL>XA9*N0gRfA*9 zA7_w!Je1F;$mK++TB0wO<4=4-#gn0`gEQ!IDpcD~hw?X`nw|+&T^xktY^Z)dN9|z0 zKwYs6_KVE>YN(c?&cEb|XQ*^NR3~s7zBk#I7^X|;><-g;_>>FdoN1UAU>8)LeW+3` zOdWp=(*Ufg5vCp8!t{O5Fs=AGOqL&&m5mn0kB((_u7Jxcb5F5w3b@g~O;~2v>cSGKT9MR(gi(J-oca zH5lW(d5oV;;p$`#mwdu?4{z{`Z@4B}!Zi=wtl=8!;4$v_hwFSmxbC7xu5dNQ{(Rx; zoIhLx@e_9k8G@IpA_;IDZqu_1GOQ-z>J_A&z8+>r$C;6(}1n z&r0EHjAJNOIb6%|A8J)$p6J#rTzh+ltH;mOx;HWVhO7Eu>NbqNBf~XqY`9vC4_EnV zj5CuqE5o%E!&is%Szfp@{$adl%poj7pBqM~PNN7pn?&d*tVQ9b5t@sw@M{*K_IQuN z%_CF`w@|!AgdTT^P(;@V4erMF?h$eik5FG+8bPd45z3kop@AqeGeX%ojL6v$3Y-(6 z?F%C`LseSjZ}EMNNpMvsTZg+BvLU$Bei>Er2a$g(UD3V6RCz% zBQ+aUr$wp}?!Y}GQcqEFZX|z8A~j-Vq`twrDpEz(N2>G&+F~6X8zc1tmf-|G!u!ui zWnc&7$-lLcnuCmUj0^MmNaeo} zsb&`=)df{9N2)2lyAr8KsQyo+&Z64YNDV;Xzme*RkZX}zg^TERJyOMQMCus4ZxZWP zr0(GpX55bCx}Qj0Lb3nYhH;A0Aw(FW15?7EvXWv zBGscb9o6bZan2`7_v%M!QiCY%Xi48zQK|%En<(BBL}_t{C}nqylA}|U=3+qaD8>I0 zrBP@;FiQCbN2xPr4~f#7F;TkyN0cgTh|*uExiLy#k3{h~c$A*w8x|jn(vPR2v=#Nw zF&9)mAEgG+g(&qzp)2H$sH==|H%fbOJa07DG)Ak`&1kK_XC&W>Ru^2vBgEW}R&fl& zKAc9yJJH&V4tJyV9A7Z>ezbNyh}Oc#(YlU=C(-JLm1zGoT66FQ;m@KK_&i!KQTRo) z2EK}x$Lna7!Exk$6RpPh4M*@1o!*h>`)IBWiPkF=`4G+d#AuyE)&HV32@#)o{54vs ziqRQ(dBkWCPGEx}Mz;}Uj8QF&z;WdFj8Q!-#C7<4#mJ4$Sc1zid&j60x?(9Vz-Ee3 z20CCKPQcR~qf~UlQk;jkPmI#h7b|fU4&NAMqBGW@i6ur|@E$d6G0L&W=wY51g%*s_ z+u#@_g~Vt~XpE+Z#i)4 zs6AexT6uD*z`QFn$IUVN1<6}tl!Zfx_=^}jVl?z(j2_*HQHA?4oa2pA%7YkHgx^E9 zKaWxP3&wmIqhhaObpL&fLO#T3z(?}_FGd@`#poF-dBm!SAy&)0V|4@R=2%&LV)a)* ztUh36u2^k@J9n(+<%w1Myxb3p<@p$^OTn?K9}=t1Fo(wS8aP(gBC%>yG**$tV%0B| zIOvcTtNt*i$LgnySjCr))sD)s`h+!AVzm?9s>aG*KUS6T4So$`H5IQKGH#<--n++Y zGG4Ta<^6iB8qbK;OuU;Jt3|V7b!tnjrtOH;ISk(!tLX^b6{|kG$z@Nh_8yCsj>l>P z_Mz8_Se1K3U)*{etKv^$wf0%83O|ok96~f=!kJ0#wO8MgS z4VCi8sV+tph||BQ7!jx1*o!NXae9QhQE_U8GtqGhh>O!Jw2fyBti^FONr=;GY(rLJ zoSG%Y=_-mi<2bJ!rw_2X;*^4N7>^rxhF_E8v=MuY#Hn=AIPHW_u{d?dDx5{_;&GaT zp(W##CnZkpQseX|TBOA(EuDC%lo6-vu$PWgH+)2kOlpQX?l^tPic>~5`IU*|xe=!Z z72@<1Z!1x!%5lo6N3HP!P3p(#G;X74gE&=2(}vU;PufwF_HoMY9H&7j+J(M2f~anB z%H5s$4~o-V{5LpGH-|Fzv^b?sXTJD~zh=Z~*F3gk?ff|HM%e|_bYYx&FN)K#ZS3F4 zeyrWaew5wK{ylMOyf;oA4#jCD8Xb;PM-)6ly-#p^lJ&s9n0P8qEiX`i)V|0X;wdU# zj#K+99A96kFMPgHb9^$y^BO!}Pw*LoJ>zxVE1vJP#LM9mud49yjprKucumI}OS}$S z1vv%It~PFSxolUcc{) z*WZWYWjstg96;qG@mg^-Ub~OQ%XvLsWAN=JdEScGwA=Ce;ZD3l?#HV>wmgW}{D<*+ z`5$pV#dB^UUbV2{OT0#WB@a`AvhcS#LH&IbG|ZMDulxxb3wwbC-7lP=ke~z&2u@H+ zNP=cZBP01}d5HvVLE*FnHGp4wf`YIVhSCYzjHi_n6jeDvL#r@e)dY=e zlAvSwrD=l3BTusgb#0!Yzgi^lnR9|x!*@V}cHzp11mzx?pe~~l6gWCTgJvga8}iRh z(0Tm3B0(#DPta{-u1e4oRNk4OQAppFpei^E=bi*z#pt66I*fkDmuqPm38Cniy!V2({xbp1pPMQWo& zjYsEZiMoIntrL~gCQ%Sg5wj1%Vx>uqG_on~UL=8j2tVFd#;n|5w#2J*I zlc--&YHp$`py)huT$rf1MTtsB4FoJn)Yqlty)02TF!VR_`aMxgS0$?AABpO{k2d=g z)f0XGPL#(1>VVG&6E)yaqDG_m;Y6)ELjR+Q3Odf*P9-YhU*cX*l;uXEHlgv&L`B_7 z)S`#v@rXQZNlLXRsXSgI(~-pYg_HEqKS`7GCg}y5=1_4*@8!{A(-q*d#Z z6uUl2?KURqz}_TH_&Z5+QT_n=A@9K?J;J(UNg97XNuk%1bnqsRU-I}(lIEb?+a%4v zN&N9XNi#j1@-jG;hBZc~N_#nV2{J`n@^NaJ)v5e8ry_6)4nL;` zJDlpB$Elfl*^lb^oLY+T{7$`$bn0xBQ#)el7wgohqE3B5WGSaUz?|Y#aH>;@n3nET z>kOxQVOD9Umj932sn77qa%v-9qHr0fy5bkamUZgqa!$Ut=hVE4#IEMl$?8tk`O&GA znoj+J?PyiYDR&*Gs-X!EU_)J}9@KYgY(uBUH)f2VoXU$m2x#I|1uSSze(jx_j0LFF zfx2{LE}fnHyXMr~{!ZS1GbTEWqlV)d1GOfQ<4h-??>bcjrrAz?oafZh`A+?VaSNP! zx0re_aq1HKEp;mFH>cjhYq^u_TByMqr>q;C%05UxyhY2y%n6UqQHzUCeZ`7PPBpsh z)RAk{_oh?1-#OJ5KO^+LQ%yfOb?&26&p$i$;wv@6@^8#RF6HuYsg9RRP4l|cB%h1# z^0+uBRX!lWn8*~`YBF{$<^W@D+SGArd|j7L)N^TTBbOptF)rS=c4<~y zmtNotmbW8zdt!HVDX|M<;Y(MSW_Ne-J2Wn}?djrrF=~R2DA1dE_HikoA8`f}2Vby! zkV`Q`=r`1*CnH>HJkq81$Tx~Pj&^DB7?*C1b?MP~myS1?>Obr4B1ynzqWNH>+LJA1<|9>(cpkv|Uf^ z4K7vtlYN_9`gOZY*LJ%2eld05>(cl8TsS9|O-J>BWHrGVfkW^iYIFT z#%3gI9_o}%R%={Fkel|1DW9xP6_V8tckmW}R3u+asFbV^$gYyCW4MpqRg=}BTCzre zpR9YB^Fy)%eoR&)Y=mbGa=}gH)J#@ltz_+osZO#g)};*!)uRpwsLy;GBx~PK$vWF4 zS(}=YXNzPFY?G{lZK+ecWUk3#{;1g@S;O!Q6+0&D5$1LxR+nU@;}S-9P1XWrcViAc zll8ezvU>MT){I}0)ny>{!ymYS?*=6+VFxgx-$uvyxhXdnoX{q^e*fjv?ShNmas7Y{N^$zAUNcn1i$M zeN|GK=z&#ujL6p|)euv09L6^#RSI3O3^$SgZAsODt7IvqmMW#X>7~@LX(<&tSW2%G zQWTw-!gmf+G#l3toRp#_n1?IK>r7EQY=_;Iq6YW_9?2=HhQYXiq7_p34U!Z^R7_DZ zY(xIaDSC&CHB;2Sc8cCNW?S`rfLN4j$+I)scNw@RrB$A6?v^r)f9NGNmc5fsp^3?}s$4LD3)6G_gjS>eXbN7L19MR%yD24!@@9H+YUn z(_TbOPg7%TpOL1qGt)Q+o~CbDKac$=KR-=N7o_RV!ZfYjlcwH#)3jh;nhZD7l!@0c z-b&L*+`FBoNq5qe@ia~Skn}7~rSUgHU!>^<@_tKG4e(15%7?l5&m&#S4C#vXPFHJu zXG&Kb*1_(R&exaI^{*pcZ}X%pDQ~*QL%Py1^T%{mtwEfc#6iPa#KCKPUx&Qv zrpw$uU8msNAziIHrmIk=bh$dGs}n-Iq$?R)kf$3tVcO7iox|{9>6(u0U()t07f#j14O$E?-l1m~J`jr}8CrPikF(AIQ$ z|CO$-IE-rB(zR-Px|-}r*YShts&t4Ne`J198ET1n(HZ)RQ!yF3ftIludJ&hQvCa%_ zOXjvnhUTJt(G0m#GPD%u(lT@hZ{V4pq1*^ZQRJWonxi|0VhWaEBVOXy(i!^Box$g9 z87h;L!Rx#Xbt*@!3K^PNF++)!GqkTthU!$yP|_5}s$N=it(gj&kg2T`GgWPJCf9Lg zs_(Q+`OnDIZ!L z&v45%*sToQ98TX6Zk@p`tQhImW;7Y&)(#xO<8f})8ShrV8E!p7#2mKiG;RlquAnzA$>PIHzTpc`i5LcuJZ4WwP+EOml4C`&=8 z@;|{@dWv0hcj6ki1q(-mYmNK_h06SuW($;Qp*2aXH9VOMwZ^9(9JAm;Coy{v0L22aGN-H zvve6Rk#jFgs6#$bG0wu;ARYb%@y*{XsTiP;*B z+)3GrLiPV~X6q$3Bxh?vk!)?knWEXcT0C3-mdI8>$!wWYvlW8YFr?ET8UK@!t!wad zXDc3Mv$7SQO^)TWHMK^zX4TBrZp78fRytb!Pi^AW$=1&L*}8+opR!d0_pzo~wk{#F zb+#sT%+?kh?V7Du@a>kZP^92E-s8Vs*$VE>954!B=nt~r+WUD`ZdYi3Zk@|skLFgCq#COV38N``$ zR2{7>Ir{Qlj=~D%sBKV=rl4wkj=Cc~iT${qoFktiIciiaMP6_4aZ6hjgS%uL?+$CQ2{0i?sPC8eynoL5oXO74eeQFgnGG;I zbH}Aj{amVwqH!)Y!oNdZDlm-oBVDS5nB>yfg)aSyjEl$<)0Vij6&;tkGzm$o zUD}JHzq#bW{)gl)+A zoVakmaOsOwmy%KYC1b_1cP^!2FTc*{*8Kc#6)fVG58q-uR^ud|A#YK)>Y^0}VHP&y zJUC&fvWP-&%)l<(L%Yx1nt*1N+!}_|FWo9x&8_S;-KvR)_1r34->vUFZe2Is>g;vP z9qm>(Ol|4bhe5X{hukU_acgmFxBP9~O4rVi-TBL%AlyY&cv#t~Miu#?~E-cb8j5_OTAF_q&yJ%B{V~f7-2j zXWVLwdl%fwebKFQICqKH_~IJ1#^e;@BG+|ldE2e}52-5-K62|mT0M4a94J%Ha3(o%Fv!zVmCK5180$`wZZRJLmk=~8jm!ciI2a# z8_Lzg(D~j5lTaJ#f;cRF?|Xx}+6=A7zAc2eq@Q7^D14ZU9k_}XGY$RcXM^)K)D*|CVveDYk__#i zOMT`U%sIn*^VxQRp?XVrA0IC@^cL-x8C*kUs1Dw(q?W5#x7yHTB&=cEwT3FLH+1TE zLt8f+O2MA()E8-Y7%Ge}&=@y&6KfBzaRyiRlJ`FP$2=TT zIbx^}h95O_9ZilKdVmps8d`??c#Wqg4Q)SV$WCTV=yS%aLOG9ID z@HP2l@Tf7GqhUsm-e&d4D(z7-^uo-t9qu)@vnnyACw}wZRYI$VVCob-yXakQ5xjf9*>`@YqB9G}| zJ_e6gHSuUGHu^lO=y>!kHejLOqj0oG9|k-sj}LY}UNX6_H9&JJ6mb5`U*5OPmehx8C+`yu+M|lt9Ug7pMgF@zT71Z(Y02bxhM4C(DtVEbU-BsXRmP9eDeN;GyXjF}7E=eZ zo7z^=REbYb{aVFTOnpe$OcimN@-{cssD-I=?M>b3Vd@zc z^fZ;fm#J_cQ>DH)^?ZP-bOTM@gEPof>R?mt;!HIgYU<`NQ;$*L2UFv40iTXA^&L{s zYNV;{$TiAT3oO7hG#G7a1ok61#?%?)8EYyDE0I3l)JO15Fga&wa*w^KJvf0Me=?PQ zhN;3Bi+n#bR_W${y2ZcRL`TPHk>l`E}2?fHT4$1T%*>gk;0gf<+`Z> zxQdE5cpoMIGP&o3I^HxDhksG|mdQOnrhY@)+otBC%^lj_HMI}<{-## zLhu>6;V!y7r>4m9!c;dL#^zLFyd*v%ugDp7Uo$Qo#4m5i@h!(1O1v{Q7#lE3mWrgY zG!(Z#u(U6&#dkfHN~2(UOXKl-21|W1T3UlcnJm@JY-t{{XR-7>t|InBO9${pR!d39 zn$6Nc+<-5;rA6@Nu$U*u;<^D#%X3?bd}OIh9!tMqZ$3+T^AihW3s`zq(9(-SmL?Up z)VGMGbVV&qN9kggHlkH=OPN2mbOnJDmX_in4wNKbDe{D?47r!Jw79&*_XHN-3s^F1 zT540v(jIJZS)3DK{HCRDIEo6Er3v^4KCh(}$lBP_cQ}UCO)ORMk-KB5MUt{98|J6g&eYsrs?SklZ=?dBHe8R)kKF-v6P5Poh)rb zkIvKqxxOVQr0qg~_~koGc2`R?u>)tiSt{0@eSqSyv6LTP zoJFHJOOr8Th^1@D{R6q8>PTun*3xq<8pnS5kvicHJ{xbTJI-TRJlkOP1nM-=(tKQk zeqxEc*fhz~&IFE)DHi{~qIOfM-84)4QFA)`Zw9rR$?-ay@g-W!T|r$?Jc(m^uBC)| zmU7IuR3D8o^A}z(<2c5t<>b1OeTPGb8N; z$M4jClcfTiEsfdA*tXFpy8mG@&jC5(G;Se!J9+FT_dS;S@3k}vgZEh~e}K;y79V7P z9iksxK5Qw&5lcTJ-BC+%$H^a?Px1N1hso^cv*dZ+Qnd?~E?%_s>1B>Pyv4>Vd}gk4 zJf|@J>l{-^ykY6&UzY0LvNY{BpQk&P-XZ>Pj-7ktg&GezcAjyJBkOZZ)$taMUT}=3 zQma>d_R#4ypS7%B=E(A@P&Thxplx=q#^v*>L4L1(#Qefu<^9B~Y9+mTf%c`m`ruQq zB4xa4S=p=6IF3D4ygG}5RcV7?aUVIq@Tvo{RrAWgsmv+Pn{MU9U>iBR;;x z2s}f<`d*brFRW|e)g!z^i-ukuhPRPdf8cW$eWQ}Ww%CYQXz1~3436Ogllb@si*Oso zEn*=7e_ZpJK8H324Ow^L5YA@%@B`Wc!CNs#Ks()M8;UJ>Y*nV z;tC2k^{Oc*U@uZpr5UwA5>6pobFWMc$0j^Rr50YU)$(dN?x0jl>V=8egJ-DH%FDG} z)D$;RBIs2J({U16LtZsPKdi(}6b};z2{?v45$e?5E33O#MaS_vw@)2f`m_+uTKS0Y z(?9Trco0(9r`sKTD&5hi|G^z}`^KjuoqT*p>C^UZK6UQp)4YK`UBTo*KFvqj!9ITt3J1vn_tEE&PbUxiH0p>?FOKEa2Wemcqcl6|U;>1TWjob~DJtMq{v*T_4?r-X+-oxq4kK21TP$3FFa;#1eB{G85K zb9|WIR$gW5HqT(NwFd1g*y@8skP&$Y6()nhBS&sG%D+O|HzOgwXJ-H5W)u!F6sU1^Wj zeQmA7xc;_|3}89P)@3}3vsGn?t?PJ<{zGk@8D?wva9fim+d7Wn3AQGqz!dVIYU`6} z^u5;BORQXHYa1G^w>5WzttK07{d&sQKbU*k)@oEwwv}+k)>mh3WlOQu7;lmNx~(aA zc*EA>zijR|wzUdh-?7yLMeo|W^~l!GPi&2NX3KuTx>Uybl6J3b&3RP?`*Ec zaWv-xM@!Q>8lTQlxAcwznH<&1=BP||N2_u;+LY7L=#LyFe&Q%x-qFL)9NnnkD7m7e z{goUosN!ha=Z+>+b@X>NM<=Q~+Ec^PmYT$@<*0BSM|ZHZF0mRo`cETAcU_L&8jhBD z9Gx{C&9fX`!DO$a`6%1i(a0ta^ENvwiXq59*ikGp#W^Z~M7$c}C~l~u1U$vOS;WEQ z*~CHFImAh%O%id?2Zy%sdMo+iF#OvX=O2u5J8kwmx{8DYj0@!sIvRDzk?XLdTvr@9 z_~5Fe+?au<*XT2aI^1%U{UFE4qMRlW+^g3;NZ(kY5jwx3HhN;QadYW4|t=<0pQ#FX`7&oG;~9o(`<J5d5K@e*89~N>$dpi+3HuX192lFTsKMcYYMl-!-`Rl5W6i~Yez+9S)T;rl!}4qN zlM>K`rvc4Q4aog6psue1%KbVZ8#6H>eT?RP7^4*YmNiD-wu{kmyu_KMF`BrHB_1x1 zQRfvg+KK|JV-#2uqc&?}RAXa|HsJ8?7}eVoqYy6djZyV|FjWDMyFMr9AFagLDw%^6azTp>QIy!UBHXWb$FY=kt~7gBP+ zkiHlaQqG|vc`;;WNEhdXR46f|qqu~Gq>#$b4e2@_45Ig!BX-9}npm?p_M-HN1QoQtMYCbxRx8O0-TFR(Iq{AJ)YTVHL_4)=^wSLZ+~)W)5pR zVzaUyPYQ?SFA`Q5$B?CHSd9>c**J@w#lk9zNQtnL%Y^lL*|3&<7FKk{F!!p4)u~Zf zwftdSiDsKXSk+t77K(&579;wHbq;$6gqZ^|tPR+QL4(37JUFZt$Ql<`5u8WakzsW} z!BJtA!%?Ik6V}%lJC3oSUVK;sQE5V0^^t92n7QJ^>W|%%!}2DCxi&nk3)r0)R+^-+ z)?p6@%nfVeyfFJRtdsK@-vYM5Dg3-Jtfni%ngY+tu$tl1RbgdV7uJ`*hnYW}dL0O> z3l^d0J+>xI$0;8@^vHpJ3pdeyNEirk7yxc$3*lCw&FE1kBz7v#$g6BjEm?E z8vhtkADqV8@x+Rc==M($O_~%@jmZ(6NQkKHlnBqOi|9U@Pi0%wnHFIl{D_tz87as& zJ)&l4k6kD?gLbnbJQE|LqH{1eqUFdjFQR`iWPU`iuxUX=1r|kg0j(ED)M0Hz-=2x+ z)VYYRV&MNobR2h)=6pm|P!BWk0vRquRPAC!EiXlMu0gix?rtxiq~Woqvj`=(x;n)cV{Sp#FMtSPl{OCfLcs*<%fw5c)fzwOfgx557}{}+eY*{lEn literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/1a279d08513eac43_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/1a279d08513eac43_0 new file mode 100644 index 0000000000000000000000000000000000000000..2a595f71dce4c4cf30fb0f5000e3bda54ae1a3e0 GIT binary patch literal 32760 zcmW*T1$dL^*T?Z+BTdps)0X0;?waClard#|I^11`JHvgrySux)yAEf#`(W^X|L?Br zvn0=R%Q@%16WZiSQ|fhInxoyf?`BCw(JxoU1a4F+wOH#Q$58}ixu~jELEa(fxP+h=1oa0P%5RAr&OuDrHUCD<4h*U z^#6_ZzyE&Q)A#>x2lD^LXk1#lj7Mdp0%fJ~P&vtoqew3=)k91LDOW|wgZ;RTrIn;b zm8FB|S%p5;rEeHgL;4#zYe^mOPZue*tMmnq?$Y+LQnvY06sn*b*5M|ep!x!7AkLxZ z9;w%LDY&SYHefIAqhT>G4affCUit^^OL(a_dX@B&cWEzWMelN6s$0QJeK7qOFMV#| zB}+>$?Z8n4xAIZ~s-rO?T6^gTF5yfYFD140Qek9t@lwy8UiuSddVA?*A20Rm>!r~c z)St12dg-s>#0S3-Udjc}I4_wedMRL%mtJGlbT4g(?+h;;nn_Hvy%ajfOU>}-Trc&X z=cT?2yfg=AZhNW6eJ?$J;iZpg_tHyiQ2UjaCcpO5);ElSqHn!a>6@3nnG9-THt4*+ zL7M^$+K*?M3_28OP|mCdZNTnq2Gz-K(BT{g#RnPG9hZU)Y7t`4-r@#bK&cW29W7;$ zsjNXyVXb6P!^#G=MQSyJieMj{)eUNe`RH1ManQA{L4P$ds7q6WK6W%Hwv$04F%@My z8`K|Px^Ta%LD{<*6pioQ4QkYbzC8_^iQUN6i}+yeYfuAh#=CyZ+uxwP0}Sdk(4g(u zF~}gF!3L#Z+Ys`C;ZK8#VmJB^=kW-GdXF^d^%&+tgR#Uq-XKjdXdsqOBySv=WRUAG z;>M@R#6HEKeAtOA=rqHi@Rn^Ok8I!D|$46@xc$b$wL zg1K0QiGLe3?T$fB@3Qttzehax4GMf@&`IojY*4*t%=6Nq1+NTR|JtA*==|28MeoV& zgFz1v`O%<`pQzVogM3jOtKjv8oM8IOx?%v9;W2Fg8k89&ztQ%)K>`06)Cbpa;0OE5 z%c#W$qfQu&8f!Kxv$s*dS&Z6;p;n_N;=au&x80~9v~UJxYXA}EJZ4KN!!F*v7DBZ7>) z)*5ve^@EK%2V1C7XTyw|5YBOQk1*<8lu;?sMvaO!s&fMOlZ|?qV$>avQJ;`4)u>r{ zX@}eSjQUW}sKhj*2BaI+u#iz_5MRWow-{Q~sMYufiM&FO#tif+PP`?Ix`*IWoI_A) zqjqC?8KWK`u&hzVP#Ja08TAN%l{d;>!Kn4fRne$nNUCI1r7A{E$0Nl4!ei7yo2tZ) zvcJ*?$9^*^qnc5jsvG53!>D;UhAXI1lQC);wFD2bu(nZO>KL`7u~E@ihlU!}109AL)pCSUPY^cJs6*q7$}^sQ^gn-*2eM3N z9z2`E{i#N^n`zY3Sw>}_ZB$d7nZp?Kjf!4mRO)i0TI19TqpGcD{B=eh-(b}6jjZJ+ z^4wz7s%=Ik>>!Vwo99vBYlD3WrHHr%8`oCYALy zsVV+&n=}&ZP|(k$Z2l%CAWL>`u^oqVnzS|8r2Szg-9y6&jv+qMq?gDVV^T|m#hR2i z&ZKSFm1@$AJSNr5Yf_zjCIuEWX#`4Sm^2Q_g-mLJ-6&kxq@zVm+FaHoYdMoT<4Ae> zRW_+s6_a*g%daM-)i$YGLzC7tHt8UInwazgUQJCJi}}dh%%o`;-@>GYNN#CT`PL@w zYs)}Olo_WH95yTm#EiulVWa})cp>zzBK8q-K;zgv%Fnq1)z8q zv-)Q>YhO0AhUGNNH^{6NXrIfhEjWqn!DhX{&JeS$%(|0o)=OOWm}Sai)`E1DFsnpmv))vvJto&QE47xH*8sEj*EMTM zQ?n)@Q**N(VoM9N^0lT<8^*&gZOxk7-mFg@%}VTKRx2FsY}VawW}WS6)-B}eW!7ml z>uuIIjO}Aqcwe)2AgRAu8Ausm)?Wje1L=d97ZcE6Fnv*ch*?{aFx0I1$n>XK!|^XB z4QKulW(^)^R?tLp#wl!{WY)r|W@VXX)*&R!G|M=PTA(hP%rjFBD~c%##?P-z10JkaUW;m zymb@D;=T16ehJ8b#wQF+_SSl=O7YfR9LepiMtQyUFOKB% z*5?AuRnS{?(!3R!?yZX%-l|*JTcdFRRf;ece2RLj9!|llthXv)R0VG>!wF=m=&f1! z8-bO))e-Lm2 z{Nk-SR*Nnoua8BwG2da)Jf}r{vs*M7yYLKCb6T_{$f8BTw8zX4+K19M+@d46ghvq; zy~oQ)`bBXr+M+c$6JyaWe2=xrC(feg@fLN(_ymjQU|XU^rIIWsaDqH}rfV^IZ*%oQ!#f`fR1=9Mg3QQ4wTDE^B@Z&9(TMaxm* zSMtG1e8$$_EGk=#TP&+#(c+pG1=q8vEgmARzC~p)881+|0rTKNLyL0%Zc)KT7FBO- zQDfXj$tKhU-{Ed*k*AqOh4EJl?zgeX)YhWs_<~;TE&QTv(Qx>8v}jOg>W%m=7QMp# zuH@Z~*t%O3`G-Z>dNU6W^yPSeixLM|RCS<54X|MlV+`g#RwH1DMf?7=$T-ZR%)>28 z9%)e<^uQOK97R1wTeN44MXkrNHsdX7KY{%-iM5!_V=ToR1WdIk1gCL%hDFt865}ij zub=Fj*%ob@Ymx6fi)JsfD0&I?gmali6;@iba1-mWg?etaXdIT|KE`ab=mHGeEy{{> z|GV8u40~9gy%sgvZ&7#ret>+i{}5|&#G>BVg+Gq6rpH)k>^s5U#y$LX(xPFf*&kk5y&S&Tf^>Wz{^lRZr2^k8}Q3O@dD*s{*oE)gqf!U&0tK+^V1G z7-?0mXsfp1w`8k&U?`@iSk>QSRrXY?M&oL3t3IM`9;@c&x5{3?s;p>)I5lu=nKaS!OwwJMLL|O7GM?4j+Ja4UfSBW?) zTh;3qtGfPb)vwj8x>?hzVYRHOUvtO~_!?MUSs1fMGqX za`&{VS}&_^A$uRz0MGi;r=L~p`dgK6fK@FATJ;LW1~Uh);sd%3A=aT*d9VQQ(ELxU zCgLRi7{(mD?r@Ey<`{z(qpX^Nqu4*zs)gg27pKu+JnMoBct3$!PGme} znq<{(oWNsj_=~oat!j@u7&67G@6)UrINhqTSc!xgR$apr)Sk)XS;U1}bF7+$?DH4{ zd*)kZSU}DTty%@!Vyi0QC5A4sD)&;WilROq;{*0Dv+4|=R^SFHLQ&#tnsQ2Y`3qUkf@e$JkJ!5Y8h`Gx+kcpkm6YBLVt4(7b2PB;ep zd;0&&-o`!rz>IIS|BpGXHdV9P)Cm3H=VMbYEXO6J+HK10vMC%zaTHyAZ5oVEIO=bc zGr*?o$dAM5l*y)nc#n>OHkHh5(}JuvmCbI`7!=IOT!_wPQ(L%0Y^n~QFq^92LAXsZ z5jLI0>`0qd;3z6a*;E@>@Gsg&+hmNVKN7JSHS^lED4$L1aRznr+vHt<954cB(rwC= zVN)my;{+-dwW&2qma=Iyreh15mA0ufW})xN+SC`X@f}@%wdwqCHub7TZIG`9b7Cg$pnXl&qLxh)YZFHu;=mTv zt80_Bo=sVCvJqo9wrNUpn-*dpsphoP7ua+N?Y2^v9ptyurp3Eho882_hkb>4Shtt4 z@om3Nw+`6U?I5uovS}I0AGYZwVvkZ!T`m%JxMK3v2Sls>%VP$Fkn*< zKErf}^}lD+#{1+7-$&&04{P<K!}!&v;opeuJNx(tZM=Nc#NeY&*l+aFSu{5L=#;mQ23mYH7Kc#G z>7zJb9|gO8lz=X{k3N1r+L+l#TeHv(PtiE5k2+u}%I5Il{c|5J&*`JkP#>)d^U-!x z4fl~X(no=44*zJzMt5wE@zDVkjP=pXI3F!TXaX_fN1~7FB>Ct=F(0LsU@R0b>7x@U zQOZX(FaVQq5LaL+?W61nD&wPS<$N>|M{x;$6?`-ts_3H_SS$HxDEd_A1zq! zqh2d~RBablKvg@9^GEj5~bPakr1c_W9^nG(@@mK1x04qmZLM zdVn{mam+{Aj?)%>5p;riQ2wNkdY(iaKXl=t z&(sKWzA*Mza{AXt|9xX^zWXR|HoGchw<{!vU5Qwd(=KZ+yOM+Lx{N=p;MOt33Eaum0#06O71(o5J?7Wqor6;syE?>Tn0s$^GiWxFck4=ltPxNF-LgdKJ1 zU(c@nc-PdfpJ>#~u3iXhX;&R=K&#gDL)o@=RY!U|yCxuad%Ko)wCe||bh7JP7rU-? zwJW2WU0pB$Ufu0#*4M6X2<~Usr-61E2ietguwBDo9%5G!R6_Dly9(hgeq#8a%saxa zn}{E2R|_o13#5!<4xB{u(ROV^hp~1|9Zw%vC)l+cC*e2Au3zyHl_uLYVhZiBYbx_k zvuhsKAlnS`Llf+sY1iOcj8=^Ck|9t!5kQm>?>I})L+HgtR`Q~S!35-yh5gRjD?lhj#ulc*9NmL-|&KhGlPV69`o#ca(yI2!UM$_GPEx6QEn1yotkcAO#;)6#c-F24=j_^e zp0!2g3*>y!uFy;DA(Xt#x?{i`nY-O=F@_4tPx;^1TI@`OEtwomP<`iwpN+^)mO`-1UM^rcqoohezNN|N`B@sb|B>odkFf<8lpAMAmm@3GuVf$-|Wiyop~?^ z3;*MJhnM&l5kIIGj6bP4Zey(+I%sg{vC*LnlS5tcm)W7;Ee^HALO+KxWpSuWDEDy> zuW&1j+i-^>BOG!?I#dsnP$-JW(GE?=68wl|yf}yEV_u>|c|8v8&h5|%6v*SyWGukH z`5bzh-=R;aQP82~NK13*3Vus>=ssFxa2}ZpIrJ0F3Olp{GmAKMsk%e8YdG`|M%Q$x zV=ae#YCE(P|JHM;Uo(eB;cH8WYISmG3yOAk@Vk;jCsDqaLnV4UvIl z@}2C^w|Nd_T|j*nI#dpWa1V1=JM;bdu<@8f$;TZ!jbBa> z(@E-y!lxVxIqgtS^f^O21cP*nW|CE;+RGGHY_hp*2`^%c1pu zJ5=$uLo4z0jzhQavX&1VYWR@+o;x%Ri;@0rfdSMYea;2{Z8qKhXBQLpyK`#XmSS0dtYL|2T&wsQ80=;E};8x6!Fq z*ohw|rwW*z8jc63=IzvCd`6PR$)Tu^jALi6Q zs2uLpIXps4gj01e1QR2j+J*-x66I7#G_hkII>$IwEY_)~_=J0L#F@yLup~KEI@zgj zsFK1Q9;X(iI@K^-h72Plx>nb>P3s);S z9K*h>RZ#P6=+qr)FR&vQ4CZI5vg4Om(U*Ow*j&2*Y%z(r2*8;hDqOs5;lFDY%RL z^B4=GF?T*WEpY1hg-$hCL_CYx6HA;5SjL>oooc(nscYE3(y6f3P9-B`4SO8!wd{Yq zM8rC$2H_Zd*RzN4`v#{9ZluneoI1Ign6?r#EZeC&I_;pYJBeWzwcbtadz@;%kM%#u z^WqrsW8n#>YMf^8V9goU;<8hrC=ahI#DiTpdzE(Ac<$U{&cBHprEfcV57wzj%)oiv z#;Uv27q5`#9(xAoQ0Xx>fu1nWQ|5u!bEgU+|4Zh2MJ-;lN8UJ<_pMX?KJfbTk^S3v{VpW|!_~ajAP&m!{)yq-S%f8Ft_~#$|VDA5Oz3hl}4IT>1`MPM6l8L$FH< zacTem#JF@S)}V+ofyRo5!VMd5JL}W8`-!3tFO00hd-{ z8y+G{8snfrx=XY0u#iiK3cK{Og-hSiq_s=!+PKuPtxJw}E>*)s9BS{ zj7!F@h(-L;L=kpnCQ}nNyI+crOs1aT0GUI%F|rBhi=ndx;2w{ zXSozL+r{;DF0GwQobz4ky1^x{E#z^~rCrCU^Kq9F@%AFI-gIg3ZI{mE@>Pv!Uq#pR zRUTyN>Z=G0!Y1rTa5vhZ337G!RXi?Z*dM<73r%|XYAHJP^i@BE^zv0AhQQd{S8jOv z_^LU&pmSeet;23~=;y0GsL`KsU>rz$v`2#>z8d$ZuRfvnFkihH?yH0mzAA|6qkOe? ztglv%2hotfmTg;RXhVydr>O!L+98NS+rjG4ZAG22%;=lCiX&2boh^O$RquPVZ_ z*jLHReAO7+uy47qPQ$X2xmWw@&>CNL+~BJ_SijX*YqoKIr>`FF@l~09zB+o)SJw{t zYV~1XJwEBH-_QH%(G_ZO(^s|b`6~YtUsZqQtJfdM^^31Y|L3b2UT!VL4WpZ%k==5- z+{%tozHXIqyR`wIVe)fxO^aKLQQzOKiFlI3t&bQU;?_bG33Y20lET~?iO-lF?pEdq zx3WaKH5#p>-1;lltvqpVMI|$LKDRdJ=Xe3PZedSBw;~F;6<^-1E*0F$sN`1FU)(D3 zn_Jzgx%H*GTWf2$6u?7#ZQUAzJNVGfEwA=&C3JGDM_0FscXKPGyIYn1aO*wR_HgUJo^Ivt z=hmQsZe1Ge);+8k>Q>w^Zby>CD7RXTcFQovtw&?ssy@!G#^V`hB6&@6%YU+4EfFxq zt=d!FN}29fb9BK(VZa(iOkDb&B&++Rn>ap9c@i>e4J#H1iP!!(Fu|ura zVYixM1-9a!BW|@n#=OT_vy*P6o_4Fs8Mo?T`Z?x5@77Dyy5-ieyKc3;=a%KZTiwy~ z0mmLw=O=FMeoEhGZmywn>-ux*^oo7++N~pR-J0={^+c~Pw8sl{`07?4*#C9&`LCkW&Jd>oS#A~5erIG@zW-J$Esib6#1KQu2n z#g`6La>YPR|20sxY6YqtIu8%jFJl6gds3hbivszXE|B++0@Y(rpoSd^)CPP;x66U@ zyA`PCPXm?hS)dv{57Z)T$5Eub4pfI?nKhwLW>p=MStUni*7Wh2bqKZznYnH%vyLs! zthl?Gbs06@XV!{une_y_vt;2Kr7W72EsL_%$)Z;EvnW^VEPB*Fi-vW}qIUhWX!X%7 zGM>pI^N%c=YRIadVOjZ|Dyx1C&#DF3TQIAR6w9g{rL(FXiY&>>du3U94rf)JEZKA_ zCY!b+JZq! zO$$;P?8W+$LCRe!NJTLQci~++NN36fX+yanMU)TH8uY3Vq}xcX6r{?ihf2Q&sSeVs z2dNz1;!Tqv6>k-!p6!EFpi7YE;RXV`1}PeI(6L*Ps`d!dU`)VwH18Rtl?dq-q;;s) zJ4h!G)h9^9QM*5FFaRe|XmF773<*-=&>*GZJ?j4%q|azGJV-sT11&}bsVg?&`p6(X z#?(i^LSd4$LdB=B|LgZ@BV>_m=57LN@|;s7$w&ZUI;xzrp77vxgPqFkC47Od|GiwIUSE+Z*ASPNo< z)h{lXYjT4Xm=LVvm|Z1UH!=2?V9i16s==z=GFV%oR>3NaxA1Bmti{OLCRp7t5nnLB zZLrqDr(Lj0VlwXH6{@rk))<_HcZXn&#QcuIx`TPCOIXdh`!7&sk%P!d{em5zKW6!5Z7o**+mM_NDE>5Y-wSqHn`OGdz3(Qm7UfLbVRLO`$4^J~)hv@K{6D!4|5uj!@mhE1Y(P zD%3Yro%}=f4`PEuRW~|RBjZDrm?u#9%%qVSqf#jg$3ppBt& zYzo!o&7rDyh`zXRI8=*{glgPTj-&j^P(_{!)#lToN;w;4(0nrp=$Yqeugj=#|8Xl4AV;7#1G^)g{d#X%wa0!9j0hYm=djFdWGJ$ zFin8NCrst>ADs3utw*#YOl@%xPw|g4jJH`B%QsANhw=TRFx~SDSP$7RfMVDDe}h!q@E7rGdyBB6Q<_qjb+%3Zzz8@Oto+Uoz8`6*ZDC1jiaU) z!c-ea;l3EAKQ2)_xUNuFEP?APdEW}tV$}MZIPnSC`w=aRy84IPVx>oRO* z!g*ggT=TFOD$6-ksuHgDzlEzG)>I4E?k?f_rF*!R{}HY&=-4A%o6)9cxXz(huW&8K z20TJ!?{MYDY$WvwS3uuzO~ox#?#H;eiuD7+RrSwsHJ%u*UDLz)%s5=z@D)X8hU+k_ zv%(dJrr19_Tz+%Id2cjahV|iUxFKBCH->Ba-f(5z7p~^V!Zj4f9ID$#1!u1K0PlwC*Ot|LaE_$7%KMJ2CPE5fISkH$m??ujI5&B)CJ-%Yym2lmM z|5fHi5B!Z4H^TK0#cqWw;WqKS4CnKsa5Z{O+;76w?Z0pxM}0-84_sams)H6dj!K3I z)kQ&Lgf3yFDMFuNHb-a>#(MJ@e^?^a!5SgiBJ>YFpubOqCfFl12UbUfx?mtOoXq1J zp)ZJcM`#Ep!0i{I%l;91glYj1YK-8_5o(G)dU6q}vTLeGmu$fr2R@DwLXMCe+n2xTiBAyb72HN+_t ztQess_!l)Qku$n9iO_-W5$g5_Ytxf4dq=41AnG`jz9S+uWlV&cjf+s(DaQ0BQ>ZC$Gb+V*sw_T#e% z%t!^ziqx+8ks7=?QoE6TYoxMlW1K^g+J`QOIfv*Y#DTZyc8vbGc_NaZ)gm$W2>V-}4yBeuGn0+f!SCQv-q-=L0b>T^*98ams zGh%!msco+!^$E*gQwywk6UooxQF@EYt)mptCQ4fdM(GVI4USUmkSOgN5v6}ob5xX) zMn|ds131^pNY~2#GQ@O8eBRT#lQDanuWrbm>bs1 zQObHHN=>dtsS^^fMQJH2U5`>@j7N?eQF?}|H=}eBRc=M8AAl$P910$nibPdI$W3&K@iQ(Gd7_JSD zQOSfDHHIrsj22^g@fg0x9HSu!FCC*LWn%PqS;ns%qy3m#BSy~JF{;#r+omyEgW%@G z)FMWWTE=i42{E;b(Nz>{9m9L)G0NJ8{y2^-ZDX{d8^?RZsNg;3!*`_Kk5MOF#WTb{ zh*3Ta#X+1$`G+yuigu4;^cw$R$m1C8eG;Sj&tr54i7#T*1uN0^C3V0DM7)Yo(CZkz zMXon78t^VgUhjz&r;+(Xj2dDoPT(s#e4dOOAPN%$LJC&{~M!;i2TOm zA2CW-tS-Rp70WfPu{wi|hFCp7urXFOFdV0m)fB5bn2$T~GsmhJI${y7!|ENYg6NFJ zxB{moR)x_Hb8rSGYpl}I0gG`N-nLj3LT{|ZEx3JRRTLeu294~o>V(gz=8RQISFD}} z#wsj(tUiXsDmgS(qr+k~H9S^LW4X;2tAPBms)Q8<$gv>f7Kv5nqOs~yELPFQW7Vcq ztd^r*=~%VJJ5(u4Eak|%A~|l2Rez*zi&b$PL*x#|*d41OS7Y_;Zmh~Zj^#6hSfxFQ zReAV6<@oDZMZ96ox3S9mE>@2}$13zotonT=?tf#o>1V87p@LVOavS2b#5+!RQOFu6 zyDd&T{NwZmD+A)R6U8#cX-;6A+Ggf{a2&5Oak>@~r@EnW>IiFC9KSEb$&ouwt@6Yv zDsP2iJ5HA{Y)_n~B4}@%dhH{Y{c$>Q zDo#2br;Rv>9%tfI<{5o)|9PD9y@=DgS8>YqI!^Hj{T3&`?>t71pKP3$tnsRik=f$)H_AuGt0oTMMpV3>p>}kpQ-WMgaf(bRU}Wm_P~}m zUR|*Y7f~}`yk=oYfp`U`#j8zvyf&j*M!Yf#F&-)uj@KQyio~l6zM@%CYKK|H;`Lwg zcoi-|jHTjvj>M~8xp=+A#|qS|V!TS$q2_plMs?$L9uJVGUc4%zaeeBI7j39b+jy1e z7_WiI(}}(~f#@#r%G8zo2gYkQ{v8yrdqbFeO1#pik}rN>$Fz9uox^dgn;WlvC_Rt5 z&W~5m1@Stylkpg#Ty+Jb;g2|9=NSrfDj=IjaD0c%u(O5-bR(Fq!d7cmL?J1#+` z_9v)6ZXHO_ih~I{d@Mo6C$p+)2=A{Jck;_Y*YbL4tmLn4r+d z395^2PZBiuX@cJV%edbXc+V+8HL&r&1P%W|9F{~C$6;%t`uZels54RKtce-}SGGhw z&XuUp;6(KcNmN>BqGm=W>N-Y8C2AJxL?^0g{zPp6fUzxG_9YnMNe4)5t^x zjY`zOnTgtotg{n!8GkQN)bbUHdVr#<67>QV_atg03hhl)C0sJsAaDbwdKD=y+Ng)iG1FhC_k?x zwMC*SNge!>v>LzrC#fSc1te)C9^+i*B)PIAX+O@RTh=5!$M|eX`Wlj?PNDRPP0}}5 z!_lE$H9lO$cio0dr`*(yn2P`!1M)Fw&QP`V4_VRerr4eCk%$w?ZD z#2HCygIqI{l!OZ?J1a?lqTuW#l|!C6#5g}m@e7hv2-V=fC`msS6ZeuN-Nlfl#I+(x zi&rJ7{Msb-JV={EN$QSXhm+)WggW5+(IoXdmZVY0cRWd}PSF2kl7df@+qon~{>`{| zl4QS|q%CN8FGSHsb8`tWlq)`G|rl=2icO9 zKYOxD;x%&TqXsT8QRMWL2AWR1m? z)ye9yHd#ZFvMyPx)+Z}&L$cazO4gAB$r^t+S+i002=O8F(PTZt`cugocR5*McanAV z9*^Jh_(QU0q0Gl*O~YBN{hX}nUMVsgQj~!;#uODXr|1|iV}N&x9$HfL4kl}gTA_w5 zMN1qh%IZu}B+kL@o1#JP6!i>D(e%umN7XDTT8xOSDS8`~qKnZf+8s;3xD<`dlcN6+ zRWL<Am#D?n6#c;RYbk1QJw+#OQ{Q_j%JeBkt?>uKKBuVhmlR$4nxfa=Q}pHs zHNvu=o|;GNvUzkThezqb9!)mGSVm;ylWX-e_6QqfwPSdV)GtJTh1H@b@=3j(}f1s)^&jd33WnbJrjT7;Dm| zmPg}idvvCbN81~C6xo7#@v)^xGg^D}2LEAM8^&(S*zG+^>cm|5ud_!pyL$NBf*!T* z?%_H_YJ&F2){{JYdF0=RaRx9B{=>3?9>or(-w=;p4ELzv2#?w#%Sdt@<=$C^YbvnfQ z9A?dqdX(b?Yj~0|PqV&fJ&L*DQKd`N>M}W8C8ulTd&8qBoJYx<9`(58(bvB{dVANS z9gjV7Kk=w3=HN7Lpu|%iV-x!qs(!&< zm`$mCrzKT?`lV_rs`{s@5iTHWrc@0>-r!V~hC)*1#y}hmO;x_IR85FW)dJLuPgPs| zjqt=&O+??^sTzy2c~Vsi$KjhVRsArgaH{5@R*_V-#B~H0qdj8Frm91^RQ16_e8k%F z#EbD2QuPHTDy8Za9%EnSRJE&;s!_kB>L1MdHC6teMEcYyHR{)!U_NC|;p_ z`&2!{><*08DOH7V4Wl}zY92~-A&2g%`ra#5J$t8WTK`ma8bJN97FUpCV5$-aQ)_fZ z;t=XIHC3-+n3k$0=!i2YGM)HmFdlqors|JbsalV$vs1MQTQOimUe$Y5K=beqvb`># zN*IAt@PAW46)*%l@fLA!3#ch(;UawA6;M%h!zw&S)cXRekI6U<SktG<|N!v8HJ%(IQQyTcv3T z^0!V?89c}AHfg$vv2B?j#oMLn3-Yy3(^GuK<_>A{>&o0PbW4*zrr~4vG;R1JO@~LN z$v8SqTW|yw$E0cb*fcdCm!=1c(-gEMO}&<;smro7&E1y9_W&7x2X>PGi8SRrnWnS2 zgJ!4Fbl`NFdY?^G-)H26_RrI}t{_dO7u4xx8t?C?>ANFc`JCyRR&ot7xAP@x=Q|%&cEmB zvi+K_=D(%$w*}Lsy6H;8)OzWvUq4+h8>TDz_jC*Y#(VrnF9HHeZwg57NGI#2O=bc~Hk(~)3Min`t4dph zKVAA#rB~@9RRjd2cj-uHL7FJNxBKO}_wqcSC!3i$?|IKV6IdoQXVTfUD7{S;GTZbO zie#~=B7Q-xY&LH9x9LJ|n;z%0scL?kMisEBZb6%z6>S=bPb=9tFKp9(l&xaZb#%1Z zv=oszn>yhk65?%og^#^9#gMm=O(n4ynSAtz^oce##I%r2{v_fg69F)CDEG*;E6+B3}=3!sNj=oxrdmHcf$Zs7-%OWVOdjUbgA+IzA&_U(Jfw+u8A&JU3pI=f`VXF}s?Uut(jlgGNy9%`-HnO+1 zt1zx$bw|50cd{#EXWHU1GIgOJl;~<#1i8D}^$~WWes??n-rCi+k6jzFysw?#A?lo6oWQ3hLB<*TF%C0TgkAKG4)oiR?{ifP=8=uUuYam)KuxlC` zFSIL+hKuZ6OJL{vCcBKab~V9g>+I^b&(8lF?D~AaUEMM1fL%2&+cgaR)9l)W&R6Y9 zLDy?`x$fFE2(|9n$P3W(D032p7aha!`TcD?!R#8 zyNnL)#w`RgIhaGkp}AOz*JzO0Aq&4CK8r)MQ7x-OVf4T>oGR?l@nURO+@UVWQNp1T z@V)bqL;qrH8HfHxLRp8Nlyj(Kd50$85IhweI)R5MUXA5=i!0TMQ`5nGl@6s~WnKC~ z`g#t1ib@R}O2moJ$St1SZ~$IAW5QkZbU0MO=}kb}mGL1qog6WIzC)8x;urcui(eh8x6vUc(pFAfI^fWSL$o>UP!p^`@goi`J?hY( z=yc4X@3H!wLjo?MSeiq%;KL+bMEa`^ z1u+U8u2D;@{@bCya39&OJ5&ZPjK#fM4&}d1y^;4H#t$!sVE!G4s{HHFdR)e;`>cQ9 zkRPodaeUx|#|{m8=Fnmsdf`y6mku3!<fc{#Sh0&K@yFViTuq`0|~m#BAnN7&Tiu^*gSiN-L+5a04s9 zaOw==zjA6qXQzI}f$mN{K=vL^l|+3U!c)BX&Z&=jGaih=T0Bo7#vrHOz&?_GVUBS! zr-oD0=Qy<(Pf>84Q;l~z)g3nvI+g1Xxf~-GoWNZaI*t?66S+@OTg<~+Tzu!WQz>Vh zI`x-Rui(DuR0j;g+N(~T#hn|}^QKds|8;62Lie2Nk5-SJ8j1$b*heV&nmkcNF1b-L zt4l$A`JPL!i?~#(s7vijxHJ*|N-p(;tt#trsfJ70YPuAy<1 z>bg}I_ib(!iF2!y$E~ZTTkXAWxf9*$f=MmhdN1tOgosKw=%YIs|pr( zbgN`%w^ny?%ihh+_3v)&|HiF*X#1^O-(lW6-?`=J?beAtZZ+=f);OF&nSQ*-Nu*(A zf43gs&lKW(@78Hl9_&`8p>ACnO<8FRx%CD9LiW?t^_*LI z&%0F~XD;v_HLtK=Fd>Z`kmo9Ozv))oef9zNJ#gzTE3ZbQ}J&S$6tt`s!%6dxBtVME(-y@;Wi#SC3|r?{d1B@E^#FgWMKdd#*A{epAv zcn$S!WGG95p`FRZZDwdHP9tk8gTH?bwQFN&6w=9!_GYBT}&V zoo@{0f;6-aFMAv6)Yssi97A>c8A`xWJWVl_ZGfTO|1)$31qK_cilI1%+CvO=8)|3; z{vBqh-cZbi791 z(}o(pbH>nlIL;Cm#n00gUtDB+%zo#Rq0cU}9J8)6Cgi1pO;{RI;*1 z4XUsXYpQy*5B_Q%&8Y6twi+JYM9xn=`UPcbd6b0z>UdP8o=1Ca9+`2(#%&a{dsNuv z;W{plJ~Tbd_u)||uSY8zd$buFd>&N}c+>&wu^{MCG|{8?LLODXa_qxRv`+Gpe;sYEl#!M=LqA)H7tyJv=gqF zN3Adv%ds8zT2qHFJi3HxZRj62(YBpO|DeK`9<{(OwEv2n@b%Xom22z*E-U4w5t z+Jn!&^=QNpj}8p?XxL~E-`#pNbE-!Zw|TVn55}>>qec5YntYNRPZ9HsN2ShF`wJfB zx=bA~ERB7K!`D4Z$!=l}dnJW2-sh_KvN{Ta8{WFvE+@?J7rfy<}-BhyER8f~H zZ!=TQ=BCQGHFc|-sVA7<-Bf`drlP$}mHx)m(>|s$_BC|}fqtf*_czrh#Z=SpOLCjL&(uhq!zY7HbwV0i4l%VAd4`&5j`?^3`!G|3u?KmFn+oF;J{)0cHdY|hXj31+ zH^$^#rpcTRCeP?Fbre60GnH$qsUjGG{68{Yw3^QNQE-OI-)D? z0;b{?o+8Tu)*Up}{gA2k$4$LGN$oD1dV?ib*gvR~MvajDs;NG>jLO$ok5Ye|+}}jq zubWE2f2exHh*|qk4@b`_z7dcZFGFfKEV6W zOm)El{Pvs}FNlxWOL9iTSBwq&u;ev4zTx;p$+xEZV?Bn-QqgplzQ@hvb>gJA6V-6p`|6*mETgn0>r|If|i~Xvh=L5rSU~9eOuI0#$uMHpiFT~ z8_=?ZrEDKrx`a?kON((IdrJ|oG*S)5y7 z{HCQYID|@;r7`#yKCh+a$kE7BCmhDA#+Iu2$UR`Gd4i>fXq0Fv9I|uBVz!`7OG}l*mU2cc^~W9Tj}Z@rS}}ekwkBtM{kf%5Us!sC zU2QDRpIHi^Ge%<-j^hFHw6pXnnqnk&qwJULM;t|^uPn_%m9H&rLAUnQ0eL!*6Ebw9 zKP>5F$=})1G;G7EE|!XSW#8Zw(sj4g7}HRrhoxdYEv-ZPUX}{Li_>tXSek&r11w!Z z-v5y+Y7C*~BP>0|!jbHkAE*;Va_xt_ID>zt+5IDeknU$FGaMUFwd!G=qGelBxtr%{Wm z9AB7q&C;>I8QXPB4R2VQe3Q@DElY1P`X7#^JLHKv_c`95P}`@LYU2%@&p6(nQ@59V z4)OIXK6g31%;)A+;hbJI#}~Q08kyfKdjYS0z`P<}<@?yHTBW>thPI`>O8<#hv9ez6 zEALgE3SRBSsfu33SMus8&Q$iQMOCkc;RtqC^YV-@V&P}pMedqjwL{KYUKw~;*Q4_3$?IYCTHY=o=j{7*9|r&Z{!$fwgw89^fsSJG?pouhXmFQQbw~sA8}!HsB>3 z9Xf@8=L@ydzsumaanB1#;j;xImpQKz>le=#&JGvz#jO<`?Pd|PXkhY z>M`A?U(jZTPd)JhO=q#qY@Z?Z+xMPg(q)+uR<&;mM(>}GnOdoi5g}l>zO163wdk zbq@FNzp8#^t?QS8=g3yiud%pO-_P~jO-~lYn2>68v(s^J`LP+N0ICeyzpG-hLhI!)rgkF5*FoU)2WqbrlcM`+L7m4fJc! zAiu^>@aqT$rTR4i1t*gKB)>kMOy6t#dVv*d{n`TOI=|+u_p9*+zkWXM*T0x^!mm}R zebTSgQ+|DR+OM2xel@}yS^S2q;9?bnS5e*O5!ufb3J z@;_tQbH@3Cb}#*!@ygG*v~^fM%u-XmN&sMr91BOQwKASp%wESPpyEC)(&WAoq#sg zC1$;ViZlr57PdDemOY?&XF#`I0lhH-`pFZ}X)~a?RzR09!5h##lxq~wkj4S#JP)WC z2B1LyfRd3lC7^YO8GvZR6NGq>BPZ=8N@-knZ%hzo7u!cFYMpM`_1Hs0|;(m zoWC>1t+d$_&}F3VWn3t~FQB3O19BY*D9@#U0!V*3puCuh$5-exjXK;2DAUaV*LnxE z7yerTExR31(|;KE-GJU=^}PVknFz?dAJD=F^!qTN5zlCgKFhv<8La%sD zm!M^crcY33JVG#If?gwct^^f%KS52f9gf@y%9bZV_fRi?0?&#`&}=MHP?gdJRSyyD z$q>{-9LyM0{!BroWDRO~zMyWvQ6Q+qfd%jYx`;17 z4ytXbpbp_|=^)RKV|iy{bqQ({o^}l?&$mI98WdFa5kbvN4Ql1Ypz_Wo*8HHp!wsDL zDX8M>f@+Von}YIe4)UxZUiSvo_e@X~%Oz@Ovqb&=MWRZ#O;qk)iOhkJsCGLNH3(hy zCF-N2iMoy9#}d`!bfO-kLGF;+Vs$fL)w`VQu3&f9*zy^{G^b|O%6#@LTZB3X!T=Au6ZG)n;+8sWyIYS z(p?5wX5_4$zgcOj%nmqS{MWmo7YEu=AzLz?kCB=?JuI=>7l@2imfn1(T#k~H_dB&Fe( z97*cXCP_!|0;d)yY3x#7aerBo+AmMiW)xhNq|oXleZD41bv7hvJr3+hl5J;_BDlCK zNws$;X%S}aNz(YeN%~-4lAhj6Qo{WtbaLVl}cCOxCyP zSUg#sN+!!!Dp~!@Bx_(WS-rX^%N&)gb@P+8YEQCuVBkJt986Y?tI3+BCTf|kiF)Hj z?Iy}%HBp21O;m7m6P}+E)`E6n?dllTpsry(>=jnq-eDcaH+{oAGcv3t{lXeLAgoE> zhq?D9tm>nA#q@Dul^h>dorz)1oD`O8YMAT4!&*K)tiNZ3b!$CwHiUI#V_3ia7FPBx zVc9WyYgk*ih4tN@u!@`r>vCFHKRpO*_QNpucZ9VuLqzV35!J~O(IpJc6;Y%2Bl<6Q zM0xT=_KQL;ejB`7sY!H%62X z-pvs$LbGiVJ;FyvB07xQ7b1KQ7?JBSF;MFXW5g|tejd>kym%2&tCtaV$q>~Fw8|J& zSA3W$s`HtnDx4*%L%4v{tWnj-7S&cH=U_P=6^SZXG^!{LBYUx^oJhb7oJQ{AQ58e1 zWK<{1MpeCBR7)#Hl~_5-eZEnB?To5kFse(5Y!iyAb_?1Ib;Lq+zr%J#VygRbOvf6;RH0#v-|J%vw~6V? zwlOV0^6;3JU^8AJ+lZKK7>TLKJTj)&X!Ju&y>J3+MiFatOgG2HG=6+cbtc4gG&QDj z6JtD!H>SI2Hi>P~U~-J-H^j6QCy|EyQ(|h0w)g|(r^Zx&8q2VEdW>smV)COehT|}b z&5Wrcip_~>8Qz~8)4v!nFQ%8+I6tO>3u8KmR*Pb4wUk88s@$dC>{r`3u{(po2_xgVTnSP7~ literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/1b59a768a7115c35_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/1b59a768a7115c35_0 new file mode 100644 index 0000000000000000000000000000000000000000..05745d7cc0670c562d53a42aae4a1cf3e3d8fa88 GIT binary patch literal 19196 zcmY-1cXX817w++IGCkCUObSQ~BxEMjXA)9o5;{olAgDA&kfNx7fE57+M0&5%qzMRu z^dePyFCrjak>0D`=Xck-e_Yo3IPIK$_TJ|uGraRg-|HXzP^!oC7bc*JRD71(N;d?n z=G4me)u`#OSuH0km|5LlBTy?;P5;Tx%+9JB^7%6ZwS3k6Ikf`*tn8{avZ`fQ%goBD zTD4}48vaaw&5%Jc4#XFp{J&WL`;$MZOw|8w6D6Q~m!xkr?2;))I4w3MaZ4sx;A9af zS`==|pT*%&N!S#EU$eoQtGRMA3^_HRWKHPO7?w7H(oJEFRBr|;%^_3j$h)eluk39N z-@m1`dcfN~;kFd}5bS*w<736>2bBlFPoKi$&!F??(EUqTF%YVL1qnmo^{=6;WPJk* z<@Qi`a~O1!dc&c$R1UIB3{!Syq&Tm@TX_G*~FLAh;$ z4YE)2HiP9?NRlIRQJQUo?c3qFjNAb;rT9*$yBpey{WnOJ39@G|oRRVSV4fuGSHBO# zVtM-r^p>l_G4)$!Na#4!l>emI3HU<3lj$d+#~CpF0h`Z3%y}p!$K{H&{1X~ofc8@I zA~p*tY85n^9b7rD4Tn^34@XZnTJ|ZOdr7$PF3ODw>a5M`M0XIkbr;xqURd zJ4SO)KIjz9ptqwL+9jGoU88C8ZZt*SkEW!2_CYiaKZ)k=5z%-@MiZ8|Mn#i2I+{1e zM6*v~#zymw+>=+vMRQm#%VSBN6isk)G*zV0v}n#r>F=XyJ|~(#rSH6Grp#B&AENnT zK{PiPM$_r1XcmZdh1Qny^42fW9NQGl1zEW@n%O&|$=Vss0Qpfq*Bix--O+@8i{@1s zDwPkZM~9=yIT=l}Q_59NOZ*wFbv7FR`DhAXh^FezXs+E-FK;WC$I9!8a(${b1Rl7+4)NkfwLpx3UcM7H?$(1@e$H3aKfju%PVqlz@^9?j8FtAbP zRyD9n-m7NdbGa+oH4H3}FKa6gsb9yy>vBNsbq&m_XP|m>1I?vq3)L*6%4^rupQPT(vZ)3gYwDMrk`@aMER@@e47|D6 zKsVXG#K4QC2I?%+UM*KICFUmslUJ#?68uHImm6ygG+t|9!a4({^#rU0P%RuGb2I?JFJ(7LYzz-7lhx#vubE-$K+%nMf zwt=7T7^ra9fKTpA&VBVtG9MZk@W{Y7Vt;I4p8WGf$JI0KO<^Omix^oZsYQ)!kekJf zd=_iOA7`YhESEn2^B5`QH_|jgSb_r_#TTk(F(A`?`_jH;inTn07|`$w%#t{MymT{kOI5JIbkxZl(LX zMh=Usn~@K?8)@{uk&W_xFC$;bZOQ!5$Xr<=oqDS$66~v9iSZL7pUd}O7%B6mk+sr& zppj4HAMp<|@_evSpWBR>N2=aYM%K$ADLUH7(dkAe%`kFqrjZ7-jC7Pj^Nqy)Xk@4y zTxukLnURIdjWqem$Zso**jE~9`?GRhWu)b5y(YJRF|uyGkrEq>?35EybEA>rn~XdY z>t^LH+vSz5+M}JSSJvz@Qfar5kYxR)y!R+?c_M%BH8NzMk^c@D>2=7+AChuJ`z#$# z8L?e5a!Tr4G4kD2BXw_RU+){aB#wthR!P(&Befr^-%{hLk=;`Cxsgxh_5Y0Alk6xH zMXe@2Dq_-cXX2FnC9R5?m|omO;aC$_Dw!CXZsMTBMC%L_4SXhkk$3$j`pe(q4VsuC zOJq!riTb&^%`*`dHjyBcs+lO?MC-`9rY0QCOjui+=qt|GOytT!x!uOZ(br8}kO`ek zyp-i{nb;!Uw@vi!Y~r%qlRn){oRFd2O-vSR4-*Z0n%F3NW#We>N_}LaLvIs@q<>%K z^0A3gQoWyvX7a082Ph9Y`H9vTYvPDB9A{$Oc#}SJm`IWZ6HTm=;5-w1r1%dezLD|r z<7yKbznB;-mDiYyNTKI*A6}2Y2wXY zCRWPR-6p#Hre5qh!FoKz z%;m4mIER{d~)e2FaqGX721V z({8t!?ow#4nI`+x8#yj_B<6sbx8(y#zNGc#tZchsChMk|l-p*y-Z9fhu8aSkneSz( zoOz(vADQvWE04`|k)=<}lzyt7JvVdXg_*W5&FqV|P}N}JYomonVzXFiWVNtKRu-{f zE^48EF$?{QTi7op;w+RCX9){G$>Vqn=Sx|5S;0b^iWX+2S}2xgVL~N6C(F|$}ME!4H=ec;i)Xivamri zDqHB4tub;-UWr)rnaV=td<(T@wY(^>(5;GUk;tnSCds+F78=x3?sBQ2g{_S&RB3Es zhZJgRVOJ{)$7IlJ7Am&2;FtLl_qv7FZ|HT|*}+2jjuzhOWZ}!s7OqG}7v(H5JuPIu zXJNqm7IuGRp>c2ZrjG?vUkfE=(Z?2C!!3O9t%VEnNMc7=xH-nc=5ZGG{h+lLDy~eB zy^Ab-v_Z8?!6plpc3Al5l7$a1TUdL=Li$zJCSS?)>lT{-qdabCUvF9{BX7tL4=j{^ zsJ=f^-{qPF9&62~7P>#Pu;RJud0`<-M!&Q$Bg)DjQa9SlD1#NZ(Mo~Y%5XVsv2rEG ziocMRzJ;wM6t&V(78J9RSlp_AA6wZfmJ(KK+pUb1(+O7gCt4|&WTkVmmGoDvOprfH zTlun#mDy#jyp-zYt*nr@(yaU={&Xv|C&59F^qPt$ZVlxs?h-v-`N_BmR&GzU zk~c~Ho2*==)>JEV$s_E}c!v#oTHALdwjJlD$G^QUPy42Y2Y$*lT6vF)KGDaKg&> za{G5HZ=BKbAeOUM`pDEv>c>^hlVei$n)XxD|5EQ{-QQLm*R5p9(toU!x~X}x;g*%( zByvZ4aaVhD&&mP0B>zgG`&QB(TA3%M9_yHpFP>UC@l40ja~-QMREKPp>$2xRt%;4E zQ8ot1?@~G1#-|1w!{oMfGurscWTUgy#++g{Y{hLfinXyxj>;{0E~nybWRV{mbTHajE%qKWLX;(%Gu~zUUTJ(6s<4iD%uz+)8xFoma6>H zY$R2(F+z@}+o z-AZF$vvEig+S<6$LF>J1S4pt)5d%6**GVuy_Ca8HeN{M-ZuR#v*~A< zjV%)T*hc?;HvX1M{cQ}AVgqdC$SsNb#74YieQu+=tdQ|v+IS{azEaF@Y;+&4SYjSw zqqo%g&cA~Qx!|1X4>c>D`(l5INL_AIW~%}P#&^p zrSkaM#*S4s3jLxyWz!lPH`i(})+?4+cdK7=`!^eJ?y+%fuZ@!XwTCi8jvi1SPS}_) z=jHY(8~JB!G?b72u(4KtllZeXDoV$5Hhz?`=XJcuN_q898{=fj1sjj$Nqh{|?J+bc z7sDjkFV}Ko2;{}^se}t+I3#PU#!#hN49=P{d?wp##Sp9=!-6_7G;0;Z$CBGR2J35j zEIDmraI}r#BMHon#u^e3&%fa=rl-v+Yk&Use5*@_ckYih7DZ4e6slUcD zd|NCNx5qMcS1bc}$Fg5?ev9S9y|HYPANIv^|3EA=564pFXe{%O#d231$79)XK9=Ht z#$vq`OEU>xiKXA)u`InF%TxL7pID0CjO8^+xD`vEd$DYlRu5wN?4j~~9LsL$_9T`u zhB(g3f|xi47K&rP)GHjvtRivzBWH`o>Afb7jM?Jqv z&r9sOIM#`2y*A!1{b3AjzVu`1NERhn{ zcw%GXd0mPX)A+b}noECsJnfU>SuBo{@qAJ$o{Vzw^pTTk@pN^@^Rv{?h-Ysgo`hgL zcXQ$i=f-m-FP`K1@qFGQo;_0f&3M*#jK|z5p3^e7OFXybjo$H8>Jv|qzVZ0_#WO(u zl)3#C>odjrJf7iS#1lPGW97%M;^{Rgo((c#a6IYX#Pgx#kBz6zgm~sjwTbcMO^#=X zG@laBgX!@U%!uc^nemvukEgM8ovj)c$CI)|b^j92n2qtAl`@;-X|+9G{{~Y%JLB2E zE1urJ#nWY7{E&c1qf66@Rf zK-xC6>)%0k)-}@OCYmG5o7%b1(vGW@oqDa6-I z?Og0{$34JK`_JsO_`=RCiTTpb>96cm9AsyiOdV?Hs$3Xu*B4ugEl0-M89vL-3F$i5 zPQM@QY+7W;w%AU`C3Y;U?KG7Sf6-d&6i2KZ>`d6CIMQIVonN-tiQcO9ezo(aER+j! zdAl9&4m(?S+4*;`Vjfc7@~zZ9ZfA__k?()Eb3-bgvGd18JC!b}ZB@0bL(&P$;1e8pItK)PQBTY zK#`pZl--v=nf(cLl^ZhQpyo-P!fkWKEeweeO@>raUc|NKS=BeJ7U4#EOY* zN=?L;mPl1u=uYH;yctO3lTf10NhNYteh(+ouUaD8WpRx}9@WwKR}-O0A}?Dc>YQdG zFWM&Z-rI?+ldWA6Y1<=_`7-l;<ESnZ2GH-DrcjWw!i6s7%NJp6>1Ak6rzie2Y$ZMMt znJeYDBr$YkVg{vhIQ$30D^%SRZ5|x`I>D*ruFIy#1r*#rT+9YxOog~V2 zNy6AOiL4Kj_)6JI3raG2H|o=n`> zWNuAOCTE(SpP9^=1<9l>Oy={&$-Mis))42KWP1IY%myj3H<{V{lDR204(K_t9MoEp zcqo~UGDW^UnaoLf<)Y?Z);L*qEtxHUB~$3{WXAlHOuYxmOptOflKDEOBuAvTy(Cvt zOX5!}$;5JRC9`o*WPUH*2a;P9vL zk({WS!k}s?G-#T_B$?SEh4t^GVD6Ga`CcislJ8{EfD|6en87Ku_$Gx}GH65!dq$^V zAEP+aHD^W&nPOd-LNi&oAqC&&6b8um+ftbKTMBn%&(RdRo=V|oX@50^h7VGhEGH}# zuokL7Gl@yAz>Crqs9mN4&Oikcx>TTp%NCeI}BaYg== zcEc;ONP4cX$n|X%$=qI%Z6_*H@_9ujlFCI16;Gu>d@7S9yId;&q@=)CpVS4VLi^*V+j_d(z8k`8C6sD z{*_3*mG|Z3*x@ z-;~#$G}azW!+0o-509l$`$QUJFH1V(sgdFuqZVQhh4X=znHcVv2mYqY~9mRMK@um3VQb5)ZCb zqTsJe47*iH-!JGnS^l6B23tA}FYI`_prPve%Pb62KpO6T~Fbjs~aXXKG|Rvk}=6MFvlbk3YhC+&PX)2^gb|7tp8 zuB9_muKtyd>v}ph0}fJUy!;V#P(S3LRlb8Rl2YIxAamuPDh}FKb@1n_ z4*h*}u(+;+_2RDQ;G_BuF3ZJc4(`j3%^hqMZwm)~S~|EYciTIN?%-g9?34VC4hDB} z@KCmQb#PopzUyG7#CCJgy1PT)`8z1yPxCbWbbqsAZgXJW?x4{Q z2b-nPKK1;7gKh^MoRMD+J9G`5gC$2DymHKeU;0VG3FUdx!6PYj%0Z2D%Kw&wRkyV_ zcO2x($%hV}K64QBT>X+`QtO3-5ihmx(k#l!lxQb01}ERfI5}F#N%g``mK1aHdT}Rn zVx9WF#Hs7UoE(>fWt=3Gb23E6q&PWU!O5!?olJFTj&yc9=_7xM*X87v-$`PQlQ(mn zl&<3BY)vN>YdaYyt6z2UvaXXJ^_;9~=%jrkCqFdS_$E%KH+6EknN!z*IO!_uWYud< zUbJ!2y{(fguR9s}hLaO-I_c2fN$YM-W_EW{tcR1sy__U{=;Rw&`mvME(yyPBp^`qp z$+a(>JdqV&I{8&X1Dy=`%E>?SMBWCt0#UZr@iP51f1?=bvgH|8?@URQ=CM6WJy) zQ5p1?k@C!(!Ms8ltd{o+XYhsGlboU%ER;>+h|l0mQU*6b4TuugaB_TJ1H}W#rFBfHS)eLGh%%Fu7YowSmT23|2 zpiUEwmEA2fIQB*crP^gMTn2W^V5~HFORvj8N$8xx5Sc3G?iqaWQ3hX0q_@V&W-<58 zppOifN1tSHb7%&k;TatLHiOGDV?+i^<-M^Pq)*oElnl;G?`euHRisSG~;J%fq&GB|fXL!T!zc;!(BogS+ODgG>jR?joo zB|p8$pv_Cg{5ONx|1xNYi}_J55~5waVRSLqC`@ zRCe)xwoBiMy0|HKa$QsoyZAv$7r1zbcki+m~HR(W?By*^88s=iC+?Q{^ zbunF9jd1afoR)GUT`V5uqRu!M-%oI{Lb^}XJh>&AlU>xE=3>G;7iZ_YXz+v9T%z@5 z+K(=lNSUQB-d^V7xJ0i|KV`q1l}0Ny_h%R8RjTtB)wxD>%8GR^p00N>XrqgRTUFaO z7o|?RbUluGbK1p`i!RPf-5V}O-*gdm%f-OkE;8?Y0PW}nqfi5NFuN!LPdmKSzYu85nf@owA+Zl+85l5V<`a`W#iZfcfs zbEvFa-vhZhk?N*anw!*gH{Bg>{*b*+H*qdE1Ld~YO_txS>sZ~amwN#>TO)3)1#Ui; zmv!6}ebvowIVE-Lx*1*1O;mk1y&Jl*HFDFqv70S2r@5Q2Te+DeOVf=KSk!p0#sRwS#Kw=w`q>ZnkxC<9Oe#>%H7e{J_n*52d&A?(1f}ERy_wZki2p zGi9)wm?3UDeC^g}3OB1HWvF^H%&qf_ZfcKGym1;c!A*ZTJz4#l>SmO~c3XRw&<BpD{n_PcpY z${cXxk^KiX_Nbd7QstO>Be#z$uRoR71vjr>c60xQo7{g@ldSwty}*Md%EQ-kAlgH| z!NU(G54X%7-n4iK+dMQ7ON@s^87hYgd8ks@L*XJGnici1O&Y{$yd;(IkS*!`qEKjBMiJL{ks7nt7P>x`*p;crdi{P`AB@R`O*B zkFHzxkljgn%F(V`yT8^R;L*7ZQvnQZ&oL(EVQ{bkH>52wHN@ahN;lSXjUmnV9-EB{SWPbO=ew4dVPtTdkLVXxGf=3$zQnC{`&3_YId zq1`OiEhA=o=s3s2!nq!j=Xn?)-^k!a9`-HP9xPD~Qu9X--!AnqSxPVS@YZtmYqj?5 z7Y|cqfz(>#;rT`nPd90gws=@B8>P}#^=_NuZuc-=3hnUFbf<@3<)94OrTyKlJ^W3_ zft-==_j~y3fQQxx)yu;kMj!DIb<{(N;~v_a@UTa!p7L;0Lce>ME5rWqaQLjAKj&fK zc@Mw+>EZPY9=ggy319NCMAl08D;|!>t!p0Q|Msv!uHW$BzooS$=bncz?t8c+FQv)@ z^-?~1=wbaM?Wy#C>|yH@5A~mUxMuO{`wlNNWOSDURGD|@>@kO#nZeT%+RgZODmt3U2-kpB`)aYwUC#jT-`>z z%*xl80x$nn@lvarVpjL+bFP;f^)8qvQy4TN-ruAoWx;smJi*J^NnR>W@iI>So2s0rt7e%rQ+du( zp5N>KVlUPuUR~F${w(+M=TBY=R(l!piw=cb5vu_Xv|qJr7wGV^Ol!+ zx4qc!cscpN%NGyTw?|$oKUU38)MKgoOnFLKd~}ZTaY8m4d>BnWK9YAVK9*X2l(G2; z%CALz^ojTJwN$nH^z+2WHi=2}(O=q?^fAAbkAzoz?5*e{F3rb4`NXAhZXXN1KJNH@ zwDVRR2M1O7(?4R!ZUJKAQccb>;7sK76Zu%#y)teYn?Y zAJ+T0EaNx%_+zv7WUCL)Z$5hO@ew+teK_jln`1tnNYm3kCjai^(HS3+vp#;5ug?3} z^QVv83(8-vUG*{bo{x+7HU5E*&ma5P`9$me>tlDEpE~9Jj7;(KpA@d(XIrYDm`Z;7 z%h!^U?#C^QGHQy5FzgTkvyUp5*!|2_O% zidECkI0@GEQ?Z`n)%SBo{*t|o{KPf!Gf)mU^^?@x&zu&1+P3pEyS-lP;HR^hjby7>`}z4;hDf>oepU?d^YjxxT|ZU5pKJb?%6E{T-v;|>{u;c342|ra&`WbrK&je|5R{MF$PpvDeS$1F3 ze*Ep{b7}aGpYb=;S25i3Q}?!?bu#gh>VK?ypJJIMi-mJCp)RDgnV z0UAq8d5x2AJIZn|80ObM+7(^pNn*-1o&cOK!kqx%K`Fbiu`^>d0bOYGDB|3yuSk6 z_&dPs*8{ZvC&2r+0{n72K&3m1b2mWQ`&#>f`us$Fej1?VvjClBfz*2*V9X2k_GN$x z{{}ewpNJB`2T7?Hq-*^k=}m*W_B+TQErZl=6=Y<)px#H6Lx&*iIw{`U zLB8!AB)&(GwmpMfeJ_ap;~=m13$jnz4N%Naf+Tzzq|ui_CJa<<-vk--ZIHbqg5-S{ zWZOvPGCD|q`Ds#+CzFG8nWB281-U#uNb?!0cUF*N-v_BNJ4ng7K|0I}a#*fP^nB&_ zLy!s!gN&60Qev5E*rOWu201OS?hi8RKoAZF`SeJT#z%v6I~L@Cq_knXpG6x`9i z+zk@@I7sU!L3Yd9XUaPbaKqNWg^$yoVA9-2d#Eg`nZA*p5!G1L~KckvKEmI?8o zY>2nYg;<^vqGg2;(<_E3k{TklQi$&9iXrQrA);L&K9HS0y&eehscgy$Vair4DIN~d zDiUITeu$d|A(qq((Xf7q@eMSlVTf8SLyTw@()Yw6zJ4vlfi@vtdp*RNb|F$agcu_= zI)xbiR!HZTLM-ST;`YZOUdZr%A*M;o{vkTcDJlC&h((`j&4D34{z^4T^+6&1+cLxs zDLf>^#IHkGhlgnNZHUeC=(`Y+QL0-uj0x#?CPNs;h1e+jrC@xBS#oWH;!f0SlS0JH z0XZj)CoATZ5SFPSa;Js(a(alnGG#`H3p3TP@73%1A)TL4OgSR0mxlO#lh)iEV)qv1 zx>LFA3gO)y((eR?^xc;Fdq8zwQ2v*+h8&UPE2>G}y&B@DYazmahuD5UM4^WvlH^-C z`Y6PkPt<=)CL64oxNMm`FP=%YxJ(+!W--TSQbHEUZF?r|5;AcoXYx_WOoHVyu~o>V zam7rw$iLDyHIr)+o0iE=IW0G&m@|`Cq`SQ8%4C!~lb)VTR(Uf?^<`2iM~`ze8QdUK z*Hvc{Zj_0)X(oM|Wzw~ErmjO$oVT=Q=S<%1k%^^eCNpH`*i4Fy&m?MgCUxfM`Gv}L ziE{lhlm5#xG5(TCy)~JvmrH9iajwr~*9NV#S?g@cWcW_ybTpHd$1g~W zTK%3$t#g@}E@bk%Ig9evESA`^h$@*yol;pGeI<)Gva*<4Ig3*{SqyHL#lGfQgj;0M zM3%{s_p?a;Ad64?XHj={7Nh5A{@g4Qq@yfdl*PlvS;Q=p^P2Z(7LjXNOetHL3*{=) zqHaZW&WO0nfKRM=9dkXskW&ySN2uLb)YiSr05@&X>qnP zJLJ+|m2qCL%oHhivoi18s!ZC0%Ji;~&4!BEIwzRT9#1y0zHGjfyLs7UN3vNUy=r8$ zre-$jwX&&QFPrb`XVa%)Hp{wY^QgPV_snMKr`a6(ESoByXLJ9HY;p%?vq(0}>|xp5 znv_lElx*h7IFUgmJ6a4xQ*xl}He zOUL+JswCvG=29XfmwCZl=I7*cGdGuE;atA!n9K1_x%~WbF38Rol4}fC_ayp_B2L7NiVqTs{gP-y!{EOB-lgH1O@;G=oPv<1^NWPY*UTVF+^H_F0j}21!pFBRh zk;g4rcPo#mJ9!k9rSkA@9&g{vwHC6=P1HDM-k== zS(vUljxb}LVGJ2z27AKn^M(og!c+=roy;%;q-0i@4wb_kmUekz=7+;1M8e#t7A9CD z%p9pvE6niPVV+B&SHm=|8|GITTwgI8C}zVjts8}z**HwGCSi6r)ot@IpUc!1VJ^1R zoK|68eIv}MH^a~_%(C`j9(4%QxufEC4pXg5m=)6X-7w3$g(=rPOhK`&PXgrCyB=^S4wVqn?Zn^Gx2Kto}|3(`S}q&QZ*{ ziYbNWg_*k~%+6KXhhMZ0GI)(*uT|`IVZPfK=J=*CH8+Q;yFJY49buw&h8eUs%-(%r zt{x2YSbjPbW~;P65~lHS^;1fn2$LauPKGJ*dzdz7bYI5&5$5z+_2OKZj<>>mDDK-~ zBC<>#-BC~Os)y3-Nth{5!^AubvzZ9y=m-}r5y~V*csn`5aVb+;_si(M+%6X(D`h+5E%#7g9icqU^gb~>h>gPw;|7wKzdJzW6*YzVDXb>U4VFW|t z2z8r8SSOC=5#DbR;ZIrDCc+!9M|fA-z7b*en-P}Dwe}G_9V5(;p`9WedMiSew-vv$ z;&)Me+0iXR;T{o^WxEu5FG7;cmcQSR@JI%H5aHJkBOH{0A4T}Bx9X6deIl&t8{wl* zbvrP^i?1Ts21W46X(=~EwaG9!{B?w?-$ZCAUrXGu2(JxSEIA>rZ<)%!V5aE`XCq*z$j! zM`$`T!sJ;ITF;O0^U?^bV9YAjPUeSgi&WBoIDqy_IcI! zr*gO$VWmvIsovjGKDU+2J@xv2M897Up~&M1&7Y{35-Ok1fRuc4)AMoG%BNTDd@e{# zy?mO~&u6Q+8s+n0<9sg3!KV2nG|y*nv{v~PZkXm%l*YdIdosY3h z0rkojaH3oRKcp3Kt5N}PrWf#Pi8bGQ_8?0CyP_SdS~b(n|NS$w vz#Nr4pyQ-9*`MZ(U(s)Ok9nrY|1{~D8J99{l4EFEssA@m|F?$!@6Z1M+ex~f literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/1c3076e9c36ae0ad_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/1c3076e9c36ae0ad_0 new file mode 100644 index 0000000000000000000000000000000000000000..5496f766f76919678714bb8bd89d4fa4d5757697 GIT binary patch literal 32764 zcmW*T1$dL^*T?Z+BTdps(?ao5cT0-5#ofn->u`4&?hNT z>$4=!bIUpBzEhgyNj>$uEX&#c>o>EcV(@8FuN^naSE5kKGG0$=-qeBx3l+*++FK}Z zYJRUbe}UqjJo!rGDN{0Uo>Y&=Te5UPZ$59Hye0CLC{U<02MQF(=P8+*uaJ>3&SrMZ z_}^In`!D8Z_y4~g#Q&F|Ng3%19+s5~mXjtx9)IF7YAlon;XHcn zm3rThLW=olBlh7Q8Ws1^2plNkqkqt$q>uWbcPStFmhn+G^eOM7dKG=t7c+kH(WjO^ zvb6HiP8>r>Yab<|2AUwUjgOAvGS0U3QF1#U6+uQtvXUAf=Qpd8%|iov%Y1~u+U-(CjI!XD)AO?t<>a4#?@ez8H>mKk(=xj|!B5dUg} z3St(n;q)46yw;!&>zEU{)*EyVx6p7i^*&(GN#s39TbPd0=CnaC&lC4egKU2q^L@d&nm4a$O2UupZzpiKW6)EC!r@H_j< z$EYO+qfQ!)8fP{ti?30?Sd7|_VOFCi;hxPXx80~+O9^RR^(buQefi4hz}k4U55MjPdcF=}+2QC$+bpJLPlk5RY1Mtwx~RHJ6+ zqaFUvZ`6B!@+PGjH89<%Mum+!i-e*^y}__zMy+$ zDEBjcaQqjeGO8QZxrR{zHI15&LA|XQCp)d?Ti`#R|lh_P!3nnx|31IIvbU%JL`&@J&bzsn^B{BvPQkw z6Mc;8)6b}%1{n3%Am$s)9vW)Y0%({~J<)NvQLRQA^%&u!j5<8tsJs){NB{E&c_8Z) z=E2jc+@EGt`&mXknQc^#IYu?Z*}06dz^ItTMy0MWstr!BG^+X<#$RvLiH$~$*u+|H zCeN)#t=?`_;!g6|MXtDkk$c&5`-tNh>vo>`ZqoObQ6(M`2l^uWWA+WkJz@VnWv=Jc z2cOXDg;51x8rAO=&kd|b^AAQ%_{iFSGRpYbsCibCO8J?z1WWBEt#p`VbDH$fWl}kR zlbYc-w@IV09)$u-${uJ^BC_V-7CUexmr2_~Oga#5(p@x)kE_4+0Dx9Fw56vRwk6l zYSw^kX6?^z*6>_r`3IY|5*>1zwH2q3BgCxd*cEEl_As-KpmMlbd+`Ouqs*#;Y0+k7 zk1?w{{zK;kv&N%xqFJ|7%zA+%^I{?z4xukf3^i*T5{H?!0GWR`YXttq zZ1ho@dr_+(z(x;zsR- zX2mTsYt06;M(*SBNwY3pFsscavwW_xKCoUl>mfefFl*FJvz&jL)d$DW`IcF4Q1>s^ z4nO`jYwm5<@Qzt49+C$NJ~AuviCN1K`;_s~=#^Oo{xfTgd^O7At96-twHrQ}eHDZ4 z$Q0zOU0IOLSM789s&8&zjl^bzhj1T-e>R%kq z@2gJ*nX8bm>ZbWBD&1F?GJI99h_A-rAgUH+Ecg}kRehX>PdQ&z#OR8?T8@**TFFGXI;TiH&Va#g2>VzY>`V0Bg^wl>Etw%kZ`08~FUtJtTJx2Pf4a$$A7I2Ry zPFx%Bt3DHa^-{LIti?^snf<@ghA12z}<1b7~v1lHC_E^*i zZm&hbIE@=PmTFPeJQl6XXVHiJ7DW^wUVJKM(ND!Ka+R=X8SWr+NsE5LC8U+IXkTga z!I-iZ&A`TTw8IMwC~wgNbg967EUsvgxspX&aR`smqOwIRt620AC4RE#4JuW$Xa!3C zOg>nJPuTX0Mdhku&6Ai;5n)^WFFjaWKo`9Eh^O5q8d#s zYJ$H}swp+WH@KTwqL;YW zjl8=PTMvt(ezPchALhZqejFcQQPMz*stvNJAvO+Xj3L~|8e|%3(f;2pG7h&W%Lt27 zMp@JrJ@FZ*MpKV57VRBtQJe9s%>;`&Ol1E|W-X@h7|ZY)nWkA3iZi$})1vCLh;g=s zpPlTRITmf6XOaJWi{>o0C}t`3gmbw?6<1lbXfx}um3nToXgrqV9>#9B=pqa|EXs!S z|GV8q40~CheHJx7U{MeJdXRi@;4o`()S^Dvjo*&3rpH-l>_5rg#$Ehz%A({n#F&Dx>?dSWBi-LdE} zI^Jc?@aaA|KA`5XKco*zVG8!+BdY&HF3=O=L1DDSc)UQ)rxt$ZTa@(;`_^EU*=SV= zqJ6EJgS)6;vFaWC{j4g7_I9gmF01Cdt$Kof0h|l8YBKyXTa_uRRV}ky^*NmJBCPs> zPEl6nj(^ofK~Q_R%JtDq!hC11oEa? z)fPQr%&_V;S`=oiVpdfuZk0+~cNr{;Xxy@Y+`G#~FM=-TGFo#ShGCU{&UZR)t{>ay7Qrnx$MBw3 zxqDevy|-1jkfSeafT#WF)8DG~1FXtF(5hC0ta^#!Lzn~C@E+ZV66-LlyjY00Xz{yM zlW+>Z4QCE~#*`6OwH|3z54c8AbBsmH(N@jGF&r3Y)uQpti!*3Afpx(}yqicZCovu} zPqu0gPT~dfNtY~n)gxmL|aj`@s% zy$h@|EF|YeR;`9@iB*;H0>hSCm1mh%#n1qc@E!-2TXh!C&~62DuCyv>l~sk-T2%&3 z@fI^TvHv$S_BL|ZVO4>htTT+etSWVqnxA5wa1A|9Ge35q{u%0zub6Pws)P&F{i0RL z=yr*9xolO*t5*Gmr`On5DDjYd(d;R4KVwfmXN_O*{K9~jJda*mwFL)p8*|@KCme_U z9sU1hZ{se$W9C=d|HqtGo2uJvYK;B}@Utm5R^T#H?KWj`*%X0dIEJqNHVwf?91FC` znaQRcD1amAoY|&9c!y3wHkHa^)52^vmCIq%SQN^|T!_hSQ#-grZK?skaGR>)euPc2 zkv5&foG6=C;utDL+f)Zv@h>{W*knwgKa#Kowes1tIKNFBa29n7*yLM~9551R({0L} zVN)22;3O&+v#AYAm9}XNW?(Ctm$9h}W}!|wo6O~H3c{QU#DpCcZ7N^MrUsR5x>m)e zDphT&k1jvibO7zE+0+lO@D1I5w&}tzHubJfZIHhvb7B^5qeCs$qP9(w>JUd=;=oqa zuV<6BzD?P1sxf0Xv1w`xn-*a|sphQH7us|f?YB{vo#eO6rX{;sn?1z4mwko#Sig_4 z@%4aBw+`CW{SdJowrM#k9I@#I;*L>IT{B{Jw+`~vu|%w>%VM#C}2}C zKEZUG^}lP=rhDWH|A*xB4{P&&+W7dXsliX3alq)Ob7*4r(`jEn4YK%Y91f$n z(@*jKehP8>DG^<94}Amtv?+_9wq>Oqo}fuKKXt@1l*{SId*^;yk;_kEVSZX2?x!87 z7U3srl%Imo0)a7%jULz%>!*V#6z8W|@qSv4utZ|S_ar~nP4?6K;(kgi$yg{+%1f#!opAT-Hz3%ll~(j^Q!_D*9;zRLM`VuvYfdF!ZlNe#lkTPZu%s zCqG@lq8fhMfcG{1)V!9Tmf{6A)}}^v{4{b^n`k1JN`w9r+%7kh6qc1<@HdkY3WRa>!rGuGn&RUgy}=y0Tp%RqU#S->?X0;jUv>Fm~3X ze|@_S;B7OzexPx4yLuzMm0fkQ5v|+M59Qj~RRihm?V5-@9qd}x$*%9H+S#tJUG2Kw z&902@c6G%-`1G)=c|W_lBc#7w9|zfG9BfywA$ARid8l1QQ5h-2>?({m_<<3>Gw(>d z{zSqkyINuep2IVmIdBRs#@MwT9mm-l$?rF?F z-LCmqi|jMW4^6RemR&<;lP5fL?dpX7I69B9=i8M9#TSqx#{KVhpgEhtooZLx1yT}KncC#j!f@XW{T8Q-+ zyq8*`%|80>w=4C4U0DxOm&0}y!I&e&eS#XEByCj}c^+J&mY98=^Ed38ig!0z-#_ij`!_M)u`Bv6`w#Uo z0skQ1efHr4)*T%mQjdSAAr3vFE|1wGX!pdfYERk2&+Iyae9svV#a`I;(@VP!;^ZsV z>Wy8q-r4mYCEwErKYy@m-bcG$q0}cHV<$YH*+bA5)(~xQ7NP(0oWXu%`)XINZ_If0!Nm)#6ZlEDCTab5@7ChH)Qv z@e;Sfxs7lrD$*fWltc9~8HJ;H9OKXoEXDUY#*24o0p=$;l+WwXo;(hnM8UicO~FF^ zo8O@)1swW_nuQ!%fwVM-uHu(;hwhd z?bHlC@E2DRA@@1zao(Z#SaiW5&qaq0W5*@px$MxcE3C;?ht^{8Er&Mz zu>|SQiTi~^&2StaVS4FME9}836nN#(AdE+r z*ABHnH#|n6Hx8A>F=T&BoiGcp@g42nIkXeUQR2Nr6EP3jKRDC`op2Qi9~lcv@DZj@ z)D=f?36($74{MP8h1y^^-lEvQ4%xplCZ^*NKA_t-;=&b_{f~24ib~(92Ob)navPm$ zja~R|a;l)&sS&u3>b_1b!6zhJocvzrR358SL-8C%Y)(x_jGt3^(HisNvO84=yO7u6 z)MPlEPOWk|mD}H`t2p9zDn7ue*>DFsbr^$!>7Uyv-w>xtV+THBZ>UpM!klW14&hGy zgDMeDoySAOMmkj&Loq4JsqMIrqR~!;#t=K^qf4w)#p9fMf{(ZxPn=1N2}`n5Wm25_ zimD#w@H(|P)v5M*o%$CQ@^Qa_Q%wrezK~P<)0|33cWN}IWH=R2*r~TgoU#{n>IzK7 zoT`od#Tg5oOE|RwUyxkNsSnsy+Ns~lIQ0x!%aRj}<(L=$!LPhispyU&SYOepTew!) zDW57%MWQ}h<2d$LV_onCu3s3Zx>Ln!I8_;AaU7j$Qr}umtwihEPR*<1R7PE=)*`f? zQ|0PAbsC`!ocbN>@t~nofsLKohaOEhkM&JipJq-qZBBeG$qjpvxixd)O*^Ne+dFju z86BJ|kHxsrk^DQccAd$&3;B0t?M6BIUB#*K_yXV2#EC=D7}gO}a1GhVat_B4GmaQ> z7a8M;3ppk@^$n#aIyDo^kbM&M!||!qWtvm=Nsrsd4J!l`yEow|+#tDFj7<5UVl*RsdqUdR5& z3q-DWYA}w&e*=36zixD@&?f4<*{M@oh-n)!!?J_Aqw`Mcx{DZgQ|mp%zSpT1`&s`( zJTHzDKNg*Is^%H?4%VJ!Ev`5fh6?bxN<7$&bJu8ho#)Oi=KPDeQRZ(a@4-41g_*d3 zzp?rb^~Fo%z001#c~pKxO`ylj^MrZe^USHjDDZ;0UQ&x!?2*?_<$L2)|M&cS`M`ep zNPo2a4Yf#s|67KZ{HEvbxkGn@cnB7t*u4)EqnU4C8aSv>#{Sm(#`T2baFVmdmBJ=osRX zLR~uWKd~;Ij&rGIyi2Ae7oWknRLJX6kyMvT<#Fjc_T_b{cs^px&lm+<%8FKKThOId z*p3Itn#MS2nC{YSJSgna;UX@*Xz9{dG;QNj`?fAMYUh%py-U?G35Pqlbf_zHqjh(e zj-l3XF4=pMXD{aOOxzzJ_mwp++Tu2-3Qob=9 z8|zZ`aW0-eE-i!qc$boKd4fwdCc5+l3n#hseloF7ajDBxmzGR(smgSh?xOn)mu}4> z-q|ii&v9{WolEQH5$6Jzx@~mHXDfLea%uN*>U_ebB)qvqtbe*R+o8Cb=v5!+t{$pUu(B>ewV))};u@u$CP-}P64$NsAE(qFIMlj~=Hjrq@CGkx4zhMPt=zazWl zbh(uSqy60~>vn4+KEV{==6V*lmY_kPTa)lOr&}K|BGj!#C>rM0Y$S)fH42|FC&H~P zk#1#;a%&9QM7#AzoLhP0-HJ|O?)+|TD!}oAZr#G(LT*JCb}ONRTU{%F?IyL2g|h;?`ZP9OhR1aBfGD!)Ui!k8#T|)~$!*+^R9&ttJx~XA*f$b}Mj-Tdk03 zs#|rYx#gMRRtt2+DkRULAKv2kxo$r1CXZdz3D5BJZtAhetqC}XguQMR#4r@u$Fak# z*AcgxVI{WVpQCPdIL^E$ShG`ZrJixC>RGqyW5#*rzu?vj)V}4`@H=j`yX%(ao?AW8 z>psUGQRl~Q?Ri4qr*5vFa_h!3>hzL*^UAHGZ`_*sf%Qc1&$P#Lbo}C0U)cY3^ZL!L z2PpHOTW2x#hg)CJHz+_ma1_=o0Xmj7K*zHM=nBr{2vFnP0csr@ppIbyiVhFZQ#_0a z(C)|pU5^UT;^+Xaiw)4SgaGYN4A9Kf0L>{7pgjcxlvap#X#x5(JwSnl12m`zb765& z<|-bbVI=|-S~5T*;3^%UwXl~7(62azGUWm^t9*dMDiaGzRt?Z*e8cLW0~Ga3fM(zT zUeyZF$hrYa{WU<<`Uhy#=m7mZH9$)r(Kj?uyTbxiBQ8+WJb_w_!QMdS%@e2sc>`6d zYM`oNW3@p2TRl*9YH*8=wF1?xPM{jp4OGs0fpRwv)a@pLI?yywkDCW-MT#1s5o3ehjxK_fZXi^H5N0`wp$>3I#5pr2I|HL#+ewX7E=QCa!sJ-tPRxBb%A=j zl{pRv>I!cCpe=%YGHERCnlmY?i#oMAm zI$b`1nVTC`vz+S>I|R_2I3?N4+&P@p}|TT7OXV9LxbOg^$Bf91gj@@qUFe7b;D-d z7!|BXm^M0Cx5fl3aD1>vV=nID6{b!I)`v-)n;gt_A;H=N#~;)P^YIXgQ-akTOYjd? zOr<}9r%@~9n;xu=Sb<72g0&Z4kuWn@cd=j=>wr45i4oc6a14oyf;DAvuofZDl3)-+^GA zL%V~l^C9YmhKGaI>R7P4+-iYC3v56{2lW>kt*e8~C&d(Guip8=~%* zgwI&eE=23#*FHq0Fa>w;5>-2dXe`dbw_}J#VL_)5-NvNO#Dg+jLbMl+x`wDdj^PUC zb_>xH)b2q{zlG=qmiG*ivsZ|6;%@H{#rFwOGaTqk`+mf@F+?@c5|c0wSJ8M=h&tjX zzHbgumMtObfZq|lHAJP6XIqFWZl^7J?g-He+((|B#D$Z)LR5Koh??Le#_tVLzkMOP zfXxSp>0pRP90}253^^L2O9(#}qJubjJVe(JaDsf$0v}NNWQamfQBT}I9ipOVLsau} zh&)$9bR0J^=30nmp!5xLyBVTB*npXL$l*bV9{xk!ABCtD5}uO7Gu9ZRu@9x6hj1N2 zh(^Al&0FgDE<~@e<70@TK7}a9mk`bJ4dwdKP#r5UQ<6suId~xoD5~wL;}nJ5=3JxNfK_pk%{P)ojlkokDdH z@4JL5up8r`WRFm;Ph-5_LY1jE?fZnPT;EU``_Xn#sA>-h)z{&n8nTG-SB2^Z;#U*j znoym?vbCWytqYak`cTcna!l9|s(U!TF;o>dg=#YXMDpfP)z})UBHKgNb9boP9%kON zp&ECAzVN*fsumAI)fKLXpeR90i_)Y7rK{4Ap0Re@(1!L-hn7;rbM+ z_SlDusQx)rRlic#Z=w42d#F0#+K*7pR+ttV!n7WFOkpa9zBqzQ@LI#v(H5q4jxgQD zOPq0qDa=1iodd)458^_?R4*n>qY}cDls8OkGs4upUYN>u3{!*_ECp~%`WC9Dh6 z;7wt2Y!1_vEn%vEn7+7pButBshH3mUj-$em~Zw!Zi^Nzi?H+e{kBvwE;1XaJ9oBJi$NCaNcHNEdOxH9nN=;!gV(woZpkfbp<25 z;hK(&RN}z%JmG4SH(Vq0hwCOb7YbL)qKs86TpzKlc(_a@!WD>7cz}8(!*w3+QsG?R z8m{IziT_ZubhswqMVWA2DjTl!+TrSsi*>?vqi(ob{T{A`_%S?OgGUe-%8m?|ZCr>%;RuQiHr^z1|k$NVa&+v%lY`9vW50+yKzM{gpaMi{|bUq)h-50|7 zH;$TK3|Ac-gZomre!EQV;JQj(u@tUr1f-ydAEyxDUU(oJ)?-b#y8o zp)0VJjo^Ld2+hYns2t}|xoU(u{1T!5SX(_pd%8yGrydbn@mqwpqEpWZZ9&^!5jv0F zy(6>)8}SfPeIk?xbCBFOLYewSXc}&zN`J=1HEb9dp=!TJsL7-V?Vb_AXT}lQjxQ)S zD?&$LogJZgG{b>85ek?W!F!_-GHi%Yqm2=&u_;0`_C+Y${s^@=9-(2lfRZO7bP{_` zM(7znqtz+K$5Bi^9ifkyawbClXCpKZchLJB{ZZsRabhZ-!+Ie?`7UuDi_!lw?ePWc zuSVz|08 zJjNeUjE$h^NJU^Wo?uH%qzc3m11iTw${tT!EI_m5NVQ0bR4q@W`gtSOIh9=UM)Daf zV-|>1)3iuk&4^Tb;Ydv{LftUGC~@FMu}FS~MCw`bNcolE7@pu{$w*x<9jWYPB4w%= zsYW=BLX{%56#t@TWpYN>rja_>BU0UeV{LjdW}iq^8%!OC(RXB|rjCtN^YM`?Hb(zgats@*V3E$|hG8%3%0uTgpnQ{yOk@GI6Mcatd1 z!4CL0jZ!;&Lhfc!s)>8Z-#kjsI!7t0OOyt8<#@L!6(1g@KDa)Du|`Fy#Plc)M4lN@ zDv1+_o)x9w*-_fPAWB2FL}?FlY>QIX?Tm9cO8e3E2>RXAI-n_(VC4S zmzf*ZE78h!HCj!tMXNKCu19MbD&L4!6HGwPo6&lTYJW!S5~|*cR(}Nl6|Ei!`#V~z zaSdH>M=SrGXq|@dUBy(@?c;4DYwa=%0Eqnp8hVds@)9WsEAqw^fXctz&q- z6{AJ%V^p$3jNBb#Gza~A#VBz=j7Fi^z!+s69HUN{H6%vw$HeINx)_z;6r-J}u{lQH zPsVT^LX2MF2Ns=<(J$v?v;*}nlMgCgiBWy%YK(dy*G=L_%q`}47^4F?i`Xo&I)j@i zkTq6yv&U+Cj#!n>8LKk6V)?u~R%>#{>NP5c$7*&&EY~&0>N`e7$Lcyt#KdYL6dTL6 z!LeK$9IH}^v1$TW-dHWciW0GWhdEY55m6>qOUuUUuX2oEB~}M8t!Av8bz)VyDYwmH zwH6^Qh^b|)8n=q&Iuc@P9jj|7-X@m!&SRCWE&Xu*{wGHhb#_ARR!_Y^u+V?nC3!cU5HjR$?tbE=PE6yOx`&c!?GMvO0bo@x2KE-maQLNq~&*xa)pN`dKRQWen zlMwZl$KPX>t~gzU*(Z)`TH|yUn+$Qfj}T*=YGMS=Ae$*pb+G`q5nzr}adg6B+rl0|0s^n z4C0jbI8GJd|AgbO;uQIsIp4%7-`hAn`V^dWniY@ycU}*HYhj z-9ce%yzI7k?F@|9XROK;uU#mfIbL&v;?*t-_e0|O856JTq4BC07OzgQhR5@IAzqF= z@oJqnUeWpD)i<4S&^{wx{a`E{uV0JAE3s(2_Ed`3SFEiZuf6D6C0?$2@v4L$@UI`Q zDR|p}c^k&_K2N+R<8|wJ-rI>+qv`RQfsZrdwQy#<&To&`)IIUKjNyCZH4VZ0;?;XU zu^fok!PD{5nRso&A@n>Oud+|+i+j)FmH&CX*1wEb?pN_jK-kxK1$^T%a{h={M}+$% z=vQPiBq#zQ#snp~6VwI6a2=5W2};EV3<*roO(bMWP$z81HB`);pb01wl%Pd8j(1R& z1QkR-jK+6V%$lGdsF*E5bucP>g8o8^qcG#4Vvz*hhO20Ty5b9(7o&EV zT|7bml}J#LlEhd#f#*nq>X%Q@3w)?Zy(%TBR9$M0*JxZXK^JfzdFv;r5}Gui-gw@Y z+O$hh$xaCxguI>Ui<5}ynxM?x$bV3R=HTDK3A#I!xu+&5eH!`VJ9bV_(7w4G$NG5* z+K)2xsq2CS^;(#q)4Mpom-AS^kMk(ApYsP2)aYP>+8*90eu;bsCsEVz-kzuvjzskhOw?9n%ABb4=#VW@%VExusGYDzC#np-z!sCJ@pvAa zsK4S9Rr)}p2H@7gM6EoOs3XS{Wjw)nIEqRq6Sd-0qV}Iol;?J$#^A?Y;=GrrsrM80 z^Mgc%JxWwPY=4}nc~27c=3mDBn#g-jiK>ZB|0Qa~cjB-lsRWK#lhn^INyD5;GG|ND zSh%t$=~3<^g@q)ke`u1@!jd#ADoHmmCOS#8Q8y+@%?c!GJ91|vsXqJ*Cn*F=U?`fT zZFo^JNimg@G_*4FRY}sg#z{Jj0Zo!L9zji$)TLRHb~aDqT81R8fnWb5?ZeFxNy+SSet#zEcig{49sVYc`_urX9ww>iKS^5tGD%ziOVVpp{*lDz zy-5o2Nme@~nUd8pAX#hhYhbcEA#oaP!NtW6st2)YbWjw6unXJLR z=szV{!;myHS#6PfRvt5IldST{JC_(2Br9QIvI?U*0v9Li`x4?_nyfn* zx{SD1CTq#+WK~#~tX_v`b2wQ&(ECWTe2!8Fd^?t`{>PIw8u?EoYxPO`pGsE98FD+H ztf;>j_ja=EcapUgjqWBZ=3cTEJ|T{$#NkX)x+_KH@D9b?Df}Ih6g>$@(c~;CdW|O8 zQglCiiVEaNQ7ODao?P4pr)X$MicFClk4oXYXDR&bPEnuu6kWxAxRO(3^`s~W`;m~E zqDFaAG&gUGe#w`ji$zj2uy~5bqF@R7Af{xB+SN%>%X%sNZK@Q$&z+**k=igt>XV|H zXbM-~6jkZRxcyT!dQgfQ3{Fvd#12W(fl0(aIYo=m;*S&!o}QxWGg8zHS!brG?(7ux zUYw$Fn7SrKJ=djZ7(DA!w0c8|;y0$K?dB96J(!{iM^ZEg<&F{`vK&j%Q*1b$qVZQ! z6n;BJ$L{j@4UgZaXg11zNYQkh!@5r?n&IP-+2BzI)*3x3YWCy@ko@ zQESw+d9>8wQ8uSXQ8*8`zej`J9`y?HXhs&!qgqyvmLM{lM{lA%x)kHlo;do&do(Jq zNB<$ZkVl_kP4g%;-J@hoE$mUNA|Ca`%%UDG|DWO>eS@upN1O2mxl4Q01p^RY#-rcL zdiegYM{_GMc2$qgRr9F!FCL}U@Ms-&qh(Exir4n2DjMS`Hr4UyaXpX5Ht=YCBj)(k zqbxXpz{Vbx$NXl**UqEKn2(C>sY?fP>Ez+xHIL@>^YC5+bE5q?YB-)bP;&w?&hT*E zfJfC~ndQ-!xgMRG=h2@SH{YX=i>UWvkFKNd5|1L5dGrD1DIn z{~!l>mC47e+GeksWbvwTRxjUI^YT8Km+z^0wLZI7w{v=x9^%zR%tiT7uSSJ=`Tn<; zYmdFWf92JDRE+Uz1ZpIDl_$lkVt9tu9yaO*7a&fL$9J*GA}-~@@i%quU_LnEN{!$?HId*SIM233;%WTYF0Nde^=0}Ha)yt zhe%D(0oi+zXK$|p`!dcz#=(DBKFF)MA@m#S)$i6AV{k_-A-#Vb~2fg~~kXM}#vpz>y zvtwT6JjoiKV$3tF?>VnxFM3t^GPSxw4%f)(I{Du8DjFA1>QAqF-ty|pUtYbrRCu+&af zg*voBuDa9#f%V9@eyR@rnyO2UQ?<1TaW+rYz}BhC(S|y;P32lY@<)yKsTzitsL&x* zPcf$>V|7kdVO+=PE~%Q2l3mH6N2T}ZFZ_QAlsZ&Eygws+?Y@GUl!DS{DbVT3aT-W6Z@(Wbve_Eq24@O;dfW zgHLLjs$wv%B5(OL{ytfnqAH{*A9f*Ir8IrSwHj$^S1V1Q8gZ;yno71zQ<>Ij8j1pK z(o`1DFsE&r{=~R;%#RZ7)ASknJEZ9ezFJPvd)ljK34R$p2)Ta-B-kIow9` z(`h<*CQW_LrK#Ujazck^Xm~~HNmo$cboq=(S5dr$VPv{S;Nd9d9Fwl*tI{4rXZnp$r-BW~dn6!FVr2Bk|Au3{85Fp&~Cb)E6l)GgK5u5dJztcaY^r zhN^?VPNS@t^M5tn2b2?aw8!xuy$A>>y(u8QBb}_9Hkk<|*=%;HDWHH#uPR-TE`0$( zVChH~sUjdCy-PSsDrC0l3lzy> zQ$_rOT-j`V-QTA3xovus&!(#RZ5my`rn&`fa#ply5I(MC}FF9{EB=%$O%)1*mNAjhuZW5oWpGTYZB}IU{kv3 zESqK1mN_=P!pgZeZG|z<#&u~n1s2$}c$rPt@#AuGLbVk(jrrN8dMj<(v%#j!zuB|_ zdlA@Z)3QxAwcc#g!QD1B+Cz_@QD50OwL@yTIK9T7<>Pb-?JC6SZpAo_sTQY=HF&HU zr9>-^madNxj z_&qO9T|C6H;xx@0rz(x(wA~lS+>LRnI*GA@pJ--|c$FF-uMHF86-bHaI>31Kof5A+ zQ{(m1w0PO3$LrXPczux?uQ#*eHDyk`D$k48)?#)wEn(MxAK00H($4t_yOtxZoL$>1 z*tNKdUFB=rRk@K}9Z9ujb%x8Ig;&4#fTPm?LzOCc8$a*VY>>oAvUtNwW}~L zV^v4HGIz2oV`sL-BV_8rI4IH8t_X5>v+D!wK>hA^{=K!UZ6CWfU|C-~zeC#joW`!| zgYAmL<>72Q!mgu8!{U*4=8v?i^=P{`V;}w*Yge;zcJ-TT*DZWB!>&PSIp3~nXuQC# zFd8njb1i|L>znK{*4WhqpRBd3+g>~WZ?NmreRg%nm*m4NT9 z4;=azTgo`}HxkM^^thZu9m_j35eMO^;LveAK=EoU#~WO(PMn$!=BjjP09Mpx9Hg)3 z(8s9Mz@bDO|AgG)iHTX*53ilNa0fjd4pneE)C}8P)Q$0OhdLV$l{Ou!4qK8#pW#X~ zhf1YTBVyBui4pT0nv4>^FeY03>QKE64l$9oa^m8Cht3~ln?nvY!EzKo?9h@U4*iKv zM;-bWtKK?B&c}&+o;vXwxi2_W|E-Jc7aYFi&?6MR>`)vMZ~?{A9I6E$CgTFqUvVgi z(dclMeqz<%4*i9D$ac-4GH_uW?%s4L|1Elsy#G)?ycmjkw;ihTuS4r_2`lgM`hAD| zX#J351n)g^Xz){q7UAG?hjP7e=;%v_ULyF0agjkzmCxYRPTaxS>`raV>C`cdDD6~+ zkDTg;6dcAw1j{&;id%SC)~V*@SO@d54R4UIf>RAJ5Th}!qEodiIkf@RDm&#v+bT|d zkN2xORTjawsyTHJt7|wlzNS;_aP(uR&eeA6d>yCq)^#dN1E)U37f5eod&IpJ=hOvc zvO84?E*K7{N;}EZbZT;vQ$Hpf<1u;Q2RBebAeFFcxd@YydF^JM|j&QH%?7tdn^) zoSHt{sYQ5#f@_^>yu+#PxN*R#TnEYJD7oM`?x4^y9H*bieUjc{F4o|}Tc?~FaN4Pp ze>wFM?h8(Jz+kMo;?x=3zD_@HIMw-IrzRnE*Qx$!^~kAVXz-MMgp#kw6Gh~b8x^y< z6vXH6xb&)sOQnjs)V_pEli;u9Qcu{b@;WZoa4B0&m!h>?8i7gmTzrqqrOY;$s^NOP zOL^=r?ee&E7li{Z#bYY|z@wl`MG{@=ftje6>{1NtaT$4#S93Jk{Gt~dyrB?VA zX(&3@B?o@Q4x~(Q@oy|SOmwLM+D~F!v0q&BVE1a5_N}F#X)aZTam}TUc!E~NFT>2BX zn=Z~1xRmdy-n_ETV-0I|U>x$`Cd#_vWM7O$NatpWK3A;5h;#TpPTMJvc75vn#jBVVif<+zO zD%shsRbAY&cXM+Myj%Oea_cVIe(lybnETc@ZaI3pb-a&Tjr+Pa9;Z>JAJ1_DX;{(U zt^4?M0CB!`>l7*vaVyg>w=Rz%uT*-2tvHH{@XdB>$wIb4x}V(o6^UCI8yB!?EA{^2 zR?%H7L#y3x%|y{X)V|lP=zcfXLs8pd#>1>*ZtcW56gbX)fbFDPpW!cLKSf{9x|R2w zTjg>3JkL?{GW!J+)5rmNuF&@zZpGbWA7Jl&x9;HlBeyap!$K%*XdA8-F*LK7q4RGQH`Kp`!5jq!=Y4n`vn)fu;Otvo zLwy?=%93DcM>27n8Jdby$lA)_?_Wdh+87#*bnOk5#XnsQ<>_YVOizQGlNjoV0a*0b zR|fMz8d{4Ny$yBhYw*1sLv{NZO28338DJ>eKtsE}GjtjSh8U`fVK|H0Lk)EsW@tJ7 z9d4-QNJE3L5q-YrakQc5SU1*C_Y^~|f1oa0K&GjNiou83*osSNKFv`4j|S&)4DFsx zZF3CfG@?&)d2OB{+fN2_7a96sk)hXUyTstSF+&aTW;uOW!LpTxCL(1O>#jCbd99%k z`rz2FhBp0XC=E?E8XArrTj&)sY&BE_HPHyywi9~?&v6nLcarxm^1&SJe``1UcaNb1 z`wZPjw*7|MnQqQA3Hjm6WV&fKy**z-k z@^C$uNAH^+=Kb)flh>majXm0g^*)a(2R!P4b(kOYD4OWeJ0XuMU>Ww}23jY1)Ds6$ zF`04jIS$|^vNjTyRGTNXC7TdwKj~88))0kqkmB0bB|hJC)$5OPWbXmkIJ?8=v7Y-_piZM z9__{_Uwbris7L!pcr<*BhtF_5nmN^@Nn1VI@&|Qn_h{ihkEWa;$CJc7?NO<7^!~g@ zxh~NM3{PX<;m|dY24pw2Czq+srA(Fl$kfl(OeMvcs{V<|`EFC5cvCkp!)_|sX{xBp zl((5FXLD2K+nT!B&D3Me>u#z*4^z=zrb>Th>Pa6{8T*>LjX*zB&-$BcGr&~SZ%thr zWaRH4Dp;X^g4& z;2UdlPSa#=2b24Bm^y;*$D7JE)l?CTME)PC7pu~WEH(A%GE-e~ZiT4>D@`q0XR7ylQ^Qbelc~Sq+hTJ4zNsu*P1XLx zlnYCdZ98?N4m#rxoPc(i$_WRCU?OttG&L64chO^X!wf9Oc|>-b>VPAtwug0b2F|^v z5-=4v@dR1+^V$JZ-4B{tcg)nA6ZGzqsn=M1nf-%0Y4ix$ubAqCOQ?L6*HP+klkYjv z_iLsG;6GHoZt}e{Q@`M|8>VLC)0=F2%hWF9|A*e*G1coKuRSt#9pT5+fLrMJgnfW_ zpPK4|{rK$}F`g42u@~fwhA*iNd$ITxIlkujM9DX%`ePl2$x_jDmcGS}^ph&1|Vx7E7zJFRP`x*(}XLuI!e+!X+fXV`&d+=CCviIdWR+i>vVEva|rc zcP-{~vbYYx($c(^V((e%_`apZ*qPr_z5>L;$byz07qaxUu%!t_EPY+nQpRGIen6Sx zme!+X2}{{Nuyhfjl9m?X9`=+XUTN}#t1P*fv$U{+#pezdpEFo8>stD>o~0dF=dw7z zK>enrE;xuvmZh=y7e240WysOUQYRe3%Ep$e`N%zBsd<8>2WXUNDIBtN8m=UZ|7%*x zn`|kFd-$oTrTWb*&RH;Sb7Hn&o0gU;hb`rdSn7}4*cT%n3bmqsB(^4JeEF%RQlD9R zh@EXL&ZAihpfko`C63`f^0c$`F`8l&cA@O&>_;3yr7tX{qRN++Hltg6`hYwg$O#!b zG9DIpvgGe9(Zf=)o|e`keJ@J|;KeC82UwbjAp z{2z=yPo{TBoMLG=>i)p~n@X>yalFo;zEq1jR_F^#%;K1yZ7F4rrFZ9AibEqzTg>w% z9LG4elw6my@33!$rS3m-Jg%f34FAQ_aeT4L(h2lj&Hh z+h)c@*WWGX;~-}o$8{ubA&>3kzr#}RotB27|1L`v_VE6~!oBRTeT;((`z>WYVCj2g zJZNdaVe-ds$9Vr@{&7q1oM2y{BG)sPYMr&z8t2Z@`}3AQy1+4r*I0j%_s=Dc?KFCE zh2smUS1ld=o7%2fYIxn!lpDOiZd!VSG5>HZ-6l`exySMTnBG3IR2#41e9H0ujK00# zeTXk#^1jRAWnMS03g`5yIX=tf)u{Yl*$a5}J?0kiD&L1*)hgxHQ?xDZRr-&-ik0OS6}xx=gd@H)Nv9o1cojVcD~Vm)5K z;qht&4k5ise0+fgxPcNDv5V_4#f`W~`YJ?%!g%_ynV_dAq zYt;99nTyt|)wqrF0s4tloWXkuUIj23yO1vERReU#PdJafiC($T4{Px+N`|~@iZS>D z4^b(J*qDi<$dc@p4c##x7g3~%S4}V$JMj$Fn$io*!ZGA*=9P)T*nkJ9(%j26VqPu9 zO_Xjyzc3Cv@EFxvdbx&-p5iJ>hP{g52OLF?h*wU0gXOq}5>etH1&8o{j6SvX%IfM> zu~9tF>r=ZHKFvqdmOkS9^e?;-Zm1dc=|(%B%6#tAU$}`bU-)$3OCO(&`n08sPwjj7 zG^ejm7csG)PjgYOzfVI4_%vpqPp5|ZWED&>Y#vi4=6F$|)4<~&Jo${&mCC0$h%jBKrQ_4M`j$p`r zpC+O31E0Qr=u_uM{G8FRW_Tx)UqvtnuQU5qA*)}B<^0N6-p~DN{91*!mHg_37id<+ zud}#|@2dKhwXRenWZUwM6gB_M;} zulFzwj{|;PP4LUn&acUx*&eOF_G=AB_4eyPA0GSpbpiJW_*HG7Usvz|y}$MADU7|^ujg34#;?tAuJvp7I=>pP_v`0le*KHt$NgG~ z+9&))AZ`ZeUS zU;d{odq$nl+3tm3GhX_c-`1~#Z~R;X6wu7{0WHc9(CCZ-b;%S^C~H9Vat2g3S3oP? z4QNB|fQG*pQ0j*PMJoh!uVO$~D+P3-azMMQ1T?Q&KvSv*G`2=S|I`ZTNbP`j)Cp)~ zU1HV?s7Ql=Zem+QV%Yc zJ@DTQXz8thn*KxGcLI8YRd)m2Zz3S`UO)@(Gwy?cMm}X*^m!K0DCB+~P^T9G6?(~I zx&$pnG<||P;~|0>6Z8tXb0w(Ay9sK7ZE)mHP_{e?x{G@G6S!wgf@Wc%f~u4*sCtNC zcZQ%I;6TQp@@EQaK-Qo}I9~soll%Q5j3M%g$V$BQc8(hbU zpMomBHmLSkvoR>orXcqW;&D$VSe2q{O;kftH} zRY(cFLu%14q&|4sKcpQ4LP{PT(t~j!otqp|xhWy(hme}!6k7cll51{A>E?xWZz*v% zhI9u@6Lxb`BF%0u=FzHq=hv0QAjhMh2(x7Qs);T<$W2FAJZ^4QS7%_=S$W?VJJsbsQzrIOXZOtJ26qkXL9ejd_73Y1zUmw1zL8-q?ibdufniPl zHq3Wm!m2)oM@%0dR>=ur)tMC5%*kQ7riQr=JgjBY!}@zhSU1-ZXMI?QH-z=uZ((KM z9F`qpwuH51Ygpgx4y(xVur8&A_0#>ZW<3b=J&&+9WQfR}F`_zIBD#oSxgu)xZbbj( zjwnx_2=7l``zWGQ?udRgBAV!n=)^Y>)f^a6?r$UVV&Jrh&drRdaB4&caULnNBC0Su zqAPfSS92n&F`xLjhye>C%DIH+xUo8-hHE0Sa1AfkMpR{8M1wI7XOVw>M1IUg)(sKm zgLhLz3(;(AL=W-7;fN05*7*pZ1xDn0L=4n=OpUmSG0!5pjOWiIYV{(bE*YX)j#e3? z>WcR>MRhK7RE4udbr9!~k~OLt*`nHl1IW_zgko~&}Vj3Vr;@oWE&Zi4Wlp>nMcL+3XQ&xsTYo8^=M*^iRs4pm?lh!sm{chj-c<@y2uq%_g%h8cd0CABUKh-~`f;|A&~GqAmVF`KdA0pT;umnI7X>nwb3PixD`4 zVl!i^h+?y2T8ek)#Plx)&W-5>Hq48u;DVUWqSeBf+O3YM!^xPAosQ`e`u-KuVcbHx zGci?z4O8(Hna{>l>s*YvY+^cX&-sJ9%kzinBptqVVHgkp`zN*M=H>HVT^-bM>(nKE j@6Aal*Kyl}hW)CP9@($fS6}JwivQm(!~bvae~o>d za;j$K__C_{42p3euJF|V#rof$wOiKzf42$xuRj7VNxw+gEz^u}TC7UqwoEd^U&Y~2 zN!T2OU$eoItMPI&1Uc2AWDV%t7*;fa(oNxKsn!gVn?r`wmiJp}j?8@*I`)7&Qmi-F z`e|-|%^d()gJAV1@Z?kI^ci&f0@e(MDqlkUFnIGT=pvb4!xFhO9Nr!QU8UYgXe~LT zpr&;C271e&Z{cfsF-Gym!w+j9b}cx6P#=DTtuk*NEZV4=H^WBRCwW_-j+_wluaGE5 z=lye_@sM ziilvlREmtCqx2Q8A%e=XTDC}*F@k|IQfinYXd$~~ggJug(!!#-azgT=Bd9M?g(8TT zucds^2>fzWUP_N*5xf^-I)ZBQN{W<;;4{fej-a+g zR?r+7BIBf1#R$&G6ng~c9T7B2kKj#NC*7S9RP;u0BrAf1>U7J4bM?O9Uxh6|cK`IU$1a z6C*H8QjN1BI6Ygr&WYf|xe@#_FM^f}BG|e&0`vX|`u)$T2sWRN!2L%A`~Hle#JLE* zly0U-)<#8A!5m4g!jXJaB$9uncYGx46C!Dq6v@}AksPcPNkLj9_2rD5a7I$q9Z4fe z_C_++A4$jRk^EUBk}qpU@=OY9N3ueS)s5s6*h`Q67{;)dn1yhc9HDq5XpV{@SRA8bc|$p=ST{5iKNNpxRW`CdxD(mMY}Qr2joWnlv|iWn$V z)WDfy2EHk7V3rh#G0-g5z;+o?!oYNC5oe&IoRl*08Y_1b3`8Uv*dTi)oMd1~Ndpfh zqpX3NLOBD)Ww88K-at;Wf!!4hoRV=B4a}3c6a#Hi6+@EslP(~)j{lAgkqRwt>z$27U<{_+5sC4NQ=zd;<*%3~Z7GRSf(nJ*yh{Ozuf`bpwm# zi(1M<>en{#rW_DkT?2FK8K~CWKyxYDLN&`6IoZ;{mevNWZ4H!^V{%zqwlgrZy?WO{ zbGoQ!?<>CC?rLC9H^t~-Afb=y{!EWQ*WUUuy^NJW* zDJeyb+$v_|(-yArH&C-T_e5gDVB_FXe6_dkr{Hav5`B{ zwuzC#O%=D9k!@1DrBUx8Mh3oVB#Q3q1&t&fBM#_9)T2G8re`aKl6n$aj6M6GLBljgc!bDMviI0ky^jb1;O8%Bs z#Z1gBZlZ9Ei7S;%3{Nw0&~Bo2x`_r}6F0dx`{+tJlRBGp^4w6_;)70mhab@NdL*iP|5n)#0+Ww zi-|7lO|0BtqRd9kkp-JHf18P=znXX|Eq9ohCx7qM<6S1+-fd#7JlkWU^KYtqzw$ev znhxr?n2wm}Ad8QhNH}I9>a>YBWX>NZik(q!&T0H#CK}5cDR;p{r;8?PUNUj}mWj`9 zoABQ;QB_vUle;E%-ZSBTWMaIWer%%l6B9R{n(#h1F%}yV-)pFQH+g>(k}~9*yOM!ii55wK6FQMPqMsGERqdk@I_H8Gm5R*Q54FFqO~lO zd%01x%Znm5KZ>EUw;+n#%2D{LMiEsliu%=~cwLIth+?!Htr@kK&kIkdHe=@wd3&jpBUAC{o^w z!rCQ@mjf05W5truL$uydJsuXt<*%Y}43A=}w3rda^qEma&x)d~G?){`+Fzo0zCH@` zhA5Uw_l@esR`uoAD2B+=T~XZK9Yxzcs()`3P4=l5a$Gtdh$8t;6kYB{(N}JW?|u|> z<;+7JdmM#FUV9QnXIb$yiqg+i|BEPYzKo*Ht0?wGnyF$i^Oe!eW3igeG_si4ENhFH zi7INQelarxiksOlC1TB#6GsU%tK~_Yne(O0ysBX4jf!UGq?jp|YGzU;JtwQu%xo2p z-Ao^cnah&n)HrG8GV_ickwlMjkO-fd&Qi*6CS9hf}q*sRYaX0r0l)RJ}bvcOE&%4WiK%uJDUb(YM%~Wh-#wUv;_DwUb-_mi})!t0`4rbna$IKU<%v_Q5&dO1udzi`SX=cy|X7+q! zrg0zjpsyKIKQkp|X@4`$k!C&|W#)oBmYC6IZjCduWrCS~-)XHSiYt?3?@}`#ZB)Hd zu-Qzdoo4>IWTy9JGrwFhlXg{g$(J(ohMDI7D36=kzguR?$XoK=Lo=lxsmG7iW4R{& zCtCBFnQqU`ta+h&UYg02v9HX`im>pf)Qz+-#$dr^v``RbVWb>3TeuQ!!B@yazrq&c zi(2R)i;G!EC~nd3d=|EexrBvUHVfnBbi9TA2^PvFTIiHyA?-B_ljP6R7QQHBVP07a zucTUe3v1-vR15!zFU`UndA**674opYg?AcQ_&~msKtl`rB(0IwZEWGJ3~g%RcWKzn z!cw{0+(O$H7Cw8!!cj?j)56zcYHOjj%xY($NP7$4cd`)io^tMNVV!*Rp@ppy^^t`> zGN6xzR(&l*_p@jpEew}~{Vn7Vu;^!j)|a)zEVTH_g5_%qiSm`~A8sKu!a@`2CXo}B zn@pHw;m%|Wc~jJbsmfDoPPZ^$uFp_zGcEXMTliFV%&}mbXQ91(H{ZgO1r|Ckw6JWE za{11JM z%)(9apRh1j?)+iltuxwFF`u>2SEgT5Kdx$?9FwxwES!?GztuNcf8B!phJ{R7@sEX4 zw=_>S-nJ0Ft39}D)Tjbf~9mZNf8UdX9fE14y%d>m(G zxEz%)Y*u#1TWOqV<=Sgj0;R1CC}ZVsIa$_9g>qK9l-FGOJXz~Yxr$c4l^JqgUQbbe zsa6szSs5)y)2vjrTZ!~qnJ2@1R`&U=E<<>9Siw%k;mObj1-1*JQ+rL{mw%1C@{n|sBB}Wga4=1cF zlJj!sl$HE5RvOAje_HuPev`PfRw_z|b5_2W@#pn=k+o9iFDnyd`2{OaPBX*)P{}qw(iO^NEBCqB$hLREef?)o2_wqWM&I)Ql!jE1Jc%qiNPEn*Ng8IvUIC zdMr6_L}PCg%}3&25W^>OaC);YZPnn45BJYYb(##W4NX z7)EZ7Ve*a`hVPDH@SYg5mw?~@qzNY|$^ zj5EY?Ru)IcGPqDI`=wstSmqRoTN>X}UX>nX=-L;-67`S@m};&2GjrO9tQ7ya%xqc^J#xSFubgQi2Oo zx>5-m%IT^ls93E8wY!&~`@jA`QjyU};qk4A5 zv43|QeSV9h<^DM4%CQ4+{P8f3lt*zSK96Jkzj2(CM%egWY!No*8*Fqo*;p%?W*hx2 zHnxk~YU5E+8HU+|TCX@_*=S?ZX2p>PTWtKa)kfqtt@o>qw`GZ3 zkjp!4cy`*@w%f+PdlmDL@|ICj>$r_^^1ICa!^Taic*e$`7j0C!q`qBNZ*SY^DAVrP zxc|^bg%>vZ8RB)CES~3*Q6!$v<@=)XEJ%pwj*Lo*XVGi%+!K50cn+t;^IB>=mn+3% z@x;?iw)^AxCJ@hQ85xYHQf53K%Gj)UD(C7ssTPW7Ren4#z&XOzjlU$M46pTRh$4nIsn^sYg7^B|I>mujTL; z@w6He&pc^3OlyCo{A8EBJtCeZ(r;Wm+ZM)Cc#&c(i)X-!cy`GAwed9hA)XmxSg+pf zjHk%1c*^dJr_BC%y2wqLbWro8_HosEDV|MI|3*B?cjM_U%b&!v@kKo5m+|@>mB2fO z1Xf6#DS>Ly349~|LJ4drkw8>j0ux_Lpnd5Cmdnp&67*R;fm`ydTmm^267=0n0+TBy zusJ0GYia^jWQi+*hw`>Rfsca;I1Ln*e@H`CGh&@ z1Qtm7tqBa>nZO}gvrB92PT+I#?@CFIqRyWs@~TxLwOc1L?2SZ@zn4h4 z&WRX%B$D}IB45a7z4ct5M7qjjd9QCGYouzwL?Zhq@=!{Bu9#mc=8#054ojrV@I-!) zf)R@UjpBc+=f@_pZ&D%&lQnmmZf7OZL0-;IWapejiqB2twRw6hwdN<%Y(XO1DFC zlej%SiJTdFes&UP7AKLqB#Ft5owIsIwokXGQNsRj^iFyx{m?Y(1Ch=8tNsdS#TS=~_ zl*E@>l2`d9DOIf`o#gBrB{|x?BxQP(tuWSYs6jmdboBr{0nZck?6Z^_)1-;XBK(raQG__-?;+qWx>D-)c>>slcns)3XB~bmmlbk|kg%n&BQ*{19 zk7b}Ug|H`uZQc}K_)@6pPhq~y4yJHJ4rHXTDqF{7er^hNLwcOA#}X(=p-1Hu(yOHC z=TnOQ4x})kW(xP}r0}3#3Y!~hohB*lYL-H|*Hh>!Yulty^{o_rUzS4a4kD6&lPr2Fa= z=55w|d2eS5W%i}eMZEh{sCP1jNz&)f6jIKo@PVAXoWifyH2?1u9^Fde)uR+@KThH7 zQ`Pn&g6vxhF-|r80bbD#v8- zZ_4ZURDL;_it$h?y^p0*>qIK!VD(TvnO1!*MiHFxJ zQSf&qM%=EX^Y?mARz0kQ!J0-xxgL{7UQ!yvWKo4Q%>Fcex0l8jP1Cs1F^!B)X*7C2 zjm4j)@jzS)HEwwt_hj1UG>-2~quj1EzCDu0kH^z=@sFPWBaJiX(nvj@#*8az)W4d> zxNB+5maBiK;k=Q?bQ$+gny!yYqt>l7E=u>?8ha;=w(_A&xSytT*l8?#kj8zP_B@Tv z|D|D!u+v*Umt9iSV5hm!&UQIg*v=P4?CdUTC$pHHb%}OfCE4j-($0+1b}p5%)2ytW z)D%6JYUiv}wABS&|Fv_+^3oQ`t_NDt7*= zW7pqDJIm_Y*&wcZc0Q_a=dxUEX6J!?-`vh7@wBkhx22t{a<848$o6(N%09{OU}xw% zb{@%&E_RN~x9{7TEiql~wC-lt_uF=g4^Tb>Ri_;J)K1dpc7{u@!FGQB(oWhCJBz=z z>v}IcZAaMoX`G#Z$J^;K!A|USJHuwE=9zZFv+O*bZKq(ao!{r#skPY7H%l~D3N5u$ zSH?--m3GFgw$pTt;>m2Ow^qk~Q2syKDJI?4>G)6Di=XXG|3&lH>;5L)->myv6nncJ z%MLq@cG}q@h4!iU2kdk`Xy=UlEk7Mr-O}-ho#jXEymrivPX*_doRo6lHdJcYU=%8IA2j4Z;_$Cf!Hg#~hnM2n< zIOrnl<;T|@ynMq!w>A#0yy@WEw;Y^!+d=zw4qA70FuR+BV%;4a?&Tn{w}Y=`MSlld zWWWFi!zFEygKM8Vcq(hYaPX@H2Rj(_rGtOusk}SXLHVy8{4S@Y!MRrS# zkq+J;<)ELG7_FM*oZOan->8mnRmT_yDKbpno1|POJE%9+!POZKT(cB^w&E{xP?`00!E?1vr-bx48S2pT8XJyQH4W14}%XF9)Sr}KwQ$Vq2`#OJ2-R$e;$<)RF& zl1}x8>9mkyjTBSH%BjZb)NZ1&vZrM_$KFb(RNHh$%HVg>87~dq)p0o}@tx8cCetOV zTRIJm`15pHy+~)btbUo!8?O}e-*jUBOQ$VP7DYITk96{u(a8dnlej1+#bcec zDxv3-oMe}BQb!E0IVmASWnXD0p)yY1Dd%Kqc_$^4om{El#F^q`h9p&T(k{)(A=&D1 zVs<(i=W>#k;iPA#laIxo<>Z5Gr@q&8ayQpWR>;YBQo6v&yOo{vl3Nn2>f}K!Cq?Tz zX;II~PWeL~%ZE*!{L)OZnmfst@@U3jn-=J4^E2Lq((h`|u4OrMKIvO(_qU2F@xuoSrHFRyC5C|bwG9yuj->$(_Q&qYLi7kwJKur_kh zxUq|^GQYWtuUfg7B28Pn=pe_W)Eh2F%1xQl#>M$JT|95=qDp(!*1^S~_grl6?85$m zOV?4knEauObG@aH^6uwiqAZpC0WO*iaWQSEi|Ao4+JEKJ=MNV@O7d{^W`s-UB3;xP zqj(cEW|E76a(b%zHQmJ+am{w|(Hs|-<@|T*?-G~316S`>xLCQ;McGv@s;^PLYhApM zoW$nvuDt$IUKd=v zdD+E-mo9SuRZX(?KlK7P<_I@m$$>~W`35)NncUota`U#?O~~q|ftaJ+B*<_%RLD)` z!fpx|anr1*o9)sdR^uhHgqt*(CKuw|G_kpv5bx$pf}47YZak&j^nK0ERq0;V%@5@? zCfQB5N^aJsxv5}xQ!d@jdrr5m*>w|N-OXDy-0YX9onJdv4`++3dQ=AQgFMLn6S zanf#@o3qk*x|_XHeTJJEGJ2+)W3%*lwwtzdRJV+t=cdDaH%k_{Nm}S;kbEsem%7=v zOnb0gIY^D~-Hck{W~!84>E_*4>eo8$*-vh!%VMedvzr&2+&tT?J=*GKm28qq+tj=5 zio3(jL@Bh>P19X&ewBkVWViNrkM{64y$ka!7ef-NSCi9&r+oQZWhRDX?n)ZQW^25o5N={?wrQS7#V!t&2N9X zdGmtyRzjEDESDQM-S}=RA6X$e_uYK{z|CFx=#iTZkF~!t@QIskPu-$QJ`!|Op0iMhHBdzh22F$Es}tL&j>RmH64(dS_g)$4110}oSL zdN|+8L!;Kpp^b-c-}KP1gNOMYJ>2Nz;f?n^l<(r9^ZOo7$&jud_IC4-*WE+0o*r6$ z;9-}Xk>p+;93Ok=^@)cI^5GB=X|br+Jtl|4moUGgY%pnXNqMD9^dNzs!SWxkuLst3Rte{I%Lc!8#Aae)2GU zvxn}7J^XM)agJ)t8I3vXq4Z@BZ{PN?@Qw%DT@NQ8diea2`u5mE))UqIR6Uj|&y}Z? z#Y?9MFDGP^!Hd!4}7?;OBt(|fc#q2OW!yzUr804SMM!ewo7z^mx0o@q?bjd zyu`oeWp708D6$zdUgG`mp`O@j+e3WaTSfP zsx_;5*(Ob^d)ZOLORt*BrIun#Y#qgx#SOjOX{0<`cq!Xfb+l6*@{bJeGqsp5U+<>lvIz8#`DL%sT$qIE~;_$bvQ|9s=cKgP>EF^%)mXo8oM zlf0ar?4{yVFB9b4G%qPLyiAl{v%LH~+e_LUjggA;G)5jS@RGO4tLtgJRQpbAO0^|k z)=J@3UYf1ex^jK37w?Z==E%@rytvkDA2xWoEE6|-`E!f*WSbZFZ(jQR?j?9g`*76D z*T=j(m8Pe?O#Q>l<1=2uXT5wcU!M2!`(IviFDQSxcGb)D`(7?S(D;X5K6~P2*Hf+c zua`ZsK5Ccu@oln?|D$7CO!ts;if(koBNpG z!bh97KIXOa(Y})pXJ;Q_c_QX6J_g9v_kDP~`l#2<$6{G06}tP_A!#2fr{2m*Zpz+1 zK2FI;eSHj-f_^?4$u_YJ@X=p}Nx6YO)(rCT>|-BYK2bfNDb5$lZHSNGhWcp!m5;yY zs}BoRn*_d7e-`^NE%oW#g^xvReZ>FZqt`kgKmX*T+AltuZt^j8vk&VQA1Al@D6`$i zH!^vjk8}HdG(4cX4*SSI>SKkRI_6`1=z$9kFkShYP-El;&SGVi&M>o0t~{!-8V=VL#9!V!K#20snNZ1j^L!{w04 zPvs~-J&OAIOmd3(sUsUCGRDt`QZms`x?GV*@?Mgk6(#+YDdnf2oS()LU0&m4lpIa= zQ>}uZUg>@YOUUV`zHAng+fN^v9q@BCsN)%aZs+*P$n&#M+86j)T-i^cs&c5K9P0TQ zUEj}(CVr|m^Rq_cTKZ|z%FkZu@P=R4)A|X%rDGlZJbTBle+T4eX)izbK2*Hkewq&Q zGxcLX6+czoqx`%*+Rp*`WW1jp6Et_CpFgDhWIto&k14u8&Cl}beo8IV8p}0zrFyf` z&*z)`I`^bCclf!x)6byYe!l+A&%xi-i@kmxNbY{EFI(jC0Y5zt`uX>a^8M3K>^ape zdoTDIc+t+r_x8j@)*PT{p#Uuk2l%TUDo1bDA(fEDEelqnzJg;cE&Ai^HN=nUxJ za0G}B1X!98;9h2cRUySK2(YMfK-WwMNUj&4OZ@<8O#`|XI>4VT1JrL7;M=wVy>Dyn z_5s$vqj((yjOr91u6uwsJpx?q8Nk**z?%aC?31>G6!YT%@t*`}^hJP4gH_Ad0fvkU zuy=HTyl(<*|5mw-4KPqvPYLjJYJkquRL6_}muCiOK1+4Z32!Clw1&?{lWl; z<*Gz3QhwhBsIVl!cv&nZR;q^IRm0u@r=`yR0AmgW;9!7Hjs$3YG(gv50eb$UdA9>} zyAz<`Zh$xL1&DbPp!L%Ld*qkr$~z*+ZbOiwrXZinc==NvMFoj62iYozq^c#zaBGl0 z#e;lbCdk9GLEbGFWL0vImKB1`tQe$7N|2OFLAs?WhHP*IiF5|}PAh!yFEUyuyVf`Qz8)!_!AT?VC8Qm(V?{kBE^?Hy4Zv=V$%^+vm z21#xoWSmrgC&WO2VBclrl;DI*62nISC)2I(ZHr0mB*mVTl&2M6i@rD~FD zLxTFfF33(PJS@oMuYy=c25B@Z$QIcr=FveOe-k7;M)k|aaY6kXyOK{m;LDVP{! zj$E6h_>*;PN{~1?Am^mZKW~*;=)$>I`ojXuWIU=oB z1o>mL*4z?g&sOEUOF8Wh;@J}^3h-F(*@OkNx8`pNxGt*$op4=tiGl-t_RuiAV{G{K@w$@9DN+*?Wfv5 za|RnN891#OyeOVQ)z}Og$rg!<%bkM6Qq&V+t%}yD--#r6!j|^tXuJIWZnV3PuybNm3*Yiu1>vHA#eFg(p zW?=j&gL*$_ut6^Ul7VAG2D>+Eoh@2tYX&2CDW{_utUZ=Nh2t5_Ii>thXVB`83~HXs zz;q#lKcX@zZ^>l2HIs;vnba(_4`eYzivF2Ji?dnmluLhS;kc2- zG%0s0i}!A4k@_%;J{7XrSTS4Y_pe>8UBb&6E+0?3+ z%{TS4>Dw@ym0h!W+)d+qWHbDeYz}>zP36zBdGL8Qxr4J=DqCdUh-_|8$tGi3HVb9F z*rsO_H8YzAv$EMFN2Ke5Z03KL&5gy`ys;#ko)Wz>oA@=^ytOu){c=$rZOA6!U^Z_b z%I1Jvl7T05|CHkXke!V7nPT+xu4Cm2iY8bo~_qf4kz6?h zF;_nmbD8hRr9^rz3j?_<%E{$cZZ0E2xqQ%d&LeUpo2OfJ`E z<>H=`%Pi@-Dwj2@bLsU{F3mRQGHpvP(OYvVcO;khj^=Vw7XFdT%`>?yyO2x2E4ggG zs`=M)*>N|QLickSB$FfZI2W16OiLc`l*nUgTplHDd3wF;woD!)qQ$R_9UpC#`!Xj~_1Oaqw~;N3P_NbS+Q4)Oy$RSa~Cljgs|G9-rRK57okzso zJc`N+d2}z2j`#C;_AHOeFBDgPmj7Pn(est^iwsf37~&K8$sFQeONbuU5R;3BI9Dvh zKQgg+h(BXO)Q=5OCN9KoDHA?&h?`YI1geLaFV$;?7+EXC z3n^45MANz-6whQsNeTYsS6t`1|s+~iukuL9tSk*N|xo#l}dW9JFp~gw^{vlcoQ2jD=h}Ipd zb%%xcVT9(74AFIzdNoG98XMxeR2!$Bj1Tc#KA5WhP7Bd@j$+PN%ms=mg%*Zbusp=B zAGHrZX&+?h&x-wvVy_SJ&885?H;1UPB}CmFA;#_u5wR=8ki8-H?hA4CV2CHO`cQ~% z((Xuz#>dr9DRm-5y8M1JM2SB_ym3bNW!#@3PM=jT&V}f3J4A1B-3bwvmGbzmdU8)a zlx9yuOnVk0`gw>ggo%m_bI}~8Ok$XhNnwslnbNvnM)&1TxiFc@VQNKhQ?v)HVLy{?9Ib` z&?3xVvi^-QZ@n4jeQEPnn0ar9St-}rg>iQXGfRfQ6XwvnVJdf2{7#DBS@C6O*D!^< zhe?thQmAK`M42boKM3Z3;)pjz>vr}QloDFmGT$oztRo`FA;bNGzGWC{v ze_Q$7Q7-q@>jz=|JAyDpo`h-sRK1j7`FsW?=aZY3kE3Qjy=vuiL89yB)1-br+r-%@ zpWco0xg-ah<`dsMpJCFXWj-@nZF*%>ZQ}U@Y zHJ@^G@_BD=J||_(l6;;m&8N$s~-g&jKb&%^?Mh9$LUFIWoC`q^SiA zm+v6e`vfouNTn!MggBo=FI{=xmCa|DRQ@f=JyKN zA^8sq82Ye)aWeB!0pC6;V1}HkQe<+Cp3fgf{O|u+l=6Yzu>Su)EynI$l79BjI{oH; mJYn3!Lu*F;xB5&*wapX1oK-Ja?(rw@|KEA~KNb8xfBp}&OjOeV literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/1fd8922b7d038339_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/1fd8922b7d038339_0 new file mode 100644 index 0000000000000000000000000000000000000000..de9b3abe92d1af42e5eaf9203baea79b6b63de90 GIT binary patch literal 112808 zcmeFa33OD&);4^4N@rjQ5HJD6FbaqWVUS5~5(p43Lks~C6;3DV3?%6e=}sVA^+rTQ z@FHVyLE?HyeBFuHZ?-EC0UE=d&kAa z_2}6%u~)ZlNdtTK?A;xA1`SH=megfHTwFq8x1Qa*b|2VvK(Dxg3Af(bHO>YcyQ1nm zL0o*T4LSV&*`H#rZd@8-Bs^;0?Rf7(_P&i4S%|-uF1KHAi+65qVRqzIs57Si^>(|- z@|Mox1}$w-&eaw(gk`KbeQpc$bzX$dyWSpU;+xTOK}%bkg=Rf`bwpdIhgqUhGEUrY z`+zV7-pt~BH>yXaG>B{%@pCM1X1cR-J-iv2l78ZrlkbvcS3#!XbVN8}Ee_mnQ0H)u z_s{VDm}0k48i_A9L-O3lFj_fR#I&(kTRC26*xF*Rm}n2#-@D2Pji@Z|*Tx#&Dr7~I z*48=|-KuQ$me=98yefNSdCNBThJbLkwnvqRMc9@(T05FFwN11~@9%93X&O;kZ=+$D zSO56q4@-OJZI;ZflPqO+kmYL&-j}R~ktE9FP2RJ_I*(*E=Qq5Z%}v7|T4;ns#T(9O zen*92&U@;I8kROA8^j)X`rDlAP%p>tFZA`f<(6VkVP1CU3~#|LCB^ReI729&h~m>V zO*UCks;YB`IR$cyw&QG?m`B3c#vdk0k*)#JrVw^kQeDH+IM!L$k`V&>ye(d6O_^bdPRR^ONgEo5 zTmIYvchR6?PX@l58-T>pJjES8_raZYaU^5p~Lq*@b3uR z$n}jv$$*^P{7l1~2D(5F_$K>Yo9m0>F|PdF%z?#4E`P4qW0;w!;)ssR3p4wnn3!4| zDao&c?;has6}mFq!(D~uLXv^$wR(S8tOJFUirugs&@WL8wklivA{lf~DJ*jPe88RJ z^|8W9LV|-9`-Xo<4q%;`DMjv*qKPQ?i=8e{*~ks`_%g#rc^7-5K6Y_Xzjod>FpZTn>Dw28<(~OA2j* zY8hTniMz<3RKC{_S(^PQYY>_9 z+^%#I$;vPG<&4V6anlVH-7ZvO&QS`PlXBZIV#)Ol@)o7%W@frQX|8NwX-atmOL^h- z-@=5Aj3PH=A_%cP?kRp$>P{>W;gj)W%c&G7wb1R!9PZ7`&B}Eb4R;mgxr=b$tbhn- zidL=P_sos7z`}gkOpZ4{6BW$+*<{$whBMDSOYf8p?YHR)xIVa`EH*^`YEl+CF5iG0 zmnYkuiNX=8aFaRW1$GIjE!#cN<#*w`*#;DyVUgxJd|KM4-hra((C)?hL=M z{gGK|?gDV)ccb+H>dr=k+>ZClCQ*4A`7Rh~R%vR|gsx_DVuIkeq`X?6Htd7O3P<6O zC!4A<%oz%Ln|ZKAs6H3C-6<}APHK|b2Zdz<`N7Dp@hr~wdVTI>Po{gy$SiXxZb+*= zVfZT=;L7F6EfBpg$&;B>!ae{JLm?=M<=ooxR)UD%Rpf`tMndrB5)?zsU^4vnM||u@ zcO;|@7?PAaVZgAYgb|}t408!ph9-v3JDp337P^XjZYa#15ACnK!M<4?-W^}EvZ-Llh}Qv#gyw;cYQEs+LDGG34H2%*#mEHts}gPFq4;SA}m z=nn?uxHIyg6>}&mNp?px7@10s?#j>iPIhMw&iAIf@_o?jOx%Rfz;4#ruahA`Hrg=9 z;R~CY)w0_*sykp^BZ~%kaBa3z^gRvsdZ@5$fpLh-lbP>MDk`Eu8Rjb#H!QoT!GnX~ z_35_ApJ5IoH1tsNz{_jcAAD}V=v=9!y_|)BnwqeqEukj6a{VwfbQFbdYS*2yEKuq- z%*RpSh~9E2)C8zN?0J6Y7et(zFk*1hgtU==Pa1*2RZ*Qaso5*Ep28w;23#k-kI#&R zsvObh4u_hLvKrbxe^UQ<*>-fhv?7{zh`pBiX z|Ims&WD2*CP*mh9HO$Sp!N#pPJEJ4p;7#|ri{L%Y4J-iFRksg*i&QZ}c=Jo#gL3oz z(u>q#>p^u@*IU+*d$5#Emz3;x7nq01Gt6PV<=Lm`u+X$ArFZ0_^SQG|dnOmT3c>eh zC@2#+HqCq35ybi5-K8kLBsm9jYaXz5k^1ta(bt(J5Dp+gV9)-kzlaW6?Dr1vT_c!& zN-!1cTBH(vp#LQT{gaCS0||E=5&Xkfx{F5n(akf=C{=jS^7x~K%<>kY|H}c~d>@6N z4jVmc`D6%a7{$35xzFLYl=LY}K_sEzuP}zC6nWX&flAxw=1tkh!a@uLX)ZWP`tGH; zAz=@6ZTBm+#DOspZeDbpeISBf0Z}xmSmbh`ILGVF!}wyDFDbN5Djph6zv~K&U2LNi zAqItZ>!;S?pdbcmxY$6~)j>%d@W`>O=eY^bP~!+ogg=EyiiE#o$VVRftZ(B-2xRz+ zTo|K$ZgV@O1zYLU@R?*nW*57PGLw@=jTxL+oQ-QU7W!g^#MI{Z(MuIzERvEQ0cVE_ zO^E^O9F+KvX>=dCzQkf!TCzuvUK6?+=3Ere;)cex`UfSLkq_rHMq!wa8)ahrOSPuo z8I7w<840kl46On!HVYNIV~Xz1AU7T=mxH?U?B-9n$%c+O_xzo-J6C2VJEdXnq6Elh z>Xb6!<%C%TFbi3l(WnGY0H4)xbvp`*%^gXv+eA^GxO8w^DdLoT1S2EUCt?spMU$bA zw1bkw#Xrz2VIR_q6~Q|$#0}x6;y(MFMw0FJh_)5E5f*wNWJ!10w7*x>? zB8hg+{DY;GU9KnBpESh}n+Mf&rPw(|Lw2ye6N(EnAvVKY&jRSJJazxQl$3~G2Eb{j zyE15g=Idw>5Th$BjcfmJP=PSLg=QkYPyj2=4RaD^Sz;YNQc!UzyR4mG&y&@FK z$dg?JT?jW&42m0yZs;i_1U`r5X1Oy;GdOKB%q)r!@EaQL7)|+LcyJZx`(dgszuB4m z!rC`AJae4Z9?+}|GY}T~7|9rBFI1c%@KiMXLAWn5^h)pMGq(^A_&?BU(LC}GIg3!n zG|@y-KiIJ6Cln(U;4KhAv0+YOA*dfteYY29H=GdAN4xSTWJnt26nC=&#ZS#z&a zQ*a=Xv0bWpC*n>wlX{|Q3_))P*IQT!^E*}1V~B8ijC7%>%zzP~(iDZ^Slrg@X(L7M z0&j_X0D~vA8}cWHOR47<(twLSc^>a%j|%JuxS$Qhylg!hd1~pU@2Mgo8sT_>ejzYG za%g6~ZpZ7gpZRiJMQ+RwyoGRfr2{#a6+@G`kDNf44ZFRW%%GvLsMzBcG?G02A`Cu- zAXFx-r|D}^tAQBS03-Pcw=sNv5o&hAEmQz6^}5ZQz}5&}q+c@3D-s?gI(M7bKzJUv zN9u5Z@GA&8s1v|9UG~9)0dtcs!!T#D5YRm{yjQBD8YK+q!{ij3#@*-piGH$INH_GR zYF7VG`;29$2*msl!4wW$J(UI$N1ghRJX0PhE6IhcGf%P*(i^nQJ%-XNa!pS2j>-{% z5F)!wuP48BP`)eMJcvRvH`Mn;FNR7o9YkhmjVNi_o2^hNkW`9}&+CS#OQ*S_4 z2pthTzXM4S?f6Cq9-jdl4y6{go|7zlp`|gE_bvUMszjp#e$U)TzCpcS>#z2cdWM__`)CEiec+xs5lUunS-N0S16r=z!)dx2 z{MM2+6s8WSh^5qp=T7#>FtZ^b!4?Qq6wQB^a`(91nZ6NfXqA}@!z@BIj2E3!a_=87 z)QHtsv~p8iMVMcsy-9(Tgt-tP2uwhDhp)+xl=&UDbFy=*kr&}wB9g?3`3R)`MEBiuz>f`8gK$pAAN0fFN(Uzo$a2I2d78rvr_78`2V*wl%4Q5AQb6#d zs454!{+Xe3NHC|gFvsoT(2h3r!XJ8~{!tJ7LOdcrln@wFs^@m|C1;T2(1EuOq-D{g zG3wzQ)67ymVnmx>Z&65@xyn>GgFYpZ>JQ6i7zF?4@#p$W%|W;jmel=~*<_38#C!|i z%{W>y)H3eE3-jpK3S6b>)!`~CoFG~-Gd^nTazbMa9_7wg0aS=89J=-R=75pvxb9J< znh^`b1w(o6QjQZovmXk|1X9oRPfrl(1RdOxr5$7m4e`9b_c~!=?h&IH*_zEI9Jrlo z-;>B*KRjXVgwZJj6Vj3<3>Z0jM4IUbtPH(o{BTq#A=i^wGFw7g>De+i0A;r+v#X0y_L35;L3B0 zDJyf1O~@2%|4KNk~a!dCuSyWu1 zoWyblZkUx462&_*Q=5^hhyxOf5Qbuys+7$^am9rVP3aegSfqi_@MCD#YnHqh-ZOhifzDFmMxqAbh0Xk;%+8D2Rn zHyiZQa6xG6=k0R{EhBOv$G~*MoT#8f+!x;_^ki3&rw#m**$}kle6f`yX)EGROeztOq)MEXq+2XaOxW-S*`NWu2$anVV^GMPz#iAc*Z-%(il zCsqB8@jS|)a(}f~)CtCW$q%tCYCVqnM>UU+PLXM+F{*HAQpv-@C%6ic-r|H0B)X%v z^NBiUg_H~0)c>K2&1oj=P$>x9A+-VNZ1hak=(x`p{)-hR=j8gOuT4#2^lo-Xg)+fM z`o(Vj$Ol^OEkZozCm$VA46T5~R7cB1iY?GFlRaVvX!ZKBO>JyG_VEhHBZ{+y4znKGF!UA2l7Miz2b!WMl)`9f^-9c%m1 z6a=y1Zhww9(`UX!V(6^%fBfVaJ8OoT=$I>%9Om>0{f%-EeL;**QXS?@w8HsFU9%1< zI-(OVhMG^ptS}Uz=^KhS)ML}7SykJVc@j6}fV`#n@Exq;_hx73yGM$Qlt{R(#ZBVa z=Gc7~d#MkyWpBXzLuLUVl}ZHDTih$|Ceuj7Qh^B1R8uQPzxD&=T0I$o96YM89=Q12 zwniv~+hX6wT!wQ?l?6={y0LdM?`CbVakT9d|6u#k-9ZAGX+1{I5j82h6F)|D=9s9m z6v!Fkf)YRF_|ZiJNfqSsD+yw5%lVfXOW6bQ zmEw)l*{`KrZWAXLD}ngRM{PQA07EL>j~>bF3hYL;&$`VrT(-|6-95aVPt3@Wzv>7b z3Dj@cY~)!a^ax#!0J*did~{BHp&07*yzXQ28t8L6fgKqTL(}p*W{}$n z6PUu!_L${_g(0^XlNLpWL|STKZb>dzp|GgH2*P|{$+=a#*c=j&Gawx+g0ZJ1V`z29 zZSM*1ArlQES%ZlhSOwoGj?0?UFz^QJLLgk8CR_+vJZ5~B|nDWioxrn|HGZJr} zo7qs2nHK3CVWX?0`9h|tSzR_UoKVhJERryLVXjp&8MEz=&)7#~5H12MF7hB~g-poy zxF+Qz>Apn;#ONaO)tYIgDvdwT=qs`v@I%!zL!a46as%;=8}o8|x(A40BtpKTA!);h znXeEBoXo_K%qE=3W)v5}p)2{JIeH>$CI;kOGNb=atp?hku+7f`WbPmI%a1IUdKM!; z7OQZhOxW3sG0St=WUfcajF}vN&4$20!<{wggZRKONPqkrge7yDPi|{4k|rd2MZi^} z%Iiv=OE#?NLgc>ULV9dp3JsNca1U-0`I2^JkJF(*1~L_NkW?X@6U zyLpw}6osn>#rB|ORVO@A*qM?8$~DI_M6by8$>x~UICZz?Qnxp$yIh}053=j)rB}mT zrBH8ZmpFh*$@Se47>CUEU)T=oHO`Hbb-|*8= zvop}sP%bq&{RT%Pk*7eVn!yZkdXyfogrpskz712G46M|~5(AjMT0Zy|YBAmAa|dR& zK0po=<04VZIS02cc%-toC?eWKUP3AJ`<_e#ye+Yh?#?t8$mA<`R5@P!D64*qw2_5)X8 zVSecd3|e+-4J(NwHr_jkD~W%$zz_d31l|w>kzy-#On=` z0x?SKkn#*Fu)$NE_NOSpQKM2PB&4OKnkg)Rsoj6$^{r{okpH0EBAKYr4t_|iW(`7!dj&h!Hf1e!>E)BQW;pt>qF&8`dwbxvvmlI$7U{sGkw)gl&<4uZ1D zV#l#>I^`&roQ(iP?*@{+;B|=uWX8Sp$vnycn_{pOAOJm5-4@|JdNQnDp9aID! z2z*X-uYa>wWO*PW2B|&S8Z>qO_C^Jwv-(srpK#mo2Z;qpaLtsSOou@q@PfnejmXwV z4>%|L9%dS>PgSBHplHkEcgLAm(ZD-5kNDfT?pi12@x*l`(L&6U~u4gZh=nkKan_+>+$-BPNc8M1dBP z319i>L|h;S1-gOwB3s$8L)rx*cY47q%Eka)tE%tU zfGk|kaG!ZMZUY^SEqU-4><@}RCMgig=5z5K>IDGNc7AKb>*P{O*6%eT_qr zr_@faFDa8-+sqtX05z;9@vW~*Xg$dzlGBnChE34B48|l38=Zvv=2F$02OVE27OBKo z9N5l>3h5LghzvcRyi^iND-xUC$PBq3`ow@4)R6S!6t3z{uyQj^X*e}G|2G2oy(*lH z#|1lT>L)ksXGg6LLQ}omoo04HyU_-yZ~R-CQz>nXWfYBE$PP#Gqk^&fJN)ZAqNat= zH<%2uq{E&QcK${phoP$JvYcd?p{h~yOU+*;TO*1K(h<$ILTv~YRF{0xp%E=vDFqWI z2;+>@8TejNHRC!Nq97B;AXralr=yC*u>P%f4T&M&n*m=e%grgI4EXg`8zZIX7=f*g zIYllXrX_GM=HsjY`kUT*A+%y7_f%9;s=WV6uUy*c^J;@#s?z+>8+-@^pS9oNDi1lGif&Gm%aI=K=4U^gv z^J_Un3pEO=2}@>m;--?AU>JM8y00C_)m*H!V7J5|Z$_~XBMyRNq}iLJC1pYq2j5z= zhYnI~2ne`0u$%)t&?88m_~gcyX~i<3P@Q2@ISnKylw3}IlJOQzMdvd)PcxU2ameLd z^3Ox1J`fQkO)7TfgUArnrg@)x>vTV1MR3!Mvdk|*-4R`64Kq(kR)N8K;__*t&k5SP zWxk}E8?x!Ky&N)BR%bxaLJ-1sl7ZSoI=U0s*a@m<`!+wK18^_hyS(y153>Fgg%u(X?YU?UE)Rn3?0+Oh<)4MuQ^gp8 z1q2|Ku$_mNi%G2HZ4m5(xd230Cs3af?0jXyT-s!HXKmBfj3(zm-1A8@lZcUVa*6Gw ztsr-2g9vjfDnO5P6<5w2Rx^v7+;k);Gm+z&j0IW_R@1;>nIMyTV#^sSO71-?2e=vkv&(ax?PG%>gbv9dCP-BA$%p zrfOS)n0=5&T0q$)6MH`;xzHgBinjxf14GHgBR8X_;r7D7E`T*jby~*>{~%SkDj5e9 zQe#ldj7@8b*zJ%&;@Xwm9|w}ApA`_7&D!+hYYh9P>{%%nc{Q&N&14F32}DFa%$eF{ zKkX39pT&i483~vjDIm0bPM>kz9Vo>1E$SCMgM?J@lJK#=i>}7~uOcucEUKJBJtAJR z=_xP$ikQ>MGAu6;F$z~S?cIZg8Qi(!#+Dx<-$d=BfvYC=D-zK>x6DARV(p3*B2ht7 z->|9lFuk#I9PnJ+b%5mF3gUojH?2Bk&|zR7>VUr|jvPB7HDO@#NVy}?G$<%=v3W;Y z3Dx5E_==0%1F-fCA_Iwmg;&B?NWaK5kcifhB9!U@fgOFmKVLmm4R-s{jDV5>-pvYdjbhL~I&tz+ z4)TF?mY9jbN8_G(34h4{(Gv^BR!r%-rF%1HQT`C|iE%yOp!~3>g*#Ik{ljl5Ny?( z{f&>~7!QWvwSY8n_VZ$}o#6MX z%{?fl10mAzm#5~?AmDFhTschXh8*EVZZr+v+JhOC#Dj5jVzWm+ zWi%wy9&#ol(g7;tWNtuJ%mL7j8O<84rRUPm5SVee5Cvbq@Pm|Ea#C;HGby?TlCsc_QIbpdL05U1Jv| ziFR+^nKGREgDa66%wAyukZ$?=)3*_6hT7RLW-=|vKjgpd?G7)};-U3`wad^Fl#i%J z?)ZCSJ8e(yLBjqVwJF-11rk!x2l7(yQ2}alR&bi_Zdwr}d9ZKS99h9XK<2RJE+%t4 z1SJ=(PTkeJj8)`}epH%{DaLb@Tz?;wA2(Trgk6pOQ_FUR|>KNN2 zz1=n2rN+`Rf|n~V&rTy2^vgh_8H}4&W!2V`mu{xWr1#?T8Ke;kXfzf?>UHXw#coqm zqiR{MmDDE4G^sQCUKPQlx-xUU0lC_hW}3b-FiW^9ne*i;IUcFNAF8dzZ(p3C|6p+7 zW>e{0CK3|LZqa;LsT`g?gSidZjHj3Z)$Y;vmXULA{?@z5&8=(}pgP`dzn3Nglo+!L zk>mtA8JPCzcjy;(uw0+WPa}k{nK(AnDLYtm|GTdo;quD09yqa7_I~plMJ(~@b1PH? zAq?JZN8TZpL66QINwLVjEEgW#xHi||kIW;C`)&8fY`gFZvey|Vu0_N$zTZcO&{|^x z+^z|CBifyQ_xx}=DY3mqrQpnR@(g{AyL&)eW#mZjVr7h5Nja_qz&r|mv3z(S{4=Q9)X9&UWZ@xW`4Pr2A9>o`;y#KfOpC|&c)&_M5dTWRhh12eyaZ0#k z7A+6ky1jDe8v(IEB|J| zmz0=_aH@k#+%x--3z)*3{JUDUkEH~N_ZEtCsy0XdlU$Pbu3_~@%5q=I>?bP0qw zP!%41`uisA7_@z{^NAdcL7{Y{r~1uIq$B0JSc2XYr}Ba3LM5_O_rCb8?7cy&YssE0 zFL8}UYk&)UTz&fCTPZY5+T^Ab1a0PF6hkHuTgagY!~n(S4wTOza#>8IBkq|8--RTZ zN6RsD@QqUF{L7UpN+B1U=j75jP_{rJgoH*8I<)9LHWEt)GIBhC3lG>kGt*P574tI$HR!wXSSnw!At5d1I5yH!iePI2{O7h%tZ161*boA zF;u$-PTkVIQ^bI4T2)K3R<|uBYK&YA8ItMU%@iffiTC{QJL=&XW4QGw#f)e8krMh~ ztPmHm@nWf(D9DUw_=;~>=*q}&7wX+BenLXSBkt*I7lwW9^q10mj=F+SrVdXTCxs#& zJ-{QecnsI$_YHG(55jAgiI5`}aEtA5}2 zYa?92jz@UKRzOsd^9-z3OU@wg^{dae3yiUR!jxFX;}3aQ|F6NFI5NYkxvk$Y_o#vm z_Y5r~b4+mGfic0{1`VO9bfnkc)l7t&w3dKDGGR+40_nDYO|^3tn(oTY7cTg2TmTkL z+i+X|x1~?g_MGVsWa}TN)BvCU?$ujO?f! zFQ4R>wrDrE*|B=*q@kxm0cWukce zh(04&jNJ8V2*NFf)~?=8V5wUkpsX>NN(l5;Z7|`Qx8WVBf|AiE^6+A;$r|vv-7f0-qR% zq5n1ge=w;inNmT} zn>T;iny`9T#(InE2@EYDgnR7%?{`x{HS(>9rTDO@ zStJ#NR$Mx~ZUIeIhS=QZDt5UbA*w`l<^GCSNN6%$1g7wQIXA{=#0m&wuhu(tmSL*+l7R&gr1wx6O^4xxc)z%le2D~W;MqZyg>6sf!Bx2Tl$fq7Hy4=FnplD73KfsICIg$f1AnA!o7~VVj*>>_Q;Xgx-b2I?e3NfWk5cf}r%7Pk*#@M51>Gi( z?Yu?JysM{NM4xX5JapRb^gmkAlGMh|u4XEw0K^?{`Sp6)@zkTSw1jr3$%w1tA2(eF z0$4(Fl9|by5JbB_R>pJq()KgF*ykVZ6Fw4K45Xq#vHvZ5&eMvf@TnQ@=(%4tC9!_j zO^hRaZY18sBdX}d+oYVq(9m0YUlC#u87S$x%prg+6D>_0S=o(h%@y6M+P#@e0#(MH zzR;Le3TvKJVVJGhX0%}Z4UM)_l{)4MJh#TspoJ1l`nP?>vzRn6@uUX}hp`Zk8Ku9s z?u8qGp*rprTXghTrDtjAI;znVy{m?>!;7uZA`S<(Rk%Urc>Wo`O>{Vrf+R7@D=5zm z`_CzpP{S0UK9db4+#kKg6VrKkr~tm+XZDA((9Iyl8LvKmkdTc1Fhlhgv-gan5u*LG zCM*$g$^?`K;sCKYi%Js}?KwB(j3Ea700>4H^gpR4;3$8unMes|a8ZPZH3SwVpiR5N z@#K4U@vtZYA~6|4!*Qkpn1qvs)p~BZP(gQ5>~R&9;&2P`JQ}vNnbT1P12xEOK7HNa zsj6JxpTrCuB{#sd?b#c0=?(NE`QW6qw4_up{4^B?JUhGxvxx_pAeD{Nx!#fA{jw7km-@rzb4ZniGt8woTox7iy{W-_vqi;TV$t|o3PAp$RHq()%Pr< zg$D*iWuRubLVaT7XV;4mKs+BYfB_!^I)qu&3|et&@6|u#reV5H5yA{`75cF-A~tGb zOCg&JS)BS?@gbUl%vW>k60me385ExQBS)-sBj5|zk$Equc}5gnR$#tzm*cSzllC`~S{2@e<#)pZ|%5uKSeh{okao zX_Jrt>aFYkpZwH3{hy@y{{~uY_n+}m;{Z*bCK~13ZE2C@%0}?_G~VKTO?#NlKGxpL zZ859{gYftU76W0O@hzvPc!~2byYu)<=Izw+m-mI4EE6Y|I!hZM7Bm1ZUlF#J<5z@4 z*kZ?TR406PlBZuLl<6wtfO{+6_LdHL#;1L(NnmGzRdG_!utt&-go(zHU`|vMxM8aa z*pyAkbu6AI8o*$fV1)Rt2H1SGy8{4*1%OtDDj?lz=1Gp$0-6Va@nAzzI_^|JQHm1h zYu^V0b)l#jDJxOEP*YTyC+V2bb3o$iPV&d#T?D4>- zP?!?aJ>YB!-jeyY_CDs9$^MwXJQNaH^UgopF- z2uu6(mKp-FL^_Y8lL%i95KvasM2UxKhJOdMti;m?+AGCdw)8&7f<-mN!&%EuHNeUt zo?QUw3xP|Z+d~x)6S@=+r(4Hs0i^(7Zvf~SO-aj?)4vn7fNp|*ED*P#go)`j?9teN zt_8&1Q``w5*-Nt9$1ZYP4V$5LPVt|t1r-Mo-G{e?ddRU*Nl-)a^Os<#GI1a-?kY2{ z8*bu4onhRbN+%&pcir`=9d`eNm~HlhtZ)L;kD(^Lmc6S}P>t74;PyJOl}|$*(ep2b zIzM*|5eD6h^kRup9>Ci&m|h*yBX%5VcqKH8l(nmgu~u|L58j^z1M5*`-zZ4c?rP=8 z03O3zxlDVEL@x}Bet|DXWSKUsFd7#2MKb>t#mEZ?Z zjn-~9Tgcuu3KKDn~aikKMd-iXQ`Rdx3?=zHm6{fNpt8|+`y+-MkK zUmiL;#ITl!%ywF==&(Ynb1kv+vM3R9#KXl#nl*{B%C%yCS6Vk!wJ(6IU8vjcLvGa7GxUmKf*L@N&_*`()r}T`Pk8l zYfMA?lk`|vE#C5RQyy6zzsLj+$c)zZI_zonRRcL*o(X1jNO=o0o`9i?ueVQ9T+YKG z((^@j-_maZ&WKJB+>!W{mWJ_VE7D0xAJMYU8x(7n2iHgm&5w)}i}o2}%Nz2E?NP|y z#KNYf9vbDb9?I+*LkSQG_(wQWDlwbH0q)+oldAC{4K z$!6W#7qW}E^dEe7BwDbCtpH=|yVv`I<|-K*&uH-J3fM`z=v zlqLkns|IIt3~TeM2-}TTSoXedm#xd zs6hrBa81UGTpYwph$q^)pYhU7Fu76CrX|{Wvn3P0RlIh0EXPP0FUCV@I!JaM=oyjD zVWZHSUz(MhpU*WJ``CHH@M*XlA+E>gOTlE6;pc+H0=xsr(%&=1o(6f`3{e@zLWzsr zjJTM5J|ApjIn?M>+*KO=BuJyxgYgh&a##`NsU1UveVMIJQ#)LxWnY9n;j&TD+G5)m zak=PnmBq0?qUxW{edC-J5to;v@5fh#_OONZt*nYz6m8UvsQeS<>%Q}PXT#_Y2PDrE z7kx*0dC2leCWk$~)*7}@BhlVG7M>cejGYKxLNqWI#TSAbIF=3Mg0yPjcR>w=$$EOB z2x!DB!v1oHvdgbtUVF)?vukyW^B2}#K7YwrS$}^;L}gF=`Ae3*wo2Rj^NX4qjtCo? z@fRN8eY9YHSFm>6t}IrDt2GQZ%HoVuylV%5{%c$e=3Obe1svi|yah7*BptkJ2ZzpL zT&e-a;B`BOfzR=lK<`=*huRPxGu)sdw8rPl~s*#uM0YLyGmTPDE_qYZc( z2%eZ@pEYyq?ToaznIX_*F0%`3UTBh#C3;aNIV3NRVb<_6e9{KXMK~EvexagvxU(j> z-z)cWD;&Z?DBThZ_mai2o3CxRJ&k9;;#VciNYq|N>HY)9!gA3^v=d;PtAcf}?Cc>J zMbkFgWcJy|N-*t*ZUWeqV6bRL|LFi|+?H*c7jSh?B+ng+HW&yH6%QvDsgOh4Undm( z8jLJz0gx>OqBdx^G}<>Y{b1kLe8V{y;s-hKDQr-{Y(r0rjngpihNwA<2D$~6e-9>< zLPJj>3OW22DBBgkrqP^+PIGnMUdMTTxTT9T#*!Y1>rlM;>HN{^e9n2uy1;qdI>7mz zb-?_E`IM&veDVbm!e%ViiifTC4tpXTeJVqjMHa*K*B_h4xKx@)Z)*C8o?`rG48$xQ?spcamK>6vbw6 z4>9^&bQq>3dF=fe8@ z*}e2&L1_sW0JN`_SwqY4sSFU&f#_X5aBD+w?^2zhAi*%!;VlqaumpG@{(kY49~V8Z z*;-_j&vio>Ml;}IkL`<33u6X;iUi6$81)HYTLP&`DJO&hh{+QT)DM-dwSYDZfvqKL zps(x-h@vAUpfqf?fX)J7)-Vn9h(!VEu0YL+javAuW^Yf9VO*E1fn3)DjX`BcElQmL z@K69K$!Z@fC815{4nT#}f{HFQj6}SpBp$IXRyxtG8V4w64Jes_dJtNE;vX8Ws~*eP zA1MrOZVL?tQ;zZ%fJDteTid|!v#&!fz8<@3dF(+ej9}w~)(f*Cd4yyq($^}ce!w{C zL~mzp;+}xduwdL#99&xi>$kHNLpZyDAsa_mhH`{T$7gsgs8fL0{+MpYySBM#KK+}9 z$^cYE4Jg_C`{rVKex8QA*)n&&Fd%w<5`)Vy>eK+ED_snLLmG&|^ycjoem8F2Y}-V z4fLoYq)it#YDCt8X^Q$|0x&TSPW{-mv=zcYjRv)#@&U0j0Obgor>s!Znh2ZYz|*J(o`uj${U;F|;w}5Ye(iG^+ESVM_>8Ir z^a211pHe_1J+4!4ahxk3g}|<#Ye^RXOXFHtUId2jPixZOg(!Yw6lo7Wo74ij9{{ff zfF965nqMz~uB!#K6#$nt5cz#_d3P~16}hvxAw=`5vA`!7(Y3JDea0~UhPQOZ7*#wa z>+Tb=q<$VUD}YHWZxS%Y)WVboEK8Q?mOJcdIW1D#NfCgW)&hDR06#q&M84;=hlZ29 zI)g^+3|BJL83+uMpVwF* zj>C=P<%#IDK5#?g3X^VGF>YNSj7ho1MZhz2xps~0nS8C=9|*QjLt@QHQhPNIH&r}fue{PNyz z>(9ISrEHIN-5yD-W3{e(Ha(Xg20$Dk;P(~?SsM#wzEwA_6va0LQ&&Uy1E9U;B`qk3 zd*TxxpI|+)n;%kAco?R$75C#aHW*JdTk#$+q^+We=4WdGeO_Vx_*3%y&8OD#&*a!q z252du51c?u@n}8%6Gbh95l1m0{5g=;e^~>K4pZD{M?4Kct!e>v0Kh-iX`q#M0MUZ= zFvS3>buf_9^D_WRdF@&~zx9LltsmKpPk*#-ImR!B^*LaW%}90%Ju|et0XHe3>G*6D zj9y9l{?`p-Bi^!yV)oN&c9(4wYxNV$;s|+Tk)GN}d=H~a+hBar994G#Q~h_qY^Mde zq|DcnpRLnQlEdR?teYHriVR@;f8qb8lN(dS`7A&1JR{z zT8anVO;+SzL_In`?k^p1BJE zEx*!0^FkF+BL#%$!RTBIXaE4N9??L%odBXyXtRC-K)2Ka+V~xgxcXiLHMRmMSdSQr zjV`r-?gGGjr!>%h2Y@I+tt*VYM%P+E6#%F@qk&4X_JUA^Dvm^TiULEZ5my6DO7QWs zhSBSs2JB#4ETdhHPG`8 z0MRjMpl1QpqZW_{03QZ`dRP>DO%!|2;j?EgphEz7;5SX_dbWw|X&?+(#;vu0hW&0B zga6P#H-`ubQt%pVDZs>8*7y`Qs2t<#0NUWN7#1c`M9;IJ#!J)eug$VMEtnFBhxvm2 z!ZVN9FFk_kQ#@t|vPXv5=gt#a)_!3bQ1q_Bqf}Q!h{d=ak3~zc+bsZN(>SV7%Pa8N zrv}&}sOu{LxWY8hGX$b(XovP9fcn+~Dh0r&IQd6XI*y1~S(K)QLCxq_3+xwwq(x}3 z2Q2gE*YGqe0d!j}AU^=|>uR8foB(30nxisXg;CDvUkhk90J4#clMFh-07QFgrhqWY z8R7>F@EPnf_5)-~Lk;%4rlke{3c+j8;y}Byk;V7}Z%NBST4YcItp-p+Fwk6PhTsWx zdZTeY6BjB4I*geidQmQ~todi$4_17ifbf^s{Z~Hug}C;}>q`qVdx>kGyv|Dg^j&d{ z@SgRLKHc^~aqXAaTP7t*_(}5m+}9^Ji*n3hSl^m+j?b$Y6A;+*`pMCevVNAlZuQU; zuZr?KdEKyMQde=EF0TjueDFPST_Ud&|2?v&xMunS_)4z3{R44bEU%9}utZ*G%WLcA z*B%k&m}|2Bn(OM8i0eYbxEFjGyx=S5U%hSk+o-qAVvT9g+h(=L%;=5P!kCA9+w7q+ z?RwiB;W0PjCtd5rJlfmltQRx0w=Fa>W>#-oSi_jvy=~!9F#~$rBAUb`_O{iDj+xin zR<~))+}^f&&12^Gw$*PDv!J&vGPYLwOp}kt0~H%^BB?zgR4839Vj%-?B)gSl(TM1@ z_D|k{1kv?q4DELfswW1Uhl+W2G_e?mnrW;0+aY)MKNZ2)2i(?i3001XNTQvPrY zK$^FQKNLwq9Si;Ov3>t8?8=AFimw_`f@k_00hSyLCUVm^0HCrv0DH~L zyAd_$;(t0~pZz^~SpL0z#gF{*_K)@p;>*Tk_MeXn?;nA>$Y>wihn z*SdHU^@ax17m@nle}7sC&-$Fy z#eLO*y7p=B0p+k@luCRNcAQ~7PHyo~?FV`A#)LJS_9 zI8o?2oWX3t7*&H3y-OR=Xg3&ix-S%Vj!MSK8IG49b~H5NznQpyDIyCbA1yRYIqFn+Zu$33Tq}*mYv0T zQS>A3EAGnad>ef{8}A497+Rv7KU!QEImG&;y^|$+WG1h|@$MW1;`#-xj2)sBktAFZ z?UQG@e}5qb-61Uxc_;(#*csjcmmiN z8uVA#vmiK?Q^U~=rRCOCVghUL=Gf#@=Rp` z7C+C#ZL|Q(7!;xvZ*Ef~J)Qf7`Y=fCK}keg`ZX<120l-r1ui_PCw1F9L7z7Ik5B;7S>1rjq*Q^=JA#3fjXwyG#+k6aAqb=k`=SCkv?l9g8P^YU}D)x`yb9^w^wLSiW;2vMS-WS-kM?2;F z#D1%><~XbsU9hNeW09ld6Vc*u0I}-`)?eQL&Y`q^H-Es|7i|53RXn8FTMsWFN8<_J zhc+I(Ad3PKj;32D^9eSi4Ss<**r|-n;9V!)?BpzU-Ii-H3i6Z)lI*+dBbcG+v=Y;%|RIk*O zzXu+1Dlw@b#%?%u6HmlNqq4GOqvp1-M9C(RK}jXK&p-utHRSRkgAf5|AeHF4;4iGx}It`%o z8bEUXzX>2~9?)!KwD*)eD}JlTD^I!_nCrt)BQP)E3l7W90H4@{hEJiWXpZ&`aLm@5 zcw3?u1|sXq=^?K@6avvfe6n}%x9ina-K4X?l39a0W`*_x)AWb5AU?4ymd;ZL9OnV# z4h9nY)#>n56p$Nf;zC6Mf!&jq_UxyOwG^yjf5Q^gHI=mm#$S1Ol;PS9PIk{y+{p1g zxOZLz!amxXq5dT;Ke(Ml+TbDC47dEn5J_br`ihPzI8-C1h+6ETJ7ARMJmj!H6zTdE zlnQ2RYAUGH{qYj&ao;vybYxA9ckkt88~j9{zsOq}prhJCK182X<*voR{J`A5z>c(< zA&wu$XC~gzn|z_SU`_QeDw)iymRs|HRWDyFW!dgK20BE>X11(}YkCgOmIt)OQY5{Erz?F|RP+JY8 zXKqMg8b!5$zTb|Gf1fBIju@-@PG3Z~BhL3wXM2D=l^&&djsPZKEli2P^18-k{~%OM zJ_x40e;t7NYk*1bzZXCWJ2VUEw+-L^c~yPQ!YCYRq}Wh_p~ij8`SNf#6e15v%ZKX45F5xx5*^zH_a&p|O=#E;K7Uw+n! zuKUZg&J)i&>lyKvmOAGxbE13CT<-jKIlr8F!THPz)_G@zbMGpr%@SYnvh(+sS@gpz z&dN3XvT3dJyS4oC%sS`7^-iSJ-+0q`?)rpZp4#F3 zXa~O-i04-RdJ-&0mj}`?CssH=SVg*QO3?j^bMQu zJ9vSmKBP0bmW;2*USFFn9%HL$v>ZSdVbQ@rqS_{i@VCZ{VVR3#$(rh)S z(*$Y@pnuc?8U=ua^P1mJs=c-D7wrIcZ!lOi*C{dq()uC{sd>4ZT=DhQPtNk=Qd1px zEv5e>lYN|1#^M(FxDg2N3r48jKhW7PYfi!}03-W4km&%h`)h!4(i;tcew7;ND~AHo z)2xmF`e!Ymj{s0orGefeCHhG{KHUVMvS1+9dEP}J-y#$f9I>;E9*D1BXNS(6gS+ux zJQg~4ZYT{k{C(V)t^ZvLlpaI#)CK4t2u82ke=Cqw;w=E_w8C31u`|9X_PGc6d^qz1 zKS7Rgh32H)UpL^I7K}?Qsb_~-jkOU>H&ichpI#WcYBAY_Jp?H1vFzAQ^Nm{KZo+X8fXG52)4z)SrH>?g__o|>7 zvUJ)NRDtLgh`r0K|IqWHXI=<(+Ts_l2%W!L2(Atm#6`zv`MXO)e_9?IVU5RDIlu+B zW6WF@`rMU;+n@DEaA_0%=-fdT{H+V?vx! zt3bD^fr*Q2(_Ph1tXWaW_wrlp#M)(r*Fh1%s8=Bmx zOmVSz5P`)MF1@~7KE}p#@enN%SVmv^2)u%0iZ8&y2ROA$+VkjZcZwzeVn(n8#a78L z0N`q-fsPZ1eOVh-B7h#Q1r*uBYCMX!G*8H@&$c5wDKD?5#+ftRfEzpn4*<5AwXofP zgVk7ucL3YbipB?tO`1i(B8V;6Lk|SDM`~fS+-NoK##>6ER7*kk=_CNnss%I&0O=hy z&{tx=EE#VIF6apd0cv(IR6dif)2RUUkXl0%7s~qDa4k~I!TPD^CB-z0*@C4wPq5W& zSRXP7>F!pyQM)+j2@W77bI*kc@smkDZ!u;|JXDDff`Rf&_`+Wu7LO<_HgQ!$?=K9r z8eifq&TlP$t*pRS_(S{{@eqheOc5&FbC*j|#HzeE>s<#wVY_zM#T+OUp-?gY@>T0pU*tw!&=G*B1@K?$XY zSe}nHFBmG!LeuAuwKS_gD=|q?ycWOVR z43V*Ub&7y~-u}DA5;-!RJ%&B0GtT^SHOG-^kK-*cAzi3#Tqg^p#=eP{je9DZRE8P*@-929%X>7bJYnpMs9GM`r1HG67Y3Pk>7u-Yt%Az%Ni~*UbZ&b$4Vua4eN^f;vT&SiMDn`@9lOer0KpG>uwh8 zYG%9W#?z9`b(UhDSYBtA9?~%Ek@3j3ti@AU_>4*s&rb5b-clmRn7eRmez4lF9d3^Y zYdx^KRC~B>xY=&Z`A}+|qpN*&&Bw!o2e2L!ti~3X(k6%DiKq9!Nk6JL4Juz|*e_~D z(@g2i`0ES1m7@Ra5q55k5tgl&P5^rg#0Yy2ZY>CIy>bG_z}%2@hHIFV1?D~TwuXJU zwMIuz2q~8cX}9d>6M%4GFhb#rCIHn>=%d1V?cWJs#2%}?g9}iLYCy>u>+gU`&DLgQb>nYd6x+&~U- z!lbGf34@Y`nfSpjtde%dLpg?PcCOWU9dFf1xj%uXsQW0!bfc>ZjsoM*yg zLZ8Ct`UR-2o2b!Y>J*GD3&`RWGHF`Xm^dVA#^5{*S0b?N|0_({z|>8%6;}6JWHs2L zE4m0oz4HEotsEfhu8|2pG>AFN`7a(^QLUg{FyBMV6x2sd?If1o+9=!&X40k70Qs6(F&j+x#-wfL{@GRz>K5y4 zn-zEL_Sp^_2lPl z+HIA_`!Njw7aYQBwE~lyHSGQ+F+2C_03^%4k@2^#c#rj-^r~p4k0yu zL_7dX#fZH~(J6>9;>CAFEaD%P0W+4o};6e?a$@TH6FBfpV81gDbh~PH~!whOgn^#q-G`l&rE^|JnwooV6REQNRm;(3u+OqfixDw^Bep04=En)DZx_M>NoColMtxaV!WL&jtgj z0ch0Gd9jfevvY zpFnNF00sFE04=Qr)CB;K1%O)G07QG%Q`vg~v@94%ET5APHNbUxPUzmro-Kw zaYC$3Oqk%o&ICXpI2qG@b7L-6O<;5)&dQZP(w0pmR{p_@*14=sH*B|D7J^4-?Hh4V zh_JSo8r#ERSbI8fEJ4lVp=umU;6TKt98Zi2R_;T)mIt>>34Zr-t1)M-mf;0FI7t!e z^yV}`y-)*+%PnuA{=e62n7UyAq6piAYs&pW0IjG66#AOgc>i?`)Igtqpsjv7fL;s+ zQnvUxK-S_El$z`Cza0;+I)NY54rIUVZRM_U@}Vbb4*}&%!6;ReyJHvbvu|onKCr2U z1MLPM2H46PU|d$o+HN%pc50w^0K)``CN&Q*tAb&~ffeH*5M?#@{i)Sh1_sak3Eyk6 z!zh0q4hZAK@^`n!xA{Q4YzU4R4C#8Wr@Ovj01gn10JD<9v} zbvA$su{*AL20ajoCAp67MpxLQ+C*$?W_?$|kVWiY%j8dd4f5C@iBh2$la!327of4* zRTM4VI5W4O0nz4t8X3}dp39@f&%;P$`ov|46psaqVnGDnPkV~iaiwv8euh7f{@G1+OVGh>tuV!>HqQ)HhMpu+$lfIA6Z}>@QrGS&>h{FZgBbq5EP!0}X32wPaP|W~T>WG4RI8iEc|Ds!s25jeFxVaH%;lY(?Wz02hF4}n{lf90w*UH8kp*U^| zzl76GxjT%!Vs5q=9Ig&-sYx9d0!X#=Y;a2hIz~oH979&fW(J)Gfn<}#ij$C*+0-FJ z70_}EBjyIn{$?RO5TcpmVs7PSY>{udKfkid9=Z{2yQXQhYrZjM{nE{P0?k?z+^lQ;Oju)+;NpzN>SM6jx2OL2q4@2}z&PZ?>Tx{k zYHd=HFW*>wa!zx7a!%d-6-G=m%g(%W;@q5Q!@(@uUuka02WZ|FG_UP7_8EzTvlQ#b z>xMN>X-wyV)Q9-QV8>>)>2VY|`0pqWX z2z;@*p4c3JL4J=|U!gk#=f2}-#_{tNouTa8?UrF9Cy~tG@E+)m^?3cU#Xfhe_=(n= z0q8A?#Sa&V6X#?36B`<{FV^J?;yX99Ppr{kdKX~P=i;=+*&K~5m{3`*`(kd!S#UP{ z9-RJ`a~Y?>g`j&DRU%J?Q%@Y>;$X%)%bFV3MOZ2tg~06NE9>oVpYUhEd+dp zFpfb7x5p1b7AoGDi+jp!TBwfxJj`Zou-ViVnaAz8t?cIZKeZbUsGF7-Kg{`?nnN2y z5M*G(6Fn{2ME5hCXYGlWeklb*_xeUdL$YdY0kj&M?v9neW8#bDPf|lq_$8-U@f#1Z z_=zLGYYG6c!d(O3V&`*-;Wiw*ke#s1iA7>%^~LyiV#rhtk*{EkCX#WH)n zjWhSh*wCM=tjiOm+rIqIke%aT2Ir8GyxgP8xwn;NMN~{P)VUP4=V5C^hrX2;>y+1{ zigz}$?Z`WKw%(%dMr8Tyn7YK%VENdHs+UvC&b@kW?b$|kK3+Ze)aiBSPMvMEve&NN z5$AhWojMz}H>TOPykE{Y*%MQDYu?Y7qMKFz((K|%42hS@>pyI7+F@(Nr9MA9nnnEF z_m`8`uRpbDfN?{4CrL15M*U5P#_a?}QF9&Qb(qe5_FLG{JSu1$p zVIj?9Kjg_X)+Q{6?QuB0PTAg47}>gD+pCrJe&A1S&tBT#&rI#3aOZR7I8~~K!IUrl zlRGe=J^d2?Jpe5IwE@Y!2LBxkvQKIpu$Pm6ZZA6_Tx+v)l`*zmdFQL_%j4?ogW-fs zz8t!uEe$4YCyitWzt-t<)>bd#Y~RXrkr9{gY`AYxd!teL!kD@Qj9Tu3o!nJ+{?+qq z&o!yDeRay|GwaTuKG$Sr!tT8h7kXBmK6f4L3%uuut;NTy`vvdD!CY@NvZDKBugq{A&x3 zIMuhRvd;Rm2;=Jgr)c0R#Mtyph;simZk}=6|KjXB;G-(GxbN=X&8CxHDN6_>A)C;o z1Sz2e1O-BUA_1~VHp$ASm_kwT1q-4PUV5xZSFs^>Y>0v)J&J;gf<94EkQPEzaXJ*cvIdkR=t=`hdn5p7C+8s(@o`-nf2)4bVWgF92R{|v1 zwqMIOXW%ay)xUl1lXuA3D$cN2G#!zBeDEq)a%l?sGj0^(V)1@! zJCuZ`p)73W-FQP}$|oWlKe+OWsE%dn_<=bL-9u2DYuE*>Q+PO1#5%_BX#8%8HXe>t z4$r6B0yfyUUhCq1&ztViF<63}FC$>^ z-%!cEsDT^J^oE(eq3(+`>>Y4H4cr^8|I~izq9G_jWv>}SHfH#@h_A?iSJ+{{D~sAA zHuv!W8$`5cbH(Ou~k zZRC@)8l9!qo&XM`G+fcdyqT6fjbTB-RmvktYTiUeMKhot&n-UTV(i}x$ZOgzCX7q| z7xjwQWoaiG$hIWV3{HA@JpPrY)>H3@pu z01ycQxth2Ipf|N3VNt6GqUMK~=yI zgQdyxWnkX(z$D=P*iI62gl*u^W^Wr%?`u(_T8e-@JA|DAP=nskeh9mS)7-+WhtD7eEp2SV#a%fUu0J#YJ$i#5BE+VlZv0wXpv)Q%7F=#Om<|S9TYTAPv(ZogMzr~0fNsCz za@!?e3L)!{7p~|7qkRq{bb1i;$=Ha+MSLC5s)ijbM5Ng(5lvBejv(1l8#@g!s4)n) zUWoYWS2`oQdRLZ!8H8DT5~jVyt`jm&^z>4)dV486@Vne5M#Z6ZG1vhVxv4H*6A8h% z&*)oKbrYMs&?K2I&2b1m;B7i=tZ#wEV`xanhb$qRzg~~(WWJ&b4N6SL(f@2=*1)#E z@`kUoG*F20DiVV9S%YlmBb#ct2-w+}O}BMnO}X?6(qS=U={t`JB*QvmH-qxw|7s;a z{&OoyukD&`A?n_BUDQ_bUPE_-e`7W!gprml$I2R3qRqO)RLO@N(8lzrWfgoEVoh+q z)K#RTD9+ksC+9nCqhsSSC30&v{(^fNOO`QcE3^RC86>CQMlr`qPNPjewrh;H5jaWa z|HkbaH*VJ>tb(1g`*78h*)p>AR27cvB&D)WUkF?xQrx^!z1JNhDL^4X;R_K~> zI9;-cuXG(n>YtAAVy))vswekRtI4(JDcL{MK@KmwEB0ziB&P}hx`H=KB+U?()Q|aha+{;m{q*~G? zdW@(y($J{KaNP>^mc-L;B$}^(W9>~e=a0c*ulS#IG|iewO0+>Kz{R^Lw89bBEZa#A zfuPgqr;dsgbsmlQlnkNGU&qvQ6NGULZ4_uOSJwFwB0u4#&!cOX}dRWO@9p<>ZPo}CC`%> z#mTZ}OdO|=w@ZC~a2AZP&Blmv!kNB|9uReqJU6`^p%DpFTkkKe_>}Q17uEs^8$daz90(@w;>w zs^S$dc#-2j?>A@;fHhME^DBezhDhg6xVR0tWbog=p!HJVp^csBek^~jEeQT_`UFF? z;Xn^#$i4v=y}~e8fC_7h*joUNI4Z5x6oZEYT1}k~L>tmty|Hw2AROA+zs>t+n-lTH z?^0T;t~>4$Su@DeWMjZZga1CL)P^2ut%ja>7_Coh^+{lq3`rp8o4hfE05?!Rq79Ta zv@|?mPyPDvrvqJ2`!OOYhyQ@IR{w$WSHR%3)_^qmEAYm&*1+Kr*OIBgokkw0hVg1& zLF=W9qY$(o>tvFC@ED|dV{2Q61RDI)T0_R;mmkU)IssoIu65V%U%3xv!2uTxNo;y> zb6RWIB;c;JPr*7H>WcM=Cf!ZVrBhkWVg47kRq-~{c$3bJwU$i9Z->!4d%4kft%8{7 zRr-jvRYu?J@s`$De^7hk@7p;di0^3dVvUq3}l zHtq>Ed=lGs)_(q+!L;o{W1NB@;=pV50Zqrf1TpB94$+_XKURt`UGb}`@|S~9h?t)c zmv?JR+|d{P1#O9)OMO)0o&n>^vym&(TIoYpV^O+6uF@sT(sf4ZF7VR%wGC>&&}#ZP zw(WN+q7RCgp!iV{|Dl9~P`ZVqP{Ox5SY^Yo7DkeWK2$g5yRKV8Pv_HDk%9Dy$b=<35oq;gci&T&d>%^!=pa`D$FvE!lvW ziwP_RDTohqJR5#aKno@ZET#pY5rm-y_pN2iT&Ne*c`s(A2<;h3EB?+!DtsTWc8Q?z zq}}unc0pJG8ylK}KMKOjm=fSGty6D^Aq@%R2o{EJxuVzMsH7H*DD7Tv-~gpiJ)O(7 z*(p6~&BxnyzkkHF06iJNd^aWxP!0aEYWoH(WT&+o0zotg`m!2At4VBiNR5b53F^g2 z_K3LV!=OW*ynz$+N#dis%PjJ7F3g_9%L ztTAvG0+XfkEccDm1lJXdh8DKe-QO4u>>H+)`QhkEhay4{S&(txWWp3Lly*d_sy%Fe%Wdbg>EAsFkOf{}-wkx9TKfCIJ~C-V&tK14ITBssS<_(DL6tEoe4VN3jP$3WwoQ*?3n> zNDE0FWty=^-#v$Y&$q(WRtN{uX!`#(cVqytKQIcbIjLMvV->lTmbtTd%`!>i^ z0UNuhGewHc-J#3nQR2uX`$Sx`=rqGXEz|$SGo=oDsNccWv0YORNFK~<_P>S8gW`O9 z0o#z7>>Iv%Kl@)e}F{&)zN4;uvDeJC{AJ^&QB{{T8Zq31VJnMru8kF6*cwWH_=Y)-C z_X}iqlwbm}w8c06F`7eYXdt6FoeomiH5%MPqrpvhO$;|rYFm_3g=m1-mJZqOg@p{LaXoR`rFJ~EeEO;}y=JYPiWLy6d?yd9SuM?~#1>of^C`WVv< zzEy~t<18xrJ8I@jBz{nc6dE+b!-I$Gp!+LwuqV-Sh4vc4LmLt+4brQcHeI!|O;^aH zmlw8>90)Z@Z)}VShaT|uO**KAUAg85@YbTsScc?lD4&iOVvG|G&Ur=U4x`^ZJx}~*+ zc8|D{OnOOJk3-er20i0jPrN#yEi?gHOlylsqHN$RUJ6aXpU7kw%dcER7&zsC16)p_ zU;Xfl-dWIg8OG@=*ZRAD_oLqfT)zj8UNbt}#VZPW za0KbXRnUQ%F3i?z^sKFsV;bqf+(rWDG$y$|1NnP<;txKqrjB?q;|irqizVM*- z@N9#!_cmFiO=uLH5hM?Z=LkcfeCdJu5s0EJfijwR*6ADFqcooe?5GE9B_O}LVEyYQ zOmgs7z>ayqjB^dja9pg0jpm#tf>Fztwe=fdUwOc00kX;k+gU4N5u$7ej-Y()0ow$K z*F0xxWnBnHMtd^U5KGPi_KgRu3m{WmunXN}*<_ zy$Hxr7i^nRmQCtB=K=f91NJ*0G4q{es|%1YnaK-)o$!FA05U_u$R0H=eerHGDp&B< ztBCrbR!AJW2r6tD62G|wqJ~=x3Qswypc}mSzzs{Nok1Cx0lUwbl42}mR$wa{Z%eXv zFM-A7GuxR)$tf^uCSle3e=>&-@tjvWHVW z&qaR!nKzPZg;Rp86}g2>ucUP5&HZ{7<=$Sruw;R449nw9h!atcdz8+pr{6kCqdm22 zYSL7qv-R&>rV?56@@5fJ*}I_C`=y!tU9`sX0A)msXaU#zk5{tDCc>G>q2%ZiQ#9ub z8YlSuQN?-ictK{SF>>~i*Ak=$XrdOxLew+>Fc=Qf z+7LCne+y_k6F@Ena_w3tb0F0k1Bl(MB_^102S^RAl6lxKm_bLnNl9x2@)kEFZLOOP z%q{mx+$HSN(OLz(fSKfhvE%)o4@k`6Xt5ngN@o*5lRZE;0gzTLK}QHgDM{Z8Z-AzF zfTjTO!ow1Dj6fvPrH1SS5FHs$A3pF>k@f=c;c5vwEwp2iWx5B*zs{iaYLuW~2t-YWgc-Fnv_fTu z2WTV!H#AAm83NG>EwX|G0h;LnnhC(DM(Kyv};^Oyv+5=g5O1_AUh zHxOsxt$>_bBVp}=g*4p9iGl?Kd8-?ef^n)(8I&V0N!-RvYN2zThCXzDG4M{r;>wp>X zxx{se5l3>#nMM>q^Cbu)!-}q_7t+X3#A0fdV>uxjdzP?WNq0l$f`xZY_&os+trT+J zlIy@wVWEB9_S`X=?@a5oupm2ZHJEZS1vwb_v&aRFKqD^v8f^qAHrnBTWQ)o|gDNco zMrEIzB1uASRpP|+tCX|Gy>7dE@=6HL{rL7(7VZB+FMzSUkveS%-L z$xEN$U+rzuCj?accJ!4M zgF5LG!mERW^a&BwA;J2D$m-A#eL_@qSg1ZBx;i{epAb_W5w1^&t&WV)Cv>fjiqt1` zTbW=OV2H+%t%ewVg6f~3k0fuxwrjJHXINWe)kT-RHrGWPTsI^216xf8R`}d_xz*Rd zWx$nK|3&SAn{5#|g!&+@$#%l3D97)|tCxZYwuX|QO!!7xvUGbCIj}VvX>^WdxGwwU z!+pSA>^AUH_x%Ofn9>8TfIV9p3w6CB^|KQa^o{G3ME?Yzkc7?=ZDGp6&@MzhDWOYs z*C^pt)1b>XomiL*mQ&lLjj+MXe<4ThAS@vTDa&!`RBt8!5z@fW!DwrQ0pkj7_JW%$ z{_%Sz{7-(DUijZgb~N^sDxZ5kbyoOBv%kTsr+V^A=0clV&aJ-~l&^5{j`@p$T(*d= z>@NtVrJUAk?_wxF1I)Jb7)IR=JALUo}}P80`9zk5)s z0+oY0RWN9|3XoRj^Z@9b79_ZT3J|-IB0x~!7O6g$$KB_V;0(sK} zXncH2&=b#L^h#HJX3kxdDT;eU2ZB^bau`Se!HZggVKhn=g4pRu$s;4P9Z?gN<3JKn zmpo8Cqg2I#i!-7-8PNzNE4DX4ty+-a>{dYfMI-lap%%})9CYtC;%wu#pv~+Ha*dDR zvYw2AL|rz}WIVmBr7pNU7L+gG;<%am2EK`1c865J+T38&MU642zE}xrM5qFHR3D(O zc%W_r;zuXy2u1*qKvbQOT9U1U;s=mGM^3XH6uegOU90V)H)*j0j_7t?>~ zd)gnEKRqz9c>k^hiHY_h^8}?Nvq#Ilf4QOfF#QNHJrX7ExS`QKjQS0LU3G(zMQAtx z$CD&zCgKutbyn&*1A+S61NCihRas_{D65xnT9$%w5J1;FKx+YbBt?RPO#o55Fr%%I zemNK*h-mh4S**4K@MNk4rRfAna-Fu;>pVa@#C`1CUxM~~k^3`sbg5v%kx;MP2|A(P%GG9BTQ>rvdVp>NV5J0^e1Z__ z9R*?Qbi|8c02w_%%>ZndAl1i9fJnpOSX>$%G(Xa8F&tu#$giYqZgjwQYfYa=Hmt<_wnN4sxo7&05Nk*N_V!a0*au` zfp{&#V_QmsQJ~`ML8TNFZkQmGJ`PFfuH23W%FhEe35bIeC92g6E6~(XQt;h0o3~FH>)GmS2SEVu!HoX8z22KGe+ynFn0L^6*^s-TaWW?J{fFe9V zZvZf?LW1sq{>k$vQB#3pXDT@x8u6%VA;jz=i8}8kbUn$U830AOCB?h$ML1WBz0J+Nz4K&#sgJ%kE&EZAW)=F&DuTegiD`dlQ^Z0 zFLFxJF&mU(wUk6lUy2~BM<43g((kVid8R&u+NO_aE3+}Oaf&i;w}E13H;QCA$%AX@ z$<;*9bynV)M?&f!<Tq$;TSftrtsxJf?pl!45CK{KIC5@*?rk@dSit9pS3+KTmGZvt)sSPa z5hGh)3)%HLFHO~pRXh!HQ5 zvs%Uhk+qSy>N>0C(N98-d=f$ti2OxSyZa!VBN3D1_w67SuO-F;d9B{0Do1eftWPzH z7?8A(K|?VD@F_jDAi z9rDM@P=gLb!981^=?&uGOQSQ)<)in8o_he+s&w4vMVv&To`^3p(L0c6f;Lf6Iopur z{N0i>HX|Ky>7J7CY z zv}ehb8UPyN2IBmSi7+bP;o{9=u7T_(#6LMl+yGpf8;;~pI}n2-CF-yj%r{yPBGxHG zJwVd|I20v8k4lhi7n=aO(E}9G-H0Ih64b5})+ISCJ`2z=5755=csx;nNGY5cd(Rr` z^%Z5-;&O`rL+g;3eF$n&7Ht8w;U3hsg3|gVNewE^(A2+%ka4oWR!qUt;``&f;DF56 zbD%WBgVF%(Yg(5gDIs5{yHw1gam6iPoEkL~IaPTc)JA$xdmWUvq)KYYSIC8zzSice zpJ%>a0Ht&-B_Z-6(~QbdT<#+8`HNvK7sE){D58NJb}Fi}gKY)HQEn8;c5?=_R?i2$ zvGv6RfTjVey*2EY$HFl#z4Ao(A5VmXZ1a=hCpTa@BmLTj@O@k9&QDvzA9_DL5Ge+3 z`Rn#7OiJo)G%C^O%i8cSo7gir3!RWT8ffb1;;{`m8m-Nd5W;Wg7?n-Af?w)>@5W{u z$za+3-U4il7RHuMe*mDU9tCmKFZvfUftQpupN3!AOS#>AD16P~aHtsD4~M_`L%2zo z{>=~J+fLD=FHVKOeVV@9dp7+1iik*kdi4VlUq2XuqP0C3@#8xBa_{OSN*|W&?%XM8Suc>`=D6bv3xsn zJXTvQb}rw&DAGw>yxTu$1V}42KL#kn1N0XF)+PyRR|QD+9>iZ%#(9A50$}|k5_CU- zD0@=A>;Y)J2k1=zLY|PIQ84|v=kHUXZt_4S0`a;N6<{FUQCq6LKuvH%aT&M|n6@Wn zYDw~_3E9H;0XESMMp}*E8ly68tpxQmibE~rc)A~;n>|1U0Q6WdL0wbD9ZzsiMTtf5toMLj&zLe zzdi5{X{)7Wwi#MA16iOxBpby^P@C&P?O9OzQ&Llp^H90OSJ`2|2W*}jj5oouAC1Z{ zxOg^#GK2lk&fel6FZT-ge8LHU(w0-#A3$Wj8xb-h`~i5$DHn;HaSts2jVMqI#10hx z3kumD6o#BOD);^>8Tf%JKvEX|2$0nS^aKDm{3eqH11I;qndKB})pWM{&z;*8P$N#r zIy?nxIUdv|g3{!3G7H@)3j~rK@NV>JV2=c#9fh~9Rkw>OeU#x8kl?!%-n0>s@_Yq|5Y#z2yras>TiIt^8-MJ zuS1#+>rkPO0;C{_2twee=nAOAkoxu3im2~bM4{K8ua5ezHp-;O6w-7bp2asiPx{*N zpQwxfp?4mwiTbjJzJQ1L@Gf{&g*%0ot7q`A&@JD*QAQ#0a`=^TSdou_Nf~hgFuNO! z2GoZE7}QCE0`vkTtNkKCw`)OciktyJ4=hk>r^v^jidwT)6>dNhsy_oVBu&DO=@3tw>RXoE z2vDU5Xet1&4VR$fMgfvtzzd*-T97Dr3n1onYN}d$)sAaX7p}2#%er3WEeJ}z#sq?k z+z66_G8ClpZUVXZ2IsWni+iKrxIY^5;Na@$<^Q2CioVg=h|)|TOmitYIQxL`Vl838 z%nFc=oFEJM7H>o(QRE2a58x6vAbGgl07$D7Rw)m^mBk1E=uQt%AhsIso+Q&c?%ly_ zG!US>v>?IEUF{)H>+%_O|HOR~WC**6`t_?&sYh`%xfzkCv!l z*7G3PlqCyb=c1dMtsIzQ0KC@?Nc~|8Ak*ec*pnoMsoYX@#{zVp2WTY#KR7{?B&a)b zO(Lu_K=*rq9JyY~>$rHiCP~pOv)2Wn6&|3y0QlM^C|HgxQY?1`=m8Iq8Gx^Em!QK0 zBAF(ur5ivi-9UU`{~eH?4hbuQl~xEt$qX}q54r(q5J(5)?ji|0V}R(TUL!?scYq%9 z06hx8=u!!KQ0*YE;{dAm02KqU@eT>PUoSvOg6%y3de{T>836qjNl=P6K-4Ovc!>vS zl?P}H0PijqAcQz;B^Y%gIWF`BY_$jMC?F3mk!kHGRuD)E&RzihM+;&hGt!ZLv4>gL zJsUs7o+0NRW)Y<6j!|fr3hNtL7yXsYzyR!uULWOy)A+23ctBev)NuDWpK|N7R)O@n z6I#^+=zTX~Kq(zY3F1?8E&B7S7>KOedtzR?hrVpNFXof`=*tWD$LzhIzWnq+%quJD zOM7+93#;ghqNhkPyhWcksR7;5Vu-sWpvWaR5hczOF1fdxaZ`p+;0H}&pK}i#MNrV| z4~xkD2?luS3ujWqXfT~X2jD6$i^-4gd`cPzQq#61G|A-RO0Dcbb z9)NKchkTAd{WK|%6fl%FE@6L+!a|4W5UbYrw{Ekk(~5mc{BarEd&DAIF>bhRF}W4N zMQ)=~P>8)zB0mT&(z!O9958e@)Hy?rQ4Rlvob(kr>00>bIGGa}you)obE;`Qzq_5r zF!!8@`bby%@szZ6{|xHguZ9LInmmx|L7!taF)!7|z*M=pKBl#qzF^g^M$qAHY!cP1 zb`?ipUcCxlIWH?pgcl19Ia9ImXEfiaXFm@AK12Dmj;V7`H^)=SO3v(R|X# z_V%hqZ`colqt^fQXf%ys1QGF$%eIN!KFBZx{=W^mZwh_F1D4?c?0;)0xr_}=Ze(_U{k;Xa*uv}Z^ZwV#1P41C33ocLue1|`5u6y z-4IRYP(eEmXjKxXWA$gc9&u(idWFJ<8mgwX8=y_~9j=a($RX5d2u{ixbg60;W3$j2Hb3tdNpfM}F^ zw2jg!^bkCwm4~_$9F2e;F$NbaXok}SK~0XLRZyOGzk@&c6qxac;w8{$01Dg^9YaBN z^al&u4Q-d*gKBD8$&MZf-5ZYu2bM;9Q#Rq5Tqh-uYJwu;fSw4%AS3(GjI~i)o6IE! z@rIRS&J1ICMF!w0#Is9-PLqV7_pDjC={!Bl8l5?!QHK_El_rfl{o{pM^c z1RKp}?*5ddOO6eTqhgaRwd#n$@odqZ4Rf8x>6AkLN*bt`+$k_tm8^;vTl* zR+N=20d=15oaTFeqWe~C-CPLT^8V_-yZl9Y%(Jc(Eq7wU8 zi58y4ZO8~@-49V|Y-QNqoNuFjs_fZ;N20D$-Z+C{-pyU$#Fd>omqOiKKC>4T(5_fT z_Xr&TFcweZaFN6()u4EGOA3jj5_X8lBwJa5Z8}zeD{KXJw$0eImiW_E83ywcL;=(a z+Oj{EGB|YmrN1Z>h;Nry$@Z$wu$SWZ7}e%I#%S*T*;uN|p~rvpB9^lv-efJ#bJ)s8 z(}RfvtC=I-B5PT(xUY;Rx-Gp!22la*1;wcRJQ3ak+sM&Sa9f$99?{p~m9T=O%>(th$Ivv`kzUvoHQQO3sXXUm`hqZ#1+(jskI?BuHuP*hW z`k`Z5X5tmNXexCktIrrp;)~cn{V6~59d^jlCAkh8->;3pLlog>c3eZFS{c{WtS*UD zm&K{e<8;qt25%hE+jQn}p!n%RS(SbJjvh>Z$Mj91|Hckte}}Li6De&(T-7} zTY`e0qzbi{7Gh9ZYA?0s;ZF(vl$2BI4|NLaLG_tiSXNSG%j%Prm&|0v>UGaB`C3|N zEv_gjx*ekwvb_ExDLl4u&%N*mHKlwz`dZ22tUif=B|%n=3O04|rL4@G=y#E_Qi>gc z_JuZ(^f>(or;V>=g10XzT})TzO4kQ**+BA%Qpa#!!3k;Ci|R=4(}zwW8*~Q-Y$m-i z68)&N((pqA4hC;sSOfcskwL+c6Y?j<9EI}TF|yaK*?6FM2KE|&yO~0VL0~VVc`Y~@ z9Jb}rRy|c@1w>tnC^&TS;kvwDN;>Y-5Q`-?bh&(7rnkJZX;xRmc#uatSd7PFjQ>T$ z1B3JE4U^6f%nc5@>>tbK_>d>LwsQ1$G|f|`Y7!OIR=kikhKB~u@~0Y@H8W#=#^hP- z-hoS3pJl>{2};;+sa4T1O`pi2TLwoD*w8l~V$ZlKsRy)oI=^URto(+bdN2Gjc(;VA z3)|snIJC(ak}x!Ks0_NzV_9=@it;MjOx7Z_ieP?PS%Zx69ANT9eg61cri>nS%lwEh)K9pcjDteH`D0u!fu&HZ;tT#rh;jeXS+O>w>FZL-EEQ zK@MA<=n?-^qeZuj)akBs)}VMpS-%uJ-Tv*=5NosP0n-rai%LJxD`;XAv+Zi>MXu9 zOV(3oL6{!)`?mDvK9m_!$q+~BZoN9H8@)IAmJMTAr$T5H`t9{)a1M21Izhx3we21s z5}|(=J)cL?J-?U*>RDWY?{q(AZtrYnY(E<6l`rtr8=BNl66{5JLC+ z|F!=VC2TK;-Gk1|!*>$aYx+n1MfHmN4h#}`bZ_FC-Yck8+smi0BnUro=h%FrYsC?4 zx#OUpm6R=^`;*5{8BcWC{YeO5i0^8ePjCYfr3dsu{8DhvPff!XZ9ik09wDc_()0!| zKU11s^$twa8-4w})AU~c_-YEoAMYUi@d@!$WA*JDy#}bhVQKBY5q>^tdcP<<@sGiu zfX*Rl`oOOE)5#p1rVon4x8QjE3F(DDp^1LJY5K6dW8Zhml*h^8XQ@nH^3pf8&1$G1?M{quiLRKxbD1i3j*#^uZ7_PQ4nA zwOx(Wp!6|@nAVz(>&Kc->c_Zb(RGHeTKD0L{|q4#p2L@Q_;@U?;9|lCX*gvWRS8W2 z(czU&B7coVR7jmdt(~1ypl@+n?;!HkgQ4ny2aH}x`>VZl`k|LhCL1gcKL4ZV?*v0% z{ExHei@70L2}s?bPDCdV!qfwX=`cT}#AW2n;dnY-+xyv+R!!1d|3-NpyGfL(zQaT- z9k4ZW(D-~x@F6P9C%7gcd?x}KEwNN$mW8jjJj-P3WK6xs(QTT8(@&=Jj&qb)EBMz5 z#TAx3X6l$ZZG!6?`VODpTWrN-2cd_~Z?1=kl~ZV$Tv?Q3E3?4Y)MjA^3|hpgSEEZx zAbX1~m_Z;elVzH%AY*Z#`Hy=U{CsCDrOstm!u-z6J*V^)3EhuhA2u6YunnHdIsKKCkjK> zMRYk5@YL>DmkaijS)yUzl_`3tW_Y{lf*883HY9Z?#vj(1YCCXl96;+uVzs)c8uz4r z@vY+(SC4eK0?Ja^q;pFJ<~8dZNTKy#B9$f&o6UHnvq7XINoH7k+=@f(XA6+p?j?c> z5d+CgkKUqe)Pk7lOxxdp_Y)|QM}%6j3hP!jHl2T7?UIODLpqLkA^Y7xadv7P!LD!x)> zI=Kw~$|nFWiJW1bjIr%=TtYis7BBQx8Wu@CoPz&-h*9{sN91L9FtGMt^vXRnutJTa zV>a*>w41PouG)q^)>fJ-pIiS#a!GiR>x^OvQ+9OpXT?{hhoSh+iu(iU8IM=S5^$y9 zoDPvK0<-xkc_biN&(geaoq@!zhP#GhPZn zHD0$k=+lb7pbpJ-4%b{+gVko2_=Dqn?fFZ<$AKXBa{*Fzi+`|YukNM2)Oa4>uX}4h z_QIyaqZ8Dxo9uKv2oT8@(EmDI^kK^iEVK*`%^0cIMPqG&QD{V;If0Tu^}@wh@1_R>H0Hhdo3m*O%|hv5Vto>4fR}xbKR9d&KYzfV9QqSSKjk4N z>_qA;N{}nTC$;U{HJjn*zG#*dAN~THuD%5f6*jc&<0h&wNbJHAsxaKkAA8=HaK<@h>v6|N`aVXQ*KqbS+bGugpDz44-8 zd2r8c{1EdF*D5aS#C!tz6YLLlnD(+z6gFS9P1Q8LYD%_}K(po61h!}uCI#1^G}KD`iU zm6a@#uaOZ|9d1%5uyY)yZGB@si8VIAon$SekdZXK^4-;c7;%)}w^_?!M8+c_A*uQr ztPi}aD9_?z9EHh3tY1li`!HUAj@mgsyzZL1Hd;RcVEuan)F@o4BxDs{eZB)E!+I32 z-?u|RG62z<0#*a^f)>)zj&X;!8M=BtYlgG|ad@Rpxo441G{OuYK|c(1sR{m!|9PZr zDuuRB-~pTIKJ@*Qv#58LRTgX5<7%ay@T|#Af5Ds97m?)6OGL7K^w$>a7k~`1LB7?E z^N%bXd?G{g&`FaLPleB?^%&^++$m|oCmR`bD!Qlf7D7(34^7Z}JrPX{c1lTpzR0$V zyl0m2mh};kKKM`Me+4O{Aa68(e^u8p%haVHiKgUIqBInwlB$gVtye)aty z-tZE1|6ffi!%pj!oWJ#Q(XB2Uv`B?>4M*IdLg|r11!or*h(F;@o*a&TgoU}k-iNPd zudmk|&H64nW7ITQHCQ{U>8g&>Tc3GDr+kWw^@o}c>{lU9UedNxt_Q9%Sla+ugG1>U zjGNK4a}6VaTO|;qhwoS8*}B>yiZF@|zZuM4aq+Hl>O|&T^z|I9+)zRB^4)_UdXKPX zsLZrGnC@Npd3F#n)J%Q5xU$r=%HI?a#0yf}Rn4}pMKrNBUE$jQBs5Jw6?^lpkV!CTQk*(9PR)p;YMFKHbTeri{Zj|0_8Wu@9M+MvIe}Z$ zOZwuX*B*OvE%QCY@?AMaa>al=Dx{t|^cQpA)-ySTp`u=0$^ItkY?geS5EH{m$>Ceto_e+~0R^_ReAwH24HQ?nY4>#DICM{qQ& z?;;e>E~0QGxJEr6TtgL}^Jct1Rd`A9Xw7mf{F$g_ulZ!gW7M)sirFeGTajd_-bodQ zNeoI9Uw9R$+l+BtIEvpU{ga{oD2u&7(#?q~W=pv|t$5w(a)L>;0AQGuvGR3B;&6^D95t)bG?v|j3P zq~A-;=%r5RrB3RlPVJ@6?4{1`rOxf8T6-aftZ#K3itW9!QK*bCO8a_Af3fQy~Nu>oSm^I7lRs(P5rE z0p$OX0Rp^NMy%gO+wmXZ6Xr- zQzV30y^C(6mHKcfqbjDIB)8ZC1cWsxms|TIYFM|S8p>L6bu%dcB`Lof&M9-t4W~^x z25a5&%zYFT>&u|}5+Z&vvC6d)E$v%C`>LeJgw|b4jF^jmaOLq$BvI!CXBWWD6{-YmhEUm!mP#%uWa3#dgE%Gda ze3OdsH$z8m_`UcFoo8VT>m;MK;x1A z0_U)&ReY&Xu)&WZ8$372`vhQ?U+ZSeqY-KJ;2{fW+Uc;~xdfwkt=n{xUifOk#Gdp5 z*_PR{sN4P=&0*@Jn{7ll!M3g;MwPdS+m^~x(x3SO%?-d%1qqlQKHhr3bU*F}@5chw`;w>#q{rx}PfMVUjQeE@XRpOUn@ zB#6CNk}_0VvIi zmL@f!RKYf@-v+(1aHGs=cgm?&DlG@qwlQMs9 z5_h^|>2e$C9xv-g1Q+PK9gWJ(Mtb6+@3o7*8XIZ7$3$@@Qr#|6^W-SWZZy7b+kwxphcvj$%mpeZc#-EgfMP^bI;>8cNCzGHKc4CBv8*?=X5|DgU| zFXb+?dBS_5w4AHqRz2b-=nw{h%SX(XX-|c0mNm%X4w*w}Z?oR-o=ML%1QhkP1jdh! zhoA0G$i|yOJMbqDV#=kibjqDHBIe+lQD`&A(ZX|_nY)&m%bAz0Imc$Un)Ais2Ih)F zYlXSY2EVuBa@@zE%_-I;?%}9tsF4M=)xFNw$ z-5BMk#(8ZDQ6l|xEuqR`M>{sT`r$0v=x|+&11o+ob<)>Z!x|08O-3P}C8ufh#4O2LQJzX=RHP3`km*E@M5;k(9(-?s^#5oC%Rdk- zSC{o*tYyysT|rNn;?8JT3qK(@e{dx_RM(=dA%yiA!N*Hui`WQ$8c+jHm^o@md)$9E!Y^X&8*ASXsSPR+T#{$ zDvi#6qE+UF`M&A=YqL8(2>!VgwGcl+=1yFC2NZ?S%7Zv6dhmu=@7E0k{6S@sq>jq=+|M&;b=vX*2oV3Ty-3z&sN z_JVlRi2^fY6)lIO7X+mTD>{9zPV{}Bsk0e;M1^u;grMjc(H}?6eI$huDee{I8B+%$ zqCPXU_31PX%FRNRiFi}i4@rUG&EdrN!?9j%vFhbmV=I~2AqW`X;rfLQJUUfu;PFB= z9Cln`)v(c*e^-64YdDtt82Tmxj37VVOD0nLBmzG$W0WWwIGiYM zL)2>TBy#DzTLOvoLRy%R1E323HX+}%wfF>TahH^DcO-HrKz0T)6@N8jZ~ zcPmX`;_;IRQ#&2c%%-FLe)21Bb3L|aZ#TB2V}*Tq z76pMrg{^fd)-K6Hvl?Q<_A$jK($a1Q8%A+1AkQwXQKLi>`@jb&t^M#bHP@ApwLICN zyq9X=nvWWgS6DZb3e##e8!fDpL3xjpdRj;7dqMqE*}SRi^M&@XdS~?}*9rf1ClOu*w^2W? z`>Ve9f8~2|pR)mmWtzuo8L@MqyOAaXIoiVHl>N(!(-TaNc!jUPKltS#vV<<)t=pt_ItUDiv z_nEgFPBlWtki#XV}a73XEi&sVP5+T1y>|CvY_hb?L7U4%(#CJ40O5iM5glyPL!DXIkaS3gV zwa_-Da{HY&d?_!q=F$Jo6mURq8R%e7WHJ0Nu~i1H$cydd`^Y^3q!VNwzR)@m^2*Y~ ze>Q881ICirX7A;zox@bUZNm)UkeraiGeHJ_H#S5Gjy-IKWHUnp#jT1Fp1Cgz@Hhql>JuK^) z=~HMOmEP7V06Z!|5>(d#bR3}1B*g*P48O{%* z-{sIuE%|U^NBblk{nyV@*xyn(z*2aFrEs97aFC_2psb{_)KY9+i0Ws1>(G`LTJq4) z9hSTbOTN7z7uyA42%)cV_^_1Pb7}XWrLfFmFDgK0EJf(lmJ)}B`M6pt9Tux4$70RN zDYN9{*>ROv@HLk_g~{R9LWT@WUVgE~R%EeT7UblCK-mJz9hS0E3;IJ@MXsf+GG~be z4boavYC-pKz*n}^T8y*N%1R(b$}4klm0Bw7MK(*NWudjqvIr?K323d%vzLG%p3-JT zwA4IX2~x^I8|DkqnA+K%}^m{UIp=))axE5O-W)TQC^VZUwj- zLlP{)U{M5Vh|0)ul;keBqY~}IV$TOlY!+-+EU7>f{ANnc<_tN9CICc{wH!^`j$LoX1u6U`mJtFtaCk1F7g`IfeP`gfZCqS2>C(G{ z(D)HT<8vuAh*C!fx1PPTL5|z5Fu9@-AW-jsqEGZBUCRPk)He7j(UaL%*R;+x(L%3h zpA*k`DYsz58Frwu+&DLY1!4Y2;)OmqJWgY?VkVALNbQKsBfQX4pTE$OgjcEcScbv2!YWD=KDlcpaq`PB;Oyv^;=mg(G2@lH=^~m?nc3j-K3_g7!`NUddm?nm|fBlwAR-qcT(e zCS#{;s%c&4o7ommZd0V0<0F~RvB{`#J!n*~>YF^b#<2G>NqsjQlhg#w`dEhbZJZuC z7-#yirbP=nkM+AN0gXwiEY5+NG8X$Kh_&Fgc>epn)E9%OW0N+;g9g>dXx} zltaosk!4wFY-;?+`^dug>kqV%)5jcyZ%9qfN|_&@HFqw4(_pOsCH#4kN%QB!V+p@6 zEcoy+|DB7$xxurwAgyLmVp=|y>mg*up`JhVg?;zZ1f8p?bWdZ~kxOGAz(ckj7h_U$ zhYg35z=y9SA3PKY7wh@*9-ACySl`6aH$4}sn0nBr0cqy?_H^*7--2m!r#G{-Je~ih zA+@h%YAFBaWs9Gq^3O|2Va}PiZ(VaIl@0ch?sjakfd*Gx5sz{?<(=wdvPLh%DNj|R zK#f>@*J}R%LK5G|BwTGz*i?vVr_)a%N)DVSY&i>P36&}$u5kOUl#xj#ce3BBAId)g zLfCFC6Q@X6Zy?bn_lSfukg&GV--`E{$q_K!|KMZ|rMG(7{KqN1ta5C%W`!gAJ8>RO zpSpjbKOgkJl?9`{#;1I`9-}S}9ih0KE%P8@Ot)T4Uws!%DEWX#u2i^BA!`1p2#=$d z=>jl!eFo}v?aNM7kxmdE8O{A(Gn(&cV&KhN63x^FIM-%4(`0rnKQ)kMm5UfhUC%PG z8^CB@_kz)^tEJvK`rr9MWIg3HMzH~z@<%lE4_EA>sVJx6d`2WdH+uRJ2%g&C$nx=P9kFfDKkrHZ+nZT1|# z5L<=~URZ_B%&luW`Vz?=K0eXXG*t}ekY+^ztG|mB5&2;U65@ZDgCSif_uDp?hHNTcqq-|u-IJ_a*^n~~w`l!`n(BCF zrvCPueVwT~tfi%F7kne3?~J);ImzZ+7@gRS)twTC5IIVu(R5ygOAt)UKbO>y^u?qE zZoqWXHQC4UpjSv-K0SaB@;hHySWznWN@)kc|R z2~*Qm#n)sxBUkICvU$?BP8 z^?b70nyj`bt5=gXLhd@N7^=>q8RAzNtuNy&obTj$INbQC9cvrWGJbMvX>e4Z>1{Qf zQHU==U{V)g|-AkTZ#6R2XwLJ=3Xo5$C9mFI1j5OLgoT>TqA{ z>Lg9XYmu3cu-1x+k>=R7sy{<7{7IeZ*}p@7`J2AHSrvBga&}gWK3(a{vdSB|Xskk-44g%J)zgDk^cdKc%i#9d6MLsmUQrJ>{HQ4vJd`C+<3wwhl`^ zby)u3yHqT%{gQb{BAjdoofRPUQihm`k(uRh?1!(ty&t>4{I= z7k1!*F!Bcyak#mmR67d6rA;|4OUi~WZjCzmGg-m{J`MP zru?cU9OW7!!~(EJgO)1@sUSEp80F|(?~E_^@)Kb@)`!sw2WG~aqhG3?3R}0H*QCfq zKZHDTTgX_0O#CJ@;jt~5#M&P({WzLlz^>y-s6`TMu5rTI8oS{Q=c+VSsK%;K^+d~A z+6jT6W?h1!Tnz76Ef<~%d*@kxTu>F~-h&nb;$Y|k@f3{WHrTtv2Lmbvli^? zR&^2TYvF2mIJL^UmPtv}D(BCKMI*OxJ~sObt%OyrW(qv3(v}*}o!1rXU9m<59toV4 zd_tkk&t~N3tYjq^_eFS9JqdJ)XKdR@-Vv86J-%gfm!-R5nCUfLQ4a3uFMU7NG%U~( zTNt`h7Z^WC>9NBQVh%C)@6mN>J((+L}iDEb(~(&5xorKn-0Y=5eANfR<3^MI#OwoOvo z#vCOg_KhJVhO+L;x+@V*si{k|%0^}tCnb+e%37ASOrdR%tB+n8K>I`Iq@?yv9yu@m zu4RcyOXpIv(;{s#nh-@pH28cmyO-yZiAmo0_!F z|K@C}2I|P$k8l2vujWAo$mObq8r~KC{+O<=wqBRmybdy*`?P%^Wex-<{NL2I$BfQ?Q?mdaCTgK3Hk^Z0I^(Z{I#hKozFE-6fk zX$R65QI_+fhg~1Ebz?J2CO=m(a%OF&||fL2>z>}Pg<7Br;e$^qvgUr7;59DI>Tt_rvoEIM$CEh1qFgE3yw z-I`f3=v)886Touvxk;RZzi|n}Mr8FFJ~ufD9gJ=cPolpghsNP?+}z$tamh;)@HGKn z6Oxw-%>Z)^lBcJ%K-_@K< z-H*fx{eI}nnXl3Btf5IGO?!-VE9T9!`2?AV2@>`2{u>s)LOLR2SyrEsNh3I^dFKYF z6Lj9NtUlB;yH>4lr=B@y-iW!q=^e~3Mx6U<5oyWuhIJo1Wz3A(nHgq!oQ%iJV)>QH z>j+`+JPSrYcJHxW1{~1H@6Dn2P}KLTYmSnX6H8fQjZnA<&^tGg0#7TpWG^J;hf1<- zuh&}2VJ}C;jizufx;5yAM{yu0ZWZ8G7ca{9Xzz2~DG$A9-RMTBO)tP94*L}S{(Bc? zqZbzJa91(CYgAWtH%($ZDvP>p3nSAb?MBlC_Wr4R`|V=y_ZX1I-v7WzIluhA?Ov*+ zUSPPRVrfCeQc7kih%Uv8NjK^&nf9IA-@Jjex9h*N6ak-?_Q0#GHg*o3#-h7oUj|zc zA{oU+ASq7jIxp*sLy(O$A@4l**}jCjy&&a0syDEqmc=TYm%en~LijKYMMkLFSLiy| zkqVESOX=CrrSsr)oq7A^zrM4?;eO(rtn#esb9-YfDo;k??8Qq<^4WLsAPIC(xKCFO z+DFrD3%ZU4!`57MB)qQunKUvU?}F!RR^K(7vNkU(acNdkJiGVpg|6W=$()xpC$)Fh z+<1ELwrM$^Qk4x&Ozn-=*mR_;d1e8rxs=hYR4NNuOol4d3FOGOTl z-{I(o$Vz+?O=SX4ezAyQ7p71g=ER{e0iw7p{l8xy{x)mYS!G$p7*UBgsfG1Jh&OZ0 zS@~HN>_IZ!*I(%pPXie^Ams|9(K0BimdZ6B>y#Bs<}(`az2<9R{9Rn+C@vp5c{&1S zQrX5O1u~U-9=n75drS$`ly0WAT07x&rqH^?Mz?VnW{+k>uxnN)b!)Dx*JU^6BqBe= z6V_R%9SnQFmby8ql(`i=`uG^w5}Tp4H>+KGH&X%s7!X`VFWJjy7GpgYtBaU(!2Jd@ z60q@)m?eFQ92THQ+itPtS4@HD2HvT`a$gPN$<{!NsA*E$Q`D;|^)vuBts6Iq2Ech} zOpD^@&rM#Mg;tV;MwOLBVtDw7rSqg`B-#ub8odX>I}#7G5?Q_H&m3Ds777>g#@=WW zimoto@#$4PEm=gL0zyM5&X0$T1ObxoXbT-~F3p;gzy$rsgt_=0$K?OWIQovdq5nD} z<|g%y_jI`=Ig^@J@)xNQSV2~@2T^u#bK1M+g8$Rnm%!Orh5w)Dd1uD*j%8fiz1fBt z$Jm!tl(H6CLMWofG8hbIWSK(4U~rnUOJ$28LYAhYR1&2SN<}FuMWs@dsdWF}=e+mM zT-AU1eLjCa-#Op2J?EU~EblqzJ@>rgh?nikTPo};mMmM5Qtx+GSe7H>2j1-tPJx-+ zT09V|=F^#X%6N>WwMy>dImX4dtvL6rj6kEH=HxrYRjvX3rdG@0A_TX#49B|+mE28y zAY??_l#3Eve!Q359RzpF;1(IUgy@AYJtK7YW3geoC2d&%O60jYKV}!EEspRD)zW-V;o-Md2)t$3VtapZTg)iK zEylKh{d@ZylHsa7j!4K4NJTl*@1ELMY6))MBHP}Il>nE}5;(tMGAyBmY|*V)h+3_7 z%xw}ib!Z)A2G<))KOeoL)dJ~qN#2i-YK+D~HF@L>tARh>ok#N1URji>V?Mbu{)&Su z<3qdB|2`FPu)tMa{%}@}f7vz8AIEadgKIy>K!@HZAMm!HVdp(eG$zJ83g`w92h^N*>=0 zhktyVJibG5LtgE@Lv@H6U4x=A_(4-|j@Y_Ws#C7PTWoJ`vb)7obLO@e1>#CPTyTHf z#Y^jkcC)$Uj+J)Wk%nV*a_kH@5WoZHAiwLOxOP$qCh1sjSF z_Oc%GI*g*FR@QZ!yH_4!@!?>|2)??gqRuoF?}~4XTO_?Z>}_xAgTKwHjsIxQmoj?_ z2SAP`x{5k$<4^tM*Qt@>WvVXzOXOC-(w*Npg6F-`-eDmvzdZA@QKNS4aK1f1Tav~I zyHp}Jtv7eU|0H4)M2tG$P@?WHoqf;$Bx+Mco%hez>QOtZFSf5_qyhA)I0PTRMHON{ zW+codi=yHh*~yi?kXoMBp$_A3lnl#1f6irthF*%F!>jLJ*gv~=vvbAz%0I35zF!ww zkGAr@yClt8Cb;t3{{l4YE7B10&wfn@YdibTpm!bncQ*?8s(H0y)i-rw!y6FulEvei zUslKn>D}CiUsl*HhbwT}7~XP_{+@9mQ9|_}gs2DaihD=e?rQ)}yrmA6Gfz0>g(Ej9 zICO>cSaMEnupHt`8HGPMvNXK@z=;EKL~{_Pr6b`bXP5@d>kv7*g~MYw)GvzoL7M?O(;l4;*E^}|yJ9G@FDUiOgiG6q+s{Z_o#@n{TUx7aJxZ#dCCAeG&J&}1pBl6m6B zXCC`Pw(vr^kprS*hSr}TH>caVMxPm1;_W)k)j zxud#gZn^aBJ+c|2G4H?(13NR5`}c2{R98=~XDT-5xKdeBf^9;u!Te;B6B9 z<0#J!i1k}2Ryay{zh54F*uN~=ti1!b%GJh4TnZ&cZq?ohNxz3A*>46#<;TaJZ9W`B zX!y!m+ybX?exu5`p!`@!N8wsB*3rgc)-fi^VO`8bN3kw$Vxn1>FvVh6mo&wTv5qw* zinA_dN|s<<+PEcImoc#}>$0X)EbBN^x)kejrc7zpK2x>~>+&Y9EbB_9TpVk^@s;Ca zro4}jnhNFlh^bhCbq!OgBI|flxf1J|#$TCrEfetb`{ud;>)NKub*#0iT7`8TQ>`lN zBvZW_>xQOAb=Hkcd=1u3OwD+H*VL-X2TVdO)~!uq0_%3Bb|UNcM%QM2x2dC9_cBR! zSobq^lUNTh_3E;|-_)%DumS6VrcpzF+ca*(dXQ<-nDt=Ov^rhPlsV@-$ltkccy9av|WJ8tK| z*QVng9Qev~>d1Pcxw8}NNv89itTRoQ&a59YUAwS;*mUd4da}8z8|x{i`(3Q3njYO* zKVo|JU_IU3-IH~;>2){j8K!qH)-z3?-mGVtd-|}>G56lXdba6%FY7s`UtiX9&3*k? z8`J+j){mM2{aNRl`v&H#<1FYwnfyu1rn?VCvFEE1#v0i9~3}(H^qzqxb z*bGf!y~GR~%6h38K8*DfCUrRLWoASw>nF{~5v-pwqeilR+N6zQz1)mWW4*$R8O?g7 z89RpcDw95z17DhqbPk*`<1#pK+B`Up^=dQzK@NOjCX8qOjF~ur1D~5o6Irh{nUh%O znTIl2uQLxn#CpA%{4nch&6LTkH=3zaSU+bTnaX;T$$EtKW-~2|1EWKU-WsU1*{L6MGILUGK&{+;DlMSnDsHUbO{GO zF;6Vzz{h6U6RbZpPcGxYN9L&~Ssyn~KgEILX8F?`_|U9a&iW&>as}&;&8n5GKQXIU zu|8p*S;n(fi;X^Phl6n6y%t~aAybrT7 znWINw2FM&c3iCQL9~^^Oh0KQ^z^qE<_=hm7k@@I2%<5!5{s?9bGM{`5GoH)|e0pBj zBy;iv%vxkVJqa^`%x9m%tWD^O=K?o0J8;|A1}acN#>^?Ik3z8{1a>)$Xxsx=IvyDxd`(PGQa);vm=>H zzryT9<}yC>tnVcA+hv%Y$>4)jffvn{-#L(P3NWS7J<0r0z=0RcpMP**hxzMI4s179 z|Kh+l^Y>K_Y&F5ZIqH*`$m^c-#b@QznW)0~?izrYMjN z%EVy8jYRGye6*5q`MJ`)K#Nl`q4$86pyERB1uaP>g!Tn>sU+gBQzjN4?SNZ9xZ(a+ zq4$B7rcy!&fR>@sLhlDHOJ#&U02)VS5r2&`qKZPXfHIY-lF*@`eyS{V7-)d}LWhH1M**R!pjGHPp(8-6QWc>iL90nQP;xkAT*vdeFj3Wg6fR3EZ;b)(|gBKxcq9 zqJ~0ef;Of`LT7sf+QB$Fqe3wzx zNH>Vv<8Zr)ZWKBXv<2NHbUtWHY9VwX=*`qp=pxWt=w_j~*}}ALK(M(7UOp&{siw(cMCKgZ8FgLSF;zL%oH*4tfvu5&8z` zy>ySzJ)nK*UZHP-_M^T+_k!L>{e0T6D1JL?9-#YChFoQm z=>d>Ol^ICMAaj)&L<2$QC^MJ_N$}4RdVjs{B%!gO z4^gJjQlJmhLqbb~PNs*2mI0kYlZBQ8ok~-L;_Q-ngr-7y)0N4hN5ri>+@?_$XyB2c zGSg|A(5ax=G+hEzMt~WVEv^s4btcUaS3g{5(M+K@oNsbymeA`!XH$;QDxh;{w$KF7 zxim*87O%$8T%ol=A0;DHgXYqspn->w#AB2zG!yi3dQ1Y;MSywqxX^l_^J$*Y`k)JN zRvEMb=t5c`v?1ssS}3#;=wezVv@z%sS}e2)=u%oDv?=Hlv{Yy_&}H<5(Ca~;q-8>z zgFZ!13dJ>g=4pCL=#8Mu>1m-ifv%wCLR)~Yq!mJ2g07;KLT?6LO{;|70{RTC7TOAQ z4Lu|DR?xMyM(Ayzd9+q&YtVI+C$tUddRiy6E$FkfUg+(h8|Yb~cYtoB4MIDDK1Umc zb^_f*&k4N~bTe%d+8J~UZ5G-E^m*DMv>WJFdS2*VpxbDx(C(nyX`9dGJ@&Bu|a(M zlvS;rxbI!ORI`lWF5EJwop4mo?G;=DANGHhV$lcu<*nU^0SV&ctjJNG$kLdxg}pII zN$MlTrz~c0|9i2oQ#rJ8mHh^l$I4a*l-WZsN--pQ0istxvsUI!dMVPe5*oP5-b;Ro zQ&pL_NJ?24CxFSHs!b$U*oDsYoeOe`aP95<@wEJ~4e>1ff zIjQwI-RZ?ebNqtvl16F@{50VOOo*SM?%N zitz0<5e61T7_20?Wc?grUkn~zS-+wb8_4T{mx9BTzA+>?`#hyy6LQ2gAxELL#wh;{ z1Hyv8BYF8zBzVjfw3G%Y0O66B1LJ_BKh0y&{5+1OpiD}Pa4ZhG)Cf@K8DzF?bP6}VLe%y0B6 zdg{%RV{8qF+L%|I-)Sa>dzEm7a-<=ub?p)03eE8(j=YElhRx!&4e{clfO5Sc@d#2t zk9$GTHvgdc5y2PYnV}N?q{RrV@=&|A{-mW5{>vZ^+yB;8->R12NSpbKcFUlIERDzr zK7}Vu8GV~FSLwAP*X4M;DDyYHj*_$u51!~)QgAzXuEdiD>o9%;0q(#$jQ4GOF1Y>v;h81KjLn@Zl796CIA#1BrImLLpghydbao#K8GlC^}hc^s$Ryid(KkV=F zTb}`6P8r}&pjPbft?s}$>LWi%G)b@=_F?0=1w zR~fy%oZeAth<l>CQnDn3klMe=ZO0yQT1r_%3V8~*Aw;W0D5CVWuoBiDwbrr9hXx-RBTJH6+bq%*MYxe;Z4%yNx-{v} zv8d-`DDSB_h+WcQ$A4vy`!JE8 zfXak|S12@}FT!z9#Lui!BPJsO3LI0RD)iKSGgtBC)VhVMfsGAT`obz?q|DB0SeNjG zxF+e-s@bt%D^9R+{HJXd<=o1($r}ezOUKZ8#{@MNqqp$~g+<2vDxoze*}~$@bgkB0 z4t^cXJnVzZ2GryODo{u-@FA{At4aa8Gj23cH7Uk$Xcd&&JqSU>JZ?s;MNaes1u6xN^bC;t#(12~!dLxtVXgUFvE>;WD^?ge4V zJe2%{gbn23{aRQGk0tjjVM95C+>eD_z}|v;Lf9~# zK>lOGhVvwHKM|J750U?QVIz1lxt|Fe$y3SwRM;raBL6mFX*`|WkA#ip8RQ-pHil=B z`=PM0Je%B~g{AXca=#Ro!H<%AM%XxhjNH@09^`rCej#i;FCf45oxqF8|A4r~;4%S! zvapH#1i43rP2wlXJt8cVpCNat{f6m{*Z|P}pRChTQjrP2siVzAJ1huOs(> zut)e=a^De_#T&_eTi7(-MDBiJ(|HTI`-EllR&w7GHiNg5yI0sueu3OKh0S8zz#4iW zzf6JGE8S{G3oJwmFh1-eeKuB~!$t^yRPBO6%pYrMENOZZcyqT@i9@@GO3#XP~Mgd(O{#-9r<4f-U1 zArxb?d5TX9Ek&WpA)c>?=@TU8Be{0hX39LxxVy~e3)8CQD2{TGNAML$sVLY={u069 zyb4LFW|uKzIvtX*n!iFap^{xj$-X3iy|Ajw^VgwZ&wv#M69r&>R+x)5eAW|xfzCxZ zujOwfb683s<)Qo?GUxFz{6itn;~xw8I{rB#`g;D>lRBDzfj*w)bD|GFw7Y?^PJwn4 z!8bA%Bj9)j%y^D}qeQH%A*3-9mH~e^n#k`F_Say??q{L@DcG^^S!h2AJ9az^?VrPr z>HmyPOq?h>$5sR6de5&`(g2xDd1-me`LLTe0DBucAvbkhM(|b4|=BhIGKDt4@Dx>i;TU_P^dhvhz+ZkP)WA;yv(x8xs$*5tQ}eQG8A10I$;<0p3n^m$pl^=Q@h)f) z`=Hm%)4ioFLfV?}CV;OHw#cNV`rd$vvghpKBoRM4=)YOD9F3JO_C-^qQlb?0LjMN> z@wU_o+{+C;f!M*~pQJn@72BpEsn{z0KTGxP3rX6~%|cm2EsPGn&6p~Ngka;;mI_+g zBVD5h-^AgS;X8;f?N$oWk^?)#?gt{=v2ChvL63MB-Gu`$hl9Kq5d?dvx)p_e4o3K3 zA64Iq$cOkMil=WY40Jdm5VloyYf`@VVYWfwBj|ykZ9$LnuR_~_9z!<-ZI2Q718$Gf z>Mn)SK8%ot>5}eR=z|x)DB(35m6$8(ZV>np`Z5PzQs!fHWVqe+kHI*+8pQrY(MXI* zl*T+Hv<>=6M7o$d=^pRCvyx2F_HezU9 z<83R?8UszBj}*?w9W@sE=#8=LJI=tUqWhrUzUOhFRQ>(POY%XqPLH4C2}th;{v({; zB%59y2A#+y^?%mNLrAMX(z?KtBgRd4y|QEBl+c*z=7sGtV5~)t{*fQ?GUTrDvXjLg zJIB*)>dzq1PdpR^p0E+`VenRgU#hd>coEy=89tDScbCsD9e2lSCITsrHl^+jlEH|XFdC-{0&+!6i z>=OSO*4QGOofXLQWnL1>^KviGOWC#T951tho<`08#(yEE9ROsFj^B~%1$f5&&ho== zrI&zT;T4uIMSm&as|c>2fS&*0l~Sk6;QA;39VuiLLOg|x|HaRQGVqj_fi>(}c8>FG z2A+h{uJU>-{b|Vgn}d;Zo`sxMB#V1&eKv{^1(sY+|*+hjZD{h$}KDk03$`JI;}s1(FXCIFB@i>#c^OPL z!%8`dp^|4&QKg+-R+XEr&amm8Q^t8ER0GSr8hDjm%gQ>hq1nVagt+MTZu+!zd8QF=R@jA`ka3@+-Xt!<0T~TOvq%FBm7uut&{mDXmw6#AGwo4~miZU<7 zzKA@>kOfTem!f07&4DEh>$tdsVWuQqlwIw#`K5BlS6lgqiqiIwnZI3ZP} z2U|JlS%tP+oidKHFF6+k%cS?&-da#32)d?3ikE`3vK8`kVyAvNO)_h6r4yUH$ zJ}#`IlVAfq7Mi`H)noD2$*GN&kG#DsbH3wL#|h5@BYl-0lOFgVp}PO+@9q@eqg4OD zeP0yc4+vMXhh~_OvfX^~Jw}b4kfy_{91L=II!*0hAp>4#2Zyai{Z_>bgE#zN!gq0Q ziU|K$u;n$Wd$V>d_A&V474Kqs#fx<_a?;hgn2uA1ts3rfZgnK0ys)*SEEI_I zI!;+sO=0s5z3y)9sO%n2TSwO2So>%9blO?|E?VQ=PMjCR+x*5aTr~Cra(X$p<2Q{` zDY;T{y`4K8_fcVeoKCh14eI$Gr*kOKTrW@;$DQK^>ShDYMxcA0?p|ZSQ6HzA*QEM6 zJ*%uu=(TvM?7cz;_YH(k?D4tu!`Ya?+ek)U(F>`s~rpL$-Zk(@vO zz6YP`%(d>=pJ|p8?B^IyrS^?cF0y|C4Gp=}*t5ybavrx~%d*Oz=FGEPwi>28^F!m} zbm=A8&H~#DrUliE8O|bk?u2$xT;okV7TaeIW)-sw?Y4Kj)53OnK4hVn&2*NAM6VRl z3CB&Q(CY-dF%N|tz4bXFo5Jit3Us~z_xVRP^aCwG>x zxlW#g5gP0`t#{m+!i=*4;}pha@FVn`TkHc2X0r3!PnF zDU=^p=|{drs2cQ$k@AFo#pYnKvm5yg`!9*`f8F{ob@oK~Lv@Am_gepD&b|nLsI$=j zZR`J(b0ESWDlYVY&-yQS4n_E{i12^k`mc0wTWn$eRz>)KVEtD+$0PioiSYl}`mb?L zpzbj4XzU{8taUyOsl>$@IaENN^BKHxNDh2IeeU2P1GdgN9g0*3DqZhXfJy_9ftQS5 zqK1+%H!2!so<*9XThzCVEX_s-H#%Q~V~q1X2NUNZhK<2UlNS8ObH(wTP0l%R8C%gF zB-Sw5iyIyM&QYz?gFnDcBtkN57d%_UsP`lC(C$C;u*H*R^YAnHzw_{m=W6qC30(4k zwiuCz-)yQ^;3j$4YHhgtT5J({_yc*sORnr~&R=#Q=pZ|ax+~PR-Ki+*LhzB3FuA{q zs1v~_1}6uD;1i&t325kq!)rZRp3~*=9UmKfJc2t>vVy^BvR)xSjD{jg{G!8ty^+id zPNi@%vg|DeaeWH+$Ycf+oOt{Sn4-@&=SxouvD!OcI72So4 zCznfB(Fa?&St_P@7R6K!p|*sHDmzaV!)LVQKBXOsOJ-$tRP(cLaR_rhC4bRxL7q)7Q^k};KB^?+E+>R34-@uXZg>Hz6VTIEA!l6r@(-TJN7xN;%CE@&H&@3jG2H^oIaQ7C`% z;ZADY;TBo||Jvi4Hm+{VCixAwC$z0(_%F0=j4OL>Eo54Kq0U9GtveQ)3#I;1x2v+E zD`sUyEBU?qfB(ncg_7lAktqzfw-&mw^5V;{f4%?0qVPGSC>u-MB+kG8hh0TlSf9W?pr@EL=5b5QLFrSkb`gzC498C3yZONb5!`t$zF<%jVu0M$-ML> zl$V<1MN$^uXd5@|9uDu7%u8MJ6@^gY(n#2F$t8zg=_O`39g*rulsH~IDUXy$^6a^K zr4#Oj76~Fb3U++u4dFc55>9-Iavz!7qPP;K=)Wh;%W2prT)J>xJ-e49Nm0UiZjx8| zkZcqX&Sz0R!a4EuBY!0wuU5SHUW)(Zl0rC*u&yL_QU3m^H7`Gr8V*a2ENNKBMQ%l` zD8;X;yXMpp-MW6tnl9i)M09AqJKv$qQ zkOt%e`{FA{9S6<=7l92WTSK6D0H=V9K!E_BR1;cY*3AY2l1@Oy2bOPc6&4CU;*91uo zWT22VkZHhtU^S2r>`9QE9fgb&z$v&C0B68UB|;HEB5)q|i?$3`!J=c~3seB&fh3>_ z&;n=!bOL$<1AtT@9moV`0`q}oKpwCS*o~(>$`Cspe^0=E*4i(E6#!I9d`p$89OW-H z4XiivG5|;cl1jBkLE+U(NGFgUKwn@WkP4&&nZPt)4lo~B2CN1)0Na3_z#f~*QLq!h z8Q?r{5hwttG#UjE2c!YxfhoXDAh$G1aJm8FC3!I02jdv0E$D> zKpfx)5`hLl3!p<>tb(Wkps7GQFa?+iN5PO5u1d=5y^ z6LGU(y$owyIcN+>1R4M>fDS-cAO#V}1Ji){z-nL{um?Be=Kr5gV&>I*COp!p#LGpYeFCT0-a0oaLTm%XL zDlhe2syqY&Re?l-M*RRCfZk%ltt-$Q7*HO9Q$bQS$awfp0cHZZz+!P+4U&!!nZPn2 z4>$m~e3-|9^WYa?UWHkq4w@RU7}y5v2BIrK??6{z3XlgJ0L}x^6;WQGInWB|P!S3C z0O<=11X6)?AQPA-p1Ja88EmV8ZNM4eBH*ut@d4-!qyV|V24D|x95@g7DfDS-cpf@lONCVm+epjF`kO})VU=A=JSO%;H5(AJE zfNENRv=P!3q&F}CNCDD-@xT;dCXfp(29^VPz-AyH*bVFh4gtr3Q@~l^GB6%Fh`tUb zxK3K3A1oe70-6A=fDYFo=^h{hgrtI`1DQ7bOt4&FF|ZuS12zNsz;0k4a0oaKoC3}Q z7l6yaRUoa+3D5#)19SpA-5y8qAqMF0dHbSr-A8gX965 zfkOy%9>@pZBe4(3pA)bZz%{-eDqI{cz~M4*wTe6^N>oJ)stV_-Acm&l02hG^uwMqK8l(VzAie>b6OdR95t~$# z=R+Gfcd9lQYyemakOqtgrT{a6TwpP<9LNJU1Np#i5pn?JC~yKe1DppgipN!u=;}xs zr~p(25`iW_3!nqg1LzB+0BOK@U<$CUAyS5!TV49=af46+=^ z12zNsz;0k4a0oaKoC3}Q7l6yaRUj^2bQ_P^TPvV%yrkP3xlV^|0L&C%Id~p?S|=x9 z);Uex*E&U}q;egU+yp6e(1oFyXtCTk1ibp*F0sP{+Vl5Kk( zm3P4p)hO1AhO}<1vLtBu-{=mdLibVOJ2|HZW3R``ia}a3H4aULtz%g%d+~2UD0#PJ z_}?dON-ga$<_~*Dao5=STf?&Z|I)5{cGjiKJ-+Yv;F>yB!C_!x^Ts61|^CYOUYF{XYrD`)6#O}N=+-8 zJ9my^CG)1_NG+K+cdlG%dD2o!@a!GEF?UeU^FY8&e_ z-3bS0aGtZA5IWllP3W&VPUtt+34P`}VK$whDI*5S<#U5AB^1+rb$lj47-r-BI;p#ph0{bZ35?GIdeWtoYtlHR$dP z(Yc2+W*EEJtUXmcE8P1yqaJOdw|zOEe$L3*-x(bSIAa@aALtCvLC#1qwhnfNIAl2g zj+MCJXrGsFku<0NN@ z*vTpvD|Q%{SX=I1HPN%iuqGsO4n z%HxJJL@L#z!8FHM$xisk8B=dNqwyU+J}CcPXE^RTBmF~XoS?mroKg2F$MnJ(^Itk+ z-79DOq>gW#vG5(&?!CItMt*Qc`;WY)pOg<Afp{XhA*bh2QPvjxX37L0MVAcLC)zgsQXOGDh%1XkShu)twcL9A%z zWkGds)s_{18R;Dsh%n=C_7j!ywV*YPrS)`)cBHr9GKFQZ;1(4MuwW9+4z!?BMhjk2 z-b@yBrY{tf*@AjBi+0eUEEWt8vY>BP3+~V#!4{k)k5CKFgjp~?oFAvI5f;3SvLGee zf|0QnbWGse$re0FvEX*91s^G6HVbCvFkFws$d(xwr*)DY%46WP?hoU94DEO5JBg`qCB@H7c@o%BY8|_`9qH zwsID%qpamE7-}R{u%JREHI02}#Qw&Q8MWC~l{sH3U4_S>qra;HRV@%5swv;<7R;ri z#$~p84GX5#REyaMw4jy+pKGh_4J{B)jZdtY*obpz%=K)h8aC&CYhl5DdPk31Szv8# zK|k_tYeA$@n!Q9V+FNj>g9TZ-aNp4Nt`@xLX2FQ=+ygzh4|`eAtB(c0^|Rog0X+Xe z_4{B8<{21bL3e65)Pm;2EqF{}BP=*L)`A@4xOc_hoG%4T;`!+5WWGJcf;KZOcrw$1 zOtUO#Os8k_81pQMUT8tKWfruglgllrx{AkNYr(Pg77W|KJ+qPX-fY3jttw$V*L?@) zPSaPy;+g*u}WdbJW)HI^6@~~o~uXfCu;se z<#}mApI3Z5(@JXc!Gdugx&J;{VEL@(xVu24dAeW`Ew;H}xt9w(>@Ild?Sj%iE@({M z94;6^YmL0VF39NTf&>c4q!QR|#-S`O5L<%PzAzVvyHr0y9b)4n)eAN-#s$qOEY<}% z<6N+nc4kx4bGV>JP8Zb9rTlZdU;w4h>w@7_ynq_ZisXVWXhyrJP$3r_DdK`nrImXb z7j&e0$J6&K{IrK;9`j ztVnLI%C>ZY*xOnaYQr&-XImB5&IKZ*y-MrA>qB)rs(QU#FpT!~=I#2pAb(#~i4}j- zw|*{YJHQ232DxDAV9sx-y2hRzrnU^{ct@zvQ7#bmr>PAyT_76H<#~*j^IR}-z6)|M za6u>9O+Tr|A{X?fJ><671(v01=}H&uSg*dbCpM@Jn_Q50vkO`u;(j`-wp`?OyXJzJ zn=a^j+XeMrs53TKh#X$Z&D#~ipNa*jeu1tKdo!w`SzIA}g4A+Ww9V>@&2)k?1-s%o z?Fezj)=+hbtq|sl-SmZuMyiVJlqgqZjCMs;`eAg4cg0w$kf3fSyF$F6OR35whbzSV z{6=w>idR&xtGPn_ph-1ck*%gHpL1QYuZ|kr*cD8*DMwFNoT4VZT=9*@^mavfA6IOrq<*RZ zo6=wXJ%Hz@`~x{AV?0}LkUGT{8|;cLlrY2<^C;b4t{6sNjfultAwCXQgT}fdXo4#` z&`H`h(G?4(xFTSxD-Ke^3|ClYa(#_DY@=DO7&yljOX)TR&E?#v=6qMgE>Nr1xk3!z zqiP=K=jp;Z)$)QXgwqw}!@6H}#Y6gZ%@rfAyTX3M6}^ljY=@h!ctf@S;U1!2w_Gv% zHuusUwd|oQ#1$Q4aMjLJ)<&7ZdgPgX+W|Y*3rro zH{7Aa+1=0}ryIV~;aqO`l!s%<>xSC-+z^@H4HpWyp-v&LGwr8Jh1DX~vxpn&(n)eE z?S^tRvYZ>1(s2qX?}nN552df*hUT<_o*CIIx}hc2sjS+whv@R}>PB@pe5b*6czqkX z;dN6toFAZ)hjV?YrBP-C=Sh9YF_LqkD`VZzYn&TiOm@TP8Jz!2H;kU;hSd4A$PE!o z)D1TGQa2>M;yTr0y&J?>qwNMah_9R6P<*Q!Tz9(RhmpFE z$ET7;h5c?2@kcqobG+XrH$Fbxu$un3#l7=H9sKNu+3wc=Twp~`PgRQ*^SrE>Ygc_T zSs^CTPI^jHvRJV=NG%MuLR>IrgjgYJg{ryXRvb1ivf^QcddG?vk!oiY&p~se)oNCp zj!`#R@jX^~##ten#;eY(7?+@CvtnzaDv@M`IBWdFiV4YT4qGKf)n|nxRRyspjccqp zl1)|0ZiQHr(~1wdtO(D|HKR{OtoW^{72d_HSYq5^(-pVkcjE$^FU^WQCAhXUs+5|> zt}m_bu;K;vD`Uk2>R49wV;7dQ!nM5G%!&iXV^%b+V8!x^R(zylzgh8y%2&2x85OU> zbuw14;*+uEcPm8cs%i@>mR7f7Q4K4C>sry89#FnNR4G6Kds2y zz=~=ORYUd`r8QDjSn=I(H0Cv+)F!GB`*$b?-KC?aBTKR=jD~1_&iJ%WH&1s^{^siFDn|-{yzMCKPwXZTTyv{s>iM$XocS( zEB~CeVioxhwqoyJR#=8wkztq>$s??2Wpro7XXC_3uK6e{c8^vq$66u!jI*Nccs`~k zs^2GZk5C_4La)hxiV9)HDdW;~D@4^9Dt;#CNEM9Jv#fBMW5q_pXRZ~q7FrR#nAeo- zOI5iQRxH@aJ+hhCbc+>Zjis!(XN=xzg*b0GZ?i%K(pl*a&Skfny~m386t&Na21Zv_ z{JCGPV#U6LD&Jx5BkE=BWJR|ls{B#zU0P0ikMlXjxXX&aPpF}%_!v3Oxt&o(&hfEv zUin?%zQ1Ti%q1&!UACgoRV#*4@-^-~+CR{d8sUm&hBuvs9;t^xv5#KxNDTPxu|>tqmQpUgpZ#) zCK{gU+#&n}RI`lk5TC=8Yq&dpQTs@DWQ}&mX8JwZ9o>x~teBRf`lY%;YS&e(S@Fx5@rOG^x_T;<6|;;i4csAKG*rDCxkDs3R`pnM-T2&u z$7}ZgmbG$+IA@e;&Hd5t{~hPs|C6V^JN~CV-~OLV9o_LiZ#ua{ICWO-S<#1*yKtX& zQ`On~G_<>N^l*o$+Ed+RMW)_rE-Rk)QSJNkxU{yP%GKW;qWJ*zk`+YFy9$jmNC0HA5xLJKQ8~NN#&9|s@+jtEq_jWal6_y<;?YKKc`xB}UE3Oz_Pr5^_ zG`6v#?kV+>72k|;r`-{MPKBQ5KBpw3^94R%QPGR4_+@v9e~hPB_;{mFMzM$P5Lb=H zPu(GgJW~gr^ZAi(zEDqC(eI^lea%1PXp^y@6}OGqZ`>hP7)M!Qd#8$h<@xENahDZ8 zjp^UG=CtXDN^*)cJ)mX-gi$*q^2Sf&M70!wx#t~L@@==3W@zFTq z$Ip}9Uu9xNZsQOuI;2wrSn|cyVbaG`JDbj#k2meR0uomtq0D&<8$~2KG%NYa~=77=Ht|8 z$y&a6VAwa#@jIUnfAV%to@nH(II~b^Rh@M6!~m-r!-|7c)b5EmA5R23R01nH z(LJNLuP4NY3~Eb&C&WSH3EMDGwPVE+DxKMrKVRgDWm!BC8tRFaVQL#IDu;W*JyNA- zMN{&NR>7?3N@rIVoF~LmBQ$~MqYm^lQPocJgm_=n6Zwks{6?`fPaLP> zB|K4``qM-@K$po{(i52|sFbQ&#uH+KafB5Y4c~H}5W@_V_k@Ts+$(UtG{opz(G%hx zWvS$e^TzbwJR!~*3#xfStTWzM=Uk{s4YinkVXUv|2~o6`8avw)V)}fwgsrxK`(>dg zk{5d-_YzP1xzrQ$mwBS+a?YK~ui!OarN(XWgqTHpHmQ?rr_G-DPHx+{2HQQ+ewQc0 z_Ijd#x@-7<^u!fo+9ywl#Wee~Cq94SdVcl9k8ivd-&M|x zHi&YWR7hqUM53`ciw(j(t4a>GL0mGrh1(#qMyfASHi%enhheRwCY#J#;-%$(4vA3!4+*NPu*w%ohC;u6~qSCv0*!PsB6PMdfQn2 zVjDEEp(lkkx1lzzrxq=F3@Y7PRb%tFv0*%AZ)?Mn_BQ;aN*!$Y*2#veooy)4#fDBs zf7Yq14Ndyk(1n8g+VF9JvJAAL#~?M76|RGAC~Q<>J}3JM1rYdN{{NHzLv*~4>q?zt)hD~irj{aG!o?8+rJ+&2m@<62S$Dz}_tF~+f(R;U>EkCiqAty1yq?A12hFXT*vFOUJYTzL^`;^2A7S>m)&d}WMen;`WRiziTjoMU*_}1 z6<$M{d6l2PX2WE9cb)t2h7CDxah`WrvC zXu~T?`=qL{+bQKU_dMYXpLeJwou-hld~Tq<6!^`CEZ=!PnoSFS@Og$_7++Zt@sn#x zmR~lkrCYQHUO3?Fg+~@I6maoEXX9^IFNi;_stvoqSEUQ^g6I^=_vxD`b#(ef`E-yUE ztv<5V^Lk+!<;&-V%k+DGFWjSM1-$T)G8FW}FUnHL3r%P_%_yucR`Y_WRbBndicvLG z`V*?V*`8hy#e1oZtZ?e1 zS`YMs*fLc4O!9*GHrES*^LgDCs4}b=NOz4ntGw{a_|CRn?S;J*yT%K>=@>3$0hEO%W5^d@TM2m{o{r5x4f`|p4|4rtvlRj_q|a6fol8A3sa3nZ2sq}`U}pB z8XHGh@zHR3>4oOB%Q(U2e&vM$##lDPYcDi4I1ZJ zyK$5i#ol{iyfKH(_`wSejrQziivOtcvWw`W;qr;sj1CzW*b1M$FvnQMCVk<$8$;Q* zROG9ⅇ6INK@&N@qrbczjIE;CAQQL-p*LemjB81r-#mVI4pLwFm|v%UF^u?YR53T zZ&Y=&V-bC#B&(hOcC#b9yB&k+ITi9yQ`u-wm4j_TbIIFgM=jbxIlSzcNM3fe!rP9l zK6YHDLk>IQeAP_W;inF=Vn7g&m(>opU^`0CHsd3^JH(EPp{fBZ+J@QjFI5b;<19U- zm|E*?V@J_gJDwOH*}HL^OQLGa3Tu)bC6n#=MwL={ z&Qv=VW>al)*zuLh=Cq?tZaW(0;eGPju{WO`@%hzAc2WU5d<)v~wvZjR!ggFDmm+r5 zq+CULOzKcftz*AXQkoqfXh#Xvt)v~#jDS*{H(5$^9Q4EREMrGD>S7FH*Os&6CS9pu zhf_s6BB-v>f;~!mEAv_#Us&(o)xxSgJ{75^DzIWS9i{fwdA(}bv7B1ev|~;!I||gc zV>N};v7>ZdJ5CxQf7tOCt)&O`?C@(~#~$k1khh_=jd;x)+tH{A$KTA3b;fQsT??L* z-n6zOs*N4zs6bm)h7}9xT05>=d+vu0b_8^^qgy9cdj$6dH8aMtUktaAoCh5sjN)FQ zNpyuWj^^j+C`FIq_~|Yc7|StJrg3(Br?l~QOgEOW87J5=h>lL?I!>{p4!KOVV*@!) zvm^g>KHeyGHjhu0=h!is?ojTzDvcGRXwE#&d%hiiF0iBCLXK?__uFDS{Fn0l%j{^q z+>WcXZ-pIUt5h-@vf7TB*alz-zM6juV?WzAYR- zS-0^TQHSkZ{~a91PF|N?oX2iEn(pO3I>5)`QO<=H9JizTDegsDeVW(ok_u(ZlG9~7 zl4&QMxx(9Ct*0E z&;LY)vQE$JC`h?qa2zkWUaz>{UfYrLjU9d8^SSW@_ufYyhnjt|Y^!mbc)1|MR z?>Da7Pd?`0jeniJQQpNHq_K6s8oQ(BG z^*C?1Bzp7b%e;{{)f(xtBp6R8WY%qZM|`zlRC?` z=;DndRHK_WY~8t5Jvio`T$^6r7|_QX!Tq=v{k<`Pz8GT$cq48Qug4H?bpK2JK8)j` zd?US)a}+-|+8Y_isAzTx`Hb~O5?vgps*U%Ccw)?-;0^J9qN+ZLYd{?*t3^}1Au3K) zcUjS8nz}iI^PQ=pW_k1XGQF{84(B*ebzbic;j~#*J;1f0okw}CkEulV%>^~!2G@WF z-BPEs`ao2VR?&5RAaWQ1oqZr8XdrDg_OZcTcpsw?o3*QoXD`vvZt8EgQFk9Kp$ceYmp%}$ z-mBi9eIQ2tP}7|p5KD~f76-&5!|v^X$YhN4aiEmLf%WvsaPf5@FD;@!{2Z7-k29+e ztQZ#Jzyc~9>cC7&3UgoteWF?64rGXMARy9#QPeWZfxlxN$Pwp2R5Hhw%YhBK`SCms z+@#%k9f&CCK+aMQe5LrZ4s84rK4^z`y|xTpXnCvSRrV6*rU}!MTof zpv5Q$oJTwGaEt@h#yZe&9FIAH^PcE{-y{c`lmBD~YE4lo(;N^@jZUmsVI zEi3+-?cmRVtHnFG7PP^5##Y(MwcX{wI67m*@8&ot4-KJ0d-%D74!9grjoIbK7FPUw z*nzf3IqqZJ8z&sdcFKWDr&V2c+F6eMoC7bY=1m8N-f^JyT?ef99Oz0t?(<`hcr710 zu)`ofCd>3y-yILr$748AxL;ESVy>Job@lP?-%^+k&iU$hJLMO2tCp3=i`U+j$V z#nnh(ER6ESniyX!iTB0c1Yb!h!;dVnm>}%wQ$4&gOtf?Pj zn)CiG{E(%Uie=AH+tz+~Kv~=PVYD%w6|Fj}?yPvyUtJsK2XTA6YC6de;^iteYqcN5 z;Wg^*W9bLIHa}*3V8xk*YVm4+i1BMx=WYHF9}LTOf7ILQ zj~Vou%IxyT3VLAV*zJ!AlzWdV!Oq(2k8%fiJ6dwkAB_(C*}L`QmvS4Q*j^bm{bZDDn?XnKhFk}A1;dWdONRLz>{A=(%nhoy)3ZM4chF+GIy zLiOkR^!RtH>b^TY#L$E3vEKN^cDbZ{Z>EQM_9Q(rK2;5#rN=^J8!L_&DX-E)v@4q7 zKjV96K;^+IZA1o$Y2z~Bpy4q-1Aj+O9bJ?GBJPg5#ER+Q>Kf4E@O+WS9&H$`B5&+BT0J#1Pz!c{| z%*Yamw4gxr2n*!bcmh!+JP`AZJ$VBmW)=v<;i4*Y$w0KBzuN@jBE6-iZ3A(N0@?-Q zH`+s$+6Uruhd}J=7>MPa0#SHzAisAL$UhrY?SPCBCu7u>8x9O!e>#!gH@6obnIC&U8V@ zl{pB`K|#n97KA%dLAV-?l!iqI{RknOV5T%SgtXP+(vX=;gC_awCj6;+!R`KzfitaxL*ZWIJjtcB{)HV7h5 zry$HVuCpS2XBEwg*+%;=L8#na4PwQ3<2x&w_E0NW5zNqQ+daGfqsMSw3 zWkrAEI4cScQaJ_(K_m`Q`B?Fe{`e~hpQzO^)twdFso8MVnH3x9+6eWC6;nnA;pV6y z_>B$1NSaOej909fJT3?yCh#^BgZTS7Y6I)_H?J$rrH7O-DF{ty5&df{o6O@;&=g){ z$~iR%?PwX5pQd)R-za`M_ZrQcq1LdqW^yhRIEx=M5*7qu(n7U>71gExjuU^Y^H!dxIdd?^9=3 z(R#mfJHS0ppNx73gCLq8QC(Q^{g}#nE(qdx<4;yxG>Tseg2;436=6pkM_DoGrrO13 zx)p?3#(Gw)x~&F|&kFI{@R^VmS!SvnY!jmoyWhw#D=S38Jk^vvFh46&7OI(H!4Th# zu!vxYWV%F2(ZQG>8;rhjYAY+!C#Ykrm{m#LV8xi<)NEF?tgLD^4~E!6XrT(R;*H_d zG8kf!k)>5I|4tW-F2)2_d^YB_4u)7mo^67WW=vx57%$mMZG$n|IK#TN3&sdzUV9#c zZW|Li@EkPXDA_R>Vz*JhQ!qpuI$~U6XLk<96RO#j^X(RlYqYd`Fzh{4X7+AR71t{m zqOq~BcQ9X@fyd~hoYr$4s2Vk+3C0}uGBwzs+OgN^=SG!bQ!v^Zf3Z=URS7ox7FBL5 z?@Qgc1!EcAH?nW%=c$cxd`B=ug`KJ)D~=mucLziC*`v;}V&guQd4Dj(utVxGJLs^w zz>2UVYCn7YsJg=X9^*P1P1z4r;&?DZPN**I{gbNj>0pTJ7lV;#P`cMNMNx ziEFCbb*?Y%bId#7HpV%tX*`6(D8(-$?vEd*kORUKkQkh{v_5dslQm2GNW))0u=vFc{N5C~fl zwUZTB)6_#&M3qs?%7#E}HWDj_KrA%YvEqFVJ|e3o;+T!5R~p60!ts>cR&bg4hq4yp&=NwK&@L5f@>7F zlIyT41ZQZ;>JYfB34!NYuA{M(730>0;GS`GeF#Lk4Qe8LgOWCepxWjT6xyn~?+k%x zbx=i}=J;sLIW>b7Zr4=P2O$uh4DW{_5XERYr9D>dS@GP+{UiipfwAx<*PlKcKVOGH zSl+59toUenf8u$ljj@Ln=Z&hLLm(=BO`v%@u3ijIn?R` zp%7i_s8a1hA*<@zWT8E)*i>f(pJA3USZqeVNyXE*q_{ghIGq zRdrd>f)?HgC2v*K?{7*-fJ*q=srmoW4(!d$~p!c9e6!yppf)l0UQhZ@fcFHcpL z6+aBSEev9v5$(leQETG>E1uB5b`|0s#&5B4EIwg?L#1cMU0*dNC5&Gi3&SO2SZWx= zRHHz)Fo^TU^Xy>|Epw>hxxyf>8yoY6K{P9@o)qDj=%cZuXc&Y`G3CdOFdndViihDW zInq=^X!yzsi9;Lz|DjIWHv4>DvwP!_zN~-Pe;Sha|)m6hG zc6Cy}bq$AD)=h0@Mf>h*6DwNvP-oemJ;SlcSkFGB$X+TtJByNfhr_>5IHu4|s@Ruf zFs`s-U4K>iuW*Ql6T;DPQaFZFk!j)BX=I!pj;-{Cip&VdA#$G?jyR(+EB4J&zH`DM zj;>YC>%t-GuUFMJghNc*qXPGaLo_|AhOp<1;>W@vj?=E=;do|zW}BbjxQxT>#FOFp zNRv*5!{>B3=FlDLc}AUM3!UXU7?auOhWk0riE>_0Jz25P=zEd(qdWA)SbI4f;-2Am zB^;u-(VZ3l7|XARLp(5w-VBFGxTTK2;5^CYrE2gh9HQE5)#XPx#4+O!L_qX5yqzK- zY8%a1af~WBt2(U6Yl*-`TH&HTvBK3g0t0D`8{emH)(Et7j{rO(@UQWn?dPe++ae%l z8}42a5S@$xtSDgT*nA@Jnc^K07;KDZg~L}}@{53YXjJu&fM{q0XNW*!<6uApe`7tITg{LlA4A|YzlQ%za%jSkjVE&hyzcx$*ch=fQn{$#~k zBWuG*h*`!qR`@iEL~G*{E3!6@M0MjHD{?ha&pJdxM0QjIJ4HfN@2rXrjfCh$SBG&7 zBUG`ekr4fj?9(D4iW|q+s2Pz6nyGfqi-Z`oN$p}qrY$O9Yb3{C)8+GT%w4RYCJ2lo{Gd^Bg4f=h!VyCR%|q$vLe$ZRhAV! zjg74Ey`pZjV%AM{g%vq&DUaKc5a%B&uP2cZEuN~NXIwwp`ci#l#j;mw8!MK-R$H1! z@oRxmcwqV#}>7P6`8lHjVGcY7M)h>SrKLe@N?y5%jI4=6v_{NH<_tosrQT#o{C|osievN|oW{g2J#8D&CIT{`ol^PHY(aJa) z$lK9}OsZ$rXo#&wt6<)idKpe3(Wn<1jcH-ZvtTqtnlZ0XG(^3^YDuwZzOG(0?iz*C zq9JT0)Uz_t5V2*|O;$WNI+lxuI8$CNtPl;6y|S9Zib}QBa8~?VM@^_34Y8}KvNelF zIdW^REG?oTvb0hQ+C-yx+h{o2MPruHw?{NYLO(Tv6^;9=fPv9yZ_F4J4e@@Iy1gbE zWi~`(yHRapG{n#2s=$e8{=P{xUKzhwvEZco{cJSEHlxnPXozV>`Ag9dbq!pOhUjW! zxz2e}EJfc`jURH{w9h!rikJ*B|2f5q>qhQ?7>L>#)z(Zg5G69Jl38LP1_Y^9Sz{nx zQ@OAh%nXm=@0F{ctQZj$gR4fd=ori=#3)OA3||){hOY~v(h_1I8XDd?Vjvb7%ZkN7 z1eZ{QSrJ}REiM%U@lR=vucF$=iYe8Vy;clFg+|KWnD5hSBe*G#O}U$?2F+t2zEFu4 z>Iz%5rP|Aiz*cGid&~%E9fS2<)ZXsA9p$~Nma*bHWxE%H4#pK$JT+qP$3WyVhOpv* zagG&bAH-k_wRxysvEl~}eiVZ}k7F?JnYzu2#OJCLD^?h-U&KJnG~Tl!;-w0D6$A0c z$oe`4qW@dv^ezUXgmH=$8Q!b<>=HUoUyODiV<0S_R25ddHL`z>ff#CBWJSfVY62@F zzp0Bq`FYBZ*#Deog{zYqz>3qx2Ip9a`$n)Omao4Ti|WQOR-7^dU1A|>8}nFk+wgUb zg(zyYXT?I}8Y|r0R9;qeG#0VqvSGKzLKHIEuwu4xniVeYDnBdQ8H-qP$#C?B-z@|E|;*(L;9t)A?t)8Thg$T=}K7_@s<^pN~?lp zxHfdEyehhd*OK}f*|x?)6f=&pB67RRu#4lM!B^DNJFyUD9;u!|Xq_+|Li zjf0qEy!|5%Vs<@Mt9cy1w;zXz^tweHzkjdlPmP0^MjxleVg7V=c558Ov<}Lp<_OA7do@lgb6e6@O(@8`=HYRpA`*5W5YJobl*vtYpOnqed>S z56v_N=ZS|%pHH>Q9}ls~Xi^{^qCi14mKEg+soSjZF04AS;)~Iw2=7npjG0AwZu(J7 z6)GMNQLKbo#)`US)C*R8D5u_)=boXo+UhDRUKO95SW?H8LHKhq!rKWje$6>6GygE5@HyO)tkoEHr9d;r^p$#tXLWwRp6?t~&mR zhgfNN{ECOzZG3Z1fXHi6&sp)^80eA!aobhRa!cUrEhoU?p(?V%$y52VVv6zJmH=_g zOZE0kfY@yKr%Ql1YqSkafLLm{W=eqAZn#G!K$JATu)-r+jb)$5B;cPoRbpQPL_g!^ z{sg|RTLP9JP=}5tKv<5c&8#?Vls}$;WhWA__oPa>od7Y)_;oh{BJVvl`F;XKl?N*H zQ36CAW9#DtzAi}u<~&hvz9vAF_@=UaPvFmBB%r#n;YR|*u%F7^ng~(MIOLuP(Z^E_ zu_r>f2CC7l@Xn|nWle+#4OV?a5+U-1su_`q5Z8=RQHc;UjoQ(P5RG%It*ppeK-Fc1 zPeB#TibaNV;Y5fn#*1=^5Ygq;;0lQl#VV>X4H6+v8vPn3LX0)iH%dgu#);V8M0M(& z2(ilW?3)O&$GAQ$5hC4i)nP;;M9@ezU`8Uu4kK_@B7d$m5todAmL))mx!Cj$Pn-m`Q2~D-x%x zR;{@L;RjooiCIO(Z8q~&E_el?z7RwRqI;G z5Y6hS&TMd9^%pC$)l=w|3{l-^#0u};s$!pHh`oK)$N|X^e+*P@SP?Tw?VFGcF>#_= zz>21StASIKA*xPOjad;eUDckM4AFC;8pDdot5o+j$q+**WvyDdE*Tt0aQjNWo3=wu)9l4tfvF?o;`<|btnN;e7n#zhZ#+pyb z5YwDe{^RPL0#U$NZApPB?5d8k;*!zdEd}C%RlQ|}i@R#Uis~L}u~!O2pj}0>;;iBD zNr4#XP(9M8KupV^7PFND)FM_y1gbYtDG(Q;Q?M&m1;+6_G$M!k!HTH7>N6|c^Qn;h zDG*7<%?qjSte9R{EoJ{xl%?;6N3j%$jm8^RWG$gOvZ9|6S26{nTPd}T6|>8# zAC)+6I#XHI{5=ICUp2Lc6+4Y))l(pf)>M^P(ZD#&iVd~Y<2or2qyJE2>!(0?{HZdq zVxQsHAce1OlY%nF+{P&oA+6O!R?MYxZPbIdycX?Mbf*;l8z}{|`lwz*Q}{h^&dq2u zCIzDKSXGG?)yJuh)3|<=HeFR^g>{DdGCKw0#2j^l6=UYAj|);DjxJPJShpH#!oDG(RGs8`=pAYT7eKUlH!mkLBGguj!j>6!}BFoS9kkP5NI zILL~2fog5WREXP|RsP^qi1Eg3R+I@*BSKRleub;TQK@{rs#N}Ljhf4fa?xrSE2<@^ z?8&JRMT}>xXpy33rKUnu%&rFIPK9_cBNDZ*UG96E1DbrRk+4f!#MVPD#VRys$6x>nQD@yhN@GO$Dpyb z)alx(5Zmgh$Y!Y!gNzT&Qz53eRIgd_!&urX72#iEGqOFm!M=HeJp31LxD#Y~u>NP8V7)u9mJQO=f%^1w{(eq)d{_s?Y)<(dH zRETyX)q+u}5cfu_r(;tgPW@j^cL5#M)rDbr<5HkNaVZpcNbnfZ$xLA4K_gJKxE9yq z#hn7dDQ?B3xLa{baVSo4xBvUH_usXi^-g3m=bn4!woPX4ouGPZe2?`$LBnYT8N_Yi6U$#BA4MuQ&Ub7mzP`OrhU!b$LbRnF0z8GrnX*n#p-wK<52ZWiHA-v3)Gm}J)K%}$Ah$Y>(mk^~+*7DSg!(no zQ|PXl9qlQUGsaUA%?6ax#;X1(-88{*o%!8nAYR%7{@~Mxf^zQ2^GX{D}mqA!tum&zb!NHzV@fWO7=nfT! zVl7NpPtnvfJf*qmjGlx#GcjMksZZ#)vpl8eY_$%}H%Bc(H^ZRy)lOr)?|KBOUU2!Kxw6Ugi@)ODgmXb<^)P< zUa8tBbumj&x@q#gt|b&}JZjYz@~*8K`PLRn_)!%)R9om}MXwZPDtQStHnUK=W{Ot! z5^83WQMzpMRPhpOXLg{J%|pebw8o_J^b(3NLr}V4s=2&`x|)(G-AlSHRdcs^3H@zqY{R&>t7}KG-=WYkbqb~HrsZ)jp}i-(r0*%!|Dl)AcGK~Z zm(T!{_A%DZ6ED2}S$)dlEmR|`nw-sBXy>=ena^8jh`FBMTWCiCHQmEo=(MR+)m!ML z`CQvuD9TGUsN*d((fsG{EwnyB4Rm-5oi+C(yoG`z)u||N{6DR?WQta;V!VZXVwE)U z7Vgprg0YGc&KZ zx6ox%v#+;M?tUuONN=G!<^@WrN2!tMzoW5jV^qr(-a>QDrOHG%6p@? zP!Bk>$y*j|Q6(RF3r#Y|Q~L-NO{1=+^AXCMUMYYZ=Xti(?`hPyhJI@Ej0?IySLS(J3c~w zPgFmYD*vbIpme|#d*&l_!{qtuBNS_JrCOo9W)4apQmG}WeTB-US8Y%#m_e0CX&q$C zgl-D^$!ZMJb(ItwSkwwDLh|W{e7t^%ZI#rG0azJ zx(OPN`G&uzD9`EmIgo0Wnm!lb3%lm4&nT^3pmw9=Sf~~*^2K>>d?jMBTDH~Xlxa=-P2EKY*jS}C1*9|;pHc^*qrn66S`wwp_JBF z5kG+GXq_*%2P1Ls5&wyi@y|~;4fPz`b)%Qf1Dr5U;0k-mmD+v<@cHX;ycS< z&d&CiHp%|-b*{fmo9{0b7y8TY!U58tNPzrTG(h$gQ?p72$SSy1CP4O;3y@`%0;FsW zRk3b>P&@N|y#S#~<}peuV^v^WfKaj-**HMxpy}NtKxmYy6CWUyzlCamQs$Pb07^H_ z`t|`r={u;j9Rq{{&1;m>byCYvD$-dcpp?CfDvHv6 zK&k&NwH>97x77fYI^R*jPXmO8nCj00ghEW}=K(@quhlV>CVW&UQ5yV7O+=~sXSD() zpD!vjb)e7+b2&{Q&L13z^9QS5X#<50!UGeLE)drN43zn1HToI6(<>Lc4*WByxhPf1 zsNzxTW@e&vp@2GDI8ey-z3PNgmLjSMO78zFiretS>?#!~^sk959VqmsjA~ytP-v1l zfl_EWbq=MM=KCsvLX*r_lx}*cB2_USNLwvX2AI{g0)@_+)U^YJs+kJjfkM&dTpc_n z`1`B5C>=9l0f9mX%~O=R2dZ*GfkF+CduBpNAkOs=C>r@4l8gEgxw+4#rQdv>DeoS3G5hzsUq^gh7D)ap* z%s(tYt^Pu(!x=RQrS<=J7Ple#oN9j+V}(iP3rg9qDK9j|brdd}Q#S&IUYkNU1BLud zBudvz;ah=1)r}jaspc9=sc)+&l*X8Lcd!o4`hT$v@Had+neGM(l`_F7jW^F81PbMO zs6tW7`AC&ODa;H*Y2jm4=}Dl_CUXO&wa-Ql?f`ks3rzriCS?$RhBy`q{EDrljhE(quSgUZE6K zN+qKY;ZG2?~O3G)`E54}{;-a$f9 zW*kZz%=-aBLYIc9FDM0!R;^KTj#Hgbnl(=?Md_`{w=qbl-hR~;rTfQKwi7`@mCmSG zl+Kx_DCIwE&Y`f?WWNw3RKqMlX@j|jrnrd0fJ^Ga-$6p3Ovtq$p>}2nN*ivg%P2j* zr*huM8ikHe)D)Cro~iyQHGQpyqvZWgwM41dXXQkxpaiD~L8*L36@|9`Mtv?AEL6OZ zYFi{&Xo?B15G>T)_*M=UYHhB21`B1XsuHUQ3ym~WYU5|YpC-L;uuv6q&p%iwM}RsQ z8Z7k86o?2G@;5V3+G}1%1q&67R^3pVV`|3*3niJ&DBUzU8sc%Grn%KPSSU*qH9sj> z=#ZK4W3bRRiBjPKDhQ?j2C005gM~5TS$#7%SZLHDwFadOihrwWxAy* zqvW`&+N1Q!q`!x8LzVx#kK6E<@qK{x4;LP(+>e8WDw+h8dYHv1?KIinVjkgu33-R- zCRBZ|&ZFe@K{Z8b`B#++&t&?PK`qD|B9y<7a--DFj6rFwIfK$0le=(;kdJACQa>{b zrETUiN_Y`liZUogn(ipgFndvYY+95L5gKP2R0JSL~ci4PH)l%T#(3K3e;R7L$5B9yj;s)W+g_NrLN z5TW&*R6v&yp+CE-qd$iTJu@wPh6wdC3(yq3Pzda;&h-fqs@GRdKW9*#TWSkRIc}?Q z_p#=|@40G$(vcVHDN0vgt2A#yg#1jvTdXr^ZLXqJ_`QlmX;&&oip<#^LRCyiZii4i zb2Fbq=&ku7ze7?KKw*!$ThJjir?9$;ruZI({zX(8rvuk$bl`O)Y7a_tU1}Xl|NLJV zZbRR?Dnq10Xn&jvX^8Q{4092sj7?P~lv=e=V^B)fR+UESQD>E-i$mygcO^X>Lha1} zl$QSA&$tcFo@ygXAA73~eH}taO|5wRx@OYNaNs)V4k>Kh zD9tmwQMzFo&2$L)|E7A*cHp%n4mmVWWt{K8HP6+Y1z1baXrc1`-66En6kX~N`T{MN zt1K%WIA4)Nyv^5D4xvh`Rm-*bKA2=CuXo^@<@lL@sEQjMLNTTfN@usI9orm2w@m%* z4xtfd|1PXccx2M-#(IZ>rYcHx&E0)?-awZ9swzqs%=H5fp>zk;IF#m_V`z#)D6~7Q zjvsXhy)c=MVO>F6)8@ECsD~MH!Xb3q)H~%6dS-_H0yguU)+I3b9Jm(Oa zb6)khfX9Ma<}*q;FDf52#U&K3n83>pp*H6GD-NMgruj98P!BT~O>rHCIyclOl#*|& z{bOI=(srm(_=g%435d{Am)#-Wt`9o8X~c&}p7_GTzb^G%Bn4xy3e$R~$T&h()v>Y~)p z1ZD^o`jSPtN`(qFFx^m^Sw=N48!D8&oZ3@9ROl4+ub_%m3>EUOq?)7jM`d*crSK|h zwnwPYZclX|rL5ILWgV2N9xAc$U(HadR9hYP4Ha_wVO;Rg6b=ZL0>Pm;Pf)1ja)!z; zu2AU^rdHPr7207oyF-O4MyPfuZ8D3ZLWL5e)i*JrLgip395MINX0f5t9Zo>`IE>4* zMvub-ld(R=06#Pc6+e@JUV-4rfz4i#vsil~il0 zIE7;Ult&$>P(u^y?-aUkW(PQN9s{Su1*t;8PNA@dDyWfDsBBC1po>%Jjak^$DU`RH zO6=hjD)F;=+s7%Cwy%1OM)Y&aul=3!9$E}=N`pa8xjR_BMDzXPl+o}HlpN}m4sZ*a z40FmZlViA38o@$%0|6tPG87I$&XFn}y#TpJIc2U{g;Kh)>N}L&!`8e(iT~DY@XPrV{&#P58utwmES#}fq4epwnx3JwX%4EKc z?SMY!21*t0sAVV>|5q(XDc4;!0Hyy-<$F${Hf9}4&F`yuDE;_A^?8WLhJz;0BdkT} z`Be3IC3Zp@V5uy0k7SW%8$U35_vZ z(z}FuWKio-I+{_{%H$H7Z?a`}3H@wtpcMCwI*d})ENU)FS+c6WDBUscY%Zb2#{Dfm zh6~0&y9@8LcFBsID(O3yQ2ShJ8A=E8sN8v7LO0B)d@i9k`PI7uE}@A9RnI~$p|pk7 zbd*YcuQsF9q=?E?)FpJ?#1wN0Ej7l&6YXV zz+K|3rGBjK654Mz1-tM!Di{7Ht_nG^@1c`9fl>vR8i&#o;||08!b+2+F7^v_Feg!3 zTTfMSyM&S=RHI0j&`VP{+9ebpqb{Ko9IK|Hlrv66q4eDR-oPc~)ll6=X@4WNvN6UA zb(^S)@h+jP393IzkIm5}%r(3;`I}PM(Lm_-P$EI#+*i}LK~HgQl+2NPL#T|Rhv-C(N5Jx zDNTFz6H3cEsPK+1p_#DTT>0$1xJJ%)r{1iR0sJ z%zd&8*J;Ooh9YxuOr7VF$@5+E?E;thnYt*=T&BKVj<3U9IJ*LKu?o)xIJ(*;UDx0^ zwN?#9N33(nIcT%qCFi00A6Ty&v2QowSiMD!-s+Nk+tkP%n6sVgAlms)7p|L)?Spf0 z52ANrocpk?`(4uefEteWKj@NjhtDn=uq(82HMJeqGHQXtLRM z)+KZw7M*j+H|MeLFJe0{yQKO*E@=i=u3&v!bxFxrAe&CX?F!m9iZ;w@5wB~ahuimIEZ(ULYzCh4B9HZW2Uwp)I z9De$Q<8ziUsb&gf4HIf)nr90W8l6W4PXozsaY;e4#S1=Vd7sQOish4ieb{YvKoQXDYL&ym{5LCwE(3x<|#_qtEyHgWv#9p zD7~zud}@bDB`@3u!hFJHlPTtlu|qo;3U5q)KRhm!f^M)OK)pceD>MoWlVcDT6efRy zM=-_=l^m)YN}J6`lmbK5NR&>R)K1JBR5xuv4Z?)ln7JsOHCY>C?Ss<{L20XbiBhFT zsy#|8%mb84G**pJ8gKTa^u|lVr}PPIho;CPjGf?H^_IfRmXqFO%5Ei`bl>Nd+Qw9d4c?Z)+++|u2AKpQ0EzH?Q= zR=3bB6TZzYlxXgt6tF{;-su+l@35+H#4U8)JVmL;QFZ2+TWI)k_3orwsKzPv0Hyb4 z;9uAdxN=%eIO7(Q^U4dQ=@(SYMYmA18)_Cx?`~p#Z>h=8-9o3$&=+o@DWuGs^~J|LTSsY?&ZUU)|-|U!i9R6k0>>)6fXam zXDIzrS!JvhF61!pQOZGmwKDknzP|TPt3e?_&TgLHO_|%O}?P&Tnrb=dP~(s>5IvBJ6vdrd430T1xx-_ zo$rU^I;G*V+BAC*F4V;oei$xv?}hs9Rk+a5H!A#HxKQEu>bnovZ!qPfn*AwUsKgg_ z;%m6j*i;cI=A@1gTAD_UNgE;5DV>VR7$HLTL53YHRigp%LGyUsG+b6(KaHwkqfyA@soP@re-H z8le1xB7`0Wt1pfSq2EK*MQ4Q2e3!b8(xfo80Hrc@BV<^;2+8PHg;5%4^7fAqiZdAp z;QJt-Nk-}8zz7*INKHoRwV6K)V}R>s(rkz_pk?KRHl5kiY!sHm6N zP8ju09YU$kdo>!R>>pHzj}b!oKdBC>B866%#MF^O9nCA0qSC6*C}q#43Vs_YR3G+0 zVD?DKlp|7}LG3(|@?G9YnF~uKDn*4i#j!`nQ zQ1FPr=YNlq?>DNp=!Wf461qcm z{4+`@^swrCDN3k(ndlVz8%7KL*<6)q87-8(hw@z-jq3_WORIfq2uhufsG_H%g&vxb zXQHLsMfDmb@9Z%tTIGxpDju!2{}>~*r$vnHZ5bnz+p6Ozz3ry5bdM35X%c^q5sK`s z8uyD4>SNyZj}h8GK*f!T5qddZU6~pqRA!oz=`m8@Ttu7xrh*s52&GyWBhOc0Y}?gS zluqwZ-FC(Z4Tq1W|DQ2JJ$9>Hdt!tt?^BBp#0V8XsGg$q?O~PfNQ_X~qblH7j8N@! zF_Pz^Du>egE9#f4F*5ar+JLUOsh;1$_+i{@HT!*xP{;?>@nekS{G`IsnPyzNSfTmf zs9Wf|EUI0LSfNwq14?!b*(-os_wT5LjPq~IdUZ6-z}|O~xd}q$=Be8#y)>WaC*VE)3F5g(4M*v^8L&7(DC=@H z9HskzD4z`pLN2%qA2%jQrA=xGO5@=l$g?>?!p#DdGHzA5Q3~6kmY~#dw|a$A(NpRq zN)NB9cGnW{KAHpxeyxU}RQ-(#LFs`R`#wSFrupz8L8$3R)hSJ)&??h3ZK69fOk9>kp%dm+!9<~`LMjnG37HEgN|1>}XTwFv{=F)U zCKXfXOD76>lu^seCkjPZR5t??ab3Pd`6)=%j!G1|9<7pM@N=L>V>KHkNm8Rw8roZ3 zLg_#sm8Nf^&?a*brGEWX!TyOtjZBsSi9&_UWt7ScQ>{?SKU|eX>4Zr)GEu0R88sT? zgR91OY$ASdlPG;nrE!TuekSYqM4^lmRd1B`O;TZ#6NO@bQ~#i}FIlCUn<%uw>_@53 zJT-oPqR?k^Wd3p(keGf+V4jX6wQvp?r(gKPWX_qFVitB-HMLI(sQe=!WV0H^v61;31^CoFr9@ zFFFI>ne_i8N%bp9()enUTnflKJ*3lzSE)o~NimOJNXkEL#s%-r^H-m0M|1fM$+hrU fmj;>rbJV@CrgM|>g9?`Yd&S%T-!IMo?_m8OW!xUa literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/21e096c84ea13d9f_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/21e096c84ea13d9f_0 new file mode 100644 index 0000000000000000000000000000000000000000..f6311cc36c74ad6b975d251065b3b26ce94f5a37 GIT binary patch literal 35560 zcmWjL1$dKZ7sm0sN!nPGrVYj0w5fZFySt7J*WvE&?!$+>y9^la?ywDq;qLB(@BeXK zzpKgnK61`^o|MR&`s#OCo~`}YZ~l^sA?EL9qxhlxCDVO*^5-a%Gf$o}Im`IUOX{_sdH8%1INU@{$8bQLutkAMq8X@JdoT_TvVY zSC*Dkkq)AFRr=JBzG7HS>0e~8Ep^0$u2PO}(kE;mFJ)OM#iA;@V*{??5o#SFeMtfJAeCo>WZU$xTZcrS)^)RS$FZ%X2Xf}2uybrO#(%+zl z_!DmiFz-Nvat|`7^I(IvW5*DKY(ow5VcRfrf?u%7vleS<+~aUBge8)VvV&#6ueC=cMJ->Z_r8XduUMoC(QHQ zphYhXTJn}$-WhZkG4H9(M}vY;0&8IU%-UfPR^TD5Uku8KQeSEF%^>%G2KB>b9Qe-u z@iS_v!Kf2PqcR2<^^4i4eHd;rYBKIvjdIzI3Pa04qiQ;h>VQy}QC|Fxk0>8(R69(- zMqI$oP@^uwo6)EnD3ZyjshF49sH$0vdV%~|jp~Na2+L+vL(Iia49#xT=rE%Ogd24W z4LnAjgEi8qvtFYnMR6QGqK$eJYm_g}sIdt~bxG!Sno;+BM%_#|Dhs~}=j5ghZsalQ zU4Eld3K%u0pizwq8+8UrMU8rm;l+$viw8(4Zq#p>g?=T7wWLwE;VI2Igq1OBH&&K4 z>Mlad8C4urP_MjE_wjoLqwE!p`UByWj2em5%0^YL%6TOG#BJ0?+iJv&azE1^$9^%Y zP<5j^*Dxx$rcn!U3>Q(emQgcn8?_Agu(*yf7I_ zp9UKB?_lN|!oC^C|2D&o>V=LYjcPU8s7LUQG3w9+qjF7T-~8Y2CLL;Q(z+%l9fYl^NzdTdjQp_>8Jn9l0~1@C zv>0ivOsdevqWlHyOjVh_Hf)>4xOU@roenPgl+JZqRAJ2#s24JS8|<7U=$ z3+uhtq`O#h(4=;US?hD$$N2NCEAm~Y{#Q(jziv{Go8!(yll;{Y4~+gA=I^iT zNVogzEOG_`GkTW}ItJ^p%zoe}=p7U{3z zG5)H8>9PLG66de#=$z!Q3893Mi{Pn7azxLN7re^-i z(}rVhX^)@U`D=a$e|_lWuawUIYK@~^{B^54G502Zi3H}P3Og=b; z?Nj``<2B=kK#zDPm0s4C|v5gK; z8V}EQX3fL46thaFnspBUVse^U^YOFKtVVF9 zn-zvrxPqfO%&MBxto6CgdY{LvsJz6BkHyUTskm9r5@s#OEo3NZ)-U)61xlH0_S zx3Xr<#I16~i-G0Mx`!?mxQ!(h&GN5g))pMZBebY&)~YIIeL#ty%zBMV)y!Inl0TCR zR^ubK{$f_S>iootnr1DnWtOMDS?zES1sa%D7E|#IRT?r6?lv+j=dWhvZ){eLCT2Ck z4U}q1J@5^#W@e=~H>(JoEzSBJ>21w2wKMA}KA}$sGcO3u8ikNfW)0~=y^++_tQWY` zjo5ma71PtKEPa^=2l`Wwfo7!)GOOBPvl?RK5c&`0HrB#D%&dJQ%rcHNE8{4$(#Dw8 z7QOHZC&yBc-&l`{W_6gvo|!`Zr*a?5@e1zgW<}sMF3d8k`fTEwW9Ih_X3@tlcrz6Z=lEe{mbXpEPUaY4*Vx<~(awvA@^@e^Y~hSmX0%?Y>Ce zFVhBTS6CDLiS5^@<8}7V4fZ55-((HZ0KKpg>u;HL2pw;;F8FwtobFLu*zeN^Q?U;p zQ2hZpK#z$9h0zid@EqBmm=%vqui2Xhi~Nlic@P_5(Old{1+ztO5oEKd9NOD0vN|nV z;Iim3`Ui6^#G)y%Ww6Md$)c87Ec)bSyeNx)pi_)R;c*si!7phR^}=w>^jS18-J+~H zEcy+Xa$58r^>SG>Kd(jhd=_O!V;s+KQLX|OwM8!&3t99Em5N)W(iS<;4F8~M8Ro=M zoX7UE7L6`PF6D`#l7+{kMQqJB*+N^53OLtMqD<`$K2XVL4f7Ws7}7W7A2cWT(vqMEpi zk-aQ(^|q*bAB(OdYd`9WC;jO&z@iNUEy^>?~dVz0PHN>LgLoGUiOL&Lw!-#3P zMd?_CH)t`!qLb)3l6mk6Q%70UdbCA7;2c9eF%J93TeNrr^WiiaPNdHG8*e93qsfec z3{x!HjT3l?jla`&szn`e6T_wv;|z-i&$MVfRwH?qMVIjib!Kya4zZy2Jd5Ta>jK8W zo`n_}7Ln^>i`Kxp)S}9Gj^WEJ%DLR4VrYPec!&KfEINayXt$C%S6LLg+M@jHEGmPh zc!OD+*vp$4dn-9?w=6w|1@>SS4=!(QPN-3`EQF- z(d{4B;k-p9FIx03o?K$Tpu~OhMYAWw{gl1-jJ18vV+8|W@R)dI(VsYgo0#{SI^h`X zZ|VPqJ&W7;j#*!6{~vQ&tg3Fcsxby2*k)BYR^mKz*saRwv?>b4a1>pGtQv|BI2vM= z!);YovcHWK|@J-~=ic zv#JeBmA2|P%)}NnFJn~~)G23`e|f7yF}DKq<5Cr?s#LYAKDzv5)qb?EW>tT@#5Z*N z*{Z*Ov8qpXtMb%je9Xp8bf`t0Yg;wB4s+IJPHaK_dRAHLTa_6n8#8VbtERQEYBBbq zT1%@MVtgBNYfEnJ$PGQ(TXhk4k-dXe`8rxv8c&eFlT{J@sqp}-#-hMLtDJ)v52x`2 z{RUfQ9&Ob!xRAfWu{flW?R*Fj#Y0kZ?0AAFkl|* zIG;EdS#=2Qw^ENC6u2+^QtFUs5m3d}GzQx9s!x?B9>&#Ml&y76^%BZ1ljN@irYm{sfz5 zC)%_Ek;%k}?NWzz|iENxRw48jx~#6_6P*pwAvWo@cn zp0RKg=Mh}drcqEO=Ev~LHVvpkt&qK{O@Cw7Pd5F9#WigD1Mh0u)V!8W%kUh<>)145 z9_$#Vgc2MjemS7X1-+f_YHkq)oj~+4StRO`lQs z4D~&0)8=#3;=D}_FWA%;x6$n)?eOW6O;4`awELD#v5$xc?#I*-+wcV?p4c=AS266F zO?BSb)Zs0+-%-o=j0g7zn=Zln(WaSLhIyYD|1)`gvFX3Btjjl>a%ZutVph8%ve~sP zyIq!WyV5*%T|mz$yTW7a`W$Q5@kF~E$#!K$z7lqI#uXGSX;(Q6EN@rq%656G*i{KV zu^4CIs$*9ecGRO^eY^JKO*6ZGpmB4%`oP=DuDaNW)@|sAa_#J@fr9PrnuMGk>{{N* zuJ5SY*{-i$?Yi8}u0q}I>WV?|>tR>({&sbTXMkNF2HRyEVps2>c8!GpFuRJPGSY_I zRT!`F1EWST?`XTOA!&?VEwK{M;2X;vIEfa&*|iNF$J;f1B7I<)WY=z-MDP^5e#U!L zo@&?VX|%(x>C8XFt_4_!EVIZDO|f^jT|?)PCw%kl>VyF}GM}***p(5*7m_2!|NrMA zyLRF@3NN9yIEI?b?3#+jShL)&yC}MnI8bpFb6_H}uC^;44c4$WYsnY$*4cFnFOXpa zV_`M6HuGoS@NZ3Nn&>g+DvOl)j^#H}Tv&I;O6FbOfC;6b% zF4hE7(QLO}i?9Jh_E0Od*-PJjcIDV_SEd8h<&a%P@Y`YHK28l!kn>6QDq5dntkcAO z#;zNfeAcdp=j___7i)_uf0Oe+c150N524fr)*XW`+LdyNT4K&+&R?->8s1)IeXrS- z>jp93vMcsB`w#Uo5f702F8lBv>yD21smB9qh=UKQ%Omy(+C8?b+7tHhQ@ai$_cO*r zvFCRE^un$KIPsFTdTrP2w|2cl$#?X@&+qM;|G}=8DD{#1*a6=s_7L=$HAEYnLBtmx zGuVgBU+v2Njd?H+i~r+shv)c$=b15x(RJ)Z@H?`hc4G1GN$b3IysRekmBJJ7`&m^T=2@P(RSTNT60> zcF{ncuMwy^H3RhkztsvQcBus%@z za2#M#&A6ec9stG#bB9cBZ7M9`zOdqK$4&xtG{zN~lMe1j2gOPZHVqXGf|H_z{frogH zZr_Lt7f|*;&S4oUeWxC{Z*a(Ebf`6U;=9SAeEtrN!d+AkaA+w$BGv5RIiW*2Ee;LC zGZe8pGy`!qhjO7c7QktDs19}_SD-^v5a@7dwbP;SAcrpEu*;#uV29?w72?n#3=X4z zxI+ORhe~5RK44FTLscRjYK#tEhaR9xltbrmAMw!+)x|JOj&W!k?xJX{LlJSrjs@rv z?@;jshaTetZYL6F3S+{Y>QI?9hrXh!k2%sET9U(|_PHGTf(p60o!6lz`DmZtp?w7$ zN-F5kSWGSCP;g;~-V|}jUeuurFcovCHu4l_EOaj6&>#4W)KU(;$Ij9Y^(^DiQ)DVj zPB4~ZUi=4Jd53bKJBDIIMTf5AQe}tysyGyl`e=<~*jJ5p!Dl#sVVvp?6|3P;WsJiy zbgD^xYdN$Et!q0pzm7wN>N>Oz5%nA@SKpyih-l!@2yDQ;h7N@^c4#kpG~qlpG-Z97 zIn=Z{@wFs3>_LXs%!SwO9Exr4&|fIj!J+b4f-4=#zY}ZMnVh?je^=ISjDzPY4o$#k z1dJt49E5&j9WfP`kYya_a13$di4nI^XaaE|>qLjXq0}UYW??z9Os0M~HjTPWcc>mr zGaT9k!%T+?&SH-veI8?@+I)wm;TG~PU@ZKG`3uQukwd>OcBtVJ;#ta`Smuy>1#_-+ zsNE`uE@S^{hrDYYN<+jt_BdSY+5dQs=nW1H!7&8=!5+e|8y(8Oi8^m~=;WWow3V1) z-cH@oc?WgfNesKF^=@L{<4}uztp7nC7srSni%&RI^E7)0>&~zi7aWR21^8Vg9_+%| zOSHSpW9K?^{!82_bHl;=s}99r7XHEwthq&f@dCMSvuAJ)l^;?Q=n?ZgW*+!Gb*M1% zK4-2M)Z!(3|Y9{_g!7NTS#|}Kj zgse{O!)e&EIeER{)HhhOJGBlSJx(dYsr~;K@6@RTr)nlTWlC}K8H!W+)14}k!>Lj^ zow|&@xtuDVn;7#jMqZ~fp%vQZb80oV;T|#-U>r0o=+qqCE9}&vB2GPT>C{&=ZR1q? zwoWx_=Tu;Or>bKz4s~$qU{~fw>+Vh+MXjDr*?W;^Z|3hqUVWV!+}|nBKyn&HKYYgc z!A>O(rG~?u>NUctUq&$(3XF9s_ir2<=Tw&QP98r_El1D?K|mQHu7$_%G&qx(#!uFodkIZnmSbt-b6Q|spw=R&8tZFI_S3wa!LYS%I9 zeB7xNy#9w+uQ@gJhEr$4gH$svNOARplna@<1t}Usuo?T|=}sFoMR<=OCE)@__6*YR zXxb}C%h9=akOm;4PmoeD4931eav{B6kXoQCy7Ujy2JA-10YU1AngbaJ#=*2l2Q(ZO zqzNN}^Z|872IIE)gS2`A$0rBr%#GGit8{-f00^T3sUXdLCX6mNHtyr z>E%0e{S>6%{tMD9KbMx{s?o)BWS1OHm$G7PkV|D)4aurRc&gB~@^#Yekm|Rd%V`PcD`G#ij1mUHVkRrS&ykimXMfwOuMx&&6wSmj*PV zUt^b^HDT^%E_s`~^r3}I%UZhh6vf)Ov=2X!zb(0818yR|olC=T6Ytu)gH03?k+|2aH(=nm)>H1FPHx7?NZJGE)5y%()pn--NvfnE+vlS=NNJr>r(6ATr!Mv z>Hc_^YD{pc$wbDPOkPu53YqFsE4Zh*RA;(NzL_qyKv%3r>RkHa4Mxm!DSZ)n?4(Y3 zil28;kKHa!#91WmaVZ~$qsU&49b&x>yVMM;uoVxExYXeo^B!l-PP&xiv`babxKtlA z&oTdBE>n@GFe&o{b$Mk*T;+i6tt~{kqFW5IPT{`mG zrCIM;PxSdjdptwO&o1?Y{fmp&Z!X|!P<@^uw)F@(M-WQmN{4# za5`(S8ixm~bwsc_Mg}X^8>}a|9~G=!(ZRYL6Rah%!CD_5tmR3;+Ls)xSvi6=H*c_Z z=L=SW{In|&tZM~>6;e1@gNra1mK0^K;=vkTB3Kb6gEb1y(!p8>dzoPUii0RqE?Be6 z2P?8Nv7lttU~R@Xtob=uF~0}3^2CLeDV2v3Yte>X^YuQ8kMuccr zWQb}cglM`iL`yIvJw&;3hA3~Y5S6MLqH5S!Eks|chp0{sexhTo5Ou2)q6T$Cl&xNf zT#Z9?vq^~dHx1FF<{?_yB1G}6XxlnO+1rLF0e_)GyAa(&c>55I!z{Gz7Q&tm(c?iO zx-yD!CWWZQ)DXQ`8=|@ELUd$(h+g8^<`Dh9B}8vfeOrh&A!vJue!*rG-w~p_n7lhg z&Gv-IxGzL=P-cIK#=>=od~gA2M?%yElaGe*o??hjpwp=ky*SW@m7#T}HPypm`Rz zwq|uJLpHZY;w+wLcWX_UTg5zXr9`;ZEYhvP(THL0IJe%Qdc0fPkU7DvPPmciR>363 zN@EP4Td&jInwP_^n@G+{UtB=J+-@zwoqTQ$%JNzmQvl5L(2oCm2`E zE&q~keJJHttzJ)-MUiGt-|%)+SS0V)P`=I!r?}4_59VX zyp7#TZ%XXV-8zF7Er_M1TO(SzwP=J}iDTTFg!kw+(XF>L7;~mu_3;*(=p39ox6N=8`KHlT(61SGEqx}ZP+s-i)?R%fWDxI*<3t)fD;3~!2t>QwPiC6x(P zTBT6U{5e#$Ylo^mx{M0dPvb(Bb4sWTOG0@~5X$?Hq3X3KR3i_CY9l_P`-M;iUk}yO z$DzvdBvg%`hH446<0yPDL)Ec(MosFMQPqZJRH-o;HFIJ{9fEaIMy?^tsAEerD)ClE zT|mvZ8MW$bMm@srOqsZzE0gAA$)qfGGpTihObTz4N%uQs(#YnY8#1f6H#4uvGwbK5%vyxK`7`TC@yyCrCbQb3=(5bb*P5CC12U^_rYt%YpM}Rp z7Cp|BMZ?Qx(abto#}RbvF!SOJUiDrgz0Cj&mX271;SJo zdvOY@3x=smp)j38?ZRO?fbvDc)TL;csuv4Wo)TevpCC+slnPVM(qSrwakzzmGGRJX zHcT7Khbg*3nAV|B#W3AKj>?RS`l$SKnChZn4aUZ6ylNVz60O73yF-}rbq&)3Tt#TN zFvVdWI&}|IwO(Nwib?o}7QKlX5q-k60oD74=>$gg3saqeoW~%XK;fZb$~7!ZDZ|55 z0B_M?M3_FJ?Wi#I!Va_?9j0#Bj4NZp^bpg>hUxlmVG5ZLrm?t#mzXv&Oz$Uid`cMC z5rt_J0)MAASb+OTo*Jg+Sc(T&IgS1Zn@)|8dq$W#VkP#>4AWO6%?i_PES$|cq0Ss) zL*}_0L-OJ-NJ}~F!Fy6Ng)6wtjmmlOA5w7OQ8W}EkRJdAWH&UX*l@K4UFkiSj;3BeA z4%gW#;X3qFxDNjkE<^Qj<*C8(n&IkQJ6xL^g{w^Ca9u%glW-Mi8m_oz;riY(TwB|Q zYkvE1HS7?s{2jwJrc<~gyM(Jn*KnQg7A{8*#z2!^;VRcVTwk!SZ@6ys3)eGz8xXG1 z1H)w*6fV=SaM?$OD{WLbpEHGP$fR(+LeS)JWuFtSTxgE|IDm|E!{xo~h%xO_{( z`K%{gBXAU7@n&tf{I`T_*tT$;IzfJahjU$6xPHZQ6uug+xi`a=`&GE+cs=?CZ?s2g zxPa6+j}|3(G$7H#wd5X!CVO-o7csZ0N7pd^Cy(Z#O*M~tp~cT0?L^<|9vN$TxX!_& zlv*B5tnJabIv)Lpf9rCtzDJ$l*TADnn963`)7T?J6OVGBEdrW)v<~iO9#w$1 zIsH(eg-7RGdQ_*CM_ZxR9u>iB__gt9DYCcqs5>U(6Bf4fXgzH0Jt~E%xP=#}+JX3R z76BbS8iR$MJi3X=ov8!Lbn$2p8g=!kJ&xi6=5_PvF>3dq4m~}(f)%|ya`g5n8*caU zD6y|c&9J{8?fZMQ8a)Skv>ROp(Fa|JlG`xqJKUoz6S<8Mzf+589&N${9GStmGl>^# zW)VMX&1RlC9(A1SQP4b(?jvQPN0Ey-hbyoy_Gl1ZEv25zJo89WVm1TRbX_oLfDrxQ({xwcVqYxQm=Ss1Z)=^r-SKkDA~F zF5w6A?e=ImChYNO4kGq?)E|Fg^M3LWrTrJs4Y#>%77uW9p!+P?MZCANQH?|$?s>u2_SKm^xyN9ZuZED_3XjZgxr z*(3Bvc!cUEMCf{f2-%B8XcsP*iqL(;mXFZN3K80ZlqwN?f0FiiS1Uq(wIkFGh3iJB z0!lWFP|fzt(J4ZI<6V~sg>+*al`&Xl5vn~jLSIKl zXy{_bUmc+1vGvs|7p~ct$zb6se zkH$|URPTf- zks(qWkkb^Y!?+z7smP#6bqt(MlU{tzSGf*f8ap74`uiE7DswW!f z_G)wYuV+-9n~vUKOnERd@Vd$Ez!K$phY|Ud?On)sGg`s6F#^^s3beFRynvHqxsh zqsRkgM|)Kr{V-yTSAOHjd9qj5`CgU8f(2eaQ}AjH!WMb8aIsfAS9&#jl~-+7Q-igP zyUwfN_0;YUuNH45hW%c(KI!FiQm^WtVh!*&a-8;Z{Q&u%@u~&-Vg>%hS5!FbRc-u@ z&gZ<^^_Q3DKjiYaS9Nd{u79ZSdDaiki>xh{!FkE6Y-om-*S%Vb+W!(8UZCPlug>5u zY`4A2jO$3e<5lm6^m**nQOe&T zO1rxfLyssmz{;Lc+Ja8KqVy-)_Kwmy^yw3&rPzr3i0K=poS2K$eo=DwkJ5BpN0kA@ zf=l>gP?V~Th*Fcu#5FUD>uaL44WChLc9agoGABxjXomfBqZB+pO5w=3AWCIdM(HBf ztcv2Zr6?Kxh*G1CQL3?tF)`x*wnQm@Ym_GLq_%sblzCs2S{#egaQuam$D?!tyH7;v zDL$dqN#ei}OgR;$514v7N^uKt$GPox*ig&PGgFf}gTS>sS1Rn^+YVt*v+*9<7F+Xtl*6eqLnwE`B6C`TJ}WRVj-HPMyo|yv}*aH z)jvI2opX>wF2>6nt)>N{b+J&i3Kovmj3U$p3yKm0t`v*r_i?nI7LSjq0gCrU=^ za_MMgDHAPI#b`CcDdevdt!4Ovnw7~FU7JShK#yp3?@8@@GiKjtRU1O>hSPU+w5E-V zR`UtbDmRUJX3}PLw3cGzT4LH8ts>W$?*(~8#pqju7}ahVqZaszLycn8`qvn}fvItf zeE1a`5Z)w4bFm#kO=Hv!9}(UxMm2EL@2yx;yx*sDpTsslN^VJxQ!v#d2iqRy5pN`QmWIP|E(in`*c!I1KV))EC zMt!gu!Ixrm6VDKRIY#%c#Aw0Q7}dMReAi=i3At{>$a*tIe?N**;A7V02{m~dqeL`D z(PuH*_98|fu<|8qf>p0#cwH5%*QnAaR?%%^`Oa3XwhWHdD^wmDtAt^(%7d2pG$K~N zjEvR3(Xsl1T4Q6C`dh3DVhf6ni`83v8y~BV6JnKhQmiUYj@2GCm>R3us4^{94RH^} zXT<6`D$I@LcX2GQRbur6foo!wb0gzzqAmV_YjdoA#xk72X9WBit0EYRNic4SRaI=o zH(0lF8`-wSYV*lhEj<&fjYvEjt93YkE|%wcv6_P-=b0at3$e<4F;-14#i}z>F2`y) zDqo3J6HG+5tFd~5YS&`*52{{|)c}P38>=3Oyb-H4xP-1Zso$+wokGBE#=R4(2l$E^ zcZmt75q6K5AI5TxdaN2fiPfWLvAX%3y1bx9uVdBaLoCoDBYPx{n&>IHhNbQ(GL%9H;kLIhQR?osp6~PJP1Tv<+=Naq0`d zh&VNjjMGeSoR;G~&c?=RUp(U_#K~4TPNlH02owae7dX`}N~A zAMdcWL7aLwiqq~E%-1qb6%o)XPR7=8ye|-^#qHx%vO}C)9pf|?1A50Pc_4G4*`PRO z8WN{Ym_3y7ev8x1^>He{DNZ|3V{@FopNQj{x;VYW4=g?vr(e#+X*=qjr#7f`Ax`z7 zi*f3K>{rPXao3sSew_B>bjEnTyArSbx8t=E-;m=@ygK6&o*?0Fyz*c;4&pCVxEIg= z*YRq9KVC2KABH`Q*WO3*TKF_xH<9uzUR|*o?ViVL4&EX9MZCgZ#_Ki0U&U+Cn|S%X zjaO-$M#gvXYJ}xDfzRmpfjB?LbDe3t-XQ0vcs`qq*LhU=60gaK`O5w8@hYeU{SAM= z1ilNApflKHNYGt)j0viVQ8i*T3|R0QoY z4`*PqB&Z-dVks^lz?z`K=!@034wo%K#n1`s(Ab`!&iIJxjs%r*Cg^c!f<7QTV}iU{ z6Xe5WypKpwT4aKL^CoC|RDzl%&==G5B*>jNL6xy8A9?3b(0Cj~he8P&jvR#(^b#40 z5J%AjWh|DUuEi4+S0X{V(6)4fR-%5H1hvB(R4qsR<*8LA>asOK1Ce7}f=b{RVs)yS{vH3@WUZA31qH-D%RSd(iEFe+0P}q_vyERdn zu_Gi=pRn4UsGTUDAyM-}6Zu>)QGMW-DN)Z5kvUPL&^v1)-`}QvwnWv*PJ2%xzjG3G zIU-T@A`{gK7H^_LQ3Xrz4~oSkszPicuV)h#m@`qWb0sP^H}Rnn%H>H^zkPo+qkZJDKT!uxB}%6gwFw8&>rA3XAj3K0!5JL+iyHhxT-OqH|0c(7C2IWb zL{+>`jt^NQlzl=BSdTkT6P4##qBgupRQSt8B_Z-_qJqD1AK88+sw2F9N%|FTLz1H4 zF(xU+m832hj?0J+PErp1fuSKux{4%sk~(1$EBuzw_&?GI!F}#H`CMh5KV=TU- zVx}bhK*h{Ss)I3ElJqYs#3ZQ}4&Z8RlAfSWT#{Pi@AxFuNK8^lQj*@FO)~Rf15TrH zN|M%MCrYFy$&{9)rnrurz9gjozg_2aLFk_-(ktE%OvuKjK;xn2TqkfoEJW2nR zNK%oK#92Ct-w8>oUp`6C@xCH8tCXZtb*VdEp>e$={e`>8RX<6U(4+x1hrJ>BG)mI) z#!2#Pk|bN(Bt1i&c1bGPDM^Eot25)_1me0TDML5vGB` zfb|D!gOm7bNapotvYz1^hM1Cd(?6N-oF{8Fa+#CmvL>qv{A|g5*ELzw@y?#CBEWvuVl7K0jH#7A7lxQL;+! zPu4(OKfu@rleHBOarjuWjK`@Pj-b+sWUV}ztbM1Fbp{EilXV{t&eQKgvLY`g^IjO^ z!*`RIaUADvCF{p+*6&WTrrk}}&-aq~o&o0(`7l}auRT#zS0iaza^_C zHvN~ZQQwm_6&7=fO5m_1MSr8eEk(l}DVhxb%qbcNXOg;V6gQW%P+ z@c&MVo>xp!T%{BZt4w@VQdAY=8>i?L1~y621cWwCQI}>Z+R;3P>n>BY7PbK?+KW># z4@}W=Tpg9745L%jc}$AJ#-=C{gJ-8`Co<1X(FNQ=ws|S~ePN0+ElSalWgN%&6)F06 zWr|j=O3_^uTSFc28M)S`XaRO^P2o8R^}q?Zx2LEv-tS1!jGe@}D@EP#2eR%?QKda8 z8iT@nQ&buMz_&j|*YN~p4^YpeDH?k+MaR+a6tzUi=@fN5L!4(*lz<`d{F9t4{Lj+YDjPTPfgWuq|8cHTZGR}RVw~Q zxjCsCf&6n*RUWzK5#z#CB`r!-VN^%Rl2mqL?dgou6T8 z8sYJFRi?|DCYMLy*G=*Xxl5(V}QO-2Y%ax{Ia;NFZGY+?b}eo6~gUK$<2VPSaeJJ3@TOcr;B<@W-h%O}LOI@69wFz0LjC+<%v*IVk%+ zO*3#7>p!Mxrk_v#2A>LHozbVF{yrVU1q=%C>7LoAH!xXzYK@v!pOyvsl-c1^49>w7 z-#;2ZTef+HypXOCy?5aMUt>#nh zUwkT1!>9Gwg_bpaDqh>Cs%VTO*i^@-NA-Lf*TAOdb#pDv@{QlFxh`}7|ED|}pUP7T)i6u8N!l1J%>_h@mPobcp4wYcQdcdWeZ zQ^PAhowz}LZ~K(tgHLVH6W)(LHTmSz`OiMR{N~fE@6-q@evpIG<@QTgZU1yN$(XLj znbP@N0qMN&ozC9~NY{oe>AIOMT?IYqnuK{MACayxk?H(>oOHgsmCpOp=~{q_ap@X` z8p-L(nU=0%c#77(bj?jqSCyRU8k#pB9r5#x?7N!SYfK8S)epIyw^9+L|1XATb#^APiU#H6xEO$r{TS0||96g8cu-ZLhZ#@}$C zHL2G*lU|-T>ER`le!pQ-?wcmHLK+U?3|zOkkL8HJZBjQJhW(C7C-D?Z@0wKg9=ZKz z(!Us!&dmFMv*NJ@nKGI=C)liEdCZ!IguG_8z)=+V#H`_{QOqnaRNSoG7>qq7%={f? z)`aqA%|}WFvpV2BN>wszBKlV|Yb^ZL&1#H&__(H71287etTZ&PYgSwQgJKT$M>)S) zoei`4;ToRemjL-AZ}o5$gGZGvwny->pEs7nw2+VRupTIF^ODo8SZ4W zDmOH1C$cm)E6{{}P^2k+K;CB5n_||E=4KshVb=OD$+NXtgT6MaP&@k6-psiY)Q{wj zW_^$U5a?vqZOraWtgdF+aT-5#Gixqf-KpUlv)=SEt9M_srVli$>md4vUvLtI2b)#t zJ9>>Cs5F#5O*890(oZ+5CA#1+>dqklABl&LXPWixEVF(^f!Ss)#0CsnT|+7V)z(~G zN5T8G6~ss!MBWFrRUbpK2@g^JVQsa-EF44jN3~TCJ+T~jQ2KFgrD6&WA;Xi}s)Mdr zjLRtSw6>C9s$ECcI(5{d?rd=P|amvdHz7Mc%J1 z8j4!&Eb`$FX1BNKEXHH0FR^G4cA>)07R~w1!kP+<^*c6^ zBetOHW{a|IrEdI!^xG`Dw%wvSJ1jbfNjoj7w~OBGx2VVgi;mzTS|7A%`yq?^9qfP zt!fjovK}+>nptJRv=pmSQ>|);3Ah)ts!VgMhPJTE@ugKE^uR^{twRY@4w*q^!w zu-^!)>f#a7kF;t8{vAaPqpfPa%&Iwfvz(e&P$M#}w92~9s-8Hy-m3Y(S@jE!A#E#j zv%|`7=&h>1%c|^qts1b;s=bG-avim*!7-~YA7?&Ju`gc!W7YICR=y*%s>NCMKX27v zSFHNt4mD#AM&F}X_nFrhRvk=lQ}GNoozG-b{>(Nl$YRqfochS7JUMKdQozO zCEBzS)gv}dNV2JEGUK);2Uxzc={g>xL0cPtpV&BO$flB=Y#REFO-;Tf?l7BvLdFp` zZO0Kj!-kQ>9cANtQJcP)W>XBCr`t4UhD|@>Pi&iQ(|fE=<5>9T*tBS_P1oj8_coh) zZ?|dg4x7?nwy7Q-Bf}M&M&kNanwjWXSeHoZo8i5v#ZLdc8$(&SM36JxhmK- z7}YD<<;H%LschGEJi+QJc4ew+*Zb;rb+FsD6sd7`b;M)D*R$&lvODZLjLc5E)}Tbd zt{C#xx2q(UAXAXMkUr5a8)ii83MJXq41>`jnfOR;NPIj-d}HcpVprAn7Y{286~^gWyWvF*PR;h1Py!GHFc<6$1(hSyQaZ4%&vbXv;Q=^(#>Ss z9J{v6v+FHZ&9`eSybJ97E}tU<+tuO^^1>b*+GAJ!y>>Om509zu8Ff6Tju*_|OL|f!PHoT~e<7`GoZjKDa&fwZ zHs#~=paR>_red7d;1&K?DNZHO2hY%~N}R@2jpKZrIQ@y6ra0EjjMFBJsTQZ%@K=vh zLzpaaT7=`aI97E6oC-VQ_zg>(JnlH&W5lVm zk61>WW(49?xj~$E1mjqHJWf?6Ggd-f&CXFzrN-CO#tHQlo>Y(XE9$B5)OyM@y`FxW zQBU@n^>l1jJ+)1%r}uN}Y3jUssDGSq=?GvxN@LK!ZgNrNFk> z!SC1{{HE6-?^=f%qV76}y6$uEp4Fi*_dC=LQw}&(?UF;o(f^7=o6za1Lj%y|nnUjU z4h=z#2M&3V{vowIb?5-bzjo*_2ETD=0&2W2<2^2$h*QnUn&?gqz{=W;gY?@YxZkmj3P3U+8$$sX4!v?J*K4PazH#ae65cZ|GRUQJ8C=?h`#783rENJ~I))LSyOiMzm%3sS zj^GIrO1qSX+jvsOr6y(B2Me(c?~$*(OI8fTXpF1iQq77kZA8^dE(OuLvP(bUlPWHi zLBa=BU3!Q$W|ziSb7?(}R(I)KO_$Esaw%_Zm$F!0DuK30Z|8W#eGuo;1!Qu#R1t1? zoi2UuB2T|dQ<7ZzG1;Z9sL;?QJHGm$5iuLPl!9u_T>2B&P`SBFNw|TPEnPZ|dTm{r z*vX~eaG;w@kC45)OC@2!Aw0*cUM>~yO+6TkwRkyz7(-lo2gfMJg@3Gz_3&JpIoG8n zc#Z<=Txzh>rEa)+(4}05$mJ-x;5hE1;4vJhpU8cZ-eNx1;=%`~TpDoNrIY`-^ah>_ zF15!Hti9^e8Qi@=KX1C!>7GlI5qaQJe>8vU(lA(GFh?l)mON2dZh254t6K^9>La(_ z7Iv#t5x3eEb89j}72WCqdleqXMYCJks<{=d;noODuH$C?1-CNW-KvTk_1wziaBH{E ztp_L+cB>wyV>_NExK%jOt?rnOI>~OuumP8mr?FeLaHXkRIhwgOFXq-BjQ`Tj^<3OC zwR5Wx(sy*LA`W$PD{C*e%qTj*Ef@Y9Wm!b-)v3zCk}fxarnku-|g?`IKAv z?z;J{lUu3iiADGWxt|joo)>Oad+F8*SYA;tmcDl@9W(tVi%0YGdsMK9M?tj5Xsp6f zJVU;s9@)?g{V)^1;|%yvTV)ZC9+-~pxQkX5JQ|Bel|34am(@KgRl}oPwLPkhhjxz& z$9dGz=h0QaN9_V0c@jP9j44e$`Y6StiK!la7V~IvbB_|f^eAI1k1AtH2M_N#JX+n^ zBS%*c=cReH{~M1Up!K&N^}_rQdU@pR?a}c*9yRFe(RiFj>3-bD30%R-{vJKTUjv9U z$fHxJG}NO^!#uh?hP=|~4YuMaE+RPBqos>E2I+qC=r<&8VQgH$=B?Db-J>GA*@otO zJerLnd#Qb&N6`Zwe)~#oM;H%tj(M~T=aBz6^8ouvk6Pj%WIsh;&w7;ioJZww`aJhh z?K1O%iC4%0d9Kp;n;ykIWDcLuYSeZ4+38Gt?yNq zc&~OQ6SuKf({Tz}n|t~9*Q++Iyc&&k?Yt_3J6*iW)77gpJ-l25&#Mj?fF&P%<7G{E zuh!vpZ?8J`^>U80SGD_j6_3C1e1KQk270yoJFiY7|4^^0U>MG#=J#H89p=>v+#Bvy zvyom6#wPUnf!onuy~6sjUUi$~Rf}oVg$u|u-K(MqVlKAg5}M5Ls@{)YK0owo&s=Jo z=VdKY`ZS-%7IgBh*URm*e1$|h_wpCtD#H7{iyT+?Z>%5Af z503rj)#l&5x`KwAyc&+3Tj&)sZ1t)zs-Zrv?;!S0?&Bmb?jrBqWLwTyt;}8N4$D~p?`U`6!-B4Pmg-F<(O9kk5l6bjydVoOuR+j zQ(oCVIPKLrIL{ClpPl1aw7kInnDfC!uj*c6JJPOF6Y^g3su(K$Oa9jx|AtqkZ+rFi zJ+EG(&3!NDmwEY|l^P!M-;cbkgXq<56nf%SEi}ZpPstI*o{{c%`ZUYr(^j)jH<7ctPrssc4WE+mUoD?1*YRnu-6ww>v2hzk9X=Iu z`?#i>PoMaGtkvgZy$zpMHt=aPHUxdD6!xh-)?;CUPtio5K8pBM9?P*0H_;-=rye+j z3dxLvuW%5zkhLLkQKFGgaY)5EyhO3aK6x>#iBFqQzbVIJ4A$agGyXf3dT|YlqCV|} zJLXe!48wA4!-E#|p{0*=pnR&@it%w1t=sr?2j#!=sVR1$U0ZU(*I)Zoww+IJd-%An zBEIoy59)sF)5!0AIxxbg;bVOKZosG6(|ww})u%1nsbhyvi}(99^#nPdB<5+KN}Z$k z=Y7g`i9TTX73L0yulqD0yI*^A`8i+SuaaN*^-ER1lH&X_)%Eioi(kHae%-_@hhNDq zzlym13N-f1)x@uIt^K;y)vsq*(9N&>-TjL8^y~9){CeKUuZ(^Dx{Gi>zh3tDtJMI% z8V&O6`e45vqri85jlx-cG1RY)xPoTi`?UpmhWXV53-An%;eHLp9;A%$>m)uI>DL^r zK&CN%{SU#hem+C@vlg45Yt8xfH+~rJSFY)P6~;(>`XjZX`Alj@fmwe3Eu+ra9E+}L z)H#P^7P8MzzMK4zy2r1od)bCFaP9Le z9@B9P&ynSTU%%qaLBF~k@@xGuzuupqPnZ09ho3Jq52$s8ejxi*zxv=3DqZ7ol=|1t zxx4iEx?cnEAFAB&bFMV8(ekEWbMfUZj=k;IZhU%&KHm4M=Mx@#>emgVJR@)1Mu+G0 z8y~;$t1}MZ_m{+YMSR3wlQV2@s1N(_^ILL!$MX;+-}}`c>oH7*ilj3*&(YA$^oDk4 zF!)~5P-zs*WN0*g%WSA;7DKDCKdYhI*$mA?uIz@s!6hVrWN0s{)i&QAyB{HP-h%MMZ?fo+(R&6XgPA!H`Eb_v8sWgszGuO8)_17=rQUi8cK;6It_P{ z!TU)=d6Nw#;30l$WXRIk;ByJaZ9>eZ9MjBDr4&OsQw{aUUF?q$4+Wc3KN4GzGrs=P zP^p%No?urigU`tfh0zIPunNcU2zlBVs*Xk&h21Fg74wL{QL(L|G*tfD&>!g9jy@ny zdvZdC4vdGNI~odgGBg8Qak8_a&$=)-IEi%K3^l+En7bP)+QZN~r0;1cKLR)f*8oEk zF?67z%gFm3xx)NCJs)Z4ITnp#UVflYxP=O%4Ryg83?9QiST&YDjWaYK=b`c3;x;x; zFtlxw!TT)wJcZsNajKy`s6CDOn@+E0@O+&`eQ5^kAJP{To5OQ@uAxcu41GM`P#o%G z#?Rbe%JUetEZ)a_?PnZZIAAFA zK|?j*vfoKgR193y&N6=mc|pid@eas&UrfJ0nBq&e8kxhQ7GKa}e*a;Uce} zOFXx)(2J`)zmRs#(9wSl*=`t`dXv}IEko}y<_^!JyX1&k4|%RXqp!~m)xnYCZf8I(a|JZ&(|{cL1Ns5;3kQ_1L_jr41@r=~KMyGV z7Xih}1hlVQK()#Tv==8U1XQnLK!4+OrGT1N31~QuU}x0;*W4f$e!+d@t`<-mK52!0v;wlO>2&g`WVmDr+ zc93zg0qIxPFrbDQi(Pn$s*UIc=HM7|HV(*-A=rq=sN5vL zZw~`nhFkc&DgDAY?8GxvZ5H6SiS!iLP%J>nIi_4kqC+K8ew% z)&Ut^0xCL+`+0+E(=@1sXw)o7{Gje3kQ$VtLEUT*?fS|?<4C>VPLD|Oym1k^Ft{Xrc)5Y(`PK~2VKyf_?G%_G!`ml*h0Q0M**YW&fl z(r^Vj5tIefP6ib@6;yM~In8+g1Xbt^IbqNFpjuoa7reMkAFhxKYF?%8ht!3kj~Ew) z9tZX9lb||14XPh{J!AWeAZyD9wd);^XAG$^KFSnQVa&t3%psM}8d74}kTRAFam~q) zR-<*rkb2@Z8dnbKEFR#yDj{X99g-I>k*!Wh<8ap!;ykC29=bxR;tuHw9-)^fq!Zqd zHv2-_k5c}S@&-eSM}|;H|HBMC3x{+qo?}oqA*A1uLvpqWX-X$zqWQNWt;ML`Asy_) zZNCs}T7`56ANS|D0U=c#7}8ZdM(;r(og5s}kRc&Wm>AL#44D+tL=>1zZBs%jF_pa5 zg!Bq4)`s*4TcCt*|!LCT5+m3R}avg>5!sIl`*v3hTBztask9 ze)5HN${*G|Bdm*<7zk@V%GM9-`vzfU4Te<|1ChUfSjosbAglsN!|Q=z4Hy*GBs|5u znZ&`wS;Rrv*~CfXm^s8jPwd~s{mtZu14#ITI{&1`EgZ8atV@`*m%31HUs%KThvhyH zR-TJtg^~VJSa~rWPcJj(75Z=^tV}nU_$Ir}^VG2aA=Uis=$m2dUVTAwiFE zFk^x~&6J=4SrarOUxIGHnLj~^1rjs?H&Co#f*Kb}&;#TvoWT0$3Hqyef-c~z5(#Qu zDnW;E=JN!7(uVDwh}AhkoAA6#g7SQupi)B;lzn7^W=~4c%E<}JJC9fk64VPfaN?%~ zeYP$^?XY%Jf_$43)ag%d_a>%0Mo2Z?Q6ZL1yM19^mQMr32%DyB~ZFVGT2s-ae zRPnzPbsHm&CaU|XL_LKycSLRSMpP;>qD@~$w5?S{+gnF8sa-?|@w|IPIeJ7i1JQ3H zitim!(|!^4!HfP8?HmwM^5}>jkBjKsl!(esjY!iXYKT*4{$oV$`4OdC5YfYB#N8Cp zef+&SqV9i0Gz_oN|IdheZjI=ZZ4p)35z(SuGVP0~-2R9h2O_F-Jfcre zMN}TE&qegz`G}@mifApCU1pps5siHs(X5vdd0s`->2*YT-$WF`42;c`q3{o@^!!1R;vXidOSWX?|0G$pu^yfBC2KMA5`(yJyX=WcZv?|gcQ}9oTAxNQskbV!nqGAT0S#H|ISL$t@Xs&kfI|SQ}p}qDa!sw ziX0fTB}H4drl{AR6cs+6qDxm&^wXmh&3T-{xmqdOm?2f3jH#-XB~=$OELW=Pf1IlS za;GX!o>X3+JoZJZPI*%Gqc>F(gQ+^vD^=A7rYiTKR0S|_Myk%uPF10_R2{;3Oq!Fb z@^e#l6_4?DUaHIsiI0mIuqahImvSFB*QCm}HdO|$JZLjQr4)<*`nHluVBKt(5s@ardp;%NSF|>D7r?IO~ zly(23T94i6*DtEV{iAAv90Q^%f-@-leN=5wa9C93a0r=3MAZT#M^OvxW1{Md%44I7 zL(Xwgu8$T~Z|s;DRbWz-^Dd$~iydiErJEDw`pQx5M4!1)jhh!`E~7d+pZXTC502r- zg;6zJ9@S*{Rz%eZU#yHO^V+DY{}$z%Vf1TnR2{Gg-R`nq;h1Wdi0P;`rt-EJ?>S;h zX%*8~tz%k<F&#S{(9ix~G*9POPtr+B95QebH~;s4j`t}8*UvP~ pU466Vy_{3k&V8q(PoC6Ouk*5>+I{`zC8-$39Xk1$8x_x=FQs^q60WR##Y+_|SfX&@ z(xpq4D44&LE6bfPrC{-V#S0cGQY58Fi4v}S#j^_JFIgaeiYvdnbb$f|OBO6upn%)R z7^kz@X8dog|NR#qzvlmM2lD?VXk1#lga>7$!eyoLP&vttBS+v@pqxwQ= zAkL!a9;w$gDY%%2HexUCqG6VYhGTzm4?RTt5+3S}UL`%`UD`uA(Yu_7>Q?YjAI$jK zL!VlB$kft9J8%TStvr-~>S&CJ)*ku`7je3chmzWQC==;jJk+zNhyFmB-X40<$3y-4 zdT2BT^=GW19-2Iy_~19fLwVsI=OM3&9txP`p;uTv!$aHQJJUmW|M|xZl;F+}#X{#<%VUHR?g%o(9drZshGnd@%Plr~&@O+kVX3-=G2m4C*w{pzYW( z$RMA=2Dz|p2zkNqhe5@#8~um#c!WW{M;i2M40EBuSYjP-kR}*35X&Z#Hx5lQ$T69? z@o@^VPc^6@cH%NR%`_-{mO-g=3|c+cpnUTT8j6WzE69)*EyNH_%`+b>45#apXThTX_COo0A5;JWIUS4YK@gkQ)s!1oN;O z6aO)2`YnT+-e%2_c856b8Wi}zpcB~l$e?;pndgN;3tt+v_#Jt?H|QQBKTwxX2Kk~m zR>SiP>xKbXjz_TkYfyHS{7Rc|1_k_QP#;{yf$!`e52KbCj5=;KD!aE)znYBNhoNSp zCgQHeD5uq^AhfU^4uVT@3_+!h+Km-ujJk)wvPNa0GU}Ey>H#K~H_BSU zs13+l(Wqfas$^89DjY}b&)i2Hw5dwmDEkZTar9TC(yJNOsk%{qHH?~%qqvM3HI154 z%c!Nek43eO`dr7T9gU58icgr-ggBa#a|@#yw=`;OE29qJ9UiqY%GB1V{&2K6DiURJ z39ULBb)=I~dAhNtxZd5U7rz@dvIpzalfBT}sNQ{z`nkVR{|sclLF}C&{OdH-s2=Dr z%&3+ljCzc)kwzUFXH@?2?4AFaOb*B~g*otaD)*-u)ozwiPi7mHdyY{}ae6LeEHEm1 zu~8{2jB1T)YZ!aIQO7nKHGC86x0(F57`1wvQ3*SUeL=5PIT#wl+82f}h_mp{_Qx|+f%NIr!erZ(SSG*Rm8qGc!HU1;({mCffXQSqs zJyp`jQ%kVa>M4ueQx6=TD(ma1rug0Isr4x0=cydIJ(Ym%IGo2*TZ28dKg?5i&@h7M z5FhEO7swgosg?+f^;Cg4Pi@1l6i>~}@2Q#vJXNQlrvi(3Y6ME8dukk#Gd$G-yOEjc zsUyWa^=Da6nag>qGq(KVskMzgbr3#HJoOx7n|f*ivN!Y8bc}D|sYOU`>8bLqJ+-eb zW3{7wdr!r6@Ki`g^6liQdYwJhptq-nV}Bn{rSt0{+_xr*i*}gcxuNmPhG>= z;mk48Q=y~Db%v)l&GuB|`SeBW1)iF;&{KsLd8!Nc;5%wA@l-!}FZGmhIpeMN)Xt5b z`i2vmsOc7Jc#+(%c`D|Hr@G%FrWc+%WA##go0q&DUJ5|*9A4_5(@Xnud1+W4FZl*} zX(ig{_0krcK<;2KJ;%-vFKr9;(qU8z^U@xCK~|)fDq~udmvTjWsTw-PdubdhC3xvp zvX@@qlG{t3`MtC-4JEu(qOzA>SNGEXx?UR6)Jp|h^IRL+wgrQzqfNXzwX*mAH#}Qr{JkCo&6UhfBv3-)47ESX~j_F=HgoIgMGR`JX z)J2myUK%vdOUrQ!LGy_jwHA6Qc9ECXZ1B>Ey*xhdr3>f0)cS&#Jg!i8n6G;20X|*x z(#Y#xvj6R+-Z+9zH@x%)b^c*Z@Z+YJ=H6m$ZhL9P19Cv&M_!6};-zJXdCK@`_{vL# z{`1mkd26J}Tk8V6wF@5EycLaY2nh7n&g{tPt#&_ot505UjlgDv1#=&VFe=nr({T{V zVYI_m_(gcDZ;ZFv#Cod-F5xat$9d~-9F6zZD`X^is|wb@BhgzY@C@aWy!8-<1s8{w_i zC^wS0;2cGNTp8!B-s6dBnYRip_g2yhZ-uP%*2Hz*YQKqj{`6LfZQki6A>zfSVkZ5ZWs;+~Ny~5>*-Du7D=r|lq)B^Akq<_f zF=+-imZcqDpno}&?xS;g?qhKUle{XLv;_z87|ko0w6d~EA5r{glir|WRg+er#4qH7 zRrrLhznWCG8n;+p!=xoOO$x4OQd`_dYJHQ+U<#h2as%eUy@n>``^}^xjZCWE*rdj| ziIPpI3BJME)FgK^lQJ>61^3&S?M?i$X3}u@cQk2GXX=gkE+)Oi-LB-_ zjo7-I6#2VJxq34X4)o>u{w5_3FsbT5lNw;-AjTNXeXK#i5R>-(VUlr}N!f>+lswX; zHt2!RI5CQPj5cY{7?WC$V{OKp)P4f{XA)~Mg~wQi*9e$qQV34r(oB=8%_7FxCVtki zZ|0b^d7eqW^G%ww*re#C)D!mQCRJEv(xT0*!xrkf)ueG)j=LDM&7|`%Y&R(<&i?Oq zCo$|{efFBvXunC_@!J9N!Tv+6#a|}%#xDGRgf%_NI%D5)_BQTd@(GiMonn8SCWbR6 z6+6e?I8SXZu=W>C+I^YzxJnx&Ut_KCC$|4heQ&U*Zn9sI^A>B1`sjg;Sa;i`L+Ega zHN&TSgaS$!1nS4zpV1GV5~~5rggG3VULmurh0V%|Mo2DV)-mKyHLDGJ zz?g2N-gGg`qbsqXFOs`a&)?0efqNL%!z^b{v#Rwn>jrZ7p~iUHmp=W>THoKS zf&N|-A7-7v@52}$pD|^)S*=Ex)g6wJX6+wq z)}nEYk5gzcp8DcE-c6t;6X}a=lg!$U<9LLPlW9A}toFEtAyduzHr=d&Gt3%`RY;g= z)>S-4?O8mYO$?|t*R0vdJ)beKXMtIUh2*x#tktkAF{=_@VCYh_@+~u~80zB@-edoA zvrgj~+OA;Em1YI5GONg1vr3~0-eTq^_VH%M-bxPJ%__8m^@4GyStXBC+Y_t@uAuu# z=Eru_J4K!G72{8v6@QNUo;NEAT`y4oi)NL$Y}P+`dWHRg;t$9dO`j6?GxpYV*760f z6ZC({>*2Lof8qdcVeT91grl&&qyN9`QQX0I%=}9G|CrNkQ8kN2jnEH%J{IN03S2~r z)uQYUi^5S1N6^LBqQUrxBmNfI11!poLO6_0*(@4}cjy>sQOWEUEzD_A+1wV5L6JPn zh3LE%wS_apqU!Jov#1L0g(DT_v92DYGCX^T2z7HXHZ$g7-1 zftXXCn6SNqMdd15RKJo%S1Manxr#;g(D`SJ_M=@@i~8afzM<Te-B#+d zgZy?{v}6}+vzvJLu&*#5>-RD?zV5f^#sQ1E9VE6x7A;5l!xp_j>=EjTpN^70F2iw* z`W$C%Pf*K~?Az5A5?#>{IxDW*?w6j9)Ao{*~Civ5&vg#=}QV3_j|F z{YD?1L1Ql;o%Ht6K$DNg;t;azK8o}8QLxiT3Fv~m=;P<3P1$|4H3#kR1dVh0r~{Uv z>`y+Nll9SxJU$8y_0j4uA8kj~a37f?eH4i1@Q-F}bjP1DK01IRu|Ap==cDBaO&~^m zPxMipBpKa1272(aT%u4KFW=tGCrzS&PNk*1Q+2~!AHZP ziav^gxss2DqF-h5L!K%=I**w@`{*1NRrk>byszP-W;K1Z6fdx`7B#Bvqj7U-yO7*b zeG#=??4#tRJ}R`#N53ui(ZUrz>b25G6<1NSH9i`@$wzar_fKk$E?a!`4c^;{afgpO z?)FjGJ|F#phA6k+M=1w=6mrBz_wX7uj`}FqG1{Upf{rr}%AfF2&yzlSe#%E*Q0Fvj ze8xwc&r*|%K5B5uM{RHiT`$uPpRf4n=`|nizU`x^$HaqxC)5+$@Gpu#_0a@e$B^ef zs{PhS?cZ_#JvIHncnJ9Dqbr#4i5g+qhQwX~`ZHlkH)`k`!FtEwZdomCT% zuf0{vI$HG|RXSPqwTo3(yIPgr&8jXK0FUlgHS23tHw5>y>f=DGjDxJ|IoPUU@ET%O zQB*?mP^&WV20t+T59S?V)!&F8X;llXz;n1pF$Yed`Dm-Qp~G0Krj4f$%oD8IjT7*j zWYsVDfJ#%W8Zni2*fov$r&~22YmsXv`JoB+&a!IoZ1RL_u2mh;4}Z;L?DFN%xofSu zjhD!_p0ThB+wpP(_1b9FP)x$1O;&ksCRc31A;fN>X6S|(k)iD#^8aMr3#=U7`*K2OdUtO~uz9zw}WtUCr=wkq)owZ!bJ9KUAORJ^;+ z`u=TI{+q;n+p4HL>_61QcsxXbd+fvetUEe9pdJsYAr3yGE|1wGX#2#fs!!R&( z0?!!_#a>wT^GmA^;P@-n>Wx*i-dXh?CEn8qzkIN2-bbrmq2wnXV+UNH*+bA5))1|6 z8X^Dkn!!Hg{AyL6Z_IsCs4kZ zO(lBUv>6_KZE8Enrme$l@||MS*ZDT(Tu6Nu*;EdLa0m0&*z^kD(0;8=`w+X%ram}^ z==C;*dvFWHy$;WIug`bZT(+TQ{%#${SoU*AW`kba6@}8j{XKi|qMdxgCoww-_wqGEg zi#F}N#F|{TX)PAtuxZ0THdVZ7(<(fAlF;!gjslv?`ZqZrX4tn;_q#mfO*LE z!KTLOh|7ro$XHl{kMR6NU2zx}Q0X)Mum(wAs11hUEsFhXll3cOVmcn-1G;`AE?h#H z|2T%FsQ8_F;DNy|r_ruf*op6+b`|!rYdG$qnzvm`@CivKJMZW0%4fD~2%aO;V%Ky; z``DEqtuP-Bt6jCR6Zvg+O@hsC*D8lyd427=jKfa5;{5EI4X3|dhcGaR{(0^44z{Zl zw&NrAgxFO%)UHNoA7R1UZ6EFK^x!mc_Pf{BrKZNohjjj}5wn%FTPon!3EinZ$r zKH^RsaV9b*Oi6Z?PPXeSs<@cLZP(%yyV~Wq>tB>F!2LpYH7-p1B6jUdwJSc&u2Gnh zZkJz%U2ik(vKF=L5?>+qD5-kW|vH57=4CuHQ@B^$a=6kQ0n$nHT@T zr<`3W=!U^qU%{>$xKhb3kIHsMpdMP`DE3ulUGN2tUm2&GUB#-~RS9Eo6dh|&-5+U{N`UC56zkyx;jqKWs?u|K)^-Wlxrgk-HMtm*E z4SSHS6?5TDTf3s#*>w)-?d>Xu#kkgi{5!ICoyfT}`FCOMM%sC=V%Io)f%hol#6f5@ z>xe11f?Q)bhNFlcON_XK^l`+6+~e)~hLRKPnu%q|HIe$^=v3-5&91ueoNm`97-ra& zHj_OL_guzC)p>SJ#cdRt&sZ3Zc?-yCp)ph@$FAo4SpS2(E{+mE79F>%#wqp=)}Cf9F4+}|^6*Y*Uk;* z{D-(v`lg+8sCGqSCeGm|R^O(+c!~UX*fThbN{^@s^q6^`Fb_PQ*_DApFPQ5kwRpuI zd2LsLH+J=V&(D_+?3a)9M~hE({rcIi-d~stm;NQ6uhiu`uK_vq(BM!-PlqO$9J+3H zsHw%FM`&(!DA4B6P=ANUWOHa-phNw#J9IaPL)~*aGz0%2Etf;humjI9F1JJba0)&@ zIrzQ7p>MF{acC_%1UsY$84exFbm&D3hrXgoYlqskaj0QihivT} zs)mU;)ZU?kU6>oKx;bg~|Lz77TVC#M1Q!xxMl=uq5XYBu}~m>L`Z_jOMv94&@r_;PvCsGWd>jC0YTO^b`iR=Y zeD!*`uM$T1st9I`^3}SrzFIYo=O_B=^dw&`n(C_-(|q;UbYHEQ>8mYBpXICPb9|L& zuCHRz9EagIpSc$Msv=BFe3iW1SBNI*Uln@ntLiU(_3Ayje)iSq z|9mym!>MJsZglb<*(tljsoWUl>r@%1QycLKo_iau25s!az>H~&{IJF2x zL!Fw9q%fyO;uGeCJC!}csT`3`jYjJzrzXcbl|Rm@sAT3Y=+ve{JYU$U8`x9CsfY}x z;>$bLrGiuGm7J>jvr{F0b*fu6r#@GAYF!PdLTeIhEvHJ?b@Ds7Q~es!uaQ&F8#8xP zr^1>!^|85AOItYg48>YIwGTf~qz$=YJ#HbUty4pA3-8-G<1GB?6{8RePFKt{F}>M;EL@(j5BXE&iD6lzSn0?4(Y3hF^A3kKIm< z#~H-$ajGzeB6Ba#9b&x>JJl2`u@w*ha;p7N<~_!mop37Ulv7nsJ5>)e&NBZwr(U4e z4X1|PcB<_ir%ZR9>W-fGc%UHZe{c5hfqI7h56|z9)$a8SA?IgM*3-Sl%Lkc_-R?ZpY|pAX=aL_<`nYN?!tabEke6g zKmDENC;tpT4a{UNEH27iS$-N?+)p7T{4^YnQhr(sYiU3IhJz?w)=#s_`6;v#v7kg1 zKW)Z0tp3GMk-z$B2KM7sO+SsOjU?ys1Zv~A_DJZ=0Hi*sn-)?fFLx1GPnU?$ph^=D7}>&XCrT^r6g6a3YD zioag2@zYQ+_$5%aY6YqtIu8%j&tn3WZ&IKPivxL27s&ae zK=s%Ys9}c!wGp4t?NXrpZUpMtlR)Kq8mLCk0<{?1aRjbcf$ETzT@(6bSJffeRdQr@ z%^06uhhUkIooj@$>*$i~io2a%mr&zfcCGxHU5~LlM-HyX$)VY~awu1w9BNfRhw`@0 zp$F}AXjr!#YS%x9)*Q(p6~hZ zqDymft}G|7;hd_IBbQFbT=xQ@WCL5jv)bnF(Ssy%`< z7!&Xf&3guE6+(IiX+5g-4$^T%^$F5&)b39k48U<@3=UHMAwfzU8l+UbL;XL3^a*W- z2dM{kpv8zFb;V{}8yTcWm^La%H%14^e_W78VJ`0C6{e04(uav0n-s)#9YNXz+hl5l z`FMbYDM4z6C3uJxQ|XVOY19e@rU$75R$$MJAbmyr%pl#tf?2EqYR@J<F%-snk+(fN6PtyV6DJC0LPC8>k9mikq?^V14%qJ ziF+r5RrGYQYFrGK>r$|e;yOlO3Dyjhx<+o-gVh@wF!MG!+z-}+ht&O1uv#MiDLFi2 zjWG&)QR;ax*B%6G#2ebYrH=1{^$OcR1}pMYuyTJ1)-3N3u7wQIVFZ~&l*baHSX8x! zXhYr*)rk$!jnoiXi-l+xu9ghZ14NYz(TegR+JeN&A$%W*_IO`2L>{$5)D;7oc~6IE>^b_v`&x*a-w#n2I39#>9Y=^(qU7Tcb;NTNdJ>{VSo|_XpYi=Q zvAzw_6SVsjqP;keYM-g)w-EjIJw)ws&p<0i8o}oI7JGM}T`i82Lf2bZJ zHaJvuqeC?^K2(YML$x+NRNd-^s!WGaJ?RlD^XgF5I~1zF&xC5ixlqMi2vzWrWBGWNs4H`~dC^I5V zmU&?+f%)^pI42gSRwu$ZZy%<5C&?e@k#Z`G&$Ec-beNi>H1f-xD}?;xCfs*97_t< zRdmb>*CklWgmaEHT=TIPD$6lcsuHgDzlN(H)>aGG?k?f_xqG-){2s0?=-4A%f1*v# zaGgc3Ug27Tjd*~_-r>rJIY{agu7JMbnuZ&w+>dc_1sev0tLh)&YCJJqyJm#*`DwVe z;R}k*3fEznXNM~eO|gGYxcugYbDl6H1_zROxhU+7yoC=rk>2S@%ZS*=re`KB|PE5sfn9qf)zy*$DG5TGk zJ-%T5<#64F{}tv%5B!6b*TZ!mSvSI!aFcjmg!5TSxEj48?$_b!_FuS;p}r#22M&)2 z)jY|7-LKm^hGeV!>_8~i})ToDS% z9ifxBfl5CSD;DGDJQ4a0=Wq)vgCevQPx40Sr{D-RKpQMXk&p;Y#v-f_i_mU(g-2*6 zk|P)&k1;utu@M**p>RyX6Z{z+p+YglfJ(6uvc}OC3(zzvLd}ySRMQoqzU~NhN+Fm0 z5quuWn1v$LBsD^p(<79Y5uxds)D82C5(lmoi{NKSgq~$Z$fr2Z;R%kHh|twi5z19M zLY@^O)DS08q+*1Y;$PILM9%2aBti$eN2uHHtW8hG>>Z)1gQ(+B`i_Xu)G-liHZDSC zr!vnB+N_Gu5)4~IOnW1g`8V^uB$x0=eXAd-S`8xA9A9y$VWe997OA)JY!oRMe#3g? zZ5*jN*bd(&k!p)i$lEkhHEqbr$|M1j?|zoJl{1^S;HdL8&`)j*2qW|pB||J z$TuTWC2$N;vmzBVJ5swAL~8J#k=l*iTO*ZY8{-^`)IM}M%rQj&MI3m8Zb#{lzmG@q z-X&6Fa0wA7BQ*hePep17vR{l;DGbDBJVowHk({%SR4;6X-<3$+!kinCx`O;SBW1Z2 zsq>E`WqU$ho)Y7;NNsx=sgGFkidtah>qy?8M(GVIw~kUon<#A=7^T;!G&oAJL!z{A zM3nwT%~4TG8XcwjQ=&8rm8V9j0q!GfdX!$E{G2F$CPiuZswn+{ZFQ9LZH!XUO|-=Z zI5$V>7c9kTe1Z3$QOd+%OhA<_QQC@cux#Z%e%cnL%_pL?BVh%`jYVvLqMN3`1D zXwGPT$Q`X-d84%rZGxlK8y+FiY7iQ&8DY`#$%s}-EXd@!qS1V(B3gHlSu$GIQqg)= zE?TkWqjdw%(YZpj&Qy%n;!4rVS2bGGP^C^Z=bobVux_*_){EBe=Jah5tqSmN87*V0 zXny~Q)}nUND$zb#&JNLuj=C4g2Nf?xs~&VYTHTT7I`Jd=26H@!)_$DI9>evl zF)DH=Ml0|QDR*Pk30LqGvG-zB5JPbg=TQEBjJBfPgBZQSe;D#8MtdK}Xu-1>-9qB? z7DiiH67pLKAj#U~uUd z#n2IJ(a0LBPWXgs_E?p4#Og_4tip1~>O)AZl0#!PIxJSx!eiAmmfM1{3Mdq-N?2K# z9E&h+(O6|K7OO5C8;=U>Gt;x%)=iB*BOv3m3=R-vC`)$a>&{~N2# zKVtO~6+GgU&k(1j-f_B(40D{UmN@P3kJD$Y3W(EAWMzxf+`u@s&CdPcI9`)+x*8Iv zx}kCE2y<8*@2}%z%NM6s`QsE-AWnVK7zgdrc*)ee!#b0oTlJyedcWt$9aM{O~UI|ahw~7Q^V5IG1;#BZ?oYudLQ{Go`ibv?z zIQf0!F@E|Hrw$17h}UljFvKey!NzzcI^)$DLva-me(_4d1`PI(*LB1P#H%B=;R-5b zi`RIR4vg0#9K|~*d%OyxFGk@zD&&aQ4^+q*ui6-yD_;Mgd}O?8;sCBk#p@|*N5`uL z&d0>7dR)Bxv0N=663W7J5f9-UY^PEYJwZc=ZfcCd%Qlw?v7U~%3vIB z<0bw`iPvTv$QQ4o`Qx<*mICqWiq*J)ng!!E8$$}mD=;-)ZPMcPCz_?lD?NkpP$4s3 zx8NumuP*q4X2qx-W@p9gzvA)AEJ2K=;(3k4t6sTyy}*YG)T?5=O4gy~c#TGN<8==A zkiTBMDxz_H>W$}Zs7>2=mFO6+fym#9zBrEPF7e9NmHY?BYYzS$6t6o&n0sox(x#Cw zzGKJqc*_B z&57#klc=HgM0w>*)EGE&CF)V$M1=+?s$WQ=QbQ9pD>6~nFghwxvr#8HQB4aaY8&#V zC#oKNGZGbyB`_3C)Kf;rxMlSbfSJbL%+Wh^#|_Vpbj^Q;~q6Y$p?ul`Y=(; zUnXkHe~EgHNr~}q>*@pv)Pm6$dRP|IEQXI zlk^PZb0z6ZNRm2*(kC`aUtx|*QcT?>4MAFiB#lGICP})C*DaG&vQ?5kqk8KksZElq zp>!9OI9bT{JJFdJV={EN$QSXhm+*-7j?k5BT4FaG)bdS@K};o zAE*C`Bn6)$x3fu#{D*OGCCPd_Nn6nHPLiVUCTZal;&@6N_GG0wl2sP(P|TUk-%?1{ z6Tf6l%ATy(Xq+=y_i`nxQ0`=v#4F^>!);Kqh6E?eGlJ(Mlli_yVZLO|&7Z7a3nc4&X0irkC2I@{7pD)ROC+mp?PRs6o6O(IN#?t} z$@&8+4U(na$*O@SaP&!5<-UyDFIl4oCaeCSWVJ)g;AHKeNc@wMwFu28Cu`93WL2Ay ztft5@Gg)cT`zDv(!qe-~DuHZh6M8;?kL_F4g+grPS&!t-~&~sNqspEtjgG5&pua+Ack= z>(ZF|E{$u*9KX4g9sA+m$fa_a-<0^;x-<#%QK21mX-_U4UHrS|(wx37em7@Mv>Qte z$1w+Lj3>q!E3KCr4#d9`Ws{CyYz7p^8 zC>P?^$WS-m{dIHQs+;pYZp}x9Xt#!=dV*W|lHDqXXK3YeYmVEk%K6+HT*$2_8E*A1 z%J`++x{gPfSlX?RW!(JDDz~zuH(Hi+Yg8q-9-~ebx4f#l`TGYvkAPp?s)=L2y7hN; z=B_~wFxI3^Ew{$icI$K?q)QP$9UuU;w zb#?Q%&D?6;-OV*@)CBF3t0#H(a?8ID;|yRN{D)UL%&d+gc#ay=r z%p=$N9AD{HyH##YUG3KUHEwC0TW!|6b!h`_H!}7nx2pWfu`O=>vCFNSd)$1_ow^@z z>*s@RbvnfQ9A?dqxb@R<*6;*lo??B^xD|8Wtx6ZE)g^McLQYr7_qtnAIERvdyVc`{ zTVMWh>&rx{ME4`P?nn3u1fe)&q?3 zNKr9EihjmkczLGqeTWqO;g_OmsOq1hMmUe0*-|tN1%gvl8VX5~69aK1G(`o&QZykh zMGH|cK1FTu55f~uG!cFCrD!b5=1);A9D{Gc6!pWH%oNQ=? z6!pPeMEM>%_<( z)!U_LC|;s``xHIJoDPiDDMcB$icy_YG#@3pkVE$ree0E?p1o5vy?=^24WNElhs*eB zV2Tn4Q)_fZ;t=XIEk&Rn;g#}u4`@qJ+x zK_@K59pwB_Sk>SzTtsO_il}x*5!G*8M0t)B(YwS{#U!Qjoy%0s!cBxEr>YU=;ySXs zQq=~#;Bcp^9@fDlB~?{02$zw+Tq=KWDOHi>Q&j*vk+Wi|KH^ICRJE;{s!t7hu4$@D zv`AIyR;e0-LakF(2G203O{)IJ*tX1%;_XuP83o&?>IuH!&km{b>&o0PbW4>#rsG5R zRBik{Rfk8V$~ZbzTksbuj!D&uv8if4E>-uIq$+4>s(LL;RhQ+dnzt>L?~pP64(ufV zcFW~^*)oTzE8;s?VqLcxpb;LpHrt7shkf_)i+z33fj{&$&ser zzG*6(GfjhVD_0tSOD0Xz+-W+8qR&od7x1`B zno9nh#=qxjviy>!=D()#_t4U$x@k(qw0dc(Uq4MR8m1}ww=@lDl%}l4X{yySO%w5| zRhm|}PSfDF#Dm=J)ASnid#33+3iVD?V4pO33{O*0yoF&znug=SNah@!re>?sG!Nfa z6W5wFO@`OnG^PESrfxXDB~1&rr77|mbK;~ST_MJF{o|Fc9Ny_#WJ=c+Yr6bw>6(%= zT~kBSbrHit(=`o2Vd?4>p04r{>Dm*QuC}GpwG#D9r*lnHy58aEvgvY^OV^sJ>3W8_ zzocs|^8cEy3Dwe7r#kaAV@{;DNY_KO`y*Y;;5j^92M{?eT@A5odb-BUNay@`x_)5e zT#lpcymT#@pRW50(zSknx_TZ+*ZhO>cd5F}#EEZn{R`;k|TCyq~Vj7wPJQ zupC~Mm=A_uGL()PzhVU9L8A`!61a=`NOdXP;ix@UEL(@>=j|^R#OuK0r@|eYQ^D?w|L5BXr`h^+Vhti8O zxUMNfRhDFE#p(<_!pt?q1lQUOjaiqWBI`4BbbE%pcVuWgj-krV46WXkp+>tibm~Zk zDjcQ8U&t>yQ_V3qCR5*WHa1hY(L63wuj4Z{#+9j^Dct7E)Etz}pDA~0rk3DhdZzB< zJv=iql?@TdkCLc{rs#?xn2g2Pj5qkBXr_M3%H*@TOqD8`$@{!abtuDFix}ca67ZuaKpe)r4&eF?}EdHKe7Uw6jv<7!$vUD&mODmGH6k9M$i50Tc z26-!HF@KhxV|BGG6|bJ9xfot2OMjtf-7Jkj(Rx|R)s(T}(=1E5aR(dQX34uqR~Q!!l<{%!FTTtu8(oZT;ot=#@hgQ2n(-%TVu) zL!Q)5EyI~KPOjZ|s&`tacHt%h>72~F;M82Kz-!b^@05*S@mU6^W}|XOr^4ugsW@4{ zsbhuNu831zkfo?oMd5qrL#OUwOG&5xL0l=Po|JZ~V;QF=;vhU_ojQ((C{mf_c#F$b z=%<>KIs2SS!irjqgVeR1`UK_cIu(!OpAy?=#D@LwI>-rk(bMTvS(j5yvCSZ7jCVWL z*>tLe4YJfOg zK;aaps>6rLxPa7GoC;zzzPd^+vFabE{>FV|y5>|#7#N3pH=W9Ji+UsHzvK@uhGPD0 zrz+lYY8@_N<$cyaaLSL*A8~x(gU3z{e&*B?9DLzawwF#FedW|E1m7|)(#WMUX5qD$W+S0$H9A^1*Zm+oVARhPzBb7>upe&W)(8ZMo$=~B*GE@i0e z(nt6Lsq51o4c=+s(gmb*xKthnOs7jFT*PU)G&#YgX^AdvMY+Z<)kphxn$Txcm%^yl z!lgfO6%|{$lz{74(b}cc`0NXpCU$n|H|+23(gS4f;ZiZw!9hI5i{37M*oS;D7HjZ4 zi9QCq^ahSmj0)HaloZ)2Z`kYrxr~N_X#bv}*98p~FJ!1gQA3m9FK?(P>Q`btE><;^shXi^bweXC zskXuWKZerRH&hwdKQolWVQ81f&^;6g82SuT@FyMz4Hb+x)B`h7JJC=K>v0)5ni{H! zl;(!Av@kR`W@tCYw=$T!*HD!XhMFLCCqw0Nu)Cp*y$w}G;Uq&Y{P(S)e1lj%)KEnn z9&YG4>U?jgC4NH+3XL`7#5C+c@&to_Ux{I&p}OcWiE)vAGHp?6sv#d1;xN+BAO>8X zW$3-xhDI(h^b0a9Bu@OW*w7}lUutLqX0J4~6NP^@$_F3fm@wCZe6k5>fm+D9q(2bOm6PhdttXGM%*eAb8Ascw}P$Q zO54V*idfRotzwjXuPrJ46Yq##9?Kf`q#=LiWyXEZT*73e>HR|Wqc$`Mb z{=CNtq+rDWw;tfHB>MT*ty8El#I1D0+`2r5xMoosY{gMrgl~>pOBc}wsTRBS8{)Sx zHZEY(R`UJRtwOt4hL*eCnu$Vt$bGL{(fw|&9U`~GjEC9B+}eqA$a|dqfchuhYK^~< z`4n|M>sHQlZk565^Snp3%j_3SOd$s3xI*1;xYgi3`v7|%xOErjAG?+23CrPl>gGOO zmZ9)-_8+#SGL<>IsmgHYHuV)Q=QH&bALT~@Q`>N@psAUKO`U(Ih^YZZP3~s!`cB#oVR;KFW?Q-g{f@LdBO+@l4 zwq0$i!dg=y^u@8?Ol|tzR0@)QMnf9CNfG-Z1>V?4vORXo~S)uS88`iV!sqGWZC67XM5k1E#oXit5QtOoRr zTPW=CsDR;N{(O&eSsvz!@Tim5qZN%j+JyB!k17N_`U>l?Am~vv-lO+I9+kz<*ozzZ zJi()$IEZqIjDz+#fSbtJn11n56OS4of^&F|qD?(AF{7DB8_}>iZ7~LGaIytIN5~gf zu`ue<4j3_yT4ES}#x~shoI14j=prh&VSL;`+jbuPi?Z!KYL1=g@C7m9%P&1D-NB>R zJv}@_17CZz8=rpT(a515?H}RM@G%~~yY*=16ptot^=QkVWDDcZ|YiLWg^?Q1D*KTEd}=x^!y084F> zEH(Mo(zQXB9wOg&mPX+$J|1GJ6H?G(sHH8)G0ajk%*PWrhFcnf-3X7cbP~BnTAGdJ zNH@mP2k?!xIFD&D7l6fc1uPxG_v0;Pn_{UTMk3ENaz)GOGvBW-+nh(k{*=?!v9+u$@Tzf6WVG3^I zDKhM5-2qG84_aDx%+lKv)aa6>H~8r?`v5gls0A`#vD6orP~j@;QT!i^dtj*VHA_kO z50$Q4+;e2zhGP)L-dY-fbr>dFg;Lr27B^Dc+LgxUdm&pTkw2ZS z(fBRBtzH>yt-`*HwrXXvH5b`3+xi-pkocahJ*bw&)@)?SYO5cv!k5j~Lipadndism z8UtI)a@vZ0V5?&;TR&lE9$UHd(icYNv-Kput!D*nO(xN*1xT9xaO6 z%JiYFiwG67wFLLEr#StUAWj&ih`qF}MP+TiQ?U6C!Io9aR;${!c3_=hbN+z*En8i1 z5an%KV{r#QudSbvrJ=1(IE0mrY*qFVd%#w+I9m_VFy2-;Wa~7H1e@O_ZRJd~6~uik zZepuWQ=4-VjN6Ppo71L+tqNgVStGUv;5PQf=nwf@l0V`LZ)t>!`BPjocty!q}rLE2A)`2=8$5+IJG#wcaKXtO@ z?`&%-w&G+LTSdCEZ*UT+y4z}msi@k+R^gtu)*^K;TY2HdDY%ksO~jCawk{**cf^XS zL#g>lTTiiY6#M0S>V%spH`-QLoWYn4V)Rd9JPZ=hc7EOzTa()*hFrd853Rq zu$iZUm~kA}5x<2vwiEvjTYYxg8ioP8Y?a-^=L?JWvcL8*4leAsmHvRO?~(SPt)#=m zkKd2+`NexD*w3ek^Ng+PXKkH3XY1n&9Cvtw^%wcfT;h06A^$5JQPx+$Jv6ywCCdgjzneRReF}ddBhnoI1VabB8Zq@j1)lWqvQO3S{-F z8CqxaYE&Mt9C^L^9`g!%mHQ*Fsu%a_8QPZcD)q-+#Y%a#w~SXc%X+m3C(C*DS$VIH z;B*DAnpg5_I1Xb+WiQVeqA&b{yU1S6t9Hm*-76ChYk5_#wpSJFupZueUadp1`izaQ zFa%GKzkydJ(F1E7UOm8DG;?~jA6}PNf1rxN*r;f-E!N{DoF1=6;1E(<^p7vF5I0cN zrY|JpFXZ-;55{0SUZYM!uexCct{`6{uNqMnXS`Pi`eQBbpjgPOCK!W1@d)J;=o>R}6d4k|s*mni zfQu;D*sI1Ei=B9m%1x*RX5$#LHucKFU~IrcRBYzudM~e*;U-Enr(PI`9e9GuExcS0 zMon=Q#ll`i@FR{QOT;S|dSf}Rp=gwTkc>mf6{AjVy|TM{Rd^KdbNbY-xlaqwq=k?E zeYyj0ga`CReY(-kr;_b``WrXV`gCfjPxZ(6lw+(dPie>dv>vq`BZANPyg-lsr+7Iz+Lp(=hM;sJ`FqI)3ZZ9)i_M-c#eU8 z`E>4xPvei0-wB`U;K!3bg--eO`6b4{v&+Pt;#2Z{pN?S21D__Lz(b$DdE`^)$NZeu zucmk}onHkp7jM%0RW_qv@umGrTgK0GNBmlaw&nfmg_mer(XX?(hwm!+m9dszCY~cx zZNJ9hb{#+0*!y+g|<5y0fUvWs|_v-^p#gl+vSL6J0w)1Op zXWFCXH-4?bs6Kuj=*w$=zb@cGl3$ev`gH{l(dS#gP7d;G@L<0tO!Vt81}FP95&0$& z|75>D`hl@m`}G3L*Z8#=uC;#6S?5=y^?ver%w{M;Aq*9v@o)30tQe9N!v5B!?;$gd$!{PI6z*>m!ILA#fJ&3NT! zo>RXLzV&lGPe3zM2ec$jK%>(J)FoX&p^O35&KgjuYyqu!KcEfS0~-E8K(jsyC|Wk4 z`{e?r}22DI!}Ku!K7@4ErL z#j1M&o;MJXbw8km4;c4hKqH^g7JZ)wGz!^Y1k~weK>1(snkr7q5KSGY&Ul1i+Bm&N z_H1z~_D3aU0D*qtV*hd7Wns66R{O3E12 zh}=P4hcjW%9-u{fwAYlG^5H5-HSYzp%1 z7hd-S)$eprapA(hz|l4E~JwU39C=Tt~#vFcn%-<=O>@}-d0 zVA*BHNeOA}YdlK}) z-UL0pm!P=&3F?|DQF(JEsutFvbM8bfLhihYieeQq=S$Q#=vX9Cor)#OS3FSzN+xPh zFj2j_C(0U~sI~JGwQ_f&wqwv<`Z$oNs#g*ImMx-&???1s_K0%ii17Jj-NzA~az`}H zjA)`Sq7%I%sx~m9?B7P@#lWc%otqg^fmsn9#Casoj;QRMh_2uvUeArF>H_-5MIaB^$#x=ZL8&Sn|5e>#ToJF4X5&1C>88<|f8{SP3Eke_+5k10(ha)#ypScGG4rhsO8Iux}=F}Ia;QTsw;A(i|SnZs0w6=>LAV| zIb&2+GexxpiCI{VM+Kt_7K$p0L&#h>Di`7~1E-L^NK}OpD;Cv>Qc+bY9o5ouQN>q? za<6MtU%H~I9gON?Jllk#s?nUbP%NsE7}6)I)7aTJ%3O|7t-~(#?;lmc0Z}zWmZYc( z;S5R-jjA2;4~wb{4kF!%s6NNYQRIU9W1{MZiesZ{fUM)9%y}PGA8el(l{Y!c_2f~V z#r9cIrJ5b(IayKdK;Jo0jhh=~Uq*Fw9{J5@8yv&51yMErIjTwUERU)QK3)-3`ZZB~ z@>`U7;HlT1s5)XHy5DBIf-%+lD5j%zV=7xO#{cVM3b%==ecPB8AaO)YKVcJIA=Aj1 z>SGk9ApNMAUZdgnG4;Z6tR78YV`927KBfs1VyZbYrX$HQm7Wyixu7xKMbpV_i@HC= zn9o0^r8t2UP$?PQ6E$A4C&9tRQ+6x zXBWnF+L84~cb6BBQt{~R;P2D2@bbTZ4$XYEF{S<0rW^hkKJ``6FVD2R)h^8+$>)1M WJvO)5v3ft>{r`4p{=dQhz5Wj@+?oUc literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/27cfbae9a082b5dd_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/27cfbae9a082b5dd_0 new file mode 100644 index 0000000000000000000000000000000000000000..97d61c08d9230129bd28bc3d83f9910a6b384aa5 GIT binary patch literal 19300 zcmY-1ca&4r7xwY*q)Za}3{yecz?5Xtlj+F}O?vMFN)rSriU>%tA)xf$tAI!o5EP|@ zRHYZG0@4-fz3Th?-nHI8Ue@}UN$xrO?7h#0$=ux0+xCNROZR;7(hO9Vdp*vz&;uD6 zRs0#%y*b%A{*0XLs#R-vs|0-2ebuwGynbJe4Dah%zCc!WUsfRK4^|D-2nMSAvwglQ z)w6=$>Vb?J8Aio87*k}%|6={`Pq!MI{_kVF{_Br`%hKNfdt{~wPK!-R+?J^pI9U|_ zECGj0!ImKWk`2~e&5@HK$f*vcUWcxYU}a+{(*)Yc&r+=^^pvD#szYkYyDc?W_O*hq z-_}|^p>r>|BgOkbY=6c2NU;V$)*$%)V|eljbomr|d=6`dK$R~bZaB34QuRpYSFlv> zjDWXBLU*Y<3R+3dXs97w#zG$%G!DL!7vmLg68x|RqSu1+2Uzue zmP_ZO&{wVr$Dx?amEiC2y8I`_Przp~R_2^kZ_k4H57>Gh3SEHG^1ED>7Jov+i_l(5 zT>^*9lEIf@jMTgWEoJZjT-CnIq-(HHVy;8QzqPj9mVf2F8}RBM<#kiz<&@OEr5G~z zHms6vcVK|rkOTMOyi9)pOC<3jq{{tAV0;Xl<$&ZrfqJs;sm?+9{25FT!*lgfR!Q^= zct<`G|4XPUYh}CCd!=5;UsC5^SS_LdRI9vB1iPenL6LLlJ3Pn&)A`3?lCtpd0ViEY|ro5D1#Upq#N{^Bj z9YMA%lb@weYy{B>5mc0Oa!cAJYJQmrs>v%US~h}DB`Ya{T4JcEIWklxO3g|UoRz)F z5lpv7aKRBl!}JK+$~x)kjG&S?f}>dx#AioPTSm)SDVw9`GDW84E1#+n9FRX{T(t<= zSC1g!^$6aop?bt$D}uukS0{pD(zR{`E9*s2rhWu_8YtIB5e$|QvZGl9wiXe5B(vU% z;9@(~&>@14JF1^@S?q5|FhhRm62XgiBIw>Vg7e)XNbas!J=NRE5losAfpMy8og2aF zdCGTw1Rs1I!TJRev{)3uwtW#;4n)xZe@;cP<#Yt@GZF0nBZ89WBltpkm<_CrG*HoE zpk@&RV~ZO2SNg;m*br}^Wuk$vQVbkQHBgXdpq`wS6HWtF-3A&;lGi|WpMea&feF&N zx`97lH}FLb1J9(OmVuSBQJzZiItD(L9d!-(>lt|2*g)^51}Zc&uvl(3H_)bqfv$2> zCbl&2Q7Z$HZ)pA21`^vF*xS*-efgl1fuWrZjOc2ha5n>u-!)M5eFLTBlMf6u7;ND0 zF$O&2420zE@dn~27xV6+kr|%6c5$hTQ7v$}q3>@EL;G(SEZs74w1GRSlcK4j!K85%Y+St9d|)GsiySr%0>@}s<0)ySuEPqM2USt6g;R31{VmXWq{ zP-5#CnP1mPwPr?|NwMatS;ouB7Dl$VGGc3Iq?8<&E7GF9kvSdIyN;UEO+9;8@#S`R zBYS%&MlU1reO33Tdj6T74>5B83nTwY?_tVuq7mmLBOgpQ@?wgSucxbzvTBx5=bCyW zr=Jb zdF3vjO1Dc!uHH7%>yD8h?i#6h&&UJGd7z%ikCO4o$e_nYzLMA{M!u1Mp6VQWu6-zC zVnI<8t0cLYiCe`@d=h2C7j2@7td_?mO*$VCC;dz<)7?np)-6N_Yxbn2`ANT9!Z zCZ@qAK9#ROGg0<)6YHhN5EFytAMp(}@nV=s@A*tbj#KU9O>C6IQfz{WV{=SQpKId$ zJQMZjo9HNo7n_Lw&cp~gw9-WWDicdrn`r#KiC@>4h+S)<%@4}?M-wg9>6qO4$;5_@ zCQ5EHv0F~a>zhrC+G66lShp&7*(tAW*M99*z4G%O6RCSm1SRuV<^7xTmZ$RfJ`= z;$vz1pNadD9bu-J)y#)Q%{u4IoRYt!WpOieN|-4UW#($CnGtDb4%yALN;gyAYvw0; z*Joy+{4Jhe)3=M6D{^1@bvJWDM)WW;eaw{p z&`gKEW)921{>tSeGvlS&05eVH7qJdf9&&Q9)|h1Gs5F>tX7UuX-fNgikR{X11imrz zo0Rz0%vbW=Iy31%nHeToKbx5?9oC!aw!zG*jb_Sj(i~Z|S@XA>S@w&Wr_y4lnFaFK zEgfnrN;!$?jxj--2&NWO0xN%>}at$8FG;_*6kw+bcp1*T$I5bBl%0*Z%1;Wb0o>{L}Kd}$;*LScd*uw zF+-KdFg+h0$(1i7ag2y$hBTiY$*eh%6q*}JIjKKClC|r#-iAml8zWgJJvXUG+tjaL zA{i>nc1Ln|PbBU3sxSK@X}n)OlHaBC!AO$sMAGeUB>m)u`0hvYwVZvZV~->8$ZJm` z=_)IqMpEXP`tl-@n=d12^D2`41`Ab;7QQrDcq}%Hg@#rOTV!of3z5Yv)GKabKnV*6 zq-3;(^5Q6I;d^-!W8p$+3$H3#XkE#|{A3HoQ!GqP)oZdk&B8YE*e&#RShynhCC90; z($r<4lN^-r7sNBfHE-Bo^!k(5Ej?2(D zEL3V^!6%C)x~+v)Z|b=0?qH!pM+@(CvhaBq3s)t*tMZjXy)0zBXJOF$7WRHtqZ2ztvhx6<4OpzGW6Z+@!jtV2g#+ zT^9biY@yE;3+u01NV}%GKLqyH(GI-tQ16A86`(7R<0JZ;wx;We-SHj#jJFc zCB?18m$2&RSu5McQqoGzSSyp{bexp~@m9(wSm}~zCG9mUQ{|5`Rz5FlWkESBucTT9 zD{JKK6f6ITFU`t)`A!I0X_H~)r%WrSq)nEUPi089mBmss$I3o2gsdFTxALIC${Tg9 ztdxiKtaPex<$d{9_BT)t4V7ynE9Ycb6Dz+-gQixN$=zmF+BH}F)>e*5Vp}U;iMgGX zRx-D}m7*P#R~IW0?`Z9=R@TXfA6VHYksn&=D+BskY1z+8q5f9wy_FGi=p!rn1FZU< zqxEI&a4XHfv||0rN`ibT2S!*4jkMBOdWd0)a+AqZt=ySrC2zX=HbZ$zjagO}%HOk< z+Z-$Yc~(A=o%5~4F0j%;zFlbL$s#MAzp=7>v2yv=ibtlcu=4s^D?dy3AFK?L8{%DO zWuE*X6E<706p7n{HeARl;|*5BIb$_pKb1%kr-j zeqbf#k(FEA6I+a&mrje!Gf{4J>iZ48y-gKXr; zZHX9cBStbmwNXvh$du1*JeSH}DCSo-dW=#mi5z32uhbfAW4YWLXQTai8!aZ-SS!ya zs^%FsUP-lCiX{>AZ1j}1^KDF9V59d!8^zWr5BY7a^7z5Vt{-g_{z-YtmY;3hTCcs> zs90j%tA5FyUv0egn~mf9Y?L~nJ(Rg}?4bH^!p35`Aa_pL$UkeNfqeLfjrH=Y#GJEH zNjjdl@tsV%pz}r6O6@;wOqLZFZ9I{uF@>lWTZsDQ3o%^|$o1Sp`11bxHh)-l^jY0%!7Gg=QLNskzh>s+|V)V&0J`Dj$nt@$o3`iT(E|c3p^~#Gg@EFGtZ-0#~CL@OKm|Z$$A- ze*GtkVz;7rL*i~n(eHi~+ok2hC_Z_le4j+ISGqrqVxlpcbF!pRG(!qUb3p1AiDrJ$ zX#SCN#iI3nC7O=1BPyEyG12@Y*3!{T>L1N{`SLrx{-a)(s14C<5c5VIlO}tjnIkI? zEB;xK2MmSoQAlKdr=_Lk(6-%IkVoWEX@b$^#6;zmgZ+%Cz`7bQ6)KmJ>i z75|mwiF6`{Eru9u#u)xF#qh5=hE|a=EEJ0+h7PhqN?K!xDilLoDPCOTqhn|$17l-o zpAf@xv6qTraOoJ*%g4}9PNu}r%@M;7QZGG*ef}8Y0x{gni6N95!_~YPe$S8L)8;Y! zCS~4=VPnS_B0I%!S{8MU;f}o7H-^-HF%<0|gLgm-gXB+HG*GcVQLIm681-2Uh9Md& z-+d87@1ZellBvUDNc$>=K9WBvhSpPK_(rNuiy?1D48x__%orZdiJ@R_3}ffTVE#IW zM$&D8YFHja(hAl6Qw$R~$8b){ZjGVk&KUjNqUmg5IwIP)-u zw9k+ZM~CVzE>%9?SR=v6P64 zrHz!2j@5hLSo%tCOf17=V>u#q;$k@|N%66)krm}NE-jYZ>9KmR8%v%mmQtQr3j1Rj zk{QbZ8J-o(ce$}VmCbpvGz!Pku4*jHWLq`OtrN@sy0OI9i{%4p(;!wq)5Nl&p`JI^ z99i8YmWwT7akh-5ZY$;YRxI6RRKN<>6XiGg`b;c0rPA40{Sguqih6rHmd-NsPAvBy#!~S`Ed7mf zx`Y?UbIB+g$7k|gu{ajR$8kqSC&sb(wK(pHy-XZOlH+(SC5|hpaacWZG?g9xIK~Fz zI4z@sainI(@qtXpilcI_UXyB}I9BJ!@j@O|j-yGnIOa&P>Ty)47e^1-(IAfLt>d^X zneF3f-Z73#lH56t_hm+xI0nBP#~$(YjAN=?l*C?ftdQ`)IKGl2pU2U1XdDZq!Emkp zrSg;A^47>WmP-GLacuu4jv|W{V|g3{R>rYY7Ost>@egs#7UKr>W>*|VcgIm~e;j2G z#L-P|%G5)eC$)Z8t(W82EcI^0k#skXp0eUe9GhOmVR;#+_fhe5GRCt~V$AVWD-_RI z@fVI~W65|TW8#_eT09-f#Ir(vE*r1+`0?D5XXWF`sTi-%sp6SdDV{CK@z_%0sUk~V z@jR5b{P7G9#_Re~Jm=(0D4qdT06VH2{?7`3K|qNBSMoxFf1fzB(Gu!sGGWmY;uD>=W@MoQ$WD zEIq4!$(?iYOn)5DWm!uCU&kbHQ~G)n*d~d-1lngLut%aZ6PPLWvJ$u?J#!N1mzThH zsTa~?l>~}ZO`uS<1S-^3oJI*`HBQiVx&&UeOrTb)1ctXx;P-bDDBm>!Q?CRvKSzhD#c`WbrOJI#u?Vo_*qXZsG>CY7N3&k9oz|-LgbQ_Vt4^l8v@y9CuIK4h0 zf&Ehxh@YmpGxaz(fsXQWUIM%3Cs5++1YTR9=TdWF0!2*VrhwZJ&82UOJuI> zs+NeQdLos@{dyt;WP6Q7_SH-zu2v$wq<-T>rpwYMiNrKZ`UQx}y?_o|MS#S&8J#*6Z^U zIlCm0l%< zD@7MM*SZwPdX}PWuTq@dQGq#kD-iv>0&j}3a1sMzlGrJKJCd;blK4yX68can(gnnZ=(Nwk!)vTRTik7VMoB$|Jf#C#b#CW+rBBoRANapq{w+$1u@ zx-^NVvUF1t-mOUtlCO6p@y)ME+?C&sCDH9v5(FS0t`$MLNi$ffcFuNkyhfxlt7vKcOOLrN`Wg^xIsK<+5jcMWTOEtRoev zeYzr(CG}E8U300(>(}%cRf){#N=)fgiK_2bVvHp9uf!^OF8+@y@u##KRf%QNYhxvD z?5IS>&Pwb!QHfG7Dlv^@E=jONGWBDUnJ(GolldnpnaqmGxGE*1NM?1mj>*E@Wa@@Wo%E_cxN!ItLWc?jTWarRE8zqkhJ_{Yhtlht1& zb8D1x9-Yj;6O;L3n(~kuGc|{Qgo6HXJ%uA-|a>bLL-zT$Ri{{HayOJrp zKbdagJ&;V@lgUh#zJDZ>d?A_l<>ZxQez~ssePYTl{E~q#;DR^>IsG6U`?iwjX)lA`h(-iu)N@1I< zdNYM0-BM^NOZ#Z-Cn*e+lu;=R7_apteQFAeze(Yq6kV6Xh#e^$mm$9@uisKwe<%gh z;S~BDPod_C6eh}((C!Zu z%3SGDC6)DUQ!%}nO6h*7H2j|hsmzoDi5!xQt($QBX6hbvjV*) zs~@Ifw58EN{*Fo`FENebvbbUz7Jr&PYfR(wCTZO0oJK~MG#b8}#*$Cccp$ECG;T#2 z_hjalG=ATeM)}=oj60gfkH4qE3B7(MjkD*|NV$;4?5kuJoBYk#HTyphH% znfOnd?lDTE=B+d?NzdCFdnb){@_|ggpQh{KX)J$`#(kOjJdG{?rD2M&(?>p&-BQeG zr?vj^v$&mg33gs3+UZ%!&g?RFE|;~_w49xkWWAPR=bTis+c_XH z>2`)nN1vToznx^6B7X$z)C<~anQy17Bo)~4%Od%wvYj?n?EG2VuD_3Vme;YfQCxNH zd|1!U6}i;Z&I9?bnVrqzX>O-q3p>~3UVA%+4t6%le#!4>XILjYk7Q>zJHN}gckRrR zsP1-J^|0%6csnHqD4&6lq96RB;cAn0&Q}DH&-xk=Zxx~)cr5Y=Rm)WT!6J`AOcIL=AX|hH! zWuDYstK&bYh9B(|m&4LyoyPp6J^9(rto4esL0@my*IV@UR;{taj&-Mwd*$q`IA-Uy<92*9KnhMM?~`^OOW{*?s-IUqx9$9RM|*YGPOhAM zWars)JB41Te{x)EytFgsmCgfc8sT83!9gLTgVBW?94qXgS`h~;iaTgq!ok8Qhdw89 z=w2=dzssSr4&ur?7%mf&9GtG`pmrq(v+SB9T^tVj$zS4eI=Jm~5TE1Vty~9XDmys$ zx`RqJ9ZZ&WwH>^wKLaw#yd!s;quN@r19^x9Sjo3=UFxZQzaht~epLBlgzTS}dE;E;d*bg=)j zdM?whC?`q0sxj9b9G0un=%#}<_taBKx$huTmdKq4%HyGf59Pu$?diV`zLYBeIcO|9 zq)6ELKj#qBT zbLo+s&f1i8DyF8BEeoCL{FJ8FqF2x%vrc97i zjnb*rSYu^xi*$~^nNI0;>5P&gozj^k_21TUIV5pi(itwZB(g_3AAFe37ZUEPak5n+ z`=`@SM#D(HTPH7+!ola?j*dZLr;(oSlN@iiwU zWti+Q<0MqpNvHBomQ`?4D#^*!icXx#PG(DDs+0CnDQh-3dA8BX(9KQ`ZC7nO zoK%$3C!KUWrT(0D((X?u-&}NZ^pcYc^6av5zp8!w%gJ-G+)!>eolLmpB;vM{A$Odl z-_;(&! zI@P+#Mff)t4aB<7MS_f!rUzWSEoBe7aLa*18hgyeaH)J;y^%Y=E3ZG5*F_g?uef;d z(napSs!7)Vr(WR365-}cIcRW`Z*=pm+0E@pH*Z*8Hx=z}%BQ<|$LZF6%x>bUyLt088*KHv?tjC^x4^yQw|K&Gd0@E{s=B6SUrBtue*T6PYvB&6R0x?#X}C)sq<-C+%mt zIVX)~x!EVxXSvviT0#BbaTlCNagGB^8|YY$c^ z2YLNFH=|d&nIUCXxp{lF`n67b_LG}gvP5e9?B>O0H_x_ckG8p4Et@5EyLz`nad*0z zB87LkX|mhRFLFqR?$Q44)gJz;^FYqZ*9YAEbaC79GUO(?<$OSjQ{^_ReMK|5#k%TV0St0AC$5l5+<@R+qF@L++ zBsXrl@!i(il5^k9XAj)ml~+>vp?WDFK6111vG!C3K5?`CshfJw-CVbL^jV3Axw5*D zhbM(Syi>$OL$Fd%_%Mqzo&cn#^9-hm4Ngmc!^zdsX4<%AO97@-t z$3si6hdpxL?;$$i;fh(0gzK7{8JX~n$ zpE9ugpqlY%KRZe&Eu&}d-8(loKe#b+F zZXUY6>*16P?e1Y;4-a`gJrsY>LyPx4?3S~V)Z2q&u!r6sd$=ec4E0cYn1_zTJsg$q zM|kKm(!+P76nm@(-*^vSONYrGmP}DDQ$3uU?xE6550mA;S*mf4dL+~5sjm5|>uY_z z+=F$6NB2CdpQ}Cm`MrmNbsmQQq*}Ll=y}A$4@VW}n8uvdm~$S=T=DSMZ4ckv@eq60 z!^wvpK6|7-KlYIIMD;(_o=BDF%2UeWrAvgD6SCRp#boyKp}b@9veN3Mtj$Y6ektaq zUyPS8rAn+<|NeN{A%)_-43u`Iyeuy5CGIsZ`zm>fPVq8C20Jy*y=y3!nu;yawG~^IH1Kk# zq4I3*rCdAJ(Oz}PKQg3?m!iGAG<#3;JmUXo{fnIgUCdii;tm$dmB zBb63tj67WAC2z4;_u+V{_N~^GYD>MWl_IOXH2q%d%HM0fcz^UVUxuys;@Y5n*y!bo zOxfb)kFDC1?Oxo!dg=R{m*8RT!!a*k9ryB7nw<7Br@ejRx`ozobr&{k{FMFeX)T-cPT#}Ffq)0^{JCc1AO7$^NzLcai zA0Fv$_p!?1<8iu=&s{#!d_Mi&f{zRGG}lK#NXMmB*vGtlAH@rN7_0jDQC?P4tk-=^ zmOvdJmFg;9Js)S~FWJ}7M|5K!L*z&k9|_HTENt$hO*`Ub) zeMk7n9O>hZEFR^f?Pwn{V|;9tzGHp3#`(A|bI1GmcY=?#6V;bVKK9P>adNJYcjoC) zZq8Tl7U9XqxU)=KmX*T+Ik;NHv5>d z#fNRH;%)a)c88C#GHt()^9Ou1IH z6qNVVND5WZI2kR+lKfPw=%;tOpCJ-*`l%;d#O(IdSLOx$Tnp-WhM(Ixelqg>d?OtS z{4A;LCs0*6)K(64{fw#S=S5>bRh#-*BQY)fv}x&QpLA^P*L}x+f^X_rM?cRx`Sp8T zewOw2bMFJi>*J@%AU`t(`>FJa>K^UqtucNM%Ey!Z?3}E*Q~aEf3e)^dkTcWu^-Mo2 zX89?-Tx+b*+*Rt$CO@BT_UrnY*4*jm?k+!r_W1egS3ie-Q!n=Uc_6t5w7zVW#|Qnq zcgWAbXO-_CexlE-X4!Yq&%jH5wqN$+yP`F(YR&6fU%vUv&&|L6w7ub{)jxjTzwPIz zJAP8{`Z;yaPq_z*|4==AsvbV`)8e_GPO?PmzVI{grTX^D&(weYocm9EPJpeZ0FjXa zCRhR#D;%JCkpO=d4UiBOpj~u;LsBCqz?j$ouVh4gfWrv^Dklb*Qzk&)vH{*H7hq-i z0A(u#cp+6Q28gf+FgXMIJ(&Q70s)p~1h|(OV0B1w3j!>z9MHYy0g~zl=vFU4T9bh8 z9S`tFivaan1{l{apzkYMyF-AcvZ0e=b`CJQOMsZ30owEmaP7SS4hxk@$trkeIC7pZ+9 z!1#j!I27RHqX8Nn3();|fcO5Nv z9OM(3B!9@G$RLrHAlu}yRJ8^fVGGi?M3C>w26;MsgPd&_B&kD?iBi2&kWp_3buBB%lKw&Nd=%uRj2aMR zwzL=+q>G%Aa)W~``&erZ3G&ews!6I14eDprAiJc<@F3H^3}PJ>q~YiwTjlZCAmQ<< zTQ*G$>h~;z7$*nWEC-}uN|5<-eX8P4)3ND6V&tHlmqs%bb7m0BtRT6wgM2etum_2QtehbX2Tl~yZ*oY|r^w+7j}O}Xw?E_;G__6GI)LqUDcrv4sOofnn= zWvwAcCGo0il6S8K`Tly4(BDCJJ_u6yQIG@~Eyo@QdF!eAZ^>YjH3O$DgBK+-s2ZI? zL)j{kF&UJUC2}V=gLZKlxDqq?uv7+t@)_7FX3(fo2HWIcX_K76b%{#JV7Hu>n^N47 z!E4e(YCAI+@5-Q;JA)rR86(C zt=T1mcY9`F>6O7;**z(PqEj-6Sdc-jg?fFda$TWZzsq3Ystim&Wl;C$3^vN;^%*!e zX0T_I*4e6cwq-DCw{kj`!P?^)RQx@I`KOfs=?q$)$)Lvh49piZI1`yk1#2cNY?(xq z%A{85Opd*l$(xy(EXvB{R8A(tnr5=UStg<8nKYJFa`gR75=j;`!kd9^-N}#%i?1BEE-qH;&inv%DxoW9{14r zUfGQJIGe+tWK;RmY#w};P419vmdRFGFfyCl)3eE#naww{L1JfR6FDcF`g60{EJvmL zqHGp^o6U_S*|c7o&3jU4RW@;JvUziDHV5RAJldE|{Gn{#I-Jcxxhw-u=<8F8dnTJ< za`ew^5-%w)S#v*|XAiPD_B>nXS`H`OIpk&K=pN@B#t+x?FLRhWCWl7ja+o$ghfgNv zuxnBd8IyCUBVDBG)Eq`k%i)>4y*!8ID{?6PT@GFuA~#m&;9HZ!*Yav_4%L6tu_Kyy zP4lkjQ0rC>lON}B_DK#iU*&MMNG{G|xnvd3rDIGkmE&^tJuX+@<8oQ($faa@F5d)l zS)7y0t=wEjhH@F(F_+&vP`TngXMWsppZ z$m6^rk2%&nI+e_0Sxg?KV)Jyq>#=MeBc($5Ji1oMqiR|nLtEtOJy4$RtI4C0?0zGU zn;r8Ayq(AWZh8DZHjmfF=P_D7Uy#S%g?VHz()h)B4Ea`LByx2g^}o-f$WL1LY#u*c z&g0OPJYD0+Bk_8kda3pP&STY$JT^(zKY4s|GmqP{;dUMock?JFE9KF>JUZXcU*+NV!7UF#I5dX-O5+VMG3Q;dQMA?`S zd!$%gh)-l!e25~6A)b~C>H0@V*E~YH<`LpES(>If_7IaCA&luEhPgxR_k;*}L!<_^ zPDY49QYteM3S@ z#cU9wRl^YT8igp{IKE~#HALR(=tTuH$#knD+KLAtZEuu4Y9g=i1Ix`6!Z=;`~!`X5+8+VIY9Nxu%TLanARO0;)ju%KPp7`(dyNB z^=d+hzoptl^<+|r=kopx^>=27e)AP`p<*slOey?Lh(#+x?EX>v@RRmIhW)JA>lJ%L zh_RbP{Jtf`>sv$A*%@NOt`HHsLk!&)V&DD{*A9hvBHtelv0d694bkX#^;1fp2$3$o zoeWX(Oo-NJ^|eg=BgE-*>c#mG9dC!|Bd$9k!m>&p-&IfUsfW_^X^5H6LKJ!)Vk==H z4Ph=>!jw%2(>XEB?^3pmzAme;XT|TL_+1rWc6AR^q-U5!*(rtJ3zHxVN+7 zS792+ml8cP%p0Q=OHPP$wDKDhCVpI)N-{|pA0|&m%drVzojYL~$s3cx%%2>l#1!>X zZprMaVQx$0^f0CwVd~Bdvr+cSpjpa)b{PMhFiqx#nK3_1tHoh{SQ+NUsxXG1!@RvS z%<^68;l41bCsfiuoyb4R({SFaz0^}7yX ziarU`?5TPw!3y~dO3EiUEgwgXe0tZ+=b{vb=jZdz*ZG{3HB0k( zwk)4+%ky=eI-f7M=kr9aUCqaJJ)hXW^D&hzpl-PWPLwa;+mr%srxx&5S^;l33Yec> zz(9Wi6*?EtwMzk~ZMa&caPQ%3 X{nb1FGok6b7yjQo{huEGzd!#6P)*!X literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/28102b08922e7bad_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/28102b08922e7bad_0 new file mode 100644 index 0000000000000000000000000000000000000000..bea9b97d7660fb114283a1906dd78d4a15dd57f8 GIT binary patch literal 31332 zcmW*T1$a~E+sE-=leS43Y1&e3l)76|yap}qGF*qd%W!A74|jKGI72twZDR~~cNzA6 z|L?Brvn1y{a^Ls!w6rHDbv5j^;)jl(zj#S1fs`kY0(el#VnvD;O(|L^E6bf#FuRz$ zsJmdvqOMW}OBX9vx=blo>7qr7lqyu9a4}bzELV16R~dJy0!0hEv)m<17c5q~WU-P) z#yFkBHtT<5{qH|>i=O}gIE4Q%L$fl{CEP136)h)Cg33#F96?$IsUc!2O8F~EZXCdM ztf(w4ts)&lpQ`k!C4I*5+S0$sS6Awc``yW>hx8FUCrEh~Nl~bZp4fQ?2yW}41k^$^M6~nJpSXzA?LCy#!9$ry@9v>KeLVCF%J%cnv;H0$IKV^W zFmw=OjquQ~qlgcFqdnv`#X|v8J@f)=XED}w5B0w7p$AVr^bQ@Ld1yWAJ@?S|mmWHd z60bZ|`Ll;Udm7Z-%b;`q25k*6=l~w)Fz9fgLHTkUv>AKz7*s#6L4W*UP<)UKzu zpw=MtaxBSA)i22Fi6aXb?Vj=Xno<^7b?+8ee)D)U-E!`xrC_dy&5{vB5mRpvL$O zuLm;kAcG1GHmK_mgLY!qP=kDi8RWu_;p7CvF9wysUJM$=>(K`F8)MLm@yvzB6Nq(^ zL7HsP5UiL&&Nw{PAjhx7jrY@teY!z~u^X4sb+$p_a|}wIXVBXD1{GLf&KBP~bg-PGJ87gBm_&o@WLves0jx zH{|fvpgV|sM@>E$ZJdaVu@*33xpAhteQH?PVyD==EQKN&58kpaxn`jhl)LB?U zjXD!%)Z}oEqgRAcucM4|MH@9X)~Id?JWn?2uFI$!Zlm&~7&W&LZE(G?QE!VGm6&SO z;54I}WEgcC@x_gLg%Kr;T8H~c%ra^mW}|;Lv6eLI7J^H24nbv%+KW47sYN-XvQPyL z${TeLzg95HTG6OY$Y05*kw~g+RBSb)Dx*HyS0_%Ct3f*){n4ndwT$wsZPY>>#bwm4 zW7Mp=MlHu(EU9PI$NEO?YG%}9e8AM^%-w<rVd68f}<1j z;S$<*G3rQHqw@7+-Eg&+QO|xhYD{m|p%3fb&!~O_jH))ssDFnr*HHGyaQ-D3VN`E) z9%)pY(MCN)*chV&DB=03uDoMoP?^t)zM z_5~GiuU%qgH(|%J|W!1!hl` z^6}I%EVp{ph7-se z?4_sJ9pa@Opw{au6oJ-5BZ_%H7~tF{eP)5zF+s!{2SE!rk7UTBVH7J z;H8L1URr^e$Bc<4FT7ObtCz;fTVqV#+7RHaJ@Clkt!V5(K%lpF=R|IAb^O6w{quWk zG`1ovnCCc*v7z3Yi9<*ZqaC)xFTz^`V!YKp)?2-C3Ab@N&RhTBXuP*xAS1zBRk02p ziQYPaCn%rft@jv`?5#~$>+;r3{8_+TO$&MJKm1wPTOW!telc&=PxV%0nztHc5>rKQ zwW-WFXi(i-=Z6s6Xm7Pc`7y)==UDpV%0zGVn?y`2yj5hSw~|(QD`d5|rfl$5r!CC$ zo3~2t@RrveZ@CY6Q*&>vN2BZH{m5I3Y$h$Vn=~M=NzkNy~#wS{iK91$Y5|ir6f)^uVUxm(5HCKIFsWLWNserjR^TRb zlr-r_j4Nx>EZi(dd>B;Tq`T-=f#>k5WYRVq!b7yGY|`o~CcQ^?HIrVUQgxG7p=1r> z#u|LU_8(0uSCdDqtZmY=Iwl1-G^qpbBDIl8Wibs;QKd2S;7${h3jAbJv8E=~YGzV1 zTt}(qP4etu(i40{-%cieQ88&0{JWSmv>SCre0P(c<8}|? z>Sa>o&nD&R#~e5~fI18^DRHn#)rXkW7@LREe;CiP4gteW+W(75#*rrF9A#4bF(&oK zN1PZ-9mY}fNhWog%)XdPji>P%EASElGfWD>DO{RuQq4KUG}pxU4fex4leR7}$#@+Di&SL&PlbRkdsTY1aXwreh z)cQ}8`e6@#KEj$EWgW5qIC~Vg@aqYaMxJ8rPc!EklS-Up?a!0{1=jYWNqa9-@4sk+ z$ z6-+g&J$l2KZq`dw$}&r(&9b8fE}(fC#>5d^#Llv2jV?!=<(Z?BnXfUkURP%BDrWVq zW>$|HX4R-^)<1R38d=w@{WygWsNc}6_4tlCjm*l?*sM^@L%ybFJ!@uG|K?^Tw=ks5ENJbDld1|Yd7_4(PX+PH&}z0Gp=F{@@@v#ud;e`V%HbcyMj;vv39mf^CMbF{HGQuo37UMNq{bJS${5+EJ@e$KTnbmf*S-s#GW7dHQ zW-Xb>_&9~elUTpW)M5(xO*LyTj^hC~|H}DkW_7|144-b+mzib_nPt`ltUUn}Sz!mg5$^6)f zhNq}4K4a2pv*OQD)AME}p~nSke$lLwm(BVYkFT&NkbRGQ(c&?2KVd&TW&NJ9*D>fh z`}(C>zu_QmVE!xWgrl&&q5psEOWeXY%>GRKugqz-sHVlDrWgo6AB*y16)qyhYEe#y zMd2ucBk1mH(J;Kn5r2#90T$&&5&VI!IV>82H|P>*QK_63EzWIGxx5yQN3nd&h3Nbi zb$~O(qFV3?v#2WWgj*C7VbK}Pi?nDpj-XPMMfGqQ|DjW~MaFpgBN4x$P9cky7Pe>; zPNRMii@b}H14iR?nngL%Eeb^@j-zr3i`t=7X^X~T7Pg^f8H>81UO9`r%3BnOc@>BU zSE^W4rK&{@(XENnS-*O))gqV*U!pLJb8oQo|wjE>u>$1ZZ)ZPBtltifJl{hj@Th1j@{ zvGMtUMb{2m)bkLr9kysCD*R#5GsGUDj`-myx#Kb%$EeM5*6;*%JjwpN%6|LT!i7$Y zg75*JH(2Le7HzpruJFA_KKEIp2NwPHKMyVX^$~S?Y|)^n?E7aH#UtPa^}?*z7M*>= zzJJGl{=j~O??;Oop&g8$EE@Hh*uJn|ztP6SN6igB>WTwKADuxnFCU%s_R$cNk0#(S zvg|&J^Yu}%(?<#Dj@#((=c6q-eY8Cn?eGZAa{H(=R-oJuK3qri(W-nt3Jvwq+AtsO zMD=hVnInA^h*t2AW^DArZ!tbPh+?rmniJ=vl?Y8BMtn>3QT-$zz0LAbYDvaIb}1hn zN6FGYs*S;zibJ>zQyCxSMNnBE)hzF$DL8_Q@T=&fQBWlx#b88b9}TQRZpc^FN9QrS znvc$5Ni833!rR(DYFWoe%kd0Z^?WpOKJ6BhGioiNrb~U4yxd1cR`}?rl|EX$%13=y z`>4_yYPHTsleYM19`^l4tbB_~`N9KH7WJM^O)%2LX?$4|d=`WIy)N zWL(AYr#`Cp+DDz<@cb<`ddGMOc<-YtnDv3YG5;fDeTDJPp~R4ie_8Y6@MeGq*diGsJvBeD_a#@ z#i~m98B1^)&U#h_VOInCHMHsgUbnF7JDRq%sxQLYSXCdJ(Y77^P_BbjwUE})s>vwO z$*L7ytonwkU9I}u-KxKOSe4$>s_qyJk6u=_9AH&X1P`?8{Sd2+L#^sF%&L*_8g5l_ zR7Ua$t1|Ek-!bYJ<{fR-KZqY=RcoxmQ@F-52Tq{XIIDJ`^8~AAOrj6Wldal|6Y!gA zRSmpDZ{bST$@edBQc{sxBCaKNm3eLaTBjYY{nO z!v7u@TeTae8)qRxM$r@u6j_)F$ z-Q)NYl5gpQ8t<%H@ZPEyDD{EY*ag=|_7L=mHAFj{ zM#z7B&0s%rf3_;$7v{lyEcwdU9iHJoM0}%OFn*`zxQ-37>5##u2S%IHJ#FfNU%hPl z$z)SUEb+4`M=qPXhw>b^@Eq5|cnr5GGQuWDq)iPm6&X>yj<#tQmg8G2e;jc|24E}U`w0E;!_)&>UOnh8%p%D@%xHRCs3iU zO(px;v=tr$Z0a!7rtKqb@||YW=Y=-qUQB(K*i;@vaSIF9+4KTm&}qF*`w_drrv5mF z=#4hD+ho%fG~Z%Vx9yCxgPNfi{zdJbHXYnUt@o18?>43Fqb~cY^#RTwv}w{I#yo73 z_a8Q0#g?NsB_Fft6sjF3rW4c?nI~-uIb~BH^gm5Ioi8Z-w(|RnuX49sBZK`zLrZsqU!=~#uS<5>%HMvWEPi&frWk`EU+|O)kfund2 z&*wI^!Css|kry@%!9?VIX;Uloz(W*!Wm8!kL7vyt33Kog-_YTWO}lUu*>7!{j0MQ^ z&ZcJQg3E}1&sbQ7_wf8cUGWDlpz=rhVI7h_Q5%fJYn1rUChKR$#7sQEJM{QMT)2d? zUpa^6sPv6`;GV%Qr_rvq*o|+Vb`|xqYZUIFrng{Pzr!c$jqe{44XK@cP5q8zba7>A`YX|P2c$8fs(Zr60=oVvFR;*o* z@E*6~h%=EfVM?;AOtM{{QPss9Zo8JI*wwM1UH_p%A)Xhpt65Rn7qe@Bs$KDEc8$ff zbi4dA?0TJPm$kTEm*82#uDU3k#aQT?ZPzAzLQ*Na-eGrXyM8WX*AwI_OHMGBV_tlP zPkFmi&=bS3v7%kqaHXBtjb5^$RxQZezRro7%Mxy_#_z8=JE}E$nLElK5Ja z8-7QQw#q^eu$iF*lH^$D-Dt1l8CwPw~P8@>9 zv5uIAE66jRb2y6V3B-t7NS{bt$UDidFDNzHuGv_DJX5G2j!vg8Gwf;r&zW{@fnkNPin08WkblpW= zcN4=NYQ2}(f48gEe%AjGUl&J-A4`tgRr?fs2kTF>7MJV_MFn_VCLZj;nJcvWi?5w) z%=s^Iqs(L&b87K| zJ@V47La*!^_?GW4@7OQz>5tYQ?E3MeUHv{W7cTurKA)+}H@*hs(0zkLl{_7qY;x$T z*`XE|haRAn)uBL}LnHhh8lS_ViGdCc%<0hWTn_ch?a(azi?lorwZtww!Nj}{?Z+wj z{NUjC1&6-ClFy;_=p5{jLL55qKQRuSjCH7XoI{?84&HlksF>TK%oK-86>#V;>?`O{ zRv}_6%os%+%7r#)U(}&B*nzvqmC871oaWG6+|6+4aHd1gT08U^&D%NDvAsi0IyhwO z=uk~e!QoC09qP{9Xxr1FBdGJUL)PBp*@yZ2l2<>6h752hcn~=arXN0G!VrhzhEc;2 z4)y-Up&v&v7gEPMRA?N>#ygZ}f`hLghgQIMqC-izILV<}lO1}5#Zw%5JC)d{In-^s zL(673RAr_^x6pHzL)YdI?_7tX<~bBP-=Pf)h;xxcJvKY!v5hvHeN_;-diW{=L$MVH5ZseCXpa27d=-yN82PiWens=%zFL8< zeS9?#A$@(7h~Y5y^OY0s{=RC3?&vnaR~xYxod^1=KWYzR92ket9-Yv5xUVMu;;Z+l zH_}%xNBJsYw6BU`)>vO{nBc256FEM`SEr}?YRPn8wVvUtKWF-C)ofpFL;4(FJ)P&P zeDi%3i&pppehZmvsjn)*w9Hq@D}B`rJFtJ1uTH_VhPl`I>hOABb=mBz8`!knSL=6h zez&jg{_d-?`+arfkgxta?5lNu`0Bw4U;T8>SNASci+_Ao_m;1UJoHtq=e~OJmRvvj zYTQ>}&Gv9=1+E&M{EY0B-QiSTjP-S@tkbE@_yA8or;1@28u>dl1rL94>K#UfIJE@D zL!Fw7q%fz(-~;A`JC!rSsa%mxjYGRAr+$rfs$iT`QOV3**r_c=I9}ALYxupGQxO?X z#aD2udqt*r`}*gZ>PTYajL*Tr-lx3>f$h`ZejHZr{YHPIEEa?I@NZZQ-<+Q-J9T4t%*)G zo5VO%$ZM)o{?nXlgMjHy)tljzYnD^3&>d@#G>?9GjbG+FrdIPPM>lY{&gSo$7Ryd5^JXC!9(-LJ6iSW~3k$zel<);lXep(Ulr~L_jnw{dOc}4uRx2T^|i_tFC zPyeL($v?wSLo%5QON%pCmY+ss`zfTPpGLt^+E43YE#s%3a0q3}`DsphKZRB%7L=^& zr>*#cwKe<{`Jv{zy7P~uX?q3MCUsG>QT>Mjq3aBhX(#~HucwyX8t-9F~IP9-Wxb~g42=oZhc--;|&=1}L>TL?pXE@CPGFSriW@doO z&I(XNyn$v1s1zn+0rJiX&{lMv7od&!h~o2kjdwV+G(gMO(|%)sdhFyFjJpEVcu#=l z;3dlM4bU3gMZw<#GzCTW1*kOU?GI4JL!8Ho!vSjkXMoOQ^sxY?91l>l&jDJ9yt#6y z40@wL?i~DVkVAFy zS(9?=Ff5aEaz9N@9bJ}FaW`}75^BH6snwrz>LK>#%Ef&wximLVF6F78OKltFQvPq&)+^P|tTZ^%;SZ@89m0LfQ$*qnk zzC1VA%5w8HoLlvC<iUlbpHArQ#51UE_sX*xQ6Wg{(YIod zt|O&#kgA{|D%S{7eWcY2QhB_>%jQAKZX2XNoq|-fdyp35Dgt{1DH`+9rDu?;_YTr9 zOvV?q>Jy|j2so?M+C5{MED&C;cFG2c%_M?K- z8@teYbdY*rEB+o6qz9NWHb~dT1<8M6kjCORUSRs9AibNy@u@-FFA=0Iu>DGHun_l< zFfB+eu?+XIYC8Q9G=mzU(99rp#wz?iD@dOaKRZabuxJjoN4>ekhTQWwhJ+2Q6_7<@N??@xCC<+)uv) zK{|sD2U*iY)CY|Z2dT}GAoawTV?oM)E=WJ(CtO6yOF_!}5BmY*aTLR@1!*txUJued zY{t49K^i(azh1(3N`B>=n_mUd5(97$Ip^h9!lL|Yg+q(;%e6GW=7t693&J9Tm5fVB ziVoJ|*kBEe3)T(WKbTN0So6`Yda&xX3D$O~ZLl)&3Lfo(wG8>%2dgKh z;3F1w2-XJpbPQH0Ov6n)N7YWj8jmyZ?i{Q!Skxt0H!!6u@t{n%VEv9J-GkK;M{o)A zdj#td>h>b0pM&)`R`w2-y-%=yz^%T)it87w7C6wK_5+AW^SO#IQeubpc^Vf^`tbj|S@s{Em?iTHzf^AE%ZlnCE1$ik}Wv?Tf*3 zT?*DwT*bI6!J38Af0NhMVD-Z$%)UwdcY}5BJ~e+3tTu>$O#Dw+UyQ{*lztk_eF4E5 z{faiPso|Soy}-`*!HWD4th}FsHOD)I`vpVv2ZGEY%4Z2tEUH^Wv?+gx>c@uYT55=_ zB|@|Zf0YW+Jw%lc(W(j|+J?j`A$*R6_IO(-L>_fR)B_pyLsS7J8;7WNN9O1fqVss$ zEkyo37zZVLg>Y{cfWEZv7ou|gLu4F4+aV#UJ1j(>M}}zF62@N>qQ4QhmiX3% z=nPh@50U4F5czBj(HyMAq)j2ZjiZ}GRB=m)rs5wYZ4FVaZ6V6s5u)CELe%~+^PUdT zgmd(T_unCEbvH!a;kXyVJr*HajZzOo)CEsb%t57XAglZ!Sc!uf^+_Hr#)HhUJ{X=yhvB9Bg5FM&9@u5mA z7^?N@q3YQnRAoDd>QV1dnb(G@;o(sIb0$=i&xI=HLa2f-h3Yo?Uk=q}bhtvBze3gT zVW`$V3)Qd}p=$FjRD}#-%Eo#8Y7EmF{DW^O;2EX?2=fY4Y40#ao5GZ64%2h=vxI3f zY(8PCfUmGy!?X#}wlH% zv_P2J6%5np!eP3Kt;NFBx;SH%2-AD4$O@BZc9{Gz26xe*WSGvvSt?AaXo=(airS^a zGzrhjgy}-rFs0QEQ%{_)7pA}KhpEjkVOosuBf~Uw6mg;K=rCCpgsCJJE)3)PSD4zK z2;&-km>QlWf1F3ksW9HVB9_x(YK4ASiQn)U70!gIF3zLt*)Z)n7smH{YI;6Q^>75v z3t{^CBDI6#GIhmrIIfWQwJvkd~R_rDO`V{OIElp!BRGy>#5;d zh<#8w&Y^PEaCQ1ITm!MbX1Mlt4_CEb;ac@`xVE87?{NKw_I<*27Jd7MYZ*4<9wPgN zs{rO9seiZv283${uA$06#>EwE8XT_bzl5vVlyL2t70!F5;o5;uC^08of51F9TybcD z1M|Y=w;-Hrg5ff33RjcO;i|PIT(kCtEBF3zwK^KE5jcmE$HH|Sdyj|f2|l9D3C72t zn0hi??=kIExO`8CYXNSe?-}|d^DJ>o)waFfV%J zU#z|wuDi&(7OsTr#Pcki_f5jp^aXLh3|G&u;W~y!ico(zJR(#dt#J&M4H0U9V#Wwv z#2U{CeSnu&goa{*H?Q%tDMFpi5t1cB_wg2kd?Ga28lm|x+alB*LonRQaX9@Vbjd$L z_fRt+Le0=3X9V|(M5s&d2o1(7d`C#$2%W?=RQ`dOuoTtuMd&A-!wswsiqLjE${(S| z!4YbY#V8gMpB7hd5JnvLWL#>PYZ8p*f_jEYb=rs5HPi;hr{80JUi*a%tU zXp2Q?krbg;$q}mKiqHUegu14XLqWzX5~1d)5xSfnp|p$$&CH}OSXi7G@OOy_zDGpp zNmhh>vN?uFI9@VBf0d3}0*Mfc_rI@l{hJ%6V5eHgP} zgsKmvb|dIJIzrRON2uk*2$h@8JhN!CCPK?Favd@4i%{l2%=er;!Xx#iQKafNj#Mjr z#^ENBYWq{9Uc<9#q+Iw388Ke49tA13n;si%8YRZ4_=9sV7|{71=FPL%Val zN2IbwMyenF8pT*+B9%QeQiD-oR-{Ve7^3DxDrjz`_AH9ju-_uJ7kRfwD%TFiIUK3| z=>7-i5d9}{;1zlvr9b{T9;uKMks6Onh&UOk$;f{yQp1t+Vx&rA2)5!e@?MJM`g^4M zVk`WvMCu0SU5nHe6ucfO%Z*5#e;6s-BkJ;)7@tIH$MZOUiQED_TN^?+UdXyUDF0y7u=@}}_i{g7u zlt!(I(s$U_MybH&C>7sATWo@JYm{nWIZopfynl;QCWc`$s&0$Yc6@QQSimrN2<< zKaOF7qIDFJhGqm1PDO&d% zL~BaJXzgu9-`3Hp2=6x0GPaH8cZ+B(=@_k&oucLJ9Ibg6*e6;EgQ7JCEe1y`*U)Hn z!JJ{ydOI#!H#S78{FZ3#LanXQ`gS~;_t&HK0^hOZWVC)f8?BvaaFKja=~A>BLYJe} z3;C`RKccTO$GvDBz^R-u+)EmxVz*+n3SW?NJ4Rh`1&q&JQu%a}uN1DDW|c>y$CNh${cZXbK`f^ZHwi(iE%n@bZY|-o#j) z#uh`Y?jYD0tJ)ZaQ^@TZtNK`k8}RdrRTjEnDgK7pJ66Te4a;yDc2le}(Gl};8lL7@ zrJ*yH;S#(pvC2R{tid%nePUGtU9cWat+DEg52$I6RVhcT9tFlKEN`sdg~Td3G*;un zVl^W?RxM(AEF7zVBC)EB)kVp%7~>X?Rn8Kz>Yf#==;6toJKgMd{C*uAuR$ITv>NzTU#HoNGPRqUHbQ2loI9V-m+T|aok605Br`^cP z5vTcqaq5th=fQD&O~&c3kT^96jZ+tx!{Ye)IZn0$acWyIPEm#8)IW`J&@nwu17OUE z(@&XkN+=$uy_Mqh8S5*@>34Lm5+_H4I90-T_%@8wG`w!ayp7|y1`wyIc-c0N-}~d# zWM-UZ;r*;QEuI~xvpeE6eQ%sDV&v~}nt`Bwaq7FDSPsPL;K?}YRGhZp5PF}EQ`yJ# z#qB3?D*QA~8=uE1|BE=qBlL5e{J!uSKYWin8*l;uVfyW4scb@#=;V_zMw! z@k+ra4D*lIRm2Cxs|$AE3M%G^*Cdn)jMowz#TzJRyozD~#^M_)=8D&MRLmW(dKi-@ zUjL#(WW4I&Ag)Hm>oMv@$E!8Y$Hc2vT)h0_ z#;bi=ynaK=^mwIbFdiyq#_I+g#pBf-pU|=db;I1Oczw-|S7u4#D;>|*N4y%AkJmH2 zt4OUX#j8|(>W!CZ+8|!%a0dk&#;X#VHKNvd+Mc>}h*!xj@fw1HUFnPCi0&S*96iW? zNWA9ZzoGHEHJrJp$180H`QjUP&5YN+`5ec_1@YRCG7G8cqImUL9IunRIsZH7v2h>g zQD#5q55%jO%?o<7k46 z#~2TPqSEmMtvZpQ{U;OTx{;u9_TDQG#Cm$GD#p zxHgfX+Su|nL8HDAhbd9n_`{s20X~TuVNaA-?nI4;BTu3pvC2B6}M<=R9kwoo4{`5pOgl|Tog0T#S;)&XhXB86_T`5t+D>Gk}L``U#sFN7f zEKw5?*gR3)S|n;$%S7JKPSiU13{2EMTpg9D9HSG}bxfjy#wKdWoJ8$L?sg@~4N&S{qKe;7)XL|H+V(Y3FH!k>BJcSn%FiQ79gygmq|SaxT8E$flhg${ z0+KWa4{$bTk{r2`bO7hjGk21nU{anWeF{lZ*HHSzCh0TGaY>44kfh;AYn-Hs=+Zn% zm+`Vql1jBr(nr*4mn5}MQcaZU&UjeYJ4r+P(0^KzMj&x^lG-ExoFpaTJj%^Y(l01B zFG=N5a6U0EN>cpdBxRr`{Ff%_+cM%_o}`-?zJj<`Cu!N*Bvsguq&|meb2v%8(D#od zdHhKo@a0I71|Ch)SQI{%q_xNCe`GQ3_9H$eSxpKgYkt9G{a7ej=QEQvI4fD>Q8b%A zh%T9|4)v1NxM<^Ci-#FM~_zSZ{QxxR*;uaS4OHUAk*>=`}pfF11B%i%ZLGF6Fkn6p6EN`nojK=~ACS zmuBVUJgVn%X&EANyYwo`r3=w6?Tw{hoJ(U0y7U!M#a#LbbE-=rX)YyUdWK7FGF|G8 z*~ML2`9E1MeSsz0rLA~{{H0y$hCzrcM%U3|{crTG;YyQ)iPs=HM8N0(A-xwHX$ z(7LuuS#@2iil+DzTk5&=uz^eC8@V*G33L49QcfIze^ZyrV_^&8>)_H`0Qsci}I)0t{ z-f}6&dzaebXM}xlso6)DE`D<9#TS=eexpWM`JEi(R)B|Fb-mnbmeZ}Kx!io_$jx;m zH=i|fYhxa_Zv5a@TCiJ_F(2ha+!_<==CiYI?mu;NoyV<(s2J_mDAY=Dt3a|_CGZ4o zU2e^DyH%xtTf>UD^(e!we#IHTv|Cs408`4i^}eiIp5@%iiGFBP-mS5f-Fk@nRo(Kc z?&kCV97jM6x9Z^7k8b@_i@9r)1B`WOQ`fDD_1rpL->sdE-HL3@ym;5ft=a9|dWo-C z*`BdGFm@-mlDaY%zIJnKP7gPK@5-%qz1-Z3MorKOdHRrNU$^}GGtOYf!B?yt;#TZ1 z`VDvM=_t3FjCQL7a*ZL!v2HCH=hp4|J}`J!>Rj0x2hd-tLtIb=MUEGh+97#XAMs<<|)?qj9W41-Ku<%T3sTC zE9CSS`CfG^3g=MjAGdm6bL-Q;ZoRtc)~*L`IUl;!0`qYSS5fj2udx=@9=p{Ir;+i* zt;=|a)lc1WJtMZ~Zr#Ipj}(K0E?8~lynEZQTsT#7oEPf>r|#XD@MK)je#F-0FyvT}+};sN$oNm0kDDH>ZXMfWkc zMvDA@Oi^QOg=bA-!7Y@km7=8DDLM>O-4s=*M;qj;PaWXjfP5RK=+I9oy3jO5+nNz) z%M=Z6o1(n!s8jnC?)M^p)asa`5qORYol^7|^ExwD*A!*oFO2P$qJ=2gog8|l=u6)e z_34+QnS)Z)bujhA23*DuLsFDDj9Q}y5{FZ#87X=J!^{*lM;Dw%@ma(_oAKZ~Cq+Nc zP0=Rgo|mGf*p9)Q3#sArqFRXi$n&D8Dq}QG!vAGaRm5=Y#w*0VDykNkiwp31T~sB| z6KnAVQE!T>5vJi3jBkso7`kFPZXx%(qN)jZ(PBy~R!sFWim6evV#;@@6FM+IvOA{gBMNs))gyeu zZ=F-+*MqrX=$R^i%*4B1soMN=s{R<8D&x3RZNs0aG(J_UCZwv>#8ll`ma3rTsp`8T zRoz#nYQc_FJ`2Y9yRe)5kEbf%iBz4z4YWL&s)MIe)$dHI20SJwbb6A?d(Nryd`g|3 zrE)DiRbOmrDr`^FR7aZj`lhK|?lcX>jXY`mEtNFQaHr`Uk_x2h4ZapjQ}xs|)hV8) z$#`BOO`EgQG^k9PF5qF+G?l8B#=qxjveZaZs~^*pUNcQYkEk!E@EV8x@I6KEM0xW(^VlNUBAbrt3&B@twy6V>D-%? zt~aPwE?tiD=~`DkT~9E-M!MFc;E(B=Tr*wuYcWqt=0s}iblpeCU(&S#o}pM2j=RC?SNY}E3>AJfpT^kRitIxr7Ej*Mi!>x3cz#ABEr)xCs z-$~b$yXne&mahItex9!4_yb`t({&R$zo)Av_^Teug?aeTBSXs#8H)4HP#gSU%1}Hu z!C}eZBikAJ*O{Srff-89nW1sHGE_8ohDyd~Xb1`>WT+I5BRVNV_t7CEL#xp!GeaHm z2GvSr=nFzCWT*-JD`qGRE8$g{`CzD#p>)jpF+){qGEObVL8ID?gEy#Fm$>R>$lM`A zXW`Q^L#;byC|~Ccxw~YjGs3!NCbX;o5|Vhd*}v0|3mBY&kV=FieotgV@)>{?lxk5Tor^e6f>$kJ#OZ{nFqmLveXF9u2~AfVWf7;;@{gWwd|Xvomks1i=QF0 zcuyls?x9)A#I2F^9hIf?xQ$h#v$P#e$7N|Rj^oLMEY+QurT#Os^cazIvor(^mS$-d zDlN-WL!>Xy;(hfj?tRHpnXOr>jpDy$sq3*Ues9Q9v*TInhG{3VRN!WoMqP41@qR`7Mm4@LJxxCBL2~7H&rPCPlB}4`gK!q&w!VC1s&Q@H>?EkCjKA@baqdkuQ=tV$4 zdR0Jr6Qr{!$z(DUNV3`NQd3Zx(yR0ZkuEG{K|y*)5Jaj7NbgNL(piuuNH0r$U*36- zb3P}V$;|!VduOshGV>ob!#0DuF~Q|f7t^6qmP4N)Cf=dexZ2F2lF8JF=yYOY)O?4g zp!jc$i59;*RA+-jObn~+xOBjw3y0X|utQC-9L0_}wDhP$f1&d+hlXI)JIBfS1aU7= zC*C0EMThFXbBX73eydpMWXscqSvI*w7LoJ#kxQ{9n_BY2EJX{To4 zHXfI8s(D$~!2)cNxI zsfWng)2R}ui$i#Z7k!=jupjjx32Ts=NQ|LQy+Ok1o=spVh4SkNO z*p4RwLxtlE^~6lnNiY<}dR#%SW`=4ZrG=qvEe*|$8rp*iUmDC2Yv_{>hMFR6XG0Zn zsE47%3cn)-MUo6T@Dp|-d7{DJvE(qx zP(5^*%(%!og>6x0njtS1;s`R%AO~ETW$3-xhDI+i^eZwgBv1UX*w7}lUutL~X0J4~ z3q^l3yp_8clf_ky^t)VpR=~tOtnwQ_Df<;{Nq9ev)C63`K@)mWeK3ZZRrsEHs z1s^V|EMn0MQ?VU)(58Y*NoZQxrEih?sY@kmxRj%|OSSPJ#-+jyT8j;Y2aijx zIG4I&N(-0X3%N8Y>{79)ON&~$6!_Am^le;y#sgfMfHNpPkmopw6s#EJ(nI`}NSq-qokpc$E@c?u(v@-K zHH+S0D~{n3ymMSyx`=I%X0c1ZBW??0<03X~rQYo>71_-)wA$m+OcdEm?fYDc9B^^& z5Vaj)Jj_1s(k`4w{uAs6#GG=eHU37{)AaS6OS#XxR1Rk@@Ep~zuwO7Kg&dIUDt*7{ zQiBKV1MGX~(mh;w;!?V&EJwpW?2rUn%^xlY~Wb01#EY}?dtIQNdn)PP2&GR2zOnLylTrl#UFGPg4M z{cEaS8&hMErh}<6__v#>T-{Bb?PW4?zNt<~#FBTuF`1Xo)LOjkXR7l6lWQ|f)gEXn z7Dw?c(Nvbfrgnd4>J0J^GgSp6a1J$xo9aHo)NsF3D7n zWK&=KNL{#y3{y=Ng%@+M6_?R`nyJr!GWi_G)SfxiHrHfc8~QYl*XEmwS!^$4qTGZffueQ@)ebiQcD7O~-5GK5eT0J7-LthvO`$ptNugq+XmDN3c9ibp35!(6m^VQLiiy&{i{ZZ$$PI5N5Q zCYxJ!X}6l9C#IEkt93cIa+Y^%TLrg{U{FQ3N>p;IUS(dx>MCySgRiPvGd^)^Yc;oS zBKxOq{f5#t+=|D4wcM&)$F03FZdnb8joT>N(5*s-o4MKD%44~i`@yZw9=BFBc54&X zd)=z!cdH}TVL`yHNSs^m1>Gu-U$751@kP8_y>JK>5*P>VaS*qVxe0OcQB$`XAdK@! zMe$~CnV8Yst&M2Zf^9JlYjCP1KZmIo*RU|+)=n5vw_0HYe!(`}|AIcWcIy(VwqbnS zMB8?5{fqML-D-hd=I{ROvjT&52gnZmxq;p=WCX0^08ho#LW zEtUA#(yvu5#W%3@$!8XycUy9QZs{gwG_;i9v{b~f^iz(3GZ>L5#P5-l|yV(I#~mL8$Ncb3NB96laqsWVd0a=4`} z$Th-JbIiw6G#qJZ81^7E%F-$18Et7cmLtPBOCP|SWbt{X#kKvGcH$_$pI|A+R7-_1 z8u@;rR4VFNlxmOL9j2SJZ`l`1v(CzTx;oiMN&pVI4-u zR*^KehTvveTf5WQd^cpPGzw<0H5R{TwADM4tyS2c*;ef=w&o&7R$JfTG7{diwHMX1 z*_w@P*=-HLHF$H_S_tp^HgopaoM&KbS#Dd=4{UYHW9w(^%4aKYeqv#C0b5TC+In8d z*2KcL`V_I1zNoDqQM#C|^=Mh#R+bNKT|%>tEJXy(NiPiacSIA@{Pj7L~X8Ucu&j z1Y1^ZTVK|(wG-jMn#$l{%Y^$o5-2Jwi$J%;? zMsc=6L0e~F#M}H|(pK&STLC=4;-sKBI36NbJ6oTkDaK$o%Cu)c;wUP9Wos5H ze{E|sx_6)t$kmaYkggNs;pfh_d|hl!!&aQ?YO7c`_6<%UO%Gd*F%8vv+A7-1)>@?P zZ7V-KI1Oi_tw|U**wz)~{*GKxZ8$w2ZR;5pj$yxiPoHoL6~@}?hO_u~9P40Z5`7wP zYaT8@6L`dJY?x?kTe8jnvFP&@dWX0lZ0$kqAK8CX>D4rj*BR6|%Vr)8`hw!KIi}~> zN}g-${du+;pb@71%=4uj$2h)>T$i)&uz!WE9=~!tuB0A}{LR)0e6`BfN%UIH{#i@k z*75%Mo&ImIRp1X>qc&07X2wLfKW*k*AZMJw4a99Bj~(Q{(^kJ-wnkvkZd>K|^8Ui2 zeeAFOjDw2@Y-K!X>wBa>WGnFq`Qwk{ynpfDN%r$;@;qy+#yMN(&)fR=BF7!xVErZD zGnYA@Q>gzc#}sB=vvuqrTlH_)`r#(;r(3q(V%)zRJ9o$nwH|PMKc$z?Y}LdYIG=NT zr_!gFyzlV!E8b_>Jj~VQQK9S}HAm|l9*xQ8QN#QmeUEvCJ<9u$M>R@%^c-zVd6f2J zkD_Hf+E>n_TID_3i&GUm`n;k?M{%Z-M=h#&G!jR!v#N*t*ANT8;vRBV_oyAR*YL>1 zquL(Tuj5hWy1WigeUH|mL=0o2BZlEA3O4YlG&sNCGc zIbR+v!!49*LBB8_JMk1%TY5MrjGp2eN`yQL<3}7rwy;M|^u=;qNAU=8kc`8~6QxgW zJ+ixbRCEl_b9>dUg;xvEw56B$UfqQ!%#GV3UfpcxRq6I#{f%4b`juA)zxMK7r&n9L zdexz)S91q=bqSLOdNmJa2YEF-(W`NTy*fSItC(?Ke9+fu^%qXSP@24PH%$?+>pcxQ2$CyehNVtN-?TRdF9V;2wJK z_v+XIuSOj7>iJ=>Y91kXq+;-2UY$Sc)r4czchal6`0@o7Bn)b(+Wy-yFEK2VSBXdF3kI{yYx!=^`E``c!qWPgn5>{f78- z>RX?N4)tl`B%h98XtGa}P+&6oPx0xa9~gVJPcN{1jZd55Tt-u$zeCm#(w|%Wq8LxcIS?bfFw?5A4@oQ#Uzm}x)YixSIx@PbznAxv7+5IY$ z!><+Z`?VpbUn4*8Yt~18Mauj2pn_l5D*AP@l3#l&`!&C+Uq5`}S5h^<{;lEH(VBkk ztmW6n+Qh8mSK)eo-NLr|#A@i*=T5(F8-Bep{aWny>$K(9T-&cpnB?(m9?CZIYj|Tn z_tx{PCv{Yo6-S2CVp?sVc{(hTCD>`da!Vw>5-L2vBe$n#C) zhXV*~rp`a9aSPk*@#`{@_fi+i?elBIe!q+Ze&xF4mmg^_`;{A0@#G3)rqG8Qer34n z=NxXo_QH3|uVuIWYWgpA-}CD&R^9hA*S}xZ1HTqNWZXx7jegFy=%4D>80386SLc_0 z6@0~GnpiDEByFs^;4uQ}WAz$2bHu9f`>|?*ZE)m_RhC?_x{o^fV!3}ttY%}80;-rM zpgIU+Pr85};b8iJ@?{7pF>^qp@&HdjRCng1=QtF9`^<`;7mXj%EoDDvpD_PI!>k9#wlm-IK?c9Q@b5; z8j7y_;`HIsINipmV{z(vI!;eeFK1BgatBp1E~t%P2DPnCP}|!EmE0kygLu|6sBFE0 znuf?XLB;k9s>Q&d`s4Yapmrt(l`uA_N8^J!KP9NLKLn*8gKC1)X!TQ2#=M}?%n$0p zGU9Fw>K=}63aaPkphn;&2K^aS@2x@Q*%nll9YHPJMNYd}7w_*4D#N~@%Iy!T;env) zoCqr4>7dGE)%l>lyAafr%R#NdvMY>}5>(QYpk|~7<$4iRmzP21eif7t(~y)QUUT1z zR|j zFfQ(jSIyn=T7+49;x%z^ygt|$uV?q;75gAw-LfPof1U)@#yWJ#o1jI=n?FGjtU}fT z3F?DR#S+xHM1s5}6EvuFg1!wTsCSP9Sz{Blc7B3Z?n%%Ne7lbr2NP87YJz5|iCU&< zqJDT$vxzdGnI6(VGeWwxjyUT>I*kOeV%(OHwrmZl@1Bqfp9tx4N=S{I=!>T?wteiu_@?h|^u+Gm6tI({l4&eflXNOgO zPFPp*2(RacRc!(BaS4eF!^*yt=eW5#tom!hvT+?R*M?PjU06dg9_Ns6eONxsL*@-( z<%MTcSc}kXYgmu*;gPTofS5w3NO=xb+0bpjDxiesH%L^WHmEfkGtG=}wy=nQuCk1#J| zMC-5{0|!P_cu+*mku5QzA~=h(!y{^kf+Hd-heOCPDxxnidJMH7W?V!AP&p~02FN}> z!u<6S^}~)y5qXj$oKqgrIqaAfQJUEi?kN?~PV}D>(fGL$_GLuJ=272#*1>W7v>>7; zzeF?{?&T3R#m6fm%D5(?Pk)avr#t=H8&M}LM2|bHS2(KLA4PSnUR34lNBMVsRG~Ie zwQn2M0wj!z>St`iD`XiRRSd>pDl(3V>NOgDA60Lh!0NHY8W+{g2~ka)7*(xFQ5{W= zs_f(__o0mH9-2*IUDW#_%G~@>EyYQsAm5KsHAP!&N4cp{)t$yN?42Iv+?c3*7=TeY zjG{B6s(_+%qFRRc=SFoGgXcx{5*y}6RbXLM=g?|VRP9zr)$vqR$InD{83X=~>IiNl z&Dp4`A_i0O92w6=RpWe=`}ak4reXFUU0q*1PQxvkzv)+e6A%CU=UB|WheMJoR$Vl9 mO1|?0l1fI3H%b`i@b>M~>Q?XKe}C}n|8JM>|2O!*$NvFVvLJc@ literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/2a2e2a437c07633b_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/2a2e2a437c07633b_0 new file mode 100644 index 0000000000000000000000000000000000000000..5147acc3bcb62d8954bbb39fa209341beca71f68 GIT binary patch literal 36588 zcmWjL1$dKZ7sm0sN!nPGrVYj0v}v0*ZQA1Q?u_9+++Bvdy9{@Ch7BDK!)-%`Z1`{= z&fxohT-Wbv^1hFpbDk$O@}@Z&bzhaO)8{Y2l1dzy!lF%&XFT;jy$;v<|>f8RIZYF%akdTvrNG}`Er-eS*AeQa`|%S z&Ydf7ZX;uy%@8{0|6~3CUuqEr{r~4stU&W}(k0w4FBPaDO@S&(4je<_N>U>vRhFWw zNI7v3e`8fuX?Zp2F#1-fPi^TlM%0o1LiT!67yQ#h%GFc)fL)WMEK4LGs-qV+;W{3o z_EKWQdGy^U^}8y0N(5;O_TvtkmJHGu94r;2f6%#fkou!vnIMIf3sPqEuNb6;m4h?@ zbG{4G`!+!`w++&69D}D_kOHWU=7?_}q~CB6XFCKbtz(dip-7J)_3ay^Q7GR(NY4fY zY0$tRO~A0hj5RVyKaC+igpUnU@U$Sgrw8c;*3V(Azk}50PLLiv4boe5dKRROsQ)}j zGhPH~$IBocL5WvEs`@!dpG^j}2sY?KghAWf1|7uX3WzyYgWALxw7--=zoTqvgN~Io=uriOEL9C^TFs!2$W_ar;y3_DZG+lj33}FH z4D@Vh&`&K4>e14mw_OeLcQa@lW}!lNg9hV64{rA~C~Gf+67i+CLCyNmx359-uouz& zhz*v31~tJics+=D2OE@kh(XkMA204EsZoHd8>@y9@hdsEAZgUNan`cm=1qQ8OXi)A& z293ltxRw}{yxgG7s|>oi+MtPRh=0971u$cSL8q~Qqd}d2WK$C3-nGPCs z5_t~M7N*~5bK0Qi=ZX26LDuUA2w7(3Rebb=qvjt$fy+tqfQ!)${1o)O|wx4Fw$bwG~BTo<+2+Ug*Kr^)o~it8Idldy!Z+4 zQ8C=8j+l%sxP(2CMqP$CqfvjOSSF)pU}0vXs%J6kISOVqswX}oDw|PFumF27JiAe2 zql_99ZPYC^_84^@)>xy?d5xMH$8q$IH|n*|s2qt#jrSYXJ;3dBqweJ}>Sj)(vg9&q zeqP$(?|er6ThOS~LPiZKY*f>tMx8}Uaid;gWC^1-;2)%xG-?9oVn8WkEp60oc*=4P zQRR%DL+(rX*s6ouA z@ICEuyrxk_Y8ln7wo&1Aj9QH2xQse=jha)>sFk>fW%Z5v(7>qO&5e4D_n6*-I9if( z8>5=HHEL2jqYmK>9&|9u+|j7PaCSB-0Tplw?YbIutea8Ud$FFl*4wCOKN>Zz4{Otx zebC>i{sWErZm>~*4Q0Mz?3)q%wi#(uA9NXQRNJveJ%o3hQAZ{lm1he3=Kp>o2V|PT z9C$pF+p~=7G|#9<^Nq^7z^IluyO1%K7?rr(s9bA|YLC-vjjFYQ@i!TDVvA8@wz7uX z$Z@+->vtLz*i8<5$P-sFb|3p}KXDvmz0Nb=HTvE#s?-DGzyM@<$X>yuN9?)B%=MJo z;62(tGpfLIqXxd?O(Ph#&Y(l|sld?pZ6u?kq%F1o*!qMy|?eLhC%WKj>+(v^qla8ZlJm-;;VA51P zL)#?g@SBu3*`%H5o5Q4EbD8vKZj+Mpm^2r4^D;(0lPcwBKKzGb1x$)8Xwq1eEo{;Z zlrCb@WV9)2(q0rRX40_|CjC;uBuhn;y5j+UtHgNKOsZGiq}|y5y-9`Yn>4Vzf8*vh2Yn9|0iWk_#JZ0$`t(2+Si(Wf)9cQGlZD|PK= zQi1L!HA0jA)MNnX2AWiOkV(~1c8E!xhnjR{xJj!=m~;(UMiJL&ldj_Y80tBeImek4 zJHaI1MCO@fQibUz^~a={CM}&sZRb!oyhF~pCe6nQxaXO)b-qc>7c)27FEME$rY|)q z|1y($U?0As?h2CzVLw7vnq*u}OzVjOd$ySL1*f)>^ESr(g?+G{y|Uk=yI6kMq>e|4 z^DKMhJjXEUBC(^upRCJOlag+j)cYp4A5)8GCPjQ^4Hc{|7;gyHKgM8<2oBZ_t=eep5ao?V43m+YiVJW4p!-E!FpLcSO*&tQ_EoGYtOL` zw8wWHgSDu0u-}uda(NA7`ojE)+;pli`wJc-@#gVlQp;%tTp$8)$~QM^8XjC z2@26TbBKO+hv-)XWe8CscETMQqCFXrIYgbZg=j!@h{j?YydG}j2*$^TXf_Tb-Ag;{ zKzMwJ1}255gFi%la0z#CHaSGsaXckNFAyFGQBhRK1_Y&s=oFryVp@paVQ6}YHe-E` z5Z%IWxkJ<}Z-_qOw|pUbUw}CZhNwZI5G522(H})Z)Ua5HCg2dN7Z1@2*h++`5l-VC zZk1%d3gl2ZM5}QUnW}_nKK?>v)eyDCIy^z{Y9VTmhBZRe6-RNsPKdr>L_=!XJVY;B zhiLfF5dDt*qp8VQ`k>-C>H*hyV#bxpA?iORM9*f1=)*knoFAfz3qq80DONDtlgZ`S4! z>+~T+OG3?B>@aI!R}IWuGHbcVtUoX>#;p3Ww2d?CH(bR1c(dN%Spxlh zoJ%xoBhDt7bpv1gX4#U>YMo+MPfQ7zwGcZ~%_^H_)_MGeY3XJy!uL7MY6@3Qv!ZYs zS8*(tS=Do!^>bdc-sUqaElzZ{XMy09o}O{ zO|vT0;wM(uF>6I#vpkK=>WF(N)Yz=@n1QFL)`WR*x2ajVe=w_HGqY+pH>)}RMwu4W z17F~3X;#iwW)*|8jafe-X9u%P9nE@z59rs~%nM+%#vr1rS;M+hZ>01v>pAZ9B(~mW zCH!bsmj29xLj$SDV6#$(m{nt_SxvBI82yKH8ynyrVb+0BW*JADm2r$&>Eq1mfIj$u zQ{$<}1lD7US)He{XQosC8QjMzyo7s}Sur?+OLNVtHIKOFoB4l^y|TcpZHvqbTWr>X zgZ`HmmYFGrzm2|90xQ!>q|zjXRjQ(=5X-vohm67VbBz*+H{<1B;e#MW+Si9q_Ck~us|Kc`&I%U@AGwg%2%z4hN5*OG5zf*%hSmTRk?Y&Ih|D+Al zud*ii1-q_O#~bXOzuA+>e3LaqWAwom{Cvx-Bj|FQb;0|)MgD{F}6Uk=1F@VwXja zFfg2R5f)8{ErUhwOcu4tV$laLfhLKbyE9~g^R^b%D{TBNcTInWY+phY?6#W7sO zuJRU*tw25%iJ^*x$D~ECs}f%|i~4)E18i(r1uGn+98yZ-_;0hg$R;U$AzVMJ0z@bP`waFM5q2rjZuq z#8SLQ>rob+!jGew2OltFj79CnTGSiPanutNad47F%O*1)&Y;N@>WtszNwG z7iwD7ua;H$>M%a$;U+rQrOx%NnpU4V8!#ufqftYvERC$nj8n}Rx4Bg_TU)gZ2T-Gp zRZTFdJ-Kxtw~pk7-kq$vjJwF**{T9vtSXDgDA?7in1R%IkX7SRXs}hzA&iGJc#Hu< ztul|bY9;cHw`xBYOt9(?OrL1g-pN+Yn9aIjKWfggs^vVZ`p>uOH5M+gY9j_MWE~d~ z=TfVVpwkZOv76lXSheC;)?hEO?qk1TF*faIY?xMc94v`G+-nVAY@h z_t2`J9#N;qRtiiq_`CInyd-fl~K3LTl?P2_A)tJx3_J#fV zl{P^(wJ_M!4F`=jokR0rn@)$=G}LU0Fk%@MA zgyxxT>Vj3Mkj=(>+BU7pZc}WmP3yfj?Lv(>n=A=7MWQt#5*Zu4@k^3ThfvUO)4XJx zRwFh*jQE;rQ-d^{+Q5;+rgf;9)5d#&HcdooZktx*C6|0QCFQs27#?DFL7S=-vhh0B zrm{tBnpV`NCBOR$IySYcYtu?RL&^F!Oxh>E=RzwtSC^*u5P%B!lmu1fWZ~*YFE`RPc^%$;72UO zS-9%k6@}dm>DS1vgLvK2u5W18%C3I!wzaDPwxC^m`k_KcyK19wC%dL1cW1j+b+zj& zs&}*Na}T@z>}gk#UUv1s5CrwMtJOfedciZuu6IN2G7ht=?{K?DBY1>e#ZeXMBkd}R zSNMi8qnLNBUDuH^&aO6CgQv(bo;h#|ttZ&E6I~|RHERleV3}&yUYtVsbi2OCTU4E4 z*Vvh~!>_ZLf3{tVu@PD3k{?=N|2(^f&nHjhSZG&Q48m`V7<;i@8BuZxIbzcPe=fCa z4^E)ya%zj?sI$_p8CZt(tL(aq;%kTlmDe%{rXcG&yOPj&J!`Xpe6et&UAOQY88$H% z)?pW(Z>C;b>>7#bII`6)(>8L&b{v6!J2gWu^x47w*lE{4D6xw*#u%L3O+I_b2W5U` zO)vv3_u91-n=ou2wL<&-^gUo#u7h@EIz(NL*i{S@juQ6?YIu^IPqA0g?lfbaA?~ww z{f%ko>}qn}uB{hXTU7g5%{A8dx?Oqx zCgxjq`EIlS&H7C{&kGvv8>HpiL3ZBV*A}eM75ap<0W1 z#Y1(mcBtyt3DrNCP&ZUv>xIfzKUAymsZpo~wF=dEd~6%4dfh^`9VL2)^13Nhr%4p8fZoIez*DTf*J zNT@=NhUyx&9uHOeiBO%vcPEMI6!k>0)1itv6RN%#aF%w6K1V&yhw5J}yAY}zzlZ7w zcKty-7elq@5^HifR2#AUMyNLb6{;$KhiV-j-3-;=w^+-&p=x@M{GNnrHddhUQ{sLW zs+Ks8cQ8EO9cqU?_-b;fK(Iq&a2K^g99n_*NHaTlPUui>i$f#u z6veC#%|@clp*(1Z#cT)PK+@bk!ML2W>L!;;) z?NErvp|aS8ci0!>P_<&Y|zt~syP&oMreoQI8cLi!ACf2GEOarO4N3!DkkDM zy4In-bsbuZcJ&-uRNtW@4IJ8tn1&8jXynjo#58tj6gJ^r6Ne(2IkX?Wn{ytUTChGX z9cs~v_}Y*g_8~(%=EAFv4*5DcbOA*=J5&+NakUHicV+Fmk#l$Q@4?!QbMRcnp~?7& zknzNc!_WlQ5i@WFStfE0$B{UR7;zg#CKDI3PI2f9%1m`=E>4@3L9*65^_CKB>ev?DPa2#Qq*+ckYi$evsQs-?Bo%)5Cb`Uen zyQn+5?WV4Kh~Zaiy_eYcIn??9>wlQX#c|@tvXc(gIm6z;#i?0saOo5Ie5Nj6c?`&@e+*7l zF*!BW?9?@jQ!TAdJwR)_Q<0%gjf`+=Vg{!sM>;hqqf>V>In_I}Q*-ba3TJVu6?WqZ zCTDf(0M5Xc&B^Npr@p|N-KmY};&DnbP96NeB&SaMovM@UlquE8=O|7U%;{9ITuznA z?c}p~r}pP@s$^bb%*Pn{oyvr^=up6^b=Zk}$W(}N(4??a^Kq}JQ%8z9^{kCkpV6Yd zQ=K|E)wH8ip`Dzng=sj_*{Q=lm>cbSIdu$me{{;;hdlc-e?Ri-@6^zNPI(5C(-8XM zBPI=XDtS0H9O+b_QBKty!(1pd-l@D3I5yF#ER&o(ewfh_Vr0UPPQroa(v7si5uTaoDL} zk5lIpPNm}2AH;gyso{S+bv8OobrQpr*eFbSkf~>w;xP={a1fqev_T6*_YPAEE@AYK zVfqOz`h;l}y7djyAjI?wQz}Nl*gs4z0`rP6rLPWCbL_-{HDNjf^E&3<5T+v=!_;+4 zm~LY8jxcT9$@x8Dy0$ntKmssn$RIZ_m*WfM< zYD&LmEFLvL{dkWM&Ks??c`EWXO{xq zTau0H8*ie@)4tMD`){b;3c{D%Ak;8bG+D&lD zFwv#^lU%Aj*`?-F7-t%JO?N3`hD&YXp6OEkSuW+6<5Fw%z&fNYpdVgi)It}ZLzBlI z>Vzlw{#WX;*QF^qhm?IT6~IUo+t0Bhtk+SOT4F7B;Gf@I>U^AePq1dET*`IErRry0 zYJ@rGng4=I&rt7%OQUbO)bX}U<~uI+M&G*}dqABZy0rHZeIL8Hj>@I0PpH##_RR~I zetYH8+_$VJ`hB21o}$Y~mj=N8$;In8m+qn5e=eQH%x^Az#DK_f?ZR)cWDM7_OyN47 zIb4@;CTqBwMTe_hOt`wlhRf#-*JIp|3)ipl;rcTnT+4mo`Z+0Ft5U*sAP}y(xx%#| zf4KG*2v?zkv?~;@>xIJ=Q8Zjbi!m3L7iX@L;Tl;gTrs7?H3rVI;o1m$xp4h}!zfoF zT=Oc1E4C`Jpmg*aMQBay2qm?pZMz6%?+_tBE}(PA2;D<;rwC2NTy*Fe!JdxL zqahKxI)-tkMyU0S2tD5rp#>Ww^xMx7dV#2|5qi2ULO*Sf&}-D%8KJER+ZCaj*oKn3 zBXk#@y%Cy*mir=PJP@JzD0eVI<8l2k@g5;JTtfP95$cX<#~2rNjz{Pux}J{En=_1g zHbRFlM(D_8;=B@}LDwR59HG}ERQN`OR{uqeHzPFkZiI9%LRIfaDCD0A&3Hs?k2&^) zIi5$T31;IICcWVP%Lv{0M&9^NZbb&UH4$@h!r)dnqg%h5+)4>{>o&55xYft()@QgZ zZe4-F>Q)%GVusDFGj6wHGq^Pm9W%PM39YiYRX3|!JCGrpTcdFfiP_zHhV@Zy4UBfH zgvYJa7`Nu5WvpAXylxGRM*?vry7d}6libSecdIM@PIjwsidzLz>5tzKk>*w->_}&h z9B$>z>DDXM$mP~T+(aNZW8xAD=XGm2?i6rqa6z|{3ULmX;4kb}!6I%AL1Zzv9%Dsu zVkzNPaA~*Rl_9UPZeE+XM%r&;yj>iFakpDdeq}G^L?c1)r(XobRQF`?Ike;GjeTR zMjc;~QOUP5>JsX_$*8rTGwLDsX3E5MZkaScOD1J$kV)+tXHs$(;IEl9%aB=py_tFapIP6>W!6&cFPK@smCUScg!h2|+L&Fdk7w7{6WO`8B1+%m z=YmnnRVYg3u^*?gu5gs96^YV$)GHdLL#S9RO5KY`={;(dh*G{%QG913N}J0>DR#z*PKgeXN!j?#GC!3)fs z5~a7(I6gg!YnP(56`?;-8!X0s1ZG636;|LMteHuFM9rc`$U8eqU9blG=0xc;QszeK zHkQm|tx$hHu_5yUjv=rtN;8&6X&G{_h*H^=#1Hdo)((%>Md=+9HgF!hFlTd=#%?7S zyhGG4tpCm^)kQ0uK!v?gTDm_=l%M5XH4iQQG;K zK2M?)^fXG|7mR_v{}MZDyd}PO%=?kJK2byL_!7nY=21HKmHqRLyknx(3Rz>L<&KM1 zJM2Yje6;*Y(Td6ut5^wHKS#y6|H==IbJ7Ped|SQThnNjYZk4m z2yY&(LM@_|*fLsQ+eB+ehiEP86s;zmqgAj=w8nLfR&4iZweAtEGd-i_=*<{t-X~fW z`bO&$4)l-K-vgrc6ki5KYwX}?S%yT*G$LB|(a}mD6V2yb(Hb^2S}zecEn3;hR=AtAzH!Pqcvh@v`(KSzu%*|HZ5AKQ1n`~ z7Tklyzw5T;}X&mJzDDbXi&0;YxO;f40v<`m$9I_N7pgwJC7EkeGQNL zApLufT4N9T*Ye0%$HR3N9;MdxXi7bgCf4`pKm65zbB#ReilD|GRl)2g9u@k*ql9K2 z8Jc^P3mp*B!lR9FxAdqIyshYmLajZz*v6y!Z9UonwezSLULmNxM=OxMgGaqE4Ii+i zqenl(*2$wXn1Ne(j_RF>59bil#iMap($%AznAVM2pj>y4_MvGHk2>KPE@5F$j~=03 zZ))+QM^~}Bk4KKa9%aMrejX+F_oyWf4xs%&kJjPG!5-~J_aXE_kKyDt!lU9NsWY-n z;XX$FL_KDDv=#s0x7mz6hnTT`E;*p?Jm#A3QI`cCg)Q{xKDIAnU6H!Pqu8ai!Btq7 zc{Bu-R(SLh8&`Vt31ij~_j>BL#iQD2gK1cV%V@Th@o^1bw|SKD7mqq)6nxt~DvR7Z zJgU5tw&=6VqcymT+`Fk6PVVuj>aQL($4OklHx$_G(MU|*=h1w`?DuFOE@0b1ayvwP zM?HFo;lFwG2fW8TI)szQ83*AfSOc`iTa-P?IH%YHxO zGTx6da`&Ts{}@#m5F_J2+769Tz2PzXJUT|hmofgj7+pp3dg9vsPfhrO~-YlZHrOu?J+90Ge&)WjZudq%zHLQlP=H~Ay;G6`d*BB zz*r#$7G)mBs4Jc#|DzZ!!zKhhj?qChdlIAKPh+$VAD+c1?{n&b5BU0$TwcfM z5jwq((SH1nS|6zOml*x(rdS=t?a)}ohQ+E|M6CXS-xI5b ziLn}&606iavD#Q9R=pa=s(hDNJ?axH%lcR~Iufhv=VCSWLadVhh?VD3tnOgINy}E=kIlY>VBDshQPjh?KK95&FqFG+A#^&?t8XjOyQb;nh2=D(RJ} zlvfcLhkIyP+N<+$mGN>dy;rSp691u2S+AzxSvjx%DDTxRWUAoRbo8&`RpEMG^}_G< zy}H_fd{Cj0S8EX0nEEyGYC}`69{%9f$Yx&UYfjBtc-03vTXGx=TY2@ZwO6Owc-6YC zSB7?8s1eGK^{N&IVAMFT zf+l)Zc`9p%64R(Htc$!Vjm3+-e3s(XdPFVtYRNLM_N?)0-de9ZtfST&m}8??;XkuR zo4s1LgB%Zf)$Wv+&xgHgbebCAcjP+b<+=&#dX^l}AFJ^TKBLk(uj=7&ym2Y}=7I$I0?Nw&n zK=K{0`aYn~Bd?}Cp{7q+gBR?Xm$Z59)d6(>*Q>_ws3m?-oQ4F&$!>_#Xw)^vX^tsQ zxy*4~t{$f^HjanJ={rZ9USYU9PW95_^e4KOjMF7p%g6BLmoRdBUgRrqyoPI^;I&m`BjnffitxvngaePlAPB&Y`ajij|93A7>7jY`s zIZk_f5J&GgHO87BMC{EGHxHwMb*Tm^E zj&F*SVRM|CZi!Rvt&E3J|F=C(Nju`SXjh!B?~c=yJ=A%BoH8GXQ|se#8i@-ieIiaL zvG-)0p5O!8o+1|fhUur{^bRx5#3}477B0=6H3n#7owA{eyoo*cPv;_INFXB{W_=Fcc$P9EU4BUY8=`bsx3d@oJ8i z8RNNrG+tdZ$7={);TvMI#_Ke0plUW^!g73PYZl)$)%^u;R<)A0zuB*rU$67!>~KVJ4^+F}V>rp2pu zdc5l9h}XcJ@#>a~9P%(;{&=-06tBxg;#Ih4yk-}pE?8Wg7;v>jJiiO#^`vCHY^6Ac zM>ttJUVoO2SC(?|GF6UOQ=CS@D)Cy0PpDIsT+yRNybkq_SFazbeP71xAFmq2sNG2V zj*ZvMiScSRIbIcJGS3{^tc%wQjNU*@`{PyYI`cgzkGKSVX`G;XO%l`^pK+vVg4+F% zpw}=pOHdB{fK7;Qo}dNTg|HS0>WKG{%eAs?oCkMeZ-C;2NN^{!;U2A0D2r{3?%+W{CI_4$B7x&PbTmjIzbb03Gt^B zG!@Zj5;OuCFD9rghGH8YBkQFEK9^5WKWszzl?2_yQ^fz7pnF#nwD?+r8eV6<8wt9C zJbx$1dNV=4KTJ^QBi8CMwR)1EWHdwZrwQtb%+C_E^Lc{aVa*HH3~OI<3=7_{Chrq; z8=+ql^a*RfCFs0-s%G-(MTk!soIZ67^XVVhBYc{OKQj6BdlsL*W%Kd<2cPOh`_wYV zr>U_%ZS(r%iSy}7qE91|e0uKpDRaQ5N@+gj`rap7O`po4KQ`b4KG&jcZN{zRQ@*-B zt#0JgFU@?~+}y`&Ri9p=T6>@3JNWo6o=@9{`t%Z2hx_CoK_9fihfzM&9PQJAu|9o5 z-SIx9P4KBOwxjq&pWa}?B%i*Z%VeLjPW7qsG@tgN@eH5lq1sHJn&2Kv&i3gUDlPEw z`^Cp=KJrHBdY^J{Va%>~5Sa*3K=_Nm1cpSmISPoGwy>Q$ebV+yie^XV~a zT&J$6euK3_)L%aJM(p1{t;ZGgxJeCf`E(i~w;A^i>y6KteV3SU22uBj`GJq`9{AMs zu}=@5`gHRdb$L#WUisAhosa9Xefkr5KhYnS&ps7EUrbV>jw8X4D62718IjwRC_`|f z?xVIjQ8_aussoN^PSo41oXeJ|Zb;3ZsD9Cj+KCRHMD<5dOrn~^CTfm1QLFG4=X{Ae zki>ZYMA?castlGCqg`?OVJ23UO4Mx>E0ZXD*+gZ=kGPBi<(RX4qMlStl)qA z-e8XVi8_cg8I$;aQj!YZPSP5DL9RPV>V_+L4FBCE<-ND=@p`1CTYm)Bn7=mQdyiq#($I4 z6svF&AJOFUS~Nz;(zOjF#A;uov;vRVY2vD7+tUe zmk?t0t0?+o9d5v7^Q#29Vk4T_{pyDIsO9jhjMJ}2k$$~HbVk3tS^dg^X?PpsS9+{p z6TE)Siu0?bpT3xt&o6g=zp7$w0rD>B*CZT9=OTWMM6RNKy+DRy#8KR@j3xZ)QPQu( zQhwz@hq8XHL8Eehb;N5_uR#12sZ|xft|P5FHLO7`Yx>o`7Wvkpc6F&yeZST>@as)O z`Zr;AUw`yPe`-09*auOA!G84~;+Mwx zHFy%^q19yKoB#bdXCCL$;xd=Rtb#6%8+E;LQzYy?AByu#_ot@eZV?*vi6{4hGZ>_Oy)D{Wc5Q( zrer-uOy*?O!5H+-n#|uHpij1B)z6-+Pk^}jKrUa4^L4pY{u}2 z6kS7#J4Icw6IW0d_Mrt6q(Xf)B-nM}G%3-D=Jif)e}e^i;6qK1=Glzm!?8vI0zGgDM}7U%F4yJx3p z|3Z#q)1nj|K)J=N!IBj9U7DiPdpN(3^VqbX^C)+K^9NJZ^iYaA9Z%6ZG&zx?&d7R_ zwK>brbF3f!!qoFAYJHitLftE@JD#D^)f9ES#-99-b%6C7YlBl5semR01@zev;Jt%@ zp5hCJnF6{Q9N_OK1hfu$%mKNq0aZhgEx>oS1Db_@?E#$#4QN0_K-=NY5YT!21zTi* z-+uw+L@`W4e5Qcfp>yVdRwFoTK)Z1a|Kg|kfGoa%%Hbodi2+T<(2AAJFXv0VOvKXkMd$ zy8l4#$kidBMX+@YD1RsN>=Mwlt^uxR2xwLBfXqJzGyzBZ22{9TKx>h$e?XUp1oR9g zh6Pk}I5D8~h=4wz{m1}+KQW+6V*`3LKA`cF0(`z6(4SKRYB@8Y?27{Gvn0UpynxCc z3}`TJ9AfOl0qwv896cV8@dUNSZ>VxIpf#rgI&eCmv+$n@=sy0rNWV(~#a<5Z{wL!j z$4z3!37o$b(6`&H@tuHX-VNycdjY;v!+FF$2&f@;KBNYZ0$Pt(pNQ!*?U4OTKy|S7 zzktSk4QK`|=2Vr!QA?_R$3R=EMmkb84Z)dHH4)A%scM9$SyMGDTdE#Jrz+NyszEWS zDioWl^5}qk-cNEy7Pt{~Zwn$a?mZ{p^DwS)DQ?&uML8;o0(=ZQC z)hb*Yld243Q`K!;s-niHDj7rPrD_i{FG$rT+(EX5srqS2sxmE2)v%Qu$E4M%`fE+9 z)~rp{U6fc)9qi8cG;P2S z5ozj*4DK|I!vmbpm?meYG#$hR^vay3Czz5YO&?>@)Gd}i{xp4tB{@w=4b%8LQE4jN zBu$giwMCjP<7L}4m1&oz52)QfP3n-QS}50p@vxy!nuhhI|BN(^MC#l$bwKpIG^OEp zRG6QpQ7E_|O%;)6Au%pVQ_9jb6-6yXEKk$d6~w(VO}8*&6>+Ui(~9+Js`PW3`W~ju zku>#2zoTgi`i(l^%ds>KI-aKS$af-5>rc}ERGK_z$nAWZ68>V`n`yG&O4D{Uy`84S zJ84?_h&Ub-ha+8uo$0E8Hz?ss=kFG#>rr^Rre{poOEk}%uDe;%l|O5`%HRcZXXj^B zx<+`?Ws2u`Lb~ev(s?eBuKvmCx{SMUrlrf0BVCa=fRtS6YMMJ;3-hF_X5MuDUMyWh zN~UWf3Y4M`5=*D6WBqisX_(I6r%mT?IHhY8ay3bp`lqW7TEICVUDXCM?x1vyADXVl z!_w6WNyF21a2oMXPyb&{_W|Wp^~HPqM=t^bf9W7i=`cy?DFf-bfh1F@GZ|1oq*tXk z5drDF4jqv$O%asdo6@B>=}7PGeR=CW*ZQoGd+#}C?|qVSCb{=qEkK(|F&Z*0MoH6S z)Cz@W#HiV<81-2gqcNDWB1XMd#prvOR>x@hFEOgLCPwYo#c22T7>(N%quB`TCO#D0 z6QkSsMbPB+(>mvPrA38DBLr$=SrD2wGw{);2Zi zW^>pBW{oUuW<4k~*D0F$-odQ7Xi(m);YhAxR`nRO>f;W+HkmcsY*x6sS>M$*>z2c; zzV+zeYt|XuzyzOJ&-`X(4wzLCebLr1>&K8;H_*%o^|4T5dG4>^zbvBu? z8<7JtHRhNmW{quX*5PJmZH$`r`B#jKr)|xe(ax*~c#9?N>AM4ccQUJ5SH{BIZf4Ew zVP=hRv)X-Q=9(pHf=(#Xn>_oNmA@bT45A;r#gf5hRs4>2L(RH7+^n<_W_3WJk>vQJ zSqny)b!D_!x5t`wXq;K4##0Y0Me+o*mQOV6(j>D=P9dLZY@cD)n^|TZoo&|7>1GX@ zL#}h#ztpUb%gmax+^i=n%+e~e+OIb2#4jAXhQ8OD6)lki#i*I!(T3%qoY!;W=wouXAR- zJa5*+OJ@Ck!>qhF&1!{o9Ksp6Z}A+<5qI0HZa56b9kWj2DVE+f%XE*}{xj=ejLu-; zvjU6aumxE%Te$w+qG9>WYJD! zYhqEbDaW9AGwOi+&B-^#q8%+PI@Z#n4POvvYl{YbZBfy7)TzCN>w?H1$sH~F9{(ZO z$)eks-I>0+TI9fK{MgN+xo~$Uhi@!;)5oITeJz?c(4ww`s2^70B#I5TsOopr8a+^T zD0P}@(S2l`X3>}Eg2Sjco%mZ4Jh)NIZs1;`67;-+Uqx$HH<+y`#kLxHElW_={p43rYbj4y^M&YM* zlmv5~y0X=+tEP^+O8ug)itnkb$5pMWP|eCZJyy-c1(b@hswL8K1_e!4wZ~@UFm!f*H#Th?RHlA zaR;;8TXhy=Ixs$59j$tSTAi%Ag_l_0*{Xa!7#kUTT9qHu@bnw2)_iN#t{<(+G|I|% zNmlJf!_ij#JjSXvW39Tn$f^>Ht?KiWRo$0ZH3+*<`Dd%<{AOkS5XSl)n}`ux&~>v_ zIku8FRw3gytFCRgs_qV}&SBzCtLpEfcKfX=e!!|DxQNyVt=fLbs=i088iAvKS=IAz zt748?b>O&F5B{;L^ckzZ$GfvueRSWLoA9ErCnM}kdl5^b!v zPJhj9vSMnAO{u9iwZnMaOS7qb3!8?vw8{B}O=0xKP58gGXe z+@^YXgp4C>8jgQQlE)~US}(I{4&E#$?-k^UEGuoYt+%Nsj&87N{%0I~kJ)tjIQve~4ln<)Y1$bZ-y_=8 z@+@u7+w|8Jn?Aoo4KN3z?oqq@%<~JI&c3wiU`D%2WwPsh7P|^%wQE5(yH?}WM|S1Q zW!L1wcGl3dYf34*j^l^Yc1=ZzGIsSTYgh0yyBecFMZ5m2WLF2TT}zSbvvW;{U5^nL zuq%&Y*NS+%?jSwEu9c{fXxI28yP734ZfjzI^((us<1rexwevfRoonXoD$~iXq2Jim z^jo{$pk8mgZVt4w-ZbM3v+E~h9&Xom9KkdEI)ZUV+WAh|uFt31m4?mJ>>54Yt{M0f z+h*JK9&6HRi@+Sa7R{yKdDLN>UA?#4HFt+y886#aACHmgid`dc{ifmr_DNWIgPtMAYo_b#kb9XNM{x0&^FKI-^Wihb;IF1-g?1o}f_=ho%g5 z=s14(-l3^*4|C|BNgO}bp$s$GHpihY^Bj7M)$<+N3f}?;*Nrg7B8Prn?$8a)SV4?1 zt#oMgDu?Q>c4+TL^8VeSjo63CCWn@9cBtha#DzULw8xbZQFuHoIW+PA|R*hh`#%d9c+hcVNPmtLWt55J5YQTdev_cOI#Uw1m zIy}U%da)|zjOARWSb06M{4Elz&VKqbVl_P&t7;8nwIdYEy#-uGkb`YJoF zzBZ1pugJvuTmw{JeW%n{zG?OK)Aags%&f0tv+ApDdVRg0Q(sf&)mPO8^|iHxQ;kbH z^K(}qsQcj_*dCpqOxb}Ajin>n=` zy_-8V0`*dyD$D6Zh=5l()_IMs5LQ-5GT?u>D&$ylfQ zO>^otKA+{(U^HLo)O0jl~|XMwgc1OePoW3AofNvrD^i3y~}?){}H;9#-NlY*}40@C)i^b7>At*ORO4@$Xo4_nH)^e^JdyY#GrOC2h@Gy#X;ujJBkJjSOcw&Oi6 zo9U;zi+dWlGyp5>Fb*=-b*Tob*j!4$@p{BopV)8!K_@xkK6ST97!&HiK|UqDm#()#zV8;T&la#C2sVj+_-qarSpeq zbJ(RuSbqb?1?nh%ZZi8z8Mh%e_>I&R}hdAFKY;212#HoQlHN^aRO5Th`* zvRk#PxU~_cs&0kQx|&-*;*%J+$|L>*lUon5*5cN<>TYeo(Hd@@tL4`D+HU2q<5o7C zTcyz!86C7o><6)KT|gG6TUFqJ&*j!m4q8u`K4Q@QNOKQ6FRx|8xC}H>k)ExcdHDnIE3eT)yu6?y~zh-unsQ= z(8mzB-oZJNaS<5fW{pUZ;N?Uwzx;_N_sR2;VK^WfFp+exM=YxM|F>)H9Z=R zNp(G}N#apfhesydsP9oer$@W}9z8(Oh)4A?4cqZF-lJj(9(BiT)J^s%4Zq?t@-^|O zHm)@DC|7fj=B0VG2jjl*a9<~n%47#Ddb(-!5YdlbSV96{Du z#DL4`9(^>&qY(=|T7_(jh!azO@@O-@TI$hw%vtTxE|mDiBR}@6^=SWk>UqVZ82GMx z)B#VB^#=9);HF1^!EwvO=U5&Uxa;BEFppBv6N~T%@;;|;cwcx_{iR1IV0}ftSo+?h z49xVKY+lVTZ25|CZu}xX_{Ay zTX+@!g;$wdc~uQdI(Ydz#H%%(y>fQ-a;>CS`@iw(0a}0SRWHo{pqE#!-d-K=<5k1H zUX8V?C;eh{561n26=S~Rfl?&Wtdl&M-x{%wZT>##YKeXdbM;hZIIz7 zuYNWzL(thc@;h2cSJHmLFbIhwi=bw6&=^5MM zeD3AagQd|Hp!y?yG~*T;4EKGo^xQyl)r^8r5P80gdP?|eFq zLPLFu!7!Xft?zy6I?SgPxc7rk%}4k&7@N@NM;=G{SpUMO4P$)jHqob+Q^^Y#kY$=r zB@n_~Y{exso$gcp89qK|^l8sra+~L4eO~G`pM48_a{T0D9bTVGE%E6cS}*l+9<)z3 zyk9{bR=2YqfI{jfSp^Y6*6u0sTiuG0j}?$ z@0~oyNnG4T+`EYf^KjsUJC;TSMgCJh**`e#(>b`#&@VncM_YV(f#WgfgNr`ZyTo>+ zUnM8xzvfd(RQ;FuuQUD)pUU0#>Fawwy+oV)KCW@}@p&vcJmlYxe5?)X(`^)e;!|xj z!naR}5hb4y3z}mL^1h&+`0S-mN$7x~n1@!cd>W2@Z-^tSUk%U%u55n2%jK6*&acMk zj_DQr`m&;5c`Ny~t+HQ7(7%dbWvcpRtHwU8jqz(A!Y03Fnf=;o@#`jX*YN8Xl&k4i z68@|0SGBr+?REGSh^24bMhT~1MLmA*t?1V$0YB?k`dKH&uayn`+KgXAepQY5)gBwL zFy60df?ppc`c(bVOCSW zHlaZ?+F~@;;be3Eol3sAhDA}ocEXe9R|^coa%{tcmek=(Ki9`5r{hD%u7*EpYX}`*zqxR?h%5#Z2;D;;B9S&djYe3F`_T~w&hC@JQJ`ZS> zDWIg-fXwv*d>0dtzkWbBG0PcHvOA#So`8Z)0&+JEsAB7YZgmal85VR4s8IKSqCErp z?3;j|_X#L--+=BS(l4Nw{R3(>AfU#B0=hmppvNfuT|gso7M~9ds3WeR`S$^BLB3%D zHN^rvgY$=ghGGv=h6i*KpNt4-4ptz`=z#u*(3k+9wFg+AFu*-01Ns|3jteNyw1A3X z1Paa|SG1T(?kGGfz|S)BoK0JFO()Mev{}e8KM@=1EeR;Y(tzH=w=AG9mIu@Y=T-)E zaCJaSHU!lB*MNqh=H`I@MQBTa>jVSJwl$zy+XM1o8FK6(XVgX~Y{v;`XF$2(!ca^= zu3Z6*LC)R8htxd*nf9^`XW-r!P#mV=7M>&9fq;I&nS%j!I~34{V*$NCL7grI^bS8? zW*$)c3iUwFs{!@FB~-n}ew6(;!1d$Q_As1h`(GzVYSFfacR{h z%DfM#KQ>^P3>D8{aQ&;Hn;8x5&SdcYrJ-^tlEu&{{Fc>F&uoU)V1IT)b#fS*hdenA zeS=F#{>ac?RL^B-4szu-)ECzf%428|LLVEfKWuO=jG<-u4W<3hP=`+p{fu1&4HYOv zUl>u?(6b_jUKBMnzL=qJiyO*Z!q8Nd`_#~{XkOA#j#7p$BC(92C3uLvW$EuT;)JI> zu~#s(xRSwlUk2ZG84A=f^hI4mJF&rI@EHR62Ml$_AyhF8jln&Hf`*nOR|7*GaTu!` z8Zw25Jz}V7oT0~PkYFe!(a>plk_`TyG?YKtP&^*ur^be?O$f853XH2Oo47UYkFmc)#&zc5txOG8hvtChj$WQHQ>gwa@yV|avoZ4A{wV~oUZ zl>dr(#NVjW)=)aCeQoFubZti+kgq*4AyWs&!_OTJg*zFVj;%P^+0dt5m>Zl#hHi!$ zVmd6{4VCC&XgxCaG*k#doPv9Rp$Ql|(9mV%|BhH;`JS4OF!UUYMlvryQYYL( z25W*+7nGdCYkIDsiSrD7Jl{|(8esa*JYUM|7{`_o>k8%$`&Sz3wu;x|YVyGkzZg1> zwrdQXK##S|&wA>%f%nI6)PJL)!oM3DzM0(qU`%xR(_sBbV#aaYK*AQ{*g^a|4fWn- zXc+qMHdJXZ?=LLg$9(N)99%eHDCxE98Hb*A&vP89Mr}A^QzOQ*QEpx@G7+M&IGJbC_LG8uK%0bny64c)~T{Wm?F+u%+BiLyQa_<@X z!YbTH-s(ZMLGGGC`S7?-Q1-e(RkN}mL3>aeP{zU7Xpf+l|y%|a|ZPY@6ps1 z)ByzDLH!A{hp|!3$FcYoui^3sH5`YLF+l%li$%DJk_LTYBK|^wAo*Z4cHk|n4T9>5 zmAHz+4TEZcq1cVrs1ssb{EBz5hJ)NIC8)Kyi;5BIiFBO7|Kfs*U=(&ELwry+bi+?L zkNgQidC(8*aSvq@gKCV?*p4Ttl0@H_jibnx9Fzmyun-qftWi*nFb2Eu5~jw~0&{Q- zxtjzPzz}T2V^nJz|trQfqX> zT9g_a(nRb==5ZnYiaiL84{7OykOoeqJ^sd9oR}JtX6! zl)5pbnF#+LQWV$V+#FK*KSKI%Z%9@45hw1W=l+n69tdgJ!H_25G+rDIsn!wl#7hkP zE2MLOhcxaewKx%y6;n@!lz1wn7MOFIasCPE4-`E^JlJqHq( zhD;1=0t!ze$H`%po%#g2?)72K-4Is8U&C5;EUbH&dpxYwsC6Q&i6@Ek zR9LyMgw+7=kmqVxlko6bSd0G+v&KrI&Z!Gv|_eVFs$BAT5sq9vIk8kISs&RHT#%pOtQ+!2+}6Vb|#BifiZq96Vj zQF`f!qLm_gSUI9=RU$f3HKIM$B3fXIXo@+aF_wt#)QsrwS`qE69nq#b^jSBeVz!8G zVVj-4oDtP`M|9g0(K}y6Klvj%6^Lk_5z$3V2u3s?6&ghJeZz>dhaxJ0fhg2JqGV(r z5K&>Ihv4j}#y^8Aw=x6o!! zM3*peFL|NjzKDkHkH~W%qI?%4iXh{qi1K3^o?d3mE7ajeL|JY|xRxWLy$IimXxZ(E z8s8!B`w_jzngiPyd%T7hh}R9c3dJj-aJ3CJHkf5DS67=Vn3Hq#c zg7WrEkYh=L+U!Ws5Om&`pi+M)=r)EQO;Gn!33>`!-bA&@pQy44iQ4o7*eZc5aB{Jl9*-Tz3`FuX?pKNHn+Yob2cmZ+E=iCVOan09k4 zKHi(CEc+5waetzm2NG5Hc%llPN>nARIhUyK&L?W}r9`d6vdfHfB~fFZCTiBpM0sB& zs?+O4<$sf?Fs5TnmL$#lC`niFORglfZCuuR#_atfj-X#5RUy`0bNK)LxBz4J=tU{k8 zs}44xQ-NeHMu9@fiee3N7Eac;=I+jURsBE(OmrK^*_+<6$maM?2WUXJ2tkrvx zwF86q(Z|7LS*|84U5(T{LnHOZt6Ghe&1fWByGAO!xe@m#P0_+ODcaQ`MMJuz=yA^! zweFpw!}z9eiiYFoekmF@Fh!FGrEpDQip-;V#LRIiDlshZ(S)r3&0PV`Du^?|9% zJ1A8_44j^-bF))bG(A;^a2^xqq^i=~R9(emyq%XS%R>6cMGRP!s@zL?j+<*!WnY&n z1K06-eX6Q$NYxOG#aR^mHC18ENA``WDuCeTR4qo6t*Lr~Qb$sC7`M--@*QNVJWuHZ zHJ_0qZejGxR9(iaSE*|8I#r!BMYRGgGDp<~pJa*ZT-K_)$SQ5EYSRa4{|5LI!UL51(5YJ(!f zqN<2P$TB>tmKZUTT;LcTRbNya6ICp7kBxG_z^Hm-$AqYY6Qf+45!G4jNRKMRoGAAk zk7_6S%#CX7yeM-S)zSInw}4}C3^Nu+)o6KCli*(wRbzatnMmz>tS_OyD1Z&t24@9Pp> RDrEZq?K1uU2LJEz{{UBc*s%Zr literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/2b7ee25e23fcf372_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/2b7ee25e23fcf372_0 new file mode 100644 index 0000000000000000000000000000000000000000..25d280b66f812abc4c47b8bb08e360f83a9957e0 GIT binary patch literal 37312 zcmXus1z1(v+J@ne4ih9zL_oSb46s|VyJOqk+YapR?(XjH?(R4ycI*DX*LVEqy6*Ex z%{dBm<6;?JzsvGG?SKBV5s_kQaWDI-8cBAmrjE;^^D-lzw zcwB63@zfHLQ3=t}G4YYbOU9>0$CQjnh>VJiEEQWkA+`!0+6@iumsNEnD*ff}m4-o;k;Z%Qw2(&R`M~c8om6;*Z za1^!GLiy2DTMG$esFW63j-#&HzT;`67Jg2kc9V5XYRe{a-YgQlMP&0?htus;ga!43+adH$Pp2^YK%WB0`rZW$3&pq396?B z*OTO{g=xmA(;{%&n0iJ8mKttnb*x|T9|uX&)#jaxg!Gm?~&tu5y)d))xuMw<^vI^{E!-JA@?H+)WU3|-(wLNYm|N> z0=0}2+P|J^)lFmaGZ9#9xI7nuLN6#<3vZ1-TIl$ae!mid?62vB7H$}2--y7xx3pdh zZ8E917G4@>KZw9RW5!1jSYdd65`hn&$?A&;>^076p~zR-_Duwi8-u=!z(m9HhX}O# zNxifX`HNDuu-Rx~X(7EyQ_K87){A zB4;fOH703q`_Ktr3z-o>_X8~iDhE-0Eo@WmgUKh{Lf}#yxyM@wlvQKYZ6kkzzRsAc zh3Q48YpR8uH6Cckr%~e)76Kk6sbMJ#f!9W48C?f;!Eh_5`>lofe+`Y2mRE(A+{`rm>}^g}~2N z)V8&Sz`ZsW;@eio(4KN@A9tY|-7IACAPadp#6rAA=((Oklc(zImDM!Lsa>zGD4XdP zGHD*&oNpmeb^+DYLYIXWvU8D+Z?V3-gqmr)uC$QQwK`9Af4zmw-(VrJn=GW&X5E7= z7IJ5sg^bu?A#L{Pn(woa<_9cf|3RJOVLeAjb~g1Co|Xd5 zjX}9BWn(@|`JuKIu#~Z0ma@g$QbzjG`NEb0Mg6IQ7H%8Yf-MD7L#eVByu;~5gr&g5 zNNQ2SQs7QW8dAzq;JZ<@jNV7BGjf!(6zH!Gm$#J23iPY0r9kI&Dp=i8V43l{hNVEg zn$%hguhpbl)T_3ofNdSBP*>-sb{pTdP_rIA)Iyf}bU+K2jb~c$Y)pPy=w+lewG=p^ zJ{Vn^SqcnoK^d(r1+uiUl&b$&O14h)Vyv#C3L8(!T4+9j+$UNJG?+wZwBR_IT4~{f zk#~xvz(wPU7QQOa8I}??lZt7f@*GRKXXIOGDNubeJt%cJ@il>#p(A@M%3o!+#lorH` za%y3)ak8M5K!P_NFJvWf!W&Hjg0XyI*JI?>KbAbSUL?`|b@dJ5*W9Eerv&Tqm|6uN^i6fwVf7eVZHHshm}B;oiuHim4MA|a@In+v15;w zK&QR*Tni!lX^s};5RKBpg~L?zh@NG2`zQ@Qrt5p$O5#pX`HNNpA5{EhD_L$h-_dcX zy@u62D}gS?)3;Uv9WrUlJ1c=g@9Co!5eV;>n(~9{ zXSEhsl#SMF!8bd-$zd(4dAWH;Qi?kNl6iwCRtOb4>E#mb)$|HgNwJ_bdn`kXiA&Kg0JEYP6vep72<)~|U zYk^0`#7fozv6X3#79LfhOf593N?EH}3sg&|gIYMJ%G9J9+SkT+Ep)17Eq&_J=6cow zed?2E18adJ%CV8P^ftORwiYkw7P#Ars<+m4Qg@AZ|5yuLG=ke&3v_8ml{;Ar z>@_-d)^VwUMy3{Gy3!IYY*Nj-(;F>B^`u2wSg)-6(Eu$h97y>GSqtnm+6~rms(!{R zEkq2ZpTn#LT8<;z@zw$rCeUszTrjdvv=+ELmuAef7PvQ`DlV`VXli6xrsqyMucZtv zoL@&p)>{j#+(1<~S__=qM6R2y1?p{~;H|pOs^&IYsfEn#v}?DuK(0M>ObgeHl6$QM zM(?8^TJSqYU9_;{I2Ar&Ef8(Qp479e`kkUzTKHzXIBhM^`2yY1g7+nIcx)|j!zlAq z&#@Z!jLN;X7MT8#9%~`sGi}v^#TP35)mos$cRHbk>_4f$7V7^;AG8o}Ve?mZdmDjn z*~mA$jec#iksHSUv`{ODjm*tyBUzp3X<-|I41YQwU?WgFh$@EL2y8e0iLepqW4zEp zSQO3E!Wv^zf{j3hM4FVOFDr{=a?`?$R4Q22MxdLqtD22KKswpiwh`!Q1lF+;NHkVz zA+s)Bu5Y9Ntzsk7n$d49Y-mmgv=G*Uy0^3ucw+QuYa?*Y$Y`hQq-GlS?R7k=QU}_r zh3Q=>Pd6KZCf(_R7W(ugw_ZAbHNi;hZ6lCw9ManN)%hCN``HMDO{Pm)s5FJ9OtlfP znnoU4STUWVmf8rMGIB1r5g2K#-DV>Yw4H`&A#MlF(L$4*)Ml5B!1~>ke~*nol(A&5 zjlhb7wCa$Jz&E4j5gUO;#{Z7$IaS||QN!al0-KHRCu{^-pQOyQy3Z=@9A%u>{ZZcx zn@ctVO^p?obsWn53fbPY5vXe{xMd@d<2L=ir{_hbJ)kOD*kpJ;w2_vNY^2mpMF7-bNtwGfmdQ%`a5utBt_RZxsH+Mqs|N@{gW(mH8k2(n5c+ z{p+I^5-e$j7WNwdY2m0fmAA1Km}pC4XRCi{VJoi2MSEL;^C8qF)K=iV5f^SNu*}%4 z1*-@u9cwFaAfB=$*b3A(R%_vXA~jC36>u&>!?bX^C?yuN6^KYB+caB&3MHtH7P6P5 zvD(X}Y$dfcSyZwWSY{+v*6XS3RjF+?TY-(~G_{7Uz#^k!ZCimlb*N)qTY;7JsBU9h zfv6_7a>aP4?bnq4r-jhwbiakIfNv{uXk#nzs}H62({Zbf#@L~@0+)wT>TrF#dNP6n zGi(KB8a3wF3e28Mj`M5<3K$g^=zP@Xo%Caut$^KbTBU{dd+7WDJqOD55DnGBs$=x- zxUE2=6O`q&?zgIXh7M@qs?p+{t$=qXwRvYN(8GACg@_NdPz$#|k@pwX zv=caMu}6=Nsx-B=TA zC$Pr|iqnr*o#W|&7V@UhP%Xq2q0(B|X8bB@C(yPSrIfW3m|@&2XD3jxJUy;tCvdPb z6{}(=aMZ|B%}(HWExMwGp>@coo}EC1u}llj^{I9PJAvcIu_kr`1)EZ!2LoP<|~mFqVI^6Ug_OntjnTtS%YPwGjE0-h9{jsdhhT(@#5rg1;zM z3lo3SJPUh)J4QK6dw~g76k=^JP}G)2YvH0DJ$1Afh{!@cv)T)|Wv8ZESdoL=bJ`1Z zaH4}+u**fIUF`)X8#mqT1Z&iGWpUZ7b;>ZFC`#+gd?0{)e$LlvE$x@!!pW-oBcsFZFm zu*!H>-Cm$k4H{6_Uf{CfS>Ik@q+!#@UZA!yud(i<%GQL|wzL$<9KMz=2Z z0tXD+ZuSD*jo#hu1#0ym$DZ~Axs41hobN?NdfN-68y&Q;c{tS=VJ~1ml0399!Z@3u z`>T>iQB^IpGc2dt3sf?uOtTlroK8tI>;(qRq<2~seT}_9$<4Gw3vIVhUoE^e!nfHA%r~}Z zVd7rubjee8v=@jq*1gitHI?TL_0Ynex0LeE zUcmD`HTs~RC+eK>SPOrQEFbL!{65oCE#&!1%d{}?J6-!>FA(vQw*1odSEv3Xe{m4# zU_pJgaLb6ZbP(uoMWeKkX|%O=5ZGu#E$tly7Uv*`oDKq&ooJsHE*o#P@YA^A>>v=E zi~6}Z2xJ(SwJ^w)j=MPsRPmtac^w3z@=@>n4g&u(t`~3+DC9+L3OWefFa~-%2;4Hf zd>jPE8*{X9->Bp3Ake|jK|Bi6SnXwh2T2Ve%WwyQMaJ+52Z1w@loaJ4P{jyIbP!ls zfkG=f2z0ANkG0UG3hmK?Wi{GYOV?N>)u9VoaH~hJn>YxJ|A%gCpD zsOCfmfz8JENe%*wX3}phq|K&HTCkW;?X|FZ0Zm`zAkcX+W#8l=Fw{7;*+C#-3mx6+ zAdqD{_0ht<9rR|WgFw`7TBHU06SPtbnJ1~?DF=Zorz!VY2Z0P@o)#{jqmI|~Jg8;H zeJy0(pdz;&1S%Qb?&!HyJB^cCaJfr9T4;KY)@ot$eOj!A%|_V=4gyn*H4hyGz8c?L z90k%`siK#ozzpN87M>?kWRjyme4A7=4(gA8``MI8K94I0>9J5>7e^bUjV`w6OdPeLUwR zF#jSIyX+*e>?DwGL_Kv9=>3A$y>t@zZk&AOB#`|L)zO06 zTk7$_N#LMS>ywkfzn`i9S6yFq!f5-=Nnnzd^Ivzhu)>iBXK@xdYn0FGEU+LOz0$(n z?Bt%)S^wL>S(+M$oty=Fy3ipl*yo|iJ)H&a86(y@3-sJdhqU0di*{+jW;fl_Lbc;G zR}1Sd(BRuTes$K^@IPmP^w%^`3xnU$p^th$mF*L~`|T_+EnBX?9%><9VXCBso2lfJ zmP?>adurb&m%t8V=ipodd8SiKEkv%Qxf^l`{LkA)<3l7zgz-ejb`E^u+NeltXu?MS<@dI7lGQgv{(yvcGN@*Ym8j>E&@)D zR9_1@a*%_wUSCx=`nb9XH1?p?S_sHZ{qnd71bI;pEnN4bHi0ezTZ{@pE&`_`$t}u7 z;C%umC%OncO`@wsTm%Nxpi^4N*N}EMbrG;_MmM#vq%~z~p+R>l+`~m6TTcq_?IO_E zc%X$PedztaIxdwwfJP5=5wILg4YaU!2z4InBCyApHq1r9e5356XKD)!(lBttRcIyIRPwmT8OoyUiPj6hmBANSAoyjsaOtIfeAS&r<1EdJ;Te{Rlj%Ys^2rE?pjE6q2aEs z0vC;PZmt5?4R3c>flbC5FIRy;e|j6_Dv%INNg=KRxx*++q^rQ-SURhP;c>J!(N*A^ zu{X(8ph^lgN_7=jWgJLz6?j{Y&Xji*aIZjJv{0`SEz`oT%G9N*zFqA#HdJ#JcvzEy zYq<)PuT5SJb^TOZV|E8ufl?i5q86%mBG0a_0?m!R-SuATQ6CEF>nhOrU#cMF3_n4O{bSI>-xqjlU$##4DMT$)Uy7q|*sGukY173jU3_N{Uia9B-E z*SHGUZKG;h=(?Sn@6x%c^@jZ(SAl8!=%E%W?x*bsTm>u-lH(zrpK55V)WSpK$q`q9 zu%mSFxU0aQ)8ueL$Em6tW3*8EDoxVDDP!R+SAo}t&uv{#b>|Tke(WkxyQ?H7%|!01O^&wv%3i_ai>fzjPaypdEErw8v*&;1TOkg zUOzX1CxyvA%uOKOI2`FFFfNL2YGHIV6^?Zi=weKaa}y|*NTaoomP{LpxC#6;J{NNn zsFp@^wUE686|CSU(9SqqNynpR)TPH-h;2+Ynz{)*GJIRO33M`MwsaHd_YWP{LRfp6 zriF)wX9qWdHAYGwH-VAH#X-7`s@70iq=ibuDQ$$#Ta7c0X`$gLTB(Jeljz`5H-W6n z=;3M|i|W0Oj%Z==W~#cyO<;~;waZQ5&{4{E%uS%c8OndwO`whOS_{+8(?czkxk_Cg z>)xupMunGd0^aYay%yGdr9D601nhoM2Mc%o{*${jv!ZocaIv8@M|Xj7Mr0Ouf!(>t z*2P_5YF=uR&s|`Ru_M2`z@h^5MhoA)D4~$Mz))klkGsG=Uvlts7btG53~?9uWHgL) z7w8vFlM>wZ@iXpn*SMAJF3>xbj%ZyT)R?7(!CUC87WQnT zI{VxOmKX&OxC;zBN*A=S=@`Wv*LkRcM&t=SUuybkdZdNMXK2AWcY#+%kMr&Vn=aCC zEsVTGi?6r~yft=Q)$^#%UL%j|?gCYemACbLsZU1cU3Y;QU+A$GHjBq!3tc<}UK`!R zJp>LIo)I1bjbrGz7Mx>gmKG|+(IYLiPoN%29s&oA3d#C@>R@ron(86om_`N5dkDO) zLUC0+1On3OcP$TrGPP-VT@Qh)t;nmjhk$hlitXYdFvu9t)kDCmJGIrq7o$}V4}nca zYEKUV%U<+J3wZ|8>mfQ$6*rW=4fhaelR;awP;?ai9;f41WyaIDiTeKP%rtVJ?jevm zi`?hw%c`mIYrcoT(FK%qp@%@;Mf6Jxr598B5)XmHg+2eu?(ZoO9!BX&o&xiXqiLQ3 zb|t8o7D7u>Z!H`wMW;)93b>V_4qB*Km1byRWi@iC?kTX)xTA%_HE63Al4{d%EflUt zJDYn7Sht{@Z9D~Pw4()DDBhm3chLDNw~l1l%TxDK$7Wm`=qd1d6crn-^Ht81>FsP! zfrL49ZN9$0y1jz@R(c8ySWW+I@f6r<1n%$@=zNIwXd%~WT6D%!;Ehq@oTtDZ!|uH9 zgIZv?U+@%YYRuBYnCo<13wa+==O=n!wZ~Zh+*9Dd|0v4~Pk~9VsQf2SfoX=- zhItFr7)cAXFmx=Pn&>UyI*G2$)$u6Xc@(1s`<0Zgg_V0Ke80CqUt{56Z-J#J>75o% zU8XiSyal!xjh}f7RQg0SwQ$X@&|mgh3JIhej-G`Ce&wUm`3ngIMv`0WLIO>UC4CC% z_gV@`g@0+f77C1}2@?wm+&0?HD+B;iwHc-U<0CNE@b2j&u-^Egg~(p?KnsmV(<&`=*iA1F`v}Awp~KgF z1akkR>EbK!$cWDAD^SseW@sVai(YyA3d9zo5FcNG1^)C(3w?qqCCpdgU^xAZ@D(T( zNsF~GKbl@@;am)Di1!uvX)I3E_gCeTX+sfxyZUKF74;S9P>h0#`wCP`qtKGR`g?(| z^e#p3%lZm@EKmC?`3fwkO2^WD1-$A|TPwNUm&rcwxFtrcV`>Kydksv>T=SGDvKY{6n zTeP3RlLQJ&^b<%eLdQz^2{@Ied+B}x-D}eUEv#=qS=;yt)G}6f^%DsDm-=YIZ#4Cu z;3sgz2%6?6uxu&4*Fv^!lyTTk;EFN$q@RG#DcX77Pr&*Db-m&zQ2H88(!$r9l>Wd^ zV4kt&xu3w5w^Sh0PvGcx+LO1ifL%ViA6Hl)M?6*3!VDulrLe#}qh0aB0z2!Ib%VkJ zd3sP~?O%(uYL?OUXkmf0Ycx&^zn;>k=Y<7|{*OkzEiAAxlYVJo!zZ$G@E53Lym0at zNb;oNT3A+y>>~XIsu_c-`3t;kK`|};1uFkTEB^Ht_-KSI^%q#ShTdyo);_v=)L+2s z7>&Q=FR=A0$u)n0S-0r+J%0he`!wgNzd(g&H0im&z)3f!G|h%_BhIw-l=mQ84n7S0$&ng+>)=`e+yX9oxjpF?No>VBz|dGu|5fI!iO zbZSw6K?2rcwBieA%ss^Qn^ zix#rnpc3~21UkH>t(gG=zV9ee3)er>_a6ZQjz8&$7Oohjegz1O{Y}5MkZuw9*DT9G z0Y@tu;}|G#ISZv_4HQ_DgX-rD6jQ!GdqSWeZ=@7Iqn1>*#gVue#K(UZB9!`ZT^lpun|; zfzqTg)ovRoFuxt;XdftWu`_ve4HOt@tm_phu;1w2J5V6Q@b9a8p`H(HiMK!H=n4Q3Z@@aP(|BML~$TgOHv~bUOtA)nnX!&?u zTjf51e6=v#Xf-WRVBK^oKQmC^*&GU)7btLQKHXRrC{SPpjn~3ItH@)uuAgeOhR$nY z(RzBZAy8n&HX6GtP_FC_loESr%04|mYQ=uqb0AP)_d&8e94K(_Bvrl@DA3r*eLGMf z(0KJg*Ib=>On0>~{Ru7Cg6C6e{7kQP~|n%dmkv!&hYyXC=hF`&_d=%YV=9h zL3K0ke-9Ms@rOoeq4S2u5!k2#Z zCL>57dNf@g6D07&m^U^^V4cx%a*%-kOzJpGUsm^x?sI|!h8xA^1_@L#4r#$*KK0hZ zIOF@0Ac1|W$!2Ykz@l}udSj5l9;3%5otqkNeA7bFEwo+>M~tvtK?3y;(Bgx7epIeQ z1mo7Qq5;mejyHSYU|_x!48^ zEV{EWMKpb_74;FY}yh{ugh)bsBTF6(FnimTe=xn^v zLUby9EFCP6y&TmjA1rXxxTS?JMwe>A0z1(IuL~Av zv7WAK!EzJj(!yEet`;h9rfFOBzRGqhW#6v*r)un=qgvRsi@xs;78tsh&L0dGa63$S zt_KS=y+Lno>N!!D9#Og1I$t&M4OzSm78smKLGOYEl8rA~uzgRxw6OmJg?$VbsQH=Z ze$l;C!@f~Rn-GC*w&Z6QB5=l@ayfma;O|4RjP!@0b_CX5P=c3 zXoeQ5)uyIexMJj~8zL~;c&&vQ_2_>65P=_!sCbhQfiq31Z>tc2!>uWxQ;0yP&NRJC zh`_zBMt809?MYL$u*xXXJ4AnuF+|db(yU=20*=F}$%qhv6(eb@7Q8d4%_u!5O2$*^ z2_XW9r;y_`y^iW*+?*LA;5C~jXdz^Nh;&;JB2SF_%XJ-;-%6UMh1Tn6{rV7r0vo8r zrVxSAo9U+(I&P(H+w|P4?t3WZRER(&!~V3M6Xjuy(n9)KYOaO+=O|PQXU|jj%X(ck z+$eS>M4*b1c~#G=k_Wmz4@0E>6Z-foL?H1GtavZ4Ces!-Wztg9F*@VOGTs2nOVzG|pks}?Gy(rI!1P=S{X z$f{AOK)J?LOACXV(21s@`kbku65os}YTa6)JaCmD!xpZY-s6dJNq0(ppwbR1bMbvb0sH|KPDxOQJ zuNFqCVXNrO>QI5?HB?p$CD+oJb)fJm3(tn?Jm8-=Za27oA!3%`wGpLAW-X`|ccP=VcF=!6#f ze5HfmLIo=PpyzgB0-+8xPYW9y>1&oSfmT_`B4?OD87H!H4-@#3kL>d6%j%$UQ447W zXp~o&zz?INcbLGoLUht6OdzKpoev5V$Qeep!oviP8_y%d#5s!UM287@BvPFeeOWCi zLOF}-HPnB_s8nj0z{NEBT`o+&zZoVaD$x0gdT%wOCf%+lDm9n3X<^2EUB3mob_;37YJHuuUqipvh3Rv->N(j!4>pDg6x~L{w}%O2 z?4$MG&5tS1Rr+Rr;p; zseTy6e}oBaGzv(#KuZg{riHy$WNi~J(9LLN7cQ{Qp7J|{3q%=*vWE-waG?=eDDFyC zwQ$&QbPpHkV>HSgF0d>Qx#bNPIPF8ue&GUxjef!50*6CrWmvetyKrh85iW2hntH{A z3+#`ju()u2F6MB#WfV*Z7no@DE3Vg9hf^skP3Ni(8r4dK3mhp)olAuaK(%cju^K)hYNUjCCBc%zAErv z>O4Tlr+y8j@k7G}t_`CmBf|C1_d3^6TPU+?y3H;5&z=YN7Ky+A%*|z<&YV)q>9=nxchIODJhsxWH;7ZF#uBFC%TG zzN|JISvQ0Wq;I6dT6nQJT*9}8%K~HA&TxT{UDR#2eh#Q7#?*Z}ZgporwK}Mu7b^55 zbw3p@5PgA)U)J-lMqZ(BTBvrDX5I=H_;Q<4?uHAjHFjx-+^16y!UYl^Qe`bXe@3%E zgbO_SNYy^+J=B1&bnIKWz_34b!Z|{qOhFp&9U<_aao9IPz_Bp((So->tq+V4_!2~e zLLvnGBO>%U(Ie!(@hveze|9cHiYC)~E!0k-`9&fGaug-2)ChsC#;>#pfe|Iir+kD! z+X{4B3#TiSbJYle!N$dE5dt37X>pARfqIQ-QR4`KCM_wrb%a2Q@l^|UZK$^v4*Wwa z+C>QXccG45b^hwUak{&XOLgl(!?aMeCso$MLBqaxgg`H2Q{M>r-Y-Jh^rvqFbUjta zLDWw>cqpA579mi51pRMugh1F*ny-bZ<x>&$A_PWVrHj{e zFIC1(`tPxxS5@jMZPUVu=al1xo+&lJsPszjr>4FptG5wSE;B-Q8PmV$_*BuaH2hnH zz!ziD4?QdD#ZRj9D?(uSe{@zN1yU?1*(y??qG4wpDd28oXfN1AN-^@iFti1&>KrNX zz6&+!s^e4D`qIpPkpe#dlKYrQX*f1g&KdnDM+zL7LeW$8e(IJ{aC)S`MB~;BeVZyc zi`LAJ6v(rhny%6DE1&h0ut(2>8n~CT?2pvPwdmZA(7U6N0)3Cu$di!*=TA}5)4Koa zqmg(vQec&_UkhK(QOEO<0)KAnn%*JjdyxWzjnfbH^{US!I`}wJAmRz#da83&1)tMI zEiC;Xy?zlXQ2!;>eibRu=`C%~j1(yRj&8h<6e#eKR(;a(tNGvP*>^pAs^$+W|1(lx z(l4_7t!GM2`$KpCixj9RQGe~XjuNo7rHOV?0@<@rjjT}u53-SmQXF9KiQZ6*s zHA>*Ok>MUCaKVF$c}5A$%}3qyM+vklK2*20@lG)J|s&2je#g} zjG|RBQ3CH{X+v_9K%=6xtXPylL@Ifgj}mB8f&8mQ2~4d)cWOonRH#Mc8$}6RYfPn@ z=)BdgW@OPq$EU`$B$xJ40`)r3vyM>$uDz&!?;m0Sb!8!y zSQI6YdkHmJ8YOVic%}u*Wprn`uAeHjk|t|mg^_E0lz{gsYI9omLESXUo{bWiaE|1B zltBMWROND%K-(+S@l}*Sp|{j7GfJT7JF5FWO2FwW)&3SGaKhO6BTAsMMf6|Ct)d08 z+t9ySm~7n9!e?8uwTl)wU|i5bsy$^mL<@A!No(^*3w$a-&Ap-pHh5FbLeTc^}8#=h8S0h@U0u7#Y*R4XM~U|A7*Q#4v& zO-ZU$AzG$Z)Q_!1rD{eCjIBk#wJ@R%ovRxyP^UiKZWJxx-GnA-p+qwp-8@>rttGAK z87+|6i+*WgbZ?rYg_?b+r50`&1^Pt`tm;p-2J8G(uOXD7g|wlRu7#sU*5T0t(?^i~ z=xBk;V`#q?zKo-k3DE*;jXjg11wKqBt0~a}dyTVNC_0rEXyN%Zsx@85tE^^_ix$oq z_q0%DCQYBE<5YIDDREA;z@WMGUJJA4(Zl)C0__%(?J_;js^W6mtA$HO?RC)txAxK6 z{W@25;sEtJrt7NqAE&Sr(E=|{Q~23v{aF${v*+m7L)}l6_L!<@;gaF`G+G}wrh8=k z^DJ6m<8w-W5iM}!BW3vZV95eV_5ZnetoA3C6gKSn*@7=h=8lV6O$G2^Bd zUK=?AV+8UV?X*xfm?nh82+TD)gvQ9$uo&?Tr@{#_0v!@5qIirzW-8TAixK!(iiTB; z5jazck}JmugjI`?9_caCrZ)A^dNrhC&2+rYDXOKegZigE_0-yRAQ$aCW3_fiCkpAR zYpISJExX4E#P*7j#NILTzrHbYaCnR~nMlVb>w2kdQ>pc|7=h54G+Ya}=8?ss7=bd2 zX@?fR80kx5^kvmfv2r7Uo@%cp#>$V%u`(>3&Qy;TNUlLuwXoi})G1cLvkTqm87m)q#Y+D^G)jA< zf2{u9W32p{9xGjE#!B(ovGPPspA##O=EaKFf>@>O3HI8r``J|R^l`D9`9l$ z@26P#=@=)^v&2bsjySP*iWBQxagy#5C+@CsawSik%ql<+z2XF_7NmyS6NTcWs4qnq zj+48^;^bx;d6kS4$XbDlOpFs4Hi=%$iWBIxo3`(X6G+`hPtU{&1fQchTF8EfYTS(z zIBGopUz|YTOPZwxuQ$}{ZJdDLC+c1(USN+81^dS9WBlUfR46%x#|sQH-Y3Ni#HY{- zEp#qHJ4(h2_?M#6<>Lj$RiGY~;sw^Xr7!K`1qOAXjQ;Tg7yhMU1L6fL8XpJ73nUJv zRa)3@EE*Lr@OB2p%!(ISYV6X2>uj=}8!u3C9_`h_C8O<E()efx0WHqZS<3 zliQ|vfd-rDtQH;_pLfR#xSywn7vcrZ8IQHl=Ng^6p>I>Jw`iCaCK;C==vbBKBg)Xi zrVsS}W4yrSA2cB(L4U7Jkn5pTIxInksYj|qc!JDO6(bV#?`{&LtC|*_ARA*6Bq@%{ zXtNhh(7%UC5Z@9B5>hrnlFKDXzw!xkt73v&sgfXzYSYsO39`3wf~;kSiX{1g|5XhKL z-?h+uHLYHw<579mQn(fd8!tB`2t;h6g*TT|U^!j$9!0Lz8^J${MzGoErT<@=ryrV215(WAi(=Cz&?pe}Y`y_#8 zxoDM3l0a@(x|}yjf8W$!=ciFxDCkA43nmGq`qR*wNdl*9QBv(BeQuN_sbUN+d5yh z<#Cdnf087Zo|5PDB!LX0^$VSsTK|&vXd&(u{rfse;H|OiZIXb+JIbzwb?Wo`Bx&)1 zzJE^=DE5;oYGH@*->)Qrj=$-cWwJmvYwE9s?RNCXK3SlH15MAKEO0Lez0$(eoOH)2 zS)hV5<#$OIIBsNjOBVRoIO?7(kkymE6-X8s_h7FgeyzBEY|XxWs0w$$;e)Yh~~3vK?P4Q-PJyxLLG&dCD9 zyU-UcR4cAIj&K zBCw(`^@vUp*c(G3u_*$j;%IDqia>=Tbhd1YfJ=EAs)Z31=v>7Vfg+X2s!EDLxvI2F z3jx)sQ;igX2ga_t`gYZzKK-MGdJSk%!xVw_#`DH00-;T5o)$8i(S_zI0>xU;*_Jwf z<tOmdBt^hsD1~d`rr|X_MIgi&rG<+lsQAbffl9^*t@9|VGde}!q;X9P z!DDpI#*+K^6agP&vKC|lC23)dad~2jK-wg#qJ=t>X~C2fft*t*pBCO2bEc&TyftiR z=;wp7o=N3rr3mac{;y_w3yCU>@nbDZ$#AGJ4mTP<9$NyoUePA!n ze!&$LSJkr`o;ypbRfa3Ft|_12fylq1in!u_y&7w9AetUHnEFV~6dUHncr-#d2Ug9`RI5a}OPHdp-XRjGYEPj=7p zh4~z;cTi>iA* z93%Lwb6&!mD})rEit`ipUMB>t##@BZ+k|~}s*LNYCycSi#{^ds;Q-s#OgPGtTh-|R zK}4;uUkGAVznVKh5Yrc#2^otGL`R&ux!gbuy44Pkfhb5Y@UJu|Pg3zk2BLV63UNix zL4#!_2A8e0lLpmQ2IJOSufYPJ!CC80i-CwdQQfTu;$4SY7%~uUE3MN&RKHi_ToKcy z5(f-K>33Dh6>EN|<6#34wql12ME0<1;|dy4RS^Sm(W?DzAkIfs4OfIxV!azm{zj$% zIPtV$DQDuj+wMFJ_ZQ~OO07s~Px_YIHsqRZ=BMx6Se#r|xAyh=$$ir%H`x9Mvzk(y literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/2e1b14b0cd01ab91_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/2e1b14b0cd01ab91_0 new file mode 100644 index 0000000000000000000000000000000000000000..aa5066e68de7105945b7f502b524d45a05b6922e GIT binary patch literal 18392 zcmY-1cX-p~7x(dZn_Xs0(*d#yElrx8bSEu)@2#i|1wodGfPfPLW$!%&M3#V{sBC1) z-a`bHsmR__pU>~PuIG=3>w1~w`@QdTpL6bzrpXt5ufF?rnV!#{n}DjasMM6_x}jEP zsCI3C^rgfn7O5;tY41^y@r zhfBle5d542);x`uQ(?%h38ia6*QT(t8I)}fKT3@jkkS$|rLMf)MswuLH=%PcxFsd} zf_;GIzOT7TDSI${`yo8~2)cX>JwAmsL!jDckT4ux{T#YU))%l;ZjFG~M?!aLFbdjA z?r5kjUB*IR89WZYkZ0o+ZxVdB2IAI&>pNKcJ#3W)>tOLl)w~%t%6`e;0+yd4Nsh_| zX|Wx4?0^$8ZYRu>lDnY(9%v`_Um#Vc%HDl&R;KKSuO#7sdV2(xOXs7|PdE;t6WU+- zPfDDGPh_n0JPW4ZV9R-k`5ns03Arq-|9~ccLI){*0h}^RKDY>Dq|PO1BYXbmvi4IZ zU4exXe-$eIt##$5{42e$!Ha*O_;rn!(^BsS%)JS#q}weRDA(k`T{th(@4*sDz7KaF zfZ-u*k^@rk2-ZE;^GQB^0uvI@Em6#pR@Nvw%Sp+PiK3yHi$swiUr5E`Q3T|=JeOW2qIfMbiY6IRyejLYrz?ue zz9^1nN0FElMLiiUXQf=O9?KM&RuIL3>QRiV5k-fZQ6$xh;`Q3fTLN{XI4lYEqZlS# z8$_|PVH9N>MX|fFa%&pJ2Qosow~WHpI*RvY*6UIH*X}>=$D2{ikng%g z@$9WAx_6D@e77i4yDL^t^>A_&lcq#rn5x?5Msa4I@|+*VyI)4}(}E~kFN$L8z9=jQ zq8RW$r=!?>CJN85QSARMic;sJ_)L13qFHN>rjjL^Iz^)yTP&J?rEfws>l34ClN`+# zY0(_25=~)xG!5mfoODG~-4jg{N%2K9ArMXHn$i4LE1J)0NApAq>qfIuO4N_$L)qRS znn1&7o;Qo8Pm5?Owv1-6TyGUkyVlWkmFqIGO*HSfjmG@4)_WzIA5G$fXkMEb&3=iQ6wO<5S6-SN%@MgI zk0g0|G{G6sRFx*Pqd6~Szl^5k!f5`G0bfNkbFpH69nIHEqPej&nm4|U=Jz!^_Cqws zH%IfQtlbvPf}PQ1?TTiwd?O$0#d+tRXhOe4Q%^=n_F?tni1IqExR12PW3Br{vE&;m z`$F;mji$WOK0RBx$8tyh_Y-i5d|F3&NW;1YUX_DluWw*}0|PZ$8fYoSTd8IlFQ-}?*wWU3 zt-XQLa$GJ+>kbCybX4y;X-+rw>}|!Do81lU>7f|C3?%kb-5=}mCwe@@z}?T3+e8Dd zNe14XY~a}x17A*8|76uHgPt4eiL_d3V5!_%X5jVZ2A;1pP02+ zDc65A(DWw*Q`Z|XZ7}fTMg#9`GH_MgTeRoG&)Qo#yj{KAq5a>fJ=&$*b{ojvW1zti zy13Sjwp9nvwDeMusLEIhA7MLb?%ehLHwt zBWWHZMf^sZ2aK!<8EKhqjZsgq_Mw+~1WRtwp$H*sgOEUW!StM`tQ~eSgpq_~F10x^Hm!B9Z z_o;Fr(hb7%`7iZR3q>ki$}Zf{|l$j7*#n*6VamZv9|n{RShYHX7L_C#BXV zBcnDOc`9kURGa*`+eno?>fc)o+^ED&Ec}`gJjJN&0s;aZ*O~ zFfl`{Jxw(3Wnz;|>uaLSdnP*eGjUi34Nwm6n;0)O2AXIgKZ|v+)|OKrDE1^1N2T#( z6O*Ty^mExnk}R2KBKVbwy;AaP6JN+T>r7<)U}BhL|7c>ibo|LgxAi7gZ7@-8qvpt> zO`5;W#Im1FJeJlwOe~PUcIxpi6R+~ka$4n$1 zH(@?w;uV?ytBDe4)tmDg|A&dDvPLTWX`;&o6SXgzxOv0G$2Uy`Zkebq-^!!gCU)L2 z;dx+UlAL*HqV6LT*B+bjJvA{;mj0_e{xk7hKE%vD$&EI%L^jEPveRg$fyvASvsrK0 z&DiCL)yyHcnRh*A?nt)J%wpLf2EUm)S!TB8m?@HLrmZZOJ9%b0Fe zHq-kRGfUf(8A6uo*s6Z~Y-Xq|+hykVZZqxo zsP27cn(bE)!qh4{CacpeY!$D=LO-X4OOor-IBDUw@P-_fB(HLiD8GfS zQYK&_LuSe!LFE*(Ff!A^6IqdEVWVVZTj-Oc^YT)}qW2XRvI{KKk#+LC&_egB79#a5 zOqcWZEi`Ii;bLP8+nQLY+SI~MDbn1+?lu;V%g~oCRBmU%FN-DaRSRuj(|Os|(L%*e z7T$Wp!lzvYN}<`xC^=%WayiC|zlfCqMXe+hx6(ee< z^Q?R%JLX%lFR;>4zFuhM(IP9Izp}D?v2yv^idUwsuu^NSl^>=1cUA_=HSw*pGEcsf z37f3EzfCzwsqI#VNa_yNB8PTrZ}(XlcihT#37oX@rQG_}%4=t}pJF*@rN7L&sD510 zJUK4quUa`R>3^wjvi@%?j%!xR+|YR0c+*Pcwt9a@dvVvwLAfaZN|Ae3(jHj(O3FO4 zvRFQOV&&vh?fo<5{apL`pJHR9SCoyx@~dP=+xXC6W2D@Y?nWEmnrw8j+E`e^hOMNH zCb2d)%Q3kr&*XHRjjU2OK8Uw5LXOF&b{o4BY&1=>arGq|!Ll|6mb3AfoGNdlQUx2` zDr&BLlA`scLS-A{WVZY+FQ+QMG#g1(Y>bg(={Bl6Y()EPERf-T8~Xz`@`GAO+<7*Z zHnibsWaGWYHoXqn=-AZ8Mu~2&yxVB(%Qg;6LOUDRJ8HeRZJd>gJ#37Z%{^^6dfDjR z+s1iG?V}vtv+-P-_Ot0V$EMdD8(SsxzKuZxZTu}&2H6-YB?jBbm75avfsJ^{`q)Md zStCQ692)t@8NJ#?J3;6!}4U%H|(!-1td*u|cuKx<~zzTff+N zeXot<`)rgxpgokia_pe`aMH$N`CV?Ewo!1_Mq_#JHyc06FA{&wMrG-A-o`gF>32O} zWUbWu!^UJ;@u!VP@;E+*8ul0(Rfu7_9FVJdF$D5s_)x-yF&vhks>M*XdJN85F?=LD zYR3?)6T_0aF|=qC!~2rgHU{g{5zJF*J61hzx)$R@f)$cED1Mb z>3=ttZPMm`EFV2kzK>$rBi$dzGSLvnIav}D$B-g%9FPV@lWEwM-n72E=h*KL19?zt?ezT_4AKF>TN}X}&v-IkNJw;-6J~S^ZZWEw0Bg zSBBiyynAsJyC28x7jaB2R*FBRY?V?pmNV5$QMpDb>h>%}&q1a5QGOayiZatm(M1AF zOEG74DgKhmdrI-qiBkL`=dYGx-QT5%x>kyTH%l?}St$<5_y3k+#eb!EBySMU=ID5A zhIsxl#`CW!p0?(A7K+6ZPe)lHrL6J9#>DfglqjL`aq+a2LH2k$B*n8_9Hry=piDd& z72@eHr_$o-=8We%X_yhuzCb()!FcZE#uLtq=W>2LCko>ExK%uRrR?kRZ0Hn^`Hgta z$fB+P&#Z#q!JjDjY;~N;yVEIE94N|O+6zk)7Mtu@b^bn1eZ$68s&(L@_%G6=; zq<;}lUn!Ur&nr{o`AVu!izk0ZJj12s%y{n4iKlRGJY(m@WBM|lrqXSJYFHjm$_mx} zLp&2V#dA)|ZHcGNj(GjvqI!14b6|Ho{eFq3^?`W4l;a2E`SpH0sSn~wdK%B9f8#kX zO|Y|9>``_W8tim6*;y-D7CY}-?Q9p1&CY}3cB+=JGrpvqlCgH$NrgDO-lN*-CwcL9 zhTH8Nk@^XCPDx6loi(zeg2tuWxtU?t`%*jkZabyDc8Ub-49T){K!#`A`6kcKW7(8% zr)k7a`|5U<$<`X0Ti?$926hq~+Id&nHMZ+_3p?wZ=y5a6k=4!Z{Mp)$tBsuoZI$2a zcDl=~UUq8twlhImzGEl3ubnq#Q$ITw2H9~Bw$tGwJFPykGhbppwR7e(JC%ppStYYZ z*tsHqjqa|M zH!F@b+G6L2t#+cfX}zEAye>=SPr0ZM*IKyH7C>D{mPsbxzosD0}70U+r9% z%4hBTcEL`Si|X4Y_4cNn&NB0soxAt#RC;D-fFVI2btUjrGK(efiF{K$fklZ4+>+7B z2`qjofjimw6bDg!1auk$PwARB$2O{CvsbU z|0a>dZxiVxGiAtki5!rP>k@f+b0UkR;?_il?M&pbtl6bCb|>d zPvX9m`9v{4Q_P`BJRY7zw-HHvCxs&wf2`t<)A0#O?4O!M;xx^jsoS|pbdu-ulGr&v ziIQI?@zMf4mO2ZQXt5}X?NyQ~o}P@)n@o%RWai4w8p&8{CR0^BwUQYq+iEAXuTC-v zb(85OjhZDhU6wXaCcb4dU&?P%rByQDOMcsAhD()p$^7(YGRDryl`&%~)I6wTVmYL>B=K-Eon)qrK9$TVdFg`YUeY*Obv2o-eX#I5 z%id!tbUU5GchccX3XSilFhfpSDq$^Bi53!*T#4spD^aIhC7gjuBy_DrM_Dwe5)D79 z#55^CsuJTTRN}1km|Kbdn<}wfc5kah+|P=2q!RVcRARDJxll=;msFzG72U>GCM&Ko zQ{Jdd^|vcCMp6b;W|cgZ!26Z?L)wq3%rfbWB5XK#wI@m`bmzsbo}3)z7C?{T)bUVC_`y)Jx@FgH$#*);i5n+0`PI3NNS9 zUDmcsrTS~B`kpJ5ww+RO^+{!bxCiU}hpDWS)t{wuW0Z0poyxxxQ~7L~@{rmyGsSLunWfr_uL#8g)*lF;O0!Nu$LdY0Q-s zS2g}-8s%@LvGYk98(*q|rEC>`&#pp=oGLVu>Cz%ng}KtBS`~hJwF<`9s!*nX6`K6d zf-20EzB{W><75?GcT$Dtm#c99Y849qs=~;dRrFcCj>+o#RWR7nX)J%orjwtX&Tv^= zDIH57UEj~8^J(*Ru60f)vr9Tn-cD!9N9o)X_g5OXBAq)jb8|W;cBWHdS32X4rt|%Y zbU3Nwzov8cd^%~rr!)IA0??GfO7^ldkJi(y4PJoeR?QrpDe% zr@g!@lkcYMbL(`L-%IDN%zT>8=Ks<$Mmgv!pU5sLZg9}j=wQ1XFY4gaVh(l}caT-W z!MY>|FOnVfEbU-+SqB%(IcQPdL0YPgr8zh!l^qTaNPLEaq0-6kz#edrDpTaQpo4}X z2W<)*bd{7s2LV|m|5SC*u9|~C>N)iH(ZTZi4mOCpfrIxNI=CbkS~$2T-?VhFNxZEb z^l$CpirneoAiAT2jj~?~Iyo5jhJy#Pqnm>hGVW~$^CY&rgSI^!`d->W$$`pekm{79 zA2~?=#K8#ZGsMAR`zi4qaE}p#4Y(KTLG+?<5DkCOe3mRWUhn9 z^Bfd@>0s{y2X&S>7`s$sW&F1eny+!tV6B6R-zm@U9h8tB>va4F_54Q%vwm_=WWDZh z(*4c4zeO>&JFxC>&}65BEmCB^dVJ79_d^cO$`3~zx^BwBienC5I_|(P1Euh!@;c?< zp%gjopyqkyd(*-9x3m|x9puTW2M(S*brADR{gLBR`?-TLFSO6nBFf3kXeTiSC!=GW z94q3aMo}j#N;rA7q?3iQPJLhD)b&G7PROBhP7*3O87>o3oSdoTq+VqwvmBZuU7Sw( z%U|MkIl1X~l9=n{^*kqKt2#MX%Sq)rPA1E`dQM){cha+glkXcl>CnW<*G)CPnUguq zom^_+)O86?y2*O^{$(f6Uvbi-os-M2IvMwxlasGI>Da+Z+wM;0^>9+6r;{UnoFw&i z@`bE?-^mskIMB%mNgwRw>L*Sf%bHJ}{4Aj%P6mJG_dQ-X5(U zj8WclUT#WWlb8>pIlk!WHue`lXxh;3n zeua7|3syP#d$p4#>zs^P@8tLfCp9;!Kbv)Ii<6C8oov|VBzn8n{>4d?U$wTBKI_CO z|NP-(|3&pxrd?7_l6+ZXt~fa?m!;`-C++U2Z<2P`NtP^;TlbX5eJAh9?@zRE|2p|x zs{QArnQWJss0;?lIC*N$;Hx4Ttdn<&X7GvJmE7VPES1gTh|l0`QU=#$ak9qBfbtoX zubhETuE|sBk($BUvn86z9aVUci1{_FFnlQjYq0M zN>{U( zi+W;s$wes{Ci}~}2$ys5MgH|-mL1PkKB+@br<*QxF}xVMXLrbcFM2v zP~L6s;-?mh)zU?QRBWf5d#IM4E)K{Asn^@Zk&$M_EN=E&-IR)P^O zIX8#PyY=0Uo0F+-YNxqLO?T77;pR8l=X4Y2ax+A3dEI3B-7J<3ayQ^+Tf~jE(9Qeu zqOP0b_1x@{(^9{_n+XlvL^X8Nudy3j6E{tpy4flVTe|tYjhpGxyseu~a$L&1;%1aw zm+9@?{Qjz&r|sQT>!{i~xf%SHo9$iQINovVnk6^W-gR@nuk=&i1KdoJWl}KEO^cy! zW)5=`Gu%zb&)s^T;O2Wt8KK^cbn7!iH+9A<-eirL>SmCfnW28oax-4s^W3~Q-_0fY z{cH7isaxMqt9L8itXk!!{AxEf*C^k$Zk|c+@3jx>RO?1Jk-csji*=uyBpE3!4!C(! z${lp$kpqV`_L!UDQuVlcBezZ{uRoO6pKe~ghoZ$iv?%UjyEKZ^cu6YdAzfz5pYa}= z**#27@NhQKLxUs_-ZCEgzvSVH^epe;y9yeU;-NaG4~4@#tdi}Ydx#m~VUSE5<>Aa|5B0`)m_E+K z@8gxz1g$q&YfSO*NajrSaA}%{JM!Oj4`b$dI6l`y`}wL##w_sAX`zRui##NMAfM9%lXEVTsiK(ZjP%9-eGg&$oJ5Et{muHuYk= zhc9+`m?A}XdT74O!_RU^hVIsW?a`k6qJ5RK^5p>!e;xGD_K^A}*2Bt8>L2ki;i!kG zV;+i2S1EPE!z(8}?3HS#J=~DcuO1f3x6=Hqhh;MIHxEb7Y0P;Kjb*$H`Q5`We|UKH zPwkO}FM3!Z*RFf;-&7v5QgZKl_~f34+w$H64;vn8pJdP@58EDlX!z8_Rf|{OOL&

qF$m(dZ`=h#ggddVOial^Ri8jNR9GdMpp3hRC=d)Sy#!+FO|KNO!IOm zL$_WpZG2vK%hiCFxS*GpLtc{dbQ|$9zd&OOz5G|zOYQ24S;MRMr(S9{)ci(XrnmO; zdmArJ+A4>3UdFxZrEw=O3p;zc*2T*!Z+WTM%}dv}y_}Yz-M#GV;U&MPmlD0bw0_6S zE;%bHeY`k7@Y3f)FMrCrL%oz4=B3kcFGuCu5nj5C^zzLp#UAU$Kinq~Stv)aoa-+C!r=Vka0UPf&8 z(({Oy?~W?YF^xH^G3UILz2xQfn_j-U<;8y6%c=WbK6#+NJ@k_ONHsrJkEPmEqUd01^EV(5D)RPSo9UI_XDV-D`LoUk$ zc`G@<%F+SKl?hN-AwW}!si<)>T8^azs8K0EpNs%QB%P&SLn6QG~W3kJ9n()r8) zH**7I<_GvnIu-_4QZ+!Zx^k$e92x`|(=foZW&x_V2(U)tTL);@Ccr-F^h!Y2odyWK zrgNPFJb5FafAbPxS)TxR-c`K50h$jEFyn&&l|NG5qXWD?Ccr`Ya8iIBlQnlrfM2EJ zv;Y(2*Xg=HGr)>j0m>}b8Y?t+m3p%=z$cpm`aDN#?g(&uXMn-G1AOsIfJ1xLi+us^ zN!|giFI(i{!2rDv1^D-@^8GD9+f{qF#; zUJKCnp8)UN4DiFP099@WIDIET`Fo0gUp;)R9zF@s`e}d$&jL(*u714;F!kR6=l;`P z6J(1qh}j%uf+a}tB0*Xe4f02^AW5-7+Q$VsB(>v%jIjrKAtMrl98L;SH95$fvO)Tl z3-VU^AS){bDOWMbGpSxFNR%Up(G}FcVF(fv46-aU$epYptHX+07-VtPpspf(#uUWZ#$|`D24@AE#U<1Q{gXP7m^UMv$&ERmbcg zm*xa%IahVg4|4p=AT<{RDZMC2$FG7Mkt-6tSowV&q|(wLlVpjMTBREHs)l_*&Pcrj zLB<~p!l57^9u3m;Sdi|=gY^DK^KJ&|aVtpS?I5q*2@?A#NZZFj_Q+39m3LH#-G&gw zO(8y#N%EUKFo!T(LTr`8Qr#M2ge^qBk|Dk+7vg^T5N}opu{tG0>q;T!R1Q%rHAHHa z5IxcrLpC@=M7u(~E4zF;9|-ZGY|aW{%26yS84l4V5@K;dh#Q3=R@4g7xM7GXjWnil zh}x|~jA;|nccCFZe>ud#S33eiPQOZg8%Ec;Mv4hix8XR1kR3=Qdbtq?n<=34R;l%vviWr$xlYt1bo_H0$oyOh)J5Z*l@{@xeT_c-eF zLDl=G>bR&i{dYqTZutu4>MmUpjlT5tLGwI(VlWuJ@ zb{Wm0TPCQ%DAsk>0emnzp4%JrK}2Cd4(_(LWQe#~Tp zT>L2$=Y~vnZ`3+lw9eK{M(t8g$1+)aJd;W%GMRr``Jc(8&99l%KA(x{&rE(bXHn6b z#R^*%QKhq}TPBNRFJ~EPxxK$R-WR)C!CyV5Fv-ogO7WEfo zF=3(RFUlf8I?2jqSv**tMa(MsUGx6PB62m0ndP(jvqCn_DrR%0Mm7~{WmB|aHU$&1 z88$JSzh`Fi&W3D$*qBZA&DmVupN;EaHnXMpZ`rgum(5PO_*XX0YuU_{3OBNO>t;4- z_p|9&DTj@fbM*OG4tqU0#QJjhRPN;GkQ2#aiS((N!;iIcNUxnkod!9KZJ0y<#yPC& zp2Nc)8s9625g+Do_@f-Eew@R-Pjbi`lEX6DA`3?5aC3SNnKN_vO4f^gRu1MlIW(G^ z!zMW@-52Gs@ar6|Ey>}Pr8)GLm{mC>tjXcEwK*J+3-Vw?4vB|yc>Qn=2j!v+I;s1o z75CR1hRM-Ca!9_QykyPY9G=|E;n>q0J=bzM<;f*KJ6G4x<}!Y`9)F(8)G@g<9hb|r z@wt37F_)c_a><;WOMU4g)u-k%Vp=Xw1=Iv4+%T)vbSdvd9{ zSLcps-WAQenoHdqxlDeT%h^Y{%zTl{<)V4GiszACB9Bh-c~niv)6cd%{cOu)p)-$C z8F_pa%wutG9yjvx7#YrEY^OX@BE<*{vS9@g=BT%DVTXMP@YrTgkU z)_j{spC9sQu{n>KTk?q6nn#7BdAxNjk5ls1uX$WQo5%7$^B8bBkIh#!|7spPZs$?t zZXSbWT2wygqw|?#&F76$`7Ddir?fp^&v)IH%V(ritdLLFiuqJe&u3`se7)z%*L55D zG?iU1=X1SNKEXHhx!WzD6JzsvX?#AT<{*yk&LWLpoX?Q2HAc*<^J(;LK1F}f zx@YtG?qWWNF6DFdaz4pd^VLhO_jf+4uH~~)vj55FqwD$Hl=V0BiMpLnaak!3?&QwTm-}8KWzfgYBVTu{Ud?-Iy!u)Fu)5{iSTJbRFON9AHrj!ixTWpwy zabe2EhuJN~6T*BXI}^hcO%C(8d|1EphxL1YSik3o`9zkcYmOt#Bxe{yMwnrqF#Ek> z!oDz7LRu#?%wQ><6{cf$m?P3YKg{BAn1o1}>(#>qYlc}UHEV|%RVU0dDN-*?^ZH?a zmSGJQvyoyp4%4#!1Qd!?YQw`eoQqtvgKX4iEF)NX;J= zru%61YP@4oAZ@J)wR| znUi5MWbdgkrG5?b%30l)iNA$8b56ZDAEwjIFnz^+D@;UI$-~>~$sP4jT09Oj^GTSP zr(w1b!5kgof+a$^qzIjpBb<*tN5sLPVkSsf-Nbd+q zvOxZRC&EJ+{BDGw`$jkh32CugL>aMdOw z<;dp|s(lfmv3xFZBO|;#O0ndmxJE0#F%c5SMW`&3gz*vbWwacd5YcldLQ{EpQiS=F zBb1z?Udj!bJvG8jF;9i*V|EggU>gzCV=1g$Qe9#trrUrt-O^T<)sZ z_aeHMK0>ia5n4W0FC|p5fWavRj=i3T+Bv&pM;J#Xb{qF*d>yDY#e2u=|Bf zlsOLy8TY7=*>bvCv1zq>KfNEN|3%A<);pK#=Kubgeq?P!@AePxy?npzH*cIhlCry8 cI+04 zL8h|z5>Tchdr!STzvnsbKW>iWWtuDJ`CV6N)8s<$TOWN}s@sc~CZMtmt=M>}Zpg{3 z;mfR+6|9k2#UISBmQk&yFURYx9;}(+%l2m1$nsUM67&XYW>*bX^VaZY1%f%5S^jE) zYQCy90zrQbpFuGW#uc9NzgYkK({J(G|L-z}YS*kUKuC-CG`==d3Q{Tx;gfhu1>{BU^dOXw__U%^tjGXmZj30;uzx&wCZgcCAu7tE95yW#b{&{}N2LW)e4-}b>dnX(_gk@y3e z`w>_s9gae8;Wz|OKn?j%ik*bPGFG~s1Jm!Y^#Vj+gi>-su1bqPpy8j;R!Uw1hs=^e zmtl<5x&kd_@BduYxt2-SV4=iahYEiyuiTb@rN<3;^$!%isr7PN>fD04w_&Apz61T` zh8(yL7i9VaSRzRe;r=5qJciA3K=Pl!x~F=s$>+~tfPb|g2;$`{DPJ@Kzuc6U(!E#& zZ^!6X(qbdXmhU7sF@g$mUT#U7B<(95K{a_LMao3*nPeqLP+KA^Xpan)iE^%D1U*tB zm~M~Yq9cNa=@Gmo>!h1Af{NYxuN zy4ywYNqfyrE{pxW2xiFIjuE_gKY}iuBDl~wf|M?b)lGAp9Kob15g4Ybzqt{dnWsAE zNAS_t5v*SjL5oEZY}*%s`9K7H|L1fBTh2t_J{!UQ-yRlJdM-87SY&XZl9HYi}gMUn8j_BP8pv`aYssPDe8HiDEugu4mdW z-%IINiurFOWsL?}6gDush=D>y4V)`xU~F*%bEQa(fu^wrcF4#Q24+d~I0GHzl$43r zTDhBGAR^JgM%gFfBm+ZB8h9ufWewC6${8pwL*&=;26B=O?5SYjv`nmMV1dM?7-*fU z7?P}?QUSRoucU|Hz`B5e)S!X)G7a<=PnLlK`9Yp$8|ai{V13BIZ!$D&V6sHz8>nAk zV6!Z$V&F&VQPsd_a!<0W8(1Qr*HRr)ueO1=UE(Z2?RgCTi5_+re&vbvV?hi3={|nVN z(SUQ3fsZB|crnGm*V8pWSvkv~=YnP;&6gTjDtEp!@Xj&=FIO0-y;A33m1ZO}e$>1q z@RQ~#H-9$JXuW}{8w{8>8u)pWfe$wuxGt`(I_JVKI=6Cohi17`=YN;Z(QehY$3WIz z19gw6KFL02;9H6PU9%L!1=T87ZyV@-$H3aV1}fY$@IZ1NsAtJ|WMJT917C^liGgqA zpQn0$JlBj18(C1q$Vy2mYUEZiBcH|?@x>acBCF(a38S8CM#{z;8Jc9|RI-svX+}Kh zM(VnZq`Hk1@)>F3H?lftq*<1cSJENdNMeqWG?^ynbB)x?Gt#}9k*#%%xL!BXtFB_n zga$@38ycA{ml_$lBW)TRDcnSHn;O|JwObguDFfazlJvHbof6%~NPqdbt&v~a8+p({ zdEQqIopdW*KQMAcoL!83)YVAC4~=Y=4|^IJEO#WMmyt#CZg2H3fxeoF7zY{oOuim$ zq|E0=)=SqRMh3}0;u~t@#W15@(-?^wr{2aJ*(isl=maCj<`|hi*T{u=M(WQu(q0NJ zHWK^2kr8reg^~P~MwYHJ()b4>zpgf7TVtg4TGjibkrwOpnB4iv$cBwZN^CN+TTV)i z%|=FTG4fnecdIw~d5@7wdo{;jRpW1}QF#igNcCq%_DazgMm~|Z{xfo4vLj3swV3$0h)K^E6Q|`bX<5v~oZ==5 z$C$WU$;5~>6Nl_3TBVz)?=|t0eBd)NK>ij_z{FfxE)#Q1)XUXvo{5N%iFlb_)kOKm z$|D<^n6NiBVQFQeuQ=W?kt<8(&YLEVy=7wRyCz=As`pH66Hf;dy*rw?B7M4;I4L8# znwTM$ZYCOZH?di!^)gZFV-xLqn>Z{3`YL}v6XT^?e-lmR7qJXfZaFnbu_u{0Dh(!^ zm^{U#pT8y&Wyv%Xfp1LwCdI!s@s)hP&P4i8CWcAY&n9L|yY(hIZ!ocPqlq$`v_}?g z*8c4#zWc?*Q)#i&!~*$im+tR2@y;F-YvkEp6PcC5k~5D@)P7>(##0mC=O*UK(tlOQe{8^vPTCR$Bqd49! zib3t8_)FaHMRBo16e;gVVeK5n%K_RyNNZ)xP{kXj`@^HS@?{i`5mC&L=Ch-iH7APb zxlxpr`tze$vp$OF8=^38jN&`#wn@EiQ{TTtF;u?W9mU-}QMB2s{`N)Dc)xm;6Vl;e z6v=m@=zKSdK5|2R_oMh)&OOv)kE8I&Yfqx+BrBdqQTmzsdlALWmr=BS6~+EYGgS;` zzBHP7ELO9bh88nhWK9t>QAN$vD`uvDaWe;`M68)|;wWL}2YC`_=3*%`uPT^%v!a># zDQ1eLnweTj$7EHSnQh{+o9XQ^b47BTS|?3iX5N*flIT$l65%t`NlN+6q{~eCBcPgs zW=3Y1c_zy<&1{nNEHgc`^|-tiHtV&6nXG&>wPc;VEHKlhvYBulGt=e5>t^cLHFLRv zne7eDRBmKumlSGZW=~5q669P5bgIXBES`$u)$)H%Clri{ET-##=` z`jO`PSaX%@;(wx?&&+gvZf5lh_4Cq9rc8KcW^ROq-{tj43*!wITt*88Q5HtY5wnG> z(H4A#Ec7jGA-<@E_Ohgyg@oc3{k~;kyO>K@sAaP-NzTMuIFMkWT%v`JNfy#xvoKYD zFKyxTG8Pt;weU)+mA9~3-b=OckNDCo%$GOnT38_u>sffWzJ(9vTiM@0u^K98BMawc zSQ87sNrR>qzLUGnEVOBE;j=d_9FwHCEPN%VHWpgR+_n~qw6pMiM+*_}tKLo)*2%{o zS=c5~A6w`x{d-$z*~db3UyIJ6g%NV7pN0JX7JYA5epxfzLh~;zSiZ85C|}Bf5f(xt zEi{&{5;;Y+$>gaP?o6|gH(mYDP@Ph9mW74#_iWWR$AW*Jg->PYd<(V(7TU?T3oSfZ zWTC@17M3kmE#F%3$h74aYOJyFvvgT&VW8X)?>Y5&%(Il7H*3Fq=m2L&RGj@pVRpi^LYz>WY%TP-$mPYhN@${p!qwDN<=N=J*8g~hB`i(6?JV`YmRliTt_PRClwEMa9( zoRtxBOg^_+*%NQ2QKFUWuUQF{w$i_hmA~XvSt}LFS?OF}du4F4@=LjjR>sL}xhQX> zsJ>JyiIuF3kz;9As@knYdaW#w;XW(-{Z{e<$|J5^D@*HHao4xvII-v?ICN%^i;#>SbsNwA-l0sYncXI7?sZsoaD{z7ZNveI>w)=1PCE4`)mSS!oq-Z(35$6IMJ!O9wW zHc`FIu<}Z(&9bsuBIa4?CTr$fnYO@6&xKZsuC_8%ep_QDXRVc8KUyjDlk&@!pRL?l zuNiMtEV1m>9OTZgR^Iu|%JF?xN*>U;k-2j0p!z#$WwBh8JEyJWpR>|HKK|Xxdiho2 z&ReM{?JrpQUM5}C^FY=}oj+4 z$XFl4u?;aC+89I0O)(VN9K(;ICnq=M__i3zZjWKsFENbT5yP~dF^t#~!;rl(9FUw} zW9YRnhAr~#{umw{jA7o97%Cr&Ve#=8?uq?G47)DIQ2dV=ESFQoT=N*ehM0#xT(k%XwK69m|kHu^f=Pg=3jt zB$j{Ve9>5auaBj@?1+h_Z(J4_5jDi^MoVBOy(h`3RL{4ElEh$z^>to|+CIf77 zv`vg-nb=FlF{o4=>E+_+Bd1d1=9ZPKzUNMjXSX*~~Z|&WWR7ZX9Fh#bNq7 zjz-dXfqGaLNAhy@{ZkwhH^*^a%506J<<2<$uAzQ*$8lg!9KC;yqs4(ZzLw($<2d^; zj+94nBtDO0(!X(BkcQa!O>7Z178-1HGTB%onPwaPEH-wC+iK%cQ5%(u*%)8kM)4RM zt)*P7O|Lg?^p@N>8^dijj>zlrHcm-$f{oR(yqwmh*|?o<(`!r{c`h3zJvIvYZ4Ak@ zaX^M=+4w%!##7mxXQNTrMw_ZOzLRa$wD)xz`|H|BsAuCNY2Co4-v?}LXsG**wMSMp zvGHdM8_t$C>b6pS@7U-fv%1@;*~7*JY4)Lwq+T}Olg+(tTpD1*HPA-ePi-_GY-7Ge ze{SQ<7d9#mwXsrWjj(Y|{v2h~hYyM^M<>}BHQ&Zb>Ac8B|8H$<`Ob!QnT__#ZJ5{D zXd=CSQmze(BbH4zrfyLjslV06PupxnZdblvY`h~&$srOTSz70vdxjSe#Nj*a^dZB%$+qpu-eZ%xJXTr!Hp zGg!Va8qcDHc<#vPq<9v;7SBDgmyYL1N<6Qn#&e}oJQhzpO=X8ap0R;=&d8`>Je4xz z`A8;Y#Zx&~$D~>)o>lqrypTtg<7rYYo;gyqdOYRp#nV-GG>B*VoAF$h%(n3~Zy(Pk zN$C*JhccsMJcB-nXODQg#WPj@l%($QESKRF$rQVHrlJCaTO_o22XVZ&#%rE2h`Y3^S4GFA}I8y@Eq7xV^{z3_CERjG| zTmn;GOQ2op1eVLsWfJtdJAqsBtXu*)6%zCrM*`C-Ca@(X0c&akRb;6vfrs*rKY>BP z1ijCazIpoqt@U*hpm74PnkVRewgg_bPM}AJ1UAU_P6@Q`mcU|} z_o3?PnLuM1Auao;7J09K0%ry$P;pQKE2Z7%s#P+EDb|PtYK=_5FgAg}gakg7t1^6E z0!L)ak_5h4mcU)P_k@clO9G3e{I&#!?MmRVtlq60dlDEd z{=J&Pz635w+x-d5KbXKj(&v!Y9Z_%c)zJhN9#7!5{Cq;OPbQFfDuG6_^ql4;cg`m; z{c!@9WetgZ9hb;W>FrHqn1O5~Ds%Soh9ULxD2UP!l95-D6Y zk?3lPl&`BejS|UfoT&G+5_#1!k=m^i8UAJ>C*Dt_T&F~g-4n_DD3Q4$gcT`6#qJr*B0o$)LNKG(?yBwsFXy}v?RQqB%0(S^Tq?CrV*Ptb7&|0U zymJ!GyCyMTs&rG{?uyqVNj)l_oE)6QqmjxxDv8)hN!*^5M9yp-pO?hBB}t?%P2#g< zNqn$YImGdE5}lqZxfQSO;nsY+A}wq46!Utrl~C5l#F+4 zG6Uu79m#z2YchA`w`0k4KAp^3X?rc11`m^&At%ihuoS95Q;ANhz{}DVs8yx{4u1vW zJ5`{aEE-UOdY@Kcnv@+?f$Hs-X8l zDp2E^ZeuEv8C#Jl?^dMh2NfA3$$cxbQl5*yUq$|qHlr%?opj$=ksCWIlCiTQJ5E-l zmDS9tL_ho=Hg|H`u?cNk#_)@6pPhp|V z3#M>G4rZjVDqD}q!rT;I59xls?n|H`h3=J8NUxHjpHC_JJCH*Enkn3?lfr|#DQsz= zJdIP>-86-AZ=}#g*0fHc>f0&$Tq=cD?Ne~}Orfv12I}!oQdlRezDVKLDAhbVg?}fe z@WnLMAvI@c@2nKYNYB|R^qZT)4)M%Op~y1DlWsqxuwaY!%lo@hD6>C>&f-0gLfum- zOqJfhr;u_ng%9P_l@xxtuKjl^JoVT#y4 zY3-+}43N}Osq`POe3CvjmBrtra!-n^OJ&54RF2D#Uscy{sjNSgit%tNy^g0+>treu z<;j^;n*Nc>Tv>iy>u;x0_D(9ho~5$swMv*vSK?w;C5mNNqP|R*rr}D=m9AAPvHq<} z7~if$sXmox_&*COF;jZ&szkMum2_Q5C0<^w#KY^ADEO-qBX3vI`|CO;s~%RuU`?Ze z{2h}Fceo|eYvP13m0A&rcVX*B#GjU}I^@jzVPXx;KO?#aw8X`I-V zM!DT-j60gfk0;XLq>i6WYdK&ZO+FxlnZ=^9xCjOJA>qpX< zd_PU^HK(!cf%ZO6W6OVO7$fZTlEJcDiW=-RGuqi9#|zu}yojAWMeSr3v$HPI&Z{Il z-AdY-UE0p&GIpAlwUe5nW2tt|OGUe#0}_{RXQ;II*|GWUq{tNcJz%F^&`!&IJDnuC zz>Z%Q$v>6tw60?3k2-e!owKv-bvqlyRoBkP_3T`cOHJ)Oknfw>*({#scKWoib4~8G zwG-LS&L-I}`R(ltd)Lk*+1c672^sf+op}<|#ZIfPc70ZCr+9zWGeCXH(NFCp4Yo5v zdJeJk^A~o~hT2*3m0j08*=aM<&QBBV{5#1`_sMo*XW1D(TRqRQ6P|15={!3HU)%X@ zft^}Q?2KKiwKDz(J55&Gsk_F`#I>sPN6qw4Le~RO4+sKi<*& z@7l?gQ;+OCdu}KCg=QkhrRGaJV_xapO4A4jGb0^D8yt*|c5tkagKC8xEHCEZt>O+A z#yIquf*_do^}2&@bshZJz(L!F4!&)q^^G0OY2x5YQ-`h(aL`#c$d7M0 zc=@J-uB{zheapePw;h~($3eTc4qA0_Ft4kFV%;1Z>FFS`mxHflML!2yrGI}1BP4C0 zgX@DGJeAd-JNQL{LmUkJ!offC-Y^H{zjE-K6d&ney?iiQGZ>?~<$~OnwqsT6IMq7d z!TVE{XPSe$GaOu-?Z7ox`{y}0z1Tt7C8|?C_)aw~bI@kFW+)3*I{15)gC*-6jM?De z_(liSH)$?gbZo1GP1_u7-0mQ9hjRYvpy65Nl#=HhIOLx{9PGcWdCIgaszs8nYRxqV zhvlj?y6K?xJoqpC35G1>UikjW4ZWD=j&ewUrLq#95j|45*?Aw02wFGqtf}N zP&(`6!@}tdmiv-ZG@YfgMeK3uoJ&mSrYug_%yBAw%J zr&Fp;I-_LByXj1l`tRv+IVABN(-|(aB&usVAAOw87ZUERb+T2W`li!IM#D(HT zPH6pGx zXTgeemi>^=e(2bl%#g`D{<8#4pMvllG+Z^}%#jOV>l`43gWD zaYW}w>YPev{ONT1olR%j{d6uoNZ0GXbY6R$&bv?4gA{+BPRkeR?2#W{rt{`2#r!v& znE%pggOkM(PU0h-ylr%{$mAq0%1QB9CoN0pc#@OsQcmiK;WZ~EWSHzP?Icvj$-Cv8 zd{^E{$z&&2D>!kcIGHU;m7KIqb8=X=Ih>fCPA0mXq-8kik?F*q<>bR`r#>fiayQpW zR>;Y>Qo6v&dzGE^lv@(4>f}K!Cq-X((!8#dU2;|)%STO|tZ%AV&79;*`PQnptNQ5X zzYW^k{>!MtwnqBO-xF`|r z;tT0q$i=F{F3J^gaV^e;E8fK%DPPh>r&2Edea%IUGA<66b?NgL7bjC()J%1elIEhT z-No;+&*380>0*f7@wmwJxmYY4<-Xs=_OJ^}fs20fsQ>M3eaq%q|&)c}D(oVg#cQNpN z7dtw+uz%>%^+GPDedOXoFX^qi`?{DS-${Od7fpw{m^sWv^l%sLzI5sJfQug`d4y&& z(xvzRT+|w`c$2kes*3?~W`^c9%f)zc&2#bbd>2>b;dcehdQs$rww;VX6wZ~ixm&(UA8@Y2r zb^W2b{&exy6&DX)y2$-kJ;|E?Gz;9ABiwu`2P56&8{B+ra&tS%%{yi{A*-AEVvcr` zAS2{(Avcu^yD416P1B-oc1ZnLt(U|SZqj6?{2Aw_vCYlocsJ(~+|*5U<0<8)&ueb3 zNw>0Y)|S(nWH((axmlCurh?r~xpX)0JKehG)J=SKH*eQ)b3mTga_c=TH$TXV`feUI zaMPion{kcZoNVHzW>Yr{-*R)~Z8wHCZeDNerlow|&aLZ9-DJP3I^|ert+2Q7^oo=Q`p~`~uB<$6!f7SVtuMfES>!6!fht%&8HxrJ! zi8$t_#0fWVo^ zhc|*A5_5GM_AozRYYII4SJ^|&s)||7qt}ies@K#0`W~jY@NluEhlZ_GLu(J?-ty3( zy@!PzJlyE$;m!9wl<(}J(+3_-%g`|x0i)jZY1`RN`i&h#)@{+p$m z=cs3yK2LSdSDjz$>t!A+%RRc@RP$No;g26Y6s+?w{3j11ws`1v#KYR7igQeB&S}kg z52deoc;~ig>6K3e_AKV!Z4$9q{Irioq}PWEzYs+aTAyi}awWwKnD=_O^h zmnqV7u9u(Zc}bhEHBxbb*2u#}Uh)=ubq$D@YTqiSR9ot0jTBzxrRfjKD}S%?;{DOf zd>OXhi)(|FE%>t%1OkJ{yZj7#?MpX^BS z5naj007*{svC`q=ak`JsT|Ux$K3x~?wPrY>|@3jAJ(lt zPHp#5W`~clGHt()3kQ5OIH;PB_{cxzV}+bP?qlQ$^?B0Ah%=h)Wgj)K`dBA>uWMF+ z`}j;6{NrQFP0j7LkJs<`*dWs$tEVSEhCkKpWx;bFf4}hY#!DUh&&L7$gd_Zf41Vg1 z+2|)hM#y24pUP2wx)=5HndB7nQ%5#RWQ?DWq-3I>bh#>z*N$xt-%DBhSw_(yqYIlFEJp zRaHYB)lk>Zn0kI*H1<=qsh`yn*TPThmVWk0`#1e8ZS5!cwjOKm=h?e{{aX+}-}Ur! z?<2+Q<)_I&KQjjTsrae-9_{CyF@6rpCzJf_oUFZ5{G65Y)BH@3v(xqUOh3zK`6;zb zIhJehO3h}IpTV2`dap$}clx=z%g?|)e!lwE&!OKmi+z3`NbUjUm#y;npr0Ox{QP@P z_5SWB_JVqreSi8HaLLd1%YJ-Ul=G@`URQqk<}W`t|Mv6N4L_~^@$=zrKR?~^Q|Yds z)A#(8eW3UcHN&Tx;WIxip8Ki$!q3E)n%65oQ~&jI{y&{-0&Fz~h>8j@!5pAyp#aSb z2l%5%fW(*pZDIo)lA3V=#@GV9k`W034krevoD^VA=>WaU1bDw}fEDEelqnzJg;cE& zAi^HN=nUvO{{Yc}0N-T_0@(Tmc&mSa{nBQjVh#!r|4D#`p9h#a zM7?|!VCd)o`^E&w8yjH9IMp&CzySGSdVr@h0(6?GK4u5FGABT@x$1L%fa6~WsJjMO<0VEn-V918Hs(EyE(1?X}- zK#za4?{W2U(mS z%^+{Q735r-Aj$25OqA;H1{w8UQ15{RS<*Mioqj=H%BcQ9W=o3!K|0E5DLW|0cb_Qd zkRbiOP)|~AXi&cs1=%HqhX-?C|9Q2#b7h+%S&&2m5r zrUaQU*QYA(G(9#wNSqv$3({zYV$KX=o)si_c975K1i2?O=LY$6p62znX1zG5->DT- zj!LT)LC$Vb&aFZAZd0whRm+|rp1nc--WSwoCYtX-_4%jjzpNZ`RFbZ$C;8x7kRPrG z3H=>p=Yt@H9tBC1(Q@o@kawPH{^kreSu${1Gk8%vgQ~F^G?c9p6_-H?St56A8MKMd zpsPHS+{6rANf~@xGJ`<546GG0XjCzSZSt?QPRZc9#H41hTh7Q$Ddx!FHR&pKoEeOF zWzgN7!H=E{QoI>d%F+GY42IRu&^5Oigc@exX_7&orWtf@m7!~06z4tV?3lp^-7+wD z&tR_Xo|Hk6DH%j8$e{K@9bc-tm#gmYGZ?Tk1LIE_)crYwjdFQ?29Avx?AfF|Ta{;9 z2BUVXrehhbIi5j<6B*1ut@_Vo(DG~sH7{gf`ZI&GQJIvtWU}0vNkqv^YM097*lU@* zotep^tV~YlWHPL2Ci|OZ5^A1FV_7LjKg=ZQqf9;-kjd){GMTVY`xj*rFYRT;cbPm| zmPzzVxu|`AWD>rf$;`4@{8=uG#^tj(Q!R^fHL@sNFN^#MSqz()#osft_;6zuKW)mQ z>Xt07?$5$`FpJqz^!F^9pU+~KT>dKy$BiszO1WEEynj23)Q4I0u8_^9irIP}E1Tck z*~ECW`CRVhWs@DwW{LEyp3ToSvPr9%O|81wjIEbVp9a~i?2^snu3Fzcn-QO6bNJJ2 zDu0&EgTdM44$0;_*(wW0W^;RbHW@Rs`9?N~ZB{l>bF!&FH=E6JRJtt6X5qKl+*p#$ zn@h9lA<-+diC>+~+iS8pAeZFP#%vM}W%JJAY!1q08E{fxpH|$n*$k7Te`J$%Np;EU z``J8ukj=5@*?O+!aLS!SURDmp2Ieq+xbAU5a#*%Jhf?3?;FTeAV^t2m)j51EulD9p{Wm>!MEkC3-}M}7-^yX~ z;~dUC$zkTJ9Ih75#aT3$tYW#ekISWUe6D`Jh zE@Rv0a^l@w*7nQgMgLs749I2s*jy~*bGbe@7x(;J=1P}Uxvc&nm!3c6(sWBMGq>gv zy)Bn=M{{}qST3jJo3pvxJeSL|KXd7OHJ2^dwEuc8JMZRF=zcB(Wm-fY7b5eRW69&) z5_x+NqNuZvG#Hvhpyyt^lBbS z*Yh+><@-C2l{fO(Bw7FD@#)PxZp((-c|_dJqo}NqNB8pRa6gY{&+@4JLUHA1`R`>O zJzlB4$Ph)0AwH3x%pv}@gy?P!F|BBb3&leGBU6fp_&p{>z1R?C;zI0^qVXX$l#rJ(X;gcv9#Gefk? z3UNf*L!x@_I%n*I%E9OGQT%?#%=$jCWmWSB=qt3%mIuA1JXT@Hx*c(EO-5lb?mJl_z zhIoBvhzYwwMC=YRbYF;l`$Jqi6yk~ea5%(vX?rw8qZ68^lsXwAU4AOlf^xMqkUFa$z!)!_=-2=48b%rBlN!sT8J9FwEwRFs{rnHM7Eu$qrL5Kg@wT zVdCnB87g1a3v;l3nEVD|42{CP-Z;z#u{R6zVe>G5$c8t=y!}>~52W?mVHUg-W~E$j z8^+x}%v>4qZkWUGg{j;@@jEJhC&iatUBVRZ7A8q{N}(QM5@mt>{b88LGVr4?zw`=o zNQQhI=GWfpL%R0~^JCvIAAb_&a~b@p?hgs`@{2Imp<%poM#>FWk1|q@d>N+7S791R z?8q>0j8Z%~DbCTVaZH$mabYUTBpE$E%&`e!J#WG^k~b!WnLjy9@hO_4+>+T-bq=P7 zG0q56cV?K4vR4MqQr)w|_~(RaGB3=G`C(cu4zqSem=`O zJ)H{k>~xs%=fj-35T@2e_49}FUkbBEX57-uZ>yF&s^h+9{2;7r*TWQf5~kTx%}|2n z^BI_&Pi|U1j+*)Otd-B75?wc+#`W^qF3yJe^lFsPWjWL&pZI3^4439D@|oQ-pTe#3 z8SsYIzM0S9w)tG@n~%MJJ~L$Gw0w?C&!@_ae9Fzw=l!qqIVG!?=JV{kd^#`7*L$n^ ze7QZJCvxp-KCbKe*#6GPSf+rwWeYf2u7Gb-3%FgWfOpagc*9Y^{PY3__zNiCp@2>u z3pgzox)qSpqkt(=b7%o$h86Hij!r8eX+{Af|OyoCI3MI!yXneQRX}FGRG_&Hw-BMdOW^jtq*qv8+XoBXqQ_0hMby1jU50xHX_^YuU14K*`s z`m<|f)b!vG6PvPeVG|m zgIQTw!R%nwnl-Zxig75e@bv%1`rm&OT9k?S-)(~Ub?=h&jfA~2!w6@^sv_>l6f^u; z9FCNPtwH!X8!Wk6FQ-G0QyogyfKH8IWn(Da1b&igO(D4%WJqoKpr!W6H}64*?r>L% z^#WU8?d_+%{UK{0eE%st`3yR$^R8dOn!!-zONbu^Z+!)wCG%@oDtCv&J0qZr)Ex<} zBxjW7B^}2=FBv!%zLpo`6mKF#OoOSiZVkk)1?M_g`vYv3`Rn0nEa84#4fJG92 zP;);D%ca9H=q;Rp;7O<<|4Fe^Fi6How{u|n9kyM7=s%#8oRlll;!kM!7qpd<7r`Mj z<&#S=T54T}ma^}EuIOCL#H+AC;;uo3>&h#4#> zBVI!UmF0UGV2og-)G$TRT=vKaa|AP`xg~-Qa!T@|Bd8})g(8TTucds^2>fzOUP||3 z5xgCvTS<$JAX}D6Y+?izc}WLCuMTZUigqMNqna1bZ8(zD5yzBEw~8vk0s$BIqYG--+O_ zHmbW_1fRCo+~ktj--}?ntm_!Ti}xew(kX%qog+x;qFCKD$4L=PoE(8+iu#)q!P&X0 zb6x}=eG|ck`4O~O7{T`a5tt7~(D#4NM6mU21n%D=IPiM}B`!qprF1n#vNkG`3g$>^ z6^>*~kx2fPUh$D^Oo*gqQY2reMsm1PBn4@a)RS{^${9&jcO(rZ*&E4ted0`(I-~@-6d+q70nSG%6a;J-deO(o!yMct>>ics&9;C;E4gB+^ zYMWrdInlsJlMK9=Y~Y(|nxCwiY0zsyGm+*?4J?(r%M84;+`!9~25PU;IasY3$@CvI zFA4mpdCIMy3^dwcV9G`VrcDNZ+HBy%Ee5WMYn#rw@UzaX9NDQ^?$Y_+t#h~x#c)Bj%9T3?y5BXh?w)}P_YFLdoCoSzG9DQi_}IYLVtZm> zk=%T$*T-|sxUiA=MU1SHl%hs%7c=r%j1ga~kt(uU9+xocwPvJjypbVEMouRixtM0e zlWwH0%Sfu*NFkq*CVnGpf<~HU8F?igvW+C>7)g_ zmW*#;B(tHBS#q(Fk-O5Sv5~?}6t}679a6i6ky|q0Eh9;98`&k%ZH)AnkJ}pgxxJAG z9hB#N)zC?|()9x)N5$F2$VXj`H2l!W7WuHJkwJ1-GI|+VDDU=G{}Sk{nTYWdBcIDR zgN&5=1v|gure=yQwy`Gc1KN{J%$w-OKM)t@l zsjpQfZ&&_={@%RW(Y_BSwCgxoYI~TRJZf zj9e1?BO^aZ#A741o*1eA%*Z||`ohSk^45Pw{*mkm6Gbg1J}zR?>&3(w`CD2RGcmik ziNY}^u2eEHJk7*myNOomChB`l{3svzObn3g;t80TBP(P=j){7?y3I2Y5i$`k)2f;% z-&lEMV-pkhrY0<{O!O7U8zypPsoZ_j#PPRGOnKMDD_Q-XiS6R)V4`o;1{-cSZlJ%2`S<-HUiOw5MtlDIv%x3M8 zgN}*K4(oX_9W&8hmK-;c zaKc2?Src!{yx&X|JEz%P(E2}3G?Fz^?k^J^FPf-%$;6%8CO*Go!hhF9Rry|?+%vKJ zz6tju6BFg^V-vNXn7HxOg!j3Lxw7Emqo`|&VtiDT z-ke8alcSa>4!ffG$Q{Lf$?`_AST>2l7e%eiD7I%uQ79*hRQ#^84Jle9iqUesW)xLxMG?_Ju_d=*6sH?U(WOZg-#3k7a`Pxo zw2R`C_EG#T?)RejqeB!a??++n9L384+W(2x%IG1AH&l;@MRED7C>+D1m@ds{MKN=B z6wz~{C@b~nMX`266wfzCVcrzQGU>Kiy>3_EKSwb{mhFk+-rgwM>{EaHqiB3Uy~;`H za43r8yHRw$7eybrA-;d2_(sk>)N_xc@W^XVqUaNGRk#bYs@|#JQ8S-a9 zH3iL#$T0IvR%DvlEa_QhdS>f+c`a<#dj~UF`DSX#dU;u3rb}fr;W}of$%WU=)URvi zQUfzP8k(ux$jojj)Wpo*mS!rpHnUh_-!jwcZ5@+6?aY*KZ|41X&3w_(%oR!Rq`D-! zyP1q0W(Iy}X5YtV8ueD+eax8pnkgyE`k8T#H1p9YGk?iri5YF?_5?HACYd?#t#U0@ zT$v*Kmznu^vwD<*t!66iHgofmnO>L8Y`9`3?W%f_FJ<-(GtF+Qj$1lsx6PE1x8>W1 zW=cQOTpw$$a!veCl=GRHuFuV^d7*w@n#q*$uguJeu<*OQ9%*5m!Gg}+@jyNEbI_-2@ADs7ADHscnb#;ER;*M&@stE+G`f3 z$nT{sd{M^2{IV8aNwxA8*2sIQ7H*0!&B8o+qppRO^01zTck5gDP`;G|4HT=PayGJX zUWPWY@T)XvYGIk&Yi6NMa|@rpY2mmey=CERF}1PKO6Ih+P^6uO?>btDcwhB)vanu0 z{>Z|1iTc<=Z|UFLLd!lDqWfBO4lN9q!~HDe_qXV0yYkE0VHTQyWx?{bg+%#E4i2{v z8eyTabd|`-s!b+Mv2b^)g}iC%f4b_Fnlmjdkn6Kl+iVN|xfVW?UGps1=38hd-!8E5 zWTAx)i!3Z(tXjUc;E|~-EYw(Q;V0>`&cZ;sA>Q>C=E^!5zr{ko9jZx6?6fdgQg*2q zIlNovcE5$OCoJ3&|0xUK$lc#8ynRmRQ_SZr^pTmDG>@y=Cnu!rH4A4X?QhLZHeR=2 zzhR-&ZLOEhcPxbOY4-PZF8;A_NG{30Qs{w&)JGN;NvS6m7R#V#7EV3axqqR$U+R4R zr`TBO9${sm{3cnERz5XY86kJ2i_yyWCMz8+Ru&YqVl8f^VT_fna$N4n3po>OC9{N; zPvWc$m*et<&C1?*D~%GZTzkz*ptP0#Wvu)yr^{NYP|ix{^4cqdl9gY|RkSizX2~D& zMvCf7wUSuL%4j*BW~Hj#N~G7yd>Q7ma=>pTFQ7c)%C)kzo)vd}D<3zo>SvFYc8#oT zmdGZmyQS8?VdaR#x3+Sto$`HP<(!o7YGs^k?PkT^-Aa!hRxU_NPu1|Tm6y_}w^cuL ztooT_WxE9XSsBn@y?<_H@)uT~OXV-M_G>F$M{12kjkeNTYLBt9T<(vx(srDc7UQj~ zm1h&w%XBNRq}og?Yb0W>m2R?jo|UQdt@K=ArRW+fL*&=BR&v%^+5Ll+LO&|MZ2if~ z?G2joCdCrVKFvYy{$k~wU#*8ixog0}W#}BE$Q&twsA9DAMmHcy78py}LTiGDL zNZffV6{Y4lN zrx-Fe#Bh9L42L(xP;zq&MYhE7gXqP{Ejh70hO#?inE7)IBX`Cybyp0-_r@@IUknE& z=a(3I?T=xre0v~<2Zv&qdo+g1$75K0B8K~7KN-XBKVm5UXAG80F*KFHl^FV8k74DF z7@o;5H)AMzJBBwT{!R>i{)u6Sw0s!DXOC3xlNk0%m!~mIFvN0RmPE%gxKJzyrEcL^ z<`s$MrkpPttDp6;w3nSRvGk3L82< zi=%B~9LvRCGLBD5#gSevjy`faHIB}XIMzwM^f>nWrdzZ1u%_HjhL8^>8$*eQ;?@^`@Q%Q$)tiDR=&85&30*Kzcc{E2bAIVFxoQgvz^dDG(|^HOG894&Xn>30qFvnP&&d*kT+OB^i@#_^4uI26Zk z593IA6i4FoI41rZ#|3GKjbFtUVPk>8MkkYvwUTMJ(a&OIr?{;)9u>7wxtNV{#cdRi zvC&$}#oF|K(?)N}jk7V#X5*;59&h8cBq!KdBP+^jU7C$M={CK`w2|ksQPN|hkl)7O zOdAJfSeA|Na&0`7EqOK?g>AH{YGavfucp1P+c;3yMnXLsA4%&5HvK+eV`D=-Zmd1B zx`~ayTG(*5v{AQ}>U+mV7n#}JM$H~J#!IsgZ6x)w@t$nyZR6qq8?J#i+J0uE`5+tf zB>D>*XTP*jafppoGIO|%tMb=Ko4$NdY&ka3#>ja#PD$s5Hu`^SW9u>-*5x+ZudrcW zZ=;Fy`cb(yDvnq-+nBOdaisn>8$WKh5xGP8ezx(BES10H@-7>m-8OdYwejzM#XO?A zWt7x9X=8%?D&PEOMj7o}U@oVwi7klY=j;6%(T53F(E5&2+#M4xE`r{cBi07<~48~I_ zGoFuRd{#V_b9GFrh2mMAAI}SUR5_j|)#8~gMXSeCzFs_CWoLtUro9=@CCO|XPxJQi zT$Gd!@q8%LJI3?L2l4C`Pq%oc$X}AwJ)RX39uUvha`cOMS`LY4zBCx7++V3a*(2|a zh-azvoeAy0bU9w6xkC`*#q&EIT%l8xg}E$ zYoF9Usa`L|vqkFNh$s18Jl$l)lXy12h{yagUhj_*c-N4?N{KTiP%S!vG2$KB`6D>z}~cfeBRnB!N}Z?hDl_8ABCocmlOXBw!emKwx|VpUD*& zHaCHzvUN!Ui64ep4yhN?ZIwg{ zS4||kS|a7^Do&$BvKlAq^Q=T(wM?XTt3-yqnaIia6Dijz5o7m6GCxY>3;Dd4j`dEY zi#(S1`y{ePs`gDJvR@((rPLtB{8BN8B=U4vBAtgPvQ7#{DE=75AFJcz6FD#?k%Xz* zJ43f~5@|0l=O(gyULwW6N#wQpdMvdTB+_(YB0DQ3Q8XU0vP<+Y32ds*vb z)wLwH|D8mk>q$(wnMB=(NlcM)FO&Exx+KS>x2+^sQ%d4XEy=6=l9Z}el8$oz&5|7N zR+2K^OLA^!d1l`$PweyZye)=8$@Gs)W|v%dBxCm_^Rb+&lFX2*$<%L>%ru$XE}2d5 zCll2vnesi8X(?l5*}!BT$%LWFH2*r8c`{^lGQW;b#x_B5W^2!!WHQ9EG?}KdbaOJ^ zZOIIjZ+0fL=$B;f$*;$g>3k-cb<*}~G7TOkGhI%ZD_|*9fu<6jRDqYJD^ROU1swhg z#CNJdJ6SlO0`)$tz*H$avI67ASKyp!M< zgH)i#Ro%u^Br~=mli#gK)ekB%T9W%#WR*M@f4_?SDQ!kpWSMl|RFNAyE0VFRB0Eo2 zq~wc=OeKYj5-grV{kRmSNp`suZYHOYSs?{i#T0!Op~o`7nL^l;!VYf=FMKJ~^rx^u z<_1%^A%`+jSe>osWI=8UuZQ$FUymhFkV5y$DWq3P(ce!g`ZJJ1|C%Y>uam-qx+!dJ zpgfIJ*wZwHa&M&2Mb@@Xq3YWy`d%u9R_#-8_DrF#xCZL^Pg7VgtG`U)_DIz{DusV1 zr10fb)gd*fYwyeyMoZ6GDfF9@!cOtbO`*tg#glH|r!ar3_RIUbQz&yFh0fwVm_pst zDNK>xzo(G$M+zUx>B}knd`@8|1vzVRriFRHk z+38l&&aBdQE|syc?^=Hn`^4INb5?5V2AJ?;USuQrU^FY39W@n3dn%n8q!p>E> z-_}lKJ3E`@faJHgGxS|Mk7QS8J11rA2X^L4Ocy(?y4v+!v7O@mRnGwRDaSsulQhWA zaOpYN&QD+3NgHBk$=7yW_hhHd2s=Mcu=DRkJKZPQiJfU@*evxt+fI0nou_l{6ntan z*ZFp8EwM9Zsn*K4@9i{MW2f#~I}_Ha&L1@ApX|)sV5iVV-QS}7TXlb%_U*J|*=48U zZadqg&;iZ$kex1v?VOVzkJ@#;lARUD?Ywrvj!*ha!70^p+RkGsbjD8g3###sogeOM z{`c(U%IQaTo;|k{{X#R56H@b~ozbs!Zl!62gBg(yq74p4MLRfN$U(Kj4ptO%@K$jL z3t}AlPQjt;b{w3P!(|-Amvb;oCL}vJTfsq{iVkMlwMRNS9Q2XD#p85v$LAm+$H63p za73<1qgxJI-`Bh(^&bbBvPAAaP#q5)d@O%F)A{<>!BN{3erf(pf0+x#_%}m(D@CC_}5HQ@uet&81jF#gy@KrcpYz8*8oXYmv^0 zx6>)rCY_No_}z3SO8xiryd0MJj_C}OnG)4CosT|F=SvCq);ifHQGL_tBO~SUC+XZC zo=$LNI>$$)b6Mt$PG_a`n3zu5bluKK=MU*UOR=T$>~tE*&tjdMPJbCA&lYM<%hNG^ zm(Ki^=`8;~oz2o`jrPe?DOi`zD%mBTjp@9#UGv$IPKlqDOD673=bJ<6tdXvV)A>a1 zNXAi}AE|RXopEQ<>GxYYQ~ycl!h>|Z|4Zk!$LYNLL_J9H=jpV3knoi;dG9N{EB(#hLKCkstZ;-Z`sk9E?rgpMaU$u8xjju>8ZQbLBxfznPwWt_ZQ z&dIX!PD&;_xl+N2GsVd)Nvh~u20b`Nsmk?_ADnKW;^vgp_6;L zPO?HyzLnAiPTs5Rq^I1LU{xm%YB?$Tx|8O0o$Qw1GGA6bCNOK$tNS643`HoYLt`N(sHzu_vNgV8|!5G zI489yIr(OalQq(Hs`kkp$(Zis^;u4)EOK&wv6K4WD&Gp_mRa99Ss`UsI_a>=$w`S^ zqZ!IUIWG;@YVSHHQ9r21AJyYe>QUBgbnGyO_g}=4-BZoqhB5 zbhW$qUG_U%#5!FJmb)GonLZbbWt05lcd;Yv!cyR(pS-H=qG%l#`{azg{<@3tbzMZ% zbJ4qj3u{9cjT*VwE(@Bu_^PFgY0{*Xi}rFtO1kAueVNbrC(xMZ2$DdOzUe2T2~T z*^F@M^FJ50#wp$;t(oFtfSjGKdChb&PF!fx@aJl{Voz^gfuR9%0$cUPHa|v$hCc5#Ia?|HE zH&>-wSvTv-X-%@5u9e)ZO>6dN_hPqiLJHK)hJ>1OznK07L*->uljCM0^teZc^siyJDH%U1ryLlqBr?|O1 z)y;kRZ*ynxVbIC-`p&e5x=`RdS1sbxEcJ1n_vEP^VVOQr-UxKSs^!W zx$)gme98I8&7cQv?#aiG+-!QRdCGt%ZgxC%Q}4N(Yi5tW3-B;UR!4hyQpm&mg*`+R z_fR{=gE_&&fx%5c(u)czaUn+Vip6cOnx^6ulT6#U~m1}+v zu>lWn1U)3?>Nf0QUcS~8c=)ffhniItvzkZm9X(X9r~UOkOl#rckCq-9wo(nPJ&b+J zLxc7n7Ig4%qoap6-}g|yvxiO}csL_Nx_H>%)k9u455;y9bTajiM0 zHRnB)zU<+hJ02F@^IFH1dM?s>hm^?5lE^wKZG%eG9ft|j*Jo0QM-GG0EZqV-jkvznJ3(xkeVT{XP) ztf^XRDYnGcQEXY#z{}l+sPK#l@!}unWxkjucxgDv%jqdz&QJAHak`gDa$$y- zlv!RTOV2r8ewyngZJyRh#rawz4;OmLTkO>}AYQ6{tDI78sh71Tk#kf*sm3PO5bT7`Yg&G%8Pz=xr#k00b^ zH6LHq@KLd@k1q9moRj?xeZ)5QF<6c^@sZff$AacQTDS2rzpamU9ep@E`3TDsF?aUS zU$%eXV@X%#|48|JDZlLR?c?JCO z-R9%;4j*N9`WPcq5BRun&_{zqs`;po{Np}W%9#^BMx0cir+f@QtJz-iQS*wA^|J4p zW_8`i=hEP&kIA<*w>v&wzw2Y8Ont1Lp7gRLGDdwk+Y?8r5JlRjR3VwQ~`xz`Dr=NPVRZMO_y=88|&()xw&+v06$4^F{pGDHHz|WG( zegaihLmkyn*U#vBeqJ>8Q?;p|H4@jtPwSR`_DlOW{VZ+mC-}CWYwzdTyMFy!5I@U$ z`nms+;`Q>=WT2nvpZKZxnfe~(=bh1h4#}qz{p^~gy_5a?CgrF4885$0)BPEKR?PHM zYPoW((B4&=&1OG?w)pi~i*oMrb8okwfqVUY{fnQ&ziJly{XCG|gUT=4b~$Z;icyF%FmR4{ha?#=b8Z9i~*ve0*p5YC|W2$ z^TGlCED|6wCP16m0EeY!T!7KG0Iy_tLVzQQ0V*d2m|Z$R?=k`2FB@QGxd3I#2Y4Y> zD+GwJ2QWGVy3Rj9bRfX8i~#pD1FQ}yZb5*>l>@p4H$ZaT0G;avNNW<%wY33$ZxNtg z%K&5B1oSglx!VQU_^#r02r#N+fVge}T6Yg{wMPJ3zW{Ib4{$)*3{=cd0>pnBpy3w* zrVLguUk4a6D!~5H0rJKK*g00Uj1MqCzMmH0>GS}dW~h%@0WQxD&}@$SoEPB4Hvy{8 z4^VPpfOd-l9F?mQxmfjm8=%6{025`2lvt%6epL_q1DusQ2Lp^d6oA74K0Owo(eVIX zP6X(2Q~T}&=z2Fm!My-)-VYG-BtWaD0rts;=c+p*$X-K`qNX69$wc{G9z_L-G6&f% zN2IDH$Z%_r-o=A_S0>2AvO(S}7i4vEkQNn!%&r)uNJ@~DNmm2Cqq1spHIG zoGXLw?hJnLWRT*`pi+(==Vmapeul2O%^=h;15c9-`ZUd;bE^zp>!LXCDQCwFKIoQ# zxqAk4WY5G5icHQRVtxj-7wGs>)xAP>f0x04RT&t6%%JX18EleE8!~Wg%3$wi<=Lh@ z+cOxsM>QSKVC{(vDxAz<-Wk<@HiMSGWl-}%2ByC<_$?}v@|H|iSTl(znMv(ZnH+yD zleaT7S(uf{nVd|9HqGQfvrIzGGifZVv+6oQJZQB}ISFqWSqOcFU!|vvAzVVuqBvoyGfivPgZHMehpPY_6EC&#|)k z)tya@H=8fyeqJ`&;cS*j&+6IyR3n?Tn%UHx-9MwazhyI2j{TWU(nZxJ zYyQdR*@JA3KhM@{Er-+Y9P+YqC^j&Mal`cZs~o0`&Y{uR9Hx%T;j;-j?4FoI#-tox zmyS|(N)E%P=I~73Tb{%66*-jpE(fm+mK&>c@U6+=8+o-ahw8uTxue>5Rr{{xQ2TZc zlOE@A?nw?aUgdD5a4ycGxnvc~rF~p3mE&{u_gk+1e#>QnBbO5Cxhx9gvN$J~+qt=n z2<0-SeJ&^8&1GG`Twe6grOSX^c8tlzGA@^Eb8>Od%VmyqS)I$8?{n$-V=hg%<}zbj zF45a_DR(TF_mAgtS{D75%dK;{EdMK)zE^VDdR6^5|4PkE&^T3~7<4_dR*KULuc1vgeIFZne)N@LnGO zbk5`Cm^@w^m&YjiVtyX`7UYq=Q0o`xG5A}pk*L*q)c-z@!apkSxjfcg%H#0mJdRz- zBk5Y6W~qGF^H_BwkIj;GGmp=1<#9(g-pM24ULHkdr98TyM~8p%c=jxh$}bdGevWd6f#2DgJ`OzHWUrUJY)(}&RhPY5H#7&u8JjCxYA?n43C=(ZAuM~|B@tN#S z2vImG#M81N{oWta@A@JAt{-BMEKSoMdx(jS5Qg*+L){?`ctV7{Au0uxCnLl_DVZ6f zT~>&r(k3s&;!ueAaEMz~LjnUb^#cU9wRl^W- z8-*y=IK;jtx@{KXbD7yZ#Kjic(=tSzw?mA3Cj@OmtZEzLak~&5+beFz5LG*cSR?5s{;{8Ij?63Z1=n&-{s=UKOtQ(>IBSUlV-K}KTLjuFos59UT+*`qu85;`LKDIKV{>aVcvc#%m>o??J)D-3A0MB zwGHELA7+jWe>cpL_rg@}p!gjXzmww2?k-^pcMFpwyQEN$Fo`l>u74Qju?+ku%+I~T z9G1Z!hxw(q`jGB@!u-%T%*UUG`9cPLrpJTBy!I|eO{PWi^Hs28Ro^RFp)ond2d&k<-0Yz{b4Gd zQctJDJUbI+-1#u4FNCS}hx++b`7ef9E7Nal=66)fUDffAX8a(mYuCdRc@n1CQ_WC< z80^V>GFfYA;0saEYcPOA! z#{$mCg>D6;^eAAm)ErX4=%EF?l4DZ~NSa>2aQSXa0S~tp@cZ@xj-M)^Fok;OObm8G`nBGF3EpTz|e;UOpw`+3K;vOfLU^;N|C8G zdOUv^q5oyc``v4Kbn}1zJFuenDpQlw3vR9*zpGw@l_iEZo43QV`Dogxkn8%UV#Ut< NzkT`_>Hpt<{|7|Sk=FnK literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/315acd0d601e7899_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/315acd0d601e7899_0 new file mode 100644 index 0000000000000000000000000000000000000000..4accca758b212e247ca239e33be70608468dfbaf GIT binary patch literal 31328 zcmW*T1$a~E+sE-=leS43X<8^YO5H6fUV|3*!Ehb!F2fl%+=sinGu&agJB;D(F2mmM z|J`+cmgJmA?)!e8miFYNuKHb;{?z`yGoXD6)sV1=3zjHdD$~dqr?T6o z|8K1S{Wr*S_5VK(7=kLU_gzKW6?`)~tGD@ltg zO9#-a3VmuwUofPm^e^((mOA1=S1Gxh^aO1bAtk*I?1SciY`2sIW+191kuc1yjl zN;-$)HA+4Qhwv>IN0VUf63G)Ee{AttMljTRnsRY-&)~W(K|Q zWKc|JgGOR1%62hm06ul)c{hXdbT=ppUwatTxF>yk88j2Skgqqf!Q9WFhWHC_`ZMnU zg9`p`Q0IXLZNv6K2Kfv&$c3##$O(o&3@VOY7%-gIBMj;@(x8`PmaE8k92IpjC4W%0Jhjp_mBge1l>a8I)_O zK{uBfG-f&RuQI3z_N+0e!&>G+-gO3@#&tB@WRT}RgN~uVeuGZH^AK%L81&){v0gLC z@{d7oG{g|h#VSnv*Pv-P4Qh6awMOb~Vz^^azOWzg=LRi!VbG$tI~JpyR-*#Z(q>dmhfy66;4~@}f8ry``5Dy?+aDGq8jhbvo3j z31J*Zk8q>jL>lFaGHO(eQC;GBo@CTLmr*y}M&(X6YF0to;6@>%-W4?}A;qZQQ;lkr zZqzBn6*KBJh88z!H69>=@0g=81AViIwS-Z(5mbtE2rO;XF5E3cEy@~|iOQ%~&ZztN zv%FE(3P!C*zKTW-Lt-VPVtzKN66&IDRpLb1YP7?VUySNp!zjO+M$N+!TtdxSMoq76 z)Dqmo!a7EMs%zBtCPqEMM@(wU+|9_brBO{<88x=GQTy>058E1LYG>2{I65#NE~0fO zqYigADsOkz4cB@Y_53%ZM)qVKda>SpjOx?RsGkQI_3uFD8pQq>!oMU#jp~Vx!;ES* z!l*|G9cfg7@$8NN`IFd@b28)O$rPSXHLCqgqaM#PD$i`An&H$O`p-8iYLQXN%Z+M- z>Z=)dol!?O7&Uw&>$HiyHXF5St5NaW$!mvES21F@QC0RZ_hHuK4D(#0-*uz19x^}r zBKITq0>(aOPd#CdXVd~8(dxNTMP3-y?8W+dna5M{*oMFJdTL9Mr}l+<>NXmMdnzu%Q=u`Q+L`RBx`jMdBF$6d z&@$aqyO5FLsl&xR^;cO>nag>q3pQ8t)S4!qIsl)ho_dC{%{(<9IhuQF8pgNu)Iub+ z@>KaYp4!`vvD(wVgQsFUdMdaRF?aS<{Vtwr*oT<fxcU{5U@;;HS!JarXk zhBNL+Plb#o=INf=IE(i4Jk@5trzS1%RN;l5>Wba)Ug9a^GWxIb)Q%0F`ikQlJymqG zr=qWWs>e-FowjuWEQ{ zUp+4kY38LuZ8+AJ_V~G-mp*jzQbK1hwZ`EtUb@xYOQ(Bz={gGZ_R>i-@8hK}7~9uN zVg0o_@Q2!kL-VVX*dRt^HShM;>QVW zo8+a1Q@xaPnwJhDex{d--GTcPqJmN&{1zw6-=%v-`y)FNHt$ z(o#e}VN5i7>7~Noyfj+g8fo&@+HBt136JdFio#Z83-H#C9LVLZ_CI;6Z$590z$SzS z@f-&+D#TmUZ~#f6w8Iwog?p=Cw71&Ec&jHa;to#5dg~t?iSyP=q{n-!3Rc4-!CS}i z6y*}V^#KEuytN*yT;95cL;1bcxS+TG!=Xan`dEbVi+ZbWink(Cy;U!Rm@0UyRVBtj zy{g_iH;~vyc&iP{jU+BON6{ab$9b#Icw$=Wt-{N^mAKqn!7IEqajmyHY-FClyj5bW zx4d?G%e~K=ntN*v8r&f7$KIN6GijdPq<(o!nv9)zf~k2;S`ui|q9BvbV`i{PbwX$x zX3`;C!2NKO-r{)#{USLRWzrg)iZurOw^Z{8voAeqLtD3YNC8`lOR^lVJ z{9;ns>O5juO_LVaGAXFON$qeCDGf|2gUNV?$_<$ZcN>|M|5uZWHa4k76O)?Y21+(1 zcYKAjnMv;ECS~BymOO83l4m=Up5haFcQEmbib=!a-^rvwU8pPKx|;L?ce)W*50fH( zGbwi;=D_}b)M0>03BQ|Eb)ZQNv0)JX2lE`Ok!^@cd;c)WILxFR!%b>C(xjgFgyW;A z!)R(g-lPr_*cX$i@nl|ODPAGlRFi^n5*KHfRDC8f%`)+QgZ(huq)l^8@||bW>_sL; zEuns}FEgpaN|P3DqVAii-xia`VHxgV%vO^O+f2%ZGnli-q{jP9>VaSPo3!sBwLWB0 zAMC_$hgq{DtRwawV~^rC{yc8du#>F)Dds$FQt`8_{W|<-h4nstFd2LC0o5On1N4|! zkdBrZhv)d|iHYxXCgpt1o-~-{Wi%@Yk=|y_#%+{0ne`UFK4z6gd#hO%hgtKSW<7?l zzgd&ulijRrIn8RB+pJHaj1^|q4|Iw!D_@jZoAFDMSv@hguvyk3X5~U-94%^AffTda zq9=@LX1zkiOtVzVEIXRvJernfOdQ4qY%62dh_b|4jyWot`5H6pO(o{8Y*z1|&FWUo ztZLQG`lpsz!)lwg7bo!%b?ck820t*ffmzubniYcC$lKVg=S|G&+tjS2W@a_SHGFDr zR=IX&z3yt3M>k?YKO}XhKEIh&6L&GJr&-QkW>xQP)^+6ROU>}4AAS0pwQhh}g?=}y z)j+deAak%;$8Z_%(0vH83^mJ*1$cuNf0%U~zYSx2e8S}6X0;w+Ru4Evnze7NSqsN8 zK2D}oS*u`KY*r;a$IvBaO=Dem(I0EZi`v1qi#BF@Xj4!nR#++u0s#`2-jQ;TRu_zyw;{uYc7UghQ6o%qB zjIO>G4aNr?_P5BM&7wRgjK9%2yF~->7M%htDw)Hg1-UFLo5!LtD4LhK5S7oOc5nt; zR0BSt7FEIBFpHwYEjo?a5f-h$VN{H?s17dSKXiz)$QVa|B;YU9DrnK7LKdyZDby`& zk#`YtzzCd5wJ3XKD4iDQ9r!IS9Ggp(b-=t>RsKULNys5GjS6gYEk#v7EP?foOPKKn^C`> zMdtbz<-+mCjN8PbDJ?8oh`p%V(xQeK+lJiQl3P1+Lyz{<1$U9RgGEI;T2u;8P_&ap z!TqRte~U&TWq?JF-x&`l@dSMbT4Wkw(GnCKWzinY9&OQiOd4a+u5lJkp2j+24}O_$ zQL~vA^_gYS8_bz)(Hiuh!@ABT&IJ}7MEfn&V>`L+uxRm4)?gR0?q>gB9@gz)Y<$^g z(e?cnbw5CC2Q6BL@_$?O95IKfBYrwU?zjZUQEGFHH9SroPq06)vETl+aG}$pKzxMf zP1gCgMH}ysD}3*h&jZ%zp+#5z=aEH!KBi7jEE@2PegE8|IAnWCy)gZaMQ7f!@87eZ zKe8X;`^lmPXanPCi-vz8wy*5h@3isoQB#ADI%A*FN2k%m%SR`?eKgSIqp>)MOuLU_ zeSH+<^ie#z;tu-y`DkMfA8pA=J3K~{Tt4cEr6~K857!ZWv^=kmLPC7BD%3~YP&Ld) z<_I4JpauM+7#ltCSG14zqiBqeX2$wx8A9TT5#JMhR5#H_?=pRqQi8FNRnkYtP@$Hi_*L-HaHyh>qA|3RkNQ_8H{`A2qjQ+?vyaYV zVGSRx$Ge(7YF^7nOYj_-b$m2#4(%3@GiofPri*-(w8Te+m-^_}WjJ{eRLO{j{4}? zN!IMNk2akl#|u7cc+p2~aU0z(aUP#8`{>D4AMLv3qsT|hgKUqf54PezWIgfG1YEwm1#??fA&*tTKUuXT zuT|!JRwV^lbrHXXS(Puss?U*D9gVfh9&c416v?uxGp-`FgjHoRpqy2$D_Ip(*{X{8 z4GVD!&N@~FVtYOM)wgON-ZZo72O2lGsy9MgSydMs(7Fx%P_~^_HIUlgstL&7!K$U5 zton{Bovr%P)v7DqtV-){Rag8Dj~-Sv?`Kta1ogM-!$7NygRJT`*s5Xh8e&y3R6^2F ztJ3irKQR0c<{e?xKZqM?RZA?#Gq^@E2acn~XsfoO<5;Vvj;9aI6Rg^Wo>e)JIiDOc_J5BH ztlEL2NMA&4aRfD&STz|7v1+MRcTsFPaiGEq=D>L5S!q=?8mwY%R+BI0tg-4AULgBA z#==T$!;AIQYlBroF$o7ZTIIQkT(KDk5wn?^p*wnRVSjA3>H&&xV~sH!$F`Ht4)Q_C zovaBaquDO27GNC)?WR^}vxmNWtxDc!RnGm?<)Bp=82vYKAEk!J$oV*X6|GM&)=A<% zWz`K#JZ)9OGgfUp%i5yyIdVR4RmcVQ5K3NT-SPV+s}e3#OU$~$`Kwk|-* zxIxUftctwN{zH9?#{(3+%Raovx})QL>hXXY;=n`d@`ycxc8{&9`h-3F)T+Nx@EPNw z_;ag%eqq&q9DB)Hy|!xRTdUro#5?+++Iy?!ez58#N`B-uw!`&_Jp_Gb4bcXt5d0rs zGuVqZ*k2)D@*VN-ofLV6^xqimXvCHNl0c(FFk$Gila3c79D zmEWdgC{nIyNoEfAwwZ-`u8A_}t2-+MR9MjN(0P{Jvt-ag^_EQ;9w{ zZGuNXo7xSsY0EI1d?(xVWu8sB7EqssHkHF5+{WD1Hoe4GbXa54Uc{`msV|NqYMo7O z*4uO$O*h)qWeekMrDo`Xe^GOrP5XCJ>s{ot+ose#)MYQV-pBdy|);pUfU@mgMx2Xv_ z;S%CLFcuc$13W)cSNx6hsPu_`SdGNb)CR-w2F3rg$@+ycF%1v#9^JkY7cQdAH_l-R zDt@OPxNoq_X|$^~cHq0GT}8a?8jicD?rqm%d_pzq)$n(N>H7P>-qIT^~u`4dsu2GnrW|v>O zU2ih%vKF)JB0P)RRU3se84I1W>{^e{NGxgBd+aD>*KeimdWxK7$O*=>%!_aEDQ8zQ zx??cbRj}(iE?2V4qq1G$sE^h-g1uE)7kq}}7sjb>SMeHlRl*n?L8qG3x0YQi(7Lu= zbL-fZR@bgI2(D*W+4^>!KyU-Q{=hoiYiO5$W4rdCM-$FtT~pSlnO#kr6JJYm!)|16 z&0Kih&aTMzcAZ692fNB)5w3P5|4yu3XL9aB{#{wSk#>Gov1=SY!+R8Q;s7+7b;M*` zM(#13!x2P{B}Uvv+Bo7up7C~lMacRh{~;1&wcV=Rou-1+3Rz^-2x+SPCo@hoOfEU_!wGUi-vSGyH^LFaGgBW&F z>s`dY+pZRSS^ookT^u2PEIejc&6DgMtU1M6T(m0$<>7IOc(4C^Izgd z=^J*gS=tqW890j@Sapl~;spxaX3yXZDm|no&?Dw~%slXTYF9c6KWDBN)Z!(3OuGzEGF%d=1E<2L^{KdO9@0 zJwywuLjg92hWa}+Cc8u90vzg}!=XDl9qN(Gq3QS+skt3$j_r7gad{lti<9vA$-(an z4t<3suS09lF~}hWJGAeAq8&OB<5105hddJ;y!YTxQMW@G$qtpw@6Z+ODd13ML1HY# z7=<0miB@P^#G#egihIbJ!Z>J{>d-9QOLypChC|O=I`joi+c?y|twW94Ib>_^P<2ei z!43``=*rw^-QA(XsP&se)}G|qi}`z#S09H4_H!s`06G0mKYYg6feytEriMcu>iLI5 zzYJ$Cq>OT?;AoDGaVYm#2VXx9ErstmhZ1pNyhAl6IP@3`COY(P60uKqsLK?G7Eg7k z@-&BTqx*D+uFoXiSq??cb|_?yLu=;}=X{5{ZE(nAGkF|vXy*~?eAJ-?ygpB?|2Q=G zhC`?F`Ko4=ucGSvssM6!^Hn$oVH5Tts5@=Y6#07iDh?Mh>^EQiiKab$wG^Fu`KmvH zd;2N@LtyOVD<|B2eboY8(WRfS)?pVq_V-m^)EvM#FbkXXaeSh$PEGRF!YRILIn`H(rul053}0Ar>g$!REb}l>R#QcPc@ucThpnKTEtr0snYeF{0{C^|3>s{?9{U+%-zhX(B@8k zXyMe7mQFoI@itEF#Sav1OKw<)n}}}b)DYanyY^0bbZ{!Zvr|30IhEDjso)+?Rr<}T zw^-ZLsc*fU%HQ9qK?9w-FxaWvSTWS8*kL@5B!^K>wI1!1VT@Dv$2wJGoKsE4GtNZv zn&g!KWT#po+Z3njOm)gN-KiGnij_#5O+UQBA9I{?FCdQ{)Co^fZ722E<-D!&&9DMn@ZgYB9gZ;XQP%9ZQ^_Zts&dMy`j~!(`OiA_9JQ}IHSCsC z?QT0|y5m$2^t#Kjht&CzQ@bA1_lc8xO`N*=lsdg&-@J6{&}*k=yk|Yp`xEW)3>`l^ z)fd+Poc#Xg)IF5`=F}-n`Qg-O^bPRSHXMREho27T^wW`Ce!7U0dHmEkpPyO>`>A7y zpCUv3^aS_A{IoONPgf%Rv?$U~Yoq-N|*K1%yNDTsYEO&QN>T2@D;17 z`6=QTKTXFzysYJ?5q15P{Hvd;_V?4sQGTj6#ZOBf(l^*&J45_cBgS7-UH)2xL2iE) z$nUSh1^iXAiodF2LsftMSKVKAYVe4Twfxnsj=vhz_191J{N-%yubWN$wXdna9yRyZ z@)rJzZbjSH{>t0dUokj~4(w>=_Gj0Vm)SM#Lw5azSBUWl&|lU7ZE*x>k~2Ur z(JCxJOYo*xfKFrvD6VvXk}3vhdbI%6t{tHE=rTM&KaUAe{z(BcEDGRfx&W>p1*qrl z01Z1Bpbhwl?iT~(cRfH)9|tJ+lK?e-8lXkkhQn~Z3{c0+9GcKKhpG)@b7;kv9D0OZIdgI!OHR$oom08%=2YtjIhC(XPTlX2 zQ^UIFRQmxrwfb;Q8BgVu*Y}*7YRIKtp}F{-DwnE-<hI6TI&fGc?om*Rya_e!S+!|UYx2D(0t)SkymG^aS`E}1L&y{(VvL>&V9m%Wj zNAvPNaiFSUZP7p_rv$1D_F#RY8af%<@m)f~q*OkW?U5gW+?9}xH#>$o*gwa^?#QFd3L7VHVsw7vA(7pT){ zx1TjVKz-2gV4zwZ4peu1JsPNdX9M*Me#HfpxEQEB|F9o021hXXdZ2b8&y7IM#s;ju z8K^-M^63?PC+1V$S@~1|&Cw70kz;l~#m~>D7C5jVpInRbX;x^Ez9KX{NJ+Se#Hb)G zhzU~v*dT31KzxvnVs@1v{e!VT2Wbx4R1H#{RzcbVwGL7SUc;kJkQO6v+aPtvM0~>h zc0pPTpY}m2iOINy7pT%9NMmps-W`K967xF+=_V$2CLWaT5~ST|)HO)$aTpgdr(2L7 zqjnEs`YlLTv8-p1?7f2Y6K?koQf!|fHN(EXwC_iZ8-i2=Ein;uaS4q#2B{;i;rpf_ z<@hT|9qbECIXR&D? zG3^i1@V|rf2!js=={!OY2WdZ!9SPE9_#Gu5w7`3mIz}yzGtY@26+0EAniqoPx)`J* zxQ5Y}gESqbu9DZaAoam|%(zAT_kwi)0X2UZq*jP~Li|rzUyQ;YlzJA#eE~rl@tQVo zsNvfny~MT;L5lboq&%O4G}Akn`vrsbHv-MU%4-Q$460g#wLV|4>c#}?dP=aY#e=mI zS4sx!J|fEnYkB!#ZAL=nU_M7ed%UX^ERWj3>W1{X!77gu4TDv)J#%yl);YZE5-k62 zjDr$Ag1I+~@qP{

MmtUWk~>Yu3P z*I@nnJy;!Z`A4v3DMSklAzFw0o+0`hw{0N`@eNUD{}4SuOi+mGMTKZ&T!<11glJ7# zh`QGcQJIb*dfYQa=2ao8e=tPiN{ISA3el?P zAsYNLM6JGusGuQKSvZG3jiFkJfAAgoJww$GpYTmp?ZNnmQYQA%_mgl z@eOussMaIO7OHkQfX8@X59RU#WBGW*`DLUpxns9OCIss;ElEL4Mr6Bo*i2$f}Ss7heoyil%xg{t-OP_EI3 zs{RS`$2laQ4CTEmVmTG67U+Xz_zPc9{&c8n;~YAl3DwTCp?trmrsqOc2Z!N2AFAIj zP&+s-QCBR1<1%?)57lDS{+BrM0u^qC>J;w6=QigO!*m6mGQ)HcmNH>nPYu&N?19R1 z4wb5eslzW}>W?+m!?dewn11dNrscndX)`+Y4AWm|+bc|G(7Sh-7GneMBce~3@?$m< z`-Ul7zc5Y3byV)pxVVhq5h|3tnO2nt`Nn#>ON38Ns*+hzwU4CgCyuiV9cZXy!+ym~dHRX^Z)2 zmKd%UN#UyH3RgdOxH>13LjlGs9ImD*;kuL-uGI8!P0OGzm{*J#aJ6_i-y_2HG&5X2 zSscS-94is7E2YAfyL7lbD}<{NPM~PTa4o@qs9A|z(Y0x~_V)-^_ur^}FUIT>uBwBm z-B9|D2-lP`;c7lETxF*)&ve?X4A)`|TTM)R!j(dyyhisU^v6HPA{2Z)LSt|d;U^+A0r^fwXb5s#h)^jE#3npJo{JG&e~(aaY=YnA z2;Ic&>k+z)0yiRLxf!8zk0NAyOkJK3WV8mUdkBenQc zq&6V-bfnhc!kI|^U5?Z&WL#iwm@h^u*QH1`y&S2|NVpQIrKof@QcW-(KV6H|6IA^t zQs+_SdZhXz@ZU)FK*)_qt-@t=y&0)Ow<2`{-nSX|PNW{-3#Q$T;lC@Nno|cPJO!+8X$1`-P5T(-U zw5tVuTSln@yjw-d*gA^eEuyrreUwUch?28olxCxUuPDV2h|)+j`#nlI2Suq9W)6`}7o$`kx)h}z$a{_W z5p|t8?nh}KPUeW_Ueah4y&bLP_=@B^(dvxLc!HR_(JF+YIDoS#e=k~F(Efh3Ug8^u zJdDKrr zR_$`|JSdj0$yi+pj#a&oSapIqG?t&AV`a-9tJVc#6^Cw|=Z9<4ptRZ5YcnfLKk!tJbmn-XE(*(_%Fp zAEw7@!Hig)*&3@UyJB?#!*<7NDgyV!s`p-E*%zz*Ct{_OvD%0O=y@tuWuDL%cb>+o z(6d;rdl9RAFJl#lkT0?F`^szl^dnXs5$X}AUy;oar!WK=f6DH-cA z*gsC!5SJ}Zov;;`Q6YPr#-nsVoEG8;-ax`04NJi|b;By0N3B9}nuQ@n;uMe)r?#na z`U}m|;*^%oc&LyOr<-sTi&Iy8M)Ts-4YM-i^ern+86}9XR2*L)ajIV~PS5ea0=23b zr;>H4H(sG}y*Qo4T@qT}^%Y`jYCi`M{L-yg3P2jcbjk$4%8G9C`0 z;<0!wKOV2WC*tM08L!d!aho{r#B0jkcvZU>uaJlFs)wzQ;x+eiyk7suxL@MAHW9Cy z*!V48!@m=UDM4BI+nk_&J_#CXPmoux1dV|scY+?~OHfEqg8Bz1C?zC8Gb0jo6{8~) zGz)d364b14g0>=GT7v4sH$6c?SPVn41Z~0d3JHp;n4lq*n6Gkz#x_pS2@GhGpm7Lj znxHPt612T}0`F%hXf=HLCuk3@4Np+^5ee!%GC_f(5;SmTf_5O+>;zrJzsnP}d_{up zqWG!=JwwIa2^xv?JqfCW^Kk7;&~=PDo}i=XdxAXRe=_vh$e@oCSRQi#?dwvP>^GH-XBzPvOqhF#{<5&Mgbwc)Ri5iKA zIFln$j+}|whqLIOD^X7|K6j!%2Pdj?2z_D_^#$hGL`Bz2)DWaLOw>4ZYMQ7^c-1OV zC0i%z6Kb?cl-ee$I!bqCJgn}Ss6oBxKRHoDkuW1sZIN$gq7rcqWoISo4-}o9sB$PU zhZyH4DsDld(or4$ixTyHF>xn5Z7;{db}~4p9eu zJ)EfiM-nv(g^ng_)iL@XPgKxJayyf#h<_RPW}>XO615qPZYL`0PNEh(CXOe>VNX)3 zBS~fP7R8-Oe2za!kNuJ~DMylCp-HYJ-OZh(!g-QZ5-*WIFOPvq8WNNw&v1@MB=I?+ zB))GasZVT@F5xa5iAgfMk`#cwh)YgVqx?ylQy@vd6im{&j3oV@nWQl&l0_dxl}J*% zI!S6-FNwdmlEi0Rlk^9Y8zxD8l2j8-;pm&B%KaF(f09NGOj3hENotSi!AaUTk@zPi zX(3wtnWRC}l2mrW(U+{Gk?-b~Wr+q{0w>vu_-g);AxG!3V*_G6N!d${Cf za48LIj4l=Pa_I;z;&*SC?wMSA15dL{tx?nB(h{3Xx$G`Q;0&C;E)8Vaal76J8@jt;J5Xtm#r_ zZI`N`F%Ds49hV-}b7@Qim&P?>j$d8Mfqn3A>{2<*YeszST$+S=sL-CebRd^bF8*C} zX?8yszn3#7+K;7%7w(dM|S63i>W~ zDQu}r@8Pw~#XU3BV2w+*jV_fqOh3Fwi=*U(Cl{#2WtYBV`4yKMUUli%4eEQ_rR*PE zYJ=Yp`q8B(pIo}|*`=3XU3&GM8e!QFa*$iuJlv}7QM3$PhQ5opp2nshjIOZp}l5D7S{AM!Z}3liVtfr)ceRYqs01 z%K62CEY#`vY&x`v0CSlX=*W!&;C>sAi*L923ZjjH6ohat%alAx--VDC*#~YIo_?{3Dg5CP-CK7t0uX1>rc0WrjXAxj?ZxG z>nyj<&30?~9JhX-ORn=czrwBdE8Uv1%B^>+-O^gO+OBi!;(FR{VC;=HvS&j;M9P^)=$S+!{dy3lJ!09R`fZyDqWyf7s=r=Ib9*& zYi>p2EK2_4R?q8heg4<2*SFl-{?IMwBe$Ai4o>14N<8K@R^jI-Zgs&aq(61*65eCQ zGq+sNiS313_c6vJS;Y;>`WbuR<(bUq8j|&gU$Um6s(-Q?;~a8jPu4IL3`$mMC^%V8 z48-A(WEBcc)`Zw(EkOOaWVOS;2un!TMD)v_tg$FtAX&9>6uyO$)gNOrk~IglizTZS zt|BOt_J}E)td8Z9)fe~h9&5`JFUD6$)+dyxl&lkYh`p7Q)xJuyM*WzV(xJ;MZiGZ=9^nO^CC3vVL!! ztUPU~Q`=BK*S@!&f%S-;In)_UZc zovcOJg5Nh3RQ(r4G!GAu`(+VT!U&vz|EnUZfFam{*NA;xM9nY@=i&3Fh>D{-R^cfk z-xg5=OvXtV-xX0&bjA|gMy~foR2}XjMU`5#sOqE_Rf8r)mG^K_y-i3_bYcphflSd% z+(2+riW*}Mt|5mjMQyPY4tI*`V=X+AQ&a_ma0vyMFp_~xhkgU11{G{ zQM+0x`q+qL%~DjNWr|9-PSFq)Zj+)ic#7F=Q}hqUwqt%|wNKF}6zY(o$M}rDI;P04 z8*{_ZJw^VQhW9;EwBffD{XHs0#?dL-j6b*2YU6-Y3 z?$#7O3&!}{v4i}Nr6}+56rILRG(VA|{U=k@=X8qtJs~G_c$&g{&MESIMxCCga4kGV zUu~%>WKY#3N2+%DrmAeNR1Lz-+^PI6l~hf2r|K*c^QY=9z7iKB)@mn<|gtsVasyFpNmmaNHls zoTF3Kd}XTU;_E8nTAivt;k71Jseh%aJI-xR)q<_5ig?PLIAKUrurW>ldZj6+cbXQO z(sbFHCO=!6Cg)1il;AX7z_5@sO+{d6ntF$&seE{vcE_fvU8yv!K!eh0+?$l9xA?hi znjGcQw7P1Vo?=e5G_65_U(z(8dYbCiV4mj8iIkRUdVuzSq-iNUho@;jBBrLP5q3^X z)0pXLTpLf*4{Vsjd6b=-rp5EpbZ>r|*6mAEul;G7cOXrM+i5C}w=mvG(+E7co2H5P z(vf=@xSQNKpR-i#fy4vF{elDJ_ zuLvohu14^$kgiZHgI6WygP~fw(lGs(bXBg-I5ijt4QetD-s0!l#8oF<=62~i1E2Qk zYS|%Oc{`@d-6>ri5!yLj$=Hg3uEc~XL(+8t!-l47DoXs3uB(62Zfd$bW^!z9y7tUZ z*Eg(NkgmNby)d2ol+smYak`eTO4mcoSWQfDtx4CIwdpFlE?q~qrOSJJy0+mcs_aPD zs-5X-yenNN52vfb5o-LI{Gu|{0&}7>^c`nnGIR?qVl(tAE<~C3{5Yep~Q+AI#4M?wX0+(=}+dWT1>NT#T7QbxVB9wt}2s?b5B@t^_fy!e$$F; z>Ga}CpIKbzXBAhgImPv3ZgEYSUt9?bi)(LSrfLOc>P2uSf6pzG>l2w;jXTkqIuM(w z<%yY!DU_*%3Ylt)d=)d9KU2@Js(PlfYGi5-hS$y1A@r)3sSzkvKU2AzF*bafXDSbF zV?(=4dAHA$X9xP?J-j+H4}v;nssWsxGZl=3Na>Qvzqgrc-aAvusy!}KeWzvW2_j}?Y9Q(@%G7jJT%4); zNL!N0`|6q8`;w{Bn=(}s#s11v=cAeY-jJy#$1>FglaFUA|E)|7L%%zj+JO#tGu0oR z?q#av%S;VI!B?3o1;cA{d7r7{82=?xr!eqqrY4}^w@j@>+V@PAF=S~at{Jnq2R}m!*!d1!XA+ zmHsCpy&pNr%8f!l7z$)CmFrOQ%(tSQ1g zFci&F0mP?fsTwX6BevqihT|xoNlti)ZdqB1Es>?#*jJLAF}~FQ)pQ?FPE_$8$A9!9 zARv7~6p-Eo=|xE;mAW9(r7tK5EWHSVNR{4ula6#2qzTf?Qs0+% z-s7Cl$!2Em|NifPCJRhv?l{!hbf|>o(5I*u?@%jTZR$|*B*us6G;+j3~BQ4$gAnUhsqV4@}f;er+!49N=}tR;GN1&J;2H;PK~eX z)EXT7%&GI$ow`uNsoXW4%2daxkMT9q)}uY@zf<3-i^$Nxsq!#jI-DxuBu~q!$?;D8 zlHk-T5gRbo9ZRWX#Ms-Z|VLnAP$mce~IhBDSOR2etEFqEr-q1|pn_fg1i=nG82c036f ziitDS12a%7!B7-yaRs@W8mfVm=7zGhFf==AXb;AJWiUUip-B?uIh= zHdF;g5)C==-ylN;zGwMRLltpkxS>?k{?SlN{D~A49&5;fU$7HN6Ab=-C5MTI>Y)83 z`bEykv_+|@hP;@MBgi^ zP}NjJCsF$aPJWjP7Iw*t4j7H)IEJUlTg0WhXo3EihV?iLPAsZ4 zV$l;*upM{Mx|~a6(WIhF-y`)imx@<&DMwA0YT`jXmtyL>)XDAARm-LJ9+zBkE_K1= z<}SS#a%p1Nr4OSnEokXd;47EXw|1!_7Ik!~SZ9}3baAOcHy77MyR`pXm+qs@cP{nD zoOgP=gUpUoI%O{yvIqTVA%kd9^$V=;tX=>G%5^nDZ?SpR}Pm@XWO?5;f7QOSW$(($qR^w$KQ=R&m+?QdhW`9$$IErV9 zrm_q)wfhHCXOMr0sY)1zbErPlRJUQKmg4SkQ!PfC`W_q5_eWkwn|gsYV@-8WGWF%p zj0+c$VT!3D@M0FW;xd{|HTA_WCg*TW?U}{cW}D1uL!IWZZmy|%3r*&(G4;_RQ*Y2_ zvB~vSrt0ABQtGgbWy?)XMA8bjU1_SqYEwb<#qmE)ZCr0E1&ueD8jhV?s1?#}H5G%Z zXo%}Oh`p2dIE72Q$a^>WU^WiCvxoh=*VMuNrXC{80aNYq^+8j;F!+$Et7vq@)O`&3 z%hY1r!z(;FW@^iEQv**h#*?%;WojB;Bll@jb>BH->O350iHi@<(-y5RvOQ+LbIH`_ zmsyVFtBeV`ubC=}3jdJ*b^51 zYM?Q`dqR#V`jlMI0%MW$IrT(|R8#Tjh#{Db)-Ozrz`j@Hkn5^)=GGr5 zS zz#7a8xD|%E{`W$_#K;U>O}cdI83pkCRHlukTiq-@#oX?e^7pV5>1CX$x`zFvijc@Q$@Ok7;pFzonfxiXX>Y$}z=K3`Qc~FN_r} zr!jUEm~QdAjB(DOExIK$&Y85C$2JSe4WBQvlxDG|*D#k@`sz1JU2%SyrGv{YEm~u# z&ss~vP;H~7f8gC>as9fbOj|8g-)_mk5@gxIm{9|ru^lI&otCo0fgzZPY`ZLtMb_Qq zhwvUtmG`m?XW`suDHc<33(t`00P7A~>VC-5n&Xz_N&@eRiyioLZo0BbNzwhE`Q zH3&D;+S;AY=6fMqB~dVgtOWMkvU@L$JSlGl??WQ*8B<$MF!k+S>XIO)v_(QK}vL5l2z}Yg@^v_>HYi z=+>S(AXf)+Lb{IhhhIC{@^!W~6(j4vTtw-X}a5LgsG^~!&Z@=wpJr;FI)NH z!D%=XZB4|Gfwrz7_YdTXDnqIHNL$Y^e-!)WN9u%IC^yi#>&<8sD>;eXgVfv;ECI*Fbu**~kP+ZsL} ze^UQ-whFAbHDV)U+eDw}y4hyF1#-p-+(6tG^4LNCJ8kvZWosA)?6y^QFP|?g*vJ0b zPd~VLz*feCwthtVL$(r+kU!QR=ktsAPO_g*ljm7m)y~;Ef8N$77dh_m25T?znYqmI zoWl68a!eulnyq91*s6QO)=xM2Jl(SO7GwV9*ttVqsPTZ~`zf`2W~(~h!1HW4jGu7~*}@(<(Hl!~9YrI=K@tulPn0^f@yPD# zQIS!+&+S#)=3dQ1lNMg$dvzC{Fb{2ucy+U_S0&qd^*3&z%hz5V{Km`ooL+6|;#K<| zUd`_3)g?^q@6{ZX9^lo`M6bpS^y>6buj-BQD%V)A+FYK> zyc%}UtLKNks(ysrk&1zTd3FA%SL2T{zLQ?n#?Pm`3ZC}r%ggkE=U2!(#jB(TULD1d zhh9xWp+{bQ_t>k>Pxv{#PfhV&2A^Uu8*eiDR5r6uaix7qU&hCCH+))wHsyWlg_mer z(Wi5`j~^=el)0u)CQ^~5mQUkwr?!vl>wS9Q^r@2JQwkoUx68*f_|3u#_eR_eVt9;r7=W3s3t?{YRTAzMD?$ce&I^olD zR6prc(kY)lKkZZY6rUR64RT!dX%Ze>^J&39KJIz;X&Jt}+ zeeykLSt{dvLA#eeO@HNMzEYnKz4dWDk6$y=`n4#XU!&9e)g^;p!OVWu%I;UG9DXf( z->-E!{Tlv(U&$Z)6)Ef2gK~adEAQ9I3V!XW=-1rJe*N^RUt_EI^=~!5j#l?;XAQqL z)Ffstzhdh6bqm|-603n+Q`jt4yuOvLd>}kZo#OcIA=^4aHrp-*^pcnRU;QdDO!vO>~ zG0x45aSLts_;ndcdl?tX?DK2be!q+Ze&xF4mmg^_`;{A0@Z<`8rcj3)er34n=lX5G z_QH3|uO+wrYVt4RzUS9lthn!Io`1ir2Y$_eNWYK#8u^^I=$q=-DCB(MSErYL6@0~O znpiDCByFrZ<1qs1WAz$2bHpm<{a7`|HaK#|Dod_d-AAo_u{=8?Rx`0c0hLb^P%VV9 zCtW~~a4>y9`7#8Qm^q*kc>}ruNB)4~3IsF(H&C=-Kurq;bRT(R0?bVp&|e<~bP?@7 z4yaA>fDYkoiGcF7WqD^}bqQz#o^=f<*LMLG9~@BDkpay}3TWA+fO5|!*4%)4;|5MH z4Cuqv0ky}f4FS0~2Gn^ouX_XPcP5~6rQ@`-X`D8wgpvbM^N*3k<)Ir#ru1M%CIk}GW&ySa3H8!CxXg% zI;gT(aXzRYE(A6Ca!{+VbVJ8z9&ID@clkw986G^s|iY0W3@=rSbgxK zdShj>8>>$H#wxI}G0(3EX(_^rbyG+U zFlI|gTegPOdrwF)CqlZM64JtlA6-o~45H28TW>{rsg>@B= z@OpMwRpt>NmykF=tn7<X99SQ3&ZeIxV-CkJ66Jns+Q^tr}7?T>-6})&6R?C-Rbx9Y|QnXATQCH;2 z5YhRJ5f#c5(IH$wQs#)NWQk}C60)%zk7FVV6pko@!^m1BA}3-o9jB4=!-$F?S}dZI zr6T&YbVQ5GMHE*d!hNn0edCO%Rv@BFacmQesCskSLeYpuVo0Be&R|#H2y-$5#S##xje8c|ym92QX-972W>5q*h~qZkY7jftoqDvph)KC+LCFn4`K zeXwIX@X4}>GOmi~vp*xu=T5!$M${4W(ftnF#Y9!}W^bAUngDft|** h-CTWsOySrUlQxe{_TR6&WW?|P-!9$%H~7ET{{d0}Azc6f literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/3346dd9501715af1_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/3346dd9501715af1_0 new file mode 100644 index 0000000000000000000000000000000000000000..638ac9f08fcd7cbe33df39b5dcd011fba01258ef GIT binary patch literal 19196 zcmY-1cXX817w++IGCkCUObSQ~BxEMjXA)9o5;{olAgDA!kfNx7fE6jyd#?f_O+Zjo zI#Q+gA_CGC>AmWGes`_=$7QY0ns&}Ud++m_nY{Bx-|O#xTdL>t7bc*J)O#^+s&2@v zUOgD7kySN2m|ZoidX1{tfk5>@$d{FwQ#Cs$D<@RLAF5W}SJm$i)bv-bTEkyc4}+o1 z8reD3g4JsJYZ(;dKz!lp|BLm%e@j=TMg8wKQ3ASmN%}>@E}3D3(_&K+w`7V1P8NZp zMd7CWSsV_PgiRs%H5;tCnky&6kW&Ln)`YH&VMP-t-4uS7>dhdfx$2NQ@=hzwk-e?q z>$kL4Pw3nWZcDKbz}`nm6y zw}-=jzl#BW#iRYhlp_<+cen z$Ue#243=LZNsh=xX|@fvZ-?VDb_dLr;ya=4ZfGm^-yl_{$ez7$MkeorZzN&A`h6Id zN#`TbN3IIT)Nh$1q2o|f{*z)S;By%xvrj_LGhq4yHlKr-^H55T%N1$)Cp5YM?WN>J zaLP>i_!5kk+Lxh~?EarC+H;wB6&6VRHK_2n)|OlHue^I5UjC!JZfLxml2>mk$6K&c zy4{BUa$WY{gL5+NJ}j2x2XOBp7#_h!*)REzp}yRc4o_gM?2<2@!gz^(25&!yk0kH{ zs>vGJDzjgzU(r$Y6`vuBD)PN-mdeH`2FOUMX^NtS?359fC}v6vYZRU3gyh9UQD4l3 zqDYXhq(QWO>BtlX4#$(mO>it6%Gij;}sGpU>s zMIDK*pgA&FCP?jyQJj%!jwsGMqiB>7#p|+Gdb*;h=!@b=!}`3ielpAC=63n`l)QM(=td}QJ ztZp=)$hLaX1nNigqDeHpn?+N;xnjwU7SXhA8BJHYAro3f^HJ+)%&#ejHqj)vk7jqr zXzt1TouV1sIhx^JqbbxankMf=Q{=s9O3J72N7L}*X#O4@jdyG`VR>s@G>PM*d1FE} z`y^&!G;hm2d1X>Ghvl+7mgH&C1gA$+MHbE^O-7V3FjHE@8|W-2rA&gx%AG_5 zQAq~Y%U+2j8yH;DzyrxFYoL};&OmV)B)^q6kdtCyR|Ny7WI{y)^CdpjK-)CMkQBdx zpxl&~@@~Mu+Mt27kb$?d4D=CiWdjBBy*$Y_&^5=vFJS|FWN^g5Br)e3Xi#8aqb#gy z;7574nt{*cu4LCRuvosRtvsZD9Rsh+0kPLLFt470>dg%_m!d6Hvy79IEe&jLZNS#f zKuI|!m!)NU1G77*cO5mSn|k(+;>)e>26p#Qj9vy3`>5{E^!Rf<9%SGXx%Z`k|77wo z15Jl3*9it(6AipS$-o79KG}eEih$i;Lc-V7u4+(yzoMhf|jGz}P89Wv6qvXPh4 zIon85j*)bkDra+z)Xy{0MtW5@viVgb?z%=ksHb=`zM+wjU3O7~k zW=6J3ot8%ZyfX4s2DCA9U4 z*e)44C3UVC8FST0-5c81`$jH_e%rE^eZ5tcfd?ObkyqanNC+b%u!sJ`+F5JAM-bn1M9lujmI z%Br_aY!Po~6MedvxGeXiZ+8O2oI{ady+d2~~*PAG_LGxtcM#b4`V(G6Yo=D5>Cg#guJM?&`i8ptd zSR+q&o9OzRda+-59#DM;^}3jjnCK{rkD5q4X2N{hL>rm+yNP0FOuQnK<+9ZLL%ovY z^75SG{Ar@Gtd?>YOmw+uqShr7w{DvF?3RhZZ4=exdwG1v#E!e#2k|^KF;PxGGEwKT ziR({H_@0@VE6ZiczsmDJ6EEZw%-olpXfumtqx>g3jArVY%#1gi^$U<0yBxNfIp{X? zzQ@d6sq8beNY;zNZ>DyZnJw973gwt-Ez9I?u9^0EX5#YA43WJBW^${T@mDiru5PA& z4KuGv(VAvP%h6h9s?|0V)ljh|w~?8XP0Vy}YUcZ9W+t~VGhZ6C*1XruyxYdilD1}Q zyl&>1%z4vHoAzdc9n2h)3-WPCGk=NaEi>mkn@N4!jIEoQ7X!4`$BHYX2W#yidOXz3 zW7PHLEoNXp%j+wI3V4j&Zzi6#>W-RN?ER~)c)R!&l(XVC(%hH`@?(8zt zZnv2pQfRN4Ci~PIIWBi3=75>b^1dWr()w~%w%st3b<<4BZ8P2OnCUCm#edJt*Rn#+ zJkaZp%y{LM$7Z_9iYI1DKUL43o4N7AOxu@c_C;H$YOpZOXyK9AEEXDBEo_oCMJ$+$ zTBu*lLjU3x_DhL43+2RF!ov6RINrkfQWjoTu+XNWg?XtKilteYQc2Irs&orm#Otuo z$7$iR+>;!a#!54{g-&urlDx`8CQFpxLRTpju#h1$H})yl##8T^`sift|UWs$_aZlU!XdR=yQuu#6Eg||Cd_@ax2E0WPwIZI403z_d) z82Fxr-5*+L+(*6XYr)jdLP=Trkp}U%&Cs^1#$-=&Gwbl~Fl_|1! zsf7D0i=d-AR9Yp5I=Dc8nU&dQLcR`$qAY1qulQn}OIO1lDuvXbB5s`oDCA!~+OX)(--^(!k$GEDXlw-O#mH)azg?qtb8rE zf4B0+866K|Icue_%)F$2T-7`|CS|W_KPCMy^-k9PZN+ijN|vnn$4aT2nkO4>S@}&O zceEFGwKw;y9FR-$uN1m(CGDY=Z=}>?9TW2TQ!6K)={S0>WA%mVkgalE_WY+cvC%8a z#z6U9Do5M+#9(8D+?MV}8{eC3bg|l4P|Sv{xQ#}!Ha5voxh2o#RGf{h5;i`Lw=rCf z$`^JUyAo_PPO@?B6&u0QHu{&b@t2$|YokIr8{Nulu6&-N^`%@z8)IdboR`;9m0y~T zq)IkM%h7Zj)f_gWeKzLHP`{0R0ULQitt0MS8%yfj@HDXTVMCjKzS-!|*v1BlZmPUn zY3yq@4oN~=8#g*=y?1P!k@7ukjFU}0Z8&<_c=uf!=Oneaa`@233u)ZPrk`at{VcPw zMM59h7|`Fw-%@FSjloiEpp6{4B~c&Sh?lI-Y*d%kGWiP|&!oziiusj|9wQY?%%g4e zkvd~+ER(xqZL}X}qvd!TYvkz!)jZwCOQ}9nu_S7)jh?b*o{g#VZS-DXqv&eoA$!&+ zj~{I8_|Zn8pOmL;`q{?KU$htN6-%tU)i1gIn~gX3*f_S=M#=r!LzyE-52z0(Y%G%V za{H8x{4+Kh%7=g0_(gt`__H=DO2>0HzLSaPb-c(LdG${llVte?8;|8ld<@m?F*GO_ z!!+41*K%VBeec(Lu}&IkqL1vRh-B`D-jA zx5YAbdo06u#WHAjEc+$rw^%;d8_Op7c3&*_55zL}a4c1h#)a<*uk-fQCMDBEJ==ocTyuVO6~$HabdoReYS>G>b^ zyu_}HW1X1R>osY*D~{Q+;*jE>QG8kTR~*f5#4$$(-O;@JaTIwF$DNmPOes==3sSmL z2^z}jY9**xy##f7mZ0Z=68tQ`3@SmXsU_$lfh8rFy{ZI%NyXhI`1E)Qev@<8O0f3t z5=31uLH}DN82r2h2j$0qOR)UE5)ch$r=7JW0>unfPx!=cEyK_J}>o&H{s-t|mKcB+FvwBdeWl z;<4FzSkz9HVs^$Aw^KaUPFpD#XV+(9JAEWK-p)|Fox@T$!OlrZNwl+CmY37GbUU{) z?D`CBC(muCq}NWNfSo~EcJ|BA%67iXwev(a=Gkc+vD2=aou#s+y5`okv#*|=#QJvL zm$nV<`aQ_bx<-23L~~?SQ#%)0+HtkAQ?Ir1d(%#Lnc2%ut#|E=m*(%;N&djjTe7i_ zor?qPxCh#4|EZl8pWB%yF<;m@{iU6XgYB%8nZxZ|l?x;7`eIA5<;X-kBj?#UA>9_* z>Hn>rO-t?Amf7jJ+>T|fou=}^Pg-l8;)r#Fohh3XM;dIl^V1eP(Ob3NuXf&)C2~P7 zZ@1&!VQ1?uJOA!g%tOjsMoI1Cb|%Ok`TBP|H>BbjJAYiXQ|XfWc3Hi>Wv8>uxNYa& z13ML-+v#UW&?&(Lo=Ikr1U{GViYBlyF@f7MDmj5guOx6+9HkRDoSMKZX$f4elz`Qn zKr`7ENMKAbfzvWFlt87d1m2hNl@q9vtLLP8IDu992|SmFRT5}gJ%QO$v_=Bu>nG4d zwlz#(TAKteNmly=T69d{qNH|C;60h%C4rCMNnn?FdnPbNE=Y2(1eQx=KmuRM;V%+s zH8_F!(r~EO9;Wv&67Yz1fjK zk(~*Y-IqX_{RwoF8#3jf=1HC7s`XL=8>RmB1XAuK&{LK_PGH0H1S~HS^f@Y#PKHEQ zNW3YL>M@CokwBqD)|W`c9G}SKR}$$^I+5k_bD2ba?oZ^VJS~?LBC304N4=2*US|ZzJS&c*<)zSD@6QM~WFIyz)oMs{~ z+9vXD=S0@Y)~<=P?U~3Tnfspd>77Uu87{5*Di?XHe_NFO;if4pFS( ziPRpEh+#}3!SRWFDpzFa+(Zt`rp1YTvn-K2a{jwS62DKRqs)*&KP0kWHmptLwM~gE zl=52=8L}ghL$Z3O*4UNE=Mvbh9_&rzqO{+a$h-rI{3Cr2YTRMfCSM&%WWljSZpqKb z75hXYNhcF&EKAO)Uvm3wBGVova!J;Z#Mkjj+>k!LB(_MhKZ*94N$iritR!Yg{mMyP zl%6?B^vz3RtJDwcwrUcEt0fUrJ&E%56sK_#m765#++PweTP0DabrM6{Bys%hB+7M7 z!q_W`toM`nLO%OI&-F>7yF8M&`zEnks`X1E`lBQsNU6^i^Gn4XoWzr%Npu^Y#1B$1 zLh;8a{#ZRfK8bx(l1QAYxifS-Cy9>oVr~*U<|R@5>m**8ug6k*K@!atCb6wjGDXvq z@p+SJmY2*N*-9_<5So!e>+of_*3{$ zPE<`{aJ3W~G)-Ze%ND3{!N@1Q19-YFT@hR9R zD9&unnUg}MSeK;GOqOg&!M8buf%5gX6u$W_g*&q6XbRmi(#paKb9E6_m}4yZu=Pb)B0%8snSxbYP@BR%F+pzp>CER$VZ zD-idqVjZr)tEVe4Nh)2epz|;lsCiYlu@%XRtH|U|6{+@4MMg_XzlyAsXA=0RB7aJ| zkri1gz1COc`nHN>Zm-C;6BQ}>ydqOc<)Va&r_vxkm1&Y)E|q^$Qpu{2io0T}&V}f) z3~;3q@usrXm&$X0DzyTsEReaORIbZ`%v4ro>or-Bn@ZiV9_Q<^1PfB>RV9^-s;PQ^ zO4WY@sr0Xv%H3B}xnD1pO%1h9lT>y#OQqavsdSe$ZBwcCMykF;Or>?lR9wAN=_l@i zdi|4B*2=0cQ@J@(Igd)^-wCOFIaPT`t?8OOGnLWOdsZqR%}HgOc;}{4WSQbg&+k*2 zze)4u?H#F<*_TQ;@$FBg-pN#^NS{AaNj;y+dvfw}D!*RS{J&Cpcr%rk4^yf0D3!BM zRNM1Zevx}GQn_kO!*5EXcuX3uLTU7qmc`TP8Jot>vNbM^>G5e?mQHq!O-kcqsaP_N zA+o(x8pU2oqig9juBWAuSxIx9Y226mj5MxEeQz35B_X6ZIca!v)2No8#?D%4#MVyZ zT(dO#v`%A-tb8Ml!rjtnB}+cg*iX|KAZa7h=s!;DNyd~k7JZY(T`96Qjp5tUI3|OB zQ(k-0_~l?4#zSd*a4e15C(@W8k58x3?9Vjj$nt9%e=Ci$x6|11G>r|fRKila66Y&d zqF8n%8pt$h7OBJ>=~1;3zr0=v;~SMI)wdFj{%3wAX2=ISDpCDJC0%D!i5FKY@!(n| z3jV6Zh+CEP{eqs8RSzm*u%**b{*Fy2FFBo|vZz8jmO#3`zf9+grs-VooK9w!bQ-;r z&f-tgxi9W-G;Vo1cV)(=bdK*xr`*nT#vV!M$K&a6LeKx6&Y5%Rq@7P^)|GVXUrlGi zwRGmn)xXklT~BAGO!y~V*CM4;`(`>9rROb;y`4@wd0!^oOV_#bbe7#u=bp@Xmd>XC z(lJIk_&`3Fol?}`pt;e(HaS+?-OYtC)keNe*5nJLp-`!K~5_E|qc6tgM5y zR6UpG;H*@1IM^@o84dW3V(%6HIJQVJXdWTE_1#X;Mu4*q=A zq5mEoEUW8ay}0W+_^`f%%W|=qgZuJba|av6+rmNLmJY7U-S!TmJ2==N`y{`kgCU(9 zJe2L-92}Ri?>Lw%vE3cC?%~jP{tk-wS3Uz&ryTjzLGtGghD+~34u1a9LHb|^i@$Q{ znmPyVMmYFsf`fl2I_NdYLEKCSLuaYx*$yIe96Xuppx|os zy@RH!6+`Aqy)_Od{GgnFbWltVNsqM}^ON@AX9qKX(Y$rKzft!$>HcQL+~&Z#-9e)r z4mL}ned_rE2i*@kI3qtDcIX;92g{E-c;%P_zx0=a6Uy_XgGW;6l!F@Ql>aRUKi<~f z+;NaACm%X^`piMhbM;G(Nv#(SM!(d)OS32^Goqcu7@UlXadNbflj?e8(pUZxugl3TzmvoqCvWCD zDP6_M*_uu&)^;*U*1qcGWnCvd>pA(cp_BHFoP66@rL;-s6blOJDm z@}iBC9&MdmdELp_H=LY!(@BT+PFi<&GPj45Vm+N4?(HP$11Dd}ijSOZmj3;n443qQ zPOg3KNvaH$x2I_RsZQ!mcXD->6Zag&oU53NoRnRx{N z->aM~Uh8D^Iw!~0JE^fj{o17GHapp{#mV}uPNKJI?cba<`dw>F$umxz^3R`6_FYn+ zW$I<+B*|Aa=BkrJazz^7aMJd!`Y37loMg#jxqV-GJaF=%oPVl){MX4asrsLjCbCUp zqB0mDW96ASgKr9DuvXqHoWbXEPjZT8utYYABR+#ONg3RbMadc~{mN!gwqgc8xh~J7 zM`{LZ(lV$}DT8cT;L6~)>fzg(0dRWqp3FoPCStdU~McsbQL zgE~z#R(7|{;Mf}(lxmm3NEy^AgNf4MExj%WC80|OLuICzdt~tbhZ%e+kvjR?joo zCEvfupv_Cg{5ONx|1xNYi$zf`5~5waVRW(3F&; zRCe)RwoBiMy0|HKa$QsoyZBa07r1zbckI*(nZn`7pYQlsEh8yT%3`=By+fO8sTEN+?P?K zT+EhMqg}i$r={Fj7t6-Es58mM*Hc`qmL5|zPi{%(bQg7JxtQ{ei?fSdH279)F4y`p z>pK_ArOXN!omaXzF43#iPuVYLrO_JA{lSI#N7eb0>ik)C%IbA4p00N>c%zGhTUFaO z7o|?RbUluGbK1p`i!RPf-5V~(-*gdm%f+DEE;8?Y0PW}nqfi5NFuO1DC8Ruy(ru85nf@owA+Ze~mQl5V<|a`W#iZfcfs zbEvFa-vhZhk?N*anw!*gH$5C~{*b*+H*qdEgXFf?O_txS>sZ~amwN#>TO)3)1#Ui) zmv!6}ebvowIVE-Lx*1>3O;mk1eHyy4HFDFqv70Tjpt+l2t=vqLrmfv{lw(q=jhm5j zL#DNLbN+QV&)T`E+CjB-bTja6H`}_palGf&^DF#I5hh)w>mLR<3kYc9okNtCjB>H_zqWAGHr_RqF;fkv(o2igmA>BpD&i_PcpY z${cXxk^KiX_NbeoQstO>Be#z$uRoR71vjr>c60xQo7{g@ldSnqy}*Md%EK@@5bYt~ z;Ne@7hg)V3Z(2NrZ5|qkCB{Rd43|TNJX9&{p>Poo&5C;1CJo{=UXn_9NS7IMA>Kn1 zyN5{$9?m3ssF&oyTgpSrb-W1Dz5(bPk&W*!#2?&10y9t`a~)NSvfm3+~` zqwAJEWOq`Ya4{Od8&uI^4~P|WV*&l`xze2O5>Rx_DYRe9%jkt*&dF~(c`%u z+RanlGJ3v;jte|2S?D488xI5JD;cuX!@gzOgXPLWYJTTo)Cv#NrSwV>_l)@sjw z@-R~tORb+hJm2Wy=_c*b77wdrqg2|e-fdId?H(pep&cHY?)31h9F)Pkw7zar7zddY_>o+|3Z)t7Gx#!{Y`yTGdOR4fe zy_63hdRYHRdnyASd)WHKL;YtSu35bLzQfBLSry~uaUm~n7xofW+)JHUFP20vk4o#d zjF+u)SgM!xGNPQ9XYy`}m$enV{8rIR@iZ?7Gj!|q(#q#$ms|^Yi3@spE#xIBSGN%_ z^YS&Oz{`JCyws|unAN@doa?1Vea&y+Wm-!w=UaJc)LJ>T^)mK#FAY0-SFve&v6tSTc)1|&5B5@Oh?kB- zy&RG6hkNNV!pnCf6?=>q|2QvSONU8b7Ee~rQ@os==B45cFO%fInaX*#YL;npmFGO= z`L*sZ^I~1@)pgD4&nho}e($AVt(T!cc^SUROV7hzemJ5yM>Xb*#+>z1`m&cdZ+ZFV zwio*yFDD;(`TU{!_Q*@+$Ex{>dMs6+DNiYjk1kO@PRK@s52MM)hw`??#|o>DGBzJU z`L(EzzVSYWNmaW~KTmvYlbA#w1EgI^AB#%)NO;A^-ikir(tHe(k6jw)_OZn4y=y6#+KMf4uPU}I zZs_B7Bjwq`N7;6&qrK{oe`HV>A4PikX#TF|%bDIjQa(_=eSA1SRlLu9y!hP5*uk1J z#HaTWtvf=mk5WDI&ln$paX#jYX@ZYNlYE?<;^XX89~Gzjm?YJzD}S%?;rr3YJQ?zf5BECl z!+IZ=W%4E;e{9yCZ1v&!%}1X-K0=4I4@Z4`bTX?ohn^xu6vI^!d9*2j19<#``_ z{`8T1LHWzIt3GDl^KtRM#y{}!*<&9&pJ=^*ee90&Q>VP2u_=E3lfo7JY)kbMQ_0T& z873*|e!SA%;b*1O&!Y@KU%36G`~CX61wZHINv@xQuwIwe5kGVD{S+(kW2olmM|n|Q zv1S^%IfDV(I3mzifHO&*C0_*2?yt%Kd%i{(*9ry?y+A*w@bx zDd^{?k!%%fe?K3|P$@US&+37Go__47+b62`GtK`(`40B;+Ymp^hbag7YoaVrzrIlq zWVsj@spfCh&&7UBOZ_^3;b+krKM6nh>Alv^&p-L8{)?Zc8~se*otN%HdVzP%psf`T?Fd2~e$BfYlP;GC2#R zi~!4L1}L>mYb@8?mFm%k0H1FR=)9EH+#cZ0jsOF91^DW>00;M|Cwl|jm)!kYUpC95 z0|DMW7~tPC%KMK1apzRKjFmI8_kwDX0T%;oy%fNIIY7S5kl(K;k88?F=EyDi=C1%Z z{toc^^#HB^3Gm*n06*OhQ0b21+zn9nzSe%AK0i^Pp9X08EI=n&EcKoTnD9cqeHmcN zzX8tvr{jVkZDg}Ch}j&ZuZ*_@nIm1SL5da%(xPyX9r9<9AU7o`Hb}d;AP1#Ze2~%h zATMQjVvs{gL8>GNnO!_gWPKwt# z$fzzs;(G>Z+bhV`cZ1kJ3i5jYAp4}g6tg~ByUWR zZDWF`aE!*W%k7b(AQ zgH%`&WTGsV5-U~19@Vfn$Z2_Xe~@tpf^aa%Cr5%bJ{qL^u^{jMqj|T2^tc_Q;Ewj? zZjji=L0UfvvRi(6ro5v<>@tKXY6|hGOq4(5p*e)v5@L%Sl4{lv!)+n@6c6!TnGg@k zhIp%7h*c>eT2=@#yJCnUsUcD;h3Jv47_#0OBH9(=ec9>L>wyrT$fm3irfkKM;^7dj zA|V##hqze~VtLIF4eN)P+(2U*hN#st#OPKbeNP->*lQsUvmkmx3z57ON!gD>Ed4}l4hr$nm#Rss4-V;f%Md%H z@X!!bhlQ|?4AE#*h|Th7Oo+%h)h!z)g!DI)Aq{Fge6Lxi&>{r|Pw7A>!qL zoRh}W6>~-i%ghkDvqF3^JH%a?F(<@@x$4)~>h+?K&QB<&9Ff*5Lj1l-Yi_1}`o25TlRTPDwoXHqRLlSZ;x%<-9&ki~M_o=LleOx($td{{D*V7W|e6*6gD zF_SIwue43gDD?^*C8p+TUxVAChzpj#L_F1IkIzNCPgM^5;Z@QIt%pt66LyF zxqg?)fR&jTf6AoZ&zY>3OTT2|T%XCV4O(Zj*4dKD$eqgRXeMipWm4gICi6}y|I?YY z`aP3c=Q1%}$mDl(7Uiv3EVpG5RWge@rLs8sN)~TqWwEew7N>Hu7}6|@ea*87x5%Q2 ztdt|~Ws&@T7M~2rqVD`G#xKzPg;^v>M_I8ni-*gyh*>G;HSfYX2^uf{5_*G@2#)QPa7&zZBu2g?5m9HKxJl0(LXBF;%sGh z$fdt3PB5E2o@`=$*?b{)^Rmf~WV2X$*U0AQ zn%Sh+%BFU`Y{t~jrf9Fgt|vsv(MHrE$t(`HFF?@G+dY!X&y^TwKN_RB?i zxIUZ2gW0@!D4PRvNd}zI{Zoqjdp1Ml$e-CHUsPVQ`d&6q?`L!LS+xy$2H&l;@l@iYV6T#hc)l2=3UF7&dnSqJ<8$C;~ZwZ%;8GmTwFzSsa!0V zj`6uvNyycETdv;Qa#`Tar9?(9-vo16l#|QN++0S4a~abym*bss`Qf8np7+nC`+!`w zj>*M3E|+U_a`DW|WsY=TmCNeybLst4F3mROGGlWtF$q3c{<*8TPBYYQodXs zUCZZDEj^FHE%WrbDNon3O_Ka9})kzu-zQm@9TSL4I{E!8KeClkXwllP{pzca%0ou`-!6my|s zN}+GUEL+hff}wGQ zx=kXi6G!t1@3n~Vr>tue;f>cLyd!Pjh%o=n2rK1U`v{(n5$4G7P7w~h6`@LJ#qXl{ zT@_z;bdONDXM|+gE`{EWkR`1OMb2W8NQ5q|5VI;2M`HhZ{I5t8>nJA2l zkSC+$==g|^od}KPwTThtO^Q%_vU({uW!97kx5PXxf^m9;dNU%dm)$aOrt+T^Auu~a z)436*&x_D{QG_2>M0mb3LiEoO-r62v*$(w^Z-h!GRNKi2PftY{cQ(Swa}jEvSABmf zhl>%`$n=}){VnBlTe;j*ukT0n_XQD(JdV)(iFzra^7#x*$tO2GA7`z6de_e9g2dFz zr%C;Mwu-A!J|8sB=aL+3nomOWe1=Mkmif$Tl~3W;`3!hXW838OdHZ}W_RGi7KcDF` zVro8zr{z<1dOqdm<@5H}`J9y1OY(WTG@owE@^xN0pJ7|`c`R42Btpq}FMT|6Sw7^>+auTrc2r$+}U%CpQbY zDMjuS(EM%z+a>>g0Ye@XFhOQNEMV;80%pmnszs*OeD~RdDE;q>+_k%Xt(*V*??+3S udbX;6&X{~7w$F=e<%W&fS8ZPUfX@B)wAw#-LC^kW{@*R#Yu9oA=@a0tV2eLAK)obJgt5)@82eN!wKEE#~C*$?(s@|N}Gcv2>R10Qj z_^Jl7t9Y|Ad|rcM9EvME{eQ9k_vb6)cmMY`L4W%r;Ij0MguODu2xrBrB5unRGyG8; zj+BJ0LHIcvEV&vlr$dla9ZJ3qof^W*Mo_vjw3ZE0tqF9K*L)R~1%^>yTD~KNoZw-UalKC|(lRLxV zoe|JQ>WqYzk~0cwNXIeIO9qaGujR!!#hVE0)177_DMQ>`noRQkMV9sq=C7tg;f4LzC@52R| z_5hYj(nGla2n>&5iyV~vC$RphUSIO%GZ-(C&*A+S&`$m)id#B@YVt~ol!@ST$x4o( zmPA(292qPVqbzzUIcsVtGw+xq^ zO|`b>5%iOp??mut8`a$|f=}D4zj9gZ??o_O)^&{F#rqL-=@h|*&Jm<^QLJw2_oN6W zPL9AZMeCar!P&X0b6y0^<)ir#{Io##7e%mre+1@(5%m3^GZAb(8-e>b?U@|-J%SP! zBKS(Wnj%>n6-fniBwo2JH48^Frbs0JO0W1xHYP;UA}Nyh(odNSBj({ zEt0x&PEI)^sp^iTfh2n)`P&!Ccz+}vsz>ts>ydm_Ba&xQP%Dy^QtXXLK9!wyBJtOa zO7whWi7BkJ2x z)pbU3pD4#u<$b1D@|~1^rTG6wQr2jod0_*yiWn$V)WEr72F4UOFh`2S7-$k}V5f{I zVPK{-i!;zcPD`11jg`9z1|kv-Y?A#FPBJjKq=AQ$QPw~Wp`3x@GDvn&utdg4>3^e@7z?6*!Oq&eEN)y?z*}#We3|tr2HtoOgv-Vkz z>{MTO>9w$1`?W`P?lq9L&p@4{s#UU&8~8?Ie^+0{a6xs;)!PQT-!ZW6u7L{o3_OsW z2U@>mJTfrwv4O9}_Qb$q`RA!#E6>&M!bTPpF|tZhiW<39%*bakMtreGs>o`2T*9c= zosqKfMg}JtIh}0eQkoG@x{*3ABdKm9g?vUD`;Dv#8fltk-H@pNpBn3CDCn+^p}s@8u_`skp~@=`+e2bNw?DV10zSp*~Q35U5zyO(8w0~ zu&0qPs0R#Mw+kJF}d@jk&T;-l-O)!kDQX%w-_0@)yQ*6-J`Y1hP_5A?K2XT%wJUJ zuc}j?%HR8q^gLqZcS$~G#CqAt8L4&E$e3$J-nglKdtl_U*dH1BK_VU-srkf6^=C%* zNzoTZK9#rrGjdrkkke zHSwc-;4?8m{uWQb#2i^66LL({&DCw5iHMMic$rq!MEOR_BO4o=us1PbX=$RbINmgo zE6e0gE0ez8n3(deiC41vJrmo-)4@dVjwY^1pDrd&$?&cwri-PUiTd45Y>}zGOqBZA zM7!Q5j>v$%%HPk#IH}g(L=*X0ECZEWPJg1<6HOeG`jbpdnrza00TYR`bgGHKViUhg z@o!9gE#Iv-k^ZBJA(FMh#4Ks|lZnn7O|05vqReK^kwsfHe}{>0e>U+{n(s2PK>pgT z$9qh?v)9C0dA83)r(d-0gR1Y4)^u3M#dOR>ds%wiM8XLZQD;rGl6k+GD0WW0xuEfX zm}n?#q}-n-I$knSC|b&LxtAM7+q@`Z^P?Cd`wODTtsI4~Y7|k`qNrOviZ`X` z>rsrB<29nFS~H4>`id>N4Wc;RD2gtPqxil_6qB1pu|Vpz)Vw#N=+P>QWv!!V)i#O~ z?V|XkeH4F*`@JYGc8DV7{V1%Rqj)($aX(QE89i8ehUoFoD6R~P!ZAFG>C$Xg6f z5j`i0vQlqe6l;Hq;`zoX%$uV4R=RCg54NixKSwcGzTFeW-Mvw?*{5~ykD}25^*~Na zheJ^$--)90-6;CV4e{NNV!oVvsAG?#@W^XVqUaBV&mh>z$J+pOOUJIM`{=-aGzL}b`US1ZM=~CHDxVD*Ta^Vd#_3D_p zT;I%&24*TZG_zX@H8!)ig_#pF_)RkvTbuF85{Z4wOv|@*T=ujxQ@*{K_un=1Wk)kt zCB2hsl<4keGJ2R9_@SA7ADd~|TRrGw#?;qLN%^*)8RtkdAB{5er#zOJ(PnN$?O|un*O6YZfgH- znJFW0%Qp|rlzyZhKURXv+#K<3&$ntEel_Zsf~q}GN-MDBJC`E*U>`6 z`>MB-h4u3BM;5kA)W;TjOaI;$TJ*6H-PfW$v@l!__p^}S-=eSo$}ek&T4*-Rg5_%q zi84$M4z~~*VWE+9mB`7eO(spTaA&H8ylGnhbk!*}W?EP%f6r2Fvn}}NTKG(M&9h)z zV43N2ac@@cLQ{8>GuR3j^hbc-LE)E9+$Z77P7$s3s|~ z)50K0*`>9};oaKX{T9Zauy9lSr!35uJHJ_Y`<(Vu%;zoik(rm(k87GIC#39k3uh$l zFZE3}{%yg2!$PL4{KrD6Tbd`EZ(9i8)gIi_p4_)^NG{92Qs{w&)JGN;OQ|OomdF>+ zES!3-*T4(a|5E$nrv ztbAPGs;@^@+BLMYSt1*&?iL#Rrj;WS-`dK}cFOmGm2*vFdA&mF*JjXJtTtD}PI+0agY}v4K`{m8bs6CW9a{Q3`aLUROxhQweSjj(UrM`UpyOp2h7l}J>rJ}UIVC6fRcu}txSu3^w zurf(j{AuNhJdKN{nk|}o<)WD;2jzNhH2%D3K9x{GG)Ls8D$!J~8ja)iXg-r&HKGaB zjAm)AXqvQ$rk~`tjK=b&9!pNEXzZ<{`B?mmV)#^UY=|M_rx=cJjN$O67)oxAp~#jP zeh|HgxhW^M$53`h3^RX@VdTyjrtXSi_}&->?Tg`{m2VEj@ZeAkbC1SQ z`FIRVPQ-9e>?dQ`eKCgOf5c$9977WcT#cds-!ZJb5yLb2<)0Xe-iqN(iN75~pZhWF zkQNVP`0SDDeGGCv&35HnC%hKpr1{I3spwuZG%e*47{3GX!#_D@REbV1yOe}rl zV)^nXGgPxa|jj?PL(G{yD{$)qlm(^6|0q?R<{y#8&HA`^3$Lal$u(Cj^bZdg4wG} z@RwBFSAx$@mf#n;aJ>ZU|1LqqjS}>~U4p?cN^n?y__qWr{wu)~d6zi0M#f<^#PN?Y zj(<&Yw2X>lp_t8aw38K5!V*VJbR2IlE9Hg=G-B)q+9301HnKC4fw6Ejn zCHWKMXf-8{#Zq-@9C_2@7%EL?#PM);90haY7&A8x)BHFZO6LVy!}2(iS7_Zo#xY?_ z9OtFXwm4esiqp?8TF;(14(^Sk_b+iYKN!b+IdLeC-yX)1@+gkP=W$H@H;xO^02{xG zEyBh^gN;rm8*3%gY@?sW#!hitZ9FP!qjE7D)Z4*hK-F4^th4c$m+&6{%mf;*}_Jhma6X^8(m~( zcN;Z&*cdNOKeUn5%f@@MrMHbs18lek+GzWkjb>lim?zO++Bo}_jf#V9tdg0-ZCsN- zN80oujAF~Ni8e;gvvEo~FS6198yj1{wP9Uuqx}jS=JhrjORpc5Yop?bWwVVbTNOv@ zZL{&?b{mm9l<#L7@5nOwQ?Bf?;n{6t$6g!%?pMqss#``$&674J$geX0Hybyl;yD|? zU$Rl@vif#Ky}fOtgUq;N2x+3AmGOdy`KGBOxXrObFflJQybRL<3NQY{qE>il?K z$fL^fG_DrUY$;kjp7M3$=_)(x$1|-}JeMW2Z9L7|$8$+iI>hs#Oz#-aCm+PKS3KR~ znIeBmQulaPNO(XzU(3-i<7qKCo&{2WsB#ZeeX>X184=Gi={q5w9gE{ByhJgU$J2jh zJiBD!+ISkRi)WS?HmWzf<0-Nyp0WqxDRVHM&T>FTaHn=wCH~U9!A- z0*`BHeC-5il)$TI2|BNrz{}PN^yrYlM%mFRf!5s;SR!*jR6RWtXe7g>MIY57@AXgM z?7##nev-f{Y4@dSm5d>ZH9UcuBN8x-NgyyjfzRZs44s?6QQ5jQfyK)cxGNXGOCaI< z1lr3C8MH2egR*&j0&i|jV3CyHp1_dZ2^^6%dz52u0$+%KpL(!AflJc%Kmzj)CGd~* zIjnI zBwr$JGZNV=v6+d?kh)okT#{}%iS)@!WQWuZ>9$HDg{vkKT`iIFbrh#zB3X?Rb&f2N zS1l5$)iRNxtr9u;ej?>MC1UKJNajb0d?}yz(sR8N=^~Hi{XU7Tk*a+YiR_oiLn-xz zVt%EVgA;i=G?C836Imw(BNTs(;*Zty;}bbBC6R=wnma?ca}sGUFXtw*dtM^N=O^;o z0zH&%gx8Zqle{G6$nI)Mn5!pIS=_HD(O-7dNMe7@B;so&(Ov2_ zN@AKUYn((}(+{t^qiOvE0-i3Nus^XkWr_TI4!ST(%dT=C#$X}vHh0Xj^JIgcsZh2y#m*;IU z6iTLlTr#`lZ$~nAUos!dsVd0~u9{4}#>q^Rx$TnK^nNl?osucvGnp1LM!p@G%p;jF zB$;MkCo@k5k51;-@yXaGD9&unnUhS0Se7NzM3!w%#=9+%T&POuRwgK3bd0&11eDWvkFX=vLh=n zZhQsKN!K|Q=(D8)%VqD53dH`bSVt>R`)ma!Nu^5_bl#)_uV2$`OhqzdD>C`rid6le zBBLd_Z$(zgbMg19$RE;XWJSJ}?wcxdV`oJ&c2#8Osfv_*QIV;na7lv2Q>Yi0!ZgV) zm%=~EDP&ei!BsIu=PvYE1~^j)ds5ipP2q(vg&O`87RuaU3OD3XMhdI5bxaoKrtn5c zkMs3d0tG2_ube`9l@xt{O3}Z86#Cal;a=?&9@I%;YklQul)|1SDU^FNg)XwTbqZDA zPSNLLDYR^#g0p7|eZ@6U$3IPBy{!H!g2N2lT}luBP|UObgyld0g#8f_!iX~GSBD+eZQtY) zq_X>2Dw|)cgt>GjE@oAtSav1q$uwyauEZSaTBQ;{y;TY0+m$HQrxFeRXF(-qNUz7ryRETz(r6Z%Q$v>6tw60?3kJ@(qd$hCs4Lh5}RmaZ9b?sb{OHJ%Nknft>*&?21cKS58b4~8G zwG-LS&Sp6v`R(ltdDqS(+11(3Ng4Zrow*Xz#ZJqvc72X*r+9zWGeGNQ)r{^Z_)j&y1z~HcG|J*veRI< zoo!O+fckpKPM5=W&dHBQ?YgGR&Whu9UOQpOC;g@1lxjI`=dlzzW2gEB)p*;^4|ml6 zyLNKr^dmdZp4*9jp`OSIsqxaz=vUfXX%gXJMx=vigM(4g4vrUcP_3|o6~!F9RoubC z7>7QqaOhel2Pfrl83*y@91N8S$qvp|a8SFVgPC^Ck&X@redI6kI33*fIY`KH@J_CS z(v=;Yf89aFnhqw(`q~a&z2Tr+9S1+uchI(hgKrvYd?N?58#}nt#Gz{!9CVhA^23`B zUbb@3wY7t*Z#fwIwu4jeIB3__LCY=<=5}>Zteb)i2d+7aH&^kNI4HYRwaW+Js?OyO+N@AtWx*;3f3J41 zbiISo8y%e3Uy^=hl0+vZ^Nb_bhwIEdV-+`l+z@SAc=$#V`I^3NX*4qR4`W$G2x zBuQ5_=9+^ea#b4MbkO>qdMK&)9c0Q~wyUNjd2(lK9+o-p)(spj?t6RnnY$tbt<6csbKBom!1F zR`xYd=fvCTlxmaCNE!5QIuoVddpa(MCB9=iLuIB!bxr4^kJI@|!o4+4wn(bJOWBW8~Q) z^=WxJrti{Ouri(H->0)#`mE7Bc`60#(pe?D#IrG-x3;T4JJKofvvSGAz3I$9l+GII zdN`d=#S1`Ar_nM~$8Q)I_nGI?0#v ztyOPVt)rWhgK|k~_i%FbD<_FVoTNy_p-#FCb8=2HhCBIWgp=X&Kt_#nGFw`VcJjWQ zm2zX9EFb5j)+8tMr#M+7U8icE+?I^#PTrX1WXfVE=a)FC_l@$cP;Qy^os$((W~Gx3 ztDKya$TjMr9F+6YV6En^a}xD~*7&2=xIt@_H5;8g+vH^M7AJ>yXk9y>k#S+;h_x&z*gk4w)T=bJywOkaf?P8ytkvHCO zF}{wAh`KI%*LPuU;G$te7u#iFQy0TpxR@r5Te@g3C!|y>7bE4SOl$4p;#)4Bw{cOW zoz~Xg#lZJn?Cj*i{-I0PFS(fdk&6qxq_^ts>teEeEBXChG#Tt-#t;|LLtV5R=F)ov z7e7eyaP?+{OXmw+)EuXHlQd?Eive9QN3$jypSG0Xdl*Vt(#qhe|1q`Ec;y~$_Qz4(8YUF=8y}w96YSC$6XAS z$|uwtxpPu={h_-4bn(^|7Y|;#$o*GqlC}S-7q~G;xEUsgBHiR0+v&CR5EH|G-E)Jb&X zDdncmYi_Pdx3X^5mD8AHH(e{aS)1mjg56EIbT{ui-MY@!O?-7XZ@=#5pggbX);TXX z-^*7tlj1w-7dlAXicL=Sf}KqicIb9R)Q+N0e}8|&ucIMp;>`6emHWH(P_ z_7pc)rns@XpOQGFv z8t-xQvn1@(p8TSHmH7wV{B_7p%fsr+Q8(j{xrsRLro>4%txmc5RjQnEb4!B1xmhG5 zes^>9yq>?{X3#}9zx?6mtv}s#mPZo0>}G}Bxar1sTR9}>zMC%|xVbB@r1C>I`{m>t>HWbMP=nR!4hyQpm&mg*`+R_fRXwgE_&&fx%5c(u)czaUn+Vip6cOnx^6ulT6jI|mFs>Fu>lWn20bL^>Nf0QUcSZ@ zc=)ffhZ%`qp?-T03p;qY(a}Sz_dS&F z?4i>K9?r<%E*|!G^^n)iL$Mwnnt$kFkDQa_o*o>Zc15SB#l!h&9xBf8FiHNKshVeN%`$DS>YS%K=j;A* z50(`kU019AtoHE7_Z|w?dl>qohv8d2bUW%{-7&>Et}*8{=Ddf}S3JCP+r#2J9&C3# zoPOxxi%06)V-HzRwC1Pku~d1kI;AXLI!1UoC0h($j3zH1%ll?8D=l8iSiJ<~=b~Qv z#CaJeRcu~;4e+v4q7%FfkTxZ~EGgwB{xvWAD|(4d^)g64acZ2)%QBCbyIwDCeO?X( zz4XiQvMtlAYo@*YCgpRyjF(TUXna-Wtmb8hG_LMt*Xv$-)=(`q6kwG236zT4zX%Eepb3MHz_foyRy*NHoywAP7{KCuF!J0F~tFQga zJ3_}tX+84K7%%>DUKWUHf|mx9yquom<@{7H6{mZdBo}6QNtxwkvhHVvh;1TV^aW7w=@bXj|pY<~RH!qLRc?qBQ@|}Ej(aW!Yc**@! z^~?2ZUS{6+a_ND_KlJkX6EAz7D&N0e_Qm?BRo=(gWFP;@&J-Wfm3$14M=VX5a zAF+*m43eXbeIz#Zv9Ots)@^(&XzQb0M<32kKEm=u%$fYpQh5ja_+^NXro(*vwa|xWvFet< zH(KvfAEs}8v{~b0$yy)r>wNTF?_V4Pa+II$ zMg4p(ImP_cmQ4~F5XGPeX|=uW>R;jwk!6R>4ot zbU%Y6?crFHPluOb^MI3>*qxy zKUJIfStD`H{j_f3XTP*><=3^Peu8i7SbIOu-u3JEU;KRA)6cz+6t9<`#smFK|HMzl z&$RAQe%=}F=a76l(a)|)nmgIgZ&H4$pYihBG~J)!XT?lErIstl3e8=m-fZ^s#TLKL z+bHKQKX-Tg8MxQa*T48V{HuDg-_HZdJ*fP$O&%Ze)8nw8f6uAj-~Gg1(3)lcpMC~h z^0VWzAKw+_ysDhnm0uSB<>%(#e%`v_r{zC>KD_Pc$2)#1-Su50g4t1(5!HPKZ*oMj0w;tHo#%2 z5f@;zEx;=oo)F+jVt~p?0cMvD(7Q~4_sa%YSuQ}C@&R5*)d~S3>;a6LsQrv<7ODYF+{cwQfIsrP@4UpD2pzDGI{N6l3-4+4Hwh8EKuyVHxu<>2R z>kwd6#{hBN0<`WP;98FWwtfNL>L1{Mv>B+Fp9F~iG(dwd156pDwR|05@TdU$M+e9o z6JY09)iOT70Qr7efTz;~bef@c%nER2c7UdHw9a_}PRtKbeL;YdivqM;9N?&2lgK5i z@0$P>mIat7OQpmrt>IU#VSj+LQu|J^sj`RTdpjtH{X5TvLn$Y(N9ewRm4L88n-w#yNzY6&vj8l-peAm5b< z@~~`>_sRuXogAcjg&?yl1}TyfB&AZ2u4#%Pn;bzRok2d5JzgF62l-UCW(F~3E0z=w z1!)luvLrvqt%4vcUJp{gZjj0KG^T!#8qI@@ZV}YyoI!@Y8RSr_AaA}E;q|g8VsG{hF^{FA3^ramAEl(sE^x-?l2}wjleq ztJXcLWp5DAzMy{3BdE`2)Zar|=bx(ovU12VNxG^v$p_bhe1APi=pCiaBRw8hV0#(!3jy< zl7VTP)+7hEYfU>8Lr%-PKW8vns_x97nRJqodoq|NxxZxS_p39wyI<=$l)()-aajF4 zp26A^8B{o#fmeo{&S2gd?ZMd$TKtwljSI^6r`8#jNqI{qE3BDBl+2`7sZ5T)mdV?h znJmi6^qD4WHf<+5m0K8v%}vMBd@7KQ6(kv~3*ArrFrdqx%?Zpz}v%~@34 zn#I)vSvU`6F-wa6o<+0sS?rd}e`Vpgk;M!tcPoqcZ)cJEFpJ(5ve{fQTj%Yv`PH3G zj5nJvMsetdq@{y4m!ppUtW+**xy5@!hi-{%JNxKFg-^ z=h@Vg2VZ29J1CoPWt%J*k9Q!Bh2LazV`(<6 zmSxjJqE}@Tzb2cv*Jg82F3F=!*(4m!=A9$i9Fog2;FRv4QQY6M86p$p*dN&>T~d9r z=6*KM9%OU;dA9!D%}%N*&lI+r!y=hE}XT$*gnWyZE# zqPOQ#?pQAGAJ65qEdDK*o9A*_{%0NgfSl&zpJNY@bKqy*%!B z&g0~mJYE}@$0+%7K_2@S=8?Tf3W`eseFIuvFb)1n{%X_Uns6@kpEuh z(c_isiwsf37~)g;(H!DmONj2)5L1hWxKJ#_KQg&^h~HyE)Qt^MCN9KYDHk zE5uQ0lNVx1C`5cX#LcQ90@Xt-lC`YwD~0J346`L8j4LxtjjS-Ev%}QQ4|A|~ zn7BG&2FtLzVGh*`lV3lKp<$Re8im;?_NHMzY!>DZ+1M(~+i!*WKw7^YX2CmQR>}3Y zVchM*%#q>mhB@+Hn93a#zoX)JQheFnB~0ONVUlE*6zUNsQ5MMGABK4>13wD$bFVOm zWzffAe(9}sNcTQre&`$K<4<)vD9p>R!dM4~@yb~#H&knr5pr}`m?~d~sV~DMc0`yr zM=F+_66Yw@H#$th*f14kqA)H@o{W;?Ms{UDF{IkOpNaML-rq2u0a*6gx)~yWlVwL*%Lzu`7VT#G9Eqc5o z%zL}SEZ?o(?hjMxl-7JY%(FAfb2iMl^I=Y32vhT7n5Odb57l@n%vza#OM7!$_1;mf z_q7)f!unl+Fh!nd>{Inxg5~oWn4C{;T0V{%`Sh%r&z}-qC!a=j^VuQJ2Kn@An9pT7 z+&G{3ruht&iPEfjKC@cnQ@CY51K!m5R{4C-gz@3s{1 zaBBg-Z!h5ZsRBx#DWHBM%cME8GuYg^W z|Db>&4-1$evmX^O_DKP=5 z?`rbCkDPO!CnfTxzWQBOWNZKRo4=%Dxb>fR1wWK4f2mTXO6Jd#yF~6%rHkh&!@d0J zIr8NzUdopzy|mAlH)rmAIZEd%lRHPwGG+1=&y_D%p4_E#l}XQ^Ctu#;#Y^TeGRCX7>;L}@ZQXwV|2Y`T(4>rX2@lIk`N~O?pz@Lv$5F6?R3GsbrSM8pIu7C%R#cXj zR*?>)cUAh-kiKGAP3doBuPt@NKV799-K0<0IYG*@NQy;ObjL>Az+=={Ol-J--ut9J z*CbCdKW)Z-+(V<{ej0^?CH(XcI+XNNU-T*Er+_kk%8b6{{Zy}_pZa0ePk#E?(og1A ze%giO@U-?*GHRd+qTBfC7%t*mTR)|?^HUKN>guQ7z5O%-W&8T+ML$0c=>CtmPy+`{Oep-(@Fa0#_m7li1_R|p* zd*i3dU;XseWKdIogZ>CHXsg?xgLs<3pd+CMWzTHTX6(&kP~EHs9nEG?QkX$KaM5E> z%Ls$^moVs0lrCw|@zMr8DQA$SvO$fi7}O3qsvA@k2jHw>P-`qgx0;NBZuJcMt*Jp> zn;G=JlR*ic4H|kP z4q)Da2IU@PQ0Ku0?ZmDj2HA!h#5&0! zO*UvSR!kvh9GPlR;BUl@57UT!xkw^WI!2o_ z2EDvM%-0RF-Y_T~4KWN0uohGPHfZK;gPPr8%~9|!vD`B#^r1ngao~|b^`A1&3xgKF zG-&C+&uWy*Zd4drI*h6rXjBJ;x{UJTH+)3-V58b$A~xd^ zc83~u8QzRW-9nK}Moq)~%tlqsV$@6I&uUaRd`4I{qZ(o!c4KIEqeh1rH6YxmJ80lB z>H@5hMxFN>H93mo@WmN5Ho>Sa$=pse>VeOw+v!GS;Wyyi+(x~{tvp7(%WqUl0iy;L zG^$Zyqs}3zs8Me)yqHnz@DEao8#NBI(XRwCmNe=vJf%5@urfyN#j3JK-A8CSql%*n z>XkR@A%3f1l)a)+n-E^fsF6smY*gi{oJYb>+(uortwzi!_cQHr;uoU|RX3`04Woi< z8nqB7a2Yjg88xf6QOofFOX?W)sjgAGni%yIA2GElaWo_6mPR#cWz>Y$MjgVxc+}P? zb33C3BCvx|F(`*iXx+)Et=(Z%@-A}NO`f=h z(fin6`-$T?>ve(ouG9CXQ6(M`2l^q)WA+LrJYlarWv=Jc1|QMtg;Dul8rA<5j{&Sj z^Y=zg`oNlhG|KqNs09|2CRj}>Wix3RmfKBQ?J&veH0fcWNj+UAZAAWHld^=El#EPS z`H7u4n%$)B9+M7wO}dLl(IzFunB+|`DR-htJJ8!_(w-b9)y-qlw1Os;EM(F|v@C4W zUKA-}((z&@{a(%_OL>#J;1P~hpidQ(YF9OB7q@>fb{f3?Q(F8;dH-CyT>`|Boh z_3_tPH1F%Lub9x!Us3)2wF{{O{Z$CQLH_z}u)iLl;1K4)WHcN~Uz8Z;ukA=4?yp72 zFv4G>@C6@6`)lY#e}zpUADqF?ss36r!(W+Z`s)ai=lIJwmpoAqP3QS*$O3<@#BGEv zBxclJ?5~6+{#v)mU!(VP|CGP}`omvs{_>aK73vJjRez1S?l0#JfAz(2biV1YH>mqJ zwa1TJ{+fTAHMrxiRS*5u=#{_n{^zf83eXsHfHt@TvK7iM(bx*Fhub)Uv5^6qiNi?q(hl1Z937zk@d0X^5TIVTgnKxb7@!+Ckrbd;D4ZOi zs#piVlmMN^Gn7va&<6}o3(zL4^#$k-j^zwc8j|R8M`$>QnIm}wABv!-DWo?=FJvzCXMwbWzQ zUzihNR-H)NMwxXC7x6IKtbg$$hJLY}i!*CI&c&N`6WHdCZE+OT744%&eb^n-y5X ztQEL}3?DM!2*Sl+A$=u&~(SX$96|4L?U!(lu|i^^uL zu42{)l=#W4H>gz2tW_xaGr3?5K4SYXW|gbXPpqtI*0Ne=dFq?h4i8YEfmvlS4bM@f zA@ksVBeQb;YF7TnX4Pn7RukMpsixEe-{5LyR(f-@iXgD1S-&B@ty!jaW9#*t=a9A#G87_-`<7e3+iSn4s3^_XNB=thnXW5zdunRa|4%lC9K#8+F`n)mjoa9--#P%<79h=y{yAJHdM5z$x}G?&7!8W{o_{J~+pm z=glhi2YcX8YVa3pe9^4Em#O11(zUvgir=2XijOqN%WDu*jXsqLx`K`s8K2D2sleQ;bF7 zaTaaEFKHI_!f?#;Su`-+qO3VA8iy-6Eqaf7xhz_c*CKm9i!!4zPUg2LR{@LKq8E&X zEP9Pf#Vt~4i=1eNztFS{bK*EIVrN;4MwcU(^2AWd!sF4Rx0Q*libZ{XvZ&k77X4h^ zq8qg=8d=+-12~J1s9WEn_4t7~4J^vg(4t7pL-xiNy=Y=lzor(YHM6K8uH#d4i^{jN z=uKCP{JIef`XjA7HSB3oP29)GUKY7}TU5P|MK_VPA9cmk{`47O(Z+!m0L0Y4jY)JotoZqbzDY+M*r^978=Z9tS5_ zv}7Xl;Vc?XqR#je|4ybxQy2pordqTYr|<}yf1~X*i#p&ohD|5NnHCM6WzhtzLGo;i zuHrH3%;ElAVnOZs7R^Q0g^YoHi!3rMCf6kvt%Y@&MV0Xa!bA?64&;XC{4hL6S zbPmtZZWVK`wkULsMfulTR0d7)7PGgom$x$Zc5>KhQQlpwAB?*#Ds_rlpJsh<1wGC% zKX#)2S?Z3jm~_sfq(7+hpBAN}+h451MT<&aw&-s>y~2J$iHGEiW>1Ox8GG$HYx{!7 z3I@L9G4a}>-*E`HG5-y9!U@>_rT-W9EbihvW`Cvqf6QsIs=C#x#u$KLn^oahg^S2x zw<=?xRZ%F0)lhuE@er$=ZmY5)FOH&f2CD|+Uvvt!s#Hd+7H77qTvn^bBY$@0 zLR`32?cj>Ass?OctE%FDlvVN3R-MPZ7^_y}I4Z?jWlW+yQt&%!<+f^R9;-It9O~w^ zDj***V>Hecv?@a(t0GYZr%<_=Rc%nJv{mCU3)|4Vj8$Dwr<_&(<*f?Eyb8>ZD^;wj zQq`*Z=<<_Q2hqNoRsHb_-_Y%6tN!@Ksy@}N%2Si^F$cHNp%!(nZPk=I%vqN?u?_X> zS!JnjRc4%S%(zXgn%=^yB{+a;Ev;&Z32n%&ExENLH}q(4)n(jA_6}C%>u6PJJVpLa zRz>uu#sjPxivk0!3LM0EIE$y~H`prkXsebZ_gJg;W8OHc{=(GpR_&c=)wG$c8}{Ru zSynZhV^!a|R=vgic~-5*fcdQB0^(e3)e*GcPCa&!+it6t?O_e}66-$p3l?JIe#XYv zgI3)@`>>Uf6zc%A+Ax0N@2tqQ|O zm~OMqcdgoTk6aP-kbM4OjUHKb_5U7Q_1hEb^wg?>&)MfMtV)9W74^cbw^m*Fmwo=8 z{ri#qhoDbZH9#8}KU+2GE3tiJe}1QppG{2-Hg(29qfO`0#NVbf0X7Xb+cW`3P~2%# zVvtQ9mrcp&ihJl6Y}1yEHf_&DJ3K*?%r>JLN-k)Y}2A5HjOT7(`&pdZc~Ah#D)^3Y&wOK zrERK-L70lexD0a{o3bLTtWDL+GZv2HB7!U0GzzN3{1{%@rU6x`6|z^g=}*l5$)-QB zq=rqK@UEs!&1>1T94}D3j!hHi({3>}M2#h^(NdezmfMtfg-yS%B#%`#^;vCGr8U%k zolTRr*fbCOe`oE`b(>A!5U`WjcG=WvuT9rLJ?v`U->&ZP46y6N zV7rV%?CL$#u95H`W>-;EM%r+@3gZoaVAKfa9c|YQB#p7FC05}%d}Emdr_o}ZT|3Zm zf?YEv(Fc~vcJ0M!1W&c=XS_${X?BgCPCM+G!TdArT8QvFYd21!@KS1v6R5e|u4!0;wJYqpkD{xH0~J>@2PPrw z8oT1rU@dF2j(jnHy=VUT&gZo9!BosW`I5F4I07#lHUAGJc8{q#LxSB`^rWjaJ%j@VTM zc2Df8_LM#R%&w!z{haYo?1f!Fy|n8PPQ7BS-q8lnx(A>s><85}_7uXbhs#ypshCI9ib!wY;t^mpn7;}2?%Ti76n z4jUYLWOS&I$)Rre&EKJ4%?`E4l3<52WOAr$B)4%FFLBe$&nSmtq8$p1ai~6~qHrwt z;~biW<@lb!c!>@z!on1Xa;H1AH>X3VkS~`*)36v{@;LM)uR|YDGrvQtP@sTAm+?zM zhwh<<9a@j2Hyzsaw?ma~IkW~(ZaZ}A4r_Vep+*nL z@0mk0u?z*D6ZZ>;n&AXK!1U6gR@jTv$otBn!I+4QuN`WEZg`CRZyYL%(DNoK#6w_O~wLbdGAmYbi!pMePAps!v~l?Qdb$*Fw)PL0BSR1a`!89pM_ z?BqG2Q#mb84a0L3u{t#qaW_#q!Q&Zt^I<+Rysqi4DF5{@nsl;HX z=E4=?)Da90qkp(l0UoDHV<$dfUxZUtBAsfC4qm7JL6s<{F5n^Jqn)aYVVDx*)DGN7 z(O9P<;)op!(Iwug;t5VY!3W$;B+eAZggMozGHFhIMO7bjq&u}Vhg0oyIrRk-N~!cM&{;*`CpQW=2UIuDb85vT*9eM_>9z2PQAzO z(oXd(P&`j}z!rlls;OhNp9GO46T_9Z`wH(+uo@^P^g1b<*^jkI+A}U)~+)-cOn0- ztlbzV&sCh7h|dTZOPn|ijbj}#4Oft5Jm+u%aTACUcTs2}aUts@r@o=oWT$3h1+q+` zemF6my3BB@9!xWx+5*EYrwYzyk0X6PW24#vr>5f$@-Ad7jKhLO9ur-tAJf;O>-@atx$@^7Ke zTb(-nJ27o1W|((UcXZxGU3U}19%{Xp*!MZr;sEP^n8(El;>VIxPSrfi-og5Fti>g# zB2fW;mx%{^aQ+JIuJYKq$((-^H_F^{^8Tt*F_?`%a0_eiP+z=6uDk3RTtMYV)C79W zJWrShe$SjLjJz+H>m{{##U6R>RPHxU4S2`zm-pP*o9}9m^Dxba2B>~fxKP_)HhhO2WmY!dIF`0Kpp(Q_&}XW2vp6)K$%hk z`3xmc`O^bcBuAi1Z2P$zWH5?wOULyka%P8hTfw6(gJ&t4J1C?b$AdjCwtw7Mk zK&9g1q(Ie}9H=K)JS9-?rV{(KKy{fOsAV$(Rb^(N?xOpwK;4`}ymJE;J1YE z0dX!0RJYB6^4mrphXb|e1a&?cs1&^Ui&$?2YUr&%oeK|A&A1@N)ellGWa<{AXbizt z9E7JkZO|0qJ%W^kOBmTRNWYa=(;gkra9EHgjtJ5R)EOD1*Q0`zJUU4EF>7p)HcSZ8nu#2r5~Ooe zgS2FNkXp_N(y^IAS~WXJ+fZmuke<&AQug^lNPFybRK-cjWphNaOws(riDMR^YnP#dBnroPjQ7#n>R1%DP2A zOK>SyqD!%9%$>)jEqOVf&!wB#m*1u6!Y(CMaH(rWmkL#OsoGC2mHfq}?$urTRKukW zHC>9VMXa@5DpSwJYjBqaG@@T)m!3Ca?q)7|o4fR(g-gp@y7Uai+PHK8KajsIxnU!2 zBfgzW!*Cn#+Pmb}!KLKRF7@i>Qi<*^Mf7l~a!;53#fDxk{ny*2oC91MGT5byLtVOy z)x%v%9LdiyBL`r$1`%y%h$F?sB!PI!i&_fU_$E=|IDB<*u4ABLmIevTbsy^gxn46Csn{~U9v z!wKd+$(o&ZDaTots-APHK4x8D{y$uLf!a4+8hOX1c6VJe-*c%4df(^RBkKIvrM*w+ z`_#p?JT6^(Mx9==Z(g}{?2Sva-?N_R^NIF&j*g#Q>IeH57q8!3dVn(jxpWTGf4KA+ z{X&Da6USi57_8%&f^{NuurA?j)?hUb4_51lV0DZPR;)KzPw_A+SbL&_bu}hfOJjqz zAwF0ul7e+0IasrE1Z!U2VC~HptOEIIS0Gq73I;2raIgj!VJ<8!%3Q^RHM~TyB1#5p z6aq^JYd!2`g7qs7qfEJA%_$$O$jZcml2wDX72mM-=U~PB60BJ`h*!0OHM(xFa{L;s zY6F5bW^Ay2o*t~_kLVi_qCJrzs*w<)8NLuL#gOz6<;oeNytzVDs%nU;VRN+*eW@Oz zIyLx-jkwsc8=?gKfe!6L z^Z?=QLo^<<(Y9L%dpbl<28HO_D8`u_q88Ia^m1K@=B*FWu?-=5h38vC^xL)&y+!pM zA=-kVogw-KTTy&hi0)&`-Vin07b4?<5Y0uIgCQCV*Aeo;C8Qk-Q5Q@(9>RNyAv%Rl zXF~MvS;jdRqQe(MbmTH|T?x^E>mfP;$BhsbycwdEe-qQ~5DmT`qJV!wH0?=<8omtC zOq|AqSKNOcqMJX+2|vlLP(QcEV>V72-0Ey}>razgN&ar#MYaI9dYRq&3YW#LD==8y z3c?mlv$-`VgInz~y0sC_v$(ZAt6Leexiu2!@glohYs1_s=5Z?}!mVbJZViq`40Ff1 z^%gtg-O8NcRwvv_bgN(zox}Gbn6ld=5}i-?&Wi9V1Bpa3vdpX zkWkRA{Ds^agwP^xJ;nH9ZuysV>q9BGYL#~Ly1^}X8Mj8`Eozo!J`6ACR{8R7jYVVy zx7wpmMYqmkR3*2HS9WU=YFBZ~S=Fs7)!bYg>DIdHjE%}Q+$vkwt!wq%DqP>KJq_GS zZRpk+9Bt%Q&tKij+t{u2ro`Obt#fG6f*4x5HKLVUi$}PXIL58Xc#m$A-1>JWW6pA` zKK_MfyHyI4u>e`;xV06X=dlL(grf7gkM}sg)UD;~X}^*2c5)2HU2Zkp!`k6B%I|e+ z4IUuZKDVYI?|!#RW8ML`Djw!MRvdAw=`r>QMxS&m$0@g(e06IfvS!MlGU$bznKSTQ zGJ|Sm$)MT33<|HEK{J|X&?WphltE8lWzftI8T30|Bf&3JzuQB#Jup;LU7>n~R#Bl^ zj<-cab*6ZzlFEcCtx~9F{T!;=wL{e&T}FlKr}3f6IW<&&)QM#om3SwkE}`bX8MXRrMm@&fOqsZTE0gAC$)qfGGpTihObTz4Ne??@(#Ymt7&5E3H#4unGwbK5%vy~7`7`TS@yyCrCbQb3=<>|Gx0;#X z`I%KWQx=_x&%)y&i=O1kqTyw;XjYvp^7P4~>~FFtxO;Y))?`DcHuA`Lir+L>QXdJ)r*BGPl+(D*ALUCQenzj zI!whd9(NE>CQRqbhG}#8Fhy4g(|Yu&7^YjuQJHa3AC-R&Q(Y9S!Pt0%*Gj>=@rZ~(;r|w~@)+`qBk)kqEDDMqI%yjox-SoVX8Bb^B9Cv zC_FSwxrT))Wq6nh;9oQt5vGr5J1R`QunR3mhp8L3;@X%nJ;IE!VY)dkOd%7)G#2;p z3ezWr>HQRrPYvU`p)hTM<2P!9g?NbMX<=%PW%viHrqdr`GpG@A&kR#XtirxoVfu=s z*X+}!urDwkCouG8nD!#;tuW2QW~{qSKDc`~OrP$BDZ@X+@+gdJhQhSt zDea$y$?tiXyszkw-tUMT)!q}^2j=`7#{1M^I{uyg@`F4h!qpsEBg5s63Ri3FMM`wI z65_)Z<_lK`Tt=44;W}R>Tt|Ki*U?|XWvCvmJT*98GhDrEhihx2aFuBsu4@Qx60QPG z!xh&oT;E%UYkS*pEodLEh8@C{zhk(@bP88wmvFV{8m_b5!sYD27--TfT;+O)>kAI_ z4cD!H;d+j51Hv_WV7M%U!ets3F8j!ErHu;bbER+%nH;Xy2$~YE>~q7F3(e6Vhmdhz zxRMt!7Y;8Dmv3n}pY4Qe1dih?{I`W`*p6_WIYn-NhI0*AxK^O>^>EF*9j@H3!!_6I z(KmRbJxaqRq{ex)IKiUIA2E2;RW2jYrFny{$*xF$JHnsGUa}U~BJDDNMs1 zyhPOw#E0_;=;+ZHEb8RZZA|G*9Z;r=NBhvIt4Hl|9G5V^n@3Mjy9agX>CrW;?B$WO zw@2AxtMdf2I~@!2I2KG>bcybFBr9kIM-6I z%^uZ2OH9E6Tt?$9jEU>`zSX0QzkAdHBM`gIqteK^-J^;-Xp3GuJz9nP$hnIe;nZ%A zD(~^A2~Ob(ejwjokA`F7K9A-iV!ucI@dvgZB%edXchsZD7<$a3zu-OY(IK2V!8iy$ zNzKs$?@{^`(JYj{M$XsSr`UwqcgXDlwfl#? z@yMfANP0?c&)EMMi~T75+{3k09*urOo43^VUyoj4=Lh!gM~||8X3qyiaQ$|Kjv~ww zq3qTOC7_x;LYu-PR5u|)Hw#3_UMxa;aJ5u~9wN4UgjQ9E&^Dx0iQs#Qw8y(z5%Q}Y zp>8N#H$oLqvSEa3wr7q`5&9GFxAq5wdNJ&>XD9q)idJhZCD4RB=m$rs4)t zw??SOwg?s35usjtBGmQ>^PY>)gg@wufNK$I@gPE75%@5I>(U~$8l@gbs1u$e?~@2E z!AAH!jnF|feiosk&m*)IpI$^L_e<)5Px$_tT;4|L3EF>*(0=@h>Yu3fw+Q|EJwhFD z9UQr+uCs%*zd zJ?RxG%i2iQKN6`M=OZ=wk4VM;6)Df9NZmuf%aOW_c2{U~HBx;aM{4bhNdA9{RIBfi z%5Ctf1pdTtMz7Z32EHSw$*cbG`g>J6z^gd3S1A^+UZStntI2TKysCiz;Iwmi~G|uhS=saFs$0Kab@6|!HEXrKPy!wC@#l13>@G1mj@BsBndUXM=QeLi4_o_Kg z;Xl+Y?bRf_DC5;%WxcwCOy#^PSlg@a__K~z*Xoi7yiL8D-`uMoEvQj@=IQ8Fs}Wva z=WuMKS3^dT2g;82syg~%#2Byq#*_0DudEBaDv5;)y?l1y)mnrt_G-}*uiCC5_jQc7 z-mBmZ)NB*;9`vg9X)m9FdR6}nb;qB`an{SV0pxhjs}|^smG~WBQQ^E-wecr9U+`+r zA6}m85dWWE)xmMN{-UNASu+G)W<9YSfmgiBhGuAa)2n5u{Wo#pB`V(b>KyLFcGs)S zxQWDjUiE%NpC?{Tc}9JndzI%EYxkNqZ@oHzF7Lc*@PT^aS4C-%UzF^ID2+rdW0Yo@ zqLjlN#iiIBb42MUXO!Ncc50NaqEqoGU4pf26rYVnX(9GQn_x9(1S~C3CGP9YNMQv}+K>wf|AN-872N(4*vR7sc8}DSwA3?d?ho zJ)+bAt9nLh8#?uh((h>7J4zSOr%#lYVKW{grf-yTVjfcaMakViN;7a1RR$0Xu3*!k zC{-H~r6yB|YgQE3&O~VkKBL&2C>@1mZj=(y3Ta@CrM`_Y->bgHlnGZy%#fc~l#~&zpGD@eg_f(Xg;S*Y&CI%eC z)H6}~fN5u=6m%|13vdU0&eI=7E|3eR<2fvUL@D=QoX1iOxJY|^#>UH0x`&V}%!^+5 z8>_EJ=>dx0j8gI~YK}G-dM`@bA4KW?!zhJ5W=zCCCEgcNd=?+2#;?frHMt_=2j==5 zrIuf!)cwCGokRmgs~-aWqE#0yaT1jc(W;01#%Nu{8dJ1B!rwnyLogwL`{-$oR!2*; zWR2E8c!z_>jwH;5wqt(z8t+rT<{1MUm4NI`m8?C+YkBZi8 zq(w6}9^JhE(J*jm55Hm~!kffs z9(E$AX^h(8Bf^`-s3z_qPxBZ(>l~w)E-@O?mE+xFRD5KN`r_&+#u^i&_LzrDC^0ie zgOGDpj7s7pV&}vtY;FwS!->%(+?W@mvh!m!3Wu?0QH)NZ=i(TJEREqh{ur%V8KYN- z+YqCnzsG1VvTl!2rX4YgMme0_MIO6jG<8pmp6`uO?tR3FLI-0s4MUE^=m5GNWemg} zBTl?Q_Y=g18>eD;ej20kxP<64F`A6 zH8xhM<6>11+fa0Ttp3Hf39;%pF;-b8$ExC#SnWfDX|bAvD$`@t5D!p%W~^SI!n|01 z56AM_BvwD*SR1RHn;CBlZLtZit+DzU%W)2$5%7DgieM-vqw2O;ZO1oQw{siWcEoDy z=~yj07pu)kJRhs|xOgF!=X9}}iy{}989*DdZtF^d-uD7Y(omibgz+J|@7ps5p6*KP>6V4*+0Wm*{ z<+}4&HF_GW$IoMR`vo<5NqyeLs>_F1uE~wnRpkCce^|c8Dj#}dg5q=nF@`u8CU zzfI<# zds{GH%Q#g;K&vx659jD}h%!Ouy;*@DfoH}97P{tb< zr`sFiRDMgGcA>`BIDJ1A$8~aXdW9cYawbl{T!_<7)VoM+Q0Y>f>O+^~)C1YClPBVC zGRMO>9mLs;@q8a8Uit6FYZbmB$Gv!U#uYq8!u@#V!EhYLAE@vkp8u=k)&60;Ug19s zdlawzkK?uIS-fr|<$1iiVh!58h}T@aL-fmdg}sW`8-%}(*PyrY^7}VlrEwM+-^HsD zR^SvqqvHqS{20%*qw#u+oS)+PyfI!EQRPd#rXc1k_rJ%hpc3>a{QVO6enW!JVT&O_ z_u(-ns3u0?EHaxCR2PeI8^QhwDvnNAifgb0Bq%?+U>PpMX--fPw8wm$gUOPhg6N24 zxP$;}f(oNA*5D>wwgeSJC#*+fdxARSBdR+SR4On*PeK#)0pS@F%*c}?xuiMoTrmPFaDiOP&!A&L5gHSR?1 zM)3@Znjf0TXMKt41HVj(dX9+9i5i98SrhqAHtn+|s!n#=dlLDblc=i^iK-Wws7|nW z6BUXoSc<<;EGAJEViS4onkYxkM77S9sMy@ZhejxuCsF+h5)axJN>qOs3n%K=B8f^a zny3QUjxXq2EKw)RBx-M^M195j%8A;Cu2m8hST9kP@B=~h6EzKQ8<0~&;%$|vsd(Kw zk@p%CwHcSuXl9~j;lr#%EuNjI4TzqTsG0bEd7>`tNaVWRL`~nDsEZi6FHtiPwx1du zAdiEII&>ycI-961IE-HB5;X!DE)WmS;n*M4;4k93k*J5aId&&e6YeIe;zM$L#2TUO zQ)0jd+uW%cZ6a|klNhz)*b-{34 zMRahIa$pmNh9v1alH5t^gdMnoiW!nL31vc)v;-&cFO)G!`OqI@@f{U2CFut$W=>Ka zjLDLuzfmD3NwshY*JG3P6m{Z~)DnNjC#gnal0uS_^cHQBnFkwj7L8Mqv<|ybA~i{- zv?MjfP2}_?aeY9NKEauuqyi|5iMWH87?C4MTX867lCtDVQc>)KHFuJ_VJ-ebtvpGZ zi(&ba6j~rjZ3`ypcQh}Qq(X%m6BUaj={5q3CaEhvqj@pvhq=X*^k0c26)8!arIYxb zkfi$Mlk@`bD^jycNh(#By5lt(*GtkLxQ|@*lT-;!8c=iC8B&}$iB)=v}vb9ap zbJS^`PIG#I%$GagPMu4|GqbfYeVlQa)sh9v3kF!D#G@ky#TF-h5{B&qIi#5g@k z1!r&$-?3|ElJ?K%I5sXw(gBoN$Qmq4Qt!n{ItTOlvYh1D>;(0uM6O;7}g9|3>Us%g928NYQ zR#LfS&8?WMVwIA$@8@L2)=1_%pvlToD_L{uC+q94$;#0-Sqormm#n<)iMeC4rgTc? zGvZ{e=#eaQ&t#3m(cZ}_*e6-5k*#mCE)7c73ltlYtY3yQCrS=W)+e+Xp3L7QOIC%^ z$$Bz2Sz{+8^SNcRu1-o;v+2poz93n>79}fwak5GuOx8f$JjB?CleHa>aP&m7j3=oR zj-k@2WUV@#tOI9~bq)z;J`@=>ztVaH=?@FZDl@#YILeWe|;e@j+PZ22!)qrN9=8Z71%mB3L;ivC1@ zTZ)D|Q#1wsnNu_#fmu>iAJ4OC1x^XFLmN!K^a1>?prKl&u3o$N&3a7|}WiS*?;s2Qwy{MR?xJoG+R+;#!q^K$; zG)~bO3~Z93i3n|)qAtx+w5xdv*G{Hr9c%+qv>#_+9+;vPxIQXH8Ahk5^OzKcjZIM^ z2G2>+Ze*U9qD#1kZ1Yp}+oBX@TAZRG%Q=n-D^v9MsuZnSoud0Fww5~JGjgp<(L(Ir zp2Bku>VZ>m?@Uo+yx*0gnY)Q|Pl~!>6SD42QKfw;8iT_7Q&bs$!FMo4H}Mo@4^hwK zDH?k^MJLhk47Eha*%Wm=N1W$Vlz<`d{FS0k$Z>^nZ=`4h?%!nXZqXj=?z3Jf^)N+6 z|Dg?5zD&`!|5EfCm4A>6_-io=_DfYeq?l6GF*sH0@M}n_Iw6BQRb%i77c!8s^aUVY8VPOOw~kmYMQFcc-<;hrCO)z6Kb?c zmD;ANI?8lqJgn=Lsv*7UKP^?mkup0~Z4o{vRjK$B<>sbp1oF>IRe9u^PmGIFm9#ij zg;5$bsTtGs8ci~%>3)_p<;|L=Qh0@&+4&ikreU5mnW8x!lcqYcY5aelroM@3 zx{Uh>Oih!;m!?o0KvIr0HOiT$`MJ{cOYSuNStLz^il=Ej@|BcEKSn{OkbC#UK`Rh9KMZdTDvJtiJQ~Zc59lB9ZJ)rqiLFl za>s}d8IPywDK?!+)5J?@^4?C<@w?oA!~J(@nv1gU(=-$3vEgHyX8HN#Z}6!Q)*F2) z>hIGDT*9CLpB|WfdJB`qr`D)x^=Y}or_4^DVsHVjAfJY~eCi$Q)2xh~N3~2oEkkr> zpWej!^jDludlTrF=+l^7KK+N-{62kxrGQTn1$|1z^uj*1D&kWw%r5HF%Kt0w(>GX4 z__P&o5MJ7+E*OZ!GCuVz>*Md8_%y!)V^{U*d^MkH|Kd}D8a{2n9<;3KQ}Nn9RYhYQ z!tl6_}ck26$??ZJ$30oE}eWlr}1fCe;@A| zGAG(kpoSBf12rcR<18Q7!ueDk<~crnp6}D?1wP%tgoQqRSVFy*`g9fjmiZL5!l(D} zU+LqTacZ#MC&w0_N*<>l-lN4ya>CP#)Z&Uy-?8edPYtj6bm|uMz3Wqk4?eX)Pk2B2 z)Z~*-7eD*->YGomzf&Wu{6P*%m)kF0wf)o8BxAZ7XG-V${^`8OozD0C)3q^6x^8Dn zS3ys@CSyLzN2F^^WIBK2CY|qJrSl$ix)!2hT)IY~Msm7xrlqSGo}slbUGvh@RV8P- zhUQJzlfvohTa@ujr|UW%VM>{FeJGnQQ@M0yL|?QjpRTc$)Abm2tES7pS~`Eni{o(r zoUU3p`AfQP)L`zKTC!CG+Bat8~q7ldjkJ4=dX;c00!I zkgn9u%!U8Dq-##MbpGycy4v(e=erox1Rap2H+l9+S4cm`8N@jF4=V?!D`6=8hNbKI zsB|?NovwDsG=?0v+GaT>NMPUruOV;v{zzAa9P+vC)I2lKO& zIolnlV*8lG{q%W|`8^z`ibvuUI7Y3Glfy}JIz_&x<5V7h!*wQ3-<*xpi*s>$a4}B5 zUyoDX8*yrjbR5KKIB#+v%aC|0PCal4w%c(!fhSmUCr&l*65D@q`WK@!nE0G;QX)1Z zOJ)=2^_ny+pGi}Yl;5P*ID*0-n=~ACN}A+>N|}@wgR#4`iT6<^jjL?ZT%=VosT0nj zY&Da{V?ZsF#=uwGq-NNQ59^vV5ToNwN=LJXCVhc_P}0u+sN^%Lt6@@qT*VXo;wN7G z*vO>ka0W~|fa};2G^umQq#qJZx`r9aCgl&C6vY~3P9YXtf-BXe>P<}Afo#o8@;7H6 z6mLNtkiRAQrkS+8l}Sfio3!pT;%sNqw_lo6v;%eOXySYa@<(cClfJ`$@OLrk7G`#( zukI$!XgH1df1*EpINhYLXPERW3ePlYKGx&gRdtm1UwzHSH59p5UjdB70p!15 zUyU#n8}R^@AJkV{%)n9Pd{|!z=#6E#jq;D`D}qTlh)j>`s{y)WAugftlln?QT>S>J zG-#mawg!rP)u_iX8jSfrsF(H)iA3y(s3FEYns&&n~*2YtTg+ zGZ@o}@!{xf)^pVDV%AN(z}l{6&gPNN-Q+1@6TrSTx8a_*oi8O&6@R_nRO8u>vwDiYwwrYp6Ly%Du#?*DGpqQ1vkv0|+8r=!+d;GX9X4wuj{Id-@4wBeam1|s z$IQC_k6EQpoAn*uo-wPWyhzz~hj@f-II*oe$EGp37qB1bBVE}m#WWNy>HN-vmQWM91a$D*mHE&L{C(O;J>`t&xrVirc-wdg=bt4d|E z>RcA93T3rwUN);%;^YTb<;!K&q{3F#{jzFuDXWfQcxkJqphOv~`j)lIU(TwgC{W3& zKPy|+$!*mVL_AiGfw$@r5`9+XF|1miWYuk?CtI}wwZm48OR=g&D&w{z2ADs$>KY!Q z@fTL!k61a+$Eq@2tQz{2Rn5Pq-(gn$jLajf+J?h;iuEJu_j@b9d0O@96suy`G}Wrn z)2#Xle`4!QtKMN%I&I;bWz~Y&R$ZM#-dnBev(2j6+pWrY$*KfALZ-`Bjl{JpR*k=E zRs3D6`lH5wRyD* zb+XyC1d(`~I^z)%6Kr~ooOYWIA*;it)hO+^DTe%wY$}6A$PyqfWK6cnifLh+f+;q& z#9(wvrGG@4&_5m_u^D+Zw<&ukoBl%1&NhAC#irt2ZK{M2;=0+?6=k~HWWsMK(32eS z7)^TFGS1<2m#9f|^u_S9|otUr4VQuebQCQoJsredT!FufjI8uNtq_c!`gy#j7;>;wf6z zh}Yon7tv+O+}8`q}xsV&`{fyW)n}6^~29X*S&Cc<;c6rv=)dUUK+SPrpozJLteYVf8 z9+u38uE8jb;%?b?VgSL_;yZddJc-Lq>5>fE=>jf@Y-<%wPU@#8DI4q@zC=}<`o-YezMU2HDz(7#Bm;Ly{G4t1*J(0Ck#x3WXW@CcvO zWINvBQXKu%a^bYjGac@9lN$zK@{Eq-&T!3Kx82#Rv! z!hVO&9i+`6hniqHJ~`~rlD{4L3!RTR^etAsca(UK(eF8O#9QP&?~wVu3(N@)Uv%gR zieGXl9*H=Q5|_rnnUH`!dTqD=}^I2)EoJ4 zlRy0U4)g9fRQ;|)>u?b(AMp4?hk|JRnCAyRdg9QK=MF8x!Iuu@dF9ZN*ABf#(mTdQ zCOK6plT$l!4`*^ZwKca>M=_$DQ<*+>syim&FdieRyi@78g~t_~YF?3jFdtj-4h1SZ zWx*hf!q_TK)vfB(2Gp$PQ~>R&JM{xTuHjS#B)wPDsRvkXa_YxgPOZa{+D@IV>(se= zPUWxfR5puKrSSza+GvmX_u`#8k1Tels=@`2!>Mvk;`BK+DaEOuQk~j@DovcS;q&*J z(q}WL(on0VQ-9(rs<(0~1=q2njZ>$P@P$+3yEye5_V;k=A#(O~stn9Hh-Y~DjZ>xi zkPpUS4PFeSk0DOIh5dWRg>Q_LHSC<4KHI59c!t7jooc+psUEm-z^Ob3iRB2f;27?q z$Wa`lp2&NG+F~x&;QV_hof>$`sT2P=^&0N;PIbf(thwUUY23L^J#RSG<*ri`5x(!# z0JM7I)G%0{Ge;=%hB#47F1b-9yGu#<`~#QX6mzL;ahE!jbZH`jRbA=@TMZt^1(QoT zYPl4xb#SREGIn;UDh~E=Df>4rnNVV&OHTav ztxJUmv;8}ls^jo*mtMg9gG;UO8!n^x7?&LQ2|F-hoQwaz62o|xEa)(iaglctZBb#G zO93pvVPu^_47il;(g(9#8adykUyyA9aboh%E^Wf+OI#Xd;_j8wOy>RI` z%rD6oOWwJZfth}t&8@kG+$vJstpGY=6jtI0o}xerx2$N1{+N#6aTTV6ji`s6Lt>adn`fk<71DjjL;@#@(b?b`Htqy*-+{tcr#iSN)eURqX z_=sDd#N1lg%B`f&+{)b6t?F3R$<1dDw^ns^%ii71Ic9F{`^v5RX!o^S-(c>0-?-)I z2KmnXz#mo3@beHn)oJVjEiRc55bz?;-cSZbkRIIj)u54l^ER9d&Cb z&Z5vU<^i@7ZneQb$a#{wo^dPxS+^?T)H&{>)+Ocz<1Z5f@?D|sH{6PUz#L%jL$~hX z+!MDlJ!L!W&)mFsW*bVpVE(Wh5rNSOPL+K(Y>d{tQE9TM65+0p< z?-P#(l=QG3n1}Bdc^tD0kAB6O_xv99YvfV3M2~i)(r+`5rs5>BxAO4!*Q54rJsO1! z9XzUl+uc0M*WIJjy*ykf&ZABkh(+&x%Al!(9aY@kOu z26?pWe;%Dep`jktz%ZOa-S0f=KFp)#xI5gVmLokHjE(5~1Gl3*dWm&oJnAvQqt;W% z3+It#sz)Udz-(;6MKqu0QNm9izAyA>_iS>T<6-?!>NJ?H18#Dh85|K4uqcaMkjTRnP+9Q!@$fG-Ys)Eh$%dUOSi4|{YU zL;vz<3GU%Fo*eOL^HGlm9V5r%v^n9?bi6_SlO9>$JLSNUv^mfInDyQT zj~ZTNJJPR^6Y^j6s3fZWOZ?Xu|GG!zZ+Z0PU5{R%{XGxoih1~6l^h=M?}r}NF7)UY ziaz$J9-83mC&Y-7Pl*LBF$Q^`Q%{t8;ZX`YVJPOH?MshFVDD?<$m&%iG=n3XS8sE9 zWt8`-DSBdBMX%aa@+xm-ueMh4>M#aW^{PxYuPoJh46AE+wHLvfUd@Q}YKzIM8^~ST zt6x#Rj#nx8ubx-c8+f(H=9Mp=zHtjB>|PahdAa_WS0DSltgq)~y$r8bH1=u})(5<* z7V@ei)?t2A1B5W^m)pwvS+FNIj{0uqz)KC>J(KF)df zsm!N7{ZiAXlz5-w8v6K6#V2oqPd6~b?o+DMr{XT3{LOrFHutGgJD+ZL_vtC-_3)`s zPoJW_eJb~rPtW@Ll)0ZzcM$6D(~AK$F=>C-GMN0!k(eT2XmAK#h#SU=6jb=iFS8$bN$ zQ=X|l6~jmr{E1xAYC5^2@C+Y+%gA#kZP7iQJZI5nKKuMkY-qU1rwmJcdIQf=pFUgW zQ#YJl;nRVYJ}p}3Q=j!d4MUwxKK+ZpW*_H$`IK#oPj$EXIe47>`^#eHw$DyNC~w-9FXa!#13TbFWW{n2MWthHU$N`W2@S_|)T|PwS5Q^zJxy zy6DqeEWX4%px$Nbft*)->Who0c9q9b_Fo_8;ZoykJ`KcwsBzuLdC&BXHaC2ljn8h< z_Lfh(Q1CW&yysKz$2|7Lr|U?2O5C`GPS2<}K78&|SM0~{FX-bX{Ui2@m|=ZQe%On} zZ;0_N&qI`X=hFbJ!!Q{tp26V!MMF0-8rqe~;CDzv+3eguv7B=*>h@t024UH>i=q)>8p=`1&;^9c7+Qn}*i)AN z$`L1A6^Ol}p@o$Ve#0{O&B~CkzM;<=7}|k#E`#q7$lqtED-NQnVQ38QBH%Z)47nN^ z>Wo8J+1OCc0I`P*HBU732#t~rrG*Whf-A+~^Q58tsfLp906#Z1WNv2gy#(Vnr_UC& zX=$ihnxWhgLj!OJ`(pHmBCW_D$*qYQUw&q&Y#T$5v9qng_hg1b=z`H$iKBRkeC-X@ zMpJx`U8wLm^N7Du^$SDksQ#s)KhV7cbwIw3#Dq+p7!Qj(8wz$YG!0vDqN|}#x-mC6 zfebwiHO4fUdKxOx%g|b6>}{wJ{5T2cKttm(bdaG-$p1fLh3PwLKGM)LEcl*z`GGp& zCaR1w)D5RGcr^Q9gMQ=|x3FQHp{)}PK4($qNz@L>lMU@g{VB}fRBAPi z=j#meOE*}vkh-AcES}S|4NaJ1=)<{&;?W4x7IS|I&tn{2O03J7JM3FwsK+lnA6JqO zhW~2l7`|9#=s0?y3>E&}(1=as_6K94+n)yO+YvL4;X0Bx6UTPq z-(jfFPD8^mV3(oFdw6|e;a=uzALHQsenVLg82SO34;mVHnE3JgQC`28f6UMa$C>Ms z#CqCLoim17dNu_GM~uh36O2uNpe?uOaJoLz8dt+PZ1z z9Y){gd31*uQSSlI^{3SJnW4IP3+Hp5>o2I;D_(>6@-?ryTz=L__N!=aznY^>9>2aX z=$E~aUq4`OF~16w_Nz`=zn-IAIlnS~>Q}6SUwbS0Rj;yNdvKzPUkO$H`WvUJ`PHI^ zU&C=2J8Js5P6mD97u-YMT7I=h?mB*X@Tk6D)&_o6H}g3BR=?JvjE%9;5kv75MdJM` zkDgd#_v<0vp}E7a{qQ^e`V(<3#zu7y`(iy_!Qu651P&pikN)um7T^X-8uWz;_zMO6 zbY9&cd|`nj%yU#oEkl|s}L={Sv#68#Ec z6m}s)l3y0|z|S~`{Kw4Y7iGeJHN|Lb!(&uUp>NE@5oAmC%Z479j|(W)#IGh8 zgPnMRnoX$%X5lDuH}lJfA=rRNsNUSqv4(yv#Z8oJLA@{*JMa`WTlzT`k(%Nv%B1-f z!4w=pu83bwe1qkE&M%{zUnRche*S>kw+LuHnzjtke?WKPj|8M> zKsVY4RQ~gT{=rRj{UV?PUk3PXIiSs51M1K-pgH{lx`6Th1DcD90|NSPU_he>1$6Se zfNY}!$~PvUcIbiCC^a^q3D||qKL)fOyAc={(30^14VplE{Eas_J|&=QbJ)mFF zc1A$G@DfeaX*VmN$cBKXBlvqjQCx+6Q$Q8|2>YeV?EX^yRjHkhQ3Sx{VJ9&~9K*H3tQC1&`3@+n`Pi4r<7dpvH|4 z>M({(2x>eEPb9ZVL6x3NT&sh6iREj8`UB3jLCszlRO9tQ{c<#@yO@0}sFkRDJg5mL zi0@=jxi1IR2yc<+N>CH=;A&6{{|&N6Oi(M(`esnwQQ}rm*B=J;)8n9qJ`F1PoNX`2 z{Uz;Q1vTS!kn29a6M%NDr!nbhTF>HB?Wh;h#`^TxAf#fJ zkZxkDmA>pDB{)O6=A8nv05!Li(<8h-=!1R04xgXh2A* z$UZQn!br!fK_LzNHlzu7f;rRa2jgeZ4=T>2pLE*Hq963ezKz`9M10tfq(8{>PjcK$ zo82K@#DqQMg-Uxv8n!Pa*Zz?5T?i?Jj2A=7kEwWai7_uzhwC9_xe?-AjF9#qcr&D> zw?b-qo4oIZ^bV`;hq#tpNWKRlEqKVdk3t&xoVMuuBBbw;_hm?(UxifUHMbcOwG`2e ziRyyKNXne3H~1h+BFDcbYDU&XRnC#9OgR&kH&3F9eVC{w*a}D9MCHhrsQYM8kd;Xb zC2AHHDoIr{B&h)+*qtd!k8mJ!k_u)?(!lIV8c`rg*WoCXq~yX$8i(sBStLo#iYDnk z3KUCXo$@68RVqp6@p_ z*DhIkdne1bC|T{dCu<10?oC#yzms(fBaS4i=gDL}fhBKP?em9KHaV<~pM|xxZCKmd zg*Bl=SO@T|XIQy+GbkDozedQ^IP3 zlW6r*SgyHYWtbP%gQfJlF|2#|dsA3F{|IXsUSYtWVfEe;*2i1JsD^nC+mBJb> zDXORcvOfwHL@P(D?IlTy{YN2+|IQnhwos#fk!)piWt zOCJYPWxA58bTv`S3{BJrFY7i@Hlv9w9h#`{rY2lBF-`N^r)g)WG!5yNrboTg)UHpO z4&keQX&QmW{nIpTP?{!vo5p#4X^I=oEvEmNrZVHwRBvLMW==|zYib(jH>7FV^fdiD zBTYBg(a-uc9o~?p-+xb2&Og#*$LP&z+Po!A-|S9Pv14hvcsWf!KTOlCM`@gom8K1u zB64Srs9v^+E?`)mh#Gwu(SLa(%9k&~>yyVmjp(F1qMtkwjSob0{F{hs4T>o5w-Na< zXj(*PXGT;sJ)(m+hY7PHsysWQD|m!Ab0RX$r+-|)zy%TIUc!CcSRIjdO+*H+;nmuR zs;`S^2*%N8oF$@iA`vri5_vy~ssv(XqB>q7sjf&qz)gDELMO6t0k!3_w ztugX@a)E7hRQ*tWOjPm6JvPd9%%bXp?c<~JPl$4EMO0_7Jw2)nv!YxFIjSA#J3Fee zbE3>;R7d8L-#qrgQT#MNswT^#nh5XmsG8!_6;Wkf6IJcsqFmdHdhLm-6BeMy9ri00 zQ~lC09kIkz*&5?>MoejKWBR;ZO!JXCBBsUIgxAP1GA0|o$5dqfKBhNl^g~R&aSW?R z(bwphZu}UNbzDqsF%IdthI->;a$_r6O^EUSH>QdcW7>mzXf`RP!8iuX5s&h8RHRxkHWzRju-Sy?;43fr{ zD_M}6|NGytv=ZlkDtl>QqXMfA{*g83%IRCurf)bht3!ck_mvOQE9U$E?K1uU2LJE& F{{X}fl#~Df literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/3624cc1d0b168fa0_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/3624cc1d0b168fa0_0 new file mode 100644 index 0000000000000000000000000000000000000000..3f1708dc7f82329adc729a42f05803216b543306 GIT binary patch literal 29784 zcmWjL1$a}}8^`fqo3=?CX<8^0Myb0c#cR}X8w}Us?lOGXhP%7F%W!vh8I0lXF2nxc zKhN`dlH7aFd*1V&o08nz#8JP?(x2LY`RXny0}sy3YRZjDBo!~3lvJchu~H=pWtUEJ z7IJ21mC7z!qO`+Ns!*}g#Yz{>PI44-7AalAnVnrYsZc3rPEw&FS=pIcg^OerEtO*+ z#_8Oa>Hm-Q|9@p-bGiKgb|4m`Nona4?w65@mzBmrVPAf>!iA5j&gf)ynv_TdJW zR+1J~mJXm-75dbWzF0cD6Ep^0$u2NDr=@Yh%k@C%#x?>&w!6WqAE%m-C1!lNt z1NPt!8fCg@81`kk=m9!pyQmL(=eWqDw2S=Fr<{xGRd7*XO#j(MA6vS}*vduQaRh;_ zT@;5JXo9ddE;@{hINjDo3GG~zj?}I$>eb6df1*qu7d`LmqW=9{Gzx=$C)OV>nlz03 z;4|Ds?h{;;Yod!@V%2nF-EdLQJ1%s?c0l{ecOv&v#YKB3Jn@ zb=A#ft{T0Z{8zc^%sN+HN5f67a@*&s<0!n}RVU$gm^C@+suyR;>zb=P|8dn^Tz*H+ zAF1JIR}FyYe~e=?XaekJg96}ZHz)*?@Db&F3~Gn5*x_f;WrXB0=mygB8Z;Sm{0(}M z&!7_d4eEx^2>8jMhS-6@1q>Pp2Hiq~K!ZGk4LTEI(D+cc!4YZD$Y_JQ#Bo2- zpnDF3ZaNLhmt@eaA_l#|jiLs_b3lgLdI=8Rl8mpiERoy>bTK$E5NGt*>C%>W*tY40`^XK_hw^)UuC39fum!YPdm<5HiA`!s86; z@PCuY19>OYA5W%mf2u+4XBzZ)mO=Sv8`KP^=g@z?LDg3qbZmn`!!}aSP2{xMpjBH9 zirY?3I}Eyt;kym0vWKybP{Xsty~g<04a$1Rc<76Kk61H|dCYo0F(~Pofxjut6|J5d zRQ!cO{a$jMVHKLcH)z}kgO-0Z$neRaxh6N|c)4jYmYCgi-{z*@>~30zy!qV}hiy1i zz)f2M-Lx;nO}Eh~%uTW3ZVHKZ)6OI})h+6#>{K_6Mawid?LvCGn~r3->94YGGL>^v z7i_NPrZr96bO2sW-SiA&nz?B{@-%nTG>mKMriDms<)-p&+_bkHvD(wVgPUSHx+$m= zId^tb{Vr~5*oU0@x+$f9G-E&v|bHQCMSKPJyzPlQ|bXT!&?iwWzjWBv>Z7vV($OC^5wg1UOeG7VM zWUz;P!aUS3%0q3VJ=7DIa0jPjJoFEa#(L-_(&9W+1*_o_@1YZTiVq1MI$YF4AB)q! zgoo-Tdni1`L-o>$U%^AID$x%0s(R@BKo2Dj_fQ*@8^O4+kEB1YjP+25jUICD^U$=% z9-414YM#}oe))}>jGcIbsRfK$5@6J#K%*{TW{^>Jf@vFS)L~r2{V=26;(54HU$8TR z{gFnk!RaWYuH$R8QC=}dwTLyU8^*;MH3wVcjVhI3)LHzC35iC{MKy;}jbL{g6@Zht ziX%xzRVifD+9F21FKSe1F>=Po45NO|G|HA`)Kc6+?rfue!KgAuO~jjU#@$9n75dev5{-?j(S&}uft;q)17Bfp zW|XtJQR$e}lKX9qa%*SQQ+z`24n|&-88r;Pos1gPg<2!Ft5Gj-ryDu;Fe>~vqw@7( z4D9bmZGJZ@et=O`2O8B78wSyTF!!+^NgCk$f(FAMp>5`Rbi!3 z3pcR_o2lCtqsC$x?qKv*qg=Nc<&U$Nv&X2$`;6*=U-uie?;tfkY*ZiY#BWDfyQ8cr z_8#Y$#cfPFVbsu590#Wv^Ndj$=a};a*7l-NyDn4XzuAw(t43}6hk9M-c)7uG2mhO_ z6B?i=Hel^7qYk3uZR(E-_oyGt_i2yG*ozOS{(zjJ$Bd0Mw8U6E$4^g;ibCGk9FMLh zxf@IhM1+S)vvC{cjV8T?x0gv}(cWy5r_H2!c9R~%+t;Lt@XBpcuDmAw>u*xad?tMg zAzr9SKhP=Mq=JzqZN@K&CiTSJVkVi3o8*tiI99@>!pSDJMNb$~O?rijnI@@}Nmew& z1vD*9OdP>QY%62Z@UrAujxj2lc#fI$rV?XUHmUc|CUvW3Qnl(P{Zq@Np|wrgi&OZB zy7f(3gCCgLz@*#_O$x?r6liSH^Cl+sZE8|tGm{$P8eVrb$)y`PpzLqN>}is{mr2!o zn{*xd`%)h~=|`LXCawG3q@n{%YBkWL7swoJ(s5kDJ9Hnyn17h$!~(p*i9b#HZ78wv z36qDJ)Oxr{`^K2Ga4a!#3Ju4xKI56^1ahBf(k>jwLu{DD{>dhFz)cL9V$#=XCJmf! z(ip5n+zgZc#v|03$>Uj!huU*YnuYxHh=JYnO>$kp92T0i3Z9Eis)XnGV~I(HmYS4- z26%{l%S<|rr)amF@m84Rx6-5%YfLJQrg(!H8#&H45qAsuZ!@Xbc4`m94wG_@Q@;}? z^}`kPILX-9hWe+dCB9(XX_I2lQN!~lC7{~{YJAb8?8_XFcyficM%I1iie^v9`6F$CPc=q=_;`6L zkIhq|$iNYF_4d?Ye83T3Pg!$$DnE+h5IX1f)IhvNCqGZ+KQBSSMY1A#| zDUaghjNv$);;G!Jo(e`fj-yhBr`jN=l&3~vIyR$uX;0ND>nZngp7O)&@}9a<*;AFP zc&f|Kp4x}@RXx=YFHy9nr#jT4UbQ_np$@U?5(}GAzn-T|^*!Z}6OHNH#8XpRcxoZ` zqH0S|jcG%^ZOOMC`JzXAPhCdwj-CqYM~(V>D*1O$*#^)Dr|<-Q2YSjl+*30aUBJZAp4v6mQ>K}rlFYPmUsfoLnPI`E0pwUZXa1b%xUJA5(DGpt62Yr3Kv@wsD zw&bM^n)rLEBUXiYX&b7BddU>-B|o%)ZzM6$1Aj$%X+KItdue8jmzE(o&P$!~J>E-o z6TI{;(@V+O#6nh%myRR5l$UB^04Cx9F2h*bOZgE{#!J=9d1(TU;39k~cxf0^(MwS< zRr1mw=wF$6pgt!>Yj|lr-qrL{^IBe7g6G&!+e?{syfk(WZ5J@_)m|F6 z(Mx;&@=~?EUTTDL`@EENz)L|#ymS|xj(O?XDe8L0OPkJ;=S43yyyT@PSG~0BmX{(P zQBUN0%zUsF{~_y%m&W57hCK69oi|?U@Rs}UnA3YN-A1ktUb=$mAITAOK6&ZWXXgE% zm%e?WHebC|B%fIo@|zX(lUYj&m}M$xR$`!8m+)JtSp~z*`W#`_u^6+gac1R5@hr1C z<0?|J%_@tcIc7zbHS@aDtk#vx3ao5aMf`?^I1PIpvjVWa9{uZ^wGVHane_vWo14`e zA+5}+iw$VqhJGm9&a4_pX>Zne6zX8s(oSZ5N0rWIed%h}-`&hg?QT|A41h}yvzqra zt2+YwoAqI!S%yJo^%`u}P`D2`%rWZq`4D9br~WEXOlAMluFY zpv5S&wxZ)0v!;%t4@~3D+JzJFnP^ruyho+UW(}W0JM5gw_|wdqhc(DIgZZH;_RKVE z@GRyD#~iadp+64KCH6eC@*s0QbHtec-!3p~2aX|a5w*op)LdfLWGuw0rDokl$>rpM z3M&``xKraSew<%7jxE_bqg<$dmXW`65H@%J@wjP)*qONgB#6q+r(V483z%) znVO+HdT!x3*=p7UWNc%NF$~AIGoKyI2RS=g6HG?4U1lx7ItD%8v(ho@5P2V?hR2!n365E`K1r-oSG)ppvYa0!+WedI^L%q z52zsyJftpkx`OBOWrIoAvVxv-acoOV;YOSu@|7^$ywZ=!0tS z&6@kcte437$YX4W;}gda^qDn88=OYae>`Wf7ye(&D)5zYFb502@w~%x{D-jb)C-0m z)EqakRu&y_wdkS2qEt7Fx?z&LMZX#?YLA6J7Uj-sQP*JZ<2GL4dI-0n7KMjdWDB>b zJ|-e9g2#~-O~(>^k0xG>Me{K)-l8H-i*^;V=s1cOwrDaI;J>04JuYU^2h=QK(Q+gw zTXY$}q*!zZEmPT#JZTpFK=X8qR$yjHi!Ro%s7_6b9$-{0i#pY|$g7S;OYvWQi~2XW zXe2(jvZ!`vi#8*phlSVD7M(!(-WFx|v1k)q`dQR&kVRXDTI4<1qA&9-@?SuG7Ftve zgK!&jS6lQFU(sQWMSBsw)}p>RhRAgmwOMb`6*S#wQI{>m*-FjO1OKAtHjDP}q}IEb z&u)uS_E49-)OsKL_gggX05K0*{|3MEXgKf=*e~3w=-1 z4h7FpkFyrN!@_eGInG;j5Zf-0&qa%NTw+ZwTeJp?u3NPJUyCZV%nih3{zh)}rk=imZ1QjmKQ%dv8$_bi!rCejpYW;{)72QdbyQ`NlphLB;RX1NU96vKy>wjUD*zW>s-_tA^n&s(VfwDOwCszN5KhTs{}J*}FCNH41jqc!HiX11yhcA&7us)?{zty*cbs-U-3mvP8$ zRg8~SvtakN>L3ON(7&Kn9)VVs!Zv)s?jWlw2V2z`9YU;nfXbm(oyC1bg;`Y>LogxS zs;#(-k`Yz~MUp$_p-YrinbB4~#s}PvAbhFJaZ*WUFFRtQv{QsaE-q7x0Y2a(7Lu&bL&`@TGy&I2&!jQ+4@$UL{I~({=_=mYiN~k zW2^R{M-%pAT~pSlnN>}jlV3~bhTX{Bnz8V@omCO-tvZL)4px=JB3$jr{5!FBotbkN z=HHdI8)4d$_$QiIOh->Rp(kY1-DRa9Q(m+}+u}B@#8%ux-elsSVTw(&a4*fK zgXuOsZ)wvPG;L#3`?fYUYG;$By-n3I0S7zSbf7C^qjh(ij-b|WHko@e&t8n*n|bxI zX<$E_0)J;t1L%j(7&FkOn8DQW51V@aY11#m7z@cGZ7MQ~ZKG|E$EKz59&1wq zE{?OQ#(0|^W5EQQ-c2O;$u@PFV$4M&>8R@Oa`rayxyxqJNhC$ebeF*GM z8#G119^Q(@B@F$|Ta(bVr?-}(b1!f8M^JBX#bXEzeY|Cdv#+;Wpewrc^VT}-LdX8z z>WiAc69J0VPt6|=X8}6+Vm_E{5YsYwN%0>+m#hEuZ17%}AZ;t!J~nRbY;{qR|3};4_c07I~{8jElXMxXfEkuoZikd+QX8 zD;ayWw+^oHR;LZ#x{38$ytQU4`*(Qj-fnM|+3T$%2fX$7L2s=-?(o9Xy9wt1U&l5uJ;%gWYv-2L@uKtba*VwLSO&GhGT_Mfw`q09zB`xiGii|dP?Zpq2Xv^HN4mT0i&aNT2 ziFfVoa_L}KTxYv_cC#z1yIny&?5gyeU2n0rr(NHA*;S~&U4sVNb#bs=x3S_6yJCiN zJAyfkw5#?3ntIkxr9MkP;fv#AIgxU1N z8~i!PF6RQ~v4c9{DXQ(H9=q%shck%XZC7#pf%H9WJIHz+va1VaN&+4hh+KeB7rWBNX^^EtR( zSD#X+7aTV)?K=G0t{LxHPxSsodptwO&vx~N`9C}F-|V`F(%hGgVIF;W=jSKpyb&!ub2Ky)?#79qXKh#G%!+i92xQ`Y^_-JjEkCw*z zXm6a4W+eG&b}=9AD(<7?60}S9(LX6Z@=f#6z;wpKqLPf2>7zfgd=!-JqhYX>^3fWY zOZ(_o96;%^KAKt1N5PfI1=&@6vsA_*7jTq^p zYEyi)c8r~s#Akobgbp8 zZgqUspsufes^=?vV_)5D;;Vg4ef6lhua>v)Ra7h5w)Rzlw!VtSIdo{}t9vNe-dCeB z18uwca!mW`@c>_49Y&n-zG^YqS1(rkYW5mm9bW6JH=7ybpsz0B`VZQ|&n1^e5+`J~pty=kVYlb7Y3f9i8sm*ii5`OH@ttT&Y zYubn0`U|fR?c%4u%zoNp^V3ATpI)L>sGpYLO-VnU%=A-iX+I@a^waceeyUyDPwmlV zn4f+g?WaN${p7mHkJoa3oHz1Q&)t3+deBcB@DbfF`N`+HpPoMUQ@$sDYW&nsi?9tx z;CSh$j+uEhzHc5?9g;^mBl2kaxI8)t&+&P*Y;GPMU7SZTxAN!`YQD{*6<_k`5q9Ox z%k>O-H7j3U<*S=ltsCT3!8Unyze8RP?VeZdf6uGcNAk*WIGolTU%Y z^Qpk=eDdjDKyE7wD0xi*EjwC3-;WjGGs*x}!`c!7N=gn;8SKIOoB$On6`%}^#w~c1 z4$$c`0oqV5Kw;$rvZ4M%0M$iGjR2LyYrJY2psdyb>eV4Y#k&S* z9NhX<$|HsR`s06oOikpa3sDnPzt12htM@DfwT1?c?*woeS; z^Y{R5M4?IKjr)k39H8cSfaO!@hk&Wn1VyF=s3VqR_w)dLLF|kG-NyWx)EaeW1!z0` zXR{4)3j;KHQGgbr(Bc42B;RA;~2{B z3ebW*0h+d#e)|G+2JQBa+^f7N~Wg((xKD zZ349z1=0=C=#fT6nb&)MVVk3smV4s59{B7^o4L-ziWxF`+Ygpmdi&?M9=n zfohK~0`(ZRdyva-fx3!iJp*O!6{w$ZyLX^s`UI*O_VuNGKXTg;s2XUA37Ct^ zXuL5{9r1lrpz{0`s1EoO5t{>53Wc@=s=`*Tvf$D?xm~o4|?*;1qgFxjx3{)$`J|XX?tR+Tb4@x}?JHL0VrhNOhxwbUisp z=8Pci#NRnVx{ru*L0VouNShH~If(17X^(fcg5**=NZpWDH%R4?-H`a5f^;6f-RO_( z9zk5!6Qo?dY11c2wFd`j@Iqp&4ARmyL7KTPNXu|%eUOfB2vUWOLHY+ZHU}wvYmj>G z3{u;JMm zq&+x~>Yu2=*C74+JxCpJ>*qy9HQGkA-q-#(IpIXhG-g6 zlgI!(Ug>Wt^ zM6FMRaK1c5^-nT?oJZ2B5I#pDm(w9?fj(GuC=-oS1i?IRs z5#A?Mg)kcleM6P2U#O`M1f@xN$ zV$clxW{1jWZYbyHLgl(XRE;)-s>a4pP2UqL|GlAVaWqta;2g4#h3YtV9S_x0d_t=e z#K&PwJQ=DFn0zW!-lsz~7q`&+4E>RQmOL>9&tN(isv;NIk45Nzk@onEb(ceR2fkMr z7d`PWR$L3!J!D=FRoo5oc^=AV7@=zXlDuDqs{6N49YX_!sV{6UVXBLkIEG5DVXB7` zhA^#k3)4rqyN78I#(3};@(j}hyu_Gz<(=TP#4kpfF9sLaYl3 z(=ND&hG_;KAu){Dc!Wve#D!l(m_jiTkMUPzn2JR)J}O0r$s9vl%ty0?FttbwQ!PiB z`Z>c?ya=(1g{f(Bm@cP=agBbMrlnH{%qvL_xSA2h-+?ea%?y)Q7TfR`$Fsxqcd0Pt zD;*}c3Snx5lPFO!OiS<|YF1*N=-M<)`+J0``)|~`7cu*Usp=r=_6L23hiS^_Ff|_= zrm|BQXF6?GhG{W|t`6gKwlJmt!+0;4Luk0ZHV9YkhT(EF4%e?(hk{MQH5=RD-85Y7 z@DT-@g{vm+plI`OJ?$K>@GjvR)Rpbs!j(BRTz&BOFk+1eSJt#}4M3sk;mXD_M9d6V zz^riXoFA^ie}!uo@^1-O-mSzr7_PnOdWe09JWL*VjqXS3kAIGbE9gYHM&lB~PKIkd z3Z4qr5ahWSu2L9?O?ZO*m%=%(9j@Nk1fMJ6x{2A>!*vCPZ-mS9X1LBj3YX<^xLQ9U z$EV@i`XXE(u>2*pz=~Jlyw;1*YgBF%p|G|Q+B`5quTW`lgrbK;Xz%a{{fAm3Ba|>I zLJcNIXeKI8iBLn_L*}#yJxBT35&Zp#(6E&e`T@(T2o>58p^_VEi}kQ?icmEy!D)Pk z$6paj$6$;{mCX^_g0KI--4danwnk{vi3lw|9ia_~ITN8ZxOg^#|6e0C3+Wdb7p6-Q z^1mFRrdJ}=8I`U^s0n_$7NIA&@DK5?N2osn{*6!%1mB3zDqKO=n-MB{D?%sXaho`I zBJ==XFzs#x*W*O!Zxs2DZ5X3S9Ywfnq&y9ga^{UxTO9R|)cgFA>Rm8WThTT!QhneO z6sd;6k(wS7DX+9hquU=M`~gFNM(13l)Yo5W}|L$P2v zZ9~0_%m)=OMXEk@IZ{1P;2QZO@;YPOkJLV#$`i%4g;6STJ4(y(6-jrZ)EQUs1krb+ zR1|;U0M4QOy(n!#`}CP ze~(g%qIDkbF3}o@)7a=5t-A;`M5`u-;S~JcqE#33aT7l7(aJ<8EW%ZoJfc+sU9cFJ zVKqi89qlm(r{QLbRth>|F)qQwGg@irgO#`ryH~U_&R@cmEMP@~-ZK-H2 zNBz>#YKJ$dQkGoGG4G1ZaZ9v*N7B}4W#K5ow-aMmw1!-X){|S&D)%s&^RLlLeiW_p z@P5qpm(dD)#h9<7Rpd>y9)65g@TX|?|4iQhMQhWKXuUuMmlzdtjnNX17~MjeDMn_` z7;X2B(I>3T6{8)<%pIdSelcp7hx>ssJSSuHcTkM#1;?lpOd&D6?v0V9P>fm^j!{IB z81+pd4%(;2s2>bzG5R$9j zQ!(0z1L%1=MrEGR7k8eJ$?{bIEcNAVWQ6RYCrhmrV> z3VCDo0~P#ZRR<&T#p+*_506zX?8mi;SUo|V$XK<+`KVa=#>VOm+Qcyi*5MQy$H!_l zb|5PuR!tLQbsdEqv7B>`)hAe;u}Vf6jKwXyz@{X|D-^4eg=4iFo<(BS4XbbgwTi}S z7KRj$m0xnK+NQ+nFEme$RcacsP$4~5H(@IotFHKr<{8urvod4#Eh|>(+2mF#mghyR z>X(bvbG)xWjVi_}r!IBID>SYbt8=)E!u4ZS5ltFUV?1k1J=(=8yHl(NqHt&W;y5C^ z#wvF=<~}f1v+>`cSlu4N*i&MaGL^aFJGM`Y)t)(Q$GW+(+KbZjsOS7x^;!_ClRMbI zoBdd~hy5tMm;L)<)o6dL+8>S8N;Etcs}9J2oLZme_6%!*e=+`StXf>A_NaA*^}}h|}JaadO;@(V9UVm8Qc)YG+R7AXHp>AZnniY%JRuoK)SABS=#VZht;aW0YTkyO>ydo>cYe*%=s~oQ} zjpKC^zc-23Sok%KSC?k-+TJ{#&w}H%8eaY5wFlRR#Vhylcy%5TuYi&98aOjvJK#S% zUYGFi@^~#@5wE+*SQW2lsJJ^`BapTyUX^eGj(zdEj*%zgbqsw^G7tEkidVYJcW$ek-eBk&Ms^CZZYH$nSw4&D6|^c3UrCFpZdf;tD&Cptl2V2VjlRJ{ZZK}y2} zjYX%X3A&6|trC>eIzgXMqfLU;HbK=L*Y5(I6pzL3lfxu>hN8Zpzn*xdr5+BVaQVQT9Kf|s}fXxZGw6opv}Pq z^+4}K335419q{!?g8Cm#&`13wM3tK{>OpZkPVJ~8n64j_sqUID%)GtL6bv`{&12Pje z8pX5dgUIYewX2h;mh}?(ZGc3+kC>=Gk<>6z>XWFNXbM~3L{;ub-2RCgIWSQT1|_OJ zq6Q~w-vsiXn5czlF)2}lrX{NS^h7m7-WiFiJ1bGW7bR*8rmRj>&$WsA1CDixTD3k= zF&h%qc2lAb?@!dYLy4M=vWLkJd5$FN3D%!X)Ywaj3b~o6Be!|{n#b=FH4A0lCu$nb zVC~05O?Pp~-PNH~tT8xL(%qq>xP$>74&5_4^agGwhgzeir$b9D4*6Rh3ddR4y&W24 zcc_=2L(}uHA64@@v>0Lj4!w?W=t87JyQ1kAa-U*VbM&?dY_!BP%&!S9GE?a*&!9DGmCp*iJ=UB#g@RUNARi$lpZ z99oN=Xj#*t%-RlBL1P@o#ySo?s^`$?1`dsF#2CLiln49Z+t{IUnAeQ_+Bq~4^H8BZ zb?LxdIyv}%&7s--9K82tOtc?E4aYJDYK|kv=?*@3b*MUwGadRo$DtE*9r_1j<~j6X zA@yG5(BJ60*rCv+4!wu_G6&b2P=hrNSvES9eT05^j~2(66P{e87FQhlj^%$l)bOf9 z$8S*I+YaUa;7}XUVxyiUGP zLg>(sV}PKCE*T)c1P)QmPx zy}~yvYfJ2Q#O~l!LTARpw=Pc2?B?WmSe$Cp!^w4A)C3)nuNU*|?UZj{;tU`TzG2xw zr=kbbZ-`URhB?(}xKr(rcLZ}B>D0nePTd*p)RVDJof_v<(0J;B6{s=6sZ|r5x;4qE zz$wgU8rx?$^>vn0=Vv>$e2!BC<}%lL>|fzj`;|^jS>@Eb)lO-xQ*GBdb!k0qHxPTH zQ&s+A-)5)&-09Sf-A=yGOWpT7_45IzIv-?x4zXrOocifFYj}c~r&!-JPDPz}s?tSj zb%{A#VNQQD-)l}q;2d)PajNHar#}Dd)azSLZGY&L{gG46FbAh_4cU)*j8*vgiBny0 z8fj0Rx{UW&@ysd5b8>s()P0P0Nm7Pul77Y>xVt6soq#0$>64_XsOp=f#yAiE+({aW zB7sRN4Fx61j)6E5oTQ>5Ng5xMqy?xSo1}L57oqV5gk`ihr=^%`?lT^MAZBU>tb%1X@=375W2YyY`g~mzR z+=M)vCuug&7nuqMJ%%Mk; zzV=R1uRckd_Ir{#51@Wni_7?FV3OhoQ)_fX{1ECiHAyewIxR^}(Fvzfayt3XARfGD zCh50XNm>v8*-2W2Ef}z&i0Z#6u6cNXd@qZu5{Ba>d|wq;1q{IsyhhCH;%bIjxB#y= z#g&2XScRvEcw1ZzFd3&{cvoB{&>2f`8~*Q$t2&&;ODLs83Drp}p$1J#sKAjDdK;gt zsDxy`_m`}hxPhR=WHrVdTtgm5vf5%NY|doW$6B}~C94Vs;W7%BOXfE}k`-P)Sw*k| z{uPt;0at1yt6i;ReQd>}Wc`CN?HC_f?UVHhMLQ(x zF+St3j>+=r#@KM}o-AKX!}}h|+VESl4vkEfVN|j<<1i|YPS)}<$!ak+S$7vFD_}{o zdM`~@*Ja6?yEU2bQ4xPTb};|r$trLnS!Zw)%}*w4|EXm4Ig_k@PnZ)rJWb}a-DJ5v zqfXD0Ij^0pua*=QwWesIEk(P$Q&iSJMT2lNUkbm6k)o;26rDptp%lHvw-PC;nw+9q zB~vsWFEUcJAu~n4mrl_IJgSnSoS#$p|2##W)l$^rmlUN|Pm$`SC>c}hr>H@L6g_X0 zqR3xUG^BBgGMl8RcB>Rkz{}PtTGb{+gWHi0@^?tlE6nSaqH8GDCq;gJQ{*x%MJ4eD zuESF_4EIMc=BN}kUzwu0__~U`R;OqZ+}ETi<*yWV$N9}ETCg=m;ZGS8CtXt&WJuM& z?y1V_k*bBpR9!Kr%Eywb$^NOD5|pZo7#f_asR#&3RqxPLl@CkR?wC}yE0wAhXiz$p z>w8l57C)Cwm91Q=R##2cQ_QKBsx>J5ORC0KPgUI-jMJPkk=!y>577S4R4s+uuvG0w z_|#N2!p>=_8a+Lg^WUlZfemxmkFs-9wRm2t?#)ltx_znYwLew!4y4NUcB(S)7KS^i z8jc5dQ#IjUs?wjQsxJ~>q^cwiA>>u6ZXwT)R8#q?j&RJl5FY7hqvY7z%;@pEnRs*@&D zyEL7JSNk-z?2x7c9n<9Ol%|dd>71q{Y=vJ}a>A4$X}XA^f23(Dvj0re)k(CQnkJW- zY@3^=J@eD_4eJ)9X)j7IOyk<0G*wxgrsb>B^bj*vlM@_k(lmN)no6uo)6s2d^4OlH zZ8(N1JJPgjXPO%CO4F$$X{vCP8h>Vfk?CrIIZ^5Qj3S8LuF;Nk?MULb zP`YNLY~ge{lhd^r7gN)95AWcXmag0gLt*5gI+~#yhF}sFVG~~C&ywl-DKnkV*wR%h zC!N=M>FQX9Smn|+y?nY7DyHi|rF7MOf4UmM3H?x@e~2D`cuI3RcWy{7gN=s_L1_s*$NV7*;n^htaEEriPR+Mr?RB z&s2Wg#)fv8@@Staw+{5hd$@OG90YdCR0G&MXDSE>k=!Md|8FzZymzLyVO5_@UPET` zSw^OugEEzl+e7I)EK}!k2g`?NY6}{V%G53#$I~&Hsy#MSeWzvW3BqS(Y9Q(@%G7jJ zT%4);NL`Z2=ir%|h|-%fRTCxu%2elLnY?evRFmVG>VnB9GF9kSriP;5olNaOhr5~T zk52b8mGd%FgHYsErb@x}HFJ5NsS_CYB~zy{@N1^VqsX^RtwiegOqFrX(n?%2WO4m^ zmU_Bn=`bFnihCB{@6XbFtid;=cx0&@)+581rMYmJvQ!^kF&&rlXX!!!?Fwe8BP@Yg z3Ph#<3(C@S?1{+Ief%7mr4LbAY8RcQ2{?r^FXK6ETVcl!CzsXW%G=9fABiH*Z4f>R&W$^mU zym9KkEZM%`YnIOA>;HYr(yZ@Us`?{Kzu_tj%9g<;TMH3w$krje#6Moy+Gowy1q=(L zO?b9CVb;KS#D+V`Eab#udueX1J!&2I>Eoo~;{j&&*aF-j&VP5nD4`X=wR> zwX%7QpRL{XvULv$zh-=Dchz!$I3^_YJ~;Zgd6{NC0qUf&er9t+4_o7H?q|hgRtptwyxpX!)*CJ%2tQx*_wo3 zUS+Evetn;JdEzJKs1#yNIjV}5<{W+dDMz6Na?~a;N0U%FE=S#vmdJkG zOv;gGp&T_VlA~dmR3eA(tmMceEk_PK%*c^XW{wV*$ubQKus^zFF zW}`%n95uog+=fr>92LWzx;e7c%hCKsIXZ%IO>+2+#T+@?f-?V#?AS?L^BJIU0|->vD7m0qb*A z21hpL==fjM^G=QuQTjoS+Tk5M9#YT$dz7QIxcoFne$R6FEIUUH&>f4h3-*u1MX66Y zD)c!=myrA)bH$1uIdWl@|5wv}KuJx$dmR5E9qH1SqJT635v57-Pnk?IkYs0PmpTQc zC`j*h5d;KeL0AxwvUHFpQl&}Tr57p7@~5+)6j6F__v=0Pa?a;uGs*kpd7mVE*i7=~ zWmb^SyzurclT&*504u5@^F8!M+f_RbQc{5cr*|T{x#5}MuR*$HQ1wOLp=H( zXHae^^GHQHRuA*&K7NlU&etBLp~@(aGLP}-N&R@OBGISw6{_1HcUoS&v`x*?eY^W>ZvFu;{4aPe& zv;ji~8hSCvP`4ol&l?!3J=9P%j-$dbL&I?dUE&QL#S>&7ZfNf}hR&eyC_^7&49=nE zXhXfm7+QtDzctimoS_leioxG8onYuWHcm9uJJC=IZllyxLtkJQCQLJQ2koXakBi7W z!%zv>n1`LXj8-!Z{pUx6YcSLlN3n8_p?8uD?VCq^<{OOf!ma1!H>;@SYCcUTrSaR)E) z=!BsiC+SZr>z_6>3$Ktr%}~96oiTJCjm{DiCC}3i?Ju%ElKyqc&}WzV9CNSIALPHr zK0uW}$o)^Yece!=8`Ks5;OtF969%+N?R`lnd!I%<;ZlTsgL(MVZ z5qYB2V{$?pOhn$N)DmT%8Hz<$jKX|$cy4Gc4!k6vEM7H5OEk*r)$5#IS>?QHfj*d7 z!K?Nay~bqvEQdsVuMS9Pnh4C_Ah>HwT-Ud{fW#g^gI`_bMFY z)!PBDDq$rK;0D^odes+4@If5g!WTG>0@mYn z8-5PaPh7*|uvf`w67i}n#$Y9O;ch$n-`=ZBsMdk);s!c)^6D>C`ogQ$NI{n`$pxJ| zdsU%}SFied8S@+cz1oM*26#1Yv{#45di8CBm+xJ@nlrEXO*L+1s$xe|H+z|SjD@{T74Bmy+|N|m{-&M`HkE0JDR-!; zXTwZ&h&R>ZYg2!YF!ccAzcFY?I$z^lc7p(Q7V! zOQOvp)>%qk_-vV}49iWug0aHX=POP1#QD{x4zDq_Y@?|`n@o*Cjcum>fW5=y{%})S zcbclX+f);*K=wWK7q!qGyO9bdo63bo7=jeV!MKbn*I14+f0$a10)Lu{$3OV+y2Z&r^P9B2Woj=9{Y91*70%hKMA7T?!cDu<$(Elt3$SuFL-YH2MF zX0uc~yQTTaox@UpTt?j6miFW0oR*T1Gnb_yxCT47rNyxGSd2kq@!h|r75Obi-m%oR zfTf?1Qpi%l!o-^ZRtN^+L1Fle{QKvdrJ?I(!t`|l_eM5k$^QgiTlXc z$(b;iqnvobHxpVkb`buvD@q z`v#|xp|_=Gn2G9rES2bMX#?KsXQ?oJNJHazOH(jvxTPz|{|&jK`e?gvZzP`-*7lOK=R1(MZJWGl5E#+BYsR5c|=1^Azfo$aCLZx-VRkS|W*I%0N^ z!yfWZwlpZk(ijZeYpK$H&MhoCz`i=jc5v~Kr7VXneTPg(ENwZ-Ig7Vb*|%xrcGgmj zbC%AZxAgu+jy1f-rc0bBmpO*h>GM^NBh0;K>BJwF>Rq?=!wt@%o0i@n;V+Jt+vI~< z_c&f2b6g|m6Jnw9Q;z9p)aC`}8alt^+{)==yeXfG z8hL#hi=%kUBtE{xV%$I}i&#j+?kPxQZgpd}@kO*ozmaZL?i$ z!fSl$_!tM%r**iEiY_(7T%5%_(LTADfW64z_o*&=V<|2me~eE}Fccf`H%bS5YJmjo z#zRz&B{t^Z1hU5YR3E*u2$vAm+^6Q4h!i|SwHDL@NjQmIEqyXE5}WY=Ra^PEzsjc- zxQVi@sTU?88IMt|jgR}Us41?YbkL^|rsD*1hJ0#_fmnq&5#vHcw z^r)?x$H*PeF#LC0=a1X^{sjF?we=~cpSBf9v(@f0+rZN+Y7FDCPyvtc4kLWn2*<4997EZD5ip=Ocfp8Q{ZSVI#zbn4=>QNs-ttbi*G)3 zl&!WS1J97Xj-yGq{i(x!?2hg=cJyHrN9nkafgXoIg%{Dpu`J|)2G4GV4HK>{DDDkwT&(a*_ zN_W&0uaWzzqp7%e&C!xS9G(ewv>NShI_iZIw;Wx+@94*ejz&FpRM%2sa0IeU2hd6U-lSCZ!!@;f0ZzDe(f`2>x{Ea^Dpv^v4myx)iexc$4 zS7Q#kYI4X`zDurLymi@Ce$2q5D{M2JI$U>^`G(8=(ysQyx#?=fEmtl6qThF1y}{bM zF5{=WGVi%se4p(;a5e5JZ87+ntMSPD+*P+1u8O{7nju;%5PmCK-SH6qOwoFUyt$(l zl_y%wu?vOsMynCB=Zn@|)F~9rI|rhbguc6?HTh_??wpF&68Tj*gI{$J!oG}tJ;32i zeih2>S9~_V#uoJJIvN%BE2fBFlW`rTiu%>Em|u5MFv`!kYJUCxu3s1N#e05rEaTS^ zoGt5Dflhqhomf5m+KMMV{mM7MuQDV3$}!HbIf;I)p6XZr`NUf2*FaoH>QcW-Zt$xM z)^GL8yUnlezcJnK*N`)QeNZ7r$t`2_Tl*N5?HHrH{bE#qS&TaEiP1>(I1rauI8ruFCP?H4#Wmp){y%ogW8qgga-xg4x z?E#I!3k>@$pnf|8DzGb{5BCJLIE9?{vM%!M4=D42fGQpgsNtc2>YNIwP+CBhu=adF z-&_c2+U0=OW5pG=lOE8-M*+=#7Lez8K;2&il>cQw4rXFv=2*>tJ67rVC1JY1A zc#hM{Vl`0u-aq8DQPUeI-ZCDtmHT&YU2O|y;<8Yj+UyajTHCLMq%{2(mYc^L_tGViS zX|5vMn)BX(pcZusDy3^sBYOt*pkGiO2L*K${f7iK7C#LQYRvGUrhOgcd6J+$N??jv z-v?ECa!|FV1~q3|P)%k8xu-g)m9v8SV|GwCHxg%4P{%e0wPj0CIkpGY5D7bi+OadJ zf%}4rIu+FA^q`jB4=U+FkY^@>+MF>YPo|J+Wew>P#^esEX`Yb&$s1C>d?C(Nmc1WR znkS?mjgY3;A*Bus>Eq!c<^4J&ABN8i>HM6Kip>q_2reKoDWppCLb{3vcr`zy>Whev zONd__Qm*C9>a7pS!k>7tA*8AsLmG)mIEO-;LUOPG**1q%5Wa08EkVnjAw9&q z$3i-aTNgrnR~J%~N5nvl$Mg|5k?<^}D|r4qq_!_Y>X9+5RcMP4GXIk za>j>M9A{BsbXc8GbWB(kaRiyihSd(^#?u$nPY7!Ws!j~60dh?WGwym=gRo~xSiZzC z_j8AJ4twT?l_4pt^+?9xd0|bOA7)>Mbz%YiTgW;%i60k*)qG`GQ{i0|RtvnpI;B+^CJp&i0F%s5iLU8*oc0@HoQdk zaS_$Wc+5bS@e#d3)9)hchf}DO5YdhABbq!pqFPfTI-VF&g{cwV;}+2!w4BCzsQW{N z@#G^~j#Q+h(DaB}pd)sp;tbl&itrwZh)T@CyogpH&-{q~#_$CZy};&$5fxb+(K)nT z5>cmh5q)(!qLXJLx{M+Jjp!I|A;Z~-s-Zq+;3=}4i>Su=h+1EW=uE?0(>*<&Kg_^u zIN#0W>BZ!K|J5k80F2kMSKHS}%;SR&yVGL)u`>^-> ze|KG!2%_-3c530nT3pu zaXPzg#{b6p-+$*CZ2SMOgZTdvG$}1z!hLa>>l&_-X#(vzy zvP#n8%F;pfB3gS5=?jL|l>R~9+EPdS+f_>LCVj&8aZ>IDQY5ONJJ#cGJVK3y(jc5g zuRYY^niN#rLmROdchM-*LnE+1%R~R7LkSP{LGO|t@-FS6T&tA~2^^3d-n)5k;4`+BHSAU^nw^pMvi4`rL|p_f=agRyRUsOMb|J$&Y&_h|pzLu*mzg@?Aj^3Wj^ zf9;`4Up(~1)1ana2A%UaXmd7$_Tx!*gAN54lsA__8?igLL3Q&O^w&=Y#RVGF0~dn~ zY8h-D)xhy45r2kERB7 zZD!E>P6owvHfR*4p==j}2H;ay9(OY+Pj`c&@U@3QjeF9!mqD|z8~J(@8_fL-YKTAa zra$uzFsR@_gE|i~XghWcHppj)K`v|?N=`8RZcuUT#()t#A8AmZQ3kyn%UozUj#wuc zq=^O%!m>%^j6;(Ra{NKu_%Maory5iUJ8>DEXBreX%b=7w2CbfJQ2u!a4Z|cj7Z?<~ z*q~g?47#=4ps_26f3-nHuy?IN9o8`q@~$`N3~r#|W`jKU8+0564j6P2o`-33(x4Y- ziS@ccmcI>hqalW39#&)0KL$;|Wl*!*tTj^a5W`)A0v;H20{b2sRR0O{JU3|J3xgKF zC5Lwg-9yBCYVy$_Uu0o5JU_E$7>MO~2+My4XY#Z?^m&c5+5YKg(9 z<3^)$cpLSL$*6r8W;SXP?plm;T8#=sOPf(O9Y%FPfYYc@{DF@s=Vw$qjK@Y?!p;Dr zE+aIDQ8$s1)2Jz!o6D#dxs58C$Ea@jjKH6aYKS@5i6ME78X0I*|9nQ>MuQ-u&cYI6 z)R|DDCWdhwJ;IH86KRwy%BayXMs^6O~b~ zoKX+(M|q>H6^z<|d=-rvj>Jkv#Z)z_66&IDHR43spJ|7qzZliIhEaYsjhc_6xQv>$ zjG9r~sHM1%MRkn&RM)5-O^kYikC@z)xtoz=OQV{!GHP6FqYmIL9=0{g)Xt~@aCBfk zTte$kMjh#FRNn5a8?N^->iKU*jq1rd^kTjH7}ckrQB?;R_0J&Y8qEF}%D*JTjOvMw z!;NY+(x^uW9c5I33G9vk`GeSza|+|*$y6RsGphY8qaM#TD$g9Fn&I?Z`Y$jlYOztt zD~xJ`>T4Kxy-~+D8Z}}Q>$I7?wivZ~n^EyQ$ZMxj*D!LAQC0Rb_Yv0PEc0Ba-wmU( z9x^}rBKITq0>(XNPd#CdXVd~8(dxNTMP3-y?BGwc?{u#!p7gGkdC} zkEfPksnt^t9G?2k>8bT7>gTDPc{~-5?f5INr?v)pYJaGw?x0b)r{W?!6&mBIUCExR zTgX!-(mXXDEz>=<8yOj%I#S$If0p%>xtyoEV9U>*THC}^2jSDyQ_nE2nWq*YM{`e2 z$Ap%iT7;xlo+{tQQ~TO6R(sla@KkI^PX%`(?#`a7-^Ei6`w&xKPo?(vR25tq;;H3B zJ+))Fr>^1b2*w@dsgN7t=wzNmpc3%3>$x8{Hz0?{R{%;M4TEzo7%g=X5U}Li{W*8E2Ch>Y?czFAbjOrRBJV!1=_9+6%oDv&c(p zHh5{|UY;NK(uH$gYIDI$9#^O<%vZfM>bjTgf0G|N-|*6F)cuD#)_dg}uQC3$NDR=d1)8;A3It8qbZ{fEPay!EjN;}`W--4t&{q7xb$$@Bjr3Lm^1~u@C4KHnzS^~q{Trd zUBIkhlj?-fHq4~MxQGYgCcVY;2>L~GF3O~}I2~=$4SbC;$tTvN7I7wZ!-RN~=3-ld zNu?4^I*WfWDaoXH_}OJrBRJhA1>z*G;YhMcRq~s(uAoWp3z-yFn0WEAxJgwrO>$(J zv<$bAy@W}>U`!d4X5e;N;=_P)Cf!Gu@;ruDMU%GRAReJbC6iWGHt7Shs+#l~6|0%F z0wsPXZmhybZ2iTgveo&DE`X;r*eWWxnsSKvz87enq9^7kWQvP2}D%#kj z8cj@Uf}1GWl-%(Z&SoaLo12t@KU(s*tx2BkOnQn>=-t7@FDxdFfPW{G26v&Zi0f+7 z3*7BSTs=&R_|2r;eV79W`ca1gCM66ssoEfu8e-#M`VZkT)*#zZllJ{?l5x06IYyY& zc9cmy@d+nJQ-?9se1b_GCbBOkQ{yQ-$1=P^wrM5>;}kBj!B#6 zndCd)q&bUCidstjU|()hg;gdk+DzTIP`|AvjmL7_#n^2o8Md303uiHRuSt#fo74lp z9x!SDA!>ctq(0b%-;S_mM_EVgJI)@(9sF^^q~WJn`_s&M#-!rsSo`zje}T2VXwvS> z)cY!JkaUf;z@OOuH#NM$e!0oML#|t_9U7n~He%gvlMbQd9o7UN?~&7e>I&-v`d|w7 z;RCAwOAgRuVnI4uVmzMXrza+U&Y6_+HG9%vmY312AVhkbH3xT4-elHW`1+Vt7VWKO zSsZ4~cbfGWzW!!ShEI00vgI_ZWp1-Rg)&x{SwGMz!mNBzW^KVQNoMuLyuxN#imfm%qld{tX6}}dV$O#W*x^ByhHb)#4^k*Hx}XzTKsO-3H&yk@$m^$Mwr!lq**=S z7-iP}ab_(V&-gfnh7+hO&g1PwYBGtw$UfPu-8hbi*!Tx+rF6fK_G{U29fpG{qat+{C`z%-CDWVY^v{cd%YC?li09acX;l z^}rSMILZ9jj{2vlGrnNLX|v+aQQz}sC8FB}>VMI!5|_>T2T!iBKall+e9`O)aX)2m zJ!37Ov+ptB1$+FJS%2aHZei|g>V%`PzNP`~mocg*}k`)|x?wy3(rqQ>YCKOc+o zVFfNC*=kV^hecs1jw9&mYtayVz!86o?Aa{JgTnX=owHjs2yf9Tz@m~lELxb$qOy4` z8jGTNnF~?*ENTa5uthcC6KYWv+zYcPI^3c&m=j^qN*qDONQ>&=GX6t{D2t47^hW~z zM6H4rEiPoy2AoFS!WMZKAqR}a=~Rodr&$z&3>-(L;uf_*$x;@L!3=Cc^U@Y|L7lP| zd6ly$0CUO{53W?UsB#sH>Z40li}s^^HH-S;CBCBD&la8g#iHKTEhse&3Z&5CsXw0}xESlQFqD9z;YAr2lh;ePmtu48=BRBMDPhD^i zc{^BCq@zWp@B~FWSrpuln)kP8G*SjwUfg< zd7b_CkA;h$76sxXJa4hicP!d;mt5idfPDUCjUHNb^?x2&^v7fB^u(e8&)E0REs8_7 zm(&Y0-dJ?@E&KjG`}rgL5x$=+YJfH{ezs`D7h?O$e*I1x4<9u(_^31X8+~*JO}u<` z(%VOaOgnyLd}NOBQ2<)NKZ>!@1Aj*Q=m3hw_-IzFkCr1Oo*3~x!AEryee^EV zM=2#33t1(7bQ~p0`KTraVlocmGEAj?lm~%jd{n)hk0#*=F2b*Zk48WheH4vhm3-8{ zGPxmd6(60)%&I;*heb7fv;psG`lxv=A1%dmWY+P~__?%ONY1FSh?*|;QPNT$6<+3} zUzhu6;R+x1Ug@KXtEkl)A5GZgqdD07C$&b`Ek61R@9o64!$+NV`zUmukA6lYl-uv4 zb$C(G^Pxz?UNgq8s<)hE2dz!U9`;z72@)Dhe8AF`hKXdcb$bjDxM}HN>jn@EU4WF;qg*Fsst>8b2`Ncjg^w)!&F4 zWmQY8z%#f;GY3wf#Tcu$q2oBKrcIy^%oDBJjT7*jY}LHn7h`h+jxQO>lq8HupKWpP_KB55jehse0Gu#O73D!Fa^zaTeT4DF?bKP zLYuwx-Dg$ueyegGpe~23%D|Yvi2E2dJWkFh*sExLlCe$^_i3wcV$vC_8lJUk(>c}_ zmCuv&1*<|XvWHOe66=nEm#s>;LM<`-D(A0RH5G5Kv%Y^@Rp2Hu-?l394*L)FF#-Rg z;63)?ebyZvA5f2fsUZ$Nq%M!xBWU;7s%lTz!%waH3k9Ds9*RG=s_F}?4&eAp*6OuY zv))?u4kg~v2S2~JYTgH{UZUhjo?{1GpV&jtXVwsHa2mn?@jZim$o0jlykD6IbFt_f z-*Kejh+`$Xn z2<2;-O%dTXIU;PTkI6`nirUjUvU{gW2O}q2kbR0zr*fa$T@n0dE z9v8Oh18NqvX$4YJY`TnJQf<16mT818>O&4p}RHvp*|6)unn>y9D z$)}D@%kW=)oBB7mX*52!vZ;1wo3@~M4;#PZ*mMHrd)ri^k4>B5(a)xKgKgS6+$P^C zHhr0IQ?7;7XOT_iFc^0*Z;eea@f97`+O!Wb>ulUDSFv`RuVNbuV?T%YlcUW}JCf9kJ4q^KR;<;$k&P%MxWt-Mw@eP|c{9{wa zn>MY&<6Ab}yvJ*(GP2o_?g;ZINqT6e>PdaFeawsA>O0gSK`7Yl=;RvEJeld)B_I;b~%l9wZ=|- z_q3~smt7-p57oWxT7r*AG}(FmW>eJOUurP?(bQ_}46OSkJyhF#WTc3pyJal2}x zP$pxcbCz8j@EM6E?Rt-$rR@5xv|Ue;vkW=GSeAM54L;@UN=A1K!TJhz-N2Pfc6n5` zD;)LF8b`6O8ta13aQwnJ)$J-?!>&pgi=*gNlls=OYb9FOwrgG;yVB~~wHCqk>?&K| zu9FCEVAt;OhNp9GK?5&v#uiM!b+1{>mNb6u% zIV{Gtj^y8owd+jIUC6&HYd6ZyYZbf3<1@TR6DJNrV^~K_!4>2l%Q+lH)Hq_q9i)vX zF65bD*H@IBXxB_EL+(k`4@aj`muYs@gXeU+Ho-8%uGE?Aak%F)Hmc3DYbtJ|@O;L? z7|dHhP7Ce&b&*{S7ZcAC_QX=VvMp!M6?U~-Y1dWkUu9S58oQDZyp}x<=Q{R3o+Es{ zU4wBHz8ly>_;sUQMK@9B&32vmlbE&=Gfdm5J38;6t~-fg7q#9^?0f8Lv5)mX$oIuj z;>V)ncGWz^-oe__ti>g}LQozamx%|vaOMi_uJXNegE{{pZj`=h=Q^id5txZ{xQW%b zsV`ojz#aAs&Z5#oY63lCp2y4skEeE}qwsU)dOX2Aayc{u{~$HDL(Q=RPcc4^L;G+FK0i75eZirxu;g`UEjk7{q+o~k z|4+0-Cu1C{8S9W|f`j)f94hK|C?naSlKCCFioFFK$}C8Xg&3o-Lpjk3ZHqXx3fpiW zIa3%14O1POjr-{i9m;U%c}s`BplKV2+P8J6Q9Flh?H#I)NjTKOp@UtS8?C!LbOg12 zbI970JbN*JZ}RHn(4c+}1q~plf%L;?j2q-o>=0@=%%PsYJM_y4=0eJ7hYF72*jR^h zk8|+-#7biGWW1>Tkv2c<@?nhbm8Z=nlHiaOlP?;+^eK zL5Fr7rOwA3O2F$2#QL{GLvA{BI-jpn=s zYCOj$`Rep!UoD#ItCrJzb$Gh3R?PI(7NpJc)w4Oi$~)IrF=&Cm;5VPS7W=9qOiO%~ zwA@!sunqfG`05l)tC)L@uMVyCRi}-s1@*3GGyThqG z813s+8K+Yl@e!VWPVOaeY6%+nJ2eT9esbzPMg%*x2*pC2nvKLzr$*r;=7c$wBiyN+ z5l)Rkn@Ferh;gbwtW%Lm%w5Q-O@%pL#HkzDQ`D*Obf@CVJJq#t$6=Ur_~}SaKON2Gr%O1M$4`y(`KfiVpE`#4DKgYgPw*hjPrJhX zbTz_HizEHCF4|Aa;{3EP-cK`={WPbrpLQ4VQ%X_VrTFRZR6qHr`)N=Hb765Y=F0Tb zuq;0Xm+;dFI7<0xEv%*e^eYacbXh;mD(9z=O2mQ^Rs6IWU$OdUKSliFry1Cfm$m#f zvaX+!fAv$f{(c%Y+D|`E_0!Ua^bPjct`L9Ki1F7nm%kQcu-jh+^82fB0e_XO;;(Ah zSj}JmRrgn&8hk~^TK?)*$6pQV`s=59{&F_<*R3Z0+TYY)kDB{yMGJpLx1w!pf8}lK zuNa&|hj#wDk9_U@H5N0`wwphD+Fy?c`s>;V#+m4^7E}E7VvWD%to7I7b^dy@g*guS z>k@AKpe+JCvS}>tcxBU1-r3aClucjYG-s2+l1*=?XH%IO*;F5Ip_$oK5)&~Gd1htP zW^|sDP3!Rq#pd!H?{Q{vHZ5IC`}Nt>Z9B(c+>uQUcV*Koyh6F%*|ZAxQD9FtO+w+l z*;ER1_GMFrgPg~*L)p~ya5kOC$Ya@*d_0?)e95Ny$dfa>N~0(8=gQ7&gY2r6JG*AO zvMXQh?3&g*yDs6!f$VznGP|aK$gV%}3Nao5`qLVqt&RXqb_VDrT7?B@Dc%$d(8cp-0%AGbi`HU5bvZ7dh4@bZCLi{2FibrZ>z0#zCHQR(ME)kSKJ zK$XL5ylNV#tk!|*)ge$tx&~@Kt|OpZprSArow^6ATF*cY!9;vTi(Y|Rh2Y+ST94{| z0(BfC`Ua}b0M26|jw5|Ypb88PRKl=8rQj_Z{2r)}XgeZMJ+T8VM+T}JHsji;Kt05? z(Sf=#CQ$z412r0V@e)%f1nT`Hj!zEc9*aP2g6$7#gZX%X_$h&EjwSdPE2h#PfzzlF z3QiAHN36h}8G-tOxS4^vg9WpwJ?hLRHsqSaF~lzl)Re`6T7>*d0##}$@#FETKz%^O z8jfQ-W^4%5$W7#c4+#8|b=(%HT4;`AD7!mQ3-<>7gAU;UP zFsDk8{>HefL7Iy;)q+%~Rgktqt%H<-*YIc)q$SAPHb~tu37@c_U69tnr+tu0VhV2K z1*&ui(pa2-1ZfW%bq!K`9Kj{b?G~iRsNI8@ehbnyEbkd4 zd#@n16x%0A&9J{O?fVhq#vs)|OH9H%Tt?$fLF$O>_`W$vIsOb%2mFr6EkP=U z{9A)mVH<7Hb9<0h;2!etATAu=8Kg?Pg46`ZF@8^w`t1$UIc(lfOb3EA;;$e*!jQv3 zx`5ClK{|lrM}u?)e#giME$|+tjt43D1ogzdlR+wWI!HAy2FZ0PNJnuUW3B{g21;Ec zx9dUbgAJH@n;h;3>A}C${b7(=A?^t|JY|hB8hcUdSrGRS1Zm`J+PtBTZ-ev_+dl*; z;$x8Vd=Anq?_lmT4Ax%=GzTlMC0H@2W)0Sce8H+46RaC4!Lk+))-GHv8LS70EElX5 z<%6{a36+ES91896u2!%-Y6q(u((4ARJW4bSR?YUz(J5Hx@vcj-{JSv@O7sZko-W4w zEm+xl)4orz%JvPGu^(**1*`UuV0{@LtRagSe^s!qA$B$KtqIl{EL$5a&vn7_Ss$!f zSdIxBf^`>1HwLT1reICR-$>jXtQuQ_m9Z^YJ$D7G?IGqp9jtNZ=nL;_!D?|oSY6?G z5X}7;!CHxukAl?+&rtYruohwQi(q}i_gBRFCRmTr{$sHA;ykKA^Q7Fh$fy3QS^ln1zif!UG%*iqRVJ^g*I11)aOx%RzDBXke4B9^*uxd z4WY`ydHi7v)hhgr@5t{Ns(uLd3RNlZP(_(Sm0%9l3-qysY9eetp(>AWuvZ!9i1AB#E;>j8a#ryP-bMPEb~HD0`upGat$n0txtq<*c7H2d&87#Uzl1P4bw23Ly2QyI*#4P!}JuN(CP%^<1i+l4ATcpITa?~(_xy2 z+vt6U{>V5>oS2GdFrN!k!3&(nV)VaAdwjhb)kRAjLnTAF>Y=DHTo`PhXFp}nrIEzT$pX)>WV=a>f|__e&M?0AFcSz~F71!$HSt`=UkPgQ?vx`i>0O)Un}e zK0aJ!r!vnB+N=uK5)5BMOnbwX@i+6mAdj#JeQgk-+6^Pr0$*^bQG{Cm8lgAvY#bpM ze#Ls^YZ9S3*bd*O5o(8z$k!}FHE|b(nn&nq=Lkh~iO}G#9PbvP%;6F0gR3JLYgB}? zrblQX^3RA+2^>S@tOy0pj?k_J5gPJmgmxp()(GX?#yE!}v=3eX;vAw569-ajwYYdT zl7E*YH5(ZhnH%Oyk;-*BQcbT!sxuOShLnTklvtyLzpntC@#Se(mC^Q=wrJRGK)CseOMCsj_DBW5YrE;61 zv;#FZN9p_VDBfd_(o6inqLWej&H( zM04M1w2Iz|)(U(@^4(~4#uYq4%)Mw8!Y~}fIh4O2t*vPPAX+c+4MQJBYwx3IEqEHO zTS#~ot*%&wcF&_V8}AVQB3gkjqxBm3UPWu*n`n8wjaDg~LXLOQYJ_Dtj?d`$fjB=# zbKgm{-XQ;{Xs%U8>mn-u7p+N%_`>t=(MnZ}&cn+ihWi*}bQ+rsF}jB!V~lEI1WqBB zXN>A%0dB$1D@K{8EWsssTVj-sK3Iht zaQeikI67f18e3!386Q#I9;1?u7(EV%QD~kRy$_C2Qb>%(gvMxESd5y*@U>8kvK5X| zC9Et$jzt-_Sd4NMk5Sjm7)52psBNhjtw8{AG;7Uoq$F7!`aIqlX`36!IxX{XY}; ze=*wpBStS!!6R1r4Y6A49jn_&H^<6qiPaAOSbf5(Y_Zyj%*rY6^2e%mfmlTrj8)%M#zFhESoMQ3JyySF#45g6taew7)fcR- z6stYxS~*sZdacGiZ=~S#X;UIdRj#Zf_^u^t$u`2W|R_kBHD&Nak z#UbQNto*+696$YtRY!z+#OYULGsGzjLB=>GIOEg>!*CVhesN011`P3!({;pUi&H0T z!xdD>9;XQ?9T2BQIEuGWjyM%TKa9qARLB{pAE=NkPIWLUcbxt~`G`2x!U0^5jMEd; ziHcK8oR5xEjo3K($HnOl+Qc&t*5ec!C&XzDb|Nb=PM%3|YKj}k?~3Evd7M7M?v7Im z%3wTh;{|?Cj?-ow$RDR-1>&>^mV$BWhSj)$T7}{?8$*l4DIg_IZByg)Cz_|lDJ`Ax zP$45ux8Nuir>^*n=EbQUW@pCfTUMMhN)ThIIKD^XRKHxDp5uK5>QymLCF@diyh7u8 zaXN>4C{RC6715*t^~STd)TUjWN_2|TAQb3KUmQnN*EnVGM*f51Gzb3;j?|1*PhA(psn^0do!rU!J)Fn-y_`qseVpGPr$z_j)c$Ck zR-xgsICVgtW^AiSW7%d`D<}%cb$Fqjrzj!gPP-uA)eRq z@p^`@80;CZTVC;eb}3#?OS~$>!zZ54SHx=?-dW>y%oeY{{_)y^Y}w;=79DcMYdO5~ z#A^r4k?|^x&#*+rYdoGs$LpWic$L~8uK~DmAYLmE#_O-6@iHD`JRC;F;gpUSsg%4sqU%*VKFQ`uTpmLLSDe9=1J-*SyE^di@{ceu?M$M7(NZ)3K_Nj2>K~k-l#m3?ib&8kjEPLpY}AcPP_x1b z+J<~-391j@^aKTA2@J&&v=z@QBq*w4f`(RNzRC$2*Em5ZF`!9;#v`CEhz zXcW@-Ca4lFz_mX?H!%7{f{vl@N%DaIsRVUAouHr2(C_aA{f>J#sKZU-xJM08@&;#!%gC94xveqEw^9i+{nMD;-LzY^tfm^$F=kwo=BnyAqz zbSzP;kJJA|qJmD5+u1}#{KL4n5@o%es4Zx8Cs9#%6SeR$aXcXody-NeNh*uCDDF(+ zZviCfv0suV=Sb2kG|82ud%2TTI8TyF;wAFuJyu! z%eV(eVv@|RBn4m};*yipD1VaX7D&=B1(S3>BS`}@lQb4Zvgm`T5=m-TCrK^qCGj^~ zlK6aVl72^W!z8Isl4_zU9DS2ixgX>9Ptxc?Nop`SN$n9mBuV=x5&z^QEkcVwk~DaF zlB&;0QZwY7nWVb2lhk{0lEz``nk4mHm!x5EtxwYG4M~dKn54FwlXUn%k|z9>q&X;i znD~(6NRpml!^tF#zm%lVTS+={hv%<({w_(gQRaP;rsE9OeN55}50|_QE~R0u(WPQu zE*-@s4D@#CzR9IG@HD&B8Z|90Ew#Cn%kEMH&cf;I(qN}cy#idCk%RN7meZvr2+!rx z>qwU_M7gv(hJLXwjVj>MH$)b7=@ZN;E(NE$l!&S6F15;VsV8O@b7}eiWV-YfmMoVx z<2CY?a;XajAhxtizm;+E8BLewmS^lLE}g07Qte+{N~z(}I_yHrnl5G5cBu*)<1jYW zap_S#m&P`5X?!E*_|>Hx*bo24E|tUlX2jRdrOB9&3hk*&2Xg7;;@>rw=Ja#%yE${B z{Wxkko;gr+0x`~T@gA~E)nS_D(&xD@otWp+-xxRFr4Ng!_hOf>qVE!y!j`%89$w2` z+&e=J*1BZd!t0ZZ*l_R^yy*KBMI3T9TX3Cb_jfw_CSh246b z?pB{-j9<#F>v)JsrQP~a#x2jXZskB9v?}M;=t^!qLftBEc~x`sw*xqiY(KkI3&(zO z>+c%OU6UMOtVNsJZjGti#&U~<=>Za1~Lx5Vfi4pVusLfs9VoQxYcN+TkVi@ z6giG|Ytb0D?v8cq$#}O;O>irCBK5#Z)R^Sf>d9{1{===HspK=A<1^j*I@_)DbKF`n z*R6r`$aOyFSGv`Hm0MF+yY+63TUzH<+x2c;+CbZljJ?UNDt~fri(9|%a_if^L^T?GwS;J8$XK0|m5!?z-6dJ`QKBn3^hnm%-pT6KCt1@6B&+j4>W6i> zjGqQ2D`5z=MmHo3rB2h5^%92Z$!dyDIE`X6h<_&I!FN`&ew&@F4ahYoS&Ok112+~_ z{TD?vAO9lv%Oa|TkvIweS4C6-L$MRD5&OD`nqf9Bz~@a76-Rfh##2PTEusdPf>SWQ zE25(4jHS4PTI(Q_fs0s$-G76MS;cpA2D589d3SuX6RZP(bT&aZ`$Nb1@pQ2AF)FDNW@fm-1Op#wV=7ynriu^Gh z?|YF?CZ7F;vjPZA1 zC;1;wQQi|NI)htielkS|PNk^NnH2SVLQd%LG==w_Q{?%KIz3O}dU%Sy+EP`>o~p@? zRPFXnRoPsr8jM@HQ~5hAshZ|a)j1^QPt{v|E1IfmDXFSeEL9WnqIjw{W~ORD=~P|7 zqbjK?Sv8e^&r@ajIaMuwNmW|)RHNFiuyHGLmQ_mvq`FIw@TF{ zylkDS)ooHWq#f}fPlr^!!u(#Tx{ktqQWelQRURW!RSa)n7@4XOcrc1N$E2$Hs#MLx z*VV+eCRKmHYi+7h|4dbPoZphFh1*gU@sv4n(vYTLW19Z)N>fhnG%Yfv>54T?ezr7C z$(5$5!D+gP;UQ_7hQQD?^$tr@`S3LDiA__xQfXR=2Bp)uM=4EjQMGKE9Ocrqrdpbw zV(!mrT8jd|q-kRHG}W!aJk6OCDJ|3VFWUc}re*LPk){KPn3kqS*fl*(V`rpseLPJ+ zuyHQuQFdOMmdsDn{RL@SzdudA4y0-R!894}q^UUG!gx1LBk}LOG)=mnri|xl>Wico zX)1=l5c(=jw~^yVnyQ1p2%?;rga16zwbYQVSnqVT!cV4j#bE;+mUKSiovweJ>3ScK zuB0648j~|!MRKL9L|nQCp+J1PO5!-864UiB+NGy!B^qR;t3BSLYVmY^MM(K{HG+SI zbcJF$yecst3_qtU4Ksd8SLN!AQ-g8PpeEzsEvnWgt~%*5w@cSq__R+~%MR(v+c914 zPU-51(9Y>f#x?|WB_>QAny!l&J}h0+P~!J=UHgM})6(TJi(~WBwRb_fzG3~sbnQdw zMd{qHl&&gE(zRlBx*lTY8e)QLZMw#;OIOkL={mYSUEVv=wH?P$WoNop?@CwW-RU}Y zBwZDbQsd9$7nPwFm>Zp;?>HNiq1$K?o1s^685--#(9UGO=FiX^lr4}UcS?qq;9^>a z?&BRi(=(JE;V6KTsE%gnhN1Wai?JE6@q4ih{gj!(dvh5oRWgIuc^T?hhOx?JXh!)A zC05MP!AcpbT_rAnuRVye{FM>1qdvKXtpUBi2+>OrE!Prc#NX%4Bp-d%I z$W&Y8tC-3BnR&r}yoIgzRSw=*>y{qAOJCpz5ARDX23pQ(~BGc_0m zUuCKk46n)MeWp%e!k0{)#-Oj6nuvnmGPMe6-!oOlkfl|)Zp`9d{4DkK%+g^zMis9t z{%%5+7GN#DA=Nue<*)(8O<9@;mpM!I(G@drIZu`@1kx^FmO8=~l%*h4`k&w|J;&b2 zEImNgs4RVm&QiOWEKR~Gl!?vKMZ85m7sv4fcifDVKa0OSSbFDu zIqyBr`J8NK=HC1N|7WtmWadsS#zETJ4tj@# znqr$l&KU1E#nLv$K3V#GX$CZpKzjECmy9jd*-Atshp zc3e8((1k;^IqXnlEJM*F4lOzA&|m0u%%MS8`Ob0TJwd-0$PsUl^P)p_-nqm+!I8@j zJx1Xx4%J5-E}}?^L)GEMWL!krs}2P)8Xc}tORW6Ip}&!eEY}?>1q0)7|CU4fZc}gM z{+ImW!BEV*<4~o$4z0yytVm`31BZP0;t|IOK6vcV;Aajk#-SGu<#_4Pu~!bgLf|dq zBAuKno6f0SxQBCDo!XY&spA+?(y4SGJJk)zID$tAlyYh&ZsSpDr<#>v8_dTxyhYw} zPSwRgjK;X~PSvR3)CN?k=#&?2DmnE7@>F)JGy?BbaViz7sya2knp10W>{F-C*Kq1W zO{a3#aw=0@r#`}0NE=Ig)PJYGQx}n;fm0R0bkZ^%PL*^Lr{&b-1gCyZbZRTgH+Cu( z?cQlZpG}<#p;`;4{=_v@YUxx0ZeV#Ur_SK>ubi6L*{St7(A}vA$lAlH;;4f|c#0Rj zo%*m3`Cu$o<9QN&40h@b8jNCGSYw^cui(_Q*-kCSQxsU^RHL0vb;r$vPUSd6EXRli zCvXo1kK+XOM9x#x7IU#07vDMURMHuzPW|oFE4VH?)d7RC`l?fBapwm0yy;ZuyG~6) z@V-+6(DJcU!%+7b`v}Ef6DMM1$c6Hm4F%BdJwvZ!43#KssC_X*li;ghs3&48vmTeK z8p=}5P^7w{5tvll;C>!M8DkAq!Hv%iP-&50V?gYjP)%rR@|llF$1AZ;f@6>zA#q0GGvRYj2`Lr(lR z$WVdrSU%KHB^()U=sD{AV5lY5BL#)W8gk%g>_qYegTG&iVWOeBXg`T@k#jO_QF^K& zFBaekGEOH3T$yR;y;+7v&NuWMGA$rZ{J6-_CbU~(XaZ)fFtiIremCUCo>hkSuc4kP zhAP9nZm1(3A>$3|`OZy4eW zyh~%zq>@YD;rXX7m8kAgj#@6<ao_G4);QkxilVUP^v%gaS|z5KES01_$!Hi2Dx+^6^FQ#VVFx-#t_#`YJ;sfhD-3yc4^5% z+91s$m)0YG3uEIVHf<%}?JgDG%`&vy z><7f2a;X*mM%L5R^_)w&&%0C>XD;v_)vmB#FfoM~kn1XSzv)u_RQ3V(J#gtBEQ+!kqg-mV3^%zq#ikQ0aPEk_> zikaN2ZgS3t^_XRw`W@%q@tEq@&{U>4Q#%vsx2dTqIE~CLO@9BHYTMe>XryUxsxpSRsC+~3z zmv#~NZsNfl9C&9B`**LYgZoWAK$Zih+T*K(rg~xUAyZe;=!mKN81k2?CAf!Iczn#% zmgA-do*>7Qv^iyJ8eSv!X;byyIb-TP9B1hlMbFa~tuC@XX1#OC)MuAjj+s}<3AwMC zDu#;x5dU??zhSD>ZBt+0HT4{A@0nbyZE~)Q98&rDfyulYrf#FqBU3fe7~ei7MihHO zENFqT$oY(VqU3W^3FwF+n1j|YOpU<4SHzLgt%hg{M<%!4WOK_dtpxm6)2&Li z-P#-LmQ|m=aT`S%xK+q-Gq1Z_c`P?`Ke*M&O{F)Wog&2;)4SqgYe7OiXX))% zKb|DUQ}lVptrF*{{ROvjT&4~fp2EJv;p=WCWwo?7ho#LWEEWIQ(r;BPCDga{$!8Yl zxh=Urw{#QJ8(2zoS}JT<@-(&NY-Xu!8%wvkS$cwb-7V$sVJXtfQps;DJ?(2LeLqWg z;O}qg`2b6;lPonEWa;{MmL8(O_m)QC96lamsS{GrVyLAp$TiGTGt9#iG#GAa2=*W} z!qO?^8EI)2mLbC!OCP{H*5W*-#l8KOcH$_07;h=Z6iYD}iF`kkD_Tw?cNCaz@w<#X zXV4biW|HSD+RSI0MZ|{B7F$ZQ#L{b+OD%o*tEH|uzueNn6_ysSwbW;wrD3SP$>>y{~LTRCL-G|OJk9BH}N67$5NHOEW=qi z_gRX=6x_m7WIDjQgO<7w3Ht%qnBZz~kEbp}R)&Hp8B zPmmaRD07D{f=M1Y6sZ zZT^o%ohMT}#Q$h(4{H6y{+mLrrgFSaC%>6Cb7@c)6r05{J=<3D99!?twN)PtG4&VT zFX1@G@ukGNjD3gw%WZZ4jpK0z`C$0(woc%ym9|cz=PLHk8tS%|&&PV|zrj|4KWvTI zL~ffI6J7tbnRkJhaRN6GzlAt<5dThFeRkOzh5@^6mD|hb3k&zLzxFc@E*`Lz@u00A zkp7UZq$9+SKaTVH#d{~&&!>s=tgY(jY@I)E>*I?YcX)$!m-x(F=6Fsa|EnBRn0d|C zv43pUyJ73cn|z*b*?NmH|8nfyAuiNR<@kO=EuY$|fj4kI}!`H9)oMrPc zUzbOPvU}7Ft#WuYDxXIU@_Y0H=EiuG_al$0m+Q37oMX^6Ka83IF9U1J+d$u8}Ja7nt8b1%cG^Zg_6yw7sg>H zo}fw#57&cHQ(QywkVj$sgk#7S_Q;9eScdB;7NH*`<1q3>sZ$$|?5-Xa8O8hDUbSuR z)qFH*;iZ4C?!pu1!EX_-ZnpKRR6DQ!#w~RD%BzE4d-=>_djrFPxc8~Ka{dlj|VGq0$yjn8RtAWX0^_b?>?`S>U ztDbm)CNtS)mRI2oUQL7V53eG)h6bCwD!tjO|Mq%SVIMKz9(wKf>evCVh8^_k*UCzPn+C6<@Wj%hjc!lKEPBw@%wZw z&L>A(pC)&vJz9S2(`t{spVewEJQ*YfxM+K|();UD-l z^CQ0^<@`!5@7J{oex0o7*Pcp#&8yu- z$*%&KiI)TYN*d%>G9F{jH2T5B>GXp#Gw5d~ZD!FAdSU-Y-ftp496(?*dHzX`TWGV# zuggf@OI|3u&#z(o{W1>tmFtpUex$wZS8hzf<137rLLF}SmEoqJ>$m;d3*RljmfrTO z$-m@%&#$*wdEd`-0sOL3{aWyVaUc3M@)>Q>_qkuAkn@FKonHD?@D;CV;o!Il zi&u}+@p_E9IfH7OJE#)zL2djpsBNu-+TJFp33sL_i%JmP(3yW zH4HB?;Lo6XZ4D~VwxBBS2x`GDV%p8Ncze2+Y|209IP+&!Zf-4jB<*EeLT$iA=IItr@u{#qK#>HI;sn9oZ1lAAf|Db#q7!FlI|gTegPO zdrwF)CqlZM64IgvA6`C2=AzVQ6tgy<>4(lo&;`N-cs?Mi> zTtd=Oui6MO=I)hz(Bh1Yh(OT?A|Narh42Y;1 zvL!`S7-vytXhdyMa9BiTaR?bkMDztljv^Ptj)|xrDvgb(KC+LCFo%6aeXwIlx9|hXHiA86Mbh#G;U6WeHqcQx#TyGZEzev&yT3_uMtgxds#$H@bU79 zGOmv3)AbSNb*El?BkG6+=zfRoVxp?`QB=q3Mpdp}lz-Pp6>1$-yEakHN8*U6e!(WZ zLY9$H#bOkuAmga0UZdd;QT4(JtQt*UW1_k_KB@^5qN+JDs-wwKm6;UfIhIk~L(|D@ zi@HBXnV&zZB{+!`&x zoT%<%;M}NQV#Bp+IU7|K#9|7bA>+BI zs-KVY+`p*KG|2vwtILZ=X?UdbmaPRjDe%94%z~w#q~1C5bp6f0ch{ITdrh9U7fE?O*`ZH2Nki)Q5%DP6iyR`J3`i{%t6R?I+* z)446v{~zoB|60#*clrPAKrBX+($Xc|FC!H%D~*H7Nmd*|N_nY1qAExQD@so6!woF0 zBrU2e9YC)t^r<0z!H}BLzbH^!>WBwjrKE1sCu|!d<(n^c$2$CjN9eU%>U~uT%y7{L z?72%?8|b|19ZrCQ6Kcqagj%97x|-4ITzKd;G({m{6+PNqlsa;*vtCx%ZM43J=dfwMX{rkCS6bAiHtUp{dX&Cvz zXSj>pC%7orL>Ilps_DeK;i8^*T=ejni{7LCa~G{aofj_J^2$XAk@4C^mA<&>i<_&O zy1VL}ud6oYa@9UO$?d9xey%Fu@2U;hmCsdm^SkQMPp*m$a8(an40Kh?AXn|la@Bd1 z%68R}Qm%Sj)>WoTu4+`-Rqc>e-Bl&A7uFiCYK{5mR+AX$R?k(Fn!2iMGgrOuk#Gy*FRmAfnE507>|d$s?P{ly&TP0XgG#k$GJ-5T{RF( zCopFmoaidsB=W|G$>cu8RYkD_m(h8Kt3qeGDtWf6R?Tr$p}DU50~27M@2Z$ZuJT{% zs+-GPHF`PuuX5Fyb*{ROhMQdFw$D|^QFy*q(7&JVbSA{0@u6&kBhsLe(FS#i<9?z+ z_Z$Y@bQ+W|$)H(940?kbMGbma!l3wMg9fA+)F{oM(|BFdpw$^{&opQhW}t5t`D7b( z8-bh0v1SWBZa?@fgF}vx$%}u}A-LwvQ^Sdby+i<9W zo3;eHXU7XwWoatH^p>xQ&1;z z?(C-eUEI{L4>|R9Q%Zj~Rl$|PZdx|PP1}dM=_<|+Bkl+{1&?ym##ywT=cYFE-86B5 zn~E)TQ&;T9vQ=){vB6DWablyJ&Y0a**y1h^o4c~|x@&JfcWn)JS7x}oD#f|$W}>?; zIo;(}*j)=!knOJQ%Icirmlt~0&dmGHZ}90S-kh`zJj6}`}1tJk}0 z_#SuFKJKmy=iJrig1cOLLULnrVQ9}+xtxTuFd7N>s+ z57kZfPZKFEf`?jFq8;j0_0ai&9!ebUp*AQtf^lIVNq<}!>!A)CJ>=Zyp=pmj zG~Z&>JgZUt@*6c7JMjcl3mCN|z^FxmMqR+nAfxI8(>Bzo!?=k1VMe{h^KhfSU}psT zBaK>v(@{oU$Jc11ykd-M5o=U8jEggB4z|V{RVu-#v-lSi5{;URY7V0s!R|CF04H%3 zN0N-HQpl*aMT~l1)Tq#6QDuypj$38P5xK?k3 z=RVvk8nqb*@CYp`8MUIaQ6G@?vr&8T8WpP=)f3B+U5)&)5+AYU7o*Bn=N8Lq8nw8V zQKxDfbrVhM7!_FGsCKxA_=MgajJzl_Y8ZSw88xU2wMJ}Lqh8=nH*)M@RQPX3H;r$!V66=N8AvY@@vA88v&6QISiGvMw{K!b+nS zZek5KQ@1Tfjm0wD!RW0Mg}kph9$igx zH<%QN2oIBH<2K40O?nG&FO$lmz1bvBn@RKRCOw9?uSpZ(mD{9Tc}@D)-=voLO!^c; zyik*Vpi{U>1tU$`j9(H>>WR6R-O;Rb7tZ0S{ zXj+<>ID(7VR>q{^Wy!T1V^lQp95d-nCC097QtzKl>Q>F9YSm5przlL&KQOa_Nx2)E6pYy@(AcEsO-$r+24rS(CB+jWKEASYqN78jfRq#xu_eT^3)E2%Z@7)`nDK@7-x$;6sp_7dYK;Ey@$yt2 zo2NpNfg|YZ?Ww`|fFr)1vgYzseiXwYbk6Omfq08fexAz7vKS!*M#rQ@K+;6^wKoN2Lr;wLwlPPmRKKY)13ao~l#UQ|{$F<%ikjJ$0qBrz%(R zRF|JUwGZv9da55@qG(M|b*M$XYI|xz9b(lb7B-`PJx`hHd&(at8q>Flr>3;<)I#h< z)s~(b(}sN8l5acmMUVELx{Tr-Jr&fC8uj;7^6#Fq4WJKB;R*T<^ptV9r`|V&fQh3$wQH=WCQqa0*n?lDd#c$?PxYDQsW+H2+f!@Me-3Lfms}Qj>LA*0VP4zG ze}|_Q@1%aa$Z0ogjd@tNhvVQH>-w)JCp* zkY3v-@E@0lPy)`Cu#lL)H^7jmI?%dFG`$Z@kpuE%)Csr}tjEja(nRbOqBtk|XAP^3tcz%=$1H!J8Tvz8Pv%T&;;#6Yty;kQt;3Wl5YIl`=CF=kog%*v1AS!Q*{ zRitE_RTf2a%!(>&=5?o8tt*)oSlO(K_zeqj8umJ71z>wU`qwvWAKo-G>jxS)H>)>7 zTA5WB8_>E9{ZO`@Sv8Q--mLK`)WNK!oy_`%%~^41>(-HQ217a35k;NmN4OA7-WDHGW{&pNu=)tbY(Y!mO59j%RR;WDJ}@ zi&186MaMB_O&v!cn8us63n$<+(X48Ck4lrx8a{<~*g2K)rb1eFKQIvoH=5;jeK0BBXa(1#Nn2ct-%vykT7_^&Oq0Jup?lmiEpILeL zQT5%IBH$1+#)LattBo z66=lum(7a5LM<`tZ}wj`YYN_8V}1WItMCnSzGYU#ZH_*p6{?Z@$#tkr9?X1+D+9kSoi2i4x2 zHTQ#AFOl<+$Jh?XCypWLGi!)8IE|qHc+Oxi{J)r0;49-`4i1#` zNPKQ(QSHtaZAL~93$LXuI)U=NEz0g=(I&X`v#8x5i?$54$a}IyU*=ilzkvEIw5S{g z;Wp;3w&*3kqQe@C_9A+%MSXD$k?SmKv)-aBXu8p&E?bDRm71Xk{zc7g7VY0jt#>h> z-4>uLH(1pgJMi7js^ace4Z~ej_poX) zJ|e+rh`RH4>9kt@25;>P@;;=8{%jf?I}FwNW&aSm>N()p~qJLXK7M zv7?k#zm>M?De{(KPB4^ZTzrF9IjfS;9fPs1f>qaXrIJ-Hm8}XxeYD0=?5)bW;4^H$ z5U09T88xh`gwZ&PPBp1-Evr_bb#1HW*0CzJu2pLgRL`oi^{qOIpaxd`iFLTw&??`? zR_#HLChW($rmRmhtC}_^zn07myOFy!W8rl>t0LN4bq=W=tSW~^xZ08VcVg{2Gv_YM zzbk7u!pdtEtH$CpJVufy4nU(=M@+^QQ+e>StLnjRnpGR&I^C+2864wq&LK9c&b4X^ZlTybVqp~K&Sy>wton7KRSg%B z&ti^=C06BH#+b{kYPZ6wzp-znRUxabN<`2aj&a!6a{S{t!q!a(-v}uaT|3<=k3&W2RZDd*1O1kw^c3nvi=8nUK}NVEIe*i%~KpZSaX`S zxMWo@%ERR{`Cuo`T%q0HJa?`$=D*~P(l@M}H?t}nGjI+!u<91|#S0X^%`tYuwBd@F~^4hBY@A&)jp5x^M{n7HHRlj_)s?TS}!lnP1 z&ll?Qo#%jTdf;kPMK_zq8*RE~vZ~#wNFT z8|S}mD&e##J;|n=LN@)4J%w$`EJBV&iBZg^yl92C#cf)Nt++UukL9O3xGWTSjy%@hY^Xg;M zzA_ zZX0ZJ*~~l+*tGK~bv|ZOJYHWQ*MDppe8Z;G1-(@>(p!=By;T@_yLl@NgRlwv5ZIkI zXo`Y8ycLT}82X#HCZTChZ!JaVUf$}Dpx)k!#}F9$c*_oFUvITQS9Iy;t##Oij{UvW z7d3w;4h#cnj}B-!#9L$k^wtN|8S1T9!@LzY+*>6ueWbV6j`7yYv235WF{7kevlnYWr?EA}q;)+rcQ zGWKe39bDtBP8+;+6YIBlYt2^n@9@^W-QFs**IP#pc(_JMx__Bk z{Nt_Kx4l*Dk+*8R@Yc(B%=MGEMt$?v3>UkW;+nzEYh=5uHoNj;q_~?LyN4WXe zRRW9Az}Kz`c=VH9?=dXMu7xNWY}YI#gxEC#A2B=Bt~_CO;2syMlVyRp~do-ePS}yT0|Zt5AQt1`V|9;$XXOW5pkK#SG3i6Ako7ubS2L`@7Cbm?SBImFdyF+Z zVOP>AyQ-YFt3IZmW&Cq?JxA^9b`8B{SG(JG8SmKD1HJCD?ICr3WY@08^nGIIb8x$^ zKBZ1CIBs6rb@;ViGv2eF=>3WIc!rLj?dl8je|Fx#*>w-4zu9#fQ-0X>8GZeHv<-)0 z%HyLWd3|)$-$$2lD!-2!7xYoAr`RMO(A1#XT(b^~5PR%B^fKzM}K7bC@9-U!(c1rqct#> z_R+66fYN1sG_#zKf-8{=va9%L6TV_qH6Mll;-l%4@{Fv#hv!i9WQtgx?gs`#oZHdOW1f7N|erv|s^Sj$)4 z>iDWbU0?lF&sX-wzPj1OSNod!>QQrFEpOqgs8+OX?W+Q9eHD#!=+Mqr_fW9CuSR1A z+II8hnD*7<0lvCAj5y@~hRyw+E5HZ#USUtPlWAGC#^OD>JZZTDRI z$s?C~8guCj?513D^~|NW({icI^jxZsx6q7S%E5TdMgEz&vwg!tA}dRN(;ou=HRqH9ee5 z=P~?PE+rk$r6yl;X&&8IGzeoCz9r|H%FRJ*pH+M~-b zKm9z~PlYD>$#sz*ujTwWZ{(+*yZtoupr1D2Bf4Mmlh1WOJ$>w_d{6w;_^F>3VH=LX z@zPHnGxKPC-#n^1B#&}NlyNDR=&K-S2wR(H^{4kZSv}VhrAlvJ+IpTo>!}nJ{S8dntca z3-#9m>?z@|!)LA1lCTlmV)SwIu?SlpLTk*n{;s0V-4~Kp7Z~Tkt3y zpwndnw4q#p!pa9|4SH7y&rc-1sOS*-)qt3!Z_cMZ@y zT!UY?07YUBs`d=fV2sCCwCEL}l?dt`pmnI;CqTy$(KkTDQ0I5rU;vIIZE%1J4+&8G z9|20nTYUU8Ky8Nws3%$u4^TI3!qpK0dWfkb19W{htJ*ck!3jrlXFHR{X?(02IG zW*g!b259o404+qJ#Q`d{gq-nsWq>{)d^Ov#4b#^LX!u5Q#|H%b#ky?`P%SjaF_hgE zpapvZG;J^a_66t++U;iz4^R^{JQ$!>M*`FxUylW-;JE<(f?shF*_Q&8{~y*Lqj402 zuLo!s^4|#1Y;3^ln*ka$zMx*gdqP1Km{m}P(H#A-A9-dMRNVZ6YJmd_3d*slpk{>x z>MKIR0+onMNQey7g6Kf?j|tRP_{9b47-m-q)IS*WbD-v+P1QivX%(m~Q0qXY<278` z1Zpt~v<*~uOu#41Zx^Vw@M<5Z$+(3VsL~-&XW-E>P$MwEQ=o2QLTBM?5fAeY|)brs8c2FltiP(R^z??A=$2~;!e>r4B7w$JpJ0 z>bECQ=dfuX`RotWutR}*gu#acbpatq0<|By~MT;feQZ^sQjM;HPa)A>%W3@2mz)b74QsFG^(0|w7y`F>P83YdUBA= z89~~KzjK0g9}(q(w7h(fHY2`r5Z7JP9`9-e$)$FXx*@G@kjf*wA@Mr}={$V9(I448 zg1D|HNV$5`rcaP+4-V4cg~V7Hq@`{$mf_C&ARXNhqzW5@^bcxm4pREoAobiC zq_zji<8+Y5oTEKFt_G>ay&!dk?S7DQ9tEiro}t*|AT7kA7eV@j@2`SncoU?@X#X)t zdvG4rKT(6PLHhN3kUHSXk08xbuok!mYaI%?1?v!QTY?qr9jwm2!Fqt`z+lyj4AzL) zV8s^>)|%8{b*~q!G982UxM#3TtAbVkV6gr<6Rh#)f)#ZkSb>*uU`5VgYrJjMfS2ygX?jM7MoHc&!$qOBm)1(KMtc zkq4d?3Q?QFAsSvZMAxvXM2K3JBvwX;apUR zTAv8ve0hlKpJe_xkEBx}e2zper$f{NeXtCF;S0*22~lmFN9VI4+IcR7zsc0}e2D7c z2<#U^^xH*h2is-piY2gJVcyq6v>3JjB~QFSg_|Kdjl1x=&AxXU2$RBz3%`gkg<>Kee!Q`6)yT}}<-8vQU$OQ#N)SCSlXH6x6_17Uia878kRw&5|3XNT$UQenzh zI!taA!qf;SQKDj)mf%0sti(LgwP~34_Xtz>->7vjV)hAB)j`zl5Bd%d)0EL+YCbkh zWv4LCblR*8(_#!=9meNuVM_mp@m?^8&~SZi5U$z{!{ulku3xbZ1)GFxHnzdLX}H?q zBMLSPS54eO(dOZL+Bsa|UBWe}E8Dw;D|2YL`rz+j#2OKI5s zS>f6_KU{=5c?2$m^|zmzT)nXgK3BqZ6SJ>}>k10r2$$#0aGie?F3aO^wSGd5 zPs6qKMYuj-`Acen6|cg1trwx!sN5z(VQnL{d0>QIq0-<8MGuM4-r*7Y54A={C}C8D z8cdGROjMo{p@z7J%xMvNj`Fi3`1=u|VJjo_1C~`0DzqU&B{$L*>tWv%p=wxy)A$UJ zzao^5!5EJ!nl(l0VDOqU|$ ze>p-;uSBRbDqW3G6Z~{7LQinvAL3t+P=5sc8=)Quz7e5SxPq=XBUJQOgigZaHgWDm z=mEZ9+T94Q$BEG2DDofMFh-F&ig4FRc^V?+%p0k;IO-p%_xU5$yI`cYqHSQL`oJY9 zQVoM6H9aI!UTKla!TfZ#m5k*2@JQW8dQPOwr6TpTT%@AQN9sDBp-Y8Gov9e9MU^5| zsA{C9qDtLJ&c#IPLA^*#s2{0aE$G`aQWfCQDpH2lk-Tn?)WY_W%I**;d&fx4M*m)s ziu*lMBhYL>r1B1mR42?F9I1DsB6V|Zq{?lK)OOU^6shmWBl(OvQZMlX3r|Msm$Q-D zhI$v74=P@YRDI}jqflrEz3e^Hu%@Gm_6 z9;FmT>pa|DqBRhwvC%bJcM)iaR!t1UDfqiZt1jl_CVbqZm5EMRgsU)lM5_e4U@YG9wv`>vuKN!+t^lN&I;!4J7SH&28!J0}j+KsN2V`Qrrql)+e@A@&Cj5iG!w_yzL zuVXY3uUg0Oo;pU2rp0JFK1`3%f*CP7yER5rcE#u-hVG8hR0QmaQSZIvvM)yaPsT{6 zVzdzl(DQVR$~>Vj?mUfA(PuGQ_aa6GU&bgF!CzwJ^OeW==|_w@BE%(Dzap1wtU?iJ zh*i8jR$cH1{zjNjtdg)EgMDLl4Y9dm)d^d11r>6~Y8*=Y#cCmr;w_XXR>jc|Bk>&- z^2X{1D)`5$4o2jQ)xRho9;;f|k82UJdV)HUv1*C)QL*xkjnx~piDL|`!znb5kJW1I zKvqJmnkL5TItn>rIp-X!Pp~>;m5eeNi(7bsO-YPbC{`s4$7(k`i^QrMR^b9_6^+#_ z3@IKfzvNi8O^MZCXr3CY)HGtDLVB!j!d5a?UGW*sGpHA4Wyb1TR;<#q$*oi@&x=^q zFBhxlcwd1URg6_mUFwWiXk0H==WrK=>&L1hnlzxsc-EGBw2M`Cr&tX{;m-8MaYS~F zRqk%gePFC+&-t}2h`%!u?`}f7F(f(MqKN_o*Xm~7E9gzPxwLZ=58P)>-V*J@ywYW^}QR@ophvz7N zHCFAeacq5~zVQ4(&GE%Gj@R6AdWNqUm31IF-g{ct*x)ES^Qh>ED<*mD(4l-*J6^oK_r& z)1jkrG8`iw4x{4nI4wUBr@bfRzF z|3};}ahywtQ%!9A7N=p~$-@}0EF3b$tDjfA{;O3M|0VCrzaAv%Az<+kU zF5%zh@mjtjUU!kPDqhb}ad*5%AZ<^)D&Ybg`{H#SBTvNZ82X-M9`HRCua2kV_0t*p z{S&W0arZiPxIrFwsR45C$E)OncrAMoug%}$^$L}K#PfMsynI{|)DH1(3F_#Rpw;-* zH$k0{J6D26;33ZDNsujXg7)DYy89>SDaPeX(C458bq=Oabb`LX6qBH+dI=hWl!gf! zi%v}wbQ!N&B`BwLfD_m~Br0Ev7bF;RaasbQkjCs8%g6t=#Js@#vb{S!5EV4@lfN>qD9 z4Nla)3FJR9Q47&xQlbV;OH}pgiE4(tGZIyIR-$?@O4JxkS)Hh!YZLVc9P1LbYJH+& zHYBR;rbHdypQv$%5;YrT50fAA97)s@tUsBkv6m7Rax+m!Zu9sxkKZL~7RtO&)HIyI z+K-8v?&6TUt3#<+V{oXXyF*8D2?IPFx@UCg4ctr)wMI=(hn83z^0zt^jO0#yE_PbsTzB&!N!`92(n*F@AL@5B9;gu|wrBuNnEZb7&&wp+bA= z(t){ja`69}L$muic<;@aXg`J;j%5tg97m4R9enQUP<0q*I`nytLnr1s^bf|&bLhiD z>b=OJztMNGL!nC@dJp$y4z4$$25TI$Y;-952>tLLEsilKJh@0Mt~m4^%l~$$;Z=u@ z-=My?9m@T|p*HvpAs-!T^2wo#pB;Mn)uC74sS%d_U=DIBmy1)i-JNQZ$En77oqV6h z$@w5B-=%SCT|TF7{^V3jpi|>92jzmC8WHT|yN^z;-E?xk#;JLz5b4w~)QEGcP@+>A zc#75zr)E2ys$9sa!Nr_P8ame}ox-NC7Z&Wwd`U7VWP&B^buIMt?ylk2#s2|6HOFXq|XDc`=t89*F-!?J-+ zMGvOm5T~9EbE?sBr`jR!2iYm!re zQ<%>*w$E_t>nx|v&vt709H$1%Wv=tszrv~ZE1jCM%Bgp&ozhyT+OBiz(t6r%AofP5 zs{F;i%})Kf)2SP~oqV5{y6<=D=L1f4KFInUV$F^?_0w_I@B}eWvA$=ViaPI9rHj<+ z5_7o1oc?CM*PM#LIpqA~RL|>9eg4;}*SDP7{?IA=Bd3~S4o=}3vLEvptMKy^r@G)Y z(w;hX8Sk;;nNyDE*f0N;Adw|PJmq%{1EkzJBB57}LrLyshV z?VY4veUdco_at>5K>e^5m+{lUB*hP=*64=#A=GJVl3v1fT9TTg6HcS#bn>4;Jb2Gc z(r>epv>yJmle7q1FknLw)qhc3^Y8%qUKUp+497|MzACN?7=j&mjhNTP)eN(60bXy4 zD+ArJ3QrO7wzwK#GETwpuDD8|GnU{s{NEQ>bvTQcP)dmss*_ei4Vsitfg>gKHa=NV z3CVo#FIh8j13`(&YK%F!hCGgBwZ%@@oXM(>wQxyFRuv4wWfU%#%x``qE4+NNieLx) zD<;M3 zUYe|~%aS#BYck)XBK~&lVE)IGRp3Oj&fq4RpG?;NQ_1RcCRzQSFeh|)n#^ar$#Q!} zot`IiUOQP|Eh#E$P0>VKigtOYsH}gA2H|GD6n+mQMN^$AI){WpDSC@A$3@a&_X=APySTBo5x<=i1~|Crzey zX*vt9_GxO_Ax#B3rpehUO&t-^IZa8}3cs%8gegPPbP+@UNYhkg|Cy$%lV~?JO)fLp zHaAUs=BMc!)-6cWUX)&##=O$)71iVqSEypXQR_~3oT;O^(r=9qaEqmk;HAG zbj?QD!s&7*r)x1Trl#v2-oY&`UAYm4!pK2&G($HG!6YogCcMU8f2NU5S$zt7=Kjwqz)DT!yxd&rp?#8C+wPp*~YG z;#hRo!% zj7&KPWhx!FhthXgrq1IImJiR=7Bn7}sa-gZr(-fzdu*oqPRrC2gwM*oY9VLV0^_bk5OpQZU&gKtRj$Wl41M}{#=bKx*$sXn@5IxgqW(uDxp70gmcSOT*Y zh)Vw#l%?m`6OpC+_&G95AEL6sSa0+E&vUCw|QP9D5{J?D|aSCPedsbQMk2S>^ z2Zc*yDJ~^T)o`&Sd1a6nPT+86mR_P;R+j!oOm>!PV_y#Q#kf*g>QFjMVP&)AL|XMM zHO1Z9Sqh!V+|Xzy`C-_?EKNq>dd5TDtywCuEld1(p{%%hB1`|CqR;6p)x>HPJd>pr z=dyGb?ayav05<&J1@gT}+<%!LzQcYaOUeItll8!vTUmOK0=Ki2j-PP@MecA5*So~I zpQWpKjhqKr8jDwtv*i1fIbq?mEG0b8(q`Pky4P%flcmaN{El@-uJ>6Q^eIcr;Psh# zLl%^+%R|!&MlRErUz879!e^twVT;f4s7_&zh|Z7#2pG z@N9L)M4Z7p%!$b6ygc_KvsEXG{aA#3_yNC|Y^C6Lj6%`4Y;A)hK3kR0JRw^nkvlP4 zk*NBAj%>Zg#-wbGE0nFxa808P(*G|#TQ}gInXNdyE1Rv!)w4CDMz;1Mwq~}{(DMIk zW%C+8Tf6IJ>mCw*%~o|h#G0nr`WqRovNfSYwzlF#mu$U(SJ!NXAQ`9d5&!kfR!}eU z!x(JB=l;YPl&$Z`9Km=fJ0_do5XjcddD&WqkMRF1TNMvxs|y~T%$DsGxtu2#T*OP{ zyMT+-2lmU<3Jb6aH~#NRw)+2_t;<)l^%bRVWUDO(Vbk4gUBk17+46mqtq#w#H3`4G z%2q%8`aWBKBIOe`N60tw#81jmDa4v`R241FIr{cfjzSCMs7+vwCZTd%j=CW&k^Q)t zlq1hVIciuWN5e3wL=N9s$&p7|jvRQHkt3hX933u`qgTjZB}W;UhW&V7HAg>H%TZU% zMu{3ZYJ@Gg4WHUMDuz3Cb7ZNPqxp?;bOhs?!eX3($1HNd?KwFz&&|>BMLAjv<6`o}l%+Y^iIyvJG#+!;<>(Ls*5{}U zj%>`)@xQ3&og5{i^n)C=!#j99q@MrxC`V^;`Du>)p5^dac8(gLI~HRX>>r7XQlD~E z=yQ%PA^AV%iWNU{{6$o z6a|rvbWj8YWIpl0+IiHiwB=3{weUj{9GszpD zW)<HkX zp-*LN_>`x%PqlHUzE33@`1Gae(`C!2PJW+!aXxj$q*gw?7V>FA*r!rapXRmkDe$RJ zncMkP6$?81RHlnhE4upBu)B}@gMHfbl~1?PzK>6RG3#G_eQMOtr=$ISYC6EDA8-=o z1~QLhxP)bce7cL@2NUOOpH864FrTuF@abYAc_mXDY{6li$H`Qm%Fp&`(LCDW*ZDrh zZD!jzhmBk4?>3*_*uiILv(u-PBR-|0$Wfo_ANQ#(Zl3n3z!{$^;^bN8@xeuEjR}{C zi~N_VcyfZ_q zF`%!ZXZ;L)Il$m~14Fe38j8gsR2XDv2==4XU_%G+2swrr+VQQSlPEIG(0dqx)2KPz zQ1=mrmg4X447DC*=o@T6|L>WOG4vE`#v1C8WGEdsQF@}G&#)C^CKubI3Bq zP)RtLi7mK*mQxM==O=?}Fw_(Wuw;gz*HaAboJoCB4aRq2*(}zbZK(cymgCI@hF+rm zB7=LP4AsS}rPOj6pDi~u0ZA)Zccq~!s|_9b)zHTEhAts(GxbHLErv?q12n;(+liIN zJdWdhI(hG4`$)y!f9>SB*kx$n9z%DLV=uME=lcxx#?bwSE~Du|L$@*PcSDPC3(xW3 zu%XRI=+80MKW=CmUZB7UL-qc3($E<+Iz>#BIzv0OJ;(Y;`PX?vA79{eBwwaKC~$>+ zfGU5G`=4z4s-e8ss4M=#sq2Qy-7wVgZ$nSe;g-QY(gxS9=+7O4F(nM$K&|_RnxW4F z@83i+qo%CEk8wC?1_L45?`M)X+%meoj7FO*KIaG|Fb`WiC^8IaAHi6H_ag zYFp7%zDlOHzH90r230myri!V$Rau6W@0r>Sx07 z=w&kIH@-5p6Cd|6HEOu2y(3M1muT|6tEm}NOikQkYV$Vo-)?H&9#cOaBgf;!JZY-z z8ESskRGtg;AKzVKpW(otrUvJfv{bRZrR&`-J;dxDmWuSW6zOg0?XN67>TfCY088FLOHT$_YB$(Y z^RF%a`HiJ}82zoK(|Bi?r7v*_n}=J_lj!rQ;|#%2EoJB1@vB z*Wrw{xbA52{JNzy9K!cMSjscSQVEPg;h*Rq+DxOrC_3HZcNcw|L0fcBrf(^OOgsnbr*veee)?}0`Wos>3m$sGTOQC`WOJ?G=Gwk3tG2CA>)1-eni!kE?diW|t1I@SvTbWD{)XeXwFJ4E*!mI& zu)L|QY7V)3wpzy8x`!rlwn9N$ClM2G^S7d{0tvPPxP$r4ZGF_j=6V6!ZAr{lv}tXt zO2}63u&qJ3i9J!`p;#OGkGN0B867{hRkp3I`$%tRbM4BOhb~COavZ^3_GX?*pE1b%AeaxM%9kCHlceb>VW)TkP|X>W_wupr7gFMt*O|8<6Ui)>c+moab)OW zt0|_UdQV#=d)ZozjJ<6YfgdN(c(APr7&gS#MHKj!Tv2^EH6LZ`5$29&zkE-fa2@ZC zvDFQy@J%A?VEI_;G|tv6oP~a1iW^ur-qzM6j*W>ne@{`nN!0E~TRTyEGW%}|wVKND zI-UL{+l&iAT~IoOV|u2oq*PmZXW43iCYZXA`9&PZII@^rm$L7$XPK=YKXW`Tr$0FQ zi>=RB*gA$@E7>=zso5INjbEw#I$K58+Zwr%er;lV==Ph<_yOdLqqvH=&E&A1ywhy; zOSd%wgLc@ew2N~K^LDeZ_OKnC+iNT9K3m@-^L|_Fk8sZ7wPWnt6XbTvR*loP&YZFJ z&N+@Xyu{k`oF^AJhA+|Q%N$2YzGCa}AGYdUwe{mQ&Y|nJULo->j+dL{gIaeuULJB> zBiAEhq48sm=_l0Y8Rr^0KIh!ZwC;9;a8!z{Hjsb zug7TrwqF_F@he*1uU7B*^&Ji(t(spaP^>y_@H1{9-v@qmK<*lT8Ms&5uX=U-s`?Sj z;jiacnfk=X7Z`?zDAvHQa_EUw4gI={S7_PDuf6a$_UkviAH%j$)nHw$#WOTA{Thh_ z$Y>ECpJOhrp|njbB;j`y^3xwAVmn^oqb7cJ$1+?-(WZVi!7%K=Gt_q2F4p2DK63qx zgXz~w+(bo>njsmd@OrFY9>!n?G6ejpiyoMdvnUYfR}2PXHU37KpkK|Ah;6u!%JIa; z3>-$b1i$K|2j<{BN;LDU8O9yh~;HcbZj{XPN(e-mj`#L&&ujpuVS4W+CI!Ybj=sYG2 zbTkVU200o&*iqsTM<<3ms-Ng6|5!)uv16R0%s)6V>Chp3FKaj>794O@q7MQ3O}eaHFI0n;iYK%TeXsP}-<@5Q*fguCeLb9on&tBt0s0*i9RVh7NT#euArm7@Fj20*X!~ z|4FXi`jKs~boCTVSGn4R#;aY;T;r|3jiMVsc)x1Ako(Xof44+(g)g2{oxVn1R)lc_b4SVRyeavT1=;u?~J##hvxy#s^ zuJ*rjxqrsfjEtTZWb!m7v!||EJO#6Rs*~GO`8=MM<@K~KpQrC$_mupWr${AFci#1M zrLw1ERXpvi>S=a0Pd~ozX>4^*f7S4GsHUg1TAnu4CT1N^CF***j;-~G)zH&_8hg4C zH-jj!n7d#cf6g;@dHZM_!tDdr4^SEEy(=NEzJuSZBsrg^@`0Mm?r2`akhB8u^}j`tq5lV$Ydoh}B|5GRCS4?jw*nRxgk*PpnGhja4&j zMUi~5YJ?p5V|5#K3di!!fmo%W*Vb5#KM<>1M`JZl0aeZrP#uJ^GgCnKurG5!g|h@S zID0@N3k7r)jfw;mS2UpUxQf!n0%}n_pxY=^BEYz60sa1FK@5K2G_1$Ep5;ICa<_r=jS&J5FyNiqj2@JRGN< zC*t$~b@K()p+Hb&gSxnpwLEXZkjY0L?6x0Yj z!=T@S>b)hXf?I=nZ+lR4)5&QE>mu*2pt9@^s^XrY8tx6M&e5O>p9rcFR-6gy+p|GU zx)9VVEWXHgE(JCAK~U451m$}gRF`K#6?h($i>Vl!C0?no#p@D&$rZ0J+QsW2p5pj| zc#T`c6n7TKtJ9KrZA8)K@d~bp*QYDvRcmd$)?n}Uc-2pfR~YBg<5hDNOL-bl-@a{q1{5d*E^*4{X#l`uLguP5(@{0G-60dlfDk|JV{9JCo;vfA3`cK zKBQU`Lz*!uq?joo?x_xG$+VFEm>$ygHN;sP(!q5htzREf&P^dTMB?UrN#3yj$ro1s{9(>jmc0|!313)0 z8DULu!aCMBtPh5SmGA4Y{1`GdtTQvhDxMtHew;;8N?4UT`&X^B6og ztlW#3$F-GV)ms&ojX&{hby!u`gf$f7a2kczhUH=wvabuP5d0g%nuiu!!n%()4~BIB zH_nFnt}d*Y2gE>)hx8HGk@zI6i+K7ptTxZW>Y6E{rD&5mqHZXdC89G~BPyOPqWw6F zr0fw@&k@mPB;?|A+%FMP;EjkPIDnibBWjFTOvef2D-}^mM9V~Utb9c8SBPlQyAj1z ziST@BL>(JPR3{M8`8d`IMpUyEZJ}sHqcE&rL?@BnKf-u|5v{=v3>+9yi9r#yM6SUR zy@6AxFg&6TC^jOZir9}VBP03*qejyg)K83P0IH6Sr~z`1i!knbME$URLPY+g2={YG zbQ;@}Bg&8x(JG{&|ICQSrAFA75gndI|7Noej^L*`5j9&9(L|U_BWjL!mPM3xRYV{D z8euGQ>a{DP&X|iHH(9SlRJGrV>TuntD%Fef|NN*z?V|dueN=OhFfyuz*of!IF)FJ1 z7>y~&Iy$NsX!3njy>S$k5~I5ILsa9(M^$S=RELtHsxUFid)%VBg%*=o4|RWxGM;=? zi*O8=P1b?#aHcPw!{oHJoOx zgpy4D?_c`5wA|BbEzB@|%$DSSyO!R)@O{O_ONz#=?(j~=^g_wS8veIkrvEnh|LOk% D;dXtR literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/3e552927c58d6b47_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/3e552927c58d6b47_0 new file mode 100644 index 0000000000000000000000000000000000000000..7514f15140fb7467d6c6f8c22440ad15a972ef3d GIT binary patch literal 35316 zcmWjL1$dKZ7sm0sN!nPGrVYj0w5fZFySt7J*WvE&?heD<-5KugunmXd4A`2HW) z^}Cw9?<41&=ShjYsjq&Q71`Q<{pK&J7)lk$wv-<#QM^o^e5J~i@umAp<}Hz4ykzkl zxpS7tovU=o;(2oBELo~}o|3t8rI*Z?FMsjUxl80MlP7ncyv0l9@#V@{JZH%=IZGND z<6MToS^ppF|NnB{^!NM!&%s!RCS{~ccvx1-S5BG)m6seij)E1W`iQS6g;$c&aS*q# zqO!EKigXygtJ0^2^cBNuN`E7JZK)&v=_=*uCVj%r2~w6tQY@;XJ2v759;3!$V#5XW z-Y50BCV7haX*2fY9vT(*(UGagkDmMKJ=(wU(|Xi->8EM0{IvbG zpN^o|8$VV4>Zh+JgPQsq^hbz6Tipg7#M2B09SJokduD?+V{aCN>Si_QXf}hA!VKzx ziynhoMi{iegh79zbV-Abmp150IfE>f4Qf=ypmxYn-Jqg407ngjT4NEq)np8Gt7p(} zO%3YW%%Jz33`*#1&=|}>xh@6`#HX&@?q*Qd?gqu-TMvU8_o8oagXUl_!ut>#Ed32? zh~M#c0P_wsDEAB z3|jospr!wk%R7VaBj!D|`DjoON?*+H4XDK8&x%nQ7@4{t5MzX8DZIsYKVE*jiK3%8XacTfN-Pk zpn=Dz3$R8Sb>3^#74V$@T7#MGw5(Ttp18r7tgQ4?AlbqN3B zQCp+T?Ti`-X9uHVP!5;Sx|31II~$d~JL`z+J&bzM)2K1MSd-qYe_x~e_BZOMfkyp3 znE8gVUxx9&%y6T6q2oxST8%d9F}!1pIx^9yT$9)@|Mwd?Ak#GFz|-m6o?%q`IYvF1 zYgE>GMm58^`HZp1sJNv@jLv#r|(UpN<1PC^h1`%>=jIS!d`pIT+gWuKBCnNqw>8ps{bn< z16YgZ?~R)Dfi?eVl<|{M3oIs0u$olLX3{b&x0|#&&?KwFq=!zEdb&*7i2T7OWeG7U z8JV*36FYGXQZ2Q@y>Wxe~(%7W+O-worTT_#s z!><{6U=cDlH)$p&wKQo7(ps5Rp^Zrg+A&vq`gAZUv7<>5oyfbhN%gy!)UYo(^fRg8 z0F$bs^dOV23^i%xFq5t$%Lrl^Y0@=Z7{wf8Oo|+5(&8E9Jd6DB0qL_%nv0Wg&oODs zT$7qCWNfrqWYT<0U2Ia`B_?&nJ`7l9(tZRiH_5n?IoC1=c5gQ68%}Sb{@YAidf23P zN6GV|N%^i)!)qqR-!!SmZQ_4n(s{eTas~P;!09hHN@Viaz|8(Ski}mkv->M3%wMa~ zA>3cva2i=X{(6qx5&qf{>9683{;Gl*vHr>u=dbGMoaC>GsGRJt+iCuKflKNBGUf8u z;({pYuaZ^#^}2??4%YM6ux9?s(}rVhX^)@U`D;N3e|_lWuawUIYK`Mv{B@_hzs~pe z*G=T=Vg&hyuh1^!xz z+X!1o%&5KCUkOY6wQiHYM(^kTDS!R-hrinVWky(eA8cV zQ1@?Yj~}=EHUBniaK~S(9{Q`%D}Uwv&tKydpfTnEZEy!@5BxF&C=NT|4h_)mjL00I z_Spi|FFZh_u@znqw{ZkxBLg%Ohmq!`9kwGlIzav71JpJlK)rAY_i!#TKsRtADL}7K zI5|L7u?~JI0XmImD4!aj4;Y*lpiNlo3(y@L%Nd}?xdZeC$MOW|V?M^uAE3Gg0u)m) zK=q0cQ^f$as?0d3S1mw)4kotI0cwNtV~7i`vGm84i2>?6iI`RdDDTPurLGE4#OeS| z*$|)(TbSqf0F~SkApbo9NS{`QB zQjb}GVNQfubs}jSW!5oV#KUN_{>6(J`o(fC&aCw~7jM>0d`mFPmS|RsB(u6@%woTr2@CHw4z!5mCV|P!+4Aq zmCagR#jFn~@sn9^P^p?(t5EW1a={vW#P(mzDp#GKSXtAoWwp%m)Hkag9-u%2v&v!` zo})@b=E40&X65|Vto)75s?o%(Cb)%CO{oXI!PU&H^yX$2fwQGqzahP?S*CVoJ;NvT z>0sssm|3F`(#fnLU8pybx|;P8_qq{V53^!=nw6z5^Wac_>M_u)ltE@y8*ElXY#u`Y zq1?tgxQCf_V1!x5k!EEaWmei4v)ZB;KH>CO>M@S>m}FLm$?Tb_)PEZHu>!B*o?%u5 z&f?N+v#QS_uDND@f3R2PnYDF+SwRcUnzz)fxaHIlj+JIrTw~Uft<--Tb=+>&M6AR; zjNf6FVW(M{aRKx9o7MQBSv~OUA+ru1q2|ZT>We+-d7QO7!FuArDfTb!;d*DxM@E2=*(X73fsryyhAnh7!g5R<826ep2-nqq|MCRM9AsV0;Hedv+IA-}Q8klZT)*Kd%!-z zV2fVj8&(gosQ6HePT>mPq5Cjm8g5ZK7UL~ijIii5dX8ise8RL*7PTI2Q4cuBP*04< z!3h>EnaF%Ni-wb^GycTClc~`Z#z2Ot7VX6;Ji_MRXgkfK4!DhB(}{7WMT2KqGy!Xn zJlmqHc#Jx8xIdRzPK~ucN>@Do&t&F{$9CliicNgmi<8F&eoubyKSsz?M zk2B1Vov447y5lP*owF$E59<7nYBE0N;5ItcqRzFgno@^3>oO;{ zp?*E9EcLC*jMI%7w~1BLTUfOO2T-l0RShwr4Y{=?w|3-)9__8VjQhym!K!>6ttySD z$luATi2l@gfK_8rV4zjbL5zp9c#3|5tul|cYB_R`wQ4`+jkD@6OdW64-icOCo5{Li zKYp2IRkJx(^_^?gTg;zl)p`t=&pIw3&c#+8LHq60V;8yYwrbfP)?hEO?qk1TAvW%3 zYbN4Np_YGwjFf?61GAyyi6o=~T!RtcYS5 z^Y`rEkL*7LeX^ zDU>X2Q%wxQR2;@-n9JCd6=7vV=MEMbk7+LX53ro1a``gJ9Ftg@-kYMUyp zq4w)+nzY5HdD#CuYlp7eZ2E?Poy4}wrcQfp@*c41XEZ|jgEr+jY*WN>o9^Q^YM!8u zCuxiR2s_0*sBqe*-e+uje%7YXsC$n3p0{c11!{58riPbnYKyz*cA0kgbj7Bp*KFE* z$EMiF!~^#e>WCfqf)Y<{nvClh_S~jAZ*A)EFSp-O%lC{2_XnGohTBybZ}0=7MlkPayKW$9j9o3U3eVvi%N#h37US&N zfsPaGnlXt!uuQgVFHR$Ps$DQd^ur&E=CqkVpp}N?BQp29YyZvjE7<`?E2}YU59Y$6>Igzt~vkO^$sQ9(FZ@jw`;)% zyI!HxNA6=6e4p4u&}Y^VZEy||UwF*m05X5IEBiO*!F(+FkH;Ne;0vO^Q!f~QP;=bE z1_kP{AyAKufhuGQR5$$QAE;l=fohK>!GX$9YDf{K=s2(#BB^zn@xebf~H#n)nz;5?4V}ofxl66XP^%4 zq1JoJXJ4QS?x!vXsP#e49}3i@!;E<(Pyt5+bsbwy1S;)hpw8l_Q^a(ddZNggKt-Gl zRB!Y~X{rydsq^$tt^2$b*7Kpnx(zli5zpmtwkO)dv&J(k`K)TX}!Rq0ls*5JwQ zK;62-THX&-qX*>oEKoDC31Ci=VJ}W2@2fx!#zbU%9jF%QhR4YN zCQxN@99iB{C(OZXd`G)~1GNh$P~u&nCSw7zybn|pbi!pMePAps!v~l?Qdb_)CYho&OX;m{hV zL*YRVUB*$DLy5r-&4nw(p(7X^M*nb!0z3|t#!h^|z6gh^L^{+M9lQ?xgDO!DUBE-c zM>|v(!!RYrp&hu7qOlG|#1T6dqD#C(#S5NOx#y z4u{(3a_9>xhnnQ0eSU`y6mTf1phIIZt&l^(g&lfZ#36f8hc3ZX%%R%IQ=GBT zxr9TT@ENJ49D0x4r5);7#-V4(RF<4zEXTa~54Q3Sr(A z8Ygg|8ta13aQ?zL)g3BU!=cI;j}z!rllsX>;OhNp9GO46T_9Z`wH&+uor+P^g1L<*^jk zI+A}U)~+)-cOn0-tlby~&s7|nh|dTZOPn|ijbj}#4Oft5Jm+u%aTACUcTs2}aUts@ zhrXfIWQS&B1+q+`emF6my3BB>9!xVG+5*EYhYHSSk0X6PW24#vho<8W@-Ad7jKhLO z9uhlbz; zf;O>-@atxW@^7KeTOB(6J27o1W|((UcXZxGU3U}19%{Xp*!MZq;sEP^n8(El;>VIx z4%Ix%-og5Fti>gVB2fW;mx%{^aQ+JIuJYKq$((-^H_F^{@cybpF_?`%a0_eiP+z=6 zuDk3RTtMYV)C79WJWrShe$N~#jJz+H>m{{##U6R>Q0_Ml4S2`zm-pZ_z>eM5&usanR=+y8Kr^aV+YGSBU z12Q^wFOyR}GCMU3f1_X)r0q70KaLshmz-#r|AQ70*qKc^D(FQ<=~TZSy&`20QQonF=rt z8WwbFE*=zi>PQi%UbJ-TE1I@(s(o9h8ntsOu)R~&F$G6DICZ!ybE9>4r;ejmPp9m? z$g?-|_aU#oP7UtwlxHA04Wb`DW5Qsk5{FX5;ZF4$;nXjqmmx$q#>j0;j+{UGH+rfxxs z#t>}9L3p~;22By(BS=ZOgpoai^c$M?3epO6?j587i0Bif6bys0Z;)I_?-!&N=!!1= zgR~KQ(Q!bK`l04P#({A#?a=`ZhXrZkh#-AHosmI$Jt|1aql1(mv&IH#!-OEMnaJ@e zK{_`zNK2*%spX6y9h(`XRkMS%4Ta_e>G`}MWuG6U1hl|W1TSQ+r9r9$^RghNtqf8V z?7)FlK{^Zb8s=UXq$BHt)M;~&Ze!E-Ag$lQ`Q1T!urEku4+QD>;UHZ-5~OuUgY@Wh zkbeCmNDnVliyJ|zeK$yX9|x(%%OJgaN3NfOH15A3&GvI?1+E)iJV$oP;dCi0#s;}m z*5%S>e1s|3#WfZ#EklD4m!{xxHkaOGRD?@QP&Cq|xk&Z8GzK3rFUqBi(Jp0*acLad z#Jcobf=js)U5ZU(?mRAS$;gS#}K5&asw^t=gkH*?9`+@%jKTw31JrDrJC#-#)Jf&6XB z4I6PA@$Fn1hTC}8-X*^dE+uz%saH3bN_2NAqK8YBd%E;5HuQ4ozuqq89N^NB!7g1K z>e5}T9_~`&NPdnXhp{fT9_Nx_yh{%!xKv}JOHC#*&J^;R>Qcxwms-I+-K9D+T=LCw zsRg=X4N~XP4{tGIzDwzg$zwNl!ZZB5hkERFX%fyOX`f5^FdRkpbLhzL*^U9@TZ(N%Fp7lhZPqfE#bo}g6KiI#xc>U(m1C;sCrE{46 z!==yY7aFXcI0j3`U>(mCtP`1obqQy)2CH#+uv$k1t7BxaV!gq7iic6b+7lhDt1-b^ z8XK$)@xfY=6s!Zu!J3^TSo87*Yj3__706G!0>QdbFjyglgEhDab75&w<|-bn;U$6< zQ8HMg;4B@i^{|%-)~`5>GUb9br+ly?D-#P!Rt?rxe8bwGgB9~jux8;PUeyZL=(@qm z@oTWE4G7klvBCOzda#y1qHjcq_C$uLMnZ^Y_(HT4L()T(D`$xE<_b}%sv)X|&DBEm zrFw|!)ZiyN)(TO#Iw5LMH$>U$g~-)7M7NuS=wQ8+ioH3=@2~`6ryXR7-w>bT1*Sk%XJ}|w?0J2HiYOEo^K7&Z`(rj z7S(rzXbXaNhUgb;Me$uBx{oP)L)2_vh>Qn9G#6zKhG;BYN5}`4kajFYT`=W%2=6I| z=oC7g3DLi28RuMx4qpt>k;}w&B}4vRjK#yNX+ms%}-O=H}W+x7Jl>Y*en{R@u64U90C-;redv zY2a3BL$}W0Xd}0J{_0lV#%`rICFbUCokNQj#L&{M5v|->Ji@KSF>X!9dvu%R*1t0u zbCz56@h>#ntx}kb1;{$bt*z)hk2Sz26rIm~yvO;aZY^I=`;CmZlVdRMa;xDU)()>x zey>|=@Bq2?xitlO_q$aZ^A5OG@i6DH;)q*KkFiHE`lMSqPPx_Ot6K|^HB$zaK`-RY zoPp<(8B{Av2F>(W_(2VOQ8zB8LDSbLY3uds2V>D)l%%larj<^s$=ntn%pm=stwDiQe!e|)})L& z0_)_ATr-wYCzfSY;+>4Tgqr_m)atJp^%#3IW#am+Oq!b|ld{y!q}B~GDZEW4J?xN4 zBfDo(`+=FX?sz5{&t;PT_e`2$$gJMp%)AEAte>MYYcclc&#Ys`Gb>w}%xaIK%QN%d zYG!`tXI9-zS#%~o3y+5^dXguLhL_EvS#`3=((QrTm~J6QWyVE)RQ@?kby2VeW8)28Hw{yX z)?w=1Ax!zYhG`+LBeYwX;xHebx`(M+uP_b8WPC%5-o%WEK4IF3>V3m>3Zwdksm?&o zV-QZE@X#>j8WyIM;bAI(f6-t>m_DNIs4(@yF0>pSrf%4ZYh%Ln2s6fp>E^gFg-i_7 zSlq)aOrI2{_ft4NHH_v z(^n+T4%1yMn!`Gw&Rk+c=6M`L@{%x3TN=#g=ro(W8H1?!QH!I`gAW$8U7)bM`2tu z6s8?dY5y!te$T_?eMNuten;G>_MX^2Fz4qm-lq=J@$c-HALJPkuI9)Z87_BJxLRW` zQli6^5Ff5EU${EpGO|<-*ZC^pI`UJvj{XuZL-lawsloA@;p$yGTw5E3t4!l?T|;n_ za2048uDE95`ra~J+uMd~LHlqu>=3T}9m6%IQ@A3#gsVl@aGmWIE=Lc>K$BkKD%U$) zUvQvrxNh|e*K>Ru5U$Y!!(|y1F4M4Z*++&eZB#g)D}`&w1zQG&qQ5r5GHO`~O2_6kd^l%-wN1@3coy29#tLo7WO!`Djzkqh4t7vq!tp zx4K8hnjWra@F=C0N0VxMG`@~U|KabtoU89qC-^n+s1jy2^r*nE9>p~F$k4>29B7Mx zrXH<_yO~E7;B8Jn6lmem#g-n`Y30#&sI^B$@CJTuJX(hAZ9VFaDfom%?L685TYHa6 zVH)n>C8~BHKAcBDM~}u}Q74aXV@hZ0fHGY?+J{D6J!+5RxPrpct>__|l9<4#ofgbHemqGMF*P-M#jQS4uD9a>nW5jRNV!B6L z@DGm7WZYTAi?y?fAGPK%&s>i>&hsc}zDEy{vdE*z#hk-6SeJM-2(On>&*dI{!KgLF zxt4lu_NWG0VhR@EG8%7TOkBtJtsZ6k-J=c|f!J*xl}66(9#z~yTlCuL(JI_W&Rx_9 zr*?Z(d5=d;a0*xO1NruPG#nH6c{CRh`#tK9Kd|*6`5Yp?qaHoR&|@C`1@Cc>4&l@Z z#zF8&YK|6okJ6_Y=QL}M`)52Vdd{Po7d`S_^5_JvW84*wW});oa=y+!#U{+YLv9bK z-9PM&M;^68(o=GK#{S1x>__S69$f9x z6k(PKWw%Bs0oCjg+7uq4x(N}wSs+68ViDSdtED3J5V7SWw5mdcwjrfT1m8=fJ>J!d zkYDWxbwlC05vqWa4I@;uJ#%!5(4TnMB|;(H7zZVLL~uRvBW zWjjXdNv}v*)<&xSkx1P*AF0WIL@NHTNO>+r>K^)Cj?`teyF#0*k?Q+6QfpsC^8Zt$ zT78dHZi81P@F#vVdbI{O@Eti#UiF99->cFAUd5TcO0jtL5`C>+O-7*2s|xrJ4!c*I z5EtlGI~>Ln{NwQQHY#HUc_o*Z@3eV!H<)oyHN>mUpUtXFrCshn2@YkSolf7bEpT3zyhx2ae2n|t-61vP5VJRQAi zHNwm59FC3jYRD+^K-tk=RYyOJ7~_@ScygZNm34tvC9!a!m(LEoT8ps7UM*VURogY> zzK-$MdlkHanr&j?x)dGF762IdsDxCMKHvUBC z3tsK{!^?9W;{VgDIyes3U)1y>YX;|K))UL&yy8_hG(*dqUM)lIzljSkQSr7{=Wrjk zyIy6+O(fp)s`n%MJn?GEGwSo)t30n*yVtaN>(v2tdFNGw57Z04DoTU=qGUHjX(VbH zqcqDDr5xrcF2&|pV3dAxMClD`r$*^2Iu(!7C0NTw@!43E7GghCj&tabk>#WKepZxT zREXkxfKlr3OOys+ef22qL5G@AGS`aI5oE1Hy9QBQ`yZv-O{4e>JxY#tQLJs0@^^^R z-mb*ZBT5ahs%Mn8p;NCY{f@T1qjUj%`b23NHsc{;`bH@y<{`CTl-&KJGy^wLWdO0@ z3N{UjQne9LYBGhmW<_!BOq6!uGm6cL(otCEMkx`^aByCff)_+792plzsqCsKUB-!x zQ8H|bQlrgLsJrku5n07WwLFb~h0C&*mJpEDR0=Zy1p2PA-lyd*Yc`U_%i?qjQY`h$$dkDG0 zyy%6$vHE(H9-#QmC?(&b=4gYV_oB4@L6q)4j8f=h#zg#6;(ZatXYo;L{EA#(lPfZQ zV6M+mYWXEf-T#ZyNi_4<&M}JV5~CqqIo>Ts#Ye`dFRqSatT8cak9oL+ z5;J2o2svlPs3cAzc211K=Em?noES~Qjd?LDJ3mIFa2R_Q#po1zE{;*i(ipDekI|}? zF?xl#4KW(}dyMuX>-HFB+7Y8@l*8Fw3;!criw$F&JC%6j?9D@L6(<`d}-9 zuf*s!o+J8dj2>Kz(ZcI7s&|9=ZpP>ea@~rN^>&Q@d>o^|C#=a+YVs^biD-OgjT&xOW8;XvP)xY>QAyyqH#wzRNSXG=7t9@uNEmm_-WqPa{;sJ`!jMWQN zm>0|M;aFaq#OenE*TyR6X2#n>TWo@BYpj08a-73w1pFSWA{dIvsJbmy+wl$7?c7GT z9kJSaI#$ch#cDGW&&O&#E?$V`IbE#gqR2(&hUHSMGGC5W(<`y+jFhXfT7k;fV$}qb zknMV`o}$`~Sp9{nH)AybVSmS}2O@99YAvpy>uqXxCst<=aF=oK#p)k?#mxJ}gtG{H zK+KO~x$Znxjh@Ep@$*>SenCxMQlB@m>hd9$YjR_C6}i9AAC|AN%7@;Vpg5gCj3G`| zW1KP~rzuVb|2REF4Rf5*GsUSbPGpYL`>dSH7N^cg$sVUZ;c?o5ww^fkgD;%d%SX6{|Md^nXCE|1!MM}lVUOG;h(G!>PtbCjjD#Ym~ zo})`e#;X*krIq8f8DpvvZ?!nhz*1bVPP{eZ_#Q-@s@9F;^Pf2VQ;+-gOrbD`OwIAt0Vr%sqN zl<~&J>Gp;=mERJlU8u1&PTx<(ah+V8Uf~CpoQcyf7vi)N^)6ByRJs(W`q1S#^+5LP zR2P!;>=l|+>wSO3| zSNIRZ9>r__<9IE47O&e#c^Sc7&i;x!lV5dAVC2-;khl z*kVY~eRzxss)=q&YPghSe=i&^CxHm4x>Y%1Pw=y!U=kX3`K~eXo4~p zOHkM135qL`pj>EMIzg*Yzf6MK;Vr6`BmVN#suFeCo}huqu_HkxZ~`&A7-w&ShFwX} z(>n<&|0sdajT2Phae^u!=t+XYQ1fYmzF_q;>iQx;&k>P1QKQg1Ya-vtrhT?V)yYnKPa?l_5_L5qQS~Ad z)d?1FqC!yxOYs+q#U!diY$C5+6BU>m{lZejuoRqNd?(19ECeysZ*7 z6|Y+-@?K-2HsdlH%}mrRe3+G}#j_K&0nu|3H50!tPt=7SiCnjvsOftXbrB=?C29u3 z_EVz+(Uu9Q%VB{6$dY4qTn$mDaDnf zE*Orhhz?Ft4s62EkR)A4k~>MAume|6F+-9jp-gC!mf!^bg)$~7ANpe~zN2EMB>h0e z%t@+)F4uRH!gxqGFLG-G;MhlDgtEnir#fm|Hwa|CLBmk&?t& zI*H#2NvdByNiXoeA~ma&q*8UMJ6@x4y(ImC`^Z&4NtMu~0X2ucA^9{)(u&4O@@tYL zTiYZ(N1b*_D%mMXgORH< z+Mh_$8ZinTe%&-1Jw{>J1BNosMKwL+~ctUF$y!nGu|yUw2ck9C0c2Wx}V z_-aVzwP&)P;~R#Ul6BiZneUM&YYlRlljX7|s|x&V$$Wn`Su^m?o~)CB$?6x9tZi^- zNY(}XjnD7PvUcG(-r=|CWLaX9RR*77jZ4-v`h+&allhxu z$*M3qSx?3$YwUz%KDSKP)k(=}Ha%I{7bL6KqGZJ{PFCrI$r^~8hZy^CvbN(9j-E)C z@g#M^F;qI0tW~Fzb>K|0&LQD!vL51}i}bsctjNpByywOE@ZBb6oWzAY$@+1Z^}3g= z>GzZM^Mho*E5La~K1x8<(PHc~i6lM^QFkih3fv5aS}KaEd%w21C&l{+~(Fi;5|VtCXT)m5HxP zimGBl;}o62z$Pi0h|s1f>e4JlyPBtP?PQA9!8Ra8`*8;5fhk&n>!VVXVRVW*k4aJ3 z*c2sV@SGIwM&@}bx`cbkHa|tbElN?Q#VH!Hoa30VGDUx{O3|v-DY}nhYpDZ1BiFhV zEyV8aDLm((9ykT}&J;Dq`&}uTxtlomq^KJ6Hih0 z5cNEsqOqq_bQ1l}P)mfIO;N{l#CbkN2^a#;Un%N@99J0kMv6w@{!P~I7VWX_KI?^2 z4^ve1AKGB$%M@+sF~M)jCz5 zP@_$%)HYSsQKl>7VO_6O4e3q)X{j2Hl-a3ji|{$AO2wZjH#b!ykbhpP$|Ki&VqBD} zq{XQ!jOqwknyT;1h3jwRN3#OY8x8eO;y~zR4sl&98ZbEk*0#qG?l}@ zDCSDzZ-b@jNpPB`W=zv-G|8N%`&rVIH*1}ZkqZmP16KSUzes{8`3l!zKv;GyD3eHo72>GYnqN7O4FpH zX_|*}$A}LZkEiJ=Hl0b+#7k-N-cHl;yWD@n{dZ}ai?Z+2G!y5s;bWR+`T68;@Tm~i z8+|J3@6!of!k_@39+-W43zNmC)~IRqX?dVenH@gG-~wDhJ`HjC)H~FtSs6KxYMFdm zhUm;by@~bduQ;FfCeSa@r!l#F`VX=Befk7T0iPlY`jm?4g?(yO#HU`EUDT(Q|5x0n zZ?Kl|X)E3!ytGeUFc67leCk=&$KN~gX?_L9uIkhIYChHe#is%_eA<9LXj#*z;c)T+gTR4Sbr|h&g`sDI*Rdq_I!sv9KBOwex8z7NTN%>e7K+I{A1`1_He7b=N3w`>qgnBRa=_>jy^C@bD zPw(Ns(#JL9)L^|&fm?hkd7OTDj}|A%2~RIliz_~T$EvG7HN582saw?du1^_0_|yhH z;r-}SlTSWf{Or@KZ$7>LPK~hg2RSHRZohQZ_D@%njOl8eDV^{8r}G|nI^Xk8*TyXA zx}7au1wHASjQJ=Zk*+b3>HLkGbiRL;&U?`5T8N5q=^BL^$?3|OmabxWhSt7x%}Y;L zm7M7snm1if3a6`YQN}NwuIqS&DP_|2p=`QL<HHlp zj>G+Px@zI%FX_5bgSl&x1B|t3Q#)M~>!j;k-E{42n68+X%!~J}(lxtHx?bZytZd8J z?HId5x>7qc7yj##t~uS(`MbO6YSSZ~?_y9BbU>Egwh)f2b5D)w8rs| zUIYXb=~AV)2|Z<)^xQy_naK=wl7Ipty{hyg(xi6;h9;;qkt%}HJBW0oH|a?4?frS{ zJ=glJkehqX*?XU4Ou6^mrIX@xVRD>GOeLS`Z2vw^uV%&R@a#DKoF1n^bI5frk1vi> zrzLTkx-?FYmc>cG#HquII34?yeOJ==syKz#@Yvco4ci!}bAQIMjuUm?8mGikzotoJ;j3j*Q|!U}bxaz7G4Up)qiF+^+TkCRu(LlZ`b_F#nA8tf@EE`N zi5KG=n)D3LfJyst4V!}|bqbmEU7|@>F)P`m{9%)#SdGjn#Da@(rJ7W&u}RyJt*J@= zX6%Dv&8Y+Ow;Ug-J!)Q>P9l&UYYxq;@jtTl@!qXOnJX zb{G2UW|9pj@m+V5=EB*79KJN^RUeaj_cdwyK$E%+qJH=V$5C{!Nmak0*64|6t`osG(P5NqP^@-oC+Sq_Xjm&z26RBo(Y+}~a7~5K#<^0?%&lhG5Mcwvhd2tJ~ zJD7DEV>>cF9G%R1hB}?ix`F3d)5WZOJsBGrdzqCV)A9IAvsQj(){gJY$~4-{?;~dI zM58fg{XEvJw&TpYywI%Ti_Gftqgg$EGHVcapz_aV&H2sDx(JN*J2ns_Hlf=_vvO=E zZ~TIcTgUcg*}Y zXx2$gziZa6hh}~K$gF~o%^HmoPt0oi%*=T!)bP1kQ(rMx87%4#Q$`C*VO!+NWKs9b z7QM=4QJvftP0C}@AMabV7pA-x{h8k)Um=Tz;Cx{V>pEJr2i=QWG!N6_EINd0H7$Aw z)w1YyeT$OJ7By+W82B&2qLp@wHsLk~dMrAE>mkNZWM53ibsS8xC`YnIZNnDUGN!*4 z7MU?E&7w%eqV|}8J28vOx3p+zD~s%(S`D7mdgP1{*C5qH0^XlZ+k z*5d-c=}4X^(%GVWc#TqB=o=4^p(oohx3@*7P`9r|1^QW38V1()C+`95H^QO@cz}!} zEgFG;N0Gy5i`p!)XbxU2CFf=2h%C!3vaGSF7Y?trX#Q^&{emM%-^|=>vv6FzMGbdY zlykR51NK<7`+!Bx!xl9L`YnvT7QNm$s@;8LRwdt!jb- z6|MTSl2skuRxL)vW91lls~#fJXH_18%e*Tto-I_)hE-eieck) ztH#W*>U;c&Ewin9iQ~k3+GyOWgdBNv8wl0tLARAD&s|~67Ue2E?G4aS1(&N z@rqUPcdY7%>i=2Q06S3no>dp{(Oauhz>110h}n3N!KOtSZK{;jrgkWr&8Euu6?t;l zSpLeUTX;XGO=t7k^tgac)jzUnbU~Zy6|%`$*`~p$RmCP3_M&_>o37#!R#vwuOAVXe z*0QOi&8EeO#M{&f50RK)(<|h(+w>Q*I&4~nQhu9a$luVW()bBk0>p)k$u?OrBWzPJ z#ikY*jE<@Fk4R(s$3rAGC68t{W$$Ry-^kg?rq4UuRIH0l6%j&QSDU(^bT^w!_zeYm zkOLl}aZj734z=khhJS0*G&qOZ^v`7WpJr2rnQWV5)24Ygy~c|9Hf@GyfsJG98DpVM zKQFcE8opmfjHt2PrZK4Q+9)vd7v~;6Qt^Ob`?81RvHZ|OBQ&W8R zko=yI$5Zln#{4~}CgtPR7CrDc(ksO44gRheuM22fDPH#~vkh&l#A_8^;Df61Duq6H zf)>@|HKs;9=hVdOPh5|SXPwJ=UHZws-W+kXydV=20Nzl}J397mv zL7R)))ue=7|CO|}2DzQ@>+D*FOBL+eR>`iPtJzhtj$Kt7+SLIcH?lLnUAM6`#V$vx zUFjIn+^(JI-NLSsXpm-C;nwtxoNeqXf{R$$(XOnW?8@Akws?#zT^I)?y4n>%-fni4 z#CDjw+j(ziSDQX|t;f>7c0RAz`Q6#BxFL4Mz#(l0!%F z5FgiIJKo}A9R1XEu#UMy1F*av;~-;whiajU#i3*zZ9r@Z#D;zF+sO%c(bM5jC8tA8 zvBgEs81Htdv&W&bK8NC9OL6EkTyE-6nMve_*i2%?hy@N!L5W`(56ypbsQ!9~xCn}J z=5Ag`~HP zi%fE=VkW0{;4V(*bZSd(r;cDmS*J36;#4Z zb)Cvzz{r%It6GTLa5_;=!+I)^NFr>ejOkHe|5PU7@AH6_KV?^B)HjLMCjvf=Z0 zn$Txcr_xZfg;Rgx3aYhqDh1cD{4=LcBB7mA6FWQg8}@Z~>H%{0aH=%SIDn^k@wHPW zdy@~wVl|!*ppPL=y@7oc zRDZO5?9?z=o-s!#{hByYR4%zuIlD_q`20PWUKe$#Ofi?*mvCt^f>m7V30rj@$9a=W zIcmBTt?kkXOs?-@%>(V_G3AvPj>DY?LNiG#lcBuzuqkgJO zF|5NyB>?LhHgUGierDwp=I zp`Mpqst(UpmpbARvRGg%#8w3)q9>+f zD{iB8Ww*wnNj0|y<9RK&%G7o%Pd&Hl;l9nSqVaBZ^15}|=T>{aTkd4Hx?oCkx86&0 zYhuK$k7I5vYUx(er*36#?N&AX)X~jn4!2fzam(J#%{gXn?fufNdua2OTVG@TJ72ry z=(+RjM7e(4$1z;O^8Ri;z~2MtXOLSbP<5zVS%$fFaSU;#QyXl?VVp-` zu3L*2(FPfQbn7=HZ(?km!^X|zyVb2?JK2VoyWEu zfioz0lzD*dxLcp$ALKkiT~E7}|BPD|aq=wpQS&16f{B-i0r@Ud_v>!O-)9c6=Yd;y zarUuWnVzs6_NQ*%JF^YNpEG~hl)>QE;e7)iDgGQRiEax()Ma8SV`CsKrQ+24e&Ie8=r*k6vKySdY3-@~G7` z^1?Y}neI_>1TYtyaRJR{c$DzHhwlqL+BKKl=6P5@lse7lu>~I4e)Oyh+>Kc#2=z}A_d9?9&k1nC{29Jhg`zC6IOq)F_ zikfJMtJ~;%JNI!M=XVhIPU68l?0aVy^Sj%_`K=y3K#qMLwMV=C9`(YI10G#Qqk|sZ z!_dDyT8z7Rg~x|I+H}ODfk(;l7;TPwG!w6p|Aa@@cTReA298toi;vIH7N4DCf6RI3 zyhjZ#upQ}_$qD(dcvJ#a|0VvbjDO9eayLEt;*Lkp(e|!~bHzM-uSyR0`S$}4YZrQS z6Ga|*R2Pl$)nj5ri6_K@78r}X&!{KLKKCdE9WfO1(E5c(Be3Tcab)$XA)3OG&8s)L zyfVsp)dW2-qk>nTRrD%vC9k$r_Ua(|SMjQJRj(}7cnqtmd$k9_8eYwc^J=rntLw;J z%d1~euC`Yx_^+;4)#`h-+vb%op1yGt#qC}dae2A^m{%YAysWS1WxWiqmN)WhBi04H zsv7dD1J>e)B(I{$UcDFgsuGrB53ZwCidQ{x0F_f22cKgUAg52e^Y}RD z-KWx@`1DH+pHkv|ifiEGHx-|}2|iuNEW1ysPM?aoeDXK-$=S@Oifw$l(aonPSkT?4 zf<1hS_VTIhmp(o1<5T9oKHWyBpHI*G`_y`XPfZ5-bak*#4^ikFpGM&{J{js$CtN~{ zZ++T?e8YTdh6Q*6`*5FzVi(dz_;ef}j`V2`mLba+pFTiftdH-^eXO76~Yw46!qC^XB*-!k%?OVg5}!U@ z>Qh&oS?<&R6+Zp6)~DXV$@8-4m0flWTn`|>H8tBD;L5v72o;1?L{05-}Y&@D$nh`SdGJ?f0qs0iV_$@#*a` z>U6=UH~9G?^MJaSs0VUh_Nfmppz0MKN11DQOCPJ^?Jl(kA1p^v?s)ko9OtIdgJ|PK6Sx9{QjIiUeG^cFNqn}SLBC1 z`1v(4zTtU@(r?-0n}XQ&Gfpo(E=EbbuSH?$PF z8XD?^zp$c_p&9{V4;gBfXy_ptCL2l%8#)PBioxeeL-|t;CE-4PY+}gV)Zlvw#%)HQ z&1uuZP}MX;xg&=9<2Lrj=nsWkl0TAL5i`E{)KHnv3_Ze*)&}2`8495@#$W}G-~sZr zHB<{tFbX?S{&VILhft-Rp>$OH!q6Y+)}A^bUk74BrjCqLu448TtD&Eu38f5Hcs380}0p|ci6ESq4p^M1>4Y9)XEj1r$=qVPCVqU(Z zPPl=}qYZV%DGVONK3Fl9I*l_lA7`QQ+~OwIPcXD)lELRJ>O6(oA$h8yU8pyW`I}Cy zX7GHSMSkf9YZg)$l$gVFdaj{K^9;Q|-%vanV#d$hU(E9uN0t!lGUg6@mmBK-3(vwZJuA@c!40}c{Dem}zN7w;Woo=*_x zDMPhS8#;5w&?o13-r)__o#!=kf#>rj^1sY;3h7r29sbvl^_ron*LgkNF!UBi? zOmvJAB)4D9@L3+eMt$U$y`W#; zVSZ7+3Y7Azb{W5(p-ox8GJfJ$th`@)D*9Eol3%-Vys}>jRs1@HlU4m{Ufr+ZIEd{v z{9GG@zVHj~B5zH<+9G#tzdU$Y&o66zzp9ye9Db``Yf;+9*ywc@l4a;#Eg&O(Q5JRyOFHtYRxLAibFbDly%fYWzxQ&V->WOrm!Uu_dg)kaBks--1 z3%cV+oJIa*zg*~tHMoP)VZWMS47TDCs-)02X5%ojrTS$|%ZDLYkB6w%%+K+Kel5Wblx=C1T|XtIsTBE;tEQq`4z!597e8) zUrv0DWw?qGQTo9o{Dlu=)TxbMMpwUzkK%s*fZ8?>=m#`u5upEo?!X@jNYQ|j#Vf*E}%)+iOk~zT8CW-ObBT4#DE4)qCF1bHI7XSsK)ewddv*ySG1lLP*1!- zlXTk62`I8YpqU8%9#9llVBZ)}`9A{sZ+Add_7ErTqSxMl4(|(S*#3Yf<0PK_6;Pdn z39CjE5o*1N!PwK%E~4)DK@jVf(WH>%IrH;|-5z4yq~M%Mw&k%)^_kK~>5g zRC0x&GFJ?8J;IIgq4(bm$*90|pZBUKY1@+63pzdJq(V$kK&at2-9VfmMLFK*_ zR71Q$p36Z^#{DZnE&4aex-da4N2?n_bwlx+L0x+g)c22q8u}!t;4`*8C-)b$dl}TM zS3#~#5!8XVL5^JuX?Dhte##Wm=*%H?$r4gHdr0+jhg3dKNXy?3X?@<1hJO%Jda012 zl|s5-IixF9LOND8q+QiQT2LdTsc|8VHHCDmc1VZngtWbGNE_82~BH=dAw^oDf87t%ZROKyhL@)>Q>=Xpq@koQGMonD4i_!YMq614=;jEU-uM@Y(? zsMmNeOCra-CTdpJL{-X>s7yH%l{ZhKioTzy#@GT!-bCfdm#BNF{}HQ^7EII}EK-uH zWJpqdM6fGUk{)7z<|KWTB}oIaCuu~1Bwd4}V3LvxC20b#p+w;%H7$~)dniyeiM7d- z^moZ5ox|s)lGLV5k`CZh*(80~mhGMCt4oqL;Az(+<@+j0Wridv=g1_@o|L5JlarKx z9(^rH($~0#V?QS8<26ZYkJTHJdJ4t;{CaH3TWNmMntUo_XR@pYm%G)bh zwx5#Kc3ZNBpv#_Ql{}QJn;3C8Sv^i9>oF{O!)lv9tTM@AZTK{-Ev>`a+9s???ZeuS zr#-^T)ibOah<+JXV(+k;_Y12Jp7jrF`+%@gM~C%rTv%tOgjHc`Seh1AW1K+C@56G< z4=clhug-b66j439I_Huomthrk(7I_jiYtWlvZY z_l9NP7gqhFVSRKWtV&pUCaiDHhBf6vSgWz*BI8^NYwY8&W<3wf{UWT+FT=|JDy$%8 zU~HBY&3i9Jm+)(@6m@8wqJwyW<3FWn++uEVe@TkkFHO-#6k3s@@X8d{ZAnqxbtzhl zecMuG+n%Bb&h1E1ot-IKg!El0ny@=XAM8od(|ajOyq}`3IZ{>d!&KG7T68XuszoSJ zFjY~kM9xB~`U)LCPF1JUsS1=yRsV9S8l04>UfomW8=a~(3sSXWSE{yQ@E-cupDNSk zRHdu2T4ZRf-gr@`v9cMBWoh47g*G3LWbWGEbu4#JMD@|>Br|BU34I7xIDTC5DmoH6mW4Oi4@o6eOAx(8Br)l<-G`XgyaZW>;md;Gmzq8VGV=eux zOVh#iY5M*5H0AswO?Hggl%`Fa)AaSOG!;FXrVE$S^y7mx&3Tx{Iaq00pD7}D=7{QM zi|9Ot<%y`_`w{(@H==y`BD_9%?30L2xFh=B6Vb##M9034sOG?k@(zl~kAX8HIx{<> zBIywwz*$V16H%qP5naYZyq*`4=?D79c??(>QSQau$MsbaSyxA7;3{6OiKyDzh=yPs zPUE9>5d|?H+1E!@0RD{;Eke`H5j{f5gAx6On`a~Z-WZYVF@2!+6LQ22jCmf>MZ9R4l3}{zA^; zQ8|%_SvY~bA4gRjvC>f;D<4%{g{T%+jw-oolr9qO8du)mrRCzkX2_?H^S$3c6D#M&8*FKJFJNnFxYTUdia~aj) z`Q*2NeQ*Td{}5HIExi!vb>(r#<_(M9*sdng%jf-~ElhQIDMm`!#>!eO+z$|F_HZ{|)}{_J0851CTfX literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/3ee3150cbeaada59_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/3ee3150cbeaada59_0 new file mode 100644 index 0000000000000000000000000000000000000000..811aa06e23df04e4d9e2f3a77ec32157fb211cce GIT binary patch literal 18848 zcmY-1cX-p~7x(dZo1{s~Y-u_`R-vUyvy+yNq(wHeH-gGg5M+tS#)S-7%HDekf@~4l z$dyG_s#gtG%&bvSbY_%A5qCu7=n(;9Lu9eu8Z>ZyhY!q}sN?COIIv zTfzJ*B+4QWtdIS$1gW(BmmV=V_6xKb{>rK9T4r3+q1$_7t`ilP*RF*Z;J~D#d z;x$B2NmfaJV+13mnkj;&vRg)&BbY8tEfKVrQ<57UK^=)I5J9|rBa@_1!3fG0j=(Rs zK=gLR0Hzk58_6ROIBB-CP*s@N#IwL6Wjo?_t2oka)s3oK1 zoRrGeW0@$E^CCD{IfC!1M9`*c1c}umc(1zFCjOcc9Fh39A{ZhaYe%rWP6Q?EMzE)z z>T95N%W&DzL~CmnL0_5vUIc%&R^4qQ_^h4!E0@LoK?GA}ZHEY6ei%XLjuBkw6hTU7 z#pkfA}Dqtg0H2EDUvl&k(4t>;+4x%qhKW87K-Fw=@}o%hJ;9(Cq?psd{sP>waJlu zlN!n43X$ZeMN&u3$thyM;;)kyxR7RlGuBY7_QH6vLrMc#_! zGucr)5`UdYUNwxQN8?D!Hi=}B+-e$0t7egOlv^^cc_e*XL=yG3a<+_Qqdb>pts?nL z3cM4^HaRZWB&kg#snS=fw2Ne~JdjV`k7RKBNQQURoKBH6{3wz_AFJNck$Ap~BqSe< zi6micB=3%kO$?AjYia9<>~ zWVlp3qP`tfU1t>csd7A1-sg%XKT65hivMpUrHuxf6*MrTkbwe)4V)`t;M<}GW=WwK z1C3)1?2r+~3{01%aR%DUX(<)2v2riLKt!T}jj~_DNd^WNH}FU@N*kyylrd0L2Fbp% z2C|b4>?vp9jEpO9V4lRK7-*HM7?SKW5RlvQTDtoUtP2=O4I20$(?BorR5Xw;tK?ah zfsWY*ehC@)O$LVzOpvHN19kHaY?cLY8u&@NS2pm4+?TAX1{TX#HB^VxscGOHIV85X z49ux*ph^=1O{8#Bty#v%>1GDDwlH9AZJ@ZEkSo%xje(hM)w_0@(@8!1Nb%)PX9Ih? zC`LB}3B9!LFZB3JJsxD>!Ply7oB`)}1D{MV@N%Moxl`0XSux$9*M@o`O_vy0B6oi< z@ZM4bua+CAxk7ueQazIBRR*U1q@GFOXZ2K8$gTAT8vJ5l(gp*jjRs<+v8>-@;N#5( zu8V7{UIW6f+G{zoL%rRp*TXLD*>2Uk$3Vrs25KKwy^?j@!1ogShk7f93#whN-Z9Ya zu7S1p43xWX;GtwcR1YNMv4H_k416QDrv?_v&1ZVOyim^z8ktwf$O=g*Y~*$kBcI0@ z@x>Z>Q&!58Vn)68jFgTyGC0Y|>0~39(u{c0jnsA-Np%}3;4{+5Z)A1QNRx_2UQ7Ed zBZ=8Y(qyun&oNRb*GRW2Mz+>6;(E(S&)SM5W9u2otZ!t7TxwwCuC#7wq+lb(ZER$_ z9Fm&Nj5L*7@?842G_t0ZZr?GI^sbSe65ZNJKl!wckzd;xdDvdLKU7^Ebt_#yGICU$ zosE3b#Yp{+jck^Wdl>mr?n*{aBMapHUh0Vi`lwH09BAYVnfs-YQePSQMY;?!GEi=c zZ?KVXc{l&we94ju`nvl8+g&UN&+@YF;(+?KLBB-O|22G;&$&kB$5! z5l@WNcxt5Tb0d4D@Jl0~$vgiUc_3L4CJI|jd|Jq)*OQ4e^0zcEVq#`d69r>TT&-YY zc$$gBb`veqP1N<8_*p*kndmS7h$moTmMoKT*(U1b=r-3xM94(EOsQ<5Y(wRd4UJ6L z8=J7SFwsXGZ=1-GC33f=N#Ao!OnTqMYgze$iEZL(Z=zQR6IY~nXA`Gnco!2>#nRP8 zy>2Ep%jBLWN_=XfZ7&l?q<2P*b>6UU_91QQb`n)H6a zM4~L7Y$CAG#BWmcdlTQtkLygN|7>E2R9tUjhP3^~M5hfVR%|p;YLn*3g3X%0-NX;S zns_G7cAA(cfA7-c-6r1KV`7aw-)o}dKCSzp>N})09oBI%9W&8R79Tf}aKc2?SraW~ z&hI9QoKtTuX#Afh8pvuX^OuPZmrPW@Y~s#s6JOjh;lFF5vaFJ)_e|`%Z^Hf9#CSRT z#6-=fCT=`4;eBCZwk-Kqb^K@Im3&4N4<$P?ip8>7{*ztCC~BLc7#kI(A2On_$x%xb zhh0&8;*R3JRP;u%NH&VW7e$TCD7IxqQ6M{t7P3_C=S0yaH;UN2D2B-X{3voNMd7O) zMO2k2>Qs&5Z7EzWiqUesdK8swL=jO>u_dQ|6sH?T(Ya9+s~Sf!v1t_Zq;3n%dpnBm zEu&b{DvFkEq6oB&;)MJq1KUOMx41uu;$r(KQa+5r+9`@x{S|+pV#(;i$~Q!hhemN_ zSQL)oQB0MlGoqM2Gm7Y0QIwXtbD~)DOB63QL}A_-#ShYTlX|gDefc$t!SciIDDLfv zqV-;_e}5DW52zP%QraJiBKd9k$6-BGpQ5=Xg^QOVfFr%3#Vl|toZ!xn)))X=mRoG0OB4+v(HFHpk#hNK2j$&q3 z$N(`Co9v;Y!i>&OfQF-E0XQhIBD!M^S&IDM2~8a z2%njbQo?U0U8c#O0o4>VGa|#xb6J*YW|O2>G}9wX$K{Q%S?@*6RLnC|L)OWwd^4RZ znF-f2Ges`EWu|UzGnea`*VR5_oU>GHzN>X%y2D>Iog_O+Q= z5f=WCw<0Z!F<5XJE#ya87%4~17OqBH@D;Gor=W%S!WP=e;vyCjidytDq=oHbE@q*I z&BAy&8*kxYf`u}P7CIzZNPEM=B>AJHg|A9km{;1uYpGJ!!fN>-)xu5jrCFFGZ`Zc4 zTprc2@P1tjAItZ0pq^sYSI!0&&dZQS7Jid@jV=5j_nKH}-PFPtEiD|Eq<1WQBc|3C zTF9(677Des@M8xH5g)4FjuzI*r=M8ZCQ+YS=q3GnS!mwdLUbRC_Rzv`Io#JmUO$Vz z4=BH^8ET>FFbkG%EF{V>IXK)xXoQ7^(nTUCsy3N0$->>q7ILR({Zmz^RG)5PzWg&o zwav8PpKalD**V98ZJvd;^8I`ZPZwBdztFDWwH5}*4e_qC zFk9Bj*v%IDZdXlGY=?zGlCo24k;A*RxBD%8cf!Ig@t?9VSML69;oWoEPcfgj&|9Wo zRzI$3o}7@<*Daipw7=Ci+3=4A`wa`3vizon61O!^Hr=rhzNbC7uRVES;gDRGf2F`f z3#pGSER+&YEi95RpIbQfLa%|Bs{fVt^*`mnO1B6r1LSw97-{7*gOw3-S2`Q5tTI{Y zV6ig4h!ty5EA?ZnY?0$~M_$UASSy*utPG5^GF*+oyuyie3`8LQl`9>?_`Etl($nstA=o>gCuth8-lWs^iUQr*op_H8RiB)*lETWyu^BP-{mY!@qI zWJ^~o_HI_XceipuQhKO{Pp!O?2EDBM+GEw%9xK}<*w;$`epddG3jM7NmLdbJWXm0i z7-%I7An zyI|!<8Gli)7g-~<{ zw#fGfVt9BchS^7BsB}DrMJHmoFZPo$?7A33(LZCbT#li!1g^%=@1Gc!--zM4?7JC5 z;oC91E%A3^==~su?b7^F44*$%y-#DTZ_X|yMnnX>$d;-6D| zS^0M?jc>&=O9tK3yoa$AdKAmO*Rf10RE)o*WQAhXle3kJQNBtsYIZF~*Z##=FTV^b zMv2MA=pg6onj1rS&YN-)4#=7_Fplc z%KOBzB{B}HAIIQ})o(IP62`C>N5(N>m8F-sgV(Q&*ZMT%&AY#dFbzb%e7iE%6y zd+|61mWU(0OdP%CbZQ)(9C56bI_Yuj_s0<*h~s{C9HE>zuI9#ZGB1uVn#S>)lzcCa zjqT!ydOwb{vY=xecjet)aa8CXN1;A(c>BdMK>m~k{T1tT#rh(Skzd9UIY?vW$FJk) zF*uG*GHFO0Y2U=rQ}V{g(Q;B83#IbpIC7`PF;tpNi{sJEIPz!3@$Kw5OmpLCAf4uE z4NK!lUZ!>b9LKoLah#V@TjOZHGfqFpXg#~*IJhT{Ui;!`b}){)a^g@Nzdwp2<#8N| zFX9;gZyXn-J~n<6TZE1I1{)nsHr7a{*+yTBjUD2)+IU>pMx`P)#uT+tG{#0NDHChc zdsQ2~Bqz?sP@9dT@>aZ!(~_KEW3? zXLB31Td2PGY;>0C-E36vZey%8`PfEMPa7Y|=3X`~^|#>~V580FHky8EV~#|BW#jDE zHp&mSu|lQ~w{cDW8fnu9G>R?9#@iS<$Hpn?w7^Ec?`>@P!G?9IjdsgynAh28Bt3st zt__MKmQ6M$ZBZPlyVb_e+iXN`SH53uyeCWKFS)YQhG&3RjR%ixlzVBTk0D;C#o~D(8HM8cQhqEP z&w_+_?#ig7cow}8&wa6%jOS=dJa44NbEQH&7Ee5lWrshWZv*k1m65@CDrCm4E!jbJ>uya&m{RvlDfsSOv3%+`9_X@6;JcQ@ywHYLzR1&>XY5_-iUaXNS|@> zY+o2p!9|L(G@gFT9FQW&68T| z<#;wrog48a-;1ZKEPEQyrkC-UU&ZTvR08iC5?C&ArUa@)C-ANK3nZ|ySOQUT2~2z= zfwm@386KK^nfkiU=W7X3m zfrc_%n)g;M@O`>@6x)!O8nV+qVZk-!~Ue^RkeC6IVJfd;bVocbkq&nGbDNdlK; z4T;Q+OXQaH@+PuPl6;A@$w*|6#AYTkP3lxkH$NpzFC4U?E6OBy8+*CdI#@`qGtn#50%+aigfQlV86zkHB{v3(LnJ0;Py zOA>SB&92JZP4T)XX^n~}r@l<$@d)J|nMCaPB<@U4B726OpPj_H#YvWx$yjPak7iD=@3`r|OM!AUmguB%yee6a8l}qN@RuXLV>#N& zg8t>G^LaTYOX-p27&EpU=cLQ5a`fI@j-|3^dpTl%Rji}ssCBj+6QshWayoBPj%wF* z8&jUl*z!z#zdV&cD$i(1?o*x>@&r7%UZ%A{~JIfcw}DY(j~=-h=KOMhnyVNVL%y(zr(rBL0U!hD$>OyPzc z%1B{lmX68%oD|*)>2aPOOCUdmZk19o{ z)u(Fi^b|%*j~OZSot454@yt%4&{D;duB%d*w?*^i!(AzqI*>vq@g7W}_URNRNv}Ur zNV%B8$8!2g3cp_0{J&Fpd^?5Lk5j1mB!%Qi{2~utrEtxdiqDiv(dbm11yboF z&5EYdH71qyvOPAHsd1@Xk@syHo0!T#DPKI5A+obXDn;H%rDMrdZltD?Q9*MZsXUat z^i-}(9ZxEgB|fM)*{OJPQmLGm%I@l^#MDUTLgQ3=wMb=~tavw-f}K)nE=zi9?B}WU zm(-D|^c$mml0GSwMGI58FNM~nGJHoWCuGn*)%9B{zZ_1*cqEmcCsL_#DwT2a^lU1P z|4e0;EW57pcTy>RHE^k)gmv<^)e76E6 zdRL(S|IDkvH0imk0#!~`(DgDEcy+Y`kFHlB|L+QnxKlyr?)99kd{hC0HH~`mPfQxQ zNofp~Mdi{k`_uGUUK(FDO5;ZRG%`A*QU9Yf7Jr_`LvbzCxMgYFmuXwlIJqm0GP~3G z?pPW>olJvMdj9t`&Rs|&^a?F^Q7K07wQofMfU ze+2B*3EF9%XQ!hi=iBki0=ZeqPOCTV{8`Jce~)&SzGY{lxN6(^w2qxCa;dSMhw@_+ zJDbJR)K2eacCN|&Hg+Q0+Sw!rB(I&FA@AFHEIT{dIVsH9r!|b#kVdv*@cK#i2r`rTOvD57gouM_) zv=g3X=h=f9b`$e!82L?m4ja;ILN_(uN~Z!XY#=i2W7u;@SB{GX2Ts69ijT= z7x`$EdNNw;kPC80+I*|pzfCo)h{3Y zpjwwYXuV9mm3b>1{Ik-*;&l#2Z*Xv8ql2oO)UPdiZmWY$+Z=4%?jUl9a_@6c|99n< z;^!PVGJ7#<%YbFE-C4(Nlm9*g>yyNk@|`$W93YPbZR!#SlQbwofGe-Q=)Y`BW2M0>5P}UALzIomiP|o43+5;)g_%z zK27Iq3HQ=C*(yCvB>3r=@dIdd*O5 zsWda42J)*|XQ$IozLn<-)TgECn0`!W-tu&ou1aT<^j@ub@=WsArn5qJif2PQ?`%_l zwx?6j$jSFoGT+Gum7MgD+Y+qoF7 z^1D2dPZ~M-rLkf)agrxxTdCeIT1QtW2j!B~>h9#|*G>|LI7yN6L!ERU=H#4Y40kec zgp=X&P)3b%GEgq)N&{7S2#H-k*n21IVk6){u<3)>m=$Yt?_5AalO_kt2a1#zR}6x z%}x$)*SdB%DRJ6KyEE#`StrLXDeo;OV{bc&xZ`BdT_@@Hv?uaJqV7BCD_b8p@jP_W z?6KDNM0@v4{WrN-7v&<=?BamMMX_iXUrVO~E>;$FQKpcKYjG}I@h)ac+2SrbmT>X! z8!oDqa&e@zOP}qyIF;g}da8?*G#6d$F8+}H4i~Xb7lY)k$3>>k#Uj}#5Bx5+hh13m zUG$aLHC+_0! zXgt`(v>`5{hq`Dx%%%4UE`E~a;p)u@m(Cfws4+(ICTPqg7yaezRP}4Ri!tJw?c&op zF0RPM@73QWE`3g|-Ys{rVug#+D_vAwt$NqEcq!d~(mt%yS~s}}|K_5eSoXU}lo8VS zpoH+yE*`#ek@K(CBy0XtFK}aya5GE} zMY_o|xcT1X=1!EG_sniWRyTFU9PK7ShRcxxZYmXYQ?QVm#)aMNkh-xNFNww6q{%e- zE6z25xBx^>;H zoA|13-mT{5puDKz)_E^Ct7LgyH;?PNXk2PadYEcH-^@3-fH8f zxqQ{ut!ri7WWBFC<#;FM?yuYf+&cf|*7tok`9s{SkR8L^L=ShypOm=f${+ptnOw~APGtJF;X)xW*eyKXc%?uem)6I!l zdOX`r>p5DtjGpJF-F!Do7Pv`T=w^U?BSU_0b6~0VV3}%=YCpOewcO2ADY?SU2P@UD zb=tF^-AtFoQhmLfmz&)@-=aO*=4PdAmI~X|yB&(V)6GOFu**%O-EMxBguU9kecFGS zd(h3_hupL{to|K!GxnI9h~sXGopjUkl$+n=%`hqr?s5_5DL_An<;WAZ)xSII;5%8FUVqxY;H zs@Bo`x*n!9^Kh}bhx#p4Ln{y8z2l)?I}h{Qd$`fTL(306l|wW@ljI&A90NV{_{_s!^2uNiC5CutH`K#1SvA~4hY=or9I4pfdhm_$ zFjv}6@UVEIYM$ib{1gx6r+Jtl|4moTGqq-!GFx@dQJr&jf2jw{GLNpuRex4`_;Zzq z{B<6N{_J7+77tyIdRTi*agJ-uIgL5*q2v`0@7?jR@U92jJrAcJdHC|N`u4;_#iv^H zGxb>Be4#p}G+sJHcsV7T4PJ~UFQ3YXW-rSvUP@WL1mxGkUV6uQ876Pqy!u+#i+fpA!b|)cUiO#w5}WE}kPLKcoXg7+kC%I1FKv8Y4g|gQ&G51{)2nN(z5Fg^ zv%QR!fp2PjW#z2mWxF)0>Sbp&FFmTOmKusJv9%Oi7T5D~x4!CZ>ZNpRt)q?BAva}E z2QP)Xd1=yJ^W|I*FUdVsZ!a&7&lT?rFR#Az^4(y~8RFIV2<082o{G7XkAAZ4BOi;qDE}wQ-&6Tze=i@O_VzJE^85IxFWbe^ z&qrTbJ;2BFfj&BYrdq$yyswmZu#bI1d^8#6ud7%8`1nHV-Sjc>mil(b$6I%OY>>%Mw5F#%hCWm8 zW!?)P|Gf0^_A5R2pO1t12}k$|8T`~0v(Zn243{G&Kb4~VbSv!V3&}3xr2g&b%ZEvRmKXO^s)V2XGJYCJbXkp)QF1)lPnB|hdZhaqBq67tI)1&JN?|-#KmVRny?^+Ly`VMA{=fY6zvO58Wk0?v%6U~euPeVS z{M*m1fBd|2!%vHwem=hA=jXeAD%|sP=DwfO4;BBBdiYE|eD0^&3qQ4A`Wg31{d(fD*2+*`(fIkZbNQ?>4IyS&zsU8<#v@O7E8J-Z}NMe9W zNdab-4A84ofDcOtSY9STsj>lHO676^BJ2T-&VYXJAwYB>zz-P#?q>#A8B*N*0E;RG zbj@*qzEPX%FF;wW@(*s0-Tr|pz6E;#TNuW&Dq#}K5jDahwCUjC5BQ9+{2LAJ>escZ={+!~};(I7vT3i7CQkPpfPS(zN9S-BuH z%Lgfx5+tQUkS=M8AsZb*BAr1#k=ys3BvW`s&5+{e`f;5<_nA3uorw7TI z5#+0xLGH`6Swa4qt$xi_uNMXNGrMBSF=??p$nRT}b8C>j+f?gr)v_muXKzry8xqv# zIO^{qt@AI{e_1)?m?T}*n&hKvK~`N468a~|&WAw?JPwj5qvZILAn!d>|IHa}vSi@2 zX7I9T29;wos4rV3DlUU!vRLlgGH4y2fh#G4Pm5;|D3gJ;Tm}uwXRuBFl~ySkT$h;C z40g*|xg|v$8N4A~q?R*-F|G_|N;h`~KY21p@n%pVTaR-x@V%*Al{08jC4-06GZ<1g zL)Q;y5UQVnr%?vI8)wj|MTV}!QS1*?M~4hP>Y9PMTLy75OV)p^I(ufYOFHz*pzT=I zGd_bt6Eo;IDFgS^3|$YE!SAy&h?ti_&H0)mPo(jJ3@(awVFp{|s9X{A62+IPvUr(l z{4s<6D>4`+i&tl0{5gZ#>oeFWd*$*k88|j(FirMs%HV{gZ_dE9Rcn$1+q97tUMgEyqk&ic4;3C$TTT)yCNUnsYvRhiu5X%#isIEI=`32Z|*E&yjgrD_j9wz3TLrc zdQ{C~eYGsos%KH7b{5~($)b0?ELL>R;z<{c@0P{z&$2l3c@~wv$fB-1{4$H2L0SAD zTV>veEbdInB4b(>3uS}Yre_f~Q{!i4v008u=LK2J|2~Twi?e9CB#Z76y&{YF)mgl| zCX0h|Ngi*^BH?fr?;XkFkX)Ajr*!{};{Kk+5E&=O{>&ojlIoMy53+dvFpJ|avh?pJ zo73)Waw}%*df;rv4AtXd*-RRpO@r^UnLH+&&&Or6YkW2t6S8?rI!NV7*$khY&2#x+ zX*NrjWmDqEY`ii^Zmi74w>q1-@_KJJRe#g5qndY3^R8!8^L929o@8_GX*SbdXLGe+ z4$i_kR4kH1ySN-G#pmezbB?}0=P=)qL$UN676x)yl%2!voE%1ka`?7g4kzEwVQt?W zUiQnObN?K+f1874Ob*v)<=~!^!z}5%GKbZxa_I4M4vn|uFl}oN(c5w;b1a7skLPe& z7XF^Yt#dgn{VRt)S992MP4lnku=8FH1s>!uKqg1zav?I8nU-AMFP6&>ak&(? z+fuoVkg{cR=~y&K`swE<#O`dT;3Ry%P9G3 zUM_p*=aRKR;}_*J=zEQksFk_YU6o70pOyDqE^9C6a`;Lv$FAm*bUjzSRK9<5S#cwm zO;Yh@E}!4Z<&JE)lS{Hb>vMTRJ34Dp%# zY!30SB}6xCh{=URTqqLarc5jv;*XdRbz(!5iVLwv3de`|Ty`adD3}!DS?Q3@TZDA3 zBBXN_A-$l#g`o0egcu;jGefkk7~-h3&JD3B6e2zx z;#TDlfvO?qOV#QjM%D=NQVP@x(dexZzsit0idk1N>xF1hKg8??A&N8%vA2Au`8 z6DBh`OwDp(PL&T+GBwQN3SoK&!)(q7+lP4Z~~@dy_C9Hx2WrY-kzg-FL!#B(2^JGw;1HE982cFz$9?X36mP!yNe_ zOr`dU-$C&^D!%OM9HwB`FiEmg3Um*XDD&i>kHb8X0iT5VwP%>aGU(GV`+8{|(ye!x zpZbLP^fTQK3iImgFxJ6gymD5`4At6Xgd80f=FM-y)RSQnJ0i^6BNae*((F4 ztNs~b{4>MkOQYFgrp^h|Vv+Vp)-Dh8a)tW%Q<%v0VT#D8&3e2&%m+KeEZwEv?hjMp zl-7JY%=0tKb2iMF^I=Y32vg%?m?rY-Pt|xS%o>?`TYGay_1;yj540B#!}`5}Fom9K z>@)RRf@SjHCXY*f^04>IW2%gpoX62AdAvC_k1})e_;79>r)Bk$Jf8oM zN2jHEI=`I9u$hQu)*_ozJN<`Fx+6&z%bSyqA{G+m3wZr03J$ zpHJEL`E=}%&l$PUHJ_C3`An4RgYy|ZB%jxEY;rzHQ}Y=vKW@(F(UyGv*p|=nQ~4A> zlTQVyepcgu*LaCOmyh$Ge0tu<=S#`FmCt9l^SLdB?&Z_uem*-T?_oYe9_2GmWi$@XqZ*?5c4|Lbf|NXP?c;!O%-}$##sTgy;kq@^SXWd-2+c)sf XP8p?A&SZLv7yN(o^gj~(e}DcDlSNi- literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/41050c8a4ec7148d_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/41050c8a4ec7148d_0 new file mode 100644 index 0000000000000000000000000000000000000000..577a4c92072b630b6b8e2cbaa72ae57e421d4b9d GIT binary patch literal 30692 zcmW*T1$a~E+sE-=leS43X<8^YO5H6fUW2x{vjM{y?k>Zf;Xd5mo#74}?lu_1-Cc&g z-~YSo`Yi1^=eeKzzMqqlo}AQGzss^8+JFAyC8;Dnzr1pt2f2$D$}XN+IJ;QkqV7_K z-R@Gwl8a@z3b_jxDqXyEW>!IW!BVcQGG(%gm&z(trf_n>(q#%2DO1elE}E5`U96ZZ z(@2a{Ic+ok7wdoj{hYk%{~rhO|0QTrM!JZ5Wu;=}qzO=Y$&SNFtsvD$bVaE^CGx?3 zT*tD?(&8%8LG-H1n408`p|zxck-xUo5%;@F$=#%n*gj6myFiLWRdmOC{DX(6xlkH} zGw8KP>U~8DD(Rt(*o)g}l;4NbBmMUcEf@8_M?a(6hcC>fg^p zV=#CCv4(l*_Yvd=zmXpDn&hDzlRfkTt7j1Fx`%q+_Rxc;9(srN&pfmib)I`@>q`$E zLdjPis{GkQpFIs~>SfSbe}gvXFlav>=QQY0fI<257_Js z)U}yG?>ZS2)7hX=n1*s)3>tusUHQ73LHW8H6ooH63~JnyvAqnMh21F7o7`aTXHY}@ zf!F<+cYr~K2O89QkU`tAW3WL!Lkx0Z+fZtP;WvXyVmAhi;QNsV^%-T*i?PgwhU3U} zf$?EM9nxf*&xU7(0QgoVY3WMnPbrExds)SXV5TAf^&gE zv5O7Lv&^6y%MBX4g8Ww-R1AC98q{GO{aH+(|i4@Nb_9PGr9{6>uoG^&3Aqi&)>kWpt~2{Gz)s8JKc z*bY~eQKMsw>Jrb_Nk-ju8Fj;LRNiExW*0WTPkO5>kvBm}*p`bfZoou7pvq zFs!6eYj7V4{8Su+ndqBEj@d@tLQrY;A+U^5yK$#1Jt${XCaR!bd86*(_XM=fGa#QAPMr|#PYSPN6ajlIyfH!#1)+kduqXwW{2cuedGU{+=qw;rWeQ>ph zQO|xgYE)19-HUbYV^p7hMpYYN)W3t6V=(8zQ2uooW>imf9Bx#rkw!g4=qRHKP2e2( zpWn$Dxu*~xkEinWG^5(jGV0N6qw>u$su@nrW&8r8q81xfV-4}v8+CM}Q6o079-FCS zi&3k$85O^SI(8a$1ta$uRdp|O9;WYSh<}xF*Nn<~z`W>-yboD(jC;g6^Vq25r__!Q zX!XpfV$Y50_k!~ntI_+O#*aqLGkdC(kEfPksnt{W9G?2s>8bU|ozGM8 z*p5H*dunTtr}l?>>J}P>dnzu%Q=u`Q+Li37xMVItZVpo_dOL%{;XLxte=wIwrLA)FLFc@>GR3p4!)rSnWB!gQsFU zdMdaRId}F{{Vtwr*oU0@dMdTQr>f%e5Kk>1>Zu*WJ#__VMi6(Dr$WYfYSV0vo$skO z3p_P>p{I&2@>Eys!SdCf+PTqFUvPYrr=qWUs>cmaowjQ%}_g24XZ?%o_R!>~SZJdhr);~BB=dBk=kM~wptbs>@w~pfp z$|rj3Jq9ItYXerhymb?Q74%l)!ruB1e--i8hhoGp?yb5h-ik=|R=o`7ujs8-m5GCT z)xC9YkhhXXdaDh}k0LKPM>8Im$9t>K1aeyDt)k1lmAJxN!7IHrX`Qz^Y+{~2yp_Gp zTVA`o<=*eD&ey!P77ea@Yx*N^EwGt1-)>UBd?ro7EN49c(~KZq=LVgRJ^fCHJg~!1lLijDK+8?oXt#fH#aE*zqjP; zwkCPDGwBIFqIU-qFJMg?0sl@W4emn!5ZBeD=eXUCe0rD^@vBLB`!EL%^rPMZCM66s zsrn$38e-#M#t-3ZtU->UChhypB;#E#r@ z$1=P`j%g+Z<0LN5G^xfc)_aagzVl6*v)H7lr6$>zn^bX?NsBhq&n@(7t4ZUr9Jeuc zn@NW4Cgs5y%-w5J?l!kA{(OH|4)2#H_we%}Q!!RzqCH$L400Z)eu4u4Z|3BNy~TQg{0Et68;h2g7@sytmF7~IPvij zQ%0E8dZbxB;234r{&8k48c%$jM8gTJ-$Z&biTWm+wHwFq0IhyEYa<#?F{=Y^VCYn{ zCL&@Q{l`*#nQqpg8D@>cD#Xt;>u)?nomu3C_}OL^#}s^o_Z+jDp!Qs|W@9Cs^XS8T z=EI%^W*HWe!y>a*!?MJz%BYKH7`D``g3HV*i3WIpx7fejtW$V`b}PtfrC9;1n0u{R zWzZC_F>@2=?`Gm}rS9!!72UzQ!no6{QpZ?>$$H>3CY&-W?kwwY z&a6aqJI^{@Ff03#S^whkWzHjH-J>69_L#h%a1K6Y&7bl7z<}pG7han62M*u{=Dwnj zI0EY%#{b8;j9d7InV&iSD|4DHs$sFHG5W*L$D#sQfeT2sT9nISQ5Z_%FuM9$Gz9N) z*xw?14vX@kDE>s}oE8nj8*~b=s8lYC7Ur?2Tt17&qIiDhLR0~Z+QAuYQBC-ST2vKx z!Yqmox9BwHL|C*EhfyigB4ZrKBLRQl=fV~(E@IIJoI>5A7I_yVXN<(DREu(^Srmc{ z97E-j7PUdC(iV-u3~WL3G8T0~opKg=mA5DWb1E=DE?2RrN>z*Mqf0f5_M?4ui~8XO zzM$KW7M=acqTV$uDpHI1n1vhY@H2g`ZPBDU%vqN?u?6+(S!AwnQ63y`Oxz|GO>JS( zBJ4x;mKKd`LtSmDs~vTrM|+Dd;STb5u&7u^i%R1$ig&UoxF7xPZ&AtsiyQ-qgOhlS zzJn|>jkIVf3XisEFXoJ~=sYHmwP^Qvi>6Fxy|5QQ&9JE1EQ|Wgw&*qH&ar4M`p;$k z=8@k*iw>dvR{F4mns!>WWEZ{PO`dx=PcR?r_i_$h<(&A}!i6h~0`UQ!H&~ln7Hzss zp76a#F8Ar{1B?FtpNAIx{)qY>TQuM)=jJnu;*jG7bz;VAi_W~^+`O$|QkjQvI*okkNcAD!^_(IAtL#^De$?LLb2^-+-1NAc*2+vw}( zqfNPdv^6)!;SrkT@li)CL%AP(xEAE275RM>65^xPp+4G<>R~=INBAfJE#MzTZ1lh% z(LOqW;xRs&73-tr2#F_0d`s|A-9#U~&Gb=9HnEUZ%16hLUD`*rFc6b*5SL&ohj9UZ6@4@Us^p_+46E#;{#B?A`K$Wq9A;MY(OE32>7xyJTgykyfA-N* zJVRz3AB~^OaSN##H5bv-#Xd?}>Z78|eDuq5A1z$rquwihRB08xTH~V$n|!qQ5BiL* zTYTib-A6y}^HC#|-|wU3gFXsA?4vvAbks*rPqIFzeYE)u^<3~#!;3y@i(BY+iT(I^ z*+-AB_-OY{A4NVSE^<7g7ubgXkoDL{6LA$opZciIYaexZ!`E-=$2;O7$9o@L#*7ct zh`Aq${fVCa=cBKm>FXCC70zo_#e7x;|6tY9{8pI@Sd|oH)kXXoW>tX*t3E|qbu`v0 zd%RWoP%O);&bWfqY^%y)KzXZLSGFpsidB{HD;D7toOP@U#EyE5t8dkQyl!UIcQkHp zRd0m0vZ^jNqIDa_pDCt9@|$Kf~Gsvq$Vm8V!Waw^AR*EHszZq!>sS~cbR&_#u{56l*^R3E-%mvhlasPWm>!(<%VWR>S;YQ+{D zLd+I=hVJOOmGfhpRrgVHJ8O&)IJSd&c2W;Y?P5(Z1zhdB6vzC7d{LAys*Re#Jm{KTq1QTQqGQ1Y2o)t*~*0LNaiR<*mj_X(_n+_UmdSJ9E&C{lC_}$BQvh%pE@=z!+-T{ z>fhX^(fHKLrrMot+JcfjZ2X>K({WVjZBuq1n>NFvpH1xs+q8AKO}avwM+vpj3;9u0*ZqtEX z^m;e-?6E0zFMZiZulKY6fK3w)67!Hv-hbM36`PLOlyuallc;u#oQ~5^WSp=m_@qs} z(DxL_p}=YSamJ>%SajAV*EyRGVf%UVxnR@Ii>%2do7Q6SHJdj4Yg47`Hm$;=8#Z0P z$y(mAsnK2Pdt%dcEJ5m1@_uGhGaSKtcs{qO6?Wq|ioURE5XK|dOPgAt8y=$gE1SyV zF!H{pPnd<5_=a|GY}$b%$a-tjM9f3pcQ!RaCtO0@dtzY;-ox_)eZ`+RkIEkzhc!t2 zL~k%0uTk5JIJom*pBzu6Kq$N5W5j`p~r6w55F)zNtr@URs=#C*+U(v2>xLnyTk1BSBqdr>W2=-NH zUGNExpNLb#u97wFs*JHXf=;#Q@6UFvMC;mi&8uTqT3x%=BDkJiKUJ`VH%G zx1nABjqTct9!=Pf^-WoyW_C4gPJS(^4SSHYHFM!rJG&y=+jSOc9qcNP#kkUu`a7|9 zovFDC^>=0MM%j6-V%Kxe11jJ#vnha-p@M~=9KwDIJHd=u>Yf>IOh znu%q|JBj|`$W;0=&8~XzoNm`97-ra&I+Jr8?zzN9^?7zp#Z45QPb`eVyam*>(5_z= z+0}3{`7Gg_SZY^}<;=Olu68T!`WyRK*%i9Rt|SDns^^kt6wo9E6o=KPnuQRcdx>x_0qU?$GuI#%DLzj%&9w>W2T z29+Ps6X+rHJYpVrJh3YsMV~R(b9(WDbL6F6g@DO_W?^zHLX4sg4yZZ|hK_b`IIvJ5&RcaHxYr2fH#iT6cHoFn<2kA!|?S?8W@O zsjH7egZeoXG=Q20G7g_GZjeK;UtINPA2y$4t1I8(2{8mRhjP4Ep(sZ(6w3QJKLeiISz%)b!go@ z@?79hw~Y>YY@v>W4(&QZpN~3}fLG_q^&f|ZTzBYH0bkXM@>NuQUll^`ZoUe~U~I;I z1a;>aG(~|PzKX*|4FABYYJ<(pSYXW3;coZT2AxTU(pu<-TfyZP>TM zS0`aw#oTLrb!e@xI&JjT4Q$xztF_zMztdND_xP&pK3^R^=&QdE`D)FdzIt%nSHGO~ z)xAsf;vZktzU8Z;4}DehxvyTlrPhzW8uQgxGd-MIhO0&=uaTXyJDkdg(Y{WVbvm^X zAK>ZdRBuNa_ z@-w;CcB)K0C%=O`)xQzr8aws033E4dDzv#%?^`&vw53x|P_m6v`|usb+fp0W;|8MJ zIW-hF@V32E9vz&D@9b31Zcb%&cPhAtQJ8TQbn0s_rwaCWYVaVZE(~$%7FG^( zDt0)Jqo`rDQ?181Wf<$!y>U*}9Pd<<3B;L1U6Y;ipW;+23c|xC_bKbmg>aSN$&3wmtqW4FR$5V9tZixJ7v`s3;ePr%!cU7M{j@IH zPs`%`v@hOIGn4%^r>LKH7xPm}agIyz(?6+x@=y2EpbX~1;u6f2>8D{?ehSX^(+D_9 z`)Mt#W&HFD4x&ssKg}xdr;y6zg6yh(+Kew){iB~Ee)7`{?8l3r{WP+!pOSy^Q}zCS z8a3KaKTh@2(g%zU_Sdcuf7Oif*EE;E7Gtp6Uxf<#t7svAm8$Bm>eyJ_U;owcSDl(X zqT|p0>Q={J4eI*qhkE{UHul$zCjQ#r)L##q`)frDe?_-84qIOMO3xb~f65#W(S zV{ywXhko$Rp`NB3`V6NzhYXe+dNVzT%Ff84`gjA)%%M`4hrXlsZxMu{1~9x zwFA^1T}A|`+SmXUoE#v-;s9RD1#sOcKt1;aX!xN3ZNvw3zZf9DYXN%lC_s512dMFr z04>IL9ER&ffI4R8(!{>GRDEbJl^T^xGbZHHAy_8n((-w^bYw{`#oo-Ni>UP`msWnx zrH9y^J2&@(lM71TSg^1sR}zwY_vxhlU>*5=ppBl-31Xnx+;4b+cVS3FS3DS;}Bz1UDHPz6f| zswBqZCcMi8>Qvc4Z7d(C@Ct!ii{2Fjbsfo-162j}QTfL})kSK}K$XWUylfh%tk!|t z-xa7{DAqMl^Klgc-2xSbxv1VVP(v^gU(ljgpjIKccc9jzMxQ_(!-&3tsxyH77>Hv? z9}=iSLj#pCEKn(Ug9g6^>I2%22vkq(K+BPV>W0m@GAd9HFl}_8u8j$l|M)f$E4A*fS$gpAk1R zP`9vP7QIKE+2n>ibJ&LXMS+^KI8cjFa7my_FC~9GS{11Gh*-mRY{!fZff~7q8t@*0 zf3S|*0`)VR<0#7Q4%EWEfttRLar*;x8to3SrU&T{8XgK%tHXinjxR?8Rp4x(e!?&K z9T$*&F;Myb;hex&9Kn!lf!d9H*8?>N8?oj_paxGYpqKESR6zM>7f>NIM?V}ut~mu1 zzo39x;NZdnaxE^P*`Y!Dg3$0FCE+3xqk^YB{D#OaK`M=cTZ2?_8^@vN_8_gm9TeO_ zPB^wRNR@X5sR@o@{GK57+Z&{_*u0;74g_h$pFw(vA%6wwJVFl#=>U!$3DRZw9iED|my}c#}?T1v32C4;pKf0qi@Jw%od)`|+j+Jb~C!QAK1@p$`lusmu9 zs~ghm2CD+H8wRUZd*BeI-~e?gpzX9QT5`uOV0~QR-o^I^ijbJ_^<% zEPfuWkNEbITwe$45!!zU)?S=LjgR#5OR#?V7OW1q{5@E+6{3ZP5Uoc+&k+5ITec8| z_=c#ne~9iQCMZPpqCzw(E<_21LbNt5MBVF!sBFg&J?a@E^Xd@QKNO;WPKRjX*$_pa z4^hy?5Zy-KOCh?1c9%Kk?-2EQ7^2nBLNw$>h+2IMQDH-LNzCLp2>~$>f2j1w+-QP^d;03Ds3>E*`3uC5TlrRPV7YGgO{gq4LKl z+(o_YP@RFZRH#zW9LMk#wMvI-0-lu#)%miaO06BL?l@N`R9EVTs?~3yT8Qt%Lp68= zd78 zx7e2$roYiCGfWp@DI3Q1(=g4)UZ@=VP`PTDI{Xx-{#aWhOuM^=salUPt@t%eThOUz znEpW9UST?e-o3-L1RHS=5q-i`5Oa{&H%vMDg=reDp-O+^;xaZ23{&;r!qj9^n0Czw zE;6r$DgHY7JPYG}k}x%XLEbOJ)ctFij-r9W z)fWzraMeXi97SbAxay&}Fld8G4Xg|d*H%0#5Uz$n;cAP8C>|WH-?0emL&LQjUSZ*yiKK91;~{>JAT9zT z!xe_fc!WQq!c{by`B6D0T-I2Q#R4=-3|EV!aQ*BGS3h^SIww;@A>tJcSJRYmT}lgA zYI?Y)XV4eSFF_8tQZk&M5#f5087`kJw&4+uWryqU(&5TmCS0Bs!_^2UP`pyOmf}Cu zs!Xlu+B94TdW5U{uk^kbG5dt8`e1rDjIkrbHFa#bnvV}xxv9)EgJV{OYYB$0A*a3J z%J_%*o>NCyguXP0Q0;~hYJtyq{Y!*A8%M~6U$7npnnY+0w!^n+gxcW)3N(vQE!;+t z<`H_*IYJR#A~d)w+q*?5b9jXM;O`N{8Wo|e=@A-;f-@qNjiZR16`{b{5!$sNLPP$D z&~D`08ll|Vh;t}H`_T1I_95yo^1v%}Kf-wYb1Xu^$0IZr7ZH9ULK9KoWQ2wy*M$g` z#vp9QW8}LS!FBcs^~PrSU5?NV%()h!%P4d`LY5m5I`=R_wnq_a{g@n|L}=Ud2))OO z7xV%vUq0Q1k^)3*lZD<=5r9SWo zj#9&rD9s3sl23Y+N?}0;+e$=n?|zhSA){23tfiy$q|D4nhprNxz_ zRIqxKrlD%xD6SPn>3+Q^O{yQI-7Of~GD;QU-6~4P)=~Tp5v4`#qm8CSM z+Kze`s0WoUMyWn@DM~$%|0?+->Kb$0i_(6a%oWW&oY5+ND_Se?10ZnU?tz*h`?5UsrrqqX2kv~D2bX|%dx71}+E)@-~*`15E5zKGT< z6nGh}fv=uRN ze~VVCVss8(9x>c&7^73zWQfrn1Q}yg3nOq6c|2oO7YlF$eqJ%kL?VFS zK#W53#pqpdjFLiPG$u4g)52oZEQZG-G0IUiMwPL$7&R6rZiyJ>DjB1$nK6pWic#Cr zF5f`}c&*d3#xmt*w!W{k=|h~fHhj8Y!P zr~-T+vHeAi!e27ys~8o29is;yVifW*M*TmL_kS_k{5?j`QPCq-1r4!U>K&__NH@pI zYKhej|5$y*svNP}iOig_ni~+ScDeXED3<4Bto{y;RlSf{b%HrGmeq4=L zEF7!8sl-A1v{?0nF+EnlWW*}IM67mKiq&VVtsJX8=vpOKj(V}GgzxaJAFC;N-GF%; z#`3#sWrjk5!}Tv6_MRGh(%HW~|O^i`CTKvATfadtx;WfqP@sdmp*%kJW(_ zvC_#{ZNfqHJQb_5j~R>GPhwT%X{^>ik5z#ev5G^;=UDlD;d}h>JysnN>Jg`3ki!tC zFa#Onl;Dh07YxJS2=|LqGB#j{f1Iu&E=Qa?VH+-^V$L{CK$(CzEy5AJfpW#E82Vu} zzM*37IDJROJaMXnQF-I^FDgXD>1Q0k)yOzKMxCfQwZysTIMs}elYd;CUZYJs^I$zr zqH#i;)?g>H664e~DNff=&=tpZ@i={i-5sYCl*M@5#B=NM)bH|&@mr@eF8j`j26v=3$G)6)fU z>a{RVCw8)b5BsrxFZ)quAN%*msnLNrwLcQ4RcLrLP92c%82vuQ<7w6d|6<~qIJLM$ z|MBx>))CK8;Yys^UF976N`GPbPS5e#5YOxOcs<1z4EBuI4X=1U8x$|6C0{k_rCFqCKjQb}+zv0d``f!~*?$862x|g65_Y<`Id4jflP0&kJ{+_`5dI|FLNK`u{ zcqXc&U!vCF7ym?cLe3nC8ifZqlPgh<+=<$cv*?~DQBN=-Z=ya0C#rJ@V`38Z8RpnT zMb}HzP^30Y)Od7iny5>7*(y<`S|{owYPLy~+9s+7%5)_j*7Qu&;9iWMlBi)wn3<@y zC@?Egi8zOHvlI0jiqA<@c@&yUjtdeMw=hxZr~&`QiTbvLyq6~GCWbB}ua${fvN}-} z)+MUfL5?|;s2=G3XQDj*q7V3TI8ptNBx*E@98J{fV~jtZsGyV7b|z5~{}T5`qO3O) zwFQlCB`WH6q82_PkH_R;Pg1HQN#*bcC7nrp9y>{o{E{>|SCU?$NuDI#$(y92`I1x$ zFHkT)kAX=V8k8i@aJEMzsZL}PKev9k_KibX)KCmF$PiDNorRoNiFLo@i#D%_-tvCenWD@B&ko5YN06{eUntBA94F9 zY4o5ZH5i8azEoHD)BK8FJ4|Qr+1}>b*Eg<1lqil6tO7 z(lEHzCu#MDB*kt_Qrpc*`s+ZFCj6PCIVkrR`61WgBt6E46G<9>F-f5}l63eM-@oGf zw@I3fvhR{K9jCGGLy~5Axa4JUDGh6lE|u_d=?E@jptnnRO)kBLr`e^}sAX|!sm-N4 zc9$Y>22Nj>20LBq72wj0T{?_lI4o0n;p(KFxLM z_&k^X!MOP@yG7_)U8M9ZuKca{L*e+#RE(#Q;5jtGb)d*0UWsest?+9R10ye`+#!Eoy-AXO5}u*7!PZovQ2B_J(dn zv}9hqYvtC=Hg3JdS1fN!>~_TN;8tR1=EB!5Zq4fE=5G+W)uxA=`_1SHIv{T^>g?^7 ze_!GZBo4k}`5?DqhA?iZTTe&0)o7$!?T~vEHI8;`(HOUGk9F(uc(+bYa4UEs{lH4p zoaEN($!^{J-L0Uh)H9v!Gu`?!+pTkR+*&c$t%38Xbw2x7y48M_TT@rN^>&S0TIW{V z^=@6-ruypVOxA2i&T5(5=pgSf4*xv%_xvaEvuPPRx_6 z?`gN9&$(6k0=>FO4VS6uZ|c43RwT}%)IVZiCdTO4lAF!<$6YL&)vF*u^!1PX-HNz?1h(SGM`;Y)^C2vnuhBB z$!d&q$dfZ!!%;XWS!JN$WH~ViheMK8Bs5tQW0SQI_2ZJ&4*w!7Az72quVAvqpvE%Em`+5`^RMY|CFqT*bL7aP={lXzb<`%e?980 zpR9wwBWcBKktmy-i)p;QO!#Z5T4}+4GFoa&C8xn@nr)kN00mJlUHAN?! zLWvpVKa+Uyot3O#XD4d|^2|xrVr<30jfGYJc`?n$edK*nOqDSbC*c3Gm?~l@cH$Lc zUlmg`%*J{6ye_7a=#JHRg2*?;)Bsa(62`a1R2-eL6t|G)T`|>wyI66h7B8+k>BZHc zNpa;rTwHGwQWTw-!e<&&Gz-@eoRp%*n2W2(_nbQDSD5~HB;2?=M;Tt#I|NB%5IsWGObfI6h+&ls4SjfPTLgygK_Pc zA6e~F^btimr05Yo;g60f^6SRjFmz9mKc?edj}&eEHAR1pPLXj;inib{R2rM272{IW zVtk73EJ;z|(iHVxmZGl9Q#5Z|3ZM5P{toP<{$nZ1e>_E}aRbdyr0BrO6!kfsqJEF5 z2_2rK@IG^jJfG61XDM9&PSF=zs*2cCHQAA>-M*)7+^#i^PJd zdV{aUQ&l}BRX>+V)kHimnW~MMsTxowRp;@rYN|?AOXc75R9SvZRg0fel~yBFs+X!1 zOsk)&1`Sg6tWm0>eo58P#;M9|lB(LRQZ)%LTBmAtn^X;HM?T2cAyqFizgMcRqG+E~ z1@ujo$B0ywz-t&rrfLN4jbhF*scOC|RrBy=HF>Q`)$j0Ho2t}5Qq>*jwxnv|wp2wt zVNRSdq$${#rhmQCl-oN^i%e;{Y)zA&ElpGMq-kn!nl4~?NSdZ0Ff>iQ!_rhCJWYFI z)6}kXnpUDgnKbT0O4A!uE0-om`82Jmo~9?5`(v8cqR>xinph)Eb!#$DbLK=!%QW3b z``^;E44xy>bN~_4($omMrl)D_j5Mx`r|CO3&SgK!%}djg`DwblAWiG{r>WP0G|fMl zCc~{XmBbquZ>MP_?%zq%q`PU#c$TKVNP3>868ICLFVl1rxxS~V2Kb8`%8fbr&m&z+ z4e5&YPFE}ZU`kgUHo##?=VRCD`q!DRcLC{2%9XA$xzklFPr9<>(lrQ$;?q?M#}Jj6 zuKQ@0p01T>kddzTc!O#s)Aa=*71GrR{uR>|iskUC%zQBXn65O;_$gggY7nO;anPU^ zaqtG!YLi!;beY?w>kNF_r>kX$bmi}uE_bJNbwp_AbR}aO0=kkDrVdTl1q>gSu4%~r zEnQcB=eTL<@|eZ8dFk4_AYEUveqp-yq0FLm?nz2l)g|d#u{vE3Fmnw#!L>GBW7nmt z`1*7m*`6-%9qHPRqo}$wU8{GctMTr1ojjbbibv@2C+dsJPz%hB&d@iUiOJASw1~~n z%eV}Ub!BL0GLHo_GzaAhWyqb9p(VJGmZ7_N3(xcnM1yhb^ zs^HB`4M)G*nc9gCcQVxQTKOQt5G@YhVO zLfW@Xl{I8(6|NeyxX(UIJw3DZ7apOiR~CQQAWI9d7GII-ou%^FfRd&x&4bIFrTXZK z8Mu@$OXmYQu0WPL!WNXJAXNUJ;4D4E-pDN7L$#-)r z@g29^#3`7?-!02hf2=LWJTMf`QX#~rX6Z*Qy&`5B1eo^l%**M+Q59MyDdw_w`Ykz)G0e| z9M96fCmC}pOSP~D1x{ya<=HHqLHl!A8iZm=deeKSk% zkpEVeGEfcI5qLXGg;5z(a2tC_|b(X52@mtOhK0K$v?z&s65*66;RvF4ArVm{2;p=hy6BE*A$mD2&&Tt69ksVDLurM8%hRXFp) zF^`gudvx?KkDkJN#-mR#1gkE1bOP5eQ_m|Nb-UrwM1*d6GzhKldz6BDkJv{j{fs;j zCqrIT%wZ^qj=2pzi!)TFgrUx*3{8Yn$xv@JsLJ~|TisC3cMU~r7#e|zbqwy+F_f)= zp=!ANp`ii|4Q=-sx`pDdp${NWaKGiMDuqs-XZDU_Y`=CkLFLX(;zBLnG%K z`U%+=kSD%fWM~6AE-^G7vz8m$hLS%U@?pnHL%UZ~&vZjoVO}!S1^1BcGWC4nilINz z;Htqn0z-wa8+=c0D1ts%fQ`uikl64(GW2eSp(CjKnDJuCe}*!#r=Mo`YHks)ik0vx zfKMfF? zy{e7d4ZMnb->a@ZuP#_#b@qGZP4KEaCbje`ci5{55wBj0d9|>$SHU)3WohSC6)f)J zRq1YCt?2Gm!%w|j2kq7F&%C;Y_Mdyz7js|e>s6zEULEf5Rg(c;eS_mDJCN5nf^;k! zK_dNRr6Vk~61ujtcD_*^Sn|**?cf7iZ)Azl~{DAdn_|VHewX8$Q4E7&3 zWipj3zo}~Q7Bck-&KEWH5N{MiaZ|tJQk5nc$jP|=U`LYzcO_kMTVNHiWHng&0(fKO)>Q& zZVWfoYNV+zu^#=uW;xo_W2_l#s%NUHk0vuNoI%zprb;4!+1QM8Xff5)hu@i;!!fmE zHe;J(GH(ran#+6hOf^_!GCz%}*B6_5j`mATuB|dv5C8p09hR|fxv2?AUBR|1O;uiP zDun(x^oywtznV%%)Ago?BW)A4Lgvk;;_xmS@#%%P4=6*g`t0%T7sK+iu(smZ8~IX@L|Sygf>S_O~W%3 zJZ7r?3&%~JLZcJJ#cQW%i?(Oj9@`!J zZkWnIhnptXW}BSrVhp$W`Hsn)8K$nG_&rm#&=jBFCr6ZeKrU#7vB>|3dg9FtQ;Fz; zp_qeqk4=rhuBYUY&8Nm_jz-yidY;E8yR1*m&k?@CZvs@#;uRv+yIbj^;i)YxF@Zv-}3T(fQ|`({fuw^%Z; z6gjstX4FDAY{3yI%~D=8!ca^=o^6)KBG-2ELu7}gYCBnn6Y%V^6ptymiibF{*HX`Y zmew4y^xqNcbI#Ipe1D$$qgFa~K&}gx`r{lbU*vt1`P<@t7HWIRQZoKU)yo$54_W#d zZLe6GjW$+{CR<J3wiR|8i0!kK^ftPLOhh|s@3F10twKeJg^@*VJt$`DQE^-2<7|Ci!d8}&wkD(OYqr*+RViCJU$=D@q0+V% z<2H7dA>Nzh3FB>YFK26E1)J{^Y`#CRW!1LTrjD&NtTAlP9WZ{&R(I?}CEM0m+(5u@ z>j&g%Y^y8&!15-xss+g1wbdft)?GACuoVv3Iu0Yz=Kqnl3MSbK;x-mFvsJgb&G`uW zZ9&YIv}t9la@bbhh^;}mj@>chp;&9ikA#oN8J*hLD$~~1J#1@dbAHU0i*6W$z4W9s+3UczyVLrcl^NA?|dFSFJ2 zCyvMEj0eMiwsjaEudsCly;rh-R#Ue%d_I1m{_AWN{ngfp4UBCgeWJ&2HuEWvGY;c2 z5;l>?R`O4?)o+`v6b#yKtHMq`Us$+{{k5BZaAuFKY3+Z^8ysO3XjHSrvtM;zZ7)aePIJ9K)==PZw(dAR&4p4YDyXq(TkQHA|# zSj4ZdF*nYyLT~t0ql{mV(Ed%oUV6)~*xP>XD(_dV3V!Xx(TaY3Sjn#gI9}PWmR0>4 zj{Qih=I1#h#KKRwiTv;S)d6{H_+{d5ZNKW*@vBN*-iN=wU!@z+FFwIgJV3Gc{VI!I zSk=(4JNOSR8u_&cever*Vl1r%-KS7Qvtc057t0R3Vuo};egXWmf1R^mF!yVMdhaRRTz`{iOZ zwj)!}uX^Z-ML3Ou34R$Eh}F1((jmW^VGOq59x5dg8#8ba*^~TgfS#C-vxsZzS5u6| zHe{e$GirfZIE1{-{jx9w>u?uUTKKun%de%liZ@$QFN{MP9-vw)Ki7d#Q(Q#puwM~O z#zEwX_~k)g{D?~^6(tT*@dsXwQK$BP***L!If~Z>1M1K+p!sOlDnR^zZonVm0b0?3 zu5<{fY{!89!c}ztIH0|q0(`$2(5CJIb?z0=oB;uy#e{(Y%|*FE0S!wIXw2Y%jtvW_ z!I*#wj18zgwvP)a%Qpe7#SR3<2ef2DK!Z~Q>NPE(pV4l5K)vx8&1SOAtbiix0-6Tr z*MOq9h=v;idV6C)|LzQ^(k^nqP4w9v(7`c#Q0nb~4q)h=fF`2&-GDy77f`qR{G7#6bL7tIC=PS* zJe#8mIUFUFbCjjL!!s=$tw8%qj{4vUnpbgj61VVGRYy5$J2H`hoOK+H!}Yoj*VQ|^ z?QvAqaFmWa=<9WO9-5;KK1T%uj^dHoar6qN;(_bvV!We99UM*SMtijW+|eqG>gQ;0 zf0hFsoxz=CN7V*9x`4ar_l2XQUpg8x#L@T(j`m|ns-p=gI+6S*IeOz;`d;biF@9X- zXd^tU9nD_jsL5JKKOJ&(1G5i1T8^4W9Hkz0^uaMldD9&=#&hJm;AkRlUv#waZ-@Jv z9WBF0R~>zdlGhwvzT@b-dya-aaO6Bd z8lA;e_pGi$Ib7Ar>+0=%u9m&*YF&O;!(VYV^9@(g3a)NfbakCasI{_H_>K?t8+-*$+%E{m#dWBu8cjd3Y>N2;-z!03StWG zpQq1s>Tuar)+;X8ZM)hD=c=ov*IYIGhjHI@^&eK;a+ycpm37sv8%36TorrDGE=;kBKlIiy5SyzS>p8!`SZmq?&Wwj#qTJRKVFTHvp~FVp-$m= zo@o)US@5-q=ljrjEmTmIG6hu!5$wnu)Lrb&5>(-=K_%x1YDA%+E~8PApc0A(H6E8y zs#s9XiwAWJh2nzDK^N4YuLpGo9p4D5eVL&4;l!Ikz1o5G-H6pasP%Z*Bd7wO2UTWB zP`O41H6t~sWfOxcIEPsCg6fOQII<|H*H#DB8LQR@<=YTcx8GRq3~IpfpemM2P+Ic@ z{nj=?Z?;cR{yqt6usA^-wkBu@y6;NR>jx5a4I>UFsMoOs-ABFrA$2GiQkjI1*0%}i z_jVy|X&+K*=aBZ|VXu(#^bTn%qMwBn-!G(=14HVMM}tC2OAaY%bVzr{g>-6CNael_ zNs~irieqT~T}Z~Go3Mt`F%Z4r~ai*T#@i@C1W?3#rfMkY4>gq^es(TCk0r zwzDl>-WgKXT_Kg<9a6(RA=Nn?QsHAERltf6FTt$=gIl8=-q^_lt6eyFVL1mNlWiUy7dM3#lout+ClC*qB zlD6W@UBuX%r0N%vG*eC0DpOPS!{eGwmECTtdYzl9=!T{|D%#i=*RXPJ467l=Yzk}B=CJzi2rKSzSm)BiT68C@S$D(Sw-MI5 z%n^CBL{uw#L}!tbFQUdTNAz$0hzb;l@HyqZw<0>`jp#cwq6vYBj`WS_-N6y%{~{tk z22YLX)QpIV&x~jvP9t?zL=|R7bOCqqY)(Yg=Mx`ik-Q+Hyi0hED=Qn9O)&m7f{Xq_dh9(XltRHw2E7KV4F}> zHCxgaibXXNL;FQ_9NYRwnR_v+HQ0`U1EY!?6jcl4Nsg)nPN3Yds5+onN>t^s4_QY< z^$|vnVk~GdCaM9bGB&FBk#}5_IqIY8hpiK$@~1|*raY>X*g7++OtYd|g*5b^9o4uw zQTAn22j?=rd2EA2_-=kwO@D}LB78qa)eLVfiz?fysNVY}%DnB=YiCqlumC-;vt3+F zwcm*8V7-_s)Q|CR{FuV+V(QpFruj%35!3hBfTzegGNuL?g(=83DyC;>{B=xya2P8` z6KhONSH6j9{P>t^O^E40YE0!O#(0ikOgGVd65FEQw=w45k7)^xARUD#$J7k%u?6L) z#8h`G>#%cLjAwzwRB{Gp$FvkL&xz><2G5P@3D(Vvspx{3PNMa~m^!SC>64=|9XcM< zISlwKrv12vOebQhh6b2|N62zoFB8PSqZ2 z?_Ilg?W$AV=HLHuE(IBadEu|+JIwMRGlY? zi?6jIhu=T@Q_R(kOGAu=NA0^E?_J1F*&s-Xa!Z%nueZfJx3(}l;@T4GjH!RU-EOk1 zrL(v}OIwt4wZ#l!8Ea0T+roUE7oqd6w?~=yX0%+;($;37Sr1QN~TA{$2h9Lt-T?yOu7Z$_r1pSb1ZyJXo_kZCv_5sp}k1GgL0Io$L8 zGrT{h*lm2sPeD~+cHOMN0X+uiT3FIakh}A5ta2e8islG zk3asfw0GWS$=o{0Qf3EPzP8|f$!Zu$qCDQ@Jxi?fNLF)x!^_#+H0+^;Mo3h=;f&^Y zR2b&Gr+%nmX*04x?188MopT-P<@o)DzCO3yQtTJ`DUe&V9seVvg&HiqsIgb_Ku2n9h)EnRZPCs*ESa(R>S|~hhw*ON*yLYtsk zhSyW#F7hXNiXmB--<=5=kb85gz=-DGA7&neAf^ccOg!`Gig1AC`cmDl41aD3t8T@O zGErQ#Z@r81@s(r`@Ou0%5G^vJ0Zq#*4$DX`@65ylQGKeFD@LF@AX5LWbbOS}V3ze92ltSjD+%}9@a(#omMd`VjnQl*-D;rpvQr^H)UU>b# zVZug6ksC4*gxDVU6hA8UAQp)5$@sD5R0@<@==Nj|_h#m1<+_W8yNdGMMYwNPK!h_z ztJd#(=0;jzVLogo$D5yt3g-Q6GVErL7Uz4tK6kPw(>-NmmN^tRq}84< z{1pvwZ-cnb<)zL~&s1SHTFj4a)r-}JE^0A5dq+Z={3)I>K+N{eRr zp6e4%Mp%=_pOl&FcctgMWv4Tz1UTt$Is7?WA`OsaydL2ZLa7f}Xkym~GliYQ8PZ$P z9}LKGXXHUE=1^3U?2c$KGL;_Pm7njO?9LpV?@f2*`=HmExCx)h&VN2#Nea}X(RuhGy;RGqB?6*vsY+6g+<;BxK4T>pBV{N zIik-U4mBTTHMD*Hr2g-+?dW!CMJ|sITwpXnv--2cf_u-TrptvDNj$O_T|uGrkxOs? zz7=`M6mB7*sK`}nn458fjazYcMn|^6o9=TL!F!q;SOBW4ZXf&>sbYli=9jn!<>vdP z7pcS6gX*fTx2z%eU@4m}DcSEXFb|Vwn8SL@vro}sp=nb}@5n{xb7zhAOfGU2g742z zP$qC}n)k3Hi1WX@OHq7Dat`L!JYef0_2o&UuQN*^96*A=p8ZpQ5goMH?;YT~Mlk)9 zU@F$NNG19}|4Rh=Cl&t(67D!6_=m4_7mf0xn`f9&s_>xY@ka@n*migPh?pTlh_=~I@1NJ7D1VGK(t^0Ku9mA22#o3f9Eg%}9ZTyT=~-Ai#p z!XD__?pJDw17jlGyy!UlKm@%4qG(dF$mKwBj@O%q@x?G-QfQl0JT#ns*A*DM*hVQr z3<~YmPp!j2K@8Gxv4O6ugOYB*Bge8{=O#QujUy}({uCl968?@MA9?7rzKtItkl`VDKptzyvhF(HK;B#1RmOG;~gVQF%%%TVZzoFrd(UcE{2Ul^vAExT^o1Muo ztbJ3%GskJ|0nN%V17V?$k&I#XM#UKdPesG;h5Hgiuk>y{a|`i+{{yWS%_IMivj}BO z6HO%bgAIFqLNQVS-U1O68|D-ig8JdqcYAYo!wCU>v@1VV_!b?inOD$;GC|;&HTNnt z1qUJ-+ohU!qTA_aQcpCEA?WSkdJ79-ey1vW4iQd|kuDUK888A=nxZfq>$dfJ+DMVR zz+2)Tz~Bk(hWv@)QtJ7IG~i-Sp2s`cqXPQ@E@%TWFI$gBo?3e8JE};CMmS!eUkD74 z9GY3L`|-N$XTBU)ksI>^Zy}sr=|Ik9#n5E#BPY;h!|rb;GiWF*D)zVqjU6Z-iii8J=&fVuV5T3{F zkvbe8{0c%2>ICpjmwoVHz}%$EFw9vj1az+q@0IGPMhOG@FgeAhargOdqMz&)(ha?- zn$`c)K4aM_0x>^CFogqGFQtLRQKvp6&y)wsN^;@q%#$pH^ad?+kD>I6T$9thqjE$b zgvc(_>&Y)2l<&$m52BFF4fQ?Io1u~nxsnPB{iVX^nPsZNh}X_FCLeO%lkD;NUGO#F z!z3vvJN3IoUsKtE-Y_Zyy2|7f#V|1&76R)3THl^>7!>1t0){TX*`Jnx_K$h+)Ekf$ zLPrG8??4hnJHF9@hiHWe;JrneNm=Nmet{YH%)5yeJ!t%blG{0nfEyd(os5E+ieA=- z>;5T>%Uh^NL4;bUNz@a&uPGwOh55x9c^CpPSJIuyFt;4*DLxDFVZ=kynz7iLNoZ)MD7a>O_4^J7EG-1TZ)Zq!klE)>Pzp(-uH_La= zQOZrughvZkt7f+t2+0_*%=zxcx-@769tf!5+q^|`Ub6)i$^-}Ht>=6}4(@RI(QVOh z_9)So`RbnAs4JU<(8)isrvdxqIC1Oy3AKw93qdVHTkp#*0oVx%Uqk zYQ$2d78rvr_78`2V*wl%4Q5AQb6#d zs454!{+Xe3NHC|gFvsoT(2h3r#vgj3{!tJ7LOdcrln@wFs^@m|C1;T2(1EuOq-D{g zG3wzQ)67ymVnmzXZ&65@xyn>GgFYpZ>JQ6i7zF?4@#p$W%|W;jmek{w*<_38#C!|i z&2F?}sAb%R7v|Be6}U>%tHV`PI6<^vW_;Av<%Grg6TaowXz zH6s>=3x@LCr5q=GWG4ns0U(A9G7!%_Ja})G|#sKM)Q9pk~5e6JT zkuq%SA*%rG(&ZDE3f&;s7c-x3K7ac$P434p*Q|LOv=ClU}^oCfG~ zn7p#}*nDuxWRzhZ<4yR(t6P7`j>1j2ms}rQ+d#LwFcB#=q!4^&h_Wo}qLIBRWq9SR z+-%TG!v&$OpSRB;w2a7w90Su0bE1L{abJ9!(34$7o;L7LW<$`H^Tk$K6&R&KUUC0`oOP_~!{*BJXC(>_vIFK_kF>ASiLJGD|&x=k9mdQ-|OGH|R`HsTU zKdI_(jOS4XmHVr`qE0a0OMZxDQR{KkKdO0rbc#$njZuX|lS&>IKEYLp^cE+4AkhQ0 zoln#;E2Lb|rv49IY)&&_he|=<4yg@DXQOATMtA#s;lEg6a!#&a`r6baM(<`1R45aC zq+jgbk9?rj-Xg?fe)7=~#n1{!Om(zOq}T!-Gub0%fM&0NB~NQR?HHMLF;4?S^Ls&H z1#VC`(|W!zidG@=r+$%G(Gz8#*+Oyw;m`TVn<{Qy~VxaZZeHTEES0GOf|J)^lRT!uGNzf$ibuf>Vb>T zZEJ)=xGnZ=%w;&YR9VnOp&NTA^KRA#8%Ntd@ej5i-5n&5nbu?U98r_9JMlwAXO4*~ zOM#prE-3L+jvrh!kc3gAlF}xm-Id<9 zBZ2x2n~gk+gdU;GQ2@5!;Oh07N}XcTosZ6mFBC()Ue|q0UITqjC$J*}VrW`^#|&~i zVFFY5*&ef;urTBnW749?kVs1n%q_{~DijtK7(tltD>=7n7n?%@at5ShMKJcXWDKqD zxa~dRJ!GOmBx^8H1FPU0#oe-|zoP>UIVb@7Cs>3Wnfq@mET&CxV31RF6vxwGz+(Si zCk`@T=1}IEtUR}*V3-G#UGyH2R8c2mDa=%+P0clH5RiSUtXh_=d zVdg8u0VgvtB(n)8vKhriaOg^YXpWwUnu!59m(1wDQ>%gYCv5Yx0Gay-{qh5grJlve zkHsq7C=+%zW6bhgHks>DGGivkU$Y@F&~RrB`XD|q4ALL}24TsZ=9AkRjHC&PUJ-DW zsPej!=aLO8x)8aqxR4&(mqJ5j9^8YQM82e5+2eF5kbz7E9VAr0 z_-MqwO(u3^!dg;|L zS1HsR+9eL4QgVHF1jZq=J(z-@1&$pnzWstd3#$bw@QM}|D`x8K9a7?GLnh=_CYpHc*h?aT#z>l>IQ43dKoh6I_c#1B z)a(rOG?YtCPQSs?NaQI{sb(+(oF1jeDBN#WD?mF<22Y$v?F5Vl z`3tPMiDB6^z@nV-cFW$}jH84YVMR&?Gu}?54jkQ_t-fXF1$#QK64PuhX_zdoN|sf0q6k$^1X!!MHR~IW_E_y1GZ>%d z^?1A%;?e`63lh7?0mLq2ZSjY^0rs3E_i#eFn?wIMolD|)-OX1T< z0^B$Ga&tJX$H%x!W#-JZfZSXCbS6UBA6Do5A}*8BojDCK>F~SnSDVzAx3Cjc&z? zV^{&6An~PtaPnj1bDimX8VEFz_@?`J%0YEiXqsIa4(goL1SHujwEY9BAF4$xARPo{ zlf{l>-*n1RE;$63Ys0XD^8i$E!92%VVI!AF_kB>gAXTJ{8v zP&zFoCS->pN0|XD88T-BEz*bd*cguri&wEF=*d%O7F^`?GMC1XpC6cDi;)ob%{r(E zJP`Pt=-xlFS7do0A_l3w*cvo-{`N)%qOfDm#@*^gWg+zfC zk_lh==tNu~1_io-_##``utVAfBIH<)+@KsKHdA3h*D&m}97+e{7I%8VE6T%$<`{q*Bn+F|VDHf^3 zSRB~ShYINwB8Ut8#YU(F9>}N-<4nkAC+?{52LA%igsBipRnNulkjAay!T*wYb@uPyV`#b#WTcW0g z&^MS2v82PE6L$VaB8Q=>>9U+;n4zjs^GnTNC0iqk3(^tIwL)zO6;zje(xDM8St$h* zCJ5t<)EW3*Q8nW_8KNK)#~@fwXQ!iz#IXLYb`6Ok-=UgOym|z%tzPhg+$JJb{v|zWyAa6#o4*w_iOw^Rp!R)wWrxNjG+h&h4?x|0IC z`piLWCYTM`akVj-&G%-DS-QCf&@eg>XwkG|H0_cmADEfr+Du1>A#AHz3G3L8Ia9?L zfdvF0m9U+MmWxTOmLZxs zf?5QQF{`e35eLi<{s8VuY*v*sc5^yN0SCAl|KzW4Q$!pP(sDEM%*_EVJRNU)lp>yt z<)&&|f|z}fMp{7GB@^SGl3eHz1;yI|$AO__;*pzC({OuXU>Creq<Rgny7KT$PLi z3aK%uWyYp8MeKG+AaU(V?vDdW)6WWs%VuqQ@im71QueHri@cgwhh{Q`xCA1i9_CE# zvY&Q{<@`xf;JoXg-BG8 z)HiG@Jxp(`90xoXcO4+Pw}LpJ+D)qt8FU!fhdSWzi6h5ONKF`+JW}pRGz|(0Tx{Nv zRzkJ7J-*^1_W-OtgUCQ)VBwYU71A#<4J4v9qzI*YKww9o@6J~bRfFArG$UZ--zyw@ z4&GWIjXV$0ru2~J7Eq*c_k?%6!Vs&#?IL*uoVX|xv=8>VaGY?#nRl}ST%#DYk4~Jt zl!JUAoh4>s@X@$uUcw*pfAqvcu@zIgZt334S(HCSd}3U$Hz+^sY2nUP%^Px&ga&g* z50>00dLUfB=-PWIGeDjj+O;#S4`vAmoGLcm2%mlssO7S6_)`sDmXhOOrX+`l7zA7O zX1`+-eorsavcL8M!ZL$RYjV?}TsAFTZi@@}aP%jvst2UsBJaBCls-fX-P_dkrQ-4BLW%o6;^=!I{w|;SoT@n zalipBp5p2F_0GoZ7z`A$@M-Q-P@S7CoIt2F?0_AGIBDbv6vl%gcr74Joc+8QY$y1= zYI6^Y=|G4y{N<@RGzj=x8CQ-~G8=l=$VY@3v9GDY(d|WzV@9(^Yw5Z4GX!QgT!@0NU-({1EjcL;_e_eeOcc$3 zd+!2OG;$P+CK3jED*v^hi{Kv{b&C8l;uD#lKFXAz%zMd4Z-HG|TnOWyAn8tKp%Vf* zcrSl@^gSH&1N}v;G^kt`iM0Xms0wMWy6ed#sdYU^K=D}Ak^0+oSDr|?6sU&{MAz6w zNuu4Gccu)d{@_aF2D4XK0Hj;~{`74`nxS^~iD zkvsn0*iPG%dyud{M{SBWXMu!N^ntw8dsKj$oE4mAyPH-7NgnLmHAhzP50E)*xr@mh z4?)RAt5bKym9dJP(T_^gF@@O%ILZW;OK*4kn)=A~4e;i3Hv())=wladvOSk}o;t?% zNN;z|cB!#+jNs+U%d^vn1^qJ6Xa?h^Rav$5gzdQ&tPr?HsdK~K(%}Hy=CN_o4@rga&s%21*nd9+wY}`042t( zLL@nXP6noZ`W^a(9W2);^3w?6YbK7(bjl9a-2d(?N4UIltp`plmA&8mMiEPV`rHZ? zK?s94+mUyOWzeH@M^Y@ZFUy5TH?GY!_#^WO<9^%yG21S@g6wsMiE9zDjPLi+A+*+* z0Jm$x-H3Ll-#tH^PD*UAQ7JgHoIFEcC*J80fjUpw!2I;~PyyifKOwY^;RhA6s569M_c!03#|AMNHIL#8QQrSs{7)2tSZjki1idvxiNa}j&p0Jq zvT_7$iPRV}NIqi;iIsmd z;7dwOML5;LCGMGh$OTMcPX1lD)3K>FsX=_`DhLkvrjDAnqz2Gs4(a5jooC=^@x}PDHf4u zGH0j?t9JcbzzSR<5glJ7)ORdR+z4@SFKy$yxB_j z2)Q^IU^lRqZjK?-2zb~3_Qylj0k0meuW8|LtPH_!>hv!k1uLUtgqLaFk@=a)nY3eb z4I2UVZh9wU9y@WCnz#r*-<#F~5p4O*mq9Nnl?$a#5!pKIGy{n;gG6@h`e<}Dk)T8d ziPU5JP-)MjSHu*idZ91SG;Fy7F6r10<~RD80xgsaZvi=&^~evHJ^1LWBBX+Ot8@v3 zI8YTHefqm5>=?9tvGa)>j6tDvq^J7LOr#^_x>$nV6Q}Zl=0YX1Q}@33Z`pf;R@ag} zSzh8Ai`D=a__+G?!?#jsn6$}FDG1uk!zhMKAhwW04~PMZ%^fJ8LFBSLo|+&T^o5Ys z54^+}03HOprUCmLw1JQkHq+`*ryg?Fu6FI>`NM!9SapbEwcT*{Q;hqo=RVxKH&}${ z=227vFA#m_n>!3+v)LcSdJ|ly*tJBKbCe}_d-uUR=r#iT9^|t`SbJs#xQ%YlJoqjo z$vj$)nS*bXLg!zuR8b1K*gPkf#(}a03Lzvka?qhg@3E0sGLVtu0bHTRHgkVw+MSVp_6Bq~ukJa-5^9l-Cam?=9IOn=;MKR!UurW_9=LZ8`=;sr0MzYG*h*9jw%hbPGB)-V&v3lyCG z%*9ac8aQ=J_f8Q5u4z>*$y(jEl&CRsF=R-lcQ;d%Fel#g{qLxUXN=+2qZBiq;YUj7 zgRw$f#Kw!IYN8-Bp5ZILVWBG{!(FI%ulNZG4Uf2|uU#1SwbNfp?>XuULYX=|Wt zc=P~|#NshrkKZ@U?aB7%pkkKh{QAR#*o&~|lOc~x#^$JYkK5g#gmxnAUIb=hY)2nN z1xIXRN2|G9Rh_kZoY+!@X}j!73|Yz1QB)|SQ8lPDwP5sRT!B^z5>Cph%AaYRK?Wuu zk--PogoPC122H1Y_(A`C8Yoqy@i3O*o=Fta39R~k z->;2u1v?($6FAIPW`LJ52S>r=a5H26Y`ZEo~zq9Q)DjX znv2xH5O+QT0iW3hG-SLLayUyop9>WzAC3`ozQhmF*E@CkXPUj(KZFc04a|%O2{|ok zarMjZSe%JHfezxm-Dh{->IXeO`gh6O7spun>s*A6^?P;!Q;O z$sX*cmU%clsH*flX!D4xw2@4Ai65)TtfE?7{`Wd?xmN@G^kIH5Vp;4H+dA8U{j|Z7Ez2aB`D5f*}1`5Y`!lzPZa7JPuy%6a%FjOXr z$B*bUg2l*PPbtjL&ER9g=2)fF@oRn%`^y4eHy|qz*dWyc8y$N8kr(KL)W}T}#Ka7n zOT}b{EkLD`&3D|$O4t%BcSeY~MLlZu5}1`Lo-wDdjr` zGbDTXM5W&63IH=xiE7UH%k{;;Hob+Mah&3GPWa>iq{`L{v&Nitof*!wU`#BkvbqZEV=6#yE5!POU!?d;R2$D zd2HVNWoyFf4gSe+_HM3Ud{0#YcFUa8$+SATG>S|an*mtxy`%HJ^MzROj6U{yVuuI% zO;hkIyY7L*2`-|R`{g(w1=Yy6B9`LA zqGpj)5L$8R@VW&wRT*M)o2%I6f`q6N(UtovULm2$bP<@s`{mpiqY*10jJ;a#)LDkH zYUE{m{6)nXNJ|D5M3CM?Wi%az6XN~iPVyxZtbu0-RTj2AnFm+l-cw?_uH0N;N^hQ2 zvaR>*hbvS(;+hO><_`RkvTbrh?{1VdI-gqfM)4jZhTxn0yYwgpUwxVc#+_|I3Ruu> z^4QK>)Xckj%0=|~cECfY?N0xr1uaQ!?Cff$QVKxa@s?k&mmN<%8cR!PhnkGII{tCf zWgvhhBqy1fya_?H`(tH1hc9hE!;5|X(LUiLvBf|t8Wj8AvgbUlXbPX2;f|jBRZ|k{ zciqG|!skZfO+2ECUc61p84L}*CGLt4gUCQh*JTa?Y?)|j>d4CORBNv2R@Ls!ToR}< z?(~JmtWsF>qzc1q#Wte_<8NrRovPF^SKzrdh6XK^VAB8HS3HYJ0~1eruy7a)@t9Hi zd+T1f0T`;|Ua>_-k5zh>hOVO;J<+>r2s^yk3N7MrU|WS7RF3DL@!Ld)11U%nqr8Ih z+_3+gG6^+I0qQf^P{REYC!Uzj!$Sq|^**ydl!a~vDb9HH@q>h9?1veux0t3}n8VTbF>P3(27H#2-0gr5gcXz>ds&$vq*xT^^)oK_T=mb93ep z6qXqc?g@M8kAE8fUw!|Cw(%X@zCXLC%df4g@9R&N|5tT%U4H&g>ITF8PrsAS|0!Dk zQ{MhN_5X_ZKf8bJJzigX?x_SMdWx4g|FQ>)Kwk)40^J^}fSAywcsSiUUJED%0DA*K&uB_orkwtrs0DNr^kadz1tm;OuVIhI z{&OuL?w;aK2+3ZO-9C1a+iKVht#gY1WG$#}5Yc^jOQ?q&3zY;l6hD6nhAI;W;^M9{ z^Sa?CF4P&u?WuGUvh>hhpW0#fKZx08KgbFvF#Ql}(rekfItA5u?F4SG16%nt)Db=Z zQmFHD#}HxAy-6>YDCGgXEraRRAw6Qpk%m`7vq)LHniy+Ecl6->Sun7kRrZa7RPC-- zjtt;2yp_we$4K@~azvJC!wREeVP7QkUs3FQcvU+}YE`ir7sMtVCF=&U7GdjI z^`8v>Dp=|UY5f^n8Vyk@ZE3dXoW%BGd`{_tKQ`6h9z)vTa%+pRr~5^#b#MLM*_SR} zu-|CyZnK5#ZDhx#?Lufpo&DXb9O08I>#T^0vF?qi>{(TJPlLXfF4m8zytBdnMa_+d z5%%SwvqKDPdB|+1#flCqq&n9UJ1>h8A!j_B*%6syG_W{hnO(Kw-+W<+k*ZTtN~eNN zN_EQN=nTx*N>f~o(MiH-Q)JTRbTFJS4Uw~vrg3MG%xyuY0skXR!=^M46D^%j4xEo2 zt+>WCv_DCYh1KFMA2;QZ)$xl=@PN!{ZLhxPMu(KQFyjdry7+qgB*o=C z93nkmWcMxo7T}EN1i>ANPibiwU$!Ehl=KlT`@BK1W_fUpl+gUhNU><2A-23BpV%IS z>`g3eT3TK}qZNgjN|M)hFJZ1j*sJ=WsxsGkL861XPK-rSz*pP$!(1zkie-&rZ2Msu zd6#U~y?r6Oh)e&$XGfw1d)Nvvw!TNbFKDiku|Xao@p$`vl4_0478-d(TXh4-^L=zS zZc1rFaJ*`8Hpj3wuZpnUXoY3(>wej4-CuuicID+u_8V=pp={ab7h9s{W>6{|d1##! zr;ZwAumRU(yvW5tyo7k7o%;OIHkLz;PQ_iN(NBUjT0IyKaVCcqQJ&f{MA(NK^(Ra*8%*b^=r6|F6{ zeG!+7E>~F``y;CU>D)KYSrKu0Ir@HlRcKFJSl`O3h(*yx-H6IRQNHdwuXi?#9&kYN zJaN%?l$VDrk7RP#<7=&93pEn$&12!I;mX*F;3Y%@V^Mq|xPfEYKrTqD27VjVK$xtj zH;RBpydvx`cPP93>gBbUj5@nkw>W=c-R1L_jFt8GS433yvY)?X>1(UBtv|o0so{vQ zp&5VS0p3Ro=63~a$L-2uWw=_yV52O~Zi;v90MLJpi^04rMYn)M+=;h9W}l>kSMA`? zS&U0Hz!z( zg8RL4FSo)WEQHc6v2ZV09J~42cH7f<1}uJ6!i+@iWt8qea4akreMCC}wz(=;_sY&5 zf>AVWqfKU?eXIo2e&{BET?qz@X7ry9fW~dvrg;HZ_eApCp=g7F08#O9a*+x-wEcBL z(XYYCq80$zLLh2`c1xpu6Vng&ZOu2FgCTy91E0bM1heDMTTM{{m&Z;@32q)6i+I&fDuauMf9$amHBEBXJ#yH$R;}Se?%~4_OyDk6Q;g zzqJmSzc8QjbbwF3AVS!T#ai*O)!t!Ggrmg6UeWnX%BmDNepZqPoPCS*)~gI|$cN_5!bCh~r!F89W?4(cLh5MXv0$6F`@Go2m{o!3<%cvBUp68M(*aqy&_PtrpN(0L&VufgZ6aAl((HIk8a-pVjQ`$uW%Uay5|aTA(qg?5IVl z6966x03})NW2Gdt>D&RRkXlgDg@%!cx0J*qw#7;(x>e%<<*WfE6HpIA%TN46!*$hT z8T%uJ!Od-_qxn#nks0 zC!Of+tWDe#@EI12JBovAYheBNY{d}HE?~&U(UqYbq0;dgUJL3JAhtiIoAIt~E}BpO zrlB$b6;T69Hvhi4Se~D!;cm9foi7ZCo}a|vGK@Mk!01XB1K^MbVlcgV`^0#FKuH8*Gxa!<4WRn9fYJfr zctQg`st9S*g^e1KwP2c}{+IwvjDu4@b}em%Fi@jGEvS4ztPDUoLgpze)U+l7s$mT% zsfKp|b5+ApqT`1@EOrxe+bfT5RPIxoWghS}s)1)A^iuyx1c!LbKCoZ=T!yw(WZ!h0$^!e3(JeZ(Bo-M`r8o2Z;T@C!Do|NK=%XS zwE)lq8c6f&1<-Z1fVKkQvIZi*PcH8vhNdES7B_@wel-^O1S7f@mb%Xv#^3Okt{9_= zr)1rIB9_$8LuLgqY2{4QYh@Ig|hMK$&#m#DAssffw_^V*SH9HW-iyRkv)^IRa>n;Y@=)ZW1IELcHtVW zWwCWJo+()urJpwVH98|{dv0jO0ipbh}|$2twP(heY6 zupXuuK(!7AQhI&{ASth1tLL}Ax4!iQoAK!n)-A{Q#jrjH46+%?PN8RpmN(!gB{UtM zZGzD&N#FmvVQj=(_E5}zTFvgVjbg2SVp$v^Z!FSN8;S2>RB0QGFPfw3E?}zv4w&t< zAeWT+TJp1X+DUSF{ET(eC4Sj^$@<`BA$sFnnW79GpSbwr%N*Xgv5XIsfFcE?r8*Nu z?P^hc{(U5ywt!;vf=rIWe0}(U?Wu=sAY@p}q(FXfC}eur!x(Oe=dST71F6Me|2Pm` z+NP!WkPSc~hEt@WD8qTE+`bkE4L-&&y#r{PFK}~i#MhUP*;dXI9N5?MT5{1c1PEze zTIcgo)FBvQ6uGeNG>i}SX`p#_1=I?a$;Co^cB}<-0019WXrPZQ0CE^10spuNKsVI_ z+WEO*JbOR`C08#C#wuFn_~hacUs6nRAU*p9Lhmm%;O!yha+Rqms*%OT_`JCW80VS0 z0MPO)4Ky!Q0X0%Uh#rj2wSWcy;OY?#wA%?F8ih9NCjfLyEuf9x;)tv7G*DwJfP(di zq1fnB3+OHYymv|i?RNl(64biF$ZK@11ylimsxum>6l*UCMX2IPRHrB~gc{vyfJq5H ze%3I0pVNRHY>VZT0*L_uhSARGUIUB{Z59A-xvYVH2>}p=p(TjX&gfAK=pO)R@v8=U z-T@#w1`YHqfO^&f@&Mq&08mehVy}r}?>T(-ss(fi01y18DP7Mtkv$EB0n50x7SOQY z4P)>h8tCQ_AwddWgDnM^ILjKJ!UmONd>ud=92UdEB#P*H7SwoYn*Fs|cBchX0`V|k zuwQuQ5&NY_Fnx;0>_GO&F#FtjLd)7OECY(T8azsMMTA(4+woYm1iRe=FgA^&3bnif zpM7e8ErPnf0)Q(_13g0^nud00F9N7D;rsiKk$~cETlySHPC7RB?JS_Wo8JT zP^UK<*E4aUQlP__8KM{E^2(ZjcKhCn?-LOI^1A=ZC%+Ka9(jFfL1u4p?UUD8$)CO} zt`Xj|{?Vt~J}9pJ@_NgpBndxBUZ4B=fdBdx>kNFMzM)y4ybx*TwSs*aJ)Cb+){= zZhq|%QI5GL>#w=4Zi%=qG>m(}m%$6ZV*V9p!{0`6Hj6c;L7dHMkC_pN)xwyE<81cO zn09eCM|jMQ_(|6~F^|UCob_U6#@Rw6V`jzK!WzcRjiV{4_)H2HWuP_Y3glG+nOh0^sR7BT=wvRg?OjfhTb z|KuG=5M7VP(0CWJ7|HDXGsTsxG=&A6WqwJk#F@u;gGck(<5&0F^xe*n3{y zji^Bv|I-os?C;3K^6%^`e&Cn4f3RN=Up5}I|9o6{{|MAYJ{uq6b^0g!?&CFF|4WL# z*2SBsH#C^Oi1Zuwv>4}mX{N6y)4@T(W&r&?7)a@&-mMnnEZ#MBvGTP2yVF8=*5{-y z?yC;ewNHBwD2D~3RN{-kL+?-EEdgT~n^Jr_Jox}%!)t&slza^UC2<<)X~58ZYM3p6 z8Bq)7chqm!N5OFB->v(|t&Gcyad09ZQU(?(LJwmfqG)6-EUSUxKrohbFK&HSVc{`G z*J9ZUEGf0HOzLYfmf$TK&9$gR*U=Yf+TbPd48P(>_r#A-EPf&ipVguL>%cO{@1*Zyk9S`9Kik~K`6%5PicW&AH56H`YQV({R^ zi9*-m3}y?)s2Y^$UD|*~yTPE-W1+BfR5DJ^aJ>AmqoEQ1^-RYTkMPUM*^V8LI$-c? z|K*rJhhMm=AuZyo>gZiJ>JuPI3ntZ%!(%(#RoVZW>zlYx!((9I)*wVwSTmur>@3EM zq91WzaaT^~+vwxjct5bm&=TeR!Q#TmA=W4Doh;EKGkFz`cjq7w*Dq*g>=31hB;kr^ z$HdGfzPD({Whe2u&N+R0QuW4~I@OcU?aN$WksoS^^75He)?nmV@ z!I~A$>OlackJ3OrLjgo*bptAsQUyNm2nJF%{vbdaXTtV|AdoKXi&}imT&fn>B?+eGuFQww16Y@_|y;4*D z4tT_=#H4~4yW!MLJP{X-%F2?Bn%lw>C7VPBCC#iX*R!D2vrsqb8mvE{X78Z(%qou& zzu4QxjdMCkN%&x3RvtId8ddJP8<;EnLD+-+?J;18(;ktZ)IML_I9T-{{nCx}h}M8d zoCm2KL4TE_1ACiI{NrvvVvfR_ef?XMG_K*;7*r1XCvuT^3jxxF9t&yFUKml(?>&}l zOoqVp3ox0%RxLIyzXL4ylqpR1+Yr^t$)Qd{odT4r7St3#JQslaDrB)7AawL~8bIka zfaLst6F}BHpxMS~?{s&I8CD z3?%le)8VNoAUD#)g^B_KyC*H}*-sg3DOkh)h9#(LDr*ajzw+=X!?hcn?4G5#k>h)C z@4N_veY7=0{YzSYa65^#!9%hcZuyHLlFCB#6&+J>s76c?wb(^>z$nXk$YFmd()BAS z70lMuR8Xh;<0aJNzHPqf$eJ4O-pk82_=!G$k+(EJN414~h(4*xU5kPFfw_Ny9ceW~ z96yZDOuV5t`9g2On(AN15B(yrUfdGf?qEfmTG_-eg5>L8BvwDmAPhinI%Nz&%xpS$ z@3HIY;9qvN3%JufxT~oF=sEBn`!pcpF|vEQq84B0UJ9AJnwGX}b;x6D_+|f^kb|%C z%j0W9cCE##fBbK2L)Ne37bA3EJYb|nzEPcx(sPJP6lMooml~+zLAKvYB|3Xoo6584 zN$gdC<3gS+ou~tN_Zd1+-+H#pu6Y164^0 z!X5)dy$xVugaqyC{*~mq{HDd2{k{f#4x>UaR0yCvHHgu%yomZ6KF}~d?EnfEpc6pe zT0oPwSd0-LYM?i)3Mf{|A{0P{wSe*g&~U2;TEui7De2jC7=R|#0@@CMD<5m1wi-y! z+>pXFifRFUw;db*K2bm%F;?}RzKCu|obRE|_5gV*JxcK$0ZhJHm=b~Ib&bjXL8zE~ z5KMdjIso(60F&N-FMtwuXco|K8@~PXs`{FRQ8>~_v7rJ(jSrbpqqqh>#;tpS>84#8 z8~oBZOGc?fW5Xw~1g}BX0~YazoVMJCRa<<4xz0_gT4oi*wT!7R~t3xo#W3to_8f>l1!?YKQZq z9sFV-o?H3rNw6GU9!SHSSmFF&73s1mLH8@xIcKjIP@y&MpWNj9Kk3cy;C+hLJcTNc?WL(i8_4x|UYJGNl%lIlyq~Cxyk{H3UF3 za;@Ih04l8o6nflZB>fUZdfVGxu_}`*f0I$Gm-a)_ZGdHJEiA`@q3>yh#rY9Qv(=nV z6R0hK{!t5P6aW&=Ykohe_SU*zv;)|^!C=u`r^p0I>x(d?=H+g3#n)FqIm?erO?BY4 zl>QG)_Hj-bi(BO5Mj*T|7@>CmKxejO^<`rUSt4uK~tMZ!`e=qL5~bQ6Hef`L@$c^83vi%?8(#LhB$AijQ`9XfXo?#6%d zSm@ljp)}O+_ip-E$f{87G0F{idmxOM3mJ}+U4PCN2)aHoausU?ztAb|8 z(rH&v1)^IZ_AayjL(hkvc_Gwki(kAVbpC1~xH?!67agDF?=B7fX?bXbH6B~#02kPf zF>_hyi_3`h-^)U)#1~=Ws#Vy#IqrOyBwDXL15_LZ6F6{0$xp`=NYfhAgIgya6XJ|o z1-exYOk7->?y7!b&5A<4m)~MHrggWAm@(CQWDR3R&R)gA$?b8$(CxtX@Yd`s@*p4{ z3pJn=KO`>GkFEF*cryhiH+&GWya-;1wKGd;tzVz^Pr*o=0E1Q#1h(GlC^3wn}~h z09P{&beur!%i5?C0rYS!pvV?h<59e&c|u-&wjJ3?d3ilG&Ya-}+~6U20IK~FdcP_u)f@|kR%P6eok)Eb(&P}bLmYms6O)=xbzDW+M>7A(bif~{u5 z`jA0LcelEY+Qm6fZ~!TpdoDzXpG@+3i!oc`p-OxZ43uBO7yjz7ctl~biK`lVe_^22 z_!4g^KOic9%EkvkIUG(Y9V||5HSBI0B~6MQj?Z5qpJ?oOhsc2aIQG)>iE>(Vqa>>_ z1n&U8Ij>vA5upMfPOIk8sw#Td$dF|;c4}l{b>;SaUl*XZ3k&A2)bXhV&Z$HgAcmv>NilX2FHs+S*~qGhZPgcp_~N3wAfNU2<1mwufTQB{`ZaQWSKC>_ris zOp$w~VaOGD{jB-zVCm6dor%V+K*Kf-)|$3pPlud_XicX9>R-W7YDn1+n23?^qct`p zys{u{*)w5cL&7RX8quZ~YQ+Y-QGt_w?YRxbuSMH`k_N5Pi7-L#)P6`A zB4hLF6aoFb{dbEca%4Jt40}>%ocZNyjw96`$6H`Rx=`D=P7>S=Hg{>W6pxHFIN4hu zAR6g^D`Aw@CY61SeG@Mm_f#~g3^VrSU3OTP_iR#m!q^v4wLG#(<#}T-3^MQ1MSFQf zlgbMQo|bfk#9g+8iaJdyTN`ngt>NWq;A`4;|eHP zjVK$Ihe!kpTX%;wYMHua4VM@%Tbt}-rIO2rbwzz~k6wgCTRWoncE1$TbYF~hHw$(( zvt4xKY02g~OEFI@uQN*zX&Cm%cw}4F;wdbAMx}^nCwX6QDUoB$UAQ$rSnbyix5tCE z9#~zfJ=`|jY&Yh7D7DVf)xNss;RXX6xYrru%n+J#ob2QXyJCd19aOg~827nd^11)DiXO>O%^RA6dT&N*#Acr_% zQq_xuK}o|*{9qSWNju}A9K$s`*J`|ux9X(apFmU8eH3H5(NzUUfpKVFAmh!r8Us(E zPvLX@0#w&c)aWpE3PzR%WZe`pXyjH0~i%7&PVZzv%PY zfDr49@6{rk^IhaR@uP(9pu~Y*C*bfXvYjH2f;gfBj#A#>f$27f=?1p4{`yVW>O;bG zjUj+gDpJ!?t)N^m-&4yJ)JIJ1B$nRVDBKNZ(xuV>`I=cV8%)Px(l&GdY%2$Ki*>fm ziaU1uY=@15d`Rn%P`E5-_`dG8&^mh>h3#%ub)GJ(-Zcf`yPH*tf=E`}7c(L5azsP< z)r`AbCrW&sUDpmjSg(n8ceS5H>$cx+l;F2E7-VIAb6A{1%I972o3P?{a%+r3NR1y6 z55Q6}VlPs33L=bn@f{J1_(x^HjOFwTLp-{8CZsf?E&kvY?9@Jm&{s~<-L9ooo%*5s zcpf002<~=bXUvBHxEqJCTbj$=IYfK>`>@qN$yfs|sowo^;)k%ueiAy=8z0}*hnVO= z94k=9lfgv9igGasESjP@`^XN?s6_1$ya0MC80gxA89oSh2!Z9sLDh}d#z;e=F;3v2 ztN89Z4yxlH(0!%WHi1c?+$G51O76N-oTj4TYdCoEe6k27tE|?)wt*>U?Z!5%L)gIh zj#mrl49Jc!fxz>>b4}bvH$+mNDyG;Son-hT9lBosDnwCg4Q(@Wo{lyRovtN%r&DFC z=_hF-MF4sxSfXMS@B$!orUv>bR7KXU6p#-r42h;`#93mxW_f%DUy@Prbk|M(FzW ztgFT<`K(EBvZxp&p9?0bLfOy-R%7vE&FLg3oD0Ep^QHpq`5Iu%qP_=!rcY|1LtMxw zP+KrSLH+|kOKSmj0l;Gcpq4fO(Vq2G_Fe!j3kDL)=j1~Ta2=vdT&MvqV9$f;a5rb1 z5Ni_?CU~$j0T2jI#`M_Sn2S{t7@df-a^;V-WfO^&fAFGpF00cW+bx%c;L%z8M%)u3 ztnH=7_H-E5UJe{fQ1f`G8pjei5V0x86QhEa`_QiC!R=Cl-@V*w%vq~tcmWSiQiM9a zISo)R)PUl0%Uh`b<9ZEKHw-`&VS8{*xjzV?6}5muU$YwTzpjBA=<^S>)lUb|i@`w3 z7C#5bTAYGXa~=M-ZYIRIB|?Hk70J@<9oW! z22de($2HHO2O_Z~*U{bR3VT$Wh;7ZRZz~wGi2ZAs{E4qY9{VFvDimXql2P;mG7>P`uxGa(4u>iD5>}Ms$g~0fU!suZW=~nrgW7xzY zFLs?0h_Nnf9AjJNh_P>svE#$GQRKuBLNGBVJ56;hdx{5w_*^#6c9!JC9_t*YWjQ*;peK$4%jv zaJnmZhmlvz%@%{h)xj+_spCQbsg|A%ZfQWr$ViD}$O_rapwl3bY_eE!64El8I%KE< zT5e&)++f+?EQAL_G;>_ct-Opa@-6r0S610WH==FVG>vx6SLat8M$--4S!;rub*-NXYitr+oY7c)3>N$L)E_<+zg-y^hkRH)jz?Xs zO)B!`8>>&wX|7Mssk^_zh-qfonRiZ{n-gs~m}UDb%?P% zuy#`#)A{P>(6m>BoAw+vb`pe?#@YrqtqW(CQ7CkNP{#siv*yRH8)+8f?{eKdHR0xQ z_uO^&&3AY1a&z1S=#d@Q*|RQv>WNNcTW|()PscXAA05UYgP7<#U&;*z_)S^9H5L;v{>q5J z7n|#e&G8rH_l)%wx-)R@JAP&yKVQ)q%D&xh88&hf$@~rPf!2EogaT;6*x@S=(@>DqW#1SqIW~{TUsc~I|rJ_*?%s#%d-u_0;_{#eGu{ky}rg24H zm962j1~HvbKQv0zZ?Zf})(;c)qggYCc5+QG&@S_Cn8?s=Fq28wj8C!7BU#)+z*h+4 z7<6!Z{19ZJ;*Ghur_82>>gdnIY}N*wOYDIZf^fmyWxPkX?gL(oWH3#v@rxh z1~xp=(~?beKf`&}o@nWpQZRI{Z!|O{tHu^UtFh_sSou39zF7VwHS~mEa*7qd@eqrj zIP$xu001l8HSjHVKDXGCl2WwF|E)C<__WEvT8iDVu$@?MA*~^{m0+q>pIG-4SP345 zjdgiq#jgp`2Jl_}dPb*M&_Gj;9{Ic2pr2mskIjbBNSi<8XmDl-RyE}q1Yc&WVp!}g{fwnkj)^RuH_#LsQ17p=k~1Iu%roJVqRf{gfbz}6xy)^_zG=Z2NFf(ITJ z(meJR6rrCvGnpK`!eqBtTJ(D zUDaWGqp**2&cb4Dia*zGXa4zf_M2;G0ko~;?{yfRKZmX4+G^X%Ei?qY9G&6~$3T0# z&@M-eE{)pxgcR#C8m|8`CIXWPi8uWD^L2MtY-S`A}$LP}#*-FRr~{ zt+Qiw-?Qh|T|9fiy0X*W{SlXXRh_+H+ZPk|N#2>uj^!~ATbvy}j=0?Clr@xpZQ&88 z`c_reS$`H`T)qDk4P1p7n|=vV?!U&(GmiUToP7s)R7Lmx-QBy{bkZwj34tVJ6G~`7 zN+0&{;iVaXK*boH^J&IyMK|fGYkQPEzBD;uNyzB5*eqOO<>Kiw?jr zs45$7;^Q6#q0||Ugi_GCRzr*NNT>mWtzBeDJDJ@@NYBGcFY2&Eoym zv?~csLs{6$d+~(GlutwsesJX#Q60-O@B?!gx`v=O*Rcy&r|@v3h;@wL(fHjQZ9EdG z9z>AR7X86U!vTD`tR9HgV}0wQy{$#{Lab6+75)b`Aosu0|(!wpbaJ`x%sckC@AVBl)WD5qdcw?}Q1?d~_N84^1NTMiKeb=JWC%)7*<;3#jhX(<;wv)X6?Vk$>Vme2 z&AmLp#*lq}ZT&AsN)pj1Ufayr=7!!%$7Kn|NcH)y)t6tsy!BEi|4&|wIDcW=<@1+1 zJ!d*R?@DXu?dKap6mz8E`QH4Iu6U$7f28YkSPE^4Rz8kYKXUwjt~G9h7ZCA4bX9sp z8~NmHmCjOQPXLEe8m?$!-b_oL#;~B^YUQycHGjOKq8U(+=N6xEG4^i;WQVqk3FDIg zCB5QxMcRq_vn>fUgOeU!&jRl&f+kVR11 zN1q4PH?>qnxyP#pWt+($aBXm`|ktOjZ zfZp-|nE{yQ1hp6eBCSlO^fEwidw?7OtcO1;FV{(v0Lg0E3eYd=@cisRQaL2JH^<9AeO# zYjTJ@&F%-7Z_6jI7A);xMb6={!mK?B)80bY2^lB4dnwsHy%Zk!U2YSj;?TMn>;Q_~R2Q#_gkaon z^sTPGnN413l1y*SaR@%(Z3b+tZ-T|6Xh_G4EFqh}S&!;uzM={ZN=(Mlf3`4dVB24L z!`E5rDMWcS2|;?TK{gAJO*LEu>}<%P%et_}JbDD_u$Zy*oyP={VV$v?LHXc+wUSf+ z+)6TPI_Fr3x_50SwM9Hv-__vXkV6S!q-D#ovWAstv+f90@?i(GF+FNo1>c2O6Pzz| z73mm?vo_hu`F7jr*mz8d+?In+a8F~&G6rph7Qi}#j^qK?)z9af~BP5N`9)BvWrp!=T1NU+w;V^sZ}^1lAcDp{d;pN9es*xxr&ukOL~hQ zBkGMbH0m*2w?e%o@w6L==4;dV34QV2SV$UM&vOjV-Tgd<>;ZuDa8s=3Uzk4+C2bq#npgF^=Jg5 zasQV`<8HsyXxFd|`fyHArO3+jB;KR;BNf^3aMF;yn(uERUa*pggK}w+^W3cO*$K3q;jR;O>E6!Q zOZaJ&HY?<|>t66ST?R_FFJ`D3j?@Q2eU7@`da zyBS0Fr(N<2!(0I>tSMq&AvEHs^cGVLZl<-EIv$KRq_=ou>E>WKw6lMk56m0tWAV!mWegpMFA>+f>JKd253^v}MMDys9^8`N z5;g(2t8J68&W5^TeWFo!b5q%5R&$vDg>6;5%{1O*aAU0{OYz%f^v+pg^j)hUCVI6# zVr{k2H)jdWRZS5&I(@`0v@5E0?xrnU+dH_LDTF4vMiG6LZJqhQ`y(2W5}-@cFNYZe z(TLFGxmuPKiA|wSM+`p<5`^Q_F)3q;1qb2EQD-8XJt-U?+z+t zroOqtSX`dNGDwn$uiw*TU*G(EpXw_wU)kEC`tN(O$HhzAu3T(UpNl+vB>LA+(UOgy zgc?4MZ9QkdaNc0rez74=K@f4^wfcaj<6eds^vZzfPyZh)MVPMmRag7VK`2DbPl(HV zwIy!vi~gdv#LlHYDslIKF%>z;6=|*XBCD||-2hkVl4a>SqI4H|>HJy;v|Vg5eH7dJ zI~CCfMNClqsEGei!T~7V{1GVOo9(Q!VOR?zNkcCxp`vpx7|9vf`zYZ@+7hyJO@;v= zMw~r2ETO0K>8r><#&~4Hl9LFuy3O79)Fq!s(*QcamB3fp1YAn3#{l}sNH3)y62M{t zOF;_aBOK3$pA*o6$pMRL!Dj_wXu-W}*fJOD#dN`oSt&xhN79PFbCC+)$EuwoXgp~% z{exW)7Qlx3#^4Ww@GzzX_@s5}4Kbu4VI0B2(5+YXIvkbMj1i^H>vbHU6so6lxi&kc zC$0H-yRP?*xE`P<1DNl|gf!LQAFH-)z(RI~A+(yrR)^Gx7?q%2jAXZn z>plz`wK3`;Q%n-pQU|wr$I_=yr`R@3|3RUP%vM)qs~aA{DA(POJY%#?2`Zc%!Dftt zyAYTxm1ntcoF=%gSTwXio;rkhN8v?>De5Uv2Z`|KBTE3ij5*az2}arn(j?OazPow9emJQc8^ zlR90b*whueTs|d^OtM$Rb&F0j4Ae0FU))n_v4{F?yxX^H$^prPIZghza(PfvU@wIG zGhNs2fPi`GmI1L^up zf1G@R`gc{O-C>L>FYr;X8C}Y{Yvaca`gmzBt&&@Fu^rF)@J$9~FWx+_V1{$T#?9wk95=1Y5~s6=l~y?D=j9hu6Uj=BK4s}Y*XHew;V@A?K0~$2{?KgGYr1f zh??UpD*8KW=1U}gNQe{~G{VD!hw7mFD{`w%!YIl$Jcd9Zw>7l zaW$FrlCW-vmxmkljBnlXXj*G%0<)8yxPN83Y z@Qa?A*LnrU>8scKx_}1PMS`Y#2~d~-odD>t2gnY< zGZMs>)dY-|t0=9LfF1FGy${GwIG&Y{7*84G5tK5AKLFM2fznMdD5EAy)DBZU*Y+jo zM}R)_0L=lQ*CZ#%TY%({@n3*GcLVWlG`pw4usvPCNc@jk`N1z#D9BZ~^3sOjiZW}S zO=(B(C(t|UMvvS`{|2R#w`r)oH0SdRBna&l(@W-+lrAXAg%rjKn8I}g}*9Ekoirmq65TOF-diClz#qmmcc3h}s#HfoZV&j4Ca`LS`klqVcvQYxgp! z{os+OH$dr97bXKYCCbnP*U{?+}bp-!Y0T zNVc>A^j{B969BKylb~RoXeSc%2SBGhKs$;Jim_CJ0*rJZ8jYMG$SU#fPoPeFpgIFF zxlE$0-VNMeUKZ*vfPV4-l>jgezJOdZR+#{zb}SX}YXJSM1+CzIZ!QgYQ*;h;B{bXz zNW*1w<4!uc#!u?R5WG*Leku=}6w@bOq;&24Xxt3a{PJ@7s`TSwQv;~El;HTUNoBZ3 zN@wC1%*JmkE~{KL5jRFuvg;$?&s<8H6OV{6rFc{>+7O=iO~1O9u9w@2OXu4NfU!~+ zO=~+#Kg*m-YdZ`A54uc8@wk#1S>;sw1bzHBa}3jOapX~@4R>)}y-b4mV9XyC)MiKz zcbaAi1*$8*9}-KwNt}}er0WUl177!rvH1bkiEQO)wM6f`*pAnzMf1#$A}@P5)$?2w z^qqbasa7~8$Xc0K#Pmu^XU^D_!CG$(?*+#KE-i$aA6}U#}oPOrbV>H@RyQU^h zB|2C4_7y6TH9vm_F_k?FT0LK$e!xX*G!IZl#E2GfJ^y$mn`|PSi5yCfE-}TkzMye} zUmsDD504jQW(woA#G`y$>O!tk`M6_{rhG_yP$SMOvgOSiT~+2FuT+XIfXq?a zyMte~P}&7Jk91uA!f_>&9Qky8^Wv&csA9{AD=bTR9%DaD)j_jjVzZP7w^mm=vpy8O*@nnKe{v2y${P>U+%%CWSX?ffZV>(2pD zDi!Z)PV@a}vD1w5M$$@w1Q@3!$Ts}dfmCIc%*Y-B(Qqw6dVt1jK`cZ~JpcpYAgv8i zv-h`v*0TZRQXto^butH1tucVuEm~rN8Fzxz;A)wN1A-ZJq??qqMj&r>L(n|8fIy z7TyNP=`|A8CRj+reViy*Fp#&oAt@NA`m{kg`m)4bi$*vq@}QA576Q;r4^S%r*S1NJ zE(RcCVXR0g6rkHZK+)R`$~nAw|27hcTA|c+!vLD)0rGwY!CK#yARht|-(~*}2PoSE z)D3`d-;|^Zw9h53 zQ;ay0OU^W+0Gca77#Ws!J~N+2hGG^|s{+dj(b%(u?Mk|SS@Y)KJ?{4e+_X~2c}t!H zLxqL*b=&hsX}&Y9)53!6u+?D7#U$jQ|IZ>9Gy)B~_-nKgq}XVO|Hu}Vg$7kx1dc|w zazwU*?-XVgh*`W=DxEvF!l0s0Fw$PN1TSoM*C&{ks|J07_j04EPw-vtWz;A5EjM}T z6a1HZoAe0*%YD4{34zOfee?+(mizhY6M~leV{J5ed4Rt@A!K=AfIcB~d51uKLfG=4 z4*G=f<-tMvgox!K!TN;A<)I<^gsA0Vq56dA<>6uagqYpL-dVL1+3~NiQy5Ne}=Gth3>tdw7e~anhQlFcywD|fr zr(KQpU(gn~*%pCAs1MPaYzM50a{K{2dO5g%ODOrtgm0uJOSfB*{ad1uM#or&>vTZg z+z;HPF8wceJy3{^Dc#@-*uA--NY^7$KQkdg->^UBA$6Z4b7a%!8j5jJ?qFXX5lge9aPWeMIo)mtfej5IKGFxnbnz_>!2z2N4G zKYq=G|KxY+h5tsfqp`bG`P}oVqrx|u{S96{-JMr57uwWvZu`Zce2q8nn74UkX(|ZqZyd99+)|J z{^eGQxd10feiWG;5V`_&&I5G;h~jGkMat#rt7qRLrJF0P?8peEj^|nGL~)?>y9cFe zP&uSi1%sBT0BL1TH-OG-L4y0I0kIn?0t5wak&4vHWkEF$2Qf9q%HIXB)N$ZDwDPYrF)P z^<)er>au|*4AyG^LHmmOtcS~CnzPEJzDPl%MHbc>BoTSmMC$@4Gr#L)cXN;%?(Btp`idA zPm-YNh)cxPS*hpr2kLJR)OS5q$J6A=K<0o?qkQk5_G_e+@GnVO9c~-go@q`#W~mr z%x1)krYZ^%^2QUJ21O3)Gt^G6`53}*rq=#f(4G^|DaOM+(l zP)tD@6eMa4P#v@=A*qvrnR#3LG4Q3AgFoMj*$xzswY-Th0h{*b{UkuE|Yn%=>E#G~r@5VH#;>VlWh^(2d?0Tkty6z{s106Do(!rqiH zIaDEZq!R50BiUEHNL6+%mY{Hx)M2G2F$1U=4^-`as2E7#3{9W zkyDC}nV=M_r6gMVVgy+|_DK7d{$O3mvvncVHhn}}nTe5&Qc6tFkSj}PEsRA3 zTh*v4XYtlX{@U_l$WJfA=-@KLr8E7Ns7b+N1+^|(YGEXJ{F+qdSG;-7pVJFPRkjE6 zUNU=t{2x=5TD&>vO``zG){qZSS1m|th=4440y(!p_qLl!Ea3IyD7A!#ha<$yGaW-LyD% zR?8S5vNsY}U1znd{y605#~~Df$X^t-s}I6C5-~Y`-vMIrT4F4a*UC+*aujc#^~pvN z1CkapXedSiKBc=BB>3|aAm?639{Pbl^LjAuKr8z`q~%BA#_CfckN-?x9y}BB^f}I- z`|yx%{3Bbcg@jf2KxXqSk_e;Jiji6mx74U_UPn6jen@rEP(+Fu&2D#H4f)_2(LMTi z$REo>4LS@3_icH$Cy0YD4bCu^tM3mz{}8NI8Mw}iIDtYv5np7YcOuaQZK9%bwj;^8 zdnIRVMmqXNJET?tm*|G0dCXlv>~x|W;^Z4S%*_WT$piD&N2)UL6PZ$rNq}Trv;_e5 z^Z<Mg+;1pf;VbF3Dl>Ie>gnXUpR5^pj6}NnGYSc{RROJOw8}32vHBj1;Dybn~As1i%Mw_ob zp80walrprGgvg6bH!8>Qb{BasTncNx6h^{E5e?*sQ&E*2Y%3^^aHB}Jo3o&`axUnN zt}96cng*!0matzQ568Il%9G)LJQ)tMO;3fN+<@hbjO!c1_iv>uKWz(~%O8sP=HUnwt@YuEQ|su<{p%z4Z>BGb@0ROl zP*~0BA>V! zXl=3BxqSDdNGI{;-Tq-CKw7E!5kQ$9puYgHHcC*NDnPRLApW8<#shRW0P7!Cr8IMhOprw0JK#RF6bK)3Z0)JYW}DK!oPbgKtw zBmnA039=H1I4FmMLjX&BGA*Yc$R)icbFv7>Ajo*Xkb6+4j{-Ht1C1^9-V^n^|Tl6A2qn@%TCCZn8O>;|(bPwfSWbudub=9>yqy88`(>*}L0q|;; zpnLQJB%A100L{>X1c%LlD4(?#>+3c}e!VG@IIL9jtWU=Fk#+XElD9oqd;!d z=Q1Zciq1=Ame#{>0lUo&M*6}!0Dg3WZ1RjQ+3t@6G}8lg4S**Rorq^~qew^!j_-iE z-2)T!g;DAGrNrE$6CgQ|eh<(r575m3?D$H8F35nxvZb8>DBA;+g}6H_5toMLj&zKj zzdiIeX{%-BwrN^516iOxBpby^P@C;R?Kx2TQ&Llp^H90OSJ`2I0BnvMj5opZQ%2<% zym>Z)vV#53&D`Q3FZW9Le8LHU(w0-#A3IjVMqI#C8<^ z3ko?N6b79!D);{?8Th^`KvEW-0?6tCdJ=$szsY35z=_>&VL63bHI=RYbLTb%)QA(Z z4o`zxt_QX8pfvHk%tBYn0)b=)`3ayr50D*z*Dgy?6`f^9?2yV}+I#lRtfD{A~K?wX5T_JTCQor6@8ui1{DD?UZ%cH)pi8ARig)}{Yd+|-qlfHKS zC+gCF=$X~4qP|>3U%*4Wco)2;!kt3P)w8%+g1^mi5tk_4uq>Q)-nB5IV z1L~sy4Co+10eS(F)qV+}JG3A+Ma~4E8x|}MN3B^a@-DkY?v^!+DyS%M@FS-X zs%ElE68A6T`aBQH{Xq3*n84jAuZ{X(J)`W)%Vt`_1*f)?T>&|VmK6nlUM0nnkd1g%g7NH*%f04mXfgw#(4WN%kw-R+Esm*0u{;60xC zwJ5pB$y45fsFY9FK(tg#RLK25L2z!o%u9`{HA*3lphZfV8;~Uby?`uDkgyeAja>bc z(|WK#xzhvG1i;`#3F>YHh}LjvB0v?U1E^dJ66Kx_NHjuWxR?9K&!ZZ?;LV}hRqmsd z6Cx@*yBRXoE z2vC&=XfgmhhDy+JqX5Y+;04fpEl8BR84z;@HC3&>YS;Csi`QAXWnHiE76heUV*r^}#r@H*KNt;paA;-plK;>bMc?3TMCm3Frn!_HoP9uep_Z^< zW+li*j*|s^lQ$xgC~}1I2XK)akUU)a0n*}xRmsC|WibK(y2}F;h^@wZC&;vpd$;o% z4Fu?JEl4o)I3Qal%SI&Uo-eJBKCqq_n@L388lKaED0vP_iQEB17rPOqw$L!eO9`A# z3~h8u+RvYfzWxjmT=!h`$Io%f)0_;o)1koBUgUC6FbLnHB`g?f0ojM}=J{E|TPHD8 zDlcIG-s=V=S^GF3t7b^pIvT^Ytuq`T7A+7N;`%OuHULoaFA2(|Lp&)Z*`y-?s`g0f z0RWCTLB}OXim*t4mS{nu7XAy!fLXE@sCCfmt?kh*uP|Prt>MK>-N(CK_M<@bJ}ptf ztQSDAFL}kov*N; z1GE}|k!2F}u-Z;u#{sn515^UQ#ychGLA?Ma3AT3w=ur>QX8`nBAVDeK08y)u;w2uS z6&|2b0KBtMfDq!Wg<#Z)(QTA$3SG&+!yomee`9^12G>zKwn;bFlOI_^yR0AVqRHB zU)q+(ytsnCD0+$%!&~$PlN!(!Erz&D0*YL66H(%P;gWlY85d;;1%A*Z_BnUcQ3M6O z{)mX|pJ0HOzHlZ*j0V#QbO5g6vY7n%&ZnetAVqyG0V%A~^0fUKc-^%;{U1?6>cP*! zT>~)A;*ig=XPzMik^+X(#wF~JQCR2@9b(n`{?=tCby~4ciQg_~dyiN|E5;4CEhe`i zxXA5P3JS3|LgWX*MLO2xkOPLUU#&Cb7}fA!$VqRJlg>qdj*&T$!JBwaFsGW*{rfv; z40F$ksE-V_4^K&3_s^o<{Z`RnMUw|oJ?Qn-s+gB+VqmJ=To=>QL|?FKw@T3AZEOP7 ztacRX1HR{pn$>wkLuMev6}VukV_)k_%t%L8zH^g1d1NIHIR1v$paN{TzsNYC@rN~$=Qc^J1u+UG}OrqO)T z$oBTCMsL^;f}_^|v^ttbx*=9`QMs*PXq<0cuVF+bDl0f_@3Mm5$n9oGzJ0#g%I{G- zT>9al$z=1lmz3Db>AV4aX8{*!{d4KcgRm)J0l8bB-Z$ZY6){AzSc#mf-w@gjd%n|f zv>T$y94>6b0j)~HRIL6?)g#W#Mz2uVP(#)9HY3!wsd|bQLkAFe`8J1|*wg;a{tMgW z9(xhA?@m|HzVd_s& z=zM|E5NXmkinF{wSbnpXp%B4jYH(i-N(Jhn4SwD4vkq?mO*{B!ckgjp#V7SFe=nPb`Z{Z zeDq2hkFfp0g0^8{&(KFo1#Mci*ej^ocYn!3Yz98k-;b(2B{6#ejeM+8ve0!j2#7}c ziMCNXg&u-uwD3@Of};`8BSzuP3YzIOK~R&UXcd&Fy>H_KuR=3EC|&}+(oo>$=okvB zqd!#CW@x?Q9#m7)N_KTa=-zlNIIuJ_8gmHGd`+GH*< zh&QZ!<;*aKS7ZR5LOi=P=rl?Qde55qn=a73?2(DH=u8qPw-~8OP=^}v=4Ee3ip=j# zvPO^k!VDdS*mT3h&_cJHwa|t-wbjh`0aa3%QrB)p=FrF>C^Wh_(J=?hKr`>G4Vb4w|t-_vidUog2)y%e7 zOjm6D+0b6i>_`U%=i{^j(?IVIo{P8@9&9x$bW4^u|M%=?z z+{*IOMWD{}o!fNZPjuait()^fTV7xJcc;H7kNGy&9ZKV_w0%s(+RDpI%STzuDyy)6 zm1yB!+=k3R*8LEb##WB)%>_2vr^@afd@Sl3<&85K=H0w`PF(rv^C{HL6o!&bAqw))Id@D??y@f+&Dm zL0k4mQw9g`y!;ns0`cwgtJq%EY4$Sw9;Mp6M;XmsKO0R|Ir#V~FJd_>;?35Qe21-k zB;6R_e>ro+TVO3O5!aQGM7OzT$N(yUy|4t8pD)5&U>i9a3N9GQ`Ss;q zR6le~%XB;f7fq$sWc3+ENqiCer$6OquEP#lx+u?Kd z>OFDlk~rP7S-~5J^)#J*0w{jEPes| zfn#u|&zLb|va9+6gdg~aJAHen(Vf1%`}L;JfkdrupF#B4sNU?ym`wag>)pE#?u;Ht z1jeMZJ7Y$Vq93Ej&|{!HTA`zmuz!EezaO=el$P2(>=!*qhs^)>Gr>X6Mg_ z?{$4 z!VrV#%haX?w){d{FZ`!#1$CP)Q{P0>DKE979iu|G z1O-1u6>2Xl!l1O+US`e5M=3r^D=76xIs|p2`phdTFDzVYR_2WNyF^(j!;V1v zd>cr5oc@E;#@8~z+nbawrYm!$>;1SKAo)b8eK@b+g!CIlb)@I%MW>JrxDx|5linDK zPU);P{Lp}d!CMzr&wgTLP;lgg{E0C~p?tTG>~&iXZYZ9Cz0z}52s1t){U zwybW^Q$Q*rxT6r1JxFgM+U4$Fey-mZ=BJg_%NWmLCf8wXCOX>}4HRl3WkqTT z{Xpai%06DuqJra>K3;yF#=N<6sX(JMXH1(k>DH-p$KE<=W_#Zg;i#H34h|*C_)akW;G4^Bq+o{JieUfl=(&lvZWzU?8NoW}x7U}!xzw!aObcVw_WOLOQ~zE3 zLO#ixf)W-wW??11)Ag9yJ#+YVIo;&fuWT^y;n!Ipjd3)vs`e1->I2M~57G$e)M^Ei zWXtK{%lDG`$axR3C@QTbdEgu7NY-f6i~eexo)Ug3{*^VhEq(%XC^{Cv{&eo?sNAA^s8jv?v# zz|Q#SU=B{#2gTuAa6CRjdf+28(a$$sAJ!8OhFkDEBDLKV3_&-E+w{8pAU4T8ihQrT z!AVKI`7``@Y|B>u9|42eaoO@W{-aybCN&%`#wNTpDGekZ;01XIp*Kdo7LL_M=sUzm z;xDBSsb*ShI<6mWI;kJUwPWf?HxQ^ilA%+e@}K`8P_0A9!rYHH>xM{!O-fMXtV(E7 zf-b6b5c#Vurb6lzYV9m?zP{OMPl6Cq4~41+A2NC+9a!$A(+|FEGTAT(_PN2imkf`O z-C*cT|8e&6x*WQJf$0RBA5tfxGx1=2Kz49$s$1_Lin~*_y`N38)Fi$2ZD zXA$QxjVvv7*sLWM=(LCwWSL?s%v@MznP4rmOtn>7#!sCz(Sqb1mXY>C%0{{E&MJ)l zylpgfR&6Hh^oeL(S%MQa!m=+pF$#r#T5^KToB%p$unq>Gak2o_wgZt0zE*%tPx z@%%bbn1&nZL&1JBOYU7Qh?33pcGFIZtQA%plDZ4y59>^g?Kn3Ep!Fg#k8|(P^O|_Y ztwP~zSXo&rn{;lez~Ezj9VxW@OQcfgVMQ2=bT)`|B*{!`x7%>c`b+^*+q}fO3o(!k z$LKA}MlFaLbJRTss~>b{J9KNl9!h#Cy*}Kjd-ZJ{S)>KY8W1GWK$3#G**N^)BnX;j zYes%`wch#)=uMd`klYTUt(IGW&DQp8Z1zzf)?3#DvNngZQtRBV{`M~2fn6*kM$YzC znCeqTWGlZF#GcWXjM;8_;Hpp(`p1K$R1%z#!Ci5)=_W~{lHJ(gdk7U@r7|s1h9l)F zsY@bfS|?&``y6l944Tvt@j{a#aZWb$N%-$WjKa%3Ml8F6fwk{~SMDRhkC<6>@B^Mg z{3EzNXdC)yTUn~SZ~YU=CE-DqWTtS`k}N=fR(xf87>e(zd@zvi@d#Qh0apr61)XNc zIE`^qJ_$(Hvoz0Jry;ScdH;|ggoolM6C~Z?wTh3aIQh0R7*+ncIP$*LjE4eHjW;X~ z`n2LNsKZP*i`$A=gVko2_=5vw?FEa#$NnJpb0Jc8+mXL!pYG*-)OemapnLNGc4ub5 z#}L$SnCw*C2oT8@(tjP^^kRl?7VHGaI1Jb8qG9c36fir-NJfts@g~z5|D!b(`Yodp zLr5!gJDhv|4sFW%U*9t~ouu`#0%k4Oe$m(z|g8g$x z_+%b*hf={$qOtPw;^Wj8i>u(1hSeK&o9r7T>_`wnL@AMi%O#2UL5m>ta;{)Sv`wc7 zAA(VtE4Xir(l^6m zOS%_ji1I=ISu4ZxN>zN5IvH#C-Pi6K2G< zn251lsuQ^H2FXBD-bqGK1)2mO#z-;l8WzdwRU;?M)Kh8hjIP~T-Pf7K43Fh(W9o!e zS%@WJyl>d7A>I{lk&xOJUqt1VEqgiGPcu%6w~nC5R}K0bp4AQndo}(DkLwFgZLT(l zt~zT#j~_-0z}nmc#?Tr!On5E)EvhTVSnBJqc=ms=N1 zE1hDq=9iW@(81BMVGfKPWQ)??pIU^|vq~4p$H=Uw4mGLc*vSG@w!Xfe#2QRu*76C~ zatdNd(<|RSeTNW7`E{GM0%lFz5)zWCug3b&JBsog-i)I)YzWp`#vjGw&r>_ci`QLU z=UVH>0IYvkfNJ44rycWF;L#V_K{Bn!@c09}WX%aDJ}K5$0`j63!cHNJpfq{U@83NK zKg9Ic)$>_1Bwvi7RXXLq1v=3PGo@!?7%rNOFz2cHy8kh; z8gfRjOf%Ro&zgmfE@Xei<_x#{#6&Mqv&K?MJVNAu-ybP6`lzIq?NzPi3nZ#3&W z>5NfRVAWvl2#YNv^wwuz*D0Uk&H6(_JNB!{_siOL$|q_o4Axda*5H^l25a)rWQ_oB zl|YOhzF&`JD?JM+<|VeEW-@!lrMoMrN0{@_*K@I!Kn2Ca_YQpIUBa57GShxlx_0sB znL)%zGxhC~sxs3Ge^WpZFGyo&HOIOZ@vYW?F)Ty%2nEUcg8l%$Sdg7PI3PWl6Y!(jMG$BCkqw}0>km&JR z=XivPo+2w&MUZRE39TTmneW$IZ#C$Z?RfJ%GNx&BnSxvvxrAwO*bfD(meP=b8PPZx zbn@-AY{cqrRp)x^Q5AD*qof8$IW4VJ(6UQfPRKMo{_sCRdI55WfT-Q$)TB5yB~I-V zr}mFi)8o{kaq5UTbzGb}Ax@nfr)I`cwaobHOcQAveNzXf_8EW-9MO@qIe|;mOM2r? zk3Ig>TILOf1*Hm#Es6noM93=Y&|l1cOV8vGhKg0{3jbB=60cS2`=(XuNqm11?>F&2 z>JP*^{~EOu-jCL(M(iApHrA+<@pC4=+vxrg?^<=bPpujrP>Yj+YGFRFRlDN-KCbr< z#sir?b!wlWI&}ixUwPH3w%|G(a9(HHgYP>qUsQhytXEs`)^(^?qw&6GtjD1c_3Ar_ z_P&QG91U(zF9bJGh3CEz?@tw8S~60z00=`Twd^$?PkWqNc4-M)7i4Q>4AnEK@(77R ziQ-Fv0(HAFt`kS`%cOrY)F0)s7fHG~Q6+3~k*9U$=3Q_5v76KRWu(S3vHh))$M}sA z&SgPHZpz3mZ1u0SWVB{oP^8u4mXEC@^-4>ox-9@QU;~Zu&Bwpn zLSuYsiM%P706|*qAJU+Xeo?*Zqo`ceEvgnZi;6|H zqE=CUyZg z9;#0dHK2zY+(QlTp+@&mJM~bz_E5X`Kn_{oYCjaG^vFS>Zafrojc{o)PSQ;i9Z@aj z&Zp$qM|`B=_-6F1HYp9WsDqeshwjn~1_a)z>z$KCsTu&4@n-qZD*f3Z&Ihk6caNk^g!1CLESk)q$Y?n2Klf?NScn)v)0#<$gY8!gtWuj zcqH_vNC>lf7u{Mb^wY(;6$T|p-sn#R< z6DQYhM4SL(e+yzpbKl1V6G#i;8KqiyU}er zNe_HIZ+v%pfNaa~yUfbl{^v**4H*Vh7H_py{VJN>nDat$7}ck6*HHMBlj%^dzDUy^ zHN{6(s}Vm_i8TIO=RcuWUU^FJT0P#wL(jSw<$X;w8NT)j#~Z0{(+Z!{48)qE%puV} z2)Y?hOWG%U2v2)@j#MV7w#w^*a-FM%a7~`votk8h=^^Bp!kR1AnV@)Ky`WkTnp*i$ z4VrHVn)U5z#%gI&6G|0qv-)k&EAuzXoSvebYN;*()i)(o(`rA{Q6Czh=dV6qKvE-d z_~1E!$!LdRu@R+ks#nQQmG3TCKCL z1z_ZR0@TzF^e8~@v@UVwZI^yH9W^>!*X+QGA55L}HP&!7R&9+n zUa_}bHPESroJTGvR?;Ns_31jJGJca$h-b-Z>M@ulSt~12sf>#BN(eHY$dyPn2+f0g zyGxIR2C)2n!E$v(H^y4#j@}vcgbieyhPCiqar01CqC<7fN_2z{hb=k}Ds<(U>VRHx zTa3!1c(=22Qs(3%OtIizwK8*$A#)3zg9yy`?Tv(cG&wUkD;?*jF%z7m%<>qjWEhkq zN^}%*dR2ELZyWje?JpUX-FV+1ue@Fr|@whg# zF6WoY{>+VxTdav!I{)!jnHT1bCH>yCH-djI!=n^}nqJX^<{P~An~i}n27FcdR~5%~ zMs~xghG~~{`U7-OatC%|G1^vi7u|tauS>D&#aQD7I}RcC!fhkY%3RhQ-SvRuGMr)j z)aUQ7zWnm#t(ScLKY4NC`3u`FpTFe$oc-Vtzm@@Q=P&sk#((wvrGP^?IJi@^;p2I~ zw|3YN_JBUP`^Wwt`Lz!H{ai@w@2!5n`?bcl{T_Su+{VDPRzuj{!n3VcA{uc<^4@u8 zuS9M1^1IR){D2zMeXsu>zbiw}{ub+Z_NL#@b=rQup;GB`1M7^?X_VhyHY(>|leHv! z0h^@rUcf9IvKPdgP86CMt7thKy&xzfSkdWwbfEA1O&!hPBPx^&BZTS3xcdZZ?n5bz zNO5Og^tB)&>eDANhbVF{dZ%enZeOWN#64L*Bn5&uhZEnA#Co;Hs#ju-Eo5egAYgol zGZMCx=v1+##0%AM#Br5X!$x2JUG=@8;aKux@EZtufshfr)w;BrbYz1`b*>es;U|;o z{AXXfJ3CzJ%qjR;FMn9@112~AU=Qt`?)X9a*3#G&d?|u0anRX6{9%$EPBNXeWFob9 z$jpivqeRib;Y4v8qE>q+kxM7A5=g8UhM8PP{;Ke}67o%3i%+5!_elBHKe2%cICd&8 z6>JjkYk5bdH1Qq={w{kD!B1+!)P^wYv$#aH+@9r3lF>lQr*%|AsTjiM!v|94 zoJ|C2_{D}~1de#`dpRPi_C&GLDF?+hD8WZ>g9cu9q9uipT+K1~sW|)`?Ffrzw0`3p zI-1yd?Sumfp`+7MkQA>^;qqQ>3vWN;eo(^~2!5J4IaBvjw?Jq#Ldb}fI+xHVR?#bP zmr;2eZ}otV4foL9a_BmDJ=EspX)2@4$&jq#gNK)Q?2RYqByzuv#oWJRvGC?tEYHSS zJatiVZmDB2_ufc~C+o+%k)tk!5H`D_r*lw;#z~%>nq@)Zhi;l2V9NA2t?<$L*XIC* zHawnf-=gpGrMrzLF!A_FgsGj5WoFZn{=d`e$2^;@EXC>|hfvln?)&*iWHzJ^snQ zE^JB13j6R33QL9xTg$plyZI8$YKRRxN0peUvEBkUjNn`V8(dnWMu{Z$fe%tzlg^Tw z=Ss+0k!(=jO*L@MM?I40VVV5|4dr9eP{bsz5z{P}8mgX5bnACwqk#1UsP@IiDAo{B z4R9<$?wy+Fr=a_Zpxbz(!n&DMh(B^tL;}e=5tKi1QcrJBeIKZQDw{WTeZJ5hwu;U2 zNqctMfS9llI~J@zg5)jOwZ`IR6p%trdcnRE{x6^Or`TR6{ontAz9{gxu5)e&`s;-M zx|0Zafy<~L*Yy=Y_`mXlxX#%C!!qrc)iPo~vbs;3Rpv?L%4mE3iVYK18?w0)Z%(*R zoN#54LhK00?sp^WKKGzLa;MP=p#}+C#n*)py%v>8XaC$AZ%=n55T6&6gVKyQD_x^UZ5%`C4vNyLCvULgVLGKZt%a2kqvAq=PY~%L@s7nae>EKX(3iC}d_F?tuLg5e?Rx81$lW1lrDomn$B}*yk&w*e2RmY!q>@g(v*66O!b0|~qRi%S zumj_0-Dl2IwHM;>Jo9$LIXlQ0a=56B9QDc^Ry$*T3SXS&*@6$#GV2o~4a$3?M4tFG zmyab1vzL60TpgCVdRR9p_(2_wm{=uL*h+RmmBUd1v0y8)Fh5$0wW_kTpfs-%-d|1B6~izN?34co(+pv#qbg#ze((+tc3SuG5i+cM_J7G*f~n! zELeqN*aOAr5S)?x>miD))-qqLmYG1ljBsI3i`P=PkuMpH~?bIW{tg`G~+ zh78Lp8erPIi$;y2%F43Ay?QNJupo6oT54%|VXr>v>FK=|I_xF$oE5!7Z~ZP4r*MrC zHQfM_t+h6Ng9<$&>zV0OXdPAF)=2=YmLPH<)PlYRsJT7JXtcfqz$FQ4Y6m(F&}S0l zv2U1+A_Y6n(jH!=Vm{p5$*;fhnZJG|dx~dCv5Tj7FM5vIIKRH9{tXq+fmub=CB7cs z@EmmsPaHTjs2BOVvJcu;t6QR<6nu}K(k<5$q}XA}EzMtKp)KH+BGjgZ7|LBnxmc*Q zSE8k0iGe!1#afONt>||JG*e3fT-eb*2}l3>Sc>{uiqb4a{VYZOEky$?MTO<1Rb`eE z>wHu{+wFz6Jl~R!hVHQBS6XnCd>%Hi!4N`U;qYN8v**!%HcL^t#a>*9%vg%isV$`r z3-fWcR5>hGORmM5n_F(l&9~!SYQfh$@)RbAUke#BEcpc`7F)5!Zkd;x4+7=$EO%PU z%Pi;*<&}As@~YfL7Bom}ahV0(!vSB}GHVG=>nbmW6sf4n#kX)m@}sx0%Z<(36V zfk{AXRldCx1aX(P&!MH}+e(pAF4{0(h$io3Ycbk*Re2tAWG$I*MM`<)_OeRqSNsc3 zjX?J#>BY;QhvMPQnI-xLtBXojH-knuw9~OH7SYoqa16?T$Ct5{$ssZ_zH4Qw=I9}HQ^S`OqPnu2Ws3g?`pkp|v3@732xIm2Q zwDz8c1EBHdipj~Oc0%J6gvRGmXb`3LwyR%~azKuo4=}l+pcGK=fTCCQ1YPqySkyN7 zDbW+zSJ$-8HPJ$^XRi~_dMUSJ3l#Q5vfRL%Du-^c`5%cFdf_-Tjm?UgI8GzAqcV^1 zLQj3+Vl!q*EK;APguB$!j;{r!7apMz*YvU7VW#bb^U*mJTkv?%Sb)z~vx>2>`T@{ThIAWX;U`PgJ zI0j=V25MSWqf2aXn=LV8TBG_-c%yo%hgOx>SfnvRrt*mabb=qCgoovddgMDgWn4R{ zyvw<*$^*kf7Gv&pD%J*ZW$>FYeV#<1rx zNqr~07JL&~;|7YiaGv2noHECn7A@#J-skQFQrN3Xa-pV-#(oK+ZL4suIFK&93nsJ} zG|;cyvWOdKmG1LVow+8La!A=HvMejLb+!L^9a;Ec{lQjp`j~})0;$Q_DRbkqXV1oO z8jSV7gug&CY3^KjEaCUXc^@3%zwJ%r3S)bj_wxc`2dpmQ~q zu4(K#a%t@SJXLAKn=y&@*K4b40{HN?IVtmWiwc%GRY0n_~tPBu__EAN^6 z1f`cYXG1T@XapQ%++98;~h~L__~*3dnzS?y%Bj&D?zyYT*pww42aHON&DxDVg8c}5+Xb+dC583Ra}Sq!Z# zDbcbx9z%;RvEH-)HK=`hHb5*jXvB`I8xlX%Q|=BYd>4gcjrvqoy6h9Vs}pBc%SO5g zc{?HMvQA?TGmmGRD?#>#FVAL$vtc0_&&Jf&)UjIHUG~D=#9=hBjh}@C;xEbZag$_ugmih08l@LZ5g#6zf@vJW-@;a=RtkyOH%D z1XD%IE(09Rcvfkxaj<}>-IJ|9Af+mtVWNw#aRzW&|3c`|7ecXM{nAUJKfJ^a5Mjo2 zELgLHos>DGG=Ux;?X1~05aXXVv49($Q&4F&LukAB1$;yn^i@m{bB1F<%1k05LRl`?~+ROjZ?#L|&2Qn5%Q z=_g`^E0*O8`$8YsPpN#qKlG^sJh=>+8fg&P)E-4@r?jbYtE?y&vj9=KMA@w)k=9YX z8C%uq$&9h&5+{4fe?afFpx5Zx_KBZsK6&6lBl5$J$ish_gCSif_Srt0hHNTct@?1X zx*}P(tR{B|F46iAHPx}qO#R)r`#Vx~Sj)=b=R^i>pzn&gZwblfJQ$tWg_Ru=1`#<* zq}Fr+!9B>d{B!9llD?RfzzvwrUM4th^azP7pd0W(o^R9M*n8FRDv4Nzm{!VeF+`(o z{&c#*5Y8Krm*dN_TPd>)!5lO>LDuOSSNnfQHyO(9CNklBd3SGOI4>B_1+2Yb?nqYOOjh4XR^Lz72)P@qVyJtPHADOgqjeijXZc>9(87(6 z+Of6)E#oJ*mIg=l>E2euc~yzWn>DGLb^~-HKtDS{?ft&Ss(X6!#gJ`@qf{7kH9ga* zcM<2PjxSc7I7fBt8tQOe>nbTt#A}h653$yYiIL_YuAAl{fBBofyipx? z{}Oh3h(1H<&9cuO=C!46LIHk}1@O=?)S=zb`jNTa>nc8>E>v9VY=25qqpGv$1~uf8 zrJiz5EeFMIf)jTWO521bpC&AS@Lj6yBsO_n(ePb6`NSX^TwJ9dOLiA_i6oN~eaz>Vv4PD$O&lgkJ;%vC(h73QC zEa$>)?%2{dCy6^}HrUCi=u76WY?PK_-5aneYhHLSpTYmrsqP2e9jS0&0=OnrobJ zw#F`a!nrC<6{@l7Q$5jgmUcoQs96`GD3`+9SIfm`!`^<5Wn8J|+?!xwB3V00T!*Zm z6p>iDBX4$Ld+rNzTG-6jyz@zwDcU*Eff|PKyWw z`Ecj5nNe8tXxscs!~&==V+F(pRlc;u4CT~ph4&X3jNr#L-{vSSBl{N~f!CKEu?B2| zeaRAA0b_Ncy|Sn(Hx=4fulZHBJ1Xci1t3Ng&A=L`dv#LqR!V;p-ZM+9%rG;W;mBM9 z3l+-({KmAY&`6i+JHa~7W~Tjd=E_ntIh~o2Gnn&4L@hHtWnNHZBW#(YbP*AwjJqC5 z^_^<7;W;7!o0=K!YckU;r_8`!SOxQDFHVBWm`dhiV$9~M1i zV@&iAXCOu;y0;EN^RBjDQ5)mB8N80*4SyBY8xa{*L}WDfzlsoyUOWUNBVr0{4(Z&s zDJk9%gs?mRfC*_1^=6o`cJV?GjF069A8!ouRYnf?ZSRfM(R9K_B8pzdunai$R4Zy& znL_(holBaK`LIGfgR*Us+BW7W5wWiiA~BSGclO}WS5m|h2VW$T zs{*bCi*}r1i%3|)V2oFEw`Elh_|E^xIIx_2ZW3qVGcIAsu`8o2au$s;Z&8CS$7XBZVD`rbb+3q0)t=5?Bv0V zGZqhC+$|}4)~q>5WO(*$ZK6H@zZ0ddKQUoRM>1v4;(`0-&YqQ>lAYQ+C4DZxK%>wX zr++M^t~$FX@`>O2Jx$5f{Yae9??=9zzJq>e4^A3x`ou_=V%|7cK#)0@AW;wRyJ7w- zq$4txW%nAMG>ns)bADh3LFWv~?nOPbbM^W*>Y20V44d7Pp27TL*!iy)kd{1WNY~Mm zMopWUm1(Bi$+*odmS3B^juHm$Ic+AMkwMSXYqs$(SO#8Q@6BNQ$I z^vunqz|)E?*$YYep^|Lh=e3q{*uznIlPTPbE)D3n8b?IpQXwvN@}hi?^giE}^3a3U zjc$V4^dcPMuuswNzjsqMdSJm0R~6GcMs-D3(*(w&@~GRlFf!fJZ!(Qz&!4`(&mQ)C zx3qNj{QE}A`IYx<_fsYH0K*-Xiwi3kQ!h_|P^Qhjy`WhCi zY);1FIrHJeFc=x3YG11BSWDATTwF}|1}~lir|YacuKe}AB@WjUXJuDpPo3QpV^Kvi z3TH1_Tw1`siyKLxgTj5fY`}h+W?Rs8EEu+Cqa)#Q?a!p)@pu+IU$gS=nUu9T*@=s@ zlj7O6?=E%@r%C3V>{+QjvuDTCbGJ{){gkR~aAImtJjSLYoz2q=NzJ8AL=Er+6C3zyT>&7>(uuQ8iSqxmc&HTr`)_ zcz1`df$?`?v7@A7@WiPI;Yej0lN88Q>N)HR^6xPvP*b{?)@tp9H<&`}5^LSYU6?)U z5y7rrozSJeX_YRgHa8LZA)c_#LhWG4do|R}Nu|uI7{>>8i5sLC1(I-2N$QjV=knNSZr7L zRAG-PhfI-F@8iQ)KSc5aYrAU3kDMY2*d%f>IGcJ2v#&MZ*ayKmFmP;yXLYYcY2u0Mm zlk1FJrqD3PV5Qupa;q7lh%}XIDv44ErJ@vS3Z+sMmCpBj*FNXWQGNgK`9IIc^PBZs z@4CI~y4PBJowaZEW^jo1@OPDVN{-TyP07SBNpbdwDD3^mA{V|xO(pe4#gEw^xAZ{9 zu|(}U@b3nvt`t4fWV;Ne@5sNRFI8ZN)$S`FYA4X{^e6rXgl!lKctX) zqL3tkPXV&?LSONJ2D@$7GhL)uq_Il-zV7^jESW&sU?K$fo&0xDq)@ij zv6_;F?%|@g!7r~cNVv`+VBtO9hcct!~-;z;L5kohM)S`uTx{Am#MnAFO*vW%isFeK0NQ0_6`ea z`Q@3XM(qX-B6@pnHYd&Dcaa2a*?7)^|4qOa2b|YD z7T8xZ(g1o@9fZ%Zq6)DeGXmzq`M!hA?BvQ`kt|Q^aECb(+hL+V=dxbIFU3#b)prl< zpIy4yxngb7Piws|s)g61sos}>q*==ZSAP3{0nPfnG(`Nf-*>^<&i*s#T?hW%jl!;K zUcChMZNr4f2E^iYak%7{71A@koBQy~3cKZS9-{S;EeGlEnWyWEuf78ibocFv?@8Nz z1Hg&5;X~xi6Ha;IP}yJ{y25!ZIj1&I4)F~hi9a~9G^|PgiT!aza{#8LBj6-wm>=T046aQ3t#qk_aTvs|wU>Hd zd8lhpD!cE1$&y(m^ThQ}J@S=o;f1x41EOPwG?^fGdE2>0uNfB;r4QNJ2PTl1sq{@j zaOpk^Hr>6~&O>Bo5^btk7= zNqSV$H@WYFllxBjhcx|P{?a9_n9ZKe^W)W-1@Yl#*1Aske2+}|Hc<69TUtG@wnljt8ud9FmL-@>6HK_dJ8^5Db%WyxmkO}JIA0X{1djVX2+aus6w zJsgw$ijA+ZPGWKEVHiRqSI*)VIEC{Y)yIY8$3ohNYspy08HZWN8=u3vl!^1PE^XrD zSeG%S;#rq9rAx6+Fl9=!E@#S?VO`$1Wm#7+2`=l3rd$H+L{q*T>q@3VdDebYu>$ML zCb1&xYNk>m>wxiB;sd6#pZA+8m3g13T7`9OQ>`lNIwq+a>$)b8#JZjd2KYmBS&(%D zQ~fg5+SI7dx}m9AgLR6jRg-lyQ@a-H%T1lytXr76b@+W#uP*O0$@N&bH}#WQ-(VWl zXWh~02CVNe4K?c?CZ!?kKBiF$>wczjBi8qrCXHF&YnnD;oo<>nW!>Lg-i+Th%`ay? zz_e)2dZ209g7qNNswL~e=89IVhnUt^@J@4OYt}=}Raf#3bM;lMhnY54v%b%?ZNu-F zYufU5bL};(N0`)WIe5}sm&(BtrrmWM{LZv*$9kmc(4K?en(I4ou-M#iJ?l}X;|;9G znzW9rGt7-?tTW9`H*)YBbMs9c{MvN7ne{|-ODEQo%&oVu&N7{EW&MEZ(wX&x=C&@Z zC!5=EV?D)my`A+`)2%D(hfMcwtf!khy0gwPJ?>yV!}RRII@k2-$$F-_vlr_;bJv}$ zXPMr2v7T-E^kzNB+}($@F@5i5{jllRm-Sq8Pe0a=n0xPG{isR5m-Rf;Kb`e_GoU}~ z1!mv?)(g#`fvgvq!Gl;YHbVxpUSft0VZGE08_N1IGkh59W#+!&tRFWc?qmIg899RW zlV;RN*2~T4QLI;(F{4?pG-JoGUS%@Ia`3px%;4ZLGcJ>ZN6r1?Sg$tY@8{rGX2N*Z zPnn4mIQXTRG?8__$(qEvz&wz}dX0JT0oH5Hz5^(*FK!+NWk`!MTQ%_DPJzh)kNg!MaS-lME{nfdcrzi$@IXZ?X$xPbL;vuGjf zJ!bJD4jwW~7PCHJmM-DoXXde`9Q@QQdyMtR=J915{KP!*IO~Jv$tO5?&@6wFgCCm} z%UOS7R<2^=D@FD%OY0Q>$5jVV-`9^)ZwGGza&af_%o;ZPpZU@I$k94F~s{ zXV$VlZq_}+`fIa(9S7ew&#vd-TjsfES$}IbJjePwvvC9K@6GcYS^r=*Jwt;oEy9VU_4 z@eWKTvlI6lXot+ZJ7LC?c@MV+=u%{M;pPBcn#}vVV3r~C!TT`FlG*(M%*tf;?1ou| z%-%gPtCIO}FU)FW_TiiKI*H7Fd}dw;$sE9k{FO^$Q;7Q&~;rhhY!K5N9OaxFq6rA@j1)}WR83Rvmu!;kHAbJ z^A&#EsT+|w`W4K^WR4w$*@VpTV=$YM`T97_%gKE6HO%H@iob!`g3PzYFk6!O?pv6x z$ej2N<`ra4o`Bh!%qe`-Szk%!`%^HlBJ%_0?D}dlr+6YD5N;JQ5nM3FdW>V zkDK7L%J>L0xL%n!@`0>VCLR-RBytDgGm3=E&z0^0TAE4;y%V$yl@@vz zXjv*Fv^S_rWf6XjG70#M1Y~_6D@O@J?*=VT<%ISFtw804-UC{ZDhRz7G?6MI{L{)* zqC}CUL*}PSLi>YOCO@24D}x_Ni)5L7>&Bs!%MTOcGTSIs`O8NkWH$1}PwP z80cjb6gnKVI$b98KF}IeUFZnVnp8vRNYGliaS3!3Xl<$`bTnuksx5R3XkDr!bS!8+ zsw*@DG@0rN%>=Da$wJ40HlX@K@e?Scse#Z3K^u}5IvF&D8Va2P+K5tw;yxSGm>LOv z2($?`Mk%aRrYTN1K$ZhpGrTAPodJ3|H4~Z(+MF&IIuo=7H5Zx(+LBrboekQGS_;MF z!(2hFgyMn})0(ajifd2ImDCz(Em!6$x>971LUuJ>C3GHW8@gKPe9*SkM(9G&YpAWz zMWENxH9~Q-g-NAr5!DmQTt}%QTMk(}x=tv5R&Cl-JE1Ep-uk4no(1-ayw2 zeHOGM-5~Ti&@}2ObR+1ElqU3f(3|K+p_@Q&rkjLr2JJ*Q3w;6f7V0E)3+SzMi_jNA zJJYQ~3qiY3XK1@jncJv~$XM8V1&^xJ@(6>PEqC16d1MN+B34I&15A_zh9rSMMBXlQdU%Ff9 zyP*B3uh92E@1cG|@!L^zFWrMY%vC0x?ge>Rnf{axGDn#K)E{KFG6QLVc>faK2hl*G zUx5y$K|-;)VTRCPp%*}h(h#A4fDWUfLjMFEPQ!%$1$rM17kUwN1l=d}Z_tr6LTCtd z6pa*$m6;h$ql5xx42>4bpkrx_PzN-F#tOxKjwX{bgvNo6qfDXkp!d@_p`}2_)BQqA zgHE9FLd$?oqzOXHf=;4|LS4`-nj|y<^a08eS`PFF-hHM&Tg9aZ8DKnj>37ra>L(|1W5x6VL@Xs|?x{bRjJe+6;6NEfjh==wezVv^nS!S}e2$ z=u%oDv?b_cv{Yy-&}HNhNwvxhy^34rv=a&H$zH=X@Dcad zDFJ;TP}$o37?2QsqK$H-7iD?O*doptq$Kqb;!+Vaxc_^!Z&D?+ah3BHRmRFz2bI}I zFG)5e_yq*7f@ZDE+w^j*uo@b;%Gpi<2~$IvcSv#>4HLxVPu1H&c;gw)U2INv5?;9F zmr?HTY6)&|IA*2&7eN3Vj^SN>h38>t!ZQ*BjWH&!z~pgOAlUX{0->Z$}A zYq*e6rmea(Yt3a}_ebh9} z_S5BIc7R%_Ks|B&h+3&YePJI{>#*xVx=Oj{MD_`_!L3!9A>Bmfd`hx`tDCBNpV75m zdHC^zZ)pqA`!L~MGxQELwTibI6Z)LmLxN2B@f+LV=#U!bWoC5fdh1i-Rhd$;q&lKw zEB_Jrljb!!Gjt>Rv`YSxZpJsd?$NCRtyDfVsrMz_;)O+X{EG0BMrsQDDB%T6m>;9A z;D~#O#NA!(QTZspoa593>PI|%O+7tNwi%xd-HFk{J*)DY;Jct_L*Gzu&(&Y-We~p3 zq9*RP(gZarGt>`b%6|p;_L2bilmtk}$n#$TzPltq|B?U$m3SA`PZ0LS;Na!;YZ`1l zc|GuKXsFUxg(J>6Ny9JkdEX^IN20aHtH720A`zb=dHGQi@t8}zXG9c0iF{Ak+mk}g z`GLmUFy0U#r7}V7#*pB3^wTs6V`(MbMrv#gz7rD)p+-NrwAubh4|s|Ce?sQbGV*?= z$tpz!M`0W~L$9F+wjCAvg{C0|c*cuMEF)us6Q!a*km3*G^q#>#` z9pT|T&Gup(aRvFbe!}u+DxC!ep-Uf2BN@iZ|sV!M&emX{#0z7*HomBoP6^RftqG*I` z@i+=Jv06pLiQTK34{04@0?+gDvr@IFMH9zwOVy4E#q)C*R-js@R4l8FI7lHw)+VL$ zO7RQgADK0!dAs<}43*(6-Y|5l$}7u-5qFp0@!Wr*mpu2*SoHA@KOG@qoEQ4q1yApM8l~;}Tc;(`a>q)#fJi-Tf zUzi0M7xURs|1$pAE3mt<^5hRna{P(XeU%@3tHYJQChO74UyJpa|LPjG`7@=*2ga-X zehPmj8+iEF;lpUax5h~7@)wY_iILRfFCoz}l4L##30k13&%03%IJs|gEead@9 zJ!!}C6hE%?gmR>_%dwtTL1U5LkUuO@{~N5lD(Dv~=`H03>DOm|tBYoSr{9>R-<+l2 zs-(A7(r+i|?Fo8^s+Yniyt0SVjrbH6Gm^v+pPMiYCEkAo%2U8&U%gcXE3iTG~r*sp}!xKTj>Ykhx%Dhiq_JMf5WwgnW6Ja ztw}&3T+aKD_nlZe^L~)`lpp)fdzBxvT!{xE4$}pjQedx5#g9p^#5~NKK#d9gsq}}J z`oDOIf6R<8@gGup-=+SsQGYy)68{eA{j>B(m4Y9snQ^2KSJI!WM?Zxt&=7Ovt1n}qk6E>HSPEb93H@_Qr^(JpC5QWYr1WPDxF#`_Io z!1o1X;;l^TX^A%~MZB+L|HW2^ef%eR+>eR;1XLypc!fgq`6?0yS^UBlYRqILNWlXt zT!mh7U&GbCchQPt`|D3z0Kn7~n6MS0h81Mkd@01HD8!0r9Ub^%389uqQ@NfG zT8sY%uWgLj3!j%$aF6nLjFGgU;BMtli;=XV;0MZ&#fObwLbayg`^t|sNK|qa1$QYw zmLgF}8w#Q|Vnq^_TtmTkl^+X}s3etwJCz^nlc=N}1$QVvmMKw52MWHU{9R%sH&Af9 z@?-rH^^->W8|A;9gWE103M0!9mDiPT!u%Aq;cioH$A-G`&E&o%tUKRA?)Sp(;LhZp z64rxnqriQ_dU96^j1tz1yOUci>`v}M?g?RcaW8Ve6V{vWBKKQieYg*~CxzY3eaZb% zSYN(}0)vG0<8%rP5q1v`puk{Z_wpcePYX-uAru%OtUnJU_XlAE_&y2@6*iDZQedpG zK|Gq=Z-fozvE+U&YzSwP`>C+g*jsQ92^-22C~!d7FrGy2XTpZ_0~B~(*nK>i+%JTU z;Hl((E^H)cQ(&{OQ9Pa8PlS!;8RQ-mHil=C`?0XGJd50)g=O#@a*qqkWZHbVH5 zlE=#Hq))26S^S3dU6v?&C3_Xnb2R2doGtc@69?sZ3;X|Hv9-fNWHsQmbbpf7z zb}p-ZbZIA9h$n~5R{$584~l8T)S(P zGEXw@F0*=JTD2V6Q7&`@UxAcLyshNp@CNZJB&AxN!;I-@IEK~yHIfPE>>P4-oC1v_ zMO~S{3441AEb2`P0PC};7Eg1r7yW5E5hKp$Z$&vQC6MwEJ_Y4GK8AmY@&f)b%GdDE zF~QgJcV4Wc`4^POGkikIBY@If$5^MJbnAn!XDmj*@eG*pEdNIJv9d-a&5^JS_(f8bfd9F=WWG`?zR;ixM);{9d!r1SWbpblU8ct-D_agflT?8Ui$R|;d@bwa7uQTkc zfU9D|>Sa`t?LDus>~e19?>+0yEPI--qS~x$N0!aZ*Z8z&y^(9e`Z_Aox)yP5maM*p ztiHi@CE3i7`2^_1dt*FdTUECw<^K?7 z2YB9x9te6p=zjiH=nbF;&<#O5Vg&w(J0iEbb2PS(V`9T}Nq335-~}*pc*#a3=1TfD zMED8%G6!E)=2LWJ$Zr3~U>sQuVt=A!B*r94V;&OT2K_81T}+*Hw|_)YGU++QUD%uS zyeN;e!+aaNTZDbiUD*frdpUHicQf_t#LNn}U37rS}wvt?mA)L@F0#nJcn@b8I@Pe!=$~S#hY*WcjO-3We*KU z$NG-Xd)5;?0@jm!!Lu&lQMRA04Fx*bfZ=tGx2-&L3`zohBsw2=)L4{9PmE=!I1{6a z?uB~$p2vk#4fG)|$@|edJ$`~GAiW>>k4SoxYoiY}88_Xv z%8rFo!egde5V6aEk&hnzBR}LRt922V%pEc;E=ag zS(%|n7#o#yP-4IGqmdGu8!oYVC^3(p-~}kLv;1eI#1>g~RzT--yd{@n$ zmsw9wqUL|&zYx+60J28M@5uE6JmY?6`Qf+HOTf?b3d@(Gzg*yp@U9<2Isd^crB0VY z`X~P#8_6p8cmj(5#ZQG5c*0ZQX?86;!39=<$5Ch(d9988NyPIvhhpP-2Jx&SS=?jm zvo%U%H3}4aPWmaB%2E31ust6pe&eSL!tymR8TPdp@)0KgK@@uIu7KmLXSF`%A5x$5 z9IJJHoXd_wScx;@H)GeRdn7!vq^LaVbSd?Ie5NFzs2o9vx1Ldr^|Uewi7+&b(-ywPP8g&w{6E= z5w$zgmfR`^HS`K$a4%TV1mCC9rIldE>U@von4XvMEQ)& zAF4R-v%5rCRR@ol5o^$7_i}J?ptZ`s8pYym-gt%RZ80N4e>EtDA~Z=3BfBz0MR!~F zVWJXn4tRxx10D{%NP%4De1!6;jt_cRYYhj_5Ic*&3M8+l^JyeNEho+qD#n}fkw zJKtb3(9rqT>XhP~h_N+tPQhmPIN-Cf^FxfSiSuKOt*P^KjIEi25h@z)a_4M}tvP;@ zP~z6YIUi$d>HHC6YvueEW4prnJI2=9L06q|rNa*9l^HUxL|ugEkTR`z9E^ijX0=ZZ z%TQ6`&kp-xS!CvTm4gn7hO+>5dNsb4f#&}XMvpd58KFB+Lv5W>jyDNhAmzG-OFKAL z;*|AjqlnQt5q^FsP{%g8ylb5V@sEZRE{cp$s)L>twO!{_aFl(?xgeD21m`J#V<&x{ z%4_HNozfDAJI_m~G7@U5=g46|EkNw@yw2w0!9H zip=>AQbQ*)3ygJD0Ze+}zKVXyit7Pt?u1J^ zvdY0AcZ<`~4i+-t-Rj`5wG_WC;)S6r{~!K4J6Ff}e#H45>Q^)+EEq-i1Rv5MO00+`G#M2w|7)dH|Kgs*45_r#ygxuFNC-GjbFHE><8raaBjqJ8l_U^O2zebZgSj*h4pee*(x-s=R2KS z!=C1No;o}3Y|qne*3&F_y36V6H3l5@aVmLDs*lsny61%=v(vl1a0l?A6Z=|wFx)*24ikP!DBIug@p zFRXtU%!r0L&~WU(;><*x*r~}G?%a=8Zc2X)exEbm#(xlegfqeNPonFGkv5J?Rwok? z$)_|+X>7jajdHS3&l>ORb4EK4*!G1@mz*)qgO-0DjmT5xl87cFBJ9eT49AZKqVbkK zC)1f~6~Jyx&N$~G%a4KI?_^tk9DKYp&GN6oCpgn>I^Td#baJe`7<`g5!*cA(5$ z^-rUrK}(H2o1ARtQR}xNtDI@hJj-RPVY)LvJT6X`UXtT1u)SbfNX?kxERyF=co)Sr z-o#_Eedb_RF)M1fz1y7@vCH!z8@(*oSsIRdr9_?VJcf}Or?kLlI*)_nm=<`R^Q293 z3WCgXR)m9Oi&Ir+CA`4_{8neR)4UQV|8}xeK5&Of=W}E0_`-1Jk&=wR^H5AQUr_dHn4e&>tmn^Rd{;2b^ z<+V^`^PE>O#OT_f^PR0i>tMpNz^N?lq%NcjomahFr~s_ekNk^JHRur|C zfHMxsf$yX*9Xw>f);LGQff}Mn*E&^Dq(Q`imyE|zLn)XWm5egaAWbP-)VGW*twx8| zJKum~jPpMW6Xzj@j=@MXD)g-<#qpfyoD<+OwxT^qsG+hKH#&66QSCEAKR_liB4*f5 zd$yQS??>ox!++|q(TmOM@H6)h4u!xcpok`*p%V_Tb!T}_ zSH^dItoQNo?)YQ{gVSU^!fqH1B`R@?i@5bfGA}ySBFV_Iw-lo572P9~8BAmjA^diy z4BYWMtC$&1)ZG+1Ns*a@>x+5`bZ41xyyTSg{bTB5=MHa%DwOzjaa<36Uv?6$Eb{Y3 z-(7SeeqQ1^T+4*pobWJ_kDbL=?yBM{wpVeTxpaD^bQQO|jhn6FOJ`GjQWy=ykFVl9 zRSKWclKYglC@!0weY2XMeYKmN-5VcCS72lbwrdMi?@JP4iTPmSBbP!z-zi;<&Yl?nx?;t*#UY3fl2tBH&<1Q!o zsSFeLg_4$+hNR;G=_E9lIR8HYW#j7{pOjv;J$`qKGMUDuk0Q@*lT9c$=mS%@ySq&p zn|}5MH4gdtl^pmj(PJTT+4PnY2RBHlxCy!=-ipm_7%%@Zx>iIvQhWp7ZVBIB{VMT@ z4t3kB3@Iz{?Cdt$>Qza~%qzEe>%Vy|lve`@XWhg8(_5zhyF7N6N|LmZuW%h8T}i8Q zI8RdVC~LP#do`|7*sU|#2IBYHfUTR-QZ_#1KYec}HEwSkEr5H2aV?wIvUwAIBkc)o zD;@3&Z5!hxudRhmTVAMhDcANlN6m#&|ESwl*>P2~v*VQf-u=J-WA8%A^034dhTB`C zGFD!A`Sq{&UziV{L-N^BB9k!x{vVM_Y>_x6E=jEvLi=!WsuxP^xNzUPc|PJ{my25E zzXJ^-8jAloYZn%8b#s(_Gg9mXiO!zX%bjq~x5OZt`C!La-r&!RTl|SjiT1JD zmV^~QCI7wHB)$kMDUFD(VoE5{NKzE;$wXKAkgN}g=vksiL=&%ki@PqGWmPif>c+GRh?RvVhsZd|(-{ z8rTeM1-1c)fMdW(;0$m9pt4E6GC&QWHP8j<35){f0z2v?`3?fbz!_j&+4hJ~9DpOh z8Q_8dj#L+LlYEJQJcE;bX<%Jk1nCXZ9~chgil7L7i-GwNB-X2je@VU#;9G$j^^$x| zfn1;f*aq1yU^DnuU>8sfTmZ@>BYZL4uB z54{tn>_(*ad*fiEFuXNxne2X<&i+ND)X8lxvTgfm5oGP9WWY-avm~IFJEk z0n>olzZWR%zAIM-J3z!Wo2MQ~S z>f69}0sDbNz%k$?upChp0B6820F;QNfkYqx)CZaZZGg1I1cj*jfer^UfGI#OFgFpY zF9TT(tOJS==YHS_Pz-ENlm%P#SHC~+pN=U`2&gc1Yl15JT8KpM~mNNE5&kOuSw z1_R@PTwp%18Yl#M!fysJ1(*vgt|W;SfNcN@fg)f(Pz+oE%J`u~6+e;&>H|%IRG<^k z6X*|25l_oO3j7jZAy^Tx2RI3w0WJVkS?ar7Wkd+n0O|uLq1OeVj7C8MX^?dRdIJ3_ zBjVv8O*KdxxOM;}>s=no7BGJq^#nmEptKg(cS4QvLE0cU^! zMz9t@Phc=G7gz^u0}cWwfj|;e0aAb#z(J^Y2A~wweu|V`Q?OK^4P3hcqkvps8PFf{ zTwpO!0BisX1#l|@b^v>TgTN7>7&rv?V&F9R1t2bf`T?o{HGuj+Q=m1F3ZwyDfSy2q zU=$G72-*QPfGpUj0keVmz%pPpP(O%xf+(6cARUBs0qF_!0|o=5fbqZ-AQzYmEC!YX z1;7TN5GVq60DFLgz!9JrI0v+W262}m2bW1J41m=EQh*jfDv)*=lI{l5PsnhP3?R$; z&jp(cEC!YX1;7TN5GVq60DFLgz!9JrI1QWwE&_4Ykup#Pr~#w^Er2#a2cQ$stvZtJ zCx3>+mH`ZwQiGWb%mo$$QyRg;a*zUG127++HUNd-+a&ZJ`Ev-iB1nsYVW!8zb! zb$L#dseyW_0dWnG`ZYwJ|1@KqW^;l}Ws+E~hNu!PHiTb7Vqkh#EO zU^!3#^cK&-L+-2hP`Pz3A%_5k}KKLivvw(2xNfI3Z}L=#D&n^+IR*Abu?7!Rjh zpb$6>`#FGWqDX-NPz-s$rpQT61Z+`Lo(~-$?o@LQSU<4Az$jomFa^j3<^qd>|U$Z6mla8U$hYNPUi08pnk1Wjv8skMQ% z1JDWRCgOfpJRH^xAPblV%oeA`Aj^RQU;|JH6ahPcJ-|WW2v7{12F?K&fy6pewskOL zO9gt@k#qx>BLUdzz)S&_gBQT1eR?uxn$y(X?FY-WS+0PR+aG1#xiCEYEH$^Buj8=V zkjS)E{^4gtYJWXa`*1UY`fwyJ*0xtrd6)W7?NX^UsC{#lEnXx4MyHhv-$8|M;~X96 zgIwZ@M_Mu+4o`lqup*Ya__rXOyj!+x+0QzZTbefJ4|^i<&*y!E#9jW4yJPc=&p$tv me>(q6+JO)Ad;Gp3bBXHOCFQ*V#|M`x&iybFPUhFK|Nak#1n;o` literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/42c13fe32396384e_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/42c13fe32396384e_0 new file mode 100644 index 0000000000000000000000000000000000000000..4926a5ac30cf3cada91e9b0ab6aee1c69e059eb9 GIT binary patch literal 18392 zcmY-1cX*TK8~6Wrn_Xs0(*d#yElrx8bSEvc_g;d^P!ME^$aW&2?7gRe$Py3~m5oeg zZxBIcDzf*~=kxs?zvqvK<9M0mzOU=N&hxxNnkF~;UVZngGCiL?Hvv_pF!yO=-SBd# zM)hEBbzhBYxuM)zft;M0{y_B_IW=?r+1bJBS^ivqZY_T(SS^^D6?i%5&(6yB1%lOU z`m!=}vxBvALI%Y+7+-Ye|6={`Pn*EH|L-~h+_@g8o zE)82k@KX+0^E6&gg(0^Fl&%R~o4~53P_`NTAk~{gN(;!8I`VdF&5j(wCa-F zF;GjojDx;1WITK>&n76|WcYS1#HoDOx3KOz*d`0t!;(#^c?)ck{gS^GEI&b#9F+^w zdL#j-ZU-rRSnYtgol!OE7?GacZosU94;W&g&Ku!5i zN}Pm`Wt{Xp3#Q*->v@Rz9m>cFxh$>zfX0792Pu64oHAS9zX)Tc_9bX7d;jOM_ERQb zfkhI36)OF$b>*h~E4{D5i+`Z_b&Z$PQuhYTy9ukM+btL**W|!mI4?8q!BR=S4|gAc z;UR3615)q^)<4$sNj`Z36D9g7y!8wQO5izElXcQLI*R_{Gel8UzLCMkC`L<7Qxq*_ zw~VqxF8NfhtPNZHXM3R|lv2FmQ$qxiGEa_$(#2c6V2xhRe|qnIh*c8TKI zTTyiH8pZi;QKWWPte)!Olqe=ojlwWZwats-%zWj!Ac}Xth~meEQM6hd#kPG>SPn!n z;D1g>vE@t@o?oNb|63HL&PVa7^e{!U&Kyl8OEk5MMl-HhH2+H9glIM-M$Dc(G)1~a)Aa3VioFxf-(#ckj*liRZ%&9Nabh&DO^Rl}#7vInEx9W%O^N1+T#`qU zJR_Rm%xJ1g<2lism$F|((_&FHf5?C@qnWitF~5rDtEJK0SQgD2-$e8KS{?g7n&Vrd z`BT|87NZRz}XT8#+5WMPm0AFXdY)^hm0y^V79c3H_%y5Nx1}#mD`C1 zqLK`3lzkFOHZZKTf%}qK-asv(f`O7URDP~#AUDOpo=OHz%cRN%7D{}ofp%$%At`q<6r;`k;X{{lt1R%RoQzW*aD!Z{%@~fv&j*eheGg7)D|1Ry(ZsoSeK=xh(^^Yh& z$vI}=D~bC}y%fWFtRqJ{S8V17FHNkM;a` zsvZ|Lvapzu)skA=$c++4K8!Wuk2CVJtdWPMjC!saDW70uShA5*DMl`&8}VissqZ$D z<}p&lZ=_kk$l8#R7THE#Naq|QNx4SSWxAZpGtwa6NU!Qfw$?S`u4klgeZ`WAjf`Y9 zHZn&pG%<2Z+BY>)w3*^IH?m#ov@+`T!pPuPjU>NjWT(WmH!?`x>tN)kPDbu^);ez~ zhpxJn9&Z~tBChU6-tA$e@jFH~%R7CHd@Q#lv#*iG@V1q6^LW)Z!N^8AEX5}pIX2hGjCn@R&o|O=fssy9WQmcu zuZ@h9L#vDwtTwW2jgh9`82Ndv5&JqL?Y>pM-x+DOUgzZ2_eM5sG*W7lk==4qYHl_% zdW(^#lD1p5$q##sRN1RO{;V8-QI68*u#w*+<){(cMI)!B&SfLxt{ACzUHfv+$VG8H zF!G&5Jv37Lk&zltjO>--&y0K^ul{G`uH;0SC~h_JUNMuNFD6dQU(&jSiMb_B6pb}; zxr&LA=_U?2Oti@`(a>k&dwJV$VzB%z-k^zjvQj4HnrM)x+k6vIVG{{5qne3|O|_0} zXlBCE+(edG+n5+2&R0z2$uhas*2J+_O-y^k#0y#TripFh?QEi77ZaDHe|HlnWn>Q% zGsW7|M5A6NHp}$BCd#~LqGLZ3hh^{p2wppFHQU+CBHK9xqQ9eM8@|fhD-JjCgw=TA5C=IU}E(~6XiB(jx64+ z`P)q_|H;H-X|>bDLiuZ#9`82s`W_SOy8P} z0~3?w%tI4(9+|lI*o5z?iTSeZU*++iiRbbGX6{LDw3(%{S^kqoIdjvVCTj$VM^v&D72^vn|I=kz6xvWQE+xGt(j8Ok9DP;j*vLOkPzp z{%U5-)y*`hVdfPnUenB2IabR|wc2K)8Y#BqH8yjqshRH0%zV?_%+!`<7D~f5n)iyC z-fhh+YiFiy2Q$Yznt8vInZLyIrkUS6n@N4kjIEoQ=YtjZeZ`Qm!?ezDJsx4^(r0Fz zBhAc|mUGO^o@*v%o|*E}aDkb1Kbm>E!Hi|2ndQ=RlX|dC{rJhuFj>Ca%3q;k$}Kb9Zky>Z*TjF<%olR@zRo=~mMKuX0~s36W#7QT^3@fLnB zW8p<53vDY~SdeO=M4E+ZRdh_&q+8e~UWbK#P79YL*QIgN+->0vIVwqBROl~ z=j&N$Sl`0MMi#a=wotW+g&ik&RH z^@fE{x>&d@8C{j5#PqU|+1tX9cP#9E&q9-a>Op@CrU4d8%kqI1T%#?#JI2DF@=#*O zTDURE!qzDk_J5_dmMN}GlYPrAythg9O5qj@Rd!kU=c0wamn{5v*+Tji)g_UnMtSqBow#ONtTwdl33EJ-_xvY7fUHCwe40W%b5f# z2NJDRNV3u;*-H9LR;I~sWvzTt&dS2_R$fT;idNRjn`u`55r4Xs1@cOLE34#w11oPd zwDOL8CHosGR%5N%#L77t-ptA`(x|zW<#M})mG&*IeAL#;F-d;a%I9KgZ>5dQ>tLl= zM=M`%W!(rX zEkCnj{oG2Dd?p7*S_zM`(o}j#^i<_0Q>IzDHQh@74AnnVc}lI>Ru;+MbCla$D}nh| zK9rpctk@S?=_p?mKYHr%+lu3wl`=OpUN+sd61lD3-_c&&wQ^7{%D+HXo&+0Bl5AXk$wsiOjX~vX{3WN#+o)8*Mz@NZ zD<7w5eW_5{#(0?{zsoDB$}i1EQWYCxVgx|*gfQ|g1))9A}jb#mN zcpBPxuaQl!LpC}#v9U>_n#`TU`?`<1rrD6{o6J$$I8;)K!diS<* zUQ+ughxcqemnQvedd;!vHOIy_2@SL{c#w_1rOIF%!=%Iz8@X~*qTaU=FIgYis4i<| z>L)gyO4Uyl^K%$J*#8b;j9PA$P{x=rF-XtBE$&$&*Q{d8UmQQhl~!Nz{BB zJ!Rbj8`Brs=(EU1@wLiBep#nHzO}LII~zs5SDv!v2OBqj)Lv{HeUb5 z#_@eNN*~Z3$~-xCP<=RQV~PAOw@%wAIBTPky!V@pALVC>KWC$|bUJV2YnlAJo-eXa z>i%J4imd$8#v^$gA47F}3=J#9FhdT=)w~!2`7wMT;ldaW%a1R|P_GnSEiVi~$OmIIReb1Z%L#j-`d+8@ikgR#s% z5=+%%u`D?r%N=o?h-KIBv6TEH7VE`WnoIC6qSNE`>Ge$hA<6pP~@IafSRKNI5UBs*f` z7!V)FPhu?-$K(NVoR`nO*75IjTw*uGu|Z55bxxY?iDRy;I;{9-6<^l;6-V>yam9rx9L4U(ar;Fa(~6biPbpia6piFewNg~BUWz(BOVM+1DSnV2hnAwu^ip(@z_L=z zT~ms`r1IWUe0ZW1Kg;>6rC9%WDWa~GV$jV}40~3JL-O6frC9l2DIUoi#Iq$j9-ASa ze~j_`Yl^3hIi5vgvBc9+R!S*rJh3tHyecJ1Xnb5eEo87go(@UztPn@(c-}7)Pez4! z`pc=bc)B^``BoZa#Ir9DPeL%BJGt?M^WwRjAJ2(`cs^{XRipTs$JZEHa z*LZHpYyIM>(m$SJ1LE-wif4%YA&Unq)`yDqQ9PqRjwgDk#>&^9#?xn5Jey?N@OaWc zkEgE`Opd4Rw0ORhYSZJ%pBc{xX)!CF`*Y(doEOiy`SF;(h^L8kTc{dV#FMg8b$=hv zq|Nc1lX6?*X}vREzqhEK-SHgQ6HmXN<7ssuo-gG1!FYbXA5ZFoc#@vRGx^_m&P!wL z{37-!JBti2_{r*!8~DPQKetX|J6k0Xsvp>>Q90*>=9pv-4Os=i6x# zvD3bqo#nEvy5`oiv%kKb#0GZWm3EEn`rX3LhQ@l_RC8oaGdq8_vg2xPr+ypd_qv_# zGP{?ZTD|Q|los#UN$zXsP1)Sf&V|8t+(Ybi_|Q(vkL@gwm{07S`P5G3VRlx_?2&e^ z$e*L_`f@|D<>+KPqZimYDcu&^8T6H%Ez9lLR@mvZ(vD@loo3Sad#$xWam2dG&a^Fx zBMrCO`F@+7=yJOA!e%)`oC#z^fGb|%R$^2M)qu1n>! zc7D5Hr^-e3?UH(X(@tlZb<57(`*tclvopYuppUu|cq*C268KoYE}p>R!~|~1nB)YO zyp+Hlag+yiT6Rj{f~0m%;2oLSC4u+fPGFCC zdnPbV{*>fi39OXJ-~>LGBcCMDdRPJrrO^nj{h9KU-SYaV1eVEwNeOKKGJ&E?6k|mK zgH|Q5Qx>gDpy{^>%n`!|^=4NB#dar9et!bx4kXY`uFJGTnkRKmsMd=KY?cPs5=gn7 zKu=luD1lAS60kf^(EF%F-Y_JxO5#n4RF6qyoCJy_vawVm=J-UWzLZGEvWcveAIc@_ z{dpocw!ex4<+hzn?%mZui-=nRZC>2 ztf-O5!#WyYHxZg9@}gy;KDSHcdAmef`B(yb)q{PBT#yd?6IpOD zk$)2k@ap8pU6jjb*x_!-Q}UY)jx@~Qf)vI(F2pX zFJ(Sf%uf|_SQ3v%B++eT65mSUD8(PA_~UhaViNnOC6PE?b7$#xUJ{+;`TQhyEl8r| z7fHOdP>-edq9mFxPGU!uWQwOJnYhWx+?<_E?i?MTpUl~%$)qhy=A#wKy#1}#5a$oc^!X{7 zO;T!KG7I-7b3+of_)~aKPQIMNuxcqZY?i_dncp#mjc=u3?wUfyJ}I=8ak6|! z3J+w`@Dy5pp27kdHa3M{CZ=GYq&RamXI=`KVqKO(b6K`21>e>bhR7E?Quy-c6mH8e z$5QBaI)!hg!<7^o-A`eroU~NJTBH)qB__EN&&yV#cDYJ81C>bVT8WObcyJ{ed{~L; zQhszLCQPivS?Mva68$$Yk~@6sdBdl0Gk~M9nL@jjc>pTxF)d zQJHFQS7xlF45-X%c`AW{mH9*3kFLye>9w&k*LGAUb7y6CoUBagXO)>wDi(fJQjSubloP36XDpe2&2GwPtGW>{P}| zpE;=voR`WD@y<`B*b2pyp5LUhaEs>4Tf0&zw?CC`;yaK^{Zpw-lYYOYlKOip@5rf3 zsr+R^!&J^aR&CEx`BCmZPvwd+4ZkUkk}+wxili|>T9r(rXKWfj z$o9B2X2z#+N#3w)Y*HHUOXbpO440i{(kSs#8ePk#aV;&4%qp7eOyiyuWTbIb8hF!~ zE(syU$xXwXmqxXMGZg%UYcXecwJd87*Sq{quu`0>>$7+73Y=PKDj+j6a&rcPG-} zq>lfZ&e`+nr2U@GoXhDnxRTDKtLe;_D}SZqx|Ystne5H)j_+L9sE((p}&s~R@8H_QQY+%yw||NCArYt!9Dr9g@euFZRwzY zD+gEPP6r3k9UW|v{Zi1$!SFX6JdmB;9GsBxZ#$STvE3cC>EY1#(hf=vQa*!KryTvz zLGs5AMoOQd4u1I5LHaNUOFwt$x+(|lM>+U@l7oLIJLomVLELNyBj%{)xeg-p96X-y zpzsR^zbtf6d#QtQ%QRLdeB+?mS_k#lIhgdV^8C(03F)z3$G=z4e{eASM+ZeV=>BHi z-=h0l6=R13>rMxacRAQ9MfR)52OV@jOCdSFJ zB2KCob+WRAlUGYRSrqHk_Z3cEKjh?u94hA|p@NeUGAYH$nMzLTR(3Mmp*hmU>7>8> zC0>`4n|>#WxlUfsb5gddlXEqlRIcr0imb2e@9>aq_&alOFAyTz=Kb_}84AeBDXM4o=#1cQU_+lM+3h9O>gEsjrjI zWz|3@TV>E7CnF_&h?A=yJ9#W?KXLMtgoZj9@~M-5*Q#y=OuH%*K1ShF7Lf)FD^`<+iKhw#TIZoX36lcDZ(@UI`U#fiN?d8gCg_HIx z)k|5p+R5K*oGe}MWb6hf$2U5uu}S^eqGMZ~Y})2z<8~*}JGA!CP8$EJwWah~Cr

cSn7bw7X8SWU1V`r#$XEc~5?SqJ8_<$!GHN ze@>dp4vC4%V6cprr{)a4ERw-`d8cRwAIn|IEuO(L*&>ek49+HHa9x%pYpe_?pF#P` z8TjOyJe3})8LUgopi-3#a%7P!gP(IU_*JIlX0TWi@-lcWKZ65uL59DaL5)Tkw3HH! z6;me4=_VP}X{xcZw^atmU(29O`wT|Q&^I!eEDhh(c{wBrT{0LUv&GyagLmJ{;8Th8 z(>U2G<^dV>m(lX@{S0o5%pf#6gJWYdxFqw&X0S?nPtG8Hrfz3t@VoSzqu5e)ZU#-{ zC$Y`XV33THCyUjm6&aYm&S2rH3|4%T!6xayR`cYs6n>k*YS}5?4H>+;P5s%PL8+g# zmQ3E0!50TJSSvjaW$?b-l*}XAAE|pPg9)cI82D=j)9+?*{$7UOFJ|!4!wlYdq#C5; z(+pZa%V3Xu^E`vLFBJ3N3}XMwpgk^@M7coQxL4an@p>*=)_1W>ewByv zZZj7@Hdm|`E()Y#JLTL%we)mxKrTq#-Y$-O>LO{li&UvR!bSJbT%486k;-M1i;;3q z#*A?>S6YvC@s^yC3gca@nBbz$6c=AibFo%>OxHZQDVZ}})SKgC+LtcQEpgHCE3LOu zYs;LkU96OHt6X$m?c#()uT>xAfSi-Y>ooUU7v}F&0;81ID#p#H(yfS_HAUT2DCXu$yc>6do4Hc4w41JF-2D5Jo0{d^ z94_zHcROxQrn;$><|Z}WO%I2g-(;WDO`OZkP`TxGljV1_L^jIZfSc_RH`YQo1LZ{> zH^u9^*(;}|UOhJx>${0+;HFU!`#do z?j~l0n~tBk^*+JPcakzvy&2`!XNGQSPf)xm8Z*t!U^z2W{hIA&g1G0qd2fN6OY-|y z>hChQzMod_R=HWd+D-X2ZfdMmzU$mPliuHHAJ(hZO>QE;xM?KTeQuIulr%r!=1nPg z(2Yk99MafhZbnGeYG>(D>tck#KXj+9-@wU zC@x*4)Cmu5PkQ)8UOw&NhJ=3guvos4W@kMtmr=iYIC4&7&UfO4 zk0gB2!%De!-Gl$8@{m=Md)LFq_dMK|_a1oI_)z;KgCBX={@6o?VmomelHL@y7^>b9Jh?Q%q_m-jNNf|sY#JH^ZTN?v}h?4@LymqQu4 z^?GUT^Rh>-2E4=ty}T0gl9Z?0h?fNg8dK=yzp7qpRa4CBUcEo{Qlo+9H}o>2m6zXJ zduiN8IkfXK{#7rHI(b>t*~_&qUfRCprD8WPUElU{T84G^vag4i{GMJ)^!C!~9WT4( ztfchu;(XsrpAWqJDen&RQf9c9P9wY=m2XCR=`za8*P|7CoEQHDFJDNb?^tB-OvA3^!4xR3tvK0cF|?LNIm_}C#ai9QBP`_ev^l<|@9 zl8=3reZ-~t7%K0(G|uf~nb*f{pN|fHANxZ-24?!$n&s1V(msBbin%@}%KI;Cd^N3E z-N$xmR>Q~6nm+o}QZBU>TjJ^}wk&Pr<5pwk+0sY(_Nt?U>X3hAXcr&FdiiM4Tl3{? zA0H`wm2W>E&JPvuBOlK{_A!2#<_!1gXM@%qrSoG{kNh*vM__`Fg<_iIqwy3Ur>6Nh zH{D0&nLeh-`B^?v=lGZ^edhW2VZM*_1sWrj7ix^$U+g1)iBH$9_^AGs)|BeYe5{kA zYkV~SM(fJo>wNgW^RYmN|LDWLLHn@L$0eD%#m8@3wI|zscz*WL?-w7T!`g>qK0ZJ0 z3+YidH3_XJkIk|7}j}d6Y(>@ zz)y)nKZa_4zLV$G{d`u_Pv!c4x;OB1R`xaa6W7$wP&v}fPf`m%i(2|=*WS;<4t_dz z@#E_1CnAr;(#_8x+4i=dr9HI%yIQ}m)|Y+#{JhuS&u}Rm;HR-{7waHD17+pZ-p>!; z`>Fn;pJto=%-rI~w$;z6?S9Jb@H0-P@Aq^5fS*POmGcol1;_lXlGDfij5?t@Px={o zM!mi0r`BaZ>t*j%_3CdwA4#Ks{7k*BzTNaw@0OnpGX0@ydgN!sWA$DZKK1kWGe569 z*RlWn93Vg>DnQr}prKfd0TN}T95w~0Y7Wq=cz};2w?u%tvQeUA1H3DxlLBPOWqBZP zB?nklIzYKH0SYSwXd*EcHBQFJv6KMSD+TD25n!l%=%7BP7O^pp9)09QgfpBdn0 zZh*}E0AEVS!T?LF1_)MD4t147{QzSd1bEgoK(*!p)=GS<0PR`_*e9LZ26WwNfY56? z*D1i0Hv;-MF9DYK32^6K#p@fO*^mG;-w#mvL)ASd!0TfJ9Fz|x2iQ49bEgLQRVq#o zFj0P;q5HD}tehR7%nGfsQgc_UH=6={yg8uHbF}8p0JnDq7_uk8=RXHH^ox42FTg#? zJD~Mtt2{gyp!cBw|DIL8zXgapubO4wp8*D62(bNP0RJVed0A^-)%x<~UjeTF9pKe# z0owc%;GLTRzP}Zq%IyHB?*u4+Px0@ohmY06CjnYL4N(7CfJx8QuNMKP{Ttxif7)w; zY&8Zkn}bZW1Swu5NXw!@{wNkCDK<#^xFCn5R(z1L_8>20WMYuRNkOV62bo(oNWXGH z-YOqtRfQnsDh7Eb)hY#vas)BDg8DZML1KbImS+aJlNDr5SaA!3EU6mQwZ%bF>Ido8 zAV_+%pspDX@>{DQ4O#~o-#)0rDKRmQsa#fqu&ha^OX=w2ZXpaFvN2iJt)K+ zX*D=R7db8E-w(0;1FbnU#K2EglT;rT((hU!c1h6@A*O#8!a6!c<1rz&%6_qo4e@YX zh{y!hFPkQX^zYF^7^Z~SEC-};YKR4Lb(-Q&*SQ%X;^m;6mnJh6dzNC&4v{w}#3yq@ z+>u%HLi{;jefvT^UlP*q?20KzrOm1kzi!c*TSM&Krkr;xr#&IOdqe!aFQo5r)aQe$ z_fOSvQESLiNxrPw(mo**cXB50mChtsAro7rOqx{AWSjge?NT$jDzRyq?3Ocf zT}n7Jc}aRmT~{U(+?n+9Wb&OilT=?ORdV$>FO%U7Gj)w{CgH}Jc$;O?zj-Fz+GOgQ z8^w83Yj(-x?Vg!fdSxf($?sqNvH6c$w+w%0YEssUcJW6Hc z@ntZNCAoRr$jf6?IFE6i@;LEE9^VekQ4 zCXYVf=h1vi9<#RQ5wk6i3PsTJAYu4w+%Ja*pBqsZMn zhRF1&e9lMbGuN8W8>RAD9-mKXd%m9Ux-FN_D5+Q>pRN`2sg|D4uvYnc&y%m~Hu7mA zyI;xYdZ&DXZ{~BiTRtbo<@3^ne8$Kp3-j5#D4(3g8owl;p(Fr}N!> zo;=B?>NCZaALPI1`SgCF{G!7YGluyhGu*TPJAJq+!`tnLuzVaG6C zIw@|KFx9$-Su5S%4zs3vm&dNMi8Q+a2m`a3I3{{@P zVKU^GQ(;Q|8m8@8-Iqzfg*kIhy*MAH)6Fn_#eFMGL{`hg+v>?3^-!8W4m0aXn3$(w zwi3Y{9pQo{Lb;>}os%P+kaA^pznt#NtqKvcQXol>NCgd|xg zf4>vqp$vI9!cTo89Fn2$Mfka&>X2UjBYZa?!h0X+c4&m>pGL3^i{O(pQelK@lTmWy zvj{JL9-)zZCUK)8yfRv`9Ge)?b0U@OSzpK7Kl*5Gx>tyB)_5P;vxusn0s@L}- zx|Tjdu}2YFJXS9yRIz{|DFx)E7vQW_K%d$L{3$W@3uxM)fbHUHTtMF@1zeOv%?e0p zQNRdk*{Xm!tqUmHrhvh(Xl&a8KJHM!g#iUP1{E+@SJ1qHnIMFFQ| z?Xm)%EH9wjiUNH;Tfk@A3wR_~E*IdwT7doU0*vJfsb9X3lNAd2Dy@*4RSJ1My^vR& zg)GP@WN@I6ik%DT+NF@wa=vFFsl5xCDz%0cGIn?&FXZU-LXu||GE%QUL-&i#G<|DC6QasU7P`9B@u(0l*@ literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/476a34567a9b24be_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/476a34567a9b24be_0 new file mode 100644 index 0000000000000000000000000000000000000000..1ee4d15ee47f940d8c868c3666f4fdd824d4fedd GIT binary patch literal 19196 zcmY-1cXX817w++IGCkCUObSQ~BxEMjXVPa9I!Nyzs5C{8qNsp?6#=D5?^QqqK|oNX z7pY3`O+dOLy;r@@@2++KxUBVA)6Usv?|oh~lXu?ed-c8V%Jh8p+yqpWQ_BaH&<&y5 zIkjqJ2Wr=@9jKX^9m=Vmot2fFQ!OW}TDH$$+gB~KR<+Dv?bg-?MW_BR*8lz)x|fRj-)*7T$=5RTIP^RXraxfQS%^6YW#p(_mR5g4)wL`G#`5 z3CpD0E$A=TWba)#D^u>lLP@?4cOU4udk7n3uM|9j269(AK897YQ$BwJV58JVFN#CiQ6%O>@v@AR(^4*1 zk7c4vE{I}p^(aQyh@wNyD3WSL@p^6LE`hpH9FT;1Q4Eo;^`ltYAd0dLqj1X3M#`~C z6d%bj+1ersTdOEOlp#{0breU%{Yn(;+G=b&_3!m4&bL=h9i#ZTlX@x_#qmZIQ{|^F zQ9OGqitb&bINL3X)b5(sQ$3y##rTO)7$&LqSy7yvts3S;@!mI4teG1{tNBrE-W`Qy zZxsFh=R_16Pe$Q66~&%Eq9}DXiZ7&xDVmk$XewEvsZ%tXuZu;I zRa!Lrt3*?n9!&!|EyrBZRQE*FSWy=Xp`t@Wb`G>GPT(`b4(kEUV^#ggkSqiNSFnyzwP#F`%Xohu-rbxGFn!X)Pv3H{>EuXv>O{0&Z`Fm6}-qF#7<&81XB#w>d zwQ)?a^fIh-RStAfM`uV*9RWLcc}x zvJ8{#1M1PiXmXE7)BJ>Tm6H;GT5Fw&#(yrFqUWQjb|adrH`U8q%H@&rdaPWZXifP+ z%Dzxe|3*{ZXrNV512c*lC{o1NEAgoY+NCLm zr1%X4<%YbFcLD}h1r4Ny47`zLppSU74HU|c@;Jvp*IWZ@!Uleq!4U%!#9UyYVWEKy zGQXOEpXD9BQ-3OVB&Vi!dl|)U&r0Uv73cu&ak+^fHjxM|FRy$Dir(AOj!E-7gIM zClkLk&}^7;9cREb-oSek44ju|6Af4=88|uFz&BIWTUj>Upkqz_k`vN$k%2{W>w5#Q zFE-F!wke*=^dzXRw2UU;c95(Qs#QmZEi{Y&5k;^v? z^txr>r`rZ9-7(;kdy;!ky^_oa1_nMf@Risf8TeNId935=srII*k-5c;ER)pYM%K%X z5=K6WHR6vmQcaf2!%{{ar$)*r7#W;wO^n=<_Dzix zZKl}Gjck#+t&IA4W#owrXlrC;JKer&B>6QX+a#vFk^b^Q2P40BGIH-tt^1a8>Z)7m z@wSnJ;_7bXy&gsyziVWJyxZHzXL3t2-#0Q}R!HYQ>WKvVsaInB$jGPi&1Xi+eQsop z^cZC1Bl$=CgN-~JV$|n0Bj(YncZ`vBazKiYHF9{Sktwr`oSki?;T$8Kq{spzaX%Ot zCi|BfDOhG?(Q+eAe>C#j3M2NFM%w+PoPRdbYL#A-TfZ1tyUs|d^+tBcF{!n|$cT+b zo{Dvoa+huL(iZK}4%I8GcN(d(%ScGFepBARD{px$fA2OjbdQn$_8IAYz{nqxa!C6u zolY3BT{Ln+>RvYT^%W!au4`ZK8M!Eq2S$FDsE0=CJW{`<<`W~kr1&!tZ@&qLVB8Y#aYGq(?k=yJhC?TaRE-Z1g$O%s7zCaTMi^60jS?RT^f;(1_VyqtV! zqV6LT*B+bjJvA{~mdK)imFIsZp3BFWxhJ{NW){i@`A@bR&D1xU8EZD{7a%isIcPPr z-)-hSkC{7??K87L)``JyrcRcb%{gX@ zVWvS%Gp|VTT4qMc;o4@Z*D({-NUO=Evq{Cbl#)R~oj_yjRS;)7H$Q zc4lh6YUZiTdfiOh4rYQK%^Z>Q@=+%8r-J{;fQMoNK`^>y4?@97StuJR}>vc0(H_W8mGSlt0nZ9yO{CCZK zBTMD`iM2YfS=qhCb7BXa-{25ekAq%g`@JtI&WJ#8V z^^%cop?8kP$W3`EV$o+R3)ux0>c}d2UTC3vRn;Pqmn}?@v-K=AtgqbVVj~M%8e6E^ z#KLwd(#*on))tP);8!eEZfC(S3ncDU3vFK0>$0Pxg^Halyw%yl=UpsZmW-~-Sz>xw z$b84bz;`X|`oKbyKI%k_EmYZV;h&2Z-oIpF&1DPeS5%vPAv3R8Xz`EoxUPM@VWFJ7Cg0t+ zQ1*fP{!o3Fs}gvmHJ@1M@zlbKXR7D9g)ABS!osX5D}PA6Xe(n3R@_D_g=Q-w#q_X@4NQs2r_x!=G_=Z03^mG5LvBjwOoxi+zKMus%A^1B?DM$N5!FSlD* zY2Q+7w6$_rl3%s*m6+OFX(O{bSSi*~xplD;^_JG}YGsvt@Sc^;V*bEN9~mV5`&en+ z*Gf!3tBwIH!({)5RtoxC_1>jCWaUsREx)v4{mM#`d?|Z}SqTrf(o}j#^hD(+6DC=? zHQ7r36!mYaa+TWCt<00ZXDGj!RsyrFd?MTCSh3Hw(ow#fXXVj+D{p>lW$^;#@|_j0 zOkQH8)=Dd@rTb4-2Ff+@t+Fy(ev+{ptbDjdIZ3Ils!LM0sTSG4UB||5E2EECxh{cY zR=$y2r>wkoTE~M}&RFRy(=VzYS2RzKNcpSUPf7nvy_2ENqb=BTPgEM$Ao}VSw8*B`hThiTV<42Q?E>;`!O4zWKw9z=$#zr|TH|3d}h_jJZ%Em|W zHipSz`P^<}XM&9;Nj9#&WFuJCM*ng){*vS6ZB(jYqgzGImCsVNzEr4eW3<9Ih<~zy2D1a&&FIC>bJ2cU?V@Mb;O-#V^ISeo`yC)Xk^pRHya(B*jO*o z&6Ia*jeW(&0ZC|Q<9bJ}_qL7GQn81PF|x6z4M#5<@4RE<}CF&y^@sjnajT*8-CVpS;IxfK^1&ZA*2r%Xf5t{->2%h{4>JCoju%-eFaK#{f-E_2d$kD-P= zhK3blm?C@SYF-S1{1`r#aA6DwWKFdgs#cG|Su2K5WLxbRf^}k8ST}~|tz-C5^4i2; zeMOHYw`~lLb}@V)f%&m~EZ0`YlDQ_9!)s&Nzb=;2>tiXlA(o#-2Qk;>$mUqeZ;564 zud$5S8q4Huu?*W8%b;Dc?3LW#VtIdeEF0y!J+a)|7t8E}u~a=A%Yq}Z+!4poShk;w zrR1NnSTDxXT!NQl>Hl{uORvT9M1K1xmf|;Jc|{U##?tq0EL)`Y{a8MEpnM<2vP-%@ zj%A!7jx(|_CXPWx;@B(oi^eghSRDVznc{JJuZg3RY>kbhUwj+^C;%I(7j#)D3w&vZ7quBj8Zoi0QQn6B; zm$Fq#(MV2KFGb}VrKsDp6g>x&VzsOpREjc_OVLFFi%Kzbc`5#q%DYPO$y5 zXQ2Ek^9Lx_CyMoHJR?4fCwh>^$`4<}(|d3{>t)iAc+$U$=Y1&{A5Ys!@q8=QC&!aN zHJ+i;Vp=@+XU0=FE1s`s$7A{?o+i?5u4-5uPs$S2{YyOKHpFvA%593L^|pBZ4yJl` z#Itv2JbiwPr`6tgzL6vQ;yHCcp412NBt4C1{J-&>mB!flUF=bI<{9jCHQ8AySr$7V zTJ3BVkIl}5;&!T*ursEloszM3+DU~tyFL@!=_7gZc81#R9F%$qc8*I*qMa48q=Lq! z+qs!x*Jofm`EEO^NO>@+xa2S&STk-Z>LGbPW$S1zL(84G`F6eJ@xG* zHn8)av}vp=!^j>yqzhh^tw0PG}^80q) zkPUt8To_=-J{wRWX(sRgqP5m4j#$^*nY2-Hq~RtzzihS>y+!N&YUg!X zBl-<+~@T`Hfp^T!1{RW7P;m(<&vcHWd} zx9r@#Z>Q2TJN*m^IwhFEQ^_orz-RJ9@dV~4CU8qeCMU4qr3CJXqig~PQxkY8ErCl_ z60mv`Xf9g=349$);G~QQB~T?Rf%jx=b^=xN^qkZPC$PLAfoJldY68t_BrsEo*G!;d zg9LiW)vfh7_dkib`R z@bd&(4^CjNG#aY4zf^v*LtY=Az#{24E`crICQx*NVk}Oe|I!4u$-I>bH2o=o8Ddzg z-fT~x*p39s?@6HC-UPbIb(yqZ^Q7)k)p{|34btFR0x7o>=qXDcC9wWk0+#0q`W%%= zXG0=OCEk=sjhIBfmOzn2)|E=c9G}RWLAw^E|M6H8=r zo&^-N@e%zjt-^iHIy43pM_iUA#)XM|yEu{Ca_)yj5`RpjlT4FAKP9qP)~`zB zm5qtamx`Mc8L~Z*1F~X=*4UZIXA;<@9_&u!f^^uE$eewN{3Ct$YurKACSM&&WZscP zZp!MTihV4Rq~nP+kwvG~FS&Ilktq)oxhN}1;+yy+u1gs zL3R=sq-Smtee;vpA`Qa2t(HX5>Pf`ZNTOnW#c7g6cGD!C`%B_Q>m=&7Nn&W*B#yq7 zM1`(N7<(m=^ao zO!4$&eBNZ5=O;5uw%16;QZt#V;;EHPf7wzynca1gNvNAlFKO5`nJKcUSu*i0lKDpd zkSZ;c`C0PYBr{a1v`c2q8_5{oOr~VFWLow}W{yS(&a^Gf;hv=_*Q+$Aw^n54?TW-bt;lO)D3U_|_!PFu-_8^q z{uDltW7Sd^Ts?(`%~F^mvpc4+?yVHeT~nyoJB8NrwR}G?g$FWjND3{#N@0!+9+krH zV^gq?Q=FNaGb@Emu`WuXxhz_rf^Sm_1Ld2oDSZ1|3b*C=!zpw-k-|^X;YtdP?x!$S zj#(;UEmDc*5|dns=VdEVr(7kRfl4HFtwcweKcEr~KB>fHDLF)sYKkbigmCOFQ2T$1gUbNlFq|aqSh7N##SaPt}+ulSEl;gl^G=|{VKCeo=V`u z%KRzqM^xr}>9wvh*S1zBb6aJ$9;;00XO)>uDiP{h&PojzEqz1Q>h(DWuD9qrE*R7Wu~$`N3Y4eyj1Fi^|(NfC0LkBud1nJ zR7=(SQ>y+ONTq-6RPMZ-%DwujY;2@;nx?X&c`6lNNu|52Y?n&)*HZNzVk&JqrQ+(H zN8Xs8-ZN79a8@c?#XCEdVv7|| zdj6Qo+>M$qZ*5Pd+@4griEnQz^^d1AN&5VeO6s{(-j(B*Qu+0&=Kqz-gBz*5c#uln zhpC)-tlFNXvPSMcPvwd+4ZkUkk}+wxilos`T9r(rXKWg)WlLNdQ{&UPB%SRVo0P^! zQn_>*Lu6Z-G)labM%S`wTuVzMvx??A)3_%E8EIUV2HrF#OF~F-a?|kUrBS^gjUBbq zh^>>x+2(2VX_LlgS@v2QMZ2ZZS{A*pv7e+dK+;B}(SMBAlZ;7eEciB!J5p>_8pF1x zaYP3Fro4VnW6l0Fj0e(q|415jj-@e99-U01`JZXbk|kF){$?8GZ>6#QNgC^4s)D6# z70zW>p+rs<8p;%D9;w1C=~1l;YhJB_@wF05=y|1-A=)8zf_Rj6^Simo%N!t={j zxPP?@g@09H_{}Q%enHR4^7~aV*wSevf5)bipPbH6Sx_k*OCVj}U#9bUvvjV#nNDVx zbQ-^%&caX9xhL*#HEu~dcVybebdGLMr^1eOMjuM&=cDOxOwXT6=k(ch($1wb<8nF; zuB0>WYC5y!%3tZYuB9_w#{HA7Ymw5ab0eJ#((|Uq-b$yvyeAXxrt4gJI*ae6b62K4 zO=shO=@_FNyf2^04k>PM(8B0os~jon;PYY*b{2P#Rl>olBnK~&9rP^iU`AO77t1+l zUfw}ks-8=8a7HRS9PE|&32d${#@o4MGlD7dYrDDTNLKGGG3w>Y!aU z2Y}(C4vxy`w;jxu*zOM6^l<1qe+MP|E1v5`g-=O;&b$^p$ZgpVY z=AiL*2b-kG9`$^mgYNqsoR(h>I&=-4gC&O@ymZ8YU;0boG39yO!9yu>!a>cm%KxT= zpKobzZac`6;}0A>dFmkMnffJ1r1oo}Ppt6p~UqMnnU^_~3O$VrFBPQGiR@lBn~Z06)rbEmEWaneoJ z%FnMjdEVAZk9JNjzv^W4Yfg^6?xbS}CvCbrncc%liJndl_I8r=zLT$H>4#1>N&o&% zhDrKBCs#jn@>o`U?&Mbq4RSK@3n%}`V|inUlZszC`CU#(t6@$`4p;uNM&2H&o{Ul* za#n6ihp(0UXyrb}NvaH$wwN8$#b5e7?`n6HdZE~`Hvy*jOoJ4Qc+P^tzd`fFe>C;Y}^3R`6 z_FPn-W%4EEB*~XG=8BU8a#@;Ochc^T`Y364on*;Exphx@+;{SUoO_~u{MX5sQtdw{ zO=YXZL}f5QM$1!k2HzIRV3oXEG=tCNuH+WaV3BMTM|=jSlQOt23z9Wf`jyY1eB}&$ za!sB}kJJoSre#p6N(MPH&y~S%IT@Ui3Aq`}mxR0wUdzv5uUwEJ)iS8rD1(+#qOoGi zSUJ%ogSt&MR(7?@;K*wklxd&A2pQBlgYnYv4ZSY=C80|OLuI;{dt~t52N`@Jkvn^=WYirXMnxyEKEvKW4CA`mWGCc`SuLWw1=PiFa)VuWnXzKAypt6B&GXDuc;)GdO!ML!T!zc|G5~5waW^^&%aZU07T$#<^XjXS#SN z%f(0H$ae8=j!WN(y0{^?^IT+yU3@2H3thZX)kSZ)A))Fn?$vQoyq=4e^<8Y2Q}R&W zYvy82bH!`nqChIPQ{FvPPfr(n<$}EYj*Ej|xJVk}B2_96bL+ZNvSZ}#o{q8>P~R+%_J8qq{n2-dU4ZqWx zOSHbs_`$^zDYw+co6B4rmFN}fr|gw8(s-rj{^Y{^v+Ddsb*@&OvSO`^C+l1c-r!>Y z7S*=ZMVaF+U5}&QoOE&Mf{Sxf@4AbzH(W&BbTR0bi;UaaBY7z1J1#zyO?O>*@40C8 zK=nP;UOv`-nB1%~yGgUS*<*E6D#pzh(yfS_6do0(Fvw41JF-2D5J zn_A`E94PPB_dsrrrMjt|<|Z}WO%I2gKV-MlO`OZkAi3prljV2oI#xI9ooMO`<=Uv{%gPDs6aZpPMk6V<>?pGIzMjomb9;%2kVYvJb0)^4Uqvo>xz$q^~j z*3AgHE>qgMIrplYr|sQT>!{i~xf%GDo2^~lINo*ZdM`JV-*a>Jed(jT`?;AY-%CM% zH_ZpTnKr~t%uqKSzjW&}g`1xxWte(1+^zGAZt9Ftya^gJ$;|*cIaU3d?q-a*XS?}e zj+;wz?mP8&kz3!9t9MJ?EL-NL{Bk!nS18|=Zl1|IKWiUWsn+#wBEP$7B-Y(-l4Q6v z-|OZLDYws!NA~X5*u!pyO4TFkjodn_y#7>P=iR(|$<4jzZu0(BO|tSo^#Tu;C=XxC zzGx2x1`pqvJlr&Uc-`V5Z1d1iEHNGuWtbc&;-P9$4@HZ4XkOgIR%sZg@sd=^L%K|p z^YI><+C5B2@NhcOL;WNV-ZCEgzU1MG^epe;rwSUA;-NRC0Kzkm2Dimq*t* zdq}A1;k8;G_R7;b9-Sle@S`kk=;1*l4{tX1FuJLSW6eC&Zth{;s~)bs=E2b3L%j|j zTFd7hJ-Tk$Lr!PqDTljh?EzYQphxG*Jo+5qp>T+YWwP~44>7|$43KdnJe(Zq;pI^t zri}J*Zj5potMw*mjfox}$;?R}E=~4uNB*0lo=nv^=`hX18EG=z!)~cL!@~?2HPge9 zS$aI%L;E?ZTSm?G&}p8BMe{u*f9qkOd?iD^_poQN_F#!}kXk=@7`fELR4Kd6!yC)h zuT|Q!Up!2gg;IO9hi4l+JlUu{+U#MuY>+Bj)Vr;UyUoKyDYD%|vmG9OmHje!r}lT3 z_V70y2Xb1z+3Vr2eIDBES1%8G7<$j(TW&%){?e?SzLL5<2B!z6}4v!@)Cp z{;Y>V=RExOr-xV1d*~()Bz)1s5?LcXE_*m6H?Mk#|J%cQxpv)y|EAWK+`Aq=yXWDy zypXE*)l2!{froVuwWl)Rk%ujhJv4ag;i|=}?>oHAlI1a89u@KOR#7ieCB4**^hI{#8gkpc~#XrW&H_~x}mxU9R^CT~4rg*75&C3M&Z@O}xshVZV zY~?ved48k&i@jKvcy(Q~`m@~2pFesjT;*lxFJ6Xi^wRU7m!A$P&S8x?tubf3l)dET z^_yP4z2(Jz+spC$UOs!EzCHAk{YW)GR*$9HQ{^e;@zEv9$1&Mp@L@Fh_(0yW_*iQ7 zQO@QgD8Cl>(Kp`5mr~8{)6WwhTO}sZ#{g+x+Q))2J`!H?vAeR5xHKPw{R)eQc}cqjzoPQb(~R z?q$W6g^hgNYOFk4`Y7LCb#zc2@{bJa;-gqEA1&U|d^z3QN6P!kw~r6!CyMu}kLREH z7(G~XhWPY8qIHMs^^vMa{`uNRV2qEsVjAb8@dO{oC;2!t*+=E6J|@W7X+BbC_?RfY zXZct?+ei8wjgiW8HAe2w_mRKAr|V>V)c8(oN{vN6R!Y(3KAQiib>;7sK72p>m?J~h z_;9b)KCJU`NhWUe@y90Z$rc};-+c7>-ACwv_TjLPua5Y5EX_{(n0m^`!_z(@XMFr1 zU!3#t`=37Y&MSYpdd0`|yFM=5)A;*7K7Hh4$78Mcua8}Ee(F~AGdji3e^RuPpRK8W zVygHVAYV#Kx*xA}clcT6^z$&o&*yGG>3+ZdZo$tvd7S5`Fs#?5O~lXa0zV}R{TQnI z`B|RVP^?;hCP=WJpUU+WuYsS_@|Wyx>?f|NpFwi4nV+NGrYe{Z#WmSH6S&{5Hf-i!YUf{54+Y zsbAl!2eL$r3sm!W>gPf~rtkeaf8l4rNQVypCs8K0E?~DM0B%KsJiW6QGaG4hFaq((9Q4ZsrEa%n$Ib zbSw<8uxfx{b>;A~a;P6*RD%G|ng*!eJirQxZxx_j>j1mugzSAKK&Q3=UHcm#^qR(W z3h<H00#yD)^^Xkj`ltZ=f_t)*4GRcbR&$KEP)i0y;0HHMa%0y*<{qoY32P#fVi`&T}I1k*?nHM$bbt0wpiVe~}F35hV z9Uo+rJ;)0gmKfwfQjn_2L1vZ>(x+UIx5@`uS|Lceia|1@nLLx~m4ZY$f*4&v{ryXj zm|&3aGlSg83bH(`_=Q0hR1NAH@gOPngLG>UB)wTs*M0~2qg9Xwt%HniAJqGZa_AUj zZD+-MGsws;LE?J`Y1b>rm3M;JKMe9}{~&v${XoV1C`iJ`K^lJ^WYQqj_EnIonCfBgmzhL0ZgGy>o&b`6fusxj{W^N;4;4ASFP zkiy&AmpegX9|dXiILIzp^Hh09h1h8bQQQ>b6B#dm$OCf-vn9l4IUv=oA%@vP^eGwQ zhjJnAmk;qqg%HbALbR$BVrJzK#Zp70RteD~T`^>xGeop2#Cx*Cr`H1^K9-GHAxt@n zB_+clT1P@GCGzw9>RftioL;9XL#Fwvx*w;41E3bw)-9AK0 z#}MPBX6Fzi-U#X3Qiz59LfrZ=#B&+ZKg0}aH6TP6IU(gg3i18NT60i{55G`NQe$vP zzgvdbE=7linEYi3>xdAIM~2uW55Eo(8Kb&o{kV|+W-^3fLWm8rR|+SFm?KvwDeh#w zHYG&7?31(7WU69L3t^caB5y{B&u50XBhzMuI6qtc`bNE85YqVx#gs$RW@(618@1-9 z5W6-j*B#1bX9(}Ekp3npr0=%W-+ij{yz;-OHRO;aUsg@>_LUGnUJVicJH)noA&NW* zkt8GK@WT+VKUV)OnXI>F;<9D(tYjwD<1%S1o5UQSNhw(aWgZom^a#iE~{hJJ)NSOix@EFB{8ARLWo0oxJBt&!Sqy2O#hw;f zgj;6ORF=u1ce6--FN=={WKnN!7GvjW{`@Qwq?0WDK8pv7vxr$H=QQunEFxF4m{vZU z^A)mbS}~iGHL|HtE1RMXvMCsw&5&`~{5>t3ch_a}%ld4pZ_MWMo@`wEvY8>p|H!80 znQXSp#lNy~Udv{hRJf7NTQ{>wyPr*;N;#~roTGDsIsER)A=a0}=W-`Mhnz?b3#E6> z99GxLA-#4Eb?WEvb%PxGHp*dH_Z%Mf(D+_C4Es2T1E1tj_0t^geU?Mspd7xJO)__Q z4mYRdkU1@fZ)L66r{`dvnM1=_Ic$(a(tUmo^S;aB+QJ;#F3RB@iCLCI!ipSTTbaXN zxgZbL<&d~Phu06}uum?^fMdFULUB*!FhmahnM3jg|9+}oXeP@di-TBlSbvzWOOc*$K>+KxLmf6&n0t0F7>2~RG*Z~u*tbRkvA6SvUo`@ zWq!!TCxhhL@?88Ya`{GH?8>F)?|SW^=3UXetGU#@k;{aKxtxBK%d{7{TrQf2t9TyS zCGzMLpGVb%JiWK&>AfwFdCojaW#sW~FpmYfdECg$V|X}^uRG;&v~wOmeVE6y{&{pC zkjIv<^RSM|)5U!DU&_}xiF}f;=Bt-l@9%t;UCU>^WdD=T zC)e}2DQj=$6LmYE;<8j8+{x$7yZJnMl26rViYu$-zvub9^FsMWhbd+Z^RfJ53G=Tt zOfOrQ$;HE*EfMA)nOHK+AF*K?#DysrA7-Z%PYCmgY)=eRG&#)U@?o8?2s1xRy6nQyJvwC5El_3ojv!P-(3e%=>nAuIjlxP}eS2NwV2=l2-ZyDx7 zE6r&g=H=JIjCnl_?ZYhV5awaWFkLz+ZkI6CyM|dI-QEtfynC1mJ;D_B4m0#Ujgyie zhH2ej^~;dKT6c)n9UA7R;hH}pO!txM)fn|^Y?!~L#yIt4e3+;5?o{=6TA03b6my

>OH$ zk0>#R@9_?&7v<2BH5|V#hq`WK8;sj?sKL%0dWrJ8a%d$A?arZzD7q(yN@Mok9IAML zeOP)hhngJ9p>r54LpQB5xj7Na}v<7I4BS4d!0eXR!VF6l#*ChgUA~Qg7Wdf8`DL~VI z3Q(PSSIAsvbni*WN|LV-pr+osQD(B zR(#H-huD=nH}`|&)~vj_mA6iAwW^<61zP9Uz4o~^tXpoi>z`Yz59gNgRBm~F%dM$~ zJn9*mhu@|0=%=teT7W&p^XO1!9{o@zkJ_Qck~~}^%foXwkLu*ks}s?AwIwO99u>)} zp=I-GdhNUl>XlddU*(lwxBT*4nO`Yu@@v_V{Q7n@Kkw@X>L;u%9;oD$K$XQFtS=R) zf~5mh5@T=^-em%Hs%)S(ln+#Rg+Q%AuZn@Xj^xULs)Bl`{8OOnAhkxI%HtJYHVIT# zt3dAW3RF)N>k_DWxQc+Tfr`Q$RO=C_!I*$AXx=kWD-ql)Q0q{=cc6}8c%MMk?$3S< zz%ir`4pgBbfl3$}s1&?G{oe!i0d0l{st2~C#fU(4#U@-C8K?)CIx0}tMhD7&T%bnb zHeO)L_&~jz$o5Hr+`ka0jj;VeZ!iz{5I;Fk&9E5vv3v^S5jd3|q42aob-;4$o*t;r zh?^0pTbMtS-lO&`azmckY(xCQKuum0sD&uFI8ddRkUt)+4Agr>tY$m5Vfy+&jo3&H zc#pt8S;wt``UTB!6y;j6PUqH=qU_k-778TH}&>($5Xn2s4a1n`7L0S+Kq<*nM+KPbqARWc*szLe(V}A_N z9JH<$q}nZmv;}Gvqzt@*N9!OhM*cQI>V}E(FfL+F*C0JYt?uOVTad0`S&tyudj{zT-0Bsi*xo^E zihX@JzAw3L2vQBSz(mZ&B{bR?qz?GDDM-2g3{rdij>yeHDvg3$f>d!U$DzlzAT7ro z6x>cuIJP55m3IcIF^*x}?jZHu6Qr})w2yrD2Wj|UL3)V6hk|q-p@)OCAIFXa=`#F| zQVW{n9ZDagf5(~UM373H3R2ArL2_LT(h*$6=*vNxj?!1C>1vRAV?AcvB>%fXx_3WF zr5*&SCE^~F{}a{}qp%01p9b+>e2_-G;+WU;?@f?iVB7m3MSKWSzE44#=^f0yb;0@z zf#zW4w*)H&)vUopB}b94;WIlS#0EdQ>=L3a0G?vWziZ^6pZi{pC-t6ZO88T)eV zz+lxH9IVg7f;D&{@mB`x3Sw80-|AqU#?m#x@?0A%pLM~SiDekSK3KPLWJ9njZVc8W z{DZ_z!K$%2SQ%S`)njL{+8kuwQ^6X0ma*`@60GKTgVhC&d%@h-5Udp_^)Of+@f1ZL z1#2M|JrCALe0xc*uY>gn?LGu+56+?bM|$}sSigP?R(o9j9;{gk(E>w=)}f$hi2lMY zTZlq@L)6JXME4OB6r#FOAsQJMqJ%;rT9X!{ZgoRcwnK;>^$3x9Rfy^x4ADQQLp0%R zh@#JjDClB{Zllko5M4ss%N+A}hXu(9uLnbQ5yRb~nufGw^1#!Ap=wMAxB4^@j2#3~u8_gI=4D$lG? z`C}yRqHcDm&cInJR4HhNWB7`ir9(9y&&q`AeA!T?)(TZOoU0wGD|JHE^7l|J!1rOH z8Z?}|PwoRCLgMLC#WCikbE+f_o~R{RH&MxHL;J8Fzu>_9G)O{^fi&5)e^2Bpgyb-EX zxC5VC>`M&O-{_bbri-wY4deQ0nC4**RE~Y9Ts2JXe-2YWtf?NRU0uTTWA`vE|1C_L z(XmIE{zRLeVLF3ey~4B@8*mR1y~9)xvys>*OgZ|7X)3OvNmW_JU(IFr7+!w|7GSy5B!T2SHpA{nb*P;f1P}uh4DT~m>Rtx@0Vff_BBjL zQD5Qe1BXYr>YxRVqOu`eby3_Ht_xV{8LkiT@(R}=jP>Sw{ALPQ2XnY&3DLgRWzFUQ8^}D)>w|kd^AlASM#KB{o)E&Uw61VB~wEo;uQ^7laz2> zN()zNdbp-#&=<@rK@PZ5GMt|g;d+u8E}ty6;Sr8yhwJas;mTVkT%Hxf)et98yi&N9 z;6K!?Os(kBBwYKuhpXFf^u8xCdxxvqAbK~Hu_MAYWlXr5jSE+~DauSA z+(waR5qi=oLJ^%KG^h*PyGAH;ScH1x@8QH68KJCc5gLGk(<79Pqllatp}<)Y+BrW$ zga3@sF67%1q1;=Eb1*`C(d94pA?gr$;1#+ZVLbjh7NOwd5gLPw2tN^_2`F$fLPL=2 zLWD|VAU5GK@?DJJI(vkAVH5l=N9YD-UyIOX6uKTE%Z&(~dl(_xqX@NnOpZ??wDoy} z-edU-dVv)$BY2$|saL4dI#S_nBDHy7q+X)(;7G*`iPYW^k@^q6jEYp^=t$L{9I2V8 zG9^+Ca2J`=BJ~UvW=Ha~CQ`#!M(R6kt0Gl!L!?S<#!V;XqCwTuEsSFIp z1XSG|sV(^OzsD_+`eAFNHXV=D;!}~@fY{TKT7wH`BKfyCQnQe8fq7xR7^ys$BGu$_ zq&gwt??^30+)-+SBYC3qE?<;-6^PPSvitit#k!U&~O1TF`sUv0%j?&xFQM$1yTF*U|EL6RpxXiCk}^)euW@44=^9J$ZhJ=Dw0>y+*;0(Oip+)&*4gFIp23 z@tN+#OMx!j4`T-;W&vro-wL}`M3c;uNY;bBNpKb%-%67 zj?P$&OR$?_l!11bgH!M{$0!vYuoxHNZHZAjdSfN7!RZsDlIVyvXk?91CwxG4dyGms zV)Q5=Mxps)^e#9?Ng**B9U7ylVKHhN!()*ch@El0gFF=~s~s9KI(%2RhGYTOc|{z%>$qbwXj#CBrriqVkEF?xJ6M&%#GaD6yN zDGy^*0ltse{vt-^LtUh98j#%wLX3kj635ZqOTznlA%X2bTe+S2^Zb+;;!WND013=n;sAP_idEUijK%FIu`2R3R_mU}s=$j_#UbQ#to*+4J%0Ees}2bDh|{mg zVTe;0f{bxWaK@=KhT?C8`^704>oM3rPFE3^BTgN$6_-&lXPm~POhB9#;t1YAx#Cm| zeK88(P%(F$zN2EEIMv3;ym9&$6(ZvF3-;q`WSkzOc2t~N;9PW^YQ)CLKQ2zM(K?=a zuns5DC?QU(u>)C&acYtjr)wzaisQO?oIb+tj#CQCVjOPbIet%$(e_)(uHIkLTo9)dJJ`RQ{aCk${V21S{rlq7aDSZI9f{LQG&mZk_Q-dPexKs;H0yzXG2u*{ znqQ*-_~kO|h-av9B~ERxa*lnazp#9#=lE=h=XHC$p5hAzdB*F8S3I8$ikH(8uPX5H ziRW_(@tTUa)_5JY#jB5hyf!08&Ul?c`#kYl2Csba+75GMyvpDcEK%_qho{l;`ZqRS zrT4|FKd$YM*NOx2`s+x%j7N!wL#T8tUdxZiYwwA8xo*U3G``;=&)e~uawlFt-Hlhs zgLu`&)`#($`zT(o{v+<^c&pv_+s^b(c7C-A;rg8V!Z z)fNe!iR$2&sMYw@KT#c#Ge@FE;sMU&N|YmaqW0k|y5&jK6O7NBs87L(>J-A5m_&Vs zIW|$zbrUrNsSOe}4jr2$>JnbIOjM~>iTa2dtrMj-iK>n=U5JO(JrXsjC*vn4YA6zB zB&rPx%uG}w&Y|3_ME#E9vlCSwh31gs{6xhqNK`ti!+%ktzAYy2C5gI;Axp_?MWPn3 zN>qiliRyWPV-6;&J9_<m^|!BN_8Zu9NwU$Gl|b*C+U%2k|yO!(n~bXlcYO&lTCg~FHz>%0Fvnxpf*o(O2BsDCUq&bC> z^mE}Poy$nlfXpO~L9r~xASydaZEGi~McpL+21XK}EltwzNN$iM^-fYvG=ZZ}lB)D2 zZoedr8knT|gObz^(Swt;ZzB0mO433!|079*rX{KR^dvP!?iop{Gb>5G7A0vcrmRj< zkF`k}3fH=`}pfF112Ui%Uyv zF6FVi6oE5v`noj8=~B-Cm!{`pKdR++X)(g{xb!O0rSnlP?TTSstV<&cx%3s0#a;Rc zbBasBsV*gAO1eueGhFI{86{j=_CJ{}eSsy*rA>H+0;OH*jQ)r%=8r8yOd zUDc)2)m*Cevr8#8Tw05rXi?Lp%vvs0MI#)-#@a4Dtn1R4`Yw%Y$Q-}AlneXd-^iu% znAep2+PX9e^H8xJeQ8fE9bNpp=F;rGE`BFxPP7|K563YFYK|wz=`P+McBwi{GhO;L z$ED+QUHS)O=ehKLA^l$D(%@-G8gy7(1SHD**3bAeVB20hvrAA36C$( zi_0#3!}7mfYH-D+W7p~LEthh>cd0dgL+A&W8h>=@!Y7wrd~xaJH+qC+->E@vT!Q3^e0mffArj}ddYP)r+j$7Lr zxE0ZYdGW5LTQgd_^%7sPtPQc-61%-yiJh1WUpu=sv#XoGLF88J?r!ckqbF#OygjM2 zms|dQh%&q;+&dqjf`5d|fzlyOnNDS>@K-)oy96 zTW!|4b#Xn%ZXotXx2pchzRhm^zSFJiyWM&F9bbvnrU{Kc9bcI$^@tl@ED zo@9MbyA^%Tt;!eZ)kSK!Oih1N?^U-VaTcZiajVBQw?6&r)~lOtZGYgF^PyW!F$X7c z71@vY9;@)t3>2I!CkEnhNV1BACTl`$vKF9TT(a8YUxXzjYa;p%gzcI^QT+n;Vm7vt$ium8^WN=~J6z?&+d_)M%Hip?Ho8?UVHwvpW#0Q?k|J$ol>TK{Bq8bJTB7MJkDz+@#1rq}3-gdy~4YO-FyFfCb4 z&=IFlVmkTHARc^YChNCZ$y$#*vy-(5TQFclVbyzHO!IIbd0!M$WsJZH_`fWsiWq_& zc!k(k#ncqDa2`Idi>V~KVHKVr@=Y<-$7Gy@@og~`M<*=7E#!GuOx58oR$QsYi>r2e zan)~JT=@?d*PDbCMJJ~4nZ^{&#B~HGrKl0+;3{&tQq%@J;c%y@9@fGmIYm`52$xW( zd&MIRcnt!av~TcoH=s}v1E(bg#{izk@fCPn{X zY+L3>R=X5^M3MF>dW28-vqOsfx-vHm-BRR_X?WK?MH_xg(O;udWE`EM%{YWgV^Xwy zY>JwXOVORhDGFSYqFzf=)MZ(U=59^l^IpW?jvds0EJgW`r|2|ppxKEO?LV2K-ltR4 z_c1l0{gV{lXHJplQ~LBQh3nrb`eI8}5qqj8Ia0ODH&x~Gq-qdujrmlCO(fafJswIMTA{mZ24JRVj}RjD6S`S(0kmY-79{O44qRZo@b zrYZ$f>!qrG{Zu_`n5w8>Q#GVfsxlj=s#eQXO~i{kBF&hYKWcF(llmz8rQ|s^c@@Kupi~-rfKoKG~Jz_rgi($)N_BD z<{e0r;Z~YT;thrB_XfOIA0O4sPz=_-~dUD!Zd@%f!t~5;lIbBt%6Q>4o zP`@T|@CHBDBCp!%GPh0F8ThnISBv)P%HJVf?vCl|fY46qO2$?MbRj298IrCG7&bIr zQ<439x~}}eaZ}UfF_Ud`)3s-Qy1ruFf^_XgnT6@xla#Kii_^7yRk|Kv#%gkcYfZYw ztW8((b?G{?EnVK*)3pspQFTYUR_#nzqh0Abc{p7akI>^!)EAYZ=9m+mp>H@7lcAev z9-E<;aTyxp%FvEv9t&n@Hp&&skUJ$qi*X?>LwE5Op6MCNiEtD`DO5*Obj1+-fkoJa zSNOd|hJMJ*;JvsEl`fUR>%0tgC`+vJ8Jb=pLy46#bf9vEYE{ip(jUxKt%PRVN-Au8 zNo|`@QdK9FUc>OG~T{HB%E(&;6YKC`6G&nl^wb4u#_+>)9yzoZftmek(BO#Kp+ zspr9&{9Ue0u1{oYHEu^|>OgF!mM3N^rbwm|DrTw;3RKEu{!Bf^s_L1_s*$NV7+xn+ zhtRWbrbeJdy-ek8N^JNv%Tzwx!iKh)@@|(Y&-RSPJ9u?q9t3sFRDC!*Whxj4kZC zeWqpVF(PJVY9Q(^%G7jJTAZnRNL!N0d+C|n?~F! zlaFVr;LS`8L*Lt(+JW|WGSv?q?`Ephi%bnd;g^{z4Z|yHd6%i<82>p_r!eqKrY4~9 z*G#QM+P6%VHDqZet{Str&pt~%JhOBNk5JVsi@$4-rTJKcuSoUIQhBULNmG{Q!e!1< zJ#@izT*{ZF^MM>!AWI!!3(8UuD*sP#mY!ixWR~vX$EYm5kIqutm@G}iNtBJv(gnOh z0Tn1Hmck}c9~#aiM+{$>rO60d&wQw}HA}^}Wr;u3 zDLZZ)&(gmq8FMO2HL)56PG@Pw*({wwyK`9@fDQk1o_sG5_g`wnH#o0nDdm4|uqHTt zGfVG~|5lbV@FT7x@OG98qcSGrIt+KRR1Kri<}SU&hI?7Mf>*HI&r&2xVH{pQ%2KY! z^c((9s2>$D6bqkbDe+mBHsdDNy<-3CELB0Hx11ly@h(e)K4xhdPX3oA$LB1a`;w(E zsP>(CVN|wajM@4NFYu2~w)WYxbsodRvt^9PRwqotX}m?X$ZXBQW4w*ZR_$nx!6NL# zcLc;{D;51Q8sp-!RU|%J+u%ybR%J9x%+@I6Ov+Xis{M~ETd%M&Ia}ikW@|If70TAN zBH8-4Xtw-|Wy_SBtq`J+3ZU5Zi{M7r!!78Im+1VyBZfFQk!bfmK&O_W}i=KJ!_dz|w**~#So@BjXjSs;_# zpur0bJUWZ44Lzy|17;(S-tv&A<a^y;dImic6^6 z+M`5V!Lqgj~3%0imdji$u^IA;_5z+^6n>>L*#-ZxQU{NafEsz-!W>7xmbm> zFC6zM`GiNu{`BZ6yk|Y?jGkJm}}@mOu-i14;qR~Fw_e(P&>&`3~O-#`I{T6iS(9+a}YU-J8s0z%>hPvP$vR$E`FI+YB z2kKulI7eWp;0=TC$qhx&2Me$f`5qD*-baSs%P@2lbsjTbEcwq+Cie8x>|V_+>{Zd? zUIow@W3e2E@Bjr%cvTOrFc8!53r>O)izFQqP zt>slM+^+9cTm!GV`np-!X@JBLnhIn-xm4Hf(0R zTf8d1gLP=V)2kUMzKgN%_A0v9%QZuc?Ew8@)?u%<<1`8%VLzb$F|XRJ@j1s2KyzsiIK_yM@LpM3+!~2+JoB9c- zUhtb5(AZS=cvIVwh}+!M6dXs6)+WDyO?7BzYAiB!GW8Dr?qMqbr>0K!HkruWR2L*; z@e7}s%$H|sHJZ}s)7+Xg&M<6eLBL_ z5BO)KsaB&+eS!7p{}s!zrXFKWs;Qo7rat@2kNklb<0gnMA{0rU1_S) zYEvQf$Kjt%ZTQ7hI-0IGH4@u4Q7dHLY$^`#p)oFRCH6L6;~36uC+{8PgE`py!cO+@ zE>rvVn7V_Udrfu1$NNn6!O;DtE~3c+Q@1ee4^vBU6Hjsfkf}|FO$|Q67?0BCn5k)a zh62Y;)qCNDsnck5lDK&NG;PuLEZbw&3+GIIaGv#;d66-pz$H^9QRy%8zfAvEOqIEA z>XUy=WuU`NlWVh0&UG<{+x&dTWX=pz*HP@AshVht&+n5XNP^P+1iTJmsPnB!?w5z^PRs&+=I!ZM3 zshHto4sD-avwY0!;8Rz>Ps^J4v;k`aK2>sk>Wnp*AM`1j;M2_>$p`awtR!!_h+N?g3z%%=v3;50H&vbj$trnm5EJsP*9EmE)w$6E1ogz@4M7DRp8 z1|#NEYmC76_zkx{q7H3+I)|$5=pR?nzJpJHqkKo7T4FmoeN0aH>ny`y{@nd0NSTc2i3@oCa#pEhk_99w-_xW}ijkCNjtVxI7+^l55; z#;3gJsRKr)v+wZxWuKCBS=yD?(#F!3O1*9A$EubR8(4bx1B>(AmV6&tx{B!yEhTv@ z6*nyTn_KdG*0T2Eu_C^FsRcNycHL0fz}lX1?X&3v|5 zL~i(Cv87B)EIos{)KZ)8E%m_ZWtR3Wx3qYTrG9HIjX?Dcmi|Iulf^abma=cQRAY-J z151%}D`Q4Ybi)=Lg|=DBgGLyJiO9X(QYv!oAU{NQTB^E>bvOynZcFi)f@^q)llv_7 z+;3^kVN3rVr9S5^J;!$!s6T3^QwQX_XsJKWqtYebN9n&T?q{L4mn|jZUsSnbasQB| zpV0QIrP*k6jkebY?bJ3Yc*c#W2-RyI1W#;t%(>m*wzIU_>x>vZ8$X_ZR;Tx zjA6fgMV)XB6~@}?fs^A4rl{$^HH5X@~@hov2>n7OxEzRctSJZhjwL`+!wsxY{ zH|)PD)M_fn>vYC9(`Jqg>VlH9IHqUYN}FTrmASSWpfRR?$Ll2=$2h!{Tz_ESVb3yK zJ%8kQT+Vnf@+VtI@bL;;N6~vF`)4(ETf^t$XX?MsR*_$9joQH2Hqs}0{Ax3w0y*Od zt{`C(d2A*BZMOPtw>1KTcGxPvi_aGp?q+}Op&y*xYb)D6TVEl|ep|^0$REEP=JSh} zkFuYSljliW)lb(`h< zel;xY*H@Su=U2fu{icHvkBzdo$!*Fl`9ecqEavk1>zn)*E>eDYeV;CNwXam2> zpchs(^y?1(LyJa!?Seou#KslFMVkS=F)p);L zjKvOQ3i?$SJ+TO9P$0oC0|T)d|DaUJuVzTW7TiO{L}FtG4k3GzU-i)w^KlMwP5o+$ zRBT5Esy3q*n1#d0)7&o$L$MBbQMrYm>%9D0ifeeQCH2BMY{LUoZRO`WFlvfRC>8cA zf^TpLxg&mg&=)`8GD=2?gEah(*J9MEyM?j|!1~mQ< z<2xEq9ei^vpwRJvJ~~eycyxih(*sJo9ne7xyA#kP6uTSH=l25YcAuZKIBJfUvpR~y z96ZnFsC*7b31uB+Dd+G^3r8!^zM`W(c!K7Y9i750d|Aa&j#`dPWFTj4N8@m#j>C2J zj&6G#RWTf;;|}_I9iE5gXoJsDfq*&YBj{d>yBaW7%#!*LU#~gid+)v&wvc*)h` z%&x{}an(Jmt56PCwez@oC$Fnzuee&5&(+9RUCn&cRkXaT+Z9}0s_5!yC09EuyP8+k z)z|O3O0DMV@9M4&)^N40rmOX}h*{fJTwPb!@LN4%HFWi%$JKSi)pOI;BA=_{ma93o zt8cQqGf8@n3b#N`=hu1a7q3J-FXgdEAPieM(540e?~#8n#ZW6m_~wV=X}cH~%I$VFVvj3hudDp$T)BAZysHA3 zg8LWfGo3nIah3I|%XQnXcEP#kYUy=X&HiTGH(mXQ6}MdG(RXFtcD3LR{oZvo`Vno> zKf~1+l0T+pR&vpuce5-6t8Z$hhUa?Jwv{{@rrvTUQO{E3g?SgBjn5Rmws>V%NLhD>RBlg54flpr`$$NIj)znpD^7>><(ZHspATsjmR_Kr^pH~ThcrDS zB=6&px;+W0z|)W%OhszeM9q0QQR(<8ccMDCOVj~8#<9hT8n=WcZZAz#r|%QB0Y#Q4 zDzqX|ZB{0#=GsK9!QQQjs=qB!5uDwgs2V#GwGcCRCTha2M7_E@Q4en=D*kq&dgM$} z;n$K>3v1A=V3HQ1VBsW1u>!e@Bc|A#8OC>2#I!S}dBW z{j{+DnjY4*HN;sP)`4|l{qjp#xi*H?5Gk9&+O#>WzB|K;I}+CU^spA)32WBfF!ybQ zwJvi+-YgN-%pTD>jK~{N<5wd3H(x~g^GEoc^4{AK9rs4`tr^k8KtxCTM)cm`i1H1I z$dAEOBRV}JqGB^6+K)3xn-x*{*%4jDT|Ao;QMLKR$2lY~h$znzUgPS@i0ZA1$i`(n zSshX3H4zQPIGjSEwGla(iyZ4BDhU6Eh!&#x=7{d$jRO(=j_YS4e7_fwai18d{(v#! z8d5SMx`4-zBWnF5qVAca`T?!8MAZYYWsT}|wy26_k7_^8AT38!)pAC)2}!wGk9%=Z z1&c=&#qY>fA}SB!F&)Q|@AarkAXX}>qwhrZZrP}oRER2}Qj~jLqx!@XRqbF@=MvZ^ z6jhCuw1r|(jmEHkQJui{{!!*$jA{*bVBo;0;s!<40=bi;DvpyVJ3OimC^{mla@dco zqoVoqslZZs#VyA{cO|F&(NKQ~7!^{*50~xLr&g+s8B?Nuy%=4jb?kIY-A-A7d~D*~Y~542{2vsSl1| zmY* zZc0pbrm_yZrp0&`NK7SWV0KJP@yeW-{=wk6F+IV$c`+4P5Ys8NUKmq{l`(Zb7SrJq zF`dVNKVv$8>&SF6rmCoqDR_izr(&vpI;NIqVmi?<&o|!gkMCvTk+>}z7P!pffB%Ft v{utMJddkQpW3xu5rZgM!(d|fZsMrlW$91tzkGFf}gLz`{wlPw^`BHbR!#{Y0Uc05Wk?=yXa#}7a3c*XgiJ| zu(gZgPyEoj3eO=VQpNmFe(C@_h!$p&Z zkso}9yU2Zli*ikL(MznFPOKX)>UqaS51+Z{J=#Ba(Hhiw;i4_CTyzi_uU%B>i;KRv zxvHtVtIqklYEv#(?ZcDYt~%)FssjG5+JIg8Tva!}s}B9-s@MQm^}xkISG5ds)t)R@ zokyu`R~;$ks>fwrWvb+=MwMOF4oTHrRT6t)t>LQHn2&BXiGgnQTs5hwtGYIG)%#Aa zitg;H5txdyU0n4$K6T}OH&^BF?y5+9?cu7%J?Y!aRWq>*1$&blO#NKd5P#uKf5!dY zRYeB4s`EfsZNv6KuJRh}DhIX>VNP)U(^VPRh2Mwqc(|+jjBwS<(Ts(LW5{)!t2EwK z1F>`hbH>4muCh%cZ+w_c?o(V<6gzMkooBczbf&A4XS-_E99I>Z>#9F60rvT>idp0; z|D~?Fxy)6gmy`c0SDjhss_SUD$yILqTy-3U_q*yO+zzuQCtda8EO}jXmFGXMnv2Wt z$oV5R{Oqa$@cfT)Oa@JW-E2?*{OksWU=lu}oR2~6Fcv%f47!YvJOFoxyhgdW^yh^vxol zY=dqiuoU|cP}-nfxLbyKmNh67l~J#pLH9AKyg}wn zS{XE^wLx!TY-iB#Xx+)6Bb^N@(4D&DS`UMs|7OsLo(8q-V^GJT2DKV)&?AJ5FsSf2 zgF5`rB=SJs$@IsQDcqlGQ2Ut%J)UJy{@DgK!|6HnpKnn0)dn5gV9>CQ)N>O#Z8m7t zR)gZUlhY1^u44FZgR1OdtRvL$EOD8n3UfuP z=LQvjVNk!99A{XC=I;#}_raj$9}O~mGH9;JO*vj}T8t%TH{G|n={LKZ)*)|xH^pHa z4i#|ImOwY{3vttJGzxQ5Y`B|3qTRGJ$xU^Ox+y!=O=HnA%}u+Ip6;e28E*QkteZ^b z+|&h|tGQ`S6E_`zS5r4V!c3IZAYy3wC~`in2v4= z>O{_+-BiDen;P~Zr@n4V>F=g0xH8yH%Z9jV`%pJs#o1xR9pR?nQEu8ei?;LJ)Mmb$ zCN6MOv4w8xirrYY%1t{qxaliSY;@BZv%3mg+~r|&S5{tk?ak+|t-;w~#yAs9!Luj8W5Zt1LO<_i{$v zLznX0hkHe%Hsb&up+zO5R#Z0X1G0WLYA;@+VpXGhVmY#_kv~@ABewivRN3m>Vp&b2 z7S}TBRBfYfqDdX20_z*q4)>7Uz^F2qjAy9akg;*Mkx_+yHL65oqiQsvA8sJ0DfPft z*qa&UY;IIKCbi^#Tch0C8TAyO(7S_?7iC5bgKsCJ26ds0&Q1FAnDXXr6wBMmJv7SHk16QiP#_ch0( zt4Zz#lL8UpVbW~eMtP%2Z{h7_QdzV&o8)OTX`bDr$ME(wX(GIGo0KcBN&otr)H0t* zpF)TiYSIsM3OA`>q)D6cOQK0VF}IjW=He##qcM(^FsX2|No~;+hE$VYp<<>cSDncF&hOMoAkViNqw7|l-SIqhPZ~;T}^W7Mh+yDWbb8C z_1-33NB+Ll2T%IZroTz+emAM;0Fzn`H0cF02b**pSMUzqhcM7 zr<*heD-k!tq`&b9b!PH-7UQAz9Ft}t|2$$~_k5FF7chr~Car?!Vv{Q2IsRB;QlX_L zWuO5bV&5{8PU9)sEoZzHCi$&2sl*zSN~0;>V8%v{vrWX^LjK!KDz=^4!?44ooa5B* zgh~By1wBqOHnySuDQbx?7;~W12iw-P2Qz(H}lu zp2}nMR46iV1YNy7H5eao#Me{ST%O90VmO4(xji)yZ_&xmQ#pA&wZPv~W%GM#G)fd8 zHX;jpsvYb>o~i+_5KmRX-B3?Og?Z`>W`}!f1&*L%gr^L#v`0MtLaid6T2$0i>v0-& zi+ReUI5}fDPN#S(cdDm?k&ff2l;Np1$SLKiQJ9X+XkOY=b;^3my_~1~FuS~`u2l9^ z@lop;^ zh`p%V(o$y-BY#!^uZ}SLEnL%G7k6D5)>Kf zsXdrI%2O9GakQs)jrG*zY1ABh@XK^hHJjjJKBp?OuvQSKL8gA1`gp zss-a#og?q^lE#MnT4D`TXQC`}Q6473o8RMm82#)hoXMB(M zQr!eEz034cayGG$mE)!3$S&ojniznIIDpGAmiAJ91eEbo^>SXCfFrmFp9)?Y237P@ z6ik)8^auJ^W*#U|#Y^Wg<7Y3O!@?R~T90=%z0|yxmzLl;Hq`b~W*sk$okQCN%zL$$ z#%=V{p1-_QZLgOaq1-+%B^~fm&=D`)MWB&_u?YiZq zh)2{DxgIkgY{h@bdg7(=xP~Fmyj16nmpZ)V{yXOM-b=TU>w}lBVERXL#GFrF`t+H3 z|L3J|U#QJjFBQpWR)zd#1^r~!k^*L#3YwJ|Xx1hC7HU?(aI-!~m~|}1ENh%u`B6N} ztj@TKlx(xgqG*m;QDx1%?lh})C9?u6n^h6NVIfY#UdOBeY_CWE`eyCJn`UPHK;!0S z^+rf5v+804TDPGe%CI8mvsqudn)P=#vr@a8)fEHa(!;Fg z{mkl)!2V`^7-*JZkXgM3n>7^fL(D3PN=W>}tTepF4-EU0afh4r4`N4{)e_6`433eE zffHyk%B-#EIL550X zL~o{M=#HLSI8L^j^#B>$SYr&s@$JlK2lGMBPSymI(QKDl3$PA@c2g^~*+bvGW+m-2 zEAM{la?q@Fj5lAsPHtPl^oH486S+h2tV{K9SJafKaR`5lR zA>>?Q-7(;@S@Bn>C1(B2{;Ot9!P{%B?>}Z0zCq5n%!;_p@rU{thX*Kfm*emr>yD21 zsmB9qhyxF)%Oj2vw0mq;)h8UoPt7`nBF~72jOS+k{KBmLIR28gdTrLsw`RRV_B;BZ z+IzF+elY7Laz64H+u``cF$8^P4bcXt5%eF=8SI7s7qbd{WgN`G!f!n9@Erdk>^t>> z;RiLx4Xl+#2V5Zcq(#%Q1mB~H7h}Xrq8*o5lgk#Z!J_LHt^e1eiZ?7;iN`lBx^auO zylYXTd(7{tMboetDbL9Jxkb%z6d&OB!lG8#g%c?D(xQPFi#)F^YJqNegc7eUDuW}) z_l7!QCSKt?+P$@CJB}jjokim@7x~^>)C8Sy8L=OTg~j*)w~y2nhj0OvKG6@Wk?@(? zU?|=o<3EecUxAt_LaPF31z;q4@*$-JN3YQSF7v>t6F0RzPnjf+})~SxQpr@ zRxQRyBp9u{X0ob~$*LiEhICJ>rXkYHs={cEd9azSs)HRUY_V!0ELN*l+N>(*ZPjHQ zvRf77W7RC!eXTl(fdTX{Xq88xRi&^EAFw;fs>;DuHAaUJs~(_os8wfiA5mde)x{7@ z2)Al0?xJLbRY8&Dj(O-3WmRUhRgdujw`0gNo|rHuSXDaFsxPSGU<{{Ki;}ErU)ZYu zP`(KFi&@pAIPFVVwKv(S*c7WqVsffgK516HNw>;e(yB{v%do08ie?fEowKZ3kIzWR zvFbf`l(Oo#(pEi1-ZIPyhO&%{Z}2K-RT8>mFxFMD>N>7evdX2hRbi-));Nm2RaqB& zhV2*PRJSUlhEb z<=fb*J?PPd{aDwO^=W2R)8^#YlDT0wa<^tIyl!VzM0=~wA+>{5<**1>J2L-HtX*g3 z+=cmfW$i{-d97mASbT=ZNbton+a@m9^i zQskRJ{cv;&b(v~aJ-AJ?Y9m~yTa_|{V;s&o#75P*R!zYz6q`pZjKbXc%xQsDzb>?@ z;Ue-`%rUXVs$9z$bGcRRR#^2n_N}xkWVKa^2wKB24*Ob;e>_LnI;#fZD7@Em4B^)e zR+ZRDoi|x^;xBUALe4O5qweUuox1KIhn>`V7rF1Ys>NQ`{{YX6qvVf;$E~V)iem?B zPO}!5tO`bXxLhV5?8KQXwELUq&UME8m%LH>hL!VXR)u2*&fx}D-J-sDfx@>rW^fjj z9#RwN5#u~&9JoBSDh9Ty3i8X4811P1j5|HS@ITAzGMi^0V0Vhp$bebK5l5&!+x)Y`T-z zrXKz_O~=1T$!Ak@Y{yfK&2Q6QoPyU+Hr_Yb^c9{3Y+8ekfi@|~rhWetWz)%Mn`*|` zEP0w4}^aV}Z*wntQO^w>wWNB|xbxgp)4mKU=%GhY#-KHa`^_xxRp3Jis zeQX-o&!)iNnbQFJ;WNezv?*pVHT=V-o`2f(%P_`5@<^MCjAGkpoAQmZ@%*uADZIzp zlz@xlY^pKdrpH(?!KQZ;$$hd-U8dNyc&bg6r`dEH-KX1heJ1(NvMFM=O~G?)T056K z=iAh6gH0}*na2T}b{?h9$83tn>kH)ik4=Mb*mSy}w`xXuE3&?~3L|efZ-rqHHenwE zyVC|uQLu-%VsQyWfAiKPH0|lFrRdztTm2E#+gtG%0z)5f+2QQ#trqBtF8#c<4!h8? zzqk6L=I_LTVIb|%0S$+EYwVxi`hYq^z4dCCx8jC-s|2Qx^w!!j-dZ`9?GwCpdZM=$ zPVrXDsopv~&0EW7cxy9KXL{?|Y;P5q;J_UhS=eYrNHIgST#C{T6Sn*~&O9b{e93|s}FhW;R$d3dd^$- zFH?(uyjAezNO5h6UNR5G8}{nuUZAyGGz6W{299C(N$A;dYHen+UrmMcY+4 z#;%A‚t#$s$QZr63}E@4+#nq9Hw?dn>=uGC6)RsGqn>|gBaUfr%wHSAhj)2`rJ zsb@VZe~|VbGtsYuxm+6yPhJWja_^310~urH>|@=M76VP z2yWtCd%IjZ*cI2=uAbfO%Ia=cP!GE*{btu&tnF#nw_bJ?>TlPefp%RSY}ak9_`|N4 zq1=vO4kPVqJ<2ZE(RSS*V^@u_b~PDCoC(ZpqFug|?P`TwQ|ziU)h@?$yIPzh85U?2Z!zIaFlV6 zv1TXiN;+j%mD6_B$Mmy|f6lJwsD0h8p||X6ciS%G9lLs<*Il+fq|T4*+Vz;ePwadS zZr9bP)aeDs%}cuuzqV_}d)5=ZKhYk~(DAcfePRC3&igmJ?xFNIyG~=u54%32ub+>$ z;V?{jd~_tQkB<8L=n_ul_fg}5K58B0qmIEoiU{%16WkB=(ata*{T=S3MG-z)8|9;= zu|C=x=c5@(KAK(3N4tvqD7ggfl6~|~ijRELd^9kfv9PElV`cj2k1QVrW&3CtY^8j( z2IkT}`V|LIx~z|8mh(|?C2~P_6(4QFSFEb$qwrsRG#&f!vX+mA*Y#1-uRf~U-$x@x z`l#9zA1!%E-ymP@4E9xxXkSfr_-YXbIek^Qkgtjr_Ek<5Usc71s=oTKy07Zg;1(Tg z`KntTUp1)ftDoxm%HG&lH=FosUsGQ_YVND$EqoQ#ingtNRiLe}qHzu#+WG1p3byyv zXv{#{ZoVATzIr^sS67D-XS}akO!n1_)xMg&##e{e`s&SQ#yIG!OSt}nw(xVwrO~+U zo=ZP@~KgKQos$q4VrqT8B?4Ifuu1 zk28yMX~`Peugj%w+t>!f_FQVXGnZbW+^$?&iNd>cX#$Gv$)!@5y*HOC9AF=o9?Yet zhjZyXh9AqNq~p2NQ)0V`1dR#Q0{wR}A)9d6@ zVDEe?@H(G-x)+e!$^uGWQ$Wj(7SQ)&1^A3IK-I9eM1Yc#15^fkus$b1g-Qh|1EX;Z z9;E|xx=esJlnYQ;`2ej!?+O9Bfuu?Ss*L)mR4qVtky0Z-ng%GVb%1(x2vG5^ z0h)(v@aqV{3YIwC+1F?D2su8#_k@7Ms1#2viElyL!iKY{HN z1Nb~XKpRnL5_#i3;wA^EIUZp76#5}xDm6ioX#whp<=8zvKwl6$BS5z?eci37ocD8D=s4YQh@UR!}?=1 zj$-ij0PRBl8v&Y)4Oo3MK!e5?)GK&TD5wIn3aT)gqaXGo&+LMVn_o~Za9}|}ITjVv ztdKx`MMzkn5^)I$k%3we9jN{>f!YecxIi7l>?(o!2V;H?)Eu;_8mKz00<{Hd9jJ7? zhD)13Ek=R1f$EM4_=NfG0<{)i?E^I#x9|d0It1zrJURwy1m<@N)J;t2OdcrRB~ZK3 zsB56w;|MNcPPafkM(rNt@>`&;Vp-2XS$hTQC*1BGsF*&1YKDD%Y2T0BHUz2$T4Dm` z;xZa<3{*#a-xR1ke+8-o{zSy)K$SwFErF`Am3HX4El|sG7lpQy6OQi)RHdDPYJ%e! zyE{<*_5|u2Hti#y{ec>GC{T|u_;8>uAmm7(_T%``KwW{)G3J66c#l%Ysox34IT@&u zrvr8LQlPG3)RjO@N2#mKFy8j?hIS&KX3b9Yf`zdRQk=TP$&jR^e zI#9!3)8-9zdmE^i*!Ce%;U5E)|8t;bdIWL(SC9@Nz!anco+qFj)cmk-ir#8(dDx@+3wU9BLw)DBWNq}2^ld1N;vey1Rvhi^Cf zBfCcs*YyM`S8v+%2~zFBK^nY}7%PLcbWMylAhoy`q^_{t4^qyfAa%ks6nh+`g;?|=NT2ZiRgesCg7g^e zKL%+J&ZGJ#YVb8kzkUx=2VD6Pq*)5q0@q-zLm{_d9l~u(u!6mV)!8>#4-g#~ta_2b z8W9_;_`<W2{b5S8)>QKT_M@um>H zKp)Q#jfcf6MCI`fR&$8fBhnJ0b~u2?cwi0Ttv<25LnM0$*9nK{woeGJ)k1U$!<-?S zhSVhTz_UUjYEw8w!;6OK8a9;(QOlCV$_UX1EX@p&TULmCF#`8cFFQnMVb2LsGMeK! zzM*ER5RJq0(jmG~CPXQxAfP-4M004^jP-%pd2GbSi|;k;vtAh+3czmfMVNq4%K38 zz|>!ij$Ow?^%S4b z>ICs|7!yy1>H{X93YGWiP|d|H^gcs>q@N{EOu;jl&V{PT1@>bR`d_3yK4abGP~Cy= z6~;wR{EHRWLUj+B*FzO|gM6Nc@)<^`8owm(SE1_uEmX(QKw;_&n@gDLq9u-@l53di zp@bn!E8W8M5$^6`8iX+(Jcc~O^Z@VhyH}XTo5M5*T`gf6V&^gL`Go0`Zf|4$0eFoc2+AL(lemsbKQT5I;pYNj`W5GJ6DtD3v;_?V!_*cF&@L!Uldur$ zLc+8Q?xA6tfk#LTBQ_pkQaEwp7ZIjVOvGdS6&a>tQH+mD(P1*j&=&L2EFnxS62nx> z5vG35FcmLCtYTqmnjEIfsbO5BAEs&P)B*EKk^`=0gzHjd^3+50SuCEQkRl8xh9F4>EE7qZ4lW@((Hh4D; zS37(}!DivAi90CTJX}vZhbz2GxCV7)d$(|94h>fy{5_0VBf^z6EnEXoXnMG^aSRbN z!xb)S+e9d=ZG<)tjL<7o8XTeMAraa;JVO7W*2oAY zjEYc$$q|}~%2OiL5ciNdEke&xes%<56XEgtp-8|8BQL=%=j_+H@j9i%&;r17glZXbmo&jo{zc2+czJMaG5c zQiS|3N2uwQ2z5rKs}X8~pRPsd2`>CY{Ob|wkAQz8)C0jcBD4xu(Di17ir$LQNqF2Q z&YcK7z!yxr8^QHB5&9cN{$m@)C{jle?iwjiL!_K}Bh?m1{Uh~0f24XBjMP@N4UAMD zxCBM2VQ{3TheXONEmAp{pU$?Dkz5}hsoO};iIlliq@I?GRCM`BUB@$YsSv3%6(hB% zQltu1jnq_BsT;|;m`FXS7pV#LBekmqeOpGV0z6tp%FsHJ*X@y7*gjI(9U^7#7^&Il z-z!pazej2Wnhl6l-a(P-gqedQ^=?$8Zmx|~xs8$9jvAXH_5FAxpHWBZC4OMx$w>Wj zHd5PA?;`U-#Y>T@4_%H_4-~jY{)oKJ822N!52x}(acyCgO5Bdpa(qS7ohWt26+A)o z-6$2sA2@(>D1R?XThRV~lwRT+hCGbYo<~ud|1?TB5&tYoU9l4Fo=0gG-XZKolmcEx z=`{+ziqe2LQF3`3rBXPBJny2^2upDspV9FHd47!Ix{WBkL7`7koa>9yMO6MTN)r(N zg~#8cl%i;zhr3I(2I4d}x<>0R0u9lsiD5Vef46AW#eCd^k9)K-(Fu!i6()~pl|UCP z#${NI(Mm^q%)x26nWB|~j#!LK@bHXQ8v0-*uEXvXtqgR+8ZN zTFX(tbhO&x4XTtSmvYRzB6Hjlt>2NfHCkCXitz2k*cGiISEBXgRu42u6Rn3IqZRxqTKzwh_kYpa^dnj?P{AcegI73r46l1*WGNJ*)`epf zQ6xrvQ;381sWIvYLt2b}O^;Dr$r$ab7^5#(Qz=Hf(Y11nZ1rMP5kKHvKSq=BrUBzN zjN$!tj3(k$>lofs$EeY?7){5A=`mU`BSvSp#%Ri}7+u8B-7%VqfITtly_a0}#c2P@ z80l1uHsSz!o{mwOC-lXgr!gw}EJo{I#HirQ7{wy^ON@NJ@)$q;h*3v`xWwvL+8%Hdm}VVJohnLhe|NLutQQEyPj0h4RFzIQn5E zzN13kSp7f+|5(+*hs$}6&5CE?xJx0SXD%m2GkhO+ER~pvC8fgtAQxonZ7uV z$gZ)<-Ho{qjMZ%XHz-!OhcNb(Sfxy5uK14a(_*z}4%@MAZmjmA^gQZ0KUTdK#OmY@ z_U~pt*6m?GO7CU=zF0NdAFK99W3>_ukHxA3@*k(xr@1}DTHs%dKO3tSm#IB!U19z3 z9ObXZs@*k?t#8y9oxfoj6Uo8>edb;uQQaPW7<$QJm&J zj??S^i2Egua|v;(iH+alH0(Qh7~_?NL#BB3^NQCW)_A%5$7?if`Qr7kV7!6@jMonM z&yLq6{JT6}%U8tfE;3fd>lrHUj@JmJ?TJ?M(zNg~V@pQa? zIzzvI;`Jx)UZ)N>$m1?GK+gSmm3$DdWiR5j`CGhRq0*0dJ}--xk4u8uA>J)P9eonC z8o&A`s1tJMO3(;A#MwLvvgJ+CKAb~${{%h7xO@rv9F(BW!Ssnv&=;6u5)@T0K|_$z zFhOI{scC{P<5jB!<+M)FC)8+@Ahk_Ub(HQ(Jgn}Sph3OpKRH2vAbv)I+M?jh1SQ}+ z%FasApC~aqLFG_*4mr+GQ0#&PrJ*`}7bWQXV)9;+pj#NSl)P3XXz{89m0z2nUI%D% zFhM=g`%r>h4pRqwJ(8gQM-wy>MUN$D)p7ctNKoJ@=5{tg;r|l%W`fMO60{kOZYL=6 zPJ$LZCXXlNVNFzuEm39h78&+LzMq?@$3BUgm?u%M(8NDcck?BxSpG!i;3Wzb;5Hyp zLjn`!7RL7QMAeB%g%kBlkwl$OPt<_S zM2$xAEczfaJ5lZGB&ub-M1C6}k?$iW>Q5v!OqBX0swSGk);Cd=`w_Q)qDBr(RD(f@ zYLBSFiP|@T{3j-AAzDmI)SzjJsy;nY&5(CSqUz2{RPRNJ8iOgT6V-EVqW*wmU7}X4 zPgKl?M773=CyF|@GnfHmB zhBH|EF;UZ99CCMcC>3iA4wZCw=qN5>fQLi(j1Iklo5`WpsOjm@5{pCrR)@lI7Itrk z2H73z<>%1!JnTo+ybdi!n7>1>BOJOA>Cmod`o%ajqOe2X5K+RRPcS7r6qMpn0;Z%n z)GFPfo|sY6p=JM*>CjhrW;wJ8uTij+LtXGYVoE#oTNwx6lXGZJd16;_=uB0IYX9O; zat(*pVkcVGbSSg7Lsifihq1AaLyzh?G`fL9V;eEXuMXwGKKM3vs2t`sBfoYIO~gD@ zXir@_Fqcja{#|ouc0UL2y%`hj$56wujDect$Z@)Z&s`m=4&zLRKF@LJ#9W8|!I*gt zeOO4n7diAd`Yv`Tbg4t{;l9kl^(NF{jYF1=4rL#qAKs(IG3JCP7pcV+hrVO^-wrjr z>d^5U)c3YSxj#762EQTXqeD$TIdt)}LodHN^y)h`!m=OCK~CjzajLevQ%&+X)i|${ z@6$LrALQh_G)}F{=hV%goJt9FYCPtkT#!>Ef}MQ#(aE)&PR`djH4hacof?K3aZVLV zbSeW+(c0nEY^PI|3pq8om{X6_oa$4O_@$h>hKHC?+Nlp^oN_DcR37v}t8z|_tmM=q z)UD!_dsQdj$!0rpRdcEqj{V})KQ$P;CUbzH7Hw)fHMWjZr|UYkt)WxlEg2W@TRAnO zjZ?4i4a?dRyB)DRIF-nQ!~3c`5hLg+VpU89Tzo02juI;JbOFk+m|>4h=Xrf zHqfc)!SoyA)U#nuH5%?zJLDa~97j5}aFkPbMmzOntW&4PITbXXdSC@=OmJ$|M5k^| zaw>2N^O?r>8BTqj<<$AvPA#9~)PT9nbsqayIMsfoQ&Uzs^=`FOTI*EXbxvJcPumT| z-sn`7zu33gsXuo*bz`@a@AFdk{Z9RSz^Tp$S)W6!*%7CHI?fuNAm%C7_l#3f=bfr_ zky>414p*4d-^}-#QxQ0aoPV6^dEKec|2p;hmQ&jwI%R+4R5Q%MDO^MLV;*A_etzOq z7o0}gQ>QNDJytw(%JH1sUO06hqg|4e;hLnMu?OyMNqi?DNq_nzX)3DvCaE#b!#{VD zhN4Jdl1f8CNwQ-gjsz#EXh@RA$0TV1>c=Lj9sWgVe3B-hU!f$8LD|Ads*PjtE}EqN z7@eM^IjCJSNv&`dftj>NblD_zESIFdxQF*xTb_I|u0oPNA-htNPU0c`Aumi6V^SZd2VHPgH z>rHWGpgUIKDI(q$R|8DODHz@rR|#~+65NLW`{Jq&XYmqBDN#ao(n_d7lM*U$q=eqa zCo3u;neY82YbI_WC^1=$F$dR>$C0eI*a@36S@p3NE=kF%f_^V^Ge7Z3*N3u5jmaIb~lVuo{tj#!#ildXYd`z-hj7`?v#mNd- zlC0iKlht)uvgU40=6h7c-;N#3|9G+roJiIg+(h$}$=ZJ^S$)nVtKSpmgbq)W`D`~? zZqKOG^JLCzC+n*vMMbSCnrKVWF7FhT^-s|t+{~B4?_s29sxw9BkWeT^Z}F`}imE23 zs8-1ojmL|O6m7^%(eI^GbODd5q$ua-6#hL=k!Q6OwfH4Psnt`YdMQfA)cPrE&>%(6 z8>J}n*AxwDoTAJoDXQHnMHBF{b&6KCNzveT7e2R0SDQ z^{;!X@_M9dp)plg%&GFRq-wH%s-^^`>LP{)r)nw!LQ>T`G*#upQnfoKRqaZpY6TjU zPUZTZRK3N|Wm9D1hRgJK7TB=4*Pv!h~s(xU@9QLE^+*B=|m#Ta7Q?+his(S5D)w~0#a=o3Z47`Qm zPO66E!QE6%xRI9yZT3zCxU)f9+{{@0X^;JZT!0H%-O;)07>XrhzCNm!=#XM`S{p9-v)XnpU7e zdYanfEq=~O(^mwSPg5iKR!CC_mchLexg(hJkL_9snM7N=?Xsx&>sjMd}>$C@;aUYn*8>(X>|Tbew! zr)e9Gp~{Xlt=gHU#=FvV>PVU@9HqvenO|hOT3}98y1wIVbh>V#MNGP0#inbtBV9X^ zxGj{f*(h5$UC!imEyl&vblt-{xTU2lH^NXDIjD|i=!PMfghkkd*Z8w!x_-(`=QFl+ zmC8xybzZtUmLXQTbWJaxu7rx|I#4NHwX38naS~%yEvea-426!%(6;dzsxmQyYpgQV zXG(^Are$d9^bDoV%+Q5d8EQ2rLqFzbXv+Ky#V^dz-hfQi3e41tpiF+JDUiVLOf~PFscl%*CzIEZ znS7R!Dd(U}rQ`Nc`VPy~dECMB;hEZk#-lQ|3&-(vOr~m&%~aoMnR9r#(l}uX$<_DsqrZCEmJFz`aM%+T(h(i*9=)) zzn-O@Zdp2v$Ef0-#rONOG#_j54JjU3Du?yRFlK2k9HuPQM^{Y8<@{N?5J03@Q<^c;I4vUDFmM`r0mRF>LBXK4aXp-fDcF5)c;I@pdMxa}lPp)7vSDog#b zra0rEaEUC%rDUlZE|w&(4D!MW9L~(rOLWW1(%*>5&Qfjc%VEA4S1L;#N@ppoY?hoz ztDdE%xLZ3*p%a-K8qFj>3|p9`$p~D}c&NKIOC`2ti61YN6*o_0>EBcIIi01NSdD^b zvb5q{md>L6`78~B9d6-z zmpJ#cbQQ0W^B_xO@#=Awe4jEWEPR%wgy&h>j9Xaun(c40R2hxmvChc#K1+i>Woa3_ zJ~MBe`Y%hiFZi0J^Z5Ed-?B98dzPyH$kK1P3WKs`aLLv}L>sbo2ru!ESGM+9vvmQ( z!e|qotO`?0i?9zr;1`pv6#R}+C>ocoZE(bAs}hP3DSgH8C{pBRI(^&Ocb7!PH~Wb+#W*_t^oTg&hf{(ohw;=ycn!K0JevYjHA^W=hy zc!_)$aFP1JewkWf0XE^r|6Ivd|G%?!`D(VlqSTFSwZ$N8x|^+Qc=j+`zK^oi;d!W5$7XX{U-e4^$E`9_}jNjWNoSW}LwqNO=U-+szbXn`EH3Cz(XRF2D0H>4%9 zA2*Y7x3i+$#CWbMYQ6ooZcIWqOk zQ4#|B=O`O52IRK=WK%>Q^)zLrP%>v~id84W#(YUI(EUXQMt9(DD3F-XD-rUP)XrJm)@(GXjp!i9T8lLv318$%5sPK7@D&x!r=JDYb zYK@dtG&VRRzvX}4NX9nuEfV*Jq;D=W$0{Qg8`Neb;EEh`B#5~ z@y-mb!;pc7o)0qgkOUv)zFqrhSITn8}&uj?S`W8A)4dQ zUBueWJWk`%9`fGH_K|{v|4QY!*k|a_0YmqZ`yjQ&=Z6gS!^p#iuA;?JL-#Q1cSB2Y z7ccPWxS?$)=+7zEKW%6hUZQZCp$7jtW9U4ZoFyj8oTnW+Tx5MD|Lc;Wk1z8%lCIJp z6u!njK(#-}{ZF=i-B5uW)D?f@>`g-zZW-!w$51BX?;6}AZE)R+{$v=8DPiaq>O3^m z5(6HQC(1r1C$z&v6nsi8@lK|pSaicEq@d$7Lu0Z31^MLgsySMtNlvd`<@L&{;8iR1 z!OTitb*SuB!75(uc+ab&7*^G*a@D-5U!7%G^S)R6;neVI_6J^Vuj$ndQT--wG#$J_b=4E_iuaa>XMNBW_9(c8~g;!g!!S(v)nj|G0O z!ZBXG9`LFPmSaC|;L}*I`rrfy(%V^eWWO}*L7l&`g^rfp1B?qup_FH?^(zqhI4eN2V>nR=(csV9R?WgBA3 z9cn6bn5mA#O||;U)Sq9QdVulYm^z1dN16H(>DV^fRG~4Z+F(8&qw%+KAmlVQMZuyGh$yruL%PU)1WZseTVx_Q=$A1Rs+dZlT)~YKj6+P4&P*Y|13YGvXui zoSf0%1^vQ){PdC>UvYe)+&`vYWc`WtEWyHO1X&*k!YbhCd^H~~#Yq0ZMS_r#<#TYae-~C%!R@hSH z4NKjMSo#TjidiaJoLCrF!qVfCmY$ZfG&#!BfHy5=D{W~yDwMIb0qx3K%Ket5O9+&+ zv;-O0SDtw9kSCf|B=<^|7FDsh)^Blb-;!C^(r5K7?Z*0M7Ju8*f74PA97a{k(nQ>W z?X$ETd7E4M5=XGAg{2xcxx1FyL|b}*<}sFn0ZV7lEY{+0MN5U_Ecuav#jPxT)Y{^D z0o!du%(k>?XQ^7yQofL-VYrP05#pg_d-{)OH(jvgrzGe{0+IH=4fg@&e9Vs z9M69FjymBc-kV^lC(h#Q1lGZ-iPUM5rFpmjea{rPuyL}b9f=$pQ!W0UqIT1$-4B*h zQFl7~Zw9rR$?-ay{v}zA3qf5_Hko63uBF5jO9kdxYJ}#P`4jU?IgW8+8M&@t-{HVY zOTB;Qcw9w)aPk*RpRcxb3VqkGZ`M(>^_&~OQu~dTN^G(;b_@O5%J$InH;eHD$QLJZ z9WmR;VHbJtwlrvur7;+`*HV>zoLgA5pM7=~r_Wb8j*xWC((ykmHMnl+hZ~$jH!b~xguggm zZj%q{WN^GZ=D0@QC&WV2rySFn)aE(o8oIpT+{)`?yeXeb<@2cxI^_3hd@-LI7x(Eq z%!~4==-WQkD(}-%bb809*WUFhQqiZj@B8#Ej$(HWpVCmWCT;LD?xNs_KE)$nEuRcL zsOwXMdOlVEh~@A#@Tpuw;^Pa9!ef+d??-N!#@)5NEP@HO@6H+;~HZKJxu zy4Zl{XyWy0ERNtcllb@?3vmNwEn*=NzoV#+{vZLn@Dd+2_o)|F;wnnC@ToaQVK1Je zuFZC_0k80p<6|65pVr_uD!bGSNjQr)qJ45P0eg|f?^AvB#$sGR;TWHqVJOz&4$1|5 zYJ~*s#6wh#B{t^ZIC94M)DXR~0GANe(x;Y~h&{+ejaJkG$vA<0t$i{v5*zUV)!X>E zzsjd&xQTb#QZG!xZahYfc0TUEqNccpazUR$n2zJf8}g|s24V&NMAA*RwY31P+S$anbqBr>FYgK4x)E=yLT6k5#ZC11+}5EkHs34S+SbEX z*FLsVhS<7aXj=^vY!#Yls}uH4vX$+7TN{uHd$O&iQ*4b$ zwAE*ptzXb_wynN+hE_?elWZ%r(bg2An(s3UHJr3_;aJQM6_B|g3Bs257#a&-N^qaPnS8ui$b^OVmr>E|=r zJ$E$wg~QmIjt>9haQ}>}Ij^}|lGW9OY_57_cNNIxs$M=<74y4VS-{oCg08-O!&TDT zuEJGZWxVI=T2)u4s<}$7?rMGwS3i88F+MsZKhL)>#nljaJgUF)jl{kT`jxis?}fg`>v~h zu=<|M`01|93|9;9v)u=-#yzDi24}h&kAlx!efiu~$rntsL~9wsuSKgn9>Sk3S}##B zf3%_sM5`rspm@P(H9_t|(Yl9v#iDuVK(vz4cSp1)ABoo8lhIlvzp7^Os~$o~&Fa?! z9LnZbvFv^g&*j(HqJCXRlj45Gl<;dZuA^*8zgm~_>mG_m`59NuuixMD>moY8?N_Jr zejUcycl;_6&*$BV)x)pNc+%6aLIeCNKhm!}3r*9NZPFhPz`G!o@wYs=YT> zi;$EWtI7Lf^~U~KJ-HXF=!{tP%pIrVMdDN!>(RYvoED*I@i>LC8hJ{@X#l#FiPM+m z;$)YP)36G0`r03-e!b&lPKeXG`Egp68mC?OdOtA^#i{1iI3=m2+GS~}L3mcXrE*#= zRljRXmDtjf_XY&DAU>!)-GUm~GpGmsg6cFVs3Yh}`PDjwivN=P*q z5FeK?d|^oWmNJhUYeH(UHY5vw;`zFes;>`eBqre;ifstV!93*J7*bLAwuH0@t+$8t z5N{m~=?HFJ2=QHANX;G*1GOI0N8Ch0W=L1?>{&?dpNG^VYgjALK3iBlQ6zg<=W~Qr zDrZ=SaRG_B!m61&tZj(P%jb9)6_)?au);WkJf*{GifGJ68VZ&Pt283z!a7wktPd)M zwe-EPVycCCzBH^ZO~b0^59?A4>jc88-IlgcB&=~5H7Kkz*fTiHc!FWA$6gE_8dlV> zu-YK+@UY&*SyUPwRy<0M39B*=Bm3B}KE=54^aTwQ!Wx3=6T@nRe3QbAyB^jc?3xmm zFEPyh++m%=uB5QCB!{&YyD@lfSd&u1?8~r@&!d0ySqCTZ>f9-!1&A9P(NEZd z7sx#>qJ|ic8OSj{qL*m?T}1tG5>*l+y77HPlP5=1XG%oJ5+kZKHNtz`BD#y#(^wDn ze~2)id_+re3h5{|J)&0Vgq^57gLbnbyhkFU(sM93qGc$M644!um>1D=Y@8oaiG>lJ zL;FP$#jlCzi_;OEI1|xj4Eb+FM{x^T&PG%N4KV{xk>gxMwa!P>_CiEw8t0qt>GAAg z7GA^oaeSZVO#b)ZmH&3Tkztj+9Y`2;ZT^VtkAB|p$(>mni=@7qyXsiy>;1F;f4i*z J-{AkI{{xg*f`id*T?aHle9@1Y1&e3l)7t**PysFHe83h%W!A7ySuv#cNp%&$8dM|!TWpO z=lOh>c!?5O`HYNl zI-7mQ|Hk^?|2)d9`~Ta4{C5c&mzFN#ei`N}D~*TBNe&!AT6w7+qAN&wD@tzc#|VOAbq?E4GCu|=pp~=IE556Nj>1$8}{E0XH zn76+{1qK+@X`n&dv15=y-h&NF#aa&E*D-SwZ}(4JwQ&YpCm5gW9iSF63En&>37ugUtq+_8W8@`41R$5~jnnIcd;~ zv&4JNAnQK{xzPYaFb}IS@n3_c-!!P{E!G=pw~6D9K>_y-I)Qx;4XXEqd7c}z@P$De zUK;cronITY_$@iTGw3cN-W$~M19kdnkPnJuH9S6%3rwF`PYl3vJcRX&LD^CAD{a3S zbTLUv7Sa{_cH2Nvr+pn)MC^`+_4(vvKbYK7Ivd*IE`wL z0GCmrn2e7o=WA43jKfA;#LfVtE+I6#Q8$p8!>B2ko71Qlxr{23+o-PijKH6aYJfS| ziNSe{8WCtzzr04>Lj544&cYgE)R|DDCWLVu-NTJ~6KPa(lu@H%jOrZE{UoFAB^!0q zZB(ulqh=SN4Q>=P>Rl0|5>kyCkY-fF45LmXuBcJ3F|?RbYw!RGSw@Y(^f_uz*{_QW0bkAQT^d;&wRLuRvnEx(#fbi-B>$Z>u%KZ-;EmCgSF_%n)f!U zcVDA^?r+q;1DR_Odt?az+6*bPX+@EGt zyIDp(o^4d_IYu?b>ACb@U{us%qf%BF)f&~-Fz$Mzj%_q*_$JnBGkI+>YV|gw;&+hO zPNS}3#2%xn>}BpFtjSsCxkkV1Miqa^{OE&RkJt|w`~*Y0v-d`g|6tULk470k88y#h(palWCB02rf~7W-R@zOnI!vmK`%aU7cbT*vMSM-l zi$aCzESHmOz>lXhUsFD8wuYf`m_CLL;I(%Qx*9fWri zlb*q&DY;+)vNtnnI>xs!X%UiInpD2EN&DI|S3CN&Hz~G*Nx>b-y^~4xI-As>H}Ur| zDXpJLRZwbxNtXwkw0ww3*RW%lNmp@pIOC5rDP*)sb;p=gc9KcGv1vB_=bO}efk~4V znp9|!NnNl9dzUcIYLj+uH0c{oY$C4B)OxQ;iw~LHG^d+I|+PbGBnR4W|m?5SJbh`A^6BY!VXokFwTp8ATheLNM` z*Hb%?*xys>NFLy+$pbxg4{3v#2NTd>Fnv*ch^Mw9eyFDwAlo0F8jdgcFv3%V$9XDn zBKhDXwomfZqG_JWG2KI@UP#@XbFx@a=TQ-kJtYB_Eqa6U1k)?r)uQ{j(2wG7cu7#9s+daBTWo*FGLjWl~{oxhiM!6TcOqOcAA0bbgf9XY+!?k6wx z$?K&N*o@F1?&An5iiwA^-@Hdm+EE` zQw1-zti(8|Th&YF2NK%|FSSOwk;DbpDEi~_I4|`cPfW|aRA{-E5?6RBc%_#nuJcm+ zP0aJBmr88&lIJcjx%Ycfb1$t${Tt-{*h>rSX3ck))i<|UQ?Lt9FfET+O9RcC6>L`R z5ZZ*9br=_LKisUhcpgFfNX|u>wHBwN&AN_nF=lzkn$lcx zFFE%&D`9|HRR@~Y02>F$#!_3M)+^jYu&FX8(S>5s50kifWqPB<4>Wy9a{fJo=kFrMCcbxr)+n9X9 ztYN2E*VD{-#;juJ$n|ftN?b5&_a$n3h4Vr#+@%A3mVk17e0AGdD8O0^{%;KRq$?v&yU-ui0M)i#&}M1tHSQ zqB*#Y@@9+P!pGa9vS??s$m+CczRRM=@bR-~61=lniUaCzf`m6pPCj8t7XwXoWe)csb|qz{J^aG z7G-N-Q3&QBPa}(-H@2ux6N{3XTGRm7@Tr+a<=R^Gx{E~~U5N#Kk<^VE{cceW+{LgS z7P)#_RIQgq*O9vqb;Fas^yz2O`u-Lb9AHt)ffl_$)?kZ{<1*f%+Yn+IYLOcY@dnNR zu;>JSAIA9jgek)5?r@H@Xbkp`wP?{e=D;a57*B0+9&aa5mx=U8wn-N4#&JAE z%gGjPM1v_7wZ}~inQGAlL`-8nuoT~>TQqQnMPsoF@iQ&Df=8%5i#QQK+oB?vf=}?8 zV^L$&nrqQ)tb}VGb(zn6*t5VQ!$OXsJz6fZXf>=$EUJV$c#ba^y40e4%PcB}`gn+U z*uUJO(|C%uD~NBUMFFdbW35G{(FAWWa})b}GjnXE2HPzvw1YK=ai>KkkF!1}SW{d^ z_mjkd?WlK(wZd17KW$OmIo9aBMTzM8H*0voq7s)Z`WH_wv&T^UKD9y9C&c}f{rQaj z@SNul`oG}0^2(w=aR4_l_cb-eQP|$n{|oyZxA7e_zta9c=CoK<&1zL6^n~kbPTYnWOl0-=CrD8ZmY(i zNFL@wR9>sv!WC>)b$EwbRRwp$tcnh|>I~*YShW&IP%+Y~+PH)-Xdh*jF^>L7z@MmD zz^cUst=fRos8h%)ufpVj5jdS@Rkn1iLXe5$s8r0V)+kxZs?nH%EofHSs?Mlg)+*0( zRs~>AdE&w4%2rjbVpTnK{@JSiXjj#$zIcgm==zIQ=YF-SS2e2&)?j?h!cDZVN!@E% zHL*5x)?rR;LA|pG7(7g}`)?Y2^n9ptvtswKNvgWbfs zhy8>3SihIC@pZpd*AH0L?I5uovT8ZX|7F$hc#fDO)Dk}(C4XFk^BDCx&N`l;mM7Vx z*VuFaT6y!$QM5M$>{;>^w6p+|MSSI$&abk6RY|^WA8t=Dh~cH zsTpRxvFhww_WpaT>VION!1&p!;a`d88~gM-d)>oZO$^@Zg#AWuok3$yZ=Lk=)~_@3acI*HzTm*uV05{!l7 zCB1bVB}#d#1_odf4&oBbrM;CKfn~f^t(>$+Ys(Wh#-qr9{vzp#ois#6x?X7WhX}6G^QGF3LUF@x-rQRyE%v--L_twG{ z-s-i|TNPJPt2N#lzsXy3u=h`DjV@cf^$lLziEW3sI_~yX=ss`#f`%x!-&-jMy%l`K zTX*paHI8~K*D>0nF9MG<56YkLR?m~(dUncNpHb&DYkS69o6k~<3*KsQ(OYeB8(lBa z4xcW2>&aDb?Y`x$$VbEj|Hsr3+wcX&pLlBmu3^YCZ`FR|t@dxZ|BhO|XFT|S@YZF_ z_(**)_Y-4(CZ{jn`tK`i^37WXa@kZNw@tx6*|ao|O_sbiB?Z}Z5x9C zG-_s3FNC(VsSY-xRcrd8Y+IYEBdwiH6OgaHP0Kpk^c__?+4QxGO;@_wl-|vzE*Joh z?lv{+Yg0D_^|R^2K%0z%Z0b4KreW|LVpCC6Lefy1GVmHdF#HeZ9bwZyh#P5B3#`C1 zB#&YaoIvx@Hf=+Pu{KQ`Pajw&*t8ob;5*5tU+^B4rr0!MD($dq8uL%LX+G8>*G%$5 z6YQO3)8N_UiR8I9bwocLp2yhpZOV?U1>}ga|GQmi(@q>i#$sxVqo}derYTs2)yr(U zi=r!t0~J;>2gW1!Dx0EFe>H2fhI}!1txdP^0@>Cx7FJ<9UTmOV8*LhjNjS90Cevne z#TFbw%ob{fZs@U<{jtra2Pn3kHO6op-$6b*$phgzZaUi$8{ zDP_M+ISx>lLpEh%^k2k%j2a#%=M(Hzv^vRHr-=KsO*b&{j7<&B+O+8$Ym3U~$@y=a zLN2g}Q1T+{jscf!O1MldG5ZSVui7*fZ?Cbw|JaoO1~K2VDe^Y^5A`q}4^ZGP`|uv? zjt=*!#{+7JgAb|8BlZZ|KDMdq6ZY^^oBl$9XN-qp&u#kog-r)={3UDk+NN1=ZF+|i z@92YH-rF?qgH10{@*|J21IeG*L(pf|5Up_|aRwJFax=D}Pn`j6)wp5qI` zzf&(5e^7JWz&hD=&|ud?qh0AHySiesr(M69?P`ZbzIJ8HVON(B?&CII;Cd*xVRl7? z+vSX~s~#pHBa+8acFn+2e2-zgSi2Treu7;E+;;8GXV-BQ&TrQgEX0?Bc0Dd+*9X)n zV%G|!rrLE0zoyxB2QAV$kL($C{Xnx!yH;XWQM)cwx2tvyyB=V4O}jeQvdg=+UCZ#L zo?ZQ#*)a)nMau|f$n778Rm-vSEYwg;Hn00pb!7)Uwx2yFAyDp>2Cc8RsWt?r)4BhcBYHYXb zz%FXNn|$`zmA03GX*>w$@j@p%U%&t@T`8YA1pq|J)X;<(m zyLzI}Y1$$08R~J?u6I~;&aUM1b{)d@zlrC9T{|zbCYS75i^bRN+VHPk6>r$J3XgBv zb>kLmdDpIn_sH+5UDL4yY0rrJxm`_h6dz!EVOLA+#t9U9Y1crEL-tp8HAh!GLXp>Y zmBA6@dPAKs3$O4UZQt6p14mK(om~?!54qmk)fgRd32`473rp|;rjOJWf8lRb`b0mh zLE>j>gJF1sVqfgCePv8c$3whF*KfpyizxFS=dctNzf%v~H#p=nI@Ag~@!jN5VNZvK z<1VUsIkW^Hk!W`C`puzy7Keu588WR7O-GcsL;2AP^Wn5PR2w^y-|o;P*c}e7aypdP z$DvF3%jHn4uS2up@^k1A1_shUuR~rz4wb@oe88Syhbo6S)ClcE9eRMuVGfRyA1jd9p(V@~w4t+(HWae-?v^d3~ zcKIFpg7O8pU&x`xg=t^Jp?#?i#icnk3RBV@^38DQO{PP(q7GezshC5xP%w+J(5bjX z8}J#4B^`Q?ouwT5y|hD5k)sSb!C01g@gKa)Ih2BK7>xB59J-Fnl^pV@>`*xBp%so| zUscuxpW*zKajH2~thz&$Fa}4_u?F?6>Cj5Fs^!qU+76}HacC`q>pE1nokM^s~yO{ zBWu@*oI8_$7uIg1gV!n!jl*YnjUrAQghsQDn1aj5HHLFIim0)~h}%dXM_kA~-l1}5!=bd9>~Xl~GB&Etb7(4Vq0oHB!f4D}Ku!xC z`fZUz4Hgs6686MWhy0f_=L(0~u5{=M_OEg%bd5tv2wuw`hie`CAI}lK-l0J_3ZD(^ zA^f({p(2~8^Ja%m{7Fn(i5ceY)E%96P}iNru!~ynCiXoJHQ&ejALMy)l=!jexI;Bg zv3IccG;49up%9dZ$0g#yE}XecyDL0*t~2Mq#EsH79K1*BPy}Y;9ByFsE$WLG$bXwX zgR`jgkeWb`nCCI`z~iYy87TCexn59(m zog7Ye&*{_*{EM_)PBp_0JjJ-&PVK`fc>m<&_XVfE!J5aZwdfG!l!Bew|3A@Aos4m+ zMyyk&1Sg+eI90^$RA!1(CG$CT1$*;5l~sTk3o=F_r*fbr+7xzb6}I6Xa-=d28l*Wj z8}~AtI+W?u^A=8hMU&P}wQJ*4!?sS@+c{MY6LF}$QwO^+H(GUb>IiE7?v$+udG=)f zUgXu=seyf+3hGZz1L%j(7(39Z*um6rs8c=uaO&6L%!SlZP8ArNdK~aO(Oj;+^eOL8o>drOwBkO2F&CiS-|+2H$Y%bY36Ti1JZXJs;&qj;=lm#~^IR zegt)+4VoZtcOS*!B8L6$qseH}!$-@|si%+nA-I>15-rhkML0u%oydPbz^2eYAEP=Xd((-X0&7+2^Ap2YqzqkdM~<<)eoueDvEn zAKkx1E&lOQt=m2-^vFlmU-;qwU- z$GDU~)}_cK<}T>cra~Mq?9z4YDdJLihD&kfUFuT7rSwWJRsGqe62H3Ct(r@ps=KtV zhD#weiM5tXrR%!*9o(gU4e8g&rDu(qyQxc|&0PA>+@+;0TzZOPtzFuOA1Km>+^`-u z5#83MA-IWm?OgI`?^1jxmwI${sdzV+g1fs^>35gjVqFiH{_E*dzJ4wZ8tBr6!7km# z%AqdB4&!ztIgE0t)o7OtV_dpF)}`v>TxvX?aVC=2B$xcAxYQENgxj>9W3>RnAu-m52o;s`zR%zG3w*zKZzOS2M65FKha0L>*tH{N}5w z{d_fYl&^l7>Z_#>=^N~)T_Jv|9^uMRPwzx1?<=KjmrTrx=_=`?h|% zhrI3lGzK%#rmG)&+E0%M`046!#+l%!=2QIiVvV2Xto763b$)uYg*guS=_0QGpe+JC z{51x*J^l5Qm%nK?UuU9Cy+h41Ye~-T=qR?J{mBO5T{;F`0b69rB zUri4C>pVsr^H<7oe>MKPBeQG9`0P3a>xArFgOgoHmtcnf>s<2fmPe*ld6c>~kCq?JqwmM^@OgBge!;pTfl5gYR2l5WhLVBGS1M4& zFb22aRXR|o%LHm;xj==N57b)pst~9fNU0R4%BY7*zXYld(y9ll9A4v9lRy=3705M> zf$E9ET>>>9*AUP(P*IqRj@<%PwMU=^V*6_#9@v2vBLdYGn{jnypdMn{s6bsG9VowXff|K7 zc!{aw1ND9)$0r4H{Y9WQ!9JP#U_S06eoCO4VF?~!#Z>wua2j<&f$4$jfECy?BT!!v zH#1PTv0xVUNA20fhMaRahWJH+nzA@hi;!PiW5$L+ zjo3sk_<+DaS<`KSs)=SehO)Z@wQz5srthQQ{y?2U+XJlcLF$AChXU2|NT9mm+p$39 zJr}57@f#-N0!myARPKM+9~gt97<@fYyOH}wpypsB*4zx#pb2^P3O*C_D$ne^%8zE~ ziv!3$C$Hic7#gAWJkZ-gER(g7Sl z8l=ncJw`rgj`t{aJV?POs3Y#43{uh4L8@^fNXZw2bQISx`f`wFpwv}zyB4J0*npY0 z$l+d)?mq}p$%jE|iMS`^@RYU1DC|Y4XF*&$5Tp^WY4e6Uz75h#Z2u6Xh>t@&>C;Ot7w}2Fq3~Si5kgWU%fdvRtrMln>SxBvcOO zyEC-MyPCoBs1>ZP$fy&n@+i?DST)))N5^2D$GgtK^6SbtDA7HbYrYuo_h9+=qJ8gR zmF*KOV_(`13|6hd!TLHZSc4Za{;FVIMeJ(gTNA7^ShhA;rgg#cULUMkSdQ@$e(a5+ECFBp$+Vl{0s~e&+9YXZDM~Ez|Lsaij zi2gYfq6z0h6#aLIf-Z*W4*FaQ(IvFKOq(kq>isB0tDlEx@XHXj{2rnLhENs9c}zBj zY8C#$cjPmLsxLx4LsiNvR8i(oC0IiB0==!FngF|ZsLJC%IBcQXfGB&Y+TtJ{UT6M5ULRcLv;-gvAIa7 z_M=5n#x54B4_KBJDpT=L`C%mPp>By#orSAps8Z1k$MGL(lnT{&JTD!pzsrOwtyZYI z;e72-U9A(UmVbn5A$|-C)u7?Ti83QXWt|tQ5|}?fl=s9!)#^kj@7sr}-bw0#^GG=r z%I8_caynGa(HqP0C%&TmnNZcjd2~7(s$J(o`Pom6&xfiuj==RdxnH1`a9*O$SPJK5 z^1dFbC8+f;apDCk+zi!e+=cgT&LxKF3OZ(m=_0IU!g!B0O!Ki9D$6X>jf8yBv! zQ<-N5ZB~VA35Km9roG|H{D=8okVjaAzSWOVtp*Wlj;}b>FhZ?zhOP{ zHjdC7Y==*i2(`sWS@tOy0pj?k_J5gPnwgmxqM)(GX;#yE!}v=3eW;vAw569-=zE z>mxNAnHQKFmWz?fc_~s&E=Q^p60SsQ87f_kRAY?CPuC*#1Xcfu)ZeIbJyQJ;_-~}T zBjiS;R^u|d+>BJgTah{muiK1!CsGga71QrVa&1ziuAsmdj$y2#bQBSWC|QkBa_5Lr z8yw9UrT4j`)GKe4wxLZ>lzPJ>I7$sdqBJ8kO5Pb!Dv1S|94i{d_Z^~i8<{1eWGfY= zr{$s)Q$9-9@eG|SMCnY$C@roOrF>PRG!0eiMDhMqlpfTL(!_dE+TEPKEuvHb##T}M zo)V=+?V?noeUw}sqBIBndPXU}f0Ra|>3}HZ7!;+Bm^C;`??y-I=DH}A+Z3f8sJ=N$ z-;YP}nSGRA;s+L;jMA@XqqH4$FOUl=UW`&b=u(urBhNKrN7QxZxF4ncIF&t`>sO;y zmhyJX*8y4&g7N75Fk*uaWmvvHj1C`&^J6sEu|(?) z@_mZtz0YV}K;_akFvlnp?JyUoVY0+14IQuq7vW`%Q3iTr6|TeO9iw9C zh_z^Bi%}9LxD4>Mx5aAvH|Zj05_-LblW zVS8dV4S{=O)oUNI?2pxfld;mNSZ%^V^f(=>GEeA>J5OU(@L88^)EPr@1>wGNO2GyU_KVXs#QDdmBevl(DrAe( zc$5x^(;^(jTPS;+3ZpMZ;X5kih|>>L$Qh^F7?~?h|Dt?EoND3#u0_V_32H~hsRhnQ z$EkX3oc!YA^aictnFs4}3XKxtv<5p-JTXqDq&PLfb>vHqU;4_*Pqjs2`6{r7-$0@S}F_wzsITELO<>K@l?<-KRig7AghnnLR8r6-{Iow75 zdU2|V#`UQ;p0%MiZR1p;W1I#ee<%9lIHJ15DO*?a9~h@O_%bL?w}&wI)HtP0BVT;S zj_GmQJD1~FKQB)EP-L7D~`Ix|d&|MT;ouFr^xFk-%q(3G($wR9hsN64k*sQETvJ&nsm_&VrB{osfbrUrNX$=xJ4jr2$>JnbHOjOBMiTZ@Ru zT^J8*dL(L4Px?ot3CWoJZN&iTVRY<|L{d^3Ns41&NAVn5Ya?gWuvr zeP2S{OA~bqLzWTO%0w+$ov8Bb64mn{Z4M=>J9_<jY7d=iCTS} z{wER@bc)>0CMx1z#=V&++pR=xLBrdLin^1ig^!8j32``*l;%uQS-eFtR}z2QAW4sX zlQb!Nl3t;4&LrKmc+CP!_CnaeSnomyBpy^4fHX}(* zkz;0(>da13uf<6ki>Ygp)MH(eh9Y@=l2&g>QtZYgwb`7c!v~Ty{;wp>LD|E^hwMj^ z^aLADCTZNoB!%8g(vjOde$C@|Nt%r^?~^ngXRz*Ll4f`$%hQmobgVTdtEgwPj^ZK) zcqQweIazODvLve&YFLxC)Sj%Ij$}pPEL=Xx8sth=&wymj$j*6G&5^7n2+x_U*OAHk zJ1SYbW9S!~tdaSX^&cXOB16$0CYkSxCTnha#;%gAGgXsS>(^wZR!`PC>_Uqg$;zsgtSV@P!`M_i zS&!-_YfSxQjcdppza=X>_QS7HvdUq8Q{roztVx)U3hk&%dvfWR%)e{Nn$tI#-^-a3 z?Z#5Wam;}l>%!+`z5JG}SKp}-mj56Jx#jQSRxMAr8fSN_Q4TlXd2;hUlAG^3xwSr*TQ`4l zD=o;a37Cs=!ETKVaq~T3H`legd7sCv`KS=()^JphcPn3#TgC7ct&-iE<94fZKDP!J za_e!1TfK`iekr%E;UOlLcI!hKw@hW-%8uS>Sg3ZvC;#ts8sX ze6O9lA8_mEgKl*?#QOZjnjLZLr{k>Q3C29d`krws`n+3}E>NqB8GGSrO5ytwDf+`VMbl8#FGY=T9yzn6Xc!6vrKmI%oFW$n;z&q} z3Wla=LTri_qF!8z+Tve?C8TH~`sPc~Sd`75qFOixpMojshcTHcnu}URQ`8by5tK!H z#FR}@hjJ)c{<13`-6G~J{(MdeSzRD?TS0zQGeooN?%>E@se!r%u0XD-_ zjaYCSC99_>u||px!CWgv7A5dV)C}7^_o?GH?Z>I;UtpN^~KI?kW1#D@8qfr)YZr6m=Rv z{jd&~@YBE)B@Cw4=!%3P)M;9ZUcxXvMNQBVr%`kU@y}#D_{>Vt@3T|10XgTSXfd{8 zz{Ucq_oA@o;{kHLEUZcxfs^oiRag};1UvB>v9AlODQ4quc)uyEV(5m|c#6okg;gI@ za0usVdPTRi#^{Y6uFoPE{E^#hf;&`Uhj%GCzv9OVuY7Y@e#f_>4b0q{_D|bHmUr zReqR`_uW&q@%L2yH7Zrc(W%;k!>BkWRV&7(s`>}e|K zNYf-|ns)o7scgE#R<};m;I_nr-0jo!3iErW=^6_4PE$aiGJ^r*^5N;)6PvEKrP8$$^-HI7?Nhqm;^(sIa+XWi znyTq~in+g}Yc2Bsnyv}e(p9HA^E6{lq_#-c1GM`iUCUq^o~{Fkn3k@F*fl*}V`ilD z-gvrxVB=iQqwKtNEt#LLdkfOFet)`p9!S^xgXuEdPFFF!h4D_hM&QBSbWOaMuFU7@ z>Vu>g=_-o95c(=zw~+lux~hS{P@)`|gD)N#T58BptXGCw;wN*4;;;cuYX)Bv&(OcF z480G?P*U~`jn0vw!Z|ZkA}&J%kv~2|C2<^4i5Yr;wiy{(iTartYKOP@xmbq2A*6hU z8p5wahC;C%o|TvnhF>z2jv2pZsB$&Nsm?g4UxRV*7C+Y_uG$&0w9U|2c(=6lA#M2HZ()iP~wjaU7bw3X&LgE#j$xA+Pfe_|6%>Y z4DCbdMHyTJm7yw2GPGiKh8|+(8e&57+6;|Zm!Tr-Gjw!&hP-xUXgiLf%FYa}-j$(7 zyEAm^NQNpLrN*DhFDg^bF*iC>-*Gl3Q@7AOHdC+SGBqYSQ#(_*&6lY;D4Rc1?$k^z z!G-ip-NQSWGBTA7;mD7YsD`HKiXoVc#n_D3_@ij1e#*+^bGb~FDw)aayi9c{!&v1q zHKTl{5-VovV5Lm{UR&=R(_tawYonB1KW)xG# ztYZ3mb}_Y_TTDOZ71PuO#gwq9nDzx`sb)}?UIb_HH|?@`eRFnL;dQcf7(MG|X#|Sa%TlhUj1BK*S;~#u*w{8p zUhT4EYENIhhi3=oK~Tpm)rYH7mV$8zshzX<_clw-dSz)lR`<^0HDnf_Yh=kiC`*~R zJ&eA?vveMJuwq1(wxZGKEbYc|JRO^*TH~_RXL^>NAYyiw2BPlbEX_d0C0VM6^rcyR zuAas9G+8RWIZHKA^v^7HI+n%n4Owb@JWHK1L3)loM6F$MGM% z2na}DiUQI*(phwq$z&#&WV6|&rl1rRX;PHB6zS3z6r^_qK{_HJy*KGdXF-}Ey)5;8 zdFMUO`J8NK=HC1N|7Qa1Waf@GpwpE&C8NvLI2m{2Gzhis#mR;A_sQjPoc3efi#Q#^ zz?X3vk6N$dv;+-b$H|@Ep(Qwz!NIlt4)x6F&@SABKa+!b7#y07Wq5@KnH{pR0-t1Y zXeO#w;{zAv24h_J{w~i6-ar!+^j(CmS7aXep)KKNXb}GY%PJM$E9L6IA$~ZLxxA3T}Q_ah<4d!7h z-XMPkry8I?MqzA4r)pPnYCWn|cFK#kRh;?(`Kmfq7J;{_IdvbaYB)8nrc-Ni^dqOv z)pqK99jEfvbt+2(r#`@!NFPgkGOZcdd%eH_G7 zJn!k$`@P5qW3U=&$@DSEsn>`b$+)n_IGL}(sj0J^T7;)4w8p7VcR1A*Hx4+J>macl zB^DgVT@*fsy%T;r=2?aw^J|Sy5Q8;7=+bVoH~Qs*Qw_Xr#jtn zY9fO7oa%>GkDVHd2G7_>DEW#w5hFt`RLp89fG^%L^eVY&8uFWF)=)KE|HM$9I77SKhVG$=-_R$RjBR)vFcgzus2irE zUXr0G*5NYpG&58OsVxlUXlZD6)X;8>``lm-T|?E|8)}O59Sv2&!LEj~_B2!j#gYv< z@!tSLg$A;Gh@mPtJj_rU>i=M<6@Eu5ijFblz|Yu$l<@}tz7oR(Lk-Y=BI6?WB-*0v z6hmIj$6;iiMhv(-!_Yf34UL#*=r?4UPn`I1p`nfVVzHs|n7Q20P83^V$c^2r4DDM( zJyQ);g?Y_T2RuUN>(ukD8;1Tu>`jAn1cvh8Hu$dGP#8ThADfW-DSgBB%uvlVLnl!G zIr(Do8$;>X(=W5QG^e0Tg^Rl6#n%{xbtn2JAe2Ao(_ImDwoCSx0J zqfJGZ#-M2xmj)v3BbQ3maw%6`m+InvtV=PCT5Ao2dyh-51eZEvQVW;f3Ar>O z>{9WlOAA`L6!_ewjBQ-1f<+x%D%r`Um7QIR`^Lrf)-LV))}?!B`<+WYG3TwGE;)L+ zbiB7qpZ0NS98RN5U*6*cQn9R`OAqi@GW`s2=@cptb}7?PmoASct{Kz@TW}N?;hp8u z;svxpx`i(Nj)cvOjSJYgg?zWURCE{1&}z3!(@}H}x$ku;vfssZL*#at@i6n4OFMB6 z1&^~I5PQ<4*7zIQPf^#iF6BMvQhA&{&wJFo%znXyRANA$E7bjlOO5Wc53u)vOLuYp zu}c}AupDtuUEIgZG89W=|6y}FQ`vKyss>knQ(xn9AyZHBL17dzwH4Q5OieFl>ik>9 zP4z2ba__szIUm+zrfq5k&c5X_)u*wkEb*pxB++j(Q{cEaS8&ji@uDz+U z__vFxJl~i))7|9Z1ExA48H?Wf)?{u$Q)}>|m#L0@Oz!zGRkyFHcpSmgWK-Gto7(lg zsnaMp*i=;v#aYxIV(Ocrrk3K)FjFl@m>P%;==}q)qf9-=+A*fOrkMKdC-TAtWSVTM z7`&K;Ex3f{Q%rsGv&lIeQ@dx8+ia7$a;VcB*3C5)yU=7#98>QvGW8m57n@vPWvT(* zETs<1Shn2M1f;BF+f}A2uQ3%wZyfvG)W$zdrJ~6OQ^T-hGqpm7Ev8~n6OD0gJALoq zJx=1{PU7B0JeZCBZ|!FP?lE;>pQ#7Pw%=5He0jiB4-7hJ>IyzRZ0a5c|7B`1?&2jL zA2qf4n5q89$?*hjPMVsESIB$HRKvGUn>q)_8Tv)>bF@Y43v7>>Z(TI?@gzjlWV_C&UKN)eSUsmGEax8TPX6#R2?+IcaMn? zC7uuqT4D@xKck)~on|T#9WWTP(dN0S;n@3*{uduScg?r-P#LZHMgc!cWX-xw{9TkM{cb^nObfo;=ej> zRjKFJo>;f6M)ZwaC>G~d5yQ>g^={>}+{`86R!5Ip%RY5$Bi4D{s_b{`Yplh*fLoCS zx84c5RROd@NF_1A7yYs2`sfwt}3`WF?xaH|D& zqWzb|gs;AGt6Y1xUUhf#ObdML)^2?Kom(S@xV3+{Tf;`X`R>-O>66`>xW%o_+sI?P zTMPEN_2UU*JV~FY-70mC+MjnT*CpzJVX5pp9J=OKa&}95a#`9`%2LS>E&W!_Qeq=Z z)jzg4&uz*5iKQEu7H28RX{o4T$`6Z7tpW#?lka?P{rDH%pNomP&tX>1l6E z8T(ke4S!!tY5gph`?=6kQS$sIyQb(ks&t+%iiCmRnl1)>5x^mWHC% zMoa&|yV>IUbxT>cSgO6vl7S`2ww;_&2c57DC!igca>9YZn1CEREsa6;UBrj*ZcEkn zuncG5+-oTwlW`MIk!3&Y4p{1X(9+stmfoD8MwcwT#xIxI2dI-uEs*_+rQW!N%2!#B zQvX=oGedo^SxUx#sCwPv9wkdF(E5g@S@`@WZEsoHg#!Ol!@HJxJYwBrOV<&4Ld>{@ z4o|5y-hF1NGxp<;H2Qc>|A@XIW;A?BZrF=oUJ>JKjzN@sW2qn3VyJ8tO=oKWZlt%h zD}&AVLbl4Fa3))$@Ox%kJ+jzZiG5jZ)y-yWHgaXR^(`(T=^a~pP&0?EnaGjTRv%o2 zH7He!q%i-&x+U@A7ksgqP8*? zv-K0o6t}ewElb$S_P(u)2$r<92=}q46#bPZP8em0y_~HD6>Pp!u=x(bmQ~l*=k;vu zz*@uR`~mq}wmRb=D%rNi;10YVTfZVlV_O|@2+KdURn1H6ep}7sZ9PQe1Y4n?tmxM9NbEw{FW8Sbf=XZ7nt>``+1i9}+EWMQ z`I?xJp#$ULmyWi4oor3P7M$#Ct9Tdo4Nf9mS6iQA3Tkw-Rjj+MHAvsXRzY}h3eIF( z6EL{Ht;@*!J+Y$35NbZc)>F(M$$t5PI^iZNjNM8Y9Gr*7@rqkm zKi<~X6r10%sPiOhhlC$(?MB_7*ng9$)fA4`Y2-J&`^6l`IJSgXm$L7$Z<(#Gzi~V+Cm#%3Ve2@)TxshBy02pYtf6je`F#9N{ny(n z^oOnC8_8`GW1`ESHuE?TGmhgr5;haZcH-Y*tJh9jLs5Mf`J%!eK4Vz0mwmR6v2bC( zt;`2({eX-IZ6zNj2mEo2&oJIO!PqC+->3LIohIfpwrZWVb?%(44=->G;x*P?^{vT;ce_jH|Ye{$s1*bz48);Innp)*Foem*eO*F`~|Wj`b(h^{K7ecn#+>j`cKZ z_JYqKzIw@LE{BJ?z&t9F)5CL9JZhcGqmczXiYw^R5113F`w<>yc5}#D^=m<_%_NYZwkA~qec2x85%pdy0Z@7!xH9cyFoV7eM z@vyE(4eNPSr9SK7Y3R{fl#FG3e2u|)g2IhFDuZrV9p}*lyg_q^NBiM%dh{o%8;p%A zCfi~iUclk@XgCfby+!}{67z8bC2aaa3jRWV5BXp;w&NA*H}>coEW;HP`qZPw7>r$b zfx2GC#X7u3eV>OpOg&nK+bHj+rkH^-GX{yEOy`tsJ&6-+Ows zxwBX8yLmOck5?Blp|4kSP_Ca>Lz2B3-QTNIL%fO|?Ny#JUbV%pv0h~y=hZswhIhPI zizj&1KgFwVQ@vV&Hq*T7j^}7PgKcJd6<+VvRQUezDuSzs+vrua$CXfoGSAJJqX{ z`(7Qv;0In!M3IMHefP+#PLKIHqfgE7P9~pXFdMHk`&1#TPYLCG%2?jV^Fe%CiMEw| z>VX$%R>h~YxQFkn`joYpTkIokO&sT1wd>N}rSV`ML%4)o@=uTK~7AlavC{e8NEhv+rH zr;`JH8Z^kK@e_PHj6o?rO+cZE#6QWW4}N6qRX#n(($zj~f^&^ev)20b={lc&JLc0J z%sTGVa@0QIQ_4x7K0f7B&QzZo<27koYT z`H@e9pZMf^#d``O;K23Y+V_sCB4!-emeUD$$)BCk3gI}XE`qep;U%{+?)ywHu z*<5}td)Ke^x&0dUo?kOQ@GDZmulp7Kx?0Jv6P5kiUB$1t)%^Ogx?f{z`1NlszmC-Q zYeyZwHq@ohdVa+;@arbFHl(jOzdmvLb<6PUwdvPFw_m3$zh>KhUBm>BUvp5dv0pmqd=yyXnM19>RQHSvyCl@7Z>|$PVe@UX+|C*?cD6~9L z!Ig>nd{v_AtV`5d?BAZK*d2)qlrQRDX{>b<>*dU`KW@%IzeC0mjT z=1WpttVO5%Nm_vX1(OuPN@OpTr0>w7c#=AnOp>=$lKPcN(!fBHdUQ>aH7ZGK<|b+R z?j&u;z`gWwAW1c@Bx#14sAak)>V@aEn<$IjL=D(qt_6cb?e(4+1(EcG!8W7^XmyoKD<`q-Ng;a8UNOdNLG<{M?#^ey!euwny z)R6v}7SheN^s_Fc!|Ox(nJfushAuW6m(#(e;?(GO^ zeTJ}H8N;fRC9I1Wnk%fv?}qhX?y&OY3GFATj#@k2N;&|m_AVJ2|3~> zMyG{!8PA`G)#^o9oijwV6sp z(PtPjl3WlwI-)+PGA5!%$T>E`-1!mp!uAOfc~T-=cOKDMY@ZQPx|tEJ#t!tJ717w) z5%y(7N9T~=T(-e6{5&tBCcj2B5$>fCHN}U^BFelvqK|%$FrPg2+7nR+%tzPTY!?$% z-4CKV+90Y54Ws;jKdMlhsJ>_$)jT8(kLnj}#7krw5mhWkVlpz1jOrB{{}5FV9LK6r z^ffxF8{?uHKR&8D6QVkj5>>g0QJ&`+)m=236xBc+M}r@uJR2aY#W;af6!`cqhjJyWAxLlcz`eJ~t{P;7cs6;W(fR7>#g?5OUb|D32^VEx>v3eAt|ELtsy zs@1vb6B5-_Jt?)qfh_II4AaYT#ILQ{=Z#@|8MYr Gum1xq34i4P literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/5ed57338c01e48dc_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/5ed57338c01e48dc_0 new file mode 100644 index 0000000000000000000000000000000000000000..528173952e165d247c71430fe394eaa99d2ebff2 GIT binary patch literal 54504 zcmXWk1z40>8^-Y)1{h!%7(fLB>2A9dyH?lM)wR20?e6aG?(XjHuC-meyTAMSp7UMT z@B0fg^S?Lv+E1Hs;lA0&2 zL<#=7MDCo~ilyYto021U?(D_#79QhF zIwdov_0=%8K9?DuET%jD~DPOD7yLF0p4?IU%XFD#VHcomBVkP7p(= zR8RG?mlH&v-f9#p2J}@&2XhQGX&BeQ@Ez_1k(E-%I>B{<6Z|JS;We$AuC}v2Gn{Z} zCg(WY388bG(1eD}bwb~HPUyYB33KSoZPo3*6U5^e>Lc6cr4!artyfN%{Mrdy->5@u zk+-VCcPEJNF3xD=>WuS#&e-Iy_Os8@Ipa`zXJiR<#s=D*(HXTfIpc69W|+uGeoDx>SKFn#CCAT2xBTMN_SL!S@ETlD&3i%r%YW`G%J2|RSmj1Lv-%$ zjG4x6Hfs+R&kFb6&ZtM5>0KYrr>`?|_H#yu{?6D=I|ewzbD%R)jBSIQAr2ePL!2Rs z&~EBGj2{noM$Zw>cs*MEU`4$#>e4u_1!27E&x)lJ)CE=?ny9=dIYWFjK23Iph@GNx zv0|rjg%urUsPLK25cy`SRdbvnvd>k6Suw$I%y&lIA{DsQ8F!Yc(aW77;#a9W>`b~! zr&et8$L z7j=B=j79Icb|2IOHu9r0+JE9T{j7Z0Vzi2!zHnU(m#^H%Mn6_8qsQd&O=V!yzVop^ zoZ}}Uoh>+Fv0#j=1sU8d_|s~^J{s(!JSkKK2gSO7R=)B!0+gGE(<>7wIDH{1^x0{P`{uBXDGg~1#f9^5ert+ zf0S6%f>Fi{wpTHZxwr-QD7b`5WP?ho-K(` zc+8q=3Hy*1*0SJBZMCDJ1>%|UnH3Woaoml$e$72WIytgS8ROWtiQ zh@{eVnOd~B;AjU6vUK4dp&MN-c=?Y7Bf9Z=cjtcVX+h847W~oIf`9w-+ym5~gDjX& z7;Hf|YB$t^=EE&`LSZ8;I5gIR9OJk@#U##?0w(iZ^lS=$J=KCXGc9;J%Ysa^Eoe+< z=I|KvEr?!ZLAK=-}Vvj8lZH->6$oNF1uw$O8ozJ-MDccM6nEg!6U#dK>Ea?53 z&skbUO+H#M?i2UgXA3M})LeHLh%`?ZET$zk7p(Adfrs4%kGx$_+Q$Wr=^uv+M$kGV zudfR-`ne#10y3!tcDr#niwnfoV6{KY1>zpnk5Gr%_(=7V4UBO?a|(-fLC!cAY@=P- z)QlW1sFBkJwR0)|+%D)(>GQf^I2A9T#@`D(eKYJC^1X{Zje!n2Wj!3w9wE*N9XXEQWW(^xUCnOew-ueS^G_feHtF^RtSbwS(y zF1R|-1f zR2^n3gt=l5eWjw2svOQipg~jHL<*>Q1sN#7nxIs$6ooLM+H{6lbY; zMfIkdE5uKlT*DRFYP#~Z)D`>ds6mZgA;wd>rmlEMTbj8dS4%#=70*Y1w06bZwyyZp z-W7=*T+xD#c67zvF6wM|t{2^+96eldnws=<#djLh%N60hU9p3b`lZ6k80?Dqlx~PChS4{gIE-T&?uvn9T@f^a>qVz%`$ShPoa%~z zX|6a#2{T<`nZ-3U>adMwyJEmxS1hAD6f}=>p_&U^5xY>WUhfJqe6Ol`g16Jf^Qz@V zR|u!8%7=Bo=88x3`MN7c+;D~crYm~VQR;BZ6>q8bzuX`6`?f3Q+~GdC>x$)%)K)gn zV^>5xb;VMOdB$^5{nsk@PgjUhaQnXzRyT;X{%RNNl+F#&w2l1JyJ2SrBao#wnN_c> zZVe4B4D(!}HG_srTURKPrtKONc5R+*aJ)@~vtXLAH76n@&E*djKtPr(A)x2;k zju@9%@hC#QXT{4%wJVC}pn1`14J*#Xs9UV~5vx4otPoA(RcBU=OHgxIu`N-RNU}nl zGyY}8gk&|Bt&*bZv%-<8g4k2WbyghBrYdE(Lafbc#m8J$gy-g((dQyo{87{j?_yRg zHSV(Mid*rgagoiJX2sqTTw5AdN=;`sl(yoo@sjOZ#)^m3v8?LLE-Gh*Yk9SW6$gzc ztY})niWL>D_(aA2u;MM1uWZF~Dqe+aWUOSxXJhN1R*2G7)mBz4t8T^O8de0?wW2jW zq^# zBe~wAtk^T!ik4%!KgL$ug5vBol1+&4yVvqD@T=j|$x zJx75%IgdTuLwl|GKvDaxXkc_@#oq_iYIgr2mG21m3-vU1vErYjs{AqTQCdO!PVjZZ zxW|e~C)Lo?d@h{fe9o#O=lLACp!_a!e_yg<_Z2G&U9(~+C12-%ykte@XDWsj0dG}PXLq<-R4^-|+|+DV+%w8r-67r^KA!Fg4zl811@*fk*MNHb zp*mM_hp19j-K^mbF|?-I$BNU&XI9j%tJbjMw=wfCcZhWLR46NE8(A8-L%eLLdNp!~ zNN%j^vEqjDr3sJMOf7Ha4sqTn)0)@5ojSpaJndC`R$T6=-ga__aO$kuv!XX8ci~?9 zM^$GZ(9mwm(cK-QY7cdb6`6Xed8~NWTea`Qkp=u~Az8I5-xkI!VuDY_`Be-X2G&LKkX0YO@ zv44y^#KN&^9V<>7^~UkKQ7gJY@5iei6S&W4D5aaIcC+Gy@t74GCaHRpc`Ryc++oF_ zDeA{GcZmMe)fiT+G!kaGLtHbSu%gyXl`xC9(-))W9CwIWMy7eZwp7p9Gv6J;d4X!a zkk^t{86J!I+C&wMm#i4PL}g#<4pGGTixrQJ5A6PB>I^HM8?BeSLyTFW(yw%f$h$_B zWJM$69V=#RRQERVHI|xhRq3|#8c^;XYBnn@J5|~VcZl{URc}^YHM*X1hgfB7XGPu9 z>J=-#8{^KnBmTS!y}-RpNk-?3eC?s4msIg9?hyYP&#v-0MW2mgkK7@y8I7O0Lkxbd z4!+=P9o>4Vp0c9vE9LrzzZcPF;{Yq}7<1mbL##B8vBLIV75m2X(zH`lK z^G}uJ?g3HNLp5MUAH&zv10t)joE4XhY&H*w4Bjf76-A7rtmx#U2D0Llanz5uligos zVnuG_Fe^HwQ~g=--e{lR10pShS`g>~Q96?v&5FEPR3BDEXH~6P;RsRHSm7C_DzV~0 zxQdDJfH-T+j`V<7VH{;e`6yM36<3UJtY{mpEb$%?4kM8jn~fSdJ^1xk4=l>1*0bV_ zQ9HK>gj*h!ffd7zGx>R6N>@OIvZ9c2f)y2tsFtiqE1^cQV!E+~6-`R2j_gdTRa&{0 z@qkEg%r49Ip%t{foCnI3_rPBjJaDz5s#wVbqAqp(L+xipo64#;D_$Ev*v?fvaQ;sZ z^r*_cK)I@`GBbgT)UBi3>v}*08YdfgKj9CcohreKXGY%k+{^TYLVBw{ zeYme_q>-<$2ZVP&wT~62jc2Ur)n8eMdq6BPa*p(X*lWxl#p_5HjftZ@Aa;*clc#w= zEHL)6;?L=-@k|ehp0m_DR?L~L*07?_92Gs6&rhnnKpkR5o2}~g4(1pD%oF87*1MR}T#P&UyUcYt}E` z&&d;woK**QzeSy88@j4fZl36GRbyCjh>F@h5$EHHV24UzMJKv%^z!wD*qA|W4e*3G zWISaX2C8-p66QQA=SQVzWv!ZgiC)^`ddR8 ziGoV0s%1POCKyLqamny4=Ls>)KzUDy7{k4SCk7jRDtbcPr!18`alx4JhbP2&V_`K< zi1o&Y>YN8PsiBszFO3Z~c};7nv2#2jW-L%k*=h^9PZoJ1d5I@-FZIOV%RI4QxhHz8 z@I?8QysoR&xQ(6=vuW>Ub&Bn@#S=fsZ9C_^!xQaydm?O~C#o3r*)sb*k?o)-LXLXk zf$@f|e#{dYkMl7`Z#L)z&rfAfdZPO&PrNv-zOuE?a37ylo6dPcSTCu1mpvg`8TVMx z`3fIze7Wk0XV=y4yPgnHPgEyX_&-$>S+R}2QL$%gJbS|!^uiOO);rbqy(h$=59-oK z?gP4K_RPlzQn=Zh!4eC7Im^Tf~Z+-pBn&WtvQa+y>}W*bBzEy<$Xv)Uk% zgVkkL{1dLSM%p00Myca*HVAuy%EXGy#car9bYR7GBY$xlL}?>enhi0fZTuRnYEi+4 z;EFbsr+;W6ogqgp6~qSCv0(>wsB6Q1de>O}W*aoIp$COEx1ly|pcXB83@Y7PRb%tF zv0*%AZ)?NS_BQ;YN*!$Y-pPh*ooy)4#fDBsKh~+M4NZF6(1n8g*zl>pvJ9}H`#?36 z6|RG9C~Q<|5hEJ8XzLGo0h2n-o97hGw*!UQo(N)rmbxO-I?VjoOW|Vd^+O zj@-xFu-iDv`cAZ=3Vk#xOtwJ`pQ5I+yQXrS(`=Y$tYI_Gu%VjKh}}EWhJmxxcs6B@ z4egCS?2)-V_dJz>6-DQ(eykWHU0}mb<2YMz5wD+djIF-JhRMc4cGXfF9vFp}b1kU? zm0Q8F7~|MXD^(2p*D4!=R;ze+&Keu;8n4)N>v$eoX>4a-t><;wpa!#IA|2XjgUcr6 z%Wg3av9ViteT*(_x2@dU+thz-k?q`n#xVB84zABmm4Qv$#XVw7W*hIeVS%xZ9k7Sj z#%Q_M22o_6%C_GI5pY1I9O5;hLNw|y*WkEXbHWC3?4-KPwm8M}p5{87QMcI%XKko= z&W4TWZTL+UFK|6C+7Nn)&k0Jq%>7FJuJCo@Dz72Uy2jhD+c1UR-{3yHX+w_NoabE| zqVB2eY+V{h|545ds?tO5Q={D@uJ3=mPIT}w_v{nyYij+}hRVE#G2Js>vEo*kdKK=4$OtcZM|zQYf+rtZ@cu%#76;8cX>j7R6TZby2$zBlO=XoJ;0k7LaRfZJ< z=$S%HwWRk!)A`m#S~~!hv00 zXtP^2+2e)$dwFg4aUbmGeGaH`2YLKMUT{0?g&VZ-m=}_dd*L+wae`w#$?HmmPI)2Z zv=_QluQR+KWj)KaKc_yh3(tEY<$@Ou(e{fR-z6{Xyv#jvMXg~M-SWcvf4xxtwii~? z(>q?ceV6;}ffwpORBfMoVVbd+&HqAGf5~}KW8)YrJ{c~rywIF>8z*kMPUubRa={L~><^bg|kvfAMm zY)1*&ZhT_*gxFCrR5f5l+b}!+ql)2noTEn+6JbYf8blK!?bt>SsBn}WA<-&{oktyG z>?j&*$5Z1IdoPZ2NmOlFVNJ55WU?LKsZt8hnQF(PY^qHTJHAoboOZOyZAZgAd`w-~1MOQ1>;Z)I%2&!weV2{zh%DmRbSJwMawWunO zPerP!3al7S$EbaEUauN?mE=j#Ea+Uv>IM<&5W_^SHo>2=RpSvqqtXSGF_#Nqj?)0qv$alKi#7OV>xEZG|rA6 zls4Xu8OBmJ;{-bf(y=LA$EkMIA(v@(Y$WIDcI2PI=NqNY;qj^RTsx-FUCKRArLkfZ z&7IGAFRvmov>ac_BzmwzG#p|-0^VnlY(|z1W z2l-q)#<|eK6LwTT&Amu#&hVODR-tTJa=KziGVP+XS9#xSe9qqDdH?13jgq(dT%*7{ zDw3T+=Z)L!s=K@f#w#|*J?=d^M-?7(y$n3z`Jbv#*6Fz&1u6GSj^h>A>oxb=8#{8o zwWH4mzBYd3-uuMkP_xf={Q1R>o?m%xy8Mmv{mym!#pfKn@t?Cd%DZ@Dyj9(B_eNt6 zZ#<@^HgBZ&^2T64Z;Vdojj`#y(IRry@r@W`zKSkatX=R4>0bX3@if-Z)f9y=>+U@!e?Dl5?d; z)TWg;hR{o@-`X2qZM;#{n7|%t>y3k*)H$|A7jGP;8vl61){Se`on!97wdv`N{=K~s z+?Q+7&l?lyt1+g(H{u5JdJOhPw;}4!VH^+T8|jUlqxiYe-pDvcMYBuEXRJ4p=+Zb< zZM-+cQ)9sdZ-@^QRrSeS1L`u{#TqUw^FRK1Gxdt@wwmOs52cmkkimvMek;4e+>;n-&189@6 zpAGK9#~6*+tX)++dzps*qb9M9y7^!!b?C18upvEEB0GpIJ(Yt^?d5}}MklsoZy&5P zcC+pJs9tRKzN!&x>8~7YTdFrmjUD2HPgHBDdNa%i3By%hR!kr1gSBIPuyU*q-b~=S zO!UFRDL!a6)dxqW`C#sJA1t4twy*_e`ryTEA7q)MVp-9Y4wLUZj%AS#%9C}m50aPp zpdoED_AU2;I8D}-9N%gm99rXp_8WX~ht_ZP!J2KneWwo|?(spXeLgsPP+dFZ1F`zB zdVJCc;_vh7(G?$vJ~vg(dp;1kpQviDd>~$bP`$qRK#cmSW;i(@mKrxK4v5Ew-P-|? z$r$P5Kq-d<8|bs);_E( z{=%{mssmrDIk2|61EDoIhnfzQtmEL<^&IF^pO0^#UNq!58aoiy#DPyu9az%L zf#+1Dr33ruH|1@mO0i-c-JzJ)Y7l#eKD1FzZ5>GH;6S&|4ixL+KuA{yD*WTXds^Gg zfuG$S$lk|+0sS4gG*I1R#frfyZYVo~a~cA(N3RhON9j$=RX zz)Pxm%YmVH9cX>e0qcDSx>ENC{M=(+%O?)(e#*x`bMSkg9Jv0R>;8&+_q78@-f~}m zR7+XWs{ z?9Sthe0h1le7?Au-xq!bebK)V&uc6y%ySm?#o%JT2r2H1VdP!H7i-8?(ieZzK`L3= z7cL&YokViWzKRaJZu`KK?Y(|+T14PS`iwNRVMm)T-u(Z$`Tseh{5& zslRIbL1eC@91Z+%r=cJAH}b=iCVp7n)DJPu`S=!o$kIy1vgfI7Yd<`stZn=-+L*zL zR-IKhRy^&et`GBrxHDcgo$LqkYPFiZ#t-7iTJ>&=9~_6&Wmeq!t)8+Xy_5g{jb_C? zSC!e#AKk3}_-;7d{UMw^)ca}v5T&O3qb|KSFvA~dG~SrYW}4}bO-6^={t)Zvi&1zE zKWBVo#o0w_$r^u%@#|FQ?fwuS4a*LH)Z68cne>Lr?Doe>dT8X>G+m=0n_ipp9u z9i}!>m)YM3)U(&=Af|m%o7p!M>y-ZgHrvueZ1q+X9qA!n8_mPhLoA_ph1IE|=^^4v zs^s$NA*NSRHEX7aXk&C7mLB4d(JK4I^bpRA)ZZJ@&61z`2j09eih!1Y%EraA{=W|lyt1qGseSRlW~6NoC|fmmSd%^L_Y zt3V)*6jhl^2BHm3Y7>Y{^p2Xg4a8{*Xcve-XfIW2ABZm<0QOETw~cHSf>6<@ z%ZdtBRBcw|ucped;;r$fQ4mD27OH#OAc#Djf-ujx!HV>qRWvK+811_Rp>j7hkQL*N zAFOEFU9DtANDsA+6;*qx6Re2p6@+0%t-e7JO^tr6IAIhV7zB}HkV+gJ1d-2p&;B(e z2%o9dFx8C}JE+-k)tMEW==uotm=#k;2I1DIAoz_9!bqA!_l?)Am@+O1A1ClW6NC7D zDrzI^HHp`h=FuZcm>h&Aw3z-gmQUgFC}=9LFXfyTgm$!?%1;l%9{Nu4Gq}fS{!F!& ztu>4DpupMuoRP3F2$L77g{;WFSe019xs!ES5NguXmFg2KB3G;Itk_P|*9T$vMm3cc zpD1WE_wqJXgB4AT<80~OL0GU?P1_d)k$t~9%Zkb^2`7I}`-b{HW@}iXX>S z*7HFSe;R+Y;*wGPau7tOo2m#q+Bn9Ffw$CdHq-4O%r-W#V)Y$0V0>1HH-^uItjID; z?7;N{SA~g4kg6iBsEHkv>5k zXT|JF>Lx43{GsNsqGe@Ot9dZQRzeF^h!t-Qr4A}b2XCh~#)+N55EXW* zhO9VYjNKCq(R;5t&x%d^RptZ15W^0uC+xr@>LM$`j;aIfiDT+2>wBE*Xf$O%Qi&76 z2sz2UKo3r-!e@dZs$U95%H?1jGj6bA)KxW|6(z2#YB#vH)YDkciWzrR+lO37di0-4 zd(6E>&5ihH!4T!1t3Iq4Y3yZ1i5Kc1D~7*S&EN4@bp5@0&5G@xROIJih)iGAOt%n- z5mt4W6+!MQi$@4VELFCt^;tt8YR9Tu`9dIUMbs`@&3#|CiF$8{{)gx9E@2a-4BI=(I`1j!P zdWN8MuMk*z^RfLyP;+1iz7Gw-z=dl4$`D+qxK&(-)gd@bOV@I}z6W6rCYtZ=)onm!DH=wx_5 z3V|p_D=6)WYR`%nM((E}5DSe(uekp7#rX9m1j6!8J!Qow^8OrxHpX67TrjGB34y5e zo%`m8`ukT1L|fzP?+}Pt2>rhW&Y=+NjO;F<5JjjL9X2kqsqUd@=MjpvUZJ>Wykbv# zha%KRb?^&?_|J$94uz-_twzL$LL}x;YYK!ybg83CwF`wP+dh=9y`d=FH58wz=s%%& z+D(08I}HlOhryw!H#8KlhJ~WV$WSyH9g5`?J%;0^g3Ce?u{;#+t5kZn(3()huMNe3 zjiK<`6pG86Ls9pTYQbJO9EwFpLNWFzZ=S6X6Hiji^iW< zF&9H2f-kH4tmt(`U13G*tIGWv&ug?`7u^iy&#(wZ&by&lL4V)p8axa|&nIft%TS1c zuhlrV`#a9@eJDIWgkt08P-OTPisrvmPUkR)V#WnlOtOSwrE!z}Wn^~=LvJI@H4G)( zRJ1h=BGFyFVtab1@vQLjRApK5)3DpZAl4hvUOX1HHV(4lDg9?xA>Lv9r!9`fCk$|? z^sKn&tEQ%e@oQ3HxNHnd4TG3w6v!3^alv?zJq)5{4mCVi7{m=@Q{FI$W`)($A{-Na zGL{w%gK#OP{MZr3L$*%wFq|Vtn##wDCdLU?{G^N}!uTFULBoaW67-`-&RR ziY12kReqkD-BOELQS)EboE5LA+?_C-F&?nO^PZ}i6b^CCXkRoO;lI=9*$i`#u?$*MqjDO z%y1kg_gUeHGa9pE|7_(uHyq;FI_11R9HRaPRc&K9#Pq!?a9=n?(_?Bdd)_F1JRIT# z?LHBX=f)Sd`ALq;IKoam6^>6d`E)pZ&V*ww-K8F9)p@qiIj(~-g?(YTpXZz?=S9_n z6^o2Mm-slkOJ9w3SHdCg8-7>AA&MK_Sn;p1;zl^cL!;=eaEOH4>cmUVlU!b@2Cu^* zs=ZNNeuhIFH~vBdL@&eJDFULl(To+xse-er!-~9?2wb9-F6uKYTwNnDfX2A-WBSJ$ zfp+c@fJX%WGd{3=J=J(y1jHP}-75m3lhL0Q1?(J~PXxYDydwgGjPa~+_^Qi(5fG1z zs{RoW4UOOo5ol~23W(tM_e7w5pz6npx5jT)w9FWRkWA_nD{dJTGIL$1jni$*mgYi-5RNAOiUds%eEHAU+uL3P(V!Gp-kjfcRuQFB$>iS&a9gr*xvYx>h0r zB4bJAQZ53bzHy2bdCRLMtoUYBuMh#T!syh9dy@`yRbBpxfIxS3y(h;;l?SMPgCihZ zhN~%~BOscLRi&pyKs=wWurdORY3OQ|e=paB3f)vEUU6PDKRojPe*6^)QL~8~0g}tBHEvArd08 zqZ-gD5~6x%Rdi@1L{GXljAIy~icO1z=x1b~9tlz0IL=1Rj6~2ZwQGJP#K6sJH!Cu2 zRRP-~AqE^$`&iNGuo}pU=p$-2E8ZGijzvNoH*TJYga|pQMzi8FMVwOOS&{X0BnBB7 zE=59=F#5A%lktodnJ%lctmt8EVukNjb%zzRZ>g)S$Z=bF+=+y^@I-k%jf80NOa(pX z`q8#m>JuxLzgF8>vEq%|+B}M1i;KcrqhiY_h=^8dOaCZ{H%5hlQ4q0%)V|?S5Z{a% zBcmXaMybChM?uUqDo)|?sh;tW6-B41m#io|TkU7Xu$AgJE4)@kA^QeZcw-bqJz8%# zHbtR|v4lNCUk$g-Q7A+Mjqz-yEnElV2P-_bs;#WZyiIL783nQUjM~78xU*^vd+A&h z|8A#dv7*o=&Vk%7MKQ94-&7Y_QR!9``p{Pj z`d4*jMd)p{iWOIlPIsapa@|#@SmAb0HM-An(SOEwR!n=K=6s3b_X9@ZnvwHc6vTI9 z45A^98IjJ>@UW=VfM|$T#<4)&k3MEnJ+ekaY%^K~^S;#6a0-b=z0hb(4^y56qao6a z`Guk(>J?T?i$(KixkcliQ7A1M!d5~(FB1(BTUOm-#S5cjxoC*9<<+7J(Gb}ytEsH0 zR9g*a#ea3wgu2lXyPGOovuKnfx8};yA{rt~E48pqG>W&4hNE3HW*dFFM?)m^RU=r@ zxSt9b5RLZ6%z@DmA4aJ=Yok$SV>EUc)iy;#{5qiuoQ&r8c|_y2@tYM3PpLo8MMG>i z>RgJ3m~NE691T&|z?Eo-u11y{oEODX^exr+5ywsYjWcXah8UbSZm_unVo*C{47O#8 zL5a*UD48XO@B5Fz>Z~z%L*>F^Fe^NU-+LW{Uo;{r2G^)qbPN^{Vq*BSER=&yONc>3 z^3D;1#k9Ow41X4P3S`1vllmn#G_& z^B8{L5XaRb23M(Q%NV|AECzwC_;@-_0j*=Op$k9XEe3h-spYKrLD}xdpo4Lh70-;= z2Qd)2jKQopXq;z7*@rRMN^Ksg*R1$SgC56V?~@qJf3EJZBJqXl#EO+h>z6SQvy2a{ zh-egH=yfTnmXqolw=D74Bi`Lbf=5 zoiz?#*;R`iaS%~CRj>SU5Ic-E1>zuj8c&A#Hs1Xe2QjCfs?|J>|85fE+C zh$*|(B~}dGqo%SVXs_zAFAgGVzdCR#4g#muMphg&x}AxGDD_M&V8#9CD%XoRh;^@2 z*4J?m@f7-9`TmH5$ZBN%9S70Q2y=>u_}lPzj)w?0f-UiUt&B&aLv>^a(={W)Hy$Dz zt*3#0>INI{uiCTQjH_(9bZQ(cN~Tu}*<PWi>hL%cIuCd5N5G}f`=w9z0j9%8kz zlP#7M50~V4G@@HZ_LO+Oe^z~Ag*{c}V?`-rEGzCBuUIi8o7%)4$gT?Kh=~@el0uo&KnO{k)y6E z&x(eBsjIAb(Mr{7&Amaz+pGSp$k9QivEqag-6HogsrhqyOL{hY#i zQ~s&y6)S!jJEp}$?46^2vSQs_wT~4g=c$GBxi6{v0(ELL)AK?N$3&QF5PJ zxSx-w`Ug~-WAP9xje5u9A=(<5PQ*jpI-@e3<;Qf|_?H#q (Y;vp6pHLi01Q8VKu zTlRW9THjC|f5t6BUA!Zr1qZ1(- z=T_TTk+p!T%L<=@Dwq|E4d=p%5L=CxLYy-CHcW&VYou?K zh>ndDv7?FV)GHBUwc*((5n``#V^|_Yy5XwBh(w5>k*fd9M2MY6;Os=cUo#PxjenOX zLM&gQ9Hk`@ zBGE;)^G$+SZT#(*1kv6|=br>I!g$Pza~YI(KoZ1$<2)<61ght(7?)9f4M~FN5USe8 z@?7-YaF0tuOdU0d75VF_v8-s{NL^vYo8~I5MH0jpqgu-(2((gFSy8f+dd`Z~-PC~Y zNf0rU)nHa6&QPsbk#(j@V#Nic^sFR^Ax7TWNf2d>9CMN&9?w_t3z8rT8dX`pMe5h$ zB#3iM)Lm8#TB_VvBta}*l?1odNhrHkbw8K{;ddwrU8%?6Bsd-6HK!j(Ri9%?5F;tq zakc7162#q;D)@8~#P@S5^4}zgUw4%4ZW6W__3tGi`o3E5GzlWdGtSYT{D1kqlOakQ z?^#jAq5fgTQ(rYPLo&o0qhVk&e|BLq9%NLxGbKZ$8LwH9J&SrB#E)rEuyTn=hDeK4 zwW5;wb77PDXJ6GbE*avA@qqPCQtm0q5b0^35uYs?qJDNYCr2{GpE=cqLdg*QimK6U zo?_|&8(mzru9XbYtd8o;2G>P910c=u8jdnZHe>!U{YPlotwfNH~v zn1O2lgk*?`6V*aiG@YadOiPBSI$bqpMZgSIdsZ?;k40(>E2gYg-PR^U45pNIYSsE= zh`0@^)uv>KBL~#D!^se{jnYTBXXpWCII5npV*M#K_Hr^r*d2BBUNXe`w`%MM-cGZq z)JHXq6=#jLpOYb`JEi=et8)rO0b`9N1){L4I>w62MnAU{h=*47jukHMss$^md#EK| zDG-5n70HTohQlWXVt_++PoDxYJ%d`pRt`{$SrHMa-bSTBT#Qb^?pPHV$MevL9O@@4 zqVlRQtZ>h#Lh`3TBpFi*ra&|=q`I+UMq#y#{lB6t{V+U=r9f;l-m)TV3DuDmeT}%1 zDG>jZQrlTEr>y!}iQ}fTl~v6@Qy}tHQ)^kV%V<_T1)^w8Rf!c1j3cbrSW7*rlL9gN zFEzG)3WUesDg!I_8-5K^__JD4P{x?oI0Yi4wVKF^c~q{Adf1lNqP>dll)}FwrC@e% z)pKYH|1FtwGun(vfhasyRboZ;ajN5Vt{U!tax@wy}io)K);OT z*HR$rT~{Y=r$CIjr_y~&foN&`!-}xas^OOuh)ZA9>mMl)Z+@wttXTG21tJx~-$~VU zO@(NfK{W_Sh1hBwVnw?^wJu{S#GTA4e{d?qcw-JL%7my9p{WqR!&Tv^RQ~*>RK90L z&0|HmXf=!#)e=Qz0s5R|9jWLOd;~dKTumOQ;*Hcx+54nF{f# zlyWJZ%Ks*HDl!;7S<$?V8d)I~;)zkaQYwUNWmSh2%?eKV5Hnh;H>~(+ENhht@uan?-Iimfqz-B% zD}HuVGdrh3d@)*fO@**^Qw>L9LpY3UPOm3Z9Y* zaeSIuF@yJ~AG6ej*{KlA=cs;jQz2^1Q^70vcxtm!O<9!+@nN;X+Ej>E>(u4-sSp=7 zsM8xcZmP6deb~as(U4v0_MTLTuKQKR1Kj8I$3fNMe>L3&m{esO#_@*^0Rg2!lP_4o%g)wsJk=g z?5!#^YM-im0Q(mdI;_SV!TtwDkEv@Xu-`(NQ_6j&s!++Z>d|>@2UvPR6}X7)3#H6S zltM14A1_xGdV58sT(2s$<*v$kuc}Z>NQPtPA{u-jpEE1b$Ol!WI~)hUhgIdAd5JE6 zq^dl|Jp5Nx{x##$c;P+vUJ{U2MWVC=GNkvyIW*OXTwX%cO;m0#q2}fkn*VDr8EI-1 z^%8Oz`PK{PSMrjaW(Z0LzEd@ec?nG_rxu_TUtV=Y>53^{(MxEu8BonjXuNS&_Y!Jk z4x#jAO*IguasDb9rABpCTa^AWMFYKr#+$NEFQG0j)gPtX<|RtMhpQbZO{}Nhpuui+ z6s5anr^idEQ-u0C(o5)$nH}vVlsm>t63sf4(#NU+DBUn2ab7}|8mPS}Woo3t8+!?@ zGliRY3H3C&o8s}HM!ee7%uDEWbG6}nFQMdCYH&L*p@Qwzhz?jkFs!3GfKps1H5{e? zOn7IE2OgL?UA*vG4~(gs@5B2*GUh<)@m-Ol9B{K$jNw>jRTkt!a zgF-{Rq~cFlqtFv74#QfQuAZQ2XLv~q(-l1qb!TF}epMgPFK2m4@7d}PH2)m62;B&S z*VafC|6gsPdFBpE1)eB3N~6tDlyW~+^-vmSwxX0`%B9p6YH4PpblPNnR$C~*^g?N+ zd5BV}=PCiEY33M8>0YQhD0MSSP`Y9AzpO13YpT|+Bji&@HTJ6`l<>VOe4vid^NQZ7 z%2e_eYGP)gbk%%Y*;}Z&Nk-|S$y>!+sDs&tQjV%B9;M$+8ZU352s0F=bEdk>Td2D! z8SX7q!)!$i?>j&o+<*Rw7pbrlxCQhKX?nR?XC9x>@AdTtlEImep7#( zx6rcjs`UhKp<9bpktN>J_cw3pu~g07}pC5AEE7EDrbHlp`qql0Ux1l z1=aMbK0+r=rD{Gx&&|g=K0;C6s$pFpp-JYy03V^XfohP$N9eS<7vUom5~)r^`QZO) zeI!e?Y8~SvY8ULr5&wCq5qD-a~rE#t?&_=Yd);R z_JTpH)Kru*tX4kjeS~_!sSQ4|V3R8O&_`&pIhxj2=-YJaN(Nt{d>PfkOujNT;t*4wqUL zxIqn}!iQi8wggwk^p8Q>@M!F(6)CzNDz*Ygu9W|pFq!L9y4DQ&d!MQLV?^2GWH zb&ONXQA%i_I-&F&A{$|D8mr75{e=EDSv&dR92I`jrn4&C#ZRbeSJefjV%?M%N}C{0 z56p@AWtgAP88dRYpU`v@JOc9#|4db0)A4g4%`7#2F1{Cb%vT>#TC+gyM9HyGEnMV> z^SAg(#A3BvHO8d4HjCRn%55f1z>J)EtzY)m2q* zf1$iSEeK!3as%3nf5 z{P8;~f9Vp2$94J3%y56HRNr6rxc#M3guhgtiZMpjl{wi0r1-=D**qygBBli3oIe55 z@0S3{H6uWNn;9T}vjXJw>;P$-93Y?P2FNe-1Ek`@0NGh2P#P8ul>fdBlwHNttdfDU z3T~DOls)AFWm%;_DO*!jtQRQM!F*FcP^gl5gwo1b6%-dJlx#*d2^89I`ZNs`8g1&v z2MQHvsT!h`wUsJ}(hak=W1vvRPAYxpK%pS>5~U1X)H0Ncc2x-|FXtfcg=3~`%ln$GR z;{$~nO;G)31PVPcC1(c;4KYm@1q#hH^%n;U#T(xxfkJVAswpTr)~N<4)m^W;9SRis z-F$yIP^i0^b|g@!+I2M&r2#k9R+Kv5QUg)ydRv7&2^1P?YCH`T3N>j{0)@O^sv{^( ze6Nn9G~|Ptgi?)t(s!&N_~4-(oB_f15GAY7|1NamZ> z=tuC$s9fkD5RggDMX5?=6^~L6GZUqA1=Z;yK|-!?R2P)86;(x1a{u4AxDAiZj#5EF z|C-3sK|-&}sE%cWgeIF~D20_%XHa@>zNr!L_(>8l6HK(o4bkkDz9 zwoZ^xbyLA7NGRHzsf)*ifB-cYr6VRhFi2>>d4f{UAXP3nNT`w76%r(L*Gvoz!Z{Rz zq_abna0UrgHGZ){LM_a#MnOWwr>H6@CCySDQ5v;SO+%^ZAF2XMO*W}In}bAlsO%_R zJEE=}3lgewTs1&xmHFlb<{y@yRDYw?>699b(%Sz!joT1?Ms>V`vBG5Y38kD@l{cE| z8VVQ9iR(c^FHPYaK|=l}5~ZuA$ju<38pe&%G;q@DHSz zEO&y0N|_LpCYY!9gM{)vP+=(LeyB>I6mEv2wD6It^f*XpgSn2>nr=0RZX^0`3Qbi7g%tCrSFq5;YH9;Yr>d*VHG_q&)Ka-?2McBL zQQx7|)}-|d7W&%wqpAE+xN0&41`Aa%At*V5REgkVp$#FJPp6s|8!Yr|oZ5*}`3A}l zr8fW95Vs*yBNdNQwWjJXlx~|!&4Ptu&0UmMw@?>Q3TUe)cMcZXWR7$X7J6o~_6Qa# zX1q~4W?rN8?nm`)pJ1UVGajXN=Iy{>p$kLRCzJxms5U4$$Ez+V&6=l{qV(G2Umq+~ zf3NC}(!HZ9$FX3cN~csTN@vUylnR_SXHeK|a-Itos%aLWw9Z^bQ=La);01N=pJ1U6 zCiH5sPzN&lP4G0m+6{z-yg$O-01tUU)0?Z7QcAJ+`Awq?sRS%Trm^yJGLP=&LN;gcd zMtEGPWo|YJ5z5w7%})vuI$$P#A0o8HRBaz3)X=2u6e3i?9P1t;l=(;Hg;J4$Dj22z z2CMu-LWD98SCvpYF;cxn$@^#345dxxCQ60Jt00tqHG5H-GD&SlDc5A>gHrpcY9dNG zrzvlgO3zeolop#4C}o_jDxh>DS$#1#L}>IP^*c(L7OSc#{qmdIhEkj5Y7$Cw*Qk9c z75PJjp>*I+b$EScd8jm%Rj3$*pul)Cbb}6s8E5z%8gP7GZv*a z<`hb=Or9d4LcXRcO8w0&l(v|QDB(qHsmh=fX?mhG!|X=sk!e{zRA{_uSSeI!hp5g#fvIYE7s6e_f& znTq;8R49E*RSBh~9aXW;p+alBsK9QaLVtBvhkpnadTLtr4i);*EI?EJh(b^wb*68q zQ2l;tB1#ubss5ojM>W1?&Z2bFtR4_5^vwJ{FjVO9V09j)io;Zf5urji#;MR`%olVp zJ5f4iuA$_frt5Hks%hp+Y~Jt0-;TsfzE$_JzXx)sHAOJD}#ERQRAu zIfU&FiAU5pl$M-O=TVw_TJ1yWvdMQQRA{X6I~OX{!u*3$*7NGoC9GMB1HD z2&HN_RDYBv-&C7W%5_VPzlSvs{wb;@N{61QCn#NcsnWd)74kQMud&Xcjk$tSk+&)m zr5$M;sj}vD2vsqmc^pC=%#HjGq1WcS0uD)45QSalP9cZToFeK9n(7-A1{784oDN)b z(1F*Hs9h+{b*Vp4y7YhHxDEa4sZ5a$p}lb`v=PP&Gt7CEGB;C|P-@*$jYTOYXvHnsaZgd)vJlwJ>1Sq3?T z_Wz_Vpp$R;||H`(Uz}vetoXaN}qGsVc5_ z2*sGbD4pJrtMLOP%ks|m_z86sei&D^wbRd+aa{v zJVEJ$d3nkqwBxiIbjBex=d9{=4vz)1%tw@RpI5$UstYJwHbEC1LT$}AmmNYMOpB`y zpMh#(iTVkpl&6^Y z6!p_Hd=9oecgO=%@P$LDmT7=e@0V%^N=08OUzD1f@hIhdgLMcc-l|x%qZx+MeADus zLuiya^uZyNJ7ZX?dMGtAL7BpYK4nv`Qei?3O%If2mQgLrh6&{?r*@SO6FLC{DyU)= z!-RY)sTL^xSy>%I$x}tmt{Nt^(@Wh$DSP!W`2$MT2$NX&uU42;s-q72g$X(RF)nyu ziUfv9!H_VV&nHa2c81AMt}y8ou2$C%6WV4ry2FGjMyL)bZ7_?X!h{l|)fX{gLgip3 z95VON=CNVY6OKXoIE>4*L65?Hleq!L0N*tX6MvI{UWT`(Xd{dt9Ah=y38a-Sc85Jfpa-14IEe!85 z43jxC)YP3}LOXUV|2>#PSaMkXayCrp+&Q)H0>%f$FRMSUU_C*O>#96TBX6n`C>_6} z24-~%9n7J&7k3I3E2)03;uMPYS5@meg&LW#0H@GBGds|U^B6cKE?5-~aSDYuQo)U# zLSkPN94~RAMiuP>CPZ>%LB*^!?N$G@`##ejebIx6pE+QyLC-%AFzV zIhy|`r;LG1P;!`4I>Ak7I@~EcOs)}5X$%YD6$FlS$}l(pxkouA9?rqnqn$F>tU@Wn zIQ11u?(u3FN?%S;dr>-Rex8VNLyj4$5K5yV@2{A5Xf_Mm1M<&y;=d;_w{z4ol)5FW z@VS^@$gxN@`wjPnPNwcsr%;;Z>Lcn{p}t?~6zXa&uXYL@U89z6a0>O=s79bvW1IRH zCHD?B6QxW$Rn6T_p%AkIr7U|?Nt9}t&M57Mvmkp_b~FfvnaOCjeNGtVJe z%g`&3a6olHPePT0YCK98P4FSCPlz-#P`Ynkqm=0g?sHUiKjswLa9Vvn>l9jbU424n z*$s6ErCK-DXq2+vQhianZYth(3N16m|8)v2H(%eux`ct|Ka?upRc%rF!?d{P6q;wg zzmM$?eIKa(DCK>qdOyM1gI+JxyqCBy+%@s9uz$d8^8lreuhn*xzI>y)pmfA+dFvGV z{+;>{rKI=jB1*m=)OeH*nPnd_H!%8>x`$G+&uRcl8_WoC2^CJG2BUN@t=gZ?C6pn( zOG=pn8C*hR&8CblpS2DBDYHV$|cnCYqboeeR)-$d@iBuW^{g+(5nLKO+lB? zq(Z89VV6+)B5FEHrM^)cQEFOLW%<@6bj`#Ra|taqDJUH*u9lU+_~5V!DeV&4R7Nc+ z=Mu_WMg3mYh1Y+(#93Q?U&kf1*K7!J;crte{4HD+c4FH@7jq1y3NAGsrN_n{j`@X^ zCR;sh7wBY;qqL^Js^WGDB}J&lkuIUm z-9l+^W3{pg#tQYCs*3S0q3j8207{R{;Uvs8JU0cJVZFmE6W!b;^t);Iy-TQg3-tn} zeJxeiRxZ45$t4k{GfLyk8kA0(XDH=rt*WEc(2PN8zbW0uB{bHYM5#hsm5frQc4|9H z-P)@SDCO#)>Y6iqqJtc8ZZHC1{Rnrs7!Rp74rb4&6CuwDK7jS1?zK~dWA;+;*tZV_H-O0 zA=?bBjhQ$;&c@s)yKud6Y-cDs7su3jE}1glC0{OZiNC3b(#&P*%jNhw%!Sh{Fc+(^ zFTml|F6sU|j#F#YFm&V}E;$2j*Sh2^^!yX+bv?H21{|w5sWF>fl7EXDwGDH&UF}D^ z{^i2;pYi9bFbKnLu1Nx6gS2b7i^!g@Tc+M;yzh)XgaRX?MY z{+Jqg!X-4tY&q=`x(AESxa5noSoi1gJTJPW#wC|Dhs&3-KCZZ=rm7B1CI!R+BejZKRj;X-5bs=$2VLO+`Yg~BDzci~c_c(}YV ztxAMT+LGatR9YP>8!olVh08%WS3X<;H4Iz^t*Y2 zQqF3sHA>lQCS5VQLgg$4y!%<_&6?wkRz&_fRV8QjJlXV*W-c zPq=D=(m1mRrH{tDUbs*X~6E?KkgHs_j-iP}*odq2%pRy;1tp zJVL2#gldISvbl)TSCJ|LrLkr|N@=2$4@%w5Zzx?cxue5{LQH>@)|9#2rk9mXyGaaQmbp7CJv%`Hgc6Q*zRLps|Q1k0*7D{h!V193^DJgEDlV;d6 zx6o8m@VQ&4_Y1dleyIwk_XssIUu5tI6*BYDPZ>Q@F0+a*;}J?cYQ4>&l&cyR7wkE8^v${`-1o8}oxKZdHa z4v)~bFqPZw5sEbFJRYI1%uMuEghy^is-V^$p=q5}3QEm-t92-i>7$PJ^$3mWudbr> zY@n(#$Rl*iJV&X|V2_*|;*p_4)uhQDp%Z546nq{goBUHfLcOMWFq{#9M?d2sDbkE}M$?|X#0nIaE7LU*63Utf5HhP_grHy)uPZ`D`tu-#zldo}xm zN2tUnb?mc8Xk40zRCCfs2rW&g#-@)D>XJdlWR4K3lUXXo2tBN!PS%VN+FMI)tsNmWwvH;~6Crfp z?DCBe+8n3?f+K_;gs4xB2%+D?)Olxw(0rG=hSKD4wE(3u^&(_={RqkIRz*-6WbzG& z5Q;OI2jcr6zez^v{h$aLI9N?V>7|)J3uAz5X7X%|0T!4tb1)7Vo{XP8R~132mpQyO z0@qK**S4vxC>=3T+arWl|D{Imz;=TL2h??xrW{lYQ7U^VLPi{pkdPxP*R=?t2$S}D zgivlX1ErTY)cl)xZgAkP%5X12Xp=dJlIOl!@gPE|;X}3S3AQVIHfx_o2<VEl%mqBk0|BLp$dH& zDbxUVK~T;}$&xEloR!9wfRo9Djp?t%v>xHC11Bz zS35_^s4h{m6<&9Zl3cx`r1(&kb##=_oGEJc)F`3c^YNGqqvS_(7d`u1lzg*ZwMW-& zjgqi!s`Fn_LSYA0zY9@9<;z5;+S@2v=&u&4M5}0_oV}Fa(r8>?H(FZnQA1Jca!7r9 zGFs??8FeaJdYo4;QS!+dld5&@7@^|PYU}qgLc3bV$nI7#GNrvbiqh*IDqGJOp_wM} zhZv#AKB`Io7@@xA&43u8y#rO;*chSb6V&BtF+yd2Q8GP78kqBFvtL!nf*7GR3u7c@ z1;(~jJwfT@Hq~Q$jL-;pZwCAoBh+iB`g&K4P~|;p@xB%2iT6vC@8}+J@#|6Du)mW99olW2M$cwE;b{ zNBQlIl?1rDPu1KXE40KUABYv2bWnYDC|2n8Qx%yKE7UbhT&jFu#|hOo8&K+;M=e1q zPd=51(pr->f1FTn)A5@)p-#n=yLg6s*HI1a8ZXa#saAdBg^rsa z`o#;4f@S^Hh(Yl}(*~;+L*j9s`*^83PPIU3)*#>tY{ zf>5P;9Q(c~uAXG3}9Yg7gnKCy)sN6ht3#I4g^T{8n0 zCkSOtlkdT*ZC`vV6sZf;en{jUwgl?F3?-GQXy;oh*B?_%F&C(|d zbv0jSNEEu9Q5DRTD0IwRL1{{6<&`B-Xorc*mMC=0yeO0?6jfLyqQ@a?kwghLk?3qV z4>`Y4MbM;T>TKymp{ixn^74s7(G}H=phR5fE>YSAt2$AMLf4{IQVf0$)NG<=qa;ac zG)lwzs0%3V>#NfBOBC8*_M_ClzbZ5!QK+%WHZW1Bu(^m*nc=E6N(Dx!vM3!h8Ac@v zH8-QjV0>`J_>D`%?`;yLpQ$uHQOMt9pO7e&d6Mdb(w@mGd`hBF?62w)N_&!3nz@NW z>`p#1m<|hh$G^Z9M3guj=_Mmjy{JJPnsKH7#6{WCMsv$}xSF4Qc5{0U7QrrGY z6pA{iI--lA`y&-rC`qXHcj}Z+l2AEc)!UPV-v=j2d`s1)Rg%ymh#RGrq1)ht$uc@g z{9ufkfo2?&Bp*$^pOd7QIfK%lWAS+7)V+yGLX#$`T9cE6PEJu}rY6Zjcw!n&OAer6O($4!wrNkZjK zk$LzSR+um6CkZ_^gBBzSy*HZ|CJE(VtS+I{Y>8_9XOd8dbL#YkB%$l3-#-`|oPYi*6Lp(t5w{S>v@@K|G!_l|KGv-KN(A0z5oCK literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/5f00a5204e963cbb_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/5f00a5204e963cbb_0 new file mode 100644 index 0000000000000000000000000000000000000000..30ce06486d0947d2c9e87b1676f3bf21564644a2 GIT binary patch literal 35088 zcmW*T1z1~I*M{Mj1c(s`q|_l0+>^Sy>vX2BQ+IcFcXxN!sk^&Py`6fe?k>~*&-c%D z-9wVI&)RFPy`dyI!Be->@+@t?|L~Jk1TU+V+{YK?$eyia(PG6)G6)%;;>+$Bykv)eeZ;n#l5+zF+iE%bv zz|8-}`rm)Sp56cdbs+y=ibkcR%Xm~;%2P&~0F{;OIEMV?q`HVNFNIf-yf}c{SYAmq%@j&V|^g;FdkqboMxCZ3?$B55Gbqvu|! z*LBHN#7CR35BJfasEd2I*Lm;+uBE|ZG2P+1v>kvXHOpuL+Rc=dfCTE{rdW73QL?x}$4VOXw2VRKiUu{PWKbJqt7=eT?1#OYK`pTmU8)lUUFsM#rLjSs zn;7)5gFy)$4H|{%DAUQH{`k_F+g%LG+|{5s{OD#-!ycU5)1cYdgYaJD26JD7>f&LwP4azydppF9#+JT*e46+V3$b;=es0oH)1{J{`^dG_fkp}f1Wzg%f%!T^n$aR82 znrP5KET2TpI6T>)z$xU7PgBW#nnAg+3s=x_mO)Xo4azsypf&Rh%0Azqp_l~6LW2^Q z7?g3jL3dUdGC$>SGAzV+|(#W6+E{1~s|Mnj`-`a=C9%=p%zpVgF-;>ONzhmj*3* zWzdrM)bhcg2Z;GdZ$29ogko3&->>nSa zmKuyYX*4RmzfpgfjM|T(W}_zIzQrhq&8RRm4=}2Fpi%7*>M+WUDfo=C!A7;gcx=LD z>PBM%Bk$?84xzMvV+Js$aNKcTvw} z)OlDUjXLKxYGM?R!xLxJ=meuWC38E?sD~b-?s$#Ll+CC)IgNUU+qsPTkk_b`d`1n( zZ&ZVVMx8}cVWZw+Xc42<;$Nf`HEIlIp-(Y#EN;|2xJq&iVfg9oMQLm8urq7v$q zHR=(jlrzd!-l&ZTuVB=0q*gR4;WwiyqBdGrAy1U~opCt+hfy7?85LaJs0BEVE2v(> zsF^j5T84*MT+660wT;@@$f#%djLD6ey9qTmH>yz!qsFx~>LA|ZaciSYZH(%Vz;;H( zpbRdfWe1~OiFwHRsC6Szkib$Gl{IVP|_{$~m`Aj4GVz_V%Go^Djz*+xB`V^rq3Mm53NdBj*~ zRNNAyvaK|#6;7`*s_I(eZ!qe_CZk4dX3e%x<5r{AY&R--CpGM%PF%;xz3iubUu|>w>VVr<_s}5P zS4lCxawqs|cQ#+u&gHA(1$;Fg%?tW!4+<6X)v+SJ`m2nu%w>Jm36HV$cVDe*eHpFYo_;$WZZ11ax4&>g^S9Lr2s(x?s z>f@{Y{d`p!R|orQ#SmZJK&D~7+Bw`;*KvLX@kjY8a*VGQO{a#L`e*dh{!D%vp4Cr5VSZYLcHw^7ic`q!^3x0K zity9+NIw;g@lz#CkM&cgI6qZI$0R?EN5y16-AVJ)OI-H)$v20e7Uf5AKNYX!r#IF7 zbfAu(hBWb0u2wwOn(_Fpji2VX^V6peeoE=+rK`spF^4`LonME${>i(*6kv<=Ba{j?D2hWTj(zTwkI zKMfx5r?5%XgVWeC*-wk7`zgZ=KOIK$Y(E+2P$%l3@mxO*n(wC-xP!0-6Q*RtY$6J1Si`xItd;GfXr+If+ zgS&oO`N&TVUi&Hce|{Pxe~mKvYrWH7yWx}0UvbzDXQ;n+rAJ18wawzMKH>fvi7jxu zxQ)XY9qF$bID|AejJ5Dd@z*Il zN7+<=eZs&re{IAXkH7BXXm)=!%;~RhIGW2}pYsquufJ;N^H)rMf7K~OPUZd8q9Son zr;5KW4kWjc{%VD?qsR-6(VUN~GTV|Ii|wIUfC zWztbx!lP)D-s5Eq=f!d?&ZKoX8*kDr{75j#nrKq9B$K*eLb6Housy}3lBp)0$3K{q zX3~88?lGwW9A1;ca2nTfESpJ{vzxR&r%4}knG}_qeDS%6Nxu~}DX^GH%W)U!iktKY z{zkqMChaRpJs4Bkq?x!|hJ4Y#tVs{isT{Ylq`XOf6-?TSLwJH_6-`=I$)ryx_M1uj z@fH=TnA8I+QT%sm!fJfRwm(cNQO}vM)Y+t0xZi~wyO|Wz-K0#tnF9y=(x3h&r3^5s%0QFqW78ncAIxp6 zg>wjf7-o`jxJl_pn3Oikq}J$xFE}-tzKmggCYaQ2B70~u>oJx4SdKSvPB$q6XK;Cz zNmXZ)*Blc+PuM$iP1-Wwq@V>R&0S(r+%ozJ`wElFuQqA%7S>}cJ=|u}c&xyEjNNXM zVTVZ>aUS#bnbh!rN!{@0L6Z&~rr$?R>W$s#evEZI&iZ2iN%k}DVah3!hM!?yoMp~) zCKb8Bp14R4{${N&nY8B$J-@~nq+Mq{@E3O6q>s1QOSjph$ashKLp}7sCak|}(qXi} z$GYJ218RCmZ()1HIhcz5_=KweQUmmqTu>0rF&;0G<(WzG$nciEYB0;sXqF4H{$|a^ zJ(M$<^&UZ1v&x{Y%`8ixSqmIyJw@MOj)j;t8P;@WIWw5mJd;^p+{BAA>lZr2m=zvp z)>izHW>yaj#Y~S`{k>*o&SusaT+MFQN7Tt-*8JRN+47i`5e;!7uUR?rnbjISU@TzP z8&oK2mP(psM-%*w#-*4O$8ZTdN}DyZ47HRchYDuCKh1hqk=!bo)$2F2y8Ld|?^VsZ zS;MU1HO<a?q*fT0}StBmZPUxRePCr3z_@SS3K*>IsMGq(BG_F1I%hM(5zSZ zfmMUdDmvJ#lemfx=sJX)hMMKYBD_PhVP>5|_uW08k^b=!oV4PWt z$1@+!p#B8{PSb;SPpOBgYwL4V-D#IIKqUEVHiR z32M#e{v2{a&3R_cLFNU-z}|&s85U9NVzbu3vec}Kc!{CQ%*wvptRkp~$M}E)E6h5J z=V-H%Iaiq#y4tL~>&z;J#(0NWo7u}-h`o&(c9@lWC+i2}F0)FUq}QidA6!MZ)69<@ zsC$OK<2xptH7n@?eZFW`D!Tm5I$ScV_!YDM!LzIE7ZiI$y=d}`yq~kzUa+<=`CdW) zSA0*rG3zfJ#2w6gOP_EYw)dR>jXjHd_=#EH8UG)1nk}kov8W;XA=qkBI9B2kve_(3 zA81h&ir^SJ2U#>2pKvV1BD>R~%*c%+=$Ou;fq0J&p%#@$Z_%QR7M00t(OBfo%3O#G zx2O#q5f)X0)ooE_JczO=KH8#lm>Xl!DjY+FSc{BFj7JLoLXDgjEy-okMw~_M+!p!g zA!m%l+58rzD_~J13gILw7O|)mN|dx{3}#|0nwGMt6Ka*Q$giwLp_p5a`Ej+9MU^UB zR2Q9ov*-ZYR81)uLS0iI3U1gLXCOb4`mT)nd-t%!#e2TgM`E zU5hf}R72u6vS?Z}ixy))sx-H#KE}18w${|vhT71rtwmSx09o5vl&8H#CGiY-J6IIa zmmc@CXf*Qmw><~^>=!J+hJD1w_X8H) zI%rYXL*#bYq7^82#G;o-I7T0l zo$pz+`98HG=n?h&%Njkl=-U50v1rOu`t;1A{x8_)FD*)f^ELg#%y$-@f6qSu$o~Dz z{zK3gi|U~jj9)Dp@txd$us?q?#>cA02CF*afYGXRXyj+rX@9E*nyea!!zgOEDly0^ zm&2-LbjE%33ASo;daJf&U>u&JQAVrUV>!xXvGTg7RV%Yv6&Y#O8n;zDP$kMLbBtA? zXoiqDVxt@Winr<@@+Md{JJG5Yh)gC&{7kW`cB)m)VfR?I8h?1Lyl!OGSfpgPYH3bt z$z@f1ZmW*r31;NAs!~2H&lRmIS-`4E1+7|G$f}Wrt$KqGMXkzLoZL{XgjFX|yrfmt zF#wZs2v=Y#WmRT`mA0yCSz_TBE+M$QRU@DZ%#WcJt?E~aULk8`t1e>JZ&qEv;%ZiH z#E0ruHLYRQGQ335T2_sp$GAoG5Y-m5MoX+pTV_@6=W{V z^C^AAc6>vzXI4$b4GeiJUB`_7vD zuqtOJo62XlDI$wa%d*;J4!0@IWz%JJkFqH|#-^{aHl0Yc$)0ReX5=YmQ%77!{^B;3 zLI1KgwXA59tCCF>&>f3$7LHmrg<)qM&Z}$F0laHs(=Rk^YEv(`Ti8?^o6xcq=b=m+ zo2nsyTbm{#dpnz!cd+RvDtEN$duN-jb+M^HSDQLx0DQXH)U>ZnUE%6y)2D$p83)O*7fn{CtJIn)WyJexY8ACAr^ z_5z#Iqv%3v#JK-`U1ZZPoIt@P^cKfaeVI*Du^4NX+w=g1SCR+HuVM~NK<3pp#iQOD z)@CjBV%|EN?&1~FZ6Fp_V+USsq+gqC8j8s{yxAt-E!2vwIE;j?^bB3mV;lQpyG{S1 z$PU&RBXDvj_3WY^l-SLhU@DsIv1t)DV9;KAg;x7GcfU>94%n38AbmM(Qz48wLf$9n z;Yn&f#a>0r)5JPM-e+yPjY;Qhs(;?5%@Q;yr@eAlMfd+a~d#RU9|oDbNC4_SA#e?&k2rH455n7%w=kD$#{ zo2oox4?nl*2y(t49*VrQ>9VheL0s7Mvpte{X9H4X=0@OK@+qj2UxaH<+RDfcl0~8n&pt_ihg0b9>3(!m~ z!_NfbB?f3A7Ni6yr#C=*vIpoS^5h86R4l@`TmgETJ3yaMJ#T7LY0qRgQK-O9TT8?jZ1Jti+fJWnMivZQ^ z7@(~v(k+1JOaVHDa=ijnymx@Mz^8A3+6)TNw&4K^ni`<*3j&mJ5&c;lpt2Z*dzimA zK(Fxw?bZcoKN8jls1HscZbN`tZ4A&=G~OJbPTPpHot~i^{z3H}0Xn#wUhkovy#dO< zkG|}u*9SO$FhCOy5%X|>{Er0a1~wlLP}+$AoxyJ>$>|jRM4{6GiZ~OXp6GLyaR@(0 zKh6i}0~TKhkmq864r9mPi`YJc%*+5pl0ZTC&>FYK&5dEncmSS z%*Gr1M4R^k+KJ;R_8~wMF&~*e2B;A_;0lsH5erN43BI4{D~{lARQ$quSc}xJ^ajK6 z4n@8N$o8F>n1RRmh%P_K3zt#)KaOD;D*U7$cx154VYI6ycHyV5U3vWM8i5C>>TlOl zd`7Ct&hLYEWjEV31TRp?V%H4BS?$V!mRNv5n_acA3poPpnv4LuU8@7_3Jg&JVZC-(^=x?7%1Njj*dyq+Jcs&TZGfs1#+_c|1aVv|Y6^1e0Ry z+KvY(9BWrZ9JylwI>p;nG{LT?_=J0jRQ523*RCbm>}s3Cu5T!p zliRuNYLtiZdF|St&#t8Wc8$i=0(J!#wCi0VyKIH+x(weUcGX0#qQpYSVs>rBSEQD( z>mzoRw5xk5yPhLMX=;M84D;eYSj*a#4P7x98_L^t3s)=JDp1?5b%>~ASDCtYokm1GyM|!{9@e)j zq@i8=(5(^2v7s^R)5NaEP06o0wP7#PwPY^5ZDUt#Te~ixKs&q2VhOIdr~VGCT}Nu} zME#vvyHR$2SFvk6zQTVrdEyW>hIPbLTt%j_9K&(MjUz|gLxJ(+h0GJ|`hgM??V5$< z$TW%m;rKNAGTp8^@SS1TW*BDLm46m{9Nu}vMwR(?O~YN}UO+62!Tg2Pw8*YM7u!{T z3HdB#Pb{;`xq>-Y+SO*2UDt46wO#JDcBLU=9eW&(_3VGVMDzx`2H`k@HnNBC=O(-I zZl=#$>^k)qIc+0nn0C;2blgc_cag(xdcB9-_uAELKkI*p?~CK)kHshLs(yyOgLP+F zi_3OJq8xm#kPmj_+*QV1<9p{8bN)l#D0SP;YpZs}U=}XmHrCvwzj%cl_t-NykBX1! z3G{?{o-z-7p4(LrxnDBZD|+#oJ@Uq`oNw*w_ko`;AK5RTI3LYF+x5p6yLx|RE?oXb zJ>TiePre5fsDBNCs^A-_iKal^FbArMB~Xvi%oeE7fItlm3Dnqhff^qgsD9}Kbw5L( zx@8R1O#FlVnF7@mJMkRjGY4uv&cK=_kmn15`TfZWeZe^?18$5eK`VEG$%RcB1Y~&Wk3tG&J(EB*p7$DkdHX1pFdD@ z@UUQ@4i^g4%jSXlj>fG5)wXq@8ng*iK-)l7#UvbV7pOy>nHw#;2I?4UbPtrR2X*#j z{$AA8J5U4r2Flf+ng(zlzGB?KKqU^QheHF^V_2a67{Oe~H#$%`$MD$LKxG;i$oEg6 zmLq6`N8`D~?*LxI|ToIaljR0`hyO|CZsHTZU*&V~o6dR&m=>INwXGIR-2 zGzMV{4#3rwF=&kNZb3@IWeo2gq$z0JBS_29v1gF_A);51QZNL@-a&G}+b2lP&>5Zj z25AHKpnbm}^+EOi#DQ@jHm>Ga^XIBZHI|Ge-w${kR~l9?#>G zf^>FrkQPr1QuFCSIyxgrD`y31D+vA%~x|Mhezdq0N;4Rq+z zV2AEu)li2Lhx2t5HH>zs2+UcgQo- zp=Rie)kvMod3c9m^BnRnqK;kk3D5ESZu+sup$RyLq`eO1!B7<1$76?CuOkjM!76OS zzegQvcbs`oux6(m%67(~%4Z#_i<#${|AIp=QS+8V!|yuO=AJ{Q`wn$O&j&pAm_9#o zXwOs5edgf$8;7nxr%$igH?JK!`qrUYA6ZZI`oeg;K>M!_^?~i1gXeD!Jw&Ph96F0> zza09CKB2+dfuk^|57w~^!8)EXSeJ1obFdnQ2dia7u-ZokE7l#XXLuA9tliPUx)u|x zC9%O;A0MpcNx|Bm9IRQ{f;BgHu=eB$R=&K9%NMMh`GXZwFjxZ%F&CB;X0D>a8d@w^ z5ygWw0)ZuiwGOsY!TJ-2P^wI@W|s|CWJPj8@yfy4f*)A(d$3~u2-Zv-!0Q^p8d*D7 z+5QYxm43k*H9A7EcR!60u4*9V6vca9L1s2rjy*iQbFRyDq&eT@)xsTHDnwL_GpPKX>0Lv*K6hz>Lk(UYbjTG=c_@huqJGDKNhhbRFT z(5_909wNMLh{j?TT6YOyPlxE~fDm0DL7a&pYBn`QuhxcW?z#{iT_2*?c(El!Q?`ca z9ja~*(Pjkg2+<$df}%S^^Z=9ggs92h5E=J}Xbwsp2+?Rb4pR>H1I)){QnKn)Tbe; z|0+Z?a0=sIbN@|Ak z!eDVK2%9n0>eTFXPPIwz)CM%o{J8X}4Dr16E9dJ9*sr*UAN#lHvQ*XUa&CBN09SqFw)Mez)>C_V3&*N18yiUdE z;}|X@A-_|33ph0Zp@p1!hOtGQ@+hZ7+S`uvSpnb zjmUCNwMDP;PMyJs3QiTR=+r{gtmKrvvQw3+IJuV5skK#!jf&NrDqY*D>vfzeSl6lD z^_)tr@6?e7PIdp&soV{n@-`;lrcRwjvu4cS+^JzLoLV%@sl-uEO~glZnc&p>8N{3E zR9(D>W;s;?6EPo|XFIh89p}=2d_m!P+{Z_pTjJERb&TIYyd69S<4&jQ?`GZb24(j+ zwHgnRW3N+_kb9p~B{6ruQ{@kF9LoNHPwDg*-XOszRDan*wJk7IlO3UYjTTX% zT84LpLv^}nsFF&BDy>4OX8sbJ3>%04+%h9#l={vXO~jiKtXH&nw9 zhiVf(qwD2R1>XwQ^QWQ8^ej{jpNDD*cHkI1uS3%R_6~>r2=6(kD3L;bP$~ihpB3jFy$&1#B}(`E!rp*L87M@XI;rlwemf3b2J=Ob)7JwnbIVQP<+*gG>!-;p#c zO!u&GHfw}hbI1)D=kgem7l&!;k}xes_N8Gexs3erbaj|MA!aR)V+Uq#4AaQX)PPS2 z`-}D79;O;-iW4ZaCrpd>g=xlq&N~pMb7*srH9bUsQ2%h4S{w^gSNu2;rtk}4`U8LB z5{h3AQ|6oO2aLsW489enJ;;1JOmndbYwu78?%fO1m-}H#_b<6T4&(ZuFl~Rv_~&8r zc@ZY}YtBc{59Ez1AIa?#bAAoub?Go2`^i4}MV%4hYKqK};c`ZWt0ndzB|2OQ@!<;d zgsUB{AXCL~ovReC!@q^=$RFV{R1H_IYCK*&Ts>=sYfFQ0m1-ES>j-WXu6&Kd71tzO zKbwbZTkCMmZyT=q?ZTC}eYi$-2v=mMa5d{3t}|W2W$#7|H0lwqGCjlf4f}hC>vo@T zy}*xt;TqXLT;>7c@*NT`+wgFujR@y`q;L(I7_K)6niQ_AbHbGaP0<$zk$!Htk{2=; z4lN3oXGu8k<%DY(j^R5_pQNUX;aukxuH`6rBV2RbF8zQz+NCsHMrxc(ixOPwm*~=V zgeJRm0#`7%vP(BH?l+g_p;Z+Z*9p4R?01)Tp?6i6jMZIStKd>f4VNa=bZKlYm;S>) zwK-PTr4I0^=TZgCsP9s~KV6Dx=#rt4OWDvG{*7H)2WJzP%E8@~am`%1)ZC?7EnM0L zwREWv-omGqOG}ZpwM$(w316_VjZ5ocZR=7AOvPQiLgjYkhI8<5@6sqN?BLQJOzKDv zP^yzld(oh?OKousmocx4OHWa=8$Iam(siup;gY?lOIdKQmrIGgU21{@eHh=@rPbKe z-=$6i7>~|_>BSKGI@G016I>cLh5Dztv>E^6=nUe`Bu}iFMc$|}oA`5FYCqSdpm{Dm zLdrsyA{TKC*I`-g(g3_!N)MO0^bI3cliwQpw8^DvXpTvkk1J@nnV7hNpIcl?|CdYc zFbuI8U#5u)U5%Q@Sp)M#`J3{49ynckLw`GnF5xR&Eogx&{ zg*YhQErM%YiPt?s&R&e~9icLPB4q5#*nttMIXFV!hev4eV&bok&~+rPA-}Z|I)~-! zBILV1Le>otnvE5hurWgSaePyR%5RR)WZXpRmIzhb8lghlBh+JegjyeF-m?)JcY$-^ ze?3CY9!97$0v|cH`{;8e zQdiLCDr2ris`ryft$7*Azdey^@iS664Q>^~MNBcewHi0^6WM*;>I=7@TP6M7iZi*D zVs`5ldRyF@hybfwL-mqwO~A`iZv9=_t-Huj#;yD{-Rg>qwcNU1 zn>yfb?AE-dZvARTkJ>U%d$(E)bMw4~$A-H#Xasej^hmd=q7R0Ra?58dHBWNOGT*J@ zSg^p&`v7jOLD(X<7A|(H^=fKgOT2Y%1+S-P8=3cjTP;tyc|X&wx~J(oE+X3*H}CUP z<5{99ft&F&Z#QSdbe9Spd-J0~A{=9H2*K5}94P)N9wI7{6 zxK-~H{lcG$(g2?**$hz{jvB@&&Gd~@Hd7RrRP$Islzy{E=`CueM(G+l6phklSV~9n zK39|$U>{V5W9WN=sMsXcXl(yq5ip-AE5t!#hDG^O@ zU~ZIx=SL|V=@&$)^vWn*!SM}IGHi@egH2JYwwZVs_CH&r6u&J>6L!(peNoD|KT6Gx zM`oy4A#QF@LqXmN@ha1@hIN9hx$o{3V>*(lA&UGzG~`6zUrS}+YSV7?Hg zoPTp1OVIBUXw`Q` zt2GuOZ$z}FU@y1{&Y}Am0c)6q1IA64`6o^*-g3+2$h`wM!VRFFrBGLTpjn?y` z(XtlfF+9b|;?cTRGFq8RMa#E*v>MYn}GJHeziqwkEjiYt2TeP}%r}sUH**jWQ z2GP5roI5gF)5b=t>G)`snZ`Ub8M8WCOEG*cIqi#9p_|P2iaMfV^rK#kYSxcYGknM4 z1~F>+XN=y#w_%Jt_!Aot-Y7(PkW7Gzp5#A(5)o~xWn#SmP#~8(QiqW9XJl-Wn zMTf_zH?EB!)~Fb@#avuQu^BNMfb274R2(M|J3B^Ub7J@`O^hbs=G+*So)@DLIE38` zV{{VT7sV)KNetKG$7tn>7`;Z^`WOxVD@J>ed0UJ!Y>!bi%HYgS>ev;d$-86pVo!{6 z?j=VQI1r<$7<4#B`_cIbF%Wl@JnF%+hRl~^cuzP+y|4wrS7USsFA#k#Mh~yYXu*vb)w#)hw_7OOvo$7=t`Sbal{(XmP$6RZ5#io#=K^&UUQ#j5@ISY@6VtMZd#wHNiK z#%eYyO^a21JVenMv3iMeb7T1#9Lw{OSp7o4npkDuM7+(6#YQ-`#Oik}!&!WV|6j2x zgu$4I%3EW#4L@Mn#%*NT9;+>T&&jN()n0^pNrKT6uQLRFkg;U#w)RE zd^J`bk#a3o%Te)qtQuhgvfPN(GgP@5tG`kCR;>CV?4MY5L*(sPt-)1vzC-Ws#_BZu z?-BQYtp3G!%y>XfID@c<1Awl-GRkn5kKKe8jofIPH&*)1!nqSqsLg1Qr%zTw%_`@?vqihe9RdWGfk` zjOdOlcwRP63FYE+3op>AJn<^TX-UO6ZNjL^Z2u?Ks}IiPOJz;xwsl zoaW;Lw$+PM&jxYY(~NnV$EiI0Tg1uOGLGl>aa!CqPQ}~B$VVmUi8m%rch<+L?B+P_M71q(`gt;r>)Yb=8o#jkbe#S;AEzCtbBUgy!sR&C zg|5V@8?xS@KE&N(jz@7ifHUdi`3y_V7~+vMF%Xwb(sAVloy?_6jxw3C8!YE zVjj-I*PNjIXpg1141Y_43Zgew;}#s&1QkICtV2Uvf;!?es@fA&A}~QuLlg7~;pr3P z&YU0*CgEd5g3=-rG{&8v=}`%4lEAr`o-0Al+zG0PRe7j8Z-U0*5ZV<;&`@M6n4s54 zSBN|cCn$Z91a&T&ptxcQ%7NA;6SNX_OC_ic-l1|C@-IuTD$tj03F?n*+Y?j_#}TuW zIC~N_yUBPZJb|>dzAN4Xd8h*Ov+U{S|BQnsX5ShJ4>9 zDCaxk;v5X`6ZH6Vf+D{p@OvFS`Iew6=!z}B67&k?eG--3kf(Zx{HG5MAbcyN(pA3n5fryNW8iAgf6Zu><L6M3GRsDSK=YMCQZu{p^P4bUe)xu9)NS zV50skl&IvwiOPp<_=es^5_O_fqV`ls)OW0_n5ezzTq#k3brMwpzYtV6QB(1*9`)2G z*A|JIj5jS4c?~g9n{WjUW+ZARKFv(jqFISrkLcNnnt{KTCF=b4M6R_>)U-W`x`g3- z6Ez)S`{>VpYB-RngQpXvGl|-aL+EifQNxh#Jo(@(j$WYtzsc)nq8{DhvAc;HcP~-p zA5r6D)(54ZkptG_{_{lTdXcCNuM!phI#Ef8{GO=bAKXWlUx{iDw@;G(gwv3uD7cJC zN^vBq6Ncg%qJxu^4I42yBuO`r5Hd#W;@lQ2He0L0^osTo8m1&^ zEq0+;YLa}@lGGTtklmBSd-_TG0=qX!`A{0;aTl*JEL)Pc;9&M770!{Qy|Cm=QWvbj z->8u*NpmnHPm)6OC8>4(B>jb^1(H;tAn{PXP?GK-uyB$(<13mLp?8>5G)eyzOH!fY z;lZfk_q;y^A$G{}b#kWC8x;KQnQDJP7>WoiP)=5dKJ%#+H zB`N=Oj^QVE&PdX}c|48{^OLk6r54cpg-PnUC`qSxaeObwv0)#_QEETO4SU3EGiRY8l>eA<6oJRzs8d8(+yP zH!@jIM<;9axMbdIOxCpt$!an!Sy|^NtH;7*#V<-$$pgvik6Qt z$@=|aGS~HU9FdQcRR`Oj(1WMRT7$RW$mu)dko8Bhs$=ti$r|x9SyN#)rKlK=m{W8S zeXS`PYERK5_+?DdSOjKDQC+;qoTBMjQuH`HMUk!)^@~VRzQ`1nMr-79r|33j$E4^w z#>A#*4r<4xs7dY=ZO0Lm&Xc0<2rocf1Qkq?3rk@roWj2^DSBBxMR65UG^8T=RZ3B1 zjBA*p)9BwQMdK0LI7OYBq-bZ;6s~hj(OOvhrDz{c!_+@T%W-2wiqeftQO8j!3LBlG zL=2prqFu;1H$|6mA6e$5Xv)GAWmuG=LCbg?<5r~TpOq{O-VBFfB3)iC6po2s(NF^?PdnZ-4yQ$iW2KQ1GcRy8&o|4Bi^022Ve_)!*;5~{s z()b%(X?hx*rpf8k^ahPGrs+YZH092mrV@CK>{1S&C>K544dm$?1XGJ3U$Tf`4e(}79kKRHc{(QHbZ z2F*xQ)tPB(f(*0LRC`XEdM!!QI80lcrXK6lG!&i#95)3JNpf6M(3X_|x5AJa4g=dk{Bnr8ZV(SqF9_>lsyhM*iFoQICGW zQp}?*c#H6o9(6*0B$o21dub1Um&Bua<%nI`qjOa}s`-aU`Ko!e9=p-Jx<^H8dQ=$= zaTJ?tdGw@?M`P=GG`<0I{OM7896(4zkIG^}6Y^{0(PS(@`L^_>9kq1u@H>r1bNhOD zU647^b{st%&m5>efgERgxOUB>sxZy==<7U>PR;k|CdMuB=+k2Qy~Lwy=(E(LsO27g zgx?Ae*LTx{bshz5_Ne$V&cjDEJ3&o&c8OkG_2?&7Uh}B_b&pQoroZ<*O83d5R_G4* zXO9|v@#xZ5k6!=q=*>@hgcZN2L0&n1ysGKvRipG?HO%1UbNOCg$M*7he6KcS^6E|& zukyRRnuvKQ8{yTcNH2ej#>;1=yu8lr)dG}{^J)aDC3}@U&8s4Kj+P#;=6b!Vl-;Yr zxxIQ?(5v2siC@yI8+eRKrM&u7+AH5OUZqEGv?%M<=!#xFLG8+3`Bm}q_qTW)&fmSN zffIjtb+a0CSEmLTYcQs!SL17Wb+)!wJL-EC)0}znv4vN&T6y&b|6xUIVz(i7JFikZ zG8g{q9OK|5sXNu9mC3h6_f0mQ+7STWG6gu$FQ#H$x0ylODg zt2W3miW*0IwRntI_s4qmY`j-zCU_Mwk$zwms!j50&1A3cPVve$je2JA_$;q}%<<~t zT(4Hn^J>6+YF)tbRbI7S?bWn3UVT{WmDYRJdV^P&H!^k;u{V2F`7e%b^=jB|uWs-4 z^7oeL`$4aMJLFZz!>rE{*6f&9Sx&Nsr-*rm^*!fR{6()SUZPi*so^R$U8CL`Ud7_V z|J8ICP)=Q6yvKjI6e!T*P_(!Pj|>yf4J4VF%%GD5TCBLXIE6pO-6^i6SSeZxE$-Ih z#jQBS-QJhC-s@VQ6>@XWIeYJuOe6Q63)i`7>UF-FUR|iBN0+PV_nXy}^Hw#r#2g&P zSvYTVA1jb>r<%Iq2yAz&=@gz}*}ZD2dY{<-tEPW3CXI>D_9i7@D>9@vaSpCYLvxul z4T-r;YJp?O|G7!SP_w8>9;lc}IWY)(i<@{KWzvN5CM`f}1(Q190!mggX(IYpH)$+< zHB4%Z{rI$&Ndqt@&ZIeLT+gJo_ySoeB zIJ=X>w@7L5+>VI`K4>wTYK^+A!0*8?MVI9@S5NyUHlz&u5 zEintnk@ayM#iJ)y;4Vr(siO#{;4soXt)sf=iY2&${Lktr8P)34m8EW7HL=xIc004YxQp5C%{qs%9T*>uj%K|? ztxjg$#w)DvY*wxwjE%HC&B~4Gc=oMXYrZpU_b9W{jW+Weh*^8kV2oKmk2S0HIJ2%T zHmk@Iv-1a&0b~7+&BTbU=(@$MEZfK%zaZ^)v##$jtL{#- z&STOpv*LGCy8~twK4{iaTtcfuX6-m^R^Ov$jX=-8&8l+Dtb-@adial7#m}1c1FoE> z1{cgKb;-=S17`KVL+#M%u9;(<%u0Wc`M7W9H$St^VEO~I_C7JI*Hg3dJu_=Gias~1 z@k=x3l~A`=W=(y|{G_p{KTK&YEGKP|E1gB%(p&U4n?<##JEgVg>C`*z>t-}^slj*COMP^J(wI~v?s2wKYe$1jW%`F}1hHyhHKM^o_?z(}V4p z*W04AsNL71JpC*x0Rx-*lk))f8*WiOJVx3P77fS0BgtX3MXi=wG#77Iknc*1CL_Zt zi!AFc>WO0;EL!lJMZe%U=4@kLc3L=Y-J<%tEy}vjq5=CY+IQF@=P`>K9JlDo3FhK7 z`{LC<7EM2E;dd^J{<><>mv_k(b20k9MTgQ_RVQdTuWo^n?GS>CD+ZmX6d;<0j!x>Zk*;Ik@+ zVb#h+tL|b>l2xlvBW%@#WUHE{Fm5YifVquTH}C`v+FE)4VdWegt4egTYRI=%HTjNy zhg$U$(hs+42ae)7Hjbd*kyd`kwCc-gR>iPox>aLlSoI_R#P-=%eZZPIw1sc3Rg33Y zb$vd0Z?~%V4y)$vv?}cttK#tl>8@He0ynN%HSxMtardq2hbsSBRS&yS;-OWSk@tgD z$zY{J<-=^ePGi%Ov^JH`Xj5Ah%4Aao{E8e|Y%EJ<(_MU;)uszMZF-i+rYd=D8lBIk zI{9sKRfG+V6$l%B5^i##1kaM+w>M$?KT}j zMu$ynQQU7+47uyuR02zpAwXP6n`Dy}Gr~3nlWl5-LFkY||A;iCe>_1#WAbQXQ|1mf z{e`R@ZEDlWrox?VDu)oNb+M^4N_4f!gx`>-J2~Jf8uqYh>JXbwVAu~fO@ni&P5(@0 z|7kX*naQ@fHf^16(>ttQVAD2u7TP%eoiP^M^z#avZsNz4#E7b^Y#Q^6O?6k>v~Lr6 z|8CPJ>_=#`O)Iw8)Z!1~!d@KSYg7GwHZ{hmC*=2>JYJB;OXlwtH7OIP*65DEFsE#s z-s7)wak`Aw<>U0Q0^88KVw~3EH9o5pr{d^?=V(?XPGhRZan4Je{=}_naoTKRTlF~2 zhOb7P8lsvxPK$BE8mH@ciuATPeU4J70T+_d5il?BS{ScwMeJ%+)UN-E*;(J)&UbTmt;E%`cI_;0 z*Uy#hDp$*{O7-n(k1rb78Q-pZSdna(BgL*c7~a&bJ?P!ct`Vr0YFB}l^o^{o>?(*W zSku9-j2-Pt--)((h76q<2SvNs6+zCfb``@en7i3|A7@vqK6Y)wioSL}o7nkX*{*7X z?TW*dVYD4?*D+kh&m-*oZLzDxXuJNv0o)yHSL1PZ^_y;$mN+`2QmJQT}LqJtz8pP^POGGVSR6xH?2d1MR&}=se%q2FT#FbIMf;0iaJyjfscwg zbRSzwJM=FS$~g4AtV12jIW!T6;Vtjb2|U3URoRXYxKfRNsykR~+@S$jRflnqwyr}p zP|@O05>C`3ws>O0LHO`=)` z@_e;xVArNT zD<OyU&a@TPxlf|jxXp6Kq+9U3xIHxWmgWai$ zaKYnns+5yBeNIhDcIw9zr?#O&L#J$L^HC%EZ0uAjsyB1$Ph3ak=1wK!CRTmz)EUIL zb!uWKr+&l1ZcaT$*6vP~fEkDJ0vP3p@o+Y|eD9NSnn2owAF2%4BSCFf*OSN&esY}_KximlK(q4@J%Efg= zT&mX2rAA2G(WQzw+|8xTy<9S($N-m|`0sm{@(*JB4=z>4(P1vVf_aon&G8$qqVQOk z9QYBtFlmB||GyH$M3*dRH<@vfa|&%yW`;`vEXGk}oJ9<{GRLJ)=DIXukxRcI(_-Sp z)Sq11f;P)snt-{hUD}Nzzq;hb-nA|rSWi8#x>N<88!mOgQ)IkJJwLkT(qFLMcJbYl zOL^|OI9AD}2zp{M{y@$b^bPk*m#V*V=_Jgr$rsB$xRi#Oew)dy1^L`6P}r>i+G8|U z;~1VJPZ77QXoh~6iQjP+d||D!NI(xv#}3>>%L;CdMWf1Y4Z^D$Zk4R*R*pJu)xjg1 zTZQ7>>gaXrn$N9vez)97Zgs|#rfz+b>ej@FTVKT7TGHID#IM{+-_othSlYqO=MA^k zbau<$)y?@~ZXNj6t%qp!om;)I;GY}J4{+g`Tj`#&9rhP)-Z!%iMP4y~*qX+ptT{cZ z3U?ll+T%)ok6xg70TlFTJ8l&6Xm$~gE`0QbNBxU>Sf|UwcZocXxrRr-;@n4mkNVd4 zC{uz*yHe=4u}9N!8kw7W`1|Wo>y{pkMw)gWmBHOE9_8xl(b*mzF0$rP2MoZ{kG}P= zHo8aa@us&&9s7DXkJzI+{X9y*-*_>=qbvhG+Vek;&LH0qkE&oO&Y{*19(5h+(MsGO z=25c|9u2}~^cltNXpdfF!&r~HP4cM4H1fhlWSH(z5d<&~+i)38W_T3;qlfPXJ=!~u z+~#{&*ONLe;IV}s*?#h{ey2ypmU{Fat(JK>?$#pMqluWbhJDw1RB63O zVf4ZA-#ps#yGK{iaI;6luxl%|Lb`1p6+(5?$Bmuzy^H%eg-g4Mdk^toJ`R4gm-*f2 z;e1q&9wW;^kJ_Q_A&+`u@L`Xxp}|p)9%9H}9xcNIyv4I)9&J7D(ZCbrc#<}!JerAj z$bH%)>qloiIuFNL`o$OLX^XEfvOng2bjhQ7m)VXv*T@OEuX|J!mHs9E8;pO`qtbUg z`sThzuh9B|hx5KXe1}R7kNEdv4{Hi~bO!~WdQ=+?@!d0GMA7HOf@TRk^n z*X_f%UhPG_@4OoEgI5QKdo^r~mtz9FnmygC$=kfzx`RA+dbQ+$S5r?C<0<+)<5kJ? z)c%53IWAKN47Qi!@Pu1%A`2EBuZ@f>pFw5>! ziqogUE}#63eR4MOsaz|cZg=(RITm*FDPMP=qCI^o^{r1Y`uLQ-uTS?7>gUs|{yw!F z;8UaTeY!Eorzgn&Kc7b89KIalQ%77yvmbogid;i|YJ!D$4*M{lhF~vJhx>F2pO5fq zE>pYH<|N1zO zmipfCX#oC1m76}!TlVQ!e0|HOdHCu!ZSVNB2YK&O!v{X~e9B|be7cF$=fsRV=Ff0FJS0pK|>P?8TziUq4Y%z zO+)D~3~fZSqK2{*Gjs{z5{8!I5%!g&zf!~rR~ce2YiLP%gWswQew#Ant7GV^x`uXP zgUjIi1M>G7>WssvXc!uc`v~|Atw6T=hC1R1RyQzIH9+hkLroG4Jwg2>L#bgyXW&XU z_$+BCcZ#7zJiEDVh_r+VIJ`}Dz-H=2bI4u^ar}OqYlW` zo|urX1LNW6j)sDr49&ncoa$`oi!RI!P9aSj$X3UdFCSYi5snvXE_0*gm7FQcdvZll6zLtStdgT}BAR*$7l;|wjp1!z3CxPwg- z3~ire@EMCbPoZ{5nrdh->P%z)rc00P{r4CuzmL}!mh5M~4loWb9yFBk zkfBjXf7sA~qr{KjkMsJ)CnuTb)5Lk!P|b6O&Yw5*^oG|RzIn^* zESsOTiv22>-LEG2I)`5)^ZI4a=hrAKDCAe3;(paE>DNoND&<$&Fa3&@@oRrMziOBF zYadQk@GHKeUw`9FCBK?h@oN~4Vpml^*Q%f|{DKF_S>3PJ$X?Sg51!QV%Uaj3%4Qyi z-|E)}l&~>2+G7Zwqd=TrrO_Sh?0!AQ2Q+c`br621Uw@*Si?LDJ!@k&vH*k3U8jd4K z>!W|P#bVq-QG>oP34bAvpL{R|JMj+Y`hIoADqKVU27cAY5bVJl)Cn*yHsU?ZK|j}5 z@M|sZpzwhljxTP-S87GAa{~qF7(5C+((J9UyU#ZJMa`0lj$3? zaSWMK{Ia1N7U2>KHT0_?#$q>Kp=u*)fw?%2?2Y~MVK6q~2`V@7a~z>x%W)f}no=)} z!!A5W)nDA(A4TA>@(qS&~ACSecKj}K@g_98GLpk)&S8aRpe z_#5wVa#}!Drw7!1W!7A|qE9scE~s@F**mC1eYouxWR0kx?&8z_v>Omq)qz1> z!xQxWKB!ZJf*L$Hs0kB;I*P%Qf|`i@lgVvLP{pSb*V>?7W97P_{(y6RQ1dnf)nH># zzZ?(hKIWYWYBg$|3~JIT;yWEw_NzhF$9v?s7Sv=sx*pV$e}k;+64WZRxE)ki6uA@B z&BsCg_%x^?&w~oSWZNrpe@(kLLCty_D(x?VA)la)f+TREhKRYRIuEu^ugknYwD z>F-)0?W!Hp<~sCQH>5(AkZxnUmA>pD#XCc~;|l4$C#0XeA)WSxG~Wp65+?dXT7a_k zL;9gXi0i+HR0IQ&uYX7>$UGpV{Fs9`14A0{eMpn=4D)Bw4<^o{AC#RTs+6~??u z9d3q{;Z}(AEJE6c;O&r>-wCPFUGjbq(g&=07~*XOJ_%{WOWLB(tB^(_ z=j)I9Qs$XO09F`ZPfe zu^o<_3CfZyK@U+kFDr!ROVC^_QKBlQNmN}#us2-?0k%1#YS)52YO}QM_IxN4! zI9J0O`z)+kuflS_4y)6fuyVf*D~K5wn;}{AKS|bA{F*IU?OP`6C|={#(qxTW#w{K# zPgc7X$=ZVatCJO8lg#=n$*R3ESsQS0XR>U&k`=+l-N~x8Cs|7{XK%75>`T^X`;+zJ zVX_h)C96x86y^IoMRl+No${n;3G(DiQ50*CHGhh}Lx(R?)Uia00wq(_zjTTQC8nrn zw-otCr)d4c6s_KyqMaDDpFR$y$aF15bJS4H(lk_Wysp(ynT&?Av}>sRTN-lh!c;A4 zovPg(QZ=|ss-E;rRjb~qI)ZQerfN8T?w6{e15-8S`&7=^OI5Wo++ybVRF#;Js@juN zHG4{`T+>rIcOg|PW~S=jS*g0cfqpio>gc9a{r-EZvi^}OJH~8H)z)pP>a{mjg-)dE z^3_!R^f*;>pQLiGRjM|ni^!cmqS~1vx`d%QBC7vsME~WCC|9lsuTLKPGNRM&h<@}$ zG%*m-$zBmv9~e>2?<4YK;EagQ&yJ|zoQMwN0w&FksQkQ$uHgyZ&5y{mi2iX20~SY= zeHr(0Yi&f(>!Ae-lyXbWyED^Yl@5!RHyGI-fDBf|;T^j0>2Q zIVw|@sJ0>{8{6@;P*jP9ql)4PvKEQTi3H5TY2^GOsv?M$i0WjSsH&BXYFUM-k}5@6 zCn2hDoKe+HjOtPn`-G#a)s(hSEUFP0(mSd%*xe_}I{8s;z#jDL7geGDQ8huf0Z|pk zS(N=Ds@5nlG^%nqj10r0YJm|W$pyACQT0XTu~Ee#`?x6A6N{=hc211SKPk$26H%SR z&N)$~nH%L=#8K@+pLtP@n;&H^qdK;L{1&ngj^oEgQ8io<)ns^AM%4&ku8Jz-x~OXW z7UddS)N5Z<9k3YP?y+B?nCcXd>6j&^^41uiGh#|@8B?29F)c#M@R)wa7Q9845i!{? z64Q}!WK8c+e^g98aRO^c)7O}oZjFy=!i1P=PmJ*%H>R?aW7>xYXgnpRK{x@+)EL)G zi)k57;wth^i>VP>VF$`hkI6iPZP+(6#&s!UDl!}MVp@(*=f`v(0~f^f2AdYflz(wd z=g@pfOs&_()c#aV$Irxc8GZkW=_u|X&Dof$!iMR1iHzrBs(C)fwclepW6wU#-TC#? zG?KF4d3l7{nibCdT59392kRaW9~=GquqPFs59+YL%`cY!-!9$% JZ}9(a{}1%^SzQ1C literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/6075af960f008f21_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/6075af960f008f21_0 new file mode 100644 index 0000000000000000000000000000000000000000..52e367439a32d2477b7971b050d705ff8d600ce2 GIT binary patch literal 18392 zcmY-1cX*TK8~6Wro1{s~Y-u_`R-vUyvy<+mW$(Qem7yTW5|NFH2q=5+DIl^01Vm*c zQ`s9tP?>`4J@xr~f4}4T966fR>hYSsOmE)#-X^vGyfOse}CGXU;qEzCg{KZ2)HEuB4Mx0GQwH0s)*Y%%?y7Q zha)9nYY=|U21~BS%jpp0RELr^pmSqb)dWg6g&(C_Ge~Z(+NHL<-%4}jt9PMe54a=6 zdV{T>=Jwaz0gyEazWW%Sd;*<5g>Ik0+M!V8bBG@SZ+-z?B=bvHCU-`{+oPbX)Ef=0 zC1(uOluqNIw+tE&U&@OKiZ>b7uZ7rk;9L*uzK89ya04vatTk_i&2m8Uwt@L)NR(r8 zQJU?9UAy3m6%iv2eR%%^_RnixURf%TmF@vH{jJjQ1qt8%NeP23+CO1)zak-43Hag@IG9S84qBoBt3-t zkHGL4w#Y%re*znx>iHy}J%fo7`5fMR0sY1Q5~|8N=@=P7U-23us4U;fKw|`>rG_bj z7P3c1nIo7jEi4gqlv9!y9YKAGDilGyd@1FNM&Os5@=|&fi{Pyo-AY<)1lh7&ViO~% zAm`BF9>E`u2pXkF@TP2#?#>7* zdLuZN6+uFF1a)MLoRcy+dMs0AdVT~4t41)sS_JK?N03+}g12j`Zt>TS;E2T6jbONR zt{1_o`Vo|F5W(Jts;zMZgJq=bY#xENWd!|Y_S+Hs)mAmPkKp4D>X}>;`@0d$l=Yn= zc=28YT{}l`p-TiQT@|aldN?J5$x|aROw-!tMR0b$>Rb@PhhIhT)4~W^E{wu5ylfIluV#^yZyw1Kx!EF;HZ3FREH`CRt4R8{jwI@J<$EKNq;`?)>k!F(`S6`c zhINc&Wamf52Bk_!nBqZ-nh$LZRByUZMiwL~$$iR7E5k=$Aq$vfXg^2b^o`yrAO zTO;{P*6oO7;qFK>_e3&CzLih);=FrbB*9-IsUssL>xg=BRCS$E+$YNMRC%8%mV7Iv zUn%~-k(4zWXj$06oFWDa6*X|Kn1OM{4a}1wF$S8&8rUhLN*I_eE#eGxl+#isUSs8M zf`N!c1Dj;Ogp&*mD{0`NWRx{fQz&PkxD1tF${WZ@Hn6vXfip6xqJf1Hmtvqzs$xj8 zeli8*mb{Xleghi<22z6t-pw@7M?6^u3gkO^nr)zSj)9*-27Z-cVFObnD&IhZ0s~uQ zaTNpKOV6qXK9zftUERP^`K*@ekovU^yeWsoR@cCSdIqXBH_%*)w$Peof}Cz?U|VYg z*0u&p$_cqFE!!EG+g`ovpgCRCv-cHWZg(}XubX1@Fp$tk>;6=ahv@N81NT2yZIcW* zCmZ;1ih&nX4SY32{gc(R4SH^e>fn{=Mxq-J=7};F8F(N$542{w%DQe_aF(aSE81cm#sUmCSaS5ZIYeve(8yS{lNm1BXry_Tkyp|&+el)Lku;eu=W~tJ&ok1anvrdFjJWC=>0M8;WMV@j znT?Fhk&BIu+>y3Tj1+FFxXq00klHPcdc80*@J%C0ZyDJo(QSBS*#A)yRk4j5PYd$QJpamyscIM>2XFSuF4L(fTFOPdyRiU?ZQ(S3``H z`OL^q(ru`b!Savzh8cM=+^F|4Mxw@RZ4-=ak|R=dqLJfsjm(&5iynG%MCgwcYZLkag&h}n~m&|Q&MA# zkf;ceDf+_5$MWWXM(#^?go&aS6CV{Z>G@*fjQlOFikX;O+(h9R z6IUvk7@20`u-!!KbQ2A{CVr6jeI^FVb@2pD%#)QeDaS`>BThCMHO=0VbNs&te&*+;V!bVox@4Od3ux zF=eVrKbK7;%F^j30$-c>Rf>OO;!F8C>k`o!lQrRN^$!=p5^-NJrjEd45 z_9$#})Dp#ER}>$*qqrwo-YAyHCNcP;sFfMT_UtGM-~FDB9&k5t|>yaM@oF zMQ-INd{v`}suo54>QTHdMQcPcR*u(HLS5ye7j z&|33ekD})rQ7mf{#T)ISIMF_e!5yObTiowP@khrfQr?Tg+9isY0~L3$V#wHG$}?P# zM?`V?izpl;qnIfz=0q`jZWPh;q9`j37DTb`rzoCpjKaJrisjOMvwE;y{rEYGVX}Nr z6nFPV(RQEKy+4X32h;;ODIE_*k$fkLE_b8oD>uYv9+(Vsv9EC?-dlE%wS@krE z($BQ+7g5}N8AY2{Q5=XgQ^jEB3!|CGVl|s-WHGZ<))g@mRn$!VVrB*uH*-)*#F{B5 zjuK|RlP7Uz{wQVURRuF|R5Y_7#Z0kOGt(;Rn5;=Nvt2xPGkqLpE=!J6M z0yAAJn+ex3Gea)aHPfJ;nM)1L>}X`Ba$_^QrBG8dds~?~A;VrbQ?ZR1pDdBsH_fzu zOXp=zdo$%bn0fCVGoN)bb4AiSt44|LVJ4%enL!_z+4qr|#(mU-zGh7Q%#@Vn{mnQ> zoB42znZM+*#Edm_Ym%95Q_LLrM!A+Lu1u5t%gubWS?iU8t!66iHuKLVGrcdH`RR(8 zw5wW|d@gfum}&lx>bR->yJe<~yd~c}G*kMKdi+>DmTTgFqMXmnbbD@Q?F+5vrI}2b z_{z+@2n)YU-AD@)3>I8Q3k6XYM$1vNg)7k(e1$CZD{LXYsD%!)w3vm2;uig$W?_ez zOIWC7voKlC##=a;V4+;1g-%Hp(q6MLO@1$J;j=Op7M8W}N~)E&uvXqpweXMl(kv{H z*XvnWB@gRcc&CAd59Av;&`_}&DQ9B~=Vf?P3%^RkW)_yq-R2hBwy^N&8y1dB(wi2( z6jNIZtz}+23q{&n__mXUi1$=)XA2wTqYo`?m#B{{^pOF5EVSxtA-bPMduU;#9PV!+ ze}F}=|H?1xMp$U^g$2u(782zPIXKcnXq1H}(oG_#sy3N2&BC4O7V>6j{WDdk)SPW$ zkzAjn+U8pD&$sZ2>{?*Kw$MU*`DT%YCyOm~{My2bC935c3m%!i(n5`O7Jihj>n#kD z8{*wyVZN-FiCZl6-=UhM#7+xCC1sb^B8PWtZ}(dmf5O5|@t?BrmE8Hw!dvIGpJG05 zp|8xoq<&o0JUJm{uUR-FX@9G4vhlhF`wa`FZfU%1zHK3VSG~Wdy|{1TkX({~rO*Ql zsgEptEv24VSRzB7Svd7vd;dapztn#Ir`TBO5n*MJ{3cnERz5aZ86|h5tI^7LCM%sR zRu&brVl8f^QH+(Xa$Ii93po>OC9{N;!Eshb%5nM3W@T@@mBxuyuDxa@P}<6XGFJYU z(`BtxC}*WhdCip}$;vO~Dq0yYbL0E?8M?D=jBlStrjXY0WdO zypn3O6-y%KTj?(A7Fe0S&`PgGR*J4w9rEis)v?~n?(eM>`ayNd)*r3h`bm4SNwLJT zPyLcRzgT(uS1Tv>TPb-^dnohd_#yS-l$9m&huk@1CI6h2hVs$xR(_ISB<{SGiqheN zm2YM8A9}vXI;r!gl_|3FFDp;vXPa`mPv8?u}vSz8DTl&Mz_a-XFtO z`Q|_j4-UmJ|7Z-AkH@g&L=5-DelmvLf5cGy&loJ1VrV9TD=`eX9>b~|F+7uB{)wUJ ztr%XH_}ek`y&uC4Y4tFMPadh>Co$}ku1{l_WQgUwERBw3XrWjRO1;9dEGQDoKXSfk ztbQiM(m{5{#L_P=mY>B^DwfIpV!0q+e5>Q%>$t>hjAf&kHtC!+-5bkXS#?D5&ndpF z`8$?oH)EM6L+@(dgIJ0@jOFgDSf&*z!Cz9kQVAN$*{UU|Sgi!LyO*H*z!Ll@KMgHG zsp%!?B>rV3n7gI~e@n%ECHUlI34W0a*GjPAdI=(KlwiQ^5)6A$g2VFtza?1tUkRSb zJH)XyG7hUDj(?1C{A-G%byOUS#B7eEy{wcHmN;Uf<9Jhw71Q|GIGW2qTO92Y<5(f~ zl5q?!6-RoxIQq)z)Hu30;#e>B)8p9hk0U-1$Gx05Lb-8V$&2G;ejJ~+h~rl&{dOFi zI>Zt6P8?@tapySh$Xk8lsMI%(BK_j<4v1rr{3(kED%K~8^=TZVhr|&%RAc4a&*SJd zERM}GZFn4MU&hf}@+Zgf#N%Cl1B&+rv0g9>tOP zJdVl##&JO!VdGb^Mc7zmu+iCMW1VE0ZS=R;*ePzSjYmaoR4!&?LU9|#V{EjManTEmgEE*Yh`6QjZ3p}JKd)Dr8e?hHcEPI6!O~`nrY*pjL5R_ zZLW={vL(+(5wbd}jXY}D*&W1=+wz(!JU8}G`NJ~l26wBZ_LqunPqS`4wVK%zgharSc? z6^GeaEwe}3xGH~*w&}|a#g=1}ZH!)E(F7LA8*==LTUK{`JSIi@-TgFJOlQt&F zukzJzHf~DAb2fgzXrt04_3g5Hd)r1wnRUm;{f9Oxys**F5U-EA;(0C^MdBGE-xiH$ zaY8(IWK2>#OJ0lTp4dyrb2KHM*HYuTTqz!lC!S`q(;v^cKs;wN%8z9d^!_}7Tk@=20yz~D^c_k9(<>&hH6;OSY64YcnJa;Z^0q&L!NCN5Zj-=y z`7M;dfT{`Xk`>hxcwAfK>m)#v1YWgB(C2muylj&|&yERflpUQDXwyA`B{Kg5)zd41 zCNff5^;IqM?tlc&4oaZn-~?7n`_ELXWDHlVkqOiqm4IPf0)dGMd?Ht5#QX$~%GRX` ze7z!pyYk1k2_$@%KnIy6L)Ry8P&RK!;PtHuESB=y6Bxcbfg`eZk8}q<&T+7o~enB7O4`*&+2qx~-B(;i`#5S4*UP zJ;iC9NLG_XeLj}Rt5%8BZk@=8HxfDdULxf>Ct~c8Nalx$d?ugv*0DZ`bd|^QUf)F4 zO4WXeMD|bQp_Ce;n4c@=utc7YNTkciMAl2eD8(PA_~UhaVj>5oC6X{*b7$#xULqaj z<@`i;FG!^LSBbo~P>-e7qC}c4PGo1LB#Ndb;q@fZEH8<9vb$Om=ITjQ7I%##2FQ+@ zN$jtcM11WedPsvNNz9OCO_PXgp2S!3yHskC#P^cdI*AcdsZA0;y_rs6S5r#jOD)N({F0QaR+3I~{*96x?_QEJJxX$J zXL;t{El=$8^1LO6Ldgt>OJw8Hn#>HD-#(d5?GFQM-r~=I-I;jFLOIM&)nF=`k6^QR#f%dX^ zUu3e)oUOnVsdTY|J};?2jjOti zsYqsQMW((}k*e=kWUM6jtH^43F8=-%`BU1CuE=ufv8f_Ac2*=~S4DQ7sz}Kf6`4*7 z7bRFcg$8jc%#iGIDg2Y1LS}^&ToqIFnS~z9KxYbJPYOG{DZKEdP}85nBAFjd;f5T_ zNMTL3&dH+O6zYcbIA4z?P>@28$|x^HV6YLh+>gcPT8~s`>KX?i9)#NTG{(52jG>bPCg?&+jRu z{E@;3a{6)#KVQ@Qzf*X0D}`5&QmFknh4W9fwihY=v17AQt2lx zi>J~(CY2v$M{FuH<5IaS@7OdpF_pnmv1BU4WmlZnwd{A+6Qt{-bQZ+x7JvCE_sg=rwW~uaPoyvAu{Z=Z4yQI=emi5-yPf{5u zsiRXFFhThweOf9@zE0(y6xoo<$epR2kfFb*u3uC6>2NB>BdPR0kxH#osZ5e5XH#kR zXDah#Vzbi57b|rmQuVb?2VI>UKG#bkFm^AW| z(ikC2Dx_idr|J8-G(KyZ#*L0?WOPcS(fesE{UnVC;`&JdI}PWJG-k`Bf6{b)N*c9prEyWZ z-`3bWX|$COWy<|DeQuq`iU(=jms!u#*!o`@#t1vTWr*yNq6Rz7jdpg*iNbb1D`IDF zQ9GH%>}*K1^D4?WCsYSgM`#QqgYbpv0xy873Wkc5Hq-DKb@l z57?<6w9_izPG?Cju;Z7-@=s+uZK~M$vyNSVAMLEDYiEe>0IzMac*v6-C*@@;cF zTg21CPT!VxuFAc3b|Tx`*(?Vnzk{9O@7Q@HySmspDdXR_Ghbr5+G*X*uJ5Jo6d#~^ z25Oyh>=QdlL+p%{UPJBt__>|5VRn{&Y1egCcG`}z^TQ-N|4z2kV~U;F*>*gpq~F|XZBBa z3T@Q=ExNx|_qQp=PCJ%eb{g%rvrP&eP>&DU>3Z1CIr-tJUDr+7S$W*fYbWgZWPlW$ zQeCI*JeERd>{P#?dT-nL{*LzIuAN*t{m9O<=XRoBs6TQ-YQD5H_LcTonngI673m<_ z;9yL&gX4u9R4eRYWibbD7I&~H#-Z;k9J+qU!AUt>#zA~J2P0%svV*e~9Mq}kV76Uz zq?5xzU-?@+P6xMr4ia)4yq)WybY%zUYdEM_%fS@cP{+Zmx(>S6bMSpb2kja;_@=SO zH*qkxse{YS9J(&SK^NI5-@oqQs!yT0W(!sA%e3XNq zd>wtJVn)Qe=d@H%LdTm2|2% zOs9nuYowSmQO-0@r*;#Km3=MKIq_CHrP`)5T86%p&SYuuuFlJ0iSLxo2$?NW-O~B+ zqjWx(a3776Z4%WloxUDzP`u1aUccj;`FzH2p4o=U;`bXLnQ@oY@z&F$*X zj&w@=tXwjAZ#rKcN@uNfJDkp7xh)w-wLenlbUG8xq|^Vmbf(`==fZ<@y$|E3f3Upj4ZvLwPue58}Nj7}DtoWw;rDIV*jRS6wW za*|!jNgXk~=A?uSmjk7pgvvO1r<{}J<(-sFc52OAUIqT%uMdiKeWa2F+5x1QTz2hYPuJ%P9OVm9l{bk#IC!PmR zT0YX+9&7)eY7a~0;%b}=SG(X~SE>5MmsF~^_CCx=QyNlmtzr#hW)5TD^<8hJcbFoA=$$h_z9bp%i z0vG+|Rc#kV>$un_XQXaj7ZdBbh^X(PPeT{hMlKpRcClR+HFxnvD;G1QX=@i9iSc4{pI4#%Pt) z@>iUjCN?)y;@zA}a8obQji;2GzOT8tD&5PvSzk_LlHGKxJEn$6rSdehB~x7--ox~bdF zO)L4Vy<6A2y2*Y=b;|KB$~{oI2f6k6mz$@byD1p%X0`16!cFu@Hv?tTXg6oaxT!PN z&5ZGG{+OVeCMw?)<(TT`iOikm=JIqm_vF7BZpO}ab7G#GwhOc-8N1L;hed9dEq0Ui zwVOdQe7TzgE7aSSiY+z1bu(s_o0(F2wVQX>xS9Qfo263oM>j9FxOui!J>TwTjck!h zJJgGvZob^*W~vn0?WXA-H$Tf^8MasZwNHEUi}qE{$yW#6{C&tx>%;1sSdOSRse9DT z#A9wEj=L!;ou$M{H*cJB^Q%-jhlUSlq}X($t9=pSx= z`P0pte`${-bji(1xpC8t@3!iYRg!bx&5#Ff?#f4x+-!QReUgDs-0XPjrv7s`*UTP$ zFX3UHtcmvUq>zXA3VVns?xA*!2Xlgl$E9^!#={OdD%Hw*7*)>0bLpAvVM7HEzf|;4 zJk`VDblrM9wDNk`E7$xUVgnvt4|+(<)os|rf_#lB@bF({4>hYQW;KuApL(cXU-KJy zn9A}WiapMQZ-R%fr2P~R zOQ)*lX&%nc@KAA^A)$Aj&zhtm%|40)u!J@%0GL~DMk9!r(y zs#D71rBj5LQ?kY2#c1;Kk-TU2vdZG6jMYm(elF^zZ=9Deq>9a}*9b2=B|5>&Kxtdj z%aT%F;$QQ!zoM7eR4+qiuv6n)UY2>h-1T~C=kszP=%s&#mu;C|T_^43Hz}XvWugqO zqVZLgvznJ3(zLplT{XP)s;OFPDYnGcQEXY-(94}hs;x8kMRH_9p1 zmU&qxh1Ym#_MP&|^>tpn-+Ngg!+-MP+NgclGP|X;1TV^ zaW7w<@bXlep7k>GH!qLRc?qBQ@~wRShnHXf^pg9R>X&O*z0AJv<>CX4f9U1YCtmhE zRla|{?2GkLyS$I_$v*y*ohd$|EBP2G$!R`TJA6D&_wkv_N1D&4Yu!+Icneq0_KsKj7oSK_3kdspg|T@{jviC1+0f7<7|)T`@0K9z?5_?UWAeY@?W?j0W+W%^^S>4}dKPt|)__}s_! z7d~Epsbl~7IEbHcgrAVXPXjR<{UpdpIb!ltIm%CuqJBP=oML|J$R>%5@$;dSO!Sj3 zSLBhrm*i(vNk3&u`6(#pr?Etr*Eks?$CLe3tKg?sx}TvEa{8$+TgBw|(?{k9{9Fy{ ze1@OfIes$o{Cq9#3;Zmt>?crFHPlfJ_56&j@8?AmKUJIgSu1fZ{j_Q2XTNlK!>{X3 z{RH3Axek7wz2n!vdGWKnm!EqdDqe3tO$YgzIoMCdPqgkae%>DI=a76n+0U*inmg6c zZ&H4`pNaC@4BemQXXR`^rB*1%O3huZ-fZ?WWQ$*)=P2hcKX-Tg8MN2Wm%sQq{HuDg z-_HZdJ*fP$O&%Ze)AO*Of6uAj-~Gg1(3)lcUw#H&^t0oVAKzu=yrP`flwZF7+t1DG ze%`#{r}aO6KDh1YhdX{M-Su;a6LiQrv<7ODYF+ZE=9) zdI7rB50KV0plgN${N6G^{Z;|Sw+-kuSh?E=*!Yg(bqp}3Q-HYc0owEkaJ6RuTmJxW z4hV2S+7438!2#kw4$$bc0MmwQEnfy0HYULSu>tbN1=u-WwM+~!P`;ZH;OWc&oo8ts za{^qR8=(0-t#d(u6JG_WzA!+^#R1xX9pI>3mB=Nk@0$P>mIatBOQpnWt>IU#VSj+L zQs-cR35No3IKaop0yI7zpzDbMJ^#_X+X1@W2~co1z#I1h#5@Vm`e}fD^3!wG9T8-& zAxKeEkWXZ?{4S58f<&2vY?mWa)e>Z+HAtW0LB1^$=kkb5#~UXZ`$t8ZVa=Szb6on0~In6zFM02Xh9SEg3ki z8N4W-LDkp{8p$?^ip!vcER{R94BEzL;7ZEiqmmf}%4J}!kU`^$8Elt-rAbE7!#Drct*-tV4)xkm=`WY6RbicHNQVqpfg7wPyi)w)u(ew)F-)fpIn$e`Yj z8EleEKV{(9l)>K3%Ck**wr4PUk7_!e!MYO}R5+Qzf-|cBYzD1<%b@0k3`~Dz@LN@4v}O`fGLzb+GCBTQCU0eCvN$V~GdYv+6oQJZQBSnADqQ&_vcFU!|vvAzVVwRM+zaW;#-$>zq=Y~EOwO;3qlolX4OY~EUz%|W>+k2YnKa5$T{k7RR5F3G@C zx_?G-f6HdL9Q!kyq>HLc*51$N*@JA3KhM^4Er-+Y9P+YqbPa6|6GrIq7dcEDn?vLA zIZU6B!zYt+*gZLij43(Pl}=K1S`H(p=kQG4U6I3zl{u99HV3Z^l^bhv@U6|^D|xjq zhw8uT+)>TDs(IIPsC_GkDUWkF_aui|uX4CjI2UKpT(XMg(jhLF%JI4S*_NxHZMiIR zt9uR{WJqzbm$XfDqojPfJUW-pqiR|n!&>I)Jx`vl z+sLD_?0G$pn;r59yqm}UE_s|Bm&a=p@)#qZEzD!zqCBz}Yy6TthJK?l6166e2H)jT z_y^@Zm&f``c^tl+$FVDUBwfo>FO~0l9;WoodEAzbxATa&n@3SuC6Dgq z(eZvB&z|K``Gw-jkMiHkJbJ!TeUTxG7(;w4KbS-OYYEZA8e)3U5EqJt_(!G|5Al0U zi2AW1%EX1(D@Ef&d?LFOLKIF4@w9A6zw?Lmdwxj2=Z6>~%hEK*9%8a1gdsh|aCe9U zo)95#h)O}_$p|q>N@j*=pB3V$w9N~#Borb(9O7ox5P|9;7D@G*Ax75<@j?pK3DLA} zh@WM6eZ_2`m<>a;ZWLmE;}FG~gxJ?qx6MO*DzjUJxY$y2T7{_dR)`62hoEhU)$Kw& zZXcpk2gU6aqH5<5Yo*KkA=Y#aQLbBvf?gp;e5i3!ynl#R1GIh_K1_LsEANO9>qlw+ z=n!4Us8b2v<%5~(@2n7g7bxZ;#ayhIQt0ati&uu&^S$=r2knCl z|534jQtXW(#%&34a%+eh+d|ac6=LG<5D|Mq4BH=K|A7!!4~KXn-yI3DL)sk+(fFkL zDWy(@NS9wvhbZw|h&RsZzD)W(#M$%e#f1VJ@1(lt~QJF)7SRDN|ba%jmw`DHkR)IZW*eVNO*HQ#v)w(n?|a2E%O0 z2;<5OQ!^{f*z7R%^TQmh6DF=+m|^lo{V<0bgvoCh#?UxS-6ml+ioJQ54_buzQ#QU4 z=B+owyf1Cu3bXL-FstQSyD;t!VdlxmcfuTbH%#S@ir-1`J1f5I?i!|W_b^GaOA7T2 zlPC-2`Uhbi%b*X#{MW^rL~<7^XyER3FpI{z7VF?A6nm^s^Maobu#modVgE>+)*v} z)$0dgT}vOP$dfS5pQ@JmZwOe-eng6RMM&y(TBYqW{2<@%&tm;KiV&&l~^ e#hcB3*p#>0J$dc4a(xSR`@i$_FYf=JKmP|9;M2?i literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/61108a49fee20cc1_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/61108a49fee20cc1_0 new file mode 100644 index 0000000000000000000000000000000000000000..600928c2adbdb2e0ebdf25a6fbafa460c5f9266d GIT binary patch literal 35328 zcmWjL1$dKZ7sm0sN!nPGrVYj0w5fZFySt7J*WvE&?heDV#x9N?LdAgZ~k1xbNTZ7^5n{wBUi3GWlELF zQ6gu)9A)z4%#|~}RPLO4is#Q;x^$WJl6if(O5`Y$J3U{CJn4Dz`AU{d&y}l0dJZFF zoXrq8>;Gf@|6h@r;eP-BIT*{(q>OYC56VjU%1M);@{$9`P_TkjAMq8X@JdoT4&WwM zRF;-jkq)7ERr=JBzG7HS=^tdTEp^1dUCF1L^a(pANLdz1v8amf*ofB& zuhi$NvpZ-OMl78xoKBfE=P{vQ0(YL&x>Q(epKg{~cPaj+Q z$=u3MJ8=x2)_zJx4KzV?8$TVz1)Oc`r_^?SDuO~?{nWd+pGKf;Uq3zX=cfVv{WK0k z1~S%gKm9g}_z*nWPySQ<rv;0pQgR^)3#TB zI*ekk{Z#p@pT3$5YU*#$pCJZqaT|01Pcj&EIMkr*nGM>6Jy{H@o7JEr*$hewGpGkH zcnoS8VbH!32K|N7B@H@O+Mvhf46;- z{=l07%sbGa+=C42JlLQe*g3=?+faji*glM$U>IRgG3>#>QQRMGP~R~Iy&TV6XgGmb zCmE#41`WoFDddd9Qw?(dM%?%?jo7Cfln1+T37uyf6g9`70`m-7JKvz33k({LDR3<^ zC~>JlnO7KeYo$TsR}ueOgYse8I)hGQ-+F^OY+ycQ-)PV|+(5%E2AK{RbP~A^(iWzp zv^j0ii}S>M%^>S_gVNCu!>|BrG36hFX5KQW*=^Pw1@92cU4ud&7<3Bz9~xBu3G+NR zXz>e!mcAvIcLv=<%zJ9{(V!rdz*?9-vvwGSm3Rp27lSgQ)K}VkGsyj)LH%$A2fwp_ z{ES*=FzTeysEh$d{bDw1KZaY3nu5Dlqg-~Q!q76%sG3frIv~_#lo!9@BgzLG)eaM} z2^X;|)Tm4FW;E(1iexfs8s=vJ4t@G3s4@qf!bO zHK?FbjS3re7D+{odX3@5j9Q0(ky6~KahQ#MC5W-4QFq`e%{hdXF=`K1l{M-fLdzLd z992-SyipJETLq)+6^;5G;gyUUiPXwQRj$f;B>co})J5BB#Ef!3(;mlvF{)5?qdM0x zD!8Um3vnEmP_vd%vuYc)9QU!Lj!~cL8nv^DQBUv@Q=1Y;GjeWeRFhUlO=xY@LA=Go zwnmxT88r~j4o1bG94?}DC!>yaHY$5}))Ciw81=lTQDb_sCcRnzzDD)!Z`4l%jrwOW z^9^CY4C8;9;YRgB$B{<08g0}gc*huZc%o6cCb3`s?>BNlrfJN9C)2q-!>IOijCwrR zsI2phYKF7(8Do)AaZ8QLvC616IKA4a>gyPPqfsX|88vD%Yq*6Rw;Hu}yHUwI$zd0H z;wnb(Wq<7>j$^FXdFH!D-y24ict{-Rhb)iSE12+@z4nB;o>3coM62gU<$GaN|Cc-l zuolhV8#U2qP3nS&I9h=|RZOZ~)uf%+`m;&Z8<}*tu}SNjm~;rXrY1du zUo-N+B4liC(o9ThY0?s;wKAzf80nY~N0TBtk#}d4>US}zVPA6SXHvld zCRIi0K_*=uYSPMKCS6085yUXkq^meTiaExZ6gkeM#WTox7Wv@=(r24A7boDJW76ii zCN){e*l4rJr1_Y-*rdEmOzMig7_iKweF#`?l5r(-u4NAF+GNrvng4o$Kwd z8_3niUuV#~ufM)xLO*{+_4n6Kqz?2~A@~OQ>$k!Fx{rcGmHMop%eWTHidj}8at-?Ysn0MWt!=)!$_XvFXLSDL_IW}=dU3P{IwFd z5Vnw*QG2n!5|;RD-S7Syy^s4R{q^^s{%Z5Lzx*y!XIQTIYs@u&Ij;MwFOH$}4S&5x z-G8V(e%$oe{9CNSZGWwL;IBq6{gwAWe~nXs#+U=N!5yI8@XHXOIBbVIG(fvDB6EP+ zXA4lj@Bod*7I;0}#$k+&4A4v*LYkL$*oNTf0QHX#P}_t6^}h<7SCho7t6Ugv)1EmyjeH!Ex{~XqFF7H%<6_o$!5*R z_7t;9r)2t1-&3d25tf;)ii;u<3`l+~C z&Jt#=z-?qGY1S|J8wE<4wXZb!U|dE!7X5B}Z3f#uhie~v&GHWXi;SpL? zHfwbivp%52PiDPFrD|raLdl=W1#9pT+kP>tTy=h8Wlgh|)iTRd->i1Hj{*(MDvN1& zhAIu22lpD8mGf7#@;5fCMiaA|;3i5nr5^YOS2MHHo10Yx&X#8VhV-^(ncA846ra$i zgP9j#W{pBfC$olhq25U9YSs(f?M7@p%!=u0R+hfZgMsS!rX;YKva@gi~Xw$2itwl35)lvuCDK|7qOE3cP}QhFK9f zgNw7xsy>If=9>Ba!CskX)|Lfk1uZmd-cqyTmQzPKR+?3Djaf^!Q2(veahq8au@ZMN ze!E$Q9cE?5dCcEuR^tO^^}w$O%{p+HnjbZ*FLtBnG1l%l>xum**}u4h-%gn|@(lan zEOVYStJt6HfxoE1->mTkv-Vt~?pJ7ow5zNM{=kmw)bR#;=O%j+nQyU%XnK?So#ZxLj(s2tkcEwVZ-TIjOqG5QB{F2tg#uw}5woynq>SuFbGWxObhexOr~ zMd5K4ZN)EX7WKk#%<@?@Fx{f8IV>87%Q-E2k9xT*T9DTwdp?UYqcKk8wT zx3lPVSBw0*5exbwtvfaBX;Dqw!^mD1xq4evy^lpVkhLFm#gqQ@8DP=IffnT%WKpZZ z7QMhXtR7-f@u3!-#AUog_hG~|+@f?W#v8O4VbLk{9LYTRglVHJYCYPb9&nDKo*0h< z6D(RXk@;{24JT1&{DrrZsnHb1K!&Ln?ZHVr#HQb9JI$gFxP@WUiE*YygJ)SZ0c(&v z+oCIYggSG$KbKfgd%i_;k#!+sVDBP}42#KiiA8H+U1m{bJjd|m7Uf)FQ86^YL%hR* zl@^`FQ?y&foU1JgU1L%H^%j*uQ@p|K&FtkZjJ=Him~Qsp$4M>u|xMl9w#{2Tv}uUr^!!`J&kq;(p3rd&b&6 z=dpr;FL+G6vgi*S#4XH!O`UKY_P6x^!k)z)e8=pswEvGeEml>xTGbc>5Nxw59IJ2v zIqX(tbXpaKVmOAbK~@dL2OJBr%Hg&uEArw9I%lwIFy5k5s8yvhTD3T{Rpqi;H6Ho1 zGZ*5*t!f8XgjF?Q^IBCE_oA$dkGAR@=EYdG8plv6)+%EX?U8~%P%F1pOY>OuJI^PY(c9s6tXH3MQ{?8i&@nMrAk{h4zsWo&C6KT1$D|<aP|T~q{J31j zsw!2js*f%|S#<#It69|_FYyiCezxk*U##j=-Ksn_86R_S3ms}v=h{|Hsl%LgnG;)4 zzn)c=`c`Gesm6@k#H#5ntXhKosMgY|hM3TX+}e^`J90yh_EufOJ!J1-Rlbf^mBtg~ z?_^a(e`-9ys<9|A&?@I3#={vrLBGLPnMYf-9J$9@wGZ>gS@k!jj<;&hM60IFWZke2 zzs$0#*&M6-&b8_d=FhWgJqFBY9TyPiVyh0L{Wj{cliYS$wQM(Qu!mUpvR|+e8}~6b zz8ZBDX=r>Ns;_Tx47*FRR?^tCDs zA7Q%1I^VHs^IdX9&;#=Mmo<85)s_EyWYuqvsnZjy20mk-Kes9g?w8aHv))*B{w@3b zJ^S|~`wu~%tZINZFn+db)K_Br#{T?H8$X+x8f@x}14f(9p^3jurvq#nY_@3v4x_lk zromFW9Ed8Ex8@iFSC5CYf#Oh!rT8&BptwHm%BTQ)Hw~YrQt@K(#2F zEHO5Pq6I?Y7#ltCN4!l3kw3wvIf*u{L}W5C;(LlsbyIC>35U<7HTWgn#`{q=jYmpO zo0jD!mpnGb=e6k=9${vFo2nGB@!HU)(uHiAQrMf)TUQ>SKOuoC5a6sO4)Q0 zB}>~>6N4}nhj0nzGB#yJSXrB@muD;-!vzFav}qJniTN?SvP}c3P%C7wYSUks{gX|9 zVo42~e#g6-HZ`wh({emV@j5n5oKL&O)DSh6utrO5N?UGI-W4|ex{^Fr+06UjW7B8UJxhJh*|g<6wYXqY!;3bx#T|6JL_2)CY}1pgHto4> zQ|u$+f%`Fa#CCi^i6=Hq#x)FkW>cLvHg$N*?RV7jJ>$Xs!KTZweza*8mSg@W#{W!S zUu^pCE9>&jrrcTVs+iTTh-`K(&u*6`+^#f_T^G?a%C7JjyFSO-bt2I&N3va6k*|bZ zopBWfOWIWq1Iydhy0TrKDt1*uPb|S%xa!yyhMo23SKqD!c+-Sjpqr`7S4*tIGx)|b2Tq~IIJ>r^ z;{>~AOrj4glkM7rQwW}F*Uxy5%G2x`J)L&gJ%jmY+O-htk!3ddp(*ywv1{mD@`P`` zU7auhM;9>mLc21e_#$$|g#Z6sY}YQFK;fm-7ROO@xn0w+1Z!8=bq_^X5eF)+W)4h3 z)-`s;qrqC%W*zxr{(8G^;{`HoWGt+~4!roCdTp|6IHuz8X1h#V$Q4_07ztac8M>p_ zHulGMyZ%M79jq}%;p9&8*+o7mwVO4;G&I{|*J5nMkiFCjZT8W3zg;;F*p=xZbvbNT z5sW)R+$X5vNpe2LUPbHEjCF>%&)RhpQ_k7d@Vs4{|72}Z>-r8$hu?D zCA(5CQ%lUf!uhLqO~>17tnYQZa@{26+jhm?VgI2%CgES?zQ;bi&$^@I1M2ZFHN>HZ z)a4O-1nnN%RqY9T_^Dk-koy_qq1bb~etKcoL7aTaTD`Vw&Re_Qq2xRI;OF;tE%;#9 zOO*P^ee8tq6MG2y%o?H%&LZLqj~VPo=C5{T|HeF+k0t-{xWjXNLG*X(1>+BDj+@w^ zKpip!>Y*`Eg-n6!hTr@H^{Y8h?Xe^{P#H1>s%s>-aR)DO!^_X8K*dA{${7==`k0Es zvD}Xf)GRE=_XNgE4AdelObJx(^g!*&8K{%Umn%@yuoz$R1nP0#Kz%^X{DE490tEtf z3BME!)LpbJ#Cc>a9H<{?UL;VfF{fytF4PEAotlCA7vpLLs#EPi+3Eyp1-{e|)PUxJ z8jH`Z0#&XD)MrVc z%3}!bV8OaTy~HE=Ln*~U2AsTq3UAJp6tsDrzy z^&axs8>oW&sLOt8eSq@^12yRoV;&Avz>z>*!{+0GN;?s#Gx+HwF`c5GC~`Vb5oZF` z8~x7G4&mph$N50L!;(J(<@+m8hq2>t;<*s0T^CuCOMzOCr8ffg`#*uIbTd$E@c34s zZr)}s?**#See!!6sF_%Xg3pNid7zr%I6lDiB2cZc2d9wtWuOLQA~L=TR10*&BjkS_ zsIoYQEN`e2=HL~+qutv;?Zk1Eco(S2Sb!|=1Jwkba0y8t7z@kr0j7`C6-V$lDu1FM z)*yN4Iapg^MWrALp5*Ts*gF+9a@^h zq4v2P`hp6%xt-UcCi!Te-=X~l97-za&{#|>)s5bHxXDoCs z;n45+jMP#Ny~nQ74)rYK&{Je8OHMGBV_y6RTX~0apgV?QV?~E<;BsY${HizJ4i&56P-TqAadfIleQP9v5uIA%g8dGb2yH;3B-syC^V6{kadzn z-%x6@L$k30S*B1w9G^~IW;j$2rkM_HhGCXN1!uFzkv^ZXQEh=k({USl7cv&cVZkDD zTI|rTOB`yrlz5i0Czdn4ZtZ>G*$96I#}F>NDen0HWjblyo_cM-#GYQ2Zp_d3*KKkI*p$Hj5t$C8r{ z)jY%A!TPhT#YKlAQ2~CJhzGlI?lSGJ@YuP*oc|Cv%G`AD{;ESUn2kSi6Kii%U%WuB zJM0;pN9Bjq1bW0gkC_L4PaP_Zyw92I1+{p|9(mSjUoie33`3%LW{OL{=$>CI~oK9WAzFbZf&rOVZ7$dJ!na~Pt^EtH!+i@S63NQ{D z7IbPZ?iY6Ia1p1Tw{+?&nznJOeOsp*wR0-4y;IdO1&2F0b*L+Iqjh(uj-gghr|iAR zvp4hiA+Nqp4esxhXCOHZq8~nE!eFNohf>4gPW2k$)Gwo$3kAkHm3th=#ygc|f|JLO zQ!5ZO(Wz8inB-KA$xc1S;wetOn@a4{oa!>&sbw>qsxs55JLo>ksT*^Mcdk>h^PGyD z@6?6`#JR|+ZkwF)+e#jXoZ5YyI-hVV1+V`m*6U6Uz3J51@F3NU3sPMDAmu`)Zb6F1 z5NyE#c)HUDO%dKBNJ+Sekv)U-8=CeC(h79$9i#z>=o6$A41=+6kX%Ub7o-;GiZ1}lAbmickwJPjDoDwrgOne$#s+D_gdnY%$nhyb zIy*H;OQr{@<%}R5of)K6vxBr1h2{k5*}NcSpC6=3W=1!|Q|8X;YAH;rDGpTECt1yMlCoZ;;CF57MziLAr7{Nb8OS>EWp$ z{rYE+9$cap*Mn61PLT3G3Q~<1L3;U)Tt5YA+W(m1q< zb?LVRmvSY#6r0A}d0g6@m*e?dx`Dmj_lP-T~@{p3=~UtH>5-K9@8 zT-s36rN~;uTHB>E^<2CLcWFQ)`ZadxSrg`N=90I$OCMUew7jKDPf@ImOZ)Ky`P-5k zHsTiI+qpChxA3mLOMV?(O784ZuWl}t=bRZ!luMOX-WrV;6P8Q~bP}dhBs&63!uMuS@wb97XnV>@e$f#HD6fjcxe% zs7oD=Gw%u3?37D6&bUpb)S>C$u5zTwiy+b*@c*S1=SME> zc}(9YF0SQq>FQJJ^n!i!(xs!XU7G!#^+cafw8t}a{OnRc*uS`V{pQkrl=;u4vzY$F zrO)UW8mt{S3QNXd9m^D~|iS!CH|Nto_Nsnw=w9^YR93PrhIk$WOZh!Ma{BSRsXjHMj_KVQEq3DjuxiC4v=E zGFYSFEFG-%u$KweuQ-G<<$^V*e6S)b6AMaK4b~QX!`h#N74u85X5j!{)(Y0>y1~lv zYp|*f2-cXf!TNc6u$DihZ$yZ8M~0|ILWpMgLbMb^(nFLhXNdCV3Q?)5A*zN=)k5^8 zdWh=O;3qoP3Q@N@A!<-JMA_~5_MbE}xgt&|A2nnk)bI2tj` z9p}~?Y>#&3 zIb1|SLAUZ3a%&Jmi@5a!#8$0D%WtUY+bjm)^n?HeYbWu za4WT;Tc>fPky|}~bt`XUx6+#ub91-OqD2d0XzA97R&FgG;a1`pwkeq*S5?G4q) z!=c)QkLZ3eRKYhw_4IM5vOEb@o1Ci#EQq#1_H>g~CyP9NvMBrOEDG+PU8XhJRbYK~tvsGx-%n)c z`i3z5j1Bq2l%qhH%3>c*V@<&@RVfsv^Qc`oOb1cENSL}54O8`EVaih?jO+Eo^n0l= zhFjeanrlFXOZ)nk*m=Vz@OdCK=QOOHODgii&fLdx$!r;o&f~Iu@qx_;w;p z;eUqd7yOC~D0wkVS+BD%FdoM-^hTKWAnVOA&BG?FyG1^@b05ty;h#S@36Wa&o{2a#n)L}aIo&EBIJR`!@99bj7<&FwhYwSTv zbhr}Y!xiQWR|i}|mdfEeS0!ABe+t);U&3Xm9cxW;q}S7euPwdfkIGu^`F=)o9h(koo$dWY)^ z_V*3f&3@r}hHnGHHF{vUEQ7*j8Wt}5$Z(~N3g>gBa1EIpu2%?}60YoX!<7ro(H{qq zabCER7cmzOEe@A&X*i$lglhzj;Vb;NhHKdNaGgF$ZhwVy4OqBVpzyVD&ASz@+^@nl z*Xz+Yc%wZ^!$qXVd9*meqXCH?uH*J7G})sQxP*CCJ-UtwKY27CZK`?H3oU;3Xczic z_sCe&!}SavrPT6hQf-gM*YW5-{8N{6^*!nYzXl#v!pw#q75LSon8qF%ns}50Z4uDa zqxEn%^QZ#6&FO~%Ej+r=(xW=9JlY1e_NWM6!>^4;%aFaTN8K?6pRlN%M;l;k?@=jC z!)?4k)egjma|r0@(HJc1IEdj_h>Wz z#nG9JJBxU+b~f>&)*R-U>ruyf9tF+!=mAm|c@(*rbGQoY5|0Mq)iUb2+@miTwT3v? zQm;)O)j&&3!2(=D*Qlgm&XfsR%tlZ21VSst}>ANU0LR_Y!H3ceNtq zS35%8P`GY{DxhS;2-R%Q9GxQc7v6P=P)Ik%LCGEwTocQ9JtO4qL;JoFD%USU#{RS& z9HH7nBlLA-goZ9*{527}io~_Vw=P2Guws3LOdBF(+ZdraScyr$N9Zn&Z;DXG%@LZ4 z>qy-ap&DBwRAhUEdhL!-+r!LzHbN8rq%Q)lMySR82z7qiO^%T{}`ct_zTrPQR{CJ`t^H+ zI^gn;2+dWb78@e95jjnfI)Xcak%|n8ROgUL{fh)or0T^*YD`k3QgTIVeW6HouNSGZ z9V7L)SEMX!BUS%!q^_Tf)Z{-S75{gnJQpK%7yT|p>Jr*rrp=W|^?eknwa+8@|0z=#9SiE|HzE-a$Bhcnm1^fqx-K*ab z7wA+te6Dq{tCC6|})w0U(Wm~l`w#H&rAUhRwY^19foix`#e)l3x1L0ov2 z)2lYQyy}U@xxE^l$E$02h%NcOI)Ii%nX8yrAF!ghSEdqPgFd(|C()$!_TUGjjpsaNxxd-bCQHEPd19ldHb z!prL%j*awc$SCqa+0kBAM?Z`hQ%V(fo)jv($@fUKO@p5edIiB^Z1^Qwo{=ipMIOkPu{Dscv zz1sb!m*+af|Cd*Fa15@$sp$pQ49-ieCziu`*{f`5hL$(HT87&H5Eovc;w`Vv;vQ^w zyvmFlNWAM+?}zkx?A4T~)aRL3d0w)1uW0ketNrNm&Z`C=s26@!lm_`l$!>_!NYpY$ zX_hHUIm}U9ip{aWDE;J!(reUCjnWl#Djubau$GPDv#}^G#6GAT=g=P`%SZA3tSCLN z5XJWZqtxM-C=I~+>QUN_4mG1>t`()j$XbVX4WhXAKT5ZnM)4VXlpO7%SlcM&?+~Ru zU5TMblp0`F&nRt0r(RL|18sXp={)-MiPAD`!UM$gjZ#j`Lu$V$x%)?H25z9r0Aj&q z{5~j3)kZ|A$rR$66~(nPQQD5rC^jcbM_`#7r9?Etfq791UJ#{lWLy}fva6zW3CA}^ z$?$uW8f}VFjm?aQ5&yR}O7YvGG-(%g-4~_I`=iw2c$9|YPn0|nrIXlmGD=VJ39U{M z1CC2YaV<`q)pglfgi8>Macqjc{m)kRC3KxIR;>LI@|S{Ja!6s?c&_m9>PObFmUdYYrv z(Go3LqxCP|VW2HqlkL%(4@+RQx?(Vfxi}72aI`LlMC$>nyQ9?v%`!%FEo8JhWscS$ zyv7eiWR2Eo+(6}Q#Dt~zDSNbj#hCQTBJp*mM>cU)1%cn z2RY>L zm>Hu%$T=%UC2<0=b7B-WH-_)w#Ap((&x=vn`7s)WL)g72Mkmp8ag0Ki#&8{fj8?6T z(M!Z_h|$nLVzdWYx5X&a_83K@9M0?{k6kgEx;sYC_QWXnUSdR{12LM0A%|nMA6<_y z2I7tqCtjobabm;ulQBF$jnQ~qMD*zxO-A^c7!5t>9sw_^0yqZkD~W=)<@lczCCL}L_v7NhMi zV)Oy4Ua}@w{VImnQL%cBDs5sF-8Po*V#R9f;8?vv<)N`k7#6EMXo*iFV)e_&SnVGj zt1qZEHdd+QVpR}ZQFMH)-s0PYSaqBjtE`h_RdGtJ_M*YGSj|C|>9J~v`zSs$R?ksk zUM#^g~7;iIe@jF~wV)ZkY<19WS;Ez}p!B9*_)vdAGhHtQL<2JHw zkJXk_v08RER-2G`E>`Pt;e0I5>0&h(MJ_NmEEi*y`BJQ!UXE2~q+E&B3RJ!tt0tI) zY}aD-1l6v`>TguN5vu_R`zKaC5P36JYjGJ}Z&AD3u{w=_JB)ibR{!EFX5J$voI%)q zVtyFQb?32a^dwe~p2h0cb87N}`n--+mk+UAlN+lm$o+->uzZbGKJ>-}#pyU=3~{m= zr{#$LRrTnB$b5DNb#1Jae4hXXRYBICVx!_BizkkJEOv^~9+!{37DiFfvZF zym4BA_c#|Dr~UDamk=jg;W(ATq9U{_NQo4Ax<~& z3|%TRUZprKtsJLK7*myatHo&smf~7<;;j+K_aNd_wQd}r|HSFvdfcxcrv-S2Z4Kho zyHT9>v|zrLajJ-bR&g@6j^jOmI4x-(r;;7wHG7{N_0AM2#(R`hGHw>*V6}5d-2MH;W&gpQQ>|(|5wMW{eyVD z#D5s}Fkbr}#cR>ic-=zEvv_sI8nk;Jueo@K=oj${dl|3S2!9o?L2u&a_cmUoaRwRR z#j6ok;3Phy;|JpW7|*q%@p^-tpW^wvFg^U_{&qPO4Marf(9bT_5_u{am4IooIME|b~!;$ zZYQYx!vsDzPEdhI395jg#|a8U%_j-^g4Iu{>+=Nt{DL)jNgqVNBHq^t%Ke6MaSn#J z33~W3L6M&lc%Da1z9gs`x?{_a1ie5-zeMFUB&ryOV|hTLZlkazQFd#hGGk{*qCR1b zJ5jq(JVT=9hbHn_U!wZJFH@qPAtH04Mxl4sM81PkeS>P051 z6D;0Dg`x_U;%^j-NmPZ{L|(flDlliFTIWhsY;NL1Bb3XNsD1^B2ki?bsy~c{6ZLD6 zL?stZQ~_+m7xXQbs1s!pwWm^|zG8jlMD0b_Dv5H|OH?KNKv4ZeO~ac8cK6J-A>emJBh0JfE*vP zMkxD)7_b3%pC&5LvqWutk*M&OiAqA`*F*(><36(eNK{97{gU)6+=e7Y!DCEPiYrN7 zFdSD99h{^b_#Hz-l5`D8?j&`>c3eiq3`v@VGNDOYg5!7#WlT~&^v76yN5xD@`hkj> zlT-&|vLxvrRESAZEgZzP*d#qcowy{m#9#4As*#wakfbENL7Qae!A6`xj3Ky)&{5W z)sW0<&tyHrHw-Z)>z02q-y=`f8ssu3%VkYg75Leb`TlCMX5gJYStkOM)h{GjTj9=- ztn>H>turO7L*`_ygn!m#?Zh#>!*9{avcx8<3_imem#m3+7Ej;AWIe^;g2{RdYZ=DC zu(HWYDwnLe6_Zu0QnL2`oUGUy$$SSiSy^f&Yfk-Sef>3AIoc*`0c`D(mA5@HcTCol zPRV>moU9c+l4b6htZ_KfJ6Q$$Bx^OY^-b2rLCJcKVndSk%TVS-$zjR*gf_#I`I}_P zsxUfPkH;o!?1W@Kw@lWRNy%z9Jz3coB&*k=WW_H|R_O!D8i*SQ8T(MOw&5X;98Z?< z1a-nuR63cgRi~1*|8%m>BH>K39^l^#^t+g>$V$B`f-Q#x|^)& z_mcJV{bar?zLR2FTK$D5*?m=lwt zs~8uXqPeIWm!f8QQ?wmNP&QwRdLq0K<07bViab~bL(vrepGnd4iYbb#l%ipkiLXkE zs$xRp6rIMvCMlYT(55Ns(kw+go2PK?WQx|oHXud&a2n=;DO!PRqf(S%bc#BUNm1C? z6eVKtoD}Us=6NZ)h`Y!(KSjSSN>Qf8DH^hzUk_hV^5{%1p1w(mIyhMqK;>Y^IVD&Fa(~zQ`8ALE;H`+6pg^W8?4<;+GE{4)(fQ` zq^Rh>w86?3Dcbs9ie91e4{`y2Ek?n9scMH5Q>r=!r)nL34M|leWN@cy3?AZq##A{o zrRo6wMEA_8dWuO|QuR3^Rh=X0laQ*fuq37`zFw+^pVZB-QssA)I^f%}R1G+u zsoC30rxXIPqsdD3Kx=6Fn+>cpn;|9P7F zCZ_2U?!lRwCW|jkq1cb49BFElGfnezrRkU4Y5J>3ng$h5(|F`7K_A4GOjEl$X=+(7 zjlcPr#^0q$(+K2fm?rg2Q%y95vtOF3^k>`wX&O5?O$~;msXgL{rs=>G;-8wPC1~+m znug3wQ}tPCYKBa+(^PkEn))nF(*#Ukm!@7D(li{tjcHo@dzunArK#F@ z8sjK7*YW95J)g!m@M&Tr=J?g8j5vUh#y*wD!e+$R&ZntZh>Gp0O9yi4b=ybE9ke(r>GS^ zy@&rwAJ>digY`ZIZuY6TAUy!Jh?zEF8lNytFHLe@TyNIZ&KeoK4tjeQycVz z_oGiuKKXRvvrjL-`Sj{LHNwgty2eDN^EYnN`TkWp??I<)Au7hDYZPiErz>Y#x{Bc`TKm#9FFjpV za;9r&-gG@KoUXn_8NYP8uHhl3lu6fzvgtCFOIJqpMXU1Z8e2JCk5IR2y8Nr9^LM;B z4)@RLs)ZB3r0aSO=B`N&FxH|??Q~77ldiLM)3u{vx?)-~FW$FG*X%awdWHY6vMpn` zW9$y;O6|;C_^(U4=5$Nv@9w6nO^4CmW)f+-SO#qGBI6eCZ#K4GWEb})R>a4wNumeznbm?%Bkv$ z_xO)qq$@>=G^Mu*J!P2m+(43<$qaRpfC3`Ds`T=wDxh=_7&_8Lst8K&AkvZEq$9nz z_vNkkTcMY?LWoo^^72Vq~i(F^(_>wqv zS{kRx%i{ESd7Si1oI0$G)A3)~cNKlFj#FqYkFAT-@J(?#|7RTQI8pa)aZ21Cr*1o# zpPkIv?l=|O#~kjb&x6eGp*U4I5~sj1YIU3(PLk6p@;x1=aySgvnK*rWHcl_j#p%Jt zIQ@P-PWf)csWsAZ5U1h1$$czC;;lG!$6v7Bj?)P|!IC?1s&SXt{)^MU7?Z)o=X{eA zu^Cx1n>er6q~ZBZnu4SPCbhy56#2-c5vX0#Bo9=|qatpM&SSo z+^?sG7>bQ}fJzVQsWoQcC~`imrv&uEGTcVFNA(oJBpgJh$MsYn-LMdsP~=HHr68_e zeOc<)S2J6EMLw^u;=AkXQB|`lR5P>wh*{Hd9;K?A)e7l2jY2id>VQqi6K7T$enAG4 zSs@I;3Dh#otSM^NXMVG4VU1{iCSG7|7qjyBWNc*YWmW-9#gnhiTJ?=tJHIz8(`YllkC?R! zjmDU@c&u4%e=zIH0<%giG^@|gX7yNP)*$Re<;7;r`pwL`2#obRHWDK?quVC4a%>@Q z{DO>I&APhHtoqx{I*SQA%u3iv?e>{fe7{+TZ~<)&n6>SoS$z+gH3~=mHmlcRv#K94 zYyUB`?*C&}>COTEINuCA;wQ+UrfXe97?h%N3un2!xq*uroR>z znK32JqDaJ|_85n|F^kH#v}kB6i|n6U6hvR#fcFcF*0ixGxvfP_+gUUo_r9`dS$m5% z;3EFlkvvhfvqksu2Bo{uHy$EGPqt%rZ;MW&ZeNQE_OqxA3~cC6-UHZgq(u$z5E(~V zG!p-QM-HPcYO~a$S$MsSoR^a$vaGPkveu$rII_;7xxZQT3yvav3v;vG!g28yHQZ@Y z&OH_l*lW?AgBCfDSk&mKMVF2-A1B!tFaEJ;>S+tViCOgbWs5$$O|F=Q(RVF6kkP7A znXEdO#j3(tt(uq3s+BnTfmQi)Sv9GMm36i7&hxRVOlPZxer;8=Z|HZpRX-#1NUOHt5T0WFDEj@*%5R=leKy6a7&c9{ zYRojNe!`#FI@79mSd~s&_-0wPV766P=aBbSt9oyCmnwL`INHdV&2$dkjy z@>e$9M&6t@oy%v_lY%x?FJ#l`!Zy__Vw1D7O@mRZicK!;L-}epUBhFns%}%38aBPF zWm89+O-m4ox2Y2zAu++G*T`wN=`Un;*t8m@{Wir=prK7=un1WK#D$E>Hd!$(Y*R4B zrWP2Cj;ZvINMriPBP2E@k7hPy?`YHC$l1xJFFV^*yo*g05kg#7o4TM(H=9iO4F!9U z10JJsPn#wWwdoi}46|tpoWpJUXCnJgu_?oJw#~9>^BkMrVC7t!w!kyb#`FOQO5B!bv3h{c2zbnS;BHC7p*ZsM9V|<+%aLkV zIz~3PYZrRAuxk_=q}laxYx+jcHg*-oC9LXbSJqB;W$sK{JVBN&jDwP0?TR2@H@iw< z2h82=ytlKfO&_~9U|C-~pI7Ys?rc}w5WC`WX#{OY+I0k%v3Qi7zb|&R8g17f*oWI= z?P~giUHzuobqk-(uxl_{%(rVA8ZEFZ4c3Krj#0C7e6C%dHFh;dgSB>b+iT}Ds$HM& zv#UEM?YFDuMY~3z|7E*2qVpBI2B7OzyIl9|8iLyQ?Q$dI19Ev{*M9u?%C5gK__bZ* zQ2UKtOJRL$mp7wBOL01rgY%so`ZlveyKobsEDqMYb7&4$;0-KU9WwAM60$io3pKJk zl!hLdh7&~{I$DDLK5?iEa+P$bBm(c1a_BBLmviV}B$jvRX$6NmR&;1Q4#Hc>p<{T2 zPin9o?{F!Oerh^c$K0U-SW%C0kg>i)wNS<4P%@4+AhrZz!+!Yf2Ro$)1ju= z>LO?S=ys^H$DvPs4#mNi;?Nhk($t}{6UYy->BNYU^BkIllD{$@n*Zid{S6Lr5ftUd zh5ZhlJ4l_rnnUH_!VkEA)1gAQs5c7S zCV%)b4D;?dRPC-q>u?b(AMp4?hk|JJnCAyReB#iM=MF8x!Iuu@dF9ZN*ABf#(mTdQ zCOK6xlT$l!4`*^ZwKca>M=|nKr!sx!R5wh(Av{J>Ij7Qb3y;e?)vN;hU_Q3u9ST-* z%7TFyjUOsIRi}zm8&IRFQvtN8=G6E2sJc_-k@Q{-rygLn$*CV}I<*c*YB_bbj#KCA zI#r;aQ`sy|l}0;cw9y{%@5MWH9$D;8Re=j0hf|+AiPPuQq!g!qN_A=rDmQk@hA-c1 zLZ3~YN<+;SPW_3isMgY{6kNxOFPu7sgmzAi@9flX*x%i$hsfE(sWLF*AfDmnw@#Jn zO+FZlHFz9>C}KzPM!G2sn>9ycd7%1V9gb$PUFsX>UqPd&Uc-fi12-< z`lIC&r-sAwoH;_7H^hlza>;%=Td}Rl}hXF1>*HdzV_`H(W;Xu`W6A6Lw(2I2ZqaC5G`XS6^iUD|{%m$)WIh4dYyW{cf+N>VY}(#`zV(R-f?j(lS>iw!UFt(e9!0`?&mJmeBsh@ zm|v1Fmb`N*12g?Pn_F`WyY+E#w*u&Z(O8Kic#480+_Itt`e8bL$7%2-wkjYIJuwyA za0jg`yEPU~s<|~7FKW3}wzgY&>bX@94{UA~i+8J&*R3l)x7z#Nawogh1(TY)^+B3j z<0Ec;5_4-|OSh6fcPn#ix2j=LM>n52+*;MeEqgaN=a{**?`ya2qs=#NeT%v8ee0H^ zw_C^hxYekyTR-9y%Jt(uj^i>`^mpqa{vJR-gWNiaszcq%GTg08V~8uA+F%Qg-~s}( z-CDAcHpuX^TfZTBGh^dCHfTydd95+XWgoZQ|GvknwOXtjK53_$bW^p-*7Ab0ds)858b+l zb5GpL^px$eKXdcmnQbWXg89Sd3?Ajo=TQx~3wqQ6mx_4w45dFtQIEFbS}~7imhkA@ zd!KmJzodutz&w1v$m5u0c=RjIyyy3*Z$po=C3>_Ym42IgG!-Y2y`_i0zaF)1?a^pt zXzx*Z-0td8{%#(f?&;w|aUONV04#d%YY*$Nd$bm>dVAEVuZQ!LJ*wBwqeL9WvjHCE z80gWi|9Nx@g@<}n9m8=3b%uG=ZMa9vad(7AEk=1X7#q>&du~U2^b+gFdenV_N3Eui z7tSNgRF6s^fZ5oBi)c2@qlBM4d|&9%?%Cuv$HV%e)M+k{&GX3ivxjv;Ju0=xqqk_Y z#KUpA9$D~iIdxdUwv`@@$AnevyV|3wYds31503uk(Wc)$x{SsfJsN=>o2eBtZSklW zYN8>oZKv-Y+{X!A*h$>GhzE19|GnMJ?;a25w|evtIre+h9_$JLSNUd~u%rG3&hx z9yPegcBEe+Clt8qQAt$&m-w$S{&kPa-SX(GyB@tj+j}0)74z`DDmgsh-w!>kUFgv* z6n*SbT{OlwPlypEpArjNU@Y=Ir=Ixqg-0pqh@qH+)-OF8iM_9hBdb>p(G-qsUcJrb zl~K;CCg_1_6}t%SgqLEjdus+~b z)sR;munzN+yox4!^+DLHN?3-yxPewFUiHL5R8D0ae2D|NiR_K(7p0qc6^{tc;sr`J z^~!@8&Ai%(hRtbEqF(KQE9O;8497BT#r;;);R`S4HhEQ}HRIz3 z+O+lRHY$DTRdeh_`*y^HufFoCLVK^?^z?G=L457iZZ!DDt5L(e+CS2(5o5d@C*al0 zsa{Ro;??GD6aQlrNsLb*TBbbDn5A=e7b=dcArw6J{5QQ|n@>+Mue(o$ zd-xRX<;1=!lwf(eOk26r{3#*8jjkVeEJuG%|6ci@+sREpXzM$$%UoJv7MYz7oD*U$DtiQ z<%R=8F&?>g`ZN|fcM%^VyM3y$hiy0w=U$%@F%>uQ4B7Vk^eavu@TvPjpVl4q>D_Va zbkV1`SbT|jK;6sK139nw)CU()^(v2}?7u$F!==X8d>VlNQ2n}(^PcG&U)=C%Ha@>e z+gm>ELZRE#@t#k;9`o1}pRObADRJW#IzFS`$ot%)F~j}BE4QJ(xQaj?LkkedYp_15!7(j{mKHD+`_NFwj|?rw z&O(L?7N#$ZDq`sA$A+F4H8if6p>K*C%3Q+G6qNhK(0a5eX(&f2Ll+P(V`vc`U{6{4 z`;<80Do^Yc3@xl=@EexFZ&rqU^$dMp-_Q=Ma~XVxK>j{MU2qUp3`1ja7XiPaWysag zP$&F_m5mJ52oQV7P_slskI*pLP+Hi~DY#M$K2I7dkZLFi5AbsnL*}Li-%BuVGx}^! zn-+$urWwi|G1MP-urEe`__!tcBe@kZKB+FjVAsLnAkl+aHXHu74V=Z%52HhU-Y)OdQ*Z ze}|#oI}Hs-|6PVE?cw!>g?pK=eT;+i`weA1VCZ{fK4@sbA>zmHM|u5X{xL%z9A~ai z66# zA;0W}{rVnri}_Wsv|qK$`t=-bKJ_c(XMV-X`?a^CUv(?_wFf6E`;}0|ufsT1)vxB& z{ThKo*ipmJbu#D+zu+G7)%2?^a@Y3DgGcrJvex&jnwiJpxB9gXWo(R%4j783_&DCL za_E6IcE29t9hy1(+7G|euRjszVr*3NurJo*6&zl_M&d7I^wB@sVF7NSq(NVpfWJ}D zPd*rf?RW!oL%+IV1+Jh-BflDAD0bl$>IE1V>+u%mpr7kH__Z2$P%%V3k&e^&Fww6N zMq?K;B>81Qcl?ZVD3I)z3;nPbcTpznR}+lEHatd^6#B+Y96`2JzijA^`M7{$js0qj zvDk?hsL_O4U>1%dcT>N77=jIWglf(F9Bb&;QryI+&8ZiDzz#e`jTU~6MWm*y$-y0i=Ez*hl&TMlS*mw?*$2xv~bfh0$MUYpn(%;kHdI_<5L2vF*Tqb(*yby zt!D((6ED#uop!SVifjmII)c9k6vb88Hw9GwkAVK$6Ht}C#EE<8wJ)F}`vV$&AfSmj zh39_-ROb+R;spl&9njgs0sVM{S{x6^j43Aq3ZD$9C1#ysoPPo;dYV|U`&>Y+E)oNt zUn2L*#DF?i$n^oaVCX}}L(xY8ee*b=&QAjBhi{*<{ds^j-~-zEmd7&()f69O391<8 z;BD5RDrFBUxk6BxD+akXWKgTnrb^M2QQGLeo#N)jycG= zOF=zw236e^)MY%xx9%XiCm>kFztAgDxS3I_Edrr~KQsH=&zL4%~AeoGC? z(Ke__o#_)TzX@s$zUv*-fj->!3$hkfP`8n{KkWttRbyaKSMUhE2L*Lva8N^r1T}7a zP=_#NLQvyTWFomu3aa#E;#wWlODta#)E{uJ4Qlqfpc<_Y>X)NI-No!|2Umky_-~LkVuD(MRyTv{h7z}ey8bYzpB@J_^l4DR=WKgH z?k{QgDySK+gIuQ~sDtl<9LE;Y%#0x|$`sP*%prBj5>hyONcD4vR6b8gEAoc4Azw%% zJ`5?nbV$)kAw8%Z($y*<9j_YF?rI^;s}a)VxRA!0Lb_c$q{DSW+EF*8jrHiWen`bE zA>G7QD}C8RN^pjB%N5dFPe?y|LptdTX^s)n1&sHHG#3>bhBT~Eh-=!1R00E0xPM5g z$UY#XB1p%pfgueT6w(Ad!JO&zgYh%y2Nh=0PdaU8(GPlI-$w3lB0lU#(jVmcCpm7W z&F+vcV!|HsLdCry4c`}%Ykx@jFN73A#)}~pz*IcB#F&?MP2TrHdWTi_LtINPB;SLO7CdC!Mel2jiN?9P;=M>vou?lKQgV?bjl*@6{5VNXizewl z3KmOZo$@68T`EcE@nz{GwJDpVgE;+Zl0It7_RjRxB}p6ctZS0;f0LxLLz0wpRFY;+ zNYaXlNh&ahzUC$ATU^KSpOf^-+9b8dnvF^FZc0+;Ke^qLq`s$;RJlU3b~H`apI;>F z(>BS<*DG1JMagQrJy}E0WpA=d9ZuFQj69O89w(Fa1eSbZwJi`<+2pV`eje7=)?saH z6V`?0c!mCdhSh6JSRZW-tNQk^7VIRZUF?gz zd&0`HH>`^L!m{rVtNyXD3Y`qA5>}lJ>wo9MnshO&HCTFyaW027_DNVXUWDa-8CK_4 zVHJ2CRuI!LHcN`;e2}8c_%&CGIW0X1+(ON4h;x{bJt|XH zql)4$tZQN>k=YDwj&lB-5pUm>cmoKe+Jit0i#`-G#a z)10RK*x4t_`utI?!!Gpe7ge$TQ8h!Z0Z|plX;c^%Ra<;KJgSN~h%6(c zYK2kXkqc~NqUwukW21^k?jNFD$1JMe*gifg|AZ*#Rz!6M+tZ`UFe}P+kfYjxKC`3x zVNR5}jOxf-@|(v#IEtU3wj!#mYoe<4Ta;^iQLjBwb;JU6zr%jT zVyag4Zn}67mi`| zX!;rx(~TcvvW|5s$GBc*OeJPwc1%l=cTP-qF>r27udrcWOhp#NbOtRK z#?*FoOdU?dbo5kA7t!~hm=568a6YJPt(5b#y0R>fC6P@_h*YQE|jSvi^hDuL=* z{%l{3>Q%C97!>13T;Uo2i}k<%CiP5>_}^`U_;v4!^oxXjGSdj>#i}Ci$W$}@UL1~< zgl$3iDH|-gS}$iqkW(E>)_~59VO0|--4uS5YRw?IIb=v}dB2tR$bxsFV-L71#d?FS zpZ50G-T{y`2)_FSo_q?OK7($b!`dNGST1)*z}q9CtJE6>ttDqP z)RazRp|=bg2VcpH@rpMIBBsMM`F<_Lt^?=yux>rQy&1FQC8pUqV$`Cmkar=qp}B z1eN7G8EA}Pl+-Xq&_edgNOJ_Uq=hAdj&erwq9dp;QH3Iim#?IJ(Fpue-JKCs^hR(ZD}sdV2K9&)(t9b<0mJ#%qS#L-1M_bk1 zK7vm=Xl`;v?C(Y}L%#16!Hf4I=-N4gOI;#J>8e=WHOI*jOqvpbVXFF@8^QT`s&jq> zA1;Vswu5ylfIluV#^yZyw1~xz!?)HZ3FREd5(Y67{?HAUlhsj(r<}kejUlz%ObhGJd$_5 zi{!VpI`%^(r?y3sxi^wQ@~wQPAJlvHM-u!wk~%U%vW}_m%fdctXo@N{9oMT{P$iM*^8a6OlqVf$iC@`>9 z7FRK_UV2tF@R{6~?CJ)V$>+6Hht#ia;7vIqwz>x9*E3M9xq;?Vw1s+>@p87Mf$gmg zSlb#XDW~MBv}|W!PJ7L+gZ6aM%-&agxzp9a{%(rV!$3kG_5GP157y%$2LAa%wM{hO zoMhm`$p&6bF|c5|<|nIX8T4AvOr*tf1Iy*^HwNBbVc_K|1GQJ{9IVldWX5{UO9DS= zo^tC)1C2Ktn7YY;X|sVJw;1?ftAQKh+OBgh{G@X$$98F!yLJBe=p5};ZTk#l?Ke>G zxayPalLo$)*k3hEF2$bOC~fl zlG(_}Y`NUn$X#jM#7N<$irdV{PO06}$SoQ8rjew#jO>=^wnhfXN9~OK)WOJuj>_|% zYUr$6>Gr;n4Kebu{4KtrMqUgv>OGB-sB!9TyphdvOo~o0a&nH5>2r--nrEcJd?OvC&{89@ z-x?VqM^_oiUu|Uh8Y4}~P>s^-n2}#4`GgVc6(i@Q_BA78uN$d*OXuZ*kt@9FN}O5Z~kZGAIXj|QPg7Mqar4~UQC>mKc!VM6LX52C>&$r zS|t-B(o7t+n`oVGqJh`M5Awdx#6bB=JOLAPWu;8aF;PEPw|OQaLMGy6dQ}tUn<$TL zYHGsX%!H-2iGJdE-9)Y|m%DG6IQgcDsqdJ0C2QU_u|qr^P4wwx;;QuRYT}HH=w@Pu zSh|~N*u%tDnbzAxsgF#w?_=Va4D6@;{Y{LQY6DC(lb^&gNV(dhv~Y|$QByjA;m zn)v1?6Hle(ZW9aT&pmp)*TmcVOstb<`%QHIS$!W?eMi*OQ9UoF6DB&yvXdqfPML^0 zZ{iJ^|BH!Y7c`qoTK~I=##AkO*`0tviD&NVIdnWeWH{pI{ zVv?MHY@+rP6E~ll@IE&&PnQ3yI{q{9Qa&My2a*#R#WL9{|H&R>6!lC|Oo)oooAW4a za@-QdQCAcnx}&%+S>7m?%4RY6qNtS_#g6PK3gtx6T2{#Y+$h@RMG>1H#V|Qo5Jhg~ zD123;h^iJv{pwM?E=6lZF-A_-jG}6-C?Xmvw&XU7;%t*Bx;BmCyJk^LX%WS#_ECJ? zA&Ni6{caS$b&MkAy(p|*qIfw_`#;uN88cMzhUxL}D6W1Pg=0h%Go;1rC}z!xB6@BV zWu?LVDAsL^;`yd1%$uY5M!IiNuRGNDPf-k&Z}vuUZ(kH`_p85yQ8YQEUgflOJQ79n z-6*=;i=waG6yHBlERYKi_1xnqJo4I;C_2lkr%{xCrv6?;aqDFiZC*ujDAG(7gPAXl zW*&>xY^IUL%r;q9#7tCCGxdv^8BpBJVJQ)7rkprRnE6hg#F_c6l$lo*%)C+2%={EH z#Zt{ot)yeJCe6$a@z~AuahSO(IZmyUW-c@D$O%dGs0NAfndvO0{ASW+ru-gIO+hmw zGt4}bm6>L?NP3o;UfFtHUJIM`-oZ>(zL{FGL0%S^=~~%LxQ?0Wa;dJF2KCHbX=r9= zBQup7o7p3Unwr_y%1p&JW|m6qn`TnECsPnci2;Y`kVB?YerAFJ#V5GtK{29k+DOZks71Z^_pW&6Iwm zxjxoh<%am5DCaXX-JY9S`$GM^G?OV4UYVI2Vc}P)8);#@!GgGna4p(` zuaJd)g)PJvwa`J96|;~~+@jyNEbJ6>2@ADs7ADF0cngOUER;*M&?(76+G`f3%CDs@ zd|t-F!m<`#NwxA8*2=r77XB7rnuYoDdOZuPq6}+l z;ea%3X5kyT*W5ze78X8x!@@~Pdeg#JVrpxlwajg2p-6iR-*&PP@t*4KY+-|Z^r3|v z67`XVJ~E(>g;sqnMEA4k99kG5NBdjIA7IhXcIB6K!!5M<(t_nH3yJcj93EjIG}1y7 z=_Zj=RGUnmYT@oQ3whJk{|wbBHD_5^B!A6TZF4O6=UMnvcF(t9TWF!Ze7(rRlf@P~ zF0rs;scQM!f=8yUv`}N6g&(Es_Z9}pP4RB9Fi*ah30p1n->I6U#4Za%BxSdHk)wNb zZVy@*cgn&o@t?7Nvgt1i_L~+; z-PU^9a>qjWo@Rev=i(m=N92n9D}^3dNPT2siIjR`VW|v$X5q|po%Y2_1xm638+x*Dx~XR^}CVr5Y=E7syx8pT-ICMV^NypVITRx(Ri`8dwX z2stUA+pO%1x6(M#%8l2o1WH>OP{zuia<;6M3gxVHDX+aUI9d6nTtzG6WVZY!ucxTK zR4a*sxU*u<}tutA6%aY2Vn&7Kv=C zx?5@O>sF3Qd>bpb+AH7tRxU{SZdS(2w(eH!J*@QXY2}in^imBUS$Qdq`&jie$Eu$> zR(43RzmvrhIPYxm5l_YrnG6ZIsqX)EFy$r1n@VE9Cw-EA7TxX*t2lI(arx zz09!kN~+DWvQ{GIS?Mn8=3AMz&`PgGR*J5*GE@$%vy$_@l|AdN6#7B=W!sNdZg13# zH!GG{_G=Du_h&0_AFy)jpp}w`b#7#?oIIlb&RAJ0zscQmR`M@cX(%84YGtGREO8gD zRFn>vtb8kze$(qf)=8b;txT4ce^_}UPvfGgW{ajlxoD=#VY!hTjXy7%Pb5?j%`w?n zC7Q}rqjA)T=2O{SGnzoHXqMHErdg|K`b%!>Xe_VmvE;lFjlE4YABlf)44=r&A7jYa z7{kd;F&y0-L&+^M6xkZXdeMuMTXJeg3}tu5FzcrnM(v7W+U^)e?2BQ@{umBR&d)LQ zJ{ZF``T9@{501nz?|2NAPsXtHR1EjUemaIdzr|4e_ZTc!VrV9TYcUM?D~44!V|XS% z{~bfo+cCT@@poeA`%erzrPae2K7FKmpTw|Vx;~9zq9K-xvMf55A%$W&EcFVqsaPiUi{+Ah`K^wx*Kvv26w4+tZPs(rbYCoUWYsan zzo7WC=FeD~-HK(d47sO$4`M0uFqV6-VwqZ`1b;~BN+oD0=c|^WVzm;~?p}iK155Cu zY#dU8QqxM%N&L%8FlS8({*;RQOYrIG68tQeZj@ldUnPjRS%Lv~N-*?A369G8e@n3P zzY;u=cZg$KWE@sQ9Df_*_}3Ii>!>&uiP;=Sds!(ZEOEp{$ML2VE2j0aaWt2Kwm8}) z#<4=|CFA(GR2=E$;^-@9Q{(93h~s;ypB~3Se;o0FIPT}f5z39@T3#Hd^W*reMH~mD z^xJW4?hr@RJ8_(s#hv50D{u9Qqf*~Eiu8-aJ0Olh^1Cb^s92vW)@N~y8XQOD5UrJO zzlfvP&^Wfp)M0U?eHBM<$)6O*8&l(0B2}lwkvAib;nI9&91rKjQ7|`-vGd|EEr_GB zbXlk#R>YCKQhomr$Hc91T$D1~<7l-zPQPoYpS^J$-WNxopW|qGIF1E!>PQ^FJd7jd zQ5=cSm<``qrb(*E^%9JJSu9Vaxoj@i`yt3W223f zi?!+frj0(58)sv<&Bk%58*k&RBq!KdD=W)sU7C$M={CK`w2|ksQPN|hkl)6TOdE$~ zc$STCb8S48t$8*Yhi$a2YU3N(QB8a6+Bj6tMnZiXA4;2sHvK+eV^bqNZlXQ1rm2lT zTH0{7vQe+K>U-NpSDDqrM$Mi!CP?!SY$Wxz@vdy`W8?Bb8?He%+I?!H#b6urCHiw4 z=fAK~aj1>eGHZm5>+;7ao4$NdY&kK>#;Ex=&PbQVHU@lcW7{`2tSfAESZTw&!A4W* z{eyCCQXH{tu`zX<;z)z-Hh$P)BXXzm{bb{9SuTIb)!jBcdu;67XXD?4ig`?R%V?=} z+QvjVAPau6aZ4&*u<`3<8>od8PA6@ zAuFEBxjH7*Lh-E0kLQIvsvJ+#YVpjGqSfOmUq7C1va4Y{)8B~aie$Enr$vW&E=x+s zcs`IBo#OfU{do3?r+Yk83UI1cvQN;Fzr4s~r0h7%cw% zn!&*YE=#*Z3Cur|z~9pMsMZ}SrZ#S-R&W(l;-Wol-xf+bW3^u9`@6 zwM5F-Q=G<$WHm|D=UIuoYL!Us)`<*%BazeZB~q?)BE}wxWPX^)=ki%^9qW@wS9vV& z^-W~0RPC2YWdB4SN~yt$`GsN*P2}nDM7oSfN$8Ni2|GrBaI|)=OUNB!)|+Hc4!JHwk0MB#L)Q zqD8kP=1Z0C%G*QndM2qy#gj9GlXx^zc}FD?J1L1fvy#Y}t>g2OxUejV)a6Nhwjzo5 zzgG@%{Fp?qpOV-jB@QOB@K6%BrTP&a6Z28!l7wSPbdZ@c`fL(s<+aP&dsXXX^^GKU z{Fy|dzmk~vcM|m;CNWjYy-ecE=#rd}KDLrvPbrBnwIr|dOH!&@Njk~JH%fA{dr8Xl zD9MFg<(YG@Jh9Kq^OhJ2B{Lu{ncec2BN@9dnUCa5m1KriO{PK9WTwl!_Q`C1FPW&$ z$&~MvOe+~H-waCTkxU$xOpC9QnJ+`fBy(UwGPa3|Ge>*oCX*qS<;gUYA zEZCLIlAn{gCkIX@)8$+;-%Gpe$uxYJ%nUhWu7IUb1)528QUzX?u0X9a6>#_~5Z}21 z?Pc-63e^9!0@I}Is0xgqP=O25ZEgknZmqxy*|)O-u|Fx+@e0&AUxCR|>2d{q4pM;{ z*L53Hk<8eNOnIjwRo}137)kC|k=62C{QWEPyR;ouk#D5O=8D|hRgsL{71?#BA|+o` zWEv@4mSFJ|8pNeAU9!ui@ON?wnH5rSRZP)m5qc~GohgJpDeUy7@WPiuO@9iDWL_|Z zn{p&0g*DlFP8Q{+P&cH<`FbpYf)sjGP9eQYivE5|(Vu}72GmU9ew`E^)JtJoL*;3b z!ro>nlzTmeuClI83RT}q(f3j*wC<3CvsViJ#5G9If0DumS@T5-w@0bw(JA~pF@-Ot zsSc?*LwjeXFh+XKPNDzY6n2ScUJ6B4D4ulxE`^2Lv|rxalR}w8DRdF<;S}nfO<}6^ z`89=<-%|KM&R$L7ryJV;X9|yQr|{}g3bh}naPg^ndy&FM`R8Q{*Nv(8OsN!)PQ_U$ zm44E)cq-jvQu$GK#-=hOE|shDj!kP5Q~6jbmP}=s>@Jl`vDZ@RTsoDTsi|aC(q2a@ z4%Ksmzs?H?;mvDrN7cvgcVUTVAV#xpXCd%c?}N>`F9{>C!A*iMi6PN+mYFSqbA? zl_=G>5{>?6VI^it?>&{McBYc93#r7*Yn6C-qY?#wR$}CxO8R_V$7IdJN*JtZG?c$$ z(#T6nW4J7>kcQcxrtj0z_`GQvH#?@0(J75a@29cs(=;B4Yl+saOyj=H+?K}aJ!zEN zo5r{kX{QmUgbo{dRUD z+uPY9ha|s)oni0Tc_h2L*f}lZ-nTPPV!GOC-OaA=itQ91pn3+XPdV|aout8bMo6zA zc7FWAPTEjA%f7Pfx+gnrN80&eqMd&y+37LaPV6i@!)L4KId;Nx?L3`lr(l7d0}Jic zT4rbLa;=r|-`Q!p)=s^3b|!wWI@fE?KiZkK(N3XFy1!NTx9R?N?b~I?vfEChJ$ANB zp+lPM5j$Ov+PNS<9JlLwB|9rm+Ij7i9iI%4f-|b+tewYF=$xJEmsH~&JL~Ui{`c(U z%GpPDo;|k{{X#R5Q&RJ#oiVR;Zlzg-gPD;Iq74p4M>{xK$U(Kj4ptU(@Mdubi((x5 zPQjt;b{w3Rqh%b#mvb;&CMG*LU%^40iVkMkwMRNR9Q2hx#p85v$LAm+$HCjV4oX*c zaIuDiinSa}mJM|rysGPyzCRzWwgO_hO z=+?%;wKpA%d&|L@w;i-^=b&|02lKi)DAwJ<@m>xRdpr0_R`qwVT?PzrFhbG>Ik+*{ z!BbiLxr3i1IK;uAFC6?W?+$ZN{woIur1(e&8|D4cn!y;=Etlkuv>U5h$Enuw4&Ixp zJkuQ1o8jR4YzMBn+CR_1xup)uE>oTI{x_;=g@d*$HA7jr+QDCI94y=5V9X{5r#3sN zzD0A{reoV3Y}w&p^G*kmyOi^12aSGFPAPf8fkXcO-NB(Nnx{;=s#+xJn$}!*a7?aA z<692e+}FG$^&bbBvP|wiP#q5)d?dd;)A{<>!Ix6yKL<@@mqbUTGf>9K^Qd%|6iR1< zd{8)@!Savf6isKjY!iE2Iu{btxg|@Jv{w3+O{Z+dbi8s?o=dlsbk?P&Q=w8i*|Nx) z&d=HD{34Tc(pfC=x#_%>m(F3iEW@g#Q@vq2Eu>f@#gqwhu5miGn`o`y&Hx!J&lYP=E7CE2o6f>j z>8$uJoh{OLt@g=NDfm8})v{YWo6>o6hvu_0of1DOmrUB1&VnQ9td(v@)A?BLNXBuU zAE|RTo$=?=>HkYQ)BZ{4(t~up|4Zk!$LYNDL_J9H=jpV1kn zowhhx8sQ{9(#cy!CyPx^;-Z`sk9E?jgpMaU$u8xjju>8ZQbLBwq0&x5Wt_ZI&dE3B zos>*=a;<_BXNr^Al2pk_yEG@qWQW6v+394W%Sl>>lb)GQ>{(7e$ad;`LMQifon(ca zd@ZF5oV;7vNiVrA!KzLk)N)d^u9Ft^oa~WbH4LU3z9Ly$;Ts|jF1O1dbE={(rS#8_vE~k8|P%jcqg?d zJ6SN*$y(_)P5b1IWXy0>ZHNf%C}OvW%jpDR!W&wPCBl3a#|wSYKC%H zE=r?y+WWnesP*dc2le=)dX%-BoIKm?Waw5WM|Y~PT~11!b<*LS=5pT2iOb4+%gKb> zP9p9&8FJT2`aPW!c`Q-)o%EOO|2XkHaMJRTdV8#M_f+#Yx!4fpBGv5Tki|ubXcu2d zmqISq6n0Urh>PoSE?n_0=1BRHE;^TT@$YLcYLszttgK7lzqmM);-Y4%irq9Jv*)0F~UF;0IuoSrHFRyC5C|bwGemN&~>$;dw&qYLi7kwJK zur_khxUq{JvZ%R>FI%~oE=^mz=pd)0)Eh2F$t{`Q#>H=Mx_I8!MV0pIt%Hj}@4493 z*@gWBm#!CbG3`SamwHPd)!om<6!}K-2e@c9)WytUE~1CKX#b^4?+0A0m*f$e%}AF% z|8r4myy8vPnyD@Z%J~_Z*DM#~#Wl~xNAq1=mEXSBe3!fQ9kOP(%Eju{F3PTPQGKoI zUFYJ3^jxp=utB|UaS=Y?qM=w0x=56f((JH{ccsh`7j8LxRBKPV7%r7hX*P2AwCeg@ zb^YPu&8sdRymXQKuX>Vo|7jMuF-N%hQjSEr$v3$9+T`X=l$*EBZbDW!4a6MnCP7BX zu|jSt7j{#)h?{0b-RzPEv05*QCETRRO!*_uO%t1&$?R!_8rNUdye|u-tqns~Wg@)X+`G zMsCJ6adW1ro0`qsEPB(;&9~eb+PbOR&P^-%yuDl3m%7P*M|H}{F3LSnxd*xRS(clp zU$`k4=4Q3*`qEAG2sZ;|;wU%gN4u#r#?AC`ZhjlDnkFdUWaXIR=84Ri>gMV+H}~bg z>2Ai%adT>}o3``abXeqO`C>OoOWX{SVc)npv_dmo>88fFZbq+iGeb(RcJuBUH?w|l z^K6@DyTi>Isj|z>SG(OzkwSaiG~MgwCrQ|^S^uo_B?}I_`SXaI)<@OvaW@lAxQRIF zro?GCZ=7*+K&qT`b6bMHxLGVCe|2;GqK;p3GvqfnKmYFL%|A3x30-lsQf}UI~W1 zbApG*rFC1z!%jIa)yjGpS6z?dLj?~%SM*Rk)x*(r-FiH<@_N`OH~b!A10G%v zdPvOGZP>&7e61<)@Ly#QHLEISHILpqdZ=Ds`x|(e-qOQwtvobpts2^R826@!h8;XC z>geHSCl7DD=b?NT51rrla88DH^>DD8hrI3{iuLr+@&gZh<$@&l^5FQ`L$6Of{2?C> z^-yY4O5c_`T6VfYUoMr`xY{kVtkPbkhwt+}8z7d@1| z>f!A>9+uqoV7uqx>_ZQOA8BrnJ!Cym&rdaDsq$QPN?E*gitutqwi>(`O18PVh2N+LrXPw3L_l*Ss98=p{DQ%Mkh4sdX+d z%ROH1dA+prc{vpH(m%t?_Drv?CHC@*l+W=pK|Zdc^;MO#nwOo@w7QqwHN5nysak3& zw#3#^Y+2UO%iTt*vxS$kZPiCR^&x-DkWOBT^zhQWr}oQ*US5)WtKL3d9G@!QXI@?o z_A+j$_6+mtXSni?)bpd&kNiE>i+{YAg<_iMrO{+BXQz6(IL%AN8D1vKrI}t*W_y_; zz2TN2G#{%SJ|3t0_}t|q&F9l~;XZzor@1}~LV8|WhkeY;_ff3ChoP#E_42Zsk1uQZ zs94WO*ZMv#$iYTFVw?CFBFCHhNNnz7Q41e!+WJ`7&PV%BKAfF>gyo5tyZ9I&JKp!P ztef(GsQkT^Uk>*1@ljtN!=#{}k4CanECYP>m$id@Jp0&3mrqpdXWI9<@(%U!^DrOH zzx46vA|IY5s#^kItKVflOyBruyVl3jbw1+1_t9&Ej~{>VQEj7-rdxf?*yh8!-N)IT zKFaL!F;=D>@^R^~kA_E7^Kl>fCw;7vbEkZaJgq*@_!x0sv%TV@<~1K1Wd9A#>MtLk zNyEQ=Ou41G-SJWPu8&PJ?Xh}#;$!$z&0ZEh_wm;YAFsdEvHyG=#!ooHPsre>ftZbc z5@duNGx@0;<)=qcKc7iXF+X)=vqZ-D`A|wG`bn2-@<`rG^0TU>pE9NV6qNJRSfa~o zos5=~$$qL;@Y5^Z&kzYY{nVFjVsiWGBl7}&t_SsehMzk*elqg>ERpsFewJ1C6R4^h z>Zpc#e#X@I^P-8Ls?GeYmAICE+O+a>P&&NfXL%bx!MF5W2S3l=@$27$`1z)npZgyw zUT;552l<)tv7d^cs_)T$-X7!UhWw zMFJ$o1ZW!@;HcD$3oynO;FXL>2yiShK;@(Wb4my3QzpQBWdp1#7obe}057C!g#Z!u z07hp(*ZBvC4g~lnBf$O40Bb^uTM%Gr<$$ii4Uk+fK$rRf(wYWzZEb*GTL!4#D!{n5 z0sRbC?)CvTy`y*?1B~tzAg+6WHa!Ad?-{_>Kfs#<0vwXIgB0`Q0P&v$X!Lo2sYBGu zR{@5O4sdWxfV{B*c8yal69NpB@1_TMIwL^mnd)P9fU9!?G@q+J=La~oAVBqn0ZJ|o z(0)mP<8oahm#V(615{WZV3I78606n20rhY&zf~-jn(y~I3ITeExNePltDM+_8#gNU8Ad$`>AIe^@p7#g& zM7CuHF=Z>36b}Vy6%MjAKgjKZAS-JGX;?qVlm=SUFi6doLB_NS>ifqaU%npX$Qwak ze>2F1wn38H2bn0<-w876-Jm`L39_tTkh}eZyp&M`g3Okd1A}yub5i!>Am4nVoI`^2 z|3W=UwV^@%P84L16doRA+Lu8rqk=RV9b~&a9vdV)UVY1!i9!9_tRRNTLAJ_aDVP#u zzTB9qxYP99^dNC^L@r6=8HzbGhN7UyZs{e{|$O%chrk>>e>p{M|5hV0i zklhc06nYdSQAW$j$3fnHs`;BU*kZ}RY0cn8@eHcQX3$8sOH^D2C1jc0wPnyYK7(%Z zOmY)5a3y8%QOOJf40g!B(k3N?8xoV6!CpBpx1^XOgV&^+)Ny7o-jzWQ zcLwV{8KihKsFb6}xfu*=kfCdCGYB=xz|%B?zRfb|(mF%ex+u=O%GoJ{_q%6c?vcS< z**htNB2zMmSeQZWMLND*b+1(2-)1mybq2;CGN|`s2Ak!|#ta;rGuXF9dA2LhjtoZa zRZS-|Sa&Le3a2xee@^wE&!E*W8PvR#f$5J7eu>JYyd{&B)=VNwW>ULUCMRFZ;=%`!REJd;q1Oq$4QIq^XzNgrnN$-qqNF3e=YBJE$CNxXEBRo`UtXhkN` ztK~QC`#qEJjZ9{i&Ek)8Su`o1#rbMkl&g_N;rdzRPsn1}#4P@rnZ*a2v-n|47FD-p zaqUnR&LdgOmZHCA(c)qjd*sTWSvYQHF;mLj&f>j0S)@M9qECfvwp7g4=UCYsaAyDgq=%w~yf65Fh7qUL1NU~V>B<%D!yoXw)Iv$?q}n>Utc z(^H~XXA{3Ro43|wb676Rqs`eQ9L?tKW7!;$D>Cqm?w?cKU$Pk{Cw|W+>9XpQwf|)E z>_IjspJ(f}mcvh zn!|``IXshhSLCo_We%mj&A}@}x zp5!p|RSwq*=i)4yOIER5I>hBtIX+i^zvb%hw_FxEaw(CX%aTAYOLKC$otw+ZP%dLT z&at^z#^-WlZZ7Wmxy+TWYjRopT`s+T$fen~TxM?1C3;6L z$XfDBc*(~JUW-pqiR|nLtEzQeNUdQm&l{B?0r3tTOINUyqm{AUGg|R zHjmfF=P_D7Uzo@KMR{Z|*7~J+4Eb7XBx+3_4Zh2x@DIv+A&>8`qQ{k1dk*cOIYK%Hxh~x|2u5y*!G_DtUB2kB>(yOLKxCR40DG#z!y#@}4H2jwVv$s@8Ddne5HF-qoe)jyhWJT_)mO|0irFwk>qa5wH4ag% zNr?STb=y3|XELirh|4Xtr&WkLZ-p5Db_m*rSluqfJ;eh;%t{HbjYELcDQ7_hsU* zAaor6Omeun3o@R1iGn8geL(F^@BKmoV?SzSn40G8Wrc7d(j!9uo zOPSKTUq<)kZn-d-$zf_&2y>=ln9`|XmQ@PVHyCDXMi^ISn3`E(#$<=7pC9IMoiK6r z!VHx!>xVhgAWVM4Fowoq>NW|pN$kzTe9$7y@3QHQFmJsX=6z}NR+xovhgmH*+J$j< z2s2kkyc6cwyJ0GKRQyhg-&yfxPuDPoyN5}V-BPG$m_%79e|-?sQY=A%!-d@h4O)#D*yUVahAIy8(|&P%!B>QP3@@h`(v`6^69i5(f{ z^-+o^XT&*LHI50BFfL3*nIxmfhdDVRtk+GL#`5~4F!LveDLzGWl-n|Us?NdmFvb~S z>dg$ZS@z4IS*m+>82_9wP3MJ~F+WV}rD48b73Rh2Fp)ood3Sf16?-(hgJCM2QBP;X zJUbU={KYV5FNLY~oBH`(`7eiACo^tq=66)fUDffAX8a(mYuCdRc@n1iQ_WC<KF;MW}moIF!N$#Vr%lA7nW{uiwm z=U)Z%zFELv$-Gs-C$|f@Ek*7X(ENS@yCwfY0mB{^Fj3|_Dq!4`0%ps(Dn+K%==uC% zg#MQ$aqryM{}JT>{+DqsIP$|CJ3R~M%-j0k>*0?F{FGbiz}l4e$F(@pzg5!KD*tbv L{zdx#_uu~kJoA#S literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/67b10b60301b03bf_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/67b10b60301b03bf_0 new file mode 100644 index 0000000000000000000000000000000000000000..9f4ef34df483236824a2c078096f2d76c14a2489 GIT binary patch literal 18392 zcmY-1cX*TK8~6Wrn_Xs0(*d#yElrx8v~(mbd+)8N3-|_tMa2zj_-1l{z*Lj{-NYms--|O#xU8=|P7bc*J%siED&<&My zst0Rk2dh@g4Asca3RJ6}RV}M#Eq|6jr)Kr)wX$p0$gCEq8LV0>(_gtpuvV?iU@#D@ zUcG8|)vDEM25JOz{ukt6eBqh@i}k-hO+9`8zuQFpHxLDvq<=K*ky%DKBQ_;*OQu=i zkK%B+By0)6&)Hzj)p$7-hMXEuvL1ObwRBsL`Eg)0s$h)mIN4|U;I`xFx zQmhZy`)lq1%^j#Z2gA1?!Q+pi^C!^#Q&>9`s(uCuBjEMVp{rzl0n6m}NO*G;bd&m{ zp^fB>fm+ge9Q2XFTZXLM3gLU7-Hd(kHmTXeZTVRvym%OcD`5BVr zs9cohJ7DKdI3eSA!F(yc8|v+awqpMUQe~R_x)09D)cx?4Bpgt0kH8A)bQJmu$02kA zYRZ37>?914anj=)n0|w;7a-<$C?zN4inRIz8vhCHrQ}6$%53@Y5{#AFm!Y-n{huq^ zPnmob7D@aysPMPem0R+!^tui&|AC@6G+s_i-J3A)7Oa-8w_%`Mmjn0Ug3P!NOC|XM z+^GZiiU0zC&GEsaYl~baqBheK!M~2BHIae`?8ICA^cSg}TBZ}8$z4UNJ zQPCI0(aKRIW=Bz1#>hD-lcUEnRi@`haiCfh4s74X{6kmMDd}FlpQUiu(gU}fXsd~ia*;a=MGVP)KNW?OX7Gtikb3V z=O~`P6GgW!QC#R6MQS(2>Y*M^iDL59C=An7+q@{w%vYWZqImzyD1KTPMXSY8Y}*%w zbe+P2Y{C$a~TJJvJKe_-MlN_Jn8>Cr0zeq-gd_%;ad^k$dvWlxU8~ zWqB;gGolI3jHZe-o)gUlDg9+MEfz)dhxGp{npsN}^Xq87UK-8KWzoF#Z8X2H)v+I< zIld*DKV{waXcq2@CTn*zgXJ6fL@&;}_C^!>C7QZ2QYs%-FODd$(~A38Ydq1qPZdkP zk}|KDiJ8V$56Y+z0i1BHqjI9JTTxZ(!pNs(9s&EpL0kWnQJ%$An%20FvQHw(28NY1@IW%l8mJ|dGf-TH$}i;&bQA2g5_GVpemfxhCcY@k5Cl_%K-y6C6bPhkVU%CLxmDPqny(6GS3 zW?5X-!1vOtnt@N`u4LCRuv9*+tvsYb9Rsh+L9y2}u%Nzy>MabkkfJSBvrLdvtqg2! zW5CwVKuI|+m!(yE19Lm5cO5mSt9tgX;>)dW2KIJWjGhJ(`>O6w^mvFK4>fS_GvzkP zfNQdW_ooJ=>t?hI%3`ml;?lx0f4ubA^Eys|?gxtvy(y9?8t_)h`MD zpnl4Y9}P75$-uM?222|b{J6=$dz%eh6Zcl_x$v|0Ru1n_FL!GHcWIAyE4MucD(^K= z|A_LF>|+MLmbl;4OEFwfu5#s;fu6Swe0Rq{g}VmsOU`}OESV1t41Q$b3$Z^o@Rj`Y zM9+_B>TzKs3yT<8EvZF~+$?6~<5(m9I3rbMjXWx0)N{>9*#slQl8u~7F>*28h&RJX zeYcS`kC8%tBh3Ov)`pC z$VgUWBXi_p6C<~!T~i~4n<;K{Bip4;E2Ca7j0}3+Nb(y-c1lb;BLn4w_C|j0Xykq; zt@Dm@=%QQc{;rWD;_7DP{q9B@zh`8#yw}^v5VDVNQq5GcFRer zx!K6*Ek>S6+HTb*KkhM7X|MYDi*o!`IZE%tMt+l&qeg6(jGUG_SB#9iYNXx`?aO^5 zm&EbV$oCTU$VlzSMru4YvR8^eH}a9Z{-2S1k{xBDsMW*=MNE3Wm^dweN$X-J<`y?m zIM&3KN+w38n>ge!(I&%0L!XHs7fyClh@;o473fx|ujB zBfFcJDb^k)8uc`>S*G_fQR)K|9r~I$EQ9(hhXE!gNcDjxn#<2(9jvwG)Q5^a*~C$4 zG{wY}sV4ngHjyMtr<(|VW#U&U{Z^ zBpx?mK4aoFS#Z`wv2*Ip1&#m1L=#yn<^D9$`J#zhmrUHcY2uSxCIYujRFiMz@f{Pp z?wasCG%;DuJTg(|v5D(XO!%Iem@muzRUZGDcp)EQ=Dy@an^`KGQ!pklW1r9y52Pvd_#C*(e6Tnc7)qwq=_slw+oitdP68X4>bOiOV-LT=o^1 z$*p3>U(JlUx|s$w%)BZ^YnmA=$7-3WR@+QeBgK~7#%4}6HPfw`nQxn$ncC9KLTT7W z^IkR6>oqgW+M0Q-y_w@3%zW6<%wOVp+syBs%%r|!#@5x$i$RL}p<>9`VOnRn9*;0{ z`ExVQk!EH}%Q&rDfqxWLT1pUgblV8*i1%yQ|mNj=!6e*A1^m@MCI=FT27 z?e?nfeP){OR}bWbbUJ7z<+howcg*yY>*Bv>=1V#EK<6Hr@yaWY&2*7fPt25ls=A+> zx$(kG+m~kcM_Z_Bu<*Ij!XvR+EHt)S*dptSSTGm0(4d%wfyFHxkP>kg%89dtg>U6? zyoKLOS$J8&!fO>REJ(FbEX~5SN;)QM(k*NgufsxLr-jRs}D=bvbw@_Qw%ZmaF-KtoK z)U_}}F4VKou)c*$jVx?$Y@tdM3%jIHGYflKTR1MmUbRrMtp&d7iRoz}vzLXz?^)RUfrTc0)q{Q(O#LmCl;r~~xJFxee~g7c z<&ngWwQzHig{@O8?EhM8EmK^XCi|9K_+XRjm4Yo6D($lH&m{|eE?fBNiiPy6s!KkT zxz{bU_(yr%(Ei=DP)6R6uOC<_{ZKuAq#nyP2|U)CPc3wRW?}7f)$_tamP~wUVP2G# z-=to&l?etbZljd~vz5_u#A4-2j1_+&EBy;wNhoTiqbx0EC9$|wzo%K*E|wBjYTK<$ zmNN-f4kTJBmt>`LvX%5#tW1;NN?ZA~jFp9Dt-O@#<*lrhx6`crBmQ(N3*^=MR#wS_ z23Fo`XyrZmTJ|?mtj1ciiIwv*yqT3>rBQP$%jHfBEA3iZ`Q$Y#$0Yf6D_@AIos~8+ zuf3Hb9jtuQ*-F$q%D0P^_42{{Rk}B(NmS1Oqpio_H-+GGgSXfxeto z#76=vw6=zphgr-`Uvpy^TUYC{Nk)qm7$CX)iV^mRR?yUvm2w z8*lz<6s6L#uu|$5C+ox^hpR>_OKKRYXPx6bzpSMv_I$p5xjZFSs z&lg!Ib^ow2MOOZ4~z`T5b%1ycj-`a6t@*<)^AKRH+t&vt|q* z%g$Oc1Z&5zv`!4oTgNa!a@)jUeN~So=d~CdZDaUA0*hn$NUr}FOXg3p9NQ4fp^dSW z+!RZZ&9QthdJ=O(j&F;l?Dkk@{~XKc9kEQ`8Oz8$u?*cC%K^#xC6+$>V%Z{J?~mpF z!C2-WiKWW1Se6`*<*qnR#Io!6Sc?As9 zU|9*~t|`G^QgLqyK0Z-`U*y8I60HBb1X0&ZFz{9hhCMIAA^HB_60H2M1drt{;@J`% zkIfLzKgM|eHO14$9M2-LSmNm*E2V@rp4gapUYBCUG(Ik#7Ba{lPy3{JR*0iyJRg>d zC!<_E{p3_yJYAjfd?yVu;@KC7Cm|Tm-JE#Bx$#`di|0gsJfF0T=T|BHW;`1^#$$df zo-?wzOFXybjlS_z>K9Lu{_*$*#xq#{ki~-(>tn_GB%aYj;)x!rvGUDl@$?=R&nB5R zJf8F~;^`y#ljC`9T0CD#wdwKX&5UP+w3rpogSqh(%!_B-{CG@X#?wT)E>sOG;z?Pl zx_^jg(&l*1OPQ_lwB8x7-&<7A?syLDiKp)`@w7S+&zExiU_56Z#FP3ko}_2-O#U~X z3(^=nzluG|&LV@IE+#wcB+FuFfYr_p@!0G&HWv+F&ooxYMA zZ)b$v&Jn4XVCR&iB-&XkE6ZtIx}94YcD*mPljpWm(rc$sz|PPtI|pP$Wjo*G+Ib?I z^XxQ<*lAbI&T`pSU32T%*SbDQ@@S! zd(%!gncdS)tzLE}N{jdGB=@oNwruWe=i(qc?!k82e{84a5IYMb=2JUoKC@GCn4Q%! zd!(JK^5z+36&+Zri!{z)pqdcKRC<^ifv=&m^-*0z>4Rq6sWcOyIVR zNlswND+$~cN9hEPq$co6S^}3VC1CX?&|G!|5*Qau;Eaq8B~U3Vf%j!%X=jy zC$J_zf#>qDN&?NQCoorv)<~dyg9N(Ejz$U0crAfTlGQ$emK_tgD5;$icu!__PT<3L z6WAl(9tlj7KP9f3Eywx4bzjfo0NvQUcq*N}%u( z#aNNRz*PzCltt?jX!>0ObHuPgz1fvOk=+TD-Jd|20||7M8#3*X=1H9ss`XL=o29|^ z1XAuK&_h-}PGHmX1S~HS^gb$)w+xA_l6X@h)ngJFCxJqVY%Gz8IX;o8uO!l;bRsL| z$1;g}f1b!qd0H-!oC=Bh4keN46%*N#nuskek*c!HoyY@uGmyxKp+tRdlgN2F8%|_k zwM2HxiW-SLs-y9B6ZIu#A}?De>T|n9UbIc5SEoca$o4LYwC$0|5}E&=^68yOQyD3( z`zaTBdtf4G1}9SS!$ej~hfkHOWDZxXk%`nEm55$YkVg{vhIQ$30D^%bW{ z5|x`K>GQE9Ubar6PMah~yq3g?cakXAB?)8CB(mO5;#2vgkB;?CqMJODclsrg)52Vx(#r#Y$hb8f3L=s&`Ch?sVj8gn@ia%b*Cnm9fS`vxVHFuV7=OximUd&Ho z*McO9f0@K93-wrPFG`~M;v{xdN~UOfGCprI&GV9(C%dXAW2uo$74g(eW}s}ZmCU}{ z$t2WCrl&M)n#>GY)-0L$7Rh`mze%N*$$T$)ZIT%wmD(or)7!}yJ0(-RYcegnC$m7R z_RzXL6|YyaYE(QqIV72fqqOemWa1_#b8B`oIdgP;elq8lCX==-nNLKT%uT6rP{+h_NNY*r;bc0>EE#hunN#x0Ma{jeakBbaGTZ)2rqJKX zO!_C8`VW$sCgolv^Lb23j!Iv9Nv@`r#Gh7@m-!_rRlOvg<@{?UIo6{jWqOw6+>Y|h zy;GjJXXSZA424n{7@xvU`P-R-!=J(jaXmwuvrQ-WPXPfHolXBxl0P=d#BJ^ z#>w)*DLj-(!&7MaMG6aK*w_?)otT1slH$zOoOvl^igj5E&1Ko96ntA#7%X4zNa3qr zQn(|(9!sI?=@h<`_E%GA^dNmzd-VyeM6P+GQ%>3{)VYO9eW};z1Q? z@NosEOWDyCm@u&d=cN0*3iR7tffcf6dj;ZtR;(ixsC%XYQ>4c zno2iW*EW@EZ=~vbu2kA|OvTkZmHy%$tn(kGvR>AFmdef1%6UvG|4vHfv+2r1YR%N# z*{O_`-g8nJFfWxI;+>yLkrj$3J-$t4;TFx8cXp*xW`8PO#djc;`lnKvCVhWPCH41I z-jh?8Q~CLt=Kqz-!<(tRe3(j|N2#2DqS~IP@{`enUyrxnZ|v|&q(8% zH1MV|T@pfylaq!wH;rofY3#0*Mr`dgE;LW0Z<{o>$?7-KDBLxT*0QXR#(tc}AW0jY z#=r?$Pco*ZvE-{X?n;sMX^h;F#&H??i}Lz4jh_ysVLY5hpW|uNKAFZOd3+{~=6|Fy zPgY*j_*-d|y`9Fcr)g|@r4p9XmH54KC5mNNqM^)?=8;OwlkQb3@zd*-FuqZVQvE8? z_?!IX ztC)lJNe*5nJLpl;!JN_#E|qc6ysU$?R2@rma9%1p92}7N33|%5Omj z4MGlD=R4>kDFqG!vRMA9;-GC+2Y=Lc=!AKR2a~>2p5HqtCf(QT_z&v&j}B)4Nhn$>{LuH&KlyfpdCZ#wzQ^85yicV%bG)Fo+ zo%EBx#Orc$%kLyH$H|+yPD)pCa=xaMinX0gk@a<*ysYP>M|~&XH*(Uxv6HWxXna#A zbDKH2+}x?_5}b6E4f6e~PF}p`qf_`KSvA1PRv9?Z$w)~b?Bv=ICr@PUr%ryB&`>9XKXdYrygl4W`7fOOD#b@R`AOa# zqaKV^-f}^1N&9iib-Z$&;3QQ>$UD=t-gGDRXF9n$$BBEM;>>q)dWn;=OO>y@yIi@g zaMEt2dMOK6JNbK!lcnpOjNRbm_(mr+HmN^bbZo1WP1~Go-0mcLht~eZN#nCxTS}gD z;*@{>aI*iB`YO{eDBchxsZyXPcJmdfq>%Hx5P59If!+P8n5 zd@fc0bJA3HNK8})gJirsGiUHsp$yi`dxbL?BKIVxXa>tc4Ox<`vC_Y6 z24yQ|;FIg}OuDCLur4iw3Y9X*mPM`%e#y?@tW3$tV6i0RX7EN{1_$J#46m9&jYb)? zlwyq)QzpvkCK=Resia3`Wb)w=$S44d2#zIV1_4GZ-PW#oRrE_dm$s zGl}%oIN2)Z{u%U>(emiS3~r9hAT&CIV`DP7Ec3=@uu6JO&LDlJZf9liyY!u-*ivO~ z22JE=vCYq5pp28Ji`AzU8JNDwVBx9^R(zYmCh50U^W=#Xe3!v$*(u%)8N9wt{n?&D ziJ!HWOx}~hmj^RgE8P!e@S)t2%p=+#se3Ae38ym{a5jVK_cFL}KSS>qGkE1u25&u9 z4O0AB2CbiGut&aqk-=*(74zQ=V*ksa9WItcxk!k1@rKdGVv~z_vy0+!E?Sq+@njd- zrCih%!z(UI$Z*+T+C{jGi?_cX3#@IbB#>E+)BM zq-VP5mF40?aa4BkUbai$N4mI^>!Nbl#n)20z{T5DT=bTk5~}9ner*>;>$zxI-^DID zE05&;W-fkeu2?NxEYslT$H-KTpan#MbdB=sZw!-i*BF0I47ASmCGm> zBjvt~8RKHEv>xl?9XTWA#=BTC!9|@ZF20=RVy$$au6c4xGH1G|H^;@auUwp8;-cZ# zT5qM+mO0dP4yM=xsK8!jf^bP;vS#n9U>GVW+!l^@44{achTyh zYI~&pd!jusxmj;^lV)+V-|D7BjGND-Yausl3cD#+#Ld-sH|_*CbESMqH(g4(`S%q! zHOsg;T-L4ccHEpybyF+NO=`NE?hZG<$v&r>IG3BDa@*@B%kO51Y?ONeH`^m_tOafc z$jdrziq>_rS58a4dTu7xcN5jXP2WatY>nMCY2s#^ENbEA^VV)=NV7I>I?8b=^_rW} zazkdcb@Th{Zl1MsQ?-L?>*!|iJ8pJ#apQQ;t!tLtOn=|ag+9_(dG~iSRhCQsKsU{Y zxtTTGP0R>49X@yKeS(|sC1s>~Gs>;c4Bgb8pmW}2Hpa%QIbHQUVuanE=2!2&mz z<@c}E-(_xnKds)aa5eLV5k6y#93a`eirwU%1KrS2fAH|I`aSSfV_9E(fDM zN`i-Ti5}`FdGMC<(C-xwSEWZ;58sv3m=q7)D|uL#?xBLiL%9qO@3=g=7S=;T z4G(YB^l(6))%NIfFAv|!s)imOHuBJ^v4`b{^`r_t08C z?cmY%t{$@AQl4_GtJWT*wFi6j`Im<$pLr-4?qRj;_}oLxNDqT#(r6E7#(1bZ*29eP z9)6#ooF;0$DOzKyhsQE^nup8NJ=~T5W_TDo*TeC79@;HXO)_?&hmMOpEL-d$`6~~D zW%zOr`&X#9D-~O6e&b=xDi1TI^lA@pukkSZ2MZZ}#wXi+aAz!y4HvmA0!F zJ3M@`)5BCLw97-Y-5!3HLo#fS_G_>9==`RJurs6CPeW>ETzYdfLNH37z$@SiY5J=R7QzQNMXOa$aLDcxWUOWa#f6e)+@0 z>wjvGBz(!kO1XZ+ga4NDkX4d%&%==W9`48o4?S#rqk3DRE;-SGa57#VSeJ|l< zo~()S^0<(fcM5xnD(_TgJBy)5eF<$7l?uf5}?d{-}B-t}@?hIR9@ue+DL9$t#|^3v)( zFT3TOr1bXU{LoA9kG%XT?+^1*YPgqD9Hg>dzW4e|+nuV7-?SKX@6r z#Y>MPUcNi3IL9>RoW`8@Qu?x&H*b0Q>b4jA9WSRIcp36geS74k@?+KfL_L z#Yg8TA17tA!H3c0;{$oe;$xN7M;V)sp!{6aN56Om+~ zd?dW$V_!udacMq=%7-qEbNg84^>N4NqrKn9{*aFWnLf5=`E;GMkF!!f$HzqZu&Tya z)0)+NY?o#=eC(|0qjxRkQd_YluC8Ls(ndaRH&&i4eUxpdI@+ra`A3F!_EDs#j~2Z& zU(WURkk-!}q<91v306AMOp>hmAfi%hWACe%q=&+3v&hi;up)`UoA?J{}`q}drCGtc^Xbk0ZQypM0>v)_IE`iGC)Kb5~+yXs^1Js%hEYy1NrpFH-l`-#^3 z*T>#CKXuCc8K2_kKiQG$C#I60L6Va0XSLJMqYOWvy8Wd4{krDe&+qai*H1xM=cP@= z&-{Ep#R~iws`>d|UR3w-*`}z|T3^*Vs>7Q$IuHNHaf4E&MEM>8EWwKMULY z>CoAatBaqAJQhn=KLcgkyMC5-*ZS{k{XSY>_VxAiK|epkrJ%o`#kCf{tn)j*J9p>kk;eJ|t?&q&Xe!O2PZwY>_dYAe!E%(!It)C_9{3Lwmr}uh4 zKmOpS`cHnEZT2&BiyzxoKc}|)DYL`RIGMiR&xHei8XZ*5NBra;^Rr4$ANMorgz7x$ zXXF|6_L84kSNyD(z1P&Mzx{k7jsEd7^@jR(%TK-Aem2PTN2=+upAk>gds+C*&)?7e zy!t}N{_}Hy0FkHwVMBn1Vlf6tl#z1S6rhSZK+mE9K9QVa0qV*|iH;5MzLZP~kRey( zp}dnEU{%QgWl9AoC>NlK#FW=K86(G10#vUMpm#=qp%QilXdqj}`b@vQ>1Z5?2rbbKwK>rMlN z-q5*@0iM1U(7$;Ju)KGGyYDMrp8(AU2blR`fQlch?lA%092?-Ed^9=0&MBHZHNaUZ zKRv)iIXgr5X9ZX}J3y%wT4SZ=u2ye01sJk9pwDx(=FR|jb_E!`C%_lK1UU4oda*CS zeaStb^<}F(IvAkWp#cA$Q@+0ih`XSgW#69x23-uW{Zat`WvzKdYhKg(^3`7fZu}kK z_3HuJ{1f24TLFH!9iY;k0H^N;D0^S=AE<{<)WfF%T0IL;|9OB(FVwG>0jB*M;QW8u zYl3Vw1~Hq1Otb_kS|~`%!a@Eh5+o@$NV~Wohon|~kg@h4FJ)w6ki$tqsw4-QTRKSJ zGC|%c8)Q|vAZ5x2c`nr|1c`D4F}i~KHw-~yfDnMjdb6Oe84mJWs~`W1bKa6 zkp0qbuws4~B;lhVjXw=CZK!JbBFL~YLH3Oek~c2Mj`7N6Vvs@d?TjE#W(MgpOLfc% za(Ql$7V}i+f*{Ag3{qoZkdljoboeUB5xFYSOO)T&K`JZ@GFg^NiPfs%SJkjD$Qh}7 zAjpJ+K{yoTqoYBZ91GIzc#vNIXx^8Z`(pwV}o| z3Q?<7h_S6h`YtrY=dXr1_*#fpUk`DvU5JzpAtp(Uw?d45JEYH7LM-hc;`V?LFJ$z< z5Obu}pb(wqw3PiY#PW}{=FkuWK2uFneOO4pYlYY)g-3*#{&@)N=n##^gxD(k#WFU; zqj4c36I8!!niSH%M+;$?5@NF)kbFLSjdv7MGzDz3R=y7f)!y9Jm8sSXBjWh8!%cNiPOuDwo z)HOGX^S0LPoXNXAGO_f`WS;DvoJodv%eLj}WubymTec5~}ck{Bzj%2e`de_M2$C}xs*UF}L{cOfH$fjST zY*u&6=23Tz@0rcWkFq)ZaW+*x$>#o$Y;uQYvs|{y!cp1WnvqTBtZcrL4Pu|2jd^Z1 z4d-RES&mA##n~+SI-BcDvw3Y*5 z>i%iPJ)6yNIr>L7$rqKEti6}b)BD*RdzP)|S`Mc?IpkH&(KWO=OcxqKDOWl2shH*<3t70zW`$6QXlmCJVna(O;5mu`b{**-28>x5jc&CA8JAeVX4 zZA~s~zs;rh54kkolFO{Exx{SCrQFe6-Z_@bDf#MbE;r8Qvf|HN`d`Uq%T>+4mdnmN zxfHsW%V3!vmB)qXJmy;Sc&kJn%j5GXY0uO1UAJZO7$xP)<K#{g_JiYbM@3bS}+nBCuNAAZn2 z$nYN(`zOWT5N6!wFekQzskt>wy`5nu?g|sNJIt_sVfO70bM;V|$MWsrFx#d5(J)O; zsGm~mWS9*3^;DP=XT!X9PWNTfZ(+`yS1&Gv>3AzlA93Ff6Oq;O=#F}FS3Q*GPr}T4 z8Ybphn5{%GM@P75iBKjfLZ{>iC!|bi-7lm2a=ToFtdt0KDnvM0F+%CI2umwP=ogBx zIWvMgD?+Wx5yoamXpkS_K-~!O^&p35$ZLKut6LxBD~i!!XL8X zwFqy#9^qYS`$mL?Z$?-x*V;$$bc`@hM!pr{@Y@lpbW;4zir+=?WmmTdg?mIumYq_l zSA-;4D1W~f;gJk}Kf=#_A{>&TA4K@2uj-JV{UUtdKf(te>2_#@7oSD24U6EDGg5AZ zYLiiNF z!h$IgiceK9<)+M;7U7ndXGAd0j8K18gpIOS2G3Uhb0P%hMrbxa!psE`+AN9i-Kq%B zS4W8cF~ZwBBdpk^9`1`!>7;5q72)aW2ougnICUXH?cY`3AIjlkgmp6Wrh0!%`P^16 z_tfkA5nW3kp~&M1EuN^C5-Ok1;FNrF)AMoG%BOejeEyV}`uQ|%kk58;HO{9`lYB18 zp=S9cw8&?Kv}~2noYwgiZj;ZTS2gyve1^2o=VJeS90T*2DWj(6b7V$7RcGc?Zb3fp ze3{QFS-UKsr_1x{x*}hn&*t;__Iw`8)hqe9ujOO^J0D}20_vA7;AFW1zD_IPR;2>o zOfTS7X8{W`3K$e9pnRtSx^yn!v|Q*>Kx(f7rb?}01&keDz)Lwgy@2GI1&ow$HW%<< zO98)aE8y740!p4Pppw)&qw!}oUR-|{(C2yqLnP})0UzBg;HDJ0Q$UNm1?-gk`vnYt zP{1Ua`>=rVj|-S1r>hp3UbEM;2T}T8w5(~-UjJ8`|Nl?$&%eqAes27A#(T5p&nj{> g`)QL=U4k*Q_f;&KGvM&qGNu0SJpGIN|L4#D0STbe9smFU literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/686121a6d196d5c0_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/686121a6d196d5c0_0 new file mode 100644 index 0000000000000000000000000000000000000000..33d4ec176a8f7783ff0b099c26483e5af0bb1666 GIT binary patch literal 19480 zcmY-1XLOX+7x(>dGBu$lWKuv{AR#lEnM_NcN$9O+?8n-I9&(| z7lu3XS5Y`p9JU1Dw=A&cXs(~9I*ystI8!3W*po)qZ~wtkA$U$F*2<{jq+if zlf6k{%&>=X(Gf<2)G*$Wb<$0L<;#1*IF=bkTviyhWQ?4XQrUVeQ)PNy7zZndF}_L| zZL5Y6UoDLHs;dt1)ePf^#MTaDm~^TW#>%>3l&lwqL-y2Ho(;noEF)z{(=Z~MhtXe# zNs$&|oD|pFVQg%rv8~n5_rkc;Ms>9dccR)bPD4_=P;7G zXkIte|zhLi3KXQF&iHJm@Ih4V_jsvgb@$*&pCO4%sSrAX~?K9wDH!tvD& z=XIlSdNv8CY*WRO+s(ph-8`I5a$6>~2&aF`aLjKjhgRVvv<+u(`*0pguMXi1{UDr? zox&;5Ih;lxg;VI`aEi-ky~3$KIGmef!$}(-PEg*T5Ki30aNeC1&H;&>9L|UGP~Msn z&QZB4&m>_+IR2U8RFnpD!nq(NzX_-5qHz9_e&2>OYl&ih7tVJ}!@098oDM&RvsA2W zw6itzF?Pl#Jcs43Zz@bG-@e+8a*bcfBqnCG&`Sbu^sp z)8RBZqnzce#GKQb=fm+{45#3wa4Ovi=f++2^qzWtUwJ)Kj?b0%3#~6dNXa+K@857r z8x1rsXkbnu0|g2jI9J5LxS|H;NuekMO`;9#kWs}9%$8;`20oC}QYuzs<$j!juy_L- zWxs?H3=A!9;IX8aHc(wCW1y%Ek>AT2$WAn{r<{Q^GO4_Qg%XowpmnlhNTSz(U+%~o z>ESc5PVeB!0R!)680aHunFjLZM|qxQpi{Pi^+5ysWN6616fx%+sF!bGvn;M;;AiPk z*}&)WK(eYDSSnxEP##jZrh#|lkl1P)SWw46m8J%oO5tXzStiKo<_5O5G!W6oKyf)C zSEYGd19RJ{ckMN&vwHTC;>+DG2KIJUjP3^F`l#;D_4o@t9%A5AdH9uq|D@+I15-yB zXgt!ujq%EPk^$#r1HGmgxFoNp8n8|?aCW+ZZ)T{+vTC+L$DjHpXQbIO1Iy&z_Xgfu zZlH_oTw&n#N&_`lY0p-xrxN+2ftf$6$KwA*dmy)eHPCRqfoU5Im^K=SmL~G+CIcUD zR!-vDs^dlYO~-{C*`a;dsbgoC_IJ1H+G8MduYo#8RhMKPH}IWA|EYZt!v)nN*X|nV ze$T*9_YIVLV8A1fB>RziCh1QM40>wdYq32u@U8swT*uc-?NLD^3kw-pB}s*iY?3=g zjC>Yl#2am-lB|}e#f&;$jg*cxGBm-+=|m%!Q;ejg8mZ$llI%88z-y$j&&Zm9k*1kO z-pB`8M&h%Lq{wtRpJSwMu8~%9JkQ9|ibkR<8R=fd$ktj$T(yn#uA|s8vA&Uv21e${ z<%UM?Nt;GS3O3d{O^j@pLsGN3k!EsRUdYESj0|jLWNmBRzGEceT_ZasvW<}e@=04G zzqL2==mX{Rp>pk{Tj~0dk)z`5Vx(7BBMm+_vROXvY2*vJC+WS7ES5FWp^thc{(kDA z7zZ2qT)z3jNU1N4te37sj0~24#5>f;t6@fcUNmAJuRcsLvQdsm;fddy~GM#|xpM)Fn}S+?3pqaTg@zQ%}ct&!G0Dd(S!G+(FJw_EkfuX~JC*lQ#p8NVy1IBYl3GSx&q zkBML8Bd>{pa#Pa$Cg#ZsnUrm!ZjNqqO@swa#LA4yCdxL_I3b%QwKFlTgNZk?`h64IB<%weeL9-BDi7uSM<)7qF>y*pb~Q0m ztldo1?`~qV?3a&wnwZ|(M2SyKwCiKyhz#tf-1?iCAXNsKXd=Ifb&&Fs(}T6vWaS|B zr||63FLr091hzLu%-!#WeGznB;%nZKHtBkk6k=)A$is*NT} zZPGkhyjgL!oA~}W6VIjjP7@2|?_GMl+r)c&Ostg`drfruUA;M|JP)bH!+Kpz$4s=B zrN>RgoiJfOYoe7b_`^hzb0*%Bsd81S{i&YGNqKWYasD#VP}WG9OC~yAHc|bGiMw}9 ze16x2@1BXu@}oSvZ(`R2?Tfgdn3ybQpPH!o%*3tdCOj`q%$F6i>|f>ipNZGE$-_Kr%gMmdHjic+J$vFtaVoOo41O zEoHep$T8D4*GzPtnPIX&-%L(LGv3N(%vH?Pt!n0NDO}CWSUFzZOywG8!s;uw zF3I5bX8soU`(`eFU?%B9GZCH5ydJ1^2Wt%(J5+fL)8pZ0u8uI{7-?pvG@D~)_FOZO z^URc%dJD{~U9a^vn6Yd$^SyN2q#kWkzkV|_RKDMB=KdZtZT6b!Dh2kNX>>q+l9O^@ zA`hAQKzd2S6|FDlWyftZ8F$Pi-ZRtrzL~yqOS})wd?PF6++)4|)J&SZ^~_8sS^3;d z$rtM1D>JuWn`!;V%zX0k-m16@76&qUEB?TH=*wezo z2^spfh4QT}cx8!1zhj~0yLw%Ax3f^Ty@d}uSopG|g=>=9Nx4g8cMIt~EDZYC!ro6T zH0+~3^|fH?XQ8-!-`|3Bw1r+{EL@VO5;fMsokSm=G#!uo3#Qm(5u`AX*Ave5J&<#Ahke8)m5c~`!BY@y^6_5Z2*FE_;Z zOl!Wd(DkK-HLq09YYQ1N@r{LfVOIW>+Tm6v7_7LAR`ShOM$1u)m1~h!yalZED`+LQ zu$A_*w1}0sqE`L-kIAB2FF*6CJ$$*^)pT4!4MT!v&>St2#Et?ZZZpp_GORvzVB zdAp94mGZc*l@9f+d@SF|f%?j!fpTqV<-81QY-OLEmikSsd@uK#T4~cvYqYX*ToT@~ z^0k=SSZOKq+FB{pPPuio6853i?__12eA3IxHZgx4e0e!5r=xZgipH;_zm639| zzm>cJR=uYw4_Q0hO0yAGtY2G+ml1Msq?O<(D~+V9gilp|GG&^Td(*At&QSkmDp#pK z+sY!jIY;@;wc?v^005m3H#oA}h}pTlwHyE6bNCm+!2k$@CRgs;#y1t91Fv z${@KVo^@8{%TF?Kvz7kam6H_Pp}Hh#r)rVIyL4>qw=({OmD}PwW#t>W_lK2t&*^v& z%Xuq(W%d>IDrWN}wD;cu#A1fv9Xr64kYvp$d-Pc|`(B3?> za!9Vozf$0lmEFRYw;spIICj@8$yL$=E;+4rB;B!cc?5e$+)Br`mM zPYn@_l6%s{7{QOG2s&CLSX3l}h@ufRh>Bo~9GAQDO3p+_kWnmx!7&kxl;iTHErLC< z5j2dC;Ko}K_)A7Gpi~5Z%jwb)lq(ZK=dzkBUnFXMDN{az@iIp)%G*iGFFAtv3K5Kz z<0%nTwnq@|iD01&_eOBQ7eTIH>xe5Sf@O6haMz3Alll?*_bq~U4I|hj;fimZ{TUqQYy^Fz z=C}x!%Y*R|w4D$^^NA6xl^2s#^UMg|NR`=&C1LX;=q76yL@<3}1U(l;PFHk z(L17;zB7uEd!iV!H;RLj{d*L>_eZfszB>@bqeD^5KN>~F<54U*5ybiWl<*_{SK-zor;knqycb7E286WQ7#7 z#t;=5!#h%>h{i|9&{PK6VrUy5!*a0~k700$7*fl`&{s|;$I#gk!%tE-HHQ7Z7-Ib~ zJjjkAm=nXb+!#*g#qfEv81_lY_hQ)CJ_d7#7|zP#PBGk*cl*Rpp>GU@`o-WG5W^t( zOBN4Qtj`qd^B6{d5kvS8jg=q1ilOJw7&ghYVKJn99Yb%)n;b){X)$~&m8Zv$J2Qsi z(sWh~kLSjaKQD%H^J6f56GKDkyihePk0Eh|>i#8$Nt4ByC!LoxjEIEJJrF~q-&Ve-E*T#yFX*eA9y8;cA!I+<*&l?;oG{#F}1 z#2sPdNnslmi`bY@)JD-L8?B{Gv`wFnZS;|x7#qWFHjYZ|SR1D$G0w&sSy4vgQf%B! zwdu34ja-+F;%PPt_-qWxuyIg^XWIB7$HsHnoNJ?D$VQvWHoli_RW!G@jRSRT#MQOY zOIp{r>E|OG8ye_wBh8W3jcr_NZo}EaMxB<*?>!q`WOjEO)qB{OC`~`Mk0?Z#qx#xP&k&wak1Q!F$u9Oc`KF&VlNrX(WF@3N{;1fg;=a< zu{4n#zF5ZjV>v6M1F=-dh^3cI%#5XCj-Hb$!B|%3#qvs?RE(u@m00FV;i|Eets6^M z*-<~18LeWuA{lLCY1TfL%aZg#EFa6vjD3(2v)-9H4a!C@p$Ff2~17rDGj(!dmfL z3hj=i^nqAP9gL;3+?HvFHBV}uRIOKH*(`N$#gceGmTt1*SuC4g#bS9KtItt!bTGuR zQesSTREdmZocIdFv9VYj=9oC9z7r)M0EWTdp{t6b#$0dbri6i4~NajcSdUn*BgAEsC% ziB`EeYTElcD0c6l84<>C)<#QhjYdzmFeev0FuY+4t`+gsvT zEM>RFF>F^HM`X=zt+6MLFT}T3J=h<|WodgLjs=I}_(%F4*0`gpO};)B$D$K)+?8KX zD)y;3;!nrXP?nujzvSNeIA%PJ@obX>Z#-?&G{3Q9K z6n~uJkJs}P<2f)bp1A3nJ4?6o;%P6h=f|^aK|DpjiRZ0_dMq^-#nWVQJUc2RP&g$4 zPg(*^aub**yQ(B$shU7VaaT)VfNZax!2TKu#MVrpyVPrxzzkW|IDwd^349}eN`+<# z{4BXG6BsTPS|_mn{RE63Bv7<-0?oQ6us|wx)4JUiuSbGvR6IHLMFLMoY2DEYL{CoO z?(77z=ji$Q37lJ+K=QH#K3|@|M?Yx|ar~M<&)*W*B*pe8u<$?vcckheJtvmKT1(=N zB+y=F$(Yj#oR+sPYwlHzlT|ko*!Fh<1#TuV>7NAZJWgPmlzE-Nh{)m`lRmcMTu&;F zH@P@(@`_WUN^v^M`Bud_-mN&Lx)|f zRVk67l@qDgIFT7Lzg;35KTO2jDUq^06KNsi=k)NdP^+f7FPGqK>vXsMG zpd3vkGNBx=OO~TXsd6}c<%sQ6j&`zmU^(i3R*vaXdUQD^Of1Ja={m0*eK(h5x$N0q zj_BVM>u5P@oh`={sc^ZR&cl?W+I8JVl_w**JX1TAr}9VT87qnX%Ckydim!ip{*pGM z%k#Z--&meoJIa&3vphRam8bZt@=Pa*%MvJ>M7@|KW=K|qWEBBNXquJTDb7ox{9 z(3wOiEs5=(Bwl%wsP0Q*k<1SyaZ3)RC$Tz9ugRjEBx(osI8TqopPxkcibT8`wN$hTtM47jf=pt)dCsFy`Bz+f|M9cO`ID011Ph5la z`lm^(lht1(ac8u09+Skslalyqy7G|fGc|X15@V(3oFw|sOJawl%}=7xa>bKwKPIto zi{{IRyOJn%Ac@Z6IhaJ9(@9K|K7S^WbTNsK<@D7ge!HRhe<$(eP7-gPBvJEe66c?* zwpU54mxr&DxNc0wYf7eQWHQbI$@G)vMU&|kmCUcQJvy10G09w&4mORAPiC-`FP_XW z*;yi)B5x(rsbn&@l9NfVpt+7@9!XwmGB>1dS~AlmHlR4!$)x2ZQ#mi0-PMzcs*%iv zCdu?^nanm>^=>i+J15gZmi5-y&ypD^$)l4QFhT1{>a=8*e4ESzDYPz`kvoz(Awzyw zUi*?+e>fTAkz{(GNT$ZAWG2b8v&l61E17w+;)cfGO{Vm{WOltsX46|0u#~L8#mov6 z$*Mp-nITO=6__VoD^+0qI~6d#TY(aNE70J77FJ-E^xjp0DyJ&w8mJ1qzE*+9H!6_- zcLhe>t)TB6^qj1ITmeHw3iah?R0_EXDGZk-`r0)u@rtjnF6Qu{2wWtyO2Wi#T4dTOQG)d6eitB zVZL1dI|b*h6lTk$e^PXvR0=ijq;Off-PPE8DYTJZGUZ{4&YP#O{80)IW!B3Sw)~fZ zG0aYH`9gL}VS}BfMmsy?L_s@W7P7Oau$_z|cGkt)d6QtLTX8#cO4_+n%1)Egc9N6y zT(X_>Qr>Ropv0uw87l3)c5FU7NitRb^xLT$u+t*XPA5ssx8sw=@=rxOtt;92tCn4V zAMGr!ZD*sn>e%_DuAQrLxrv=e@**lF3-u4@PE6dj;^2C7au_L-f8FYJtzoX`jwrOp>~#jZPzt_ zcG`@x^UEYV|4z2keTtpv*>;A{QO$Ghgyz|KKHpCMH+J?dv{PfLopH-FRtkJ?r?yOz z2|wDIE9a&08pV|PQfIAR|4B9cY^R7Ek*@1B<`?bBuXbjySDX#HzghRU=>Ar%vBQpa zr=147>}-_+2eb!=>~uM7=bZd<)UNCO?5sF$=dBZVyfQ%YPbu%ycAiRsGj^(8P(63; z{CrP)b>B{ooPJ{G#Y;Ppuhc&|A=O{o8T&@ZfiwwoFe}_aq`|?MNC(FYIH*$4!HOad z-YM!}QItd9r8smwnuC*axRis~G7g5zq(ld2%Q>i3-ob3U=150}gTC^&q&Xej^*V^l zcJN+~gOU{;oUi7fd<_RvWL+%>Z)!W}R>#55^&PZr;NZK48sEsl+{O;BHgV|M5(k}S zgZ%uqgV(JbbZzb6+B*)$zw6-Cdk)&QbM z7%3@(9NhTA!E;&jrGwujFvP*2uN?d%&*lAL4$6M*V4s|k<|7>x9i{wby?iuAJsGPy z6W%^a+Bnj6v=DLF;a!nfEcF_8P`Y6c{9c0K-x%WtUJa+JjTzsK@{MW$s}lT#^IA(bpy4>I zJ*j+iD3vwR^>8YK<*uY3)&5AW)2U22lS=k&^-ARuO zCxgYF>Ez=qr@kw7a!2mxILQn;`A$maJ9)pNlb&)%0+pRSs^O$?Z70p@IN2qC$W!Un z*va}Pir3Uho|J8^yt}HNZcYx$WvSJ}$S z;H1B7edr|Zk(1_6RPR&m?Q`vq$;CRei)4$716CKsB3*nXoeQ{FUC>3DLN2byxNya~ zm@8$AyXaKH#lLU4s8-6wk{rY=Ub za4|y~w{+27PDqJXE=J33nbF$C#dlo1Y~!L*JJr_S#h?#e?C9je{;^Bf__&zf%f*G> z(nopsb1_xEm%ITknhbR@YnY43;V#;ZaOpFLi=QQNqq?+JN0*&OW&cZcPm}2TIHhjY8O@4DBra%UP+IiwGZo5>n0bW zeJ<*Yb-#;v86`~)x_Dno9dhB8gNHTtxQpRZ@q~IK_f9IWzm(S{7w=qk@#wXSoPSl5 zto={Dz>Ou$%?LRZ?k3OR<~x&{yJk1P2h3#20guBD3UDjGIO_H&bHWoQrc)C*Dn32{(P;a&uj}m3H$}8I4JF)3t(|wJC1O z+1->$b@QRqt!t~@#8!3lZZ$Ut24m#e>2pRnHnc;XSq2q4QIRA zFIDHbnImK8x;ZgVkLSB-vp{vr*oAJ|FLJYNv73Z%-3*eiW!U#_4lLImtWXY8?FTnw zR=SxfC0Dt5f3^CxPJ8x?o7u8ds{iWd)n+#@wrG#GxmhinrNVagZinLTbTd^7>~hn1 zx0~POungU!{oSiQ{9VU^oRe=3y7~K%o0f;w%cE{49&;0R+)c5QZd#pkvrj6WadSrk zf4EsJqyBVr^t_(G;AY50H^2Yo=ABD!I?EFYUU9QR)=SrGZjQ;_8*XB5y4fVRZoBc` z)!LH%(9IW*+}xKpQt`2RDW5!Xv+=3+R0ckCv;Dc7x-Z?_u%zkxkTmAW>c}*n6-eX5 zf@y>mO`~R18kV>;o|e>YsWi6BQK?cojZtONcqu&+(^yw7jo-_sQ8YP?!>PJWOQVG+ zjXiS1mqxTdjkg17#OLTXl*WQQjmb~rzlv#8udJ9=()77EjjDAuzg`+Mnx}EGMH&rS zDu>o-jDIJM`t8$L^g$Z8I;PR;!!*ivPNUODX`GRvUDDX!HI3YEX%y*^M)Qx;*e&NI zv1b~N!D;mTG>uErYiJrJhNaPdcpAs#$B}7t9F@ioqZNBx8r}(Md?W3qq_K3Wa-NpP z`59@HpOwZG`ERyzo~xQ=#(d?uKzV+n`^(d?u1M2$)9TOaH2(TAjr?_K4F4sKkz3N} zb~KHjjw#M@jX9?==hG;8HI4V~rt$5)G;H_NIQ=+{FP^AxPt(YJrkbCt$5QE~@|4ne z=oseVlx#M5Fq%AkA|F~jth9P472&}zzZLe-H^##Vsbur$-xCizBr?v!KxtFl!;%sn zV&C$xzr2U&WDi4Ruv6n)9+stfxbN}M*6ZOwz(fCZ4_h-lx`y7vA5u2k!$cWeN#iSP z%_<(YOXI2@c2@Jyv$}Grq1X~#OR;5XeGm5gdO1DuRZB>W-BSSiRDAe6U(;k{H z=X!cb?5%wJcyN5Cc%OTC{e_3|Lp5iZNADwAca&Zqqk80@aUOgVJS-H`Bo7UycsM=H z!};kR%FpyLMJ~+pkTl1`ROva-!>{u_q%6=FDZfx-bck@3f{=S>|D_ z6kP40$&XrBZm#v<`Pst)8MfYoYlHS-qlc?9b&H2Tw`xzedvO2mq0c@Kfg{?7;~u^~ z;o-S7KI>uTA0D2b^AI}k;RpHZqKAEddC0k>{N=`V53?V7xco@tAA9)xnTOrawcfuT z_C|ZDS=P(=L@)nI!E#=9BzcLf;ANnUki--(Y0|~+WtGFr(^M~Cy1b-#z54wKFBj!` zj+gwPUYC|3FZ1)f6v_8usO;rud0j=Zs(G0r{@Py3*HOH>Ue3wivcG|s=tf?K$kE1L z;+uL|)XYokHeMFC)obm%G?X7CySFi~IZ2QQ| z(ym_C$~+r>J-OMe+IWd?d#Gsw$}!CpFls(L@y z{4c!>mLWsE{60*14foP?gmRHSBfVsd@^Vj>jP~-*7%wqny=;{}lfCSn>*e%3FCWg=t=wLqUMKuvI zS?eYCCoetMdHMAhFICoiX}sCX%q?CbwkqCsFQs;P87I>Zc)4)UOZ`LYu{=AfJ|6e7 zQqG+4GU}xE;gpw3r@f3k>t&iWI1m4w{_C8*8@agx(e0<;2$Aeyq+uKLuK|W>< z_EG*b)j!6^dt-eZl20f5*f~XWr~3Fq%1-w&QT~{r`?GwknC+v)a;>pKb62THn|yq+ z*{5?~T63q5`@4J$+T-Kv-+dh3r=INh@knwGYJJ%%PY?O%aoESd=al!KKB6zEb{Q|{ zWd9}AA_Fh`*nY)__o|OPnI(T*Qyw>zlgyL5^6lR~Zr}9r&MhA;|MBthT_3;P^HJfx z;ymzC`jOUttUfuKdoe|(T~~er>{)3 z_?agit$qp@@YAfIpI!1-AwPE{KFUv5_hWSW^*cL$BK>~8Pxtd6!_VrV;^+HWQqiyL)%_&a z@zc4kpOnUaU4QQ9&*pyWw(v8)jbHCg%AuW~4ILEk13zOr`ibf0r*(Hf*L(P}_4o76 z06zz$%^<}b>?ih9KMlV0Gi``!``XXYF@E-s^^-f!&yMlRWul*f^5YCY&u9ASG)wi& z@pE;qpQiIv?*cz3zVTCap`YT5{j~em&r!K9;Y*a?cYew(^D|kNO0iX{VV`Q)@8_)4 zI_PJ@AwL}U^XV}^4UhZja>7rKe>Cr|pRV`(7vw=>YGS39vdbK=X0|=9UjoC@DZv zg#cYs6hk&T0)#sQ^pf2kz3vO}scgvzV9HV~DH;sWA{1arUVuCK0ajECP`_?~sr59b zet_!D1B`7E(09`TM!X&1P^$oMzZ2kGn*fRJ0!)&s9RiGgKcMqh0haa)aIb%W*D`uQ zfH~59V1SNtMoJG3@cpM+b4Y;xU#TXkGBlu{R|D*lg2Mw$9}&PhIzWRl0k+E1aREXT zRJUxJ6wvQ}1~5zsuvrdD{?q^q3zzpoU~_i5_yA=P)I#9 zd0%UGOy{F+=~%j_Gf#F;PN&e+bix*+MHV?jviM%M%ED1u+?|m{`m8Lzl?`H>orQUB7WL+3v008u zm&I8u`YwxGOS5RTEQ=lzxhjj;HCep7Hj9IDS)OdnBJOY&?;XkFkX(_0r*!{};{K7v zFgf;D773S?m#lf1#fwK-9DkXmV=bH0?rd^1vvnn3sclK@Rhz%jz7~{Fp<} zUvg-&C5KsCbBNrQLz!bae0V&E)AH>fIov*%!}3cx^t+bBmg|~-BZr;$b13jIhe0wu zESC%6xy-fZ(xF%`-^b)q+?K23UALuj86{=Qiw8Y!C$oQxmE%JD0n%;chNr_j4&ME9J?9Tt0Z1%ZnGe zRD7kl@~iy!I+q@AlwWv|LdGDU$}g56|5}4|j|eioaF7c{g8U;>iw5~KDoEYvAf;l0 z?2*E;K|YgRaX|_u1bJRMsB<7eo%aapyho5PWLb*l*n>=V1Tmxr8RiahAT3DH6Qn{w z>!b%6B*im=w95=~RNCYQSrQBq8wzr}au9#jAd94G^&q2b1bHO|Y6WRrJIHS`tgd3# zQ_T87S~dtWzhRIfje_iLtlOqRK9||ef?RH{IW2C!+U9*6zw0R#Q@bW!-i_zVOn>1ke^0r{^%fG#;8{l z)T@a>Zc3F&>dE9FFXiKz>hG)|eHSR^BE?*+m{Q=|Ad6Q7+5NNj;TP?L4Et5F*DLmh zAmcU%Ik_cBwXH#F?+h|=SCFvXL5A)Rvj0Gk>xY9plOK-+*)DC51!;Iv{ge`?f~3m6 z(?N>;5v0{Q-Iqy!2043Py|@sh{oNqF#dR-8NLIIdTkjR%owi3b| z9^$ekM5*`?A0&i0DWyv4ekt9Tdu2joB!;M2F2t$wAxb8PSXv=O-$01X=^vf__$e!zhpzJ5bwSd;v;GO zZit2Ng;*sw+J3AjhZhVOHGFg}qB3H)9@rfZFJ0Tj%+mk~qm=dDsRP|Es z$ed{*?uvOv2;Egl}$$#`8nWTo9t=k`OMpSK^$g%19B+Sfbr2McspT}GB`Ey%7$4})` z{7gO-r21Kn|3l-&c{88hxAOTyGH&Pd>79J;NTK`rG<}fIPRV`z@)`du zpE+`-QlaV9dc1rbrvJXF+i0`?*QNje&ymuNdiAd~J*Lm_9p34I_SNPe?73#&f_nu{ W?_9gO%=KSN|KEA~A13~vKmP~4c@F3R literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/688bd1bfd07ba01a_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/688bd1bfd07ba01a_0 new file mode 100644 index 0000000000000000000000000000000000000000..34d6b98588107cef3ffc72f14926f9782d09b85b GIT binary patch literal 18392 zcmY-1cX*TK8~6Wro1{s~Y-u_`R-vUyvy<+mW$(Qem7yTW5|NDy8M61DvSbMeipWN$ zvNwpJG8Nf->ht;je#i62!*RS!a^Kf=UgvpUAx)DTy>EW_b*b(zUYdZ)vTpH~pL9c3 zR!$XvPL=FHu%^Fyjz6=yzed#>RlU`MK5x~G9G}md9jub+^ZTm%gVn0l^k-#eRIgFR zU&H6~*9cbkRd(77?JZUUv7!bYjq43e8ehSZk#TWOAb^)7Vm0e7TW zZ?N^#-2R$7Ky?m+Z$E}7pFpQiq1)%`!4RnO1;h`BH%CAh$@~(Q%bk(%_9*Bo^+rQ$ z$r%GRrPDa*ErZ6xm-1qQ;!TF{)cnWIB ze^Tr;d?w?h`*|?^2HP(}^zTqgPRUhi`3E%m6WU41OW=^%GWar#m0DMzmF)kYtJ+VQ zd<_;!+;yn%x7L;0@~`x~0k8gnqBk{O&PttIFz+_3kuG;&fZUKn_u-<9Kmd9VTquloR+-k29jpm(rtH1aHOYR?=c4$d(lnn;1a_ zxgfWsZIb4dj-Z;nk|Jdy_*AlzBd9Hr6*NbN$|N~oF@hQP2!3}&&?r5EH)Vr#cScar z8^Q6c2oka*s3T+Kyp+k&W0@+`^CLJ^HG=WgB4}4Vg2WmTyj@dyi@$aRM)1jD3r zy$Dv%>aRfUKL|{G? zLBIbw8^N}75x9Si;NWi&l(-nd7t+lX$@-{BDwrdwRXCDyMI!lEddEkyDItz$27U|~_(g_>4NQ@!d;<*%3~ZIf zRSbMDJ*yh{RPIT3bpy-f^IFP7>en{#rW_VqT>}g18K~CWKyxYDLN&_-In&a>_SOch zZ4H!^lX68`wlgrdy?WO{bGoQ!?<>CC?rLCvH^t~-Afb=y{#1`Y)8ioq?th`&CK+%} zHt^vT123i;_-cmwCu?RK^xRNSq{VUr%jM1r18=W1@N%_*+H152Yt$R{yIe6dEV$Xa<^!l>t(k+Shdh9(&~lWgQtnh{UBk$Ns8 zscs{Md`6o3jjRhAX`W@|m2}KDl9*#8O{U9*TqE`KjP$5xWP2SWuDV8g*HbK+*w9F3 zBO`OR{wSN3HXo za_FpE>Gr;nW8&;;o``X8jO>-uQe&%; z(c6qXm(;zgO*ZZ`Qfa^X__K2SML9~Zqegy{BP3_AABbUYg z$jJ8+@z_YMCq}A2GqPWbzA*B!y!oGz`;r}DqNv5hM@39}zL+>Ge@UxiCgv75Q8>oL z)k-EtrkOZmH_ zsi_HjGZUF&X>FpPI9@lAE6e518zxS?X=2(tCSJ+fcTMaNPe&7dI+?g4eY=`CEhD>` zm?@U-CK~oIu~nw`Hc{#$6Ycw$I4T4CDTn?hCP=jbCYs4lVi}~h<;-Bko^0Z{G@N2$ z%2bnnE}KY{Wz$UrmYDcOihph5OZjGliS!>#43n&lCgw={A5C=GWMa)`6J@q&jx64) z`8!Rl_{qdmX}R0PLiuZt9`7~r_C6Eq<=K7{oqtx{hm_x8)pSJX#dO?62U&K)M8ZiE zQRhs&Aq##rQS7{Wb5Y~}Fwt1nNx45wbh>1s=4BJNZ<+Y?wh8|o6IJC~d2-jpo_i+T zk4#LKbB|5beq!RrQxo3jCg#iXf0f67CSJC|b)(xtAM7ySyl3^P?Ch2MVId ztsI4~Y7|k`qNrazir1xRjVQ*-iJDPVtrbN?L&cWdMp2w;5=GahQGDAhim5H4SSSrz zYu@Wo^n4?V@KSeQAR_u-9 z?!GA6?pNIhqG)nZJ&;q<@o*H$ccSQWH;TS;Lwxt6_)5+{)Vaq|c;vMwQFNBoPopUP zOm)AA;^xaJ+PsS5V5FHU1~Vg!W*&>xY^IUL%r;qH#7tCCGxdv^8BpBJAt@1SrkprR znE6(o#F_cMl$lo*%)C+2%z_j%#Zt{otE6MHHqFcq@z~AuahSOxIZlm}W-c@D$Z<*Z zC1jGkr&ePCw)M`jxLQ4ji>G4(T3Qdaag;~Z_~ z!!c(5l*bY?*37L*X0}f;bMR}ewOny!njBbR=A$jDR|>Y7skFz;KbOt)zGCLbt7g)! zsV@0K=H4*V{2%3UQ~P(zOc{AgzJ6$?^dt57v3e}m#s5TWJ~PwpxtVn@RL@H@nKJQ} znRyWwev`V97A6=hxQrGGqAZM-V`d9iqb>LfS?E{TLVQsR9b{QC3kk(7`aR9UPBE9T zP|IdvvYd;za45k-xkL+{k}RaXW?`EAR@%bnWh^W#YvGktD{o<)yqjv_AMvGGSRk+0 zv#?qo*0=CZ0}CI>*K)9-Vl~p5jV)Y|VNEUkA`P2aSRr?tTWH(D!l!RoI3Y=ITKG~- zZ7sBxdF?C|X>Z}1P8K5GQ@))oY>KC;k92K2Ges;`CUeirSag^_ZkzlHn( z7QOy!eOW);LW>a=EMHnklo4`hq=nEZ3r(b(L{3$1GG&^DJJT)X%~1U_m8aC4ZDEo8 zJx96Cwcwv`;S<@tz=Ca|h4%9GA`4FzTj;pN!pfz}LinzFe@}aH-@;+JEdNTO2NqHv zSy&>ao>*8apFOj1`nmT0h4Ox>{rpd{vC<>L${_hwvLdZ~Y_Kv)?nqaom2XW}I$5kN zDrUu6+)ASuE8FCR+?E$|Hr7gJ2`hu+tc;Ws^102*zIZE*6Rli-%}SuOl>ud}{3U0~ zTB%UZN|*AQE1xB6eJNMb%6OS0zsu_>$}iPQVkIkMdz z))7~(mF4xVxEomcsG(J_Lsr^1wz5Scn=0>C8vDAHqY~f7%FXs#?|m!hrF=Il6J%R= zEA}2%diJz(QBry-hmWkhl*WCmdd;!wHOI;h3HG-#aDbJ+rP4qvL#5atD>-soA_iND zlgv-8RFicw^>ZuFrScbw`K6U^qZLb{##-qkwZ~amDfh-(X*a=2%ZXOj%d<(Ud8U9xp8(RIp0ep#Ub?B@by2WuBZktUjE!vQ&PTJ7=xrpSRLbKKjkdkMgs`U9eJ7I$X5! zjZFSs&lg!Qb^fq2MOOW3<%v9vi>8__ng->fnIVVddTuoSyl6g_P(d_D<;N<~RIVD0 zqee8J$nKia1ZqXItadcbT1C@ea$84Zd0mes=Z$FWZKC-|{EK7wSZ-{LA>+pwPHc+d z$mSSIZi%7D))>AQJ&Cy~CwIh9c4rK;e~MxBt{A58j$!1!7>4YR;gIC~97FE|F>I5s z561A|a18U0#ZdV~3`!+^hISbZagXY%tuF%-QO z!|M`%JBGgZW7sLJ9>(y=Bjx)fhW*m@X$+GLv0RX4(Xk9E6w4v0S2&ghMPm6!E)Do&PmgKvCNg#M-~6P;>+5< zVrh0WmU%MduI4?6rO3lr?!Jm;T9Fd`DWxlwprM?rT7rtzN>ICd3Azs~!AALUNC`?! zFF_~qFE7E|wI%pVD()}AC#OpAvs}Dhf(?I{AmT;|2HY;e&=(~*BH#a8f>r;O;EB9L z9NQw}uo~j{#~8=IrZ`$h#j!}t<~Z8RDk))!BPKeIH>FrHjgO6^xeT<$(JnELm0~X$ z$KXYDUmV^6aSW0_Wbr`7`b4oljbrp@aYPQ$So!9QIC>3@ zV~b217Dw8barBn_$#J|fEsiBpb$T3mGvgR8&1c2&aBdt0^WqpcKMvDZaWs}L3su9) zIFeVX?jPcqv^99JABZ(~TNjYBd#%f>gk zHlE7XJR6O}HriITu|jrK)7-i?4%V}gP~XOf(x#zJzgyVY)JTt;XpXFHYU9tAHk_?& z)N8H$-nP+IX7{jBv!{)T()ptUwB zj##$Xn6^!Eq``I@KkTp(xl`-?WaDjFE`Q3E-8MXXZ0y`;?%25h&_;z9Hu@Rj^-)(m&n2TsJfF!oMdMkV z5YHVMlN8U=*W$S+_R{ejONr;T)OfB`ipS!KrX=ju#j`d)o)_|{ay(6|#WPomR*$EA{dl^`u7>fdYa7|)k-?DKe94UK1^G#swAM<_qpD{qgAXSwv76wl5j z@f2RF7%Sr$usWXIvS@ugO}>j~juGo!JgI$3wO)>A ztJJ>{Px9S(y3493@oae!kNIW1-bW?yjv;~75@$-FT66;A#9t_Z%_S0uic4VXYYDV3 zoxm#DSSCU5&l9*M&&nl`Qz1d$p(HT9VglPz60oKwP(_xz5_l+Y`x6)(Owi{x30#n0 zLkSG1n!s*ZSv`TrwKcv@0yIhBRf`0DZkNEzHVO3Xn7}64**SqW-4j?U^FL5Ny%K05 zBc)Ye;7{(^(>%Z3DA-yt=Vc`WbsO=O)^ z?UzVo|3n^2sm~Pi3&k9o$kXA8bQzh*cTzA)@y99tcpaaZ$iZoeBuv-bS-PEhzT_cGBva@Cq z2Wlk|Upt8&(x6EaGh}(wB;uMU@s<20m0Be6z2vn{Vz^Xllf;kjCSmNDMDZ?3wCI+^ z0;$qn>-JE*o=K`v@#OSpNjw^*bw?)=J2{Elvy;e~qvP|FIKM23)a6Nhx-yCPztbAx z*qB7GpOV-jB@QI9@L&?Rr21hU6Y~+RB?(89=peIX%$X$4$ZMB0_lm~Jn(ImI_$!G* zeAe6=f? zB|j%~SAIE>Oqa9Cd?)R$CDZU>GBf40xdN6#6=){WNfmfmx&pPzRKVe{Kz!#4w3o#L zD^UNF3QU)>qbo3BVg=4iw|N!lyR`xA)KhGdsZ;h*FbGApFus+gkBEc93gI#URHQrPKD;e{`Sn*J0P$^2jnH{@_e z3Tv}ZP!)q1I`V!ro>n zlzTmeuCl&O3RT}q(f3>_wC<3CvsViJ#5G9gKTctTto z?N`F9{8PY6ViFwkkN+o`Lvl7O)Dp9I$ zB^v$D!b;4N-g_!h?Q|twcT$O$S1a-GdL;_}s>G<+1Gl`vS-XefWjq>-1D z#&B6$Aq}%XP2bO@@p;oUZgfl|qf;7<-cMuMCuuwo*Ak6emBu}pwJnWPd(tSkH;wVf z)A;^W8l2YgU(+~$F^$yU)0lHLjr!Npm~=gj`Eu>AG@Limm@Sk3Nz?TyY1F!v#wF=~ zTVwB}(N;c`DfiR#xpf*VAEa?#W<5`1+ka^oBkc5+&t$I@HP~rxw6jZ27Pj+w5j*>e z+Q}?tXG5Z$S4nodm$Wmdw4KXk>@+KDCpAUKQte!jigr7PBre^~Q0d^aWAocdk*V@q zz)t<3omTmFI!kha9ltD=e=6H)Q^n37b?o~4XlG?zJDbH-&(25n?Oc&d&FnmoZ<^cL zDxMa0`nI%lP42a`6WQL*7C9*S9qbHy$Ic_!-Nnu+8UMbW`4ZFBPU~)VeJ^dN_yFZI zP<6`jPwXUpW@n`I8e(VT7k1Ky+FACcUDs9FX*24LbgVdcM)l>>uqE z+NAqib$^@gZ&!?6b}YN?G}>clyA(R89v`;T^@yGG^20H^uA8#6>V%!wPTKLw04X@F zyw2EpEQQY6seV!U-nR4o9qq+kJGpY^k)3DH?L@y&f8?apd}(LwEA6v1i*PV2(m}Mr z!I)?VCki>JR@lL+Vh-Lc?qE@jL*G|8bp4QnQ*xw?gZOd|hRdX62j?m{s8i9wY`f-2 zCx?T+@|Sp=4sQD#B;+`FJJ&(!$__5na8R+9gDJA1j)PZq9dxhf;QNLS+BI_Ubz_Zh z;$Uu52UnUobX|gjF0x6!f8D{$Hym_p4#vOb;Pl%L+P8Dix~qfv-5eC_?%-H2 z2Z_BMd?~B@JJ>D*1~?cgX@eYG|IEQtS@*evpCmZM!Jsc3{3GuUb5QT>*G_5z?LA{v{uFY}anx{DP9h_b2pzJc`EAOvR zZYv$MU8P>i!Zi;5Uh81l1_xs|IXJo5LG>-_&o&*~?qJIf2b*^~h}@;Me|FI5SFJ52 z&pU9)KYutlcv*dw=~tAKBwf{*YYvXeRcU14|yXF5M;r}L{!$w_Ci#OJ2-R$e-X9mkyjTBQR%Gt*0)NZ1&vcF|IC*Mk^RNHh$%aC`{nJf+7)p(^p2zJm`15pHy+~)DeETw;H(n{`zv;yMmrh%pERApyAL-;Rqm#uZCvj0uipM%>RYJ#; zoMe}BQb!E0IVmB-?-O5gS$t?+1b@HH=lcIH#&7I^+`8LYAn`-IqyO>?qNx=q(Sxh)wpoz$J{&dKphTKA@tiMO0Y+;%eLj+6Ae+822&QTLqmm+kkRcpf-u z`AD@r*8V-!9++Hgh;or?c5%?+qC~WdFQiK$7i$Z zH5WC?xHwwYrSEoJoKA63Gu1^(nu~6B7r)5?hl^OJiy?By<08}NVySGF`+gTY!!9fZ zF8a%>+AfOLaj{>{O5M6HCf0KiQQt+MhAym)Tr_U%Vuvhh?qWnM7c-=3YZo2lq?CHY z#b~)HGupWL{Y@9o+q$UIUbS^_G3Y%PyE?nDf8f$JOD?8==;C5;>7%^+xtJ;|B!7U5 zWvMYS{K#VDc|)jUP#aHwGSIq>lPQ`UtBa4%K;aOGD?~q za`CQ|IqbqMhmL6M2^Yhq@=5hZ?wnFye<-g%UA%e4#e$$o3Bl7Zb!L!+w3M}b<;r1(QXoCq#P~ergC97g^RdpR@BWdX%MUNl32n`n#__v zf{xtS90=6r&idWmj4rQGy=&CNCGUe?Wboamyp2Wss>Zhijc=IIx13Wm8^BfCbpi5}@@piCO==G+)Jb;i1x zG2YGZ6O_|Ltv5w$Om*`_=1y~SWxAVt^4| zGf0N5aC2~_db>)orN%dI#;kTTQ%bLK^X^(Vvwv{2Olod)^J1%;XWP{C9d6djR;jd8 zz1ZdE%iV6KN})Y&n(lS;lN^zu`?O#CwI@GoU*)`fb;!+MhuyS3qP~gcsB)9K$J|Uj z?k3`do1)TLN}O`@#%VXdNR_j0Zb|T0H;d(4X?otx3K{jAn`0L==AxU1GC_v??&jw| z+`Rdx_DDjP-K>%uH{JMdD-T&MIrrUs_Q1_u`RI|G&5yNDGVqC;olo7=f9~eG*`x0z zJj|1|(H@=@^6*|^4-v&Z)Q<6BPVn%!v~J6I*eS=PT3HXH%6WJ$J(E3bsNmt}iXMum zdN`7v+k=F$6857p~yegh9P zT6*}sm4`;Hl|vg3NCd>HbO&mQ@~IORN5@_3+2H9tt*i82*EY zk=s0UKjz`PL1rMdKczFA^hb4DB*zS5b^U%X*kJPuv9ExwI4=>Go zYQCKBgDBUUd9jAoMB%5Y|y%+bbgHLk$=W{@lWuwP)w7&G@9b& z%rq|-rhBP4)5{dOILk}Q94}L)*E}y9=X*(8pfOT$p~lF=#a{B3dUf53mug>YO{uor z%X%ri)=RT*wXXcV-i!BpFAHSYk6v7xv=5uTT#>2Uy!^IZd$QAu`)4nGe(@4Ks(m=& z<;#;^o=VemUS|I4ijU|@J_bs1nvXROACJ?0eD3m*=JV;AcOSpY(_9|~A)S}j zVITAJeH1J3VW{fkdwE&S$A}s}D%SJSwZ4z@a-flq*d{)P$g!qA5}W&2)WS!bwmufN z^U=PO4`*i|VR<6vE!$TT)cU=(z8vV|2r zeT+P(-d^@m^Qw;xvj4hz^|y~trQtt5rruQFZu_Wv$Hyj_{#Z3V@iF|VdM^u~`}q5X zkJn%7*nd6_;U^s7CuH!`K+Hxz2{KZSn*3Cb^3$WJpHC&Hn4dbbSt4Wnd?+Oo{iMrP zc_i;8`B`1kPnlAF3d;FuEYamPPR7WIWIxp^`017IXNZKHe(K9MF}eNpk@*2X*Md5q z;pcXapNu>|OQd~)pJkQ(1ga{BI?AD*pRx7*ylCR5YBN9UB(9~OHm&>|kPdJ7b=|3- z;9EM^!OydI{Q5U9epdAIbMHgN>+PrMAU`t)`>FVe>K^0g?Xi9i%g2-b?4F{zQ~mrZ z<){0ZD8J6o{aJoi&Gu7jrPf%bxogy$Eq*@R>euHvT64FbyL0OjRB&f0!%aqC|W2$i^2i^C=wtsCP3TR07s-|T!68*0Iy_ZLV%-*0V*d2m|HqP zpE3d7D;r>Sxd3I#2Y4Y>D+GwJ2QWGV`Zo*#q5}a|WCXaE8DMQlaSH-0tsKy`#Q~D* z1?W;gKw8s)t{D#STgw3TTLl>3HlWvFt=&Grrgs#tV}LQ80>pI>(56R#Ydr(l`UiM( zK!AhNc93EY4iNuwfJUDOm^MVUd>LTqm;eXH2FM#1VApu%GBLnF`F2Ktr!xa|o~1hG z1h_IcK=XO3b3uTUUj?YXFhI%00opGKa7?aAQeus2_(e4w2yjm7 z911YuZ~%@3`1p8$#wP-FJsF_qKbm(tK({*q3hoAY<6eN6CjnYN4X|H+e6GABg6uN{ zDQXJxiAu&}*-!@2c`yi8~`a3~JzZ=x&D?yg^3v#D_ke4!g zK#)1oa$t~7a#qR?4zl87tvMt}|1VUNR2v%9?^;3jNa5i@rjH0>86Bk2m>}EbpqR%7 zc|0yic!KJeEt7)!_h>;3Q-W-jLsBp`$O5@OP4TDe+>9V`a#$`(x@VzI46mJHVa`ZSigJBIabd7KZp+*^anr6_qSq5EN zXXu(6#d%k2cFN%W?irYSWH3+mPR^jn)C?jPW>9;PjxSfPtCZ_E84O&Lf$@h7>TS$m zvt0f$1IOkJ_HEHR+qKS)3`Xx&PA4*0e=>s#r!rV@R{5XHpw+J#)V!F1>CX&)jmo6F zC6iUwOd?8VQoB?pCtl0st;|doXJv9WCzD~#GC9~hlTeFHn#dYC{y`>5A7=9Lz)b2c z%w*ys&0m~JymXM&D>8YsGLz^v^1J5!kxBS^CbPEXA|Si=5x81mrZs!n`P3gdNvztWRq4in_Bg<8CO4>z74Zk z(>0sN-88;OHX}dI=IAHcRQ@!Z2cKn=J0zPGvRxLA%I5ZrY%*qLvqUzDZFV+MbF*nM zFPp7$T)HmKX3^K#+*p>)8_TolDbZ`PiC>q^TkEqqB$wpT=4=vBIEV93a+vihhpUBiaTd)bt5_}_;&Q1RpR1p3x%%0b%OXcE zCDL?>R@+fJ`)AL=oW%3v$<;&&KxqKc~)AAVFGEeV$@^sxs z9*t%1>v`PlkVoL%JnnbNsm*z3#YmJepwRtr7HjlzT zXx;O9e0MpIBUkb`el?Gz>v`&>*84k;H8=9uB3b|B@yX3RZp)_Ic|_dJqo}NwNB8pR zct4M4&+@4JLUCoI{P!}Cp0AW&WQZch5Fg7A<`Dl{LiDhPm|ir*#bP1;k*UQ){1y|U zer$*`aUu3e(fAOb$ex4{g_A-&EgRDB{2~3GAJXsnAwHAkX_{jXG1(EqkRD=~JH$ax zh>$l#rJ&Zy2r)=XW`<~=72=q*%?q(K6e2zx;%3zlf$AX^N%fi`M%N1QLJHLh(X?)e zpJZ5l#cZIM4MVhU6k>kk5XG8=*xyvQ%|m=Dvs;9?)KYU=g{bpZhzW0pplygX?Ls_m zAEHwS#qAWLYUdE^q|5su)^-h1u3LzLULl5msBu!fe~4BCRKE-xs&$8H-Qgj=8>RW9 zLv$UZUQJN1CWiQ1s!dW)CWm+~AIwyLXNBmyKrt67=3>Q^LQ6s{UKL{R_u7Xav=1_D zqhkN4*qcI(+Zy83wh%S8hp4+d#Kb)zBKC$DdLYDsgCVXR3Gqa}JsM)Cv^yT6@hSCF zN}UdoF29@!QR3GSZ=BbCneB zejZ{wVWJ|#Tr!6#lNhFBQkYXxrnK&t(S5m7E=*=}nA#P>oURzAbZVGomBRE5hS{1C z#+4bSW>%Q7*ySHoXz% ztvAEGFKylmv+(UOYvg*nFzyav=E=x+!W?}!Oy!P>-%0U1E57XM8m4gfFiEmo3iS+= zC=2E955hc_K_7PQ{~Gr4P}JHjtcYoXvLD#;vA#=#)e54AEu&A7AAzrlQD8)Vpz|eFpcH)$zc{u z2~&KkdMUSL&a^PMC2B?(0qh>z6YUT5%MAyrwN&S3winCEZy&LCqS&lT# zC%$<;!=**beCD*ur*P|h2EMMbZ{+h?yL>M7%f~(-pP4dhdOpWy(J24` literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/6e639c3d8c1c4a41_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/6e639c3d8c1c4a41_0 new file mode 100644 index 0000000000000000000000000000000000000000..b79c7c2b04e22d42d6e1c8436de92e5ad849ecb3 GIT binary patch literal 29784 zcmWjL1$a}}8^`fqo3=?CX<8^0Myb0c#cR}X8w}Us?lOGXhP%7F%W!vh8I0lXF2nxc zKhN`dlH7aFd*1V&o08nz#8JP?(x2LY`RXny16?~;pTdob7RxT;D4dm*lvT``St=>1 zgfpvHma};AVnrQAa-7AAm2ecvE?vB+Gc%`9cCqZzg^D;!XBR4#U3Fp-&Cz3x?E`{zZY>Qb#=KDkXK3K4IG!Dc^jlJJ#VJJVLMCQtzu$V1|n} zU=Qw~QKpNAVPBSu9-u?Ei~68yT~7X%DJds1sCfg^rqcG@qV*TNwNyEqw zKEqw)KEXw~Cc5Y)R!t|?4Hxyib!8#mRBx1h>X`Rs`SN0U))^P z)ZJC*d|kCEm#g;SNp4pi^mA1Ke^+h5u6(Ylo8MK3esWc8fUA1oVxX&92DxfamaERA zRJN;*lycSMvaT{!a#f?su4;#*>aHq@y|C7BRcp*gx0=L2w|cIc)YMg7o4M+JCs##x zcGU<>McFQ{`W>ITa=)9a@^^PtB);}=RpXxY?d7VO*oA_<$qlA{u4;(C@TNcG{_d(G z16g8z0Lc=lSI?h!Z@2Y`V zI)ORk;6zv1CXqKjOeXg!t}2QhxQxy-TopRgRmrnmwQ7#53e9!ZAD969d{@ORa+Uv5 zSKVCZs?p2If0e7wtaH_MG~DDWw|%ZUj>7w0brNoeS(B5ldU2M#uDQzdA6L!A<#*)# zks5w>)c|<@$2cZ~CcthsC;)zTgF-L~A5qT7pmrFG9exH~Mo1omZXi9cL6b4Z-=G)y z3@VY|plZN<0Ee8?*~|%P`Nf24$i$>XkF-J|>knXnh3(e>V&oiiAoAMgMG2CDg^ess@#< zMjIUc#h}hL4DzXI&^#Q)Wz?)?(Dd2{Ex|o3tYgrpx(01;V$c(O#KfkI*^K$LG^j}{ zgT}Nr=q-%x4Ei0dI~jDOvq1&AQ+HhJVbJs63>wkXpq70M>NwP(R>KW?gpd&i6&`0$ zhyR;I9>_bH{&+Hl`%?{SKhvPcvkb~V+n{DRJ%|4D4XVD{pko^h8n%&oZX&162Cdp^ zP~3KM+F{UD4Bu@~l|77ggc_bD?ls20Zcx@k#zSA^d&HVy%wyL3i9t!v4E#-Du4wh# zpyDqK>i3f446D%my+PwX7_|JOL55ET%{93x$IDHNvBd1A`!+ZIW_Qy%Wv9AnELx_yX&2Jd-E<_wO@Ebjlc}7W zx?poPH?3*nrUUS5>ZWHH)67ltk*B$vreR!5H!VbBD>s#I^} z$hotd>UVKd!#?EH*G(z?-Bblv2D@q55I1cf>ZYqWJB+v^+!Q>@O&e#?cAlHs%y-ko z1#T*~&`n*j8_QO?X~zaPeZ`55ZaQOjS7D30JZ$dD%ImJZ`P{WN*j<_7?y3~$uA7PO zy5w}1TVZ!CNI|x{vMammRSkFTtLLsE&D?dXySvWxa#zCd?s5!Z+aUVRa#!?1cdcIU zuHk#!Rr|QRE}U~$n+xu8x#F(n_ubX#rMrrKbJr+&XoS&2Yjb&MM;`clsQphK>RZr5 zBZEEU6Xv0QQ66d=?V+ByggZDLT&Zv9n zQl9&8uV~a}9Ka*AsASZN%0_)a*3U-m#cNcoYE(}wM|L&x$4Y#}mS2o2Tb)}ht7+8Y zT1K6!ZPZOPsbf@NeWTjp9+DdvRR)vs43!%)Htseus?e`Sm1t~KjVAQN4dgVX9{37- zGozf%jY`L)mfUY^lv_Kap5haFcQEpz%&1}T?PS!TF4P*aU5$EyJKe~!hf(3b8I`XO zV_<(jYV*5M@dJ#iI?$+w*f5CxgSn5@$TfsI{ArY7s8M-_8P#?KwZJEw7)eb=u@2*m z>M)+;Wg>N-%wsIYE99DLR1i+#(hQ@j&m^Z=MxI+7BeRY2o@dnTMMgy~G0M8ks0u5M zTDXZd*i7BF7&R8la0jEe8s)mpD1V&AoIOT0-e*(~{JP($eFv%WVWawBCw@D^+8t$0 zvG+K~EN)}c38RLd;y5_Xm}iX2ILDkXu(lVC+I5*4|IL0RUNvglKh*0w$IA_lJNVyZ zozMV1u>osu8FdgHZ&QC%xJUh9zE68h#$J3t^#|k(J!WjAp(V!RIevO#R21^Q=6G~9 z$=zU5AR;_WnvL5iZ#3yGyuC~+i}q%dJZ&b;vzzo7-o7SHgja5pa^*GYUw@NY<}>M2 z2=PKq`hia2CKZe{X)}IFG^r=%7Bk6Q+$4WA#<3D66;3v(EqcO`YSJrI%rr@*OtPXG zE}&^?V&VucVp|!LhLY#BvPr#vHmO@Rld4rW>7QCA4Xtg`UYx>5 z)U9vQ8vMY_1}5chXi_j{qd;Smo;NY6Z&Q;Jo0-%Q*YLWlNiN;U0cC$9W>1ssy-cd! z+obEr-7RCy@I@lXl@a9%92J_D?pc18!o-6qCMAGil&- zlg3~r;%1oiHy)wROdii-Jk*|J(k$ekM-1$qZ<6Z*=CIJDRq$MFQYAdcA4^OswA7>w zG{8gbTV~Q}JVm?ZjJLuhzm+DHSYuLYG{qat*vN6ViMU(Hf163gwo`i;c9@iNocf(G zsUNPO$4SPZzzOPo2T+a8Iqk5mb!ulp&V(h{s>3Rm4+^ih622PNQxy zPk9t4XAH;b6i?+&^;9s@aU7L0Jko_^OPTEm-p0_%ATrR z#Zz5=_S8PKuj;9Oc!{DlJ=LKW^{VZu33Z57msr@0`t>|zs_!X(oM=qnCZ3wo!cz;e z7gbw&YD^pQZA-rG$QM1@d+IWZcl1H;Q?_SCMio|-(3nqv=sneM4(Gda2dwZUdoSvGG3})&Px+;1Q+2`!ArxSie8F> zsgjreK>y0j0|lyh={#oq?4@&9Si?)}@vf$qn%DBu5b&t%hqv5+$DH1K={9nG@X{4b|45FQ^T|t}J~QwC zy!7o0wfX9$BKgd!kl(DJpUhfPz${Zivl0W%x`f|C%_VW|jWa7hif5VC z8CQ{#ZB|(n%`q#gteMxHX0@(lR$yhbD&jXR#A(>;m=%ES_2^&UtbKUX%&Z@1+}y0* z2x(HuOW;c4pN;N_(@$qfiI4mUc4hJF0Xx>q}R&{_bX0YIn1`VgOuvnANeS<%`yx!tJh$&hQfV_StU^kiGP@thS&IkVSh62aI^kF>NJ*qUI8_CSxI1Ej8;dN-if4 zR9L|n7>E2TSvNFT#oDZ9zL>MdtXp`2-0O&imDq+C>#5fUv;M$D9NcJ@+a~6U%{YkY z&D0Ft(Q^yO$yT!-AY&VAjA1ywo%!rwKFHb0nqV@T?J{ct)?v_YYK1m?=)2dfqE49G^IbpwFx!+Tb*T{^L1=z3~5HR)MdKgE?6EjprSn<3EIbr(Q7p zpys%NwX*1dt3?kD7Nxpb)D4r|E&A1HQF|=(u_$+5i@FALAGh%W*F(4swJ1EyB3rmc z^)V4?5j>8xXgZeQdo=N4ESisb@fHMaNORutk%x0RI)W=y5TNKA>g^ipUXqn1>Ug&$8 zb|`p;dYrZB9TuLm$Z_7HgV=U~d@fqF;}UCf*`hUAblsx$|5{Y>hD9s!_@+fSZn2hk zEoyX+`8~C08Wtnv8F@dqs2Psp1KeI%)C#+B0>xfhG!SEv=aoe*&<&4J;--fTQv-KQQgC; z#rTK>qm|c8RuwW?H3ZL)?rGIDM0#0O7_Bi6HnUZAumgoHR!xM(YSl`cRRz7Rx{O11 zt73etngzSBRR=LJfc^!o@(8r56t>|5b_ZEiIoPVk=n!Jn15^&R>MZUfD$J_77=j7m zR&B*yl#H+{D3aVU4_%_H%8a(^F+SjS40*;A6UGFqN+(+N1yvl3;k0T|l2z>sTlF8x z7vX*}tC|$2eF>}fCR-JoV%11YPPNJ>&8j!)R+&p$bqQ`6R@Fw)Ok$yPmR0NV83{R7 zy~mDHR{d7ms;9_XhB?7dmT~b7UgfMxLU#w?d) z{X(4TR%O(%suD)yC_2@ozO}4cf!4LHnp?-J)Vfx!K~O!b%GS5)B!U`P^(WThUPG&V z8(XypJ({o|>zcAY&8%wLocvlcH|$34){KSM?W~GuZ`C=ZcCe}(7U60~=HH36>&%?H zF#oQs-3TkMRje9|&+r&Yo;U!FVjVFVSCDTs`*0MIW5^M=kvf*Vkbj(2Uy(E3su@^{ zd=sc2j!vO2Q?058w`o>wgzI#xQf6?B!#Ri8s5;lGDY%7V^N58}m^+_2EwJj>g;q6O zL_Ui-CYD&0YZ+rMx2oL=tNzBml~#qUwki=pYdFSXU(4~2=LlP8)gT;&_j-;Y{JO!a z5*w-WCaX^TMNV7D8OCkY9i6vR*B#`rlUna0_uW>t*vtAK;CXSB{IT%3RW(m>>|o7l z*5Z;?!6*-x%jAQdICF(|fAieA&Y1s_H%i~Ia^B3UaLm9t+`y_^)E6&M_%_E3&Z5#o zY63lCoX3mxq1bcAdOo}r`oH7v%X^NO5A;XNk5>Ki$*Mk|84H*G zV?JM~%Xgjwvgv`VO%>g28gI1en#rbSo;E#13$smr7MuR?wP|#2o5uRt)IX0+ckH}({^DYFPU79~b8oARO++7`EICAQ)o@+K1p4O48Ig?ni> z9Za|Bc}ttVplKVM+PAf-Q9GL~?QN=#2{_onrUP9W8?C$BbOg12v&r0(dG=!b-ps3y zO#}Pc6!<%H8bCjM#+ZRN#SEr~f7sOXPn&)j##l%mX;YC=Y#VJ;zA-kQKQ=9e_gI?} zaB-YXHOAZY7z-xY^ll=#PqwMc6q^=LwW;znn{K1~bepcvB;Q#!Ma;G-c#chL=aT1q zo4ReV$z?P1IAGJxqtyABP4Rerfn5KwY48o3P8al6%}8%W*7sIn_cF8 z+Mp>4_V89LE@9|z-kOA_J-xLQoqKt!KZ1IDD;`5&=;JLroPE930$tIipSRXw7drO$ zR$tWooj5QIq&+&I;Sg_){nJ|?P-m#OUJdhB+;DG|!1R&cT06#DE61{Zg11gj^wz>D z-fB73TZgB4YxxXsZAR)$Z#|pstpanr6^#}+1fO|~wa8l)VO;F3#AV)Ug00xQ+*_w$ zT*=t0y>)Pnw>oX`)=jM6;;l7X*}ubE_jY@$%wBIDIpD3o4|;3$A#XiA;jLfKdF%dV zYVnV^YTx!&u}9vj@xog#-!a!u-Wv7ITQgkjT8e81JFk)LvfAv*kCEPXm9g8k0UzP! zV^;|*Mgw2FCg9OecD={2AiEZ#WUyVckPu?m2zE4I8{T`Sm?TFI`eKiif4i(TET+x4l2U2ALF6`+hx3CR}b{M%eIHq`H@|_9@F=UozKDT zy84tlz2LZcY1iS`cFlOtdZPCy+T$5IezvPG%>UVW|7O=cl>TPdX-xTH*Jt$g^U*dO zhAEGaj^y>xQGXv@!m0c|YFyAqt%H2jG1x~DAwGJ7`=LJC8RnzE!+o?U!bfYPe6%#y zM|7L{bIOdtJ`<)ff%9}R=8l#kZH zT-ry!;s8pQ_0i07J_@cxF37IpqfPjVRn>eH{)>;MV;^4D^3m|RK1%x4M^*d#Xv9b# zRh#0YB@gKv9PRk6ap%BkY3s@PD~SN~P_Rh=5#qGK&z zb*tm626cV)Q$1hV8~f^J6JPCX>Z?c1eYL!WucBJfwzaPcwDnaq&Y?p)U)@8&_P!d8 z8ED(hmt)#jj|ceb>M-Jr_f?C@zIw6RSF_jn>hM}$z1hqd2Yq!3*MHC!elEE*8n@kZ z=_ij|>S@fSFR+_($<;HL-cHMGFJSws7ExzueN+hEw9OAUAC(kqnPl}js8cy}&MK(Rf!R0^~A=2C?N?8DN7xzzM< zE}h5lW4V-cJeQh$$)$P7pEtKkqbCaa=jJs*Zq>?{TQeNFRj_t$O>LfAm+)hMZasOK zThl(|)?avqXcs^IW%kn+o1Z4y{qz#8LjAM^Z%X>?`~bX1Cj8IecR$K}yMc#hAbWpnfB=;Azzxs^wkQ1fjbt@x5hkFYCm zUan`zt6BN-Dqr2aYTY2O3bx6s`yKLXX!pEo|9f7oK9X04(|P6oJ+G#^`m0xnKkudd zRV~zC3$UkzzYb^m>!;HGYLAjj{5ePF&vVybb@S%a$*6qVl9*4Ai{{fGW%6lyoqP)H zolgZ`=aWzO0&-hfK*?(gXxY&M`hKhcpHT*=8rGHwP*QS$%3u%H=LD!wsQ_hQG;YD8 zbbwBm3DAae0SYT0pf%`SAwV~fR4G7}Q6H761*k4kY6PepUgK5M0A;lfP_GUFD&93f z^KcD*-2xPeIjGt*K!Y(JU(uphfL0=?cYxNRdY=FtM?~KM4MUyZX@dbcj)Dm*Wlr9(uR#5T+r0x7(WJ@~0+r{lKy|>Mh}aycQYf?~P!+b)4n4O8YB}zr&~|dd@g0Gxv@=jma2#WI z2ddwmK%K*;edM!0P{R%d>JbJX4%7vN90}BZ96uVUEATnST+jmVQR+DLJHa?716A^L zppIS&)HRH{5~%4Yb(OhX3sfJh$BbL#eJ@b=9|S7rVW3(e_6d1EWi2rhdr<0GAfHPI zYWQo~yrFJy1N9QyJ_IWKW1#YX4%AGKAg=!k(jf$xf>gjWNYSWj4$}I9L8==ar0dB+ zGG_#7C;rX}(tSjf3)1rPLE4P?%0XOrO?$kn6(pD1LF$IIxw|Q3Ly#(L4AMWSu{lWTTZ7bd zXOP++B#+ZU8gq{J@VFYJ7WabG6}J09%6Sx|PI!i5kAt)ji(Ulj6TZI+lHpB|9;5xo zAnn02Jiftd4$*o8A^L!&nIUq^3Xv~H;2!E_hv+QqIU!0$a~#Jv z)GQUEad=)jL>J10D5Z9Yy5oGE5M8YsqE>%~XaRl<4bh-sahg!APgs(+IC<2;g1h448NxttDB3-rM<{Dm(leo)rmLiIN~Wrpe!Jj;Y~ zZZlN#um>v3K2)j_st&(|sz26L57n-&q58Q;sFwd0s?F%sGgN<}ZLd(BMep9BT8s_2 zkMKUBDumfc=o_kB{X#Vr*HO7Yad8Ff2ZXBXpP_0pAyhl3hw`~)sJ7xWGG>PA5KOZ| z6@zBjH#<~5b3-{l7b@5Fp=z`tR5dn+YWki~`R@%?i=(0X1Lu%^EL6v_>v*W1;uBh( zAU+Ob;>l2bz~ob*@;)7^xwwViXXuagv*d{>cm~tCP!+krek?-&i?qjQth*elJMg{2 zxaf(0vEo{&?jiGfsN!yr&+|||!w6O5m*o8_RNcRY>KGa*OnqT<2~%CP#4%KI4O2ao zFobEPTbMq=-91c$Fvf$&kY|`4;2nPV3e$LVnC76XB}_x?JjOkrFkSKu(|uIW6{aRQ zm^VzF{KGT=ukiyx`NMP)*HP&w#>OK2Tp&!p;v8;bML?LgpkZK`+F}9P1%+u67GhmU zn0CQEG)yz_2#I0D#v@D$CocRV!W4>$c#OXy!&EGa@lh!{Oy(HcVm_KBgsDYhm})t~ z)Xy2F;zfv6EKE(4!*n?{jBE76G%cMvU|vabz}1W}{tkrcX=a$bve<^lIG!D*ze|NF zU+FNpRR~ifoJ5I=VOoO!P_q*AMAxQa+TSBg-G8Ijy@=T-OjQR_w?F7RJWNwYhpGA4 zFqNIcIMZpfGE9pxbafb?vxO=BAI5vZ974nOwL!RQHw>4fakzfPIuvXYuG!cI@225u zhmR=OEL=5l2SuBQ>uKk3g?9p;p&6GhY@Q;xU!~&YXAyO4_7vhA!25@ z0%nD4=lpOD{wrL&kbg_K@@^&0!Eo(G*F)?>=dWA}ZBNRO(LVJft=s(mN8KHzx z5o$0wLNif$N`xBX9x|sz=sC*Ij^OV{godq*&<|KvMX1n*2$kGOTdaqDQ-rEv2~OiP zJpPJMItF7rs%(zX7JU8x?Uo4rv^7GTPDE(&=?HB=%$W$S!Ns!?{QnxESxCRgxG-Ic zkpJZfHN6s{&Zu-XLQU|~wFo`Ig@1^DJwp8v@Na~AAoxavR^bY|-i%PuTM;@5kK4q# z6QKwAf@yanxE?1$f1}8MY{M8u>L|ipBjss`lrwLn+Ty5xq~7O`RPTb3+KRS;k?I4N zphz_gj@0y!NO`42DhKn^*;X==>%${;8|gWbGM9?f({hoDE+47uc!n+&B6X%>q!v|* zRH3Sonu;oQBRLlnsR#8UHKBf_cD0~y%Scs#N2^E~T1WD_JyHwXM=HBRr0g9dH5>hV zMJn$1NR2?V0g=i(C{mp;b8w{Ijf&LGwUH{fF;d%6V^gHQACKfS>PWrB4=g+xsb9`U zY8&cZWIm{PDN^;J%aQ7V0@uhNk=GgHex&x{RGuiVEsRo$+fiDMuSmKRrOvp5Cy2fq zrK0!)2XGGM??q_~+TV}TOMJtShf&(|C`$96M(HNvpGB!FR-)bWD9yqZ!W z_1dBRI1M*bv{KL!i*X4ap3zD}AFRZ6*uA2aflgS1#^z{s#z$1QMk~h_t;c@R z3dtX>_d(H0435^QkZ4T}jaIX0Zi_}MSFvbS!iwU|u>^5TMk`N7w7O5ruZA(RK zIqH{=Ry({wm9pegj(JyPj$5MjJCe3WD+@;vzMUAmqBZ17w4U6GR=J1KoPUj0@}p># zhxcQ)zl>JcE5>{sts-xt_3&e~fUG&``Mhj-d=WC1RSpAAzuCWS5 zpdnWA_E>enANU(#KCw!|dJOiB)iuQCid83U#T8V@9jkFD?H8+sIEuGWo>&z}Ka9k8 zRLC2vAE@9Tt2!8wFINAee0Z#CVLz@##Oev^M8>Km&PT<{H#Syp&?b&CunwotI6hXZ zu>)BNv1*zatLrG_h~=DftUkf&j8!tqU@UIo1vVuyUZGf(EF7!d@GKImZdip2s8uvp zvoNH1to)K=)ixzof1!D5tWwj6g$n7hx(Qp!Saro`G|!-3n3Wl;Z&|TQ&nCB0u{d`J%*_~oF5QRI_7snCV zHCDO1G53M7nvMSk#p?DD#-0+Zl&Q=W-?4pKtoF=dJJ!vO)n1gIM?L4qs@H;8o!r6x z-R#G@J?uy6z3kr?t48}{)&6L#R-)mtSam@DygvE?#k57aymocxR5& zF-x5K`o?K9a^;TGS#sGucsPuT$K$m8M4a}XjFaPLoJQftZSuSmrzv;iRPA1zf*;1I9=1M;)7-~# zdi@`9zr=AaAx<^1@mrjReJ2lNys~h}6t8|>@%qCWFL(cVjfO2>ydD;eS8!mw`Uk}; zIXGT3!{c=oqaxxp3w0yo)vQ>&wxVEayz0X{Enb0G4A+wJ+Jfg5;uTpjUPCG|Ugda= zX&kSU_`ONI#=@^@yt*`t*Y@V|d=?z9)$r;cuRXXnEMB>X$E)**cm<4%*T9+a+5!LB z@w$Y6m&a@Qig?{c#;SNdL&e?k8iBMu@v4LiaO{iMb&Na_uVd(Yl6k=QRJ=N#j@M6T z==V>&{>0tu)Zqqs+@%J{xgW2R58}1#MZ7kDi`Oeu`Vr6PW%2THNl-h)yCtZjPl8tC zSKkD6Lhf7%8i9v6nH4P0(e$YL%dz)(QHA8f_A!wh5|^(p`y%)jbn5s2BYwC+H8v&qz>P6r7o$1e{0N zSqb_RC1xk69171N$N340U67zOREO`P1btsj-b)g63qzKY*NOx!UX`HoYZKJ#0BsH? zs0VrVU6D64d`_f<~g~u>`F;PX7}L3OvQ!&L$}QU*g_Okoi`EHlxw)1V!FS z(1OS0@q|3AiAu30sx00j!=A|Za})L0Cs7mgB!QlCWCL{r%MCaQ8j;`UF}$bpG!Fep*& z5j8kb`zDb8#6&Gbi%E$ZG%Zoprzffz^3F(9-C2q1y(m#*FlBY3dag~>A8@Qo)T;G~ zirJ8;wwn@lcz>eC9ZJ+}ls!y-$a5r7Pq6-EqQ+iIRLIRl9l6cp*F1igs97lUK2g(f z25UbiYPyR7m_cIX=-N;vchreueLQXERalr)E0 zr90FUGfFzN?Ef+y`U=l1hc@9g3YK!H3w}pTX@`C*?#hOsp?SeUmQxV z;m}&_M9Z2EW!8463L4`uHr8?IQ9Xx7H*jcdBgXjEp*+|J-^LD=!@OqX*Uq7dn1>4O zsY?gu(#gU9YYxrs=it3JW1{^SYB-iLP;(qPPIvIRt3%acoaxZ#IS!qe>(D?8EUd$c&lobco#wYcKYcP#(gp@vr- zI(~!t-gYSW2Z!3=H-vn2sL3aXE`E0CT#M=eM%C)lvCI65EDu}^`VSYZe^XygFa|g&Z&`=oO*=1 zRh)9K>f}4wY)7tYPSwJ(U!3}<24mM`4lvZBO>L*f)^X}|U8lA+bSk_hJ`3WSzBVaBX$R;5;`*$zIAbGW;Z9l!{St%9!{>~q9*8oe7%@wZ>N0w5@!H$@D0lb zIu$*benXskHq5C;!<}k}yd#+7NT(K#a_Y`#r=E;;>eM)=g2q!1tU!$kPOX~g)U8QQ z1x{f;)7U=4sjst~IzQW~<#U`GFqgT`WB&@L+OKqK$||Sct#(Rlooc(zsY~l=yMfpn zovQK|`!+lE=T4_?>~`{fUh2Nzsh0_TwPk5fIbJN5Zrr(WN3YWqW{?2nvkhB-KeYsh}gW30l@Pn_z4 z(@1;j)MdQKif2wao|D@Pr|x64OOi5Nlk_w8z}+p0?*t_2PoE@BMOEJXzX**_(ggG?l%z2zTR2IzaSYx?lhhxh z(~~p@wM!eM!gYo(Y!YP3(%A9#WC9g_3}vpW*2bCS~VH%4|z(mZ5$Wez=( z^tE@Adi6=twBM7|c>wjpT3p6Y1Cta#m|CM7;)hVDsY!YX*J(*=icUC-`CaW>#;2QEclGPSFVRI&{KGwn|DOpu82$xZ~Tr$7;k*x6Y$tr>! z@UNJx54chzS?y{i>tiFfHA_}@%Vd>qova}!)+SkH@D#J#ChH%JX~+1;YM-o6DB2-e zkMS9Qbxf8|H^zo*_hk8E8s7Iv)`s7bb!cR=45N~@8HZ7Ebh4I@Nmh%o$-28ZSpiFu z)q82Ox-LuB+^xxckBa!)v4i;^Pga2w$vT6ZXnrzT`%fjS&zWTPd%~R1;b}6T?Iz3Z z8FhM|%z5o(eYK>hs5M0sZ7JI2ouab-DH?>E`BL~jj1*0Ersy0J3Z>{RzLiK()#Mb_ zDw(43c#)B!4VfwWy>yB$;8B$n<@}t&|K}<4td^n{zoaO&dWuvpMah_2KSd21r0990 z6h;1;q9Kh_l-VRjwOgfV0$#RG(W*8n8r+V2kiSEUUSVFZ6kS8HJ}L6+nSnCb#H#E*6mAGul=c-cOX@+w^NmYw=mpE z)o?txo2m)-QkDKZReh28B2^`E2qCXhbqjfZq^dgjWd`NNZ2aevrX{Xvit$KOEBs_k zQ!LiQ=9$JM3DyILErpnccQ-e5YP?I=#i=S(gSDiGO z+NJ3%yxOO!Wrs8s=$IyFr!;j$Nar*qVJrN)k`ty3Nz+9P{Uc3Nk^N_yu1=!e)HJ!w zWZT>{?U|pZZ&8NmGTR)c7;=i%eGw%!x|Zcbtt**DbV&N!P2`bd7eTYey2d zh0-+}WecavnVhc0xR{!*dw2)8v~=Z07z!f?)zJ*yFa(pZ2%GR4f0j(wPnqd_#+I&9 zIqAI4OIOD-#44Ar>E+XvP%&KxDy6G-m2@ReVyvnqHQSP*&~X{sHa$Ft$J`7}nV+Hfg&Eo#kf~aMnR*eF$?r5}a(*IHt8phP zQwL%)wLBqH(M2;AUm;U%QLthr<7es_R#nebR*g)}!LYiSI*eZRGBq3}>t`xoGh)N5 zd8YE?Ha4`<=qaxpkl~-ow2k;~=n8rW(NBIa5J6h~zGr{C}IN=Djnu4XgTO@)|Oe z&oVOQ9F(ba+#X8bVVOFQJ6JwEQ(Mq@RHk;}IG&ElRPC{u>N_n{PY^yUQv*?NQKqJ& z;^IuzN9vMHJ_pa#M3ml?shTMHSEf22%jA7SrkWhjR2NJ>k*PwrGBp(a?qq5QI^4}v ze{{N+shpRY8iXRRGF1w$ubIpHOr5~EFPS=xfnPH<9!0)oY9&&?XR3^AmR91LA&cwR zv((cqONa3oRot`qet(wcV-3C`#Uo4QupSx4EX{?(l%@LUis`tVKT8(^Xjd>x9bpN~ zQXne*Ur?5wV^2hu?&IgkEPaT|QoHCZO~5IXiOJGMyhT9=+wlXpox~}W#qU{VsXx{f zXB-qRk)^nlELFqBlH`>^UO0innOS;?ZdqCS8!_2gs*Qa)%opQIWvN5yEQOWLk`rmw zv(yxKYiB8RB6CBdndFCI3$rvCf$JF$b+=}z#I`K)<>`VCiMP__&%*;tE?`&~ zZNjtF853~^?=UAKoAdJAkIYt`DE4C!_TdNoVzQNj-!TeBX@ay|*{fU%M)Ept-$P+&)N2L&J%28FcH0S8sPdN%LkfSz%IhusZaXIRSv_$sf zW>Stk3+1R`ksJ-fq!KxNXC+4-X*qJ>VMdO8GIMmeOpab5f0Z0%U>f%0ebpTOR4qqc zF&ianr`i$g}Ira1ay6=kWg_IZVh=3ffF! zT-Ybm7m?F*R0)f51|GA>0k`Mm$UHYk!x!afEsTrF6H}JvXeU~($kBMrU6-Rn2w0z^ zGB~m^N5}u7o_BJTh|&*o)DG|9@sN7{-=iFz#pS0t@_UxUXW2PwfbLj~U9f*7E=qmM zQK8Q{x`gEam@8KN$dL=H{J)y+1I&i=?c?}QbkU=4kdUxMi$sf(zjEfx9A;+Eo?Z16 zq9jE0UK2qOOIU&^YxQUmHCWMCC+d22OSBNZxA*J4-oNYmT(fg#o_p@+o|(PuoSA1{ zWc6rHVULQw>yeGGF%~Ou1dmX#xJPx+3WG2m8*mC-1XMI)&ptVQ- zFFeZB&ZA0L)Y+p_T|8RZ)uZ~|J=`Dc(cV5D-9h`l9`(bVH~M+hpub1Q26)tDphrL9 zB+3k89>s2E+c<}mE%bMrNAITc8Cvi1DCww2J5l(UM|Dql)D|~SdzAl-N9AzxEc5u}BDKcE zbmAi4C2D!iqk4C#EB4&;=r&s2_h<~xKJ+N#BbKB7V-L@a@)?RhW#3?P217aW8maTz_F5Bw2=j$LTkGh6Xk^ zlr_fCj(B1>H#8M#$ky86cdMZe?F@}YhEBxCKiv%F>u%^&FM|P=4Ryv4EPA7l!FXqe z)?i>iL(lsg`evZP^9F`$4l)#j!-yViXebV#(-1=k@fg{M8cO}%&`A^?Zm2Rw;xwv{ zFw}jdp=G%BgP~TV4Sk1=81N(0v4);u?Knd{5)JLdO_ZEu=u2$H*vW=&qs#j0XagCv)e;7*HU??3sHd9|@++rvSpP(_WY$w(Z z=5Ye&canE1+eb3?y|IhqVz;6Fdkx(~_I=bAU+p*48^aD5x`ZZ&4Bf%-zYHzLZM?w4 zBZf8~r9a16|Ae9Gc!~UJhU&a=($E<+I7Lj9I72(MJ;(Y;dgHvI&oA&fW?iB`$bXrA zfQo;U`xUl*)li;m)D{2Y)OAB;ZW!u#%g|GFxNUHcw83>N`g7M{ObJ6bP~(B2rs(^S zJW=uyIiVHCA@37vi4UF{ibH1%M>5(yGc*c&UXV`~uNtE{8f5kARZg$0GF~-9PfUyU zs%<&1@|O2%>qlN4!r%&Cm8$4f?Mf`es>)vNfm6k+86SJKrK(rgkn2;gen**VUd7?x z8eUbZ<&{~FxVVAh^}Q($p-i+O&p!m(bx z9q_6=mSPXCp-r4uy>I{@#j`DZiT${aY)y%a_nUcD4 zMR)S*WiKydexr|9yYP8muSSpXYTqcYen{~0y{lI8vM^;;EFarI1n{JF_BYE$0- zn7W1;^-aY$H1%#HQ@-Y=8n!T1uDz-2-Az5h+#aS1_cRsmZR&$QrXCM4m1&?UcaW*4 zgH5#?VyfAORJNZ|XEY9B%3xq+|04Q~5@kYJs_Ug!(_28jf8Ejxu!u1xA}n z!ZKt|F!c`XaVFOtO`cyjwF8Io<4>k?Pc;>V(J1r_{X^^N^cO{DnEdXdZ!>9&?z8Ay z5^d(O&O-9S=Zj2bSZwMgj3uVNSZb;p&MY^ze}$<rI`8~_GXj&!%bz~ zVygN!Q;o0$*|*bQ)Ib+(!*OVbsa$A);h2b=J57y4j#TnPXqTxfyQ%vgYK~L;P4zfn zYVA=|ua8rU3#MM-*NfB`HPY!ba$GVs02fg4GRsl=Z&Qm=;EJgs_!pJ0nmkWq>UXrg zW@D>&LzQwh-ETv|&_`b$c85GTIX)ON8VySmlODnNA zo28oBEhQs&4oiJ-0r78J+Ko?gT1rCBT$TpnGVI)z=EKfoF$RsrcmI}_f2T;MXG!D05`z$R* z&c>F$!9lEOVyTKv?yjX4F_!M5ajd0az|u)HinI7z(Ng|+OMcwN!e*8}Yi@D9fbF&* zW=q<%vQ#l>DObqSVBEys2=P#~HT_3y8*)a+FD#XAYv}=YwzIf)WywVsBwz)O;vVvK zu=FXKVGL4H_Dl974x_?XmS&++M@yT~y%TjnzOTs%89TE*{Q8Y0r;DX&*n$&XEtTlT zzQGA(=wYb|rlD$2OT~LxT7$QGTPh46($H{-rHL3m)Y3)d|DIe?bp$mZZRs)Qk72+3 zNS$yUAC0xt4X5y30_$MKIO;Us(j1(HeqxFnSU9X{>`!&7lOK=WD>{pY)gsBmh#N8R1b|Y?N{a(a~$L75^`O}zQf+-mU{fg z@wkHi;Mnh$zFKMNIC`yO->ji#YdJUmp!Vx671>~ER0{pt#P-nbPmA#b$QQ?O6|tMi zVLN&6u+)F2rI8q%YN`Bg&Mhq1!@k}%xE^rK|)8|VZN0@cl(viO{)wycv=WCop*Dbw9!ap1@H^~Pz z?sB|5;$$j zXyEl}6b|Aollb@w^KlI&En*=Nf1#j{{vZL{@e-dk_NhCT;}VKA@u@L}BNfk4(`LI^ zhgbN_@i7jjPpfbflpSvZAvVtjHj7OBYK_o+5|U?I*Tf2>c9FbHdK3#9@+HA4cn z;Q=bd5gRjc1X<&Ks*4_&hx3SP>QhsU!%jR!m1fieNjQpJ&3!U44C`?pm0I|?zsjd2 zxQ-86QZJ0h4m?7YRzB{(qNccvQbC_Wn1Un78S<$i`e7Napk$ahNW?)Dh)}2YK3Uy- zDn5q!{I)u@v^5XSTG_<6bql@_FYgK4y4Jx~nJ;bq53Zx@SGM+dwE14q*5UN9D6Qij8)Zshq=m3LLFO`wEVF<2jmFa&#JZ@O@=R z*=jm6@D$l=IU0|fpE=ye?&xkqN0l2nO2<9)^EkYV$x({eQGVM|3^F>7-oZ3Havfcc zanzuLqsd)pkJf!1t;U%Cj`j~=I>^yE+#BMk%1}p_a3B4@b#&r8N5h6WnlRDPAq-1& zG!aE6k^f{z@BhrUS2=oyWvd-+Lc=wVX0LVBWSyhmjyk%9*~c8MK=tE}5>Gh#Jk3$A zbVrTx3b`*inuNQT9WD6V;hA7Z%hBe#qwXkv!_n1yj(&OIX!s*X&J#X+Nh4FbE?01MyrQdJm0ZoO;_By*U5%^i>Yr+^4p(=zqlT-EHHlfvRa9+P*Riz@vFf|} zPeWHX8o7F9xLW9Sm1eq1wp^XZM4ziUh;Hm^L=%_sj$IYUP!t~QDjwN}xGI8Kcs|tC zkZ)Zj;vtf!69*G#5C_pSi8G5fNyI^K?A^$G3i)9l{F~_KpY(AvZFaf3fW+PO3+48> z8oAe1qkXROop$8P zd1BNQTTwV~j2a+&z8Kv>twJ%pb09`Z=(ROQ6As4c_OTc(kY5!t_*Dxb?8@lZeeBQV zSE0;)4aw%$sDgf7MT5eA#TM~v0nOJlE>W8a1zR<4{Yy9ej z)f@ftrufz6Po}&58hFyLkD_C>qj{|UY#XZ&+Q%wy?^xAc6sr!~V>Jw2_r&VG!?C)7 zQAc9cGc8sRQ9Exy9r6cMIyRtBa;XYDJZfcPJxwi`eId_YOIUXTI|~%r@A}h6vDZkajKpgrv;d` zD^3%3$LXCtae90wPBC}m)Gd3w3Kxi1O{_(ig7I2_f`#K1#!BQU60g4KTq0iIl!}*K zI$ndz#OphMyn6SDmpL|GYv#sl#jbd5$9H>(u|Hl_FU4z?nyOWXrs|Jp)tf4-)l{`R zHC2(6ro1;GsCgZN+Sxg%Vcmkd-#e)G{ewD)J_Caqg64)$<^47!ABIi~>CDWKip>h?0L~&YDWvkVL%M|fc$pkh)p^9n zc?_8!Qm)0!Z}gQ!WBGU6H=wMAq~TLoJOH_Avu_XZ0kcR2wzG_3($N^NDuJd zp^y&Z#@P_x)rHjPAu&+x5q-pUBs>l2BAz`9srB=ax@HV(8Cquws~ZYr4(m*ou!?03 z>j2IoFew)>TK=%k$Ffc!tm-Xk3q`^jjp6;nI*FYF!i*;v)>@=u(4erQ28Y!G zIfsPxE>0nOL|7eAbYxiNZ~&P{h1CY5$IutlO$cisDvb-P9&(KjGwym={jq&wSiZzC z_j8AJ8rx@ul_4pt)!2anv%?yn9A;mJbz~0xo69;lieKi1)pTiCli*zzRx^CKJgh9M z!}|1(Fk_KZuiasF#(ea+$$C){)qFpqBef$cUnj!<^CJqji|EVt5zRyVsEB?=3SJ=l z=!oiK45lK>n227Y@sAPp#xayni0Il+5lxs7QH_Za9ZrlWdQybq`RZYu4jM|h7!M8#)fc0@~%Cpn^97&<4S=U6{Cq9XGnI*rx~ zBI>XzqOVUxbo69I7clUDB07W{$Z#s6DyWO8c!DgaBdT^LqLybPI$1y06i?S@4>Ir? z&dN^)tYz|l|GuB}`qcc(EwXJ)4qojuy-l^4?M?PIi%!jRYti5Jr(Q`p{oi&O|J&gI Gr~eBQzkx9T literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/6ed4b3b7ebdc670c_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/6ed4b3b7ebdc670c_0 new file mode 100644 index 0000000000000000000000000000000000000000..e9040918a16d531dd115c7740d5566df7ee6f234 GIT binary patch literal 35316 zcmWjL1$dKZ7sm0sN!oauHWY8urtT^3?m9MHhr7GGySuwHV7R-(HXMdCT!+Kp`+r>5 z?`rbCkDPO!CnfTxzWQBOW^4cTo4=%D7+Ab~K7Oc7z7pvra_1|PGiS-%`AX-{nIli0 z(xvjG=gHyo6;CgnGf(~!dD2Uj&Y2^SEc+EPdS(^bmRP5OkL6QnGQrC3x&cWlB9JVuQr#D)v#y-(_M zP4X1;(`M|)Jv1urr%^aq!cYI8LrFjNMW0fB3Mk{J%;;O*PxUJLsUK$lPisFVqXwEFx{aTX;Udnp^;2p)KNUftu72v>+fO4UGagkDmMKJ=(wU(+1Re>8I(h{IvbGpN^o| z8$VV4>Zh+JgPQsq^hbz6Tipg7#M2B09SJokduD?+V{aCN>Si_QXf}hA!VKzxiynho zMi{iegh79zbV-Abmp150IfE>f4Qf=ypmxYn-Jqg40A~$@T4OP~)np8Gt7p)(rUrFw zX3+ai1|@VhXbfheTo;1|;!{^{cQYt!cZ1^at%pI4d(pSIL36Pe;eCh=mi`7c#P4`J zfO!WRlzWgtod+AV6T5~OWE*Ob4?BjD6AU8^Du%rnIEwqD4eC3_pjYFW3k@d_>m-9T z*`UE#Ifa~YWU4`d(})`%rW5-NgYsZEE~E1tgQDgdRA9bA>lPT4bD=@QF$J#01|=>t zDDz5#Zm%+E{A%J~XHY&&UvJPE?B8HehmFjK?3)ZakDF+?)gaSBgH9pWA=<)pj5cQs zdU=7EuN!2&VNg06Vi*=;9j5$k(5%}AHM_%_qu^a)xo1%5LxWD^z$1g|KV_a51}%AM z(6WEY<()zI5%Zqfd^9KsC9n>r&#WB=VHF<1`o*A(DD{;#-wbm9XHY*}#i8%)A3vj( z8;m+-G%90&QNNgtI)LF8qo&}V)hL(Us4%p27*#XSs168q8Rf+^d_?(RquOC2Hsca@ zhZ=Pm-i$`wLXk{HO~-=FMpeyX)Jx>gYE(CTMp!nZ8e%?nV`z4xMu!as@NM`$^tilYkZ zl{e}krd2S?UeT!E5MIfskw~pz_Dqk?N1 zwFoD088vGeHM_P^EARkI>lpQ^u2H+181)n%F|{diG$ZGhMm1?=)P&YX9m2nO)Yd3- zJEI07u!B)CD2GdE-N~rqosG)gopr?Z9!9X1Gzk&~ce*$TXcf@N@>ZXByRhu2E0s8I^Uu zQO$5}0b?vSDsGukIaV9h24~h7Ree33h?t5|4-j{gCA`dj%7ou-Be4*K=xvk7)J6sC+Mt>i>$z0M?=T zd!r_OV9h@oW&C8+LW@ZgtR|JRnY0`$>?W;om}GUD^f1t*o-UI%A%Cz*Swc)oMy9O% z#7-Q|Zqjy-Ne8_q-9@8llagXg@+O#+JJF;a=}XO%C-UxWQvEI_HS9|c{Y)x2z@(}u zJ;7K>8e$=HVpVb4}VZ&!i@c z7#nRCo3sE^mzb1ysYzY24+EB)v>yR0Ofs%w&UMUz-J4DNhSOW9|2C7B9X6@mQS!WK zQogIy@R~{SH%;nsoA_Utbl&c-Tn>K)1p3R35}EupFtfi7WbxO??EVT0^Vb@52=~`E zoJLlUzn)`vguiw~`m1=1zp7wntiQ6v`KvlQC;4k4DkuBvcACFl;8ME3Ou78Eq##QA zt7H{_y{_S}gZ2D1teL;^wBcA=+T*8o{#w|*8k?O(fhf7%3pu|;jcD-`OEJLb%y1tzs6kmm-B|d`r< zXeMok-e7nRN^o@i5w~fAJ!QezBa3Giw9R#hY~#-xAESC7RVD$*gXelx)@l>_{=I zbgEew@HeKUnY9o<`^;(tSGrkYID>0Ap2MuFInCOb+pPC_%!*tj>YLRL4^W_iS!FRD&rziz z^Wc6XvvU4wR{q9j)o5Z?6Wl_nrql!9;A&=8dULaiAh4xb(~#cQEK@tPp5YVvbTIP* z%&bue>15WBF4P-IUCnxld)iyP;O&A z+{4T|Fv2Y3NV77IGAnJ2S#8k^pKy9C^%%!`Ofsv(WcJKd>OY>B39uZ#_ur8 zu+yx}xPS%w&1!tmtRDFFkXZ+hQ1fGE^~E0aJkHvkU_Ei*6#ExVB0rNV~?G;CJl2K^DJoC~pNDr^}na%ZxrWfqG*c^NOtq95oKV^MgV zMceR8nnk@Z9J75E4NSKvYYvOX;Yv=6-lJYFix%d!$ez!l%xH|0`7O#-z@oP31!EzL zUZYZRi&WYoCz|0eG%drNIF5_hS=OS_<;bNxF;uefc(mwkWn!yhQJh`lmKUcTt zMlFj**0$&X&f+8L*0*Q_eqe3`i!wB{C=&CLy|G0vnpo7YsYPkcENY1B_|)8@^6e~o z)72usZp4EANb61wdsE zoydGRi-wb^GycTClc~`Z#z2Ot7VX6;Ji_K_w4H8I2i(T68N@itqQSE*nt-)Po@3Ef zJVu?l+@D7*sJ+0VdC0nmF|cp3MTRBhy40d|ur9Z#GG1W#3X5{Cw5S*w;1S;8;3|vG z;ThVkX3jMhg|4+I{|1Z7pef#B&KCCaR>s~=4m&N%yNmUMakoXKPEqUAtPifB#~J3w zPSih3-SHKZ&RLZ72X+3_qEvMIi*>kYQOU~|{f(zr*e@vYkbKeXDRDnzuRUjNU+`GL zz?VEGUR(4#4&gQyyrE7w0sFu7|H7WdU3|x!ueAS-R4!&!8t3olq0`uca6|1UL zwW>b4{AATZw6A7Wf4sssbo<$=KYp>QPj##E)MR|j#cgz`MV)I~HKh)7)@4p?L;ZSI zS?XJr8K)aFZWF6!w6JO^4xm~~s~TcL8**z)ZtchoJ=$A!8TXOBgH`!DT2&fPk-w8w z5&fz00ISBLz(A`42QePb;wkzKw#q!(sujpR)~fxOKhCPZFm=3DdnZ~oeHQD6{rF|J zRn6vF)pwp%Z?Ry$RU0s10qeMsIG0#;1nsv|k6q-p+p6VzScAR9x{v*WMcA~TvGMhw zRW}b=)%`HB9kFT^Djc=y1rm-^M`Sxe?zoJ=lho!EYj~PEo?$;;XMg=|6u zKeGQ2^vS9QXanPCt44h#wr}ju@3ir=sj0!H&Nyha={%bF+jJ(trom>LCg2E)J8en~ zvdQDJDH&aH5B-8|+LF^4P4+O*DV(@s>2vdI!- zQz%*>B#yDs1HZ@HbO`wqY?_;B(<($J6C=K-*i<*wrj~H}Y+8$7(rvsSWz%@14+R)m$csd{?F2bHg(!-llOp4Kcf-KAG9gQVVfe3+jJkVQS$_KJV{&h zN7yOmL50&c^*&?M^RqU6M%{DN_q*7nFEv(_~!7u;(__d23ULf4TjRTE1sIxIfr*1=f!?&Bh8W_{8|1$?Jd~-d1+i#b&f_ zLqC*jXIBjrY;V_OTXw841!+|yPEg6t2;ac?D{a+ zF5?ipdJna0B>acjRTPzxHr%elc!M7pHG+9Z+jRp;W9({))p!oySmwZKv>0dC4s@Jg z*UU-ufn~B?dvO}UQ|hE0rxwb+T5zfrHvb`8f=9NA)*X)C#68;&4h8#P0B^xDq; z*kRW{D7KR|#weWHMLxU92c`C~CYX+9d+l0+O&GF|TA|H;`W~<=$3eR?9ilEr>?(qB zM~V9+H9SSmr`fA$eTK2l68AZ~ZehxKyBc1wYs(+3Evo!U&VShzd67MYQkPhF47zMr z$`xvfc~?1q&8`{v_d4r)!>(Mni206Pv3J>jsE4j}VayRv^{9xTAp|9ITt1->BqJN1I`2Q|knY?MQX z4GujrI#kHyP&Z8Tcj#BML+!CN*r5!W9O@d$ZQR96-1PD@%AuHOhXP|9s*kBC9LxPU zhh}31z9%qVqC<Ch?U%jM8?EWwvN4n4{1&Q53oN*}PtV6xg?;PzAex7<< zaOfSD{^5}CPlt|R=U>Eg(V^X!Sd+^RZNRdd4*mAGLzQkhv=&cpJ9O&~YkA+HMi0pE znM1R%90i{f_X~%b;RHUw^wObL*o)K1`^urgn23z89cqDYc#QmS94d?B$nustVJ=?d zJKFv0&@P-niFXc7#zJIy?@$wT!eu0VU@R=h2bexmR~*G(sQih3SdY}t)CME*7RA0e zWdF*Tn1x4pk8aw?b+{DpC< zJ5{WPQM+^`QBS~C~kv~w!9y;FanPzR^VV;Qb>B>zsVU1xIcLjGM@ zyD?6lt2i|gpAj&YIB^&n$2wvR*Le@!6eM70qPR+qeWSK(! zaAF2^ndwwLm}WV(1%}y96`aE!NBRQBMzw`b&A=VxUBp-zhlPvDX^B(6E_JHmGU8dz zo><|Odlhr8cB^4QTBp40ok~N*2KG2y8`=MOf#^+64Z#Tn{l*@`ubZ99zlAz) zb?Wr*#I&85VctpI(Rmkj-AxR8sP$fA-{(||1FZjH9v3HwA4^X;Rr4%+2OG|@7MGlg zLRgHU=IGkEv&mkeen{x?y_fa0hJ$76X-GX zJYgRAJ#(rs^1fiMm(=1Fd*roKx!*W7;2pnT-m_mm&>t;7I`zvZr}}vC5vbuIff}D7P!mG~H6UZ4?qv#8kIaFZ zjlWSaOQ4!#7oK5a)<7M=S=h1#@_Hdq-(bxis14}o36vrNb@2b<19c`LP&E?+Wl9O; zGn7E(PY+a)9Dyp8Gf-EtKUbiN=O)HHjFC4`na~Pt^95=xcHjXr6<{1REEuSHcu+V{ zM~VdMMaw{aMbkEcYTq_cjoJmu(LPYsF$G6D1nO{C=0@x8fjW*_Jp*O$MV`HxzYlr! z4b>!=es_=_>vCx` zKEf32;u;H=mZL$4OH=STn@jI8D#E3uC>rU~JfwPE8iS9RALUZUXqPg@xHJxJVqKb+ z;8LzcmtxbHJC93S@^U<%OEebDq65U;j=;2c3o-X~1jlEp@ueVD%2e>q3uuB(*x^x$7 zhP#wFlAmM9VXRB7$GKz}@6y8wF4dUmQjDj=^SSKaOpGp zg$8RUj=_>KSjRI3>qO>YUBcO{!D<{Htkx01>KGZUSZ}bN;$c*<_CyEkYD}<}#Rh9* ze6Us~1?xa^u;%0l*8IG|+M6#}1@hCbK(KBU3|2_tU=1$9Tv%3=xrzsCc!^*|lnmA= z1eOlg2H494>sK5`nR3CJTRvEkm5Bu)eu#~=4v7OQawa< zYVZ>sYlWy=oe(vs8=`FWLgZ>3qT5YEbg*fN9ybrs>J}l2Z$;bIAi>8$TGoDPm^0o{%+kxwg9(!nceydm&L6sFj(CR z!WK-oxivR~TkSHswF%9$xV1g2TN$#sH4^9XBD-7b!rUt6aVsUlt!9yK4UR?(bH};$ z7CYkI%ADXkZ()vYSk+*}*!*81vv*sb)Y#N6Dib7;|m7+ShDqLo`qM!1zY#;wVCk8YFP`gay%&UULl z{)OhaRSJ`_5LxHCwH2M`vj+Htq6@f>_c*`ItrZ(+zlrg7aty{@ZZ+J)+Tk_I?{#Y} z9w65~x27QPez!_v{sFft9_Bn&9&xMbG4=>XpL8q7DYu$@b!!o_X3C&4=!Kk_Gw@t8 zgKA~TpgFz_3a_0(Gn;47CHy#)K~G<0(5w#`^gCW7!7o(5+e5WIFjP}rp?ZZ@QK4Fa zw?#vBrg*55%7iMdQmAJC9ID#2L)9K#MuqC9@uA8&HB^RWp}YnN<^9G`_1YJzkw-$c z86VO8QmBG&hU(dqP-S@aVkwG2CP9KKhf>R3FZCilyzYQr+B)R>H#Jt?D(z&bf2 z*NkP%)AEAte>MYYYFz}&#Ys`Gb>w}%xaIKD>C!mYG!`t zXI9-zS#%~o3y+5^dXguLhL_Ev*>$qW(Y`u`#>N}GZW^W%t;5v2 zLzwb)4bviAM`*V&#bE(Dbq`auUSS%F$@qpAy@?qSeZsT})%%9&6h`$6Q=NgF#~_?S z;h|y5H7rai!^2bn|DwT&FnvVZQDN$ZU1&KvOx>^**T#hD5oV4J)6H>V3Yi$DvABm< zm@z3#@27BlY8clIg=q^M)2Iy=;USWzhp9Q1;~%V^L4SnJq(;a+D@+}+8vAC4=_``v zgy}98&t;uZXCAR3^L&mWd1;uYFALLB=#g=s!EWBqON!QH!I`gAW$8U7)bM`2tu6s8?d zY5y!te$T_?eMNuten;G>_MX^2Fz4qm-lq=J@$c-HALJPkuI9)Z87_BJxLRW`Qli6^ z5Ff5EU${EpGO|<-*ZC^pI`UJvj{XuZL-lawsloA@;p$yGTw5E3t4!l?T|;n_a2048 zuDE95`ra~J+uMd~Vf%13>=3T}9m6%IQ@A3#gsVl@aGmWIE@uzMK$BkKD%U$)UvQvr zxNh|e*K>Ru5U$Y!!(|y1F4M4Z*++&eZB#g)D}`&wp~F$k4>29B7MxrXFp8 zyO~E7;B8Jn6lmem#g-n`Y30#&sI^B$@CJTuJX((IZ9VFaDfooN?L68DTYHa6VLI;M zC8~BHKAcBDM~}u}aVL*%V@hZ0fHGY?+J{D6J!+5RxP%4WJbHrKJ*Y!ZkFH@=FOQtP zJ<5i=eLPC+>rpct>__|l9<4>sfgbHemqGMF*P-M#jQS4uD9a>nW5hISF~g%R_y@;k zG45>Q#kx7fk6Lq?XP!qL=X(^iz@vvqS?p2d63*cotV=x_gxAZd=L(O$VANXTTt~e& zdsG80F$D{88I89vCa&ZAR*y3N?okJfK&bhj8iy;~@AX zHAf4)N9j|HbDA~B{WBgFJ?Bx)iyrwdd2|BTG46^-vr+mQIbUa=;y28>Lv9bK-9PM& zM;^68(o=GK#{S1x>__S69$f9x6k(PK zWw%Bs0oCjg`Yk*{brT|Vvp|IG#Uiu^S4&0cA!5r%Xmy1MZ9__x2)>s{d%UX^A-~!Y z>W0E~BUAw;8%C&Rd*`s0v|?jU0Q_Jpw#0Cb;5JxeG;Li z*aW|)5ju#*&mvUxd4#s&(~Ah@en~y>3Ey9n%i9P&LHmyp+K)d`{S&qR7NK9iN2mj? z{D{yzMQVv5Qk#&|6se=Q>xfijP^3DCMCudHXB9)RWQX2|Is(ZaimF*a* zC%qzNSr@7LMGz@M0A^lB|`;5%}fyy_3HzgMLLyoxh>m16PgCHh*unhb}{s|xrJPPLn{NwcUHY#HUc_o*Z@3eV!H<)oyHN>mUpUtXFrCshn2@YkSolf7bEpT3zyhx2abPntS!51vP5VJRQAiHNwm5 z9FC3jYRD+^K-tk=RYyOJ7~_@ScygZNm35(4C9!Ccm(LEoT8FSDUM*hgRok`XzMknn*GMS2fb>2+RJC4Ue!NC-SH=Kob_^T06CuXss;LD6@JH8R5A$;1#d3p&44<^lCY3|4m$YiHf(qI*0qP-SsLn zZX)rXSG^z6=ZRNSo>8CYUgdek+P$XDTdxkF%R8?ce4t+VRZ$w`7bUwPN+VIr7^T^! zDCICmaVa*(98vno8KpO;jInJR!MwXA_`&m(XQ6Y-& z0Y<6AFHstR4b`Kx2OVlg$y_T+N07A+?HWXJ?SGVRH;v*m^e8#oMX|O~%HJVMd%F@t zk0>?3>Yh>BhEBbr^gG)2j?xA6=@X^p*o=pW=^Le-n2*$cQF8Z>(oEb$l>x+pEBI|t zl&X!0Qj;mfH9LxHXQH$NpHXaXl#aqOFG`7MhJ*8?6udA>;mEisN@Z6^=`v1iijv{C zC^gy~r5alp4Ta@CrM`_Y->bgHlnGZy%#fc~l#~&zpGD@eg_f(Xg;S*Y&CI%eC z)H6}~fazzW6m%|13vma1&eI=7E|3dm;5jURL@D=QoX0W@xJY|^#-__rx`&V}%!^+5 z8*8pd=>dx0j8gI~YK}G-dM`@bA4KW?!zhJ5W=zCCCEgcNd=?+2#;?frHMt_=2j==5 zrIuf!)cwCGokRmgs~-aWqE#0yaT1jc(W;01#%Nu{T2r(>!rwnyLogwL`{-$oR!2*; zWR2E8c!zz6Z{?*t-SHfkID(rvM16Oi_t7KS}oF|Rm&Hx{^`-`oP!*4 zF<#ziH7yXW%Y~vYxf#qe zn>K5swHzbY6Vv`^6}iEDFUcb+M&BC5sCL5`wZK;#X%wT@zsBe-OpRmY!>`zc@Fp>u zkDUl=8l!gji121Hs)>8Z(>zAcI>#ucON@qe<#@Lk6(1R+zPLJyvBt!xJ?7&QO3aGU zAmp4Kqmnp@*tszZn-|0PaAGtGH|EEv?1C7L!eQ)L9HUd{xgBP2Cft=X+z6dmk~P(7_l@$B-j2I)JW683S?0 zh!bzn{RFY$#;F*dpT=lBE+P6%j3y)eY>b8>VvHaz7nI` zc#i0+F?w(Q}4@*1V44byTe0ph}xqMYoORyI8T>HaJ$VQF&;r5{AVp4_e~Wh*x z!?CTl@ys)>!?F6*z~_2>3l#MKBbTQFU9aw&NSD+qsQwJ7Tr< zbgY)2i`8Z%o{!ZAT)Ys=bGlf~Ly?Qj4a=oiWxgD%rdMLs87Ws|wGx%D#i|J=A=~v> zJw>$}vHA;DZ^mi>!v2m`4@BOI)jC{3*W1+YPOQ!#;4b6di`75)idpxG31<=ZfS4b} za@~2X8a<8GoX8xf_gOiYEl!=0l08m+!sE09Z9Q@73%`gsHH?hYY;T-a z;yupC#_2#j<0Zt&Ryay&1qbDxoS@}36REX0}JV%#` zj8`d6%PPldGsaXU-fD50iDkH6op@`+@jZw*RjnJx=Ra}!rylp~$7vznVS9r(^==fW zy)BrpWt=J^pjDiVt>btPAWlo$$Ejq8IJr8;X+8$@j#KhL=0dYUamq9#PMt7!DC3Qb z)9sCMD!(O8yHI0moW7rm<2t!Gy}}PHJrk#2F2rdk>RqHZsB|e#^`Xmg>VfRn$rEum znd4!c4&rRac)pJkul#r8wHn`$<6gWv;|iW4;eNdGU^our4^(&%&;Ql&YX2}^ukas+ zJ&M=<$MIVHEMB*f@;qK$u@>!K#A_bjA^K&!!d}Je4Z>f?YtY+x`TZNO(m0EZ@8Z=6 zD{%^+(eVRuevIeZ(RjT@&QI}t-WacosPZLVQxNl&``_bLPzm}I{(cF3zac^Au*Hy| z`|ubOR1>3c7MV>6s*Ai+JwcuE5!IauDixTZC!q=Yfbfh7@@7qt4^!|yB0*`9 z2^!~3(9Ea=HA|o`X68wdJ8yz2V@*Et&Yz$OIE)U35;Pn+3Mc3lG87?>q6x}aEJ0n1 zCn&B&f^wm4=>)At{W1w^hqtI&j`+({t4h>mdx8cc$BqP*zzM|cVw}AR8g?Z?PwynC z{G$XuH%?H2#|f%{peG3mL(QiN`hqpjsOyUa{rr+OctsyXzb4){3CjJJad94oe-rfR zV}c?-CGb3tntVx6HFU?;9|?Miihha8X-HHt49ALqMBPDQOQP)7L}kXVkVJjLT6dy$ zqj-iyEeK8Iv%W<2fnTOXJx4_5M2$l4tciRloA%ifRVO>`J&F9zNz~PdMAeH-R3})x zi3&v(EW=+Y7L%w7v5CBPO_U>NqFU!lRBUeILnD;Slc;_Li3jZqC8|G+g%kB_kwhgI zO;iDF#~1W1mZ+0u61BHdqP}87@wQ6TRJ?AT z$a{^6+KkI+G%HcF@nLqNmdr`iMnum|)GYkIB2gE1By!zuqGs$()J2Tkm#CQt+fR)S zkjKG99XgXJolVph97eBmi5h_n7l;SvaO@9i@E392NYumI9J`aK33n4!@gX@rVvSJt zDKTIp?mbIXp67|$^fFQ5uM(An$ghbC{>FV|`;n-Q@cJd`SGWyHih{?Oq!d?@x?ni2 zB04xpIq(~Xh9v1alH5t^gdMnoiW!nL31vc)v=k@sFO)G!`OqI@@f{U2CFut$W=>Ka zjLDLuzfmD3NwshY*JG3P6m{Z~)DnNjC#gnal0uS_^cHQBnFpJ27L8Mqv>v-rA~i{- zv?MjfP2}_?aeY9NKEauuqyi|5iMWH87?C4MTX867lCtDVQc>)KHFuJ_VIBTLtvpGZ zhhh1W6j~rjZ3`ypcQh}Qq(X%m6BUaj={5q3CaEhvqj@pvhk3=5^k0c26)8!arIYxb zkfi$Mlk@`bD^jycNh(#By5lt(*GtkLxQ|@*lT-;!8c=iC8B&}?mB)=v}vb9ap zbJS^`PIG#I%$GagPMu4|GqbfYeVlQbV+h9v3kF!D#G@ky#TF-h5{B&qH+Vw{nr zf-^aX@7OgfN&6RY9Gey<=>W@K7ex7Ij@HZx3NK%W-tQBfqVcqcp6|Nt} zj5t{y?T>zAR-iIT&T^$Bf;C-XPSl2u`J zvYw1h*4PQjd~TVntCNz|Y(}!OFHBai#mS0alC07PlQj@G4>9)PWNpVI96gaN<4Nj- zW2kg0S*uSc>%f_0okPOeWIe<`7wLB?S&^5MdC!aS;k!-DIEf2)lJ(;*>vb<#Gwvtr z=LgArSAg?~e3Yzu*zuSeJW19%y!k>*UulQz-;z}mTmDPdsPD;|4vRTOC2-V|qCe5! zmZIU#6itDD<`j)bV3ris$MdWynwc#{kHS+F=}FOmh!howOi@|1MILX8ZeearimqW? zY>MWgZd{6*)=o0QB+kzBLTb!ayOHwps1;;UARf_&zoubuiQgk21)=>w1My~ZKT7=!( zQ+UonJ#Y%{ohfRJ_q$RwYd3N3Nl`cahOB#2RB2y|#-Q;26jjDw@EuIiO*}=}L)7zl zipHK!(Mj|>LoE?YpAJxo#2 ze`teMFH^MbzZAVjt59@oSYDjPTPfyiwq|8ZGTZGR|RVw~Oxp}D?f&BARRUWw(5aZ%hB`rx+ zVN^%RvQ&LvPTVU}bqB*%64#nkEnkeq^bw{98HzqG3tPC$5S=nM5@Lj z&&gD+J4OG~sq&m9w+pF?`I~WXr^eo&=|9YQ{9ZMw85Gx}POYd9$Xe6kZ``c7BGXX_zNXrf81Gq^VA98vmcCsc&MM zF5^A|Q`2Per708#kdz}$jdG@GL9R6Yk~>X*7D>~f;%OR>d?o0ExRPmVS0_y^>!tBG zAJh1|G-(=v91YW?zGkprYijzcR-rP4o*{pA!%xl_@QY!IEDD9rfDf!OiR;{ zS!t?1J59}yX-=Bz&P!9DWoep#8SB&3Yh#**!?!6->wZg9;^s89-I}Ijhtf3ZXqx7u z+%e)q#^Y&vir>zpY2u|cd2grb_+9S5;r_cc%|qGuX_|%e*!VF`v;BPXH~3Tt8;m{` z_4nxnE@4oBPY=vKy@ko*Q)|?;`n1B~Q)Z`6F}MI%kWWKgKJ^auX?8}=qgp1PmLoc| zPj6y<`YX<-y$SS7^l3~kpZ-H^exE+UQoyH(fRiibbf{p1O1(mrg#O)A%&MzmN9} znG@|NP{WDLftr(uakh_Z;e4tN^IV@kFYxK~LZ5D6!XlqOET!Jde7cH$%YBMk>C=1o zukvxtI5pVdlVgidC6Ch&@6qBUIpOI=YH`JDH+{U8UW%k7u0+WzTkk}+M4Go|x=|8(BtPUn06>DrVfUAMEP ztDq-cld%BhBhob{GM&G1lg{_A(s>U$U5ijLE?uKgBRO3;)6!K8&(PYJuKDTds**EZ zL-VHVN#S($Ez0<%({&w>Fr`eoK9o(Dsa(1;qAyyNPuJMW>3WR1Rnz5PEuFvP#c{ZQ zPFF3Q{3TsCYA|in>_oZE2JOe3}PJohgE~ql`xck!_xJ9 zRJt0CPFFi*8bgj_)3tP5y6%ln*VBpVIy)&{5tFG0)}Y3ebgi43t~=BISJQn!IaPh} z9{+;h&}`y^w^z30ZM#ANcB%J!e)^m;~|j?9eH;`BIuH;Y_n^Z1fDbzB;! z$;;yOczK-kOPt!TjMMR7*>@FvuZ~k_Esw2>)38l(I{#-J>o`&OZE;H69;dE5n4g`@ z+3q+M-Nzj6r_Y1T@8LLAI1;D8F=}<398QwcDe^rXr*ilkt}}7!bv8~f&c*4$#W?+b zJx+OV#HlsXaS*5ByvcnmL*lJCb;BXpZpY~ao?ywHIMujIZ2!gSUyR9M;&Z-9iP(%R znN6J6YtpcMCQU(7ev?|^2nu~{(s0x+VUhdqzzE3pi8fGM$ls{}z6l;(acGRi8iSr%EAE_Np8jAnm?_|;~%L~?r_3Fz~ zzrLE;>MQbjeHGhXUyrJqRiT=h^+(K_j`Jv4-Ksn$ggkL(rQsK3Fqsv? zV4OfL!_1nZW_{*2t2Q>GP$RRR;$*5>9h#W+EXKChW;wq!%k#BaLr}M!Szg@6%=TuT z!PpLr4@XC{o}*4Dvu@%A)^;{4Uk}Dc#-3*7$5cG|#;jG}nzi$Lvoeh~^ZSTdyU=Ki zS&PS-)%FLot}HOC_(HS#{A^bDMP_}6ov6IntXaRASr>t^e#b^)#AbBeWLAzXJE`41vx@CE>o6{$%>lEv9W<-&VY5c!$X{ml{M)SRN6gxP z%&hzWm{sbuSwr#mj9FitHR}@Uo-?cL1vBd!nAQIlbwsDzW{!_CEAt)Z=B}CF2F*H! zsrSs<{m86dkIgFh#H`UM@zkuQ&&`~-LJeP-HTgAjmBFI^FlDr`6t+dKOcr&^Y|-mn z7S+jZ(S$q}{qdni`(Vmz(VzJ(@)fdZFfJ6fu&$#;d(o|^MRPDE&Z56jt)@kfpjsBa zsc%t|*`g*57z6($ShUJ+(PrGiK#xU7aU;a|iR_DsxPik-7Uf8`sBPH7TE_I(!Xh)K zq*)Y+Skw;Va5rXA`IZ(9X=Rc9bBluLiyQEMVbPj47A3c}sOeW0jmN#OEn3#jq7Ar+ z|8*cw6zOEqeY`=b&h(9k$k2oBnBCi=)2Q3mq5}OaDh&f0`jhtn_8VbQ13W~=krs`> zzoW=uv_)-}S~LrwazvID7FpI>)DuV6Sv2=Ii+;gTq;Fwvwp%zZ-lB#(Ey}sa zq5*p?+H=q%=Mjq<9kuAvG3MhW`{Knv7EL{E;Wsgh{<>_@XSc}}voQLuMF%okRWg%R z=dxH;FsoJbvRSnfCqJ+%UoNXA6|%DKmsOKXT6GM=OIbAq#Y`BOW0!!KT;9X}9SRvN~*9jZ%J_V#wdnrqWo1ECJ#|#$=nUm=?Avm|{~4 z3_^!g`bVTO{o@f5o03N}o3eMX=`ZB$Xw#RSY%12-riut5u8U2bQM#*5Cj5p1-N^xu z(YS|AlZV)J48w=oGzHFKHvKb^{ioQJVLIDp*|d3%O>eMru1#CunP=nJdd65_)8b_| zUB^$$i4iqc*fi!Bo9eH$Y0n1o{@tbx*o)9co0e^|sns9Eh21!~+opzlY-)<{ACccv z@_0rb&zZj$)TDg8+M+xDLVAUGy~SS@<8={jE5+-6WwxPhm3XbjOMFx{UZv0nPtl@! zyvEds=bV~&{fQfK@vL(huZ{s}--th%?7)0ghSYbrp}1*%q&lQ5Ln}LJC@= z2ZmrG=3@;WU|55A6}886d`i6Bu6RCE#H+KHzKnQH^T(@Nqj+r(#IvqIdv$lKMflGp)r zH#_g`>}u1;t_@h$*Usk^JHI>I6*t(fcw8Dz+Yxph!DTESY3J{YU9Cpj^#}Ih_E@`` z{$N+XsdnAMXEW>?gckGdnubOT>`H@mp`ByY>>QtKmuHP#jnQDOU0wIu`HX7U=lksH zhDrPFs(I0_;pl(au8rt)#jXM9a@8)^J-Y^@_IvJd$wiJiHz?G&Bm6M^oH!kdV z=-fft9CD~JmgCdI4lViHp})}ah(q6D)q6*Y_Za=2BS*YN-t!Kb-@Cw^;P6FAE8d|%C8sPH zh|&0=vQu@cIJE&asyY=wn`%ydkB_T6RUS$2)o|(oR-2sqv8Ge&aHN(~XX`k1uC7!0 z>p7Lp;#4Vog^V`ZBmTX3r_Ljb-Ki>Y!Q*hMtdlr>PEAU2>ZeqvwxDujr)>E0y(aY8 z)TuPoY~j?OxQc2mol3!VtoXvIQ%LyAsqvkh`VITLIrR`ZyE|1HW*o#byzJ#v$=>9H zu~>r_1L$M0Q*U7(#klZ|b+U$?Q`2WVwFu8pXsuI?b~x1yHx4+J=OD2hAr>6NJrq8Q zW7HFQPf%OT#TuM{@1#=$PC0erAE#c!ecq||7>qSnoH~s=*Qw_Xr#jtrY9hk-o$8O4 zPn;SC%X8)krQZ-IipnK7Dra{o315ET(wm|#l_};@yAm!*$7ZZ2i-<&p`-2e{OB^hr9Fw=I>o=>uXbtQTIzY( zrRwlpbEyL!BkOhQ`Q8ne{(|kMi|?acDsaceu}m&S&=U*r2l76nZ@8bkRP%*P$6uhe#E$CL^Vr~V{9;2}mNAMH{io0b+3-rTu{EpM$OKep@B6?sdw&4z1 zS9WVGnpAUZ5MI=Bt4wXT^3-#y9v;}-DjM%rN3UB~d~UV#yX8)Ht1~7wck6>Rx5h`@ z`ZVU&!j^6&eePD~)^1h9q7H68bGWstvs?DAZq6}tYu`6+-A9{m-Rgz8@AY!a(c7(K zecWo)*R3CM3g!B7AIEVSEBd?j5PuDzpYPl{iK;`~$}-HYOJj&Do!Vdvj^F|Uv)x*< zkT%Hhvs=F*c{5|7t-0jv(6x&1Yd)Uzel{Ab;&h*RgdkD8a57mUA549Itdy5Dds{sD7R-acdSD*DU*vJjGCcYfXWsLB)VHBW*%Ce4kxIW!J(`M>$llV!-(Qc~w)SW=GPLuk zJZ^XKC|_5PPWSL|p*W8^U;q}q_l<{j*gaZ{SG_&z*w@2(${yA0=TRd5#8$BA19h<2YGHvmwC~Bf1 zu5G999o)wWT-Zt6yNCyKu>ZZ?%iY+k+1<&{y+ zt0w42HLds z>NYBU=~Z*=M7ytu315HhRfTq5z3JiQ+JpGUtKDeutyd$5dbNLqSHs76IZnWz$EVDFeY%5CKc8Oo_o?*&pPGE<)3rf9Jwl=X`7{b=@YxWbI^r@~4E1R< z@(uH;8Rp?B?8AK;g55|P;nN9xJkqCGSdJ`XeEJB1u|B>t_pyGOkL$Ae^f$i$(Wg99 zeJYBP_~a*YMa${rjzTkh{4FETnY2aMbn=`eIX9)ajy6 zZ?X6i^MJaSsRwdi@u?3kqUu#1N11*x(`}>32T$$2ts?p<)>f&R;ZiBcq{RnGAl1G*k|SvltqU-?AF&na$8D?8|PbUJgTZ zkSC|1Z*UQ*9~jz$nz;N;;6sD;Q4Nl1F|;(lq1Z=;I(%$sF?N1p zs6avb!pK5~o)$LryojN3MGbvh%uwdyhNht0r-s&}MF~SWN*cO=aA`w}@Bn+t&|g{N zgsVKUS1`1&lEH6S2ESPu^3^l+d3{4Wu+C-h9Rm6L40XmqR51*V#a#sahL#~$Lqi>L z2rC;Isu3XekfCOYh903|vZ1uFp;K_B7<`^Ilt0x_5+2~^CWg#S4ZfFP+-CIIoHi{C zRZTOLJ7TCm?qFYx{!q9j`6Ia%G2`pc4VC%A&|~auZSXyrp%6M@3|8VO9wJ{`L$%NZ zqp%C*zhoZqH>!MPC>_#X0ClZgC46#u?f=!QgWib)H1+kUZJYZq%E?{7t1+(|Eql zAis2jH4CW=O3dOpJ=@TPIfg!*YbYKKF>NvTm+(Bs(WS(?oVmlk6^6R~!t-$@`C$03 zhK}K@RfdkE$7<$hEp=PR>*F`-zrj$U-wln}L~egDCc6A-u)ZBJ;~1_Zc{6crC;lCV zdhawe4E=W*shy}&9ln0e>nxX_b&>rllH0Fl_#%&AqdxJ=UeK@aF}J8+ z1xoormRp*l3R-c#6XDew9Oatg-v`5bw~; z;n#lnoqqj^I2U81numR{9c@l z6)SKBg&O(Q5JRvFuTU?*xLA+3FbDly%fYYJxPyuz>WOrm#z%>Mg)kbskRi!03%cQF zoJ0O(zg*~twYZDYVZWMS47TAhs-)02X5t94rTS$|` z6uF!F<-=fXz#~*^=I8iAzn0=A$~LE7_yIfc6g67-IsTBE;wnm~`4zzw96_##UrzMG za$G}+DE(jp4&mb%b!y|6(Z#Rgqqv_xptj8envW(e0`woyUHBsbDH_m?wgHv>b=)l(jeoqc)bLW8Cbq{Dx-+(S)e7}I^qC)?Gh7Jg5%)o$74h_gQCZK#{18ReA zSdEfD1T+D=kom`e)?+sU;{sYTKA?dUXpg_~2FIraRAXvD-KPiiD_YM8s0Uu6NjmLj z1r*s3&~yZU4=9SOux|>e{2u}Rw_9*haSG251ytuSdEx~I z{uR*KzXSU52(>sKkQq}>1Qb3QP)p1@#W?>2ROB?VVE4IzT3sXtJikQlmx%#&u8`{k za>0;?jE5qR0{ZrGK%Jfh)DOL$vi*60b>9Qp`Ig5s2h|iGWC^M$=HPACpekh#D!D>X znJWgl9%N9f(56aIJ@E=ns|9ri_wm2#L1nKOlm{=6qkd37;Ep-S`AR`Oa0XS~71U)s zL@#%cYug94$s5!@l<@_XKM+(RG6jSB2-EO16x7v3+Mq#FP`{-H9fmSzz>WbpGg1Y`NsGlAOHRNef!RKsyLGCYU_bR9vuY+8h zBB+D!f*iXR(#(t@Ey@(q=*%H?&Jt2Mdr0+jhg3dKNGm=JX+z$ShJO@Nda012l|p(@ zIi#yqLONbGq}|m*npY#F$#Ef#HHCD$c1VBM328^&kT%w%&-x)1wS;sNTdnkE4=KSJ z(k)j=Z#^OX><#IpFQhp}NEa~PAJSY@Xc*GaMj@_aA5w7)M8WoA@9qOI=%|2@M~@}Bx)(5857kBkCBu)QE%`; zmPC$uP1KC6iK>(%QJHckDsP@d75y+#jjo_feo|5^Iwu>93MW zI*%_)C8j^A*!)lv9tTM@AZTvi}t*yh_)+Ve8?ZP^MXWhff z)g!EFh<+1RV(+k;_Y12Jp7#%H$AGX>M~C(3hp^603ai58urwvC#yE+VKZWI*8&-yS zVLez%zZ=84hrc(4)%}mKhT#?Z{~1=#En$7UHLU8}!&72TN1bZdr;pq0q_{g;%ApZcB>lu20cA?BAXu z+l~}PaDHcs>g-C=6z)wk&IX{tJwPF0{xs`{5p)u5zQ_3V}^-{@4WotLVWyHm9tgZ9$LfmE5Uq$*vF z)gnV<^~TFOjg`%4EK9q_DzvFF*Gf#&{I+S@*&$7XyQJw+&os5^ou)(hrf-@?U~#`R z4I7xIN#CV$E?=7B#&C=2Kc=blxHQ$Bn5LPN(&U<&#yJgXS~fjR|ISF$&2{v%K23)= zr0MtH)0Fd%G}$p`bDB19NmH-gX)1awO&2ex>F0-On)N7+bFk91AyY)|%n{Yi7SRO^ z%M($<4MRrJ)sOG?k@_rYQ9|NaFbarM$MbaZW zh;x`QE22uXBf5e|crzy=(|r2J1q@gaQSK$&$BoqyS=U5l;2K`7ji}nXhz8>aoWUpS zBMM?JvTul}0Q{RGT8O4wB6^IHha)#zfT@ z)y75@kK8{*xprApy|I0KRQ?H3&Zmg#47R67m0?ztYad6o1AS&k^~0Pfa~ai%&5x?_vZyA)yF98U_-sW~S=U5W>$fP^^P*mRqUwMJ=yr$wipEs0R7^)KF;%k0 z_?!__TI-m;Y!lObq>hMbF*e~fa*T}0hEbS`tfOLjgNEP7)Dy?BdNh5FiRs3VFX_P}i0SC5 zm@cC4KQSG~Eo3+yQw`WK70;3NOiZ=U#<=c$OsDL*r?@-6e4Ihjqg7AVbMt@yGa4Q| ub?nKO%KJK-cV;fw?$`N?GWW}Ijt4$=F*@A|*>egFE`-_Yqkr)m$i z_pV*LcGaowd}q-M%?f_~&0!cu0^Wt0Q@+86(RDzN?p=HKyy>Q%H}&j2p!0xky?YMq z*}F^6fnAetN=ojL)c>Y|1Cx__cDt!}&!irSoxAqzp4=t5N0*OV67++kj(d zOr6Jxi?20dhu%B$Q`{dLmV_CJkJxuP-aVf)W`ji*;;*IitykL;oLgF$9e5S)jH`dO z-EOkHrL(v}OIwU{mBkEW8Ea0P)53g>7vXcSw#S(GX0)8&($;2ySr1M^Meq8mp29M79s?re{jH=|QCj^B9V9kT2y$TFOcC`Y`-f!hu0 z9P07jY2F`Q>^4fH@x^9Hp4%8kE9dgKHWq6u$MX$aTkI7R>|y(QR~g|^mF0cgSR-47 zEpO7=TBo90m95^gI{cPbWsfdz*~Z=w5YE>2nDU4y+fqksN0X+u3HI21y=`Glqblod zFbwmLKmYvG($0B{C2Pw>OPL*H`Pz*4MXO;Xi}D1M_blWkvhu6$3{fZ`%oz~l28W)`YAV!P%=n0--9 zOf3$VFYx#aU77A-u0nGG$-wkly*D)8fx?N!ZrBd!mna5Xl`VRK47w*57PXgB!9k0?!@ea4u+FU1B6mr0zPrHf4H%{slCZQ%&FK_>zGY)nKoe8ECFC-_ zw9q{a$Xq#sR2nc%Gc56`*-hTNAt44;{kgv4{Hy`)Okb9JxO-AQ4Bu}q13pv(#^KK< zhc`jBOrN*JT@*<67DKYGfIAB^Aou1Jff3EWH^MvsK};0_m~i@$<&gmM_|x33%z&qa zRkz?qnJ6yWyUs=V_)Bv7`@8`ch!&Z#fF@@p?@b-i2!&at5T7SAu_z}o5Ge9w6bIaf z`4lTb!c)qg8Ak${kZ`_diaRYC1Ulme*oLHL&MCFAzxzwQnIqkS;=+;nz5rxt_NA;r zWcIT=Ge{&mzu2EUGBejrH&Aq|P>DHPDP(r)EklXL;~(fN%J5`mxxMMG9AIfmc>_y% z;nm;3gpJH1H)J9Ru|4j|0aWTvED+%n31iBs6ezXO?adnI%kpG<+(pA&MS1Qb+&3#A z!WnE;gP3)DpT3SJSeOr^$@S%Dp@w-c+YG~5fBM;H=$6;?_xG5CP;pB>MQkW#D1u( za3ubCbEq4`oUWj^ng>dR?mfWmPIU!x(~`|TC@d4m4@7rKU~#_B=Xa-gv)q$MWSc{9 zLz?YzBT&%*S1zxoKy<%kZ&q>%I{`=xfuJOovuny*2_gYkQ2;s{0m++-Q4BeQ$;ewD z_Om11mYCjuaB|xC{zH=!hmT4%%*E6hnix6vl!p>6bQSsC(3m?P=ue}GKo9sPw=O+K z!;k|-h>5>}o9F?k(yGCAuU1#-?<**T{bm8nVUR#uFtl`iZsSLG0QkI_ZgVKUP!nA( zsV$n}yT>oQj4&r}AUVquaAoAXWv??Q2RZ3yIrJG@A}x?)d|u%a!l@6KXi}F4vV@_- z8`53TA@t96XXZgG<`7hp><(`*B8@KHm7njM= z5KLbsn2NP6(uh9T|B`_I3B~{Z#M=%F{^2a$MI!^~=9y-UDm-9$>=8m{`-;&2>G zdkJnx*!^AF{z@%zWK4pe7aeCWh@e+M6iq4?x*RCZ_4)EJz!>I>3T=~$2Zzz`x`Klj z+bBhdQK9X+DRnq1h*26YHrRD_RMHiA!rw9GBM*JnwFw{w zG6F>|4AOqLxsB3-t@LU5bP6GJid{unDaj*84@xS|!L=C=eX&APTJwA8r3x?@Nl6cf zvqOcZ!~k^;O#0VUx(|;(sTh`);?={~_%4Py2L-gaAzfSjixSMthw~Y&FigXZGBE(A zSu<{r#Z{IJ1=v`|R>2mVg^JzLMR#VB8!wg1QC)d<^C#S7Lr0%|?snRpD=Ukg(lB>Y z0%S97a+&aQ!YqQAg)GfjR01b}&u+M?Ed|Bqj-c0Vq9{*TGU!?<;?#UZBO@{W9+a>BZ>{X9V=ouKYCNTXd{uUPc?r1c9Sg z&mYtj9EfCWr)u8uuBVzwJ<&7VB&z1o& zBSr24Ux~XvgD12b@+XFiY3CNufQ!9(Uf(3IitPKlpbZ4QY&{xza>>Q-s3IX6;dp_5 z0Wd&vXlA``$Lg}5`Ey-GZcGq-g>ZJI12~x#LzB6eoIsZiyS8mlTfEd;QBl!upF?@a=Zg#{iQ~)pay3HNW)(BptUoyaf4?D+oEL6TmlJ`u+n!bCWK^FlVw5&^1B@F1pl157`g&xKUxCXKl*`_ zuR~S{9T7ag4M`B~xJLUQq!l87_Z4L&XQPt_1ZLbb?<89EpmFm{ZsjBbZfv-35(;K0 zdf6YWy-ygIuTYPI2(?g?s3&w=T||xx^NTa{Fa%(-q&t&gZj)MvQj1#8PLaJZp!*i0 zA=T<}Bd0yi(8D8Vrol;_n7Vz+Hh{f;pZr5OD0q0`gUs!0F{GaT$v0yt_3FtnB7e+} z&6BJE$f>V(dzG%Cz?Ydfz+DJmi3>tb_cy$QkRwxur4CIVKYT>mu*9J$W0TF_SOJZj z>A&j;ON8Z-hA1XS>Cz9KoV*^CNhf`jtbvp**Xx48o7 zw&*vzm1xWTOMa&+(Ws!`Gxw5jP_Nhe%YCGtDJQ~yT7hsMxMxm)lG$69%%9kRmh1L% zo~{PJHDnEiY5gnWDRtqwQ@k?FYzRoO1p*aC^WLG{y>54wf4CZ2W$MB(i%<>YMaNXn zz5Rz6@fwR(ZmO#Y6Ku3MIhd0$7XSo-2?%fZH~E2FVI**Qiwhxjc(kW*1B9WGidT1x zr93?TF$kXW46}?)23$q!^#jQ;WSN-naruP>yoc6+6NviAtD|~R)J5(b_vB=MrmIj) z?-6eVMSVQ;bg_2RT~XD141eGSLG=&+=6^^7SCSY9enr8^=PK3MA^eRQK!KQdXEmL6 zL#1#=)g!54u7UQX1Y31~^d?FW`l}A~r2{w2RLK-PNQd+$PjQ&xl$r7AAk1c5IgCL> z4hVh}RplVpFDraD3Fej-=DNKc+R=ty_(MCnaiRq?<6^cfBQ(a~k?wpIK!vHoAzO}Z3L2@7 z>mE_68NMJ=FqG#mFF+F*F{}H2xr<(!5%Ft{2_eX>hJl>=t-z3Zoh&ls**xH!^ z>pU7^Fwr2~5h`$gLE1CZH@`_CqO~F;W~Qpf%=>g+F$*$bOpFuEjnD@g1Ef#H{QMzB z7 z1yQ{y4qHi}1KjSyB&5`kLhzem%Cf8rNA#kU z;gz#JIiQ!03qo5zYnMxC8IcP)2B#b51O*-DzVH^IC%KBeZQ!5GhM+Cyi>(~VTc}?V zxr3xx2ADF@lny<%SBlP@mG0A-H}gek0>z-*HFs9V988y$mZllQlS(J`e8r2c3&wq~G*#AZKJ^)^Z+&6l|X!7n~F^3egs&uht5%W1h(gXv*rKl~Ux;m< zV@+S0f*>}`9mw@%`OOze44rk}4<8?8XU$X-9do&o!|Wd6zflgNFNpC;s>7UtRyZH7 zYt}(UM{LrCaPtY66^0@-eSPuzdThEht7@AvPvE8;kT(|}x{Xx=zMPzV_Xv@Z5(&38 zxJeva9lP#eFZDyV>yLIKYT@Qa21@hYa{gt; zQ}#f7xp>1g_G{^u+jNzyl|X#?!#3?XfFYG0K#yd01$Lv_XWeQUCfnzg?jBywFJ@%O zUv+?v1nSpqHu5YIdW0@V0oa0rtJiZ1b&5%MJ~}79Pz?2YUiA@q4fZ*mz>W@zp=tST z)5-1l@l4_8c+GOc!jM~xPLCl&A}uw*Q{v$=6c!a2L749;Ik##XpGyLA2Bc#}F!q#W z46W|4^hGU&u5qyYohd6UzCDMG|H&%r#0TqqqL~Df@^F!bM=kRUQPb zkO|oy+oXI1-M6TK7+plZS~IOwrE&WkeMz>1eyDn8=r=n`ZXmv~qhD%A_W%)$K*(1# zIDObq^JU_IlbH~f)r1q-%;F+AbR|DDM^8k}q@bKjruW;S)j<0bw)tt0%)JAD`GLh! z&tl}qY87sj2|JrUdYOk!=6aOOn91?iYzPcA+?fO4PY4c!^vAzJSTd*i#MTBQXhNb_ z1YISnyr$&2c>VIuMD8yxq{sHB(omTP_u?jzFK%1*7##{^AX7mHNEO0ao?UM%xh|9e zOG-Arn}4vIqHyKF_#U*Z>Vzi>J5h2#x%z0P=oKEnY>r8dQ+KN`c6)=m^Y}%2kX>J| zy&C39g?fG4r2bTj$A4RJ95UO1Dfn67*uMPR&)KuET969==nWY(F*A}q1BO;H`sV>8 z%fW7xn2KgGi1eFtfJyd_L(6?)rq13WC5|>^L2hNDiARsVC=zIlq#24+ujX(xaVmU& z!%xD^PC!pXx!B~?>l}?lo&uF>1~b6vReHP}mVQwBHcV|Yu~ZvR3}E(;@3*DI>SAKAmLFtF6eIE1PKe z`QADt2bI_8_U0F?00lN(bRmU|VxlHozuA+zA?k;ou3nWC;un)ntVy#1w9{nJgt^pC z&}fjqz?z#FmQ4dJ${BChoK4L*N{A6wq+~GT?MUjt(bd`NTXtTsr{gLy&E}GpSqL0t zvCky;5wfV=fH|85V6oq#?VrikC;5DwP-~ZVx6~}W{lKg4ybJsqBE7K~Ux;wXpdahA zAGit&^Gkez=-XCC zQ07W7)nFW9GNygF+DxaOl1K~?cVFIZcTfJ{0Dl9{2~$&tD!2L zVh(|1$^?$-R~_F#9N#tLQ`#svHlpR&i7I*BtG!+B13( zKF!Cd2{2ai`G!2I2*FKG4o8-fpav=)GG>bSOD%Wz&&T39VV^}6y1gSGRaBAlfDc2a zSYkyXZB>fn(C4pxLUH&Ih!!9WH#Z}P>aNLr7dahJ->ndw2fxBBUHl(0Xn&ILqVCZjuZDqz?X+V(0R*&N@+`cxve zU|{)2M=e|n@FS))|4_s_4E`ow%oN~VRpgDiqiSrYG3&?DJ0}jkE%Ek|A-TjqND58u zy6w*lVLf^&rymQ@(4M`D|71f&dO0+&jCd8Hs4ud}61&87r zk*$mEe^&NA%rsb^szg6P(dNhQn9d@23>i_31s${&l(uhsYc+++k(~()F;kw68-&|E zIJ1-R_nxB6;(S+;c{fc71r_Zkf58GVqkum)e*+V;QyiL+Z{uLZ-BU7jrI6JQsCFoj zgVD+GdWYCTFWlxp=4tWW9L}bIsk6BQHqnfgF>tjL&5=BV`sK%t-9+l#ljI5@CXRRTp$Jox&iniTiLLE`gtPcSdZMG93?hUVL;a~;?rD82jdpEdciBo#sFQb zs_#~VEL_hpzj-Ha109VmWzgsB4~jn~DGY$)Q-oWoW;FuW-cy(8rGBa=2s=Oo|NG!=_!dr$Ln1NqZ5aYO2&P2iR#S*kF5}k zRAMX+?&m{=3?xtXpsoR*UR8vz17 z6;3ALf*m#O<7@V@qgDr@X+CaGGdrW*Xam$Y?#-+zls3jPibgJEN22%ew7SSkcndutf#ZnP(@-`_h#FM#E|dHgfEum=44U^{JN?Q(b97a z$KJ-=B9|Z261W%hF;)Qmjc-2u0Yhk{AUV%R5tg@RtHMpU-}|`i(CB3a9y!3#trK$d z?M3}a7lAc5jX-4JJW}a-Yw5X{CEXNnidTfY?(`zJ+sxM$9$qhEeHc@4gCh;xETMhF zq;|*sTF%fyje=^zl2x6!sU#*C#_ligY0GidgOwKSmKf;EEcRo>L2!&Tdvmm;Oi1Fu zo2z%zL5d9lLH7ohbAbnX1j*wcU-uHNSSA#zGi)lSf#ige%gK*3-=wMNd?x2<<`Oav zxtvY;d5F{pB7)?J#jbo18I0OA@3U{7>MN`WZkkb+`30yuVvDR1=1IvaFj$XYIz{xk zAzQc17gck^Ha@zCLx#%g^bc7GLfB3+Pkj(_MVcY*`OlI?aIbxP>t_C!W4g^{>?GQ`5q{#W0z0MXTP)TabHT^>J&Hd)%AA4<&?8;N<i~>11aDDH{+i8^(~5s146ndGtb-<Gwk3$!4{4+am0dES_mh$f9ipIk8{jxFluS5$18N#>9}Mg~Sd&zzb{PLJQiZFM zaX=w82DMDzxVnhl4hbZ#UCI4%AZZ3z0dd*PjW4{)uwTlal|0C+`E+O|Q;3TpBI;rG zl+OEThgkkBE_BOC!0bQ)q2;stjP33~A+~Q(zu*}pq=FYmj`>}5HST{Efgxd0|1)XCnDJ?e15!rF9f_tvL4k`+ z+tW*^7Pr@5T;%SLwPz3+KnyIr9JyTjMW%s7w1yO+R1XMj@AKWc>Y-|oJAh^cjr@Cs zWA}lZ3Z#+eA=;E4(%cM+6z=ZG4wo5X6}Vj_kAM>wWrFsBKIe}SE;RFQR)A|1gZ7aL zla_Fh52mxkObk96_sommy6hlr1l?fE+8hdnLanW}k1E|Sn- z?#O|X>qHNP%NJdHH)RIMvqQRcqV>Tn;egY`rW@hY4*<1X_Kke9!Anwd9L$vD@Dzh! ztKO`)ZNl&AC0h2^ol8GUT?npbtlX!m4^u`YrOVnnvkEr0~7@rHGv5 z+9+)xU#Yj%^-Wul6lQN6?*mvw!_*Bo*p9Z>4_eN43?DIG2Q(s(F<)i{$gjgceT`+G z)g1>M(Bdhc4qxqP%#Oi8Ase6OUIo>u*@E$eO2-b^k%*H<3`b!C7=qUV(xh3>iNSV! zz^69%pqLJXNF!gGl1qbtzm;+27$vhIcZ_&gm=XJ$8XV2OR3%Uj`FZV)q)3TDA6VN5 z%6XtDd&=0i5{IyzB99?l6qeDEe=#4SlpyhOc`YpzrAQfagcrHdba-noW>69j#?1-M z9{z;UkW72XnT$vWsEm`j9#t_1Ks%;4YqW-*OFu+lcEyD#`0DxZrPNZAd*hx-(Upm! zd2j8RuZl*DWYGk|Ku_hr7IYT;W1~({Kt_Bb^V3I}@)LP4`sppOD~k(Z+!G|-$xL)Y zAP4W|Z;iT(V}7u|h?NGF>mso>;2l*V&6RgNku0^Y=LjesgE~@w8}G;y36}!(w1Mav zJ1I%Dd()28VbmX7iQHiJG7Ero^FN=ug-A2i&VDhIX+i!W|E+Jee}NVctp}}LhL)gw zST%C{KO5U=dvXsF_UEWg(dJB$kc!@)mv)y5P*bu)(`x_(7{c>Mi+`P_{FTN3)%iJNTC#T_S) zvOUt_nQx%|?sbYelj3^tmmgQPWZGudbI-~AZ5losZ%i{~m)vh$t^yLBB!d1zfFIUO&NCo~-Z7qKL{5bsw zg9A64O6M|xkWhAu=0i*6@a!GLZNO#%#SEynkG#8-oOAQH-bHS1VY2|$;ZFPAG!dZ0 zm{o`*C(y~jv`^oIzp#UO{31V%5WZ&O*vz2pV9ovRynL9;D_45pq*B@Y&94=)q^Hg< zR}q9Tc(W~ehgb$aGG_$EBKxvjcy#01T#Y|6k1+PPT_3US!YjyLXPCGa5zDx~A09+& zjqz~1Cfto^cgCIbBI%^W_8OIfGt0>{^fmU*{?{raM|u}4W86y0aUB5W5%7!U)AQkG zS0!9;^XA`DOo%JplR5XBN<5HX(TSf=vw)j1unz-07Z;TJxUc=As7NvG=YWmx=0?@t zlA-;lv-hBjg)ID_LN;}V5bWOO+w#~T2BYQ?d?Ctve@pm@A`okBP=}zmnkZ2?_0H)h zg-ceBfNe38fTK+4X!dWPE#t%nGcN3J*Fhgu&b_0ce3(Sgpm`nNoay1|aeisxAorm^JfSDs_XOdgXuG^KxH5_a~9MO$+;jS3ZJ-?^cy?73bMQy|46 z@=WG*Rbl1MUkg})ON5+{GPw3K6*3by$@G$rZPw9#LpI%UjS%C=P{<0?^>wOs>zX%P z!5$$O2ZQVe*V4_=WEuhQy5IhMusYz?!}S#{{Ed|%*o__k?WbU6bd2ya-8UjXDe?{q`^p=>t$gII5Z>lC||$a1c-D0r-%515xx$cm$P-O`a2 zVFzMgT~K=PEMgaR6J`2iZ~5_ldN$>F7!mr-wiGXTN&97hSh`Leo-!;^Mz@BUL|&la zjHfSzYuCW3TZV747;sIiYDxC0YfFh5BNs!46nb|vRS9##UElwXdU(hfZaqdZ;~jRm zggzK6#6@hpSgIxpGUFY#{A(7vGBe$UdiP3zkkIh(yKc4%!@hF*OX)pJT|p>QhNX^` zLJ^N1;F(xFhwBaahq}Evfm~F~)|_8`XdrtL_Ixtrk;&Lx)$Xyo8kEpZgx!n4OpNX5 zgQ(z$PwHSbm#L~VSB({0sxWPrU5OzpIXZ$0Wi+Y=b*2=Ix`ZpxDnY_YSylPdjWfx> zcqB6T;F_?ILfoL~ln=Y7fP+Y;A5S-8ONrTz0RcG1;$5=jLN-X2>hdiwN_n?j(nPJu3)^C`* zRl)kZhLn*xCb)0Im|$*&hR{?x(yQ-iCc;fxOVA*hu%!}#bnCyT*f|T$aC!2D3%(N< zfJM{R-_q|b>65fQXSsvf`o}0Wz-PSk)eB^b&X2iEa|#Lo57i$iaDPM9OGlB&ha0d7 zA^3DKmTzG45D(ZqdhpjRf=wAU2ba>!DUutWad7hAEq)*+JUxdz5}J^&?C@;e##thB zDc4-21_rzH5eWFrHlQKnt*}Gc;`v;tK>2WtnDZolh`!#*Q$N$}#r`2=fN5Z60!YYd zNsB+e_>RR{*i)Vv5P3YmIRkB#`t8tS?ks5r$Rv5Pgo_ZJ4XPzfI#~k`gAgzndOt)i_B%pG4wmxRP6H#Zk}M&wx5MS-0#qucoAe;XzfU=YgAs|3Mqca+d_KO7Axj?F-0({j8s|Yhj5qWKsjJ?bI*?GrV7f zm{3D*BTEZ1eEFzsmJk|+X`5z=jr4esIm;)`C4gc&v2UPov^R1JWd>&?_R$NGP6b0{ zqIlf!KEqjz-1X$bd`~7H6E?>vrH)(ugVoI@QbERcxKi=DL&tuk?T9rWHM17e!gNvxXpt&EYWtAh|Ve8ntgQL8j?aWicJ$mnVyQrWV`BubI zd|1>hk_tjAE*@GtpQb89Y;JQEyIhbERU*24Z^g?bG>I+(Q}}?K8)GzL1%$DG)H`{G zVXPW?*`7dAaVFA|!37bd_fQ#4hv9_zKEIuOi3Dr#*+G?sZAa$8Riy8vn64`~7o5_Y zCzNdKJ@dhG6_2(#R3sYhdJ32jl65m$#l zufGHYu!NLkGmAGNh_-*ONZ|0L?PplAKQPKKd?dCQNJWEUzZ-X-qZLi&Q#0JrbFXSj zQvEI)8AtftNW6(hRMCsKN;!j}AvgBEEW{u(P||gog8^G6TADVZvK!Uv5#6fVy_t)H zRmPq=-ndWg#9j z%6NC}^Va}Fb=)hq=;*OZ&(hF!RHG;ORt{!|7h9o491d(Naf8b7-j}ddbU2WLBr(b> zDDO4<&MK2o!xW%Cl?^4_pS{Hs(|LHP0KVRD_Jgv}%^=0;uRL~ukc|B>L-iH2_l%_x zqWv?+FBWmic$5a?0I@iWN)r_A+1KQbCI1%U&yYVVPf(Lx3Kw z?_EF>4~~e+Ld{5p`}l}YuNEfuz|xsyP+1XZljZ+a9bK27|C73*aR1Zqr1O7@ z*8h~Z|4#kC^{}T;e_dnJ7@0R^P z#YOng_kWk}|6lKauO0m-d4}pI^!wkzu+HC=@&4bH|K0t+!}Z^-&w8Qnzr*)`^FI0e zze!)yCLjORTi5+R`KfvOKS}fd4Yb(qzv83D5t=+tG{(8h(jwWFgW&Heyu}Hd_6VDO zjJ=oJVpt7E;Ry{a2Esby8_rMh5+`7G=K+{Z+^GXF?};#3CeAE%mNq~vXaHQkqHHb4 zEf0&b#gE&d&iL#o&%aD8(^bX-_ZGbEEgkZdPx}~?z|I1z;-sEojV31u6OF^6oTw&n z$5s=tDVyMNESf7Cz+jkQg!r}w*gUkmJphIVfmVboAl+&vN{-Y5nhSt&U_(+m=2Sp2 ziV`Pm--QBorl=SxD^WdPQ&d?f2@zGRuno8txGlBB^b>;q(U>mU?+N=GF*Q6IJaVq*lDDyFMAf}EG#00!0&^sE4^CkkZZAU|a zt~}57!;lu+qInD|wdjaFav3gEG1RZ#(xk9 zPv_$ymiFf?H3VXbb{@_k5xyKCpsc8g5)bnXKZdfb#M1}bE5%#3^d86jg*C*(S<6o~ zz{(+>odCEQ0+&FyhASXubSWNAw~o~UN(I24AkfpAl9nmwf5&S9T@U?OAZ|ekGt(>B zqp|;73y9mNxD`UOmu$C>S?IPJHbd*2;y+Ofsw+fv58e{$LB|3mK@G*vUqYeE#F4nT ztIWJ^q=^f4ig7zCorEmib=RkM*!>S+w%Hf5!VyeAgq!qQ_AX9AH9}7<4bviziBX1aHewdUZ&T*m0)eI!N76&W{ara1 zFPyhuXYFRQh3#o%$EEFjctxFk-KrdslPc>hkBhVJiK^^TRd;uTn=f9dA60pKgMAB| z8x5oE%fe@c8P@W!Sx$=;9acznjwOC>HYGyNcsjEqI@M@kamF*fYQ?{K!VsfXr=*ll zhMJV>l*7;&n6j0oxC*0_gwv+TtjnoTIAIzhX(LVJ_7IudLQDhxN0^39X&^3EI-guP zA3Iucg=uJik`WK9#alja%0sIY7MkDzsnObAhdr&nY9PnU)1izGE^lEb5HNhv)%J;s z%egp4dY(w{Tl&t&Dbb07I})GV(lEYgMLMY&!&~-wonp=Q;u<->dC}2g)jm_~c|$_6 z9SYf-SlG0*ynse43bT|Xuk2pJTnDpP^+8o-u5&{~2XmbekD{Qjw(WztRvHyc8^zi7 z!7}nL+N^tShU}s){s*5OjTY=?E5O*g?)5&Wxk| zbyA!dAjU&!I!Jcy z?-`ZBVWZHOUz+X7&*!3yeau{8_%vLO5Le@~c_vN-ldRo&;@JJwkdb!i#;enM4v4_m~|l~qv-V~x5|m4Bgp-FIH=WEkDy zfaHndqVFg#4_O}0;;_fp8p9TDB-xwC!&AeRu@k{dhz7=^_hG(Fs_bb$chPdQtr+rzSnui~PKh?gc{r1?HD8XH&Jp}n;>9RuaPYkj zx01eK0o!r5FN1}=cDUeJ!MQ1I{~)2DpdE% z&K`tOG;O0zX0LsW1k--#dVpOH1&d|$p8gRbuJlsQAt1_J@2;^D+X6>@0% z>xiOXLy^VI2eJh~)CTRAM*9Y)AMD$jZ#V}-{3HiHg+K(%R`j&^t{Uc@Fg0ho~8Dv~+gHSu&z=9ga6Yoj+Ke&pHoU=R1#C z`#Zn2_Mf*PpYn8oPre{R*o?(m@sQQtes`3k&jp(!Dr{<>3wCES+ofjqi|(pQdqlk} z<4U6EYk8JobjpV5TCSL}(7q{7zQSTU$CX*Ev~N2I*HQKYuVaYwTk#ocFOPRKjIX*= zL!rabqTKx+8VYS#iaRcR?tEc@dX@pf8h?h0PWXrs6;5WTAhZnX&QU8)llBpSwAyahrF)&Tb>+$$dQ z!kB@dB7rg&MtvOE7DH-M%83yGV)8@-^+jcCEui&- zVQVQG=u5i-qUcBoC=FXJpfdoNIaC8ZY*9eED^PP{rxre|+1s6K7*}~Tkn2jI(WvaG zMX4hI9t;8{TkT_{B(&+=2B@%FP_c#Zz<5hZJZxK}bfQ}|7EsO_P%;7a0JQx0zcgGI zJ(jUQQW)Ib79I+w;;>%;5;GlbZ3Dy4xeB%Tdh`#=qYqeN1REZ(o}UHDBP2VXu|_fV zJ;q5VdOK?q_jr6pgyN3j;My8kznP^N!r=uB**Ll~lp|CIJ|k;Eodm?TM|CsavCTpA z>EAR|CZM8fK*{FcGY9MQb2Z!zmO1l;0nzi57+i)?rv?~Z=^_9e)IbcTH*K4cKsQsQ z9&uAx8YnCD$8;kXBeWfa=u(asgoIV;U%#Ky0QSM{)pEzZOsi z0345NphpxTZMv{gBf1t$Q`8?Fgo$%->c_67tq=xkG^hoY4~P{(C`Z^_Wrdp71VA;c z0VUP&HemkHaFpn{VGoJzgxvSavm2HB)Ml9nJdJALSpdD%e*(cF-m(wu(>|A>EtQ#% z&zM?3&jX|X1=ehD(2yFYgl5_#EG_Hl^1z_m@lqUUcnBq51k@n)VNiCpz z0q|-N=za~P`Sk(ls#-u>0B}hIk>4klbr(ZZkvp3^LNvb`3w(kRTMJ9wrw!vDcuQA| zQN>%b_8t*S>IWjTgP64PCIVAjEllaavUss>xxR00 zjn*>Um$rI~MI`>|=bGUrt+fQ7Eoz|WfcG>I`(6O@?(;-^jY`J%A6r-KAnMn4SbyEg zFYoTM{=AD{%641V?v}(lRO`BD)3f;z0K^#r0bhZTwXs0vTXo|~QG87(bv1XI9sMDL&wK2{P+@wH|{Ls(ISeDL!ZeP?+HqX(-BYE-JUH#X*CQFidX;n&$J}oE!1=#iOwFgn!&>JNZF4r`!YP5{v;v{^q6pc`ueZTJ>vTz#j38e0Jr zsz(gPM(0{UcL3nslNxBB13;9Z))huxqf0HI3IJ4{)DO%!|2;6CgZ|V&H-rfZQt%pV3Bbf**7y`Qs2t;K09x;`7#1c`M9;IJ#*0(!ugSV7 z%ggcErv}(UsOw7rxFR&r(*&YvXovO!fNrh@R0@DkaP*I)bPN%(vM5apgPPH|7T7NU zNsrQC_gm)9tKn%@0O*!lKmh>c*VRA|IswF1HAiK(3ZtCSuNKfO0OTMUCmD1^0EqU~ zOaWn(GsG_#;4{=^>;uT=h8pZSO-l>@WrEkB#esH3Ba87T-jbGuw8)?aS_PoQP@p-? z48arX^hV=)CN5M8bSN`J^rBo|S$$vE@2&Vg9^o&q`>lB5b8+pJ*B9q!^%B>9d7Yi| z$vfg2;XUggdFt8+#C1SkZ=RSe;U~)LvtOOqB+4;^VSQ`vSw660j7MP4>nBD<%lg^! zy48b^zaq->-*xmSY98!f3dvI zk=NEuuRbiwG1p}M)mPOm5!Z!=aX0ufc)?fPzkA#8w^47K#TwV3x6Nvgo8B9%g>et{ zw%Nnu+V-|NBIB;ZkGj^0d!)C`SubuzZ(DeD+|1s#h=y^qdfOsn;`;ZtMKy^_>TRnN z8#lMNt!~q}IlXQ5n#axSZL8lRZhmiDbbPJ!nI@lrCo0zCNK$)ZxKO%Y#6kw(a84`9 zq7l_`&0oBO38Jgf7~1b@R8I;u4;AxlZ(=bHHq%!1ne&R-?JEH5UjvM@@e2U>C!Q9T zrg(#0O>cFtTmzs1wSXo7;6MCDh^n)0)`wPrh0gRh04yaGOys7o0YGJU z0QQ=jcO7cb#s75JKI=R3uG z*Z-oTuXXVT>J15{FCzVhJuJq#o|@^a$#iH?un9o_3ahU931||L&9! zp7mL&i+idAb?wvM16^b}y| zJ~hl{zznYi^E>Ld?W15g^Y7Yi#1_Wo#W*>UPbmWn6`_Z*4^T9s7M4}Ous;;b*%!7v zqpVR$65_CJ(4v{oXT%m>0|sao)c4N z7h>?>#EC-J;S6RA#>g6!=v~@?M%zK4(|v)kb5t@;On1EWkfWiI@YM{*;}7%8iCK>A zk2qlPYyRz+H=AF$sv#}n%j)P|H|k>`Ne?B}m&0RQ+*R5C8|s_5P{U(z-_}4xR9G{i zvg|Czi=rQXPjMGc=iBJ>*?2#=$Iuev{K4YF$RXAz?Hw(#BeHlEiFc_QA~}%E z$wQR|Si)Qrx6uMDV^D}zytz${^mOhQ>cb$l8zt9#fj@XjaWe3E5-o7yQ9Y^K-eD^6 z(VE?d%A-RyE1cB>0LU1rfqH}kh|cO7R3@bgeBKrcq-^{FfHcm6?F~jCU3fEU@ik+W zW6dg>*nw4!XV*CpHE&zz`1y5yS-9S@?+t!=^gYL(&8+k07RQ>c!X6`EIZ~#$ULllwhv`NLcQb&f~;x z$NhVytjc723uKT_KJIzAFDP6rUXj$r-e{cayZ>v!`Pto@}LZQr9gWi&2oLM38LXRUg3& zMW;Q;5mfFO;z9a+JxA=V0B|OpfkZDfq6?##_wE*Z#ak^^F;d}4rjul@>#XT$J zpR9VNru-f7h+~OK1u=HRDI0ktE*h1cEgLnbg(XHdi401b+1ajVK&wZgZqgN4e?ZM% zA?=x29w&aXw~ZSIb&!(q!N9CMZm>0~+;t}~R|G<^hx*&2z|dQJM1E5Hd~xGo)dP&T zuA@h^20h|jNaZm4s~jEJ+ic<=cl!}@4BqVP-=ZYGhGSz;IrKi{BJmaiqzgS7)}oy- zqL3eaEZ3L}f$0}uGDEFeY+8OBSneuQnC!P8s+E&NorF3GC|510$$)q^2=!&yA~`_l z=<5`KGHL+H`Ts_MtiE5fjnUp)@{IVg9-lnwYJkU&vqoTEz!w^pod!O!2MwP>QL!BD z8{nL+H}JN^E(k`}mD9preJ~87gZO0c-e=dVtGY>NfF-L2cgzay1Ey&YYC(K#StOmO z4mi#M$Q=qK_N&w3sVKk`ZQ?>j0m0pqmUir?jI|W3VSn8c(lwQ}1;<}`dX(YX1x|L& zRNTn%J+yaT0Kz`nnxX#1E#JSDMB3mf*-W?m$q-3p0s4xLDL7OkrifYOqB~%eT%yTUvy+mjd$+mWgGlPU!cfW8lpwryV`l&X&Ktp)ByA>c#nSy5D6IBy4qw*7A!HzBd6d(js54&PM4uL?sGyLaj>;R0$y4cZCw2 zy^Brd+4Lm#4}j&?0ORt(7yuj$0zK~l5Ia*GD$}F5}DDX z!Rgq6;+jwk=yw22U8RBkt@C*;6(tLR@@fG+27o8mXrT5Hpu}0U4mhj;%C7~qc&)|g zw@w39NeRLpgG0RyU}A&>?dtxO?7H-Z#hCS;27DHyLMT)ipu9DR(XqUM`s?4nVeCe{Ml27t>S zX`pL0ke<0Ag=rMk0{U(nHvWCAfH-2Tym{I}x*c)AhdSH?JYZgZ0Oe4jH3Jf(qWJ-%bj~xI&GGOikF>NUv^fm=9i6YoZqhDm#5b{7p!w4rT+RG&cpAqa`|TG#?366{(*DtR(@IYv2*9g z{PN^>=ZD+*#Xvl_;@1;kIkr5QhB?06`Tk1MWm7`#SFCl;S|^~wYurDv(fRRP_$4;h zmoDgb2H&9zEcGFsNws7=4s!7y4VCe#tl11BaYm5%;cTTT4lHynt$<~6EiAKv;o?sU zi@i%2fN11ey{!RMS_>%rn8ir`C4}_Ww|rt%#v^}}QLC5sL(*-4WlAk9$AIDHQwodo zLy~5zIh`iZwE+58EufJANIa+c{kYm&>weJ|V0VXt#d4h@3m~m8z>u1kyU7(_U;gAQ zKPENRp4U?PKQP(HIb}RhbA%0F{LTsm}8b0{Irdr z&TQOG`25lEIdj5ksFCmCzHI&PQlRu0ny1b{e}5=?)&84+q!ModNT(IqaB?f$v}*VIs4Vo5zG!fLFEV!EMvf&0{g@Rf_mChQ?dVYg-bE}Dm= zfCK9MBKJfJdW1qE)p(#5g}L}Sn)O$KLihO-S^@zo8DA|9U;hj#R6G;DcvZN~k+6PM z_}W(l&9Eg?FQW=XH(%^sX8i}B3qSpQxYL%fXnFX&RYGueupllvKFi-(68_V&@F;5n zw#or6xE*80((o6S66-fh!>hy>VdAP)*tV@A$i#mUL-aKX@R|F+21 z>@4ymAf5}=zZAbDE;$dbT8OzBGqD#S;J4$HK_uH94X>EBCV=@HRjiuLPcp)nn1}IE zms!x{24#wi#DfSdrf})??P+mT7jWcJs0XK9A z?hkA;YGJ$g8mqAs?;y4#6^#!Nn>34{MG#x4haLcI57)wGxz1|biMNzOsg{E7)5!pu zSqo?)05UpgpfAOKSu)-bT+kB^1k|ihsC*_{r%?gwA+?4kE|m4P;aa4agY{L}c56C6Nl*6#CB;y080zGBRlc&ZW~1Ow$4@r6G-EFMu< zWa6rZ-k%>}HNL=G$`6RjpS1A-P!5NaO9zQ#TMfILMoE)mhvV~C$R`>*-zG9(KZd>Z ze4?Dz+$h;<48}W%Z}w|eaYm@XhvTYwwyKKWH8Nxwja?d9L|wT(-`^Ri?ZSfjGj)8b z3(s&xIj*xdsXA`#gUwrdS6U5uVYA@EZf)(b!yx^RF&7z32Pr$!dZ%DW+TyH6+*l1UyKy7v? zH8sLq14_@0)Lee(m?M|dv=NU1*rPSTIMTlcfX~x4P@Ek=v|$|u-438RwSeMBS&iOz zXrKrTf)Yv(u{^GjlB~t8Fy7Qsf;l8=3R1Fm-T2;dED3=RkbX-N#!|X z4-7Kz;stwoRFlf{2A-C5g!R5;2^V#mRJJyHU$RD)r;E#O4ojV7odDRho5NObPs0`$ zpASV5U5+cDU^Sv_SRN)3C~Vyv)|jR0mNimhyku>%mz7E`8P?_X#XWiv5^e2>-P7%2 zSkt|6)?F;v+01sqji)7>>nz1wvAoVKJ)~jSqZ5#AS%asr@EMaTo}J`wrA-dQ6He`WgML(R z8dSc_uwT%MrkT>2@#h!zC`JF*BkY_SBP?4lodEV0h!OTK+?pTSdgTO;g1NyN4A(Fz z3(kAyZi)C{OO1}67*;M3(r($$#{=PlP=vx4jR&fq&_{*!+P@XPh&@(&2N$3g)_{^T z*53h>mZRZ56VGXcj#e3fE3W~^~>DtL#W-GQpuUiJ1Ue6biJA{hV1g)z7;$ zGI61XxB(pEgh>Sh5S^mt$diR%?7}K(Cp?s6xMq2*#%p-1PRjiWG)3JF*pyyl>{vN{tiRvi?kYYYa2QjwaDY6W?~d=D*CP#->}qgZ-tqi{EvL6=Gccohzv+CO62kSM_?ymNeXkGW&jS~FW27|2ZuMdfXNcp@geiT;x zP;QNJ2&wVI;sIDHM(jn3O+|!}Aig7F5&x(Rn6aFGVTeZ;&w`X%|3y^(35334qV9Gr zt?JYd-N*9)_IPNw6FXx*0KlC%h27Fz?#@9aOa$f5AqH1+$L-=Y6%Aj*!HegUMJQQiwf?;gOg>{b zwpty+2F7*xqkztU>-Dcf6t$_LZAQ-1(54~N zv_x-rs%$m=Bu%6UKu?ECREz>X0EExbKp%#y$hwsR@&jmbEuann@IS19R_SEA&WmF~ z(0C>kNDW|%0P-TvWVZBz7szi95_~OvGV-UVB4Nh+o{oHNF~3wi7y0|rNNh@3yDaj_ z=lR75U$>5R)mSB;H3>}?6@%onp(Ir(8$RD^ELx;Fo#=#fA((F76o5Tf1B_YJcLC7! z2@Q0R3;6`P77S33{{qmGT0orv@MsXIr42x|XFZj@8$e4#fyDAT`A`E~`xp}!YJdyc z^B_9hO_|5V+Qj(rUhGT&1cH;%-8VJnV%2y?C*rVN`73QXL}KM1yl9vY3*%cWs> zbk@EB_k;**d#N!!9EP>01IH57JRYjXu>=l8Y|8P(sbJ+Ev};*tyOiK}EwdW4*Jv4@ z$Agm;VJsM+2&V$-`5I7MZg~^+e_W?w>P7&FB5bFC9stntT0r5iT8;N!(?AXM`3KtS zrvd1NP#|TCp8;eIPC==;4*%P+$g1P`MeShr%YLogHBLVCB<(?j5x4jECiyg=AOT_8q0vt znLpusEpiy;&%ps$U^s83traCi5>2WBQ*(!Z7*gQ~s zDO6d7jA3W8u1wRs8LF({tOZZL<1mamPDgzcRSip>A&B$kE5QE3by>b}PEzM6+p>D% zAc`EGGF09IXXoTq+U?82qU_}jrdh(S-B$-EuG~_2$r)8yZjZ86EURn8U1dR~st81s61 zeZ|2tR3IaAzIaxV9XS~^i_MxJaUD@VJVw-SvMff{j}Y}^Su>7yaz!uDF7r;9$dIitlZjW1Pw~#f z+1x_FR~X|MbZ~pZU}T{Zj5)Zc%%+9v=+D7y)`Xf(U6Fa*hTF<+Zv9KU;efhvS@A=h zzo|L2F&IGxHayYOl1+3!!+FM@Wa*n)Fl3K^6f`8O#uq@V@fq%T`9miDc>X3e^n{;s ziWfif5RczD3b-Z%04v-z@GWvayU3E7TC_6otu+bww8_C*irw+Bop@g%ts%aZV5(K0 zc=u#j2_A)wcX{K*&k4~6@Lm3VM#p&2KvRw!{-@ZWpHUo$&w~2Jt&x)%{JPnqOiK==jt?cY8XV;u*ROh2rgHE1Wd-mj+ zMk{*l+!b}MXVu9wF?-^gZO!}TT$9~#b+_dGd@;6Ja;_7uL7xp)c*~FD>U@-Uva0n*jUu+@o<4Q*munNw z#Ba|(d&YiUR3#o-YG3Q2B0X#-edI9K?1sHvunLO|F3)vz9`;-h8S&+Stwmd`ZRtr&lT4TLL3n8)|#CvflUqrR~{E8~l~2eHiI{wj8HQ z)i9XyMSpPz2DH0x;*b5o(%&19+-vaPu^{`z#zA{I@z?gU1H!d7J6joN+nIN+%D${? zoxL!eut}G~mtRYRiP%9S+0L(Z`kb-Vi#l_2<=N<{OSd=NyRe{1|bHPsT zC_DGcxix2-)Y-Nw_0;LL=T4n%vLbQUo~ZLZt4^K03ik0~-iZrw&CdVQtn%cttKwRI z_>jGsG!I+z{1ZQ4XaR$9#JB%2>O!9rww6&RZa(=->vg9V4mGZo2D7tK*p5cdkGq`? zzixY6oo#uis@iXB6!B5+8CcBq31{2x$Uk@1enagnfVP$VJr1MOXRsBIt+uV)NJGHO z(J{er46wHi?|j(k+$fv1-Ms6%Hg*=}jJk|XX&S&Wgy53t)Y{yW$F^%$t_IDajGJzmuq&F&-4S^;G zmR)$|!kY8eI@?#>eCF)h3un$-S9IL7FY02?sx#+pd*dQL&O3d{u`KQ(i?jVlQJ4Ch zw1)GqEi&rl%~h3k*8MNez5_n0VvGCk?%ixU>6NmCKoYVECA3gO2?|OtPb5HYl1;Lb zW(q~o7c7V(JkqU5SFs^>Y={+UCW?ZJf<91DkQPEzq>xx*!Jti<_!Erz4~{reDW48Hu>ikf|Qv}k0Vi5{BToBBwp^&T%1Z4O$5tL#Z)El z!=eMw4XVnfVZ7g?Ae07Eb0`I!YcsW)n?p_LYz>yrqA`8bs`@xPTfdCU#^$2-%jN(N zWhFAIOecwbjqAm0Sie$g>Mo=Adc_$Qi-x0eu)hUTds#2FD%L4J1jdEfPV2?ynu)$q zKOQB6HU1m3@(F@WtE(;+7`3}s;}@5CE|DW8aJ{NTnbqB@pm;0MMqbPqvou3{IkLE+&@5$hPgqw%{X z+T0we9zc-NR^x$4(|&xpsP2z8Vt(tqqrFx2Lab7n75)b^ z*noAs!(N2yDB6EJ7Z-E+NfX`MT8&2Ttg$jG_mjx^$6_q28X`zKD|UVL21#uJ9n6To zbnnbB$1jn@>`QP+U0wyd_m0n3$Ennc$>EGfetqy9LpFZ9Cdbvztyl-*91YXh_n;Ed zdNl@#?vI3SzIXvYedKrJWhxM?@mjQTZ_&jI=dr=Q^=cRQd){=9&cPDo zd>H|g|E4PTMGf3+r8lhX4Rv3nX>ZzjHE?gV@l(ge3#On1mAz&T*_`R$BEEtFudrsn z%ZuA1w)XJ=n?v^cwGTWWDM>^ld+l>#TN?T*omVE9Bh_cRS6_VL;`R$&{P#Q;arWGc z7tdbk^0ei%g_qj8?l{{JqF5tM&-CT5bjK?_`77O@##Cr)wDL)$`f<_kXWHU6c>xg* zM0cfEw3!di)*5Uzjs!>;x#5N;#?3V4X$}htu2vpOQu8J%Dyjjsc<%8D7k&R$Kwi-| zG2vYDzhG3nE=fPpK(-};MsRY4*Hgf~>V_jvW;Y-{{zIZBcw_g29`rOouX%u?{xm8# zUX`GSO#qP+kh6)~0D4^y5+1cWKu(!3*kf}%fyfzs&fVjG*S-F1S*9Tqzgfjs=NTGd z^N>eS`bVDu)i?B1MZPDhCgnwoN#NSCu$C|PlQ^uKR(87KXfeVg-X_J@N1_4@O?(9d z^=IUMd>)`TJwR3fW;#KwW`M{llPSFb&|4m$A^IEfqD(7-Fg%|JA%gNLbY#+$i@%hmvFjUnD_80#Gs`HXrLIh zuZZ^$gVtJ;P2_2GKgfDh9<6G@)DC9kii+%cQ;Vt!n2tmj&U{n5fAA)?`rXNjFG;P6 z7jdSh5A$0EKiC&{sk&6r%o*R)nO>|h}x&0daZjKXsS$&T9G zDb1wDAl!N(;;UcojOglJSprrNX7x$9_LjI#$T-&1OUdf(rSQP-a+?@shvvoL2TxyB4f%18eFQ;V!Ju18Khr@DFS;A{YDy$))%%&nIR@{F z)CTHP%Odw(Z_qLDwU1?^SxPGI21{8zqh8+*{8Ud zqiAGW(j{7qC^xdusKs#G3gwo>({3P|uYRlbCYlSz;MAWCuDp@WZ5iWMRk>b!8ZX8_`g zs{xVfp$J6d{x6Tl-EpeXp%WSG;esd-p#q^#w5cW9_!+F-Hf315iKevOE4Qw_1`YL6 zR^XE7NsQ)XSv4k!)5qIo$jb91-bI!^l7?(}I9bSEEqAw)ELcv&Nx3x1d1mhS>y9T}OdKUbmAp@jjgQbO^m&n1sGREX*OfX^{U0N&5drXHKH~FsI zPf=+6E;hqdyzGTlHLW$ZfO@y{`(iUUJU$fb0@kV%U^2? z!g@Gkf+^Z`pockRU)lw)FpL#o!dfEs7QiBoN^iBq;9**;rSpMkQ+lg6rfv>|!#ex7 zb^jb|BEI-tOm8)G$6X?81z8$wq+Kxi?}JHg>XF`R>WPQZ#`IR71V+h}1aiK~n?ndN zfcS_u5o@Svc)*_e_2Ewkx}Nr9M34{vwDea0f$~?t;PlpjboncASbA&Vh={Anl;KXJ z4y=OnYF|O?#S5bmv>)?il78@5q&cj$EmHzb{^_kD*Ws5R@)$Y+Um~t{H|}4#4{pJ< z^QI&=Jh&mfHEa@am)oaco(*Ni+C-z_`lhmJtmH8M3)`-ETdBXv;LcjxRK;(X**kl= z*>}BynCR8Ui1pQG-|XcyR<%TA8;lXVP_L-e`7&);+up|AOrbQy69y)&eMx%w6eXK{HpV~{ivpTDQUzOm(*e$|&=xU{`h_22tkuk#mPymY=*eLC{9 z=ICEPMNKyE2{nBZ+jhor?ySkO<9tJ$f*|6+>+Jzu!@USK=#>H0pZ-5)iZER9tFHE! zoluAvpOBP4(&xD2TJ-1iId)FvPD?H5mzj=y5*0W)3|UpS}zRGA4ovTXrJQ>Wl7cPhI+X9Ce_BTnQY}C*U$_Jvz__ z#&{_MkN_qVSPD`RH*-AeevZKkrUh8c3O+3e!wT+O!=|}VE|zm%%u5m4Gm>Wfos(4f zex2GSg8Gwo%Rl%9;Q?%@Zw&q*2rpwufd6TpdQ%KpNa#l}F?8c)qX9=HwV+37_j(Nn zD1{p7T&}H7?MZV!-md%oBd!J*$pPlOIU!9o`Nyj5n=p}`-fjv6(ID8%Y6#6HvDqOt zB1R>s7bDpt;;IjWMs1F|&k~b_xzwTU-m&z*PnXzs4F5r)n`Emy*y@2-(98Aoqm?oG zsss~G_F%KeV!056ERAQmZ=43Wu2?iQL7qCCWJlpeM=I(GQ3i=v&qtmB`k1q;F{ccz z25m;(089f!tylbms7;9}0I9YZ! z(}E)=sj>0luRQDGeGnggm^kWi_Kl8sGV?oPn*>xUJO9SHx=n3{Vyts2Mjm=bCV>?J zOfl|85})WBkr?ic>}gVJad8#f(}#xhG~koF_dWz}j~kB0oLhh}z}3W2BfLB8E%*qa zPdz}90Qe(H2t?v51PZwQS1Sb%3(xQ zHi?xRzlCIuGRxSb?ViQH=bNz9RwxIuX!`#(Z&U!Vv@r0xqS73#X!O(x_|0Hm_&y&s#pE9Ng_IG_2)YyV7EoTbYK>Q|`rlf1 zr>?$%Z2c8KPCG{JyQ{Sp>uZ$Lgs6wwmIDHD zP7N=1I-{-~+BejYVKO%NFw$%R&dcb8H8Pi4Etp;LJYPiGLy6d?yc3t~M?~o|@3eCT zP=?938c}ncSw(wC$$Uj6BUB1?8sXu=BMd{33EA0`YPn2%4Y5KS8Y>;zYZYy}YG<3S zz@wKJwvZeMwaC@j=o3D>&)YZYpb~cZsvpP?z2t+4*bk$Iv#;6s8W_pG9>>>CIEC)BRY6z~-WD8-uh{SfV>YCVIKHl1 zdRu7sh|9@jmxT5BY*o0)$mG@&ucozyCV<8CwumHR17Gn{XafF=Oop@k@>PU^Qw|hC z$|>}#AAZq03)?QiIeqzRf7kDR^gGSM$5JQz}>%F6ee(cvy$ zQLuv}$QG`K4a{s|HeX|8b&VFLksZu^Bv_orG}q@K-%}KjtEwYj%ylN^!3k2~X^5-E zaWXK*cfcLcYdp4Zb1M+HOq8hQrg|PaITCD=n*1K1gC3ye0Q~C)37X|4Kw$!Oj0E5T zascq81hHu~0i)?EO6xda%^tA#0Qm{Wv+^F}ag#iPQgZkMP%R!P!z7b3cCtjhVyWlW zz6AXU(B~eY`2h5p;skjMknA%43(yyCAij-e_e?mpX9*ao|M6?y|AjIIy^5v0v>~{n zOv|+^9q9c8dWYQT(K6D%LFxESI%?0)|Kc1eLPy1{l7%Iui%T;3QXxT27VpoX_N524 z2j`fSy*JA&Z9%2rf*^fJGDjE!MTop1ID+zx2W$%< zUh|!)m3JW+Iqk_&Ln1i?*tZ_AE`UsN!OnM+d6ShMQ5BS<9;tu{cyB$MX>JLUmP0c56xkw0pD#*&Z7sa(lx zuOiBWY9UGJ0;sTQNc`p+h$?OgC_Le$f@bjieFK(KJ%ceY6Mmnur6riiti)C{UYBI) zUIeutJa~E?lrHG08SncdlS~azn^C#6$UY;tvZAv% zD-hGlBuevc;OpgOrv3uxCl62w05h=`kZZ;&3qVwlr2&2gpr7@i)qLHX%fj6foei#p zg?kTKxNL0P#USVS$($ID>mV00zBKjyv66=XT_hzQe*$L638;eFrq%j@ZWxxKh_k(~hO zD-F>!x3l8&%o#Md!ys5emswOip=9>daw>g-KJuG2hS|3`@~F~|r?{_PBt?86=8p=h zGh~N5U9*G&)ivJ_kEPZm&Pf8&^#-*8uRFuo_yF@n_Hxu(qW4{F=POjBIrC#_l|2^K zb1w4x&l*Oi6;27#Dsu~&T}kQ8pZCpd;@(lRsC1!yEaUNd#EGcDJxb@~lW!cR-k$0; zRcXr6nYy~8es`ormEv#vf!!YgK~Iov_^Sh{$|}johXkVTT7rxKP1J)}h?;r;24jJ= zK19t&zXi0N4xl9ka_-t7Ign;d*N^nb>5AS#>OM3x$e~knkl_1%_Vjmt(rO<=8+4>zI)&G&O z7lVtbtIb`U2>nc)HQuQe&X8YJi!0#TJAWk&T3wNRPq z0U8CsfJO;AO&~g-9J5z2NP0nj`*5EtPm@0pZ}772@v;Yy8ol-4F6TDZMRbzthDlfA!!Ecqt z%b4K5%G+X02w3IgZA=JUC*#IA~rFeY?e6%}br z=(aM!lxB*?k*%f}V}k0RV2q^Igl$)6gJ*bKV%5c$ytdXxn_M>|jRRXP2UhqDyVUCI z-;#DY)_-w(;8uGC4xv6sbF!TwlQzNzFaL!WY6oEoDM(q4%b|EG1Q7th-_1x zLH$=fb>2c48H&%Wd5fot>>e_JAeE8q1`? z)XhMgaH0;;P@Za*6k1<^+C4y50GQTACUvV3AaBgT$nxn2&>tS4asbR-CFof({FiG_ z`vdc*2PPKp-<}{b(LUs!pp+zgG~N4`8;W<+4*}C7QR0r88r;LE4*=|n8;m?cBLFy> zBtf$fmx!CQ(#{zO)ZZSc?|Q4s9X5&5yu_kqsTcI&JH zg8_nyW*?WwYC8arr%F(|L4c&xX=}Z~17twl$IksFXulUNf2M{m4NNQ~RE%yYF2P1% zwjy36uYyUIMjll{!iEB7a)Z&T?-2u4Wn#Jn9aC@OX0t4RzX#~Q z0L+{uLHlXinm}^QGY%l;YeTv4icGmI1z_q730h8J{s<(E;Y@%6JyI%|iMgnMNzfc0 ziYZ8)f<%o6s*@fiG<7mCb8hO`2R{Eo@E6-L+JWJ*o>%eZ5EDNqSJv_CKrzUTA}t9h znWHNI&Zd5=$r(>-)$764yMn1lHIVO!HyTS%pBipX%UU@B1cUVig}Sc+xin2??TS&r zbC+AP1rUAvyRB~1{l2P>{sM*C5b^&+OX1+mELq1r8E1Ls7b}6fm$~`wJ=gVeodANf^!>eZ-aiDLwTdA)lWBIrAEL7y$V!?8T%5tL*!b)*ne451$BmP3AU2~Lii?gB1FkBg$7`7a>me@A?{ zHi*6SR_NikLP`5cmwmW*4c}fTiQNrisd{2;p-DLi?ZU-b2=D@k^o!J(_X5<%1N0pL z-rq~m8GbHh7RBW21iO%vlrYqdJrPkDMLL# zGXVH3N`fAiAXzWA05r@46w%$R4C^UD?FQjplHKCd01fv5{R@Cc69tHj!ilkWt)o_7 zS+12-Q2Za7hs5YZP?Nf78>o%&ptc>9HYQ1GFlmOS{xyW0lLht?3YHe%AK!%pBwx>f z(nt?VY1r4aAw^OGU#GfM&Zd6FjW14(s)-z`JPT^0JgB`2O50K;HSiU3{)KP!eD(9> z>p4)$&{GmBFEZV%9LD9Y@}9jA)^Z_?l#L=PNVC&Wl?`k=D2{fcNWPoXptWWJ=#8r@ zNduZXsP@*dUmgiZzx2{$;eR|94zf*;hacaB>5Po4o5J^Pr#nAw4}aj@@Ia&(xb3f7 zsxc_3vs14`pRa1dziMR9uvqArpl&?yqCD$`dRq8=5Ux8JDbB_|1sQR$oTfh z@Es@V(U&K~-#kTM?miQKZbd|-F=N$z5#QV&fvmONA8}#>eYtyM#J;WcMe*Hs^%OFz zJ3Zvv@53*DPk2SmptCrrD$wWNi{W*xl;l^f;j8~(FBp`mLKs+qYxF_3^nLkGa6C?* zEp{&7-N@2$T)f%eZw5%OH9rO@(*yJu09vC2wW|UoTMyzdD&svsw*#>8Aql#dK*XNZ zFM9yG&I9y103nY_&}g{+-1++ysOvpYi9o#SLCS7fTY$q0MLydpfLcb zn1 z&p~vWo+z_&27p}Bo05~II0iw+`-R?vIeiGI=^m&YAWpp{QM1g_6(a{7UjoGzwx9uW zuMf|+*V|_0XI!Ec(HZr`qSPo~0XEYuF|s|Bcfew^1a&ubIHUeBK(jnRqX6(~k)S(_ z0wk;G5rAgvK|;b-K$Oors`U+9BEQ}eNfK77IqTD~eWXLj|20VdOHWd0(I}7``-SAh zK+${c= zUz(NPUrEdz1_6>C>GuH5^#ENDz$-^2=$s5VENj{^fU-P5QxSJ(4dT);?#Ra2`P+SO zk+oV@Zl9?)Gr$71Az3MogW5a~YEOgGpOTt-l!wYCxylCn17P#rV7v;JpD-)G;Nolq zO%3)xGiO^7t#Yr#noleOptR-C^+ym{;6{X;2!8-xdeTKAXZ(H3eF8$WH*}dVm}Nyn0cBs^}~;5|@nA8#H0du&)s6%}a zfI*!kD8MK{ve+*Gbc-IuhRB%!^uPqAeu#YZiKun!1@E$1HG zk|h0$xWCYY@&Hi19xiY<%Il-v-^eKY^1NA=bH%A|WS2m$NKcMU=B|Pn9fw|xi{!Ks z$D$EP)*1u~Qi?r5LjdU1Rf1Nl0wgQ-UjUWpK|<>%1M*RKu_(6b zl%XJ%cRk3(*E@$DU)~-4+P%@x2M5jRpdA zyB;Kjc@&Us(_|%*W6$R|M(^Lqv&}RjuMJNdK$KPvN{!qJM3=b{rMl2C-Af6aMFMSf zYT7TJjK2CL5!~=}^e0bq$}^n;bKZ;g*ZsUZupb4Ycj<`=VLc0i zjaf1S4z9YX+RBb82Ee=BfYctg0Wy7oggs7LnDQ-EcPv2ncz{*{@S_tnNrJkAYf@pI z0lL=%RFvzbyo!tGYm!vWlD#eft?&Tt1;E!KLBX_@f14Ok#s+V|xR(pWP z0`T?{0YZqgR)SF@lKnzYz}9%c4g+%kQkm9%5(R;z;_L;`fAk<0G9v@*i#^PS?%DVu z_6#}qFpD5fw~j`=R9M@{y5O%&4Gh4p=#5c6IE_zB!~@zYp@zH1`IK9q^#-KRZLq5D zL+iU99ZK17N)Vs5SEIkEj)BUmxhv*{yXecddtyGhhrT>_Z_M6%>B~>|#k{nVzO=83 zd2Tg*QH&HRhS%tG7B!$dY79x26cjDVO+=3K#FE@wthgy-;PQhevCp}Ofg&gvjm;vm ze}W0C^u=OQ#AvV_Lj&L@E{n;J?|eua2U6755|F}Ly-Yivf!9+n)Bh1Aq#p7d+C2dM zEDrg+?$ncHKvKX^+PH-MF$xPEVnD1~-`~2;p++nADe=eUZ0`|^XvL)Aw#DQo1Q)rP zazP>XMhkurT%>bNHZ8y~45)R69HSEc3!L;7oOCVxbG+n425;h=U`#c==l8czALh=9 zD31)aA5TeN_D`YQ{nk=vMS}-2J?L{}ZOjWbF>qCGt&3@GqA!@WTPx`BIyQ+)R^N;C zgWPjP$r?POAu|x-3Y@dlv9I+dR-_{f-?_=1R%Ewe$|wm3I1X(y87M^4G^3FYZfrLV zZBxyDZLa~xB+5?|rIM!cPMyI>3Pu4J;#fdL1!q;RFK&%GOwTavA_hsM^l?V*pj1JY z*V=yF4M7b#^qk1jyWFRQ0QanZ^#QpAL5@kXlHv|D();|hlB(|6_#xVCBJJ~|KGSSH zZf1LXRkJtz2fnonFoE2oU*BQ)TSWqqB32@27&nFXz@G0k z9PNf^GM^Q+vS$>QRu$!qv*%(GhRfL57NRV!pwrZv z{pfswaZqV;Z4?*zK!`k1FLKetKl+51@}KomySAHze^qv%LjbGOYXV_yly2}+sx}I1 zgDoqjl78ren4dq0p?P#;H7zWlMn<1^K8X4HgBUP^@2rN9sCTz*e~i?SJwG3Z0pQ$5 zZtu&^0C6~!dXX~IxEsIlwoE|e%iTx4$6KBbAPJ4%P?kY$wW6rB(nbMr*kM#Cf9xQf z{m8gA)E{B{gAH}V#@?a-QYvWEqRml3#lHJ17Gg8-fq{Nh>?w&^i>c>hm6C<7OQc`C zQtr`LN~h98@QhX->P|>B0(Qh$Tr8uRP8S4KIf_<6Jbm&O{==uhivK8H0)5hu;g;wa z3aVo~SlDiAyW}2JQ&&rN^+4#}cuY93G%^~q3D5L88F^F^6d4EfL?8wk*@s4~4f@h# zOJWdjSUKWk7~Lxvz)B&`E_FJM5`xyVZqb%=^ek&k;#@kD#3?OCY6{GuMqE7a9Y~S; zy-AknAzyd`n3w@nGtF8MQcA|fp!I-KmnXSEUX_O=7i=#JK<^o~dH}XaP(z3GdII#Y z1ko18Cr7l>up%E6NtSAL#Nc=~>CU^4Joawm%Aa<#{)W9fsk91v%IV#mPgFDC zVlmyZ^LJDG1U=xQJF5)L+Uea-7uIc~yzqSkco)_G=9@7Oh*}hk5%p7W6jp?pO2%W9D4MG7m1u@@p`Q!ugG3L zh8|2DxQZ>rTdb9ri2KSIqTA9tWDsS*QBZ=y&lBM-u#FrQ1-F&C>LFt-PQIz7ms4-Q zc@9a*Q88Vdaznd5(15X7yjE?Esx_c)8oPe^1l3KPc~)VcTBKFdl)DJUQA@n6`TAlX zDjzzgWfoq+5>2JnqWO%aB)*LO)1UZRP~?CvU7A~D=liu0c!(nW%!#XSP^;n^o7AOo z>K$?F@;Jj&Q-e2;>}@&yC{X-#p{%ODea8%@|Ht-Cp+DmWvHyp#ALH4N@$5(1;Bk18 zHh4Uq^cz2Zd{$L|fbau<@T7m=G?%xkONK4M0PfA-HeS}gUdH9VNsnk>B7i8tl z!`kfzf3wwKGFxAaC80e(WXCY7>{V#(qv0e+y&(7>-t^EoYw9s7_TmbMeOYC>BM;B< zFbZ7^qAydO3LNoy2pK!{hBZC4FWu|i`MO7`r?BT0*!$ow-OI1ra*^65s!n;S1N9gM zx-BU9aVk(pSs^;5WsWi}5C4_oztRdy{eezFJ*Yf$3(HH3?OA=Y@{*aZShL|NreDhn zwUWxx;#<&5f#r=C$l$S$f9APAs4C?<(AG+qWc5h|ED5@5bg-q1FR?OzqTdB#r3^a) z9gFNB>2dlGP8(m(6mMTLx|prZ`?vSvvVr7ASI2N(!3pWtit0%3(}zwW8+0o=Y~CS> zpu(P^xzg}%lCVM$n#*im4_O3Tb{gK&a_F8Rl@F*@`?uDt^76;&YqRIAan9;cJIK&D^D}!!W13+uT(3jo25_W&~1aG(>C>uhuSi4N$LUX zo6aBF94o)!r_l@lnY>#<)kWOdnie26hBSQ=Cg#@}Jm0!^f9Nl!?u^sxl{aa#3V^+CdC*eg>DwF*UR0pSpw zAjT~V;ZUNsO*YjK{2eZ?}G2tqIp^IfEL;j@V+s8|h^ zQPCa;sc-b;cv*11hT@Hpf*dw2(Ifs@g*x3b%3!$0X@TMmW#cmJRr|No#%su?2h7H! zFDm^&yP%;-qbz?Wi$QqOTcpV(I+L2nYT-RJ{Y!jb>jz?{uS=KfYQ5@t=1P{__d(Q)7+oo4wLh->~#{ z-v~dSbfaGsp7_V$zktpm>BhjW_^*>SINcZ&hi}30_%Eav{tHd?^G!E~^~Q_gHvEoA z?J#6TkW!L1eJDS*kC8haV?y+s^+Yz%n~tT>i#iC^6d9hr`&Iu0Uf~ z0!aq=@JNf})hpqcoz-a#N*{fQWxeI7ah&D2ajZ)hp_!a8XjJ`Z!~+6`um<)slztvH z%by|i6CG!V(30AS>o7fnizyqV;nZbRB&2ZA;FV5-znWsoq(PzN*hvG%7N`FWN?$z~ zsvfw{?3J{Cm6yRd^rFRLhtI(0f3*DF5a{#&akl*0Y@&;f{1_WgQzN1?1mUcKz;JS{ zTk9Wzr^))(&jzJxl2Q8``FZ4ek*6lH%0uQS1F&_n)A(Xa@Mn~nPjF2@08WG=T57Ap zI0;|vdA7;gWDK6i(`_0>(@$o#jxQ?JD*4w5C6%^3=B$`CeS+&7+72I~+w3Le$)JbM zZ?1=kc2j7ZTveQ7FSlW}sNKen2(*cFtHzX;Lid)~Fa|(mCEIj+LFSS&+a#^b2EA;X zIAh9W8*3Q4RLi%p~?#v;>CNJ+4fCP2qc z+E4%*rwLF^2hccx)(ep3aeu>*sYUrdQ~M?3c12}rnGFkE7C~v)D(pr1w%p3{B3nhF zBfrw76;;}b(dupXCC~}iGS(1ilpAXZW8+?{DfDOA> z=YySwm)|mw2Vam}3xcE?NK=s7n1H`q1VPI@ZfEfZ`mj-Z3G}8f5J>Jf(ih7Oz}oaJ zJF2OxdcRTI2*~#bde{ks?=W-j(77)->7tmQX?*pvF4F<)0N+!aQG77vor zNN`3{cf}c}hpao_jSbNUQSenNv&v=o)|;~F4VOmF)Fz{E`vRA+4vXW3-AdgenTJ#G z*M|g!k9$mAb_X46|HUueMI9^5I65dpP+!|sU(v_e%TncY?N20^gcrHZi1}f?V+-wB z@s;VJE55Dr-arx$k2uB>aHZhvPsp2q^DL+2k%D9`OZUDu6Nz2U{f7jhJQP2fAlVMD zR(wL)$+MTi3H8s}kbvFs0G)#_{)TKC1hZf`7#bhPDcZgf80m~ z28~@%|J)GvEQIY)D&$Et)?8e6l-go(71r=!wo5%K z+Xg8+QbbTuN~Dl-Ng{sGq!E3bGky{6vnV3_z{{Asi)inoG)J`0W+8p42oBIO-t0IP zRswtmPz9U{3kQv}zkCKz#?XdhR8ocX%~8e{c(}>-B8G?$`paq=rlU5*H>!8wS{>iW zZZ)l~VeOtB&C?q%3XvOnX5)t#cev(ZSs%*>kU!lDuNa2Cj7xPAU+Y3TFc>(}5mbN{ zA&2o&jk|gv@)E8^e0bJTP)j9K4^6wPy0E^Wv-2b$x?ip>o>@BGuH}`M z6rq8mVZ(hIJH#HPe?FrSr;U{^mamZ;R2^YaC$N(krf+|3BdIkuzMZ6%Q_x2mUip65 ze>h2$-?wWOa0BC!(2!JoYqk5{R+Oi4F^R%uA!eXtpYtGIe}?KgKD_K|yVhu*0I=~L z0jj~W6n&q!8m~Uv0g|a5#_RX&k|ihB)W}rU0P>t3($SBh>8qiupRbkd~6Q?Y7OI|6z>w@I3q9RY(*6W|oyLeMDo z!2mtjzt>~YH0P$2=I0B(UGzP9##`D$pndS4=>G~*WPpo*sCQlius zq>`$_%u&zNd$tsxr%Je@j3R&j_a3vbFUH z2(}I)VGPw_;i5htHn8)eUfxR5= z9!yJNN~W}Y9*duCnG~S*GkA_RNcVVcD0+bDo%4*I5j0s?H8vGj8oI&)Ddy&=s0ykoH{8^offBN#!<1%K60vw z%#Hr3gH!tr0t3wkQa8tNi&{xvT=d!_kFRIT$1np|LBUwjBaaSgBA45j^WHQvMTEYh zNnP#Vq%QYrQs1*QsmJmCIb3hxI^<7%xc^$U3$6#(s%EdXYBcuqOvBGP_-?1?&E7TY zET0-RJfH?gDb--Up+@bF>pk2b7>pM(eQMQyLAB~6Tt{%`g*~_yC&JfSKE(G|Fkn=F z39M6FaTz+*snNKunCozgMxFXL_RoGu6b=Q~tLK92slanykN2knFD)6Pn=!@g0@dtw zpUixOYIbP}n@DAoiVW2|sj`{$phWSxQ-QkK9M^@T_-$(N4E0BO?0M2|PE-k-jpb>b zx_;MNe(d2aejBMVCU(3z<}iOS+BuKP$W0&9jZK%9mW8k9-SCMs>idoL8b+OrqR8O4lJMj@k& zQN$==lrM@`eGr9iO&9<6O>zxi)aqr?~!Ln*XC*8V}=IYOi=STDOZ zLehAY-ql`1BD)6b64G~T6OquLA|VXxU36LCxdiPSRU!1_H_&lqjJ; zsE)E;UEKi6e@V)3hjYr@b;D^B#}KU>&wQDIqP+;JFCb_aQ>)x8(bK*Ww693oOM7zK zFdGD;dRdb>qzyqRuZ;+o#mRN(5hsDz--4Lg+W#RT1hPUnqg1MJ5^*6=YfiN<(u%5} zx$#{alVMc;gX@~KCxiA?$>@f7C!=n~hO;!eH9{|@=J9d4<~158CE~g!-6^2UMnw2S z+Bjt62Pdd6t;FZDdf~*L^a44TYe=3u{v5-?N5g~40@T*12r*3$=095;M#Uu7 zwqH21NwXR>Ul%m%I?}`nDHlzuLa5wqS&-(p$*3&aEIAD(PW4)8IjFuNsahWPvmElF z4tmkUNApQ*B#s(7f7#rW1@n^lx;d6EcarY$(l#SLK-Zn9RBV$C=>qy3yWo5Eg0Id= z+T<}(T!~b7id1=4NL{G|P1+EUd+ANVZoSy?Aw}>2U~js?>bj~YEZV04EPYFW8ajaB zA5q@w2zuC{tp{Mty8_hM0rVh1Z+8TZHfuQmOxYzsO&vh10b;f{grE~tvqf79$i5Gy zph&yZXZcFMZ4da7`%Rt7bWe?kpw@uoyKa1Ny)I|Js4l6eG2O){251b+X1`q12Gr<& zc(VFE8t>SPNQd!fWNg5d!hcZvZjySJIX$s}qO5|O;hGVl4-AN8!1W`B%d{;*mdRRh zxJz;f>uvVC-KWws9RZvIoxtSL@%+-a6SDE9unzob5ioISD4TK{^@usRW)|A5aWwNB zXXUHItQBmbtTo4O)vWpAd;)7_p;l=vw`1vANd@lX+~pLsDK-Oar4Gbyb(C10lfzav z(dD4wN<}J$@m3^6QIqN8XWo?Hr*4k&Q{%k0geZ}IhL%vJxu_lcRQ+(AY;?Gxr3h1g z@O9GHSkvWLwJp|s$ZDl1YckBVFb z5@b1+Bavzlst4a5AQyl%K;-WUk*mc$m}uGh{jQ)Vd~rv0qQz1lwJ7pN%HlZpEoPJab1H~UapGr85naqtoVrk5!@Q2=he)P zqj?p#g&2Jjvq=>Ez(v<;qiOzZ-5qyX(+dXwiJIhvEnhR>i1&^Uf`2Z$EBC9%FFNPy9djYa8+VnUL7u+x&j_Ym06FJ@)dM&4Foc zrm&9+PPbi(XvCq?A1yq6DQdHq-=)Ujd(@boANhaicWK1w-(vkv5BvR0mmOytDwS^6 znD-Vojq=+IX65XwvXo>iV1snt3YdpOwt{%eu>va-70rjE6$E7jD+Xh)PV{}BrLz@s zM1gW;gt+GDcOON`eIS()8Sa&|G^Q3rM0pO>m#5P=DEIqRCE`t4KBNVLw}zA4n`6D& zV%1Br=2r5vLlH2!WAzvI;22b~2geJ=&|Gwx6~ks<{$2IGrsr77W9aLM5rP;Sywpn#4kwu|dNPsvClUC85u-#=$KgbAAEMrRCzVS_))Gie7>2EzT(|TE>@eB*l~W2F!>WALxb1`2g}BHQmq-{r?}6AfVE@skKsJ-v>(O~?5EP6p0GyS*$$ zE20&&tXbUk^_v5!ptKz7kaH`?qJ_a{r6s}*7FPooUJYD&HE`&$u}S0c{@bX7=Ih(B z`N@#j4VX_9fybrZES>@AgZgdOA_pp9D>0 zV=KVf$1)l{4qm*5{}eXYBYXCCV{7`(q~=tB5EDtSkZd&PMhr=tYIS=hw8@~n$4NcC zBlW$Y{;90q)b#mGdsq`2<&*X7^Z_wtA+~sEKZ4{9*yhIqjpUO-PIkfGWBxB3_orZJ z$Nk^?fxakMqF(DjSk@Qa>aoM$@t$1MjJM8xuc`r#c$%sNmjId`CDqw|C);VD8$G!Lw?qX2w@k z(9{FP`SEzSfp;W`^(K3-Xdu|yLEZ&YebM!^RPnF1cF-}>q_p5-xohw!jl;;@0g*fP z_%&ucEGLYX_3&~{&3mW$<2}T61sxvA5Bb5i)~O4>{=mCyPuzEup!c*SR2er*2GS~5(^7o!D#YcWREPq-cdcL$w?I`x)6ng`rRN-~$9 zgo$aAN;)RchC}WO3fQ-bGJ8=GJ7JIJeda%2doB*|v*m6$m1T z@Y!k378WtB)E*sUQr;aac;drc{fyVw;OaBU)%}Jk!S@=d$HXk5!lttGtBQ&$pcd>U zHnxz~rd3sz=9lJHRj_YJc&UxCh}DZ^b3lRPZwdBA6;;sc#3HbXzxi4f*5ir4@_q3W zYcl{AKe&kbZ>&+wb5xKh^01bX|E0Y_npDf10MJ%K&=9?0WO0in77;HGoAZ4CtNh$4Zwb4$a3de1Be5okZ^60NK1)Q;4 z4m#M@Sb_zZRTXxuMPA~d#gBX`fLsNchc7fw1YTKs_+!_Ki%?BOwV?;4<-CkBKZjF* z?YM;kw9~$$Vse|?7C9;$bObqc*wn&7maV&}*C?#4EF0RV&*H_4Qx~VDmX;Uv>6f0K z-e*aXqhz78pjR8U?=o?0*?3XX^-$S*Z__s@&}LcA%$`E+sPfjP0PwH`(F#I6=v#nV zI)cn*?QH-qNKj)3&{2RsmmrUg*5nk)f8{i7dR8hHVVyf|qiB5cuV2ZZ;+a!yd+OVV z-ec4MU*A#xI_WD2tB{(+*P|MqrY7NugM^0kp~bH3KiY?ESZ&-%d`?4Z&qFk zEmBdHgR9I|=_t0_s%(q2a@%60z%-y%mFFl0K|H1XhN!7|_EMyjgF4J7qG@@uR*X7c zRh|ouw30;{QpzoNlvPr@;$Lvg2AU^nFP`^YWDge?mS`KSEGk*qRHA_tB1KzHRb?ea zMOiFzRFL@WMR}NCMmdxtw@h0XX*r-?WXEPSWS#T@>1|G0DDcv%O4936flGz%)br3H zI9n8o%b^vO7Jx`e75k602t-p1fkNGJg>6G;K-(3t-WZx-F*=K4XhRf6PEl#@!dt6Q zKWvVCh{SHgj>A$o#tq+22|i2}@Bl7UYMWN#KvjmY9OYEAa*G^g@WdC|a;wUrDo7=g z4z0*VQh0=Fn(rv0Y~_Q4lzbc_PT9B9PD!>Dz*b-@C|X)pi29=y*r_^0&!GwcQLI&< zYCEuTt)w7@zr<3)e;^3WR$8>Q00O4J3|CGaUBzMtX{8D_Y+$`1`;Q?jS9C+ZD=duYwBr(-Qv=6ru@qxIy>5M5rkG` zt12(TyM{8dx%%Q8&7aU;7IeX~9+Pr7Af2t(!2fi7x!Fpmk(;e_xHuMn;H+@7bq9|A zHe2Z=Z*^XDgX+Ll6^%PMlbsP@NCsp$24g4&YHV6-NUV1oEiq?WgZg%OgBqNmH|2#d zfoym5kg0rN0Gr?k7~x?#q8#}aSTc(BCdDPl=}RdmRx4aH#FCzv1I7MW(E3W!tAV+y zr_=^YUkOTL{Nf@-<{PmlXQ{MvAk!;XuvQCF`mXFUNFA0;`CH7LvZJ?+H=iV6hJ_f08hu1)Ey7{q8?M)m2IT*+Cv8qKAI*;_bJpq+T zsVd2VnKBL=CWyAZ!a3tWwlJ+kjX?!H;>IE#px<*Jj~c9NbBIG?pU5&+YHDl#@jh7i zVdH@|TJ$j&5g1aFvr-nsXU&_3-_#i!e+hqo~op=OPtD4}H|R?@k4;{wYNiXo*6TA+ud82mB7db5 zghys;zgNuGTN@d8>$XHIH32TQna(tsU&~Joq*3K!CQ;Y3Ol$`*TQ@vswi;@vb&mOW zeh_(2IgQb*Lni)+hVjA54{0dMX*iz|3DCIf4+H*_YcJP!RlAtAi8xE=HeCNu*Rmn6 z!E)9E>xXaKI=hbCx>-4iOaNreEQ3{+lxSNPkFLd#Sm)XP>eYF@>!FtFb!x}e3`rj9 z3HJpjd>e(LMSZF&-S!IZYDM%#Di(6!F9mPML|NAA++o&?IZRLJdNj=~uHRRptZMqGd4Utl_Ho0j( zYCKz~ZDWC*_*}j{kCp3=L-kLPESyu1Vr?21n(!z|-NhVj?H1{1BavV&0|Fax2fCI6 z=HC6hqjGtBUFf4vgknBRkw>shO71X4dplVFK?qf(>~g@-h^I;Kje`e7otCWqfRw6m z=!+qKtux})#%DthJsXM%>*t>j{o#3b;tF%7a|Oz}61~Q`1L^)K(yjCCz7QUUbzYc- zo|;?Rc=!d zTf7xCp(EC__5fJ>uhbbVrCPT&O)MR`L@E|(B>hC9aGg2u?B39O_E9Qd>xBEI% zacE^_Y#V$Hp>K=1YdPuWTsWQBjWwMTh7dVQq{ebi#gZVnmVYi?OWGG5FO~t*Vb$ax z$AexWaryKBYmgV&^$$L}Y+EJLsbnw%hO zbd3-De@71)%IzVT@V&UZFA1DyjB^32WorJKSKr%CUS0k`2g5x^cJ`6{<=7X&x# zA;jH(=I_a559L*1HXquh<~qy$KI(hP>W9hdp5%IUf3n(~tR6~Mk0h%{lhxzN>WO6a zmt^&HvQEieV-`a_m#pjJSDUpLah%Qf@<pJyZZ$24vG;yp7XRfYgI_)l!9F_6;s$*xUj9pzF?(5gwNf+^Y zF!KTCS}`!vot#$vXXyDqsWCnMcjzyF)0fw)!|qWaGW+G)pzQ0L;x^>yTTfkbr6Ie82xwxn5m*)1C!Dph8{TlvN>hRAy!up5G@YfN=oQqo zrO3*K@Q%fD{;9CHp5`b1RCDPqwK0{fA0%!7>!$_l*HFo77aRJz(Kd`)u&rA)M5wQX ztKs2PD{EUOB~h(humB#7+`af#C7dnRA8W#flf?P8<#Sj;A|W6Sr{oJ(8oxs8;) zz1UHS)s$E$h=ne9;6LL)AH%XKcTmqj7WFtRibbG+JS@txTfwq*oPALxw)9t6F^^$~ zL0(#7g^6j^u!f7=K3I*l$X--hMqVtug0))?gbc6`^(B951zgSrj>^KSoK)CQeHK;O zZ>gaFQvhN_sW9UVFHZ^HPU&yKHK(-73TL4e%aKdqXJRa1^_M;s>aS9LCus}qR@&xf ztt_?D(lIMIgHuif60_1<*2RT(!j=`4E+t~bxa*Zv-x+p0-Xjw5j9IY=O)||mWp46< zDmW?oa1xZqRC4-)&)}6-{7-6(KG8PpIK*c3kYRn zQS|x{UuDcF-;QglI$Ms}Nzu^99F~ElIn|09R>roOIwvNfxna#eiM*vtn;9dGh}hSL zkTS`-J?r*FEGuN5#!W4q{A}UD!T9d=B`2YQ(ajM_^#7=#ad;dzuXj>h^0EYcO~BWLV>{M`C}5g3QM-hgx|5O^aTl?v#lvtIw#Uk(|{0vx74TI)8XpA8MIh zt2ee&%bYuZO)}R3o<77kxPhQ=32AzvnttxWV&y> z+$EkmGDtw`6-J|FP*e@&YXN2(E0-={G~Ri|*Tm$zq`0W0V(8=1a)?eVAI!xMOvujixtcbcA^+byLOG+bkfQ=i*PofTRJ}T4V_yzNlmt~=rB%xAe zC6O8)F>={_xxNu~1{ICogW?^9hgpfN-1BFRD<(gK3puPes)S-FoVw)H>YlbNqEC^T zp%fRyLq~!D>37tH4mX!&%}rp6epJFde2-)Le^eZON7>Myj)-|lz2iL>PLiHUO)ve6 z%m~Z_E7^mH9o(G$wzYt6V#-|MLxm45+2l~9a-SIf@O`8|FhiSb$KUJ>dH_`1V@oHJ zKE?o9$-a@_4E7%r@xTevKt&L9_C&f%@jOrV7+Od~5PYQ&GZISnWO@Q3xBQ>hz68$3 zD*XRE&pR`gcP!&t=HBdP9AjTnQ4>ND3ZaM^`@YNwDKrcQrz!hV*~-{LWGU4Y2`OYr zq7+4;R4PTK`~N=Yz4y*l{g>b8^XK!O^F7ab&c3|oocFxv-qrWAsLLmKY3)I9MGP); zjF)$6utBGdooY$-Nr}-zvu-#H8gso?Wad`9jW>fsuqVGQu}5;$64{hY{G1qT4|>Ah za|Ch`L$xLL>gN{PPgFV~<2Y{JzW3i%FWw^QY$=;wFk@nC|1q`(_pshW4l$+RJ@V=@s_cF!&_7S& zmIa`Ao{{}SRwQl_!Yx!wbG-r&zk7o6hW_*HMZR}oMj37~wgv3j)#ZQ;S1oYRK|TYO z!kP5IgsxIcka-ms`PW`KobE#OuI*)sPt6Gc5gl*yhyP z(&bXTPlzfG!*Mft;3+E4@4HY%kn{yG^R~|8(|OGJ6UuAjRTc#T>T&Cw%(Lgy`U9sxI!c zu^%wU+a7Q|eyZ6{auW@vd@hdNAb zoitcN9VYTomQ@YC+CGmL*qyKocH@@il2wU6uJV3JF0>v^^?m?Jnzc-DyC?SsU3Vlz#@j>&U;mk>`jOR3%=0Q!PHc0Wl{{9B%kNLPp5BGAQ8Hh}VU#Lex0C zMbudMoeMaI~6|NT>;+^aoIBb+0SnV}RF3ztRo-*JNT>nwB zhlE!uxcTh2f(4GnVi3E--erEviS_}h?C!nBNoJMI6W6}@%$Kr-7fOvB^Bmr<=4iRX z+|D(+Oun8VeaOx}FoDEOrF#mzOZS<*@!^AZ9wIZ7u$zQCr2W_pzkd6mY{qEJJ21n* z&dj*(-D{^**W)T%N#%&7^0+iBNsCCjCv|^vT=((+kf!}hFHPc#+U(ghD^6XW9T#e5 z4J+X#rz`_x$|vVmZbrpk2{khOfR5)=&JJv!7pMLPyiFqbiry-@1-^a@`3iga-)_0y zgUjKn;@4CnAw@4kZbeAHheEPH-V?L6Qo^~012BY!Z;r)fZVIO`%8m@mCqFs{w~Mik zH4d|mGcgY90wy+wbwLvs%es&$5XZW(DOiAYyeU+WbrDmz5bL7GEzG)@iFa8SH$~!E zCzzr|SeG!xin8{Z;>B2(GzrC7moX(0So@8y1RpUaeSFxID#?dT=~ApKnlhzXS2BrZ zSXVawMAlVIz|S9nzA>s)}~xp*40e;a;#HKh4QRxn~D`!*D;kUvaV+;SK<#$ zmCC%&BvoPE)FdadZf>e3vuT=)aJdWZXMRWOuf3Sdza*@^Zf?N3pJ{kA?=iPDWZmD~dJFG1 zx82HmfN69a>p`Y*BYw}^-k5ipJ8ow^*reXUfeYr&R1TasP448tx29X#^HwVs|R`+n=YtyoMlu)~p{lZSG|~ z*0gQI`U%snE$b)EeeGC}Gxy)edc0|WKkEsmLwnXwnT{P;Pcjd5WSwO?J-~Xh>D-C+ z6w{?M>#63!F08Z7Ll3f^X1YGadb;V>mGunsa5vV*bbpxj)22sv);Z>p9;}}+k3Pcs zS(ElC>zSr!8tYl6S5MZnP48Z;=a@ddS>v8`t@Z!-}LXtdVv|xpY=jBZ~*H? zX3#*^&zZr4SU+!u3}*d;89IdZVl!+g>m_FRFxE@Wh~cc4ne-7H_{wCYbKr~_nZbe6 z=CP5imzz~_`*CshV=?F_Hov^=83VaSDGiEV7(hO>-WseXIbwvvu3jX zz|5Y-`a?5kHtYRn?i|(!%)GfAIAP|`V|~Odn9qSv&B6s7IBpg#Wc{&uZV?AQG0#88 z`j~m)c@7*ii(lZt$7ac5)}NTAOIRN_%a*eK)GS}d`h;A3R_1cxBeQBH2M(Imt5|#wo? z&1`?2_3!45?HqX9y!i&}tLCjYSzj}GZ?XQvyq(8^JoC=mtp74Q-eG;+?A*cnZ}aX> z)LjJu=^% zgIS->jto1EqzPkwXRx;mX&aQ7GbLo4SjmZ3P31(w5 zKmNdhH_T5z!q$?^<)2{QP3GszFz+Gr3x4idw<7cFFECq^xq{zY*7uV6?F!5`Wbn&S zfoKcA)#GCT`CO!E0u}IuWvxs4KiHgD)eE{qEtj^571&%ROln1#i^Lk zM?n*)IQ+k)ObJR5SsG+MDj~EdXi4(HdATz9)LCS`AuCO#g!Ta~L#2h{ac&Z+jL?3d zeo7SDA2dLIp#wl~qJYqWpk?VMp@TrnQCXpbLCaG)p+i6`;L2;zp`aD1g3w{0m8hc7 z;h>eNlF$*LRj9JibkHQKA~XXunUaK#1g%QRLh&J!(NtCFlc3c|3mpfVLe+$h2dz#i zLUAjNsX^6+J_TBnYM>OBDpQMUiYyDV+IUd{IvKPMHY7l&fYzltLZ^b(qq;(~LF-dJ zq0>PdP<^48e3+Z5flyp?Vj9xTLUDPCxrG`cuEomSO1FsYS;%gqTZPU9ZA7;Todw#M z8VQ{PdOI~1Iv4Z~x?L#lr!c8>2ZDNDnL8;}WQ!qdLU#(q$I+%KH4(ZLv>7!Ox(4(v zY9@3oXmh$t=*yrjsJYN}pe?C|&<&t>Q%j+*fZjuQ3*89XitZ7*3A8n}68b9Wz0_Lh zX3#ctuh1=^ZK;jWt)T6wEmFHknfs`n$X!9uFexchzJ5YO}Z-92B4np4q zeSkU&eG9Y`Js>m>v@>-Q`Zj16>MZmf&f%;(St&Ff_9~cguV;fjk*fm1^O^` z6S@bqJ3TCPFK7?yF7$oSN2rHTd;w}6rALs59A(nzQIMyV=}BoIGnDB?Jwc``)0=vU z`WH~|L%oH53EG$X2*u`x=|_EqUIXn<{e=DjI)M5M{S$N`4G{Vl=pY&>^g8HZ8YJ{@ z&>=KfXb^NL4H1f!nHfeyg#u z1wcp9V?qmpj;2vU3xSTI(LxJ@K2BqVx}am}aiQ^`PtaJQML?gVCxjLS9Y;?JEe1NC z#tAI}I)TOu#R(+y6iqRt0^Uj8F}lLr;SS zo#^CpwH4XqEHXamqiv{2~HpwH1Fp$$Qwr{{#?GCcDFJumcD(8ctE(Az+l z&|;yDK$p@Ip^ZV8(NdwegD$6KLhk^5k(LWh1$~KL6nZD<3VKOs6VO~*A+#yzO3D@5 z40IK(6nYovYFZ`qZqPNfTIfBXYiW(pR-iA_TA{5$*U`&D?*&~?>x8xe-9YPwwgr8K zHVC~BbR)eY^nTDyv{7h#&{t`b&<>!R=~d9cJvbtWA0cH`Wjn5I7bn#qBlrgHiqlTmt0#LC zx4DPi-=cW*0e?wr_hCRn@Ci1^AzqM0F=GomV~~>A2a8K_%;5g_!M;N!(8g8P4l0S2 ztqv%&leS4V#QQaPFNJ2U%)9hjw6F{sxXRi^e(_UInfFL?8SxXqIyiad{BrD%O($&@E52&I_)-}}R52=z$KB%(y zQ)T=@m4q59WRz)x5y1mg1#zVZi>bhH6tWcY@L)1Fk1~P>Nvr<{W$e{K`6H^K{7J$N zQLPX=Om#x+2-Q>mD&l&S8Yq9Vu#c%>$n_ZAs@y9g`-B?d?x~ERuBoz)lWgGXTB^#Y zbca_SK76(%NqEA{>#I+H+blo@1eI6bxHbp!oCCCZqOWp)*7e$xAX`He39hkM}EM=Z%|JUCjce# z9bs=z3N`C{8fE=>Lx5y*wAzm$0dDC0m*{bfr6qJDsj-##xtCxNHTvO=&GrX+!i&`R zBQlSck^K{mQztcM)OyFy^-drNDJ`V+%GgS6wa>*XSnnk z1O_h%C*&mycR}ElzZ6|gdhiO=GJ?go*rrz&vT}g=jov~}yI7`^Rn|hO~G)l zlCDy=G(@$s1r)B*bT7ogm(jqmS-he)UR+$G98aYZRIbspo(kILA2cgUeGZ-(D(O#} z2W6Fu+O6^@Er@bogy69KZ>9Q9H6KUX%wLozgA$T7C?ohho;1aD6J@T`+xgPPc)Td{ zH@$(LgL0YLK=H*_pCF{&DMI|K{&mMnkwPL6W z2Z$L_B*0a89QkY7R7L!W-K(09XbnOF&yL}jrD{=&CYIlosvRDT<8>HTkhBb`SXLWw zkV1y6jY?$~;8#T-nKcD@m*{5%3-M-e7;2-k3-i{nyUXu+?myEu&%G@ceY_hvYl$Tv z?*VD2l8W-{s&brKiCyC=MfnZ12t15TG2TlYukV}smcAd$KYky|?Xmddefg!DhXNyQ=Ime84LgZ(L90 zgP{@L&xb-Rz_?z|j`}z8$6kRwjFl&Un4jZMl~ffSF(ZrUx`nm0k?^gROZhiX%r=?!e2n5qa;au8WOZXlg#^347(D8`i;(;`mKI@ znto@R-cdsDETP|x*Sq5NZdE0P&wFK$L|5mFSjq?c>hK}teGit-d>G_?<-@-7LFL0NSHgjhlXT6-^c~WNr|F|50!P)iG!rdny6J&aX{U6)46e{79e; z_bfud&jdz=TawgE5^h9_aNolIi>(g(_)qk>4-@&(s7w^_5{2gTW!Mk0__;0AsL4ox z0!LJ+3ccdKoy&URRJnu8gN+E5`O+51V40m&w36_IxH9R}s=<+9DkoV#{?oRKvhU=o ziki?6xYHU=MrW*rI~P`(yXl6n-_uY4_|Bn>F=q4HtzVZ#?+4Jq(}@?i}Uk=#mw zeaeTWNJP?z0%(m`kwhf7Q(&+1VPO)Hq*7py@?m`vku;&eZso%=B_e4?f%lZJU6iCb z1$HSP)-MsAmZZ-r-~AledE-zRUWTab_IwZKr>G5gr)oSR*nwM-yF*wSvLBcw7d-4wz)`dHgdrsJc+=<-t!XDx-=O1C+!Mn3^JwxP5jKDyC-+lf1NjN^zanf9k0bYU zVS{-Bxt|Fe!kOgXBy1>8BKH$v!+0{e$Ak^%spNhvYy?ju_a|ZLJcHb?gk|v4w6Mo`Cb?e<8->sR{nm9f&n5q(B8%hszv3tTNJnKw66|rr?Cq3(I zJp1fiR>#ndon#K495!EmxCFd;h0GX^VwoE&$<{6yM&P8m7(rxetBaA!nulay#jo+= z+RW$A5Q|O#UBI6Ug%`7sPYH!jvxvVCS`_p-{!%E$X7fCs7FvWtlS4dT57MWI%tvy0 zu1%DAfpG(wO&6wBi;*4WB8}in5L3R|QvM2R5HCYis=*b^m`;a6Sk7M~no!QJAZK5Z zzec#IOY+%}+KXTjH7NkB&myUKiO+e#U!wC-;uZXjBo0dn#N3ZBB5@uc&fiCPF8>hW zEBU7=@2mJ*FVtcDGsKekvHKZuKLtDXJtOv$uw%zFV*dhmO#dgZW8!2fb8IyrT<`gnDh-gih!>Z) zoDa*q0odEn3CYw=8Ns(OlV8sHZrz9CvW1y66*+w z71NSXtn$cnZLA`Dm5Z=S^<=j85zc1Dey6Mp&=FR00;}vT>|=Bhh|E^LfP#e9HpX6O zNGq31W5en-RFdsIue0oOZs+ejYb%yL%{NeO*0lx8X6BoG$+OhL5!F`=-Z>p_zjdI_Car$r+Z6VXxf_aCV+1ew#cNV`gXuX z-m`adiUdC_=)YYx9)^`J_C@%K6e_k# z|IeZNc85aR!wo`7LoEyo?qy6BLxEu9)aDAMvQxT72fmHNE5rBUUD~Z=qA>@yhvoaC z5^_2als2<@4Pt*Hei?{jClFV6#C3_sMU9*8 zDrLvQ@u4x(%?;aSz*vDE{R2PcCCGirOHL+x>^x7hvA+nVA9->}X}PB~g-e^D!HVR2x`Pn0`G@rJ(yXGFE1r@%kY zo##bX=>^pMZ~Pa0+5te;==d63&&D(Ecb3n$m7WiNm6uq)0R80}Ux&J0h;sgemr9*3 zg7i=RJ35eM(0CpR|BGJ?CE$540WYy@*?G>j33v{LcAZz*&|g3}e{(Q8oYe?t8Oh=v zTb~V48p~0j*mKe^!o)#6{Zh!j0w%uk)43t}N|+4$Dh&DXv*Jk^tNF^Xh0DypdShAqnVw#=~Uo?Xm& zGgJeMyc&3mUCW9)Z==~HI0V1w_9YxV-=yE-j-P3Ph1ltG-i_`=FM6G3SGW@`i`Z@3 zahF8wj6`y%ojLlQ8-Ux1Femjm-vc1dTSWB@^~ zmia>|=L2@<3oGs55i@utn(RRi%=0%?D{e!vc$+s~A$nWP2+&ssi9!*YM2C@G8KNS) zEr&2s@jFMnLc#$L2P#q^H#tX9K4tN<9M)RS!863pBCrCVdK!BO&jC}> ziSw-I`6R5BoC2P;vh%rZ@N>~Et2keTeESg?;!1M9WOuHxWao@kn*+6~&ex$Sn>Po8 zvv$s6GEmL=#-=I7IUi-K?p%b;?r}h~hVy-tt)}xsl&zNYQIj z4arbZqGyNwkSsiNywyPmMZ=kmI=v0Qc!B2s9!8HwP9dSYQA3TL0**HcoGs|L!=33xR1y(2bzCo^=3E-qW=?!K-b7gMa*B9XoC|eSc5|m}C~DKfDJm}M z!In-rC!E<_u3!`UEZW4~PNh(`W=U-KIF%juSz)c5B&+mHX!eR$kHuSSrz%=L()PN{ z`HoRFCp-&`c2#~%dfWBQGhtF;}l2LM4E5tb$3%oWp!}wa%A0&wSQJe zr@7@Hpfx_=BzQi&&2N0+qOl*4-O0Hd-!w|4E)Ko$e{!XO*Tw=^>}R*BEfr$0^}8scudO>z*A9&rToq%E`{|A8-Ow!}9J?^3G0R zN?6__O8y|yd=S}s#IfH-Y3x{JJ?eCGWMXg#kGM2X7xj0NBp#GFULm8`;-#|p3K`tj z6E4w1ZVx9gS^03MWk~ZRJ?e$y>kSjjb^Ee;a&TBse0pQ~NfI|1%lp6#hc+3j(!Ne0 zEBdu|U$}cII7#@DQ2g6X`>fzV&lZ`Tk{XQsVXq~tpEK0v=?G@-`7g-DcQ~YBo?qVp znBf#=A%!FU6=nv)#7<4tK<6>Ma#Q+a@IlTf8~!oy!Om#QKZ&d#hS)G}Se=YPAjfH% z(%5{-9_oxmJ!`zL&l=`DVcQorU9yHdPg?$2Bp@#_Hv}{e0by6hq&q$|5RJF=SsBg* zn*i*_WQ}y5viuDAV@{^!UxANuCR+YA_-JR6jpr=*7$?ih&w)SgOtu`mGFfAtDVBc= z{)98t>SJ3b>q#fu$}fPAbEa92J(;ZW&UCBu9ry%ihLvM~ra^YFn`68pwQr1ako-$% zXh@~To=sM!^Q_e^&MIr7Gt+X}YMA8A3XO}Cq?cqlvu!V!7*vxdJ9Fi^6WT>_jW_X_ zXP-HkRZNT6ZSQs`hVAlv$V4xj;w%USy;Oouau#A_#wjiEsm^oYIHm=j?Yv;491kzk zoFySInc`I1Sqe2cfVXj$JML@3rsId0+^NE5IJpi+Xs~0n%5kR%GtL@}Qy7=Q57Enx zyG__pTJNaAzad?(IAVX=*<>RfXJ4>A8QhFwDubfQakko`DF^LyWEnI?LHEv=SyPvz?OCPAWq>$9coch4RBH{m3^LRf8TeSf0>t+7!%l@{rE3 z`}`>PcdYvYXJ?c0~4 zeW`;xUnA*T7Uh1_x-WN*MY+Ei<$m0{zvP@i-C^9(*hR`-;d~Y<5*KIWPyxBl=Wxa$ zIq*I7g@cC-*h=Sg$Wt{G=_;obiZp;Q@RIQ>)KCiMM){-6YQ!mJi~5$4rNOY^TIVb{ z#yH>0FmWED|8R^nLxbOVQXJ1&=bQ(Zu@&t>eD#;TxM9JIj%u17{2nq15h25N$+Ja` zdOsiy&HpnE8@$kL8h!%*cN%{7q&5w|f=e3E7NgSen~n7H@g5!cg@X;uu(P-#|!)qN`p3^1q zYdltc6x5veeB%fonWziT^Gmop!=GWU}fRY7h@ix zYjN`vuHafG+~$ObiTq?)T*>w-ws=z&+m;Kal}J;u`y08L_;LG8ic1Wks_4WNpQ#Gq z$FSr+rOk>9XJ)oivoddUGc&v5r_Q+Gvdq?StLx9q6z;@l0?QN^-J!T(X2@KYxlhH^ ztm{v!KSIT|<cT(bt-nLX*F_p6EeJnm|3GU>`eNThcs9PVDy}%vQ8o>CIYFl+ zOxWj0TwWX!j|apPUsuBX{{WOtOxw7`w9-xSDJ#lkA{RW3Ji9eFqTG-kn8MxtjSAWL zGq0(U$j>k2KsP@fbBGJ4)t4~1YJBmHNISwUUf25Z@*kDf;wVRos~WRk{5Ms!zTTO$_p%cCfV?d9aZdz`g3o`gJSVyh(b)?Fnrw z4eoPn8{j{AC^jJ;V>mEiLC&9$Kd)?&zIP7ZN7E$G~!^F>sIBz zgA{~QDEhJ1E-cQb%~9dsKlWmDtY2~Wa^}S^T3&3D7KvG0W3At?Jgo2K%!^&p6$7ns zZbUbnb4j6>d+`~LM?&>N6hEFn$&chn((FmS+zI!zB?JjM26p^b8}z)eMNeGvQy-n$ ze7~ZT|KAJEOKI38oV##ZJ-e48iBa@CnWR;I4mJh|r!zkt;gopgBY!0xuU0(&UX1_b z5<@tSa9N4({Pg{^)V%aWmvA`b=$wYjIA4~}@?(tlnIB^~jbcg;yp|?;l`z6BDeN~a z^>n3-ymAYNm!A^R47W;=dZj0Ngs{cMtI@DtejApS77j0*I%y+b+~E|4!}iSlGW1d% z_Am9~m4$>aVaWe*uk+F%adi>(AoLM_VoZ9W#F(+bbYK>+2v`nm z0=5G?ffK+P-~w@*3N~Ot{^>ufxr|IFle zun9N}?1XF|a0>h!a0N(6N{mSc8Um?F2)s2&2O&K`(t(MR02|fdO#zf8PFQ&4Dn zJ%NEhIxrTP2uufN0gHg;z#3o^upQWGV>t|V0yqO)04@X904j<`0VDuJfl$*05kaBiC>fv!%3~-n9>@Wf1Dk*pxHSY)ftEmr;_%c1q%SZQ zm<}ukwicJ9?*!Wi90pDRXMhX9J_L0bxD0*`paet>BmjOO8K?y`0$L`-D+JX8bRdup zj0dIwISGh;5y*024R8TrUIz+QMOeV51gY*kxaL@6Jl z29kkVKq}B0=nV7(#*5NokX)aHw-qc8H~?G#E(6y9Dk=3{q$C0a$^ps3HB6u(&{6qGt}EC;pb=a<07HQ( zz#957WRq2bYK>+2v`mz2M|sGMbikRnUHoMoq--eUtlOO3K$Pe z0djzOz+xa5SPyIk@_^mI0pJ*L3OEN`0s0~Zu{R+HH%Tk>gH-}jfOayb#zvwxex-WuotbOkEGe>0$S4JZ$+A!XNB{H4Qf ztdJ=nIlw$%F^~&P5#@PSITwD{L$nph19k%kfa{RQ))73M7|@$9m=E`OpmF*5zk_^#JP&3pF44w;@rfEr-bxu?dH|;A^Qn?OFZi1AffBw)+ zv_MXgm=*&nLLyUG`G-%6)Zr?m4&jyr_0bSqvTd)U@-FzHiUm@sPt&?8Q&hwMhP5mb zx{nIKc5}Kn_IhksafnN%#-WL@6&A;`7ymww_58Yp?Y~c(6>ApG>!-|NSq_qa7On literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/7031e56fff3ebe90_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/7031e56fff3ebe90_0 new file mode 100644 index 0000000000000000000000000000000000000000..02fc8c3b24bf2f6c312727ec3e25dd69b81d5b12 GIT binary patch literal 19500 zcmY-1cX-p~7x(dZnxsj}Y-u_`R-vUylQgS4Y1u>eMo?LTAVU$^sE7;!QI_l_Ac7zp zWDl9j-b+B4icHx{pU>~PuIG=3>w1wU-}^rIIp+>-^3At+-~90VQaxV0Gy|38dYb~H zZt(enRcmI|s9G~4%b%SQtWhO9r)u?#D%G>9`hwn!8da)fW@c8&$*Ee+>&*z(tXd}>!4f*gu1Jnet6{`aTp){p=1ZM^>W8{mrci-5f{-2`XFrX=pj zWDERW9FCNPtwH!X8?3n+FQ-G0QyogyfG&+-Sz{>O1lq`Ysn!&FNK!M%klONIOU;!} z-+*u5(KbWPMJ%jNQ@f_ZL z0sY1Q5~|8-=@en0uXv3HD$7b4XfiNHYM2c)mpwAtVqk_ew;Jdqr{t9CF$06;KY1%!_a!yPK(_oK>m|R0fp5hYYv4^;Exqjq zViF8gkPC8K+9oP?X#>^dl@uvs;8V#;GEiG0Drk-jlL>OZqJe$M2Bta;Tyh#{n5Ou$ zPI|ZuRP-7+mSrG5+dv)pQqD`69Nm|1WJ;3`*9i{hT1D+q1mt0zIV9p8ynX3%EyIM7` zG4R_u10&ZP=(<@oZ#D4Fb_3gXDA%3p`EK=bkAYTu4Q$_Uz;e()zyCR7VCz}MJ*Vf5 z9Qe&ZiHin4m+s~WR!2rq!4iR2u1KxI5qwo7f`6rVTm&2ABWRfz!8`I<$p}`Kj^Meh zD;vSsauKXair|Zs2o6_@pddAZdU9S)xgx0QiJ+k*c_aAC7r}Uc1f8l!@LP=tKCcqYRgaRj}ZMo_+41PkR>^9b6sh@gwyk_jy%=-(=W$TzfR z>j*ZW8@?pmahINWyR2R+Z8bRatA}I2K z@*NvN`qvSJyA~>;C`OE4Z5zN~iLFS$a2FZ`| z>D~x-?~5S#O9XXflw=)I-;OG;Gm85}YdqDu&lF33l+v#h|KAA8nvAq4Y-DB;BZZ0@ zIbY1kSH+FYmLkzcn#LH}DWgjmnIX+%jdYUJQYKDgjFknf=1rS zG}1@Xvy2qTN_m=Xq)U#G4Iv}H%CNAJNfMcFq`qEiY>@?3jI5RSs~Y)K?n`!cBa7s- zTFOJ})i&~`91{EMM&{NvQmvVhW>U1dYL;_^QsqPQa{h>zw`CPe8FyfkMa~FOTGnqi^1&7(H^jY7&kNya?Y|t^sebR$b7Z&nagXxfYb0x* zk-A4!gJd5!^1a0Trhbd@qUw=rcZ~GBYh=wmBNgr&c_29t)ECKkWMt4|BVUO9iIMN* z@27eWJ=Z=IHZiY=iRF@9)Wq##CO(Na;fpa*MOMh;5+*$#O_Yr@F)Y!<=_C`EQ%$6& znW*bFk>W8?$Y-L7-^8k*iDp?QUP-5H6A3vcQe}!<$Td+f&qQnKSA7a!a1c2Q5tuY;9t78{NKXBJnK~ zyCkZui2?FaI}<;5F!7+1a(Gwybo8*WT z9dF|JEE7{_o47c~ME$uYI!K{~CSraxF-i_EGm*dC#Nrhu8m~0*%PJH0)h61kQQm7! zv{9Fw#B)j6qZ(!XUK5q}nFvbeFUs>*0GexatJ}P3?^UKT``BPdJGc&8WnZnU#u2nKKD%H$khnZGsX6k#*{3P%B%nX#j zBt2kewk(wiIcDnR>Nd}eA!H^_rdBmmzOmMkjZMrrnwqh;GSg3-ZQjlucsvMN%s> zlI_`%6v~ODl`N6_xskNXizFsLlHszyAd=k5k@%`c5?L*hdetL&LyFdjWUL&o8A;Vz zkr)~%w&XU9l(?+fr>v^v1IHptv6ivM?`XUWF*c}kxY~3Gb5QXE0U<$k(8DC zb0b;3A(H1CBe86XlCOQkHls$ijYMGJG2EfhE&Gc9bEv@8p~vUOZu3tRM>#X?rTg<7&sUKUvBR@p+hj)kdm@pTLJ>sq+dz`~A( z7AiNguv-c>v9PzLg%dLD4GR_9Sn$b0iFwmPtG9Gq_O!Q9zJrB#J6iaxvxRGt)T?^_u3frWh^S!mQpJ?Lw}+|NQu`JulB*BA>Qere$kc`VUmE!>`9VcR4N2fo)@ zixpQU%l;oMe6(5hO2JkOm3CYB`-+9$S1oL~W+C;u>XOf8)=dk|{#G8hw1>AXl##dO z`-c`vKT?k$tH*Lf{7qvUXZEBOPg`dOg$W%URv%|}|Xeqkj+M#{la zRzjn#G?wlX@r`nmNt3PIonj?#s_LJnJf-FgEA!>AnaXXJ75^M7pUAGcR_ybvw3qMa zTY0j;N~iCvELo^rzPFMtQ9)qoAh{{tbynuc8X3REO8*_oNlNUrGE|ax zsTMiBTYJ0T%GW2X+!FsOE8oi9b5`Cuul*Fu1uK1J#ufGBy5`9VDSN}p8A<(9eUpuU zS#jL7k}1pnwo>Z0=E>$eR>JqR2lurn|5!OBSL9zQ^uS8WBP-uYsV7zz%8+MPPCeIi z;Dz#kseS!VYha_N!NwptCs`3TJ~rAIEqA4x$;L{vjm}mZ^NZQA6}Qna+QwEnE_dXG zoQbiKS;EHPSR13{xO`@}u{X{}qXZi_Ub7J>ZDT+g8-L2_vNkG|v(dG@=E{&HtuN&& z+W1;#$|ZRtS^1^dNT_6EtQ=3ZQPp81!fRumjPThw;J1+%&^qGIwXwLK4NrX=A2qP) z`;m?Ijcja|h$hOrrN+Ktv|ivH)t<5DVA9Gsb6yU7aMQ?YU9Ly8zm2F z4`sF-KcqgKvawJu$=x$H^3U67ARql^V}tx6u@`Jqlnxhd{3sJI>G>k7rOxj*Cdtx2 zY&?;tu~AgBM^V3A6jSA(+{lf>pBKf)5-Nz|h-|15MdhkdIBP`liR`KwMW9v`i)u&F zv}F|iCAU=+);Dxta#}~>XcNUp;$INW$8vLhG#MMBIleKP!<(WhxjC95TcTMjdJ=O> zPHc~+?2c$={2a}gozYC$70sx<(G1-e%|XfeC7Ry*quDCoABg6`p=jnDji&PPXcnG` z=Ds*iMzi};G{t|9#(E{1rV_Xo&49n6S#~p;XY$M6(GrIwno_#xP5k9Z~%AiZ3hvjG^hR7-q}Rdz$wkh9VDR zxc4fC$wf-=hm@{Vf(CN7Y6&VFSJS zjnqqvWxqd`xIirTb7BeQ#&Rt$mXrCheA+ygU#0Zhv25xPOJv7b&dP!=vD}rn`ovPH zZ!AUn#o`?h%OLq(77SFZPZaCZSjG&AC1R+?%8#GN(rZ{On`QFwSW>@;rMKiyjHUJD zSiY00Q)0=R7Rv}}Ha(VyvtlWj9m`j9VljUkOC#wzPcl-?Z{@_HSk66+CHYY-3D0Ah_-`y1r6G2H6}!RCe50K% zW;?4T(_*K;)y_`w*z7ziYNv8BJL8JmDIRU7jg*VA>-DOgK9U=2XN29(QF%Si&S^=C zx3fx?meaUYJ9pCTdVOjq&uyn)H8G+BC51{f3>54Ryb<=E#aBcK&E#$JNqK-B!x)Z9Cm$Mo&96-?uYf zntfm=vA3OfWJ@1Amj~K$53M4xt)r`>@1fVqwHLlKgQVgA(LXu zv59uZ%(Zh$x-PIY;Cnk;f3Ra)VyDAWJC=2Jnn>@TwAMz&5$k3M^Mniep87953WiTKP0hd z97`oUFpe+e=x1@X92UnsX)r=-k5qoLN8TPC$71O>A&wp2#Zh>nVl0Vcz_K`Y$^6xE zG+qsfLmP|gZc~bkNYP}N27O8hLj--2W^pK@b;@JEm z4$I3py^e~fqcNUk5^Ij9T2wq=iN8=hn@YqJ85_?xuf@~8bUaICeVKT@PLJodJS!JZ zPK9`V4i(Roit%hsj>nb~PZe40j_0Ag?T=@0Fka_z;<+H_Lh%f!8qY3SQazr>wKcv@ zJT#8yRr7eA?~CVUn|R*u6wgN4(IuWXJ>pp?b3RZ$z2a#sqoieDj7ul;0lD@ZIqokyU%N#@={_h<~4Yus@#5((XV!a}UMyxAZ-%aYt2~ zd~qzE`6uGJBkNBp_NjOhPRG+o7N1wYzb>X|_1hY5TppZ3;ceG=#Go?wCYkCMI%cMj|;g_4u4b&M!(NWpN^(E=lCQHCjWQ>l5kqb0V9i#QsF)9Z2N1 zR6nH0#Bx|`N&JySI>>bS@^m7n<+aP2dsX9P`He)j|CvakzY>}7cOrEkCNf#dy-Z|e zR7s9WAA3ozCzr&RQj%BsB`H;{B%S3#>yjMrQIaw}OLBf^d1l=!Pt5c3yd}m$NeqZh zVwe2oOv2$y;v+d#C5d5Glc?V$iK#NDeG;4AO(L>O66Jd((NeyW9|k4yNG1$VqWKp| z%#~qdllXOf67~s-GfQ)3Cy^o6#Yr@k#ha7xZcAd2e7iG=?|w<*p8R?|iLPgoSR?JO zC(+pyHO=hZOmrLgF zq+~KHB;&4_taBH-F9Ti4gwvDR;Z5d+FPWPDWai79U@|x5P)0HR$uO_M42Ml#)Gb(>_WzLl)c z(voS_AsJV%WcrDFkdA+x%sN@|c`~=hDCaMe`FBDxpHER9QgfQ-&PZmg^qQGW|Jljx zl=L~t6j`Ep(qm;Z^R{Zfyt_M@G6$0BD&B+1)IFWdWa;x;GRc>c`9MxzP3Gqtn*V1q zk8UUP>QOSaA18C+scL(X%m(@AWir=IDfrAO6pu>5RVami(xP|@J)%=sFFRsVm=>GD zRq1Hg*n|`YOU05Y43}M{QYiLX3SCO4a5E)^j7pm8OyPm#r=@U1>ZPYJMdE^rlaoSv zZVFZNQ`l28h3Hx-Tx^;`pH?Ysm*sDzP`GOfEoE_Ujr}Brfs!&Ng#qKVo}^7qVc~Zv z+?OKjQW&)}g%dLL7v=S93L6fmU^@B zXDMuctrC{fmAI5uiDKE6s4r8cX}A)zrF)f1Y+Z@$g0^3jVCb=sT5k{$7vCiiedj+EQsCe?_N~mzc^3Sy&+zi$7JL@1^ot zlT>bYN+qLnDh=ODWzi?8JP`MH8n-l+`!aoNDkpcRQf^NwUmr_l?a5R)rN_^ua{gi} zDVI{2c`cQC*Hf8rBb7OF{m)cfH&dA*6aG%sbwR1rx}C~p>2XJ6@21jLK9ouSr0N`Y zDoY-u@{de^p32t$QZX4E^p+vAM~WI9G&4EaDJKd$_^gP7y+s{l7IUyJ!NIFU2R%wU zm|5Dvl`;;RmUWPltjAIuT#$+m2L~lK&A~9~;B#R2J4lvqdO-&*^Br`Nqyh(i zSs;H`cF?AZgWu~o^zYHZlGhz<5_eq(AJubkRW3Jm@IZcS=3tAYH+Rstg@fyIznz1K z_6|170m<*+V0cFdk7QR@2Pft0_Z-ZT=xz>Lb$95qZwJK(D4&6*k>CXa_${aPaR$2R$b_h?(JF#7xyZ%RzXygQs&G6nyL8*Let9d+oMH3v(NJ9zDc1D_0#f>X-nw1dY|=!}Ev7nS232W#)D|Mwi^ z%IQZAo;`OE^+G+76H@b~gR!r)x6;($WO{^?D5H}vqnsQsqt>C0iMJF>Hnj@W^PWsB9lJ0VH$LAzI$I08dPD)pH za-oKkinW|fl67^Qyn5Y9kGf9QHgM9ep_A_$X?$ZRvzj=$+SIA*9h`KPjk5L)Cofw& z>E6c4wKtu7{g#tcZ#!w<&Pl6oPUduXQmluQqrIFY^mg)vEbH%Nn+zD>WR#>1a&lvc zlc%!kGbcYwaHx|(pF8d9EuAs6M2wEIfA zf34idIZ2ig^6q49Dv29K^Z+Eh3hm(k%TKg9#4bN$9DS6(BQ~v(l$$=~CvrM_F zoFws@#$0!DM6OArTTa^CS05$iA19fzNbWvR9uJ*-B$u9PAOCeSQmXvtq_OOjC_@?p z#04fBs_%v+Yml9g#}mcFYrPo7G_nlzTnE=k{*#+%#KpB-tG_*rYo#Jy>Jdnk=n z(*1B6gXNB79M%3vozrQIJCjELb7@TZCyk2_()5}!jn^Kh(ea6DkmAqNX!#LLXmdV8evy0eB7sX>-v@D^=6J2DNa#2T&uem58!{tC} z7ojpPI+k`RYwmO2j#NVdEdp+&s`)8caba=N4V%V(#3hn80BK{Xcwd8fqeO;i&@fgtc!Q$ ztd#rO#gcI@YEN?U?PM3Lr27=jlRJ_z&Bg08T}=MY#f60~>VL2GmTGO8`J;=aQf8Tp zPRm`Kl!#U8p&XP8(r~rru5l5$RyF>l8rQ2vS+&u{vrR6BZE@9nPpP zXI&h-taWd>7=PP^;f{-;cU`32)1Jsc82|x=1%E z7B>g1Zc0SC`CPgdaV)7@nH+$@w$@{ixmj<6eRft&vFsTeGxGZD zZpPPjW2on*PXjl$hHe@)aZU(*UW@i^Sjt|_ruF1`m58YhsEq#=CKR4gV50XE?P19j+rVn=$HNs8%k#49>y16QszE^)2yY)G>dbiBY z^5t&Iu5eR*mGWKf=7qe!R{O9{wQhD3{?$zbvF>-1Afu(}K{xM6nL}}B&+{ZFYsV7co->%B0S_9J$!HWa3|8k+ZGQY zn}_;hiSiIHqvS{-50wjhC|txt)1n@BO8pp(mxK}?Qf0dQ5$mC`-NU3f59i}O)J^b^ zUdlt?*F0R89%VhODW@?>9=ccZusYR41&4=nX&&Bnd31fQhq&q<-m2l@pggbT(RnWq zD`i=I504sn=+w}|*Nr`#YT}`0QxEgs^lWuX;^=l88#wn-qT5pop_{PH% znKjwN)hQnC%YReVlW7_!?WTLUAdO~t*e}&*dYCC=XL&d=TleR9XggPR%h-7yI?VU5 zc!7t+?>r2WFJ$-+9u6$g9xPQ3QsYMtUoP`7O-e8K@XiYLYn}G&Cl51ZkS6pb z4~F9&N}Tl2`jm%XrOFu(w3d zEf2msT0?UF@i63phkNo$DnC@89q8wvsZ5T(}@YB^F}b8gk0T*)0vyEF$L-TS2>-URTZ;Zx?Z!UQ@x(%*H33^i*zov zOs8Qh<2!H7oij45TRQu@r<2zsonr5&)8d14 z_Q-ij>XnXja5}v{PUjE#a9BE}hNshEL^{W0<*0Nzk51>uF^c_FI=*q~d@JoIrL*W8 zQJWDmp)H%v?uJZg=UoT0=x-?za=&C;}()oR5ItA;}8Szs( zqqe5g<7hf-jw#M@jXAF|7t$$xHJ!Kbr1Ra~bnN%iIsGu5A&=Cz$LVA}QO!@)W2y37 zc}iKlbT)W7C0mSMOlB`1$-5RW%dB3?*t`Vf=b~Qv#(EhkRqS4Uukf-{qT;;_l(r?k zEG*?E?lmv_D|(4Z@iJ5fyEM-2WpTQfdtNW?d|nO&z4XuUvMtlAYqGtZlkz!U#>?O; z8edgwR`aq$npF3)tA>|eHI+*(#g>>liY<#8c)8n9c{cY_wyo-Dr#j?s8QR%Pk)B?f zy|4LlzL%Gz-paR+7w0F6_oiqpJIl8e*5B+vBnjr5xBW&Ip4sdF_(D$dgwdAPt!-a@agWARe$d#x$e z7JFGOg;#iKx>D=PU#q=%*Ls;N!#8+wZ`3|)@^V$a+3MxDZQ7F^UOc~e>GP|X;1TV^ zaW7w-@bXleob@v8oR`Pvy@W4#`B65?=a;K5Ccu@pY1q|72&fkElvM21-(@kL6AukJEg7=Jt{5^XVFUAD855u8)F{ zj!Ubsk2(21iWT@UR`sz~URLulvWAa}b$xWJ=i|KWZ|EbYv5%p0w26;|WepXBK9vT4`}pRTdUwai>vw%@lqru@*ApKjo~r*c z@41h^Uif(9r5^jw$3gsr4SqsKKlR08@)IwkBby{5+Rukl zGQm%pT$4xgZla%MCH<5s<)@&WpGFc@UgP9TIiBRFS_MD7()ER0&nk&+;ipYYKl`Oa zYrn2d^%Hzc$2$0V*3qxuv+?soFF*G`RJ`7Pnhf$YZLpt;pQ!FH{k%Qa&msAEqMu!p zH1``n=cN1;KjY=xRDC_&&(axwN-fbEOEq`7db8QjkS%_l>(QFK{M_5^XV6|hU;N_d z@UQB{em@T+_n_97ZSwe#pZ5>@`S-l?{moCzMb#|(|L`;LvY#DS{P?bF&1+iohSrzw z{`7O}FF$YI^wa8ZKOfxj^V3~FmG1dDbKg(d2a5ktJ$$MjKJ(M!xu3c({7iVMe!cQD z`CmU5{?lF)V4EpGWMqKxmHj8x!EL)Qk-<)*j%MjEWC%Bq2cM z!~nBO2k28Kz`JDwEGrkFO!)vWq-uo#21fvsE1=(r2oMzr@Iyv``v2k_!T~|1Q8$xh@e4mEZRPDl85#Q5H#w<*MOV z)v!OnS*dd{z_>#JI2_>PV*wf+576yIfcO8_ygLE9-wjZ3FF@=20ivG-X!SI}KH2bG zc^iW4H3lha4)Tdil;7l0WROTpknM6rs#=4LvIXf=Jjjn_f;=o6;Mu207n0NK*SC6Qp{_AYRd~ZMg4-@ z?H}Z&j2RGQrnDFsq_donvV(*C@Uhk$8l?Z{s!6I13+laBklj*vM35;XgILD|Y4~N3 zZSwf5AmMSUTQ*M!>UZCQ7$*hUA_t}5n;>)L#$?5vqGMBo#L6MLD2=8m=JX(z89{Pq z2Kj7Okoz)yc91{js9)cz*9(Js@2;3~Oj<1qa&D{E+!kctcICQ9x$F&+zAvcX6A9|` z9QF5*>ik3bU(p(JOcJlDCVB6Akd-%rg#HS$>p_r0kAft~mva1ZkhhiZb)=W z27BbJ+>&C>3|^D&Qpc6SICloKq^Bo?wdolodo!q%qx-oT_^N2Fsu{GZmcfIX84RzV zq3eh<2sO+gy-5arn`Y3pm2Rcn+Zj~us5RbEKAkgouSW*`#L_c^SeY$LWc>%qyLSe= zrE{MQGW%zcJ0OEU2W7BhLJAgRxR|X9mrsi;UTm!BolpB}2cT zp25BSs`XF?H|4}(_5OGUt50N5;baD0DLAdzGWU%3>}&=t&t*{aqSpLFbw_4W-kQl$ zTPB8*nba9jPHAwOmkwLFt}IUs4PGS%Nq`mD|*YfUC!tj%Q9PnoRUkV*SZ znH=7nN!_iPSa)RVm;6=BzD%0`n#q9unVdV9$+O=w8F)c4FDd`uGbw&Olkg4YAzN-| zl6_Y(?`87Z!%SX8WpSfW7Qtd!SfjHrmB^xLY!>nMEKZclVtUyu{wSA4 zh4ZH3O1axvyn82$l!saLsgTX)irG5fna!`BY@)r{d?xqvvdIo-vq*YX&t`p%Y*K4x zQ>$(^U)9T|Z-Z=>cgyB+ca86v&8UyFIr2$1l|Rj2d zJ)7@jqu6I;6FE!cXJ@lTj!Cx#+06ewo12TWX}vg`_a$n1HgT)6d24kx2j#Ln+LTTF z;cVVMlFcExA_Gt9>obabE}P*pL5}^NP2y$cC#(L+=GlX6jz7=V_m3P-dvd6ip2Kjt zEIqwBOqKe+9KBb|p|?y9=CCp&hrFyDYD>|A9KAQoA-Q@E?m9VyUe950-5k!<&*4O) z9Okvk;o4g{Y-yLnk`6h%)-{JIJ##qLD@UK{<>*@M9L9~%+9MTvYz~dS*70#Ud@>=2 z-4k=jn3Tio(pjob&SBJ)9G=NLOB8Qu4yAs~!7D@M=87DAt8(~OUhT`F`mZ{6RP(ND z-VNn@JBLY+b2$Gbhv~1BSK(Y-MRUn2mP?1&Tq?)q>NQcWUK8aq-|6E=S$feuBTy}hwi*;NsH)iMJnVZXO>9!)5RV#Dp^;53? zUy)p$3I>3IQdl`uZ_#&OZjYG9{c9!k-b3U7v?eadySFE6?xQOnMdKDwC?#l)?CTs z@YOtyUCSf!MxJ`9_5R9Z`OQ2wOV;0cd~z#~JF@Xk9)^2)6qRN2=zboZ{>kInvpg!l zP+VCr|GmuP{a4B_B192Wh>ztbONf81A$r;@M#1L7WsyU7j6P+Q9X(5JtLL5jB5%Pwp6x2Ey zAqGjw%nH1!X72QIV>mH(@SBMcGYMd1BAEM;|)i1+`Y2D#kcSMLaqcwj_h;Co1SL4*H z@ge?_Y7^9xi6NfL2h-Hw=^^^gRm}N{xj-?c(03sgEDf<|t@hz3?Sl+ouh<(Ddt->N zwuCsjHAIbVAzt4VV*Kt9hCLyM?GLg4K#1#yLp+g{M?&n7cE>_AI;nn2sZ$}+W@*9LPHVX54<1ib=(Jagd&BOdI8(W8Y>&-ClNt?IA z%zHb`a=FnijHg4G*)pnQm?Q6msoY8NJ1c${#h2aP!W8ZiCQ)`tq4&ci$UOP$gD{U} z(1&4u?j7c^4E-p~FMU*p^z0jEZND%deXQG|VP1Y7#x^XBSI$bg5vol_%h8cxs(cZq zfsB-x(P7>gqgZlETwf}`v0>uB4pUJk3gg1$$(M3`d|1z&FpcDmiDBkW3RC-H0TBtpeHOs=hSgt;<4HL0G zOfiYwq;3B~y+*d9CXs;fG^*bG5iagQ0r`ih%md|HUQa-t< z`8aFl)2miKe@Il_d>YrwXNR~N=F_`TK3C*$lYHWu040?KzPpiAch&d9|c1th;;z&BEJSOH^)7w}4sO(`I8S^=Zv$1Mds+*-hI z+Y2~;s(_Mb3aBJC&uaWRjhCqN1-Skyp!dxJhDheE0zST7z-=jVuYhLv3)m(34+rnw;KPh0QoT*Y|N{#oQKQ!pSb-GyXj#D@P_s?J3ia*_25d)m#QSfN5$a}>{+GjqyJtHX{f!b15X;d7zLQhHnIZFZ)2&IIbJw|y-i#lv<86c!AkckdxciH9T zfFjt2B3VLCawvSaFQvE_=1bd*c7oJkPBBD3jtEd-zihCiLdYAG-?J{2ILo@#o z-y*SJk{2U8;%8tkR{nn9|q)rE?SUrGo)+9Ss}&Frec=19s5PK?Ya{8<0`kKEwd!2pNVM zP>}Xe{}Ft9qyfE08Srkb_|4WE$9tP#049oo?D9zlT%^O3g=2~VU+C*p-sd!to!v!O zspBjIB4!(qd#(X%<{6M>z5zqENvw0B0r5)=2wrZ$y%h$GUCA|EBXY7+*BWq|_N_CZ z-FjZ1GHfv5oOYY7w?&u^7@(ZgvK}-*IjxzF@^Q*=TD(1Pfb#pM@V#Y#l8Nfk5Sp*8 zVJF=&V8%TIn%w7}q&yEe{)YwxJu%=E?SE!KotFmOeq+F*w+1Zv#5wpZ9UvG@_7J zo~>QVh$l3qv=O#4Mr@>zvPKN2VT~F?n-bVE9Ys5eO zjkq(A*Br#XHiZ9=Kh%gG)PA@TEk+vgoWe&Lad^BDStoFBDN}e)lx8ZgK`*EA&(n=) zJKKmCbBstg*N7%`b{@~M(1@5NMr2-TL@PSI%7`j!dHxMXoY-WUuO5GCHQ zEn-awk24`#yb0T>XGRltXBM-vnovC(&yigOrO<31R9Ad4F#cNja zYQj0x7P6_EiW#gjp}APhrnC^HTbZEjZzJ-zo*4K`uL5EE`v+F`t>;o=5+euPLpiesd(F(yQh}f?Tsr*gQuxTEKB=trnUvk0viNA;)49I@4bIL)Dj>(2w?! z&oUE?D>%kA91HE*B!07}HjBkuxX-q7FYYtp5iL1nLYpJpf9Lr&jl0afMLDl?t#6nR zd)tI=_e`kw#)QCMCIrD7?dhq}8$-Okaho#Pym3y;>gNr`$01y7;WVOuus8On6~i-l z!{6HSG%Z#`Z8#D9Rg3d72*WjkGb|s6rhRyfL22C5n3~-ca7q zl}y5v)f>v9JX#T!ij)`ct9nB@P+JUX!uz7^t@wCro{#=%==V+db zu8sFW?+HG*wcH0eR`?)!r4K?^`C!s|AGF&ne*Wu&BHMl7z1s(w4v3DoeXx$|-u1zZ z7h<8G84K*9Z#pxSskED3()0{wEOUz`9y2b{>`+lN%nW5ggc(P*%j}a#@rivCC3Z*i zoU|ZDtYgo{ireh(IAM)9qgjIJ!cIsO^Vsc4qFAyS%6aV$J1IrXXDekC^;u^o;bu>3 zH`rsDMTIP8DC@JC@g=(%5ji*q^sS&7{}eLAQP_;-be~ccF{3hFqTEHz*jJ2mL}N;b zne6?N;tkuslo^kyQ)$tkT~fvj@3LlW)ef=GsaZKQR+Ts7D;567j1N?{q8TfxNF_7o zX{*_9w5_rkC9ANsqM8{?tDE7eV@4Z#Ou6fd66{oZP37yEaflw(HzP{}GjcUFqiQ43 zh`mci8;eTpZ*n#2Alb@(~Py`8e+!&VP+VI zn~{2i87ZU8Xsz{NztgGFoU<`p!wF`zo5+1TnQJzcZ_{#mPp;`Als!XNW|>iCHpe)} z%#W+wlXK13GT#jU1!l}$Vn)m|&NbOrm{Df68H=}YowjnWx0x}XR?tHlyWI@K4l{!3 zJk8r@M#BSUbfX3b%{XwFYjV_#-n5&#ALAMy=epDWlV)7j9ezXx;=JDG-n+~FOu_fK&QzCr&?Z`c-;Bf5 z{sGsDzCGf7J?1=!eUhAdtPJDZQ1(|CGA>0gRiHq8g_Yl8*eMhiR? z?PI}QdO)Sk7JMRqs|6*gt<3^ohXo6q7QCRo0emdbg2`k}Wq~V=1C^!+xV$bu3s%e`$7I3sTh+VeDMW(9nW6jV$QX*n*TM z7SyAg+V`dwlxkzaht9&Qiv>yttuLF>m21#lRAV2}@E#U8dx|Q(EV!+u>%%qDUiRgA z`iTwwEyzAVv>0f?TkSWyYLEqm23v4ayT*Rjx(=~G2^%UhvC1OtBdatUX2B_~`)~`C z;o5grnL0wW9BF~ljU1!6o-~#YjI&_zc(H*!qt%i2x=a$o*;JFo9#%O? z&$LZbEKurA742B%o;GBf1(lUF{jGe5L~{#98*0)@G#z%D7b) z1g#di)>)twr^ebxR++V#ulFsY#Wo9+R69hDofar_HRCS6)~M)7?x|CvFMEx;o#s7h zJJ>pBxW}|#?1ZxxBwXMgx+s#_E|<9PE?ZFKss(qnm)9&%zER;PoOi9sOU}tFap*Po z`y26s?f+JIzqjCD?I3$koA<#2Wi=hwY@hgXg$n<);Ij6B{iDtL#krw>{}ag;UsUlG z4cUHLfYldD2(6^cl-cHs)D98B7SxWhN@ssDm{q=N#{zv}cZqat4($l5bW9}%vdSl| zLy#|&qN&BAU|%RD)A?eomMa6tti^=*qK)PZ^+i?98t#h<+M@_x#72s9tTH!BtYVL8 zWutwe7!!n(P162lmFn4iu_U|L$ez_|fAdu#H5-WYb`O8-Ky28?F+?HM+CFVsfOY} zBaVfpH4}^3{aVH5zEJAXxK^Ck*21R^=ay1y-P-y>xvD*4Gqm$X&i0}h`;u~X@I`1} z?wNjKG@HA>a17vewKMEXt@wq3oew2Yhk+pf9=}@`dBDFIG_LBffY;amTp!l>Rv9pRSVQ1lQ^$_v|UI z`DtH7+~n)^j=)`CxV3MrV!G#xum@uELtiNS$^QxG>?!x$GhbX+p8I0T3ttp_>5Kla z`ElosNMK#>L?}D+qc6^X;>VsZ{8;gguV3>2?u)uwE7thK7bAXg?7#Us|HJ2bS<%=a zIVxU=!V-HgyyA|>NR(PBuk?l+mwLSq>D4SD@ZE37f4$}*26fD}a z%c*2~E5F8Q#mWp;goRnLCS2@bD@Ishi4s92ozJnpU@B8NH!GHLVyw zPt01x<7hcmUCe#3#EO(&|F`wxTg7jvtp*UjGgzLFbe5bog`3@3o9C%x!vXr(MEqqNHnpJ_g}1Pw7Hy)I zt#~|@Y$K|&dD_}Ak+QV2VR;7|{!oREHvH;r!}TsU0Z0I>y3}+SZAvP4y%CRX!MLza}_Lm(ojN=+9Zm|iYY-mm^={02>%`wm^YBt7( z?bLpp4bvy^7_v;XVUKo-4VY|0CHkV3n`(nHa+;XV?w-!^&9GsCwvJ6Z%Z932V|L$c z8wSr26WNUOZ0Ml%V~@_~wHJugY@vlV4A91@F0x^lc7n~fgzKdpXR9rsoA2txhJ%#Y?D1U zEYdcxgZ6Swv{w6UPzvrBnGe{Yq&X-u9_Ct5ej0Oxb8teeJ86S*{FJ!Dwmi-2p5Z*4 z6?fT5=WM8V-iFN=Z1_v%FLFLF*${S_uK_B0h5M5RT(u$T8rP8KT<7CAY?wx$ZgT(K zvLWkT-sgQAq92GXY#o|FPbu3YzLp+yZ))wIaBiP+jp)!b?$hVo%hcwD4HaMVwfM@0 zBb4nm&r1d0*znI=8xGRRcibNzY?%GYhR;;wv#7{c`eMWUuQt4+qTfU%b|+>0&OJ`} zVM8pnqO%nGlOF?UKL!7?A;WK8kLJBQ-e^DB$UmG%GXAw;1Kp+d@WUa4AD$Wg zkk{mgF4`1tKPU~%qAj~PK%`3J2c>fu-=+uJTlRLicpKq|s7OCJqWn;YCR4s>z8&L- znc6b;PaLlkFBY;3lKhY@lOOhE5hvN4S^Y3oTg3j%?uQpS#8IY@C z_M?R#lo}nyR#qw4O*nh{@$*oAIHi^DigoOg+kV)1 z#}8%i`e8M_xaWtv_qo3w`Jw(}(e9NWW@t;b~e4&{;+L6`C+GaoGtv>4->WdY}zk=Xry&u zuTsKSk&9hQUp3P=t`Qy4F0tjl`(eJemQDV_xz>iWAF1F^Vf*C=B`wXMXWAFG%WvL` zc7-kRAD^QwW6S>GeA5$y9ZsViEom41G1-yR+l~?Rh^qM5v6Q}1ve}Mtl*MAl5PD7d zeeIY*F;M?xMuM$^>1b_C?J<70k1Yz6GNLZ*Ut)S&Ezcs}Y_*p7|#gOZEd@r8C3v!i=) zJ6=(m61+b$mgIHmKh0Xoj?C0m8_aGfW5;c}R?ZHu@^(a09jzsMoc34b`e{E{M`f|3 ziX8>3igN5&I!+y`aUH7Lv5H#Ouw#BrJMz}DV;zOowxeVnJ5Fn%b?q2N8|ZO8I|3Wp zv5&en;&W(2W3FWrI~q6TxSR97wY_Yrmb@l?Xk$loTRSdL-gcrCyM%7E=Nxt5T6g5U zbmAO!7PUrk&8az!ryrWnXpWx_5yo&2&{VocX~*(0I!-a;IBt4CdB=0Clx~6@zp3a% zJ7#Ii*|d}F7)-~fao(oeQJYLN?AT0(nReuv#n%jFn#c1~#rbwjqx+O&fhfw3q4^7W zuZ!$xu-J}zOE|8j+)K;saIN6ASK85Ll^xgVz-l|f*NPN2be$b@$hn@cDSAVZ8|)ZF z$H{*q_a8ObWJj*eT!$@oocfnz+s3hzc?Z{pI_~70@8URib1nAp9`@SNY(MwRA-=wj z^FCOC|ysp}jLc8hQH9q$`Ux&AO-8&q=R{SnsM-+TdM6t8z zf_9f(bD#6Cy=AjL;C`d?RPGt)OT%+s|Ah!+yINox;-f@q;wmz@g6KJlnFX1IMU(cL!`eI0rpBo?g7?-VO}x>wu>}?{ff;r5`kIpab!PIln_4 z=rPQJ$|D^3MY%^ikZla#H`al)<3tR*oczZ-kW7~+h^iAEP+n+@COM#do-C?O<^55o zX=3Sg2bA(N!~<68I#b-9&3l~VK=fP(!sa=!em?JOq3E*70mW;psB(yNLA#H0?M{d! z_QNGH@D}fz2HzEDL;RssixDw({Gnvk(sc2M5=nz-i*|tZbmcKxV>YClNMNtf@a|#? z+qj26mQ%-`q8}UDOC+&F$k(M;>icIxYo4cZ>IeLvBMt=3;OW{m@dlWj-! zhKTXQ{PC4)4)@3V5&lRVDRQwhNBd*_IDf1j&&MWlJ|_EP@ic!lpYD&NGyJh~me|VX zo$Zg;bN!KFo`_?c(Gdz*z-uq@M_Dp2^+(DIe>9@)+WwXPP|lEfHOI5oABWfZqr)bD z+@p=#{IPC3AK&GV$9w%zV!uC*9TL|M`$JiKL_9m?52e8c@#LyMlzz8FjR*cvay%DR z-}*y&_gVD$?hj?me`1!G6UuVBX%x>`yF;X7NBcWb!s)~&`lguzocz9BCzev(Kqn^A z^Yr2iJ0jGH#Z(~7i8+)U?!+kiMsp*aNFC`!nkXm6P^)Msro=gsHQtHn6pkgk6Pt7J z{W+buO?z`W5t+}4gwjrQF5^Vra!yqI$B819o#w7ryUr#5p^mAg+KqoE_77y4}L!F2p&W_?ejdr5t z7$*#4op>_NiK^qBXf%Q6n#B8@>_p&HCt8qeniDmrJCSjw6V0^F>}pD$%VV{V?67%G zWLhMa?c#mXW_m@Hc5}Y=I5C0FX$gCIEy_tlDgQn`cGwBi5z&NQrEO!M9(AJKagOVR z6JJg_k@<`h70!w}?9B5V;{_+)P>tJ848QM0n+HyqA3D*EdOqU&o^frSJF({lkALap z_nbR%;}z%gtrO4QIdSv@_v06_oK<>#7sJ`t)c%L)!`gm2`S}Sa9#irEoH$F<{)!*0 z(kCbYJG7&$C3OIfr3t|CU~z>#lP&-aLjuq;Gyv_x0uUV@fS2?nA^^K118_Ym0863+ zus${b%M${yKQREaG6!I8jsWb*8Gzim_`KW!xRoaWf%yV3Fh8$JOA7FMg#s|NZ~#J! z1YiU?iUnXD*@_3C0Ue^^B?BZyJb|%>ohIg3oOkhzzYo z9D9MooLdr zKz?l`5GSd_=|Frs!}FXC#G%W9ID9n_J+1|!-_1ZAC%;>P$a6aoEADVi_X08SQ6PMt z24d=qK-7C1h#7Q>#=Ya)?*noBuXw@!0~dn4#8_6DMJEg{bTqnf(d0scw+j!n^gb^1 zFuU+eb6Q+bu93l4__Ld7s?~+rsa$B2+Jz0&G_4EU(z%c-y$i$X9KFfl!Wy>=1wAe# zg}Trr%!PrG6veT`xbTsx#JaGZg5zB1KzHL^$dkZxrSKdXUHFj6g?X7>xJQXucr0C^ zJlR}WLJxDg&_9<8vAOveU7@%O%EmF8=$|1y^ww zM$$*BR)W{0p(R~-N2N-+Fq*<;m2u$=jVSBl_mR3#sGJK6sYZDh>=j%nU(v;% zO>$vv6<&kNRdu06Ef;Rob|GIK7k1ZmA-SFlr|C$27rHlaAxA?OGBxJdo4Rn8nlncI~AD6 zwWlxIxh0%uTDDG1+`#itmmT5@s~C5>P;WQaoZeHZJua-K$CP!i3zI0vK2eOFyWfQ} zhxi;?e%OV^N4ej$ktaCsl=-A+^veZh0i{cm>i>$fN)Ihda4P;gL{v|k3d*dEBBVwt zOm8Z#uzwGVm+w+RnekQp%f6>Lub}_?*A@h2n?p=?20?kJwTK9UvWz|!5T^?TK}jes zQpyHFnORBHs1XFEt=4Ho5R`w$iY$|Zpcs~j2AhKLbi3%WHwen`!$H`jePg>`5dpV@ zpuBn!gtRY3!&gCAqU~UnV_L>{K~UNkO8tKm`=mz2A)@H0)KF$lNR7jq@5I#n*#>cZ zX=*6(_r(=fsrE^%`jr~Wb8SzWG*EU0i#ci2KuKFmw5*#3N=U0Tc+xHnhIdVaw*Av! z?Xfg4o=pSqKWQ-C5R9JT!TfwzFe*g^V-fAkC5{#fM*8BxXiEi_1@r4j!TkSeQ7cVa zD5qn^wv@E|_>mSbvWuZ5(n6V8Q+Rr%g_7Ze2ZE$exUb_-6-7Bjh^k? z$l2MA1$2{wy0{TT^Qc2tH!AjUW3V=n{Y}k!@_s0^mm3?XN^dt#(uh88)a);su>PAyqN>6F!G@ggt(>bSBcWg znB~R;S~y#*XKT*kcqw=;-=`%mc4O)iv6#)W)Qw`x+~`5(6<*f_ z(T$Ot#dP*7x&P&U+U`bmttoqgO73xE(LOO_zZ*)H1L7R3v^gkz4srj`H>!8ojTXm5 zSN8V_5puze%31^VG8MTZ(%o`HDM(|rw&*T8ChM+Yr=i7lK^vLoljC2*Nsrpjqb-oaqt* zdpDkg8ubW4$(|wjN&9<;;BKD~yr$p%LNKy_2rL6aU>Xtv+wc&ij0oZPAcSDhMDd>W zpA>=&b3|6Qsn(Z0sHL780wr;wXvQ8|6oQOPL_T&H9iw0Lacu~^w}xQI_7I#t$$P&T z!k=XbK?7P&`EG__?!6FXdmn;1;hz8d%_`xMB89y|$uS-*iu0gfyx7hvL5bo7t6ZhI z6~rx88TXHv$11HViXLpUN*?T@-c>v>R`c+CD?Lc6?!kl_9*nK&!GCn879XqQK?m}x z>p@wXQO|?i4Lpcy=z*b;2brlg`84)m9l4r#P@2M<@;J)f%!A9#J*e42Y-7>VgZ%V? zyjpp%lrppyU0G$4_MKH0wh`-DYg-SB(p0*yy=5!3L2p-uyMF6um(^D~6&Hq?W(6ZmHuHih#!&4bPKl#b5ewPy0ZXw59%D^;KE zLHao!w4dvN|2z+#P|`vV!WQu{xY!Rvd^`MH+imjAXK9s*>h|j0b z)kEP`BNSaIU#(D-rXux1QLQbn(IFHU>2s%01a{$hs7SX^{@fbR*F6-jUVMJQ2rc4C{|I? z=b`98ueBU6LZK|yHn3hVLver_z6wQw*P+-#-`|8H+gr{JeWyR~h4CZrk6vhPzlB2C zr(I-~D&Iwh-&_}J@JF;`m1}>+9E3qxWDpxzC5uTMVU-7dBFsMwO2a5p@oSLAiBKOuP_=*h|85B@7R>K3BtVRcmvN z$6Ob^pNC=18!`A@82_#ih8BOqkj)VOe}&nL+7x3rR%^G|KUx-3IQnYg-r*?bBVx?q zP?9X-E!*2S923dU8jjNRAK7i;*hn#cq7ADY(q6Dn?IP3>&M$NEdj8>nQv|Wfg8=cC ztq>TFO+n$<7Z%RXorU8HjmQ*^8I(6O?@4=|B^*kttfD*HFk3iAW)H_r?HRizmpH&S zFA$Cw1;tl(c_Cpc91bOrM$u!cT_ham$yrq7W|gMeNmluf(iRKn_dAOTtn#L~xKtt> z%6&>xG8}noh_39#n&G%nOFU)68;4_F({TK4#x-ioF|`jzi(z6BtNa}vjzJ^DbXF-b zQdD94(6CYA@EXfGofHn=`JxEBU_m&)_AJ)0?nU8PxHufUR)%Bts&KSk&ADF7>#Yk% zz(&3P#t-7kxctm3#TCbG&h&2f$Ir}Wf>n%@>nS*6Au(SlXp zQki?hvDe?jOTh0j!Cb$Mz6z>{T=t;`)~w*499-z^f?@LzjCdp z0U|KKD*`q{1cp;}V+3ZJB9Pe}!5?Gg`}`vCk39k(s77)Gu2Y9X5x7FWB}92vS)lD> zQBrhZmA*8*R0MxdN(A1Nj^OVMia@){q93cQt0H!@?W#q?Z26E4z!WY=<7=Ush?|Q=Dge^@_k!Z4>*1qI!!g z>|9Fj69HG>2u!EjRK6d_s$FB1jRQo*VG&RoO^QILsSy}S1!qR^cb|x~vm&saeo(>L z5jaAYIT480ny|`&xgubG1e6d;y&wW5Rz~0|tyvYp@1+oijS*1lZxU5EM?h&r!<4NN zh}{-}3A?zi`yvp$KLX8;i=pfVt;mT8C?{#p$q2mCzOyY(aopNbcJk>6e5I*pBH({E z0`uuU^*Sdmu=&q(p0sJ~Yt3?j_e|L?iC(O-MC*5%$I*TIp>4Pt0p+0QS z+|gFujDYf3D|9;oO5$CSi)}@NA4Xu?;|M%@5`m!S90$d|imNSUjtdh$ZiOaOwB)+kVw|684 z(KsKzP2J6rXm5!Gd?WEx`^@&Yiix&JDDyOnUnDwf1KGTGj>$g~-zmWvi6PoVR&fSI z;!2=+!YWlnr+C5fT3N6+)ghxWzL*5aQm_;d(91lI$ zrbO`=TA~F-M?#69$@GH$jfq5#Sl$Dbi;ILUp2uhl*(S-6XqFO*>KP-^H&Y}!X68I) zjpX+k^Ex>q(KvS`uI7zIo_vv*kv|fjwFLztp={7@6pX}I?Ny;jSPSzpdO;_PMB;j} zNTe+u2~(L!)Th&wt865e(NC&Yj&nqv8%N?`w@7sD&b`w!5;uBBqT--P3>eB|M@C}W z*hn-TABmFFBJpY_pR+m=OKJF8j&WZk^55e1-bP|!L==A46*cNbL1{+6=y3fgv}_QC zk7Q~Xg^XGQR@tD1G>U>USKGlV{*9y1M*GGpAx)xCO?${H*_(=29iyN`brOR*M?tC9 zMHCty1*JD#AHgw<5^dSJbcG7f5Cd2x%S=&(RZdX!>?pYBhy->5-I^PP67!-kf)3H{ zh2kXJeNhwwmqhVr#-p%uMHJpq%=#z{{#Wc_m2}%gn(a|gBB>;u*~z)u6@|&Wqwso9 z6teB*eNo;6QJ6}D4o6`>bw0xLQOr@^4}GAn$2n%Yby9?$isHXdqcB#x!bYAJ6ImtX zOcaJt>dT@Ss|?h(u*yp<-4%|TN^8AXWs4SYEegs#?KK;DJqnL+L}9_rDAc~i@!l5K zSS9OS;d?I%%Ejlx??n`pmM?|-71x2{sUa139fj?0#aC8Y`A+O$l~wP>wieM)K4|4z zMMH^fEi$oN2a5NsQf{z_8xjpAJ2j{8!=h1ncr^Bp6hB#|`e>0nCK^f}+DZk+M&lFx z9v6-FK3ipE~5J5|hPmGaX>Jyv{G=b9J6faq& z;;m?0(kk4JMn7`j5#3lN?5zb{U+iq8Yl_#wwaPqkmHGUJh0%AO(j zW6r~~X#N~~70a(^O>G4M5t)NB@03=G~ectTapG02ogv}Tp#!QxB07$}DHG3ZE18Dh{YL~Li3)*jKD zRlGuDP%kV7GsDGl_6wbhj=}y|UNbHR)_kHUt1Qef>J{Lz)S8wT77th@e^Fs876T=i zy3;J|BY} zRQodLoXTE_K^?-?7<8iyH#sj9bDP(AA`Y<1nbfiWXH1CY?|g_wt_NZz`d&!I>eF&MNk6pqUt^&dzlln$@=?q3 zJr>Gv?J}#B|0yQ1O4KiL`41nbJc#?hi>%`9B?hv}S#7f+4$33VV~pePaf(AVZ3L^F z(Sl8JP->J<;2j60kk)}!mS{Iv#o{A!u}UXxDXU!7?B+Nq`L(vJGEY0pDkh7_ z!z%5yrL1yA^YM*?l27Z+Dyy~Itm3qaf~?X(TgNI5ZK5NqeABAfNtd_6B*e_^d(fJgvCJ_6E3Dl#6f8iCpxmzvkO;_I4I?`RXO9J49q3Qv4^N#-Z%`U z%=zN*j#B04y%i9t3&ug|Tu8(ej)RhwS{D;5S*1>K(S}t%Y86VxLCIH2oGHtFLWQ=8 z{;ZODyC}>m$F-=PaZpn45ks!UL3w#!lzJ8iWw@66c^s6|n*WP9C~m6uG7dj!)hq6` zH*u)+mizV{&!a`YkApJsgUI$V4oYD4Qj1=!SDJXd zrqJMcjG&(B;`#d=d3^eK)Xc!+Jfb(NTn~*$?J&`SRV?8mh%HY`=n@r-ibv__czzyO z_+^QQ(lV=v&K3_P3)QER+2heCkJ!m7ZS#u0tYXY38sv{hVgZqx-9|sDcfoj^C?1bJ zWyLR6SyxW%WtGn5g`;*nl(O1iR`IVRrn1V%x?)~E&LP!oAttl$TgLP2uwoN?mFmwB zGuf{*io8cUe5nZx?siX?w(FRvErmOlKAMKGAD`Je24I;^66cC^#cF zv&tc@$Jux&!zk5x-YcD@qZhb7mw2DI;_>7j-*-PA;~sDyKH8J!$r-Rzf=maP)wVE+}J~gL{u?eUepMb!G1bn1ci3wP&ZD7w(!z8hmRd!L~ z=b;v>=bC zjoO?-yf*z;SmZB~0Hts-v65BlloD@PS>?Ufur}wMF3=;&T1S*+ zl}2^NHCD0J<9ydo!19I(@M@F*YwHBO)@ruldQ*`OVj!zz?I?<}%1JGza{`o9T}0!7 zTxXiA{T!44<-ri~mMuFr0ky{`Aj6~t)SALMnI`f~Pk{1P`@80+hDL#cEcmcS5vd zm2@Y??X%q9lQiRTlbG`lL6uuAo7qB*O)q0%=J(B`J-^j`v$HJa~V?swX& zonn6(68|rkF_E8NPQ+{NH>(UXiF@9OQ0DrG)ofOCBAmXWJgazFMF6Wz*FM`4p`7p& zeF77qY}H(;5}};e?yxP>B%)ogSivgZ>BLS}IYyspN@OA|(V{r3{Lp-35}}Nz*RhGX z6E9w|Q*tNb8V$^oh)?8OoY$ctB@&TPG7)piB%)y1MC`4Ui0G<`{Jn9BNLxJ-4{9Z1 zb{)=LgG6L*orw8lZIg%`Z8;C^6EUenBEJtd5$U@nVmX<+Ct?g8>6wT;y%MpC()Uip zl>v!(Lj?yVqVix~n~Drc#CK{nG?D*JnnaWynTQvo6ES*RBELT}5!WXqqRF&GWSF0b z9t#r@yC@OG4v7A&a{HiIb%@uZZS;(e92dqDiBPs`M_Hxp$waI?m5BYP#aTA)Od_7p z)5|>9l|+PHP2|@lIR?sjPmE!e6LkK5BK|%QxgK&~(X>aR(&I!Z^=S-+JrlKAW&3k6 z{{`oi*3gHaqS!CqBUPddzeP1x+5Ddv@h1_=RI-?p{;x2r9I=RtY+tJwYEObPiM)fw zSXObQ6?NFx>5?!#eG;C9h%iqQlzyQicUTgX64aWqhbQ4K&5jZ`SY=GKn8PZyVnmZ1 zNl>Jk@bZU}>olQmOK1op4YSw;9Q1)r3S#$p+ET@|zM5>WVP&$qh?$Jq5;%VS) zv5QrL=ZY(=@{rQcOTv_eNl3FO34@mL{WNYx67H-_!pc?R5vvqjBVM!056ZeW2@7b~ zwj};riR(ot$+aU14e86yB+S^wd)=LcF0_%-?MXt}y=foM4qcr^Ogn2|Sa8_Gfu-=R_Pkh&-2)(19{vdO8EdIQU@|&T zDpxW_(K9-qIvI{M$v8k4sB3UCUeScK$@mePjE-SECN3Gj$P%B7*xJb$LV4;XV?1?e zoQ$jVzC|*MwoJx%s@f_UXq}8IRJ=3KM{9c|V^B{XKQ$RcDQQ+RT2sjEWF*r?Dmf<^ z!zkC>WR#+;^Ek$Z$w*j~jC@pu0+%G?&r*(iSu*a^kmVfLs$?u(lZ?{qlhN}KpK~}F z-Kf`*WOyCrJkalB$>?`H8KWutiDaxf$>UEY!*hoBc0L(VcX-}=$*|o|##XBTAQ>?a zldJEafcBV<@Ib3fk06LG#)v{BO3U@OR&*U>Ietmjd)oK{aYjjy@?U-o6f~hUvr2ya71(O4GEFLMpUH+Y~lzxDMAbY`AN2*I|RfaF;Qh;r8JScl+*# z=iRRBcm3Bk$vN+P-UeusbLwZZU~v`;@@2K)JNlcle{I3w>=yLOZNcU6&&AET=ESN}hsZM*&O9zgnlZAgLw_tWZ z3x6NVZBqL&oWrr)2Gt+OeVlIL`_U|jrwlVKc$;FukvSGzq%m_Xc(s7@z0iX5)OV2u zC6-w5lF}`;@ICLGgVh#fS#N>s0PjaHspTP#iSD1~T%5Du6D>P$LEs+?4qxH?Ubi6E zD+}6C4=VoJg74p0aQdwUk3U%Or-Z^c}yQ`(B*lu*HnDwVAWr3dt* z#fsThE264c@pBC;?m4XJQ=5+;VZ{ZyLlfLqyz*F))@wx`>O-x4R{ZL>;x09gwjy1u zmDeia=joezRy3ePaaLSR;I`{?43wq;Z`06EO zk(RdQW4GgDcd(*TXKsr=cClh+H!H96X+@i#tUTWZ=Y%>?{$3nsZ!2>4<>L(G?H$Kl6S=tav!wisTViw4=NuImTbDSTM?p8>6kbKh}z4>Tn z?K(d8dMlzg@@t!{7`n}hE8DHS4g}|Yw-qsatmwR#$7dgp*#RpG9_BGT!pA(u<9pnS zGAFI@pXOYh;TXC@2ci(3LP^pu&#Uj zoUxLPxo<@m`imS7tT=1DWS2iwmPg#*f35hRF*;Qc-=`bIpI@pNR_vg3X@htUJT){& z5X4j?HfIn-Gvg$iFINzT8P$peLAVVR4dS_2f{@)9#EJvORQ2LP{QGGT#+Os`S&>*? zwPVF)qeR6ZhzUl&DnSrq3~$vSh=#@?R(xGu^=HNC5S7A;hP72|R{UcWaRxz*G0J*_ zAUgU~U-p*qk`-$r)ecsStE1kqF26d;iaW;6s33^;(dyTjAc)(>ta?EZIpcy5FgCDh z<5fRaTsOiKf*>l@S9@8Jp`nUw6a=xsDAYIzqMMPk3AaVn64jojK@g{!sZHMpL8P=$ z1Ah#HD9}a?ZOe5-L)xhWtVn3DeqqJGMq~%>58XFrcMRh1FS$>hm4g-MjbFQPerPVa zx~erl1>r;QAoS`JglPkU(0L%&6s@7NRB%ubD*nv1N!_U85Uzo#>M@&oS`dCPI6yQ z##UB5HOf7$3DMk`#fno#=4Uk_LXGaMSZO?9MXBd1i4~KLW2{K?Le*kLXJaudt{eGY z)`W;RtTk&v*lVdqj#>~&->X6gYC$}&X#1i}B^yLzVyh#^LeHZ};4@qiVx+p3GK7}HLrup+Fzdc%t99n?KmyfrpNB+91-5Qkz(@->5s<#-EAWuxyNKIo1YobCD{%*oNLqZ0NdF z4P^IG`DHfD*{uFyMfE>ut8%eBsPi@(GVSCsq&1X!mkqae+fZwd4VP%*UK>L9alIT? zg^t)DjvH55(c-AueawbF$JGe-gbV+N+hb*dkRy)MRZ0gUi?GT44D7zio zbK2p}rv|g)YJRn?fSuQav*QqTDQL$$nrc-iSW&5pdd><|wc}$g6>GCYG^nk{v*O=S zwa#gW*g+3zfLonn#ocHX9>Z}_EKQ=jbUapNs%M928K;8d?YtH*_oIojv0`eXN=mXr zw4w3zC|Q+mYKIuoOgX=|Lqt&@x=WrP?AXx4j(RQaXxLg!V8!Df)yg(@h%I!Der~7! zWJQ4v>Io}8Qn8NQ7kWmiy7BWgx0kxWiW+@X?!I=2;^d<({dgSu^M1osZB{%pQjf6n z+TeB!r~i%QT#ZsKR@fot7#~)0z0iPFY7#5btycDpc8KnDa+4kNH>)-5DN5PNb-2gQ zb4A!uXP+IJ58BcHkR1n)+2J~AN8M9)TtCfqc8<5DxBu8N?Sh@JeY2z4Mc)3h9e>}j z?5yoUPkBnE$Q{=J|+%QM^MihWr$aMm@MM zL)8*iq#dqyv*I|tqTfew+arVdy3SyHH&rFGV%sz|dU`O#4BAe+W~nfBL&y6%Uf+0p2w{LRnG~t#Cc@zxM*Qoq&FwaRD zjM~ONRuq4tuCXG|XBE#1UeWH0ysVgQyi4VPSe#mwOYeYaZ4}JlfGBVL#%9ap;H6m9 z1NQ684qVQzUgmZ{RL~!ESN+0IHdMXyFl39_njw;TIrA9hGw@tqpsp~l) zf{p2M4xZ=Bfv9-ZgdIff64Y{5B-K~#S@E1=8gechsf_I$5Put)+dKH)cL!Q^P=z`= zAj(oSSv#qYtSH`D1+ii?**bRQ!xa^s5iZ$CY3`l+M;H#+v%<~gx72g z!B%5*6@Hy&8{VoR{C9f@>XX$LfMYs{qisnW)RtzyF zv0|aIffY|_XzdUbbcXQ#DV{yCKZMs$4?*Qg+{f73 zn4KjQCB}tf%lJ@4PYmTbVM5VoN+@zn3&oP@p>WI$#i?1LXq^&@&vQaCWnL&ME(pcW z!cH_O;>5p2oxEnen)#g*tLR1p0PtzOC!zemL=vR>nIKmf%DR z4R7qke(Kf4i4jyg(TV)cxedzP!ifTOoz}H;B7J)&(stl|=_RG>$Zb)PPEI6I_RdZe zrM+b9;^e=%ooLb9i7m9UkCQ*MbMm#tPFM#!5kl98@xH^II7v5X*$5~9EOMgRC@21; z!}MT`6Ai~Y(RZ2?_vyP?P7I_@VvS3dSP z3eBMAu$GJ}kriEy>Fn78VK`M-`MwQ<=xAgq5(ZJk@UveO4Z|baQA+)f6)~mNt1@8_ z?aHbNtT<+P%5ltenw}fqT6i1!OxLa4W|c5rw>=E~X?0ERAEmAphN@J-uIjO;Ypc-E zFwCJN6zL4ZetJyZ!opC_r5duk!qpviTtpZ;xWiD=tE{XeUj4w{Y^X|141=&x@=Vo^ z9lk(KW{do$DzJ?=hoRP%Fkpwu%3eJZhRes4)0<&g`wVQ&hce6ffb*O>{r4dZ2!5+wMECTsh6xMbX|q8BF4DFio!R-P>uXFnXXXk zn_-BhQPlPpk1ehHpZbS=N||nlp%jJFSmVjPFo-<&xdtfb167h0k@O2Kc&I8p3WL~W zTw}%Br>f*L-jAY;W-r1Z?it^_41*Z_MlEH;PjFJGQ(F)hoEL#jsR#!Edyv>w&VLRn=KB-`K#4EB`s?LjUtFoc%|AU?Z-m zw(MZqa8q4iAKpMQlJU^qmHLaI%XaEM7pRE2PeZib_BI7BPsYEU@OzZ#BARaBr_IK*&cQY}6fZ8y?8 z!XYfiozQTI98R_06AtmjC=eYE5o%0h#ctzeY&b;0da5fcW*fBkS{9#zzghMniQnwF>s9+rH5)P5ErwU?4;r`0Sihl>H ze1pOvGXA0}vEukJ^_CU3UsY39Y&LGNqR#)=unURF#TuePuv#{^|(MVm=#94oR< zRyJ0Yp050?SY#Y$MfzE)0xPbksITUPLyTCc*03VOB4uU8lqG5#D_SjA<5@9ht=h+m z!oMjGD-Ntzhc|{pWV)d$v+mof9V=cK>F;o#$?~7O;rN>z_rm%6S(W=?INzHVjwI?% zi|9|v{#xy0MZ_CbFD^G8i-`Dc}i-<=;aL|}eimA_B~grC~dC|XM==@sQJ z9D!hJLVal_{XrLqF9bmuilJ^ajds&RYF=KAVMT*VY7i^lR#hdcML=Y$scN#~sY4YE ziGXPDQ8&F25N#q=M7;=zj>hE15fEP`stHLE5Z@-N#Z4n1V!u~un@2!YGM2WBfGFNU zt?L*8;q0uocZuM6^CEEgC-sCCEqbV)teF3wo)HM^6@k;eRoy-j5aW#VtSHr2)n(5Z zH`vwvBJhm2YGA`MIdk_g73pui;qX(oH6HA1jIhNM0rnh zU6JFg`hoq2GM`fqFLKRL&Px#}OXn~1W2$nUYtEQ(gU69JQ;wTlQ+HL!(+G&>bm*CS z%wB$}(!Ao=$@yBfVlPwSw_LZzj#O@l%-NNNjmWLqvf_F^^_msM@*4%**hRMsx-q-3 zy3Bs@tsDJ{xOqJ(RhAXIXpT?)#)^yoiFBh+9XB$>xUn~Z`_NELW5qej*i=y)Y4$-Um7}v87rH5QcSE!@`mnRDY`* z!;HNbIpdYTN?yQ*epQ~=vzQ)^7%1yPG&3Q`|VJrTR^K+Z~en*wM z?}qsCk$TIveC+1A`_$7XoSUco|7UJqbI^_ZRN#dhHH`XfkCz-P6?w(|H=3|xDEk{8 zS1S3|jd*HDLuj7S{GA(OxN+!%8zN_V&lh!A(a;FX;Nk24J@}MG`AT^p8c; z)&r5foZ401196=CRZzt%dLZnT)DNs!Us)YuMU+L&vU(tP2C2KO$XeBd->6hI58~T4~j&1kjv}A&pr>YUEsm$x@sFMe)p@2(H@Al#wJ!Q zj8%bp9*D2vR5^Af9Ww5+&Eh@iM#rdp0{6*i#U7=5M#lQw2P)RUgAgN$y+m(~A`Lxo z8?zd5PH3x9r?CgEjM3}{I@?5zPV(@ztejiAMT-JzFDt^6J!onSWmnQJdeTho{DJdM zR}D*Z?mOKzTD0`w0hMdzL1Wryv}w&T(T_iRP^OIsAG@j2-97l?Cl3x#?H+2xFCH8j z?!mCp9=<-^gW1zOn6%S_9lJRvdpuZt*n=r&IHt4Q#(57)T;lP+>_N6`oLd@pgX@g` zy6r*#%w8PK=H>aXy(s>j7i%nD#D{oct?lJ&=DhHPdU2O#IlV}5c~L0bi^zsvxEgs; zwuKk>I(zYo7Ig6r}kFE}9p6=>+{cPGy_sg(zr@VDrr2xT)z(&I9F}<>j9@9P@0ojP0DlanIp>7xH#X zRC~7eQZG_1_u?bDS9tOLO4W(Iv|1fq>xEdlN%i{O3o+EFw#^IiKf}L+W1#6qhMiuB z>bq4qD^?hp_Hh2F26ZrYvu6lwc zn){OXr8`FAE3Q$RW!z^)yVvSZR($io2=R{xm*_bZLDkW#muigBWFOPVa;0o&qW+orRJR@6XAH+|_HC7~ir4F*9N)|PT6Qs1iI zS<$43%2d<`an*<`?t@rrJY~hf5^7mV?jIdC!b|%gHkVP0%lRPkSkxM;kFSUH!CO;( zU&{xv*Vq*9a)oRPd=WtaxPjBRRjc(#TSW$A#J(f3ae1U1jn6 zAd;h1qZl8=bE8f@A4FoDI?symcr}?7ITKVYE1nul8u%b=4b@Fn>}{l0Hs-!kohGVc zq7Nc#lIq8bhsNP#&NV$Z@;Bvrr&mV3WD` ziqXbeR-7`Pu_8xHRh1PDjFGI^ZFpR0ki#blPd0?a1#p`nD6lSLm#fs*4YzE=@Ory80jrcT*c#k-EDNc`4F3 z#|l?}HGvgF2B_<7&Y#sORs{W`I*#Carq{-zk$iq2@2_eJEAAQPNBJN+85dYFXta9G zinU`@zp-31G~c+)Vw?|`jr;7D@jmRD=;O~xxh^Mj{ZPFrJ{+K$Q~5nJjq6}Kp9^Pk zo>P3ho+pnf6`8~5&$&KKoae*W^L+?0>af$7@pH@hd`PEOaICAi*6HwSAG)mJ^Uzu~ zgdO&q52va1Iv>tZxAk0)8+q(D@ws@j8o9-Xe1G^bd>iNEPi~(&ZTIndjNE@ZO?Rl? z4(`()j%BY8z4oc0Y`^_Jlsm}ha$0+3MLM^}#ckp8Ipl@)1^`OyD3$3=gf;-4?H z@U#zKo#A>t$Nj(HL$!-OzP`|hOP6?DFZ=M_6@CxXC;I)Wx_XVzH8(gsNt;m%Si3zoKZESH7gbwcUe)yry8+hqVYE?a!0DhtQc+VVZ}$o zRwojov$2{LH;sICBl-S-NYpWguwuXQo)tCysw*pgH$Jh#7NvTyV!iQ@6=kDU3s$5U z7g+I4jEZK(C}Te>QpGAeE4mmF05E+TxCVU`l>!F#u)op@z$_3h=gcu%wfeTBWpvhd-58CS+T`< z&WcKnR6ACzFz&IUWMkEc6=RLPtaxQuns9%pm9dBww~XS6oJUGBrn2IsktHb-!e#Vi z#VX@AD~beEBUVf_{$fS0Wc9E`Bz&DBQFtUj&guW6Wn(|YLZd+wKSV3z5gVE02LkGD zOFu-ZR_Y&C+%r11_Cp-~(a+b@s~sKv5N*1ud42p4SB(jM{SfnwGX4Azzw}q52lye* z{h}PB{SZ0Es1~f~LhGsMSU)Dxek1KTKg93G0ap0OtK}2?5CbNv(d-HONHr(>ab~I? zmT7);ovD6fMe|vz8!O&XgA_jI9F?@i4>8k-`oj+qFmAEJxlNV+(+~0QK~>?9AL6R< zm=)a*tCL6k5JQiuN$h!g^OvfA+z)Zjc*}|bf2&I;{1D?#sucDH;f%7eV(M8Hcg_#d zl;)i0IR5dYzy*$-4qW!5*)=tj6>qNdc->I9*y=ZVT%M{EtQhi4O=3lX=c>mGKRUcr zec7I``1Ln_^m^;ZzE8YO+NduYvf`_Bsvs-o(WmrLD3?*yD-#8gwyf$_J_=%;(V{{W zM0evoD;idc!bRf=D}Ju5GS-ZOa2sz~k*Ss%%Zi6K^@lx*=hBP9QGUc(3b$g^Gq!eY6gDSBA*`jE+#w3$snN7Y z6vPH&WUnZQqrKJ0zWkW37!TO5`*DB!E6ac=h?~Z9R`ePeg|maAFnF*UKOqX@xG{Jl zKTi{ke3POex=)Tmu_6y;Mz)(#5R;6jw>WRK_jtO&)5|l4Y9?kLS4}i_rujEcQnKjk2>d#hM4D5 zS6MM3Qq5;YnL5$gK7aQ${vcw(8JLPKcaG6jfRLeQeTUP$Z1St#mnnz-VKh84%|`c?nXmwHV(2P z>YiG0KN_OJ1GVchk1KsP);)=a*ll>9Mnf!mredFSoHXK%I>3tFZ`DXvWPhjHzmJB< z|3S4+6$7!t2&9gI=wQ5HMQmF2kriL1i{UvvVlXRx49aDSL7L1l$ev9V{5l4rKJB8g z>@mocBL+{XRvum{J#P%=&|<`XQ6W_`u4?yzT;#NykHstvngYb-q5REO=c z5T1jo&-qx0@@49MvA1D8i0wb9k}c{%WbdvVOY1?j+@l7wqT?Y|^h7;~`^NB-_0aX4 zddUiV_P8%v=8S_VQBQ6CJ`Q46^Em8o5r>Iw)KONv?y9nMi-VYM1b&Kxi0P#o_l<+- zZM^9h2eG%mN*EOf@qDbhG&v5U%oK&Gaj0*cW1G%U;q&7lQZ0zX(-qvet?Dr=PHaE9a3oh+3!PkmsB# z$BK2A)X$gWF!`F=z^=Hip5Ea8)0mfP*4sFUhP`#9wMprY96#+Y>R5c9rLH`w2@ zsJ6}HA&wjGSaEi#8oQjOrz_&oW~JK3=35(&xOMToE>%2g{H`{!NA@Vk-gqR@m3^xE z{&|K0n#Lx!LvFR06}j^!AVBLVbG`)h zFxq{a0MWj90{kTs(65vl6q|tVU6glJ0>s7zYVCmph&?pukXn3{+o7PFDh2f+nxs;_ zSn;m9%HXRHdmEK+TYZSE-z0vquw^2|zIJMGr$jvOo`@E`67d)P)F%}b& z$paI4&ecR%N3%3@Tq25(PehGLiI_b(5#iGkc@D2ctelyM|IJFoy-j?a-xG0sOCtXG zBN3VZOoWq0??}Xsor&mqAQ1&mC*s@U)BBA{sI(~wgJ~>X zq&&YTA&TZx#w|(6O_AG@u$UU|Ou`E)dOQh#(f!LwXnQ3I;V=0ZRP7bVNcU*;+az44 zckhzW^nDUKrU_sbHBB2pC(4yBfJ^BED3Bq5V|1A&W(*)GQvf?CAqziGFA4?_TPT14 z{Y9Az2jHR@nnmX*`?moUrsU!QoGBfEwM+oZ%Lh=eVu07!2;fIo0JUNRxLS|5i3^~5 zW8RmL9KZ+~(kp=Tw6AvnY5D}PiS|?9z5x{M7eFJ*(m#Mgbb-qJ5pW|D=+t4YRu`q!8D+8EBo>c)fpzl@(kbXk|RW}E)ZM%v+$a$l7w1~Pq zRGxy#5H*XbllEkYa>1%cR5E|omyE>bs#S|*h=r6eTrFd_(FY^bh-5fuq%n<6KQb8~ zjXJ+3qq}jMT|bK38m;b*OGfbcWHhJoltQqKeuow<@8oe>nUra`| zOUY<_IT`1jS*J#HeD@+1fVJOz;E4(KzdPGc<+Yu-6&SOrd&xC7qRy5{^LohP>yzSU UtUOlz?2x>v{<~kA|L$P=f0-QDZU6uP literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/74d9a4b736ddd0a0_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/74d9a4b736ddd0a0_0 new file mode 100644 index 0000000000000000000000000000000000000000..896c6aba4746f0ac95408e091b8460d6f63918c3 GIT binary patch literal 18180 zcmY-1cX*TKAMf#Zo1{s~Y-u_`R-vUyvy<+mW$(Qel_dzWL}WV<0cGz!1w;@81Q#1* z%HBf+lqtyGQ_tsjuIv19xUQFJp4|6$J)upL2fc58@J*>6FJ78}%Ch6VHXrMT%@_Ws~Z&KU|ivu|BLm%KhGzv_`kOa`ma9%E=m7L*e$b+a7L^u;iEeg(D_s7{u!(p3ROOb_!02t7tmEQzl3FSXC%Bm3c5+X(a>6Q z#z0N!JP!KE;PLRKyqKVPlObXTOqUn<)~bgX4`eXcEAZ4zZ2$5@m)}N53~{6Z;&F>WbZyWD^vHw*Ajm~ zb3X#hrPER9D;$U538*3eNwJeKM8-*vvtarIww#CP3s6c<$Q5b%Cp7vC+DXZa;E>t! z(IprwwJt*|+4DbFbgpIcRahi(*Pz06<(1p=uk^YBul|9eH?>|)OPyOV?>4NGu6JOd z+>itJ;k?Xv081t5A>4lihR3i;4oLnJ`01&hYx3DMm?)9Y;oTQ7K>RPEs;rexkrDJ0 zuOWiU^1Tc)Mlf1xm?CH)yJVC(g4xo-5pteL-&>k5kljLm02zsSN zFvA|f1xEyp(j$0Nev%%}2r7CbIGPnfLUsgoWQ?4ZGC8_0Q)PO71P7`{Fuqy@?W#wR zSR;bBYpQnf*N)(@#Mg~rxOAx(!OHp(lx`5g?uM$baReX9NZH;z0&B|%2FUEUBlxSW z>TVyw#~m~`xg_>?BA6*ZbdKP~yAgEj62bYd5u|ietR9-4KRB>zgE_(;|#MA9lLk}p#uIaDcBkzI@Ozl3|@98QCS0LR}+i@?IoG-jC$^*hoC%BMHen6Cz2N7|C0cBH1s| zlOxHNcjdmkHYJiHa#@~8U}hwhrO}*7&P$Vdk(B-_lIDvd`BVCTt(f0L^3BpnZY_(X zM+87$w)r}{>{b5A6}-y*3aBPHvw`aYssPDe89iDEugu4mdW z-%06LiurFOWsL?}7B(=ah=D>y4V*1zU|ewn^Q1_Ofo8D=w#%pz24+i(I0K#Jl$43r zTDhBGAR^Jg2H7X!Bm=`r8h9ufWewC6${8pwL*=*f26B=O?5<$ov`ngKV4=jN7-*BK z7?SKW5RhB)N_zPX{1h;d8Z_`urh&fV$udwN-^ z2Aq=(d@#kpi>U^_nxXm0s@VoT7c>)TvCP0Sx$~`ox0f4uxza%GRXPW&H6xk%qvj=n zpEXap`HO+Z>kLd=Z@{#{z%LsOyuZo7HF0gxITwD_xs}7)HOn13|2uV#cB!`A2D0`T zsCPv5N%k=V-$?8qnxz=dt5&&k+d$7d27b6}pu#-^4Rhkm$BX2Fi!+jQrZc$b(MG z^R8;>qFd?yo{=Ns>}KSH?nWBDZ)B6a-`mI#xg!~Uj4YOpebv7N`fDa){K&|s^3@O{ zWj-^qPPz{@@{#-_zF|gQ3^(dEjghGF>TQCN4RTnDPBe0Cu8|q@jGUiuq`?9s9i-3_ zBeCBZ87YTW8p&T}WZ7yXO};ns+ZrRbwMN?fpn88a(()%gCU<@|vVMb+5*v-|l9N(n zlabMzjXamsUFuDK*=?lK9?kJL)wowRO7Fu){*dIOMy!{NoR->GjEuW#r0z|fmj^~J ziT#n0A0^_kky=lTRDWhe%rEpDQ4 zjEO6iOpHu3ama3>b-IZLUK2mddp;9`Sut zVy0Mnm}uD3#3q^E$3&?QO|HluQSngy@^#DOqAKEJ+gR{ z_HQ%s?XM=DO3NK47Rui{b$^$Mw|ARZE6?_r=<=KTKA`#zs;5JGTuetzbdaUTOe7pP z5p~AI8?xYc6UEMIHs`hePZN!0jg=?I$K~JT>8cZeqSH`&V`RXX2%NOcW0!Co+nqvPu4voyI8YnWC5&6{Q#F zQP|{&C5l6?C_ZpUaZj?mQ7n-SV(>*#D>I6%*-;eAiK4YEmwUNUw9AVkHb08tvacYD z+{#h-szwo2EsFZpqj+74)`()P9IF{c)ml+RG*oQKZ4||+CQ)>28pZd`qL|tuisS90 z_^3k^e~bH_C@yr0BIVsEtX-pcIY|3I(pniiO!0>6{)i|pe-VXaWE3-{#hfT+&y6B_ zUKC}e!Gb8(u8ZRN`Y6mBqWD&NY*epX)%UMa43lqnMR9j`6m9pYzkN|O*{@#ZgmgL> zMe>~}y55bVpWG1N{V2YYvk&#y<0w4x+LI`{$jYZtlzyiEUPN*8WfW~*MX^89OcjHf zFN|g$i`8tVk;TkrSzE+RR8ceai~3YIVjD9{B=$`+t>4ly+11`m`3`2@?P%t+&StJidKc9t(LK#% z^fEK}eKUJLG}E}R`tE1O)Za`=`F4OA=V&t@j4|_%EVV@=0#ZeL+VCam|(ErGFm8zvM^eXm@Qn1 zw%{vdp?_fu@kK3kkfp^eBow#k_bm(C#9YEcEt`eOawguwfdmWX5-oI2vXJ(gg=z9f zX$zl~v9PeLg;!FoyoELLPO61}#Fu7afxKSN!b*8q-$KU*7T%X{WPd}&YNVWvEu53# zO)cz|hRrN|D|ee)XxqZVr*Bv|CP{Bv_)<)5Ewq+-?JN{&Z{fSn79!qNy}#P_KMT?QEjou5M#`Z97V-yL^u1mAW$g$HExxc|`O-q7d?5!$S_qA@ z&_udRIzCGu=Yo4D~-#bxO_I78c3%IjU{01^;{tpU92{7HkVGw3lxdS$MM8 zLZ`1SEMKBpzOmqu=_@SMSZm=I>Gp$#!E!^qKUtVBKgh&Q76xonO;TdJg`twNL%qnM zojSMsEQ~*H;imXcTKG!t{BGf`vpSz*K4+ny%)X>~T-81~E@iJ-I4x;^Yi_dsx&`|U z3#D#py==T~A$(V}zo&C?-@-w;B>zgG2NqHvS@>E?J+ZJvhCH)y^106a3)THn=kq_s z#!Al!D}&{C$%?e{vBAnHxg*_-R=zh`>1?sGsF)RNaVw2ttZbHJa$8===~ye7C9HfD zXJw=ulh15ccE?+3oM`3RYgPiKtqd$<mGLr1F39UC zsxQ?_VkIkMdz@`x+f%Ch=a+zqUJ*wCu)JyzN`wz5$o zo2u?sTKl?{!xG=d%FXu5_nwurQog&D39`9|6?;!By?R+WFDboM!-rO0O5?s(eb2G# zdybW@5*%P<&_MP6sga-q9>`j$^QV<5vf?i*PvmJ_G}Ua;G$#9UkxoR|y8qs_rJ8DJ~s1?o9+R-#?70m$2Z5@r}b={YoH=?n(iRMG`FOK13x$#R3 z8S7#=wmybK8)7KAF@_?WV)#+?NZ86OLHHOjKW0<}phLO8t7`i8h1CsMw z41M;+uvxy@AH#!#G0Z;_L*-*JEIA&-J+YsNVdsSyivJmdk@xEhJN>B*e0zW#_-7_)%zrdJ<{!I43iA8oRg)|u?#H~%K@oZIF!qA`fG^`zn@cMN06Ol&(~QhH|EA2`W}ALG2zT=rO1S zzsS0wB`7t$1f9jdtORpcm*8)yxTgf4oG8I>a{gKge!5vmHrB|Ba$1*W<951DuQ6@pxonj5*eK+;F*MW0 z0U42H5t-nusS*RzpO-^K^hrlC#057=1WNcWp)kF0KL zWb+L_s-`LpvtqtpP8y!~IF#lwu zsr30-xz;O=ST@?2wpnqc!4?}oZ?zG*P5FMc@wP0JzvS``8=jpuw(Yj@?>@ymth!~4 z)H-2flI)eQez$Q`DxS6R$3+{JE@^I;HQU=ZI?1d%Hts*PQQ?J+{)TwHH5Jcu$tV)f z5c#fXJc|?Jxg%qe;#u-qJom(2I-Vmb@w}EA&*e(-SUmAGlkNU^#s%UzBcp@yRLYF! z1DTi=Pvu-4lWL)OR_Dj_LLOC)r)jl#=1S4(@szJ0Pj}hgFrFE2#B)h9+r`tOLp&EH zrBgib%goO4eDq#CyT#KZo@w%zB=wAEg@gyi^Q9d5ES^@w;#nvSM=19fs!w*w+oR%H zCjBSHv+e763NKNNfeYb`EEQtWW|$sHol0*{4!pzj}qu;NMNPJnG&cLoxnKp7fN75i3FnJ z5}5j00_{sDutI(*lc3k#3EYxrFZ5ot0egnX_t}6Zi&rIWR}#=O5~#S$VsGMULxD1en_`f5-D6Y zk?3lPl&_~ajT6aglBoBy5_#1sk=m^j8SzFUC*Dn@T$e^-ZH<51g zSl;cI$Qr5IKat1*i9D22LlpCK#T=H%(-Dbu9ht}vQZP#K$0`1J9iN!U{%MIMOxNC7 zx}BFu2YER^k(~gj8yi#JYEqFm_6! zc-JIabWdV|ROz9-Jr%E4l6q7;IXNVWN28Q?bP}k#yQsaFwN6%D zOJeKaNff%C#H4?csP{05X;SWG5?@4@wlNqng#d6i$1Qq@Y*SX?QX%zD#C;3>%xw-igWBCMnKb?U|QMhFF#*(@d6aOvbw< znZfea_GG^PEt$Kr_gFGrPbc$(w7Z&2!-vVtl#}KPSPE63nM5a5;AQCw)GAW}hra^x zT`JIC77waG{ZA?|UCNHGz=VkvI4j-fRiNLd3M`l1+bR(It709gK%Fxcm?D)fR?zz( z6{vAlw=osTjIGGjjuol;UPZ=Aa{r2~lIP+dP?0~S?dXbpD?K+<J^aE`=GAT`q-xl2gd6kbU3Qz7%TuQ&=SP zgDKpQgBdBT&emhHC^v<=A>Gf{eF+q#(6e$1=~Ytn^C?At2T~YVGlhF~Qg~1=h0P6> zr%4LCnx#boDWqIT;e9!EIfY-ZY5(6TJi3*_t4Ar+ew@O&r|RuR3hU(l%M`8}Q}LNnDIT4Q zvrsDirDgF{dc>sii)@QcWoBF|m!+dkYZFuXNGg_0Ww`7pl}fSKQt47Ul^dz4WK_~# zM=B2_KRuOeQs0xxbcqitPEIPG+*GROr?RVNDlxTEIo~XmzO7T)Dy!Z~rEu3&TFJ6L zTKh>VgCuoyDg!4dpQKMqWy#m6+>;_dr807RD#vB$Z>no=D(eoVVmzEmpW~_2I+@BO zd2%L|W`CwKPgY#h`rE0Ly_3q$XQ^y_trF(amAH^qiDKE6XdpABS-2AOqW7suSkq`I z*JIMiOG;yeEUA!&*`KD*)6)2?X&N^=rIFD&jYjXKvGkKP9*FB}ty_`CJ(;yRjT1Z5 zD7Pz(@ki76@kAP&)bZcbID0;g)C+0Mxspcxt7%NSmd1R!`ga=68)?jzN&lqj`jIrI z+)vYc&1o!upuNx2*!*7_#t1uoWQgpNq6Rz7jdr%n@xpdKD`IDNQ9GH%?EI8y=T(xO z9wqI}DQ)Lc89U9&+DT2(u~a+fq@vx<0f|euGfX=8?AZKvQe>+95wKG~Xs1=aoi37G zV8<_u<)6xS+ElUgXC1r#&e>UB*UkoU)wA_oP=vr+a-eg`|lJKA|9JG$CAA>-e(Ghbr5*=gO~uFs0?6d$O12B}Xu`iY&SA$CSe z@1b^n`P@$0Fgr`XwClPjJ8ehV`FWC^e<$1NImJ%wY&#?7sOPzM!t?Aroo}b$D?57^ z+NrhF&bVb-D-*uA({zoUdTZ@W`ayO6s5$>)XZAWfh1ToqP5OGXzTTpJ+wE9(*lD!W z&K4=OUvoWZr`sVrXXWQ3c3rPzXT>o)uN}AJlYvrjQnj42^H>UXDsi&+SCN&`jjG)O=}Y>?@sHX%^vNR-}VygM%^A4vrOaP_3|o6~!F9S=_;* z7>7PnaOk=n2PfoE83*y@9E^}j$qvp`a8ReBgV}cNkaqy+A9N=J!3>@fSq@)dY zaBYZ#r?TcV2fs>isDr_uJNQT58SbF`mk#zy@lg)e$$MiogR!bx&dY6SH%_&VSFIBq zygN;KraP!N)4|m_4qWrJf4+m$OB|G4sygMpZ&lNB2W?kqhO%&#gX^muEd9yB*!2#M zZ*Wk3qvo<%$F?}wxYfaiZ4M&0E9Y+x8vU-EQu3?=hy3%WgZ-B@PnmvMwMfzxt-0#p zuw0SGHyyOOr+G>0eFvGcRPH=b9SNgTeEsX-3#sy-gC??Fq9f87B;)0IR61W5 zO6Mnezi>K3G7JFPeXA{%8DNB;HR{EDsr)m*SSuF9n>AaPf&H=e7!>goIyaXPh|XszsNna=UI z(kaz8ozXJ1V>*+i!8>|f4oQ6HbVkT*iRzxt2Op;MxrF;_ootb){^|6S(en7CbZ(7I zCpbEtV`I{}Ec3>uvr>9ZPA6@qZfB))LHf>7Y^gjqoyPL3Sm&oRP{zr##hTOdbWGo+ zvv6fP%fC-&qx4&&eezTaen@AP>=4iTbl%*m`D{z4#IMRFlXs`{)xmVuNcThOd?dFe z*)89{Oy`YPiurFk zG5@907AH$0oWw^udCTZzvB^nXl#}AIPFj`F@gyhNrJU3e!)s1T$Z*+T+DWL4laA$_ zd|Td0$z&&2DmZbbIGH0!m7KIob8=X=I-HoDPA0jWq-8kimFdKu<>dWrr#>fiayQpW zR>;XWQo6v&JC&XEmRl06>f}K!Cq?TzX;II~PWfFP%Lh%JtZSxN&7I^+`8KMzyZY$i zu#di+H_%9`~~o^5b4Y?G5i+tk-~C#6m~>2O+eIpgH$MdiKe zWa2F+5x1QTz2hYPuFi=(mZ*D92FRBCPCO5sw0xxA9_!pa)%;B^eu{FDYId>T;-W;f zi_fKNAs4F)yC_%0#nm_$u6P%7rF=;jT}rw5_ca$a%D6aO)}_y1T%1gCQ8U#=N}7xA zb{BuhK8K4~r;DL-$KxW?=VFO$ko$fY+rlm^1uh22tJ*G#)^V{%PD|aoE+*D<5mDbo z--a%%ja)Qt>|(1dYVP8TRxV~p)7CCJ$Z;w4hKtd1Q)aYrap6rD&)d4F(q6rFa54B@ z7u&nIu)pup^+GPDf8gSLAL*;Q`@5Jb-%9>K7tMybm^Iu*^avO2zi{dGfQug`d8B4D z%BA=JT-2JNcvG}ynu|elW~Syf+r*6dcgShdPU+0`zp zuTi~gUA&N9Kk7XEq+U0=2=8^#P%QggB+4jhcEH6uQs$rww;VX6wZ~kHkjlq38@Y2r zb^WQj{&Ml=Wfu=#y2$-kJ;~btGz;9ABiwu;2P56&8{B+ja&tS%&D&--A*-7PVvcr` zAS2~)Avcu^yD416O|znIwo8Lpt(U|SZqj6y{1xY>iOtQFcsFMg+|)~S<0<8)-)nBJ zN{_N`eki9k$!@w=alw-mU9P-DG!EopP+Jat~7O!EU{m z<>u+?Y}JH-lyPw{G??*GyNqsqvkgF)Q87l+vr*ytCTP z?4R8{+pO7cb+cNkYzNd;)I(wPP*AERZhFPCBfg_ES6D!xH)o8$IrVNdcn zhu4E15_5GM_OKvdYYII4SJ^|&s)||7qt}ies@K>41|DX#^l+h-heoYcLmLm{-}KP1 zgNH?(JlyE);f;4al<(@H%X=P9%dl=9_I3A=*TX}xULIP$?_rmmmE_(Y93Oe;{jrC? zL^WdA{;VWrB#lzC6s(G4+b2B_toaJGP{5M-Q z&sEPdW4`KKpgOB_O{R_0liS%NJ6`=GEV2FWV(L!OI|NThhytQeNU;^Rlm^m)KMRxu#@Y1`c zYN@5z5?e>HWobh%cN(eA7GBD>RUhrthx{W$J9{b8(@XPS+An8&dr9u2di#2De4==t zdU-j-%lKj1Gu*51;mSKokB?D5^3OOg{s~?difNLUMpL|;n&#!)bT1WWdYK~UXL(7P z<7KM!p6BJ4`Cif%XpK}{s5SC%v6s9hUR?v?rP?>jDb<#FSu2HCdujH)^2+tKUc5hg zSs=sLd2y}RdD!6PvP|9V<&P~oC)>QZfAi9Jub1FqorhyyzC7;bsWd&~W#;c*9-s9R zKIi2-`TT;Hy?=Vi{Y&-BwX0rc-}iFyf!06t^63*VyPhiFzh3sl`lwyr$M|F)|H<|g zAJLV343gwDAFCWb9;f^G%;h7^=hJoJJ}$`9TptA?Jua=oKIZ59C|2OZP}Rqe^0Jzb zFKYOxSkFhd`aaIezD7P`oA?+iN1FObZ0=)G3m|jgKX3eZ>FZqxVlfe)-u)wRJw4Zt^j6vk&VQ zAE&nYD6`$iIGMiR$N2+38Xi>5M||WT^RZG+ANMipg!(+`W8@jl_L7g9SA6^=d#-6# z*L{2{4gc{m^`_=_+eh6yKGw_h$Li^cj}cEbds+D0$MqLJUVo`$|M@t8pKyeqkiky_ zF&q6P$VfSC@>4m=PtT%$K9!tee(J~uiHz~{fs{=2lP*`}k-VGaXJtu0WlH%eDCeiK zM3>h(86(G%{Zy;qr+2!ap%QZXsV|$wKeu!IWaRnzTG|)*Sz6go zpsH%9qZ;b@8C&1aiza@mHuJMa;#&G?)5_02>F|c1Wo`Tf-_m0p{5 zt{f}0ca>(d(a(@ge!bVCoICv7-RWoWZa-iC=I78}&0?RQ2aC?UEngW#zo0oY$0JzW&?K&Fg;Nyy2(yKYrf7?dRt^ek$Gd zbNZg2vJVvhp=S70GkoT!<#RvvUig{xQuBJ{XWGAh&i$uzO@J-N08vo^CYl2jEfkyW4Y0CYfHLI+ypXCD z0z}vY7@YxK=N}+C5a8R40QWKjtPUw|L4YNd1G)w`KytkRUF!!(YZ}nCwE_NU8K8cv z0OQ*R^gUR)+Xq4dIq@KD}Zf4fHwyQ*e`7dE9OT5;y(`1=(7OR zhN_n@0}LAzVBgpPdE)|XAFo;_1{fsY&j|2zW`HiU)W@6vm*)m(K2Lov2ypzX0M!=; zD7iR5`>z8Wk*gB9MD=|Wpu(~MlVz!tSfw8Js)v06&PbgD0VW&_z@Y#i9}Up>Sb%QF z1N8bw`)&v5ekVY|-2iXg3lQ@pKv{Hqe@eL29-PGPYGvpFalq;`Ja0 z-w5*hn?cUD4U*hG$Rw%WG05n5f_e`m$kP5n?hFX>QbrF9GDlht3es6lOWBWteEYF- z4h=HkbM++Eh6VLIQIMTdctnutUj(s?4$^2$kS+3fT#)bt^(`AG1@&*Uf*7U**(3*~ zU}}&Ba&4O8PS;~Ig2c%|IWLW8D(0*p=Gj4V=LGp|ZjgI2YhIAQ=4)PGY1T`E`kh)a z<*2k?8RYlP%DE-To~^2NmulG^#Iq;J^?gBoW}^8XRG)vT{!7XsMkM7%qB!p;XXgyw>yd%E zX9n|R*W?U}OwAx-VFtAq>G(3$y+U<=m%*S_85n=gpx!STY>-RqGH`6jVE0Dl*`hpK zGZ?)~H66=f?ePpMoXB9oY1MxwgI2$1Q1g5SroS@yJt~v(mP}SyGl?jfN$paZ9D6O3 zw=y$XoR!JxoJ@u{%VdA^OhPR(X(FrS==+%@eUQn=gEFbRFq4Ukw106X@zOz7ew)do z<(WjUk_+1RXC~omnanDi#b4#JXi`3lGu5&vS0jtU^|Q#In8ol(SzMo$#rqqw_<3U% zRX1mGWq%gVgIUaxqJL!3;#?Lx<q(01|Z-s0&R?OD>SlR4# zXA|Si<}F%{TgPos#`XXyK8;VY({>Z&EZe7 zsr+d+4~AruJ2abbWs58vmCfxL*<{Sh=4)9mw%OT4&CRC4ylghfQR%ign?>Jbb7N^X zZ!F8Emqf41CVoveZ>`PdfLxSE8?s3_l+D|RvpFc2WY9@{eOhsU&t|wB{WF`Si>gc3 z+|TCOgKUmH&(?D-hg0qx^0IO$HaLd~BXs|Z9Hx!Uq4D?}rccP>lSw)3oSZ|(lpN|x zXQ?_Zhmq5BcqZ>G&tdtB97=tcgI9*ijnz5$*5vS&yxNmP^}TxRi1uC8zH2$uzLmq2 z$2pvRlEbW5Ib126i?e7hS;cbc5SL5k_+0&b%hk`fToyTUDUqJb*MVG?%wrP=0OW^KtO zdTTD_j^^_2v0P5c*T3g-^K355|H`HRm0UJo)&6U_?6{jtq5HWEmgy0BoR7?7t|gC- zCGz+-E{~G7JU!oaTPBZDQodXsUCQTCH7$=}E%WrcCr{T)V<4 zJWh3$y1p5;;bh2qLD^54rm zdc9J8ks*p0Lwqbhn?w9-3DMIUVtUaK=Zl5-N2V4J@kdOE`mrI(#D&-`MdL$!B0Cd8 z6iy29v}{Pf_lNYmen`LThZrKu(zM4OVzMKIAw9%!cZmI-5Fu}fNkk z5XG8=*wa+E%|m=Dvs;9?*iw61g{bpZhzW0pplyg%?Ls_mAEI*y#qAuTYL^ger0aVj zR(A_gu6u}r-XTVOpmkDwK!{cY)xQiMro6+IcSMLEMrr@(5Z%UTRueRBejZ{AVWJ|#Tr`I%lNhE` zQkWA`rnJ5;qp#&oxiFc@VQNKhQ?v)HVLy{?9Icx-y+PPvi^-QZ@n4jJ!$h+n1yeLStZxn zg>iQXGfzf#40HIMFqJzgerLt+qWH42TbRNNCkrTfx`0Yj^NiO2 zuJz))UO=B41q_kQn+1G)tAJZlg2>lqi$#-z>q^6a$A{82HxW5)m6 Lr+<1pT95xRph93SdwnYshVBA zMzvZwHT>CG{w$v_yJj_it(qC3s=+|DkiV+mS0l4VHD9ezPFB@g!C=7WubCP0`Ks3l ze%yMP~jl*8lz--@oer-X`e3fhf2n1EOKC%re4Rv8jk#GR*>ilz=0p zU~33|$_8t$#>?rjYO4XIYC_j0u(~OfX$C(?_2!V=0y3nIywh59%sLctp5(S%fbz?bhFmH6*kKO$=e2&pCD0=$wg_t z6L#%_lQMoc%$E{-px!=cEB2ouMW)Fw`{A5SJpfB2{-An$6jn;7W6)1H0ilynQ~s0U zr{EJACq2)B={MMR0Sf&NrRAhtkyd{|<3FLjl)4B`nJph&g0WKjGPIU`|8qtADU+|l zB8j^O75`RVxh4Nf@9XgLA1HQ1Lhy$SPf!5Zmy8wSaBId~5)$c+22Op+eJy@z0U z1Y6{wiGBuMp2I*1ynt%5UOGib(O-OqD5}UeGT0c!XsKz6qNVJS zQI;rXOG|4Mo#d3{6^f#PmzL zWkr#Y9YtLkBj==SjvmWYnVuiT!D>;AuO3DF8c`(HjN;8&s#^keqBtV)^`aOqUF%1& zx+%l$PENU^spg5Mu_XJVnHY$sQ;leTs~OE_wW4_{1$ClXEye3a^P%jlA5EY^ zG%uP))2Def6O;rp@_8SPw zO?fH30|qt(4Wxz)yq#&FpLnwj6v#L7B-=pO90Naw4g4a*A_k_2Ip09T0s~uQaa9A~ zN$+X~K9;+ZUBkdK`Lwp`kOp-Oye@~tUeCaS`Ua}EFwjDZwbYtrf}Cz;U|Smlwsr;71eKhfi%2JU^P+9nxrO*Zh} z6a&wv8u)UC`X_5<8}!^zPo(8?1Iy+13IlJhH1J}zfjVon2W!{A$mwJw7t@S*(~Z=38%gyT zDeO1WEMR0^$ViJUBQK>>wvogfBWW^S&gU9wkY}V=a!P7$F*16q zk!O;+M{AQG_8O_YPksDZHU6R+rOy!~ze(~jBeqLM&PbgrM#fz=QtyWL<-U z6C=}19Cny!lWwA+&&2ogj^D&!`CGg}6Z2%1Ov*9QAXm3}CZfV7;$=oP6BU{&k8Esa z!qMDBrdZpU7$DA9P2|dQx&4}n3vOjx8aq{ELUx@|PEW|N7sn>9xkZ_)f6 zCRY4p;)%4{Wn!WHwOfz(n0RxqiS_bypNXzNYuyJ`-yyB(u+EF=n2C$HeZtCOi*K zOqR2cOw@U7;`$R4zGo)p%kqC!$A2bX$cLD@FFDa>mdO_RPj(y4)Hj)#Xg2E&yBWJ2 zwVFBXHuIjx%w5UynOQ2E#NanmJJZbeY%_&(%(Rh}ayQpZ`#dwT`DTX8{sJ?(Rm}LS znK4&4)1Zc#SEX1@Gh^j=Ei=_>n~7?q*pl1W%;~0Px;HcPO>;9-TbfxY4clnmt7dw? zW@dR?Gq1HbbE1Qp4?3FpOFVCz`Mr~wlrCm$-ORigthgU2hKwDiJj3;Pgqh2qn{kdb zGgDg5F*AFvnL_i-l#_-F%&h;>%(IPVESt=%ke-{>gYD|aPiBV6ialoT>^0MFpVqzK zOw$AEft-|1hs-43Hq-5nnf`KJ{P)a!Dd!&O+#@qydF8R0uCn@xnKDnc?&oH1yfD-D zrI`cK7OEO7d~USxNNg4hjja~8%KD-f%*8A;C~jd;2@40MWUPhq;w)+58+jaO;rG%O zURJd5S|tk$QY;itwJ@!+j>+0I3){u(u+YzG;j-koG)|hkExaYiB+;uHB+750tCS8{ zNS9giM^H6|ER4#q@Kjc1TG%Y%6=YvFLq;g{*uFwPl06D6r7IiiJpB3p3tAHzrw=%o3&mk*lMBjZVUfhve5Ukg&(h2NV}?a$!9Y6x`h`1 zsE!-jznd1y${X_40}Evys>hGiW4R`Q$IAKCLXT$_);-sHURcPKi7ze8i?Z^Y)Qh$< z!C=L0v{GQUGFpyWtXwH%#b4OUfFf4ni&^O?%Zgh`C}Gv_X;yZKrKFYGb}N(RY`m3& z30BG{TIrl*CG8a})8w}@Rz59jWnnohFQs|~E9>O#R4f08Kh4Sld9}Wk)$*W$mA4vN zc~`!Y1C11`v2r%Ca$bfvv+|2HYHnqP+-YH@T}vw;zh>pQB)x9s3o*5`(njXBw^Fo& zm9INniRz+yyIR>G@4shdyO`g%(oY8Uv(mc1l|loo+CwWNz}DQrPgdKi{$S)s%@^7z$gGS@FvBRaR=QxAKE@|JKS7xh}p9R_4pMGI5KQ zfjd-_l-y}$sHE)DTIBF6;oan{Qc(+)?lEYA^0tIV6|lUnzXwO6o%^OQiH;D@)~* zr&dlq)80Q<-7mDC|0y;$dPUh7BEL#jw2co9Hb%*9>29>~jmbu5tBpm)ZP-fKXdGi> zs~neG@?6fu+Q=+vZ zp^f(&+4MSOqeBxLnTa#Eui7{w@ojC~=%9S>*f=K@df1pCTYK7Y^s>>rw~Y&u z(nmGCZ{vkD>1Wexj!myQHnvM>ppC(UZ2T>i2iq7X#fR9)ky{e=fsHuH{MbfyStnCJ zwed`pt~MZvSlK&0lPs z*l(lMLG7W;ljDcfhf_9|%I|XfjE($rHX6zMzuEXvewMiNHY!QS3pT!%$-nFQBI~8@ zA2z1Qsy}T!mM3wAsBSMr!}5igAqVAJZXp7Bh4@gy1%)^wKUOV7m1>1>)-1$Fva41h zg0%~=tWF`Cw=Tp$$!${z>#KS!IjdZTG29i$$ryJ39z%&gVz6F{p}7RF#4zaZ7*=18;i>%mPYlIw#_+1d--@CC zy%=^#>jyD>^icIaj$xm4e-gtaLoDZIS)o{l7LMhh)Grdtf}*kfBj=07>SsbM9c5=s zECb?V`AMv$W0^c4mJ9Ov*E;^4j!VqOST>4jlg>%Ay|K)d)khTnoZ`#czhY^ABbIqG z^p57;kEQ5?Snj-xWm?ga{3&HBm!y%LtyYps)k{*RXGwYvF3At_ zj{b5wHI8o1IKGtz>2d52#1S8i<8DqI;oLZ`f5_s&iuI9VeH_Q=PvVFks{LR!p<sk{i9>Px`XG*!hjAo6i(~S?aa@qb z*!e~5QFay?>~uBRSudFuI|HqDc8bSl=V38BRf^l0P{K}$7&~pHe5_sXQSJ1T+&DWU z>~@Yyy?8sPB{{*)I$2d-&fBu3pPh???YM{7Y5$R(mY>*JAca1)bM`Ykm4?|_BeO@^ zxhj8-w(H9c#g=1}?TlVv=ah6?Y-i9{cDAmtV_Rvb<0?Cr4R)GI-|v-cqvD8lvz=*M z6-OFwv-ACSJJCCo?OqXCR(&!FbNf=ukYBGvj$rCT7J`C0EC!dN`i7 z`SCoLhgITfRz04%QmjTi6&l3TLv}WbXU1#sT$0T8@wDt1&qYb;6wkXdvvWKjyc5q} z@%D^on*1qAz2aFVk-_nNAxA%rr}eOS7D}TL%Kf?OlRfh0sCbskfJyP}SQ1Z>rHZjK zo*W*dP z6HiZB^*El*&*QPYh}Zk51l}?vuv+3w2~;nXz&HsMPGD2X1k7;>OnoJR4rLNpB|nr+ z(EIZQZpzd03FK5v(03>aOs|x{)|3QnsR>k-X6dUr}-qwMIKK--=PES351s-8XxG?kIky1#0X zw+AI~c1Qx1K1g7Vbof-YO2%--8ks=tQ3)8vB@mpLz(;aLM$Av(sBB%9z><{-+>zhE zP9Wi%1Ukwr8TxGk2W9hy1YX^mz+$PeJ%Qo76F4I4_9(~R1U`|#KJ{RK0vDzIfdm#D zO5h*qe^}#=YHjkxu>=;KNZ^+Ia8j{PC6IVJfhMy2ocblV&nGbBQ397_J&Al7m>2 z=SyU}B>59*pOMI3iOo!8mNdvpqDgJmJpP0yjX^A9E*W6jUotH>Qc`-kc-3t;a z@ns^fEYxGEy(p39ixb&dIf-IvN%*`;G|x+7p6srkgr!CjRm4*>i9xcXRucPbClOyK ziC)sMX%aJJd9x(qS|stM{3exKCh?u*wMk-xRBoHZk8dYo?36@_Zb`K4k;DS2+EaOZ zDPHd+tx@sh)F(+i9HqRYlZc(1#I4y$t8y z$vl)v!;@+GMKTLy*w|!#nV5`ylH$zOoO#J)h;?}~&1L!KWPIC_86scqOlHZ?$=s1& zjwjRYOfug}`>V+`dXUUaIc2GcwQxn6OQEESyeLzV+GQ)^3{)h(YehQ9;=vVZ@KHsk zOS#b%nJ}>;=cLEHiuB)7k(IJ{M@3?PQmmsDse85}Q>606iu$~yA~mn-Hl`Apv6Yzm zRwb&vQ;D&XJfIS5yWzDO{9Li4+>f zr7%OX%ct;9atfIhQ*c*G(PtKVEQ4JsM7$~N@TKtFpF*ub3X5cZD23~CC?kcn**YhS za#N@m*5iCVmS8~&y{e>;UNuEOpHlR9AcaA-Qn*_;h5PkW*xE>Wnx?R)c?#uUO`*H2 zZ<|83H&XOHR|;)9rr_$6!T@m((fJQk*dS{^OX22d)jTGJeu$*wPtGW>=edI zpE)TEoR`8*@y<`7=t{+tp5LUfaI5A^m)$9pJ&-~-@f}Q|{^=B^Nx$DxNcla5cjffu z6n?s<`G2MG@Ma1xAEr>}Q3~guXl>6^_)+e?Na3n66~8H!5`|K66;5SUe87{j@r&9ctRJxW)<$7u=8I?8HnaX|1Pfz8VH1MV} zUE)KElaq=!H#(tE_U`ZXF%Ag6# zC+X8tS-K>ZyHa#RDkFEMazcjwth#}gV_e3hSPo*+R9-mF6`5&pwlU3I= z{#GjGZl|*QX)2pvsf?veWq!}9O!4f>G?W?AJW`o?(xYl+etf+$#y2Wcx_@OF|Ifn8 z%#yylD^vYcWnFhtnHN_o^Wa)#3jV6hs9TlwS-p}*wSbuf5)Vemz2f`Sz0j- zOCU|(&!zEcvox-EN+Y9l8jascW7$V(+!yx}ja!w*U758tjg!06D8DC-@yF8m?qnLA z((zx@ICmk9)Zf#Xb0v)iSJRkuEsgnd^{+Hs*VC9Slm1E5^(kr8zL~~F>3K_IZ>P~t z-jgZ!()77?8Y}OoaZhGFOJnPQX&9p%^p#I!j}$XFXkm1)Q%)3d@M%#8dy6^9Ebd@K zqJx)74tkbyFsF=zOJyB2FXtdNMaNPdoR>-t2L~lC-N7*F=yzZbI7pGH@>|eBgOG#P z`3|~Da)E<@ES7(&IA~kd!5?)U`upf$WjzO*#9iOP`wbjimW$0D+?TIgIM^cImJa&2 za&T4dws#QS!NF!ZAo(2~41dePL)q2M!ATkaj)VCU)7?Rv9u9pk?V!XU)iYS@lw%(` zNczOVNa-`w!4ID~NE_y0*%uC7SLLAHC^LJ9y=U1HTNCf>WyNw1Y=d z_>6-Z7gX;p2jAV+UfgkzE2keic>2siq37z4oRC^C9E^RbeU|1?PG&_rDP(XmrjV24 zg`HF{;$&5EC$E=qvM9!>?<<_Te#ps5Ib7CBe0e7$WKyz|vlX4xt>k33Lvy6F(@B5% zOS~>8xBN~La-6)G>!eH-C+BNAsZ`s^6xmSM$;*09de(RHT_Y#$8$0=`iN-f|GPjwN z%gvp-F2PAR*(l$=>g2_1PI|O;a^-a=P;sd+B<2}-O2nOPKx(*aT2wAnoh;knWb8&KCpI~$v044us$<)nY~Jo<(+(%mJC*xqCyjqqZYg!niBtah z!^we5>Z?q@tePb0ipE@Zazw63lN(Oj-c{cu^`4VVSthsdtBwaw-k0B>YTy2K^0`#~ z&q-6+DTSia87$-FnK_*$h11y}?-oht6S*fj#nM?WTg4HV&bh>NZphLkjgG((rAam%|d@Ih_$QTg*MudGGynK9fj4 zjgxI+9*|Cd87+@KNayCrbV8%kIX)(x%QA0lI;*AkULH-ze~S4iY-;$W$nU3k}bQZ2oXXQ8PY?l7(G*6yL!MEwGkzL~5n9l3l)t?>dl>AA# zWb)p0zC4u9I_YsZoe$)eWE|E0NZr%vOgNLyz+cmuelML1_tW)$F`ZW)rSsNftwBmW zOQ-eoboRHC>Qb3F5WP@SZs0;XLeB{)6$0EBx9zFdUIS%TjJvUQWp)sQodEn zEpxthu}aFWcF}2#i<1()PJNVva$Xv**W7Pin7`8+ztCgkMi);vxfr&^#o--V z*G?CuPrK-NMtwQ!;@Cyyz2RcwO&3wOTnxSKBK?l`MIMRyu8V=P?VbzoeHX1BYHg3S ze^0arCN~?*Zc;674p`lkEac`h=~mdy+9Gbs7j<(r&W$_X&0MKa%1zhOZvK76P0g}y zj+ArjyB#;DQry%^b(50jria7LZ?fO%Cf4OG!KUEMg|b?cfXH`Cv9bD^*FQ{4mHOqCUqKgdnhE&5zMod_R=ZiV#!b1kZfdMkz3bgPm)_rLA2w*Mo83fyannew``skUC~1Ds&D&D; zkQaI z>s>u$zok0mcsJ!9tlUF9`uxkolg~U94EL}`c7E=m&`1x1WzuL5XUBM`JJ!RD@g9Dk zpqeHs-xTGT>fy1>o#x^4bPspszZo9J&h>C&o`-e|v?dw5&_l;X9+ofmkhH|Z5E;J0 z!-19R?JC8VnqPYuv)aQs#ZC`j z?D8;G3h(yNY>$VZS5wB4^hWG z6qBw}@}!5?PI>r6s-E$1Q$oLbSS;U2vvVF+$f(~u96hfw7d$kQ2{QC|4?q9m;q^bY zM-sl|VU=9J;lY1Pb;xSTx#!`N`yTGd`wu;AdZc}l!H+%cc;cbKGY{7+UVSg&WuB}p zB@=_wz%i(n0 zdcCyvdD$!10$yT+US17(NzB!4#LI$wjVbW*UllL4swrl5uil?}snJ058+w`1%FFMq zy) zPLlh0aem;X&xc(Pom&WnG7moKHm6feuBs^)24 z&d=~tX_l8M^51OLJXdR$8S_==0@eAY?yvM>UFFrawCc}VFMoXFrC@`X5#M_mxz$V0 zqh7u}rZ~qn=A6cy_fqDvmp5;DS#sNp{f?K@54?QxPZ7d9M^Jt$=A(a{kI$v5-KW7!3A)lyrrCAO|&%d$p3ZZ}q)Eq#=0r**W~I^-W2+Sy0ZUOrm%)_ghF z$47Es)!Wa9^CQLk*vE@ce2gEaIm3PW*`U0mbbgH1Bma!^5t!g(p_nH5XgtNo>1jUB zPxn!2rjIFdVU~}SIXFs>eF>AKB|AEoKk(ckM&Yy zt&is4D6jmz-iPly9}8sok3QTRwGW$oT$ZU@ef+jfd$Pla=Vu@Ne(@1HqJ22-*+4p>0ysz;Oe0==a$DSw3_pgtA zv3}}Q@H0Ny&wsKr#ZRHieg;c&nx8dJKabM=eCqa-=J)HGcR#<&lUzRqVV##Y5kK?u z{S+_oW2olmJ9$yv&*wG$RI2Z%djmh`WPf8nu}%F9m7~r4B)0IgsHLB_?ffik@25j& zKd!ERBJx-)-TVxa?eF+m)4IY6&s0X~+T;sNT)CW(#-@Sc=P43I8Y0n6qFCpL<&{VI2j|ylLJ(*7@$vjfT0q01!y2!#pDUlPv!>$Tn*`bMu1y6 z0W$IeERhZc0hUz>5Ui#e>Z*qN0me26@Vse&YRvK)LT~6? z#{f^?3h3Xw1X$50z}@#0uWx{6LjuhFAV8&$wC*th-W(g?kbF2fz^*BpJ2k+sQek?4 ziSp|V-Jca;)$9PJS1QLU&0VA3Y!2|rmViFbQO;cf?(7aQWN&~kehzT>7xiL)fcuhr zQ2Aw>JUSGh_u&Blo>RTQ1&F<%HOu}#0}Q?xV8^8Z{>#dFMLDl2zbyGHz>U8Hyna1E zn|}hldn>^Aw*yqZ6X49<0Ojs0{sZ;!iF)`nK&xi~>OT)K>4p0BGQhNd1DyX)drgpS z#vo>MkcpNc#R>;$StQ6GMS~>91Zfu=mcLX1@#)N+#P~!d`s~<1sT&hNLc|+B=ASV35}b1vwz? zhA8F-LE=9Q()iOL(}rp-Uj!L8CdmG=LGs20**RXdObjwuzL^o^$;=>KXK5XCf?S>( zq{Td~b3u?3Uk0hMFi5GzK{_l6a#XHL^itLLRgj9ygG`oXQgV&f@Qc>4Kge0Bdoaj^ zLqRwk1J{lZWOIW=n|eazv_GLyWYA=vN}d*JVRIC>P@G@*&nHhiFwX#N0|Dil&4}sT`t5 znqtT%XNYK5i1%cVPv-+6K9sGQAxzndB_+ZkT1P@G%@1+2AjGPgAsRIZF}0z_Gzw9x zRfw^zL;5Z>#OJSuIP_YGS6>ftu3d=a4k0E*x@T$As7>2gEWq#G`Q` zA``TJ**qzve~%WzFeStmIVc5FLoASM(-eQY&dmrBCx_&MG?}T`vlMG~h}=0LKAjul zuFRSj;?Mc&+n4J3(vW^u-nkm$n`*8Mtg2JTH+! zwb%?A%Qi8`Wl&O<$!&WE?cy_VCuQ({sSJYUGq6?6ph=|+w#&cLHYI~=5|f(29yu#F zq_{JKSEPs3b!9NYok1^82H$xzNbzM*IY*CkGZ@}5L)Qpr5N@1-w^;`Ln`h9iO@^+y zQJlAxvvUUT^vuB0D}#BmXL1Hbr)ChfFoQaabbPsLU8P#T&S3DG42<7rQ2&PvHp!(Q zGjMLoVDDz-*`_?(GZ?)`H671j{fP`Jp3Gpu8P$I_gVw)hQ0qblrav?I)tpHMYbL8~ znM9S!q)zEfj=z%08=09b&dTIWPA0>fXL6uLCgGNuG?g`S?A=U~-pk~}!I{)sn90ON zn!h-ccVWhRBz$nTo>M<$VLnanDe#h>M~Xj&nQv(>XGUo(p$4YJ6en8ol( zS^PaKi+49=@%`p3s%_2U%7H9ghq9O>#eU18<@qdj%cZ}va9+=1mXyDlMVDJyq&~=^ zU&U-TSIXAsW7+)T$tK2^&8KoVFPrR0Hp`?>jck6XnN3=)Y--ofW?X}8`ZvmEP4{db z_0afU*^K-!ny9&7!ZexxOr$*Oq6~TMDhoCVpKuZ>-Pepj?!Po3cqboXwj@vN zqe(gJo}5F*lpN|wXQ?(Vhmq5Bcq(tN%wgrK97=zkgHMLa^|d+p*X8h~yxf;VjbC)` zsODYOylXksxtYV1M>(8(oWrb_Ib11{i>p{JS;ced7?(?x_+0&L%hk`eToyTVDVd(j zl3*@Nb8@+vo6D$hF5^1pa`LTQz8#p$^Fg_EADqjMak*G0Z@E=1=s*P6#$CG%Jjmq#gko}TZzEt|(EsZc(Tt`+jAmX^n`R(X2Qlc(!8@@OJ^ zUd`i1$2@{>=W(xF9w*1;@ydie#>l4&^Vqj2kL<-7zci1bUule(*XGgin>>nque|5- z`1VpBhcD-G>`ER<*Yea$<@-C2HP`dlELs2L@zISuZpp@5c|_gGqnNCghj;VnbT5ym zPxGkqTyfKdj&L!+avk(=^8sX0kJkAwA4+PnZMVFkxSq z$|2>+2s1=VWrpdH73Qe4%L}tK940;z=0>$J!5U!}NsU@zM%NDWTng6>)2v>YpJaFg z#cZgUjl#5P9A(vs;F_*h+I+hpGEUmrOnHYZ?}#wpj?(UWpqPskbFpGd;U!@fuL`s0JMF{w+6Ni_gJS=v z*c-!)+Y;vF)-W}9m3e#8Ix5GqajXb)ep4?RrrTLREvz~@2^eoIa zBABBiT(m?en;4-}QiPLIwv6tV)qS~LK0;=4ggO-?oT?O|OlpK>l_T^IMc9%N!JQeQ zR#t?u*%2D#M>tqFLR|d_!{qY@5e_wskl!eRp-F^#O(Sd+M~evWwv6zHY*4#>wbD4&@!YI;6LXXI0LW zSdd=8;6MQtIu+2ha{*`MLeBzHdKWNNY7Hx3?C=6!%CYGMB+V>fqP!KZrPf)E|5f9~^>+b%uNUx%WZo#?!k4g}Tu+@nU&@9)y%G0-Jg{etX{*LS;HUj)yS+` zy=tIlux3v7|AHKhD?H89|rRBHyw%^^c-%loagM;5#b9ecnXDb^co z{j|5g_6~roLGb-2@Z?kI^ci&f9M%khDqleSaCq}e=pvb4!7{ls0^S}8U8UYAXe~LT zH81Hj7JAE|aqyMA7_WGfAYwX9lXYt#b}cy9!P*~Sn=Jeh9?1EhVDfrBz7bx^l1-Y& z7T6^FC2uR3e}P0fDwm|$4%oR9PRO`jFi(o_hPr#9jo5yL6qzc&?SpeNWj}l^@dq^b zBd}aL9)&)_aR{D(8uFhMI|+kjtaLvIrr%-f1&F=~rR0QMm6m@%qd%dYl)MBEnI#`z zhA~p>ik?@p_kXVHT+5_uut?&rLxsPUS8mI{((?wq`Ui^M)OtBBb#B4j+ptQy+<^gd zLk`@B3o`uyES02(aQ_h)9>ZoiAo)+=$ESL($>+~tfO=ilBw;mXYQNW=RW61Rdq1{5HDXz`Jxf{<)*xp9>pSf zD@M1H78^mfd@Heu5mb=#a!cAKXv%UQYM1WBr7?B+7ekodt|6glyem$=$R71 zbbACB9T7B2kKj%DQMx-LsOXL0XjTLX*%8!{(Q;18xM~r!s~$mO zjR@YZsoKR~JA%U!UpInb(z#v)E9*y4x(vBT4o~GQl57$Lf*%UL%q( zYDV%*3Tj8PQi|1$@$~TW>iQH@vNt>3Dbe8_DBZ+!ldESU5 zsa+&{J4A9{K71#Vp&cU`(K(VrT_S1nek4Uch~)1vk$A>M5|VevN0KlhlD8&CvR|Sn zMUpM=$$fckawJFOiae3Pj7Ta=quG&MkS22@DZL<)=8GcvL;8KKnBPS5&C*D2EsNxx z?<2XmM#p}NvQNTE28Nb2@K7?!8mK9hGf-TH$gkxMAyXyDyU1AWAkWuQR5m#6xv);Y((`jCO&WN6sHWQoc*(4fG; zW?5Xtzz@>1s)5hso@7@yuv9*;r8=a3Z3A!0L9x{}Fke4%t2H;!T#B|(&oW+4wKTA` zwE=5e1106ST#=UT49sb-*>%vKE}GfK##il6}m;Hxm21W+{dXs#UJuHqhgafpvEcRJdp0f#f_;&yw-Tz@Wzlz7pFL17FKO zPxbtGt{E3LvapDeRgzNF$gN^VK8-Qri#1Y3R?FiOMm^Vzl#MqsG|9-RWFwc-jCj(G z)N>h0bsH(obt~Q8H*!RrU5$L$%}ApUjBJ((AN4PRewv9GKQ{82EEsI0 z%;!edOSd6LK9+yPH`K_BVMe{CF%mUSy^S}rQ4UMd2}X|1F*1Fwkqh&TG?;IsgA`g~ zB=$QaBjnIZBl)Y0EL&})$@fNnU1P+y)<~Oms`m#YEq~Nwa_1)_8#Wp#vB}78IVm+Z z8yU65$a6{Et={D4Jw__+)f|6SjlZcz>2=u1?~;7fi1o6O(^C7Yk+Ii|)V-d%bqm7*_$q$i4kcg4%tn#PB+oOYvLz)-)CZ={4JhX3@iM)tiSkX9 zM>aGyVQ*%_(%M8nalCFKSC+}0H%uIR)5O$wOuUlS@0!>qo{lE^bTV;8`gS#OQbu$$ zF+(ifO*HIbVzW%^ZKBjiCffHgaaacSQ~v%Y#!IyUCYs4FVi}~|a_VEno@C;vG@NW= z@)VPP{+dXXrPE9VzBcij6#vG=SMuGDCenX0F-)?4HZfb;uQ$E6?_t==`htKA`#zs;5JGTuetzbdaUTOe7pP z5p~AI8#4c_iDKt8n+sb1hl$3rM#}wZqSGZ4H7}dEeapmWw@vu(n5Zh>%agk%cHJ}K zeq>^joOx`b_7f8~o|^DJH!)9^{i{0uGx1VBA&Li*6B)%)*)0FbE@Kq+Oi@gTiqebo zC~R`X62&1`6d$^yxF=cOD3-`ZG5DgWl^Mmh>?jK5MA2H7%e~wv+T}$Nn;*q6*;f!n zZsjO^RilWi7DfH)QM@iiYeX?dj@68!YON?D8Y;HrHj3g@lPJ12jpF-eQA}wO#qsu0 zeB2?5zr_7+6c;;2k@8*?)-F-J9H{*tYpskKs(8b6e|QvEzKp^#B8nN(Vs;d>=0p)a zH;S^-V15*9*GKVuLlowXQG6@iH>uZc>id@{hRV0Qqqw^#ine>z-@YiC>{qXHLOLFd zBKb}fUG7HFS8j;!eiRGj+(SL~I0}!v_9TkVvhryZrJt$47g5}N8AY2{QS6U2Q^jEB zOQV^`Vl|s-WHGZv))p}nRn$!VVrB*uH*-Kr#F{B5juK|RmnU&%E|xO$s)Cs}Dw>&} zVy0NCnW>d@Ojf6v*(M&lnLZ9PS0u-&b<)gb<{ddIi5}G;5k51WrIg=Hy3CY60;(x! zW@Lt$XR;#G%qB_CGSe$tkIQRevtB!x$;vlVOMaA>1!lTdHWRL6X1ZLcYo~3$Sd%7j;D=0;ffUFt?!7;muPGFm8zvM@@Hm@Qn5 zw%{vdpm?XVv;VUt()KqkQzC zg>4e`k%c}oppS)CeJw=yv*;XJ7$JxHTgV?^(f4-cm$kz!wD{73E?J+ZJv20ycK^106a3)THn=kq_s z#!8O}D}&^$WJOx}#9(El+>x$EE8m-}bh21kRLqLCxRpjRR<_77xh*f`bgY%k5>`Hr zvob=C$>%mJd*ZD$PPB6UH7kMARtA)@@|T<{Yo$UtD_zQKuMAFBekoVc$~c)V7v=R7 z)t71|v67WBaxBeCRlAi)ua$)|+-GIK-%4IUdBl}#Wm$bI?gmyqYG~E>9xLq|TiGO$ zO;vX*t$p3fVTo^J3d*8}ADc{Y?c-hk3ioJ)Go;|Hxkd$7k;UggOth2J~2P=hsQhwR;vz1%x zHRFwnC6>LKgWUPm%G`j$^M{qmvf@uGPvmJ_G}Ua;G$#IalxoR|y8qs_zJ8MQ0s1?o9+R-#?6-|H1Z5@r}b={YoH=?n(iRL5mFOK08x$$!h z8S7&>wjqW?8)GQBDTX4OWB5Vz;yC5BNuVwkowh7o&W7_v8p1CsM= z488ZoutmPvAH#!#G0Zy>L*-*JEIA&-J+YsNVb{eNivJOV<#G(oBycr`0e{D^@%{Kg4*3n(0yPD zewOt^N>FNA2|9^?SqbK>F2P??ac>DeJyC*R<-+w6{P=eXB5ssm!0i$YeNlo#^25I+ zSn*#8p2$1Iu_ZDNt09hmjB)&HilcQ@9E-$kj-$P-kP?&2gNUGF#(lwKGn?Yp9>yaU9qaN1tEgXn7!x1#=HC>~>@ zjg*VE>Gh_KK9U<}W4O)65vdz*3o;D^(^ABt!^|tY@Z0=*@(m)%oK{ncbYNN$q8}lXl za~o&Auu*ZSja4#hgpF(R=O~*#d{AsTI?2YU`8G~Um&G;)d}CwFw>GTHZFE>+!~CO- zrqcT-<=UV)V%cP4>K4V323u|Xw9Q83cIErU#@n(?{*)^_ZFqLs*uKZczxx#Pu?;g*>VpPt$7g%#oti<0)T1o^GFUkQtrg`S|^K_K2r@JX7UQN$L^L3JDL4=PNn#c|5I##!3?UGWsz9Z%W)@sv3bPZzlfeYb`EESjWyO5(z}b zB{1c+1lpHQV1@i#CPA;e6SyVM$|aCfAwi#UBrvUF0$WlNu%;$ZMV7e|cqniC6Zklo zp!Zo4I4@^I2@I&3z)o3SJ%PuywZ2XQG)dr9iv+#TmcYw43H0okzy{ggIe|9a6Idei zK2SZq5@;eLq*Y(lBJU1J;LM-|Dt?^6Drx_@YL$#(iZvpES|bxMj7=agA%Rcjstli( zz!BN9G=Z;|CvaCTewRSP_X%{6nKEQu0taN%j|sfKC4t3Kep>>=b|r9F*6db}JqZjJ z|6a{tUjmn;-TnmTA57pM>3c})j;J^J>SzLsjwf(iemJLeOa z{y2flvX(>^#3gc5`gjxBCP}_T+GQlNM`AM*nJM+N61gPZa}w#Bm&kUhAJT1=L<(0; zB)VE6hQE=>iT4sI*Etbmk3=#*OyqObtNfCbs#cOta{i5y9P3_^ zGCfLiZby0M+$~S+^YXkUhC;~%&Yl6fQ(hb7bEt7PWO&@svUHX#|?M8%n-J#&-E5X-V;n#r15VPyKBibe3;A(IcctdrBDT$Npw;LUY4#vtuhsG_$v_K zxdQEF@xThy|FiGf{eF+q#(4%q+=~Ytn^C?At2T~YNGlhF~Qg~1=g)I%0 zr%4LCo25|h^%T0w+BPXveJe$uOQq1dLkiAbDfAQ9AU*y`3O~x~FH*QQN;Qv8;opfV zd@)URNX;4AJ1d1T(rb1K{pY5zLp<|RD6(Afr2F?NEZm~~^4_i#%Ir^}i+B&DQ14U< zQ>D-EDWqIX;R88!C52zEYyV#treu z<;j^;n*EW=Tv>5l>u;x0_D(9ho~5$swMv*vSK?w;C5mNNqJd18X5mWAm2OokvHs0U z7~iTyslJtH^gjzLF;jZ)szkMum2_Q5C0<^w#KY^ADEO-qBX3vI`|CO;s~=XvU`?Z; z{2h}Fceo|eYvP1Cs1F^!B)X*7C2jisNa@jzT(Yu$=8?#aw8X`I-V zM!DT-j60gf4=2*#q>i6WqpX< zd_PU^HK(!sf%ZO6W6OVO7$fZTmcg=HiW=-RH`>`D#|zu}yojAWMeSr3v-4x3omWYA zx|g&wyR@ClW$ZL7YbP~D$5QQ_mx^{f2P7`t&QR&#vt#qyNs%e?d%#Zppq*Cvb~;OP zfgQgrmVYYSX;a0{A9d{dJ7;HkT{|1aRnN{x_3d1dOU>*&knft?*({zGcKWuob4~8G zvlH3g&L-I}`5o*Gd&kZr+1bU;2^sgkop}<|)lTbfc70ZCr}zNXGf;iX(NFCp4Yo5v zdJVDj^A~o~hT2*Bm0j08*=ak{&QBBV{5#1`kI8moXW1D(TRqRQ6P|15={!3H3+(*1 z&`zzTcE&E#S{eVnou+H-)LUz3;yTs&gXa9RomuPc6xyJ#H|y&y`g*JO?XY9nX{XUH zJ6omDe$Dluovw%MoRgo9*mb>;ti^p(HF<8*M_=O7`+!P~hG zN>_GpzJ`N}wH!>AAL}@HRo6lHdJcYQ=%8IA2j4W-`X&zMG<9&LnM2nHIOrl9A#0zUg4xTMkaX?Vx=-2d%q0nAgogvF;9z^m35c+rd||vcH3^GGKs%5t25@ z!S%rop30if9sDA}Ar1z8;ou*6cbJ3nUpe?qijQ=#Ufv(A8H`cgazSoOyRoWuoN68K z;JvBJGtEK084j+^cHo+;{qr20UgDtaQq?K%f2*37J7~K?Gn9p^9Q?i7!O|ZcjM?De z_(liSH)$?gbZo1GP1_u7-0mQ9hjRYvpwU_7l#=HhIOLx{9PGcWdCIgaszs8nYRxqV zhvlj?zUiRNJoqprE=$i>UikjBf0oY=j&ewUrLq#95j&~5*?AwKp7{`qtf}h zP&z-#2ZhraEcYd+XgbSei`e7RIhUBuO<9tpwbHL_I%O-S- zN~cuYbVkXLchZ?84c^t`a!BGkr88V+NmRFVKKv-1FC^SY>tw4$^-HI(jFQJ6r*msW zI>Axt92=d^6`4CGot4saQaWifbUQPhi_&MdVoT*Y=`@yK#5ymX0WwyeE!Lctr(^mq zorNpYS^j-Go22g=?USccur8fdvQs=8(s^^6=CeJW62B;yOxlyqf`jR-k#2|5`B-jC z#u1$#sdFlw@u$=2e>RU<4I1kOF5|{hS!{wkYTdFw3AR7C-0PV z@@;u1C6k?8t>DC&;$*fYRdUiU&B6$=zHh zSs^FiNa+G6?^brwOKwT9s*?w`oD{9=q(wa^yX34qmJgdcS>H^tnmfst@@-UaH}%oo z$pN_}b$U8E@`aPcVNOz{;&3NjzjSg=GDbN0c%+jN@<2w9b}~m=jdAjxoRMzYW^k{KSsGoHM`hvaZw`L z#TU}0kc-uYU6d>0;#!;wSG(b{hE>5PnsF~^_CCx=Q zyNlmtpTkA0)5Q?E<8hJcbFoA=%6-3!?O_*|0vG+|Rc#kV>$un}r=@OP7Zd8ah^X(P zPeT{hMlKpRcCk$sHFxo4D;LwHX=@i9qz{L-eJVLV> z>C*duE^3WeyvbTK)x|(LGeh&5}nU) z*QnmLE?!8_A9NmmRIi&{gnx6cEH8EQs$rww;VX6wZ~ixm&(UA8@Y2r zb^W2b{&ex?6&DX)y2$-kJ;~btGz;9ABiwu`2P56&8{B+ja&tS%&D&--A*-7PVvcr` zAS2{(Avcu^yD416O|znIc1VL*t(U|SZqj6?{2Aw_iOtRAcsJ(~+|)~S<0<8)?`v+Z zN%yjD)|JzmWH;R^xmla$rh?r~xpX)0Io-PE)J=SKH*eK&b3mTga_c=TH{Z+325ufT zbknhsn{iFtoNVf*W-~X7-gI;0EjNa?ZtAvk(@H*X@7DFDZnED|opP*;at~DQL2kX5 z<>u)ZZVHCEStUEZbQ3+o%|Mwr%FUV4Zt9G2Gku(!i{n+(1m&Bo98=spkvUV{T$$$P zp8Pl6&6qiEj?Z<|cD|bqi`*<*>?Y}JH-lu@w{G??*GyNqsqvkg(JS4|kkYH%yt~@X zte@OG+oIWSbF*5i>~QndPB&Ae&@MMkcf0vT6837=zv_I+f&*^;I_ReLA@zI2&4iRmH64(Q8K!)$4120}s<%dbrriL!;KJp^b-eZ+d9h z!Na1C9&U8<@Wy){%6IY5`F#(kWoTCq`?`6^>+YdgPY*3W@UUCXNpdd_j*mU``ozPZ z^5IYqrG|OvFx;$huU#W|)m=d|X$ zhtgL(ynWll*LOVF?s_=&(8J(In%iR!Sx?mSQ_WbaJXf7k7B8J5yquKH1}{dFmyhH< zvzL_?FJ-J=0`f~yFMZ>@d?{6IUj1G6vO}U1ybP4KCA};u&<KYI))xJ?qskY3^S}DBROSA8lSN>k>#ruPo z`7&(17uN=zhmBsY$doN!e&4EdvfYdOS1)~j^AbF)^Ki_|SI50Pm8NIB%sA`i@i{Ny z^IpD_FD`od?GG=xf2w}De$C6Q`(7?R(E5j7K6~P2_fzHj*UR2mAGOQ-7?!To~$E9`H$Gm(W#R_~Fs`~grURLw* zWepz{>-p$f-^V%G*T_d~6CXq5NK+q)&3!Ct;iFAk9}C<0Xy3_)v$Kz|JP~sj9|L6D z`#zR-Q~nQ?zqj(szCJ!a>g!{e6!i1aNVbb*fRFyNW{{6(AN%O?iE8~!`#x9Rp+0^c z=A-$SKK@$d!}GQ3mcTdacc~B4w?5jg@v&sBkN9;ydj06*=bwC3TkoUkW*;-Q_^@vE zacaAdGCO>Xm1+BZTsYvP;X&1W#7F)yA1mebaUUa3sLzu=Mx4=XFZ-x@)yI#r_qt~F zw~x=H;Xgj6+|=A|`>1=z#|D}9SUo-QG5o1!FAJah`1^&A*I(+`e?AW2Cmi7?Wbo5K z%tk*6GC~fU{8Wze)1#=L&m^aqpE|NpB4hk~C?ym9q{~%#B=05pSy|FgnNofV%K2$5 z(dD&HM$55eKh-Mu>6Pwhh=iPe>dO`}x&8E!c>zDyf_gl|&+QyP8F_xbmi7gHmR9x? zsHz(3sD^re#?<%oqKTiX&HSv9xR!p}wDPl0I=ta$SsOpWxAa&CKhNIr>)(R-`L>sz zdmk!ZZ$C{3`I+&tpNgNV@6mqV9^>brd@{+;&dJ(4#m`wOKh4hsIXhin&-AlmmY-6~ zm1BkWuF`Ba`5C;~ulHJ%bEluXyZj8=HfGxc9T=l|2WCcsu>fT*Yd6U+gM77Ea! zaDYFG1W1et&^9)}A*mS`V2mxmD;bdx;BaDq%1Hs{ln&6ROn~>w23T1xK$-FZUP#pn z0V3=HjLv|r^A8Xm2=Hx2fP0w%R)-X~Ai$E!0bPR|Ah}+EF7*SXH4W(6+5o?|3{byS zfN^aD`W~#@?E`FhNAWra7~LsAT=xKNdIY%EGk~psfHwyO*e`7dDdxuk;y(${=<@(m zhp3mY0t_7;VBeSkd1C|Y7^hk$1Q;maPY>{PMu5&U)yM1rSLOt0K39Ft4{&@zfa(ha zlw2I3{nr7G$Tf*vqWZoGP+?hsNwQQ*tWpoZsfT?5&PbgD0mdH;z@Y%291YO;Sb(m_ z1N8hy`)&v5b|*l=-2iXg3lQ@pK7z)MFoj62iYcv zrK%;!2y2i&#e;lTCdk9GLEbGFWOZ_omKB1`sTib4N|2OFLAs?WhHP{MiF5|}Pv{G|-xcL29-PGNx5fpFalq^7SAG z-w5*hn?cUC4U*hG$V93BPLNUW2K63Dkfr^C-02_WrHmR7WVW;%7^IV&ma-oQ`Sug# z91^7e7wSo>4Grpdq9D7Z@bDnhz6@d+6{OMVAY0|}*dXEY>RUEV4C>!z1u;wxvRMvD z!IU8L<@!{`ou5!CTea*7;@KPI?|ngiW}^8XRG)vU{>#cCMjc0LGF=uwbF87;>i2YLIc=5NkmlO+SEHG>z$GpHJyK_l5JQE?fRkfn0RmOLA{?d*eI9RXW-bF!JbXZvsHPv zWiV>DYC4v|+T$5iIFZ5p)2jbW2CdF!Q1e0trav<{8eWwO6{CZQIYG?7(u^n*;2KFs8kftl1@n8}1i+P^rHc-tC2p$YR*UEdHLE#RnU+_-RuX zRkvhub$=GlgIUa$qQ7U+;(Qjnf^=y8wkxg37Y--iZW^Daz`ZmmFRo84DchmYF*^Kxko5P=G zQ~9%O9t_SVcStth%2ru8GMn4ev&op5&DXL)Y_qb7nv+d~x!G)%qtbP8HjBQ==El-& z-dL7RPl;ZYP5hc{-ddZ@0l6fPHfED>D4VwrXLC?4%fOTR`n2Mn&1RS!{Ue*COR7uO z+|TCOgKUmH&(?D-hg0qx^0IO$HYkVj!*&159Hx%Rq4BsJrj5_x(}_9knv_GvI&tdtB97=tcgI9*gjnz5$*5t52UhU1H`fqydi1uC6zUw*EzLmq| z$2pvPlEchbIb1EAi?e7hS;cbc5SL5k_+0&b%hk`fToyTUDUqJb*MVG?!rrP-ETW^T!E%WrcCr{T))KYs|g{bpZi1BZSplyg%?Ls_mAEHwS#qAWLYUdDZq|5su zR(B0iu3LzLULl5msC81je~4BC)V~ZHs=ULLcX)_(Bej22h_0hGtMQuEgb;sAwTYU^ zq!7>LgBhCd%n*I&E9N4_T&$Q<=<5)RSA^L8gU-WGIuA1JXT@Hx*c(EO-5lb?mJl_z zhN!zU#DrZTB6f!ux-Z1O{UNR$3h_j~KOADav^yH2@d?dSN}UXmF29`$QQ~ZfH_qv6 znfQB%Gv_sn3n4n(4$)g&cS3|^l{~(yncUM1rPKhQ?v)HVLyq?9Ib`&?3wqvf+&|Z@n4jeQEPnn1yeLStZxo zg>iQXGgn5u6Xx){VJdf2{7#DBS@C68*D!^YRQK#K{yAZq&I>bRewfxv!mL{v=EbTokw1rdcW0R8yEMCfVJe+e zPp85>I~`{H`7oz0gsF8={rsW)m%^--8Mid^+p6V`>bS2NKM3pE^)N-AglYa%Gn8QY zd0qh>z6YUT5%MAyrwN&S4bi?dNay&LCqSq?SLC%$<;!=**bd}g=Gr*P|h z2EMMfZ{#z$T|Srk4lQ8JumWDm(P;%F%_v}me7CuPhg%BxeOm#?P8Lw|bODv5<{7O& ztM%giyMW#|3K%SzHw*aWRspx9$lU^(-z#9JR!!6)RJXE0(s22#35D!j(x>9#{cXvH?cXxMpcXxM}Q={&3?%eO%-;did zo-s+Xd@V{yc5v70vLa9WU%%A=3RCXTq$~`0i@J*!O-za}=J9#r;^K?Blf3c8-El=r z#FcdW5{krm<4d@Ulq_1bSZt9vpRYusr+7kaLXtNr!5v#HE-taSl5LzfWSu3oCH?Ev zHY7kwGkN)yGJj13+D!qrZWe;K0QRlGmTkg8=Hl(Z^1Ynfeqk?D za#ogd0Faa+?O`E=DY-0r%#>6;A{;#mNUq5y90Mc^WI2xmlCmd-x=e}jlwe^>rpr#B z0VH>1)6N2tWirz_Kr;K1u!bpVep%?wlsqR~6|ytuQ|vXN1XJ>#EXQ^3FAb87XU@C9 zb8-hz-vtib2Lc}md6<%GvS&<5jfXP8lKqWvk}0_7o%;w#?#pI=0wgPCp`QUs6n*?6D8B-deX?^*N!m9dgZYsfe+Rb9PB0~d ze+ZM962(s;C$r@*p%+u){Vfz_O18)jF*E*fpXpyJ`xn?q{{Of?R007wMx6r!aD<{1 z0cbAk!IZd_LSd$4lk5O9K^1^LvN23a3AIq2DLF11tqp)=j;y+lk5hBmb*AJgr34BY zOo=9oU}8!}$_ix}|t7SWxU5x<<=6~ywaM?Yk zXaFSMd_pm%X?nM|c30&s^;S^_ZBDm<_S zKvFSAsK?w+?d<`Ga0lRWLIBK(0VqRb=?>*j;%%BnGtz`}MFSw2P)ul4JOGlA5<-KL z0g$|rc}sJCbWvt1%k`&WvR35+AX%Rwg|DY0LK83mH>+#%RhkK{-7DlF9RhTMGgpDYH=MvM2z%76+ilQsLm407$gwgr3a* zxyhvcw*=?y07%Z>4M48@0r*GOPOX4si$)07Dj+G9RT!U50m)xkSCayg-DaU?r~;Ca zk-~*21tjUwLI(2=UAGHGoeD@QQkYvzf50dIx^zbh-yxvBz%stL=Pk~h_bx-}G#w4ygOxuycWYAK+ptw2T{ z1wtDsaI%R4AE`@I1%@_PU{ot1OKSxxw^1NlCm}a;KoXB%Uy0K+ zG*yYIq)Ahve7X|*XlW58wo%8TN(`hABt5fVNrOvq9F$R7iF$ONjAfNrSWbyz)s(14 z*{gHTG?8x9P~t!>CG-uI$W2%2Db;AC#Jt8_yC$sDnrqgE?Ner3B~G?u8y%D|cjvqZ z^7bI!9->5l`uL9$|54{*N=zG}M3qrWyqLf-PZsP`l#q0pDm-HTnkML`D{*Uv5{qUE zpP7;kbA+DDlsv0kSJ_QwljYpYRZ6U)cdM0Xuttftbabr}zt;<;Hz*+)zft(Zlmu>4 zV%9d{EmPv#AuMJ}-s}`A?NUNAeYc?Aql6@ws?yHAN_5)Cxsu}m&mrM3&l_Dl!u>tU zGkJ{X<~Y~ugc1oSl_+qUuIlvqK*ce%f$ywA0vXPHWLc&EhH_ez9+P{K{0DCraT zg5tg?(f6woBgyzpiDmTqJJ0P;?tNAj7H3mo16i`Gu$SKEP+>rj3Z7sUiqJ;-noGs+ z0~HFGR2Ukn!i_K$9!IO-icz7QLxo7E3RyfVRPm~?IaY;g2`c=NHBV$+3P}>8nUWc@ zd&w$DGE#&(%qwXstSqcTa1j+c6jR|q85JC5Rp?rd{nDfgD#TY*VJ$(S`LYq-{`P)kYO6ZxT*zRzYIiBGlcgg2cW}sIgrI z$tu~q9h^7q-XrANtAgaX>^f6YVxKT(zY3C{GTi~L4IQPthj`|W3tgC!ohO8-lPXAJ zDgKnu?=;tlUdz5SU!GB6_*oVHJFi0Liz?iuu**Et)a0fL`X?&fl$CzQvqa;c3uWJ^ zAer$=c*2xezX;oyl7O#5sc$Mss!{PDDx9S3zf|Z?_5M@gBP9l?kzJ=ow`^*DFRF2q z{-v5Z)R>o3jjTaxJd09eRJ0lwtZLMXQKP(D*uj*v@d$mGl9w`Zoz0o*IwnYXdd*HB#ep zV>PBXRpSqBY^KIRay3_@dkZz5(np%mN{xGM)acPxjq5b3of@-9*ItbZ9oP)OeQ~ zt#_-jVUHU5_p&Wox{vK2Qe*XDHNMMg992WISoZHR?lXNqE;Km7KIz9vHCmnGnx5ml z&T~yJ@NrUKR-*~6yrPErsv4SGYSf{Hx7EmTM~%ERjh<48yIg0wMt|n5aRPBn@iG)-WX>l7&Vo8c2fEG#Ex_(ltmftbwPf z2AX0TWE9t+Hf1lN!8p27QiGzUGzh4`z9_jOAEz6YHE3H!gH2U6C|Hg6SJz+~EvE9d zSf;iH9qVYYs;&mb>uKF{ z2YIxR{0SH8L}(#dXc2NmY9W~(#m8x5v=#@+W!0j)O^c`Wkq*UZkz{8bs_M|9DP5)z z7w1IND8QpdE6U^5B8FzuLm%fBt3`bp9jC<)S{tv$UW!T3qH`k4P$nfO^YIid@}_F} zyMY!7XoxW zwiXd}weZk#3a+O`t@?bNjyKk#P!la$Hq~Nq3oV{eOe>C^0y}6C*HMeUowPXFO^Zt1 zxlTQ_Q1{d#H?8iag?)?`UB+thh`v(LI4#~z*5bfa?)?h(wTkW1bUL$Ii*9>`AI$Xq zT0|WaUO&-7()FpZ>zNjk=;uNzQ}T~&-YYGtz2-RI@C?1xB0trq6`!@p_l5iOmHR_4 z$oq|B`k_U;pIU7G#rgi$BAzDw(PDmp4tHf`6*@>JDg}p12T8g{7{ioY(hAQ4b&zxZ7!jdQ3uHs*)5X}l5=LEV2BQq7NJ6PUL7RU zWq0#&E;Km5u(*H@l0ULyg>;Z?mNkpiLGqeB(K;-Ytz#lqhq`e(?1C=3G11X&ly6~@;XR5(F!_SL5Qx%@l%IN!ab&BSQX(k zQ*whUR25b;CGV>V4Xf)Q8CXY$D->E!hmoXis6#E9-$;jSjdfVpLWh8s9Cs@nwo|t* zIvgZTHyygu5bE7shnhWf2<)lj`PN|+UFfAlT5lbnpKy${Ww;L2N9dp%sY3{jpmU>i z@Q>D^GPNVcG>(;~PS@ex3>{KtazAEqyi{_I4om3eT#j#^4&DVi44|V6bucd0p)svk zqQkePIy7IV!p0uh5Mt z+5J+mzS2PwPwQXnkms$?gDKgYDV$=az86A2aKEVGN8vnE@ZY64;`-m6gH}Q0UQLsmEw~M{QMlY*Opd zLZ`=)9D3+;>QOOBkNtFoGU*rH4Avt)mmd8LdW@ngG}x%e36ma`LiBi%R}Wu4J$mQY z<6pW_K#%Z(dbBRYx-=+ExXqLlj1VR;C3EQk)wXcFk$Qwg=`oJ3MC(!1s)xd@$6^}p z(c`RFj}#yKB}cLzt1|R(me-?O1wDT*=+U^69(zeqh4ZM%vbFWNNT#}aylKq-+URkI z3boT?BJFRlhqZ$q9XslApDdj@hHiTNrb^xQ{28F<&j39RQfx0h`t;W0B}MhoV<_e5 zt49)LQb0dF3=}_5k7Bf$rVZBPCl&sOZI0BV-59n-nsIt`r_$r~SVJEs=+S7R9yKQE zv4wt2=A38g@rR1dVOtciK#%scWuYE37VFV@i5}TEa~yPf3&*ilk7L{P$g+dur2RXE zx4ZO^`1S~knG)Set{=TSrALF)dR#rDNA7dnW13G_&U0O^>#>|3(7T&L+8sS46=dD+ za{Xx+og%|MJtC;deLdFElm|Rtw1vt%)MF~GeWb@X`fdnBF=HUg7YxKqI!7;(1K~{x zM1S(92jU{_DiVmoMFU|gAq-$1Eg1-3DPd*lKvb<6h+dRjOVHI0grur0sZJmy*1AGB zro_86=zsb%C9if0al3*bxw2chuqOzT+JZ3^^GD$vIilsUS$Yo)PvlB`eMfpUwwCvfz?X_(~8Y%dZL_m=fzX z;n;&9NOC?DbWegHsVeh53xcHgOJV)1AV_}5PQ4C-B>P*THdA8C6ncCNg5;2_=I0BbBA2&y-X-A?X&RyPcS6Yv*r4qM@&h+D4_yVa;vBiQ7jiE zrP~Yb`{aUTr)<}dT#)3MA+%shysLzH8*@SOuPovu+oJ*3gi}n({TIUam$@JbcqR1C z%!Q%9a^V7P`X8HlQy(q@{h>)&RCO z(10<63{VVVSz7mx0iA~$u$QI}Ga!1T0bMC=iUD<|8?cOu&M+WlmI1@5+H3 zz5(MG7@%HcKqYFum~&WTK-gN&dxrs&_Ze`H@*gmu=1~J*gW-IR8*uJ~0o_j-P~)5d zi|Fck18#pd!1Bd_ke>!j`D?&^st6-alQF=EB}yY&sg2k|@meE#>5Mo+PQ4LdvKvu2 zhY=HV8j&-|h`LlT*vQ{4jp$Cv1|xCE4i#8%N#>n3jjYx4A zk=tcN7OxRQ;*B^*!xM~Hmu$p$+LvNPrBovt7Bylu9W2JWWsNvn&Iogc5nZTm1tVXV zFk*K_-mc6#w6Tg2k7^iUuW3ZNS{z>kBihoO4n~yhXv8F{*2##_u0}MYecg?C+{Xw< zUn3d~FrxY(BNkHNU?Xn*V?@MIBR0^SQARwcM`Mh8Y7ylHA1`Hh$_@|2m9L1c1X9^i0S*;4wXM(#EyeTC=Ri|!$vfqRrH9S9yP*s z%!orLjQD$oZC>QKX)KkxX2fJVO^a?D@rEMq7;*Qp5m8ULZcn+knMO3H+3$?__}Pf? zUq^(H1fCQEY@I?=2aCiH7#!U=Mk||9QN}A1!rq(Ep4NUdVec;!w7*S!{%l55r5WqVpf;me zpc&)Io5hShxy;ZQ%$SzfjK=xQSW7$eoB2Da8E@%FK{JxV&AgVxj2RJT?6;Vqk2IqQ zt#X+0nHqS_=of3|>)dACquYKndKWe0D6J`O#@Es;U&ahnHseoqGv6yR<9A&%IyN_B zHyvtaM&0&iET;vXIG)aCRHji>vj@jQ&3c=0tFIXm{mj@vjR$kA6gP}*jWVOuXfu@K z&G1b!V*ov);S0>TMEh5ov22YQ@9DuhGt8UJXhO4T$W}AX(cbN5)ZTB#QYv)NjA6&j zxJa9ivyT&I3?lDIuE7~I9#f;UW-L5!#%tkmjoShy5^9CCiHtj2#zfbLC!@X$h(-gsnn7XR9zZ^BT=Eq9vup|D-=~z zLNT9?6$^#7cqj^!vqUI*)1i`~I8!PVrqZG4K;bKit6n`v5<Emu z8-LPrBTup1XhHYtVb3=3)KxGg} zE=xG7QebE}e&-8Esr=!vdBb696^_QVv`;uP283e<6&MqaiIc){huX~#M~{8sSVJcc zg(LVd+qx8vGPlApm7*Sp^L5E^lz7ezia>mD1g15OK+!f47)N0}Bd~#flDAg`9#X?G z5m-$f_C(;-kqE>cjlhxX5y<^30yAL2V~WjbL3x7(Gbyp41+T*_h!3~G5n=vZDEI8!0;FrgOl3ojz(1KVCUeWnD3pOV5F8}>t`_8%j zvS1f|{B6N=RU|y>NaPHRggr|ndQy#?k!T+jiJf#PI1;lAk$6f?jVv1yiGCE3I}*d_ zXr4&q$Qy}P`6BTuG7@o7tZR$JCrXQn#0$!BMPde-V%bhoBwWdnD4G_D<0T^zR4Nkp zt45-Gtw%%a=vs17+JDiBU%)ag~Og z;(xkXwd|La0Ixi3iL848Y!XC7*5N>qoMUi^BR(946YK5SIwgl*CHAf+eBmK zfM|Ro$1;{%8;uV%dw(>p9g9Z6=e+B!iXh`PBCckDGy7@*Z^)?!hseLBfco&U^)P<&g6c#bpe2T_Ln*B2x`~MSE z0ai%5$_6oyQ+A~l)l^m-kzLJdg=BCxD^6s$B0h((J;aJXp;oldEzHel#gqJ2R4pJx zT6lk?758KjRx2du$Pi=2P+1d?6%wP@3JXo6yFM#2VuhM%R!CaO!qTnq(o%X|*owME zgokCUkbID>DQm?Za+I^8TZR=+Wsj>`A^9X*SIvrjfuag#8Qd5@}W78)`aP`NEEx0UnXCgfmVq;}g`ZU@iFPAlf@vLefF zq1ry)-p{WO2&Il#A<-SRqT(?t4#={c<>M4_-io#tthgiFamflv^UGGOy<$b)t5$fZ zw=DfS=X=A7uaxDc6~*rh9Wt%h_KxT0y%ouHEe| zhB6Vt9IFkIwXzmA8+y>czMQbF zf(?>J6>V5i$p&*}VO|v*o>sN-I!PN^({9IV?(>T!n1ldNG8;`;d%ob8aEPZ zwY6bEI~#Je7cO)qRiQ54-*crnNZ$#>c2!8RPG*daFb{l|va zvhU1h!-PU3ZIGOn-DK7nWkb%^*3MWX~ZR6h}DDQ$oetHb@%Da^JDRMz0?VXP?+0 zxhI?Pl=Gs{XRPzwhKux!D!mcvey~B(P8RvmhIm>@?>=!3pKa(y4}J(e{_;%H2w9Q; zY^Y2}C@>%feP{yx)CkM6#6YrL)+uWY2GK`K${vGNw4ba7;Z8^lByVKPLs^%477z+V z#6aSfy<+~Pc9s}yiHt#bR16YniCs9A7z4>|+0>*MEG1KN4C<%E;2b@sVMT=E6=EQ% zF3VAo{m~@4St$mkE3+P*tRY;jAA>v%V=zWGq-hK!Q)K0vu{>QMQ;Qf3r#Yl)Cv@o+ z1Ia(K)b24TPX|cTGX_0q41Mh^LFldCF z!FJTl#m7R0#5{IL%E**??Z`#L=xjba{P~5Z1?^Z}$d24$!n1HY>=rxb%0i>;XcTS7 zMcF}{9a_5`lN~~IoE;tGg?>zHf*qX_?YtgFc*}gBY)69Mjuo2@?LEOchRrP!i& zd@3bmFKb8ja&{b}+w@h|rHUQ9sS>+D!d`PbXge1jd=WQxspNOH-}G4D~u zEp|-bYKLZ%##($?LezM!r#0O zl*sSE#R9^F2nViP94HwnSfU+hXLaDN?2OHUV7miDWba%K#CsfAPJ8I1S2&dFfG*vE zUa~)>9gt)%Bb;R3q_Sllm{iVzfDEB~1qUShiVjq&=We#ew@>W!)XH^mJev zt){fzLe-%T%pT@I;BcYw2nSY<6t*$LMmf-Ww15c?l$t0Unac9h9q1#wHH&*R$AO75 z#{vhsEp*_i?7<4|@hS(eB@a=i)^Qup#&)jZULp0g1Ck0d z-5Cc$Xtb>AIR_-oWcklK;G}aGgzi_^4h@$TzRG=}ch>|w9+&Pf4Nq& zE&n<26VCt91~@T-&MTZqQwl58PGoAFXrLARdM701W!gX|%ruHFW^tl$Rv~LPC#q(5 z;)tw#FzZkQSx7D?qG>igGB{D$C`>guamVaLxe&pX$B7&5U%-j21z9#sXcy(g zmS`u!twO;VCtBK_{H&f}D(*!65>A|x{Ve6=YxPcSlC3ZA#Fq+AG_NR3sO-e`Do&KF zDlDnz#H;#(vY``Y8woX;gBv^fSvw~Zn{sY+rM1w$569To$=C9Q@BcWFKFo;?vLhp$ z2pr`^AKBzFPTU&nM455I%n43Bn8@)@5++P#|I>tT%z4wDcsfJ)!2EBfkaZU8QKQ*T z+@nf!oH#?p=Q=T$#?5o$>U`c_;6%fPLObTT#ZEL?;>4<@PJ}KK`Z6UWY1nEf&aUCU zuNBHLORRHZ?0R7qGv5X$nr-ABZ0EVz;lv!-N@mHOPW;;E#E<h}r z!hVhl)0kO~IZ@@f6NhCNm_twSoSo$PImPoSyTe>`&WV4|J5lR`Q1+4&lP)_Ea7D;< z&51hKoj5Hka+CehTZ+By#8TPlyG~rX$H(pqLmoJB>Y)?$9to|PU&#N&iM6s_%y!S5 zxJ;QZoG`p}VlTaVAJ~QYvW}jU6@eMg$hlCCCy!U)xw23Ermj@U1-(Dg`2XWZCyCi z&V`irLXM6u)ac~Gak@icodsJz7drQM;gPJ%P!}Y5hPlvWxC@tMn?|`HX))S`bz_8A z<6ZDfbYYRK@l+R9PUC#13-@Na5HZ_@sj~m(aL)6%hO(IpILC#Y-y&h=8W(hHh2QJB z2OC{@xJgLg?!xdLE{xhQw7=xS*2`@Fitzgm%inV$-&3JMrVGp7xnO)R-1zK*WY8Dx z(^nS~z6lk+b3N%N75T|I$_l`Z76EQtm+e!!p;EiiP1aKD#(JF_`Sou2=x}zShrtcW z2w4%MoBvn4afAZRZuF5g%lfwtiV269k}Ac8qb1ysbS^36FU9%L8451LvB*|d zaN}J?&bPWypdr_$5!Z%Z(~uTIwhnGo>&P}`cRITf)|K<_F4zXJpMh@t9wbZ{$~K0% z(RhS#WHif-Lek9Wg6(T&A2^<+0B6{iX}rn@1zH^YsHS#C^~-Jk7-Wv(03WS!@` zv2%eN(F=up%!tJ-FZ;aIjg;kXUZ*P*Tj7S}x0I{g*doii(T%E`xTdm~TikGOb7P@w z*e*9Dj@>*bd)#;`o3`JLy9eB8c}Q@ca-;icH)1aeMXtCp@~Ru(WmRsuG3&M)U+=h) zde4n@vVR`9ar&Vf$&WaHdhuMC^U;mRpSY)=g@NDPIR2eu`74|Z_CQj)kOvdOJorzR zHQa+E77qfWJm@1E!3>KQT+Fss4>s65_!{HEV22Rx@$hrf9z2kJPxc_)&vLR_sU9py z^B_mMpe*WvWE=f1=D~;(!c?ZOtOpV0*iVKBcVz!E&s6jvxUvUBWS6RV5K_&9CDnzx z4Lw-gh-DgkP>I%2QWFoFQbab(SyH}JlHbXgMX*+49xT3#(WQ2E@0A|g#AMs$kY{pp+?w|9Z z!g--C^V=ov(-jZa%WhuvKr;H82bZpUP~-;ZchiGWw}k1;%J;Y@54i6Sd6u7eQ1Y1v z+hr$T@XWpRV4$qRYY(Qq5f(F*nI4pV=fQ5-jISO@(!Y5y{5#LNZ1GPIUjFi+_HSYM ze;%BJ7pVb)U+IOUyiBX|!c3#+qS}kX8lgjWFC+tHNjbbILwiUO(N-c66Qs*aG`UI7m^_|zuk)r+D~ey7u{tGd|o_{ zWw|&ZGs%m%6fc&^8mD`)valDvqQags9CtY{#$^bc<@uG28p-NvbX7%$TVt`;C>qUccUYwWp zpW?;QscdVSaGP0Zh8L4$w`cP9Y%kW%5%R3z7}m0_4MNghF9z-N^8FlP)lo0rAM>K` z31Q?ZFD{(sTAvXFh*YiTh3tmY6-r=0@dJ%k|>nNMRyhCRm2{)O29(!@< zi5H%yLK<^6-G0XLzTo&}^O>2n>|Zb5y!4{pE1}kFFC?8Zz1Z>2i>UX)%@1A__{8yj z78ZQxzW(r{#!sOsb0wAg<;CRR+`~V@^uJ!*`;X@szW=GiJfQMHqw%2!P0|YUnJsia zWY6M5^{hS|qlejqx6F_r9~uVxa6wkm;KMkh4}WB%%syNU@u6_2FfX4ElJ5D1mIZuR zU(kpAg@hPp75YU*!+i*_3M#vgfA_$LK%cNW&W8{2K5X<04by#CUf9Raiwa@od}y8F zLv$5kT6G`p*6<;trZAzQkI!R#DA`!p-IV<__hD=c!O-4^x*dFY-cd02@}XXDAI{1e z_GN$ld@%JFDh~Ex`Vg+sNMYz$AI^;PA!WR9WCF)M$%j6&O*4J?KFfzzvxRwceRw+0 zhidbMaSMI8y2yv(i-p`veQ3PQhfDOF6w8IXD|`rF<--(ONx3!%VW&C&Gd|psl{x3b z#PdGjg3$l650Xk(d}w>shmNm>@JzNx?cNFL?|rEAK?wThL#^*VoRsbQ=|jbU*#9}9 zj74^JEC$dNx-0vliG@U?6%H~lQc+zjM(JbGJ*TiPe=I&1h()u4!p5*zNNR+~VqQcn zvRMR6R4m#>vwhhfTPzgzSagvcce9)~7X4-W<71&tWFNAe{#evZ6_%&P;%#~?)|L<| zWW-`xd6usrl&lepaW!Lk{hTnOb}Y`SPY&Qix0Bd^JDR70rzQgMAz61I7AFr1y^eDp zCt~3`DZD%r%WI5cvFE(-`w`dSiBO4onL?j&ePnH($70iqSomKGM?b|P%NHSpIhL+` zjYWg+LU(N(_Uhtb*9*UL#-V7iP?33nGzK9Tb0xhq#-X7}aD>L8Tkbgc3JUu0I8=&= z!$JB>buDptK|zsmI8L|d4dt*2d715~j6Dt$9YP0Z9JaaQU~vmkNpa|q9EV}$i>;)s}}-t$D?$fcwEUV)Q^wH(u8>2OcI7wjmOz)@$grV zM`hX|yWA-rpNfPy6wkTpX{o0NcIlN0cAw$N!$0(R_8K+*lev$F}XpHIMCS@ydLsD3X2 z$7E0bO@QrH0%pq!zD+>O%mhS!7P^NgVsAtu--8oQI};J)PQ+l@hm=GlrY2>aI^1 z>@1Op=#oOIa)}t9k%%4@gbi&I@wFZ6cMwMPPsGImi6}f!_%tXH$wLycnhwz7(L(0T zM8wTb#4_4V#yNs!ULwlRPsBdDOl_A6OI9S})yhQFS(S*66u3b!ZB9h}Er~cskLk-E z!F(YR4K60)JUyX4*M;*p+0X4n43k}cn26BFi5Ml@{4o(fJ|*JHPhp}X2{)WcNJ$WK z^iASt7n3k?IPV{kgz4jiN)wVWW1=u%auSYBNkZJzB$TBVvZB+IFlt5;e#n}wNy3`7 zNyxJ<32qu9d$lnMp3O;EB>QtR3B^yd%q5}dbGGv$38mi(Q@@ z=1wx!JQ8|7OUC}^Z1aV1^nEh2d`w1P*^Gb`+*hPvo=#|*D+Q|!DadUUuHVJ|b` zbqWT&NkOJ;cV-F#-V528>*>pf6g2-R{P>ZA!oP&_%$@Y#?-X?WBOF)wkxk`Cf7uSL zAAfazbkGYkviosAhwz#?EvFxMgZ#({7V;bXkes0GCO-zqj+y<)8tTXQ0>bEme!h4_|RVmdJ{i^kYmZKYq!wl<}iVSw9ZThGnq7^6aaEP^+RJ3o7}Mqq14&7N%<;~TRN6pa-*eqR2q&46s^9&X{lkyIpTYs8LZe83Uo=XEvq>uE%SJU##l>c+DBN5)*Mj}GV*j#ZZBvo8y%5SgN?AGzAET4N-7pkO-0UW zLO$kOnmauenWUMS3e~Jsl$)K3J+hO`zH>OwxvB8Z6RIpo#jJ&?sI^?!x;_=ZHl#wa zQ)qTH6>E;AqRkm0>N?lsMk;>X6eiwF#f|%^DD^=2{g7jPoQf^7S#P<|nW?DsPFVPn z`}rxApYIm3eM?2P@7yC%z)NXPYp!ivarWJaZ< zL9|fYmX3un>FDDX3N=qhs}||FDZAf39hQ#im?kSZG#%rHrQ?t6@{DwZ&PvB9*}8q{ z_`E+IcMl3zuBRjSO(BX|@)qmgW__9cWjeaP5(Y8j-=w4e+jP8@WqY5FY9G>ZRF?KB z9m75glbQ3rq+`N2VJ`D#k!&+cbo}`_fPd0{N%m=_8UOpIY9G1l;*D?5ZXXKn|2uw7 g#HK7KGJD-=*W#n@-l~l8ee(TZJ^t0u|L@=b17LSCx&QzG literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/791aa115f3631fe8_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/791aa115f3631fe8_0 new file mode 100644 index 0000000000000000000000000000000000000000..d25238efc86b9f8daa075c91c26c9602a399cd39 GIT binary patch literal 19084 zcmY-1cX-p~7x(dZo1{s~Y-u_`R-vUyvy<+mWy#)KP#Fq>3`Jx+ks*8UJq1BF$R0A4 zJ!FWWG8LJ!mp-50b6w9L57+fF$v5|X&biN>w&^$D>V5O0Z%TE4@zMlTmN)9WT%j9+ z{;bRz-fC5{t7rMDdi_~de6MHLs8Y2`mFz5^KPMRUW(K^OnXmh+`Mnw5pg%h+SS{eo z$jA%^s`z}tjA{nOI2u=Y`u}46?_YZQcmMY`LI3qfz!m8m2?u0`5zdQMMck1oX8650 z94`qwg78B&SaLO9&W0eTI+T1JIyZuqjiGcCXd|1XT2tsQ$;}``YRUU8HCH}=1LnW0 zJl&yV54bDEdV#I4V)aw3{*W~g)_e+2K7&r5L$@zs?I5V~6~qsPH-|wN$^06Y$=%`b z_6X=Ibw@%g$r%MTq|+GaB?HI8*YaYV;!TA0Yaw6v4X{fVY=j4L@q0bD6_#vM zojYKg9G1MDVEzFT<)mDerh8!TUiewY?t{5fd_UAVsD6m;M@W$=^3x%>Ad?TnVu?SZ zzMp{Q((xqpmg~Z4C@OO#_%pmN|4Fek@P&+#*=N<`3t;*cc3y($-=LKIEZ3yP@6hlM zXeT8vgF|M@Cs$y!)VvBU<>3EZ)85O(>#$JbZa{^PD5!0;Hh%Mr(X)7#Tqy@fsqiENf(dF@llux+#L@vR_7+BbX`8EfI8-Gjdh(q9dp$QH3Iim#<}t z6e%1*`Jxf{<(9mZ9>pT~ME;YvV)R(jVk5|wZ)KC@mxy4#SmPpiQ`Si@TLiI*5mbv%UQYM1WB`Z0CS`t}7b7ZhgkP8(fIG7T_GTe&xrybO9xgz#=BbYAh zJ4Nu~y$HH?j^I+42vWK#R(JJ&QUntxM_`zubf}+Rd*x}CD|LvU%p7j z`y=UCJ(6EvkL0Twkvx-vT9K@jVs#?!%_3PMx0*-NrbQ&3 z<(5on8A-oZkwm?roUJ3-D$k@vn@IkULT^U0OHRpkNop5Ks`Qg;9U?g>|Hw!0L^8Nz zB*QyvPM1g;zaL4F4^{8zNIYXB3CX+TB1sq@$y*a5IV{l=BY98$k=G_gazd`k6G@sD zNnm;;m8IdVNG?g~`H?hR7|HL_cX1>$mMG>ok$kf>lH1E7d1p-|zpd4=?;|M=SKm&ku5*g}L^+-+?=!`c@1*oA#s4>w zvPJ_f3LBVJ#6Y2<1}+pcFs8VHIZ`CXK+{+Qdt^ij12d(0oPmyVR?5U{tlUd55RqtL zs~nPWl7Yb`4Lp>LvIc4hY#(+htJ|0~_Rn zss=un`;uMVz*70Lrs|M-wG6x|N5xjhz`VK!sx>pvOo}$wnq{1vZDC+%D+AWH21?3l zxhgH%8JOK(z3ZSkUDUJp6<_XjHE^(-V)QVO&|B;NT#vud<3R@g`AW4-FyNeM;G;X`(-S5IY? z+}dQI(PjfvwiqyNHR$KA_Ek1*Gw|Vd12@FAQ?CKx2ko^S-=p5{)$3uO_H4guJzyZ~ zpnl~y?n>LnMhZ7k+@?l$%TcM-!bo$uCC}u;mPQ7&HnOgbZr?PL^p=sm z65ZBFfBCqbksmr3dC*b$-&1X!bt~Q8H*!LpU5$Ly%}B!!jck_>dm8yd?n*{4Ba7sn z-s+14`l?s5N{pWv`CR6IVWiBLMm9^gK}J52zr{D$$crIHy+<<=HCF2$XJo4!m!jj1 zoSJQ9+8iU7<{GI#&qxO;w8Tj4cSeTGv6V*hR~cEh+DPLyMt)pt#J0{zoAs)BgOL^+ z^_<-O-pH1%MoMfmvR}@~>)VZt++pOor0&=HWYYm7l@1ySO6HHM^C#6QPvx&eMtUAM z@~b4DG-ADC8Gss7B!K`Hve$fxq=e@6b1 z>S{5@gySRzMF($56GBG^O#4)>xR_P|{drf>V@B2&)kiWze zFfm6~$b=jd^>THaXCfkGB3`CdHBr8?^2nAZChSd3SX!CrD~>lzGMSES+j1u-L>;Qv4eeU(0tJO{9Ns zVu)mIGBHcqZ#L0oi-}cRO_bTDIkITG=I=J~?GGlNN{hWF7RaCb^mxCCw-189Z!T&4?|?7MHm{m8^bIse#1ttTdKJ~iQeZep%1`&V`RXX2%N zN)!(yCo+nqvR(d@ea0y2nxYsV6{TN9qOi#cOBBakQGDc%;=W{gqgWza#o&vgW@Z$- zvZE-J6GbaoF86bzXqOj7Yxv8+uLt=mNrXdlIC`9nVG5XGP3 zem9EWI!2N5UKG|YQM??W_@5}2j2^6fL-crP6jz5u;TRspbZI^-ikY*ch@KNgS*brS ziglZ#c)leH^VTT7mG0Zri(Tr=4^a%3Z}&%W??4o74{H5~qG)_ry^x=!sOKI>;gQ##MA2DRK8>REGp+wc6t`YR(dJbYha=5YF_;-fW_HNBB4(nBnyFXJO#k9$j!21EGv&ll!ps_Z5@+VOQf6LNFw?rCnRzK@ilv%) zO{P@Raao;aW|w&EW_ml!T$LQB#!6F{nRn!*BzjbbMEJ~fmQsE*=`urp52&u7nGqRg zp2><#GutFR%S_K~Juk0?&3a#ACM(}eP1z_f3(Rz_Y$jaW%rv=F$4vdYX09|av%8_0 z%8ktIlR{0*9B66gvK7bm>Kw?nS&pjY1CUi=wrsz*Gx(Iwx1d2NHZUeGV_N#mYC6IZci|?bCQ|E-ze8I z#g!>?=vy-%Z_|3EV27DX`^@}(#Z0fOW;S0llXhL}lCNa;O*75@Rvovrhquj?k+Vs?QCJA zeEgAxT@v-Nh2GM?w}qB{EJXLUXb&w6mt*}bvTBn_Q!Lz_Y9Vi$)<0c!N{yKo7Rq03w>nf74_q~=E-R(d&9yxN&8cMlP!N) zu-~+hDJ%cBQ0lhk$+kNd!uPZX_q8YgSU4(I{4u+k&K%0T%=vLdZ~YOpdw?n+mql{F?Soh()s7PDe4Zlz(2l^t?Q?#K%{ z7i%T6gq2U?tPGb^@}MhL5eh zlt#U+`rc#J_Z};|B-qc&fc{qgl1c-t43=U8t>nlZiTK1yoMe7(rJAgj$zNJ|E|tGh z%&)C<8>v_lHQGvVsWryRa=Aa&O1p7ZT8y`{PM%HBnx|WNCDmpsmPE|8(p}cgvodvo zm7WW&6kV%2|%iUUkZjO;&Di)?RE?EU_F^zvS+ZR^I-}%IQN^N*>W3 z${aa$RDC#OWr_SIch6bLzhI?-eEh4G&GMtfU9?hBI$W~yolN{quNPS-wSTuVNml$} z<%v9vi>8__n)>CUnI=c%Ms76zyl6g^P(d`uWpkBiDp!rh@p?3$$=({#1ZqaJv{p1t zTSn7Qa$7}Xc|(sSr*$;;Hqm@6{zWl-DmOR9kg++2Q(Iy63~6T{TKF$_Nt!=QsP9Fd$KW9W4#h8^4`cZ3 zk?MUC!$Il#G=>R=ST4%a=vW37isgvZEgZ|dBC-4}7mLQ~XG1IiedA*JK`fkkXY(&_K>tEkVU4ElO(|AP<74A!CIf77v`dU*x!6m_@kyyT(#yrsN6x0k(ZvzR zda0Kl$02_l@qsw*=fn}pjpJHg96#sB@po{dIf8*QuF_*QmR z)7&~X4%fAjP|wCk(x!n;zi-&s(ol~ZYmTgLV&jh%Hk>VO)NQ5u-nP+IX7;dA;{zMx zrP+rzl6u*ASGM=Iae06Z*FYQXKC{vM3mfw!`b!(e|)9I9BCV$A)y*51iZ0tT@Tv4Evb0H#;=!cRJx+R zT~%-I*yt!T?%Me0p^XYJZ1gq6>l9f$&n2TsJYUFnMdMkN5YJs1l@!mC*W$S^_R{g3 zNQu|)8u47M6pzIdPgB|Bk7rCEp7Sy?7*D0lcs`QxS@BfP)iJ3Sif46xJTK%?<#?J@ zi)XeJtsYPLdhv9VJq_ZS);gXmlG!ev<{jd>EGZr1`B0{JiszH}<2fLn?(s~KKP0I~ zJS!wTAfB(~#Fz23930OAX)si|hp9f^CXPNY!5YO(#@f2R77|Y}7zcQY^vT$8I zjn~IBOAK4on|<*V*&k2Y!|{|k5>FSoB~y-Rp49qTYrPWBcBywWp5%M+be9!R;@S2h z9`nn1y^l)Z9YX>uCC-#Uwde%Kh`&$*TT3Jm6_>!|*Ai%7I)N3ksZ4_2rzdb*o|Q`= zr$T~0?@3^4#RPVwBw$TVpo%PWCGb$*_9yU3FhS>W61XV8gc9gqHG#ddym|tUYiWG# z1ZbSVtL6zh*O$P{HVJ&tF@Y_zyK@3K7?V0;3f$u$`|H-QtfV`&15mnU#fe)}$ggf$6tkQp*) zeF8^h+r|Xm*pa{@DZeX$A^Q?IE^GHI$AJXC5dT5-;7|gWrQP8K<{eGoZ|QSP<4$O8 z^7Y9C7M@Pvj%@l_vCkxscs7AXvh0HTC3i0-Fzs;yS7aTD%#Tatmh|=}vP+VDiL}c| zV~<2KKT70F`Mj5o^-iR#JeK$RB(hej_Dv+RUm_2s)EA2Rm0}J~ z#LDa(GH22~#z9hHmF1(m`I%O=RD^M2gQ(f-p_)m=*Gi&?)Nh=`G+EXp ziMVD-%$HxKQu8D>NM5TXhDxP2No;;M31i13ig!t(dAB6yNtN!(+e7g_NYWY=PtJUi z#G?_)J2HvbiAmgaEx8%gZ?Gl@cfB{AXeB=DTyz&B(L&IQmR@>I?2V>B{|i-BxQP(PZACtK!Kb=aZ%eiFMOS|jI zGE<43XB_HfeX@Y zP6hgGufTFSu)6}WKPc9T3e-Mdfk{&7as{0?sle;kbsJNW%-D)dey1W;->=AMN$y)w z=lU!1T>Ski^1HMhS&?t0$JUD6+*6T^y%pJWrXnR@RAeeCT$W(*6za#NFio<{rSNxh z3YisBa8*pvxeGm(0nQY{o)mU_Q+VM^p@u(&g)%po!c94vk;3Y1JtqruQ>YWt<9t1q zKtT#UDyNWMB}G4rAC&{fv8NulanDf+xD zg;pI>aP~~0ueb*4`A<{WD679p;r2+?JSv5MC#3MzRMjChrfcrZ6h=$WSt<0JlfoYH z%uS)la>bMGYf@OSL-XameJPYVoI)4z9!a6@*%YQo?_X0$`7MPH9ef2Q#0 zb_%Z^rBLf}3KyShZ7)*TEdRVr;kq#upDC5%(Wy8KrP5bg6i=mlOe&jXcWf%t<5IaQ z@7OdpF_llGV#!p7$lg+^6nia|&ZSeinVL#QCCzoD@<8&_Q@J7aJgH2T_@LtCq~gg< zrD}dE`)i~UQ!|xIO;hRJDwSQb>aA1?cS)tCEbFDQpQSQDQb(rJf1L73`jk|bEKcRV z6xo={@I9%VmO($NuAfrbd@L2?@l<-9PNn9VR3^xi^QkobJ(W4K;)cfGNu})FRQ5ef zW!r0&Fqf{xZ&{TnmR*VZGEJI>D=|m9RjI`0H!ER$s}iO9RHEVkEU3f`>9wyC)y`DX zbv2cEd94x;Z&ae-&q|EAQ%UFVbxc-2tc1auMg#dPCXKwLG=|EO3Tc@AY5H6*jW3&| zakFC@8J*H-_NiZt%aj2&tGyf2M%`_mYEGK~#Cr@m@C)+Ov8CIjhQmx?=)R|lSa+kXcQp2H8g1nxneB4rtEMn(CQ9GH%>}*W5^D4g!QEU60whAm5*`>$)&ID^A&Y?X(@A^p}D&s^zSm$5QB=o$8lV;~hI2?yCRy?BvSX zM|Pe)w-fzBJ(1H=p=%l(bdfEx;SC2bTRZ61 z#=*5W9gKa;!I`%mv~TC2RaXadyE!P<-NA{T4ibAg_*z!>bFfqT_jfQ{(gr%X@r8q@ zvi3^{KS*$pgMnW;_*X*&({wVciwALY)0C%m=awu<(pc$RHl4B+)A7npc`n^j(pi_9 zPK8S8WXnQlIzMKo^NUQ%NoSG7=ce;kUOGqQvJ9z`PW1-qG?!ux6;sB`xkl;KYOJwx zuthqj-%6)c+jK_Cpm)-lDD~gf^Kwk$JEb#JW=d4IbUykxov$R^TjOM>MD6{vs&Q+N+I-QmB!NhdZrt5Y_I=@NpS&A){XQ$Iheh};2bo$E}dA3M> zTAq&SyL1+;OlSF;bhb&KwVEeSrC@zJt7NZuwxsjsF7;=3IwgKkE}3{Bo%u)8Su5R+ zrSpm0k&F}CAE|vdopI;V>Gw-IQ~ycl(t~upXH4g{$LYNDL~D@Z&(mr7BAo-W=4Cpq zUn%Cl>BRh(PFtKTiEt7h>Etb=lSL*caZyf+$2w_QLdTPwWS4SMTMVx`DIr7TaA_x@ zGEUwp=j7Y+PD&;_xmLl6GsVd)Nvh~u20b`$p@KE>{(7e%y#N? zNhkMmon(cad?Td`oV;7vNl&>g!KzLk)O1p`j+5qfo$QleI-JKkf%ToITCnvsgk~qXkic}oxr0Xyz7bIi2lTSuC87>cG)F>yjrR8WR@5y;7 zH`dAWaZYMYax#C4leN-qs^-ZZ$(Zh>&MYTW7CX7P#7X^cly8M{%dGF5tdKG*opfB~ z;IksEt+T*0uStlLNsW0c9 zoV={Ox15Z>?IhxklR5-$IH6(*^Y}dDK2WH zx=2ZL(arASS2^Tx5$kj@NbY)EWcpkzk*)HN-^K2*3rm5Ee)6i8i=wq%9F%iXr;dy9 zbzMZ%bJ4qj3u{9cjT*VwB@3Im7}nCoG-=YxMF%-8rCPffDYs-=8yCO5>Ed}?7ggG8 zZ5><;e9y(6&Mxd9x^zvGi>V*ExYSE}tM0xoCd;>y-`_>k!7gSDaS=V#Mf+hcy-#ql zL6V27HzQm+XXv8lIK`W!F;iR&kn_{kubD2!iEFNlkLS6#D!+ZB{w{Orb87W&rHfUo zT$EkyqWW6ZyUxW6`Cx?UM& zQ(w%{ZW3g;953Xia$z@xi@0f8)Xg5LAFJ__Si()3%#c6g+%&einH2BlLV}yRiEccl z-1K?P&2{Ns*3J5I8k6j%TO~K^(%e+AyD69M<~^rd*WkK|ukPlp*WDbE=QZ6r@8xEV ztgP?mQ3E#}8@d_W*v*+HZfZ1jv+zwfH{Wt&XzQjxSIhoVWgY$qukUU?Pl6oH@}TjP2-hsl5$LT^F(G( zadUO5oBQ(LH1%Y<#!0&wZZ1lrnQjhA^;vFa$>`Z`PS4Tfxo+Cd)4FB!0yiBNx>>f! zP10gF1LbQO@~xZ0%e4n9RD-YV((?uRh=!%;aa`ToO z-yP+UoPXSW@xaYJc_oz}s!#IqBR5+gYrkZ`6F0k`x~ccv%?-0hpHFz0Bdeo5JSpVi zy}}+MihHOPJ-^D}c_dT4G!CgHZ>gFM@yN6;QcxdsVhy8Lvl6!h^ zeBzzq1 z;bD^eH&Zpw)|zG7T-7;GbakRLt~#YGUOGj1IV0N* zUW_I$AIp1YFDorx%2>Sw?R;Ji2fg&m@Uk=0tLv`4{37LZyo{Gms%U&w<*epqw=}8l zW$)`=de%@aH5FT8Yb&-aZQ$i@L)F>bOWC$sM?0-U{+2NCqp)Sac$8)Z1r+gChzd_>rU;-ZZGa1z4ZRcOYpe%;gpxJPkVVPP0o9n z{)?B#7rcZodihSa$XCC4`RR8rxqoO4a^t#}ng4jX{6KRadinf`m;Fzb^ItCqV|~;r z?_+GTkN;#(ijU|@J_bl~nvYcuACJ?0eChI$=JV+~dLO^Z(_9|~Aw4gx!anBa`zTi6 z!%)@726j__&XcAyUxSM?={ymi|8a$=ZQFo_*q@%crXK zbItqG$0ssqu#X>y_-HoF$Da#*cowU634Eh9FZE&i)<@g5K9;QW5x?F?&y7Adeea{% zW*<$q`V2?`S@HK{Ox1%E%ok>k2-gKY>}ytwXP>VhCWsQWx;bFf4%VW#!DUh z&&Lt`gd_Zf41Vg1+2|)hhRbo2pUP2wdKC5Zx#Se{Q(Lx5WQ?DWq-3I>bh##v+6 zD@*z*Q_4?4IX{ggy1d58C^?nvr&|yb|48wA`DrrH&-73HRQycq9_8ol(SDA~rxX3`ous*w{rn>3r}`N$ zzf9Bp8GcsG^iyiNa;(tYRqD+)KVNM3>s*g=?)7tTpPzvT{CxeRpJP9%7l-^jklZ86 zFFWP&Q9mCX^YiZo)%&ZT*h^Zo9Qwo0fXjY%U-9F+s+`x9^M>-v;y?Y|`peIoH~qBw z+s}u0{Ct1cPo;Z)&fWJ@_JQI*R1cr3htK@9c1!2Qest3!%g5MW8=fUZ9dkX$!FmwExx zngn!Rae!Z21gO_Cz}U6{eJ@t-_5rrMqj((yjOr91u6uwsJpx?+Ab_o3fH(UGI4o@k zD&{8v;y(@0@XG*G25Bu{2N*mmz@gCr^2P+%Ggh^X4=_O1ObhUIdVtO|w2oN;uFek7 zY>w7BFTm;f0je(uP;ya#_KO3Ykn0k;MD=|Wpu(~M6J@ECSfw@mq%|B0a9(O32{7(x z0FDLt^kjfWrvh|69pHn%HSbP$f-hFgR5E*|8&GC>}e4f1ZeAghyuw5SkdcEun?Qi7yZ3eqi2 zF=VSFNTf5!N3!3m=lwxGl^vNuOxcPh#X~__hJ!504|2O8$cop4G^iJ3a(#_y5Tr(n zAfsCb_1S2UVQ&OE+B(P^Zw9&0Hb`>&AQPneJ3&Ui8`Qa$AWQoOx!W(uOBvZe$Si3w zAV?=UCuKhg^6jU}IVecKue2tqHaMu?y@KqM!b5{h9TvngGDyQwL3YaHF+sxPv~Jlp zA*jD^3u2fQWV;-Zg2_SV$&D$BJ5|q33lb+s<&rd-u9!1|m}dsbofYKE*+K5hj5$I6 zn5%xxSFe`@^}D-b%1LRpGRQAGlyhg0gS%Age${dyi05EXeu=Q--{QLXb2)qh1f zp|As2om}$$leD*3Ox#vD5K=m;~;N8RsYQyY_nwGv}W+4cm`EtGiWF~ zB`Pk160%h8+A?SxpMfhWgO5vQ5Ga>{wL%7sDrT@t{*^W<8QhSV)C~5^dATLU92vYO z-K4fNgK@45W=juu1{*vXqh6`nKIzmugUo&zccF0SIA~t z#cZ8t%;qO|HZk68zLfiU*<^>aSt>oNXS3<`Y|?6EQ?qV1W9ntor$IKWx@PmZo5uIZ zX85Ps9RDnv%AaRbUmkpsP41v@|re%{cBb&vtMQk&(iJGnPbF$ekC#CD6 zY!-f#&CR9Rv|g6Y2NJz1oA|ZaytOWyBXU_DZOta(ST=7T&*rFHkpX9P|D59flFbmA zASZv%Ch4;3lePb3^Xx%3r=Dl)>o$k8?i}*6a&%pC4&#RE@vt1GjLxCa*c_&g%i*&L zIqaL5L&l^W>PRQ4IwgnUQ*(GG?=H__`HCD$eV2n*2FcCUIr!G*FkfCB%%S>EdhUeg zUDv!DIn=tH!=%SKTzHbhj8{2aE1Zk7Xf9dBa_JD4OXc`ny+6p+`-5B-I&vwIp3CAu zE=zK9xt*KKh)^zLI^^>6JGrdym&=R(xpWO z-{;bFM=mpV<`TUtmvSd_dGAy%XJzp(x!k&t%kn>R>3c1g9oIGgMlO5r3w6Ku7$~?k?emX zk6Rt`2)vueKV9UZn9$@)-1u#z@raJnFB>qwx32dm)eY zSMoS^HII|m@<_Uor(P=GUwN#$na4KC`a6%$Zsl=Dw%o}h;$9v_Wu-j2pGU`k@_6hb;-VQUs3#LcJeLortG_cs^qHra3l(#bVoIUKAr`F&v44a1;d||a4B4dEn-zOY zh%wtk{JbN?>pMf#*&AZ~z7P@nLkvC?;?Us`*N=sGB5RI^*e&f&hG_J&`YEN(gh-d4 z&W0%QONiDNbYCX?8shv#_2N>94tGNI64%`jVOb@Q@2MyE)kA6eG{lT&A)=p$*h!eE z$S{}9Vag6jGeXDL%!_si(M+$|R-GdWDH3SrJv3{yHa%+g9>`UJyl&j{nn3{xX3 z%;@Ye_430UsU0S+ZkWL`tX`O-^~2;h2xDjzrcUE9Tg2Wh%!kdx{4QHshk5JGFz-v7 zx56xVJIpG%(JqX;Lzp=-{GBkz-wji_qvCf`{LYFm`?`iH+&xT^?3F?vgh`YI^4Eu9 z9?QUw!u-%H%rP1CahM-_YaP;~PnZpT!+iXyZU=>V`BfO};4oe}FXe`6Z8Abm3=31` z>o5&un8c0<^TtTUk~88QrTRvPNf;ZZqD&OVg~^jqa%y~7ubnWBFm-2y*(wKR;7rv&D~x}3m;z}sH_Y^TVOlNG9?ANZVP33KA2)=F z+!Usm#BEjH?K-wQ%)5KTEZ?X89tuiG_nKm(P3i^EoSPm*w;9+kCn#&!>;1t<2|zL~Y5ZtF+mg zPd}-=E1zMz^LZlIujS*qk&o@Ke2irZs9UyxGvx~SCbfV&l?r$}t$;Ti113ix$b0jJIsQ1V;> zm88abjsHdCCHg`E&c6!ib+dpkB=c4QpWZIuwiLNnK(qS=?3Mfn1q^vuzyz87sDQCg z3YaD5suY>}`UlS+M(BSV)V%rcO?2~r|GnH>`^=O}zm~XlxqDub?foC#+fwP{SJ!Xv XyPIGsx-~C-@&B8r|Et3P_wWAz#`d2u literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/793aab6913f01a4f_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/793aab6913f01a4f_0 new file mode 100644 index 0000000000000000000000000000000000000000..b59ae3df623953cfd19725f77fa1a781a517fc78 GIT binary patch literal 37644 zcmXus1z1(t8piRD4ih9zL_oSb46s|VyJPI`F~-8~?(XjH?(U8;v0LYUukX6|d4Bf~ zoWtI0t-TJ8a5#q7@3JgU`yW4TM5LIybF^hsjfBTUr4~;uo)Dgv8c{MfQr|2U6%m+$E`X6%kllmGV^+si(H9v~-d7%DcKqj4Gr4szp7ukgK-HfI76Gxd=G4rxqPV z;IPV6Il7W-PZ4O{i`MqmbE~+%w4uKUeEFMN4iJHMgJ|Pm5h(r-xeXJ6`opP>7Gg)x z3TU3WF}0H=3Jxpw{(9ho7=SSt_V2ZqdZ!;Vm#48&HGgOfe17-7aY<@J}iFriG$qXss4544b_KJC}SCF7|U zJR6gr7J3HXB@z4Sl}n-0*zBbEZON2#xNjWOVurNEKn6n(-{ zpsbOhg}C#U(*J_4$907d88>V^#&Mt^TN))k!qO|bZ z_@#x8k+e0+O299gn(N;}p}P?lXC+Y7*r0{4@zgrON?=Daoz%jR6q>9B+agr4sFlDT zV{vgSfh|VIR2`QZV7${pd&%YYWe}(ytqI zN(*<#k95>L6Emi`rji_z97u7;zofckgrz$(F z1g7pJn_X4{&PKWxw(q7+d#nVW86o?u1ZEp@P#KY%j zlDOkk{(_ajdli4lN|qVUw{zf_7~)CSysZTu`cqhtwLtk0@(Z;V$Pz)-BCQ2BMpN}TYk^-zi+DYc@<A!i0(V}V<@#8YpvfWvliQNRAIbcZ?(%fuZ8Rr z=+Yc(f$4MU?mTOOiu0+d7P2fQ=QY*>8OFJ_)&fP=(Terf0#!HAiH+6*uA8XdW@~}q zEmU)>wZIA^bDOTI+PRBz?Y0&;YFyPq$vre`ueHE;!|$j*Zd4`J#n^t#TA=W8iq=Bx z3F>!J*HpbUzG~t5De8RQTHvtX2~fs6wKRz{Di7NVXAh zGp4872o$VJ-L$Z?8U>`=2-w%Ao>~a3Ly1~gVPw{|5x7*JrZ%$?_+_kbZX>YY2y3BZ zSKV9EV=eS(OINj!(T-+l!M;6J>R=>uJ>qXuu$oF9T39}fqL$bQoHTMSvk@3!tl4TK5VVbk zY9Ver&DKJb9n@y0jljBHlz+F4K$Nj~kBz|c1GMs>jlfr<=3yIwg~q=}bf2oPN6G7$ zjWjeiY2n*(YJI{+AoC2Roz=Bd8RzJ$7Hlq3Q!OmNMDCYu1Z;0mT`kPNNjYxW2>iNB zY4`Q`s*15u3tkUwq~${!DfNinytWY-@P;BYZ3I${4O;l}mX5r$5eWT6leBQ-GnM&b zBkJL0@ z#nrfAZ!2&vgt~;<3cNGo!fgeX8oRV$6+xwAZ3XtnQ;#S(N1NCQ6l_YZn%M~qYDrJD5Y(DxYQeDs#dNe2=-Y{oce4|y(w(OE z(7m8+dQxsJtn5X>qwEB_jHU-#_-r_hu@iVbk@iit6F9w$oLA_))F5N37EZ0CZoBOS zzNw;n?WFJ#dilsspzCAW@x)HR|0$(t;U8np3p;`8FKOm0T?ggxn(}L*fwAnPoj|@% z)ah=PSYS4hX_5zm-&-(TPBMh5H z_5!tyxsCNYs%%YYO-p+Li&j*+wXUn$YIN&jFR+g5_^GFODXp< zT^kiUBPl7$L7<8elIS3?q5_3hbP(uPi5_X8 zNfp|y1Kw2*m%8lH3zxO|FopK%b#Fy?CE(plFTB1I-S3iLOUi#iINH+B?v6eyNTfh8RU{x%MmaukRvP0PzTN_s8orG>=WWM9Wo zAl*o)>nIRVkGg3gaRYfMy+Z5*T%erX6+?$T&uWk2?vRF%nKV33NS0d$q9aG<`VhBrxv+6}#jlu=Fy$ z(?Y-%I&#lRAm@Fuf8->PZbUtC66pP$*1m8O_-34V=_HW-HPz9A+Z*cf-bvtqQR}0V zz~7&!{})|fb=+wC)k$EYmGd8Ww6NTf24`^=IAfI0>MSrn8@<%Ro$TbE(^>z%;4Dpz zLr%^DJzeOa7VPuTq@KO608gx<%`5Mx$rY-`u&FF>}7PqEMEi~v(g?qRNWa~-cyv%TpByiMZjhORnbD5g>-F|UI*p9n(A-U>#Zj4p*vd0zmIAib`e-;xE9vQx1ft^(t8QcfpVfqI6Qv#Wkz)m6WrO5L@P=t9F>T?H-}<=k8at{L9$ zt^ym4)n2Xwf&TO+$WB(O>R}%W>FX-c_;0E)&{bf*;W)@u;Ko1XGsIP3 zoiQsz&##^u4@T*@m5ihETDUlgM$LB>xN5Xn>?+WE8SP!^D&Vk+nyz*gu-i)2w9s`M zHQ%XoQ|k=--L3*t_tFC`RNP0~_PYvL9w5hqIzQFWSfPan#^b}T0%1q!z%f^W->1mo zypB^AaT6F}To|P5sA>(Ng<7aIjM9edywzCas1_QIq!n7|Igt)5aTCb8lpd_ov8di_ z>97_SZKA51-2`SERy*AU4j!RwN8JPpoTmI|+yvSfue31r96iuNnJd)gkzQN1$Efha zO~Cstwb#PxFSPrIn}FR<>R{on-+OYGW>&OT3obU4=IAak)`-mFF0d;X*}Aw3Ovy`4 z^0^DFHn!(?7g$(;UTfi-7bO&O7Z_qp^Klp0>q`!P?gGV)6(Q~dAB~2Q?gIUyX<~xA zKG()w?ie?d-35B5(qS#EDnXyixC<07OH$Qc;8zVQQ`23aqvtL^>ruxR?gBfF1FhW! z>b0k(TA0^~Y&+}vsH#SW7HajNg<5Fdn{M=V7x3vv>$K2h5Utii%uxE7q2p4eN0QZ8 zcY&x0^tTqC7{lhd3tTYvF4uKdOIFcaE!%Bt(1<*)`%6tbMGv*m_%zKw>n`xp=yA?nVB-b)rG*g}Y0+hO zfj7qXE4m-mnXBY+&0V01vEr8QFZI#LyyGq~{WCq%!Y1+fV}Xl@z$>GBxQD=g!!yD| zpm7Wx(}Hs>&D27LIC`js_6gJ@$wT0PQ6X9Hrw$aStf?LXj%ie|yobQ6Dil}MLm(iX ze%102C{vq;)%6g#(u%xVdk9!}px7=R0)vbJT|ET6x>H*%d^TG3@DSK&r1ta>uY#;+RcX2wR#YRG>Yf4%jN4i$T!Xe~A*nVE(?a2Tw4=GFfOQMX z*~U|#Mmw6Xh2rfgdk3Aba_dNzy*%|=>e!5{13d*kjih3ubiT@Y61|z_DUdLmuFli@ zt6R&-Z-uA8fK~L@W>0}FM&Nc&fzAhMw-$1pqJ^hD1zsB^&Uy;$Htf#nbx`vS_w$|t zO^uma7=4YdX(8`J>ik&Gt9Bdfo_PxF|Ch2n_Y|1;lFEPd6qssw{qz(V?wI?Ji(2UJ zN>6=r3q<(QuOhhx@}yBqE!?R~m)hqR$lrl(9V#d==PfyZFDTH!u*%{s(A$L$YvFky z1w?oYbTh6N_ZAqEN)@Yl3rsiWHSreM)rxFedkYloOtrKy)>zrsTi}y1aj3UIjS)0o z3q!`x$qC*9t`q6%9379col7xVuwOyxT3E50!uNR#^feY7@)lTfg5GN32w#Cxk+et)^P=g6 z7S6`d`gmV~AI73Yy}v4#OzVs2?dpdSRn%9YLoo^}?ki9&jY3QM>YoL^(z_JBE9)!p zp*-!aroUxTGv_qo=E>p^A$L2l$xRIrc!6o7%g<3O}*y&3LG-R=J^U_TSc|C(0&6g-0Lgw z+GuseS0MjsYNLhlGgSVXufSBJ`)ywV-+RS(h zJgA=*d~(xJEga56Ir91mw9ZE_{QLxB3RC+)J+Jy;6bbSZcxF@x^Anh6xJCO3JWimn zL_dMlB6PHrpMXP?bElfAkQwj^rHQE&~EU=?KSvM#wkf#S#*8Z_j zt7aNqj}#V2yGmoV@bd|Md{$VX=)W}bO<{oznepzl}gTFu}1czy~8_iNCQU*j*OU(-V^ zw0}btGWEEsk3-P&fp^BLasdLnjF9pH z(yc;(JT@Mt2MByH)>ID=*kgp%2#_8%1LUdkuCX3lSvH~FS~zVKX&N9yn+3=x<8Ye* zfh)$izXJ4mIsr1zaB3SMwc7>g?@?3E-T?x&`p_{gT>P6n2L=da7@Y?P2yFj{{D%Yx zEFVFc83Fp5U;)x-ByF1*AipOCNQcSfJS#w8*lap8N3WMknM+^i1qc*fKqnUl2$Wt< zV^;(S{5HmK2oR{Yk;-oh5SX}`EVt;osp{Kl){X#yEIXZE zNPxgTBg<*MpYl0NZO;V=+%mRZ2oPv-kyc*{5XgI(BDB!kD0)@rsfJyn&sxZGol4vd z5a{rRwqynf_`an?EnNFV-@XS3IR2o+TDWYK`WYZF<`@0aLb^rZA2Tfj1stttv}2&a zr7V<|HBex64yvCsP+*Z0<#Gh8YvR0|jmrqOv}L0m8YnQrSlcU5V4u;ucc4Iq;on!Ug?cuSzG`9PAUddp=)r-~_n$y{ zX?)c}^PyC5M4-S)C(NfdcuA9a{KnH02tjdqepcceU`wXgpTeS}hw#?&Ec> zm9H^O3$3Qo+G#p(RelCNogF9;GM7%y)3K`SOR2!}K!I__Un_N7%3~EZS{*2G&RDoE zP~iD`TD~<3U2gveJpupV|RQYD0Kw~5Ktw4c5 z;>T7M6O_RxR`_Km~k)1j3CMTKI0X^9>T%mCGsA1%&93)V{n4pF0Rj5qWAb|$P@tQ#bmm5%?MnM9j zjKR%<1ST03n+FLrFwSYgttAc9!YsqKU64SRZuE~9Qo2(`E$lOFd+PmF4`Y-TKKG;7 z89@Tkqv+D;Ac4om+%Z7{YmJVRf&~0$P{*12zPe|0pB*GH%qTV|NT7;wPzw(8sJ9lz z8s8QN3G7`(Hfw?e7OtgL8-fIO8$CAa+|)4Rs}_oGrgd64Y=rF$5~#nQ79G(2qjDW2 ze=STpMhngc32ZdlozwlO`WbJu5OaZ+Xrb&i8h<@Vpw~^B_C849?gy&$F-X537$kW= zQ?oBY0+)=O--85d{h(u7*zl9;{t6OU@SB|e3leA~!GA2Z2o`X&qz2Z(0*h_P#Wq+V zr!&>c6)fQ9N%47t1enivu+;2%RBV}k_(;;2)6u)uxeZDO!MTrw@wLcXHZyjZY6XXCXN zqEqQZ>0p8E<)}vaV1XmXO)Y#jx>O4m*pW^F)pcB|h*7X!uz*`Ty$?O znM@0&1`BL7+D!`<=x4mqLd*;*H#=Bh>JqxMG+3bGGP}j*|+KSQ#H2J5iM-oN#Aw_3k=yq=MDr5xE-QA z*MbF_UZ>YLbf2h;52@TMov)hknk?P~3k=Srptr#S$;M|b*uJA)TG;oV!af8G)cizq zKI^qpL%&i-n-GDmw&Z6QB5>NCayfb{X#@ zLj(?_gou675b0(7Dib1*y(}Hq!gZruxe$Q~<;kK#h(PyB(RaXAp+kUQSl}r0;ii&-&P?4hgwrWrx1ZoooQN^ z5P`d0jqY0I+mohfVWm-|cZmM3V~C^=p_xNN1RRG^li?u(%SX@_EqG^8n~}Otl#HX& z<3j`vO(w^wdK}fqxG^I{z-tzb*Fwm=5a~8QL>?RWmgzbuzZEo93$54Ex^*D}1=drE zjUfV~Hqj3)blgH)x9YxE-FH*U$q<1`hW#nsC(6SZsfF}2)LaYs&r+xs&YYv}m-M)5 zm{II%o#+iBN$CCFzV7zL%!rWkdD3R-v-NSX(hv;8P`PQ8`p#T-8vyS}jycrPHGNp#m=& zkX55lfpU$hmKFvzq2o}`P5DeV-`}=MWM1{ zaj1AMp}txeVGLavDsXxgC9l>!ugV%F*Mtg;UQ08ykZ&C|Umq$^Xe$-jrjIE#%UG_3 zQrqdro=|~rd#Tudeaxu!#vUycK0w6}={{2<4$~AZWI00Bj)n>xG~AEt<5M*}L1(qF z;0*nHHdLVYIVyKS_nn$>kt{BS3go&%b+3jBoHUAG*YT*=M)b{4fyKti+o1v%?ojc& zdVe+e9-X)!Dp3Ccwb8;SBl(f8zglg)c%}PGMZBQ}T1a?L13!ccyfuDlq1Z<{rG;*v zXxHaZf#XJ>FS`HLfv;5Id#J!OyRbh(9m4eY6vAY#vEDIE;7b;2l{HMjA}5t`3KOt% zr_cGq1nlzD0WDlG(h7tLjP#=KTIlFaTMLB=obaKXeqjRVf+%O0zOQP9(=jbPiwqOz zD5?`3Cg71sbyDu$TO6h4hs{wXl%#`6KFY-){F`hcrlhD#)kGO2`=Ih!mpy{jhW6FLt{ahQSuOF-X zWIf&A5GGJ`D-GKgCXlh0+FuA0*nE+EF6lVb&s&ssM~|cOJ*I|l!emKin7F>BYahb| z27aPrpLI{ExGz-ct6op_-6;M&OkjgiK*9xDTF_N3?6D$in{a_{Mk~8;fwlIO-yvKe z$~c%kT%d;w4c9_(SE{OoLx!V!xIiDHQSNYorFqCLZ@9oIA9D5!7Z_~x3l0}J6hbS) z!Uf)jQ{#wmfz#2{D<)iEUo3^ih3o4-hs#Z)U_!XS1fySZJ-#}WN>OP#S9QRsRw7*B za7pT1DqJ9cX*#6^=dv_d3(G4}X60~!wKb?fBfTD~Wn;Rkg_p+QmiqZBTL-G%Fl=Ra~(;JqxJJuALHfNaETlr zE(;BtiQxj3C)2g5;R1K2kFElRl)F0jVfsfB;; z(aHPa0*Mc(vKF2_rCIO81s;B&Y9IAHYQPsd`ZZi&=x;ji93fDqAdT~m5ctnHPijq}o zguoW#XIg~7@RHy7i!;S}59+Dr@0@Vc$DKpqH_+ zZ-jj77a?u>)7JsIo~q*@>ZgUlL+HfN2!ZOu>EA^W0%1#No))5(QJ>{{U6svBYP2yz zVCg1u+Z-X#c`I$-79o(fgR1R`5SX!-9QH*BTsuJd4@C%!HKv`85V(7WDxHlG_;P`Y zT#67_Yh1q^Au#d^UAU^(Q)S$s{~qa{Ri&QLRxKQVMme7AzET5>N-y<%YRW6JdJ`e# zG9zTCG3~RCPZj+_!@focd^Q$-*ZrcN|DZZQBLs&1M`t8bAjN``ts(^~8g|x^0`5kJ z_PkA`6tkrc*&_u87zsHd1Nh?I1gCYe68_B^sA63EFtF;M@l1sw0c&gK%Q09bhVCO`K+Ua-MSytz&(^@U!*=SM(1{z-X4h* z=zEMtoQM=Scan;p((A827>Q>h1y&mSwD9>Xbvzd-@cWjo>1}ep8!0f@IQ2k3uKGNr z1CJsFA|BJtCpt$}@EJ|e!jgaK)$>S!`Y)*V%SeGvZ)jU)q(I@fbp2hVK!Fdm@}rJl z&HGAEzvX1aa-lJpGfH4iKI)!7N}yE%TI&@hkiQ`P&_Ze< zvIvM0unwm3AyN8o8$^j?6s?Sj5_lI&>yx7d8Wp9b#i9fvQpvk~lt7ybc8n5m?M3x_M+uxZ8uit2 zs-^wNt$&n27Vs@h?fjz!ZX3G-qXjI3sf!klhEujk{e0Em*c%%yU=vT> zwU9HJYNbRAEGi$)8qE=iRtM9Y+l`ni>;RLy9CF}3KI7KYcMvvs2d>eQ!OjiLp- zo6tlplxRkynnw$`wWQ@eqXja1(N8Um>P@q?P_qxU)WUV6K)+~#mHnyKV4a`p^$%re zA#DhyYvG8Iby&2(wBckwDq5iOXxgWR&toZNe6+wCWB0^pf%lWhYI3x|9^;G_icX>V zT6i{bk0Z$0+Q0w7~OI6n-XJe-}mf>{VaMAF560OfO(`#h>^)y;w!!t^L9xZVA17-OXE#P5{*21OF)bMMxKzF;CKX%*4 z2n0LOkDM_Asm@ec3;PUPml*wh{TRt*EZ0J&D>ZV95eV_5ZnetoAKI^l z-$p&(7=dSolV6O$QR9XdUKu$8V+8UV?X*xfn8t_12+T1$gvQ90uo&?Tr@{#_0v!@5 zqIirzW-8TAixK!xiiTE<5jb6mk}JmugjI`?9_caCrZ)A^dNrhC&0+*zHK(YSx)$oM z_S91gb{)t?3v-QCTG-x+Lb~eOsv}0r?lA(fy(qDFjKIHrW8}cF7-=#=*KZPKn-U|? zdMbs^h!GfO+?*RDV6l+OEQ%4>ZhY24`eM4L1&1ZHR|^-6$6BykK`vUDVboj|Bd~lm zWv7fxulfQwzs-(`79L?ID|e zF#L^XuLgI-S{r9Np?J2!}XX%CZ z@;PdEN%ykabeRfWi4h1lie8Hm7;4PF9wYGV2GzP5BT(ut**ws>shhU3e-yNj61;j+LS5bh>)1KynSLs)cpN#ZIvT zo?YmA&sh1;D^~jVp^;iR+&@--t{E%8r^QOw8L?7)R;)Z$(`LuY!@05IH9uC$Eu;yH zVg)P~lbaTr8f#a^3Vd2cEmp_Mz%{YrxQ^VlaM}pk7^{0NR=RJBmAK8ZGGa@tWNeF- zEjwbR$u2s#J653l-dM3e5Uc-CIW;)0Yo=mF6TuWO=m zKBbgru>$3cJ+EUWK2y*8HdgX}q#urP0?)EgbdERydndBa6(^AH5-0AibU9C)%q&0; zyy66^7NmySkEHU-<;NSusH_S4ohCwG-q? zg9O>rI6+o5O_0285@cG31i9EbL4QvxL0{LH#t+l6sB6P%>KHwrsxpqIjn~gpe@~<% zlM)1CCQ~^rv@}wuCJ1Cqqi&K9%u|%DhexnEaV;eMu0Q`HP-pO_bp5i4vECnz|$k6mz2t_eA}kN1`kWOq5(f zv?MA~U}*xqPD~USnM`AwCJJ0>Mw@#j3jF9zZTln&92iUX;}Zp*&85)!i2`$tw(Ir& zYU2j#ye&~6eJ{=2mnh)4pS&(63beXJ*R-(YCcV0qD6r}Q^?Z^ju=gp2KGXB7!*40e z`$U1h#x#p0fxDJ8$397*SuR@Xk|dDZl`iE?(m!wY?ff)S3kAKXb-^ToRDT*$GfCi7 zElR4Lq_5kOBvp)~b&>>LHKnNLNdoWN(3P=C0(r;NXe|s{NXHi?3B)g^q@{X%HFz1l z*MjYOs<yq%MJ;SM{`;9E(D4@?wM-VsW=;LIu+5Hs+b0Wj zaG+_~lLhYPpqE;hl9O&bB@0w=ru;6+0>_N(Zpi|F8%Nxe1+se5*8<4`BfaQ^PqIEA zC0U<`LIbt1!k;Px=y}wnK(Y!-78n{zr^Av3lEbNRbh1E)80xEq+_BUoE?MA$(I_cd zU}-YBr6dcyN~Ne0$pVXv5~Y#_MwO-?TF6qCs+CI?IA{#5pyO1hD^hYL9jB^YndVhV z7RXVRj#o<-$WfgJXkk_jdRQ}Apjs^|+aOtBd_$5($pY&d)8{710xg@;kCr-KmD-v% zYN5?vw7zY!fLA*z+BsQZSQq-Ng`B;pR&Txb#?T=;S9N+QB@ffNs?8(m$0$9wYCD>y zjMqJ-Zcm`+T1cBnBPZz|QQwVDGm-_i&7>allLd+{qG5}5jOw$IWr{rHOh4}S)lGMI;n+;x0B_@9o+|asp*?!fv!eKX0kwv zu}%x0-%`tWx;NBuBmHZ#z|3#t_&r%*pQQX@YndYO(2nwZqzJU|q$^s;pO0GP*N>|! zMy6MaK&&^FDU>2`)ra!=r3fr9Og*Ag1op&GNNkEgsW=)FpCVA92%RaLBH&VQo~|;J&f5uHLR1)Th6+P_F?kY?vaj&Un^1MIf{( z&DBCiGdkZqMW9#OOIh2e2zVNYwUDJFd1zsw@w`)tz-OaxmlT16 zUFn<_26v+q-BSdv8XbD12yE#|-TJ2pY#B^H|49*W7((G%xM6q=OA!b$Mrz^0a4J3` zMWB)~TWoSeIAL7XLhxu^voYj8E=9n{n4|?6Pf1!BZTzohdI^atisLx`tIUNY zwy2;$(;&ypHWDp@dyXRMLLrkWA5jEqWl<7>nGy(T56K>ykEt1&HbqHBR^S7}34@?T zq@ZKk_@YE{eB^|g3H|^6j~70CH|Jcq=l)OceG4q9Mx;|&cCBzfu)sFgiEt|O8_s$Q zY{m#~r29bXNsvRNKD59(j89Zn_DFni(%F-Em(Wy}@mM(A7FgC(kxylBo5k`g3#|Q} zSl?=ag&A8qXm-f$PSNh6btJD_G<~$d&V3fPJ`3z(zwlAnl2-%|&^MBsgTgjM>q)V3 z@4E%o?-MD*7MR`mH$pQ)lE%avDs%Y7$PC>tl0GX=P;=+#{O9Rk{1OujbdN}8K!h&R z`~T4F8~dXa%62Inj1jTP3hYvf7^Sk1RBhf&p_@U>AP(IFz;3TK`u^cyYD6_#Eo6f}uq zDvN0r%T(6VrV!jN&Qsa(4pBm730>lbM}aLGKYu8&eG_8qqyh_y(5q5+YOuaY@hn<{ z&Dg}r7!8&ktKr_OQ5r9z@-^7m)51$-z6%<=3pMJD?MY#0< literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/7effe013c1380bd5_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/7effe013c1380bd5_0 new file mode 100644 index 0000000000000000000000000000000000000000..d8235f34d5137647ae484a04b6145ce8275e57af GIT binary patch literal 32740 zcmW*T1$dL^*T?Z+BTdps)0X0;?waClard#|I^11`JHvgrySux)yAEf#`(W^X|L?Br zvn0=R%Q@%1Q<~&SQ|fhInxoyf?`BCw(Y4I6N8HF$%#*uBse;Aw<}2>WU#xVol+^sC z3zSYNm9IqpVx>x_6ew1#VD7xdQuF4^TcUKS+y#pjELFN#YQcheN|nr=uT-%TsYb>) zlgTmte`Edczqtpu{r~Mi{=XQFOG}sWsEkygtTY}fCpmEx>E)$*h^Zjusz^N8kK0&U zNm^7{I*6WC=u=(#h9Nbizmc<+)B*o=ky5)#U*PC2Z67OTn=eJ73c6t(ZsG~5FOUY} z9D44NdR>=-i+X7T_ToMo7W2|@>@V)6f6%^!mwKaDNiTVq_EJ{#F6X7X6};33(|_^O z=N4YFwDi&r97S*|FD0Nl8Y7~$myX~P&b0ATQd=(-Mn)Ge_3Y`TKT)Q)mtOYqQop`l z8jV5y8EdGQ{u)kv@EhT!T=0zZl6j(+0w#IsHC9dc(suaH@Y11~#5CJWp>w>{41dn` zQvZ2g>bt;8b8zOimwMdy(&HCi`iOQfy|f0kUwLWrYcFkm!x$*~)=QPXdFh+UpeAO6 z&ifm*DZrrpc$UeaLxBe6%xcgE?9OITo$Ll3&S6k|kU`yXDcGPEAqMR&ZqNmkDq+yk zQU;mI8uS#_N(MEoY*1UIRx_vw_Q6@*pjMcVt~D43UF#b3R}+J}G&SgBM}uNJ88i}8 zQMR)|{qdy>_q!UDy_-SN_}<;1Mm^};)1aByja&LwP4az&fpiTn~ z+KwHA4DuOlPztsUAukyIG^i+cqyKOok1(kBNP}LFVJhd^Z=0`4eI!bdVMy?7sas(USG%wrmw6k24EQ;!}hO1nNji^ZND27@Sj0_a1953 zu)n;FT5K@tgwd$6W}`BD8}*yTsC^h}HEJU6+l+GCjS4~whfy_LMzzPE2y`12hQII` z<@}6li*eY1%h(xc)D?tfHtIGCXEACr=43UhN;acjpav0SBv#}F{a~d@w z$f$m~jJk{Z!A6~fE!3#9VMa{|=Qz4Y81*j7sFY}W;^#Psqkk z+F5yNhuis#`cTlQ#5AJ@q#M<+kWpt4U&N@l7+Tb*)%XXA#f%z_8R%1-cuN>{55c84 zhoI6%?Z)ylMm<1aS)+=fGU}Ey>Jk1bZ?^Z?~zQT^d+Z&W18;xbxwH0o$4qjGj*U2&tkQ7`{6YGe=A zs3&`(w^6x??S!KmRI zS<6l2xy7he+l)%sK^{BF71uFh4|{GeaU5mc&N1H&`rb0C_+#QgA7p#NzQNe1?7wHs z^@94~Gg`hhs=zCw`o8A5fmLYs(WvpCSo_aL8NV1c*J@HpACneiiQS|X4wGz7lODND zD(h=fQ~cpJX(ZO6pr1+E{7p(gmh9YOI}YbGX=|`a`@>AShlUXxLwux3FOfCIq?QPa zH7ReLN!ze1)ub7DOsbjJq&oRb3M^>S2$aY$X&jOZnbZQiQMj;4M~j-YxvWXnawc`g zk@EDbY*MW%ChfqMUrkD@ZBn&{Caq~~(n0t%G3f=onwm5g^O3okNz*XCg-HvM+|s1- ztxek3mU-IIr@cvW9ZU-8NNqZqRIjs14SJh29Q*s2l-|#zD)-i>4T3}NCg(h{u9{fPf#U}N`UU)At z$+(PhSDCbPgGt|UawFqxW*xSe)b=oIa*lZ}QLpPJ#oRKf`yFC^Y0_D{S$Q00dArOC zK=CYQ_0MY7zHDX<%W0NxkXb9xK9^Zra1z;r&3b{IA!cn0HR~`cg_*SnUr{X5tjd@g zWmdLmv#Q}gbc#1?94aN4btl=Zm$>XP%aq5g1?ebZR*A}Hy{S%nOs;8GYArKA1I*fA z*Q_B;&6Q4e-`3cxCcd zG`1li&|5n*BdfRCp9?ToL2uPb^HyZKw=QOQt8QU$jm7~~DZ*IrDeA3yI0dh=-l~966}+_!Cy=G0 zw`SpQ1Xl7^ORU6meHDEeWz{Q84W>Glce`v<Xi=#oi_YP1OiZ?DE`Ck1 zs3F`Qi-K?p*Kst}qAIy9TASCRkNGSL&riJgT-2gpidp0;ZqZWQMWzxK{f3K3D{0Z* zQsjftWh|PG4P|MEm*`*4qKD{Qp8Hr-!6I`-i?-k(o}hUpi&j*&=o5)W>I1M)q?wNEHbsV=sCWiS9=RDk}Vnz|Be<7>P)>6-^HR= zxZjn$yAfM=iz5H9C|hsl!GXRU?{87!0E?;)w5S0#3}TGI+{bDJ46$h6pB5R1S(JIW zMad&AYJ(p5f|H}D$7qZ8jIpToIM!yoMeQfBeLOtPJW>JNe7A@SwI&7hyTP+%gWw?(q+bp^O!*+|Z z;@tmkcM`)M)@QFpjrLpA9lswSAM8KGS{$*cH+JEVqpayM)*1Uwu(xp!f1R{w*lG61 z8DcnVQPK14jSJM~B5QxiqTN?mk889+@^#hZ1oXVC`Lt z4xz(6)(oE?kmEyY4*Mhepd=<^A3mYlKjZ>EB_0$)3yi}{elvPeN#YHqJ&HOluOW0nQ>Rlz` ztZY@UU##l-t5v^Nv+8C|tA^FGY9CJHGwRf{Y7Ks3W__zNHLxlavyrorRWBP`)u#!u zHnpk&Zs1EZ+P1K2c^j+Fqg-2R)xoM0DA1AEaJjQpZ@XCK)s@HSi{x(9`wy#X-~op9 zu*%)js%pKgx`ph0SOYxkOP_vLt?O@9z5!OX9B9=m6dTMOxQY+xHiTG*TIIn4yhHOp zt(u6F_+uDz;0q=Xx2n|$tGdHAlA2=-T8y%4299F?SgRI}V_uv_gYm2jF5vwHYB`bd zkZF=tyKw@KvEeV;PPVE&?qJ9itG-XOYT$IM#$qKBW>|F%Pf&X%k7p4VYR$1~7P8M{ z4D6Y2m0Ta`gqIk)#H!p&ttyK8c#IF&zs#yLc#gKqnRA6zfh(;lxW=l| zXo7c`v6211iLtkm!*;9k?_ix_+-X(G6V&`9>x8T5ev0|A9raFAe|*FEGgif)r|uW5 zNX{dgP)I0xv(6UkZQLnv&*J%6va_=@wI6%KH;dp zP0j$DvLinZqf;iE2I4(B2HI3IvrP-K+Eg~XO=D0nCvzb>mrZTq4zZ~^e8Oz1f(PL? z#YEV27PBL5T7jde7-ds!T*1F+A8nH{p8iP0X4K4U)1rJft;ZSE$#0W)0dl|yoJqGS zQ-)2UD2x-RRMe){C|Sy;(U^`cXja;$&X|eXWo%M%l}SFovEMVsnZvgvAN zn<`hasUAB2V$*)Kt7=nUyvBEQ{ne)PzuDBQ8nr>b8qA5AxP$gJS&LdWO{`5Eb%+C7 zP_M2{)_OK&#mPpD-Poon&23tUeW=>PrUn?>nta=kZ(H(3_jc3@50JCHO$9pGR0_{f zu%k^+5Ym^m=x5U?r1iJSHGna38qd&YpiPz$HZ4KkQ8w+x?9nz|#H2Ac?H*^-Th(Hr+a4Q@4Y}cF3k>D1X?dmxw(|J(1%W`Qr*)$EnW=*7hW|JjK4fL9PF`@u7fC zLHG>Q9oGMzO&jl%D|{c3&p)iyW1Fu1&l8*edP=RH+0_39&xe;b#UtP~^}_UbHl2IV z^Wh`={4@I$zF*h}Xbt06n}&ZQw(soYAGGoEQ4@oYI$^)jM`zL4?4wiOJ{oB8(O4Wp zF{h8>e0>z`_E7@5;6D2J`DkNiA8pM-J3K|>tUl_1r6`-jhxg8Xv^=MeLPLGDD$GaQ zQ8nC0)<_=(qB;Dd85`ZPImSl^P%zdQ-BdCmzs+IH6L>$E>_*L-HaHyh>VqmT0qoL?mnf#EmijOW} z#xFiPkA>BJv>qR7_^4S;A1%R4Y^X(zYWry19NI1*cT`_UZ5R0{d5MqmFZI#y%Y3w8 zxsQ6S@KME;)NHkn#&7h|Z0y}k&Cz9xkG{iuJ2CF?QODgr3ft$SU(pcd_WLOHppQb1 z`se}PpvEyDWjjt=^hMAK=0W+BKI(bOM=wtM=qu`+VU5rFXwx}ra>+*xF8inr?xE`y z+TqJpA3eM7quqCX6!nC75b%_GVjKQN@n=4ofEyU{!bi2=`KbMS?th@B9~ln;pL}!` z(?3%q%=yCDU&-lTAN}`@wfXL&yxHukkln739CjsQNlv@0x$H^~w(Bzf2)8R&q+MU5 z>^dH2movex?8s5vt^(+U>qswQS6SpMX;(~HJFj!>YE{Xu;L3JY#2;9QGjP|oD+oL4 z(!ZWv`|+-+T|d#NnO(gQ*3zyz*nn28>4&my?W&ISc6Lob?)G*q?P%8zROw{bw=Q;F z>uOg`F*Tl~cEKbd!g zT{jUw(ykU*ju%K7#T+<^=A-S}h7M!xnmV37uuiaRH%`KDl3l;zBPva{Ys3`VVb@gV zpJvxQtUlh0wu^q40Q?Ctn z4aFoJ+Gv+)6S-mw4k306HA6S_*vdZHX4gL`x}7z~aGcmdK0C<=C3mqVn2e^o?OK3! z7_^64q4i$+?z1a(zg<}lP?tk?6~^ep#C@C^o*?Iw>|3-t#aO3_`;1+;G4ZTj4bIuM z@jPpb$`{D_qFtev*h46JnRUm2D?AUbQcKLb#`)`ZO~LyctnW>`^4uooyLLt0WB;KZ z#^WF4eZW3^$hxD$BkJ)FHN?Tk)a40#1Z|(%RrMKr__ES-;tp^E>lk z4i^5$^A0cZFCu6DW|!p~+Z) zfAcx?G`~ZiP@|wj%aNAm&=vfa?$CX-$lyFO7joz)niY0v1!fj;=u&luYS(b+AB?W) zP{&#h`P6o3DgLeJP`_pljl$QK4%O=9&=wT!?%=hOLnl$bmqR6bJG2R2eI05$$f2#n z9P*v)(6@OGWnDmh7CKZ8gK!UXS3C3?-_d@JL;DcB)}cN)j_7p`wO;SgRW#Y?Q0J|T zvyGaeJN`zE?G7E-MXh&}&mM=;_fnUA)OtVX4>&abAY&eK$osHEH?Z-TL&?V-I*ngW z5YtKOiNdEG3OVgiPxLuMJLEb`J+t1wnHoN^o~Qf@3NK;9BTNG{GK~B4U3Wfg1BEg)D*|?38q&LwZv|mME=(f4a7KP ze&bMcbj1@CeCtpd97VQw)Cn{320zgDy+b>248=byZ5$V`3T}<0HC$CoWt@ng2M4C8+p=df<`4DYwz7 zR@jLjCZ`IRof?h@sOIg|VthuD#mVn=PUW^bH3TnE*yhwUMEf|E2dyvC{S>Q@MPdx`M-Qr{esangzGNQ-?4xi2k{p@(y;Y6t?3N_JlZ9In=2}XdmX( zKd2n;)HystOoUT)Fa#4Lo!W*6C=%sVNHnoy9y-T3RV>!2r}%_>am1O(n6M-{RXW+J zZ>W;O93H0@r8?Cvk5m7md|vM7cdBs#+81DRCB6mb*Cy}4342=4eDFdsTF8d%c;4woyw@=)Eb1; zb*gMVr%oZHzEgi<9UeAt%D<6Qd(piy=drE{>(kV!Ce4Vi1-W4lGPPnZylv}LR6D26 zBcr`j<**3XJCJ`z)~*vdcP9TXtldZ_zpFSk4qxFtia2o)8qGRlGOi-q7|!7sqQ?>= z?jd6waUuJ7r@o`)1gB9?zQZH zyhOx0rv~8|eAlyw@cRa*3T~v%o18kinV7Z`Gc4PwJ38&4t~-fg7q#9^?0cMQzK``k z$n)YD@nhi$r)r#L?_kXt*5a~Lp(qcpE5w6cID3_L*Ld#SV$Q#b8>MeMc@Ng9NX)=_ z+{UWA)EBRi=N@|o=TPY}HG!Tm&r{}s*K?-|A^%I}dPOZ>vq#=ImG`Yv{XX#X$q&`N4BQF8yP0siMiH2^N=bSY2vrbLlaf+g%EDxHQz? zr7@XY8W-qNzsxS(&*D<|tS(K*-$>8qQZwwpbBxRG(mtGqPYxHaA6)tlTTYkOphK`r z3UO)w|HQa-D%PbMaW0t>U3>=PQbCVPg;QNBncJmn*qg_tVtI)%A7kWqDGOSnO#zoy zVjCVJOB&;#LApz`@UW0ehYGv&vV}|E(4@6X?b^81u&qmub}m)JL>y}G(!nmwjaJ=U zI*OWqxMc4^o;{hr7kTw|X<%QMg8P%x0Q%u8#tw8TZZI_*>QawCUHWY}b0KY%OL<3g zY>Z3U#=3a^xU>|$<6KI@rSUFRpWxC{ESTuhhe^af*`>}?Tv|NUrOMM>x`%GlUAi@s zcxSm3HQU9tbuO))OPupv>bk)tuPx+p(4}3+sPl1`67lvTvEFoP@NJjQFTQp48kVtM{qaVpb2ty_f3abO%sd$dP`A-)>-r>{Pt_Ap<)8Sblu5xy#j>7#tL zcC4>fj^p@5U!9rctA$g1)nclzj!g5_@)^F`f{dBIdNJEqIp_E)7R_-Oe)E`Xk*_Mk zve;M2%Y4-s+purBuTI0VlDSv=>d+crb==^qJ6ONfS8KL$ey6Vd_Tyano0|?)fVJ6JJ$-<*U~p$n}e_M*rul8D4HJ#SNpI-;v#N zy4=c+QNC`Kal5qvpJDQIb3Kb&i&5X-t%-P&!>x}P9^%$Q6bW@}7Lvl;8i~)C9qv}< z2)D9Cx-}ZDqulx{)~!5oZbc=GLd?ZY^oy)^ikX z?bbg0M8P)XhIP1un6_>W!5w^P=ayG{w-P$J)uXFh#k;u`(%r2}f4KD?YkRo$Ur)Dk z_j7B|K({UpcIzHi40S7R7`G$IVU$~~M!RJg-5AX2j95Xj<=7$C z>#$o*u>xE1&k?uUA7kF*tl3GoQct^8<&0bPF#R0!pLgpeYTa^c*j=~U-gC=x->vTG z`G8}Osq+)Jc0Z->GdI^yxpnVyI09>CKON2Dr(;?DbQ!0!`>9bbKeY<+Q-@GLMTPn486JiE zX;*}wu0{H3QIwz7#`tMzyr1?Z_-RI}pJwOx)9wO(N-IdaG(X);_mh7iKMgF*Tv$|u zxr+H|XmLM?>etsG`%1^&e@zavW^bPUXu26qfkM-Bo6n`zkAdkQD&-V)wxB7n*Qoq+h6tT_$xrP{T?Qi0*C(Zn|yt%((TGFeOrG$M6P!J8iN^V)776n?XRZ;{B?ae<4o{Z^U3~twc1~^*ZAwmT7SLU z!W@VEbs4vQ(iVYU0UCpQ<^bjJ4p0wEfWEft>!BS0lF0dtXk zW`H)K)9e7P!xt2p!()8J*+l_bvWE8S0@QUo$6(wMpa#1FG!t)7Zg+rI;vw?v3D893 z-y5J(n7uDR6%KM9OAiI8$&mnEz=-1kN<9&v#@_-o581P1Qfc%+?yQ;k-5`@{X3L}* zDVdb3RwhktmPwcK^FSs&d!0$sK4sEoyg{s2pf=kBwbd1&_nEcgTV_4M?krijJ}HZ4Wy_*$b+V{c{VdAWI*T5)&!S=7vZ!7EELwdu zi;QQo$owOVrW&%UXINHVQ)Sh!;aRl+dkbdOkz!euqjXlaLy;v}d9N%h&*7}9lO>x@ z#bndg4mx%VQq>+o8jK0}j^;gsv=Sk`g0v3R zdI#wQqWT1BIBNH&4F=!@3JnfYo*_X>92%rFyhr^%gY+3~h6kw!cA&+GAa%tiTpt;v z$Cx@QNVi4@$$wmsMqv)_<29y?57NhpoSPKHbs<682*+R42=nj=36q1=42$s(mQSHS zf~Ha{4@okiON ztn)$Yg$9R$)bePMy5alrAmutAq~Gv6E}_KbAZ5SF9>EwK!{A#%+KueDgESi(u=-Ar z22IGNH}IX9OF3udQXVuzUmQT@*}0T3KbM;0;DTIAS(Hn&!h-c3VG+Sf#$_Z$2WvrW zu=>RXb3Jab0uzFD9J8wg>n6tj60A9BT{T#>TLx<@)GAno@fKdKgS8kr+XSl{CgKa` zw++@>__PaFNleCFyh4@s!5V|J@a_<-k(l2xSa&e76Y-#Q=V0wY!!E&UhoiWRIbDPG z6t%h&(;vaQj%7W9mtIA2I~M$91GS}_#G!7G{;AjIuWdplhhLrP6eyTnPAnp6s(lX z!8(Q;7=1NZ(^2X=x!nj>Z>-0RyX5dNSdadp?vI1j67kQ-;W=xJQP_)8FM_!aAy^~c z(&im?d>^dW*#0S4k)MN={cEshdWUd*XowCY$Qq)Ywh+alsy#&ObA_l*Y=~~9g~(ns zM7waUWQZOis$7Vcmk-evBvuaLyIi!#hngYssuiNHC{!mzm^; zv2;y{Olw2rvo1t4u?*wahv+_zZ3t0?jUk$Zn@HLeqUu{hRCrs6dh7~On?uZdCPZV; z(-+>?L)83Xh`PY_D1>V|LbL)UpMA8&~DU5K9I6I`D|)DC-b z0oA^QsLD6$`aMLy{|HfgT>TlMSqjwxL#Wmvw<%Ob(Fccd5gu!(I@m(B))A_Ec!krh zP=)%2s*``H{y}VTsOmpR4HdebrVm};#{bHV8Z!O#as+k z@a0h5N1rR9x`MV>neQ6oq7@e14CT7#Q02WFsulSCJ~=%MRqrRETJZeF)XY&!K#`C{!(f(9aO2;<$jnjA2@doA`m;rZDwIm^nyPrpp-a3DY!W zq!I^Svh7^^3O0Wz|Ub}8Z?}^P-aA!Y;(g@0`umD z@jhUfTAd8zvx+d)J4ODufYj4re1=CXXTsDRy|E0N@eSqAhN%`Vpwqc9?K&UEzj4&` zLYQjfDBKsr^v5M?2iFzqiY0JeCGT5dT8vtM6DMAw!ksXk!2|f*<6Kg>uAyVGa9xJ2 zOgQf=hie}8LS;FJN>#$u{J_fV z*nmff>>aM$n2n@9;R@&*uBo_%%KaD@SFwITxT^jcuErC?wQG7fpBaa18@{6G%y1os zbym3I&=mV;hs$qnIPZ;y%dkFN4L5|V`o?fg-y5#1`@+@ySh$AbJW3o7*9q)C5w7R> zf|e&4A4f3hRJcB2^67B-o(b1n+(oam^he=y#EB_*0qgm2<-N#xEJD9aw8vMhyArPZ z@W0Bu=z+hn;zqb0qS&o)CEO;Sm*ISV6s|_EiTh2sy8RcflG)3q$%;pFU!dPz};}1)OI#?qlTZI0>2lV%e&;)yg=D_NRP!|kDhLd@G zBlHFF?g$OR1i1YoblE>bk5DZjLX8oeIYLcwC`*JoW{uDQyv0wn&K9AN>=8PJTd0(S zSg{Dd%!g!0D_11iNv$R0;q%tzCt2sKZRP|cJG_4P!kQ!2USiQqF>#>^j~ zCTS76k`bZwLJ^u)n7UzJ5#qr0q7nQIiO}<65%MX{F+9bI5)ryqDni*xN61tmLJe^W z1uI5q3I0WmO5}_#O(JxldxX0E!P@j>%-#{II*2+BrSFIcO&JrRX5%7Mb_(-Mr_IU; zEyl3b#I!d;g>N$7D{={s)c5+4s?{J;&G8L~8b+$s?~!^3Q=>?w;CHM;uEvp?jqUJl z5~;TMj9g74RRi~tuUVv?cZyVG=SU6e!tt(=DmE-qy>V?gV~vbd@oAA7fZWp~RRYHm zH8WB{vm&)?exwF(j?`{s-x{eb+Zg9ir1qi9Va_4?2yx&ox*elGZk~wbceO~3!DU38 ziqr(;IvuGY$b2bMr7#ei@C?~6NAfvEqmJ0wc`Mnvgf)EpJ1 zq|s5TKRHS>QF%&~8sH&{O^eb?l%E~N&!i{~Um2yJaIA__?hR2YvXQn}5BH`h{fZ?x zgRk)39Hqh-j0vc+B}!ZI9k#99M~-b#+H^8Xi_b)91LDp`X$>x&i{jt=D9u9QOUw=H z}$GG>S^bfva+Jh*ry^7K`EHe<9rS)$bj$FfH2WAER)f%JO%IEfPoZd)#Qee>D-zB3P@;7Yg-b@uUMgD8%S9`;e6()i z1v*!V*4c{DT2v`oxvNHNDyr0p=KZ#4{Zltu6YE85cXRr-h*kx7w~UstRWz@+qP4JH zv`Vy(mb*i=W}{!vXeIQI)<`rR5UnhOqSX;I2S@9}=xE(p8?AC1qqPIoH%05miD<4v zh}LWT#KKe2`t4k_wxjMP@89-~q@VpKY344-$$Xmzd_y+MVr7|jZg;kw2c{lLhm7+pj0=ol@4Vq&;9IEHJ3 zV^lIBMvdXh6QjjgUOa~HFvn;J!b`_!Ntqb^U6%1H$7nyM)`*d_c8n@D;kIdv)*!e! zF|~+Mqn0sTM?y@kVssV7TF3C-d5p5Qp+AlzOWPQ2=*ICLF)DbE`S2a7_hZxvSMdz7 z4`P%LLvax2QT}0!wxZpm7`?`S81gtqd!NK;{__~!LE?)Tb-_xseMueg0THia6!bbq zZ;|Uwj0U`mk=J`-#c5>z5Tk}ziWB&X4xgyg=NPUviqSjd{u0Cc(=ob)%Kye_A|k)> z_(zP=6{`y{d&P21Ypl*-qajug5NwQ94GhO=WHrUA4(8(y{LHZ`hK^W->#%yqsvtUJ zF|NRAiB(~=!yKG}$r`J4biiUxoE7q6pK}K@mRGf z6|3c_S2|X0@eWnW5=%Mqu1JnsW7Qw2+hSE5#}K)LF?Ppl$kkXqyBn)=k7N1FAXaHl zVpSf#PdWZNRuONQ^KGp1zKhl4&#?;q603e+iTmGJZTcCjSE%3>r`(1(E%A=iT@#32 zipm?OKIx2ub{TQ%3uB=;{a!du2}Rmo?<7b>YAj~UXzazj9 zuW$q#>Z) zX*5cV*J|uU@uYZ}lH=6`w~#v}p3h6-^#x8(ywXqx<8T+R@MmhgHsL_-cooSLuRXBk zjaOH!!bQ}~7q3|uQXpP|Y4K{497iu zI>u`t@^qpvP9VBVyfSqq|AFzEjeiHl>)sINo)WM0spN|v*fA|$d*^T*>*mI5A4<=o zuJhy7b3wdL?d1F(&STwP&ZG1`&hL*`!vpbZcPw5j(cpNz+9Uf3>V1aWv#bgJ#)Nb6 zYJP?KqvloC5-(Bydc4}+V4wX*ePR1a&GF5U!0VO-y})-2G9~DaIf3udCCF_{P-S@e zB=8-a1Wm;UdxDNT64b{(L0b@zDM9DZK5K%O!JIuoJ7A4UP-%RHEjmHt@FFHbf5#=L z)cyqZ$E^biT5&KzhmR%5c%1QY1QkytX!*$m?K_pAlsgF;ji2|3^L~P+JV?;54-*vn zI6-x>?MZ^>K26Zue;M~%0`EB`s0KFvm!RQ4h{KYo;y7$gR9~M&4Rt2UoHbEn;L4V$ z$GH*}8l0$pA&E*0P1MZDL|w<|s6@>|o#;e0&7Y`k$d!?(dhjijs9-FHp-7^(;$?+I zMORGJkV?!~IZq`561D7AqPF~(s5hweGm+1G6XoZX zq_#*jC8>j7l2+q)|0H!prhp`k#ABSxoFrG4B<;s}bjzBg=NO+YNnb;f)G3rcu}S&{ zYh03I>L&5s@+74u{31j!*}DKboX|$C5M(`Hm-P)d~8aOj7V^ayyr#$iEr) zPLk|*le7g5?MrC#$8TU*qvk@ zy~pFXJpPcZSt#={S<`S9Ydt(Kh7@IBjWI<<%qcpC%NXFDqKB3gy@Sb`qE@J3 zOVJWXin2OW6p3?i`=)4+J4HPMQ#3s@=TS9FiWVaxYl_}RrRZXGigw4+FD^wR^Q7oM zL={ZY7g*C$6q25zBupukqLzhI)B`h$q-fdy6id-}*ovoU6W$_MsT6faf5eqe(H~_} z`2KH-=9FjbDk(Z!HAS_4OHo?&6s^TBw5XAyVzp9K1&we78*8WNN!=8Ush^^84VmNj z6lKPK_%}*XIm~NHd~H)S3G+~)9d&6>E*(?&cP&M;`=;<-19PI?SZX+qIZ$IfF-}k6 zx`7l`gJoulzRpR}$+;=IiLvui^l2gWUX-G1=(9LQ;Y(BW5$0tnTrWip)}+X>F-0Yg z(hnce{5Uz`*(GXmHAO$L{91|{Tu;%7+tl}7iZXplQEU8xu+J%K{3S(~zNYB)_Y}SP zL5;BNCppNY056YfnLTQp*`r2TJbYix!~0|&zNhBVx@;cZ$>C9YutyUx2jxOM8X4;0 z``;d}J@)Yal}GbXA=;zisGi_a?qrXO;yGHScr@GNQRUno4bJb;(?TBgF2eYwJi39$ zm{{7QPh~v(oj8v&qc>WX^Jr8hkDj1T6_3nSJ^cL*jw9e#k80xhZyw#O&fGP~0mhoN zspZkQ+8&*$phvNT={Llq7sEYjIKrd0$TE@~M|rexv`6>H zc=T+XN2kYo6f%K&UD_(e%@{-tIdGrWlyi!%vkg8v> z7iLo`-)TwJpMI&DimLvpYJ>~OnkiMokT*D0rJ;~ixiJt&LsOM6EL9WYQndi};#1WY ze(T-5FfF& zJn>?Dg;ae(iAt$Dg~!-eIaTedq-xYJsrm=AeodACZ>eg4O)ym>7TiP0>ZwYqk*Y(m z)Jj$P+O$E=I@AIFb;-A0st*31s*8+Do5!d48}kXQ9y70^8VgKV!0 zs1iot6#U;5Pz4OZPP|3j+X8BeS-1$FcLh`w-LMMJ5%s=+>SHoa!}y_q3ZfI1;2yGm zETC%e6ey_lf(2E(P(jsiTu?cW7S#L1G{q#P@%`B}&BSelB&Vqn=HLc0r=+P3cEROI zQ$4JOS8AH7U=Xe#Pq{SyK3SR~%cm(Xb|P!VG=0L=>S=0QGfkfxa;#~ZO0-B*=~ihP zg8Z%1R0hv6yG@#IVr*OHNAY%P`htAz)ASTyvAIK<{JJtX4BgV?k7@YWJxv?_NYmj_ zX)=yZ(-s^-#W87GJ~mCw$EE4P;xq*?)U@jXDs-+`Uve>Iqna2D3Y5ML+S3YODCb`nJ+c#Zhv!-hh z?qo~n?+K-AswZ9Nk(4`K@9|&3bX84DSIr{nnt)eD)3u>ky84$+*F`+3lCF}!r1S52 zx@^CutNCx~{9VCxscyQ`FtuK~>eo-#%ZBNS{ykko8l|gP<8;+(nXZX=-6~zHTBmDp zTjD|X_UU?qc|Fs01NnQWE3i+xyoRT%2;RXkB3;ArXe4uvPFJ&)>6(l0tB7lLy8eQB zO}f%Ir>h$-Y)RLGZRv`9&YU=9$WVweLw}nyl*Kzk3oRMCYR{0LBSVw3W@t)ChAv@P zXojXDC@e$0!ZTDpB13!PGSs$IhE||{=?tz*%g}rLQZ_@bav54(HABxa=hqCaL7v|- zG@)9C>QrZ*X3UAS78&{n?f%TrQkaHk=l~+8W~d={P0P@j=^4D=pP`@FFo*LfJ2yj% z=Vj>O{0yzzpP`-yGBodCh79*IR21)Fyq}>F_~$`}CO*ti;g=cegXC8kDuTlZdy}EN z$ow-y)xck;Q5MYpznbm?%!%ra_xO)q1O$}c6p-GLPS#DE%mk8bHoMdmP>Ry4N?U|K zUHSro^eSDXihzLhE*w)ZHggpBb!QMF*5n+59t$aYKUneoBT<{NhS^=O^AbsNN7f0 z&27rs$)-P%y|Yd2yVz8;t4-Cr+0+#!yW3O)zan2xa>A4$Hl4ump*H;h=P;Z8n#6WL z*pzNM%VyiOb*@dXv1*=8+hEMMab22CfrU0LS#Hw}{J4UgP;I46V}7=&-YT2+ZnP=$ zZ#HejJ_I(|w0yHot+&{8Xpc>e_APc2?JC6SUd1?#sTQYA zHF&KVrsYpTdPCv_UTn!6YoeTHMF5&*D_X9>;f$ zadNxj_&qO9T|LCI;xx@0rz(x(w8Iz2+>LRnI*Go5pJ`@}c$FF-uZ31K zn-Z@)Q{(m1w0PO3$Lsivczro5UT?1g4Lbu%G}wmj9qAp$H>%`eo&&DT@mE&Zr4ZHiTXY4{CjIx+rD;f#PWW2euuR4 zJ&j$}2ip~gE5m6!!meXT!;+D9=8v?i^=P}cU_bsDYge;zcJ-fX*KK?&PSxxlVz zXuQy_Fd8nhb1i|L>znK{*4otspRKd2`#wAWZ?Nn0{dV=hK+KpQXWO6WvhC_3)60gx9vqKhsL3|d6W}{kGhr;NIX*gBbq2tBauDC;8k)wn| zCE$DKBZvOQ)-n$LjfAoeJt^l#36VpICKIJQM?+<@fKIA6Q`zwxhfq>!OFVy zgY@+r`V^HKIFyJJpOITUx#0l3c51?1^l~^TPt0Nwk#{mku~|;Sg;OJJbX#Q2dBPOOHDA zCpsT<=sT=_=Q#PEAnpZf#2e(k=urK4F0oH=L6iaic7JQhDi%5Uf zp&&-1<2A+-tN(WBFWg7A>kgHH3*&I_mP7e(Gv3Ji5B0-~p_qTip(_76v>unS>OSiq zIOIp`M;ssc;ITu4pE!m}-UODs%!MF5_405V`2B&u6F3x3lYI{znj$=e= zr!suvRClD}2p%C=#;IAjjYnmjYF>_QumIcf7WpbT)c^xA8sjQDRlAZ?8&R#YQ$Dn< z;?(!}u&PsK5qzhbQ}?l^hEwBfI<+3hK6UDRZKp2OaVl?Jr?NC~>SKI~^fuZf?wvTN zE+UiNsY-Cca5z=kNuH)tlarkKG1;kYsMy3Q8`{6ql$gz&3ZrIAr+&vZRB7c@5^iAS z7fzi){FhEm?Bdj~IMBnX2gu&jsgkIVLwJf8-#YbCAL_wati|&bVhncb4eX=n7v@+e zb80v>eU4L$@e~EuIn{WlQ$29=pi{XHk;^f1!3o?&q2oBgcp~>H#uoFi78l<+?NrJc zr%wIl)GN3zI@J+_vG%G{XL08S<9XAmF8?|;388yV4M3~MP7OnYXY3=Cd`+GxBA48# znAN2q+P~-0>mn|dD(X^)5-v@GzmiM6V5`b{T&m$xwwf+QYq>N6lj^y+hs&kRHkYd5 zM!ZXT>@My0xO5MN11`m5D*nLZpi4y(UFwOMsF&$C-d78OY2Wc%_%F)uLxiOda zVEpGU=D>ETdIy)9B7J91SkFNS>JTlS`Y?eyK|nFng6tyHM;Gmps_B#-;u17|%49s=~PLQYSn@<{OOXJ2zeW z6Si9}&Jnnj?~aS_%3X?}Hx^Dbe+vbZ&`fLn!% zy5&PhjK(S)!xQ8y=2k~ZU==~f4?Tkb@+x?*w*x84i8H8J8=@t9kSTDcYc+^vjl+^T}b zo!lzf#jVv{-LiLgbN#zp`@eSU9@>86*0-4V&bMwk`nYwXuUn1#xiubVP^LfcaS~}* zIl!$4_%nq#-??=fm4~>MX_#AA#*o)6#s=GP442@WxSn$> z?|HY%^b`n zThkfJp4(70xbqq6h${sRJ;ld`P}tCRTrXm1W-&t--YITqKna8S2@KBpupYB5L%-nM zJ6=Qm8X3xxU}$GDahn;Miqpv2%HZ!`L+#oa8jW-v43)({-3;aFZs=?;g9nos>Vy<5 ze&=h0xgZU#!^=K~I`=cUC&y6T{)Q586i-tOWgBQ{_x}u?L4hHLs$v+=k zfq#b^YB|!-AZ$Y4?|B_<=mpk~HPj>3Q0pJ43m1`Ts-a@=VGg$8GMY~_6#t{aIUGZK z=1|*QgZYdYr+KWKZ^-tO!MsI=K3Z((4caa>xMs{y1H4_qIILvZDnk>Ix|(g*7^=L^ zPzZf-{8vMpe>0SZCYuZm$Ih*c6*6oyR0K8A2-kNIdnfO43YT_~_ipmRTpW035Bqno zp@aJkJwUbthC1NOgNAxz@F7E2(fEj=dl>Skp{2NsS9pBP(AMLI2A-hCle9TyXgXda z?`cB~-#KIGJRE0f~!3Avyp#v=DK#uKHV8%jba z48dHqd0}V-_PrvH%pNsDGdQw%^d^T#RvC|)q9>-6^XQB69_6m!(e{cS9l?M~9+j-@ zQG+V1!DE>w5^6mH<9yGkA6X!S{^0gzd9aOsprvNn@46Gv2h#4>>d?% zdAN?tqYq6F^L=>K+3V5D#vX0P2A@Zj10Hq6dMpTf6ixK#y^u#0upIkv6Rndx>V-q7 zm`p!tkAt{{tWAiEkDGcFhX~H&IZ8D1$iR%|9&JLS7PQ3}ti`F8{2ZZPT*JbsM?2w) zdDIHSupHZQuQlWFg-4fAtquL-Cfc_1=pR&Q?@3JSugbvA^I^ zuFH%AhNrRbaQM1MDcMc!&1Gs!DN`jsG4*pbQ%P~As()s3p4*fs-qcOZu$xMDnkwot z|O32=*ZF2vcF4!iOVG&Bh938e{4M z_{N%?%QTtO!Q}ZIrjFwK@uqT3HB|&7k^e{PMXTx5kAgEy{ywADnY2asS=2h4HVfG1 zC-TE*i%q3lYU(wNWu`t~ZmJv3uQYXVm8r$+P4(GeY8Yy5HuX1rTTQOpHg>#>& z1Wd&(JVllRtUG9`$01YekDGdXlCisN>J64$VgH~`8e@d)S55WBWmLY#dX)Ox;t_2 z%v4t#z;Dlq@q+k>y(DKed_`^8hb6Dc@eRi(O1?EU0P8VKmWrmc^c`-dx3oKh#dk)Q z%AimtOQZ2?W=p-ZSXzz!SuNGgW@#>RWw-P-E+hFpOM6i>ho#xbk<(H?T!Sx{rG@al zZ!wRP#q|f4mgTh+`@mAC4=pXhuKbqr6(ANy7PR!FkfmpZElnt5>6@aKG8VJ+1IiS) zv;i$kSjzU1rAr8vw6qxav9}cQN|PsCWy!sqr9~AizHhMje!-Gi*V5NhQQ#UWI(ERDs#@OdpQM~+68I^!@_HMUgENA3Yj%@Zs=M59DY;gF>>a3xv%Khsj) zWJ^KZ$4^Zy)o*5TzJh+66SD_pUjeUbtNY}$sV@yMho|cOBva}BAds`|1FHXamVre3V4779w zdH+YQs4i)p~o61;C<9MAxeX}g)R$*LFVm8P0980NlExkX_QXCp#+7jL` zHk6#)8jg|`jW@*G` zYTH7e==QtCJRIbV6S#rIt>m$T{C8UFv&+&j4A^a{!d^aKShSD*wV!@)@qnew2Q7V% zjE5|x93g-FcAU>I-aE;DK24ryE!8?_>HK+1pIqd)!y9b4#AoI*$8#F>U*(v>tZSBz z{cWk?4NFsQ@_D*t=`F_m!?AORyin&p$M+M)@~NfTcmwA%j_>D;(@Q>g`05p(vm9RL zZ}X~fPOqBdi(Fof%I}rEfLGsRUJulC|p zMX%y3d36+LDtpzUs#n8t1UsvFd7c-s@H6frcTKO_A!jYG3_PssRl|B-RjJQRT=ceTDw;d@D|M-ULAnf>DBM3?xJs0G1wLx@DdJ>S0iv3=}qF} zODx1ql(2|}RQ!p2Uh2UZ?7(Z(Z{$^Xti)9mZ0uDd48d-^L|q^KVgufwzTeB7vtF&i z9h46+o|uKR_#nZn07hds(gnS0fFAe>7mzp6D;N4>9sWhhkXKDH27llYDkTvcGjR-A zlD)E_2NvKGiZt=63C3aAvB zf@&?jTr0+y;u=bZy^7!m97B$XS5AD36}XNPQQ{yKhw)*Iacb+8)y=D7qj;a!r*f;KaJ z>V+3*I*V;)`xM#e({%WM^C^mJuy6LM>=vK?+v`)MedK_<=)K>kV+VX1cF?D1hkdGj zgxv8Q1ON2t{869AAEUmLKGnw$r+f;X_Nnz{`oOa*V2P%V#ouZCZX^{pT2qI zQ%P;ksxH6M@BrVs{X7TNugxC6^7{NrKnA~GA7C1u1pK;| z;FqJFUz5Ag9<9FdYb{3g@#|n;Ui)F z)vt*tIEnlx`}Oe@`d;JL3#?e{*A_U}`88*~UyV2T_49GR{>7XVeyu|7lYXV1^6RtH ze&tN_s}bHH*HynJ;r=zh7X9t#o_D`iqV+Amx}(@_zivG6>&Hia4SC|1{~61kQ|AlX zz4U9wD?jtt`gQ27pKE;rnwdVJ#Tfz`oiU)UnF0!B4X9qufXe0yXyy9>ZOk3e@DBo- z^>IMa3IW}(7|^v!0iCQI(4Hy*&94^Fl_JHD@0o`^5^u`G2Cr?19&4A`w0bRmGZ$R@<-34V@fdTb69*G#5C`RE5@!}|W)la!v40cqHd4WAzzUoa~1~m=SM+ZMEj3}YFjF(LpWPH z$g|>D-i26QgW80r-Ga*VO;Du<2bFzfP%~45S~)4GymN^)Kd5hU11En9s`$E~I$-Ul zpgfy{JR6ADy+QRm6I8`=iQ3sLQNMqYsM2i{mAiK$a~>qB-Ht>JM%R6b`siq)Zezr; zMD;wKsK;oKJEV4bLn@UR(x%Tt+TJFlKiY(M1&vKApl<_`o~+I#ljSRw ztN~?`H7J;@-aV3Kj!xFP`N>+fCs{i%Xdf{SCacEPWX)0&wM^GUeej}o6J@cQs6mG& zD!91`&r1nwLA$VabqZ^6x3C`e4y$dSunyzveqo*u8P<~iVGSD?*5vQP-0Kon^)b9+ z`uMO)P6(^cq_AdA4$Cz)%=O-3EuS9N-!sCxwVpT|!aA}stlxeMEBltP>=?5(tgYL^ z`gTuPMNWiuIW4T89)vafVVL_l!rGW2B6r4!>ST%N5{Bi9sL}fo{g*qUJb5B~K3Vrk zM5o;m{b)oq(HGIlZzHNXFrwVwMdZc6X%U^D8ByU`5goz>q|T10!kmb%;vrtoji|-~ z;^Puh7DkkFDerM}O+*dXMr7eSUapI%%KC@~V;s&Q|AvVCn1`$zBgzNw=7<)d*|vxt z;iDrF9meeo5x)0}$n}^QsP%*zaSLOfM|1@*UPRRDWkg*wM708~GDg)6A7+Z`eCDVM zXNl?%E+92)R5h|iwH3)ZSdK?Uq6!v`DvHC%UMwmn5-QW-xgrch5g0@gBs*xDdC#o~p)i=sqol&jFZuIXTRgnQv zHAjw=sEXn&$_EHN__@ zqsqKCs!xB7GS5HbwKu9xSco2X*se%Sbw7^jSc8}q|keN5ptF|}_S(*h)qh-nEn z;}x=vjLC*kn2OA!VtS26-^bJ&C$MHTvBt!7b9_t_Cd5={VoXOm;d|cZfe9nVQJezf32^jODo&|S!uxspI@B& Z;RiiiS8+G|qqXt>+hzFw4gTNj{{b!3hl&6I literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/8436ca4f5a3ce2f0_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/8436ca4f5a3ce2f0_0 new file mode 100644 index 0000000000000000000000000000000000000000..d51562a7f1903cef50ecb7075b095d0d24868a99 GIT binary patch literal 112424 zcmeFa33OD&);4^4N@oHB1WW)i3?d*Rvw+CWK!9)=VhD(+a5_n6AW3&fcLL$6HzFc} z7a4;iDj*690xBpfDk35?QBhG4QMrQ1JS3?2Jx>jt4$=F*@A|*>egFE`-_Yqkr)m$i z_pV*LcGaowa(D5I%?p41&0!cuJl-XbuYDaKM)%}y-I9AJ_DUSkD>0$ZElEAQcOB5Z zXV-y=eY$t+-R+h>y_0%%8JLvVJE?om?up&H^cc|VmTm)YN$TCZ&wyLHbnTO11CE{1 zkxvj8Uu!}Ry?^GX*ee^Bgcu2r+IKnLJD-!f-XaU}*V5(oYi;q)EiKKCyb5*3Hn`Sq zH(B1wS<(9~wOwG=$5%&;by}DuIyLk7 z{k9JXQ|QeqDR85DbZWz>MiD>9@n)7gJI}+LQK=cnZ$9xZS#}j>8BRxpBhKQ$?S_$u zdcJ>}_eYnwjj||wu^E!*wuaH#xjeS5#oF5OLZdbod*uXs$i6<+MrcG;MZdPz@YW&A zo3^n=R(7wp)n69LZ~4{ssESr??TrB8Y-5kE2#c^Sb+mCbZDyNbkJ;D97Sb%Ds{RJU zFt7aa#~+sV&f6?mTP9k{?I6q7X1p(24I^2U$D6!oiE|##ZozMOIa`>9J+#OOiHLGv|Ma)H*Pvdm-(TeGd-KgDo}&Dm&Y9lAn@daF@!brUz=A*V z8JZ@WtSD7S-eFFL++ytb9~C3iVChATy^;?)Qe%Tn;%H@yalT>6io;h|Bf~g^cdO18 z<6%*BtUfhafuI?+n?r|G$5~dxT_FKHq196Izor-?4)~^fU7H$+;?b^xysQBw#V&uI*JGGjsN#s}mLF#JLoqS6 zJX~53iSHiZ@fEo;-NRf(<^qy|>9u};Xq*Fu6HDB%9nddT47M&`^dcE_PcABU`+UHi z>h-b02||K{mV1YNM-E_}S*gYD(&Penq1)p(Oe-W|X`7nUIqrO`Ca8cWrg%!pWqMhW zdl-sc#Dg-d$^rOqe0hZ@WbGtJAd8Mqn z1vkn?aq-@DF3QJOnv>-9_+21cY{meZoRz*mbwpznW|cvFd6@~tISGD$ab8A=-))#r zvl1jcrTp1(B#;RS7vxQGrzL|x7u*2bkkrgMWj6MAUzsO!q}yLoG_t_!hb+y0lr@OV zer{(5iDVa)_;N>P=DO(yif9`|HFD)k^1i15kyF%?t_lv?EWWDWCXel;nJT$e8? z*X7A^XQ6PoD%@xee}P>BYRhpCaQR*MZngzQXIPYZ7N3^(skvL@!#-?=f;=C(g*($P zY=1;{y1NjZ_}yqdfO@deAh-Sf@`+SlW`PSvnq8KbJie>hf|wxq&8e?8pbh(=v7(Xq z#gpZpJR;j1f*aCm zj~o8VhPZNh@(M-oOZH?Xm$DCl#1IHdVmZ5}qO~C6cNP1gvJnuxxfsO|Gnfp&{ShDg z(H#ltNrRKq#wQI;P8dEa)i4)RWoTmf+*5g!XpyVf=Z3=E1welqO$2(tH@$u7G1`S3 zCxR^eP25BWK$X@FZ+NYyN|Lv*2)_{+2_ZvnA31Nyh6D9wC(afQ2S@eK1SdIh-NA z75za{t~)ayS}}*9l4N&y!x3rp=&phS?<9BDpaO4(tH1}n&cICw4eVy0`8ov>WTOpp zEWWUr*{!;7rMd&wHKKT+2iImhMc>nKkB17&5f}%%JXrBmM&4lZu_wkug zP?aO*?4eNeQC36S=S}SYF58Z7mtO4h_`n5512n5YJ1n^OOl-DHSdqjdd(mYSN*}r8 z_8(f4hb-Y15{ipmWrn#4H`uu4XQp>#8@w4lcQL%Dxt;}}y7KlxZ;>iS2ya2DdthFH zUwV;9wjNYhcD;Euxd%%*bV(_GccFQRJi{E;S)P504hv12Ty{quI-fgxlxI@0s|b95 zhJtc|W8>V19YLJ`-Cc&_i;{CNxB3BF7pX5#I(?m43gG|}1a|M6@{8!8C4O&`?<&Fc zQ-Y~n+cJ&l1N|=%=$};l?@zenu;3rQ(p@~#k8Yl6MytXDmd76@WVW{${a+5?=KClF zb=c?;%O`_D!zjta$bA;KrKC?<3Zn=Ge}yqDwb;wn4p7=YJ9qM478YS3NO!?W(swVx z4GFuyYr9{mB@T>;)0@3W%a<|z_G z2r($MTQ?<=gMt{O;bH?_R|h5CfJcsHz0Qt*h8jm$BK#>tQY`!(Lq77*cU@aQLLkFm z?7|rBbDP^JE!axmM$e=WGN;5wi#!nFVk@qZNi}xKS>~zcg#c zoiVt|l92!#%g`#&VzWrGJG%JpOmgF)ayh6g&u;#Nn{4Rlv(Mj2yK`k_u~Qo6PD+4m zrcEvvUQU=r0JDG}mT1n}97R<)y`*xV8Hx=j`32}=fDFGZYMfM8@q#smz4sAw|u zk#_D1%8;S%Wrlj zzp(a=jZPn^WFCJx01vR93(UP-(KlaJ1W&YiT3J z?m};=JBh&)+70;=!^O073uwS4o_vpYl1ByhNiJvuF)v$>MxI=9@q4OBh(zx%Oz>}S4QSFs!O18)(WUD*K6WyR2B?juL5{^eP~RHNZ%I!fgznUxb>Sa0?Z{Oa1P1$Fntp7wMM_^Rk2oiO${UHWZ%6 z?U6c65`G0C2XzAYW=lVKFko)dWfeR9l4r^TWu;~cLV5$2x<^xb#jZ)|-jTT? z5JF^^<@FSl4J>fwm_`hFr;oMgB73^UQKpVfbrjn~)DV?@96a{4V$! z@L`e^l%4kd!mp|9KyMhC30-Aziei|U4GRJFf9=+uau^ijd;*3pzuBLbfcB4m@Z=ki z6+%Y@&+kAIL_4nW{)cFV2;jZNS;^Vxq<(=J_sqMA7CmU({LiZ-*qAP0B2{OGpm zH@lT+D|}0Srz+8?fZsFsl5bG2-{z}*q@F3~!9H4na38p5PJoixTb9h9*pQa%_Hdf6 z2ER3A4TWh*m2s51@Z2dL8D=&DB-jFh%HnzNQtlqNJIgm*4XrYBVVK3JhVi0PYTo@x zLyS0$MJqSeRgC#H+M66mNtg=&g1`iXxBHs@NUksvxI86AkUBit)3^b`&`9NLJH}ET zdA>0Sp7IT|oJ|H?Wt;T_$uMM@P>|>H2@7~1tpO(x^^w;`^`@wc-8t^b$-Ycik(k{h z-Ux{Lc;@L6?WVh-s`)tnzzc%v72oE+Nds4s7zchu!N}*U)Yu{Xjp;{$oOU;xc2kvb zMl~a;VXlGpqy$^{cS@3}@;n0xq0Mz&@P2?uVc z*mozg*AGh=Gk#R+fQ0nq@kt{_4No`yfR&-w^dF80CFFS$i@lRDGa%{={9$Wn`mOV5 zgn>kZa7U=X`2}guOyB$#g^1RQgqWGC8Z+;+c_l2!gfTHrFgHRUXbg}(8U6D|6k)*e z6Dh;C9y#eKGUt2DHxW!^}pC?(+2am(jju7y;O5CE=BA*W5x|D0Jn! z#gvsf$EIWox>?@igow`I_A#gx2nSji zNKRro12@bn35nwES!vBlRm1^_#Rx+&OjXI|pt$n<`et+yuyF)?!ZR9X0d7zn`xiv? zrZ|MTF+T@!hylAVbTm^`IlE=`2C5;?hdJnQuYVYQE3VD@GyxE}=wDSx_Cx|gi_-vo z4wIL+9GwSFnT#^bqr3@!cxB5kInlTY_mby>Ya8Hp7bPO4h7^L&3{jS4T{xmQr3|l} zotFc8>9`=Y_4D?*gq9JxkYixFVNOucA?^!r6MB-X*wYsN$!rALa=zHwk-UZa6_Gng zn&p5g7ftEdb9Z$^%9W8%p+Jd^Dh@Gy;gUSMuU) z8QMXT(%H+fq6=ArbLsogj=#~l_(b|m4+nBaCT1GqvXnBWV>Pf9e;B6+Kb*nJpz35dQ3syje1tE?u>X6h;(rR>Bs2L-|5%^BimX z(G&!+VQzn}H_KFA5Pd<6Pf{J`479@eNIf$W z6&*2&7edV^VOAK5(Dd~s>+7@W(yVH1$~=LaazNf(a_A0L@q2S}3fv<^MoJ{y*5D>_ zY<29qi@nqb*|Ila{voq~k4hzi>CNutcav!(VyQrcXR4`{qh9-ga;=$+Kn@<&SNC6d zZfj!{!fml{V=lwFrOJXP3fAbbmo|- zvJ}V};(`)C>G;t_14$S;GC6&G`kkrCBMmbRH_8R-LvK9RnW%-E8|g1AaLf6Z8AsUz z@#T^Y)7Y=2TW;G;E>;5Z<&WBS-~fhHx*t7~*%jE0YM*thWteQAN4k4>IiHx3A%E2o zIufYgu-VA7Nazu|0tH|T4z7N$Dby(@-392J_(Cz%?{&?`42iVVfV|Q?u0ml^ff0oHzLIn6c5%5RAZI{2Rs>^DOUBUZ zj$7Xo-a{rDM6w1GHLwc4QQR$i+B-VXkb?rCe}YBGk-7iYq7vE!2L?G+M{zt21}ygP zb^HJWW)5YpNy>9e3Wm8~33lN0dLOYv(gUZtMGBQGX4!d@k+pdg1!BrKeaAxjLd;0K z`EF)IMP^#0cZ7|ul;#VWre$~8$Z$eAU$IES?1i~T$z=4_KR#n0kwLf!thmU7pcOJ9 z+hdznjG+4#6%eC~$X9EowW>63f8(#ncEAtS%nW^IC&>-OH+J;P?dcvMf)NP$iU+3; z8*08n9B?udLb952BAZ!K42Q1dhvw*ssF@g$bLsT{JG2^Tf5J9D3y`^g;4eS2Sn64f z{8+5QjdEdU(?>7MW0ScaB{ODn{52Z^0}XfPzz^aB!yx_fZxEKuX+F8N;Ru?L=oJB1 zi7Kxvc`jbRybF>0N{Z;QeW^55=D|IQsdO!>Wkgqr0(*3B0b2iua{m8 zbEQJPzFlGxm6GSXBQOq`?ZFiMEO2aJ{@oYsSy(Mdg@5z}4Vsu4$({j2s~r9F0Fvck zH%d%JvlvAB%sId$d&i;WUNKW=?~oEl8?qp`a?!-2M_&>NG)B@4#i>_wIGQ*WzQ56@ zp=M{Gr=eVIdg=|1Mj}svO0|O-;PfaxUJgk=D195IHknwdjUxsyd!=H~&D3Is%jXWv zY<++nD#($@+5JZ!q%{Vd(a0iqW}d4cu+&_Rs$d-08s&V@S;l(0$BM;PWX+XLH2Pw1 zB*{VLwYt6eB`ZLI%@$oqA)}b63DXgcT_n%y>JII&gGzw*HQt7wqY{N=&o4q-7QX2U+Yp z$$f+@YBylcW&v32zi9jCvh|5xFDKO6rQItv3vWO0n!E1-zlKO}EXEfi95U$N4cHG{ zMMVW=!!c;tsWq%54&QL^K&~YI*#bZO&tP~%3`B~pv<>Skhy_U|LDzgo$$a!3E5j&r zC72qsKOZpJv_%h823%iFqQEfc0l75U311wa&u#~Mtig~bi@|E?i_u@kqF9BK!l(xp zdke)VtwYMwsK5qKaoV4v1V@fc8=sJ#o@S=90H${T4cE4zJwyHj^NM{U5)rGRDxG2u zfn>@Bj_KDN-#{GTM-Vgbm%IS|yh(SI(rF=1k!$@+(9qeUXRW^!aj$ll!}2EQc~H&d zk|G)j4Q_sMdIyS1yGxlnM3qCh3A(7V{f>-&RI;q16GfRSxN&MsC?L%DdI1++?`Z_#dE?whbnY?M?S8sCg*-HhD@=< zibC3|6vv@2UjLNh@FEZ`L>O*%f;gn3zC5YD2<_Bzql$|GeVS&5CSAE^+7)WQ1PkSP znTU&BzWjlClMORUvIovXw%s>`O+vS1SdN?tU?DT~nMPv{F5+NLyJMyUOa4BUE`?7c z32@)^%T3|59v|Z_m6UuqU+ZT`{r+zKiv#1nj`T z@{f*MxEA0;Ole+G#5xZCHcreG;9XVZjk%+0Z09lS$I?3|480@a&XGa6#499)rgq!* zM~1K-y_D0R1!!om-X(vqp(4E;oL9y@^Gp13hSf7S;#2s7ZP$xrV~Hn^`MxxF4!RX9 zj%EdTg2b2p!O4$Nz;&h{Xduu;;+yW@DF@Y6p=owyIH;BSYuFPw zLg}=Wn2;TU9AyTqbnxu;v`8P)W1~GPEMCc$peIk6QFwvV%RCxGK|x@GEk;7zHzQFI zcp&iEF}?rIUXksAh!~{yVr$UUdD|Kniq7g&$$Y|X#UCUVAi>p>dodjbeZUJ2#Wx~b z7n5{W_C3rrSf8pyKS0su$M2fXB6tiLQH%v0v=)@MZ+m++h02kg2@Ek)o{bxX+dVk5 zv+(zM#hE1qu440Eni2{s+fV+I1!6`4e{B8+CS<2LG^4=A!HAouWavsEs|`@?Q6LAS zlcDtwv4tME&4J9*;=4JVO#xG9a|djq87pJpYA2c_c?R{%j~}~*)VU?eC}+);}ovyPOx$_U1>NirQkOL_`NEe zjK>8#YT75)?PEu+2}0An+?{52LA%igsBhd`SyL!&jAay!T*wYb@uPyV`#b#WJEEqA z&^MS2v82PE9d_;pB8Q=>>9U+;n4zjs^UBO$C0oNw3NsMRwMK0S6;v00(xEXeSt$h* zCJ5uS)EW3*UOoL98KNK)#~@fwXQ!cx#IWwIc8!Rkz?%tQEX&Qwqzw3V)f=Lu=NOKy zjk(1xAEqU6FXrQ{0Qwu>dgMcf&`3dYo{u6dZ_QSPo9?{-3E831%L?=407th@$jx^a z_a|Kh*4#7#k%9AYrRS|>=U$O?Q#>gi5$?Lvi`{OsKv#HVy@>T;Oo9E4G;p(&_6?KT z9s6qqLkl$ustHS0P2#4Cm|z&Yzq+p-$JIQnv|zWyKyPM=4+ivdi>HUqR$Q5 zx@Eqknj5n5u{|6zR8}V`Xdwt;JIO%pAsyWbZ0va1TWSJ8tHM%0+_#fh#2i5c-N}Jn zeda(m6U>HeztV)v7I<^SEZtlUXc!#`v~1QfhIUDl56sMQZDydu5VrNqgthF)oT*}r zzybo0O4!arD#RpK@-`6m!CU~MtK+Co33k3behzK2rn9!~YQ~UrAnx^~nMK6NIJw03 z($vtfie1r?x2x{AxE52=|&Ze9iwlv&8}Ou_;!2dk-Iuw0NyJHGie6(#o`%Mi^R zPAvk*=#|&Hhy&&ae*kwSHmk}RyEzS{fCJo&d-B(}DIyLC>3Ny?=B5A_o{qOYN)b=O za#M{hLCii#BR!z((g}T@l3eHz1;yI{$AO`A!r_}x({OuXVCTV_q&l_Z_@`xf;JojrUi6h30PfHk(GD7Z1Gz|(0Tx{B& zUP`sNJ-(7+cM{f~L1X|iu<&yDa_JYD1`^R4QiM`HAh5mf_vdPcszGi)nh`Ma9~6$= z2W}~pMxKvoQ+h~qGbmEHyTdzPW{6ejc9A>+PF$1=+6VfcKSsFV%)40$u2BryMLW8*@ z2TE@cJrFKmbnV@g86eLN>Drmr2eX6&P7|AMgik*J)N+!d*gWT$08c0Zn(jAw7YT8a<*gmi19k05rK^P3M)W<9sllaBKxfF zIN*R5Pw{m8dPfs>3_%!z_sLst7j3-n&cEFBAoHSxM3gf{LycUoq&U#)9w&VR? zwYdkybRa|;{_>Pu8U*~Uj4Q_|nGLyX#3RCt*w@tHX!fHjfpW;tYi}k+N(}nI+CEUu z14Y?W#=e~}gzXf04B?`%jE?+^`6#6XiI2-~WuYiV%8({-mXh2D_e_eeTolcF zd(V7TG-4!+CJ+XCs`$0Ai{Kv{b&CBm;uD#lzRHxJ%zw#8Z-HG|TnOWyAn8tKq7wo+ zc&~VS)IA*Y1N}v;G^kt`iM0jqs0wMWyz9wisdYU^K=ByVk^0+sSH4KN6sm^}MAz6! zNuu4GcBBrY{@_aF2D4XK0HmA${`74`nyGg7igzdNtvA^y5m~9tcLH0Vs#I=Z6#`XK?AX;mT zhubybZbZ8??w%J;CndJms1%%8L7t(nv3Dn3uZ$e&U9608D=Eiy0GLO>FP2Zwhnn4# za6K(rd`B@Mu5?f4+;1xJKz_w1em>0tZpOeq4D?)FQ0n8p@r|M)#k8LTHolu1ReMW^ zCQWDWK^F^J_(6qi>I@;+{VlfTvq20-%_I0il=uG@{}V+Z*4m&BL2ortqHyZn(@zSQ ztQ-N`VkQDdxzN$<-#%Z)i4A64*x#;$KB}C1M?v{8iJ(FAI=wT6I#Nm~md{v1Vin&c zeMyO_2&X2v#67bwxqvCmF1YJn4USrMkOJ zbGoXqa_6swtiUBg&PN$sdzcEDiJN44NvF2!Xum<5?zl#XabzfDh3Wb_)w*>pny+Aw zkc)!>b^~ka=4djFfOp+*e>_wZ@ap0Esuupn$`I_vPXF>zurfMEc$w}UQIM6AMLRZE zvk_45#&kiHq>_y=g5F!RFt5ne>uUxlrn4k*&i{Gmt1ZNM!rYk4DuH2})#; zNPV^sm3BXRSxjMS7Wx8B!I#ndGCwg%HA8ax|ZU} z_7c|^vh1U^3(#3G zPX^35nh6jNKe%cD5n?j}RuNE09=~BB1e10!`YSq`z(6Q?teFp(mr=-yqj%lbi4|c7 zVqaZAdhje_7j;u*`eSeV_XG57%JDEF^qK7_UhtCk%K))-oiIFQSb~gh4KtCvK*1T$ zTnN>!fm62(?_@FHnpV}4>{Zv75j93Gh72k6?q;eI=7f8G_#O4|j4|ALv|`3H>~JZ4 zFjk0**?6&3O%!CtGi>=cEOcdNx{LJg6+a=N;o+* z9zDP#v3LyE0WXL0vvAL?y}R65dY?`kf>O266aXHoKTzoYma3PIB7qM#U=u>% z>0m71z~mtwuzB?0uUiD0GHMPirI}MCH$39tp6M5PJfArOZI$}%*mCYHX$Ht7-q zTrZ#Gm$q(BmnHy#_C563WHvL)E4LS!%amj2f3lg_=M~sI!KiIN3xT-*p*3+L-b93- z;=yienTNxJs!GoTHx0i+8_9B)`msvyGZF0z$btQ>pRsFUi8E+Y1Fr4VFa$Haf0&q1 zLvAC>3NyR~sBD%J8ii?_W{HjTc#t{ED~=_AVmh;Lpm4M&dge|dhXM~7b)T34}fmx~I>9cROk)K@dT1oc~V=BN5QT$AwT|HBE zh7=EXR;-ro7%c|t6BMjv}UvBLxX zrWyE^U3dSX1Q$`u{c@Za$X$TuexR0Bj(CQxWA6@(@_M#2PYL(v{on7Rf@)M(TEig#$Ks^@(jaR zHS)4O{^F8Mq$L9jB1rF{GMWy<3Gse$C;1Wy*1)raDhu15%!8|N?@2LTS8gsar8iF~ z+17vd!{sU-aZLg?b36V>**3kdcQ;BJolh-#qj)zFL-0+%EjvQN*PJGSac3)#0v2?e zKDOg#HS?~SauI!j9q`a;yHo#YNlQ{2JG+``lmZZUy!qE_Wye#G#?lhnp(Z1)j(^;E z2?$^bDamFQZ$c35{#X&u;Y-`kuo9ntlu!6bY%!3E2F3n2?>n#`wWxTEKO)s(~r zT{kk0@VSwA6OX8(7jKnv217$`?sHj)L1dt$>oNxewp_F{ZA4Xfsx?n^s~Y!aE)G-~ zd+K}>Rw=4|QiWl*W}DH1ao088Mpf#VEAZSJLxYw|Fd5(8DxSrpfr%$QSU8l0c+4o{ zy|ph~2MjfFuh^oa$0|KbL)TG_p5R?Mm>phhg%)u*u&u-mD#!EB_^qPDffOW(QC>lL zuG@E3nS>gq0QH${DB=F-Bc7Pf$3q41^**ydl!a~vDNcX&@dJcp?1veuw}icCER7KD zpE-W9h*QR+G!O@f#aUFEplHv&E_XCB=m$VB!l3_2H33J(d(A~kIFpMaJggzGC;@HS z6^7^Uf#IjAFyPtlJ&;2@$ONfuoYoa8-HQU} zih5>Cd{TIoH~%Jf9Rz37%(29TNM`>Z{nm=PJ$F%xC#2Fa<x?|-iy{U><_>nHg8U%{}>UzPFxUzPvW{lCKX->uJj!SBDq_kZ&~`TM^~ zU(+TZ|J7U9{XhAsdHO#|^ZyOB*zP~$qt*eMJWVv(xy#Zr*_DIf?`gcn`I`1Hn|+ME zx7%V^4F=)y4J`)3I^$bTPw^7xU-sbfm(1I#<1g?BXWOeoh?#sc>iyzQ+V@{CXW7?Z%xLaXAWzG00bCkPXb!@-=WCUC=6 zQ?MzUkmp!5S2TdZFu@4%T`jPAXmWJwl1pT8iTeRO7@)u%iti;6Gf!O1L zPoXd+rhCBIV!S2u*V`8^5@KS~ielnS^v7W4qvt?Oogjz_cuSynH4vvw1Y+Bc1_NDv zn(aqHEw)AR5L9Z>5p(1~sPoRqT#DOjU|NA!Y{b6q$c0trR9D%om5nW>)ltTO5C{+F z;}Mqj=Pk7aVu^Ad&L9!K93Y^qsHqYU(+vL(W?6}+FSJ*Nw`}Qsj`<5~iHEb6pK5_s zKs-AEa4Q5Zfo=~~KuqXTJe+PFs{@n@fIR`AXEY@(Q%?Vm*8#c_`msRVf)XaCSFuN9 z|G5qjcTaIAgk&$-ZXdJIZ8dC$);Yz0q7GCyi0D4NCDcQX1xkV%il4s(LzRmIadB6f zdA)EG7wQb-_Eb6vS$gQMPwlY#AHZz0A7q6Sn0^d3>9y=#oq}q-b^^CY!d5;Fb;QiO z80!4oF<2OMZ_z;_Jp4IhsH@x-Yg$5B-cQ)L&u!Yem z!oDnYR)}G(2$|)ySkYmHROeXY=4MkO141; zsZKczoq-u!X^N{bI!QQficGqk3WgJ=A#yg-H0}(Nxh=>v;D3Z^*pvohW2E!Rh4Zna z6<3*t_9q!}uv)z3vh=E8mI7#g;eZ6WgPZ zy@`d*$|?$Jw4yLeN%HFMCCqg&dsSalRpvT3NOUmQ32`V2_-flem}`|$xwLVtZ67Qn z|Dw&h=T^ur;^Kes*->c0Zngr9t?N<$3!1BBY@kO-Jl=kvq*|-9g+?9LR^1Ttd>@^S zn^Kw*9IslO%{Htpsv~SSSYg?FyI-Y)OyE;~2q>LBip)?&NyY}~r$l$P1 z~NKqy%F|=OGafIi*0Yj zrQ%D~7RSDb>VG=-j&)W>Tv~>{A735X(-wAXRdvL|7^7Z9)t@L|_np@}8%7T}AbFm+ z=sU{GLzaiLIPCGY#;}DNiS`z8@YHZ+>_qSqqJeQJJ|En`F>D|gq*VjI3u+)t*3%nB zKqFoe_Ln=9UwZY@nu|u{&Q&eXonL$D+(lzWgMF0|RlV%zE?RE2RoT{^TiDESMA*=b zzwiL>qXqN2g0*9IWwA0`t!1#$7H2obyLJHRzs7}N-j#=I35U1?Z-LA{Q3tQu!J)Gl z7i)nrc-@9!;B&ks(7P7Ip*Doa3^!;9ZSZ+17-%TvGyr#%oE#A*F4O=W!vT|B34`p> zP+^4e3tP%(=|d~7wKq|f=d`j#%~jzW4hv>Fchjf#PuT^q*$qe8$|a24U{m67TiM-i zu{O6=EwxX#??rHT$?=!&^=T+9q)*Kdr$ig=Jef0#+KU|X>l_{pvhcj7uLMMBq2-8!Ypz~*Wwsz4KK$hZLmUwlQHBMDr$#2;^0(# z3Xv=Katj>70w~=Q2ltZAv74{0w>^z#z~WaXOi$EaM(O?o$ASvcN3;`Qo2!F$uk7q0 z7)7(T+GO_H$4D^khi(Meh^Ft(D;d$@QJISsbisCZ4 zhZub>CJfV(eD;1FB}CZpgCH#)#2q0w3!-nUZEyA^n>hB$FM535Ky2Z-LN)CBXgh_lu|e zxafJ+)*_=~jvLTMbKqc)y_L9X;hYNtJq~P(AvG!GgfIXxd7^>(0mxbhX#HT=T8akx z%C3MYI#L2k!&V3A3;<>h)j*F}6p-!;)STF;g-_XJvbQ_eFs{kdK(4ESMx(N$4y8^2 zcqjmrY_*S(lF+7e2cSagK*bapMk3x)5|7vxDV^w6jRlmm7L?S=t9;MxXQzn!HR!r283**Ll~lp|CIKEvxkodm?T$8EAR| zCZHl}LCNOdHwVk}b2Z#emO1l;0nzi57+i)CSqqGAaS;FxY9I#Fo3>4er<*BOPq-;8 z4HXs`vQe)Nmbd5ON%Hxc^qnCJNGmKGK=tbYxd1TqaSfDAAU0EvBRK$SPzNXj0FEa# z(4&fwHeJ}L5mg7K8S0M?z{EN@^<&r4RtN(%8rFd-0K|#_lp|!WvO-O30-zezf|6=@ z2QXJO93?t#*u!EsA-BEq=tku}wOQr^Pvcs67CS)WK5k8N>J+-qICgRPmIq zy-&oF`gzFg04A-xiNF+F2U9w*EMBZz?y#ffv`B3y#QvXBT**+A_o29X9Zc20a`ST<6U0&fj-1&XSW7$*2tE}SEe=0!wWxz-05D8?USokc z4mF9FC!*8(zzvBjOuA(yxOHtXCgmCz0?&+P+BLFg^0jh{^~bGrjel&lUfw2LqqQ9O zrLEp(5s82Lx#qY@Yc0iR%Ub9;qC5k{-WP$q$2<{VqmuE%C)O1^i2C&%)?at>%X_=5 zKkwp~^4-?8yCt!XHM;KA>})|80C9wX-&-hTZ7h)aR^7NV6kiuiUB$5vfcEN_w4fmF z2~T`{ob|+Ren?5-VVKTV+>g(=U_3Ew#e2YzzLFxEm!k#rd8PH^Ps#H)pIR$ElVe9Y zprwF5Z~`&KqxJYt6txOQ9L!9YsS&j2L#wX5~~)(_UVeq=K~{n5JlD8Cri=YT;rBgHB7%+T^W+@yr2;j?Wp zdL`-mUpI^mc*`D&*-z_PUA9uJHBT&yBjk;RdTJx_J&Y>X2jh$3sJauF8oUE$JI&7{ zWxf{wY@K?793DGu-FT5-_FS|+cu9!fI9skLL&wK2{QG4NZ`@eMhe<$@0@6~QfueSG zC_eu_l1-aIF=l=iM`6A`e8Be9LpBgHtmRT5KROgLJ?vo&H^g(-_>_UvBCvl9h%Ro` zQhdk;pb*0;(omG)TvTpfhl7S6W0>9!G%e=4IXB|#%g1ah<_Zq%>v%1>XcYp4v@Wgl zc_``-j4+y9*mfAk2YWTpT)P5ljmqR=0X{p{0oo6M4=Xj$M-~7%5FG1{wh%x!)&bh_ zxnVrJUjwDoEDOddS{3-@;t*fKA@-Rs3}gM58u0dz3c1SE4AscuB7ELd3yky3od9U{ zl?Iv{s(>0RAVd#F=Q==10Jw5k1MPAGh(@8!`UwEtTnA{wcR1qedkxgY3ZP&;VkkDc z)B(B+0PmgDK>Hj3q6D?BF!CB*>i|^(p!&21D#O|fLJ_Js3e_nJ453E1T3|91dHjrF z^ggQrJJ=S{SQoAOIftO;fs-Z6bRb2m_XJOC6x0zZ=G& zKQz!yAwq%_yarnWFmaYOK7|b`$M`yc);lbQg-I0A^DL-Tk6`)~kJ*9jkzw{ZbA^_*UswtheQNP2)fEw9F>c3W(Gu)-3&7Ykjw;mha(wo! z1-20C`U(K9Fb(t!foK}qp}h#8Tk8Oo0pL@d{39tHLqx1BO4GuiX7sBA_6tDLBQ)3p zmbvq4d72dfx~&e79{>gQG|)p%0I^jqP?@d5C};Gq12hW&IY`Dy1|4AlqCGWNKp5o= z@dF0<40aj&0J6D}276x9(t>}5;I(LRpk2|}V*G)(q-7y3GN^%80Vp9DXbv+&@Ps+zBTtOpI0%)Be3W7lcS3jEuHrgFUJv~FzCH`&$n zR`<#^02)vSXaWEZ1c3U4DIncf)&eNG4$!XvSc-)$N$G+OKb0kSCq;oLxI_03-U zg}nk@xZ*F_Hh)2_PWc9q4Gu=8q&|nJy69$oWCd98On(EwQi8!mZu&X^RP_L0@45Lm zpaxz1PlxTZz9$dMzPB&`kzd~a(SBZh*>KeU^D*K5BTyIlY&98Q>)gaR&S;NGs;~>CF8_&$IA~p8X56l&u~2P2)~?|<=FnH0|vk5 zUygaR`Gu<*(jva9iQaXiJ^_;SU{d`!JhsDKmHoe|fr$$>JO=h{4MaqRH4`e!&SJbM z`r-GLbmerutv;TO_XB$jEz!;&EiQ~4Vtvxy$r3Xni&x=zcMbw^{eo7;4OWUs7OseP zOw3&3+k?;BNE$C1-~MIyiJ!dn+?4{{|GZt}N5B9)0qhJ7 z`YY@?QMk~H7_kfFrlI`mDr7rXvi?1209BWq5#15=-Jh#q) zsCnBu$Iox@%fj`JeQ)y1WA8imY-XLewm8;o74{hZ>XCBA^$O|SX#6dKkSu(P&oRL) zDCgE2u&`pC^~GH0K8Zc4sXx=3xr~Fd>AO$`q&?t40Nou7qy&2%Ktgh_b{;2oJ0938WmPWQTPTBk z@}WoMLqK^?FiIt;jzD(^Zw08+Rjm~Jhw(Ws80_jE|3Pq%uUYR4Y}%up@_l@t)mVKD z)`~7z+@y)f(ea6BaX5h3bp-3L=zr%BTECk=VC@UG{=h08QtWMp6_TTI1n*0i5xgLa z0uhd8SSRrbHlrpy zZ{~=-6#&kJGmz+ohO`eMq(U!hxE26?84g#iJ$&!|!m;8@skrBa{F7C$)Reym9&su$ zsUXH~G-V@C#6_dBvt^^^w6sLaCXqo&GdtV$ENJyC(oMPw>yN0}JE%P~D`Lej_O^B7 zoDNbFJ{Xvl#|^YbmAmc+=1PAM_F#W|6d3wwkH}AIpD%74tbUO3)(!NC)__Nx3#lAN zf0d&Hdz(%C<8D7emP{X3M554J_I)p+PXk&DDz2#_xHXh_TU!ia)?@3BH-G6bey zfXS?b=^bFXr(9vO--f7GP7ZYv>Lj3Cb)Y5#;<*6SS0Rh!0HLF=Qvk}S1tjPH8v(NV z0nIi>dr#@J;si{*ga`!&wk2SOTilUH!MM2Q(0SJ{FR4C8LnO6WYR;UIgWE}@Egq81bjx21kyI9-ujrV9Lp5TG=tVBN14dcSgAV&cQLbM>sc@F2rh+=% zA1|UF_igh`1E_;`m{FX5kIJ z$rpMH)>Qv8e&`p0_2O38b_Xlk*xDw35u`x>BC+~e24Mht(Rmfwj`DNegkOQys%j0W8cCHBt zG2(w)6S8hCzZju=;{hWr@{O8ol%7LWp)eK@5LAKutB|3Xoo6584N$eGX<<3gS+ou~tN<#g1GIRp#pu6I164~2!X5)dy$xVu zgaqxH{*~;y^rpp_^}Yst4x>UaR0yCvwTRKNyombiKhQ8e?EnfEpc6peIzSUQTa4i! zYM?i)3Mfv=A{0PHb$|*0&}fSWTF7)BDe2jC7=R|$0on$D%O7i?>ot&`xgmvV6xRXz zej7IaeWHLkVywJ%+CsV=alVH-+XLjO^k~I%1TgvPU`hm**EJ^l2ccr}K``z8BLU{G z1tz`!9snh5*DRplHhTN#l?^ltBXOjWVnYRn8Xq#HMoBGvj9d2r(~UbdHu$BnmdrAT z#)eN|30{M&4=my*T~H(pMD_0ez%k@U^zN6?yBj_}8^v@HKR)Ap`B^8r?k~?ek3a9M zZ^U0*;+(tGiS9jPne*Fa{BrsQ=QGP$=bh!wJu96yOMK6G z*6_Kn4cvaSHhLJcTNc?WL(i8_4x|Y_!GPw?x*}!n|Cxyk{H3UF3a;@Gr04l2k z6ne~JB>xgbdh6R>u_}`%f0I$Gm-a)_ZGmM<9W2Ly;nq_Mi}NFrW~(`!CeZZ&`bQn0 zkpM_Ir}_P)##`%t(GFnu27|?Logxb$Z7#r&T2#2n6<=TdV1(NJ1D*Yn<|NDlFtV=$nGOKEzZMv?{V@ROSEYfzaws4@&FToCf7Su| z2mqzk8t5%jqMy{`(~STs4+c`5=UoKyEkiNE5j)H1f%y7$R_L7BxEue)W1(~AgwjyM z-^YE~`roBM=`l1m)Pm5Ji^wMIAwXfbW&19ghope>>3kyhL<)L@LL$|8 zunvW}_%)jK*MLHg`4d_J0V)|^FAiP*EGbkz8@hN^sLc_-epTq&R|U3Pd+w z>|JL4hn^2T{X(eI7QbkD=)6@zaFJLL7agDF?=A`bX<2B5H6B~#02kPfF=J`yi%W_1 z+ohq^;)^hG)hg`W9DA-yGObsh0V@cX7iJb@FnJ9eAHzYG`T^U;v(@N0*fhJ zdVRTkjE(2wAzCD`jE90nq0I6NaPR?6?UMF9>gt`M2>_d33ycBQ7XWZI*FeVz#J;SJ zDiJ^r*8z%ZX*C|jTbd{2)pzUR9h8^XQ|rtbZomy5f|G!4MjdSTUuQLz;vK+tq_W8Y zVv}YOun1xc_Rs@>?U6dzEH_wok-q>$|g&i3??YZMhaH=3xEQ^O9nk#caV6oF~|N7OW2$gba7<+o)Zf z^8^Qwnzj3Ug!suMpSJ|FB_6882f;x3C4Awp4vR+=7MZxJ6-&M_z-oMnx0D|cRXkG?!Ct+{cs)fkL-0N?D_t>TDK zfe)uu^JrBSy=!F1G8#KHvaot`d%mv=P}_wC^H=KlR2QD%ig4UuZCZWY*aw@p^r^BM z^1^1ph27f5VaGFHAt87oZ8r;cHMd=KS6#A)V$LNwnj=yabcXCj5uHqtd!=E>6?pxu z`R!oo(O{j4#w|y~HV)F7wqQ?(oQ7ykrvvI=!BA>Q*$0@25%8n6HYB_Uk6IhkJMa#FgtIdy>IMp=zMcWIz741y9$53xKSYi=-9n1!a# zA8%2n|G}S|ejw{eU}|dldb?4HlYZ@ajl{1-+kcV3^$Wl-8zI zw;FpVTr%#dY+4m&?9IRAurBM_wCcFAH==r3RMV<+#vT}C{>2OSiioCF=M6k9=?Lj_ z$r38+G_7i5^togWuSge{-5r+5Wt{=oth>Wje@~;97hecQ5mkXJpkOtkY*Y~<5h!fk z9oFcj>XtQJV!UK+x|fwoFB#V54a7Zq5fW|Vh}qNqVo0;SvDRHI*xB56!HuUSTj(ss zT(P{)EIp)Q*rVc+ZCQh-u<#k3DxRI>eZ8ebjxl%P*1TY~Up?F&3)XsIb*b)f+h~*B znEj#DI!9Ogs@ji-2TzK7j<*_{T}qoAh9{ib_a^>{5#U zuSeK9wMJOBUOEBnEf6E@J-9VLxb?~j90hZOGZ?O6QWlu^%-s_9;g(t*Jt3q*BBb52 zpN|K^1;Ge~FB%V2KcSBb>$QI;d=Y!B_6{yUEvyA4XRN;iCM`$9eJ-BU2p+9609R29 zjw}B8fOs%hL#?tSnaKo)&Ln06Xi+fGGWK(3*;GI8+StT}8sY|Uh!ZANvq%_}G|a*e zc43vYGakw@T(k15#_M>iPRjiWG)3JM_>@j!>8-88-Ean7Dh-gY8I`lZbRSIGX6&0~<)Ch{&azo?$8MkHuyK$N zX%i9(m*ouK+uar#xw~=LuIAO}=(6fxRS>?bd6g)LV#U3&kBVrN%s0^5~oPJ@5M;Fh6lpYW6KWZrd6hdDyQFpsmR(0x!?&J9Ydm58_yXGM)@3B9@^` zKw#ly&DlqGa7HC+hu{U!Q^7!2AI$JUutNweHx8`v=-L=*NHoUrJaiS`UB^Im+ylC= z)Y&F55tO?G8C>aIcZ$t97EdOBD*!l6$?n}$r&61~%@veopHG?8KeJyQqB z3xLoW8t9`?6bq3hPMt{SW4vnIjGq7smN zE|{dU|IqnXW6>hb=|m@-3&C{rrU2~uT42ngz6XG2PimlpT*xQT^|P8rdD&EtiJi(OLTj+!G?K>!rr@bQsoN4jfBR z`*^5Y#}YUYu_?zBtAdsL(5_{{?NWl@wajYFUZZ7r9uH1ZggU)B6;LnKf?_t{E!6+_ zIt^1V3_uiNdvHy;KM0`Zb$~)&vl{Qeu7Mir^AEJuPXo}4!9dCuKL^MfoPtt&9sajt z;nm0SgW7@Ym;HLVYn*)ON!mj|`BE@S)#M)7h5PKAnv)M~YT-b;!G{61q81pJRkF8P zjlvxo=pDc?0isFG1^2oeOE=EU?Pox=X|G0x zw4LYDDDm?!5}7`6St7+_0cexh&q|C7fbkQB(ZeRvt@1V7u!%!n>^db7YhBtT*0$6U zYu^xS$A@i$$cZ6@U}8*mnwrcQrN^OIW~=nUVDmuj2x$OQPr?S4ndqRUw-x%uFLX;bCSA5*p}572T|nkl%a~2I6Ei5%5Gm45@D}s zIL#7r{k}+?xN=+7C1*rcg+0PnxvZWMdyNH^s>5(y9cW991JEM5_=3ZT!!bbiPp;Y> z&EbgS6<>@*&RN9a0_+jZl@q7{hpz;;TqLNb13tKgOgoZDdhV%QHjn(N4Sp+4Fa zdLxM#(+wUQg?3M>vMuk?z1m{mi-V(VA-i)fRbL3*TknrjWb>Cd>RxRP7X^``pgvBN zirTmE7Na5C`4?_(I9hmM1zH(UBd?g7EdqzD zf?H}*$3*~AEj<(5(twVUkrKy{6|tE?r$HduWU=BTq@^}>$WSG;+|r1>&a$t02oHp4 z?zoUwbqQPKTkR{Tsnrz+D&Op=c}JX(_Rg3 z+H=&{2@p~myFR#ST{yFhMxpbANDG|J>VJ3LK(iQkm+Ph}2{(MfahQPdS4ITBxI9l>uD`ILXPmFd zor!bb@iXK2`HId^_U(4d&=C_!=5Kfp@Wy$({rDXk7RTX-3&e@@ar}u5 zjoBCH@&)mom(@4UXgIA4u;_Df+Td)C#uiMdtk%7;H{mQen|(JW8~6i#x)U^%Elou`}nH*`x-mrs~YUX=Gds%CYAZswnj@E#&$ye&}dP= z>9S~9KTOn*Va-_D$yL2TyUe>`B15*qOeS76KE*i?XLAbyUm=WR(82BTgOP=bH|F4; zGMkpFqdyO`SrcqF^+e`z8*VGRx&2S=h6C!xWhD=D{-);8#$W^)*ziP8OE%H{4Cfhp zqNQJI;gCJPQP7aA8dnId#$~wUiDNg*xLmYnM$nTmA0IYD=!nerz z+#*YAYVk_{ch*GU({za~T*z<2rU z8J*%l15G({`0rwaenyEuE(b;$_Uy?sjaT&Exhvvauj-R$qW8o$-ut&Z`C?4-s$ZI4IDsMYVnu_8?aexDiMZJJXGimhpKtx;#I@^AE=)46tLP*N zhHP)_+}8b6Xsb_RBR|eRS>5L2#$j7?PoFyZ%k}YR;vcEjE-ScOFfmghP-59i$o8S&+StwmX^?dnI(2`g_64?HxaMcjuxdB)n5<*+>t zr`IUkTLL3n8*F=ZvfdB;sqNXz8vdE7eH89|t^%h@)iRihMSpS!2DH0h!oQQi(q9{p z+-vaPu^{`zCINdn@#prk1H!d7KU)=R+nIl^+PLTkATt3T(Fb7%Fn%eZq3=Ik=s_Ko;tnu+^Mro zS0wD(6LG#*^{KPhz&<|8KXDC==9=11^=3#45aN_3+EnzT@xDFph zTH`UDoXj>`R<1jjZ4qM5y)wPwIX$W{ZI>j4~0rqyGT@D*v8pk&*FaIRi zUbL;~;cY2wWnHkX+{@u@2@okawIbM50!OuRK4WYfgi-f$c+W2pyxA$r+OgF z`5awAxBKgh?HFn|rctrb{%(^=CJ+RT^hV{fA<)FY@(ZtCSaaSQxqa2GXU?v@aOS*q zMW;RcA};o-K6Bo-H#Y2({L_~l%VHn4I6HhCajEY~YbgKP!Xr-JT3r>n?hL}X`u`~! zxB@XY`x2tuca@uG9LLpLz8tCli?i7EgQ~LrX5Q~n5K5il zNGJuJYc;eOkAxb~+3HN6Mq~P>MfGuZwtg8`^+z0SSB(K4%1UHZnM4x%8t-j4uzsb~ z)ZKdTHHtGV77a(`V1FZ|_NrEDRjgBd0*ni>oz;rXH4}Zic05W3Yy3Ax4@G+U$T`k|W7|4puD-g#9hc{Bw585fH1X7PS&+U10Xp)73W{dht! zybZdXJ2fc_#L$~HeelXw>eN9Mf-2#;$kj8 zX`*|ZtI^1vHC9IDeik|3E5@>_E`p@9c=wlYlASS|&Sk`Zx_0iDlUGP$w)r@tF290Z zd&lR?lT>QOaU%rH&KJvSM zgC9hac3F=Jb$YC$cr04K-*NfUMQpHdx!%eBnm1jeW3U7{Uq-;-zrKonQ3E%a=?OD? zLOl>^*q?S$4cs5C|HOXzk|8KTWsey{He~uYi?3k7E9{8h)p>0Zn|gVGjUoH}+WK9L zlq8~&y|(GG%?-Vkj!P1Zk?IRwt1oZ4y!BEi|BqjaIDcW=<@1+1J#YGS&Xv~A+s`+I zDCS7R3%&UxUGYeF{z%v7F%{Ypt$Y-ze(3o9Tx;BVFCgN9=&JOHHuAyQ3Z13Ko&X6W zH{8&~xS6IrjbTB-)yfk|YW`S7MKz!n&pkfjqVL}X$PR526V4_7OM1oYiu4opV_Onv z1SeN`JqO%tZaDH}b^+qUKO}05H+Da0LC*v9x(6ugPrY*cbqQK&0Em=;oK4&e&>LEi z@Tk=Ra>jtc9-HF{M9%1S;UWJA9`i%GvEelXIt>rIJ zuLHG5i(+R-(D+=a_Kgua_#ylfPIn9Q9zKT{wA27~6oYn$cn&dW%{4hho<{fm&3EL} zsuoP`U`Ed2u;phtstTEoL>JC{Q+s~!CbjzA>54B%t%?V6q^1w^TLnMf8&~C6xbD+5 zwCMGIh!C5OvhizahB0eATzI9;U^*Odef|}nO-4Wc>(S=J0lI^ZE3KD(DTJ&)9=NIx zjP^N<(CI;JO~wXHF5+uiiyC&g2$5#5Ml?p@K7wRNZRn6@P-75oy$JEuuXaRq_0B8- zGYGT#BwTy*T_Lzi`7jd}D4(qS=U={t`JB*QvmH-qy2|EeXY{<)T9)O60V5Owd` zPHKyIuD+|mzafVbLQl)4V`T{|(PrHdD&$Wcu*UQ#WfgK4YE4MK%$22M$j+K%r{vph zqhtLsC2~g&J|R7gC(9VL6;=Ri3{ui>A)BM5q){hV?H%cD1WuCqzofmwP1?0!Z8KO? zHwt%Q4QC>()e}; zR%^~Jd-?#?nml{HlJhei``RxUg+~g{p4@pm>-u}HQm5x5ewOqwYrX{^aixK5U78rVsym=FaRXFszWhdz&5Og~I)Zvk$%)@bq zW-w@_+xx=mlTPH(CSwq#xcTVeRg_|d$b~vHT|t)vxzma*(3X_+35%Q}L=7R*~bM_v-EvAl#q7CUS-k7>M6b|d`-{ynU&58KpcR9U9*A-WZtQll! zu#tAj;C}!nwV_*ji=jJiM(fjCd=eNXLlVgOCT|EKz)i$Qw1HSdO~Va#*RL19+s}2k z4S#D)jArMHBQ1MX_u1kAIc ztXP|9)ZN-tHj$Ma#(!a36>l^3HyPYnYspglb{oBO78!llD2Rz(t&dn!ZS>7qL}OJ` zM2=1$u^aV@N}Vs$mbGmcu4W3QiKbCRUu9iq>)-tmjYtX5CFz&Kje%%HsPfz_ONzv% zQ0GDnKXej= z!9d1XFk#6_1X|tZzV_6mpGQ##+TWGHSK0(zMy*E&`q&6BG z^#Ly3BGi^$+dn(^>_oI-`6#+-_-b@FUu|{n3a{0L)j2IVVv-sgAO6a-F5U<6(SrD0 zX55wzTn+JL=6A$438++d{*7~Wn|cI_vCgR&dFUCL1Xctv#kdDae57qeVz@W7yFsbN zo2%IFJ~W)C0iWExw->mN-EcJK+z5mYt|pEe;@xghma#|MJ&%3Q zcVMZlP!43#^!;n*umE6bVc;!}(p;-!c-9#FX1R9GE0ImvyI!6O*w9IxDpG9f3R^Cp z5(ks)6>;67({uwh%>Ebmlv?beejD%h^_n;!eK4!Z|8}kqN($_SSpH1cwL2iNx>_B> z)8j~le{(p;J)x8`Cyp7qh24az>eIj<0gbHK*g{Q~R`7eXMBHv7h} zqA`Sq1{lTZbkM@C-r#oX4Q|C_qPuxoTceyNL_O5D91w_eYIw2J8Fg*YzM;AdgZ@Z2 zJ9vgRg;+?CVKvp1vG|G&Uod7vI*H@!x}>*;c8$22Om<0Fw@;Ub z8}v+W-SKEzYiI&kOmB@yA~x_94}~V+BQhDz@~hVo22MHTfRt0{S0DVMXXdnCfphxm z^}ep(edu?Z>vtOcrY)x8`F?Um*=D zJYequ@)M3{@xlf(C2O-zKv$j6gal03K*&X(aYceg)#-bilw}?A-JNsu#bQi8t%_LT?BIMbjE!JCz^ z(VW{zFsk{ow0;BZYY*5oK$f{+duk*sLgWp>5tMH{U>gDPn&nKbyc5C5X-|$C63IEh zzV(200%U>MRs-PVAfE57pgbSvRZ4WyS*moYVmjOBEf^9d-yh)qq0$|^J zzT7rqpN^C{rbxD@)Wl;OUgQqt@>5`V3{*li! z$C!F1q)IvZ2n-E(-ciy_rlaoDyWM%qwDc zC8aZK<~P%bdwa>;(mA$~jK^CMC!zw^D4o;KzIlv#d#cw|r71_}>fXLWIkM*GPa~nS zXF;pymZ=9_v_|m&Wkif<0oU`7SF*_`!iC78w9qA{c*YmhPw?x*OY*Ve1SHR{GLi~o3C|;~+KJguv2KmAGKNW+SfP98N}@(k2U@fsznm?79bvV@ zHOz309dFL&-QgrGi?Eg3@_C#Tl4W4#naNZUIS%_7LCfps&}l@=T0!MV6>A)EqTEMw z6LNN-{r~@Uul=+C*YEbUs8alGJJgdZAFoKP!i=se$)k0hyg9oK5`}^1U13m4@#gJ) zSG2k2V4Aia?~&rG@MR z5FHs$FW&J|mi7bi{&ERAEFi!OugK~6>#9fO-9J5z2NP z0nki05EtP`?-`VeW(kXq;Yy8ol-4FY^)Dp0d{Emt~s zY=uKbpJ1fDY6)K0?5k|T( z`ugY-IxO|`)h7fk^~c<3@X`Q(eL~36zyN(h=+X{>`h>8hK^^o7;Y)*q^a&A5LxS}Q zkxN5E^a)W*!$S25(M!X_^a(LbBf|9wu}dQ(^a-7pMn&oqx-3aBq#2@dWUC=YpP>3D z=p$)0Ve9p2;2GYQSaseNuT8bl2G_+%eZLmdp~XHoUup66Z%(@!>p!n8aFZ&T686u~; zNgH8<7yUvDwSzE)6r?P|Tc>&}1y7I#h6YAkBMj(QXtNiVx#EvsGvPn2yY#|;Bl*$T zT`GLO@~NZ3H=6woS^c85!`acIcl=^dzQ&t3%wG(&WQ*v^_JUAa${8(6bmeD(*?s}t zsM}$uyT0x4%WK@{L4>r88G`x_U9A{}$Trmx)PL1d7rp8=P=2dLa&@0~ zEkBk(c3KForTpdwqyFb}0LEUCpnPCRFUj7~49r;%%q%>=rBz}sU=bugicEG0U4c61 zfw}-h@il=W_&x-P|c%3%#1Pf@*HEVgTzVyNjBm^@q(73kobO3yVqMVLRqT4 z>HZ$BEHMS7)bSCsq}2nour!ywxS2;QB?Ej^Wl{uq(*$UIa&ypAFQE6zP<*D&oR=lC zdsGL4R7SEJNC3f0T7qHJOBI3GnMf%kBl8_m6_x!!5>S^tP~D?c#ep{$L|1a65l9wn zPk>sqAR*bUfb@w5_imvU&u$BPa63u1VSCUf_61zyC8Vq;XCP6R6*L)luV|?YDUSl> zi+FR~RDC_)#4ejdDqyW{FjDTu7!+Tu1T`R3fjg=fP**)rcLH(Bi8@L{d8%1bXuSby z^8j4~U}7hk)ZKc3yfFhK%cl=Oe|Uh(0Wfx!pclpPU#>mv3(TJ$m{>f2Z-T@``;dEr zQj+Y^bnjnoDBev!0Zg|JSk37U$yMBJQ}c1}N_{`Nq9 z*HcyQvq+THODtNJim^XH*F8XM0C*xrf`Ux|QN1vuu8@5>03fJn_HucwwgT{UssyF$ z1V~Dqw$|%BKsv;I?ATX=4tmk@XKLuuz{EmAMel~<5^Mx!6XHekDwt$yZq3H1(cHp|kw86edIbSD5yB*^3wgi!Cu2%D!PSquiq=mBa1V5bDB zK3)PuDvm%y0P^wxeFlKfAjw`;`=Ihe0Wx`jx&rXk%@P#sJRMw$eHc*QZYVCm^T0F= zmN*~1SP3qbVg_J7ZZJ}cB|}tY$|wP1?v|9UY*z&gL7M~dTEvQNsR@RIimwNiGElf_ zj7<7CG@-k3I|3*_57amy4v&?n7B9>|Q$>*-<4Az~JwX2jV9GcNI!M#j1d?N(Q2;St z8_I=OWXfeJ09lhIXc2|^Bak$PGXV_L;Y5hGoIAaH-f8o z2UCx#Bi|8kG^Xx8HQbz*wQ>vy25SilbzcK=X;zuFYkC2b!|2-p3vq*ywwee)CoG2G z+z&UsLal}pezqX5Z>w^;y1cz|99U~r`b-3|Mb^CwXgfnsMW zIV&2;sCq8c>^zCO;3aH5DWWL=MY$!#o9-n*PR^IGHziDVRR|raM7zOA_Z2TtmE8*^ zDBL7%SZPU211iP?Rr`RdEPX_v$ex|OT?o}pA5mAPqi5q3C2x0vVn;WM`+-+OzS=>8Y}paA_cflI>X)l|B09wW z;j?^_H8gD{PMeAl>H(zCd%a|CrHQ(C(gISdcHp{caqO&?(LiKxAgQ{}YFYVF$kC5N zC<2kc$ZA&~gmWZfvj4sd#NxHYSoE*u8&%~f-kkM`MiB#&CNiiiMgTsgyA~wm^AjNF zUI!01K|XVOFzLW5`#z-QN0P?MQz5HD-B&~2zeaSA{vGnil2C&VUBLsJpX&+YkV}Iz z%;m}lL(e|~Z&e1a^DK^|P){Tmndsd}G(nrFD4gv`a`rwc8Jm%gzR`B6Rlp^>;bod9(;uD0Gy3^ zPuiXUDwIvx56uUaWGxj@k~PQBBYs7-Nju8iygl^Xb|yDpQLC?^R&z(C)MVA5Xwgy> zf?Ex0#}T=Z%lmFG>f1QFF|ioN(7RPcrie|JwWjQ zeB%TK%ar5*;t_!Qc!16UP7IS^8l>}pyHeaZAC&< z17&@w1*X3TrWVh4{9R)DsDe9LzI6Z%@BpO&P~!v@Nq?41sUDz#ZXhndmI-p z%rubSgybj3i0gq%cf*nXX#-+Fq(mL@g8N1bLc}^{kOyco0G~!l&`JrC^}y(^A}N8dGo31@ zQNQBG7pF$mL=IJ61hruv)LsLn&8du zFJ203z7$5vMiCX{h|^G&4QwkY4tJwSzMHe4wR|?{jjAh21DZOhwwAD8R)wQqdgZC` zKb{H)*`}w%Pp-#wM#lB^;Rm+Tm7lhTKlW~TAW{t6{MTL87?jl6s8^!bmo?#EHnMwI zEObJ0)X&s@iN|(uG(yXfP{MEJ8kLQCLSE`Y?}jED>0nv^-UMu<7RIJce*~bo4jFOO z&HERaz(dOFPr|S6CvG==8ov5SI82P4N5bFuG2Eof`1Z%}?WgJ17pKGDIzwL`JQsdp zaYUp(W9cIi-#i+DthGKGacV7nd2n6Cflc&9@!fp=3^J=ZJ>=W(!>@i%cty>ivpA?K z(CgvL;dL#Pw=#(rW46MM_`ygA|zI-P*9;M9|JK^s^Wa%W{yxBi$1W2nj zKLjY#1N0XF)iZ%Mtgwn1z_D167(>Eh&`!aJ_hI(56~L`gghld!{PdK z=kF7sZuLMV0`Zy?6<{FSQJbs%K#g%jaUFO7nAWFdYDw~_30cDr05;YQMpljAYNIk~ zjRf^EibE}Ae|iw0+dM#p0CZa?L7h|ql3L>sK(~8v1YEUQle8t(zR2tef~39@^WeWxv~BS1}XLvaBv1xEj@#0`;=LuKF73|N*H zChaUhI=zXu7zhR@<8PRaprA_nrf7;7&++p0w}hy1r3mUeR#gTb{UnQ@fNL!&Zs9A zrAGM@uqkedk?oFV4m3t-Dd}0v* zr7ef9KZ3|?HzMRj_yh3L(=HOZqaRuH8&RMbi0vr+7Zh?lC=5JfR37|Q3h+HufTS)w z1(4MP^b`O${U(!z0LOQ~jd2RIYBHPs=Zo7EP$NmmGCU1xxgONUg3|c&l7+6s0)b=$ z`3ayr50D*z*Dgy?6`f^9;*v7|8K8U*&?f+Rw@Of(UZf;5`wKue4^S!qaaSd1x4?9R zkVz|@0j9tMGxIv6s`nE0e;Hf@LLE!J`Ws;E`~Z;Q^N^+^Iuz(ifD{A~K?wX5T_H6X zGQZwj9QDKED75+uOQXK8i8ARigfu;bd+|-qlfHKUC+gCF=$Vx(qP|=~Um!!gcoV#) zVmXCYs%LSt$c=AaDWi~h1=f{uSh0_QNgZ(!FuNO!I@HGj=-)wt0`vkTi~SNncWFUv zh@1&PH%w4!hsejDiCVoz@GhH0?&j4CDkv*h;75x>sF=wsNz%WJ>vKFP-vp|+!UgU| zc}>*&>lkHUo;TAXt~j-g>B5P%My zC1{x{K(bQ*1yG3=B(#1qAp5$4b+}|6R`f8suDX^0c=gD)rMf5G~ab6?*?q z5S$$^d8u*LMybRRv`8s)1Cr*yACScf61L2%k(+;VSPu~>cYA=E02q`gLEVi2(Ht%f z1gOAt0F`S&BHvR1iAE?4_k92Oc~rv}ygF37@_m#zA)>Oe>p`?aOH|}L83d0a;sr0b zr?FB3t&o7yi=+Zr=>{aF`ZFK{(6Iya1Z3 z1&Mq&17gmgs;c!@?Yh^dI`7=o_4sDBT3YG?tQ`vkwT**Af=OtOVJ}F*1X1@=8P+MfOns04{I? z(h8TG0BLc;s^sCfG8+K^-QxiY#8%^d<78ULz1yuC4Fu?3El3FSI3SxR%1R{1o-eP9 zKDdr&n`uN|8=lvJD6Jfn8o2|AE_5SGb)jLBml8OY1ls7-w4Xm4ef?P?xc2$zkDlk0 zr#J;_r$d3MzR2mIU=Y4fOIQfh0%C}VAu>d{f0a^mUk514y3F->2NriO;=wT0#BhO2D4R4;WaZ)u) z_BsKy*aNg50AITV1mf}1MtmV5_E(>q|;=vbOC6I8;E!8zXQ_UAz{Vv z(h6lLg<%HpQ8yrU0vUkZUo2r~4N$$*YNYDz3eaO7pp^iOD3hQ^)pq(i4xptTpb`K! z+$}*5>jfxDh`k#?k9&YV1E9}52}h-!sYFYy2^^8k$mVAp&BLWr{#f>9%q{X%!Z zmV3aC0rKbqnbtuP1%agE>;ce!v>+BTBLnP$?>lO4(pa5U&;2qd%{X zfy%0RAZE)0^kwryF&{ldUtW4RX8*(V<)=qtURgq4+Lp$=w2ZzedWsaoYxD(^8qgIr zhNMdhik9RiBFFh+N$y={T$CXc_(7A{=iE(45ft?LBOgL#$fg-?~hvMl1Fy@!REW?-7e=#iZf3#pDhI7rB#iK_T{r3w{t>q+?AEEx^#- zRO<{mMkV|gIO#1o>0I>ZXvv8T-o!bI!eq?;Ox7dL%m%Me z_)tUD^fn{Rw#j;m7DERRc=e*Pea=F#=lw6K608NJ^5 zAm-~2V!#N#vl>F8-qX7EDN;kWf&v@{fO8wUy)Qch#NkltMaoR$uKV2EGzO6`_Z;^g zZF)X{Bs6+$Sq8P$3P)+Bg#zHP!>CaH*g-gL)u`pvA7T501$D#1o}rJF3fi=2u~$&B z@A;C2*bIEEpC1)_N@Dgr>iJmnW})j6=@+k*A8RY6Q|TdiMhg#hCnOpHJ7Of>ETfrD z7X(!~idI29?Ry&^comxQLGcpkm4*yAN5@c59sS{=Hbd(b_n?}ZTC%$v3Ns!P4lIp~ z#vH;ky-r3Rl>|k`0X-3jK}PnW5o?3CG})3E#2Z$=ax#qW6%1gd5NDSsdW_ z;|02xJtA=iok`-979%wQ=1?QvJn!vDk^8+#mgrGmcmlYk+|XIgG+Kj@QZn8QS`R37 zd6Em{Re3^k!S=EM^q$^Y55PtVYG{{UcYsz(5N%<6c1Q~iJMu9DnZnK+DNn&>ShgdR zpMk`r7j|0?RZF!k60xVS;|75Y{Tp-Gt&H1pC=;wVo4W54(k{6+Opc08vQ(=h2E?;T zciw&Evu7KZ{IrMlH|*JQrB&EdPS5UqrkeQ{i|LAuKbzVs=rI@Fsbyf+M$djSr*1Rl zh3^}{v#9=e-Z?y&)F0_2vr^@af zdLrr?@x}!V_io-CC$9YT`4npA@}9l0kaoo?x+mxWfKj*;hc{__G7UZ#~DrJX= zjI)&&+9qT6x6)Q2#C2r^(QWP-(w{P5 zFDyaf=Zo+b*hY?ug3HPb^{BoUC*Rc4!>RY)Ih~|rub3oGxuIPjXu#MkUaPi5)#^|; z^_{T)DkbtzrNgy%7>0=nTkiSL=*bl>NAp(_#*aCf8uAh z!wy}#AkSgr`?V2xh$8$jt$lfXRZ&ZKwIgtGr&3=q#Khg$_!kx4Mqj9It=+UFItNH?jANYqmeS4?ToxZ(q z>P?>mh+5x11L?7mz1fe^nfQ^`yLTVl88v_ij812FMvodvKSqtF$3S_MLPsHC|NiQK zKW-;2Ib#+nZE^GwN`2_DH@8u#r^e6D&Yy|3+YSCkv(8{NZ;K_Ny*zOH%~aW|(AtN? zNsf9!@ISoirhaPH2`cvD3cGD#Ww|{c_i-}{T@0cxQ=JMN@>vKOJ@kY*J+(Jo>)G*^ zC#k2ff}qT%o^)=iC8JajzIfd8%TPb{)5xT*D%G~n~W}IEA#&Cy|^48 z`9P_CIIrM@^czKWr03~Hr;zo(8yz;&-sp)=>8#ZKP=|xgTNhT(exhekaO8yii9Sam zzS~Fkx+4cS6wkn3X}G#dD0Bq&GMd*wlEGn{SGMS>ASQn>iVZpkxj!@QDj}a<=}@H-#f<&taP_x zj2H+xvoT^H@f^m8`87GIfKc)IPAy$W#fQK#?Dw4+O}$k7CL;lneeTz*!@JOP<8NO- zk`*(8bD#9?)sk3MA>4)5DhTBlnT>9%4~cT1)aEH;j?2(WaOD z)iymP{Bry&tEp+A?SJ}^sK2Og;<^KBE1#~7 zUEOmrRbG3=1eOHh$L<+bKy(ay2p>Knerl|~ zZG%^u>Km5c<{RPXldkuR!X5t@d<1k1N!JH<#zzNpaJoJy4&Q>~@e$GkAEAkUzUlg~ zo_H|ag5MFT?S^0ox=GTe*X4(?N$zp*z4ittCH3ad@Z+&9Tls$k3}(k=%is8qW<{IS zaJU#7@Y0|(kYs=t^dXeqX!Tk+W*cGekQ_eYX^rW)ew68?ek8Y!sUh7!q4G$E zPKC;U{)0lb4!H&He!N*TL>g>Rf)Zy%LW2@CQKf_6ueO*nsZ*%7v&i}SW~V<1N=Q8% zsvdg8=#_MEsh3Va=(5RV!x-4-2IpQfJU;e7pfCT&*~;s3=mt8b6Ks4)jfl>~gYyCG z;M`QV);|PypVqd1Hpo(w^wz(TpH;VtJgpF(b*f^NpA7t8En%Ne2>z5Z^AX--5Kt1K zbrx8vVE5yzE#ETUIv#_;(R7(ch4hnIVWSE6UJMRyu&iWUPx?|+wQJH@6YQ-Q)ks?vQ8b3%9SM~Q6oJ2QW7JP>1U)Q z*vJW>lLqS`02(I>P;EO9nc!;#$n>tCmX=wtU}G+nhNZ&hD6r&J zmOCsJMfQS9i`7wSDMqWe*yckg+{pMq;7o3OVBdgyt)@_#VNLF40{=<18V0pIQ=Kf9 zRM@}s7o;Kr5p>P-ldu_PipWX>tJ~VKVBn?1A8dgPqO6R)PgA4Om8>qq{v!f zwIQi{(EqT;)YwjPqXAkc67x9s4lS>V7u*VDzJ}$MrLs}ymI@p`*4L3j%fCb_bsk=X zTaeCrk&YypY3+6gTFZ0+Qro=5ybB4C9LH!a$_6cnIdjy#2CE-zXFF_bJ|9YUDZM_} zseAQp9eJb$$r=zO)j*npn%Nlq-zW&0W@>tVb*0|=3g}ImEs)#~qAix&fZgQA%!TmDX9o)?rF>@B^NLb%Ui3+KN8PR+cL7TmM9INqCSYnJE@(NfDqu zE50&4bj9~nJ{(B*cmyq$fGY*3fli}ioW?jIpA;l(S(@jqQ;^uzynjd#%0uy!36kyb zTE$0{oqSsvoGSmE9eLks#zO%p#v5h_ZCddc)ZwO^!F@%n!fM$i`QSiVd%*(8u^)*2 zT!@t2cI2<#uiLVpD$kP#b#ETT?#v9VF$DD+COa870z|Tf^k0WJy_ln$1v|kp4#V`i zXn4CB1&q$olhGqayvcRO|7cEye#@xDP}0hCqKcXx4bV88;&02LK^+V3f}!3?oJw8( z13qy44}SiLk6ikQqo49v4R%IyHYLc%ZX31r+v%J1oaB1^3v2`W4loqhpz;qJslcGI zi%O}$aIIj}1uJE{wA_xfh^!9hB-lSUgpcRIb|@9{BpS;vFFZ~eEv~|vG|b+p+hp4y zWk-q#DoTkIQZ7lv51Is_mvaUyqHQWg81Hu#b5Rj(y_6#nZPQqYS}KA=bSyPH9)y)Z z9XgT|c`D#kSU5PF{pVBdQuXxKzjSwHu@Z$#^FnK?P_Mau_Yu zxT{+vuUCy6EK^IRu``->XLWyPQZqc3vyGV(R%Je>gz>&%wT60EyhTE4TYM4aSJv#M z5I>DLDc(AQB40J=Z+KQa5bV|XBUW5ra9VSh);Ypj5-V{kL{&QC9reCT?)b>5WHNj7VKX^8_391R=pz}SJdDDC~p zML0dHbe?>S++49Z!6jxbA7?G6Aci!&^4;5aFiDhOw^=LT*2FEL zA*uLktdHzMoxz()w1#!TTF?07c>D!XrFhxZb*{C31i-p?1gIA4=Cpm@GC*Ez2g$S^ z!{ZO_mL(?^@kzD59FUi^5OxY#1g^@St$PlBh~clR<+Ex?YcYmY>68cN=|m;Wlq(Cv zfT1e*GydyE&2VoMM3qLmkNxoUG-{pYRV5nnxN2z!+^ci5U+|>$Wh8mq0+B55{k6jT z1t5d0kZ*S3@@s%q#0N5@51lkA@l>orw0;G8KKDqPSU?2^ohHB;JcS@g>_u$%cq*Ev zkd)Gb0>QS6yeG?e%K8LIAO0uuzk-xekT;rtxTb5*GBqh^q6vAFD0Ky?WGdso^%`h~ z{9D7eRuI482`@nxLq^IGf3apcOsD%F1FOMj^h)mEdN~c$ltW0j?ufb~9+R6+kKy9N zG#pg$Pk8iYQLjv=;PdRO_u=!a>+1AIv%Ztg7&QrA4OWjZ*)m*jeeQLg@(JFoJv6iv zzY4y$XzM8-s4X*CTLD>(W6~I`$-|O00=QKI(R=uQeG8lEnMW}%u?01glttf5_f}Ag zFz2DI=VC5_GKz=qAMn^agf+utrv0jP?c&eVgGi8OYTG4MWu|5Rrhp)xk;cwyj&%*< zTdjs*7(?|41-3dc4*;9%HJf$ckAJaE&pc6~r~;{d()|2EDQ! zZ_XnVnwHBHaJgLyjeMX#6s%ZGT>?f#W8l!qx6`x{E4vk)>#avsjIE858WzfFX{CbJ zE0UHIG6j!6`cIHvfV?UoYWFxbDNap^Q~SiJ{o>U0ICV&zIy_Dt6Q_=gQzyo$nQ>Gs z)4n>>MAk;%)B&k|`h$TZI_iN>;1acx-gwhvtDauNRzqPzse)pQqC*}YvVt1)7c<|| zGd+Z^VuiZQe}%fpYlZrrX@zM(u?6<29-gJBOoE;$)y&xX)|Vu6VzP>-~c9K&DTf+9#+^9f$W z`wom3)n5YZ)fT*U9qQF+yssJSaVSK+x(m_X_Y#Gp!42w#;07x2+&AL=slZE1MrbAg z;pn8Az51gmtEgs|maut2Hb=%#J(DVrkQ$UIJ{2fXcN*h5aTLEy_9sLAQ677dw3`!E z!X_7aT4!$E{k9*wIh9{VYK)2PZ;d#{Zwz-%3o>$(Ms#7bf2Ad(H1mQYtsb|1WF@Uv zS~A&f0+1m$uYLABXM_j6l{0`1)WM>(UI zQOYP}lrf4JC5-Y#@v4uba8b4>T9hmb7R8EEMWND3bX|i{nkY;ZB}x(niE>0Sq7+ex zC_|JW3J~Ro;zQ}7;81QTH58h9t-Gr0p&EOrK0VZc9%^t8HN1x!-9zovL+#o_?cM_% zvbNQ}D^BT=gG}AHE9MsA;$)npn4`^ntU3@WBpxmBX2 zeLHAhleEWm=d@uq2u8KCCTqw#5Rs|YA^H<1*RDq#2V#EeCRbt|?;HxcCXVY$_7I1c{9`-XHU zfG!&l;U8(^kaZuNqQ0~e)^k1%a&RS7$I8(&3-U?I!rw?{_3)`_yEWU(6YGnGi=zjf}DdgYa;g{;-%Jv{8J z`;p(*M1J|)Csyo8dz)tXoNgdi6(xs6`w-}6JR@nJ>>*a#({p4p!L(Ig7nJK`~zJ!oq6M>S}^A!ydOrx~lINmVFSh|TJ^Ua!pEAUQon zoNB2q0@XJqRntm8(@`Jlpy#eUUO-wSaoC_)3umOvo|(j#fw6SCkMv_N>jrFh@4OS0 zitQO8T|loBmwc~Z^40iAS9lB*mmt-hB2}IhQdep}gLNRtz4De|w?S-slwy4hu(#Y` z^_|sIChI2vEO=Xh8ry;39#P(I4_c|St^r`gy8_hI4)i!cyV`?>8?CtjOxP_zE82mU z0mN)?2tgyLBPQztKo0Dcf+FosuSHAzHb3S^-ZwRi>7H5-K`jT#cis5ldR?w2pt_`< z#qt3@FF-?Bwwk~-Ye0?ehi9wbqgHBjkPhSb$k>1}8r=U%- z31BmIAU3nT#O$0KHnVvyI}KMVQZb4*BOwX`OfNs<`UF39LzJHy=e03JiS*Mohbl)L zZP<3{htpA`!*$IL%=p38Nnc|PS7X)ISmPCY+f@UdTF7POTEt401ie04YgEQ=Gz#@B zB~2{`qaIZb$B->TDBa$Gw2B)$Tp2= zv2w+2g|ZSIs%uuFBXl@y(Romzi)ShWdc|!vDv#sc&d*8A$w!!B!B^Ev=AHm^dt`ke z+o`>iaIc0lgR{_aej0PZNy?1JP$k2l98sd9!0A=pjaJ*p$M1aEsO-V}2E6ieRg_P` z7zD|cA0P3r!ln1Myc*f*DzD+P5aV$zv#!N26aCpTGVZY^S?T=8S|u-RHI`iWro9pT za~U3`5Y+UF9yr(Ft>0t}j4|M=%D<{Ot~0V5PBl!sq|+aygOWS26N^!|qPyr0#(G_f zRWHUGFW7Miu@`O|aaQJ%=IE{m9hb2f#!r3W!RpIfE^oc$>;Lgf^Uq({cKQ4z-{3zV&*uLTiNo<4~=M3Jwece)1U_LZtc+>_-) zS|E5+ILZA;tXFHSdL`D_LT+{_0w#AXM#7d7ohr7Jc%c}MIIgl{*x<{*tG+jM97}l& zdIKRZ5Hf<-T9;Lm4mOxp=T>nVelo4jfA*!jGsC6LoPwYA@`nXK;Bw;+_R!wxjvr)i zEskBrry|%C2c7-HA12-5B-2StCQ^Hc+^iTeN)&Y*P89bcYOQxtxpV?6fy8`a7$zoU z2dHAjmC$e6QhW-fxL4}8eu)iC!Ld_$DeIynXWpN<|ko7i%CT=WHNI-7hvIBXGpK-^(6RwI_<1PT480Mh-rF z8#M5;6D_HPthsvgT5UoL4y#Eet-Zeu;2{#nr-vR|}V3EgX7mY|?nL z?`GfD;v!}-`@`?HD^Yzf zQPZCUjb&piz}d?*96b&myn+7|HrJ|;_jh4aI#&3Hr%_lk6xbTpY}$>NXjDUD*g3Mq zM3wb6h+#OF0>t358Z|~Fi4Ss++L~;Z)I3*0){10<@=mIOTR!TML=VsG$EYYDiHafy zag7*exy(@YWTIQU6B`ArCqT6?Hb$|Eh+@FP5^(RdJU;>5j|JVv8)eqbr9$$NgCbH$ z*72bHv6Fgwd+Pf^{S#Tesp<2H_OKOfluy>P(+9+qh1juR{ShQ@!>%L9^n?d-XAYA8Jqnk`?F!0XGUzhkvJn<55ui)NPe8(0lH=hHX5zJj1GGJ;g z)y(*c3YvPLur(gfHu8>ymXnA+FB%B87Mpj0R9`gxELHp)ti`t4hZ>Y-yjkuVJxb#k za(77NPCa>p84uGby=e`+Tv_?=9Qp8L;<|#)LgZ)GV3%groUcFd?%W;M?Iq|vEtDB6 zj-0db5fCjg!;A}7oRt=0hPDFFxhg;QGFY2449e%j1%EXdqiW|{zXErMorRip*B?i2 zdW4i@9zWO-(YW8=wiOn#Zxv-Whl3p$NAo_jp02$Rhv(U9H=MHr#=zl%GFqrt z=CInC=u`OQG-nHIn3hn>M=1(sIZyr zf+~lj0&2llVqxoOE!L{a(t^^wstWcE2`{iP7O{AdYz`=J{4c>aA4df(PIQ1x{4cOp zVL6`oFP|4bu`~l<@q>$)|Hcxd9iPTf{obV!p@DQHsTa#bCo;1}XDIOG;_0riC`nRM_va;Y&r4 zHJ|=FQ^1k2<)DLIdL>wYSyf@fQsnt|TKmXX0?0*>`S?QfMBtUBhkrI}u>;jaR2#Zc zTF%QD^K&@V)`m+cKpSnNDJHkMWv;!#PA6(Zhh-J@H*MNYy+%=GW!a!!z2?oEmpU&k zwY0pjSD*Cs^j`BF_L4cyf?lS#ewT?;xJHYTZh*?xdYisMfgX|N%^X+(-TJSZG zRtnRCUkf=hEcpc`7F)5!Zkdyt4+7U2#EmBdHi+7o&(q3${R9WU)%PsSe0@Hxjs(gDX2;wenpF>T}x0NELT-0Gc z5lyR;t;MM0Rpoi$$XYVjij?xo?PZnJuJ{+68iD3X+KcBs581<;3rn;ORu+}4Y%0+} zijblux2m!dqM|H1>=h(Fn6}APP0qs`6a${(MdFU*Pp$$uXT$^kjOY|1BzbJ<8;k);89!er$mouUtPmG*FX!cp1n>y=cU|^El}7K z$+*F4svNq(#($(<=!N6VG(Icl;y8`ej!GV}3O)73i_I7%u}FQE627FKc6`k%EoaKV z9HO(K4Lcw-ho!3AfoFAPG&Z8a8qJ^3e-=Z)v<8!Mb^1oOUIU*vjT@ghTpOP_D;u9U z`Wm0xjr56wsT)WnaT$SunB&E5gwK+%8~ErlyU8(^?C(z`a;Ty)e6@PF^vU?o|ps0c2Cgy zQqrr1xvDizT0!YcK}n2XT%^c+BT{mf%6b80dgKY#>Oe}{m0bm?W0EOizakd z^|?2J4ECy$T$m}NuwQ~`+bWzh4rB}Oh6^nQ74$1N7I6c$(tSLtGuN=-7sNi1WvtZJ z)&Apku<*mWL#?#vV+H~Wq$X#l%#P2VIg`=O%GLi8{vzq5*|V`?37zxBIqx6gzw^*J z*Lc;SxQc-eZHqOzRssjHUZr6+;hg5Vh~l1TXt7m^3YuD*xz2LDJ`JGR)sf-9+vN4}i;PW3TaqwmAHL)9WfwIZCFY!LrK z65q-sTy;ku;0rcD>wl{*Z?dOr>I`9 zBhdv9h=enduvU_H;Cbe91WfloB-udeEx&K}layX|1vdY(%n|)PI3cB1?LW|;4f@~7 zjM2)k(>|TQq9zU-p`?OM^B`diw_eUzelJObcX+gv3fC!U${&^Caa1#10JdD8fqGp3 zvIF@mogmyYn)~c9n(uC8;7ywo&C~?A)TTJoWPU9_HIPP?^O!_k_cE~?z-V6klF_WI zq1HL#-vvSBJ>@ipvksZ~BO3b0EBDe+l+$qDBNCwTz#lq%$hDU>oz+f8>)1wBxd-om zsB1Zp*Y{FhSU!BurfGHL*3HgMWC9>#W+AMyq(sZYcyukg#Cp&6*P!<4*#NcFpiw)n zW=Qf-Pq{BR;kzglYt$#I(q+Hku1=g)Ei35)@ODD*R;O`?na8rtl^}b=muI!Y*|5-z zXJcw>>R2i5DSPo=k}x0HLAE&Ey`&Jk!9~}QXo+#2ax!n})yknWEn-FnaN3(-zk=Y?75 zti0OBV_Qh~@cxOWrm0}Kgfue>nEjoXNZ8f(vSi(on%u#-MDssXRc~Q#>hHci(2h_ls$day68r(d4Z8_( z_nq>4GFfc-RhZ3(cB#F^^r(;8kgTpuR-aC8P}e4_8Ef3et=n)q%lGnx7Vdo1_O%VD89%wzG%Qq~>TNZgSCx3YS(U13 z*FiS|^s^I0Ljw{YWrtM=b#G5T8L};LqzY%Qre!+qE|MIT@x`hW=ctTbT^+7#mr6<( z@ftAm0p?mUFwz_ZR{dw_#XqSrJ^y#;FMrdQH>$%PT*OWf(Pt>V8T)*}yf)WO$iOc$ z10EKJI;0zFKbYIIw&G)ILdB)d`lmECsyd5qU_&l>>WOp8GP2u*MchruZ4;(^nlSyr zcd541*tF`3y6@VFCk9gI;>z_cr{az^HqbzR&i&nHvZbVLhAjtClb# zW6NGaOaN;vXgPzB3W8&Uk&limoDt8qJr%ZlT^P-9U}PM{uR}IU^)q2>*YT1RO!SEZ z6WZLZ1{1$YCOpElkXrj=%c&9c0CpXZLn)G4bM+I>+Smn8IA^7)Ks8={DkqxG(hdj& zHR}RoD`(G!Mb0=cFhhxG%yR>qwzXJWF8%#SOVa>G3U-k6OAK2Ag*1igR&IfBA=rron-h*rL!S zy1@AUO1IsH5OavRZ@111BaayaEjnbd?l8ae0HtZG8%DuAjp?j#C zuoc@Yu?`bU46#J!K78o=`REo-xR3f2vc*SXIV~a#NN7?39A{Ib}88aX@ znDV71W*DbtD^`Dz!wBoR=Gq*kW#s?DBUtriN2~$cAYbytR=`0X@>yp_`5i1+l;Dl^=SW-MebfrpB*fOTWqRH&y*^&MxOV>8qK zICEvGnHHUy!5Q3nBBGX=o-)rXvJtk-QM!PL5#z2$Qhg`eY(H^f8_b_QZpqI>HQH1BHb6}2(0 zo5AY{-dL}qdLtsEiinKHepeBK(Tj&*WJFAX%^{uJHYUXzf)IA+A21=!q23G=)-GNM zg7Gna@bSh#UuDEF-}bAqI+{+{NJY`h7?y!WJ=KaDR>t1PIJ(Gvciof^1 z#H58YvS%WaR5tT7IQ3)UJNK&!#G^^S>>J zih&yP&f}Zj=d*b*0rI$Mp@w%xyGP{q#ud86I=5j|z0SWOr#+3AW0zcY(clN2Ha4xm zd}y89yeH|xi=|U5s7doM95ffpGFa<0WGO#IHn^r(j7(TAQ+gSd-|*&I>?GG>+K%*P z)(nG`X_!6%92tbl96qMfAJBod}DnBW!N9a)wA zzwEgSC=R#dX7)^qOJ10OuL<~?ki1Y} zh72B>14vTRFe=K*tb2zRHw6|*x0W5z5bGAw(hHqoB{ z--%MwAD^(OBe}9?@W6euXU@n@$xiK^l0KVXpkC;U(?6C{Q=QopeB!r$Z&NZgKT;?3 z`>`*l?x5e1C zdr`~mT)nQ1TIP&dLudA+XE44Pdj9KqWF^lU+;!B1kyEB;Wt!=BGHx@E<<};!qlCfz zY&iYcwN-l!I5Lo5n?cVZtM4pbag4N_n934!gkp&RJ##A=@HAsf{z5W-C@0(Zd#xc3 zdpIg@Hidi9rT#aq#1WCWRESHRyom1+-sig#4?Sq!=w_HrFJVC(_9^=P_g-S72PW)r zRWa={s>`~X#xWU{N8P!Zk?EFxvuO-_{`7-=_Oj=@rKPjy-!l^DSKhTfNQKk`0(Vp{ zEUa8e$t(oXg?KROW}PL=zGvqfH<9&r<7XBk1o6Udc$AgKo5qg;lQ zy4K73@<6bWF7zEAHfU|6EhyWIQqQA!1M6#8tg=}d3un#68iqk&go=H!u463?Lve8- z-5a!U78YG+-F4-!?=5k-o;V}BB75@8p6H7zl94%k$->eC_Fdda0v%-TlO_ER&@kJA zrei_3H4_a9k86J>4U5OKkooH6_f99)W@RTX%ub4D*S@>hIh;miv$AKT_RO9cPtV;s zDfbg9vO$TdJ@FVDj&wFpEhICS7|l+lypYFakV4h4|E*JJ(NHHlb;hhzZ~%UXpdEsh z_#_(21fKk29>dN}p~%3AgWv*0c3Jv=zc%D8R;{zkvrEvUl5A3o>IRZ*W|*@JvMbq* zWV)`u+9{qoGDtw`6-J}Ee^d?SYc}R7D;LaWG~U_aYhd!7U+gHU7&Lw|LO4?1MkfU_ zlX@1r0{%UQ1Zqkb(;BUx@CHL@U1F_UzYDiVJtElEtK+)VH?7d+)aE9FACd`cEL0B$ zzgt7ioJ`8RN*)h;Bz%eWFxuG+??9TREc|U_~_4sk>6t_fl3+2iUlF^f>AOXQ499i=RC+ zd0{qcNfIhmb`q)KAww6=k}D%oXHe1TIVj#?xS5^E%DrIfsABR^xR5vZM3qoL+|A)oVca#nNYmbCl5;!180s_~ZUH4jRud_C? zDVg{sG1eXtg}whc zZRjG!B8^qr_l=k4XUGK71`{E8%-MejMGB>BoT@Ha=pHI+8@y?`LDD^J@Q_2yIRuZq z^o%OIA4?1^khEn1D1qnX{FoIF`@Cc-}H}k-gFOX3QwVEylKhy}NrI zkm0I5j!4K4NTqP5-#xXr)DmRgBHP}Il>|v>37pX+6_(Hs1d4CPLeT2<;%<_l!-v#| zGPrP8`uUjcDf6YvC3`3gJPZ@Cq}sWJnI9@MaV{~%tY(CoAd^rdCUFR-a>J=x6Q;_&Qcg-nEa$Y$p28lWu>@B! z8*TWhpZ+>EI(nI^i~9n(6|n3bI}hP`ue5hqNXswJJT+?8s~6VWbF(>V2EPj>V2g%x z=KpU3Hb=mi%}pfe-m+Qu{BMG`K+r}1e61d{qsDyuN=6z$ugZh)IaX95_G3oETre-@ zXcIfRvR5R_(>l~)PDFQ@$j`Z~*U(GxGkEpg1N&!JZgwtTpZL>y?~7`o^=OLsB_L_m zGQpMK{uiNHUy_E1fA;$>Sliiu2EFUZzq?V$Rn4svufC}tAKrjilqwEa{IWuNrgw86 zepz9+94WZ(v0}yooT?y|>+kFGTiMQcHv%_c`P}n zHc$@n4IYI*II=XXQU6K(aYS>q(6!4Z|Jn zjWXmo85W*0T;aY*dCQMORMzl@m+(=j&?!~;!M50-@i>r$d&x$5XTpY$nIK192TYI~ z`R5BI%pd_mRncr~E^j`Y(T}l2+7a z&$fAS>iqn;P%~>)D|Eg`rhIbZsXI4ZCdl&=K40g+uU$H>yakq1`eDxH>PmljJfGX z4t#6c-o$#8Y1ftm-JFreSx82HtuT96>IPjI} z)RFZhb9*P&51Bh|XPsd>-@*D})1@=(N6ejFSWh;0-N|~2>3SFIsis?3){mO*-B?dI zcXwx-lEj0M-l4pn(V&Ni%#H>!oJIaMn+mkt0|?ZAOh`{frqsiuE!xW;E;NX6zW&E6ljDtXG<} zaU3{p($hF_%8XCvz)ADqc-E`Tga#b%+7VB*$ zdj>z9q0!}=BTm|?xc(|T^ zkF$Q;%zc9OJ~MAF>-Wt3d92?z3+A)lZx$|KeZVYQ$bn;K@gmko%#y_%_|!bPgaeQMH&5Gr$KQSv;u>RDnTFLsDS-pz& z=Vr}n)~C$cH5@o>^42oGZnG|r10R_6>o{=GY*^3wwAr|U^;c%oMh?7Xp54TOo#we` zS$|_TKgar8vt={u@6GdDSpQ(QKF|7`*|wGSkLHDKtba1wUtoRSyttk9FDCy**1wvU z@>yRnFTce4qIuubn-{~gS0 z$^3vhyS|RhxgTJ*CiCMtm~F`X^dkpeH9!9ZTL&`de};K0nP1Msyp7DS`0lapNan(? zFguaChz}3z+sXWP5#}9a@QI|rOXkw=9LP6Cn9}I(Wd11Pz>DV3KRB@6{PiaXUND#c z;=nfZ_hk-jHNn3*@VqjLf{FuMlp$OV!-368uD%3$P8o;rxCuO~ObmerHYpQJF(4b2 ziNk~&iQG;2j3VLkbESKLmZTCw?*T1EC57G#TAE4;?G5TuX@p;=Ogug#0a+i&%22$} z`#{T58KM0^%TZaO_k)(FazY;fO`!4!zebq~lpwNH$b3{mXn)X(DzJ*q1dKY=ou z>Ir=Wv_5H}lR=ZIzR)S44JcVC?z1rsse#Z(K^sv+l)?&S8smfmWLc0k!HW{m8K6z6 ziO_7&X4F*ZOwi`kOlS^h3u-QOHfT#~ArzAjb2YUTiVIRqE4o@Ju01i=P%EUhOqpxx z8j(E#*>!ZS(7B+k={lkFK-*Ajp$kB-r#3}AOAqC17Y z0@{`C61oGl8+8@>Drk4=CiFGXyQ#a-*Fk&G-9igMdr}XfZ-Dlqo%9AySje~{VA45R_#{R?;>L<5C>2|Abt3B~4y8A5}F7J&|>AwvHE9Y#Zi z{s}sqh6()(bOa3-dKq*ijS%`b=qMT~GzdDHMhV5r%#5MYLIE?D#t3E5aWqz_1DZzT zgyKF&lTK+uV?oDLy3jb#2Wh;}5}*_4L7^oq>B?l%qav#a*)+-o4LllD zW;#t1Iu$gFri+I}c$h(1B7FqXY?>ibKcq7$TPP0an;e=c^eWI0DXcU7Y_~KVJsnAxS zPt#LEagCmNhMpFBE$A|OM(A~*%W0X=)}SkBxzIMCD`|z$>p@r1N})G^uBKH&Q$W|y zYN0oRuBA0XZvxGuwL;s1uA@Am?LgPlI-xg%ZlLu-Zw1{*8-(5lx`{Rl?FjlTZ4%lE z^f`J~=T%VNeBcE%tj zsgD$w@|eN>-=lq#Dxi(4tesR5D_b2R&_q58@%%H;RoN+7NGZW!nrOqWrQ>QxB*g_Vg9?^gP*S zd?9!bMho|XTH6TU1-%gbntFS#zCtg9@O1$-ai5jOtB2Bq{V=BdR{;EiF4Q|D!2QJm zQZe%USAcJ?2++Scz(6J5MfEd;eK9zAdHsq8TTfmOybv6!^tGXgv(D1+D}0W)!sjTo z);Q(Are8SX??_&L6h}Pv3h!xQ1yCa26ZZC`P_urZ2{w#31V|<)s{I%eypDd39>Q2! zLARC~TZiw&1cRv2_pfZWKhncqqQ0Myd9;k2pJ}p6R)NtNhtAV$=z(oU2Y;a{2>%P3 zzZ&d~G>=AFfY;`JrD>sfE+C$<(q|AEf*_tykSuJ(;+4M?U2aS)9X<7W(HL99p*H4a=Xc7+aIcasQI0f3wXQupT%y@tj3dvZfnl?FZ4D56}? zOD%XQq9;5rXq$h~yeRJr@XSz2f6^j&R(Yu1I)BoVDEFm^4%`1$s&7<_aiq=sMFlb_ zL8TGt!Kd-0DW`8z<}$reEM11ji!y)Ho5;z{;lUFfOEPW;&lPymU>(Lg;o&x{!*~}+ zN0r39%2Qji&b%f{l{`Fq{GHU=(JCAvW<-$)*W+>IZ)CNKgcG}0H6PGM!~~ub!_P|9 zq83doza>>WHW0e%o{ZgZUqy?+!^o85cZlQl zoikt8cVYR*@4|CeEdF?3aj6#If$8ri%9IlYEAX3Y<}Tg+%IBRt5p>UR3rD6<=iVru z9`yGNj|P&_x0LRsX88DRRrg)h@~2=$-h)DtoL1uZBvr3Z{RFS?K-cJJZ)M(Rz508F zeMyAxV;MY4-nKSb z{sIymB}w9wke~&cy1XCtFdi#ZJ^=C{)~9?>)RT5BPw~@APb@<^vkdELZouDR zF(a9LT=}n7Yi6PFy(f*ADVx=I{O_o>V-)^|vf6-uu+6HEseK9Qyk(xs`qpdZ=IUq-ZTo_%|ibluP(RQ#=ZxDIY@K_hRYHhe6&|KI}UmR6fjd zB_4!0PDM5)|3RCI50hSrd6+kW8XNpm=?|{-fB6dkm>FN;KdAJfEB#}m2KfxfkLmLj z{vFbXXXy_s1U^(VV@V&cpg&Vd*Ki!kpwe4L&kPmL|2fWwaDoxR&E>65eCF zEa@+>sOKZd?}-FNySNESRiGG?@O42O@7IU{-xrLEw<4)E5^qF`cwfi(g(_)qk> z4-@%`s7w^_a)sveWjGA7__;0AsL4ox0!LJ+3ccdKo~wHC)VYDHgN+MT`O+51NSU40 zw36_IxHjpNs^yVj3Mbhx{*$(fa&F{$DS+096-h*LJq6xTJ}gWkk`xN; zRX(gwB9faZut)i@Oo>R^QQ&Rm>k=iog#x>k59^nRpAMwIR=&G9uS;XdS^6?Px@CHF^ReffU!4-(doQ^`L>*!?_!{DXx(z=Oy= zCoGkRkbi)%{ydD_AA}9y5#%2#Y#@&!|2ScTcnrB;3meSi$o)##5Kbre6Jh7Dx8NQV zHk2ol|A??*{1CaH3LDN3lmB^PBX}~op9>qwQ_1~I*eK2<|2AQxc{;ft3md~T$UQ1- zEYBqOBVprs7P&tQOXE4@o)(tQkCA&y*m!=N+>^o{ zx%-4Y${WaiS6C)*BKI9()A%`Z_X?ZNTgcrbEQ`02`?jzd`~tbVg=O=Lo$r`U@so9*e_d z%C3^WQ#rFSXGzvS$Ll}+3$5RvZP6H*UZb}|y;(+S?49Mz!K5QJ)iL}Dl53M5d<^ps zY@+a|p7n7&oUwbt$2{v?JQcBR!pA-9d_4Q?Tvo@>m7Qb(o*Xt`ez*j@d47c?AEmpIu}(qh z)&<|hSd4(<88G8n{*CHlWsOLhAz>Nt3(!P@v=!9hIs`TLNn8|PE81{B7a<*`+ z(6pfYx@waae4gXjV_O;9pEI^`X-RdQq>5=tC{=mnxi(diy})HyrFb%1`-o>dW4}|@ z1?ULtIDu8pi|k``5r|AapG85!*Gr7O&XBJ>u8a+RDvgtwhHPPiwu7eaYf6&)QmGP@6 zMeKuKF;DlFw(x0d!kYlTM%W^gmg?IH6M4_s#mN%=n4tf9)n*J+};H$^-hjPitSRo#}9?*o|a;Q0`GAn47Yhxu2bw}2i&Hw0~u5%@!H zkKF3ck=QDv?F0XF z?!oR>k)7aP?Aj^97kn?fTSWFH_hEOlu#?=E-RFdz;``ZsR@iAyWp|UXuXq5v8-;z% zgE;)~9KwMODyNW#Nqa$yH{bB@$UVBt0UC~u^(|lWtY>&6tY^8%v(D$ywx6vJ`rFxn zp>>V7tvquqN&E&V2iC$9wXRSPpwE7~gb38d}+;rC~I~Gm}jhSv<*e(OcTJ-22`B6_Hca5h` zCVT7*Pq(SBhNqu+M#$4D&r>$LmYv}o>uDwS*M8>N*k;EGPqgFn&}JG;c`c8b+lOlH z)yn-z$_UJX+@O0Nmo*TTea{B&MO zz78hCz8*t9!mND+g&w^t;5eIDZA$)!G{$+3)kYuAWyd0{#2M$sc}3U~&X)fOThiGY z3R?mDheNi6A8n1}KbzWe#HYFm(;EOq?l}bH;@1+-QLkNc}9(rD4wYU^Q#yhWo z$!1s?M=^?I11hSl^QtY%&9=<2>7G;0c`Z}}OT8L+on6byJ8z)bBshey==K#HJl~|> z;&z}}fhV!k<-8T$iB@}^W_P#~t&G@h+i{mi?2fc0_nC-2#@e5X*ki5z$*^5I;S%I| z3HC+gIR+Il!C!)o`3?sbtDK6?KFI*0+#vIZO3r)iE*4hV!6RnmIyBjX99ZOUrPf}D zV(~U_yh8N0m=U3`3Y0<-nnZ_@T^XVxyDf(>QSm!Ryh6eO4+mbPK(2B=MEO+32R*E{ znuBMEokd^;l2hIJBpjfI6YKfdOLz{LnogW&J;TRgt>u*PthJrbZG&HkZdu3qA{5$> z$dFc&^Ci0rh1GRVS#JyAt)BB$Xv*fz!QiZ&uQ3^@?|fr*N_Ngf*%~J63_;^=Wz|I>=S4cw>q^#*_tO# zw>h;P_X%Mgoh0k&@zCrQtsaZFPEI|veCYOy%=wN|eJ4B%jCNIiOnTsch#LH-ySqbN z4^yN6c6~`)KO|hq9-3iB$L;2e>k(?^gi1QR%E2IayVJrB7Bb-7;oz{f6u&Lv1;K0n zAO1T#*G2h%JlN)n)V*0d7W)`{@rrkmyyC^W8Jcu)Zun21IHu#2V_OV&IX5~IP+r*D zQ5FS=^Eys>R86G$hF*8KbyQY2=VnLN-B|l)b$4#D{5`bByPX6tgtz&PU$|)O2jui{ zZpCjJrBZUG;(9u_IqqY^dO4kJ6&lp@JvZ)R1CIJQ z6}%?Z$LVI>bAsX7>3v=~+1dTwPGDwO-Zx6#(+OmU<^7`M_dw@^$kzRi{cV)Sjz!i3 zP9H}m28Zy7OZEJs{*IHRgA&IpWb|6RRQ6sWgZui!C3?v1=LBXbA8x}8`8-Y!c=7lK z!o+gjzHFWm921m~-dKK|#7)NXK`_Iy&A_U3uoK9Neyu$i?w$t63BM$i@OINaD>&S< zMP{d@Mk0UMYsnhojJA0?f|+~q3vvk^j%kb+);A1hSi>x6IPPC@rXx=5)MO2J9>gm* zr9T26;Y_gc9|a%jOtk#t$ogTFjpK^d$s|Pb3C&U(n=d(|oeb2o#{2rLG0wxbePPoj zYpnB#<)1|&@|3wEqREH|yD}!t@u7ieyrs`dccxkeup5&#-g(sWQ{WFenU*ss$sm>fL$No&qoM0cvctvX880A9!b7*MLQe)31E7N(x`Yq2YYnn6Ha@lH_ z?#v5~i_@i-WI6L~FPIioGiEpo<+&5uMRAQc@mOS^Iha+3|3eTlOx${j@)3BTLAFLm}r zxuZBE?(bOlr=5LK?kM7j`}@{?nR6h@eR-7o2iARsgWF;w`mKy||IoUxa*js1ua0v6 z#JaC>j-l=_?r7{H<*ao+3l)irGjgbaJm+&bH zKpc35EsMw-#VZ#*fE=RD_} z0hh5A?Lk5fmA$wz!S5W^HZAxAWD+A{hV7hZiyHNQgbug-rw&`Z*sKmega2EHUp%SR z;R3kmfVLQ=!*4d#OOS~UTdfUuUyChDhd-bLUUFq^bN;deK?m7U)Ll?qFF2K@xZr){ zLzvuOM$k#%lY*0jLGXzvqKRnegu`pyS)S7s@f{!QeFD5YF|vZeX|f(6H;jf7mAJ)* z-FhOK7o95MWMtV}0@3w~?2*X~COn4_ewR}U?)aTm)C?!$Zt|VP@XW!DiFomMXPI!k z?BxO_~(l;_fk>Z+=Pp`mI=2x;b9^lJBzE>RmGNX zt71EI$Q|=IyW=3H$IZa zC0Ay4f?G3xW~Oi_J`-4}xa>~FB{M_j%FKN#rcpD0YKw6yt}|CotLol6#Zh~MtnBC3>8-%dQ?rtT~6>*5hm;lBrPuuNyh`yiEk!x{(k_Il+ZZQ$Z7pQl@XF&9Yv zqi$Db##YYEj8*b`_y7Kny$dDF!(vkyZf}jqSb5>)*T3F>VKKOcGRB4ynS}ZG|FBeI z3&$yONopk!ItCY~dZEOQ3-_&?=OYewxu{kCJJ2Akq4qih2>%YUe3JKMX#7h+@8;H&P78n_YyLkj>PKu6Ma0LBtMcP z(bkOFYQ+oh>GDq=)pUGK4X;Kel-Gx3 zlKPK(|72hDi&*@@zr>idQi(Acz-(Y1uoPGYYy)-xyMSZBDc~${9w-8+bYe^?pc>E$ z=mPWvMgzIPo?3}9M}b1%Jg~8JTSO=hzzN_yP$YmO)dt+em;^wc!HF>)z`D2y(i@~d zFdWDhK>_?00`nk9s8a?15@R-l?*OXRNsMU>WCMA?F39!)+rW1K`+!2A2q=|=@JWcU z8c1Cs%|SWU|k3Ha;=?3Xl!tmPOJ_tvN0(1bnl}Dg{AcKJnU^cJ}$S*Id?*iKg90ra7r+~A-GDMXJoChxgC;>?W z34kA{3p55=1053L6{6|~Ivhv?rU2PMZURzY3bG2=2oxaB!@vok5ZIO=)m;FWed6_4 z!c15%!kSP4B?i<58Uw9?4nP+mxgP952cRb~7?=QL1M`4YKt9kDe$#*{KrXPTf+Us) zwi(C=3V_2vAy5RA@KqsIl&>xs0o|b{+`6Rx4uma!!a27ZZ6aiFG z>bp!uLH=q>R}oN3qac9}kaYoi0{to?;^82THAri?wgWl=-GJUA91M~M9~r<> zAP>leEFb1kU^DnRn7d#e17hnVATR-#2Egb%EM?aiECpx{*KWXQARAZ;^oKkfSOnw&n}K`*+zNm_zyaVWZ~`a_dIJ4`!N6!>0x$*026BN#z%n2Y*bL+Y1;8HQ0B{sI0Tcokf!5F<_A2Dy zDrtp&uv$Pe&>TnsI$VXMyMgo*G8`lg$guvi!E%8`z%n2Y*bL+Y1;8HQ0B{sI0Tcq~ zfQ!IoAhs$}1}Xv7fMlRK&>Cn5bOO3nMY8?m&v4k%fWcB~FtdSNU=c8-0X!@N$pbb6 z^WbSSkPp5~LLZPn$6zafv=BHYf^!gD1TI&V=R~P$sF!LGR|BbAO+?M@-*&Kf0=fac zfr|)VsUZ|@2+t`ErR)YvxHPzB2+0P?1r`CzfIOhLcph#&XCUlmi1L8~U=MHrI1KqQ zps=A;rx60wY6K-3NebP>dKA7+0ENH=IAsI*z&Y420#qGE3iyFS$on-$PO2kd^Xl?^ zXa{kp>T|&Qfei*m0~3HLKsJyIECQARdBA2MA1IJW_JJG*jsd5Dv%q?ikMB1GR)i>(qET>Y!6oECvB1M+~) zKt50a>;Vn{M}ZSSA#e`32wVmdYDwAF!i+5i=v_ySExn-SCpqj0gdy@JZS z)Q4)8NTES(o2g9k8vZw?Lz&PWRQNW|$$>GDOI&eCOQyr2$*&cbw;x*#;~2bU`HJOBUy literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/86cf8b04d7f57e3c_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/86cf8b04d7f57e3c_0 new file mode 100644 index 0000000000000000000000000000000000000000..1470977e279b6980b0c3c18f6a8c91d43a88aa8c GIT binary patch literal 35328 zcmWjL1$dKZ7sm0sN!nPGrVYj0w5fZFySt7J*WvE&?heD<-5KugunmXd4A`2HW) z^}Cw9?<41&=ShjYsjq&Q71`Q<{pK&J7_ODyb(J3~ojXs79C^}97cW(^WQkn4bNO=T z%9THFo{~9Aq~|JADp!eoIns0F$dNC9zMMJo7SCTgJx7V+#q;FIogiEv;IHU|NpJt80+`{pM$XsP0C1@@UX0uubeaqDla*390e;#^$}lD3a=!k;~;Kf zMP+Ge73nZ~SEWx4=_`iSl>SEc+EPdS(^bmRP5OkL6QnGQq*zo%cWlHBJVuSh#D)v# zy-(_MP4X1;(`M|)Jv1urr%^aq!cYI8LrFjNMW0fB3Mk{J%;;O*PxUJLsUK$jPisFVqXwEFx{aTX;Udnp^;2p)KNUftu72v>+fO4^Eh^HA0IudG7_RI!t#@;Lj)y-5>K=FKy71at2u{8`P+ZLG6&Exh)-R)-OZq^-3^Mvw;l#H?nU3;2F<}{t(|XB&IJYy#}v30 z8I-uxpv)@_y1mk%@vDe`twH%PZJj}9uz$Tl9X2o@vTro#JZ_@lR)b6j4LXHfhiD7a zG1{Cl=;Z}szHX59hC%6Qh+$ZOwV3j^K{Ia~)a(vxj)HfI<(@&I4-Gnv1CI=<|CD)N z7_|7MK}-K7mv;u;N6dR_^UlcGEqSRN~d^5=XpF#a_6^FjF zfBcMEW-#iM(Ws08M*U(o>HvmYjGBUbR-;^Yqr%WK(5RYDqdFkeWt11c;Umfi8`TaI zu^E@JJJhJl@MbjX7K&stY8vKeHmYhCqh2C^R-?M%Gs3bN)e!Tr8$+`jH9E|w0pUj7 zK?9Fb7hsJv>b%#e$x$4KFV3j32}X5E=60G<4}3=5PB$t`4x{GgHtH>IAl`(2BR+TmCK0?bG zRUB1Nue?zY@mmF>>=ljLgz!p6jYMi?qbgVBJQ9B5HtM2nHDX4&pJ|U1zZg}hx>22L z7!_R8sD(Iz%cxn)s9Cj*T8;-;Qpc!Ib&cB9#HgqEh^bA9qZv83G^$A}qb9UA>Ja|L zqqatw+Zibir%_{iu_nD)|Gq}`?Qhgi1C9E7 zF!K#zzYODlnc+tDLdTItwHj^IV|d3Hb!4JZxhAn+{_i((K&ENTfv3~CJ;SK>bBua2 z*Ql)XjB18+^BH52QE^L+%CX9*HaN4|sOsw&f1^<+Hybr-3v0NQ9Jd*@c85{PyU1ZT zdEy#I?_+=MCywK+*9GRgPT!kGm3TxP=!Yzi*(;dvguV8Zxt>!Sd_=1kM&)~HRR32z z2Cx>*-y1dQ18e@#DB~xi7FbN0U^S_f&7@^mZZ~Olph;GTNe`VS^>mrE5&45n$`WEy zGBRc5CwAg!c9XVyOgiW_=`I>Yo0Jq|k~hJm+=(XbKyRN(dvcgmH;+lv3Yt{1kVzBK zvam^eQKX1T$BUWtdpVOVM>tl2K2=PrUDc#r*!HtY)f<^~q_Iiso0xPMwx%XM zhhH=Dz#?R9ZqiIlYH89Eq_r}sLK~9~v}3OJ^yy$yVn>rAI+1s0lj?UdsbODo=x0*F z0VY*N=|Lu48EVqXVJ2NimJ!4-(xhv+Fp4?Gm=rnAq{TDHc^3KM1JY-kG#4k~o@3IM zxh6GP$k=GJ$fWt0y4a+=OHAsDeHgIJr2Pn3Zjx~&bFO6$?A~nBH=N!={kNI4^sq_o zj*{m^lk#1qhSyArziCpB+rw| zL%6@T;WV;({Pi5WBmA`^(qF}6{8a@rV*QmR&R^BhImurWQ90RPx6}Of0+-VLWy
vau(9jxcCVa@!Nrwzy2(jGsx^Vfn7{`%0#Un!ma)f&gU`0Gx0f1U5` zubar#$6sgBysy8$VnRQEMfLaBE~F0hS0VTY`RljA{(69dLzoAX(QqhzQDT_Cwj+7C zzZN0G2!D;j7kn7)ub~tD6*h%@a0WZ4`fJGye`T8KuOmpF<1gb}@=CYuzS)jo#1wQ~vtv4}Z1!%U^z1s52~A{Wa#gzZ^IG)fdOn`KG_# zpzhz)9zSmRYyNH4;EummJ@i+jSN_WTpTEW_Kx51S+Tae*9{6PlP#ku^9U7qB8Id_a z?Xv}_UwD8W9g4869d$D5;3g^P~MdRN?jG8h}8j_ zvLQenwlL4{0V=s8K>m9IlzuRP+6HJn8r&l9CjnX%Xx2i9S^cw`H4S_46f?4$wLHwM zr5>~X!kh@R>O|5u%B*9!h=z|@f>DV&1u$#+-AMcV^&mN;>E{eX8ly$ zEN2O`R^SdYlr-xX{DlIg%-Ua?d@!!8S+j7b9Pwgcd9xm%O9gIYX+^XAE19(ohw&IK zDx0;sidi2};wQ7-pi(unR-xq2 zJV%v=%!B)l%*y$zS@|2ARilYnO>hgPnoCMe50%uFJenWa&vrO&GdWKKv z)4|LOFtbJ>q?1`gx=?QudbTvkiCBqy z7{9|T!%nj@;{xXIH>>eMvwGmyLuMU3Ld}nv)faov^EhjFg7w6KQ|w>d#c!w08hMs| zaE>|8n^o)&_Q0Ri;4jwrqFH+{Q}?U1LE1Ie1ixeF4eEH4y>p8_iOjcILo`4yY{rH= zW*tGtyQ~X7-Y2IA)E4%K^uaV7zz0En4WZ=n47qG%($wtT`+ihbuWPdXIX!ELxD)B6~iIGNUn0=C>$U0gKwA z7mS50dW}lOExgfTkps=}7n+t~P8`QY>?~{1=yK#zo){`wcsyG4wlc9*v8c~a7IpjC zqMxf+S$llnZ7fmec*VLl4W)?NXb$n`W zQTcWjz3FO^UpHbwf24J%hCMB+iTfDY%OY2Ai>mjr=q9rEqpo<`pFRUD+BndnJcBH1 zHQ1t;_=eR(EGjUM379%V=jh-W!2cIx)ltryaThs&2G1L>| zad3h~OC~ZO&Z6NY>Wn|}?__E;g)xv}szrNo3Xib)H`-3Kr~__e*mPo?Y0= zaB!tX=kN^eRx#&li$d2}lz+WNWzZCFF?$Ppc`IXYCx@LD<=w^l!MNL^Qm3f(Y1Ri< z(BlmAV<+mLrSABON#`s|`hzoPhmb`hQ{1;x4{p_E*~f$D9_cs#~pUi~$I?Srv{| zxQHBft1>#Rib63QN7o>$hT;Q`hgjusTa^`gaTJ|1STz{`qEo0OAJfShX6*Q7P6cV-oF=g5Oaqw^d8?ShWe~ zP&cnt0r`j-qj9dFRT&Cd6^SA^h04XOYJ*axtr~|}*oNk1tm=X~<*f2AZ&fJfRbYNx zsbW=?s#euUm!GUUi1yX2>W^3WhHgJw^~Wz(^{H-Eo|=r0Ik=4uwWxD#tESXp&brKr zZKz+*DocH153sc8iwRfUb(`K@6 z*pFXkS=DTgRek4L^%nEzS+yPm=Ch6qh;y-3N6>yd_1HyjyRBNbhc(zstozt6Scr}L z85>^@T6Ob~RoxF0+Yzf)qQX(DULfH(bwsukV;Wvt-A0p z`}{ro_aplcL7%K@fHp9GwrbQ@V*AGa{7xG`o0=MI>WqU%o6e(&zfETXY#MB~X#$R* zxWlHzAe%fco08EL_s}ocrY#w5+MbDac!DOGZR&^>D3{H~`>8gq%5GC+q)ltRHtj^U zD4Q%XHie=ELgE-3J@9+HO^1*_!KOKhHmyWtGBM(NicNJ>ZE6XJ&!#o_CEdpRQ8tZ7 zN=}=WQvo4f~X`WcN-{-8}c4%-xQ+@||@jhZK@ z<4M}0Kf+Ei4=S9tsrMP1o}abpGwPnBzUOV)dVyM8w5j1Go7&=`E&@;-e@EE&3$J%u=(Jn`_U0IQ@ zgk7C+4FyZuRSpBo+ts?VU7jj-RYFfJ!8y3<*cFCd_2^gMu7h~n%&s43+}y4{@V2t6 zE;gfe8~UMKJG*M2V0*hJBWDM@R&=uKJF0fJ>uXoLu6DDlPHuA-=nwBdFY#vA;=s1eLN+O8W&8e>;Wtip5n#xe&^qs2J8 zcA(<~yJk$H4=j`I+KbZ&o@&?6c#q1{>>53tcGxq6`Dfa-5bKd;Hu<3`_Rq0v=v?xI zZ@yifFaXCEF!n;bGNSk*a>RuH|6FX>Zk$BnrPLNDP;3hJg90%>nbcnhf zv8xEi9VPCQ)bJEJpJuP3^%=%GOWfz|x`ip{?P_?zt}TDCwy5$aIsau>Yz35cHWfL>rt##1|ejIDpJw?aKa*c`zSK{^N0n7x;qc@6-#%AJiPT zut9-3YzWjNW1tF|0@V$_`3LG(bD-K|NpPStWC~Q*NN(dUUgD;gpHYE|i4K%ACQ$V; z6@_ED9~Y=uSdQ-rjF%XwMOc^;sNCs++M6>_r;smKpr&ClzT^qile~fYfSUOOwF(6a z1nM$=DHy1GXjzE!$XGZ~KhV5LpjKl}(Li0S5vV#f1N9Ha)e2On+JUmw3DgRFsUN5T z%>y+SpIZg0cIQBCL$Mx#ylx8AX;kPFsFHmHwH1E-1J!Owptg?;RM50QeO(x+%!{ed zl0cQm5ZuLrb%Ar&2R!AV0sy-R@jTv$onc#gE0{qUk9oMy5TYM zzX?=X97mS7)CqI&8sE|G-$3oc36yvjsL5D>Ebjx=1f6ghNgo&s%kTlFkJJ@M@fRw8 zq94{F^)t1>NW4X{FM+auWlYS(BfLkqZ^VU5DElAhupE`XQx7~eIOH-q)Ec|--Q-X{ ze}_ilKB@;evxzHL5;j}wc2fL9g(4naabU3ue z=}>r(Lzi*XsK&bBGn~ILPIZTh)o`dX#^VG!)ug_)99oUmwH;be$Du-X9a@iwdJdJV@6Z`U zG;nAHHsV1;he8@Vv>!d1a2^|*vOdimYTBImT9O;~Awz5C!kcyu#kP0o4;1R)Pgk#9b7cNLr^JRLfd>!t-%gFK&AqW zgN6m2nu`a8ojOv)sTVDs`iiD)oNC|JsYdOb3T*FGbxgsL4o)5J%G_w(-KpcK)zc|^ zFY@fo{C&u)uTz8jJLMTjPJ`%&&zLaSsl=hwaJW;wMmY7$DCRAr~I~&$6=@ToS@Dpol3!*zlimQQ$ue#buK(eHRFO5S3gL(kf~dc zqA>(paS)#Fv_VsZ_XtuFE@5QPApM4>y@Ip?oqGpq03!MXDFwq|>>DH(()$Ie1-hb3 z{~&F|UUVD~q<*M5ka1ufOnY=d!(l<1I3h?NP-kS2UXKb=^5`Jt$E>kI+AtwVYbJ7h zN|4S?4bqb7L25Z8NXKRdY1Ql?Z9}0sL3%zfNZIEHDFH2T6u}FbYiW=w!MrR;X)A-& z1UqnGRgliYyoR~g1?kB8Aa&Xtq}$lEJxJ?!aDI1?9_$NJ*#kj3emF>1j|6Gm(I7oK z9i(6X2-3sL)Z#{vYTpe~-p4_z@iIuS-jVC4AdUMkNVEN1T7m0E7tfJhayVVeim^d1 zm36ta86RN^c5#h`OUuw8#HA^CoXw^87!~2t5)_SeX)aQ|E{(xQ%!_g)|pG!BfFTYFCgGX4MtnP$hT%5ewRg#{gGnD0{hV)EEco$w4l@1Y)hU7CdRNZRL8J`6{Z{Tw^OdL4DC8CGLE z{yFAShZD?uk~KT+QjW7ORXyiYeayPR{C~Lg0<~|tH1dv1?e4l{zUNX8^uEurN7VVT zOM9Qt_o<6(d0e{oj5@t!-@J0^*c+E-zh^zs=M(Mm934Nq)DQMAE?&R6^Z;f4bLkwW z|8VIu`h^B-Cyv3AF<8el1?xoSU|qu5tifs=9<0_8!RiuOA} zmc|BaLwvASBn9h0akwsc8=?gK zfe!6L^Z?=QLo^<<(Y9L%dpbl<28HO_D8`u_q88Ia^m1K@=B*FWu?-=5h38vC^xL)& zy+!pMA=-kVogw-KTTy&hi0)&`-Vin07b4?<5Y0uIgCQCV*Aeo;C8Qk-Q5Q@(9>RNy zAv%RlXF~MvS;jdRqQe(MbmTH|T?x^E>mfRUz#Abdcr!#R|0br}AsT!?L;?SVXxfty zHGCPOnK+FJuekp@L^pqs6Mm9gp?+?S$84N5xYgO{)}JP~lKkDei);aI^)kEl6)uZg zS75NZ6@)FAW^-#!2DjQ}bZaA;XK`zLR<|-_b895d<3)D2)`q!N%;Q!{gj>xb-5MN? z80L<1>n(P~yOlY?txmX==vKib#z~{U&#gDDDC_%CHNt@7pF z8jHvZZna0Bif*07s7h`Xuk6+$)UM)|qpDj~s=2u~(yevX85@;rxK*~UTi5EjRk*%e zdm6Zv+R&{tINHdqp1-=4x3OF4O^La=Tj$WC1u?XAYeXxz7LRZ%ag1A&@gChKx%KZ% z#+>C=ef$f}cB>R7V*#?xace6&&tnbn2}S2~AMbH~sawm}(|#l4?c^AYyWDEHhqc3N zl;7*t8azO*eQr%b-u-Ts#=HY=RXogjtT^IU(_`!rj6UgBj#F+m`Rdj}WX+U8WzY*b zGiTtrWCqpBl0mb585CYSgJv|(piB61D1)B9%AlDaGU#`_MuK0cez%8eyE9Z%U7>n~ zR#Bl^j<-cab*6ZzlFEcCtx~9F{T!;=wL{e&T}FlKr}3f6IW<&&)QM#om3SwkE}`bX8MXRrMm@&fOqsZTE0gAC$)qfGGpTihObTz4Ne??@ z(#Ymt7&5E3H#4unGwbK5%vy~7`7`TS@yyCrCbQb3=<>|G zx0;#X`I%KWQx=_x&%)y&i=O1kqTyw;XjYvp^7P4~>~FFtxO;Y))?`DcHuA`Lir+L>QXdJ)r*BGPl+(D*ALUC zQenzjI!whd9(NE>CQRqbhG}#8Fhy4g(|Yu&7^YjuQJHa3AC-R&Q(Y9S!Pt0%*Gj>=@rZ~(;r|w~@)+`qBk)kqEDDMqI%yjox-SoVX8Bb z^B9CvC_FSwxrT))Wq6nh;9oQt5vGr5J1R`QunR3mhp8L3;@X%nJ;IE!VY)dkOd%7) zG#2;p3ezWr>HQRrPYvU`p)hSh;BV9h3-J)i)56po%kU3YO{YJ?W>6#Ko*AZ&ScQGF z!t@nMv%_>3i{`LSs56(?ka-@*kh~;J)0T#5334tAQ|aZz5A#aa4NumD=>uZcaUMG{ zYg3p;Zy^_aK-llB{f;ozLUWu%xxHapygy7c576&mn9if!A=dUVbwa}d z425aOQ`$cZli%|&d0){Vz26Zxs=X(+56t;FjQ6R-bo@K}xQr~7!*#w&xQ_f3uA{$%%TPUBd1`RHX1IFS4%gO3;VRQOT-OlX zBwPiWhAXaFxW2ax*Y>vITF^dR4LgJ@f5&i*=@hQWF5zm?HC$)Ah0D={G0>z}xXSeo z*B2b<8?IaZ!u1^A283($z;Iaxh08Q7T=tRSN*fi<=StxkGC5qY5i})S+2@8U7n-9# z4k6>ba3wEdE*xGQF5l8{KHCY`2pq>(_-_l>upQw#bBf&l4CflKaIHY$>*1PrJ6yS6 zhik6aqi^s=dz6MtNR9Joae_w!5%)1zxx z*~=qGZ;!I!ZXb^l`+C$22m8^!zej7(bD&3i(Pa>Q&~+%e4WqupJ<2kP+Zgd1wV3YF z7W{)_GZ}Xl@nY?4;zzAH%rn=cj`KVUn(xs=q%86%axv#{4b~+d4Z`bX)N{EZMj&>ZN2QT-yGIpw&=$RRdbA4nk#iR{ z!l~UJRo>%K6P&^o{6N0F9u3FDeICt4#D0(Z;}2{-NIr*%@2E$QG4z;6f5Cg)qeD1# zf^iUhlA5Ch-lOy>#yQQJlk;%qgg0@jhwHuPq7KJ?~vOA zYWEL&0U162bQpX^(fc zBIH*)LfuffZiFhJWWxy6Y|k8>BJ?NTb%{_&H^xE99uZs<%XmE_hCw+CwAsb!3EwE@AvN5xR!NwZykBLg%q!eS}OKB4pbbp*dKINt+^c4<|N9sN$9g zO~nnQZjDflZ4oN6BSO9QM5yf%<~(U~$8l@gbs1u$e z?~@2E!AAH!jnF|feiosk&m*)IpI$^L_e<)5Px$_tT;4|L3EF>*(0=@h>Yu3fw+Q|E zJwhFD=gTwCC zCd37L)eeX81phd^yp76OL0-w_n!V zp6B$cO)jr`qH%7oM(6SBIv!zbeywC{3jd*IX|E>XMH#RDD(lr9WGd%X!P;JR$Deh)x>lDw;BD&F{N`T$XhDtIGfzja zT8;4XI)`H;y&5u#JWzJDSJlxEBgS~;H=dlQcx7GSRY@#d=;gBmuht@Lu~&4b9N5w6qI49Nxlu|)GaQ^3rQiio3P;9;Q7XGCN|$kB zW0VY=qSR<}lxl2YJdF6iZBdHf9;HdUsq6kIWj+w47AK-K9DktX$taz|-cwO}hEHg9 zniy~lQ_n={1E!sgQqZ|5Ex;Z0IZuBSxj-(Mj_0ua5vAOJaUM%C;3Dnu85=K0=^jF^ zFfV%HZ>+u^r3WZ}GfK&~s5#nT=)EXye-Nen52FYpC1 z&N;{-7vtrPR?`B}x?Ct)1q(-OW)bRwg++-0*NR2+`!`z8ibu;TFWqU9Wm{XR*@Ub_mVuKV)U&+jA}QGQ44&WizR7;8+7+G8Fr zp~TD>4MNUYF)E3Zh@BIou(>gO4<|;GaARJK%Fd6`C>+L~MKL;so{M7?vNVS4_+zwc zWsF`SZbOWQ{vM;f$htj7nRdh|8s%_y7kTWC(bPRLdcHSCx%Uwx3LT8mGz>WsqXX!A zlra!@j5zTI-A@o3Zk&qY`Du*C;}W9J#Aq_Y&&FsNGG2^PX$;0zJVn+^F?^OBqdwS* z;43k@jpvBI8lwl-VzlsjjOyKBzMC<+f?T&^WW61uKOe^^@Cj@3l$tz?Q6d_n=<^uu zcp0M)SoMlE!RpsBypD?18&qi%tLV0|d>1QL+Xlz#H7XB{Rl=}X?#A+WJOpDbVRGA*DhIoMDGh_7v z73RhAdpMTYCb9Z~z_qc;xtZ~{&=#BE+8V2$u^i{{83Dh?stAT+GOBKi)pmS?bvw6_ zZAYxOo{rVBbFtct#PhLQkBb*#c}^FrxhQgxxna2!tIU^U)$~fNIwR$3tX81%wOBR5 zBxJiDtEZ@TBUXQ*>djaUK-k~0>Ve2xv095O=z5#l-HFv11l(oZd$IZlUorDOG2tx2 z9uV`RSgt#dRime|di*?Aw_i|`m(=G?th#)N<(k}BT}AFM^oQkZtn#5ZCMZrP5Mzjw z)flIY$Z3j`!9Pw9QNtXk^h|MTixZjS^gb)+vc;)0QnJUXPk5YmpsgoPec=}or-qSn zn&pkt3cSbp*f<@CXS{?s*$T(06c!bsT~YdBMTt1wMUhf*vX_oiX7t2mJS!ikgbH!G ziRb82k?|_UX=&v+ZN`|Y#9J*+Gq4obs}paHIKBrFr>b@1`1~hM|J37t{WvYaJ8W+d zr{0a?w6_KGwTx3m1hk5iv2`5p0mNxZ`#6>C5GPm1IL*U=-f>DE$XsYPC{CG%#HkbJ z3}w7=ak{-BPUW}6X%}j2jnns2aa<=Cr&suaC1>LF%Y``YM7@jD29++wsXlZ$PCbzQ zI(Z`QCUZQD(?Oig7|-`n;+6kyyjI~Ga@>noXI#NkB;1cz9t_7}{DBG&;`zTiUhN;o z>lOaPut)LQ|2STYp2h1nQl7`FE7qXhi+Ih&J4C;XSJ8jq z9JUw|bRQmLf@)$E&LXoZL3ObRw-M~0pyKF+rML!5K!Wn43zp$B9OeWSL3_-{IhZU7 zDu|9)hD!*rCa5s_VhwJ>WlK;obi#TxwkN1FKBBrKL8Y7tdJ>wT4+zhgAaB+L`7j0V zBNCJrnV@mr1kH#_P_qR3Vn&_>x$`EdGFIm!@B9gxfWzoeC_%%Kqi}*=Awv=3D4L** z#S+xDc!J_eBq$f!mQK(r)Gw2uc6f`b<%qvLwW>s2wkK#Ha_mS@37kO8F2>oLpkY@M z^z=@G%0EirbK?XRc$}aL2zrvBFw}gSpf6bcjJm!^(9bVfgIDxH^lRdMlc3yh85iea z_%}h1J|-ygQv%QPsL7WERYP}d{gI%TsOXodoQ6ad!*DDQNYot^wj|1KO;l#=3Q5!_ ztZ^r5H;QLS)cnvyKI=I8N0C^lt)S)wp(%D39!C~||m#7iQaDjMm4#)nW27eLPjYK`X&9OU)ns7H!6(5r0 zBi0CIpArK$;NG)D<$0c{jV}`w{wh&Pi2RzU;BVYVwjYV=2(Mp~eudkRq$qfdNlI}g zsSAeVDx!mvlmnYEG$cvak>pNNC+xr#RLqd1NhlMVq$N0kf1!*?%7^|Ki|?qIDM>$2 zF>{jYU`&=I{f!DSNvefIxE`CNr>GN`q?Y(IK1nqalN6Gaq_=33%skkLvuK=>q;=Sh z5~)ctr6s8;ZX%~IiR%NB^a+miBo#neOvD|$#E2Y8+KNLtlawV_l8RyWA3xUNac(2cqbPSQMl8Iq*C!^j_%#wV%X#3W^(lBBx7 z5##hE6`a92e8;YtN!mZ3CA4<@8di+?&mzp9N_%HBsDse zr1mG0v<3}NCaD9mo?>mz@$)?EhrcoTLXuisX01@`3hRy+sBkSw?XI&Y|6?6s{lVJc zG`<>=dF`33=lF&prexjrPv(2%$y$S4=4837$*KZBTQc8YP1X#&vnT6hV6ys!Bx@Vo z8IpAYf1`D#WOc}#td;Q3nyg(oj(7MiI$4(3WR<~ZSmTm45zpi4o0zO;7+f$}|H4{^ zF)*xbvXaUrYi`A46|0o2eLp8Fwnj4F0ZmqxTFIJIKUrUYO;(P!$yxwgyJY2UPs|;Y zHKkKBpAjc(MUP~ednRifj`mJg!9K}ajck3Bb!kwtUZB{JWc@OfIZ<+0vOb~B@MQib zS+XjOPS%sL$r?K$na?egb#+p*noUnu_65o6wJ2Hfi<4FQV6q0{<{`#DoUHA5grg^t zWjslpa151BC2Q5`WF0t@taC^>o2-ZU=OX#k)kQ^&zz$1aArwSeLT;aq8Zsz^e8+c*w0S>6=wz)_UVm!h5sFT}VADx4w@mcdXoh5u(#^rB*l;wq(RSY_g? zlA@}Z&^SeBFtACACL*+Hin=sQ(XQqxTsxVfb+8Rc(SDqPd0>iG;QFW(Wf+~J&SO#( zHa10x7(6FMyODWbiZ0p2%Eax~TtW440t5URTb&Bqz*jnm<&&ahd zMGLWedkW7vs0U8Ly)#9P@qSl|X6`1=Jt^vjO~|@8MV0oYXbcMPPf=z31>eCG-NaLr zJw!c^r)ccy6rDuBGt?3xXH(Si9C4mcQ38g*^H+*GA;%TQy^*33xPOziyG47fyU%)| z)WZ}N{f9PK`7%Y@{!7toRQ^FO;IG9f*e_M>kYY+z$KX`0!>=K!>VypLRE@zST*#Oz zXQosg#2@IMIaSXvDNCw8N2IEABz+Q6^%a)HRK?dz)i4xnn5v2B)HGF>@w!#2O0`ba zC)8+@Dz!~jb(HDKcv#mfRYQ8ye_E=BBV~4~+9G^Ts#5VM%FRvH2;`ras`AJ+pBNXV zDrs@53ZptgmZs|aGU8sIsyi6Ag1A$bsTtGs8ci~%>3)_p<;|L=Qh0@&+4&ikreU5mnW8x!lcqYcY5ael zroM@3x{Uj9rl!f_OH(KgASp+h8s$vW{9I}JC3l+sERv={#nUt%`AX0SaV68#u1=a- z)=T4WKBn<^Y0@+TIU1%(ebZDEP2ud9rYijzcR-rP4o*{pA!%xl_@QY!IEDD9rfCUU z{FbI6Gt*RkR+^e2)9f_WotvgUOVcy~)7Pb`*M>9=hi_w=)^18u;^s89-I}Ijhtf3Z zXqx7s+%e)q#^Y&vicM$IH1SfJytmVI{4V$3aQ|JJ=A!KTG|j|$Z1|X_S$;nG8+RiiiN1yp1O1(mrg#O)A%&6 zzmN9}nG@|NP{WDLftr(uah8v3;e4tN^BkW(&-dx{0-tVR!a|=uETP^@eY%Q%%Y2Gj z;nREguk>-vI5k-BQ{Wb#N*<>l-lN4ya>CP#)Z&Uy-?8edPYtj6bm|uMz3Wqk4?eX) zPk2B2)Z~*-7eD*->YGomzf&Wu{6P*%m)kF0wf)o8BxAZ7XG-V${^`8OozD0C)3q^6 zx^8DnS3ys@CSyLzN2F^^WIBK2CY|qJrSl$ix)!2hT)IY~Msm7xrlqSGo}slbUGvh@ zRV8P-hUQJzlfvohTa@ujr|UW%VM>{FeJGnQQ@M0yL|?QjpRTc$)Abm2tES7pS~`En zi{o(roUU3p`AfQP)L`zKTC!CG+Bat8~q7ldjkJ4=dX; zc00!Ikgn9u%!U8Dq-##MbpGycy4v(e=erox1Rap2H+l9+S4cm`8N@jF4=V?!D`6=8 zhNbKIsB|?NovwDsG=?0L3)lv7o- z#_^9{q$@>=ROxL(PZ=gXH;`mzGDDptpnyuRD!oV-P&x<<9g!wdMNoPNQM&Xd9qGNj zKX1L~TE7)?bI&<@?~{xv_nsT43zOnhatirOWBU(rdNngnhiApb)2aCwm2njk5jiD z%+F5dYA3-Q+fOi*XcNYeI`!N&&KKg zg*g3oEl&Ba$Egj{aS*5Ayup1eL*mUib;qBu-HOw3JjRmSajJQT*#3*tzZjdr#OHjI z60sRsGMhNB*QDY3O`3|N0w%S_VHEkmq!Fl7(j*U5%A|Z4jNPS8ypJ+zd}Wj7A+3r@ z9dQoI6m9i{zOUvqF3AKtC607l^e z3f!x&Mi`2XxR1*B>#GfB;s|m+sILU{!ZO@K`G@rt!DJjnrbqSF0Nt<%7g6MKeWf6- zegjz=G*EL}14TY*pyIn5=wUUpDpohM{)kyKa1NzvnAIBTIE6wr&FX+n$P;H)8h%Cw zlUX4Q!Ew|!%&aMD*2jLc>R=;^G&buAPNbUEv8h>4V{B_R{GsjO)nwaC9>38R~X6>js`}6H~OvB?Z&06)9Sv$WqE7KS=zmJ%; z3ysH`_0u@B+I?r%<%MRISY%e8AI<8q*sMX=i7G#tHTzdH>mo4LZ`eqT*o0?l3E1C$-yWR`LC29m09EJz&!Xhf16d~ zuvz<$nsx6Vvr3;bYZ%^~HtW+fW?e+Rvu2e$Z)RNsv-;npj_7>L%<)lXWxmba+%fap zpjjs|?XFq7ADZ>`BeM!WHfsz@J~6A=Gc)I{P{ZeDO?ky!Ww59}Oc^aKg>8{5lSSP# zTl6ZIMRjvqG%=4wzvs1RA58fy`lEnFz9JS4!TAp@tm|meUUV;J(OgW8v*>SBuVv9g zsJ2C~8(5TNwy0@C#=w6G7Ok>dv>CTC&|}dNTn{mRBKu+zuH#UWMLCi!Y8SS!mNEUc zw8)I9X%xjYBFkEfdg1Uoi{|}m(a$)7^exQIb_>VFThwT$ zMLG9aG+?hqdk$LUJZw?pBNkme%6yz)Up)WEqG_ir{3d46UzaTU_!hZhHpbks=s-rR zN@cR@Y!<5uXSHg6Hmg?R#Culd&t=u*B39P@vT8~xtBztsX{)B9L>a64l(ouV&Z?#; zSjnnCDqGdjZPgM)JXVf@x9TAheOBc$tXiIA)h(naTeSkU!&Z$?v8qKX7PmLKh>rTGuSrUrphBsGsZ%j zep+VJHTU-)!1|y$EfzY1t;5TK`U5*o}j`ZECc~re^r| zA^ANakEi7EjQM*`O)A8z9eUs|q*sjB8~jx%UKh}=a=h+UVH?_2jn`_t!28wWRT_Qp z1TAaCYi!MU&Z&vlAGjVD&pMa!+K92W;x!At+VN_FICH!f;;1!VSMUg#ZSnd5f4r(Uj@R};JnMSLtHvb8 zN@}QCxe`?N`vh$mpP*N^du6+Rs%}@Mx^`7-WLF1#)Y#7WcHPFZ6uTU$ zcBNxv3%hoqcT2lQp<$X`AGV=yB2ZD+10KH@^!PT z6n4Pe-OhVEyV~}#YXg?`wexw!&hO54#SO759v4T@cBEa0aS1<-vh(-FuGVAh`W^dl zYn)xpzO$>}G`nu%X*G6={Y}WvEy<(T^u3bY==bl||WV}x#?enL2kV$SGyp5=GY&E~aHuw_S{zEo(T2p9Ky26#znz?L7d;&gRdzbm z3|n2~jPKnJb@n(^&gW1ZY$* zfm`GcKZarcZHKDgacCVbVC8)tf8bCMtsn9H!26FK8uHAc#W?uFp*$}gI{eC^S4eux zxX2`@DrItNC+^~OPN%l!cIpU5mUAl8$4+&_L>$5+B$an69XIi)f>X^avJVzuE8e1D zWv46{h%xxCic@u~I<)~ct2q@w+v-kziw|lzRRKxw)O6}TR-2sqzLrz#aJaTpXX-k2 zww_Z3>N}Oq;#6sTj*K?iBmSLur_LdZ-KnZ@!Q*hMoRc_xPEAg6>W5UPwxCKAr)>D_ zou>5J%&9cgYU$J;xPt1foJzqptoYQalSug7sR^B(`W5@TJM{oLdpK1FW*o#*y!hIw zQoYFs&yBqlX*v1WoxS#2)W#I*#M^4ne7<#p*EiiTWDz%*>b<0O}gCA-uEv(O;b zr5M)ZBJwwLsU9x1a4A zOm``Og*b$)Gl>Bg(_MORwo9WHxb!o!EhJ7%`O&3K_-u(w<1u@sOFL2G7ni))z1pRH zYpLfYmukRs)uoPjgsj)7=R4P3`U|!jF20X)so-rF$1=GTK`$)C@5uL*zTtl6QmyAM z9fSD=`C`dimohNZud=x{udrJm7I!Ov4j6-#IE*JKSi&tUTB09j;5VECUt+5w644XW zuno7-rixqR(6qW+gYmq!TV?CGm8ZU2^>N?kR~pKV-z|5tTU{`@g>nZvDBUEH#Fb90WFTl>Cr>mJ&E<<{4j_s-XD zIeNQww2xbj`?~c#PNIB2?&BCPVMTwp9^kJ5^fSn<6R0-Stt`Xcx;U1&(y0x$;4sc3 zFvqPWi)e!kKf3iRk~cFp&SBFQ^4;cE@m*{~tKDwRLh(K1zSphjemBRplG`E1!|Wq& z?Zg=rKFU16cHFH`@egvIpsuIgDsaZFN;r9z`>1u1dBKEB#DM&lsrz-e;_ovD*!#e( zyEyyUtxQkY4*OF#@15C(63>}GY|h|O&U_x#gu9?e9dNOTM^91uLlpIBE3OvvXjTc2 z&c5@JNBv8BSP#s@_lrD^*@j2I;Pg9wkNP(9C|jaOJ5uSlnMc!b0@+)6`1|WoyEYz; zL5B7oRlu#T9_8=m(W#yuE)?fcM-0H?cfRzn4!cKd@v^r^o%(t>PuZjT{X9y<-*`H} zqZ|W0+Vzb`CsBB)M>Q}Ur%`v9N8N^dv>bOvc+_%~M}x5ueZJ*(j7Kl9Zk$KmCwkO+ zDtX}?vP|=+1Ok|YEx3T@(>+S~!Nd239_^k(ZgV}XA4;9(@z{KiY(IKfC)A@-i#>XS zwo5!5r|XdgZMAS(F9Cf#lEXOspLesIs?Zk`o%|QXp2wJu|HrO`~3TXhqVhm zx{0EXJgSE#`06n+qT~}|K}(E7zGu`E<(_+#f{qx9xoGpkqmkJAia4@*)dO6+kHN4u3U`?-P#(A~HL!&cmDO&vbgUt*{yw!C;8W8k$<>P%`qQOU?1VrQ0zw9NS}`5gHb-s#&TpC>(l!PjPvoGxsUbJd|a2!r@!&- z_deyB=2J0@LZKhX6|H8FJBrNo@wbdTXVDhj(#dl+Z5FW4kHm(Ci+#$l#HZKrEcNM= zWj=MqnH4@ASn1Q^bw2f8@6&M9+2qr|2yFIo-j`3=w)j+cn@=t*MUL&{jC$ydZ8!$) z@F_PO7>WtVwbQ3@$hnL75ZUch%{^?xDLD7~l!$4#fv3o}-=|-2>VQw(5Bjw3h)-{i zQKt(&y}?fxnFrLnL_Lu6vQK?*0oAVXILiL(<2+nyeATA`_zyL%`8e;HzVYdGpXT6` z8??RY(=HUcMIG<@)awzCJ@)Au(w-1EZldE;>W#e5eCmSz`0Y7;yr6%?UJ^5`ugDL3 z@zZN!e8ck)W#0PKAL}q&hKgq}IDgU5^^AsgWit33(olJPn8nZ-{F>EJuWW`^VPAGb z^>Y}Si#$0EeTfT5eb3My)XHUOHge@Q)E8F}$YW?B0(lMAM>RO6#n93MhGOp<>iB`7 zpRlu#p@N0!3!{n{dh(&6XGIN-FJ|bg;)XJpFfPZ}87fpso}?-0n}XQ&GfqN-tN9PS|CH?$17 z8X4+@Ke4j0p_&0=4;gBnXy_ptB^yc$8#)PBioxeeLj_U|CE-4PY--5d%;0+o#%)fY zEojryP_;Bexg&=9<2Lri=no&ZB7Y>eCT4u`iJ`Ke8hV7CZ4ACAGZaE+jKxYE!2{%P zXQ(!sVl;N4!e`7Q{zlc$4W*;{7lwXExAxQl`8yC3GIeA;{M5-%u(P4**n;C-41Ls< zxxsN{=x(Snro+_3P>G&~)*@psLxthT2{;EBnt-7L4P8WmZ-^D9Vbpw-p{H0lntAz_ zI^hPYj4{*|r!aUd`(Wib>hztVc{mGw&n<3Z!+1kmCmMXtqRx}49g?RQ+Ku{CnZIe& zYC6x?ndFylux253LCM)Xr{@@&IM-0#d4}TA2-AP!{t}+YII@&jmosEixZ8G~f{N_(~*RPTI6B&KDp=t_!V-^l0TdH3+bjJdmN3kY; zHNiOS#B;h3~KfPf)X^pJNfJDXySQ znqLu2#bM-%_~pdcSdObG8Koag#Gm*eMxEOFWpwqc#Axmp2&i3)fEJ)>%K-fcbO-)O zK#B%*y&e_ z{em_#1L}zvXqryD*#Sj11T+J|-vWx_3hbK#s_=V2|LqB=>R#f+UG&-)(Bb_74L=aj zB%H*vKLe_Jh&=He1OE!>%-;chf0$Yv3&@PA#{&wV2&ffipJbeW0xEinSg`wSK&>wj z1D;(Z_e;cpx|hlIKDl7%1I9zqhXH-{D4@=d1L}vbpRoN|fHmL)+WCgZGY8cS?_~+9 z80O+l)}Sh94=TB0P?;+Qxi(}_tI)P;P`&UH&8i1=8u#!`ji9pE56Xk*$k8CE?{M23 zZj*y5J%zYd2lWEW*97%DoNI%cvo5H{>x26FNKkh$=V(wXQTJF- z6OR+$iJ)>{3aSy_AkXEXCgJ{-pcefbWQ~}hR-pBbpt_;N&7iJ52O+#yxS6Vi&jA#KPP z(uns%N-rH!v~o!ItAuo=YDmYbg|xeRNb_rkG$k&iai)-N)d}hEx*_eT7t+T1^w}V! zVwR9@V5^nB>>(vML%Qh->5V6(AH5-+@P#zj2B-v*;(CHnZsmy|8a1_cswA_9N+c^8AAw zH`8W!NEa}14|$=|-jIgx3(2)Vr2OYY3L)c#kP2WL9$#e4OVr_7NLj9jI2R+NJqX?i zY3a?7n%*MsyCJ>Bs(T@>B^Q$Ken<-+Fz&;UMm?h~`aBP5H1fR&sng4lK77S(hD0qz zG-IMV;}McFC+aoc%aX|PuZfzOHBpswBq~$RMCHqqsA72&)dXAN$d{-b`4e>y4GOU` zY2if8#v&!DYK9~=Km@xpCFvm!WKL3{EJ+%WJxL=ACg~a+g_D$ABuV3O4JAKJQnR8- zx`%?rl31raNq?0}(m8xqI!SHICg~tfl}pkG?bzO#zPco7Bc66mQvR=!RCY*`a*j&U ztcgilF)2v}=F->vBz=u*IQCih?{dy>@mWRj{>OxBKO$@=5d zWR+{1tbDzaWm}xAcH5IR1YPzftJL4gx`~m8lhxxyvL3^dFRXS2!YZ2_*2Yi5+S(?p zZEeGv*gmWSc-kYZTs^~@j_8+RCH4-hMZd86;938$b_@tBbxc?fzYFWk>ogtZ1sFEY-hu*N+OYv%K?+%LlF z{4%TpufhsqI>u#5(cJe^bP2!YN>PV4DLRA~IKDVV-!0)5_m`%q{jwBoLXnjz3a?6G z4VM(vTc4tJ*uOnRwjC*o;M~p>)!mh%MM&SBqVaoD^#0xyJ-wHr#QQ1gnj=+(KS))5 ztV8F5sak}Bg;N#9D&#DZs;|)Tqf~V&ld3@3RP`^Ps=-OA>eW3}zA>p^sAYyG>Wvq5n<$&nM3(kVRAf^VuA7*q1?|$bvtycubWPL4UTJFE zJ57J$%f4wEiJ$tVY52f2O&*lSd3|Y$8_O+be4nN=PLpd|8s|5pY1xc4 z{W~*FH`dY5`ZOKdkfz^$OHI-L74U(cdpUght zsOq+$EfkAt6o&SW>LhmdiLyR_RO_${{rW{!tbbI^k!wIy#c>K1heg#69}bVI5)LBE z$f#Ol)M#>nZERG1QGHxg@yPvMlPGfs|R2gPRxejtvJJ4rN zRNu{wGM7;uo=1N3*#}4P!-A-qEQ@Lqyvw6%ijP-Bm32*2wSSFrZ7=GzC#sHEi0-%9 zuUJg=OUHEB5>sVsjL#V{rL~Fav$ioUKybO!_H#q<&z=EqcIVN9pd zYEew>R>#!gcuYr5#&iLF|B2}kZX&~}m}#fCdM`BV>)TiJ=NXi#iI<8 zsy&QlYq>3J{u5hoJ}@m?P^Ea^6*&qluk~A(4Rt#A7**(-Ts>{!|8JM+{~P?@ G?f(D=4wLc# literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/8a5dc2f9a114d343_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/8a5dc2f9a114d343_0 new file mode 100644 index 0000000000000000000000000000000000000000..7224158b527fc84b3c751eb4277543a8191bb655 GIT binary patch literal 29784 zcmW*T1$a~E+sE-=o3=?CX<8^YO5H6fUZZJ?+hDj3cbDPAHr(CaW!RA6?rwuI+}&l^ z`~APWuFsO3bDsOT@B29^=}A&YgRaYd=d0~yDN($*t7!3T zSDC`4vyzjOvmD8#U0H?8WR)mV#+hBZWa;81N@SNTQp{N<$Kfhg-04a#>?m5Mh^t6R z12InJw#@intpELYY*WAgza7N?m!N4G=_2lxl}eP8#zW;LD-I*Ig46)f6{SLzBq#Rb zI+j(I7FUt>qjy!t)RaDBXf5eq6s#k4!u@ViGSz&J!#{Y4-n*neSEQg! zH*LUf+(u)Un}%a=mYeRQW44?6qEC*Syvn#KANrPeQ~io=>W3LWy6HnJHyK;I=`S2c zP#ZVJqb8anyseuK;Q~&zb5mk_H)SBLo11#~cGK@D+t*Fc`nhR9e>aWB;9rULo0}#N zCqMX&aFgdmH|3h-rWaT}gIL$y)a$mJ9z1o^J9K#FrnRX1+)Z0vy6FHiU%9FBXE%NJ za91-=cb)Zj*QQ+V+Kb1z-E|RT_}Gp6-Q887hr6QirKh`^^kQspcg@016zW56F!gs=Bm9Zi1DN+$ zcNHDzt}cVzwGDp_c9+i(cR8?iC^fcFz6CO^B8m;8F>wwg1Pw& zdY<2)k_8Ovj!y{u!JtOijv)mN8WCvFfIuA@=$A!4 z*#_N0P-*rdu#7=Fai=VGmNUqODyU!HpnI5H!JzdO4gB0NXc!VJ8x-@SL6uPtcdHpx zt~$ry$WI1!scDd3EraIc2ri*kZG&diF=#37Vo_a#KGrknucih)#s^Gl#+=Qmr$EmrDUtmy;H3l8sV9@Z5^m7wAZ8m82 zR)gaIBB$*JUBQT5236h7T!-o58RA}L{%ZzhJzzfcL;i=X8OA0V?4AY*+cb;c_=&0L*vjY-9tN(k>R1knI8JHoQF*1 zJ=7JOt9xi|QxENjPcsia#n|Q^T7Wz)JTx8STX|>^l3IJHLR$~*X-}*U9N*DHv7I~= z+?kxac&I^F4>jsbPW?QTI>19!ae0V`mJjvNU&B0f1!sm6cch0xMtf-EY>u7pp|%S= zG-;uSiZAj|H|)al)gIcu!9!nge4~d>n>|&;;wdkir?T>TYEOPoZ4L31E5cKi<2`jF z$x|1dp7JQ-sfDS?_EdHiPra<^slD|*HMF^>Zuaoh>E517{MA#AfovPh*x8&lT z>peAMx2NhH^VIpXo@#sEQ*M_%wc?(q8o%&V@voj5Eia8Udg+f`UfP}q`MlKO2QT$2 zcJoQn0*KR6QSr58w#_fl1?fm?!?j^hd5Cwl2nF)w{6 z!T6G1s+Z!Wh*U4t&mew9FSV}Baj0L-OXmi8DQSe4+M@hO=7oI}<8gVMmpX3rl5?+@ zra$u10*g`etw!}PVAK@sz++4+Xw=d`qZS7lbsn>Vjj9{Mv0+9X!Ufz5H|hi6KhnKsY*|Jv!%gJQHtHvgE^E{b+$=|q__e%I zchR*1_u*N|sLj}qhiF;ZsFhWWdXKChjoO1(s8r3UURZ(b>g11A_<$`x8C9+Zw^&}w zs3o3&CpN%Tn#HgB08Hel0X+}Tr z1@`7fIa?T&fyu47-_9tH_C`IyNA&4vU@U809WdxtzsGU zcY}38L-fK1{BhH$1L$;%{-feu`Umqpj>i=2!F$xWPtMRI=0-YNVH}>}hsQ=mBkwED zM|YDv4JHL4(#xbdxP=NvlitAB$E0%TU^dCyX3~7SNsr*`Z_*_AQjflN#YFUUf6ctvflO+%LrJWs<$O zNj3VIbPWai(H}hS&oKi`TKB6-#Ri(xdXP!a;TmGnFG>C1GJ z2F);OELI_Yrb&O}A?nWJ@oeTpow+8>MuGXnz^(-*xi6%KMJBC=_Y#vT;~9QiYEt24 zCS{@_9$@cslTP6Y+OJ@~l_mwOGO6TRlggkOUSsA)&a+L#-9rA`Oe+2ty@z4DNjb;p z-*J=r<1%`lU~X(fgOl_UpE3TFNpWZC;W?8M(fvFmIeD`D1c^ z!g=zP^?Js6j9;H~zP>c+Pwc}D%zZ_Va0KQzjQ@}G4Y%+OGe2|uSLQT%tA@9?nqUC@ ze7u#%=B+Sf;xM}TdTR*Y!a)0h+Ct(7>8N|D|&#Bn?l@F!{)_15BI-dc}S zs8`%uUM0vGBXBC!Te;J`6@m;LL*-0wwM9;8Z;i$bY(|SR-l|*9Tb|{;6@WPvymh&X zx2jb2R@WcBwHF<#d8Ue8nU1HTE7B-_neQ%i>cq<={H(_j3Z%u9K ztwq>_YOTCAwk`R#Bj5Jqi=G|4bqOUpc`LX-JsRMxlwZAN8^{=(#AEauYMvKI(#R z2|lWq=%cqTAEjgy3t2fnI)?1hKB|R*n1ubf1Y;Q=6+mEFAJr)Dqlq|-3-GJxqv22` zA4S7d*+;)&Ko#mh!KywwhnYY6=qwi1^wD~}t>vQ@wSBY{&#koDL{6L1wnpZcioYaexd!~M6^^v*}Okn6pVE@Q?Aa>U$^KKl5H zy8rXh*U$9ki;s%tH>+X+vx0vxYiU8VOohx!3Nq^=ehD+HP=r~ZBF#D)YnCY2z6K(*(12;yC;!nN=O{P1NHxTI8QeeQ1W= zv&yi`YgT6rz@d4>o^MtjxE4?&#{Tbip;_B;6zPlUEsmhpQnRLD5mqlV>kdk- zAP-br$s8Du0;^azG+fQvtf5}aU2E1&JV)+z#KJ0U!}Im@YlB(8VG<5(G|OWXwPG_4 zAZ9Z?Ll5-Y!g;dQtoz8^#u{Tdj{QYF+o=aRJ6ID;LGztvEyOwu-bJs_b~j`9n3cTO zti1c^%K@`8F!~^QAEk%KsQEbOEZUqP)=Ba{W!7~}JZ)B^GiGf(%i5yKIch#{R>%d; zA>>?S-7)ZzSqYcvC1(H4{wrop#ha_F?>}Z0xlYbE&5FFm`G*D=kNYTkhx70*>yA$M z=*N9}i2V=f%R|l)w0~q)wa1*pPs}=qqECs3%x7l(_}r|0IQD|IdS%wEH)g#>_FKlF z`a84cy*KLxaz5}Ff5GvQa|rsx8lo*uA^1O@GuVTCpUo=xg?TU+i@x%_!!!Jc@Ne`B zhVS$o*YSre+V5`B1A|3r9u{@SWKWBJHd@pHi~KCgo!6pnA>79;JjbXEK1!?U-r=Jz3ks-(fIwuJYbR6L5r?p;}MIJj#_jQKOQ5eG*beevgvFI%powdku&Y}a@cAk7LShW2jYjVk=wOD-3qV@k;ROz}!tMKTCMb~e# zmUk>_e3$y3STr3=kouIopIOu#NAMmV&n;?=oj8u-FDx2_ame%1qL%26hbZ~VqOv%Q z{IBT~X5l5iq5T_+{=yMty|rip<{|$(i<+V{E+Otcv9JX1;qigK;vmkW@<+yD4H7@m z8w|s1Wd3K7`7<#w9S`sh-M^3*E~4yL_F*Y1eWM?^=WdnVU{xDz$2SkFN_bi|9CuK| z%c>>#fJCE}*GyIwHd!?kPm$qm)pSJpSXBgVFdsIvRdul)MJ!fLg2igpDw|b>e66~K zgLbQ8{j8b|yT4TjFes4mg{<-lvZ^$;;XQT*TU8~*swU_dYSn#I3A5@9?jbtds(KiT zi4j(9#T}H2v?@4?+%X?rqpfnqSoH|+aVwTQ6Nm|8qE%&*ton?q4(4!LwK&N_4tIu z9IM`8dugkFDPz?Wbr-oITHLa?QF*t(Gwdikct5%{-9joTmwJNQiRcjGk->PyAtU7_(;M2#g!+(Ozo@gIgzD%>KK0KydwGr+!tV*59IS%JsVx!tTtES>6iq9t&Mq}OrYFcR3&x@>T zw3vLBa84|>D%W!6TwzuFl~(P#l5+=Z zPq7vktqMT}xLqP2?7->E9QQZRoomebFL|TPbt~7+tct))oW*slzDa-a97S$%&fp9x zKcFYjL*{wJJaBtrRXU14W3K1);sxi(ORI{$vTDFve!jfpe0k4!wEAGxPam!7`-!=5 z@jvSMOkck79FR@--EFGmVbcVoO;=4eHTSmZ0a}`E3b5Gpo4-wCa@#a6z@`CtY`UG- zrk?q1nt^|jn%|}t_zO=ku7FK@a1uU0*!aD{rZ4a=XwzDB3bIMTHtqeNXq!&N*i9i>$*`}PrHvNs=MQm~vCC6gKC~i|;v_`uUHm$-|+(q6L;-FEgO|x+~ z-KGN>Ha%-)(`PhmYg31IHZ^Wdr@a^=I=vY zeQg@l-=?5nsc9hN@CjoF*%Uj39{y%iuitI@X*hEsWt2@tN3(5=P5H;#c>dV548G%R zO2mcnHr1S9(<3aLXw%zCwc(`~wi9y4sZHj8{`+Y~v+rjWTd{V|U` z7ueK&gH3LmsbjxQJC4xjqc$br)p>IL$EG3IZ8}xRSGA&i71h93MUc08s61o8_ygb9_~BuCHRy5(nWopSc$MsuGM#e3i7^S52`Mdsg`B zB#f(=dyTISto2pr4Zga8^;>+kb}Re0`|9p4UzOeCtHb+!_4ff^tvTqc2giN&^I2cr zyF@Sk@l~B$zAFCES2dse>cv}X{phRFUwt*x&8}s*YOwPf*)FTit^ye4YgbvjT^sNL z9)5O}#1b_0w`(FE{$STT3=g(z5lV&FH5-Ycc8$ab%n7qAPqJGfl~8Z)kmT~C`bcXPW!TiEr!rCm!~+4TgOZSC5F?2?+H`@-dUI*=Jj+NMg`-kl6c!YV6 zvS!EaNG7@f7Y&NsB_J(VK?n+f6Ff8ZM%A+_Z_x9pwAEO+WCmFkL|n< zZr7D3^yxY0%?rB@y|QcOJJu6@K5{&sqSGh4`oa94o!{T=x{ESj?K*|2-|hN@egS^k zhC?vr@zdeFemauRPZx2rfS;Na@>82&KXnT6Q)H;09^+n^pLT@%>F)?XEspflAJKkV z7U!ou@qU__?58=!{j{@$pHfP4T#BFmN%fO|x}OGRFc%h=VlJ1Te#`PxaJHX@!&cf) zYhfSM}2-e8KAKev0_XPcyI=FKYW~L_I$x|Lmt~1N<~{ zl%J|k_0!S^j1BhJju3yg5r5@W^;b1)sOGQ#YWS;eO>WVt zw!ga9^;g4s{`#T5zwAx?b)%`j_BQj^!xsKp(b8YhtvR-hzY4bVR}9XgV|#zyMWGJ< z8iSc=*WI6U+Fy?b`s>PY;!N;Y%PIbPzQ$j3*81zvAO3p1nK=&l>msgw=U4=|<V$3ye7!4+WB*9rX#ls)yb`CEpqE3zVFMe z$1ieg`up7a6E6|t7N9@P0oq~<&?I|+UZ8bYfR^HQsQ{gD1t_jefRZW&Xh!t_)u|Jp z4(K{OKtGNNP~k}da$g+4Yqt^f@?5TFhCfF2hEHH3L;1ukf;2pt9Nos&~gg zmFO0z`M8RJ?tzNJTvY27s3DkuFKF32P^%E!Cs6B9qi>*&A+lefhNJGU9D{*4hV&tU zDl#-s3BLs@1#j@-_dvB99;jYuH6l>mu?bg32I>K(jSAGY(SheXN+uI0R0kCn!2SP@S*>yJiIHGva0j>J}EvqSvT9 zJ5YZi-yF6feo>&NEDqEn6kZaj(o4x1k5&chJtEey9osNteV|5cBzL?=;GeA9)q)zy@DM)$#3{pq@j>yeHDviQhf>d!U$D!A@Ag#b16#k2xaBO>!D(?tV zQyjy%T|w%G9W^m@Unfb2%Z?;Nai z@bAueWcLi_b3MVz)rVvH2CL4HU=3MBj8(x}wl-L^)&*-hZm$p4kqyDBxG`A&pyuXa zWo!*ruN}c^cYr)j1#9eCj)&KkV70s(tZuN~3s%mSrMu@*+g7zlEr%d#JK-4wDU`T7`e`4TU{I)gPgrp(^baswiWq z5=^0bj=tWZngEMWs4CzqtmaUyN0cR0?Xe$^aNiorulmID4VCPnd`>u2xBNnRtrn__ z814+!bfhJd2c8xVRofz=8c{4%SFx#Ns9KdGR%WQ)W0@;d9$BIC$4J~o{p?VkfjuWw zDQJOX_=;MkLp2`H%7p5C*-)j{2~`iAs~f5-^+MJ9_fRdw_hF$LJe<5xc0{PW=Y=X8 z^XG?hEh-AhBPVa`g|>G+aZK0mQ{+tREPrYQKl6>BKPYm=VVNmSNh8Psp4V zrh_oe4pS_eWAB_W`OORC`dpaY*N3U`hA`FK7^WG!!<27Nm|7kQ({DJ7?4w~ihMmX4 z^aLN#`Z)1%2$N2P={=^L43qDvFwMhF^f}FVWSk*SOvO`}&W5SzdG=#523+8He8Rd* zVY&_f%gl>j_!ld$hUqR`*TNKkoqV2!@g7E)n!F(ImtpGhHB3j*P~qwan_IZ*p%spz zvU|Adqog5Rt31N>0iK@W8jP`CJchi(bsul>t53Kln8P&}-7Mi6YUeTT`i1MFf4J_U zMy_x*#euxx>YOiJ1Mv#q5nLc#CvXjwe_(Db#*YQV^)t@m237`!YYQ3$g{vJFqJ40< zCSwuSg@$V2o3JW_U;jK4U14;{5_mlBO{bGJwgLfct(V> zaTJlWA{00~LOT{jXvm)t+KB>NB9wP4aSlXi54s&>AEFMC2VSAa5ys=6V-X5I9-%R~ zi0~5;nt(zlBQz9wE<~s_24NE(qrk-ou4_lA4>rN?a)fSR&b0_#Mv?0g^1czFa}OhA zc@&{GkIC^#gtk79(0iW8h7+H^cpOHM^<17c4{YAr6DiR9ncNXBb*XD!(yGf1&24D1AE?#e39IdV%j) zbRtSWor%&m)W1MIsB|$(4WLU=>WP9^$sbYInB!iQ_TproXg*sQt&+E*wE|y|d^=iQ za2bygb0=EG@Ei8yEGpcM))sWQ7p)igilGmpwfkYT7Ced84J15`RyV9d`)ARbjkgGY z9<9I^(RzhKFQYZ^b+p{xM5{DTBG21sHO4X=!zXllPo5v5`P@ddUZe2GXs-1|>jJ9$ z7p;ki_{`&P(MnZ}&cV|yMuTt)8{K1c2SJ7y)xvO`L_Uug)x!eZfS+fKT?#V3fExwiBTpxV=bDPW7Gv7P{SId z99xVY1;i+{K#bl6$0#WzMx#SxG%YMf&11MN7NcCnV^kR{OHgA;;+Be0p3E3^bHyks zD@N@~$7lr_l!;M$yhhb>I9sdH)xqP2Xem92MPSRoFdNOTA)s z6X~W{nZ0B6mw&82VpXnKZHFs&tmX#9s(l{r2gUN7jMd-4v8o>utIjZm#`3y1R+hrC zYEvXukws(GFO@jxkQS@{Fr>%o=Zsjzmx|TSO0oKkwUuMF3*D;3%2q#CmGB+D4PrF~ zuNyLNqgZ~wj@2Z*Y!l1x)Uj$jJytXDenzYo&WzQWt+ATAGgcQcY*(zNA#iuB`s^W> zy|LPNB33#XtBu%?UZ-MJ_Az5|`$?>dJ&o16=dmjEB35w-`5Y_1FFeK%-(%GYp>A>d z8M)l!6ow!}oD%GD>Wbg+H^Tkml#KNl;vc80h|3kH&e)2}sF*uW<54CcPK$5^Z=gJJ zDuMnOg>R^sH%{MCF<+eOVr2d}{fi0_ajK1dxEdL!$EX_>r&c%@9Vh>|IK4*Oc;>)5 zoJ5m^IIY2UWF^L_SyG&?p|B&4YtC`{2&*$rDJY9^xQXZ3l+1jE<5a3hoOZ#xXq>uZ zHO`}Uu{h1f&=PS9NQqOs)HwZ#7HM%xOD7g8X2j_RY^CDV4WG~=lYU{gD^6dt;*^n1 zZl&XRUc{+E`8YkpyNdLvQk-(?(Pz9wllpNwi#sUNAWoIgv>`pl({}WueVnp8$7v9X zbYU!xA*x%Pa(AcpL2;Uc{|3kD)==i28mH80)QWHTYkHh^&t*H-&5P3>l$lRI7sRRe z!Z@AS&i-BO$GY9@N0~kB-y5gK`{LB$NSs!o(a|_{M1f=U`V_aPSquD&31{Ne@)EsA z?aQnmo}t2(IJLjZx%HL)!uvZt$7lC=UUSFmDZXH^N4#!$#`7JLc-g(=M8sBe`=k0h+y%VqMcjFcEAYS#c z^|A_lJo@)v5s)dbT<2C#nc^DIvg@dL9_4i58Z`K5P=1b5R*zzanL7@bN z1SM!daDq}o5;Q9!L02$3GC{LZFDgOJizjF+3Z*5e0esUF6oe&kFO{Gzcvdk%QI!%j zv@-KmNzm9P2|9sandk#A0dF5=%630ko-L3fb3IzdlSX;*?qB7Jv)D&ssHdlPgGqmC!&DEghC4)~u; zP^VJ~`r$O={z=g9xO0s@Tqln^^Z+^c5>)Dbf|fr|(B`iRdWp*46L`NYL4IzDYL5hu zM0N5@)EfNkpQz5rohwlz@c?J?B+8aIQG0O~J@O^$3C8D7)TiJ?bqQfiOrk!+6q~5% z`iUBf)JBOKhtACsbqOz9Cn~2+qCTQ#+eE2dqH3T_H{xMUuS5;*&G;#a`V9#)6V(od zW+f^S=TL5TqJBroIf*KdB6G=cL89UoCMq2@;J-Lg-v=HQ-31MxofzM6Eu?_~VHRI!SG35*6_;ac?Bbd^1s- z(fC%PqHZT@;Un^ROdi%GrP`8I4sVcYPvZNzNqXd$q)B;_^b$?;CFxH7Bo!}^q#V3J z;ey--CTVC;l03rM9+9NFkxBf#PEz04BwfNC*bTW)$5ZKyCF&KHYMrMz9fx5n4~!KlQe2d4gc>Fd= zvr+b4lBVM{{`ioj8Ey`Fx;vDHwFZYuc{+3i7ctPwp}R(hUcIP^pL{2p+n;uGsn*k<-uO~H*u&u<~Jw5 z_6|+Ld{pc}Upi7tX9xeTIW(uggWtWG6CK9V!*R@kTI0!ahJ*KA9jXE2EQdbLb?Ep! zhyKCX`3}8bM86k1^f&q~aVTt=L+{|Z+`;Ef=)qctEE^rlKFm10L(8MogvS@?#bt-S zVa4ALHM-)^vFr5rmP5JUJJc4xAoPPnO+Pwx;gdrzzBu&q8$H7E@6;fta=AHG$J42% zd7NsJ*U9&3oLmob@?9FI*5!BV#t%-V201kWb5TCnsgWU0zWeCpvztz?*ElsF6{DOQ zj+*gK6;5(06Hm~_;nWXc_SC*R3tJ91Tbsy2@Pz)+iG>Nqv7u2ZM#Ikl~kQxUD0 z7w=j-HM6Z#FYy)2+Y!4xu{%1I*oC?9wX0LJx;yzhEKarU>Ev@<^aLG|zc+REamv3R zaRw3xU$K0UQ!zsrH`J-8!<}k8!m0MiJCYhlIkjlCQ@6)B^?009C&xP#Jb`{-C2CG| zYV{b8!+^k^P9r zSdAYaJJl7Zkp9G}OL&KsPn~i+Be&;H-NP8SWM#T1>qqQ{r$;j12}suOe#x4KYW~S; zf^*21J6Xd}G$>hRpx|WLF$jl4l2t4;SrcNDwGa*BlGPsnA}k?U6VbnLvc{rZk!01u zQTP^1)&PvjNY-4`DV40&xPl-T$0Md(vO1MdRzKXuJN!|Bd@;UavOXfaa z{-2X|zDcq+Hzm&&$r{)uSq0kCr*_GFR*L#jvqQ3e!*f*Vn5@T`(}`GJl9i6XF{*2_ z<|DfsHS|o@mp;kr-8Wg&e@#}Gf%Ff5;1Yfql&pjy^cvlfFqA$`OV$gxPfu1ebjB%^ znnC_Ei3i_V$@*n>veqNtoMbJ=77W}_R1Kb&(0trS{ud=w86$84{x3_YB8Fl+ULp2X z2{p%ToQKcr63Rpmti}^WzA2%Gn1Yiqye*-U=z^uVg?#Tys0N%RN-DKvN!3j+sfJBU zs^H<0dXtc%=)@Gh_m`qsxQ^hY6g9zITtyy7irQfZY|a!lz#ni+PEl11#w8RfpTgh# zNKr(E6cxpG+=tE<+HBV7?s}z-KlcJ$0-Zn*L@dR_)rRX1wZO{D3 z>X4$3DAqAWkMIe9c1n?7cjktBj}-Z1I^Ok6(S~1AbZ}IP45L%D8HZ45Oo~>FO;O8n zDY~;HMS)9G)Mr_Wx-C!9ysasGkBazzVLSC7OHsk&DLRcCXmKJ%`%b2)@97lve@sp2 z_#}n*c2nf>ls-L6;ktH;zF1OK%$ll6wp8u(O;x#ksTzzM`BV9O7^#}(Ox0N=7EaY0 zd@Y%(YALCzT`E-*@H{hB8(gXSwM?qc<6+fQ<@}h+zvrp)uAZuvKcyrsPZ0)ZjE-z_5@sO+#R4n)-yLsX};~cEzTt zed#oJ;B`SXF$Cwt=pTX-uu!te}9_X zZ>1>{Z(z8crV+S*CruOYrYYlDn))H>d74V$AVOcJ=_c}gPg4!>ml>27bMT*Ax|X`9 zE7mJrt?`2~U2#|sn|C^2Ax_u7_H?}qNLNyxbdAoNt`hmul^vI^K`0WRt{fagRARdB zqkVe1R-$1>x;o$ue#}hQ7lc$uS7Z2BOjjtD!?QB;!M%FA(lFzvbXBQAoSMWz!&=0_ z8~j*@yy~XQ)IMEj;L{;ptvaTwV5f9BJEyA?Lc63Z8Cwz1jhrxbXu2+7*l+2YhV0+d zb!9TgO-q;CEVj){*X{-B`igZ6)3pa>7NzsqpLA7SlCBl2)Aax|*N_t&YtuF6k93t> zm#!n*(&hD6y0+mcs%}r$>K*B7vNK&L52vf*5qkWI`l2$_5_6+7^bKcXGISFyV>9$J zE<5-VkBf8`9-shXjr$;?%)l;&766*fLo+a_eH z>ZD9QW0k4CQ#0i^JyXkOWGa1Drq0jKRO`8!`aUmHQx{|^VNs^`1iDl^$ff7OF8)rF zi|Z3Et-vE;q_cPgx>XC8i7&` zT*}{^*zjrLQUTn;hW0Lbb#Td}BV+Lno}HKnL7iP{2zwWof^h&TU0wWp>r#t8E^Wi= zzAj!vx_B?cCFfw5GH`1cV~4wR4!5ylgiBk{WVA~=aSTt!x>RSJOZ}$1^cWGdT^fY? zi(Q(5N=sa7fV8D9-UoMS63T3HsTNB8=~9=YE`D!tsp&D7x?;+4mkQr>X&Cz7c4<30 z-f?LFI^T6E=Y>myQS_xtrQ!aHTHd*I9OFN`bP9vMxHJJpzq+&vY2REb>z<`mxN6Aa z^Xpma<&mXBc!a8+S$w}gOAD|TUy!C`+AS z3CdCsD*sP#mY!jEWR~vX$EYm5kIqv2m@G}iNtBJv(gnOhAqU&>9k-msDV)XMv&zx{ ztS!MjC{i*@@u^v=jtiy8E0er%9EV(4dV%g)S^68X*;%TCy*bp2@ujoWu}qf2%Vo)l z^cq=ehC6k#6gG+4(0CU4VfdmfO+nCl=0m-$St_|LOZ@RdS#jfdmi|4-m{VD*g*7O2 zI!i0hX6Xz%oXgTcZ1|t^d*|56{m!G1kUDgSeW^}y+yS$cNBqgZ^lw!x8*t;%STn5|LB zos_L8RQn%Cwq9Xla<;}7&emqQr*jN4{wE__*Wu~PRy^L8%hr?{*_v51TYC^!D_iMk z^*^<EH>fO0AdWz);G9DG9Su~&E{_iWNX&^Y%RwJ1*NZNs~rYo)17Qx#nT7b@_(4Ej?c0+ z89%+uR)75bE?d7N^&>q;=vVT@56V$##F=tb4Xw;M`uanT!V2c7ZBULTqe^^^x+6V_ z{kV~wBk#gFYE(2w!!fyJ4&PbHkym<-9C(nKBR^M;4wcQ(OBAS@qfAW4KD?`zqaUj0 zs2k>>WX&8k#unUyU!5Ek$L)GKveeJfg2p*IjPXr#_#2Bka<#m!lDjbMyy{OUM&bm*r>&TCL2{1k78Pqk{-s zpQExkyfH_|{-mF`bCiTK_jA-9Z{hWTe*VwH9G$_XCpijun!|h9IckU=Sc09fe;_VO zf6P(gPdU1Xl>ev|E5GN+jaB|)EUktASJQofS53Zs9RIP0Y}pl1P?juFmJI(uPfl_m zNl#D9JOc%aAhMASihzI=go1!TOWCqSrYzZ%jm+}0DJVmfJ<9U^`d;s!>-t=2PV(Hj zpF2q}nv*;!;ZdnKJhJf_CSVng<1vbr@u(5nV<=`}6V8H*fU1lb^urA7#BFqX*Q1GO zUBjcVkokc}73z3YpuR`-aj&sQQB6Gh-0RU*)1z)ak36v+^~AJx9=#UyXiCVVvJsCK zb@0gliAUKxc~k>Sx_eZdepSHhx>y)I`D-@chPx(M*}hMUjsdAHprusgFR|F z#G~(U1{H@gk5kCN%3&Ve$8W=l^QA}Ws6NW09AiAXl1N_3)CSve9G7q=)uT%DJzBbm zcKBtnN3q-3HZEezcKW;1qc`^Q89JnSlybtOJt%R~qsFH_>WJItJSuYDqbfLafqA@t zg<4}u260jNDz&`fQImVr75nddbO-Gpcr+dt9(k1QG0V~PiHB!K`3z+;**Dmh#ZcZt zhHAl6%+P1JQqs^9yj2RN4edasC_{6~7`pJUvWAA0Gj#4fgJ-P`uD`GjQY=G1^7!4u>eVQBByhR&eGC_^W`6!4P8acqlWHc)Nh8C z;tpQm(Q!lDPSBrItbf|jEWAXKbVH5)b;i(nG&@U7ls!*7biBy=Ncq<#Lmyq{b0lA- zKPYmIeSqq}llvcR`?{fmH>fNA#@U;OD&8{G^)Ex2NVsEgkF>#cEBbTKU`z=^w@~k) zp;j31h&)m5F*%_El=z>GIiQKJ-i?>>P)dV4&M^K*!P;u;o)z1ofFh*upj2FtMncR!~89lg4QTAkP~ZlH65SAU{v7q8l354wFy zF6i3TtIFNHdfCs*nBVxqt2BHxz^ieiy*fD7t8Ws$eDCVjoEctC-R{-4o#emEt3?OA z`u-F-o+joQuPU6U<`=vwaGCz&n+*0Dj{M=(@Vut>6)?56f~oTFnEI)fskkPl-uuYp z8nr3!e@xxL?53vTo11zg+LW)2spf4>Rq1T%W^YrEF~5(g5`9gD`34hd!os8N0aB*P3^`peEXfL0y9iSVH}G8K>yHT7X3xZ*(Sfc=-V9H zqIWWVOQFpI)>%wm_-Ki#EK5zjgt5%jC(BLs!uge^4y`h^WWA|D8%&Ksoh_z*hrP|@ z{%}*dwwtQE(^NE;Ao$h(*P5K1#uYaeyrPt9@m zkf}b0O|3s+>Yr28;1)1AU0(Z;~DW0 zc}~t~^n!k2KYn~kj;}brQ2rlN!>}G>Wa*78mcGP|td{m>v-rNoQbm-?VQB(>$!V#7 zE=#L%Ah)IZc`T)(Kwe8<;4jx&|(Z4i|_s|Eh}Ov z^17w&MJ@e^J;f~*D?u!bD{1L*DN9dFTbdkYX}}wnvX`+m9Tm%3+JN@uEaiFA(j^4S zTUvs9*jIsgZ<8mYE0KF;ON**nTEwr|O-Z|Rc;mUd%(w8h`{^xw496NgdFvNREY z!S-2Nj(jaFeU2ko)zVTeo7`PXZDTAwK#N#Q!GNVRh>o-PThUUHcuRiV!{XMKK5S!g zy@2huC1yL?w6|0}Xeocl(lFe{fe7(XsssH;?8oGcuAf+{(9zOE?CE52?aGpi9!SJ0 zoWOk)PO$U=T4Ox+qEZ+3BaWfkrhjcU_ZfOcejj(hDMZP9i)E-UE$60!U zh2z;T-%=;s#JdwL^}<0+HIX_^vNR7DpzoOC7B)_{v?GaQW2(j9Q`Bx6wfo*u z8tPAH|IMIQGdW&o)4ybkaUrM+%B65j&$X14YN_BnOHI%MGk;`$DaSEREF;$y>^mG- zX{pao9FME$4^IAU>C@GgPNCl#_RTtKww`n27iz!JQpru0#%`fsTiG6Z{c16O0Qur1 zt|N9EIqV|u-IfOJu`~w5_FAgCk8=x)_Oq`JupL}HXes9*OWz{<=%%HAkoYIZ z%Wd*Oy?Y!lk2$W9?+LNc{3*wDCbfCaxrVMUIJffo7;nm_()oRAi;e|+8eiO}rX_s( z7W1NfD)yF7bt?Gu6rJDpDeF5vMJoB!uBK1l;3#(2@+lpqYSRWk;SLJD?^6Qu*YU}~ zgZe%-YT#3i4_OXhBcIAQCO$sHC_F}~CO%a}U#xBF(|!Ddw#|Gx2w!ube#LvyY#TKU z*2M-qM>DTaV{rsoP2%HIEW{0zvxtQx{Dxva`h!I5!b^PE!l&L?iK{5t(x(;}g}r!= z`Zn9e2E4+Dj*oFLeOiOtsNzyHB;zbzkMYUH1nfl?zfTR(2a9n5MPhx5#!#%oUnn2& zsWlR@6Aw`>j@X!kE`41LeZRK@yIjXoNa- z_Q~qyQpwA zBwKxF+4>osX4~qAXK0{T4zQ{ZSdI#+YlAJ5UIhNE-1 zi?3@s%3a@)flTCS;Aj$Vf9P-@yQ6!}9o39>l!5yg=y7-#lcOzOM@4K$G05gPdL1+I z*mZO*#!<5bN7H)H9vucaT8r_6932|Wbf}|?xIf%ctr3o{;sFMI>FD%Vjz*4jGW6 zqjX34GaR+RD-^iuXe#bqbF}Dphi8Hvt;EMS9rZ?;TaK>Zcl5(UN24A)a-Q;8CjERy zyXTH(zi=2^)6wC79PXcSH7Bd9CD~j}$nL6V4p)KPt{UWbRjGihl?7dGEad8&*IgyQ zd!i^j@5OwyPm7f^@-WQRa8S)H?gA; zv6{O2PjgqdqFuc*TrKvxN;h4lTCOf(iqF+NRBqvFbW4}h?7j46yl&i4s2$A3;E$7{9Ebguk>*nZPHv_M$$g| zg(~}9jXB^d`k<@Amt48Xdf8PG%)p~7Y%_y8Tz8e@hRglZuJ*yX>1x?6SFQh~-*;U7 zgVlFk#!q);-gC9^KHGiZYTQ%WVsNIb@hJ4n)#uM$m3qN6ON^EwoHa&0@DTp&F?xwY z1!5FcFh;Gg10@Q@s2TDUj?rB-C?3N*2V#_hemi0``ACfJoQ%;T`Bg28UkwmKS~kBP z;81qIis$facy7PO7W3;mnw9V?wxnN^aUJDK`PHVhUw2U~%FnoJe*N~QUl-BkEx$Tf z@ar(nzU^1h1U~OUte$>t#*7LwG!x-30*V|2+T@>6GP>%fpRXGq)(}MvuI2lm!^nj{j z_4$Clz7Wu~%K@#$vMX#SBcO?o0-Bu}kmp%IJ)Q?t$H853YP>s6Aza)Or@DLN zvhtwX;V;nw+7V|iQ9tO zwmqnUX+cGu4C-=5P>b&emGU6SGZR5=%odU-dr0+ig>(sH3WU_6U`T%#3aN165a%k( z-U%t)6VeYxNK@>PP7Ms{{ShG*`Z6RRM$8Q9{G5(x7m$<^Qq{R3UBv^uObw~_ z0^;KmhA#{$|5E00V@*hn)`n!^4?JHNQjPT?jl?9JL-7qEIhcps8$&7v-!dgFS=8j3*e@dhEr}pi4G-%LoJHl)VI`o{n6RqgFmj9y>tl=?PhZeDF{~k|F)^$r$UiB}xa(mJ!mcS{ z`I5ri&mGn|>`D$ROG;R4u^WTuhBYZQ%)Sik_&oYIpLK8oKP(8V)$*{W!n-1@)_7-S zSUJ~*^}#P;#v-R)`@-suh3Ipe^`auG|5ilD8%9*MQH1~JM-=Q7QJ2mUEkOL(h%h`x(p)qFQDRQ2RsLuI_+Fgj~Ow;_+Jw2a2 z%))Cpx6WOYmC678EC1oKE@LyE-pTi(SJK+;329&Nxiz>}&Az49J{vM;$BMP-|81A; JzYYF>`oCoAg6seQ literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/8b48c4906cede63a_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/8b48c4906cede63a_0 new file mode 100644 index 0000000000000000000000000000000000000000..77e07e8cdfae017f2f9981bb7a752c355ad7aec3 GIT binary patch literal 35328 zcmWjL1$dKZ7sm0sN!oauHWY8urtT^3?m9MHhr7GGI}CSsXSln=HXMdCT!+Kp`+r>5 z?`rbCkDPO!CnfTxzWQBOWNZKRo4=%D_&HPXdwwWAXUUxTisvkoqj;GTxpL<%nJ-`I z(&;5jQ(epKg{~cPaj+Q z$=u3MyKo$y)_zJx4KzV?8$TVxMVxEvr_^?SDuO~?{nWd+pGKf;Uq8L*=cfVv{WK0k z1~S%gKm9g}_z*nWPySQ<rv;WpQgR?)ArYX zI)Y+v{8ag?pT3$5YU*#$A0Y;9bsKaLPcs;FB-EhnnGM>Ey;%&Zo7JGB*$hewGpGkH zdJJkAVbJ~(2K|ZBB@H@W+Mp-p46;- ze#hGZ%sbGa+=C42JlLR}*fqo;+faji*fETpU>IRgG3>>_QQRMGP~R~Iy&BJ4XgGmb zCmE#41`WoFDddbJQw<9Ijkxh)8nI6|C=YhyGCI#TC~A&D1?CyFcD_M57Z@}gQ{Y-; zP~uX9GOsY`_DX}suOj}n2Ia%Fbq1Zm{`CfR*uZ?qzR{rbxQT{a4Kf`x=oE4tqAg6v zXmiG(mlufnxMQ|5VL z(BhW{E&Z2V-WhZsG4H9(M}vY;0&8LV%-UfPR^kz?Uku8KQeSEF%^>%G2KB>L9Qw}w z@iS_f!KhP4qcR2<^^4i40~l^GY6|XIjdIzI3PVeWQ8fdN>VQy}QC|Fpk0>8(R69(> zW?aJVP@^uxo6)FSD3ZyjX_%kcsH$0vdWrm5jp~Na2+L+vL(Ic&49#xT=rE%Ogd24S z4Ln9&fHl&n^IoGSM{yj!IHSfU7}X`2+i6BU@ELVG-KZ@52ArGQsJFP4$EbJtjY=tC z)S!Y!H7ab>IV2S|>J5e$Gin|FK}vC>#$h)4l_18FM%{&{H0Kaj#;CnmRo1Bc2rXw+ zaa2LQ@9mX4N)oIUZn19iu+gHELHAqn_d;rZy#xX5`$`s3xt9n$X&)L--eu z+8SkUXVgFhb}%XiAWMjT+O7HR;Xz_cf|-f1`dHXw=_> znQsXDWf=d<3^%G5I*v4|)o7z0!#l>PBNL6vHHrQ5f4`9fGEHL+Je|(%8Ai3AW7Lzm zMrEC6R5P5L&lro0id$+_j#Wmr!I{-YRbR*W8;v@-*{D%lSi`O4xXq}wJB&)+MGm{k z6W1_$ANy-RaU5s8E->G9`rb6E#3SNBKV*5#UcrPX?6s%N^_<$^BU-&MD&I?^`oH2a zfVF7;-l$0*So4oY89y1dz+%z_t4XD7CN0BqyGg4ZCRv>(Jq$Fdr^}>`$RBJ{mJpMY zktr)bu@gtLo3!0y(m}6DchM-?q@);=ya^`dPBdu;dizY;lf$ICc}$vC(4>-uOqz(6 zg-zOvB1KF(Ud*K5%b8>;Z&DXL!m$eUsbW&?swVBiwx3O^-pHgQjZIqL#H7QpH8tru z{F;#m79nGElV)O4OOuu$t(8d?+L&~p9dos(PY06{JDL>HiM%_TRKJT!4f~QqKa&a$ zFsUj^4>IY>P?J^;GwC|Aj39=QCSAjYQOq&Mq{wk5EuKNnv&au0kUra_xi|^;9Fw-p zHL1x$#zvb(Ce6px#U|xlVp3P^!+>Qb?MJ|JlZ-2wb1idV_hys6;q(^jzs;njhfQjC zlsqq*l#rxRmZMQ!alk zE{Kx;Dp|!}uWR`0U_E~gYv!*!Z8+AJ_V}rtzZP`x*N0C2O6lyc);Qk9Uw69u>wIs2 z-9)ZF{yK~1ef{+n6Z-ips=vQ>A$6d?3c)wXU%w6Z*8>zB!aSIahC}I#62ttp9m&J} zwFntT_-hot;KOKt4V~z(uqot&GuS!RUrT2AE7MGW9YOLOe;MbJC+eZ;Jbw*Y;IEaq zjj)BpjM|I+m9WHL>o)mo^nUK2^4DK~_^Zud{_?v*ong7^uQAvC<-FmqzBrD~H~sYn zb^oUJ_;Jf$^KY{Tcl@>Lp}!iv@>kyf{54Ji8e)@9XpwoDU@~Hv(fWc`2+Jv>f0Nuf{oB?W_J3wD>EKh(w=41T)0jgUdKrsaa zRIdmzRSZz8%8Y}0)dKYAU}75`pf)H!hPdDwOMhIM7@)qBh-pQD@~#X}>Z$-mtPaqW z4FT$~g?WAtP{|zu^4}An^n(G^HbCpq;1+p53D6>kSqq(J_0MY7H0;4s%*bxm@-VZO zdd&I@b0W;D6G_`BvyR~+9!8t>FJ8pZFP3w0X06A$c(ZQeTY_1(M6+5Xnbi%GlFgcr z9Vup&PBrTS{>GFvvlifIpIMFIN;fMEXK)S2bC^{%r&$|voAo}ASy6e37axn6^;2=P z0!x^+0(X$1q*=e9^U%hb-SXZVCZ z9n8D{Giww=I+-=33-v})SF>K?UN>UvVOC5}v$FJM9vtdVJqDVUGRUlIgUxD)%|qxv zl-pPb_b{^#j4;bM(yWZ5%t{+$R$KJKC!8KjJ;t#flg#QcnLRU=`cLCNR^T< zSzMZJR`of=HP_7V5BADDv$ifUD`=rv^Ol+wx12h{xzenPYs^}*mHKa^j@!+eh?Tg9 z@jJ{i>@+JgE@1wCvl<^Xs|S8PWY)nW)clxPeX$2UkF$0sSWg@{#s0-z{C3)`k!RTl z=a}=nS;hWf5By0D{$hbb-zj*q+Mf8@H=+ippG}$JGa=A$b6eML<97~W^A}) z))92P%evs>eR6t0ZDD^%A56mmd_eVo$N_pnEGUeYn1~n1_SCF+WO~EiG+5+sw8(?l z0E_0~E-IKU`WHbqi^`$B-6CtCMGIXPJwg9q&V^Vs6}Ai(xieYRGK)o@yo?uR(GPTr zu_!#wqHXvk&7xiyj#)m72Buq-HHSsxa3!Zj?@=$8MGNv;WY1?&W;Djh{1)XZU{PE2 zg0YZAuTiPEMJjEP6V31!nwDWs9LGiMENju|a^zB;7%EwKJX-X&GO<;$sLxLpb^F<( zpQ~GRqn1S@Yg=>xXYmnr>sz!QKQO0(MHw1e6p4Ar-q@lSO)Toy)S|Rz7B$3md}?k{ z`F0k)>1vT*H)275q;;o;JuRw<`xx2FB3EyVs`s(zCbIUUu6Wv?J_9V;IMAXzgDh$_ z*rJ#ChSftXDn8VrQ@Db6=st{?hFg@5#dwPrBP=?No+FtDpD=BdMXg6$)B}NIs3*qb z-~@}7Ok_TsMZ-zd8Gqv6$<$~HV<5v+i}vCa9%1uuw4G*A2i(T6>BKnGqQSE)nt(M( zo^8=pJVu>4+@DJs~=4m&N%yNmUMakoXKPEqUAtPifB z#~J3wPSih3-SHKZ&RLZ72X+3_qEvMIi*>kYQOU~|{f(zr*e@vYkbKeXDRDnzuRUjN zU+`GLz?VEGUR(4#4&gTDzoAYz0sFu7|H7WdU3|yvueASnYBE0N;5ItcqRzFgno@^3>oO;{ zp?*E9EcLC*jMI%7w~1BLTUfOO2T-l0RShwr4Y{=?w|3-)9__8VjQhym!K!>6ttySD z$luATi2l@gfK_8rV4zijgBTBI@f7_ATV)Yt??t8)wyDm^$97y%VjPHj{P3 ze*7}as%CSn>O0q}x0pZAs`VH!pLJY7oQthGg7({~$1ZZ)ZPl_ptifJl-N$~xLTud6 z*!X(Ts+)(b>VBBmj##x46^>f<0tv^dBeI6uKeGQ2^vS9QXanPCt44h#wr}ju@3ir=sj0!H&Nyha={%bF+jJ(trom>LCg2E) zJ8en~vdQDJDH&aH5B-8|+LF^4P4+O*bd(@s>2 zvdI!-Qz%*>B#yDs1HZ@HbO`wqY?_m3(@I1p6C=K-*i<*wrj~H}Y+8d~(rvsSWz%@1 z4+R)m$csd{DQIyvC5`Ct8J>Z zhT5;QY0?&(=3)QutR1>;v*{ZGb`skzn>y{a$$P-2pV0{A589ODuuT!iZMu)wsCj}q zo}?}MBkUCOpu%aJdY`fB`B|GjqwYECd)}t47pTQWn;KrSsV(lJ+hy9}(-oVZUbAWM z9h+hw6A#=^s3UgZ3rak-X)>;3*mIleytS#rzubODE#EU9+#hVZ0_#VcW??zze`5U4 zJ)`UjkFo1>tX(G)?Q$mDl@<9) z*wq==P_U$35U18W&kAC&-I*7N;?D~Pm&F$&~Z!5d% zVl!H|p&!b%v#SOQwzq3Ca(1w5MJKzyqiScnzIL_iYB#$Ib+@Z42Eng~UCsO3)g7Jz zc6}IZmvM+)y@%R068^*NDvHWT8*W!&yulBQ8o|7y?Ye=aF?O}YDm;g8EOX#AT8y)6 z2Rcr$YsMt{z%tpcy*Q2FsdoL0_ozJ0uF=zJhdncxf2Lgvu^w4wlOLL5{~Wu9&LvOy z=G)Z?18{5sV=uHTBZ@B~M@;zt&&77_#z_=jN^NlhHJ95p4NI_ggkeKb!$!u!8tlZ&P1I|%UBfXIN4D5y+Dfk2h9gMWM$OP2 zy|%MIcG&d~itS{LF$$-4k|ORB>SGfALGJtP!w0N8IzFTx|4>65 zened!vq#YGiCxv6vWK79briXuGaib)u`;bG4t0&>HtymjZhH9{CitISIePJwH>n6acBj;)OTn=bBD&_ zb1R2xcXntSiuG{ty2+u_sL;oul6@W83cvmiwHxBl_K^++O>^k$LWeRhrans?Dvu$! ziv{Z(dWCQ3u->5qNZ8;|Kb%C|Mu*yLa_9=0ZgHr~cE;I3&CmmXqvlSB4(*}Vd&y^? zLk0I!mjl%LAm(+>rij>J4ZW& zpQj!d9D0W(e>mj()1f2S`4{nAbZGY_*5tB7>#_8vL!16~sM0Nm*5Ju)hi=_rE$=(j z=mGgXb7&@(q2P1ke&J9voWKW|UOLnYdvO|hUpX`w6Or+?LoLt^kCFe4LuGLsS>947 z%)x7XN4tL=+JzG+@y?;iSb!|=9cqG3xQwI^jD=yY}H+F&H! zqSzOQ>|YrZGw}%T(d`>?;S$RJ$2lxVrSH@O4-HPaj83)2ZhSX6mCxU)QMixl0ZuK$ zN2HpaJSTK2r^TsZc#a}gr)DC~=2R}U#zF+zovMS~$mMWqDjZIy)&x2g9^}+z9CbOB z80^$sxI&ydg27?*4|giS<5X$v#0Tt)aH>kAQ;pHV>(oD}66MqdJVbo7Q*|*6Q(~Oj zf%_;L>r_M>v11{+#5+|y!Ko+sfV+vrnZlSbr#e+8&8e@b>SK;{rM9Pdamu^SsWe2aXOF|Rf&Gsch~DVb5S&2JCiW11-RxBU zE!26dQ>T9?rtQQG^G@oH&bz4VZerL&t@jf9KBrn7VEqsCxHv)lSaQm#nrGQNSbvVS zxa3qMD!}hD@n8?mU!mPq9y>Rg^KartnOjcYUv(-5v+)ORVeK92iIL!j>(N*9(FA25a^}tw%>spcE0PgZ~#Fs51$Hs+kxl zQ%WG8p#&;_dZ3Er2vn(@fx3$QxdK%@H!S_bMXnzjj4`?i5<)Gknt_JOL7DLB$0P=~uRH(GZO)N$1687O-%^6bt0 zeaNeCpa%C3lxHA04Wb`DW5VD-B@U&A!voc8M4)~d#at*bHc+|8acq2`vP=l%@e`;O z2$~qER9u`Cs2Y<4^#qHj1nS*XVxJbMF4F_GY(}7}%na0Bbe|Qdn{$YFZlGf41uAlW zpf)TZ&P9RhwmDFK+sNZ^p!S@g&L;zvf;WE=>y1DSy%nf);X$ey7o@oQLCS?p-GUU2 zA=rw8@N}mQnj*YMkdkl-BYOtvH#F@Pq!sAgJ4gc%(I-eL7zShCAi0phjSbR<2|-#jk>gW> zbZ%;pmP`*)%NapBHZw@8W(R2-3e5@9^LataK0inaXn~^$UdUWagH#FTWkE_?8KfrI zfdi|8bQb0{%)Ks1N7e_a)8-)E#-{B-TEBzyyMy##Uy#Zk2-5MxLArV*Nb8OU>Cx#R z{rX3c9$uyvH-c3AZjkam4pNPmL3;I$Tt5YA+xuyOb%$rEzEz z>(XxtF6ByeDK?F{^SHDnFURw_bQAmXyA)m6rKAcjb*<=9p~@~*`^lw}zqr)Bx=WvG zxU`|BOOdsRwYE!T>bZCg?$Urp^lR+W^CryQ%q4Ggmp-&`X?aVRo}pM9mk!_u^0y^7 zY{YHEw{vM2ZsT2hm;5@ol-${+UfoC(U0(95O&db^Z!fJ;LLyL54= zOLwt)xJ!v6`8kFh#=6vcoJ)rBE&+zje>ao|QNjQ(BeJPFacTB@))Rd`(H_sy@v}?)VE^Lc^_xo%Q070E&SClw zmp-FkXs~wT7%Ulsbv#qBPGk<&C7jI~tj6KNY8?@*j*-EN^#!$lz>0b zp#WE^9MQMC%F~s=hk@4#z}))osDk&X>u#c->tjI7T{Jdvs+)`vbc2x z2CG{^*n(*`x8`JUt6fI7HlleJx3*_>D?>K7M&dkPWOr+Am|Mj>Zly%H)hyDj!O@6e z?l`yJVn@7NnG@XVgj(|Ico`n`$|n5 zfm^8!-8zG#joj+_t6O;+yOrLQn47zG4lP;`Lrb?tv~p|l2)7c)xHTE?(QT4j|ITF0 zS#H(GztC*AN?|e6|+1LWH0))eI3?^bEdJK$Eu!<@&8BW^W4#vZ}wlWyfW$1}-zE|dJfXVMHqX7%=F<~4X`{T!89i?Kg{W*sY@S=q{DR(lj(o|*Sn zGxIw?v+8EbqBHSXcsyj$lRQ~8ylfWDs*^>YK3SCgO%?@r&o0xN>?*K6yH=jauJ0$a zbA3aYe#VCUVaib;Ol7ejXRxMVn5q;C(*@Kn9Hv7kUnERjiiW9ru`uN+5ytiUVcJwG zOgT%3sTjuN4g$)A>0H?`Z7v_C=n7$4k3JQ{bPG8uGcM|*^3P$ai-I*68*lKsX_!j1 z4pZ+AVanGvObc-xq20n1hxzE#JxtYlg=r`z;~QG^CT2wR3DZVY?;EC57}YOKbp~=C zgK!FkhlVNFurQ?z4^sjBiv}aY^bu`Gg{c>Iq2=f>b;DL%8xy8Sm@zg?H^+r3WMY`c z;vQaM`lK+upThB}VO%#9rY&&%Ms2VV50N}AOwF+j|6tX0`Xg)xHA3#0Vd{ug*f%Ro zUy(FBOn0$p4(o(EbBPU^=Wz_lOTsj5X_%HE=dv)BUQYZluVmfuWKEbpAZ8usu@kd4 zg=zE_a={0L{m$C&2vaRI$4Qji8>Yqk!!+{%{SJodJlY*%Z4Xl?G&~ZfR>#BC9p6rd zDg2Kx{eoX{5hX8$DeDdP1;*n9hTaU*USz!$rg_+mb+^d}ckhPj)4ecd_=i{?g>lVL zn07p+{j)InJr9%j75&ls9dV=Ddt&>*oS(yZpE^v(zq4O{kY_}=nj>puxZF|UYK^@} zi4Ipne7M4V;p%|P$Wl36=c|P4$WP%q`b)SB)x(vi2FGiLt9R{iZEX~;GL6G^4Z%&q zRiJ6O;+lo)d&_WbZyT-!?ZefuL%8yH4A+=W;fm}Mt`=Rxb+%i$oIMx=O?ri^T<>sw z!GXTvy45dS&+%^96s{qY!}S_LQ^J*fZn$!xIr`%e zGR_NE@*?KK;l<(dEe+?hop6o7aeRgUwr~yG5w0_*$nDQ?t^o_z3KYH`u6eh^mHTzL z=6XH)25+=SX}E;cIFA-5cr+lco z>K++udbpm!qm)`6O{(qD_&Of_hrjD`uD(Z|;Mc&TN|@QuqXNHr6w}xvLlcj3pe+KL zdbA$yW*$|5w>kY#poK>lTY6Ndl}Fp5)*cnX8~C;HXc@A%^{6|h;1d?L^JoKX?L8`m zX}E)zsM>+}a2^32JsN{WojkgYDV?bU%5?E)9~yP_s6CG366SaF=m~1~pbkAfx`vg# zJaYE-C>!qf@hGvcN6m1sAMN{lv<5u~dbAf^2GIvyhmzYc>O0({ER(p65x-H3=^kyt zKR7m%ac2=P*3Kq=)SAOQb3N)f&!eFE9z8_LB99^$a}L*FUEZIge^y^vHL~qZ7D}aaTN=h0@o^`8xX)n=tzhxjmqE z|FAb6dDIF?Ps!~W`yXSmAElprxR%PJ(Qjz;mfHU7(JSoyz~24nQP$7w`G5$n-;U5x zgjph#-5Q|;RI^8DQ+R~xCPe6Ffe6`)MQ9JMmWt3r#FmfHstOU>hLkE1d@qsqcvmYz zezhai4TbAQr~*nhj8M(?%+V=Af8t%22!(WG9F*)4!8Ngr*E2%yKD6%}p>q8qWb9Ad z!4axGG(ulTMrh~~#$OYmYe-y6eCr}~9xK*I$h09swv7>*gO!-HDMI&fVsnHlZi&!T z+(7Eq2-VmYp&~mX)N4G2YnH6EkZ3GM5rqQA4YIpT7*`k)Z++s!gJ(( z5}_s72*0NhI*7*4B2@Hwgtp?-iwNa@Nj>lh-(Qo<+Xy{D`;QUYk3UiU6Se*ppK`O{B2_OgQe%=Lm69t`>kCDyd%Z}N z?HH*iy&`2<8>#w7B6Z_@q$d9nsrbJl<+&88d+2vLQkT*03T>`Ns_)}St$h*6|4)%> z^*vI#4PKSNpZLw_)f(KucjPpA)gNAeuSy4a6=(J;#p2aV^tF0584jCQ74RRNcCR)e z&f!%%9L5v;Fd(|C(*753EUGjjpsaNxxd-bCQHEPd19ldHb z!prL%j*awc$SCqa+0kBAM?Z`hYt(R_!BwKdbu`$9M5^x0)4R(zvC+^ocF3W{zT^s zUhVnA%X1y#|I@2FI1ble)bt{2hQQ0LCzd1didWgt3@vYZwG6fYCN8{0#oJz;!+qH9 zdX*VBk$BIm-jC?>#H%UKsLyk+^1Nd0Ueo5SR|nALomUM$P%r$dC=K$9lHCxck*H;i z(kxSya+ssI6q{p?DE;J&(i_xHjnY+gDjuavu$GPDv#}^G#D1t8=g=P`%SZA3tSG&x z5XJWZqtxM-C=I~+>QUN*4mG1>t`(&t$XbVX4WhXAKT5ZoM)4VXl$`CNSlcM&?+~TE zU5TMblp0`F&nRs}r(RL|9c_C@=>q!niPAD`#zVyPjZ#j`Lu$V$x%)?H25zFt0Aj%v zY#J1$Y9pf5WD0T3isIUtDDA*!6q^&Jqp-}4QX-n+;JhdWFNjh&GA@i#*;P@xj1wE9 zWY`p?Mw_ElV+-S9#Q$xJQvCKPP1;Re_eUx7fhe^&5vAey10_#J=@j;!iqbQDLaWon zfMb|?CQ2VL?QE2S&P8bf?x4?k`lHANa=~;whvknb<^GHFSc(A`X^+p?csWY<5ORfi z(F=cL_4Oz{K=GSVO1?$S(FQ~BMQQtkDBXV;rO?NWiTJ0)`yz_Z;-l2~6}i49S7iLa zT%V)V@=KJu{}-i`XrO5IL!e)@>Y^o1qOu`c^^o5ft&3P=iq=Q?`$uaCCIoOFJ@ds{Wby&2v<4Jh58hWDD7K@QTB3i#;2{wA8wHN+T z(VC64XvW54{1(Hw2#t+a6sF<{evgY*-gxFm<%DS26KRV@XqFnS7HQF{<%?GT^k{X? zK@PbXFK@J(7Kqm6LeVN%I9fA{P!}vLN({JGESlfH(Rx-qTDB4#!xNk;8Lg|Oqm`vh zv`iJF)d**hzf!c8;|pq5CRcQA8m&V;qSd`8weQWCeWO)v2(=qd-_g;UK0aE_Cq}E> zbmo~wn>Eo|hLP)tX@9he++eF%BL@5Pc>_lM#M4M#GTtVvI^-Ft*|;vR;bev*Z}{!Bzxc ziP3F5NA%SgJ-8O5h1X+L?*{YTjL{Y3x)meq?HK*}I7W^qtjSYq@+?M)XpExIW3=OC zj6Pu1E7k<7U&rt|Dpqe$rA@4&+s5);tXORu9IMx;JTz7b!(x>OE%9kYtbQ38s{^BB z^#!%Y#wvAOtO{ZqijI%fzxXyGRvjnCD(mD}Rh$y5eP}Q(R&!8gdaN4a0gBIz)eBUZ z7t8PASYDgN>IWQaW0i9=<87fWHo>(uRzG7o&fzlxevefV48>$r-4?6u_y+5CZX?@{ zSZzHWt7Ye6wHb-$W3?U^FU0bkE>?3<((YJy3~ zc0E>4QSC;o{zBE8u^ND|zhl({k+)*C7FW>qHnqDGt1}3=%eePq^$)&c=6zzqS%f_x z=0~wycOI)oPh<7?d8}@~pe8S=&zo3v`4G!Bxv{#6++XMq%hy=tLvKt_oK7Id5GSiK zP8pHY6eoj!oF1ZvIZo-B;?x!=GRNtCR?cOMQ)i@Pk5ixUIPE}NPn`O~FCtD2BjYs7 z8>ba`kMpr{IuOrz330L&j#DWtDnh%W^uvl0ak`5lrQ&2S9jDCbiOYCaK28Z0;&c&EfkgG7X7SC(Iej zc;n)9dqbScZ;8_`)YuxQ@2BFpPA*Qb@B>TE#Oap{aoUM`7pV;@U5ZnE=yIHTAp3Rl zMBGj0co?UHIGZt^@1w*k|J``4!Z+l&7q8B^f~QEhAFn(Zj>Gr^6&}R%e|5atKaAHa z{D)zW;bRdVi9g5*grwV(Fsd&4VHieL6ugf} zP+DYy#(5JoBPv1766lK=c@pH#o1n^AosYcpCujl=qeGzt4M&c`33`PLMTnzlf-)9M zP}kxKiYt+zTxeT5L90-|OoH0sEvl9y{_@nS5_Q?0pn=G-BS9r_0x`Q7XK#XrT}jZ> zI|(ZPD1pz76I9@Ff+`^BNrJ*q^J#*qgpvX@NJkO&hUlLRe-LdsYf?lGcU!rmv5>*Vtu{JMY#MEzPM zQOQLURRG)Z1$~Pp>SUQj?X8rkuUKC>QTx!fN}>YmC8`pBAgF$#rr~V^a%xDttr9gA zuUjYbUSpy*<1!k}Ow=rVn3br-vlF!e(Q^_t6TdG{)P)_1T(_I3>3b7(5hM2{Y6img zQ=w?j&l$-9%M=um4o*@IY{JlxBwa_6J4v0e16NQnLy{(;OlXpp-~|4KGA1b>`eQ7Mqtq-b;V~iFGl?^w|J8NE0LrkC5f|i z62B9YRKI+ZUf_L2YE~&prRq|5yhh`CN%{l#k*j`^DxpaOY7Tot@@bT$6^)bR*Ca`{ zwn=)9I_;8FvQv@j3Ky)&{5X z)sW0<&tyHvHw-Z)>$ZO~-y=`f8ssu3%VkYg75Leb`TlCMX5gJYStlLI>KBr%ZE$Bu z)&=~H)|rykA#<`;!ar-WcHubQ;kW2ySz?n_2A^S#OV&g@kEd^9vYugZ!DRglYZ=DC zu(HWYDwnLe6_Zu0QnL2_oUGUy$$SSiSy^f&Yfk-Sef>3AIoc*`0c`D(mA5@HcTCol zPRV>moU9c+l4b6htZ_KnJ6Q$$Bx^OY^-b2LLCJc7VndSk%TVS-$zjR*gf_#I`I}_P zsxUfPPsS!|?1W@Kw@lX6Ny%z9Jz3coB&*k=WW_H|R_TMu8i<>R82fOtw&M|wo=BGQ zBz3|uR63QcRi~46;7qd4A>nMY9^#*i^t+U-$jiyR=f(K&-6m$7#DzP_`f-=_x|gi! z_mlPWgJixdz)AWcuWnRBx^0+d?BW37DQb-OyHYfBH*xMsQ8#Qt*1ajJv@bUlgxV^62(B>J79mIyhUqK@Z?^L&aDFa(~zQq&1Kt}yP66pg_Bo2=a}+GE{))(fQ` zrl{yYw86@kDcbg5ie97g4{`y2Ek?n9scMH5Q>r=!r)nL34M|leWN@cy3?AV^##9An zO4UL9f$o`8^$e4;r0R1-syau~Cm~f|VM$C?e7#f+L&1irnutzKQ*{}yTcxU0>r{P0 zjW(%L+f-FYnXZh7b-hwGq&NMirD`}*W~Ztx!snza6@Q}K+*FM~{&}e?k6iPKaZ#$0 z7N@E(sv~4+s=hBH?&YbvgJCO(YjvuYtxZ*h4XNsVm^MdJ)dPKwrpoUab-=gdsTy!1 zRb!FoWUAJlqW|esdCrpCg;d4-&A7KyWxtcEZD@2iRdM%HwfG5fJS7finhFM{sT}@A zF;^OY8!Syvg3~lLW13#0N#-=&&yuFRS<_SsuaGl4Kf}^A%#$WlG{u2T67)e_$uzaAlctvS z()gQ?Y5ZN9G>t%xhG|mYG}S~?1olf)mHv!7AWdTjr>Vh^G_^&KLi|(Hv;-}F zOVf~(bO~Lz;%ew=qp?H>D|YbDG+2P1CVMX_|C2 zP4iIh81W(F@iaZfrZZ`pcqvWZ+i5y}m-}zH|1M2)QTBbBX5u_Hd`#0UKcD;!J{7`x zqfbTseL8_l7!=^s1G7(WVY2wt8a1sxEqC~o+38aZF2EJ!(-4Rzit}l20{s$w8k5VX{}7wsr%$jH@F}98PpOz**r!%SeCmbSMSWWNf5m~s=2Puod@4}Grw!PHmNk7UUfZXt zXpCdnQpcyq^?VxNz^93gnB!NUGU6aY8v9fp3!4#NJD;XvAu6_~E*;3FlaJ>#KF#az z<2^&>MEeQUa3XV{<|JaA<>Oj7pQ^(=$EVNpeLB6sryH2C(5DYesP|HzuA<*EpQ2Xy z^d9~zeOxn64c7bQ*y2;kYJ`3rWmo%guY`JR8eHfBlJ z?QH2P=t z$JiaxmD-uP@L!j7&FPlT-`!1Dn;z+W7lWFh1G4lc&pzo2>Bl&O7zh7h<=}KB45i<& zbUh!Hu12HN)ef1)kmJ~NEg6@td*jpfbYi;BPD)qAWa@#{s4*p7Yp15`e>L3)lvC9g z@9`hK2nZ;G6lqFt6MD)p>A8Upj={tdN^~&e?mPWK6mD-18F>RB{seOkw+v33@p_L5F4}Xi-Lj2F)bbSvVW7TEk;&6EtjNg3kVtz&cLUeQSb}wF-q=wFP^Wa4wa zNy*rRY*|g5*K5+S0wzsHxS&a`a0o@-H)%L(mo&)(l`<(m24h!g6Yrx;8e7SvIY_T; zQb(LY*{UXuL;sp4je)P0Nlmc_@76JC07fU8l!2xVOlpUJP}0u+sOU4Pi(yhfT*f2( z>?dCQ(9oo(a0X1;kE_@mG^ta_r0A3PXUa? zeiXc0PYp2?8*mSm?$uLkOvhp5zF$vC=!K=YiEDT;|WfGiK|sXn@40WP4(qk2k3 zLcRL3)UU5*w)%>GT3^L?)z^cnW>u(WX8jSfrr|6~RX3{@GH?hwS?Ty0 znM`JdFa*a?%P_O1s9B%*&8m$JDALHR$2gv5R>vl0J&CiewOP*3&GLL<)=<=KZ%=|uL z)=o4UZPubOX0`p^tV{FFDzU(a9zZ!_yO#&0((X$Q62YgX}nW*x*iwApXg)&pksJ!sZQ9QwuoSjMt}GUH z&uY=jJQmf-Yti_87XALNMSEe&Z_ytGE%FtyXb8@IXklGPi}s*x3Al!XVT*F5SkyLRVJ&0& zYhjTYlhZAVMlEWOvA7+#sC-L{hPJZE{;5Sl^u;xJKeK3c8;erfTGX_iMdNVi3yYSv zw`e`i<9{8=6Gb~)bQiBsx(j{dJ~H)WJ7)E^=p^d)wWv@(i^{;j`u^lSfc-{T)ByL9 zd89=n@b967jIF+ z9Tw%@ZP9=|7VSP@k@Jv6jSgFM;Ry3_oPF`^AB(1(wD6mlMSoqi=#!h|ikTR7+oJuM zttyqpsx#TFDxBS_xjC#_f#dI3RUnU56N^|`_sgnDrK~!F;iavbj1pz6>QmM#|HoD} zL7|FP{ZYxPj&7?KBkHko47^njknFQ6pJCOquvIsakz&S(iRF`|h!b;1KAC)xB8x$QRniR=!WR-v@trZ@^Vw5be!Lbd>LA#;jNR!oi9 z6il_L1qP#I8vP^MnEvqq$xX?lnN2x6+VmH4ce3g8&NdbAVpBzgkkHkpE-2H@CKG-| zp&sObhiKf>rb$C>I)dTf*fbf=VK)6Uf&C}jlxZ5h~{?fMDG@MjYNZVyFP49-^ks@uA;brl^yNM-pQ`4ooS0l$kv5%P_nCCQRMGt zS1D|Vxx1bBc6PPtW7m2t?Q7@rik;t`?MfJ8S0XM9r|k&44&fpejkNRk#jaMP?D`#h zadV7aO~1FR-xRxU;FIZg4MvN3c1=a2`F5qly1>pcYIcs#wac^GuEuDv#;$IA?0iPG z>(jkyBMRQ2VZ3Ze+ekE|2WmhaXNt|OGq!FqQN&Bk)Pf+f2{27W)-NvSJ4*iSd@(w+&;84ek4voVBcq=({ z1P}004YuPAE+o)TO$Y0kJ2U{x>oE>8*LSEEs#qLK!I1{UmPBmW2fv-1a0fjd4pnkG z)D&A>KOYL9}|v^8@caa%jj?hkn9==MLq2;n1O%4!uP9 z4dWtTu%J*+Z0^+Qdk*5Xhtr%u;# z>P%gy3f6NfhsCMVXot);+9UC;M5oRoo874@aKYnn>SHHy`kb1W>eP>EPHjfz#!lJr z`CCosv#C?*sM*4)KX4hVP3weaWelxOJ6!UURDRZKoz6 za@VQ;X!*#gVX!=9j!@(TJ6PFU&yVL}kJGoQ^2fDkI^J|w(C^5h# zC;l7cQjx)I|Hh?iI5^y;XE1-~QcL`bizq(EB?o@Qc8nkE;{UJ2FwP|l+D~9ybH$~Oc!=y*spnhQT>1;P>n^^Ja;eZQ7soQW6h$x0$M4AhgudZ^>Qc>T zE**vWIr(Do8<#RM(=T(lHK(v!9~O5jfDRai6*z>)C{)5ND_Wo*rr|f71YcsS0+P`a zQ?M1c(7Li)W6-3UTZ8eemRn_OyOpn=TU^hK_dRYEOLVJ~*R4xFx7z#Na;Lb}1rwXQ z^-j85n52+*;YiEqgaN=a{**_e;0#qRm%seT_M9 zeeIT`w_8X0xYekyTR-3g%Jt(uj^ZMg_jl_){u)3(gWNifszcq%Hq5OHqlqhn+F&yd z;T!_9+*-VVHpsNltzVI{iLr4O8#j~hR=0}pWE)!Ua%%>P?ZpHSwIj)u54l*8Q z9(HR7PNVP<<^i^2ZheM-ko!1wJ>^!x({5G7i8I_s%?r#6#$6-^6u3m)uep_Yk2%1e z`)=LAnMZDAdCYd$pSXGN%r=yG#{6MZCXaIG_oxQkg*@tj3q?G7g3=$Ns7G6HrI<%E zN_ceUt&cqFU(&;RU>?3-+DI)>pC>U`r-w_zSF!|mZ7wHWEqU~E92@3kx0A^t`&ZF5>kCJ}$@O`02yJnHwY!B;)Ql~jQHrFHDLJ#YNdQ|Es zk6xqAVh_jZdStJ~;fVM;m|h=pq_#@Mt);Z=zPn zve~0zsELNSvW>pCb05cWZU=GiBp%GhzPENUzq>u0-|EqQx4(A;W$aZ_~XoG$k6~4Hul68V!>j2DUTrpc zbq#rIdG!m*)%GeC|JC)XT79o}+r086(l>6Pgx#y6E-%*~^Xh${m-Y3$te4@{@Ya#Jm9P|ha1E_ez3PbrsGP<)_#FFj9XT7*FG@G@DiKkf z#xs;`>Xir6n|ZYX4V%*zqp=#tTJY~E`QkF>$GqAOSKO1?Tg1fD#!)IR3ZStx{ zYsSYlv}xgna$gZR>`U1;!?S0lgiYTpR2hL84g zoPbv|rg$}Bvsat8lE*f$7VPzE(oteOMxQ6VDtnsRpYbZ+dFp`S7nwW!dBv*%xqaH5 z&&N6MK9%{zr=M&1l$z*MLIWSasrckg^646;+kHxN`c&NIlfS7?&SpMUY~$1QZazK6 z-0nUV?%`9cmroym>C=-wK4tCe(=CMh`Sh&6Ppt>|)MSuPR|fm^07d@i)3-QNeR5$5a&04L)J11( z#ZhRxPkG_MP>e&K9X^dg?w!Pk=q{gX>}DHI!nwz%WK6+zJVB0qKK+7|`+e$uz^Ao` zeR^}0I-U3FH5Of99#Hop^+4`RKJ~$QRK3jODEqIE^Khy06`uy+KUBZ!JMqCy>UhVeUJrTfkxy5V{+PIN10A1GZ@l}|r!Lrs-=5LObNWa81u?_= zlKij-i(V1qYo3QF^TwzCSc_pYR6LWx`HP0GWj3@ki^1=ZhRWf?Y=%bR*X)LRQ1T za1Xo7(%;9#30HYyuV83FC4=9v41TjRA~gPzI`fVd!^sYfl|epaU@>OGn1TqE3c_oefRJW*qBc z=%cR84UQpGcSDUZ6{a4BO7t|e2AO*qDhxl4!#TjvI1C+V=mHAsPjZ>hm=W%cA?&6 z=5GqMn#%KaI{9T7tXW81P;w^E=~;%x&o=b#97Bm{h^dRXznJGS4lg0rWy~G+E;rQu zXP%EM$OprJF?0m&RvJ2ro~xLjHPme_ua94;|9V43els*;Bf0&~nCSY4!TNT@j3c;; zlug93jrg}4>b=9zF!bMPsM2m;Us$k*`P$1kIJ?hK_Wg#wL)HU^1{@@Q{C1evFXkOF z^v+S{`Z%$kG*tVPp;kD3n%bW+^vPMCgLsW~=Xm{`=ed26T3q7!g^bIF4*hG$dezXR zYrM9u8+wD$H+df2B1Y7`$8-HLb$w!}4qn6gl;`?0YW9NHAij9XYc7wUHIn@*n%A#p z_$;4a-+thiy|7>3VNNl>3YGS&c3HokqRq#CW&XskczM6}RP?KECBJs#SY^MGs`&Lc zPE_@)d3C>r;~=)z@N=CE`ohn+gZwr9YKy$J{qo>JJ-@8={iarmu%twk9dW1|Cx z;xRr<^s5|tV71+^`*?$94!`!n@AT^rB)AwG)jaHrb$9`X*RK)y6PbPVk9L@kYba^Z z7slf+6!Mb~Mq?XZ!Q9ZVZdi^>DALHUh8T*Sc!7EW#>G0khB@fxx(*Ie!0*OYj7K7B7QZ&Xl%tpR7s_8%)lY!Nb}2v?wE&j zDAw4o#u$Sgc!nBHs0C)?F!DC_%ZDLYj|ZsM%+Ilgel5XueB7LR;d^YyW7KHj=U7B) zipwaI?pG9(aR_;$emU_qmf;FY#^?v*@h9GoQ>Qk58D0G<@h$fY2Gq8BK=aU~MS%VT zx($CcAjJZ@);6GWp9l00uA@u4fcAe8;J4*~HgyT8eUE@<_YLSA#`Ozm4l48y=$ion zjUE`#@oxgMjSi^5n1I@#J6568_W_N^PGtQdpmo@Vz}SEmj|*tvc-rG{yu#7R0o9li zP>*Q={esrh1L}$AXp%v@nE^%D2Q&@A-vWx^GVB`zD*t;x|LqQ_${ymx9rW58(4l<+ z4ci~k1f0OrKLe_BkUa4W1OE!>^xpyfaEMwQ4akhi#{!BR52z((o?x7R0xEivSg`9% zK&{Rb1D;+W_lv}UI+w`x9=TxXea1u42LXNcFrdzl0_umaAG7^wfHmL)+VPslvj)`^ z?_>+A7-r*j_Mj@|3@W8UP+2Pmxi(}_E77J(P`&U1O{)cU3U~3p>OtkK7nBFjkgI-B z-{Y1!$hk{F-E#(2-4)bD+{f4MAlJDMYNI!(y(sGos$d|fWMl~j^&Y0;aVV(E$+SU( za8SRd1?6ZP)Wpv8iI!glwHn{{4r+fNZu1@ zLxu!3c3e;gF=TvD<4|M*xlIhJ^d#b171VPqTOHKzaIOhz*4m&Ntqbbs!$IA~tRq3K zK%JvOjXy?w$AijyF{p-kjeM7ant*$kgIe%!kTqh0T8>uNgX)G7H-fr)Kd2uc1~v3? zP{F5cdq(chY4;+i=`Vv^ry{5WZ-N}h7SfE&A^nskq)}Nz>XI#_NY0Sz=MAZRzL1u` z8`ApxAq{^oq>R!b#VUn#uX0G2tAup4YDl}Pg*3NDNRtvm8e|mU z7>L6CLrO!=0U;GZ23`ydX~3Y6#^VuYPop1kUG5x>BE=Y zW=hr)#4;zVGae$GHCeClPPSx@e@)i(?8&N>D_L1`Co6xxWEFciS&gv;j{M2WRUlb+ zQU3#0CM}$-nOLB(s$>eQKBCx_C9DV7pEaxxvV}DuXILW&g>@B(_e5BgE2L<9(-i&j zS&BYxlcM~+Qe^unMQyjGXb8IONl~f4Q*;9(4yCBa@f1CRC4WS13r18nC874_0lm=uvF zN7NX{(elTLTyrAIG&iDqOXzn)M0fD_#)x|S9?>woK>t4?>a{td_qRk;eOpBHcM#J~ z_QkuqBg(cXqKbPXvhRzi{*j12I37_YtUMjj|IS1-@q9$9vE%~dT#RVUqll(Ii^%;v zqRuZOD)=&@Af{qWwp7i2Csh~mOP*A9Xq~Eqc#dN~rRw{|+~VGnRJC84s*NbJB2|%< zsjT6Ws=Dh^wHEufrOLKFRZ*PXk*Yd7Q?&pYyHYiFcdFjold30oQ#9V-&jR9Hs-pC>6+IzT{}9aYe?60J?NFL zHoepJC%){Pt`S(&FI~e1rfcG$bk6HbSHfs+G3|$Rl^L6^x)ahhV`92oQ_?xVAze$S zrR(46>AJp_e%7Vy;QDm^_FKAg|DG;8MsG^jrp@X4dRMxN9ZA>ui|JZ;KV35)q;o!2 zy4Gij%AGZ;x;dgchhh1mYWQwc|K*RWK!GT)PagXus^jjce)L2&E)dnxucN9tFsl56 zqVi+l)TmC+h^lBtR0nVd<7Y-yX;xI1@Bpu7M`fBv|2T&M^P|eUnESZ4Dk|&hs0>`e zi#1VITN~97e2-K3U|m!}%t6leQ5AxJV^j;!baPY>QR-k+f8xfOD8D^M<$6RPsQs86 zaUG+dMRftspGVd5MO0m~#Iy`8v&PgF?`MnYboQ8v=7{M4&R~4bm`u51+Jv+`Y{$c5 zF@=lA6vLm$T_PqYk}(~}k^iHZN+4b)rlaL!N~jRi;>t0lRE@E|LQG#cW2zsH>0Ao? zL}IGboVHLrrjZ!hJEjxZ(I>|G{4uS?PW0;+Q?dRrHA9{OF%`#2RQM*Qw)k*ZOcike z*+#_F3M0QI7uZI})ECvp#FU7<-^aL)SxmjLZCp(L@iES=i0KrzWyF+eW{m3~$Fv=N zX2taV>=<(y)1f)!HToQs!zbc8kG}uJbr3g@>113rV8awVMfOv1)jl2P8uW3Uu;-oZ?(+O$ zCP|B)_8-a3|NSq#a7NxbYYyh9+j-aUTpy*)>9x>tBUfzc`1h(eUAU!PaN7TGm*xLA I_0D`=Xck-e_Yo3tZC=$v-du)naMkE^u7AtH)VQ0du{@%${&_rO6UfE zwd|U;{h3)cvO}5Gb8>wFf3S8ar~3bHYvtC?sp0q4%nb!<)yS-wTQd|4RP)#HSF2U6 zX06QH{+!&*8r2Pou|K}(^#8^B-@niwrl|kjCQ3l}E=vDs*d;TJa7t`S;-*Zoz=>i| zyg1yDKTE>F(y%E6zvO^5Pjlr&7;Imp2S)aoa zxiu1A9|hf|{%B|;xnDqS>GCD?kwIhOb9pvS@g~9#s~~PQxPE}uKf)H7zXldtg0h`Z4%sD6{$K5*BfI3&Coo>3pTb+u-~$Of zhw8Fgw#w`m>Q{6W{lsU8qN;o^n^e{!U+8j+KOEh(gM)PH{X#SNx3DK-ejHY#RG@qwM zbD&Bzh3U~WkkfM96-{+dG>s+27tJDnG?{^D#><;Eqxqv&G|%L-+R;3b!n)Bcm-X^k zO4N(yL)lh8nm~hSo;QuAck^f}wooj&-ZGkYt)l5F*JVQMXg+8YjrkSj&^DUn4$B$@(G+_(n$q&od(ku+9L?WjqVbN6CM<7^izab=G_OsF zX0OCdjOH!5D=$ro=8#;HN0K}(n&9+ks!HQo(VUgCUq#bmK{S6#|F5H&u}Cq$iRPQd z(cD-PP3P~USuEC7T3gP^8$U&JbW=3vW%br*=I@9mYiBfroDBAVtWm8+bR_|sbJOf>#;(G)!&O|=`*T)nAY-cl})l-FbB`b2BWcT)C+ za{4!#@22D;`NSQ|F*n+%N@m?Y)`0}TreY?Ou7 z4E!kX=$-mwxg$9>4J?*V>nIOtP}jh#vR~}=49u%Rl(z>875&t@v`YyMf(36r-1c#J;NgV?F*vkB1oeQ0{(a;6Ir> z!a%c;%5{PP*F*#FO)_v^o=rAjonqkBR0Cg4Q*UL(OoNU!^-E4l%OwVu$gOV;yuQ>x zciFzo!1Lt>>aNgUtyC{1=6eIve^hTJ_>+1s*MBz9WUYZI>kOFI8;FzU^794*?`|}3 zRot6(oCv?@c#wnJ)c@@|W_D;_cdDLU2C{b>sDDWHNX`)h-$>ja>c1Gysvfy~(?G9V z27b70pwb-!KDj5k_tY!Nd|+VELj#|S{gHvM<)6nouAXXdiW-?;%*YB!EpB9k+$dq> zqgW&UI3v|$r93QU)NyL0e1ego$wp437`c#c#G7HHzS~He$4C*sk!ArSt3pOvWE*)Q zZ{`?D$~BTMQ{_yakp}rj+Dfk)MmE1}#9hxwpZba?;~N>tYHVbdTxeqCmb7nbq-Zn6 zZf<0&)NN(d&nqKOWMEq(tJ~@JRU^r-8QCr|?TrkO_d6K*rIV3+Z))AQlv7vTN{_dV z91>S|Bk%Pv()e8?8|B^JMm~{SlG(?|LRlr9`>H1r?5|#laj=n(<*QGOl>5}kTIn&w z$YA+L{6mdA8)nq!HY4V-s&|}`^>R>(k2i8;wvlObjGUcoq~SaxoutSjBXQpu87T*r z8!1>}WXVb+O}{tt>nbDm)kfO=pqzg+(rS%flUqL-S-0LusSQSU%5kZ+(a7jcMxKgw zvvQa1^3qoA(N5JXKkqV9Ww()#Wc{kVe^cJ_SpME)WcXeq|Lr%@`=F6OB;~O7Svs9G zV!LSMq}07^Rs2q-ZOGh91o2AC{YiM)Onvi31K3Z8A(W^qKfc-u9aqD1VDLXkv~m zlL@&d8szCV-$Yc{M1oAKZlYpStt0E2nQ$~WVQpigzc^npkta*!R$CKCUNv!ErgS#( zLRP+EVvBg+G|{(A2QJw{<2~tT$0^gXYP?jf%6?#J9hgcr2~9o0ucu|gxnK1i(CcD4Y@(AaK4K#As0s5a6K!SQ?vPvqPH__#SiP{%U+`M7pV_OgxtlF>_CHqs=Uqjq;!DFq)}vGBe(6)-OP2>~hFz=78JG zdmb})B->|Zk*pVk-%On>Gh1@Z6v;KyMwZH*JTo2g&BPU$876xQ&E!=z+;rT z{cbZoq{tpKP4}uda!hVZ%ziU(%6pQ0QR~YY*>>Gb)(tZ$x6E|AZKj`G6aQT^U&(Sg zeP6FXG~<<*9+~MX%O9I5`$Ro^X6E{HGwoiO*&A)4n!&;dqlJfJvsh?swXjK67qeh4 zZlOU53j<18*e9jpEL0F@DGT4rqj(GF%2;?&$wJ%87Urc|D3NAiN)Q8TyKa%Iz%pWs$_aYN5?*dR=yQv{12=g||9e__T|K%aYMmIZI403z_d& z81$}%-S1my(pSCdXTj9pLTUN-0}HOv7T){9!g+Zpv12UUm|$V^Bnx}L(OOFsSEk6G zZ!NsPLA6WaCJR+|Sor6ng+7-oti5a@{fcUn&t&#B3oZUp9@n+6H!PHs*W{b~7Ro+Q z-yf>)a#aG4wB{2FJ)T-v^-T3Vw~!^{Us#wEW#td47j0#n!HU~xrO<3;v>dWnxg2A~ zU&KoPqE-@$Tj?Z=OIS%PY1Qw?R5^DCiEA3lq zjkZ>fNb;*zJ{MDaD{W*>2P?%oDz`3HqTbT_U9GH<_usR!Ma=J8=_^BIKwm4Z`&o(U zZ`CniWuzSVz)HaYtKPemhpZlMrR4}K*3YdZ$q3mu(n@%gm8Q}|q9-dqnKZ@9t*KV> zr>TF_m8;aAX=Q=@Jxlq`wi1|Y3kmFp5XZsjYv z^}ChVPV0CO%NZ;EWadTn6nmDo>)2lRL9XX9jnh(hisK=^4ot}6C1sv zYz&g$B|F;2hXxy?`JiFB+16rmuv*f+89vI#$R%xyp2i~Y;>!rx$;Sh)|U#EZH$#!a!y`JReotU zlB(DkBS+G0RCm~j_Su*(!~Hh)25jU9wT`&+Y%FPD!_&~l`;Bb+`DUYI6B`>Ox|#BB zt+B7zI4BA2Y+UcC_1?B|S}OLiF-|u1wBhJwc()6X_;tkqtuS1hsaR=?!duQp!)&BoC^HcIc)9?Bd!vR{2TZex+0 zlUpZk6r8rvNZ$X$##;GR;?LNqES=8U_)aFC)A1s!<>fzZOp;~iZ9J04@iEk}$I!4s z4AW$vT+NFikRQW`5-yD4pscMHL)GdrIBUi5k!-IWL$FQ^i|fYFymbs8NM4&5tgq;? z^q>`AaOL zx5YAbdn_Y&#WG}fEc+z)*I4@OiDi>~vp1G|`(v4VD3+>6Vp()FmOJ7&7R!!vv6TEX z7VE`WnoIC z#BoLz$HXzDNF4j5e$hDQ6^r8^Ia54N?=^9Bl5MeZ^pB6@7qOO!V`Bd}&dP}I^!$%{ zUSik9u})0u^_n!>6~}B@eo*mGE55A!D~{&ZQHr`fOVM*+DSnoG2Gg z7Bk|xKRcenIq`fsHy+bh@idWc^Hsyrcv6^SCgI9l4Y^;fz{47 z@!0G?t>^zo@`F5H_?6j|L=UdrQLv!od*<0UEVgozx zNxMdN{T^gzU1L3NsyVW6$w% z=fXfc?m>1sd}OEPCwAsZ%%^rveP*ZfP&+GR=14nNfI}_wL`RaE&*QN4lJAYiTQ{|%ic1gXxY3EIuam&u# z`*tclv(w*@pi_bgJeAC1349{o6;EJcVgk41i{u0ry_CQmag+?? z+14n5X>Aj@C|Mm6XxS-&3zGU~0`JQ7E(r{NJAqx|?U}$7IWNh*5?CgYfeCyrhdxc9 z_0R<7OQYdhdxY|no$~sq1eQqu2?=cdI)S2#6k}-u1C}SST^6iPpy>|@%o4*o^=3x` z#dao8es2Qh_9f6wuFI4InkRLSsn&}LY?KDq5=gn7Ku=lrD1i;n60kf^(C4T`IvWyM zF7c*BYQ!Y+r38v3vc6Oz=J-S=zm!PFvWYB{pUWlcbAKW?WOTZr8N_ISXbj;PK2h3yl9!IbDD`f zZ!pd@mUG`FlK6chon(d#`5}>gvSCdkuWU+W zp;X+G$gmxW9F$c%wZ^VQK9Rs~^JamYT^_6;G{X2FTXh$?U0-$=&zW-=waCDXD;GV`QbPp#Wa@!m;RjfyA7KS}1nD6Km>nYf9` z+?<(A?kqh&H<{CmlSx~W%*RWUdHV;gAHSMG8>G~pWajTp=7!YVujj;aKx;|j z!DKqg4Ef?jGAHDv3z~aL<7CCvWVZa3Op(8nneb0C_3tM$MJhZ`W<*SB4ohEqX|AM} z#-CQ27X_s$Q=>Fpyj9(~7(%h9W5ph)-d={OwG^;ZNax zIbJP=q197p*er!)%Sj+%<)Yy;Eo{U&^I%=za>*<+!C1 z)*_W?E-}fKcwV*=b;?!38K^`;*GhDhg##ZV%PD_tDmFTyz5=&** z)=I?vqF9G2@$#ukOp+=WD(O5-C2C#KZER(-;wm$_b7iW(U70bG(!Vk*Oq;f$*B~xh_pUO1JsgTM)DXC;tO2u6{Rp&zV zSO&UMiFi}l>PzLBKb6{nR2InGP%77Ce`YExbM%@l$V;VOSdRUODAe=SwtA*Rx%Q!1|Bsq`23 zAie%!Dr;orXQ|v6t(?C|<=+XZd^S~iNbTvGJ2RCr(tB1aAIwQ*n|SA@Qf#T>Nzd<7 znZHT%<*gm5l-rw1H}UODrT&RjrbypEQb|3R%DZynQYyb()%?Fwd2l0@7Y|aY`!JO= zk5${VRMyJf=c!yVrr|fGQ8FeCSCKUOORJJ;^o&j8XW1H;#`O3!E=gy*#wMjPSSpuJ zW0-6&lSYY`(&$d(!iU>R7nUaPHr0Byfms8q_MMh8nJcK zINLmpzHQRjA}d}?qiDA@TFa6?8v9Wi10`*A8Uw~@J;|7o#-gv&xFf~Zq%m?^8b@Ww zugdGUG}azS!+0=_K1b82b3Ba+^5|3=&Hqeejx4*X@i)^be=Ch0Ptw@%QWY#^t8gy6 z3MF!?&`_pH^GFruNRMh&So>-fjIULpOus5L{-60(m?3?3RH4T4D!R_73ePWB;r`Vs z6#i9(Q8%mT`vpBGEALmqU`wZw{2iN4esVg)Wl^PcEP-@=f0@pw&CsfZ(mA#xoeDeC8GAULACINOaXtTgI;YR3lXfnhS(npka3!4y zSJRm*SN=-JbuFElGU1pew**0&SD2&F40&i@~wk$ z-#ciwN-<=v)L-pj!Vk*%M+YV3p!8UyF+XV!es(Z(t>&%M{f)Z6N%uD^<~9e`?G766 zaIjg5>{ZYAJLrDE!D;#FkVDtdIaqeY!AnOS_+@|;9#@_x96XdFCmqy0tNd>|`0YVOoEAWpi;I{EPx zC(qkD>Cw)~NH8F}j;AFJHQIZ2h_^41isKh;V7=}xZ9a^jw&m~$0#k(2U^mA}0Gt#V!Jr2R7WR_3p8 z^7l$7i`O_Av(CxU^-gMTP`@_mxy?>CY;m%FtCQ$$TKiWgjepnLQu?$Lr~LD$lf4(! zXPJ6QIZ5(mjk)6Fpj?(F*PXPxqdrR7T_;(xSZ>`@9`~KRFXx_UAOCeSLaP1eq^WF^ zn5YZ}%2;`7&fx1J8LW|ai)QeN+?Cwo87z@a;)u`SbW#S_Wl^%mO8@d1l&_qDPp-*R z>5-bj>a+|hRmmVn7PvC_H7A4LWm0Yi3nd{hgV*vi*e4fcShWmlHp-x-lxVD&GG0zL z$)Ijijg{T4GC2BL24&i3Fj|Im&S0W6d_%9x0ZHhR!El)=<{lZm_kISSNu;mF$!0P4 z&!C@-mWP8gxG^$=(C7?~e38K=nKLGXjOf$6&p<}c4+>Gv6IkbbK)PaaF*4;ieG?c!aR!K+);pRE~``bBHW#9bMD zwLgPZ(&In|gXN}V9@75E%O^4zcQS(ye$Qa)-3-p&%h2b^3|@MeLFY%RK}tT&p!Ks1 zcFFh8GidulG5^gV_P-3;<6=>ii-c$wuNhq|G`Wa3yC@mwqID@fpX?&1jEk4W@REyC zGEDZCbrCM-qH_fo-&S-{I>p81N-kWfE@nw`6&D@ST^y7xP8SxJiwSNQ>6tFx$#OAR z9N8}3&2i~FQ5QGlcAksuu#0b`Y@v%cs=DYcHzZWu#l1Q%iq~_|vc8KQ^1D2g_nNs_ z+g$NlxG0c{?UZ*9)zj0(KDi(-zvJT2XD*V4xk#1D!(DVA;o`LXC7C0Y(tg9R7j-AO_-cxaRnlXs=E+UTobICDEEiM0c5!Bri-zB5&1G6& zW_{;knUq`Z;>{HF}q2#xY=uUQ!2*IXVR^Ro0Ub~R4C@=O1v9)f}7b=v9z16W!(JxlABuP z+#D?L*7rbej;Fe*o#rMr-AxaNn?Gca(@mVq%@Dceb(7_H>pE69>*a31&DMw;YoVJD znMCY2s#!ENJ0oL~A$Gq*)s`o#d#LY3pXR zT$gF>+?;#W&C~X7s&!Oto!kt1%gwf~ZXEBrb-kCHsqeWt+ei8;@BVHk%ePW6z)ka^ zZe|Q~6EoaR#}RIQrf~D4q>NN=M!9u<(M_FkiZ@APrnng>r>3i4Gu@06_gpvc&vSE0 z&V8f)E^+HSa`kSxn-weElwawl<|^g8+RZb0=SS_s8r8bNP2@K>jl{agO_Gd~=KI{d zA?5bF@yNad8hgaeaH)D!y^&kTl-Hli>%5y+FS)t*+)duUs!3M=r(WQ}66Ilp?2q

+y&o^qs{)*h&}2YGa^%%jf%9twwfSRva+c!(M4VW3PH?cvlH9$p^fVcJ*^ z=f)|g@mg<^)|l+!k<6ar;nGwOcjUim>dADClMXXHoRKCoJ?xR1vpmd_F|$1!oukKd zJ+z;vx@F9K51kfxShCPV^4A^)$>%ccTMv7eY7dqv2dVX)hcA|Um@Z{kcz9!_`n5)T z_LGO1vRG>W?BUr)4^K8}kG6PNDI2BAR`qV1;%@gaS&HoN&}^rNU*v!c-KG8Atv&oz z$AO%dul9NPYrls!2h__$9>yQ`5Ou^usbe169{2E@R6FV6hJ=3iuuw+*;o;C3J%852 zkaHe>{nNv%=RI_j2NJ&MVVSIz9+y2FmYY{S#Q*JKgIv4r!GBY0OYU6{pWO3sTV6=j z`|72<|G>lghuTva_{hW7#~vCy^>EeV)%P7<=E%wzFOQ0Nd8??GsFGgl#(J?NdU;q@ zx8=NSl|xdayq8fGygZe6QoO9Gc{$hGOXD`mp`DkpuX<_J$;*N_yA7>t&~$mXzLJoP)je{?N;Ld2gtfGQ+%d z8t&z=d_U4lmr-868?D%1dhw6*@|AR)F+!@@efoLgW1GYz`WPtfOZ!+<#z(?SKK4}h5trs;hzxdVoZH6|uaDb4 zA07NY_J(|Xkm+M{mQUBV`}kcd=K2^fgR5zLb*)*$$5v@p)5rE&K6=+yE_D=J;$Bv4 zS=`9St;Wi;rH}IMRYwQaA^*sbEX@%d37kEPiuAJc#L@$j^d$Qd8s$!F($ z{Pw4hyz|Omu3qsm^RABz_cZ>#kB=Yu*!fuN{p(|QoS(WC{ftfV^Pd#0|6o&P>w2AncTi~Zep&vtaKR?Rz z8j4lR&m;-f^HaIL;x+JdTK*%M6d?&e` z{B)M2&VDkaKst8u(@VC9tE-=gJQ7PcKLcdT+kO`J@Uup?_f+ohDfd3gUH0_#^L{@+ z!=$jkpT@FPtONXfAj74?KtHPn`FS$fPqz_8=E>g|ksGp1dn7;Mv{Dq%ItNkSW;HUQ*KR^HEr^Z@8%{Ka(zR8bmv!4@N{gm70 z=S!Ko*U#B~ej4ppKjhIN)qKRyayfa_&!}VS*>OMBPWTyl%Fh&OdPe(s(NFEms#$hl z)qec#=VNK~kDtlc)mJgx^i%JapLH_zq3VC6dLL_#W&Tq?e?Rl{%5y#UpPzjMh(rYl z8v-;Gi!nf=jFf|>09DNadKC}wvE-Hr@UpCz=-2@7N$I2j8FE=3$Xm$)mX{7tu1tW! z3IUo(Oht{8FXTu{fEtwo^v(z{M8d8B4P=v;JOTR3++ct!A-$d%;AU=s%=`dfOUJ?h zi>n3*R#y%$D~I|4#xw}%5G_*MbhwGOaHPRhPl0(5E{(6zq-La%8|rvOhn z2lRJV0lw`W;LdxB+b2M?K>?-@4p8|c)&E6+*T)3dFCR_}uzix|P7d(9RGb=My!<{* z_h$rHHZwq(rCMW|=B`kWHU#)&V?gJnwC45zw|4{>v@5{pzXmw)n|iV*z&**^r}bsC zJlr4PodW^>J*~X|2oQHxwaZvJEql(Z78!UUz}AZa{Fee0$PD@Yvhuj9oMevNl&}8^ zaQ*K9uU-q#=AQuX-VE^5tpHVSE6$w&&4S%3-8)!P>V zru-Y=%zrvA2+~$I8-tk5LHfyfOOQFz#Tuk|ksvLL2H7Eh77KDil466jj|*}@YR3l| zV-NB|MkWS1m=vUHa*)|&gY+#I>mVqbwH54(teO)4i1v=VUWh32AMKMwS69B=odluj0uwe zWsq%SmCN`b1LgZ^K^{*J(shRFnHA*H>>w@XsNQ)&j(!!S=KLU~7Y6D0b&x}HMWPoe zzi)z6S`uWUES6F$RKstoVNZ}#^76hQb-uXxKZU*UbD@fsO z?aQ4Yv5$hZc^qW7tbMAyqeAR5geYzb@sUiFKjeWqgxL~eiyV~d)(|6YA^MgK@m;wP z_sfTPqe6(4DIr=_3NgEKh+?TBQmcgMk**lB-Wej=72-YF>C@|h5Fg5>tPrLg#gdZY z5UnF278QiJQ5a%btq_eGgqYk=V;Y61-73VG)**dQ9Ad;PA@;Wo@ye?qPPY${(lNvY zso6Qi=r=+-w-jP={}8u62=QD-4+t?!S`7@*MNUfj!6Cl=P-_ke@xf=RNoouY>37Qz zJEZ9F5K~8lu#OJV_=^ym<>8khBI8uIY?u(z-%N%uObW44_DSL75cA~f6vdsY*QSMt zm;G{9noL*B86hk)L*&g0@#*XkcVxz#5a;KrUtg)$i$Xd-p_p=5+AI(8`zEcqImGTQ z%5|r5*%iXOJEXq}3hBEo^>@GOJg@vOY7IFo$(L1=ynQ9a_g6!N{|>SJUWg(OLL|u- za^zu%*B`6@mP|HSGjZ86c~&x$>T#Jgmd#?0&!m(rmRt5r+9zb|JZU1}y*B{nUSopMU9O9^KtFG&x1*_FvScP70&nf&O@B-NKmm0Uf}%Vb!? zOkG!LWW8Kmn~8IMCc8Fhoy}TjOD3atDyJivtUj7arDK`QJE{Cn zWzzchOlqIa#B@HB-_2Q6v}Uo)mPJ(QEb5lY;>b%`yq1;4!t5+g=4LUhc@}$HWD#ze zMN?TJhu_U2`MoSY9GFGD`B{u#p!o~4NRUpl{M#%ZEX^Wjg`Cs8KeLEj&0mGS3Fh#dCx=*H4xh@M{2X#3IV_gmHFNm6 zRu1X4bEs24hc6rC(63PrE4t_Ku!qL?%3RL@Y?De_Q?f# zus(;x13A2YFo*qeQ3f8@{gaCOdk(|o@Siy(Ur=7M>TV8C?&WagX^xJyTuyj$$ud3@O^k7J$l_~C;*o(;&O`@lT5 zewl}LTpm~F@%fat=j(XaZMl3#NyQ5J zbgh_A_4Is(w#wJ%rhHw?l1~%a`AR<5JLMC6BcHq7@;UZpJ}-^S=L`9Cem=Vw@1K^7-g` zJ~w6E&3vM6=Tlsk%Y!@lym>dDCr|RJ`b=@3YYo%O z7G`SkFlS4I`9~&~4D&~9mH%!{UE*fC6(PKw(lO!cl|R!O(F!>sHcrb3S}g}uWJe^2A2=cO$@d4tY?Tg&!!$XjeoC3+VKU^m6JbjI9;WSS-Iob}ggJFay*L}D)6Fn_#C?3^-!8W4m0CPn3$(wHWR@d9pQo{Lb;>}Zze}LCgsZNemUKjTNNT?r9`M( zDZ=r}5z3}TSX?DSzfgpYnGxJs5o%{g7?TsBK|zFlFGq;4A7QABXb@q4!w3b9A{d%P zsMj>YI&rj!@NUZpf6BVH5ng*W!rRjBwFvWHkFY|nc8K8V6k(2x>>T0X8xg9$srX$K zzpLWQj_whP_Kc7$+oi}m5t3xS{QYi(hcf8B2*31+a6pEt(kLnyLI}MF`A} z&}?pm>GLAASrp-i-+)^%g)$4l^{e3}%Vvi!Uc&uJZsA2(wQVPgRFTh#5fZlZqI4?2v z3uxM)fUV+cTtJ^D1zeN^%?e0pQNVC%*{Xn9tqUmHrhtL3Xl&a8KIu@vh5iLN1{5$| zMolf?(6j=oO)sFryaL|(s(=%+YDoc4zAd2J(gK}VE?~sg0v^eg%LTZv7GVFo0AsmA z>X$F%c!ff~Nh{=Ll|o)mFXRzRH`DqS3SS~^IYe};krJ~%zf{@*4k?i$&?#?ufF?rnV!#{n}DivzMpNAZpaGO z@`Zx6vZ~kc)y}R}GrM+nPHt{?R&JnXD64jEwc0gn=2X*Z-K}0Nn4Md_R&Hi6P^+fj zUn9rouU0$Tpcn_^i_Z98tpELqa<2dXZWHz2Kone*0nxBWW*Xs)*i^(#nQDPQO2XmN zuq6aP<$yI$ux1EU`wS9>!>gY|H_7?}mddRW@cKyTE)7OOTge>_ zwWZ5g=qrQA!58vuyy8uQ@76%vT5x>_YrltWvS1x7R;O)SV3X{Z{H($zJSn*w>hFbiV*eRZWvcwL56;Sz{qU6}98hnMz;fw)6#5CrA#?(2$$wJf zBzz)crRP~N{RUglL(K0`Mo!3OY5fN@`4c)w=?mbLS@OX}7$bEqK^xioKbN(iGU*B| zl=!Pq>2KwgoAR&pz6LM;f#TOSUQSEB8!-1KtdefGV4z%+19$bjl0y9_#repFV*J68#k3dIs-H;5k&6wbD5{ivHp=L{U|~l|jZRMoBGG6s=^p zjI=~COIlf@=qx8CKPHNXVlEOzf_xzri$@WV>+)QBm5AcCSlvo`TogI7OyZKFs3hm) zhO|%Cys}Z$kQY*{TofNmc1jd=CAyO4$WWOmXDdfB-4Vs_&M2B>MDePulb)_9D*K{1 znjJ-AP89WIw49Z4xq2*9WLiNK2dYOgu0|9cYDSS%D~i`^t8NL@jpDE*)Q@7AbZrpD z%7#&tZ4||x#;UDp6d%Y4+0ilzTk9y^mszhz@n?J0+%bv|JE>=KQ5QB0Z=g<-1JHaChh^Hk^jDBk@tiXRt5(Rxu7+xA6aIS|Ew z|2ZASmNQX!evM-PZ&8#wAH`?V!xYV0b2ODK(bOp#&Ddhm{40GEqS=rbO`GIszDSGa zP?cy3)1zr9XXT_Tn(Cftnn;Q-nhAkuI@gTmw_4GBRy&#}Qdl>dl~SU9G#|>22GIl> zM)SN`G<{k`Q?X?Mb9^+36QX%-Vl?|DW>Pe7$z6GAax_Qel01^+ z>CpsdL{n9o%#P-~l>IWAmJ6f#Lk4^m&CJD$`E@j3FNx;H(rDiJHk#kp=-3a@9N!Yn zpR#s)Gz)e`leIgV!SaoKtRK$1_C^!>IhuMhLb4C57e`drX~lh{9FLXviDJn&Quc-7 z{~Jwtqk+~%4a_cPph$58XG<6uThhQ>DHdy>MVx^hGP0C`S<))rKxa86%HtdZU2_fm7&h>W42>9=Ean0OjS3BHmPOSJ zd@sGL8~9l6NKQ=yOXSl!szVyqHSnq&6nlLG^BWkb(b7OmDc(wJmhp0`wSlc|4cOWn zC@sh3lCFS@Xnq|;)Lp_mJOARcQTgwc*zTCj`l?Ljr(jKfX!t6P(S7R zdIL>=G%$680no*yAXS0E;;@+w~7k<*-%HbXA=yl7$cef2xx?|v;-q6i zJuYfwK`|q%B(=Da8zqc<6l=sEXQY~}mWQQ`dafBMpI~HYvXN6MMlPfq@n#rl;5L%x zF;c{DqTZyPxxuI@(O?O~+JJ4QCkJAI6NBDW;7uaQOaMnA1zf&lh>Eaa!AWBOB$g6rW(^*c>C%=NdUb&q$;BMmkB6#YW=3 zF)~69tu#`w%E;2yMw)$V}!p*`%d+KZ>04)os(NX7}>DVNU2RmcFRerwb{t1 zEk>S7+HS2)*6%S=Wv}}9vugZBHAm^dweNt+TT=9Dy1G}grB zDkesxn>ge!(Kf?GBcF*MLw~SQy$sS z+=Qcri7c_UH8DV(FPq4drE=>P6USaPG4%}-FJ$$bCbo&Uvx$CPOk9%w-A$a75j{-I z5Nl5pjeD8cEYtd$DD$3)j{Qs=mO%ql!}})2OO1ghTF6gg9jx4P>I21|Wa6kao@`?B z6q9~0n@Ex+(@X@vGVzO){My79^36IE89$g9CfVyv%$ANnn&`H{#Hx)Z%5BmdS+rU6 zx0_h@lZnUDdZ&p6^4Bgs-fiObJto%5lf5Ro{;YK$P<;orrb9X}rlTf0$&zCx5|5iO zpE2=@%>UIyiL>g>d5!Q!pklW0=9y50&+h=C6Y!rjvOr0z<+j7hl$u-kfmdl+yGad5H#1)tsCi@D_W3|mxuVW^vv0_VJ6Emlpnd#o#%(pGfOlf6ifi!BXc`uvk z{fe2T?aaK=!OZcFWViWW9w$-`5?vpKrv*@P~{n>$HUEB`rM3j zgqa!AYPOkKbIiodHB(+1%{R05M>9`1n6Yd$vrKw!QV+JNA3vEHD$918xxL3s`@LHC zJ~Pess|RvIIv+HXa?4D&+h+R9HSymy^QD}X1dDC$7aet(Yl|Rx&GWt zyBB8mM_Z_7u<*Ij!b7oHEHtrN*dl9-Suhv3(6EGsfh8>*kWz6LDu}a`g>U6iyoKM( zSa?y%!Yh?6%ulsYBF)0oDmo^s(=BWhufsw=r-e(B>(V%B;kNLG9F-)mYLFYGC1FV+-4xSg6|6!Y(P&+`^tV7LLo%mn~FoXTdLvCGJ%VZC}%Q+1=4X#ZDI9 zdc(q}T`XLdjIOFtVtQG~>}_H2I~Ml7XQ637^`O56(*O&lW!d`{T%#6ow?O>%? zM=RfSu@d!`>g{S}oxJz1m2F~v&q_ZT*w0Fv{#IfJSha^%M#!P}trQHj>gT`m%i7^q zT77QC`h}Gw`CJZ+uo50=rJ3}Q=qajACQr3;Ynqk(>018`)hV@SSy?E5&sJ@7tOVv+ z`ABxow_;ylrK5bk(8{AlRyu!WW%**&^0gJOOj}{4)>Zmzo9Xza^24ogBi8`nE3-`h6MO2r;F#> zrhIDSsZ{+;F~6|UW0Ycvd5n#IQg^J4<#K17jSk~&w4PvNtvs2iHP5i|LTb!XEQy+D zqo=H$Z)4g58+{hqD85E@$S-SE$9Fb%eQ%@452{nPthaIFNA1N%#S-gY^-FI3Y~%G` zY#iTbqx1poq0E(I2i1p@HWth8a_h8>g0nUn%X`1s_)&hA_;WTYOQ-WTzL814>-i#U zrQRPlCd-OHZ9J04@iEk}$Iz%k4AbR+T+NFikRQW`5-yD4u>4pphN{(LaMp_9BiUIy zhG3l-meh@*MVlDjm%O$ySYOs-$$cdTN4pr_lfa@_K9puwXKgZH{Uo2bX>;19ZI~dEn zBe7IH7R%z}vD^{IiCA|19!tqTVzFL~rG*49$1?EmSXN$(<%#_KPb|f6#PYHv+>E9F z-B`9uoBOeR^g#7Kie;~Ke;mt1LmcO1NlY9=io|h18WfFVez7?Ik#oi4^gAJrPO>95 zjsfv;{3O;gaZDNz$9ehu8y){%$0c?{92>;6QRk%jo;c>n%EO9(R`F%^Uvad!9>-i6 za$EE6#Zl~j9JgP@F|}AJ{*~U6Qt!kc9Q$rc~ds`vvXmP9rs{69X_(t>JvNjCFWB*XFju2d8nOLGHZmL zEArw&iv@t*~QRXQ#RJ{Xw}lD2`Y+*_paU zaiq~!J3nl*6TMyeezNnrER{dy(oQ?xU3RwbvGeaf#XPLKWwg{eVP~TJB47S$=ekrr zYv;EMcB))d-!7@QH|=zmnYZlRy>F+|Gdlwe3Hqojfv1vLEP+qto8k#9N=)FEj80Bq z@kO3#cL)|v0(x|WJlu!roWQFMak-rK&ws(T#(ex3A`gSx+L(y+X?Iu zZ_fm#%AbJgw}d7fz8tJS^_Dz z6X+=`9wo5pSpt^l33?rs$Qy=4R!Y1nks2|HjFmuOrvc6oR zUY{p&L!MMfB)3wczC%f5TIEExq$XlZOQf1CbtiIPUJoSlK`2q5+az*MehnuwuzDgp zWqHj+9@f?PdWq01kr%BJ^|@Ul&)X%^yK^ENWP8^{+VxCivCMl%_4G-knT(J&{Z)&+ zIWUnkgA=LzK_aW9G?xK9b8ad|o0)WXqC7zFMBhZTbD1 zL=wMEq?62)A>So(KsK#QbWWJaDw#f{aD(#Z_@y%q6os%iqEtyt5l9?~ndMa-( z#p|7{H7cH*{3MwNBb9elGI5iVxj8GD+}S!lFPXDTl1W>d%*V@X=v#DVHQ3PNtL0l+mY>IVCS$(A-NJC#$X|v+b{Biu|3-#D9`$ za6g%;QsH?rpU0HusPwa!=1OX5{As0mQBayPHA>S(&b?BaV?9e#u2*T!?x@I|+ZBm> zT9MbpP$Y$c@hR+-znv*K{3*OAC#$6}w0a7Snx`;b=5GW zu@t(UPT@Q0a3zJt_fwc5CoPq*7O6xFiAk=+^RktwQ?3%uKqV5oR-&UU8dQmfA5~(S zlpj@z@e?X>R(i~>ME}i|ST1|ES0e5w#X3@ndS@yzS*l#9q|Zw#QR|9sV=I#tSD7hq zRHpjdl^G)`11hsho=V{T%KRbiM^$E-^x9aNYdb2FxwA4mPFAM$v&u{(l?xIonM$Mh zRHjQ#g;f4YNhPaND(=du`piO)WsobCh&Pq(zEqz1Q>h(DWueRqrE*OUW~Q<_N9SZ= zUMls&dR(B#5-d!mSJhN9s-^1pQ>y+Bq%yE}DtGFoa<4%uTN*1*vs8AsNTtHdsdSgM z?NX`!TB^S1N~LY5R9t;h86fV#I{#rR>tyw3soWT)nn$Pd@5EF-o2ELX_6*IPmC6|D zGdq>{=ccklyz^2iwp{U~=eMaW*rNIJ)~-~_?N6nf_ztAf;8ZG8rQdI*!(?ZfG)labM%S`wTuVzMvx??A)3_%E8EIUVhTb%$ zNkT|*a?|kUrBS^gjor1=h^>>x`4(yPYn#S4S@l{PMZ2ZZMwa%~*pJc}Bx$447&u<} zBx7nCi@!?ajucy$#)uth9G4+KtFB+t`0-F0#=~j!J)TCLlW9zpM`zM#@kbhSWyMvE zznMn)TWRcilE$W&s$eNwh2OKQP$H)ajbysCh*V*&^r%*aA78D4@wF0gB=|FfV9 zGo|mYD%3bxMc18F;rZn%+`n3d!oR98@@5r%RiDneoIRgT+VAPizMM|OE9p$Un$A4A@>e>pYw66AiT|YQ`jm9)+(_qw^t`FDx6)}Z z@5H6F{o#pq^xhpfDrnBY0bc|6B`pPG=TZ$VTv@|-{A;*h4__UaVJ;fblm2j{w z$-#?c2R%zWm|fPv#c~c>ly{Jps$*#m&Pip5g98$u;b5qA@;k5x9Hhz=`7P+6VaP$7 z0ta0srO-h@7Rf(V9ki?F;E#F^{e5(>yuO2t;%?yJy@n1h$%PgU?#VYT9c&hFD+m2s zJGdfuIyi{#=wOrVmx4|XhP~n7f$Z$&;Dn5O+rd1E?e3s$4~M>&c2IJl>KUYU%F&M; zB!A*yg!CEWVEtzf(uX=&@`Xd!RXJ!s(!mcC9sE1VL9fXU;$}G*K3i*^;~+BE!Q*)j z3cqyl%K`^=mN*!@RAXiQw+@=GanN9`gNfg%&hH(RkRI!F{0H@Xy@OdlIw-P1_c!bQ z7Tw>f7&{zTcRFaY%fVJDvR^$u=%D){2WRDnBMx0R!I&4?XK4}TWM;IJ7=x41F;0#Z zaZ;nGlNBYLyjs%9!dR!iuW;)6Atxu~P&p?F6`Ty0i78IbRB}?UvXfa3&5Cw)~k6`a1bS zR=)3Ks|+0IWQ3#-c5?L-Cy!;#r%ry7&=4nsKXdYrygAHC#V?%vA|*#U`BB~;tsaa~ z-Ev-TN{6wkb)0G)?<7@*%Ue^GZ<><^Gn`zR?ZiD-appNWz1T_lC8}56UZ&cXJ88c{ zy_5y3ocz7o$&z(W#%yqMe4~?^o7A5zI=0oxrfp6(Zg&#BL%Dx;(&Sg=meOaPIOU%| zob11-zRI*qs!5VBYs?iVhvl*~z3!yl9raDp?mEemC35SY>bURZJ^B5K_U&IMpG&p> zoHUai5)+ldAQ>l5%^7@EB!hMGPSFfLk-L&xJcFgOMI7-NoK4E$x-3rCSQ$`0gYuO# z@X0lKDm_v&SeuqXr79WZ$U;{JKj&odt4z+#V38!`W$;>l1_$JV46Bww&BhtDk`hf6 zQzppirWw?2rm?cObq2>@%b-mA3`WV2H!_$cjo#FGIV1^PG8iti#M~o;ci+q4Gl}%m zIN2)Z0U7j{QS$JE3~r3bAT%n2W1};;By-1Puu^(Y${>A)Zf9ojyY!o_*iv;)22JHB zvCYe1pp2C#i`1v(8JNDwV8O}^mVcYUCh5OM^W?D2*(u%)8N9kp{n?&Dsh^Zf zChf`K%YzxLksgOK_&{z-<`M0W)H{{I_|qA@|7!-*?q+cQUWQ&TX7JL(4BmL8HAu;) z8MJwp!5;bcc?Pe%P|SZbi2W~v_PAIa4#cM_vi%c%!%`QsDxoA^L$CF*;lyOl{ z3@^DTCBtNYSr_4QF5al%Vp&BOrBhs7uH?d%>SDGeS8>rH-Nj+q=5%3kxtQp7k)G+I zcb1C}#F6ddogA0Gk92W6&qa3F#n)1{(8ZfoUG$L~5~}XvUL6<3>$_;xz{M{4RUXQ_ z&0YN1La|!9D3FTnRC5olrKgJnazX0#c5&o07fHihq)O%CF1mm2;;dwjP%R@}jF5XW zdbEo<(q@c{x8#ge80TX7co%giyZCadi#5_?n&!z($(-S${%jXhzjASIv5Q7uE8hy` zmf7F9SRv(By6C*h#R-XCqdv+3IVVllYVLO~%-?H`KWL5XwMJR9!Nrq}E{1M)acH~N zwZlc3Q!YB4R$tDzIC?>Oue+FV!$s6h7ej8j$hfV2k%wZwbo{QEGw6=%Z zzsK4GlbdyBH)$3(`>k$D#kl!Qx)pJ=x~Q89#oSzpcjHcQGe;_xcGI&bt z!{y!jZpY2ZR5!KL+@z+v>EUqmo9uJCiF3IbBDcJ5vixoq%SO2yaI-z)##-p+eR)yW zP4Rke_R49gU*FAy25zDny6M;0jjf5BrcK>!lZ7qaeBQ>*bZOq!O(!`nWnOVJO0LWF zc5Z%u)y>oPZmMAdl za}zV%O~=pOdY$0rdr29g-i&nXGeb9Z#w*@rjhX6Zker#Je$8?-UflECyf@#?CHehp z^>?XT-%qP|E8VPG<)-{Bq59_qnO>QE;xM?ibeQuIuq_jBT=1nPg z(2Yk99MafhZiY+M~K!$XA(4{y0Vx)#<$LQM~^ z)$(vap4Rc`b1x6y%F0F_9yIpQxrv8y%{-iJ?xA)I4+~%QaP2h@hV~xncks|gKJDny z^{yUr-cX%#tebKVQtrVXeg5U)@n;?ihj~~fJ3jXiGs43lnK;VBnb98VjqxyjoQL1X ztELIcH(5ERcz7gprh2$E&BGn}Z@Pyub37cM>!JO8tx3i#@X%?Yhoy@=B!A^$unb$~ zVgGXVc7hdT4t{eG}_p)h6|ic$je1L)0-3 z#igs1I^p4!lOBGNYNtKikkGFl7Rk5L{H%v%GV(VMN6u-?c@K?cybSr>!_R+sc=b>1 zk%TXLSRvQ0d+^^>9kNn#?|S&;o`>7=-UAOCA8Mau&?67qAA4x{)WcPaSKmu`nJcSf zygVx6<*lM#qDp$H8|%fA=;dKq-InvRU5-eN@?J((@bXl8r+8Uc$;;1`y_8JzawtQ$ zUN3EYUiQeWW#ztJkMqYBtpTMqZ}3_VRlh zFHPF2hIU@Yz3QcLCoc;-d%4!d%PVhrso2d+*SEc#mZ9Cf?Caqrzo(ZHy}h)4$IEUx zD=B@vI6v^x=R+@l%DY3olo{rw({L|G<=YWnx{UPl%_zkl>%~9b%a_t|vX>=ORP$6X z=caq9Jk!f$`EQnLo})F(^m(dtzUur^_m_LIuJGzwTJ>kOmp{JsQn=2`@E^R4*y5$< z5ij2zRh(lQb5>){c`19z%j-A2e09r<{kE4=_q}}bKz)1YCHs-q{8&AfYEMG#yH7tOeC&{zL?45seQ6(y%lJrm z$;ZCRKH}1R43Q698t3-0)a&E6&qoKpkNqJZ?`Qhhn&s1V(msBbin%@}$OqLlzPfVO z@UdN**YvTomXAKQRZAVkmbiL~ElV2vxYa~;w(?QFz1Gn|>yUqBNEaW)diiMCTl3{? zA0H`wRc}8Z&W{xDV;|2y@iA_w<_z=ccZ2ed)cMg`kNh*%M_{~<1!9`$qse3+r>6Qi zH_b=o89pY<`I$aaXZx5UedhXDKhH<{e2tOH3p7UVFY=MU*r)4OeAM__Iis-KuDeg;WOx}Q}}KMynfeCqa-?)U4OcR#<&<2*lwVV#$@5kK<^ z{FEs4W2o-udwE{N&*!!LRBqs>dqY2GWnU9Nan1Y;kt5ChB(?Oju$7;7?foq1;HP63 zKd!ERBJxNq-TVxcZEyQo(nI;*RsO!pFZ=rWd9S~pVNy82PZQZL)`5QBmo+Br;qy?c|z+v>1V_l z_4cBl+L!&Tlf75ftH1qxERFy1Gv&JacGFM&TYfgkw1-;LBR|6*tM{_tsh_`}`FZ)d zj{WE700AOV0m6m=jl^OMkSHVMuqi-QbAVpO1AHvGB?8owjS?Lj;9V)56d*$`%L92U zIl#)&0m_vLP*@>AQ;DglaWYztr39!^DL|i$07E3~3eZrth{+S6pUevexDwL&%m6oY z17zk0_)0n!23S%xK(M-MsHYkl1Q^pWz_Vrns<#NRM&ersXxApdKI!yIK-ZlH2)(9r zodP_0BcOlt5@1=M0C(P1yuJaN4-PQng8-F3(z-_nczsNOgYw~|06QmZ?vwz(O2ugb zCdjYTb$@1n6|(}AS*{!_G%%}xVA6sHc0!pAcv%Oe2_8rATMM@Vvxg0L8>MPnNv1Mzj8s| zDj#HJg&^fB26-mcD+P&i1TngT`Zo+gVuC@IWd^yE6=Zc-aSMYit{T*}#X(XU1nJf= zNP6?2t{D#UTk9YV+XNZcKB%9;%H1)@hBp+ibCA(pg2eX>(ymvKE4_o*-w*QYz##jj z{b0rXAV|W8L7IFTWa<#D<%=LgM+ezACP@C+AUnpXmI*-y$+y#kJf0Dx>rAaKzC& z{$LOe1^Mu3kfz6ibUz-X_dl91etfFBqeAR4geYzb z@sUiD-{gTggxL~en;e$v)(|6XA^MdJ@lCl9_sfTPvqFf~DIr={3Nfd0h+?TBQmcgM zk**lB(HSDz72;jl?bG={h!15;RtQs$VoAwxh&GWBiwi>BC=9WpR*1$8LriI;F^xmi zZXIGwn~=T>4e|NQAr8J0;^kLEoNXT>rDKSRQuB=vquvbZ^OX=w286iveu(EXYG8=j z(t1#cE^=DRe-L8Xhsrr5#QUFVO;TfMNbj{m?2@9xLrnWTgmqMiCZj`amHlEF6XN06 z5Rvg(zigTq(!WOwVVE3ZvmB7ZDIw;|)v1aS^V!IH@)YbGvRCeKP{ zQavt{CbCt`@tKs8C34H2N&AFM+{u}|S2~kmg-mRfGHF^llWp>^v`fw8s>G&cvRlr` zbt&P@8EEy$$qLLFbKT34vnZ!#IQDih-mnKW3R$ws;O zVOlqIc#Pnw-znZhCXw71U zEsLnqS=23)#j%&Ncr7c7McG-L&dp+2i!AoH%p%+>i)OM)j=qyc^1E4lI4Fzy3$mE7 zQ1cgMkszI9<+3auEYBilmHe)Ge`FE4n#IiW+5A}{n`RZWIa4E>3bnE++Ay1f3E2#r zn9biavw3G@Ha~32ruvp_F7MCAbugRRQvA1UTAj;gmt6cS8|SrbW=e${*}Qc#o3#7c z^sAJ^rph_`d@P4wJUPVra`;s4BXhVpJ%`MhIeaA>#6Bwr^PC(S&COx6 z9F^{ia#;9v4%e3C@XFF0dP~fz91_;#@Y>oO4#)+0urY_kLpi*DIERCBQ3jpV{nLv3 zYYxNY=pQ*GUr=4L=57v8?&WaoX^x(2xt#LklAoQcYiM&BKU|ML&t>YET$+x{W!m^$ zKAM=zu1UFMPR^yibdl;)a~Ux$mnZV(@?4g$$fe9Tx%gy=Tw9%se@!l5%8R|Z)ci%~ zj%eN$&AXaQ-5a?~ewfSIN4d;=k;~PVsqEO~}*lwmkiA%VVK4k5UO9tb zn@67?@@TOokC|KZh}o7$g`;`Abu5ol^3|_-TtAz~@;~z!a5;}HS2X`>9y@R6QRHqO zgJoJ&KIfzJnPbi8jZ*n6i_fRDJzvjv-ImK|q*SbsPuGh1R8P-mXzP5v=E>J}8~HSq z-7n{Jy;DBHH}kpMEuRx(^Lc4}KBMK+1^MhjgDdBW`Xh6($^ zR0%0hW|+ZJIx9@a>@Y{9eSVn5;V=o2FxRVx3Dyj=P-@l=GpbIQXHukInCA7v{3OE~ zDrO_aY#gR-lQ8p|hAGi3%--g@Z5ifcnbj)Hh1QzWCQQB8!i;}C4DG|L>Ja8($1q(w zDQ=fA)w_mSBi-H(v$}hj3O&LU_6almU5%5H?}uqKQ0tdrLzQ=!@(vI4-AK(J6{h=W z^=iC&H6hI3Qe&ceGAYbcd1r?DJ2OoG`HHzvF&8PO6!|L5q7`9wf3JP`LHi)X)+_dp zioGGs*v(;1Yzb3qYnb{w!%Wx}CTe$>q5Hz@+aKo2p)il++rweDONXOjnx0TUrOe4N z8S=}iFr|JC^U7J>mx;fHIde|EI3K3d%`kn%eJe~vR>{NL>d77TP+B|=GxJH9n5SX3 z62TlD;esVXxugi4lOvpva%FYDobJo53K6nWBGj!E;bi3qWz!-osS=@oD8lB<2=1&1 zwX-9P$%)XgAi{xq5#k#}7%HDPjBv0~go4Hq3{4}{Zx&&LI9f({r&WYMWWy^FUVAmd z+tTi}2n$}1uu86Wh~ViIVXlmLBf{Y~BUJ6I_+1pgtK!S9?h%UijF2olrAY4xNwPrx zeka018T@X9pZZ2PBtzbd@N++{Lwfa(@cn=Y?|rD-ArYQ`7Qr?&f=|v!h2dJ8jFcmv zN2vBigvRo@#Ep#b@+ifUlj0h!`o=^^92cRoOcKUN$d}P_Y(hlOod`|k zih3zGWcJhuH^n?Xf^kNK1~VgUl)W-|mg=7!AuuOG^LY_w%#YA^afI(yMtHU=LiG9w zZ|;n+e3yE-FG7`*THC1zPfkY|e=fqQ^AYO&uJ!$)8ZJawD>H7W_cv9~E!A>Yy}lRG zwe%5+J&Mrsv3e|99KE`^+y^F0em?On(esXeriF~bUZAxEbbl02i35%SIELhf%VC=T&k=kc8{#T6`*WZQoy;jI4l6Ae14{sE5LyFxlq~)DLc1pp$LWbQhWTMP@ zP{_DPh0K=I)rw84)%)rFDE%*5+7z3mH#7hLpM+({=IvNM{kQi9B(z$T+B>n$it?s1 ZSM&N79I?a)lOLS=zw`7j?*E@Z{|76q(Ov)m literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/98d7490707cbe557_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/98d7490707cbe557_0 new file mode 100644 index 0000000000000000000000000000000000000000..41e5bfdcafd0a310458b2786d8f066d3084f82ab GIT binary patch literal 31396 zcmW*T1$a~E+sE-=leS43Y1&e3l)7t**Pz86He83h%W!A7ySuv#cNp#tW4OD^u=o3a zcU_+~Ip>l4zMrQhJvnJoz0S*iY4`P;hooZIJ9zgMz9_3eva3+Z!UYQyDp06+$$~`+ zX1Yqc3Khs-uuy@*S;b2fDwLJKaDgmW$$|y43K!2Rk}tDl{(`0Ql`526xMaSP`AU>9 zGREm_wi*8$>wo{veBAT@zYgU8OVGHKbO{eiONGlwH_PO68f@>1Rkk_-EB z6U!<}iz`V7(X%prs!Lxnq=xh_^3;+#;9(ajxvTUU+s8_|7Dy4OjBZ$ufAAR97fJ(h z7CrY!y{<`t#oV+JdvO;HGu<>C`?K8i5bcY*sW*C+aFb^#H|0d{vTmwd-c5Zlql%k8 zwQ!TErJHu(2m)KVDGt@q7-6m5bQl+Lx{aF>+PWzNXMCsmcdeO&C{rb9T zGzRr&tf6k2Je>I8Gr~JPbPLYtUvtgZATTHiHiN8QDLq~(6I~g<*(@>_fLH+T$3y-@Rl)IZjk@(i#phi9D+tZ*~*p0lshz;hx1~tH6 zc-xP8`x{hXfI*!G8nhid1{vfv*q|hA8$wPn{Ao}z>_-3LJRf0D?~w+*8pB*@FqT-y z8>9&a4aBmE{AUYh@H5MPBRS(on=tU9D`QRH7MUagN9-voC^$! zS!__wWd_|^ZqS$&#J}30!q~gkp!VyS2YJ>TbOtxjV6#E)`wcpd{09s=3HQUaIcd<# zv&4GcAj>}nxzGSZFb}IS@n3_c-!iD_ZPps8cZlJxLH-X6I)QzU4665(d0rT_@TEbE z-;u+6gYF^x12y?%kTbTLU?4CybW-@9YhMJ9X+B3+o&IC)LB@9 zjXD!z)PzuuqkEW9ZzGIKiZp6ev{9Yoc${d|{UoDqxs1w{Y}D)mw871SM!hd$RD6n2 z15%A@m~PZ*#1=K`4TcsoY7HJDKGUetn2A1F#9G{_I|wYvIRun4YB%ncrWR$4%0wm9 zEo;;ROfF}XwY*Uqkhg+S!;nzXsOTz2RYV=MsY;wE^DFIe^f#kARX56~hEelz6qiw> zrcpC$8MPGmv8c9DpX(U4qp?v>@d=ZfFn3dOY++R6mPUA{QH# zyuzr~sJ4c2*BfVcbqyo-7*%;Mb01+n&N9z+`rR-p z>k;##4{|+bFJSBw_S946cup zc)4o{mRjBQz~QbxobFnWB0lcQk=tEy*p9#RxNB>myY`2;>kb-*xhpo@T_Mr#+Li3C zItATTJk4F>&?4PkyOELMt|P_V^;a2pnajGXGq(KduC}>8^6E-Lg{E(HyL;Z7lXkRW54a?&p?*I?2MEkrR z+JY0v9q6Iw*cs%ZZNVPO4EInaOpEYPu1F76L#J2|jYGva58X=i&Nd{$3tB zg=W1y^c7?Kcqp{5hjt*LzlYM0G{8fX2YTo}QU@^yCg9Xy@*Lu!t%w`yp#{kHr-z1P z@Hh_zOeB7s#P&%ZS~Sf=Ii`E)5aMQe$T*w4P!~<+cxcc(4=u+n1k5K+)LQ7F=tUk{ zv%y0n_VWC=hc2A+Q0ogGa=SuZVZQ32k=H$B|A+k0>4t~ipw7S489#4&XznfQecMAT z9uO}IKk`u66Avvz)KkVp!&e?E^xZ?F<*AV-Pp$Lw)GoMX^He0Z!O!1QJF_FFr`rAE zsXlo zbOE!1OsXAB+fb7Z<02k}ne+}X!s!>mxk!`N;&hZrH}EamB(E5gn#Y>d731Sfnu~4m zCY4Mu=`8-m#6*+k;nyUS8p7!^DF7#N4M&nqs+`ZHbp=fNP|&2%Ld1(t#Z0P_X_6z$ zq-D5`Y{gCb4Wmn&Gy}KG5Fh%NHR(P&m*X)!Dwwnd2k{uqE1I;jl1U$tRmG$?s8H3U z6)65Iabp!eVe4-um8r&8EU#hGlA0z3)-$Os?jxnXNu@Cb&rzuX^Wa`Xlk)v;Qjta` zRc~xkW86fECghH9a5go`)y$*}Om4yBHYT~ZHR%~XqgQ(qzp$7z9KIb*8q}G(BDRZ3 zFLAdkadkH-{120I^=1wn=t~{?n-o95q^bi=YJiP{=s%dpSOdQyChhyvB;zoXvJW?@ z%}A4a;4@B)q7I{}`FNAsPhek6qQ+Brj%9caziB1~;S?^-G^yGwVw!E@=LY*>j!B#6 zndCj+q&bUCid;(lU|()h`Bf$@+DzTIP`|Avjl*)>#h7g-8Md306K64ZuSt#eo75e@ zA24bEA!>ctq~6$tKaQ|wM_EVgJI)@(9ZWu9(y&vk{b}YrV^Xnmto?cNzrfmFG->x` z>V1_qNW8{c;4f_dhZ^2szuaWsA?GdD4)xIk8?o-TNr%wk4r_u>_sHo!b%pf-eJ}<4 z@DbG>k^}UFSdfku7>5`5<*A9Eb0+0@!=5ylnA#fo0T`xtS$I0(X1YrSI8`DVY70g z5snoxD}RbvZO{Y8G_zi#LZ(?NX_g&LaRE(AF(!`SBDR+{YeX61EXy1f%zTfT^|m5& zS2C+t6|=hjYSypS%=)LMS;K0XwGXH833ck3wH7}ytG-#;8kiM~ImpwV>eIxm z#HMC7z;%3XW>(p@X1(cRmRnb1L0=?xqdtF_RRi}htcO|7o@Q0+W!4Sk?nBM+v@d=7 znYF&ZSp^4})pDR&FOfOetmC+X_vki+ScaPA!a}@7^FPfxfj@>ZK0ag0aI;#CFsnNp zBhA`B)~rS27$2w5U_5ojdAyrIO(xP8*(RB_8^`eo8z<9tidpS(3qz)w^=-OY180~u z7ON09)2yp_jM}q!KARX&Ypz+dk$XO4V9x@x3=7F^ky)!@Sz=a2yui?pE}z|60-|IVCdi>g^HYJ`69@vSQLt4ID#(T77fNn9Pzct?q^YM6vE%=l+B`nc!!Su7L~|u(ZZY-mC0?< z7!=9FT!_qTQCm2JEUFH#5Q{3~UZ_P;VHTaioN$X);s`24SX3LA@gLepT4ao+KjQHh zY8J3)aY2hV;56zKvdFVAIbZ}%r&^RP&7xpr;5aH4v#2#nl(c9xW?&1Nm9nTaYL~Id zqpU^#m{X2;aHWz(l`30Q51p%6v>)xNTGSV>@C{vmwdmY$7WJxTQNbFFk6E~d_BE+{ zEsG}BX3jdyi7lvC*CKO0i*n*bBgSoP(bVP^Ey6xjZDCOZjBQPBZOE-HxuJVI>VkX7 z)83-O9V{w|rzq0VqM*Liyq`s*kka2G#{kB|DLh4=ffkuYShN%cMp?8Mb4FWq0h7j9 zw0oRIQ>L?y*o)t0Sk!cuMZITR^cHjHShN=X=CZEyh;yMuhtO^-_1HmfJ1ttWi#6Cy ztb5o$n2+^)85>{sTXf@qMcob(+aZgVquk#Xy+HI4>WE*Ck~=QLag5p=XAMtK$CK>O z>+H9GEnNJxC;*?}ev5U!W6`F&teRJ-l?% z(@O(QUK)!-$h3PY#@kDQPA|ow3+|$ikC!%O_tMrJw8IlL&grENScWpccyVpfODpnt zDLB|mt3$lB9aTfUWDfU|KbpfglCjYpe?@ue0E$F=X;zGvmLoWh81Ww^gh!| zDa9EJStY!59K}m|sRjmM5)R@rOr^Y(8v&)gRIRL+CgKP#!l%5KhC>y+6osJ`z0|J~ zxgk$wFP+ECDqcE=Mb*8u0q<*gsaZ`gEyW9D*7nl4xwKnI&ZxeKnlAQI;!-aaTIQwS zmwRd93NQ6q>7@#*sMQ)Tjo;*@IoSIbwMLgMUit>l?ZmdjOC5K6DP*6Qenmr+-S4I3 zgI)?c;-!0djT%S2lz*0oO6)xtD6c^-}wHJbq6tKQJEr zK6>d2W_+SPnERQrzmU^^Ui$u(HTmYH0=cXzpWCXSU#wc1$0~DPs}cjPx`aPMt;!p2 z)t3mXj>TAIkFzQ_3TIi>3D=NX+^RC@U)HKt6|D-aWK{+HfkikCXKkwju%j;h>RGiP zZ<|{66OEc#)e9jlt*V2KXw{m2DAU%e>PT&8)db{gZ`HDnR{cQbPF8*GV%62IR;6{b zstX3dt-Dpt`dZZuf&HxdIM6ENAgg)~wrUtWhFDb;6_Gg9s&u@;PYnN)c}H0F4`N4J z)dDN<97&^?11HdYv{l>CVXRft#?uGp30CdK3HVI1>Q{U~#VJ;em`XeBn#TOot(uRu z$TgGv&;)yDSv7bzc_L}9RUOd}hvzZ&e58m#ZlB)YSk1h z!s=yK-9yn8#DVfFnFHgIdzDpDsK1)ESwp^m>#Uvcs zWR?47a>W)LLi84DhHmJwmHn~Js)s1Hoi)aA9N$4cJIMzncCjXyf~LEzT8Q-+w1--u z^fbTmY98&^Vh7Jig(vp-+!#if0LMRTNQDK{fBxOkB2C5 zk9~Nbbw`H>)Z-yF#KA|@_F0I_7L=iHAHKiM$mtJ&tM;NezhvkH|D`yEc(v( z9bVu+g#DmiF#e?GxQTVL>7c=;M@E~{+->TL$sRWSZnCKz7WvqeEr(5Af_aQPc!?V! zd=0fJJj^CXxJ~si3F#3$kF;q9mf}Y=9%FZE8Enrme$l@}6ST z*ZDT(Tu6Nu*;E#Ta0m0&*z^kD(0;8=`w+d(ram}^$n`e0-eA)eG}&ZR=dFyhjhdl5 z{zZ-LHXYbSt#^~p9-C74QkQ+ydOzn6*fjniV;-`}^KYB3W7AQa5|7z*3RR91(+TQ{ zjFUD6owBJX`kba6@}8j{XKi|qMdxfvI&aeki8Z-w(^@RPVbg|xZK`n7 zrd4=y%ch&RS<8DiHM~!L&up5GB}jcv+%Ifuilg`l_m?)c#BQ8Gp;tBy#5iPsZBuh} z#bXqCV^e7yL9Vyd3A6ATKhXA_O*?QDS?_I{fO*LE!KTLOh|7rm$XHl{k8uA)UGXE8%UaZ~OK>k{S1lCG zWGr;bvTFmrAfbd^AF#8eU4N9a>lt#CCMOunFfYEttE^qg=!U^qU*4`8xKhzBw@P+} zp&nY{DE3ulUGN2t-x#NwUB#-~RS{!w6dh|&-w(S?d>Xy z#kkgi{5!ICoyfT}`FCOMM%sC;V%Io)f#)dV#6f5@>xe11f?Q)bhogubON_XKv~k3R z+~e)~h7uF(nu%q|HIe$^=v3-5&91s|pKjMC7-ra&I+HyP*IdR%)p>SJ#cdRt&sZ3Z zc?-yCp)ph@$FAo4SpS23UmPWV zEIMvijZ^F$tUb+IT(T<|<=}Ric(4m+uF&o(-#a&$^Izgdshf7LbJ`V-nK*}=SbdxN z;wAFmVb9-22y6iEzEYPTd=JQ>hX#i#xH~k#J<>d^|!bAdx$H#+3Dg**;AwCgB!KITw7-drHoe;gWo)1lLOy;UR9Taop=l^;2} zdMgZruo?Ri*o`)5g1p_m6^lz4_J_A7qe%~MEkmcC-s*>-Ufznw5Ey%V%L!K>Z#733 zbnfe|_1KLL{k+u&HTp9Sj00(p_GmD~TjT!p)<@JH=B?Mmy%jgYTSYKql(*K6_13C! z9G~c|)04clXsWkbO!L;^>E2o~(_34RHp^Sj=Xfj6TyI6AIsS&veCAs0tqL$L@mAt; zZ#Bj?>|5cjQ!uS!?ls;zwANc4H+t(9Hf;6Q+HIWQ>8<;Fyj6Oiw~ie2*40DaTJyKJ z9-Z*k@8`Vr;4-!N$6K}Tc&pH3Z&iQktyk~K^|QA|fA`i*H>Z~2y3xsNWT)&7r*dPI zw^OB^PHn^|xcfM{m%yndsPF64L_Ge*sSg+)QweHr*ecl zH5#oWoSGc%RQ?#JA`+Rqpi`R)alEioH?XIOQ(@^&#g=obOL?c#DmqoQic`gZbE;c4 zr#@GAYF!Pdf@>0MEvHJ=b@Ds7Q~es!uaQ&F8#8xPr$U-J^|85AOItYg48>YIwGTg0 zqz$=YJ#HbYty4pA3-8-G<<{P*xK2*>=;~BfH>ZNSJ5})yr`};*52wEObShszrv?pl z>f&Ih?qKCmr(%ZjbtE~Aa;nv6rwn79dN9_h>f@YhJf3kTlGh}se5W|o5`I&isy)rA zq!~^%M;EL@!W{bHE&iPAlxrb*?4(Y3hF^D4kKIm<#~H-#ajGzeB4aPd4zXT;JJl2` zu@w&wJJtRu^B!Z(PB@i(%BjkyovMc!XPN(;Q!h~KhEv0CJJt4%Q>MF4bw|&89D78a zA3L@C34NbBxlhHZYtN|DOZLqxrw+eyYUT&l6TLpu9?#L?i&K4I{m;qoZ%*Ausqapm z#?+rqeL)|8A8p5Bn6vxnNDdzz&FP~{IF;K+jq>`aRgjN51p6o=#79r@Ak;^@!hCc! z+((Nee6%jgN6TV;v@gy_Gn0KZr;v|!7xqy~5!$8r=$}*{`KJ45UV^wH2P z9|aZn(Qr6Q`e-ezrF`@|4x&^UAI&Q3qu`3fg5s5Zv>D&9`d1%?|K_6^*pF8=eKewu zkCK1)QPqAv8ac{GzfSeh(ns_S^3|?jUsaFx)wCpEEyf_1ukz>fRiXU8DpA>2Rk5+E zul}p%tJ>B1iVih>)wQ;->eunrFLiz8Y~-t3jeWJhiLV|v^VN#xzKUu|+g85H)5cfP zIEVIaeRUss+xcn?W};13U-q=Go(%BSwc(62!B@?v`0C{vU(H$TtHbMj^>zz$9P-sA z-1tdb_`CUO4DNXN=@(Bw^)UJAE1YIO87zK!H{DOAXZWce-a#|{R00z)54mUgX)`*_ z@zZ*IM$x%E#|NBQ?5Cw`X}{i2UAJ=##vOiYu**-g@ET=z`)L*KBmW*hO+=x+ekzGM z`}|b?Am_2{ke`|y_S1QcIOeD1<9=%V)lc)0J4ZH^LJ#E2nT^*5*;F%EHqA`Rro6SX zX91F48S1a4cw5w8Co}yOTgqRF z75p{hSAW&2<*#<=JltPZ#`r7WB!3we`}3O4pX*2d>aoXP!w>BR-+qC4c$c@Yk~^ z{>t^#UyYvmYcaOt2$Ej;t3zgXP3V(dRfl9(iILegV|;cUf@MN>?!n2fqf4?Y=5}^n zLXCIXweo9rJ;v@FIk@*Fhi2!>pbLy8;In@qDm*(VJSx&x(bE-~`Tsj$*OIs6j z=}Ey{8d^G+X4KB5z+SnO=S?p8bju_6Re6-MHjkDc&7&X3^6=hrfPTfgA^}QH2~cV5 z#fB0A%2zT##V`i9;aMs`r%MNDW7z!@G zSb;q=0`wKJGXr!73uaM!)SgXj$T^2&h+7n(DT@QN2>F%-sN_=O$CFh7`iSr~9LILd z*btx*o5%ql5%3r5xGg|6(G15>W_N%V?hVlNee~NOpfhNDfHgfxebC@gfLb02P&a%# z7NET60`wbx$3+ys6rkMyupcl6M=|(DfOaGI%>d28My$CNpg|Mz>NUJ4=2f2Ad6gf{ z&=&`geNJA*Ey%0pIJhvck{0LH?2tfxLr7Sl5^)I$k%3wm9jJaWf!YTDxIi7loXUav z2V<)QYA#w=4OH!xf!YeS3RDK(z^!$lmLN}?Ky|}Je8z&dfm#Qzc7ZB^DY%W7sN6nK zV{itZ9Rf8H3pxhs7AAHg9+c`Fs6A-dB~a~f1eY+kYoMN>R(E3hBT(0{yhotyJp=U% z?(_;&Oz%K7#r{6D?@Npu163U@FcI@`8I3jtsspa$$L2s~|0_`K@h2j-1ga$RZ4FfU zZL~#??SWc>d&swgxNv-DpepVPRAU^+xIKaDyEjnhuz5c*9SGF$zXSCcgAWJl0z!@i z>Hv-(4b&C*93vkz#|M-=9;l!b)D!nk2CC@kK-IVysH97QI*RKUeI-ycQ1TkNT@O@m zY{1Oh_y4vf!sq7s1a{y^Oick3)CxY{}`z7Pl3w) zB~Y_GgSgKyNPi>19Hcy!AVs69HAoxs2B}VTkZz;|$yzK(yKuEckRBkSY>-xz3(^+E zR|?{DD744>nn7}_6{N06uM?zlDBd7QHQF&p#~_`@`_4h~?aDYP-aUwWx)|?|Ao=y8 zeeWQZ=@TSlU)l}~Qmw&3`Z_E~gBLOWsvuoM%xdCW6Qna(wl+xa>w@I9K1j2$9OE|x z=`N0L3{v?`L7Ierkgz#O)wcvGV_T4V>#s2-cGx!7{H7 zR=q>P`sYlrCY%da)P-OLUJBM-^tl|Y%V>LrHdlky`*E;VzX;agSHWueBUl9tA2wkzT&AvA3da@lz7e7& zsP!*#;w8%83ejoYgV!C-C4}lKI%bCI5-g=dxuzPb`Pd7U;T$Sf4psZ#Le&pztA%QJ zmrzyd9;y|8glY>q_6XHqXwx%PXVI%ysFq+O9w5ATsPbVB68eP7uWzWP;RY)8V_aOp zh5@0f`e&#bPYl(r8KJyi8mevhf?~5m^*7A3LluLj*gq#!KJ!AkE*L7qhEO%!7^>=< zLN#M=sB-QLRr8~v8j5o$ek@eSvHN(ap5ZfEo?v_&#-x*>`iLo~LgjrrRP%5fz0S}d z8E1(TQ}G<;bD=75f%905eivzvFIay$RCnQfg?Z5f|6=9!P~Au7jZnqiB%T+cymu0+ zMz4tbb*Q?157jZ$SD5<1;TEPkXn|v>Xb4kX6fuVBB38MF=@UFW!ZZkDJ$a5lOkwI^ z4wEcldWiSv?-iyA)-cV5*%qcQ7>FTGj>G8_rc1tIdVp$vVQP$~*~7T6BupK1hG_ua z;3tA|hv_74pyDsYgvF?mCrrQN9ByG{K$y1TN!~Cu2nNQOu8u(P6U2&=w2OG$BmQ6T?(9DNKD`Vd|7j z4*40cP?(yegz0ixm{QZjG(Cg5V17|zz_nsw{EP_Gv&=AgWpNBoaJ+b!u9gf_u2Nxg zFCV6cIEf+^!n73sp+-e=MVBUFI?z2#-Tt8VJsGoin5qt7_#i54bYV~`#-om|6xRUTY)+2A@ zaLvJXcsB`GTYN&^rs1lAyC~Q!T+cd%E4*{K26f?h*KlPH3s-Mk9nM%I!<98XTmz7A zM!1UO7$RncD`0lGb}b0k;J?DP8@acJE5|m*ITWsa=<+w`5P6t5@CMzE(jWgE59hT> zxW?cT!cK;30`i^;*AQgC7_O2Sh|PG4+?T?+1|P0o*bJX5;kt!6H^OxV`EQ2Haw}Zt zABW5Kgt|N>#%JN$_A*=_vEmiAz{=O*y#9>P8&ql?p|Ca)+A=UguTgPugrbK;Xy1qk z{fC;PB9t&XLiMLaXcj6>jZg#JN9Obhy+FA+5&X=F(C}3e`U%_W2<6)tp`x2;iw$sY zj?k}IiqrT4&%Yv+fx(!7%3C6|72jal%47VpEkc`5L}Oc*gf5`+jR^Haz`qgdj^LXS zT8%5{aw|dwZ%61PJnt~>-3UFzS4_Vb!F@y#x{3n-aSUS>siO!tM9N}}lq*N1+Tdu; zNPWm1sa|;_wGC|oBh?#jL6K?@9H|*0k@8B9R0%A|;8@W}K93NoJIE*zDQn3{Ju4fj z=yH*|f#>L4K2m2YL~3!xNad>WN#~!Iy_=!a)BlX+aNNq>mi{yg}mm*aUx*VzQ$a9_e5qX0-9z<$CPGyhczSAfb zxf7)o_=e=WQR;*%c#7zIQ7VX`IEZs7cRxy7(e6Q%Ug0~2Jc`oZ$5C4FEK0W!|2#@v zunKKoL}@nOBkX0A0$xSw4f4K@(tx*7a(fr0k~oFz@1xWZ%WxcD(BUI-ev0D0lPJAK zzRyuytBle`RQfMU6A}KE=Rcy9s%V{uhg&rFF-Ge&HW{LI4}r#L)xdC^LQeN+)xiSX zf{#bEGSLx>aSdkAXca+cEWu^iP0`9gJIuvtxSOMuiVj$UOYpQrD;>SD3OC^NidHdn z#9B16MynG(p_)BfB^=Ru;vcP$+|l|F6s^SIXpIhu*0j)QHI3$L!D#svidIFeEKH6? z7`JG&vKNb1m&|BIW<{$_$!M)Wy;9L?i?^s;hFHpycLj3X8m<0F-WIJa97XsJ#@HRL zAy=aH^meq$K8oi0akNq%N2?sXpK$zDw8CC9=bLC1cpI%ppQ07~Ia>X`5chx4+Wa$G zFHzntM)?deTIw02+ekOZ$ZCnv4&NAk#wx!U?L=m_7|r#MQQPc14vgV@GDcT}VpKOc zMjc@eiQ)BgjBNR0)GB|BA_~N)Pb%Y}U0RI#!k8YT-!ozqS2RYuE5zt4)>e$s9(1V` zBS+mBRlrYp*Nf2e^*6qFJqMVRg7X0{53{C z-*}E+e#WQ+Lfm5YJNyi>3PqqXR`JeQb;eL!MVL>llCc4UePeYUv3{}Yh;6un^4VfF z9;N(awFpP?4$2;@!sv@p_<`~{V)YZ{bH=JRM&^puzbF?TtC~1~>k+YfirSH}YJu}n zv8o;uE8o~yy+!Ld=D~WLLZkRtt-(%YCB(`-F;-1*1No9-xpp3_&#=2<)iP@Z~Kh*gO?)EuwTsBWyz;U4nW zi&X_Qu1~%3ybZN!8>`|SV>J-@JJA=%5!oeH*}9Vdz*x<}e}iImX9#mojaBM2^2HDA zm>#RWb2*On^J29RrRG!D1+nV6Fjgmba()lzv3@V-QEDIO_s6Q?fmpRW8mm=ka4c5s zk^4CHKF!xNtO@?bgtM_~ewq5C<`vcwFHr7UtlC~@pM9sku>7Rv_-csbb$pzj;~NIK z$LW?w9G_i^lhYEXN^tXv zzFzSfYLAyk&UlT1BUij0<&9TxV7&ST#VaK^UbDjEbq%8<;x!v}BIDJxP`tJwZ(6+S z!8<)(fmi}V(Rgjei}LY`tPrmu6`8M6yv8<)*Gcqm9ItWkZxXN0P2;trSv>D+$7>C| z`o(K6t`Cn_wh{5_G%{WRqvADiR=jp1=bU(5!oMrxwPIzw?xEP~cs)mjJ@Fce^u6(_ zhzm&CAFmr2bs}EJ(B~w1!1q+VI-HKzFK6iYPrUxby&KfwCUM-O1}O0$UPT|qYx&D~ zZTTLr*Qoe2p7;LZ<>Qv1wupC6PzRp`t-v~3L5>^=+K+SSmNP-m zFg{m;z62$xQ!ss^6Z944m;^=DP0$deHb~GobZnBK%Xr-~K_yxx=rgLfPLSFps2WOj zVLYtqk)T06=|3ewLlHkSL2ZzCR)P|69%W`H=uZ@xlc2K5KbII6Bq(-ag3?h9zKav| zV+nCDP0(!&Sw>td6SQP?g37H+P|t(3Ih3I8==FDk+zwL*d^?h$en%5D3I&fPX!UXW zpGZ*PDRMiTpzwbg_f~?ew-dAl4eul<@@|3_J|T{$#9>cVsv}Wl@D9bCiTo{qL_P6I z)THc*dX2_86Ll|Fq6+0sR0+I7zC3&lNYs$PM7f7?JUo%l6(#bsJ5jx35_K8(;7CZ6 zIVn;8*oWBUL^aHpsJZzQ^;>~NozFYb<>XaYx{L{;j`xcw3}YG9)34@y)!L=8^V{)xmtDN&2id~%`&O;1#{8Hs9& z95WMDXLh1`El$)}OkIWIvLq zr`T{ZQR6NpD&$t8j@;q-8=k*U)NGXgkf`Z6gLR)0HN!1Q9)={PVXZMqMLm*q6qhi- zGfDSNNqP%+bCO!2h9yZ$ZAr>$Pf|F}!s(r)LCz%g^iR@^?3_o{97$S&u$)PH6Op6~ zkxAMeO~05Vjm)24T{%f-swSz{Z%In2o}_iyg%&lElvyiDmC*=?v8i^F z9@kCMnEFW?*N{1WPf~X5hi{`KmBsv~#Md@SlQ19U+fkSHcc zjirX;m;*J&6XT2|-a}4OHJD~4>C4JuU3!cf&z)a2$TWx>OU# zesk%c>dak(9AKhj9il4!&dgK$oHi({G4N&xgCzaD+>3 zkz*t|j&f6KX$_`Ql~?#&)=-s5tn{B&KjOz%u}rI8JD8YyHxQawYo$OSIFrq`CfM^0_RZT zAD4REaOumxF1@+!(vC+iIUl>!6mxM3*HQcl&#@X+p1RZ-r;+~5rOWt$mCs#DdO>V2 zU3!2qZpkWUNLCf>g@=1GpKnOkpFYW&hN`~FYJ~I1nJrnvP#`c_rJ$f>IWZ7Nf|FG+ zBv}(;lC==^Vw2St{~|O#SrgGWU$VxcO#Wom!ZCOkOjbXP$w<~*)GC^+mbiw%Oxh#5 zOtLzZO;#V=#|Nw{N4ywcK3ShpykfFW;t}>$N>;nd$r@E9Sr0M$*JSzrmaGQY4EJip zf;%WtJy{7gl645CTFEL`n>NT(hdRKwF8S6=*1_MCb)iwRwlpTrX2}}RDp|Q(Q>Qk` z-1kNPsNODFL-7*j+9&HN=5%1JPRUBgRgCJKtobP3g&evk>szm6_3WLj>HU+{X#n-Z zI$Xvt1Ctd$m|CMN;)hVDX~}v8!}Me|K}VcM(HX=)lkwm^D_MWcPSytGoRh4@*opxg z3#i`9!kUkV$n~nQDq;jq!uNGymB$e5#2duCDXgZLjSKL4TUf==4Xg1C5$_7CKBnLl zjPDDp2s&XY?jYxf!m0*W;UY>cQbe`Wi>Q9%BFb~5h~CAgC@LX^&rGIh7H%RaF-46q z7uS(JDMf9t3l3L`>R}z+l2cR}gK!!7%ck(Rg;Eq=E=2{f6FDoS=p(LFPf^>NDf-lq zV@*?3yhVyiwMx+t6l$HK(s+hBZBq0P#;A&@Dy2 zn2rzKQ?&7q6#YFaMaI!7+JeKVFeXJS#-^zGxD?%6lA?g6DeAQ>MO~JsXx_FIJ`=|H zJFt`dkEbZli4>i|Ei^lsq64Q=)cZ_|`aUHmw11Yu`_3tHe@>lVq;NevMc-_xDrisD zBuA=td#9>Q&QuM;tz4=69hOv0bEWDW67r?$9ljSyRn?SK)hwE-33yp7RU0!?)xT7# zF5q$HRF$Zb%D?BSvizE==D(#Xty-#7H&rQ^Rxefc>!<2P!&F87o~j{@QkB^_Rkd2C zY9d~>O4aJtsT$mtc#yk&s$OG$&s1GUq28(T?~^LG;i)Q$w=j%I)o?r*$(*B8)ofL& z=Hc6F;#!lc$?#a4s?@(y)eYyjq-x=|RE0ldPMkEPDae?ne?8Ka!!u2bOli7eO_Pr; zO;d8FX=+fKE@D`4nx-KjBu%|S(^M`jO?zU})V5@rR-%5XH11JK(>qitlO{*mG_9$c zre~P@Yns*~|8HrUP%TY$sxwbB=0r-1G(AMSKhv}f?!(h`0O8Zp)DXL-r)kWLG_H@Q z=_fYMTO`)SH}k)}RK ze3_=A_!}Xw({vlzf2OG#_=_OQfjRikEnQ0u>5B18S4;e2N>?m4z+p+}Bi`xy*O{&l z{^?50p03e3(p5NTx{Al9YasH+rK<#vBQhaf579O~T`N&PBVFzA4poY!>l=d0rK=%) z%cm;@%i&Rx`C#}pU1^x{Te>P$W1Q-YgZecX2k%g&7ID>1m$_}a&cdr*x>~ePSDp^( za&=5s2ZVG=S2DK2zY8&8>X39@#IT|1nug+krt8{d+D%KB+boXFOV{27>H3cK3)8g^ zr52@gzf!s?FG<&m)#-YKnQMp%No&(JW?j09tWVd`?dkH|k*@7HhRQqBwR%^&8tqQk zsUztsf0P=3A-~8BHOJhj4E?~_=nUOP^Oy|1j?K`Rqzvs$=4-wT%|V&`8FHm$XbCQ+ zW#~TM!#zDi*${^OD1mBdimn)f$ykidc!NKSX6Tp94Bnf|P{|S*yw1x|htiByHbXPY zWhkLSh7MNDP_4=tN}SAGRf}qlt(Zc`7t{6$#Z-AxG42g3rruMF$!B^oEt^qH>9dOI z!t7#dIk%X8&MT&=3yLXzQ8Dcc$W+b1OuY=st!leQ^tl@vrOg29c*lyDbIG9 za&J#xe1Jy>=0RY`Ox1_8Q>KD&2q~R2`S&(c&3a{OJ68A3mk*gbf$?86bs7V|WoiNne9zP>r2WWLX+xG);kq%4d-1c>!#zuf@dTAU zviQ3RSz3U#_>NT1ES1Fu6fGqW$6X> zMr7#$szhe#V^o&fMrUavPN8&6mM-EQ@+NT{KXJ#!IQg>pn|4|MSJQn!IZ?%X9RJaa zfD6*A0@9lxokd9|lbJx0&1RRHg3^>;mAW9(r7tMGH$f1oA|Smt=}2cmnjpO_^?iBg zJ#7sHEl4Cx}gOs1>d@b*Mx#`5`);7%^hLLz7YLH^xKr-yN#G!NFw2 z4rRxs0}fp{M4Q77HO6ujJ>t;PqYnLrPRAS?gjMexC*BkEdx0GB1~C^Ms`Jhz_6d$$ zcIXKTUva2D;&2f~QXHxdFDBz6(q45afYIo1jap*WKMwtk2gq{Wp;9m~4)r zQ_iWn7>LmrSKg@_6`b0DDixjbqD>{Ien9TZPL)RBohnW}!0M__jj!g^Ivo4dsq;0Q zx=_=pT(z9aRM)AG@D0H?X3WQ)lq`S58gr?9}f#(A}wr$lAlH;;4f|c!n3f zo%*m3`Cu&8AT^0T20Qfz4Ms68tg%k!S8!_j9H*Ax8S<}ns?koTy5r_Sr*a%3mSe<% z6S#*0$8mysBIXpe#XPLR#dl6Sm2}3bQ-3@43a*Pzb--Y(x$4we+_^zLZ#vcau2Yi` zyzkTiw0z>!Fw}j{K0@)=#EC*O!M8DkAq!Hv%ihMf3s zkfHqFv3#hZN;opyP%7&DV5lX2M+yp$HRQlF>_qYegTG&iVWOeBXg`T@5i^;#C_UAX z7YlI&8D|g!uFNv@-fTl77Z~~#nHCZ!eq3y56WT2`Gy$_$8rp>-zZr64&uT;a*HX_E zLzQ7(H`Ec2k?{ugeCMX2zYu%N;2eRWJa-JfD>oEIFD%4n#5|*KxSkuTmTKrE>bxLd zEPZPz4SV`kCYR>rbE!aKm%QkJ(O8LNc#1qlT&jl_=#T06182dBMU_DudSVK;;|^Mv zcWEq|RC4J%q<-pBiRv!psO3^EJcxCvP<@v=xm~(yxzyg{k}KY&E|}chrT0QEO$@tK zH0si#mM#UpbSZsnmnvaNN0*9sc4<`?ml||)aecH)`@eDNKH7ZiQg6(Ar?*RvJ}#Z; z>r$hBE{(?-l=Upm`GZ%P|YFF4Vn3zHg$a$5z-*l<|1NH&-J#^_FELm` z#Z2y1H#z6Sdd#*>{f2Yzcue(cXev{jshx@R+tkz)oJQuBCcl48wQX%`G}5#;RT}?x zHI=iQsk1#zCf+yI5lL9`&Nn9W`I%aamwili>SuC)hN)WpO~v6To+X*eGSJlS?@gUS zz9FV6V;Ih%#!yq;hM8K9yTeVj7-{M|Y((E5cpYu(1=fu<)jiqN7eA2~E+WGeQ$^s# z9Bjp9G@EMb^JymMa7^u)LvC|T=C+|u^H?|ERP17tIc!XQxWv>Ov{`C$jg_goc)OfB ztYFznQxlQAifvb$s<_rv5Pfm{cT=1GFqMMF8%+(z&Mnjm>9(3GglcGr>pSRsC+~3z zmv#~NZsNgQ9C&9B`**LYgZoWAM3w`l+T*K(rg~xUAyZe;=!mKN81k2?rMQPzcyi3t zmgA-do*>7Qv^iyJI$k5!X;byyIb-TP9B1hlMbFa~tuC@XX1{aE)MuAjj#*d93AwJB zDu#;x5dU??zhSD>ZBt+0HI<6C_e`$UHaXWt4iEVGp~<`&rf#F)V^cNJ7~ei2MihHW zENFqTh(&At09`gk;$z$+1#>Axzz+cFtvmEGD0Ulq4zeB##Ds&3sx_D|jV4W+8Pm4N?hx>c#R zTYF>Ovg*?}Zlg#8w+b3==5==~x8-K;2e&$T+*;AdtxZ_(b*rM^tqxd+1p&7r@ov2r zbgLYG!9Lu?7YT0l#37VVWE`}^LEJ*-#`KGinz&UTVVp-QiZyl1#EfQcZA8Q7w8a># z!KoJf9422}!@`JLJ7GlKYKdX^1>11{3+m9ytxKrVn(=WHZQ8o^FUqxZt2uU|{a3_< zufKMyOnbLp_jL0-2Yln!9(?w#TO)_Mbzp>B!^gP!?$)iDQ{0-g)vYbt$zz9Gi}t(q z<4IyXMW1KfDsi6LUvMkOW$J+8DeOBOzV231R!e(xSlV2|Qt^*1{aVFRLVZi0d}eW; z+micpOE)p2fu%&JrNV|KPg6_IW|qpfv2?4OrKgzR-BP|DmLk0@mHfuiv%Z$n_p@{d z{{EIy2Uu#IWU0v@OV_`%^a%OCw=@dp@bM5!osfbSLoIDV&S93CVLqOs!Ej4Mum_Ei|cBl?n?jjchrnby|sbT;1$ z*(!ws8ElQl?-_0N%4BO5_Gh+LD~qkU$dT37H@J+%_iXJ&wQRO#BU^S`{csK59JUt1 z`@YS*JvP@E*jkp$R`df~9dq0I8N2e@%9D@2FfzZbrv+?1FKBB*AzR-Tww1n!t)Eb; zsIB#AQOs7B4{cpSu(+)yc!0en=&vMk!YEDbWo#`fXY-wc&36d4tXj6dtZi#2))_YE z56IuL)dh!8!L~IPcj5Ke`UTk<+UkVESlP%{6)&;-Z8eLt^#~2)ZH0oi&cH~p`M;#C zT#2>XOgXn7&6e- z73BJ!SW$H-H6Ll~85WLWzx+U*a0}%}+vOGWXWwD}3R~TO<#=34J{bO+trPfam93NLxtjg6mb$Iu^YJ_N-(V~MAGStp zBDc+qiLQUz%)3C$IDs38-$EQah<~T8KD%rU!+_nk%I)Rzg+=?=U;7yc7Z2FVc+l1l zNPoyy(h=gvAIJIp;=PmX=hMV_)>id%w$7io_3=fHJG{aAOMGT7b3CVz|5c7D%(`al z*gv-F-LUoJO+HVzY`w*pe>ryU5Ep7b;P`$@EuYz{fj4kI=lD*gPA~b~;ppOJgQgQqe^vH4^KUh z)}eSTW1|Cx;3*2!_ox(lU`+#$9^x&UIXpT5kJF<+@rl9MsARG&*5f4{ZjVObFw$D| zkFT&0H&M){FC^nHQ37gABB3AMm%97p!19$6TS4S0k~%{*N1<ei_i~}aTvLy)Txa}c2|#zjN*MRui7^E zY5|(G@Y26mci{>1;J1iZH`{tus-0JV;}*Jn<<-Hjy?oE<)s`+^weR88+bw z%|n?1UJXt1YRo{dP7n1ec8pg!$9mNUyT^Hze!N%fu?OA>UM-#I)xc!0dQA7~H?*GN zRZqM?lUZyt+pF*fucpKIhgT6?LxW9TmEP>te|x>Eu#XsU554w#b?ksw!w!1&{IFLw zju1OiG4L<1&L8z^{4w%7=~W&4bjqvXX|KMx%ouong}76^N`BzgQ4D$L)g%;rPn+C6A(pC)&vJz9S2(;AHG(iWdJ~dkJ)33*Ux{Em{d|HVbCw)pj<r*E&9jDea}9vz!$fC>V_h>eY)|`r)iIU8uHX9-*c9wlIIKB zz4U3uDN? z`pBu- z$*=sFg_i^UN*d%>GM-@Wbo#->8T5lPGwEj*ZD!LCdSU-Y-ftp496(?*dHzX`TWGV# zuggf@OI|3u&#z(o{W1>tmGhEcex$wZS1wG!lPipwLLF}SmEoqJ>$m;d3*RljmfiNN z$-m@%&#$*wb>Gi(0sOKa__gpM<393hnFT5c9&XPA~l`@QT+oaax8*+BkK_ zV+7L2=`~_<#HrBxacYchaKywZOU^jmNA0|EJa;2bv$044RY((1ZG^EWT|kd;FnvII zGX#{BIiL}F0=fZ5zJTKM2Q&dUP^>^eO$!EeA9)G|n4>PBzdj7;BHDcvP@56~9m3g? z0p)JX^3L?tC7_LX)-|A<-v(4-a6nl{1~fA{pcRt>$~Bk1<_FXpH*j)sKt%*h*x{VRX z;??7Hyq=(LOi*oe1yv$GsEuC+wXJnf+uH<{+&-v-c-AARY(0aTipV!X#q|lQdHkM_ zhT$a!{25fQtwH797F6XOK`q=xOuN|@@9zyN!@i)(?hmTLfuL%i2rBRCpvqy@`JleP z5Y*($L9M~ED~yv8)YvCM%}5Q(^&+UwFN4bUDkvYOVr+&4&3!LHDflg0f;zNL&=I`A zsU-;-x0F{rSeBsnza(fA@~=!#a8-i7T%Dkr>l3sN2X-VVc4vaZxVS4pHFhUx5oYa4 z(1g7S`e0vzp50GS+=B#l&622mxf4|j>(Dt*q81@fzC=Z^3R&|f>RWUyny6026Xh+D zr~#!C^<5xQy}BpL8l9-M^AojlPoj3Vp?G8Y`3CSasVs zR{l+mdEP}x3)+UXt7AxmyN2|rS4eI8gmf6+^b2VOe(oRAuz?{>9u(q!mXJOf!z-qb z52^TskZMi}Y3AgRj42_m=?>|a=^_0yBcxmF=x2RMM>d4?#~&eO-5gQ_jM);>maQT6 z-V;)x6Cqtr32E`ekY+y$anD9b8`6d4N*`9uOkrKZupD7Ed_S!JV#3OqGtB3cbsvXy z+7;F`Gpvc;uuk?4tJ=V@Vg`lf!N93uou3(2!C7G)!UZJH4y)Xpu&&|}Ue67y>H_-5 zB_u5jEBjL3a7XO#&x`08&;)tVGYJOoI~FAVfio*nKy)$2cAt~Eke_+VLir& zN5VRc+ZV!ow-=W2gg#LHDLLX6#-xUI1utHN)$(OnUD8Fg94*sF)D^iiM07r5L_bVQ$&iD+s0 zh~g_oxYsqJubmOq4n%Y*o^65=)o4yzC>qg74Cxcm8SLsCVQ$8V)?qjL_m8O1fQXtQ zTT(=YaTaBUM${GshDB5shmc`JL|&)9@l z$TBjjSd79HWE>UMYc%{Js$MvO)uZWaOjI|=M>SzWR5d3?bu>AuGLxb_$1Zf;Xd5mogu?zxa(jHcXt`~ ze*f>T>$5cHoacV-`+iPJ~|VorT>6-Pr}5g^Opq+)k&vkh@etS4!!kDJeyZ7EUQzuyhe4 zF;3;Q&iG%f|Nk#;+yCDT;{Qv~q>OYC_sUAe%1INT@{$dQkyb&fkC=*5fl87K`*0o0 zDocy2NC(iXDr0I&pE0zS^e^()mOA2oS1F~N^by;~NqHAYQK*XUSdV}35H%M{gK!4D zc1yjlNWmpNv=Mu78;#r^8i9RT9=eYX*&gbH-laU`UB*Ls(5JkI>Q(emU(BfHp${!R zWNPK1KXDkrtv!^0nrMQEHXb^J3pmx*LrLvCl!^4N9_rQ0L%*SH9}hk2>!JSrJTwM_ z2M}wRhkhSHe()dZA+Jdu$}!nPFR*$Bv95cl=WP!?cwdUwTOXk^$hyGsX<+v z8T77`L9v|;8ii>n*TtX#_}G=7yBUx%=6(h>#2LopAlG5v-?&2Ac$c8hs$8x(lYpySy4z@Yk%iT})?h0hII{D!>W8gvJd z@94t^gZz+%uAdAVh~;N+xW z8#M)U^BDC!uTjPG8PyG+5cGpl4KW8hFeJZGBZG|UU%;rFXb^1F8Tf=6bvn$biQ#OA zGuo)pu|{=C;OAtc?mCUS;W8?3iczx*8}%C3`Azq>xKW9zMh#3es!@hfrx0Jls8<+P z(x^4Kk3_doV=xnav&b>qs9Ojw%{~N`F=`j?l%)sdjB=w2>XkR@9)7Q2)P{;iejge& z97&apimhf;Wz@yp>PD6Okz;V=C!;#oG|Io0QS)&Gmr(0xqh{1LYANnwQ5~Z`)-~$S zCPqER2TX3toXx1MrBO{<88xo8QTy=*584`KYG>2{lrO@;?rc>4?yL{4_Au(% zuSSjPNxyrsu6>N^)6b}C1C0825OWOXJQ&Kq4#SMid`x)Y2W!yERvK}xm`XcW`)*Ry=an3w8D&;A);{#ef zGpg8gqx!wzJjQA?e`nN$_eQPwV3hHrQS;26D&^~`C0J_l)IGbWesy?iJ#y#sR06i+ zul%0c8tkckVV=5$MiHKhkMvYntfzLSc&cs@Pi3cjYCKwIcxo3iGd*>+h+mxIDyD%ZGaE&*7fBf-@tCJIYg`V?4EKHpkBQRGS5! zn!M0cMHhLhD|Tb~YESLh=&3I_zR6QD*F4qZhNn(jyi~~QC2zZzvT}QAZ(c8L3-yva z(o2;SymTYkOBY>U@+{<~g=xt4Qg#(Dy{ze_ef7LFw3(M~cK6chUS3KX;3elkwhdHJwQwK?x4kIP(~wJwLZcH}}H zZ?*ryTYU?7Yjmi${3E>8FUDJKW4+ZA7jYY>;=J__j>LQG1u_!6RTXRCk?5`Cc!Kgt z-g=Kg$==$4)lP5S#G!)TYFyY`|KU&(Z+$36{NmoKo9eB|G;h_*Wd4fYYE_vys8`)v z=LUHzd8D`6p!_KEf@3t}ae2JA`b;3FW!@^f+*?U2ycM$2Ta(s#tHUPd`NLb;+q~tq z(_5~6-s*hKTWitay0@l3^40>YN%L(c^~-0{6zs%fOv`W5(jb#&g_u+)lw-n8I)n?j z7h%#HJd5P`DE390v=*mgOuB|Iu_pP(nbacQq;8myVA5P{OEjr;l1XRqFD50MG!H*I zO=<*(%cLNjz!e-$F{x@nlhzeB>0J?%!i$n8K9n@6n%g9MmPyNS6FIX@`UzvonluA9 z%aI=jlsD-vx>Vq2cvUiK3l88RT2wY^Wfha&BdeN8udt#z`Tl6qDty4!pG+!O!=&K) zCbdIq1Cz>P3Z9}$L*n61Ba;gLVp8$OCe>_WQWIQ9sixG3FK{$7$<^GXO#I%GpWB+` z+0LXV_=w&eOgw=#X#@f~nKZZy{X=|Llb+*tH}dIWQsl2D>WPmyKAM`x(AxxS*-UQllxbP>^74O z+fB-YGnl)_q{jP9>VaSOo3!sBy**@7AMC`hhfS(#<}@ouZnIkEHS1#-vBJ&zj!uzg6^J%#3w}yAt0(3a zHOo@WtUPFpqs7fClxkL6^n@|pte2?dHuD0{EE}5PJermvCJy5QwwE<)WI6II&m5J^ zJXXwlU75M7nAN+QS>1j#>&F^q{qwU~!)u$h7bo!nb?ck87T+ldoKO}djKfjt)3wJQQr&*3(X4U9z)-~ko zOV9AQA7lEPwSItEMFyJHYLHpa;T~evFH+&Gv-XWMYteY(<0KkRVErc2i%HZs*{oeSh6iZ%yIC92aEe(Sa05f9nl%xT z)962z;>&ci2F);Q99AJ=rdfaEA?nN`FC@%1t2n0MBfRIB)daQYnl&3M;h0As<})95 zFEGonkQ^47wHiK4%&LsKc!pt1%__LetdeMe2Y8Ep%gs84Cup~VoK~6@xQe;gnpFl( z@ftHXasF;5{#NSVZdTDhSyvc$m{sZ+YjB)(!)5e1K@QlC`X^Zre8z-RX2qXn9nP7R zgl^|qrwe9fUoz`oJig3%gsgk?1I-?j_Y=;+r>yxi9v>L+oX5gTv;M$-+`!yd^btp3 zdBgbsIG1q?-!Stt$A4u`vyW={_^2`Z!{66O1+W4akYe#sF1wGyQ4)vI)z3#m@E(T) zd}PbvqkJfeztB0Sj|SllItBWuR4yMa%;TeS`Fu1M#q%>4q6_$_9ULJ(stMmPA63Pj za394)_~_(kBspgk3{@|p9}kFaSLc%B2qx#O{&A3b(s@eP`{p!%=LYg2ge%|w~3FY zw(!v+>_zpKJ{s4Cy4q4#JL*D@_CC6VJILR`N5wk&s5Bmo4%11%?0M8q& z%`G2ox=o(&yGJhf>FWa@{rx`=ef0Yy>U->?0Z%zMpZO>rIbKjFX1w;%nKzu9?|jtY zBkKy|Cm)UY%vyZmJo?7D=;5oT248i?KBKQrqluTVPI&ujkjYo$a1d^ruj2fC73}a; z0=nWh`uh87Q!Za^&CPLmgeG}>)e*~3?gwAq3-Z;9{Jshe_0{SyUu{SAa9^1teHDln z2#6*&df<;3U+qWnSYOSG^VM>MCXge(CHksvlCR#neU+L`EM%4P)iGq3_Ejwm#AF=6 zC78p(D*LK`6>3BNs=hjhnbmxC7K>{7Y6ITZ z@>TPneYF(N;I8AV@pCzDAvL4sB6_;mSIJ9#RdkuJep&9Tg)4m3d!?@`t)f?Jd^KT{ zulD>wpV4)Tue`VW>c_plYJ~Fpe3f#*S0RUebqAe}`s(RP*5|aZHlLxM3%+W2(N}G8 z3*9cUA0IFK>hTp{?Yil!sE5Qwjz{zY+wdQ<9{Xw{u43p@U)6c-s}67Y`7Ql;M?B_c`d4#&!UhYELxi1B69(Yl7lU}h+o4kDiCSW zrzne###v-buqYpjWm(i2SCE!%Q8^4KZ&B;Y76n(as1km~BAkMwjzvNEvmWE>TeJ_a zn_2W7jhkE48)2<1s*8781WnPj#E-J5 zC05`moTHfo$I)VpMcdGEoJG?nFb3v{7VW}u_)oUzN4!JjDHe^K%5m5^jrpfrG#_h` zcP90rDfY~=Xvl2pgmbP%ozNeL<`H|oMY-T!K#dspzuSct?Z8oFET*?Of?7*0nu0}G zz09IJD6xV(P;n)5U;^^3vM2@(ROrZUtO=%|*)EF~Vm$`$rdMdQ zhp~GtO4(;o?)~)TphcM&^A~v^rH99;`8ek)TAv`+N%B5r(REBZZBfHB7HvAq+M>!i zYCdmK=mpLpl)A{eW8fu=5--zB%>JAGS1g)}H&I3)jC!8NShoDcaA==;+LjL11gT2V}*`oYkm(4TGb7|ds+31$*T5Ps?vu|if&!9x63#HvR{ zt$L4I#jRR_)Ksf3;iojKZlh&7`;jZds_$r?Y1K;1Dq+=ynpV}RWz~I*`Pr&YwXO24 zW7RVJSKq4s&8-@ZPpzz~-Px)wDA~ix>kO-oqe5@1vin%I86N$tYB$)bt;4PIn_|`H z`BvpwNPiYtRUU(J3-i`k^#WheVXakr5xdT+zBr2L^;WgnVAW+b-DFjlt;E?z&(H(^ zqSkh+_V1+EyQpWkRcU+Z%U*iDkNx|tns9)a2d(n{%c`r`bi}IUqgI_nwPWOToPHwn zgjFFYt?Gror#KD;PScMwR=vfdvsO9JS#=QG&y&vut9D#uO)gor7K^W0wc%f@DqXi~ z6&~HN>iSLA@{U!F?o!_qtEOWK(w>s{Gpm~62;RfWJU`G^{Dt$V z{E=~3gQQRN2E*|hCI7R^@|l>Jjt6*$ZePd?7g6>r`>+(1zR?fdGuY%X+SD35@Xgbv zVqP|lz#Y`^wrL4IAjxFoIhaia%{C3iQ)K$sG#$~tHWfl^%!l1#QyuI;A*)T3VYS(` z%5GBuKbtP$FNaNW{x;2qBfzGE7!<_#0ycRE+f*9c@gBQFY^oA!Q)6@pv*|vngxhom z_Yf0dQ(X+jq)3~#;SNef*%T5@?wF4*F*dnlZF+?FxD`j9iNu5{$)+;NHho4_Cv&)L zTAX52`$9JThYE%Hxu{J|igA2#oA##K6rX0(XiQ1B$v?xU*O@k1O4xJ}o+WLnjUsMh zp>vi^8}JE9rEGeK9i?shwTw+qkh?53!B~!Y@fE)1ZAw9R48i(}HeJKz$~Jjau_*%e z(Hcjvw>s;BPq6<)oEkQjtZ7qajKvXjszrZ)wrM3=*S2Y19h=hY+O!rS^=v9v-=-4? zX<*ZDSdY66Z3<{?(;oC_!hWo8%K9|3scCcaYe{X`jhwBS3$NPQ6xH6Qvq$#^V#bN0TQGKx0@(Ou=R39m_r(LG(Cs#4V(cCokli zVAB_rnrPEZEJNN&^bbd-(wAvA)r04Bn>N8P!=|*Eoa1oKB{r(hvuP@BqUd~LVGQOi zpr(a3{j$iWhKtE(3FpL8n{q5?&J{MbTWQnZ*tg22ur)R%BV;Y-I2`LZ|M3hF>unm0 zBk=iooxY>|A5cf5{tVuG@H@(WXeu#93U&>YMZz z&r#?W=M2uE@&kGTJ!GCo%ma@nHf5mbGv<0uFJ5qtytJwCE1UYi<@d`w&X@O$N6Qa3 z{q)hMKA)Hi7yqN4&-CRRj{(_r-(XiIPrD|X?7C{UtC^2o575G5SD@9dVF7lH&1u*8 zK)d?qvg>wkyL#lYYX<&BT3)-F<4-)n_jn->$Xj7;Kk9?ArG~ zF?OAZwX0T~U7m?{-ut(!xXZ506uU|lwCiu|DP)(sFgX?>Mp3(RqZQf~vuhQ$;VyEg z5(f>_?3#_c8Fn4awCh<*yFR078@t-KwX0D(yR7Z)s)0#3*uky?U6~uLyW4dbKmTf% zr6+avV*cLL)yJ+u{p<=JKurS~hff$c$ga2{^l+G6J%6+7rxDDB)X{bo9>cb=cI6#s z=ka6LGWdDZ0L&3L$ql zKSf|LHe(-xyK@YhqCgKn#p5D||LUjT(X^+ZmZ5VmKlMjQZ$BksD2#pl8CA7pXH~gbNrNluAgGj0)N4OK65ShQze*|_$hh0 zpPFDB_O9^LNtjkK_ZmMPTFx zpF?FG4sFB-c=|h3981t3z@bTa_=7|5Fe1dEMJN&K&}<}yIW!6%FeluhToDfCj&x`Y z+C(|@d#po+;v9-fX6_;mZ7Rz4Vh&xy?&1zbWH=OG!J)1d9ZIk4Q1xmKW&h+*_Zkj; ztm)9YS`LN&Os=&ZDpSwFYjB79H)334hn_ZJ?q&{!HFxNJ3x}4rbm$36wsB}LzN2_s zYQuWmKukM_hT;a^ws***gF^|O9qQT5p{(u>h4gT!@~;lP!MdIfeeLB?!Tt^n9^}x4 zAr9Tb%3%)04d-?gHH>zs^%#c?V;#CT&Y_y)9cnUxIFqPrvO@t=9BPFeQyr=^%^~Lu zhgzU3Rv~E)hLzZg z`-dFraD;h}vS!B}N;&CJ)l&}D$BZ+~f7YRAsC~_$;Wr&>cgrEuZHIcG*B!P!pwAB- z+VzOBj~!f3;Lw#P^yxY0%?pPPy>e*gJJu7uKXN>tqT?rr`oi*`gV%2k-9?$N4xPf( z?+$%J-#~wD$03+=`Rj0Qe;vu=uZuXD&tHuT_^Wk@zdDBcD=N%ik8v;DUppiG^>?Jd z7DxGOU5vk$#rtb-g1=^__-js4f9)#fuhilkm+G&7()<;W;jclN%!S1zn9J?2VOjnP z$@bR>*h~9sEi7gH^$QN5OgVqeD(|n*%H)FVs{Y!HFIfGfzaoF~*9`2#i=X{9vaY{U ze(_iJ{{9*@+Fw6T_1Dq|j139U&d>nWj1ABR<%7@#X7h%+%jEv5wM`I-RDSsS23>jLz83v(O{&_!JP z&anve$f2>g<&{G}c;`@0Qx1KG!<<6~pB#EKJ%`H9$f5dp1I^5#QkaN&$Tus8Hly>L z99oZ$C^47&c!$%Ab7<*Wj$fZc-L|t0#y@kY;m#a-iSoO0XcY?W&Y?*tx+jN9W6s_j zs(65XSavXnnjXrba~OFvhf2(`>F;yu54=RIN1*<&1Zt~2P?H^jdVyBqfm({!B?5KA9jN#+fl96v zs2M*7s&?%_wMUl`fvPq(Pz5Ik%CI<)=W>C(ZxpDWy8|`+V4ybQ1G--fl>fCrJ$V$U zypIFb_(`A^V>=GR`65sq-MKWeZ!T3InoFfd<+>p^mBcHZ2|TQ|2_H^{95ZF1{ghuj+8J-6Bq$gMSpbIW)tx4gdP z)-*#N^$N?wYpFc?F+7hJVo&irI^@oyAIjuWdz4t3hxf?x@Yv0xy1Db}L`+_7P0p)F zMe=G`*}R%jC$EBg=T-h!dF9_dzdTpvSL)jQT7D$Iz8%fa=ej}q5$lQvDJ3;XWw8ev zN(HH4=^&NFSlonnnIN4i8>EfpgA`FANNdr%Vvw#QrE-v}pgt=97^J#Ls~M#7c!ifu zgOt@ei0iw8)Cq+=M-H%N5` zupa|)3>ia$RA^|B5{CsT6>resw;+8$+Yv$Pi9gYDWRSXHGp>vZ(gREz9i(exf)p@5 zNTYEZFEDjNklsyV`{W?5UkK7BSbwKCn2&o%m=dJsSc3alF_rNMnnsUMczTdJVg+{3 z2-0W7&kWKnESN>_QD-)}AFA`3x3B1WM2$YzJE9;FcwEJZ{N&A~>jxe=tn6AS1i{3aDp{@Ddo2+h$C z`;lu-0VOObpcXi=uz;M43uty&u)ZKHB3Q||h@|LXEsPCT|F~dnLtsL%j$%&LVEuz} z)q*t_ZK?;WPOD&Tg<1zI6R+UWCRj_5ziqI(V-h}MLAzkBgKzs_O~Fk(N7W9&It}lR z!5W1Hoq}}(lRA?J%5(|VZZzr|toAsJi!TJHWdIu}6 zPq3O{Utf;zM{XN~RTC{S3G;9XjW-3WBff18R<1vS)d9aDYD=(6qu|zHRoupL=(#;u zD{uz||0E|I+YzkFJA>5($1r|(u=?!@)>&-cM?U+5HR7*eJ;abh!8(ty!@=5*V@HB@ z8U9D91ugInrH|3S32Tbc*n`qfgZV5zSR-F?%xn7hCRi`9{e7?^KLjh^r(n(U4&mCm z5dDQ9bBOZ$geVr(Eg{-aAVhUzLv$@QM3#~v+KInQh3Fol%74Fvb7=dTo)qW^&y&t<(RM`M7MEdV~8ql z3ejZzgQU$Ns<|aZncG6tb7zR!9%SBAAsTmSv)E@*-5NzJ;o=Axv2~hu@81T7`e` z4Fx^J)DK}^VJht%rf5@`63tK(sYX?Qj5(aNicj+X=+- z3zHmSTq7Q)TmE4@9}Lq)jBtf%I?_|f15XQvsZF6UjVuzTtJqvTOf5?gt7MqoW0^Zl zo>^fEz$n~Bz3ecZfumHIQqdg8@D;U6hiL+yl?l`NvSCWA9j5L$S0_wY>V~P+Z(&-9 z@5941cm#Q&?8q?r%nMUC=Fbn~{jM;zJ|4z<@?olfg8Fd|DJR4DtcqMtg{cMlU^)K4 zXH+;HrrJ1%&S%23^K2Nu`O%CQfXtA?w?PvPp1wKc-Et82Kb^$6FB zU&FNpoqC4r547zSt~2P}J6ub!5%&<;CtL+F2T6Uym7`y{rr{c@^d~MZW5d93RsStq zO(unF=ZtVZ8x7Ysd_u`t;ra{a+2M*qGwhoaF8_JqyayOA!-jA*+8C~yo5D3?Pq^~z z4OfdJ;Tnds$UYjbW7u^pTu<;3t&S5PhcNj>xZY#R$#D6d3fDZ`MDNp#N9Gyw#8fY*tMLo+ei^Rr zU&D124HTiiuzN(PE?VL!DjOnH55m%CQl$#BnSZpjlFcS|ms4XJ>@^xgyj#g&GPGuV{pt zrbg&edW6z4A~ZddzF>X{a=?|65&Vvb&=Yrre6!ewM>v)pp}$K2Bb-3- zN)cL$|4^$kwW4d&2<`6?q3*xZ`(DKC6QSyZ>D@5Kj*QUMu@P!MK0@WDGS3W-Srwrr z7`}#__CzT2ALe^b9pRDs(jZc`8%C-HKI8Q-k@9RDDJOoxdK739sX5pVzowCDhYu*w zEK;>_8%3H&>PhEFMRtkQ;I3@%7Ag1eNcF+rBZxIBQd!d@H4p`7L@FCc5j87PL9-*Z zb3vqr{1K^L$hS38xwjGLV5Ih<>tF0c^da)VD|A1?c>HrLQX$79H5L~UaUxO^QQ%~x zh9cL6NR`GQY{p~cyBNv)?2+n?&G5e*sT-JcEmD_J=z64lZba(b!$?^lMXL2Wsv{qqGc_uSBT{Cg6vwQF@H(|3v9Ls$Ppye+2y-r5*^q9;MZ|jIKALRODuq zPQd#Xac@WIK0agmohYsoiqhXG{2$vePSHAoNJF%IjL~xCj#gV7$rG)2`J&akK(w}@ zZE&>uz#}AD4MU?fBP?3J8PO_*1(|Fs5zV#x(Yl4qQqi)Mj@Fa%(Tc4Qt!sFSE)}D7 zx>B?jSB_S}>d~5ps&%7zuP9pg>qTo){b=oK!Pu73st9B2XkI@=Yf<}XWp{{{qhqw@ zpntDuB@BqxC^Q=wt=xm7)d{nPMCj@Gwh(R_X$trz%?MJJ;5 z)0t>(N4*Qwf=U;oRUf((tscmKmD~}1jXCZ`YadSLisAar7!|)2qZRmql-n`tjLUe8 z*gG*Qf?+s-v#4-4MqAPTUW{JgD~3LZ(VmAfTJR)BH<0)=MqRNA?ViPGHr^uQd5nTy z#OM_Yyo}Mn*D>;V6Qj~NiCk}E)CkLP44=^PJ$ZhJ;hK^dy+*;0F}x2MqYJ3=UyLRp z@-z3p#VAd&ItMS0SgtdS)hTQ;#Oe-$jj^hQ5jcrFp0TQn1-Jo!uUNU!35#(BX75-P zM;9!?CD=@{%0zq2#VL52W0i)ESb~f2_K8&n`d}5V!QmULlIVoBXl#j9XM8{nTdYdi zWA!L7R$=*K^)4h<$)T|t6Bes!;jwBK%WaWZQu|+&SYkH!x1^a`AI;9FNC1{T&jgdZBUZ1anv%&zIw5Ef}ZP zh2j)dI8J@jh=ca&aq0(SMx1`hj8j61IPIzwr_WehIZnILwMv}q_2N_s-{Dt3PE+u@ z0rNJD<8^+VCgWx6I9}VwsnPT}&A|H^aauStPG`2oY3i;xUBK|&ahispJ#p&2mt6M6 zY5$2h>13QX;Q)G`ic{IgjK%FIaVqjOPV1k?slbak#Uu1{oczCVA3uDLQ%8h(#OoL2 zFvKey!NzzcI^xv@!|*pE{Nt5^4Hyy-ud9g95wA|zhRdj!GhP!=CNN%$a0G9lT=6P~ zei)5!sF*um-%&A7yy{?7-gy0s3X$>p8T)ZHDqfFKCpum&aV{oaHRIwH5FfACXp_J^ zSdWuvoEWb)*nzC1cr{Iq*EJM$#`B(dygtI_idQPiVmxl*Ietrt*JkW57_SnA;{X&0~T zPVpLqLY*0lV~Fk=ubkbee^9*U;J?A~x;2!!r^YL78uj8E{+u4KJ#*QP_4DGj7iH$t z(*^PBwJ=^McCddp`>}ox`%z{u`}f7G(f)X~KN7E1Xm~VU9gy!B{XWI*Y1RY(V&a*2 zwYWt8@$+TY5zkQJO1#=#WAdWtU??3th&UI~0JC_xUN1XY2D zZvx**NYFIAwIt}MH9>s?60`+5awg~uI^;>va(LxS(4R0zC8!KO!6!OF z>Op}-g$5_8e@LQILlZSCGErABCMr?0Q8zkK&59;!8w#W+sy_TO5*3UkFqBBtRy?bi zsOUe4Jxe>P9#^Xf#cfp7mr?ZMR%iOM-LQJqI6 zDrj_~2F*&;4&<4WsEhb_MWR-$Ow=8eT%D+=sI)s#qmZ#DQI&BX&V7lxhSA3pbrgM1 zPzM4|CaUA9ME!7@asMRhH{7{KAFh+f9eRLL_Yzg&exjB?Pt=yLiF%33-xK*vFH!y; zNot2g&m?v9PtqFv5|E@$$eANaqwoM{awW;0J4yR+7TxnC=?Ny}P12{3By|pDOl*=q z!yK2Sn0iSXinNAF8jns*lXM9$TP3Mf>m+?d%{EC=+a%RMnXbgcnx07-+>7y3k~9p7 zGn3R71!g5F3FlC5c9MQW@i|E#x+L{Fz%d7t)C0Z$N|MJR`hYKolhpr6l18J*(Il-t#`xn&3O-3~XOa~8FL7@q z$#OGEThQoMlA>=XY2hRCcuXF)WTn}YRSs`Z(vi$}v6J=4KUtG=CF>=c zFIlDV0tNGP8O>{;dplWu;*xaV^J)NF^JAiR=YaMYFRItzkiX;_ezuX8&Vo3OMQ}63r%6~o2)AR zh}%C|qX#9c!Qf=IN6e69?VCjYlasXwEq+hd;OWV#F(X;ckb7pb>dsD9@5RX)hpB6l z)pK34hQYZ$S*tfBD{f=5+HOwPq5a94@K>_tpxhzyL$1TgdW;Pxk~RKfvchg8>+mh^ zzvBMeWX(p|cgdQL(^&T*Su;GG@-jG;j{M&i@^NaZ z)u}u-ry_9%4nL;`JDlnj=+ul{>__$7PAx%19;aSKIdwkTsa>&*i*ssJA*a3~s<=}h zVNP`_B+aQLOwDkrRi;xtF|&kI%m2si)ED?*%6D?~w<*w~iRW!ySY^vkb!+K7QZQ#`SM$GYxQ@OAY0gat1 zkNM5WuboqqF&`D%)0Ym^(#grcYfjDS=j8P`bE5q?dN`grP-_A?&T#VCuv0Z)n&s4| zxlSFQ=hQzKH{YrEi|F@ar~XFYB~FDebLt(umOHs7h90bS%DTy^?8A)1JG3}TO?Z5P zUR-wS8&>@7RKqJy9lK6{Z#k9oy;E)QE5bfF)#Rg77d|=l;)_!+ztJNs|4t2ZDTjwk zwY^+wlFOyWxm|pJ$i@3cF1|P9()zqE-T1+!v|yJeVlK*uxHKx%#dlg=Twm(qeI1wP zqhhp6BTzHJrGm*WmBbUYcDgjj3vz3Jj=P1 z3w_Y4yi21iyYvustGeV>-NpCn*^V4Py7V)S{^Zg>HJQ5>HNf~Y$JBOdd>xlg)pcom zLzg03GB4h>a%pB8mtNv4mbWE#J7RZmDXBAa;cFL{W_5G%_lI0+)5FEJX7mIdkhd3g z_I4?tFL4GE2Vb##kV~;c7&p|Vrz2cyG}5JZ$UTZ0N4vCWj7zu2y7YLwOD89|6f%*1 zU?pl!a%uHsmu~*%0=Qs;xL&tI(BVV8b5#u^?c z=1JD~v`aDPT&jG5UR|Vy%hdEY^)%kGEhj092kVdp(!d7mZFJqDO!m7@hNJDe-WOTqDkmiFh%1~ zu270<<0$-!q^Li}W~OK^YL`e+D_lXao8u8%E=3*7r>HOP;vLpiAYV+Vn4*u!uAHJ1 zc!0fCQq;a`ibhvU(S6MRF+~ACrKlk`!?Omt;1){NOi@y;6di=Ac8V(0;TYtvOCJzW zk9zB;=)f;2I^Q@&Tbht(^ArtiouYhg=u_JiuIHkD)NG%kVR()T9a8idb2<{MbBZ$X zH%50!(R^fgrG_3U`qDc^z51kR`hXO59!USN4wvx5pcEwzq1Wh!#G&+QT8du4Fg-<0 z(FvzeVg~uoBp&=`rRdk$DcXQMb5gVzTQP8BVbyV~KV>O;2>P;~@og~`M`tX>E#!GuOf}#tR$OVti>ppX zaW!aCT=@?d*PFyt#U!Qjea2MH!gYisr>ZgL;wo}EQ`HtbVRxmfKGwk_B~?{17?)6} zd@6t6B~_6XQdJl`kf&0r-s5u3RJHp#RUaC$ty!wFTc)Z^>r@Rz(Ke|nizk@VHdX&% zTs!7RR{KKm-BT5S>3G*8RU3az)nB7iWgL^LEjWZqV^g(a zT&h}(Pt~0zsR~+}s@}^|)pdEQ=50&myI#cq6FaE?SgP_LPt|GMK=Tu++J7=teNLyU z-(zY*hbO6g#+)k8r}XJrD(`)#>Wei^MQmxBY){iJzciK0lcvGAkvEOMQIe)3m6`nu4xDgOIPpkbXAB* z*Y3Dj~!mn69-b^i#Sf)<{>~n#|LjIg#2j zUH8%cw{$Io=ZJLeN9440HNwv6=^8sDo%h7k^&K1MvLEHOIKecKTlT){DrWW>AHzr-_unC{Iw0`#vJ_T zk)frA48?h8s1<%NWhfpSVE4)3E7uwN*O8%jff-89m7y`YGgK^3hO*-`Gzf(fGE@r3 z5S^5v`)HSup_OQmnW6T0gK8x+^aY_6GSmnG6*Clu)jnDMM9i5T_<_ z(4ZD^@CMatlUJP#ncHRP41C*XsAY!?;kn8mhv8QQZTLtn9eVTSgi%%TjgN6JvuB^g?=IztaIa}7Dcxi&*% z*JY^q`V1Y}o+0l)GqfE?QFTX#R`1ME<6Rj#c{oEAkI>^!)EAwp7ML58sc$$Fo2i>< z5tpf#@tGRy%+!t)ZVP5=4$2kElq)q;OK>4QQ+M$eo*9|Si3k)zDbzqSbi+{mj>XuF zSNN?&rhaf|@;O|lN|(yyd0wVEmL*pCOwFi}siaDoI#4-NwX0?-`FG~3UP5!MB^5rQ zq_$5isj8Dpa_v`1^_f~y{?kip*^H9Pm{n5eXO~o~xh3^|UP(<|P*RDDN@{PATR#W8 z^*qGQ-{f-h{)Ag=a687W195JxNOCK-h+Byj-D-;hmE6ql)>Evm;Z{~nx8`C*UAGRQ zS3S2zqC|bS@-`zje4D$K54W(fom<}R-SX_fSiFN*N9I9rC$}2F(b=sK97JjtH~-$c z)x5V`+p)Tjo9B>jKGSf^HQ238+#1f<5pJEsZLApS)>bqgZq-7GKiukk)XnP#x0)Pts|%(acdOt{ zw}zwNZMSxy!yUK!qtjitO1*GvFbcnPt27L+sO6no$1&lvTc_^Vs1kp9iB zvW6_J!c}7y*Vt#Nr)QQ9;Ss8OW$`x+va|qe@fB&_St^eWC~3;lJUGo+s*kRiflK+a zbUujV3S_Axtif3dM& z$(U1Fs)aQua5_sX&t~Zi+MmnPKy3V<^W=Mhxc^ckzQJ)lOR4{JgEhhFn^}5?{I{}{ ziE6lxpxaq0jLMjT>oDBOQgw_$+q?7<8}DW53SPnIewLz83ghweQI>K&rr!v7Lj9JrzvcWuj(1ra{4q<*aq_<`**|CL+?OnULG|y<3!}0X zYs}VPc!7U>v$fBbt@9WWku76nwmM@nPU9`AM`dd+9^-9vw(7)i3>IS_z9TR$TWJ`8 zF&H18ts)88+74%8wko4}Qnp4TXL7cpQT>0M*?NUdDcPD(Fk4%2u28nF70K4WMY9!9 zEL*0uY=xo~3>l0^=Ko}7>-zuIbRSSsQ*R%~e@I6_K&cC&p!6n42NfohNd_j_+1aH| zL8>B6iu6U1E-b==g7l7{h*Xg(y^3_Cvmh*p(#z6(znt@bIp=d`CzJc!=RQdm$Rsz& z+Q_3yFkm+J=q(R?oqdYJeq{iEsqAH&3%tXp#CGa5lTHHPsGWP7Zr0D z3Zm1?hMvV4DqY-A=aPmd!Kq}ZHyT#ubDXbkC}#~r(VB)vVNzX#`*aLtYiOt%u6|%B zeCKJIvZ+^m%19NgabVd<>+UqI!YuP^5Eak4Hfx<<--kC!NHM+GEna;Lv8R2(oj6b zP-A?D?MR(q@b@b@Of*yAN`G$T%_66jL zZx$KafKE#cO~9<>hIXLD&xU;1wbIbu)zmZ1P*s>$40XXhWV=c|Ur0Cf2O3^8I7eWp z;0=TC$qhx&2Me$f`5qD*-baRNWEeVzdXE_|mi%WZ6I=RecCY3Z_Nr)cuLAf4W3e2E z@c;!&c+~){F$mM}D^7tEiz6%{Ut>aZ4+-~Sq z+s6NaURA;3E?$-D=GBVs zUN!pE%Qetm?fuNFTj_xI}P0I!-3^y+JzM43Un$1$W~*U!F%0%yD`kCSJ4 zj~W-*E|{1`4#k6va&ahAVNVW|S~>_J!9?4K8VN54y=YA3nz{+tklE{es`rz$T`$ z$D7)oMBEmprr-o}v@!YpYpP>=Q)7{-v#GN9yN9X#pPD+=+hh`RQ(cgZ#V>qjGFP6d z)p*k1RM&wf_g|Q*Gssjt4&h<4shmSh?flZzNfaJtswzg{G-?eu_2~#xKjNQ}rdp3S z^##^rz*oGEHT4*4QcU$sHTB`Qj0@+Gb&9DH2w*n0-~w7sHTA)FCg*TW?V8Ql=9tV` zL!IXG**sGX7n#gWW9p5?rkZ=59VOs3%l69yG`xiYw8Yi z?laXHAMH2Q2SX2-x`d_&P2Iw*)!>Db zrp}=8DdOVwGqgp!bF7b9FPt~^{sop}<|W320+&sdMCHH8{|fzIHC5)isgM6Lm4S{o zO|Hu}IoHJ)Zu9dUlld}CT}QEdrfQ=Z`rao;lzc!gXpI!)dqh3)R)(oWbipvpLHoz1 zMq$rW^2p{>6SP3%>^?ou?UP-`r{?H|spWiXSKg<56@2=wqE81gxROt$D*IHw3ZG$R zRiF02spix4cYNAX-KTWqdDo|(QKqI(iTJm+PgUyrw7a2C)_cUpb(Co2Q!&HG{MkOe zX8D-Y!Kbc%pO!WCX#>^t^n*^= zk88-$jJSBSxlivQf-}fK$re7DnBLN-^=Q(Hwit(1INq9{Ba9c9u^{Txb{H|A+F%5J zz;C$qA$4fy(|J^DPya|qhmJn|jS8K7YK0x>{1G|fK~acuKx;a;D3(e9zK5?^~Sbw&eT3QaYwLvXtbpRNS!SZ(+&P z(o*>jmactj=>g{Tv{bm4rDz{ZZ+&Lz;Q&in23ooScaWuw!Is)5TWbEfr7K@px{D%T zS{j4Xczc+ou1G`c;g&Wd{|HMhF%J*WXr!fK*oE*YOULorXiKy3BeIUO^eO@=7UwZ7 z?%B7r9f$DM*Ou~5u@r~VDD)j;MVo1i9Yv;F{4QghGiZxXXEM%Nw3*L3i^vV{FSe9v ziKS;Sms)E3gQXrgv&_=|<(3w&vDAO9r4gvP!O~v{Y__;w-BR`~mTGOaWMCdC(ZcFcGzo#cneE=$#Rvka%;*<&dlQ*aFracaM%o(C+gIb!L* zW7Ow@rRVtmBK1e@H0pp{mn;py1ysJw=P3P`#l0-l_KKxs{EMnrE$$t%^fTI}Tbhlw z*Jyj)(oPimoBG|f)aM?b-M4fV;Roc4>*(^3I^&f`mbzmfe$61pW8x$Bgq+dfDdWN( zeE*CbpR@m=)PI%+V+}^gR`E=>K1cdXwsvN=`A*1I85GTGYb<`rW~)zjTPv_Phpjp} zZOuX6T(&;L1th&}Yd31-wlxd6^Vk}Q%LwGPwE%%vZ06#zxxT>G(gL<(uiEPJnyv4# zqmZqFg^7jHMQlANYU@!kTNC1J^(}5IO9@-wqRi{I)}nPuTRGpbbsnKowie?yc9$mJ zTjU9&EV-AnwXlNC_X#%NAK0?$*lJtX)^@BhY|b4pe#=&O96%-8Rto+>z;EjZhBhlvnk+upX*$Uz|7B#n3uZ7L|2>NYF%vQ8% zZL4zFR-TBh!MK6FG2)?U8^(`>56KxHx3yKeovnM=(cb3#m@OCGFb>Oc1b2|Xqpf$* z9AmH(WjnDQaR`+@vNaP`KDMzopvz|B5`IhZBg<4Hz zf1S?wX4=e;L0wRC7W?#UTd8wwy)xIcG$bjR?nZ`_aIgRmOVxPjy%eD^xWvjteTi>K}JYBQ(AIAO7zH@`T zQ2RFf_XBGA&{i!xhvyOdcLsHO!f}U>pK_e#_A>{UU&ZqH)e`OU`ZcDIUyTa;^%dsE z`Bm^uziO8D>k&G<<=0DZ`xPte*Pilz)vn;zZXB=Z*9VpSI)syz{c2U!uaP*2?bZA| zV}w}v2{)0ihF=|#r>0*f?$+_EL0!M9)Z=sb8~9bKA^qYL48sEyeb28l=!I2{{JMkx z(6X^#`{4KZwF&PS^ouGc>tZdQps~-dQTQD%S;WUjSb%htw26gO{DFdg#)5I!hG(eP z#IH}W43|)(sb5Vn3_I}zbprH@wRnztj-NS0{aT3|DDP5B%)}|Y8t<2jvDk@BLBHyw zCl=u>3MBYtU=UX0ACwCD)g0rn757jnk=U4l!^ocGS3~r~e4IyIGryW41v`*|YR#zy zX5k3(wD8NqP^`mURB7qwIxoML;u_v+MZGW{+wlO^TKl;UjGE#yN`?K3;9DF&yx$vM!)$aDELaipyxU zA)vAw1NwJ&K$Z5818$BcL;f0{Z$e<2x2mJ$!pS zpwNkcKD zgmR9uly`WZg`*YdP{~mrJVA>pj!xqizO3pfM;%8dGLW;bqw%;=&*8dyN4GtWsv3^c za0mUo4$ne!w87`7K)_KvGCPi5#Z)|S9bJxh)VQOg$=zs=Hhmqf!kGS!_7C87kfU?B zlkBM45J#7A7yUnXbo>iPLx(z=FwxOL3{7=35k)4E|71sRena0Y9X-a6s~l~FXSJi* zYaBIQ>*%K=j{d>yqmGuN)-gw^#~rv&wvc*)h`%&x{}an(Jm zt56PCb@R9?o7dH{S6r>j=W67uu4caJDq6wS?TW50S8{c%va4NHT+OTI>YI05rBrwI zcTHD^YPs58+tvCy#H{NouD+{l_^ko48oBzwbdD^khgRuS0yk6g$KJzLXKotMKBXjhPX=p+*K;>W6m_GQO;`V6#VwaP^j%rET`jmnzjs}YeneXg$Z$0V`5wFK z`ovYyr@Us0*HT1ZidQ$>LoiFco*`e}c*VUEuV(lSh4aO$F>>aQ*Dcg76wmW4;x!At zw()!)8n1;4s#2z)>LP+&nS;8E{aJ!4lr^a296^mL7}QlXE*w-sk)S5vDoPd&sztG& zZlPdYkoo6=`s0nD&Y{zrL3Jn{)B&7&E2!5xvb-Cyx(Br$4|@cazi&{bhX$2vbWk%= zgIYEzr~-3{H7}@sxQb(of_i;*P@S=AeNes)L3P{2>+YZio(!sDxdd%*k)TcO67*Jw z1m)|KpoWVR)NxyahNAnP1if)6LDwhtU#_JN$QI(uP3Q%sU!tTCuwk*Bz+M~QlFklvc@K9^}Hl4-<70o_+k$+ z_9v1W-79w8PACbYktSDc614AXpgY&_6e&)|FC|? zX9L3;h3^N2HDX9ulRpo0PfJ+ujN=v4z7DI@gs^H)3TwvXu#72TuImo#hiPH`H9f3r zYlyQptb^;q`t{eaa%~K&5you}Yx9<{`t1rU?r2yS(!yGFC#+d_!`!zK*1F6Qd9y@R zJ9|XuF(Pk7OStsi1K|Nksm{*Ms#LI zM8#%CbO2|OIxC_Ivm?5MyLdJyqU!UBkMl@g5K*2byhr-Vh#IVl$i@{sSshW8H4zQP zc$`L|wGla(iyZ4BDhU6Eh!mWb}*je`;Wj_YS5e7_fwai18d`G7Iv8pdTrbP(%9QWd)3Kowlir(VC-|JD8K&(_$$I3?aPPwR-RE#R2a+LdAqx#qrRo!4z=Mz{b6jiNOw1r|( zjmEJ4QJut&0a4~%jA{*bV$h(d;s!_661kJ3DvnbqH$1A2C^{ml@;HF3qoVo{qsK57 zG#nSzKvYSI>OJHcA7y^}sQP2u#HjqKQLZVE>NK{^j4IQts8(S+2F#9X{G2G;GOELK z8Q(nC!4Z5nKdNRwL^TP%AERoHx0gkgZBJZa>B#nycdu+f{Jbqjt61}HH}1G8gVidW{u^bdy2jp+&2&5NnXf|yRD&BB;Eu8irE<1rmM8Pf#}{4=J5 zxQh-XJTq~Hl~w}@_g&<{`g)d9*3LtIe*dr@6WL=KV<6MXVc|Z nA2my_m3lI3yQf7WHJ*K+UTjv%rsjR)%Km@5%>Uouf3N=sz@v8- literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/9a576501480809c4_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/9a576501480809c4_0 new file mode 100644 index 0000000000000000000000000000000000000000..dd3375933ef76005cf6c73bc51053ec60d51e690 GIT binary patch literal 35440 zcmWjL1$dKZ7sm0sN!oauHWY8urtT^3?m9MHhr7GGI}CSsXSln=HXMdCT!+Kp`+r>5 z?`rbCkDPO!CnfTxzWQBOWNZKRo4=%DxR)Aca;z6{YY>QaTRe7FJZ2 zmR6Atqjy#M)R4YnSWW3~WUnoC#6Ml79NnZ(*f~MUvPg5JTw6b-w)0aF6zb}y-o5=a0%iO9=|w+34e0NuaTqd? zv4;EUw^780;L(2apW-L?R6o7K+F6Ws%TK-T`RUPfKfOo$7k*lgIxqb+?UkRlzxLA+ z6no>R%3uBT)nrgpe}n!AF=(sXpo4gt!Js3d24&A|&}Qt-Vo=?z1|7|2P*RvdJ#f)u zP|FB|_Lnf|Pn0fc(DBj+Jt=39rLsYdsu?*mD}A6%G%waIDG42P~%?o?QPH;>_vDVVuPi>K@IUc z-VR{ifd=IsWKie92JOVIAqLro8sx){VdMnE2!o1YF9wd{{%C{xjxp%fc;-UG3B)?d zAWb%CFjh<?t@vk)~AEvD{=nVF+H>kq~=0o<42A#)EG~8;C>7YTUkn0d_VLC>e zGX}l9K+M+-vfeN#9St!I3$PYb{x)dlZG)QKVa-wSF0tG*DDaL;O#%WhN{S~`rX8E8}ogu0CK;x~Lm`Cy~kVInr; z5_X3gbs64_M%_Y@Oh!$^{LDsG&0^F`s5@xj zG3o-Wkw%^O8Z|kJ)Z192d~rsNO)#oUGPl!=df+qacDhknau_u?H*Ih$k5TXP z8 z5n9fu;;4dp<&AoX-zpeouV~aJgjX_ZBvLCIRkQB7JIHKDap zhwv{RwKdAz&ZvP1>|j(3%Ha}PcQWdDXQQ%rXFYMfhfyzj8a1XDYtx&3(ATKG{f+u* zpizGhX1*cpn_>KKGu)_N=s41-R-=u24DT4Dj!ZNv*Ch7M|NTY|$TW>P@N_!2XBgFf zj!{qM8kKdPQO$5}K4UC0DsHJ!IaV3f24_|qRec@fZ#3%UW}`-JVGXyE<2Iw#?l3BO z7dh-EPh7+3eeARS#BrSUy1;zb>3h?t5|4-j{gCA`dj%7ou;-pK*K=xvk7)J6sC+Mt z>i>$z0@kAWd!r_OV9h@oW&C8+0*gr#tR|JRnY0Yc?Ix{um}GUDR0j_OP3q|~X(RFn zo0KKQq-12u%1`XX(d;H|_n4H!Ytlj7McpWq8bxysNiin9K&yC@ya^`dPBdu;dizY; zlf$IhxlF2+n?89=3e9iQXp}B!(lnGTWYR>mENs$V6e(iT@nRM)ug_dFx{lZGpN-pYJm?(pKa1yoP>LhNn7Tc)MO!Z zq0J(b=40w&lkzSxsVny3J8CU6X#n;kV7W=gmBg}^xv_h*N#AgK3;AtjEw{1G`%Su! zrH4&wca&HzvX01im6~5ODgLHOJ#Lfd3)V&c>WFl^zs@6X z=C2pHlFlr8 zINrryce)dEZ-3oHu0H-ci{^d(^%WEP`75fwzjh&YpuY;iH^^VV4ffXq6db}ln2d%) z>5CG>{Iwm)!~L}g8AkYP6u#iYXnzfz=&!ITfl4G#Xps^>7fIjA9 z{QLo`TOdF&1p`#C2r*R*P^-#}gL>5h^ygq=8y%oFC_jd{;2KMRT$vc4zLSV)MS$|I z3{dK-07a}0(3A}U>ac}*eh*N|9Rc#+6QJ~i0n|1?>(SsAc|QrzB8OQEoo4mVYSuLD z!Bfo0Zr1WJvzB_y`U`U+%&HSf+bFY+;UXSJoAobV#LzF6b8%*^$GLd3ZsJ>lS++#8 zS|pj(4U>}1nvWeRW|dAg>jM79lr*yz;Afv%jo?Z*D-36F4aaksRW+ws8*-cVK95;Z zd5ISvi<$LPakBzTn6(0TkfEemzu+$vC}r0E(&U42WzCv}JLQNM1IwHB09`6@8%ryi z8Vu&a7wnggzb2yx=oy6hbQ6lenw2uh ztZIYJYKYB4=s%R(SO@novkr_f%Q(`kjHAp-8)H^m^ui~c9!ovOu^yAm>M)r-GnM*J z<33j4HQY1IiojW1nr&9~Im9*B%Ncqtcq*Q{H~|| z+o#P9LC@o?-3itc2Trkn zaTmXxHf!Wr_Q5&kJa1O9KiC6*QiH!(<$_9Qaj zW)0B*y|5V@?wEB19q+O(_;{b39#C7@AJPZYZ~z}r{U36Go)8NPqa`Nd1+qOgD;}BN zus01B`5P_rAU43FdAN%TW{dtskja7lvb&&!U0p7G=$0(KuYmY0-Ps%Vp7mycXH>S(F)# zaWcO}xe8d+7QJ9BWYKF>DsGWVTjWGD{Dr1vm=niw5j)FTG`bwQlqZHt79Nily{$}a zRV?cBlSSQrw&>^T7Tu_2(a72s9l%+9MBVxpt;Y|{X<$)?h89I)9v~tsbNoxYT`ad_Oi&;+oI}yEV_xT{irLR_NUJP zi#86lD9<2^S`D`7CB9+x5Q~ZrwdfSC;2pXTBc|aNrDHMPqQwY{PNU~Y=D{aS8)Z@J z(H8YU;27$O@i;iaq9qfV4`p{2OhjS=0fyF>E?9 z&a`OoEQ=;!4U%VDbQORR=q&Naq5U{C&(R_5qOf?oMH`6Q^zyx z$Ls8`zpcE9m8e9k_9VO0{` zuc#Mhy|wDXzwGn(?B9>&#Ml&y76^%BZ1lkI@irYo{sf!mB-*qRk;%k}?NWz#8?ENxRw48l|##$}kx*pwAvWo@cnp0RKo7ZF_1rcqEO=Ev~LHVvpk zt&qK{O@CtcPd5F5B{gi?gm*PVOb!?hApLUC>A!;mPjh5P!w%n$?D{T68 zC3&o}sn2SgDy^aR>uj2|#in`K|2u1kuG?(-hJc;Kw#%kYdu{R_u<2(sLivL>Q*vG^J_Y>-f9r%J0Pi>lv>lpUjraEtJ>hLeO-%-o=j0g7zo36n6 z(WY5gj`^P$|1)`gvFX3Btjjl>a%ZutVph8%ve~sfyIq!WyV5*%T|&<&yTW7a`W$Q5 z$wa%H$#!K$z7lqI#x)cyX;(Q6EN@rq%656G*i{KVu>|Mfs$*9ecGaU_eY+0gZ8N)m zpmB4%`oP=DuDaNa)@|sAa_#J@fr9Prnv9$s>{`*uuJ5SY*{-i$?Yi2{u0q}I>WV?| z>tR>({&sbTXMkNF2HRyEVps2>c8!GpFuRJPGSY_IRTyvZ1EWST?`XSjAZd(UEwKvE z;Ty{wIE@zL?An2j6YQEXi9WDQwrej=BY3J^KjS?rPqS0?aGMai^vfZ{{M5aUAu7-g_lxWoIuUxc1^<)tX*N( zeH2|q9H_XOIWP%X*Vq-025VWHb>xfr>+QOOm&mY@v9Ja^@p2RO+HBWwOvRBccA2)4 zE4JYX61Gt@bVsl4?2jFG{exmVS!0aCsa@o=n|x4e4{L&HXtvj`#n^};`=}M#?5FPm zyK)?~E7KwBa>TA87Zs>nw4fv+EY7oVTmt1-rKV!P=tApXB_P zU6B{rLnw8Lb;qE~cBNdQmY92$^VjT}j(@MSzBla3b&Htq*cE%1{fGLPgny9xKKt+i z>yC~OsmDLm5QiU8m&fc8w0mM#wWsXiXLcP$?&pk$VlV9a>7`wVaOxFn^~SC_|JwBq zCEw8pKfkwY!3Vouq0~q2V;6j%*hA1~)(~xQ4iR5?%-{erf3++7H|D{7EcuVe9bVuI zqQ6rw7=KW6+`$3vnJ93p?}!&5Jm+8gq&|bg_m*b!s~F560DUs8el+Y;_!3 zfiLwP8qnOKvH0A|q1v4t+J<619K3FF=rk(yaj0Zphql76zeDYYIJAAFLqXFV`nu4e z%!{ed5{JrT2<~FRI)`528#=6a=l~KnIMfd(5x3EyHk%x}f~H#>>av}2c2G0)z~893 z)1gCqsP$g*+2>Hf{nX_EwLZxCLk>+k%$P?U3OMS}b!<7|P})g{&f=$2#B`c^qR1JC zBF;M08~x7F4&mpi#|4MpVaXp3`Tlh12zLHOJQp3>eTg->?9h5Fz3I@Vza6S{%b_)R za@(O>cUa5&4mEl}e$O15iDfAGoVZ^&)C?!^0j8G@wZdMUM&4Hr4aP)deC<#Rbi-rh zf8$VD97mS7)CqI&8sE|GUx#+#1WLSfXfhTc%X^2Kpc5`5=>ub789u=Dk-Fk2{zBzX z^us!&ex^1UiMJ^B#UcAw#>7lK!h3Z4MqIdrvj1@o%Teh&^}s`eQ!b-Zt+5;5O-|+W zcWM;wqk4c-%kUAYW+%@Hoyuu(Y8alQh}Ef?h_gAB3$3vbfp(|rU^j9(oSF)U)2TIq zPK5_Kbs0xpP9+9AH5aZBr;cE782!VY3h+2p8awd;`y!mG66sW9bnrU$52{2tbpa0% zAMI3K48xQdr*_~zipDw>5l8G;h%WI?6;E*L2|nO%B5|fLCd{c$l}U5zE2{dKBi*T` zIh<;r%c(D@kel0ioobSg_W7MUP{66Af=-Rav_eh=7k27x5vS}$ow@{5F{f%HPjSXV z=MqkB!e^wGa_T*Hmv*XW8K<5hQ(1C?u^jW_KiJAUl>^-|6dNl#brV-AJLOl!sc6(k zYn;G=YOD)BBk&i-sqR#<8ctQlc$`3|n$)+JQ>)Rswo?o0I8~^wQ|l2?|tojQYv z22PE@Mm%WfR7hi|_M=A=&SPU!)~A_MO`8*6OLD_LWN6J?c+<|Q*!E8SfkGXeDvzbO z){*=>v38xwxeNJsW$nf|d9LErM0`fTSmMNCXdLT^X}E$c<2i>Dh?_u+xQjv)i3?dL zIrR;tCOb77E0ARh^}~tj)MbWK^bjd4_E77+#Jfj za;oN8_72vcV=XQ@6^RP)yG%UTgY#Etca_J^P3HWYxKZYollNDhiotCBfm>L6hx+0r za@}Rm-~uW?q9)K|=6S+A@O$P|VdQYQQ^wzr1I^e4syCest=W zPfqpy%v`wig?zqJm+w3V6sUg;fvRK*)MRs@u3G}t%o?aiXkiajs3TCrLjpBEL!c&x z25LaYK;6p}s2-UEH4A^EV3t5N$1Xg>#H@ijfU~e=3*_}epuWMHJy7e>(Gw^|1nS`b z#Ruw4LZE6U2FjEY$Y&^l%AX#nA~^z8DrcasVt=kc70*qKc^D&apfaHq+U5(?8tlLW zWGcWoXjm{%bMc^XppFy?)QgsZ`iiD)0@c24pc=Icl%sv1s$&X{bO_YpuFQ?r-2-(T zwR#51-ithYGk+iQ>KmxR{R8D0NKS+3htHTWI8cd0sp0TI^%@bVUq&$(3XBa@?r|I& zAE+!70(txdY6XHO1}YU7Ck3j;

yF!i>D8M{49)Q&KNcZb=% zC(M=oVIIkk2f}QT4u`@tIjVk2nPXux~$sP4jnm-OR?MaxJr(re`!5kgof+a$^qzG>&M>s0w%IbbO-IrSxB4njR zs9Pz*vC0w3rbSp-B|_g&gbkSy+*uK7XGa*76QMytguO3Eh_4@EuzcAd!oG$P3K~T) zG>K5JX@s@nXc6JvmJ$AxwQVE3_G*N;rQK^0=Dr?bnOyAD4#F&;25N z@Ud0#XKc~acYG6(;}>sT{3XG@}ChQ zFf&54*%7ABiO^<2grAm1c(yD;^y&z2Y>TjXyLz}gLX~5x?RbPICnAhF6XE#T2zAb> zzCV@2g$OHU>J9b&rt-O^T<)sZ_agfHf(XSPMQHI@y_8VJ0tTiOke6P7vvvW!>lAQa zV(J&rv_Sz|#MQWf_nQ=OQT8`0AfZJ8L#1V_0%o)>plF){2E3xNZ43CULjf2172xP! zz*HGNxqyRH3aB=)_Pb-j>} zZxnJvirp@x#hpU7Nx{8BhTJb?oXmVs$mmCf%#ah+icPNd&eQu*`rj3eY;9kzoB#VS x=k=Ht8FP!wDpjHGvR*std^dj8_WsR&^BA|h{rR(VdW~h30c6N1tt!g>GtZLN*)oTWVxj8vG)oRtK76?_Vo*BxlnHkIu z)XdJz3RKUn=Fc%G#)0^vGyWIre}7#5RsZ)kQU47@!A0pG4ZCHg5l)LuMck697Wkti z94ZZ)L-2DBSo1VqPKF`3CX{{|x-@~6O`&Wv_)%&!hm;nODRtzX)|w+(9IVE*(!rWW1O1j>LfpT5;{{!b_`aM`8$@k%( z2Vi&zn`FNfJc4zP^?Z^~pTGo(ehP0tg8>qF4%KC?bc&9mpZE+>RF!XKkTHr;^0Fz4 zma>k`t026Ga0t7l|T4zL1K=qX@_ic`iLmMDcp8ZY4b~iX2%caY<2B zlCyGC+9hjV*(hqr3n^AEijO5bC5k!{T}g9fs7#bIm7|#Mh~m66ipCjHye8|UhbxN8 zz9^1lN0FElMO_&!XQW)N9?KM&RuIMh>QRiV5k>o&Q6#+_#T&I$w*=}$aYz#CMKMge z)Q@6igDA>2jAC~q)z&164`hUFZxMy9RTKkc)*Dg$*-kZgh~mSJ>X}>=$6Ha%kncK2 z@$Bs=x^;=-T-PX4yD3%=^>A_&lcq#rn5wnSjpFn?)j2HKY0cSCI-0MSM00a#G;e+z&G|Jt_Cqws zHb?WPtlbvPf}PQ1?TTiwd?O$0#d+tRXhOe4Q&&bv_96A+ueiu7RJz27Z;H5d)LOTwtJKp@B`Z zsG5QArB`(WAIn|IscB$|d|F#|NP{{CUXuf2uV-L>eFHUG7-%8ITWZZRUQV_$u%(Rw zTRQ`#<(OQOR_zVU>7d?q)SRyB**l6ax4IeF(_Jxo8c6J`b$_hKpXl)r1OI%c+9n!s zO)~J_WCPEp82EC!`X{Sq8T8yxPo(8i154%hG6QccH}HI=fjX$`(3>h!#UL|mv0&9dE3BucMMdzYv7*b-qV^T^MQfE4-I@F_D2T3lD{A8 z`SDaeE^1^!F(a!awYZU+C5(I&Ys4RCq?)Xjhoy{qt{EwxU}R{rk&`J#E~FdrW*DjO zHj?HsQp9hhS-{AekdYSIMqWs#93x4&M$%=PoXs=RAm2#O8b-F%HR7&kq)&atk_nBB zWHmN2TP`#)a$DLpHBz*h;x;$3P3p8V>h;3Npx2BfziwoQ#I!RqP~LBE0r+U9P(rTT~$?YGEtlway)J7w_7|6;-JGsn+y{TeI|a8cl;&>$u;o?P0W=QGBMXggFM~ln}`aVNRa8(O;l{E zJhHx-2}g4iSz>KtqQ5v_F_9-r<@T#4j=pAM>YFBB$m+LDY!z=O6MZ|IxFr3$nK&UM zx|^6G)*dDr^)#_bru8vV=6w?#`kFW-gZit60Vc*vje#bb%g8vlohCbC8<{Ar@|1rxO{nz(h-#K*Tx1a6zCF5k+dJ0^DC zHQ{++Vv?MGXrj&|6W1S`@I5s#PnQ0xI{q{9Tt39iJ;{wWvqUz@f3nkProPF{1hZLh z*v;7Gu+_{#x0&}mX6{P1&&*=kAO^pg+F53{=9npxYo?7Xm%Djp+UJ{zD=;%m_7!lhnuwaeD z#&a`mUzph!ZK0aM!skW{55;D&(Aa8Wv#c#6O2t{IAkI=2zLiJu z7S5Nk@S>81S1VhXpK75*nuV!VbWB#KTi7aIhlRdQ3zsCRD)5-@?U47Pd9EP_>DLol>Nkh25CIU;bsd}c3SxRqJ=(}Ec|rYLi!c0OFol1 z*DbX8TXo#f{@t`tPF|O#Ru;!W8^V~v~On6~oZj_bZ zrCzj^@dhhyqm@Fll~HooV&!s-6@L*c{fk;jC~l>rEGc0nv7}YMr&-x1mQq$~+pSEJ z(+O7gCt9hHWTkVmmGqaaOqJiuTKTk`l?COkypS3dt*nu^(yaU~{&Xwz<(2wYR?7Vb zR^DuA&~m%2^rK%*wCQsJWG8a;Jrrb}g-Z{Hm3slKh&LFT~W&N*kHm z-b%3!R=(+MCF*U}+r`Q{dH+2tTgCjomA*2tua(yQti<%UY7ec9kb?uP6b!WL^ zva(n{d1B?nQ|{AF+z^Yr*<2=6Kpg|vT^k#8^N+R29~q&mz*qbqf!MM zT`Ov?e3GL4QlYYqaWY%Z%PXm>FU>|$6&qvZXu6H+4ja)v8w+H(-^RXxjr^eUh&#{5 z(grp>4Q;&N$fnmJ8y%Y1*eKD>RCjBQeZ|HhNoZ^1MhE44$Hp0{*xkl>+1$g1qo<8t zy=th== zWQ|Pu)W%b(`k7*WVWayf#S-%v8-1nDSR2db?l>Fm$J=N%!Nyv7GEr-uVdI6=n59?} zHP1#5Sv%jxv;{VLFSJp7jp~qJ*Q$>1Z0!8rMv)&>r)>Vw#?7C!7aJ5ytb5cix&4cc zH-5EoY_E;d`?ZHMSB@S~A5Pd{R4s<8)njnJ9K%Pl zqgD*T+A%Dt6GQXXF$|ErHZfRV(PPPdH3mo97~Yq_qF6qZ>p#Yl`BN-M*T-^jLoB5? z#!_rkEZ>Ws#N3c$TVpA|EtXk7$1-YrEYo(xGGccuL-xe7UvhtmrO)12Hp|!hV!3x9 zmU)L`sd_Y)#m8c~D~{u_>^vV!$vL15B`TQFl|6a!>c6}V{#k4`^q}lE`=E%xJihoA&W%XZiG`|tY zTp4ml^X|n_?0y_~Uc@oASSkLLvQNQml{T8TCm#(L*#=zWFSk-b3TrC{u^U zlm10KeWYMgJg-iT=PRi`EuQ=t@eG$1Gvm2GC!WH&@r<1pkLk;Jnn>3LTEp^qQdVf) zKg2U}Q#@y-+?IG+?}*p$En3g6c=qp(r|&QEwAvrfmvZbtJipzKC-p%*Nl)XM^lv=p zq%n4W6?>GOg$6raOm@~vmc`BhtDWuQvDtZ0+)mXJcE*>qQ!>_0Td5Fd*LzeueI+m6 z&TzY(!%{E7&Php0w6jK5RM5C|JGV0IdS7ZM-)*O~*G`duogrCv_RH{WJKyBlc`Tdq z?KFwlX;Bg&rx=LxuMu{WRjgx^X;6Fu8Zsp{MyduWp-@K?Q~pW$Fj~&GwJh#a;;Y!v2L_8 zb+h6~!!34x*lH(woAUi^=M7mZf6ApDcDy_7Y};+;-@S@?NOj9-seRneMEO;|{LRh{ zseH!H?-%S;xv0KfQg3hB=_E66+xh3dol4K_^fx5vqpk#=N@lSHK9O&VC$K0nf!i`V zIf2D5C2&_9WfM4@n!rnG30$g@fYqBobJ-q9U~Djf(=sZQK$WZn-jfO02~^F~F{u$w zV0A$P&*VYX1e(=IV2%{8nLxz`33Qk3jS`stY62G}t9=43J0@^JQadH^uFUA1zz6Rn zuv@%65|}D~N^;KxR!C$}0$<4CPZMZ8G=T-uXt;8JuKHw`yfHF?rP6<50^7bypy*=7 zSf0SZl?m*Sg=-UN`dtFE#jswz*_lAGT?v%mmq5Aw33QbkGWDS5NuA?b>%{~%NrUSN zq})lMhpc#%z{Y0@Se_^7eN-ZE8WLG4@uoy-#3V9S0!0$pP%05~d?Hg`N~A;CL{`X; zgwbgr=_$(mitu{)7ZB(O(4*qg`&X}>R# z`3DmDTlyW;xWihTd~qa^g~t-PB|jcl>=TJ3olK;OEIp%s$?da=On;cjMOjM{U&beK zL;CuX*ec2XB-&>tv0LJ@l9(wCvXi(VJ#v%im!HHoX%Nv95*6z!PLm|E znh#x{gTVJ1HEg_+u4+oQ_XOV&Bvx5~peIOx?~+qN6;Ym&DHb zNtFCDiI*1WvD99eMDs;SY_F0`@$_VT-ej8RCo@-e)=0)uGnuO5c{!PZvaMD!duu0? zP$!w5(y(bV(`9M1Wa3*S^QHVQRaz$Vz2vt^X1G*oo6JvdC1dQAOv$dvwCtYDe5uw$ zd3!2euVk%J@#MrO$vhaTyrYtdo0QD0S;^$i*714CoLQ1g+R|h`UY^W5-zkSUe@v$L z&&h0*QhSqGurHaLQuBb0iRGYjN#dboI?7BLeKMJo^3ny(y`*un>S{7u|4OFFwPYs# zolO1v$xM|B&y)E)rZh*Sue~%^QcL4cE6t07(v+!Dn$B|e)zTd8QJQi+OLJy>MdsY8 zNZiwkye@_!DGZEHVTW9Err_|W@V=a=mcr2LDKu=B!gQI}A%zWZr(o`qLdD)Gw3e~5 zY;Xz>Wa6+CT7Hqjd>J|>gX#Jm z$gf9J=z1!J@1*^e6dK)6VTPQrRKi-M63rzhxf0LIR-$&fN;m_RNa#|D4zg%aB^rEG ziD^=PR3*kwsKgoRKDQG6HdSJ|?A}(1xStj4a3$)VuEb=ia-otwFR8@KS9BX&nXI_V zOnI|1)!(Vi7)j}0nN{*s0s|`ZhqN12nPt**LuIaSuT18S%4|PTnbOZHGmTU(NT_5g z4dYXpE;$ua`8y?*tV*f4E2ru+3q6)Wu2dr4RJQq2dFD^0Rv?vyGB1?Mbvclk%IX}Q zlZAPy)C=ozfgVe+FqNKFQ^}~7s-I7(`a6)yz*?!?t((fd`l)Pgq&!Vi+0{Ii3a_Nn zP1d$erTXis`kpJ5HXT!O^-iU~xCiU}hpDWS)t{wubChZxoyxxxQ~7L~>X2G9G}miPo@6JRHjPb-&09FpUS&( z@=_{4U)B7-Qh9JQl@||Esq-+EvyZj5XQ})o|2$9SiZKnpDUFgbX}F4{(O+7XOru9^ z8b8XmxHM+Or*TQ%v}uD72nnr6`+DBtQN@I|ujY?zS zc;%Cfsc9_!Dvi5RY+V{7wx@AShWw(seof=2gJ~EKrP1eD8nsWPF;O0!PNVrBY0Q-s zS2g}t8s%@NvGYk98(*q|rEC?>XIG&_P8Ax;bZH)`!d&TItqMQARt4khRVdT13XT6~ zK^107pPf~xaiWT@JE_9+%T>64wF-rQRbk|WDj00(G?Htv>EtJ;Gh7x| zO2-mN*Y|VjeA+CX>z&fc?3_;HchXt%Q9Ad;{guY8NawE1+?>wwo#|BAmCm>$>3n}Y z9Zu-@Z|R&lmrmOGbY@>pr@@tUCSFZvo?Q7W9oO}AX350A({+7HI<;@6b3uCC(%9SS zw3GK_@;~YN+&Z1*_tN=CWc?95gTQAT3qL(j1(X$_@wnB|gK!Q0eG*U=KJ*l_~Oj&_RQc zgVqHOx=2c)gMciOzpFZETg|~AbshTq=wNw02OGp)-@*G099)tM%^lp6Z(2CmB;J+| z`n7U!MeeqD5Z%GSM%gC?9UTmN)4>DT(bd6m8TXEZc@o>rL7VOleJ|~xR`zi4qaE}pxsCZKTLG+?<5C3Cp(CnhS>w-3~f9BR?E==(;HfD~>vN>6in*43xqXs_UeK zhf?H}gPP}5?=1)4-_~B-agZk`A2@jO)IrQM^+%3Lt>+HLywE;N^C%}Xqn*SUoQ#ff za)JI`w^pQ`ZkUIW7mwIZ3GCWVlRBadNtnle(3i%yMXsbap!F zCx408<>Z#%Nn);(H}ag6t?K0L%T6lSb~0Jk)phcso|7K+oqXTON&Ci5zHXxNO`XhX z=Hyayr>;wI(pA>W_pdm4{;HGiZJk_x&B?geot${XNr(1M+H`X=ue*~HJ)9iw?Ifv> zlP_fD04G~y;6NuMBz>@xtDiV|ENeb>^0S17I2rtzlfUJyVNNQ3;pA5-Inv2b^3G`W zV2tXPb8<`Ck5#SXRO@&rsWM#No~nG)oYbG;Usb7AG6GI@z$zN%VH*{>4e--;`TQpK;=p zzyENu@1puD(=MqdNxrNxSDYM@%hKeAleTx&H%a@)NtP^;+xJw*eJAhB`6t@9f1P|T z)&6tRRJKb@R0e}&oIEvW@Kuov*2%j?Gx$XQk=)`LES1gTh|l0mQU*6 zubhETuFF&Do|?hhvaO zq_4)w7BTnFpr4GAhaY5cb3_KAQ5hT^oxvrUJ0^pb(rZ!%=`(aYGlTQeceY|n)j1h7 zk)OpjFN1+HR-PGRBZ3Y{q-x|%6$5QxR2CHO;c-Lp}+E(>vTLz_m zRxX*eJA*F|WUxlMAI#tbxh0v0wLen#WCr6;Wia5k45s~)!MS@GdcT;#OAj-6^O4pd zC7)){`dJ3M<=f{Oy!t{h|IHxwzYN;pVsVsiIXbtxTBc9B!Y zMO`tx3uJ#hpAC*soTrN;m=$o4Retym500N_PL8Qk~u=PjC3(V z?#bxUF6Kzlw0Yd(<&FoC3=neDEsBCG+wK@-?=bQaQn9p~E@j;O`;wcN z%egsJ-mUL;+?+^tQ!C9)YPy^54mZEcUZkk=KO1Jp0;ySt%KIq(aqqu-E8mT#__IO*DSf2_MV$_eWb7I?(b%bER%wPZki8u zGjo`mnBi_ZeD2o!1UKJH$_Vvlq+6dEx~V;0@g{4`R5yd<^bGZDmYeb7p6BNM`ED-B z`LEUArEYyct=_G4vuc%_@~hp{T%&r|x_KtOzSlmi(^@yWiTvuOky!V-Ns^J$e7~Ew zq}%~F9@&3TV~@HSE>(}IH*)*9>iR=<{pselOK$Exca!(8)+B5HQ!nsfiSqEd9EkQ% zVDRv@$-^zPhc_%9!Zr^L#S-HoQAWt2A|9$1^-#2!hvvmSY?p>{8ZSwuJfzD^`7_=_ zQ@e-B2_DWQdZ?e|!CS^dzn45*ksjqed{;qZQap68;$dyNhe{3)6*4@$?egeaSPuy` zJ-q(1hyC)jwnv|PdH7aVHuUhIk%vx=J&bGW;Y2eJwVHca_?n07uX`}G^H8t7ht~3G z2am3I^^o(X>Xf5hm3xqK5BBKuFAtAD^H4ahw0-y zoFA{6CMe%z<(T5(k<6Lu;nFk@cjdq79>&b^aBQxJcJs9+8MDAc$Auo2F7lB4m50GH zY?+6B%hlTziY+gH<6-nl4>P3fDi3e1_Au)Q4@;!hj~b_DKdk^04i(hXzkQT(x-hy@Z#! zvO31gqat43F6t$!q?bCeUMz`T9+uT@IWODfu+%8;Wn={}Po-CimvxoA{8HIV$uutq zGj!|q(%R=`w_FW)i3@spCFCV3Pqz^-^9wYl(93^Sz0|6%m^Hk5f9j=X1I=&fWqKiecMaLu3oylhL?dD}~cQ5%pyp-tWrPaG$ zcF7q@>Fve&ftTJNdihh{8|tOZFfSd4dpRQCj_}fXq?d0-DfU<|{_$SEln#@3RESJ%?2KdZg`@vWD_bzX-5;AO;S zFFg)>`R<6~9MzaJ8gtf5*-KvDxaH-m+g|KakRNsyd}S zJ~~JFI3b%1K8z+G@5|d3A1kds%GrDb<>%r)`o;VBT&mf9dX4b0U1Ab_43c)GeJn2H zBjF_AK5%KA+s9I`k2^je?fpLXg?tRi^syz&r|YDB{3aE1eN2!Ks%d<6 z<*eajn>4HGW5>%rde>4dwG~_9>MFJ@Y2@Q}W7XNxNBMSIM|-V9{+1z~eH82IqeU;x zmovS6r1Vj}eSJ7TQoN6SJpaVUxS^Ue%%`6X$~#i$M{7Ou_gEi+@je!aX`+wDlYN|= z>f`J*AC+hLm@MaJ`beGaV~X^i>*L3HKGNrFj8tBrF>-&AkNm|xUAN++#@EUzHJ18V zD@9lPX#TD8%C)sVeBb++FT;NF;a;zO*x=)mOxf(?_bu9!Z9Y7|_~`qqkI*6Q!%-h! z9P{y5nw|DB<2N4<&-jR(_3@2-cHYOYfB4AzQ}xT$D?VoZUVzaVdWOlkKT~VygHVBq`~BRyqAV%<%K6+fTaRuWR1@oR`OWehR}nFKr@z z<`wuUQRv4|-Ou;(yoR68U-nbEzMpOl{G5@!js3(m^)o~cH}jL!!q38%e%iM4v!K17 z4xRnDy7-C6Be8V#Gf=j^<7Y{C<$q84`zXKc?d#|Letw2YVShi3Wt&(B`WYZ=2K#yP zfuF7)s@9J+?^ER+>gShXep-C)=dXo+ykDtq34X2hF7abp=BM2nKa1D;N%+oB?{$8D z{J~F+pZql2qp2Y)vEV(5D)Rheq9UI_1DV-D`LoUk$ zc{@44%F+SKl?hN-AwUy}si<)>T8^d!s8K0E?~DLLB%KsJlX6QHlm3kJ9n()r8) zw{iny<_GvnIur(2QZ+!Zx@xGa8tMla(;&dJrU9xq53ok!TLoy_I>27(_-a7codyWK zu5%p&Jb5#qfAbPxS?>UM-&4Fk0h$dCFyn&&l|RzDM+bOgOn?LO;iLdNCTs4L0KZAa zX#pn4Z_{;uW`Gs50+d;<94j<;m3p%=z$cpm`aDNDcLcbzGr-{80lxSpz`3)x*c?;gbNZo(8D@EWpI)>eq_^Q~wQc_CM`4 zLADr!n9V^ZSb`KU5~O9(Ab%7Kk`x=HU0jfZQY${l7<-TxG9od^p`;*HlY`7D8>DZ! zAa9osva&*uautI-lj@a%L^*;OT|xaDh9EJ)Aj>j?+|3HII;^;bK^9jH>e}KUDfNSN zZ4e~ASy0yu2l>5KkOr-TjB6LvYp`;62(tc7#p@Jgbmt)PJ%Y6D8RSZ@Aoc-4UK zpR^mSm>&d5_%KN0PlHSyqP2VxWa#K1d&dOH9~)%*IMp&C$RPQ4dXUF6f^?awb<7TO zX-<$9bG6R-L5_VHq~?Mkr56S1@Kun*az&yStG=&;R9YHjk}Q!@tF(q+wT8VxPD|bW zLB<~l!oeUP9tqOqXpnBlg7o@Z^KJ#{emh9voglB?4HEk(NSnt&_Q+39Rd-Z~-G&gw zO(8y#N%FfqFo!T(LTr^oQr#M2ge^qhk|Dk+7vg^T5N}lou{tG0t4bl}R1Q%rHAHHa z5Z%)iLpC@=M7u(~C%b$)9|-ZGY|aW{%26yS84l4p5@K;dh?|8WR=gadQG*au8fr|V z5Vcx`7}GkW??OX-{z`}guZDQ#wGe08g-GcTVxrW1GsLL3Li&6q#FG9YZVw3YTt*EH zF#Ec;M7hlCjLnbssVhKBUJR*0Qaba;qqpNFuH3ek9Uh%K^DEMr1E z92+7sUh9{Q6GQs34R;lq1q+Wr*K4E9aIFd$y|PU8-q!2=AT{*Y<|=J&yW( zK$s>Kazv6ZYi;t*l@Q-v4H3Q;V#mD@MIMAmlF@SXVTd;#Yac9`Y_w+LvSsqD zWG2<)GHEPZ#2lYVDOn=7?U}So$i$tT$@`@<30BC&RwX zwA_#q&P-mC?o!v4$#{1rJw2Ix@69CDmr0deJf4-cruanY_~@6HCub=E|-~nG~CnNz{T&>MYdprK)v>YW*gYL8~$`{*X!iA2Zn? z7k|pcxgnF?8QWmdgWw9tbi&ME-3~Qdnz7|=8TV~NzR>_ffvq*j~iw_57QEx#O z6BcUzqAU`mqpVz(#e?Np#H^C@n)gQ*k*itEET7Gv6|!ksF`LshvZ?TLHbom`Q!pW$ zVH2~tHZz-dH)Qj}#%!u@&gSyIY+MJjnJvYC&!*+sY<9}Uzp`;&&t|4nxS7q{x3WpQ zpH1INIc%()qtC~3_|=m`tS^U89umGT|bAh4RYw$D2G+u za(LKX<9p^X;=>#ceUwAhk8`;9Ne+2Ka#$u?WWmTBZcWc2b7l@-$$GKR%E3G*hlX== z*d#}!+oBv6ex1YhB{{shG>2Xivnq##H95S#Hi!LkK^|<#A@N`iZyd_ufLxS8Cv^Xm z;{KMyFgfx^4#^i(m#q0GhbQ-PIQle4&$V1mdUDCn&eb)vxr`sK$DijibxbZz#^o|? zd@dhN%w^}KTrwx;QcpTd^{Kgxn3l^Ed24wt%U9%5=9^r6GDNPg&c(kbmoMeTo?L4F zs&j`m?~3MK&85!GTqZxv<;Vfa?w0o#q-E6kw?e)JgO$->1SJ>ezxVY(3wZ6 zj6A*y=CL?8kDGaUj11>7wqqX0-^}B?0eL(dm`Arkd2Ab-hjn}&SLf#8nV-j8>9#tL zHQ(mZ`-eQ5Z_Z=pmONs%=278D9&aDb-GI#eAx#=QFfbzTWfX>$;76 zn#itK^10D5pWs{h{L?j`<74xAX?#AT<{*yk&LWLpoX?Q2HAc*<^J(~PK1F{} z-ZS}pcQK!Xm-0DsIiKXK`Rb+eUCU?H^?Wu;_TTw@bR(Zzvi?>+QFrnwE-U51-F!Oz zlh2bU`BZ(Txbma?_dK6oFH~Q2m}15-AIcAwF#lS^^t6SURy@qP5@G(9DJ8@F9vh}X zT$pn4VRlRLgfJh;&crZ9lfyhNAJ*^uVf~&T*6;aYK9QyAn&SvF$r;9w5oVYt%sy|J zurExNkn&`P87!r3PGX{Os2VLp~wEyG-Br8%v`)O|h7_&37PF3hU-VIFn} z)48MKb`Dd$OPDp%^_?)QyM?LHJxpQmFvH)|I4Lq?l6Vt1ydJgxU4I_TdNZgADso zv42wR^lcc7++bH_YCBVXhnu^GLou6lR;WKN6bEejp3!}o_y`QtD%pM;5d z8fFU-%+V1pSR#~5iqI)J!f`2AR`<*4zTB=5AuA<9ok|f-RE|(KEy9v25&DH9Y|4z_ z&WcbgJHnWp2n`A%?5`UkzJ7$E@_B;@2O35wXcWQFBtpHW5!Q>NMTB=-M)*V4zZ&87 z*CMWQ12nDVCfN*J#x@CPL!42$f}$Fg`-QjFzJlB6{vbXdfvsDqI ze~j?fjtI+ls)u_cR5_uwos970RD|(oBb+=Jq4s&L?+?{*A;MajaZ|m&rFw3wmVeai zdl6krAEDTz2rV9~mlCR2z~Gbu^3n@%)+(TP?E?OknEC}YZBW2AaWyWWPm=;J%E4v@ zB(x}CxU_6l!0grq6m3($pjR~Z)dD_gU%-X_1vmy4FhfR8E8y_-0;%uEGOdv08HJ3HZ#ETje{&(f zZ!P5Li9$-BDx`|kI<4`)X}q|u71HN=A)iRrjY2-WS;$Q(cBhaQcMI7e1@{UWcE6B` zGUq`d;~o_yce(TY?`M-ahODF6;HqiX|wH<%l+|jXF@i7C7 dw_7ma+Ots=rz}2S=Dl_QZ=U|e{r~sp{{RUQ)2sjh literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/48bb55e57c2fb30b_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/48bb55e57c2fb30b_0 new file mode 100644 index 0000000000000000000000000000000000000000..12c0412bd0d17c6b5e5e4bf806ff7404b8e5bb27 GIT binary patch literal 19500 zcmY-1cX-p~7x(dZnxsj}EHoV;tI*P<*-3ZOvSi5K2r5euWGEsV7cvAyS+bXa2!d>o zJ!HyWG6j^W$dtYG`TU;idj5F4u9q3#`#$$M=ZNRWlt5ywV`$9FdeK{G`YlM8&viw;&uhz)Ou9{IjSS=^()#_RPYN4vt zGOPKkzgo?g6{?z@S*@l~F%HEQp8CI7|NAHHY@h#oo1lLO3~*WcMZq4KW`Z+fQxdmj zk_CP*4o6DCmJs}$4c1(Zms4TLsR5;4g)WU?X=5nU1lq_tsooTNNOCjCklONYOU;!} zUWaer);c|)ld8NU#d?FipJMe_tO1ZU2v&Rqk3WXapFsD|VC4{~`Z>f8hc`w*SIPVW z7RjBF@YX2kCUr+cE6Mp1YD(v?ptlVA8orR{V-;@#tX>HvR)K3ZtXc!xWbRtHFXw;K zv5l}`lk(gGo8*AxZ3WBEkSNFGk~G}`J9omb^7Ss5EyZ`kYkSoXvHt=oGD-IBhja4H z0r*bh5327+VX<^N27Tn3Z~}_TED8MzugZT?>?C|DU&+i<>hU=+{{~wxK+HubEx*cD zY4JNW`~%uasY~FL=`#2-jFDPbpr!2npR3w?nQ#r}N!)d)_?Om}+w!lxcLQGjt-Nk( zyquOgx0K^;SSDTXzyP@+2mgT!GUYxjl%xmn&qFXig3WSJ@*l(6CwlG4XHQ|AL_LFd zofhw{>2AT|vmRHRNn#*n(Wic>anp+KYl9O^pF53*`#Tck3 z(S;1e%NH_9iWD|bp{Rj?+>{s6vzURw@}ImJtH+X7!a%nCAnPQ*q=9e67H8lMStY&g z21+Cvs3_;@o(b%S$Oz*1#u{m29B4L{-!r87kxDTqOg0Qw&UT7`W&(&@f%` zWv%pZ8K~qla4gF}LbicA@}-=UvN?Jz-^k>AXblj z14ktOH3P$>OI-s?>lr9h-@u**%CnJrAR}c*Gu7F`K!2J3mVrOoD*yHdKI)*J%VlxA zZD6Xb?rh-sI|jOSF>s-)fs}5F)x$t3x%`3l=0gJ$J~MFRa|7i^Xip~U@izvHlMED> zWpYBylhuz|2F}b@U2_bykPp5!uzs%Any1I}4Rn;=iwt;vR9q~@XjjL zyxPETYYmK8XQ1mQ)x5>P+uICm-L71BsOP)X$K3{6?J=-zzX8iZ1O5Kzw1F*W6!)xN zH*(-N10^pQ_*}Z1qgWLkMMX;#KDjKl3PM)7&g zD4t3|?I@N?vDc#bNOshXB2X`i7mcIn)ijC<&7xQ!H=9S%rbQH8o8AbnAQAEG4 zHCsoqQJzYRHc|W`h2Dr_n;e&GlGHAWROv6(J4CTp{*ezlMlrNg6eGK6PS+?JzZ*r7 z_m%IMD7;@s5tg^dMv*WsiZ{ncaX?}wMDdRNBd<)1;;3Aa$C5N9ir~~Jsz}2bQCyHR z-$v1FUKGDezwe@$wm>nzkK+4poR1`BBQeRQ!LVC}%R#qOg$}MT`_G zYUEroBVQFaGE0iY8fjX>$PO7*(#Uja9%rPJoRYHf8Y_1bj2IG)Y?S>HNis6Dl#vIL zQO-zBp}djeGDLo}k+nf1sUah8 zXBz1v-Yg>pvO=C@8|ji`WPRAkJ{cM@GEt)QjnpqNvRUR=HL^zDt7haAxhL5*j4YJT zYAFw?SKG)Na!Bm28JSbpNcCn$nn}^-s#(U$sTM}IwlZRCYowH%kSo%nospUC)w>Rw z(^WltSMlX`HzRwyD@IQv34K)eCwly;9uG0{&*#c*yb;#~BOgpO^86bk-%e5gBzKzP zOgFMjHc90*VCRMMo^qlt3yCWa=NIF)STQkn^G zx{11O6R92(h5RO(1Wc?9nP`?};-z%THj$WPB26aC`CJqA@=Uarp4Clktz*Ldnu*?Z z6;H-BFp=5N#04X7i+`wz=fg~T|7armYt=v2#6~$H zMaP*qKGVdMStc&bHc@|$i4Ia|fr%17niwgEmzv05W@6ED6OC7x_+_OD`zjM{Rx9r{ zCR(i3F}d@Ti47Y~l-y)ux15w$H=7u}#l$m7-K`pB-5wK__nHVv<}b=~pYoI^^4ES7 zy^fgpO_Gn9uw6EBT54Z4@zpgGuiex>-Zybs91l&b5yK-BwH}+O@zlg#Df-;RNAkvh zCjOCZgPEdMGanW)>-A;kwEQV8i>X(~U9b&%GUQ-c+If|+B|V4|6c-A+jK4Ye}%sFeO*g5s)g2w-Drje|a@_(4= ze927B%VuuhGV{r8Gl4s1s>up@eAmpbduBWj%}kIpkIdA5Z05!jGrnhLX3L^~mB)W( zUdTs8b6;|zqFE@LAl+ zquG`nO`)79VfqdC<$nr=;^Sulkwq<2w{ z64TQ{#(Ne9y>DUfhZY+3Q4jiBF!!@iN`B~X!8O{#2VYwFLmo-&7z?+?Ti80$!h!F# z)*{7~NwWV33mhrIa?P4iurIy{w1UVCL}w^apH+KkWuzSLZzX?#Rlf_gzN{KTj{@DIZ4SKR)$E* zPSqlZcWH0;TlxBgm75YcY2{nFbJoh6=d_<~O% zE~iV_$Si4NaGZ^ia$G*M+t?Ftqfw%b>#x`dma#FQtc^eAR5=?J%iHK$L38EPWUVjd zE7|y3X2?Z(Jw^GY+DNQyV~iY6vr)}qBg$uEt_=6vI1sRr7t}i9&b6_qo()fZ8y_~X z>F1G+_Kj?8lBg!iyQRjyZsUl=x3O`vz1Dlz#yP3b-Nsni(!++Mr;YdCvvEOEdMSqw zZM=|1eQf&KW7E$b8`~t*-^RcJHvW>z18oeIVuNht$ZatUwh_=vSpo(TkEwK8x>2ed(|(w^NWqQ_SrbG-$to} z+C!No#}BCwCv7Z{i*o0*jr?;q8pwyg*;p^XNZffFm88Q38$Zf~i+a7tDyj3kjft}4 z4;zo=Nn8xo?J?9ZAHx(mDA#ji2;{}^k%S9kI3nw-#!#hN49-_$_*iz+$Ljpd-^{1Qv={jqG3?+?Us|4=NmkH%8vcq|J} z#Bxs@zs9obVl2gfkHva9mZlQC8q0vcVp)14mZ$Q|-?0?E70c@qe>;}G|HQIgT0V&7 zX}qNjghlQAuVlFUg-$ zX>UnB{3^z(L;C4xdJ}=2(S@Um6mi$+e$I_8FwnW8YGsf|^DUN^5 zakPq#W1d(nakQ5uQqmenY)l+)NU>rXUm}iXGSD7JyTmvai=$K=gGGN7@&0^p^Yy zakQQk$9Ga~avXV6;}|Z@rp57KW*h~x;`nNI9OiH1Xe3?ds)ogJBrj3jKgBVAa~$WT z?AAD1?u^rC8P&5pj)QyR=<`b)Ee^)%g@*0&mHjx29t=Z_Y4TrKU?ZKeF)veQkb_q0>< zJv-y1+52{qdfRzhHute}X`mhVAUo|ow$uDmJ98xFGdpKKw^M1Ton$7s90 zWKwK7Ho?y5Id)D;*ZFn^d~avV4|Z&e?Q~dT$FkN=6Y2ev*4m&rV%=nC(iX*$`djV% zw9QV`cCGibowsC>{2^C%+VSqPvwe@9fA=fq5#=pkO08e*jF)}#?O8iFrP4V&zg@CZ z`LgMQ)TfylZ+zqd@4T{jc0yBJa^>Fq<9v*63;zx zl!@nPO1wU6#B-%`JXUW!O=U+Qp09%OoRQI?cq(Vc^MQ=Zil<7ho|Ed~c$VkK^IRTQ ziKj{RcxFn`8u3)97f*ND(IB2Ft>d{YneF0f-XWe#lF})j_hoA5cm}^4&mQsih-Z@g zAxS;sSt5~v@q8giKZ~d3(0JxbgW+0xgz}T!^46$$7D>PH@ofJtp27>8*)Ebq5@v8)a;}ZB-uFCM)2^^Iz3lsQmaRPVc;*SX=tVp1P zOp_t26F4ZF)+X@!mIUTYg>4B8+m*l(S-D$l>`CBL3G7u5_9t*j+8sz>&Y=YUmcEBI z?x<>$FODTJ??eK(W!QwcPZMd#EnxpO{&DUTAkEUQT5+qgt-N*`Y$+a$@K zNV|+g_DG4$M5al-tVAwJkDNsM<|VRS>VX}I92Z?+ppY+yqeG=&=kK~=ciL8`r{St}lpU49#{i$Mp zu9!m;c``hat|Jp!Ed`?#|0~7+TF;M5PFx;+)|y(HDB zcyjX7Bp!~^x}%dQF(HZD)04=Vq335Oac*G}sf&{MWN{MjuGSjjT$e7NijjqVp zaTPfy-Dg##@8*gumOa}mQsQUDI$DuBXDTvLDqpIo^ClH}^_p&DE0I~E65n*JM74J- zF-DU6RnocsN<5Q5|4RHWZAVw)2kE)75;t~KB4cMIcATt4spplLObVAIR6K?HaVboZ z?D8r6ot#2u#T49?QgrS@k7b}Mg@`wW?Y~H;}@Bnkn3?lfwPFDQsz=bsDFzyJ-sLUr(W%tZI`& zwKr4rU0MpQI;7z0l|nyp57P0EQdld?KTqM-XyyE63jdBz;q%GLLuyXd-03NdkzO-W z=szok9pasxLXpLaCp}iAFn5dQ%R9SLD0?7trh9Asa|_&;+iGfjH$ zs!a8hm37TeWnNsZ%!BKdDfqK8qi$E$`FlMl%O6z6XiKAk{1uxEP*tA zzn8{mP13m0DUFQIX*7H{jfEelabMiuY21=D?#Z+*Y5ck?jq2Q$hzxLnpj({c_{Q}kS_gY#0!;ozXer8^iZ9sCaL0S77ajrpAl-sTSaws3Gw z?zM9e)!xA-IUxBR91QE|;Gyj7>fl%T`dtUJCAOP`R^1)??%P4}0m^5f>Xc(2J4pJ} z!AR*f#KF4H9i$C)u<#3qu61+Jc9esk#yj|Tf`gtD9h8{vVE7ExJkvpBmV+m=9Ta@) zVBcH^wH7+~YLUju*cA?%taMO!m4orCmFF7ud7Xpl>m3x@p!=J3e~a#K)w~@JtUDbv z+~r`a6gr^39&*s_u!D2*(@}@6S#z-DxPw!eH-C+A;vQmK}ciL$nilb5eK=~36ong&kVHFWZQBaLtDWM&g5SDHF?y@QjkvO(6o z?&L*lC*9jPx%!5auitcX@+~Lr+c{~~&B^TUPKxz#ag0*6{LIPE5*p%U(C1G6mM8M|FeeqhaI#NMON)_CijPwMvR>Z(Qau@?I^=@f zmUdq$_pg=vSSKkmT;7?a^(Q;2JJrdx8BW}@6mzy>E^tzAq4Jk^e^9QAowQw|-pbr% zPX1c%WZ_yTV>UQBvC&D5P3qScJ-5}#rfp6(ZgLu>!yq~TeuEv3#mamwGnJ2`M! zeU`~rl#?V~)tGBej>uJMbkj+jd+MX4{^KN57RsIb%Hx5P59Q)h?c={rMo88FoHUjl z5@SebpnNUQqSN`VP&#Yn{le*dD*s4M(R3Ec7IDO-b1pHRo3bEDW2IlYbjnpq$0s-B znRHJ{XH{xC6)UHcE%RLI{F0r{S(%uV&U}f_P3O(LbPmcT8CEr&8V%BEF2x!uri_!* zjnb*zSYu^xi*!!BnNI1p>5P^k9n+a0_21TUIV|y=(-|()CAxb$AAFe3=Mw3oak5pS z`=!%YM$4nY>D(HbPH1#G$G=SHip(05&Qf`ALON+vbvrGci_&L?VoQ~o=`@m`#Wp*g z0rHhRov%JEPRIOXI&+t%vv@^1o22hb&66imusWS(vQxYp(s^T>`m;Tql0R!LnXo6F zZx5xjQo0{bXRzFsjHB8gsdFlwv8U7Ne>R=T|Drt`|9bUHp(4O0ABIxU~4 zvqx6ENT>Bn#r!v&*#FXLi;D#Y7x7Up-ZZ(GZ*~zE?V@-I7cEQb`6L(FrCrn!<0~#o z$}l-l#znZSi;m@8{7}I~sbm*dE4px{xR@bHm0h$;b8$qrIbB#>F2=iEq-D5xFVlr1 z%f2cch%9u#X-3wb>4Gv^m7-9!(60DrQt5Rjc{>JGDf->Jj%sLxi4RS>0+j| z9OL30IV0u2cCmP@i`o-id^^d-O6fjX^W?TTBWb8&uwi~8Sdy(L;(X8h=4 ziIiRHqSG=Lze?0f^-vDVd1<&xb62~FUZWa+QjP0WqpaNE;^{^gLpQrPyj^wea8de{ ziw>vNmoqMoUDCQYU5vZs!f@NgkUK8Y?`luvkwo8f(O{3?UDBGiTZDL zvo_jIs>RI#tDBNBZa$Z;h1@JJ?52DXH`n6axZ~Z-lnSNXbSdrT-&fqcTGq{xa&CRM zM)@b;W_!eqwZKh(d0E>{(K>GS z%4vD+H8akHa~8^`-@UDxDh@&|4%^p-x#yPunHi5c#u z{Rp?-C%9Q7$s^U9QEr_xbW>}r;!V_;Np1$pnW^g6bT?zgJ=@KPbKG2!i{Goii`@F2 zTD@E9X4x_~<(9jtu~PZ2a`Rl?Tcdqgt6Dd?iR^RJK&<=SB+4jhdeF_=QudG=j~qO# zvB%vEmntXJ8@cnV^7>tQ{o&?~D{k(;aFhG5YLZp|sTX*#7(9%SLs1^`jUK)?d$=9# z;Vp}Yu+2k#vBY>tkdbnvkcTRTJrpkDp=nVMJEVRIjhDod9@1o*{1NA&vE9SOcn{|i zJk(9};4ST;?<*dzNsn?KR+rb9WDngddsvm`p`yb>`E(EOxIDT(*F$^_4{yHe;h;RL z<HoNVHuW>XLI-tchaO%KMl9$stbp{0D*-lJ=3J!E%O zo^rga)*h&}2YGb<%cI}>9twteSSCA0c!(M4VW5m3?cvOq9_ozoFy(6x7so26aawPp z*7(N5W0^V0!epKB*-sv(%R;HS z&cpM~9-eN|9&PimTsBMP?dshQ#og)Q8!5EQLzCSeewKv2+Ph!0|MKlY4}Tu=(CV=I zchtkUV;&60J(T>_L+g_s_DR*#9&SnKtcUqB>NgKZ&+GXM9)?`>@XPNW-uS~qS9vJm z%N~}ALlLY3cK_N3I9Fln8oxJ>(@ZSGN%_bMiH&z{`JCywt3wnAN>{&+4T{JUK(`pGOv@D8=bwhe#c9Nu3oyl>*cfz?dD~FcQ1K8ycB!SON;lt z?3Qzq+{=q|u$NvRdHF*=80w|;FfSd3dpRa6MtbQy%FB(3=8BiMZhQIeju-n~FQ*=O`ShXs_Q*@tW7YgbJ(jA^l&6%# zM`weNld{?9!({gHp}b@9vDE6Ltj$MIelF^xZ=8=2Qq}I$&k7$qBqqVfKxtdb$AZ#6 z;$QKxzmksn#StdF^39`B>!L?5Rn z`8Yq>N2RGgCd!3rK2m1*_(poo^098VkF+@&BbDZAj69g{BX5CE*RlAh{=L?e>Wh4= zlETY(_it|HsFr`$0v_{?0%v( z|MjuAgrC|K{Cu74=Retz;wPrEpMjE`=4YAH&!codpSk^{`Te@a-p@sOlIy1+tmD!u z;%9cgpJD}mjMegrMiB))$?;s_BZrXqOqSLa`N!tDga~?Oi_$yKDUqw0>``FZ=uW`LM5_VN%e~Pea)*)&YL{%gRB1 zo(}fY^&{o_iROLgXRr(z>gShXewvN&^XEK2-tUyV1ix3!3;mdX@Y8msp9QP@#IN?# zYptJkKl!P?-cOUwex`2mW83QI)OJ5*clh~ACLi!~;h>)ehm`kGKl#V~ES1wI{EYfl zwVw1d@{Ia>*-y=@e%8v~>+08Eem;=~fBX67rh0eV&ue%5Y>>&1RM%ra!=I@CGWVIE zzn=Sf{e_uL<|AK#sKxjVhWHTBjt!WK$YkKJ&OkTL~@D+s3RLCDmK6eQYtY( zx?Giq@=j8KrKJLtEghhse1Jw0Q$ge8OF5n#pnAmsz0v~=k+3U3J=r2=Pk=r$I~d?v zNXIh*+|CJ*kr&`QX=fOf7GTNr0HqgejU}49Oug9@;M2_ko$Jw>I|JO^6=2Yw0AKtP;P5{6 zVt;`9l6z3=%T{@GD8PG%1N?hV`TiE5#0AwX`~L_q@KS*7mjn2(Xw9oy^SaiT@BR#M z^REDJ+z8O>?*Q-L4)D{R0G00sIDIcbx%-O$Ks|h-9zG4w;#q*Y&jXBqp?0QY>;=#1zB1?NZATOo=dfgK@5%{CRb2@6A>gP803eHAontZEDtMgL68Mig1Y`V zNOIjEUF!u&YZBCT#X){+5u{$rAYZo)>SwXmZXaYrN5$(DLH3UclJ`}R9bYS#aX|*kiYY;!Obyay zn(CMlGhEAf@I9Y5!f2qjF867AU{(gH&7;WP&V|lFL-XKGm>4 z$Qh|~Fv!?LK{y=bqhmoD9S_p&M3DFX*1X$6y59*>a5qTndqH9!2Wj;r$X;3hOnDnZ z>@kKYY7X(SOpxE?VRVRSONec9M5ATSoBVG@2sC9_f-w1K8ZHVOdA;wFMjv+?B9n!g$5DWW-xYIwx z3mH8i#0+UMFhplLE#(G>_~9e1IV42?&sCFD9~#nUuMoSW@bD0mM})AB4$<(-5L@NZ zS0N%}Rkv&!AJX5xg)mMGu~`mE!8al1$n{BzJ6Xr3gou+vazPqRRm^E2EYm~e&Is|@ z%n^x0i8<(RZu8sh90t+_SC-fhZtw{qDN!n-%5zY_`R`yBQ6 zkm~$H`Crx=a!iu0swR2&T8I_bLxledvGab2LJvbE%9nEdQHZymsQ;D>Hd!-p*)n)u zJcDW_GH57UB|0vHlCn_l*fVGwpMg6mgAYq(5G}gKMJ$W7rc9LYCltJBf8Ellja(R6Q z&W#yNlRcXQN>ff$7a!NY>oWU5Wwj+b)(nUt^&R~k<{*s};PtV}) ze${#?gBx<axyoQXALtM)-;m?%`yo$&!n*|lVk5^lJtSb z_RHjc|4cp_n8_&F`BA1m(`NGTe}8JS#~l}Y(InY=bPlX3I3{`^eh zrGqT}A(MxTGwHM>lTUxlBxYGA335QvS7xfenecO?|olX*Rh-viU)_%G^=e+@6w6#qs_-7Qlg-on*&KhCt)Cw`obu#Q%bUY6xgWRgkQ^HaNQiv*3aQYqa5b8 z%HispIc#p1!{QD(ywWv?$vty8)+E-BJ>>S1p*V-c#drS_EzSi-vIea`mhg}nL z$e5VJYtmV&P0C^9(8(oWr!2%ByfLuA;eQ70abVTrO4ObM>AmSMP~(ndi)&1#?-Dlgq8# zTtGe}CO}FGS zZEG$u+j1#?ESGnV=Wf#KOg7|kAu5lV z);v0v%;Sf+JWAQ~^s_^^W%C#%70Tz)r9vLn(()MEB2Vv?^K|`B9*t!8>v`PlkVo+C zJpSpL$FE=I@yggdzLd}A=COBP9@+CXenB2XzSkIuUYlVts!$HzDGxGfuQ=V7>;M^RZS5AWsC>7P8FKFy=bbH$Z) z^52U*-g~M1qQVq0h51N+vV{598m6Z$%;chBE))y%w|rAP%x|$_>XisnHZIH_DHkbdIdX(mm4%6*R^=hnoH7?9w zQhmI7G9k<}d4H<lAyvVs8lZ)#fn2 zZVB`1)-bQ_3^Q(57{l%`L-&W-e;~}Y!(krFiX&mROS@xX8vUw%O6ikf(q-SNFeT51 zX?;%jW&Cep&YV{-E`;fDJ4|nJ-w6|uW%B5*dU8)al%`L@OnVw8=2@7nM2L=xaLE#( zY+{5?NfCaPvSoC?tnSO5@)0tVBh;=K;bf%1; zSSHuoMeuZpFiS>ujBw=b2vs^MerLt+qWH3_TZF{Qe zVpN3JM=O?`6xWx^Z%l-QuOn2F3BuS2dGe(k9~aSUCqg56eL{pe6C)J=M!l3Ya&Fgi%?AB zHfr6?dTx7!w|7QZyi5JvAEEL|)qN_$1$lZ}>z#@4#W_9yoAy)2o{w+^}; zkWV*hvoW9kQe|5{Bev)BSgu{o$9+8?`(OE($`(+!TmdJ`7w~;*0kq8URlqGNa<_nH_X^l4`S%ML_Mm|A zGV@^pUq3EjhMcZiWb&);J$qo#|JJEU+_)Is{NI17Pk;8&!RS6+Q|7kXGkssvW*>fb d$JBU9{*;P?>-GMnbwSDhH&6eEiU04P{{!EFJWb9y_kG>hb)Ar=CkMT6_x!F@*B38MKxJ7_>+o|u zkQuBV^wtP?v#WZm1Tw1yt5mB|qed_@;Loa7CCgi_YUb;D>Z_6YdX3Dg{$RE2YSpr` zt9WY!z16GxeA+T7#=*G4)BhLie}8K9?En8gCg{KZ2)HbLBVo79Fv1zJDv8@N#SDKG zhr=ada}a*b21~BS%c&6LRELtUL&t`&q7jsC48KUVCXn0|GNhJ#*g|vUoA;r8H@G9k zdV#I4=JwNErIa-ge)trgdcLRuONbu^Z+``yB=c)nB6o(vyCa~p)ENma zC1;fClMZ8`mkb;WU(1VeiZ>A=romKMyBcEGfO9RZ`4P6t{GZ@~oc|dnt<&)h@KP3S zR6jPuM%gcUTfqD)B+5~_Bu%!%jva79#_oi;aiD6 zpuQi0WzzmA^cIdo@C3Xr|4FfvFi6Ho*K=U{9kyJ6=!;NFPRLbh{s%Pp6WU10OW=^1 z^2ucwEj6z|3)%BOS9Pvs;x)b2B+UIc==k&7mdI#H|3>t zD;B{!F?y7=*a)&^sl+BmP(jYiEoq&kd8H$$Ca=9gaM9?5Tg16-->FSK2qBnx0SrH^;M^IZv$vG*LqivZiQ}ZJ@P&InR;1d}x+nYvUZ5}~CnfY!6 zf3{ZMZ6o-!o%$x1#r}Q-(`9Xk2wr>;LFbMUT<8=*N@vCDsy*hz$d|?Dz_eEen5JBJnIUT{~GZDDYMzH_)2ufUt;7jRZieybxBo)k& z)GQpym?Dw4Hf9kiOq4=68{Nw>Xkp zOCovihe$52*1n%3IleiP%w3TTl<(zpy;1Mn6G`y5NNUS)$vUjMk0_VZk<56am`}CV zGtHOprSvPs{5O)aMgz?Y8<25a@>_WWImrfgS1@o|CR8*qU*b{> zv`SSBN%k2C$Srv#-TelB3K&QY8hAg`KyUG687Pn+$`@{qc<47@D|#rB4Qd36j_YigjW6m6!OWt^O9 zZeUAG1J>3CO3HD$BF)nSqxp4AfewbFfN1lIcIH zUlRCP{gj)(7-+c8z?Ag{OdAaRveCdtn+#kR*A|^~;a8noIlNuH+@bToQ|D-xa@%bn zYmb3CN0gsrA2aZs#Qv^cis6ECm8-W6bh~3IS*8`WIQr3@Uelf#rDL& zxAMH3%g8HfpKT;D$4Ht?mGikq>gE~gR?Wzk+D2S&80l3< zv1ELGBbg11%#uqDjogvejf@m-thh~#Y?E5ejog$0ZyQN^$H)$eZf&H$eB8#!ukDOH zXs>lXP!1jSC|y1@azvb+jr8ndq`^lX$%Y^+b%H82Mbj z8Dyl)7e>}em%&Cpk$=QD#K?=GMt!C+5;az}jWe=A4olJTMvl!kGHs5L3v-Rsn`fk* z6k22?_Io44<KQi*8L_9W9^NEq_&y4JmqA!emDsTU1n2FiN zO%#qXakY|(;b|rg*-f-eH&M@P;%E8LXJUZ-EuMghIkH?P-o%8ZrHQ`cc+*6#ERj2JnK<^gi7D@ycqOaeH?dVb?M?LVVB(7O>1^Vp z4DVuMx>&lJsNc=RCYjpHM5&KWwC!!;ung#{_4}C^C)N6!Xd=IgWuVrUQ=cgIL=#7) z{v;EVCY$v0*F>T$o@yfSt%$>L)s z5{{dQI%DE3nRnJiv2*Ip1&#m1L_=9E<^D9$;gX3OmrdNhW#aSOCj56yRFxm($z2mW z@0oBvGBHukJT_75iHRFeO?aQ1m@7;ERUZGDcqyL}#RJKSjAF5DlK*6BD&xHaTL6;*cwfp6)2_NtQQ?MY2H*z9?#DMzJ+Jib6S2w3KCXFE@%dc~QjXM=@0P z6-1F+ISOCZD59!GQMY;&Z%WbEqZlp6YD7`BW)upnnd*BH#m$#dw0afA{zx-b z3}(JEnt3c%vzZ1KGn-{i5i?Om&D1SsrhjoW2c$%-nR4PNVde*U5@+UODKoDsn0c$B znRzK@ilv&FQc3${RhpTt;<20Q?J#pia-13`OeVrG zxxSfg4a`(-XlADrYHVhA3o{j4nOP*UZ<}fPj`qo}wr0w=GxNcFX1?fP=BlK3R9+I@ z%}hpjGXp;|v*%+o4STEZK4wgP&6Jd-{meK=n&~;p%%AdDVn&;}HNni5NoMwcr?r+S zu1t}AOU-<|Q8h}zW;2y`n)&ClnO;}Sth;I^?V4(lFJ<-(Gfn?d9yfK)ZkZ_~@5px# z&6IwmzCKo8<+}KvXw7G4x;!_t`i1IwX(m&~zcMo?!ou(JMx=#t1`95ug@PyxBjt$M z!qsRCzCsrI7Pb&y)IvL1T+Bj3af^Q6van6eB`nmmS(qqi;w>CVuuv}1LWd*^X|GwB zBEOfm@I@I5^UGRzCDqDXSS|0TTKGqNX%^1_*Ni>bARmNKV}g(7V&eBZ%B#0Sc^qlKU3 z|dQ1P_7FzVN5Z%|Jb7*0>9O`EwzrRKA?OI>f471SeD+`vdEhNfUa$vZH z&DsOR&FwBiiJBnfW%c8l=E-p>d)>lmN&8EEll6aF zu-~vy>XydK#@iOcch&oQIv4jX9F)uQuM~P7`|3yWmXGYco5>)gLk-Y<1N z|5I$Nbc?VuP|iwLq?Jz%Rz}Dj>1?#}gULzTFES7 z<&!uo!{wNKVY9M3-b%wnE7xDM5-4q@e;F%($*HndDwMO*sl4XOpk%EtQmrIbvNBqZrCF(Jw-V{KGGB)ItnBw&$qQ&5aphWBQrC*Ro|TX5TlL;!rENni z8zr)_@@}EAZ(2Dl@vW@fY^(J?v~o_$cd;@~Hg~mR?`EZYcPkeprH69(*vd<3*xRc2 z9IM`QtZbEFKPvWO#Z^kbE*8L#(r(3%SerpsL@t>ORX_hmdU-bR@#iS(tNy? zHS%nNYME~3l~kK)Wwk`iwbE7A%(F6ezLg#etQ1{sWr*xuVmAxQeQs)-O4)o zP2$d5sVMC(SovNiUexPA)=2F?tW1*Se_DAWPvfGgW{aj?xoD=z0lA(VjXy7%PbE|k z&0$$rC7Q}rqj9_*&1bTsMl^w%(JZbNO_LVU^po6{(OBNpw&c7OjlESgAB%rs44=x4 zUt-8u7sIjjF&x?uL&=RX6xkHRkD?bRH|6-&7|L#oVdk$fjNBf>)EzMl-yOr?Juw`R zoZn*TwJ(Ov^4b3cY{(&AwZpFL8(Ph!|3ou9@q!4S)NSsWe9;6kw+kUE89 znO7v1f8>18SiRTB(oVL=#L_n|mS4qEDwc_TW4Rz-eXspLYQMy+k7d1>Ht3i%-W|(q zS#enL&ndpF`YVjsyg)YKAm5dV@A%wAQ3zog=x5`1=|1i#6J>m~TO_}3Ii%cwXOh}j%RTUjn8EOEp{$MLolE2iQK?THMf%3!?H|WL`9l^CP^`}s>+?894vHgk zu*S;wU&hg6NE{nw%FsB{zK)}p~WE zeG^AR=`>$8EQ=#~x$6EojtQIMI4@H_pZ|n~fv#M!bzvlAK^;wJa~EacMSgr`z-y(?*`lMoEv2LVg>A zGi@A@VOci5&$aPXHs#r97`D;6s*RVPk(C8wqu7^psZhZTfw{#`*@@ZlpP~ zsD>*XTG#iafpqTGIO|%Yx3tvo4$NdY&km7#>ja#PD-bRHu`^OWAjoQ)@3%@Ew^F* z$wp)8^|RJmuQ+1aXk*G|#gTejZ2Y{{M&vfF_p6O}Wr_SLS9aL&?6k3Mw~c@IDdu72 zEu*C72^$k+uY7aX#!abs&c^STY*f0ezFkpoZ`)`uGw#^9|IkK-7dHAD;&o{%p68NL zB%VR?ebIOpCd6|`MkU3w=(Tw6iM@0@M^fT>Ej6AimEy5@;%Oq={qc+m#B)YQ2IHxe z8Bb3cpA}E#TY}ISu)$i)2v-Q zmn5ZqJRiyQ4)J{QVLZFV(>0zc@~0$qi)Xon2gLKW9Qh)i7DM8hFZG9M?XQ%d?2>m! z#Ir>DPKamQxA7ESq!`QM>AxbL9kO6eJdM`IGfNEX)tjC16xkI|+5Pd9IS@}LxhYc) zX`a+Np;|A;vq|dSh$s1OJY8k^lXy11h{yagUZ0N=c+Zf)3W+l%P%S!vG2$64epHmMuZW0gb- zS4||kS|a7^C{DvfvKl4odR8K@S|n1dWg^4gO60@`iInS@h_PEDnLQKvLO$=MeZ3Ru zERW@bK8dWBs(llQ?3c(xDK$tjzf{a2i98*aNT=b6td)Whia$p2$7=uhMD|ZfBw?!N z&d}qWMB2&AxrywYmq_t%5_xUDwx#BRM4Bv2WP7C~il!yu^(4_GFNry_vsx17>Pb`< z_v=aYmu)qY*jF=&_*zMHlX{Jkm?ldaClS{)iEre0snjfqA0@A462qiYt0dOFpMyAt!c488@XC{#|OZ(?0ac*%EsY{ah zd|477uGJdi_$7%Rzb3I!O6*Hw{{AFxN%e!;C+0(1OA-zz(N1Q_s8dOtlGiS2?iG!b zmDiKl`d1Q#{!U`TKS|Vin8Xw*_cDpEqDyjAdfQ5JEu|#B)RMf)FG;CtCFvmN-zv$m zt|ckctt98RmuL3f^29zb&pTo$luZA)WOm5kj%4hB~$-lGSlUxxdN6#6=)*SNfmfmx&k%JRKVe{ zKzzpvw3USeDp2>c3QU!xzo(FLF@=xh)Rh!|y{`FxrSRxh3a=ieQ0s9D=bx&!7b&ch`!7?tW=zFrN~L&o zD$YWw^p)ntQ|TI$$}h4lHkIjdsa%owY#N)G$|q8>WGX{tN2yeby_QPH(y81?O(mm} z<~mY&Ao=O3T$j3@RHjONP;qin@#LmbH9wVIHByPGnaYJGsq}7{%2rwVPAY{vrP4x{ z^wQYRQW+qrBU9-=PU}hflvEado60>Y@>43qx2JMk2LGnK_NKD#P%6g5sq{LYO3jn0 zOpqsMQfcx>DsyD{b&bEBO4&Q9?0lBW#@8xgE?tR>S(PZ3U5R=!O`3!&F-N*osl>Xs zD`9-65~cc7qQU>nufz=LwX+h{PFB)=A(eP}wGt1nSEAsrN{qN&N!Qo4PgXswgu$9d zefc{kjl85ZhRLD|X_)!Ab2uo5r~dX{26EW7gF)>RwA@!u2%f%C*1JaNbB`rcC%JP4|za zG3kDqt~IBz?1AP!Ph<0cX&58y^pZicONtuoG&S1UF2@Vo`J#xO-9_zW7PIqHqMcVs zcDk0dGpn?n%Vq2|DQhP+Mf+0ioR^ArI|n2#-Odnc=d)w;+ewkh@_WEe-JqQo`F1)= za)BMcER=sL+i6wB&L6ey`a5T5*&B8?h^vmBkL%jGBA1%jc_806wX;b)&Fu7PZs(fZ zYhx#}t(}dsU-H}88Ty``N3x@nof9(lLpyUNrn8-vUF`a<*iP~O%4dM;l%t>7Ng8Bl zxbzro=a(<-qz$pN_-niFd$QAdgq@!!*!g#&ooyj|SE zf*6OsQ*h|M9S0}mP#FjD*dEc z9lU(YL6=qzuD^lxlzU!cE8wV{rJDA(WL9wn5j`VPl*vrA!vZ9}ZEz-ZggW-}k z(82XV4xY;DFC6?T!NCp&e(B&Jd4H&b@?SgHE5%1RSSKHjQV&KeZ@D11rOg=SI##)k zbMV0wtuxg@o#_s)&2r$Hqxo|koL=Oh>|*69A1+l+%N(>`t{%$#l@9)1KoOU&Dyuc!N#o)Hf(bcxm|1i=Agk@ttlnXIdI57e>m8GS^bo$SCoq+UDcRt z4i3vzX?W8?t9$B~q~3RsDU0RK1Lg71!N+p(nauWQOvfuXHLhk&rRo@ymSu8B^g>Jo$B?|X(q)QD5i{;(+$(9)ktGyPxEw+ zzmra>*6ECt!SAIrQR=;~<8nyiJESvAW=d3-bb5ZA&X*GIt#PtNqWY%OM@GuyPtv(H zJe}akbdHTm=Zef3oz4pBJ~5rN>3W=z&PC}xOR=T$>~tE+uVS5>PJbCA&lajr%hEA@ zpU(Uh=`8yposH6GwdToFDOj7%O4%Wv_36C5RsGqPPKjT&mQ388&Nm0sSuI@-rSpm0 zmW(4hKT`WtI^#~K)9-9LQ}3s9;X%4S|E2TV<8BRh(PHUVjif|Gi>Es=wlZ7THaZyf+$2w_ILi>}PWS4SMTMVx`DIr5;e`zP7GEUwr z=VWPlCnb}eT&>{5nc`%YBvo?KCe6uV+3Ij&b~>5ha*~$eq>HJucF!%4F`PIk&!c`Q8}J6YF6v6?!`m-4NYZx_|k z)yV<5B(=LcIr62G#Gy`7q~b6qoxgH&PBMl&`DBEX;qpL6jdC(uT8wt`ft-+2ck*n5lOda&9NMP3wmT_x%1OJ^>dP4?M=xpJ zn@+~xauRXd$>2Lq((me=$YY7R=cJ!(x$ngDz)AB*s_n7P-Bb17Iu&xUs<4Z4MO<8qbK#12F5-hs(P3{fmo}DK2WHx=2ZL z(Z%lKciHD~5$kj@SnhaSWcpkzk_~d-?_ying{8nnKY3NlMbX+W_Q+{@;|&+%>$r%h z>!Npk7uE(Y8a8yXRTeaL@l^{K)1+}r7wzP@lzPj>NVzG~TDiFRwu|SjT~ukS+S<7o z_<@V<9bMQza_N2{7gKw>xX?>_EAPH8Cd*RE@9(0?5EnCsx`-a;qU~2MeI9V}qa+Vk zZ$`Lu{m(_saf&xdW2U$mAZMnlUo%~d6W3f9AJ21fMJ|4){w{IpJ7o24g^QIdU6ftr zqWWs(yT-)}>Hee6!%wPpql@rf7xl%m&qbn)kR}IQyf0-Ax^T;ZLmGR`#W1OST)mMy zCzRJ8%Ii-TZ(nio;H8V)e^ryL`A@yTjXA>2S8_1YO}@d+cP2Ntqujh}b`!F?sVC-W zHwiLa4i|D$xv-nUMcgzg>Snvti`95ZEa4_iX2_p$ZW`I#Op14NF2PNmL^qyNZu-3D z=9+XZ>t<~^jY)RXrIMR9X>Kam-IPmr^MTW?drsZNS9kNy>uwIn^O|m5!*cV3tf=Sa zQGGY<8@L(U$j!;dZfZ1fv*2wvH{Nk$Xzk{WHf~zT7j50Tztm0kd&*Oeb<)}cwDv%^ zu4TD-`lXwKp>9^n_OIMT4|g*_CX94*W|W)Squop!>*nG(gJyOH_grH*=~-{anpL9n|2G_ELrF#>037gW$02j``Bf73sMo*ge91Ql-28RWP0K^7_lTSE zN8Lmmb5r7ko3~E7*(+5}ySXL7vu+m3h~M2DIj{W}+zh_x=C?oGy#1&8DWS`5mdlNs zZhW^DUvlod8T7!-UHSNtn+=cEPZ{vU&9OOaK-R#kK0UqYas%Q^S3VHaTu!o4^ z9%{vSFei9;Tw0H1JZzIAQmw3q5#>BQm+r|PeyZT%w~8K$r+PS)u1AlD7G4j#<+|TP zY{0{tK@W+!dJKD*m#;Ae9{#KBp+;53tme^YM-SEOYJNQr)0%s@*uq1Dmdc@(hp}&a zsNc@Rg7zM6bnx)j2Oi3I^3d@^52s~FXAk?jc*yJOp;&hh%|G(6OU_Ah4-bw{JoNa~ z!=KV~h=)=`J+vF<;i&vD+(U;E9=;!`*ke5S#(DTg+D`JYc(QVy;^F)>4;5#4m?Zzr zRL-+ivrL<-Jm)FTZ}fbb2g`Dg?l)C`R(bg22M+~5c^LMyhvAz&bUor>?NP-!rZML< z=Ddf}S3JCX+rzhaJlO7fIQ7uOphxQ4V-HzRRP$5ySgJf%o>CSs9U{D(luZUNMw6G1 z5yIwDCd|vhkz4XiQvL(~2dx^cAmGU`W#>*#FG`_0Vtmb8#G_LMt$Ln5t z)KD%p6AlxW@UYIqF)v>q_wrO4pYbyNte3~< zyoAqt`Ch)f=w>O1zHlEGuf{>0&%dn5R`96vj_%KxU@uR$~ z=Hsi^eN?RDqjOy!=VV_4AF+*m43;B}eIz#Zv7nicR;_)^Z{wqF2OrLkKEm=u%$lPoUw)rTt-NzW2y5Glz13u~>RL)0ykJn3Wj8TIzEj~Z8f{3Ls> zt5<*f_+0A$<74to_3gHgH}3dYFH;|@rYAmzJyq{z{&OFHzwq(qOYQs5#{v9=Bm9I6 ze(H(Y=qEvj%VCqB%29s074`GE3#-F$myr9Y!;K-Pj8tU@N+Gw;~9Q#=lIFU^Yg8=E%39r zvY$XzAJ=b(H#(a(-anmgIgSt&o&&v-dIP0wfeSw7QG zsbyMYx#q4^Z#McFw8^h)En0JjpSwH#4BYMK>)-qw+N)md^YcJ*4`_YaB99OH>3+!1 zzvqy@7=|N1%qpUyP_wip9MMFkjd4p6jE zfM$gQ{81!8VoZS6u>lTAjko}#Z2?}%@Pq(|69ZIE3NX8LfZk;Sd{8#PigE$Uln?Mi zs#XXPVGm$*26Uf)fapMgr5OS4Wd>LkQrv<7iz)|n4{m_uIsrP>4UpD2pnGcr{N6l3 z-4+4Hwhrh$SZlWpu>L*8Yad`#hX8S11GMTE;9BvFKp9F~iG(dwd z0!$gKTD}f2WK@8CqXXoP39x;vav2|Bfc!8mz|-jgI?hlXvjSY19iZtP)j2P~@oxfD zpC6#)!T@c*4RA!RN#r8s_g#PrO9D)k#ZqFWYS^n9_60a2wGRXscQ62l0(^QjK*M7J zIv)?v{U6P{9iYpd00nmgymc=?%##2up9a_?>z*s`h#QB+49Q zs~nc9mLS8eL3$St@_m^g56cF5zg&=2$w8V|2r|23kRmBTQYr=MlBO84!4V|V8KkG| z^6I!h$fvS7Gl(f$v7~q?NQ-cgMfpK)6$DxSdXV~cgG{ccG4+GgXdYyAi=e)L4D!{R zK@PqZ>p&7G#?P8gPfMKp9ER@ zsn#4Eq~DjSNvaJA>UW|bJEicjAXC2zVi_5v!Kffx4HcklY-)03dObW6| z4oJb|AoJw<6vdsYW7C4f$w9dw4W}#Sj3DNjL2_pW`C@jEdop8AkU!_DU*D+Li-P){ zS~2CQv|JJ7>}IXGCCHww%5|4=*&W2QC&=IXg8I%x{XM8U|5W~$wT2v(q^qh)KD-v> zhwDK?e+Sv|AV{G{K@w$@9D5w(-KXlmIfIRs44l>sUKG!uYHS7#WQ#<_Wl%yE%N<(= zt>ZK3BF`i@F#}gp1|OHqAW$v?YlRFNR?J|l{41?eGPo`=sTu5&GjdakIWl-nx=3wj z2IE{AbaQ9$qbGwDZw8few4Iy5(0UoV=Qe{-gA6>4Gw9PKgHA0obgzrzystGoWbk3v z49wj!m?OI;W>92u1`+c!sI@@*mniS$%KQ5a2CU4$_;Utze#u~iTwa%fV?zeJH)@?N zT4!qpBX=pMV;QVDo}V1 zH)c_Fa~4kXR%W*|CNQ~Miw)q+^sA=xSd7n!z_AN$Yx{3Y+c97 zX0JP&7;iRT$i2L5vcuUdmLAo!`Q`O&(rRQ=vraZ+>SoiYel{yRXY;s=#&^qR_@~(% z{w$lypJ(%6P&T=Pvso%zWd4Y3Zcoc5V@5XL%6hTQ%qD7fHudIYvq_Fh=Y`oU_%53p zi?exaNjBXjdSy28tFw7$O*RMQl04dwO~RpU-aVYnLAfjgPU`t-#XXzNP&xWXHc6M1 zm#n^@&9evD9DAOv*IEvz+&ScBPzLjLxCq*c_&g%i*&LIqaO6L&l^W z-jEJbbxIDyr{?fX-d~o(vgJ9H`aTD*43- zzf&G3#^mwZxI9M57xVMjvmlS`g&MyokHOz*j6|)ZqN zJd&>Gsh3*s?>tuC$YY~q{gcOMH}kkH>u=`~aW{{mvO*r+%cK4MJf1zvqw)*Im0#q) zmw9x5rTij86fuVQRDL#x_}3Dmn>EDLq9HC63-OOkE*|3dm=JYiLzIaNv0IA9hxkl( zCWI)Q6yj;wkbdtE>398*e%B8%NS35&jy=RgM+ifDh@tKf`#m8--Vl|7S|=mKKq;9S zqHR`)BhorA#G+7$_;84uRYL@-hgcxhYlIkCGsFuiR69iDH$wa>L+dJLJ;kgaqGf{+ za~p;z)+ofD#(HcT;&YkVEX1Yen$sdg?RP?qdp88FL#%8Q;&Iy$9oi{whY(dehFC3~ zJ`Ay{bBJO&ciYbM@4Y6=}h+RMGJp8QlAVYsq>~)I0KE#+!Ax>-# z@%ok!Z|n#$erJe?T_J|-3$bs1h--&JJdqy`hu9`Lj9CdCqtym-cun;oDK2T zIX#yNzlS(;UcI;wqTTHfy~K4VL|9hJvcoZ zx!xv>yIq($GW@+Thu;rVxxM0dQ2dUHFFQMjDcm(olI)N|-NPixeEIvMFpp(m&oICC z3Uf#Xe;nqw-l{{o^$GK1-!LD48s-Zb^qIB?hk5yB80(NQUO6M>hN(swAxFLnQ|0S0 z^(A&hm^Vi%o}3itDCIahOv2bO6=kA~8W-l+_^@6#VH(Pt6T{4#6sGuO^-*rgtSLGN z)4~|1hp96o%m&#b17|AlSz-LM!!({7X8OD^EfT1jRNHT90@ae4rZb^~51vI@^zz)fOP{7cK1x%3Hj|v$3q<~p+x=N9$ zuXlg`Fhc*!l8zmn`oDSn|9|#X-u1_tXKWccG`!&SkCooPUutE$3K^ICeCj*avqe2a Png2Ua|04bW`SX7O7WR@k literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/4ae4d0b80121230e_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/4ae4d0b80121230e_0 new file mode 100644 index 0000000000000000000000000000000000000000..3ebddb321b44cca696dd13ad7b6034e984155b69 GIT binary patch literal 36508 zcmW*TbzGb0*T?ZMNgzf-Af*n00D(Y&y1RSV)qQn$S>4@bb$9P-tFGRzZd+xQt-iXi z-nGx?_x$mGk=*ws=bY;bMDCEIQTJ8ZI(_~UEU5%$w>Qt>hjN!LSSo+soViQp&QYdJ z&iuJ^mClhTN6DP!a^xsmCQt5?xe696mpgBnG9~lnFOauDshs&rl_^jzf0;aaO6JR# zFK@XVxr~f)HbdzDkM+Ote);k6|9)sFR-kz~=@RajmkLynra%=X2acg|C8-gTDofE- zq?|a2zp<*Sw7i;h7=5eLr?&JNBkD+hA$vWk3;yXLUKNd3{TOprp#1t~N7R}50a%0U`{ zIo}28eVZVe+XiVjj=|F|NCDJFbHuj~(r>tkvmJtz)-g!MP^3qY`t}XdD3tFXq-O(y zG-zOuCScfL#u^!*p}m-$CkgCrA&T2I(z2JqyxC)PEkN z883pg<7JSJpv0>nRs9^K&nAOf1RHcA!k}$#gAU?x27``78k9Y=L0hmli$M*t8gw+9 zK`BuN^~ObyL2Y6T+F#0`-%+--LC4A(^r(VCmZ}Cdt!7Y1&*aU6i7wn6Q%1U>68 z26{F$=%*G2^=N6(+pY%ryBRbNvrwVCL4)z32e*3~l(m;ZiTKjnpk{sO+t;9Z*o)|X z#0JYigPPzMydK27gAK|%#Gr0N4cdj>!wj+wHz)^ojvyx(Mj2EBdog$n_s1I4f1E)t zCNdYAOd{4P25G86L$PWaIpfH5gPcDRH{Q)4_L&Cd!ya5lx48zz%`>Rb0)y5sG${8X zgGOQ+TuTf}UT#q4RR-N$ZP3Iu#J}F40+_MEpwrmD(V)&hGas^VGUyy`pvg9aOa~1* zi9CmB3)643Ic?DM^Td43AnSF5a-s=FU=h}1+Fu6EzG+a)TdX+>-zJtj21VXC=oAh- zFsRXE=6Pn&(&q*(e?u<+8gv&4Z>i0DgThb>>tXuH+F=M*;{mLn49bWypK0^OAoqU; z4Zxo`^p*V+WYh|SQ74T?WehQ@rrD?i7-=zT8tzz)a@mcFLYq*d>Nt(+j7XPJUi^gj zs2FZkM@+^RT*976qb|dn(Wt*sER#_)urRYx)w3A&90ju))e|2PmCdLoSb#kkp53Ui zQAQ1lHtH4{dyF~{YphY{yhcrp<2ZW98}-^}RE|WW#`}%x9^iJmQTK8fbu*_?S@=yj zKQC?YcRr*3Eof9~A)|&AHmYe+qs}6wxKXb#vV>6^@DEZ;8Z`lPF`yK&mNx1(JY_kD zsB%W_#hUU)-9=;tqe`M08dfywK7OiXl)bW1n-N{bsL@EPYE;$goQMBAZleJ@)F5V5 z_@4GSUel-|wT$Xk+o}lS?r79tI6E7afC{*Tc3q7+*3GEwy;x6N>uuDtAB`HP1$s3Vh&$}@$1^FKe412WBE z4m_U8?O8^3nrGCb`9@`3U{p(-UC0?VgjHlbj+Nm(LH3ScNQW#u+@;b?Y~c6dz68j&0*57xlH;qw@Jx)Oqz?jc^M<0NtN<5AO1tJ0wzTkG-)i#7B*=H zN*6I{GTIb1X)lTuGwE0flYXgSlBJ?a-SGgwRbsqqCe^EM(r#@3-lRhHO&Z_Oq*_f) zI?~Lfjm=Fu3|kA6o+79vb;1&4Y-Q4HOlf1%GNiX9w)Q3+=*XO%=+l|lyOtJzGrrf>T?`c^hN?!amr}UfFNbT`WIrQpcn0 zkMrEeq>IFj0)Mh5S4~Q~VN&m#+jrY#gLMvhLW33J z43-_25Rl_V_u(Biu zs}{PY1Zy&?27+}nJy_3hDQB=ud4jdHFiHojbhTi;tR1X_4T-5`u=2I%SO?nUyN;USodJv>P5_bi643T1?vo2^$*r(Od1fZxPigijkLkRDuNtCg7wqT zVBJIEVa$W6Xfm9>C^aHjI}jKdtR=`WDp+Ii3Gc=RYxv|~MNK0goW`!{!CE#eSea%A z>j(n#f@Pdfo@j^`3xYLlQLt9yCZZM-GwLl3mVa5WHf#>o*!|o;8LU4p1grfY!3w%U zoniSiSmUk*%W*we{c#N4ZUpNU8vI4=@$K(mExgGZ+zQs3`@w4ZB3SwV3)TdMXq-7j zKf6QpD}pkFC=om1jttSBjL00KPT4{hmr239d;l*K12hP zLe#+@qCU8UJ2;yhqU$)G5~3Ff4}_>Fs$&C!QbTkKPf#%}MDH*(Jw%(aK1Yad;kVo& zYL+)dpYU705WO$J90fzvpiqbs3Ww;AA|Yy6EJPD<2-S;+Xa#H~LevPSaSyjjGG7I9 zs2rlzIEhSELNp(LA+lHGeh)Y9(m3W(ZmHI%DEIP7 ztPPQIU5KXr9HP!!$@`ZOmEIYm;9qHbFhnWGi4R9FaQ;#V>mQ@OV^(&vRz{h%++)@sm=|MK{aD(@ne`hk;(okYZ}2REem>46nza#U zlgzq-FMhLZ$!4`qF{>x01k759ovCJ(O*88}{=&3$vlij|9A-6zE2mjeIE||~mdmW_ zxy|}HuUT*NnH86xc=5i3S>Kg3%UQ~-Rk(!=rOm2|KTxQQS^LY949Ml ztLvDxqOMt^wVRvO9Dk!s3+jO{aJ4im zXDhRc!P&;FpOCYIS*DI=J;4X`>ulzQuUTUd(bcSB-KjTHdYJVbcX|?AZ?h79G%HJg z=E0$X)MKz&sYA@FG1ROk*fNa%!?}$OaE~zSz$mkfqs_`V#;o*lW_3Uxe88#k)MEnc zF~zLTQ`s}qss9Y_V-;S)JIFE(<&1!bgtls$HkXZ+hQ1jo+>W^RX z<1yCmIO~Z6C)vNajh{}LHTn$u;4E{VGpob}_Q3Dd;1AaLqFH+{Q};hJc34Xz@ z>(ucEd*^TVBr@M*4bd2VumwNgGV2Js+-6E!nvRhrA19}4If%rRI#H)uX#@wy!#RibDw;Lys`4hT|QMMOfutXhj> zsN%EAm_mD`;uqA-Yt{06R&B;vG{|pNNC9HTSez|vRfZx~#iAHaqG}1N+M`Tat0rI$ zwxd-!tGc6p1*?K9S`~=}m6#t_s##U7x>b$P{X44;qEij42I2+2py&5iU8reQzgkx1 ztHb!1hnwhJmpa$8YFd5fY`~n@jz$fwvNWauC{ir#|s+RMt>ObGA*I2l~s*M=5kab){oJ*}bf=)ZA z$8K`lW7UdZS%baAx{v*W#n`l;vGMt!RW}Y<)$1^^9kFUPDjl`z8T`knBeESQcU*?^ z1hqNI8lIw#r`eC!*k6BHd9&TBD7=U1ChL6Ls;zg(6=C zHykwDbPmmfZ8{xd(@?WblW+tj9X2J0+2nEA6hIH$!GLg^wq~?xM<&|g5t?VVsS8%2 zLN*)kW81VQyG^mNHm&#Cv)6z)u1zcP3?=K^GZ^uucMSYuPawKi2*N9{M*G-azz3$Xte)($Tb)HzNaPtXWH2Agi?=fnu==}@zkdJuWjo5hTH#A z%eRaN_dA=e!1~^%IarB>9~l25d400!zt6187n|~Cv8!@cyJE80wKBV1mT0@uJ$7Bf zk8yTIC)oATXV-~jyBq<#vZ6pKySm{j3YWI40tQ#Kt6f#QJk{)~f*-LAXW^=ER}^+P zq+cVu4&rr7yS|}WE4%u^+t#iI*n)QL>4yp(?W&E!o$Q*5+@0-O)zz-AsNT)4&pqt= zv!`7}dfC+jLlD&4u2uu>>IKgryWS18%Q(!gzQgSrjo=Y>6-QO1kF={OUf~(`Fr8^{mYX^2Nf9cHP2rWZ1-5SchGBzL|P$ zv1=rzR?~SM8dKH`iF->vrY&o0xCe<-5)P zLnBPVKgfHReRz*`N0!w;y-L-q(dKC-LEWA^Y9yN)97Q^rGyXLfz}+^$17 z`GU22W!JnncKwUe|I!EFzqM=8JG)+>%zN%*H*$Pn4?!PUL$t?P#C+m0g9FI?*{^~lNc!p1i|4O}J{6@|3H-1*A4jV%Cz!<6`rcm|7Pr;%3!5peiSQZ|t44FdJ zBbM8^jpw-GPUObAsYOh-{4_Y*@k2P^T_&v?n9T7t!?p~{;xRC{xW>Ld!} z3DpcN#ix9sdXzs@?@*^;sMerRp-^2$&BCF&gEmDtkBmh_^$o3xg=#J46%WU9g%c9iHH%Il_3okFF4p(@=!RND|V zFjO6fg=)v>P=(D1)#t^b%Dj~NEDKdd48v_K+7PN2_=3(GLv;ZDpF=eOCy=-)RP8s1 z>IzzH4ORCYjI)!Pp*Q|Qon4_i^eeUAOFsKTRd_#jIY6xsa{f@LrW|I>BcTd88mep9 zdOTF=Cqi`w-<>3;Q`8g1PKPSyOsM)|z**WM`W*E*AF6+`>_Vt={2r0#SE#D|9jbMBbTd?c-(oHAhN|g3@_Q1h*;s+XPl@|ks9NGU-of-d zRBf>rr;z_esD@%PGQJE|YxKlJ6nqt`@;HVpuc;H};U&JJKWA!Clk}acBkJBhBpKIiW+jEe?&qQxvm0G#iOF zhw`8u7Q<YJn`mvltPmrlRIl)+gdGQ}? z6&=cjUKox|l^wc)D^(o|s^(BU8lfGI<3J781s~z8$vCwfDpA{^s+fr5=vs&R)^%tt z+SPMtQGJJsG;nAmVj4PBp^-zU5!2YAQP_lgO&p47=FoohZq9jZYQg%nbf`ru;%h^0 z*oO@5m`+B4$JH+6-<7rNM$X;IzXxkK&cSmPhbH4ALdFv(4nq@I zN6f$#WSPi097p0LV#I9}nM_>BI>n(cC^OZexmblP)2JVg&!jH19BK&DY=^eOFvp?7 zbJ^p_xsb6@W06BMaSQnuGZrRb(Gqf6>d+6%9BQ(hcvi3{RyyQf&75l->bTaSKXGuK zL*5Mzr6Xn|dmOHx+5dQk_)QKC!*PUdW)IkB?Mh29{h@PS7`SqkDVLL z`4@4c+}{q~Uv($}b8!KGWBo1ai|5F5n>~Z`sQQ4KKo6Pc5%VDEi9Vrxq{R zBQG7w`^up~|ML6gE&Jsi{n6&VLp47*)c+%M;nFAa`Al8D@)(d){}`OAVsdJ#*{N$5 zr&?N_dVtn;ry@h08X4i##0*YNj&y2JMyKv%a;kS`r{>@<6wcyQE9}M-OwQ`m0i1y? zo0HcIPJMwjyHgv{#p9G>oI3bFNlu;iJ5?vyDO0MG&rqBynA53ZxtuDK+sWtePVLX* zRLQ)=n2#~?JCzA-(V>7->#!5|kf{*kph;n;=Hp&br;ZeJ>RB77KBGl@r#f|Ts%b~3 zLOVHC3)66IPko$?GOry=yiM@$;(RPu0Y zIMS&;qnxTahPhB^yi<86aBQMeStdDo{5Z7=VUwLo!^J61)t>6qBP^Zf)W6e-eTGxr zXF9cFmQ&ScJ9Qhq<~Vg@9`Vk1%D2F&*o990yoflLIMs8DQ$gFwTGnF>Li9Ku~C@vAXCpU#bX$@;UGM{XoD7r?j5EST*Bxd!}Jqc^a;}{ zbn6?YL5S%Wrc{i8v45Cc$T=WPtE}sdS~r>F)53IidYG2Y3{#s~Vft-$nAXe<({>b@7pA8R z!jyesnEYssqX=KjT+72$1?ClDN?#qO=Gch?Yr=E}=5@@yAxuX$hNR|BV3w>huK_ui!m`S zEkp5Gm*ykQ>(V&9$AUPQGRC`A$`%tR3l6@@RgJBZu)WwVU9QVWLa-C%II6 zvP;dUFwQjcn(k7>442x%J=3N7vs}tC$EDWjfpth*KtH_3sD&;*gC>tX)Co`U{jbzx zuS-*K4k`OwDu9tFwx451Sg)flwZvNNz(2pa)cH8`o?y*Rxs>aSOV!W1)ChCVGyesb zo}u0imqy=mspD;z%y(SsjlOp|_JBG+bZPG+`aX7X?UYMbpHQdg?3))Z{r1YGxo=rd z^!q@2JVlp}E)9VFlZ)4HF5N@9|6DqYncrOchyjt|+J)a>$r!Fb3VR;7gNKpc zLFww@+J-M!|9!X;YKChL4&p`KaE)ycu3SHatHz*kjT;}X?`MW<?sAv5MHEs~0Yz-siY8IiJ z%_DTMMT8!^BlL7zgnrr{q1ULjGeTPtwktw4u?;16N9Zm*dm}Ur zE%!ypcpyUaQSM-b#^d^7;yprcxPwin z^SZShcM7;QxS(4}g*b;x@E3NgU=g>5AhMWSk1?@?TfwE>dRK;g%DQh0Mpkg^1u9l_Ydm5rxz!2%D!X+CW2(4SvZ`B4P_LR>j_PhztKsI_R=0ks>DGo? z%z>)4-Kt#It?~`ry4ujKqK(}8wXs`iP24(-qfOoV@dvl^HzU^;#NW!TvuNF#INJ~t zMzwWo=_t37$GJ5XZ}DjYF->u+C*I6v{5jMOZ=ktumBCajLe_b1Z9}&OtR+66_(JaE zEzT`>Yvo4TZ(_V%9D{MUTTOmt58x##?saP&?jg@Ux27Tgez(eE!2xnS%z3Oj;#P~_ z*l!qn!mV5<-D>{Xt;NWiDTB(P4{~SD!1L7%s+%Q)=H|$t=z1A6t5pVF!nZ>i^!P;v z&3>0bzu+bOL6Q2!9;qG9NKJP|>IK@yMQSBp7mw8Gl95U&7pe3rk(%>;r0Ug+R3~&F z6RGbeMk@F8NEwz#@;W1u_cSBbXJ4d7ABof!yhpD~kqW;NsV9#jmF01ynmvisa_qt} zVS-@F(RYNjLWDwQ!?rZtWz^`{ai*JUy)JCw=(Jy>b%LQwVyNUA@*j< z#I;_sXPBgEMKvu}m_a&7|P3nKa9gS$(~kd7YnG z-^XRvQtU67S-+LctZd~ns}qW^%*^|@nfbetSq(B}(dnctJZ7@!QNAo1Sw4&A)XySM zzbwlBDvQE)O69R1r?IYZl&Tep(s|S? z8l^+1SS(82i%01_YL$pmzEV+qA0tYe%S0)6*(jC3MBGA1xhS12AEhl7qZD5$N*mFy za+Ll?uBwcUMyUFIlp3ILZN|qdylfGrQthJDw{w&V^oY`8Ttj5fC?#Scy7r1vjXqHt zj;Z*9)_sW^G5w;n3AOr1=_JMsh*JH*oW~HHMA6|<$}=KLsUxFQ2yf7M6uF_pm?-tZ zZnPO2rJmS^tK*{d0JFwN>BfX8MNE#;c-+AY%$yRXx6?R2J&Nm-qO=vEKT#Vj#(e~4 zM5z^4;2*4+Nq-(kJd%$9TGNh9=kASbCkwzB^SIy)Gw_6&M4JIE1W=uy-`}aKT5L? z(C=WB&Y|NW*7h)ULX#s=YI`h7z3}Bkl%g+0sV08FMU=i2rL5Q47nq3S7=9y4dy)0; zC@sJiY`952xP3cHAMQjc!$0g5lz$M#^+{3M`ItUWq7?KrO5PWYfxiC|J8HZozIV*~ zk+?olL+tnx#rxw?I`)k|(2kJjGTC^72j8@*4(VFk|=nK5@9;M?F(h@yd z>i1|+vWM&NJ&Fu?bOM*Lpt?ubG3h&x7NUI(kNP0}dyiUU5Bk^g$XLh2^%NeZ*7ayg zJ&z{V_vk?R%+`oW`wW*!-udz1?u5YobG@orw?U5Yok? zaahvTqnnu4jar~wcaQd=X%CM&;TSGqVNZ`9pi;v=auvP|JVM*T!RW_q+0|KPXTj6H{#v3@Q& zpzb{8n(tAU1s;Vh^yogeFJfJhy2PW{rL@6SSeJP;1eI2J^b#9adh`in))Du5>bJ$C z+GvAmScJ=Hww3X54PUo;l<^mjI%5=k+dV3a+&es~ypy)*v&*A3xQpDosTof0@u=#r z9yP~FT){UK*z3_qOy1|we8lYcXdo_N+d*ZOlgAkc;U`!F zw8mSMJ;^wy*aNtGn!29#sLn-?a$NH0IIdyB6_4hi>{W8U#=ga7%)Lc!_o(AP?3D)| zwMEKfa(lvK0^_kCWuJPuw#%cjuW0j{`o8h#1$Mn-FTeLF>qi~~Au(L{9;2g(vcxF6 zHAa5au*Ya~bc`DKV|1fXjO-<1^eg@>6Qld^RgBS^N-^4w)M_z&Kb7|Qw{DDr>cyxh ziZ+N*C6sOwqdJ|Kqic+Q$G_cU6w#A$P`Y;v*XT0dk1=xhqkaDvRTvN><3QRDjZwYf zG5S0@M#Gme{<;`lMe=&$+YqC3ShX=mrk`VE+Z3aDSdA&0V{`|{x5TLO))-C4b);>J zQSI$9Dz-C5eSVEmha=2;Hb#>!&=(%CEo+AIF7%jsl z1U-(?K{R_3qvB6vv<)Ag#VGG{>VXgV`jT8;$LJ9{y^qm;{Ek{5sP&f^{qQwLopI$` zjOHs=OAWEwgxscB9mVa?SjC3Ls#`>?{(;{UtA>fO8kZ8Q)I71;SR_`x8pf)8msmaO z6D!O5ST#BltLx`tHT6QQlKzO5=TfZhV8G>AT}H<%wD~hu{U63^{j*s9hQ+Gw*I4B> zcvT9&<0qq6>u?=kk=x|eKzM__DjVWeqS>odi&xLl-|E#=gxb8Sg#X~Md$k#fpw zVLZY=4li%(GFF&Za(Ve~qgS`X83)xPyxJ1!)&5v7uhYG{gfTh2nvEj4hzn11d(}RV zS3jazUa!XH^XeKNU|T`24x&wQ<|^UUJFF_{m8q0h5g3PiXjs~-^Kg~%a=pA)t#A_m zp-x$^rr=pQul^|S)h%SI;MH{Wui;hUdS3Oy@AbX9+JJmep^;Z>5Z9RcHSuagQ?DNW z;MK@xUgc{}&02WX2RU1E91B}{^{us6r`mYcx~*4+c3$Q0NS!+oYZq$LjU0L~Zcnd< z5A-U-Ag|hv^75LCextn_Hir73{8+DQVE{&r^D1bfSCyx-ZYVL0y2851tI}A!*vsc7 zUad#eQm>XQ^J>o;ujZ}ws>3?!yn#73dKLaN>$BObWjo04pjYiqdHD?3t462EAHO5l z886pHP}8%-kN#MVU+@`~&UsZ2zoXlEuYSGYrW2%MMMKUfLp z6|b_PB{reW4X;+9-e1Ir=cs(stFyQZ+ikBh;|7xNc-8j-eI9u=?FsdKO8sB3UtZGY zwO0qw{a>#dzoVA;L2()q6eqhOPNPxR7^gX=IOQ_OaXEUNzSuY(8mI3Zae9T}?l{#; zi_@RzS~52@OWK{h}V78a>uJVT4s#r8qs)l%^a^Gc!h6>$r`WIxPhwK zhzZN_UG{kWfD5>ZwNdfffk)BtYT}7k2P{Rwn0Wn!W!U76*Ioq2#cM9o;~5(d@lyih zBGMPHI84VQ{E`^2{7KA@s{VM{lWB`3XqgtT*6H!8nUh}V;n@v@cT7#`td>3IEFHeOlE#miJVUQKZt1*^ns zB|f1}RdPj-7V$dNJ6^qhr1pIovwys545M}<={q)FGbhHY)#P|pn8`eIXtOR}D=>Nk zG3}36vFptDoIK(Z^rdlv>NQDFYkbC$rU`2ILxNtz)GR?c@B=m>x_N>YU>Cw#B&Z|a zBf4dR>fjFYwMx*FZV5{0o}ghpINmcsB}XTyKmHuUSmP4Z2@7xurDi8+2y)L!P-&ci zZ(f3;<|pv|qy$aD^#utkzc4{#a2UTXNzh6BxHLf#%M(<1WrDiHv?_t`IwWY#>IA*O zz_ql)lJyBn{5e6xe@W0@WZjXVOgj@4j|w=moBZ}9X!@@Sdb&43dG`@JiX2SP3=BJx zpabY}lrfO_8}Z{6dL1WbTtAt>^XCLj#3jU^PS8|DpGnXNWW1Q5vKWeOc#N!<68P*r zLH)1|;a3uL6HgKUXM*lsP0-?N32Jzq`EDfW3iAA&AnVNp{r)gPp^sRr$JFXcf|Ah; z#h)gqCo(@v(9Y)xdWSVHSTn4B$uTT=!tJ{0iSDezBXgk@hM+jpH?^W>6d0cZEo)4b*WFUP_4aB@g018x6Y^SLw$OQs>6Nq zkDw3Q;KL}NYL52lz*wI?q3(E}(kA#+7~4^NqEBxyVUkZ@&}FhuS*Q9`d74lA(0GPV z^H6Q3Pfc(SC1?Be43!r6_+N|Q$DRY>(dq_pYv%WE}r-C+}Nl2D0Y$gVY%c}=F2{{xZ+bc zr2gsCDpbAdQ*%r~wrf5;Mvd##71eLBK8X6ur{0MD+o$!of*v=i;Vqv|Bjh&Y-eHaL z8ME&a6V4#&9x*@g@qGfHnm+dF;ZvV(KBF$rsnIK+y1(;rt+h{oBJU^q!}8gu0_clL zO4M;A7!qYQCMqLxn-XORPSkzWHYX})rbKnX@yv;Oo0W6f64ec<*%Q?-I#D~(!IP-| z2#QHmlh{Pf@g`~&-r}4uQ3sM3&z~q;(L|NOl47(gPCv}Vs#1x%jbddIWiOkk%=i(P z@uXs+{FM@Q15eStGGkUr)bgr{+JbS_iMd9iW??z5)gtEFiG0T;QPmqH^4VUZ{%Oel zMu}R4f3c%+qWU&X)ZW(2*CtVw5z;nM#&(IkzmlkBof1{LbD~^b614z>`X(wcn7Pn$ zNTMB zR3qqeqIx6yHS$E_4d%F?sDn6@F^TUQC8^-;B(1?0g5nbL9=ldkC3r^B&%Uj@+}D{vVOvtPx~ z2@7!+CW~K%(FH4T2_aU$ilRT(;Rakbze=DhHlmr`uWopcS`NR;IQ@DQ>DN0%XY|XP z)vp|whPN?(rN{a;!RyzoIKNu@>5EzU{Bq~_t18wOAn$^HO~PSxF5=fnDPc(e$D9Um%W=`t?*|LzZUfL>nRHKVjX(>^+#XyrlH+Q> z3a$0)97?V8>&bdQ&vjTw^xx>0a}#T~*{`-Jxr2F-YbR}S90|Lr%U-`mT=DDiEx#&0 zpg#&d^s5rW9{Cl8I*`1RnuU$Gzj zJojdeKlxPyy|C?@U(ZoFC|S7;$tr=7SQ(P6TPSKtmff1H%-9`~tPfb{PSzfj%#f^w zk;#1aoUDEb%9O09h{>F+Iv9h#S(Eu60`$q2toqrLwHzfq$^1S|)}JxSY8acWuCREM z6^UwCjz3T$Az77t$-KXjtkB%aYL_QjzP!YVrl^oFSpy0a7djP5)<77GChLb{$qE!t zRw3-bC-g6otP|yuwYN&LK4W9mWbH$bYRPgoOjZ?qLs+9^&A{u%XQ4NB1ua2rw-2ahpDsjd`t$4LB% z`0y0v!e$JQNYOQ>J8=b-Go)w=%0;GV8II!(lrcpGFc9PM6_qok=o>0$PEmb~ z%aWqMP$?lrb#VySd?|X2`iUuOgWr=zaWg-{-oaSP8eDp!iO;ZW`rWyzDG;@Agk-W2u3di;U9`BF3= zBMPJ_vQUaT6i(4EXjLRdMT#;eDi=%9O*o6Es0TixRSD{c`6W~IU#S!oD@~kbQ}|t% zqDB={^bBt+Q?n{5D${_v<0YCkOwk40MV>|}s)FW?sX6RT$fs$FRy9jeQ1cYoI;7|+ z>UT_0>8>dniagyI4=0h>BSjf{QkS7AT7XZ(QgnL+`J>9j6g8ZjqU_UB)Ziy#oSCA+ zvp9#Z*gZQ%`xkN?n--<$0Lm?94VI*+@6r^V-oyEQoX4j9oJY9>oIjYNriW70>3E9P zp~;C9bw<{ctj$?|o@4#+7p9(1QR~aB73yAL-SG^SuBNEtHTL9xtOKmySR0(eNCh-0 zD4@@V0Phb3^b}t(%oNbg-~j&vA)s~0V-Cn=4X7G|YyrM|9ndWNYY*r|Xg~uZ0@@CD zhJeoFFW4dj{Ot=UCyHSb;xh%*4xKXxv>L%#1KN#a_!mFL2W0UDR1P0uO$=xOZxS?UIKyFozn z8jTGs&ACdPG1U(0*iq|92QrrLh4$8XwU3NdZ1H59rS+0kxbNQ1(Ru^;r_&?_5A- z4+be&Y;{?v%3h3Ky*7Z(6Gw%lU{k;I+hv7V89|Y78J0DVmM**$Jt53xAnRdwjC7?Rk z`d>g}z6LY{7IUgf;ix55zhj^+RU;j#nug%ashS99mQ*#u)2ykQl`T~dqEi*?N!6g3 zR27O%Re5wkK5wf2#=L}7UBv`ns^+6XVyar^Pt{HwMfn1$`VrAZ7#CqhQ{}-57>cLz zcPUlRDyJ&3N~%UwCBAB@s*Xv`Qgs@Go2P0rB3q=Yd&^YqZk5XQ!KvB++n`kK$7z@c zr)m|hjY(C8v8n1dE>%(EQMlyGrw;gtJR4HA7<+c4@?3>_;3V9;Qq>G^cc*Ih9^(8pRXwp8S@))@%Dz;M zL(%=Is)|35<6x?8;4#V{qMpZ6HU3npPGG=kYKe$5sp@i;IM1cZk74lqk*co9b%k-S zr)m`L-eB$irad;?WxY`5eyWQ9LmRAqo~rHtrRpWBej^v~pOO?Fl%|eIHKnObc$zlg zhln(FMFw}8#^C|ZXH1hbQ<@Iq0(xam(-Ta|lBSO_Y3deBAAg!Y!;+k)q=sqyf2TAR zZjz?S=-MJpm+`V~n##0G(+AXUpC)xkQ!SM1!FbrvCr!ip(tk#pMj~}?nmQnQUYgSI zJ1Wdi(k8stnWkG9v5L6XrfJ3cG*$XJO??m3 z=17`)qu4EFn%+)R z;+-@teMB6OiNleu!p?M6z#EisrSpFV)AcAkUDGqB>m{0JPS@Qm>B^rqU1jhBxwG># zDqSNy=`zK0JRx26ed+xDPgnosbX~?>IMdQ)$&s!|96(C0bT!SLu7!EhRWon8elM1; zAtlo_5d})o2Z^QA)vAQfTK|-;VYAa!YfidaBGcS-HJG2Se#_G}2{SjOtIyBr8i^d6 z(zSkbx{|k~>;G!H4=5+9c#q>hdJzy%I!IG`NkUIqNY4b4>~40cyID{`q*tXk5drDF zE=>>tktT|u^xl*%y-7!UZ|}=H?|IJWgv`vn_y7OjWZg|>?sQmNT|2i{*Z3XPH3xy6 z#D{{rs_Q0J?XRwJ$EvH$`Rdwrk>~e${;0ZU!~eLtrsEKPep+2KGMJPlqe*tG$YfIe zEGF&7F$~UX(v@r`JwWE{CVhd%IZRrd%cR1&P5K0XA@BPp4b5v(p8_V$D9C;!6f$WM zJ}zw1{czlOX9j8gJ zki%utTHMD+UX!|G5Gwgh`pR!&O&^oegY+FS=}>}6O`|4RlTG>=8}WH#lblUWil7yC zVofuXuD390OsYxa(io$qNd>V5`CFM}U|wtD>uAy>%tOOY)TJ}IbT#oikV$g}nE3pc zG0|x(H5|tnXgr=6XP7t_)1)M1n`P4Tbd&bYHR&|Q&NJ!BLhAj!Nhi^Nkx6BLFzGR} zEHQCi1T|P;Qm!>7xp&bHkI{AyIpO9}YH`A(H~8_SNwI%S+Ix=rUNq^$CnmMWS19w; zq)(rjbo9ANcVC%w?+rD=lDFg_vp&dRR?{qIeOl10R)x&0X<_F33Nve2n6y?-R_Lhlb_N8iC|0X4R-}Rs-C^7bdgjn9T~;Fzf3& zX5Da@)vrGNd(Aq9YnbRW>xtj2%mK3sq958BW_=ej>pGf8%*v8rX8k+1lYkkbDPd;Z{JZ@*!%=Tv8!)q+*K;IqdyR%u0G^-;D zjUvbI%vw0wtV?6ex;f6Q1LMsqHGz6yDUv6ewS1CU7bcrkaw_>uXZuXEUd=Y^@Eo&# zOgC%rTymYq{-tJhT4vVN{l9b3h*tLb}*LTPAAFtlv(BQH$11! z>V3wn=V#5jf5EKZubGwix>>D}jsrLa_YIz7IpS}c)g1@nxMkLHJjT-7W|{5~+ka;L zi!m82d_G`NJT@UqW((J@TQoeMMbnUw-=bDHjKUvU^et+Yw8#gQvM4WxU{`4izeia# zp^`-lkW$&AjyQ|5RV|u`0W~Zdi$G0_nqm*$uWivljES=-9Zl<7)DHikq?6-OFhb-EUYuFsNs8htE@8T`GirI-4<&Rnv!&+ocA{JbPC)uKE zjV;=aY)vf+Hscr+Z%!SMzXkcGShTIBMMqj$wC+>lY-7>jFDxqBo;r1~a7_>SBe|1B z-{3z4J6m)UbGp!1H;WuNiSN2wG!O0`Z$>HVL5K0+{3y`#S|Psrbl&E58bdB z7g6|eT_wR>x1MbE>ZzHdo>D)pr{cTn>0wo?Dpa$w#*S69a1N!aTh$8bIE8{Ht2$sK z@|dkk!OzHGu_}V0IF6czmGy+J`Xp#oEo?yHMpiw+iDaufHnHky8rxc1<^J3%-xpR5 zL!I_k`Ed(#I#_iYV>>cFT%D|XhT5I2x`F5TrHfVhdNMXL_OdEJrsMIKR;~WZsvX~1 zm1(qPdJ2ns_ zHlf=_t8#26Z~TmmTdcaW)v9{itU7~9+pTJ_gWB!2s`x&u4&gl7?6+#`0jv5QvT7s_ z|7BILzpbi%*s6U;t-AM*Ri#f^^$p&fw(7GpR$WA$vsQh4-pbk?Rt>mG9ntxgm2>W_ z%6yx-xnt#fUaL-G`dzDbJ+!L#BdZEMwrVs=KC!ClGb`6-QN!m}O?|~&Ww2=gEE#Pq zvu~3plTF<-+w>}zO|^5|G%1fwf4pzgURd(l^k;sX0)=fFit|NmtX*o;9&|5e(|k-b z+w?c8)v)OyRMV!{^=wM8+SH^zW8l9AHm!ErvK2 zW#juon_8Ww?OB`tx@6NQx2OT;V)Pwqcb9p7X4C2CHto-7SE)>Poy}rbp{#Z-%x2e0 zoOsW!e7WqJQrOP=cXmxJW!F)BTiUK^C{f0)zGdwSer#706sTy|pOx(D=(TGpQhj!= z)3ECy;sbW&G3@#&!LD0KPqb?VYDVpvkYrc$WX5en46uG~*Ht`3qjq+FXR&j=n_Xo( z+coSaBEW_j>aF-J$i^gUAMlmTz>Z)gQ!#T{y7Ip@zF1YKre3lHU{Z zcuF46n7`-Lq!Cw{QbOCKE#pzyUwxMm6IIY18d{8w`rO_8pkgs~2 zT40PRj%&f<^e3*H<5&YWP8%?$Mx5p#P%}=AVYbF;5sup9bOn!)*%7A?@iA(`gCw*@ zPYlCke2=xbkKy&>RLmL2IZAQzdgAz7Bu-uY^ku|pMlep*8pUZ_D2{sp#HspZ#!9HK zIk_6B?Dz&+KcRsllNxYcPXqOv+CcfHH_#6=8ptuLfsV{>pmymE^mc9oO`YFBRTnnU z<`PadDe2UIrJUURz{%%)PW^;S6`a~u$*CW!IaRT?Q&k%})d3$hax%VCx3N6QDOa*n z=@`-6sh#N4!l{v{pW;-J*7S{>ZJa8Ki&)*!sjQux%G{Z@c#JGv7zZW0I+cpN-JB|g z?XY%t@;jkZZTdR39?SbV`8&tS_x4VihdLF9i{H|Agj0uc2|tc>@-xP%R->Kz1AB36 ztW!+`&(vcDz_mN9okgKFiB@ue3luLK8shmsyBEGy!Pb#?7v7$>8aRB~GE*-@~ zd}Lxf-r}N}ermY57lBIyv7#>HAY(n3YNCqGr9>R9Pizf{4f_yuk`wNtr^}^EZkL*3 zi-(*s-s@6lpGzMHTr$IvSAC08*Xn*Zifz4b0}V(JwTg-E;Yta_~?*JOaFH1FLXNW(qOE9=Lqp0rQfsUh&RZ4&L!(R=a~~6y5Q1d z6u;;9XD%(lffp|2dFj&OS1!Fm!du2g zCb?BHlUqA*7pHT&wI#P(M=;`Jw=#X=RyRz-Av{7tIk(br6OYQf)vN-?;CpPrTNJ3| zmJNe28sjRvRlAB?>tU+uRtRmXx%C}BtnOBMB)nsC>ps?4+!|lQt#vqD)2%bL-8x&x zt^9S}%4Tz`G}XSaUCzV2>4K+Ya+m4Oup@Dwk4yH%W=IC-O6)-SPl~lj^Zwg z9KliQiM+?DEf!!c&b@QOt$`=qI{uGaui!oBRtF5l+RJX8!tHC+^SWD|@3=J?(R*$U zK+DH&4TtR+bA&Rli4(=-kr$P-dz66B-}C5oF^|d?_o#hIk0v8r#iO2ZRA)cVTRh59 z!=qR&k49i}JrC=Nc$C%QkqOrtc$ClS(N4cd_fRzAQ3FiJRydjJZg#Ga0$i7dgQ`PY{#St9{&GI3==)Fq5WjWMcyg2Mfn*X zg|G;RkaadO;9|N*@6GjSd^$uUFp#dlvw4FAG_9gwD%Y4 zdC8;d@Llz&BOW2^HR}1!b&vjns4LccX(AS&Z|y-uPz6?Y9I8NEUr`oe0(m+e#|v|T7}c^1byn)(5GziK5b8?-=;oI#|dO_>Eq|GPi(-3Sx-|u)F?PE;~pVp1_srw|K zT1_J_oI{rBK9xWS^RO8g&}@cJ4QBfIoYALU^T=(!kF|BF(*pJ_^vUsqk2Q3CDz(I? zH)yle$NA1a+3@x!>ac=sD}9=XNvk<_jZam7@hOVFIP#lM8-Mrd5*lyt>04~yM6Hl% zvrolP0}XL?8+~u*IgaD}4&vTPJeZGt@9biJcl)^h+NTG|vCpUWXt&>|UKo17r^{$` z$ftW4_LomfaTl-f_^?l#j`%d_C^;UZ&2gV*;WhG~@X7wpNuSQZb&7uR(HYv}vvVAe zx$m6!ss07FBmFWtA^#PhN}}q&#DA6XulZE&rcYno@##6*-t}?aqL0sG$>Bc#e&AzW zPoHk0=p&!%pfSFBOpGY`gjmo5W0Ch6^~A@|eM&+{48wf1e&N#y?0H2TS^a8=rf_BR z>rF1djB=|R-s%izmo7@9lxs8^J}-muRt7q<0eWt{VMA5b1y`{J`DI-d(zL^FMh3PUevEjSdKloj#f#2^~3>GPG%f@j{UfS?2YLcrJMK_hg6)w zbChiAmk+a>`LzKJo6{C!uolN#@b6Ue#T6`y`L!LMG{0J6IF@4z?zN&0pZU4g%`a1H z#>aKEY3tW5RQlYn=GcMu?T86qeBoDx_I|zY>F0i^_|mUksQ;B;Bfs%$-w40H9pmTx z0>9==_iOTIzcy_pk8OS}-s{)YW5jrzK2Q2p_6)T@>sOu&)B)dKV(xJ8s$T%qwvjhArBhNXsMYnYFoJ*VUIpzmqL;WQIWmp=}YxtH0 z^y%_|y5h`=fcCEpXvw;O`urNuaMaou(7y<63UK{jK-o42RC{Yc9xOwSZRCtP=!~s6 z25k>0H(VHoiO97hps~ogllYLjD4Ernc z!yf$jni${kIz*Yb0S&-9440we84Rv#HFQ0rp`DowzP~h74n?vU8jatw8tRqJ&}!_> zZm4b!L-Ua*r=c%#0m<(f+Kn2y49!KZ+=lw$3PO1dEkfvhgSCSV&V@0wEWe?&4-9qu z(9nLlcS_`l`60%q0v>L%EL({fZVP4dp0h=scoj3@yQZ z>@G`x9}_1$<%zw5p~aO9zWXxxuFFuMuAxus8QP9@9)r&i$Uk7H3l5-)VQ4JwAQUvT z9Jv}A>V$(>*~pM7MC=hm&EgF`M8iZwDN#cw;Yl+1d(u$;WJ3wKj~|*CvNkpNT!L|% z(Pwkov@ldP#Zc~4Lj!Odd(-F-MOu)D@>NWDLh(s!g~s!Un^-@=(3VLCe`itWDbx;$Qw{Ax-D%9< zbZRw&*XwNZOE*~0le(bfTwc@j3{9GE==}wT;?NK?e&qR5UdK4Hj97nS?yz@-q3%EP zdR$39_;!_{qiDC<&@uE}!~Fb0-PZB`_>KCnH&pm{LnAhl+aHXHu74V={YcC>ifc&R zL>$|Qf4iYRI}8oSfSraa?dJW3#e0~qy^Mo%`wV5>Z|FN@K456zA>zmHM|l6@y<^Pt z3F16usMcviXU-V<-#x%ddd3^U%cXdmMh4b;XxJ69poOnL4B4ds8I!j zauy2eJ1i&`RDse#)hZj*Gqm|QsEnTkl~z8eJr#qhQz@w3I9@rZ233Ok8z-v<)x3I8 z-{KIqn}XaohQ9DK?jmoEpxPpLt)P5(ST`tpy`ZXD*^i(-sC6jgU~F{2Fg!t#xS-0R z2i7`+dVsfR<_c;bg6^RHgxSN`sOIBX{EC-w`GXpPgUA@5f3(9QTt`WRzAy=Yp+Jy) zFb3Q38rFtEb;Al=M&U+5HN-IN#7oo-F)n_^8(70Z?sF2<8r(+32=zodPT_<2pduKJ zoyd?7lnveS1I{9UVo)CR$1k{pGSQ%#U<|h65vnB7H|F3lvLy%QKzDqP^C;FhsKywJ z9e55?6Ka9EID*_wg9>0M*5e_nH4AcHVo=L)10Of1UKoe%cmh+4Am=SoQ(Qrrl%P^E z4Tq5{H7GZF<0o82$r$}$5)R_SH0snQD5GmoB}VZ)e@Jbchx9#~ved}#Dm(G$@@NeVb}x4M$v~Mef21$&W}UtkKRw%{w&1(5klJWhW(ktYKr%= zgjEdl@g{3nm9mGGSRt&;6~o*&HLTTWQzfikc!{Rf!a9w6__}&n+3SYo!*k@Q7uGo3 zwuZSzDy;kNu&R5)x`YSl?G5XgFRYFJu=b*CAguhMu;P&^9M%VzfhUo$uEf&@^%KJS zEjcV#+pwl|rcbo|Dy+2_)hDd|eR=F3X1%nqZsGj_VI4%JfwYHdP*|7o5Pb%Rb$m!z zLx+YnVPaT^FmzH_6H$0FIZg?y^i<+o6V?m-v^K0i;Ql47dF#Sz^lMl@9|`LY<{b@d zC2AiFYtnJzJP}szOJOy{8|1kh)@0nj64v5>!>n5r)(W(`5mq;pxEa>92Vu>86xOgO zVTGTu?Kw4gLA#e>&3+Z;UM^uBcpK(CxQOOtjA%)wh(>3Qs7scJqS+&=mph{Jc_Lcz zenji@M)d6m5v7-oC{`(=`;{ZQQYE5eRU_I}Euw{{h^Cq&8f%H@R;`Hst{u_#IuUKC zOP}>3DrSr52DaGg%NbDvcSJWm5xwz6^n*X56M=~48xfty#9%}VP@!Q&-!zISdnlq3 z7=%ItB1%T~fe{r(I$jQnXyD+8CgCyW&!QhpoJ~KdFo%B9X)~98&?ulsl-iSQ=BFc9@q6jixh$ug%@wgljn> z+Kupyh?d=qsL3tzz8le7tiBiFev1(W?nkuf0pmW5Xyh~6qVMyFMj`Kuh&sKDsK_fG zGsJ5dVj1Jr8IO>VIbN^vUY2;ypN-e-tnsRpBVL(u#w%~0colm;UX8H@uDtQekuP5N zP_H1X^cITOTr5_Cs$@t|J)~k+rUX62{>%v~m?c32vnOaofdpNHt5AXx3nyp-uAyX+ z1T`(1pnE7#EP=KB6ZBW91f9d@r4!VqY=REp)W-?>ur1p=(^r=SZNSs63Cj0Xg31m} zP|lGFnlmXuD<&r>|9tvdn4sRchGRb@=%Zf})E;X$B*?!pL7o5Pad(3HolH>W3W?g@ zG*N$kmZ*>0Br0#OL^+lus_nK!4Mmqdi7NGXqHbcu;Y9T~k*LS8<&COs{;0|(Mz!J7 zsJ66@YHORQCbf@hKc4o8Dp${_W+3)uRPlYHYTiGpzIZkus_g@#N**26!*NlanG#in zsZnWKRE=>0EoVmMSrAo*g;CvKM!y@Px{JRzM%CkwsD|Su2K*USugy_?xFxFU+oD>u zgP3-5EZ*N8RhB(bRookub6-^Tjz(4RL{ycq`b<<`pN(qDg{anI*+s^=6xG55Tk~Cp=l0Mjzq^I|i6n{TSU2`O> z(1*#Yi*@K+AX$r1pir`6SdE;8ll2ukew3_EWs(&to2&ulk~JhDS-rX^D=<1)zbs7F z%3aCYh9P_CV}G(Nmy?yQ#%htFvHIXe?Z(PxG?uM>V-?=mn0t$+==-)Q+R-sZL%XKv zVXqXm>64;^__AM$M&QT(DH=W~MNr?dm?D+wHQq|r|J<(9ZJ0%>JpI#xa=bA_0eR*osLYK(O%V*0`z zQ@wrn`o_42MNI3k6aD+gRBS*@&5&zgOvP~u6~2k7 zEs6|}sUi*_%ZQj-VdN-sfn!We{ZMUeOmWCPF2=q7V(No!6JrWaig9g5OsBCeJ*EtE zW85n|rtRoEFQ#$xW6WhthZm6FLXN=^%=|v4#>-=x4F69tHNhtNUrkcOSxc?pX z+8t9zEJF9&99Jw&bxWt|uq{oM>}mY%k*1W^Y5KfPn!ZQ!h&26(jd+C|Bh%!-C`?Dz zQE7UOhTo;B7mi}hX!;tHrt9O=WS@|x)|h~FTt%IUY4TzVT24yicj7cvn4G5FxQnJ! z(li7|VVj!9eGb#K6vuE01*fH{3EE&QDo#(6bq3q8dsZ6vluc8KIhdEGWq5ynn(koG zf;7Fv`h{sKyeLhl(Q>^=4Q{LXWpKOWC{og{az>$~ny(&R?(TOWN}s@sc~CZMvsy5Ib$Zm8x9 zW_z>!RcZ#Zva+(hSv9IXT+)^Zp&0N{8=0h zmxL`r_$3=Gxmqu$LXcA(O4fi*jbKG%DBT2pmTFBQxfx_gZTX<3_Q==oL5J>eM~d|V zTVL(%r@j3lYasmaDLnZMI(`ma2gB+iP~{7V9}aJQ37sYLD_AObM!-8Gp^MZV1+64! zG}M%iW1*J}90y;?i}8v#2_mM$G+DbEV%LCkEv)$ww#kBZ@IcP}1e4e6`Hk>W7H`r# zw!kLYFL_(R{0k(?QMo8hcfih_a6-oIf_YMWH@v|)OPyOV_cpAQ&Uc`{ z+>itJ;k-4lihR3j34oLnJSoc(~H5vR2CP?ISc>e|T6aP!7Dr=-eWCVT0 zYlxt-{2&925sZ==dI>j|-7?Y~!7OQRiJ*g=l)UH&>Pb|g2;$`{DPJ@Kzuc6U(!E#& zZ^!6X(qbdXmhU7sF@g$mPHst?B<(95K{a_LMao3*xnw0rP+KA^Xpan)iE_4L1U*tB zm~M~Yf+K>4=@Gmo>!h1Af{NYhWU<_A9!cvKk#v%Nts;qfLwVke zB&lsAd)r5HUp{&_lA#?U8PO?{LY*UN{6Qo|K8)o0m`FV1A_>WR<0DC!5XsvUBiS#} zlOoBM_vOC4HaU_ba#@~8U`8aBrQz&I&P(IDk(B;Al4c7d`BVCSqnO`D^6ipHZY_=E z-5(;kuv*7{isbl~NHTXvGElyk&-H_P*WO5izeZ9=Mo89S^?gLOoQ`DX6UBV0T+g&$ zzL(Ok6!YIm${G!{C~RPM5d(#a8aP|bz}Vsj=1P$m15INM?2wTq49t?|aRxfbDJc`L zwQ@JXKt!T}jj~U|Nd|_NH1JR|${MIClrvCVhRCnw4df&n*i*s4X_;8jzygU&G0-|y zF(lb%ARxEomGtl%SQjvm8Z_`;rh(q#$udwNKgiQ;1D$dVtPdIZO@@XIOqQs81N93G zY?eh;4E!iPsv7uQ?n!oa150FZE!83QY8!Y<4vOt{1M}+|sMgFtGb!3!JomH87{0X4hVOI%{ShD8Ah8VqkAq#prGzp||?}T#pCo@el*|zff%x z4LBzm_-L|$7gG#;JzevYm9q?bEodgve5rw@a_2h(?<_O$a)p7~D|HT5X+|>RN6kwD zKWUzF^JfE%)*G0*!GLL_fuA=S_;9mz@#U#yWTvPvG8FzU5tq-?yAp-DzgB^$YzX2g?j zq^`?Is@q5*pOGehBddc(nq?VzB^|PjB<2`NlWB4;*GRoQBi*YR*;>bl>vbc&>ME8@ zXka9>p^@2gv5}EG(x$PI!c7#nsgdncyM>XPGT<#ENpBn3Dba0=^p}s@8u_KYkp~@= z=Y7@CNw?DV10zSo*~Q35U5zyS(8y-_u&0qhaz`?H8CfLn_E!HA=&PBC@e?DT%h!X9 zlo@Pfy>uO7GjEuc%K zi5X()W}-oN6PsmPFB7FcHqoxPiNi9Wuk!aZFA$MuKNBzIQ=)hvIgwE;k@r4C*A&Hss3^TT zkHRKLEKwYCMe&h4ihGjfjbgEE6oW5{TA5L7%Z{Q@P86+VncT~bqHSIjvH4L9lYIqI zLYEjgy9>p6{v_=$T@8pV|6Q5lXMRB1+6e;gVVeK5n%K_T|iPp-Pp^7(5kB3Kb`O7FABchlg&1Xk3Yfco= zbE7CL_2);iW_=XTH$-9H7{zzeZIgQ4roMlPVyJw#JBqt|qG+>M{q2jQ@qYCxC#1u{ zD3b3)(fMu^edLDt?nm*poPDV09!KGk*PcYtNme|KqVzNM_acg$FQaJvDvJG)W~vy> zd}%cESgd9<4J~H2$eJQ%qKcZSSIkWR;${v=iC8n`#8JY`5Ar0=%!N{BUR5yjW<@je zQ_K`gH8Zu6j>)PtGuy;tH`Ci;=Cb5CwN9G4%)Bc{CDEfAB*JH=la%tCNtc=OXFxRt z&5X=2^Gud!n%N}jS!Q}>>v?%CY}R`RGg69P5bgIXBES`$u)$)H%Clri{ET-##=` z`jO`PSaX$Y;(wx?&&+gvZf5lh_4Cq9rc8KcW^ROqKjigD3*!wITt*88Q5HtY5wnFW z(H4A#Ec7jGA-<@E_Ohgyg@oc3{k~;kyO>K@sAaP-NzTMuIFMkWT%v`JNfy#xvoKZu zC~aYI84C-_T6iVZ%3D}1@1*V8) zENqjgk1h0;{=F@<>|-IiuSMt3!U#Fk&q98Gi+;8%zpNQlW-c zER?#X^|I-%!vFI4wSozMRi z8!O!-tPGUjB`ea(rv@t{<&JbQTKU0brK82l!eUme#jP}qv9d*u$!&Qdr(>;Tmay_k zoRtxBOa|Mm?1{J1DACHb*Q^9eTj^iM%HMLTtd$DotaL7~y)r0S`K4S%E8}FgT#z?X zR9~u<#7b7i$gwmlRqa+Hy;c^;aG#a^ek*waT_<7G=XEB5YIdi1bzUQ&9hhL5ehlt#U+`k7*2*%uH_l4i@m5+)u(C#; zO;j&4th|zHv#hL^hc;UVfFh zb5<%!`}0=5mq{1&I*>I|=T9q>W%*xLp2*X2g4>nz9a@A-YHKO@UcGiq0P%D}xwWDd;GMavp+bSB%8+t4`Z$@Kp9nHt$UlhZqa^vS1 zGS$W46#p{@%cU5aO5jQi{jbNc;zkV5 z<9Wk-=jf>?Mv6PBsQr}q4%a`Bl_>Vd+F&kppAf}CaPMYkAWsa;k ztoUaYUsnAcOVgXN%#|T`weLYJMIOd-_f;%Yi%{Kg4*3m&}~2o zewOt^N>FNA2|9{@X$j`6D#71Uac>DeJ5hpP<@~i0th-)AA+YKY?>V;ujQ;%F5W$3iii<7g+#rGzDpnCLj(l48ZQJ~obKGQbu` z+r&7QiM?bTpOlIty<8l9jw6GxH0ad`X3F;M=LMFSM;GsXHmj!}c+h#aD| z^8FWa^c)(;CYd@cjsJuh-0`kn;FN$IdK%sjbrS*I80y1 z(MUQkP!G%ENM5eKe~M$`<~YttnXPfO+!?3eHPp}UI1cQIqxY|Iv^WsQ*K+(|9KSz| zBjr&XiO=Jh^lu#Jr6D$c6I+Chg$5g)Og7d?rrAb6i;W%Pw%T}9)JElEHpUmXQ9Q;* zYbh6N)B8;uy(Kr!#&DaBBl3E@jZ>1GU}Lo`FQ;{BHg2ce^d8ejp36o_kBvfp8$&W} z9FXBzHonib@l-bF*=Q8D(Wa`6?_^sw?S0+G{<=02>e={6S~sxi_W>Il8tQRl?U7YY zZ2Z;2hO?!Ox~){-J2tw=tnM~y_OLNQntf;^sh5rSWOHvD7YEpI4YbkrGaJnZ*_bcU zgKeDo!bZiRHde~45jL*MU!!dL@6XiGg`ga>QrQ%r|e_XUt>5}GlS+l)uql3)6W8?lq8x>yI=xd1AM^o`Umy9Cu z43h7Q#Ow zK9UJp@l?*$F{u`cXH|YYFXU0>c$!p;XO0xD9#8pt@pP3P4dR*pW;~Z9vu!-h+sAWJ zQaZ%*q0HzQ&nF+mvqwDL;+ZOcNmBQCmP>d*JYUI?!SS>l8qWf0FkHF6RDH5r-WeIs zQt3M}p6%bnQ+TmrEQ_cAigKImcEwXKT6PT-b2E0;h{g#>-ak-)Ty32aG8z?zys6Ipoqt@U*hpm74PnkVRUwgg_bPM}AJ1UAU_P6@Q`mcU|} z_o3?PnLuM1Auao;7J09K0%ry$Q1O!lR!Y0Us#P+EDb|PtYK=_5FgAg}gakg5D>8gu z0!L)ak_5h4mcU)P@O=UaKP1pzX3CJY2^^43>k@clO9G3e{I&#!?MmRVtlq60dlDEV z{=J&Pz635x+x-d5KbXKj(&v!Y9Z_%c)zJhN9#7!5{Cq;OPbQFfDuG6_^sMG3cg`g+ z{c!@9WDSXY9hb;W>FrHqn1O5~z+%Soh9ULxD2UP!l95-D6Y zk?3lPl&`BejS|UfoT$&U5_#1!k=m^i8UAJ>C*Dt_T&F~g-4n_DD3QVPc`qI7ok$mX zEbsS8WVKZ7n@D88L>@}1L5lf>Vh&B@>F`84k4R*#6pU2-v5G%V$0sDRe`+EL)3kS{ zZs#V_US7^iWY_#eihrHRYYX&PYAsBp>7qn-R7#>~S`uDQ5>4}xm@B)gC1I|fL}hW; zNTR=NubITYT1mv$PNKWiZ=A$*S=uCtxMoRwEq_R*=1Kf0d99KdE|pp*vHrazj2)6F z-Z_cpU6YtERk|r}cg5?Gq#hMdP7X@q(MaVTl|<~MByP`2B4@Ua&r9O$k|a`>Ch_^Q zBtBTH9OC#niJreCu}MnoOJc$PByLIdgE}VWL&_xyhm&Y8GiCItBu>d|7q$1Y*2&6i zNo@N&i9*+tnD|c;bsr`%Rm#0g;>+lg9F^X-l3YzGi7&MzukuS$s#-}p%DFd7a;#fP z%5*Qu*&XGXbGJOP&&%_+7z!oRKQ5V_a@~=P-IvVAaS1D$z+5cv-pvwaQe$;jch^ zrwX)_MFT2O@3RU_ld_{KFn&S>&Pvz073j0M0?TC2_6o%QqF6^NQ0GhqCQGG@74$hs z1!`Q?ZA?WnV=FS{-HKHGpdw==xo<^Q%5(AetH__yW>iJKlkOWUa$`qDGImyE$H|J6 zd{L2Uq;OG!#Z#ysm%?<(E|=HLX*q`gV%Gmr9{k`xKl#Q|K$MfqMSa6xPYAFH*QQN;Qv8;opfV zd@)URNX;4AJ1d1T(sOnS{pO~yLp<|RD6&lPq}vZEEZCy`^8T(A%Ir^}vv?1rQ1?^{ zQ>FJGDWqIT;X^rfIfY-YY5(6TJi3*_t4Ar+ew@O&r|RuR3hU+m%M`8}Q}LNnDIT4Q zvrsC1rA6^ny2YgOvuuw|Wky^om*riX)+VO%iBv3^$}rhkDwSfdrP8T%DmPM7$*82g zj#M5RG&&T{GSDtm?^z>RifI-O1dtj5-+b*;^DPQ6#QL@k+&=9^K~7QRSzp+u%^*K zuE(U2mz2hESzI9vvp-GWr=>BtNg6jgq><4vjfNkjvE;Kf9*FB3ty`YPJ(;;BjT5`l zD7QO}aYxhm@kAP&)bZcbID0;g)C+0MzLG}0t7%NUmc~4}`ga=68)?jviT|YO`jIpy z-%rzL&1o!qpuNx2*z#W*#t1vTWRUEZq6Rz7jCOX&@xpcn7qPRasGZDWcGe}@d6i_R zTS+^!OWV0r#!l0+c2ZMxEY;3Asc5%zK;qKv43+jiJ2tZ8MS;wwFb9R=!ZfB#o>e~6Zo}J5bv8kO0@_jQqo5j=IPM;QbuFAc( zb|Tx^*(CcVzrCGd@7j4JJ3HGsA>%%uEer^#wNb=TOLxK?%ks5$>^XV!W7AgW)nU*}<6#4(e2NFw3qz($V3dkNhnjr-R!*2MIY2-pO@P zy0U|FH5^o|khirb?{>Y2W=ZV__mSOH+C?miG#~c9lAciL1)<@KfdAM z<(m$=wsvskEeGS?c5w0?2kqKAXw}8Rysi$4b#ri}r-Q^^4!)8V{TytS{{0<{khFmg zt_^bVR8|jm@QVb8I2ibagMZ|`VGhcF<={6dKGMN@`CznWFh+IDdATiZ$EwzGs&%}B z_oph)GzWEOIJi37forbz&vS5kv4gTpRHuCKooZUlF+2G*# zMhDe5X)arIY^#G!+Z=4%?jUl9a{lU|;qS^RCC@r=$UlEN*ndg$lxde$izHpqnyU^D z%N1#K(?RQdnwO;BcaSMdJUPXSmFgsIKXJ^l>_0NVvDw$ySN#n@%4YC67Nz=hldH zf}_$oHaeZlGIvZmE2PJybkb(%c4j&kr1xyamdbO|X(YdhbzVCCWvo0~q&Y21$Mk(V z3s$7F?1ywVNuSl)Cr_ndZ8|Gur+7A`^VT-aXL~v&eo-!&v?raf52mwPx*kgB6S*xJ zM|6Iq&Z%_9pH8RW@99jtpU(LQ>3aW{&TEg;dH0EWkmAqNY55|ZJ@UiLbl!ZWnE$2| z^Itk`aI!eUNqnS}w~bB~nViH$IVm3Nq-6;mPjZr7%1IqDyym2Y43qt(orKCbdAFRC z@5(zVne60B1t-oFC$lA~l9RS+P7cd9hZD2Y$wZfvvzgW8Gbi~{zP0M@sy@0o zIUpCMP7fzXzHpK_%t?w=9PXscmrl+~#t0{$jC3+W9?0m?PUc9Gg5AxlV#(b z)Sm3*>#0swOV?@IC$}YIhLhK4JDK{8lXHum)c;obmMgc+{@%%QDYL>!hm}rFNaSkG zP!7mBX}Csv*E)&%Q9b^o9)DJkvU-D)XB(Xi-R$JhcJ;NxNvTs#+Mm{3&Nw-GQF(7V znQ+TV#BC=-?l?)mt8*fcCF-7&ezNtx6VC%DEgq@2$2xaUHGh+fbx|%-%`Wy^T$G4* z@r86QlrQO`Qz;k!zUHDv85f7ky7c{vi<2oXYNonKNpsQF z?&1&G=Wr40bTLHkcwA)qTr8H2a^LS_d)S4gz(qfKRog|;IxhCgX?gv17Zd8bh^XhH zcLNvJhAtX4a5rU%K>uz{QV}JVLV> z>C)$aE^3WeyvbTK)x`igGeh&5Yj!JKtX%1$>?#-4 zSF7GNE?!8FA9Wtqsn<;|!oRs_AeMbD5@n<`J>cR!DRa<;TMiu3+G8$;OXcI5jodk* zy8cvMf4O+;vWo{VUF80&o@C8`ngwpm5pKSegOP6X4Q{?Qxw#$X<{h(}kkw6nF-N;e zkP&jYkekYd-4rh3rfE?(JEVTB)=OduH)%3c{)%(c*yd((yqmKLZt5nw@sx7Y=QTH1 zrCV7yYs+a(vYW1z+^k7+Q^D@0T)Lb0oo-!o>L$Lro40GYIUvt#x%C;An;&FFeK(I9 zxarW)&A7&HPBw8t(2H+9CinLf_Vh4HFsg7QsPjwx=Q$egKeE>ClF zPyUIHEa+CCpn}IUyJ2(56X{O8F)cD@b=oM~eNa>Ys-dp8n z)=zGpZP9GExmhJucDVU!r<*BKXqTHNyWRXE341l`Uv<9Z>jQ57KIo>^A@zI2&4i327f4X_=FU?azm)tCu8#mqf zZY#dz+;=nRft$PX@gp}IA8Vd6;E9{liMhHBdzhcEH3c62tL&j>RmH64(R)V^)$3`0eGk)Hc(~BgL&H|8p|yu`Z+U3Y z-owHU9&U8>@aFp-%6InA=>rd^WoQ=<`?`9_>*k?Y4-YLq^srmbN^(yRj!!)F{M5r= z^3hNarG|NEKitDn`C){Ijw3yMKT5I3dhm_+@U^s?>|x0i)jZY1x#=D%&h#)@{+p$m z=cs3yK2LSdSDjz${xT1i> zhtiilymQ;bH+MYP?s_=&(8Hidn%iR!Sx?mSQ_WbaJXf7k7B3wmyquKH1}{dFmyhLr zvzHYXFJ-J=0`f~yFMZ;?d?{6IUj142vO}U1ybO>wCA};z?xk!S_0d*+$Uicqqn9Gxy)^5g{c^Uam*ifmx3?F^XNvc^ zmzRUQj2o&w!@T+#uDm1l{Al$f|BUtGAMa&>m?nB@IN8gosb0=a^HOn!m&tN|rk9l2 zUZzOTxn6#r=Ot~v)=0$#S|bk^dC6Ps)ioeqs(q`RQf;Z1HBxw$m!>}`uUuc_#rva| z`7&(17uN=zhmBq?%ako%{@AK>vfYdOS1-MP^AbF)^Ki_|SI50Pl_qDr%=q2QyL_bie7Y{&#|3$s>!To~=cQHH$Gm(W#R_~Fs`~g*URLw* zWepz{>-y+Y&&OHW*U(37V;@80NE084&3r6u?xS@Z9}C+0XxGt)vy+doJP~teAN^(9 z2R@c`RsN5ZznAjMzTQ4Q?&D*a6!i7cP_~PuzmI;hdZ3SIpZMtfscQXP`vxoTP#?bz z^U>@}AAc|O;rT{&OW<4eyTpg-J0ERU`&hijNBmkJJ=gj8`6nOM*86C(*~g46KCD}P zoZ9ZA%nl!8W!iop=MVU3a8NZL@sWSb#|k-p+{efh>hq+J5oa{pOFn8|@v%l=!V!K#20!)1 zZ1j^LBjm8jPvs~--HZD9Tyl!}sUsUDGRDtGQZms`x?GV*@_v$^6(#+YDdnf2oS#M# zU0&;Cv>Z$JQ>}uZp6PyuNXY4@o@^15+fQ$q7w~g6sOK~M+|Kcnk>}?dX;(YvHGLOF#Rh{hNN4w)PWzThF!k^Xy%}{w;`~?|S;V z_mSfD^3!CXpBbO{srZ@t9_{CyF@6rpr<45boUFZ5{QNHEr}>#6zfafwnSPef@>6P= zaxB;0m72{aKZ7>=^;wH@?(}nam!E-q{CxGRpF_WC7W@1>klX{xFI(mDK|ehX`T6&( z>ixq{?0NMp`~LDX;G&=Hm;CrHE9VvEyr%r}&EI}*Uib6X4L_~^@$=zrKR?~^Q|Yds z)A#(8eW3UcHN&Tx;WIxip8Ki$!q3E)n%65oQ~&jI?mwMt0&Fz~h>8j@!5pAyp#aSb z2l%r{fW(*pZDIo)lA3V=#@GV9k`W034krevoD^VA=>WaU1bDw}fEDEelqnzJg;cE& zAi^HN=nUvO{{Yc}0N-Tc0QFi1 z7}qACpTWxAF2II&6|X~p(H#TCbqmnCdw{Dw0@(Tmc&mSa{nBQjVtx`J{?h;r2M3rs zM7?|!VCd)o`^E&w8yjH9IMp&CzySGSdVr@h0(6?GK4u5FJSRZ2x$1L%fa6~WsJjMO<0VEn-V918I1(EyE(1?X}- zK#za4?{W2U(mS z%^+{Q736H2Aj$25OqA;H1{w8UP@jPWS<*Mioqj=H%BcQ9W=o3!K|0E5Df>x~?><$| zAwl|mp`N7L(4c-N3bIQI4-Yc!%OI9fK^l$@vQ-|B4H6!&zGc(Ip#E)E5X0mko8^EM zObIeyu1!_kX?kvYkT^Lg=cUmM#he+$JS#}<>>z{Z1i2?O=LY#}p62znX1zG5->DT- zj!LT)L4Mz&oLhtJ-KJW1tCl@MJbQy&-xt((CYtX-_4$|TzoZ;;RFbZ!C;8xNkRPrE z30)7e^Ffe8kAfu1XgT&c$U9Fpe{%+#EEzbh8N4W-LDkp{8p>9Qip!vcERj354BEtJ z&{dvEZej+mqzpbTnL(gj2G$B0G^&`vHu+atr(|$VVp22MEobDW6mw+onsk*q&J4!8 zGU)Ek;73meDc%e!<>+y42E*!S=$hLMLJc$UG|8Y((+oPd%Fwkgiu0awcFf>|ZW)-n zXE0ZGPs*Uklnf#kWKesdjxSZ+%T@RH84OsNf$^sd>i(R;M!B>;1INY;_H0s~t;(}4 zgHgLx)3FTJ9M7P_i45kSR{du(X!&~vHP2^Y`YVIqqcSOP$z-`TlZcX;)Gn3DvDY$r zJ2R6-S(%*9$z)j5O!ha+B-A{U#Xt07?9ak^FpJqz^p7l>pUYyGT>3i;$BiszO1WEEynj23)Q4I0u8_^9irM-cE1Tck z*~ECW87%kmvdIo-vqXAU&*tYE*`(FXrdHi-#@5TGPlIe$cFE>(SFP`!&4^F4Is92R zl|Rqs!Juq%hh+1eY?TEgv$;Jzn~a&+d?OpgHY=N`IoZ^oo6Tl9DqR+3v+&z&ZY;^> z&86A&km!}!#IMfg?KRmPkc;wYV>StgvU%rlHV5UB3^=L#rxo}2Y=+6vKeI`?sJdkJ z{cN5+$mZDdY`xZUIOWbEFDr*)19KQZT#vuZVd|J18jZ_g+V~tko0!9{NjYRp&f#_G zC{?HCFk)H`&*Z&jIV@YAL#gj`@X8Rmu__1O>Kwk7S9^1){+pgVqJ3Aj?^+JEZ{;xg zaSmsnr8Am0Y%5)&6U_?7W*xq5HWElxY!poR7?7jwO$G zOXTrgTplHDd3wF;woD!)rF^+OI+f3(YFZvcTjc3|PoA!q$fJ?$ej|^Y?ehq{m&g6i zd7K!V$7|#B7%hVrO zJzlB4$Ph)0AwHF#%pv}@gy?P!F|BBb^Tk5^BU6fp_#-Anz1R?C;zI0^qVXX$l#rJ(X;gcv9#Gefk? z3UNf*%I+CcV>^i7CG%R}t`QRm?&od+5AvtqAT>ZTv^^T4(Fx5{N}UXmF29`$QR4RyZ=ThC znfOPDGv_pm^C8;b4$(_ocS3|^r98f?ncUM1rRmcUGoOWsejZ{gVWJ|#Tr`I%lNhE$ zQkWA`rnK&t(S5m7E=*=}nA#P>oU9n8bZVF-mBRE1hS{7E#+4bSW>%On*hQVGh<0liwhWp;4IE8;98-_GV!|Y#!!M+3;qVx8Dl$fwX=*%z}5qtdwhQ z!?@drnJXjS4RiRtFqJzfen-Xcr1-L{OPIpl!X(K~DbyoOqAZZ>ABK4>13wD$ORq48 zWXQ*1e(kM3q{G3e!Mh zM}~Q0l;X)ragJ7vW5Ohi3sX@h$>{N6j!g*bbrYtMyfG=v{K;X8PthFZmdu{2b1*%O zaYmTBGsA3@y)tl?>Yg3OKPOC+d0}SE57TOKn6)dyyjU3~^5-z`?F_SQmu9ywOr?|R z=~S3!r^Adt7v|LYFtskIpFfrVVwg2D4SSEGC`$)P6s#5c=lxHNB(&+L}@6mFHz zfH$=E&3p#6&F5m@eC+-6nIR*m<#S|uK2>JqQ*M4f?|+@oDOtTVpJ(6Y(|K9GK3mP_ z%kB9*k*inoab3&Dc0C_snF8vTE#PFi0=`Wx;C7_~-bpLq4Mzd<(+e2jFQ9yf0y=dp z;Iy3YRzOOR0;WjKp#_W?R=_JcI<0`D83l}x?>86la7zJyY%Ac{$pT8AE})XsJfro$ zYrQzH7trfQ0fQv-W&xkxD&UqBxm!T9dj;&2{09XLdsx6kne(WCaZd`EEvKs#nO396 z^M?`oUzYscD_j2umjCV1CeuKUNu^;y%-*=O&4UYW@|Z}7bH$qyyEy?Si|DoT9fi~rq_o>?`^ zum5~iy;)VOW@q^`v#O?NSIzKwe3iVFJ(V-6WO&lEs#UMhlHtx}djF%HEPoc_O9|NG+(6868_IPvM;Rp}cJdt`@axe8|W+<-@+2P zHyqv@0bQidNN6e9qoBHU90R>%;8^%pUX4?{iSYAkh+YHEpJB}}uubN#g+-f`+ZNa) z2PAhZ)Dp{Y+9Nq8SER`f*tru<%Gg~nSBmb2+I!UpvHcE7GDY_7hx0P|0DLd82i5zd zuuMKU2EFBma6-M8ITAPt)#N`ZatgkbF*5tKdV3yBf56s@5P1no$Vs^_&Hsc3m!Yi` zzXA@KDTA)UXsK}xTFBo2xvu?}i8o+@#N32(e`{^IEB{K5Tkz%|<#k)*<&4z2qZl&h zF07Q!_n^Prl7kQ7qD*@PizVSPRFH>H!0;3{%R$L|26g43w0jO~WsiLI0>(@DOZ8Je zd4Vzm(>0jR!Q(b)hg9=$nTP#VPWi$3gKaVAbrGR2&1C>BwHoZ z7{&k@Db-A2G?U#j!V<mBDR4R-wBr`FLni5`4b7Y82kQ(K~I4^sX z!kA_ca%VhaWd^wtz8^()J7*q4Y zC{|H5NUzFa9F#w0Y?UzDRt+P*S{UzDSDoUk8O9NbtsTZt=~O3-6?MZXSuYHS?5VFh z8ip}QhRcqoVMH_!qn`|wA}zu=DXzD}*w{*ATdUvig>ku!>TVatXYI8Ia#if_hcR7# z?ij|a55wrvDU6Gq!$|6)dEK-hlfsxdISj)T^=D2PXXmQMd0~9=T^Q@}A3IE%dDr2E1dFCSD5=Z|XPyppf0hx0=6YlgEz zHp+7;QahZ_WJjHFe09Tl-6))%O~NVLRI%iCvv68B52usdmI*Dw>DMwG^V`ayRX7Q4 z!`a(DoQLvBhj4~`5YF&U;S}f`PNR>)DfDqT#pUx)!l^$foWDnhlQuS-pu9gWoVfAf zygMPB0}?qgoDb!pyfrDDqjF82Ny4;n{L{m!C=F(Xb5Tlu7f#a!;ruCmzYk}|BE|e6 zoF5j4b7x679exUDu~=7YZMh`x{~FGTE#X|2HQU2^x-*M~<`MPkXgJxY!)bCxIm=mzIj=P@gyX#wPQlCJRJs$+&AaO9J@x#)@_MEm zpDXVdT3>#Yl5dpXzu}ZN8fae7z^pt&4BZ?WADa~RG zd?2T#RIJ9z{Wt?*@dh@^ehDQQ7*gE8V@WStw}{M6UtA+>tlZ!)IWv-#~J}!21~ndP`cSfqeN%p6lJeQ?`NiK?D0_NXWn> zG3Obmmv3OREUaYU7wJ*iz!&mBvZ@+bEML`79#Xfafp_GP*lHV?SI0n=rUsfy;by8? z#>wgC2DY{|5Yfg!aXBH^qsXz&gdi*{KG;o2DMi%9#co zf9ji@k@kzUPfH9ek$X!Gytm9i7umVo!0QzTYOd72tx{hl@+Sk+e^H;s|Eu;vZm%=Y zaJ_*k8w{8>8i9omnbI)-*>pLeUiJq9xO8mMzr z^-0!o13yUgAKDKwTvT0h{jP!T_YC}e-$1zs20ZdevLC5;lK#ZNz^4Yj727id-^)MG zb)3D_UKKPlzmSoYl2q8pCb?6@$mdZ;ywOG~$trnT%&6nmNal?{vU}TnDX=vo0v}t6dU}LS*#K?9zBsH5GX(qSjg?!w?$beQx z*0k2`J4O=THL_D8+ZgFDpSCsfTYDpqK2Sa%D%VcBm98HdIV#RBMn36kq`}8VHp|C7 zjeIHhB)ylBg|b>Y^j5FL-&Z{p;~*nn$ah~FDfN|+_0n~)kwNm0c!wByHPoojl}5~C z)rWCLHp&qxJYM~nZDiUUBNyiysW;C^dnvF;{rS-HF_u-8aHGJaPL`&5HGm%sNL8Fs+Pe}|0pJYwVzNj#=wL1vs%-e-*TmW1=F|ALW- zt47X9&FjkXhLPI0bu2tGa#ie4jQk>DPmR=groE75lJ{JFk*Y6@?3Kc=jC>~V{Ac8$ zWQCb1Y&G#|A(M_<6KCWvX;H+)?4l+LMwz%?!Nl+s6Nl|4TBe$)=P~iCeB?DTK>n6A zzlk}rTqb0jsGFnPToYkI6R|R_vWc>dw2o|OY{K5egteuKzT$Y>M2;+xd#y|yf5*gS zdHSA-&23E_YiD9g2NQ2()%zy4N!kY{dUrH&O&-eFP9`pVWTHQ_vruH&X;!_jtdYd>R1Nth*ekR6AmHsB0$ZujDsQhGz+?GCrOq`bM(&IA| zwLe#mV*k>_ZmIXRi33ASY#D0ey2cbaG}^X0EyCZ0%%-Fi*l+oLt*#a2nW!v3$+P<=c0JHBBkm_ACd%2T zCTc!2aqGDW&r1_?Ww|W*SNZ>E;T2m}#49COXf|P}!evCa0nqZ)G#) zDrV|dHS@LSgCWSKAZT58PO zW_q+Tv!u0|s_&S2DRbU4v%Za)R&CAr+nG5bmt|0UGk=NueKVInFq8D5nTXD2UJuaP zgS3W>9->@^>hUl$*S<017;a{|G@E5+=4>;ObIg>Mdh^VzS+Dgrn6Yd$vsAimGBZFj zwy9rY`_0S{S-RWI{XJ&d>^0L>rb(lH>eqhV9#HS(q}-RtLuNjZPh{ayGanr@Q{se~ z7AMUFPMb+RW9EICb=J(f^JWsRDrdPMJFl79aa-%(F_U=DOy~P%`p7NuJ~Z>4tdR4M z_4-pYY4X-HGo56`b2BAhsQ0hT+!Yx!XSop?h;i*JeEHtoM*dl8RSuhv2 zP`8MM{zWYulw#2q%7~+wg`ebEjD<@jEW9aap;dVc^O7tSNwzShf}WFADHgU#n%zQg zhlOkMP`0O9$aZSHG;vwzAjc#=O}WTq3G-U$Bqe+nQe}qx=~sRM3-8K^bPF$Jd4`2e zlA39uXO_muUCGJO>$w)*3R(0S)k0>Tg&ML}UgulrQc-nDsFsCkal}njFh7mE7v2fcnetRThK~uVJq!raS@IBABBLG*6CJ$&9HJtT4!4M zLI!79StK>Gt?ZZZpp_GORvzVBSy9o-+jVp+kLz0LP|wQ8@`D_xuRIzk--cE$$k4`C z_Q`3f-^9vNx!=@En`T<4m6hX?@Q#&l#ni@1OPSNwN}+aEic1$Uv{$Yjt%QB3d^%ZK zE1!O1Wt*5kwbEM#OaIBt)(o@K>>DfAZ>_}3H*#>e zmEZ^~jijrDPgbrnX^NG5Q?2AqQ$MFGZ>c`h$^!X&mU5kK#W&Z==dyF272A9(?c|3A zR-P@i^1=63mMu~)KUhhVsmrZYTVrLNbotrJK)EHJwN~cJ&oX|qm44fmlN8&bx+H0* zYLUacbgb;RGWLX(+u}QAD;culA1fv9D2{BpYvp$d-Pb-n(7rvia!9Vqzf$0lmE?OSa1`+4rB;B!cc?5e$@bk{KSsXNCwy$UW&|jNm6z1Rbpr zEGQB|M9~NuL`ASgj>}znC1;`|$S4-UpqL1T%W?V27Qvp_2pYymaPzGQ{3RpkUn+vX z%9V+rb6L%mFB7%Clqny&P&;@ z5sZ^9-6F7ekDy172rf!ePv!7w1h1uG?+E=}7oorFBG@K@ei01lAHm;JVL${!q{zSs zvgNLX4T>N}GQNnQimaB&Uq$dzDt@h)-$u}Nq+*GAbOgPn=9mbU$%C;Gv>g{g^YIa^ zkrxwG^YjSbNR^q2C1G$Mjf6-%sp)i1gCdj#+8i{Qlm2#O!n9?Bd!en@>d6~Q98B=^o}-nj_!&PPyRKK&zt z_42#KT!^5&w7(d^k23L+ju}}awf>A?k}SU*!83Ut6G;_YB=yQfGEEN3&74SlxsiM( z!Td;$$ofi=RID6{qgo`N%g*YN_-jP6xMn0xT13)Ma#}`WeOr$uyHzCi){%TFzJ*bI zCb!l_k-k2P;~SzlyfKR6o1!SRIf`FI2Qs(i#I`6(Z;xW;Z&8fg5yjMaS>;+>U0B48E^jxL3#MEMR6yK6!%wAQDzoh)$VtjtG7{ANKo5fiBcQL|l6{G*%Vhnjz zjKlKFzr|SoUooCZ2V&R~9z%p7hJTDP{A-G#r8$NLVzI=~PL@kCYYb75F}x#1ifDXv z3{7Q#Erz!7F)R~%@fZe`h#|F141MHuatxgvG5jobQ)Afgiy_t@!-MP?f;ll<&yC?^ zUJPF}i(#LXd@qKL?PD-^h~ca(>=eU2dAD~A75c!%R>lk_tiD8pW85%>%w=wjRyooWini9kJQh90&xzl49CQWC=@OX9%`Ez0z zGdBj)cQG`S&hu5nvKSJVtL|T8n6Np93sP!p3@vuX=x0UMvpa@^dt&r6VGPX=#_*k- zI26OV$1x;5i6Q=F3={v2;i5Fa#y+uy*;rt((aB_EjbvDC^t0O7A?^qpPYT~*=Q|gqHX#tZKJp3#Ml^SvvE{v$J#h8iE%bo%knZBmtx~?s!gApZREOa6i>5J zz-MD{hK++VEYrr1IX0fl=3E;MLpIt}wy{*URngqqHV)LW5m(p7C(^pUO+Sa(*w8?a z8)=TLYHZ_ja~sYUHtMuge(%}nA~U<&sNTcIcxn2vjf7q{-j~h2ZCn{(!!^)G+s|z@ z`_jfdiTujO*{^MsA7W#r%p7jxhFl(L(-)bFEypI>7&*_zDe1h>M*kmdY*}g}VwsKh z%WYWJ+Gs4je$`qV6i2L^Y)sjrI8tw`jbFFf2;Z*tezWnOERoA{ZKsX2T{gDwvGMPI z#XO?CWt7x7X=8%ylkd*ixGm+++xX*(jS5%Qw`=O{T^k?BjC(d7KDJTrm5siJSe<^2 z<)x$-iseiBv2ZL4<6^ldqY`3S^j0hn#9lI%qe-#6l^n~p3b9zzVre2fe6fu2$8uIi z24bm@5z8ksJ~NhzIeJd21Y=p17t1SoQZbgsRbrVfg{#I=wr(t4Wk>y3rnQRYs${f{ zrCIw}u1L}cv3xAkJH|5TqgeJxTDMrH$Yn|B9?NnG4T$AiIr>#BEr!H0U+NFj+TSQY z*)8vlh-HcNoe<0R?_(*rNHLbh(tkxPJ7vL|SQ`Bt%PcW$P;Yj{QfPN9r4PhX>R>FL z<+e;Yta(!Nq-wny%Vw#2E0)Cjv2>H=&tlp1Di+J@Sbdg?qk|!i6%u2Lqe^5PW5ib= zj*Z3QFvr9(`K>tGm5gJ#tSc3#pAF);BQMItkzFoM-(SWtwR{{~lH!O+j-!$+amDdi z-t)yVC=jRfcX3>hbHOuzx@lDQu%pPq3vlHt;#k8+Xs`^Ry1U>xNK#j#S_eWhF_eW+p$kE6zjI1FRr@Q;t< zbGa_V=EiYUwk(e0`(<(5mrFm!5%*IZ?PZ1x{yC0=vT1D`Z*PfXp_JVg$IxAI9Ff(# zwZ@(}z7*eH^607JcBvcG zZKZe$R*omKN<3xjC{Dw8G8@I~JZU^{TEtVcWjw=L#dGq*c*=B&$Jjldj8EeEO1|i& z=X%G}MV`used1XymHWmM-Y=fVQsPU+{8}-G#PfVuJe`Nf^RwiSQ2a59KUU9=kLSRY zc;cpN?hM_|iKo51o*U1udGQqeE}pmM>#@{W5KohZ@$9IOK;e`GJZT9u$xUF6?5dK0 zrD_5d#a%6d{<6J#0{d$u5L+{W?ozK&0@Gwk;{;-wCh(p7Ar+b>@QdWOOkkK)Xq~|N z_Y*LFkU-JS2{h}Pz&xqcP3v}7ydDXvQSs!|mkB%>p>;@l%*Wj0_A8TkqPB^U9ucC zN|nRmD@SanaH&=(D*T%Vf{?azy{8SVzlI>ufnD zNrfxrbgrfx)o$oEsyrFd<(b@}Je5Bx&uB^PTb`BjQhfc&^QW{KS)QfRePelU?I=(B z&hqRyRi5In$}^QDu1KJ067^z|m?l|elK3YviHvedxXLH#e2E^*0A~`Rv?R8Bl6d7! zqPj1M1u{2~#4S0Lp2Vswy(SBClBgZj<2*eUe|{3(D<+XzDM{~7N&0^viT>4-cu*^e zM|G0eQeW#dN@91DB+9&F1pI*H2fCh7azBwDsl!r3#4zTz6F*FQ^Qt*rVwi8~{e z^Qa{Losh)WQMXC={ZP7*sLZEg~UmMNZe`zeX}TQpxj+?7PB14(oi z&%q?>oK9kj^!_7>q)SPBET^v}@!L(!|0{_ncanJXB#D|&leq9)wY^GWy*zxK#0_II zUQ;qfBa?9!NT#neFPcoZsASg3_UL4$$0T!2I@mNeKAAyMzIZZ2WoLX~|5L*nr|>CzFa?^M9}ZUsv8sX&AOnO}h!(rZ@*s+_8z>&hzd`g#Q(->g9XUlkZ}w}QUk&~vit zaRm$!Db$z0qf*FCNMV>PDwl%Am!j{AQ~0WJ3b#H;A-!V?4L(X?@#iT#64&<{w>*Uh zGGj{$CwHY#W_Jo>kEQU-$rL!H=g*~Z{$dKrmr|H@J%zeAQkZZvg}HL$uN0iOQkW?d z{z=ibXDQUUlfo70c2{HXrO-w`kx36zbdEiRWsg#LC^KHBu;srLjA3?q$(OQQ3LES+ zHQL!BCkop6s*s&Mh3#Y%v9mVb&YJ`~-HO|pRnpGYQg)h@wv(Ks=aTJQkn(mr2PG!e z&JbzuwPW+yNs`I(hu==!fSne3b~;I7z8#+|lz%GPX)N>{SDM&)BtJH_vsu!b+3C~V&JB6c)=qdkJDcQy-^SO5Nzq7M%zMUG2?TlHXu~J~Eo!T-%#{Fbxwp@_Ls})n` zN}V-&{b$wii=85JM7plkm|wLg>+H;2uQ(fYf3xmy(fzGjV}~8b{*EIsL@W zikq(X*a8RY7gXKjWyi?S{f+&Z+cX8+% zKL;n}a483|WgHBX35gEQmUB?6yn~r`&5@1{2Yuu(Npm{5>va&9?clu}2PG>yxKPbO z`5F!;$=X^D-qd!`t&W3V>N{xLz`+j=-S%B z^>-YMeb>RM_Z+lq>!4*92XnhRDALWr(VhdLFkDgwI=K0zgXgmP zD+j+xV6cOMUpx3mp3D0~9hCjn!9F=7&4)WEIzsu&df6k@MmqRtl!LxfY_w{Ui*i@m zj!_+BRmV67Nis}6oT6N&I;b<t%K1U9Guwbpz0>|Zi}AV>R{702OGCL2;ZT#e|ON}oYt1&=N&lYpFbTOxT>DZ z)N9H~60U2^4F^Z$x-`7)p!EawRFWS$$dJWy?~(F&?BG+m^g?_3uY+%-(ti#b$qtDO zOJ#tJm6zsJzAuo_mb{d% zNvW(!PNiIhRI+4&GnL=7QaLA+vQt?ou{o){o14l(xgtX=rBbziD$S%w1I3i_a;9M_ zH5+NH>}{UPiFZ>e(I%CVGPpx36Q$n!dR-1nY{yiF$xJbKP34nMQ~6p#y){m@in(tp zePpCO9hAzQ;i&{hrgD5#D%WJr=u}onkBOr&8=UttAupr1IUN zR8~vZ!>J6CyOMrX`y;hZr!wwLD*eu-GWB697ayhSvt}x9Jx!&CrV{mEDs6DGD9lN0xRZB{P8OP+#F(8Fjds$an4V8?l2yVvvMPKqZwxn9nRGs(#;NvPnYZHkj4vd!Vd;&d{>EDNskOCgT$Wc zaMUZYi(ZPR8GH5_Z?g;CoI|?`!|$ zshA%)=_gwsI!Sxvr1=xo{#5(?Tzh45vDWM&+2Z1W)kU#L7hg-~0xnh+bWx^|iyJX6 zT(K@@OWEQsI+bwo?^`aam2z>Uv`gP1xj2>NqI$B6q!brj?JoY1{SFt=P8WmaUYd&x zuS?eFITY2|&F9dH7UnFt3dNabM^O7!Vj8nWx8Z*Vk z069Bd{hH}woVez?_;j9&YjWua^>>L&-@mJOD_pEx>7w*17gbj)-!(2?NsnK&4{KHH zCKsW7F6xVQzl(SoAx#dtcwb5#a^aSPhc))Ni(yjngnA?QPAacImDgn#?_6{7=(UTS ze^ryL`A@yTjU~*@H*zT4O`gHc4<}H45i`ICFFXkpiX2|6jH;rs=CdIlrALph{yqmNVZu-3C=7w}D?dIn)8k6XzYXvuJ zQrwiYyD5|E=0m4j*QvXSt?K68YHkk7%NlN-TXXZ1tf=SaNqsjTG;lMvk(*PE-BfSl zX2CmdZoTWq(8f*ewr*O;SMA)o?%YjQ2jwZpJ8SI$T6>^d=h)o(yx=B(sGF6t;~O`T z!`%#!2_xN{9p$FhXgAZwy16t?IgQtPleETUH_v4D6gStVx_Kb~O;b;%Yn-&5;pT!g zoatu2RGsB!mW-b5=ENL5p6jN~Jk>3u=eudYz|E3{ZW6wCGf=*jp-bHySf)K#t{kM= zk8Vb-a5G&>u5|PMD)nov_Uu+vkrR#M!$K>u!H!**^*(A4a zyYb%D+LHay&6khd+?O{}@v(X-pFVN3@u~Jy20U}K{kfaEFWuav$TXf6 zNaMqTX@nI`qh?eZmbf&Ymeg&jG`7o8sZu(P5oOYNDLoR?SX(ZQ-^-^_G&zmKsk%)| zqlG7pJ#y2RMzlYTw*zU!=jb++#=Ja@$xq|IifL4@te92O^m#aqs&zHLUK-Pyr*Wx8 z8Vy=1ht_F~eJ73j?bBHBK^nI@rqSxdG|F~Pqti!eoRJ}2(%9cMjofZ&6zP#h^N-Wm zE$1b%XBv({Y4rRojmz@MkTgmRO{4v=G>*wn!_(+EB8?wMD)yK(yyMdNPTEaMWAS9= zJSB|_)6ytEBaKP&-%RB^TQ$qHxyo~%^88Nsm!)A{o~G;1)t^;q{P|NF`D@b{_G=o$ zx1`bSXc|8sQ=H=(b6#UEq*3x(8t>grIaE9{|9jE8TelFg&PPdx09$T$xJq)l-T zi%NKieaplC@*bj-Jq(sXPK|SUSd!-9zQ;pbuZIHx5B<_TY|ZfK_Ypjtld{=2e z8eds!R`IZ18dvqOvzmvV)s;&P#g^z=iY<%ld$`v?c{cM`@+NPFFlMMqB%o7dLPlcBlP+x)g%9m@!%WhVZN9qcxW)m z!|5p=E==`Me!7QAa&d--q*)#&OV2qT*3I>hGEZZq{Ctg(#|u5=F7oJ_8xK`}(3(L+FBsALZ*y9`^m|A?LF4mzy^{%zWtK$|H?`?BR=N9(F(1 zdjERZ8||fLSubM~z5FKy%X!(6=nVaXONWK?CWiP+T>ne&>&C4Y5*Y;Arj^fqza$f$D{SCZCH}W!A zjyCoZ-_*;3W?ovi@iM=yUTf#2q5LS>?Y(r6_zqrDB~RLQ^wM3niL;ZJkUSGhXD|I_ z+ecnJUA)xk>SeL4m7U#G!zZetmuisPvcI>NGxBL4FGD52ua^e0U9A1R^pjyyW`LK~ z1HHT$689cz?yjqL;n1y_}xo<-@tUmD}^wyZL%;f%fEk^;wpSagqA^ zgZ6B(7t>O&&ZTIbHC|$W_R@2$mvz5-sj}WnK{_i<<$}O@2Glv+{+3%bHdArliHh8UMihd{%5=lKkH?RG`gT(Uef;j>80vr9Y!W=H z-qo1)K3;V2>G$(|EbZyz!6%B_%SYpZKBf=yQT}t)Kg!2@qkSBb&nEiVIZ1OT`#2|M zr}`K#=ceiY3?Iv9`Y5qXYb@8?mFm$ZA75_v>AacN-09=~E*}H;`1tmBABXp;C;NRo zlAMEDU$)BALq2*O_VMp|<^6|`=!>dd#>#owe_6H2fGa+>U-jX=<|9vL$hqsvA1j8E7@xFV>bKgBjYW8=151YpTY(FG%M(5m;71C&mD=6^3x{T z&ta(^<7c$Z&l?#Y=jTYgpNa{7W|#ESyOf^~OZ!<-#!soTep02eypqc0{Dj&47@dCo zZj_%$zn`V)eja4_Srt_Ld_RjS`gKjcpTs(TI@k4+(%7%--|eP zwDYr}gW`SQXH-W&G2Q&M?(XMC4?nhke%|Tt=YX^ssF;KN#D38!3|4L5`WZ6H z&;HSVa>w}DF;=;Z_cK6#n&#*EbU&SDsGeDVuFdw-bdKts=jX(CeyYy*Q+%PHcHjFs zDmNs2k@EY&Pq`(2Cdy(dwo*0hQw{t5oRwM!{fs;0hr@n8JLae1aX(#7`04SF=H2zv z^`4*n``VWWexjcFY5CmGURnQAd4~nqV+c^#6yS52D1XQka{#j?z&1G|m8}7WM+E3y zG{BFg0z57q;QcZIRwV{#UM|4w@&O7Z1xTt8plga^$VNwiaA$x|WVc7J`vQC>TQUNe zvJ^{-1_QJR1z409;7)#k<<$bzuNz=;J&ma!pnCHFqgw>@y>@_a-VSi6Re-nO32?qm zfW&qICP>u|0Y<(b(D|+ai~9z+*Dt_p8QDL;ENMOqP;bGf_-ACM{P4IJZS> zZVj+^n{wT)T=oP=+Z)jDf(7(loceo6bzWBfSG9&5lZ5N4Nj|y};HR4bf`13t`6xhv zCjsJRlpKE=;JxSSza^bb)^wZ^>AWhMPUYxy8pu{L$D~tC7Rx1>mKrFBv|Hzg`Lo!xR)Zc7nII&Vo=spU*(oGYE~?sR@hODD;bPK9he z&Piuzy>wkCo=&hqI%$p5>C+^g&Mnh*-IU_IuQfZS^HH~SEZx(YBfBT2Q)qHJVe`|e zxj@e^QLf9C>yPOSSecIT*L3QvOJ}28U7wC)V>){_X`QWFXInZWcPppk>8v@CPPvom z%sZp}&!*GjTsqY+renIC&N*`iWvv-3kH{dbcm_2~WN`eg4BpMiU}0tkXRM_WTUSFVOsj8N^C^S+O*OC(AO3Tq&0{@6QZEH#3+~ zI+M#~GHFycle1MaDN`+zf^{>=8=uM037PyoBa@FeX7cN%Oe$~5WQLTvlgWp7Gf94&N$+x5Y$~6n^ORZab7v9d$>J+{kefwTD2v6? zvuYOWs%4QP>Tv1-K`e7C?9%XU-WtNV$Y)-qg z$<55xwb0p&8>YwKWHV)SHVwySGj&`xpHIkU*TihnCuLJxI!fg!*$khW%?o*dSvJd- zXH(+GY&ciX$;=H1Mu=ACRNJw^&9Gr!7 z$SjgW`{CqW+!`E_kE+m(Po4M+x*84k`mA7))B$@x@ z^7-vt?#hO{xrE)%rLe4!Cl7M@;9)K=UgT2omEy`e`R{cuJ>Dq4@F0bZK|YgTEkXXZ z2I(FVWNP6c7mEb>M*ndk^&NDVSn|A^0lv>-uGkO~2Z})}XP#m% zP|SsjDFwa{vT%8j-M?rbe$_t6&~=KvUa>a>8M8Ua$t^*uZ4FX;XOQu`^baBJ4l-na zko^aO+&CQMnf!Dl$aZOaEJ(wX>Zg=A6(m*moeom$T##1hbzdg@5#;Oz_2OcX_IHEy z64$*TAz3L;@2e*d)I(|VJjjd}K_XuU*-8j=c!(>O5T)Wne2@_0q?9VD`=xYW?v)9V zkr<+8xe%wyhbWmGVsV8KeF7mir-yK5gs7ewVsuuBx_KcE)(R0*C&Uo>rf!Hs^+M#; z4`FB+qIRPY8^qo;#K+A-{3#n+g?RU!5FbhFcSFp7FT_f@**1i`eTX?SyhDg1?}w=P zf#P>m{7#B5ySjuZ*eyhY?34mMLd45_`TOG#Pi5dIA%5!>;;;<8qErfA;h&nSuY?Qq+aHjH~ z6~Z?=MB}+3rq2t}a#4t%SA=-AGDP^g5by5{v22%mxIaXNQ>yKBh!>7@ta%=@TI5l%WgY|G*4S2geAzaSD}D2@ z_s?UxjF_6o(P?>9nx03Qd3k*JT^^@p^^!bZEX||yvOJy7&f}Zyc|4OF*Yj}Q%)|C~ z9>!An)G3|MsWSQeketum3i-U3lF!?YeCDO*Gr*Tm*$?vR)G?nkatJEY*kP zGkRz~Z{*n2d=jSTGhBY$oX_Je`TVghpW~oC@YCT>)4%0uU)&KLq^skBi z-#=Bid^Gaeiu^B@-7MuTUvR|73!jfV`LI~+-zR+4JATNrYL))qJpD@^|KFeg14=1| AOaK4? literal 0 HcmV?d00001 diff --git a/Covance_UCO3001/browser_profile/Default/Code Cache/js/525f78d1464d97d5_0 b/Covance_UCO3001/browser_profile/Default/Code Cache/js/525f78d1464d97d5_0 new file mode 100644 index 0000000000000000000000000000000000000000..0f6de938742942044c15446f0c9add020e2e555e GIT binary patch literal 36520 zcmWjL1$dKZ7sm0sN!nPGrVYj0v}v0*ZQA1Q?u-rB;qEfr-DSADGX@MD4#RE3VK~Em zID_y1ab3Tw$@@NX&Uv2D$eZS9*llIDj-S5-ODciB^*-F?hYFS|lcQ9bQe{h*E}5%f zzI+ABmd#PRRL&gva^xsmAb0+px$>0Eov&QUJSEGND_uHosZ#k%<;k79V41u*3g*n2 zH%G2~rHqVmIz#B}|BvWqK7OSyVTAFyMhlx4BxLv{4TMqI-~ z)LKGpIEy}esKXV>QzA&4uorjGq-2mrV}Ge2{ew=WgVYaw%LFN;T#z!OU&SCbs2rsJ znEhRl-nR~txlNFE;s`u#gA_n5G(&v5ApL>!INd%-X&r)83`M#JsZXCEjYRo=L3-9d zNCO81X*`AwVyqEC`gt_*A$&}bf~N+_JuOHtux>VE-3U_eJ3)HzG)QmJ@mY{Ipx*N! zO@9%jZ7+j#2qj(xsp{t-eKr}?JlLRf5e98>8?+yfGZ=Iz(xB{_4cdg=Sq!S5)u6-K z3`&VIs29$A3~C)?(B4u8{fV-r4LVZRphp!9vQ#ywNi~ByAXiO;ien!fwG3*D#pqF+ zG0>xdK|eP)sCx^8-gYs_-_@Y8n28GA3>t(F-MQVvpsYO&O2n651~u(X-#!M-#co9R zB{oxj)9Beq#-K zF@d?zcp|Y*Hb_$p8iJKm$r*>H8RYz#xbbc}vCl9lA9mp)y3R2uZmvOv<{PwbfkC+! z8Z-h^;aY4^@-l-muQcf9DuX7hCjNB>6~OfM2A#y-4F+}kh53+uqd{kI9gVjbWZG}g zapXBbTbTZ!%}IlvpC#t223fBeloO3H91F1yQ~x$-)=h(2++xj9_%^ZJF(~rBK_{^9 zfk6!)GtV=FmOM9T*&A~C*Py#dcuQ^G8x)38SO?Qb)((TQ3J+lYWKc$w`AnNH2D$$; zs6Q^_z*qK9kWtGGMjbaAl`+JqAIwJW!w8E}Q*p;?l*?{Z6k3NGRoiJ)Cq%l8^5SQ_ zN5ycXI$#nu;R1F=8g&ugj7Hr+u}nry$AZj8RnKD7a}>;KR1bVaR5qg;V?K6aSazev zL>V>qO*~_b~ZEWG2UZZbK+=0 z&aI7V*2bubZH+pBH+azAD02s+2Ep0Ms038N1+?vA)RC@6W$(#);%YCWp8aIh*xsy7 zAND~%qxuan>bpTk{XK;FhO%#l^V?>GQN7W5lu>QQ81)d|u|^%5WK^EX?3@4lnH-R5 zI&wKeH;Pe8>HmV&?t}&|SddA;q)Ui!Qjo!=} zZXw65My=a!RA47L>>^KG!I(Ylv%SP|g!MYhd{^mv-KbIzhy(qRM^^USCM&y5=Jg2w{Zq2*hnCck6N-y3E8VAMj3NfWImm9d$$94qW5tqC>B>M*Gu zyiSwu<0qF%W3dqh!%fN(VNw7?kSQy-u>*&*o3zbiQZBDa`*9of<4ih=Ch?p{N`gsK z@Cf~jNd?r=O&wTg~#R`}dSF)iY^a1Cwet zG3iiKlQuLn=^$*)O?rx;7Ssugk+G#ovoN`}NlTI5hS=Jfw66nmcBD@yV()BHOc(0f z)uaO5OlpY6{isQQ&J8fB@IaHQqwHXlIt?-D(lC=&4L9j3vWz6IQ6^o%+0oQ<40Db( zDR#U`z6s1T(WDB~OzMY;GfY}CliJRvZg_{Bb4;3tV{p$kY4bdjnk`~(v|DV_0!&+C zQvRhTb;lljMV;j)4a8oAtT4&AikQ|B19ojP=?hM5Cg&}T`5XISD|=y@M z>kRUQ1}nrFEH_GJ3f7>^!P=K4SfjEBD=aElYtSh=SX*%dSv|peid`|m+8!IMk_o}8 zhMB%#Wl0QHO>|8O)+AI71nXvcu%6*U&S07H1ZzoQlnz$uYQcJ0D_Hv*5L1g_*pcCx`)C;nFmwQco=Lw1 ztag6|E9eq+hUIdw#$FAU<65x#;Rw2357sNx|C`$5+l^o?xXBva3fAiT!D{j%So!}8 z)_8?ztT{x#xI^?if-;0C5!>O84AHKP$Q+`M*+SGmIz(fz1zr!gaR}pLLo^Eqk?y4( zwjn$|L<5pS)ZQPW-nf7}IGr4#YdD$`q8A7cgs3R0V?BaWLv#X9P%$k;?=U1iM89HP zju73#AGt%+G;fGL;g5VFdS8G!3WlhDp%5h$4$)slLe!vGh{odpsuvH@a@b0Qs3A_` z9&VLnz6#_}IYg^)9GR+wXdeDXWYrM0!CE{)?rI@whXyr5)CGret#*jMV0Z&+*(^ja zTZL%YkP!Wey`!kf82X^%Sn2`SIAX@7Ng?VtIYiH9gy_Ru@|+i<3G+jga|xC+?#dA5 zUlpRX)gg*m6C&f<5Ka9hM4dL1_irI8y*)(1zteVqh*FLc9}b`6{DlzKKSUeQ=mu-^ zh;{l9qQ#+REpnJOAgfu^@jD)4W_GhyM47eBW7c1o8)H_zSlY&!^#{)5e!N+4@GOCT zKF%eYwE?G-%({**ezR=JX0=K&s|O|r%vyl$sb-Z;GwUq=#?*AP7UKIHW;KB;r&&=r zi7Pmg%dG0T&H5#;S#R^16_=lQ@xFvv-<34WS<0-HxP=U*&H4dsK_Le0dj4yB2 zY}~3qyckr`tb6EIiQ8CK*{t9yW^KhmJVdLiX054a);pB?&a79cQp2p(DE&RTU@hKb z+Ye?{sL4;Ps%_TtI%atqn$-dKP^ghv^dPog zW+nV&R+fIug98Jo#~`y(2b)!6h*^!XX(;`NaU1L59&XmYk!Bf3nU!(0S?OcVYLDLd zfD_}W$9UFbvRR#`uxF-G|LNSvO1y-7rdcsKg$r}csyUaq=9&3_j=eJ9tSt-83R`5> z{AFe(uAq)^tTLkvBMW?k_9E;-$!wy@u)52j-u-l66{ zE?h7=hV2EE<&4qO7?r z8jnl4EqaRvc`RC(-y(Yfi!!4rjuo^hPa%uiqc@C2EP9D5B`s1}iyUZyztFrK^Wq53 zV@G+5##A7mio{UG!ei2+*HwwHnniuTv#7`S7JXmSqHA?58dcY#eK>{psNc|{4fuw+ zjV#L0*rHg>NA{)`J!@uB|K=8@x3H)&uHr*Wiz;@o=v8-%f_e}O1|YpBb^OVq+PI5R zy)AO}v8ZNWi>@PUe`<@z1L!l*qK$(r$~V}eHbX3WjxSg<)S{BZEIN)$_!m8g6VnKb za$*Tyqt!@@PT;3e%!3b@KH8$TV=U?g=UD2A3D`f;qNS6V52w(0GIhqEcr%3>O=S#Z zm}b##9LED}`kA)VE$W1u7(Rm-XIV64wnY=M7J)eyUB*Myo6G%q#DcmDESiU`ix>lY z7F%RkLas|KS_kWLi>l%oMy#+X_ezUOpb;M6U+iCH(P=zEhtHwVWAbT>QqEE5KP^f_ zkH1)l^A?r9Xwlzze2M*nQuoOhEglp16ZYCu*7g~X7YusNi8R`r`_)oU!6Z`B42T);Xm zB+eyP9YV)#)MF>P?Xqh5@2tUYV%@`j!6Izj%h>q5->T~etm=7?*bZ5>3Y899^$h+a z)DhW^k~=QKd5qc|XAMtK$CK>GtL(48t-SGWRTSRCbdz3}Xw~S?#P)^# z`IR<7HZ?cc)D`=UHl0DUV4F^c*fhj!(?lFXNrz3zVK#YOHU-cfchEoFrp*~`+LnoS zc!Xw|ZR(7bsF2OZd)hXw&Tdm|tWE2@Htj%-IGZd9HbtTpA`%%Jz3^L-O$SiWZ`0gl zn^qw!=|p$C-!(Q>SxfEL+cbHzP4lt$H`Wf_x7zdtAv=g| zr%hdU+vMG6)AwkCiu-NKbcR@Zpk8kFVIY`<6|lD2lqRhF2VZVrrB751s@pyBYAzY>A%mc%NLvSX0fYsR=Z-d*|j3O zU6yFO(mi%vz)x{@MJL$x(P!7OWV;*zyRxD{DZ9Gj3JRCDs{#g9w5x4ZyFAtGs)C=e z6sO^;XIB(} zuc+SDuFu`=y4=IAB0cTuj=>1(Wmn4qcJ+j3pk42V*kv4QSD#^ajY9BnyNaVK(nr`; z6tD0Nqen9D7`v_^WvpGTu^La2V;pnf1X_)^Ydbnmv}@*M`oJ>9uH86+@M(5^kGH5g z-L5e+XouftGXE^Q7GVRj%ppHC$KJVi4Vy=v$g#k#E*OYE7BcoCyE3BWVsga9|NmTK z*Df4G(Ph*YM^Sr)UDL4?>sH!z7sXc-2P&^&4opVYwRR<;(K^;Hcj6Y1=$Ee|Paz4RcMcb2%b&9x8 z+jRp|&)C)YtX-SWv9_r8CprIRSL}KA5XxL&-7)y0U8$F-CFWh`{1v-q;LTOm_nKXK zZV>Y=yL`9Ve`tuw_y>9KvJdaE?&y4_m>=nQYlwC@jhIh7 zX0Q*LKiif43-e$Bmj1`%4$trj@n5MIjNhm^Zr~S%>YyQ14~(HIVhU9c{2UyrAI+ia zh^677%8)5k-DA0p+jx%aUVg@fDj_~p&V*1k#55H3aX&Fsv#|nS{fw6!s>N888mhcG zL$y11sE(sRo={E45`4-Rsz>=l^$xWQhH5nm6$;fw{7^VlchI^B=aI2!sJ@|Pu~4nS z+~T1+Un^AgYKQ6{jIR@_E_Fj?s~4)3_|z~|16zh_96q)QRo$+k+KLjrLV4X3suQTx zH&mtjg=!0e2861^&`@m~6{@i5q58ZiRGF7hpQWLyh@rTRh3iB00$uf# z^H8Wl4u|S0HXjXD`ms=*!gt4s=>+vev6G>SITflt=zp4ah(1F-&W7q=EIk*h9Dj!D z5O(}UJm*8T>jG&EgXukW#bNw~svqcw^+@|jZ7>S2QQ}jm?4KDEv+w|K z(c=qo;R4G4$2qJ(m9NwT_YDrYj1INME_^jPR3O-)(YTA6Ar39ad!(5iJSTK0x5c61 zc#2|Hhh`zs=1?BA#UeQE4%Ndh(D=_7U$4e+(%NpL-jEnQxhE8j=L!Cb0{W}*s%!R zk{l}Ocjyt`;dU}{rZOhXX%3Z3cjz;!=U|SU4lT>&P{%wDeL|(Y+|KV%vjVg)=+M4G z4y6=!XdI>&aVWf~L$8ZDWH0W}1(-@WR2TV5G8Vd)a_ColL|Pe#-eOl-hkh#O&=X`T zPfjpaU|#$OTSbR*p(lo6V`Yb~<5E?Jf~q+bkA`TAqu5u2b-_nCe_))N4wb0oP*qI8 zQFN(Ied{>125sv)w6LB-Md~}W0Wl36s?gA(lZa{L&`4~=y~YkjG<9e%dNt!bHa2H{ zS~%3aCGoW;H|#-%w#XBpmZ{VaM`uu%nGQ98 zX_iBqVVLbu;W_Ma;zv2ZatEph0_r4BV-Mm)>e6Du5YuVT*C z4s}@L&}Hmj>yUT7L+Oawz#fO|7xq7%A%3GnLva*gzp{t$<0gj+Zl=y#96IqEF>NDe zn0HWjblpi^cM-$y)Ot6u?{TQrKGy#rkBg(kkEO>Qs(p&RgAJ!yiwh3Lq7s5G5)XdI znM<_0%wy*|bN)@-D0jobd#ny6U=GgV2G-r8zIcv2x7jl|i>eQ(3G|S89x)Gso;Xw# z`JXY@b87K|J@V3_yssP@_%Hvzyk)<r$$6LH6epjlOmlOn9->_nVjmC*{Rw18-=qt)e<}L z1e3BlwGXFY%jV?uf>U2$&F<6&boMx<7^n9CUy@TN{Z7?RcFL6M0p)Tu+ooO;&Usn2NM z&Z&;=oodp-snCv2)x=aB>g3eH?#zw0J)Js&IzKsO?@gY4n7=Q1^>b>-0H-{I$Z0VB z@DUS-IF&q%8jf(P_eiIH7|mQLG|s8K<2g3LsVoznJbs*7iLgmdrQ!T!r)o`c>JgSq zb?V<~#6I1rZZn)(KGUgcvz)q(p0l00K9_jsIpv%0RO|w$epyJIi=FDR$*G{Nw)nCMV&8cBGoH`vHrrL>NN^BUWJjm1|Oz{|sE!YoFPuie4qI-oY1s5>t zr!f7D=DowT5?%X*X&_?yhA9=pVeA(s7jpIwQ!8{ww*g_=h~4NsFiibXdl2KmIE41- zgvP_eG-+g*-l5*8Fufcdrofmm6~yduVftlanAT3>_|!0+o))I1Gs4t*W|;n%6{gj5 z!n74d=7#C%{4ix-5GFrb;V{A%G1sy%Re^bVn9^5;sTsCo-|8@(f_W`-uMg9q4PolC zDNHx<>$Wg$*v|P~VY;^`Oy&25>Bzw_T|N}1^@qds;6#{yJQt?>7pcXyFx9;sru+}X zRO@+|Ui?e0AHp>Lzc9@Sa%m;58eKd`cFEy%DJ#Z>xm4ce(k8rzDcr?1EiNrbqX?I# z;$b$I-ePo&OG{Ba)}?t!^SU$^?=e5lrHt_|WlC^qJlgqO`q}SNo@AGN>CBzarOo*{ zUcja6*i+D@_@XYQRC1|%WtWOnb*aX8E|vblrJgli`cTWIUuwG)TZdTdx>T-#i`U>T z4QxWcrY=2g#@sDj^0sv8T`QMXw07wUO0;unAHJbrdve1@+(c3bmxkje{_W^eP$!oH zU0v$k!=+L^U5e@DQq`YadV^njyYyclmvRquY3LA_&JT0xHr9-ADR~q>$CAT1m)eeZ z$uPmC`x9NNHOZxBlNo0!c};UEV!BIh;GW@9y_qiMnC((4bjMnx&8Ht;W8?xCpF@+! zF6x9Q`2Kh5vD>A|ID?cuE)~EC6x++OL#)?fms(&Aw&9;YTjDbH<#|A+G)uyY=mn0BQ!HdgqC4w&Iskn9ijYrB2=b&glb?@jR<|J8KHW$_=(PSBGjW^gc{Y4 zP__mUay5<6&1MnW-#kJOTSjPgs|Y2vp>5j;Wp5uLKhB|3hX~z6bjJuyz#O#i5y760 z(4)Z-x-yz^rbMXK^awp)AEEghBJ{^E5qg2B%@KOKB|<-MjnHe<+#aFL2-^{%AFu@_ zcSh(gJi8+_6)pBe$ha>;^H6SogvR08LE=3`Zn%K-KO)o(Q;#q%Y9EczadbHup*N=( z^K^s`o{!L>i^O>;LIbZx=qN(3MX2!g2(9{?7;i>s$lVBq{1c(+kBI4Ug!Cjrjh{zo z7EWN|3+}&+(DiTRitprBWRP1EFbBsBZgn-f^{2_Llwh}RBU^}Dz0GcYhRfpCB^a!3 zg<&(M+uVxH;MQDp$mrHaw9MjGovdzcLxyZ_jlvluW_Rlu)$ zUblwCBY}7l-Fl7fNp5BKyVV6ZlHDqt;#PrFw+7%3M5MXZ5ZlrjKZjd6bGr2kHFCMN z05=iH&6v1=!g<|VhC2n^8dT7&q(Yp-1^5fQRj`O#gArNGt;d*9!mZ%aZoMl*K4sm! z264+>&aE+cjoRgz8zU;X^#Td=EUF9 ztAp!fpr<1NlCb8E#0+HYjM9UOykr(2DGXAj^dD(-e`E$$)D9=E0<|6aGsV*WmI zJji*hJmgmMKiF>=bIh$=$K7i7*{wy$nkj?Ip*M18&cO54462hQgXZMOpy;|8G_z#} zUBI^k8T9x?2F-exLBHW8{6UfW%^s<3&PYvjMd}6G#6@ZaUKfwl$&!&uDHo~qDv_G~ zeWdEvjZ{Z;8y%_dCPXUtv`872Me;f$lJ_(t)q78*MjeXOCcH<_3y})H9;qjfB9-NF zq?$g7)H3YA5#)Fgsm>)cYD)i%sxdsH%8bpZ*^@Ks5Uf)&at&QZ9bKML$+t4<0&2g> zs5PH6>LGS#%Ea|-nKUm;CS|FgNo^ZtQgpjay5A|2M)l03j)O93{gF&Ep3bD;ubDK{ zkXe1anR%U`S>MNH))MS3m|1_6%&ctXGOHtsugJ{%x0(69l3DdLWzor`EIeki=uy5b z8c{xrX4lIiPv0!c{wj;YduEquZFUvfkX@^eX4lta*|~-yO5fv`f>Fvi zDn=>3Qj|8JZ{;Z6K(4BcjfSZDeU$2>a4p8iE4*wTrBZF9)TdLF3UrUsB3wmek0>Q# z0lM^zQjOkG8ipzOf>wQq8!>&Ov=KG?Md>(3_m5J&L7c~697oY%QOYwsN~t5FR0wa- zXe7Cz{pcw5#!j>z6Qv&5f-7UA^Z+x*Md|wZC`C+)(m33~3(S}trMFW#J}ruCl%lj5 zp+8d_EW&*RrbnqImg66+o7SCm^P;VZwA@h8W zA+R(`)0ahQDRM85QrQ*65A!P44v*GG=^YZ*a~?Y|``0Lq*-S2Yhp69J|Lsw#gO)gk z3cI7UWN(ya?W5oRD4juv1FY>q>V(FJqSWR{lzQUJu_#5Ki_#DH5$93*LX@&zV_#qb zj$+vLDD6hp8&R5%O;~@Ed~o}Als?>vQigxnD=7aUiffdjwEZ!CoJDcR>98E8rvmWvE8E8s(Z9f^@x_E7h|AV?`T!%6Rl6!*DqQ(`bX<2 zz6^}km_gC9433s*c(m-JqLn^6n$NSMHFQd}ULtI2w6f2ORvxs(031NZ`Oyk2W-c6D z60ID|qWMfIS|f1;pYeKqw1T%rYxwqPojgu{e@1f+TC`T8=+$V=zZtE(FQYZj>(Li@ z<2_2p1*9c5;Lv zhwCXkO0DD3rpYhLQp%8mLq$6k9uM%K45VNkA8uzqeo>h9k=it z)jJU%&LE_-M`N+Li$^yxwJWtixo#fqL6hztb;J=|z=9qgJwn}H)Z!dd%=>GycIJ zvlx3eF=O2vazLHA%r(!W&htGATj0@sY+cB@B6YDxu}f%!E3hv0XfP@*_vj@ytnla) zMz1CAb<}T@N43xzQ?U>i(R4H8<0`&x@hIbO9(BS<__lgf7P+^1RCzmX(R+tSt8o{( zcTzJP-{n!&-#u!E(Kz5!){_yB8c#n8= z0LPCq4#JPI255!1D0`f7POt}X_at>a?NROX9_6^;(NSE*_)8wmM%gRme3gBRUoqzv zx!t3V|FBmcc+>_dkIC%`j|q&!UX*?6;o2^b#=N4}{6MY0 z#OTMbG3ta%-(oaRv07q?)kfqt#p*C_hsG*4ELL43V)YOFo>(e(Pxt9nLtY9^uudNU!$BdU>7h)dh^s>D4S0 z$wgdvn%k>(dA#}wP4jv+CZAVV@c>&2dbJ;|i!)aVuijy0Nv}+$yo$hB+(U!XUY&)j zjF)TXy=sZ$_z$(qdNmo(%6auyd9Q9EQw6W4pg9;73T8+3y z)UUBu>zjD>@JFvkH1#T9Giuh{tKP`jg5y}w(yMQ+ygJd^t5$8iGPLz7e+TN^kytxZ zldj~@opF13HEe)a83uaQW~7(bT=W~|)zHz@2j$0jRTKR&a;#TD6TGTCg>^%TsniwL zg4N(XLS(--U?N&E|1jPY@?ZhdA~`oC6H^#~EYn+;Fic_u4 zjE9l`w>3^l+v2ovN1U$hjML;@)Ol~5GVhC1tD|umfpaK*EKbL<`*@t5-~-y6AQt?A zX(!|K4%1J?DeN@k;THOyp+Ab9B`3_lQ&`T$DeqsL$1)5&PkVgC#*1;fgNRGai{AJf zkFn-zobI9I^*9A?P=B<;usd$(HF)=@j;~IrHHGM(eFUcDj-!b3E zIJN#1r=I`C=@=R*Uj5+=idTKK#xYbi#H#@c8sl{yYfbTbkKo{V4aLL|?&BwOygFOr zC2PF?!M_+}i`Nu;ycWO`8n5mcg5fTX!xbK{3lZ_UkDBgyHA9Px@mwPsuP&M6H5jk( z4KZ2cbrRQ6H5)Nu8NSONuOD#^H?bxvUfb{}I$n)E@oJAHC>Rs3pRp7hz46+O;JA3r zL3%u6;~{=dU|dA{;uVK!c!b{)4))Uj-con#?jg8Jd|XvP|wppKZ23n(=! zL4%Qdc7jUd7<_XR6g4k_?N z*imGEf~I5Wp#<$i_rr{V#6O51uh8=-G2`0t1fD-9XaX)E{$zrtAo^5-h9l$o1eL`Q zY{6q>y^z3X?+NOQEeOAqpqqG#_{#~pcO^lKt|q9#HRijXpi9VeBSF@i3HtM4f`^lYcmU&>9~``t-vnpZ1OM=@aUV^C@k-Pld4+#V7dm2ID9C^aY(K`IL2v zPnDpX-(v+% z<0C?T^QjnyVG4{}eX5Ra_yX%TZX?@v>UF}W<)?kxgyb_mZNT}nKAs!Wb9MKCML6D?T;DWMsSQ(__@QMqN?;I_ra|zkTY3*c(2r!zFaTNeyrL zbP^%A8TSrrjL(>LmzZ!0QTK@XfsgMK_|)XFPY<8^bn_W?c}|U9`PA*5k87=cx{SP^ z=nuTOoeWlL07q-IZ4 z-{?ebM|)4A`XMMLQH^60HQSr0m3WIYzC`UyVmyDMY(*1Q28)Z)t~mWL11n1<>Nbj% zNtC^8qB7$rT*Q-#iSk!U)O9>Xx5|uJB~i<&CTbJLRww2fiJFOJxLT8#YbEj>mqb;s zpU7u>iTbAj_Zuc^A^yd-Mv3avBvHFtF<b#A^8QMqmUc{3=}w7qbxzcL z4D6Grz#!&Ai@}M?G&E6NFn1W^jZf6gUlLVubE0;l)|NzlJ)X!lkcoPMZ&-RVQ9qnb z)DAQ_Pkm73LZTW%7ZcSB*{_l(60bAI{Y34@sfn zlJa2$4&odt-Am&6Mv^+-Ptptghv5&BwD)0>7C%YSO{6|eQg^IHhi6Hehkp_OJV{Y6 zlJpAEFOxL*b&`VKB&jS;A>+SEYJ!zGj*sa4jyT^Zab0kdUL*I1BtA<{(s@+-l%%Oh z_{{yUNh&PA{zPz)pYN{tbsC!ue%*z~=vQrw#wlbr`Bfi_aTDReew9QQEW;I8Li{R- zZdi_saG3onhK^W((=b{5DvZupjtdB}`c)MDuolt^lKsxqEivS zMj%&Fzg{3iG2$rhSH=>4buZ~xVky7!pnX}tR-<7#zdGPGs#hTXiqxu#U)PXUof_7l zmOuE_t|s}`rgn9xQ9Zxb)%WX71Nt{+%ocw2Z|T?c4u09Y`qdJbyZbf2hhI-opeO6l z%dfxspdYmyKNVIejrD8LM8-nPNyI#v+E1YlGpP40zlLG&96#U5_v`9>zveAu zeHQtZw1ga2`Bi9*UuRHitzS>p`FXCxI-=hOznmLcyI=ikgOb~r2f4P>7Dth=le+Bo zYxpI<9^dk-;sg4l&_ll}A?%S~QKgnjbNukW9;r(Vzp@h_?WE5Gu-W?Y>zav1OY{{yZJz2|8(v!^pr^&h; zldJ}@$?5`&H(8OWhGqB*B@&WV$(PLg8_5dIovgNblI6=woM?gy`I6PYFma({kz@^k zv1qb>ES9W5@njXkHhens_@| zmG6_|1J(-V9}@$9!JQ|`%J(!`8=ogD`bDx*5c@e<;a|9qY~PaA8Q!22{Rp=qMRD*L zQMUku!t00MT$E`U9cUOP&q@2CZk+rik9Li-ar{sQ~(1o4qs6@ zQ;NQ!a^@7(!`Lh-`WuxJQd9>AaMhQh$EcT>qSp8`DMhuCQxuVsqSt5_U>6^Dw+XiXsc8sD0rS{f3rBQdFcUW1@1g6y1cgc#68?BU+ZAewbG>MgNsb zQL)m*SvH0L>r&LPVv3&OZDnd!B}HZGQ+K>X(*`Lzhr7trFhy0+tPwSby)pSTNzuxt zDGF+qB3t_uJw?3^DJtD1MMIFME92of61%4;Ll5dQBt`S_X=sXW4<~qLaHgzlZbKxR>)Nw~zDt zQ`F=@iaH)m(ONVVakx)Fh5H7y z2HE-rbYXBn&ro7$KtBv)UX&gl&Opj>Vm+xE7?Y|(v8gJL_Q>Z=)eX!|NYxdL_oZqc>L;eEMgCN6$6=H&kgA^$U4(HF zRy0)}EQg_ZD!-Rf^{jHL604+Ycva%7ma6KQ*fdoqF{oLpCLywUs=BpE)y|fwTpygO z^{@?0)n1&0c~GiW;_B#BWf+sHu47XbH7-@j7&13iyO4Q)sxIITvMor}&x=!)X-TSv zuHZN(u1eM4t5dalO{(sq#5(GLkI1t=Rg17|TPn|0s0WV2y(3jk@pfmbX6+)*-&55C zzas1IR8`rNs<9}#H&s>f7jo=R)pa~Z`2*DRNUFx2NYyd)KS?bSaVk}vPZQ^vRQWL! zp1)Gn1-ULU?zL2n#NF$x-3{7f{aw}zW$ve{_&>D4s^_WN`d_MEqUtwt0e>w?;X!HY zfK*eOI)|reJ${TxQx{}#r)ex6;B3Y;IWwhcKhB|N<}^LQt>PV`*A3@R|UL530FFQb1+?x!qYV^W4d0VS>|-z&62MC zS<_VpFOWMsKcmt$+>bhHKZkbpHNQx<(>b<8-NCx@x02oc+^P zZ2;pAOxL&}>1s4IT^*4$EM5Dj692SxEk&!J(=~Kfx@yi&R|{mCldk&n($#lax+Y@A z`gHaFC0!$sV`KXNYPt_7r>ZaB<3DwCcQ=umq}~!03Ulz>Vd(i>@(?Wzlk+{OiB;Zcf_Q_2_`j*nq*Bj>1S-h z7fnoZHZv)L*4TwL%}u(|(xh>zCQV3Vj8-NU!d4V$ZIXfcZHTXvNmDQ%jXG18F67e9 z#P2{R%^hgs^Iyh9=ke5V0%M@bL}Hv};#^FVl8|k-NiWh(+CR^vGZ;VLq^FCh_xC29 z!hpplmHWY@C&;qY#B~wWV5Ld9)|lkpO*=e6yS?OuTgRxyNt52<$5ST7{xNCadFp$~ zq>rAO)B#_k>@$--dv4OP7be|%ZPNX>)Cf!8k%P?oFoRjmvY7Q*A+uT+HnXOMneQvi ztYu-=s-k9HC~lUmlv$II4x_YLW6GFW%gM|&hGxD`Fl#;aT{Nn z%$jR9D_qm8|J60?ro*iM4d~x%)@fYFWS?12{bpqjm{kb<(cUoY+mKl|&>~`1mIO0v z;ISPaCYse0d!uHZNoMRO@pLd$YdlVAg%S!P1WO z-HE=tm{q+yW8qB?vu5`)v%a@k9lkPiy%9A*7ZmMFp8d=!Fo1rB&=1~V=}@yO{f~CT z&AKznthCW)bwc4WBrfS&x4*OFx^{ag|xef8p5G^u5Nc$U63| zH*3Tuv(Eo%X1y}%zRj%o?Phh~!TjuG&UTwsd>?bTpFR&VzlY7Lc*LyGF=}<398Qwc zDe^sSR(bpl&l$7&oHgskIkO&IH0$^4X63tKRvV<_AWp-5ljm50_*-W6z#%wpn{@(D zuMD2palwrC+zs#w$s=TNSiMUyeGrbXissAW+z>_y%>77fCKf}exLi;0aadJcEUq64^&En$l~M=bg_-lA)mlW0+as6{cX zMdl=8!6kT-Evnwcq8-TA%%Wg(jzNhQ)By!rl5dJd+gn+5w6#U+KO@ez77h8*qGBDW zQ%4Ke^pHQ2J6rS({zI^fMYk}wD}8mh$bnP%wueRY;qFNeUs?3JpGAH9TQqa9Mcs!` zKm3dnC_dDpYX76w=!I&-snZOL?jhq$i#|s;972Ox#Qz=rA@6L9zMf;zFDNqCqVMr5 zhODlwl>h2!KCYqYy?P2^G!CG^{d#JI;n;`=sQjRw+F%ZjBIm<;YKY!gf!iqmsGd?W z4F{3waXr;XcPzmr6nRolNif%|FI)ZkYVN47)X(ax#P0ffRL!c2)vc_tW7TY&N9h_? zwMIHlqmap}j@X1eW~);0Gcs7LieMN{pq61}ZDFfE4O&$j8&RaORZnp;*{V)Wt$LQm zwl-F|zp%>prB%aGw}VxF+{WCFR-M84PK*y%XRDs0P8X|g;sw@qwJLuv#zw~8Ru#ZZ zJo(D1)n8k+^INMjjkWTfkyX3Uc$`%~j<>4a1gowrwyNY3tNQ(5RnMhX4Z%)S`O&I* zzgb!PgRy?cMq!P_%deSX%eOQ?I!s!uLhS-Zok zfw!n5y4<#M&Ye}6?=Uxat$fdG)hW!pXVvaUR`q#oRpBRAjYX-aRyBKW<=QN2_`<5` zubHb1HVuR&qm3o^ZSrKYsYhm;Ugxr@PHvl~6Y5H%BJD1ZE}8QQyBem1OCr# zTHDs9#CA3{Yj4wJ-22j|6&-BafQ$HFC-OwGE;ilA8KAGPVy zG4`FL9bWun)6CO0zAvfpv+1wPHhp@V8eksA-lcZ;nCIsU5^kSuq%&Y*G~y{-9~z%T`N&5YS*MByILeOZd+o2^$WYM;Sn0Q zxAQxTo$KA~D%-`b;a}O+{A;^jqd{N0ZVa}wRy5;`u+7-JdU$ralu3ZCA<3HlUPL#cG*F_Y1XIBzfZB&IZ7cVn7v?QZLm9sk39>udc zR0Y2vPYwsm!Z~ysd2>2+E}uhB3OZDykV9h&J5;ZTL+&aL4MnZ04tcN-6{T^*`~2+Z9a>WZ@6 z9kSpz6zoY3c#I~!9GX7dp<@{NjYBiw9^ueGQ#pQyLm6hXZJtA$7dZ3=s}?%61-?ZN zt_5L?#SZm49YK{V=Pc9J3qh=$wXXpWaaK z<~7vx1r1egQA2Gh=~UBFPW@Nf$$b!g}yDF8jS`iP8DrK-^kh4sbaW<)t#Km+S#ehU1*CZ$kLT@ zP^z0#smRyesnXa1YY!*C6FSwlpHmyKqQ8^BbDVr{@059%Q*pR7lD4CqI)cmiakP`4 zF;2A}>(n3Ehuh*Q}+r#{=~R1Zws?^Ml;PL0IC%T8@Xmn%*ULbt0!16x*? z4E%zI*<6|jQ+Ah9&=a$8qL@oZOLE-DE_Fq&QZAK3=)KY|-NokeF8z!63NAgZ=u)Rj zE=|Tk_$#|~43F@!iS2lYOJ@41>EeC_E)BxUdW?gN^hijOI>^}eG+iV3`denpW{k1mcKcvkjMvPkI(lnI%h4Ikh zH<#*faEY5VDK{?ccj??g+8lDJ34X%Ihh19sw@ZJa^AVSZVD)=PiT4=&o+C%RMZWVc zS>Lu!)P{pk}Ro&VEQ#H3jXj|Q_Z}CwLw<;jvJ(F7xu*Txn#F}oc z$B|lYovq{6xw>u@sOMHTn_Fej9vL09N8EdHZkq;wq}Qaw`efvGQ}bPN89Ywo@H0;nqXs?CDln zSaA@~@Uo9vrTdZ(#$zpB45E)=ZoP$b4C5j&-p%@sZq1(W)>1q}k#%l0-r-gc+&JJ? zo`b}4gjjG4_fYgGj!{qKJ3(!+5NmP%y_0SYI_1`hf82Tv?|HX6Vi?w5aqBehT&JEl z-0E`It*MCKcWWS8J#lLUY|oh^lzl^-C@zn@sFK~I1bp#GtPYP%xZcpC{7#Q{`8~RiViAuTVkWlXNrFek z6FusQxu~D)Q5t^5CFF1BQC(ba;Zd%Z9xX`oXg4N)=HZ@99+^9M)D#&zdsGz%dw7(+ zk4F}i9ORK3{|)h|$WXR_<56`S9_i5wSikkC6@J5Ilo;=k3*TV}rcCni|5sv|?2!!} zrZO(_O`|O;%St~bR5=~!opq^E#XxN9WfTGa0E|Lu%uUZw8Q|+#_u={ zKKxci#G@BxVjJ$DO%<=kqiJ=ohT=snugcZ-Do;JH>fwRItKxB9b@qF8CE!(upjX~R zuexGd3$H#%@oI9aS0AT&wWO6-37>hDxs6xVv9yzyzeBuQ-PJ2+cQ4mJdbRH>ukNGm z*IxC(!uR@k#ryByMJGoX4gutd-~Eb4m7Np5fCkIP+f6r~Zw6$`z(oPx-t1bh?+18(I3)34^foy{~-Sqrj(ic-7aZ&i#E{Tkli7 z0Y1g!Z#*01Q;xwt?fRcjr%-sfPc<+CXHe%GpSq9m=_lMB=~K(mJ`Kf2^!t{_u|C$c z@M-;cpL$I3sr3x@UgZoby~>2MLs!x z@Ue!jPo*SLZIw@xF=aK!uJNhbI-jEGhoiswwCQ)BE~Cjt zpGIQGW@?2@TYM^xnrMV;+v$4;&v615b`tk4;=uy!e{VPQyT`}%*FHT&j{QD$K>Gte z^~SJ+K3zfM!#>@|@V|UohI@F8Cr5nReAK7G$H?(GZBF6JkWEr^JGm7>|6p;ZqViVK^3`%}bv~Vef0= z$m&-kG=nRfUvG2yWt8`;DSBd7MZZ3;Jd*I^8->Q~une%Y$C4{K`pwHINN zUvtcUZL#=u1G#JY^$W_^_A3eh)%B}-eZTfN{0hX;H*TS%)30J4KlerS>!X05wI}_o z{o>ck#(r(WuOYvxMf~cB_4q!)uUMjAA4L7Cj1}068)%*6S1%kym1M@j7dU{M$lip0 zQKqS1aY)5kyg;dDe)%w`xnCR6s0D2?4r_6uCI3z(UtGoFm|r{KN%N}}MqmZD;(lxD z@VTFB-TX4OVSL;`+jf54M&&R3YJr{T(4Ls^<(Ga{?BLg%UViS4im&|IjRs%)HToOB z_K)&w$~` zHlUl`1A2-@JpwA+GoV=SfIj&uplAI8%G^JoJBSPj=*7T*+6)S)>5zb~4GriKiu^C2 zF*t)yhX>Rdm(lW@fHoulh=7`75uU<1GN9qujg(OVoxn$<1Dc1QkY!vzA0jk9z-R3N z))owKzsP|8#26SLmKugyL)c4nbMxgelfc`~jbAapr0?M`}pgP+E@?be~ zY$s>bMHg(tacD00de!=Mj z0rfZ-(E6hRy*o~wE(Y`#KVD)UQ1>$RK+Y=x^}|I}yUKo)`!~Qf;netAK!flfYFrO+ z4L*J2^BV!p$7eTbdn=$_D0G`T-V3PrWA;4>=sHrK5;tz4(=+Ogyw3ybiv9Tg1%14v zf26%4X4qeoANJzMH^lgs*CEQj3uqwLV}uNq$Y5|?tDzei4eiQg@cpHs@+g|c&{+JI z)llzjhE`)=c0=`Y7+QclISqYqyxWoRC9hL%(|`0mT#yDme4dWJr$Z)gYBdkj89Apd}&t~iLQ zhN1Dei%`(e3gl{Js51^>RbxY@5V1!LHIFy+2#pdAr9=&#f+xw~?@2=ik_{!`0e)y| z$lA={a|y<6PM`S9R6m3QRNNi2a`0_JD_UYvm`D7Ls_hM>qxzSI{y_H*)B*WB5)(3YVm$oV*-*HP zp;_316I~5`+>N=x31sMDs4-^2($i4MUWV2oV{b!+5yVNj2N{}-;e!obLV^DgD=gno z^U;Q$VeuH|q{mAoWypC~nIkEo4 z++p8JLp^@x^|*?BF!C2e$IyPYq2uVahWS}X-PZH|_>KB+FjVAsL!&m4+aHXHZhsoA z{YcC>hU-Y&OdQ*Ze}|#II}MG%z+Hwa@8SK0C3~5#eT;+i`weA1VCY+9K4@srVdBT{ zM|uC^gX7HeN#Z-z=sEnTml~y6By_JHhTREsbI8i02hE;?5 z8>gxT)uKjFBXJlzOhN7&LtpqA_mHn_^ZZ)OwV4Fg7}3 zIG&Dh618bw8x??4-ph)AO8euqg;T7tI7#F|dEv(@n_c;k_4ep>)gnA+! zr}1HYP!Wv9E@Vgu%7z~J0q0O4F(?lPU>)wFY&58*7>8|mjH*fWjk!32Y{@}6&;#G& z0*W^YstLwpCtkqRlv-dOjv{xnpaK|%4S0m=&4Zkm7}Rpy#3wDN7bai_p2E~J$a#y@ z6jxC;C8$))z!Bt14a$u^_zBlgDn>t;f~oLsBfH8|^|W|3ygu;3m4Z59z>{A-;zWX>-?*I`j-_LI030VDf;F7NX+7kiHod z(zwAPo%|*w$GDL4j}NIWdSDGoPY7uWb|Le`kbcE(geHZwY;s70r_dgM;|-3_2+1@v zq@J@w`UP#~gwzW!(KMZQ^Fm795YlXfe-9~!t8i`#slp#2{kJEis(XnO_t1M^NJsXE zG~z%=Q*jE<4~10cFnQty2LBb(*}p@Yc!XLU56OxdCqjyz45=07onoASLiz*6P7@E- zp9!hSIdVbki^PNHm#D*K;z6A&%Gtw8tQc12N@4Du8rEvGtr}Kuyh5|;VV%K!{I5n>+3SVn z!wcl7AJzoiv4*)uDy#?Yuxfb1x{QbD;|=S$FRV@eu=b%`AgltRu;P&^9M*@Jg{P6Q zuEx^_4HCloEjcV#yRfEpp-;5>I;^!A(>JUG{dgP@X1%nqZX@r&unwW}Alkz;IIJsp zguX+nsS0TPllEIa#)S<7J06OH5Cu8hPCA1FzXhDwGypwhSeP)(d-e` z&mB>PJQ1zT8_|Y*5smyXqVzHm#VSYiph`qnt44IZT1306N3_Tk(R6b}<1G>0t{u_e zbt2kPH=>R8=(B!A#cdJY#8x|fIU{Q5j_8&rqPM3M9IiLD54@r$E(2+4H^>B6g_@^Ma4knfdl0@E(ehgnHN8#V_ab_S)%PRZZ!x04gNPPCWZXv)jebsB^m`G}8032y zQRi0?6@ATPhIlPUEMvU7;4u<1$LkF~$P&-_v+WM=Ew_O3))5$ef@;SrRlTdxAz4Owe_>3MVMB zNP;HeI!YByP_tqQx{rdz6IjbXL4TD_(0P1OCP8h>CFmedf0Ce&+OfS0eRWOHMm+15 zp!{DasNApwhdR#dlJz zO^E93w5Tdhk4iJ5YJ!t!^<7k+g;8Z#6xD;}^t&;td-!`(R6YNQY6M zVysgU)0gg;>LA(3OEG1X~7TPQ82(HP!0rc>D2FUCDAVp@+~7%(8F;sax9j$DIc zDuL6e_)SdhP;^90m2ePQM#a<`qsNd79OGi@kLu%NibL)RG4AyjQ(tVK98+*gjB7Ju zI)m-$F=dz+<9^{W?LfczF-=$yV=iMlvXJ~1aSV>)yYFLavLdFb@c$H3Q+&EIrmSmY zs`Xop``=NoJu!8{V)VGfamCYAuS}Yb*wR$lp2puEX-a96rZ3v2>3bxPO4Emx-l_L_DN}KgGoroHPoG)CNH+4)s!@TCr(qv zscG7SduTQ-O+#@Ew&`iy=P*sna2%IWXhxcvqAj+e(#$kjXR!@?W~Xsa*))}$i}`6< zj=T%fbQgmcrs)+nEJ{<6#c4W&R!h>6aHZ^j^@ceI_8A$g;(NGrSKe^j bBK}6BYAsD#RML7n_y2E~>HjzQe~&McKxx?pl<;o`*$ z7AxW|R=P}?!ljB8DO##b;o_NvOBK&5npL<^vErqZOBE_rs!*BIr3#iRQZ%!4sp7>; zXBI4GB*v+nw(0+i^}qjCF5mwDj|2JtVl*xzUBtbzQn7N*A*$Kq=zu69+Cxb>}D#~>>s6Re-;p?sjUFbiY??)Kad!#`x#xNHe zj3w9c25Evp1F>`>HRIqUgB*X5H{MSs_bCPy!46zPrx^x?%`_-wwn3}r7*uesK|?VS z&iMw#E;1<3QiEEsAEQ> za(Nr|v&pEv7-}|ZB5qrZa$1cFL<^fyH62E^M}X6)Q2c=pDDP)fTa3d7T*Qt5qb?yd zmr>V|k=v-rn3Kn-=Xs4Pp3kVR_=Lb8jB0?{*nz?MjT#YXRKEg7-9-H$qt3t*V$|tS zqb7v09j+*&M#UJ_Ii9bRjJoSG>W15>yvat*Ds0qiTrXnO+u}wgq!=|I)u@K)Mx8=j z38P+NXi1}1<318HjT(&^=#xc`*+$($P-*rdu#8c=aHlLiC}&hAs-SLpqwe943P!E3 zXyoUiQNxf}*{GNwjjD_~xLeJrazAklj{Iy?ry552)ii1zj^Gk%{$kYhT1G9wT`a6^ z)W7*Cd}EC+FBUZxTR5JTN$+9jel>{@()HCKN>aH?5R>do?470R!`k?cWskjJFg~oVlXR@d26!BDcny1F0MY^YUAtS?6hf8|u z&vKqJm-kd>Z2rkpYZ`m%0DPKw>M6!H_0)XiYUZhF7~jHE3z5{)Qx#f!YHwR&wd45q zo{H_@so;*}+{sh*I(w=?Z*uD6snmX+s*1~lJ+*9zr?wCC)D@f=PTY~63K{LGjk7p* zo~K&R_tc~Xo+`S~Q(dqd%T{@6#|BS*!SRirioWKl?l(Mj+Uli3HZOTQyp)yOOMCNr zX={j=G9$cHIo?Y*lDu@$?Iq7bURscfY%gV3@zTp0UfNgJOGBD^>1H=Co$l$S#Qt7# z4Pe_K#?JCm%t9}%Uhkz5d%RTZn3v9<^-}BeUh=r?rRDd$)bNFuihlLdXnAX-$y;l4 zcxy*4x4d8_w$a$4%GqRYIMxZGR8E4(#vt+(25WS&30 zmA%zlUOT^2 z%%nrOfP3L4y}`2xj*nztlu2uFD%zxL_!481PpnDJ<4o#`@$n|j!PW$mN++6h2LEDW zl1X#%lgp%raJo$j#0gx%;bfDl7Bp#XVUyk!F)6GldE!G!lYY!J$&qE!Qrtw&Y?FS* z=&~kF$IWu&hyLYFx{J;g_!?f7OxlbCc!=heON}al0$|bT=vDHd$@%^j+->> zBx`z#IZvBZ@+`HUH!1sqNxLr5+rQb5q$?(E`-eVVW9_eV4k6DC)(7>`0~@gRrb!3U z;TC;I#k=$k)_WX}$=HkcsD7WEp-0S(bhN-YJi`x9pF>6>Yv-aX7KA=uLv)14{X4W?=X9KfB zFdO+Bnf0u(S$&$AmDJR%2Dplk&CDv_)~r`u%<||;F6fJ-ZuI9jvuffFhV?MZ+0(4* zz0A6Xe0}H{9`|KTKeN{LH>=11vsw-`>p3z9n{^DA@fO{NkjqfB+*p9uX#Trd$MM@R z;^QMG4>zmT2(!AwG19DkW6fGPj`%o<2IE=33G`wj^-VHs7mncpTK-|y1~iy#R(ssQ zkSS(OK*Ut~k0tmr&8&gb%^Hi9h@WBB-*|}HGsz3_v&<@v$@mEG*=99HtvP1R!U{O& z(uaA>hu!ndGAtm6g=VdSWwBY6Q3ua3bctC7mzq@)_3;32v2U4Kr|<-Amy^>9vjSE! z_ZqXxpb1`M#zxNHO~l_q-P_D6x}9}}afex@jrRZK!vW^}uJ0KV??j zS=Qm4S&8U+o^`rlR`w;c{>9_VoJYvIM?cW?F?m1X9DK@}KjZm<{?B^(P_+%uxJGiqf(?r#yE~g0{+A=g)LfC#G>^$g*rto@-9Zs7=cr%7UfK{ zCB*EgFsK*oWdfng04SVboOV9dR4cmNKN8nCT^hpFZ8*VMH6c?XC3CmX4I=|k-45ld2qZDaT{AS zrMX25u@}`^STwdZb+w_cw$z30?JT;4JILSOqGBB^Dvie|-qE7qzVx@BMJfF)att62 zPU12847A8J!lET8Jj$Xym_6E}^O!WoqFv)Gnmmp5!XErQ-J+&5E$ThXqSu%++oCn- zH;46`OMVM1I*4{#=)-nu+F{Y+o%DVedG6*s!91+n!#Q-7bK+kM7p^P{#0PlZU~O($ zwDC51!uKAz+^4S(Ec*L@9$NIrBkFr>QU9l$o6jtYLyi~JiRrH`I`f8e^PNTYKeDbc zezIuzXV&5i=g~LLMGqe}G5Dwx_8EP28jZbtbi&(515G{}i-X9t`zY4eM?p>>#iI*u zqmQ4DHsuo<`e+-fh55)F;iCXFhkq2Y z(H(zA`)EIk$M|SwtdEuX&=?Z08GLGT!N{L zkMbd~tdFXf_t8Wg#s&CQ^wDsrl8>S>w6c%-RiQTIuj-?7nDL{J&SGH=AFapRnm%gw zi;tGz88U18Xxto*TR_dIv5=lF@=?+f9~E8dqhFW#Xu)zH^;+ShN-OErY9Ec?=%YP< z(r0wp>?7}OKKf~|j~b%J+(Oq& z?8nE;K6-q`N4swNDDok3k>e4)z*hW+tj9i@fU6kt)JL^n`>6dJzJ5zT-VqNu-uvh> zrhlMD%=t*{PxS0RAAS8yU%&XMa9*n_=CdmJ2dkFkx5`|=s-z&RF5Rduidty(h<<=R?R1F7w-nt+1styVg6A z=x$ZBzE*WZP(Q2Q546fS$f}-$tr`ZeAy$<@Wh4!?Djl!z9m9WT-Vs*)gSe4awZL*b zg=-XZ;5eF(wrVRnjJ0a&c*ejy!Kz(24!=oO{e*X@JlU!dQ#cMgr!xOEtL9-1^3I?> zG{K&kRt=s-op8;usw4X0&|G5Avnm%d=Tjrb{_k;tRXcDL>5J$sj-ciet0rS1RxP#a z4oWO14^&*i92k#$E3Jw~{Z*{ZYU;(DHCElkbL3n{EUd&fJYP@0Hdr+jlW=gORi2xu z6`OGoF`MZbx}nDw&X28D-ABo7tTBe;*mmmKK|Lt7lQqF)G~H#@0<6QJ-Si5r_b_&^ zRmuCT%Dtby9JDF}qyHlBqxA3?H6Q0(MXM9UI!WHAth$bgr>$ym#;T2HSzA;&N6qK0 z3c0{Jgi;q-cMP~>Rl;R@iCKTM|B6*p@a8J(`;S$Hu9Ndkt0Hf4{-GYm<30-C;XJ&{ zx}(EA`f;Bg;=lv?@{n@`Z68@x?J?)@6RZA0;itqy$!Avm_}r@fIQD|IdS%tjH&(qx z_FKl_r*~G(eQ(tZl={H;*bdi6&LQX%Ylzl3h2Z~q&R{R{e6}k87v{knEd0vz4$tr( z!oSfk7{AkVT*q43biiQK1EWo8o;G#GA6_>7YO<*v7W&zgGq+7$LiifD@Eq4dc?`2D zBHSiNgiZA@3F(o1A7#^YEWx)J;>FrDAM+AyD(tptS3#SOp;#fCCSw8qD`L~5qBgxp z&EhsKM@ouKm+*6{O}Eh^js3`#Zqs)(%dlw$W|pw&LJga0*R<(AM*m_{$67Y|)V66U z{;OwGzh*X#!l#xt)#_x^W|Zu1!GT*m%UIq@y;S#E-|w={WsF#tEB( zPukQIeNJ&43Y?}NXKZ?lg=cMYowMm6ww))R3pVYz$eLWTX$=-#vuXXmHdVTA(@H$L zVbk@StmPe>8s4S8CpJyPVx&GL?`JkO#Sy%R=X0A{Vi%61=nI<$VjOb4w5d6|;vtH^ zvZ*W%Bkybagqe7WZ)p3*rtLU_thY8zz+B{gXH#Qz#3jVNCl(gtJv=|qSNw(ZsQi&} zSdGL_^ajK58YTa;$@-a?n1%;J|NL#=QWsJ1d?3#usAG->n73RTVwW~IEppeb3NwC@NTIsN> zfUjMb@R!rBSUgX}7eZFrB}!FE*%v8xf^BJB!}B6rL~=V-e!W9)i__qY{Ho(aT+DbcPnNp^ikRTp!(?OK#< zSGz)X{f7#L`MRiGjf-)7al7`W*cF#**CY){m zU~e_n1)t#fnK;$$Dp|v>${2$q=vb5f{$ke(w5ny-+}d`f)v;?0g6rBKdG1_e&VR`pWv<(~&S+NzX5cKYW7SRii{~hG zi*p8NQ27BpfgUo?Bj$m}6T8w;^cizKrx!0cM_$@h_?2D#-tzP19p}q?#-qgtyMF#? zSMN{Eg^T}D&u9Abjpu+Ix^Hl(lBYuxOb%T&JJi(T&;vBLIuu}YXsEwKV{$q)F2JFF zxg5Hk+oA4x9GZ@Qk($?`X4sA=7?;nXy*LS<9~}I?;LsOX@;kH!9fBNEutWR)C)%MC zF%H#?b;vWp!L@&fin|@kNOq`HL5KdvoyWLTL)9@62irSzpbK-ORX2wYv#wsK@UP{XCqxkTS}l!lT(X#-Y4p9Xx*= zS_hOmyh&ByykZQ0FNQEuQL7m1z#$LbvG-U7Jb1vmAZ@=J z!Y1rPP&bZ26BOv~t2kW5u-|<32b%Qo)lzio>8pMS?&Yfl41uw?ubgoA@l|tlLFc}{ zT8CZe(9c(WP_sXAU>wNtXpaU%d^PTOU%f}|VZM4f+*k1)q~@{ z`t_`@?p>l6|M;rbEngLV=&Ksfef8okwSM%~=&!z-;o;O$Ts1m*jqH@&;Z#11@^z}L z)2R*k08c-sieoYA`#Uue4}Wm#9fk)xwGbsjoSKEiP^U)X17?Rgl`Gt-+!0QVM(aqY z{)lm^P^?ptNz7fusf|V1Ud*X$*j?PI@N}o*Dmc}pqEl&=ovQYuQ`tW|)vdZyA8RQq)Yr-HjXRrxok-e7GHr@r=ds$f5-1`TxT!eFOv zVZ~6VVu$fKk{U)i)oQd;hA~dv8|ze!aZWWJPn?O=HOVRe$xgLIjww#np6Zlqx>L>3 z1uKy_n{jxJ-{&~xUO*i?=o6mcr=9d;ms8_$8gaXwDu$uR*u%Ditk+*oHN^^S!Tm!{ zwLikVM_IGuP9>jos_H4H>S6jB=0EGyGt|1~)UcaQwY}w(>9$kd(en=59?<89PVIWc z*vC%pCvfV@6Z-U=^X7$9hh8}~;~ndXULQFgPtoC%Q+;6l&&ls^PTfVBuTGu9l> zX>GKhmd5#MZ@iyoB>QQ0Q9tb}=BJe69GBv!e^UMApYErD8O()6C73JIPeZf(6rAm+ z;c%4p(;8UI_~}<1K$&uWnpxgYA(hDm*;W0t316`4CqG5}?5FA2hZn#2X+#}ACI9ND zYW@5)a+IHbn&PJ=4;UNlubmm z>n;kk^Vb;6K%1`qoYVe#G{9e1h7)IkznV|>*Ynl>n!Uzfht~S*^=9Tc=&y^o_MKx9 z;E_XPaLX%)e(=tr9;O`n45vAV43->vGcAY8PS2rwcmvJIp;DNDxyUy&hc=